PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Fanti, F; Currie, PJ; Badamgarav, D				Fanti, Federico; Currie, Philip J.; Badamgarav, Demchig			New Specimens of Nemegtomaia from the Baruungoyot and Nemegt Formations (Late Cretaceous) of Mongolia	PLOS ONE			English	Article							DJADOKHTA FORMATION; DINOSAUR BONE; HASANDONG FORMATION; INNER-MONGOLIA; BAYAN MANDAHU; THEROPODA; EGGS; OVIRAPTOROSAURIA; STRATIGRAPHY; DEPOSITS	Two new specimens of the oviraptorid theropod Nemegtomaia barsboldi from the Nemegt Basin of southern Mongolia are described. Specimen MPC-D 107/15 was collected from the upper beds of the Baruungoyot Formation (Campanian-Maastrichtian), and is a nest of eggs with the skeleton of the assumed parent of Nemegtomaia on top in brooding position. Much of the skeleton was damaged by colonies of dermestid coleopterans prior to its complete burial. However, diagnostic characters are recovered from the parts preserved, including the skull, partial forelimbs (including the left hand), legs, and distal portions of both feet. Nemegtomaia represents the fourth known genus of oviraptorid for which individuals have been found on nests of eggs. The second new specimen, MPC-D 107/16, was collected a few kilometers to the east in basal deposits of the Nemegt Formation, and includes both hands and femora of a smaller Nemegtomaia individual. The two formations and their diverse fossil assemblages have been considered to represent sequential time periods and different environments, but data presented here indicate partial overlap across the Baruungoyot-Nemegt transition. All other known oviraptorids from Mongolia and China are known exclusively from xeric or semi-arid environments. However, this study documents that Nemegtomaia is found in both arid/aeolian (Baruungoyot Formation) and more humid/fluvial (Nemegt Formation) facies.	[Fanti, Federico] Univ Bologna, Dipartimento Sci Terra & Geol Ambientali, Bologna, Italy; [Currie, Philip J.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Badamgarav, Demchig] Mongolian Acad Sci, Paleontol Ctr, Ulaanbaatar, Mongolia	University of Bologna; University of Alberta; Mongolian Academy of Sciences	Fanti, F (corresponding author), Univ Bologna, Dipartimento Sci Terra & Geol Ambientali, Via Zamboni, Bologna, Italy.	federico.fanti@unibo.it	Fanti, Federico/K-6624-2015; Currie, Philip J/A-2628-2014	Currie, Philip J/0000-0001-6857-3161; Fanti, Federico/0000-0002-2961-8301	Dinosaur Research Institute (Calgary); Museo Geologico Giovanni Capellini (Bologna, Italy); NSERC	Dinosaur Research Institute (Calgary); Museo Geologico Giovanni Capellini (Bologna, Italy); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported with funding by the Dinosaur Research Institute (Calgary), the Museo Geologico Giovanni Capellini (Bologna, Italy), and NSERC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JF, 1985, J ZOOL, V207, P53, DOI 10.1111/j.1469-7998.1985.tb04915.x; [Anonymous], [No title captured]; [Anonymous], 1970, PALAENTOL POL; [Anonymous], 1981, T JOINT SOVIET MONGO; Bader K, 2007, GEOL SOC AM ABSTR, V39, P18; Barsbold R., 1990, P249; Barsbold R., 1986, P210; Barsbold R., 1997, ENCY DINOSAURS, P505; BENTON MJ, 2000, AGE DINOSAURS RUSSIA, P22; Britt BB, 2008, ICHNOS, V15, P59, DOI 10.1080/10420940701193284; Burns ME, 2011, CRETACEOUS RES, V32, P174, DOI 10.1016/j.cretres.2010.11.007; Campobasso CP, 2001, FORENSIC SCI INT, V120, P18, DOI 10.1016/S0379-0738(01)00411-X; Carpenter K., 1994, DINOSAUR EGGS BABIES; Cheng YN, 2008, ACTA GEOL SIN-ENGL, V82, P1089; Chiappe Luis M., 1999, Bulletin of the American Museum of Natural History, V242, P1; Clark James M., 1999, American Museum Novitates, V3265, P1; Clark JM, 2002, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2002)364<0001:CAOCOT>2.0.CO;2; Clark JM, 2001, J VERTEBR PALEONTOL, V21, P209, DOI 10.1671/0272-4634(2001)021[0209:TNOTOU]2.0.CO;2; CURRIE PJ, 1993, CAN J EARTH SCI, V30, P2255, DOI 10.1139/e93-196; Dashzeveg D, 2005, AM MUS NOVIT, V3498, P31; Dong ZM, 1996, CAN J EARTH SCI, V33, P631, DOI 10.1139/e96-046; Eberth David A., 2009, [Journal of the paleontological Society of Korea, 고생물학회지], V25, P1; Erickson GM, 2007, BIOL LETTERS, V3, P558, DOI 10.1098/rsbl.2007.0254; Fastovsky DE, 1997, PALAIOS, V12, P59, DOI 10.2307/3515294; GRADZINSKI R, 1977, Acta Geologica Polonica, V27, P281; GRADZINSKI R, 1974, SEDIMENT GEOL, V12, P249, DOI 10.1016/0037-0738(74)90021-9; Gradzinski R., 1974, PALAENTOL POL, V30, P111; Grellet-Tinner G, 2006, PALAEOGEOGR PALAEOCL, V232, P294, DOI 10.1016/j.palaeo.2005.10.029; Hasegawa H, 2009, J ASIAN EARTH SCI, V35, P13, DOI 10.1016/j.jseaes.2008.11.010; Hasiotis ST, 1997, COMB ROCK MOUNT SOUT, V29, p13A; Hasiotis Stephen T., 1999, P193; Hicks JF, 2001, GSA ANN M; Hopp TP, 2004, LIFE O PAST, P234; Hopp TP, 1998, DIN S AC NAT SCI PHI; JERZYKIEWICZ T, 1991, CRETACEOUS RES, V12, P345, DOI 10.1016/0195-6671(91)90015-5; JERZYKIEWICZ T, 1993, CAN J EARTH SCI, V30, P2180, DOI 10.1139/e93-190; Jerzykiewicz T., 2001, AGE DINOSAURS RUSSIA, P279; Johnston PA, 1997, CAN J EARTH SCI, V30, P2180; Khand Yo., 2000, Developments in Palaeontology and Stratigraphy, V17, P49; Kielan-Jaworowska Z., 1968, PALEONTOLOGICA POLON, V19, P171; Kielan-Jaworowska Z, 1974, PALEONTOLOGICA POLON, V30, P24; Kirkland James I., 1998, Journal of Vertebrate Paleontology, V18, p56A; Kirkland James I., 2010, P509; Kurzanov SM, 1989, DINOSAUR TRACKS TRAC; Longrich NR, 2010, PALAEONTOLOGY, V53, P945, DOI 10.1111/j.1475-4983.2010.00968.x; Lu J. C, 2005, OVIRAPTORID DINOSAUR, P1; Lu JC, 2002, J VERTEBR PALEONTOL, V22, P871, DOI 10.1671/0272-4634(2002)022[0871:ANOTOF]2.0.CO;2; Lu JC, 2005, LIFE O PAST, P256; Lu JC, 2005, ACTA PALAEONTOLOGICA, V44, P412; Lu Junchang, 2005, Bulletin of the National Science Museum Series C (Geology & Paleontology), V31, P51; Lu Junchang, 2004, Bulletin of the National Science Museum Series C (Geology & Paleontology), V30, P95; Lue Junchang, 2002, P175; Makovicky PJ, 2008, CLADISTICS, V24, P350, DOI 10.1111/j.1096-0031.2007.00184.x; MARTIN LD, 1995, PALAEOGEOGR PALAEOCL, V113, P303, DOI 10.1016/0031-0182(95)00058-T; Maryanska T, 2002, ACTA PALAEONTOL POL, V47, P97; Mikhailov Konstantin, 1994, P88; Moratalla J.J., 1994, P37; NORELL MA, 1995, NATURE, V378, P774, DOI 10.1038/378774a0; NORELL MA, 1994, SCIENCE, V266, P779, DOI 10.1126/science.266.5186.779; NORELL MA, 1997, ENCY DINOSAURS, P100; Norell Mark A., 2001, American Museum Novitates, V3315, P1, DOI 10.1206/0003-0082(2001)315<0001:AEODTF>2.0.CO;2; OSBORN H.F., 1924, AM MUS NOVIT, V144, P1; Osmfilska H., 1997, ENCY DINOSAURS, P471; Osmolska H, 2004, DINOSAURIA, 2ND EDITION, P165; OsmuElska H., 1997, ENCY DINOSAURS, P41; Paik IS, 2001, CRETACEOUS RES, V22, P627, DOI 10.1006/cres.2001.0282; Paik IS, 2000, PALAEOGEOGR PALAEOCL, V157, P213, DOI 10.1016/S0031-0182(99)00166-2; REGAL PJ, 1975, Q REV BIOL, V50, P35, DOI 10.1086/408299; Rogers R.R., 1992, Journal of Vertebrate Paleontology, V12, P528; SABATH K, 1991, Acta Palaeontologica Polonica, V36, P151; Saneyoshi M, PALAEOGEOGR IN PRESS, V311, P38; Sato T, 2005, SCIENCE, V308, P375, DOI 10.1126/science.1110578; Shuvalov V.F., 2001, AGE DINOSAURS RUSSIA, P256; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Szczechura J., 1978, PALAEONTOLOGICA POLO, V38, P65; Varricchio DJ, 2008, SCIENCE, V322, P1826, DOI 10.1126/science.1163245; Varricchio DJ, 1997, NATURE, V385, P247, DOI 10.1038/385247a0; Weishampel DB, 2008, J VERTEBR PALEONTOL, V28, P1110, DOI 10.1671/0272-4634-28.4.1110; Xu X, 2007, NATURE, V447, P844, DOI 10.1038/nature05849; Zanno LE, 2005, J VERTEBR PALEONTOL, V25, P897, DOI 10.1671/0272-4634(2005)025[0897:ANOTMF]2.0.CO;2; Zhao Zi-kui, 1975, Vertebrata Palasiatica, V13, P105	81	63	65	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31330	10.1371/journal.pone.0031330	http://dx.doi.org/10.1371/journal.pone.0031330			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347465	Green Submitted, gold, Green Published			2022-12-27	WOS:000302730100062
J	Furtado, CM; Marcondes, MC; Sola-Penna, M; de Souza, MLS; Zancan, P				Furtado, Cristiane M.; Marcondes, Mariah C.; Sola-Penna, Mauro; de Souza, Maisa L. S.; Zancan, Patricia			Clotrimazole Preferentially Inhibits Human Breast Cancer Cell Proliferation, Viability and Glycolysis	PLOS ONE			English	Article							GROWTH-FACTOR; GLUCOSE-METABOLISM; LUNG-CARCINOMA; 6-PHOSPHOFRUCTO-1-KINASE; CYTOSKELETON; EXPRESSION; APOPTOSIS; ATP; CONTRIBUTES; DETACHMENT	Background: Clotrimazole is an azole derivative with promising anti-cancer effects. This drug interferes with the activity of glycolytic enzymes altering their cellular distribution and inhibiting their activities. The aim of the present study was to analyze the effects of clotrimazole on the growth pattern of breast cancer cells correlating with their metabolic profiles. Methodology/Principal Findings: Three cell lines derived from human breast tissue (MCF10A, MCF-7 and MDA-MB-231) that present increasingly aggressive profiles were used. Clotrimazole induces a dose-dependent decrease in glucose uptake in all three cell lines, with K-i values of 114.3 +/- 11.7, 77.1 +/- 7.8 and 37.8 +/- 4.2 mu M for MCF10A, MCF-7 and MDA-MB-231, respectively. Furthermore, the drug also decreases intracellular ATP content and inhibits the major glycolytic enzymes, hexokinase, phosphofructokinase-1 and pyruvate kinase, especially in the highly metastatic cell line, MDA-MB-231. In this last cell lineage, clotrimazole attenuates the robust migratory response, an effect that is progressively attenuated in MCF-7 and MCF10A, respectively. Moreover, clotrimazole reduces the viability of breast cancer cells, which is more pronounced on MDA-MB-231. Conclusions/Significance: Clotrimazole presents deleterious effects on two human breast cancer cell lines metabolism, growth and migration, where the most aggressive cell line is more affected by the drug. Moreover, clotrimazole presents little or no effect on a non-tumor human breast cell line. These results suggest, at least for these three cell lines studied, that the more aggressive the cell is the more effective clotrimazole is.	[Furtado, Cristiane M.; Marcondes, Mariah C.; Zancan, Patricia] Univ Fed Rio de Janeiro, Fac Farm, Dept Farmacos, Oncol Mol Lab, Rio De Janeiro, Brazil; [Sola-Penna, Mauro] Univ Fed Rio de Janeiro, Fac Farm, Dept Farmacos, LabECoM, Rio De Janeiro, Brazil; [de Souza, Maisa L. S.] IFRJ, Unidade Nilopolis, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Instituto Federal do Rio de Janeiro (IFRJ)	Furtado, CM (corresponding author), Univ Fed Rio de Janeiro, Fac Farm, Dept Farmacos, Oncol Mol Lab, Rio De Janeiro, Brazil.	pzancan@ufrj.br	Zancan, Patricia/Q-6281-2016; Sola-Penna, Mauro/E-8221-2011	Zancan, Patricia/0000-0002-0503-028X; Sola-Penna, Mauro/0000-0001-9796-6829	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullaev IF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012304; Almeida A, 2010, P NATL ACAD SCI USA, V107, P738, DOI 10.1073/pnas.0913668107; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Boros LG, 2000, CANCER RES, V60, P1183; Chan SW, 2008, CANCER RES, V68, P2592, DOI 10.1158/0008-5472.CAN-07-2696; Chen Z, 2009, BBA-BIOENERGETICS, V1787, P553, DOI 10.1016/j.bbabio.2009.03.003; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Coelho WS, 2007, MOL GENET METAB, V92, P364, DOI 10.1016/j.ymgme.2007.07.010; El-Bacha T, 2003, MOL GENET METAB, V79, P294, DOI 10.1016/S1096-7192(03)00117-3; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Garland JM, 1997, J BIOL CHEM, V272, P4680, DOI 10.1074/jbc.272.8.4680; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Geschwind JFH, 2002, CANCER RES, V62, P3909; Gillies RJ, 2008, J NUCL MED, V49, p24S, DOI 10.2967/jnumed.107.047258; GlassMarmor L, 1996, EUR J PHARMACOL, V313, P265, DOI 10.1016/0014-2999(96)00526-2; GlassMarmor L, 1997, EUR J PHARMACOL, V328, P241, DOI 10.1016/S0014-2999(97)83051-8; Gonin-Giraud S, 2002, CELL DEATH DIFFER, V9, P1147, DOI 10.1038/sj.cdd.4401079; Hatzivassiliou G, 2005, CANCER CELL, V8, P311, DOI 10.1016/j.ccr.2005.09.008; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Kennelly KP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021365; Khaitan D, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-258; Khalid MH, 2005, J NEUROSURG, V103, P79, DOI 10.3171/jns.2005.103.1.0079; Kim JW, 2007, MOL CELL BIOL, V27, P7381, DOI 10.1128/MCB.00440-07; Kim JW, 2006, CANCER RES, V66, P8927, DOI 10.1158/0008-5472.CAN-06-1501; Ko YH, 2004, BIOCHEM BIOPH RES CO, V324, P269, DOI 10.1016/j.bbrc.2004.09.047; Lee HC, 2009, INT J MOL SCI, V10, P674, DOI 10.3390/ijms10020674; Leite TC, 2011, FEBS LETT, V585, P92, DOI 10.1016/j.febslet.2010.11.009; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Liu YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002722; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Majewski N, 2004, MOL CELL, V16, P819, DOI 10.1016/j.molcel.2004.11.014; Mannava S, 2008, CELL CYCLE, V7, P2392, DOI 10.4161/cc.6390; Marin-Hernandez A, 2006, FEBS J, V273, P1975, DOI 10.1111/j.1742-4658.2006.05214.x; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Meadows AL, 2008, BIOTECHNOL PROGR, V24, P334, DOI 10.1021/bp070301d; Meira DD, 2005, MOL GENET METAB, V84, P354, DOI 10.1016/j.ymgme.2004.11.012; ODDIS CV, 1995, BIOCHEM BIOPH RES CO, V213, P1002, DOI 10.1006/bbrc.1995.2228; Ouadid-Ahidouch H, 2004, BIOCHEM BIOPH RES CO, V316, P244, DOI 10.1016/j.bbrc.2004.02.041; Penso J, 2002, EUR J PHARMACOL, V451, P227, DOI 10.1016/S0014-2999(02)02103-9; Penso J, 2002, MOL GENET METAB, V76, P181, DOI 10.1016/S1096-7192(02)00046-X; Schwartz M K, 1968, Methods Biochem Anal, V16, P183, DOI 10.1002/9780470110348.ch3; Shaw RJ, 2006, CURR OPIN CELL BIOL, V18, P598, DOI 10.1016/j.ceb.2006.10.005; Sola-Penna M, 1998, ARCH BIOCHEM BIOPHYS, V360, P10, DOI 10.1006/abbi.1998.0906; Sola-Penna M, 2010, IUBMB LIFE, V62, P791, DOI 10.1002/iub.393; Spitz GA, 2009, BIOCHEM PHARMACOL, V77, P46, DOI 10.1016/j.bcp.2008.09.020; Telang S, 2006, ONCOGENE, V25, P7225, DOI 10.1038/sj.onc.1209709; Tong XM, 2009, P NATL ACAD SCI USA, V106, P21660, DOI 10.1073/pnas.0911316106; Tong XM, 2009, CURR OPIN GENET DEV, V19, P32, DOI 10.1016/j.gde.2009.01.002; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wulff H, 2000, P NATL ACAD SCI USA, V97, P8151, DOI 10.1073/pnas.97.14.8151; Zancan P, 2010, MOL GENET METAB, V100, P372, DOI 10.1016/j.ymgme.2010.04.006; Zhang WJ, 2002, DRUG METAB DISPOS, V30, P314, DOI 10.1124/dmd.30.3.314	53	78	81	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e30462	10.1371/journal.pone.0030462	http://dx.doi.org/10.1371/journal.pone.0030462			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347377	Green Submitted, gold, Green Published			2022-12-27	WOS:000302730100012
J	Karatolos, N; Williamson, MS; Denholm, I; Gorman, K; Ffrench-Constant, RH; Bass, C				Karatolos, Nikos; Williamson, Martin S.; Denholm, Ian; Gorman, Kevin; Ffrench-Constant, Richard H.; Bass, Chris			Over-Expression of a Cytochrome P450 Is Associated with Resistance to Pyriproxyfen in the Greenhouse Whitefly Trialeurodes vaporariorum	PLOS ONE			English	Article							INSECT GROWTH-REGULATOR; DETOXIFICATION GENES; JUVENILE-HORMONE; AEDES-AEGYPTI; HOMOPTERA; HEMIPTERA; ALEYRODIDAE; MECHANISMS; TOLERANCE; BIOTYPE	Background: The juvenile hormone mimic, pyriproxyfen is a suppressor of insect embryogenesis and development, and is effective at controlling pests such as the greenhouse whitefly Trialeurodes vaporariorum (Westwood) which are resistant to other chemical classes of insecticides. Although there are reports of insects evolving resistance to pyriproxyfen, the underlying resistance mechanism(s) are poorly understood. Results: Bioassays against eggs of a German (TV8) population of T. vaporariorum revealed a moderate level (21-fold) of resistance to pyriproxyfen. This is the first time that pyriproxyfen resistance has been confirmed in this species. Sequential selection of TV8 rapidly generated a strain (TV8pyrsel) displaying a much higher resistance ratio (>4000-fold). The enzyme inhibitor piperonyl butoxide (PBO) suppressed this increased resistance, indicating that it was primarily mediated via metabolic detoxification. Microarray analysis identified a number of significantly over-expressed genes in TV8pyrsel as candidates for a role in resistance including cytochrome-P450 dependent monooxygenases (P450s). Quantitative PCR highlighted a single P450 gene (CYP4G61) that was highly over-expressed (81.7-fold) in TV8pyrsel. Conclusion: Over-expression of a single cytochrome P450 gene (CYP4G61) has emerged as a strong candidate for causing the enhanced resistance phenotype. Further work is needed to confirm the role of the encoded P450 enzyme CYP4G61 in detoxifying pyriproxyfen.	[Karatolos, Nikos; Williamson, Martin S.; Denholm, Ian; Gorman, Kevin; Bass, Chris] Rothamsted Res, Harpenden, Herts, England; [Ffrench-Constant, Richard H.] Univ Exeter, Penryn, Cornwall, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; University of Exeter	Karatolos, N (corresponding author), Rothamsted Res, Harpenden, Herts, England.	nikolaos.karatolos@rothamsted.ac.uk		Denholm, Ian/0000-0001-9797-874X; Bass, Chris/0000-0002-2590-1492; GORMAN, kevin/0000-0002-2684-6974; ffrench-Constant, Richard/0000-0001-5385-9888	Biotechnology and Biological Sciences Research Council (BBSRC) of the United Kingdom; BBSRC [BB/G023352/1]; Bayer CropScience; BBSRC [BBS/E/C/00005193] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G023352/1, BBS/E/C/00005193] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC) of the United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Bayer CropScience(Bayer AG); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Nikos Karatolos was funded by a CASE PhD studentship from the Biotechnology and Biological Sciences Research Council (BBSRC) of the United Kingdom, with industrial support from Bayer CropScience. Chris Bass contributed funding through a fellowship grant (BB/G023352/1) from the BBSRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors received funding from a commercial source (Bayer CropScience). There are no patents, products in development, or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	ANDRIGHETTI MTM, 2008, DENGUE B, V32, P186; [Anonymous], 2008, INSECT RESIST MANAG; Bi JL, 2007, PEST MANAG SCI, V63, P747, DOI 10.1002/ps.1405; BULL DL, 1994, J ECON ENTOMOL, V87, P1407, DOI 10.1093/jee/87.6.1407; BYRNE DN, 1990, WHITEFLIES : THEIR BIONOMICS, PEST STATUS AND MANAGEMENT, P227; Danforth BN, 1998, MOL BIOL EVOL, V15, P225, DOI 10.1093/oxfordjournals.molbev.a025920; Denholm I, 1998, PHILOS T R SOC B, V353, P1757, DOI 10.1098/rstb.1998.0328; Devine GJ, 1999, PESTIC SCI, V55, P405, DOI 10.1002/(SICI)1096-9063(199904)55:4<405::AID-PS923>3.0.CO;2-M; Dubrovsky EB, 2005, TRENDS ENDOCRIN MET, V16, P6, DOI 10.1016/j.tem.2004.11.003; Feyereisen R., 2005, P1; Ghanim M, 2007, PEST MANAG SCI, V63, P776, DOI 10.1002/ps.1410; Gorman K, 2007, PEST MANAG SCI, V63, P555, DOI 10.1002/ps.1364; GOTOH O, 1992, J BIOL CHEM, V267, P83; Horowitz AR, 1999, PESTIC SCI, V55, P272, DOI 10.1002/(SICI)1096-9063(199903)55:3&lt;272::AID-PS908&gt;3.0.CO;2-; ISHAAYA I, 1995, PESTIC SCI, V43, P227, DOI 10.1002/ps.2780430308; ISHAAYA I, 1992, J ECON ENTOMOL, V85, P2113, DOI 10.1093/jee/85.6.2113; ISHAAYA I, 1994, J ECON ENTOMOL, V87, P1185, DOI 10.1093/jee/87.5.1185; Jones DR, 2003, EUR J PLANT PATHOL, V109, P195, DOI 10.1023/A:1022846630513; Karatolos N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-56; Karatolos N, 2010, PEST MANAG SCI, V66, P1304, DOI 10.1002/ps.2014; Karunker I, 2008, INSECT BIOCHEM MOLEC, V38, P634, DOI 10.1016/j.ibmb.2008.03.008; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Ma W, 2010, J ECON ENTOMOL, V103, P158, DOI 10.1603/EC09122; Marcombe S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-494; Nelson David R., 2009, Human Genomics, V4, P59; Oakeshott J.G., 2005, COMPREHENSIVE MOL IN, P309, DOI [10.1016/B0-44-451924-6/00073-9, DOI 10.1016/B0-44-451924-6/00073-9]; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pittendrigh B, 1997, INSECT BIOCHEM MOLEC, V27, P507, DOI 10.1016/S0965-1748(97)00025-8; Poupardin R, 2008, INSECT BIOCHEM MOLEC, V38, P540, DOI 10.1016/j.ibmb.2008.01.004; Pridgeon JW, 2003, GENE, V314, P157, DOI 10.1016/S0378-1119(03)00725-X; Puinean AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000999; Ranson H., 2005, P383; Ranson H, 2002, SCIENCE, V298, P179, DOI 10.1126/science.1076781; Riaz MA, 2009, AQUAT TOXICOL, V93, P61, DOI 10.1016/j.aquatox.2009.03.005; SHEMSHEDINI L, 1990, P NATL ACAD SCI USA, V87, P2072, DOI 10.1073/pnas.87.6.2072; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wardlow LR, 1985, MED FACT LANDBOUW RI, V50, P164; Yuen T, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e48; Zhang L, 1998, ARCH INSECT BIOCHEM, V37, P215, DOI 10.1002/(SICI)1520-6327(1998)37:3&lt;215::AID-ARCH4&gt;3.0.CO;2-R; Zhu Fang, 2008, BMC Physiology, V8, P18, DOI 10.1186/1472-6793-8-18	40	48	56	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31077	10.1371/journal.pone.0031077	http://dx.doi.org/10.1371/journal.pone.0031077			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347432	Green Submitted, Green Published, gold			2022-12-27	WOS:000302730100040
J	Teodorovic, LS; Riccardi, C; Torres, RM; Pelanda, R				Teodorovic, Lenka Sinik; Riccardi, Carlo; Torres, Raul M.; Pelanda, Roberta			Murine B Cell Development and Antibody Responses to Model Antigens Are Not Impaired in the Absence of the TNF Receptor GITR	PLOS ONE			English	Article							T-CELLS; MOUSE; EXPRESSION; IMMUNITY; FAMILY; SUPERFAMILY; PROTEIN; MARROW; LIGAND; MICE	The Glucocorticoid-Induced Tumor necrosis factor Receptor GITR, a member of the tumor necrosis factor receptor superfamily, has been shown to be important in modulating immune responses in the context of T cell immunity. B lymphocytes also express GITR, but a role of GITR in humoral immunity has not been fully explored. To address this question, we performed studies to determine the kinetics of GITR expression on naive and stimulated B cells and the capacity of B cells to develop and mount antibody responses in GITR(-/-) mice. Results of our studies indicate that all mature B cells express GITR on the cell surface, albeit at different levels. Expression of GITR on naive mature B cells is upregulated by BCR signaling, but is counteracted by helper T cell-related factors and other inflammatory signals in vitro. In line with these findings, expression of GITR on germinal center and memory B cells is lower than that on naive B cells. However, the expression of GITR is strongly upregulated in plasma cells. Despite these differences in GITR expression, the absence of GITR has no effect on T cell-dependent and T cell-independent antibody responses to model antigens in GITR(-/-) mice, or on B cell activation and proliferation in vitro. GITR deficiency manifests only with a slight reduction of mature B cell numbers and increased turnover of naive B cells, suggesting that GITR slightly contributes to mature B cell homeostasis. Overall, our data indicate that GITR does not play a significant role in B cell development and antibody responses to T-dependent and independent model antigens within the context of a GITR-deficient genetic background.	[Teodorovic, Lenka Sinik; Torres, Raul M.; Pelanda, Roberta] Natl Jewish Hlth, Integrated Dept Immunol, Denver, CO 80206 USA; [Teodorovic, Lenka Sinik; Torres, Raul M.; Pelanda, Roberta] Univ Colorado, Sch Med, Denver, CO USA; [Riccardi, Carlo] Univ Perugia, Dept Clin & Expt Med, I-06100 Perugia, Italy	National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Perugia	Teodorovic, LS (corresponding author), Natl Jewish Hlth, Integrated Dept Immunol, Denver, CO 80206 USA.	pelandar@njhealth.org	Riccardi, Carlo/N-4610-2014	Riccardi, Carlo/0000-0001-9257-3997	National Institutes of Health (NIH) [PO1 AI022295, RO1 AI052310, RO1 AI052157]; NIH; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI022295, R01AI018785, R01AI052310, R01AI052157, T32AI007405] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) grants PO1 AI022295, RO1 AI052310 to RP, and RO1 AI052157 to RMT. LST was partly supported by a T32 NIH training grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; ALLMAN DM, 1993, J IMMUNOL, V151, P4431; Bossen C, 2006, J BIOL CHEM, V281, P13964, DOI 10.1074/jbc.M601553200; Cote AL, 2011, J IMMUNOL, V186, P275, DOI 10.4049/jimmunol.1001308; FORSTER I, 1990, P NATL ACAD SCI USA, V87, P4781, DOI 10.1073/pnas.87.12.4781; Fulcher DA, 1997, EUR J IMMUNOL, V27, P1188, DOI 10.1002/eji.1830270521; Holl TM, 2010, J IMMUNOL METHODS, V354, P53, DOI 10.1016/j.jim.2010.01.007; Hoyer BF, 2004, J EXP MED, V199, P1577, DOI 10.1084/jem.20040168; Ko K, 2005, J EXP MED, V202, P885, DOI 10.1084/jem.20050940; La S, 2005, EXP MOL MED, V37, P193, DOI 10.1038/emm.2005.26; McHugh RS, 2002, IMMUNITY, V16, P311, DOI 10.1016/S1074-7613(02)00280-7; Nocentini G, 2005, EUR J IMMUNOL, V35, P1016, DOI 10.1002/eji.200425818; Nocentini G, 2000, DNA CELL BIOL, V19, P205, DOI 10.1089/104454900314474; Ponte JF, 2010, IMMUNOLOGY, V130, P231, DOI 10.1111/j.1365-2567.2009.03228.x; RISSO A, 1991, J IMMUNOL, V146, P4105; Ronchetti S, 2007, J IMMUNOL, V179, P5916, DOI 10.4049/jimmunol.179.9.5916; Shimizu J, 2002, NAT IMMUNOL, V3, P135, DOI 10.1038/ni759; Snell LM, 2010, J IMMUNOL, V185, P7223, DOI 10.4049/jimmunol.1001912; Stephens GL, 2004, J IMMUNOL, V173, P5008, DOI 10.4049/jimmunol.173.8.5008; Swanson CL, 2010, J EXP MED, V207, P1485, DOI 10.1084/jem.20092695; Tone M, 2003, P NATL ACAD SCI USA, V100, P15059, DOI 10.1073/pnas.2334901100; Velez MG, 2007, J IMMUNOL, V179, P1049, DOI 10.4049/jimmunol.179.2.1049; Zhan YF, 2008, J IMMUNOL, V181, P5405, DOI 10.4049/jimmunol.181.8.5405	23	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2012	7	2							e31632	10.1371/journal.pone.0031632	http://dx.doi.org/10.1371/journal.pone.0031632			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LV	22328941	Green Submitted, Green Published, gold			2022-12-27	WOS:000302179300027
J	Banerjee, S; Chakraborty, P; Saha, P; Bandyopadhyay, SA; Banerjee, S; Kabir, SN				Banerjee, Sayani; Chakraborty, Pratip; Saha, Piyali; Bandyopadhyay, Soma Aditya; Banerjee, Sutapa; Kabir, Syed N.			Ovotoxic Effects of Galactose Involve Attenuation of Follicle-Stimulating Hormone Bioactivity and Up-Regulation of Granulosa Cell p53 Expression	PLOS ONE			English	Article							PREMATURE OVARIAN FAILURE; DEFECTIVE GALACTOSYLATION; HYPERGONADOTROPIC HYPOGONADISM; SERUM TRANSFERRIN; GONADAL-FUNCTION; MENSTRUAL-CYCLE; FEMALE-PATIENTS; RAT; FSH; DIFFERENTIATION	Clinical evidence suggests an association between galactosaemia and premature ovarian insufficiency (POI); however, the mechanism still remains unresolved. Experimental galactose toxicity in rats produces an array of ovarian dysfunction including ovarian development with deficient follicular reserve and follicular resistance to gonadotrophins that characterize the basic tenets of human POI. The present investigation explores if galactose toxicity in rats attenuates the bioactivity of gonadotrophins or interferes with their receptor competency, and accelerates the rate of follicular atresia. Pregnant rats were fed isocaloric food-pellets supplemented with or without 35% D-galactose from day-3 of gestation and continuing through weaning of the litters. The 35-day old female litters were autopsied. Serum galactose-binding capacity, galactosyltransferase (GalTase) activity, and bioactivity of FSH and LH together with their receptor competency were assessed. Ovarian follicular atresia was evaluated in situ by TUNEL. The in vitro effects of galactose were studied in isolated whole follicles in respect of generation of reactive oxygen species (ROS) and expression of caspase 3, and in isolated granulosa cells in respect of mitochondrial membrane potential, expression of p53, and apoptosis. The rats prenatally exposed to galactose exhibited significantly decreased serum GalTase activity and greater degree of galactose-incorporation capacity of sera proteins. LH biopotency and LH-FSH receptor competency were comparable between the control and study population, but the latter group showed significantly attenuated FSH bioactivity and increased rate of follicular atresia. In culture, galactose increased follicular generation of ROS and expression of caspase 3. In isolated granulosa cells, galactose disrupted mitochondrial membrane potential, stimulated p53 expression, and induced apoptosis in vitro; however co-treatment with either FSH or estradiol significantly prevented galactose-induced granulosa cell p53 expression. We conclude that the ovotoxic effects of galactose involves attenuation of FSH bioactivity that renders the ovary resistant to gonadotrophins leading to increased granulosa cell expression of p53 and follicular atresia.	[Banerjee, Sayani; Saha, Piyali; Bandyopadhyay, Soma Aditya; Banerjee, Sutapa; Kabir, Syed N.] CSIR Indian Inst Chem Biol, Kolkata, W Bengal, India; [Chakraborty, Pratip] Inst Reprod Med, Dept Infertil, Kolkata, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Banerjee, S (corresponding author), CSIR Indian Inst Chem Biol, Kolkata, W Bengal, India.	snkabir@iicb.res.in			Department of Science and Technology, New Delhi, India [SP/SO/B31/97]	Department of Science and Technology, New Delhi, India(Department of Science & Technology (India))	This study was supported by grants from Department of Science and Technology (SP/SO/B31/97), New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anasti JN, 1998, FERTIL STERIL, V70, P1, DOI 10.1016/S0015-0282(98)00099-5; ANDREE HAM, 1990, J BIOL CHEM, V265, P4923; Anobile CJ, 1998, MOL HUM REPROD, V4, P631, DOI 10.1093/molehr/4.7.631; Bandyopadhyay S, 2003, HUM REPROD, V18, P276, DOI 10.1093/humrep/deg058; Bandyopadhyay S, 2003, HUM REPROD, V18, P2031, DOI 10.1093/humrep/deg414; BRETSCHER MS, 1972, NATURE-NEW BIOL, V236, P11, DOI 10.1038/newbio236011a0; Campbell BK, 2010, REPRODUCTION, V140, P721, DOI 10.1530/REP-10-0185; Campbell BK, 2010, REPRODUCTION, V140, P541, DOI 10.1530/REP-10-0146; Charlwood J, 1998, GLYCOBIOLOGY, V8, P351, DOI 10.1093/glycob/8.4.351; CHEN YT, 1984, PEDIATR RES, V18, P345, DOI 10.1203/00006450-198404000-00008; COSSARIZZA A, 1993, BIOCHEM BIOPH RES CO, V197, P40, DOI 10.1006/bbrc.1993.2438; CRAMER DW, 1989, FERTIL STERIL, V51, P609; Creus S, 1996, CLIN ENDOCRINOL, V44, P181, DOI 10.1046/j.1365-2265.1996.646467.x; DAHL KD, 1987, J CLIN ENDOCR METAB, V64, P486, DOI 10.1210/jcem-64-3-486; DOBBIE JA, 1990, ANN CLIN BIOCHEM, V27, P274, DOI 10.1177/000456329002700317; Forges T, 2006, HUM REPROD UPDATE, V12, P573, DOI 10.1093/humupd/dml031; FRASER I S, 1986, Clinical Reproduction and Fertility, V4, P133; FREILICH LS, 1977, J CELL BIOL, V72, P655, DOI 10.1083/jcb.72.3.655; Fridovich-Keil JL, 2011, J INHERIT METAB DIS, V34, P357, DOI 10.1007/s10545-010-9221-4; GIBSON JB, 1995, EUR J PEDIATR, V154, pS14, DOI 10.1007/BF02143797; Gilchrist RB, 2008, HUM REPROD UPDATE, V14, P159, DOI 10.1093/humupd/dmm040; GITZELMANN R, 1984, ENZYME, V32, P37, DOI 10.1159/000469448; Gubbels CS, 2011, J INHERIT METAB DIS, V34, P387, DOI 10.1007/s10545-010-9180-9; Guerrero NV, 2000, J PEDIATR-US, V137, P833, DOI 10.1067/mpd.2000.109148; HABERLAN.C, 1971, J NEUROPATH EXP NEUR, V30, P431, DOI 10.1097/00005072-197107000-00009; Hussein MR, 2005, HUM REPROD UPDATE, V11, P162, DOI 10.1093/humupd/dmi001; JAEKEN J, 1992, LANCET, V340, P1472, DOI 10.1016/0140-6736(92)92664-2; JIA XC, 1986, ENDOCRINOLOGY, V119, P1570, DOI 10.1210/endo-119-4-1570; KAUFMAN FR, 1981, NEW ENGL J MED, V304, P994, DOI 10.1056/NEJM198104233041702; KAUFMAN FR, 1988, J PEDIATR-US, V112, P754, DOI 10.1016/S0022-3476(88)80697-8; KESSEL B, 1988, J CLIN ENDOCR METAB, V66, P361, DOI 10.1210/jcem-66-2-361; KIM YS, 1972, J CLIN INVEST, V51, P2033, DOI 10.1172/JCI107009; Kishi H, 1998, FEBS LETT, V422, P274, DOI 10.1016/S0014-5793(98)00023-4; Lai KW, 2003, CELL TISSUE RES, V311, P417, DOI 10.1007/s00441-002-0689-6; Liu GT, 2006, REPROD TOXICOL, V21, P26, DOI 10.1016/j.reprotox.2005.07.001; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAGOFFIN DA, 1982, J BIOL CHEM, V257, P4507; MAGOFFIN DA, 1988, ENDOCRINOLOGY, V122, P2345, DOI 10.1210/endo-122-5-2345; Mazerbourg S, 2003, MOL CELL ENDOCRINOL, V202, P31, DOI 10.1016/S0303-7207(03)00058-3; McGee EA, 2001, BIOL REPROD, V64, P293, DOI 10.1095/biolreprod64.1.293; Menezo YJR, 2004, J ASSIST REPROD GEN, V21, P89, DOI 10.1023/B:JARG.0000027020.28592.7b; NG WG, 1989, J INHERIT METAB DIS, V12, P257, DOI 10.1007/BF01799215; O'Shaughnessy PJ, 2010, REPRODUCTION, V139, P177, DOI 10.1530/REP-09-0377; ORNSTEIN KS, 1992, PEDIATR RES, V31, P508, DOI 10.1203/00006450-199205000-00020; PETRY K, 1991, BIOCHEM MED METAB B, V46, P93, DOI 10.1016/0885-4505(91)90054-O; Prestoz LLC, 1997, EUR J PEDIATR, V156, P116, DOI 10.1007/s004310050568; Quirk S M, 2004, J Anim Sci, V82 E-Suppl, pE40; REDDI K, 1990, CLIN ENDOCRINOL, V33, P547, DOI 10.1111/j.1365-2265.1990.tb03892.x; Rubio-Gozalbo ME, 2010, HUM REPROD UPDATE, V16, P177, DOI 10.1093/humupd/dmp038; SAIRAM MR, 1989, FASEB J, V3, P1915, DOI 10.1096/fasebj.3.8.2542111; Sanders RD, 2009, FERTIL STERIL, V92, P344, DOI 10.1016/j.fertnstert.2008.04.060; SEGAL S, 1995, EUR J PEDIATR, V154, pS82, DOI 10.1007/BF02143810; SEGAL S, 1995, EUR J PEDIATR, V154, pS65, DOI 10.1007/BF02143806; Sharma RK, 2009, J MICROSC-OXFORD, V236, P236, DOI 10.1111/j.1365-2818.2009.03281.x; Sturiale L, 2005, GLYCOBIOLOGY, V15, P1268, DOI 10.1093/glycob/cwj021; SWARTZ WJ, 1988, FERTIL STERIL, V49, P522; TEDESCO TA, 1979, SCIENCE, V205, P1395, DOI 10.1126/science.472754; Tsai-Turton M, 2006, ENDOCRINOLOGY, V147, P1224, DOI 10.1210/en.2005-1281; van Engeland M, 1998, CYTOMETRY, V31, P1, DOI 10.1002/(SICI)1097-0320(19980101)31:1<1::AID-CYTO1>3.0.CO;2-R; WAGGONER DD, 1990, J INHERIT METAB DIS, V13, P802, DOI 10.1007/BF01800204; Xu MF, 2001, AM J PHYSIOL-HEART C, V281, pH1295, DOI 10.1152/ajpheart.2001.281.3.H1295	61	27	27	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2012	7	2							e30709	10.1371/journal.pone.0030709	http://dx.doi.org/10.1371/journal.pone.0030709			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UV	22319579	Green Submitted, gold, Green Published			2022-12-27	WOS:000301979000011
J	Sandell, LL; Lynn, ML; Inman, KE; McDowell, W; Trainor, PA				Sandell, Lisa L.; Lynn, Megan L.; Inman, Kimberly E.; McDowell, William; Trainor, Paul A.			RDH10 Oxidation of Vitamin A Is a Critical Control Step in Synthesis of Retinoic Acid during Mouse Embryogenesis	PLOS ONE			English	Article							NULL MUTANT MICE; ALCOHOL-DEHYDROGENASE ADH1; ALL-TRANS-RETINOL; NERVOUS-SYSTEM; EXPRESSION; METABOLISM; MECHANISM; TOXICITY; GENES; ORGANOGENESIS	Retinoic Acid (RA) is a small lipophilic signaling molecule essential for embryonic development and adult tissue maintenance. Both an excess of RA and a deficiency of RA can cause pathogenic anomalies, hence it is critical to understand the mechanisms controlling the spatial and temporal distribution of RA. However, our current understanding of these processes remains incomplete. Vitamin A is metabolized to RA via two sequential enzymatic reactions. The first requires retinol dehydrogenase (RDH) activity to oxidize Vitamin A (retinol) to retinal, and the second requires retinaldehyde activity (RALDH) to oxidize retinal into RA. The first reaction has previously been attributed to the alcohol dehydrogenase (ADH) family, whose genes are ubiquitously or redundantly expressed. Consequently, the specificity of RA synthesis was thought to reside exclusively at the level of the second reaction. To better understand the metabolism of Vitamin A into RA during embryogenesis, we generated new mouse models that disrupt this process. Here we describe a new targeted knockout of Rdh10 in which RA synthesis is severely impaired, particularly at critical early embryonic stages. We also introduce a new mutant allele of Aldh1a2. Both mutations produce similar developmental defects resulting in lethality around embryonic day 10.5 (E10.5). The severity of the Rdh10 null phenotype demonstrates that embryonic oxidation of retinol is carried out primarily by RDH10 and that neither ADHs nor other enzymes contribute significantly to this reaction. We also show that reduced RA production results in upregulation of Rdh10. These data demonstrate that RDH10 plays a critical role in mediating the rate limiting RDH step of Vitamin A metabolism and functions as a nodal point in feedback regulation of RA synthesis. Moreover, RDH10-mediated oxidation of retinol plays as important a role in the control and regulation of RA production during embryogenesis as does the subsequent RALDH-mediated reaction.	[Sandell, Lisa L.; Lynn, Megan L.; Inman, Kimberly E.; McDowell, William; Trainor, Paul A.] Stowers Inst Med Res, Kansas City, MO USA; [Sandell, Lisa L.] Univ Louisville, Dept Mol Cellular & Craniofacial Biol, Louisville, KY 40292 USA; [Trainor, Paul A.] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66103 USA	Stowers Institute for Medical Research; University of Louisville; University of Kansas; University of Kansas Medical Center	Sandell, LL (corresponding author), Stowers Inst Med Res, Kansas City, MO USA.	lisa.sandell@louisville.edu; pat@stowers.org	Sandell, Lisa L/M-4238-2013	Sandell, Lisa L/0000-0002-1735-8223; Trainor, Paul/0000-0003-2774-3624	Stowers Institute for Medical Research; National Institute of Dental and Craniofacial Research [R01 DE 016082]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016082] Funding Source: NIH RePORTER	Stowers Institute for Medical Research; National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Research in the Trainor laboratory is supported by the Stowers Institute for Medical Research and the National Institute of Dental and Craniofacial Research (R01 DE 016082). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang HL, 1996, J BIOL CHEM, V271, P9526, DOI 10.1074/jbc.271.16.9526; Cammas L, 2007, DEV DYNAM, V236, P2899, DOI 10.1002/dvdy.21312; CHEN H, 1995, BIOCHEM PHARMACOL, V50, P1257, DOI 10.1016/0006-2952(95)02005-W; Clagett-Dame M, 2011, NUTRIENTS, V3, P385, DOI 10.3390/nu3040385; Cunningham TJ, 2011, DEV DYNAM, V240, P1142, DOI 10.1002/dvdy.22583; de Vries WN, 2000, GENESIS, V26, P110, DOI 10.1002/(SICI)1526-968X(200002)26:2<110::AID-GENE2>3.0.CO;2-8; Deltour L, 1999, DEV GENET, V25, P1, DOI 10.1002/(SICI)1520-6408(1999)25:1<1::AID-DVG1>3.0.CO;2-W; Deltour L, 1999, J BIOL CHEM, V274, P16796, DOI 10.1074/jbc.274.24.16796; Dowling JE, 1961, ROLE VITAMIN A ACID, P515; Duester G, 2003, CHEM-BIOL INTERACT, V143, P201, DOI 10.1016/S0009-2797(02)00204-1; Duester G, 1998, J NUTR, V128, p459S, DOI 10.1093/jn/128.2.459S; Duester G, 2008, CELL, V134, P921, DOI 10.1016/j.cell.2008.09.002; Dupe V, 2003, P NATL ACAD SCI USA, V100, P14036, DOI 10.1073/pnas.2336223100; Fan XH, 2003, MOL CELL BIOL, V23, P4637, DOI 10.1128/MCB.23.13.4637-4648.2003; Farjo KM, 2011, DEV BIOL, V357, P347, DOI 10.1016/j.ydbio.2011.07.011; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; Feng L, 2010, DEV BIOL, V338, P1, DOI 10.1016/j.ydbio.2009.10.029; Hall JA, 2011, IMMUNITY, V35, P13, DOI 10.1016/j.immuni.2011.07.002; Kane MA, 2010, FASEB J, V24, P823, DOI 10.1096/fj.09-141572; Kumar S, 2011, BIOCH BIOPHYSICA ACT; Lewandoski M, 1997, CURR BIOL, V7, P148, DOI 10.1016/S0960-9822(06)00059-5; Maden M, 2007, NAT REV NEUROSCI, V8, P755, DOI 10.1038/nrn2212; Mark Manuel, 2009, Nucl Recept Signal, V7, pe002, DOI 10.1621/nrs.07002; Matt N, 2005, DEVELOPMENT, V132, P4789, DOI 10.1242/dev.02031; Mic FA, 2002, DEVELOPMENT, V129, P2271; Molotkov A, 2005, DEV DYNAM, V232, P950, DOI 10.1002/dvdy.20256; Molotkov A, 2002, EUR J BIOCHEM, V269, P2607, DOI 10.1046/j.1432-1033.2002.02935.x; Molotkov A, 2002, J BIOL CHEM, V277, P13804, DOI 10.1074/jbc.M112039200; Niederreither K, 1999, NAT GENET, V21, P444, DOI 10.1038/7788; Niederreither K, 2008, NAT REV GENET, V9, P541, DOI 10.1038/nrg2340; Pares X, 2008, CELL MOL LIFE SCI, V65, P3936, DOI 10.1007/s00018-008-8591-3; Reijntjes S, 2010, INT J DEV BIOL, V54, P1267, DOI 10.1387/ijdb.093009sr; Rhinn M, 2011, P NATL ACAD SCI USA, V108, P16687, DOI 10.1073/pnas.1103877108; ROSSANT J, 1991, GENE DEV, V5, P1333, DOI 10.1101/gad.5.8.1333; Sandell LL, 2007, GENE DEV, V21, P1113, DOI 10.1101/gad.1533407; Sandell LL, 2011, GENESIS, V49, P342, DOI 10.1002/dvg.20727; See AWM, 2008, DEV BIOL, V316, P171, DOI 10.1016/j.ydbio.2007.10.018; Strate I, 2009, DEVELOPMENT, V136, P461, DOI 10.1242/dev.024901; Takahashi Y, 2009, BIOCHEM J, V419, P113, DOI 10.1042/BJ20080812; Villarroya F, 2004, CURR MED CHEM, V11, P795, DOI 10.2174/0929867043455747; WARKANY J, 1946, ARCH OPHTHALMOL-CHIC, V35, P150, DOI 10.1001/archopht.1946.00890200155008; WILSON JG, 1949, AM J ANAT, V85, P113, DOI 10.1002/aja.1000850106; WILSON JG, 1948, AM J ANAT, V83, P357, DOI 10.1002/aja.1000830303; Wu BX, 2004, INVEST OPHTH VIS SCI, V45, P3857, DOI 10.1167/iovs.03-1302; ZACHMAN RD, 1961, J BIOL CHEM, V236, P2309	45	73	73	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2012	7	2							e30698	10.1371/journal.pone.0030698	http://dx.doi.org/10.1371/journal.pone.0030698			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UV	22319578	gold, Green Published, Green Submitted			2022-12-27	WOS:000301979000010
J	Tegze, B; Szallasi, Z; Haltrich, I; Penzvalto, Z; Toth, Z; Liko, I; Gyorffy, B				Tegze, Balint; Szallasi, Zoltan; Haltrich, Iren; Penzvalto, Zsofia; Toth, Zsuzsa; Liko, Istvan; Gyoerffy, Balazs			Parallel Evolution under Chemotherapy Pressure in 29 Breast Cancer Cell Lines Results in Dissimilar Mechanisms of Resistance	PLOS ONE			English	Article							TOPOISOMERASE-II ACTIVITY; MULTIDRUG-RESISTANCE; LUNG-CANCER; PACLITAXEL RESISTANCE; PREDICTS RESISTANCE; ACQUIRED-RESISTANCE; EXPRESSION; PROTEIN; AMPLIFICATION; DOXORUBICIN	Background: Developing chemotherapy resistant cell lines can help to identify markers of resistance. Instead of using a panel of highly heterogeneous cell lines, we assumed that truly robust and convergent pattern of resistance can be identified in multiple parallel engineered derivatives of only a few parental cell lines. Methods: Parallel cell populations were initiated for two breast cancer cell lines (MDA-MB-231 and MCF-7) and these were treated independently for 18 months with doxorubicin or paclitaxel. IC50 values against 4 chemotherapy agents were determined to measure cross-resistance. Chromosomal instability and karyotypic changes were determined by cytogenetics. TaqMan RT-PCR measurements were performed for resistance-candidate genes. Pgp activity was measured by FACS. Results: All together 16 doxorubicin-and 13 paclitaxel-treated cell lines were developed showing 2-46 fold and 3-28 fold increase in resistance, respectively. The RT-PCR and FACS analyses confirmed changes in tubulin isofom composition, TOP2A and MVP expression and activity of transport pumps (ABCB1, ABCG2). Cytogenetics showed less chromosomes but more structural aberrations in the resistant cells. Conclusion: We surpassed previous studies by parallel developing a massive number of cell lines to investigate chemoresistance. While the heterogeneity caused evolution of multiple resistant clones with different resistance characteristics, the activation of only a few mechanisms were sufficient in one cell line to achieve resistance.	[Tegze, Balint; Penzvalto, Zsofia] Semmelweis Univ, Dept Pediat 1, Budapest, Hungary; [Szallasi, Zoltan] Childrens Hosp, Boston, MA 02115 USA; [Szallasi, Zoltan] Tech Univ Denmark, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [Haltrich, Iren; Toth, Zsuzsa] Semmelweis Univ, Dept Pediat 2, Budapest, Hungary; [Liko, Istvan] Gedeon Richter Plc, Budapest, Hungary; [Gyoerffy, Balazs] Charite, Lab Funct Genom, D-13353 Berlin, Germany; [Gyoerffy, Balazs] Hungarian Acad Sci, Res Lab Pediat & Nephrol, Budapest, Hungary	Semmelweis University; Harvard University; Boston Children's Hospital; Technical University of Denmark; Semmelweis University; Gedeon Richter Chemistry Works; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Hungarian Academy of Sciences	Tegze, B (corresponding author), Semmelweis Univ, Dept Pediat 1, Budapest, Hungary.	balint@tegze.net	Haltrich, Irén/K-2890-2017; Gyorffy, Balazs/AAA-9135-2021	Haltrich, Irén/0000-0003-0094-5285; Gyorffy, Balazs/0000-0002-5772-3766; Szallasi, Zoltan/0000-0001-5395-7509; Liko, Istvan/0000-0001-7668-4726	Hungarian Scientific Research Fund [OTKA PD 83154]; Medical Research Council [ETT 029/2009]; National Development Agency, Hungary [TAMOP-4.2.1/B 09/1/KMR-2010-0001]; Economic Competitiveness Operational Programme [GVOP-3.2.1 - 2004 - 04 -0124/3.0]; Alexander von Humboldt-Foundation; Breast Cancer Research Foundation	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Development Agency, Hungary; Economic Competitiveness Operational Programme; Alexander von Humboldt-Foundation(Alexander von Humboldt Foundation); Breast Cancer Research Foundation	The study was supported by the Hungarian Scientific Research Fund (OTKA PD 83154), by the Medical Research Council (ETT 029/2009), by the Social Renewal Operational Programme (National Development Agency, Hungary)(TAMOP-4.2.1/B 09/1/KMR-2010-0001) and by the Economic Competitiveness Operational Programme (GVOP-3.2.1 - 2004 - 04 -0124/3.0) grants, by the Alexander von Humboldt-Foundation and by the Breast Cancer Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre F, 2010, CURR OPIN ONCOL, V22, P547, DOI 10.1097/CCO.0b013e32833fb384; Bean J, 2007, P NATL ACAD SCI USA, V104, P20932, DOI 10.1073/pnas.0710370104; Borst P, 2000, JNCI-J NATL CANCER I, V92, P1295, DOI 10.1093/jnci/92.16.1295; Dalton WS, 1999, J NATL CANCER I, V91, P1604, DOI 10.1093/jnci/91.19.1604; Desmedt C, 2011, J CLIN ONCOL; DOROSHOW JH, 1986, BIOCHEM BIOPH RES CO, V135, P330, DOI 10.1016/0006-291X(86)90981-2; EIJDEMS EWHM, 1995, BRIT J CANCER, V71, P40, DOI 10.1038/bjc.1995.9; Ein-Dor L, 2006, P NATL ACAD SCI USA, V103, P5923, DOI 10.1073/pnas.0601231103; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Farmer P, 2009, NAT MED, V15, P68, DOI 10.1038/nm.1908; Gerlinger M, 2010, BRIT J CANCER, V103, P1139, DOI 10.1038/sj.bjc.6605912; Gyorffy B, 2005, ONCOGENE, V24, P7542, DOI 10.1038/sj.onc.1208908; Gyorffy B, 2006, INT J CANCER, V118, P1699, DOI 10.1002/ijc.21570; Gyorffy Balazs, 2005, Orv Hetil, V146, P559; KARTNER N, 1983, SCIENCE, V221, P1285, DOI 10.1126/science.6137059; Kavallaris M, 1997, J CLIN INVEST, V100, P1282, DOI 10.1172/JCI119642; Lage H, 2000, BRIT J CANCER, V82, P488, DOI 10.1054/bjoc.1999.0947; Lehne G, 2000, INT J CLIN PHARM TH, V38, P187; Li Y, 2010, NAT MED, V16, P214, DOI 10.1038/nm.2090; Liedtke C, 2010, BREAST CANCER RES TR, V121, P301, DOI 10.1007/s10549-009-0445-7; Maley CC, 2006, NAT GENET, V38, P468, DOI 10.1038/ng1768; Marusyk A, 2010, BBA-REV CANCER, V1805, P105, DOI 10.1016/j.bbcan.2009.11.002; Mechetner E, 1998, CLIN CANCER RES, V4, P389; Monzo M, 1999, J CLIN ONCOL, V17, P1786, DOI 10.1200/JCO.1999.17.6.1786; Mozzetti S, 2005, CLIN CANCER RES, V11, P298; Munkacsy G, 2010, BRIT J CANCER, V102, P361, DOI 10.1038/sj.bjc.6605478; Penson RT, 2004, GYNECOL ONCOL, V93, P98, DOI 10.1016/j.ygyno.2003.11.053; Potti A, 2006, NAT MED, V12, P1294, DOI 10.1038/nm1491; Potti A, 2011, NAT MED, V17, P135, DOI 10.1038/nm0111-135; Qi J, 2011, CANCER RES, V71, P1081, DOI 10.1158/0008-5472.CAN-10-1623; Renes J, 2000, DRUG RESIST UPDATE, V3, P289, DOI 10.1054/drup.2000.0156; Rouzier R, 2005, P NATL ACAD SCI USA, V102, P8315, DOI 10.1073/pnas.0408974102; Saad ED, 2010, J CLIN ONCOL, V28, P1958, DOI 10.1200/JCO.2009.25.5414; Shannon CE, 1997, M D COMPUT, V14, P306; Silver DP, 2010, J CLIN ONCOL, V28, P1145, DOI 10.1200/JCO.2009.22.4725; Wang HM, 2001, J BIOL CHEM, V276, P15990, DOI 10.1074/jbc.M011143200	36	35	38	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2012	7	2							e30804	10.1371/journal.pone.0030804	http://dx.doi.org/10.1371/journal.pone.0030804			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UV	22319589	Green Submitted, Green Published, gold			2022-12-27	WOS:000301979000015
J	Tyagi, M; Thangudu, RR; Zhang, DC; Bryant, SH; Madej, T; Panchenko, AR				Tyagi, Manoj; Thangudu, Ratna R.; Zhang, Dachuan; Bryant, Stephen H.; Madej, Thomas; Panchenko, Anna R.			Homology Inference of Protein-Protein Interactions via Conserved Binding Sites	PLOS ONE			English	Article							PREDICTION; SEQUENCE; ANNOTATION; DIVERGENCE; COMPLEXES	The coverage and reliability of protein-protein interactions determined by high-throughput experiments still needs to be improved, especially for higher organisms, therefore the question persists, how interactions can be verified and predicted by computational approaches using available data on protein structural complexes. Recently we developed an approach called IBIS (Inferred Biomolecular Interaction Server) to predict and annotate protein-protein binding sites and interaction partners, which is based on the assumption that the structural location and sequence patterns of protein-protein binding sites are conserved between close homologs. In this study first we confirmed high accuracy of our method and found that its accuracy depends critically on the usage of all available data on structures of homologous complexes, compared to the approaches where only a non-redundant set of complexes is employed. Second we showed that there exists a trade-off between specificity and sensitivity if we employ in the prediction only evolutionarily conserved binding site clusters or clusters supported by only one observation (singletons). Finally we addressed the question of identifying the biologically relevant interactions using the homology inference approach and demonstrated that a large majority of crystal packing interactions can be correctly identified and filtered by our algorithm. At the same time, about half of biological interfaces that are not present in the protein crystallographic asymmetric unit can be reconstructed by IBIS from homologous complexes without the prior knowledge of crystal parameters of the query protein.	[Tyagi, Manoj; Thangudu, Ratna R.; Zhang, Dachuan; Bryant, Stephen H.; Madej, Thomas; Panchenko, Anna R.] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Tyagi, M (corresponding author), NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bldg 10, Bethesda, MD 20892 USA.	madej@ncbi.nlm.nih.gov; panch@ncbi.nlm.nih.gov	Tyagi, Manoj/K-8438-2014		National Institutes of Health/Department of Health and Human Services of the National Library of Medicine; NATIONAL LIBRARY OF MEDICINE [ZIALM100604, ZIALM000046] Funding Source: NIH RePORTER	National Institutes of Health/Department of Health and Human Services of the National Library of Medicine; NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by the National Institutes of Health/Department of Health and Human Services Intramural Research program of the National Library of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloy P, 2003, J MOL BIOL, V332, P989, DOI 10.1016/j.jmb.2003.07.006; Altschul SF, 2001, NUCLEIC ACIDS RES, V29, P351, DOI 10.1093/nar/29.2.351; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Burgess B, 2002, NITROGEN FIXATION MO, P13; Chen HL, 2005, PROTEINS, V61, P21, DOI 10.1002/prot.20514; Chen J, 2003, NUCLEIC ACIDS RES, V31, P474, DOI 10.1093/nar/gkg086; Dayhoff JE, 2010, J MOL BIOL, V395, P860, DOI 10.1016/j.jmb.2009.10.052; Dessailly BH, 2010, STRUCTURE, V18, P1522, DOI 10.1016/j.str.2010.08.017; Fariselli P, 2002, EUR J BIOCHEM, V269, P1356, DOI 10.1046/j.1432-1033.2002.02767.x; Gibrat JF, 1996, CURR OPIN STRUC BIOL, V6, P377, DOI 10.1016/S0959-440X(96)80058-3; GRIBSKOV M, 1987, P NATL ACAD SCI USA, V84, P4355, DOI 10.1073/pnas.84.13.4355; Hashimoto K, 2010, P NATL ACAD SCI USA, V107, P20352, DOI 10.1073/pnas.1012999107; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Henrick K, 1998, TRENDS BIOCHEM SCI, V23, P358, DOI 10.1016/S0968-0004(98)01253-5; Holm RH, SUBSITE SPECIFIC STR, P1; Ispolatov I, 2005, NUCLEIC ACIDS RES, V33, P3629, DOI 10.1093/nar/gki678; Jefferson ER, 2006, J MOL BIOL, V364, P1118, DOI 10.1016/j.jmb.2006.09.042; Kemmer D, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r106; KIM J, 1993, BIOCHEMISTRY-US, V32, P7104, DOI 10.1021/bi00079a006; KIM JS, 1992, NATURE, V360, P553, DOI 10.1038/360553a0; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Levy ED, 2007, STRUCTURE, V15, P1364, DOI 10.1016/j.str.2007.09.019; Liang SD, 2006, NUCLEIC ACIDS RES, V34, P3698, DOI 10.1093/nar/gkl454; Ma BG, 2010, STRUCTURE, V18, P819, DOI 10.1016/j.str.2010.04.004; Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Matthews LR, 2001, GENOME RES, V11, P2120, DOI 10.1101/gr.205301; Mika S, 2006, PLOS COMPUT BIOL, V2, P698, DOI 10.1371/journal.pcbi.0020079; Mintz S, 2005, PROTEINS, V61, P6, DOI 10.1002/prot.20580; Neuvirth H, 2004, J MOL BIOL, V338, P181, DOI 10.1016/j.jmb.2004.02.040; Newton WE, 1992, BIOL NITROGEN FIXATI, P877; Persico M, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S4-S21; Reguly Teresa, 2006, J Biol, V5, P11, DOI 10.1186/jbiol36; Shoemaker BA, 2006, PROTEIN SCI, V15, P352, DOI 10.1110/ps.051760806; Shoemaker BA, 2007, PLOS COMPUT BIOL, V3, P595, DOI 10.1371/journal.pcbi.0030043; Shoemaker BA, 2010, NUCLEIC ACIDS RES, V38, pD518, DOI 10.1093/nar/gkp842; Shulman-Peleg A, 2004, LECT NOTES COMPUT SC, V3240, P194; Slonim N, 2005, P NATL ACAD SCI USA, V102, P18297, DOI 10.1073/pnas.0507432102; Stumpf MPH, 2008, P NATL ACAD SCI USA, V105, P6959, DOI 10.1073/pnas.0708078105; Thangudu RR, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-365; Walhout AJM, 2000, SCIENCE, V287, P116, DOI 10.1126/science.287.5450.116; Xu QF, 2008, J MOL BIOL, V381, P487, DOI 10.1016/j.jmb.2008.06.002; Xue LC, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-244; Yu HY, 2004, GENOME RES, V14, P1107, DOI 10.1101/gr.1774904; Zhang QC, 2010, P NATL ACAD SCI USA, V107, P10896, DOI 10.1073/pnas.1005894107; Zhu HB, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-27	47	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2012	7	1							e28896	10.1371/journal.pone.0028896	http://dx.doi.org/10.1371/journal.pone.0028896			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	912BY	22303436	Green Published, gold, Green Submitted			2022-12-27	WOS:000301770700003
J	Pesnel, S; Pillon, A; Creancier, L; Lerondel, S; Le Pape, A; Recher, C; Demur, C; Guilbaud, N; Kruczynski, A				Pesnel, Sabrina; Pillon, Arnaud; Creancier, Laurent; Lerondel, Stephanie; Le Pape, Alain; Recher, Christian; Demur, Cecile; Guilbaud, Nicolas; Kruczynski, Anna			Optical Imaging of Disseminated Leukemia Models in Mice with Near-Infrared Probe Conjugated to a Monoclonal Antibody	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; CD44	Background: The assessment of anticancer agents to treat leukemia needs to have animal models closer to the human pathology such as implantation in immunodeficient mice of leukemic cells from patient samples. A sensitive and early detection of tumor cells in these orthotopic models is a prerequisite for monitoring engraftment of leukemic cells and their dissemination in mice. Therefore, we developed a fluorescent antibody based strategy to detect leukemic foci in mice bearing patient-derived leukemic cells using fluorescence reflectance imaging (FRI) to determine when to start treatments with novel antitumor agents. Methods: Two mAbs against the CD44 human myeloid marker or the CD45 human leukocyte marker were labeled with Alexa Fluor 750 and administered to leukemia-bearing mice after having verified the immunoreactivity in vitro. Bioluminescent leukemic cells (HL60-Luc) were used to compare the colocalization of the fluorescent mAb with these cells. The impact of the labeled antibodies on disease progression was further determined. Finally, the fluorescent hCD45 mAb was tested in mice engrafted with human leukemic cells. Results: The probe labeling did not modify the immunoreactivity of the mAbs. There was a satisfactory correlation between bioluminescence imaging (BLI) and FRI and low doses of mAb were sufficient to detect leukemic foci. However, anti-hCD44 mAb had a strong impact on the tumor proliferation contrary to anti-hCD45 mAb. The use of anti-hCD45 mAb allowed the detection of leukemic patient cells engrafted onto NOD/SCID mice. Conclusions: A mAb labeled with a near infrared fluorochrome is useful to detect leukemic foci in disseminated models provided that its potential impact on tumor proliferation has been thoroughly documented.	[Pesnel, Sabrina; Pillon, Arnaud; Creancier, Laurent; Guilbaud, Nicolas; Kruczynski, Anna] Ctr Rech Oncol Expt, Inst Rech Pierre Fabre, Toulouse, France; [Pesnel, Sabrina; Lerondel, Stephanie; Le Pape, Alain] CNRS, UPS TAAM CIPA 44, F-45071 Orleans, France; [Le Pape, Alain] INSERM, U618, Tours, France; [Recher, Christian; Demur, Cecile] CHU Toulouse, Hop Purpan, Serv Hematol, Toulouse, France; [Recher, Christian; Demur, Cecile] CHU Purpan, Ctr Physiopathol, INSERM, U563, Toulouse, France	Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Toulouse; CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)	Pesnel, S (corresponding author), Ctr Rech Oncol Expt, Inst Rech Pierre Fabre, Toulouse, France.	spesnel@cnrs-orleans.fr		Pesnel, Sabrina/0000-0001-7839-4394				Adonai N, 2002, P NATL ACAD SCI USA, V99, P3030, DOI 10.1073/pnas.052709599; Burke John M, 2002, Cancer Control, V9, P106; Creancier L, 2010, P AM ASS CANC RES 10; Dayde D, 2009, BLOOD, V113, P3765, DOI 10.1182/blood-2008-08-175125; Ghoroghchian PP, 2009, WIRES NANOMED NANOBI, V1, P156, DOI 10.1002/wnan.7; Goodison S, 1999, J CLIN PATHOL-MOL PA, V52, P189; Green DJ, 2009, BLOOD, V114, P1226, DOI 10.1182/blood-2009-03-210344; Isaza MP, 2008, LUMINESCENCE, V23, P17, DOI 10.1002/bio.1010; Kalchenko V, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2364903; Kotzerke J, 2005, BONE MARROW TRANSPL, V36, P1021, DOI 10.1038/sj.bmt.1705182; Krause DS, 2010, ARCH PATHOL LAB MED, V134, P1033, DOI 10.1043/2009-0347-OA.1; Kuenzle Katherina, 2002, Mol Imaging Biol, V4, P179, DOI 10.1016/S1095-0397(01)00056-5; Leblond F, 2010, J PHOTOCH PHOTOBIO B, V98, P77, DOI 10.1016/j.jphotobiol.2009.11.007; LENERS N, 1991, NUCL MED BIOL, V18, P727; Liu JN, 2006, CELL MOL IMMUNOL, V3, P359; McCormack E, 2007, MOL IMAGING, V6, P193, DOI 10.2310/7290.2007.00016; Morris JC, 2009, EXPERT REV MOL MED, V30, P11; Olafsen T, 2010, SEMIN NUCL MED, V40, P167, DOI 10.1053/j.semnuclmed.2009.12.005; OMARY MB, 1980, J EXP MED, V152, P842, DOI 10.1084/jem.152.4.842; Paroo Z, 2004, MOL IMAGING, V3, P117, DOI 10.1162/1535350041464865; PRESS OW, 1989, CANCER RES, V49, P4906; Sanchez PV, 2009, LEUKEMIA, V23, P2109, DOI 10.1038/leu.2009.143; Tomimaru Y, 2010, ONCOL REP, V24, P613, DOI 10.3892/or_00000899; Vosjan MJWD, 2010, NAT PROTOC, V5, P739, DOI 10.1038/nprot.2010.13	24	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e30690	10.1371/journal.pone.0030690	http://dx.doi.org/10.1371/journal.pone.0030690			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22303450	Green Published, gold, Green Submitted			2022-12-27	WOS:000301704200029
J	Wang, JF; Chou, KC				Wang, Jing-Fang; Chou, Kuo-Chen			Insights into the Mutation-Induced HHH Syndrome from Modeling Human Mitochondrial Ornithine Transporter-1	PLOS ONE			English	Article							HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME; PROTEIN-STRUCTURE PREDICTION; PERSONALIZED DRUG DESIGN; SUBSTRATE-BINDING SITE; M2 PROTON CHANNEL; MOLECULAR-DYNAMICS; SEQUENCE-PROFILE; SYNDROME HYPERORNITHINEMIA; STRUCTURE INFORMATION; FOLD RECOGNITION	Human mitochondrial ornithine transporter-1 is reported in coupling with the hyperornithinemia-hyperammonemia-homocitrullinuria (HHH) syndrome, which is a rare autosomal recessive disorder. For in-depth understanding of the molecular mechanism of the disease, it is crucially important to acquire the 3D structure of human mitochondrial ornithine transporter-1. Since no such structure is available in the current protein structure database, we have developed it via computational approaches based on the recent NMR structure of human mitochondrial uncoupling protein (Berardi MJ, Chou JJ, et al. Nature 2011, 476: 109-113). Subsequently, we docked the ligand L-ornithine into the computational structure to search for the favorable binding mode. It was observed that the binding interaction for the most favorable binding mode is featured by six remarkable hydrogen bonds between the receptor and ligand, and that the most favorable binding mode shared the same ligand-binding site with most of the homologous mitochondrial carriers from different organisms, implying that the ligand-binding sites are quite conservative in the mitochondrial carriers family although their sequences similarity is very low with 20% or so. Moreover, according to our structural analysis, the relationship between the disease-causing mutations of human mitochondrial ornithine transporter-1 and the HHH syndrome can be classified into the following three categories: (i) the mutation occurs in the pseudo-repeat regions so as to change the region of the protein closer to the mitochondrial matrix; (ii) the mutation is directly affecting the substrate binding pocket so as to reduce the substrate binding affinity; (iii) the mutation is located in the structural region closer to the intermembrane space that can significantly break the salt bridge networks of the protein. These findings may provide useful insights for in-depth understanding of the molecular mechanism of the HHH syndrome and developing effective drugs against the disease.	[Wang, Jing-Fang] Shanghai Jiao Tong Univ, Minist Educ, Key Lab Syst Biomed, Shanghai 200030, Peoples R China; [Wang, Jing-Fang] Shanghai Ctr Bioinformat & Technol, Shanghai, Peoples R China; [Chou, Kuo-Chen] Gordon Life Sci Inst, San Diego, CA USA	Shanghai Jiao Tong University; Chinese Academy of Sciences	Wang, JF (corresponding author), Shanghai Jiao Tong Univ, Minist Educ, Key Lab Syst Biomed, Shanghai 200030, Peoples R China.	jfwang8113@sjtu.edu.cn	Wang, Jingfang/Q-2597-2018; Chou, Kuo-Chen/A-8340-2009	Wang, Jingfang/0000-0002-1355-5481; 				Benkert P, 2008, PROTEINS, V71, P261, DOI 10.1002/prot.21715; Berardi MJ, 2011, NATURE, V476, P109, DOI 10.1038/nature10257; BLUNDELL TL, 1987, NATURE, V326, P347, DOI 10.1038/326347a0; Camacho JA, 1999, NAT GENET, V22, P151, DOI 10.1038/9658; Chen Q, 2011, CURR DRUG METAB, V12, P436, DOI 10.2174/138920011795495259; Fecarotta S, 2006, J INHERIT METAB DIS, V29, P186, DOI 10.1007/s10545-006-0120-7; Fiermonte G, 2003, J BIOL CHEM, V278, P32778, DOI 10.1074/jbc.M302317200; Gonzalez-Diaz H, 2011, MOL BIOSYST, V7, P1938, DOI 10.1039/c1mb05069a; Gonzalez-Diaz H, 2011, J PROTEOME RES, V10, P1698, DOI 10.1021/pr101009e; Gonzalez-Diaz H, 2011, J THEOR BIOL, V276, P229, DOI 10.1016/j.jtbi.2011.01.010; Gu H, 2010, CHINESE SCI BULL, V55, P2677, DOI 10.1007/s11434-010-3257-6; HOMMES FA, 1982, J INHERIT METAB DIS, V5, P41, DOI 10.1007/BF01799753; HOMMES FA, 1986, NEUROPEDIATRICS, V17, P48, DOI 10.1055/s-2008-1052499; Juretic D, 2002, J CHEM INF COMP SCI, V42, P620, DOI 10.1021/ci010263s; Karplus K, 2005, PROTEINS, V61, P135, DOI 10.1002/prot.20730; Kunji ERS, 2006, BBA-BIOENERGETICS, V1757, P1237, DOI 10.1016/j.bbabio.2006.03.021; Kunji ERS, 2004, FEBS LETT, V564, P239, DOI 10.1016/S0014-5793(04)00242-X; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laurie ATR, 2005, BIOINFORMATICS, V21, P1908, DOI 10.1093/bioinformatics/bti315; Li J, 2011, J CHEM INF MODEL, V51, P3217, DOI 10.1021/ci2004016; Lian P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018587; Magdziarz T, 2009, J MOL MODEL, V15, P41, DOI 10.1007/s00894-008-0373-1; Margelevicius M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-89; Melo F, 1998, J MOL BIOL, V277, P1141, DOI 10.1006/jmbi.1998.1665; Miyamoto T, 2002, PEDIATR NEUROL, V26, P65, DOI 10.1016/S0887-8994(01)00335-6; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Noguchi R, 1988, Masui, V37, P86; Nury H, 2005, FEBS LETT, V579, P6031, DOI 10.1016/j.febslet.2005.09.061; Palmieri F, 2004, PFLUG ARCH EUR J PHY, V447, P689, DOI 10.1007/s00424-003-1099-7; Palmieri F, 2006, BBA-BIOENERGETICS, V1757, P1249, DOI 10.1016/j.bbabio.2006.05.023; Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056; Robinson AJ, 2006, P NATL ACAD SCI USA, V103, P2617, DOI 10.1073/pnas.0509994103; Robinson AJ, 2008, P NATL ACAD SCI USA, V105, P17766, DOI 10.1073/pnas.0809580105; Salvi S, 2001, Hum Mutat, V18, P460, DOI 10.1002/humu.1221; Salvi S, 2001, NEUROLOGY, V57, P911, DOI 10.1212/WNL.57.5.911; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Shigeto H, 1992, Rinsho Shinkeigaku, V32, P729; SHIMIZU H, 1990, BRAIN DEV-JPN, V12, P533, DOI 10.1016/S0387-7604(12)80222-1; SMITH L, 1992, J PEDIATR GASTR NUTR, V15, P431, DOI 10.1097/00005176-199211000-00011; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Tessa A, 2009, HUM MUTAT, V30, P741, DOI 10.1002/humu.20930; Tsujino S, 2000, ANN NEUROL, V47, P625, DOI 10.1002/1531-8249(200005)47:5<625::AID-ANA10>3.3.CO;2-H; Valle D., 2001, METABOLIC MOL BASES, P1857; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wang JF, 2011, J MOL MODEL, DOI [10.1007/s00894-011-1295x, DOI 10.1007/S00894-011-1295X]; Wang JF, 2008, PROTEIN PEPTIDE LETT, V15, P27; Wang JF, 2007, BIOCHEM BIOPH RES CO, V359, P323, DOI 10.1016/j.bbrc.2007.05.101; Wang JF, 2007, BIOCHEM BIOPH RES CO, V355, P513, DOI 10.1016/j.bbrc.2007.01.185; Wang JF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018414; Wang JF, 2010, PROTEIN ENG DES SEL, V23, P663, DOI 10.1093/protein/gzq040; Wang JF, 2010, CURR DRUG METAB, V11, P342, DOI 10.2174/138920010791514180; Wang JF, 2009, BIOCHEM BIOPH RES CO, V388, P413, DOI 10.1016/j.bbrc.2009.08.026; Wang JF, 2009, BIOCHEM BIOPH RES CO, V390, P608, DOI 10.1016/j.bbrc.2009.10.014; Wang JF, 2009, PROTEIN ENG DES SEL, V22, P349, DOI 10.1093/protein/gzp012; Wang JF, 2010, CHINESE SCI BULL, V55, P1877, DOI 10.1007/s11434-009-3697-z; Wang Y, 2010, J CHEM INF MODEL, V50, P875, DOI 10.1021/ci900458u; Wu ST, 2008, PROTEINS, V72, P547, DOI 10.1002/prot.21945; Wu ST, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-17; Wu ST, 2007, NUCLEIC ACIDS RES, V35, P3375, DOI 10.1093/nar/gkm251; Xu Y, 2000, PROTEINS, V40, P343, DOI 10.1002/1097-0134(20000815)40:3<343::AID-PROT10>3.0.CO;2-S; Zhou HY, 2005, PROTEINS, V58, P321, DOI 10.1002/prot.20308; Zhou HY, 2004, PROTEINS, V55, P1005, DOI 10.1002/prot.20007; Zhou HY, 2002, PROTEIN SCI, V11, P2714, DOI 10.1110/ps.0217002	64	46	46	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2012	7	1							e31048	10.1371/journal.pone.0031048	http://dx.doi.org/10.1371/journal.pone.0031048			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911FX	22292090	Green Published, gold, Green Submitted			2022-12-27	WOS:000301703800040
J	Oleinikov, AV; Voronkova, VV; Frye, IT; Amos, E; Morrison, R; Fried, M; Duffy, PE				Oleinikov, Andrew V.; Voronkova, Valentina V.; Frye, Isaac Tyler; Amos, Emily; Morrison, Robert; Fried, Michal; Duffy, Patrick E.			A Plasma Survey Using 38 PfEMP1 Domains Reveals Frequent Recognition of the Plasmodium falciparum Antigen VAR2CSA among Young Tanzanian Children	PLOS ONE			English	Article							ERYTHROCYTE-MEMBRANE PROTEIN-1; INTERCELLULAR-ADHESION MOLECULE-1; INFECTED ERYTHROCYTES; IMMUNOGLOBULIN-G; SEVERE MALARIA; VAR GENES; DIFFERENTIAL EXPRESSION; HUMAN PLACENTA; ANTIBODIES; CYTOADHERENCE	PfEMP1 proteins comprise a family of variant antigens that appear on the surface of P. falciparum-infected erythrocytes and bind to multiple host receptors. Using a mammalian expression system and BioPlex technology, we developed an array of 24 protein constructs representing 38 PfEMP1 domains for high throughput analyses of receptor binding as well as total and functional antibody responses. We analyzed the reactivity of 561 plasma samples from 378 young Tanzanian children followed up to maximum 192 weeks of life in a longitudinal birth cohort. Surprisingly, reactivity to the DBL5 domain of VAR2CSA, a pregnancy malaria vaccine candidate, was most common, and the prevalence of reactivity was stable throughout early childhood. Reactivity to all other PfEMP1 constructs increased with age. Antibodies to the DBL2 beta C2(PF11_0521) domain, measured as plasma reactivity or plasma inhibition of ICAM1 binding, predicted reduced risk of hospitalization for severe or moderately severe malaria. These data suggest a role for VAR2CSA in childhood malaria and implicate DBL2 beta C2(PF11_0521) in protective immunity.	[Oleinikov, Andrew V.; Voronkova, Valentina V.; Frye, Isaac Tyler; Amos, Emily; Morrison, Robert; Fried, Michal; Duffy, Patrick E.] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Fried, Michal; Duffy, Patrick E.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Fried, Michal; Duffy, Patrick E.] NIAID, Lab Malaria Immunol & Vaccinol, NIH, Rockville, MD USA	Center for Infectious Disease Research; University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Oleinikov, AV (corresponding author), Seattle Biomed Res Inst, 4 Nickerson St, Seattle, WA 98109 USA.	andrew.oleinikov@seattlebiomed.org			National Institutes of Health [1R21AI064503, 1R01AI092120, RO1AI52059]; Foundation of the National Institutes of Health through the Grand Challenges in Global Health initiative [29202]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052059, ZIAAI001178, ZIAAI001056, R01AI092120, R21AI064503, ZIAAI001134] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation of the National Institutes of Health through the Grand Challenges in Global Health initiative; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by National Institutes of Health (http://www.nih.gov) grants 1R21AI064503 and 1R01AI092120 to AVO, RO1AI52059 to PED, and funded in part by the Foundation of the National Institutes of Health through the Grand Challenges in Global Health initiative (http://www.grandchallenges.org/Pages/default.aspx) Grant No. 29202 to PED. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARNWELL JW, 1989, J CLIN INVEST, V84, P765, DOI 10.1172/JCI114234; Barragan A, 1999, BIOCHEM SOC T, V27, P487, DOI 10.1042/bst0270487; Beeson JG, 2007, AM J TROP MED HYG, V77, P22, DOI 10.4269/ajtmh.2007.77.22; BERENDT AR, 1989, NATURE, V341, P57, DOI 10.1038/341057a0; Bull PC, 2005, PLOS PATHOG, V1, P202, DOI 10.1371/journal.ppat.0010026; Cham GKK, 2009, J IMMUNOL, V183, P3356, DOI 10.4049/jimmunol.0901331; DAVID PH, 1988, AM J TROP MED HYG, V38, P289, DOI 10.4269/ajtmh.1988.38.289; Dondorp AM, 2008, TRANSFUS CLIN BIOL, V15, P56, DOI 10.1016/j.tracli.2008.04.013; Fried M, 1998, J IMMUNOL, V160, P2523; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; Fried M, 1998, NATURE, V395, P851, DOI 10.1038/27570; Fried M, 2007, MOL BIOCHEM PARASIT, V155, P57, DOI 10.1016/j.molbiopara.2007.05.010; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Greenwood B, 2002, NATURE, V415, P670, DOI 10.1038/415670a; Gupta S, 1999, NAT MED, V5, P340, DOI 10.1038/6560; HANDUNNETTI SM, 1989, AM J TROP MED HYG, V40, P115, DOI 10.4269/ajtmh.1989.40.115; Hogh B, 1996, SCAND J INFECT DIS, P9; Hviid L, 2010, HUMAN VACCINES, P6; Jensen ATR, 2004, J EXP MED, V199, P1179, DOI 10.1084/jem.20040274; Joergensen L, 2006, INFECT IMMUN, V74, P6778, DOI 10.1128/IAI.01187-06; Kaestli M, 2006, J INFECT DIS, V193, P1567, DOI 10.1086/503776; Kriek N, 2003, MOL MICROBIOL, V50, P1215, DOI 10.1046/j.1365-2958.2003.03784.x; Kurtis JD, 1999, INFECT IMMUN, V67, P3424, DOI 10.1128/IAI.67.7.3424-3429.1999; Kyriacou HM, 2006, MOL BIOCHEM PARASIT, V150, P211, DOI 10.1016/j.molbiopara.2006.08.005; Lavstsen T, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-27; Lusingu JPA, 2006, INFECT IMMUN, V74, P2867, DOI 10.1128/IAI.74.5.2867-2875.2006; Magistrado PA, 2007, INFECT IMMUN, V75, P2415, DOI 10.1128/IAI.00951-06; MARSH K, 1989, T ROY SOC TROP MED H, V83, P293, DOI 10.1016/0035-9203(89)90478-1; MILLER LH, 1994, SCIENCE, V264, P1878, DOI 10.1126/science.8009217; Mutabingwa TK, 2005, PLOS MED, V2, P1260, DOI 10.1371/journal.pmed.0020407; Ndam NGT, 2006, J INFECT DIS, V193, P713, DOI 10.1086/500146; Newbold C, 1997, AM J TROP MED HYG, V57, P389, DOI 10.4269/ajtmh.1997.57.389; Okiro EA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-4; Oleinikov AV, 2008, J INFECT DIS, V197, P1119, DOI 10.1086/529526; Oleinikov AV, 2007, J INFECT DIS, V196, P155, DOI 10.1086/518513; Oleinikov AV, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000386; Pasvol G, 2005, BRIT MED BULL, V75-76, P29, DOI 10.1093/bmb/ldh059; Rasti N, 2006, P NATL ACAD SCI USA, V103, P13795, DOI 10.1073/pnas.0601519103; Robinson BA, 2003, MOL MICROBIOL, V47, P1265, DOI 10.1046/j.1365-2958.2003.03378.x; Rottmann M, 2006, INFECT IMMUN, V74, P3904, DOI 10.1128/IAI.02073-05; Salanti A, 2004, J EXP MED, V200, P1197, DOI 10.1084/jem.20041579; SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; TURNER GDH, 1994, AM J PATHOL, V145, P1057; Warimwe GM, 2009, P NATL ACAD SCI USA, V106, P21801, DOI 10.1073/pnas.0907590106	45	32	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e31011	10.1371/journal.pone.0031011	http://dx.doi.org/10.1371/journal.pone.0031011			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295123	gold, Green Published, Green Submitted			2022-12-27	WOS:000301640600068
J	Qin, C; Cao, Q; Li, P; Ju, XB; Wang, ML; Chen, JW; Wu, YL; Meng, XX; Zhu, J; Zhang, ZD; Lu, Q; Yin, CJ				Qin, Chao; Cao, Qiang; Li, Pu; Ju, Xiaobing; Wang, Meilin; Chen, Jiawei; Wu, Yilong; Meng, Xiaoxin; Zhu, Jian; Zhang, Zhengdong; Lu, Qiang; Yin, Changjun			Functional Promoter-31G > C Variant in Survivin Gene Is Associated with Risk and Progression of Renal Cell Cancer in a Chinese Population	PLOS ONE			English	Article							EXPRESSION; POLYMORPHISMS; CARCINOMA; BIOMARKERS	Background: Survivin is an inhibitor of apoptosis protein and is involved in the occurrence and progression of human malignancies. Recently, a functional polymorphism (-31G>C, rs9904341) in the promoter of survivin has been shown to influence its expression and confer susceptibility to different types of cancer. The present study was aimed to investigate whether the polymorphism also influences susceptibility and progression of renal cell cancer (RCC) in a Chinese population. Methods: We genotyped this polymorphism using the TaqMan assay in a case-control study comprised of 710 RCC patients and 760 controls. The logistic regression was used to assess the genetic association with occurrence and progression of RCC. Results: Compared with the genotypes containing G allele (GG and GC), we found a statistically significant increased occurrence of RCC associated with the CC genotype [P = 0.006, adjusted odds ratio (OR) = 1.38, 95% confidence interval (CI) = 1.08-1.76]. The polymorphism was associated with risk of developing advanced stage (OR = 2.02, 95% CI = 1.34-3.07) and moderately differentiated (OR = 1.75; 95% CI = 1.20-2.54) RCC. Furthermore, the patients carrying the CC genotype had a significantly greater prevalence of high clinical stage disease (P-trend = 0.003). Similar results were also observed when we restricted the analysis to clear cell RCC, a major histological type of RCC. Conclusions: Our results suggest that the functional -31G>C polymorphism in the promoter of survivin may influence the susceptibility and progression of RCC in the Chinese population. Large population-based prospective studies are required to validate our findings.	[Qin, Chao; Cao, Qiang; Li, Pu; Ju, Xiaobing; Chen, Jiawei; Wu, Yilong; Meng, Xiaoxin; Zhu, Jian; Lu, Qiang; Yin, Changjun] Nanjing Med Univ, Affiliated Hosp 1, Dept Urol, Nanjing, Jiangsu, Peoples R China; [Wang, Meilin; Zhang, Zhengdong] Nanjing Med Univ, Sch Publ Hlth, Dept Mol & Genet Toxicol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Qin, C (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Urol, Nanjing, Jiangsu, Peoples R China.	doctorlvqiang@sina.com; drcjyin@gmail.com	zhang, zheng/HCH-9684-2022; Cao, Qiang/K-2349-2019	Lu, Qiang/0000-0003-3589-2507	Innovative Research Team in the First Affiliated Hospital of Nanjing Medical University; Provincial Initiative Program for Excellency Disciplines, Jiangsu Province; Natural Science Foundation of Jiangsu Province [BK2008473]	Innovative Research Team in the First Affiliated Hospital of Nanjing Medical University; Provincial Initiative Program for Excellency Disciplines, Jiangsu Province; Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	The work was supported by the Program for Development of Innovative Research Team in the First Affiliated Hospital of Nanjing Medical University, Provincial Initiative Program for Excellency Disciplines, Jiangsu Province and the Natural Science Foundation of Jiangsu Province [BK2008473]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altieri DC, 2008, NAT REV CANCER, V8, P61, DOI 10.1038/nrc2293; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Baytekin F, 2009, UROL ONCOL; Borbely AA, 2007, J CLIN PATHOL, V60, P303, DOI 10.1136/jcp.2006.037804; Chen WC, 2004, WORLD J GASTROENTERO, V10, P2886; Chow WH, 2010, NAT REV UROL, V7, P245, DOI 10.1038/nrurol.2010.46; Falleni M, 2003, J PATHOL, V200, P620, DOI 10.1002/path.1388; Fields AC, 2004, MODERN PATHOL, V17, P1378, DOI 10.1038/modpathol.3800203; Gossage L, 2010, NAT REV CLIN ONCOL, V7, P277, DOI 10.1038/nrclinonc.2010.42; Jang JS, 2008, LUNG CANCER, V60, P31, DOI 10.1016/j.lungcan.2007.09.008; Kawata N, 2011, INT J CANC; Kleinrath T, 2007, J CLIN ONCOL, V25, P845, DOI 10.1200/JCO.2006.07.8154; Kosari F, 2005, CLIN CANCER RES, V11, P5128, DOI 10.1158/1078-0432.CCR-05-0073; Lei Y, 2010, MOL CELL BIOCHEM, V344, P23, DOI 10.1007/s11010-010-0525-3; Li FZ, 2003, J CELL PHYSIOL, V197, P8, DOI 10.1002/jcp.10327; Lin J, 2010, CARCINOGENESIS, V31, P1805, DOI 10.1093/carcin/bgq168; Liu BB, 2011, WORLD J CLIN ONCOL, V2, P164, DOI 10.5306/wjco.v2.i3.164; Ljungberg B, 2011, EUR UROL; McGuire BB, 2009, CURR OPIN UROL, V19, P441, DOI 10.1097/MOU.0b013e32832f0c68; Melet A, 2008, ADV EXP MED BIOL, V615, P47, DOI 10.1007/978-1-4020-6554-5_4; Mityaev M, 2008, BIOCHEMISTRY-MOSCOW+, V73, P1183, DOI 10.1134/S0006297908110035; Nakamura E, 2002, CLIN CANCER RES, V8, P2620; Okamura K, 2009, CANCER EPIDEMIOL, V33, P137, DOI 10.1016/j.canep.2009.06.005; Purdue MP, 2011, NAT GENET, V43, P60, DOI 10.1038/ng.723; Qin C, 2011, ANN ONCOL; Reed JC, 2001, J CLIN INVEST, V108, P965, DOI 10.1172/JCI14123; Semenza JC, 2001, AM J EPIDEMIOL, V153, P851, DOI 10.1093/aje/153.9.851; Srivastava K, 2011, MOL BIOL REP; Wang WJ, 2006, J SURG ONCOL, V93, P578, DOI 10.1002/jso.20507; Wang YH, 2009, UROLOGY, V73, P670, DOI 10.1016/j.urology.2008.09.048; Wu X, 2011, HUM MOL GENET; Wu YH, 2008, ACTA BIOCHIM POL, V55, P673; Xu Y, 2004, DNA CELL BIOL, V23, P527, DOI 10.1089/dna.2004.23.527; Zamparese R, 2008, CANCER INVEST, V26, P929, DOI 10.1080/07357900802017553; Zhen HN, 2007, INT J ONCOL, V31, P1111	35	26	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e28829	10.1371/journal.pone.0028829	http://dx.doi.org/10.1371/journal.pone.0028829			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295057	Green Submitted, Green Published, gold			2022-12-27	WOS:000301640600002
J	Xu, K; Mao, XZ; Mehta, M; Cui, J; Zhang, C; Xu, Y				Xu, Kun; Mao, Xizeng; Mehta, Minesh; Cui, Juan; Zhang, Chi; Xu, Ying			A Comparative Study of Gene-Expression Data of Basal Cell Carcinoma and Melanoma Reveals New Insights about the Two Cancers	PLOS ONE			English	Article							HALLMARKS; STATES; RISK	A comparative analysis of genome-scale transcriptomic data of two types of skin cancers, melanoma and basal cell carcinoma in comparison with other cancer types, was conducted with the aim of identifying key regulatory factors that either cause or contribute to the aggressiveness of melanoma, while basal cell carcinoma generally remains a mild disease. Multiple cancer-related pathways such as cell proliferation, apoptosis, angiogenesis, cell invasion and metastasis, are considered, but our focus is on energy metabolism, cell invasion and metastasis pathways. Our findings include the following. (a) Both types of skin cancers use both glycolysis and increased oxidative phosphorylation (electron transfer chain) for their energy supply. (b) Advanced melanoma shows substantial up-regulation of key genes involved in fatty acid metabolism (beta-oxidation) and oxidative phosphorylation, with aerobic metabolism being far more efficient than anaerobic glycolysis, providing a source of the energetics necessary to support the rapid growth of this cancer. (c) While advanced melanoma is similar to pancreatic cancer in terms of the activity level of genes involved in promoting cell invasion and metastasis, the main metastatic form of basal cell carcinoma is substantially reduced in this activity, partially explaining why this cancer type has been considered as far less aggressive. Our method of using comparative analyses of transcriptomic data of multiple cancer types focused on specific pathways provides a novel and highly effective approach to cancer studies in general.	[Xu, Kun; Mao, Xizeng; Mehta, Minesh; Cui, Juan; Zhang, Chi; Xu, Ying] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Xu, Kun; Mao, Xizeng; Mehta, Minesh; Cui, Juan; Zhang, Chi; Xu, Ying] Univ Georgia, Inst Bioinformat, Athens, GA 30602 USA; [Xu, Kun] Univ Georgia, Dept Stat, Athens, GA 30602 USA; [Mehta, Minesh] Amer Univ Antigua, Coll Med, New York, NY USA; [Xu, Ying] Jilin Univ, Coll Comp Sci & Technol, Changchun 130023, Jilin, Peoples R China	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Jilin University	Xu, K (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA.	xyn@bmb.uga.edu	Zhang, Chi/AAD-3036-2021	Zhang, Chi/0000-0001-9553-0925	National Institutes of Health [1R01GM075331]; Georgia Cancer Coalition; University of Georgia; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075331] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgia Cancer Coalition; University of Georgia; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the National Institutes of Health (1R01GM075331), a "Distinguished Scholar'' grant from the Georgia Cancer Coalition, and seed funding from the University of Georgia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balch CM, 2001, J CLIN ONCOL, V19, P3635, DOI 10.1200/JCO.2001.19.16.3635; Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; Box NF, 2001, AM J HUM GENET, V69, P765, DOI 10.1086/323412; Bozikov K, 2006, EUR J DERMATOL, V16, P691, DOI 10.1684/ejd.2006.0018; Cui J, 2008, BIOINFORMATICS, V24, P2370, DOI 10.1093/bioinformatics/btn418; Cui JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017819; Cui JA, 2011, NUCLEIC ACIDS RES, V39, P1197, DOI 10.1093/nar/gkq960; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fu LN, 2003, NAT REV CANCER, V3, P350, DOI 10.1038/nrc1072; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hong CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016875; Hughes-Davies TH, 1998, NEW ENGL J MED, V339, P347; Iwasaki JK, 2010, J AM ACAD DERMATOL; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jerant AF, 2000, AM FAM PHYSICIAN, V62, P357; Klymkowsky MW, 2009, AM J PATHOL, V174, P1588, DOI 10.2353/ajpath.2009.080545; Lo BKK, 2010, AM J PATHOL, V176, P2435, DOI 10.2353/ajpath.2010.081059; Polsky D, 2003, ONCOGENE, V22, P3087, DOI 10.1038/sj.onc.1206449; Polsky D, 2011, SKIN CANC FACTS; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Rogers HW, 2010, ARCH DERMATOL, V146, P283, DOI 10.1001/archdermatol.2010.19; Scatolini M, 2010, INT J CANCER, V126, P1869, DOI 10.1002/ijc.24899; Sherlock G, 2001, NUCLEIC ACIDS RES, V29, P152, DOI 10.1093/nar/29.1.152; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Xu K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013696; Zuo L, 1996, NAT GENET, V12, P97, DOI 10.1038/ng0196-97	29	19	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30750	10.1371/journal.pone.0030750	http://dx.doi.org/10.1371/journal.pone.0030750			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295108	Green Published, Green Submitted, gold			2022-12-27	WOS:000301640600053
J	Coyle, JM; Kaschak, MP				Coyle, Jacqueline M.; Kaschak, Michael P.			Female Fertility Affects Men's Linguistic Choices	PLOS ONE			English	Article							WOMENS FERTILITY; MIMICRY; ATTRACTIVENESS; CONCEPTION; PERCEPTION; INCREASES; OVULATION; MOTIVES; RATES; RISK	We examined the influence of female fertility on the likelihood of male participants aligning their choice of syntactic construction with those of female confederates. Men interacted with women throughout their menstrual cycle. On critical trials during the interaction, the confederate described a picture to the participant using particular syntactic constructions. Immediately thereafter, the participant described to the confederate a picture that could be described using either the same construction that was used by the confederate or an alternative form of the construction. Our data show that the likelihood of men choosing the same syntactic structure as the women was inversely related to the women's level of fertility: higher levels of fertility were associated with lower levels of linguistic matching. A follow-up study revealed that female participants do not show this same change in linguistic behavior as a function of changes in their conversation partner's fertility. We interpret these findings in the context of recent data suggesting that non-conforming behavior may be a means of men displaying their fitness as a mate to women.	[Coyle, Jacqueline M.] Embry Riddle Aeronaut Univ, Human Factors & Syst Dept, Daytona Beach, FL 32114 USA; [Kaschak, Michael P.] Florida State Univ, Dept Psychol, Tallahassee, FL 32306 USA	Embry-Riddle Aeronautical University; State University System of Florida; Florida State University	Coyle, JM (corresponding author), Embry Riddle Aeronaut Univ, Human Factors & Syst Dept, Daytona Beach, FL 32114 USA.	coylej2@erau.edu		Kaschak, Michael/0000-0002-7704-4904	National Science Foundation [0842620]; Direct For Social, Behav & Economic Scie [0842620] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	The work reported here was supported in part by The National Science Foundation grant 0842620. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker MD, 2008, EVOL HUM BEHAV, V29, P391, DOI 10.1016/j.evolhumbehav.2008.06.001; Baker MD, 2009, J EXP SOC PSYCHOL, V45, P1136, DOI 10.1016/j.jesp.2009.06.006; Bates D., 2011, IME4 LINEAR MIXED EF; BAVELAS JB, 1988, HUM COMMUN RES, V14, P275, DOI 10.1111/j.1468-2958.1988.tb00158.x; BERGER SM, 1975, AM J PSYCHOL, V88, P263, DOI 10.2307/1421596; Blairy S, 1999, J NONVERBAL BEHAV, V23, P5, DOI 10.1023/A:1021370825283; BOCK JK, 1986, COGNITIVE PSYCHOL, V18, P355, DOI 10.1016/0010-0285(86)90004-6; Bock K, 2000, J EXP PSYCHOL GEN, V129, P177, DOI 10.1037//0096-3445.129.2.177; Branigan HP, 2000, COGNITION, V75, pB13, DOI 10.1016/S0010-0277(99)00081-5; Brennan SE, 1996, J EXP PSYCHOL LEARN, V22, P1482, DOI 10.1037/0278-7393.22.6.1482; Chang F, 2006, PSYCHOL REV, V113, P234, DOI 10.1037/0033-295X.113.2.234; Chartrand TL, 1999, J PERS SOC PSYCHOL, V76, P893, DOI 10.1037/0022-3514.76.6.893; Cheng CM, 2003, J PERS SOC PSYCHOL, V85, P1170, DOI 10.1037/0022-3514.85.6.1170; Clark H.H., 1996, USING LANGUAGE; Dunbar RIM, 1996, GROOMING GOSSIP EVOL; GARROD S, 1987, COGNITION, V27, P181, DOI 10.1016/0010-0277(87)90018-7; Giles H., 1991, CONTEXTS ACCOMMODATI, DOI [10.1017/CBO9780511663673.001, DOI 10.1017/CBO9780511663673.001]; Griskevicius V, 2006, J PERS SOC PSYCHOL, V91, P281, DOI 10.1037/0022-3514.91.2.281; Griskevicius V, 2006, J PERS SOC PSYCHOL, V91, P63, DOI 10.1037/0022-3514.91.1.63; Haselton MG, 2007, HORM BEHAV, V51, P40, DOI 10.1016/j.yhbeh.2006.07.007; Haselton MG, 2006, HUM NATURE-INT BIOS, V17, P50, DOI 10.1007/s12110-006-1020-0; Haselton MG, 2006, HORM BEHAV, V49, P509, DOI 10.1016/j.yhbeh.2005.10.006; Ireland ME, 2011, PSYCHOL SCI, V22, P39, DOI 10.1177/0956797610392928; Ireland ME, 2010, J PERS SOC PSYCHOL, V99, P549, DOI 10.1037/a0020386; Kaschak MP, 2007, MEM COGNITION, V35, P925, DOI 10.3758/BF03193466; Kaschak MP, 2011, PSYCHON B REV, V18, P1133, DOI 10.3758/s13423-011-0157-y; Kaschak MP, 2011, MEM COGNITION, V39, P381, DOI 10.3758/s13421-010-0042-3; Kaschak MP, LANGUAGE CO IN PRESS; Labov, 2001, PRINCIPLES LINGUISTI; Li NP, 2002, J PERS SOC PSYCHOL, V82, P947, DOI 10.1037//0022-3514.82.6.947; Miller, 2000, MATING MIND SEXUAL C; Miller SL, 2011, J PERS SOC PSYCHOL, V100, P295, DOI 10.1037/a0020930; Miller SL, 2010, J EXP SOC PSYCHOL, V46, P1081, DOI 10.1016/j.jesp.2010.07.004; Miller SL, 2010, PSYCHOL SCI, V21, P276, DOI 10.1177/0956797609357733; Navarrete CD, 2009, PSYCHOL SCI, V20, P661, DOI 10.1111/j.1467-9280.2009.02352.x; Pickering MJ, 2008, PSYCHOL BULL, V134, P427, DOI 10.1037/0033-2909.134.3.427; Pickering MJ, 2009, EUR J SOC PSYCHOL, V39, P1162, DOI 10.1002/ejsp.663; Pickering MJ, 2004, BEHAV BRAIN SCI, V27, P169; Roberts SC, 2004, P ROY SOC B-BIOL SCI, V271, pS270, DOI 10.1098/rsbl.2004.0174; Roder S, 2009, PERS INDIV DIFFER, V47, P616, DOI 10.1016/j.paid.2009.05.019; WEBB JT, 1969, LANG SPEECH, V12, P54, DOI 10.1177/002383096901200105; Wilcox AJ, 2001, CONTRACEPTION, V63, P211, DOI 10.1016/S0010-7824(01)00191-3	43	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e27971	10.1371/journal.pone.0027971	http://dx.doi.org/10.1371/journal.pone.0027971			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	924ZP	22347361	gold, Green Submitted, Green Published			2022-12-27	WOS:000302730100002
J	Kidd, MR; Duftner, N; Koblmuller, S; Sturmbauer, C; Hofmann, HA				Kidd, Michael R.; Duftner, Nina; Koblmueller, Stephan; Sturmbauer, Christian; Hofmann, Hans A.			Repeated Parallel Evolution of Parental Care Strategies within Xenotilapia, a Genus of Cichlid Fishes from Lake Tanganyika	PLOS ONE			English	Article							SYMPATRIC SPECIATION; GENETIC-VARIATION; SEXUAL SELECTION; SOCIAL-BEHAVIOR; MATING SYSTEM; SPECIES FLOCK; MALAWI; PHYLOGENY; BRAIN; POLYMORPHISM	The factors promoting the evolution of parental care strategies have been extensively studied in experiment and theory. However, most attempts to examine parental care in an evolutionary context have evaluated broad taxonomic categories. The explosive and recent diversifications of East African cichlid fishes offer exceptional opportunities to study the evolution of various life history traits based on species-level phylogenies. The Xenotilapia lineage within the endemic Lake Tanganyika cichlid tribe Ectodini comprises species that display either biparental or maternal only brood care and hence offers a unique opportunity to study the evolution of distinct parental care strategies in a phylogenetic framework. In order to reconstruct the evolutionary relationships among 16 species of this lineage we scored 2,478 Amplified Fragment Length Polymorphisms (AFLPs) across the genome. We find that the Ectodini genus Enantiopus is embedded within the genus Xenotilapia and that during 2.5 to 3 million years of evolution within the Xenotilapia clade there have been 3-5 transitions from maternal only to biparental care. While most previous models suggest that uniparental care (maternal or paternal) arose from biparental care, we conclude from our species-level analysis that the evolution of parental care strategies is not only remarkably fast, but much more labile than previously expected.	[Kidd, Michael R.; Duftner, Nina; Hofmann, Hans A.] Univ Texas Austin, Inst Neurosci, Sect Integrat Biol, Austin, TX 78712 USA; [Kidd, Michael R.] Texas A&M Int Univ, Dept Biol & Chem, Laredo, TX USA; [Koblmueller, Stephan; Sturmbauer, Christian] Graz Univ, Dept Zool, Graz, Austria; [Hofmann, Hans A.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; Texas A&M University System; Texas A&M International University; University of Graz; University of Texas System; University of Texas Austin	Kidd, MR (corresponding author), Univ Texas Austin, Inst Neurosci, Sect Integrat Biol, Austin, TX 78712 USA.	michael.kidd@tamiu.edu	Hofmann, Hans A/E-4538-2016	Hofmann, Hans A/0000-0002-3335-330X; Koblmuller, Stephan/0000-0002-1024-3220	Erwin Schrodinger postdoctoral fellowship from the FWF Austrian Science Fund; NSF [IBN-021795, IBN-0843712]; Alfred P. Sloan Foundation; Dwight W. and Blanche Faye Reeder Centennial Fellowship in Systematic and Evolutionary Biology; Institute for Cellular and Molecular Biology; Division Of Integrative Organismal Systems [0843712] Funding Source: National Science Foundation; Austrian Science Fund (FWF) [P 22737] Funding Source: researchfish	Erwin Schrodinger postdoctoral fellowship from the FWF Austrian Science Fund; NSF(National Science Foundation (NSF)); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Dwight W. and Blanche Faye Reeder Centennial Fellowship in Systematic and Evolutionary Biology; Institute for Cellular and Molecular Biology; Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by an Erwin Schrodinger postdoctoral fellowship from the FWF Austrian Science Fund to ND; NSF grants IBN-021795 and IBN-0843712, the Alfred P. Sloan Foundation, Dwight W. and Blanche Faye Reeder Centennial Fellowship in Systematic and Evolutionary Biology, and an Institute for Cellular and Molecular Biology Fellowship to HAH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertson RC, 2008, COPEIA, P689, DOI 10.1643/CG-07-217; Albertson RC, 1999, P NATL ACAD SCI USA, V96, P5107, DOI 10.1073/pnas.96.9.5107; Allender CJ, 2003, P NATL ACAD SCI USA, V100, P14074, DOI 10.1073/pnas.2332665100; ARONSON LESTER R., 1949, ZOOLOGICA [NEW YORK], V34, P133; Baerends G.P., 1950, BEHAVIOUR          S, V1, P1; BAERENDS GP, 1986, J FISH BIOL, V29, P107, DOI 10.1111/j.1095-8649.1986.tb05003.x; Balshine-Earn S, 1998, P ROY SOC B-BIOL SCI, V265, P2217, DOI 10.1098/rspb.1998.0562; BalshineEarn S, 1997, J THEOR BIOL, V184, P423, DOI 10.1006/jtbi.1996.0254; BARLOW GW, 1974, AM ZOOL, V14, P9; Barlow GW, 1991, CICHLID FISHES BEHAV, P191; Barlow GW., 2000, CICHLID FISHES NATUR; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; BAYLIS JR, 1981, ENVIRON BIOL FISH, V6, P223, DOI 10.1007/BF00002788; Bensch S, 2005, MOL ECOL, V14, P2899, DOI 10.1111/j.1365-294X.2005.02655.x; Bonin A, 2007, MOL ECOL, V16, P3737, DOI 10.1111/j.1365-294X.2007.03435.x; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; Duponchelle F, 2008, P NATL ACAD SCI USA, V105, P15475, DOI 10.1073/pnas.0802343105; Egger B, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-137; Fryer G, 1972, CICHLID FISHES GREAT; GITTLEMAN JL, 1981, ANIM BEHAV, V29, P936, DOI 10.1016/S0003-3472(81)80031-0; Gompel N, 2009, DEV BIOL, V332, P36, DOI 10.1016/j.ydbio.2009.04.040; Gonzalez-Voyer A, 2008, EVOLUTION, V62, P2015, DOI 10.1111/j.1558-5646.2008.00426.x; Goodwin NB, 1998, P ROY SOC B-BIOL SCI, V265, P2265, DOI 10.1098/rspb.1998.0569; Greenwood P.H., 1978, Bulletin of the British Museum (Natural History) Zoology, V33, P297; GROSS MR, 1985, AM ZOOL, V25, P807; Hammock EAD, 2005, SCIENCE, V308, P1630, DOI 10.1126/science.1111427; HERT E, 1990, J FISH BIOL, V36, P853, DOI 10.1111/j.1095-8649.1990.tb05633.x; HILLIS DM, 1992, J HERED, V83, P189, DOI 10.1093/oxfordjournals.jhered.a111190; Hofmann HA, 2010, P NATL ACAD SCI USA, V107, P9919, DOI 10.1073/pnas.1005137107; HOLZBERG S, 1978, Z ZOOL SYST EVOL, V16, P171; Kabelik D, 2009, HORM BEHAV, V56, P101, DOI 10.1016/j.yhbeh.2009.03.017; Keenleyside M.H.A., 1991, P191; Kellogg KA, 2000, BEHAV ECOL SOCIOBIOL, V47, P164, DOI 10.1007/s002650050007; Kidd MR, 2006, MOL ECOL, V15, P459, DOI 10.1111/j.1365-294X.2005.02787.x; Klett V, 2002, MOL BIOL EVOL, V19, P865, DOI 10.1093/oxfordjournals.molbev.a004144; Koblmuller S, 2008, HYDROBIOLOGIA, V615, P5, DOI 10.1007/s10750-008-9552-4; Koblmueller Stephan, 2007, Molecular Phylogenetics and Evolution, V44, P1295, DOI 10.1016/j.ympev.2007.02.010; Koblmuller S, 2010, MOL PHYLOGENET EVOL, V55, P318, DOI 10.1016/j.ympev.2009.09.032; Koblmuller S, 2004, J MOL EVOL, V58, P79, DOI 10.1007/s00239-003-2527-1; Kocher TD, 2003, NATURE, V423, P489, DOI 10.1038/423489a; KOCHER TD, 1993, MOL PHYLOGENET EVOL, V2, P158, DOI 10.1006/mpev.1993.1016; Kocher TD, 2004, NAT REV GENET, V5, P288, DOI 10.1038/nrg1316; Konings A, 2015, TANGANYIKA CICHLIDS; KUWAMURA T, 1986, J ETHOL, V4, P129, DOI 10.1007/BF02348115; Kuwamura T., 1997, FISH COMMUNITIES LAK, P59; Lande R, 2001, GENETICA, V112, P435, DOI 10.1023/A:1013379521338; Losos JB, 1998, SCIENCE, V279, P2115, DOI 10.1126/science.279.5359.2115; LOWE ROSEMARY H., 1959, PROC ZOOL SOC LONDON, V132, P1; Machado HE, 2009, INTEGR COMP BIOL, V49, P644, DOI 10.1093/icb/icp080; Maddison W., 2018, MESQUITE MODULAR SYS; Mank JE, 2005, EVOLUTION, V59, P1570; McKaye K.R., 1991, FISH FISHERIES SERIE, V2, P241; MCKAYE KR, 1983, ENVIRON BIOL FISH, V8, P81, DOI 10.1007/BF00005175; MORAN P, 1993, MOL BIOL EVOL, V10, P1015; Neat FC, 1999, ENVIRON BIOL FISH, V55, P333, DOI 10.1023/A:1007580619528; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Nishida Mutsumi, 1997, P1; O'Connell LA, 2011, FRONT NEUROENDOCRIN, V32, P320, DOI 10.1016/j.yfrne.2010.12.004; O'Quin KE, 2010, MOL BIOL EVOL, V27, P2839, DOI 10.1093/molbev/msq171; Oldfield RG, 2012, P R SOC B IN PRESS; Oldfield RG, 2011, PHYSIOL BEHAV, V102, P296, DOI 10.1016/j.physbeh.2010.11.022; OPPENHEIMER J R, 1970, Animal Behaviour, V18, P493, DOI 10.1016/0003-3472(70)90045-X; Parker A, 1997, J MOL EVOL, V45, P70, DOI 10.1007/PL00006204; POLL M, 1986, MEM CLASSE SCI ACAD, V5, P5; Pollen AA, 2008, BRAIN BEHAV EVOLUT, V72, P145, DOI 10.1159/000151474; Pollen AA, 2007, BRAIN BEHAV EVOLUT, V70, P21, DOI 10.1159/000101067; Protas ME, 2006, NAT GENET, V38, P107, DOI 10.1038/ng1700; Rosso L, 2008, BIOL LETTERS, V4, P375, DOI 10.1098/rsbl.2008.0122; Rundle HD, 2000, SCIENCE, V287, P306, DOI 10.1126/science.287.5451.306; Schliewen Ulrich K, 2004, Front Zool, V1, P5, DOI 10.1186/1742-9994-1-5; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Seehausen O, 2004, TRENDS ECOL EVOL, V19, P198, DOI 10.1016/j.tree.2004.01.003; Seehausen O, 2003, P ROY SOC B-BIOL SCI, V270, P129, DOI 10.1098/rspb.2002.2153; Seehausen O, 1999, ECOL LETT, V2, P367; Sefc KM, 2011, INT J EVOL BIOL, P20, DOI DOI 10.4061/2011/470875; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; STURMBAUER C, 1993, MOL BIOL EVOL, V10, P751; Sturmbauer C, 2010, MOL PHYLOGENET EVOL, V57, P266, DOI 10.1016/j.ympev.2010.06.018; Summers K, 1999, BIOL J LINN SOC, V66, P515; Summers K, 1999, HERPETOLOGICA, V55, P254; Swofford DL., 2001, PAUP PHYLOGENETIC AN; Takahashi K, 1998, MOL BIOL EVOL, V15, P391, DOI 10.1093/oxfordjournals.molbev.a025936; Takahashi T, 1997, ICHTHYOL RES, V44, P109, DOI 10.1007/BF02678689; Takahashi T, 2003, ICHTHYOL RES, V50, P36, DOI 10.1007/s102280300005; TOWNSHEND TJ, 1985, BEHAVIOUR, V95, P181, DOI 10.1163/156853985X00118; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; TURNER GF, 1999, EVOLUTION BIOL DIVER, P217; VANRHIJN JG, 1991, ANIM BEHAV, V41, P963, DOI 10.1016/S0003-3472(05)80634-7; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wang ZS, 2003, EVOLUTION, V57, P2852; WERREN JH, 1980, J THEOR BIOL, V82, P619, DOI 10.1016/0022-5193(80)90182-4; YANAGISAWA Y, 1986, JPN J ICHTHYOL, V33, P249, DOI 10.1007/BF02904161	93	14	16	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31236	10.1371/journal.pone.0031236	http://dx.doi.org/10.1371/journal.pone.0031236			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347454	Green Submitted, gold, Green Published			2022-12-27	WOS:000302730100057
J	Wang, M; Shi, S; Lin, F; Hao, ZQ; Jiang, P; Dai, GH				Wang, Miao; Shi, Shuai; Lin, Fei; Hao, Zhanqing; Jiang, Ping; Dai, Guanhua			Effects of Soil Water and Nitrogen on Growth and Photosynthetic Response of Manchurian Ash (Fraxinus mandshurica) Seedlings in Northeastern China	PLOS ONE			English	Article							LEAF GAS-EXCHANGE; USE EFFICIENCY; AMINO-ACIDS; RIBULOSE-1,5-BISPHOSPHATE CARBOXYLASE; CHLOROPLAST ULTRASTRUCTURE; TERRESTRIAL ECOSYSTEMS; MESOPHYLL CONDUCTANCE; CARBON ASSIMILATION; TRITICUM-AESTIVUM; CO2 ASSIMILATION	Background: Soil water and nitrogen (N) are considered to be the main environmental factors limiting plant growth and photosynthetic capacity. However, less is known about the interactive effects of soil water and N on tree growth and photosynthetic response in the temperate ecosystem. Methods/Principal Findings: We applied N and water, alone and in combination, and investigated the combined effect of different water and N regimes on growth and photosynthetic responses of Fraxinus mandshurica seedlings. The seedlings were exposed to three water regimes including natural precipitation (CK), higher precipitation (HW) (CK +30%) and lower precipitation (LW) (CK -30%), and both with and without N addition for two growing seasons. We demonstrated that water and N supply led to a significant increase in the growth and biomass production of the seedlings. LW treatment significantly decreased biomass production and leaf N content, but they showed marked increases in N addition. N addition could enhance the photosynthetic capability under HW and CK conditions. Leaf chlorophyll content and the initial activity of Rubisco were dramatically increased by N addition regardless of soil water condition. The positive relationships were found between photosynthetic capacity, leaf N content, and SLA in response to water and N supply in the seedling. Rubisco expression was up-regulated by N addition with decreasing soil water content. Immunofluorescent staining showed that the labeling for Rubisco was relatively low in leaves of the seedlings under LW condition. The accumulation of Rubisco was increased in leaf tissues of LW by N addition. Conclusions/Significance: Our study has presented better understanding of the interactions between soil water and N on the growth and photosynthetic response in F. mandschurica seedlings, which may provide novel insights on the potential responses of the forest ecosystem to climate change associated with increasing N deposition.	[Wang, Miao; Shi, Shuai; Lin, Fei; Hao, Zhanqing; Jiang, Ping; Dai, Guanhua] Chinese Acad Sci, Inst Appl Ecol, Shenyang, Peoples R China	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS	Wang, M (corresponding author), Chinese Acad Sci, Inst Appl Ecol, Shenyang, Peoples R China.	wangmiao@iae.ac.cn			Major State Basic Research Development Program [2010CB833502]; Chinese Academy of Sciences [KSCX-YW-Z-1022]; National Natural Science Foundation of China [30590382/C011108]; Program for the National Natural Science Foundation of China [30870376]	Major State Basic Research Development Program(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was sponsored by the Major State Basic Research Development Program (2010CB833502), the Knowledge Innovation Project of the Chinese Academy of Sciences (KSCX-YW-Z-1022), the Key Program of the National Natural Science Foundation of China (30590382/C011108) and the Program for the National Natural Science Foundation of China (No. 30870376). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aber JD, 2003, BIOSCIENCE, V53, P375, DOI 10.1641/0006-3568(2003)053[0375:INDATN]2.0.CO;2; Alves AAC, 2000, CROP SCI, V40, P131, DOI 10.2135/cropsci2000.401131x; Andersson I, 2008, PLANT PHYSIOL BIOCH, V46, P275, DOI 10.1016/j.plaphy.2008.01.001; Andrews M, 1999, PLANT CELL ENVIRON, V22, P949, DOI 10.1046/j.1365-3040.1999.00452.x; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Asghari R, 2006, IRAN J SCI TECHNOL A, V30, P1; Bondada BR, 2003, TREE PHYSIOL, V23, P553, DOI 10.1093/treephys/23.8.553; Bota J, 2004, NEW PHYTOL, V162, P671, DOI 10.1111/j.1469-8137.2004.01056.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRESTIC M, 1995, PLANTA, V196, P450, DOI 10.1007/BF00203643; Cabrera-Bosquet L, 2007, ANN APPL BIOL, V151, P277, DOI 10.1111/j.1744-7348.2007.00195.x; Campbell DR, 2010, AM J BOT, V97, P925, DOI 10.3732/ajb.0900387; Catovsky S, 2002, ECOL APPL, V12, P1056, DOI 10.1890/1051-0761(2002)012[1056:NAIROT]2.0.CO;2; CHANDLER JW, 1995, TREE PHYSIOL, V15, P813, DOI 10.1093/treephys/15.12.813; Chaves MM, 2004, J EXP BOT, V55, P2365, DOI 10.1093/jxb/erh269; Cheng L, 2000, J HORTIC SCI BIOTECH, V75, P383, DOI 10.1080/14620316.2000.11511255; Compton JE, 2004, FOREST ECOL MANAG, V196, P143, DOI 10.1016/j.foreco.2004.03.017; Correia CM, 2005, EUR J AGRON, V22, P337, DOI 10.1016/j.eja.2004.05.002; DaMatta FM, 2002, TREES-STRUCT FUNCT, V16, P555, DOI 10.1007/s00468-002-0205-3; Egli P, 1999, ACTA OECOL, V20, P559, DOI 10.1016/S1146-609X(00)86623-0; Eichelmann H, 1999, PLANT PHYSIOL, V119, P179, DOI 10.1104/pp.119.1.179; Ellsworth DS, 2000, TREE PHYSIOL, V20, P435; Ennahli S, 2005, CROP SCI, V45, P2374, DOI 10.2135/cropsci2005.0147; EVANS JR, 1986, PLANTA, V167, P351, DOI 10.1007/BF00391338; EVANS JR, 1983, PLANT PHYSIOL, V72, P297, DOI 10.1104/pp.72.2.297; Field C., 1986, EC PLANT FORM FUNCTI, P22; Flexas J, 2004, PLANT BIOLOGY, V6, P269, DOI 10.1055/s-2004-820867; Foyer CH, 1998, PLANT PHYSIOL, V117, P283, DOI 10.1104/pp.117.1.283; GEZELIUS K, 1986, PHYSIOL PLANTARUM, V67, P435, DOI 10.1111/j.1399-3054.1986.tb05759.x; Grassi G, 2005, PLANT CELL ENVIRON, V28, P834, DOI 10.1111/j.1365-3040.2005.01333.x; Huang YZ, 2008, CEREB CORTEX, V18, P563, DOI 10.1093/cercor/bhm087; INSKEEP WP, 1985, PLANT PHYSIOL, V77, P483, DOI 10.1104/pp.77.2.483; Kutik J, 1995, J EXP BOT, V46, P1797, DOI 10.1093/jxb/46.12.1797; Laitinen K, 2000, TREE PHYSIOL, V20, P881; Lambers H., 1998, PLANT PHYSL ECOLOGY, P540, DOI DOI 10.1007/978-1-4757-2855-2; LATHAM RE, 1992, ECOLOGY, V73, P2129, DOI 10.2307/1941461; LAUTER DJ, 1981, AGRON J, V73, P961, DOI 10.2134/agronj1981.00021962007300060013x; LAWLOR DW, 1995, J EXP BOT, V46, P1449, DOI 10.1093/jxb/46.special_issue.1449; LeBauer DS, 2008, ECOLOGY, V89, P371, DOI 10.1890/06-2057.1; Liu P, 2006, APPL SOIL ECOL, V34, P266, DOI 10.1016/j.apsoil.2005.12.009; MAE T, 1983, PLANT CELL PHYSIOL, V24, P1079; MAKINO A, 1988, PLANTA, V174, P30, DOI 10.1007/BF00394870; MAKINO A, 1984, PLANT CELL PHYSIOL, V25, P429; Manter DK, 2005, TREE PHYSIOL, V25, P1015, DOI 10.1093/treephys/25.8.1015; Matson P, 2002, AMBIO, V31, P113, DOI 10.1639/0044-7447(2002)031[0113:TGONDC]2.0.CO;2; McDonald AJS, 1996, ADV BOT RES, V22, P229; MITCHELL AK, 1993, TREE PHYSIOL, V12, P403, DOI 10.1093/treephys/12.4.403; Nakaji T, 2001, TREES-STRUCT FUNCT, V15, P453, DOI 10.1007/s00468-001-0130-x; Nakano H, 1997, PLANT PHYSIOL, V115, P191, DOI 10.1104/pp.115.1.191; Naumann JC, 2008, ENVIRON EXP BOT, V63, P402, DOI 10.1016/j.envexpbot.2007.12.008; Patrick LD, 2009, PLANT CELL ENVIRON, V32, P1695, DOI 10.1111/j.1365-3040.2009.02029.x; Penuelas J, 2009, SCIENCE, V324, P887, DOI 10.1126/science.1173004; Poorter H, 2000, AUST J PLANT PHYSIOL, V27, P1191, DOI 10.1071/PP99173; POORTER H, 1990, OECOLOGIA, V83, P553, DOI 10.1007/BF00317209; REICH PB, 1995, OECOLOGIA, V104, P24, DOI 10.1007/BF00365558; Reich PB, 1998, FUNCT ECOL, V12, P395, DOI 10.1046/j.1365-2435.1998.00209.x; Reich PB, 2006, ANNU REV ECOL EVOL S, V37, P611, DOI 10.1146/annurev.ecolsys.37.091305.110039; Ripullone F, 2003, TREE PHYSIOL, V23, P137, DOI 10.1093/treephys/23.2.137; SAGE RF, 1987, PLANT PHYSIOL, V85, P355, DOI 10.1104/pp.85.2.355; Schwinning S, 2005, RANGELAND ECOL MANAG, V58, P565, DOI 10.2111/03-126.1; Shangguan ZP, 2000, ENVIRON EXP BOT, V44, P141, DOI 10.1016/S0098-8472(00)00064-2; Shaw B, 2002, PLANT GROWTH REGUL, V37, P77, DOI 10.1023/A:1020381513976; STITT M, 1994, PLANT CELL ENVIRON, V17, P465, DOI 10.1111/j.1365-3040.1994.tb00144.x; Stitt M, 1996, ADV PHOTOSYNTHESIS R, P151, DOI DOI 10.1007/0-306-48135-9_; TISSUE DT, 1993, PLANT CELL ENVIRON, V16, P859, DOI 10.1111/j.1365-3040.1993.tb00508.x; Tyree MC, 2009, FOREST ECOL MANAG, V257, P1847, DOI 10.1016/j.foreco.2009.02.001; VAITKUS MR, 1993, AM MIDL NAT, V129, P42, DOI 10.2307/2426434; van den Berg AK, 2004, FOREST ECOL MANAG, V200, P113, DOI 10.1016/j.foreco.2004.06.005; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87; Wang CH, 2006, SOIL BIOL BIOCHEM, V38, P1101, DOI 10.1016/j.soilbio.2005.09.009; Wang YP, 1998, AGR FOREST METEOROL, V91, P89, DOI 10.1016/S0168-1923(98)00061-6; Warren CR, 2000, J EXP BOT, V51, P1147, DOI 10.1093/jexbot/51.347.1147; Warren CR, 2003, TREES-STRUCT FUNCT, V17, P359, DOI 10.1007/s00468-003-0246-2; Warren CR, 2001, PLANT CELL ENVIRON, V24, P597, DOI 10.1046/j.1365-3040.2001.00711.x; Wendler R, 1996, TREE PHYSIOL, V16, P153; Wu FZ, 2008, PHOTOSYNTHETICA, V46, P40, DOI 10.1007/s11099-008-0008-x; Yamaguchi, 2007, Patent No. [US 2010/0180994 A1, 20100180994]; Yin CY, 2006, PHOTOSYNTHETICA, V44, P62, DOI 10.1007/s11099-005-0159-y; [张弥 Zhang Mi], 2005, [生态学杂志, Chinese Journal of Ecology], V24, P1007; Zhou XB, 2011, ENVIRON EXP BOT, V74, P1, DOI 10.1016/j.envexpbot.2010.12.005	80	41	51	2	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e30754	10.1371/journal.pone.0030754	http://dx.doi.org/10.1371/journal.pone.0030754			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347401	Green Submitted, Green Published, gold			2022-12-27	WOS:000302730100024
J	Fluch, S; Kopecky, D; Burg, K; Simkova, H; Taudien, S; Petzold, A; Kubalakova, M; Platzer, M; Berenyi, M; Krainer, S; Dolezel, J; Lelley, T				Fluch, Silvia; Kopecky, Dieter; Burg, Kornel; Simkova, Hana; Taudien, Stefan; Petzold, Andreas; Kubalakova, Marie; Platzer, Matthias; Berenyi, Maria; Krainer, Siegfried; Dolezel, Jaroslav; Lelley, Tamas			Sequence Composition and Gene Content of the Short Arm of Rye (Secale cereale) Chromosome 1	PLOS ONE			English	Article							GENOME SIZE; CHLOROPLAST DNA; ISOZYME MARKERS; FLOW-CYTOMETRY; WHEAT; L.; 1R; MAP; RESISTANCE; TRANSLOCATION	Background: The purpose of the study is to elucidate the sequence composition of the short arm of rye chromosome 1 (Secale cereale) with special focus on its gene content, because this portion of the rye genome is an integrated part of several hundreds of bread wheat varieties worldwide. Methodology/Principal Findings: Multiple Displacement Amplification of 1RS DNA, obtained from flow sorted 1RS chromosomes, using 1RS ditelosomic wheat-rye addition line, and subsequent Roche 454FLX sequencing of this DNA yielded 195,313,589 bp sequence information. This quantity of sequence information resulted in 0.43 x sequence coverage of the 1RS chromosome arm, permitting the identification of genes with estimated probability of 95%. A detailed analysis revealed that more than 5% of the 1RS sequence consisted of gene space, identifying at least 3,121 gene loci representing 1,882 different gene functions. Repetitive elements comprised about 72% of the 1RS sequence, Gypsy/Sabrina (13.3%) being the most abundant. More than four thousand simple sequence repeat (SSR) sites mostly located in gene related sequence reads were identified for possible marker development. The existence of chloroplast insertions in 1RS has been verified by identifying chimeric chloroplast-genomic sequence reads. Synteny analysis of 1RS to the full genomes of Oryza sativa and Brachypodium distachyon revealed that about half of the genes of 1RS correspond to the distal end of the short arm of rice chromosome 5 and the proximal region of the long arm of Brachypodium distachyon chromosome 2. Comparison of the gene content of 1RS to 1HS barley chromosome arm revealed high conservation of genes related to chromosome 5 of rice. Conclusions: The present study revealed the gene content and potential gene functions on this chromosome arm and demonstrated numerous sequence elements like SSRs and gene-related sequences, which can be utilised for future research as well as in breeding of wheat and rye.	[Fluch, Silvia; Kopecky, Dieter; Burg, Kornel; Berenyi, Maria; Krainer, Siegfried] Austrian Inst Technol, Hlth & Environm Dept, Tulln, Austria; [Simkova, Hana; Kubalakova, Marie; Dolezel, Jaroslav] Inst Expt Bot, Ctr Reg Hana Biotechnol & Agr Res, Olomouc, Czech Republic; [Taudien, Stefan; Petzold, Andreas; Platzer, Matthias] Fritz Lipmann Inst, Leibniz Inst Age Res, Jena, Germany; [Lelley, Tamas] Univ Nat Resources & Appl Life Sci BOKU, Inst Biotechnol Plant Prod IFA Tulln, Dept Agrobiotechnol, Vienna, Austria	Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); University of Natural Resources & Life Sciences, Vienna	Fluch, S (corresponding author), Austrian Inst Technol, Hlth & Environm Dept, Tulln, Austria.	kornel.burg@ait.ac.at	Dolezel, Jaroslav/B-7716-2008; Kubaláková, Marie/F-8269-2014; Simkova, Hana/F-7734-2014	Dolezel, Jaroslav/0000-0002-6263-0492; Simkova, Hana/0000-0003-4159-7619; Fluch, Silvia/0000-0001-5713-7081	Austrian Science Fund [P18414-B2, P19944-B17]; Ministry of Education, Youth and Sport of the Czech Republic; European Regional Development Fund [ED0007/01/01]	Austrian Science Fund(Austrian Science Fund (FWF)); Ministry of Education, Youth and Sport of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); European Regional Development Fund(European Commission)	This research was supported by the Austrian Science Fund (P18414-B2 and P19944-B17) and the Ministry of Education, Youth and Sport of the Czech Republic and the European Regional Development Fund (Operational Programme Research and Development for Innovations No. ED0007/01/01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 2000, NATURE, V408, P354, DOI 10.1038/35042567; ALONSOBLANCO C, 1994, THEOR APPL GENET, V88, P208, DOI 10.1007/BF00225899; Anderson GR, 2003, THEOR APPL GENET, V107, P1297, DOI 10.1007/s00122-003-1358-1; Bartos J, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-95; BAUM M, 1991, CHROMOSOMA, V101, P1, DOI 10.1007/BF00360680; Berkman PJ, 2011, PLANT BIOTECHNOL J, V9, P768, DOI 10.1111/j.1467-7652.2010.00587.x; Bock R, 2008, BIOESSAYS, V30, P556, DOI 10.1002/bies.20761; Borner A, 1998, THEOR APPL GENET, V97, P1279, DOI 10.1007/s001220051020; CARVER BF, 1995, CROP SCI, V35, P1316, DOI 10.2135/cropsci1995.0011183X003500050010x; Clarke BC, 1996, CHROMOSOMA, V105, P269, DOI 10.1007/BF02524644; CONNER RL, 1991, CROP SCI, V31, P315, DOI 10.2135/cropsci1991.0011183X003100020018x; de la Bastide Melissa, 2007, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1104s17; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Devos KM, 2000, PLANT CELL, V12, P637, DOI 10.1105/tpc.12.5.637; Devos KM, 2008, 11 INT WHEAT GEN S P; Dolezel J, 2003, CYTOM PART A, V51A, P127, DOI 10.1002/cyto.a.10013; Dolezel J, 1998, ANN BOT-LONDON, V82, P17, DOI 10.1006/anbo.1998.0730; Dolezel J, 2007, CHROMOSOME RES, V15, P51, DOI 10.1007/s10577-006-1106-x; DRISCOLL C. J., 1971, Agronomy Abstracts, P6; Ehdaie B, 2003, CROP SCI, V43, P710, DOI 10.2135/cropsci2003.0710; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; FLAVELL RB, 1974, BIOCHEM GENET, V12, P257, DOI 10.1007/BF00485947; Francki MG, 2001, GENOME, V44, P266, DOI 10.1139/gen-44-2-266; Gale MD, 1995, P 3 INT RIC GEN S, P77; Graybosch RA, 2001, J CEREAL SCI, V33, P3, DOI 10.1006/jcrs.2000.0336; Green RE, 2006, NATURE, V444, P330, DOI 10.1038/nature05336; Guo XY, 2008, FUNCT INTEGR GENOMIC, V8, P101, DOI 10.1007/s10142-007-0067-2; GUSTAFSON JP, 1988, P NATL ACAD SCI USA, V85, P3943, DOI 10.1073/pnas.85.11.3943; Hackauf B, 2009, THEOR APPL GENET, V118, P371, DOI 10.1007/s00122-008-0906-0; Hosono S, 2003, GENOME RES, V13, P954, DOI 10.1101/gr.816903; Huang CY, 2003, NATURE, V422, P72, DOI 10.1038/nature01435; Kofler R, 2008, THEOR APPL GENET, V117, P915, DOI 10.1007/s00122-008-0831-2; Kofler R, 2007, BIOINFORMATICS, V23, P1683, DOI 10.1093/bioinformatics/btm157; Korzun V, 2001, THEOR APPL GENET, V102, P709, DOI 10.1007/s001220051701; Krumsiek J, 2007, BIOINFORMATICS, V23, P1026, DOI 10.1093/bioinformatics/btm039; Kubalakova M, 2003, GENOME, V46, P893, DOI [10.1139/g03-054, 10.1139/G03-054]; LANDER E S, 1988, Genomics, V2, P231; Lelley T, 2004, J CEREAL SCI, V39, P313, DOI 10.1016/j.jcs.2003.11.003; Ma XF, 2001, THEOR APPL GENET, V102, P517, DOI 10.1007/s001220051676; Mago R, 2002, THEOR APPL GENET, V104, P1317, DOI 10.1007/s00122-002-0879-3; Masojc P, 2001, THEOR APPL GENET, V102, P1273, DOI 10.1007/s001220000512; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Mayer KFX, 2011, PLANT CELL, V23, P1249, DOI 10.1105/tpc.110.082537; Mayer KFX, 2009, PLANT PHYSIOL, V151, P496, DOI 10.1104/pp.109.142612; McIntosh R. A., 1988, Proceedings of the seventh international wheat genetics symposium, held at Cambridge, UK, 13-19 July 1988., P1225; Meyer M, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1095; Nagy ED, 2003, THEOR APPL GENET, V107, P1271, DOI 10.1007/s00122-003-1367-0; Nagy ED, 2003, EUPHYTICA, V132, P243, DOI 10.1023/A:1025002919746; Noutsos C, 2007, TRENDS GENET, V23, P597, DOI 10.1016/j.tig.2007.08.016; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Price AL, 2005, BIOINFORMATICS, V21, pI351, DOI 10.1093/bioinformatics/bti1018; Rabinovich SV, 1998, EUPHYTICA, V100, P323, DOI 10.1023/A:1018361819215; Sandhu D, 2002, PLANT PHYSIOL, V128, P803, DOI 10.1104/pp.010745; SCHLEGEL R, 1987, THEOR APPL GENET, V74, P820, DOI 10.1007/BF00247563; Sharma S, 2011, THEOR APPL GENET, V122, P759, DOI 10.1007/s00122-010-1484-5; Sharma S, 2009, THEOR APPL GENET, V119, P783, DOI 10.1007/s00122-009-1088-0; Shepherd K. W., 1973, Proceedings of the Fourth International Wheat Genetics Symposium. Cytogenetics., P745; Sheppard AE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000323; Simkova H, 2008, BMC GENOMICS, V9, DOI [10.1186/1471-2164-9-237, 10.1186/1471-2164-9-294]; SINGH NK, 1990, THEOR APPL GENET, V80, P609, DOI 10.1007/BF00224219; Smit A, 1996, REPEATMASKER OPEN 30; Tang HB, 2008, SCIENCE, V320, P486, DOI 10.1126/science.1153917; Tomita M, 2008, DNA RES, V15, P49, DOI 10.1093/dnares/dsm029; Tsuchida M, 2008, GENES GENET SYST, V83, P43, DOI 10.1266/ggs.83.43; Villareal RL, 1998, EUPHYTICA, V103, P195, DOI 10.1023/A:1018392002909; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; WANG ML, 1991, THEOR APPL GENET, V82, P174, DOI 10.1007/BF00226209; WANOUS MK, 1995, THEOR APPL GENET, V91, P720, DOI 10.1007/BF00220949; Wicker T, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-275; Wicker T, 2009, PLANT J, V59, P712, DOI 10.1111/j.1365-313X.2009.03911.x; Zeller F. J., 1973, Proceedings of the fourth international wheat genetics symposium. Alien genetic material., P209; ZELLER FJ, 1983, Z PFLANZENZUCHT, V90, P285; Zeller FJ, 1984, P 6 INT WHEAT GEN S, P161	73	13	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2012	7	2							e30784	10.1371/journal.pone.0030784	http://dx.doi.org/10.1371/journal.pone.0030784			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LV	22328922	Green Published, gold, Green Submitted			2022-12-27	WOS:000302179300008
J	Capasso, R; Sambri, I; Cimmino, A; Salemme, S; Lombardi, C; Acanfora, F; Satta, E; Puppione, DL; Perna, AF; Ingrosso, D				Capasso, Rosanna; Sambri, Irene; Cimmino, Amelia; Salemme, Sofia; Lombardi, Cinzia; Acanfora, Filomena; Satta, Ersilia; Puppione, Donald L.; Perna, Alessandra F.; Ingrosso, Diego			Homocysteinylated Albumin Promotes Increased Monocyte-Endothelial Cell Adhesion and Up-Regulation of MCP1, Hsp60 and ADAM17	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; CHEMOATTRACTANT PROTEIN-1 EXPRESSION; LOW-DENSITY LIPOPROTEINS; N-HOMOCYSTEINYLATION; GENE-EXPRESSION; KAPPA-B; CARDIOVASCULAR-DISEASE; HEMODIALYSIS-PATIENTS; RENAL-DISEASE; IN-VITRO	Rationale: The cardiovascular risk factor homocysteine is mainly bound to proteins in human plasma, and it has been hypothesized that homocysteinylated proteins are important mediators of the toxic effects of hyperhomocysteinemia. It has been recently demonstrated that homocysteinylated proteins are elevated in hemodialysis patients, a high cardiovascular risk population, and that homocysteinylated albumin shows altered properties. Objective: Aim of this work was to investigate the effects of homocysteinylated albumin - the circulating form of this amino acid, utilized at the concentration present in uremia - on monocyte adhesion to a human endothelial cell culture monolayer and the relevant molecular changes induced at both cell levels. Methods and Results: Treated endothelial cells showed a significant increase in monocyte adhesion. Endothelial cells showed after treatment a significant, specific and time-dependent increase in ICAM1 and VCAM1. Expression profiling and real time PCR, as well as protein analysis, showed an increase in the expression of genes encoding for chemokines/cytokines regulating the adhesion process and mediators of vascular remodeling (ADAM17, MCP1, and Hsp60). The mature form of ADAM17 was also increased as well as Tnf-alpha released in the cell medium. At monocyte level, treatment induced up-regulation of ICAM1, MCP1 and its receptor CCR2. Conclusions: Treatment with homocysteinylated albumin specifically increases monocyte adhesion to endothelial cells through up-regulation of effectors involved in vascular remodeling.	[Capasso, Rosanna; Sambri, Irene; Salemme, Sofia; Ingrosso, Diego] Univ Naples 2, Sch Med, Dept Biochem & Biophys F Cedrangolo, Naples, Italy; [Perna, Alessandra F.; Ingrosso, Diego] Univ Naples 2, Sch Med, Cardiovasc Res Ctr, Naples, Italy; [Lombardi, Cinzia; Acanfora, Filomena; Satta, Ersilia; Perna, Alessandra F.] Univ Naples 2, Sch Med, Div Nephrol 1, Naples, Italy; [Cimmino, Amelia] CNR, Inst Genet & Biophys, Naples, Italy; [Puppione, Donald L.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA	Universita della Campania Vanvitelli; Universita della Campania Vanvitelli; Universita della Campania Vanvitelli; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); University of California System; University of California Los Angeles	Capasso, R (corresponding author), Univ Naples 2, Sch Med, Dept Biochem & Biophys F Cedrangolo, Naples, Italy.	alessandra.perna@unina2.it	Perna, Alessandra F/AAC-3952-2022; Ingrosso, Diego/AHE-4980-2022	Cimmino, Amelia/0000-0002-0004-9299; PERNA, Alessandra/0000-0003-4048-9392	Hyperhomocysteinemia, cardiovascular risk factor in uremia, and structure-function alterations of biological macromolecules [PRIN2005-prot.2005062199_003]; Homocysteinylated proteins as an effector of vascular endothelial damage in uremia [PRIN2007-prot.2007EBCYYW_004]	Hyperhomocysteinemia, cardiovascular risk factor in uremia, and structure-function alterations of biological macromolecules; Homocysteinylated proteins as an effector of vascular endothelial damage in uremia	This study was entirely financed by public sources, no private profit institutions provided any funding. This research was supported in part by grants PRIN2005-prot.2005062199_003 "Hyperhomocysteinemia, cardiovascular risk factor in uremia, and structure-function alterations of biological macromolecules" and PRIN2007-prot.2007EBCYYW_004 "Homocysteinylated proteins as an effector of vascular endothelial damage in uremia" to Professor Diego Ingrosso. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosch A, 2002, AM J KIDNEY DIS, V39, P972, DOI 10.1053/ajkd.2002.32771; Benagiano M, 2005, J IMMUNOL, V174, P6509, DOI 10.4049/jimmunol.174.10.6509; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Cacciapuoti G, 2007, FEBS LETT, V581, P4567, DOI 10.1016/j.febslet.2007.08.042; Cai Y, 2000, BLOOD, V96, P2140, DOI 10.1182/blood.V96.6.2140.h8002140_2140_2148; Calin GA, 2008, P NATL ACAD SCI USA, V105, P5166, DOI 10.1073/pnas.0800121105; Carluccio MA, 2007, AM J PHYSIOL-HEART C, V293, pH2344, DOI 10.1152/ajpheart.00432.2007; Cimmino A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003258; Dawson-Saunders B, 1990, E NORWALKCONNECTIEUT, P329; Devlin AM, 2005, J BIOL CHEM, V280, P25506, DOI 10.1074/jbc.M504815200; Ferretti G, 2004, J CELL BIOCHEM, V92, P351, DOI 10.1002/jcb.20069; Ferretti G, 2010, CHEM PHYS LIPIDS, V163, P228, DOI 10.1016/j.chemphyslip.2009.11.008; Foley RN, 1998, AM J KIDNEY DIS, V32, pS112, DOI 10.1053/ajkd.1998.v32.pm9820470; Glowacki R, 2004, J BIOL CHEM, V279, P10864, DOI 10.1074/jbc.M313268200; Habich C, 2002, J IMMUNOL, V168, P569, DOI 10.4049/jimmunol.168.2.569; Hoffman M, 2011, MED HYPOTHESES  1001; Hwang SY, 2008, AM J PHYSIOL-RENAL, V294, pF236, DOI 10.1152/ajprenal.00331.2007; Ingrosso D, 2003, LANCET, V361, P1693, DOI 10.1016/S0140-6736(03)13372-7; INGROSSO D, 1989, J BIOL CHEM, V264, P20131; Jacobsen DW, 2006, KIDNEY INT, V69, P787, DOI 10.1038/sj.ki.5000235; Jakubowski H, 2000, J BIOL CHEM, V275, P3957, DOI 10.1074/jbc.275.6.3957; Jakubowski H, 2004, CELL MOL LIFE SCI, V61, P470, DOI 10.1007/s00018-003-3204-7; Jakubowski H, 2001, BIOMED PHARMACOTHER, V55, P443, DOI 10.1016/S0753-3322(01)00085-3; Jakubowski H, 1999, FASEB J, V13, P2277, DOI 10.1096/fasebj.13.15.2277; Kokame K, 1996, J BIOL CHEM, V271, P29659, DOI 10.1074/jbc.271.47.29659; Li M, 2007, CARDIOVASC PATHOL, V16, P305, DOI 10.1016/j.carpath.2007.03.005; Marczak L, 2011, J PROTEOMICS, V74, P967, DOI 10.1016/j.jprot.2011.01.021; Outinen PA, 1999, BLOOD, V94, P959, DOI 10.1182/blood.V94.3.959.415k20_959_967; Pandolfi A, 2007, J CELL PHYSIOL, V213, P699, DOI 10.1002/jcp.21138; Peeters ACTM, 2007, CLIN CHEM LAB MED, V45, P54, DOI 10.1515/CCLM.2007.021; Perla-Kajan J, 2007, AMINO ACIDS, V32, P561, DOI 10.1007/s00726-006-0432-9; Perna AF, 2006, KIDNEY INT, V69, P869, DOI 10.1038/sj.ki.5000070; Perna AF, 2009, SEMIN DIALYSIS, V22, P351, DOI 10.1111/j.1525-139X.2009.00579.x; Poddar R, 2001, CIRCULATION, V103, P2717; Postea O, 2006, ARTERIOSCL THROM VAS, V26, P508, DOI 10.1161/01.ATV.0000201039.21705.dc; Puppione DL, 2009, COMP BIOCHEM PHYS D, V4, P305, DOI 10.1016/j.cbd.2009.09.001; Scheller J, 2011, TRENDS IMMUNOL, V32, P380, DOI 10.1016/j.it.2011.05.005; Sengupta S, 2001, J BIOL CHEM, V276, P30111, DOI 10.1074/jbc.M104324200; Shlipak MG, 2005, JAMA-J AM MED ASSOC, V293, P1737, DOI 10.1001/jama.293.14.1737; Sibrian-Vazquez M, 2010, P NATL ACAD SCI USA, V107, P551, DOI 10.1073/pnas.0909737107; Siddiqui SS, 2004, AM J PHYSIOL-LUNG C, V286, pL1016, DOI 10.1152/ajplung.00356.2003; Silverman MD, 2002, ARTERIOSCL THROM VAS, V22, P587, DOI 10.1161/01.ATV.0000014221.30108.08; Tiruppathi C, 2004, P NATL ACAD SCI USA, V101, P7699, DOI 10.1073/pnas.0401712101; Tsakadze NL, 2006, J BIOL CHEM, V281, P3157, DOI 10.1074/jbc.M510797200; Ueland PM, 1996, J NUTR, V126, pS1281, DOI 10.1093/jn/126.suppl_4.1281S; Undas A, 2004, STROKE, V35, P1299, DOI 10.1161/01.STR.0000128412.59768.6e; Vanholder R, 2003, KIDNEY INT, V63, P1934, DOI 10.1046/j.1523-1755.2003.00924.x; Veeranna V, 2011, J AM COLL CARDIOL, V58, P1025, DOI 10.1016/j.jacc.2011.05.028; Wang GP, 2001, BIOCHEM J, V357, P233, DOI 10.1042/0264-6021:3570233; Wang GP, 2002, ARTERIOSCL THROM VAS, V22, P1777, DOI 10.1161/01.ATV.0000035404.18281.37; Wang GP, 2000, BIOCHEM J, V352, P817, DOI 10.1042/0264-6021:3520817; Xu QB, 2000, CIRCULATION, V102, P14, DOI 10.1161/01.CIR.102.1.14; Zeng X, 2003, CIRC RES, V93, P271; Zeng XK, 2004, ACTA PHARMACOL SIN, V25, P1419; Zhang DQ, 2009, CIRCULATION, V120, P1893, DOI 10.1161/CIRCULATIONAHA.109.866889; Zinellu A, 2009, ATHEROSCLEROSIS, V206, P40, DOI 10.1016/j.atherosclerosis.2009.01.035	56	24	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e31388	10.1371/journal.pone.0031388	http://dx.doi.org/10.1371/journal.pone.0031388			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LO	22319627	gold, Green Published			2022-12-27	WOS:000302178400039
J	Lu, LN; Zhou, L; Chen, EZ; Sun, K; Jiang, PY; Wang, LJ; Su, XX; Sun, H; Wang, HT				Lu, Leina; Zhou, Liang; Chen, Eric Z.; Sun, Kun; Jiang, Peiyong; Wang, Lijun; Su, Xiaoxi; Sun, Hao; Wang, Huating			A Novel YY1-miR-1 Regulatory Circuit in Skeletal Myogenesis Revealed by Genome-Wide Prediction of YY1-miRNA Network	PLOS ONE			English	Article							MUSCLE-SPECIFIC MICRORNA; GENE-EXPRESSION; CELL-CYCLE; DIFFERENTIATION; PROLIFERATION; TRANSCRIPTION; MECHANISM; TARGETS; MIR-1	microRNAs (miRNAs) are non-coding RNAs that regulate gene expression post-transcriptionally, and mounting evidence supports the prevalence and functional significance of their interplay with transcription factors (TFs). Here we describe the identification of a regulatory circuit between muscle miRNAs (miR-1, miR-133 and miR-206) and Yin Yang 1 (YY1), an epigenetic repressor of skeletal myogenesis in mouse. Genome-wide identification of potential down-stream targets of YY1 by combining computational prediction with expression profiling data reveals a large number of putative miRNA targets of YY1 during skeletal myoblasts differentiation into myotubes with muscle miRs ranking on top of the list. The subsequent experimental results demonstrate that YY1 indeed represses muscle miRs expression in myoblasts and the repression is mediated through multiple enhancers and recruitment of Polycomb complex to several YY1 binding sites. YY1 regulating miR-1 is functionally important for both C2C12 myogenic differentiation and injury-induced muscle regeneration. Furthermore, we demonstrate that miR-1 in turn targets YY1, thus forming a negative feedback loop. Together, these results identify a novel regulatory circuit required for skeletal myogenesis and reinforce the idea that regulatory circuitries involving miRNAs and TFs are prevalent mechanisms.	[Lu, Leina; Chen, Eric Z.; Sun, Kun; Jiang, Peiyong; Su, Xiaoxi; Sun, Hao] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Dept Chem Pathol, Hong Kong, Hong Kong, Peoples R China; [Zhou, Liang; Wang, Lijun; Wang, Huating] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Dept Obstet & Gynaecol, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong	Lu, LN (corresponding author), Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Dept Chem Pathol, Hong Kong, Hong Kong, Peoples R China.	haosun@cuhk.edu.hk; huating.wang@cuhk.edu.hk	Sun, Kun/Q-6479-2018; JIANG, Peiyong/AAZ-9898-2020; sun, hao/GRS-7732-2022; c, c/I-5855-2016; Sun, Hao/J-9964-2013; Zhou, Liang/P-4174-2015; Wang, Huating/C-6719-2014; Sun, Hao/T-5576-2019	Sun, Kun/0000-0002-9883-1616; Sun, Hao/0000-0002-5547-9501; Zhou, Liang/0000-0001-5973-7873; Wang, Huating/0000-0001-5474-2905; Sun, Hao/0000-0002-5547-9501; Jiang, Peiyong/0000-0003-4523-3476	Research Grants Council (RGC) of the Hong Kong Special Administrative Region, China [2140655, 2140701, 473211]; CUHK [2041474, 2041492]	Research Grants Council (RGC) of the Hong Kong Special Administrative Region, China(Hong Kong Research Grants Council); CUHK(Chinese University of Hong Kong)	The work described in this paper was substantially supported by three General Research Funds (GRF) to H. W. and H. S. from the Research Grants Council (RGC) of the Hong Kong Special Administrative Region, China (Project Code: 2140655, 2140701 and 473211), a CUHK Direct Grant to H. W. (2041474) and a CUHK Direct Grant to H. S. (2041492). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeel T, 2008, GENOME RES, V18, P310, DOI 10.1101/gr.6991408; Anderson C, 2006, NUCLEIC ACIDS RES, V34, P5863, DOI 10.1093/nar/gkl743; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Buckingham M, 2006, CURR OPIN GENET DEV, V16, P525, DOI 10.1016/j.gde.2006.08.008; Caretti G, 2004, GENE DEV, V18, P2627, DOI 10.1101/gad.1241904; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen JF, 2010, J CELL BIOL, V190, P867, DOI 10.1083/jcb.200911036; Cordes KR, 2010, PEDIATR CARDIOL, V31, P349, DOI 10.1007/s00246-010-9639-3; Fabbri M, 2010, ADV GENET, V70, P87, DOI [10.1016/S0065-2660(10)70004-3, 10.1016/B978-0-12-380866-0.60004-6]; Fei T, 2010, GENOME RES, V20, P36, DOI 10.1101/gr.092114.109; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Guller I, 2010, J PHYSIOL-LONDON, V588, P4075, DOI 10.1113/jphysiol.2010.194175; HYDEDERUYSCHER RP, 1995, NUCLEIC ACIDS RES, V23, P4457, DOI 10.1093/nar/23.21.4457; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Ivey KN, 2010, CELL STEM CELL, V7, P36, DOI 10.1016/j.stem.2010.06.012; Juan AH, 2010, CELL CYCLE, V9, P1445, DOI 10.4161/cc.9.8.11472; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; Liu CG, 2008, NAT PROTOC, V3, P563, DOI 10.1038/nprot.2008.14; Liu N, 2007, P NATL ACAD SCI USA, V104, P20844, DOI 10.1073/pnas.0710558105; Liu N, 2010, DEV CELL, V18, P510, DOI 10.1016/j.devcel.2010.03.010; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Martinez NJ, 2009, BIOESSAYS, V31, P435, DOI 10.1002/bies.200800212; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Nakasa T, 2010, J CELL MOL MED, V14, P2495, DOI 10.1111/j.1582-4934.2009.00898.x; Olguin HC, 2004, DEV BIOL, V275, P375, DOI 10.1016/j.ydbio.2004.08.015; Rao PK, 2006, P NATL ACAD SCI USA, V103, P8721, DOI 10.1073/pnas.0602831103; Rao PK, 2010, FASEB J, V24, P3427, DOI 10.1096/fj.09-150698; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Rosenberg MI, 2006, J CELL BIOL, V175, P77, DOI 10.1083/jcb.200603039; Sabourin LA, 2000, CLIN GENET, V57, P16, DOI 10.1034/j.1399-0004.2000.570103.x; Saccone V, 2010, ORGANOGENESIS, V6, P48, DOI 10.4161/org.6.1.11293; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schones DE, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-19; Shalgi R, 2007, PLOS COMPUT BIOL, V3, P1291, DOI 10.1371/journal.pcbi.0030131; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Townley-Tilson WHD, 2010, INT J BIOCHEM CELL B, V42, P1252, DOI 10.1016/j.biocel.2009.03.002; Wang H, 2008, CANCER CELL, V14, P369, DOI 10.1016/j.ccr.2008.10.006; Wang HT, 2007, MOL CELL BIOL, V27, P4374, DOI 10.1128/MCB.02020-06; Wong CF, 2008, J BIOL CHEM, V283, P9836, DOI 10.1074/jbc.M709614200; Xu CQ, 2007, J CELL SCI, V120, P3045, DOI 10.1242/jcs.010728; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030	43	129	133	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2012	7	2							e27596	10.1371/journal.pone.0027596	http://dx.doi.org/10.1371/journal.pone.0027596			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UG	22319554	Green Published, Green Submitted, gold			2022-12-27	WOS:000301977500001
J	Ogata, Y; Chikayama, E; Morioka, Y; Everroad, RC; Shino, A; Matsushima, A; Haruna, H; Moriya, S; Toyoda, T; Kikuchi, J				Ogata, Yoshiyuki; Chikayama, Eisuke; Morioka, Yusuke; Everroad, R. Craig; Shino, Amiu; Matsushima, Akihiro; Haruna, Hideaki; Moriya, Shigeharu; Toyoda, Tetsuro; Kikuchi, Jun			ECOMICS: A Web-Based Toolkit for Investigating the Biomolecular Web in Ecosystems Using a Trans-omics Approach	PLOS ONE			English	Article							NUCLEAR-MAGNETIC-RESONANCE; NMR-BASED METABOLOMICS; C-13 MAS NMR; ARABIDOPSIS-THALIANA; COMPLEX SOLUTIONS; ORGANIC-CARBON; HIGHER-PLANTS; LIGNIN; SPECTROSCOPY; METABOLITES	Ecosystems can be conceptually thought of as interconnected environmental and metabolic systems, in which small molecules to macro-molecules interact through diverse networks. State-of-the-art technologies in post-genomic science offer ways to inspect and analyze this biomolecular web using omics-based approaches. Exploring useful genes and enzymes, as well as biomass resources responsible for anabolism and catabolism within ecosystems will contribute to a better understanding of environmental functions and their application to biotechnology. Here we present ECOMICS, a suite of web-based tools for ECosystem trans-OMICS investigation that target metagenomic, metatranscriptomic, and metametabolomic systems, including biomacromolecular mixtures derived from biomass. ECOMICS is made of four integrated webtools. E-class allows for the sequence-based taxonomic classification of eukaryotic and prokaryotic ribosomal data and the functional classification of selected enzymes. FT2B allows for the digital processing of NMR spectra for downstream metabolic or chemical phenotyping. Bm-Char allows for statistical assignment of specific compounds found in lignocellulose-based biomass, and HetMap is a data matrix generator and correlation calculator that can be applied to trans-omics datasets as analyzed by these and other web tools. This web suite is unique in that it allows for the monitoring of biomass metabolism in a particular environment, i.e., from macromolecular complexes (FT2DB and Bm-Char) to microbial composition and degradation (E-class), and makes possible the understanding of relationships between molecular and microbial elements (HetMap). This website is available to the public domain at: https://database.riken.jp/ecomics/.	[Ogata, Yoshiyuki; Chikayama, Eisuke; Shino, Amiu; Kikuchi, Jun] RIKEN, Plant Sci Ctr, Yokohama, Kanagawa, Japan; [Chikayama, Eisuke; Morioka, Yusuke; Haruna, Hideaki; Moriya, Shigeharu; Kikuchi, Jun] Yokohama City Univ, Grad Sch Nanobiosci, Yokohama, Kanagawa 232, Japan; [Everroad, R. Craig; Moriya, Shigeharu] RIKEN, Adv Sci Inst, Wako, Saitama, Japan; [Toyoda, Tetsuro] RIKEN, Bioinformat & Syst Engn Div, Yokohama, Kanagawa, Japan; [Toyoda, Tetsuro; Kikuchi, Jun] RIKEN Cluster Innovat, Biomass Engn Program, Wako, Saitama, Japan; [Kikuchi, Jun] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan	RIKEN; Yokohama City University; RIKEN; RIKEN; RIKEN; Nagoya University	Ogata, Y (corresponding author), RIKEN, Plant Sci Ctr, Yokohama, Kanagawa, Japan.	kikuchi@psc.riken.jp	Kikuchi, Jun/M-5512-2015; Kikuchi, Jun/O-4725-2019; Moriya, Shigeharu/AGY-8351-2022; Moriya, Shigeharu/H-1656-2011; Moriya, Shigeharu/F-4604-2014	Kikuchi, Jun/0000-0002-6809-394X; Kikuchi, Jun/0000-0002-6809-394X; Moriya, Shigeharu/0000-0002-2519-5874; Moriya, Shigeharu/0000-0002-2519-5874; Moriya, Shigeharu/0000-0002-2519-5874	Ministry of Education, Culture, Sports, Science, and Technology, Japan; Bio-oriented Technology Research Advancement Institution (BRAIN); New Energy and Industrial Technology Development Organization (NEDO); Grants-in-Aid for Scientific Research [21247010] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Bio-oriented Technology Research Advancement Institution (BRAIN); New Energy and Industrial Technology Development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported in part by Grants-in-Aid for Scientific Research for challenging exploratory research (Dr. Kikuchi), and Scientific Research (A) (Dr. Kikuchi) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan. This work was also supported, in part, by grants from Research and Development Program for New Bio-industry Initiatives of the Bio-oriented Technology Research Advancement Institution (BRAIN to Dr. Kikuchi), and the New Energy and Industrial Technology Development Organization (NEDO to Dr. Kikuchi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama Kenji, 2008, In Silico Biology, V8, P339; Azam F, 1998, SCIENCE, V280, P694, DOI 10.1126/science.280.5364.694; Betson TR, 2006, ANAL CHEM, V78, P8406, DOI 10.1021/ac061050a; Chen FF, 2011, J PROTEOME RES, V10, P2273, DOI 10.1021/pr101095t; Chikayama E, 2010, ANAL CHEM, V82, P1653, DOI 10.1021/ac9022023; Chikayama E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003805; Cloarec O, 2005, ANAL CHEM, V77, P1282, DOI 10.1021/ac048630x; Covert JS, 2001, AQUAT MICROB ECOL, V25, P127, DOI 10.3354/ame025127; Cui Q, 2008, NAT BIOTECHNOL, V26, P162, DOI 10.1038/nbt0208-162; Dam P, 2011, NUCLEIC ACIDS RES, V39, P3240, DOI 10.1093/nar/gkq1281; Date Y, 2010, J BIOSCI BIOENG, V110, P87, DOI 10.1016/j.jbiosc.2010.01.004; del Rio JC, 2008, J AGR FOOD CHEM, V56, P9525, DOI 10.1021/jf800806h; del Rio JC, 2009, J AGR FOOD CHEM, V57, P10271, DOI 10.1021/jf900815x; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Demain AL, 2009, J IND MICROBIOL BIOT, V36, P319, DOI 10.1007/s10295-008-0521-8; Dick-Perez M, 2011, BIOCHEMISTRY-US, V50, P989, DOI 10.1021/bi101795q; Dudukovic MP, 2009, SCIENCE, V325, P698, DOI 10.1126/science.1174274; Elser JJ, 2009, SCIENCE, V326, P835, DOI 10.1126/science.1176199; Fort D. A., 2006, HOLZFORSCHUNG, V9, P63; Frimmersdorf E, 2010, ENVIRON MICROBIOL, V12, P1734, DOI 10.1111/j.1462-2920.2010.02253.x; Fu CX, 2011, P NATL ACAD SCI USA, V108, P3803, DOI 10.1073/pnas.1100310108; Fukuda S, 2011, NATURE; Fukuda S, 2011, NATURE, V469, P543, DOI 10.1038/nature09646; Fukuda S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004893; Gao DH, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-5; Gilbert A, 2009, ANAL CHEM, V81, P8978, DOI 10.1021/ac901441g; Groger C, 2009, PROG NUCL MAG RES SP, V54, P54, DOI 10.1016/j.pnmrs.2008.02.003; Haquin Sabrina, 2008, V426, P49, DOI 10.1007/978-1-60327-058-8_4; Hassan KA, 2010, ENVIRON MICROBIOL, V12, P899, DOI 10.1111/j.1462-2920.2009.02134.x; Hedenstrom M, 2009, MOL PLANT, V2, P933, DOI 10.1093/mp/ssp047; Holmes E, 2007, ANAL CHEM, V79, P2629, DOI 10.1021/ac062305n; Jorgensen H, 2007, BIOTECHNOL BIOENG, V96, P862, DOI 10.1002/bit.21115; Keiluweit M, 2010, ENVIRON SCI TECHNOL, V44, P1247, DOI 10.1021/es9031419; Kikuchi J, 2004, PLANT CELL PHYSIOL, V45, P1099, DOI 10.1093/pcp/pch117; KIKUCHI J., 2011, J ECOSYSTEM ECOGRA S, VS2, P1, DOI DOI 10.4172/2157-7625.S2-001; Kikuchi Jun, 2007, V358, P273, DOI 10.1007/978-1-59745-244-1_15; Kim H, 2010, ORG BIOMOL CHEM, V8, P576, DOI 10.1039/b916070a; Lehtio J, 2003, P NATL ACAD SCI USA, V100, P484, DOI 10.1073/pnas.212651999; Lewis IA, 2007, ANAL CHEM, V79, P9385, DOI 10.1021/ac071583z; Lewis IA, 2010, ANAL CHEM, V82, P4558, DOI 10.1021/ac100565b; Lewis IA, 2009, MAGN RESON CHEM, V47, pS123, DOI 10.1002/mrc.2526; Liu CX, 2010, J PROTEOME RES, V9, P6774, DOI 10.1021/pr100970q; Markley JL, 2008, J BIOMOL NMR, V40, P153, DOI 10.1007/s10858-008-9221-y; Martinez AT, 2011, ENVIRON MICROBIOL, V13, P96, DOI 10.1111/j.1462-2920.2010.02312.x; Martinez AT, 2008, PHYTOCHEMISTRY, V69, P2831, DOI 10.1016/j.phytochem.2008.09.005; McCarthy M, 1997, NATURE, V390, P150, DOI 10.1038/36535; Mochida K, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-568; Morreel K, 2010, ANAL CHEM, V82, P8095, DOI 10.1021/ac100968g; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Nakamura I, 2005, MACROMOL BIOSCI, V5, P623, DOI 10.1002/mabi.200500044; Nakanishi Y, 2011, J PROTEOME RES, V10, P824, DOI 10.1021/pr100989c; O'Sullivan LA, 2004, FEMS MICROBIOL ECOL, V47, P359, DOI 10.1016/S0168-6496(03)00300-3; Ogata Y, 2009, PLANT CELL PHYSIOL, V50, P173, DOI 10.1093/pcp/pcn179; Ogata Y, 2010, BIOINFORMATICS, V26, P1267, DOI 10.1093/bioinformatics/btq121; Ogata Yoshiyuki, 2009, Genome Inform, V23, P117; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; Rencoret J, 2011, PLANT PHYSIOL, V155, P667, DOI 10.1104/pp.110.167254; Rubin EM, 2008, NATURE, V454, P841, DOI 10.1038/nature07190; Sannigrahi P, 2006, ENVIRON SCI TECHNOL, V40, P666, DOI 10.1021/es051150i; Santos EM, 2010, ENVIRON SCI TECHNOL, V44, P820, DOI 10.1021/es902558k; Scheller HV, 2010, ANNU REV PLANT BIOL, V61, P263, DOI 10.1146/annurev-arplant-042809-112315; Sekiyama Y, 2007, PHYTOCHEMISTRY, V68, P2320, DOI 10.1016/j.phytochem.2007.04.011; Sekiyama Y, 2011, ANAL CHEM, V83, P719, DOI 10.1021/ac102097u; Sekiyama Y, 2010, ANAL CHEM, V82, P1643, DOI 10.1021/ac9019076; Shi DL, 2010, SCIENCE, V327, P676, DOI 10.1126/science.1183517; Sinha G, 2005, SCIENCE, V310, P965, DOI 10.1126/science.310.5750.965; Somerville C, 2010, SCIENCE, V329, P790, DOI 10.1126/science.1189268; Spraul M, 2009, MAGN RESON CHEM, V47, pS130, DOI 10.1002/mrc.2528; Sturcova A, 2004, BIOMACROMOLECULES, V5, P1333, DOI 10.1021/bm034517p; Sudesh K., 2001, RIKEN REV, V42, P75; Sun RC, 1998, J AGR FOOD CHEM, V46, P718, DOI 10.1021/jf9705532; Tang HR, 2003, BIOMACROMOLECULES, V4, P1269, DOI 10.1021/bm0340772; Tang HR, 1999, J AGR FOOD CHEM, V47, P510, DOI 10.1021/jf980553h; Taylor PG, 2010, NATURE, V464, P1178, DOI 10.1038/nature08985; Tian C, 2007, J BIOL CHEM, V282, P18532, DOI 10.1074/jbc.M700549200; Tiirola MA, 2002, APPL ENVIRON MICROB, V68, P173, DOI 10.1128/AEM.68.1.173-180.2002; Vanholme R, 2008, CURR OPIN PLANT BIOL, V11, P278, DOI 10.1016/j.pbi.2008.03.005; Viant MR, 2009, ENVIRON SCI TECHNOL, V43, P219, DOI 10.1021/es802198z; Ward JL, 2010, METABOLOMICS, V6, P263, DOI 10.1007/s11306-010-0200-4; Waszkielewicz A, 2004, POL J PHARMACOL, V56, P43; Zhang JT, 2011, J PROTEOME RES, V10, P1904, DOI 10.1021/pr101140n; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	83	28	28	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2012	7	2							e30263	10.1371/journal.pone.0030263	http://dx.doi.org/10.1371/journal.pone.0030263			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UG	22319563	Green Published, Green Submitted, gold			2022-12-27	WOS:000301977500006
J	Grover, A; Singh, R; Shandilya, A; Priyandoko, D; Agrawal, V; Bisaria, VS; Wadhwa, R; Kaul, SC; Sundar, D				Grover, Abhinav; Singh, Rumani; Shandilya, Ashutosh; Priyandoko, Didik; Agrawal, Vibhuti; Bisaria, Virendra S.; Wadhwa, Renu; Kaul, Sunil C.; Sundar, Durai			Ashwagandha Derived Withanone Targets TPX2-Aurora A Complex: Computational and Experimental Evidence to its Anticancer Activity	PLOS ONE			English	Article							HERBAL DRUG WITHAFERIN; KINASE AURORA-A; CANCER-CELLS; CHROMOSOMAL INSTABILITY; INHIBITOR INTERACTIONS; PANCREATIC-CANCER; AUTOMATED DOCKING; MITOTIC SPINDLE; PROSTATE-CANCER; POTENTIAL ROLE	Cancer is largely marked by genetic instability. Specific inhibition of individual proteins or signalling pathways that regulate genetic stability during cell division thus hold a great potential for cancer therapy. The Aurora A kinase is a Ser/Thr kinase that plays a critical role during mitosis and cytokinesis and is found upregulated in several cancer types. It is functionally regulated by its interactions with TPX2, a candidate oncogene. Aurora A inhibitors have been proposed as anticancer drugs that work by blocking its ATP binding site. This site is common to other kinases and hence these inhibitors lack specificity for Aurora A inhibition in particular, thus advocating the need of some alternative inhibition route. Previously, we identified TPX2 as a cellular target for withanone that selectively kill cancer cells. By computational approach, we found here that withanone binds to TPX2-Aurora A complex. In experiment, withanone treatment to cancer cells indeed resulted in dissociation of TPX2-Aurora A complex and disruption of mitotic spindle apparatus proposing this as a mechanism of the anticancer activity of withanone. From docking analysis, non-formation/disruption of the active TPX2-Aurora A association complex could be discerned. Our MD simulation results suggesting the thermodynamic and structural stability of TPX2-Aurora A in complex with withanone further substantiates the binding. We report a computational rationale of the ability of naturally occurring withanone to alter the kinase signalling pathway in an ATP-independent manner and experimental evidence in which withanone cause inactivation of the TPX2-Aurora A complex. The study demonstrated that TPX2-Aurora A complex is a target of withanone, a potential natural anticancer drug.	[Grover, Abhinav; Agrawal, Vibhuti; Bisaria, Virendra S.; Sundar, Durai] Indian Inst Technol IIT Delhi, Dept Biochem Engn & Biotechnol, New Delhi, India; [Singh, Rumani; Priyandoko, Didik; Wadhwa, Renu; Kaul, Sunil C.] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki, Japan; [Singh, Rumani; Priyandoko, Didik] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 305, Japan; [Shandilya, Ashutosh] Indian Inst Technol IIT Delhi, Supercomp Facil Bioinformat & Computat Biol, New Delhi, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi; National Institute of Advanced Industrial Science & Technology (AIST); University of Tsukuba; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi	Grover, A (corresponding author), Indian Inst Technol IIT Delhi, Dept Biochem Engn & Biotechnol, Hauz Khas, New Delhi, India.	s-kaul@aist.go.jp; sundar@dbeb.iitd.ac.in	Kaul, Sunil C/L-8671-2018; Wadhwa, Renu/L-8898-2018; Sundar, Durai/F-7671-2012; Shandilya, Ashutosh/G-9995-2012; Priyandoko, Didik/GNP-1593-2022	Kaul, Sunil C/0000-0002-0046-3916; Wadhwa, Renu/0000-0001-8248-5192; Priyandoko, Didik/0000-0001-8601-9818; Sundar, Durai/0000-0002-6549-6663	National Institute of Advanced Industrial Science & Technology (AIST), Japan; Ministry of Education, Culture, Sports, Science & Technology (MEXT), Japan; Indonesian Government; Supercomputing Facility for Bioinformatics and Computational Biology (SCFBio) at Indian Institute of Technology Delhi	National Institute of Advanced Industrial Science & Technology (AIST), Japan; Ministry of Education, Culture, Sports, Science & Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Indonesian Government(Ministry of Research and Technology of the Republic of Indonesia (RISTEK)); Supercomputing Facility for Bioinformatics and Computational Biology (SCFBio) at Indian Institute of Technology Delhi	The work was supported by grants from National Institute of Advanced Industrial Science & Technology (AIST), Japan. R. Singh is supported by the Ministry of Education, Culture, Sports, Science & Technology (MEXT) Scholarship, Japan. D. Priyandoko is a recipient of Indonesian Government Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Prof. B. Jayaram, Coordinator of Supercomputing Facility for Bioinformatics and Computational Biology (SCFBio) at Indian Institute of Technology Delhi for his support and encouragement.	Agnese V, 2007, ANN ONCOL, V18, P47, DOI 10.1093/annonc/mdm224; Anderson K, 2007, BIOCHEMISTRY-US, V46, P10287, DOI 10.1021/bi7011355; Andrews PD, 2003, CURR OPIN CELL BIOL, V15, P672, DOI 10.1016/j.ceb.2003.10.013; Andrews PD, 2005, ONCOGENE, V24, P5005, DOI 10.1038/sj.onc.1208752; Asteriti IA, 2010, BBA-REV CANCER, V1806, P230, DOI 10.1016/j.bbcan.2010.08.001; Bar-Shira A, 2002, CANCER RES, V62, P6803; Bayliss R, 2003, MOL CELL, V12, P851, DOI 10.1016/S1097-2765(03)00392-7; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bischoff JR, 1998, EMBO J, V17, P3052, DOI 10.1093/emboj/17.11.3052; Bischoff JR, 1999, TRENDS CELL BIOL, V9, P454, DOI 10.1016/S0962-8924(99)01658-X; Buschhorn HM, 2005, PROSTATE, V64, P341, DOI 10.1002/pros.20247; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; Case D.A., 2022, AMBER 2020; Cornell WD, 1996, J AM CHEM SOC, V118, P2309, DOI 10.1021/ja955032e; CORNELL WD, 1993, J AM CHEM SOC, V115, P9620, DOI 10.1021/ja00074a030; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Dym O, 2002, MOL PHARMACOL, V61, P20, DOI 10.1124/mol.61.1.20; Eyers PA, 2003, CURR BIOL, V13, P691, DOI 10.1016/S0960-9822(03)00166-0; Fraizer GC, 2004, INT J ONCOL, V25, P1631; Goodsell DS, 1996, J MOL RECOGNIT, V9, P1, DOI 10.1002/(SICI)1099-1352(199601)9:1<1::AID-JMR241>3.0.CO;2-6; Gritsko TM, 2003, CLIN CANCER RES, V9, P1420; Grover A, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S30; Grover A, 2011, BIOCHEM BIOPH RES CO, V404, P498, DOI 10.1016/j.bbrc.2010.12.010; Grover A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S4-S25; Grover A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S4-S15; Gruss OJ, 2004, J CELL BIOL, V166, P949, DOI 10.1083/jcb.200312112; Gupta A, 2007, PROTEIN PEPTIDE LETT, V14, P632; Harrington EA, 2004, NAT MED, V10, P262, DOI 10.1038/nm1003; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kamada K, 2004, ONCOL REP, V12, P593; Karsenti E, 2001, SCIENCE, V294, P543, DOI 10.1126/science.1063488; Kleywegt GJ, 1996, STRUCTURE, V4, P1395, DOI 10.1016/S0969-2126(96)00147-5; Knuutila S, 1998, AM J PATHOL, V152, P1107; Li DH, 2003, CLIN CANCER RES, V9, P991; Li YH, 2005, CANCER INVEST, V23, P660, DOI 10.1080/07357900500359836; Morgan-Lappe SE, 2007, CANCER RES, V67, P4390, DOI 10.1158/0008-5472.CAN-06-4132; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Rao MS, 1999, PROTEINS, V34, P173, DOI 10.1002/(SICI)1097-0134(19990201)34:2<173::AID-PROT3>3.0.CO;2-F; Scotto L, 2008, GENE CHROMOSOME CANC, V47, P755, DOI 10.1002/gcc.20577; Tanaka T, 1999, CANCER RES, V59, P2041; Tonon G, 2005, P NATL ACAD SCI USA, V102, P9625, DOI 10.1073/pnas.0504126102; Tsai MY, 2003, NAT CELL BIOL, V5, P242, DOI 10.1038/ncb936; Wang Y, 2002, J IMMUNOL, V169, P1102, DOI 10.4049/jimmunol.169.2.1102; Warner SL, 2009, CLIN CANCER RES, V15, P6519, DOI 10.1158/1078-0432.CCR-09-0077; Widodo N, 2008, CANCER LETT, V262, P37, DOI 10.1016/j.canlet.2007.11.037; Widodo N, 2007, CLIN CANCER RES, V13, P2298, DOI 10.1158/1078-0432.CCR-06-0948; Widodo N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013536; Wittmann T, 1998, J CELL BIOL, V143, P673, DOI 10.1083/jcb.143.3.673; Zhang LJ, 2008, TOXICOLOGY, V252, P49, DOI 10.1016/j.tox.2008.07.059; Zhao BG, 2008, PROTEIN SCI, V17, P1791, DOI 10.1110/ps.036590.108	55	31	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e30890	10.1371/journal.pone.0030890	http://dx.doi.org/10.1371/journal.pone.0030890			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22303466	Green Published, gold, Green Submitted			2022-12-27	WOS:000301704200042
J	Hendaoui, I; Lavergne, E; Lee, HS; Hong, SH; Kim, HZ; Parent, C; Heuze-Vourc'h, N; Clement, B; Musso, O				Hendaoui, Ismail; Lavergne, Elise; Lee, Heun-Sik; Hong, Seong Hyun; Kim, Hak-Zoo; Parent, Christelle; Heuze-Vourc'h, Nathalie; Clement, Bruno; Musso, Orlando			Inhibition of Wnt/beta-Catenin Signaling by a Soluble Collagen-Derived Frizzled Domain Interacting with Wnt3a and the Receptors Frizzled 1 and 8	PLOS ONE			English	Article							BETA-CATENIN; IN-VIVO; CELLS; BINDING; PROTEIN; DROSOPHILA; MODULE; LIGAND; GROWTH; XVIII	The Wnt/beta-catenin pathway controls cell proliferation, death and differentiation. Several families of extracellular proteins can antagonize Wnt/beta-catenin signaling, including the decoy receptors known as secreted frizzled related proteins (SFRPs), which have a cysteine-rich domain (CRD) structurally similar to the extracellular Wnt-binding domain of the frizzled receptors. SFRPs inhibit Wnt signaling by sequestering Wnts through the CRD or by forming inactive complexes with the frizzled receptors. Other endogenous molecules carrying frizzled CRDs inhibit Wnt signaling, such as V3Nter, which is proteolytically derived from the cell surface component collagen XVIII and contains a biologically active frizzled domain (FZC18) inhibiting in vivo cell proliferation and tumor growth in mice. We recently showed that FZC18 expressing cells deliver short-range signals to neighboring cells, decreasing their proliferation in vitro and in vivo through the Wnt/beta-catenin signaling pathway. Here, using low concentrations of soluble FZC18 and Wnt3a, we show that they physically interact in a cell-free system. In addition, soluble FZC18 binds the frizzled 1 and 8 receptors' CRDs, reducing cell sensitivity to Wnt3a. Conversely, inhibition of Wnt/beta-catenin signaling was partially rescued by the expression of full-length frizzled 1 and 8 receptors, but enhanced by the expression of a chimeric cell-membrane-tethered frizzled 8 CRD. Moreover, soluble, partially purified recombinant FZC18_CRD inhibited Wnt3a-induced beta-catenin activation. Taken together, the data indicate that collagen XVIII-derived frizzled CRD shifts Wnt sensitivity of normal cells to a lower pitch and controls their growth.	[Hendaoui, Ismail; Lavergne, Elise; Lee, Heun-Sik; Clement, Bruno; Musso, Orlando] INSERM, U991, Rennes, France; [Hendaoui, Ismail; Lavergne, Elise; Lee, Heun-Sik; Clement, Bruno; Musso, Orlando] Univ Rennes 1, Rennes, France; [Parent, Christelle; Heuze-Vourc'h, Nathalie] INSERM, U618, Tours, France; [Hong, Seong Hyun; Kim, Hak-Zoo] Gyeonggi Bioctr, Gyeonggi Inst Sci & Technol Promot, Suwon, South Korea	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm)	Hendaoui, I (corresponding author), INSERM, U991, Rennes, France.	orlando.musso@inserm.fr	HEUZE-VOURC'H, Nathalie/P-8081-2016; Musso, Orlando/N-5756-2017; Clement, Bruno/E-5546-2016	Clement, Bruno/0000-0001-8827-146X; Parent, Christelle/0000-0001-8086-4690; Heuze-Vourc'h, Nathalie/0000-0003-4929-5068; Musso, Orlando/0000-0001-8881-6925	Institut National de la Sante et de la Recherche Medicale, Institut National du Cancer, Agence Nationale de la Recherche, Universite de Rennes 1, Region Bretagne	Institut National de la Sante et de la Recherche Medicale, Institut National du Cancer, Agence Nationale de la Recherche, Universite de Rennes 1, Region Bretagne(French National Research Agency (ANR))	Institut National de la Sante et de la Recherche Medicale, Institut National du Cancer, Agence Nationale de la Recherche (Emergence-BIO Program 2008), Universite de Rennes 1, Region Bretagne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bovolenta P, 2008, J CELL SCI, V121, P737, DOI 10.1242/jcs.026096; Cadigan KM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002881; Carmon KS, 2008, BIOCHEM BIOPH RES CO, V368, P285, DOI 10.1016/j.bbrc.2008.01.088; Carmon KS, 2010, ANAL BIOCHEM, V401, P288, DOI 10.1016/j.ab.2010.03.009; Dann CE, 2001, NATURE, V412, P86, DOI 10.1038/35083601; DeAlmeida VI, 2007, CANCER RES, V67, P5371, DOI 10.1158/0008-5472.CAN-07-0266; Elamaa H, 2003, MATRIX BIOL, V22, P427, DOI 10.1016/S0945-053X(03)00073-8; Goentoro L, 2009, MOL CELL, V36, P872, DOI 10.1016/j.molcel.2009.11.017; Hsieh JC, 1999, P NATL ACAD SCI USA, V96, P3546, DOI 10.1073/pnas.96.7.3546; Kohfeldt E, 1997, FEBS LETT, V414, P557, DOI 10.1016/S0014-5793(97)01070-3; Lavergne E, 2011, ONCOGENE, V30, P423, DOI 10.1038/onc.2010.432; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mikels AJ, 2006, ONCOGENE, V25, P7461, DOI 10.1038/sj.onc.1210053; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Mukai A, 2010, EMBO J, V29, P2114, DOI 10.1038/emboj.2010.100; Musso O, 2001, HEPATOLOGY, V33, P868, DOI 10.1053/jhep.2001.23189; Quelard D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001878; Roman-Roman S, 2004, J BIOL CHEM, V279, P5725, DOI 10.1074/jbc.M309233200; Sato A, 1999, DEVELOPMENT, V126, P4421; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; VALLET V, 1995, MOL CELL BIOL, V15, P5453; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Wawrzak D, 2007, BIOCHEM BIOPH RES CO, V357, P1119, DOI 10.1016/j.bbrc.2007.04.069; Wu CH, 2002, J BIOL CHEM, V277, P41762, DOI 10.1074/jbc.M207850200	24	17	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e30601	10.1371/journal.pone.0030601	http://dx.doi.org/10.1371/journal.pone.0030601			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22303445	Green Published, gold			2022-12-27	WOS:000301704200025
J	Jono, H; Lim, JH; Xu, HD; Li, JD				Jono, Hirofumi; Lim, Jae Hyang; Xu, Haidong; Li, Jian-Dong			PKC theta Synergizes with TLR-Dependent TRAF6 Signaling Pathway to Upregulate MUC5AC Mucin via CARMA1	PLOS ONE			English	Article							NF-KAPPA-B; PROTEIN-KINASE-C; NONTYPABLE HAEMOPHILUS-INFLUENZAE; NECROSIS-FACTOR-ALPHA; BRONCHIAL EPITHELIAL-CELLS; OBSTRUCTIVE PULMONARY-DISEASE; NEGATIVE CROSS-TALK; TOLL-LIKE RECEPTORS; STREPTOCOCCUS-PNEUMONIAE; NEUTROPHIL ELASTASE	CARD-containing MAGUK protein 1 (CARMA1) plays a crucial role in regulating adaptive immune responses upon T-cell receptor (TCR) activation in T cells. Its role in regulating host mucosal innate immune response such as upregulation of mucin remains unknown. Here we show that CARMA1 acts as a key signaling mediator for synergistic upregulation of MUC5AC mucin by bacterium nontypeable Haemophilus influenzae (NTHi) and phorbol ester PMA in respiratory epithelial cells. NTHi-induced TLR-dependent TRAF6-MKK3-p38 MAPK signaling pathway synergizes with PKC theta-MEK-ERK signaling pathway. CARMA1 plays a crucial role in mediating this synergistic effect via TRAF6, thereby resulting in synergistic upregulation of MUC5AC mucin. Thus our study unveils a novel role for CARMA1 in mediating host mucosal innate immune response.	[Jono, Hirofumi; Lim, Jae Hyang; Xu, Haidong; Li, Jian-Dong] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Lim, Jae Hyang; Xu, Haidong; Li, Jian-Dong] Georgia State Univ, Dept Biol, Atlanta, GA USA; [Lim, Jae Hyang; Xu, Haidong; Li, Jian-Dong] Georgia State Univ, Ctr Inflammat Immun & Infect, Atlanta, GA 30303 USA	University of Rochester; University System of Georgia; Georgia State University; University System of Georgia; Georgia State University	Jono, H (corresponding author), Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA.	jdli@gsu.edu		Lim, Jae Hyang/0000-0003-0972-9271; Li, Jian-Dong/0000-0002-5593-050X	National Institutes of Health [DC005843, DC005843-S1, DC004562, AI073374]; American Heart Association [10SDG2630077]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073374] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005843, R01DC004562] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23790091] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from National Institutes of Health DC005843, DC005843-S1, DC004562 and AI073374 (to J.-D.L.) and by American Heart Association 10SDG2630077 (to J.H.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah LH, 1997, AM J PHYSIOL-LUNG C, V273, pL201, DOI 10.1152/ajplung.1997.273.1.L201; Abdullah LH, 2007, AM J PHYSIOL-LUNG C, V293, pL591, DOI 10.1152/ajplung.00150.2007; Akira S, 2004, CR BIOL, V327, P581, DOI 10.1016/j.crvi.2004.04.002; Allen-Gipson DS, 2005, J PHARMACOL EXP THER, V314, P476, DOI 10.1124/jpet.104.079822; Barnes PJ, 2003, ANNU REV MED, V54, P113, DOI 10.1146/annurev.med.54.101601.152209; Barnes PJ, 2003, EUR RESPIR J, V22, P672, DOI 10.1183/09031936.03.00040703; Basbaum C, 1999, AM J RESP CRIT CARE, V160, pS44, DOI 10.1164/ajrccm.160.supplement_1.12; Bertin J, 2001, J BIOL CHEM, V276, P11877, DOI 10.1074/jbc.M010512200; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Blonska M, 2007, IMMUNITY, V26, P55, DOI 10.1016/j.immuni.2006.11.008; BOBEK LA, 1993, J BIOL CHEM, V268, P20563; CARRIE S, 1992, ACTA OTO-LARYNGOL, V112, P504, DOI 10.3109/00016489209137432; Che TJ, 2004, J BIOL CHEM, V279, P15870, DOI 10.1074/jbc.M310599200; Chen R, 2004, BIOCHEM BIOPH RES CO, V324, P1087, DOI 10.1016/j.bbrc.2004.09.157; Chen Y, 2004, AM J RESP CELL MOL, V30, P155, DOI 10.1165/rcmb.2003-0103OC; Chun YM, 2002, ANN OTO RHINOL LARYN, V111, P507, DOI 10.1177/000348940211100606; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Dunne Aisling, 2003, Sci STKE, V2003, pre3, DOI 10.1126/stke.2003.171.re3; Fischer BM, 1999, AM J RESP CELL MOL, V20, P413, DOI 10.1165/ajrcmb.20.3.3393; FORSTNER G, 1993, AM J PHYSIOL, V264, pG1096, DOI 10.1152/ajpgi.1993.264.6.G1096; Gaide O, 2002, NAT IMMUNOL, V3, P836, DOI 10.1038/ni830; GENDLER SJ, 1995, ANNU REV PHYSIOL, V57, P607, DOI 10.1146/annurev.ph.57.030195.003135; Gum JR, 2002, BIOCHEM BIOPH RES CO, V291, P466, DOI 10.1006/bbrc.2002.6475; Ha UH, 2008, J BIOL CHEM, V283, P30624, DOI 10.1074/jbc.M802519200; Ha U, 2007, J IMMUNOL, V178, P1736, DOI 10.4049/jimmunol.178.3.1736; Hara H, 2004, J EXP MED, V200, P1167, DOI 10.1084/jem.20032246; Hara H, 2003, IMMUNITY, V18, P763, DOI 10.1016/S1074-7613(03)00148-1; Hewson CA, 2004, J MOL BIOL, V344, P683, DOI 10.1016/j.jmb.2004.09.059; Higuchi T, 2004, J BIOL CHEM, V279, P1968, DOI 10.1074/jbc.M304558200; Hong DH, 1999, AM J PHYSIOL-GASTR L, V277, pG1041, DOI 10.1152/ajpgi.1999.277.5.G1041; Hovenberg HW, 1996, BIOCHEM J, V318, P319, DOI 10.1042/bj3180319; Huang YX, 2007, BIOCHEM BIOPH RES CO, V359, P691, DOI 10.1016/j.bbrc.2007.05.170; Ishiguro K, 2006, MOL CELL BIOL, V26, P5497, DOI 10.1128/MCB.02469-05; Ishinaga H, 2007, EMBO J, V26, P1150, DOI 10.1038/sj.emboj.7601546; Jaimes EA, 2007, AM J PHYSIOL-HEART C, V292, pH76, DOI 10.1152/ajpheart.00693.2006; Jaken S, 1996, CURR OPIN CELL BIOL, V8, P168, DOI 10.1016/S0955-0674(96)80062-7; Jono H, 2003, J BIOL CHEM, V278, P27811, DOI 10.1074/jbc.M301773200; Jono H, 2002, J BIOL CHEM, V277, P45547, DOI 10.1074/jbc.M206883200; KELLER K, 1992, ARCHIVES OF MEDICAL RESEARCH, VOL 23, NO 2, P217; Kerschner JE, 2007, LARYNGOSCOPE, V117, P1666, DOI 10.1097/MLG.0b013e31806db531; Kim WD, 1997, EUR RESPIR J, V10, P1914, DOI 10.1183/09031936.97.10081914; Kim YD, 2002, J KOREAN MED SCI, V17, P765, DOI 10.3346/jkms.2002.17.6.765; KIM YS, 1995, GASTROENTEROLOGY, V109, P999, DOI 10.1016/0016-5085(95)90412-3; Knowles MR, 2002, J CLIN INVEST, V109, P571, DOI 10.1172/JCI200215217; Koo JS, 2002, EXP LUNG RES, V28, P315, DOI 10.1080/01902140252964393; Kopp E, 2003, CURR OPIN IMMUNOL, V15, P396, DOI 10.1016/S0952-7915(03)00080-3; Lapensee L, 1997, FERTIL STERIL, V68, P702, DOI 10.1016/S0015-0282(97)00317-8; LARIVEE P, 1994, AM J RESP CELL MOL, V11, P199, DOI 10.1165/ajrcmb.11.2.8049080; Latz E, 2002, J BIOL CHEM, V277, P47834, DOI 10.1074/jbc.M207873200; Lee HW, 2002, J BIOL CHEM, V277, P32624, DOI 10.1074/jbc.M200353200; Lee KY, 2005, SCIENCE, V308, P114, DOI 10.1126/science.1107107; Lee SD, 2001, AM J PHYSIOL-LUNG C, V281, pL403, DOI 10.1152/ajplung.2001.281.2.L403; Li JD, 2003, J PHARMACOL SCI, V91, P1, DOI 10.1254/jphs.91.1; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Lim JH, 2008, CELL MICROBIOL, V10, P2247, DOI 10.1111/j.1462-5822.2008.01204.x; Lim JH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001032; Lim JH, 2007, IMMUNITY, V27, P349, DOI 10.1016/j.immuni.2007.07.011; Lim JH, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-40; Lin X, 2004, SEMIN IMMUNOL, V16, P429, DOI 10.1016/j.smim.2004.08.022; Longphre M, 1999, J CLIN INVEST, V104, P1375, DOI 10.1172/JCI6097; Matsumoto R, 2005, IMMUNITY, V23, P575, DOI 10.1016/j.immuni.2005.10.007; McCully RR, 2008, MOL CELL BIOL, V28, P5668, DOI 10.1128/MCB.00418-08; Medeiros RB, 2007, SCIENCE, V316, P754, DOI 10.1126/science.1137895; Mikami F, 2005, J BIOL CHEM, V280, P36185, DOI 10.1074/jbc.M503941200; Mikami F, 2006, J BIOL CHEM, V281, P22397, DOI 10.1074/jbc.M602124200; Misra RS, 2007, J BIOL CHEM, V282, P19365, DOI 10.1074/jbc.M610610200; Murphy TF, 2006, INFECT IMMUN, V74, P5169, DOI 10.1128/IAI.00692-06; Pallesen LT, 2002, EUR J BIOCHEM, V269, P2755, DOI 10.1046/j.1432-1033.2002.02949.x; Parekh R, 2000, IEEE T NEURAL NETWOR, V11, P436, DOI 10.1109/72.839013; Park JA, 2005, AM J PATHOL, V167, P651, DOI 10.1016/S0002-9440(10)62040-8; Park JA, 2007, AM J PATHOL, V171, P1822, DOI 10.2353/ajpath.2007.070318; Park SG, 2009, NAT IMMUNOL, V10, P158, DOI 10.1038/ni.1687; Rogers DF, 2006, ANN MED, V38, P116, DOI 10.1080/07853890600585795; Ron D, 1999, FASEB J, V13, P1658, DOI 10.1096/fasebj.13.13.1658; Rose MC, 2006, PHYSIOL REV, V86, P245, DOI 10.1152/physrev.00010.2005; Rose MC, 2001, AM J RESP CELL MOL, V25, P533, DOI 10.1165/ajrcmb.25.5.f218; Sakai A, 2007, FEBS J, V274, P3655, DOI 10.1111/j.1742-4658.2007.05899.x; Schmitz ML, 2003, FASEB J, V17, P2187, DOI 10.1096/fj.02-1100rev; Schulze-Luehrmann J, 2006, IMMUNITY, V25, P701, DOI 10.1016/j.immuni.2006.10.010; SERS C, 1993, P NATL ACAD SCI USA, V90, P8514, DOI 10.1073/pnas.90.18.8514; Shambharkar PB, 2007, EMBO J, V26, P1794, DOI 10.1038/sj.emboj.7601622; SHANKAR V, 1994, BIOCHEM J, V300, P295, DOI 10.1042/bj3000295; Shao MXG, 2005, J IMMUNOL, V175, P4009, DOI 10.4049/jimmunol.175.6.4009; Shao ZH, 2003, PHARMACOL RES, V47, P463, DOI 10.1016/S1043-6618(03)00041-0; Sharma P, 1998, AM J RESP CELL MOL, V19, P30, DOI 10.1165/ajrcmb.19.1.3054; Shinohara H, 2005, J EXP MED, V202, P1423, DOI 10.1084/jem.20051591; Smirnova MG, 2001, EUR CYTOKINE NETW, V12, P119; Sommer K, 2005, IMMUNITY, V23, P561, DOI 10.1016/j.immuni.2005.09.014; Stilo R, 2004, J BIOL CHEM, V279, P34323, DOI 10.1074/jbc.M402244200; Takeuchi O, 2000, J IMMUNOL, V165, P5392, DOI 10.4049/jimmunol.165.10.5392; Thome M, 2007, TRENDS IMMUNOL, V28, P281, DOI 10.1016/j.it.2007.04.004; Thornton David J, 2004, Proc Am Thorac Soc, V1, P54, DOI 10.1513/pats.2306016; TORIBARA NW, 1993, J BIOL CHEM, V268, P5879; Wang BN, 2002, J BIOL CHEM, V277, P949, DOI 10.1074/jbc.M107484200; Wang DH, 2004, MOL CELL BIOL, V24, P164, DOI 10.1128/MCB.24.1.164-171.2003; Wang DH, 2002, NAT IMMUNOL, V3, P830, DOI 10.1038/ni824; Watanabe T, 2004, P NATL ACAD SCI USA, V101, P3563, DOI 10.1073/pnas.0400557101; Way KJ, 2000, TRENDS PHARMACOL SCI, V21, P181, DOI 10.1016/S0165-6147(00)01468-1; Williams SJ, 1999, CANCER RES, V59, P4083; Williams SJ, 2001, J BIOL CHEM, V276, P18327, DOI 10.1074/jbc.M008850200; Yin BWT, 2001, J BIOL CHEM, V276, P27371, DOI 10.1074/jbc.M103554200; Yoshida H, 2005, J BIOL CHEM, V280, P41111, DOI 10.1074/jbc.M509526200	102	7	9	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e31049	10.1371/journal.pone.0031049	http://dx.doi.org/10.1371/journal.pone.0031049			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22303480	Green Published, Green Submitted, gold			2022-12-27	WOS:000301704200057
J	Negi, S; Jetha, A; Aikin, R; Hasilo, C; Sladek, R; Paraskevas, S				Negi, Sarita; Jetha, Arif; Aikin, Reid; Hasilo, Craig; Sladek, Rob; Paraskevas, Steven			Analysis of Beta-Cell Gene Expression Reveals Inflammatory Signaling and Evidence of Dedifferentiation following Human Islet Isolation and Culture	PLOS ONE			English	Article							HUMAN PANCREATIC-ISLETS; NF-KAPPA-B; STIMULATED INSULIN-SECRETION; ADULT HUMAN; IN-VITRO; ENDOCRINE PANCREAS; GRAFT FUNCTION; MESENCHYMAL TRANSITION; PROGENITOR CELLS; PRECURSOR CELLS	The stresses encountered during islet isolation and culture may have deleterious effects on beta-cell physiology. However, the biological response of human islet cells to isolation remains poorly characterized. A better understanding of the network of signaling pathways induced by islet isolation and culturing may lead to strategies aimed at improving islet graft survival and function. Laser capture microdissection (LCM) was used to extract beta-cell RNA from 1) intact pancreatic islets, 2) freshly isolated islets, 3) islets cultured for 3 days, and changes in gene expression were examined by microarray analysis. We identified a strong inflammatory response induced by islet isolation that continues during in-vitro culture manifested by upregulation of several cytokines and cytokine-receptors. The most highly upregulated gene, interleukin-8 (IL-8), was induced by 3.6-fold following islet isolation and 56-fold after 3 days in culture. Immunofluorescence studies showed that the majority of IL-8 was produced by beta-cells themselves. We also observed that several pancreas-specific transcription factors were down-regulated in cultured islets. Concordantly, several pancreatic progenitor cell-specific transcription factors like SOX4, SOX9, and ID2 were upregulated in cultured islets, suggesting progressive transformation of mature beta-cell phenotype toward an immature endocrine cell phenotype. Our findings suggest islet isolation and culture induces an inflammatory response and loss of the mature endocrine cell phenotype. A better understanding of the signals required to maintain a mature beta-cell phenotype may help improve the efficacy of islet transplantation.	[Negi, Sarita; Jetha, Arif; Aikin, Reid; Hasilo, Craig; Paraskevas, Steven] McGill Univ, Ctr Hlth, Human Islet Transplantat Lab, Montreal, PQ, Canada; [Negi, Sarita; Jetha, Arif; Aikin, Reid; Hasilo, Craig; Paraskevas, Steven] McGill Univ, Dept Surg, Montreal, PQ H3A 2T5, Canada; [Sladek, Rob] Genome Quebec Innovat Ctr, Montreal, PQ, Canada	McGill University; McGill University	Negi, S (corresponding author), McGill Univ, Ctr Hlth, Human Islet Transplantat Lab, Montreal, PQ, Canada.	steven.paraskevas@mcgill.ca	Sladek, Robert/R-2391-2019	Sladek, Robert/0000-0002-2730-1204	Diabetes-Quebec	Diabetes-Quebec	This work was supported by a grant from Diabetes-Quebec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2008, FEBS J, V275, P318, DOI 10.1111/j.1742-4658.2007.06202.x; Artner I, 2007, P NATL ACAD SCI USA, V104, P3853, DOI 10.1073/pnas.0700013104; Artner I, 2010, DIABETES, V59, P2530, DOI 10.2337/db10-0190; Bar Y, 2008, DIABETES, V57, P2413, DOI 10.2337/db07-1323; BEATTIE GM, 1991, J CLIN ENDOCR METAB, V73, P93, DOI 10.1210/jcem-73-1-93; Bedke J, 2010, MOL IMMUNOL, V47, P1047, DOI 10.1016/j.molimm.2009.11.012; Bennet W, 2000, UPSALA J MED SCI, V105, P125, DOI 10.1517/03009734000000059; Bertuzzi F, 2004, J CLIN ENDOCR METAB, V89, P5724, DOI 10.1210/jc.2004-0659; Boni-Schnetzler M, 2008, J CLIN ENDOCR METAB, V93, P4065, DOI 10.1210/jc.2008-0396; Cabrera O, 2006, P NATL ACAD SCI USA, V103, P2334, DOI 10.1073/pnas.0510790103; Chao CS, 2007, DEV BIOL, V312, P523, DOI 10.1016/j.ydbio.2007.09.057; Chen C, 2011, AM J TRANSPLANT; Collombat P, 2003, GENE DEV, V17, P2591, DOI 10.1101/gad.269003; De Perrot M, 2002, AM J RESP CRIT CARE, V165, P211, DOI 10.1164/ajrccm.165.2.2011151; Driessler F, 2004, CLIN EXP IMMUNOL, V135, P64, DOI 10.1111/j.1365-2249.2004.02342.x; Dror V, 2007, DIABETOLOGIA, V50, P2504, DOI 10.1007/s00125-007-0835-5; Ehses JA, 2007, DIABETES, V56, P2356, DOI 10.2337/db06-1650; Eich T, 2007, NEW ENGL J MED, V356, P2754, DOI 10.1056/NEJMc070201; Gershengorn MC, 2004, SCIENCE, V306, P2261, DOI 10.1126/science.1101968; Giuliani M, 2005, CELL TRANSPLANT, V14, P67, DOI 10.3727/000000005783983287; Gu CY, 2010, CELL METAB, V11, P298, DOI 10.1016/j.cmet.2010.03.006; GUILLEMOT F, 1995, NAT GENET, V9, P235, DOI 10.1038/ng0395-235; Hardikar AA, 2003, P NATL ACAD SCI USA, V100, P7117, DOI 10.1073/pnas.1232230100; Hochachka PW, 1996, P NATL ACAD SCI USA, V93, P9493, DOI 10.1073/pnas.93.18.9493; Hua H, 2006, J BIOL CHEM, V281, P13574, DOI 10.1074/jbc.M600526200; Iguchi H, 2005, J BIOL CHEM, V280, P37669, DOI 10.1074/jbc.M505392200; Ilmakunnas M, 2010, CLIN TRANSPLANT, V24, P29, DOI 10.1111/j.1399-0012.2009.00975.x; Kalousova A, 2010, DEV BIOL, V348, P143, DOI 10.1016/j.ydbio.2010.09.007; Kim SK, 2002, NAT GENET, V30, P430, DOI 10.1038/ng860; Kwon O, 2003, AM J KIDNEY DIS, V41, P1074, DOI 10.1016/S0272-6386(03)00206-3; Lakey JRT, 2001, TRANSPLANTATION, V72, P565; Linn T, 2003, FASEB J, V17, P881, DOI 10.1096/fj.02-0615fje; Lynn FC, 2007, P NATL ACAD SCI USA, V104, P10500, DOI 10.1073/pnas.0704054104; Marselli L, 2008, J CLIN ENDOCR METAB, V93, P1046, DOI 10.1210/jc.2007-0931; Marzorati S, 2006, AM J TRANSPLANT, V6, P2791, DOI 10.1111/j.1600-6143.2006.01512.x; Matsuda T, 2005, AM J TRANSPLANT, V5, P484, DOI 10.1046/j.1600-6143.2004.00716.x; McDonald E, 2009, STEM CELLS DEV, V18, P1379, DOI 10.1089/scd.2009.0240; Mita A, 2010, CELL TRANSPLANT, V19, P1537, DOI 10.3727/096368910X516600; Miyatsuka T, 2009, DIABETES, V58, P1863, DOI 10.2337/db09-0390; Movahedi B, 2008, DIABETES, V57, P2128, DOI 10.2337/db07-1705; Nakhai H, 2008, DEVELOPMENT, V135, P2757, DOI 10.1242/dev.013722; Nishimura W, 2008, DEV BIOL, V314, P443, DOI 10.1016/j.ydbio.2007.12.009; Paraskevas S, 1999, FEBS LETT, V455, P203, DOI 10.1016/S0014-5793(99)00882-0; Paraskevas S, 2000, PANCREAS, V20, P270, DOI 10.1097/00006676-200004000-00008; Piemonti L, 2002, DIABETES, V51, P55, DOI 10.2337/diabetes.51.1.55; Rao JN, 2003, EUR J CARDIO-THORAC, V23, P497, DOI 10.1016/S1010-7940(02)00842-4; Rehman KK, 2003, J BIOL CHEM, V278, P9862, DOI 10.1074/jbc.M207700200; RICORDI C, 1988, DIABETES, V37, P413, DOI 10.2337/diabetes.37.4.413; Rukstalis JM, 2007, GENE EXPR PATTERNS, V7, P471, DOI 10.1016/j.modgep.2006.11.001; Russ HA, 2008, DIABETES, V57, P1575, DOI 10.2337/db07-1283; Russ HA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006417; Sarkar SA, 2009, DIABETOLOGIA, V52, P1092, DOI 10.1007/s00125-009-1331-x; Schmitz ML, 2004, CHEMBIOCHEM, V5, P1348, DOI 10.1002/cbic.200400144; Seymour PA, 2007, P NATL ACAD SCI USA, V104, P1865, DOI 10.1073/pnas.0609217104; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; Szabat M, 2011, ISLETS, V3, P175, DOI 10.4161/isl.3.4.15881; Thackaberry EA, 2003, TOXICOL SCI, V76, P407, DOI 10.1093/toxsci/kfg229; Uno S, 2010, ENDOCR J, V57, P991, DOI 10.1507/endocrj.K10E-076; Ushita M, 2009, OSTEOARTHR CARTILAGE, V17, P1065, DOI 10.1016/j.joca.2009.02.003; Vanhorenbeeck V, 2007, DEV BIOL, V305, P685, DOI 10.1016/j.ydbio.2007.02.027; Wang S, 2007, MECH DEVELOP, V124, P898, DOI 10.1016/j.mod.2007.08.004; Weinberg N, 2007, DIABETES, V56, P1299, DOI 10.2337/db06-1654; Wilson ME, 2005, DIABETES, V54, P3402, DOI 10.2337/diabetes.54.12.3402; Wu YX, 2010, LAB INVEST, V90, P1373, DOI 10.1038/labinvest.2010.106; Ylipaa Antti, 2011, Chin J Cancer, V30, P27; Zhang C, 2005, MOL CELL BIOL, V25, P4969, DOI 10.1128/MCB.25.12.4969-4976.2005	66	94	95	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e30415	10.1371/journal.pone.0030415	http://dx.doi.org/10.1371/journal.pone.0030415			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22299040	Green Published, gold, Green Submitted			2022-12-27	WOS:000301704200017
J	Rosi, S; Ferguson, R; Fishman, K; Allen, A; Raber, J; Fike, JR				Rosi, Susanna; Ferguson, Ryan; Fishman, Kelly; Allen, Antino; Raber, Jacob; Fike, John R.			The Polyamine Inhibitor Alpha-Difluoromethylornithine Modulates Hippocampus-Dependent Function after Single and Combined Injuries	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; EXTRACELLULAR-SUPEROXIDE DISMUTASE; NEURAL PRECURSOR CELLS; LONG-TERM-MEMORY; EARLY GENE ARC; ORNITHINE-DECARBOXYLASE; CRANIAL IRRADIATION; ADULT NEUROGENESIS; DENTATE GYRUS	Exposure to uncontrolled irradiation in a radiologic terrorism scenario, a natural disaster or a nuclear battlefield, will likely be concomitantly superimposed on other types of injury, such as trauma. In the central nervous system, radiation combined injury (RCI) involving irradiation and traumatic brain injury may have a multifaceted character. This may entail cellular and molecular changes that are associated with cognitive performance, including changes in neurogenesis and the expression of the plasticity-related immediate early gene Arc. Because traumatic stimuli initiate a characteristic early increase in polyamine metabolism, we hypothesized that treatment with the polyamine inhibitor alpha-difluoromethylornithine (DFMO) would reduce the adverse effects of single or combined injury on hippocampus structure and function. Hippocampal dependent cognitive impairments were quantified with the Morris water maze and showed that DFMO effectively reversed cognitive impairments after all injuries, particularly traumatic brain injury. Similar results were seen with respect to the expression of Arc protein, but not neurogenesis. Given that polyamines have been found to modulate inflammatory responses in the brain we also assessed the numbers of total and newly born activated microglia, and found reduced numbers of newly born cells. While the mechanisms responsible for the improvement in cognition after DFMO treatment are not yet clear, the present study provides new and compelling data regarding the potential use of DFMO as a potential countermeasure against the adverse effects of single or combined injury.	[Rosi, Susanna; Ferguson, Ryan; Fishman, Kelly; Allen, Antino; Fike, John R.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Fike, John R.] Univ Calif San Francisco, Dept Radiat Oncol, San Francisco, CA USA; [Rosi, Susanna; Ferguson, Ryan] Univ Calif San Francisco, Dept Phys Therapy & Rehabil Sci, San Francisco, CA 94143 USA; [Rosi, Susanna; Ferguson, Ryan; Fishman, Kelly; Allen, Antino; Fike, John R.] Univ Calif San Francisco, Brain & Spinal Injury Ctr, San Francisco, CA 94143 USA; [Raber, Jacob] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA; [Raber, Jacob] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA; [Raber, Jacob] Oregon Hlth & Sci Univ, Div Neurosci, Oregon Natl Primate Res Ctr ONPRC, Portland, OR 97201 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon National Primate Research Center	Rosi, S (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA.	john.fike@ucsf.edu			National Institutes of Health (NIH) [R33 AI080531]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R33AI080531] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM081266] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) grant R33 AI080531. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abayomi OK, 1996, ACTA ONCOL, V35, P659, DOI 10.3109/02841869609083995; Baskaya MFK, 1996, NEUROSURGERY, V38, P140; Baskaya MK, 1996, J NEUROTRAUM, V13, P85, DOI 10.1089/neu.1996.13.85; Benice TS, 2006, NEUROSCIENCE, V137, P413, DOI 10.1016/j.neuroscience.2005.08.029; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; COFFINO P, 1991, J CELL BIOCHEM, V45, P54, DOI 10.1002/jcb.240450112; DiCarlo AL, 2008, RADIAT RES, V169, P712, DOI 10.1667/RR1295.1; Fan Y, 2007, EUR J NEUROSCI, V25, P38, DOI 10.1111/j.1460-9568.2006.05269.x; Fike JR, 2007, NEUROSURG CLIN N AM, V18, P115, DOI 10.1016/j.nec.2006.10.010; Fike JR, 2009, SEMIN RADIAT ONCOL, V19, P122, DOI 10.1016/j.semradonc.2008.12.003; FIKE JR, 1994, RADIAT RES, V138, P99, DOI 10.2307/3578852; FIKE JR, 1995, INT J RADIAT ONCOL, V32, P1035, DOI 10.1016/0360-3016(95)00030-3; GERRISH KE, 1993, LIFE SCI, V52, P1101, DOI 10.1016/0024-3205(93)90431-2; Gilad GM, 2007, J NEUROSCI RES, V85, P594, DOI 10.1002/jnr.21152; Gilad GM, 2003, CELL MOL NEUROBIOL, V23, P637, DOI 10.1023/A:1025036532672; GOBBEL GT, 1991, RADIAT RES, V128, P306, DOI 10.2307/3578054; Gupta N, 2009, NEUROSCIENCE, V161, P691, DOI 10.1016/j.neuroscience.2009.03.075; Gupta N, 2012, PHARMACOL BIOCHEM BE, V100, P464, DOI 10.1016/j.pbb.2011.10.011; Gupta S, 2000, CANCER RES, V60, P5125; Guzowski JF, 2001, J NEUROSCI, V21, P5089, DOI 10.1523/JNEUROSCI.21-14-05089.2001; Guzowski JF, 1999, NAT NEUROSCI, V2, P1120, DOI 10.1038/16046; Guzowski JF, 2000, J NEUROSCI, V20, P3993; Igarashi K, 2000, BIOCHEM BIOPH RES CO, V271, P559, DOI 10.1006/bbrc.2000.2601; JANNE J, 1991, ANN MED, V23, P241, DOI 10.3109/07853899109148056; Kilpelainen P, 2000, J NEUROSCI RES, V62, P675, DOI 10.1002/1097-4547(20001201)62:5<675::AID-JNR6>3.0.CO;2-S; Kleindienst A, 2005, J NEUROTRAUM, V22, P645, DOI 10.1089/neu.2005.22.645; Lu DY, 2007, J NEUROTRAUM, V24, P1132, DOI 10.1089/neu.2007.0288; Madsen TM, 2003, NEUROSCIENCE, V119, P635, DOI 10.1016/S0306-4522(03)00199-4; Malaterre J, 2004, EUR J NEUROSCI, V20, P317, DOI 10.1111/j.1460-9568.2004.03498.x; MANETTA A, 1988, European Journal of Gynaecological Oncology, V9, P222; Mizumatsu S, 2003, CANCER RES, V63, P4021; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Monje ML, 2002, NAT MED, V8, P955, DOI 10.1038/nm749; Morris R., 1984, J NEUROSCI METHODS, V11; Nakagawa M, 1996, INT J RADIAT ONCOL, V36, P113, DOI 10.1016/S0360-3016(96)00239-8; PEGG AE, 1986, BIOCHEM J, V234, P249, DOI 10.1042/bj2340249; Pellmar Terry C, 2005, Radiat Res, V163, P115, DOI 10.1667/RR3283; Raber J, 2004, ANN NEUROL, V55, P381, DOI 10.1002/ana.10853; Raber J, 2004, RADIAT RES, V162, P39, DOI 10.1667/RR3206; Raber J, 2011, HIPPOCAMPUS, V21, P72, DOI 10.1002/hipo.20724; Ramirez-Amaya V, 2005, J NEUROSCI, V25, P1761, DOI 10.1523/JNEUROSCI.4342-04.2005; Rola R, 2005, RADIAT RES, V164, P556, DOI 10.1667/RR3412.1; Rola R, 2004, EXP NEUROL, V188, P316, DOI 10.1016/j.expneurol.2004.05.005; Rola R, 2008, RADIAT RES, V169, P626, DOI 10.1667/RR1263.1; Rola R, 2007, FREE RADICAL BIO MED, V42, P1133, DOI 10.1016/j.freeradbiomed.2007.01.020; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Rosi S, 2006, NEUROSCIENCE, V142, P1303, DOI 10.1016/j.neuroscience.2006.08.017; Rosi S, 2005, J NEUROSCI, V25, P723, DOI 10.1523/JNEUROSCI.4469-04.2005; Rosi S., 2010, HIPPOCAMPUS; Rosi S, 2008, CANCER RES, V68, P9763, DOI 10.1158/0008-5472.CAN-08-1861; Saatman KE, 2006, J NEUROTRAUM, V23, P1241, DOI 10.1089/neu.2006.23.1241; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; Shinohara C, 1997, CANCER RES, V57, P2694; Snyder JS, 2005, NEUROSCIENCE, V130, P843, DOI 10.1016/j.neuroscience.2004.10.009; Soulet D, 2003, J CELL BIOL, V162, P257, DOI 10.1083/jcb.200301097; Sparapani M, 1996, EXP BRAIN RES, V108, P433; Sun D, 2007, EXP NEUROL, V204, P264, DOI 10.1016/j.expneurol.2006.11.005; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; Tada E, 2000, NEUROSCIENCE, V99, P33, DOI 10.1016/S0306-4522(00)00151-2; Temiz C, 2005, J CLIN NEUROSCI, V12, P449, DOI 10.1016/j.jocn.2004.05.019; Tofilon PJ, 2000, RADIAT RES, V153, P357, DOI 10.1667/0033-7587(2000)153[0357:TROTCN]2.0.CO;2; Villasana L, 2006, RADIAT RES, V166, P883, DOI 10.1667/RR0642.1; Wallace HM, 2004, AMINO ACIDS, V26, P353, DOI 10.1007/s00726-004-0092-6; Wheeler DL, 2003, CANCER RES, V63, P3037; Winocur G, 2006, HIPPOCAMPUS, V16, P296, DOI 10.1002/hipo.20163; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067; Zahedi K, 2010, J NEUROTRAUM, V27, P515, DOI 10.1089/neu.2009.1097	68	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e31094	10.1371/journal.pone.0031094	http://dx.doi.org/10.1371/journal.pone.0031094			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22299052	Green Published, gold, Green Submitted			2022-12-27	WOS:000301704200060
J	Tuvim, MJ; Gilbert, BE; Dickey, BF; Evans, SE				Tuvim, Michael J.; Gilbert, Brian E.; Dickey, Burton F.; Evans, Scott E.			Synergistic TLR2/6 and TLR9 Activation Protects Mice against Lethal Influenza Pneumonia	PLOS ONE			English	Article							VIRUS-INFECTION; INNATE IMMUNITY; AVIAN-INFLUENZA; LUNG INFECTION; VACCINE; RESISTANCE; DISEASE; IMMUNIZATION; MORTALITY; RESPONSES	Lower respiratory tract infections caused by influenza A continue to exact unacceptable worldwide mortality, and recent epidemics have emphasized the importance of preventative and containment strategies. We have previously reported that induction of the lungs' intrinsic defenses by aerosolized treatments can protect mice against otherwise lethal challenges with influenza A virus. More recently, we identified a combination of Toll like receptor (TLR) agonists that can be aerosolized to protect mice against bacterial pneumonia. Here, we tested whether this combination of synthetic TLR agonists could enhance the survival of mice infected with influenza A/HK/8/68 (H3N2) or A/California/04/2009 (H1N1) influenza A viruses. We report that the TLR treatment enhanced survival whether given before or after the infectious challenge, and that protection tended to correlate with reductions in viral titer 4 d after infection. Surprisingly, protection was not associated with induction of interferon gene expression. Together, these studies suggest that synergistic TLR interactions can protect against influenza virus infections by mechanisms that may provide the basis for novel therapeutics.	[Tuvim, Michael J.; Dickey, Burton F.; Evans, Scott E.] Univ Texas MD Anderson Canc Ctr, Dept Pulm Med, Houston, TX 77030 USA; [Tuvim, Michael J.; Dickey, Burton F.; Evans, Scott E.] Texas A&M Hlth Sci Ctr, Ctr Infect & Inflammatory Dis, Inst Biosci & Technol, Houston, TX USA; [Gilbert, Brian E.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Baylor College of Medicine	Tuvim, MJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Pulm Med, Houston, TX 77030 USA.	seevans@mdanderson.org		Dickey, Burton/0000-0002-4780-1847; Evans, Scott/0000-0003-4503-0644; Tuvim, Michael/0000-0001-8126-7716	National Institutes of Health (NIH) [U01 AI82226]; MD Anderson Physician-Scientist Program; MD Anderson Cancer Center [P30 CA016672]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI082226] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MD Anderson Physician-Scientist Program; MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by funds from National Institutes of Health (NIH) grant U01 AI82226 (BFD and SEE), the MD Anderson Physician-Scientist Program (SEE), and the resources of the MD Anderson Cancer Center Support Grant P30 CA016672. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; Ambrose CS, 2011, INFLUENZA OTHER RESP, V5, P67, DOI 10.1111/j.1750-2659.2010.00183.x; Belshe RB, 2010, VACCINE, V28, pD45, DOI 10.1016/j.vaccine.2010.08.028; Clark NM, 2011, SEMIN RESP CRIT CARE, V32, P373, DOI 10.1055/s-0031-1283278; Clement CG, 2008, AM J RESP CRIT CARE, V177, P1322, DOI 10.1164/rccm.200607-1038OC; Clement CG, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-70; Crawford NW, 2011, EXPERT REV VACCINES, V10, P175, DOI [10.1586/erv.10.157, 10.1586/ERV.10.157]; Dolowschiak T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001194; Duggan JM, 2011, J IMMUNOL, V186, P5916, DOI 10.4049/jimmunol.1002122; Dushoff J, 2006, AM J EPIDEMIOL, V163, P181, DOI 10.1093/aje/kwj024; Evans CM, 2004, AM J RESP CELL MOL, V31, P382, DOI 10.1165/rcmb.2004-0060OC; Evans SE, 2010, ANNU REV PHYSIOL, V72, P413, DOI 10.1146/annurev-physiol-021909-135909; Evans SE, 2010, AM J RESP CELL MOL, V42, P40, DOI 10.1165/rcmb.2008-0260OC; Evans SE, 2011, BR J PHARM; Fang LQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002268; Fidler DP, 2011, JAMA-J AM MED ASSOC, V306, P200, DOI 10.1001/jama.2011.960; Friede M, 2011, VACCINE, V29, pA2, DOI 10.1016/j.vaccine.2011.02.079; Garcia-Sastre A, 2006, EMERG INFECT DIS, V12, P44, DOI 10.3201/eid1201.051186; GILBERT BE, 1992, ANTIVIR RES, V17, P33, DOI 10.1016/0166-3542(92)90088-M; Hamad M, 2011, APMIS, V119, P565, DOI 10.1111/j.1600-0463.2011.02776.x; Harris Katherine M., 2011, Morbidity and Mortality Weekly Report, V60, P1073; Hillman MR, 2002, VACCINE, V20, P3055, DOI 10.1016/S0264-410X(02)00300-6; Ichinohe T, 2005, J VIROL, V79, P2910, DOI 10.1128/JVI.79.5.2910-2919.2005; Ichinohe T, 2006, J MED VIROL, V78, P954, DOI 10.1002/jmv.20647; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; JURK M, 2006, CHEMMEDCHEM, V1, P1007, DOI DOI 10.1002/CMDC.200600064; Kennedy Erin D., 2011, Morbidity and Mortality Weekly Report, V60, P781; Krieg AM, 2006, NAT REV DRUG DISCOV, V5, P471, DOI 10.1038/nrd2059; Lau YF, 2010, VIROLOGY, V406, P80, DOI 10.1016/j.virol.2010.07.008; Lau YF, 2009, VACCINE, V27, P1354, DOI 10.1016/j.vaccine.2008.12.048; Meier S, 2011, VACCINE, V29, P3548, DOI 10.1016/j.vaccine.2011.02.094; Mizgerd JP, 2008, NEW ENGL J MED, V358, P716, DOI 10.1056/NEJMra074111; Mizgerd JP, 2006, PLOS MED, V3, P155, DOI 10.1371/journal.pmed.0030076; Mohty B, 2011, HAEMATOL-HEMATOL J, V96, P896, DOI 10.3324/haematol.2011.040386; Pizzorno A, 2011, SEMIN RESP CRIT CARE, V32, P409, DOI 10.1055/s-0031-1283281; Pizzorno A, 2011, J INFECT DIS, V203, P25, DOI 10.1093/infdis/jiq010; Rage A, 2011, AM J MED, V124, pE9, DOI 10.1016/j.amjmed.2011.02.018; Rothberg MB, 2008, AM J MED, V121, P258, DOI 10.1016/j.amjmed.2007.10.040; Sanders CJ, 2011, CELL TISSUE RES, V343, P13, DOI 10.1007/s00441-010-1043-z; Tuvim MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004176; Vollmer J, 2004, EUR J IMMUNOL, V34, P251, DOI 10.1002/eji.200324032; Vollmer J, 2004, J ENDOTOXIN RES, V10, P431, DOI 10.1179/096805104225006534; Vollmer J, 2009, ADV DRUG DELIVER REV, V61, P195, DOI 10.1016/j.addr.2008.12.008; Walker Deborah K., 2011, Morbidity and Mortality Weekly Report, V60, P1078; Wang JP, 2007, CELL MICROBIOL, V9, P1641, DOI 10.1111/j.1462-5822.2007.00961.x; WIKENHEISER KA, 1993, P NATL ACAD SCI USA, V90, P11029, DOI 10.1073/pnas.90.23.11029; Wong JP, 2009, VACCINE, V27, P3481, DOI 10.1016/j.vaccine.2009.01.048; World Health Organization, 2004, WORLD HLTH REP 2004; WYDE PR, 1977, INFECT IMMUN, V15, P221, DOI 10.1128/IAI.15.1.221-229.1977	49	61	67	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e30596	10.1371/journal.pone.0030596	http://dx.doi.org/10.1371/journal.pone.0030596			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22299046	Green Published, gold, Green Submitted			2022-12-27	WOS:000301704200024
J	Yi, HL; Ji, XR; Wei, XZ; Chen, ZQ; Wang, XH; Zhu, XD; Zhang, W; Chen, JY; Zhang, DQ; Li, M				Yi, Honglei; Ji, Xinran; Wei, Xianzhao; Chen, Ziqiang; Wang, Xinhui; Zhu, Xiaodong; Zhang, Wei; Chen, Jiayu; Zhang, Diqing; Li, Ming			Reliability and Validity of Simplified Chinese Version of Roland-Morris Questionnaire in Evaluating Rural and Urban Patients with Low Back Pain	PLOS ONE			English	Article							CROSS-CULTURAL ADAPTATION; QUALITY-OF-LIFE; DISABILITY; VALIDATION	Objective: The causes of low back pain in China and Western countries are extremely different. We attempted to analyze the risk factors of low back pain in urban and rural patients under the dual economy with the simplified Chinese version of Roland-Morris disability questionnaire (SC-RMDQ) to demonstrate that SC-RMDQ could evaluate patients with low back pain arising from different causes. Methods: Roland-Morris disability questionnaire was translated into SCRMDQ according to international guidelines for questionnaire adaptation. In this study, causes of low back pain of 187 outpatients and inpatients (99 urban patients and 88 rural patients) were analyzed. All patients underwent simplified Chinese version of Roland-Morris disability questionnaire (SC-RMDQ), simplified Chinese Oswestry disability index (SCODI) and visual analogue scale (VAS). Reliability was tested using reproducibility (intraclass coefficient of correlation - ICC) and internal consistency (Cronbach's alpha). Validity was tested using Pearson correlation analysis. Results: The leading causes for low back pain were sedentariness (38.4%) and vibration (18.1%) in urban patients and waist bending (48.9%) and spraining (25%) in rural patients. Although causes of low back pain in the two groups of population were completely different, SCRMDQ had high internal consistency (Cronbach's a value of 0.874 in urban patients and 0.883 in rural patients) and good reproducibility (ICC value of .952 in urban patients and 0.949 in rural patients, P<0.01). SCRMDQ also showed significant correlation with Simplified Chinese version of Oswestry disability index (SCODI) and visual analogue scale (VAS) in rural areas (SCRMDQ-SCODI r = 0.841; SCRMDQ -VAS: r = 0.685, P<0.01) and in urban areas (SCRMDQ-SCODI: r = 0.818, P<0.01; SCRMDQ -VAS: r = 0.666, P<0.01). Conclusions: Although causes of low back pain are completely different in rural and urban patients, SCRMDQ has a good reliability and validity, which is a reliable clinical method to evaluate disability of rural and urban patients.	[Yi, Honglei; Ji, Xinran; Wei, Xianzhao; Chen, Ziqiang; Zhu, Xiaodong; Zhang, Wei; Chen, Jiayu; Zhang, Diqing; Li, Ming] Second Mil Med Univ, Affiliated Changhai Hosp, Dept Orthopaed Surg, Shanghai, Peoples R China; [Yi, Honglei; Wang, Xinhui] 89 Hosp PLA, Weifang, Shandong, Peoples R China	Naval Medical University	Yi, HL (corresponding author), Second Mil Med Univ, Affiliated Changhai Hosp, Dept Orthopaed Surg, Shanghai, Peoples R China.	limingch2011@126.com			National High Technology Research and Development Program of China [30571888]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	The study was supported by the National High Technology Research and Development Program of China (grant number: 30571888). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrero LH, 2006, SPINE, V31, P2728, DOI 10.1097/01.brs.0000244583.35982.ea; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; Bejia I, 2005, EUR SPINE J, V14, P171, DOI 10.1007/s00586-004-0730-4; CATSBARIL WL, 1991, SPINE, V16, P605, DOI 10.1097/00007632-199106000-00001; Crane PK, 2007, QUAL LIFE RES, V16, P981, DOI 10.1007/s11136-007-9200-x; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Davidson M, 2009, QUAL LIFE RES, V18, P473, DOI 10.1007/s11136-009-9456-4; Fairbank J C, 1980, Physiotherapy, V66, P271; Hestbaek L, 2003, EUR SPINE J, V12, P149, DOI 10.1007/s00586-002-0508-5; Jin K, 2000, Int J Occup Environ Health, V6, P26; Kucukdeveci AA, 2001, SPINE, V26, P2738, DOI 10.1097/00007632-200112150-00024; Kuwashima A, 1997, IND HEALTH, V35, P187, DOI 10.2486/indhealth.35.187; Liu H, 2009, SPINE, V34, P1211, DOI 10.1097/BRS.0b013e31819e2b34; Opara J, 2006, SPINE, V31, P2744, DOI 10.1097/01.brs.0000244632.76447.62; PATRICK DL, 1995, SPINE, V20, P1899, DOI 10.1097/00007632-199509000-00011; ROLAND M, 1983, SPINE, V8, P141, DOI 10.1097/00007632-198303000-00004; Sarikaya S, 2007, AM J IND MED, V50, P92, DOI 10.1002/ajim.20417; Scharovsky A, 2008, SPINE, V33, P1391, DOI 10.1097/BRS.0b013e318173dc8f; Shelerud RA, 2006, CLINICS OCCUPATIONAL, P5; Shelerud Randy A, 2006, Clin Occup Environ Med, V5, P501; Stratford PW, 1997, SPINE, V22, P2416, DOI 10.1097/00007632-199710150-00018; Suzukamo Yoshimi, 2003, J Orthop Sci, V8, P543, DOI 10.1007/s00776-003-0679-x; Tsang R.C.C., 2004, HONG KONG PHYSIOTHER, V22, P40, DOI [10.1016/S1013-7025(09)70049-1, DOI 10.1016/S1013-7025(09)70049-1]	23	16	18	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e30807	10.1371/journal.pone.0030807	http://dx.doi.org/10.1371/journal.pone.0030807			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	911GB	22303457	Green Published, gold, Green Submitted			2022-12-27	WOS:000301704200034
J	Ning, XX; Sun, SR; Zhang, K; Liang, J; Chuai, YC; Li, Y; Wang, XM				Ning, Xiaoxuan; Sun, Shiren; Zhang, Kun; Liang, Jie; Chuai, Yucai; Li, Yuan; Wang, Xiaoming			S100A6 Protein Negatively Regulates CacyBP/SIP-Mediated Inhibition of Gastric Cancer Cell Proliferation and Tumorigenesis	PLOS ONE			English	Article							CALCIUM-BINDING PROTEINS; CALCYCLIN; PATHWAY; DEGRADATION; EXPRESSION; TUBULIN; SIP; INVASION; COMPLEX; SIAH-1	Calcyclin-binding protein (CacyBP/SIP), identified on the basis of its ability to interact with S100 proteins in a calcium-dependent manner, was previously found to inhibit the proliferation and tumorigenesis of gastric cancer cells in our laboratory. Importantly, the effects of S100 proteins on the biological behavior of CacyBP/SIP in gastric cancer remain unclear. Herein, we report the construction of eukaryotic expression vectors for wild-type CacyBP/SIP and a truncated mutant lacking the S100 protein binding domain (CacyBP/SIPDS100). The expressions of the wild-type and truncated recombinant proteins were demonstrated by transfection of MKN45 gastric cancer cells. Co-immunoprecipitation assays demonstrated interaction between S100A6 and wild-type CacyBP/SIP in MKN45 cells. Removal of the S100 protein binding domain dramatically reduced the affinity of CacyBP/SIP for S100 proteins as indicated by reduced co-immunoprecipitation of S100A6 by CacyBP/SIPDS100. The MTT assay, FACS assay, clonogenic assay and tumor xenograft experiment were performed to assess the effect of CacyBP/SIP on cell growth and tumorigenesis in vitro and in vivo. Overexpression of CacyBP/SIP inhibited the proliferation and tumorigenesis of MKN45 gastric cancer cells; the proliferation and tumorigenesis rates were even further reduced by the expression of CacyBP/SIPDS100. We also showed that S100 proteins negatively regulate CacyBP/SIP-mediated inhibition of gastric cancer cell proliferation, through an effect on beta-catenin protein expression and transcriptional activation of Tcf/LEF. Although the underlying mechanism of action requires further investigation, this study provides new insight into the interaction between S100 proteins and CacyBP/SIP, which might enrich our knowledge of S100 proteins and be helpful for our understanding of the development of gastric cancer.	[Ning, Xiaoxuan; Chuai, Yucai; Li, Yuan; Wang, Xiaoming] Fourth Mil Med Univ, Xijing Hosp, Dept Geriatr, Xian 710032, Shaanxi, Peoples R China; [Sun, Shiren] Fourth Mil Med Univ, Xijing Hosp, Dept Nephrol, Xian 710032, Shaanxi, Peoples R China; [Liang, Jie] Fourth Mil Med Univ, Xijing Hosp, State Key Lab Canc Biol, Xian 710032, Shaanxi, Peoples R China; [Liang, Jie] Fourth Mil Med Univ, Xijing Hosp, Inst Digest Dis, Xian 710032, Shaanxi, Peoples R China; [Zhang, Kun] Shaanxi Normal Univ, Coll Life Sci, Xian, Shaanxi, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Shaanxi Normal University	Ning, XX (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Geriatr, Xian 710032, Shaanxi, Peoples R China.	ningxx01@sohu.com; ggcgxl@fmmu.edu.cn; xmwang@fmmu.edu.cn			National Nature Science Foundation of China [30872964, 30772461]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from National Nature Science Foundation of China (No. 30872964, No. 30772461). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhattacharya S, 2005, BIOCHEMISTRY-US, V44, P9462, DOI 10.1021/bi0502689; Cho YG, 2003, APMIS, V111, P539, DOI 10.1034/j.1600-0463.2003.1110502.x; Donato R, 1999, BBA-MOL CELL RES, V1450, P191, DOI 10.1016/S0167-4889(99)00058-0; Filipek A, 2006, CHEMOTHERAPY, V52, P32, DOI 10.1159/000090240; Filipek A, 1998, J NEUROCHEM, V70, P1793, DOI 10.1046/j.1471-4159.1998.70051793.x; Filipek A, 2002, J BIOL CHEM, V277, P28848, DOI 10.1074/jbc.M203602200; Filipek A, 2008, J NEURAL TRANSM, V115, P1257, DOI 10.1007/s00702-008-0062-3; Filipek A, 2008, ADV ENZYME REGUL, V48, P225, DOI 10.1016/j.advenzreg.2007.11.001; Fukushima T, 2006, IMMUNITY, V24, P29, DOI 10.1016/j.immuni.2005.12.002; Heizmann CW, 2002, FRONT BIOSCI-LANDMRK, V7, pD1356, DOI 10.2741/heizmann; Kilanczyk E, 2009, BIOCHEM BIOPH RES CO, V380, P54, DOI 10.1016/j.bbrc.2009.01.026; Kolligs FT, 2002, DIGESTION, V66, P131, DOI 10.1159/000066755; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Lai RH, 2010, CANCER LETT, V288, P75, DOI 10.1016/j.canlet.2009.06.025; Lee YT, 2008, BIOCHEMISTRY-US, V47, P10921, DOI 10.1021/bi801233z; Lesniak W, 2009, BIOCHEM BIOPH RES CO, V390, P1087, DOI 10.1016/j.bbrc.2009.10.150; Lustig B, 2003, J CANCER RES CLIN, V129, P199, DOI 10.1007/s00432-003-0431-0; Martensson A, 2007, ONCOL REP, V17, P447; Matsuzawa S, 2001, MOL CELL, V7, P915, DOI 10.1016/S1097-2765(01)00242-8; Meng FP, 2009, CANCER BIOL THER, V8, P174, DOI 10.4161/cbt.8.2.7208; Mori M, 2004, ONCOL REP, V11, P1287; Ning XX, 2007, MOL CANCER RES, V5, P1254, DOI 10.1158/1541-7786.MCR-06-0426; Nowotny M, 2003, J BIOL CHEM, V278, P26923, DOI 10.1074/jbc.M211518200; Ohuchida K, 2005, CLIN CANCER RES, V11, P7785, DOI 10.1158/1078-0432.CCR-05-0714; Saadeddin A, 2009, MOL CANCER RES, V7, P1189, DOI 10.1158/1541-7786.MCR-09-0027; Saleem M, 2006, P NATL ACAD SCI USA, V103, P14825, DOI 10.1073/pnas.0606747103; Santamaria-Kisiel L, 2006, BIOCHEM J, V396, P201, DOI 10.1042/BJ20060195; Santelli E, 2005, J BIOL CHEM, V280, P34278, DOI 10.1074/jbc.M506707200; Schafer BW, 1996, TRENDS BIOCHEM SCI, V21, P134, DOI 10.1016/S0968-0004(96)80167-8; SCHAFER BW, 1995, GENOMICS, V25, P638, DOI 10.1016/0888-7543(95)80005-7; Schneider G, 2007, BBA-MOL CELL RES, V1773, P1628, DOI 10.1016/j.bbamcr.2007.07.013; Schneider G, 2010, BBA-MOL CELL RES, V1803, P1308, DOI 10.1016/j.bbamcr.2010.07.003; Schneider G, 2011, AMINO ACIDS, V41, P773, DOI 10.1007/s00726-010-0498-2; Shimamoto S, 2010, FEBS LETT, V584, P1119, DOI 10.1016/j.febslet.2010.02.055; Shyu RY, 2003, J BIOMED SCI, V10, P313, DOI 10.1159/000070096; Sun SR, 2007, BIOCHEM BIOPH RES CO, V356, P864, DOI 10.1016/j.bbrc.2007.03.080; van Dieck J, 2010, ONCOGENE, V29, P2024, DOI 10.1038/onc.2009.490; Ye YW, 2011, CANCER LETT, V307, P124, DOI 10.1016/j.canlet.2011.03.024; Zhai HH, 2006, HYBRIDOMA, V25, P91, DOI 10.1089/hyb.2006.25.91; Zhao YQ, 2002, CANCER LETT, V185, P211, DOI 10.1016/S0304-3835(02)00264-1	40	24	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30185	10.1371/journal.pone.0030185	http://dx.doi.org/10.1371/journal.pone.0030185			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295074	gold, Green Published, Green Submitted			2022-12-27	WOS:000301640600019
J	Segovia, J; Sabbah, A; Mgbemena, V; Tsai, SY; Chang, TH; Berton, MT; Morris, IR; Allen, IC; Ting, JPY; Bose, S				Segovia, Jesus; Sabbah, Ahmed; Mgbemena, Victoria; Tsai, Su-Yu; Chang, Te-Hung; Berton, Michael T.; Morris, Ian R.; Allen, Irving C.; Ting, Jenny P. -Y.; Bose, Santanu			TLR2/MyD88/NF-kappa B Pathway, Reactive Oxygen Species, Potassium Efflux Activates NLRP3/ASC Inflammasome during Respiratory Syncytial Virus Infection	PLOS ONE			English	Article							INNATE ANTIVIRAL RESPONSE; NUCLEOTIDE-BINDING DOMAIN; ANTHRAX LETHAL TOXIN; LEUCINE-RICH REPEAT; TOLL-LIKE RECEPTORS; CUTTING EDGE; CASPASE-1 ACTIVATION; NALP3 INFLAMMASOME; VIRAL-INFECTION; GENE-EXPRESSION	Human respiratory syncytial virus (RSV) constitute highly pathogenic virus that cause severe respiratory diseases in newborn, children, elderly and immuno-compromised individuals. Airway inflammation is a critical regulator of disease outcome in RSV infected hosts. Although "controlled'' inflammation is required for virus clearance, aberrant and exaggerated inflammation during RSV infection results in development of inflammatory diseases like pneumonia and bronchiolitis. Interleukin-1 beta (IL-1 beta) plays an important role in inflammation by orchestrating the pro-inflammatory response. IL-1b is synthesized as an immature pro-IL-1 beta form. It is cleaved by activated caspase-1 to yield mature IL-1 beta that is secreted extracellularly. Activation of caspase-1 is mediated by a multi-protein complex known as the inflammasome. Although RSV infection results in IL-1 beta release, the mechanism is unknown. Here in, we have characterized the mechanism of IL-1 beta secretion following RSV infection. Our study revealed that NLRP3/ASC inflammasome activation is crucial for IL-1 beta production during RSV infection. Further studies illustrated that prior to inflammasome formation; the "first signal'' constitutes activation of toll-like receptor-2 (TLR2)/MyD88/NF-kappa B pathway. TLR2/MyD88/NF-kappa B signaling is required for pro-IL-1 beta and NLRP3 gene expression during RSV infection. Following expression of these genes, two "second signals'' are essential for triggering inflammasome activation. Intracellular reactive oxygen species (ROS) and potassium (K+) efflux due to stimulation of ATP-sensitive ion channel promote inflammasome activation following RSV infection. Thus, our studies have underscored the requirement of TLR2/MyD88/NF-kappa B pathway (first signal) and ROS/potassium efflux (second signal) for NLRP3/ASC inflammasome formation, leading to caspase-1 activation and subsequent IL-1 beta release during RSV infection.	[Segovia, Jesus; Sabbah, Ahmed; Mgbemena, Victoria; Tsai, Su-Yu; Chang, Te-Hung; Berton, Michael T.; Morris, Ian R.; Bose, Santanu] Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA; [Allen, Irving C.; Ting, Jenny P. -Y.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Microbiol Immunol, Chapel Hill, NC 27599 USA	University of Texas System; University of Texas Health San Antonio; University of North Carolina; University of North Carolina Chapel Hill	Segovia, J (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA.	bose@uthscsa.edu			National Institutes of Health (NIH) [AI083387, AI057986, U19 AI077437, U54 AI057157, T32AI007271]; Center for Innovation in Prevention and Treatment of Airway Diseases (CIPTAD); NIH National Institute of Dental and Craniofacial Research (NIDCR) [DE14318]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI057986, U54AI057157, R01AI083387, U19AI077437, T32AI007271] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T32DE014318] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Innovation in Prevention and Treatment of Airway Diseases (CIPTAD); NIH National Institute of Dental and Craniofacial Research (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the National Institutes of Health (NIH) grants AI083387 (SB), AI057986 (MTB), U19 AI077437 (JPYT), U54 AI057157 (JPYT) and a grant from Center for Innovation in Prevention and Treatment of Airway Diseases (CIPTAD) (SB). AS and VM were supported by NIH National Institute of Dental and Craniofacial Research (NIDCR) grant DE14318 for the COSTAR program. IRM was supported by NIH training grant T32AI007271. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Sater AA, 2009, J BIOL CHEM, V284, P26789, DOI 10.1074/jbc.M109.026823; Allam R, 2011, J IMMUNOL, V186, P2714, DOI 10.4049/jimmunol.1002657; Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005; Babelova A, 2009, J BIOL CHEM, V284, P24035, DOI 10.1074/jbc.M109.014266; Barlan AU, 2011, J VIROL, V85, P146, DOI 10.1128/JVI.01265-10; Bauernfeind F, 2011, J IMMUNOL, V187, P613, DOI 10.4049/jimmunol.1100613; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Becker CE, 2009, J BIOL CHEM, V284, P34531, DOI 10.1074/jbc.M109.046102; Bermejo-Martin JF, 2007, EUR CYTOKINE NETW, V18, P162; Blanco JCG, 2002, J INFECT DIS, V185, P1780, DOI 10.1086/340823; Bose S, 2003, J INTERF CYTOK RES, V23, P401, DOI 10.1089/107999003322277810; Bose S, 2003, P NATL ACAD SCI USA, V100, P10890, DOI 10.1073/pnas.1832775100; Bryant C, 2009, TRENDS CELL BIOL, V19, P455, DOI 10.1016/j.tcb.2009.06.002; Cassel SL, 2008, P NATL ACAD SCI USA, V105, P9035, DOI 10.1073/pnas.0803933105; Castro SM, 2006, AM J RESP CRIT CARE, V174, P1361, DOI 10.1164/rccm.200603-319OC; Chen WZ, 2000, EXP LUNG RES, V26, P13, DOI 10.1080/019021400269934; Chu J, 2009, J LEUKOCYTE BIOL, V86, P1227, DOI 10.1189/jlb.0309164; COLLINS PL, 2001, FIELDS VIROLOGY, P1443; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Davis IC, 2006, AM J RESP CRIT CARE, V173, P673, DOI 10.1164/rccm.200508-1200OC; Delaloye J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000480; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Dostert C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006510; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Duncan JA, 2009, J IMMUNOL, V182, P6460, DOI 10.4049/jimmunol.0802696; Echchgadda I, 2009, CANCER GENE THER, V16, P923, DOI 10.1038/cgt.2009.34; Fink SL, 2008, P NATL ACAD SCI USA, V105, P4312, DOI 10.1073/pnas.0707370105; Franchi L, 2007, J BIOL CHEM, V282, P18810, DOI 10.1074/jbc.M610762200; Franchi L, 2010, EUR J IMMUNOL, V40, P611, DOI 10.1002/eji.200940180; Franchi L, 2009, J IMMUNOL, V183, P792, DOI 10.4049/jimmunol.0900173; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Franchi L, 2009, IMMUNOL REV, V227, P106, DOI 10.1111/j.1600-065X.2008.00734.x; Gross O, 2009, NATURE, V459, P433, DOI 10.1038/nature07965; Guerrero-Plata A, 2005, J VIROL, V79, P14992, DOI 10.1128/JVI.79.23.14992-14997.2005; Gurcel L, 2006, CELL, V126, P1135, DOI 10.1016/j.cell.2006.07.033; Hall CB, 2001, NEW ENGL J MED, V344, P1917, DOI 10.1056/NEJM200106213442507; Harder J, 2009, J IMMUNOL, V183, P5823, DOI 10.4049/jimmunol.0900444; Haynes LM, 2001, J VIROL, V75, P10730, DOI 10.1128/JVI.75.22.10730-10737.2001; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Ichinohe T, 2010, NAT IMMUNOL, V11, P404, DOI 10.1038/ni.1861; Ichinohe T, 2009, J EXP MED, V206, P79, DOI 10.1084/jem.20081667; Jha S, 2009, J IMMUNOL, V183, P7623, DOI 10.4049/jimmunol.0902425; Jin CC, 2010, J CLIN IMMUNOL, V30, P628, DOI 10.1007/s10875-010-9440-3; Kankkunen P, 2010, J IMMUNOL, V184, P6335, DOI 10.4049/jimmunol.0903019; Kanneganti TD, 2006, J BIOL CHEM, V281, P36560, DOI 10.1074/jbc.M607594200; Kanneganti TD, 2010, NAT REV IMMUNOL, V10, P688, DOI 10.1038/nri2851; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kota S, 2008, J BIOL CHEM, V283, P22417, DOI 10.1074/jbc.M710415200; Kurt-Jones EA, 2000, NAT IMMUNOL, V1, P398, DOI 10.1038/80833; Lamkanfi M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000510; Lamkanfi M, 2009, J BIOL CHEM, V284, P20574, DOI 10.1074/jbc.M109.023689; Lindgren C, 1996, ACTA PAEDIATR, V85, P798, DOI 10.1111/j.1651-2227.1996.tb14154.x; Liu TS, 2004, J BIOL CHEM, V279, P2461, DOI 10.1074/jbc.M307251200; Maitra R, 2009, MOL IMMUNOL, V47, P175, DOI 10.1016/j.molimm.2009.09.023; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Masters SL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001902; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; Mastronarde JG, 1996, J INFECT DIS, V174, P262, DOI 10.1093/infdis/174.2.262; Meissner F, 2008, NAT IMMUNOL, V9, P866, DOI 10.1038/ni.1633; Murawski MR, 2009, J VIROL, V83, P1492, DOI 10.1128/JVI.00671-08; Naik E, 2011, J EXP MED, V208, P417, DOI 10.1084/jem.20110367; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; O'Connor W, 2003, J IMMUNOL, V171, P6329, DOI 10.4049/jimmunol.171.12.6329; O'Neill LAJ, 2006, CURR OPIN IMMUNOL, V18, P3, DOI 10.1016/j.coi.2005.11.012; O'Neill LAJ, 2010, CURR BIOL, V20, pR328, DOI 10.1016/j.cub.2010.01.044; Okada SF, 2011, AM J RESP CELL MOL, V45, P253, DOI 10.1165/rcmb.2010-0253OC; Pazdrak K, 2002, AM J PHYSIOL-LUNG C, V283, pL364, DOI 10.1152/ajplung.00331.2001; Poeck H, 2010, NAT IMMUNOL, V11, P63, DOI 10.1038/ni.1824; Qu Y, 2007, J IMMUNOL, V179, P1913, DOI 10.4049/jimmunol.179.3.1913; RACOOSIN EL, 1989, J EXP MED, V170, P1635, DOI 10.1084/jem.170.5.1635; Rajamaki K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011765; Rathinam VAK, 2010, J CLIN IMMUNOL, V30, P632, DOI 10.1007/s10875-010-9431-4; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Ruuskanen O, 2011, LANCET, V377, P1264, DOI 10.1016/S0140-6736(10)61459-6; Sabbah A, 2009, NAT IMMUNOL, V10, P1073, DOI 10.1038/ni.1782; Said-Sadier N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010008; Schmitz N, 2005, J VIROL, V79, P6441, DOI 10.1128/JVI.79.10.6441-6448.2005; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Schroder K, 2010, SCIENCE, V327, P296, DOI 10.1126/science.1184003; Tannahill GM, 2011, FEBS LETT, V585, P1568, DOI 10.1016/j.febslet.2011.05.008; Thomas PG, 2009, IMMUNITY, V30, P566, DOI 10.1016/j.immuni.2009.02.006; Tian B, 2002, J VIROL, V76, P6800, DOI 10.1128/JVI.76.13.6800-6814.2002; Toma C, 2010, J IMMUNOL, V184, P5287, DOI 10.4049/jimmunol.0903536; UEBA O, 1978, ACTA MED OKAYAMA, V32, P265; van de Veerdonk FL, 2009, J INFECT DIS, V199, P1087, DOI 10.1086/597274; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; Wickliffe KE, 2008, CELL MICROBIOL, V10, P332, DOI 10.1111/j.1462-5822.2007.01044.x; Ye ZM, 2008, CURR OPIN IMMUNOL, V20, P3, DOI 10.1016/j.coi.2008.01.003; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	92	176	186	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e29695	10.1371/journal.pone.0029695	http://dx.doi.org/10.1371/journal.pone.0029695			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295065	gold, Green Published, Green Submitted			2022-12-27	WOS:000301640600010
J	van der Horst, PH; Wang, YY; Vandenput, I; Kuhne, LC; Ewing, PC; van IJcken, WFJ; van der Zee, M; Amant, F; Burger, CW; Blok, LJ				van der Horst, Paul H.; Wang, Yongyi; Vandenput, Ingrid; Kuhne, Liesbeth C.; Ewing, Patricia C.; van IJcken, Wilfred F. J.; van der Zee, Marten; Amant, Frederic; Burger, Curt W.; Blok, Leen J.			Progesterone Inhibits Epithelial-to-Mesenchymal Transition in Endometrial Cancer	PLOS ONE			English	Article							BETA-CATENIN; TUMOR MICROENVIRONMENT; COLORECTAL-CANCER; IMMUNE CELLS; TGF-BETA; B-CELLS; RECEPTOR; EXPRESSION; CARCINOMA; INVASION	Background: Every year approximately 74,000 women die of endometrial cancer, mainly due to recurrent or metastatic disease. The presence of tumor infiltrating lymphocytes (TILs) as well as progesterone receptor (PR) positivity has been correlated with improved prognosis. This study describes two mechanisms by which progesterone inhibits metastatic spread of endometrial cancer: by stimulating T-cell infiltration and by inhibiting epithelial-to-mesenchymal cell transition (EMT). Methodology and Principal Findings: Paraffin sections from patients with (n = 9) or without (n = 9) progressive endometrial cancer (recurrent or metastatic disease) were assessed for the presence of CD4+ (helper), CD8+ (cytotoxic) and Foxp3+ (regulatory) T-lymphocytes and PR expression. Progressive disease was observed to be associated with significant loss of TILs and loss of PR expression. Frozen tumor samples, used for genome-wide expression analysis, showed significant regulation of pathways involved in immunesurveillance, EMT and metastasis. For a number of genes, such as CXCL14, DKK1, DKK4, PEG10 and WIF1, quantitive RT-PCR was performed to verify up- or downregulation in progressive disease. To corroborate the role of progesterone in regulating invasion, Ishikawa(IK) endometrial cancer cell lines stably transfected with PRA (IKPRA), PRB(IKPRB) and PRA+PRB (IKPRAB) were cultured in presence/absence of progesterone (MPA) and used for genome-wide expression analysis, Boyden- and wound healing migration assays, and IHC for known EMT markers. IKPRB and IKPRAB cell lines showed MPA induced inhibition of migration and loss of the mesenchymal marker vimentin at the invasive front of the wound healing assay. Furthermore, pathway analysis of significantly MPA regulated genes showed significant down regulation of important pathways involved in EMT, immunesuppression and metastasis: such as IL6-, TGF-beta and Wnt/beta-catenin signaling. Conclusion: Intact progesterone signaling in non-progressive endometrial cancer seems to be an important factor stimulating immunosurveilance and inhibiting transition from an epithelial to a more mesenchymal, more invasive phenotype.	[van der Horst, Paul H.; Wang, Yongyi; Kuhne, Liesbeth C.; van der Zee, Marten; Burger, Curt W.; Blok, Leen J.] Erasmus MC, Dept Obstet & Gynaecol, Rotterdam, Netherlands; [Vandenput, Ingrid; Amant, Frederic] Catholic Univ Louvain, Univ Hosp Gasthuisberg, Div Gynecol Oncol, B-3000 Louvain, Belgium; [Ewing, Patricia C.] Erasmus MC, Dept Pathol, Rotterdam, Netherlands; [van IJcken, Wilfred F. J.] Erasmus MC, Dept Biom, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; KU Leuven; University Hospital Leuven; Universite Catholique Louvain; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	van der Horst, PH (corresponding author), Erasmus MC, Dept Obstet & Gynaecol, Rotterdam, Netherlands.	p.vanderhorst@erasmusmc.nl	van ijcken, willem/N-9805-2018; Amant, Frédéric/W-7436-2019	van ijcken, willem/0000-0002-0421-8301; Amant, Frédéric/0000-0002-5452-4905	Dutch Cancer Society [EMCR 2008-4056]	Dutch Cancer Society(KWF Kankerbestrijding)	The work of LJB and MvdZ is supported by a grant from the Dutch Cancer Society (EMCR 2008-4056). The funders had no role in study design, data collection and analyses, decision to publish or preparation of the manuscript.	Ace Christopher I, 2004, Reprod Biol Endocrinol, V2, P54, DOI 10.1186/1477-7827-2-54; Allavena P, 2011, EXPT CELL R IN PRESS; Amant F, 2005, LANCET, V366, P491, DOI 10.1016/S0140-6736(05)67063-8; Avila DM, 2001, J STEROID BIOCHEM, V76, P135, DOI 10.1016/S0960-0760(00)00158-8; Berry KK, 2001, INT J GYNECOL CANCER, V11, P54, DOI 10.1046/j.1525-1438.2001.011001054.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brabletz T, 1998, PATHOL RES PRACT, V194, P701, DOI 10.1016/S0344-0338(98)80129-5; Bruner-Tran KL, 2002, J CLIN ENDOCR METAB, V87, P4782, DOI 10.1210/jc.2002-020418; Clark CE, 2007, CANCER RES, V67, P9518, DOI 10.1158/0008-5472.CAN-07-0175; Clemente CG, 1996, CANCER, V77, P1303, DOI 10.1002/(SICI)1097-0142(19960401)77:7<1303::AID-CNCR12>3.3.CO;2-0; Cohn DE, 2002, GYNECOL ONCOL, V87, P243, DOI 10.1006/gyno.2002.6825; de Jong RA, 2009, GYNECOL ONCOL, V114, P105, DOI 10.1016/j.ygyno.2009.03.022; EHRLICH CE, 1988, AM J OBSTET GYNECOL, V158, P796, DOI 10.1016/0002-9378(88)90075-0; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Gavert N, 2005, J CELL BIOL, V168, P633, DOI 10.1083/jcb.200408051; Giangrande PH, 1999, RECENT PROG HORM RES, V54, P291; Giangrande PH, 2000, MOL CELL BIOL, V20, P3102, DOI 10.1128/MCB.20.9.3102-3115.2000; Giangrande PH, 1997, J BIOL CHEM, V272, P32889, DOI 10.1074/jbc.272.52.32889; Hanekamp EE, 2003, CLIN CANCER RES, V9, P4190; Hanekamp EE, 2005, J SOC GYNECOL INVEST, V12, P278, DOI 10.1016/j.jsgi.2005.01.030; Hanekamp EE, 2002, EUR J CANCER, V38, pS71; Hiraoka N, 2010, INT J CLIN ONCOL, P1; Hu CS, 2004, CELL MOL IMMUNOL, V1, P280; Ip WK, 2007, CANCER LETT, V250, P284, DOI 10.1016/j.canlet.2006.10.012; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jeon YT, 2006, CANCER LETT, V239, P198, DOI 10.1016/j.canlet.2005.08.001; Jie X, 2007, ONCOGENE, V26, P5741, DOI 10.1038/sj.onc.1210362; Jolly S, 2006, GYNECOL ONCOL, V103, P87, DOI 10.1016/j.ygyno.2006.01.038; KELLY RW, 1994, HUM REPROD, V9, P253, DOI 10.1093/oxfordjournals.humrep.a138491; Kilic A, 2009, J SURG RES; Kim JJ, 2010, SEMIN REPROD MED, V28, P81, DOI 10.1055/s-0029-1242998; Kim YB, 1997, CANCER, V79, P320, DOI 10.1002/(SICI)1097-0142(19970115)79:2<320::AID-CNCR15>3.0.CO;2-2; Kondratiev S, 2004, CLIN CANCER RES, V10, P4450, DOI 10.1158/1078-0432.CCR-0732-3; KOSARY CL, 1994, SEMIN SURG ONCOL, V10, P31, DOI 10.1002/ssu.2980100107; Ladle BH, 2010, INT J CANC, pn/a; Leffers N, 2010, BRIT J CANCER, V103, P685, DOI 10.1038/sj.bjc.6605820; Lindauer J, 2003, GYNECOL ONCOL, V91, P547, DOI 10.1016/j.ygyno.2003.08.003; Liu Damon Shing-Min, 2011, Proceedings of the 2011 Workshop on Digital Media and Digital Content Management (DMDCM 2011), P1, DOI 10.1109/DMDCM.2011.24; Mokhtar NM, 2010, MOL HUM REPROD, V16, P170, DOI 10.1093/molehr/gap100; Naishiro Y, 2001, CANCER RES, V61, P2751; Nicholson RI, 2003, BREAST CANCER RES TR, V80, pS29; Pecorelli S, 2009, INT J GYNECOL OBSTET, V105, P103, DOI 10.1016/j.ijgo.2009.02.012; Pfeifer M, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-64; Scholten AN, 2003, J PATHOL, V201, P460, DOI 10.1002/path.1402; Smid-Koopman E, 2005, J SOC GYNECOL INVEST, V12, P285, DOI 10.1016/j.jsgi.2005.01.003; Talbi S, 2006, ENDOCRINOLOGY, V147, P1097, DOI 10.1210/en.2005-1076; Tavassoli FA, 2003, WHO TUMOURS BREAST F; Tetel MJ, 1999, MOL ENDOCRINOL, V13, P910, DOI 10.1210/me.13.6.910; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thigpen JT, 1999, J CLIN ONCOL, V17, P1736, DOI 10.1200/JCO.1999.17.6.1736; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van Steenwijk PJD, 2010, CANCER RES, V70, P2707, DOI 10.1158/0008-5472.CAN-09-4299; Wang XB, 2007, J IMMUNOL, V179, P2880, DOI 10.4049/jimmunol.179.5.2880; Wang YY, 2009, CLIN CANCER RES, V15, P5784, DOI 10.1158/1078-0432.CCR-09-0814; Ward EC, 2008, ENDOCRINOLOGY, V149, P1942, DOI 10.1210/en.2007-0756; Yahata T, 2006, HUM REPROD, V21, P1070, DOI 10.1093/humrep/dei434; Yang L, 2010, CURR MOL MED, V10, P374, DOI 10.2174/156652410791317039; Yang L, 2010, TRENDS IMMUNOL, V31, P220, DOI 10.1016/j.it.2010.04.002; Yee DS, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-162; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177	61	53	56	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30840	10.1371/journal.pone.0030840	http://dx.doi.org/10.1371/journal.pone.0030840			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295114	Green Published, gold, Green Submitted			2022-12-27	WOS:000301640600059
J	Yue, WF; Du, M; Zhu, MJ				Yue, Wan-Fu; Du, Min; Zhu, Mei-Jun			High Temperature in Combination with UV Irradiation Enhances Horizontal Transfer of stx2 Gene from E. coli O157:H7 to Non-Pathogenic E. coli	PLOS ONE			English	Article							ESCHERICHIA-COLI; BEEF-CATTLE; RECTOANAL JUNCTION; SKELETAL-MUSCLE; FEEDLOT CATTLE; PREVALENCE; O157-H7; NON-O157; COLONIZATION; INDUCTION	Background: Shiga toxin (stx) genes have been transferred to numerous bacteria, one of which is E. coli O157:H7. It is a common belief that stx gene is transferred by bacteriophages, because stx genes are located on lambdoid prophages in the E. coli O157: H7 genome. Both E. coli O157: H7 and non-pathogenic E. coli are highly enriched in cattle feedlots. We hypothesized that strong UV radiation in combination with high temperature accelerates stx gene transfer into nonpathogenic E. coli in feedlots. Methodology/Principal Findings: E. coli O157: H7 EDL933 strain were subjected to different UV irradiation (0 or 0.5 kJ/m(2)) combination with different temperature (22, 28, 30, 32, and 37 degrees C) treatments, and the activation of lambdoid prophages was analyzed by plaque forming unit while induction of Stx2 prophages was quantified by quantitative real-time PCR. Data showed that lambdoid prophages in E. coli O157: H7, including phages carrying stx2, were activated under UV radiation, a process enhanced by elevated temperature. Consistently, western blotting analysis indicated that the production of Shiga toxin 2 was also dramatically increased by UV irradiation and high temperature. In situ colony hybridization screening indicated that these activated Stx2 prophages were capable of converting laboratory strain of E. coli K12 into new Shiga toxigenic E. coli, which were further confirmed by PCR and ELISA analysis. Conclusions/Significance: These data implicate that high environmental temperature in combination with UV irradiation accelerates the spread of stx genes through enhancing Stx prophage induction and Stx phage mediated gene transfer. Cattle feedlot sludge are teemed with E. coli O157:H7 and non-pathogenic E. coli, and is frequently exposed to UV radiation via sunlight, which may contribute to the rapid spread of stx gene to non-pathogenic E. coli and diversity of shiga toxin producing E. coli.	[Yue, Wan-Fu; Zhu, Mei-Jun] Univ Wyoming, Dept Anim Sci, Laramie, WY 82071 USA; [Du, Min] Washington State Univ, Dept Anim Sci, Pullman, WA 99164 USA	University of Wyoming; Washington State University	Yue, WF (corresponding author), Univ Wyoming, Dept Anim Sci, Laramie, WY 82071 USA.	meijun@uwyo.edu	Du, Min/H-4311-2011; Zhu, Mei-Jun/A-4248-2013	Du, Min/0000-0002-7232-072X; 	USDA AFRI [2010-65201-20599]; Agricultural Experiment Station at University of Wyoming; NIH-INBRE [P20RR016474]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016474] Funding Source: NIH RePORTER	USDA AFRI(United States Department of Agriculture (USDA)); Agricultural Experiment Station at University of Wyoming; NIH-INBRE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Funding was provided by USDA AFRI 2010-65201-20599, Agricultural Experiment Station at University of Wyoming, and NIH-INBRE P20RR016474. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MJ, 2006, J FOOD PROTECT, V69, P3018, DOI 10.4315/0362-028X-69.12.3018; Alexeyev MF, 1999, BIOTECHNIQUES, V26, P824, DOI 10.2144/99265bm05; Allison HE, 2007, FUTURE MICROBIOL, V2, P165, DOI 10.2217/17460913.2.2.165; Asadulghani M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000408; Cobbold RN, 2007, APPL ENVIRON MICROB, V73, P1563, DOI 10.1128/AEM.01742-06; Elder RO, 2000, P NATL ACAD SCI USA, V97, P2999, DOI 10.1073/pnas.060024897; ENNIS DG, 1985, P NATL ACAD SCI USA, V82, P3325, DOI 10.1073/pnas.82.10.3325; Fegan N, 2004, J APPL MICROBIOL, V97, P362, DOI 10.1111/j.1365-2672.2004.02300.x; Fey PD, 2000, EMERG INFECT DIS, V6, P530, DOI 10.3201/eid0605.000513; Furst S, 2000, J MED MICROBIOL, V49, P383, DOI 10.1099/0022-1317-49-4-383; Gabig M, 1998, MOL GEN GENET, V258, P494, DOI 10.1007/s004380050760; Hussein HS, 2007, J ANIM SCI, V85, pE63, DOI 10.2527/jas.2006-421; KIRII Y, 1987, J CLIN MICROBIOL, V25, P1962, DOI 10.1128/JCM.25.10.1962-1965.1987; LeJeune JT, 2004, APPL ENVIRON MICROB, V70, P377, DOI 10.1128/AEM.70.1.377-384.2004; Lim JY, 2007, APPL ENVIRON MICROB, V73, P1380, DOI 10.1128/AEM.02242-06; Los JM, 2010, FEMS IMMUNOL MED MIC, V58, P322, DOI 10.1111/j.1574-695X.2009.00644.x; McDonald JE, 2010, APPL ENVIRON MICROB, V76, P2360, DOI 10.1128/AEM.02923-09; OBRIEN AD, 1984, SCIENCE, V226, P694, DOI 10.1126/science.6387911; Obuchowski M, 1997, J BACTERIOL, V179, P5987, DOI 10.1128/jb.179.19.5987-5991.1997; Ogura Y, 2009, P NATL ACAD SCI USA, V106, P17939, DOI 10.1073/pnas.0903585106; Paton AW, 1998, J CLIN MICROBIOL, V36, P598, DOI 10.1128/JCM.36.2.598-602.1998; Ray PE, 2001, PEDIATR NEPHROL, V16, P823, DOI 10.1007/s004670100660; RKI, 2011, 0104H4 EHEC RKI; Yan YX, 2011, CURR MICROBIOL, V62, P458, DOI 10.1007/s00284-010-9729-8; Zhu MJ, 2008, J PHYSIOL-LONDON, V586, P2651, DOI 10.1113/jphysiol.2007.149633; Zhu MJ, 2006, J PHYSIOL-LONDON, V575, P241, DOI 10.1113/jphysiol.2006.112110; Zhu MJ, 2010, AM J PHYSIOL-REG I, V299, pR1224, DOI 10.1152/ajpregu.00309.2010	27	23	23	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2012	7	2							e31308	10.1371/journal.pone.0031308	http://dx.doi.org/10.1371/journal.pone.0031308			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZQ	22347461	Green Published, gold, Green Submitted			2022-12-27	WOS:000302730200019
J	Kyutoku, Y; Tada, R; Umeyama, T; Harada, K; Kikuchi, S; Watanabe, E; Liegey-Dougall, A; Dan, I				Kyutoku, Yasushi; Tada, Ryoko; Umeyama, Takahiko; Harada, Kenji; Kikuchi, Senichiro; Watanabe, Eiju; Liegey-Dougall, Angela; Dan, Ippeita			Cognitive and Psychological Reactions of the General Population Three Months After the 2011 Tohoku Earthquake and Tsunami	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; QUALITY-OF-LIFE; DISASTER VICTIMS SPEAK; MENTAL-HEALTH; MUSCULOSKELETAL PAIN; FOLLOW-UP; GROWTH; APPRAISAL; SYMPTOMS; PREDICTORS	Background: The largest earthquake on record in Japan (magnitude 9.0) occurred on March 11, 2011, and the subsequent tsunami devastated the Pacific coast of Northern Japan. These further triggered the Fukushima I nuclear power plant accidents. Such a hugely complex disaster inevitably has negative psychological effects on general populations as well as on the direct victims. While previous disaster studies enrolled descriptive approaches focusing on direct victims, the structure of the psychological adjustment process of people from the general population has remained uncertain. The current study attempted to establish a path model that sufficiently reflects the early psychological adaptation process of the general population to large-scale natural disasters. Methods and Findings: Participants from the primary disaster area (n = 1083) and other areas (n = 2372) voluntarily participated in an online questionnaire study. By constructing path models using a structural equation model procedure (SEM), we examined the structural relationship among psychological constructs known related to disasters. As post-traumatic stress symptoms (PTS) were significantly more present in people in the primarily affected area than in those in secondary-or non-affected areas, the path models were constructed for the primary victims. The parsimoniously depicted model with the best fit was achieved for the psychological-adjustment centered model with quality of life (QoL) as a final outcome. Conclusion: The paths to QoL via negative routes (from negative cognitive appraisal, PTS, and general stress) were dominant, suggesting the importance of clinical intervention for reducing negative cognitive appraisal, and for caring for general stress and PTS to maintain QoL at an early stage of psychological adaptation to a disaster. The model also depicted the presence of a positive route where positive cognitive appraisal facilitates post-traumatic growth (PTG) to achieve a higher QoL, suggesting the potential importance of positive psychological preventive care for unexpected natural disasters.	[Kyutoku, Yasushi; Dan, Ippeita] Jichi Med Univ, Funct Brain Sci Lab, Ctr Dev Adv Med Technol, Shimotsuke, Tochigi, Japan; [Tada, Ryoko; Umeyama, Takahiko; Harada, Kenji] Cross Mkt Inc, Dept Mkt & Res, Tokyo, Japan; [Kikuchi, Senichiro] Jichi Med Univ, Dept Psychiat, Shimotsuke, Tochigi, Japan; [Watanabe, Eiju] Jichi Med Univ, Dept Neurosurg, Shimotsuke, Tochigi, Japan; [Liegey-Dougall, Angela] Univ Texas Arlington, Dept Psychol, Coll Sci, Arlington, TX 76019 USA	Jichi Medical University; Jichi Medical University; Jichi Medical University; University of Texas System; University of Texas Arlington	Kyutoku, Y (corresponding author), Jichi Med Univ, Funct Brain Sci Lab, Ctr Dev Adv Med Technol, Shimotsuke, Tochigi, Japan.	qworkdog@jichi.ac.jp; dan@jichi.ac.jp	Kikuchi, Senichiro/ABI-1840-2020		Health and Labor Sciences Research Grants; Comprehensive Research on Disability Health and Welfare; Japan Society for Promotion of Science [23700921]	Health and Labor Sciences Research Grants(Ministry of Health, Labour and Welfare, Japan); Comprehensive Research on Disability Health and Welfare; Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Health and Labor Sciences Research Grants, Comprehensive Research on Disability Health and Welfare (to Dr. Dan), and the Grant-in-Aid for Scientific Research from the Japan Society for Promotion of Science (23700921) (to Dr. Kyutoku). The funding bodies had no role in study design, data collection and analysis, preparation of the manuscript, or the decision to publish.	AKAIKE H, 1987, PSYCHOMETRIKA, V52, P317, DOI 10.1007/BF02294359; Asukai N, 2002, J NERV MENT DIS, V190, P175, DOI 10.1097/00005053-200203000-00006; Baum A, 1987, CATACLYSMS CRISES CA; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; BOZDOGAN H, 1987, PSYCHOMETRIKA, V52, P345, DOI 10.1007/BF02294361; Brewin CR, 2003, CLIN PSYCHOL REV, V23, P339, DOI 10.1016/S0272-7358(03)00033-3; Calhoun L.G., 2006, HDB POSTTRAUMATIC GR; Cann A, 2010, J LOSS TRAUMA, V15, P151, DOI 10.1080/15325020903375826; Cao H, 2003, SOC PSYCH PSYCH EPID, V38, P204, DOI 10.1007/s00127-003-0619-2; Chen CH, 2001, PSYCHIAT CLIN NEUROS, V55, P493, DOI 10.1046/j.1440-1819.2001.00895.x; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Dekel R, 2009, HEALTH SOC WORK, V34, P87, DOI 10.1093/hsw/34.2.87; Dougall AL, 2005, PSYCHIATRY, V68, P28, DOI 10.1521/psyc.68.1.28.64188; Dysvik E, 2005, INT J NURS STUD, V42, P297, DOI 10.1016/j.ijnurstu.2004.06.009; Ehlers A, 1995, Behav Cogn Psychother, V23, P217, DOI 10.1017/S135246580001585X; Ford E, 2010, J ANXIETY DISORD, V24, P353, DOI 10.1016/j.janxdis.2010.01.008; Galea S, 2005, EPIDEMIOL REV, V27, P78, DOI 10.1093/epirev/mxi003; Galea S, 2002, NEW ENGL J MED, V346, P982, DOI 10.1056/NEJMsa013404; Goto Toyomi, 2003, Trauma Violence Abuse, V4, P195, DOI 10.1177/1524838003004003001; Guan BQ, 2011, J AFFECT DISORDERS, V131, P293, DOI 10.1016/j.jad.2011.01.010; Hatta H., 1998, JAPANESE J PSYCHOSOM, V38, P309; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; Iwahasi S, 2002, JPN J PSYCHOSOM MED, V42, P459; Johansen VA, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-26; Joksimovic L, 2002, INT J BEHAV MED, V9, P122, DOI 10.1207/S15327558IJBM0902_04; Jones DA, 2003, J PAIN, V4, P267, DOI 10.1016/S1526-5900(03)00630-8; Joseph S, 2010, CLIN PSYCHOL REV, V30, P830, DOI 10.1016/j.cpr.2010.01.002; Karatzias T, 2009, MED HYPOTHESES, V72, P444, DOI 10.1016/j.mehy.2008.10.026; Kessler TA, 1998, RES NURS HEALTH, V21, P73; Kocalevent RD, 2007, J PSYCHOSOM RES, V63, P71, DOI 10.1016/j.jpsychores.2007.02.010; Kokai M, 2004, PSYCHIAT CLIN NEUROS, V58, P110, DOI 10.1111/j.1440-1819.2003.01203.x; Kun P, 2009, PUBLIC HEALTH, V123, P703, DOI 10.1016/j.puhe.2009.09.017; Kutz I, 2006, PERS INDIV DIFFER, V40, P1579, DOI 10.1016/j.paid.2006.01.002; LAZARUS RS, 1985, AM PSYCHOL, V40, P770, DOI 10.1037/0003-066X.40.7.770; Liu AZ, 2006, CAN J PSYCHIAT, V51, P350, DOI 10.1177/070674370605100603; McAllister M, 2009, NURS EDUC TODAY, V29, P371, DOI 10.1016/j.nedt.2008.10.011; McMillen JC, 1997, J CONSULT CLIN PSYCH, V65, P733, DOI 10.1037/0022-006X.65.5.733; Mertler C, 2008, PYRCZAK PUBLISHING; Ministry of Internal Affairs and Communication, 2011, WHIT PAP 2011 INF CO; Morrill EF, 2008, PSYCHO-ONCOLOGY, V17, P948, DOI 10.1002/pon.1313; Nemeroff CB, 2006, J PSYCHIATR RES, V40, P1, DOI 10.1016/j.jpsychires.2005.07.005; Nishi D, 2010, BIOPSYCHOSOC MED, V4, DOI 10.1186/1751-0759-4-7; Noble AJ, 2008, NEUROSURGERY, V63, P1095, DOI 10.1227/01.NEU.0000327580.91345.78; Norberg MM, 2008, J ANXIETY DISORD, V22, P1516, DOI 10.1016/j.janxdis.2008.03.005; Norris FH, 2002, PSYCHIATRY, V65, P207, DOI 10.1521/psyc.65.3.207.20173; Novotney A, 2009, MONIT PSYCHOL, V40, P40; Nunnally JC, 1994, PSYCHOMETRIC THEORY, V3rd, DOI DOI 10.1037/018882; Park CL, 2010, PSYCHOL BULL, V136, P257, DOI 10.1037/a0018301; Rajandram RK, 2010, ORAL ONCOL, V46, P791, DOI 10.1016/j.oraloncology.2010.08.010; Rosenberg SD., 2009, TREATMENT POSTTRAUMA; Ross MW, 2005, SOC SCI MED, V61, P245, DOI 10.1016/j.socscimed.2005.01.019; Setoyama J, 2011, RIPPO CHOSA, V317, P44; Stanton A. L., 2006, HDB POSTTRAUMATIC GR, P138; Sumalla EC, 2009, CLIN PSYCHOL REV, V29, P24, DOI 10.1016/j.cpr.2008.09.006; SUTHERLAND HJ, 1991, SOC SCI MED, V32, P725, DOI 10.1016/0277-9536(91)90152-3; Tabachnick BG., 2013, USING MULTIVARIATE S, V6th; Taku K, 2007, ANXIETY STRESS COPIN, V20, P353, DOI 10.1080/10615800701295007; TANAKA JS, 1989, BRIT J MATH STAT PSY, V42, P233, DOI 10.1111/j.2044-8317.1989.tb00912.x; Tazaki M, 1997, WHOQOL 26 MANUAL REV; Tedeschi RG, 1996, J TRAUMA STRESS, V9, P455, DOI 10.1007/BF02103658; Tedeschi RG, 2007, APPL PSYCHOL-INT REV, V56, P396, DOI 10.1111/j.1464-0597.2007.00299.x; Thompson KE, 2004, J NERV MENT DIS, V192, P146, DOI 10.1097/01.nmd.0000110286.10445.ab; Tsai KY, 2007, J PSYCHIATR RES, V41, P90, DOI 10.1016/j.jpsychires.2005.10.004; Tsutsumi A, 1998, INT J BEHAV MED, V5, P166, DOI 10.1207/s15327558ijbm0502_6; U. S. Geological Survey, 2011, MAGN 9 0 NEAR E COAS; Unruh AM, 1999, CLIN J PAIN, V15, P31, DOI 10.1097/00002508-199903000-00006; Vlaeyen JWS, 2000, PAIN, V85, P317, DOI 10.1016/S0304-3959(99)00242-0; Wang XD, 2000, PSYCHIAT CLIN NEUROS, V54, P427, DOI 10.1046/j.1440-1819.2000.00732.x; World Health Organization [WHO], 1993, WHOQOL STUD PROT; Xie XF, 2011, RISK ANAL, V31, P450, DOI 10.1111/j.1539-6924.2010.01530.x; Xu JP, 2011, J AFFECT DISORDERS, V133, P274, DOI 10.1016/j.jad.2011.03.034; Yu XN, 2010, J AFFECT DISORDERS, V123, P327, DOI 10.1016/j.jad.2009.09.019; Zigmond AS, 1993, ACTA PSYCHITR SCAND, V67, P361; Zlotnick C, 2002, COMPR PSYCHIAT, V43, P413, DOI 10.1053/comp.2002.35900; Zoellner T, 2006, CLIN PSYCHOL REV, V26, P626, DOI 10.1016/j.cpr.2006.01.008	75	22	25	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31014	10.1371/journal.pone.0031014	http://dx.doi.org/10.1371/journal.pone.0031014			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	924ZP	22347421	Green Published, gold			2022-12-27	WOS:000302730100032
J	Matschke, J; Bohla, A; Maucksch, C; Mittal, R; Rudolph, C; Rosenecker, J				Matschke, Johannes; Bohla, Alexander; Maucksch, Christof; Mittal, Rashmi; Rudolph, Carsten; Rosenecker, Joseph			Characterization of Ku702-NLS as Bipartite Nuclear Localization Sequence for Non-Viral Gene Delivery	PLOS ONE			English	Article							PLASMID DNA; IN-VIVO; MAGNETIC FORCE; CELL-NUCLEUS; POLYETHYLENIMINE; EXPRESSION; SIGNAL; MAGNETOFECTION; TRANSFECTION; PEPTIDES	Several barriers have to be overcome in order to achieve gene expression in target cells, e. g. cellular uptake, endosomal release and translocation to the nucleus. Nuclear localization sequences (NLS) enhance gene delivery by increasing the uptake of plasmid DNA (pDNA) to the nucleus. So far, only monopartite NLS were analysed for non-viral gene delivery. In this study, we examined the characteristics of a novel bipartite NLS like construct, namely NLS Ku70. We synthesized a dimeric structure of a modified NLS from the Ku70 protein (Ku70(2)-NLS), a nuclear transport active mutant of Ku70(2)-NLS (s1Ku70(2)-NLS) and a nuclear transport deficient mutant of Ku70(2)-NLS (s2Ku70(2)). We examined the transfection efficiency of binary Ku70(2)-NLS/DNA and ternary Ku70(2)-NLS/PEI/DNA gene vector complexes in vitro by using standard transfection protocols as well as the magnetofection method. The application of Ku70(2)-NLS and s1Ku70(2)-NLS increased gene transfer efficiency in vitro and in vivo. This study shows for the first time that the use of bipartite NLS compounds alone or in combination with cationic polymers is a promising strategy to enhance the efficiency of non-viral gene transfer.	[Matschke, Johannes; Bohla, Alexander; Maucksch, Christof; Rudolph, Carsten; Rosenecker, Joseph] Univ Munich, Dept Pediat, Munich, Germany; [Bohla, Alexander] Univ Munster, Inst Anim Physiol, Munster, Germany; [Maucksch, Christof; Rudolph, Carsten] Free Univ Berlin, Dept Pharm, Berlin, Germany; [Mittal, Rashmi] Univ Munich, Dept Neonatol, Munich, Germany	University of Munich; University of Munster; Free University of Berlin; University of Munich	Matschke, J (corresponding author), Univ Munich, Dept Pediat, Munich, Germany.	Joseph.Rosenecker@med.uni-muenchen.de	Rosenecker, Joseph/AAA-7330-2020; Bohla, Alexander/J-1537-2012	Bohla, Alexander/0000-0001-9610-5138	German Research Foundation (DFG) (Deutsche Forschungsgemeinschaft) [RO 994/2-4]	German Research Foundation (DFG) (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	The work was supported by the the German Research Foundation (DFG) (Deutsche Forschungsgemeinschaft) RO 994/2-4. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Ciolina C, 1999, BIOCONJUGATE CHEM, V10, P49, DOI 10.1021/bc980061a; Erbacher P, 1999, J GENE MED, V1, P210; FAWELL S, 1994, P NATL ACAD SCI USA, V91, P664, DOI 10.1073/pnas.91.2.664; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Honigman A, 2001, MOL THER, V4, P239, DOI 10.1006/mthe.2001.0437; Koike M, 1999, EXP CELL RES, V250, P401, DOI 10.1006/excr.1999.4507; Koike M, 2002, J RADIAT RES, V43, P223, DOI 10.1269/jrr.43.223; Ogris M, 1998, GENE THER, V5, P1425, DOI 10.1038/sj.gt.3300745; Ogris M, 2001, AAPS PHARMSCI, V3, part. no.; Plank C, 2003, BIOL CHEM, V384, P737, DOI 10.1515/BC.2003.082; PLANK C, 1994, J BIOL CHEM, V269, P12918; Pollard H, 1998, J BIOL CHEM, V273, P7507, DOI 10.1074/jbc.273.13.7507; Ritter W, 2003, J MOL MED-JMM, V81, P708, DOI 10.1007/s00109-003-0483-2; Rudolph C, 2003, J BIOL CHEM, V278, P11411, DOI 10.1074/jbc.M211891200; Scherer F, 2002, GENE THER, V9, P102, DOI 10.1038/sj.gt.3301624; Sebestyen MG, 1998, NAT BIOTECHNOL, V16, P80, DOI 10.1038/nbt0198-80; Surovoy A, 1998, ADV EXP MED BIOL, V451, P457; Wightman L, 2001, J GENE MED, V3, P362, DOI 10.1002/jgm.187; Zanta MA, 1999, P NATL ACAD SCI USA, V96, P91, DOI 10.1073/pnas.96.1.91	21	10	10	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e24615	10.1371/journal.pone.0024615	http://dx.doi.org/10.1371/journal.pone.0024615			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347357	Green Published, Green Submitted, gold			2022-12-27	WOS:000302730100001
J	Su, CH; Pal, NR; Lin, KL; Chung, IF				Su, Chun-Hung; Pal, Nikhil R.; Lin, Ken-Li; Chung, I-Fang			Identification of Amino Acid Propensities That Are Strong Determinants of Linear B-cell Epitope Using Neural Networks	PLOS ONE			English	Article							SUPPORT VECTOR MACHINES; PROTEIN ANTIGENIC DETERMINANTS; FUNCTIONAL DOMAIN COMPOSITION; SUBCELLULAR-LOCALIZATION; EVOLUTION INFORMATION; CLEAVAGE SITES; WEB SERVER; TURN TYPES; PREDICTION; SEQUENCES	Background: Identification of amino acid propensities that are strong determinants of linear B-cell epitope is very important to enrich our knowledge about epitopes. This can also help to obtain better epitope prediction. Typical linear B-cell epitope prediction methods combine various propensities in different ways to improve prediction accuracies. However, fewer but better features may yield better prediction. Moreover, for a propensity, when the sequence length is k, there will be k values, which should be treated as a single unit for feature selection and hence usual feature selection method will not work. Here we use a novel Group Feature Selecting Multilayered Perceptron, GFSMLP, which treats a group of related information as a single entity and selects useful propensities related to linear B-cell epitopes, and uses them to predict epitopes. Methodology/Principal Findings: We use eight widely known propensities and four data sets. We use GFSMLP to rank propensities by the frequency with which they are selected. We find that Chou's beta-turn and Ponnuswamy's polarity are better features for prediction of linear B-cell epitope. We examine the individual and combined discriminating power of the selected propensities and analyze the correlation between paired propensities. Our results show that the selected propensities are indeed good features, which also cooperate with other propensities to enhance the discriminating power for predicting epitopes. We find that individually polarity is not the best predictor, but it collaborates with others to yield good prediction. Usual feature selection methods cannot provide such information. Conclusions/Significance: Our results confirm the effectiveness of active (group) feature selection by GFSMLP over the traditional passive approaches of evaluating various combinations of propensities. The GFSMLP-based feature selection can be extended to more than 500 remaining propensities to enhance our biological knowledge about epitopes and to obtain better prediction. A graphical-user-interface version of GFSMLP is available at: http://bio.classcloud.org/GFSMLP/.	[Su, Chun-Hung; Chung, I-Fang] Natl Yang Ming Univ, Inst Biomed Informat, Taipei 112, Taiwan; [Pal, Nikhil R.] Indian Stat Inst, Elect & Commun Sci Unit, Kolkata 700035, W Bengal, India; [Lin, Ken-Li] Chung Hua Univ, Ctr Comp, Hsinchu, Taiwan	National Yang Ming Chiao Tung University; Indian Statistical Institute; Indian Statistical Institute Kolkata; Chung Hua University	Su, CH (corresponding author), Natl Yang Ming Univ, Inst Biomed Informat, Taipei 112, Taiwan.	ifchung@ym.edu.tw			National Science Council (NSC) [NSC100-2221-E-010-011]	National Science Council (NSC)(Ministry of Science and Technology, Taiwan)	This work is supported by National Science Council (NSC) (NSC100-2221-E-010-011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARLOW DJ, 1986, NATURE, V322, P747, DOI 10.1038/322747a0; Blythe MJ, 2005, PROTEIN SCI, V14, P246, DOI 10.1110/ps.041059505; Cai YD, 2004, J THEOR BIOL, V228, P551, DOI 10.1016/j.jtbi.2004.02.019; Cai YD, 2004, J THEOR BIOL, V226, P373, DOI 10.1016/j.jtbi.2003.08.015; Cai YD, 2003, PEPTIDES, V24, P629, DOI 10.1016/S0196-9781(03)00100-1; Cai YD, 2003, PEPTIDES, V24, P159, DOI 10.1016/S0196-9781(02)00289-9; Cai YD, 2002, J COMPUT CHEM, V23, P267, DOI 10.1002/jcc.10017; Cai YD, 2002, J PEPT SCI, V8, P297, DOI 10.1002/psc.401; Chakraborty D, 2008, IEEE T NEURAL NETWOR, V19, P381, DOI 10.1109/TNN.2007.910730; Chen J, 2007, AMINO ACIDS, V33, P423, DOI 10.1007/s00726-006-0485-9; Chen L, 2010, MOLECULES, V15, P8177, DOI 10.3390/molecules15118177; Chen L, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-293; Chou K.-C., 2010, NAT SCI IRVINE, V2, P1090, DOI [10.4236/ns.2010.210136, DOI 10.4236/NS.2010.210136]; Chou KC, 2002, J BIOL CHEM, V277, P45765, DOI 10.1074/jbc.M204161200; Chou KC, 2009, NAT SCI, V2, P63, DOI DOI 10.4236/NS.2009.12011; Chou KC, 2008, BIOCHEM BIOPH RES CO, V376, P321, DOI 10.1016/j.bbrc.2008.08.125; Chou KC, 2008, NAT PROTOC, V3, P153, DOI 10.1038/nprot.2007.494; Chou KC, 2007, ANAL BIOCHEM, V370, P1, DOI 10.1016/j.ab.2007.07.006; Chou KC, 2007, BIOCHEM BIOPH RES CO, V360, P339, DOI 10.1016/j.bbrc.2007.06.027; Chou KC, 2007, BIOCHEM BIOPH RES CO, V357, P633, DOI 10.1016/j.bbrc.2007.03.162; Chou KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018258; Chou KC, 2011, J THEOR BIOL, V273, P236, DOI 10.1016/j.jtbi.2010.12.024; Chou KC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011335; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Davydov YI, 2009, MOL BIOL+, V43, P150, DOI 10.1134/S0026893309010208; EFRON B, 1983, AM STAT, V37, P36, DOI 10.2307/2685844; El-Manzalawy Y, 2008, J MOL RECOGNIT, V21, P243, DOI 10.1002/jmr.893; EMINI EA, 1985, J VIROL, V55, P836, DOI 10.1128/JVI.55.3.836-839.1985; Esmaeili M, 2010, J THEOR BIOL, V263, P203, DOI 10.1016/j.jtbi.2009.11.016; He ZS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009603; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; Huang T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010972; JANIN J, 1978, J MOL BIOL, V125, P357, DOI 10.1016/0022-2836(78)90408-4; KARPLUS PA, 1985, NATURWISSENSCHAFTEN, V72, P212, DOI 10.1007/BF01195768; Kawashima S, 2008, NUCLEIC ACIDS RES, V36, pD202, DOI 10.1093/nar/gkm998; Kohavi R, 1997, ARTIF INTELL, V97, P273, DOI 10.1016/S0004-3702(97)00043-X; KOLASKAR AS, 1990, FEBS LETT, V276, P172, DOI 10.1016/0014-5793(90)80535-Q; LERNER RA, 1982, NATURE, V299, P592, DOI 10.1038/299592a0; Mohabatkar H, 2011, J THEOR BIOL, V281, P18, DOI 10.1016/j.jtbi.2011.04.017; PARKER JMR, 1986, BIOCHEMISTRY-US, V25, P5425, DOI 10.1021/bi00367a013; PELLEQUER JL, 1993, IMMUNOL LETT, V36, P83, DOI 10.1016/0165-2478(93)90072-A; PELLEQUER JL, 1993, J MOL GRAPH MODEL, V11, P204, DOI 10.1016/0263-7855(93)80074-2; PONNUSWAMY PK, 1980, BIOCHIM BIOPHYS ACTA, V623, P301, DOI 10.1016/0005-2795(80)90258-5; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Saha S, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-79; Saha S, 2004, LECT NOTES COMPUT SC, V3239, P197; Saha S, 2006, PROTEINS, V65, P40, DOI 10.1002/prot.21078; SCHMIDT MA, 1989, BIOTECHNOL ADV, V7, P187, DOI 10.1016/0734-9750(89)90358-3; Shen HB, 2007, BIOCHEM BIOPH RES CO, V364, P53, DOI 10.1016/j.bbrc.2007.09.098; Sollner J, 2006, J MOL RECOGNIT, V19, P209, DOI 10.1002/jmr.770; Sollner J, 2006, J MOL RECOGNIT, V19, P200, DOI 10.1002/jmr.771; Van Regenmortel MHV, 2009, METHODS MOL BIOL, V524, P3, DOI 10.1007/978-1-59745-450-6_1; Wang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023505; WELLING GW, 1985, FEBS LETT, V188, P215, DOI 10.1016/0014-5793(85)80374-4; Xiao X, 2011, J THEOR BIOL, V284, P42, DOI 10.1016/j.jtbi.2011.06.005; Xiao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020592; Xiao XA, 2011, MOL BIOSYST, V7, P911, DOI 10.1039/c0mb00170h; Xiao Y, 2001, IMMUNOL LETT, V77, P3, DOI 10.1016/S0165-2478(01)00187-0; Zhang Q, 2008, NUCLEIC ACIDS RES, V36, pW513, DOI 10.1093/nar/gkn254	60	11	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e30617	10.1371/journal.pone.0030617	http://dx.doi.org/10.1371/journal.pone.0030617			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347389	gold, Green Published, Green Submitted			2022-12-27	WOS:000302730100018
J	Tran, LM; Chang, CJ; Plaisier, S; Wu, SM; Dang, J; Mischel, PS; Liao, JC; Graeber, TG; Wu, H				Tran, Linh M.; Chang, Chun-Ju; Plaisier, Seema; Wu, Shumin; Dang, Julie; Mischel, Paul S.; Liao, James C.; Graeber, Thomas G.; Wu, Hong			Determining PTEN Functional Status by Network Component Deduced Transcription Factor Activities	PLOS ONE			English	Article							REGULATORY ELEMENT DATABASE; GENE-EXPRESSION SIGNATURE; TUMOR-SUPPRESSOR PTEN; NF-KAPPA-B; PROSTATE-CANCER; ESCHERICHIA-COLI; CELL-CYCLE; C-MYC; PATHWAYS; INHIBITION	PTEN-controlled PI3K-AKT-mTOR pathway represents one of the most deregulated signaling pathways in human cancers. With many small molecule inhibitors that target PI3K-AKT-mTOR pathway being exploited clinically, sensitive and reliable ways of stratifying patients according to their PTEN functional status and determining treatment outcomes are urgently needed. Heterogeneous loss of PTEN is commonly associated with human cancers and yet PTEN can also be regulated on epigenetic, transcriptional or post-translational levels, which makes the use of simple protein or gene expression-based analyses in determining PTEN status less accurate. In this study, we used network component analysis to identify 20 transcription factors (TFs) whose activities deduced from their target gene expressions were immediately altered upon the re-expression of PTEN in a PTEN-inducible system. Interestingly, PTEN controls the activities (TFA) rather than the expression levels of majority of these TFs and these PTEN-controlled TFAs are substantially altered in prostate cancer mouse models. Importantly, the activities of these TFs can be used to predict PTEN status in human prostate, breast and brain tumor samples with enhanced reliability when compared to straightforward IHC-based or expression-based analysis. Furthermore, our analysis indicates that unique sets of PTEN-controlled TFAs significantly contribute to specific tumor types. Together, our findings reveal that TFAs may be used as "signatures" for predicting PTEN functional status and elucidate the transcriptional architectures underlying human cancers caused by PTEN loss.	[Tran, Linh M.; Chang, Chun-Ju; Plaisier, Seema; Wu, Shumin; Graeber, Thomas G.; Wu, Hong] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90024 USA; [Tran, Linh M.; Wu, Shumin; Mischel, Paul S.; Graeber, Thomas G.] Univ Calif Los Angeles, Inst Mol Med, Los Angeles, CA USA; [Graeber, Thomas G.] Univ Calif Los Angeles, Crump Inst Mol Imaging, Los Angeles, CA USA; [Dang, Julie; Mischel, Paul S.] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA USA; [Liao, James C.] Univ Calif Los Angeles, Dept Chem & Biomol Engn, Los Angeles, CA USA; [Mischel, Paul S.; Wu, Hong] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Tran, LM (corresponding author), Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90024 USA.	hwu@mednet.ucla.edu		Chang, Chunju/0000-0003-2887-9603; Graeber, Thomas/0000-0001-8574-9181; Liao, James/0000-0002-4580-7276	NIH [T32 CA009056, R01 CA107166, RO1 CA121110, P50 CA092131]; Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE [R01CA121110, P50CA092131, R01CA107166, T32CA009056] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	LMT is supported by NIH T32 CA009056. This work has been supported in part by award from the Prostate Cancer Foundation and grant from NIH (R01 CA107166, RO1 CA121110 and P50 CA092131 to HW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Abed M, 2009, METHODS MOL BIOL, V567, P155, DOI 10.1007/978-1-60327-414-2_11; Burgering BMT, 2002, TRENDS BIOCHEM SCI, V27, P352, DOI 10.1016/S0968-0004(02)02113-8; Chandarlapaty S, 2011, CANCER CELL, V19, P58, DOI 10.1016/j.ccr.2010.10.031; Chang CJ, 2004, J BIOL CHEM, V279, P29841, DOI 10.1074/jbc.M401488200; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chow LML, 2011, CANCER CELL, V19, P305, DOI 10.1016/j.ccr.2011.01.039; Di Cristofano A, 2000, CELL, V100, P387, DOI 10.1016/S0092-8674(00)80674-1; Ellwood-Yen K, 2003, CANCER CELL, V4, P223, DOI 10.1016/S1535-6108(03)00197-1; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Finnberg N, 2004, CANCER BIOL THER, V3, P614, DOI 10.4161/cbt.3.7.1057; Freeman DJ, 2003, CANCER CELL, V3, P117, DOI 10.1016/S1535-6108(03)00021-7; Freije WA, 2004, CANCER RES, V64, P6503, DOI 10.1158/0008-5472.CAN-04-0452; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Hermeking H, 2000, P NATL ACAD SCI USA, V97, P2229, DOI 10.1073/pnas.050586197; Huang H, 2001, J BIOL CHEM, V276, P38830, DOI 10.1074/jbc.M103632200; Hyduke DR, 2007, P NATL ACAD SCI USA, V104, P8484, DOI 10.1073/pnas.0610888104; Jiang C, 2007, NUCLEIC ACIDS RES, V35, pD137, DOI 10.1093/nar/gkl1041; Kao KC, 2004, P NATL ACAD SCI USA, V101, P641, DOI 10.1073/pnas.0305287101; Kao KC, 2005, J BIOL CHEM, V280, P36079, DOI 10.1074/jbc.M508202200; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Lapointe J, 2007, CANCER RES, V67, P8504, DOI 10.1158/0008-5472.CAN-07-0673; Liao JC, 2003, P NATL ACAD SCI USA, V100, P15522, DOI 10.1073/pnas.2136632100; Madrid LV, 2001, J BIOL CHEM, V276, P18934, DOI 10.1074/jbc.M101103200; Majumder PK, 2004, NAT MED, V10, P594, DOI 10.1038/nm1052; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Moellering RE, 2009, NATURE, V462, P182, DOI 10.1038/nature08543; Mosessian S, 2009, J BIOL CHEM, V284, P30159, DOI 10.1074/jbc.M109.027995; Mulholland DJ, 2011, CANCER CELL, V19, P792, DOI 10.1016/j.ccr.2011.05.006; Nagata Y, 2004, CANCER CELL, V6, P117, DOI 10.1016/j.ccr.2004.06.022; Nikiforov MA, 2002, MOL CELL BIOL, V22, P5793, DOI 10.1128/MCB.22.16.5793-5800.2002; Orloff MS, 2008, ONCOGENE, V27, P5387, DOI 10.1038/onc.2008.237; Palaskas N, 2011, CANC RES, P71; Raftopoulou M, 2004, SCIENCE, V303, P1179, DOI 10.1126/science.1092089; Rahib L, 2009, MOL GENET METAB, V96, P106, DOI 10.1016/j.ymgme.2008.11.163; ROSENWALD IB, 1993, P NATL ACAD SCI USA, V90, P6175, DOI 10.1073/pnas.90.13.6175; Saal LH, 2007, P NATL ACAD SCI USA, V104, P7564, DOI 10.1073/pnas.0702507104; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; She QB, 2005, CANCER CELL, V8, P287, DOI 10.1016/j.ccr.2005.09.006; Song MS, 2011, CELL, V144, P187, DOI 10.1016/j.cell.2010.12.020; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stiles B, 2004, P NATL ACAD SCI USA, V101, P2082, DOI 10.1073/pnas.0308617100; Tan K, 2008, P NATL ACAD SCI USA, V105, P2934, DOI 10.1073/pnas.0708670105; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tran Hien, 2003, Sci STKE, V2003, pRE5, DOI 10.1126/stke.2003.172.re5; Tran LM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-511; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Vivanco I, 2007, CANCER CELL, V11, P555, DOI 10.1016/j.ccr.2007.04.021; Vivanco I, 2010, P NATL ACAD SCI USA, V107, P6459, DOI 10.1073/pnas.0911188107; Wang B, 2010, ARTERIOSCL THROM VAS, V30, P536, DOI 10.1161/ATVBAHA.109.193821; Wang SY, 2006, P NATL ACAD SCI USA, V103, P1480, DOI 10.1073/pnas.0510652103; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Yang YL, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-90; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245; Zhang Y, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-37; Zhao F, 2005, NUCLEIC ACIDS RES, V33, pD103, DOI 10.1093/nar/gki004	55	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31053	10.1371/journal.pone.0031053	http://dx.doi.org/10.1371/journal.pone.0031053			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347425	Green Published, gold, Green Submitted			2022-12-27	WOS:000302730100034
J	Bett, JS; Kanuga, N; Richet, E; Schmidtke, G; Groettrup, M; Cheetham, ME; van der Spuy, J				Bett, John S.; Kanuga, Naheed; Richet, Emma; Schmidtke, Gunter; Groettrup, Marcus; Cheetham, Michael E.; van der Spuy, Jacqueline			The Inherited Blindness Protein AIPL1 Regulates the Ubiquitin-Like FAT10 Pathway	PLOS ONE			English	Article							LEBER CONGENITAL AMAUROSIS; PROTEASOMAL DEGRADATION; CGMP PHOSPHODIESTERASE; MODIFIER FAT10; GENE; NUB1; ROD; INTERACTS; CANCERS; EXPRESSION	Mutations in AIPL1 cause the inherited blindness Leber congenital amaurosis (LCA). AIPL1 has previously been shown to interact with NUB1, which facilitates the proteasomal degradation of proteins modified with the ubiquitin-like protein FAT10. Here we report that AIPL1 binds non-covalently to free FAT10 and FAT10ylated proteins and can form a ternary complex with FAT10 and NUB1. In addition, AIPL1 antagonised the NUB1-mediated degradation of the model FAT10 conjugate, FAT10-DHFR, and pathogenic mutations of AIPL1 were defective in inhibiting this degradation. While all AIPL1 mutants tested still bound FAT10-DHFR, there was a close correlation between the ability of the mutants to interact with NUB1 and their ability to prevent NUB1-mediated degradation. Interestingly, AIPL1 also co-immunoprecipitated the E1 activating enzyme for FAT10, UBA6, suggesting AIPL1 may have a role in directly regulating the FAT10 conjugation machinery. These studies are the first to implicate FAT10 in retinal cell biology and LCA pathogenesis, and reveal a new role of AIPL1 in regulating the FAT10 pathway.	[Bett, John S.; Kanuga, Naheed; Richet, Emma; Cheetham, Michael E.; van der Spuy, Jacqueline] UCL Inst Ophthalmol, London, England; [Schmidtke, Gunter; Groettrup, Marcus] Univ Constance, Dept Biol, Constance, Germany	University of London; University College London; University of Konstanz	Bett, JS (corresponding author), UCL Inst Ophthalmol, London, England.	j.spuy@ucl.ac.uk	Groettrup, Marcus/AAT-2623-2020	Cheetham, Michael/0000-0001-6429-654X; van der Spuy, Jacqueline/0000-0001-5906-2116	Wellcome Trust [GR077929MA]; German Research Foundation (DFG) [GR1517/2-3, GR1517/3-1]	Wellcome Trust(Wellcome TrustEuropean Commission); German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by grants from the Wellcome Trust (GR077929MA) and the German Research Foundation (DFG) (GR1517/2-3 and GR1517/3-1). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aichem A, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1012; Akey DT, 2002, HUM MOL GENET, V11, P2723, DOI 10.1093/hmg/11.22.2723; Canaan A, 2006, MOL CELL BIOL, V26, P5180, DOI 10.1128/MCB.00966-05; Chiu YH, 2007, MOL CELL, V27, P1014, DOI 10.1016/j.molcel.2007.08.020; Hidalgo-De-Quintana J, 2008, INVEST OPHTH VIS SCI, V49, P2878, DOI 10.1167/iovs.07-1576; Hipp MS, 2005, MOL CELL BIOL, V25, P3483, DOI 10.1128/MCB.25.9.3483-3491.2005; Hipp MS, 2004, J BIOL CHEM, V279, P16503, DOI 10.1074/jbc.M310114200; Kalveram B, 2008, J CELL SCI, V121, P4079, DOI 10.1242/jcs.035006; Kamitani T, 2001, J BIOL CHEM, V276, P46655, DOI 10.1074/jbc.M108636200; Kanaya K, 2004, BIOCHEM BIOPH RES CO, V317, P768, DOI 10.1016/j.bbrc.2004.03.108; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kolandaivelu S, 2009, J BIOL CHEM, V284, P30853, DOI 10.1074/jbc.M109.036780; Lee CGL, 2003, ONCOGENE, V22, P2592, DOI 10.1038/sj.onc.1206337; Lim CB, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-20; Liu XQ, 2004, P NATL ACAD SCI USA, V101, P13903, DOI 10.1073/pnas.0405160101; Liu YC, 1999, P NATL ACAD SCI USA, V96, P4313, DOI 10.1073/pnas.96.8.4313; Lukasiak S, 2008, ONCOGENE, V27, P6068, DOI 10.1038/onc.2008.201; Mendes HF, 2008, HUM MOL GENET, V17, P3043, DOI 10.1093/hmg/ddn202; Raasi S, 2001, J BIOL CHEM, V276, P35334, DOI 10.1074/jbc.M105139200; Ramamurthy V, 2004, P NATL ACAD SCI USA, V101, P13897, DOI 10.1073/pnas.0404197101; Ren JW, 2006, J BIOL CHEM, V281, P11413, DOI 10.1074/jbc.M507218200; Schmidtke G, 2006, J BIOL CHEM, V281, P20045, DOI 10.1074/jbc.M603063200; Schmidtke G, 2009, FEBS LETT, V583, P591, DOI 10.1016/j.febslet.2009.01.006; Sohocki MM, 2000, NAT GENET, V24, P79, DOI 10.1038/71732; van der Spuy J, 2005, MOL VIS, V11, P542; van der Spuy J, 2004, J BIOL CHEM, V279, P48038, DOI 10.1074/jbc.M407871200; van der Spuy J, 2003, INVEST OPHTH VIS SCI, V44, P5396, DOI 10.1167/iovs.03-0686; van der Spuy J, 2002, HUM MOL GENET, V11, P823, DOI 10.1093/hmg/11.7.823	28	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2012	7	2							e30866	10.1371/journal.pone.0030866	http://dx.doi.org/10.1371/journal.pone.0030866			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917MF	22347407	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000302180600016
J	Fang, XF; Wang, RQ; Ma, J; Ding, Y; Shang, WR; Sun, ZM				Fang, Xianfeng; Wang, Ruiqing; Ma, Jian; Ding, Yan; Shang, Weirong; Sun, Zuoming			Ameliorated ConA-Induced Hepatitis in the Absence of PKC-theta	PLOS ONE			English	Article							KINASE-C-THETA; NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; NK1(+) T-CELLS; NKT CELLS; CONCANAVALIN-A; MEDIATED CYTOTOXICITY; AUTOIMMUNE HEPATITIS; LIVER-INJURY; PROTEIN	Severe liver injury that occurs when immune cells mistakenly attack an individual's own liver cells leads to autoimmune hepatitis. In mice, acute hepatitis can be induced by concanavalin A (ConA) treatment, which causes rapid activation of CD1d-positive natural killer (NK) T cells. These activated NKT cells produce large amounts of cytokines, which induce strong inflammation that damages liver tissues. Here we show that PKC-theta(-/-) mice were resistant to ConA-induced hepatitis due to essential function of PKC-theta in NKT cell development and activation. A dosage of ConA (25 mg/kg) that was lethal to wildtype (WT) mice failed to induce death resulting from liver injury in PKC-theta(-/-) mice. Correspondingly, ConA-induced production of cytokines such as IFN gamma, IL-6, and TNF alpha, which mediate the inflammation responsible for liver injury, were significantly lower in PKC-theta(-/-) mice. Peripheral NKT cells had developmental defects at early stages in the thymus in PKCh-theta(-/-) mice, and as a result their frequency and number were greatly reduced. Furthermore, PKC-theta(-/-) bone marrow adoptively transferred to WT mice displayed similar defects in NKT cell development, suggesting an intrinsic requirement for PKC-theta in NKT cell development. In addition, upon stimulation with NKT cell-specific lipid ligand, peripheral PKC-theta(-/-) NKT cells produced lower levels of inflammatory cytokines than that of WT NKT cells, suggesting that activation of NKT cells also requires PKC-theta. Our results suggest PKC-theta is an essential molecule required for activation of NKT cell to induce hepatitis, and thus, is a potential drug target for prevention of autoimmune hepatitis.	[Fang, Xianfeng; Wang, Ruiqing; Ma, Jian; Ding, Yan; Sun, Zuoming] Beckman Res Inst City Hope, Div Immunol, Duarte, CA USA; [Shang, Weirong] Emory Univ, Sch Med, Dept Gynecol & Obstet, Atlanta, GA USA	City of Hope; Beckman Research Institute of City of Hope; Emory University	Fang, XF (corresponding author), Beckman Res Inst City Hope, Div Immunol, Duarte, CA USA.	zsun@coh.org	fang, xianfeng/E-6301-2012; Ma, Jian/K-5260-2012	fang, xianfeng/0000-0003-0161-0209; 	National Institutes of Health [NIH R01-AI053147, NIH R56-AI072554]; Nesvig lymphoma Fellowship and Research Fund; City of Hope; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI072554, R01AI053147] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nesvig lymphoma Fellowship and Research Fund; City of Hope; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institutes of Health (NIH R01-AI053147, NIH R56-AI072554), the Nesvig lymphoma Fellowship and Research Fund, and the City of Hope. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman A, 2000, IMMUNOL TODAY, V21, P567, DOI 10.1016/S0167-5699(00)01749-7; Baier G, 2003, IMMUNOL REV, V192, P64, DOI 10.1034/j.1600-065X.2003.00018.x; BaierBitterlich G, 1996, MOL CELL BIOL, V16, P1842; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Coudronniere N, 2000, P NATL ACAD SCI USA, V97, P3394, DOI 10.1073/pnas.060028097; Crowe NY, 2003, J IMMUNOL, V171, P4020, DOI 10.4049/jimmunol.171.8.4020; Cywin CL, 2007, BIOORG MED CHEM LETT, V17, P225, DOI 10.1016/j.bmcl.2006.09.056; Czaja AJ, 2002, HEPATOLOGY, V36, P479, DOI 10.1053/jhep.2002.34944; Czaja AJ, 1998, DIGEST DIS SCI, V43, P2149, DOI 10.1023/A:1018836004279; Diao HY, 2004, IMMUNITY, V21, P539, DOI 10.1016/j.immuni.2004.08.012; Emoto M, 2003, TRENDS IMMUNOL, V24, P364, DOI 10.1016/S1471-4906(03)00162-5; Exley MA, 2004, HEPATOLOGY, V40, P1033, DOI 10.1002/hep.20433; Faggioni R, 2000, P NATL ACAD SCI USA, V97, P2367, DOI 10.1073/pnas.040561297; Fang XF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010288; GANTNER F, 1995, HEPATOLOGY, V21, P190, DOI 10.1002/hep.1840210131; Godfrey DI, 2000, IMMUNOL TODAY, V21, P573, DOI 10.1016/S0167-5699(00)01735-7; Gumperz JE, 2001, CURR OPIN IMMUNOL, V13, P471, DOI 10.1016/S0952-7915(00)00243-0; Higuchi H, 2004, J BIOL CHEM, V279, P51, DOI 10.1074/jbc.M309476200; Ishigami M, 1999, HEPATOLOGY, V29, P1799, DOI 10.1002/hep.510290605; Kaneko Y, 2000, J EXP MED, V191, P105, DOI 10.1084/jem.191.1.105; Kato A, 2000, AM J PATHOL, V157, P297, DOI 10.1016/S0002-9440(10)64540-3; Kawano T, 1999, CANCER RES, V59, P5102; Kim CH, 2002, TRENDS IMMUNOL, V23, P516, DOI 10.1016/S1471-4906(02)02323-2; Kwon Myung-Ja, 2010, Endocrine Metabolic & Immune Disorders-Drug Targets, V10, P367; LEIST M, 1995, AM J PATHOL, V146, P1220; Li YQ, 2004, EMBO J, V23, P1112, DOI 10.1038/sj.emboj.7600125; Lin X, 2000, MOL CELL BIOL, V20, P2933, DOI 10.1128/MCB.20.8.2933-2940.2000; Malhi H, 2007, GUT, V56, P1124, DOI 10.1136/gut.2006.118059; Manicassainy S, 2007, J IMMUNOL, V178, P312, DOI 10.4049/jimmunol.178.1.312; Manicassamy S, 2006, CELL MOL IMMUNOL, V3, P263; McFarlane IG, 1999, BIOMED PHARMACOTHER, V53, P255, DOI 10.1016/S0753-3322(99)80096-1; Mosyak L, 2007, BIOCHEM SOC T, V35, P1027, DOI 10.1042/BST0351027; Nicoletti F, 2000, CYTOKINE, V12, P315, DOI 10.1006/cyto.1999.0561; Pfeifhofer C, 2003, J EXP MED, V197, P1525, DOI 10.1084/jem.20020234; Ramaiah SK, 2008, TOXICOL SCI, V103, P4, DOI 10.1093/toxsci/kfm246; Savage AK, 2008, IMMUNITY, V29, P391, DOI 10.1016/j.immuni.2008.07.011; Schmidt-Supprian M, 2004, P NATL ACAD SCI USA, V101, P4566, DOI 10.1073/pnas.0400885101; Sivakumar V, 2003, J EXP MED, V197, P1613, DOI 10.1084/jem.20022234; Spangrude Gerald J, 2008, Curr Protoc Immunol, VChapter 4, DOI 10.1002/0471142735.im0406s81; Stanic AK, 2004, J IMMUNOL, V172, P4667, DOI 10.4049/jimmunol.172.8.4667; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; TIEGS G, 1992, J CLIN INVEST, V90, P196, DOI 10.1172/JCI115836; Toyabe S, 1997, J IMMUNOL, V159, P1537; Van Deuren M., 1994, European Journal of Clinical Microbiology and Infectious Diseases, V13, pS12; Watarai H, 2008, NAT PROTOC, V3, P70, DOI 10.1038/nprot.2007.515; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4	47	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2012	7	2							e31174	10.1371/journal.pone.0031174	http://dx.doi.org/10.1371/journal.pone.0031174			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917MF	22347449	Green Published, Green Submitted, gold			2022-12-27	WOS:000302180600031
J	Ishida, Y; Sekine, Y; Oguchi, H; Chihara, T; Miura, M; Ichijo, H; Takeda, K				Ishida, Yosuke; Sekine, Yusuke; Oguchi, Haruka; Chihara, Takahiro; Miura, Masayuki; Ichijo, Hidenori; Takeda, Kohsuke			Prevention of Apoptosis by Mitochondrial Phosphatase PGAM5 in the Mushroom Body Is Crucial for Heat Shock Resistance in Drosophila melanogaster	PLOS ONE			English	Article							BODIES; GENE; PROTEIN; EXPRESSION; CASPASE-2; REVEALS; NEURONS; COMPLEX; SLEEP; DEATH	The heat shock (HS) response is essential for survival of all organisms. Although the machinery of the HS response has been extensively investigated at the cellular level, it is poorly understood at the level of the organism. Here, we show the crucial role of the mushroom body (MB) in the HS response in Drosophila. Null mutants of the mitochondrial phosphatase Drosophila PGAM5 (dPGAM5) exhibited increased vulnerability to HS, which was reversed by MB-specific expression of the caspase inhibitor p35, and similar vulnerability was induced in wild-type flies by knockdown of MB dPGAM5. Elimination of the MB did not affect the HS response of wild-type flies, but did increase the resistance of dPGAM5-deficient flies to HS. Thus, the MB may possess an apoptosis-dependent toxic function, the suppression of which by dPGAM5 appears to be crucial for HS resistance.	[Ishida, Yosuke; Sekine, Yusuke; Oguchi, Haruka; Takeda, Kohsuke] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Cell Signaling, Tokyo, Japan; [Chihara, Takahiro; Miura, Masayuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Genet, Tokyo, Japan; [Chihara, Takahiro; Takeda, Kohsuke] Japan Sci & Technol Agcy JST, Precursory Res Embryon Sci & Technol PRESTO, Saitama, Japan	University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST)	Ishida, Y (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Cell Signaling, Tokyo, Japan.	takeda@mol.f.u-tokyo.ac.jp	Chihara, Takahiro/G-7639-2019; Sekine, Yusuke/AHI-8340-2022	Chihara, Takahiro/0000-0001-9989-3619; Sekine, Yusuke/0000-0003-0345-1416; Takeda, Kohsuke/0000-0002-8359-8399; Ichijo, Hidenori/0000-0002-5005-6438	Japanese Science and Technology Agency (JST); Japanese Society for the Promotion of Science (JSPS); Ministry of Education, Culture, Sports, Science and Technology in Japan (MEXT); Strategic Approach to Drug Discovery and Development in Pharmaceutical Sciences, Global Center of Excellence (GCOE); MEXT; Naito Foundation; Cosmetology Research Foundation; Tokyo Biochemical Research Foundation	Japanese Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Japanese Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology in Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Strategic Approach to Drug Discovery and Development in Pharmaceutical Sciences, Global Center of Excellence (GCOE); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Naito Foundation(Naito Memorial Foundation); Cosmetology Research Foundation; Tokyo Biochemical Research Foundation	This work was supported by the Japanese Science and Technology Agency (JST) Precursory Research for Embryonic Science and Technology (PRESTO) program, Grants-in-Aid for Scientific Research (KAKENHI) from Japanese Society for the Promotion of Science (JSPS) and Ministry of Education, Culture, Sports, Science and Technology in Japan (MEXT), Strategic Approach to Drug Discovery and Development in Pharmaceutical Sciences, Global Center of Excellence (GCOE) Program, the "Understanding of molecular and environmental bases for brain health" conducted under the Strategic Research Program for Brain Sciences by MEXT, the Naito Foundation Natural Science Scholarship, the Cosmetology Research Foundation, and the Tokyo Biochemical Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Calleja M, 2000, DEVELOPMENT, V127, P3971; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; Craig CR, 2004, EMBO REP, V5, P1058, DOI 10.1038/sj.embor.7400282; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; Friggi-Grelin F, 2003, J NEUROBIOL, V54, P618, DOI 10.1002/neu.10185; Georgel P, 2001, DEV CELL, V1, P503, DOI 10.1016/S1534-5807(01)00059-4; Hammond PW, 2001, J BIOL CHEM, V276, P20898, DOI 10.1074/jbc.M011641200; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Imai Y, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001229; Kennerdell JR, 2000, NAT BIOTECHNOL, V18, P896, DOI 10.1038/78531; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Koto A, 2009, J CELL BIOL, V187, P219, DOI 10.1083/jcb.200905110; Lee BP, 2005, MECH DEVELOP, V122, P849, DOI 10.1016/j.mod.2005.01.002; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lo SC, 2008, EXP CELL RES, V314, P1789, DOI 10.1016/j.yexcr.2008.02.014; Lo SC, 2006, J BIOL CHEM, V281, P37893, DOI 10.1074/jbc.M606539200; Martin JR, 1998, LEARN MEMORY, V5, P179; Milleron RS, 2007, CELL MOL LIFE SCI, V64, P2329, DOI 10.1007/s00018-007-7135-6; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Perez-Garijo A, 2004, DEVELOPMENT, V131, P5591, DOI 10.1242/dev.01432; Pitman JL, 2006, NATURE, V441, P753, DOI 10.1038/nature04739; Reddy GV, 1999, DEVELOPMENT, V126, P2083; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; Rintelen F, 2003, DEVELOPMENT, V130, P3479, DOI 10.1242/dev.00568; Salinas LS, 2006, CELL DEATH DIFFER, V13, P2129, DOI 10.1038/sj.cdd.4401976; Senoo-Matsuda N, 2005, EMBO J, V24, P2700, DOI 10.1038/sj.emboj.7600721; Serway CN, 2009, J NEUROGENET, V23, P173, DOI 10.1080/01677060802572895; Shelton SN, 2010, J BIOL CHEM, V285, P40525, DOI 10.1074/jbc.M110.167635; Stramer B, 2005, J CELL BIOL, V168, P567, DOI 10.1083/jcb.200405120; Takeda K, 2009, P NATL ACAD SCI USA, V106, P12301, DOI 10.1073/pnas.0901823106; Tanaka NK, 2008, J COMP NEUROL, V508, P711, DOI 10.1002/cne.21692; Tomita J, 2011, J NEUROSCI, V31, P13137, DOI 10.1523/JNEUROSCI.5860-10.2011; Tu S, 2006, NAT CELL BIOL, V8, P72, DOI 10.1038/ncb1340; Wang X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001125; Wang YL, 2003, CURR BIOL, V13, P1900, DOI 10.1016/j.cub.2003.10.003; YANG MY, 1995, NEURON, V15, P45	36	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2012	7	2							e30265	10.1371/journal.pone.0030265	http://dx.doi.org/10.1371/journal.pone.0030265			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917MF	22347370	Green Submitted, Green Published, gold			2022-12-27	WOS:000302180600006
J	Sutcliffe, CG; Kobayashi, T; Hamapumbu, H; Shields, T; Mharakurwa, S; Thuma, PE; Louis, TA; Glass, G; Moss, WJ				Sutcliffe, Catherine G.; Kobayashi, Tamaki; Hamapumbu, Harry; Shields, Timothy; Mharakurwa, Sungano; Thuma, Philip E.; Louis, Thomas A.; Glass, Gregory; Moss, William J.			Reduced Risk of Malaria Parasitemia Following Household Screening and Treatment: A Cross-Sectional and Longitudinal Cohort Study	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM INFECTIONS; ACTIVE CASE DETECTION; DECLINING TRANSMISSION; CONTROLLED-TRIAL; SOUTHERN ZAMBIA; HIGH PREVALENCE; SCALE-UP; CHILDREN; AREA; REDUCTION	Background: In regions of declining malaria transmission, new strategies for control are needed to reduce transmission and achieve elimination. Artemisinin-combination therapy (ACT) is active against immature gametocytes and can reduce the risk of transmission. We sought to determine whether household screening and treatment of infected individuals provides protection against infection for household members. Methodology/Principal Findings: The study was conducted in two areas in Southern Province, Zambia in 2007 and 2008/2009. To determine the impact of proactive case detection, households were randomly selected either to join a longitudinal cohort, in which participants were repeatedly screened throughout the year and those infected treated with artemether-lumefantrine, or a cross-sectional survey, in which participants were visited only once. Cross-sectional surveys were conducted throughout the year. The prevalence of RDT positivity was compared between the longitudinal and cross-sectional households at baseline and during follow-up using multilevel logistic regression. In the 2007 study area, 174 and 156 participants enrolled in the cross-sectional and longitudinal groups, respectively. In the 2008/2009 study area, 917 and 234 participants enrolled in the cross-sectional and longitudinal groups, respectively. In both study areas, participants and households in the longitudinal and cross-sectional groups were similar on demographic characteristics and prevalence of RDT positivity at baseline (2007: OR = 0.97; 95% CI:0.46, 2.03 vertical bar 2008/2009: OR = 1.28; 95% CI:0.44, 3.79). After baseline, the prevalence of RDT positivity was significantly lower in longitudinal compared to cross-sectional households in both study areas (2007: OR = 0.44; 95% CI:0.20, 0.96 vertical bar 2008/2009: OR = 0.16; 95% CI:0.05, 0.55). Conclusions/Significance: Proactive case detection, consisting of screening household members with an RDT and treating those positive with ACT, can reduce transmission and provide indirect protection to household members. A targeted test and treat strategy could contribute to the elimination of malaria in regions of low transmission.	[Sutcliffe, Catherine G.; Kobayashi, Tamaki; Moss, William J.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Shields, Timothy; Mharakurwa, Sungano; Glass, Gregory; Moss, William J.] Johns Hopkins Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD USA; [Louis, Thomas A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA; [Hamapumbu, Harry; Mharakurwa, Sungano; Thuma, Philip E.] Malaria Res Trust, Choma, Zambia	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Sutcliffe, CG (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA.	wmoss@jhsph.edu		Sutcliffe, Catherine/0000-0001-8512-8326	Johns Hopkins Malaria Research Institute; Bloomberg Family Foundation	Johns Hopkins Malaria Research Institute; Bloomberg Family Foundation	This work was supported by the Johns Hopkins Malaria Research Institute and the Bloomberg Family Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjuik M, 2004, LANCET, V363, P9, DOI 10.1016/S0140-6736(03)15162-8; Aregawi MW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-46; Baliraine FN, 2009, J INFECT DIS, V200, P66, DOI 10.1086/599317; Barnes KI, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S1-S8; Dal-Bianco MP, 2007, AM J TROP MED HYG, V77, P939, DOI 10.4269/ajtmh.2007.77.939; ElKhyari T, MALARIA ELIMINATION; Harris I, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-254; Kent RJ, 2007, AM J TROP MED HYG, V76, P267, DOI 10.4269/ajtmh.2007.76.267; LARKIN GL, 1991, AM J TROP MED HYG, V45, P587, DOI 10.4269/ajtmh.1991.45.587; Li Zizhao, 1999, Southeast Asian Journal of Tropical Medicine and Public Health, V30, P240; Lowther SA, 2009, TROP MED INT HEALTH, V14, P70, DOI 10.1111/j.1365-3156.2008.02185.x; Mabunda S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-74; Macauley C, 2005, SOC SCI MED, V60, P563, DOI 10.1016/j.socscimed.2004.05.025; Moonen B, 2010, LANCET, V376, P1592, DOI 10.1016/S0140-6736(10)61269-X; Moss WJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-163; Ogutu B, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-30; Okell LC, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-125; Okell LC, 2008, PLOS MED, V5, P1617, DOI 10.1371/journal.pmed.0050226; Otten M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-14; Owusu-Agyei S, 2002, TROP MED INT HEALTH, V7, P421, DOI 10.1046/j.1365-3156.2002.00881.x; Price RN, 1996, LANCET, V347, P1654, DOI 10.1016/S0140-6736(96)91488-9; Stresman GH, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-265; Sutcliffe CG, 2011, MALARIA J, V10, P324, DOI DOI 10.1186/1475-2875-10-324; Sutherland CJ, 2005, PLOS MED, V2, P338, DOI 10.1371/journal.pmed.0020092; Vafa M, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-17; von Seidlein L, 2003, TRENDS PARASITOL, V19, P452, DOI 10.1016/j.pt.2003.08.003; Von Seidlein L, 1998, AM J TROP MED HYG, V58, P638; von Seidlein L, 2000, LANCET, V355, P352, DOI 10.1016/S0140-6736(99)10237-X; WHO, 2010, WORLD MALARIA REPORT 2010, P1; WHO, 2009, MAL RAP DIAG TEST PE; Yip K., 2000, Parassitologia (Rome), V42, P117	31	28	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e31396	10.1371/journal.pone.0031396	http://dx.doi.org/10.1371/journal.pone.0031396			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LO	22319629	Green Published, gold, Green Submitted			2022-12-27	WOS:000302178400041
J	Plum, L; Lin, HV; Aizawa, KS; Liu, YT; Accili, D				Plum, Leona; Lin, Hua V.; Aizawa, Kumiko S.; Liu, Yitian; Accili, Domenico			InsR/FoxO1 Signaling Curtails Hypothalamic POMC Neuron Number	PLOS ONE			English	Article							PROOPIOMELANOCORTIN NEURONS; ARCUATE NUCLEUS; NEUROTROPHIC FACTOR; LEPTIN SENSITIVITY; FEEDING CIRCUITS; EXPRESSION; ENERGY; BRAIN; NEUROGENESIS; POPULATIONS	Insulin receptor (InsR) signaling through transcription factor FoxO1 is important in the development of hypothalamic neuron feeding circuits, but knowledge about underlying mechanisms is limited. To investigate the role of InsR/FoxO1 signaling in the development and maintenance of these circuits, we surveyed the pool of hypothalamic neurons expressing Pomc mRNA in different mouse models of impaired hypothalamic InsR signaling. InsR ablation in the entire hypothalamus did not affect Pomc-neuron number at birth, but resulted in a 25% increase, most notably in the middle arcuate nucleus region, in young adults. Selective restoration of InsR expression in POMC neurons in these mice partly reversed the abnormality, resulting in a 10% decrease compared to age-matched controls. To establish whether FoxO1 signaling plays a role in this process, we examined POMC neuron number in mice with POMC-specific deletion of FoxO1, and detected a 23% decrease in age-matched animals, consistent with a cell-autonomous role of InsR/FoxO1 signaling in regulating POMC neuron number, distinct from its established role to activate Pomc transcription. These changes in Pomc cells occurred in the absence of marked changes in humoral factors or hypothalamic NPY neurons.	[Plum, Leona; Lin, Hua V.; Aizawa, Kumiko S.; Liu, Yitian; Accili, Domenico] Columbia Univ, Med Ctr, Dept Med, Naomi Berrie Diabet Ctr, New York, NY USA	Columbia University	Plum, L (corresponding author), Profil Inst Metab Res, Neuss, Germany.	da230@columbia.edu	Plum-Mörschel, Leona/W-9413-2019	Plum-Mörschel, Leona/0000-0002-1907-761X; Lin, Hua/0000-0001-5001-5567	Deutsche Forschungsgemeinschaft (DFG) [PL542/1-1]; Berrie Fellowship Award; NIH [DK57539, DK58282]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057539, R37DK058282, R01DK058282] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Berrie Fellowship Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work was supported by the Deutsche Forschungsgemeinschaft (DFG) grant PL542/1-1 to L. P., the Berrie Fellowship Award to H. V. L., and NIH grants DK57539 and DK58282 to D.A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accili D, 1996, NAT GENET, V12, P106, DOI 10.1038/ng0196-106; Balthasar N, 2004, NEURON, V42, P983, DOI 10.1016/j.neuron.2004.06.004; Bouret S, 2000, ENDOCRINOLOGY, V141, P1780, DOI 10.1210/en.141.5.1780; Bouret S, 1999, MOL BRAIN RES, V70, P155, DOI 10.1016/S0169-328X(99)00132-1; Bouret SG, 2009, J PEDIATR GASTR NUTR, V48, pS31, DOI 10.1097/MPG.0b013e3181977375; Carlo AS, 2007, ENDOCRINOLOGY, V148, P6073, DOI 10.1210/en.2007-0822; Carmody JS, 2010, RESPECTIVE CONTRIBUT; CHOWENBREED JA, 1989, ENDOCRINOLOGY, V124, P2875, DOI 10.1210/endo-124-6-2875; Cottrell EC, 2009, AM J PHYSIOL-REG I, V296, pR631, DOI 10.1152/ajpregu.90690.2008; Ferrini M, 2001, NEUROENDOCRINOLOGY, V74, P1, DOI 10.1159/000054665; Grove KL, 2003, PHYSIOL BEHAV, V79, P47, DOI 10.1016/S0031-9384(03)00104-5; HAVRANKOVA J, 1978, NATURE, V272, P827, DOI 10.1038/272827a0; Hoekman MFM, 2006, GENE EXPR PATTERNS, V6, P134, DOI 10.1016/j.modgep.2005.07.003; Jing EX, 2004, ENDOCRINOLOGY, V145, P1503, DOI 10.1210/en.2003-0834; Kaelin CB, 2004, ENDOCRINOLOGY, V145, P5798, DOI 10.1210/en.2004-0956; KITAMURA T, 2006, NAT MED; Lin HV, 2007, DIABETES, V56, P1969, DOI 10.2337/db07-0127; Lin HV, 2010, DIABETES, V59, P337, DOI 10.2337/db09-1303; Manfredsson FP, 2009, MOL THER, V17, P980, DOI 10.1038/mt.2009.45; Matsuwaki T, 2010, J REPROD DEV; Muhlhausler BS, 2007, J NEUROENDOCRINOL, V19, P67, DOI 10.1111/j.1365-2826.2006.01505.x; Nilsson I, 2005, DEV BRAIN RES, V155, P147, DOI 10.1016/j.devbrainres.2005.01.009; Okamoto H, 2005, J CLIN INVEST, V115, P1314, DOI 10.1172/JCI200523096; Okamoto H, 2004, J CLIN INVEST, V114, P214, DOI 10.1172/JCI200421645; Padilla SL, 2011, DEFINING POMC NEURON; Padilla SL, 2010, NAT MED, V16, P403, DOI 10.1038/nm.2126; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Paik JH, 2009, CELL STEM CELL, V5, P540, DOI 10.1016/j.stem.2009.09.013; Perez-Martin M, 2010, EUR J NEUROSCI, V31, P1533, DOI 10.1111/j.1460-9568.2010.07220.x; Pierce AA, 2010, J NEUROSCI, V30, P723, DOI 10.1523/JNEUROSCI.2479-09.2010; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; Plum L, 2006, J CLIN INVEST, V116, P1886, DOI 10.1172/JCI27123; Plum L, 2006, J CLIN INVEST, V116, P1761, DOI 10.1172/JCI29063; Plum L, 2009, NAT MED, V15, P1195, DOI 10.1038/nm.2026; Poston L, 2010, BEST PRACT RES CL EN, V24, P541, DOI 10.1016/j.beem.2010.05.007; Silhol M, 2005, NEUROSCIENCE, V132, P613, DOI 10.1016/j.neuroscience.2005.01.008; Steculorum SM, 2011, ENDOCRINOLOGY, V152, P4171, DOI 10.1210/en.2011-1279; Sullivan EL, 2011, NEUROENDOCRINOLOGY, V93, P1, DOI 10.1159/000322038; VANHOUTEN M, 1979, ENDOCRINOLOGY, V105, P666; WARDLAW SL, 1988, NEUROENDOCRINOLOGY, V47, P164, DOI 10.1159/000124908; Williams KW, 2010, J NEUROSCI, V30, P2472, DOI 10.1523/JNEUROSCI.3118-09.2010; Xu BJ, 2003, NAT NEUROSCI, V6, P736, DOI 10.1038/nn1073; Yuan ZQ, 2008, SCIENCE, V319, P1665, DOI 10.1126/science.1152337	43	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2012	7	2							e31487	10.1371/journal.pone.0031487	http://dx.doi.org/10.1371/journal.pone.0031487			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UV	22319636	Green Published, gold, Green Submitted			2022-12-27	WOS:000301979000031
J	Huang, D; Chen, CY; Zhang, MH; Qiu, LY; Shen, Y; Du, G; Zhou, KY; Wang, R; Chen, ZW				Huang, Dan; Chen, Crystal Y.; Zhang, Meihong; Qiu, Liyou; Shen, Yun; Du, George; Zhou, Keyuan; Wang, Richard; Chen, Zheng W.			Clonal Immune Responses of Mycobacterium-Specific gamma delta T Cells in Tuberculous and Non-Tuberculous Tissues during M. tuberculosis Infection	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION; (E)-4-HYDROXY-3-METHYL-BUT-2-ENYL PYROPHOSPHATE; V-GAMMA-2V-DELTA-2 TCR; EFFECTOR-CELLS; DRUG-USERS; COINFECTION; REPERTOIRE; MACAQUES; RECOGNITION; PULMONARY	Background: We previously demonstrated that unvaccinated macaques infected with large-dose M. tuberculosis(Mtb) exhibited delays for pulmonary trafficking of Ag-specific alpha beta and gamma delta T effector cells, and developed severe lung tuberculosis(TB) and "secondary" Mtb infection in remote organs such as liver and kidney. Despite delays in lungs, local immunity in remote organs may accumulate since progressive immune activation after pulmonary Mtb infection may allow IFN gamma-producing gamma delta T cells to adequately develop and traffic to lately-infected remote organs. As initial efforts to test this hypothesis, we comparatively examined TCR repertoire/clonality, tissue trafficking and effector function of V gamma 2V delta 2 T cells in lung with severe TB and in liver/kidney without apparent TB. Methodology/Principal Findings: We utilized conventional infection-immunity approaches in macaque TB model, and employed our decades-long expertise for TCR repertoire analyses. TCR repertoires in V gamma 2V delta 2 T-cell subpopulation were broad during primary Mtb infection as most TCR clones found in lymphoid system, lung, kidney and liver were distinct. Polyclonally-expanded V gamma 2V delta 2 T-cell clones from lymphoid tissues appeared to distribute and localize in lung TB granuloms at the endpoint after Mtb infection by aerosol. Interestingly, some TCR clones appeared to be more predominant than others in lymphocytes from liver or kidney without apparent TB lesions. TCR CDR3 spetratyping revealed such clonal dominance, and the clonal dominance of expanded V gamma 2V delta 2 T cells in kidney/liver tissues was associated with undetectable or low-level TB burdens. Furthermore, V gamma 2V delta 2 T cells from tissue compartments could mount effector function for producing anti-mycobacterium cytokine. Conclusion: We were the first to demonstrate clonal immune responses of mycobacterium-specific V gamma 2V delta 2 T cells in the lymphoid system, heavily-infected lungs and lately subtly-infected kidneys or livers during primary Mtb infection. While clonally-expanded V gamma 2V delta 2 T cells accumulated in lately-infected kidneys/livers without apparent TB lesions, TB burdens or lesions appeared to impact TCR repertoires and tissue trafficking patterns of activated V gamma 2V delta 2 T cells.	[Huang, Dan; Chen, Crystal Y.; Shen, Yun; Du, George; Wang, Richard; Chen, Zheng W.] Univ Illinois, Coll Med, Dept Microbiol & Immunol, Ctr Primate Biomed Res, Chicago, IL 60612 USA; [Zhang, Meihong; Zhou, Keyuan] Wuhan Univ, Zhongnan Hosp, Ctr Gene Diag, Wuhan 430072, Peoples R China; [Zhang, Meihong; Zhou, Keyuan] Guangdong Med Coll, Key Lab Med Mol Act Res, Dongguan, Peoples R China; [Qiu, Liyou] Henan Agr Univ, Coll Life Sci, Zhengzhou, Peoples R China	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Wuhan University; Guangdong Medical University; Henan Agricultural University	Huang, D (corresponding author), Univ Illinois, Coll Med, Dept Microbiol & Immunol, Ctr Primate Biomed Res, Chicago, IL 60612 USA.	pres@gdmc.edu.cn; zchen@uic.edu			National Institutes of Health [HL64560, RR13601]; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR013601] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064560] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R01OD015092] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health R01 grants; HL64560 (to Dr. Chen) and RR13601 (to Dr. Chen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abanmi A, 2005, J BIOCHEM MOL BIOL, V38, P350; Ali Z, 2007, J IMMUNOL, V179, P8287, DOI 10.4049/jimmunol.179.12.8287; BUKOWSKI JF, 1995, J IMMUNOL, V154, P998; Chen CY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000392; Chen Y, 2008, BLOOD, V111, P4220, DOI 10.1182/blood-2007-07-101691; Chen ZW, 2005, CLIN IMMUNOL, V116, P202, DOI 10.1016/j.clim.2005.04.005; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; Du G, 2006, J IMMUNOL METHODS, V308, P19, DOI 10.1016/j.jim.2005.09.009; Du G, 2010, J IMMUNOL, V185, P3940, DOI 10.4049/jimmunol.1001222; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Holtmeier W, 2002, J IMMUNOL, V169, P1993, DOI 10.4049/jimmunol.169.4.1993; Huang D, 2008, INFECT IMMUN, V76, P426, DOI 10.1128/IAI.01008-07; Huang D, 2009, P NATL ACAD SCI USA, V106, P7553, DOI 10.1073/pnas.0811250106; Kaufmann SHE, 2010, IMMUNITY, V33, P567, DOI 10.1016/j.immuni.2010.09.015; Kuusisto KM, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2832; Lai X, 2003, CLIN EXP IMMUNOL, V133, P182, DOI 10.1046/j.1365-2249.2003.02209.x; Lawn S, 2011, LANCET, V2011; Qiu LY, 2008, J INFECT DIS, V198, P1514, DOI 10.1086/592448; Roth SJ, 1998, EUR J IMMUNOL, V28, P104, DOI 10.1002/(SICI)1521-4141(199801)28:01<104::AID-IMMU104>3.0.CO;2-F; SELWYN PA, 1989, NEW ENGL J MED, V320, P545, DOI 10.1056/NEJM198903023200901; SELWYN PA, 1992, NEW ENGL J MED, V327, P1697, DOI 10.1056/NEJM199212103272401; Shen L, 2004, J INFECT DIS, V190, P1438, DOI 10.1086/423939; Shen Y, 2004, J VIROL, V78, P14023, DOI 10.1128/JVI.78.24.14023-14032.2004; Shen Y, 2002, INFECT IMMUN, V70, P869, DOI 10.1128/IAI.70.2.869-877.2002; Shen Y, 2002, SCIENCE, V295, P2255, DOI 10.1126/science.1068819; Wang H, 2003, J IMMUNOL, V170, P3696, DOI 10.4049/jimmunol.170.7.3696; Wei HY, 2008, J IMMUNOL, V181, P4798, DOI 10.4049/jimmunol.181.7.4798; Wells CD, 2007, J INFECT DIS, V196, pS86, DOI 10.1086/518665; Wu HL, 2001, KIDNEY INT, V60, P1324, DOI 10.1046/j.1523-1755.2001.00937.x; Zhou DJ, 2003, J VIROL, V77, P2998, DOI 10.1128/JVI.77.5.2998-3006.2003	30	16	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2012	7	2							e30631	10.1371/journal.pone.0030631	http://dx.doi.org/10.1371/journal.pone.0030631			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UG	22319574	Green Published, Green Submitted, gold			2022-12-27	WOS:000301977500014
J	Gomulski, LM; Dimopoulos, G; Xi, ZY; Scolari, F; Gabrieli, P; Siciliano, P; Clarke, AR; Malacrida, AR; Gasperi, G				Gomulski, Ludvik M.; Dimopoulos, George; Xi, Zhiyong; Scolari, Francesca; Gabrieli, Paolo; Siciliano, Paolo; Clarke, Anthony R.; Malacrida, Anna R.; Gasperi, Giuliano			Transcriptome Profiling of Sexual Maturation and Mating in the Mediterranean Fruit Fly, Ceratitis capitata	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; OLFACTORY-MEDIATED BEHAVIOR; BINDING-PROTEIN GENES; DROSOPHILA-MELANOGASTER; IMMUNE-RESPONSE; FLIES DIPTERA; MOLECULAR CHARACTERISTICS; EXPRESSION PATTERNS; KINASE-ACTIVITY; HONEY-BEE	Sexual maturation and mating in insects are generally accompanied by major physiological and behavioural changes. Many of these changes are related to the need to locate a mate and subsequently, in the case of females, to switch from mate searching to oviposition behaviour. The prodigious reproductive capacity of the Mediterranean fruit fly, Ceratitis capitata, is one of the factors that has led to its success as an invasive pest species. To identify the molecular changes related to maturation and mating status in male and female medfly, a microarray-based gene expression approach was used to compare the head transcriptomes of sexually immature, mature virgin, and mated individuals. Attention was focused on the changes in abundance of transcripts related to reproduction, behaviour, sensory perception of chemical stimulus, and immune system processes. Broad transcriptional changes were recorded during female maturation, while post-mating transcriptional changes in females were, by contrast, modest. In male medfly, transcriptional changes were consistent both during maturation and as a consequence of mating. Of particular note was the lack of the mating-induced immune responses that have been recorded for Drosophila melanogaster, that may be due to the different reproductive strategies of these species. This study, in addition to increasing our understanding of the molecular machinery behind maturation and mating in the medfly, has identified important gene targets that might be useful in the future management of this pest.	[Gomulski, Ludvik M.; Scolari, Francesca; Gabrieli, Paolo; Siciliano, Paolo; Malacrida, Anna R.; Gasperi, Giuliano] Univ Pavia, Dept Anim Biol, I-27100 Pavia, Italy; [Dimopoulos, George; Xi, Zhiyong] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD USA; [Clarke, Anthony R.] Queensland Univ Technol, Discipline Biogeosci, Brisbane, Qld 4001, Australia	University of Pavia; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Queensland University of Technology (QUT)	Gomulski, LM (corresponding author), Univ Pavia, Dept Anim Biol, Via Palestro 3, I-27100 Pavia, Italy.	gasperi@unipv.it	Gomulski, Ludvik/AAG-2709-2022; Scolari, Francesca/ABC-2285-2020; Gomulski, Ludvik/AFK-3930-2022; Gasperi, Giuliano/Y-1894-2019; Xi, Zhiyong/AAD-7936-2022; Gabrieli, Paolo/A-3206-2016; Clarke, Anthony R/B-5143-2011	Scolari, Francesca/0000-0003-3085-9038; Gasperi, Giuliano/0000-0001-6972-8591; Xi, Zhiyong/0000-0001-7786-012X; Gabrieli, Paolo/0000-0002-4996-2468; Clarke, Anthony R/0000-0002-8165-3032; GOMULSKI, LUDVIK/0000-0002-1506-7051; Dimopoulos, George/0000-0001-6755-8111; malacrida, anna/0000-0003-4566-8795	Italian Ministry of Universities and Research PRIN [2004053427, 20077RCHRW]; JHMRI	Italian Ministry of Universities and Research PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); JHMRI	The study was partially funded by Italian Ministry of Universities and Research PRIN grants 2004053427 and 20077RCHRW (LMG, ARM, GG). ZX was supported by a JHMRI Postdoctoral Fellowship. The work was also carried out within the IAEA CRP programme "Development and evaluation of improved strains of insect pests for SIT'' (GG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anholt RRH, 2003, NAT GENET, V35, P180, DOI 10.1038/ng1240; [Anonymous], FRUIT FLIES EC IMPOR; Arya GH, 2010, GENETICS, V186, P1475, DOI 10.1534/genetics.110.123166; Ayme-Southgate A, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-17; Bebas P, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-64; Bohbot J, 2005, INSECT BIOCHEM MOLEC, V35, P961, DOI 10.1016/j.ibmb.2005.03.010; Bonizzoni M, 2006, J ECON ENTOMOL, V99, P1420, DOI 10.1603/0022-0493-99.4.1420; CANT K, 1994, J CELL BIOL, V125, P369, DOI 10.1083/jcb.125.2.369; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Chapman T, 2003, P NATL ACAD SCI USA, V100, P9923, DOI 10.1073/pnas.1631635100; Chapman T, 1998, P ROY SOC B-BIOL SCI, V265, P1879, DOI 10.1098/rspb.1998.0516; CHAPMAN T, 1995, NATURE, V373, P241, DOI 10.1038/373241a0; Christophides GK, 2000, INSECT MOL BIOL, V9, P185, DOI 10.1046/j.1365-2583.2000.00176.x; Christophides GK, 2000, GENETICS, V156, P173; Comas D, 2004, NATURE, V430, P460, DOI 10.1038/nature02726; Dalton JE, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-541; Das Suchismita, 2008, BMC Physiology, V8, P23, DOI 10.1186/1472-6793-8-23; De Gregorio E, 2001, P NATL ACAD SCI USA, V98, P12590, DOI 10.1073/pnas.221458698; Deddouche S, 2008, NAT IMMUNOL, V9, P1425, DOI 10.1038/ni.1664; Diamantidis AD, 2008, ENTOMOL EXP APPL, V128, P389, DOI 10.1111/j.1570-7458.2008.00730.x; Diaz-Fleischer F, 2000, FRUIT FLIES (TEPHRITIDAE): PHYLOGENY AND EVOLUTION OF BEHAVIOR, P811; Dickson BJ, 2008, SCIENCE, V322, P904, DOI 10.1126/science.1159276; Dong YM, 2006, PLOS PATHOG, V2, P513, DOI 10.1371/journal.ppat.0020052; Drew RAI, 2000, FRUIT FLIES (TEPHRITIDAE): PHYLOGENY AND EVOLUTION OF BEHAVIOR, P731; Dubnau J, 2003, CURR BIOL, V13, P286, DOI 10.1016/S0960-9822(03)00064-2; Edwards Alexis C, 2009, BMC Biol, V7, P29, DOI 10.1186/1741-7007-7-29; Ellis LL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-558; Fan YJ, 2010, GENETICS, V184, P141, DOI 10.1534/genetics.109.109553; Fayyazuddin A, 2006, PLOS BIOL, V4, P420, DOI 10.1371/journal.pbio.0040063; FERVEUR JF, 1995, SCIENCE, V267, P902, DOI 10.1126/science.7846534; FLETCHER BS, 1989, FRUIT FLIES THEIR B, V3, P209; Fujii S, 2002, EMBO J, V21, P5353, DOI 10.1093/emboj/cdf556; Galindo K, 2001, GENETICS, V159, P1059; Gasperi G, 2002, GENETICA, V116, P125, DOI 10.1023/A:1020971911612; Gillott C, 2003, ANNU REV ENTOMOL, V48, P163, DOI 10.1146/annurev.ento.48.091801.112657; Goldman TD, 2007, PLOS GENET, V3, P2278, DOI 10.1371/journal.pgen.0030216; HALL JC, 1994, SCIENCE, V264, P1702, DOI 10.1126/science.8209251; Harvey Kieran F., 2010, Journal of Biology (London), V9, P8, DOI 10.1186/jbiol219; Hedengren M, 1999, MOL CELL, V4, P827, DOI 10.1016/S1097-2765(00)80392-5; Heifetz Y, 2004, P NATL ACAD SCI USA, V101, P6261, DOI 10.1073/pnas.0401337101; HENDRICHS J, 1991, OECOLOGIA, V86, P223, DOI 10.1007/BF00317534; Innocenti P, 2009, J EVOLUTION BIOL, V22, P964, DOI 10.1111/j.1420-9101.2009.01708.x; Jang EB, 2002, FLA ENTOMOL, V85, P89, DOI 10.1653/0015-4040(2002)085[0089:POMBIM]2.0.CO;2; Jang EB, 1998, ANN ENTOMOL SOC AM, V91, P139, DOI 10.1093/aesa/91.1.139; JANG EB, 1995, J INSECT PHYSIOL, V41, P705, DOI 10.1016/0022-1910(95)00015-M; Kankare Maaria, 2010, BMC Ecology, V10, P3, DOI 10.1186/1472-6785-10-3; Kapelnikov A, 2008, P NATL ACAD SCI USA, V105, P13912, DOI 10.1073/pnas.0710997105; Kaspi R, 2002, PHYSIOL ENTOMOL, V27, P29, DOI 10.1046/j.1365-3032.2001.00264.x; Kocher SD, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-232; Kraaijeveld K, 2004, P ROY SOC B-BIOL SCI, V271, pS209, DOI 10.1098/rsbl.2003.0116; Krafsur ES, 1998, J AGR ENTOMOL, V15, P303; Lawniczak MKN, 2004, GENOME, V47, P900, DOI 10.1139/G04-050; Leclerc V, 2004, IMMUNOL REV, V198, P59, DOI 10.1111/j.0105-2896.2004.0130.x; Lee G, 2000, J NEUROBIOL, V43, P404, DOI 10.1002/1097-4695(20000615)43:4<404::AID-NEU8>3.0.CO;2-D; Leulier F, 2000, EMBO REP, V1, P353, DOI 10.1093/embo-reports/kvd073; Liebl FLW, 2008, DEV NEUROBIOL, V68, P152, DOI 10.1002/dneu.20562; Lochhead PA, 2003, BIOCHEM J, V374, P381, DOI 10.1042/BJ20030500; Lyne R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r129; Mackay TFC, 2005, P NATL ACAD SCI USA, V102, P6622, DOI 10.1073/pnas.0501986102; Malacrida AR, 2007, GENETICA, V131, P1, DOI 10.1007/s10709-006-9117-2; MARCHINI D, 1995, J BIOL CHEM, V270, P6199, DOI 10.1074/jbc.270.11.6199; Marchini D, 2003, ARTHROPOD STRUCT DEV, V31, P313, DOI 10.1016/S1467-8039(03)00003-3; Marcillac F, 2005, GENETICS, V171, P1617, DOI 10.1534/genetics.104.033159; Mateos J, 2006, J MUSCLE RES CELL M, V27, P189, DOI 10.1007/s10974-005-9044-3; McGraw LA, 2004, CURR BIOL, V14, P1509, DOI 10.1016/j.cub.2004.08.028; McGraw LA, 2008, GENETICS, V179, P1395, DOI 10.1534/genetics.108.086934; Meunier N, 2007, J EXP BIOL, V210, P1424, DOI 10.1242/jeb.02755; Miyatake T, 1999, J INSECT PHYSIOL, V45, P1021, DOI 10.1016/S0022-1910(99)00083-9; Montaner D, 2006, NUCLEIC ACIDS RES, V34, pW486, DOI 10.1093/nar/gkl197; Moshitzky P, 1996, ARCH INSECT BIOCHEM, V32, P363, DOI 10.1002/(SICI)1520-6327(1996)32:3/4&lt;363::AID-ARCH9&gt;3.0.CO;2-T; Mossinson S, 2003, J INSECT PHYSIOL, V49, P561, DOI 10.1016/S0022-1910(03)00027-1; Muda M, 2002, BIOCHEM J, V366, P73, DOI 10.1042/BJ20020298; Nijhout H. F., 1998, INSECT HORMONES, P267; Ottiger M, 2000, J NEUROBIOL, V44, P57; Papadopoulos NT, 2010, J INSECT PHYSIOL, V56, P283, DOI 10.1016/j.jinsphys.2009.10.014; Papadopoulos NT, 1998, ENTOMOL EXP APPL, V89, P175, DOI 10.1023/A:1003580814122; Peng J, 2005, CURR BIOL, V15, P1690, DOI 10.1016/j.cub.2005.08.048; Piulachs MD, 2003, INSECT BIOCHEM MOLEC, V33, P459, DOI 10.1016/S0965-1748(03)00021-3; Radhakrishnan P, 2008, PHYSIOL ENTOMOL, V33, P302, DOI 10.1111/j.1365-3032.2008.00631.x; Ram KR, 2007, PLOS GENET, V3, P2428, DOI 10.1371/journal.pgen.0030238; Rogers DW, 2008, P NATL ACAD SCI USA, V105, P19390, DOI 10.1073/pnas.0809723105; Rollmann SM, 2005, J NEUROBIOL, V63, P146, DOI 10.1002/neu.20123; ROSETTO M, 1993, GENE, V134, P241, DOI 10.1016/0378-1119(93)90100-H; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; SAMAKOVLIS C, 1990, EMBO J, V9, P2969, DOI 10.1002/j.1460-2075.1990.tb07489.x; Sappington TW, 1998, INSECT BIOCHEM MOLEC, V28, P277, DOI 10.1016/S0965-1748(97)00110-0; Sarov-Blat L, 2000, CELL, V101, P647, DOI 10.1016/S0092-8674(00)80876-4; SAUL SH, 1982, ANN ENTOMOL SOC AM, V75, P480, DOI 10.1093/aesa/75.4.480; Sem KP, 2002, MOL CELL BIOL, V22, P3685, DOI 10.1128/MCB.22.11.3685-3697.2002; Sivinski J, 2000, FRUIT FLIES (TEPHRITIDAE): PHYLOGENY AND EVOLUTION OF BEHAVIOR, P751; So WV, 2000, MOL CELL BIOL, V20, P6935, DOI 10.1128/MCB.20.18.6935-6944.2000; Soller M, 1999, DEV BIOL, V208, P337, DOI 10.1006/dbio.1999.9210; Stanewsky R, 2002, CELL TISSUE RES, V309, P11, DOI 10.1007/s00441-002-0569-0; Swarup S, 2011, GENES BRAIN BEHAV, V10, P648, DOI 10.1111/j.1601-183X.2011.00704.x; Taylor PW, 1999, ANIM BEHAV, V58, P247, DOI 10.1006/anbe.1999.1137; Townsend JP, 2002, GENOME BIOL, V3; Tram U, 1998, P NATL ACAD SCI USA, V95, P4051, DOI 10.1073/pnas.95.7.4051; Tufail M, 2008, J INSECT PHYSIOL, V54, P1447, DOI 10.1016/j.jinsphys.2008.08.007; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Whitfield CW, 2006, P NATL ACAD SCI USA, V103, P16068, DOI 10.1073/pnas.0606909103; WHITTIER TS, 1992, ANN ENTOMOL SOC AM, V85, P214, DOI 10.1093/aesa/85.2.214; Wijnen H, 2006, PLOS GENET, V2, P326, DOI 10.1371/journal.pgen.0020039; Williamson D.L., 1989, World Crop Pests, V3A, P141; Wong R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006063; Yun B, 2000, GENETICS, V156, P749; Yuval B, 2000, FRUIT FLIES (TEPHRITIDAE): PHYLOGENY AND EVOLUTION OF BEHAVIOR, P429; Zheng Q, 2008, NUCLEIC ACIDS RES, V36, pW358, DOI 10.1093/nar/gkn276; Zhou SS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000681	110	54	56	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e30857	10.1371/journal.pone.0030857	http://dx.doi.org/10.1371/journal.pone.0030857			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22303464	gold, Green Published, Green Submitted			2022-12-27	WOS:000301704200040
J	Phan, V; Thai, S; Choun, K; Lynen, L; van Griensven, J				Phan, Vichet; Thai, Sopheak; Choun, Kimcheng; Lynen, Lutgarde; van Griensven, Johan			Incidence of Treatment-Limiting Toxicity with Stavudine-Based Antiretroviral Therapy in Cambodia: A Retrospective Cohort Study	PLOS ONE			English	Article							HIV-INFECTED PERSONS; QUALITY-OF-LIFE; BODY CHANGES; LIPODYSTROPHY; PREVALENCE; ADULTS; RISK; SUBSTITUTION; ADHERENCE; SYMPTOMS	Background: Although stavudine (D4T) remains frequently used in low-income countries in Asia, associated long-term toxicity data are scarce. The aim of this study was to determine the long-term incidence of severe D4T-toxicity (requiring drug substitution) and associated risk factors in HIV-infected Cambodians up to six years on antiretroviral treatment (ART). Methodology/Principal Findings: This is a retrospective analysis of an observational cohort, using data from an ART program with systematic monitoring for D4T-toxicity. Probabilities of time to D4T substitution due to suspected D4T toxicity (treatment-limiting D4T toxicity) were calculated, a risk factor analysis was performed using multivariate Cox regression modelling. Out of 2581 adults initiating a D4T-containing regimen, D4T was replaced in 276 (10.7%) patients for neuropathy, 14 (0.5%) for lactic acidosis and 957 (37.1%) for lipoatrophy. The main early side effect was peripheral neuropathy (7.0% by 1 year). After the first year, lipoatrophy became predominant, with a cumulative incidence of 56.1% and 72.4% by 3 and 6 years respectively. Older age (aHR 1.8; 95%CI: 1.4-2.3) and lower baseline haemoglobin (aHR 1.7; 95%CI: 1.4-2.2) were associated with the occurrence of neuropathy. Being female (aHR 3.8; 95%CI: 1.1-12.5), a higher baseline BMI (aHR 12.6; 95%CI: 3.7-43.1), and TB treatment at ART initiation (aHR 8.6; 95%CI: 2.7-27.5) increased the likelihood of lactic acidosis. Lipoatrophy was positively associated with female gender (aHR 2.3; 95%CI: 2.0-2.6), an older age (aHR 1.3; 95%CI: 1.1-1.4), and a CD4 count <200 cells/mu L (aHR 1.3; 95%CI: 1.1-1.5). Conclusions: Stavudine-based treatment regimens in low-income countries are associated with significant long-term toxicities, predominantly lipoatrophy. Close clinical monitoring for toxicity with timely D4T substitution is recommended. Phasing-out of stavudine should be implemented, as costs allows.	[Phan, Vichet; Thai, Sopheak; Choun, Kimcheng; van Griensven, Johan] Sihanouk Hosp Ctr HOPE, Phnom Penh, Cambodia; [Lynen, Lutgarde; van Griensven, Johan] Inst Trop Med, B-2000 Antwerp, Belgium	Institute of Tropical Medicine (ITM)	Phan, V (corresponding author), Sihanouk Hosp Ctr HOPE, Phnom Penh, Cambodia.	phanvichet@yahoo.com	Lynen, Lutgarde/AAT-9180-2020; Lynen, Lutgarde/A-1212-2014	Lynen, Lutgarde/0000-0001-7183-4895; Lynen, Lutgarde/0000-0001-7183-4895	Belgian Directorate General of Development Cooperation; Institute of Tropical Medicine, Antwerp; Global Fund; InBev-Baillet Latour Fund	Belgian Directorate General of Development Cooperation; Institute of Tropical Medicine, Antwerp; Global Fund; InBev-Baillet Latour Fund	The HIV program was supported by the Belgian Directorate General of Development Cooperation through the framework agreement with the Institute of Tropical Medicine, Antwerp, the Global Fund to fight AIDS, Tuberculosis and Malaria, and Hope World Wide. JvG is supported by the InBev-Baillet Latour Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boulle A, 2007, ANTIVIR THER, V12, P753; Burgoyne R, 2005, QUAL LIFE RES, V14, P981, DOI 10.1007/s11136-004-2580-2; Clucas C, 2011, HIV MED, V12, P87, DOI 10.1111/j.1468-1293.2010.00851.x; Cooper V, 2009, AIDS CARE, V21, P520, DOI 10.1080/09540120802301824; Gallant JE, 2004, JAMA-J AM MED ASSOC, V292, P191, DOI 10.1001/jama.292.2.191; Glass TR, 2010, JAIDS-J ACQ IMM DEF, V54, P197, DOI 10.1097/QAI.0b013e3181ca48bf; Guaraldi G, 2008, AIDS REV, V10, P152; Hawkins C, 2007, JAIDS-J ACQ IMM DEF, V45, P304; Imhof A, 2005, CLIN INFECT DIS, V41, P721, DOI 10.1086/432471; Isaakidis P, 2008, JAIDS-J ACQ IMM DEF, V49, P48, DOI 10.1097/QAI.0b013e31817bec19; Justice AC, 2001, MED CARE, V39, P397, DOI 10.1097/00005650-200104000-00010; Kowalska JD, 2007, AIDS RES HUM RETROV, V23, P1183, DOI 10.1089/aid.2006.0292; Lampe FC, 2010, JAIDS-J ACQ IMM DEF, V54, P500, DOI 10.1097/QAI.0b013e3181ce6afe; Lynen L, 2009, JAIDS-J ACQ IMM DEF, V52, P40, DOI 10.1097/QAI.0b013e3181af6705; Mercier S, 2009, JAIDS-J ACQ IMM DEF, V51, P224, DOI 10.1097/QAI.0b013e31819c16f4; Mutimura E, 2007, JAIDS-J ACQ IMM DEF, V46, P451, DOI 10.1097/QAI.0b013e318158c0a6; Nachega Jean B, 2009, Curr HIV/AIDS Rep, V6, P121, DOI 10.1007/s11904-009-0017-9; Santos CP, 2005, AIDS, V19, pS14, DOI 10.1097/01.aids.0000191485.92285.c7; Thai S, 2009, TROP MED INT HEALTH, V14, P1048, DOI 10.1111/j.1365-3156.2009.02334.x; van Griensven J, 2007, T ROY SOC TROP MED H, V101, P793, DOI 10.1016/j.trstmh.2007.02.020; van Griensven J, 2010, T ROY SOC TROP MED H, V104, P148, DOI 10.1016/j.trstmh.2009.07.009; Westreich DJ, 2009, CLIN INFECT DIS, V48, P1617, DOI 10.1086/598977; [WHO UNAIDS UNICEF], 2009, UN ACC SCAL PRIOR HI; WHO, 2010, ANT THER HIV INF AD; WHO, 2004, SCAL ANT THER RES LI; Womack J, 2009, AIDS READ, V19, P131; World Health Organization, 2006, ANT THER HIV INF AD	27	30	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e30647	10.1371/journal.pone.0030647	http://dx.doi.org/10.1371/journal.pone.0030647			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22303447	gold, Green Submitted, Green Published			2022-12-27	WOS:000301704200026
J	Lorenz, M; Fechner, M; Kalkowski, J; Frohlich, K; Trautmann, A; Bohm, V; Liebisch, G; Lehneis, S; Schmitz, G; Ludwig, A; Baumann, G; Stangl, K; Stangl, V				Lorenz, Mario; Fechner, Mandy; Kalkowski, Janine; Froehlich, Kati; Trautmann, Anne; Boehm, Volker; Liebisch, Gerhard; Lehneis, Stefan; Schmitz, Gerd; Ludwig, Antje; Baumann, Gert; Stangl, Karl; Stangl, Verena			Effects of Lycopene on the Initial State of Atherosclerosis in New Zealand White (NZW) Rabbits	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; HUMAN-PLASMA; CAROTID ATHEROSCLEROSIS; MEDIA THICKNESS; SERUM LYCOPENE; ANIMAL-MODEL; CAROTENOIDS; RISK; ANTIOXIDANTS; ASSOCIATION	Background: Lycopene is the main carotenoid in tomatoes, where it is found in high concentrations. Strong epidemiological evidence suggests that lycopene may provide protection against cardiovascular diseases. We therefore studied the effects of lycopene on diet-induced increase in serum lipid levels and the initiation of atherosclerosis in New Zealand White (NZW) rabbits. Methodology/Principal Findings: The animals, divided into four groups of 9 animals each, were fed either a standard diet, a high-cholesterol diet containing 0.5% cholesterol, a high-cholesterol diet containing placebo beadlets, or a high-cholesterol diet plus 5 mg/kg body weight/day of lycopene ( in the form of lycopene beadlets), for a period of 4 weeks. We found significantly elevated lycopene plasma levels in the animal group treated with lycopene beadlets. Compared to the high-cholesterol and the placebo group, this was associated with a significant reduction of 50% in total cholesterol and LDL cholesterol serum levels in the lycopene group. The amount of cholesteryl ester in the aorta was significantly decreased by lycopene. However, we did not observe a significant decrease in the extent of aortic surface lipid accumulation in the lycopene group. In addition, no differences in the intima-media thickness among groups were observed. Endothelial-dependent and endothelial-independent vasodilation in isolated rabbit aortic and carotid rings did not differ among any of the animal groups. Conclusions: Lycopene supplementation for 4 weeks increased lycopene plasma levels in the animals. Although we found strongly reduced total and LDL cholesterol serum levels as well as significantly lower amounts of cholesteryl ester in the aortae in the lycopene-treated group, no significant differences in initial lesions in the aortae were detected.	[Lorenz, Mario; Fechner, Mandy; Kalkowski, Janine; Ludwig, Antje; Baumann, Gert; Stangl, Karl; Stangl, Verena] Charite, Campus Mitte, Med Klin Kardiol & Angiol, D-13353 Berlin, Germany; [Froehlich, Kati; Trautmann, Anne; Boehm, Volker] Univ Jena, Inst Nutr, Jena, Germany; [Froehlich, Kati] Food GmbH Jena Analyt Consulting Jena, Jena, Germany; [Liebisch, Gerhard; Lehneis, Stefan; Schmitz, Gerd] Univ Klinikum Regensburg, Inst Klin Chem & Lab Med, Regensburg, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Friedrich Schiller University of Jena; University of Regensburg	Lorenz, M (corresponding author), Charite, Campus Mitte, Med Klin Kardiol & Angiol, D-13353 Berlin, Germany.	verena.stangl@charite.de	, Antje Ludwig/ABF-6556-2021; Liebisch, Gerhard/G-6130-2010	Liebisch, Gerhard/0000-0003-4886-0811; Lorenz, Mario/0000-0001-5267-4101; Ludwig, Antje/0000-0002-8369-7020	European Community [IP 016213]	European Community(European Commission)	This work was supported by the European Community Sixth Framework Programme (IP 016213). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIERI JG, 1985, J LIQ CHROMATOGR, V8, P473, DOI 10.1080/01483918508067094; Blum Arnon, 2005, Eur J Intern Med, V16, P402, DOI 10.1016/j.ejim.2005.02.017; Delahoy PJ, 2009, CLIN THER, V31, P236, DOI 10.1016/j.clinthera.2009.02.017; Engelhard YN, 2006, AM HEART J, V151, DOI 10.1016/j.ahj.2005.05.008; Frederiksen H, 2007, BRIT J NUTR, V97, P6, DOI 10.1017/S0007114507210153; Frohlich K, 2006, BRIT J NUTR, V95, P734, DOI 10.1079/BJN20051657; Gianetti J, 2002, AM HEART J, V143, P467, DOI 10.1067/mhj.2002.120776; Hu MY, 2008, NUTRITION, V24, P1030, DOI 10.1016/j.nut.2008.05.006; Karppi J, 2011, J INTERN MED, V270, P478, DOI 10.1111/j.1365-2796.2011.02401.x; Kelkel M, 2011, FREE RADICAL RES, V45, P925, DOI 10.3109/10715762.2011.564168; Kim OY, 2010, ATHEROSCLEROSIS, V208, P581, DOI 10.1016/j.atherosclerosis.2009.08.009; Klipstein-Grobusch K, 2000, ATHEROSCLEROSIS, V148, P49, DOI 10.1016/S0021-9150(99)00221-X; Liebisch G, 2006, BBA-MOL CELL BIOL L, V1761, P121, DOI 10.1016/j.bbalip.2005.12.007; Matsumoto I, 2011, CIRC J, V75, P905, DOI 10.1253/circj.CJ-10-0258; Misra R, 2006, J OBSTET GYNAECOL RE, V32, P299, DOI 10.1111/j.1447-0756.2006.00410.x; Mordente A, 2011, CURR MED CHEM, V18, P1146, DOI 10.2174/092986711795029717; Palozza P, 2011, J NUTR BIOCHEM, V22, P971, DOI 10.1016/j.jnutbio.2010.08.010; Palozza P, 2010, ARCH BIOCHEM BIOPHYS, V504, P26, DOI 10.1016/j.abb.2010.06.031; Preiss D, 2009, CLIN ENDOCRINOL, V70, P815, DOI 10.1111/j.1365-2265.2008.03490.x; Riccioni G, 2010, J BIOL REG HOMEOS AG, V24, P447; Riccioni G, 2010, INT J IMMUNOPATH PH, V23, P327, DOI 10.1177/039463201002300131; Ried K, 2011, MATURITAS, V68, P299, DOI 10.1016/j.maturitas.2010.11.018; Rissanen T, 2002, EXP BIOL MED, V227, P900, DOI 10.1177/153537020222701010; Rissanen TH, 2003, AM J CLIN NUTR, V77, P133, DOI 10.1093/ajcn/77.1.133; ROMANCHIK JE, 1995, J NUTR, V125, P2610; Sun YP, 2000, P SOC EXP BIOL MED, V224, P166, DOI 10.1046/j.1525-1373.2000.22416.x; TANZAWA K, 1980, FEBS LETT, V118, P81, DOI 10.1016/0014-5793(80)81223-3; Verghese M., 2008, Journal of Biological Sciences, V8, P268; WONG SHY, 1987, CLIN CHEM, V33, P214; Yanni AE, 2004, LAB ANIM-UK, V38, P246, DOI 10.1258/002367704323133628; Yeo HY, 2011, METABOLISM, V60, P537, DOI 10.1016/j.metabol.2010.05.003	31	31	33	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30808	10.1371/journal.pone.0030808	http://dx.doi.org/10.1371/journal.pone.0030808			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295112	Green Submitted, Green Published, gold			2022-12-27	WOS:000301640600057
J	Yamakawa, N; Kaneda, K; Saito, Y; Ichihara, E; Morishita, K				Yamakawa, Norio; Kaneda, Kazuko; Saito, Yusuke; Ichihara, Emi; Morishita, Kazuhiro			The Increased Expression of Integrin alpha 6 (ITGA6) Enhances Drug Resistance in EVI1(high) Leukemia	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; BONE-MARROW; HEMATOPOIETIC PROGENITORS; GENE; EVI1; IDENTIFICATION; ACTIVATION; TRANSCRIPTION; FIBRONECTIN; SURVIVAL	Ecotropic viral integration site-1 (EVI1) is one of the candidate oncogenes for human acute myeloid leukemia (AML) with chromosomal alterations at 3q26. High EVI1 expression (EVI1(high)) is a risk factor for AML with poor outcome. Using DNA microarray analysis, we previously identified that integrin alpha 6 (ITGA6) was upregulated over 10-fold in EVI1(high) leukemia cells. In this study, we determined whether the increased expression of ITGA6 is associated with drug-resistance and increased cell adhesion, resulting in poor prognosis. To this end, we first confirmed the expression pattern of a series of integrin genes using semi-quantitative PCR and fluorescence-activated cell sorter (FACS) analysis and determined the cell adhesion ability in EVI1(high) leukemia cells. We found that the adhesion ability of EVI1(high) leukemia cells to laminin increased with the increased expression of ITGA6 and integrin beta 4 (ITGB4). The introduction of small-hairpin RNA against EVI1 (shEVI1) into EVI1(high) leukemia cells reduced the cell adhesion ability and downregulated the expression of ITGA6 and ITGB4. In addition, the overexpression of EVI1 in EVI1(low) leukemia cells enhanced their cell adhesion ability and increased the expression of ITGA6 and ITGB4. In a subsequent experiment, the introduction of shRNA against ITGA6 or ITGB4 into EVI1(high) AML cells downregulated their cell adhesion ability; however, the EVI1(high) AML cells transfected with shRNA against ITGA6 could not be maintained in culture. Moreover, treating EVI1(high) leukemia cells with neutralizing antibodies against ITGA6 or ITGB4 resulted in an enhanced responsiveness to anti-cancer drugs and a reduction of their cell adhesion ability. The expression of ITGA6 is significantly elevated in cells from relapsed and EVI1(high) AML cases; therefore, ITGA6 might represent an important therapeutic target for both refractory and EVI1(high) AML.	[Yamakawa, Norio; Kaneda, Kazuko; Saito, Yusuke; Ichihara, Emi; Morishita, Kazuhiro] Miyazaki Univ, Fac Med, Dept Med Sci, Div Tumor & Cellular Biochem, Miyazaki, Japan	University of Miyazaki	Yamakawa, N (corresponding author), Miyazaki Univ, Fac Med, Dept Med Sci, Div Tumor & Cellular Biochem, Miyazaki, Japan.	kmorishi@medmiyazaki-u.ac.jp		Kaneda-Nakashima, Kazuko/0000-0001-6657-5059	Ministry of Education, Culture, Sports, Science and Technology in Japan	Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid for Scientific Research in Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology in Japan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barjesteh van Waalwijk van Doorn-Khosrovani S, 2001, BLOOD, V101, P837; Becker PS, 2009, BLOOD, V113, P866, DOI 10.1182/blood-2007-12-124818; Bei L, 2007, J BIOL CHEM, V282, P16846, DOI 10.1074/jbc.M609744200; Bergamini C, 2007, HEPATOLOGY, V46, P1801, DOI 10.1002/hep.21936; Chan JYH, 2001, BRIT J HAEMATOL, V112, P541, DOI 10.1046/j.1365-2141.2001.02439.x; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Evsikov AV, 2003, SCIENCE, V302; Goyama S, 2010, INT J HEMATOL, V91, P753, DOI 10.1007/s12185-010-0618-5; Kurokawa M, 1998, NATURE, V394, P92, DOI 10.1038/27945; Levesque JP, 2010, LEUKEMIA, V24, P1979, DOI 10.1038/leu.2010.214; Lin KT, 2005, J BIOMED SCI, V12, P803, DOI 10.1007/s11373-005-9005-2; Liu Y, 2006, ONCOGENE, V25, P3565, DOI 10.1038/sj.onc.1209403; Lugthart S, 2008, BLOOD, V111, P4329, DOI 10.1182/blood-2007-10-119230; Matsunaga T, 2008, LEUKEMIA, V22, P353, DOI 10.1038/sj.leu.2405017; Matsunaga T, 2003, NAT MED, V9, P1158, DOI 10.1038/nm909; MORISHITA K, 1990, ONCOGENE RES, V5, P221; MORISHITA K, 1988, CELL, V54, P831, DOI 10.1016/S0092-8674(88)91175-0; Morishita K, 2007, INT J HEMATOL, V85, P279, DOI 10.1532/IJH97.06174; MUCENSKI ML, 1988, MOL CELL BIOL, V8, P301, DOI 10.1128/MCB.8.1.301; Nitta E, 2005, ONCOGENE, V24, P6165, DOI 10.1038/sj.onc.1208754; Palmer S, 2001, J BIOL CHEM, V276, P25834, DOI 10.1074/jbc.M102343200; PAPAYANNOPOULOU T, 1993, P NATL ACAD SCI USA, V90, P9374, DOI 10.1073/pnas.90.20.9374; PAPAYANNOPOULOU T, 1995, P NATL ACAD SCI USA, V92, P9647, DOI 10.1073/pnas.92.21.9647; Papayannopoulou T, 2001, BLOOD, V98, P2403, DOI 10.1182/blood.V98.8.2403; Saito Y, 2011, LEUKEMIA, V25, P921, DOI 10.1038/leu.2011.36; Scott LM, 2003, MOL CELL BIOL, V23, P9349, DOI 10.1128/MCB.23.24.9349-9360.2003; Shimahara A, 2010, J BIOL CHEM, V285, P16967, DOI 10.1074/jbc.M110.102046; Verhaak RGW, 2009, HAEMATOL-HEMATOL J, V94, P131, DOI 10.3324/haematol.13299; Wu JY, 2009, J BONE MINER RES, V24, P759, DOI [10.1359/JBMR.090225, 10.1359/jbmr.090225]; Yagi T, 2003, BLOOD, V102, P1849, DOI 10.1182/blood-2003-02-0578; Yuasa H, 2005, EMBO J, V24, P1976, DOI 10.1038/sj.emboj.7600679; Zaidel-Bar R, 2010, J CELL SCI, V123, P1385, DOI 10.1242/jcs.066183; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	33	49	55	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30706	10.1371/journal.pone.0030706	http://dx.doi.org/10.1371/journal.pone.0030706			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295105	Green Published, gold, Green Submitted			2022-12-27	WOS:000301640600050
J	Yang, JH; Lee, YM; Bae, SG; Jacobs, DR; Lee, DH				Yang, Jin-Hoon; Lee, Yu-Mi; Bae, Sang-Geun; Jacobs, David R., Jr.; Lee, Duk-Hee			Associations between Organochlorine Pesticides and Vitamin D Deficiency in the US Population	PLOS ONE			English	Article							PERSISTENT ORGANIC POLLUTANTS; SERUM CONCENTRATIONS; NATIONAL-HEALTH; D METABOLISM; DDT	Background: Recently low dose organochlorine (OC) pesticides have been strongly linked to various chronic diseases including diabetes and cardiovascular diseases. Both field and animal studies have suggested a possibility that persistent lipophilic chemicals like OC pesticides can cause vitamin D deficiency, but there have been no human studies of exposure to any chemical as a possible cause of vitamin D deficiency. This study was performed to examine if serum concentrations of OC pesticides were associated with serum concentrations of 25-hydroxyvitamin D (25(OH) D) in the U. S. general population. Methodology/Principal Findings: Cross-sectional associations of serum OC pesticides with serum 25(OH) D were investigated in 1,275 subjects aged >= 20 in the National Health and Nutrition Examination Survey(NHANES), 2003-2004. We selected 7 OC pesticides detectable in >= 80% of participants. Among the 7 OC pesticides, p,p'-DDT (beta = -0.022, P<0.01), p,p'-DDE (beta = -0.018, P = 0.04), and beta-hexachlorocyclohexane (beta = -0.022, P = 0.02) showed significant inverse associations with serum 25(OH) D levels. When study subjects were stratified by age, race, and the presence of various chronic diseases, p,p'-DDT showed consistent inverse associations in all subgroups, although stronger associations tended to be observed among subjects with old age, white race, or chronic diseases. Conclusion/Significance: The current study suggests that the background exposure to some OC pesticides leads to vitamin D deficiency in human. Considering the importance of vitamin D deficiency in the development of chronic diseases, chemical exposure as a possible cause of vitamin D deficiency should be evaluated in prospective and experimental studies.	[Yang, Jin-Hoon; Lee, Yu-Mi; Bae, Sang-Geun; Lee, Duk-Hee] Kyungpook Natl Univ, Sch Med, Dept Preventat Med, Taegu, South Korea; [Yang, Jin-Hoon] CHA Univ, CHA Gumi Med Ctr, Dept Occupat Med, Gumi, South Korea; [Jacobs, David R., Jr.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol, Minneapolis, MN 55455 USA; [Jacobs, David R., Jr.] Univ Oslo, Dept Nutr, Oslo, Norway	Kyungpook National University; Pochon Cha University; University of Minnesota System; University of Minnesota Twin Cities; University of Oslo	Yang, JH (corresponding author), Kyungpook Natl Univ, Sch Med, Dept Preventat Med, Taegu, South Korea.	lee_dh@knu.ac.kr		Jacobs, David/0000-0002-7232-0543; Bae, Sang-geun/0000-0001-7603-7676	Korea Food & Drug Administration [11162KFDA702]; National Research Foundation of Korea (NRF); Korea government (MEST) [2011-0004692]	Korea Food & Drug Administration(Ministry of Food & Drug Safety (MFDS), Republic of Korea); National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This research was partly supported by a grant (11162KFDA702) from Korea Food & Drug Administration in 2011 and National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (No. 2011-0004692). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Lloret P, 2009, TOXICOL LETT, V187, P63, DOI 10.1016/j.toxlet.2009.01.030; ATSDR, 2010, TOX PROF HEX; Bettinetti R, 2006, ENVIRON SCI POLLUT R, V13, P59, DOI 10.1065/espr2006.01.010; Bordelon P, 2009, AM FAM PHYSICIAN, V80, P841; Breivik K, 1999, SCI TOTAL ENVIRON, V239, P151, DOI 10.1016/S0048-9697(99)00291-0; ELLIOTT JE, 1988, ENVIRON POLLUT, V52, P81, DOI 10.1016/0269-7491(88)90083-8; Ginde AA, 2009, ARCH INTERN MED, V169, P626, DOI 10.1001/archinternmed.2008.604; Graubard BL, 1999, JNCI-J NATL CANCER I, V91, P1005, DOI 10.1093/jnci/91.12.1005; Ha MH, 2007, ENVIRON HEALTH PERSP, V115, P1204, DOI 10.1289/ehp.10184; Holick MF, 2008, AM J CLIN NUTR, V87, p1080S; KORN EL, 1991, AM J PUBLIC HEALTH, V81, P1166, DOI 10.2105/AJPH.81.9.1166; Laden F, 1999, ENVIRON HEALTH PERSP, V107, P75, DOI 10.2307/3434292; Lee D, 2011, PLOS ONE; Lee DH, 2006, DIABETES CARE, V29, P1638, DOI 10.2337/dc06-0543; Lee DH, 2010, ENVIRON HEALTH PERSP, V118, P1235, DOI 10.1289/ehp.0901480; Lilienthal H, 2000, TOXICOL SCI, V57, P292, DOI 10.1093/toxsci/57.2.292; Mithal A, 2009, OSTEOPOROSIS INT, V20, P1807, DOI 10.1007/s00198-009-0954-6; NOWICKI HG, 1972, J AGR FOOD CHEM, V20, P376, DOI 10.1021/jf60180a058; PEAKALL DB, 1969, NATURE, V224, P1219, DOI 10.1038/2241219a0; Reichrath J, 2009, BRIT J DERMATOL, V161, P54, DOI 10.1111/j.1365-2133.2009.09450.x; Rogan WJ, 2005, LANCET, V366, P763, DOI 10.1016/S0140-6736(05)67182-6; Routti H, 2008, ENVIRON TOXICOL CHEM, V27, P873, DOI 10.1897/07-139.1; SILVER J, 1979, CHEM-BIOL INTERACT, V24, P133, DOI 10.1016/0009-2797(79)90002-4; van den Berg H, 2009, ENVIRON HEALTH PERSP, V117, P1656, DOI 10.1289/ehp.0900785; Vijgen J, 2011, ENVIRON SCI POLLUT R, V18, P152, DOI 10.1007/s11356-010-0417-9; Welshons WV, 2003, ENVIRON HEALTH PERSP, V111, P994, DOI 10.1289/ehp.5494; Windham GC, 2010, ENVIRON RES, V110, P251, DOI 10.1016/j.envres.2010.01.004; Yetley EA, 2008, AM J CLIN NUTR, V88, p558S, DOI 10.1093/ajcn/88.2.558S	28	38	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30093	10.1371/journal.pone.0030093	http://dx.doi.org/10.1371/journal.pone.0030093			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295072	Green Published, gold, Green Submitted			2022-12-27	WOS:000301640600017
J	Girardi, C; De Pitta, C; Casara, S; Sales, G; Lanfranchi, G; Celotti, L; Mognato, M				Girardi, Cristina; De Pitta, Cristiano; Casara, Silvia; Sales, Gabriele; Lanfranchi, Gerolamo; Celotti, Lucia; Mognato, Maddalena			Analysis of miRNA and mRNA Expression Profiles Highlights Alterations in Ionizing Radiation Response of Human Lymphocytes under Modeled Microgravity	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; BREAST-CANCER CELLS; INTERNATIONAL-SPACE-STATION; LONG-DURATION SPACEFLIGHT; GENE-EXPRESSION; SIMULATED MICROGRAVITY; HUMAN FIBROBLASTS; CHROMOSOME-ABERRATIONS; INCREASES APOPTOSIS; TARGET RECOGNITION	Background: Ionizing radiation (IR) can be extremely harmful for human cells since an improper DNA-damage response (DDR) to IR can contribute to carcinogenesis initiation. Perturbations in DDR pathway can originate from alteration in the functionality of the microRNA-mediated gene regulation, being microRNAs (miRNAs) small noncoding RNA that act as post-transcriptional regulators of gene expression. In this study we gained insight into the role of miRNAs in the regulation of DDR to IR under microgravity, a condition of weightlessness experienced by astronauts during space missions, which could have a synergistic action on cells, increasing the risk of radiation exposure. Methodology/Principal Findings: We analyzed miRNA expression profile of human peripheral blood lymphocytes (PBL) incubated for 4 and 24 h in normal gravity (1 g) and in modeled microgravity (MMG) during the repair time after irradiation with 0.2 and 2Gy of gamma-rays. Our results show that MMG alters miRNA expression signature of irradiated PBL by decreasing the number of radio-responsive miRNAs. Moreover, let-7i*, miR-7, miR-7-1*, miR-27a, miR-144, miR-200a, miR-598, miR-650 are deregulated by the combined action of radiation and MMG. Integrated analyses of miRNA and mRNA expression profiles, carried out on PBL of the same donors, identified significant miRNA-mRNA anti-correlations of DDR pathway. Gene Ontology analysis reports that the biological category of "Response to DNA damage'' is enriched when PBL are incubated in 1 g but not in MMG. Moreover, some anti-correlated genes of p53-pathway show a different expression level between 1 g and MMG. Functional validation assays using luciferase reporter constructs confirmed miRNA-mRNA interactions derived from target prediction analyses. Conclusions/Significance: On the whole, by integrating the transcriptome and microRNome, we provide evidence that modeled microgravity can affects the DNA-damage response to IR in human PBL.	[Girardi, Cristina; De Pitta, Cristiano; Casara, Silvia; Sales, Gabriele; Lanfranchi, Gerolamo; Celotti, Lucia; Mognato, Maddalena] Univ Padua, Dipartimento Biol, Padua, Italy; [Celotti, Lucia] Ist Nazl Fis Nucl, Lab Nazl Legnaro, Padua, Italy	University of Padua; Istituto Nazionale di Fisica Nucleare (INFN)	Girardi, C (corresponding author), Univ Padua, Dipartimento Biol, Padua, Italy.	maddalena.mognato@unipd.it	De Pitta, Cristiano/AAY-7302-2020; Sales, Gabriele/K-5065-2016	De Pitta, Cristiano/0000-0001-8013-8162; Mognato, Maddalena/0000-0001-6132-1682; Sales, Gabriele/0000-0003-2078-5661	Italian Space Agency (ASI, XMAB-from Molecules to Man) [1/014/06/0]; Associazione Italiana per la Ricerca sul Cancro-AIRC [2008/6014]; University of Padova [CPDA061783]	Italian Space Agency (ASI, XMAB-from Molecules to Man); Associazione Italiana per la Ricerca sul Cancro-AIRC(Fondazione AIRC per la ricerca sul cancro); University of Padova	This work was supported by grants from the Italian Space Agency (ASI, XMAB-from Molecules to Man, 1/014/06/0) to L. C., from the Associazione Italiana per la Ricerca sul Cancro-AIRC (2008/6014) to G. L. and from the University of Padova (CPDA061783) to M. M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundson SA, 2000, RADIAT RES, V154, P342, DOI 10.1667/0033-7587(2000)154[0342:IOPMBI]2.0.CO;2; Baevsky RM, 2007, J APPL PHYSIOL, V103, P156, DOI 10.1152/japplphysiol.00137.2007; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bucker H, 1986, Adv Space Res, V6, P115, DOI 10.1016/0273-1177(86)90074-8; Canova S, 2005, RADIAT RES, V163, P191, DOI 10.1667/RR3304; Cha HJ, 2009, INT J ONCOL, V34, P1661, DOI 10.3892/ijo_00000297; Chaudhry MA, 2009, CANCER BIOTHER RADIO, V24, P49, DOI 10.1089/cbr.2008.0513; Chhabra R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005848; Chintharlapalli S, 2009, INT J CANCER, V125, P1965, DOI 10.1002/ijc.24530; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Cho WC, 2007, EUR J CANCER, V43, P1529; Clement Jade Q., 2008, Genomics Proteomics & Bioinformatics, V6, P8, DOI 10.1016/S1672-0229(08)60017-0; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Crawford-Young SJ, 2006, INT J DEV BIOL, V50, P183, DOI 10.1387/ijdb.052077sc; Crosby ME, 2009, CANCER RES, V69, P1221, DOI 10.1158/0008-5472.CAN-08-2516; Crucian BE, 2008, AVIAT SPACE ENVIR MD, V79, P835, DOI 10.3357/ASEM.2276.2008; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Fitts RH, 2001, J EXP BIOL, V204, P3201; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Galluzzi L, 2010, CANCER RES, V70, P1793, DOI 10.1158/0008-5472.CAN-09-3112; George K, 2001, PHYS MEDICA, V17, P222; Grimm D, 2002, FASEB J, V16, P604, DOI 10.1096/fj.01-0673fje; Guttilla IK, 2009, J BIOL CHEM, V284, P23204, DOI 10.1074/jbc.M109.031427; Hammond SM, 2007, NAT GENET, V39, P582, DOI 10.1038/ng0507-582; Hammond TG, 2000, PHYSIOL GENOMICS, V3, P163, DOI 10.1152/physiolgenomics.2000.3.3.163; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; He L, 2007, NAT REV CANCER, V7, P819, DOI 10.1038/nrc2232; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Horneck G, 1997, RADIAT RES, V147, P376, DOI 10.2307/3579347; Horneck G, 1999, MUTAT RES-FUND MOL M, V430, P221, DOI 10.1016/S0027-5107(99)00133-5; HORNECK G, 1992, NUCL TRACKS RAD MEAS, V20, P185; Horneck G, 1996, J BIOTECHNOL, V47, P99, DOI 10.1016/0168-1656(96)01382-X; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Infanger M, 2006, APOPTOSIS, V11, P749, DOI 10.1007/s10495-006-5697-7; Josson S, 2008, PROSTATE, V68, P1599, DOI 10.1002/pros.20827; Kang CY, 2011, EUR J APPL PHYSIOL, V111, P2131, DOI 10.1007/s00421-011-1844-0; Kato M, 2009, ONCOGENE, V28, P2419, DOI 10.1038/onc.2009.106; Katoh T, 2009, GENE DEV, V23, P433, DOI 10.1101/gad.1761509; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Keyak JH, 2009, BONE, V44, P449, DOI 10.1016/j.bone.2008.11.014; Kiefer J, 1999, MUTAT RES-FUND MOL M, V430, P299, DOI 10.1016/S0027-5107(99)00142-6; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kumari R, 2009, J CELL BIOCHEM, V107, P723, DOI 10.1002/jcb.22171; Lal A, 2009, NAT STRUCT MOL BIOL, V16, P492, DOI 10.1038/nsmb.1589; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lewis ML, 1998, FASEB J, V12, P1007, DOI 10.1096/fasebj.12.11.1007; Lewis ML, 2001, FASEB J, V15, P1783, DOI 10.1096/fj.00-0820fje; Liu R, 2011, EUR J CANCER, V47, P784, DOI 10.1016/j.ejca.2010.10.025; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma YH, 2010, CANCER LETT, V298, P150, DOI 10.1016/j.canlet.2010.06.012; Maccarrone M, 2003, J LEUKOCYTE BIOL, V73, P472, DOI 10.1189/jlb.0602295; Maes OC, 2009, J CELL PHYSIOL, V221, P109, DOI 10.1002/jcp.21834; Maes OC, 2008, J CELL BIOCHEM, V105, P824, DOI 10.1002/jcb.21878; Manti L, 2005, INT J RADIAT BIOL, V81, P147, DOI 10.1080/09553000500091188; Manti L, 2006, RADIAT ENVIRON BIOPH, V45, P1, DOI 10.1007/s00411-006-0037-4; Marsit CJ, 2006, CANCER RES, V66, P10843, DOI 10.1158/0008-5472.CAN-06-1894; Mi SL, 2007, P NATL ACAD SCI USA, V104, P19971, DOI 10.1073/pnas.0709313104; Mognato M, 2005, MUTAT RES-FUND MOL M, V578, P417, DOI 10.1016/j.mrfmmm.2005.06.011; Mognato M, 2009, MUTAT RES-FUND MOL M, V663, P32, DOI 10.1016/j.mrfmmm.2009.01.002; Moon SH, 2010, J BIOL CHEM, V285, P12935, DOI 10.1074/jbc.M109.071696; Mosesso P, 2001, PHYS MEDICA, V17, P264; Narici M, 2003, EUR J APPL PHYSIOL, V90, P275, DOI 10.1007/s00421-003-0955-7; Paul S, 2008, INT J RADIAT ONCOL, V71, P1236, DOI 10.1016/j.ijrobp.2008.03.043; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Pothof J, 2009, EMBO J, V28, P2090, DOI 10.1038/emboj.2009.156; Poy MN, 2007, DIABETES OBES METAB, V9, P67, DOI 10.1111/j.1463-1326.2007.00775.x; Pross HD, 2000, RADIAT RES, V153, P521, DOI 10.1667/0033-7587(2000)153[0521:IARODD]2.0.CO;2; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Sales G, 2010, NUCLEIC ACIDS RES, V38, pW352, DOI 10.1093/nar/gkq423; Sengupta S, 2005, NAT REV MOL CELL BIO, V6, P44, DOI 10.1038/nrm1546; Shin S, 2009, INT J ONCOL, V35, P81, DOI 10.3892/ijo_00000315; Sibonga JD, 2007, BONE, V41, P973, DOI 10.1016/j.bone.2007.08.022; Simone NL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006377; Simons DM, 2010, J CELL BIOCHEM, V109, P1201, DOI 10.1002/jcb.22502; Stern-Ginossar N, 2007, SCIENCE, V317, P376, DOI 10.1126/science.1140956; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Trabucchi M, 2009, RNA BIOL, V6, P536, DOI 10.4161/rna.6.5.10080; Trappe S, 2009, J APPL PHYSIOL, V106, P1159, DOI 10.1152/japplphysiol.91578.2008; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Ullrich Oliver, 2008, Cell Commun Signal, V6, P9, DOI 10.1186/1478-811X-6-9; Vincenti S, 2011, RADIAT RES, V175, P535, DOI 10.1667/RR2200.1; Vo NK, 2010, P NATL ACAD SCI USA, V107, P19231, DOI 10.1073/pnas.1013162107; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wang HY, 2009, J THEOR BIOL, V259, P793, DOI 10.1016/j.jtbi.2009.05.007; Wang H, 2007, RNA, V13, P151, DOI 10.1261/rna.234507; Weidhaas JB, 2007, CANCER RES, V67, P11111, DOI 10.1158/0008-5472.CAN-07-2858; Wiemer EAC, 2007, EUR J CANCER, V43, P1529, DOI 10.1016/j.ejca.2007.04.002; Wu S, 2010, ONCOGENE, V29, P2302, DOI 10.1038/onc.2010.34; Xin FX, 2009, BIOINFORMATICS, V25, P430, DOI 10.1093/bioinformatics/btn646; Yatagai F, 2011, RADIAT ENVIRON BIOPH, V50, P125, DOI 10.1007/s00411-010-0348-3; Zhang XN, 2011, MOL CELL, V41, P371, DOI 10.1016/j.molcel.2011.01.020	94	75	79	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2012	7	2							e31293	10.1371/journal.pone.0031293	http://dx.doi.org/10.1371/journal.pone.0031293			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZQ	22347458	gold, Green Published, Green Submitted			2022-12-27	WOS:000302730200017
J	Liu, LS; Papa, EF; Dooner, MS; Machan, JT; Johnson, KW; Goldberg, LR; Quesenberry, PJ; Colvin, GA				Liu, Liansheng; Papa, Elaine F.; Dooner, Mark S.; Machan, Jason T.; Johnson, Kevin W.; Goldberg, Laura R.; Quesenberry, Peter J.; Colvin, Gerald A.			Homing and Long-Term Engraftment of Long- and Short-Term Renewal Hematopoietic Stem Cells	PLOS ONE			English	Article							COMMON LYMPHOID PROGENITORS; CYTOKINE-INDUCED DEFECT; MURINE MARROW-CELLS; GENE-EXPRESSION; BONE-MARROW; INTRAFEMORAL TRANSPLANTATION; LINEAGE COMMITMENT; CYCLE KINETICS; IDENTIFICATION; PHENOTYPE	Long-term hematopoietic stem cells (LT-HSC) and short-term hematopoietic stem cells (ST-HSC) have been characterized as having markedly different in vivo repopulation, but similar in vitro growth in liquid culture. These differences could be due to differences in marrow homing. We evaluated this by comparing results when purified ST-HSC and LT-HSC were administered to irradiated mice by three different routes: intravenous, intraperitoneal, and directly into the femur. Purified stem cells derived from B6. SJL mice were competed with marrow cells from C57BL/6J mice into lethally irradiated C57BL/6J mice. Serial transplants into secondary recipients were also carried out. We found no advantage for ST-HSC engraftment when the cells were administered intraperitoneally or directly into femur. However, to our surprise, we found that the purified ST-HSC were not short-term in nature but rather gave long-term multilineage engraftment out to 387 days, albeit at a lower level than the LT-HSC. The ST-HSC also gave secondary engraftment. These observations challenge current models of the stem cell hierarchy and suggest that stem cells are in a continuum of change.	[Liu, Liansheng; Papa, Elaine F.; Dooner, Mark S.; Johnson, Kevin W.; Goldberg, Laura R.; Quesenberry, Peter J.; Colvin, Gerald A.] Rhode Isl Hosp, Dept Med, Div Hematol Oncol, Providence, RI 02903 USA; [Machan, Jason T.] Rhode Isl Hosp, Dept Biostat, Providence, RI USA; [Machan, Jason T.] Brown Univ, Warren Alpert Med Sch, Dept Orthopaed, Providence, RI 02912 USA; [Machan, Jason T.] Brown Univ, Dept Surg, Warren Alpert Med Sch, Providence, RI 02912 USA	Lifespan Health Rhode Island; Rhode Island Hospital; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Brown University	Liu, LS (corresponding author), Rhode Isl Hosp, Dept Med, Div Hematol Oncol, Providence, RI 02903 USA.	pquesenberry@lifespan.org	Machan, Jason/D-3897-2013	Machan, Jason/0000-0003-2048-4914; Dooner, Mark/0000-0003-0653-6562	National Institutes of Health: NCRR COBRE [P20RR025179]; NIDDK [K08DK064980, R01DK061858]; Herbert W. Savitt Research Fund; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR025179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061858, K08DK064980] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104937] Funding Source: NIH RePORTER	National Institutes of Health: NCRR COBRE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Herbert W. Savitt Research Fund; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health: NCRR COBRE P20RR025179, NIDDK K08DK064980, NIDDK R01DK061858, and Herbert W. Savitt Research Fund. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Arber C, 2003, BLOOD, V102, P421, DOI 10.1182/blood-2002-12-3834; Becker PS, 1999, EXP HEMATOL, V27, P533, DOI 10.1016/S0301-472X(98)00037-X; Berrios VM, 2001, EXP HEMATOL, V29, P1326, DOI 10.1016/S0301-472X(01)00734-2; Bryder D, 2006, AM J PATHOL, V169, P338, DOI 10.2353/ajpath.2006.060312; Cerny J, 2002, J HEMATOTH STEM CELL, V11, P913, DOI 10.1089/152581602321080574; Cheshier SP, 1999, P NATL ACAD SCI USA, V96, P3120, DOI 10.1073/pnas.96.6.3120; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; Colvin GA, 2004, LEUKEMIA, V18, P575, DOI 10.1038/sj.leu.2403268; Colvin GA, 2004, J CELL PHYSIOL, V199, P20, DOI 10.1002/jcp.10436; Colvin GA, 2002, IN VITRO CELL DEV-AN, V38, P343; Colvin GA, 2007, EXP HEMATOL, V35, P96, DOI 10.1016/j.exphem.2006.09.005; Colvin GA, 2010, J CELL PHYSIOL, V222, P57, DOI 10.1002/jcp.21918; D'Hondt L, 2004, J CELL PHYSIOL, V200, P63, DOI 10.1002/jcp.20032; Dooner GJ, 2008, J CELL PHYSIOL, V214, P786, DOI 10.1002/jcp.21273; Forsberg EC, 2006, STEM CELL REV, V2, P23, DOI 10.1007/s12015-006-0005-z; Forsberg EC, 2006, CELL, V126, P415, DOI 10.1016/j.cell.2006.06.037; Forsberg EC, 2005, PLOS GENET, V1, P281, DOI 10.1371/journal.pgen.0010028; Gilner JB, 2007, STEM CELLS, V25, P279, DOI 10.1634/stemcells.2006-0076; Habibian HK, 1998, J EXP MED, V188, P393, DOI 10.1084/jem.188.2.393; HOLM S, 1979, SCAND J STAT, V6, P65; Kent DG, 2009, BLOOD, V113, P6342, DOI 10.1182/blood-2008-12-192054; Kittler ELW, 1997, BLOOD, V90, P865, DOI 10.1182/blood.V90.2.865.865_865_872; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Kondo M, 2001, CURR OPIN GENET DEV, V11, P520, DOI 10.1016/S0959-437X(00)00227-6; Kondo M, 2000, NATURE, V407, P383, DOI 10.1038/35030112; Kushida T, 2001, BLOOD, V97, P3292, DOI 10.1182/blood.V97.10.3292; Lambert JF, 2003, J EXP MED, V197, P1563, DOI 10.1084/jem.20030031; Manz MG, 2002, P NATL ACAD SCI USA, V99, P11872, DOI 10.1073/pnas.172384399; Mazurier F, 2003, NAT MED, V9, P959, DOI 10.1038/nm886; McKenzie JL, 2005, BLOOD, V106, P1259, DOI 10.1182/blood-2005-03-1081; Miyamoto T, 2002, DEV CELL, V3, P137, DOI 10.1016/S1534-5807(02)00201-0; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; Morrison SJ, 1997, DEVELOPMENT, V124, P1929; *NAT RES COUNC, 1996, GUID CAR US LAB AN; NECAS E, 1987, EXP HEMATOL, V15, P759; Pang LZ, 2003, J CELL PHYSIOL, V197, P251, DOI 10.1002/jcp.10357; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; PETERS SO, 1995, EXP HEMATOL, V23, P461; Peters SO, 1996, BLOOD, V87, P30; Quesenberry PJ, 2009, EXP HEMATOL, V37, P775, DOI 10.1016/j.exphem.2009.05.003; Randall TD, 1996, BLOOD, V87, P4057, DOI 10.1182/blood.V87.10.4057.bloodjournal87104057; Reddy GPV, 2002, EXP HEMATOL, V30, P792, DOI 10.1016/S0301-472X(02)00814-7; Reddy GPV, 1997, BLOOD, V90, P2293; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; Wagers AJ, 2006, STEM CELLS, V24, P1087, DOI 10.1634/stemcells.2005-0396; Warren L, 2006, P NATL ACAD SCI USA, V103, P17807, DOI 10.1073/pnas.0608512103; Weksberg DC, 2008, BLOOD, V111, P2444, DOI 10.1182/blood-2007-09-115006	49	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2012	7	2							e31300	10.1371/journal.pone.0031300	http://dx.doi.org/10.1371/journal.pone.0031300			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZQ	22347459	Green Submitted, Green Published, gold			2022-12-27	WOS:000302730200018
J	Chiyo, PI; Moss, CJ; Alberts, SC				Chiyo, Patrick I.; Moss, Cynthia J.; Alberts, Susan C.			The Influence of Life History Milestones and Association Networks on Crop-Raiding Behavior in Male African Elephants	PLOS ONE			English	Article							PREDATION RISK; SOCIAL-ORGANIZATION; REPRODUCTIVE EFFORT; PATERNITY SUCCESS; NATIONAL-PARK; INFORMATION; ANIMALS; AGE; CONFLICT; PATTERNS	Factors that influence learning and the spread of behavior in wild animal populations are important for understanding species responses to changing environments and for species conservation. In populations of wildlife species that come into conflict with humans by raiding cultivated crops, simple models of exposure of individual animals to crops do not entirely explain the prevalence of crop raiding behavior. We investigated the influence of life history milestones using age and association patterns on the probability of being a crop raider among wild free ranging male African elephants; we focused on males because female elephants are not known to raid crops in our study population. We examined several features of an elephant association network; network density, community structure and association based on age similarity since they are known to influence the spread of behaviors in a population. We found that older males were more likely to be raiders than younger males, that males were more likely to be raiders when their closest associates were also raiders, and that males were more likely to be raiders when their second closest associates were raiders older than them. The male association network had sparse associations, a tendency for individuals similar in age and raiding status to associate, and a strong community structure. However, raiders were randomly distributed between communities. These features of the elephant association network may limit the spread of raiding behavior and likely determine the prevalence of raiding behavior in elephant populations. Our results suggest that social learning has a major influence on the acquisition of raiding behavior in younger males whereas life history factors are important drivers of raiding behavior in older males. Further, both life-history and network patterns may influence the acquisition and spread of complex behaviors in animal populations and provide insight on managing human-wildlife conflict.	[Chiyo, Patrick I.; Alberts, Susan C.] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Chiyo, Patrick I.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Moss, Cynthia J.] Amboseli Trust Elephants, Nairobi, Kenya	Duke University; University of Notre Dame	Chiyo, PI (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	pchiyo@nd.edu			U.S. Fish and Wildlife Service [AFE-0314/6-G085]; National Science Foundation [IBN0091612]; Amboseli Trust for Elephants	U.S. Fish and Wildlife Service(US Fish & Wildlife Service); National Science Foundation(National Science Foundation (NSF)); Amboseli Trust for Elephants	Funding for this research was provided by the U.S. Fish and Wildlife Service grant number AFE-0314/6-G085, the National Science Foundation (IBN0091612) to SA, and the Amboseli Trust for Elephants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A, 2002, CATEGORICAL DATA ANA, P710, DOI [10.1002/0471249688, DOI 10.1002/0471249688]; Ahlering MA, 2011, ANIM CONSERV, V14, P124, DOI 10.1111/j.1469-1795.2010.00400.x; Barnes RFW, 2007, AFR J ECOL, V45, P112, DOI 10.1111/j.1365-2028.2006.00689.x; Bhima R., 1998, PACHYDERM, V24, P74; Borgatti S.P., 2002, NETDRAW GRAPH VISUAL; Breck SW, 2008, J MAMMAL, V89, P428, DOI 10.1644/07-MAMM-A-028R2.1; Candolin U, 1998, P ROY SOC B-BIOL SCI, V265, P1171, DOI 10.1098/rspb.1998.0415; Centola D, 2007, PHYSICA A, V374, P449, DOI 10.1016/j.physa.2006.06.018; Centola D, 2010, SCIENCE, V329, P1194, DOI 10.1126/science.1185231; Chiyo PI, 2011, ANIM BEHAV, V81, P1093, DOI 10.1016/j.anbehav.2011.02.013; Chiyo PI, 2011, J APPL ECOL, V48, P788, DOI 10.1111/j.1365-2664.2011.01967.x; Chiyo PI, 2011, BEHAV ECOL, V22, P552, DOI 10.1093/beheco/arr016; Croze Harvey, 2011, P11; Croze Harvey, 2011, P89; Dall SRX, 2005, TRENDS ECOL EVOL, V20, P187, DOI 10.1016/j.tree.2005.01.010; Douglas-Hamilton Iain, 1998, Pachyderm, V25, P81; Duffy GA, 2009, ANIM BEHAV, V78, P371, DOI 10.1016/j.anbehav.2009.05.015; DUGATKIN LA, 1993, BEHAV ECOL, V4, P289, DOI 10.1093/beheco/4.4.289; Ekanayaka Sampath K.K., 2011, Gajah, V34, P20; Galef BG, 2005, BIOSCIENCE, V55, P489, DOI 10.1641/0006-3568(2005)055[0489:SLIAES]2.0.CO;2; Galimberti F, 2007, BEHAV ECOL SOCIOBIOL, V62, P159, DOI 10.1007/s00265-007-0450-y; Golub B, 2010, PHYS SOC; Grignolio S, 2007, J MAMMAL, V88, P1488, DOI 10.1644/06-MAMM-A-351R.1; Hilbe JM, 2009, CH CRC TEXT STAT SCI, P1; Hoare DJ, 2003, FISH FISH, V4, P269, DOI 10.1046/j.1467-2979.2003.00130.x; Hoare RE, 1999, J APPL ECOL, V36, P689, DOI 10.1046/j.1365-2664.1999.00437.x; Hockings KJ, 2007, THESIS U STIRLING SC; Hollister-Smith JA, 2007, ANIM BEHAV, V74, P287, DOI 10.1016/j.anbehav.2006.12.008; Holzhaider JC, 2010, LEARN BEHAV, V38, P206, DOI 10.3758/LB.38.3.206; Hood G.M., 2010, POPTOOLS VERSION 3 2; Jackson TR, 2008, ORYX, V42, P83, DOI 10.1017/S0030605308001117; Laland KN, 2004, LEARN BEHAV, V32, P4; Lee Phyllis C., 2011, P260; Liebhold A.M., 1998, P111; Mazur R, 2008, ANIM BEHAV, V75, P1503, DOI 10.1016/j.anbehav.2007.10.027; Moss CJ, 2001, J ZOOL, V255, P145, DOI 10.1017/S0952836901001212; Moss Cynthia, 1996, P58; Mpanduji DG, 2004, ENDANGERED ELEPHANTS, P82; Mysterud A, 2004, J ZOOL, V264, P209, DOI 10.1017/S0952836904005618; Obanda V, 2008, PACHYDERM, P54; Osborn FV, 2002, J WILDLIFE MANAGE, V66, P674, DOI 10.2307/3803133; POOLE JH, 1989, ANIM BEHAV, V37, P842, DOI 10.1016/0003-3472(89)90068-7; POOLE JH, 1981, NATURE, V292, P830, DOI 10.1038/292830a0; Rasmussen HB, 2008, BEHAV ECOL, V19, P9, DOI 10.1093/beheco/arm093; Robins G, 2009, SOC NETWORKS, V31, P105, DOI 10.1016/j.socnet.2008.10.006; Rode KD, 2006, J TROP ECOL, V22, P441, DOI 10.1017/S0266467406003233; Sargeant BL, 2009, ANIM BEHAV, V78, P715, DOI 10.1016/j.anbehav.2009.05.037; Slagsvold T, 2011, PHILOS T R SOC B, V366, P969, DOI 10.1098/rstb.2010.0343; Snijders TAB., 2002, J SOCIAL STRUCTURE, V3(2), P1, DOI DOI 10.1016/j.socnet.2006.08.001; Snijders TAB, 2006, SOCIOL METHODOL, V36, P99, DOI 10.1111/j.1467-9531.2006.00176.x; STRUM SC, 1994, REV ECOL-TERRE VIE, V49, P295; SUKUMAR R, 1995, NAT HIST, V104, P52; SUKUMAR R, 1988, ANIM BEHAV, V36, P1233, DOI 10.1016/S0003-3472(88)80084-8; SUKUMAR R, 1990, J TROP ECOL, V6, P33, DOI 10.1017/S0266467400004004; Sukumar R., 2003, LIVING ELEPHANTS EVO, P478; Thornton A, 2009, ANIM BEHAV, V78, P255, DOI 10.1016/j.anbehav.2009.04.021; Thouless CR, 1996, AFR J ECOL, V34, P284, DOI 10.1111/j.1365-2028.1996.tb00623.x; van Bergen Y, 2004, P ROY SOC B-BIOL SCI, V271, P957, DOI 10.1098/rspb.2004.2684; Wang P, 2006, PNET PROGRAM SIMULAT, P43; Ward AJW, 2008, P NATL ACAD SCI USA, V105, P6948, DOI 10.1073/pnas.0710344105; Webster MM, 2008, P ROY SOC B-BIOL SCI, V275, P2869, DOI 10.1098/rspb.2008.0817; Whitehead H, 2010, LEARN BEHAV, V38, P329, DOI 10.3758/LB.38.3.329; Williams AC, 2001, WILDLIFE SOC B, V29, P1097; Woodroffe R, 2005, CONSERV BIOL SER, V9, P388	64	53	55	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31382	10.1371/journal.pone.0031382	http://dx.doi.org/10.1371/journal.pone.0031382			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347468	Green Published, Green Submitted, gold			2022-12-27	WOS:000302730100064
J	Alvarez-Jaimes, L; Sutton, SW; Nepomuceno, D; Motley, ST; Cik, M; Stocking, E; Shoblock, J; Bonaventure, P				Alvarez-Jaimes, Lily; Sutton, Steven W.; Nepomuceno, Diane; Motley, S. Timothy; Cik, Miroslav; Stocking, Emily; Shoblock, James; Bonaventure, Pascal			In Vitro Pharmacological Characterization of RXFP3 Allosterism: An Example of Probe Dependency	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; MOUSE-BRAIN; NUCLEUS INCERTUS; CHIMERIC PEPTIDE; RELAXIN-3; GPCR142; IDENTIFICATION; MODULATION; FAMILY; LIGAND	Recent findings suggest that the relaxin-3 neural network may represent a new ascending arousal pathway able to modulate a range of neural circuits including those affecting circadian rhythm and sleep/wake states, spatial and emotional memory, motivation and reward, the response to stress, and feeding and metabolism. Therefore, the relaxin-3 receptor (RXFP3) is a potential therapeutic target for the treatment of various CNS diseases. Here we describe a novel selective RXFP3 receptor positive allosteric modulator (PAM), 3-[3,5-Bis(trifluoromethyl) phenyl]-1-(3,4-dichlorobenzyl)-1-[2-(5-methoxy-1H-indol-3-yl)ethyl] urea (135PAM1). Calcium mobilization and cAMP accumulation assays in cell lines expressing the cloned human RXFP3 receptor show the compound does not directly activate RXFP3 receptor but increases functional responses to amidated relaxin-3 or R3/I5, a chimera of the INSL5 A chain and the Relaxin-3 B chain. 135PAM1 increases calcium mobilization in the presence of relaxin-3(NH2) and R3/I5(NH2) with pEC50 values of 6.54 (6.46 to 6.64) and 6.07 (5.94 to 6.20), respectively. In the cAMP accumulation assay, 135PAM1 inhibits the CRE response to forskolin with a pIC50 of 6.12 (5.98 to 6.27) in the presence of a probe (10 nM) concentration of relaxin-3(NH2). 135PAM1 does not compete for binding with the orthosteric radioligand, [I-125] R3I5 (amide), in membranes prepared from cells expressing the cloned human RXFP3 receptor. 135PAM1 is selective for RXFP3 over RXFP4, which also responds to relaxin-3. However, when using the free acid (native) form of relaxin-3 or R3/I5, 135PAM1 doesn't activate RXFP3 indicating that the compound's effect is probe dependent. Thus one can exchange the entire A-chain of the probe peptide while retaining PAM activity, but the state of the probe's c-terminus is crucial to allosteric activity of the PAM. These data demonstrate the existence of an allosteric site for modulation of this GPCR as well as the subtlety of changes in probe molecules that can affect allosteric modulation of RXFP3.	[Alvarez-Jaimes, Lily; Sutton, Steven W.; Nepomuceno, Diane; Motley, S. Timothy; Cik, Miroslav; Stocking, Emily; Shoblock, James; Bonaventure, Pascal] Janssen Pharmaceut Companies Johnson & Johnson, San Diego, CA USA	Johnson & Johnson; Janssen Pharmaceuticals	Alvarez-Jaimes, L (corresponding author), Janssen Pharmaceut Companies Johnson & Johnson, San Diego, CA USA.	ssutton@its.jnj.com	Bonaventure, Pascal/K-3052-2015; Shoblock, James/J-7926-2015	Bonaventure, Pascal/0000-0003-2971-6152; Shoblock, James/0000-0002-7956-9560	Johnson AMP; Johnson Pharmaceutical Research and Development	Johnson AMP; Johnson Pharmaceutical Research and Development	The authors have read the journal's policy and have the following conflicts: Johnson & Johnson Pharmaceutical Research and Development funded this study. Authors are employees of Johnson & Johnson Pharmaceutical Research & Development, LLC or were employees of that firm at the time the research was performed. Studies described here were performed with materials described in Patents/Applications US 7893197 and US 2005074814. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Banerjee A, 2010, NEUROPHARMACOLOGY, V58, P145, DOI 10.1016/j.neuropharm.2009.06.019; Bathgate RA, 2006, PHARMACOL REV, V58, P7, DOI 10.1124/pr.58.1.9; Bathgate RAD, 2002, J BIOL CHEM, V277, P1148, DOI 10.1074/jbc.M107882200; Boels K, 2004, DEV BRAIN RES, V152, P265, DOI 10.1016/j.devbrainres.2004.06.002; Burford NT, 2011, BIOCHEM PHARMACOL, V81, P691, DOI 10.1016/j.bcp.2010.12.012; Chen JC, 2005, J PHARMACOL EXP THER, V312, P83, DOI 10.1124/jpet.104.073486; Christopoulos A, 2002, PHARMACOL REV, V54, P323, DOI 10.1124/pr.54.2.323; CONKLIN BR, 1993, NATURE, V363, P274, DOI 10.1038/363274a0; Conn PJ, 2009, NAT REV DRUG DISCOV, V8, P41, DOI 10.1038/nrd2760; Dschietzig T, 2009, J CARD FAIL, V15, P182, DOI 10.1016/j.cardfail.2009.01.008; Hida T, 2006, J RECEPT SIG TRANSD, V26, P147, DOI 10.1080/10799890600623373; Hokfelt T, 2003, LANCET NEUROL, V2, P463, DOI 10.1016/S1474-4422(03)00482-4; Holst B, 2005, MOL ENDOCRINOL, V19, P2400, DOI 10.1210/me.2005-0059; Hsu SY, 2002, SCIENCE, V295, P671, DOI 10.1126/science.1065654; Impey S, 1999, NEURON, V23, P11, DOI 10.1016/S0896-6273(00)80747-3; Kenakin T, J RECEPT SIGNAL TRAN, V30, P313; Kenakin T, 2007, CURR NEUROPHARMACOL, V5, P149, DOI 10.2174/157015907781695973; Keov P, 2011, NEUROPHARMACOLOGY, V60, P24, DOI 10.1016/j.neuropharm.2010.07.010; Knudsen LB, 2007, P NATL ACAD SCI USA, V104, P937, DOI 10.1073/pnas.0605701104; Kuei C, 2007, J BIOL CHEM, V282, P25425, DOI 10.1074/jbc.M701416200; Leach K, 2011, CURRENT PROTOCOLS PH, p[1, 22, 21, 2241]; Leach K, 2011, MOL PHARMACOL, V79, P855, DOI 10.1124/mol.111.070938; Liu CL, 2005, J BIOL CHEM, V280, P292, DOI 10.1074/jbc.M409916200; Liu CL, 2005, MOL PHARMACOL, V67, P231, DOI 10.1124/mol.104.006700; Liu CL, 2003, J BIOL CHEM, V278, P50765, DOI 10.1074/jbc.M308996200; Liu CL, 2003, J BIOL CHEM, V278, P50754, DOI 10.1074/jbc.M308995200; Ma S, 2010, RELAXIN 3 RECEPTOR A, pP809824; Ma S, 2009, J COMP NEUROL, V517, P856, DOI 10.1002/cne.22197; Ma S, 2009, LEARN MEMORY, V16, P730, DOI 10.1101/lm.1438109; Matsumoto M, 2000, GENE, V248, P183, DOI 10.1016/S0378-1119(00)00123-2; May LT, 2007, ANNU REV PHARMACOL, V47, P1, DOI 10.1146/annurev.pharmtox.47.120505.105159; McGowan BMC, 2009, ANN NY ACAD SCI, V1160, P250, DOI 10.1111/j.1749-6632.2008.03796.x; RIVIER J, 1984, SCIENCE, V224, P889, DOI 10.1126/science.6326264; Rosengren KJ, 2006, J BIOL CHEM, V281, P5845, DOI 10.1074/jbc.M511210200; Royce SG, 2009, ENDOCRINOLOGY, V150, P2692, DOI 10.1210/en.2008-1457; Sherwood OD, 2004, ENDOCR REV, V25, P205, DOI 10.1210/er.2003-0013; Shimizu N, 2000, GENE, V259, P199, DOI 10.1016/S0378-1119(00)00432-7; Smith CM, 2011, J CHEM NEUROANAT, V42, P262, DOI 10.1016/j.jchemneu.2011.05.013; Smith CM, 2010, J COMP NEUROL, V518, P4016, DOI 10.1002/cne.22442; Suratman S, 2011, BRIT J PHARMACOL, V162, P1659, DOI 10.1111/j.1476-5381.2010.01184.x; Sutton SW, 2005, NEUROENDOCRINOLOGY, V82, P139, DOI 10.1159/000091267; Sutton SW, 2004, NEUROENDOCRINOLOGY, V80, P298, DOI 10.1159/000083656; Vale W, 1986, ASSAY GROWTH HORMONE, P389; van der Westhuizen ET, 2008, DRUG DISCOV TODAY, V13, P640, DOI 10.1016/j.drudis.2008.04.002; van der Westhuizen ET, 2007, MOL PHARMACOL, V71, P1618, DOI 10.1124/mol.106.032763; Van Der Westhuizen ET, 2005, ANN NY ACAD SCI, V1041, P332, DOI 10.1196/annals.1282.053; Wade JD, 2009, ANN NY ACAD SCI, V1160, P11, DOI 10.1111/j.1749-6632.2009.03951.x; Watson C, 2005, MOL PHARMACOL, V67, P1268, DOI 10.1124/mol.104.008565; Wootten D, 2011, J PHARMACOL EXP THER, V336, P540, DOI 10.1124/jpet.110.176362	49	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2012	7	2							e30792	10.1371/journal.pone.0030792	http://dx.doi.org/10.1371/journal.pone.0030792			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917MF	22347403	Green Published, gold			2022-12-27	WOS:000302180600015
J	Baker, ES; Luckner, SR; Krause, KL; Lambden, PR; Clarke, IN; Ward, VK				Baker, Estelle S.; Luckner, Sylvia R.; Krause, Kurt L.; Lambden, Paul R.; Clarke, Ian N.; Ward, Vernon K.			Inherent Structural Disorder and Dimerisation of Murine Norovirus NS1-2 Protein	PLOS ONE			English	Article							INTRINSICALLY UNSTRUCTURED PROTEINS; CIRCULAR-DICHROISM SPECTROSCOPY; NATIVELY UNFOLDED PROTEINS; NORWALK-LIKE VIRUS; SECONDARY STRUCTURE; NONSTRUCTURAL POLYPROTEIN; MOLECULAR RECOGNITION; FUNCTIONAL ANTHOLOGY; REPLICATION COMPLEX; GEL-FILTRATION	Human noroviruses are highly infectious viruses that cause the majority of acute, non-bacterial epidemic gastroenteritis cases worldwide. The first open reading frame of the norovirus RNA genome encodes for a polyprotein that is cleaved by the viral protease into six non-structural proteins. The first non-structural protein, NS1-2, lacks any significant sequence similarity to other viral or cellular proteins and limited information is available about the function and biophysical characteristics of this protein. Bioinformatic analyses identified an inherently disordered region (residues 1-142) in the highly divergent N-terminal region of the norovirus NS1-2 protein. Expression and purification of the NS1-2 protein of Murine norovirus confirmed these predictions by identifying several features typical of an inherently disordered protein. These were a biased amino acid composition with enrichment in the disorder promoting residues serine and proline, a lack of predicted secondary structure, a hydrophilic nature, an aberrant electrophoretic migration, an increased Stokes radius similar to that predicted for a protein from the pre-molten globule family, a high sensitivity to thermolysin proteolysis and a circular dichroism spectrum typical of an inherently disordered protein. The purification of the NS1-2 protein also identified the presence of an NS1-2 dimer in Escherichia coli and transfected HEK293T cells. Inherent disorder provides significant advantages including structural flexibility and the ability to bind to numerous targets allowing a single protein to have multiple functions. These advantages combined with the potential functional advantages of multimerisation suggest a multi-functional role for the NS1-2 protein.	[Baker, Estelle S.; Ward, Vernon K.] Univ Otago, Dept Microbiol & Immunol, Dunedin, New Zealand; [Luckner, Sylvia R.; Krause, Kurt L.] Univ Otago, Sch Med Sci, Dept Biochem, Dunedin, New Zealand; [Lambden, Paul R.; Clarke, Ian N.] Univ Southampton, Sch Med, Southampton, Hants, England	University of Otago; University of Otago; University of Southampton	Baker, ES (corresponding author), Univ Otago, Dept Microbiol & Immunol, Dunedin, New Zealand.	vernon.ward@otago.ac.nz	Krause, Kurt/N-4886-2014	Krause, Kurt/0000-0002-3525-1112; Ward, Vernon/0000-0001-8692-5116; Clarke, Ian/0000-0002-4938-1620	New Zealand Lottery Grants Board [10/135]; Health Research Council of New Zealand [10/050]; Wellcome Trust UK; University of Otago, New Zealand	New Zealand Lottery Grants Board; Health Research Council of New Zealand(Health Research Council of New Zealand); Wellcome Trust UK(Wellcome Trust); University of Otago, New Zealand	This research was supported by the New Zealand Lottery Grants Board (Grant 10/135), the Health Research Council of New Zealand (Grant 10/050), the Wellcome Trust UK, and the University of Otago, New Zealand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atmar RL, 2001, CLIN MICROBIOL REV, V14, P15, DOI 10.1128/CMR.14.1.15-37.2001; Bailey D, 2010, J GEN VIROL, V91, P739, DOI 10.1099/vir.0.016279-0; Belliot G, 2003, J VIROL, V77, P10957, DOI 10.1128/JVI.77.20.10957-10974.2003; Brown CJ, 2002, J MOL EVOL, V55, P104, DOI 10.1007/s00239-001-2309-6; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Campen A, 2008, PROTEIN PEPTIDE LETT, V15, P956, DOI 10.2174/092986608785849164; Chen JW, 2006, J PROTEOME RES, V5, P879, DOI 10.1021/pr060048x; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Drake JW, 1998, GENETICS, V148, P1667; Dunker AK, 2008, CURR OPIN STRUC BIOL, V18, P756, DOI 10.1016/j.sbi.2008.10.002; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; Dunker AK, 2001, NAT BIOTECHNOL, V19, P805, DOI 10.1038/nbt0901-805; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Erickson HP, 2009, BIOL PROCED ONLINE, V11, P32, DOI 10.1007/s12575-009-9008-x; Ettayebi K, 2003, J VIROL, V77, P11790, DOI 10.1128/JVI.77.21.11790-11797.2003; Fankhauser RL, 2002, J INFECT DIS, V186, P1, DOI 10.1086/341085; Fauquet CM, 2005, VIR TAX 8 INT COMM T, P725; Fernandez-Vega V, 2004, J VIROL, V78, P4827, DOI 10.1128/JVI.78.9.4827-4837.2004; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Glass RI, 2009, NEW ENGL J MED, V361, P1776, DOI 10.1056/NEJMra0804575; Habchi J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011684; He Y., 2006, HEPATITIS C VIRUSES, P267; Hebrard E, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-23; Hogbom M, 2009, J GEN VIROL, V90, P281, DOI 10.1099/vir.0.005629-0; Hughes PJ, 2000, J GEN VIROL, V81, P201, DOI 10.1099/0022-1317-81-1-201; Hyde JL, 2010, VIROLOGY, V406, P138, DOI 10.1016/j.virol.2010.06.047; Hyde JL, 2009, J VIROL, V83, P9709, DOI 10.1128/JVI.00600-09; Jones DT, 2007, BIOINFORMATICS, V23, P538, DOI 10.1093/bioinformatics/btl677; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Karst SM, 2003, SCIENCE, V299, P1575, DOI 10.1126/science.1077905; Kim MJ, 2011, J PEDIATR GASTR NUTR, V52, P314, DOI 10.1097/MPG.0b013e3181ebfa01; Kirkwood CD, 2008, J CLIN VIROL, V43, P346, DOI 10.1016/j.jcv.2008.08.001; Li, 1999, Genome Inform Ser Workshop Genome Inform, V10, P30; Lieutaud P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S25; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Lopman B, 2008, PLOS MED, V5, P187, DOI 10.1371/journal.pmed.0050042; Meszaros B, 2007, J MOL BIOL, V372, P549, DOI 10.1016/j.jmb.2007.07.004; Meszaros B, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/3/035003; Meszaros B, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000376; Ming Tan, 2007, Expert Reviews in Molecular Medicine, V9, P1, DOI 10.1017/S1462399407000348; Mittag T, 2010, J MOL RECOGNIT, V23, P105, DOI 10.1002/jmr.961; NETTLES RE, 2011, HEPATOLOGY; Nugent T, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-159; Patel MM, 2008, EMERG INFECT DIS, V14, P1224, DOI 10.3201/eid1408.071114; Pfister T, 2001, J VIROL, V75, P1611, DOI 10.1128/JVI.75.4.1611-1619.2001; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Radivojac P, 2007, BIOPHYS J, V92, P1439, DOI 10.1529/biophysj.106.094045; Receveur-Brechot V, 2006, PROTEINS, V62, P24, DOI 10.1002/prot.20750; Romero, 1997, Genome Inform Ser Workshop Genome Inform, V8, P110; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Sharp TM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013130; Shevchenko A, 1996, P NATL ACAD SCI USA, V93, P14440, DOI 10.1073/pnas.93.25.14440; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; Sosnovtsev SV, 2006, J VIROL, V80, P7816, DOI 10.1128/JVI.00532-06; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Sreerama N, 1999, PROTEIN SCI, V8, P370; Thackray LB, 2007, J VIROL, V81, P10460, DOI 10.1128/JVI.00783-07; Tokuriki N, 2009, TRENDS BIOCHEM SCI, V34, P53, DOI 10.1016/j.tibs.2008.10.009; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; Uversky VN, 1999, BIOCHEMISTRY-US, V38, P15009, DOI 10.1021/bi990752+; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x; Uversky VN, 2003, CELL MOL LIFE SCI, V60, P1852, DOI 10.1007/s00018-003-3096-6; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Uversky VN, 2005, J MOL RECOGNIT, V18, P343, DOI 10.1002/jmr.747; Vacic V, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-211; Vacic V, 2007, J PROTEOME RES, V6, P2351, DOI 10.1021/pr0701411; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Wobus CE, 2004, PLOS BIOL, V2, P2076, DOI 10.1371/journal.pbio.0020432; Wobus CE, 2006, J VIROL, V80, P5104, DOI 10.1128/JVI.02346-05; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Xie HB, 2007, J PROTEOME RES, V6, P1917, DOI 10.1021/pr060394e; Xie HB, 2007, J PROTEOME RES, V6, P1882, DOI 10.1021/pr060392u; Zang ZR, 2005, BIOINFORMATICS, V21, P3369; Zheng DP, 2006, VIROLOGY, V346, P312, DOI 10.1016/j.virol.2005.11.015; Zintz Carmelann, 2005, Infection Genetics and Evolution, V5, P281, DOI 10.1016/j.meegid.2004.06.010	80	24	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2012	7	2							e30534	10.1371/journal.pone.0030534	http://dx.doi.org/10.1371/journal.pone.0030534			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917MF	22347381	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000302180600009
J	Ishii, S; Suzuki, S; Norden-Krichmar, TM; Nealson, KH; Sekiguchi, Y; Gorby, YA; Bretschger, O				Ishii, Shun'ichi; Suzuki, Shino; Norden-Krichmar, Trina M.; Nealson, Kenneth H.; Sekiguchi, Yuji; Gorby, Yuri A.; Bretschger, Orianna			Functionally Stable and Phylogenetically Diverse Microbial Enrichments from Microbial Fuel Cells during Wastewater Treatment	PLOS ONE			English	Article							GEOBACTER-SULFURREDUCENS; ELECTRICITY-GENERATION; BACTERIAL COMMUNITIES; DISSIMILATORY FE(III); ENERGY; PERFORMANCE; REDUCTION; ANODE; POWER	Microbial fuel cells (MFCs) are devices that exploit microorganisms as biocatalysts to recover energy from organic matter in the form of electricity. One of the goals of MFC research is to develop the technology for cost-effective wastewater treatment. However, before practical MFC applications are implemented it is important to gain fundamental knowledge about long-term system performance, reproducibility, and the formation and maintenance of functionally-stable microbial communities. Here we report findings from a MFC operated for over 300 days using only primary clarifier effluent collected from a municipal wastewater treatment plant as the microbial resource and substrate. The system was operated in a repeat-batch mode, where the reactor solution was replaced once every two weeks with new primary effluent that consisted of different microbial and chemical compositions with every batch exchange. The turbidity of the primary clarifier effluent solution notably decreased, and 97% of biological oxygen demand (BOD) was removed after an 8-13 day residence time for each batch cycle. On average, the limiting current density was 1000 mA/m(2), the maximum power density was 13 mW/m(2), and coulombic efficiency was 25%. Interestingly, the electrochemical performance and BOD removal rates were very reproducible throughout MFC operation regardless of the sample variability associated with each wastewater exchange. While MFC performance was very reproducible, the phylogenetic analyses of anode-associated electricity-generating biofilms showed that the microbial populations temporally fluctuated and maintained a high biodiversity throughout the year-long experiment. These results suggest that MFC communities are both self-selecting and self-optimizing, thereby able to develop and maintain functional stability regardless of fluctuations in carbon source(s) and regular introduction of microbial competitors. These results contribute significantly toward the practical application of MFC systems for long-term wastewater treatment as well as demonstrating MFC technology as a useful device to enrich for functionally stable microbial populations.	[Ishii, Shun'ichi; Suzuki, Shino; Norden-Krichmar, Trina M.; Nealson, Kenneth H.; Bretschger, Orianna] J Craig Venter Inst, San Diego, CA USA; [Ishii, Shun'ichi; Sekiguchi, Yuji] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Tsukuba, Ibaraki, Japan; [Nealson, Kenneth H.; Gorby, Yuri A.] Univ So Calif, Los Angeles, CA USA; [Ishii, Shun'ichi] Japan Soc Promot Sci, Chiyoda Ku, Tokyo, Japan	J. Craig Venter Institute; National Institute of Advanced Industrial Science & Technology (AIST); University of Southern California; Japan Society for the Promotion of Science	Ishii, S (corresponding author), J Craig Venter Inst, San Diego, CA USA.	sishii@jcvi.org	Sekiguchi, Yuji/M-3362-2018	Sekiguchi, Yuji/0000-0002-1264-0617; Ishii, Shun'ichi/0000-0002-0203-8569	National Science Foundation-Biotechnology, Biochemical, and Biomass Engineering (NSF-BBBE) [0933145]; NSF Ecosystem Science Cluster [0918983];  [07J06446]	National Science Foundation-Biotechnology, Biochemical, and Biomass Engineering (NSF-BBBE); NSF Ecosystem Science Cluster; 	This work was supported by Grant-in-Aid for JSPS Fellows (Award no. 07J06446; http://www.jsps.go.jp/english/), National Science Foundation-Biotechnology, Biochemical, and Biomass Engineering (NSF-BBBE) (Award no. 0933145; http://www.nsf.gov/funding/pgm_summ.jsp?pims_id=501024) and NSF Ecosystem Science Cluster (Award no. 0918983; http://www.nsf.gov/funding/pgm_summ.jsp?pims_id=503663). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn Y, 2010, BIORESOURCE TECHNOL, V101, P469, DOI 10.1016/j.biortech.2009.07.039; Bond DR, 2002, SCIENCE, V295, P483, DOI 10.1126/science.1066771; Bond DR, 2003, APPL ENVIRON MICROB, V69, P1548, DOI 10.1128/AEM.69.3.1548-1555.2003; Chae KJ, 2009, BIORESOURCE TECHNOL, V100, P3518, DOI 10.1016/j.biortech.2009.02.065; Cheng S, 2006, ENVIRON SCI TECHNOL, V40, P2426, DOI 10.1021/es051652w; Cheng S, 2006, ELECTROCHEM COMMUN, V8, P489, DOI 10.1016/j.elecom.2006.01.010; Colwell RK, 2009, ESTIMATES STAT ESTIM; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; Di Lorenzo M, 2009, ENERG FUEL, V23, P5707, DOI 10.1021/ef9005934; Gorby YA, 2006, P NATL ACAD SCI USA, V103, P11358, DOI 10.1073/pnas.0604517103; Holmes DE, 2004, APPL ENVIRON MICROB, V70, P1234, DOI 10.1128/AEM.70.2.1234-1237.2004; Holmes DE, 2004, MICROB ECOL, V48, P178, DOI 10.1007/s00248-003-0004-4; Huang LP, 2008, APPL MICROBIOL BIOT, V80, P349, DOI 10.1007/s00253-008-1546-7; Ishii S, 2008, APPL ENVIRON MICROB, V74, P7348, DOI 10.1128/AEM.01639-08; Ishii S, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-6; Jung S, 2007, APPL MICROBIOL BIOT, V77, P393, DOI 10.1007/s00253-007-1162-y; KARLIN S, 1990, P NATL ACAD SCI USA, V87, P2264, DOI 10.1073/pnas.87.6.2264; Karlsson FH, 2011, MICROB ECOL, V61, P473, DOI 10.1007/s00248-010-9796-1; Kiely PD, 2011, BIORESOURCE TECHNOL, V102, P388, DOI 10.1016/j.biortech.2010.05.019; Liu H, 2004, ENVIRON SCI TECHNOL, V38, P2281, DOI 10.1021/es034923g; Liu H, 2004, ENVIRON SCI TECHNOL, V38, P4040, DOI 10.1021/es0499344; Logan B. E., 2008, POWER GENERATION MIC, P44; Logan BE, 2006, ENVIRON SCI TECHNOL, V40, P5181, DOI 10.1021/es0605016; LOVLEY DR, 1991, MICROBIOL REV, V55, P259, DOI 10.1128/MMBR.55.2.259-287.1991; LOVLEY DR, 1993, ARCH MICROBIOL, V159, P336, DOI 10.1007/BF00290916; Meyer S, 2009, 970330 SDRWQCB; Pant D, 2010, BIORESOURCE TECHNOL, V101, P1533, DOI 10.1016/j.biortech.2009.10.017; Rabaey K, 2005, TRENDS BIOTECHNOL, V23, P291, DOI 10.1016/j.tibtech.2005.04.008; Reimers CE, 2006, GEOBIOLOGY, V4, P123, DOI 10.1111/j.1472-4669.2006.00071.x; Rismani-Yazdi H, 2008, J POWER SOURCES, V180, P683, DOI 10.1016/j.jpowsour.2008.02.074; RODEN EE, 1993, APPL ENVIRON MICROB, V59, P734, DOI 10.1128/AEM.59.3.734-742.1993; Rozendal RA, 2008, TRENDS BIOTECHNOL, V26, P450, DOI 10.1016/j.tibtech.2008.04.008; Rulkens W, 2008, ENERG FUEL, V22, P9, DOI 10.1021/ef700267m; Shimoyama T, 2009, MICROBES ENVIRON, V24, P188, DOI 10.1264/jsme2.ME09108; Tender LM, 2002, NAT BIOTECHNOL, V20, P821, DOI 10.1038/nbt716; Tsujimura S, 2001, PHYS CHEM CHEM PHYS, V3, P1331, DOI 10.1039/b009539g; Watanabe K, 2001, J MICROBIOL METH, V44, P253, DOI 10.1016/S0167-7012(01)00220-2; WIN, 2000, CLEAN SAF WAT 21 CEN; Xing DF, 2009, BIOSENS BIOELECTRON, V25, P105, DOI 10.1016/j.bios.2009.06.013	39	67	69	2	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2012	7	2							e30495	10.1371/journal.pone.0030495	http://dx.doi.org/10.1371/journal.pone.0030495			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917MF	22347379	gold, Green Submitted, Green Published			2022-12-27	WOS:000302180600008
J	Tymofiyeva, O; Hess, CP; Ziv, E; Tian, N; Bonifacio, SL; McQuillen, PS; Ferriero, DM; Barkovich, AJ; Xu, D				Tymofiyeva, Olga; Hess, Christopher P.; Ziv, Etay; Tian, Nan; Bonifacio, Sonia L.; McQuillen, Patrick S.; Ferriero, Donna M.; Barkovich, A. James; Xu, Duan			Towards the "Baby Connectome": Mapping the Structural Connectivity of the Newborn Brain	PLOS ONE			English	Article							NETWORKS; MRI	Defining the structural and functional connectivity of the human brain (the human "connectome") is a basic challenge in neuroscience. Recently, techniques for noninvasively characterizing structural connectivity networks in the adult brain have been developed using diffusion and high-resolution anatomic MRI. The purpose of this study was to establish a framework for assessing structural connectivity in the newborn brain at any stage of development and to show how network properties can be derived in a clinical cohort of six-month old infants sustaining perinatal hypoxic ischemic encephalopathy (HIE). Two different anatomically unconstrained parcellation schemes were proposed and the resulting network metrics were correlated with neurological outcome at 6 months. Elimination and correction of unreliable data, automated parcellation of the cortical surface, and assembling the large-scale baby connectome allowed an unbiased study of the network properties of the newborn brain using graph theoretic analysis. In the application to infants with HIE, a trend to declining brain network integration and segregation was observed with increasing neuromotor deficit scores.	[Tymofiyeva, Olga; Hess, Christopher P.; Ziv, Etay; Tian, Nan; Barkovich, A. James; Xu, Duan] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA; [Bonifacio, Sonia L.; McQuillen, Patrick S.; Ferriero, Donna M.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Tymofiyeva, O (corresponding author), Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA.	olga.tymofiyeva@ucsf.edu	TIan, nan/GQP-1717-2022; McQuillen, Patrick/AAF-7119-2020; Xu, Duan/GMW-4195-2022; Xu, Duan/B-3197-2013	Xu, Duan/0000-0003-0550-4235; McQuillen, Patrick/0000-0002-8837-364X; Hess, Christopher/0000-0002-5132-5302	NIH [R01EB009756, P50NS035902, R01NS063876]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS035902, R01NS063876] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was partly funded by NIH grants R01EB009756, P50NS035902 and R01NS063876 (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, NEON ENC CER PALS DE; Bang-Jensen J, 2009, SPRINGER MONOGR MATH, P1, DOI 10.1007/978-1-84800-998-1_1; Barkovich AJ, 2006, AM J NEURORADIOL, V27, P533; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Damoiseaux JS, 2009, BRAIN STRUCT FUNCT, V213, P525, DOI 10.1007/s00429-009-0208-6; Doria V, 2010, P NATL ACAD SCI USA, V107, P20015, DOI 10.1073/pnas.1007921107; Dubois J, 2008, CEREB CORTEX, V18, P1444, DOI 10.1093/cercor/bhm180; Fan Y, 2011, NEUROIMAGE, V54, P1862, DOI 10.1016/j.neuroimage.2010.07.025; Fransson P, 2011, CEREB CORTEX, V21, P145, DOI 10.1093/cercor/bhq071; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; Guye M, 2010, MAGN RESON MATER PHY, V23, P409, DOI 10.1007/s10334-010-0205-z; Hagmann P, 2010, P NATL ACAD SCI USA, V107, P19067, DOI 10.1073/pnas.1009073107; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hagmann P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000597; Hagmann P, 2010, J NEUROSCI METH, V194, P34, DOI 10.1016/j.jneumeth.2010.01.014; Hajnal BL, 1999, PEDIATR NEUROL, V21, P788, DOI 10.1016/S0887-8994(99)00101-0; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Iturria-Medina Y, 2008, NEUROIMAGE, V40, P1064, DOI 10.1016/j.neuroimage.2007.10.060; Jones DK, 2004, MAGNET RESON MED, V51, P807, DOI 10.1002/mrm.20033; Jones DK, 2003, MAGN RESON MED, V49, P7, DOI 10.1002/mrm.10331; Kaiser M, 2011, NEUROIMAGE, V57, P892, DOI 10.1016/j.neuroimage.2011.05.025; Leopardi P, 2006, ELECTRON T NUMER ANA, V25, P309; Li YH, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000395; Moldrich RX, 2010, NEUROIMAGE, V51, P1027, DOI 10.1016/j.neuroimage.2010.03.035; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smyser CD, 2011, NEUROIMAGE, V56, P1437, DOI 10.1016/j.neuroimage.2011.02.073; Sorensen AG, 2007, P INT SOC MAG RESON, V15, P3720, DOI [DOI 10.1128/MCB.25.11.4371, DOI 10.1038/SJ.IJ0.0803354]; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Storey P, 2007, MAGN RESON MED, V57, P614, DOI 10.1002/mrm.21132; Trouard TP, 1996, JMRI-J MAGN RESON IM, V6, P925, DOI 10.1002/jmri.1880060614; Vaessen MJ, 2010, NEUROIMAGE, V51, P1106, DOI 10.1016/j.neuroimage.2010.03.011; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Yap PT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024678; Yo TS, 2009, LECT NOTES COMPUT SC, V5761, P886; Zalesky A, 2010, NEUROIMAGE, V53, P1197, DOI 10.1016/j.neuroimage.2010.06.041; Zhang DY, 2010, CEREB CORTEX, V20, P1187, DOI 10.1093/cercor/bhp182	40	61	62	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2012	7	2							e31029	10.1371/journal.pone.0031029	http://dx.doi.org/10.1371/journal.pone.0031029			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917MF	22347423	Green Published, gold			2022-12-27	WOS:000302180600023
J	Xiong, J; Lu, XY; Zhou, ZM; Chang, Y; Yuan, DX; Tian, M; Zhou, ZG; Wang, L; Fu, CJ; Orias, E; Miao, W				Xiong, Jie; Lu, Xingyi; Zhou, Zhemin; Chang, Yue; Yuan, Dongxia; Tian, Miao; Zhou, Zhigang; Wang, Lei; Fu, Chengjie; Orias, Eduardo; Miao, Wei			Transcriptome Analysis of the Model Protozoan, Tetrahymena thermophila, Using Deep RNA Sequencing	PLOS ONE			English	Article							PROGRAMMED DNA ELIMINATION; GENOME-WIDE ANALYSIS; GENE-EXPRESSION; FUNCTIONAL GENOMICS; SPLICE JUNCTIONS; PROTEIN-KINASE; SEQ; YEAST; ANNOTATION; TOOL	Background: The ciliated protozoan Tetrahymena thermophila is a well-studied single-celled eukaryote model organism for cellular and molecular biology. However, the lack of extensive T. thermophila cDNA libraries or a large expressed sequence tag (EST) database limited the quality of the original genome annotation. Methodology/Principal Findings: This RNA-seq study describes the first deep sequencing analysis of the T. thermophila transcriptome during the three major stages of the life cycle: growth, starvation and conjugation. Uniquely mapped reads covered more than 96% of the 24,725 predicted gene models in the somatic genome. More than 1,000 new transcribed regions were identified. The great dynamic range of RNA-seq allowed detection of a nearly six order-of-magnitude range of measurable gene expression orchestrated by this cell. RNA-seq also allowed the first prediction of transcript untranslated regions (UTRs) and an updated (larger) size estimate of the T. thermophila transcriptome: 57 Mb, or about 55% of the somatic genome. Our study identified nearly 1,500 alternative splicing (AS) events distributed over 5.2% of T. thermophila genes. This percentage represents a two order-of-magnitude increase over previous EST-based estimates in Tetrahymena. Evidence of stage-specific regulation of alternative splicing was also obtained. Finally, our study allowed us to completely confirm about 26.8% of the genes originally predicted by the gene finder, to correct coding sequence boundaries and intron-exon junctions for about a third, and to reassign microarray probes and correct earlier microarray data. Conclusions/Significance: RNA-seq data significantly improve the genome annotation and provide a fully comprehensive view of the global transcriptome of T. thermophila. To our knowledge, 5.2% of T. thermophila genes with AS is the highest percentage of genes showing AS reported in a unicellular eukaryote. Tetrahymena thus becomes an excellent unicellular model eukaryote in which to investigate mechanisms of alternative splicing.	[Xiong, Jie; Lu, Xingyi; Chang, Yue; Yuan, Dongxia; Tian, Miao; Fu, Chengjie; Miao, Wei] Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan, Peoples R China; [Zhou, Zhemin; Wang, Lei] Nankai Univ, Tianjin Econ Technol Dev Area, Sch Biol Sci & Biotechnol, Tianjin 300071, Peoples R China; [Orias, Eduardo] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Zhou, Zhigang] Chinese Acad Agr Sci, Feed Res Inst, Beijing 100193, Peoples R China; [Xiong, Jie; Lu, Xingyi; Chang, Yue; Tian, Miao] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Nankai University; University of California System; University of California Santa Barbara; Chinese Academy of Agricultural Sciences; Feed Research Institute, CAAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Xiong, J (corresponding author), Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan, Peoples R China.	miaowei530@yeah.net	Zhou, Zhemin/AAX-5539-2020; Fu, Cheng-Jie/B-3679-2008; Wang, Lei/C-5176-2009	Zhou, Zhemin/0000-0001-9783-0366; Fu, Cheng-Jie/0000-0001-9357-9661; Wang, Lei/0000-0003-4427-0881; Tian, Miao/0000-0001-9086-1872; Xiong, Jie/0000-0001-8923-0424; miao, wei/0000-0003-3440-8322	Chinese Academy of Sciences [KSCX2-EW-G-6-4]; National Natural Science Foundation of China [Y11314-1-501, Y01307-1-501]; National Science Foundation, United States of America [MCB-1025069]	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation, United States of America(National Science Foundation (NSF))	This work was supported by grants from the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-EW-G-6-4), the National Natural Science Foundation of China (Y11314-1-501) to WM, and the National Natural Science Foundation of China (Y01307-1-501) to CF. EO's work was supported by grant MCB-1025069 from the National Science Foundation, United States of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-383; Aronica L, 2008, GENE DEV, V22, P2228, DOI 10.1101/gad.481908; Asai DJ, 2000, METHODS CELL BIOL; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BERGET SM, 1995, J BIOL CHEM, V270, P2411, DOI 10.1074/jbc.270.6.2411; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; BLACKBURN EH, 1978, J MOL BIOL, V120, P33, DOI 10.1016/0022-2836(78)90294-2; Brownell JE, 1996, CELL, V84, P843, DOI 10.1016/S0092-8674(00)81063-6; Bruno VM, 2010, GENOME RES, V20, P1451, DOI 10.1101/gr.109553.110; Chacko E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S3-S11; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Couvillion MT, 2009, GENE DEV, V23, P2016, DOI 10.1101/gad.1821209; Coyne RS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-562; Delcher AL, 2002, NUCLEIC ACIDS RES, V30, P2478, DOI 10.1093/nar/30.11.2478; Eisen JA, 2006, PLOS BIOL, V4, P1620, DOI 10.1371/journal.pbio.0040286; Ellenrieder C, 2001, DNA CELL BIOL, V20, P413, DOI 10.1089/104454901750361479; Enslen H, 1998, J BIOL CHEM, V273, P1741, DOI 10.1074/jbc.273.3.1741; Filichkin SA, 2010, GENOME RES, V20, P45, DOI 10.1101/gr.093302.109; Glockner G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-6; GOROVSKY MA, 1973, J PROTOZOOL, V20, P19, DOI 10.1111/j.1550-7408.1973.tb05995.x; Graveley BR, 2001, TRENDS GENET, V17, P100, DOI 10.1016/S0168-9525(00)02176-4; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Jaillon O, 2008, NATURE, V451, P359, DOI 10.1038/nature06495; Keren H, 2010, NAT REV GENET, V11, P345, DOI 10.1038/nrg2776; KRUGER K, 1982, CELL, V31, P147, DOI 10.1016/0092-8674(82)90414-7; Labadorf A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-114; Lee S, 1999, MOL BIOL CELL, V10, P771, DOI 10.1091/mbc.10.3.771; Loftus BJ, 2005, SCIENCE, V307, P1321, DOI 10.1126/science.1103773; Lu JG, 2010, MOL GENET GENOMICS, V283, P531, DOI 10.1007/s00438-010-0538-3; Luco RF, 2011, CELL, V144, P16, DOI 10.1016/j.cell.2010.11.056; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Marguerat S, 2010, CELL MOL LIFE SCI, V67, P569, DOI 10.1007/s00018-009-0180-6; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Miao W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004429; Mitrovich QM, 2007, GENOME RES, V17, P492, DOI 10.1101/gr.6111907; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; Modrek B, 2003, NAT GENET, V34, P177, DOI 10.1038/ng1159; Modrek B, 2002, NAT GENET, V30, P13, DOI 10.1038/ng0102-13; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Orias E, 2011, RES MICROBIOL, V162, P578, DOI 10.1016/j.resmic.2011.05.001; Ortega S, 2003, NAT GENET, V35, P25, DOI 10.1038/ng1232; Otto TD, 2010, MOL MICROBIOL, V76, P12, DOI 10.1111/j.1365-2958.2009.07026.x; Rajagopalan V, 2009, MOL BIOL CELL, V20, P708, DOI 10.1091/mbc.E08-07-0746; Ramani AK, 2011, GENOME RES, V21, P342, DOI 10.1101/gr.114645.110; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; Shen DY, 2011, CAN J MICROBIOL, V57, P84, DOI [10.1139/W10-103, 10.1139/w10-103]; Sorber K, 2011, NUCLEIC ACIDS RES, V39, P3820, DOI 10.1093/nar/gkq1223; Stamm S, 2005, GENE, V344, P1, DOI 10.1016/j.gene.2004.10.022; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Taverna SD, 2002, CELL, V110, P701, DOI 10.1016/S0092-8674(02)00941-8; Tisserant E, 2011, NEW PHYTOL, V189, P883, DOI 10.1111/j.1469-8137.2010.03597.x; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Turkewitz AP, 2002, TRENDS GENET, V18, P35, DOI 10.1016/S0168-9525(01)02560-4; Wang B, 2010, NUCLEIC ACIDS RES, V38, P5075, DOI 10.1093/nar/gkq256; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wilhelm BT, 2009, METHODS, V48, P249, DOI 10.1016/j.ymeth.2009.03.016; Xing Y, 2006, NAT REV GENET, V7, P499, DOI 10.1038/nrg1896; Xiong J, 2011, SCI CHINA LIFE SCI, V54, P65, DOI 10.1007/s11427-010-4114-1; Xiong LZ, 2003, PLANT CELL, V15, P745, DOI 10.1105/tpc.008714; Zhang GJ, 2010, GENOME RES, V20, P646, DOI 10.1101/gr.100677.109	67	75	84	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2012	7	2							e30630	10.1371/journal.pone.0030630	http://dx.doi.org/10.1371/journal.pone.0030630			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917MF	22347391	Green Published, gold			2022-12-27	WOS:000302180600012
J	Dimitroff, B; Howe, K; Watson, A; Campion, B; Lee, HG; Zhao, N; O'Connor, MB; Neufeld, TP; Selleck, SB				Dimitroff, Brian; Howe, Katie; Watson, Adrienne; Campion, Bridget; Lee, Hyun-Gwan; Zhao, Na; O'Connor, Michael B.; Neufeld, Thomas P.; Selleck, Scott B.			Diet and Energy-Sensing Inputs Affect TorC1-Mediated Axon Misrouting but Not TorC2-Directed Synapse Growth in a Drosophila Model of Tuberous Sclerosis	PLOS ONE			English	Article							CELL-GROWTH; SIGNALING PATHWAY; RAG GTPASES; COMPLEX; MTOR; TOR; SURVIVAL; KINASE; TARGET; RAPTOR	The Target of Rapamycin (TOR) growth regulatory system is influenced by a number of different inputs, including growth factor signaling, nutrient availability, and cellular energy levels. While the effects of TOR on cell and organismal growth have been well characterized, this pathway also has profound effects on neural development and behavior. Hyperactivation of the TOR pathway by mutations in the upstream TOR inhibitors TSC1 (tuberous sclerosis complex 1) or TSC2 promotes benign tumors and neurological and behavioral deficits, a syndrome known as tuberous sclerosis (TS). In Drosophila, neuron-specific overexpression of Rheb, the direct downstream target inhibited by Tsc1/Tsc2, produced significant synapse overgrowth, axon misrouting, and phototaxis deficits. To understand how misregulation of Tor signaling affects neural and behavioral development, we examined the influence of growth factor, nutrient, and energy sensing inputs on these neurodevelopmental phenotypes. Neural expression of Pi3K, a principal mediator of growth factor inputs to Tor, caused synapse overgrowth similar to Rheb, but did not disrupt axon guidance or phototaxis. Dietary restriction rescued Rheb-mediated behavioral and axon guidance deficits, as did overexpression of AMPK, a component of the cellular energy sensing pathway, but neither was able to rescue synapse overgrowth. While axon guidance and behavioral phenotypes were affected by altering the function of a Tor complex 1 (TorC1) component, Raptor, or a TORC1 downstream element (S6k), synapse overgrowth was only suppressed by reducing the function of Tor complex 2 (TorC2) components (Rictor, Sin1). These findings demonstrate that different inputs to Tor signaling have distinct activities in nervous system development, and that Tor provides an important connection between nutrient-energy sensing systems and patterning of the nervous system.	[Dimitroff, Brian; Watson, Adrienne; O'Connor, Michael B.; Neufeld, Thomas P.; Selleck, Scott B.] Univ Minnesota, Dept Genet Cell Biol & Dev, Ctr Dev Biol, Minneapolis, MN 55455 USA; [Howe, Katie; Campion, Bridget; Selleck, Scott B.] Univ Minnesota, Grad Program Neurosci, Minneapolis, MN 55455 USA; [Dimitroff, Brian; Lee, Hyun-Gwan; Zhao, Na; Selleck, Scott B.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Dimitroff, B (corresponding author), Univ Minnesota, Dept Genet Cell Biol & Dev, Ctr Dev Biol, Minneapolis, MN 55455 USA.	sbs24@psu.edu	Watson, Adrienne L/GRO-1978-2022; O'Connor, Michael B/C-9977-2014	Watson, Adrienne L/0000-0002-9752-3689; O'Connor, Michael B/0000-0002-3067-5506; Neufeld, Thomas/0000-0001-5659-4811	Department of Defense Congressionally; Harrison Endowment fund; University of Minnesota Autism Initiative; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062509] Funding Source: NIH RePORTER	Department of Defense Congressionally; Harrison Endowment fund; University of Minnesota Autism Initiative; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was funded by the Department of Defense Congressionally Directed Medical Research Program for Tubersous Sclerosis, the Harrison Endowment fund to SBS, and the University of Minnesota Autism Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avruch J, 2009, AM J PHYSIOL-ENDOC M, V296, pE592, DOI 10.1152/ajpendo.90645.2008; Avruch J, 2009, BIOCHEM SOC T, V37, P223, DOI 10.1042/BST0370223; BENZER S, 1967, P NATL ACAD SCI USA, V58, P1112, DOI 10.1073/pnas.58.3.1112; Binda M, 2009, MOL CELL, V35, P563, DOI 10.1016/j.molcel.2009.06.033; Blair SS, 2000, DROSOPHILA PROTOCOLS, P159; Carvalho GB, 2005, NAT METHODS, V2, P813, DOI 10.1038/NMETH798; Chalhoub N, 2009, GENE DEV, V23, P1619, DOI 10.1101/gad.1799609; Choe KM, 2005, CURR TOP DEV BIOL, V69, P187, DOI 10.1016/S0070-2153(05)69007-2; Choi YJ, 2008, GENE DEV, V22, P2485, DOI 10.1101/gad.1685008; Cummings AM, 2004, CRIT REV TOXICOL, V34, P461, DOI 10.1080/10408440490519786; Curatolo P, 2008, LANCET, V372, P657, DOI 10.1016/S0140-6736(08)61279-9; DiAntonio A, 2001, NATURE, V412, P449, DOI 10.1038/35086595; Fayyazuddin A, 2006, PLOS BIOL, V4, P420, DOI 10.1371/journal.pbio.0040063; Gibbs SM, 2001, J NEUROSCI, V21, P7705, DOI 10.1523/JNEUROSCI.21-19-07705.2001; Hartman AL, 2007, EPILEPSIA, V48, P31, DOI 10.1111/j.1528-1167.2007.00914.x; Inoki K, 2005, NAT GENET, V37, P19, DOI 10.1038/ng1494; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Knox S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000375; Kockel L, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000990; Koike-Kumagai M, 2009, EMBO J, V28, P3879, DOI 10.1038/emboj.2009.312; Kwon CH, 2006, NEURON, V50, P377, DOI 10.1016/j.neuron.2006.03.023; Lee JH, 2007, NATURE, V447, P1017, DOI 10.1038/nature05828; Leevers SJ, 1996, EMBO J, V15, P6584, DOI 10.1002/j.1460-2075.1996.tb01049.x; Li H, 2002, NEUROSCIENCE, V115, P505, DOI 10.1016/S0306-4522(02)00380-9; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Mair W, 2005, PLOS BIOL, V3, P1305, DOI 10.1371/journal.pbio.0030223; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; McGuire SE, 2004, TRENDS GENET, V20, P384, DOI 10.1016/j.tig.2004.06.012; Meikle L, 2008, J NEUROSCI, V28, P5422, DOI 10.1523/JNEUROSCI.0955-08.2008; Meikle L, 2007, J NEUROSCI, V27, P5546, DOI 10.1523/JNEUROSCI.5540-06.2007; Neufeld T P, 2004, Curr Top Microbiol Immunol, V279, P139; Newsome TP, 2000, DEVELOPMENT, V127, P851; PARSONS PA, 1975, BEHAV GENET, V5, P17, DOI 10.1007/BF01067578; Potter CJ, 2001, CELL, V105, P357, DOI 10.1016/S0092-8674(01)00333-6; Richardson CJ, 2004, SEMIN CELL DEV BIOL, V15, P147, DOI 10.1016/j.semcdb.2003.12.023; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Scanga SE, 2000, ONCOGENE, V19, P3971, DOI 10.1038/sj.onc.1203739; Shen W, 2009, J CELL BIOL, V187, P71, DOI 10.1083/jcb.200907109; Spasic MR, 2008, J NEUROSCI, V28, P6419, DOI 10.1523/JNEUROSCI.1646-08.2008; STEWART BA, 1994, J COMP PHYSIOL A, V175, P179, DOI 10.1007/BF00215114; Swiech L, 2008, BBA-PROTEINS PROTEOM, V1784, P116, DOI 10.1016/j.bbapap.2007.08.015; Tapon N, 2001, CELL, V105, P345, DOI 10.1016/S0092-8674(01)00332-4; Tavazoie SF, 2005, NAT NEUROSCI, V8, P1727, DOI 10.1038/nn1566; van Spronsen FJ, 2010, NAT REV ENDOCRINOL, V6, P509, DOI 10.1038/nrendo.2010.125; von der Brelie C, 2006, EUR J NEUROSCI, V23, P686, DOI 10.1111/j.1460-9568.2006.04594.x; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yang Q, 2006, P NATL ACAD SCI USA, V103, P6811, DOI 10.1073/pnas.0602282103; Yang Q, 2007, CELL RES, V17, P666, DOI 10.1038/cr.2007.64; Zhang HB, 2000, GENE DEV, V14, P2712, DOI 10.1101/gad.835000	53	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e30722	10.1371/journal.pone.0030722	http://dx.doi.org/10.1371/journal.pone.0030722			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LO	22319582	gold, Green Submitted, Green Published			2022-12-27	WOS:000302178400013
J	Rawat, A; Elasri, MO; Gust, KA; George, G; Pham, D; Scanlan, LD; Vulpe, C; Perkins, EJ				Rawat, Arun; Elasri, Mohamed O.; Gust, Kurt A.; George, Glover; Don Pham; Scanlan, Leona D.; Vulpe, Chris; Perkins, Edward J.			CAPRG: Sequence Assembling Pipeline for Next Generation Sequencing of Non-Model Organisms	PLOS ONE			English	Article							BURROWS-WHEELER TRANSFORM; SHORT READ ALIGNMENT; NORTHERN BOBWHITE; GENOME; PROGRAM; TOOL; ALGORITHMS; ULTRAFAST; SYSTEM; ESTS	Our goal is to introduce and describe the utility of a new pipeline "Contigs Assembly Pipeline using Reference Genome'' (CAPRG), which has been developed to assemble "long sequence reads'' for non-model organisms by leveraging a reference genome of a closely related phylogenetic relative. To facilitate this effort, we utilized two avian transcriptomic datasets generated using ROCHE/454 technology as test cases for CAPRG assembly. We compared the results of CAPRG assembly using a reference genome with the results of existing methods that utilize de novo strategies such as VELVET, PAVE, and MIRA by employing parameter space comparisons (intra-assembling comparison). CAPRG performed as well or better than the existing assembly methods based on various benchmarks for "gene-hunting.'' Further, CAPRG completed the assemblies in a fraction of the time required by the existing assembly algorithms. Additional advantages of CAPRG included reduced contig inflation resulting in lower computational resources for annotation, and functional identification for contigs that may be categorized as "unknowns'' by de novo methods. In addition to providing evaluation of CAPRG performance, we observed that the different assembly (inter-assembly) results could be integrated to enhance the putative gene coverage for any transcriptomics study.	[Rawat, Arun] Translat Genom Res Inst N, Ctr Pathogen Informat, Flagstaff, AZ USA; [Rawat, Arun; Elasri, Mohamed O.] Univ So Mississippi, Dept Biol Sci, Hattiesburg, MS 39406 USA; [Gust, Kurt A.; Perkins, Edward J.] USA, Environm Lab, EP P, Engn Res & Dev Ctr, Vicksburg, MS USA; [George, Glover] Univ So Mississippi, Sch Comp Sci, Hattiesburg, MS 39406 USA; [Don Pham; Scanlan, Leona D.; Vulpe, Chris] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA	Translational Genomics Research Institute; University of Southern Mississippi; United States Department of Defense; United States Army; U.S. Army Corps of Engineers; U.S. Army Engineer Research & Development Center (ERDC); University of Southern Mississippi; University of California System; University of California Berkeley	Rawat, A (corresponding author), Translat Genom Res Inst N, Ctr Pathogen Informat, Flagstaff, AZ USA.	arun.rawat@eagles.usm.edu; edward.j.perkins@usace.army.mil	Vulpe, Chris/AAF-9170-2020; Rawat, Arun/AAD-1534-2019; Rawat, Arun/Q-2520-2019; Rawat, Arun/ABD-6248-2021	Vulpe, Chris/0000-0001-5134-8929; Rawat, Arun/0000-0003-0540-2044	U.S. Army Environmental Quality/Installations Research [W912HZ-08-C-0032]; Mississippi INBRE [P20RR016476]; National Center for Research Resources; National Institutes of Health; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016476] Funding Source: NIH RePORTER	U.S. Army Environmental Quality/Installations Research; Mississippi INBRE; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The work was funded by grant #W912HZ-08-C-0032 from the U.S. Army Environmental Quality/Installations Research Program and Mississippi INBRE (P20RR016476) funded by the National Center for Research Resources, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barker MS, 2009, BIOINFORMATICS, V25, P535, DOI 10.1093/bioinformatics/btp011; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Darling A., 2003, 4 INT C LIN CLUST HP; Dutilh BE, 2009, BIOINFORMATICS, V25, P2878, DOI 10.1093/bioinformatics/btp377; Green P, 1996, PHRAP DOCUMENTATION; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kumar S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-571; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2010, BRIEF BIOINFORM, V11, P473, DOI 10.1093/bib/bbq015; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Miller JR, 2010, GENOMICS, V95, P315, DOI 10.1016/j.ygeno.2010.03.001; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Papanicolaou A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-447; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Potter SC, 2004, GENOME RES, V14, P934, DOI 10.1101/gr.1859804; Rawat A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S6-S13; Rawat A, 2010, PHYSIOL GENOMICS, V42, P219, DOI 10.1152/physiolgenomics.00022.2010; Schroder J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012681; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Soderlund C, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-400; Warren WC, 2010, NATURE, V464, P757, DOI 10.1038/nature08819; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	30	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e30370	10.1371/journal.pone.0030370	http://dx.doi.org/10.1371/journal.pone.0030370			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LO	22319566	Green Published, Green Submitted, gold			2022-12-27	WOS:000302178400007
J	Sonne, C; Bott-Flugel, L; Hauck, S; Lesevic, H; Barthel, P; Michalk, F; Hoppe, K; Hausleiter, J; Schomig, A; Kolb, C				Sonne, Carolin; Bott-Fluegel, Lorenz; Hauck, Simon; Lesevic, Hasema; Barthel, Petra; Michalk, Fabian; Hoppe, Katharina; Hausleiter, Joerg; Schoemig, Albert; Kolb, Christof			Acute Beneficial Hemodynamic Effects of a Novel 3D-Echocardiographic Optimization Protocol in Cardiac Resynchronization Therapy	PLOS ONE			English	Article							ATRIOVENTRICULAR DELAY OPTIMIZATION; LEFT-VENTRICULAR RESYNCHRONIZATION; HEART-FAILURE; PREDICTS RESPONSE; SYSTOLIC FUNCTION; QRS DURATION; SCAR TISSUE; DYSSYNCHRONY; MORTALITY; ECHO	Background: Post-implantation therapies to optimize cardiac resynchronization therapy (CRT) focus on adjustments of the atrio-ventricular (AV) delay and ventricular-to-ventricular (VV) interval. However, there is little consensus on how to achieve best resynchronization with these parameters. The aim of this study was to examine a novel combination of doppler echocardiography (DE) and three-dimensional echocardiography (3DE) for individualized optimization of device based AV delays and VV intervals compared to empiric programming. Methods: 25 recipients of CRT (male: 56%, mean age: 67 years) were included in this study. Ejection fraction (EF), the primary outcome parameter, and left ventricular (LV) dimensions were evaluated by 3DE before CRT (baseline), after AV delay optimization while pacing the ventricles simultaneously (empiric VV interval programming) and after individualized VV interval optimization. For AV delay optimization aortic velocity time integral (AoVTI) was examined in eight different AV delays, and the AV delay with the highest AoVTI was programmed. For individualized VV interval optimization 3DE full-volume datasets of the left ventricle were obtained and analyzed to derive a systolic dyssynchrony index (SDI), calculated from the dispersion of time to minimal regional volume for all 16 LV segments. Consecutively, SDI was evaluated in six different VV intervals (including LV or right ventricular preactivation), and the VV interval with the lowest SDI was programmed (individualized optimization). Results: EF increased from baseline 23 +/- 7% to 30 +/- 8 (p<0.001) after AV delay optimization and to 32 +/- 8% (p<0.05) after individualized optimization with an associated decrease of end-systolic volume from a baseline of 13 +/- 660 ml to 115 +/- 42 ml (p<0.001). Moreover, individualized optimization significantly reduced SDI from a baseline of 14.3 +/- 5.5% to 6.1 +/- 2.6% (p<0.001). Conclusions: Compared with empiric programming of biventricular pacemakers, individualized echocardiographic optimization with the integration of 3-dimensional indices into the optimization protocol acutely improved LV systolic function and decreased ESV and can be used to select the optimal AV delay and VV interval in CRT.	[Sonne, Carolin; Hauck, Simon; Lesevic, Hasema; Barthel, Petra; Michalk, Fabian; Hoppe, Katharina; Hausleiter, Joerg; Schoemig, Albert; Kolb, Christof] Tech Univ Munich, Fac Med, Klin Herz & Kreislauferkrankungen Erwachsenen, Deutsch Herzzentrum Munchen, Munich, Germany; [Bott-Fluegel, Lorenz] Kreiskrankenhaus Erding Klin Dorfen, Abt Innere Med Kardiol, Erding, Germany	German Heart Centre Munich; Technical University of Munich	Sonne, C (corresponding author), Tech Univ Munich, Fac Med, Klin Herz & Kreislauferkrankungen Erwachsenen, Deutsch Herzzentrum Munchen, Munich, Germany.		Hausleiter, Jörg/V-4206-2019	Bott-Flugel, Lorenz/0000-0003-0932-1241	Deutsches Herzzentrum, TU Munchen, Munich	Deutsches Herzzentrum, TU Munchen, Munich	This study was entirely funded by Deutsches Herzzentrum, TU Munchen, Munich. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham WT, 2002, NEW ENGL J MED, V346, P1845, DOI 10.1056/NEJMoa013168; Auricchio A, 1999, CIRCULATION, V99, P2993, DOI 10.1161/01.CIR.99.23.2993; Barold SS, 2008, EUROPACE, V10, P88, DOI 10.1093/europace/eun220; Bax JJ, 2004, J AM COLL CARDIOL, V44, P1834, DOI 10.1016/j.jacc.2004.08.016; Bhan A, 2008, ECHOCARDIOGR-J CARD, V25, P1031, DOI 10.1111/j.1540-8175.2008.00789.x; Bleeker GB, 2007, CIRCULATION, V116, P1440, DOI 10.1161/CIRCULATIONAHA.106.677005; Bleeker GB, 2007, EUR HEART J, V28, P1182, DOI 10.1093/eurheartj/ehm085; Bleeker GB, 2006, CIRCULATION, V113, P969, DOI 10.1161/CIRCULATIONAHA.105.543678; Boriani G, 2009, PACE, V32, pS120, DOI 10.1111/j.1540-8159.2008.02267.x; Cleland JGF, 2005, NEW ENGL J MED, V352, P1539, DOI 10.1056/NEJMoa050496; Edner M, 2010, CARDIOVASC ULTRASOUN, V8, DOI 10.1186/1476-7120-8-12; European Heart Rhythm Association, 2006, J Am Coll Cardiol, V48, pe247, DOI 10.1016/j.jacc.2006.07.010; Gorcsan J, 2008, J AM SOC ECHOCARDIOG, V21, P191, DOI 10.1016/j.echo.2008.01.003; Gras D, 2009, PACE, V32, pS236, DOI 10.1111/j.1540-8159.2008.02294.x; Hardt SE, 2007, INT J CARDIOL, V115, P318, DOI 10.1016/j.ijcard.2006.03.015; Hummel JP, 2005, HEART RHYTHM, V2, P1211, DOI 10.1016/j.hrthm.2005.07.027; Iuliano S, 2002, AM HEART J, V143, P1085, DOI 10.1067/mhj.2002.122516; Jansen AHM, 2006, AM J CARDIOL, V97, P552, DOI 10.1016/j.amjcard.2005.08.076; Kapetanakis S, 2005, CIRCULATION, V112, P992, DOI 10.1161/CIRCULATIONAHA.104.474445; Kapetanakis S, 2011, JACC-CARDIOVASC IMAG, V4, P16, DOI 10.1016/j.jcmg.2010.09.021; Kashani A, 2005, J AM COLL CARDIOL, V46, P2183, DOI 10.1016/j.jacc.2005.01.071; Kerlan JE, 2006, HEART RHYTHM, V3, P148, DOI 10.1016/j.hrthm.2005.11.006; Leon AR, 2005, J AM COLL CARDIOL, V46, P2298, DOI 10.1016/j.jacc.2005.08.032; Levy D, 2002, NEW ENGL J MED, V347, P1397, DOI 10.1056/NEJMoa020265; Linde C, 2002, J AM COLL CARDIOL, V40, P111, DOI 10.1016/S0735-1097(02)01932-0; Molhoek SG, 2004, PACE, V27, P308, DOI 10.1111/j.1540-8159.2004.00433.x; Morales MA, 2006, PACE, V29, P564, DOI 10.1111/j.1540-8159.2006.00402.x; Parreira Leonor, 2005, Rev Port Cardiol, V24, P1355; Phillips KP, 2007, HEART RHYTHM, V4, P147, DOI 10.1016/j.hrthm.2006.10.018; Rao RK, 2007, CIRCULATION, V115, P2136, DOI 10.1161/CIRCULATIONAHA.106.634444; Reuter S, 2002, AM J CARDIOL, V89, P346, DOI 10.1016/S0002-9149(01)02240-8; Salukhe TV, 2004, INT J CARDIOL, V93, P101, DOI 10.1016/j.ijcard.2003.10.002; Sawhney NS, 2004, HEART RHYTHM, V1, P562, DOI 10.1016/j.hrthm.2004.07.006; Sogaard P, 2002, CIRCULATION, V106, P2078, DOI 10.1161/01.CIR.0000034512.90874.8E; Thomas DE, 2009, EUR J HEART FAIL, V11, P779, DOI 10.1093/eurjhf/hfp086; Valzania C, 2007, ECHOCARDIOGR-J CARD, V24, P933, DOI 10.1111/j.1540-8175.2007.00491.x; van Gelder BM, 2004, AM J CARDIOL, V93, P1500, DOI 10.1016/j.amjcard.2004.02.061; Vidal B, 2007, AM J CARDIOL, V100, P1002, DOI 10.1016/j.amjcard.2007.04.046; Young JB, 2003, JAMA-J AM MED ASSOC, V289, P2685, DOI 10.1001/jama.289.20.2685; Ypenburg C, 2007, EUR HEART J, V28, P33, DOI 10.1093/eurheartj/ehl379; Ypenburg C, 2008, PACE, V31, P1475, DOI 10.1111/j.1540-8159.2008.01212.x	41	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e30964	10.1371/journal.pone.0030964	http://dx.doi.org/10.1371/journal.pone.0030964			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LO	22319598	Green Published, Green Submitted, gold			2022-12-27	WOS:000302178400023
J	Thuny, F; Textoris, J; Ben Amara, A; El Filali, A; Capo, C; Habib, G; Raoult, D; Mege, JL				Thuny, Franck; Textoris, Julien; Ben Amara, Amira; El Filali, Adil; Capo, Christian; Habib, Gilbert; Raoult, Didier; Mege, Jean-Louis			The Gene Expression Analysis of Blood Reveals S100A11 and AQP9 as Potential Biomarkers of Infective Endocarditis	PLOS ONE			English	Article							DIAGNOSIS; ECHOCARDIOGRAPHY; DISEASE	Background: The diagnostic and prognostic assessments of infective endocarditis (IE) are challenging. To investigate the host response during IE and to identify potential biomarkers, we determined the circulating gene expression profile using whole genome microarray analysis. Methods and Results: A transcriptomic case-control study was performed on blood samples from patients with native valve IE (n = 39), excluded IE after an initial suspicion (n = 10) at patient's admission, and age-matched healthy controls (n = 10). Whole genome microarray analysis showed that patients with IE exhibited a specific transcriptional program with a predominance of gene categories associated with cell activation as well as innate immune and inflammatory responses. Quantitative real-time RT-PCR performed on a selection of highly modulated genes showed that the expression of the gene encoding S100 calcium binding protein A11 (S100A11) was significantly increased in patients with IE in comparison with controls (P<0.001) and patients with excluded IE (P<0.05). Interestingly, the upregulated expression of the S100A11 gene was more pronounced in staphylococcal IE than in streptococcal IE (P<0.01). These results were confirmed by serum concentrations of the S100A11 protein. Finally, we showed that in patients with IE, the upregulation of the aquaporin-9 gene (AQP9) was significantly associated with the occurrence of acute heart failure (P = 0.02). Conclusions: Using transcriptional signatures of blood samples, we identified S100A11 as a potential diagnostic marker of IE, and AQP9 as a potential prognostic factor.	[Thuny, Franck; Habib, Gilbert] Aix Marseille Univ, Hop Timone, Dept Cardiol, Marseille, France; [Thuny, Franck; Textoris, Julien; Ben Amara, Amira; El Filali, Adil; Capo, Christian; Habib, Gilbert; Raoult, Didier; Mege, Jean-Louis] Aix Marseille Univ, URMITE, CNRS, Unite Mixte Rech 6236, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD)	Thuny, F (corresponding author), Aix Marseille Univ, Hop Timone, Dept Cardiol, Marseille, France.	jean-louis.mege@univmed.fr	Thuny, Franck/ABC-7157-2020; Thuny, Franck/GSD-2668-2022; Thuny, Franck/ABB-2408-2021; RAOULT, Didier/A-8434-2008	Thuny, Franck/0000-0002-8727-7154; Thuny, Franck/0000-0002-8727-7154; RAOULT, Didier/0000-0002-0633-5974; Textoris, Julien/0000-0002-3821-9337	Federation Francaise de Cardiologie	Federation Francaise de Cardiologie	This work was supported by a grant from the Federation Francaise de Cardiologie, to Dr. Franck Thuny. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agre P, 2003, FEBS LETT, V555, P72, DOI 10.1016/S0014-5793(03)01083-4; Apweiler R, 2000, BIOINFORMATICS, V16, P1145, DOI 10.1093/bioinformatics/16.12.1145; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Badaut J, 2010, NEUROSCIENCE, V168, P1047, DOI 10.1016/j.neuroscience.2009.10.030; Barrett T, 2006, METHOD ENZYMOL, V411, P352, DOI 10.1016/S0076-6879(06)11019-8; Ben Amara A, PLOS ONE, V5; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benoit M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008939; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Creagh-Brown BC, 2010, INTENS CARE MED, V36, P1644, DOI 10.1007/s00134-010-1952-z; Culhane AC, 2005, BIOINFORMATICS, V21, P2789, DOI 10.1093/bioinformatics/bti394; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Duval X, 2010, ANN INTERN MED, V152, P497, DOI 10.7326/0003-4819-152-8-201004200-00006; Evangelista A, 2004, HEART, V90, P614, DOI 10.1136/hrt.2003.029868; Feuchtner GM, 2009, J AM COLL CARDIOL, V53, P436, DOI 10.1016/j.jacc.2008.01.077; Ghavami S, 2008, J LEUKOCYTE BIOL, V83, P1484, DOI 10.1189/jlb.0607397; He HL, 2009, CELL BIOCHEM BIOPHYS, V55, P117, DOI 10.1007/s12013-009-9061-8; Kanehisa M, 2002, NUCLEIC ACIDS RES, V30, P42, DOI 10.1093/nar/30.1.42; King LS, 2004, NAT REV MOL CELL BIO, V5, P687, DOI 10.1038/nrm1469; Li JS, 2000, CLIN INFECT DIS, V30, P633, DOI 10.1086/313753; Liu YW, 2009, SCAND CARDIOVASC J, V43, P318, DOI 10.1080/14017430902737940; Mohr S, 2007, TRENDS MOL MED, V13, P422, DOI 10.1016/j.molmed.2007.08.003; Mueller C, 2004, CIRCULATION, V109, P1707, DOI 10.1161/01.CIR.0000126281.52345.52; Raoult D, 2005, J CLIN MICROBIOL, V43, P5238, DOI 10.1128/JCM.43.10.5238-5242.2005; Seemann J, 1997, FEBS LETT, V413, P185, DOI 10.1016/S0014-5793(97)00911-3; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Thuny F, 2009, EUR HEART J; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Van Riet J, 2010, EUR J NUCL MED MOL I, V37, P1189, DOI 10.1007/s00259-010-1380-x; Widmer Eleonora, 2006, Curr Infect Dis Rep, V8, P271, DOI 10.1007/s11908-006-0071-z	30	36	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e31490	10.1371/journal.pone.0031490	http://dx.doi.org/10.1371/journal.pone.0031490			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LO	22319637	Green Published, gold			2022-12-27	WOS:000302178400045
J	Lopes, G; Sousa, C; Silva, LR; Pinto, E; Andrade, PB; Bernardo, J; Mouga, T; Valentao, P				Lopes, Graciliana; Sousa, Carla; Silva, Luis R.; Pinto, Eugenia; Andrade, Paula B.; Bernardo, Joao; Mouga, Teresa; Valentao, Patricia			Can Phlorotannins Purified Extracts Constitute a Novel Pharmacological Alternative for Microbial Infections with Associated Inflammatory Conditions?	PLOS ONE			English	Article							BROWN ALGAL PHLOROTANNINS; ANTIOXIDANT ACTIVITY; FUCUS-VESICULOSUS; IN-VITRO; POLYPHENOLS; INHIBITION; COMPONENTS; TOXICITY; L.	Bacterial and fungal infections and the emerging multidrug resistance are driving interest in fighting these microorganisms with natural products, which have generally been considered complementary to pharmacological therapies. Phlorotannins are polyphenols restricted to brown seaweeds, recognized for their biological capacity. This study represents the first research on the antibacterial, antifungal, anti-inflammatory and antioxidant activity of phlorotannins purified extracts, which were obtained from ten dominant brown seaweeds of the occidental Portuguese coast. Phlorotannins content was determined by the specific dimethoxybenzaldehyde (DMBA) method and a yield between 75 and 969 mg/Kg phloroglucinol units (dry matter) was obtained. Fucus spiralis ranked first, followed by three Cystoseira species. The anti-inflammatory potential of the purified extracts was assessed via inhibitory effect on nitric oxide (NO) production by lipopolysaccharide-stimulated RAW 264.7 macrophage cells, Cystoseira tamariscifolia being the one showing promising activity for the treatment of inflammation. NO scavenging ability was also addressed in cell free systems, F. spiralis being the species with highest capacity. The antimicrobial potential of the extracts was checked against five Gram-positive and four Gram-negative bacteria and three fungi strains, that commonly colonize skin and mucosa and are responsible for food contamination. The different extracts were more effective against Gram-positive bacteria, Staphylococcus epidermidis being the most susceptible species. Concerning antifungal activity, Trichophyton rubrum was the most sensitive species. Although the molecular mechanisms underlying these properties remain poorly understood, the results obtained turn phlorotannins purified extracts a novel and potent pharmacological alternative for the treatment of a wide range of microbial infections, which usually also present an inflammatory component. In addition to the biological properties demonstrated herein, phlorotannins extracts may also be preferred, in order to avoid side effects and allergic reactions commonly associated with synthetic drugs.	[Lopes, Graciliana; Sousa, Carla; Silva, Luis R.; Andrade, Paula B.; Bernardo, Joao; Valentao, Patricia] Univ Porto, Fac Farm, Dept Quim, REQUIMTE Lab Farmacognosia, P-4100 Oporto, Portugal; [Pinto, Eugenia] Univ Porto, Fac Farm, Dept Ciencias Biol, CEQUIMED Lab Microbiol, P-4100 Oporto, Portugal; [Mouga, Teresa] Polytech Inst Leiria, Sch Tourism & Maritime Technol, GIRM Marine Resources Res Grp, Peniche, Portugal	Universidade do Porto; Universidade do Porto	Lopes, G (corresponding author), Univ Porto, Fac Farm, Dept Quim, REQUIMTE Lab Farmacognosia, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	valentao@ff.up.pt	Andrade, Paula B/A-5900-2008; Bernardo, Joao/A-9512-2015; Mouga, Teresa/AAK-3604-2020; Sousa, Carla/D-4989-2013; Valentão, Patrícia/D-4818-2013; Silva, Luís R./D-5485-2013; REQUIMTE, PHYTO/M-4633-2013; Pinto, Maria Eugénia Ribeiro/K-5788-2014; Lopes, Graciliana/U-1992-2019; Mouga, Teresa/F-4427-2017	Andrade, Paula B/0000-0002-9764-3920; Bernardo, Joao/0000-0002-3736-1681; Mouga, Teresa/0000-0003-4849-8840; Sousa, Carla/0000-0003-2734-7461; Valentão, Patrícia/0000-0002-0740-4396; Silva, Luís R./0000-0001-5264-3516; Pinto, Maria Eugénia Ribeiro/0000-0003-2948-5809; Mouga, Teresa/0000-0003-4849-8840	Fundacao para a Ciencia e a Tecnologia (FCT) [PEst-C/EQB/LA0006/2011, SFRH/BD/61565/2009]	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission)	The authors thank Fundacao para a Ciencia e a Tecnologia (FCT) for grant no. PEst-C/EQB/LA0006/2011. G. Lopes (SFRH/BD/61565/2009) and J. Bernardo (BII) are indebted to FCT for their grants. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn MJ, 2004, BIOL PHARM BULL, V27, P544, DOI 10.1248/bpb.27.544; Biesalski HK, 2007, CURR OPIN CLIN NUTR, V10, P724, DOI 10.1097/MCO.0b013e3282f0cef2; Cerantola S, 2006, BOT MAR, V49, P347, DOI 10.1515/BOT.2006.042; Chkhikvishvili ID, 2000, APPL BIOCHEM MICRO+, V36, P289, DOI 10.1007/BF02742582; Clinical and Laboratory Standards Institute (CLSI), 2009, M07A8 CLSI; CLSI, 2008, M27A3 CLSI; Connan S, 2006, BOT MAR, V49, P39, DOI 10.1515/BOT.2006.005; Fairhead VA, 2005, POLAR BIOL, V28, P680, DOI 10.1007/s00300-005-0735-4; Glombitza KW, 1999, PHYTOCHEMISTRY, V51, P1095, DOI 10.1016/S0031-9422(99)00120-X; GLOMBITZA KW, 1975, PHYTOCHEMISTRY, V14, P1115, DOI 10.1016/0031-9422(75)85198-3; Kim AR, 2009, J AGR FOOD CHEM, V57, P3483, DOI 10.1021/jf900820x; Kim HK, 1999, BIOCHEM PHARMACOL, V58, P759, DOI 10.1016/S0006-2952(99)00160-4; Koivikko R, 2005, J CHEM ECOL, V31, P195, DOI 10.1007/s10886-005-0984-2; Lee R., 2008, PHYCOLOGY, VFourth, DOI DOI 10.1016/j.energy.2014.06.023; Li Y, 2008, J AGR FOOD CHEM, V56, P12073, DOI 10.1021/jf802732n; Li Y, 2009, BIOORGAN MED CHEM, V17, P1963, DOI 10.1016/j.bmc.2009.01.031; Moon C, 2008, PHYTOTHER RES, V22, P238, DOI 10.1002/ptr.2298; Nagayama K, 2002, J ANTIMICROB CHEMOTH, V50, P889, DOI 10.1093/jac/dkf222; Parys S, 2007, J NAT PROD, V70, P1865, DOI 10.1021/np070302f; Parys S, 2010, PHYTOCHEMISTRY, V71, P221, DOI 10.1016/j.phytochem.2009.10.020; Paterson DL, 2006, AM J MED, V119, pS20, DOI 10.1016/j.amjmed.2006.03.013; Richardman MD, 2003, FUNGAL INFECT DIAGNO; SCHULTZ JC, 1992, BASIC LIFE SCI, V59, P621; Shibata T, 2004, J APPL PHYCOL, V16, P291, DOI 10.1023/B:JAPH.0000047781.24993.0a; Shibata T, 2003, J APPL PHYCOL, V15, P61, DOI 10.1023/A:1022972221002; Shin HC, 2006, ARCH PHARM RES, V29, P165, DOI 10.1007/BF02974279; Sousa C, 2009, TOXICOL IN VITRO, V23, P1131, DOI 10.1016/j.tiv.2009.05.012; Sousa C, 2008, J AGR FOOD CHEM, V56, P4205, DOI 10.1021/jf072740y; Spicer JW, 2000, CLIN BACTERIOLOGY MY; Stern JL, 1996, J CHEM ECOL, V22, P1273, DOI 10.1007/BF02266965; Sterry W, 2006, DERMATOLOGY, V6th; Targett NM, 2001, CRC MAR SCI, P391; Zaragoza MC, 2008, J AGR FOOD CHEM, V56, P7773, DOI 10.1021/jf8007053	33	134	137	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2012	7	2							e31145	10.1371/journal.pone.0031145	http://dx.doi.org/10.1371/journal.pone.0031145			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UV	22319609	Green Submitted, Green Published, gold			2022-12-27	WOS:000301979000022
J	Yates, AM; Neumann, FH; Hancox, PJ				Yates, Adam M.; Neumann, Frank H.; Hancox, P. John			The Earliest Post-Paleozoic Freshwater Bivalves Preserved in Coprolites from the Karoo Basin, South Africa	PLOS ONE			English	Article							PERMIAN MASS EXTINCTION; BEAUFORT-GROUP; TRIASSIC RECOVERY; MOLLUSCA; BEHAVIOR	Background: Several clades of bivalve molluscs have invaded freshwaters at various times throughout Phanerozoic history. The most successful freshwater clade in the modern world is the Unionoida. Unionoids arose in the Triassic Period, sometime after the major extinction event at the End-Permian boundary and are now widely distributed across all continents except Antarctica. Until now, no freshwater bivalves of any kind were known to exist in the Early Triassic. Principal Findings: Here we report on a faunule of two small freshwater bivalve species preserved in vertebrate coprolites from the Olenekian (Lower Triassic) of the Burgersdorp Formation of the Karoo Basin, South Africa. Positive identification of these bivalves is not possible due to the limited material. Nevertheless they do show similarities with Unionoida although they fall below the size range of extant unionoids. Phylogenetic analysis is not possible with such limited material and consequently the assignment remains somewhat speculative. Conclusions: Bivalve molluscs re-invaded freshwaters soon after the End-Permian extinction event, during the earliest part of the recovery phase during the Olenekian Stage of the Early Triassic. If the specimens do represent unionoids then these Early Triassic examples may be an example of the Lilliput effect. Since the oldest incontrovertible freshwater unionoids are also from sub-Saharan Africa, it is possible that this subcontinent hosted the initial freshwater radiation of the Unionoida. This find also demonstrates the importance of coprolites as microenvironments of exceptional preservation that contain fossils of organisms that would otherwise have left no trace.	[Yates, Adam M.; Neumann, Frank H.; Hancox, P. John] Univ Witwatersrand, Bernard Price Inst Palaeontol Res, Johannesburg, South Africa; [Yates, Adam M.] Museum Cent Australia, Alice Springs, NT, Australia; [Neumann, Frank H.] Univ Munster, Forsch Stelle Palaobot, Munster, Germany	University of Witwatersrand; University of Munster	Yates, AM (corresponding author), Univ Witwatersrand, Bernard Price Inst Palaeontol Res, Johannesburg, South Africa.	yatesam@gmail.com			Lower Triassic of Driefontein, Free State, South Africa, from the Palaeontological Scientific Trust (PAST)	Lower Triassic of Driefontein, Free State, South Africa, from the Palaeontological Scientific Trust (PAST)	The work was supported by a grant to the project "A multidisciplinary study of a rich assemblage of coprolites from the Lower Triassic of Driefontein, Free State, South Africa.'' from the Palaeontological Scientific Trust (PAST) www.past.org.za. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdala F, 2006, ZOOL J LINN SOC-LOND, V147, P383, DOI 10.1111/j.1096-3642.2006.00224.x; Bender PA, 2004, GONDWANA RES, V7, P185, DOI 10.1016/S1342-937X(05)70317-8; Bowring SA, 1998, SCIENCE, V280, P1039, DOI 10.1126/science.280.5366.1039; Brayard A, 2010, GEOLOGY, V38, P147, DOI 10.1130/G30553.1; Cox L.R., 1932, J GEOLOGICAL SOC LON, V88, P623, DOI 10.1144/gsl.jgs; COX LR, 1969, TREATISE INVERTEBR N, V1, pN2; CURREY JD, 1974, J ZOOL, V173, P395; Damiani RJ, 2003, J VERTEBR PALEONTOL, V23, P54, DOI 10.1671/0272-4634(2003)23[54:NMTFTC]2.0.CO;2; Dixey F., 1937, Q J GEOL SOC, V93, P52, DOI [DOI 10.1144/GSL.JGS.1937.093.01-04.05, 10.1144/GSL.JGS.1937.093.01-04.05]; Erwin D. H., 2006, EXTINCTION LIFE EART; Giribet G, 2002, INVERTEBR BIOL, V121, P271; Good S.C., 1989, P233; Graf DL, 2007, J MOLLUS STUD, V73, P291, DOI 10.1093/mollus/eym029; Haas F., 1969, TREATISE INVERTEBR N, V1, pN411; Hancox PJ, 2001, J AFR EARTH SCI, V33, P563, DOI 10.1016/S0899-5362(01)00081-1; HANCOX PJ, 1995, S AFR J SCI, V91, P143; Hautmann M, 2005, PALAEONTOLOGY, V48, P1131, DOI 10.1111/j.1475-4983.2005.00505.x; Hoeh WR, 1998, MALACOLOGIA, V40, P267; Irmis R, 2008, J VERTEBR PALEONTOL, V28, p95A; Jin YG, 2000, SCIENCE, V289, P432, DOI 10.1126/science.289.5478.432; JOHNSON MR, 1976, THESIS RHODES U GRAH; Kent L.E., 1990, HDB OGF GEOLOGICAL S, V8, P535; Kondo Y, 2009, PALEONTOL RES, V13, P39, DOI 10.2517/1342-8144-13.1.039; Neveling J., 2004, B COUNCIL GEOSCIENCE, V137, P1; NEWELL N D, 1975, Bulletin of the American Museum of Natural History, V154, P53; Payne JL, 2005, PALEOBIOLOGY, V31, P269, DOI 10.1666/0094-8373(2005)031[0269:EDOGSA]2.0.CO;2; RETALLACK GJ, 1995, SCIENCE, V267, P77, DOI 10.1126/science.267.5194.77; Retallack GJ, 1996, GEOL SOC AM BULL, V108, P195, DOI 10.1130/0016-7606(1996)108<0195:GCGBPT>2.3.CO;2; Rodland DL, 2001, PALAIOS, V16, P95, DOI 10.2307/3515554; Rubidge B.S., 1995, GEOLOGICAL SURVEY S, V1, P1; Shishkin M. A., 1994, Palaeontologia Africana, V31, P39; Stanley GD, 2003, EARTH-SCI REV, V60, P195, DOI 10.1016/S0012-8252(02)00104-6; Twitchett RJ, 2007, PALAEOGEOGR PALAEOCL, V252, P132, DOI 10.1016/j.palaeo.2006.11.038; Urbanek Adam, 1993, Historical Biology, V7, P29; Weir, 1969, TREATISE INVERTEBR N, V6, pN402; Weir J., 1969, TREATISE INVERTEBR N, pN401	36	12	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2012	7	2							e30228	10.1371/journal.pone.0030228	http://dx.doi.org/10.1371/journal.pone.0030228			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UV	22319562	Green Published, gold, Green Submitted			2022-12-27	WOS:000301979000003
J	Hahn, S; Hoye, BJ; Korthals, H; Klaassen, M				Hahn, Steffen; Hoye, Bethany J.; Korthals, Harry; Klaassen, Marcel			From Food to Offspring Down: Tissue-Specific Discrimination and Turn-Over of Stable Isotopes in Herbivorous Waterbirds and Other Avian Foraging Guilds	PLOS ONE			English	Article							BODY CONDITION; NITROGEN; CARBON; DIET; FRACTIONATION; FEATHERS; HABITAT; DELTA-N-15; DELTA-C-13; SIGNATURES	Isotopic discrimination and turn-over are fundamental to the application of stable isotope ecology in animals. However, detailed information for specific tissues and species are widely lacking, notably for herbivorous species. We provide details on tissue-specific carbon and nitrogen discrimination and turn-over times from food to blood, feathers, claws, egg tissues and offspring down feathers in four species of herbivorous waterbirds. Source-to-tissue discrimination factors for carbon (delta C-13) and nitrogen stable isotope ratios (delta N-15) showed little variation across species but varied between tissues. Apparent discrimination factors ranged between -0.5 to 2.5 parts per thousand for delta C-13 and 2.8 to 5.2 parts per thousand for delta N-15, and were more similar between blood components than between keratinous tissues or egg tissue. Comparing these results with published data from other species we found no effect of foraging guild on discrimination factors for carbon but a significant foraging-guild effect for nitrogen discrimination factors. Turn-over of delta C-13 in tissues was most rapid in blood plasma, with a half-life of 4.3 d, whereas delta C-13 in blood cells had a half-life of approximately 32 d. Turn-over times for albumen and yolk in laying females were similar to those of blood plasma, at 3.2 and 6.0 d respectively. Within yolk, we found decreasing half-life times of delta C-13 from inner yolk (13.3 d) to outer yolk (3.1 d), related to the temporal pattern of tissue formation. We found similarities in tissue-specific turn-over times across all avian species studied to date. Yet, while generalities regarding discrimination factors and tissue turn-over times can be made, a large amount of variation remains unexplained.	[Hahn, Steffen] Swiss Ornithol Inst, Sempach, Switzerland; [Hahn, Steffen; Hoye, Bethany J.; Klaassen, Marcel] Netherlands Inst Ecol NIOO KNAW, Dept Anim Ecol, Wageningen, Netherlands; [Korthals, Harry] Netherlands Inst Ecol NIOO KNAW, Dept Aquat Ecol, Wageningen, Netherlands; [Klaassen, Marcel] Deakin Univ, Ctr Integrated Ecol, Geelong, Vic 3217, Australia	Swiss Ornithological Institute; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Deakin University	Hahn, S (corresponding author), Swiss Ornithol Inst, Sempach, Switzerland.	steffen.hahn@vogelwarte.ch	Klaassen, Marcel/B-4325-2008; Hoye, Bethany J/A-4486-2010; KNAW, NIOO-KNAW/A-4320-2012	Klaassen, Marcel/0000-0003-3907-9599; Hoye, Bethany J/0000-0001-9502-5582; Hahn, Steffen/0000-0002-4924-495X; KNAW, NIOO-KNAW/0000-0002-3835-159X	Research Council for Earth and Life Sciences (ALW) Netherlands Organization for Scientific Research (NWO) [851.30.003, 851.40.073]; German Research Council (DFG) [HA4437/1-1]	Research Council for Earth and Life Sciences (ALW) Netherlands Organization for Scientific Research (NWO); German Research Council (DFG)(German Research Foundation (DFG))	This study was supported by the Research Council for Earth and Life Sciences (ALW) with financial aid from the Netherlands Organization for Scientific Research (NWO; grants 851.30.003 and 851.40.073) and the German Research Council (DFG grant HA4437/1-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alisauskas Ray T., 1992, P30; Bauchinger U, 2009, PHYSIOL BIOCHEM ZOOL, V82, P787, DOI 10.1086/605548; Bearhop S, 2004, P ROY SOC B-BIOL SCI, V271, pS215, DOI 10.1098/rsbl.2003.0129; Bearhop S, 2003, FUNCT ECOL, V17, P270, DOI 10.1046/j.1365-2435.2003.00725.x; Bearhop S, 2002, PHYSIOL BIOCHEM ZOOL, V75, P451, DOI 10.1086/342800; Bocher P, 2000, MAR ECOL PROG SER, V208, P249, DOI 10.3354/meps208249; Bugoni L, 2008, RAPID COMMUN MASS SP, V22, P2457, DOI 10.1002/rcm.3633; Carleton SA, 2005, OECOLOGIA, V144, P226, DOI 10.1007/s00442-005-0066-8; Caut S, 2009, J APPL ECOL, V46, P443, DOI 10.1111/j.1365-2664.2009.01620.x; Cherel Y, 2005, ECOLOGY, V86, P2881, DOI 10.1890/05-0562; Dalerum F, 2005, OECOLOGIA, V144, P647, DOI 10.1007/s00442-005-0118-0; del Rio CM, 2009, BIOL REV, V84, P91, DOI 10.1111/j.1469-185X.2008.00064.x; Fox AD, 2009, J AVIAN BIOL, V40, P108, DOI 10.1111/j.1600-048X.2009.04720.x; Fry B., 2006, STABLE ISOTOPE ECOLO; Gannes LZ, 1998, COMP BIOCHEM PHYS A, V119, P725, DOI 10.1016/S1095-6433(98)01016-2; GROSSMAN EL, 1986, CHEM GEOL, V59, P59, DOI 10.1016/0168-9622(86)90057-6; Hahn S, 2011, J AVIAN BIOL, V42, P159, DOI 10.1111/j.1600-048X.2010.05189.x; HOBSON KA, 1992, CONDOR, V94, P181, DOI 10.2307/1368807; HOBSON KA, 1992, CONDOR, V94, P189, DOI 10.2307/1368808; Hobson KA, 2008, TERR ECOL SER, V2, P45, DOI 10.1016/S1936-7961(07)00003-6; Inger R, 2008, J AVIAN BIOL, V39, P704, DOI 10.1111/j.1600-048X.2008.04332.x; Karasov WH, 1990, STUDIES AVIAN BIOL, P391; Kear J., 1961, WILDFOWL, V14, P72; Klaassen M, 2010, FUNCT ECOL, V24, P796, DOI 10.1111/j.1365-2435.2010.01689.x; McCutchan JH, 2003, OIKOS, V102, P378, DOI 10.1034/j.1600-0706.2003.12098.x; MIZUTANI H, 1991, ISOTOPENPRAXIS, V27, P166, DOI 10.1080/10256019108622500; OWEN M, 1975, J WILDLIFE MANAGE, V39, P271, DOI 10.2307/3799903; Pearson SF, 2003, OECOLOGIA, V135, P516, DOI 10.1007/s00442-003-1221-8; Perga ME, 2010, J APPL ECOL, V47, P942, DOI 10.1111/j.1365-2664.2009.01730.x; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Robbins CT, 2010, OECOLOGIA, V162, P571, DOI 10.1007/s00442-009-1485-8; Robbins CT, 2005, OECOLOGIA, V144, P534, DOI 10.1007/s00442-005-0021-8; ROUDYBUSH TE, 1979, CONDOR, V81, P293, DOI 10.2307/1367636; Sjogersten S, 2010, POLAR BIOL, V33, P1195, DOI 10.1007/s00300-010-0809-9; Smith AD, 2005, CONDOR, V107, P547, DOI 10.1650/0010-5422(2005)107[0547:VITSIC]2.0.CO;2; TIESZEN LL, 1983, OECOLOGIA, V57, P32, DOI 10.1007/BF00379558; Vanderklift MA, 2003, OECOLOGIA, V136, P169, DOI 10.1007/s00442-003-1270-z; Williams CT, 2007, OECOLOGIA, V153, P11, DOI 10.1007/s00442-007-0717-z	38	30	32	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2012	7	2							e30242	10.1371/journal.pone.0030242	http://dx.doi.org/10.1371/journal.pone.0030242			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UG	22312422	gold, Green Published, Green Submitted			2022-12-27	WOS:000301977500005
J	Incardona, JP; Vines, CA; Linbo, TL; Myers, MS; Sloan, CA; Anulacion, BF; Boyd, D; Collier, TK; Morgan, S; Cherr, GN; Scholz, NL				Incardona, John P.; Vines, Carol A.; Linbo, Tiffany L.; Myers, Mark S.; Sloan, Catherine A.; Anulacion, Bernadita F.; Boyd, Daryle; Collier, Tracy K.; Morgan, Steven; Cherr, Gary N.; Scholz, Nathaniel L.			Potent Phototoxicity of Marine Bunker Oil to Translucent Herring Embryos after Prolonged Weathering	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; PRINCE-WILLIAM-SOUND; EXXON-VALDEZ OIL; CRUDE-OIL; PHOTOINDUCED TOXICITY; ULTRAVIOLET-RADIATION; FATHEAD MINNOW; DAPHNIA-MAGNA; FISH EMBRYOS; CELL-LINE	Pacific herring embryos (Clupea pallasi) spawned three months following the Cosco Busan bunker oil spill in San Francisco Bay showed high rates of late embryonic mortality in the intertidal zone at oiled sites. Dead embryos developed to the hatching stage (e. g. fully pigmented eyes) before suffering extensive tissue deterioration. In contrast, embryos incubated subtidally at oiled sites showed evidence of sublethal oil exposure (petroleum-induced cardiac toxicity) with very low rates of mortality. These field findings suggested an enhancement of oil toxicity through an interaction between oil and another environmental stressor in the intertidal zone, such as higher levels of sunlight-derived ultraviolet (UV) radiation. We tested this hypothesis by exposing herring embryos to both trace levels of weathered Cosco Busan bunker oil and sunlight, with and without protection from UV radiation. Cosco Busan oil and UV co-exposure were both necessary and sufficient to induce an acutely lethal necrotic syndrome in hatching stage embryos that closely mimicked the condition of dead embryos sampled from oiled sites. Tissue levels of known phototoxic polycyclic aromatic compounds were too low to explain the observed degree of phototoxicity, indicating the presence of other unidentified or unmeasured phototoxic compounds derived from bunker oil. These findings provide a parsimonious explanation for the unexpectedly high losses of intertidal herring spawn following the Cosco Busan spill. The chemical composition and associated toxicity of bunker oils should be more thoroughly evaluated to better understand and anticipate the ecological impacts of vessel-derived spills associated with an expanding global transportation network.	[Incardona, John P.; Linbo, Tiffany L.; Myers, Mark S.; Sloan, Catherine A.; Anulacion, Bernadita F.; Boyd, Daryle; Collier, Tracy K.; Scholz, Nathaniel L.] NOAA, NW Fisheries Sci Ctr, Environm Conservat Div, Seattle, WA USA; [Vines, Carol A.; Morgan, Steven; Cherr, Gary N.] Univ Calif Davis, Bodega Marine Lab, Bodega Bay, CA 94923 USA; [Cherr, Gary N.] Univ Calif Davis, Dept Environm Toxicol, Davis, CA 95616 USA; [Cherr, Gary N.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA	National Oceanic Atmospheric Admin (NOAA) - USA; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Incardona, JP (corresponding author), NOAA, NW Fisheries Sci Ctr, Environm Conservat Div, Seattle, WA USA.	john.incardona@noaa.gov	Scholz, Nathaniel L/L-1642-2013; Morgan, Steven G/GXG-5459-2022	Scholz, Nathaniel L/0000-0001-6207-0272; 	Natural Resource Damage Assessment process; Cosco Busan oil spill Responsible Party by Federal and California State	Natural Resource Damage Assessment process; Cosco Busan oil spill Responsible Party by Federal and California State	All funding for this work was provided by the Natural Resource Damage Assessment process, obtained from the Cosco Busan oil spill Responsible Party by Federal and California State co-Trustees under the authority of the US Clean Water and Oil Pollution Acts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arfsten DP, 1996, ECOTOX ENVIRON SAFE, V33, P1, DOI 10.1006/eesa.1996.0001; Barron MG, 2003, ENVIRON TOXICOL CHEM, V22, P650, DOI 10.1002/etc.5620220326; Carls MG, 1999, ENVIRON TOXICOL CHEM, V18, P481, DOI 10.1002/etc.5620180317; Carls MG, 2003, MAR ECOL PROG SER, V248, P245, DOI 10.3354/meps248245; Diamond SA, 2003, COMP SER PHOTOCHEM, V1, P219; Diamond SA, 2006, ENVIRON TOXICOL CHEM, V25, P3015, DOI 10.1897/06-038R.1; Dinnel P, 2008, DEV LARVAL PACIFIC H; Fathalla EM, 2011, ENVIRON TOXICOL CHEM, V30, P2004, DOI 10.1002/etc.607; Frysinger GS, 2003, ENVIRON SCI TECHNOL, V37, P1653, DOI 10.1021/es020742n; Griffin FJ, 1998, BIOL BULL, V194, P25, DOI 10.2307/1542510; Grove AD, 2000, TOXICOL APPL PHARM, V162, P34, DOI 10.1006/taap.1999.8815; HALL AT, 1991, AQUAT TOXICOL, V19, P249; Hatlen K, 2010, AQUAT TOXICOL, V99, P56, DOI 10.1016/j.aquatox.2010.04.002; Hicken CE, 2011, P NATL ACAD SCI USA, V108, P7086, DOI 10.1073/pnas.1019031108; Incardona JP, 2009, ENVIRON SCI TECHNOL, V43, P201, DOI 10.1021/es802270t; Incardona JP, 2005, ENVIRON HEALTH PERSP, V113, P1755, DOI 10.1289/ehp.8230; Incardona JP, 2004, TOXICOL APPL PHARM, V196, P191, DOI 10.1016/j.taap.2003.11.026; Incardona JP, 2011, P NATL ACAD IN PRESS; KAGAN J, 1987, CHEMOSPHERE, V16, P2417, DOI 10.1016/0045-6535(87)90300-6; Lampi MA, 2006, ENVIRON TOXICOL CHEM, V25, P1079, DOI 10.1897/05-276R.1; Linbo T. L., 2009, NMFSNWFSC100 NOAA US; Mallakin A, 2000, CHEMOSPHERE, V40, P1435, DOI 10.1016/S0045-6535(99)00331-8; Marty GD, 1997, CAN J FISH AQUAT SCI, V54, P1846, DOI 10.1139/cjfas-54-8-1846; Marty GD, 1997, CAN J ZOOL, V75, P989, DOI 10.1139/z97-120; Matsunaga T, 2010, TOXICOLOGY, V268, P191, DOI 10.1016/j.tox.2009.12.015; MCCLOSKEY JT, 1993, AQUAT TOXICOL, V24, P207, DOI 10.1016/0166-445X(93)90072-9; MEKENYAN OG, 1994, CHEMOSPHERE, V28, P567, DOI 10.1016/0045-6535(94)90299-2; NEWSTED JL, 1987, ENVIRON TOXICOL CHEM, V6, P445; ORIS JT, 1987, CHEMOSPHERE, V16, P1395, DOI 10.1016/0045-6535(87)90079-8; Peters ZJ, 2007, REPROD TOXICOL, V23, P513, DOI 10.1016/j.reprotox.2007.01.008; Rowland SJ, 2011, RAPID COMMUN MASS SP, V25, P1741, DOI 10.1002/rcm.5040; Schirmer K, 1998, TOXICOLOGY, V127, P143, DOI 10.1016/S0300-483X(98)00031-6; Short JW, 1997, ENVIRON SCI TECHNOL, V31, P2375, DOI 10.1021/es960985d; Sloan CA., 2005, TECHNIQUES AQUATIC T, P631, DOI 10.1201/9780203501597.CH35; Weinstein JE, 1997, AQUAT TOXICOL, V39, P1, DOI 10.1016/S0166-445X(97)00018-0; Yu HT, 2002, J ENVIRON SCI HEAL C, V20, P149, DOI 10.1081/GNC-120016203	36	39	39	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2012	7	2							e30116	10.1371/journal.pone.0030116	http://dx.doi.org/10.1371/journal.pone.0030116			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UG	22312421	Green Published, gold, Green Submitted			2022-12-27	WOS:000301977500004
J	Al-Hashmi, S; Boels, PJM; Zadjali, F; Sadeghi, B; Sallstrom, J; Hultenby, K; Hassan, Z; Arner, A; Hassan, M				Al-Hashmi, Sulaiman; Boels, Piet J. M.; Zadjali, Fahad; Sadeghi, Behnam; Sallstrom, Johan; Hultenby, Kjell; Hassan, Zuzana; Arner, Anders; Hassan, Moustapha			Busulphan-Cyclophosphamide Cause Endothelial Injury, Remodeling of Resistance Arteries and Enhanced Expression of Endothelial Nitric Oxide Synthase	PLOS ONE			English	Article							STEM-CELL TRANSPLANTATION; BONE-MARROW-TRANSPLANTATION; INDUCED HEMORRHAGIC CYSTITIS; TOTAL-BODY IRRADIATION; OF-THE-ART; CARDIAC TOXICITY; CARDIOVASCULAR-DISEASE; CANCER-THERAPY; HEART-FAILURE; COMPLICATIONS	Stem cell transplantation (SCT) is a curative treatment for malignant and non malignant diseases. However, transplantation-related complications including cardiovascular disease deteriorate the clinical outcome and quality of life. We have investigated the acute effects of conditioning regimen on the pharmacology, physiology and structure of large elastic arteries and small resistance-sized arteries in a SCT mouse model. Mesenteric resistance arteries and aorta were dissected from Balb/c mice conditioned with busulphan (Bu) and cyclophosphamide (Cy). In vitro isometric force development and pharmacology, in combination with RT-PCR, Western blotting and electron microscopy were used to study vascular properties. Compared with controls, mesenteric resistance arteries from the Bu-Cy group had larger internal circumference, showed enhanced endothelium mediated relaxation and increased expression of endothelial nitric oxide synthase (eNOS). Bu-Cy treated animals had lower mean blood pressure and signs of endothelial injury. Aortas of treated animals had a higher reactivity to noradrenaline. We conclude that short-term consequences of Bu-Cy treatment divergently affect large and small arteries of the cardiovascular system. The increased noradrenaline reactivity of large elastic arteries was not associated with increased blood pressure at rest. Instead, Bu-Cy treatment lowered blood pressure via augmented microvascular endothelial dependent relaxation, increased expression of vascular eNOS and remodeling toward a larger lumen. The changes in the properties of resistance arteries can be associated with direct effects of the compounds on vascular wall or possibly indirectly induced via altered translational activity associated with the reduced hematocrit and shear stress. This study contributes to understanding the mechanisms that underlie the early effects of conditioning regimen on resistance arteries and may help in designing further investigations to understand the late effects on vascular system.	[Al-Hashmi, Sulaiman; Hultenby, Kjell] Karolinska Inst, Dept Lab Med, EMIL, Stockholm, Sweden; [Boels, Piet J. M.; Sallstrom, Johan; Arner, Anders] 3Ph S Biomed, Stockholm, Sweden; [Boels, Piet J. M.] Karolinska Inst, Dept Physiol & Pharmacol, Div Genet Physiol, Stockholm, Sweden; [Zadjali, Fahad] Karolinska Inst, CMM, Dept Mol Med & Surg MMK, Stockholm, Sweden; [Hassan, Zuzana; Hassan, Moustapha] Karolinska Univ Hosp Huddinge, Clinincal Res Ctr, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Al-Hashmi, S (corresponding author), Karolinska Inst, Dept Lab Med, EMIL, Stockholm, Sweden.	moustapha.hassan@ki.se	Hassan, Moustapha/H-9260-2015; Sadeghi, Behnam/AAH-1221-2019; ZADJALI, FAHAD/B-5091-2019	Hassan, Moustapha/0000-0003-1927-5859; Sadeghi, Behnam/0000-0002-8721-0400; ZADJALI, FAHAD/0000-0001-5891-4700	Swedish Cancer Foundation; Swedish Children Cancer Society; Swedish Research Council; Swedish Heart-Lung Foundation; The Karolinska Institutet	Swedish Cancer Foundation; Swedish Children Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); The Karolinska Institutet(Karolinska Institutet)	This work was supported by the Swedish Cancer Foundation, Swedish Children Cancer Society, Swedish Research Council, and Swedish Heart-Lung Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The study was designed in an academic institution without infleuces of any commercial source. The grants were handed to The Karolinska Institutet and were used in buying materials, animals and antibodies. 3Ph_S Biomedical, Sweden is the new address of Dr. Boels, however, the whole study was conducted at the Department of Physiology and Pharmacology at the Karolinska Institutet, where Dr. Boels is employed. 3Ph_S Biomedical, Sweden is an academic consulting orgnization without any economic interest.	Agabiti-Rosei E, 2007, HYPERTENSION, V50, P154, DOI 10.1161/HYPERTENSIONAHA.107.090068; Al-Hashmi S, 2011, INT J CLIN EXP PATHO, V4, P596; Albini A, 2010, JNCI-J NATL CANCER I, V102, P14, DOI 10.1093/jnci/djp440; Antoniades C, 2011, CIRCULATION, V124, P1860, DOI 10.1161/CIRCULATIONAHA.111.029272; Armenian SH, 2008, HAEMATOL-HEMATOL J, V93, P1132, DOI 10.3324/haematol.13514; Armenian SH, 2008, J CLIN ONCOL, V26, P5537, DOI 10.1200/JCO.2008.17.7428; AYASH LJ, 1992, J CLIN ONCOL, V10, P995, DOI 10.1200/JCO.1992.10.6.995; BEARMAN SI, 1990, BONE MARROW TRANSPL, V5, P173; BERTHOU C, 1991, BRIT J HAEMATOL, V79, P335, DOI 10.1111/j.1365-2141.1991.tb04543.x; BOELS PJ, 1994, PFLUG ARCH EUR J PHY, V426, P506, DOI 10.1007/BF00378528; Bunin N, 2003, BONE MARROW TRANSPL, V32, P543, DOI 10.1038/sj.bmt.1704198; Busse D, 1998, Pharm Unserer Zeit, V27, P216, DOI 10.1002/pauz.19980270507; CAZIN B, 1986, CANCER, V57, P2061, DOI 10.1002/1097-0142(19860515)57:10<2061::AID-CNCR2820571031>3.0.CO;2-H; Cho Kun Hyun, 2010, Int Neurourol J, V14, P149, DOI 10.5213/inj.2010.14.3.149; Clapp BR, 2005, CIRCULATION, V111, P1530, DOI 10.1161/01.CIR.0000159336.31613.31; DOLL DC, 1992, SEMIN ONCOL, V19, P580; Doll Donald C., 1994, Current Opinion in Oncology, V6, P345, DOI 10.1097/00001622-199407000-00004; Ferry C, 2003, EXP HEMATOL, V31, P1182, DOI 10.1016/j.exphem.2003.09.008; Ghobrial IM, 2004, MAYO CLIN PROC, V79, P403, DOI 10.4065/79.3.403; GOLDBERG MA, 1986, BLOOD, V68, P1114; Gupta T, 2011, Hematol Oncol Stem Cell Ther, V4, P17; Gyurkocza B, 2010, EXPERT REV HEMATOL, V3, P285, DOI 10.1586/EHM.10.21; Hassan M, 1996, LEUKEMIA LYMPHOMA, V22, P395, DOI 10.3109/10428199609054777; Jenq RR, 2010, NAT REV CANCER, V10, P213, DOI 10.1038/nrc2804; Kanagy NL, 2003, J CARDIOVASC PHARM, V42, P527, DOI 10.1097/00005344-200310000-00011; Kaul DK, 2000, AM J PHYSIOL-HEART C, V278, pH1799, DOI 10.1152/ajpheart.2000.278.6.H1799; Korkmaz A, 2007, CELL BIOL TOXICOL, V23, P303, DOI 10.1007/s10565-006-0078-0; Limsuwan A, 2006, CARDIOLOGY, V105, P188, DOI 10.1159/000091638; Luznik L, 2010, BLOOD; Luznik L, 2010, IMMUNOL RES; Majhail NS, 2009, BIOL BLOOD MARROW TR, V15, P1100, DOI 10.1016/j.bbmt.2009.05.010; Molyneux G, 2011, CELL BIOL TOXICOL, V27, P13, DOI 10.1007/s10565-010-9167-1; MOREAU P, 1995, STROKE, V26, P1922, DOI 10.1161/01.STR.26.10.1922; Mulvany MJ, 2008, MED BIOL ENG COMPUT, V46, P461, DOI 10.1007/s11517-008-0305-3; Mulvany MJ, 2002, NEWS PHYSIOL SCI, V17, P105, DOI 10.1152/nips.01366.2001; Murdych T, 2001, BONE MARROW TRANSPL, V28, P283, DOI 10.1038/sj.bmt.1703133; Naik S, 2011, BONE MARROW TRANSPL, V46, P192, DOI 10.1038/bmt.2010.114; Oter S, 2004, UROL RES, V32, P185, DOI 10.1007/s00240-003-0398-y; Park CB, 2007, CELL, V130, P273, DOI 10.1016/j.cell.2007.05.046; PATEL JM, 1993, TOXICOL APPL PHARM, V122, P46, DOI 10.1006/taap.1993.1170; Perry TE, 2009, CARDIOVASC RES, V84, P317, DOI 10.1093/cvr/cvp215; Peterson L, 1966, PHYS FACTORS WHICH I; Pries AR, 1996, CARDIOVASC RES, V32, P654, DOI 10.1016/S0008-6363(96)00065-X; Ringden O, 2005, APMIS, V113, P813, DOI 10.1111/j.1600-0463.2005.apm_336.x; Rosei EA, 2005, CURR HYPERTENS REP, V7, P79, DOI 10.1007/s11906-005-0077-1; Sadeghi B, 2008, BONE MARROW TRANSPL, V42, P807, DOI 10.1038/bmt.2008.261; Sadeghi B, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/142943; SANTOS GW, 1989, BONE MARROW TRANSPL, V4, P236; SANTOS GW, 1971, TRANSPLANT P, V3, P400; Senkus E, 2011, CANCER TREAT REV, V37, P300, DOI 10.1016/j.ctrv.2010.11.001; Shesely EG, 1996, P NATL ACAD SCI USA, V93, P13176, DOI 10.1073/pnas.93.23.13176; Sohn SK, 2003, BRIT J HAEMATOL, V121, P469, DOI 10.1046/j.1365-2141.2003.04288.x; Spiers A, 2005, METH MOLEC MED, V108, P91; STORB R, 1970, CANCER RES, V30, P2195; STUMPE KO, 1995, AM J CARDIOL, V76, pE50, DOI 10.1016/S0002-9149(99)80505-0; Takatsuka H, 2000, BONE MARROW TRANSPL, V26, P419, DOI 10.1038/sj.bmt.1702517; TERPSTRA W, 1989, NETH J MED, V35, P249; Tichelli A, 2008, BRIT J HAEMATOL, V142, P11, DOI 10.1111/j.1365-2141.2008.07165.x; Tichelli A, 2008, HAEMATOL-HEMATOL J, V93, P1203, DOI 10.3324/haematol.12949; Tichelli A, 2007, BLOOD, V110, P3463, DOI 10.1182/blood-2006-10-054080; Uderzo C, 2009, PEDIATR TRANSPLANT, V13, P719, DOI 10.1111/j.1399-3046.2008.01055.x; Wang XQ, 1999, HYPERTENSION, V33, P894, DOI 10.1161/01.HYP.33.3.894; Wang XF, 2009, EUR J HEART FAIL, V11, P154, DOI 10.1093/eurjhf/hfn012; Yeh ETH, 2004, CIRCULATION, V109, P3122, DOI 10.1161/01.CIR.0000133187.74800.B9; Zeng L, 2008, TRANSPL P, V40, P2670, DOI 10.1016/j.transproceed.2008.06.038; Zeng L, 2010, TRANSPL P, V42, P2720, DOI 10.1016/j.transproceed.2010.04.024; Zver S, 2007, INT J HEMATOL, V85, P408, DOI 10.1532/IJH97.E0620	67	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e30897	10.1371/journal.pone.0030897	http://dx.doi.org/10.1371/journal.pone.0030897			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22303468	gold, Green Submitted, Green Published			2022-12-27	WOS:000301704200044
J	Liu, Y; Semina, EV				Liu, Yi; Semina, Elena V.			pitx2 Deficiency Results in Abnormal Ocular and Craniofacial Development in Zebrafish	PLOS ONE			English	Article							AXENFELD-RIEGER-SYNDROME; LEFT-RIGHT ASYMMETRY; FETAL VASCULATURE PFV; NEURAL CREST SURVIVAL; HOMEOBOX GENE PITX2; RETINAL VASCULATURE; HYALOID VASCULATURE; TOOTH MORPHOGENESIS; CELL-DEATH; EXPRESSION	Human PITX2 mutations are associated with Axenfeld-Rieger syndrome, an autosomal-dominant developmental disorder that involves ocular anterior segment defects, dental hypoplasia, craniofacial dysmorphism and umbilical abnormalities. Characterization of the PITX2 pathway and identification of the mechanisms underlying the anomalies associated with PITX2 deficiency is important for better understanding of normal development and disease; studies of pitx2 function in animal models can facilitate these analyses. A knockdown of pitx2 in zebrafish was generated using a morpholino that targeted all known alternative transcripts of the pitx2 gene; morphant embryos generated with the pitx2(ex4/5) splicing-blocking oligomer produced abnormal transcripts predicted to encode truncated pitx2 proteins lacking the third (recognition) helix of the DNA-binding homeodomain. The morphological phenotype of pitx2(ex4/5) morphants included small head and eyes, jaw abnormalities and pericardial edema; lethality was observed at similar to 6-8-dpf. Cartilage staining revealed a reduction in size and an abnormal shape/position of the elements of the mandibular and hyoid pharyngeal arches; the ceratobranchial arches were also decreased in size. Histological and marker analyses of the misshapen eyes of the pitx2(ex4/5) morphants identified anterior segment dysgenesis and disordered hyaloid vasculature. In summary, we demonstrate that pitx2 is essential for proper eye and craniofacial development in zebrafish and, therefore, that PITX2/pitx2 function is conserved in vertebrates.	[Liu, Yi; Semina, Elena V.] Med Coll Wisconsin, Dept Pediat, Milwaukee, WI 53226 USA; [Liu, Yi; Semina, Elena V.] Med Coll Wisconsin, Childrens Res Inst, Milwaukee, WI 53226 USA; [Liu, Yi; Semina, Elena V.] Childrens Hosp Wisconsin, Milwaukee, WI 53201 USA; [Semina, Elena V.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin; Children's Hospital of Wisconsin; Medical College of Wisconsin	Liu, Y (corresponding author), Shandong Acad Med Sci, Shandong Med Biotechnol Ctr, Jinan, Peoples R China.	esemina@mcw.edu			National Institutes of Health [EY015518]; NATIONAL EYE INSTITUTE [R01EY015518] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Institutes of Health award EY015518 (EVS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez Y, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-114; Arikawa A, 2010, EYE, V24, P391, DOI 10.1038/eye.2009.114; Bamforth SD, 2004, NAT GENET, V36, P1189, DOI 10.1038/ng1446; Barrallo-Gimeno A, 2004, DEVELOPMENT, V131, P1463, DOI 10.1242/dev.01033; Bisgrove BW, 2000, DEVELOPMENT, V127, P3567; Bredrup C, 2008, AM J OPHTHALMOL, V146, P602, DOI 10.1016/j.ajo.2008.05.039; Campione M, 1999, DEVELOPMENT, V126, P1225; Campione M, 2001, DEV BIOL, V231, P252, DOI 10.1006/dbio.2000.0133; Chang B, 2001, BMC GENET, V2, DOI 10.1186/1471-2156-2-18; Chen JY, 2001, BIOCHEM BIOPH RES CO, V285, P105, DOI 10.1006/bbrc.2001.5099; Chen Y, 2008, DEVELOPMENT, V135, P2939, DOI 10.1242/dev.021097; Christiaen L, 2005, DEV BIOL, V277, P557, DOI 10.1016/j.ydbio.2004.10.008; Cox CJ, 2002, J BIOL CHEM, V277, P25001, DOI 10.1074/jbc.M201737200; Dahlman JM, 2005, MOL VIS, V11, P88; Dhingra S, 2006, BRIT J OPHTHALMOL, V90, P1324, DOI 10.1136/bjo.2005.088625; Edwards MM, 2010, J BIOL CHEM, V285, P7697, DOI 10.1074/jbc.M109.069575; Ekker SC, 2008, ZEBRAFISH, V5, P121, DOI 10.1089/zeb.2008.9988; Espinoza HM, 2002, HUM MOL GENET, V11, P743, DOI 10.1093/hmg/11.7.743; Essner JJ, 2000, DEVELOPMENT, V127, P1081; Evans AL, 2005, HUM MOL GENET, V14, P3347, DOI 10.1093/hmg/ddi365; Gage PJ, 2008, DEV BIOL, V317, P310, DOI 10.1016/j.ydbio.2008.02.030; Gage PJ, 1999, DEVELOPMENT, V126, P4643; Goldberg MF, 1997, AM J OPHTHALMOL, V124, P587, DOI 10.1016/S0002-9394(14)70899-2; HADDAD R, 1978, SURV OPHTHALMOL, V23, P123, DOI 10.1016/0039-6257(78)90091-7; Hjalt Tord A., 2005, Expert Reviews in Molecular Medicine, V7, P1, DOI 10.1017/S1462399405010082; Ishimaru Y, 2008, DEVELOPMENT, V135, P677, DOI 10.1242/dev.012856; Ito M, 1999, ANAT EMBRYOL, V200, P403, DOI 10.1007/s004290050289; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kitamura K, 1999, DEVELOPMENT, V126, P5749; Kleinjan DA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040029; Kraus P, 2006, AM J MED GENET A, V140A, P1366, DOI 10.1002/ajmg.a.31252; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Lin CR, 1999, NATURE, V401, P279, DOI 10.1038/45803; Lister JA, 2006, DEV BIOL, V290, P92, DOI 10.1016/j.ydbio.2005.11.014; Liu CQ, 2008, DEVELOPMENT, V135, P3567, DOI 10.1242/dev.028076; Liu W, 2003, DEVELOPMENT, V130, P6375, DOI 10.1242/dev.00849; Lobov IB, 2005, NATURE, V437, P417, DOI 10.1038/nature03928; Lu MF, 1999, NATURE, V401, P276, DOI 10.1038/45797; Martin DM, 2004, DEV BIOL, V267, P93, DOI 10.1016/j.ydbio.2003.10.035; Nelms BL, 2010, TRANSCRIPTIONAL CONT, P227; Piotrowski T, 1996, DEVELOPMENT, V123, P345; Richter M, 1998, INVEST OPHTH VIS SCI, V39, P2450; Robitaille JM, 2009, OPHTHALMIC GENET, V30, P23, DOI 10.1080/13816810802464312; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Rutland CS, 2007, MOL VIS, V13, P47; Ryan AK, 1998, NATURE, V394, P545, DOI 10.1038/29004; Schweickert A, 2000, MECH DEVELOP, V90, P41, DOI 10.1016/S0925-4773(99)00227-0; Semina EV, 2006, DEV BIOL, V299, P63, DOI 10.1016/j.ydbio.2006.07.005; Semina EV, 1996, NAT GENET, V14, P392, DOI 10.1038/ng1296-392; Shi XH, 2005, MECH DEVELOP, V122, P513, DOI 10.1016/j.mod.2004.11.012; Silbert, 2000, Clin Eye Vis Care, V12, P131, DOI 10.1016/S0953-4431(00)00054-0; Sperber SM, 2008, DEV BIOL, V314, P59, DOI 10.1016/j.ydbio.2007.11.005; Toro R, 2004, J BIOL CHEM, V279, P52087, DOI 10.1074/jbc.M404802200; Tumer Z, 2009, EUR J HUM GENET, V17, P1527, DOI 10.1038/ejhg.2009.93; Volkmann BA, 2011, INVEST OPHTH VIS SCI, V52, P1450, DOI 10.1167/iovs.10-6060; Yoshikawa S, 2007, DEV DYNAM, V236, P1929, DOI 10.1002/dvdy.21197; Yu XY, 2001, DEVELOPMENT, V128, P1005; Zhang JM, 2008, INVEST OPHTH VIS SCI, V49, P5561, DOI 10.1167/iovs.08-2226; Zhao XPC, 2006, INVEST OPHTH VIS SCI, V47, P4341, DOI 10.1167/iovs.05-1611; Zhu MD, 2000, EXP EYE RES, V70, P767, DOI 10.1006/exer.2000.0844; Zilinski CA, 2005, GENESIS, V41, P33, DOI 10.1002/gene.20094	62	29	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e30896	10.1371/journal.pone.0030896	http://dx.doi.org/10.1371/journal.pone.0030896			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22303467	Green Published, gold, Green Submitted			2022-12-27	WOS:000301704200043
J	Bhogal, RH; Weston, CJ; Curbishley, SM; Adams, DH; Afford, SC				Bhogal, Ricky H.; Weston, Christopher J.; Curbishley, Stuart M.; Adams, David H.; Afford, Simon C.			Activation of CD40 with Platelet Derived CD154 Promotes Reactive Oxygen Species Dependent Death of Human Hepatocytes during Hypoxia and Reoxygenation	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; FAS LIGAND EXPRESSION; LIVER ISCHEMIA; CELL-DEATH; RAT-LIVER; ISCHEMIA/REPERFUSION INJURY; ALLOGRAFT-REJECTION; OXIDATIVE STRESS; P38 MAPK; APOPTOSIS	Background: Hypoxia and hypoxia-reoxygenation (H-R) are pathogenic factors in many liver diseases that lead to hepatocyte death as a result of reactive oxygen species (ROS) accumulation. The tumor necrosis factor super-family member CD154 can also induce hepatocyte apoptosis via activation of its receptor CD40 and induction of autocrine/paracrine Fas Ligand/CD178 but the relationship between CD40 activation, ROS generation and apoptosis is poorly understood. We hypothesised that CD40 activation and ROS accumulation act synergistically to drive human hepatocyte apoptosis. Methods: Human hepatocytes were isolated from liver tissue and exposed to an in vitro model of hypoxia and H-R in the presence or absence of CD154 and/or various inhibitors. Hepatocyte ROS production, apoptosis and necrosis were determined by labelling cells with 2',7'-dichlorofluorescin, Annexin-V and 7-AAD respectively in a three-colour reporter flow cytometry assay. Results: Exposure of human hepatocytes to recombinant CD154 or platelet-derived soluble CD154 augments ROS accumulation during H-R resulting in NADPH oxidase-dependent apoptosis and necrosis. The inhibition of c-Jun N-terminal Kinase and p38 attenuated CD154-mediated apoptosis but not necrosis. Conclusions: CD154-mediated apoptosis of hepatocytes involves ROS generation that is amplified during hypoxia-reoxygenation. This finding provides a molecular mechanism to explain the role of platelets in hepatocyte death during ischemia-reperfusion injury.	[Bhogal, Ricky H.; Weston, Christopher J.; Curbishley, Stuart M.; Adams, David H.; Afford, Simon C.] Univ Birmingham, Sch Med, Liver Res Ctr, Sch Infect & Immun,Inst Biomed Res, Birmingham, W Midlands, England	University of Birmingham	Bhogal, RH (corresponding author), Univ Birmingham, Sch Med, Liver Res Ctr, Sch Infect & Immun,Inst Biomed Res, Birmingham, W Midlands, England.	balsin@hotmail.com	Adams, David H/C-9092-2009	Adams, David H/0000-0001-6776-0336; Weston, Chris/0000-0002-9651-1264	Wellcome Trust Fellowship [DDDP.RCXH14183]; Birmingham Biomedical Research Unit (BRU); National Institute Health Research (NIHR); Medical Research Council [G9818340B] Funding Source: researchfish	Wellcome Trust Fellowship(Wellcome Trust); Birmingham Biomedical Research Unit (BRU); National Institute Health Research (NIHR)(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Mr. RH Bhogal's work has been funded by a Wellcome Trust Fellowship (DDDP.RCXH14183). The authors would also like to thank the Birmingham Biomedical Research Unit (BRU) and the National Institute Health Research (NIHR) for continued funding and help with research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afford SC, 1999, J EXP MED, V189, P441, DOI 10.1084/jem.189.2.441; Afford SC, 2001, FASEB J, V15, P2345, DOI 10.1096/fj.01-0088com; Ahmed-Choudhury J, 2006, CELL SIGNAL, V18, P456, DOI 10.1016/j.cellsig.2005.05.015; Alabraba EB, 2008, HEPATOLOGY, V47, P552, DOI 10.1002/hep.22011; Andre P, 2002, NAT MED, V8, P247, DOI 10.1038/nm0302-247; Bhogal RH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018222; Bhogal RH, 2010, LIVER TRANSPLANT, V16, P1303, DOI 10.1002/lt.22157; Broughan TA, 2008, J SURG RES, V145, P150, DOI 10.1016/j.jss.2007.04.014; Bu SZ, 2006, APOPTOSIS, V11, P413, DOI 10.1007/s10495-006-4064-z; Bumpus NN, 2011, TOXICOL APPL PHARM, V257, P227, DOI 10.1016/j.taap.2011.09.008; Chai J, 2011, HEPATOLOGY; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Chaparro M, 2007, ANN HEPATOL, V6, P208, DOI 10.1016/S1665-2681(19)31900-3; Choudhury JA, 2003, MOL BIOL CELL, V14, P1334, DOI 10.1091/mbc.E02-07-0378; Conti A, 2007, LIVER TRANSPLANT, V13, P99, DOI 10.1002/lt.20960; Cursio R, 2005, J SURG RES, V125, P30, DOI 10.1016/j.jss.2004.11.026; Ding WX, 2004, HEPATOLOGY, V40, P403, DOI 10.1002/hep.20310; Garcia-Ruiz C, 2007, J GASTROEN HEPATOL, V22, pS38, DOI 10.1111/j.1440-1746.2006.04644.x; Gardmo C, 2005, BIOCHEM PHARMACOL, V69, P1805, DOI 10.1016/j.bcp.2005.03.028; Ha YJ, 2004, J IMMUNOL, V172, P231, DOI 10.4049/jimmunol.172.1.231; Ha YJ, 2011, EXP MOL MED, V43, P101, DOI 10.3858/emm.2011.43.2.012; Hong SW, 2010, ARCH PHARM RES, V33, P601, DOI 10.1007/s12272-010-0415-y; Humphreys EH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014037; Jaeschke H, 2003, GASTROENTEROLOGY, V125, P1246, DOI 10.1016/S0016-5085(03)01209-5; Ke B, 2005, TRANSPLANTATION, V79, P1078, DOI 10.1097/01.TP.0000161248.43481.A2; Khandoga A, 2003, MICROVASC RES, V65, P71, DOI 10.1016/S0026-2862(02)00018-3; King LA, 2009, J HEPATO-BILIARY-PAN, V16, P763, DOI 10.1007/s00534-009-0155-x; Kobayashi M, 2002, SURGERY, V131, P344, DOI 10.1067/msy.2002.121097; Kohrmann M, 1999, J NEUROSCI RES, V58, P831; LALOR P, 1995, BRIT J HAEMATOL, V89, P725; Lee YJ, 2007, EUR J PHARMACOL, V573, P29, DOI 10.1016/j.ejphar.2007.06.049; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; Lisman T, 2010, SEMIN THROMB HEMOST, V36, P170, DOI 10.1055/s-0030-1251501; Massip-Salcedo M, 2007, LIVER INT, V27, P6, DOI 10.1111/j.1478-3231.2006.01390.x; Mebratu Y, 2009, CELL CYCLE, V8, P1168, DOI 10.4161/cc.8.8.8147; Nakajima H, 2008, APOPTOSIS, V13, P1013, DOI 10.1007/s10495-008-0234-5; Ohtaki Y, 2009, INT IMMUNOPHARMACOL, V9, P1071, DOI 10.1016/j.intimp.2009.04.016; Park Jae-Seung, 2011, BMC Res Notes, V4, P8, DOI 10.1186/1756-0500-4-8; Shen XD, 2009, HEPATOLOGY, V50, P1537, DOI 10.1002/hep.23153; Smith MK, 2007, J BIOMED MATER RES A, V80A, P520, DOI 10.1002/jbm.a.30930; Sullivan BP, 2010, TOXICOL SCI, V115, P286, DOI 10.1093/toxsci/kfq042; Taniai H, 2004, HEPATOLOGY, V39, P1544, DOI 10.1002/hep.20217; Uehara T, 2004, TRANSPLANTATION, V78, P324, DOI 10.1097/01.TP.0000128859.42696.28; Ueno T, 2009, MED SCI MONITOR, V15, pCR341; Vardanian AJ, 2008, MOL MED, V14, P337, DOI 10.2119/2007-00134.Vardanian; Xia M, 2010, J THROMB HAEMOST, V8, P397, DOI 10.1111/j.1538-7836.2009.03683.x; Xu H, 2006, J CLIN INVEST, V116, P769, DOI 10.1172/JCI27155; Xu H, 2003, J IMMUNOL, V170, P2776, DOI 10.4049/jimmunol.170.5.2776	48	17	19	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30867	10.1371/journal.pone.0030867	http://dx.doi.org/10.1371/journal.pone.0030867			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295117	Green Submitted, Green Published, gold			2022-12-27	WOS:000301640600062
J	Lee, JD; Kwon, TJ; Kim, UK; Lee, WS				Lee, Jong Dae; Kwon, Tae Jun; Kim, Un-Kyung; Lee, Won-Sang			Genetic and Epigenetic Alterations of the NF2 Gene in Sporadic Vestibular Schwannomas	PLOS ONE			English	Article							NEUROFIBROMATOSIS TYPE-2 GENE; TUMOR-SUPPRESSOR; METHYLATION; MUTATION; RETINOBLASTOMA; GROWTH	Background: Mutations in the neurofibromatosis type 2 (NF2) tumor-suppressor gene have been identified in not only NF2-related tumors but also sporadic vestibular schwannomas (VS). This study investigated the genetic and epigenetic alterations in tumors and blood from 30 Korean patients with sporadic VS and correlated these alterations with tumor behavior. Methodology/Principal Findings: NF2 gene mutations were detected using PCR and direct DNA sequencing and three highly polymorphic microsatellite DNA markers were used to assess the loss of heterozygosity (LOH) from chromosome 22. Aberrant hypermethylation of the CpG island of the NF2 gene was also analyzed. The tumor size, the clinical growth index, and the proliferative activity assessed using the Ki-67 labeling index were evaluated. We found 18 mutations in 16 cases of 30 schwannomas (53%). The mutations included eight frameshift mutations, seven nonsense mutations, one in-frame deletion, one splicing donor site, and one missense mutation. Nine patients (30%) showed allelic loss. No patient had aberrant hypermethylation of the NF2 gene and correlation between NF2 genetic alterations and tumor behavior was not observed in this study. Conclusions/Significance: The molecular genetic changes in sporadic VS identified here included mutations and allelic loss, but no aberrant hypermethylation of the NF2 gene was detected. In addition, no clear genotype/phenotype correlation was identified. Therefore, it is likely that other factors contribute to tumor formation and growth.	[Lee, Jong Dae] Soonchunhyang Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Puchon, South Korea; [Kwon, Tae Jun; Kim, Un-Kyung] Kyungpook Natl Univ, Coll Nat Sci, Dept Biol, Taegu, South Korea; [Lee, Won-Sang] Yonsei Univ, Coll Med, Dept Otorhinolaryngol, Seoul, South Korea	Soonchunhyang University; Kyungpook National University; Yonsei University; Yonsei University Health System	Lee, JD (corresponding author), Soonchunhyang Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Puchon, South Korea.	kimuk@knu.ac.kr			Ministry of Health and Welfare, Republic of Korea [A100367]	Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported by a grant from the Korea Healthcare technology R&D Project, Ministry of Health and Welfare, Republic of Korea (A100367). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antinheimo J, 2000, ACTA NEUROCHIR, V142, P1099, DOI 10.1007/s007010070036; Baser ME, 2006, HUM MUTAT, V27, P297, DOI 10.1002/humu.20317; Bian LG, 2005, J NEURO-ONCOL, V73, P253, DOI 10.1007/s11060-004-5176-3; Caye-Thomasen P, 2010, OTOL NEUROTOL, V31, P256, DOI 10.1097/MAO.0b013e3181be6478; Evans DGR, 2005, J MED GENET, V42, P630, DOI 10.1136/jmg.2004.027953; GREGER V, 1989, HUM GENET, V83, P155, DOI 10.1007/BF00286709; Hadfield KD, 2010, ONCOGENE, V29, P6216, DOI 10.1038/onc.2010.363; Irving RM, 1997, AM J OTOL, V18, P754; JACOBY LB, 1994, HUM MOL GENET, V3, P413, DOI 10.1093/hmg/3.3.413; Kino T, 2001, GENES CELLS, V6, P441, DOI 10.1046/j.1365-2443.2001.00432.x; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Kullar PJ, 2010, NEUROPATH APPL NEURO, V36, P505, DOI 10.1111/j.1365-2990.2010.01090.x; Lassaletta L, 2006, OTOL NEUROTOL, V27, P1180, DOI 10.1097/01.mao.0000226291.42165.22; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Lomas J, 2005, GENE CHROMOSOME CANC, V42, P314, DOI 10.1002/gcc.20141; MERLO A, 1995, NAT MED, V1, P686, DOI 10.1038/nm0795-686; Mohyuddin A, 2003, CLIN OTOLARYNGOL, V28, P85, DOI 10.1046/j.1365-2273.2003.00670.x; Neff BA, 2006, OTOL NEUROTOL, V27, P197, DOI 10.1097/01.mao.0000180484.24242.54; Patel NP, 2004, OTOL NEUROTOL, V25, P636, DOI 10.1097/00129492-200407000-00038; ROULEAU GA, 1993, NATURE, V363, P515, DOI 10.1038/363515a0; TROFATTER JA, 1993, CELL, V72, P791, DOI 10.1016/0092-8674(93)90406-G; Welling DB, 2002, OTOL NEUROTOL, V23, P736, DOI 10.1097/00129492-200209000-00022; Welling DB, 1996, HUM GENET, V98, P189, DOI 10.1007/s004390050188	23	25	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30418	10.1371/journal.pone.0030418	http://dx.doi.org/10.1371/journal.pone.0030418			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295085	Green Submitted, Green Published, gold			2022-12-27	WOS:000301640600030
J	Nguyen, JT; Smee, DF; Barnard, DL; Julander, JG; Gross, M; de Jong, MD; Went, GT				Nguyen, Jack T.; Smee, Donald F.; Barnard, Dale L.; Julander, Justin G.; Gross, Matthew; de Jong, Menno D.; Went, Gregory T.			Efficacy of Combined Therapy with Amantadine, Oseltamivir, and Ribavirin In Vivo against Susceptible and Amantadine-Resistant Influenza A Viruses	PLOS ONE			English	Article							COMBINATION TREATMENT; ANTIVIRAL THERAPY; CELL-CULTURE; MDCK CELLS; INFECTIONS; MICE; AGENTS; TRANSPLANTATION; INCREASES; VITRO	The limited efficacy of existing antiviral therapies for influenza - coupled with widespread baseline antiviral resistance highlights the urgent need for more effective therapy. We describe a triple combination antiviral drug (TCAD) regimen composed of amantadine, oseltamivir, and ribavirin that is highly efficacious at reducing mortality and weight loss in mouse models of influenza infection. TCAD therapy was superior to dual and single drug regimens in mice infected with drug-susceptible, low pathogenic A/H5N1 (A/Duck/MN/1525/81) and amantadine-resistant 2009 A/H1N1 influenza (A/California/04/09). Treatment with TCAD afforded >90% survival in mice infected with both viruses, whereas treatment with dual and single drug regimens resulted in 0% to 60% survival. Importantly, amantadine had no activity as monotherapy against the amantadine-resistant virus, but demonstrated dose-dependent protection in combination with oseltamivir and ribavirin, indicative that amantadine's activity had been restored in the context of TCAD therapy. Furthermore, TCAD therapy provided survival benefit when treatment was delayed until 72 hours post-infection, whereas oseltamivir monotherapy was not protective after 24 hours post-infection. These findings demonstrate in vivo efficacy of TCAD therapy and confirm previous reports of the synergy and broad spectrum activity of TCAD therapy against susceptible and resistant influenza strains in vitro.	[Nguyen, Jack T.; Gross, Matthew; Went, Gregory T.] Adamas Pharmaceut Inc, Emeryville, CA USA; [Smee, Donald F.; Barnard, Dale L.; Julander, Justin G.] Utah State Univ, Logan, UT 84322 USA; [de Jong, Menno D.] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands	Utah System of Higher Education; Utah State University; University of Amsterdam; Academic Medical Center Amsterdam	Nguyen, JT (corresponding author), Adamas Pharmaceut Inc, Emeryville, CA USA.	jnguyen@adamaspharma.com			Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, USA [N01-AI-30063]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI030063] Funding Source: NIH RePORTER	Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, USA; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, USA, under contract N01-AI-30063 (awarded to Southern Research Institute, Birmingham, AL, USA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Aoki FY, 2003, J ANTIMICROB CHEMOTH, V51, P123, DOI 10.1093/jac/dkg007; Centers for Disease Control and Prevention, 2010, 2010 2011 INFL SEAS; Choi SM, 2011, BLOOD, V117, P5050, DOI 10.1182/blood-2010-11-319186; de Jong MD, 2005, NEW ENGL J MED, V353, P2667, DOI 10.1056/NEJMoa054512; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Duval X, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000362; Gooskens J, 2009, J INFECT DIS, V199, P1435, DOI 10.1086/598684; Govorkova EA, 2004, ANTIMICROB AGENTS CH, V48, P4855, DOI 10.1128/AAC.48.12.4855-4863.2004; HAYDEN FG, 1980, ANTIMICROB AGENTS CH, V18, P536, DOI 10.1128/AAC.18.4.536; HAYDEN FG, 1986, J ANTIMICROB CHEMOTH, V18, P177, DOI 10.1093/jac/18.Supplement_B.177; Ilyushina NA, 2008, ANTIMICROB AGENTS CH, V52, P3889, DOI 10.1128/AAC.01579-07; Ilyushina NA, 2007, ANTIVIR THER, V12, P363; Ilyushina NA, 2007, J GEN VIROL, V88, P1266, DOI 10.1099/vir.0.82256-0; Ilyushina NA, 2006, ANTIVIR RES, V70, P121, DOI 10.1016/j.antiviral.2006.01.012; Kandun IN, 2008, LANCET, V372, P744, DOI 10.1016/S0140-6736(08)61125-3; Kiso M, 2004, LANCET, V364, P759, DOI 10.1016/S0140-6736(04)16934-1; Kjaergard LL, 2001, BMJ-BRIT MED J, V323, P1151, DOI 10.1136/bmj.323.7322.1151; Lau JYN, 2002, HEPATOLOGY, V35, P1002, DOI 10.1053/jhep.2002.32672; Li CC, 2010, EMERG INFECT DIS, V16, P1265, DOI 10.3201/eid1608.091918; Machado CM, 2004, BONE MARROW TRANSPL, V34, P111, DOI 10.1038/sj.bmt.1704534; MADREN LK, 1995, ANTIVIR CHEM CHEMOTH, V6, P109, DOI 10.1177/095632029500600205; Masihi KN, 2007, J CHEMOTHERAPY, V19, P295, DOI 10.1179/joc.2007.19.3.295; Matrosovich M, 2003, J VIROL, V77, P8418, DOI 10.1128/JVI.77.15.8418-8425.2003; McGeer A, 2007, CLIN INFECT DIS, V45, P1568, DOI 10.1086/523584; Nguyen JT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009332; Nguyen JT, 2009, ANTIMICROB AGENTS CH, V53, P4115, DOI 10.1128/AAC.00476-09; Nichols WG, 2004, CLIN INFECT DIS, V39, P1300, DOI 10.1086/425004; Peebles P., 2009, Morbidity and Mortality Weekly Report, V58, P369; Renaud C, 2011, EMERG INFECT DIS, V17, P653, DOI 10.3201/eid1704.101429; Sheu TG, 2011, J INFECT DIS, V203, P13, DOI 10.1093/infdis/jiq005; Smee DF, 2002, CHEMOTHERAPY, V48, P88, DOI 10.1159/000057668; Smee DF, 2009, ANTIMICROB AGENTS CH, V53, P2120, DOI 10.1128/AAC.01012-08; van der Vries E, 2008, NEW ENGL J MED, V359, P1074, DOI 10.1056/NEJMc0803120; VERNIER VG, 1969, TOXICOL APPL PHARM, V15, P642, DOI 10.1016/0041-008X(69)90066-0; Ward P, 2005, J ANTIMICROB CHEMOTH, V55, P5, DOI 10.1093/jac/dki018	35	65	71	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e31006	10.1371/journal.pone.0031006	http://dx.doi.org/10.1371/journal.pone.0031006			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22292088	gold, Green Submitted, Green Published			2022-12-27	WOS:000301570600105
J	Jakesch, M; Carbon, CC				Jakesch, Martina; Carbon, Claus-Christian			The Mere Exposure Effect in the Domain of Haptics	PLOS ONE			English	Article							LIKING; MEMORY; TOUCH; STIMULI; NEED; COMBINATION; IMPLICIT; FLUENCY; OBJECTS; MUSIC	Background: Zajonc showed that the attitude towards stimuli that one had been previously exposed to is more positive than towards novel stimuli. This mere exposure effect (MEE) has been tested extensively using various visual stimuli. Research on the MEE is sparse, however, for other sensory modalities. Methodology/Principal Findings: We used objects of two material categories (stone and wood) and two complexity levels (simple and complex) to test the influence of exposure frequency (F0 = novel stimuli, F2 = stimuli exposed twice, F10 = stimuli exposed ten times) under two sensory modalities (haptics only and haptics & vision). Effects of exposure frequency were found for high complex stimuli with significantly increasing liking from F0 to F2 and F10, but only for the stone category. Analysis of "Need for Touch" data showed the MEE in participants with high need for touch, which suggests different sensitivity or saturation levels of MEE. Conclusions/Significance: This different sensitivity or saturation levels might also reflect the effects of expertise on the haptic evaluation of objects. It seems that haptic and cross-modal MEEs are influenced by factors similar to those in the visual domain indicating a common cognitive basis.	[Jakesch, Martina; Carbon, Claus-Christian] Univ Bamberg, Dept Gen Psychol & Methodol, Bamberg, Germany; [Jakesch, Martina] Univ Vienna, Dept Basic Res, Fac Psychol, Vienna, Austria	Otto Friedrich University Bamberg; University of Vienna	Jakesch, M (corresponding author), Univ Bamberg, Dept Gen Psychol & Methodol, Bamberg, Germany.	martina.jakesch@uni-bamberg.de	Carbon, Claus-Christian/A-7494-2008; Carbon, Claus-Christian/GLQ-6274-2022	Carbon, Claus-Christian/0000-0002-3446-9347; Carbon, Claus-Christian/0000-0002-3446-9347				Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029; [Anonymous], 1974, STUDIES NEW EXPT AES; Ballesteros S, 1999, PSICOTHEMA, V11, P785; BALOGH RD, 1986, INFANT BEHAV DEV, V9, P395, DOI 10.1016/0163-6383(86)90013-5; Berlyne D. E., 1971, AESTHETICS PSYCHOBIO; BORNSTEIN RF, 1990, J PERS SOC PSYCHOL, V58, P791, DOI 10.1037/0022-3514.58.5.791; BORNSTEIN RF, 1994, SOC COGNITION, V12, P103, DOI 10.1521/soco.1994.12.2.103; BORNSTEIN RF, 1989, PSYCHOL BULL, V106, P265, DOI 10.1037/0033-2909.106.2.265; CARBON C.-C., 2006, PSYCHOL SCI, V48, P173; Carbon CC, 2005, APPL COGNITIVE PSYCH, V19, P587, DOI 10.1002/acp.1098; Carbon CC, 2008, RES ENG DES, V19, P143, DOI 10.1007/s00163-008-0045-2; Cox D, 2002, J ACAD MARKET SCI, V30, P119, DOI 10.1177/03079459994371; Faerber SJ, 2010, ACTA PSYCHOL, V135, P191, DOI 10.1016/j.actpsy.2010.06.006; Fang X, 2007, J CONSUM RES, V34, P97, DOI 10.1086/513050; Fechner TG, 1871, VORSCHULE ASTHETIK 1; Gepshtein S, 2003, CURR BIOL, V13, P483, DOI 10.1016/S0960-9822(03)00133-7; Gerger G, 2011, SWISS J PSYCHOL, V70, P75, DOI 10.1024/1421-0185/a000041; GORDON PC, 1983, J PERS SOC PSYCHOL, V45, P492, DOI 10.1037/0022-3514.45.3.492; Hansen T, 2001, SOC BEHAV PERSONAL, V29, P271, DOI 10.2224/sbp.2001.29.3.271; HEINGARTNER A, 1974, J PERS SOC PSYCHOL, V29, P719, DOI 10.1037/h0036121; HEYDUK RG, 1975, PERCEPT PSYCHOPHYS, V17, P84, DOI 10.3758/BF03204003; Kruglanski AW, 1996, EUR J SOC PSYCHOL, V26, P479, DOI 10.1002/(SICI)1099-0992(199605)26:3<479::AID-EJSP770>3.0.CO;2-U; KUNSTWILSON WR, 1980, SCIENCE, V207, P557, DOI 10.1126/science.7352271; Lee AY, 2001, PERS SOC PSYCHOL B, V27, P1255, DOI 10.1177/01461672012710002; LIEBERMA.LR, 1968, PERCEPT MOTOR SKILL, V26, P891, DOI 10.2466/pms.1968.26.3.891; Oppenheimer DM, 2008, TRENDS COGN SCI, V12, P237, DOI 10.1016/j.tics.2008.02.014; Oruc I, 2003, VISION RES, V43, P2451, DOI 10.1016/S0042-6989(03)00435-8; Peck J, 2006, J BUS RES, V59, P765, DOI 10.1016/j.jbusres.2006.01.014; Peck J, 2003, J CONSUM RES, V30, P430, DOI 10.1086/378619; Peck J, 2011, PSYCHOL MARKET, V28, P222, DOI 10.1002/mar.20389; Phillips F, 2009, ACTA PSYCHOL, V132, P259, DOI 10.1016/j.actpsy.2009.07.010; Prescott J, 2008, CHEMOSENS PERCEPT, V1, P2, DOI 10.1007/s12078-007-9004-y; Schaal B, 2000, CHEM SENSES, V25, P729, DOI 10.1093/chemse/25.6.729; Seamon JG, 1997, MEM COGNITION, V25, P367, DOI 10.3758/BF03211292; STANG DJ, 1974, PSYCHOL BULL, V81, P1014, DOI 10.1037/h0037419; STANG DJ, 1975, J PERS SOC PSYCHOL, V31, P7, DOI 10.1037/h0076165; STANG DJ, 1974, J PERS SOC PSYCHOL, V30, P647, DOI 10.1037/h0037418; STANG DJ, 1973, EUR J SOC PSYCHOL, V3, P351, DOI 10.1002/ejsp.2420030314; Suzuki M, 2008, COGNITION EMOTION, V22, P147, DOI 10.1080/02699930701298382; Szpunar KK, 2004, J EXP PSYCHOL LEARN, V30, P370, DOI 10.1037/0278-7393.30.2.370; Tan SL, 2006, MUSIC PERCEPT, V23, P407, DOI 10.1525/mp.2006.23.5.407; Thompson WF, 2000, MEM COGNITION, V28, P547, DOI 10.3758/BF03201245; Titchener E. B, 1910, TXB PSYCHOL; TULVING E, 1990, SCIENCE, V247, P301, DOI 10.1126/science.2296719; Whittlesea BWA, 2001, MEM COGNITION, V29, P234, DOI 10.3758/BF03194917; Winkielman P, 2001, J PERS SOC PSYCHOL, V81, P989, DOI 10.1037//0022-3514.81.6.989; Witvliet CVO, 2007, COGNITION EMOTION, V21, P3, DOI 10.1080/02699930601000672; ZAJONC RB, 1968, J PERS SOC PSYCHOL, V9, P1, DOI 10.1037/h0025848; ZAJONC RB, 1972, J PERS SOC PSYCHOL, V21, P270, DOI 10.1037/h0032357	49	25	25	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31215	10.1371/journal.pone.0031215	http://dx.doi.org/10.1371/journal.pone.0031215			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	924ZP	22347451	Green Published, gold			2022-12-27	WOS:000302730100054
J	Murai, H; Qi, HB; Choudhury, B; Wild, J; Dharajiya, N; Vaidya, S; Kalita, A; Bacsi, A; Corry, D; Kurosky, A; Brasier, A; Boldogh, I; Sur, S				Murai, Hiroki; Qi, Huibin; Choudhury, Barun; Wild, Jim; Dharajiya, Nilesh; Vaidya, Swapnil; Kalita, Anjana; Bacsi, Attila; Corry, David; Kurosky, Alexander; Brasier, Allan; Boldogh, Istvan; Sur, Sanjiv			Alternaria-Induced Release of IL-18 from Damaged Airway Epithelial Cells: An NF-kappa B Dependent Mechanism of Th2 Differentiation?	PLOS ONE			English	Article							THYMIC STROMAL LYMPHOPOIETIN; CD4(+) T-CELLS; NUTRITION EXAMINATION SURVEY; ALLERGIC LUNG INFLAMMATION; DENDRITIC CELLS; NATIONAL-HEALTH; MOUSE MODEL; IN-VIVO; ASTHMA; INDUCTION	Background: A series of epidemiologic studies have identified the fungus Alternaria as a major risk factor for asthma. The airway epithelium plays a critical role in the pathogenesis of allergic asthma. These reports suggest that activated airway epithelial cells can produce cytokines such as IL-25, TSLP and IL-33 that induce Th2 phenotype. However the epithelium-derived products that mediate the pro-asthma effects of Alternaria are not well characterized. We hypothesized that exposure of the airway epithelium to Alternaria releasing cytokines that can induce Th2 differentiation. Methodology/Principal Finding: We used ELISA to measure human and mouse cytokines. Alternaria extract (ALT-E) induced rapid release of IL-18, but not IL-4, IL-9, IL-13, IL-25, IL-33, or TSLP from cultured normal human bronchial epithelial cells; and in the BAL fluids of naive mice after challenge with ALT-E. Both microscopic and FACS indicated that this release was associated with necrosis of epithelial cells. ALT-E induced much greater IL-18 release compared to 19 major outdoor allergens. Culture of naive CD4 cells with rmIL-18 induced Th2 differentiation in the absence of IL-4 and STAT6, and this effect was abrogated by disrupting NF-kappa B p50 or with a NEMO binding peptide inhibitor. Conclusion/Significance: Rapid and specific release of IL-18 from Alternaria-exposed damaged airway epithelial cells can directly initiate Th2 differentiation of naive CD4(+) T-cells via a unique NF-kappa B dependent pathway.	[Murai, Hiroki; Vaidya, Swapnil; Bacsi, Attila; Brasier, Allan; Sur, Sanjiv] Univ Texas Galveston, Med Branch, Dept Internal Med, Galveston, TX 77550 USA; [Corry, David] Baylor Coll Med, Dept Med, Div Pulm & Crit Care, Houston, TX 77030 USA; [Kurosky, Alexander] Univ Texas Galveston, Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77550 USA; [Boldogh, Istvan] Univ Texas Galveston, Med Branch, Dept Microbiol, Galveston, TX 77550 USA	University of Texas System; University of Texas Medical Branch Galveston; Baylor College of Medicine; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Murai, H (corresponding author), Univ Texas Galveston, Med Branch, Dept Internal Med, Galveston, TX 77550 USA.	sasur@utmb.edu	Murai, Hiroki/J-4030-2019	Murai, Hiroki/0000-0001-5291-8954; Bacsi, Attila/0000-0002-2311-2975; Brasier, Allan/0000-0002-5012-4090	National Heart, Lung, and Blood Institute (NHLBI) [RO1HL071163]; National Institute of Enviromental Health Sciences (NIEHS) [RO1-ES018948]; National Heart, Lung, and Blood Institute (NHLBI), Proteomics Center for Airway Inflammation; National Institute of Allergy and Infectious Disease (NIAID) [PO1AI062885-01, NO1-HV 00245]; National Institute of Environmental Health Science Center [P30-ES006676]; Institute for Translational Sciences - Clinical Research Center (ITS-CRC) at the University of Texas Medical Branch at Galveston; NIH [UL1RR029876]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000071] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029876] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI062885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES018948, P30ES006676] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Enviromental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Heart, Lung, and Blood Institute (NHLBI), Proteomics Center for Airway Inflammation; National Institute of Allergy and Infectious Disease (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Environmental Health Science Center; Institute for Translational Sciences - Clinical Research Center (ITS-CRC) at the University of Texas Medical Branch at Galveston; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	National Heart, Lung, and Blood Institute (NHLBI) RO1HL071163 (Sur, Boldogh); National Institute of Enviromental Health Sciences (NIEHS) RO1-ES018948 (Boldogh, Sur); National Heart, Lung, and Blood Institute (NHLBI), Proteomics Center for Airway Inflammation; NO1-HV 00245 (Kurosky, Sur, Boldogh), National Institute of Allergy and Infectious Disease (NIAID) PO1AI062885-01 (Brasier, Sur, Boldogh); National Institute of Environmental Health Science Center Grant P30-ES006676 (C. Elferink, Boldogh); Institute for Translational Sciences - Clinical Research Center (ITS-CRC) at the University of Texas Medical Branch at Galveston supported in part by grant UL1RR029876 from NIH (Brasier). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Arbes SJ, 2007, J ALLERGY CLIN IMMUN, V120, P1139, DOI 10.1016/j.jaci.2007.07.056; Boldogh I, 2005, J CLIN INVEST, V115, P2169, DOI 10.1172/JCI24422; Das J, 2001, NAT IMMUNOL, V2, P45, DOI 10.1038/83158; GERGEN PJ, 1992, J ALLERGY CLIN IMMUN, V90, P579, DOI 10.1016/0091-6749(92)90130-T; GONG JL, 1992, J EXP MED, V175, P797, DOI 10.1084/jem.175.3.797; Halonen M, 1997, AM J RESP CRIT CARE, V155, P1356, DOI 10.1164/ajrccm.155.4.9105079; Heier I, 2011, THORAX, V66, P151, DOI 10.1136/thx.2010.149591; HOLT PG, 1981, IMMUNOLOGY, V42, P409; HOLT PG, 1993, J EXP MED, V177, P397, DOI 10.1084/jem.177.2.397; Iyer SS, 2009, P NATL ACAD SCI USA, V106, P20388, DOI 10.1073/pnas.0908698106; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Kobayashi T, 2009, J IMMUNOL, V182, P2502, DOI 10.4049/jimmunol.0802773; Kouzaki H, 2011, J IMMUNOL, V186, P4375, DOI 10.4049/jimmunol.1003020; Kouzaki H, 2009, J IMMUNOL, V183, P1427, DOI 10.4049/jimmunol.0900904; Lambrecht BN, 2008, CURR MOL MED, V8, P393, DOI 10.2174/156652408785160916; Lambrecht BN, 2010, LANCET, V376, P835, DOI 10.1016/S0140-6736(10)61226-3; Lambrecht BN, 2009, IMMUNITY, V31, P412, DOI 10.1016/j.immuni.2009.08.008; Matsumoto S, 1997, BIOCHEM BIOPH RES CO, V234, P454, DOI 10.1006/bbrc.1997.6665; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; NELSON DJ, 1995, AM J RESP CRIT CARE, V151, P475, DOI 10.1164/ajrccm.151.2.7842209; Nelson HS, 1999, J ALLERGY CLIN IMMUN, V104, P775, DOI 10.1016/S0091-6749(99)70287-3; Omori M, 2007, J IMMUNOL, V178, P1396, DOI 10.4049/jimmunol.178.3.1396; Ouyang WJ, 2000, IMMUNITY, V12, P27, DOI 10.1016/S1074-7613(00)80156-9; Porter P, 2009, MUCOSAL IMMUNOL; Reed CE, 2004, J ALLERGY CLIN IMMUN, V114, P997, DOI 10.1016/j.jaci.2004.07.060; Saenz SA, 2010, NATURE, V464, P1362, DOI 10.1038/nature08901; SCHONHEGRAD MA, 1991, J EXP MED, V173, P1345, DOI 10.1084/jem.173.6.1345; SEDGWICK JD, 1983, IMMUNOLOGY, V50, P625; Seymour BWP, 1998, J EXP MED, V187, P721, DOI 10.1084/jem.187.5.721; Sharkhuu T, 2006, CLIN EXP ALLERGY, V36, P1575, DOI 10.1111/j.1365-2222.2006.02595.x; Smeltz RB, 2001, J EXP MED, V194, P143, DOI 10.1084/jem.194.2.143; Sur S, 1996, J IMMUNOL, V157, P4173; Sur S, 1999, J IMMUNOL, V162, P6284; Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0; van Rijt LS, 2005, J EXP MED, V201, P981, DOI 10.1084/jem.20042311; Wild JS, 2000, J IMMUNOL, V164, P2701, DOI 10.4049/jimmunol.164.5.2701; World Health Organization, 2007, GLOB SURV PREV CONTR; Yang LY, 1998, J EXP MED, V188, P1739, DOI 10.1084/jem.188.9.1739; Yoshimoto T, 2000, NAT IMMUNOL, V1, P132, DOI 10.1038/77811; Zhou BH, 2008, J IMMUNOL, V181, P6557, DOI 10.4049/jimmunol.181.9.6557	42	22	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2012	7	2							e30280	10.1371/journal.pone.0030280	http://dx.doi.org/10.1371/journal.pone.0030280			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917MF	22347372	gold, Green Published, Green Submitted			2022-12-27	WOS:000302180600007
J	Ishida-Yamamoto, A; Kishibe, M; Murakami, M; Honma, M; Takahashi, H; Iizuka, H				Ishida-Yamamoto, Akemi; Kishibe, Mari; Murakami, Masamoto; Honma, Masaru; Takahashi, Hidetoshi; Iizuka, Hajime			Lamellar Granule Secretion Starts before the Establishment of Tight Junction Barrier for Paracellular Tracers in Mammalian Epidermis	PLOS ONE			English	Article							PROTEINS; CELLS; SKIN; ZO-1; KERATINOCYTES; DESQUAMATION; DEGRADATION; MUTATION; OCCLUDIN; MICE	Defects in epidermal barrier function and/or vesicular transport underlie severe skin diseases including ichthyosis and atopic dermatitis. Tight junctions (TJs) form a single layered network in simple epithelia. TJs are important for both barrier functions and vesicular transport. Epidermis is stratified epithelia and lamellar granules (LGs) are secreted from the stratum granulosum (SG) in a sequential manner. Previously, continuous TJs and paracellular permeability barriers were found in the second layer (SG2) of SG in mice, but their fate and correlation with LG secretion have been poorly understood. We studied epidermal TJ-related structures in humans and in mice and found occludin/ZO-1 immunoreactive multilayered networks spanning the first layer of SG (SG1) and SG2. Paracellular penetration tracer passed through some TJs in SG2, but not in SG1. LG secretion into the paracellular tracer positive spaces started below the level of TJs of SG1. Our study suggests that LG-secretion starts before the establishment of TJ barrier in the mammalian epidermis.	[Ishida-Yamamoto, Akemi; Kishibe, Mari; Murakami, Masamoto; Honma, Masaru; Takahashi, Hidetoshi; Iizuka, Hajime] Asahikawa Med Univ, Dept Dermatol, Asahikawa, Hokkaido, Japan	Asahikawa Medical College	Ishida-Yamamoto, A (corresponding author), Asahikawa Med Univ, Dept Dermatol, Asahikawa, Hokkaido, Japan.	akemi@asahikawa-med.ac.jp			Ministry of Health, Labor and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan [21791054]; Grants-in-Aid for Scientific Research [24591620, 21390323] Funding Source: KAKEN	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant from the Ministry of Health, Labor and Welfare of Japan to A. I.-Y. and a grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan (21791054) to M.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brandner JM, 2002, EUR J CELL BIOL, V81, P253, DOI 10.1078/0171-9335-00244; Brandner JM, 2009, EUR J PHARM BIOPHARM, V72, P289, DOI 10.1016/j.ejpb.2008.08.007; De Benedetto A, 2011, J ALLERGY CLIN IMMUN, V127, P773, DOI 10.1016/j.jaci.2010.10.018; Descargues P, 2005, NAT GENET, V37, P56, DOI 10.1038/ng1493; ELIAS PM, 1975, J CELL BIOL, V65, P180, DOI 10.1083/jcb.65.1.180; ELIAS PM, 1983, J INVEST DERMATOL, V80, pS44, DOI 10.1038/jid.1983.12; Furuse M, 2002, J CELL BIOL, V156, P1099, DOI 10.1083/jcb.200110122; Guan YF, 2011, AM J PHYSIOL-CELL PH, V300, pC1404, DOI 10.1152/ajpcell.00270.2010; Hadj-Rabia S, 2004, GASTROENTEROLOGY, V127, P1386, DOI 10.1053/j.gastro.2004.07.022; HASHIMOTO K, 1971, J INVEST DERMATOL, V57, P17, DOI 10.1111/1523-1747.ep12292052; Hershkovitz D, 2008, ARCH DERMATOL, V144, P334, DOI 10.1001/archderm.144.3.334; Igawa S, 2011, EXP DERMATOL, V20, P53, DOI 10.1111/j.1600-0625.2010.01170.x; Ishida-Yamamoto A, 2004, J INVEST DERMATOL, V122, P1137, DOI 10.1111/j.0022-202X.2004.22515.x; Kirschner N, 2011, J INVEST DERMATOL, V131, P932, DOI 10.1038/jid.2010.390; Kirschner N, 2010, EUR J CELL BIOL, V89, P839, DOI 10.1016/j.ejcb.2010.07.010; Kirschner N, 2009, AM J PATHOL, V175, P1095, DOI 10.2353/ajpath.2009.080973; Kubo A, 2009, J EXP MED, V206, P2937, DOI 10.1084/jem.20091527; Kuroda S, 2010, J DERMATOL SCI, V59, P107, DOI 10.1016/j.jdermsci.2010.06.001; Langbein L, 2002, EUR J CELL BIOL, V81, P419, DOI 10.1078/0171-9335-00270; Morita K, 1998, J INVEST DERMATOL, V110, P862, DOI 10.1046/j.1523-1747.1998.00209.x; Pummi K, 2001, J INVEST DERMATOL, V117, P1050, DOI 10.1046/j.0022-202x.2001.01493.x; Schluter H, 2004, EUR J CELL BIOL, V83, P655, DOI 10.1078/0171-9335-00434; Simon M, 2001, J BIOL CHEM, V276, P20292, DOI 10.1074/jbc.M100201200; Sprecher E, 2005, AM J HUM GENET, V77, P242, DOI 10.1086/432556; Tsukita S, 2008, ONCOGENE, V27, P6930, DOI 10.1038/onc.2008.344; Yuki T, 2011, J INVEST DERMATOL, V131, P744, DOI 10.1038/jid.2010.385	26	28	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2012	7	2							e31641	10.1371/journal.pone.0031641	http://dx.doi.org/10.1371/journal.pone.0031641			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LV	22328942	Green Published, Green Submitted, gold			2022-12-27	WOS:000302179300028
J	Bell, PR				Bell, Phil R.			Standardized Terminology and Potential Taxonomic Utility for Hadrosaurid Skin Impressions: A Case Study for Saurolophus from Canada and Mongolia	PLOS ONE			English	Article							DINOSAUR; ORNITHISCHIA; INTEGUMENT; OSTEODERMS; SKELETON	The characterization of palaeospecies typically relies on hard-tissue anatomy, such as bones or teeth that is more readily fossilized than soft parts. Among dinosaurs, skin impressions are commonly associated with partial and complete hadrosaurid skeletons, and consist of non-imbricating tubercles or scales. Skin impressions from various parts of the body of two species of the hadrosaurine Saurolophus (S. angustirostris from Mongolia and S. osborni from Canada) are described from multiple specimens. These species, recently validated on osteological grounds, can be differentiated based solely on soft-tissue anatomy, namely scale shape and pattern. This study demonstrates for the first time the applicability of soft-tissue (i.e., scale impressions) as a means to differentiate species within the Dinosauria. Differences are most spectacular in the tail, where S. angustirostris is differentiated by the presence of vertical bands of morphologically distinct scales, a grid-like arrangement of circular feature-scales, and tabular scales along the dorsal midline. Preliminary results indicate scale architecture remained consistent throughout ontogeny in S. angustirostris. These results support previous assertions that hadrosaurid scale architecture has a positive phylogenetic signal. As such, future taxonomic descriptions should include, where possible, the standardized description of skin impressions including the position and orientation of these impressions on the body.	[Bell, Phil R.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada	University of Alberta	Bell, PR (corresponding author), Pipestone Creek Dinosaur Initiat, Clairmont, AB, Canada.	pbell@countygp.ab.ca			Dinosaur Research Institute; Korean Institute of Geology and Mineralogy; Hwaseong City (Korea)	Dinosaur Research Institute; Korean Institute of Geology and Mineralogy; Hwaseong City (Korea)	Funding was provided by the Dinosaur Research Institute (travel grant; no grant number); the Korean Institute of Geology and Mineralogy, and Hwaseong City (Korea)(travel grant; no grant number). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson BG, 1998, J VERTEBR PALEONTOL, V18, P739, DOI 10.1080/02724634.1998.10011102; Bell PR, 2011, CRETACEOUS RES, V32, P30, DOI 10.1016/j.cretres.2010.10.002; Bell PR, ACTA PAL PO IN PRESS, V56; Briggs DEG, 1997, J GEOL SOC LONDON, V154, P587, DOI 10.1144/gsjgs.154.4.0587; Brown B, 1913, B AM MUS NAT HIST, V32, P387; Brown B, 1912, B AM MUS NAT HIST, V31, P131; Brown B, 1916, B AM MUS NAT HIST, V35, P709; Burns ME, 2008, J VERTEBR PALEONTOL, V28, P1102, DOI 10.1671/0272-4634-28.4.1102; Coria RA, 2007, J PALEONTOL, V81, P1528, DOI 10.1666/05-150.1; Czerkas S. A., 1997, ENCY DINOSAURS, P669; CZERKAS SA, 1992, GEOLOGY, V20, P1068, DOI 10.1130/0091-7613(1992)020<1068:DODSRA>2.3.CO;2; Dodson P, 1998, J VERTEBR PALEONTOL, V18, P563, DOI 10.1080/02724634.1998.10011084; Evans DC, 2007, J VERTEBR PALEONTOL, V27, P373, DOI 10.1671/0272-4634(2007)27[373:AAROLM]2.0.CO;2; HORNER JR, 1984, J PALEONTOL, V58, P270; Ji Shuan, 1998, Geological Review (Beijing), V44, P603; Lambe L., 1914, Ottawa Naturalist, V27; Lambe L., 1914, Ottawa Naturalist, V27; Lull R.S., 1942, GEOLOGICAL SOC AM SP, V40, P242; Murphy NL., 2006, HORNS BEAKS CERATOPS, P117; Norman David B., 2000, P462; Osborn H. F., 1912, AMER MUS NAT HIST ME, V1, P33; Osborn HF., 1911, AM MUSEUM J, V2, P7; Parks WA, 1920, T ROY SOC CAN, V13, P5; Scheyer TM, 2004, J VERTEBR PALEONTOL, V24, P878; Siber H.-J., 2009, STEGOSAURS SAURIERMU; STERNBERG C. M., 1935, BULL NAT MUS CANADA, V77, P1; Wegweiser M.D., 2006, NEW MEX MUS NAT HIST, V35, P119; Xu X, 1999, NATURE, V401, P262, DOI 10.1038/45769; Xu X, 1999, NATURE, V399, P350, DOI 10.1038/20670; Xu X, 2001, NATURE, V410, P200, DOI 10.1038/35065589	30	35	36	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e31295	10.1371/journal.pone.0031295	http://dx.doi.org/10.1371/journal.pone.0031295			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LO	22319623	gold, Green Published			2022-12-27	WOS:000302178400035
J	von Maltzan, K; Tan, W; Pruett, SB				von Maltzan, Kristine; Tan, Wei; Pruett, Stephen B.			Investigation of the Role of TNF-alpha Converting Enzyme (TACE) in the Inhibition of Cell Surface and Soluble TNF-alpha Production by Acute Ethanol Exposure	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; BINGE-DRINKING MODEL; INNATE IMMUNITY; LIPID RAFTS; IN-VIVO; INFLAMMATORY RESPONSE; HUMAN MONOCYTES; POTENTIAL ROLE; DISINTEGRIN; ACTIVATION	Toll-like receptors (TLRs) play a fundamental role in the immune system by detecting pathogen associated molecular patterns (PAMPs) to sense host infection. Ethanol at doses relevant for humans inhibits the pathogen induced cytokine response mediated through TLRs. The current study was designed to investigate the mechanisms of this effect by determining whether ethanol inhibits TLR3 and TLR4 mediated TNF-alpha secretion through inhibition of transcription factor activation or post-transcriptional effects. In NF-kappa B reporter mice, activation of NF-kappa B in vivo by LPS was inhibited by ethanol (LPS alone yielded 170,000 +/- 35,300 arbitrary units of light emission; LPS plus ethanol yielded 56,120 +/- 16880, p = 0.04). Inhibition of protein synthesis by cycloheximide revealed that poly I:C- or LPS-induced secreted TNF-alpha is synthesized de novo, not released from cellular stores. Using real time RT-PCR, we found inhibition of LPS and poly I:C induced TNF-alpha gene transcription by ethanol. Using an inhibitor of tumor necrosis factor alpha converting enzyme (TACE), we found that shedding caused by TACE is a prerequisite for TNF-alpha release after pathogen challenge. Flow cytometry was used to investigate if ethanol decreases TNF-alpha secretion by inhibition of TACE. In cells treated with LPS, ethanol decreased both TNF-alpha cell surface expression and secretion. For example, 4.69 +/- 0.60% of untreated cells were positive for cell surface TNF-alpha, LPS increased this to 25.18 +/- 0.85%, which was inhibited by ethanol (86.8 mM) to 14.29 +/- 0.39% and increased by a TACE inhibitor to 57.88 +/- 0.62%. In contrast, cells treated with poly I:C had decreased secretion of TNF-alpha but not cell surface expression. There was some evidence for inhibition of TACE by ethanol in the case of LPS, but decreased TNF-alpha gene expression seems to be the major mechanism of ethanol action in this system.	[von Maltzan, Kristine] Louisiana State Univ, Hlth Sci Ctr, Dept Cellular Biol & Anat, Shreveport, LA 71105 USA; [Tan, Wei; Pruett, Stephen B.] Mississippi State Univ, Coll Vet Med, Dept Basic Sci, Mississippi State, MS 39762 USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Mississippi State University	von Maltzan, K (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Cellular Biol & Anat, Shreveport, LA 71105 USA.	pruett@cvm.msstate.edu			National Institute on Alcoholism and Alcohol Abuse [R01AA009505]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA009505] Funding Source: NIH RePORTER	National Institute on Alcoholism and Alcohol Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was funded by the National Institute on Alcoholism and Alcohol Abuse, grant #R01AA009505. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Amour A, 1998, FEBS LETT, V435, P39, DOI 10.1016/S0014-5793(98)01031-X; Armstrong L, 2006, AM J RESP CELL MOL, V34, P219, DOI 10.1165/rcmb.2005-0087OC; BERMUDEZ LE, 1991, J INFECT DIS, V163, P1286, DOI 10.1093/infdis/163.6.1286; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Brennan FM, 2008, EUR J IMMUNOL, V38, P1106, DOI 10.1002/eji.200737821; Carlsen H, 2002, J IMMUNOL, V168, P1441, DOI 10.4049/jimmunol.168.3.1441; Carr RL, 2008, TOXICOL SCI, V106, P186, DOI 10.1093/toxsci/kfn164; Carson EJ, 1996, ALCOHOL CLIN EXP RES, V20, P132, DOI 10.1111/j.1530-0277.1996.tb01055.x; Cerretti DP, 1999, CYTOKINE, V11, P541, DOI 10.1006/cyto.1998.0466; Dai Q, 2005, BIOCHEM BIOPH RES CO, V332, P37, DOI 10.1016/j.bbrc.2005.04.088; Dai Q, 2006, ALCOHOL CLIN EXP RES, V30, P1436, DOI 10.1111/j.1530-0277.2006.00172.x; Diaz-Rodriguez E, 2002, MOL BIOL CELL, V13, P2031, DOI 10.1091/mbc.01-11-0561; Dolganiuc A, 2006, ALCOHOL CLIN EXP RES, V30, P76, DOI 10.1111/j.1530-0277.2006.00003.x; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; GERSHMAN H, 1991, Journal of Emergency Medicine, V9, P307, DOI 10.1016/0736-4679(91)90371-L; Gomez MI, 2007, EMBO J, V26, P701, DOI 10.1038/sj.emboj.7601554; Goral J, 2005, J IMMUNOL, V174, P456, DOI 10.4049/jimmunol.174.1.456; Janeway CA, 1998, SEMIN IMMUNOL, V10, P349, DOI 10.1006/smim.1998.0142; Jones AW, 2009, FORENSIC SCI INT, V188, P40, DOI 10.1016/j.forsciint.2009.03.010; Lanzke N, 2007, ADDICT BIOL, V12, P59, DOI 10.1111/j.1369-1600.2006.00042.x; Li Y, 2006, BLOOD, V108, P2275, DOI 10.1182/blood-2006-02-005827; Mandrekar P, 1999, INT IMMUNOL, V11, P1781, DOI 10.1093/intimm/11.11.1781; MOHLER KM, 1994, NATURE, V370, P218, DOI 10.1038/370218a0; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; NELSON S, 1989, J INFECT DIS, V160, P422, DOI 10.1093/infdis/160.3.422; Pruett SB, 2004, J IMMUNOL, V173, P2715, DOI 10.4049/jimmunol.173.4.2715; Pruett SB, 2010, TOXICOL SCI, V117, P314, DOI 10.1093/toxsci/kfq215; Pruett SB, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-49; Robertshaw HJ, 2005, BRIT J ANAESTH, V94, P222, DOI 10.1093/bja/aei021; Roghani M, 1999, J BIOL CHEM, V274, P3531, DOI 10.1074/jbc.274.6.3531; Song KJ, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-123; Soond SM, 2005, J CELL SCI, V118, P2371, DOI 10.1242/jcs.02357; Stoeck A, 2006, BIOCHEM J, V393, P609, DOI 10.1042/BJ20051013; Szabo G, 2007, J IMMUNOL, V178, P1243, DOI 10.4049/jimmunol.178.3.1243; Tang P, 1996, BIOCHEMISTRY-US, V35, P8216, DOI 10.1021/bi952182t; URSO T, 1981, LIFE SCI, V28, P1053, DOI 10.1016/0024-3205(81)90752-9; Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Zhang ZL, 2000, J LEUKOCYTE BIOL, V67, P856, DOI 10.1002/jlb.67.6.856; Zhao XJ, 2004, ALCOHOL CLIN EXP RES, V28, P1399, DOI 10.1097/01.ALC.0000139819.46514.06; Zhao XJ, 2003, J IMMUNOL, V170, P2923, DOI 10.4049/jimmunol.170.6.2923	42	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e29890	10.1371/journal.pone.0029890	http://dx.doi.org/10.1371/journal.pone.0029890			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LO	22319556	Green Published, Green Submitted, gold			2022-12-27	WOS:000302178400002
J	Kaufmann, R; Piontek, J; Grull, F; Kirchgessner, M; Rossa, J; Wolburg, H; Blasig, IE; Cremer, C				Kaufmann, Rainer; Piontek, Joerg; Gruell, Frederik; Kirchgessner, Manfred; Rossa, Jan; Wolburg, Hartwig; Blasig, Ingolf E.; Cremer, Christoph			Visualization and Quantitative Analysis of Reconstituted Tight Junctions Using Localization Microscopy	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; SINGLE MOLECULES; CLAUDIN; STRANDS; RESOLUTION; PHOTOACTIVATION; DETERMINANTS; BLINKING; BEHAVIOR; CELLS	Tight Junctions (TJ) regulate paracellular permeability of tissue barriers. Claudins (Cld) form the backbone of TJ-strands. Pore-forming claudins determine the permeability for ions, whereas that for solutes and macromolecules is assumed to be crucially restricted by the strand morphology (i.e., density, branching and continuity). To investigate determinants of the morphology of TJ-strands we established a novel approach using localization microscopy. TJ-strands were reconstituted by stable transfection of HEK293 cells with the barrier-forming Cld3 or Cld5. Strands were investigated at cell-cell contacts by Spectral Position Determination Microscopy (SPDM), a method of localization microscopy using standard fluorophores. Extended TJ-networks of Cld3-YFP and Cld5-YFP were observed. For each network, 200,000 to 1,100,000 individual molecules were detected with a mean localization accuracy of similar to 20 nm, yielding a mean structural resolution of similar to 50 nm. Compared to conventional fluorescence microscopy, this strongly improved the visualization of strand networks and enabled quantitative morphometric analysis. Two populations of elliptic meshes (mean diameter <100 nm and 300-600 nm, respectively) were revealed. For Cld5 the two populations were more separated than for Cld3. Discrimination of non-polymeric molecules and molecules within polymeric strands was achieved. For both subtypes of claudins the mean density of detected molecules was similar and estimated to be similar to 24 times higher within the strands than outside the strands. The morphometry and single molecule information provided advances the mechanistic analysis of paracellular barriers. Applying this novel method to different TJ-proteins is expected to significantly improve the understanding of TJ on the molecular level.	[Kaufmann, Rainer; Gruell, Frederik; Kirchgessner, Manfred; Cremer, Christoph] Heidelberg Univ, Kirchhoff Inst Phys, Heidelberg, Germany; [Piontek, Joerg; Rossa, Jan; Blasig, Ingolf E.] Leibniz Inst Mol Pharmakol FMP, Berlin, Germany; [Wolburg, Hartwig] Univ Med Sch Tubingen, Inst Pathol & Neuropathol, Tubingen, Germany; [Cremer, Christoph] Heidelberg Univ, Inst Pharm & Mol Biotechnol, Heidelberg, Germany; [Cremer, Christoph] Inst Mol Biol, Mainz, Germany	Ruprecht Karls University Heidelberg; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Ruprecht Karls University Heidelberg; Institute of Molecular Biology (IMB)	Kaufmann, R (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Div Struct Biol, Oxford, England.	piontek@fmp-berlin.de	Kaufmann, Rainer/N-8911-2014; Piontek, Joerg/K-6305-2013; Kaufmann, Rainer/U-6406-2019	Kaufmann, Rainer/0000-0002-4165-0195; Piontek, Joerg/0000-0002-0880-8915; Kaufmann, Rainer/0000-0002-4165-0195	Deutsche Forschungsgemeinschaft [PI 837/2-1, SPP1128]; University of Heidelberg	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Heidelberg	This work has been supported by the Deutsche Forschungsgemeinschaft (PI 837/2-1, SPP1128) and a Frontier Project grant (University of Heidelberg) to M. Wassenegger (http://www.dfg.de/index.jsp; http://www.uni-heidelberg.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002584; Angelow S, 2008, AM J PHYSIOL-RENAL, V295, pF867, DOI 10.1152/ajprenal.90264.2008; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Dickson RM, 1997, NATURE, V388, P355, DOI 10.1038/41048; FARQUHAR MG, 1963, J CELL BIOL, V17, P375, DOI 10.1083/jcb.17.2.375; Folling J, 2008, NAT METHODS, V5, P943, DOI 10.1038/nmeth.1257; Furuse M, 1999, J CELL BIOL, V147, P891, DOI 10.1083/jcb.147.4.891; Grull F., 2011, INT C FIELD PROGR LO; Gunkel Manuel, 2009, Biotechnology Journal, V4, P927, DOI 10.1002/biot.200900005; Heilemann M, 2008, ANGEW CHEM INT EDIT, V47, P6172, DOI 10.1002/anie.200802376; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Kaufmann R, 2011, J MICROSC-OXFORD, V242, P46, DOI 10.1111/j.1365-2818.2010.03436.x; Krause G, 2008, BBA-BIOMEMBRANES, V1778, P631, DOI 10.1016/j.bbamem.2007.10.018; Lemmer P, 2008, APPL PHYS B-LASERS O, V93, P1, DOI 10.1007/s00340-008-3152-x; Mack AF, 2006, BRAIN RES, V1103, P25, DOI 10.1016/j.brainres.2006.04.135; Matsuda A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012768; McAnaney TB, 2005, BIOCHEMISTRY-US, V44, P5510, DOI 10.1021/bi047581f; Morita K, 1999, J CELL BIOL, V147, P185, DOI 10.1083/jcb.147.1.185; Morita K, 1999, P NATL ACAD SCI USA, V96, P511, DOI 10.1073/pnas.96.2.511; Peterman EJG, 1999, J PHYS CHEM A, V103, P10553, DOI 10.1021/jp991968o; Piontek J, 2008, FASEB J, V22, P146, DOI 10.1096/fj.07-8319com; Piontek J, 2011, CELL MOL LIFE SCI, V68, P3903, DOI 10.1007/s00018-011-0680-z; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Sasaki H, 2003, P NATL ACAD SCI USA, V100, P3971, DOI 10.1073/pnas.0630649100; Schuster J, 2005, OPT SPECTROSC+, V98, P712, DOI 10.1134/1.1929057; Shen L, 2008, J CELL BIOL, V181, P683, DOI 10.1083/jcb.200711165; Sinnecker D, 2005, BIOCHEMISTRY-US, V44, P7085, DOI 10.1021/bi047881x; STAEHELIN LA, 1974, INT REV CYTOL, V39, P191, DOI 10.1016/S0074-7696(08)60940-7; Steed E, 2010, TRENDS CELL BIOL, V20, P142, DOI 10.1016/j.tcb.2009.12.002; Van Itallie CM, 2009, MOL BIOL CELL, V20, P3930, DOI 10.1091/mbc.E09-04-0320; Winkler L, 2009, J BIOL CHEM, V284, P18863, DOI 10.1074/jbc.M109.008623; Yamazaki Y, 2011, MOL BIOL CELL, V22, P1495, DOI 10.1091/mbc.E10-12-1003	32	42	43	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2012	7	2							e31128	10.1371/journal.pone.0031128	http://dx.doi.org/10.1371/journal.pone.0031128			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UV	22319608	gold, Green Submitted, Green Published			2022-12-27	WOS:000301979000021
J	Sundar, IK; Chung, S; Hwang, JW; Lapek, JD; Bulger, M; Friedman, AE; Yao, HW; Davie, JR; Rahman, I				Sundar, Isaac K.; Chung, Sangwoon; Hwang, Jae-woong; Lapek, John D., Jr.; Bulger, Michael; Friedman, Alan E.; Yao, Hongwei; Davie, James R.; Rahman, Irfan			Mitogen- and Stress-Activated Kinase 1 (MSK1) Regulates Cigarette Smoke-Induced Histone Modifications on NF-kappa B-dependent Genes	PLOS ONE			English	Article							PROINFLAMMATORY CYTOKINE RELEASE; INDUCED LUNG INFLAMMATION; OXIDATIVE STRESS; PROTEIN-KINASE; INDUCED PHOSPHORYLATION; EPITHELIAL-CELLS; IKK-ALPHA; TRANSCRIPTIONAL ACTIVATION; H3 PHOSPHORYLATION; RAT LUNGS	Cigarette smoke (CS) causes sustained lung inflammation, which is an important event in the pathogenesis of chronic obstructive pulmonary disease (COPD). We have previously reported that IKK alpha (I kappaB kinase alpha) plays a key role in CS-induced pro-inflammatory gene transcription by chromatin modifications; however, the underlying role of downstream signaling kinase is not known. Mitogen-and stress-activated kinase 1 (MSK1) serves as a specific downstream NF-kappa B RelA/p65 kinase, mediating transcriptional activation of NF-kappa B-dependent pro-inflammatory genes. The role of MSK1 in nuclear signaling and chromatin modifications is not known, particularly in response to environmental stimuli. We hypothesized that MSK1 regulates chromatin modifications of pro-inflammatory gene promoters in response to CS. Here, we report that CS extract activates MSK1 in human lung epithelial (H292 and BEAS-2B) cell lines, human primary small airway epithelial cells (SAEC), and in mouse lung, resulting in phosphorylation of nuclear MSK1 (Thr581), phospho-acetylation of RelA/p65 at Ser276 and Lys310 respectively. This event was associated with phospho-acetylation of histone H3 (Ser10/Lys9) and acetylation of histone H4 (Lys12). MSK1 N- and C-terminal kinase-dead mutants, MSK1 siRNA-mediated knock-down in transiently transfected H292 cells, and MSK1 stable knock-down mouse embryonic fibroblasts significantly reduced CS extract-induced MSK1, NF-kappa B RelA/p65 activation, and posttranslational modifications of histones. CS extract/CS promotes the direct interaction of MSK1 with RelA/p65 and p300 in epithelial cells and in mouse lung. Furthermore, CS-mediated recruitment of MSK1 and its substrates to the promoters of NF-kappa B-dependent pro-inflammatory genes leads to transcriptional activation, as determined by chromatin immunoprecipitation. Thus, MSK1 is an important downstream kinase involved in CS-induced NF-kappa B activation and chromatin modifications, which have implications in pathogenesis of COPD.	[Sundar, Isaac K.; Chung, Sangwoon; Hwang, Jae-woong; Lapek, John D., Jr.; Friedman, Alan E.; Yao, Hongwei; Rahman, Irfan] Univ Rochester, Med Ctr, Dept Environm Med, Lung Biol & Dis Program, Rochester, NY 14642 USA; [Bulger, Michael] Univ Rochester, Med Ctr, Dept Pediat, Rochester, NY 14642 USA; [Davie, James R.] Univ Manitoba, Manitoba Inst Cell Biol, Winnipeg, MB, Canada	University of Rochester; University of Rochester; University of Manitoba	Sundar, IK (corresponding author), Univ Rochester, Med Ctr, Dept Environm Med, Lung Biol & Dis Program, Rochester, NY 14642 USA.	Irfan_Rahman@urmc.rochester.edu	Sundar, Isaac K/F-8764-2012; Yao, Hongwei/G-6444-2010; Friedman, Alan/Q-4858-2018	Sundar, Isaac K/0000-0001-6742-3460; Friedman, Alan/0000-0002-4764-8168; Davie, James/0000-0002-0420-6888	NIH - National Heart, Lung, and Blood Institute [R01-HL085613]; National Institute of Environmental Health Sciences [NIEHS P30-ES01247]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES001247] Funding Source: NIH RePORTER	NIH - National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by the NIH - National Heart, Lung, and Blood Institute Grant R01-HL085613, National Institute of Environmental Health Sciences Center Grant NIEHS P30-ES01247. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananieva O, 2008, NAT IMMUNOL, V9, P1028, DOI 10.1038/ni.1644; Anest V, 2003, NATURE, V423, P659, DOI 10.1038/nature01648; Anest V, 2004, J BIOL CHEM, V279, P31183, DOI 10.1074/jbc.M404380200; Arthur JSC, 2008, FRONT BIOSCI-LANDMRK, V13, P5866, DOI 10.2741/3122; Barnes PJ, 2003, EUR RESPIR J, V22, P672, DOI 10.1183/09031936.03.00040703; Beck IM, 2008, EMBO J, V27, P1682, DOI 10.1038/emboj.2008.95; Berger SL, 2002, CURR OPIN GENET DEV, V12, P142, DOI 10.1016/S0959-437X(02)00279-4; Caivano M, 2000, J IMMUNOL, V164, P3018, DOI 10.4049/jimmunol.164.6.3018; Carnevali S, 1998, AM J PHYSIOL-LUNG C, V274, pL591, DOI 10.1152/ajplung.1998.274.4.L591; CARP H, 1978, AM REV RESPIR DIS, V118, P617; Chadee DN, 1999, J BIOL CHEM, V274, P24914, DOI 10.1074/jbc.274.35.24914; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Chen LF, 2002, EMBO J, V21, P6539, DOI 10.1093/emboj/cdf660; Chen LF, 2005, MOL CELL BIOL, V25, P7966, DOI 10.1128/MCB.25.18.7966-7975.2005; Chung S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023488; Chung S, 2010, AM J PHYSIOL-LUNG C, V299, pL192, DOI 10.1152/ajplung.00426.2009; Darragh J, 2010, BIOCHEM J, V425, P595, DOI 10.1042/BJ20091062; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; Drobic B, 2010, NUCLEIC ACIDS RES, V38, P3196, DOI 10.1093/nar/gkq030; Duncan EA, 2006, J BIOL CHEM, V281, P12521, DOI 10.1074/jbc.M513333200; Dunn KL, 2005, ONCOGENE, V24, P3492, DOI 10.1038/sj.onc.1208521; Fujioka K, 2006, ENVIRON TOXICOL, V21, P47, DOI 10.1002/tox.20153; Garcia BA, 2005, BIOCHEMISTRY-US, V44, P13202, DOI 10.1021/bi050906n; Gilmour PS, 2003, AM J PHYSIOL-LUNG C, V284, pL533, DOI 10.1152/ajplung.00277.2002; Gloire G, 2007, J BIOL CHEM, V282, P21308, DOI 10.1074/jbc.M610728200; Ito K, 2007, PHARMACOL THERAPEUT, V116, P249, DOI 10.1016/j.pharmthera.2007.06.009; Jacks KA, 2010, J BIOL CHEM, V285, P1661, DOI 10.1074/jbc.M109.083808; Jamaluddin M, 2009, J VIROL, V83, P10605, DOI 10.1128/JVI.01090-09; Janknecht R, 2003, ONCOGENE, V22, P746, DOI 10.1038/sj.onc.1206185; Joo JH, 2008, J BIOL CHEM, V283, P16391, DOI 10.1074/jbc.M800945200; Kannan-Thulasiraman P, 2006, J BIOL CHEM, V281, P22446, DOI 10.1074/jbc.M603111200; Kefaloyianni E, 2006, CELL SIGNAL, V18, P2238, DOI 10.1016/j.cellsig.2006.05.004; Kim HG, 2008, CANCER RES, V68, P2538, DOI 10.1158/0008-5472.CAN-07-6597; Kim YM, 2007, CELL SIGNAL, V19, P538, DOI 10.1016/j.cellsig.2006.08.003; Kode A, 2008, AM J PHYSIOL-LUNG C, V294, pL478, DOI 10.1152/ajplung.00361.2007; Kode A, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-132; Lambert C, 2005, J ALLERGY CLIN IMMUN, V116, P916, DOI 10.1016/j.jaci.2005.05.046; Markou T, 2002, BIOCHEM J, V365, P757, DOI 10.1042/BJ20011828; Marwick JA, 2004, AM J RESP CELL MOL, V31, P633, DOI 10.1165/rcmb.2004-0006OC; Mauderly JL, 2004, TOXICOL SCI, V81, P280, DOI 10.1093/toxsci/kfh203; McCoy CE, 2005, BIOCHEM J, V387, P507, DOI 10.1042/BJ20041501; New L, 1999, J BIOL CHEM, V274, P1026, DOI 10.1074/jbc.274.2.1026; Okazaki T, 2003, BIOCHEM BIOPH RES CO, V300, P807, DOI 10.1016/S0006-291X(02)02932-7; Perez-Cadahia B, 2011, J BIOL CHEM, V286, P42, DOI 10.1074/jbc.M110.156687; Pierrat B, 1998, J BIOL CHEM, V273, P29661, DOI 10.1074/jbc.273.45.29661; Rahman I, 2006, EUR RESPIR J, V28, P219, DOI 10.1183/09031936.06.00053805; Rajendrasozhan S, 2010, AM J PHYSIOL-LUNG C, V298, pL197, DOI 10.1152/ajplung.00265.2009; Rajendrasozhan S, 2009, COPD, V6, P291, DOI 10.1080/15412550903049132; Reber L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004393; REDDEL RR, 1988, CANCER RES, V48, P1904; Smith CJ, 2000, FOOD CHEM TOXICOL, V38, P637, DOI 10.1016/S0278-6915(00)00051-X; Soloaga A, 2003, EMBO J, V22, P2788, DOI 10.1093/emboj/cdg273; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Thomson S, 1999, EMBO J, V18, P4779, DOI 10.1093/emboj/18.17.4779; Vermeulen L, 2003, EMBO J, V22, P1313, DOI 10.1093/emboj/cdg139; Vermeulen L, 2009, TRENDS BIOCHEM SCI, V34, P311, DOI 10.1016/j.tibs.2009.02.007; Wiggin GR, 2002, MOL CELL BIOL, V22, P2871, DOI 10.1128/MCB.22.8.2871-2881.2002; Yamamoto Y, 2003, NATURE, V423, P655, DOI 10.1038/nature01576; Yang SR, 2008, AM J RESP CELL MOL, V38, P689, DOI 10.1165/rcmb.2007-0379OC; Yang SR, 2007, AM J PHYSIOL-LUNG C, V292, pL567, DOI 10.1152/ajplung.00308.2006; Yang SR, 2006, AM J PHYSIOL-LUNG C, V291, pL46, DOI 10.1152/ajplung.00241.2005; Yang SR, 2009, AM J RESP CELL MOL, V40, P147, DOI 10.1165/rcmb.2008-0207OC; Yao HW, 2008, AM J PHYSIOL-LUNG C, V294, pL1174, DOI 10.1152/ajplung.00439.2007; Yao HW, 2010, J BIOL CHEM, V285, P5405, DOI 10.1074/jbc.M109.041418; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0; Zhong SP, 2001, J BIOL CHEM, V276, P33213, DOI 10.1074/jbc.M103973200	66	45	47	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2012	7	2							e31378	10.1371/journal.pone.0031378	http://dx.doi.org/10.1371/journal.pone.0031378			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UG	22312446	gold, Green Published, Green Submitted			2022-12-27	WOS:000301977500036
J	Birukova, AA; Lee, S; Starosta, V; Wu, TH; Ho, T; Kim, J; Berliner, JA; Birukov, KG				Birukova, Anna A.; Lee, Sangderk; Starosta, Vitaliy; Wu, Tinghuai; Ho, Tiffany; Kim, Jin; Berliner, Judith A.; Birukov, Konstantin G.			A Role for VEGFR2 Activation in Endothelial Responses Caused by Barrier Disruptive OxPAPC Concentrations	PLOS ONE			English	Article							ACUTE LUNG INJURY; PHOSPHOLIPID OXIDATION-PRODUCTS; OXIDIZED PHOSPHOLIPIDS; CYCLIC STRETCH; GROWTH-FACTOR; FAK PHOSPHORYLATION; PROTECTIVE RESPONSE; CELL MIGRATION; VASCULAR LEAK; BETA-CATENIN	Introduction: Oxidation products of 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphatidylcholine (OxPAPC) differentially modulate endothelial cell (EC) barrier function in a dose-dependent fashion. Vascular endothelial growth factor receptor-2 (VEGFR2) is involved in the OxPAPC-induced EC inflammatory activation. This study examined a role of VEGFR2 in barrier dysfunction caused by high concentrations of OxPAPC and evaluated downstream signaling mechanisms resulting from the effect of OxPAPC in EC from pulmonary and systemic circulation. Methods: EC monolayer permeability in human pulmonary artery endothelial cells (HPAEC) and human aortic endothelial cells (HAEC) was monitored by changes in transendothelial electrical resistance (TER) across EC monolayers. Actin cytoskeleton was examined by immunostaining with Texas Red labeled phalloidin. Phosphorylation of myosin light chains (MLC) and VE-Cadherin was examined by Western blot and immunofluorescence techniques. The role of VEGFR2 in OxPAPC-induced permeability and cytoskeletal arrangement were determined using siRNA-induced VEGFR2 knockdown. Results: Low OxPAPC concentrations (5-20 mu g/ml) induced a barrier protective response in both HPAEC and HAEC, while high OxPAPC concentrations (50-100 mu g/ml) caused a rapid increase in permeability; actin stress fiber formation and increased MLC phosphorylation were observed as early as 30 min after treatment. VEGFR2 knockdown dramatically decreased the amount of MLC phosphorylation and stress fiber formation caused by high OxPAPC concentrations with modest effects on the amount of VE-cadherin phosphorylation at Y-731. We present evidence that activation of Rho is involved in the OxPAPC/VEGFR2 mechanism of EC permeability induced by high OxPAPC concentrations. Knockdown of VEGFR2 did not rescue the early drop in TER but prevented further development of OxPAPC-induced barrier dysfunction. Conclusions: This study shows that VEGFR2 is involved in the delayed phase of EC barrier dysfunction caused by high OxPAPC concentrations and contributes to stress fiber formation and increased MLC phosphorylation.	[Birukova, Anna A.; Starosta, Vitaliy; Wu, Tinghuai; Birukov, Konstantin G.] Univ Chicago, Dept Med, Lung Injury Ctr, Sect Pulm & Crit Med, Chicago, IL 60637 USA; [Lee, Sangderk; Ho, Tiffany; Kim, Jin; Berliner, Judith A.] Univ Calif Los Angeles, Dept Pathol, Los Angeles, CA 90024 USA; [Lee, Sangderk; Ho, Tiffany; Kim, Jin; Berliner, Judith A.] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA	University of Chicago; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Birukova, AA (corresponding author), Univ Chicago, Dept Med, Lung Injury Ctr, Sect Pulm & Crit Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	kbirukov@medicine.bsd.uchicago.edu	Birukov, Konstantin/FJB-5755-2022; Ho, Tiffany/S-9875-2019		NHLBI [HL8782, HL76259, PO1 HL58064, HL89257, HL107920, PO1 HL030568, K99HL105577]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089257, R56HL107920, K99HL105577, R01HL076259, P01HL058064, R01HL087823, R00HL105577, P01HL030568, R01HL107920] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	NHLBI HL87823, HL76259, and PO1 HL58064 for KB; HL89257, HL107920 and the American Heart Association Midwest Affiliate Grant-in-Aid for AB; NHLBI PO1 HL030568 for JB and K99HL105577 for SL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amerongen GPV, 2000, CIRC RES, V87, P335, DOI 10.1161/01.RES.87.4.335; Amerongen GPV, 2003, ARTERIOSCL THROM VAS, V23, P211, DOI 10.1161/01.ATV.0000054198.68894.88; Beckers CML, 2010, THROMB HAEMOSTASIS, V103, P40, DOI 10.1160/TH09-06-0403; Berliner JA, 2008, FREE RADICAL BIO MED, V45, P119, DOI 10.1016/j.freeradbiomed.2008.04.013; Birukov KG, 2004, CIRC RES, V95, P892, DOI 10.1161/01.RES.0000147310.18962.06; Birukov KG, 2004, MICROVASC RES, V67, P18, DOI 10.1016/j.mvr.2003.09.004; Birukova AA, 2004, MICROVASC RES, V67, P64, DOI 10.1016/j.mvr.2003.09.007; Birukova AA, 2006, AM J PATHOL, V168, P1749, DOI 10.2353/ajpath.2006.050431; Birukova AA, 2006, AM J PHYSIOL-LUNG C, V290, pL540, DOI 10.1152/ajplung.00259.2005; Birukova AA, 2004, FASEB J, V18, P1879, DOI 10.1096/fj.04-2328com; Birukova AA, 2004, J CELL PHYSIOL, V201, P55, DOI 10.1002/jcp.20055; Birukova AA, 2008, AM J PHYSIOL-LUNG C, V295, pL612, DOI 10.1152/ajplung.90236.2008; Birukova AA, 2007, AM J PHYSIOL-LUNG C, V292, pL924, DOI 10.1152/ajplung.00395.2006; Birukova AA, 2007, AM J PHYSIOL-LUNG C, V293, pL199, DOI 10.1152/ajplung.00020.2007; Birukova AA, 2007, MICROVASC RES, V73, P173, DOI 10.1016/j.mvr.2006.12.004; Birukova AA, 2007, J CELL PHYSIOL, V211, P608, DOI 10.1002/jcp.20966; Birukova AA, 2011, EXP CELL RES, V317, P859, DOI 10.1016/j.yexcr.2010.11.011; Birukova AA, 2011, J CELL PHYSIOL, V226, P2052, DOI 10.1002/jcp.22543; Bochkov VN, 2010, ANTIOXID REDOX SIGN, V12, P1009, DOI 10.1089/ars.2009.2597; Bochkov VN, 2002, NATURE, V419, P77, DOI 10.1038/nature01023; Breslin JW, 2003, AM J PHYSIOL-HEART C, V284, pH92, DOI 10.1152/ajpheart.00330.2002; Busca R, 1998, MOL BIOL CELL, V9, P1367, DOI 10.1091/mbc.9.6.1367; Chen WG, 2008, AM J PHYSIOL-LUNG C, V295, pL575, DOI 10.1152/ajplung.00428.2007; Cole AL, 2003, ARTERIOSCL THROM VAS, V23, P1384, DOI 10.1161/01.ATV.0000081215.45714.71; DeMaio L, 2006, AM J PHYSIOL-HEART C, V290, pH674, DOI 10.1152/ajpheart.00554.2005; Dudek SM, 2001, J APPL PHYSIOL, V91, P1487, DOI 10.1152/jappl.2001.91.4.1487; Essler M, 1998, J BIOL CHEM, V273, P21867, DOI 10.1074/jbc.273.34.21867; Fu PF, 2009, TRANSL RES, V153, P166, DOI 10.1016/j.trsl.2008.12.005; Gargalovic PS, 2006, ARTERIOSCL THROM VAS, V26, P2490, DOI 10.1161/01.ATV.0000242903.41158.a1; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; Hammad LA, 2009, RAPID COMMUN MASS SP, V23, P863, DOI 10.1002/rcm.3947; Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043; Kaner RJ, 2000, AM J RESP CELL MOL, V22, P657, DOI 10.1165/ajrcmb.22.6.3779; Lang P, 1996, EMBO J, V15, P510, DOI 10.1002/j.1460-2075.1996.tb00383.x; Lee S, 2009, FREE RADICAL BIO MED, V47, P145, DOI 10.1016/j.freeradbiomed.2009.04.013; Leitinger N, 1999, P NATL ACAD SCI USA, V96, P12010, DOI 10.1073/pnas.96.21.12010; Ma Z, 2004, AM J PHYSIOL-LUNG C, V286, pL808, DOI 10.1152/ajplung.00220.2003; Medford ARL, 2006, THORAX, V61, P621, DOI 10.1136/thx.2005.040204; Mirzapoiazova T, 2006, AM J PHYSIOL-LUNG C, V291, pL718, DOI 10.1152/ajplung.00014.2006; Nonas S, 2006, AM J RESP CRIT CARE, V173, P1130, DOI 10.1164/rccm.200511-1737OC; Nonas S, 2008, CRIT CARE, V12, DOI 10.1186/cc6805; Oskolkova OV, 2010, J IMMUNOL, V185, P7706, DOI 10.4049/jimmunol.0903594; Petrovan RJ, 2007, ARTERIOSCL THROM VAS, V27, P1095, DOI 10.1161/ATVBAHA.106.139246; Podrez EA, 2007, NAT MED, V13, P1086, DOI 10.1038/nm1626; Potter MD, 2005, J BIOL CHEM, V280, P31906, DOI 10.1074/jbc.M505568200; Qiao J, 2003, AM J PHYSIOL-LUNG C, V284, pL972, DOI 10.1152/ajplung.00429.2002; Shikata Y, 2005, EXP CELL RES, V304, P40, DOI 10.1016/j.yexcr.2004.11.001; Shikata Y, 2003, FASEB J, V17, P2240, DOI 10.1096/fj.03-0198com; Starosta V, 2011, AM J RESP CELL MOL B; Subbanagounder G, 2000, ARTERIOSCL THROM VAS, V20, P2248, DOI 10.1161/01.ATV.20.10.2248; Sun HR, 2006, MICROCIRCULATION, V13, P237, DOI 10.1080/10739680600556944; Watson AD, 1997, J BIOL CHEM, V272, P13597, DOI 10.1074/jbc.272.21.13597; Yeh M, 2001, ARTERIOSCL THROM VAS, V21, P1585, DOI 10.1161/hq1001.097027; Zeng HY, 2002, J BIOL CHEM, V277, P46791, DOI 10.1074/jbc.M206133200; Zimman A, 2007, ARTERIOSCL THROM VAS, V27, P332, DOI 10.1161/01.ATV.0000252842.57585.df; Zimman A, 2010, J PROTEOME RES, V9, P2812, DOI 10.1021/pr901194x	56	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2012	7	1							e30957	10.1371/journal.pone.0030957	http://dx.doi.org/10.1371/journal.pone.0030957			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	912BY	22303475	gold, Green Published, Green Submitted			2022-12-27	WOS:000301770700010
J	Kolaczinski, K; Leslie, T; Ali, I; Durrani, N; Lee, S; Barends, M; Beshir, K; Ord, R; Hallett, R; Rowland, M				Kolaczinski, Kate; Leslie, Toby; Ali, Iftikhar; Durrani, Naeem; Lee, Sue; Barends, Marion; Beshir, Khalid; Ord, Rosalynn; Hallett, Rachel; Rowland, Mark			Defining Plasmodium falciparum Treatment in South West Asia: A Randomized Trial Comparing Artesunate or Primaquine Combined with Chloroquine or SP	PLOS ONE			English	Article							ANTIMALARIAL-DRUG RESISTANCE; SULFADOXINE-PYRIMETHAMINE; COMBINATION THERAPY; DIHYDROFOLATE-REDUCTASE; UNCOMPLICATED MALARIA; EASTERN AFGHANISTAN; ANOPHELES-GAMBIAE; PAKISTAN; TRANSMISSION; AFRICA	Introduction: Antimalarial resistance has led to a global policy of artemisinin-based combination therapy. Despite growing resistance chloroquine (CQ) remained until recently the official first-line treatment for falciparum malaria in Pakistan, with sulfadoxine-pyrimethamine (SP) second-line. Co-treatment with the gametocytocidal primaquine (PQ) is recommended for transmission control in South Asia. The relative effect of artesunate (AS) or primaquine, as partner drugs, on clinical outcomes and gametocyte carriage in this setting were unknown. Methods: A single-blinded, randomized trial among Afghan refugees in Pakistan compared six treatment arms: CQ; CQ+(single-dose)PQ; CQ+(3 d)AS; SP; SP+(single-dose)PQ, and SP+(3 d) AS. The objectives were to compare treatment failure rates and effect on gametocyte carriage, of CQ or SP monotherapy against the respective combinations (PQ or AS). Outcomes included trophozoite and gametocyte clearance (read by light microscopy), and clinical and parasitological failure. Findings: A total of 308 (87%) patients completed the trial. Failure rates by day 28 were: CQ 55/68 (81%); CQ+AS 19/67 (28%), SP 4/41 (9.8%), SP+AS 1/41 (2.4%). The addition of PQ to CQ or SP did not affect failure rates (CQ+PQ 49/67 (73%) failed; SP+PQ 5/33 (16%) failed). AS was superior to PQ at clearing gametocytes; gametocytes were seen on d7 in 85% of CQ, 40% of CQ+PQ, 21% of CQ+AS, 91% of SP, 76% of SP+PQ and 23% of SP+AS treated patients. PQ was more effective at clearing older gametocyte infections whereas AS was more effective at preventing emergence of mature gametocytes, except in cases that recrudesced. Conclusions: CQ is no longer appropriate by itself or in combination. These findings influenced the replacement of CQ with SP+AS for first-line treatment of uncomplicated falciparum malaria in the WHO Eastern Mediterranean Region. The threat of SP resistance remains as SP monotherapy is still common. Three day AS was superior to single-dose PQ for reducing gametocyte carriage.	[Kolaczinski, Kate; Leslie, Toby; Beshir, Khalid; Ord, Rosalynn; Hallett, Rachel; Rowland, Mark] London Sch Hyg & Trop Med, London WC1, England; [Kolaczinski, Kate; Leslie, Toby; Ali, Iftikhar; Durrani, Naeem] HealthNet TPO, Peshawar, Pakistan; [Lee, Sue] Mahidol Univ, Fac Trop Med, Bangkok, Thailand; [Lee, Sue] Churchill Hosp, Ctr Clin Vaccinol & Trop Med, Oxford OX3 7LJ, England; [Barends, Marion] Shoklo Malaria Res Unit, Mae Sot, Thailand	University of London; London School of Hygiene & Tropical Medicine; Mahidol University; University of Oxford; Mahidol University	Kolaczinski, K (corresponding author), London Sch Hyg & Trop Med, London WC1, England.	k.kolaczinski@gmail.com		Beshir, Khalid/0000-0001-5108-8362	UNDP/World Bank/WHO [A00017]; United Nations High Commissioner for Refugees, Pakistan	UNDP/World Bank/WHO(World Health Organization); United Nations High Commissioner for Refugees, Pakistan	This manuscript was supported by UNDP/World Bank/WHO Special Programme for Research on Tropical Diseases (A00017)(http://apps.who.int/tdr/) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge with thanks the support of Dr Naveeda Rehman of the United Nations High Commissioner for Refugees, Pakistan, and Dr M. Abdur Rab and staff of HealthNet International (now, HealthNet TPO) for their assistance.	Adjuik M, 2004, LANCET, V363, P9, DOI 10.1016/S0140-6736(03)15162-8; Barnes KI, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S1-S8; Barnes KI, 2005, PLOS MED, V2, P1123, DOI 10.1371/journal.pmed.0020330; Beavogui AH, 2010, INT J PARASITOL, V40, P1213, DOI 10.1016/j.ijpara.2010.04.010; Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; Bloland PB, 2000, B WORLD HEALTH ORGAN, V78, P1378; Bousema T, 2011, CLIN MICROBIOL REV, V24, P377, DOI 10.1128/CMR.00051-10; Brockman A, 1999, AM J TROP MED HYG, V60, P14, DOI 10.4269/ajtmh.1999.60.14; Butcher GA, 1997, INT J PARASITOL, V27, P975, DOI 10.1016/S0020-7519(97)00079-9; Campbell P, 2006, T ROY SOC TROP MED H, V100, P108, DOI 10.1016/j.trstmh.2005.06.016; CHOMCHARN Y, 1980, Southeast Asian Journal of Tropical Medicine and Public Health, V11, P408; Chotivanich K, 2006, ANTIMICROB AGENTS CH, V50, P1927, DOI 10.1128/AAC.01472-05; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Durrani N, 2005, TROP MED INT HEALTH, V10, P521, DOI 10.1111/j.1365-3156.2005.01429.x; Ezard N, 2004, ANN TROP MED PARASIT, V98, P85, DOI 10.1179/000349804225003019; FOX E, 1985, LANCET, V1, P1432; Ghanchi NK, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-18; Humphreys GS, 2007, ANTIMICROB AGENTS CH, V51, P991, DOI 10.1128/AAC.00875-06; Jansen FH, 2011, LANCET INFECT DIS, V11, P498, DOI 10.1016/S1473-3099(11)70158-X; KANEKO A, 1989, Southeast Asian Journal of Tropical Medicine and Public Health, V20, P351; Karl S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020805; Khaliq AA, 1985, PAK J MED RES, V24; Khan M Aslam, 2004, J Coll Physicians Surg Pak, V14, P319; Khatoon L, 2009, AM J TROP MED HYG, V81, P525, DOI 10.4269/ajtmh.2009.81.525; Koaczinski K, 2007, T ROY SOC TROP MED H, V101, P1081, DOI 10.1016/j.trstmh.2007.06.015; Leslie T, 2009, EMERG INFECT DIS, V15, P1753, DOI 10.3201/eid1511.090886; Myint HY, 2004, T ROY SOC TROP MED H, V98, P73, DOI 10.1016/S0035-9203(03)00014-2; Najera JA, 1998, MAL EP DET CONTR FOR; Nosten F, 2000, LANCET, V356, P297, DOI 10.1016/S0140-6736(00)02505-8; Nosten F, 2004, J Postgrad Med, V50, P35; O'Meara WP, 2008, AM J TROP MED HYG, V79, P185, DOI 10.4269/ajtmh.2008.79.185; Okell LC, 2009, J INFECT DIS, V200, P1509, DOI 10.1086/644781; Pearce RJ, 2003, ANTIMICROB AGENTS CH, V47, P1347, DOI 10.1128/AAC.47.4.1347-1354.2003; PETERSON DS, 1990, P NATL ACAD SCI USA, V87, P3018, DOI 10.1073/pnas.87.8.3018; PLOWE CV, 1995, AM J TROP MED HYG, V52, P565, DOI 10.4269/ajtmh.1995.52.565; Pukrittayakamee S, 2004, ANTIMICROB AGENTS CH, V48, P1329, DOI 10.1128/AAC.48.4.1329-1334.2004; Rab MA, 2001, ANN TROP MED PARASIT, V95, P41, DOI 10.1080/00034980020035906; RIECKMANN KH, 1969, MIL MED, V134, P802; Robert V, 2000, AM J TROP MED HYG, V62, P210, DOI 10.4269/ajtmh.2000.62.210; Rowland M, 1997, TROP MED INT HEALTH, V2, P1049, DOI 10.1046/j.1365-3156.1997.d01-185.x; Rowland M, 2002, SOC SCI MED, V55, P2061, DOI 10.1016/S0277-9536(01)00341-0; Shah I, 1997, ANN TROP MED PARASIT, V91, P591, DOI 10.1080/00034989760680; Shah NK, 2011, LANCET INFECT DIS, V11, P57, DOI 10.1016/S1473-3099(10)70214-0; Shekalaghe SA, 2007, TROP MED INT HEALTH, V12, P547, DOI 10.1111/j.1365-3156.2007.01821.x; Smithuis F, 2010, LANCET INFECT DIS, V10, P673, DOI 10.1016/S1473-3099(10)70187-0; SULEMAN M, 1988, T ROY SOC TROP MED H, V82, P44, DOI 10.1016/0035-9203(88)90257-X; Sutherland CJ, 2003, AM J TROP MED HYG, V69, P19, DOI 10.4269/ajtmh.2003.69.19; Targett G, 2001, J INFECT DIS, V183, P1254, DOI 10.1086/319689; von Seidlein L, 2001, TROP MED INT HEALTH, V6, P92, DOI 10.1046/j.1365-3156.2001.00683.x; White NJ, 2008, SCIENCE, V320, P330, DOI 10.1126/science.1155165; WHO, 1991, WHO TECHN REP SER; WHO, 2004, PREV CONTR MAL EP FO; *WHO, 2002, WHOCDSRBM200239; WHO, 2004, WHOEMMAL297E0504140; Wilairatana P, 2010, SE ASIAN J TROP MED, V41, P1306; World Health Organization, 2009, METH SURV ANT DRUG E; World Health Organization, 2010, BAS MAL MICR 1; World Health Organization, 2010, BAS MAL MICR 2, V2; World Health Organization, 2001, WHOCDSRBM200133	59	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2012	7	1							e28957	10.1371/journal.pone.0028957	http://dx.doi.org/10.1371/journal.pone.0028957			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	912BY	22303437	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000301770700004
J	Blatt, K; Herrmann, H; Mirkina, I; Hadzijusufovic, E; Peter, B; Strommer, S; Hoermann, G; Mayerhofer, M; Hoetzenecker, K; Klepetko, W; Ghanim, V; Marth, K; Fureder, T; Wacheck, V; Valenta, R; Valent, P				Blatt, Katharina; Herrmann, Harald; Mirkina, Irina; Hadzijusufovic, Emir; Peter, Barbara; Strommer, Sabine; Hoermann, Gregor; Mayerhofer, Matthias; Hoetzenecker, Konrad; Klepetko, Walter; Ghanim, Viviane; Marth, Katharina; Fuereder, Thorsten; Wacheck, Volker; Valenta, Rudolf; Valent, Peter			The PI3-Kinase/mTOR-Targeting Drug NVP-BEZ235 Inhibits Growth and IgE-Dependent Activation of Human Mast Cells and Basophils	PLOS ONE			English	Article							FC-EPSILON-RI; HUMAN-BLOOD BASOPHILS; TYROSINE KINASE; RECOMBINANT ALLERGENS; HISTAMINE-RELEASE; C-KIT; RECEPTOR; MASTOCYTOSIS; EXPRESSION; SURVIVAL	The phosphoinositide 3-kinase (PI3-kinase) and the mammalian target of rapamycin (mTOR) are two major signaling molecules involved in growth and activation of mast cells (MC) and basophils (BA). We examined the effects of the dual PI3-kinase/mTOR blocker NVP-BEZ235 on growth of normal and neoplastic BA and MC as well as immunoglobulin E (IgE)-dependent cell activation. Growth of MC and BA were determined by measuring H-3-thymidine uptake and apoptosis. Cell activation was determined in histamine release experiments and by measuring upregulation of CD63 and CD203c after challenging with IgE plus anti-IgE or allergen. We found that NVP-BEZ235 exerts profound inhibitory effects on growth of primary and cloned neoplastic MC. In the MC leukemia cell line HMC-1, NVP-BEZ235 showed similar IC50 values in the HMC-1.1 subclone lacking KIT D816V (0.025 mu M) and the HMC-1.2 subclone expressing KIT D816V (0.005 mu M). Moreover, NVP-BEZ235 was found to exert strong growth-inhibitory effects on neoplastic MC in a xenotransplant-mouse model employing NMR1-Foxn1(nu) mice. NVP-BEZ235 also exerted inhibitory effects on cytokine-dependent differentiation of normal BA and MC, but did not induce growth inhibition or apoptosis in mature MC or normal bone marrow cells. Finally, NVP-BEZ235 was found to inhibit IgE-dependent histamine release in BA and MC (IC50 0.5-1 mu M) as well as anti-IgE-induced upregulation of CD203c in BA and IgE-dependent upregulation of CD63 in MC. In summary, NVP-BEZ235 produces growth-inhibitory effects in immature neoplastic MC and inhibits IgE-dependent activation of mature BA and MC. Whether these potentially beneficial drug effects have clinical implications is currently under investigation.	[Blatt, Katharina; Herrmann, Harald; Hadzijusufovic, Emir; Peter, Barbara; Ghanim, Viviane; Valent, Peter] Med Univ Vienna, Div Hematol & Hemostaseol, Dept Internal Med 1, Vienna, Austria; [Herrmann, Harald; Mirkina, Irina; Valent, Peter] Ludwig Boltzmann Cluster Oncol, Vienna, Austria; [Hadzijusufovic, Emir; Peter, Barbara] Univ Vet Med Vienna, Dept Compan Anim & Horses, Clin Internal Med & Infect Dis, Vienna, Austria; [Strommer, Sabine; Fuereder, Thorsten; Wacheck, Volker] Med Univ Vienna, Dept Clin Pharmacol, Vienna, Austria; [Hoermann, Gregor; Mayerhofer, Matthias] Med Univ Vienna, Dept Lab Med, Vienna, Austria; [Hoetzenecker, Konrad; Klepetko, Walter] Med Univ Vienna, Dept Thorac Surg, Vienna, Austria; [Marth, Katharina; Valenta, Rudolf] Med Univ Vienna, Christian Doppler Lab Allergy Res, Ctr Pathophysiol Immunol & Infectiol, Div Immunopathol,Dept Pathophysiol, Vienna, Austria	Medical University of Vienna; Ludwig Boltzmann Institute; University of Veterinary Medicine Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Blatt, K (corresponding author), Med Univ Vienna, Div Hematol & Hemostaseol, Dept Internal Med 1, Vienna, Austria.	peter.valent@meduniwien.ac.at	Test, Test/Y-7921-2019; Hoermann, Gregor/B-8832-2016; Valent, Peter/B-8533-2016; Gamperl, Susi/V-2715-2019; Zelle, Mast/V-2890-2019; Peter, Barbara/O-8110-2018; Hadzijusufovic, Emir/B-8109-2016; Hermann, Harald/E-7073-2018; Test, PV/U-9451-2019; Wacheck, Volker/ABD-4893-2021	Hoermann, Gregor/0000-0002-7374-4380; Valent, Peter/0000-0003-0456-5095; Gamperl, Susi/0000-0003-0456-5095; Zelle, Mast/0000-0001-7409-4204; Peter, Barbara/0000-0001-5701-5412; Hadzijusufovic, Emir/0000-0001-7409-4204; Hermann, Harald/0000-0002-5095-4641; Hoetzenecker, Konrad/0000-0001-6775-7460; Valenta, Rudolf/0000-0001-5944-3365	Christian Doppler Research Association, Vienna, Austria; Novartis; Austrian Science Fund (FWF) [SFB F46];  [P21173-B13]	Christian Doppler Research Association, Vienna, Austria; Novartis(Novartis); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); 	This study was supported by grants P21173-B13 and by SFB F46 of the Austrian Science Fund (FWF) and by the Christian Doppler Research Association, Vienna, Austria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: Dr. Valent received a research grant from Novartis. The authors declare no other conflict of interest. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Akin C, 2003, EXP HEMATOL, V31, P686, DOI 10.1016/S0301-472X(03)00112-7; Baumann P, 2009, EXP CELL RES, V315, P485, DOI 10.1016/j.yexcr.2008.11.007; Baumgartner C, 2009, AM J PATHOL, V175, P2416, DOI 10.2353/ajpath.2009.080953; BREITENEDER H, 1989, EMBO J, V8, P1935, DOI 10.1002/j.1460-2075.1989.tb03597.x; Buhring HJ, 2004, INT ARCH ALLERGY IMM, V133, P317, DOI 10.1159/000077351; BUTTERFIELD JH, 1988, LEUKEMIA RES, V12, P345, DOI 10.1016/0145-2126(88)90050-1; de Weck AL, 2008, INT ARCH ALLERGY IMM, V146, P177, DOI 10.1159/000115885; Escribano L, 2002, ANN HEMATOL, V81, P677, DOI 10.1007/s00277-002-0575-z; Falcone FH, 2000, BLOOD, V96, P4028; Fukao T, 2002, NAT IMMUNOL, V3, P295, DOI 10.1038/ni768; FUREDER W, 1995, J IMMUNOL, V155, P3152; Gabillot-Carre M, 2006, BLOOD, V108, P1065, DOI 10.1182/blood-2005-06-2433; Gleixner KV, 2006, BLOOD, V107, P752, DOI 10.1182/blood-2005-07-3022; Greenhawt M, 2007, CURR OPIN ALLERGY CL, V7, P387, DOI 10.1097/ACI.0b013e3282a6443e; Hadzijusufovic E, 2010, EXP HEMATOL, V38, P896, DOI 10.1016/j.exphem.2010.05.008; Harir N, 2008, BLOOD, V112, P2463, DOI 10.1182/blood-2007-09-115477; Hauswirth AW, 2008, INT J IMMUNOPATH PH, V21, P797, DOI 10.1177/039463200802100404; Hauswirth AW, 2002, J ALLERGY CLIN IMMUN, V110, P102, DOI 10.1067/mai.2002.125257; Kawakami T, 2002, NAT REV IMMUNOL, V2, P773, DOI 10.1038/nri914; Kepley CL, 2000, J IMMUNOL, V165, P5913, DOI 10.4049/jimmunol.165.10.5913; Kim MS, 2008, J IMMUNOL, V180, P4586, DOI 10.4049/jimmunol.180.7.4586; Kinet JP, 1999, ANNU REV IMMUNOL, V17, P931, DOI 10.1146/annurev.immunol.17.1.931; Kneidinger M, 2008, BLOOD, V111, P3097, DOI 10.1182/blood-2007-08-104372; Krauth MT, 2009, CLIN EXP ALLERGY, V39, P1711, DOI 10.1111/j.1365-2222.2009.03353.x; Kuehn HS, 2008, J IMMUNOL, V181, P7706, DOI 10.4049/jimmunol.181.11.7706; Luskova P, 2004, CURR PHARM DESIGN, V10, P1727, DOI 10.2174/1381612043384538; Maira SM, 2008, MOL CANCER THER, V7, P1851, DOI 10.1158/1535-7163.MCT-08-0017; MARONE G, 1994, J ALLERGY CLIN IMMUN, V94, P1293, DOI 10.1016/0091-6749(94)90345-X; Metcalfe DD, 2008, BLOOD, V112, P946, DOI 10.1182/blood-2007-11-078097; Mirkina I, 2007, IMMUNOL LETT, V109, P120, DOI 10.1016/j.imlet.2007.02.003; Nadler M J, 2000, Adv Immunol, V76, P325; Peavy RD, 2008, CURR OPIN ALLERGY CL, V8, P310, DOI 10.1097/ACI.0b013e3283036a90; Rivera J, 2008, ADV IMMUNOL, V98, P85, DOI 10.1016/S0065-2776(08)00403-3; Serra V, 2008, CANCER RES, V68, P8022, DOI 10.1158/0008-5472.CAN-08-1385; SERVE H, 1995, EMBO J, V14, P473, DOI 10.1002/j.1460-2075.1995.tb07023.x; Shelburne CP, 2003, BLOOD, V102, P1290, DOI 10.1182/blood-2002-11-3490; Shelburne CP, 2002, MOL IMMUNOL, V38, P1187, DOI 10.1016/S0161-5890(02)00061-5; Shivakrupa R, 2003, CANCER RES, V63, P4412; Siraganian RP, 2003, CURR OPIN IMMUNOL, V15, P639, DOI 10.1016/j.coi.2003.09.010; Tedeschi A, 2000, INT J IMMUNOPHARMACO, V22, P797, DOI 10.1016/S0192-0561(00)00041-2; Timokhina I, 1998, EMBO J, V17, P6250, DOI 10.1093/emboj/17.21.6250; Valent F, 2001, IMMUNOL REV, V179, P74, DOI 10.1034/j.1600-065X.2001.790108.x; VALENT P, 1992, ADV IMMUNOL, V52, P333, DOI 10.1016/S0065-2776(08)60879-2; VALENT P, 1989, BLOOD, V73, P1763; Valent P, 2005, LEUKEMIA LYMPHOMA, V46, P35, DOI 10.1080/10428190400010775; VALENT P, 1989, P NATL ACAD SCI USA, V86, P5542, DOI 10.1073/pnas.86.14.5542; Valent P, 2004, EUR J CLIN INVEST, V34, P41, DOI 10.1111/j.0960-135X.2004.01369.x; VALENT P, 1992, BLOOD, V80, P2237; Valent P, 2004, METHODS, V32, P265, DOI 10.1016/j.ymeth.2003.08.006; VALENT P, 1989, BLOOD, V73, P1778; Valenta R, 2010, ANNU REV IMMUNOL, V28, P211, DOI 10.1146/annurev-immunol-030409-101218	51	21	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e29925	10.1371/journal.pone.0029925	http://dx.doi.org/10.1371/journal.pone.0029925			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22299028	gold, Green Published, Green Submitted			2022-12-27	WOS:000301704200005
J	Nicklas, S; Otto, A; Wu, XL; Miller, P; Stelzer, S; Wen, YF; Kuang, SH; Wrogemann, K; Patel, K; Ding, H; Schwamborn, JC				Nicklas, Sarah; Otto, Anthony; Wu, Xiaoli; Miller, Pamela; Stelzer, Sandra; Wen, Yefei; Kuang, Shihuan; Wrogemann, Klaus; Patel, Ketan; Ding, Hao; Schwamborn, Jens C.			TRIM32 Regulates Skeletal Muscle Stem Cell Differentiation and Is Necessary for Normal Adult Muscle Regeneration	PLOS ONE			English	Article							SELF-RENEWAL; SATELLITE CELLS; DROSOPHILA; INHIBITION; GENE; PROLIFERATION; EXPRESSION; MICRORNAS; MYOBLAST; SWITCH	Limb girdle muscular dystrophy type 2H (LGMD2H) is an inherited autosomal recessive disease of skeletal muscle caused by a mutation in the TRIM32 gene. Currently its pathogenesis is entirely unclear. Typically the regeneration process of adult skeletal muscle during growth or following injury is controlled by a tissue specific stem cell population termed satellite cells. Given that TRIM32 regulates the fate of mammalian neural progenitor cells through controlling their differentiation, we asked whether TRIM32 could also be essential for the regulation of myogenic stem cells. Here we demonstrate for the first time that TRIM32 is expressed in the skeletal muscle stem cell lineage of adult mice, and that in the absence of TRIM32, myogenic differentiation is disrupted. Moreover, we show that the ubiquitin ligase TRIM32 controls this process through the regulation of c-Myc, a similar mechanism to that previously observed in neural progenitors. Importantly we show that loss of TRIM32 function induces a LGMD2H-like phenotype and strongly affects muscle regeneration in vivo. Our studies implicate that the loss of TRIM32 results in dysfunctional muscle stem cells which could contribute to the development of LGMD2H.	[Nicklas, Sarah; Stelzer, Sandra; Schwamborn, Jens C.] Univ Munster, Zentrum Mol Biol Entzundung, Inst Cell Biol, Stem Cell Biol & Regenerat Grp, Munster, Germany; [Wu, Xiaoli; Miller, Pamela; Wrogemann, Klaus; Ding, Hao] Univ Manitoba, Dept Biochem & Med Genet, Winnipeg, MB, Canada; [Otto, Anthony; Patel, Ketan] Univ Reading, Sch Biol Sci, Reading, Berks, England; [Wen, Yefei; Kuang, Shihuan] Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA	University of Munster; University of Manitoba; University of Reading; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Nicklas, S (corresponding author), Univ Munster, Zentrum Mol Biol Entzundung, Inst Cell Biol, Stem Cell Biol & Regenerat Grp, Munster, Germany.	dingh@cc.umanitoba.ca; jschwamb@uni-muenster.de	Schwamborn, Jens C/F-9395-2011	Schwamborn, Jens C/0000-0003-4496-0559; Wen, Yefei/0000-0002-2121-7538; Kuang, Shihuan/0000-0001-9180-3180	German Research Foundation (DFG) [SCHW1392/2-1, SFB629]; Kompetenznetzwerk Stammzellforschung NRW; Fonds der Chemischen Industrie; Fritz Thyssen Foundation [Az. 10.10.2.152]; German-Israeli Foundation for Scientific Research and Development [G-2226-2034.1/2009]; European Union; University of Munster Medical School [SC120901, SC411003]; Interdisciplinary Center for Clinical Research Munster [SchwJ3/001/11]; Canada Institute of Health Research; National Cancer Institute of Canada; Canada Research Chair program; Biotechnology and Biological Sciences Research Council; University of Reading; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060652] Funding Source: NIH RePORTER	German Research Foundation (DFG)(German Research Foundation (DFG)); Kompetenznetzwerk Stammzellforschung NRW; Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Fritz Thyssen Foundation; German-Israeli Foundation for Scientific Research and Development(German-Israeli Foundation for Scientific Research and Development); European Union(European Commission); University of Munster Medical School; Interdisciplinary Center for Clinical Research Munster; Canada Institute of Health Research(Canadian Institutes of Health Research (CIHR)); National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Canada Research Chair program(Canada Research Chairs); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Reading; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Work in JS's lab is supported by the German Research Foundation (DFG, Emmy Noether Program, SCHW1392/2-1 and SFB629), Kompetenznetzwerk Stammzellforschung NRW, Fonds der Chemischen Industrie, Fritz Thyssen Foundation (Az. 10.10.2.152), German-Israeli Foundation for Scientific Research and Development (G-2226-2034.1/2009) and European Union FP7 network EuroSyStem. Furthermore, this work was supported by the fund "Innovative Medical Research" of the University of Munster Medical School (SC120901 and SC411003) and the Interdisciplinary Center for Clinical Research Munster (SchwJ3/001/11). Transgenic TRIM32 mouse work in HD's lab is supported by the Canada Institute of Health Research, National Cancer Institute of Canada and the Canada Research Chair program. AO and KP were supported by the Biotechnology and Biological Sciences Research Council and the University of Reading. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakura A, 2001, DIFFERENTIATION, V68, P245, DOI 10.1046/j.1432-0436.2001.680412.x; Bello B, 2006, DEVELOPMENT, V133, P2639, DOI 10.1242/dev.02429; Betschinger J, 2006, CELL, V124, P1241, DOI 10.1016/j.cell.2006.01.038; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Cossee M, 2009, NEUROMUSCULAR DISORD, V19, P255, DOI 10.1016/j.nmd.2009.02.003; Ding H, 2000, MECH DEVELOP, V96, P209, DOI 10.1016/S0925-4773(00)00425-1; Frosk P, 2002, AM J HUM GENET, V70, P663, DOI 10.1086/339083; Guglieri M, 2008, CURR OPIN NEUROL, V21, P576, DOI 10.1097/WCO.0b013e32830efdc2; Harris RE, 2011, DEV CELL, V20, P72, DOI 10.1016/j.devcel.2010.11.019; Hillje AL, 2011, STEM CELLS, V29, P1437, DOI 10.1002/stem.687; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Kudryashova E, 2011, HUM MOL GENET; Kudryashova E, 2009, HUM MOL GENET, V18, P1353, DOI 10.1093/hmg/ddp036; Lee CY, 2006, NATURE, V439, P594, DOI 10.1038/nature04299; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V10, P177, DOI 10.1083/jcb.10.4.177; MINER JH, 1991, MOL CELL BIOL, V11, P2842, DOI 10.1128/MCB.11.5.2842; Neumuller RA, 2008, NATURE, V454, P241, DOI 10.1038/nature07014; Olguin HC, 2007, J CELL BIOL, V177, P769, DOI 10.1083/jcb.200608122; Otto A, 2008, J CELL SCI, V121, P2939, DOI 10.1242/jcs.026534; Otto A, 2006, ANAT EMBRYOL, V211, P293, DOI 10.1007/s00429-006-0083-3; Otto A, 2010, DEV BIOL, V343, P51, DOI 10.1016/j.ydbio.2010.04.014; Pan L, 2007, CELL STEM CELL, V1, P458, DOI 10.1016/j.stem.2007.09.010; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Saccone V, 2008, HUM MUTAT, V29, P240, DOI 10.1002/humu.20633; Schwamborn JC, 2009, CELL, V136, P913, DOI 10.1016/j.cell.2008.12.024; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Wei Q, 2001, FEBS LETT, V490, P171, DOI 10.1016/S0014-5793(01)02120-2; Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007	28	55	55	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e30445	10.1371/journal.pone.0030445	http://dx.doi.org/10.1371/journal.pone.0030445			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22299041	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000301704200018
J	Saez, A; Sabatino, M; Aizen, MA				Saez, Agustin; Sabatino, Malena; Aizen, Marcelo A.			Interactive Effects of Large- and Small-Scale Sources of Feral Honey-Bees for Sunflower in the Argentine Pampas	PLOS ONE			English	Article							CROP POLLINATION; HABITAT FRAGMENTATION; FORAGING RANGES; FRUIT-SET; BEES; COMMUNITIES; DIVERSITY; SERVICES; FOREST; AGRICULTURE	Pollinators for animal pollinated crops can be provided by natural and semi-natural habitats, ranging from large vegetation remnants to small areas of non-crop land in an otherwise highly modified landscape. It is unknown, however, how different small-and large-scale habitat patches interact as pollinator sources. In the intensively managed Argentine Pampas, we studied the additive and interactive effects of large expanses (up to 2200 ha) of natural habitat, represented by untilled isolated "sierras", and narrow (3-7 m wide) strips of semi-natural habitat, represented by field margins, as pollinator sources for sunflower (Helianthus annus). We estimated visitation rates by feral honey-bees, Apis mellifera, and native flower visitors (as a group) at 1, 5, 25, 50 and 100 m from a field margin in 17 sunflower fields 0-10 km distant from the nearest sierra. Honey-bees dominated the pollinator assemblage accounting for >90% of all visits to sunflower inflorescences. Honey-bee visitation was strongly affected by proximity to the sierras decreasing by about 70% in the most isolated fields. There was also a decline in honey-bee visitation with distance from the field margin, which was apparent with increasing field isolation, but undetected in fields nearby large expanses of natural habitat. The probability of observing a native visitor decreased with isolation from the sierras, but in other respects visitation by flower visitors other than honey-bees was mostly unaffected by the habitat factors assessed in this study. Overall, we found strong hierarchical and interactive effects between the study large and small-scale pollinator sources. These results emphasize the importance of preserving natural habitats and managing actively field verges in the absence of large remnants of natural habitat for improving pollinator services.	[Saez, Agustin; Sabatino, Malena; Aizen, Marcelo A.] Univ Nacl Comahue, Lab Ecotono CRUB, San Carlos De Bariloche, Rio Negro, Argentina	Universidad Nacional del Comahue	Saez, A (corresponding author), Univ Nacl Comahue, Lab Ecotono CRUB, San Carlos De Bariloche, Rio Negro, Argentina.	agustinsaez@live.com.ar		Aizen, Marcelo/0000-0001-9079-9749	National Institute of Agricultural Technology (INTA) Balcarce [PNECO1302]; Argentina National Research Council for Research [PIP 01623]; National Fund for Research [PICT 01300]; National University of Comahue [B152/04]	National Institute of Agricultural Technology (INTA) Balcarce; Argentina National Research Council for Research; National Fund for Research; National University of Comahue	This work was supported by the National Institute of Agricultural Technology (INTA) Balcarce (PNECO1302), the Argentina National Research Council for Research (PIP 01623), the National Fund for Research (PICT 01300) and the National University of Comahue (B152/04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIZEN MA, 1994, ECOL APPL, V4, P378, DOI 10.2307/1941941; AIZEN MA, 1994, ECOLOGY, V75, P330, DOI 10.2307/1939538; Aizen MA, 2009, ANN BOT-LONDON, V103, P1579, DOI 10.1093/aob/mcp076; Bates D, 2009, IME4 LINEARMIXED EFF; Beekman M, 2000, FUNCT ECOL, V14, P490, DOI 10.1046/j.1365-2435.2000.00443.x; Beekman M, 2004, NATURWISSENSCHAFTEN, V91, P598, DOI 10.1007/s00114-004-0576-y; Blanche KR, 2006, J APPL ECOL, V43, P1182, DOI 10.1111/j.1365-2664.2006.01230.x; Cabrera AL, 1973, BIOGREOGRAFIA AM LAT; Chacoff NP, 2006, J APPL ECOL, V43, P18, DOI 10.1111/j.1365-2664.2005.01116.x; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Crawley M.J., 2007, J CHEM INF MODEL, DOI DOI 10.1002/9780470515075; Cresswell JE, 2004, J APPL ECOL, V41, P539, DOI 10.1111/j.0021-8901.2004.00912.x; Debinski DM, 2000, CONSERV BIOL, V14, P342, DOI 10.1046/j.1523-1739.2000.98081.x; Fernando LE, 2010, ESPACIO APICOLA, V92, P22; Frangi J L, 1996, BIODIVERSIDAD FUNCIO; Frangi JL, 1975, B SOC ARGENTINA BOT; Gathmann A, 2002, J ANIM ECOL, V71, P757, DOI 10.1046/j.1365-2656.2002.00641.x; Gelman A, 2007, DATA ANAL USING REGR, P109; Greenleaf SS, 2007, OECOLOGIA, V153, P589, DOI 10.1007/s00442-007-0752-9; Greenleaf SS, 2006, BIOL CONSERV, V133, P81, DOI 10.1016/j.biocon.2006.05.025; Greenleaf SS, 2006, P NATL ACAD SCI USA, V103, P13890, DOI 10.1073/pnas.0600929103; Hines HM, 2005, ENVIRON ENTOMOL, V34, P1477, DOI 10.1603/0046-225X-34.6.1477; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Klein AM, 2004, J ANIM ECOL, V73, P517, DOI 10.1111/j.0021-8790.2004.00826.x; Klein AM, 2003, J APPL ECOL, V40, P837, DOI 10.1046/j.1365-2664.2003.00847.x; Klein AM, 2003, P ROY SOC B-BIOL SCI, V270, P955, DOI 10.1098/rspb.2002.2306; Kremen C, 2004, ECOL LETT, V7, P1109, DOI 10.1111/j.1461-0248.2004.00662.x; Kremen C, 2002, P NATL ACAD SCI USA, V99, P16812, DOI 10.1073/pnas.262413599; LANGRIDGE D F, 1974, Australian Journal of Experimental Agriculture and Animal Husbandry, V14, P201, DOI 10.1071/EA9740201; Laterra P, 2003, J VEG SCI, V14, P43, DOI 10.1111/j.1654-1103.2003.tb02126.x; Lonsdorf E, 2009, ANN BOT-LONDON, V103, P1589, DOI 10.1093/aob/mcp069; Morales C. L., 2009, INT J PLANT REPROD B, V1, P195; MORALES CL, 2002, BIOL INVASIONS, V4, P87, DOI DOI 10.1023/A:1020513012689; *NRC, 2007, STAT POLL N AM; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; R Development Core Team, 2005, R LANG ENV STAT COMP; Ricketts TH, 2008, ECOL LETT, V11, P499, DOI 10.1111/j.1461-0248.2008.01157.x; Ricketts TH, 2004, CONSERV BIOL, V18, P1262, DOI 10.1111/j.1523-1739.2004.00227.x; Roubik DW, 2002, NATURE, V417, P708, DOI 10.1038/417708a; Sabatino M, 2010, ECOL APPL, V20, P1491, DOI 10.1890/09-1626.1; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Schneider SS, 2004, ANNU REV ENTOMOL, V49, P351, DOI 10.1146/annurev.ento.49.061802.123359; SHEPPARD WS, 1991, NATURE, V349, P782, DOI 10.1038/349782a0; Steffan-Dewenter I, 2001, P ROY SOC B-BIOL SCI, V268, P1685, DOI 10.1098/rspb.2001.1737; Steffan-Dewenter I, 1999, OECOLOGIA, V121, P432, DOI 10.1007/s004420050949; Steffan-Dewenter I, 2003, P ROY SOC B-BIOL SCI, V270, P569, DOI 10.1098/rspb.2002.2292; Steffan-Dewenter I, 2002, BIOL CONSERV, V104, P275, DOI 10.1016/S0006-3207(01)00192-6; Torretta Juan P., 2010, Rev. Soc. Entomol. Argent., V69, P17; United States Government, 1975, SOIL CONS SOIL TAX B; VISSCHER PK, 1982, ECOLOGY, V63, P1790, DOI 10.2307/1940121; Westphal C, 2003, ECOL LETT, V6, P961, DOI 10.1046/j.1461-0248.2003.00523.x; Westrich P, 1996, HABITAT REQUIREMENTS, P1; Winfree R, 2005, AM NAT, V165, P707, DOI 10.1086/430009; Winfree R, 2009, ECOLOGY, V90, P2068, DOI 10.1890/08-1245.1; Winston ML, 1992, KILLER BEES	55	17	18	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e30968	10.1371/journal.pone.0030968	http://dx.doi.org/10.1371/journal.pone.0030968			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22303477	Green Published, gold, Green Submitted			2022-12-27	WOS:000301704200051
J	Schietke, RE; Hackenbeck, T; Tran, M; Gunther, R; Klanke, B; Warnecke, CL; Knaup, KX; Shukla, D; Rosenberger, C; Koesters, R; Bachmann, S; Betz, P; Schley, G; Schodel, J; Willam, C; Winkler, T; Amann, K; Eckardt, KU; Maxwell, P; Wiesener, MS				Schietke, Ruth E.; Hackenbeck, Thomas; Tran, Maxine; Guenther, Regina; Klanke, Bernd; Warnecke, Christina L.; Knaup, Karl X.; Shukla, Deepa; Rosenberger, Christian; Koesters, Robert; Bachmann, Sebastian; Betz, Peter; Schley, Gunnar; Schoedel, Johannes; Willam, Carsten; Winkler, Thomas; Amann, Kerstin; Eckardt, Kai-Uwe; Maxwell, Patrick; Wiesener, Michael S.			Renal Tubular HIF-2 alpha Expression Requires VHL Inactivation and Causes Fibrosis and Cysts	PLOS ONE			English	Article							VON-HIPPEL-LINDAU; HYPOXIA-INDUCIBLE FACTOR; GENE-EXPRESSION; E-CADHERIN; IN-VIVO; KIDNEY; ACTIVATION; HIF; INDUCTION; INJURY	The Hypoxia-inducible transcription Factor (HIF) represents an important adaptive mechanism under hypoxia, whereas sustained activation may also have deleterious effects. HIF activity is determined by the oxygen regulated alpha-subunits HIF-1 alpha or HIF-2 alpha. Both are regulated by oxygen dependent degradation, which is controlled by the tumor suppressor "von Hippel-Lindau" (VHL), the gatekeeper of renal tubular growth control. HIF appears to play a particular role for the kidney, where renal EPO production, organ preservation from ischemia-reperfusion injury and renal tumorigenesis are prominent examples. Whereas HIF-1 alpha is inducible in physiological renal mouse, rat and human tubular epithelia, HIF-2 alpha is never detected in these cells, in any species. In contrast, distinct early lesions of biallelic VHL inactivation in kidneys of the hereditary VHL syndrome show strong HIF-2 alpha expression. Furthermore, knockout of VHL in the mouse tubular apparatus enables HIF-2 alpha expression. Continuous transgenic expression of HIF-2 alpha by the Ksp-Cadherin promotor leads to renal fibrosis and insufficiency, next to multiple renal cysts. In conclusion, VHL appears to specifically repress HIF-2 alpha in renal epithelia. Unphysiological expression of HIF-2 alpha in tubular epithelia has deleterious effects. Our data are compatible with dedifferentiation of renal epithelial cells by sustained HIF-2 alpha expression. However, HIF-2 alpha overexpression alone is insufficient to induce tumors. Thus, our data bear implications for renal tumorigenesis, epithelial differentiation and renal repair mechanisms.	[Schietke, Ruth E.; Hackenbeck, Thomas; Guenther, Regina; Wiesener, Michael S.] Univ Erlangen Nurnberg, Interdisciplinary Ctr Clin Res, D-91054 Erlangen, Germany; [Klanke, Bernd; Warnecke, Christina L.; Knaup, Karl X.; Schley, Gunnar; Schoedel, Johannes; Willam, Carsten; Eckardt, Kai-Uwe; Wiesener, Michael S.] Univ Erlangen Nurnberg, Dept Hypertens & Nephrol, D-91054 Erlangen, Germany; [Tran, Maxine; Shukla, Deepa; Maxwell, Patrick] UCL, Rayne Inst, London, England; [Rosenberger, Christian] Univ Med Berlin, Dept Nephrol, Charite, Berlin, Germany; [Koesters, Robert] Univ Paris 06, INSERM, Hop Tenon, UMR S 702, Paris, France; [Bachmann, Sebastian] Univ Med Berlin, Charite, Inst Vegetat Anat, Berlin, Germany; [Betz, Peter] Univ Erlangen Nurnberg, Dept Forens Med, D-91054 Erlangen, Germany; [Winkler, Thomas] Univ Erlangen Nurnberg, Dept Genet, D-91054 Erlangen, Germany; [Amann, Kerstin] Univ Erlangen Nurnberg, Dept Pathol, D-91054 Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of London; King's College London; University College London; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg	Schietke, RE (corresponding author), Univ Erlangen Nurnberg, Interdisciplinary Ctr Clin Res, D-91054 Erlangen, Germany.	michael.wiesener@uk-erlangen.de	Maxwell, Patrick H/C-5557-2008; Tran, Maxine/ABF-4197-2021	Maxwell, Patrick H/0000-0002-0338-2679; Tran, Maxine Gia Binh/0000-0002-6034-4433; Schley, Gunnar/0000-0001-9929-5854; Schodel, Johannes/0000-0002-3587-8839; Knaup, Karl/0000-0003-1803-4463	Interdisciplinary Centre for Clinical Research (IZKF); German Research Foundation [SFB 423]; Ulrich-Gessler Foundation; Academy of Medical Sciences (AMS) [AMS-SGCL2-Tran] Funding Source: researchfish	Interdisciplinary Centre for Clinical Research (IZKF); German Research Foundation(German Research Foundation (DFG)); Ulrich-Gessler Foundation; Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS))	This work was supported by grants from the Interdisciplinary Centre for Clinical Research (IZKF), the German Research Foundation (SFB 423) and the Ulrich-Gessler Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asada N, 2011, J CLIN INVEST, V121, P3981, DOI 10.1172/JCI57301; Bernhardt WM, 2009, P NATL ACAD SCI USA, V106, P21276, DOI 10.1073/pnas.0903978106; Bernhardt WM, 2006, J AM SOC NEPHROL, V17, P1970, DOI 10.1681/ASN.2005121302; Bernhardt WM, 2007, AM J PATHOL, V170, P830, DOI 10.2353/ajpath.2007.060455; Eckardt Kai-Uwe, 2005, Kidney Int Suppl, pS46; Esteban MA, 2006, CANCER RES, V66, P3567, DOI 10.1158/0008-5472.CAN-05-2670; Fine LG, 2008, KIDNEY INT, V74, P867, DOI 10.1038/ki.2008.350; Franovic A, 2009, P NATL ACAD SCI USA, V106, P21306, DOI 10.1073/pnas.0906432106; Frew IJ, 2008, EMBO J, V27, P1747, DOI 10.1038/emboj.2008.96; Fu LP, 2011, CANCER RES, V71, P6848, DOI 10.1158/0008-5472.CAN-11-1745; Gordan JD, 2007, CANCER CELL, V11, P335, DOI 10.1016/j.ccr.2007.02.006; Gordan JD, 2008, CANCER CELL, V14, P435, DOI 10.1016/j.ccr.2008.10.016; Haase VH, 2001, P NATL ACAD SCI USA, V98, P1583, DOI 10.1073/pnas.98.4.1583; Haase VH, 2009, ANN NY ACAD SCI, V1177, P57, DOI 10.1111/j.1749-6632.2009.05030.x; Hackenbeck T, 2009, CELL CYCLE, V8, P1386, DOI 10.4161/cc.8.9.8306; Higgins DF, 2007, J CLIN INVEST, V117, P3810, DOI 10.1172/JCI30487; Hill P, 2008, J AM SOC NEPHROL, V19, P39, DOI 10.1681/ASN.2006090998; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Kaelin WG, 2008, NAT REV CANCER, V8, P865, DOI 10.1038/nrc2502; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kimura K, 2008, AM J PHYSIOL-RENAL, V295, pF1023, DOI 10.1152/ajprenal.90209.2008; Kondo K, 2002, CANCER CELL, V1, P237, DOI 10.1016/S1535-6108(02)00043-0; Krieg M, 2000, ONCOGENE, V19, P5435, DOI 10.1038/sj.onc.1203938; Lechler P, 2007, AM J PATHOL, V171, P1483, DOI 10.2353/ajpath.2007.070132; Mandriota SJ, 2002, CANCER CELL, V1, P459, DOI 10.1016/S1535-6108(02)00071-5; Maranchie JK, 2002, CANCER CELL, V1, P247, DOI 10.1016/S1535-6108(02)00044-2; Matsumoto M, 2003, J AM SOC NEPHROL, V14, P1825, DOI 10.1097/01.ASN.0000074239.22357.06; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Ohtomo S, 2008, NEPHROL DIAL TRANSPL, V23, P1166, DOI 10.1093/ndt/gfm715; Rankin EB, 2006, CANCER RES, V66, P2576, DOI 10.1158/0008-5472.CAN-05-3241; Raval RR, 2005, MOL CELL BIOL, V25, P5675, DOI 10.1128/MCB.25.13.5675-5686.2005; Rosenberger C, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000017223.49823.2A; Schietke R, 2010, J BIOL CHEM, V285, P6658, DOI 10.1074/jbc.M109.042424; Schonig K, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf134; Semenza GL, 2009, PHYSIOLOGY, V24, P97, DOI 10.1152/physiol.00045.2008; Shao XL, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000016443.50138.CD; Tanaka T, 2005, KIDNEY INT, V68, P2714, DOI 10.1111/j.1523-1755.2005.00742.x; Tanaka T, 2005, LAB INVEST, V85, P1292, DOI 10.1038/labinvest.3700328; Theilig F, 2011, AM J PATHOL, V179, P2177, DOI 10.1016/j.ajpath.2011.07.012; Tian H, 1998, GENE DEV, V12, P3320, DOI 10.1101/gad.12.21.3320; Traykova-Brauch M, 2008, NAT MED, V14, P979, DOI 10.1038/nm.1865; Turner KJ, 2002, CANCER RES, V62, P2957; Warnecke C, 2004, FASEB J, V18, P1462, DOI 10.1096/fj.04-1640fje; Warnecke C, 2003, FASEB J, V17, P1186, DOI 10.1096/fj.02-1062fje; Warnecke C, 2008, EXP CELL RES, V314, P2016, DOI 10.1016/j.yexcr.2008.03.003; Wiesener MS, 2009, J MOL MED-JMM, V87, P871, DOI 10.1007/s00109-009-0504-x; Wiesener MS, 2001, CANCER RES, V61, P5215; Wiesener MS, 2002, FASEB J, V16, P271, DOI 10.1096/fj.02-0445fje; Wiesener MS, 1998, BLOOD, V92, P2260, DOI 10.1182/blood.V92.7.2260.2260_2260_2268; Wilson PD, 2004, NEW ENGL J MED, V350, P151, DOI 10.1056/NEJMra022161; Zimmer M, 2004, MOL CANCER RES, V2, P89	52	64	69	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e31034	10.1371/journal.pone.0031034	http://dx.doi.org/10.1371/journal.pone.0031034			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22299048	Green Submitted, Green Published, gold			2022-12-27	WOS:000301704200055
J	Setiawan, VW; Haessler, J; Schumacher, F; Cote, ML; Deelman, E; Fesinmeyer, MD; Henderson, BE; Jackson, RD; Vockler, JS; Wilkens, LR; Yasmeen, S; Haiman, CA; Peters, U; Le Marchand, L; Kooperberg, C				Setiawan, Veronica Wendy; Haessler, Jeffrey; Schumacher, Fredrick; Cote, Michele L.; Deelman, Ewa; Fesinmeyer, Megan D.; Henderson, Brian E.; Jackson, Rebecca D.; Voeckler, Jens-S; Wilkens, Lynne R.; Yasmeen, Shagufta; Haiman, Christopher A.; Peters, Ulrike; Le Marchand, Loic; Kooperberg, Charles			HNF1B and Endometrial Cancer Risk: Results from the PAGE study	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; PROSTATE-CANCER; MULTIETHNIC COHORT; GENE-EXPRESSION	We examined the association between HNF1B variants identified in a recent genome-wide association study and endometrial cancer in two large case-control studies nested in prospective cohorts: the Multiethnic Cohort Study (MEC) and the Women's Health Initiative (WHI) as part of the Population Architecture using Genomics and Epidemiology (PAGE) study. A total of 1,357 incident cases of invasive endometrial cancer and 7,609 controls were included in the analysis (MEC: 426 cases/3,854 controls; WHI: 931cases/3,755 controls). The majority of women in the WHI were European American, while the MEC included sizable numbers of African Americans, Japanese and Latinos. We estimated the odds ratios (ORs) per allele and 95% confidence intervals (CIs) of each SNP using unconditional logistic regression adjusting for age, body mass index, and four principal components of ancestry informative markers. The combined ORs were estimated using fixed effect models. Rs4430796 and rs7501939 were associated with endometrial cancer risk in MEC and WHI with no heterogeneity observed across racial/ethnic groups (P >= 0.21) or between studies (P >= 0.70). The ORper allele was 0.82 (95% CI: 0.75, 0.89; P = 5.63 x 10(-6)) for rs4430796 (G allele) and 0.79 (95% CI: 0.73, 0.87; P = 3.77 x 10(-7)) for rs7501939 (A allele). The associations with the risk of Type I and Type II tumors were similar (P >= 0.19). Adjustment for additional endometrial cancer risk factors such as parity, oral contraceptive use, menopausal hormone use, and smoking status had little effect on the results. In conclusion, HNF1B SNPs are associated with risk of endometrial cancer and that the associated relative risks are similar for Type I and Type II tumors.	[Setiawan, Veronica Wendy; Schumacher, Fredrick; Henderson, Brian E.; Haiman, Christopher A.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Haessler, Jeffrey; Fesinmeyer, Megan D.; Peters, Ulrike; Kooperberg, Charles] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Cote, Michele L.] Wayne State Univ, Sch Med & Populat Studies & Dispar Res, Karmanos Canc Inst, Dept Oncol, Detroit, MI USA; [Deelman, Ewa; Voeckler, Jens-S] Univ So Calif, Inst Informat Sci, Marina Del Rey, CA 90292 USA; [Jackson, Rebecca D.] Ohio State Univ, Ctr Clin & Translat Sci, Columbus, OH 43210 USA; [Wilkens, Lynne R.; Le Marchand, Loic] Univ Hawaii, Ctr Canc, Program Epidemiol, Honolulu, HI 96822 USA; [Yasmeen, Shagufta] Univ Calif Davis, Dept Obstet & Gynecol, Davis, CA 95616 USA	University of Southern California; Fred Hutchinson Cancer Center; Barbara Ann Karmanos Cancer Institute; Wayne State University; University of Southern California; University System of Ohio; Ohio State University; Cancer Research Center of Hawaii; University of Hawaii System; University of California System; University of California Davis	Setiawan, VW (corresponding author), Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA.	clk@fhcrc.org	Schumacher, Fredrick/R-6043-2019	Schumacher, Fredrick/0000-0002-3073-7463; Setiawan, Veronica/0000-0001-9239-5692; Fesinmeyer, Megan/0000-0003-2003-4251	National Cancer Institute (NCI) [K07 CA116543, R37CA54281, R01CA63464, P01CA33619, U01CA136792, U01CA98758, R03CA128008]; National Human Genome Research Institute (NHGRI) [U01HG004803, U01HG004798, U01HG004802, U01HG004790, U01HG004801]; NHGRI PAGE [U01HG004802, U01HG004790]; National Heart, Lung, and Blood Institute; NIH; U.S. Department of Health and Human Services [N01WH22110, 24152, 32100-2, 32105-6, 32108-9, 32111-13, 32115, 32118-32119, 32122, 42107-26, 42129-32, 44221]; NATIONAL CANCER INSTITUTE [R37CA054281, K07CA116543, R01CA063464, U01CA136792, P30CA015704, U01CA098758, P30CA071789, R03CA128008, P01CA033619] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004802, U01HG004801, U01HG004803, U01HG004798, U01HG004790] Funding Source: NIH RePORTER; WOMEN&apos;S HEALTH INITIATIVE - OFFICE OF THE DIRECTOR NIH [N01WH022110] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI PAGE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Health and Human Services; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); WOMEN&apos;S HEALTH INITIATIVE - OFFICE OF THE DIRECTOR NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Dr. Setiawan is supported in part by the National Cancer Institute (NCI) Career Development Award K07 CA116543. The Population Architecture Using Genomics and Epidemiology (PAGE) program is funded by the National Human Genome Research Institute (NHGRI), supported by U01HG004803 (CALiCo), U01HG004798 (EAGLE), U01HG004802 (MEC), U01HG004790 (WHI), and U01HG004801 (Coordinating Center). The contents of this paper are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health (NIH). The complete list of PAGE members can be found at http://www.pagestudy.org. The data and materials included in this report result from a collaboration between the following studies: The Multiethnic Cohort study (MEC) characterization of epidemiological architecture is funded through the NHGRI PAGE program (U01HG004802). The MEC study is funded through the National Cancer Institute (R37CA54281, R01CA63464, P01CA33619, U01CA136792, U01CA98758, and R03CA128008). The authors thank the cohort members for their participation and Dr. Monroe for her invaluable contributions to the execution of the Multiethnic Cohort study. Funding support for the "Epidemiology of Putative Genetic Variants: The Women's Health Initiative" study is provided through the NHGRI PAGE program (U01HG004790). The WHI program is funded by the National Heart, Lung, and Blood Institute; NIH; and U.S. Department of Health and Human Services through contracts N01WH22110, 24152, 32100-2, 32105-6, 32108-9, 32111-13, 32115, 32118-32119, 32122, 42107-26, 42129-32, and 44221. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1998, CONTROLLED CLIN TRIA, V19, P61; BACH I, 1993, EMBO J, V12, P4229, DOI 10.1002/j.1460-2075.1993.tb06107.x; Cook LS, 2006, CANC EPIDEMIOLOGY PR; Curb JD, 2003, ANN EPIDEMIOL, V13, pS122, DOI 10.1016/S1047-2797(03)00048-6; Edghill EL, 2006, J MED GENET, V43, P84, DOI 10.1136/jmg.2005.032854; Elliott KS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010858; Felix AS, 2010, CANCER CAUSE CONTROL, V21, P1851, DOI 10.1007/s10552-010-9612-8; Glinsky GV, 2004, J CLIN INVEST, V113, P913, DOI 10.1172/JCI200420032; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Harries LW, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-315; Horikawa Y, 1997, NAT GENET, V17, P384, DOI 10.1038/ng1297-384; Kolonel LN, 2000, AM J EPIDEMIOL, V151, P346, DOI 10.1093/oxfordjournals.aje.a010213; Matise TC, 2011, AM J EPIDEMIOL, V174, P849, DOI 10.1093/aje/kwr160; Prat J, 2004, HUM PATHOL, V35, P649, DOI 10.1016/j.humpath.2004.02.007; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Ronnett B, 2002, BLAUSTEINS PATHOLOGY, P501; Sherman ME, 2000, MODERN PATHOL, V13, P295, DOI 10.1038/modpathol.3880051; Spurdle AB, 2011, NAT GENET, V43, P451, DOI 10.1038/ng.812; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Waters KM, 2009, AM J EPIDEMIOL, V169, P937, DOI 10.1093/aje/kwp003	20	34	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e30390	10.1371/journal.pone.0030390	http://dx.doi.org/10.1371/journal.pone.0030390			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22299039	Green Published, Green Submitted, gold			2022-12-27	WOS:000301704200016
J	Pearson, ML; Selby, JV; Katz, KA; Cantrell, V; Braden, CR; Parise, ME; Paddock, CD; Lewin-Smith, MR; Kalasinsky, VF; Goldstein, FC; Hightower, AW; Papier, A; Lewis, B; Motipara, S; Eberhard, ML				Pearson, Michele L.; Selby, Joseph V.; Katz, Kenneth A.; Cantrell, Virginia; Braden, Christopher R.; Parise, Monica E.; Paddock, Christopher D.; Lewin-Smith, Michael R.; Kalasinsky, Victor F.; Goldstein, Felicia C.; Hightower, Allen W.; Papier, Arthur; Lewis, Brian; Motipara, Sarita; Eberhard, Mark L.		Unexplained Dermopathy Study Team	Clinical, Epidemiologic, Histopathologic and Molecular Features of an Unexplained Dermopathy	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; MORGELLONS-DISEASE; PARASITOSIS; DELUSIONS; DIAGNOSIS; TISSUE; PCR	Background: Morgellons is a poorly characterized constellation of symptoms, with the primary manifestations involving the skin. We conducted an investigation of this unexplained dermopathy to characterize the clinical and epidemiologic features and explore potential etiologies. Methods: A descriptive study was conducted among persons at least 13 years of age and enrolled in Kaiser Permanente Northern California (KPNC) during 2006-2008. A case was defined as the self-reported emergence of fibers or materials from the skin accompanied by skin lesions and/or disturbing skin sensations. We collected detailed epidemiologic data, performed clinical evaluations and geospatial analyses and analyzed materials collected from participants' skin. Results: We identified 115 case-patients. The prevalence was 3.65 (95% CI = 2.98, 4.40) cases per 100,000 enrollees. There was no clustering of cases within the 13-county KPNC catchment area (p = .113). Case-patients had a median age of 52 years (range: 17-93) and were primarily female (77%) and Caucasian (77%). Multi-system complaints were common; 70% reported chronic fatigue and 54% rated their overall health as fair or poor with mean Physical Component Scores and Mental Component Scores of 36.63 (SD = 12.9) and 35.45 (SD = 12.89), respectively. Cognitive deficits were detected in 59% of case-patients and 63% had evidence of clinically significant somatic complaints; 50% had drugs detected in hair samples and 78% reported exposure to solvents. Solar elastosis was the most common histopathologic abnormality (51% of biopsies); skin lesions were most consistent with arthropod bites or chronic excoriations. No parasites or mycobacteria were detected. Most materials collected from participants' skin were composed of cellulose, likely of cotton origin. Conclusions: This unexplained dermopathy was rare among this population of Northern California residents, but associated with significantly reduced health-related quality of life. No common underlying medical condition or infectious source was identified, similar to more commonly recognized conditions such as delusional infestation.	[Pearson, Michele L.] Ctr Dis Control & Prevent, Div TB Eliminat, Atlanta, GA USA; [Selby, Joseph V.; Cantrell, Virginia; Motipara, Sarita] Kaiser Permanente No Calif, Div Res, Oakland, CA USA; [Katz, Kenneth A.] Hlth & Human Serv Agcy, HIV STD & Hepatitis Branch, San Diego, CA USA; [Braden, Christopher R.] Ctr Dis Control & Prevent, Div Food Waterborne & Environm Dis, Atlanta, GA USA; [Parise, Monica E.; Hightower, Allen W.; Eberhard, Mark L.] Ctr Dis Control & Prevent, Div Parasit Dis & Malaria, Atlanta, GA USA; [Paddock, Christopher D.] Ctr Dis Control & Prevent, Div High Consequence Pathogens & Pathol, Atlanta, GA USA; [Lewin-Smith, Michael R.] Joint Pathol Ctr, Silver Spring, MD USA; [Kalasinsky, Victor F.] US Dept Vet Affairs, Off Res & Dev, Washington, DC USA; [Goldstein, Felicia C.] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; [Papier, Arthur] Univ Rochester, Sch Med, Dept Dermatol, Rochester, NY USA; [Lewis, Brian] Agcy Tox Subst & Dis Registry, Div Hlth Studies, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Kaiser Permanente; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; US Department of Veterans Affairs; Emory University; University of Rochester; Centers for Disease Control & Prevention - USA	Pearson, ML (corresponding author), Ctr Dis Control & Prevent, Div TB Eliminat, Atlanta, GA USA.	mle1@cdc.gov			Centers for Disease Control (CDC) and Prevention	Centers for Disease Control (CDC) and Prevention	Funding for this study was provided by the Centers for Disease Control (CDC) and Prevention. Epidemiologists from the CDC participated in the study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Accordino RE, 2008, DERMATOL THER, V21, P8, DOI 10.1111/j.1529-8019.2008.00164.x; Centers for Disease Control and Prevention, 2008, BEH RISK FACT SURV S; Centers for Disease Control and Prevention (CDC), 1995, MMWR Morb Mortal Wkly Rep, V44, P590; Freudenmann RW, 2009, CLIN MICROBIOL REV, V22, P690, DOI 10.1128/CMR.00018-09; Ganesan S, 2003, MODERN PATHOL, V16, P286, DOI 10.1097/01.MP.0000062653.65441.DA; GLICKMAN L, 1978, AM J TROP MED HYG, V27, P492, DOI 10.4269/ajtmh.1978.27.492; Gordon N, 2006, KAISER PERMANENTE ME; Guarner J, 2007, AM J CLIN PATHOL, V127, P612, DOI 10.1309/J3LD0RBP788W1TM8; Guarner J, 2006, AM J CLIN PATHOL, V126, P148, DOI 10.1309/KHGVR72CBRM4FQ58; Harvey William T, 2009, J Med Case Rep, V3, P8243, DOI 10.4076/1752-1947-3-8243; Hinkle NC, 2011, CURR PSYCHIAT REP, V13, P178, DOI 10.1007/s11920-011-0188-0; Hylwa SA, 2011, ARCH DERMATOL, V147, P1041, DOI 10.1001/archdermatol.2011.114; Imrit K, 2006, J CLIN MICROBIOL, V44, P2609, DOI 10.1128/JCM.00572-06; Jones JL, 2008, AM J TROP MED HYG, V78, P35, DOI 10.4269/ajtmh.2008.78.35; Kellett C E, 1935, Ann Med Hist, V7, P467; Koblenzer CS, 1996, DERMATOL CLIN, V14, P447, DOI 10.1016/S0733-8635(05)70372-7; Lane JE, 2008, CUTIS, V81, P37; McAuliffe I, 2008, 57 ANN M AM SOC TROP; Morey L.C., 1991, PERSONALITY ASSESSME; Murakata LA, 2006, MODERN PATHOL, V19, P922, DOI 10.1038/modpathol.3800595; Murdoch DR, 2003, J CLIN MICROBIOL, V41, P63, DOI 10.1128/JCM.41.1.63-66.2003; Robles David T, 2008, Dermatol Online J, V14, P2; Savely VR, 2010, CLIN COSMET INVESTI, V3, P67; Savely VR, 2006, AM J CLIN DERMATOL, V7, P1, DOI 10.2165/00128071-200607010-00001; STEWART AL, 1989, JAMA-J AM MED ASSOC, V262, P907, DOI 10.1001/jama.262.7.907; Thomas LC, 2007, J MICROBIOL METH, V68, P296, DOI 10.1016/j.mimet.2006.09.003; TRABERT W, 1995, PSYCHOPATHOLOGY, V28, P238, DOI 10.1159/000284934; Veien NK, 2001, J AM ACAD DERMATOL, V44, P704, DOI 10.1067/mjd.2001.112912; Ware J. E., 1992, MEASURING FUNCTIONIN, P277; WELLS KB, 1989, JAMA-J AM MED ASSOC, V262, P914, DOI 10.1001/jama.262.7.914; WYKOFF RF, 1987, REV INFECT DIS, V9, P433	31	64	65	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e29908	10.1371/journal.pone.0029908	http://dx.doi.org/10.1371/journal.pone.0029908			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295070	Green Published, gold, Green Submitted			2022-12-27	WOS:000301640600015
J	Pei, YF; Zhang, L; Yang, TL; Han, YY; Hai, R; Ran, S; Tian, Q; Shen, H; Li, J; Zhu, XZ; Luo, XG; Deng, HW				Pei, Yu-Fang; Zhang, Lei; Yang, Tie-Lin; Han, Yingying; Hai, Rong; Ran, Shu; Tian, Qing; Shen, Hui; Li, Jian; Zhu, Xue-Zhen; Luo, Xingguang; Deng, Hong-Wen			Genome-Wide Association Study of Copy Number Variants Suggests LTBP1 and FGD4 Are Important for Alcohol Drinking	PLOS ONE			English	Article							STRUCTURAL VARIANTS; GENE-EXPRESSION; MALE TWINS; DEPENDENCE; LINKAGE; SCHIZOPHRENIA; PHENOTYPE; DISEASE; RISK; SUSCEPTIBILITY	Alcohol dependence (AD) is a complex disorder characterized by psychiatric and physiological dependence on alcohol. AD is reflected by regular alcohol drinking, which is highly inheritable. In this study, to identify susceptibility genes associated with alcohol drinking, we performed a genome-wide association study of copy number variants (CNVs) in 2,286 Caucasian subjects with Affymetrix SNP6.0 genotyping array. We replicated our findings in 1,627 Chinese subjects with the same genotyping array. We identified two CNVs, CNV207 (combined p-value 1.91E-03) and CNV1836 (combined p-value 3.05E-03) that were associated with alcohol drinking. CNV207 and CNV1836 are located at the downstream of genes LTBP1 (870 kb) and FGD4 (400 kb), respectively. LTBP1, by interacting TGFB1, may down-regulate enzymes directly participating in alcohol metabolism. FGD4 plays a role in clustering and trafficking GABA(A) receptor and subsequently influence alcohol drinking through activating CDC42. Our results provide suggestive evidence that the newly identified CNV regions and relevant genes may contribute to the genetic mechanism of alcohol dependence.	[Pei, Yu-Fang; Zhang, Lei; Han, Yingying; Hai, Rong; Ran, Shu; Zhu, Xue-Zhen; Deng, Hong-Wen] Shanghai Univ Sci & Technol, Ctr Syst Biomed Sci, Shanghai 201800, Peoples R China; [Yang, Tie-Lin] Xi An Jiao Tong Univ, Sch Life Sci & Technol, Xian 710049, Peoples R China; [Hai, Rong] Inner Mongolia Med Coll Huhhot, Affiliated Hosp, Inner Mongolia, Peoples R China; [Tian, Qing; Shen, Hui; Li, Jian; Deng, Hong-Wen] Tulane Univ, Dept Biostat, New Orleans, LA 70118 USA; [Luo, Xingguang] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA; [Deng, Hong-Wen] Hunan Normal Univ, Coll Life Sci, Lab Mol & Stat Genet, Changsha, Hunan, Peoples R China; [Deng, Hong-Wen] Hunan Normal Univ, Coll Life Sci, Minist Educ, Key Lab Prot Chem & Dev Biol, Changsha, Hunan, Peoples R China	University of Shanghai for Science & Technology; Xi'an Jiaotong University; Tulane University; Yale University; Hunan Normal University; Hunan Normal University	Pei, YF (corresponding author), Shanghai Univ Sci & Technol, Ctr Syst Biomed Sci, Shanghai 201800, Peoples R China.	hdeng2@tulane.edu	Yang, Tie-Lin/G-8365-2014; Zhang, Lei/L-1016-2016; Li, Jian/G-4445-2015	Yang, Tie-Lin/0000-0001-7062-3025; Zhang, Lei/0000-0002-1007-4834; Deng, Hong-Wen/0000-0002-0387-8818	Shanghai Leading Academic Discipline Project [S30501]; University of Shanghai for Science and Technology; National Natural Science Foundation of China [31100902]; NIH [P50AR055081, R01AG026564, R01AR050496, RC2DE020756, R01AR057049, R03TW008221, K01 DA029643, R01AA016015, R21AA020319]; FOGARTY INTERNATIONAL CENTER [R03TW008221] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057049, P50AR055081, R01AR050496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [RC2DE020756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026564] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA020319, R01AA016015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA029643] Funding Source: NIH RePORTER	Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); University of Shanghai for Science and Technology; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The study was partially supported by Shanghai Leading Academic Discipline Project (S30501) and startup fund from University of Shanghai for Science and Technology. The investigators of this work were partially supported by grants from National Natural Science Foundation of China project (31100902) and grants from NIH (P50AR055081, R01AG026564, R01AR050496, RC2DE020756, R01AR057049, R03TW008221, K01 DA029643, R01AA016015 and R21AA020319). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berney A, 2002, DRUG ALCOHOL DEPEN, V65, P149, DOI 10.1016/S0376-8716(01)00156-9; Buckland PR, 2003, ANN MED, V35, P308, DOI 10.1080/07853890310001276; Cahan P, 2009, NAT GENET, V41, P430, DOI 10.1038/ng.350; Ciuclan L, J HEPATOL, V52, P407; D'Alfonso S, 1999, GENET EPIDEMIOL, V17, pS127; Dick DM, 2002, ALCOHOL CLIN EXP RES, V26, P1453, DOI 10.1097/01.ALC.0000034037.10333.FD; Economou M, 2004, AM J GASTROENTEROL, V99, P2393, DOI 10.1111/j.1572-0241.2004.40304.x; Edenberg HJ, 2004, AM J HUM GENET, V74, P705, DOI 10.1086/383283; Feuk L, 2006, HUM MOL GENET, V15, pR57, DOI 10.1093/hmg/ddl057; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Fisher KA, 2008, J ACOUST SOC AM, V123, P1862, DOI 10.1121/1.2839140; Foroud T, 1998, ALCOHOL CLIN EXP RES, V22, P2035, DOI 10.1097/00000374-199812000-00020; Freeman JL, 2006, GENOME RES, V16, P949, DOI 10.1101/gr.3677206; Gelernter J, 2006, HUM MOL GENET, V15, P3498, DOI 10.1093/hmg/ddl426; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Grant JD, 2009, BIOL PSYCHIAT, V66, P795, DOI 10.1016/j.biopsych.2009.05.018; Grobin AC, 1998, PSYCHOPHARMACOLOGY, V139, P2, DOI 10.1007/s002130050685; Gualandris A, 2000, MOL BIOL CELL, V11, P4295, DOI 10.1091/mbc.11.12.4295; Heath AC, BIOL PSYCHIAT, V70, P513; Henrichsen CN, 2009, NAT GENET, V41, P424, DOI 10.1038/ng.345; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; Kendler KS, 1997, ARCH GEN PSYCHIAT, V54, P178; KENDLER KS, 1992, JAMA-J AM MED ASSOC, V268, P1877, DOI 10.1001/jama.268.14.1877; Kneussel M, 2000, TRENDS NEUROSCI, V23, P429, DOI 10.1016/S0166-2236(00)01627-1; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Liu SL, PLOS ONE, V6; Luo XG, 2006, AM J HUM GENET, V78, P973, DOI 10.1086/504113; Lupski JR, 2005, PLOS GENET, V1, P627, DOI 10.1371/journal.pgen.0010049; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; Merla G, 2006, AM J HUM GENET, V79, P332, DOI 10.1086/506371; Nguyen DQ, 2006, PLOS GENET, V2, P198, DOI 10.1371/journal.pgen.0020020; Prescott CA, 2006, MOL PSYCHIATR, V11, P603, DOI 10.1038/sj.mp.4001811; Prescott CA, 1999, AM J PSYCHIAT, V156, P34, DOI 10.1176/ajp.156.1.34; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Repping S, 2006, NAT GENET, V38, P463, DOI 10.1038/ng1754; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Saltzman BS, 2008, CANCER RES, V68, P1236, DOI 10.1158/0008-5472.CAN-07-2144; Schumann G, P NATL ACAD SCI US, V108, P7119; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Team RDC, 2010, R LANG ENV STAT COMP; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Whitfield JB, 2004, ALCOHOL CLIN EXP RES, V28, P1153, DOI 10.1097/01.ALC.0000134221.32773.69; Xu B, 2008, NAT GENET, V40, P880, DOI 10.1038/ng.162; Zhu XF, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S128; Zuo L, NEUROPSYCHOPHARMACOL	49	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30860	10.1371/journal.pone.0030860	http://dx.doi.org/10.1371/journal.pone.0030860			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295116	Green Published, gold, Green Submitted			2022-12-27	WOS:000301640600061
J	Zhang, S; Han, CH; Chen, XS; Zhang, M; Xu, LM; Zhang, JJ; Xia, Q				Zhang, Shun; Han, Cong-Hui; Chen, Xiao-Song; Zhang, Ming; Xu, Long-Mei; Zhang, Jian-Jun; Xia, Qiang			Transient Ureteral Obstruction Prevents against Kidney Ischemia/Reperfusion Injury via Hypoxia-Inducible Factor (HIF)-2 alpha Activation	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; DOMAIN PROTEIN-1 EPAS1; ENDOTHELIAL INJURY; HEPATIC ISCHEMIA; RETINAL ISCHEMIA; TISSUE OXYGEN; TRANSCRIPTION; EXPRESSION; DYSFUNCTION; CELLS	Although the protective effect of transient ureteral obstruction (UO) prior to ischemia on subsequent renal ischemia/reperfusion (I/R) injury has been documented, the underlying molecular mechanism remains to be understood. We showed in the current study that 24 h of UO led to renal tubular hypoxia in the ipsilateral kidney in mice, with the accumulation of hypoxia-inducible factor (HIF)-2 alpha, which lasted for a week after the release of UO. To address the functions of HIF-2 alpha in UO-mediated protection of renal IRI, we utilized the Mx-Cre/loxP recombination system to knock out target genes. Inactivation of HIF-2 alpha, but not HIF-1 alpha blunted the renal protective effects of UO, as demonstrated by much higher serum creatinine level and severer histological damage. UO failed to prevent postischemic neutrophil infiltration and apoptosis induction in HIF-2 alpha knockout mice, which also diminished the postobstructive up-regulation of the protective molecule, heat shock protein (HSP)-27. The renal protective effects of UO were associated with the improvement of the postischemic recovery of intrarenal microvascular blood flow, which was also dependent on the activation of HIF-2 alpha. Our results demonstrated that UO protected the kidney via activation of HIF-2 alpha, which reduced tubular damages via preservation of adequate renal microvascular perfusion after ischemia. Thus, preconditional HIF-2 alpha activation might serve as a novel therapeutic strategy for the treatment of ischemic acute renal failure.	[Zhang, Shun; Chen, Xiao-Song; Zhang, Ming; Xu, Long-Mei; Zhang, Jian-Jun; Xia, Qiang] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Transplantat & Hepat Surg, Shanghai 200030, Peoples R China; [Han, Cong-Hui] Xuzhou Med Univ, Sch Clin Med, Xuzhou Cent Hosp, Dept Urol, Xuzhou, Peoples R China	Shanghai Jiao Tong University; Xuzhou Medical University	Zhang, S (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Transplantat & Hepat Surg, Shanghai 200030, Peoples R China.	xiaqiang@medmail.com.cn		Zhang, Shun/0000-0002-3493-1247	Renji Hospital, Shanghai Jiaotong University School of Medicine [RJ4101301]; Science and Technology Commission of Shanghai Municipality [09410706300]	Renji Hospital, Shanghai Jiaotong University School of Medicine; Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by the Key Discipline Project of Renji Hospital, Shanghai Jiaotong University School of Medicine (RJ4101301) to QX. This study was also supported by a grant from Science and Technology Commission of Shanghai Municipality (International Science and Technology Cooperation Program, 09410706300) to JZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baranova O, 2007, J NEUROSCI, V27, P6320, DOI 10.1523/JNEUROSCI.0449-07.2007; Bernhardt WM, 2006, J AM SOC NEPHROL, V17, P1970, DOI 10.1681/ASN.2005121302; Bernhardt WM, 2006, KIDNEY INT, V69, P114, DOI 10.1038/sj.ki.5000062; Blackwell KL, 2003, CANCER RES, V63, P6162; Brodsky SV, 2002, AM J PHYSIOL-RENAL, V282, pF1140, DOI 10.1152/ajprenal.00329.2001; Bruick RK, 2003, GENE DEV, V17, P2614, DOI 10.1101/gad.1145503; Bruick RK, 2002, SCIENCE, V295, P807, DOI 10.1126/science.1069825; Chang CK, 2004, CLIN SCI, V106, P501, DOI 10.1042/CS20030263; Concannon CG, 2003, APOPTOSIS, V8, P61, DOI 10.1023/A:1021601103096; Debbabi H, 2010, AM J HYPERTENS, V23, P541, DOI 10.1038/ajh.2010.10; Donnahoo KK, 1999, AM J PHYSIOL-REG I, V277, pR922, DOI 10.1152/ajpregu.1999.277.3.R922; Dyson A, 2007, AM J PHYSIOL-HEART C, V293, pH526, DOI 10.1152/ajpheart.00052.2007; Eckle T, 2008, CIRCULATION, V118, P166, DOI 10.1161/CIRCULATIONAHA.107.758516; Ema M, 1997, P NATL ACAD SCI USA, V94, P4273, DOI 10.1073/pnas.94.9.4273; Gruber M, 2007, P NATL ACAD SCI USA, V104, P2301, DOI 10.1073/pnas.0608382104; Haase VH, 2006, AM J PHYSIOL-RENAL, V291, pF271, DOI 10.1152/ajprenal.00071.2006; Hayashi M, 2004, J CLIN INVEST, V113, P1138, DOI 10.1172/JCI200419890; Hegarty NJ, 2001, KIDNEY INT, V59, P1059, DOI 10.1046/j.1523-1755.2001.00589.x; Higgins DF, 2007, J CLIN INVEST, V117, P3810, DOI 10.1172/JCI30487; Hill P, 2008, J AM SOC NEPHROL, V19, P39, DOI 10.1681/ASN.2006090998; Hollander JM, 2004, CIRCULATION, V110, P3544, DOI 10.1161/01.CIR.0000148825.99184.50; Holmquist-Mengelbier L, 2006, CANCER CELL, V10, P413, DOI 10.1016/j.ccr.2006.08.026; Hu G, 2010, IMMUNOPHARM IMMUNOT, V32, P656, DOI 10.3109/08923971003671090; HULAND H, 1982, UROL INT, V37, P213, DOI 10.1159/000280819; Iguchi M, 2008, NEPHRON EXP NEPHROL, V110, pE82, DOI 10.1159/000166994; Kabakov AE, 2003, CELL STRESS CHAPERON, V8, P335, DOI 10.1379/1466-1268(2003)008<0335:HSPOHS>2.0.CO;2; Khan NA, 2009, NEPHROL DIAL TRANSPL, V24, P2701, DOI 10.1093/ndt/gfp369; Kim M, 2010, AM J PHYSIOL-RENAL, V299, pF347, DOI 10.1152/ajprenal.00194.2010; KINJO T, 1989, CELL TISSUE RES, V256, P27; Kojima I, 2007, J AM SOC NEPHROL, V18, P1218, DOI 10.1681/ASN.2006060639; Kostourou V, 2004, NEOPLASIA, V6, P401, DOI 10.1593/neo.04109; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lafrance JP, 2010, J AM SOC NEPHROL, V21, P345, DOI 10.1681/ASN.2009060636; Lameire N, 2005, LANCET, V365, P417; Licht AH, 2006, BLOOD, V107, P584, DOI 10.1182/blood-2005-07-3033; Lok CN, 1999, J BIOL CHEM, V274, P24147, DOI 10.1074/jbc.274.34.24147; Ma DQ, 2009, J AM SOC NEPHROL, V20, P713, DOI 10.1681/ASN.2008070712; Milosevic J, 2007, J NEUROSCI, V27, P412, DOI 10.1523/JNEUROSCI.2482-06.2007; Molitoris BA, 2004, KIDNEY INT, V66, P496, DOI 10.1111/j.1523-1755.2004.761_5.x; Molitoris BA, 2002, CRIT CARE MED, V30, pS235, DOI 10.1097/00003246-200205001-00011; Nocito A, 2007, HEPATOLOGY, V45, P369, DOI 10.1002/hep.21516; Norregaard R, 2009, AM J PHYSIOL-REG I, V296, pR185, DOI 10.1152/ajpregu.00170.2008; O'Hara JA, 2005, PHYSIOL MEAS, V26, P203, DOI 10.1088/0967-3334/26/3/006; Park KM, 2002, J BIOL CHEM, V277, P2040, DOI 10.1074/jbc.M107525200; Park SW, 2009, AM J PHYSIOL-RENAL, V297, pF885, DOI 10.1152/ajprenal.00317.2009; Patel SA, 2008, CELL DEATH DIFFER, V15, P628, DOI 10.1038/cdd.2008.17; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Rosenberger C, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000017223.49823.2A; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; Sharp Frank R, 2004, NeuroRx, V1, P26, DOI 10.1602/neurorx.1.1.26; Sutton TA, 2002, KIDNEY INT, V62, P1539, DOI 10.1046/j.1523-1755.2002.00631.x; Taie S, 2009, J CLIN NEUROSCI, V16, P1056, DOI 10.1016/j.jocn.2008.09.024; Tepper OM, 2005, BLOOD, V105, P1068, DOI 10.1182/blood-2004-03-1051; Thakar CV, 2005, J CLIN INVEST, V115, P3451, DOI 10.1172/JCI25461; Tian H, 1997, GENE DEV, V11, P72, DOI 10.1101/gad.11.1.72; Turner J, 2008, TRENDS CARDIOVAS MED, V18, P109, DOI 10.1016/j.tcm.2008.02.001; Whitehouse T, 2006, AM J PHYSIOL-RENAL, V291, pF647, DOI 10.1152/ajprenal.00475.2005; Whitlock NA, 2005, INVEST OPHTH VIS SCI, V46, P1092, DOI 10.1167/iovs.04-0043; Wiesener MS, 2002, FASEB J, V16, P271, DOI 10.1096/fj.02-0445fje; Xia GB, 2001, CANCER-AM CANCER SOC, V91, P1429, DOI 10.1002/1097-0142(20010415)91:8<1429::AID-CNCR1149>3.0.CO;2-V; ZAGER RA, 1995, KIDNEY INT, V47, P628, DOI 10.1038/ki.1995.80; Zhu YL, 2007, INVEST OPHTH VIS SCI, V48, P1735, DOI 10.1167/iovs.06-1037	63	21	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e29876	10.1371/journal.pone.0029876	http://dx.doi.org/10.1371/journal.pone.0029876			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295069	Green Submitted, gold, Green Published			2022-12-27	WOS:000301640600014
J	Hoeth, M; Niederleithner, H; Hofer-Warbinek, R; Bilban, M; Mayer, H; Resch, U; Lemberger, C; Wagner, O; Hofer, E; Petzelbauer, P; de Martin, R				Hoeth, Martina; Niederleithner, Heide; Hofer-Warbinek, Renate; Bilban, Martin; Mayer, Herbert; Resch, Ulrike; Lemberger, Christof; Wagner, Oswald; Hofer, Erhard; Petzelbauer, Peter; de Martin, Rainer			The Transcription Factor SOX18 Regulates the Expression of Matrix Metalloproteinase 7 and Guidance Molecules in Human Endothelial Cells	PLOS ONE			English	Article							HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA; NF-KAPPA-B; REDUNDANT ROLES; GENE-EXPRESSION; GROWTH-FACTOR; MICE; ANGIOGENESIS; MATRILYSIN; MUTATIONS; IDENTIFICATION	Background: Mutations in the transcription factor SOX18 are responsible for specific cardiovascular defects in humans and mice. In order to gain insight into the molecular basis of its action, we identified target genes of SOX18 and analyzed one, MMP7, in detail. Methodology/Principal Findings: SOX18 was expressed in HUVEC using a recombinant adenoviral vector and the altered gene expression profile was analyzed using microarrays. Expression of several regulated candidate SOX18 target genes was verified by real-time PCR. Knock-down of SOX18 using RNA interference was then used to confirm the effect of the transcription factor on selected genes that included the guidance molecules ephrin B2 and semaphorin 3G. One gene, MMP7, was chosen for further analysis, including detailed promoter studies using reporter gene assays, electrophoretic mobility shift analysis and chromatin-immunoprecipitation, revealing that it responds directly to SOX18. Immunohistochemical analysis demonstrated the co-expression of SOX18 and MMP7 in blood vessels of human skin. Conclusions/Significance: The identification of MMP7 as a direct SOX18 target gene as well as other potential candidates including guidance molecules provides a molecular basis for the proposed function of this transcription factor in the regulation of vessel formation.	[Hoeth, Martina; Hofer-Warbinek, Renate; Mayer, Herbert; Resch, Ulrike; Lemberger, Christof; Hofer, Erhard; de Martin, Rainer] Med Univ Vienna, Dept Vasc Biol & Thrombosis Res, Vienna, Austria; [Niederleithner, Heide; Petzelbauer, Peter] Med Univ Vienna, Dept Dermatol, Vienna, Austria; [Bilban, Martin; Wagner, Oswald] Med Univ Vienna, Clin Inst Med & Chem Lab Diagnost, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Hoeth, M (corresponding author), Baxter Innovat GmbH, Vienna, Austria.	rainer.demartin@meduniwien.ac.at	petzelbauer, peter/GLU-3941-2022	Petzelbauer, Peter/0000-0001-7080-5259; Resch, Ulrike/0000-0002-8380-9555; Bilban, Martin/0000-0001-7043-7142	Austrian Science Foundation (FWF) within Austrian Angiogenesis Network [NFN S9405, P20940-B11]	Austrian Science Foundation (FWF) within Austrian Angiogenesis Network	This work was supported by grants from the Austrian Science Foundation (FWF; www.fwf.ac.at) within the Austrian Angiogenesis Network (NFN S9405) to RdM, and P20940-B11 (to PP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts S, 2005, NUCLEIC ACIDS RES, V33, pW393, DOI 10.1093/nar/gki354; Cermenati S, 2008, BLOOD, V111, P2657, DOI 10.1182/blood-2007-07-100412; Darby IA, 2001, LAB INVEST, V81, P937, DOI 10.1038/labinvest.3780304; DEMARTIN R, 1993, GENE, V124, P137, DOI 10.1016/0378-1119(93)90776-Y; Ding K, 2005, J CELL BIOL, V171, P729, DOI 10.1083/jcb.200508010; Downes M, 2009, HUM MOL GENET, V18, P2839, DOI 10.1093/hmg/ddp219; Fontijn RD, 2008, AM J PHYSIOL-HEART C, V294, pH891, DOI 10.1152/ajpheart.01248.2007; Francois M, 2008, NATURE, V456, P643, DOI 10.1038/nature07391; Fuller T, 2003, J CELL SCI, V116, P2461, DOI 10.1242/jcs.00426; Garcia-Ramirez M, 2005, ARTERIOSCL THROM VAS, V25, P2398, DOI 10.1161/01.ATV.0000187464.81959.23; Hashimoto G, 2002, J BIOL CHEM, V277, P36288, DOI 10.1074/jbc.M201674200; Herpers R, 2008, CIRC RES, V102, P12, DOI 10.1161/CIRCRESAHA.107.166066; Holnthoner W, 2006, BIOCHEM BIOPH RES CO, V342, P725, DOI 10.1016/j.bbrc.2006.02.011; Hosking BM, 2004, J BIOL CHEM, V279, P5314, DOI 10.1074/jbc.M308512200; Hosking BM, 2001, BIOCHEM BIOPH RES CO, V287, P493, DOI 10.1006/bbrc.2001.5589; Hosking B, 2009, DEVELOPMENT, V136, P2385, DOI 10.1242/dev.034827; Ii M, 2006, EXP BIOL MED, V231, P20; Im HJ, 2001, MOL PHARMACOL, V59, P1486, DOI 10.1124/mol.59.6.1486; Imai K, 1997, BIOCHEM J, V322, P809, DOI 10.1042/bj3220809; Irrthum A, 2003, AM J HUM GENET, V72, P1470, DOI 10.1086/375614; James K, 2003, GENESIS, V36, P1, DOI 10.1002/gene.10190; Kure T, 2003, INVEST OPHTH VIS SCI, V44, P137, DOI 10.1167/iovs.01-1058; Lioubinski O, 2003, DEV DYNAM, V227, P402, DOI 10.1002/dvdy.10311; Luo M, 2008, MED HYPOTHESES, V70, P880, DOI 10.1016/j.mehy.2007.07.024; Matsui T, 2006, J CELL SCI, V119, P3513, DOI 10.1242/jcs.03081; Mayer H, 2004, ARTERIOSCL THROM VAS, V24, P1192, DOI 10.1161/01.ATV.0000131263.06296.77; MCGRORY WJ, 1988, VIROLOGY, V163, P614, DOI 10.1016/0042-6822(88)90302-9; Neufeld G, 2007, ADV EXP MED BIOL, V600, P118; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; Nowak DE, 2005, BIOTECHNIQUES, V39, P715, DOI 10.2144/000112014; Olsson JE, 2001, GENE, V271, P151, DOI 10.1016/S0378-1119(01)00505-4; Patterson BC, 1997, J BIOL CHEM, V272, P28823, DOI 10.1074/jbc.272.46.28823; Pennisi D, 2000, NAT GENET, V24, P434, DOI 10.1038/74301; Pennisi D, 2000, MOL CELL BIOL, V20, P9331, DOI 10.1128/MCB.20.24.9331-9336.2000; Saitoh T, 2002, INT J MOL MED, V10, P339; Sakamoto Y, 2007, BIOCHEM BIOPH RES CO, V360, P539, DOI 10.1016/j.bbrc.2007.06.093; Samant GV, 2011, J BIOL CHEM, V286, P30740, DOI 10.1074/jbc.M111.220665; Sandholzer J, 2007, BIOCHEM BIOPH RES CO, V360, P370, DOI 10.1016/j.bbrc.2007.06.095; Srinivasan RS, 2010, GENE DEV, V24, P696, DOI 10.1101/gad.1859310; Stanojcic S, 2000, BBA-GENE STRUCT EXPR, V1492, P237, DOI 10.1016/S0167-4781(00)00078-6; Taniguchi M, 2005, GENES CELLS, V10, P785, DOI 10.1111/j.1365-2443.2005.00877.x; Wrighton CJ, 1996, J EXP MED, V183, P1013, DOI 10.1084/jem.183.3.1013; Young N, 2006, J NATL CANCER I, V98, P1060, DOI 10.1093/jnci/djj299; Zhang C, 2005, DEV DYNAM, V234, P878, DOI 10.1002/dvdy.20565	44	27	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30982	10.1371/journal.pone.0030982	http://dx.doi.org/10.1371/journal.pone.0030982			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22292085	gold, Green Published, Green Submitted			2022-12-27	WOS:000301570600103
J	Schilling, D; Bayer, C; Li, W; Molls, M; Vaupel, P; Multhoff, G				Schilling, Daniela; Bayer, Christine; Li, Wei; Molls, Michael; Vaupel, Peter; Multhoff, Gabriele			Radiosensitization of Normoxic and Hypoxic H1339 Lung Tumor Cells by Heat Shock Protein 90 Inhibition Is Independent of Hypoxia Inducible Factor-1 alpha	PLOS ONE			English	Article							MULTITARGET APPROACH; HSP90 INHIBITORS; GROWTH-FACTOR; GLIOMA-CELLS; CANCER; HIF-1-ALPHA; EXPRESSION; NVP-AUY922; INDUCTION; RADIATION	Background: Ionizing irradiation is a commonly accepted treatment modality for lung cancer patients. However, the clinical outcome is hampered by normal tissue toxicity and tumor hypoxia. Since tumors often have higher levels of active heat shock protein 90 (Hsp90) than normal tissues, targeting of Hsp90 might provide a promising strategy to sensitize tumors towards irradiation. Hsp90 client proteins include oncogenic signaling proteins, cell cycle activators, growth factor receptors and hypoxia inducible factor-1 alpha (HIF-1 alpha). Overexpression of HIF-1 alpha is assumed to promote malignant transformation and tumor progression and thus might reduce the accessibility to radiotherapy. Methodology/Principal Findings: Herein, we describe the effects of the novel Hsp90 inhibitor NVP-AUY922 and 17-allylamino-17-demethoxygeldanamycin (17-AAG), as a control, on HIF-1 alpha levels and radiosensitivity of lung carcinoma cells under normoxic and hypoxic conditions. NVP-AUY922 exhibited a similar biological activity to that of 17-AAG, but at only 1/10 of the dose. As expected, both inhibitors reduced basal and hypoxia-induced HIF-1 alpha levels in EPLC-272H lung carcinoma cells. However, despite a down-regulation of HIF-1 alpha upon Hsp90 inhibition, sensitivity towards irradiation remained unaltered in EPLC-272H cells under normoxic and hypoxic conditions. In contrast, treatment of H1339 lung carcinoma cells with NVP-AUY922 and 17-AAG resulted in a significant up-regulation of their initially high HIF-1 alpha levels and a concomitant increase in radiosensitivity. Conclusions/Significance: In summary, our data show a HIF-1 alpha-independent radiosensitization of normoxic and hypoxic H1339 lung cancer cells by Hsp90 inhibition.	[Schilling, Daniela; Bayer, Christine; Molls, Michael; Vaupel, Peter; Multhoff, Gabriele] Tech Univ Munich, Klinikum Rechts Isar, Dept Radiat Oncol, D-8000 Munich, Germany; [Schilling, Daniela; Multhoff, Gabriele] Helmholtz Zentrum Munchen, CCG Innate Immun Tumor Biol, Munich, Germany; [Li, Wei] Univ So Calif, Keck Sch Med, Dept Dermatol, Los Angeles, CA 90033 USA	Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Southern California	Schilling, D (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Dept Radiat Oncol, D-8000 Munich, Germany.	gabriele.multhoff@lrz.tu-muenchen.de		Multhoff, Gabriele/0000-0002-2616-3137	Helmholtz Zentrum Munchen (Clinical Cooperation Group - "Innate Immunity in Tumor Biology''); Deutsche Forschungsgemeinschaft [SFB 824/1, INST 95/980-1]; BMBF (Federal Ministry of Education and Research) (MOBITUM) [01EZ0826, Kompetenzverbund Strahlenforschung, 03NUK007E, 01EX1021C]; European Union (EU-CARDIORISK) [FP7-211403]	Helmholtz Zentrum Munchen (Clinical Cooperation Group - "Innate Immunity in Tumor Biology''); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); BMBF (Federal Ministry of Education and Research) (MOBITUM)(Federal Ministry of Education & Research (BMBF)); European Union (EU-CARDIORISK)(European Commission)	This work was supported by the Helmholtz Zentrum Munchen (Clinical Cooperation Group - "Innate Immunity in Tumor Biology''), Deutsche Forschungsgemeinschaft (SFB 824/1; Cluster of Excellence 158: Munich-Centre of Advanced Photonics; INST 95/980-1 FUGG, Gulmay irradiation device), BMBF (Federal Ministry of Education and Research) (MOBITUM, 01EZ0826; Kompetenzverbund Strahlenforschung, 03NUK007E; Leading-Edge Cluster m4 - Personalized Medicine and Targeted Therapies, 01EX1021C), European Union (EU-CARDIORISK, FP7-211403). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebersold DM, 2001, CANCER RES, V61, P2911; Akakura N, 2001, CANCER RES, V61, P6548; Artman T, 2010, INT J RADIAT ONCOL, V76, P574, DOI 10.1016/j.ijrobp.2009.08.035; Banerji U, 2005, CLIN CANCER RES, V11, P7023, DOI 10.1158/1078-0432.CCR-05-0518; Bisht KS, 2003, CANCER RES, V63, P8984; Brough PA, 2008, J MED CHEM, V51, P196, DOI 10.1021/jm701018h; Camphausen K, 2007, CLIN CANCER RES, V13, P4326, DOI 10.1158/1078-0432.CCR-07-0632; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Carroll VA, 2006, CANCER RES, V66, P6264, DOI 10.1158/0008-5472.CAN-05-2519; Choi N, 2001, LUNG CANCER, V31, P43, DOI 10.1016/S0169-5002(00)00156-2; Dungey FA, 2009, MOL CANCER THER, V8, P2243, DOI 10.1158/1535-7163.MCT-09-0201; Eccles SA, 2008, CANCER RES, V68, P2850, DOI 10.1158/0008-5472.CAN-07-5256; Ehrlich ES, 2009, P NATL ACAD SCI USA, V106, P20330, DOI 10.1073/pnas.0810571106; Fay Michael J, 2003, Mol Cancer, V2, P40, DOI 10.1186/1476-4598-2-40; Fink T, 2002, BLOOD, V99, P2077, DOI 10.1182/blood.V99.6.2077; Gardner LB, 2001, J BIOL CHEM, V276, P7919, DOI 10.1074/jbc.M010189200; Gaspar N, 2010, MOL CANCER THER, V9, P1219, DOI 10.1158/1535-7163.MCT-09-0683; Gehrmann M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001925; Greijer AE, 2004, J CLIN PATHOL, V57, P1009, DOI 10.1136/jcp.2003.015032; Ibrahim NO, 2005, CANCER RES, V65, P11094, DOI 10.1158/0008-5472.CAN-05-1877; Isaacs JS, 2002, J BIOL CHEM, V277, P29936, DOI 10.1074/jbc.M204733200; Kabakov AE, 2010, J MOL MED, V88, P241, DOI 10.1007/s00109-009-0562-0; Katschinski DM, 2004, CELL PHYSIOL BIOCHEM, V14, P351, DOI 10.1159/000080345; Katschinski DM, 2002, J BIOL CHEM, V277, P9262, DOI 10.1074/jbc.M110377200; Kessler J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-605; Kim WY, 2009, CANCER RES, V69, P1624, DOI 10.1158/0008-5472.CAN-08-0505; Koukourakis MI, 2002, INT J RADIAT ONCOL, V53, P1192, DOI 10.1016/S0360-3016(02)02848-1; Liu JY, 2010, EXP CELL RES, V316, P1985, DOI 10.1016/j.yexcr.2010.02.028; Liu YV, 2007, MOL CELL, V25, P207, DOI 10.1016/j.molcel.2007.01.001; Mabjeesh NJ, 2002, CANCER RES, V62, P2478; Moeller BJ, 2005, CANCER CELL, V8, P99, DOI 10.1016/j.ccr.2005.06.016; Noguchi M, 2006, BIOCHEM BIOPH RES CO, V351, P658, DOI 10.1016/j.bbrc.2006.10.094; Russell JS, 2003, CLIN CANCER RES, V9, P3749; Said Harun M, 2009, BMC Res Notes, V2, P8, DOI 10.1186/1756-0500-2-8; Sasabe E, 2005, CANCER SCI, V96, P394, DOI 10.1111/j.1349-7006.2005.00065.x; Schilling D, 2011, STRAHLENTHE IN PRESS; Schilling D, 2012, STRAHLENTHE IN PRESS; Schilling D, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-143; Schilling D, 2009, FASEB J, V23, P2467, DOI 10.1096/fj.08-125229; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Stingl L, 2010, BRIT J CANCER, V102, P1578, DOI 10.1038/sj.bjc.6605683; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; van de Sluis B, 2010, J CLIN INVEST, V120, P2119, DOI 10.1172/JCI40583; van de Sluis B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007332; Vaupel P, 2004, SEMIN RADIAT ONCOL, V14, P198, DOI 10.1016/j.semradonc.2004.04.008; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; Wykoff CC, 2000, CANCER RES, V60, P7075; Yang JS, 2005, J BIOL CHEM, V280, P36047, DOI 10.1074/jbc.M501755200; Zhou J, 2004, J BIOL CHEM, V279, P13506, DOI 10.1074/jbc.M310164200	49	26	27	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2012	7	2							e31110	10.1371/journal.pone.0031110	http://dx.doi.org/10.1371/journal.pone.0031110			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917MF	22347438	Green Submitted, Green Published, gold			2022-12-27	WOS:000302180600030
J	Mattsson, N; Rajendran, L; Zetterberg, H; Gustavsson, M; Andreasson, U; Olsson, M; Brinkmalm, G; Lundkvist, J; Jacobson, LH; Perrot, L; Neumann, U; Borghys, H; Mercken, M; Dhuyvetter, D; Jeppsson, F; Blennow, K; Portelius, E				Mattsson, Niklas; Rajendran, Lawrence; Zetterberg, Henrik; Gustavsson, Mikael; Andreasson, Ulf; Olsson, Maria; Brinkmalm, Gunnar; Lundkvist, Johan; Jacobson, Laura H.; Perrot, Ludovic; Neumann, Ulf; Borghys, Herman; Mercken, Marc; Dhuyvetter, Deborah; Jeppsson, Fredrik; Blennow, Kaj; Portelius, Erik			BACE1 Inhibition Induces a Specific Cerebrospinal Fluid beta-Amyloid Pattern That Identifies Drug Effects in the Central Nervous System	PLOS ONE			English	Article							PROTEIN-CLEAVING ENZYME; ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; SECRETASE ACTIVITY; PEPTIDE; EXPRESSION; CLEAVAGE; BRAIN; PURIFICATION; GENERATION	BACE1 is a key enzyme for amyloid-beta (A beta) production, and an attractive therapeutic target in Alzheimer's disease (AD). Here we report that BACE1 inhibitors have distinct effects on neuronal A beta metabolism, inducing a unique pattern of secreted Ab peptides, analyzed in cell media from amyloid precursor protein (APP) transfected cells and in cerebrospinal fluid (CSF) from dogs by immunoprecipitation-mass spectrometry, using several different BACE1 inhibitors. Besides the expected reductions in A beta 1-40 and A beta 1-42, treatment also changed the relative levels of several other A beta isoforms. In particular A beta 1-34 decreased, while A beta 5-40 increased, and these changes were more sensitive to BACE1 inhibition than the changes in A beta 1-40 and A beta 1-42. The effects on A beta 5-40 indicate the presence of a BACE1 independent pathway of APP degradation. The described CSF A beta pattern may be used as a pharmacodynamic fingerprint to detect biochemical effects of BACE1-therapies in clinical trials, which might accelerate development of novel therapies.	[Mattsson, Niklas; Zetterberg, Henrik; Gustavsson, Mikael; Andreasson, Ulf; Olsson, Maria; Brinkmalm, Gunnar; Blennow, Kaj; Portelius, Erik] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Clin Neurochem Lab,Dept Psychiat & Neurochem, Molndal, Sweden; [Rajendran, Lawrence] Univ Zurich, Div Psychiat Res, Zurich, Switzerland; [Lundkvist, Johan; Jeppsson, Fredrik] AstraZeneca R&D, Innovat Med, Cent Nervous Syst & Pain iMed, Dept Neurosci, Sodertalje, Sweden; [Jacobson, Laura H.; Perrot, Ludovic; Neumann, Ulf] Novartis Inst BioMed Res, Basel, Switzerland; [Borghys, Herman; Mercken, Marc; Dhuyvetter, Deborah] Janssen Res & Dev, Neurosci Therapeut Area, Beerse, Belgium	University of Gothenburg; University of Zurich; AstraZeneca; Novartis; Johnson & Johnson; Janssen Pharmaceuticals	Mattsson, N (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Clin Neurochem Lab,Dept Psychiat & Neurochem, Molndal, Sweden.	niklas.mattsson@neuro.gu.se; erik.portelius@neuro.gu.se	Mattsson-Carlgren, Niklas/H-7597-2019; Brinkmalm, Gunnar/AAH-3914-2021; Jacobson, Laura/A-3363-2013; jacobson, laura/AAI-7429-2021	Mattsson-Carlgren, Niklas/0000-0002-8885-7724; jacobson, laura/0000-0003-2910-8659; Brinkmalm, Gunnar/0000-0001-6958-2393; Rajendran, Lawrence/0000-0002-6390-1821	Swedish State Support for Clinical Research; Stiftelsen Psykiatriska Forskningsfonden; Swiss National Science Foundation; Velux Stiftung; Novartis Research Foundation; Soderberg Foundation Stiftelsen Gamla Tjanarinnor; Magn. Bergvalls Stiftelse; Gun och Bertil Stohnes Stiftelse; Uppsala Universitets Medicinska Fakultet Stiftelse for Psykiatrisk och Neurologisk Forskning; Swedish Brain Fund; Alzheimer Foundation, Sweden; Dementia Association, Sweden; Lundbeck Foundation	Swedish State Support for Clinical Research; Stiftelsen Psykiatriska Forskningsfonden; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Velux Stiftung; Novartis Research Foundation; Soderberg Foundation Stiftelsen Gamla Tjanarinnor; Magn. Bergvalls Stiftelse; Gun och Bertil Stohnes Stiftelse; Uppsala Universitets Medicinska Fakultet Stiftelse for Psykiatrisk och Neurologisk Forskning; Swedish Brain Fund; Alzheimer Foundation, Sweden; Dementia Association, Sweden; Lundbeck Foundation(Lundbeckfonden)	The study was supported by the Lundbeck Foundation, the Swedish Research Council, Swedish State Support for Clinical Research, Stiftelsen Psykiatriska Forskningsfonden, Swiss National Science Foundation, Velux Stiftung, Novartis Research Foundation grant, the Soderberg Foundation Stiftelsen Gamla Tjanarinnor, Magn. Bergvalls Stiftelse, Gun och Bertil Stohnes Stiftelse, Uppsala Universitets Medicinska Fakultet Stiftelse for Psykiatrisk och Neurologisk Forskning, the Swedish Brain Fund, the Alzheimer Foundation, Sweden and the Dementia Association, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atwal JK, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002254; BIEDLER JL, 1978, CANCER RES, V38, P3751; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Blennow K, 2010, NAT REV NEUROL, V6, P131, DOI 10.1038/nrneurol.2010.4; Bylesjo M, 2006, J CHEMOMETR, V20, P341, DOI 10.1002/cem.1006; Citron M, 2010, NAT REV DRUG DISCOV, V9, P387, DOI 10.1038/nrd2896; Cook JJ, 2010, J NEUROSCI, V30, P6743, DOI 10.1523/JNEUROSCI.1381-10.2010; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; Falting J, 2009, ALZHEIMERS DEMENT, V5, pe5; Farah MH, J NEUROSCI, V31, P5744; Fleisher AS, 2008, ARCH NEUROL-CHICAGO, V65, P1031, DOI 10.1001/archneur.65.8.1031; Fluhrer R, 2003, J BIOL CHEM, V278, P5531, DOI 10.1074/jbc.M211485200; Fukumoto H, 2002, ARCH NEUROL-CHICAGO, V59, P1381, DOI 10.1001/archneur.59.9.1381; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Hansson O, 2010, NEUROBIOL AGING, V31, P357, DOI 10.1016/j.neurobiolaging.2008.03.027; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; Holsinger RMD, 2006, NEUROLOGY, V67, P710, DOI 10.1212/01.wnl.0000229925.52203.4c; Holsinger RMD, 2004, ANN NEUROL, V55, P898, DOI 10.1002/ana.20144; John V., 2010, BACE LEAD TARGET ORC; Johnston JA, 2005, BIOCHEM SOC T, V33, P1096, DOI 10.1042/BST0331096; Kuhn PH, 2010, EMBO J, V29, P3020, DOI 10.1038/emboj.2010.167; Laird FM, 2005, J NEUROSCI, V25, P11693, DOI 10.1523/JNEUROSCI.2766-05.2005; Lee SF, 2002, J BIOL CHEM, V277, P45013, DOI 10.1074/jbc.M208164200; Luo Y, 2003, NEUROBIOL DIS, V14, P81, DOI 10.1016/S0969-9961(03)00104-9; Luo Y, 2001, NAT NEUROSCI, V4, P231, DOI 10.1038/85059; May PC, 2011, J NEUROSCI, V31, P16507, DOI 10.1523/JNEUROSCI.3647-11.2011; MILLER DL, 1993, ARCH BIOCHEM BIOPHYS, V301, P41, DOI 10.1006/abbi.1993.1112; Miravalle L, 2005, BIOCHEMISTRY-US, V44, P10810, DOI 10.1021/bi0508237; NASLUND J, 1994, P NATL ACAD SCI USA, V91, P8378, DOI 10.1073/pnas.91.18.8378; PODLISNY MB, 1995, J BIOL CHEM, V270, P9564, DOI 10.1074/jbc.270.16.9564; PORTELIUS E, 2011, CURR PHARM DES; Portelius E, 2010, ACTA NEUROPATHOL; Portelius E, 2007, J PROTEOME RES, V6, P4433, DOI 10.1021/pr0703627; Portelius E, 2010, J ALZHEIMERS DIS, V21, P1005, DOI 10.3233/JAD-2010-100573; Portelius E, 2010, ACTA NEUROPATHOL, V120, P185, DOI 10.1007/s00401-010-0690-1; Portelius E, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt30; Portelius E, 2009, NEURODEGENER DIS, V6, P258, DOI 10.1159/000264639; Portelius E, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-2; Portelius E, 2011, NEUROBIOL AGING, V32, P1090, DOI 10.1016/j.neurobiolaging.2009.06.002; Rueeger H, 2011, 241 ACS NAT M EXP; Sankaranarayanan S, 2009, J PHARMACOL EXP THER, V328, P131, DOI 10.1124/jpet.108.143628; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; Shi XP, 2003, J BIOL CHEM, V278, P21286, DOI 10.1074/jbc.M209859200; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Stachel SJ, 2004, J MED CHEM, V47, P6447, DOI 10.1021/jm049379g; Takasugi N, 2011, J NEUROSCI, V31, P6850, DOI 10.1523/JNEUROSCI.6467-10.2011; Takeda K, 2004, FASEB J, V18, P1755, DOI 10.1096/fj.03-1070fje; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vassar R, 2009, J NEUROSCI, V29, P12787, DOI 10.1523/JNEUROSCI.3657-09.2009; Verheijen JH, 2006, CLIN CHEM, V52, P1168, DOI 10.1373/clinchem.2006.066720; VIGOPELFREY C, 1993, J NEUROCHEM, V61, P1965, DOI 10.1111/j.1471-4159.1993.tb09841.x; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Yang LB, 2003, NAT MED, V9, P3, DOI 10.1038/nm0103-3; Yu YJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002230; Zetterberg H, 2008, ARCH NEUROL-CHICAGO, V65, P1102, DOI 10.1001/archneur.65.8.1102; Zhou LJ, 2011, J BIOL CHEM, V286, P8677, DOI 10.1074/jbc.M110.194860	57	58	58	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2012	7	2							e31084	10.1371/journal.pone.0031084	http://dx.doi.org/10.1371/journal.pone.0031084			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LV	22328928	Green Published, Green Accepted, gold			2022-12-27	WOS:000302179300014
J	Slesiona, S; Gressler, M; Mihlan, M; Zaehle, C; Schaller, M; Barz, D; Hube, B; Jacobsen, ID; Brock, M				Slesiona, Silvia; Gressler, Markus; Mihlan, Michael; Zaehle, Christoph; Schaller, Martin; Barz, Dagmar; Hube, Bernhard; Jacobsen, Ilse D.; Brock, Matthias			Persistence versus Escape: Aspergillus terreus and Aspergillus fumigatus Employ Different Strategies during Interactions with Macrophages	PLOS ONE			English	Article							INVASIVE PULMONARY ASPERGILLOSIS; TOLL-LIKE RECEPTORS; NIDULANS WA-GENE; MONONUCLEAR PHAGOCYTES; FRANCISELLA-TULARENSIS; ALVEOLAR MACROPHAGES; MOLD INFECTIONS; CRYPTOCOCCUS-NEOFORMANS; NAPHTHOPYRONE SYNTHASE; TRANSPLANT RECIPIENTS	Invasive bronchopulmonary aspergillosis (IBPA) is a life-threatening disease in immunocompromised patients. Although Aspergillus terreus is frequently found in the environment, A. fumigatus is by far the main cause of IBPA. However, once A. terreus establishes infection in the host, disease is as fatal as A. fumigatus infections. Thus, we hypothesized that the initial steps of disease establishment might be fundamentally different between these two species. Since alveolar macrophages represent one of the first phagocytes facing inhaled conidia, we compared the interaction of A. terreus and A. fumigatus conidia with alveolar macrophages. A. terreus conidia were phagocytosed more rapidly than A. fumigatus conidia, possibly due to higher exposure of beta-1,3-glucan and galactomannan on the surface. In agreement, blocking of dectin-1 and mannose receptors significantly reduced phagocytosis of A. terreus, but had only a moderate effect on phagocytosis of A. fumigatus. Once phagocytosed, and in contrast to A. fumigatus, A. terreus did not inhibit acidification of phagolysosomes, but remained viable without signs of germination both in vitro and in immunocompetent mice. The inability of A. terreus to germinate and pierce macrophages resulted in significantly lower cytotoxicity compared to A. fumigatus. Blocking phagolysosome acidification by the v-ATPase inhibitor bafilomycin increased A. terreus germination rates and cytotoxicity. Recombinant expression of the A. nidulans wA naphthopyrone synthase, a homologue of A. fumigatus PksP, inhibited phagolysosome acidification and resulted in increased germination, macrophage damage and virulence in corticosteroid-treated mice. In summary, we show that A. terreus and A. fumigatus have evolved significantly different strategies to survive the attack of host immune cells. While A. fumigatus prevents phagocytosis and phagolysosome acidification and escapes from macrophages by germination, A. terreus is rapidly phagocytosed, but conidia show long-term persistence in macrophages even in immunocompetent hosts.	[Slesiona, Silvia; Gressler, Markus; Mihlan, Michael; Zaehle, Christoph; Hube, Bernhard; Jacobsen, Ilse D.; Brock, Matthias] Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Jena, Germany; [Hube, Bernhard] Univ Jena, Jena, Germany; [Schaller, Martin] Univ Tubingen, Dept Dermatol, Tubingen, Germany; [Barz, Dagmar] Univ Hosp, Inst Transfus Med, Jena, Germany	Hans Knoll Institute (HKI); Friedrich Schiller University of Jena; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Friedrich Schiller University of Jena	Slesiona, S (corresponding author), Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Jena, Germany.	Ilse.jacobsen@hki-jena.de; Matthias.brock@hki-jena.de	Jacobsen, Ilse/B-3155-2011; Brock, Matthias/AAX-1430-2021	Jacobsen, Ilse/0000-0002-6033-9984; Mihlan, Michael/0000-0002-3946-6583; Brock, Matthias/0000-0003-2774-1856; Hube, Bernhard/0000-0002-6028-0425	German Science Foundation (DFG) [BR2216/4-1]; Netzwerk Grundlagenforschung of the HKI (Hans Knoell Institute)	German Science Foundation (DFG)(German Research Foundation (DFG)); Netzwerk Grundlagenforschung of the HKI (Hans Knoell Institute)	This work was financially supported by a grant from the German Science Foundation (DFG, grant BR2216/4-1) and the Netzwerk Grundlagenforschung of the HKI (Hans Knoell Institute). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimanianda V, 2009, NATURE, V460, P1117, DOI 10.1038/nature08264; Akpogheneta O, 2003, MYCOSES, V46, P77, DOI 10.1046/j.1439-0507.2003.00852.x; ARAMAYO R, 1993, EMBO J, V12, P2039, DOI 10.1002/j.1460-2075.1993.tb05853.x; Auberger J, 2008, DIAGN MICR INFEC DIS, V62, P336, DOI 10.1016/j.diagmicrobio.2008.06.012; Baddley JW, 2001, CLIN INFECT DIS, V32, P1319, DOI 10.1086/319985; Balloy V, 2005, INFECT IMMUN, V73, P494, DOI 10.1128/IAI.73.1.494-503.2005; Ben-Ami R, 2010, BRIT J HAEMATOL, V150, P406, DOI 10.1111/j.1365-2141.2010.08283.x; BENNETT JE, 1987, J INFECT DIS, V155, P1005, DOI 10.1093/infdis/155.5.1005; Bhatia S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015943; Bignell E, 2005, MOL MICROBIOL, V55, P1072, DOI 10.1111/j.1365-2958.2004.04472.x; Brakhage AA, 2010, CURR OPIN MICROBIOL, V13, P409, DOI 10.1016/j.mib.2010.04.009; Brieland JK, 2001, INFECT IMMUN, V69, P1554, DOI 10.1128/IAI.69.3.1554-1560.2001; Buchan BW, 2009, INFECT IMMUN, V77, P2517, DOI 10.1128/IAI.00229-09; Chignard M, 2007, CLIN IMMUNOL, V124, P238, DOI 10.1016/j.clim.2007.05.004; Deak E, 2011, VIRULENCE, V2, P200, DOI 10.4161/viru.2.3.15799; Deak E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007673; Denning DW, 1998, J INFECTION, V37, P173, DOI 10.1016/S0163-4453(98)80173-4; DIAMOND RD, 1988, REV INFECT DIS, V10, pS428; Duong M, 1998, J INFECT DIS, V178, P1472, DOI 10.1086/314425; EISSENBERG LG, 1993, J EXP MED, V177, P1605, DOI 10.1084/jem.177.6.1605; Fleck CB, 2008, MOL MICROBIOL, V68, P642, DOI 10.1111/j.1365-2958.2008.06180.x; Fleck CB, 2010, EUKARYOT CELL, V9, P1120, DOI 10.1128/EC.00362-09; FORD S, 1967, J BACTERIOL, V94, P928, DOI 10.1128/JB.94.4.928-933.1967; Fujii I, 2001, CHEM BIOL, V8, P189, DOI 10.1016/S1074-5521(00)90068-1; Gersuk GM, 2006, J IMMUNOL, V176, P3717, DOI 10.4049/jimmunol.176.6.3717; Graveline R, 2007, INT IMMUNOL, V19, P375, DOI 10.1093/intimm/dxm003; GREEN F H Y, 1980, Scanning Electron Microscopy, P307; Gressler M, 2011, CHEM BIOL, V18, P198, DOI 10.1016/j.chembiol.2010.12.011; Haas A, 1998, MOL MEMBR BIOL, V15, P103, DOI 10.3109/09687689809074522; Heesemann L, 2011, INT J MED MICROBIOL, V301, P523, DOI 10.1016/j.ijmm.2011.02.003; Hoffmann E, 2010, EUR J CELL BIOL, V89, P693, DOI 10.1016/j.ejcb.2010.04.006; Hohl TM, 2005, PLOS PATHOG, V1, P232, DOI 10.1371/journal.ppat.0010030; Ibrahim-Granet O, 2003, INFECT IMMUN, V71, P891, DOI 10.1128/IAI.71.2.891-903.2003; Ibrahim-Granet O, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-105; Jahn B, 2002, CELL MICROBIOL, V4, P793, DOI 10.1046/j.1462-5822.2002.00228.x; Jorgensen TR, 2011, FUNGAL GENET BIOL, V48, P544, DOI 10.1016/j.fgb.2011.01.005; Jouault T, 2009, CELL MICROBIOL, V11, P1007, DOI 10.1111/j.1462-5822.2009.01318.x; KHOO SH, 1994, CLIN INFECT DIS, V19, pS41, DOI 10.1093/clinids/19.Supplement_1.S41; Klenerman P, 2005, NAT IMMUNOL, V6, P873, DOI 10.1038/ni1241; Krishnan N, 2010, TUBERCULOSIS, V90, P361, DOI 10.1016/j.tube.2010.08.005; Lambeth JD, 2007, FREE RADICAL BIO MED, V43, P319, DOI 10.1016/j.freeradbiomed.2007.03.028; Langfelder K, 1998, MED MICROBIOL IMMUN, V187, P79, DOI 10.1007/s004300050077; Lass-Florl C, 2010, FUTURE MICROBIOL, V5, P789, DOI [10.2217/fmb.10.34, 10.2217/FMB.10.34]; Lass-Florl C, 1998, J ANTIMICROB CHEMOTH, V42, P497, DOI 10.1093/jac/42.4.497; Lass-Florl C, 2005, BRIT J HAEMATOL, V131, P201, DOI 10.1111/j.1365-2141.2005.05763.x; Levitz SM, 1999, INFECT IMMUN, V67, P885, DOI 10.1128/IAI.67.2.885-890.1999; Lin SJ, 2001, CLIN INFECT DIS, V32, P358, DOI 10.1086/318483; LUNDBORG M, 1972, SABOURAUD, V10, P152; Luther K, 2007, CELL MICROBIOL, V9, P368, DOI 10.1111/j.1462-5822.2006.00796.x; Luther K, 2006, J MICROBIOL METH, V66, P170, DOI 10.1016/j.mimet.2005.11.008; Malani A, 2007, INFECT CONT HOSP EP, V28, P892, DOI 10.1086/518456; Malani AN, 2007, DRUGS, V67, P1803, DOI 10.2165/00003495-200767130-00001; Marr KA, 2001, CLIN DIAGN LAB IMMUN, V8, P1240, DOI 10.1128/CDLI.8.6.1240-1247.2001; Marr KA, 2002, CLIN INFECT DIS, V34, P909, DOI 10.1086/339202; MAYORGA ME, 1990, GENETICS, V126, P73; MAYORGA ME, 1992, MOL GEN GENET, V235, P205, DOI 10.1007/BF00279362; MBAWUIKE IN, 1989, J LEUKOCYTE BIOL, V46, P119, DOI 10.1002/jlb.46.2.119; Nessa K, 1997, LETT APPL MICROBIOL, V25, P181, DOI 10.1046/j.1472-765X.1997.00200.x; Netea MG, 2006, CURR PHARM DESIGN, V12, P4195, DOI 10.2174/138161206778743538; Ogawa M, 2006, CELL MICROBIOL, V8, P177, DOI 10.1111/j.1462-5822.2005.00652.x; Okagaki LH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000953; Perfect JR, 2001, CLIN INFECT DIS, V33, P1824, DOI 10.1086/323900; Perkhofer S, 2007, MYCOPATHOLOGIA, V163, P303, DOI 10.1007/s11046-007-9013-z; Philippe B, 2003, INFECT IMMUN, V71, P3034, DOI 10.1128/IAI.71.6.3034-3042.2003; PURNELL DM, 1974, SABOURAUDIA, V12, P95; RALPH P, 1975, J IMMUNOL, V114, P898; RICHARD JL, 1975, APPL MICROBIOL, V30, P44, DOI 10.1128/AEM.30.1.44-47.1975; RIPPON JW, 1974, SABOURAUDIA, V12, P157; Roilides E, 1998, RES IMMUNOL, V149, P454, DOI 10.1016/S0923-2494(98)80769-4; ROILIDES E, 1995, J INFECT DIS, V172, P1028, DOI 10.1093/infdis/172.4.1028; Sansonetti P, 2001, SEMIN IMMUNOL, V13, P381, DOI 10.1006/smim.2001.0335; SCHAFFNER A, 1982, J CLIN INVEST, V69, P617, DOI 10.1172/JCI110489; Schulert GS, 2009, INFECT IMMUN, V77, P1324, DOI 10.1128/IAI.01318-08; Schulert GS, 2006, J LEUKOCYTE BIOL, V80, P563, DOI 10.1189/jlb.0306219; Segal BH, 2007, ONCOLOGIST, V12, P7, DOI 10.1634/theoncologist.12-S2-7; Seider K, 2010, CURR OPIN MICROBIOL, V13, P392, DOI 10.1016/j.mib.2010.05.001; Serrano-Gomez D, 2004, J IMMUNOL, V173, P5635, DOI 10.4049/jimmunol.173.9.5635; Steele C, 2005, PLOS PATHOG, V1, P323, DOI 10.1371/journal.ppat.0010042; Steinbach WJ, 2004, CLIN INFECT DIS, V39, P192, DOI 10.1086/421950; Steinberg BE, 2007, BIOCHEM SOC T, V35, P1083, DOI 10.1042/BST0351083; Stergiopoulou T, 2007, AM J CLIN PATHOL, V127, P349, DOI 10.1309/UJRV9DLC11RM3G8R; STURTEVANT JE, 1992, INFECT IMMUN, V60, P1913, DOI 10.1128/IAI.60.5.1913-1918.1992; TAPPER H, 1995, J CELL PHYSIOL, V163, P137, DOI 10.1002/jcp.1041630116; Thywissen A, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00096; Torosantucci A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005392; Tsai HF, 1998, J BACTERIOL, V180, P3031, DOI 10.1128/JB.180.12.3031-3038.1998; Vesper SJ, 2007, J WATER HEALTH, V5, P427, DOI 10.2166/wh.2007.038; Voelz K, 2009, INFECT IMMUN, V77, P3450, DOI 10.1128/IAI.00297-09; Wasylnka JA, 2005, MED MYCOL, V43, pS27, DOI 10.1080/13693780400029247; Watanabe A, 2000, FEMS MICROBIOL LETT, V192, P39, DOI 10.1111/j.1574-6968.2000.tb09356.x; Weidenmaier C, 2003, CURR DRUG TARGETS, V4, P643, DOI 10.2174/1389450033490731; Willment JA, 2008, TRENDS MICROBIOL, V16, P27, DOI 10.1016/j.tim.2007.10.012	92	64	67	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e31223	10.1371/journal.pone.0031223	http://dx.doi.org/10.1371/journal.pone.0031223			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LO	22319619	gold, Green Published, Green Submitted			2022-12-27	WOS:000302178400032
J	Amaral, AR; Beheregaray, LB; Bilgmann, K; Boutov, D; Freitas, L; Robertson, KM; Sequeira, M; Stockin, KA; Coelho, MM; Moller, LM				Amaral, Ana R.; Beheregaray, Luciano B.; Bilgmann, Kerstin; Boutov, Dmitri; Freitas, Luis; Robertson, Kelly M.; Sequeira, Marina; Stockin, Karen A.; Coelho, M. Manuela; Moeller, Luciana M.			Seascape Genetics of a Globally Distributed, Highly Mobile Marine Mammal: The Short-Beaked Common Dolphin (Genus Delphinus)	PLOS ONE			English	Article							BOTTLE-NOSED DOLPHINS; NORTH-ATLANTIC OCEAN; WHALES ORCINUS-ORCA; SOUTH-EAST COAST; POPULATION-STRUCTURE; MICROSATELLITE LOCI; MOLECULAR ECOLOGY; FEEDING ECOLOGY; MITOCHONDRIAL; SEA	Identifying which factors shape the distribution of intraspecific genetic diversity is central in evolutionary and conservation biology. In the marine realm, the absence of obvious barriers to dispersal can make this task more difficult. Nevertheless, recent studies have provided valuable insights into which factors may be shaping genetic structure in the world's oceans. These studies were, however, generally conducted on marine organisms with larval dispersal. Here, using a seascape genetics approach, we show that marine productivity and sea surface temperature are correlated with genetic structure in a highly mobile, widely distributed marine mammal species, the short-beaked common dolphin. Isolation by distance also appears to influence population divergence over larger geographical scales (i.e. across different ocean basins). We suggest that the relationship between environmental variables and population structure may be caused by prey behaviour, which is believed to determine common dolphins' movement patterns and preferred associations with certain oceanographic conditions. Our study highlights the role of oceanography in shaping genetic structure of a highly mobile and widely distributed top marine predator. Thus, seascape genetic studies can potentially track the biological effects of ongoing climate-change at oceanographic interfaces and also inform marine reserve design in relation to the distribution and genetic connectivity of charismatic and ecologically important megafauna.	[Amaral, Ana R.; Coelho, M. Manuela] Univ Lisbon, Fac Ciencias, Ctr Biol Ambiental, P-1699 Lisbon, Portugal; [Amaral, Ana R.; Beheregaray, Luciano B.] Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia; [Beheregaray, Luciano B.; Moeller, Luciana M.] Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia; [Bilgmann, Kerstin] Macquarie Univ, Grad Sch Environm, Sydney, NSW 2109, Australia; [Boutov, Dmitri] Univ Lisbon, Fac Ciencias, Ctr Oceanog, Lisbon, Portugal; [Freitas, Luis] Museu Baleia Madeira, Canical, Madeira, Portugal; [Robertson, Kelly M.] SW Fisheries Sci Ctr, Natl Marine Fisheries Serv, La Jolla, CA USA; [Sequeira, Marina] Inst Conservacao Nat & Biodiversidade, Lisbon, Portugal; [Stockin, Karen A.] Massey Univ, Inst Nat Sci, Coastal Marine Res Grp, Auckland, New Zealand	Universidade de Lisboa; Macquarie University; Flinders University South Australia; Macquarie University; Universidade de Lisboa; National Oceanic Atmospheric Admin (NOAA) - USA; Massey University	Amaral, AR (corresponding author), Univ Lisbon, Fac Ciencias, Ctr Biol Ambiental, P-1699 Lisbon, Portugal.	aramaral@fc.ul.pt	Beheregaray, Luciano B/A-8621-2008; Coelho, Maria M/B-8672-2009; Beheregaray, Luciano/AAY-6384-2021; Stockin, Karen A/B-4452-2010; Boutov, Dmitri/B-2720-2012; Amaral, Ana Rita/ABG-4271-2021; Amaral, Ana/D-1060-2010	Beheregaray, Luciano B/0000-0003-0944-3003; Coelho, Maria M/0000-0003-3288-1693; Beheregaray, Luciano/0000-0003-0944-3003; Boutov, Dmitri/0000-0001-8530-4369; Amaral, Ana Rita/0000-0002-0595-0086; Amaral, Ana/0000-0002-0595-0086; Stockin, Karen/0000-0002-2981-3983; Bilgmann, Kerstin/0000-0003-0681-2301; Freitas, Luis/0000-0001-5288-0853; Moller, Luciana/0000-0002-7293-5847	Fundacao para a Ciencia e Tecnologia (Portugal); Macquarie University [MQ A006162]	Fundacao para a Ciencia e Tecnologia (Portugal)(Portuguese Foundation for Science and Technology); Macquarie University	Funding was provided by Fundacao para a Ciencia e Tecnologia (Portugal) through a PhD grant to AR Amaral and by Macquarie University. Sample collection in Australia was funded by Macquarie University through research grants to L. Moller, L. Beheregaray (MQ A006162) and K. Bilgmann. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGARDY MT, 1994, TRENDS ECOL EVOL, V9, P267, DOI 10.1016/0169-5347(94)90297-6; Amaral AR, 2007, MAR BIOL, V151, P1967, DOI 10.1007/s00227-007-0635-y; Bailey H, 2009, MAR ECOL PROG SER, V378, P279, DOI 10.3354/meps07887; Bailleul F, 2005, MAR ECOL PROG SER, V293, P273, DOI 10.3354/meps293273; Ballance LT, 2006, PROG OCEANOGR, V69, P360, DOI 10.1016/j.pocean.2006.03.013; Banks SC, 2007, ECOLOGY, V88, P3055, DOI 10.1890/07-0091.1; Banks SC, 2010, MOL ECOL, V19, P2011, DOI 10.1111/j.1365-294X.2010.04627.x; Bilgmann K, 2008, ANIM CONSERV, V11, P518, DOI 10.1111/j.1469-1795.2008.00213.x; Bilgmann K, 2007, MAR ECOL PROG SER, V341, P265, DOI 10.3354/meps341265; Bilgmann K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020103; Bost CA, 2009, J MARINE SYST, V78, P363, DOI 10.1016/j.jmarsys.2008.11.022; Bowen BW, 1997, EVOLUTION, V51, P1601, DOI 10.1111/j.1558-5646.1997.tb01483.x; Brown DM, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-57; Canadas A, 2005, AQUAT CONSERV, V15, P495, DOI 10.1002/aqc.689; Canadas A, 2002, DEEP-SEA RES PT I, V49, P2053, DOI 10.1016/S0967-0637(02)00123-1; CLARKE KR, 1993, MAR ECOL PROG SER, V92, P205, DOI 10.3354/meps092205; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; COCKCROFT VG, 1990, S AFR J MARINE SCI, V9, P371; Coughlan J, 2006, MOL ECOL NOTES, V6, P490, DOI 10.1111/j.1471-8286.2006.01284.x; Crawford NG, 2010, MOL ECOL RESOUR, V10, P556, DOI 10.1111/j.1755-0998.2009.02801.x; Doksaeter L, 2008, DEEP-SEA RES PT II, V55, P243, DOI 10.1016/j.dsr2.2007.09.009; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2003, GENETICS, V164, P1567; Foll M, 2006, GENETICS, V174, P875, DOI 10.1534/genetics.106.059451; Fontaine MC, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-30; Forney KA, 1998, MAR MAMMAL SCI, V14, P460, DOI 10.1111/j.1748-7692.1998.tb00737.x; Forney KA, 2000, CONSERV BIOL, V14, P1271, DOI 10.1046/j.1523-1739.2000.99412.x; Frank KT, 2007, TRENDS ECOL EVOL, V22, P236, DOI 10.1016/j.tree.2007.03.002; Fullard KJ, 2000, MOL ECOL, V9, P949, DOI 10.1046/j.1365-294x.2000.00957.x; Galindo HM, 2006, CURR BIOL, V16, P1622, DOI 10.1016/j.cub.2006.06.052; Geffen E, 2004, MOL ECOL, V13, P2481, DOI 10.1111/j.1365-294X.2004.02244.x; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Gremillet D, 2008, J APPL ECOL, V45, P610, DOI 10.1111/j.1365-2664.2007.01447.x; Hamazaki T, 2002, MAR MAMMAL SCI, V18, P920, DOI 10.1111/j.1748-7692.2002.tb01082.x; Hardy OJ, 2003, GENETICS, V163, P1467; Hellberg ME, 2009, ANNU REV ECOL EVOL S, V40, P291, DOI 10.1146/annurev.ecolsys.110308.120223; Hoelzel A. Rus, 2009, V17, P294; Hoelzel AR, 1998, J HERED, V89, P121, DOI 10.1093/jhered/89.2.121; Holderegger R, 2008, BIOSCIENCE, V58, P199, DOI 10.1641/B580306; Hooker SK, 2004, BIOSCIENCE, V54, P27, DOI 10.1641/0006-3568(2004)054[0027:MRAATF]2.0.CO;2; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Jombart T, 2009, HEREDITY, V102, P330, DOI 10.1038/hdy.2008.130; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; KASUYA T, 1988, Scientific Reports of the Whales Research Institute Tokyo, P77; Kruskal J, 1978, MULTIDIMENSIONAL SCA; Krutzen M, 2001, MOL ECOL NOTES, V1, P170, DOI 10.1046/j.1471-8278.2001.00065.x; Krutzen M, 2004, MAR MAMMAL SCI, V20, P28, DOI 10.1111/j.1748-7692.2004.tb01139.x; Lahaye V, 2005, MAR ECOL PROG SER, V305, P275, DOI 10.3354/meps305275; Legendre P, 2010, MOL ECOL RESOUR, V10, P831, DOI 10.1111/j.1755-0998.2010.02866.x; Manel S, 2003, TRENDS ECOL EVOL, V18, P189, DOI 10.1016/S0169-5347(03)00008-9; MANTEL N, 1967, CANCER RES, V27, P209; Mendez M, 2011, HEREDITY, V107, P349, DOI 10.1038/hdy.2011.21; Mendez M, 2010, MOL ECOL, V19, P2212, DOI 10.1111/j.1365-294X.2010.04647.x; Mirimin L, 2009, MAR BIOL, V156, P821, DOI 10.1007/s00227-008-1120-y; Moller L, 2011, MAR BIOL, V158, P113, DOI 10.1007/s00227-010-1546-x; Morin PA, 2010, GENOME RES, V20, P908, DOI 10.1101/gr.102954.109; Myers RA, 2007, SCIENCE, V315, P1846, DOI 10.1126/science.1138657; Nater A, 2009, MOL ECOL RESOUR, V9, P531, DOI 10.1111/j.1755-0998.2008.02246.x; Natoli A, 2005, P ROY SOC B-BIOL SCI, V272, P1217, DOI 10.1098/rspb.2005.3076; Natoli A, 2006, J EVOLUTION BIOL, V19, P943, DOI 10.1111/j.1420-9101.2005.01033.x; Natoli A, 2004, J EVOLUTION BIOL, V17, P363, DOI 10.1046/j.1420-9101.2003.00672.x; Panigada S, 2008, REMOTE SENS ENVIRON, V112, P3400, DOI 10.1016/j.rse.2007.11.017; PERRIN WF, 1987, MAR MAMMAL SCI, V3, P99, DOI 10.1111/j.1748-7692.1987.tb00158.x; Perrin WF, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P255; Pinaud D, 2007, J ANIM ECOL, V76, P9, DOI 10.1111/j.1365-2656.2006.01186.x; Pritchard JK, 2000, GENETICS, V155, P945; Pusineri C, 2007, MAR MAMMAL SCI, V23, P30, DOI 10.1111/j.1748-7692.2006.00088.x; Raufaste N, 2001, EVOLUTION, V55, P1703, DOI 10.1111/j.0014-3820.2001.tb00689.x; Rosel PE, 1996, MAR BIOL, V125, P11, DOI 10.1007/BF00350756; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 1997, GENETICS, V145, P1219; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Selkoe KA, 2008, FISH FISH, V9, P363, DOI 10.1111/j.1467-2979.2008.00300.x; Selkoe KA, 2010, MOL ECOL, V19, P3708, DOI 10.1111/j.1365-294X.2010.04658.x; Storfer A, 2007, HEREDITY, V98, P128, DOI 10.1038/sj.hdy.6800917; Storfer A, 2010, MOL ECOL, V19, P3496, DOI 10.1111/j.1365-294X.2010.04691.x; Sunnucks P, 1996, MOL BIOL EVOL, V13, P510, DOI 10.1093/oxfordjournals.molbev.a025612; Valsecchi E, 1996, MOL ECOL, V5, P151, DOI 10.1111/j.1365-294X.1996.tb00301.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Viricel A, 2008, BEHAV ECOL SOCIOBIOL, V63, P173, DOI 10.1007/s00265-008-0648-7; Waters JM, 2010, AUSTRAL ECOL, V35, P988, DOI 10.1111/j.1442-9993.2010.02114.x; YOUNG DD, 1994, J ZOOL, V234, P41, DOI 10.1111/j.1469-7998.1994.tb06055.x; Zacharias MA, 2001, AQUAT CONSERV, V11, P59, DOI 10.1002/aqc.429	87	65	66	0	103	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2012	7	2							e31482	10.1371/journal.pone.0031482	http://dx.doi.org/10.1371/journal.pone.0031482			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UV	22319634	Green Submitted, Green Published, gold			2022-12-27	WOS:000301979000029
J	Tsai, SW; Liou, HM; Lin, CJ; Kuo, KL; Hung, S; Weng, RC; Hsu, FY				Tsai, Shiao-Wen; Liou, Hau-Min; Lin, Cheng-Jie; Kuo, Ko-Liang; Hung, Sheng; Weng, Ru-Chun; Hsu, Fu-Yin			MG63 Osteoblast-Like Cells Exhibit Different Behavior when Grown on Electrospun Collagen Matrix versus Electrospun Gelatin Matrix	PLOS ONE			English	Article							MECHANICAL-PROPERTIES; PHYSICOCHEMICAL PROPERTIES; EXTRACELLULAR MATRICES; BONE; MINERALIZATION; ADHESION; PHOSPHORYLATION; PROLIFERATION; TRANSCRIPTION; DOWNSTREAM	Electrospinning is a simple and efficient method of fabricating a non-woven polymeric nanofiber matrix. However, using fluorinated alcohols as a solvent for the electrospinning of proteins often results in protein denaturation. TEM and circular dichroism analysis indicated a massive loss of triple-helical collagen from an electrospun collagen (EC) matrix, and the random coils were similar to those found in gelatin. Nevertheless, from mechanical testing we found the Young's modulus and ultimate tensile stresses of EC matrices were significantly higher than electrospun gelatin (EG) matrices because matrix stiffness can affect many cell behaviors such as cell adhesion, proliferation and differentiation. We hypothesize that the difference of matrix stiffness between EC and EG will affect intracellular signaling through the mechano-transducers Rho kinase (ROCK) and focal adhesion kinase (FAK) and subsequently regulates the osteogenic phenotype of MG63 osteoblast-like cells. From the results, we found there was no significant difference between the EC and EG matrices with respect to either cell attachment or proliferation rate. However, the gene expression levels of OPN, type I collagen, ALP, and OCN were significantly higher in MG63 osteoblast-like cells grown on the EC than in those grown on the EG. In addition, the phosphorylation levels of Y397-FAK, ERK1/2, BSP, and OPN proteins, as well as ALP activity, were also higher on the EC than on the EG. We further inhibited ROCK activation with Y27632 during differentiation to investigate its effects on matrix-mediated osteogenic differentiation. Results showed the extent of mineralization was decreased with inhibition after induction. Moreover, there is no significant difference between EC and EG. From the results of the protein levels of phosphorylated Y397-FAK, ERK1/2, BSP and OPN, ALP activity and mineral deposition, we speculate that the mechanism that influences the osteogenic differentiation of MG63 osteoblast-like cells on EC and EG is matrix stiffness and via ROCK-FAK-ERK1/2.	[Tsai, Shiao-Wen; Lin, Cheng-Jie; Hung, Sheng] Chang Gung Univ, Inst Biochem & Biomed Engn, Tao Yuan, Taiwan; [Liou, Hau-Min; Kuo, Ko-Liang; Hung, Sheng; Weng, Ru-Chun; Hsu, Fu-Yin] Natl Taiwan Ocean Univ, Inst Biosci & Biotechnol, Keelung, Taiwan; [Hsu, Fu-Yin] Natl Taiwan Ocean Univ, Dept Life Sci, Keelung, Taiwan	Chang Gung University; National Taiwan Ocean University; National Taiwan Ocean University	Tsai, SW (corresponding author), Chang Gung Univ, Inst Biochem & Biomed Engn, Tao Yuan, Taiwan.	fyhsu@mail.ntou.edu.tw		Tsai, Shiao-Wen/0000-0002-6225-6613; hsu, Fu-Yin/0000-0002-8221-4218	National Science Council of Taiwan [NSC-97-2221-E-182-045, NSC-98-2221-E-019-004]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	The authors would like to thank the National Science Council of Taiwan for financial supporting this research under contract no. NSC-97-2221-E-182-045 and NSC-98-2221-E-019-004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angele P, 2004, BIOMATERIALS, V25, P2831, DOI 10.1016/j.biomaterials.2003.09.066; Aubin JE, 1998, J CELL BIOCHEM, P73, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<73::AID-JCB11>3.0.CO;2-L; Chang YL, 2000, J BIOMED MATER RES, V52, P270, DOI 10.1002/1097-4636(200011)52:2<270::AID-JBM5>3.0.CO;2-1; Chen CS, 2004, ANNU REV BIOMED ENG, V6, P275, DOI 10.1146/annurev.bioeng.6.040803.140040; Dalby MJ, 2003, BIOMATERIALS, V24, P927, DOI 10.1016/S0142-9612(02)00427-1; Dalby MJ, 2002, BIOMATERIALS, V23, P2945, DOI 10.1016/S0142-9612(01)00424-0; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Evans ND, 2009, EUR CELLS MATER, V18, P1; Ganss B, 1999, CRIT REV ORAL BIOL M, V10, P79, DOI 10.1177/10454411990100010401; Gordon JAR, 2007, BONE, V41, P462, DOI 10.1016/j.bone.2007.04.191; Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002; Griffin TM, 2005, EXERC SPORT SCI REV, V33, P195, DOI 10.1097/00003677-200510000-00008; Hanagata N, 2006, BIOCHEM BIOPH RES CO, V344, P1234, DOI 10.1016/j.bbrc.2006.04.021; HAUSCHKA PV, 1989, ANAT REC, V224, P180, DOI 10.1002/ar.1092240208; Hsu FY, 2010, ACTA BIOMATER, V6, P2140, DOI 10.1016/j.actbio.2009.12.023; Huang J, 2007, GENE, V404, P101, DOI 10.1016/j.gene.2007.09.007; Jiang XH, 2007, CELL SIGNAL, V19, P1000, DOI 10.1016/j.cellsig.2006.11.004; Jing Z, 2003, J CONTROL RELEASE, V92, P227, DOI 10.1016/S0168-3659(03)00372-9; KATO YP, 1989, BIOMATERIALS, V10, P38, DOI 10.1016/0142-9612(89)90007-0; Kew SJ, 2011, ACTA BIOMATER, V7, P3237, DOI 10.1016/j.actbio.2011.06.002; Khatiwala CB, 2009, J BONE MINER RES, V24, P886, DOI [10.1359/jbmr.081240, 10.1359/JBMR.081240]; Khil MS, 2003, J BIOMED MATER RES B, V67B, P675, DOI 10.1002/jbm.b.10058; Kocgozlu L, 2010, J CELL SCI, V123, P29, DOI 10.1242/jcs.053520; Lai CF, 2001, J BIOL CHEM, V276, P14443, DOI 10.1074/jbc.M010021200; Liu T, 2010, J BIOMED MATER RES A, V95A, P276, DOI 10.1002/jbm.a.32831; LOWRY OH, 1951, J BIOL CHEM, V193, P265; NUNES RW, 1982, POLYM ENG SCI, V22, P205, DOI 10.1002/pen.760220402; Pirone DM, 2006, J CELL BIOL, V174, P277, DOI 10.1083/jcb.200510062; POSER JW, 1980, J BIOL CHEM, V255, P8685; Ratanavaraporn J, 2006, J MET MATER MINER, V16, P31; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Roeder BA, 2002, J BIOMECH ENG-T ASME, V124, P214, DOI 10.1115/1.1449904; SCHNAPER HW, 1993, PEDIATR NEPHROL, V7, P96, DOI 10.1007/BF00861587; Schofer MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025462; Takeuchi Y, 1997, J BIOL CHEM, V272, P29309, DOI 10.1074/jbc.272.46.29309; Taubenberger AV, 2010, BIOMATERIALS, V31, P2827, DOI 10.1016/j.biomaterials.2009.12.051; Tsai SW, 2008, ACTA BIOMATER, V4, P1332, DOI 10.1016/j.actbio.2008.03.015; Tsai SW, 2010, J TAIWAN INST CHEM E, V41, P247, DOI 10.1016/j.jtice.2009.10.002; Tsai SW, 2010, J BIOMED MATER RES A, V93A, P115, DOI 10.1002/jbm.a.32502; Tsai SW, 2009, J BIOMED MATER RES A, V91A, P985, DOI 10.1002/jbm.a.32324; Vanderploeg EJ, 2008, OSTEOARTHR CARTILAGE, V16, P1228, DOI 10.1016/j.joca.2008.02.016; VEIS A, 1961, ARCH BIOCHEM BIOPHYS, V94, P20, DOI 10.1016/0003-9861(61)90005-4; Wang J, 2010, ACTA BIOMATER, V6, P3004, DOI 10.1016/j.actbio.2010.01.045; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056; WEISS P, 1945, J EXP ZOOL, V100, P353, DOI 10.1002/jez.1401000305; Xiao GZ, 2002, J BIOL CHEM, V277, P36181, DOI 10.1074/JBC.m206057200; Xu B, 2011, INT J BIOMATER, V2011, DOI 10.1155/2011/172389; Xu CY, 2004, BIOMATERIALS, V25, P877, DOI 10.1016/S0142-9612(03)00593-3; Xu CY, 2004, TISSUE ENG, V10, P1160, DOI 10.1089/ten.2004.10.1160; Yang L, 2008, BIOMATERIALS, V29, P955, DOI 10.1016/j.biomaterials.2007.10.058; Zeugolis DI, 2008, J BIOMED MATER RES A, V86A, P892, DOI 10.1002/jbm.a.31694; Zeugolis DI, 2008, BIOMATERIALS, V29, P2293, DOI 10.1016/j.biomaterials.2008.02.009; Zhang RY, 2000, J BIOMED MATER RES, V52, P430, DOI 10.1002/1097-4636(200011)52:2<430::AID-JBM25>3.0.CO;2-L; Zhang ZK, 2007, BIOSCI BIOTECH BIOCH, V71, P2057, DOI 10.1271/bbb.70055	54	85	89	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2012	7	2							e31200	10.1371/journal.pone.0031200	http://dx.doi.org/10.1371/journal.pone.0031200			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UV	22319618	gold, Green Published, Green Submitted			2022-12-27	WOS:000301979000027
J	Seok, J; Xu, WH; Jiang, H; Davis, RW; Xiao, WZ				Seok, Junhee; Xu, Weihong; Jiang, Hui; Davis, Ronald W.; Xiao, Wenzhong			Knowledge-Based Reconstruction of mRNA Transcripts with Short Sequencing Reads for Transcriptome Research	PLOS ONE			English	Article							HUMAN GENOME; SEQ DATA; EXPRESSION; ASSEMBLER; DATABASE; CODE; DNA	While most transcriptome analyses in high-throughput clinical studies focus on gene level expression, the existence of alternative isoforms of gene transcripts is a major source of the diversity in the biological functionalities of the human genome. It is, therefore, essential to annotate isoforms of gene transcripts for genome-wide transcriptome studies. Recently developed mRNA sequencing technology presents an unprecedented opportunity to discover new forms of transcripts, and at the same time brings bioinformatic challenges due to its short read length and incomplete coverage for the transcripts. In this work, we proposed a computational approach to reconstruct new mRNA transcripts from short sequencing reads with reference information of known transcripts in existing databases. The prior knowledge helped to define exon boundaries and fill in the transcript regions not covered by sequencing data. This approach was demonstrated using a deep sequencing data set of human muscle tissue with transcript annotations in RefSeq as prior knowledge. We identified 2,973 junctions, 7,471 exons, and 7,571 transcripts not previously annotated in RefSeq. 73% of these new transcripts found supports from UCSC Known Genes, Ensembl or EST transcript annotations. In addition, the reconstructed transcripts were much longer than those from de novo approaches that assume no prior knowledge. These previously un-annotated transcripts can be integrated with known transcript annotations to improve both the design of microarrays and the follow-up analyses of isoform expression. The overall results demonstrated that incorporating transcript annotations from genomic databases significantly helps the reconstruction of novel transcripts from short sequencing reads for transcriptome research.	[Seok, Junhee; Xu, Weihong; Davis, Ronald W.] Stanford Genome Technol Ctr, Palo Alto, CA USA; [Seok, Junhee] Stanford Univ, Dept Stat, Stanford, CA 94305 USA; [Jiang, Hui] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Xiao, Wenzhong] Harvard Univ, Massachusetts Gen Hosp, Boston, MA 02115 USA	Stanford University; Stanford University; University of Michigan System; University of Michigan; Harvard University; Massachusetts General Hospital	Seok, J (corresponding author), Stanford Genome Technol Ctr, Palo Alto, CA USA.	wxiao1@parnters.org	Jiang, Hui/Q-8281-2019; Jiang, Hui/N-7083-2013; Xu, Weihong/C-4175-2012	Jiang, Hui/0000-0003-2718-9811; Xu, Weihong/0000-0002-3988-3571; xiao, wenzhong/0000-0003-4944-6380	National Institutes of Health [PO1-HG00205, U54-GM62119]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P01HG000205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062119] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by grants from National Institutes of Health (PO1-HG00205, U54-GM62119). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS MD, 1991, SCIENCE, V252, P1651, DOI 10.1126/science.2047873; Au KF, 2010, NUCLEIC ACIDS RES, V38, P4570, DOI 10.1093/nar/gkq211; Bryant DW, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-69; BULLARD JH, 2009, UC BERKELEY DIVISION, V247; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Butler J, 2008, GENOME RES, V18, P810, DOI 10.1101/gr.7337908; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hiller D, 2009, BIOINFORMATICS, V25, P3056, DOI 10.1093/bioinformatics/btp544; Hsu F, 2006, BIOINFORMATICS, V22, P1036, DOI 10.1093/bioinformatics/btl048; Jiang H, 2008, BIOINFORMATICS, V24, P2395, DOI 10.1093/bioinformatics/btn429; Jiang H, 2009, BIOINFORMATICS, V25, P1026, DOI 10.1093/bioinformatics/btp113; Kampa D, 2004, GENOME RES, V14, P331, DOI 10.1101/gr.2094104; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD19, DOI 10.1093/nar/gkq1019; Levin JZ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r115; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; PFLUEGER D, 2010, GENOME RES; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Roberts A, 2011, BIOINFORMATICS, V27, P2325, DOI 10.1093/bioinformatics/btr355; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Sugnet C W, 2004, Pac Symp Biocomput, P66; Thomas JW, 2003, NATURE, V424, P788, DOI 10.1038/nature01858; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang GS, 2007, NAT REV GENET, V8, P749, DOI 10.1038/nrg2164; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Xu WH, 2011, P NATL ACAD SCI USA, V108, P3707, DOI 10.1073/pnas.1019753108; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	31	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2012	7	2							e31440	10.1371/journal.pone.0031440	http://dx.doi.org/10.1371/journal.pone.0031440			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UG	22312447	Green Published, gold			2022-12-27	WOS:000301977500037
J	Stocks, KI; Clark, MR; Rowden, AA; Consalvey, M; Schlacher, TA				Stocks, Karen I.; Clark, Malcolm R.; Rowden, Ashley A.; Consalvey, Mireille; Schlacher, Thomas A.			CenSeam, an International Program on Seamounts within the Census of Marine Life: Achievements and Lessons Learned	PLOS ONE			English	Article							COMMUNITY STRUCTURE; STONY CORALS; ASSEMBLAGES; DIVERSITY; HABITATS; CONNECTIVITY; PATTERNS; HOTSPOTS; ECOLOGY		[Stocks, Karen I.] Univ Calif San Diego, San Diego Supercomp Ctr, La Jolla, CA 92093 USA; [Clark, Malcolm R.; Rowden, Ashley A.; Consalvey, Mireille] Natl Inst Water & Atmospher Res, Wellington, New Zealand; [Schlacher, Thomas A.] Univ Sunshine Coast, Fac Sci, Maroochydore, Australia	University of California System; University of California San Diego; National Institute of Water & Atmospheric Research (NIWA) - New Zealand; University of the Sunshine Coast	Stocks, KI (corresponding author), Univ Calif San Diego, San Diego Supercomp Ctr, La Jolla, CA 92093 USA.	kstocks@sdsc.edu	Rowden, Ashley/ABG-6010-2020; Stocks, Karen I/J-2393-2014; Schlacher, Thomas/J-4614-2016; Rowden, Ashley/O-9358-2019	Stocks, Karen I/0000-0002-1282-300X; Schlacher, Thomas/0000-0003-2184-9217; Rowden, Ashley/0000-0003-2975-2524	Alfred P. Sloan Foundation	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation)	The project described in this manuscript was funded by the Alfred P. Sloan Foundation (http://www.sloan.org/), through the Census of Marine Life Program. The Sloan Foundation encourages open source publication for its grantees, and the authors' program manager at Sloan encouraged the authors' project to consider PLoS ONE as an outlet. However, their preference was stated as a recommendation not a requirement (the authors were free to submit elsewhere if they chose) and the authors' funding was not tied in any way to the authors' decision of publication venue. Aside from this, the funders had no other role in the study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Alexander Vera, 2011, Marine Biodiversity, V41, P545, DOI 10.1007/s12526-011-0084-1; Althaus F, 2009, MAR ECOL PROG SER, V397, P279, DOI 10.3354/meps08248; Ardron J, 2009, DEFINING ECOLOGICALL; Bowden DA, 2011, DEEP-SEA RES PT II, V58, P119, DOI 10.1016/j.dsr2.2010.09.006; Braga AC, 2008, J FISH BIOL, V73, P296, DOI 10.1111/j.1095-8649.2008.01915.x; Brewin PE, 2009, MAR ECOL PROG SER, V383, P225, DOI 10.3354/meps07987; Brewin Paul E., 2007, Fish and Aquatic Resources Series, V12, P41; Cho W, 2010, MAR ECOL-EVOL PERSP, V31, P121, DOI 10.1111/j.1439-0485.2010.00395.x; Clark M.R., 2007, SEAMOUNTS ECOL FISH, P361, DOI [10.1002/9780470691953.ch17, DOI 10.1002/9780470691953.CH17]; Clark M.R., 2006, SEAMOUNTS DEEP SEA C; Clark MR, 2011, OCEAN COAST MANAGE, V54, P19, DOI 10.1016/j.ocecoaman.2010.10.006; Clark MR, 2010, MAR ECOL-EVOL PERSP, V31, P39, DOI 10.1111/j.1439-0485.2010.00384.x; Clark MR, 2010, MAR ECOL-EVOL PERSP, V31, P200, DOI 10.1111/j.1439-0485.2010.00392.x; Clark MR, 2010, ANNU REV MAR SCI, V2, P253, DOI 10.1146/annurev-marine-120308-081109; Clark MR, 2009, DEEP-SEA RES PT I, V56, P1540, DOI 10.1016/j.dsr.2009.04.015; Clark MR, 2009, WLG200963161, P1; Clark MR, 2011, PLOS ONE; Clark MR, 2011, ISA TECHNICAL STUDY; Consalvey Mireille, 2010, P123, DOI 10.1002/9781444325508.ch7; Etnoyer P, 2006, NOAA TECHNICAL MEMOR, P53; Furlani D, 2006, ASSESSMENT CONSERVAT; Hall-Spencer J, 2007, CONSERVATION AND ADAPTIVE MANAGEMENT OF SEAMOUNT AND DEEP-SEA CORAL ECOSYSTEMS, P135; He GW, 2011, ACTA OCEANOL SIN, V30, P63, DOI 10.1007/s13131-011-0120-9; Ingole B, 2005, INDIAN J MAR SCI, V34, P27; Johnston DW, 2008, BIOL LETTERS, V4, P208, DOI 10.1098/rsbl.2007.0614; Kitchingman A., 2007, SEAMOUNTS ECOLOGY FI, V12, P26, DOI DOI 10.1002/9780470691953.CH2; Koslow JA, 2001, MAR ECOL PROG SER, V213, P111, DOI 10.3354/meps213111; Lavelle JW, 2010, OCEANOGRAPHY, V23, P90, DOI 10.5670/oceanog.2010.64; Louzao M, 2011, J APPL ECOL, V48, P121, DOI 10.1111/j.1365-2664.2010.01910.x; McClain CR, 2010, MAR ECOL-EVOL PERSP, V31, P14, DOI 10.1111/j.1439-0485.2010.00367.x; McClain CR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004141; Miller K, 2006, CONNECTIVITY CONSERV; Miller K, 2010, MAR ECOL-EVOL PERSP, V31, P144, DOI 10.1111/j.1439-0485.2010.00380.x; Miller KJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019004; Morato T, 2008, MAR ECOL PROG SER, V357, P23, DOI 10.3354/meps07269; Morato T, 2010, P NATL ACAD SCI USA, V107, P9707, DOI 10.1073/pnas.0910290107; Newman WA, 2011, ZOOTAXA, P49; Niklitschek EJ, 2010, MAR ECOL-EVOL PERSP, V31, P168, DOI 10.1111/j.1439-0485.2010.00372.x; O'Hara T.D., 2010, MAR ECOL, V31, P1; O'Hara TD, 2008, DIVERS DISTRIB, V14, P925, DOI 10.1111/j.1472-4642.2008.00495.x; Parker SJ, 2009, MAR ECOL PROG SER, V397, P309, DOI 10.3354/meps08115; Pitcher TJ, 2010, OCEANOGRAPHY, V23, P134, DOI 10.5670/oceanog.2010.66; Rogers A.D., 2007, SEAMOUNTS ECOLOGY FI, P3343; Rogers AD, 2008, SCI GUIDELI IN PRESS; Rowden AA, 2010, MAR ECOL-EVOL PERSP, V31, P95, DOI 10.1111/j.1439-0485.2010.00369.x; Rowden AA, 2010, MAR ECOL-EVOL PERSP, V31, P63, DOI 10.1111/j.1439-0485.2010.00374.x; Rowden AA, 2010, MAR ECOL-EVOL PERSP, V31, P226, DOI 10.1111/j.1439-0485.2010.00400.x; Samadi S, 2006, MAR BIOL, V149, P1463, DOI 10.1007/s00227-006-0306-4; Samadi Sarah, 2007, Fish and Aquatic Resources Series, V12, P119; Schlacher TA, 2010, MAR ECOL-EVOL PERSP, V31, P1, DOI 10.1111/j.1439-0485.2010.00396.x; Shank TM, 2010, OCEANOGRAPHY, V23, P122; Staudigel H, 2010, OCEANOGRAPHY, V23, P212, DOI 10.5670/oceanog.2010.72; Staudigel H, 2010, OCEANOGRAPHY, V23, P58, DOI 10.5670/oceanog.2010.62; Stocks KI, 2010, OCEANOGRAPHY, V23, P145, DOI 10.5670/oceanog.2010.94; Stocks KI, 2004, ARCH FISH MAR RES, V51, P320; Tittensor DP, 2010, MAR ECOL-EVOL PERSP, V31, P212, DOI 10.1111/j.1439-0485.2010.00393.x; Tittensor DP, 2009, J BIOGEOGR, V36, P1111, DOI 10.1111/j.1365-2699.2008.02062.x; UNESCO, 2009, IOC TECHNICAL SERIES, V84, P87; Williams A, 2010, MAR ECOL-EVOL PERSP, V31, P183, DOI 10.1111/j.1439-0485.2010.00385.x; Worm B, 2003, P NATL ACAD SCI USA, V100, P9884, DOI 10.1073/pnas.1333941100; Yesson C, 2011, DEEP-SEA RES PT I, V58, P442, DOI 10.1016/j.dsr.2011.02.004	61	12	15	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2012	7	2							e32031	10.1371/journal.pone.0032031	http://dx.doi.org/10.1371/journal.pone.0032031			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UG	22312448	Green Published, gold, Green Submitted			2022-12-27	WOS:000301977500038
J	Zhao, HS; Li, M; Fang, KC; Chen, WF; Wang, J				Zhao, Hansheng; Li, Mao; Fang, Kechi; Chen, Wenfeng; Wang, Jing			In Silico Insights into the Symbiotic Nitrogen Fixation in Sinorhizobium meliloti via Metabolic Reconstruction	PLOS ONE			English	Article							RHIZOBIUM-MELILOTI; FUNCTIONAL-CHARACTERIZATION; NUCLEOTIDE-SEQUENCE; ROOT-NODULE; LEGUME; GENES; ALFALFA; TRANSPORT; DATABASE; MUTANTS	Background: Sinorhizobium meliloti is a soil bacterium, known for its capability to establish symbiotic nitrogen fixation (SNF) with leguminous plants such as alfalfa. S. meliloti 1021 is the most extensively studied strain to understand the mechanism of SNF and further to study the legume-microbe interaction. In order to provide insight into the metabolic characteristics underlying the SNF mechanism of S. meliloti 1021, there is an increasing demand to reconstruct a metabolic network for the stage of SNF in S. meliloti 1021. Results: Through an iterative reconstruction process, a metabolic network during the stage of SNF in S. meliloti 1021 was presented, named as iHZ565, which accounts for 565 genes, 503 internal reactions, and 522 metabolites. Subjected to a novelly defined objective function, the in silico predicted flux distribution was highly consistent with the in vivo evidences reported previously, which proves the robustness of the model. Based on the model, refinement of genome annotation of S. meliloti 1021 was performed and 15 genes were re-annotated properly. There were 19.8% (112) of the 565 metabolic genes included in iHZ565 predicted to be essential for efficient SNF in bacteroids under the in silico microaerobic and nutrient sharing condition. Conclusions: As the first metabolic network during the stage of SNF in S. meliloti 1021, the manually curated model iHZ565 provides an overview of the major metabolic properties of the SNF bioprocess in S. meliloti 1021. The predicted SNF-required essential genes will facilitate understanding of the key functions in SNF and help identify key genes and design experiments for further validation. The model iHZ565 can be used as a knowledge-based framework for better understanding the symbiotic relationship between rhizobia and legumes, ultimately, uncovering the mechanism of nitrogen fixation in bacteroids and providing new strategies to efficiently improve biological nitrogen fixation.	[Zhao, Hansheng; Li, Mao; Chen, Wenfeng] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Zhao, Hansheng; Fang, Kechi; Wang, Jing] Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China	China Agricultural University; Chinese Academy of Sciences; Institute of Psychology, CAS	Zhao, HS (corresponding author), China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China.	chenwf@cau.edu.cn; wangjing@psych.ac.cn	zhao, hansheng/GRS-2764-2022		Ministry of Science and Technology of the People's Republic of China [2011CBA00802, 2010CB126500]	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China)	The National Basic Research Program of China (973 Program, 2011CBA00802, 2010CB126500) from the Ministry of Science and Technology of the People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ampe F, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r15; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Barnett MJ, 2001, P NATL ACAD SCI USA, V98, P9883, DOI 10.1073/pnas.161294798; Barnett MJ, 2004, P NATL ACAD SCI USA, V101, P16636, DOI 10.1073/pnas.0407269101; Barsch Aiko, 2004, Functional & Integrative Genomics, V4, P219, DOI 10.1007/s10142-004-0117-y; Becker A, 2004, MOL PLANT MICROBE IN, V17, P292, DOI 10.1094/MPMI.2004.17.3.292; Becker A, 2009, J BIOTECHNOL, V140, P45, DOI 10.1016/j.jbiotec.2008.11.006; Becker SA, 2007, NAT PROTOC, V2, P727, DOI 10.1038/nprot.2007.99; Bergersen FJ, 1997, SOIL BIOL BIOCHEM, V29, P875, DOI 10.1016/S0038-0717(96)00220-9; Capela D, 2006, MOL PLANT MICROBE IN, V19, P363, DOI 10.1094/MPMI-19-0363; Capela D, 2001, P NATL ACAD SCI USA, V98, P9877, DOI 10.1073/pnas.161294398; Cevallos MA, 1996, J BACTERIOL, V178, P1646, DOI 10.1128/jb.178.6.1646-1654.1996; Davies BW, 2007, J BACTERIOL, V189, P2101, DOI 10.1128/JB.01377-06; Davies BW, 2007, J BACTERIOL, V189, P2110, DOI 10.1128/JB.01802-06; de Bruijn FJ, 2006, ENVIRON MICROBIOL, V8, P1371, DOI 10.1111/j.1462-2920.2006.01030.x; DEBRUIJN FJ, 1989, J BACTERIOL, V171, P1673, DOI 10.1128/jb.171.3.1673-1682.1989; Delgado MJ, 2006, MICROBIOL-SGM, V152, P199, DOI 10.1099/mic.0.28347-0; Djordjevic MA, 2004, PROTEOMICS, V4, P1859, DOI 10.1002/pmic.200300802; Djordjevic MA, 2003, MOL PLANT MICROBE IN, V16, P508, DOI 10.1094/MPMI.2003.16.6.508; DRISCOLL BT, 1993, MOL MICROBIOL, V7, P865, DOI 10.1111/j.1365-2958.1993.tb01177.x; Driscoll BT, 1997, MICROBIOL-SGM, V143, P489, DOI 10.1099/00221287-143-2-489; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; Dymov SI, 2004, MOL PLANT MICROBE IN, V17, P1318, DOI 10.1094/MPMI.2004.17.12.1318; Edwards JS, 2002, ENVIRON MICROBIOL, V4, P133, DOI 10.1046/j.1462-2920.2002.00282.x; Einsle O, 2002, SCIENCE, V297, P1696, DOI 10.1126/science.1073877; Finan TM, 2001, P NATL ACAD SCI USA, V98, P9889, DOI 10.1073/pnas.161294698; FUJIHARA S, 1994, PLANT CELL PHYSIOL, V35, P1127, DOI 10.1093/oxfordjournals.pcp.a078705; Galibert F, 2001, SCIENCE, V293, P668, DOI 10.1126/science.1060966; Hakoyama T, 2009, NATURE, V462, P514, DOI 10.1038/nature08594; Hertz-Fowler C, 2004, NUCLEIC ACIDS RES, V32, pD339, DOI 10.1093/nar/gkh007; HIRSCH AM, 1983, J BACTERIOL, V155, P367, DOI 10.1128/JB.155.1.367-380.1983; HIRSCH AM, 1987, J BACTERIOL, V169, P1137, DOI 10.1128/jb.169.3.1137-1146.1987; Hu YL, 2008, BIOCHEMISTRY-US, V47, P3973, DOI 10.1021/bi7025003; IRIGOYEN JJ, 1990, APPL ENVIRON MICROB, V56, P2587, DOI 10.1128/AEM.56.8.2587-2589.1990; Jenuth J P, 2000, Methods Mol Biol, V132, P301; Jiang GQ, 2001, J BACTERIOL, V183, P2595, DOI 10.1128/JB.183.8.2595-2604.2001; Jones KM, 2007, NAT REV MICROBIOL, V5, P619, DOI 10.1038/nrmicro1705; KAHN D, 1989, J BACTERIOL, V171, P929, DOI 10.1128/jb.171.2.929-939.1989; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; KAPP D, 1990, PLANT CELL, V2, P139, DOI 10.1105/tpc.2.2.139; Knorr AL, 2007, BIOINFORMATICS, V23, P351, DOI 10.1093/bioinformatics/btl619; Koski LB, 2001, J MOL EVOL, V52, P540, DOI 10.1007/s002390010184; Krusell L, 2005, PLANT CELL, V17, P1625, DOI 10.1105/tpc.104.030106; Lee JM, 2006, BRIEF BIOINFORM, V7, P140, DOI 10.1093/bib/bbl007; Lodwig E, 2003, CRIT REV PLANT SCI, V22, P37, DOI 10.1080/713610850; Lodwig EM, 2003, NATURE, V422, P722, DOI 10.1038/nature01527; Ma HW, 2003, BIOINFORMATICS, V19, P270, DOI 10.1093/bioinformatics/19.2.270; Mao CH, 2005, BIOINFORMATICS, V21, P2927, DOI 10.1093/bioinformatics/bti427; MASEPOHL B, 1992, MOL GEN GENET, V233, P33, DOI 10.1007/BF00587558; Masson-Boivin C, 2009, TRENDS MICROBIOL, V17, P458, DOI 10.1016/j.tim.2009.07.004; MCRAE DG, 1989, MOL PLANT MICROBE IN, V2, P273, DOI 10.1094/MPMI-2-273; MILLER RW, 1983, PHYSIOL PLANTARUM, V58, P464, DOI 10.1111/j.1399-3054.1983.tb05728.x; OBrian MR, 1996, J BACTERIOL, V178, P2471, DOI 10.1128/jb.178.9.2471-2478.1996; Ott T, 2005, CURR BIOL, V15, P531, DOI 10.1016/j.cub.2005.01.042; Poole P, 2000, ADV MICROB PHYSIOL, V43, P117, DOI 10.1016/S0065-2911(00)43004-3; Prell J, 2006, TRENDS MICROBIOL, V14, P161, DOI 10.1016/j.tim.2006.02.005; Prell J, 2009, P NATL ACAD SCI USA, V106, P12477, DOI 10.1073/pnas.0903653106; Ramirez-Trujillo JA, 2007, J BACTERIOL, V189, P5875, DOI 10.1128/JB.00385-07; Reed JL, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r54; Ren QH, 2007, NUCLEIC ACIDS RES, V35, pD274, DOI 10.1093/nar/gkl925; Resendis-Antonio O, 2007, PLOS COMPUT BIOL, V3, P1887, DOI 10.1371/journal.pcbi.0030192; Saier MH, 2006, NUCLEIC ACIDS RES, V34, pD181, DOI 10.1093/nar/gkj001; Sarma AD, 2006, PROTEOMICS, V6, P3008, DOI 10.1002/pmic.200500783; Schellenberger J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-213; Schomburg I, 2004, NUCLEIC ACIDS RES, V32, pD431, DOI 10.1093/nar/gkh081; Schuetz R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100162; Udvardi MK, 1997, ANNU REV PLANT PHYS, V48, P493, DOI 10.1146/annurev.arplant.48.1.493; Wang CX, 2007, MICROBIOL-SGM, V153, P388, DOI 10.1099/mic.0.29214-0; WATSON RJ, 1990, MOL PLANT MICROBE IN, V3, P174, DOI 10.1094/MPMI-3-174; White J, 2007, PLANT PHYSIOL, V144, P604, DOI 10.1104/pp.107.097741; Whitehead LF, 2001, AUST J PLANT PHYSIOL, V28, P675; Zhang R, 2009, NUCLEIC ACIDS RES, V37, pD455, DOI 10.1093/nar/gkn858; ZHENG LM, 1993, P NATL ACAD SCI USA, V90, P2754, DOI 10.1073/pnas.90.7.2754; ZHOU JC, 1985, PLANTA, V163, P473, DOI 10.1007/BF00392704	74	18	21	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2012	7	2							e31287	10.1371/journal.pone.0031287	http://dx.doi.org/10.1371/journal.pone.0031287			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UG	22319621	Green Published, Green Submitted, gold			2022-12-27	WOS:000301977500033
J	Jgamadze, D; Bergen, J; Stone, D; Jang, JH; Schaffer, DV; Isacoff, EY; Pautot, S				Jgamadze, Dennis; Bergen, Jamie; Stone, Daniel; Jang, Jae-Hyung; Schaffer, David V.; Isacoff, Ehud Y.; Pautot, Sophie			Colloids as Mobile Substrates for the Implantation and Integration of Differentiated Neurons into the Mammalian Brain	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; IONOTROPIC GLUTAMATE-RECEPTOR; TEMPORAL-LOBE EPILEPSY; PARKINSONS-DISEASE; DOPAMINERGIC-NEURONS; HNT NEURONS; ADULT HIPPOCAMPUS; SUBSTANTIA-NIGRA; RAT MODEL; STRIATAL TRANSPLANTATION	Neuronal degeneration and the deterioration of neuronal communication lie at the origin of many neuronal disorders, and there have been major efforts to develop cell replacement therapies for treating such diseases. One challenge, however, is that differentiated cells are challenging to transplant due to their sensitivity both to being uprooted from their cell culture growth support and to shear forces inherent in the implantation process. Here, we describe an approach to address these problems. We demonstrate that rat hippocampal neurons can be grown on colloidal particles or beads, matured and even transfected in vitro, and subsequently transplanted while adhered to the beads into the young adult rat hippocampus. The transplanted cells have a 76% cell survival rate one week post-surgery. At this time, most transplanted neurons have left their beads and elaborated long processes, similar to the host neurons. Additionally, the transplanted cells distribute uniformly across the host hippocampus. Expression of a fluorescent protein and the light-gated glutamate receptor in the transplanted neurons enabled them to be driven to fire by remote optical control. At 1-2 weeks after transplantation, calcium imaging of host brain slice shows that optical excitation of the transplanted neurons elicits activity in nearby host neurons, indicating the formation of functional transplant-host synaptic connections. After 6 months, the transplanted cell survival and overall cell distribution remained unchanged, suggesting that cells are functionally integrated. This approach, which could be extended to other cell classes such as neural stem cells and other regions of the brain, offers promising prospects for neuronal circuit repair via transplantation of in vitro differentiated, genetically engineered neurons.	[Jgamadze, Dennis; Pautot, Sophie] Ctr Regenerat Therapies Dresden, Dresden, Germany; [Isacoff, Ehud Y.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Dept Mol & Cell Biol, Phys Biosci Div, Berkeley, CA 94720 USA; [Bergen, Jamie; Stone, Daniel; Jang, Jae-Hyung; Schaffer, David V.] Univ Calif Berkeley, Dept Chem Engn, Berkeley, CA 94720 USA	Technische Universitat Dresden; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Jgamadze, D (corresponding author), Ctr Regenerat Therapies Dresden, Dresden, Germany.	ehud@berkeley.edu; sophie.pautot@crt-dresden.de	Jang, Jae-Hyung/G-8030-2012; isacoff, ehud/AAP-1459-2020; Pautot, Sophie/A-1578-2011	Pautot, Sophie/0000-0002-6660-4128; Stone, Daniel/0000-0003-1619-7541; Isacoff, Ehud Y./0000-0003-4775-9359	NIH Nanomedicine Development Center in Optical Control of Biological Function [PN2 EY1018241]; Deutsche Forschungsgemeinschaft [FZ 111]	NIH Nanomedicine Development Center in Optical Control of Biological Function; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the NIH Nanomedicine Development Center in Optical Control of Biological Function (PN2 EY1018241), and by grants from the Deutsche Forschungsgemeinschaft (FZ 111). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARENDT T, 1988, BRAIN RES BULL, V21, P563, DOI 10.1016/0361-9230(88)90193-1; Baker KA, 2000, EXP NEUROL, V162, P350, DOI 10.1006/exnr.1999.7337; BANKER G, 1998, CULTURING NERVE CELL; Barberi T, 2003, NAT BIOTECHNOL, V21, P1200, DOI 10.1038/nbt870; Bibel M, 2007, NAT PROTOC, V2, P1034, DOI 10.1038/nprot.2007.147; Bjorklund LM, 2002, P NATL ACAD SCI USA, V99, P2344, DOI 10.1073/pnas.022438099; Borlongan CV, 1998, NEUROREPORT, V9, P2837, DOI 10.1097/00001756-199808240-00028; Carpentino JE, 2008, J NEUROSCI RES, V86, P512, DOI 10.1002/jnr.21514; Conti L, 2006, BRAIN PATHOL, V16, P143, DOI 10.1111/j.1750-3639.2006.00009.x; Damier P, 1999, BRAIN, V122, P1421, DOI 10.1093/brain/122.8.1421; Damier P, 1999, BRAIN, V122, P1437, DOI 10.1093/brain/122.8.1437; DUNNETT SB, 1995, BEHAV BRAIN RES, V66, P133, DOI 10.1016/0166-4328(94)00134-2; Ehninger D, 2008, CELL TISSUE RES, V331, P243, DOI 10.1007/s00441-007-0478-3; Espinosa-Jeffrey Araceli, 2009, Curr Protoc Stem Cell Biol, VChapter 2, DOI 10.1002/9780470151808.sc02d04s10; Everitt BJ, 1997, ANNU REV PSYCHOL, V48, P649, DOI 10.1146/annurev.psych.48.1.649; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; FREED CR, 1992, NEW ENGL J MED, V327, P1549, DOI 10.1056/NEJM199211263272202; Gorostiza P, 2007, MOL BIOSYST, V3, P686, DOI 10.1039/b710287a; Gorostiza P, 2007, P NATL ACAD SCI USA, V104, P10865, DOI 10.1073/pnas.0701274104; HIRSCH E, 1988, NATURE, V334, P345, DOI 10.1038/334345a0; Hurlbert MS, 1999, CELL TRANSPLANT, V8, P143, DOI 10.1177/096368979900800106; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Kelly S, 2004, P NATL ACAD SCI USA, V101, P11839, DOI 10.1073/pnas.0404474101; Kim JH, 2002, NATURE, V418, P50, DOI 10.1038/nature00900; Kim M, 2008, NEUROPATHOLOGY, V28, P1, DOI 10.1111/j.1440-1789.2007.00858.x; Kim SU, 2009, J NEUROSCI RES, V87, P2183, DOI 10.1002/jnr.22054; LETOURNEAU PC, 1975, DEV BIOL, V44, P92, DOI 10.1016/0012-1606(75)90379-6; LETOURNEAU PC, 1975, DEV BIOL, V44, P77, DOI 10.1016/0012-1606(75)90378-4; Lindvall O, 2006, NATURE, V441, P1094, DOI 10.1038/nature04960; Lindvall O, 2000, Prog Brain Res, V127, P299; Moon SY, 2006, MOL THER, V13, P5, DOI 10.1016/j.ymthe.2005.09.008; Naegele JR, 2010, NEUROPHARMACOLOGY, V58, P855, DOI 10.1016/j.neuropharm.2010.01.019; Pautot S, 2008, NAT METHODS, V5, P735, DOI 10.1038/nmeth.1236; Redmond DE, 2008, NEUROBIOL DIS, V29, P103, DOI 10.1016/j.nbd.2007.08.008; Sanberg PR, 1997, ANN NY ACAD SCI, V831, P452; Saporta S, 1999, NEUROSCIENCE, V91, P519, DOI 10.1016/S0306-4522(98)00610-1; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; Shepherd G.M., 1979, SYNAPTIC ORG BRAIN; Shetty AK, 2000, NEUROSCIENCE, V99, P243, DOI 10.1016/S0306-4522(00)00178-0; SHETTY AK, 1995, NEUROSCIENCE, V67, P561, DOI 10.1016/0306-4522(95)00025-E; Shetty AK, 2007, STEM CELLS, V25, P2396, DOI 10.1634/stemcells.2007-0313; Szobota S, 2007, NEURON, V54, P535, DOI 10.1016/j.neuron.2007.05.010; Turner DA, 2003, NEUROSURGERY, V52, P632, DOI 10.1227/01.NEU.0000047825.91205.E6; Volgraf M, 2006, NAT CHEM BIOL, V2, P47, DOI 10.1038/nchembio756; Yang DL, 2008, STEM CELLS, V26, P55, DOI 10.1634/stemcells.2007-0494; Zaman V, 2001, NEUROBIOL DIS, V8, P942, DOI 10.1006/nbdi.2001.0440	46	16	18	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30293	10.1371/journal.pone.0030293	http://dx.doi.org/10.1371/journal.pone.0030293			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295079	gold, Green Published, Green Submitted			2022-12-27	WOS:000301640600024
J	Liu, N; He, S; Yu, X				Liu, Na; He, Shan; Yu, Xiang			Early Natural Stimulation through Environmental Enrichment Accelerates Neuronal Development in the Mouse Dentate Gyrus	PLOS ONE			English	Article							MICROTUBULE-ASSOCIATED PROTEIN; ADULT NEUROGENESIS; GRANULE CELLS; HIPPOCAMPAL-NEURONS; POTENTIAL ROLE; RHESUS-MONKEY; BRAIN; MICE; RAT; DIFFERENTIATION	The dentate gyrus is the primary afferent into the hippocampal formation, with important functions in learning and memory. Granule cells, the principle neuronal type in the dentate gyrus, are mostly formed postnatally, in a process that continues into adulthood. External stimuli, including environmental enrichment, voluntary exercise and learning, have been shown to significantly accelerate the generation and maturation of dentate granule cells in adult rodents. Whether, and to what extent, such environmental stimuli regulate the development and maturation of dentate granule cells during early postnatal development is largely unknown. Furthermore, whether natural stimuli affect the synaptic properties of granule cells had been investigated neither in newborn neurons of the adult nor during early development. To examine the effect of natural sensory stimulation on the dentate gyrus, we reared newborn mice in an enriched environment (EE). Using immunohistochemistry, we showed that dentate granule cells from EE-reared mice exhibited earlier morphological maturation, manifested as faster peaking of doublecortin expression and elevated expression of mature neuronal markers (including NeuN, calbindin and MAP2) at the end of the second postnatal week. Also at the end of the second postnatal week, we found increased density of dendritic spines across the entire dentate gyrus, together with elevated levels of postsynaptic scaffold (post-synaptic density 95) and receptor proteins (GluR2 and GABA(A)R gamma 2) of excitatory and inhibitory synapses. Furthermore, dentate granule cells of P14 EE-reared mice had lower input resistances and increased glutamatergic and GABAergic synaptic inputs. Together, our results demonstrate that EE-rearing promotes morphological and electrophysiological maturation of dentate granule cells, underscoring the importance of natural environmental stimulation on development of the dentate gyrus.	[Liu, Na; He, Shan; Yu, Xiang] Chinese Acad Sci, Inst Neurosci, Shanghai, Peoples R China; [Liu, Na; He, Shan; Yu, Xiang] Chinese Acad Sci, State Key Lab Neurosci, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Liu, Na; He, Shan] Chinese Acad Sci, Grad Sch, Shanghai, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences	Liu, N (corresponding author), Chinese Acad Sci, Inst Neurosci, Shanghai, Peoples R China.	yuxiang@ion.ac.cn		Yu, Xiang/0000-0003-1225-7666	Ministry of Science and Technology [2011CBA00400]; National Natural Science Foundation of China [31021063]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Ministry of Science and Technology (2011CBA00400) and the National Natural Science Foundation of China (31021063). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimone JB, 2006, NAT NEUROSCI, V9, P723, DOI 10.1038/nn1707; ALTMAN J, 1990, J COMP NEUROL, V301, P365, DOI 10.1002/cne.903010304; ALTMAN J, 1990, J COMP NEUROL, V301, P325, DOI 10.1002/cne.903010302; ANGEVINE JAY B., 1965, EXP NEUROL SUPPL, V2, P1; BENNETT EL, 1964, SCIENCE, V146, P610, DOI 10.1126/science.146.3644.610; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; CAMERON HA, 1993, NEUROSCIENCE, V56, P337, DOI 10.1016/0306-4522(93)90335-D; Cancedda L, 2004, J NEUROSCI, V24, P4840, DOI 10.1523/JNEUROSCI.0845-04.2004; Carleton A, 2003, NAT NEUROSCI, V6, P507, DOI 10.1038/nn1048; des Portes V, 1998, CELL, V92, P51; Duan X, 2008, CURR OPIN NEUROBIOL, V18, P108, DOI 10.1016/j.conb.2008.04.001; ECKENHOFF MF, 1984, J COMP NEUROL, V223, P1, DOI 10.1002/cne.902230102; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; Esposito MS, 2005, J NEUROSCI, V25, P10074, DOI 10.1523/JNEUROSCI.3114-05.2005; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; He S, 2010, J NEUROSCI, V30, P7910, DOI 10.1523/JNEUROSCI.6375-09.2010; Jessberger S, 2003, EUR J NEUROSCI, V18, P2707, DOI 10.1111/j.1460-9568.2003.02986.x; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kirkeby S, 2005, J IMMUNOL METHODS, V301, P102, DOI 10.1016/j.jim.2005.04.006; Levitt P, 2004, TRENDS NEUROSCI, V27, P400, DOI 10.1016/j.tins.2004.05.008; Li GN, 2005, DEV NEUROSCI-BASEL, V27, P93, DOI 10.1159/000085980; Li GN, 2007, PROG BRAIN RES, V163, P143, DOI 10.1016/S0079-6123(07)63008-8; Liu M, 2000, P NATL ACAD SCI USA, V97, P865, DOI 10.1073/pnas.97.2.865; Liu XS, 2000, BRAIN RES, V856, P202, DOI 10.1016/S0006-8993(99)02421-X; Liu YB, 1996, J NEUROPHYSIOL, V76, P1074, DOI 10.1152/jn.1996.76.2.1074; MATUS A, 1988, ANNU REV NEUROSCI, V11, P29, DOI 10.1146/annurev.neuro.11.1.29; Miyata T, 1999, GENE DEV, V13, P1647, DOI 10.1101/gad.13.13.1647; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; NOWAKOWSKI RS, 1981, J COMP NEUROL, V196, P129, DOI 10.1002/cne.901960110; Overstreet-Wadiche LS, 2006, J NEUROSCI, V26, P2326, DOI 10.1523/JNEUROSCI.4111-05.2006; Pham TM, 2002, PHARMACOL BIOCHEM BE, V73, P167, DOI 10.1016/S0091-3057(02)00783-9; Piatti VC, 2006, NEUROSCIENTIST, V12, P463, DOI 10.1177/1073858406293538; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; RAMI A, 1987, DEV BIOL, V124, P228, DOI 10.1016/0012-1606(87)90474-X; ROSENZWEIG MR, 1978, BRAIN RES, V153, P563, DOI 10.1016/0006-8993(78)90340-2; SEQUIER JM, 1988, NEUROSCI LETT, V86, P155, DOI 10.1016/0304-3940(88)90563-0; Tashiro A, 2007, J NEUROSCI, V27, P3252, DOI 10.1523/JNEUROSCI.4941-06.2007; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; WEST MJ, 1993, NEUROBIOL AGING, V14, P275, DOI 10.1016/0197-4580(93)90112-O; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhao CJ, 2005, DEVELOPMENT, V132, P2917, DOI 10.1242/dev.01871; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006	49	23	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30803	10.1371/journal.pone.0030803	http://dx.doi.org/10.1371/journal.pone.0030803			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295110	gold, Green Published, Green Submitted			2022-12-27	WOS:000301640600055
J	Martinez-Martin, D; Carrasco, C; Hernando-Perez, M; de Pablo, PJ; Gomez-Herrero, J; Perez, R; Mateu, MG; Carrascosa, JL; Kiracofe, D; Melcher, J; Raman, A				Martinez-Martin, David; Carrasco, Carolina; Hernando-Perez, Mercedes; de Pablo, Pedro J.; Gomez-Herrero, Julio; Perez, Rebeca; Mateu, Mauricio G.; Carrascosa, Jose L.; Kiracofe, Daniel; Melcher, John; Raman, Arvind			Resolving Structure and Mechanical Properties at the Nanoscale of Viruses with Frequency Modulation Atomic Force Microscopy	PLOS ONE			English	Article							MINUTE VIRUS; PARVOVIRUS; RESOLUTION	Structural Biology (SB) techniques are particularly successful in solving virus structures. Taking advantage of the symmetries, a heavy averaging on the data of a large number of specimens, results in an accurate determination of the structure of the sample. However, these techniques do not provide true single molecule information of viruses in physiological conditions. To answer many fundamental questions about the quickly expanding physical virology it is important to develop techniques with the capability to reach nanometer scale resolution on both structure and physical properties of individual molecules in physiological conditions. Atomic force microscopy (AFM) fulfills these requirements providing images of individual virus particles under physiological conditions, along with the characterization of a variety of properties including local adhesion and elasticity. Using conventional AFM modes is easy to obtain molecular resolved images on flat samples, such as the purple membrane, or large viruses as the Giant Mimivirus. On the contrary, small virus particles (25-50 nm) cannot be easily imaged. In this work we present Frequency Modulation atomic force microscopy (FM-AFM) working in physiological conditions as an accurate and powerful technique to study virus particles. Our interpretation of the so called "dissipation channel'' in terms of mechanical properties allows us to provide maps where the local stiffness of the virus particles are resolved with nanometer resolution. FM-AFM can be considered as a non invasive technique since, as we demonstrate in our experiments, we are able to sense forces down to 20 pN. The methodology reported here is of general interest since it can be applied to a large number of biological samples. In particular, the importance of mechanical interactions is a hot topic in different aspects of biotechnology ranging from protein folding to stem cells differentiation where conventional AFM modes are already being used.	[Martinez-Martin, David; Carrasco, Carolina; Hernando-Perez, Mercedes; de Pablo, Pedro J.; Gomez-Herrero, Julio] Univ Autonoma Madrid, Dept Fis Mat Condensada, E-28049 Madrid, Spain; [Carrasco, Carolina; Carrascosa, Jose L.] CSIC, Ctr Nacl Biotecnol, Madrid, Spain; [Perez, Rebeca; Mateu, Mauricio G.] CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain; [Kiracofe, Daniel; Melcher, John; Raman, Arvind] Purdue Univ, Sch Mech Engn, W Lafayette, IN 47907 USA; [Kiracofe, Daniel; Melcher, John; Raman, Arvind] Purdue Univ, Birck Nanotechnol Ctr, W Lafayette, IN 47907 USA	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Martinez-Martin, D (corresponding author), Univ Autonoma Madrid, Dept Fis Mat Condensada, Cantoblanco, E-28049 Madrid, Spain.	Julio.gomez@uam.es	Martinez-Martin, David/P-3083-2016; Gomez-Herrero, Julio/B-6094-2013; Pérez, Rebeca/M-5235-2015; Hernando-Pérez, Mercedes/AAH-3550-2019; de Pablo, Pedro/L-9392-2014; Mateu, Mauricio/ABF-2146-2021; Melcher, John/A-1684-2015; Carrasco, Carolina/K-9142-2014	Martinez-Martin, David/0000-0002-3658-9393; Gomez-Herrero, Julio/0000-0001-8583-8061; Pérez, Rebeca/0000-0002-0445-868X; Hernando-Pérez, Mercedes/0000-0002-5875-5620; de Pablo, Pedro/0000-0003-2386-3186; Mateu, Mauricio/0000-0002-2915-1529; Melcher, John/0000-0002-9375-2708; Carrasco, Carolina/0000-0001-9322-4932; Kiracofe, Daniel/0000-0003-2804-7962	 [S2009/MAT-1467 (CAM)];  [MAT2010-20843-C02]; Direct For Mathematical & Physical Scien [1008189] Funding Source: National Science Foundation	; ; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	The authors acknowledge the financial support from projects S2009/MAT-1467 (CAM), MAT2010-20843-C02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agbandje-McKenna M, 1998, STRUCT FOLD DES, V6, P1369, DOI 10.1016/S0969-2126(98)00137-3; Basak S, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2760175; Blum AS, 2005, SMALL, V1, P702, DOI 10.1002/smll.200500021; Calabri L, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/39/395002; Carrasco C, 2006, P NATL ACAD SCI USA, V103, P13706, DOI 10.1073/pnas.0601881103; Carrasco C, 2009, P NATL ACAD SCI USA, V106, P5475, DOI 10.1073/pnas.0810095106; Carrasco C, 2008, P NATL ACAD SCI USA, V105, P4150, DOI 10.1073/pnas.0708017105; Cordova A, 2003, BIOPHYS J, V85, P70, DOI 10.1016/S0006-3495(03)74455-5; de Pablo PJ, 1998, APPL PHYS LETT, V73, P3300, DOI 10.1063/1.122751; Fischlechner M, 2007, ANGEW CHEM INT EDIT, V46, P3184, DOI 10.1002/anie.200603445; Flint J. S., 2004, PRINCIPLES VIROLOGY; Fukuma T, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.1999856; Giessibl FJ, 2000, PHYS REV B, V61, P9968, DOI 10.1103/PhysRevB.61.9968; Higgins MJ, 2006, BIOPHYS J, V91, P2532, DOI 10.1529/biophysj.106.085688; Horcas I, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2432410; Ivanovska IL, 2004, P NATL ACAD SCI USA, V101, P7600, DOI 10.1073/pnas.0308198101; Kontou M, 2005, J VIROL, V79, P10931, DOI 10.1128/JVI.79.17.10931-10943.2005; Melcher J, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.2938864; Moreno-Herrero F, 2002, APPL PHYS LETT, V81, P2620, DOI 10.1063/1.1509856; MULLER DJ, 1995, BIOPHYS J, V68, P1681, DOI 10.1016/S0006-3495(95)80345-0; OHNESORGE F, 1993, SCIENCE, V260, P1451, DOI 10.1126/science.260.5113.1451; Pugno NM, 2008, J PHYS CONDENSED MAT, V20; Purohit PK, 2003, P NATL ACAD SCI USA, V100, P3173, DOI 10.1073/pnas.0737893100; Roos WH, 2010, NAT PHYS, V6, P733, DOI 10.1038/NPHYS1797; Tang JH, 2008, STRUCTURE, V16, P935, DOI 10.1016/j.str.2008.02.024; VALPUESTA JM, 1994, Q REV BIOPHYS, V27, P107, DOI 10.1017/S0033583500004510; Villarrubia JS, 1997, J RES NATL INST STAN, V102, P425, DOI 10.6028/jres.102.030; Voitchovsky K, 2010, NAT NANOTECHNOL, V5, P401, DOI [10.1038/nnano.2010.67, 10.1038/NNANO.2010.67]; Xiang Y, 2006, EMBO J, V25, P5229, DOI 10.1038/sj.emboj.7601386; Xiao C, 2009, PLOS BIOL, V7, P958, DOI 10.1371/journal.pbio.1000092; Xu X, 2008, BIOPHYS J, V95, P2520, DOI 10.1529/biophysj.108.132829; Xu X, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.060801; YEAGER JG, 1979, APPL ENVIRON MICROB, V38, P694, DOI 10.1128/AEM.38.4.694-701.1979; Young M, 2008, ANNU REV PHYTOPATHOL, V46, P361, DOI 10.1146/annurev.phyto.032508.131939	34	33	34	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30204	10.1371/journal.pone.0030204	http://dx.doi.org/10.1371/journal.pone.0030204			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295076	Green Published, Green Submitted, gold			2022-12-27	WOS:000301640600021
J	Sutherland, JS; Garba, D; Fombah, AE; Mendy-Gomez, A; Mendy, FS; Antonio, M; Townend, J; Ideh, RC; Corrah, T; Ota, MOC				Sutherland, Jayne S.; Garba, Danlani; Fombah, Augustin E.; Mendy-Gomez, Awa; Mendy, Francis S.; Antonio, Martin; Townend, John; Ideh, Readon C.; Corrah, Tumani; Ota, Martin O. C.			Highly Accurate Diagnosis of Pleural Tuberculosis by Immunological Analysis of the Pleural Effusion	PLOS ONE			English	Article							INTERFERON-GAMMA; T-LYMPHOCYTES; IFN-GAMMA; IP-10; INFECTION; UTILITY; RESPONSES; CYTOKINE; PROTEIN; SITES	Pleural TB is notoriously difficult to diagnose due to its paucibacillary nature yet it is the most common cause of pleural effusions in TB endemic countries such as The Gambia. We identified both cellular and soluble biomarkers in the pleural fluid that allowed highly accurate diagnosis of pleural TB compared to peripheral blood markers. Multi-plex cytokine analysis on unstimulated pleural fluid showed that IP-10 resulted in a positive likelihood ratio (LR) of 9.6 versus 2.8 for IFN-gamma; a combination of IP-10, IL-6 and IL-10 resulted in an AUC of 0.96 and positive LR of 10. A striking finding was the significantly higher proportion of PPD-specific IFN-gamma+TNF-alpha+ cell population (PPD-IGTA) in the pleural fluid compared to peripheral blood of TB subjects. Presence of this pleural PPD-IGTA population resulted in 95% correct classification of pleural TB disease with a sensitivity of 95% and specificity of 100%. These data suggest that analysis of the site of infection provides superior diagnostic accuracy compared to peripheral blood for pleural TB, likely due to the sequestration of effector cells at this acute stage of disease.	[Sutherland, Jayne S.; Garba, Danlani; Fombah, Augustin E.; Mendy-Gomez, Awa; Mendy, Francis S.; Antonio, Martin; Townend, John; Ideh, Readon C.; Corrah, Tumani; Ota, Martin O. C.] MRC Unit, Fajara, Gambia	University of London; London School of Hygiene & Tropical Medicine	Sutherland, JS (corresponding author), MRC Unit, Atlantic Rd, Fajara, Gambia.	jsutherland@mrc.gm		Sutherland, Jayne/0000-0002-7083-4997	MRC Unit, The Gambia; Medical Research Council [MC_U190071468, MC_UP_A900_1122, MC_U190081991, MC_U190074190] Funding Source: researchfish; MRC [MC_U190081991, MC_U190071468, MC_U190074190, MC_UP_A900_1122] Funding Source: UKRI	MRC Unit, The Gambia; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by the MRC Unit, The Gambia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002788; Barry SM, 2003, J INFECT DIS, V187, P243, DOI 10.1086/346112; Condos R, 1998, AM J RESP CRIT CARE, V157, P729, DOI 10.1164/ajrccm.157.3.9705044; Dheda K, 2009, EUR RESPIR J, V34, P1118, DOI 10.1183/09031936.00005309; Dheda K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004689; El Fenniri L, 2011, TUBERCULOSIS, V91, P224, DOI 10.1016/j.tube.2010.12.005; Hirsch CS, 2001, J INFECT DIS, V183, P779, DOI 10.1086/318817; Hodsdon WS, 2001, AIDS, V15, P467, DOI 10.1097/00002030-200103090-00005; John SH, 2011, BIOMARKERS      1108; Kalantri Y, 2011, INT J INFECT DIS, V15, pE226, DOI 10.1016/j.ijid.2010.11.011; Kapina MA, 2007, J IMMUNOL, V178, P976, DOI 10.4049/jimmunol.178.2.976; Krenke R, 2010, CURR OPIN PULM MED, V16, P367, DOI 10.1097/MCP.0b013e32833a7154; Nunn P, 2005, NAT REV IMMUNOL, V5, P819, DOI 10.1038/nri1704; Okamoto M, 2005, J LAB CLIN MED, V145, P88, DOI 10.1016/j.lab.2004.11.013; Porcel JM, 2011, RESPIROLOGY, V16, P44, DOI 10.1111/j.1440-1843.2010.01794.x; Porcel JM, 2010, EUR J INTERN MED, V21, P419, DOI 10.1016/j.ejim.2010.03.011; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; Ruhwald M, 2011, TUBERCULOSIS, V91, P260, DOI 10.1016/j.tube.2011.01.001; Supriya P, 2008, DIAGN MICR INFEC DIS, V62, P186, DOI 10.1016/j.diagmicrobio.2008.05.011; Sutherland JS, 2009, TUBERCULOSIS, V89, P398, DOI 10.1016/j.tube.2009.07.004; Toossi Z, 2011, CLIN EXP IMMUNOL, V163, P333, DOI 10.1111/j.1365-2249.2010.04269.x; Whittaker E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003901; WHO, 2010, WHO 2010 2011 TB FAC; WHO, WHO LAB BAS EV 19 CO	24	23	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30324	10.1371/journal.pone.0030324	http://dx.doi.org/10.1371/journal.pone.0030324			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295081	gold, Green Submitted, Green Published			2022-12-27	WOS:000301640600026
J	Agundez, L; Gonzalez-Prieto, C; Machon, C; Llosa, M				Agundez, Leticia; Gonzalez-Prieto, Coral; Machon, Cristina; Llosa, Matxalen			Site-Specific Integration of Foreign DNA into Minimal Bacterial and Human Target Sequences Mediated by a Conjugative Relaxase	PLOS ONE			English	Article							PROTEIN TRWC; PLASMID; RECOMBINATION; ORIGIN; ORIT; INCW; CLEAVAGE; BINDING	Background: Bacterial conjugation is a mechanism for horizontal DNA transfer between bacteria which requires cell to cell contact, usually mediated by self-transmissible plasmids. A protein known as relaxase is responsible for the processing of DNA during bacterial conjugation. TrwC, the relaxase of conjugative plasmid R388, is also able to catalyze site-specific integration of the transferred DNA into a copy of its target, the origin of transfer (oriT), present in a recipient plasmid. This reaction confers TrwC a high biotechnological potential as a tool for genomic engineering. Methodology/Principal Findings: We have characterized this reaction by conjugal mobilization of a suicide plasmid to a recipient cell with an oriT-containing plasmid, selecting for the cointegrates. Proteins TrwA and IHF enhanced integration frequency. TrwC could also catalyze integration when it is expressed from the recipient cell. Both Y18 and Y26 catalytic tyrosil residues were essential to perform the reaction, while TrwC DNA helicase activity was dispensable. The target DNA could be reduced to 17 bp encompassing TrwC nicking and binding sites. Two human genomic sequences resembling the 17 bp segment were accepted as targets for TrwC-mediated site-specific integration. TrwC could also integrate the incoming DNA molecule into an oriT copy present in the recipient chromosome. Conclusions/Significance: The results support a model for TrwC-mediated site-specific integration. This reaction may allow R388 to integrate into the genome of non-permissive hosts upon conjugative transfer. Also, the ability to act on target sequences present in the human genome underscores the biotechnological potential of conjugative relaxase TrwC as a site-specific integrase for genomic modification of human cells.	Univ Cantabria, Dept Biol Mol, E-39005 Santander, Spain; UC CSIC SODERCAN, Inst Biomed & Biotecnol Cantabria, Santander, Spain	Universidad de Cantabria; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC)	Agundez, L (corresponding author), Kings Coll London, Sch Med, London WC2R 2LS, England.	llosam@unican.es	Sobrado, Cristina Machón/K-1634-2014; Gonzalez-Prieto, Coral/ABD-1690-2020; , matxalen/ABG-5541-2020	Sobrado, Cristina Machón/0000-0001-5363-2958; , matxalen/0000-0002-4826-2240	Spanish Ministry of Science and Innovation [BIO2008-00133]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by grant BIO2008-00133 from the Spanish Ministry of Science and Innovation to ML. CGP was a recipient of a predoctoral fellowship from the University of Cantabria, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agundez L, 2011, APPL ENVIRON MICROB, V77, P201, DOI 10.1128/AEM.01371-10; BUCHANANWOLLASTON V, 1987, NATURE, V328, P172, DOI 10.1038/328172a0; CAMPBELL JL, 1978, P NATL ACAD SCI USA, V75, P2276, DOI 10.1073/pnas.75.5.2276; Cesar CE, 2007, J BACTERIOL, V189, P9037, DOI 10.1128/JB.01152-07; Cesar CE, 2006, MOL MICROBIOL, V62, P984, DOI 10.1111/j.1365-2958.2006.05437.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DELORENZO V, 1994, METHOD ENZYMOL, V235, P386; Demarre G, 2005, RES MICROBIOL, V156, P245, DOI 10.1016/j.resmic.2004.09.007; Draper O, 2005, P NATL ACAD SCI USA, V102, P16385, DOI 10.1073/pnas.0506081102; Garcillan-Barcia MP, 2009, FEMS MICROBIOL REV, V33, P657, DOI 10.1111/j.1574-6976.2009.00168.x; Gonzalez-Perez B, 2007, EMBO J, V26, P3847, DOI 10.1038/sj.emboj.7601806; GRANDOSO G, 1994, EUR J BIOCHEM, V226, P403, DOI 10.1111/j.1432-1033.1994.tb20065.x; Grandoso G, 2000, J MOL BIOL, V295, P1163, DOI 10.1006/jmbi.1999.3425; GRANT SGN, 1990, P NATL ACAD SCI USA, V87, P4645, DOI 10.1073/pnas.87.12.4645; Guasch A, 2003, NAT STRUCT BIOL, V10, P1002, DOI 10.1038/nsb1017; HEINEMANN JA, 1989, NATURE, V340, P205, DOI 10.1038/340205a0; Kolb Andreas F., 2002, Cloning and Stem Cells, V4, P65, DOI 10.1089/153623002753632066; Llosa M, 2002, MOL MICROBIOL, V45, P1, DOI 10.1046/j.1365-2958.2002.03014.x; Llosa M, 2005, RES MICROBIOL, V156, P1, DOI 10.1016/j.resmic.2004.07.008; LLOSA M, 1994, J BACTERIOL, V176, P3210, DOI 10.1128/jb.176.11.3210-3217.1994; LLOSA M, 1991, MOL GEN GENET, V226, P473, DOI 10.1007/BF00260661; Llosa M, 1996, J MOL BIOL, V264, P56, DOI 10.1006/jmbi.1996.0623; Lucas M, 2010, J BIOL CHEM, V285, P8918, DOI 10.1074/jbc.M109.057539; Miyazaki R, 2011, MOL MICROBIOL, V79, P743, DOI 10.1111/j.1365-2958.2010.07484.x; Moncalian G, 2004, BBA-PROTEINS PROTEOM, V1701, P15, DOI 10.1016/j.bbapap.2004.05.009; Moncalian G, 1997, J MOL BIOL, V270, P188, DOI 10.1006/jmbi.1997.1082; Moncalian G, 1999, MOL MICROBIOL, V31, P1643, DOI 10.1046/j.1365-2958.1999.01288.x; Platt R, 2000, PLASMID, V43, P12, DOI 10.1006/plas.1999.1433; Sambrook J., 2001, MOL CLONING LAB MANU, V3; Waters VL, 2001, NAT GENET, V29, P375, DOI 10.1038/ng779	30	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e31047	10.1371/journal.pone.0031047	http://dx.doi.org/10.1371/journal.pone.0031047			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22292089	Green Published, gold			2022-12-27	WOS:000301570600106
J	Barennes, H; Empis, G; Quang, TD; Sengkhamyong, K; Phasavath, P; Harimanana, A; Sambany, EM; Koffi, PN				Barennes, Hubert; Empis, Gwenaelle; Thao Duong Quang; Sengkhamyong, Khouanheuan; Phasavath, Phonethepa; Harimanana, Aina; Sambany, Emercia M.; Koffi, Paulin N.			Breast-Milk Substitutes: A New Old-Threat for Breastfeeding Policy in Developing Countries. A Case Study in a Traditionally High Breastfeeding Country	PLOS ONE			English	Article							UNDERNUTRITION; PROMOTION	Background: Developing countries with traditionally breastfeeding are now experiencing the increasing pressure of formula milk marketing. This may endanger lives and undermine the efforts of national policies in achieving the objectives of the Millennium Development Goals. We examined the use of, and factors for use, of all available breast-milk substitutes (BMS) in a country with a traditionally high rate of breastfeeding. Methods: Randomised multi-stage sampling surveys in 90 villages in 12/17 provinces in Laos. Participants: 1057 mothers with infants under 24 months of age. Tools: 50-query questionnaire and a poster of 22 BMS (8 canned or powdered milk; 6 non-dairy; 6 formulas; 2 non-formulas). Outcome measures included: prevalence of use and age of starting BMS in relation to socio-demographic characteristics and information sources, by univariate and multivariate analyses. Results: Of 1057 mothers: 72.5% currently breastfed; 25.4% gave BMS (10.6% infant formula); 19.6% gave BMS before 6 months of age (of them: 83% non-dairy or cereals; mean age: 2.9 months; 95% Confidence interval: 2.6-3.2). One formula and one non-formula product accounted for 85% of BMS. BMS were considered as milk by the majority of mothers. Thai TV was the main source of information on BMS for mothers. Lao Loum mothers (the main ethnic group) living in concrete houses with good sanitary conditions, were more likely than others to use BMS before 6 months (OR: 1.79, (1.15-2.78), p<0.009). Mothers who fed their infants colostrum at birth were less likely to use BMS before 6 months of age (OR: 0.63, (0.41-0.99), p = 0.04). Unemployed mothers living in rural areas were less likely to consider BMS better than breast milk. Conclusion: In Laos, mothers with the highest socio-economic status are showing a tendency to give up breastfeeding. Successful educational strategies and advocacy measures should be urgently developed to promote and sustain breastfeeding in developing countries.	[Barennes, Hubert; Empis, Gwenaelle; Thao Duong Quang; Sengkhamyong, Khouanheuan; Phasavath, Phonethepa; Harimanana, Aina; Sambany, Emercia M.; Koffi, Paulin N.] Inst Francophonie Med Trop, Viangchan, Laos; [Barennes, Hubert] INSERM 897 VIH Afr VIH, VIH, Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm)	Barennes, H (corresponding author), Inst Francophonie Med Trop, Viangchan, Laos.	barenneshub@yahoo.fr			Agence Universitaire de la Francophonie; United Nations Children's Fund; Institut Francophone pour la Medecine Tropicale	Agence Universitaire de la Francophonie; United Nations Children's Fund; Institut Francophone pour la Medecine Tropicale	Funding provided by Agence Universitaire de la Francophonie, the United Nations Children's Fund, Institut Francophone pour la Medecine Tropicale. Funding agencies had no role in the decision of publishing the paper. Opinions expressed in the paper do not represent the opinion of funding agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora S, 2008, PEDIATRICS, V1065, pE67; Barennes H, 2009, EUR J CLIN NUTR, V63, P323, DOI 10.1038/sj.ejcn.1602928; Barennes H, 2008, ARCH DIS CHILD, V953, P222; Barennes H, 2009, BMJ; Barennes H, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1379; Bhutta Z.A., 2008, LANCET, V371, P417, DOI [10.1016/S0140-6736(07)61693-6, DOI 10.1016/S0140-6736(07)61693-6]; Black MM, 2008, LANCET, V371, P454, DOI 10.1016/S0140-6736(08)60215-9; Coutinho SB, 2005, LANCET, V366, P1094, DOI 10.1016/S0140-6736(05)67421-1; Coutsoudis A, 2009, LANCET, V374, P423, DOI 10.1016/S0140-6736(09)60661-9; Foss KA, 2006, INT BREASTFEED J, V1, DOI 10.1186/1746-4358-1-10; Holmes W, 2007, ASIA PAC J CLIN NUTR, V16, P537; IBFAN, 2011, COD ESS 2 GUID POLYC, P1; IBFAN, 2009, INT COD MARK BREAST; Kuhn L, 2008, NEW ENGL J MED, V359, P130, DOI 10.1056/NEJMoa073788; Kuhn L, 2009, CURR OPIN PEDIATR, V21, P83, DOI 10.1097/MOP.0b013e328320d894; Lao voices, 2010, GOV UNICEF LAUNCH EX; Miyoshi M, 2005, EUR J CLIN NUTR, V59, P887, DOI 10.1038/sj.ejcn.1602160; National Statistic Center, 2005, POP CENS; Petrova A, 2007, BREASTFEED MED, V2, P92, DOI 10.1089/bfm.2006.0030; Phimmasone K, 1996, J TROP PEDIATRICS, V42, P5, DOI 10.1093/tropej/42.1.5; Putthakeo P, 2009, J PAEDIATR CHILD H, V45, P487, DOI 10.1111/j.1440-1754.2009.01547.x; Salud MALB, 2009, J HUM LACT, V25, P341, DOI 10.1177/0890334409334605; Sayasone Somphou, 2004, Southeast Asian J Trop Med Public Health, V35 Suppl 2, P50; Slesak G, 2008, MISUSE COFFEE CREAME; Soukaloun D, 2003, ANN TROP PAEDIATR, V23, P181, DOI 10.1179/027249303322296493; Srour LM, 2009, BMJ; Stiegler R, 2009, BMJ; Stiegler R, 2008, BMJ; UNICEF, 2006, MICS3NNS UNICEF; UNICEF, 2006, EXCL BREASTF; UNICEF, 2003, UNICEF GLOB DAT BREA; UNICEF, 2009, UNICEF GLOB DAT BREA; WHO-WORLD HEALTH ORGANIZATION, 2002, OPT DUR EXCL BREASTF; World Food Programme, 2007, LAO PDR COMPR FOOD S	34	33	33	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2012	7	2							e30634	10.1371/journal.pone.0030634	http://dx.doi.org/10.1371/journal.pone.0030634			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZQ	22347392	Green Published, Green Submitted, gold			2022-12-27	WOS:000302730200005
J	Eguchi, M; Kim, YH; Kang, KW; Shim, CY; Jang, Y; Dorval, T; Kim, KJ; Sweeney, G				Eguchi, Megumi; Kim, Young Hwa; Kang, Keon Wook; Shim, Chi Young; Jang, Yangsoo; Dorval, Thierry; Kim, Kwang Joon; Sweeney, Gary			Ischemia-Reperfusion Injury Leads to Distinct Temporal Cardiac Remodeling in Normal versus Diabetic Mice	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; MONOCYTIC FIBROBLAST PRECURSORS; ISCHEMIA/REPERFUSION INJURY; OXIDATIVE STRESS; HEART-FAILURE; AUTOPHAGY; FIBROSIS; MECHANISMS; GLUCOSE; PATHOGENESIS	Diabetes is associated with higher incidence of myocardial infarction (MI) and increased propensity for subsequent events post-MI. Here we conducted a temporal analysis of the influence of diabetes on cardiac dysfunction and remodeling after ischemia reperfusion (IR) injury in mice. Diabetes was induced using streptozotocin and IR performed by ligating the left anterior descending coronary artery for 30 min followed by reperfusion for up to 42 days. We first evaluated changes in cardiac function using echocardiography after 24 hours reperfusion and observed IR injury significantly decreased the systolic function, such as ejection fraction, fractional shortening and end systolic left ventricular volume (LVESV) in both control and diabetic mice. The longitudinal systolic and diastolic strain rate were altered after IR, but there were no significant differences between diabetic mice and controls. However, a reduced ability to metabolize glucose was observed in the diabetic animals as determined by PET-CT scanning using 2-deoxy-2-(F-18) fluoro-D-glucose. Interestingly, after 24 hours reperfusion diabetic mice showed a reduced infarct size and less apoptosis indicated by TUNEL analysis in heart sections. This may be explained by increased levels of autophagy detected in diabetic mice hearts. Similar increases in IR-induced macrophage infiltration detected by CD68 staining indicated no change in inflammation between control and diabetic mice. Over time, control mice subjected to IR developed mild left ventricular dilation whereas diabetic mice exhibited a decrease in both end diastolic left ventricular volume and LVESV with a decreased intraventricular space and thicker left ventricular wall, indicating concentric hypertrophy. This was associated with marked increases in fibrosis, indicted by Masson trichrome staining, of heart sections in diabetic IR group. In summary, we demonstrate that diabetes principally influences distinct IR-induced chronic changes in cardiac function and remodeling, while a smaller infarct size and elevated levels of autophagy with similar cardiac function are observed in acute phase.	[Eguchi, Megumi; Dorval, Thierry; Sweeney, Gary] Inst Pasteur Korea, Seoul, South Korea; [Kim, Young Hwa; Kang, Keon Wook] Seoul Natl Univ, Coll Med, Dept Nucl Med, Seoul, South Korea; [Shim, Chi Young; Jang, Yangsoo] Yonsei Univ, Coll Med, Div Cardiol, Seoul, South Korea; [Kim, Kwang Joon] Yonsei Univ, Coll Med, Div Endocrinol, Seoul, South Korea; [Eguchi, Megumi; Sweeney, Gary] York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada	Institut Pasteur Korea; Seoul National University (SNU); Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; York University - Canada	Eguchi, M (corresponding author), Inst Pasteur Korea, Seoul, South Korea.	gsweeney@yorku.ca	Kang, Keon Wook/J-1385-2012; Jang, Yang Soo/D-4803-2012; Shim, Chi Young/AAK-1057-2021	Kang, Keon Wook/0000-0003-2622-9017; Shim, Chi Young/0000-0002-6136-0136; Jang, Yangsoo/0000-0002-2169-3112	Canadian Diabetes Association; National Research Foundation of Korea (NRF); Korea government (MEST) [2011-00244]; Gyeonggi-do; KISTI; Heart and Stroke Foundation of Canada	Canadian Diabetes Association; National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Gyeonggi-do; KISTI(Korea Institute of Science & Technology Information (KISTI)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	This work was supported by a Canadian Diabetes Association grant to GS, and by a National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (No. 2011-00244), Gyeonggi-do and KISTI. ME was supported by a Heart and Stroke Foundation of Canada postgraduate studentship award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel ED, 2008, PHYSIOL REV, V88, P389, DOI 10.1152/physrev.00017.2007; Aneja A, 2008, AM J MED, V121, P748, DOI 10.1016/j.amjmed.2008.03.046; Aragno M, 2008, ENDOCRINOLOGY, V149, P380, DOI 10.1210/en.2007-0877; Ban CR, 2008, VASC HEALTH RISK MAN, V4, P575; Boudina S, 2009, CIRCULATION, V119, P1272, DOI 10.1161/CIRCULATIONAHA.108.792101; Breckenridge R, 2010, DIS MODEL MECH, V3, P138, DOI 10.1242/dmm.005017; BRODERICK TL, 1993, CIRCULATION, V87, P972, DOI 10.1161/01.CIR.87.3.972; Bugger H, 2009, DIS MODEL MECH, V2, P454, DOI 10.1242/dmm.001941; Carvalho G, 2011, J CLIN ENDOCR METAB, V96, P1469, DOI 10.1210/jc.2010-1934; Cleland JGF, 2005, HEART, V91, P7, DOI 10.1136/hrt.2005.062026; Dahab GM, 2004, J GASTROEN HEPATOL, V19, P78, DOI 10.1111/j.1440-1746.2004.03183.x; FINEGAN BA, 1993, CIRCULATION, V87, P900, DOI 10.1161/01.CIR.87.3.900; Fisher BM, 1997, DIABETOLOGIA, V40, pS127, DOI 10.1007/s001250051427; Flaherty JD, 2005, JAMA-J AM MED ASSOC, V293, P1501, DOI 10.1001/jama.293.12.1501; FOY SG, 1995, EUR HEART J, V16, P770, DOI 10.1093/oxfordjournals.eurheartj.a060995; Frangogiannis NG, 2002, CARDIOVASC RES, V53, P31, DOI 10.1016/S0008-6363(01)00434-5; Geyer H, 2010, J AM SOC ECHOCARDIOG, V23, P351, DOI 10.1016/j.echo.2010.02.015; Gottlieb RA, 2010, ANNU REV PHYSIOL, V72, P45, DOI 10.1146/annurev-physiol-021909-135757; Gustafsson AB, 2003, J CLIN IMMUNOL, V23, P447, DOI 10.1023/B:JOCI.0000010421.56035.60; Gustafsson AB, 2008, AUTOPHAGY, V4, P416, DOI 10.4161/auto.5655; Hamacher-Brady A, 2006, J BIOL CHEM, V281, P29776, DOI 10.1074/jbc.M603783200; Haudek SB, 2010, J MOL CELL CARDIOL, V49, P499, DOI 10.1016/j.yjmcc.2010.05.005; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kantor PF, 1999, AM J MED SCI, V318, P3, DOI 10.1097/00000441-199907000-00002; Katayama T, 2005, INT HEART J, V46, P607, DOI 10.1536/ihj.46.607; Kofoed KF, 2000, CARDIOVASC RES, V45, P321, DOI 10.1016/S0008-6363(99)00278-3; Kostin S, 2003, CIRC RES, V92, P715, DOI 10.1161/01.RES.0000067471.95890.5C; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li QA, 2010, ACTA CARDIOL, V65, P431, DOI 10.2143/AC.65.4.2053902; LOPASCHUK GD, 1988, CIRC RES, V63, P1036, DOI 10.1161/01.RES.63.6.1036; LOPASCHUK GD, 1990, CIRC RES, V66, P546, DOI 10.1161/01.RES.66.2.546; Lutz J, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-27; Matsui Y, 2007, CIRC RES, V100, P914, DOI 10.1161/01.RES.0000261924.76669.36; Nishida K, 2009, CELL DEATH DIFFER, V16, P31, DOI 10.1038/cdd.2008.163; PFEFFER MA, 1995, ANNU REV MED, V46, P455, DOI 10.1146/annurev.med.46.1.455; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Ren JY, 2011, AM J HYPERTENS, V24, P701, DOI 10.1038/ajh.2011.42; Salih DAM, 2008, CURR OPIN CELL BIOL, V20, P126, DOI 10.1016/j.ceb.2008.02.005; SECHI LA, 1994, DIABETES, V43, P1180, DOI 10.2337/diabetes.43.10.1180; SISLEY AC, 1994, J SURG RES, V57, P192, DOI 10.1006/jsre.1994.1130; Sugimoto S, 2007, AUTOPHAGY, V3, P638, DOI 10.4161/auto.4931; Taha M, 2007, ANN MED, V39, P594, DOI 10.1080/07853890701618305; Verma A, 2007, J AM COLL CARDIOL, V50, P1238, DOI 10.1016/j.jacc.2007.06.018; Verma A, 2008, JACC-CARDIOVASC IMAG, V1, P582, DOI 10.1016/j.jcmg.2008.05.012; WEBER KT, 1991, CIRCULATION, V83, P1849, DOI 10.1161/01.CIR.83.6.1849; Whelan RS, 2010, ANNU REV PHYSIOL, V72, P19, DOI 10.1146/annurev.physiol.010908.163111; Yan L, 2005, P NATL ACAD SCI USA, V102, P13807, DOI 10.1073/pnas.0506843102; Zhu HX, 2007, J CLIN INVEST, V117, P1782, DOI 10.1172/JCI27523	48	32	34	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e30450	10.1371/journal.pone.0030450	http://dx.doi.org/10.1371/journal.pone.0030450			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347376	Green Published, gold, Green Submitted			2022-12-27	WOS:000302730100011
J	Park, J; Park, DC; Polk, TA				Park, Joonkoo; Park, Denise C.; Polk, Thad A.			Investigating Unique Environmental Contributions to the Neural Representation of Written Words: A Monozygotic Twin Study	PLOS ONE			English	Article							FORM AREA; FUSIFORM GYRUS; LANGUAGE; CORTEX; FMRI; ORGANIZATION; RECOGNITION; SENSITIVITY; CHILDREN; SHAPES	The visual word form area (VWFA) is a region of left inferior occipitotemporal cortex that is critically involved in visual word recognition. Previous studies have investigated whether and how experience shapes the functional characteristics of VWFA by comparing neural response magnitude in response to words and nonwords. Conflicting results have been obtained, however, perhaps because response magnitude can be influenced by other factors such as attention. In this study, we measured neural activity in monozygotic twins, using functional magnetic resonance imaging. This allowed us to quantify differences in unique environmental contributions to neural activation evoked by words, pseudowords, consonant strings, and false fonts in the VWFA and striate cortex. The results demonstrate significantly greater effects of unique environment in the word and pseudoword conditions compared to the consonant string and false font conditions both in VWFA and in left striate cortex. These findings provide direct evidence for environmental contributions to the neural architecture for reading, and suggest that learning phonology and/or orthographic patterns plays the biggest role in shaping that architecture.	[Park, Joonkoo; Polk, Thad A.] Univ Michigan, Dept Psychol, Ann Arbor, MI USA; [Park, Denise C.] Univ Texas Dallas, Ctr Vital Longev, Dallas, TX 75230 USA	University of Michigan System; University of Michigan; University of Texas System; University of Texas Dallas	Park, J (corresponding author), Duke Univ, Ctr Cognit Neurosci, Durham, NC 27708 USA.	Joonkoo.park@duke.edu		Park, Joonkoo/0000-0002-6703-3961	National Institute on Aging [3R37AG006265]; NATIONAL INSTITUTE ON AGING [R37AG006265] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was partly supported by grant 3R37AG006265 from the National Institute on Aging to D. C. P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker CI, 2007, P NATL ACAD SCI USA, V104, P9087, DOI 10.1073/pnas.0703300104; Ben-Shachar M, 2007, CEREB CORTEX, V17, P1604, DOI 10.1093/cercor/bhl071; Binder JR, 2006, NEUROIMAGE, V33, P739, DOI 10.1016/j.neuroimage.2006.06.053; Bolger DJ, 2005, HUM BRAIN MAPP, V25, P92, DOI 10.1002/hbm.20124; Brem S, 2010, P NATL ACAD SCI USA, V107, P7939, DOI 10.1073/pnas.0904402107; Cohen L, 2002, BRAIN, V125, P1054, DOI 10.1093/brain/awf094; DEFRIES JC, 1987, NATURE, V329, P537, DOI 10.1038/329537a0; Dehaene S, 2007, NEURON, V56, P384, DOI 10.1016/j.neuron.2007.10.004; Dehaene S, 2011, TRENDS COGN SCI, V15, P254, DOI 10.1016/j.tics.2011.04.003; Dehaene S, 2010, SCIENCE, V330, P1359, DOI 10.1126/science.1194140; Falconer DS, 1996, INTRO QUANTITATIVE G, P160; Hashimoto R, 2004, NEURON, V42, P311, DOI 10.1016/S0896-6273(04)00196-5; Jobard G, 2003, NEUROIMAGE, V20, P693, DOI 10.1016/S1053-8119(03)00343-4; Kronbichler M, 2004, NEUROIMAGE, V21, P946, DOI 10.1016/j.neuroimage.2003.10.021; McCandliss BD, 2003, TRENDS COGN SCI, V7, P293, DOI 10.1016/S1364-6613(03)00134-7; Mechelli A, 2000, P ROY SOC B-BIOL SCI, V267, P1909, DOI 10.1098/rspb.2000.1229; NOBRE AC, 1994, NATURE, V372, P260, DOI 10.1038/372260a0; Park J, 2012, NEUROIMAGE, V59, P1132, DOI 10.1016/j.neuroimage.2011.06.066; PLOMIN R, 1987, BEHAV BRAIN SCI, V10, P1, DOI 10.1017/S0140525X00055941; Plomin R., 1994, SEPARATE SOCIAL WORL, P1; Polk TA, 1998, P NATL ACAD SCI USA, V95, P847, DOI 10.1073/pnas.95.3.847; Polk TA, 2002, J EXP PSYCHOL GEN, V131, P65, DOI 10.1037//0096-3445.131.1.65; Price CJ, 2011, TRENDS COGN SCI, V15, P246, DOI 10.1016/j.tics.2011.04.001; Price CJ, 2003, NEUROIMAGE, V19, P473, DOI 10.1016/S1053-8119(03)00084-3; Scarr S., 1982, SIBLING RELATIONSHIP, P357; Schlaggar BL, 2007, ANNU REV NEUROSCI, V30, P475, DOI 10.1146/annurev.neuro.28.061604.135645; Starrfelt R, 2007, BRAIN LANG, V102, P52, DOI 10.1016/j.bandl.2006.09.005; Vinckier F, 2007, NEURON, V55, P143, DOI 10.1016/j.neuron.2007.05.031; Xue G, 2007, J COGNITIVE NEUROSCI, V19, P1643, DOI 10.1162/jocn.2007.19.10.1643; Xue G, 2006, NEUROIMAGE, V31, P1315, DOI 10.1016/j.neuroimage.2005.11.055	30	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31512	10.1371/journal.pone.0031512	http://dx.doi.org/10.1371/journal.pone.0031512			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347490	Green Published, gold, Green Submitted			2022-12-27	WOS:000302730100078
J	Liu, Q; Chen, P; He, K; Kilpatrick, CW; Liu, SY; Yu, FH; Jiang, XL				Liu, Qi; Chen, Peng; He, Kai; Kilpatrick, C. William; Liu, Shao-Ying; Yu, Fa-Hong; Jiang, Xue-Long			Phylogeographic Study of Apodemus ilex (Rodentia: Muridae) in Southwest China	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; POPULATION-GROWTH; GENETIC CONSEQUENCES; MOLECULAR PHYLOGENY; TIME DEPENDENCY; ICE-AGES; COLONIZATION; DIVERGENCE; SOFTWARE; REFUGIA	Background: The Mountains of southwest China have complex river systems and a profoundly complex topography and are among the most important biodiversity hotspots in the world. However, only a few studies have shed light on how the mountains and river valleys promote genetic diversity. Apodemus ilex is a fine model for investigating this subject. Methodology/Principal Findings: To assess the genetic diversity and biogeographic patterns of Apodemus ilex, the complete cytochrome b gene sequences (1,140 bp) were determined from 203 samples of A. draco/ilex that were collected from southwest China. The results obtained suggested that A. ilex and A. draco are sistergroups and diverged from each other approximately 2.25 million years ago. A. ilex could be divided into Eastern and Western phylogroups, each containing two sub-groups and being widespread in different geographical regions of the southern Hengduan Mountains and the western Yunnan -Guizhou Plateau. The population expansions of A. ilex were roughly from 0.089 Mya to 0.023 Mya. Conclusions: Our result suggested that A. ilex is a valid species rather than synonym of A. draco. As a middle-high elevation inhabitant, the phylogenetic pattern of A. ilex was strongly related to the complex geographical structures in southwest China, particularly the existence of deep river valley systems, such as the Mekong and Salween rivers. Also, it appears that the evolutionary history of A. ilex, such as lineage divergences and population expansions were strongly affected by climate fluctuation in the Late Pleistocene.	[Liu, Qi; Chen, Peng; He, Kai; Jiang, Xue-Long] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Yunnan, Peoples R China; [Liu, Qi; Chen, Peng; He, Kai] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Kilpatrick, C. William] Univ Vermont, Dept Biol, Burlington, VT USA; [Liu, Shao-Ying] Sichuan Acad Forestry, Chengdu, Peoples R China; [Yu, Fa-Hong] Univ Florida, Interdisciplinary Ctr Biotechnol Res, Gainesville, FL USA	Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Vermont; State University System of Florida; University of Florida	Liu, Q (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Yunnan, Peoples R China.	fyu@ufl.edu; jiangxl@mail.kiz.ac.cn	He, Kai/H-3164-2019	He, Kai/0000-0002-6234-2589	National Natural Science Foundation of China [30770251]; National Basic Research Program of China [2007CB411600]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by grants from the National Natural Science Foundation of China (30770251) and the National Basic Research Program of China (2007CB411600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen GM, 1938, ANN MUS NAT HIST NEW, V26, P1; An ZS, 1999, SCI CHINA SER D, V42, P258, DOI 10.1007/BF02878963; Assefa A, 2007, HEREDITY, V99, P133, DOI 10.1038/sj.hdy.6800974; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Axelrod D. I., 1998, HIST MODERN FLORA CH, P43; Baker RJ, 2006, J MAMMAL, V87, P643, DOI 10.1644/06-MAMM-F-038R2.1; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barrett-Hamilton GEH, 1900, P ZOOL SOC LOND, V1900, P387; Benton MJ, 2007, MOL BIOL EVOL, V24, P26, DOI 10.1093/molbev/msl150; Bettin O, 2007, MOL ECOL, V16, P2517, DOI 10.1111/j.1365-294X.2007.03273.x; Brandley MC, 2005, SYST BIOL, V54, P373, DOI 10.1080/10635150590946808; Cerling TE, 1997, NATURE, V389, P153, DOI 10.1038/38229; Chen W, 2011, J ZOOL, V284, P215, DOI 10.1111/j.1469-7998.2011.00797.x; Chen WC, 2010, ZOOL SCI, V27, P487, DOI 10.2108/zsj.27.487; Clark MK, 2004, TECTONICS, V23, DOI 10.1029/2002TC001402; Corbet G.B., 1992, P1; CORBET G. B., 1978, MAMMALS PALAEARCTIC; DON RH, 1991, NUCLEIC ACIDS RES, V19, P4008, DOI 10.1093/nar/19.14.4008; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fan ZX, 2011, GENETICA, V139, P339, DOI 10.1007/s10709-011-9553-5; Forster P, 2004, PHILOS T R SOC B, V359, P255, DOI 10.1098/rstb.2003.1394; Fu YX, 1997, GENETICS, V147, P915; Gomez A, 2007, PHYLOGEOGRAPHY OF SOUTHERN EUROPEAN REFUGIA, P155, DOI 10.1007/1-4020-4904-8_5; Grill A, 2009, MOL ECOL, V18, P2687, DOI 10.1111/j.1365-294X.2009.04215.x; Gu XD, 2009, CONSERV GENET, V10, P1961, DOI 10.1007/s10592-009-9868-2; HARPENDING HC, 1994, HUM BIOL, V66, P591; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Ho SYW, 2007, SYST BIOL, V56, P515, DOI 10.1080/10635150701435401; Ho SYW, 2007, J AVIAN BIOL, V38, P409, DOI 10.1111/j.2007.0908-8857.04168.x; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; Holderegger R, 2009, J BIOGEOGR, V36, P476, DOI 10.1111/j.1365-2699.2008.02027.x; Huelsenbeck JP, 2004, SYST BIOL, V53, P904, DOI 10.1080/10635150490522629; IRWIN DM, 1991, J MOL EVOL, V32, P128, DOI 10.1007/BF02515385; Jiang Xue-Long, 2000, Zoological Research, V21, P473; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Li BY., 1989, J MOUNTAIN RES, V7, P13; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu XM, 2004, MOL PHYLOGENET EVOL, V33, P1, DOI 10.1016/j.ympev.2004.05.011; Martin-Suarez E, 1998, LETHAIA, V31, P161, DOI 10.1111/j.1502-3931.1998.tb00503.x; McCormack J., 2009, ENCY ISLANDS, P841, DOI [10.1525/j.ctt1pn90r, DOI 10.1525/J.CTT1PN90R]; McCormack JE, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-28; Michaux JR, 2003, MOL ECOL, V12, P685, DOI 10.1046/j.1365-294X.2003.01752.x; Miller M.A., 2010, P GAT COMP ENV WORKS; Musser G. G., 2005, MAMMAL SPECIES WORLD; Musser G.G., 1996, BONNER ZOOL BEITR, V46, P143; MUSSER GG, 1993, FAMILY MURIDAE, P501; Nesin Valentin A., 2001, Acta Zoologica Cracoviensia, V44, P107; NIXON KC, 1990, CLADISTICS, V6, P211, DOI 10.1111/j.1096-0031.1990.tb00541.x; Nylander J.A.A., 2004, MRMODELTEST V2 PROGR; Polzin T, 2002, LECT NOTES COMPUT SC, V2461, P795; Polzin T, 2003, OPER RES LETT, V31, P12, DOI 10.1016/S0167-6377(02)00185-2; Qu Y, 2010, MOL ECOL, V19, P338, DOI 10.1111/j.1365-294X.2009.04445.x; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Riddle BR, 2000, P NATL ACAD SCI USA, V97, P14438, DOI 10.1073/pnas.250413397; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rull V, 2009, J BIOGEOGR, V36, P481, DOI 10.1111/j.1365-2699.2008.02023.x; Sakka H, 2010, BIOL J LINN SOC, V100, P797, DOI 10.1111/j.1095-8312.2010.01477.x; Sambrook J, 1989, MOL CLONING LAB MANU, V2nd; Serizawa K, 2002, BIOCHEM GENET, V40, P149, DOI 10.1023/A:1015841424598; Song G, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-143; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stewart JR, 2009, J EVOLUTION BIOL, V22, P2363, DOI 10.1111/j.1420-9101.2009.01859.x; Stewart JR, 2010, P ROY SOC B-BIOL SCI, V277, P661, DOI 10.1098/rspb.2009.1272; Stewart JR, 2003, SCIENCE, V299, P825; Suzuki H, 2003, BIOL J LINN SOC, V80, P469, DOI 10.1046/j.1095-8312.2003.00253.x; Suzuki H, 2008, BIOCHEM GENET, V46, P329, DOI 10.1007/s10528-008-9149-7; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thomas O., 1922, Annals & Magazine of Natural History, V10, P391; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Thompson LG, 1997, SCIENCE, V276, P1821, DOI 10.1126/science.276.5320.1821; WRIGHT S, 1978, P580; Wu CH, 2000, BIOCHEM GENET, V38, P149; Wu FY, 2008, ACTA PETROL SIN, V24, P1; Wu YQ, 2001, GEOMORPHOLOGY, V36, P203, DOI 10.1016/S0169-555X(00)00057-X; XIA W, 1984, Acta Theriologica Sinica, V4, P93; Yamada K, 2005, PALAEOGEOGR PALAEOCL, V220, P255, DOI 10.1016/j.palaeo.2005.01.006; Yao YG, 2002, AM J HUM GENET, V70, P635, DOI 10.1086/338999; [姚永慧 Yao Yonghui], 2010, [山地学报, Journal of Mountain Science], V28, P11; Yuan SL, 2006, MOL ECOL, V15, P2119, DOI 10.1111/j.1365-294X.2006.02875.x; Zhang DR, 2010, MOL ECOL, V19, P3406, DOI 10.1111/j.1365-294X.2010.04747.x; Zhang MW, 2010, MOL PHYLOGENET EVOL, V54, P47, DOI 10.1016/j.ympev.2009.10.019; Zhang R. Z., 1999, ZOOGEOGRAPHY CHINA; Zhang Rong-Zu (Yong-Zu), 2002, Acta Zoologica Sinica, V48, P141; Zhao E., 1997, AMPHIBIANS REPTILES; [赵希涛 ZHAO Xitao], 2007, [地质通报, Geological Bulletin of China], V26, P960; [赵希涛 Zhao Xitao], 2007, [第四纪研究, Quaternary Sciences], V27, P35	94	28	37	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2012	7	2							e31453	10.1371/journal.pone.0031453	http://dx.doi.org/10.1371/journal.pone.0031453			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917MF	22347481	Green Published, gold, Green Submitted			2022-12-27	WOS:000302180600037
J	Powell, E; Shanle, E; Brinkman, A; Li, J; Keles, S; Wisinski, KB; Huang, W; Xu, W				Powell, Emily; Shanle, Erin; Brinkman, Ashley; Li, Jun; Keles, Sunduz; Wisinski, Kari B.; Huang, Wei; Xu, Wei			Identification of Estrogen Receptor Dimer Selective Ligands Reveals Growth-Inhibitory Effects on Cells That Co-Express ER alpha and ER beta	PLOS ONE			English	Article							BREAST-CANCER CELLS; RED-CLOVER ISOFLAVONES; HUMAN PROSTATE-CANCER; GENE-EXPRESSION; QUANTITATIVE-ANALYSIS; MESSENGER-RNA; WILD-TYPE; PROLIFERATION; TAMOXIFEN; HETERODIMERS	Estrogens play essential roles in the progression of mammary and prostatic diseases. The transcriptional effects of estrogens are transduced by two estrogen receptors, ER alpha and ER beta, which elicit opposing roles in regulating proliferation: ER alpha is proliferative while ER beta is anti-proliferative. Exogenous expression of ER beta in ER alpha-positive cancer cell lines inhibits cell proliferation in response to estrogen and reduces xenografted tumor growth in vivo, suggesting that ER beta might oppose ER alpha's proliferative effects via formation of ER alpha/beta heterodimers. Despite biochemical and cellular evidence of ER alpha/beta heterodimer formation in cells co-expressing both receptors, the biological roles of the ER alpha/beta heterodimer remain to be elucidated. Here we report the identification of two phytoestrogens that selectively activate ER alpha/beta heterodimers at specific concentrations using a cell-based, two-step high throughput small molecule screen for ER transcriptional activity and ER dimer selectivity. Using ER alpha/beta heterodimer-selective ligands at defined concentrations, we demonstrate that ER alpha/beta heterodimers are growth inhibitory in breast and prostate cells which co-express the two ER isoforms. Furthermore, using Automated Quantitative Analysis (AQUA) to examine nuclear expression of ER alpha and ER beta in human breast tissue microarrays, we demonstrate that ER alpha and ER beta are co-expressed in the same cells in breast tumors. The co-expression of ER alpha and ER beta in the same cells supports the possibility of ER alpha/beta heterodimer formation at physio- and pathological conditions, further suggesting that targeting ER alpha/beta heterodimers might be a novel therapeutic approach to the treatment of cancers which co-express ER alpha and ER beta.	[Powell, Emily; Shanle, Erin; Brinkman, Ashley; Li, Jun; Xu, Wei] Univ Wisconsin, McArdle Lab Canc Res, Madison, WI 53706 USA; [Keles, Sunduz] Univ Wisconsin, Dept Stat, Madison, WI 53706 USA; [Keles, Sunduz] Univ Wisconsin, Dept Biostat & Med Informat, Madison, WI USA; [Wisinski, Kari B.] Univ Wisconsin, Sch Med & Publ Hlth, UW Carbone Canc Ctr, Madison, WI USA; [Huang, Wei] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Powell, E (corresponding author), Univ Wisconsin, McArdle Lab Canc Res, 1400 Univ Ave, Madison, WI 53706 USA.	wxu@oncology.wisc.edu			National Institutes of Health [R01125387, T32ES007015, T32 CA009135]; NIH/NCI [P30CA014520]; NATIONAL CANCER INSTITUTE [P30CA014520, R01CA125387, T32CA009135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007015] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work is supported by National Institutes of Health grants R01125387, T32ES007015, T32 CA009135 and in part by NIH/NCI P30CA014520 - University of Wisconsin Comprehensive Cancer Center Support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aherne SA, 2002, NUTRITION, V18, P75, DOI 10.1016/S0899-9007(01)00695-5; Chang EC, 2008, MOL ENDOCRINOL, V22, P1032, DOI 10.1210/me.2007-0356; Chang EC, 2006, ENDOCRINOLOGY, V147, P4831, DOI 10.1210/en.2006-0563; Cowley SM, 1997, J BIOL CHEM, V272, P19858, DOI 10.1074/jbc.272.32.19858; Deroo BJ, 2006, J CLIN INVEST, V116, P561, DOI 10.1172/JCI27987; Forster C, 2002, P NATL ACAD SCI USA, V99, P15578, DOI 10.1073/pnas.192561299; Frasor J, 2006, CANCER RES, V66, P7334, DOI 10.1158/0008-5472.CAN-05-4269; FUCHS J, 1993, ARZNEIMITTELFORSCH, V43-1, P370; Grober OMV, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-36; Gustavson MD, 2009, APPL IMMUNOHISTO M M, V17, P329, DOI 10.1097/PAI.0b013e318195ecaa; Heinonen SM, 2004, J AGR FOOD CHEM, V52, P6802, DOI 10.1021/jf0492767; Heldring N, 2007, PHYSIOL REV, V87, P905, DOI 10.1152/physrev.00026.2006; Helguero LA, 2005, ONCOGENE, V24, P6605, DOI 10.1038/sj.onc.1208807; Hewitt SC, 2005, ANNU REV PHYSIOL, V67, P285, DOI 10.1146/annurev.physiol.67.040403.115914; Imamov O, 2004, P NATL ACAD SCI USA, V101, P9375, DOI 10.1073/pnas.0403041101; Iwao K, 2000, CANCER, V89, P1732, DOI 10.1002/1097-0142(20001015)89:8<1732::AID-CNCR13>3.0.CO;2-2; Iwao K, 2000, INT J CANCER, V88, P733, DOI 10.1002/1097-0215(20001201)88:5<733::AID-IJC8>3.0.CO;2-M; Jarvinen TAH, 2000, AM J PATHOL, V156, P29, DOI 10.1016/S0002-9440(10)64702-5; Jones SB, 2005, CANCER EPIDEM BIOMAR, V14, P596, DOI 10.1158/1055-9965.EPI-04-0398; Ju YH, 2006, CARCINOGENESIS, V27, P1292, DOI 10.1093/carcin/bgi370; Krege JH, 1998, P NATL ACAD SCI USA, V95, P15677, DOI 10.1073/pnas.95.26.15677; Lau KM, 2000, CANCER RES, V60, P3175; Lazennec G, 2001, ENDOCRINOLOGY, V142, P4120, DOI 10.1210/en.142.9.4120; Lee MM, 2003, CANCER EPIDEM BIOMAR, V12, P665; Lindberg MK, 2003, MOL ENDOCRINOL, V17, P203, DOI 10.1210/me.2002-0206; McPherson SJ, 2007, ERNST SCHERING FOUND, V1, P131, DOI 10.1007/2789_2006_020; Mentor-Marcel R, 2005, J NUTR, V135, P989, DOI 10.1093/jn/135.5.989; Monroe DG, 2005, MOL ENDOCRINOL, V19, P1555, DOI 10.1210/me.2004-0381; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Murphy LC, 2005, J MOL ENDOCRINOL, V34, P553, DOI 10.1677/jme.1.01688; Nilsson S, 2011, CLIN PHARMACOL THER, V89, P44, DOI 10.1038/clpt.2010.226; Omoto Y, 2001, CANCER LETT, V163, P207, DOI 10.1016/S0304-3835(00)00680-7; Paruthiyil S, 2004, CANCER RES, V64, P423, DOI 10.1158/0008-5472.CAN-03-2446; Peeters PHM, 2003, BREAST CANCER RES TR, V77, P171, DOI 10.1023/A:1021381101632; Pettersson K, 1997, MOL ENDOCRINOL, V11, P1486, DOI 10.1210/me.11.10.1486; Pettersson K, 2000, ONCOGENE, V19, P4970, DOI 10.1038/sj.onc.1203828; Pfitscher A, 2008, J STEROID BIOCHEM, V112, P87, DOI 10.1016/j.jsbmb.2008.08.007; Powell E, 2010, BIOCHEM PHARMACOL, V80, P1221, DOI 10.1016/j.bcp.2010.06.030; Powell E, 2008, P NATL ACAD SCI USA, V105, P19012, DOI 10.1073/pnas.0807274105; Ricke WA, 2008, FASEB J, V22, P1512, DOI 10.1096/fj.07-9526com; Roger P, 2001, CANCER RES, V61, P2537; Rousseau C, 2004, MOL CANCER RES, V2, P523; Saji S, 2005, CANCER CHEMOTH PHARM, V56, pS21, DOI 10.1007/s0028-005-0107-3; Shoker BS, 1999, J PATHOL, V188, P237; Skliris GP, 2001, BRIT J CANCER, V84, P1095, DOI 10.1054/bjoc.2001.1721; Stossi F, 2004, ENDOCRINOLOGY, V145, P3473, DOI 10.1210/en.2003-1682; Strom A, 2004, P NATL ACAD SCI USA, V101, P1566, DOI 10.1073/pnas.0308319100; Sugiura H, 2007, JPN J CLIN ONCOL, V37, P820, DOI 10.1093/jjco/hym114; Tremblay GB, 1999, MOL CELL BIOL, V19, P1919; Wang HK, 1998, ADV EXP MED BIOL, V439, P191; Warren M, 2009, APPL IMMUNOHISTO M M, V17, P23, DOI 10.1097/PAI.0b013e31817c3334; Williams C, 2008, ONCOGENE, V27, P1019, DOI 10.1038/sj.onc.1210712; Wilson VS, 2004, TOXICOL SCI, V81, P69, DOI 10.1093/toxsci/kfh180; Wu XL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2844; Wu XL, 2009, CANCER RES, V69, P1722, DOI 10.1158/0008-5472.CAN-08-3933; Zhu XG, 2004, AM J PATHOL, V164, P2003, DOI 10.1016/S0002-9440(10)63760-1	56	53	56	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2012	7	2							e30993	10.1371/journal.pone.0030993	http://dx.doi.org/10.1371/journal.pone.0030993			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917MF	22347418	Green Published, gold, Green Submitted			2022-12-27	WOS:000302180600020
J	Fukada, M; Hanai, A; Nakayama, A; Suzuki, T; Miyata, N; Rodriguiz, RM; Wetsel, WC; Yao, TP; Kawaguchi, Y				Fukada, Masahide; Hanai, Atsuko; Nakayama, Atsuo; Suzuki, Takayoshi; Miyata, Naoki; Rodriguiz, Ramona M.; Wetsel, William C.; Yao, Tso-Pang; Kawaguchi, Yoshiharu			Loss of Deacetylation Activity of Hdac6 Affects Emotional Behavior in Mice	PLOS ONE			English	Article							RAPHE NUCLEUS; X-CHROMOSOME; IN-VIVO; ACETYLATION; TUBULIN; HISTONE-DEACETYLASE-6; MICROTUBULES; AUTOPHAGY; RECEPTOR; PROJECTIONS	Acetylation is mediated by acetyltransferases and deacetylases, and occurs not only on histones but also on diverse proteins. Although histone acetylation in chromatin structure and transcription has been well studied, the biological roles of non-histone acetylation remain elusive. Histone deacetylase 6 (Hdac6), a member of the histone deacetylase (HDAC) family, is a unique deacetylase that localizes to cytoplasm and functions in many cellular events by deacetylating non-histone proteins including alpha-tubulin, Hsp90, and cortactin. Since robust expression of Hdac6 is observed in brain, it would be expected that Hdac6-mediated reversible acetylation plays essential roles in CNS. Here we demonstrate the crucial roles of Hdac6 deacetylase activity in the expression of emotional behavior in mice. We found that Hdac6-deficient mice exhibit hyperactivity, less anxiety, and antidepressant-like behavior in behavioral tests. Moreover, administration of Hdac6-specific inhibitor replicated antidepressant-like behavior in mice. In good agreement with behavioral phenotypes of Hdac6-deficient mice, Hdac6 dominantly localizes to the dorsal and median raphe nuclei, which are involved in emotional behaviors. These findings suggest that HDAC6-mediated reversible acetylation might contribute to maintain proper neuronal activity in serotonergic neurons, and also provide a new therapeutic target for depression.	[Fukada, Masahide; Hanai, Atsuko; Nakayama, Atsuo; Kawaguchi, Yoshiharu] Aichi Human Serv Ctr, Inst Dev Res, Dept Embryol, Kasugai, Aichi, Japan; [Suzuki, Takayoshi; Miyata, Naoki] Nagoya City Univ, Grad Sch Pharmaceut Sci, Nagoya, Aichi, Japan; [Rodriguiz, Ramona M.; Wetsel, William C.] Duke Univ, Med Ctr, Mouse Behav & Neuroendocrine Anal Core Facil, Durham, NC USA	Nagoya City University; Duke University	Fukada, M (corresponding author), Aichi Human Serv Ctr, Inst Dev Res, Dept Embryol, Kasugai, Aichi, Japan.	kawag001@inst-hsc.jp			KAKENHI [22700408, 21500364]; Takeda Science Foundation; The Sumitomo Foundation; NOVARTIS Foundation for the Promotion of Science; Grants-in-Aid for Scientific Research [24659050] Funding Source: KAKEN	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF)); The Sumitomo Foundation; NOVARTIS Foundation for the Promotion of Science; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	KAKENHI (22700408, MF; 21500364, YK) www.jsps.go.jp/j-grantsinaid/index.html; Takeda Science Foundation (YK) www.takeda-sci.or.jp; The Sumitomo Foundation (YK) www.sumitomo.or.jp; The NOVARTIS Foundation for the Promotion of Science (YK) novartisfound.or.jp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Convington HE, 2009, J NEUROSCI, V37, P11451; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P571, DOI 10.1016/j.neubiorev.2005.03.009; Dompierre JP, 2007, J NEUROSCI, V27, P3571, DOI 10.1523/JNEUROSCI.0037-07.2007; Fukada M, 2005, METHODS, V35, P54, DOI 10.1016/j.ymeth.2004.07.008; Gao YS, 2007, MOL CELL BIOL, V27, P8637, DOI 10.1128/MCB.00393-07; Gregoretti IV, 2004, J MOL BIOL, V338, P17, DOI 10.1016/j.jmb.2004.02.006; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Itoh Y, 2007, J MED CHEM, V50, P5425, DOI 10.1021/jm7009217; Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; Lee JY, 2010, EMBO J, V29, P969, DOI 10.1038/emboj.2009.405; Mahlknecht U, 2001, CYTOGENET CELL GENET, V93, P135, DOI 10.1159/000056967; Matsuyama A, 2002, EMBO J, V21, P6820, DOI 10.1093/emboj/cdf682; Means GD, 2000, GENOMICS, V65, P213, DOI 10.1006/geno.2000.6173; Nozawa RS, 2010, NAT CELL BIOL, V12, P719, DOI 10.1038/ncb2075; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; SAPOLSKY RM, 1990, NEUROENDOCRINOLOGY, V51, P328, DOI 10.1159/000125357; Tran ADA, 2007, J CELL SCI, V120, P1469, DOI 10.1242/jcs.03431; Vertes RP, 1999, J COMP NEUROL, V407, P555; VERTES RP, 1991, J COMP NEUROL, V313, P643, DOI 10.1002/cne.903130409; Wong E, 2010, NAT NEUROSCI, V13, P805, DOI 10.1038/nn.2575; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; YOUNG EA, 1991, ARCH GEN PSYCHIAT, V48, P693; Zhang XD, 2004, SCIENCE, V305, P217, DOI 10.1126/science.1097540; Zhang XH, 2007, MOL CELL, V27, P197, DOI 10.1016/j.molcel.2007.05.033; Zhang Y, 2003, EMBO J, V22, P1168, DOI 10.1093/emboj/cdg115; Zhang Y, 2008, MOL CELL BIOL, V28, P1688, DOI 10.1128/MCB.01154-06	29	90	95	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2012	7	2							e30924	10.1371/journal.pone.0030924	http://dx.doi.org/10.1371/journal.pone.0030924			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LV	22328923	gold, Green Published, Green Submitted			2022-12-27	WOS:000302179300009
J	Walsh, MG				Walsh, Michael G.			The Role of Hydrogeography and Climate in the Landscape Epidemiology of West Nile Virus in New York State from 2000 to 2010	PLOS ONE			English	Article							MOSQUITO VECTORS; LAND-USE; ABUNDANCE; OUTBREAKS; DENSITY; DISEASE; COUNTY; COVER	The epidemiology and ecology of West Nile virus (WNV) have not yet been completely described. In particular, the specific roles of climate and water in the landscape in the occurrence of human WNV cases remain unknown. This study used Poisson regression to describe the relationships between WNV cases and temperature, precipitation, and the hydrogeography of the landscape in New York State from 2000 to 2010. Fully adjusted models showed that hydrogeographic area was significantly inversely associated with WNV cases (incidence rate ratio (IRR) = 0.99; 95% C.I. = 0.98-0.997, p = 0.04), such that each one square kilometer increase in hydrogeographic area was associated with a 1% decrease in WNV incidence. This association was independent of both temperature, which was also associated with WNV incidence (IRR = 2.06; 95% C.I. = 1.84-2.31, p < 0.001), and precipitation, which was not (IRR = 1.0; 95% C.I. = 0.99-1.01, p = 0.16). While the results are only suggestive due to the county-level aggregated data, these findings do identify a potentially important surveillance signal in the landscape epidemiology of WNV infection.	SUNY, Sch Publ Hlth, Dept Epidemiol & Biostat, New York, NY 13902 USA	State University of New York (SUNY) System; SUNY Community College; SUNY Maritime College; SUNY Optometry	Walsh, MG (corresponding author), SUNY, Sch Publ Hlth, Dept Epidemiol & Biostat, New York, NY 13902 USA.	michael.walsh@downstate.edu		Walsh, Michael/0000-0002-6441-3635				Allan BF, 2009, OECOLOGIA, V158, P699, DOI 10.1007/s00442-008-1169-9; Bowden SE, 2011, AM J TROP MED HYG, V84, P234, DOI 10.4269/ajtmh.2011.10-0134; Carpenter S. J., 1955, MOSQUITOES N AM N ME; Chase JM, 2003, ECOL LETT, V6, P1017, DOI 10.1046/j.1461-0248.2003.00533.x; Cooke William H 3rd, 2006, Int J Health Geogr, V5, P36, DOI 10.1186/1476-072X-5-36; Deichmeister JM, 2011, J VECTOR ECOL, V36, P75, DOI 10.1111/j.1948-7134.2011.00143.x; Diuk-Wasser MA, 2006, VECTOR-BORNE ZOONOT, V6, P283, DOI 10.1089/vbz.2006.6.283; Eidson M, 2005, EMERG INFECT DIS, V11, P1370; Gotham I J, 2001, J Public Health Manag Pract, V7, P75; Horsfall WR, 1955, MOSQUITOES THEIR BIO, P564; Hubalek Z, 1999, EMERG INFECT DIS, V5, P643, DOI 10.3201/eid0505.990505; Irwin P, 2008, ECOHEALTH, V5, P49, DOI 10.1007/s10393-007-0152-y; Kilpatrick AM, 2011, SCIENCE, V334, P323, DOI 10.1126/science.1201010; Liu H, 2009, ENVIRON MONIT ASSESS, V159, P143, DOI 10.1007/s10661-008-0618-6; Miramontes R, 2006, AM J PREV MED, V30, P160, DOI 10.1016/j.amepre.2005.10.008; Ozdenerol E, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-12; Petersen LR, 2008, MED CLIN N AM, V92, P1307, DOI 10.1016/j.mcna.2008.07.004; Rochlin I, 2008, J MED ENTOMOL, V45, P563, DOI 10.1603/0022-2585(2008)45[563:CAODAA]2.0.CO;2; Soverow JE, 2009, ENVIRON HEALTH PERSP, V117, P1049, DOI 10.1289/ehp.0800487; Sugumaran R, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-43; Wang GM, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-38	21	10	11	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2012	7	2							e30620	10.1371/journal.pone.0030620	http://dx.doi.org/10.1371/journal.pone.0030620			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LV	22328919	gold, Green Published, Green Submitted			2022-12-27	WOS:000302179300005
J	Budimir, N; Huckriede, A; Meijerhof, T; Boon, L; Gostick, E; Price, DA; Wilschut, J; de Haan, A				Budimir, Natalija; Huckriede, Anke; Meijerhof, Tjarko; Boon, Louis; Gostick, Emma; Price, David A.; Wilschut, Jan; de Haan, Aalzen			Induction of Heterosubtypic Cross-Protection against Influenza by a Whole Inactivated Virus Vaccine: The Role of Viral Membrane Fusion Activity	PLOS ONE			English	Article							T-CELL RESPONSES; IMMUNITY; ANTIGEN; NUCLEOPROTEIN; RECOGNITION; H5N1; MECHANISMS; INFECTION; PROSPECTS; CLONES	Background: The inability of seasonal influenza vaccines to effectively protect against infection with antigenically drifted viruses or newly emerging pandemic viruses underlines the need for development of cross-reactive influenza vaccines that induce immunity against a variety of virus subtypes. Therefore, potential cross-protective vaccines, e.g., whole inactivated virus (WIV) vaccine, that can target conserved internal antigens such as the nucleoprotein (NP) and/or matrix protein (M1) need to be explored. Methodology/Principal Findings: In the current study we show that a WIV vaccine, through induction of cross-protective cytotoxic T lymphocytes (CTLs), protects mice from heterosubtypic infection. This protection was abrogated after depletion of CD8+ cells in vaccinated mice, indicating that CTLs were the primary mediators of protection. Previously, we have shown that different procedures used for virus inactivation influence optimal activation of CTLs by WIV, most likely by affecting the membrane fusion properties of the virus. Specifically, inactivation with formalin (FA) severely compromises fusion activity of the virus, while inactivation with beta-propiolactone (BPL) preserves fusion activity. Here, we demonstrate that vaccination of mice with BPL-inactivated H5N1 WIV vaccine induces solid protection from lethal heterosubtypic H1N1 challenge. By contrast, vaccination with FA-inactivated WIV, while preventing death after lethal challenge, failed to protect against development of disease and severe body weight loss. Vaccination with BPL-inactivated WIV, compared to FA-inactivated WIV, induced higher levels of specific CD8+ T cells in blood, spleen and lungs, and a higher production of granzyme B in the lungs upon H1N1 virus challenge. Conclusion/Significance: The results underline the potential use of WIV as a cross-protective influenza vaccine candidate. However, careful choice of the virus inactivation procedure is important to retain membrane fusion activity and full immunogenicity of the vaccine.	[Budimir, Natalija; Huckriede, Anke; Meijerhof, Tjarko; Wilschut, Jan; de Haan, Aalzen] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Mol Virol Sect, NL-9713 AV Groningen, Netherlands; [Boon, Louis] Bioceros, Utrecht, Netherlands; [Gostick, Emma; Price, David A.] Cardiff Univ, Sch Med, Dept Infect Immun & Biochem, Cardiff, S Glam, Wales	University of Groningen; Cardiff University	Budimir, N (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Mol Virol Sect, NL-9713 AV Groningen, Netherlands.	aalzen.de.haan@umcg.nl	Huckriede, Anke/P-3558-2019; Boon, Laurence/HCI-3629-2022; Price, David A/C-7876-2013	Huckriede, Anke/0000-0002-2646-5143; Price, David A/0000-0001-9416-2737; Boon, Louis/0000-0002-0937-9171	Top Institute Pharma, The Netherlands [T214-4-1]; Jan Kornelis de Cock Stichting	Top Institute Pharma, The Netherlands(Netherlands Government); Jan Kornelis de Cock Stichting	This study was partially performed in the context of project T214-4-1 financed by Top Institute Pharma, The Netherlands and by Jan Kornelis de Cock Stichting. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman AL, 2004, NAT IMMUNOL, V5, P678, DOI 10.1038/ni1082; Amigorena S, 2010, CURR OPIN IMMUNOL, V22, P109, DOI 10.1016/j.coi.2010.01.022; [Anonymous], INFL VACC SPLIT VIR; BENDER A, 1995, J EXP MED, V182, P1663, DOI 10.1084/jem.182.6.1663; BENNINK JR, 1982, NATURE, V296, P75, DOI 10.1038/296075a0; BLACKBURN NK, 1991, J VIROL METHODS, V33, P367, DOI 10.1016/0166-0934(91)90036-Y; Bodewes R, 2010, J GEN VIROL, V91, P1743, DOI 10.1099/vir.0.020784-0; Budimir N, 2010, VACCINE, V28, P8280, DOI 10.1016/j.vaccine.2010.10.007; Bungener L, 2008, VACCINE, V26, P2350, DOI 10.1016/j.vaccine.2008.02.063; Cao B, 2009, NEW ENGL J MED, V361, P2507, DOI 10.1056/NEJMoa0906612; Combadiere B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010818; Couch RB, 2011, BIRKHAUSER ADV INFEC, P359, DOI 10.1007/978-3-0346-0279-2_15; Coutsinos Z, 2005, FEMS IMMUNOL MED MIC, V43, P357, DOI 10.1016/j.femsim.2004.09.003; de Jong JC, 2000, J MED VIROL, V61, P94, DOI 10.1002/(SICI)1096-9071(200005)61:1&lt;94::AID-JMV15&gt;3.0.CO;2-C; de Jonge J, 2006, GENE THER, V13, P400, DOI 10.1038/sj.gt.3302673; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Doherty PC, 2006, NAT IMMUNOL, V7, P449, DOI 10.1038/ni1343; Doherty PC, 2008, J CLIN INVEST, V118, P3273, DOI 10.1172/JCI37232; Dormitzer PR, 2011, IMMUNOL REV, V239, P167, DOI 10.1111/j.1600-065X.2010.00974.x; Epstein Suzanne L, 2003, Expert Rev Anti Infect Ther, V1, P627, DOI 10.1586/14787210.1.4.627; Fonteneau JF, 2003, BLOOD, V101, P3520, DOI 10.1182/blood-2002-10-3063; Furuya Y, 2010, J VIROL, V84, P4212, DOI 10.1128/JVI.02508-09; Geeraedts F, 2010, AAPS J, V12, P215, DOI 10.1208/s12248-010-9179-z; Geeraedts F, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000138; Greenbaum JA, 2009, P NATL ACAD SCI USA, V106, P20365, DOI 10.1073/pnas.0911580106; Gromme M, 2002, MOL IMMUNOL, V39, P181, DOI 10.1016/S0161-5890(02)00101-3; Hanon EJ, 2008, United States patent application publication: US, Patent No. [2008/0014217, 20080014217]; Heiny AT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001190; Hu AYC, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0014578, 10.1371/journal.pone.0029229]; Huckriede A, 2005, VACCINE, V23, pS26, DOI 10.1016/j.vaccine.2005.04.026; Kreijtz JHCM, 2008, J VIROL, V82, P5161, DOI 10.1128/JVI.02694-07; Lee LYH, 2008, J CLIN INVEST, V118, P3478, DOI 10.1172/JCI32460; MCMICHAEL AJ, 1983, NEW ENGL J MED, V309, P13, DOI 10.1056/NEJM198307073090103; MURPHY BR, 1988, J CLIN MICROBIOL, V26, P1595, DOI 10.1128/JCM.26.8.1595-1597.1988; Nabel GJ, 2010, NAT MED, V16, P1389, DOI 10.1038/nm1210-1389; Nicholson KG, 2003, LANCET, V362, P1733, DOI 10.1016/S0140-6736(03)14854-4; OXFORD JS, 1981, J BIOL STAND, V9, P483, DOI 10.1016/S0092-1157(81)80041-8; Price DA, 2005, J EXP MED, V202, P1349, DOI 10.1084/jem.20051357; Rock KL, 2005, IMMUNOL REV, V207, P166, DOI 10.1111/j.0105-2896.2005.00301.x; Sandbulte MR, 2007, PLOS MED, V4, P265, DOI 10.1371/journal.pmed.0040059; Schotsaert M, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/863985; Settembre EC, 2011, J MOL CELL BIOL, V3, P144, DOI 10.1093/jmcb/mjq046; Shen H, 2006, IMMUNOLOGY, V117, P78, DOI 10.1111/j.1365-2567.2005.02268.x; TAYLOR PM, 1986, IMMUNOLOGY, V58, P417; Teijaro JR, 2010, J VIROL, V84, P9217, DOI 10.1128/JVI.01069-10; TOWNSEND ARM, 1984, J EXP MED, V160, P552, DOI 10.1084/jem.160.2.552; TOWNSEND ARM, 1982, NATURE, V300, P655, DOI 10.1038/300655a0; Wagner H, 2004, CURR OPIN BIOTECH, V15, P538, DOI 10.1016/j.copbio.2004.09.006; Wagner H, 2009, ADV DRUG DELIVER REV, V61, P243, DOI 10.1016/j.addr.2008.12.010; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; YEWDELL JW, 1985, P NATL ACAD SCI USA, V82, P1785, DOI 10.1073/pnas.82.6.1785	51	60	63	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e30898	10.1371/journal.pone.0030898	http://dx.doi.org/10.1371/journal.pone.0030898			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22303469	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000301704200045
J	Hirsch, A; Hahn, D; Kempna, P; Hofer, G; Mullis, PE; Nuoffer, JM; Fluck, CE				Hirsch, Andrea; Hahn, Dagmar; Kempna, Petra; Hofer, Gaby; Mullis, Primus E.; Nuoffer, Jean-Marc; Flueck, Christa E.			Role of AMP-Activated Protein Kinase on Steroid Hormone Biosynthesis in Adrenal NCI-H295R Cells	PLOS ONE			English	Article							SKELETAL-MUSCLE; GRANULOSA-CELLS; 3-BETA-HYDROXYSTEROID DEHYDROGENASE; PROGESTERONE SECRETION; 17,20-LYASE ACTIVITY; LEUKEMIA-CELLS; P450C17; APOPTOSIS; PATHWAY; AICAR	Regulation of human androgen biosynthesis is poorly understood. However, detailed knowledge is needed to eventually solve disorders with androgen dysbalance. We showed that starvation growth conditions shift steroidogenesis of human adrenal NCI-H295R cells towards androgen production attributable to decreased HSD3B2 expression and activity and increased CYP17A1 phosphorylation and 17,20-lyase activity. Generally, starvation induces stress and energy deprivation that need to be counteracted to maintain proper cell functions. AMP-activated protein kinase (AMPK) is a master energy sensor that regulates cellular energy balance. AMPK regulates steroidogenesis in the gonad. Therefore, we investigated whether AMPK is also a regulator of adrenal steroidogenesis. We hypothesized that starvation uses AMPK signaling to enhance androgen production in NCI-H295R cells. We found that AMPK subunits are expressed in NCI-H295 cells, normal adrenal tissue and human as well as pig ovary cells. Starvation growth conditions decreased phosphorylation, but not activity of AMPK in NCI-H295 cells. In contrast, the AMPK activator 5-aminoimidazole-4-carboxamide (AICAR) increased AMPK alpha phosphorylation and increased CYP17A1-17,20 lyase activity. Compound C (an AMPK inhibitor), directly inhibited CYP17A1 activities and can therefore not be used for AMPK signaling studies in steroidogenesis. HSD3B2 activity was neither altered by AICAR nor compound C. Starvation did not affect mitochondrial respiratory chain function in NCI-H295R cells suggesting that there is no indirect energy effect on AMPK through this avenue. In summary, starvation-mediated increase of androgen production in NCI-H295 cells does not seem to be mediated by AMPK signaling. But AMPK activation can enhance androgen production through a specific increase in CYP17A1-17,20 lyase activity.	[Hirsch, Andrea; Hahn, Dagmar; Kempna, Petra; Hofer, Gaby; Mullis, Primus E.; Nuoffer, Jean-Marc; Flueck, Christa E.] Univ Bern, Inselspital, Univ Hosp, Div Pediat Endocrinol Diabetol & Metab,Dept Pedia, CH-3010 Bern, Switzerland; [Hirsch, Andrea; Kempna, Petra; Hofer, Gaby; Mullis, Primus E.; Nuoffer, Jean-Marc; Flueck, Christa E.] Univ Bern, Inselspital, Univ Hosp, Dept Clin Res, CH-3010 Bern, Switzerland; [Hahn, Dagmar; Nuoffer, Jean-Marc] Univ Bern, Inselspital, Univ Hosp, Inst Clin Chem, CH-3010 Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern	Hirsch, A (corresponding author), Univ Bern, Inselspital, Univ Hosp, Div Pediat Endocrinol Diabetol & Metab,Dept Pedia, CH-3010 Bern, Switzerland.	christa.flueck@dkf.unibe.ch	; Nuoffer, Jean-Marc/C-8936-2009	Flueck, Christa/0000-0002-4568-5504; Nuoffer, Jean-Marc/0000-0003-3650-6153	Swiss National Science Foundation [31003A-130710]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by a grant of the Swiss National Science Foundation (31003A-130710) to CEF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Arlt W, 2001, J BIOL CHEM, V276, P16767, DOI 10.1074/jbc.M100040200; Auchus RJ, 1998, J BIOL CHEM, V273, P3158, DOI 10.1074/jbc.273.6.3158; Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Eberhart K, 2011, BBA-BIOENERGETICS, V1807, P719, DOI 10.1016/j.bbabio.2010.12.010; Emerling BM, 2007, FEBS LETT, V581, P5727, DOI 10.1016/j.febslet.2007.11.038; Fluck CE, 2003, J CLIN ENDOCR METAB, V88, P3762, DOI 10.1210/jc.2003-030143; GAZDAR AF, 1990, CANCER RES, V50, P5488; Hardie DG, 2001, BIOESSAYS, V23, P1112, DOI 10.1002/bies.10009; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Kempna P, 2010, ENDOCRINOLOGY, V151, P3686, DOI 10.1210/en.2010-0093; Lage R, 2008, TRENDS MOL MED, V14, P539, DOI 10.1016/j.molmed.2008.09.007; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Mahlapuu M, 2004, AM J PHYSIOL-ENDOC M, V286, pE194, DOI 10.1152/ajpendo.00147.2003; Miller WL, 2011, ENDOCR REV, V32, P81, DOI 10.1210/er.2010-0013; Miller WL, 2009, REV ENDOCR METAB DIS, V10, P3, DOI 10.1007/s11154-008-9102-4; Nam M, 2008, ARCH BIOCHEM BIOPHYS, V479, P74, DOI 10.1016/j.abb.2008.07.029; Ramanjaneya M, 2011, BBA-MOL CELL RES, V1813, P802, DOI 10.1016/j.bbamcr.2011.02.010; Renner K, 2003, BBA-MOL CELL RES, V1642, P115, DOI 10.1016/S0167-4889(03)00105-8; Samandari E, 2007, J ENDOCRINOL, V195, P459, DOI 10.1677/JOE-07-0166; Sanders MJ, 2007, BIOCHEM J, V403, P139, DOI 10.1042/BJ20061520; Santidrian AF, 2010, BLOOD, V116, P3023, DOI 10.1182/blood-2010-05-283960; Schaller A, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-4; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Stapleton D, 1996, J BIOL CHEM, V271, P611, DOI 10.1074/jbc.271.2.611; Stapleton D, 1997, FEBS LETT, V409, P452, DOI 10.1016/S0014-5793(97)00569-3; SULLIVAN JE, 1994, FEBS LETT, V353, P33, DOI 10.1016/0014-5793(94)01006-4; Thornton C, 1998, J BIOL CHEM, V273, P12443, DOI 10.1074/jbc.273.20.12443; Tosca L, 2005, ENDOCRINOLOGY, V146, P4500, DOI 10.1210/en.2005-0301; Tosca L, 2007, BIOL REPROD, V76, P368, DOI 10.1095/biolreprod.106.055749; Tosca L, 2006, J ENDOCRINOL, V190, P85, DOI 10.1677/joe.1.06828; Waterman MR, 1996, ENDOCR RES, V22, P615, DOI 10.1080/07435809609043755; Winder WW, 2000, J APPL PHYSIOL, V88, P2219, DOI 10.1152/jappl.2000.88.6.2219; Zang Y, 2008, J BIOL CHEM, V283, P6201, DOI 10.1074/jbc.M708619200	36	16	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30956	10.1371/journal.pone.0030956	http://dx.doi.org/10.1371/journal.pone.0030956			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295121	Green Published, Green Submitted, gold			2022-12-27	WOS:000301640600066
J	Peng, H; Chang, BH; Lu, CL; Su, JM; Wu, YY; Lv, P; Wang, YS; Liu, J; Zhang, BW; Quan, FS; Guo, ZK; Zhang, Y				Peng, Hui; Chang, Bohao; Lu, Chenglong; Su, Jianmin; Wu, Yongyan; Lv, Pin; Wang, Yongsheng; Liu, Jun; Zhang, Bowei; Quan, Fusheng; Guo, Zekun; Zhang, Yong			Nlrp2, a Maternal Effect Gene Required for Early Embryonic Development in the Mouse	PLOS ONE			English	Article							LEUCINE-RICH REPEAT; NF-KAPPA-B; PYRIN DOMAIN; PREIMPLANTATION EMBRYOS; GENOME ACTIVATION; EXPRESSION; PROTEIN; OOCYTES; INFLAMMASOME; MUTATIONS	Maternal effect genes encode proteins that are produced during oogenesis and play an essential role during early embryogenesis. Genetic ablation of such genes in oocytes can result in female subfertility or infertility. Here we report a newly identified maternal effect gene, Nlrp2, which plays a role in early embryogenesis in the mouse. Nlrp2 mRNAs and their proteins (similar to 118 KDa) are expressed in oocytes and granulosa cells during folliculogenesis. The transcripts show a striking decline in early preimplantation embryos before zygotic genome activation, but the proteins remain present through to the blastocyst stage. Immunogold electron microscopy revealed that the NLRP2 protein is located in the cytoplasm, nucleus and close to nuclear pores in the oocytes, as well as in the surrounding granulosa cells. Using RNA interference, we knocked down Nlrp2 transcription specifically in mouse germinal vesicle oocytes. The knockdown oocytes could progress through the metaphase of meiosis I and emit the first polar body. However, the development of parthenogenetic embryos derived from Nlrp2 knockdown oocytes mainly blocked at the 2-cell stage. The maternal depletion of Nlrp2 in zygotes led to early embryonic arrest. In addition, overexpression of Nlrp2 in zygotes appears to lead to normal development, but increases blastomere apoptosis in blastocysts. These results provide the first evidence that Nlrp2 is a member of the mammalian maternal effect genes and required for early embryonic development in the mouse.	[Peng, Hui; Chang, Bohao; Lu, Chenglong; Su, Jianmin; Wu, Yongyan; Lv, Pin; Wang, Yongsheng; Liu, Jun; Zhang, Bowei; Quan, Fusheng; Zhang, Yong] NW A&F Univ, Coll Vet Med, Key Lab Anim Reprod Physiol & Embryo Technol, Yangling, Shanxi, Peoples R China; [Guo, Zekun] NW A&F Univ, Coll Life Sci, Dept Biochem & Mol Biol, Yangling, Shanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China	Peng, H (corresponding author), NW A&F Univ, Coll Vet Med, Key Lab Anim Reprod Physiol & Embryo Technol, Yangling, Shanxi, Peoples R China.		Zhang, Yong/K-7945-2016; Wu, Yongyan/AAH-1471-2019	Zhang, Yong/0000-0001-8642-4071; Wu, Yongyan/0000-0003-1669-3860	National Key Project for Production of Transgenic Livestock, People's Republic of China [2008ZX08007-004]	National Key Project for Production of Transgenic Livestock, People's Republic of China	This work was supported by the National Key Project for Production of Transgenic Livestock, People's Republic of China (No. 2008ZX08007-004, http://www.most.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BECK F, 1995, DEV DYNAM, V204, P219, DOI 10.1002/aja.1002040302; Bertin J, 2000, CELL DEATH DIFFER, V7, P1273, DOI 10.1038/sj.cdd.4400774; Biggers JD, 2000, BIOL REPROD, V63, P281, DOI 10.1095/biolreprod63.1.281; Bortvin Alex, 2004, BMC Developmental Biology, V4; Bowerman B, 1998, CURR TOP DEV BIOL, V39, P73, DOI 10.1016/S0070-2153(08)60453-6; Boyden ED, 2006, NAT GENET, V38, P240, DOI 10.1038/ng1724; Bruey JM, 2004, J BIOL CHEM, V279, P51897, DOI 10.1074/jbc.M406741200; Bultman SJ, 2006, GENE DEV, V20, P1744, DOI 10.1101/gad.1435106; Burns KH, 2003, SCIENCE, V300, P633, DOI 10.1126/science.1081813; Christians E, 2000, NATURE, V407, P693, DOI 10.1038/35037669; Conti BJ, 2005, J BIOL CHEM, V280, P18375, DOI 10.1074/jbc.M413169200; Dade S, 2004, BIOCHEM BIOPH RES CO, V324, P547, DOI 10.1016/j.bbrc.2004.09.086; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Dumont J, 2007, DEV BIOL, V301, P254, DOI 10.1016/j.ydbio.2006.08.044; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Evsikov AV, 2006, GENE DEV, V20, P2713, DOI 10.1101/gad.1471006; Fontalba A, 2007, J IMMUNOL, V179, P8519, DOI 10.4049/jimmunol.179.12.8519; Grabarek JB, 2002, GENESIS, V32, P269, DOI 10.1002/gene.10076; Gross O, 2009, NATURE, V459, P433, DOI 10.1038/nature07965; Guarda G, 2009, NATURE, V460, P269, DOI 10.1038/nature08100; Gurtu VE, 2002, GENETICS, V160, P271; Hamatani T, 2004, HUM MOL GENET, V13, P2263, DOI 10.1093/hmg/ddh241; Harton JA, 2002, J IMMUNOL, V169, P4088, DOI 10.4049/jimmunol.169.8.4088; Horikawa M, 2005, BIOL REPROD, V72, P879, DOI 10.1095/biolreprod.104.033753; Howell CY, 2001, CELL, V104, P829, DOI 10.1016/S0092-8674(01)00280-X; Kajava AV, 1998, J MOL BIOL, V277, P519, DOI 10.1006/jmbi.1998.1643; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Kim MH, 2002, BIOCHEM BIOPH RES CO, V296, P1372, DOI 10.1016/S0006-291X(02)02070-3; KOBE B, 1995, NATURE, V374, P183, DOI 10.1038/374183a0; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Kohl A, 2004, CR BIOL, V327, P1077, DOI 10.1016/j.crvi.2004.08.006; Latham KE, 1999, INT REV CYTOL, V193, P71; LAWITTS JA, 1991, J REPROD FERTIL, V91, P543, DOI 10.1530/jrf.0.0910543; Leader B, 2002, NAT CELL BIOL, V4, P921, DOI 10.1038/ncb880; Li L, 2008, DEV CELL, V15, P416, DOI 10.1016/j.devcel.2008.07.010; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma J, 2006, DEVELOPMENT, V133, P2053, DOI 10.1242/dev.02371; Martinon F, 2001, CURR BIOL, V11, pR118, DOI 10.1016/S0960-9822(01)00056-2; McDaniel P, 2009, MOL REPROD DEV, V76, P151, DOI 10.1002/mrd.20937; Meyer E, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000423; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Moody SA, 1996, CURR TOP DEV BIOL, V32, P103, DOI 10.1016/S0070-2153(08)60426-3; Murdoch S, 2006, NAT GENET, V38, P300, DOI 10.1038/ng1740; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Nakamura T, 2007, NAT CELL BIOL, V9, P64, DOI 10.1038/ncb1519; NUSSLEINVOLHARD C, 1980, NATURE, V283, P474, DOI 10.1038/283474a0; Ohsugi M, 2008, DEVELOPMENT, V135, P259, DOI 10.1242/dev.011445; PALMIERI SL, 1994, DEV BIOL, V166, P259, DOI 10.1006/dbio.1994.1312; Payer B, 2003, CURR BIOL, V13, P2110, DOI 10.1016/j.cub.2003.11.026; Pennetier S, 2004, BIOL REPROD, V71, P1359, DOI 10.1095/biolreprod.104.030288; Pennetier S, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-26; Pisani LF, 2010, J REPROD DEVELOP, V56, P41, DOI 10.1262/jrd.09-098A; Ponsuksili S, 2006, BIOL REPROD, V74, P577, DOI 10.1095/biolreprod.105.045096; SCHUPBACH T, 1986, DEV BIOL, V113, P443, DOI 10.1016/0012-1606(86)90179-X; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Su JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023805; Svoboda P, 2000, DEVELOPMENT, V127, P4147; Tian X, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-202; Tong ZB, 2000, NAT GENET, V26, P267, DOI 10.1038/81547; Tong ZB, 2000, MAMM GENOME, V11, P281, DOI 10.1007/s003350010053; Tong ZB, 2004, ENDOCRINOLOGY, V145, P1427, DOI 10.1210/en.2003-1160; Tong ZB, 2002, HUM REPROD, V17, P903, DOI 10.1093/humrep/17.4.903; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Wang HH, 2008, DEV BIOL, V318, P112, DOI 10.1016/j.ydbio.2008.03.008; Westerveld GH, 2006, HUM REPROD, V21, P3178, DOI 10.1093/humrep/del293; Wianny F, 2000, NAT CELL BIOL, V2, P70, DOI 10.1038/35000016; Wu X, 2009, HUM REPROD, V24, P415, DOI 10.1093/humrep/den403; Wu XM, 2003, NAT GENET, V33, P187, DOI 10.1038/ng1079; Zhang P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002755; Zheng P, 2009, P NATL ACAD SCI USA, V106, P7473, DOI 10.1073/pnas.0900519106	70	71	77	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30344	10.1371/journal.pone.0030344	http://dx.doi.org/10.1371/journal.pone.0030344			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295082	Green Published, Green Submitted, gold			2022-12-27	WOS:000301640600027
J	Alt, A; Miguel-Romero, L; Donderis, J; Aristorena, M; Blanco, FJ; Round, A; Rubio, V; Bernabeu, C; Marina, A				Alt, Aaron; Miguel-Romero, Laura; Donderis, Jordi; Aristorena, Mikel; Blanco, Francisco J.; Round, Adam; Rubio, Vicente; Bernabeu, Carmelo; Marina, Alberto			Structural and Functional Insights into Endoglin Ligand Recognition and Binding	PLOS ONE			English	Article							HEREDITARY HEMORRHAGIC TELANGIECTASIA; GROWTH-FACTOR-BETA; PROTEIN-STRUCTURE PREDICTION; SUPPRESSES TUMOR-GROWTH; ENDOTHELIAL-CELLS; CELLULAR-RESPONSES; RECEPTOR COMPLEX; ANGIOGENESIS; EXPRESSION; GLYCOPROTEIN	Endoglin, a type I membrane glycoprotein expressed as a disulfide-linked homodimer on human vascular endothelial cells, is a component of the transforming growth factor (TGF)-beta receptor complex and is implicated in a dominant vascular dysplasia known as hereditary hemorrhagic telangiectasia as well as in preeclampsia. It interacts with the type I TGF-beta signaling receptor activin receptor-like kinase (ALK) 1 and modulates cellular responses to Bone Morphogenetic Protein (BMP)-9 and BMP-10. Structurally, besides carrying a zona pellucida (ZP) domain, endoglin contains at its N-terminal extracellular region a domain of unknown function and without homology to any other known protein, therefore called the orphan domain (OD). In this study, we have determined the recognition and binding ability of full length ALK1, endoglin and constructs encompassing the OD to BMP-9 using combined methods, consisting of surface plasmon resonance and cellular assays. ALK1 and endoglin ectodomains bind, independently of their glycosylation state and without cooperativity, to different sites of BMP-9. The OD comprising residues 22 to 337 was identified among the present constructs as the minimal active endoglin domain needed for partner recognition. These studies also pinpointed to Cys350 as being responsible for the dimerization of endoglin. In contrast to the complete endoglin ectodomain, the OD is a monomer and its small angle X-ray scattering characterization revealed a compact conformation in solution into which a de novo model was fitted.	[Alt, Aaron; Miguel-Romero, Laura; Donderis, Jordi; Rubio, Vicente; Marina, Alberto] Inst Biomed Valencia, Valencia, Spain; [Aristorena, Mikel; Blanco, Francisco J.; Bernabeu, Carmelo] Ctr Invest Biol, E-28006 Madrid, Spain; [Donderis, Jordi; Aristorena, Mikel; Blanco, Francisco J.; Rubio, Vicente; Bernabeu, Carmelo; Marina, Alberto] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Raras, Valencia, Spain; [Round, Adam] European Mol Biol Lab, F-38042 Grenoble, France	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; European Molecular Biology Laboratory (EMBL)	Alt, A (corresponding author), Inst Biomed Valencia, Valencia, Spain.	amarina@ibv.csic.es	Blanco, Francisco-Javier/H-3413-2012; Bernabeu, Carmelo/L-3226-2014; Rubio, Vicente/K-7919-2014; Bernabeu, Carmelo/P-4662-2019; Alt, Aaron/A-1551-2017; Marina, Alberto/H-6264-2011; Miguel-Romero, Laura/AAV-2448-2021	Blanco, Francisco-Javier/0000-0002-9929-6707; Bernabeu, Carmelo/0000-0002-1563-6162; Rubio, Vicente/0000-0001-8124-1196; Bernabeu, Carmelo/0000-0002-1563-6162; Alt, Aaron/0000-0002-6708-9826; Marina, Alberto/0000-0002-1334-5273; Miguel-Romero, Laura/0000-0002-7631-6453; Round, Adam/0000-0002-0723-8228	Ministerio de Ciencia e Innovacion of Spain [BIO2009-10872, BIO2010-15424, SAF2010-19222]; Conselleria de Sanitat of Valencian Government [AP-072/11]; Centro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER); Prometeo [2009/051]; Genoma Espana (MEICA); Valencian Government Prometeo [2009/051]	Ministerio de Ciencia e Innovacion of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Conselleria de Sanitat of Valencian Government; Centro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER); Prometeo; Genoma Espana (MEICA); Valencian Government Prometeo	This study was supported by grants from the Ministerio de Ciencia e Innovacion of Spain (grants BIO2009-10872 and BIO2010-15424 to AM, SAF2010-19222 to CB), Conselleria de Sanitat of Valencian Government (grant AP-072/11 to AM), Centro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER) (intramural grant to AM, VR and CB), Prometeo (grant 2009/051 to VR), and Genoma Espana (MEICA). CIBERER is an initiative of the Instituto de Salud Carlos III of Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank R. Owens for the pOPIN suit of vectors, N. Callewaert for the HEK293S GNT1- cells, the ESRF (Grenoble) for SAXS beamline facilities, EMBO for giving AA the opportunity to attend a SAXS course, the Instituto de Agroquimica y Tecnologia de Alimentos (IATA-CSIC, Burjassot, Valencia) for allowing utilization of the BiaCore equipment, and J. Rodriguez Diaz for help with this equipment. AA was first a FEBS short-term fellow and then a JAE-Doc CSIC fellow, LM-R a fellow of the Valencian Government Prometeo grant 2009/051, and JD a CIBERER shuttle fellow.	Arthur HM, 2000, DEV BIOL, V217, P42, DOI 10.1006/dbio.1999.9534; Barbara NP, 1999, J BIOL CHEM, V274, P584, DOI 10.1074/jbc.274.2.584; Basile G, 2009, MOL BIOTECHNOL, V41, P26, DOI 10.1007/s12033-008-9091-2; Bernabeu C, 2010, J APPL BIOMED, V8, P169, DOI 10.2478/v10136-009-0020-x; Bernabeu C, 2009, BBA-MOL BASIS DIS, V1792, P954, DOI 10.1016/j.bbadis.2009.07.003; Berrow Nick S., 2009, V498, P75, DOI 10.1007/978-1-59745-196-3_5; Blanco FJ, 2005, J CELL PHYSIOL, V204, P574, DOI 10.1002/jcp.20311; Bourdeau A, 1999, J CLIN INVEST, V104, P1343, DOI 10.1172/JCI8088; Cannon JP, 2011, METHODS MOL BIOL, V748, P51, DOI 10.1007/978-1-61779-139-0_4; Castonguay R, 2011, J BIOL CHEM, V286, P30034, DOI 10.1074/jbc.M111.260133; Chang VT, 2007, STRUCTURE, V15, P267, DOI 10.1016/j.str.2007.01.011; David L, 2007, BLOOD, V109, P1953, DOI 10.1182/blood-2006-07-034124; David L, 2009, CYTOKINE GROWTH F R, V20, P203, DOI 10.1016/j.cytogfr.2009.05.001; Finnson KW, 2008, J BONE MINER RES, V23, P896, DOI 10.1359/JBMR.080209; GOUGOS A, 1990, J BIOL CHEM, V265, P8361; Guerrero-Esteo M, 1999, EUR J CELL BIOL, V78, P614, DOI 10.1016/S0171-9335(99)80046-6; Guerrero-Esteo M, 2002, J BIOL CHEM, V277, P29197, DOI 10.1074/jbc.M111991200; HAMMOND C, 1994, P NATL ACAD SCI USA, V91, P913, DOI 10.1073/pnas.91.3.913; Jovine L, 2002, NAT CELL BIOL, V4, P457, DOI 10.1038/ncb802; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Lastres P, 1996, J CELL BIOL, V133, P1109, DOI 10.1083/jcb.133.5.1109; Le BV, 2009, BIOCHEM BIOPH RES CO, V383, P386, DOI 10.1016/j.bbrc.2009.02.162; Lebrin F, 2008, TRENDS CARDIOVAS MED, V18, P25, DOI 10.1016/j.tcm.2007.11.003; Letamendia A, 1998, J BIOL CHEM, V273, P33011, DOI 10.1074/jbc.273.49.33011; Li CG, 2001, MICROSC RES TECHNIQ, V52, P437, DOI 10.1002/1097-0029(20010215)52:4<437::AID-JEMT1029>3.0.CO;2-G; Li DY, 1999, SCIENCE, V284, P1534, DOI 10.1126/science.284.5419.1534; Lin SJ, 2011, P NATL ACAD SCI USA, V108, P5232, DOI 10.1073/pnas.1010689108; Llorca O, 2007, J MOL BIOL, V365, P694, DOI 10.1016/j.jmb.2006.10.015; Lopez-Novoa JM, 2010, AM J PHYSIOL-HEART C, V299, pH959, DOI 10.1152/ajpheart.01251.2009; Lutteke T, 2006, GLYCOBIOLOGY, V16, p71R, DOI 10.1093/glycob/cwj049; MCALLISTER KA, 1994, NAT GENET, V8, P345, DOI 10.1038/ng1294-345; Mertens HDT, 2010, J STRUCT BIOL, V172, P128, DOI 10.1016/j.jsb.2010.06.012; Mitchell D, 2010, MOL CANCER THER, V9, P379, DOI 10.1158/1535-7163.MCT-09-0650; Mitra N, 2006, TRENDS BIOCHEM SCI, V31, P156, DOI 10.1016/j.tibs.2006.01.003; Pardali E, 2010, TRENDS CELL BIOL, V20, P556, DOI 10.1016/j.tcb.2010.06.006; Pernot P, 2010, J PHYS CONF SER, V247, DOI 10.1088/1742-6596/247/1/012009; Pichuantes S, 1997, TISSUE ANTIGENS, V50, P265, DOI 10.1111/j.1399-0039.1997.tb02870.x; Plaza S, 2010, TRENDS CELL BIOL, V20, P524, DOI 10.1016/j.tcb.2010.06.002; Raab U, 1999, BIOCHEM J, V339, P579, DOI 10.1042/0264-6021:3390579; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Ricard N, 2010, BLOOD, V116, P1604, DOI 10.1182/blood-2010-03-276881; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Scharpfenecker M, 2007, J CELL SCI, V120, P964, DOI 10.1242/jcs.002949; Schrodinger LLC, 2006, PYMOL MOL GRAPHICS S; Shovlin CL, 2010, BLOOD REV, V24, P203, DOI 10.1016/j.blre.2010.07.001; Suzuki Y, 2010, J CELL SCI, V123, P1684, DOI 10.1242/jcs.061556; Takacs E, 2009, FEBS LETT, V583, P865, DOI 10.1016/j.febslet.2009.02.011; Upton PD, 2009, J BIOL CHEM, V284, P15794, DOI 10.1074/jbc.M109.002881	50	73	78	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e29948	10.1371/journal.pone.0029948	http://dx.doi.org/10.1371/journal.pone.0029948			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347366	Green Published, Green Submitted, gold			2022-12-27	WOS:000302730100005
J	Creswell, KG; Sayette, MA; Manuck, SB; Ferrell, RE; Hill, SY; Dimoff, JD				Creswell, Kasey G.; Sayette, Michael A.; Manuck, Stephen B.; Ferrell, Robert E.; Hill, Shirley Y.; Dimoff, John D.			DRD4 Polymorphism Moderates the Effect of Alcohol Consumption on Social Bonding	PLOS ONE			English	Article							GENE-ENVIRONMENT INTERACTIONS; DOPAMINE D-4 RECEPTOR; VNTR POLYMORPHISM; DRUG-ADDICTION; SUBSTANCE USE; DRINKING; RISK; ASSOCIATION; EXPECTANCIES; METAANALYSIS	Development of interpersonal relationships is a fundamental human motivation, and behaviors facilitating social bonding are prized. Some individuals experience enhanced reward from alcohol in social contexts and may be at heightened risk for developing and maintaining problematic drinking. We employed a 3 (group beverage condition) 62 (genotype) design (N = 422) to test the moderating influence of the dopamine D4 receptor gene (DRD4 VNTR) polymorphism on the effects of alcohol on social bonding. A significant gene x environment interaction showed that carriers of at least one copy of the 7-repeat allele reported higher social bonding in the alcohol, relative to placebo or control conditions, whereas alcohol did not affect ratings of 7-absent allele carriers. Carriers of the 7-repeat allele were especially sensitive to alcohol's effects on social bonding. These data converge with other recent gene-environment interaction findings implicating the DRD4 polymorphism in the development of alcohol use disorders, and results suggest a specific pathway by which social factors may increase risk for problematic drinking among 7-repeat carriers. More generally, our findings highlight the potential utility of employing transdisciplinary methods that integrate genetic methodologies, social psychology, and addiction theory to improve theories of alcohol use and abuse.	[Creswell, Kasey G.; Sayette, Michael A.; Manuck, Stephen B.; Dimoff, John D.] Univ Pittsburgh, Dept Psychol, Pittsburgh, PA 15260 USA; [Ferrell, Robert E.] Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA 15260 USA; [Hill, Shirley Y.] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Creswell, KG (corresponding author), Univ Pittsburgh, Dept Psychol, Pittsburgh, PA 15260 USA.	kgriffin@pitt.edu			National Institute on Alcohol Abuse and Alcoholism [F31AA018888, R01AA015773]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [F31AA018888, R01AA015773, R01AA015168, R01AA008082, R01AA018289] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study was supported by grants from the National Institute on Alcohol Abuse and Alcoholism (F31AA018888 to Kasey Griffin and R01AA015773 to Michael Sayette). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGNOSTIC STAT MANU, V4th; ASGHARI V, 1995, J NEUROCHEM, V65, P1157, DOI 10.1046/j.1471-4159.1995.65031157.x; Bachman JG, 64 I SOC RES; Bakermans-Kranenburg MJ, 2011, DEV PSYCHOPATHOL, V23, P39, DOI 10.1017/S0954579410000635; BAUMEISTER RF, 1995, PSYCHOL BULL, V117, P497, DOI 10.1037/0033-2909.117.3.497; Beseler CL, 2008, ALCOHOL CLIN EXP RES, V32, P607, DOI 10.1111/j.1530-0277.2008.00619.x; BOLLEN KA, 1990, SOC FORCES, V69, P479, DOI 10.2307/2579670; Comings DE, 2001, CLIN GENET, V60, P107, DOI 10.1034/j.1399-0004.2001.600204.x; Congdon E, 2008, AM J MED GENET B, V147B, P27, DOI 10.1002/ajmg.b.30557; Conway KP, 2003, ADDICT BEHAV, V28, P823, DOI 10.1016/S0306-4603(02)00265-4; Cooper M.L., 1994, PSYCHOL ASSESSMENT, V6, P117, DOI [https://doi.org/10.1037/1040-3590.6.2.117, DOI 10.1037/1040-3590.6.2.117, 10.1037/1040-3590.6.2.117]; COOPER ML, 1995, J PERS SOC PSYCHOL, V69, P990, DOI 10.1037/0022-3514.69.5.990; Costa PT, 2007, REVISED NEO PERSONAL; de Wit H, 2005, MIND ALTERING DRUGS, V1, P258; Dick DM, 2001, J ABNORM PSYCHOL, V110, P625, DOI 10.1037//0021-843X.110.4.625; Ding YC, 2002, P NATL ACAD SCI USA, V99, P309, DOI 10.1073/pnas.012464099; DOTY P, 1995, PSYCHOPHARMACOLOGY, V118, P19, DOI 10.1007/BF02245245; Dreber A, 2009, EVOL HUM BEHAV, V30, P85, DOI 10.1016/j.evolhumbehav.2008.11.001; Ducci F, 2008, ADDICTION, V103, P1414, DOI 10.1111/j.1360-0443.2008.02203.x; Eisenberg DTA, 2010, SOC COGN AFFECT NEUR, V5, P194, DOI 10.1093/scan/nsp026; Eisenegger C, 2010, BIOL PSYCHIAT, V67, P702, DOI 10.1016/j.biopsych.2009.09.021; Engels RCME, 2005, J DRUG EDUC, V35, P147, DOI 10.2190/6Q6B-3LMA-VMVA-L312; EVANS NJ, 1986, SMALL GROUP BEHAV, V17, P203, DOI 10.1177/104649648601700205; Faraone SV, 2001, AM J PSYCHIAT, V158, P1052, DOI 10.1176/appi.ajp.158.7.1052; Filbey FM, 2008, ALCOHOL CLIN EXP RES, V32, P1113, DOI 10.1111/j.1530-0277.2008.00692.x; Forbes EE, 2009, MOL PSYCHIATR, V14, P60, DOI 10.1038/sj.mp.4002086; Fromme K, 2004, ALCOHOL CLIN EXP RES, V28, P247, DOI 10.1097/01.ALC.0000113420.28472.25; Garcia JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014162; Gizer IR, 2009, HUM GENET, V126, P51, DOI 10.1007/s00439-009-0694-x; Goldman D, 2006, FOCUS, V4, P401; Goldman M.S., 1987, PSYCHOL THEORIES DRI, P181; HARRISON GG, 1985, ANN INTERN MED, V103, P989, DOI 10.7326/0003-4819-103-6-989; Heath AC, 2002, ALCOHOL RES HEALTH, V26, P193; Hill SY, 1999, AM J MED GENET, V88, P676, DOI 10.1002/(SICI)1096-8628(19991215)88:6<676::AID-AJMG18>3.0.CO;2-S; Hutchison KE, 2002, HEALTH PSYCHOL, V21, P139, DOI 10.1037//0278-6133.21.2.139; Jovanovic V, 1999, PHARMACOGENETICS, V9, P561, DOI 10.1097/00008571-199910000-00003; Kahler CW, 2003, PSYCHOL ADDICT BEHAV, V17, P226, DOI 10.1037/0893-164X.17.3.226; Karg K, 2011, ARCH GEN PSYCHIAT, V68, P444, DOI 10.1001/archgenpsychiatry.2010.189; Kashy D.A., 2000, HDB RES METHODS SOCI, P451, DOI DOI 10.1017/CBO9780511996481; Kendler KS, 2011, PSYCHOL MED, V41, P1507, DOI 10.1017/S003329171000190X; Kendler KS, 2011, TWIN RES HUM GENET, V14, P1, DOI 10.1375/twin.14.1.1; Kenny DA, 2002, J PERS SOC PSYCHOL, V83, P126, DOI 10.1037/0022-3514.83.1.126; Kirchner TR, 2006, J STUD ALCOHOL, V67, P785, DOI 10.15288/jsa.2006.67.785; Krach S, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00022; Kuhnen CM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004362; Larsen H, 2010, PSYCHOL SCI, V21, P1064, DOI 10.1177/0956797610376654; Laucht M, 2007, J NEURAL TRANSM, V114, P1097, DOI 10.1007/s00702-007-0703-y; Laucht M, 2005, J AM ACAD CHILD PSY, V44, P477, DOI 10.1097/01.chi.0000155980.01792.7f; Le Foll B, 2009, BEHAV PHARMACOL, V20, P1, DOI 10.1097/FBP.0b013e3283242f05; Li DW, 2006, HUM MOL GENET, V15, P2276, DOI 10.1093/hmg/ddl152; LICHTER JB, 1993, HUM MOL GENET, V2, P767, DOI 10.1093/hmg/2.6.767; MacKillop J, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-11; MANN LM, 1987, J CONSULT CLIN PSYCH, V55, P411, DOI 10.1037/0022-006X.55.3.411; MARTIN CS, 1993, ALCOHOL CLIN EXP RES, V17, P140, DOI 10.1111/j.1530-0277.1993.tb00739.x; MARTIN CS, 1993, J STUD ALCOHOL, V54, P750, DOI 10.15288/jsa.1993.54.750; McGeary J, 2009, PHARMACOL BIOCHEM BE, V93, P222, DOI 10.1016/j.pbb.2009.03.010; McGue M, 2004, DECADE BEHAV, P41, DOI 10.1037/10684-003; Moffitt TE, 2006, PERSPECT PSYCHOL SCI, V1, P5, DOI 10.1111/j.1745-6916.2006.00002.x; Monroe SM, 2008, PSYCHOL SCI, V19, P947, DOI 10.1111/j.1467-9280.2008.02181.x; Munafo MR, 2008, BIOL PSYCHIAT, V63, P852, DOI 10.1016/j.biopsych.2007.08.016; Munafo MR, 2009, BIOL PSYCHIAT, V65, P211, DOI 10.1016/j.biopsych.2008.06.009; Oak JN, 2000, EUR J PHARMACOL, V405, P303, DOI 10.1016/S0014-2999(00)00562-8; Park A, 2008, PSYCHOL ADDICT BEHAV, V22, P219, DOI 10.1037/0893-164X.22.2.219; Park A, 2011, J ABNORM PSYCHOL, V120, P585, DOI 10.1037/a0022648; Patrick ME, 2011, PSYCHOL ADDICT BEHAV, V25, P330, DOI 10.1037/a0022445; Patrick ME, 2011, J STUD ALCOHOL DRUGS, V72, P106, DOI 10.15288/jsad.2011.72.106; Perez de Castro I, 1997, PHARMACOGENETICS, V7, P345; Ray LA, 2010, J ABNORM PSYCHOL, V119, P115, DOI 10.1037/a0017550; Risch N, 2009, JAMA-J AM MED ASSOC, V301, P2462, DOI 10.1001/jama.2009.878; ROHSENOW DJ, 1981, ADDICT BEHAV, V6, P107, DOI 10.1016/0306-4603(81)90003-4; Rutter M, 2006, J CHILD PSYCHOL PSYC, V47, P226, DOI 10.1111/j.1469-7610.2005.01557.x; Rutter M, 2001, PSYCHOL BULL, V127, P291, DOI 10.1037//0033-2909.127.3.291; SAYETTE MA, 1993, PSYCHOL BULL, V114, P459, DOI 10.1037/0033-2909.114.3.459; Sayette MA, PSYCHOL SCI IN PRESS; Shanahan MJ, 2005, J GERONTOL B-PSYCHOL, V60, P65, DOI 10.1093/geronb/60.Special_Issue_1.65; Sher KJ, 2005, ANNU REV CLIN PSYCHO, V1, P493, DOI 10.1146/annurev.clinpsy.1.102803.144107; Sher KJ, 2005, MIND ALTERING DRUGS, P135, DOI DOI 10.1093/ACPROF:OSO/9780195165319.003.0005; Shore DM, 2011, EMOTION, V11, P169, DOI 10.1037/a0022601; Singer J.D., 2003, APPL LONGITUDINAL DA, DOI 10.1093/acprof:oso/9780195152968.001.0001; Singer JD, 1998, J EDUC BEHAV STAT, V23, P323; Slutske WS, 2004, J ABNORM PSYCHOL, V113, P530, DOI 10.1037/0021-843X.113.4.530; SMITH GT, 1995, J ABNORM PSYCHOL, V104, P32, DOI 10.1037/0021-843X.104.1.32; van den Wildenberg E, 2007, ADDICT BIOL, V12, P210, DOI 10.1111/j.1369-1600.2007.00064.x; VANTOL HHM, 1992, NATURE, V358, P149; Vogul-Sprott M, 1999, PSYCHOL THEORIES DRI; Volkow ND, 2004, NAT REV NEUROSCI, V5, P963, DOI 10.1038/nrn1539; Wang E, 2004, AM J HUM GENET, V74, P931, DOI 10.1086/420854; Weiss F, 1991, NEUROPHARMACOLOGY ET, P125; Young KA, 2011, NEUROSCI BIOBEHAV R, V35, P498, DOI 10.1016/j.neubiorev.2010.06.004; Zhong SF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013765	90	39	40	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e28914	10.1371/journal.pone.0028914	http://dx.doi.org/10.1371/journal.pone.0028914			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347363	Green Published, gold			2022-12-27	WOS:000302730100004
J	Bahia, PK; Bennett, ES; Taylor-Clark, TE				Bahia, Parmvir K.; Bennett, Eric S.; Taylor-Clark, Thomas E.			Reductions in External Divalent Cations Evoke Novel Voltage-Gated Currents in Sensory Neurons	PLOS ONE			English	Article							ROOT GANGLION NEURONS; CALCIUM-CHANNELS; AFFERENT NEURONS; XENOPUS OOCYTES; EXTRACELLULAR CALCIUM; POTASSIUM CHANNELS; SODIUM-CHANNELS; CA2+ CHANNEL; NA+ CHANNEL; MG2+ BLOCK	It has long been recognized that divalent cations modulate cell excitability. Sensory nerve excitability is of critical importance to peripheral diseases associated with pain, sensory dysfunction and evoked reflexes. Thus we have studied the role these cations play on dissociated sensory nerve activity. Withdrawal of both Mg2+ and Ca2+ from external solutions activates over 90% of dissociated mouse sensory neurons. Imaging studies demonstrate a Na+ influx that then causes depolarization-mediated activation of voltage-gated Ca2+ channels (Ca-V), which allows Ca2+ influx upon divalent reintroduction. Inhibition of CaV (omega-conotoxin, nifedipine) or Na-V (tetrodotoxin, lidocaine) fails to reduce the Na+ influx. The Ca2+ influx is inhibited by Ca-V inhibitors but not by TRPM7 inhibition (spermine) or store-operated channel inhibition (SKF96365). Withdrawal of either Mg2+ or Ca2+ alone fails to evoke cation influxes in vagal sensory neurons. In electrophysiological studies of dissociated mouse vagal sensory neurons, withdrawal of both Mg2+ and Ca2+ from external solutions evokes a large slowly-inactivating voltage-gated current (I-DF) that cannot be accounted for by an increased negative surface potential. Withdrawal of Ca2+ alone fails to evoke I-DF. Evidence suggests I-DF is a non-selective cation current. The IDF is not reduced by inhibition of Na-V (lidocaine, riluzole), Ca-V (cilnidipine, nifedipine), K-V (tetraethylammonium, 4-aminopyridine) or TRPM7 channels (spermine). In summary, sensory neurons express a novel voltage-gated cation channel that is inhibited by external Ca2+ (IC50 similar to 0.5 mu M) or Mg2+ (IC50 similar to 3 mu M). Activation of this putative channel evokes substantial cation fluxes in sensory neurons.	[Bahia, Parmvir K.; Bennett, Eric S.; Taylor-Clark, Thomas E.] Univ S Florida, Coll Med, Dept Mol Pharmacol & Physiol, Tampa, FL 33620 USA	State University System of Florida; University of South Florida	Bahia, PK (corresponding author), Univ S Florida, Coll Med, Dept Mol Pharmacol & Physiol, Tampa, FL 33620 USA.	ttaylorc@health.usf.edu	Taylor-Clark, Thomas/I-6148-2012	Taylor-Clark, Thomas/0000-0002-5056-2699	National Heart, Lung and Blood Institute (NHLBI) [R00HL088520]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL088520] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was funded by the National Heart, Lung and Blood Institute (NHLBI), grant number: R00HL088520. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARELLANO RO, 1995, J PHYSIOL-LONDON, V484, P593, DOI 10.1113/jphysiol.1995.sp020689; Armstrong CM, 1999, P NATL ACAD SCI USA, V96, P4154, DOI 10.1073/pnas.96.7.4154; Bosteels S, 1999, CARDIOVASC RES, V43, P417, DOI 10.1016/S0008-6363(99)00098-X; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chen TY, 1998, J GEN PHYSIOL, V112, P715, DOI 10.1085/jgp.112.6.715; Cordoba-Rodriguez R, 1999, P NATL ACAD SCI USA, V96, P7650, DOI 10.1073/pnas.96.14.7650; Docherty RJ, 2006, NEUROPHARMACOLOGY, V51, P1047, DOI 10.1016/j.neuropharm.2006.06.021; Ednie AR, 2011, COMPREHENSI IN PRESS; Furukawa T, 1999, J PHARMACOL EXP THER, V291, P464; HABLITZ JJ, 1986, BIOPHYS J, V50, P753, DOI 10.1016/S0006-3495(86)83515-9; HARRIS RJ, 1981, J CEREBR BLOOD F MET, V1, P203, DOI 10.1038/jcbfm.1981.21; HAY M, 1994, BRAIN RES, V639, P333, DOI 10.1016/0006-8993(94)91749-3; HAY M, 1994, NEUROSCI LETT, V167, P179, DOI 10.1016/0304-3940(94)91056-1; Hille B., 2001, ION CHANNELS EXCITAB, P635; Immke DC, 2001, NAT NEUROSCI, V4, P869, DOI 10.1038/nn0901-869; Kozak JA, 2005, J GEN PHYSIOL, V126, P499, DOI 10.1085/jgp.200509324; Kozak JA, 2003, BIOPHYS J, V84, P922, DOI 10.1016/S0006-3495(03)74909-1; Kuner T, 1996, J NEUROSCI, V16, P3549; Kwong K, 2008, J PHYSIOL-LONDON, V586, P1321, DOI 10.1113/jphysiol.2007.146365; Lancaster E, 2001, J NEUROPHYSIOL, V85, P247, DOI 10.1152/jn.2001.85.1.247; LI JQ, 1994, PFLUG ARCH EUR J PHY, V429, P183, DOI 10.1007/BF00374311; Lopez-Santiago LF, 2011, J BIOL CHEM, V286, P22913, DOI 10.1074/jbc.M111.242370; LUX HD, 1990, J PHYSIOL-LONDON, V430, P159, DOI 10.1113/jphysiol.1990.sp018287; Macianskiene R, 2002, AM J PHYSIOL-HEART C, V282; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Morris M E, 1992, Magnes Res, V5, P303; Mubagwa K, 1997, J PHYSIOL-LONDON, V502, P235, DOI 10.1111/j.1469-7793.1997.235bk.x; Murakami M, 2001, EUR J PHARMACOL, V419, P175, DOI 10.1016/S0014-2999(01)00985-2; Nilius B, 2001, J BIOL CHEM, V276, P1020, DOI 10.1074/jbc.M006184200; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Patapoutian A, 2009, NAT REV DRUG DISCOV, V8, P55, DOI 10.1038/nrd2757; Patton C, 2004, CELL CALCIUM, V35, P427, DOI 10.1016/j.ceca.2003.10.006; Po SS, 1999, J CARDIOVASC PHARM, V33, P181, DOI 10.1097/00005344-199902000-00002; Sabovcik R, 1996, PFLUG ARCH EUR J PHY, V431, P599, DOI 10.1007/BF02191909; Schlingmann KP, 2002, NAT GENET, V31, P166, DOI 10.1038/ng889; Song JH, 1997, J PHARMACOL EXP THER, V282, P707; Tapia R, 1997, NEUROCHEM INT, V30, P137, DOI 10.1016/S0197-0186(96)00056-3; Taylor-Clark TE, 2008, BRIT J PHARMACOL, V154, P1359, DOI 10.1038/bjp.2008.196; Taylor-Clark T, 2006, J APPL PHYSIOL, V101, P950, DOI 10.1152/japplphysiol.00222.2006; Taylor-Clark TE, 2008, MOL PHARMACOL, V73, P274, DOI 10.1124/mol.107.040832; Undem BJ, 2003, J NEUROPHYSIOL, V89, P1196, DOI 10.1152/jn.00553.2002; VERNINO S, 1992, NEURON, V8, P127, DOI 10.1016/0896-6273(92)90114-S; Virginio C, 1997, NEUROPHARMACOLOGY, V36, P1285, DOI 10.1016/S0028-3908(97)00141-X; Wei WL, 2007, P NATL ACAD SCI USA, V104, P16323, DOI 10.1073/pnas.0701149104; Zhang P, 2001, J GEN PHYSIOL, V117, P563, DOI 10.1085/jgp.117.6.563; ZUFALL F, 1993, J NEUROPHYSIOL, V69, P1758, DOI 10.1152/jn.1993.69.5.1758	46	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2012	7	2							e31585	10.1371/journal.pone.0031585	http://dx.doi.org/10.1371/journal.pone.0031585			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LV	22328938	Green Published, Green Submitted, gold			2022-12-27	WOS:000302179300024
J	Salvatori, L; Caporuscio, F; Verdina, A; Starace, G; Crispi, S; Nicotra, MR; Russo, A; Calogero, RA; Morgante, E; Natali, PG; Russo, MA; Petrangeli, E				Salvatori, Luisa; Caporuscio, Francesca; Verdina, Alessandra; Starace, Giuseppe; Crispi, Stefania; Nicotra, Maria Rita; Russo, Andrea; Calogero, Raffaele Adolfo; Morgante, Emanuela; Natali, Pier Giorgio; Russo, Matteo Antonio; Petrangeli, Elisa			Cell-to-Cell Signaling Influences the Fate of Prostate Cancer Stem Cells and Their Potential to Generate More Aggressive Tumors	PLOS ONE			English	Article							E-CADHERIN EXPRESSION; NEUROENDOCRINE CELLS; GROWTH; ADHESION; DENSITY; DIFFERENTIATION; IDENTIFICATION; NORMALIZATION; METASTASIS; VIMENTIN	An increasing number of malignancies has been shown to be initiated and propelled by small subpopulations of cancer stem cells (CSC). However, whether tumor aggressiveness is driven by CSC and by what extent this property may be relevant within the tumor mass is still unsettled. To address this issue, we isolated a rare tumor cell population on the basis of its CD44(+) CD24(-) phenotype from the human androgen-independent prostate carcinoma cell line DU145 and established its CSC properties. The behavior of selected CSC was investigated with respect to the bulk DU145 cells. The injection of CSC in nude mice generated highly vascularized tumors infiltrating the adjacent tissues, showing high density of neuroendocrine cells and expressing low levels of E-cadherin and beta-catenin as well as high levels of vimentin. On the contrary, when a comparable number of unsorted DU145 cells were injected the resulting tumors were less aggressive. To investigate the different features of tumors in vivo, the influence of differentiated tumor cells on CSC was examined in vitro by growing CSC in the absence or presence of conditioned medium from DU145 cells. CSC grown in permissive conditions differentiated into cell populations with features similar to those of cells held in aggressive tumors generated from CSC injection. Differently, conditioned medium induced CSC to differentiate into a cell phenotype comparable to cells of scarcely aggressive tumors originated from bulk DU145 cell injection. These findings show for the first time that CSC are able to generate differentiated cells expressing either highly or scarcely aggressive phenotype, thus influencing prostate cancer progression. The fate of CSC was determined by signals released from tumor environment. Moreover, using microarray analysis we selected some molecules which could be involved in this cell-to-cell signaling, hypothesizing their potential value for prognostic or therapeutic applications.	[Salvatori, Luisa; Nicotra, Maria Rita; Petrangeli, Elisa] CNR, Inst Mol Biol & Pathol, Rome, Italy; [Salvatori, Luisa; Caporuscio, Francesca; Verdina, Alessandra; Starace, Giuseppe; Petrangeli, Elisa] Regina Elena Inst Canc Res, CRS, Dept Therapeut Program Dev, Rome, Italy; [Caporuscio, Francesca; Morgante, Emanuela; Russo, Matteo Antonio; Petrangeli, Elisa] Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy; [Crispi, Stefania] CNR, Inst Genet & Biophys, Gene Express Core, Human Mol Genet Lab, I-80125 Naples, Italy; [Russo, Andrea] Regina Elena Inst Canc Res, Dept Surg Pathol, Rome, Italy; [Calogero, Raffaele Adolfo] Ctr Mol Biotechnol, Bioinformat & Genom Unit, Turin, Italy; [Natali, Pier Giorgio] Univ G dAnnunzio, CINBO Labs, Chieti, Italy; [Russo, Matteo Antonio] IRCCS San Raffaele Pisana, Dept Cellular & Mol Pathol, Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; G d'Annunzio University of Chieti-Pescara; IRCCS San Raffaele Pisana	Salvatori, L (corresponding author), CNR, Inst Mol Biol & Pathol, Rome, Italy.	luisa.salvatori@ifo.it	Verdina, Alessandra/ABH-7405-2020; Salvatori, Luisa/AAK-9365-2021; Verdina, Alessandra/H-8868-2017; Calogero, Raffaele/K-9428-2019; Russo, Matteo/AAD-7733-2021	Verdina, Alessandra/0000-0001-9972-9237; Verdina, Alessandra/0000-0001-9972-9237; Calogero, Raffaele/0000-0002-2848-628X; Crispi, Stefania/0000-0002-7566-1554	Italian Ministry of Health [PRIN 2006062242]	Italian Ministry of Health(Ministry of Health, Italy)	This study was supported in part by the Italian Ministry of Health (PRIN 2006062242). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ABRAHAMSSON PA, 1993, J ANDROL, V14, P307; Abrahamsson PA, 1999, ENDOCR-RELAT CANCER, V6, P503, DOI 10.1677/erc.0.0060503; Bae KM, 2010, J UROLOGY, V183, P2045, DOI 10.1016/j.juro.2009.12.092; Barrett T, 2005, NUCLEIC ACIDS RES, V33, pD562; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; BONKHOFF H, 1993, VIRCHOWS ARCH A, V423, P291, DOI 10.1007/BF01606893; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; DAMSKY CH, 1983, CELL, V34, P455, DOI 10.1016/0092-8674(83)90379-3; De Marzo AM, 1999, UROLOGY, V53, P707, DOI 10.1016/S0090-4295(98)00577-9; Debes JD, 2004, NEW ENGL J MED, V351, P1488, DOI 10.1056/NEJMp048178; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Grobhotz R, 2005, HUM PATHOL, V36, P562, DOI 10.1016/j.humpath.2005.02.019; Han SH, 2003, ONCOGENE, V22, P4035, DOI 10.1038/sj.onc.1206610; Hanai J, 2005, J BIOL CHEM, V280, P13641, DOI 10.1074/jbc.M413047200; HINCK L, 1994, J CELL BIOL, V124, P729, DOI 10.1083/jcb.124.5.729; HOOSEIN NM, 1993, J UROLOGY, V149, P1209, DOI 10.1016/S0022-5347(17)36349-8; Hurt EM, 2008, BRIT J CANCER, V98, P756, DOI 10.1038/sj.bjc.6604242; Huss WJ, 2004, PROSTATE, V60, P77, DOI 10.1002/pros.20041; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jennbacken K, 2005, PROSTATE, V65, P110, DOI 10.1002/pros.20276; Kamiya N, 2008, INT J UROL, V15, P423, DOI 10.1111/j.1442-2042.2008.02015.x; KESSEL RG, 1992, INT REV CYTOL, V133, P43, DOI 10.1016/S0074-7696(08)61858-6; Lang SH, 2002, PROSTATE, V52, P253, DOI 10.1002/pros.10088; Lind AJ, 2005, PROSTATE, V62, P394, DOI 10.1002/pros.20163; Liu B, 2007, ONCOGENE, V26, P1811, DOI 10.1038/sj.onc.1209977; Morita N, 1999, BRIT J CANCER, V79, P1879, DOI 10.1038/sj.bjc.6690299; Nagakawa O, 1999, CANCER LETT, V147, P207, DOI 10.1016/S0304-3835(99)00309-2; Nicholson B, 2004, J CELL BIOCHEM, V91, P125, DOI 10.1002/jcb.10772; Orlichenko L, 2009, MOL BIOL CELL, V20, P4140, DOI 10.1091/mbc.E08-10-1043; Patrawala L, 2006, ONCOGENE, V25, P1696, DOI 10.1038/sj.onc.1209327; Pontes-Junior J, 2009, J CARCINOG, V8, P1; Ravenna L, 1996, PROSTATE, V29, P219, DOI 10.1002/(SICI)1097-0045(199610)29:4&lt;219::AID-PROS3&gt;3.0.CO;2-6; Redmer T, 2011, EMBO REP, V12, P720, DOI 10.1038/embor.2011.88; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; RIUS C, 1992, J CELL SCI, V101, P395; Sanges R, 2007, BIOINFORMATICS, V23, P3406, DOI 10.1093/bioinformatics/btm469; Shiina H, 2005, CANCER RES, V65, P2130, DOI 10.1158/0008-5472.CAN-04-3398; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sun ZJ, 2008, BRIT J CANCER, V99, P1656, DOI 10.1038/sj.bjc.6604712; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; UMBAS R, 1994, CANCER RES, V54, P3929; VLEMINCKX K, 1991, CELL, V66, P107, DOI 10.1016/0092-8674(91)90143-M; Walker MR, 2009, J PATHOL, V217, P169, DOI 10.1002/path.2474; Wang J, 2010, CANCER RES, V70, P10182, DOI 10.1158/0008-5472.CAN-10-2414; Wesley UV, 2005, CANCER RES, V65, P1325, DOI 10.1158/0008-5472.CAN-04-1852; Westfall P.H., 1993, RESAMPLING BASED MUL, V279	47	30	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2012	7	2							e31467	10.1371/journal.pone.0031467	http://dx.doi.org/10.1371/journal.pone.0031467			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LV	22328933	Green Submitted, Green Published, gold			2022-12-27	WOS:000302179300019
J	Gauthier, T; Wang, XD; Sifuentes, J; Santos, D; Fysikopoulos, A; Tadrist, S; Canlet, C; Artigot, MP; Loiseau, N; Oswald, IP; Puel, O				Gauthier, Thierry; Wang, Xiaodi; Sifuentes, Joice; Santos, Dos; Fysikopoulos, Athanasios; Tadrist, Souria; Canlet, Cecile; Artigot, Marie Pierre; Loiseau, Nicolas; Oswald, Isabelle P.; Puel, Olivier			Trypacidin, a Spore-Borne Toxin from Aspergillus fumigatus, Is Cytotoxic to Lung Cells	PLOS ONE			English	Article							PULMONARY ASPERGILLOSIS; ALKALOID BIOSYNTHESIS; EPITHELIAL-CELLS; ERGOT ALKALOIDS; GLIOTOXIN; APOPTOSIS; MYCOTOXINS; EXPOSURE; CONIDIA; FUMIQUINAZOLINE	Inhalation of Aspergillus fumigatus conidia can cause severe aspergillosis in immunosuppressed people. A. fumigatus produces a large number of secondary metabolites, some of which are airborne by conidia and whose toxicity to the respiratory tract has not been investigated. We found that spores of A. fumigatus contain five main compounds, tryptoquivaline F, fumiquinazoline C, questin, monomethylsulochrin and trypacidin. Fractionation of culture extracts using RP-HPLC and LC-MS showed that samples containing questin, monomethylsulochrin and trypacidin were toxic to the human A549 lung cell line. These compounds were purified and their structure verified using NMR in order to compare their toxicity against A549 cells. Trypacidin was the most toxic, decreasing cell viability and triggering cell lysis, both effects occurring at an IC50 close to 7 mu M. Trypacidin toxicity was also observed in the same concentration range on human bronchial epithelial cells. In the first hour of exposure, trypacidin initiates the intracellular formation of nitric oxide (NO) and hydrogen peroxide (H2O2). This oxidative stress triggers necrotic cell death in the following 24 h. The apoptosis pathway, moreover, was not involved in the cell death process as trypacidin did not induce apoptotic bodies or a decrease in mitochondrial membrane potential. This is the first time that the toxicity of trypacidin to lung cells has been reported.	[Gauthier, Thierry; Wang, Xiaodi; Sifuentes, Joice; Santos, Dos; Fysikopoulos, Athanasios; Tadrist, Souria; Canlet, Cecile; Artigot, Marie Pierre; Loiseau, Nicolas; Oswald, Isabelle P.; Puel, Olivier] UPS, INP, French Natl Inst Agr Res, TOXALIM,UMR1331, Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); INRAE; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National Polytechnique de Toulouse	Gauthier, T (corresponding author), UPS, INP, French Natl Inst Agr Res, TOXALIM,UMR1331, Toulouse, France.	opuel@toulouse.inra.fr	dos Santos, Joice Sifuentes/J-1583-2012; LOISEAU, Nicolas/ADN-2394-2022; OSWALD, Isabelle P/A-8497-2013; OSWALD, Isabelle/GPP-1123-2022	dos Santos, Joice Sifuentes/0000-0002-1089-0620; LOISEAU, Nicolas/0000-0003-3783-0879; OSWALD, Isabelle P/0000-0001-9918-277X; OSWALD, Isabelle/0000-0001-9918-277X; Puel, Olivier/0000-0003-1946-5310; Gauthier, Thierry/0000-0003-0207-0515	Agence de l'Environnement et de la Maitrise de l'Energie [0675C0083]; Agence Francaise de Securite Sanitaire de l'Environnement et du Travail [ES-2007-063, ES-2008/1-27]	Agence de l'Environnement et de la Maitrise de l'Energie; Agence Francaise de Securite Sanitaire de l'Environnement et du Travail	This work was supported, in part, by a grant (No 0675C0083) from the Agence de l'Environnement et de la Maitrise de l'Energie and by grants (ES-2007-063 and ES-2008/1-27) from the Agence Francaise de Securite Sanitaire de l'Environnement et du Travail. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afiyatullov SS, 2004, CHEM NAT COMPD+, V40, P615, DOI 10.1007/s10600-005-0058-2; Ames BD, 2011, BIOCHEMISTRY-US, V50, P8756, DOI 10.1021/bi201302w; Ames BD, 2010, BIOCHEMISTRY-US, V49, P8564, DOI 10.1021/bi1012029; Araujo R, 2010, MED MYCOL, V48, P832, DOI 10.3109/13693780903575360; Arendrup MC, 2006, SCAND J INFECT DIS, V38, P945, DOI 10.1080/00365540600606580; BALAN J, 1965, ACTA CHEM SCAND, V19, P528, DOI 10.3891/acta.chem.scand.19-0528; BALAN J, 1963, J ANTIBIOT, V16, P157; Batard E, 2003, EUR J CLIN MICROBIOL, V22, P357, DOI 10.1007/s10096-003-0939-x; Brakhage AA, 2011, FUNGAL GENET BIOL, V48, P15, DOI 10.1016/j.fgb.2010.04.004; Chomcheon P, 2009, PHYTOCHEMISTRY, V70, P121, DOI 10.1016/j.phytochem.2008.10.007; Coyle CM, 2007, MYCOLOGIA, V99, P804, DOI 10.3852/mycologia.99.6.804; Dagenais TRT, 2009, CLIN MICROBIOL REV, V22, P447, DOI 10.1128/CMR.00055-08; Daly P, 1999, MYCOPATHOLOGIA, V146, P67, DOI 10.1023/A:1007092112873; Eduard W, 2009, CRIT REV TOXICOL, V39, P799, DOI 10.3109/10408440903307333; Femenia F, 2009, MYCOPATHOLOGIA, V167, P249, DOI 10.1007/s11046-008-9175-3; Fischer G, 1999, CHEMOSPHERE, V38, P1745, DOI 10.1016/S0045-6535(98)00391-9; Fischer G, 2000, INT J HYG ENVIR HEAL, V203, P105, DOI 10.1078/S1438-4639(04)70015-2; Flemming J, 2004, TOXICOL SCI, V78, P267, DOI 10.1093/toxsci/kfh064; Frisvad JC, 2009, MED MYCOL, V47, pS53, DOI 10.1080/13693780802307720; Geiser DM, 1998, MYCOLOGIA, V90, P831, DOI 10.2307/3761325; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Hertweck C, 2009, NAT CHEM BIOL, V5, P450, DOI 10.1038/nchembio0709-450; Hong SB, 2005, MYCOLOGIA, V97, P1316, DOI 10.3852/mycologia.97.6.1316; Karvala K, 2008, AM J RHINOL, V22, P457, DOI 10.2500/ajr.2008.22.3209; Khaldi N, 2010, FUNGAL GENET BIOL, V47, P736, DOI 10.1016/j.fgb.2010.06.003; Khoufache K, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-5; Krishnaswamy R, 2010, FREE RADICAL BIO MED, V49, P50, DOI 10.1016/j.freeradbiomed.2010.03.016; Kweon YO, 2003, J HEPATOL, V39, P38, DOI 10.1016/S0168-8278(03)00178-8; Kwon-Chung KJ, 2009, MED MYCOL, V47, pS97, DOI 10.1080/13693780802056012; Larsen TO, 2007, MED MYCOL, V45, P225, DOI 10.1080/13693780601185939; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; Lewis RE, 2005, INFECT IMMUN, V73, P635, DOI 10.1128/IAI.73.1.635-637.2005; Maiya S, 2006, CHEMBIOCHEM, V7, P1062, DOI 10.1002/cbic.200600003; Matysik S, 2008, J MICROBIOL METH, V75, P182, DOI 10.1016/j.mimet.2008.05.027; Miller JD, 2010, CHEM-BIOL INTERACT, V183, P113, DOI 10.1016/j.cbi.2009.09.023; Mitchell CG, 1997, THORAX, V52, P796, DOI 10.1136/thx.52.9.796; Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332; Panaccione DG, 2005, APPL ENVIRON MICROB, V71, P3106, DOI 10.1128/AEM.71.6.3106-3111.2005; Perrin RM, 2007, PLOS PATHOG, V3, P508, DOI 10.1371/journal.ppat.0030050; RABINOVITCH PS, 1994, METHOD CELL BIOL, V41, P263; Russell K, 2008, LANCET, V371, P2056, DOI 10.1016/S0140-6736(08)60877-6; Samson R. A., 1994, AIR QUALITY MONOGRAP, V2, P531; Shen HM, 1996, FREE RADICAL BIO MED, V21, P139, DOI 10.1016/0891-5849(96)00019-6; Tepsic K, 1997, FEMS MICROBIOL LETT, V157, P9, DOI 10.1111/j.1574-6968.1997.tb12745.x; Turner W. B., 1965, J CHEM SOC PERK T, P6658; Twumasi-Boateng K, 2009, EUKARYOT CELL, V8, P104, DOI 10.1128/EC.00265-08; Zhang L, 2009, ANTI-CANCER DRUG, V20, P416, DOI 10.1097/CAD.0b013e32832aa7b0; Zhou XM, 2000, TOXICOL SCI, V54, P194, DOI 10.1093/toxsci/54.1.194; Zielinska-Jankiewicz K, 2008, ANN AGR ENV MED, V15, P71	49	65	80	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e29906	10.1371/journal.pone.0029906	http://dx.doi.org/10.1371/journal.pone.0029906			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LO	22319557	Green Published, Green Submitted, gold			2022-12-27	WOS:000302178400003
J	O'Halloran, DM; Hamilton, OS; Lee, JI; Gallegos, M; L'Etoile, ND				O'Halloran, Damien M.; Hamilton, O. Scott; Lee, Jin I.; Gallegos, Maria; L'Etoile, Noelle D.			Changes in cGMP Levels Affect the Localization of EGL-4 in AWC in Caenorhabditis elegans	PLOS ONE			English	Article							REGULATES OLFACTORY ADAPTATION; DEPENDENT PROTEIN-KINASE; NUCLEOTIDE-GATED CHANNEL; C-ELEGANS; CHEMOSENSORY NEURONS; CILIA; TRANSPORT; PLASTICITY; MOTORS; CELLS	The Protein Kinase G, EGL-4, is required within the C. elegans AWC sensory neurons to promote olfactory adaptation. After prolonged stimulation of these neurons, EGL-4 translocates from the cytosol to the nuclei of the AWC. This nuclear translocation event is both necessary and sufficient for adaptation of the AWC neuron to odor. A cGMP binding motif within EGL-4 and the G alpha protein ODR-3 are both required for this translocation event, while loss of the guanylyl cyclase ODR-1 was shown to result in constitutively nuclear localization of EGL-4. However, the molecular changes that are integrated over time to produce a stably adapted response in the AWC are unknown. Here we show that odor-induced fluctuations in cGMP levels in the adult cilia may be responsible in part for sending EGL-4 into the AWC nucleus to produce long-term adaptation. We found that reductions in cGMP that result from mutations in the genes encoding the cilia-localized guanylyl cyclases ODR-1 and DAF-11 result in constitutively nuclear EGL-4 even in naive animals. Conversely, increases in cGMP levels that result from mutations in cGMP phosphodiesterases block EGL-4 nuclear entry even after prolonged odor exposure. Expression of a single phosphodiesterase in adult, naive animals was sufficient to modestly increase the number of animals with nuclear EGL-4. Further, coincident acute treatment of animals with odor and the phosphodiesterase inhibitor 3-isobutyl-1-methylxanthine (IBMX) decreased the number of animals with nuclear EGL-4. These data suggest that reducing cGMP levels in AWC is necessary and even partially sufficient for nuclear translocation of EGL-4 and adaptation as a result of prolonged odor exposure. Our genetic analysis and chemical treatment of C. elegans further indicate that cilia morphology, as defined by fluorescent microscopic observation of the sensory endings, may allow for odor-induced fluctuations in cGMP levels and this fluctuation may be responsible for sending EGL-4 into the AWC nucleus.	[O'Halloran, Damien M.; Hamilton, O. Scott; Lee, Jin I.; L'Etoile, Noelle D.] Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA; [O'Halloran, Damien M.; L'Etoile, Noelle D.] Univ Calif Davis, Dept Psychiat & Behav Sci, Sacramento, CA 95817 USA; [O'Halloran, Damien M.] George Washington Univ, Dept Biol Sci, Washington, DC 20052 USA; [O'Halloran, Damien M.] George Washington Univ, Inst Neurosci, Washington, DC USA; [Lee, Jin I.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Gallegos, Maria] Calif State Univ E Bay, Dept Biol Sci, Hayward, CA USA	University of California System; University of California Davis; University of California System; University of California Davis; George Washington University; George Washington University; Fred Hutchinson Cancer Center; California State University System; California State University East Bay	O'Halloran, DM (corresponding author), Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA.	damienoh@gwu.edu	O'Halloran, Damien/F-2779-2013		National Institutes of Health/National Institute on Deafness and Other Communication Disorders [R01 DC005991]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005991] Funding Source: NIH RePORTER	National Institutes of Health/National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was funded by National Institutes of Health/National Institute on Deafness and Other Communication Disorders R01 DC005991 to NDL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardiel EL, 2008, J NEUROGENET, P1; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Ben-Shahar Y, 2003, J EXP BIOL, V206, P2507, DOI 10.1242/jeb.00442; Birnby DA, 2000, GENETICS, V155, P85; Biron D, 2006, NAT NEUROSCI, V9, P1499, DOI 10.1038/nn1796; Blacque OE, 2006, CELL MOL LIFE SCI, V63, P2145, DOI 10.1007/s00018-006-6180-x; Blacque OE, 2005, CURR BIOL, V15, P935, DOI 10.1016/j.cub.2005.04.059; BRENNER S, 1974, GENETICS, V77, P71; Calvert PD, 2006, TRENDS CELL BIOL, V16, P560, DOI 10.1016/j.tcb.2006.09.001; Chalasani SH, 2007, NATURE, V450, P63, DOI 10.1038/nature06292; Coburn CM, 1996, NEURON, V17, P695, DOI 10.1016/S0896-6273(00)80201-9; COLBERT HA, 1995, NEURON, V14, P803, DOI 10.1016/0896-6273(95)90224-4; CORBIN JD, 1983, J BIOL CHEM, V258, P1391; Evans JE, 2006, J CELL BIOL, V172, P663, DOI 10.1083/jcb.200509115; Fitzpatrick MJ, 2007, NATURE, V447, P210, DOI 10.1038/nature05764; Fu YB, 2007, PFLUG ARCH EUR J PHY, V454, P805, DOI 10.1007/s00424-006-0194-y; Hallows JL, 2003, J NEUROSCI, V23, P10633; Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01; Hong RL, 2008, P NATL ACAD SCI USA, V105, P7779, DOI 10.1073/pnas.0708406105; Isner JC, 2011, PLANT J, V65, P329, DOI 10.1111/j.1365-313X.2010.04418.x; Jansen G, 1999, NAT GENET, V21, P414, DOI 10.1038/7753; Johnson JLF, 2010, TRENDS CELL BIOL, V20, P435, DOI 10.1016/j.tcb.2010.05.005; Kaye JA, 2009, NEURON, V61, P57, DOI 10.1016/j.neuron.2008.11.012; Kim JC, 2004, NAT GENET, V36, P462, DOI 10.1038/ng1352; Komatsu H, 1996, NEURON, V17, P707, DOI 10.1016/S0896-6273(00)80202-0; Kraus N, 2010, NAT REV NEUROSCI, V11, P599, DOI 10.1038/nrn2882; L'Etoile ND, 2002, NEURON, V36, P1079, DOI 10.1016/S0896-6273(02)01066-8; L'Etoile ND, 2000, NEURON, V25, P575, DOI 10.1016/S0896-6273(00)81061-2; Lamprecht R, 2004, NAT REV NEUROSCI, V5, P45, DOI 10.1038/nrn1301; Lans H, 2004, GENETICS, V167, P1677, DOI 10.1534/genetics.103.024786; Lee JI, 2010, P NATL ACAD SCI USA, V107, P6016, DOI 10.1073/pnas.1000866107; LINDSAY RM, 1994, TRENDS NEUROSCI, V17, P182, DOI 10.1016/0166-2236(94)90099-X; Liu J, 2010, NAT NEUROSCI, V13, P715, DOI 10.1038/nn.2540; Lucas C, 2009, P NATL ACAD SCI USA, V106, P6351, DOI 10.1073/pnas.0809463106; Luo DG, 2008, P NATL ACAD SCI USA, V105, P9855, DOI 10.1073/pnas.0708405105; Matsuki M, 2006, P NATL ACAD SCI USA, V103, P1112, DOI 10.1073/pnas.0506954103; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Meng YH, 2002, NEURON, V35, P121, DOI 10.1016/S0896-6273(02)00758-4; MOSER MB, 1994, P NATL ACAD SCI USA, V91, P12673, DOI 10.1073/pnas.91.26.12673; Mukhopadhyay S, 2008, DEV CELL, V14, P762, DOI 10.1016/j.devcel.2008.03.002; Nausch LWM, 2008, P NATL ACAD SCI USA, V105, P365, DOI 10.1073/pnas.0710387105; Nuttley WM, 2002, P NATL ACAD SCI USA, V99, P12449, DOI 10.1073/pnas.192101699; O'Halloran DM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000761; Orozco JT, 1999, NATURE, V398, P674, DOI 10.1038/19448; Ortiz CO, 2006, GENETICS, V173, P131, DOI 10.1534/genetics.106.055749; Ou GS, 2005, NATURE, V436, P583, DOI 10.1038/nature03818; PERKINS LA, 1986, DEV BIOL, V117, P456, DOI 10.1016/0012-1606(86)90314-3; Roayaie K, 1998, NEURON, V20, P55, DOI 10.1016/S0896-6273(00)80434-1; Sengupta P, 1996, CELL, V84, P899, DOI 10.1016/S0092-8674(00)81068-5; Signor D, 1999, J CELL BIOL, V147, P519, DOI 10.1083/jcb.147.3.519; Signor D, 2000, METHODS, V22, P317, DOI 10.1006/meth.2000.1084; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0	54	25	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e31614	10.1371/journal.pone.0031614	http://dx.doi.org/10.1371/journal.pone.0031614			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LO	22319638	Green Submitted, Green Published, gold			2022-12-27	WOS:000302178400046
J	Yasui, Y; Mori, M; Aii, J; Abe, T; Matsumoto, D; Sato, S; Hayashi, Y; Ohnishi, O; Ota, T				Yasui, Yasuo; Mori, Masashi; Aii, Jotaro; Abe, Tomoko; Matsumoto, Daiki; Sato, Shingo; Hayashi, Yoriko; Ohnishi, Ohmi; Ota, Tatsuya			S-LOCUS EARLY FLOWERING 3 Is Exclusively Present in the Genomes of Short-Styled Buckwheat Plants that Exhibit Heteromorphic Self-Incompatibility	PLOS ONE			English	Article							S-RECEPTOR KINASE; POLLEN DETERMINANT; DNA-SEQUENCES; IDENTIFICATION; GENES; EXPRESSION; PROTEINS; CLONING; LOCUS; REJECTION	The different forms of flowers in a species have attracted the attention of many evolutionary biologists, including Charles Darwin. In Fagopyrum esculentum (common buckwheat), the occurrence of dimorphic flowers, namely short-styled and long-styled flowers, is associated with a type of self-incompatibility (SI) called heteromorphic SI. The floral morphology and intra-morph incompatibility are both determined by a single genetic locus named the S-locus. Plants with short-styled flowers are heterozygous (S/s) and plants with long-styled flowers are homozygous recessive (s/s) at the S-locus. Despite recent progress in our understanding of the molecular basis of flower development and plant SI systems, the molecular mechanisms underlying heteromorphic SI remain unresolved. By examining differentially expressed genes from the styles of the two floral morphs, we identified a gene that is expressed only in short-styled plants. The novel gene identified was completely linked to the S-locus in a linkage analysis of 1,373 plants and had homology to EARLY FLOWERING 3. We named this gene S-LOCUS EARLY FLOWERING 3 (S-ELF3). In an ion-beam-induced mutant that harbored a deletion in the genomic region spanning S-ELF3, a phenotype shift from short-styled flowers to long-styled flowers was observed. Furthermore, S-ELF3 was present in the genome of short-styled plants and absent from that of long-styled plants both in world-wide landraces of buckwheat and in two distantly related Fagopyrum species that exhibit heteromorphic SI. Moreover, independent disruptions of S-ELF3 were detected in a recently emerged self-compatible Fagopyrum species and a self-compatible line of buckwheat. The nonessential role of S-ELF3 in the survival of individuals and the prolonged evolutionary presence only in the genomes of short-styled plants exhibiting heteromorphic SI suggests that S-ELF3 is a suitable candidate gene for the control of the short-styled phenotype of buckwheat plants.	[Yasui, Yasuo; Matsumoto, Daiki; Ohnishi, Ohmi] Kyoto Univ, Grad Sch Agr, Sakyou Ku, Kyoto, Japan; [Mori, Masashi] Ishikawa Prefectural Univ, Res Inst Bioresources & Biotechnol, Nonoichi, Ishikawa, Japan; [Aii, Jotaro; Sato, Shingo] Niigata Univ Pharm & Appl Life Sci, Fac Appl Life Sci, Akiha Ku, Niigata, Japan; [Abe, Tomoko; Hayashi, Yoriko] RIKEN, Nishina Ctr Accelerator Based Sci, Wako, Saitama, Japan; [Ota, Tatsuya] Grad Univ Adv Studies, Dept Evolutionary Studies Biosyst, Hayama, Kanagawa, Japan	Kyoto University; Ishikawa Prefecture University; Niigata University; RIKEN; Graduate University for Advanced Studies - Japan	Yasui, Y (corresponding author), Kyoto Univ, Grad Sch Agr, Sakyou Ku, Kyoto, Japan.	yasyas@kais.kyoto-u.ac.jp		Ota, Tatsuya/0000-0002-1115-5169	IGARASHI Buckwheat Research Foundation; JSPS (Japan Society for Promotion of Science) [22580003]; Kyoto University; Center for the Promotion of Integrated Sciences; Hayama Center for Advanced Studies at Sokendai	IGARASHI Buckwheat Research Foundation; JSPS (Japan Society for Promotion of Science)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Kyoto University; Center for the Promotion of Integrated Sciences; Hayama Center for Advanced Studies at Sokendai	This work was supported in part by funding from the IGARASHI Buckwheat Research Foundation to YY, Grants-in-Aid for Scientific Research from JSPS (Japan Society for Promotion of Science) to YY (#22580003), Core Stage Backup Research Fund of Kyoto University to YY, and a research grant from the Center for the Promotion of Integrated Sciences and the Hayama Center for Advanced Studies at Sokendai to TO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aii J, 1999, BREEDING SCI, V48, P59; Ainsworth C, 2000, ANN BOT-LONDON, V86, P211, DOI 10.1006/anbo.2000.1201; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barrett S.C.H., 1992, EVOLUTION FUNCTION H, DOI DOI 10.1007/978-3-642-86656-2_1; Brandbyge J., 1993, FLOWERING PLANTS DIC, P531, DOI [10.1007/978-3-662-02899-563, 10.1007/978-3-662-02899-5_63, DOI 10.1007/978-3-662-02899-5_63]; Chalesworth D, 2010, F1000 BIOL REP, V2; Chalesworth D, 1982, AM NAT, V119, P732; Cohen JI, 2010, AM J BOT, V97, P701, DOI 10.3732/ajb.0900395; Dixon LE, 2011, CURR BIOL, V21, P120, DOI 10.1016/j.cub.2010.12.013; ERNST A., 1955, Genetica, V27, P391, DOI 10.1007/BF01664170; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; FOOTE HCC, 1994, P NATL ACAD SCI USA, V91, P2265, DOI 10.1073/pnas.91.6.2265; Garber RJ, 1927, J AGRIC RES, V34, P0185; GIBBS PE, 1986, PLANT SYST EVOL, V154, P285, DOI 10.1007/BF00990130; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; Hicks KA, 1996, SCIENCE, V274, P790, DOI 10.1126/science.274.5288.790; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kejnovsky E, 2006, GENETICA, V128, P167, DOI 10.1007/s10709-005-5701-0; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Labonne JDJ, 2010, HEREDITY, V105, P235, DOI 10.1038/hdy.2010.39; Labonne JDJ, 2011, MOL GENET GENOMICS, V285, P101, DOI 10.1007/s00438-010-0590-z; Labonne JJD, 2009, MOL GENET GENOMICS, V281, P673, DOI 10.1007/s00438-009-0439-5; LEE HS, 1994, NATURE, V367, P560, DOI 10.1038/367560a0; Lewis D., 1992, EVOLUTION FUNCTION H, P129, DOI DOI 10.1007/978-3-642-86656-2_5; Li JH, 2007, PLANT J, V51, P18, DOI 10.1111/j.1365-313X.2007.03125.x; Li JH, 2011, ANN BOT-LONDON, V108, P715, DOI 10.1093/aob/mcr181; Lloyd D.G, 1992, EVOLUTION FUNCTION H, P151; Manfield IW, 2005, J EXP BOT, V56, P1177, DOI 10.1093/jxb/eri110; Matsui K, 2003, NEW PHYTOL, V159, P701, DOI 10.1046/j.1469-8137.2003.00840.x; McCubbin AG, 2006, SEX PLANT REPROD, V19, P63, DOI 10.1007/s00497-006-0022-8; Miljus-Dukic J, 2004, BIOL PLANTARUM, V48, P293, DOI 10.1023/B:BIOP.0000033459.48057.8b; Ming R, 2011, ANNU REV PLANT BIOL, V62, P485, DOI 10.1146/annurev-arplant-042110-103914; MURFETT J, 1994, NATURE, V367, P563, DOI 10.1038/367563a0; Navajas-Perez R, 2005, MOL BIOL EVOL, V22, P1929, DOI 10.1093/molbev/msi186; Nishimoto Y, 2003, GENES GENET SYST, V78, P139, DOI 10.1266/ggs.78.139; Ohnishi O, 1996, GENES GENET SYST, V71, P383, DOI 10.1266/ggs.71.383; Ohnishi O, 1993, GENES GENET SYST, V68, P317; Ohsako T., 2001, Fagopyrum, V18, P9; Ono T, 1923, BOT MAG TOKYO, V37, P84; Sanchez A, 2009, INT J PLANT SCI, V170, P1044, DOI 10.1086/605121; Schopfer CR, 1999, SCIENCE, V286, P1697, DOI 10.1126/science.286.5445.1697; Sijacic P, 2004, NATURE, V429, P302, DOI 10.1038/nature02523; Silva NF, 2001, MOL GENET GENOMICS, V265, P552, DOI 10.1007/s004380100446; Smit AFA, 1996, CURR OPIN GENET DEV, V6, P743, DOI 10.1016/S0959-437X(96)80030-X; STEIN JC, 1991, P NATL ACAD SCI USA, V88, P8816, DOI 10.1073/pnas.88.19.8816; Takasaki T, 2000, NATURE, V403, P913, DOI 10.1038/35002628; Takayama S, 2000, P NATL ACAD SCI USA, V97, P1920, DOI 10.1073/pnas.040556397; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Wheeler MJ, 2009, NATURE, V459, P992, DOI 10.1038/nature08027; Yasui Y, 2004, GENOME, V47, P345, DOI [10.1139/G03-126, 10.1139/g03-126]; Yasui Y, 1998, AM J BOT, V85, P1134, DOI 10.2307/2446346; Yasui Y, 2008, GENES GENET SYST, V83, P393, DOI 10.1266/ggs.83.393; Zagotta MT, 1996, PLANT J, V10, P691, DOI 10.1046/j.1365-313X.1996.10040691.x; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	54	50	55	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2012	7	2							e31264	10.1371/journal.pone.0031264	http://dx.doi.org/10.1371/journal.pone.0031264			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UG	22312442	Green Published, gold, Green Submitted			2022-12-27	WOS:000301977500031
J	Yang, DF; Ma, PD; Liang, X; Liang, ZS; Zhang, MX; Shen, S; Liu, HY; Liu, Y				Yang, Dongfeng; Ma, Pengda; Liang, Xiao; Liang, Zongsuo; Zhang, Meixiang; Shen, Shuang; Liu, Hongyun; Liu, Yan			Metabolic Profiles and cDNA-AFLP Analysis of Salvia miltiorrhiza and Salvia castanea Diel f. tomentosa Stib	PLOS ONE			English	Article							TRANSCRIPTOME COEXPRESSION ANALYSIS; ROSMARINIC ACID ACCUMULATION; SECONDARY METABOLISM; SUSPENSION-CULTURES; PAPAVER-SOMNIFERUM; GENOMICS APPROACH; CELL-CULTURES; HAIRY ROOTS; GENE; BIOSYNTHESIS	Plants of the genus Salvia produce various types of phenolic compounds and tanshinones which are effective for treatment of coronary heart disease. Salvia miltiorrhiza and S. castanea Diels f. tomentosa Stib are two important members of the genus. In this study, metabolic profiles and cDNA-AFLP analysis of four samples were employed to identify novel genes potentially involved in phenolic compounds and tanshinones biosynthesis, including the red roots from the two species and two tanshinone-free roots from S. miltiorrhiza. The results showed that the red roots of S. castanea Diels f. tomentosa Stib produced high contents of rosmarinic acid (21.77 mg/g) and tanshinone IIA (12.60 mg/g), but low content of salvianolic acid B (1.45 mg/g). The red roots of S. miltiorrhiza produced high content of salvianolic acid B (18.69 mg/g), while tanshinones accumulation in this sample was much less than that in S. castanea Diels f. tomentosa Stib. Tanshinones were not detected in the two tanshinone-free samples, which produced high contents of phenolic compounds. A cDNA-AFLP analysis with 128 primer pairs revealed that 2300 transcript derived fragments (TDFs) were differentially expressed among the four samples. About 323 TDFs were sequenced, of which 78 TDFs were annotated with known functions through BLASTX searching the Genbank database and 14 annotated TDFs were assigned into secondary metabolic pathways through searching the KEGGPATHWAY database. The quantitative real-time PCR analysis indicated that the expression of 9 TDFs was positively correlated with accumulation of phenolic compounds and tanshinones. These TDFs additionally showed coordinated transcriptional response with 6 previously-identified genes involved in biosynthesis of tanshinones and phenolic compounds in S. miltiorrhiza hairy roots treated with yeast extract. The sequence data in the present work not only provided us candidate genes involved in phenolic compounds and tanshinones biosynthesis but also gave us further insight into secondary metabolism in Salvia.	[Yang, Dongfeng; Ma, Pengda; Liang, Xiao; Liang, Zongsuo; Zhang, Meixiang; Shen, Shuang; Liu, Hongyun] NW A&F Univ, Coll Life Sci, Yangling, Peoples R China; [Liang, Zongsuo] Zhejiang Sci Tech Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China; [Liu, Yan] Tianjin Tasly Modern TCM Resources Co Ltd, Tianjin, Peoples R China	Northwest A&F University - China; Zhejiang Sci-Tech University	Liang, ZS (corresponding author), NW A&F Univ, Coll Life Sci, Yangling, Peoples R China.	liangzs@ms.iswc.ac.cn			Chinese Academy of Science [KZCX2-YW-443]	Chinese Academy of Science(Chinese Academy of Sciences)	This work was supported by Knowledge Innovation Project of Chinese Academy of Science (KZCX2-YW-443). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger A, 2006, PLANTA, V224, P1503, DOI 10.1007/s00425-006-0393-y; Bezakova L, 2010, CHEM PHYS LIPIDS, V163, pS67, DOI 10.1016/j.chemphyslip.2010.05.198; Chavez-Cabrera C, 2010, APPL MICROBIOL BIOT, V85, P1953, DOI 10.1007/s00253-009-2271-6; Cui Guang-hong, 2007, Zhongguo Zhong Yao Za Zhi, V32, P1267; D'Onofrio C, 2009, FUNCT PLANT BIOL, V36, P323, DOI 10.1071/FP08280; Dai ZB, 2011, J PLANT PHYSIOL, V168, P148, DOI 10.1016/j.jplph.2010.06.008; Dong JA, 2010, J BIOTECHNOL, V148, P99, DOI 10.1016/j.jbiotec.2010.05.009; Gao W, 2009, ORG LETT, V11, P5170, DOI 10.1021/ol902051v; Ge XC, 2005, PLANT SCI, V168, P487, DOI 10.1016/j.plantsci.2004.09.012; Goossens A, 2003, P NATL ACAD SCI USA, V100, P8595, DOI 10.1073/pnas.1032967100; Guterman I, 2002, PLANT CELL, V14, P2325, DOI 10.1105/tpc.005207; HAHN MG, 1978, PLANT PHYSIOL, V62, P107, DOI 10.1104/pp.62.1.107; Hartmann T, 2007, PHYTOCHEMISTRY, V68, P2831, DOI 10.1016/j.phytochem.2007.09.017; HU ZB, 1993, PHYTOCHEMISTRY, V32, P699, DOI 10.1016/S0031-9422(00)95156-2; Hua WP, 2011, GENOMICS, V98, P272, DOI 10.1016/j.ygeno.2011.03.012; Huang BB, 2008, MOL BIOL REP, V35, P601, DOI 10.1007/s11033-007-9130-2; Inyushkina YV, 2009, BIOCHEMISTRY-MOSCOW+, V74, P917, DOI 10.1134/S0006297909080148; Kubo H, 1999, PLANT CELL, V11, P1217, DOI 10.1105/tpc.11.7.1217; Li Ying, 2010, Yaoxue Xuebao, V45, P524; Naoumkina MA, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-132; Rischer H, 2006, P NATL ACAD SCI USA, V103, P5614, DOI 10.1073/pnas.0601027103; Shalel-Levanon S, 2005, METAB ENG, V7, P364, DOI 10.1016/j.ymben.2005.07.001; Shimada S, 2004, PLANT CELL PHYSIOL, V45, P1290, DOI 10.1093/pcp/pch156; Song J, 2009, MOL BIOL REP, V36, P939, DOI 10.1007/s11033-008-9266-8; Szabo E, 1999, PLANT CELL REP, V18, P485, DOI 10.1007/s002990050608; Vuylsteke M, 2007, NAT PROTOC, V2, P1399, DOI 10.1038/nprot.2007.174; Wang QH, 2009, ACTA CHIN MED PHARM, V37, P1; Wu SJ, 2009, BIOTECHNOL APPL BIOC, V52, P89, DOI 10.1042/BA20080004; Y Xiao, 2009, PHYSL PLANT; Yan Q, 2006, PLANT SCI, V170, P853, DOI 10.1016/j.plantsci.2005.12.004; Yan XM, 2009, ACTA PHYSIOL PLANT, V31, P1015, DOI 10.1007/s11738-009-0320-5; Yang DF, 2009, FITOTERAPIA, V80, P274, DOI 10.1016/j.fitote.2009.03.004; Yonekura-Sakakibara K, 2008, PLANT CELL, V20, P2160, DOI 10.1105/tpc.108.058040; Yonekura-Sakakibara K, 2007, J BIOL CHEM, V282, P14932, DOI 10.1074/jbc.M611498200; Zhang CH, 2007, BIOTECHNOL BIOENG, V96, P506, DOI 10.1002/bit.21122; Zhang Shuncang, 2011, Zhongguo Zhong Yao Za Zhi, V36, P1269; Zhao JL, 2010, APPL MICROBIOL BIOT, V87, P137, DOI 10.1007/s00253-010-2443-4; Zhou LM, 2005, J CLIN PHARMACOL, V45, P1345, DOI 10.1177/0091270005282630; Ziegler J, 2005, PLANTA, V222, P458, DOI 10.1007/s00425-005-1550-4; Zorn H, 2003, BIOCATAL BIOTRANSFOR, V21, P341, DOI 10.1080/10242420310001630173; 廖文波, 2004, [中药材, Journal of Chinese Medicinal Materials], V27, P897	41	22	25	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2012	7	1							e29678	10.1371/journal.pone.0029678	http://dx.doi.org/10.1371/journal.pone.0029678			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	912BU	22303439	Green Published, gold, Green Submitted			2022-12-27	WOS:000301770300001
J	Landis, SH; Kalbe, M; Reusch, TBH; Roth, O				Landis, Susanne H.; Kalbe, Martin; Reusch, Thorsten B. H.; Roth, Olivia			Consistent Pattern of Local Adaptation during an Experimental Heat Wave in a Pipefish-Trematode Host-Parasite System	PLOS ONE			English	Article							ECOLOGICAL IMMUNOLOGY; GENETIC-VARIATION; DISEASE ECOLOGY; IMMUNE-SYSTEM; TEMPERATURE; RESISTANCE; COEVOLUTION; MARINE; DYNAMICS; SPECIFICITY	Extreme climate events such as heat waves are expected to increase in frequency under global change. As one indirect effect, they can alter magnitude and direction of species interactions, for example those between hosts and parasites. We simulated a summer heat wave to investigate how a changing environment affects the interaction between the broad-nosed pipefish (Syngnathus typhle) as a host and its digenean trematode parasite (Cryptocotyle lingua). In a fully reciprocal laboratory infection experiment, pipefish from three different coastal locations were exposed to sympatric and allopatric trematode cercariae. In order to examine whether an extreme climatic event disrupts patterns of locally adapted host-parasite combinations we measured the parasite's transmission success as well as the host's adaptive and innate immune defence under control and heat wave conditions. Independent of temperature, sympatric cercariae were always more successful than allopatric ones, indicating that parasites are locally adapted to their hosts. Hosts suffered from heat stress as suggested by fewer cells of the adaptive immune system (lymphocytes) compared to the same groups that were kept at 18 degrees C. However, the proportion of the innate immune cells (monocytes) was higher in the 18 degrees C water. Contrary to our expectations, no interaction between host immune defence, parasite infectivity and temperature stress were found, nor did the pattern of local adaptation change due to increased water temperature. Thus, in this host-parasite interaction, the sympatric parasite keeps ahead of the coevolutionary dynamics across sites, even under increasing temperatures as expected under marine global warming.	[Landis, Susanne H.; Reusch, Thorsten B. H.; Roth, Olivia] Leibniz Inst Marine Sci IFM GEOMAR, Kiel, Germany; [Kalbe, Martin] Max Planck Inst Evolutionary Biol, Dept Evolutionary Ecol, Plon, Germany	Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; Max Planck Society	Landis, SH (corresponding author), Leibniz Inst Marine Sci IFM GEOMAR, Kiel, Germany.	slandis@ifm-geomar.de	Roth, Olivia/M-3379-2016; Reusch, Thorsten B. H./B-9311-2019; Reusch, Thorsten B.H./G-4141-2011	Roth, Olivia/0000-0002-7349-7797; Reusch, Thorsten B. H./0000-0002-8961-4337	Volkswagen foundation; Kiel excellence cluster "The Future Ocean''	Volkswagen foundation(Volkswagen); Kiel excellence cluster "The Future Ocean''	SHL and OR were supported by grants from the Volkswagen foundation programme "Strengthening Evolutionary Biology''. In addition, this work was supported by a start-up grant from the Kiel excellence cluster "The Future Ocean'' to TR, OR & SHL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHNESJO I, 1995, BEHAV ECOL, V6, P229, DOI 10.1093/beheco/6.2.229; ANTONOVICS J, 1994, P ROY SOC B-BIOL SCI, V257, P105, DOI 10.1098/rspb.1994.0101; Ardia DR, 2011, FUNCT ECOL, V25, P61, DOI 10.1111/j.1365-2435.2010.01759.x; Baucom RS, 2011, FUNCT ECOL, V25, P18, DOI 10.1111/j.1365-2435.2010.01742.x; Belkin IM, 2009, PROG OCEANOGR, V81, P207, DOI 10.1016/j.pocean.2009.04.011; Belkin S., 2005, OCEANS HLTH PATHOGEN, V233; BERGLUND A, 1986, BEHAV ECOL SOCIOBIOL, V19, P301, DOI 10.1007/BF00300646; Bergmann N, 2010, MOL ECOL, V19, P2870, DOI 10.1111/j.1365-294X.2010.04731.x; Blakeslee AMH, 2008, MOL ECOL, V17, P3684, DOI 10.1111/j.1365-294X.2008.03865.x; Blanford S, 2003, ECOL LETT, V6, P2, DOI 10.1046/j.1461-0248.2003.00387.x; Braude S, 1999, BEHAV ECOL, V10, P345, DOI 10.1093/beheco/10.3.345; Carius HJ, 2001, EVOLUTION, V55, P1136, DOI 10.1111/j.0014-3820.2001.tb00633.x; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Ebert D, 1996, TRENDS ECOL EVOL, V11, pA79; Ebert D, 1998, P ROY SOC B-BIOL SCI, V265, P2127, DOI 10.1098/rspb.1998.0549; Enfield DB, 1988, OCEANOGRAPHY, V1, P23; Fellowes MDE, 1999, EVOLUTION, V53, P966, DOI 10.2307/2640737; Gandon S, 2002, ECOL LETT, V5, P246, DOI 10.1046/j.1461-0248.2002.00305.x; Gandon S, 1996, P ROY SOC B-BIOL SCI, V263, P1003, DOI 10.1098/rspb.1996.0148; Gomez JM, 2009, ECOL LETT, V12, P672, DOI 10.1111/j.1461-0248.2009.01324.x; Granovitch A, 2000, OPHELIA, V53, P55, DOI 10.1080/00785326.2000.10409435; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Hawley DM, 2011, FUNCT ECOL, V25, P48, DOI 10.1111/j.1365-2435.2010.01753.x; Kaltz O, 1998, HEREDITY, V81, P361, DOI 10.1046/j.1365-2540.1998.00435.x; Kirby RR, 2006, BIOL LETTERS, V2, P597, DOI 10.1098/rsbl.2006.0530; Laine AL, 2008, ECOL LETT, V11, P327, DOI 10.1111/j.1461-0248.2007.01146.x; Lazzaro BP, 2006, GENETICS, V174, P1539, DOI 10.1534/genetics.105.054593; Lazzaro BP, 2009, PHILOS T R SOC B, V364, P15, DOI 10.1098/rstb.2008.0141; LIVELY CM, 1989, EVOLUTION, V43, P1663, DOI [10.2307/2409382, 10.1111/j.1558-5646.1989.tb02616.x]; Wegner KM, 2007, EVOL ECOL, V21, P473, DOI 10.1007/s10682-006-9129-5; Matsunaga T, 1998, IMMUNOL REV, V166, P177, DOI 10.1111/j.1600-065X.1998.tb01262.x; Mazzi D, 2004, J EVOLUTION BIOL, V17, P519, DOI 10.1111/j.1420-9101.2004.00704.x; McClelland EE, 2003, INFECT IMMUN, V71, P2079, DOI 10.1128/IAI.71.4.2079-2086.2003; McCoy KD, 2001, J EVOLUTION BIOL, V14, P395, DOI 10.1046/j.1420-9101.2001.00290.x; Moret Y, 2000, SCIENCE, V290, P1166, DOI 10.1126/science.290.5494.1166; Mydlarz LD, 2006, ANNU REV ECOL EVOL S, V37, P251, DOI 10.1146/annurev.ecolsys.37.091305.110103; Palutikof JP., 2007, CLIMATE CHANGE 2007, V7-22, P8; Poulin R, 2006, PARASITOLOGY, V132, P143, DOI 10.1017/S0031182005008693; Rauch G, 2006, BIOL LETT-UK, V2, P382, DOI 10.1098/rsbl.2006.0462; Read AF, 2000, SCIENCE, V290, P1104, DOI 10.1126/science.290.5494.1104; Reusch TBH, 2005, P NATL ACAD SCI USA, V102, P2826, DOI 10.1073/pnas.0500008102; Roth O, 2011, J EVOLUTION BIOL, V24, P1410, DOI 10.1111/j.1420-9101.2011.02273.x; Roth O, 2010, MAR BIOL, V157, P1605, DOI 10.1007/s00227-010-1433-5; Schmid-Hempel P, 2003, TRENDS ECOL EVOL, V18, P27, DOI 10.1016/S0169-5347(02)00013-7; Schulte RD, 2011, P ROY SOC B-BIOL SCI, V278, P2832, DOI 10.1098/rspb.2011.0019; Seppala O, 2011, BIOL LETTERS, V7, P119, DOI 10.1098/rsbl.2010.0459; Studer A, 2010, MAR ECOL PROG SER, V415, P11, DOI 10.3354/meps08742; Stunkard HW, 1930, J MORPHOL, V50, P143, DOI 10.1002/jmor.1050500106; Thieltges DW, 2006, DIS AQUAT ORGAN, V73, P63; Thomas MB, 2003, TRENDS ECOL EVOL, V18, P344, DOI 10.1016/S0169-5347(03)00069-7; Thompson JD., 1994, COEVOLUTIONARY PROCE; Thompson JN, 1997, ECOLOGY, V78, P1619; Tort L., 2003, Inmunologia, V22, P277; Van Valen L., 1973, EVOL THEORY, V1, P1, DOI DOI 10.1038/344864A0; Wegner KM, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-124; Zander CD, 1999, PARASITOL RES, V85, P356, DOI 10.1007/s004360050562; Zander CD, 1998, NATURWISSENSCHAFTEN, V85, P426, DOI 10.1007/s001140050526	57	22	22	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e30658	10.1371/journal.pone.0030658	http://dx.doi.org/10.1371/journal.pone.0030658			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22303448	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000301704200027
J	Zhang, O; Xu, W; Pillai, AB; Zhang, K				Zhang, Ou; Xu, Wei; Pillai, Agiesh Balakrishna; Zhang, Kai			Developmentally Regulated Sphingolipid Degradation in Leishmania major	PLOS ONE			English	Article							PHOSPHOSPHINGOLIPID-PHOSPHOLIPASE-C; CHRONOLOGICAL LIFE-SPAN; NIEMANN-PICK-DISEASE; SACCHAROMYCES-CEREVISIAE; NEUTRAL SPHINGOMYELINASES; ACID SPHINGOMYELINASE; INFECTIVE STAGE; STRESS-RESPONSE; PROMASTIGOTES; EXPRESSION	Leishmania parasites alternate between extracellular promastigotes in sandflies and intracellular amastigotes in mammals. These protozoans acquire sphingolipids (SLs) through de novo synthesis (to produce inositol phosphorylceramide) and salvage (to obtain sphingomyelin from the host). A single ISCL (Inositol phosphoSphingolipid phospholipase C-Like) enzyme is responsible for the degradation of both inositol phosphorylceramide (the IPC hydrolase or IPCase activity) and sphingomyelin (the SMase activity). Recent studies of a L. major ISCL-null mutant (iscl(-)) indicate that SL degradation is required for promastigote survival in stationary phase, especially under acidic pH. ISCL is also essential for L. major proliferation in mammals. To further understand the role of ISCL in Leishmania growth and virulence, we introduced a sole IPCase or a sole SMase into the iscl(-) mutant. Results showed that restoration of IPCase only complemented the acid resistance defect in iscl(-) promastigotes and improved their survival in macrophages, but failed to recover virulence in mice. In contrast, a sole SMase fully restored parasite infectivity in mice but was unable to reverse the promastigote defects in iscl(-). These findings suggest that SL degradation in Leishmania possesses separate roles in different stages: while the IPCase activity is important for promastigote survival and acid tolerance, the SMase activity is required for amastigote proliferation in mammals. Consistent with these findings, ISCL was preferentially expressed in stationary phase promastigotes and amastigotes. Together, our results indicate that SL degradation by Leishmania is critical for parasites to establish and sustain infection in the mammalian host.	[Zhang, Ou; Xu, Wei; Pillai, Agiesh Balakrishna; Zhang, Kai] Texas Tech Univ, Dept Biol Sci, Lubbock, TX 79409 USA	Texas Tech University System; Texas Tech University	Zhang, O (corresponding author), Texas Tech Univ, Dept Biol Sci, Lubbock, TX 79409 USA.	kai.zhang@ttu.edu		Zhang, Ou/0000-0001-6574-130X	Public Health Service [1R15AI076909, 1R56AI081781, 5R03AI076662]; National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI081781, R03AI076662, R15AI076909] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by Public Health Service grants 1R15AI076909 (KZ), 1R56AI081781 (KZ) and 5R03AI076662 (KZ) from the National Institute of Allergy and Infectious Diseases (http://www.niaid.nih.gov/Pages/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akopyants NS, 2004, MOL BIOCHEM PARASIT, V136, P71, DOI 10.1016/j.molbiopara.2004.03.002; ALMEIDA T, 2007, MOL BIOL CELL; Almeida T, 2008, MOL BIOL CELL, V19, P865, DOI 10.1091/mbc.E07-06-0604; Barbosa AD, 2011, MOL MICROBIOL, V81, P515, DOI 10.1111/j.1365-2958.2011.07714.x; Bartke N, 2009, J LIPID RES, V50, pS91, DOI 10.1194/jlr.R800080-JLR200; Bates PA, 2008, CURR OPIN MICROBIOL, V11, P340, DOI 10.1016/j.mib.2008.06.003; Bringaud F, 2006, MOL BIOCHEM PARASIT, V149, P1, DOI 10.1016/j.molbiopara.2006.03.017; Castillo E, 2010, CURR MED CHEM, V17, P4027, DOI 10.2174/092986710793205345; Clarke CJ, 2006, BIOCHEMISTRY-US, V45, P11247, DOI 10.1021/bi061307z; Clarke CJ, 2011, ADV ENZYME REGUL, V51, P51, DOI 10.1016/j.advenzreg.2010.09.016; Cowart LA, 2005, BIOCHEM SOC T, V33, P1166, DOI 10.1042/BST0331166; Croft SL, 2003, TRENDS PARASITOL, V19, P502, DOI 10.1016/j.pt.2003.09.008; de Avalos SV, 2005, J BIOL CHEM, V280, P7170, DOI 10.1074/jbc.M411058200; de Avalos SV, 2004, J BIOL CHEM, V279, P11537, DOI 10.1074/jbc.M309586200; Denny PW, 2000, J BIOL CHEM, V275, P11017, DOI 10.1074/jbc.275.15.11017; Dickson RC, 1999, BBA-GEN SUBJECTS, V1426, P347, DOI 10.1016/S0304-4165(98)00135-4; Duan RD, 2006, BBA-MOL CELL BIOL L, V1761, P281, DOI 10.1016/j.bbalip.2006.03.007; Gault CR, 2010, ADV EXP MED BIOL, V688, P1; GLASER TA, 1990, EXP PARASITOL, V71, P343, DOI 10.1016/0014-4894(90)90039-F; Goni FM, 2002, FEBS LETT, V531, P38, DOI 10.1016/S0014-5793(02)03482-8; Ha DS, 1996, MOL BIOCHEM PARASIT, V77, P57, DOI 10.1016/0166-6851(96)02580-7; Henry J, 2011, FEBS LETT, V585, P635, DOI 10.1016/j.febslet.2011.01.015; KANESHIRO ES, 1986, J LIPID RES, V27, P1294; KAPLER GM, 1990, MOL CELL BIOL, V10, P1084, DOI 10.1128/MCB.10.3.1084; Kitagaki H, 2009, J BIOL CHEM, V284, P10818, DOI 10.1074/jbc.M805029200; LEVRAN O, 1991, P NATL ACAD SCI USA, V88, P3748, DOI 10.1073/pnas.88.9.3748; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marchesini N, 2004, BIOCHEM CELL BIOL, V82, P27, DOI 10.1139/o03-091; Marchesini N, 2002, MOL BIOCHEM PARASIT, V119, P225, DOI 10.1016/S0166-6851(01)00419-4; Matmati N, 2008, J LIPID RES, V49, P922, DOI 10.1194/jlr.R800004-JLR200; Myler PJ, 2008, ADV EXP MED BIOL, V625, P133, DOI 10.1007/978-0-387-77570-8_11; Nikolova-Karakashian MN, 2010, ADV EXP MED BIOL, V688, P86; Okamoto Y, 2003, BIOCHEMISTRY-US, V42, P7855, DOI 10.1021/bi0341354; Okamoto Y, 2002, J BIOL CHEM, V277, P46470, DOI 10.1074/jbc.M207779200; Ouakad M, 2007, PARASITOL RES, V101, P473, DOI 10.1007/s00436-007-0491-1; Racoosin EL, 1997, EXP PARASITOL, V85, P283, DOI 10.1006/expr.1996.4139; Ranasinghe S, 2008, T ROY SOC TROP MED H, V102, P875, DOI 10.1016/j.trstmh.2008.04.003; SACKS DL, 1985, AM J TROP MED HYG, V34, P456, DOI 10.4269/ajtmh.1985.34.456; SACKS DL, 1984, SCIENCE, V223, P1417, DOI 10.1126/science.6701528; Saunders EC, 2010, PARASITOLOGY, V137, P1303, DOI 10.1017/S0031182010000077; Sawai H, 2000, J BIOL CHEM, V275, P39793, DOI 10.1074/jbc.M007721200; Schuchman EH, 2010, FEBS LETT, V584, P1895, DOI 10.1016/j.febslet.2009.11.083; Schulze H, 2011, COLD SPRING HARB PER, V3; Shea JM, 2006, INFECT IMMUN, V74, P5977, DOI 10.1128/IAI.00768-06; Smith EL, 2008, FASEB J, V22, P3419, DOI 10.1096/fj.08-108043; Sperling P, 2003, BBA-MOL CELL BIOL L, V1632, P1, DOI 10.1016/S1388-1981(03)00033-7; TAMURA H, 1995, BIOCHEM J, V309, P757, DOI 10.1042/bj3090757; TITUS RG, 1991, EUR J IMMUNOL, V21, P559, DOI 10.1002/eji.1830210305; TITUS RG, 1985, PARASITE IMMUNOL, V7, P545, DOI 10.1111/j.1365-3024.1985.tb00098.x; VIEIRA L, 1995, J BIOL CHEM, V270, P5299, DOI 10.1074/jbc.270.10.5299; Xu W, 2011, INFECT IMMU IN PRESS; Young SA, MOL MICROBIOL, V76, P1461; Zhang K, 2005, MOL MICROBIOL, V55, P1566, DOI 10.1111/j.1365-2958.2005.04493.x; Zhang K, 2003, EMBO J, V22, P6016, DOI 10.1093/emboj/cdg584; Zhang K, 2007, EMBO J, V26, P1094, DOI 10.1038/sj.emboj.7601565; Zhang K, 2010, MOL BIOCHEM PARASIT, V170, P55, DOI 10.1016/j.molbiopara.2009.12.004; Zhang O, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000692	57	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e31059	10.1371/journal.pone.0031059	http://dx.doi.org/10.1371/journal.pone.0031059			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22299050	Green Published, gold, Green Submitted			2022-12-27	WOS:000301704200058
J	Zhang, XP; Qu, SG				Zhang, Xiuping; Qu, Shaogang			The Accessibility in the External Part of the TM5 of the Glutamate Transporter EAAT1 Is Conformationally Sensitive during the Transport Cycle	PLOS ONE			English	Article							AMINOBUTYRIC-ACID TRANSPORTER; RAT-BRAIN; EXTRACELLULAR GATE; REENTRANT LOOP; SUBSTRATE INTERACTIONS; ASPARTATE TRANSPORTER; INDIVIDUAL SUBUNITS; ION-BINDING; GLT-1; EXPRESSION	Background: Excitatory amino acid transporter 1 (EAAT1) is a glutamate transporter which is a key element in the termination of the synaptic actions of glutamate. It serves to keep the extracellular glutamate concentration below neurotoxic level. However the functional significance and the change of accessibility of residues in transmembrane domain (TM) 5 of the EAAT1 are not clear yet. Methodology/Principal Findings: We used cysteine mutagenesis with treatments with membrane-impermeable sulfhydryl reagent MTSET [(2-trimethylammonium) methanethiosulfonate] to investigate the change of accessibility of TM5. Cysteine mutants were introduced from position 291 to 300 of the cysteine-less version of EAAT1. We checked the activity and kinetic parameters of the mutants before and after treatments with MTSET, furthermore we analyzed the effect of the substrate and blocker on the inhibition of the cysteine mutants by MTSET. Inhibition of transport by MTSET was observed in the mutants L296C, I297C and G299C, while the activity of K300C got higher after exposure to MTSET. V-max of L296C and G299C got lower while that of K300C got higher after treated by MTSET. The L296C, G299C, K300C single cysteine mutants showed a conformationally sensitive reactivity pattern. The sensitivity of L296C to MTSET was potentiated by glutamate and TBOA, but the sensitivity of G299C to MTSET was potentiated only by TBOA. Conclusions/Significance: All these facts suggest that the accessibility of some positions of the external part of the TM5 is conformationally sensitive during the transport cycle. Our results indicate that some residues of TM5 take part in the transport pathway during the transport cycle.	[Zhang, Xiuping] Guangdong Med Coll, China Amer Canc Res Inst, Dongguan, Guangdong, Peoples R China; [Qu, Shaogang] So Med Univ, Dept Immunol, Guangzhou, Guangdong, Peoples R China	Guangdong Medical University; Southern Medical University - China	Zhang, XP (corresponding author), Guangdong Med Coll, China Amer Canc Res Inst, Dongguan, Guangdong, Peoples R China.	sgq9528@163.com			National Natural Science Foundation of China [31170734]; International Centre for Genetic Engineering and Biotechnology [CRP/CHN11-01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Centre for Genetic Engineering and Biotechnology	This work was supported in part by the National Natural Science Foundation of China (Grant 31170734 to SQ), http://www.nsfc.gov.cn/Portal0/default106.htm, and the International Centre for Genetic Engineering and Biotechnology (Grant CRP/CHN11-01 to SQ), http://www.icgeb.org/home.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arriza JL, 1997, P NATL ACAD SCI USA, V94, P4155, DOI 10.1073/pnas.94.8.4155; Bendahan A, 2000, J BIOL CHEM, V275, P37436, DOI 10.1074/jbc.M006536200; Bennett ER, 2000, J BIOL CHEM, V275, P34106, DOI 10.1074/jbc.M004229200; Bennett ER, 1997, J BIOL CHEM, V272, P1203, DOI 10.1074/jbc.272.2.1203; Borre L, 2001, J BIOL CHEM, V276, P40396, DOI 10.1074/jbc.M104926200; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; Brocke L, 2002, J BIOL CHEM, V277, P3985, DOI 10.1074/jbc.M107735200; Compton ELR, 2010, P NATL ACAD SCI USA, V107, P12840, DOI 10.1073/pnas.1003046107; Crisman TJ, 2009, P NATL ACAD SCI USA, V106, P20752, DOI 10.1073/pnas.0908570106; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; Grewer C, 2005, BIOCHEMISTRY-US, V44, P11913, DOI 10.1021/bi050987n; Groeneveld M, 2007, J MOL BIOL, V372, P565, DOI 10.1016/j.jmb.2007.06.067; Grunewald M, 1998, NEURON, V21, P623, DOI 10.1016/S0896-6273(00)80572-3; Grunewald M, 2000, J BIOL CHEM, V275, P9684, DOI 10.1074/jbc.275.13.9684; Huang ZJ, 2008, BIOPHYS J, V95, P2292, DOI 10.1529/biophysj.108.133421; KANAI Y, 1992, NATURE, V360, P467, DOI 10.1038/360467a0; KANNER BI, 1978, BIOCHEMISTRY-US, V17, P3949, DOI 10.1021/bi00612a011; Kavanaugh MP, 1997, J BIOL CHEM, V272, P1703, DOI 10.1074/jbc.272.3.1703; KEYNAN S, 1992, BIOCHEMISTRY-US, V31, P1974, DOI 10.1021/bi00122a011; Koch HP, 2007, J NEUROSCI, V27, P2943, DOI 10.1523/JNEUROSCI.0118-07.2007; Koch HP, 2005, J NEUROSCI, V25, P1730, DOI 10.1523/JNEUROSCI.4138-04.2005; Leary GP, 2007, J NEUROSCI, V27, P2938, DOI 10.1523/JNEUROSCI.4851-06.2007; Levy LM, 1998, J NEUROSCI, V18, P9620, DOI 10.1523/jneurosci.18-23-09620.1998; PINES G, 1992, NATURE, V360, P464, DOI 10.1038/360464a0; Qu SG, 2008, J BIOL CHEM, V283, P26391, DOI 10.1074/jbc.M802401200; Rosental N, 2006, J BIOL CHEM, V281, P27905, DOI 10.1074/jbc.M600331200; Seal RP, 1998, NEURON, V21, P1487, DOI 10.1016/S0896-6273(00)80666-2; Shrivastava IH, 2008, J BIOL CHEM, V283, P28680, DOI 10.1074/jbc.M800889200; Slotboom DJ, 1999, MICROBIOL MOL BIOL R, V63, P293, DOI 10.1128/MMBR.63.2.293-307.1999; Slotboom DJ, 1999, P NATL ACAD SCI USA, V96, P14282, DOI 10.1073/pnas.96.25.14282; STORCK T, 1992, P NATL ACAD SCI USA, V89, P10955, DOI 10.1073/pnas.89.22.10955; TANAKA K, 1993, NEUROSCI RES, V16, P149, DOI 10.1016/0168-0102(93)90082-2; Tao Z, 2006, J BIOL CHEM, V281, P10263, DOI 10.1074/jbc.M510739200; Tao Z, 2007, J GEN PHYSIOL, V129, P331, DOI 10.1085/jgp.200609678; Teichman S, 2007, J GEN PHYSIOL, V129, P527, DOI 10.1085/jgp.200609707; Teichman S, 2009, P NATL ACAD SCI USA, V106, P14297, DOI 10.1073/pnas.0904625106; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zarbiv R, 1998, J BIOL CHEM, V273, P14231, DOI 10.1074/jbc.273.23.14231; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0; Zhang XP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021288; Zhang YM, 1999, P NATL ACAD SCI USA, V96, P1710, DOI 10.1073/pnas.96.4.1710; Zhang YM, 1998, P NATL ACAD SCI USA, V95, P751, DOI 10.1073/pnas.95.2.751	43	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30961	10.1371/journal.pone.0030961	http://dx.doi.org/10.1371/journal.pone.0030961			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22292083	Green Published, Green Submitted, gold			2022-12-27	WOS:000301570600101
J	Alfred, R; Ahmad, AH; Payne, J; Williams, C; Ambu, LN; How, PM; Goossens, B				Alfred, Raymond; Ahmad, Abd Hamid; Payne, Junaidi; Williams, Christy; Ambu, Laurentius Nayan; Phua Mui How; Goossens, Benoit			Home Range and Ranging Behaviour of Bornean Elephant (Elephas maximus borneensis) Females	PLOS ONE			English	Article							SATELLITE TELEMETRY; NATIONAL-PARK; TRACKING; ORGANIZATION; CONSERVATION; MOVEMENTS; NAMIBIA; AFRICA; KENYA	Background: Home range is defined as the extent and location of the area covered annually by a wild animal in its natural habitat. Studies of African and Indian elephants in landscapes of largely open habitats have indicated that the sizes of the home range are determined not only by the food supplies and seasonal changes, but also by numerous other factors including availability of water sources, habitat loss and the existence of man-made barriers. The home range size for the Bornean elephant had never been investigated before. Methodology/Principal Findings: The first satellite tracking program to investigate the movement of wild Bornean elephants in Sabah was initiated in 2005. Five adult female elephants were immobilized and neck collars were fitted with tracking devices. The sizes of their home range and movement patterns were determined using location data gathered from a satellite tracking system and analyzed by using the Minimum Convex Polygon and Harmonic Mean methods. Home range size was estimated to be 250 to 400 km(2) in a non-fragmented forest and 600 km(2) in a fragmented forest. The ranging behavior was influenced by the size of the natural forest habitat and the availability of permanent water sources. The movement pattern was influenced by human disturbance and the need to move from one feeding site to another. Conclusions/Significance: Home range and movement rate were influenced by the degree of habitat fragmentation. Once habitat was cleared or converted, the availability of food plants and water sources were reduced, forcing the elephants to travel to adjacent forest areas. Therefore movement rate in fragmented forest was higher than in the non-fragmented forest. Finally, in fragmented habitat human and elephant conflict occurrences were likely to be higher, due to increased movement bringing elephants into contact more often with humans.	[Alfred, Raymond] World Wildlife Fund Malaysia, Borneo Species Programme, Kota Kinabalu, Sabah, Malaysia; [Alfred, Raymond] Borneo Conservat Trust, Sabah Wildlife Dept, Kota Kinabalu, Sabah, Malaysia; [Payne, Junaidi] Univ Malaysia Sabah, Inst Trop Biol & Conservat, Borneo Rhino Alliance BORA, Kota Kinabalu, Sabah, Malaysia; [Williams, Christy] World Wildlife Fund Int, World Wildlife Fund Asian Rhinoceros & Elephant A, Gland, Switzerland; [Phua Mui How] Univ Malaysia Sabah, Sch Int Forestry, Kota Kinabalu, Sabah, Malaysia; [Goossens, Benoit] Danau Girang Field Ctr, Sabah Wildlife Dept, Kota Kinabalu, Sabah, Malaysia; [Goossens, Benoit] Cardiff Univ, Sch Biosci, Organisms & Environm Div, Cardiff, S Glam, Wales	Universiti Malaysia Sabah; World Wildlife Fund; Universiti Malaysia Sabah; Cardiff University	Alfred, R (corresponding author), World Wildlife Fund Malaysia, Borneo Species Programme, Kota Kinabalu, Sabah, Malaysia.	raymond_alfred@yahoo.com	Goossens, Benoit R/E-8812-2010	Ahmad, Abdul Hamid/0000-0001-9658-8600; Phua, Mui-How/0000-0002-1205-3105	World Wildlife Fund-United States, United States; Fish and Wildlife Service Asian Elephant Conservation Fund; World Wildlife Fund -Netherlands; World Wildlife Fund -Germany	World Wildlife Fund-United States, United States; Fish and Wildlife Service Asian Elephant Conservation Fund; World Wildlife Fund -Netherlands; World Wildlife Fund -Germany	This specific study was supported by grants from World Wildlife Fund-United States, United States. Fish and Wildlife Service Asian Elephant Conservation Fund, World Wildlife Fund -Netherlands and World Wildlife Fund -Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blake S, 2001, AFR J ECOL, V39, P178, DOI 10.1046/j.1365-2028.2001.00296.x; Cranbrook E., 2008, SARAWAK MUS J, V63, P1; de Beer Y, 2008, J ARID ENVIRON, V72, P2017, DOI 10.1016/j.jaridenv.2008.07.002; de Beer Y, 2006, J ARID ENVIRON, V64, P412, DOI 10.1016/j.jaridenv.2005.06.015; de Boer WF, 2000, AFR J ECOL, V38, P188, DOI 10.1046/j.1365-2028.2000.00243.x; Douglas-Hamilton I, 2005, NATURWISSENSCHAFTEN, V92, P158, DOI 10.1007/s00114-004-0606-9; Fancy SG, 1988, US FISH WILDLIFE SER, P72; Fernando P, 2003, PLOS BIOL, V1, P110, DOI 10.1371/journal.pbio.0000006; Fernando P, 2008, MAMM BIOL, V73, P2, DOI 10.1016/j.mambio.2007.07.007; Galanti V, 2006, MAMM BIOL, V71, P99, DOI 10.1016/j.mambio.2005.10.001; Hanebuth T, 2000, SCIENCE, V288, P1033, DOI 10.1126/science.288.5468.1033; HARRIS RB, 1990, 30 US FISH WILDL; Jalil MF, 2008, MOL ECOL, V17, P2898, DOI 10.1111/j.1365-294X.2008.03793.x; Jalil MF, 2007, THESIS CARDIFF U; Joshua Justus, 1995, P256; Khan bin Momin Khan M., 1967, Malayan Nature Journal, V20, P18; Khan MbM, 1985, ELEPHANTS PENINSULAR; Kinahan AA, 2007, J THERM BIOL, V32, P47, DOI 10.1016/j.jtherbio.2006.09.002; LEUTHOLD W, 1977, Z SAUGETIERKD, V42, P358; LINDEQUE M, 1991, AFR J ECOL, V29, P196, DOI 10.1111/j.1365-2028.1991.tb01002.x; Olivier R., 1978, THESIS U CAMBRIDGE; Osborn Ferrel V., 2004, Pachyderm, V37, P37; Osborn FV, 2003, AFR J ECOL, V41, P68, DOI 10.1046/j.1365-2028.2003.00413.x; Stuwe M, 1998, ORYX, V32, P68, DOI 10.1046/j.1365-3008.1998.00019.x; Stuwe M, 2006, CONSERVATION GIS PRO; Sukumar R., 1989, ASIAN ELEPHANT ECOLO; SUKUMAR R, 2003, LIVING ELEPHANTS; Tchamba MN, 1995, AFR J ECOL, V33, P335, DOI 10.1111/j.1365-2028.1995.tb01043.x; Thouless CR, 1996, AFR J ECOL, V34, P284, DOI 10.1111/j.1365-2028.1996.tb00623.x; Venkataraman AB, 2005, CURR SCI INDIA, V88, P1827; Verlinden A, 1998, AFR J ECOL, V36, P105; Williams A.C., 2004, ELEPHANTS ELEPHAS MA; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423	34	58	62	0	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31400	10.1371/journal.pone.0031400	http://dx.doi.org/10.1371/journal.pone.0031400			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347469	Green Submitted, Green Published, gold			2022-12-27	WOS:000302730100065
J	Moore, F; Santin, I; Nogueira, TC; Gurzov, EN; Marselli, L; Marchetti, P; Eizirik, DL				Moore, Fabrice; Santin, Izortze; Nogueira, Tatiane C.; Gurzov, Esteban N.; Marselli, Lorella; Marchetti, Piero; Eizirik, Decio L.			The Transcription Factor C/EBP delta Has Anti-Apoptotic and Anti-Inflammatory Roles in Pancreatic Beta Cells	PLOS ONE			English	Article							BINDING-PROTEIN-DELTA; ENDOPLASMIC-RETICULUM STRESS; FACTOR-KAPPA-B; PRO-INFLAMMATORY CYTOKINES; INSULIN-PRODUCING CELLS; NECROSIS-FACTOR-ALPHA; FREE FATTY-ACIDS; GENE-EXPRESSION; ER STRESS; IFN-GAMMA	In the course of Type 1 diabetes pro-inflammatory cytokines (e. g., IL-1 beta, IFN-gamma and TNF-alpha) produced by islet-infiltrating immune cells modify expression of key gene networks in beta-cells, leading to local inflammation and beta-cell apoptosis. Most known cytokine-induced transcription factors have pro-apoptotic effects, and little is known regarding "protective" transcription factors. To this end, we presently evaluated the role of the transcription factor CCAAT/enhancer binding protein delta (C/EBP delta) on beta-cell apoptosis and production of inflammatory mediators in the rat insulinoma INS-1E cells, in purified primary rat beta-cells and in human islets. C/EBP delta is expressed and up-regulated in response to the cytokines IL-1 beta and IFN-gamma in rat beta-cells and human islets. Small interfering RNA-mediated C/EBP delta silencing exacerbated IL-1 beta+IFN-gamma-induced caspase 9 and 3 cleavage and apoptosis in these cells. C/EBP delta deficiency increased the up-regulation of the transcription factor CHOP in response to cytokines, enhancing expression of the pro-apoptotic Bcl-2 family member BIM. Interfering with C/EBP delta and CHOP or C/EBP delta and BIM in double knockdown approaches abrogated the exacerbating effects of C/EBP delta deficiency on cytokine-induced beta-cell apoptosis, while C/EBP delta overexpression inhibited BIM expression and partially protected beta-cells against IL-1 beta+IFN-gamma-induced apoptosis. Furthermore, C/EBP delta silencing boosted cytokine-induced production of the chemokines CXCL1, 9, 10 and CCL20 in beta-cells by hampering IRF-1 up-regulation and increasing STAT1 activation in response to cytokines. These observations identify a novel function of C/EBP delta as a modulatory transcription factor that inhibits the pro-apoptotic and pro-inflammatory gene networks activated by cytokines in pancreatic beta-cells.	[Moore, Fabrice; Santin, Izortze; Nogueira, Tatiane C.; Gurzov, Esteban N.; Eizirik, Decio L.] Univ Libre Bruxelles, Expt Med Lab, Brussels, Belgium; [Marselli, Lorella; Marchetti, Piero] Univ Pisa, Metab Unit, Dept Endocrinol & Metab, Pisa, Italy	Universite Libre de Bruxelles; University of Pisa	Moore, F (corresponding author), Univ Libre Bruxelles, Expt Med Lab, Brussels, Belgium.	fmoore@ulb.ac.be; deizirik@ulb.ac.be	Santin, Izortze/AAC-4251-2019; de Araujo Nogueira, Tatiane/E-8510-2013; Santin, Izortze/C-3034-2014; Marchetti, Piero/J-7439-2013	Santin, Izortze/0000-0003-1651-6776; Marchetti, Piero/0000-0003-4907-0635; Marselli, Lorella/0000-0002-6698-2962; Gurzov, Esteban/0000-0003-4642-0273	Fonds National de la Recherche Scientifique (FNRS - FRSM) Belgium; Communaute Francaise de Belgique - Actions de Recherche Concertees (ARC); European Union (NAIMIT, European Community) [Health-F22009-241447]; Expert Center from the Dutch Diabetes Research Foundation [2008.40.001]; Belgium Program on Interuniversity Poles of Attraction [IUAP P6/40]; FNRS, Belgium; Education Department of the Basque Country; European Molecular Biology Organization (EMBO)	Fonds National de la Recherche Scientifique (FNRS - FRSM) Belgium(Fonds de la Recherche Scientifique - FNRS); Communaute Francaise de Belgique - Actions de Recherche Concertees (ARC); European Union (NAIMIT, European Community); Expert Center from the Dutch Diabetes Research Foundation; Belgium Program on Interuniversity Poles of Attraction; FNRS, Belgium(Fonds de la Recherche Scientifique - FNRS); Education Department of the Basque Country; European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO))	This work was supported by grants from the Fonds National de la Recherche Scientifique (FNRS - FRSM) Belgium, the Communaute Francaise de Belgique - Actions de Recherche Concertees (ARC), the European Union (NAIMIT, Ref. Health-F22009-241447; in the Framework Programme 7 of the European Community), the Expert Center Grant 2008.40.001 from the Dutch Diabetes Research Foundation, and the Belgium Program on Interuniversity Poles of Attraction initiated by the Belgium State (IUAP P6/40). FM was the recipient of a Post-Doctoral Fellowship from FNRS, Belgium. IS was the recipient of a postdoctoral fellowship from the Education Department of the Basque Country. TCN was the recipient of a Post-Doctoral Fellowship from FNRS, Belgium. ENG was supported by a European Molecular Biology Organization (EMBO) long-term Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2007, BLOOD, V109, P3895, DOI 10.1182/blood-2006-08-040147; Allagnat F, 2011, CELL DEATH DIFFER, V18, P328, DOI 10.1038/cdd.2010.105; Allagnat F, 2010, DIABETOLOGIA, V53, P1120, DOI 10.1007/s00125-010-1699-7; Altman BJ, 2009, MOL BIOL CELL, V20, P1180, DOI 10.1091/mbc.E08-08-0829; Barthson J, 2011, J BIOL CHEM, V286, P39632, DOI 10.1074/jbc.M111.253591; Cardozo AK, 2003, DIABETOLOGIA, V46, P255, DOI 10.1007/s00125-002-1017-0; Cardozo AK, 2001, J BIOL CHEM, V276, P48879, DOI 10.1074/jbc.M108658200; Colli ML, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002267; Cunha DA, 2008, J CELL SCI, V121, P2308, DOI 10.1242/jcs.026062; Eizirik DL, 2008, BIOCHEM SOC T, V36, P321, DOI 10.1042/BST0360321; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; Eizirik DL, 2009, NAT REV ENDOCRINOL, V5, P219, DOI 10.1038/nrendo.2009.21; Eizirik DL, 1996, HORM METAB RES, V28, P302, DOI 10.1055/s-2007-979799; Eizirik DL, 2001, DIABETOLOGIA, V44, P2115, DOI 10.1007/s001250100021; Ejarque-Ortiz A, 2010, J NEUROSCI RES, V88, P1113, DOI 10.1002/jnr.22272; Filippi CM, 2008, DIABETES, V57, P2863, DOI 10.2337/db07-1023; Fonseca SG, 2011, TRENDS ENDOCRIN MET, V22, P266, DOI 10.1016/j.tem.2011.02.008; Fujitani Y, 2010, AM J PHYSIOL-CELL PH, V299, pC1, DOI 10.1152/ajpcell.00084.2010; GEPTS W, 1965, DIABETES, V14, P619, DOI 10.2337/diab.14.10.619; Gigliotti AP, 2003, EXP BIOL MED, V228, P278, DOI 10.1177/153537020322800306; Gowda A, 2008, BLOOD, V111, P4723, DOI 10.1182/blood-2007-07-099531; Grey ST, 1999, J EXP MED, V190, P1135, DOI 10.1084/jem.190.8.1135; Gurzov EN, 2009, CELL DEATH DIFFER, V16, P1539, DOI 10.1038/cdd.2009.99; Gurzov EN, 2011, TRENDS CELL BIOL, V21, P424, DOI 10.1016/j.tcb.2011.03.001; Gurzov EN, 2010, J BIOL CHEM, V285, P19910, DOI 10.1074/jbc.M110.122374; Gurzov EN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003030; Gysemans C, 2008, BIOCHEM SOC T, V36, P328, DOI 10.1042/BST0360328; Hartley T, 2009, AM J PHYSIOL-ENDOC M, V296, pE1, DOI 10.1152/ajpendo.90538.2008; Haynes CM, 2010, J CELL SCI, V123, P3849, DOI 10.1242/jcs.075119; Heimberg H, 2001, DIABETES, V50, P2219, DOI 10.2337/diabetes.50.10.2219; Hoorens A, 1996, J CLIN INVEST, V98, P1568, DOI 10.1172/JCI118950; Hurgin V, 2002, P NATL ACAD SCI USA, V99, P16957, DOI 10.1073/pnas.262663399; In't Veld P, 2011, ISLETS, V3, P131, DOI 10.4161/isl.3.4.15728; Karlsen AE, 2004, DIABETOLOGIA, V47, P1998, DOI 10.1007/s00125-004-1568-3; Kharroubi I, 2004, ENDOCRINOLOGY, V145, P5087, DOI 10.1210/en.2004-0478; KINOSHITA S, 1992, P NATL ACAD SCI USA, V89, P1473, DOI 10.1073/pnas.89.4.1473; Ko CY, 2008, J BIOL CHEM, V283, P30919, DOI 10.1074/jbc.M804029200; Kutlu B, 2003, DIABETES, V52, P2701, DOI 10.2337/diabetes.52.11.2701; Lekstrom-Himes J, 1998, J BIOL CHEM, V273, P28545, DOI 10.1074/jbc.273.44.28545; Litvak V, 2009, NAT IMMUNOL, V10, P437, DOI 10.1038/ni.1721; Liu L, 2001, BRIT J PHARMACOL, V134, P1629, DOI 10.1038/sj.bjp.0704404; Lu YC, 2009, J IMMUNOL, V182, P7212, DOI 10.4049/jimmunol.0802971; Luedde T, 2004, HEPATOLOGY, V40, P356, DOI 10.1002/hep.20333; Lupi R, 2002, DIABETES, V51, P1437, DOI 10.2337/diabetes.51.5.1437; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Martin AP, 2008, DIABETES, V57, P3025, DOI 10.2337/db08-0625; Matsuda T, 2010, J CLIN INVEST, V120, P115, DOI 10.1172/JCI39721; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; McKenzie MD, 2010, DIABETES, V59, P644, DOI 10.2337/db09-1151; Mehmeti I, 2011, MOL CELL ENDOCRINOL, V332, P88, DOI 10.1016/j.mce.2010.09.017; Meir O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009516; Meller R, 2006, J BIOL CHEM, V281, P7429, DOI 10.1074/jbc.M512138200; Moore F, 2012, METHODS MOL BIOL, V820, P179, DOI 10.1007/978-1-61779-439-1_11; Moore F, 2011, J BIOL CHEM, V286, P929, DOI 10.1074/jbc.M110.162131; Moore F, 2009, DIABETES, V58, P1283, DOI 10.2337/db08-1510; NAGULAPALLI S, 1995, J IMMUNOL, V155, P4330; O'Rourke JP, 1999, J BIOL CHEM, V274, P16582, DOI 10.1074/jbc.274.23.16582; Ordonez Andrea Nicole, 2010, Int J Physiol Pathophysiol Pharmacol, V2, P36; Ortis F, 2008, DIABETOLOGIA, V51, P1213, DOI 10.1007/s00125-008-0999-7; Ortis F, 2006, MOL ENDOCRINOL, V20, P1867, DOI 10.1210/me.2005-0268; Ortis F, 2010, DIABETES, V59, P358, DOI 10.2337/db09-1159; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Pawar SA, 2010, P NATL ACAD SCI USA, V107, P9210, DOI 10.1073/pnas.0913813107; Peng H, 2006, REV ENDOCR METAB DIS, V7, P149, DOI 10.1007/s11154-006-9024-y; Pirot P, 2007, DIABETES, V56, P1069, DOI 10.2337/db06-1253; Plaisance V, 2009, MOL CELL ENDOCRINOL, V305, P47, DOI 10.1016/j.mce.2008.12.005; Pociot F, 2010, DIABETES, V59, P1561, DOI 10.2337/db10-0076; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Ramberg V, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-34; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Rasschaert J, 2005, J BIOL CHEM, V280, P33984, DOI 10.1074/jbc.M502213200; RAY A, 1995, J BIOL CHEM, V270, P7365, DOI 10.1074/jbc.270.13.7365; Roep BO, 2010, CLIN EXP IMMUNOL, V159, P338, DOI 10.1111/j.1365-2249.2009.04087.x; Ruocco MR, 1996, J BIOL CHEM, V271, P22479, DOI 10.1074/jbc.271.37.22479; Santin I, 2011, DIABETES; Skyler JS, 2011, DIABETES, V60, P1, DOI 10.2337/db10-1114; Sterneck E, 1998, P NATL ACAD SCI USA, V95, P10908, DOI 10.1073/pnas.95.18.10908; SYLVESTER SL, 1994, J BIOL CHEM, V269, P20119; Tanabe A, 2000, BIOL PHARM BULL, V23, P1424, DOI 10.1248/bpb.23.1424; Tanaka T, 1997, EMBO J, V16, P7432, DOI 10.1093/emboj/16.24.7432; Tang D, 2006, BREAST CANCER RES TR, V95, P161, DOI 10.1007/s10549-005-9061-3; Thomas HE, 2009, APOPTOSIS, V14, P1389, DOI 10.1007/s10495-009-0339-5; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Ubeda M, 1996, MOL CELL BIOL, V16, P1479; Wakeyama H, 2007, ANN NY ACAD SCI, V1116, P271, DOI 10.1196/annals.1402.001; Waldron-Lynch F, 2011, NAT REV DRUG DISCOV, V10, P439, DOI 10.1038/nrd3402; Wang KW, 2011, BBA-MOL CELL RES, V1813, P1395, DOI 10.1016/j.bbamcr.2011.04.004; Xie B, 2011, J NEUROSCI, V31, P5032, DOI 10.1523/JNEUROSCI.5504-10.2011; Yamada T, 1998, BIOCHEM BIOPH RES CO, V242, P88, DOI 10.1006/bbrc.1997.7915; Yang GY, 2001, J ANDROL, V22, P471; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	91	42	43	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31062	10.1371/journal.pone.0031062	http://dx.doi.org/10.1371/journal.pone.0031062			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347430	Green Submitted, gold, Green Published			2022-12-27	WOS:000302730100038
J	Liu, YL; Jie, HF; Qi, F; Kaleem, I; E, WW; Li, C				Liu, Yanli; Jie Huangfu; Qi, Feng; Kaleem, Imdad; E, Wenwen; Li, Chun			Effects of a Non-Conservative Sequence on the Properties of beta-glucuronidase from Aspergillus terreus Li-20	PLOS ONE			English	Article							GLYCOSYL HYDROLASES; GLYCYRRHIZIC ACID; STABILITY; EVOLUTION; ENZYME; DOMAIN; FOLD; VERSATILITY; GENE	We cloned the beta-glucuronidase gene (AtGUS) from Aspergillus terreus Li-20 encoding 657 amino acids (aa), which can transform glycyrrhizin into glycyrrhetinic acid monoglucuronide (GAMG) and glycyrrhetinic acid (GA). Based on sequence alignment, the C-terminal non-conservative sequence showed low identity with those of other species; thus, the partial sequence AtGUS(-3t) (1-592 aa) was amplified to determine the effects of the non-conservative sequence on the enzymatic properties. AtGUS and AtGUS(-3t) were expressed in E. coli BL21, producing AtGUS-E and AtGUS(-3t)-E, respectively. At the similar optimum temperature (55 degrees C) and pH (AtGUS-E, 6.6; AtGUS(-3t)-E, 7.0) conditions, the thermal stability of AtGUS(-3t)-E was enhanced at 65 degrees C, and the metal ions Co2+, Ca2+ and Ni2+ showed opposite effects on AtGUS-E and AtGUS(-3t)-E, respectively. Furthermore, Km of AtGUS(-3t)-E (1.95 mM) was just nearly one-seventh that of AtGUS-E (12.9 mM), whereas the catalytic efficiency of AtGUS(-3t)-E was 3.2 fold higher than that of AtGUS-E (7.16 vs. 2.24 mM s(-1)), revealing that the truncation of non-conservative sequence can significantly improve the catalytic efficiency of AtGUS. Conformational analysis illustrated significant difference in the secondary structure between AtGUS-E and AtGUS(-3t)-E by circular dichroism (CD). The results showed that the truncation of the non-conservative sequence could preferably alter and influence the stability and catalytic efficiency of enzyme.	[Liu, Yanli; Li, Chun] Tianjin Univ, Sch Chem Engn & Technol, Tianjin 300072, Peoples R China; [Jie Huangfu; Qi, Feng; Kaleem, Imdad; E, Wenwen; Li, Chun] Beijing Inst Technol, Sch Life Sci, Beijing 100081, Peoples R China	Tianjin University; Beijing Institute of Technology	Liu, YL (corresponding author), Tianjin Univ, Sch Chem Engn & Technol, Tianjin 300072, Peoples R China.	lichun@bit.edu.cn	Li, Chun/B-3292-2013		Natural Science Foundation of China [20976014, 21176028]; Key Projects Incubating Foundation of Beijing Institute of Technology [2011cx010]; Beijing Natural Science Foundation [2112035]; Ph.D. Programs Foundation of Ministry of Education of China [20091101110036]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Projects Incubating Foundation of Beijing Institute of Technology; Beijing Natural Science Foundation(Beijing Natural Science Foundation); Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China)	This research work was financially supported by the Natural Science Foundation of China (20976014, 21176028), Key Projects Incubating Foundation of Beijing Institute of Technology (2011cx010), Beijing Natural Science Foundation (2112035) and the Ph.D. Programs Foundation of Ministry of Education of China (20091101110036). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAMATSU H, 1991, PLANTA MED, V57, P119, DOI 10.1055/s-2006-960045; Akao T, 2000, BIOL PHARM BULL, V23, P1418, DOI 10.1248/bpb.23.1418; Baltina LA, 2003, CURR MED CHEM, V10, P155, DOI 10.2174/0929867033368538; CADWELL RC, 1994, PCR METH APPL, V3, pS136; CHUBACHI A, 1992, INTERNAL MED, V31, P708, DOI 10.2169/internalmedicine.31.708; Cicek M, 2000, J BIOL CHEM, V275, P20002, DOI 10.1074/jbc.M001609200; Cinatl J, 2003, LANCET, V361, P2045, DOI 10.1016/S0140-6736(03)13615-X; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; Feng SJ, 2006, J MOL CATAL B-ENZYM, V43, P63, DOI 10.1016/j.molcatb.2006.06.016; Fux L, 2009, CANCER RES, V69, P1758, DOI 10.1158/0008-5472.CAN-08-1837; HENRISSAT B, 1995, P NATL ACAD SCI USA, V92, P7090, DOI 10.1073/pnas.92.15.7090; Hocker B, 2001, CURR OPIN BIOTECH, V12, P376, DOI 10.1016/S0958-1669(00)00230-5; Huisman FHA, 2010, BIOCHEM BIOPH RES CO, V393, P168, DOI 10.1016/j.bbrc.2010.01.114; Ike M, 2008, J MOL CATAL B-ENZYM, V55, P55, DOI 10.1016/j.molcatb.2007.12.020; JACOBSON RH, 1994, NATURE, V369, P761, DOI 10.1038/369761a0; Jain S, 1996, NAT STRUCT BIOL, V3, P375, DOI 10.1038/nsb0496-375; JEFFERSON RA, 1987, EMBO J, V6, P3901; Krausse R, 2004, J ANTIMICROB CHEMOTH, V54, P243, DOI 10.1093/jac/dkh287; Lu DQ, 2006, J MOL CATAL B-ENZYM, V43, P148, DOI 10.1016/j.molcatb.2006.07.011; NOSE M, 1994, PLANTA MED, V60, P136, DOI 10.1055/s-2006-959435; [宋占科 SONG Zhanke], 2008, [化工学报, Journal of Chemical Industry and Engineering (China)], V59, P3101; STEMMER WPC, 1995, GENE, V164, P49, DOI 10.1016/0378-1119(95)00511-4; Sterner R, 2005, CHEM REV, V105, P4038, DOI 10.1021/cr030191z; Wallace BD, 2010, SCIENCE, V330, P831, DOI 10.1126/science.1191175; Wang YJ, 2009, BIORESOURCE TECHNOL, V100, P345, DOI 10.1016/j.biortech.2008.06.001; Wiederstein M, 2005, J MOL BIOL, V345, P1199, DOI 10.1016/j.jmb.2004.11.012; Xie XJ, 2009, MOL CELL BIOCHEM, V327, P241, DOI 10.1007/s11010-009-0062-0; Zhao HM, 1998, NAT BIOTECHNOL, V16, P258, DOI 10.1038/nbt0398-258	28	9	9	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2012	7	2							e30998	10.1371/journal.pone.0030998	http://dx.doi.org/10.1371/journal.pone.0030998			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917MF	22347419	Green Published, Green Submitted, gold			2022-12-27	WOS:000302180600021
J	Sedaghat, Y; Mazur, C; Sabripour, M; Hung, G; Monia, BP				Sedaghat, Yalda; Mazur, Curt; Sabripour, Mahyar; Hung, Gene; Monia, Brett P.			Genomic Analysis of wig-1 Pathways	PLOS ONE			English	Article							ZINC-FINGER PROTEIN; AU-RICH ELEMENT; KINASE-C-EPSILON; MESSENGER-RNA; HUNTINGTONS-DISEASE; TUMOR-SUPPRESSOR; CELL-LINES; P53; GENE; EXPRESSION	Background: Wig-1 is a transcription factor regulated by p53 that can interact with hnRNP A2/B1, RNA Helicase A, and dsRNAs, which plays an important role in RNA and protein stabilization. in vitro studies have shown that wig-1 binds p53 mRNA and stabilizes it by protecting it from deadenylation. Furthermore, p53 has been implicated as a causal factor in neurodegenerative diseases based in part on its selective regulatory function on gene expression, including genes which, in turn, also possess regulatory functions on gene expression. In this study we focused on the wig-1 transcription factor as a downstream p53 regulated gene and characterized the effects of wig-1 down regulation on gene expression in mouse liver and brain. Methods and Results: Antisense oligonucleotides (ASOs) were identified that specifically target mouse wig-1 mRNA and produce a dose-dependent reduction in wig-1 mRNA levels in cell culture. These wig-1 ASOs produced marked reductions in wig-1 levels in liver following intraperitoneal administration and in brain tissue following ASO administration through a single striatal bolus injection in FVB and BACHD mice. Wig-1 suppression was well tolerated and resulted in the reduction of mutant Htt protein levels in BACHD mouse brain but had no effect on normal Htt protein levels nor p53 mRNA or protein levels. Expression microarray analysis was employed to determine the effects of wig-1 suppression on genome-wide expression in mouse liver and brain. Reduction of wig-1 caused both down regulation and up regulation of several genes, and a number of wig-1 regulated genes were identified that potentially links wig-1 various signaling pathways and diseases. Conclusion: ntisense oligonucleotides can effectively reduce wig-1 levels in mouse liver and brain, which results in specific changes in gene expression for pathways relevant to both the nervous system and cancer.	[Sedaghat, Yalda; Mazur, Curt; Sabripour, Mahyar; Hung, Gene; Monia, Brett P.] Isis Pharmaceut Inc, Dept Drug Discovery, Carlsbad, CA USA	Isis Pharmaceuticals Inc	Sedaghat, Y (corresponding author), Isis Pharmaceut Inc, Dept Drug Discovery, Carlsbad, CA USA.	bmonia@isisph.com			Isis Pharmaceuticals	Isis Pharmaceuticals	Funding was provided wholly by Isis Pharmaceuticals who, through the employment of YS, CM, MS, GH and BPM, had a role in conceiving, designing and performing the experiments, and analyzing the data.	Abdelmagid SM, 2007, J CELL PHYSIOL, V210, P26, DOI 10.1002/jcp.20841; Bae BI, 2005, NEURON, V47, P29, DOI 10.1016/j.neuron.2005.06.005; Bakheet T, 2003, NUCLEIC ACIDS RES, V31, P421, DOI 10.1093/nar/gkg023; Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; Basu A, 2002, EXP CELL RES, V278, P209, DOI 10.1006/excr.2002.5587; Basu A, 2008, METHOD ENZYMOL, V446, P141, DOI 10.1016/S0076-6879(08)01608-X; Bedogni F, 2010, GENE EXPR PATTERNS, V10, P9, DOI 10.1016/j.gep.2009.11.005; Butler M, 2005, NEUROSCIENCE, V131, P705, DOI 10.1016/j.neuroscience.2004.11.038; Cacace AM, 1996, ONCOGENE, V13, P2517; Chen T, 2004, MOL CELL BIOL, V24, P6608, DOI 10.1128/mcb.24.15.6608-6619.2004; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Feng Z, 2006, ONCOGENE, V25, P1, DOI 10.1038/sj.onc.1209021; Geary R S, 2001, Curr Opin Investig Drugs, V2, P562; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Graeber MB, 1998, J NEUROL SCI, V153, P251, DOI 10.1016/S0022-510X(97)00295-5; Gray M, 2008, J NEUROSCI, V28, P6182, DOI 10.1523/JNEUROSCI.0857-08.2008; Hellborg F, 2001, ONCOGENE, V20, P5466, DOI 10.1038/sj.onc.1204722; Ho SP, 1999, CURR OPIN MOL THER, V1, P336; Islam SM, 2009, SCIENCE, V323, P388, DOI 10.1126/science.1165187; Israeli D, 1997, EMBO J, V16, P4384, DOI 10.1093/emboj/16.14.4384; Kalscheuer VM, 2007, HUM GENET, V121, P501, DOI 10.1007/s00439-006-0284-0; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; LAGNADO CA, 1994, MOL CELL BIOL, V14, P7984, DOI 10.1128/MCB.14.12.7984; Leonard JV, 2000, LANCET, V355, P389, DOI 10.1016/S0140-6736(99)05226-5; Leonard JV, 2000, LANCET, V355, P299, DOI 10.1016/S0140-6736(99)05225-3; Maestrini E, 2010, MOL PSYCHIATR, V15, P954, DOI 10.1038/mp.2009.34; Mendez-Vidal C, 2002, NUCLEIC ACIDS RES, V30, P1991, DOI 10.1093/nar/30.9.1991; Metz RL, 2005, CELL CYCLE, V4, P315; Peng SSY, 1996, MOL CELL BIOL, V16, P1490; Perletti GP, 1998, ONCOGENE, V16, P3345, DOI 10.1038/sj.onc.1201871; Petek E, 2007, MOL GENET GENOMICS, V277, P71, DOI 10.1007/s00438-006-0173-1; Prahl M, 2008, FEBS LETT, V582, P2173, DOI 10.1016/j.febslet.2008.04.065; Qian XZ, 2008, MOL ONCOL, V2, P81, DOI 10.1016/j.molonc.2008.02.002; Rose AAN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012093; Rose AAN, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1791; ROTHBERG JM, 1990, GENE DEV, V4, P2169, DOI 10.1101/gad.4.12a.2169; Ryan AB, 2006, NEUROBIOL DIS, V24, P419, DOI 10.1016/j.nbd.2006.08.002; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; Sharif TR, 1999, INT J ONCOL, V15, P237; Spampanato J, 2008, NEUROSCIENCE, V157, P606, DOI 10.1016/j.neuroscience.2008.09.020; Sultana R, 2002, GENOMICS, V80, P129, DOI 10.1006/geno.2002.6810; Tamada A, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-29; Thompson H, 2009, DEV BIOL, V335, P418, DOI 10.1016/j.ydbio.2009.09.034; Tse KF, 2006, CLIN CANCER RES, V12, P1373, DOI 10.1158/1078-0432.CCR-05-2018; VarmehZiaie S, 1997, ONCOGENE, V15, P2699, DOI 10.1038/sj.onc.1201454; Vidal CM, 2006, FEBS LETT, V580, P4401, DOI 10.1016/j.febslet.2006.07.005; Vilborg A, 2009, P NATL ACAD SCI USA, V106, P15756, DOI 10.1073/pnas.0900862106; WETERMAN MAJ, 1995, INT J CANCER, V60, P73, DOI 10.1002/ijc.2910600111; Wu HJ, 1999, J BIOL CHEM, V274, P28270, DOI 10.1074/jbc.274.40.28270; Yang ML, 2006, BLOOD, V108, P4136, DOI 10.1182/blood-2006-06-029645; Yang XW, 2005, CURR PROTOC NEUROSCI, DOI [DOI 10.1002/0471142301.NS0520S31.CHAPTER, 10.1002/0471142301.ns0520s31, DOI 10.1002/0471142301.NS0520S31]; Zhang XD, 2009, AUTOPHAGY, V5, P339, DOI 10.4161/auto.5.3.8174; ZUBIAGA AM, 1995, MOL CELL BIOL, V15, P2219	53	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2012	7	2							e29429	10.1371/journal.pone.0029429	http://dx.doi.org/10.1371/journal.pone.0029429			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917MF	22347364	Green Published, gold, Green Submitted			2022-12-27	WOS:000302180600004
J	Henaux, V; Samuel, MD; Dusek, RJ; Fleskes, JP; Ip, HS				Henaux, Viviane; Samuel, Michael D.; Dusek, Robert J.; Fleskes, Joseph P.; Ip, Hon S.			Presence of Avian Influenza Viruses in Waterfowl and Wetlands during Summer 2010 in California: Are Resident Birds a Potential Reservoir	PLOS ONE			English	Article							A VIRUSES; ENVIRONMENTAL TRANSMISSION; WILD BIRDS; SURVEILLANCE; PERSISTENCE; PREVALENCE; PATTERNS; DUCKS; PERPETUATION; INFECTIVITY	Although wild waterfowl are the main reservoir for low pathogenic avian influenza viruses (LPAIv), the environment plays a critical role for the circulation and persistence of AIv. LPAIv may persist for extended periods in cold environments, suggesting that waterfowl breeding areas in the northern hemisphere may be an important reservoir for AIv in contrast to the warmer southern wintering areas. We evaluated whether southern wetlands, with relatively small populations (thousands) of resident waterfowl, maintain AIv in the summer, prior to the arrival of millions of migratory birds. We collected water and fecal samples at ten wetlands in two regions (Yolo Bypass and Sacramento Valley) of the California Central Valley during three bi-weekly intervals beginning in late July, 2010. We detected AIv in 29/367 fecal samples (7.9%) and 12/597 water samples (2.0%) by matrix real time Reverse Transcription Polymerase Chain Reaction (rRT-PCR). We isolated two H3N8, two H2N3, and one H4N8 among rRT-PCR positive fecal samples but no live virus from water samples. Detection of AIv RNA in fecal samples was higher from wetlands in the Sacramento Valley (11.9%) than in the Yolo Bypass (0.0%), but no difference was found for water samples (2.7 vs. 1.7%, respectively). Our study showed that low densities of hosts and unfavorable environmental conditions did not prevent LPAIv circulation during summer in California wetlands. Our findings justify further investigations to understand AIv dynamics in resident waterfowl populations, compare AIv subtypes between migratory and resident waterfowl, and assess the importance of local AIv as a source of infection for migratory birds.	[Henaux, Viviane] Univ Wisconsin, Dept Forest & Wildlife Ecol, Madison, WI 53706 USA; [Samuel, Michael D.] US Geol Survey, Wisconsin Cooperat Wildlife Res Unit, Madison, WI USA; [Dusek, Robert J.; Ip, Hon S.] US Geol Survey, Natl Wildlife Hlth Ctr, Madison, WI USA; [Fleskes, Joseph P.] US Geol Survey, Western Ecol Res Ctr, Dixon, CA USA	University of Wisconsin System; University of Wisconsin Madison; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey	Henaux, V (corresponding author), Univ Wisconsin, Dept Forest & Wildlife Ecol, Madison, WI 53706 USA.	henaux@wisc.edu		Ip, Hon/0000-0003-4844-7533; Dusek, Robert/0000-0001-6177-7479	U.S. Geological Survey-National Wildlife Health Center; Western Ecological Research Center	U.S. Geological Survey-National Wildlife Health Center(United States Geological Survey); Western Ecological Research Center	Field sampling, laboratory work, and support for V. Henaux was funded by the U.S. Geological Survey-National Wildlife Health Center (Project CDXRE) and Western Ecological Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUSTIN JE, 1995, BIRDS N AM, V163; Breban R, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000346; Brown JD, 2007, AVIAN DIS, V51, P285, DOI 10.1637/7636-042806R.1; Brown Justin D., 2008, V436, P85, DOI 10.1007/978-1-59745-279-3_11; Central Valley Joint Venture, 2006, CENTR VALL JOINT VEN; Chumpolbanchorn Kamlang, 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P102; Docherty D.E., 1988, Journal of Tissue Culture Methods, V11, P165, DOI 10.1007/BF01404270; Faust C, 2009, P ROY SOC B-BIOL SCI, V276, P3727, DOI 10.1098/rspb.2009.0572; Ferro PJ, 2008, J WILDLIFE DIS, V44, P434, DOI 10.7589/0090-3558-44.2.434; Ferro PJ, 2010, EMERG INFECT DIS, V16, P1224, DOI 10.3201/eid1608.091864; Fleskes JP, 2007, J WILDLIFE MANAGE, V71, P2238, DOI 10.2193/2005-634; Fleskes JP, WETLAND HAB IN PRESS, P3; Gaidet N, 2007, EMERG INFECT DIS, V13, P626, DOI 10.3201/eid1304.061011; Heitmeyer M.E., 1989, P475; Henaux V, 2011, J WILDLIFE DIS, V47, P566, DOI 10.7589/0090-3558-47.3.566; Hill NJ, 2010, AVIAN DIS, V54, P426, DOI 10.1637/8912-043009-Reg.1; Hill NJ, 2011, CROSS SEASO IN PRESS; HINSHAW VS, 1980, CAN J MICROBIOL, V26, P622, DOI 10.1139/m80-108; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Ip HS, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-71; ITO T, 1995, ARCH VIROL, V140, P1163, DOI 10.1007/BF01322743; Koehler AV, 2008, MOL ECOL, V17, P4754, DOI 10.1111/j.1365-294X.2008.03953.x; Krauss S, 2004, VECTOR-BORNE ZOONOT, V4, P177, DOI 10.1089/vbz.2004.4.177; Lang AS, 2008, J GEN VIROL, V89, P509, DOI 10.1099/vir.0.83369-0; Mackenzie DI, 2005, J APPL ECOL, V42, P1105, DOI 10.1111/j.1365-2664.2005.01098.x; McClintock BT, 2010, ECOL LETT, V13, P659, DOI 10.1111/j.1461-0248.2010.01472.x; Munster VJ, 2007, PLOS PATHOG, V3, P630, DOI 10.1371/journal.ppat.0030061; Nazir J, 2010, AVIAN DIS, V54, P720, DOI 10.1637/8754-033109-ResNote.1; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Pasick J, 2010, AVIAN DIS, V54, P440, DOI 10.1637/8800-040109-Reg.1; Pearce JM, 2009, EVOL APPL, V2, P457, DOI 10.1111/j.1752-4571.2009.00071.x; Purchase HG, 1989, LAB MANUAL ISOLATION; Rogers K, 2009, LIVE BIRD HUNTER HAR; Rohani P, 2009, P NATL ACAD SCI USA, V106, P10365, DOI 10.1073/pnas.0809026106; Runstadler JA, 2007, ARCH VIROL, V152, P1901, DOI 10.1007/s00705-007-0994-1; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Spackman E, 2008, J VET DIAGN INVEST, V20, P612, DOI 10.1177/104063870802000512; Stallknecht DE, 2009, REV SCI TECH OIE, V28, P59; STALLKNECHT DE, 1990, AVIAN DIS, V34, P406, DOI 10.2307/1591428; STALLKNECHT DE, 1990, AVIAN DIS, V34, P412, DOI 10.2307/1591429; STALLKNECHT DE, 1990, AVIAN DIS, V34, P398, DOI 10.2307/1591427; WEBSTER RG, 1978, VIROLOGY, V84, P268, DOI 10.1016/0042-6822(78)90247-7; Zarkov IS, 2006, REV MED VET-TOULOUSE, V157, P471	43	29	30	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2012	7	2							e31471	10.1371/journal.pone.0031471	http://dx.doi.org/10.1371/journal.pone.0031471			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LV	22328934	gold, Green Submitted, Green Published			2022-12-27	WOS:000302179300020
J	Shahab, U; Ahmad, S; Moinuddin; Dixit, K; Habib, S; Alam, K; Ali, A				Shahab, Uzma; Ahmad, Saheem; Moinuddin; Dixit, Kiran; Habib, Safia; Alam, Khursheed; Ali, Asif			Hydroxyl Radical Modification of Collagen Type II Increases Its Arthritogenicity and Immunogenicity	PLOS ONE			English	Article							LIPID-PEROXIDATION; INDUCED ARTHRITIS; PREFERENTIAL RECOGNITION; CIRCULAR-DICHROISM; ANTIOXIDANT LEVELS; ANTIBODIES; IMMUNIZATION; GLYCATION; PRODUCTS; DISEASE	Background: The oxidation of proteins by endogenously generated free radicals causes structural modifications in the molecules that lead to generation of neo-antigenic epitopes that have implications in various autoimmune disorders, including rheumatoid arthritis (RA). Collagen induced arthritis (CIA) in rodents (rats and mice) is an accepted experimental model for RA. Methodology/Principal Findings: Hydroxyl radicals were generated by the Fenton reaction. Collagen type II (CII) was modified by (OH)-O-center dot radical (CII-OH) and analysed by ultraviolet-visible (UV-VIS), fluorescence and circular dichroism (CD) spectroscopy. The immunogenicity of native and modified CII was checked in female Lewis rats and specificity of the induced antibodies was ascertained by enzyme linked immunosorbent assay (ELISA). The extent of CIA was evaluated by visual inspection. We also estimated the oxidative and inflammatory markers in the sera of immunized rats. A slight change in the triple helical structure of CII as well as fragmentation was observed after hydroxyl radical modification. The modified CII was found to be highly arthritogenic and immunogenic as compared to the native form. The CII-OH immunized rats exhibited increased oxidative stress and inflammation as compared to the CII immunized rats in the control group. Conclusions/Significance: Neo-antigenic epitopes were generated on (OH)-O-center dot modified CII which rendered it highly immunogenic and arthritogenic as compared to the unmodified form. Since the rodent CIA model shares many features with human RA, these results illuminate the role of free radicals in human RA.	[Shahab, Uzma; Ahmad, Saheem; Moinuddin; Dixit, Kiran; Habib, Safia; Alam, Khursheed; Ali, Asif] Aligarh Muslim Univ, Dept Biochem, Fac Med, JN Med Coll, Aligarh, Uttar Pradesh, India	Aligarh Muslim University	Shahab, U (corresponding author), Aligarh Muslim Univ, Dept Biochem, Fac Med, JN Med Coll, Aligarh, Uttar Pradesh, India.	moin_u@rediffmail.com	Ahmad, Saheem/R-7016-2017; Shahab, Uzma/AAR-4332-2021; Ahmad, Saheem/T-2609-2019	Ahmad, Saheem/0000-0003-1215-0279; Ahmad, Saheem/0000-0003-1215-0279; Alam, Khursheed/0000-0001-9729-9966	Aligarh M University; University Grants Commmission, New Delhi; ICMR, New Delhi [Immuno 18/11/18/2008-ECD-I]	Aligarh M University; University Grants Commmission, New Delhi; ICMR, New Delhi(Indian Council of Medical Research (ICMR))	Funds for the study came from annual budget grant provided by the Aligarh M University to the Department. The University gets funds from the University Grants Commmission, New Delhi (www.ugc.ac.in). Part of the funds were also derived from the research grant to Dr. Moinuddin from ICMR, New Delhi [www.icmr.nic.in] (grant no.Immuno 18/11/18/2008-ECD-I). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi H., 1974, METHODS ENZYMATIC AN, P673, DOI [10.1016/B978-0-12-091302-2.50032-3, DOI 10.1016/B978-0-12-091302-2.50032-3]; Ahmad S, 2011, BIOCHEM BIOPH RES CO, V407, P568, DOI 10.1016/j.bbrc.2011.03.064; ANDRIOPOULOS NA, 1976, ARTHRITIS RHEUM, V19, P613, DOI 10.1002/art.1780190314; Ansari NA, 2009, HUM IMMUNOL, V70, P417, DOI 10.1016/j.humimm.2009.03.015; Bauerova K, 1999, GEN PHYSIOL BIOPHYS, V18, P15; Bazzichi L, 2002, Clin Exp Rheumatol, V20, P761; BIEMOND P, 1988, FREE RADICAL BIO MED, V4, P185, DOI 10.1016/0891-5849(88)90026-3; BROWN FR, 1969, J MOL BIOL, V39, P307, DOI 10.1016/0022-2836(69)90319-2; Cheng FC, 2002, J CHROMATOGR B, V781, P481, DOI 10.1016/S1570-0232(02)00620-7; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Feldmann M, 1996, CELL, V85, P307, DOI 10.1016/S0092-8674(00)81109-5; FLOHE L, 1984, METHOD ENZYMOL, V105, P114; Gambhir JK, 1997, CLIN BIOCHEM, V30, P351, DOI 10.1016/S0009-9120(96)00007-0; Habib S, 2009, CELL IMMUNOL, V254, P117, DOI 10.1016/j.cellimm.2008.08.002; HALLIWELL B, 1990, ARCH BIOCHEM BIOPHYS, V280, P1, DOI 10.1016/0003-9861(90)90510-6; Harris ED, 1993, TXB RHEUMATOLOGY, P833; Hassan MQ, 2001, J APPL TOXICOL, V21, P69, DOI 10.1002/jat.736; HELIOVAARA M, 1994, ANN RHEUM DIS, V53, P51, DOI 10.1136/ard.53.1.51; Hinoi E, 2005, BIOCHEM PHARMACOL, V70, P1744, DOI 10.1016/j.bcp.2005.09.010; HOLMDAHL R, 1989, J IMMUNOL, V142, P1881; HOLMDAHL R, 1985, CLIN EXP IMMUNOL, V62, P639; JENNESS DD, 1976, BIOPOLYMERS, V15, P513, DOI 10.1002/bip.1976.360150308; Jira W, 1997, CHEM PHYS LIPIDS, V87, P81, DOI 10.1016/S0009-3084(97)00030-3; Kamanh A, 2004, CELL BIOCHEM FUNCT, V22, P53, DOI 10.1002/cbf.1055; Karatas F, 2003, INDIAN J MED RES, V118, P178; Kim WU, 2004, AM J MED SCI, V327, P202, DOI 10.1097/00000441-200404000-00006; Kim WU, 2000, J RHEUMATOL, V27, P575; Kiziltunc A, 1998, SCAND J RHEUMATOL, V27, P441; LARSSON P, 1990, ARTHRITIS RHEUM, V33, P693, DOI 10.1002/art.1780330512; LEVINE RL, 1990, METHOD ENZYMOL, V186, P464; LI MH, 1993, BIOCHEMISTRY-US, V32, P7377, DOI 10.1021/bi00080a007; LONDEI M, 1989, P NATL ACAD SCI USA, V86, P636, DOI 10.1073/pnas.86.2.636; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469; Mori T, 2011, INT IMMUNOL, V23, P701, DOI 10.1093/intimm/dxr077; Olszowski S, 2003, ACTA BIOCHIM POL, V50, P471; STUART JM, 1983, J EXP MED, V158, P378, DOI 10.1084/jem.158.2.378; Svensson L, 1998, CLIN EXP IMMUNOL, V111, P521; Terato K, 1996, CLIN IMMUNOL IMMUNOP, V79, P142, DOI 10.1006/clin.1996.0061; Yagi K, 1988, CRC HDB FREE RADICAL, P215	40	40	40	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e31199	10.1371/journal.pone.0031199	http://dx.doi.org/10.1371/journal.pone.0031199			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LO	22319617	Green Submitted, gold, Green Published			2022-12-27	WOS:000302178400031
J	El-Shamy, A; Shoji, I; Kim, SR; Ide, Y; Imoto, S; Deng, L; Yoon, S; Fujisawa, T; Tani, S; Yano, Y; Seo, Y; Azuma, T; Hotta, H				El-Shamy, Ahmed; Shoji, Ikuo; Kim, Soo-Ryang; Ide, Yoshihiro; Imoto, Susumu; Deng, Lin; Yoon, Seitetsu; Fujisawa, Takashi; Tani, Satoshi; Yano, Yoshihiko; Seo, Yasushi; Azuma, Takeshi; Hotta, Hak			Sequence Heterogeneity in NS5A of Hepatitis C Virus Genotypes 2a and 2b and Clinical Outcome of Pegylated-Interferon/Ribavirin Therapy	PLOS ONE			English	Article							NONSTRUCTURAL PROTEIN 5A; SUSTAINED VIROLOGICAL RESPONSE; SENSITIVITY-DETERMINING REGION; ACID SUBSTITUTION PATTERN; VIRAL LOAD; COMBINATION THERAPY; PLUS RIBAVIRIN; MUTATIONS; 1B; ASSOCIATION	Pegylated-interferon plus ribavirin (PEG-IFN/RBV) therapy is a current standard treatment for chronic hepatitis C. We previously reported that the viral sequence heterogeneity of part of NS5A, referred to as the IFN/RBV resistance-determining region (IRRDR), and a mutation at position 70 of the core protein of hepatitis C virus genotype 1b (HCV-1b) are significantly correlated with the outcome of PEG-IFN/RBV treatment. Here, we aimed to investigate the impact of viral genetic variations within the NS5A and core regions of other genotypes, HCV-2a and HCV-2b, on PEG-IFN/RBV treatment outcome. Pretreatment sequences of NS5A and core regions were analyzed in 112 patients infected with HCV-2a or HCV-2b, who were treated with PEG-IFN/RBV for 24 weeks and followed up for another 24 weeks. The results demonstrated that HCV-2a isolates with 4 or more mutations in IRRDR (IRRDR[2a]>= 4) was significantly associated with rapid virological response at week 4 (RVR) and sustained virological response (SVR). Also, another region of NS5A that corresponds to part of the IFN sensitivity-determining region (ISDR) plus its carboxy-flanking region, which we referred to as ISDR/+C[2a], was significantly associated with SVR in patients infected with HCV-2a. Multivariate analysis revealed that IRRDR[2a]>= 4 was the only independent predictive factor for SVR. As for HCV-2b infection, an N-terminal half of IRRDR having two or more mutations (IRRDR[2b]/N >= 2) was significantly associated with RVR, but not with SVR. No significant correlation was observed between core protein polymorphism and PEG-IFN/RBV treatment outcome in HCV-2a or HCV-2b infection. Conclusion: The present results suggest that sequence heterogeneity of NS5A of HCV-2a (IRRDR[2a]>= 4 and ISDR/+C[2a]), and that of HCV-2b (IRRDR[2b]/N >= 2) to a lesser extent, is involved in determining the viral sensitivity to PEG-IFN/RBV therapy.	[El-Shamy, Ahmed; Shoji, Ikuo; Ide, Yoshihiro; Deng, Lin; Hotta, Hak] Kobe Univ, Grad Sch Med, Ctr Infect Dis, Div Microbiol, Kobe, Hyogo 657, Japan; [El-Shamy, Ahmed] Suez Canal Univ, Dept Virol, Fac Vet Med, Ismailia, Egypt; [Kim, Soo-Ryang; Imoto, Susumu] Kobe Asahi Hosp, Div Gastroenterol, Kobe, Hyogo, Japan; [Yoon, Seitetsu] Hyogo Prefectural Kakogawa Med Ctr, Dept Gastroenterol, Kakogawa, Hyogo, Japan; [Fujisawa, Takashi] Nippon Steel Hirohata Hosp, Dept Internal Med, Himeji, Hyogo, Japan; [Tani, Satoshi] Konan Hosp, Dept Internal Med, Kobe, Hyogo, Japan; [Yano, Yoshihiko; Seo, Yasushi; Azuma, Takeshi] Kobe Univ, Grad Sch Med, Dept Internal Med, Div Gastroenterol, Kobe, Hyogo 657, Japan	Kobe University; Egyptian Knowledge Bank (EKB); Suez Canal University; Kobe University	El-Shamy, A (corresponding author), Kobe Univ, Grad Sch Med, Ctr Infect Dis, Div Microbiol, Kobe, Hyogo 657, Japan.	hotta@kobe-u.ac.jp	Shoji, Ikuo/Y-7079-2019	Shoji, Ikuo/0000-0002-0730-4379; El-Shamy, Ahmed/0000-0002-6045-5889	Ministry of Health, Labour and Welfare, Japan; Ministry of Education, Culture, Sports, Science and Technology, Japan; Japan Science and Technology Agency; Japan International Cooperation Agency	Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Japan International Cooperation Agency	This study was supported in part by Health and Labour Sciences Research Grants from the Ministry of Health, Labour and Welfare, Japan, a J-GRID grant from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and a SATREPS Grant from Japan Science and Technology Agency and Japan International Cooperation Agency. This study was also carried out as part of the Global Center of Excellence program of Kobe University Graduate School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akuta N, 2003, J MED VIROL, V69, P376, DOI 10.1002/jmv.10299; Akuta N, 2007, J HEPATOL, V46, P403, DOI 10.1016/j.jhep.2006.09.019; Akuta N, 2009, INTERVIROLOGY, V52, P301, DOI 10.1159/000235909; Alestig E, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-124; Chung RT, 1999, J MED VIROL, V58, P353, DOI 10.1002/(SICI)1096-9071(199908)58:4&lt;353::AID-JMV6&gt;3.0.CO;2-C; Donlin MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009032; Duverlie G, 1998, J GEN VIROL, V79, P1373, DOI 10.1099/0022-1317-79-6-1373; El-Shamy A, 2008, HEPATOLOGY, V48, P38, DOI 10.1002/hep.22339; El-Shamy A, 2007, MICROBIOL IMMUNOL, V51, P471, DOI 10.1111/j.1348-0421.2007.tb03922.x; El-Shamy A, 2012, INTERVIROLOGY, V55, P1, DOI 10.1159/000322219; ENOMOTO N, 1990, BIOCHEM BIOPH RES CO, V170, P1021, DOI 10.1016/0006-291X(90)90494-8; Enomoto N, 1996, NEW ENGL J MED, V334, P77, DOI 10.1056/NEJM199601113340203; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Hughes M, 2009, J VIROL, V83, P10788, DOI 10.1128/JVI.02406-08; Kadokura M, 2011, HEPATOL INT, V5, P789, DOI 10.1007/s12072-011-9267-x; Kau A, 2008, J HEPATOL, V49, P634, DOI 10.1016/j.jhep.2008.07.013; Limaye AR, 2011, NEW ENGL J MED, V365, P176, DOI 10.1056/NEJMc1105515; Lusida MI, 2001, J CLIN MICROBIOL, V39, P3858, DOI 10.1128/JCM.39.11.3858-3864.2001; Macdonald A, 2004, J GEN VIROL, V85, P2485, DOI 10.1099/vir.0.80204-0; Micallef JM, 2006, J VIRAL HEPATITIS, V13, P34, DOI 10.1111/j.1365-2893.2005.00651.x; Moradpour D, 2004, J VIROL, V78, P7400, DOI 10.1128/JVI.78.14.7400-7409.2004; Murakami T, 1999, HEPATOLOGY, V30, P1045, DOI 10.1002/hep.510300405; OKAMOTO H, 1992, J GEN VIROL, V73, P673, DOI 10.1099/0022-1317-73-3-673; OKAMOTO H, 1992, VIROLOGY, V188, P331, DOI 10.1016/0042-6822(92)90762-E; OKAMOTO H, 1991, J GEN VIROL, V72, P2697, DOI 10.1099/0022-1317-72-11-2697; Pascu M, 2004, GUT, V53, P1345, DOI 10.1136/gut.2003.031336; Sakamoto N, 2011, J MED VIROL, V83, P871, DOI 10.1002/jmv.22038; Sarasin-Filipowicz M, 2010, SWISS MED WKLY, V140, P3, DOI smw-12670; Sarrazin C, 2000, J INFECT DIS, V181, P432, DOI 10.1086/315263; Sherman KE, 2011, NEW ENGL J MED, V365, P1014, DOI 10.1056/NEJMoa1014463; Squadrito G, 1999, J HEPATOL, V30, P1023, DOI 10.1016/S0168-8278(99)80255-4; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Tellinghuisen TL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000032; Tsai YH, 2008, J HEPATOL, V85, P2485; Yuan HJ, 2010, J VIRAL HEPATITIS, V17, P208, DOI 10.1111/j.1365-2893.2009.01169.x; Zeuzem S, 1997, HEPATOLOGY, V25, P740, DOI 10.1002/hep.510250341	38	16	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2012	7	2							e30513	10.1371/journal.pone.0030513	http://dx.doi.org/10.1371/journal.pone.0030513			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UV	22319571	gold, Green Published, Green Submitted			2022-12-27	WOS:000301979000008
J	Salzman, J; Gawad, C; Wang, PL; Lacayo, N; Brown, PO				Salzman, Julia; Gawad, Charles; Wang, Peter Lincoln; Lacayo, Norman; Brown, Patrick O.			Circular RNAs Are the Predominant Transcript Isoform from Hundreds of Human Genes in Diverse Cell Types	PLOS ONE			English	Article							MESSENGER-RNA; MOUSE TESTIS; EXON; SRY; EXPRESSION	Most human pre-mRNAs are spliced into linear molecules that retain the exon order defined by the genomic sequence. By deep sequencing of RNA from a variety of normal and malignant human cells, we found RNA transcripts from many human genes in which the exons were arranged in a non-canonical order. Statistical estimates and biochemical assays provided strong evidence that a substantial fraction of the spliced transcripts from hundreds of genes are circular RNAs. Our results suggest that a non-canonical mode of RNA splicing, resulting in a circular RNA isoform, is a general feature of the gene expression program in human cells.	[Salzman, Julia; Gawad, Charles; Wang, Peter Lincoln; Brown, Patrick O.] Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA; [Brown, Patrick O.] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA; [Gawad, Charles; Lacayo, Norman] Stanford Univ, Dept Pediat Hematol Oncol, Sch Med, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University	Salzman, J (corresponding author), Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA.	pbrown@stanford.edu	wang, peter/AAD-5851-2020; Gawad, Charles/AAP-5448-2021; Gawad, Charles/N-8073-2018	Gawad, Charles/0000-0002-4728-8203	Canary Foundation, Howard Hughes Medical Institute; Debra; Andrew Rachleff Endowed Fellowship	Canary Foundation, Howard Hughes Medical Institute; Debra; Andrew Rachleff Endowed Fellowship	Funding provided by the Canary Foundation, Howard Hughes Medical Institute. CG's salary was paid by the Debra and Andrew Rachleff Endowed Fellowship. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Balool HH, 2011, GENOME RES; Bailleul B, 1996, NUCLEIC ACIDS RES, V24, P1015, DOI 10.1093/nar/24.6.1015; Burd CE, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001233; Caldas C, 1998, GENE, V208, P167, DOI 10.1016/S0378-1119(97)00640-9; CAO QP, 1995, MOL REPROD DEV, V40, P196, DOI 10.1002/mrd.1080400208; CAPEL B, 1993, CELL, V73, P1019, DOI 10.1016/0092-8674(93)90279-Y; CHEN CY, 1995, SCIENCE, V268, P415, DOI 10.1126/science.7536344; COCQUERELLE C, 1992, EMBO J, V11, P1095, DOI 10.1002/j.1460-2075.1992.tb05148.x; COCQUERELLE C, 1993, FASEB J, V7, P155, DOI 10.1096/fasebj.7.1.7678559; de la Mata M, 2010, RNA, V16, P904, DOI 10.1261/rna.1993510; Dixon RJ, 2005, NUCLEIC ACIDS RES, V33, P5904, DOI 10.1093/nar/gki893; HACKER A, 1995, DEVELOPMENT, V121, P1603; Hansen TB, 2011, EMBO J, V30, P4414, DOI 10.1038/emboj.2011.359; Houseley JM, 2006, J HERED, V97, P253, DOI 10.1093/jhered/esj037; HSU MT, 1979, NATURE, V280, P339, DOI 10.1038/280339a0; JESKE YWA, 1995, NAT GENET, V10, P480, DOI 10.1038/ng0895-480; Li XF, 1999, J BIOL CHEM, V274, P8153, DOI 10.1074/jbc.274.12.8153; NIGRO JM, 1991, CELL, V64, P607, DOI 10.1016/0092-8674(91)90244-S; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Saad Fawzy, 1992, Human Molecular Genetics, V1, P345, DOI 10.1093/hmg/1.5.345; Salzman J, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001156; Schindewolf C, 1996, NUCLEIC ACIDS RES, V24, P1260, DOI 10.1093/nar/24.7.1260; Shao XA, 2006, BIOINFORMATICS, V22, P692, DOI 10.1093/bioinformatics/bti795; Surono A, 1999, HUM MOL GENET, V8, P493, DOI 10.1093/hmg/8.3.493; Suzuki H, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl151; Yang L, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r16; Zaphiropoulos PG, 1997, MOL CELL BIOL, V17, P2985, DOI 10.1128/MCB.17.6.2985; Zaphiropoulos PG, 1996, P NATL ACAD SCI USA, V93, P6536, DOI 10.1073/pnas.93.13.6536	28	1604	1762	13	230	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2012	7	2							e30733	10.1371/journal.pone.0030733	http://dx.doi.org/10.1371/journal.pone.0030733			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UG	22319583	Green Submitted, gold, Green Published			2022-12-27	WOS:000301977500016
J	Sun, L; Xing, YL; Chen, XJ; Zheng, Y; Yang, YD; Nichols, DB; Clementz, MA; Banach, BS; Li, K; Baker, SC; Chen, ZB				Sun, Li; Xing, Yaling; Chen, Xiaojuan; Zheng, Yang; Yang, Yudong; Nichols, Daniel B.; Clementz, Mark A.; Banach, Bridget S.; Li, Kui; Baker, Susan C.; Chen, Zhongbin			Coronavirus Papain-like Proteases Negatively Regulate Antiviral Innate Immune Response through Disruption of STING-Mediated Signaling	PLOS ONE			English	Article							RESPIRATORY SYNDROME CORONAVIRUS; MOUSE HEPATITIS-VIRUS; RIG-I; ADAPTER PROTEIN; INTERFERON INDUCTION; 5'-TRIPHOSPHATE RNA; TARGET GENES; RECOGNITION; UBIQUITINATION; REPLICATION	Viruses have evolved elaborate mechanisms to evade or inactivate the complex system of sensors and signaling molecules that make up the host innate immune response. Here we show that human coronavirus (HCoV) NL63 and severe acute respiratory syndrome (SARS) CoV papain-like proteases (PLP) antagonize innate immune signaling mediated by STING (stimulator of interferon genes, also known as MITA/ERIS/MYPS). STING resides in the endoplasmic reticulum and upon activation, forms dimers which assemble with MAVS, TBK-1 and IKK epsilon, leading to IRF-3 activation and subsequent induction of interferon (IFN). We found that expression of the membrane anchored PLP domain from human HCoV-NL63 (PLP2-TM) or SARS-CoV (PLpro-TM) inhibits STING-mediated activation of IRF-3 nuclear translocation and induction of IRF-3 dependent promoters. Both catalytically active and inactive forms of CoV PLPs co-immunoprecipitated with STING, and viral replicase proteins co-localize with STING in HCoV-NL63-infected cells. Ectopic expression of catalytically active PLP2-TM blocks STING dimer formation and negatively regulates assembly of STING-MAVS-TBK1/IKK epsilon complexes required for activation of IRF-3. STING dimerization was also substantially reduced in cells infected with SARS-CoV. Furthermore, the level of ubiquitinated forms of STING, RIG-I, TBK1 and IRF-3 are reduced in cells expressing wild type or catalytic mutants of PLP2-TM, likely contributing to disruption of signaling required for IFN induction. These results describe a new mechanism used by CoVs in which CoV PLPs negatively regulate antiviral defenses by disrupting the STING-mediated IFN induction.	[Sun, Li; Xing, Yaling; Chen, Xiaojuan; Zheng, Yang; Yang, Yudong; Chen, Zhongbin] Beijing Inst Radiat Med, Dept Electromagnet & Laser Biol, Div Infect & Immun, Beijing, Peoples R China; [Nichols, Daniel B.; Clementz, Mark A.; Banach, Bridget S.; Baker, Susan C.] Loyola Univ Chicago, Stritch Sch Med, Dept Microbiol & Immunol, Maywood, IL USA; [Li, Kui] Univ Tennessee, Hlth Sci Ctr, Dept Microbiol Immunol & Biochem, Memphis, TN USA	Academy of Military Medical Sciences - China; Loyola University Chicago; University of Tennessee System; University of Tennessee Health Science Center	Sun, L (corresponding author), Beijing Inst Radiat Med, Dept Electromagnet & Laser Biol, Div Infect & Immun, Beijing, Peoples R China.	sbaker1@lumc.edu; chenzb@bmi.ac.cn			National Natural Science Foundation of China [30972761, 30870536, 81172799]; Beijing Natural Science Foundation [7092075]; National ST Major Project [2008ZX10004-015]; Chinese National High-Tech R&D Program ("863" Program) [2006AA02Z412]; National Institutes of Health, USA [AI060915]; U.S. Department of Defense [W81XWH-09-01-0391]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI060915, R01AI085089] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); National ST Major Project; Chinese National High-Tech R&D Program ("863" Program)(National High Technology Research and Development Program of China); National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Defense(United States Department of Defense); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	National Natural Science Foundation of China (No. 30972761, No. 30870536, No. 81172799 to ZC), Beijing Natural Science Foundation (No. 7092075 to ZC) and National S&T Major Project (2008ZX10004-015 to ZC) and Chinese National High-Tech R&D Program ("863" Program) (2006AA02Z412 to ZC), and the National Institutes of Health, USA (AI060915 to SCB), and the U.S. Department of Defense (W81XWH-09-01-0391 to KL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen J, 2008, GENES IMMUN, V9, P168, DOI 10.1038/sj.gene.6364449; Banach BS, 2009, J VIROL METHODS, V156, P19, DOI 10.1016/j.jviromet.2008.10.022; Barral PM, 2009, PHARMACOL THERAPEUT, V124, P219, DOI 10.1016/j.pharmthera.2009.06.012; Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; Bibeau-Poirier A, 2008, CYTOKINE, V43, P359, DOI 10.1016/j.cyto.2008.07.012; Bowie AG, 2008, NAT REV IMMUNOL, V8, P911, DOI 10.1038/nri2436; Cervantes-Barragan L, 2007, BLOOD, V109, P1131, DOI 10.1182/blood-2006-05-023770; Chen ZB, 2007, J VIROL, V81, P6007, DOI 10.1128/JVI.02747-06; Chen ZH, 2007, J VIROL, V81, P964, DOI 10.1128/JVI.02076-06; Clementz MA, 2010, J VIROL, V84, P4619, DOI 10.1128/JVI.02406-09; Coornaert B, 2009, J BIOL CHEM, V284, P8217, DOI 10.1074/jbc.R800032200; Devaraj SG, 2007, J BIOL CHEM, V282, P32208, DOI 10.1074/jbc.M704870200; Friedman CS, 2008, EMBO REP, V9, P930, DOI 10.1038/embor.2008.136; Frieman M, 2009, J VIROL, V83, P6689, DOI 10.1128/JVI.02220-08; Gosert R, 2002, J VIROL, V76, P3697, DOI 10.1128/JVI.76.8.3697-3708.2002; Grandvaux N, 2002, J VIROL, V76, P5532, DOI 10.1128/JVI.76.11.5532-5539.2002; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Isaacson MK, 2009, CELL HOST MICROBE, V5, P559, DOI 10.1016/j.chom.2009.05.012; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Jin L, 2008, MOL CELL BIOL, V28, P5014, DOI 10.1128/MCB.00640-08; Kawai T, 2007, J BIOCHEM, V141, P137, DOI 10.1093/jb/mvm032; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; Knoops K, 2008, PLOS BIOL, V6, P1957, DOI 10.1371/journal.pbio.0060226; Kopecky-Bromberg SA, 2007, J VIROL, V81, P548, DOI 10.1128/JVI.01782-06; Li JF, 2010, J VIROL, V84, P6472, DOI 10.1128/JVI.00016-10; Li XD, 2005, P NATL ACAD SCI USA, V102, P17717, DOI 10.1073/pnas.0508531102; Lin RT, 2006, J VIROL, V80, P6072, DOI 10.1128/JVI.02495-05; Lindner HA, 2005, J VIROL, V79, P15199, DOI 10.1128/JVI.79.24.15199-15208.2005; Loo YM, 2006, P NATL ACAD SCI USA, V103, P6001, DOI 10.1073/pnas.0601523103; Lu XL, 2011, VIRUS GENES, V42, P37, DOI 10.1007/s11262-010-0544-x; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Narayananj K, 2008, J VIROL, V82, P4471, DOI 10.1128/JVI.02472-07; Perlman S, 2009, NAT REV MICROBIOL, V7, P439, DOI 10.1038/nrmicro2147; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Ratia K, 2006, P NATL ACAD SCI USA, V103, P5717, DOI 10.1073/pnas.0510851103; Ratia K, 2008, P NATL ACAD SCI USA, V105, P16119, DOI 10.1073/pnas.0805240105; Rehwinkel J, 2010, CELL, V140, P397, DOI 10.1016/j.cell.2010.01.020; Rose KM, 2010, J VIROL, V84, P5656, DOI 10.1128/JVI.00211-10; Roth-Cross JK, 2008, J VIROL, V82, P9829, DOI 10.1128/JVI.01199-08; Schmidt A, 2009, P NATL ACAD SCI USA, V106, P12067, DOI 10.1073/pnas.0900971106; Seth RB, 2006, CELL RES, V16, P141, DOI 10.1038/sj.cr.7310019; Sheahan T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000240; Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364; Siu KL, 2009, J BIOL CHEM, V284, P16202, DOI 10.1074/jbc.M109.008227; Spiegel M, 2005, J VIROL, V79, P2079, DOI 10.1128/JVI.79.4.2079-2086.2005; Stertz S, 2007, VIROLOGY, V361, P304, DOI 10.1016/j.virol.2006.11.027; Sun WX, 2009, P NATL ACAD SCI USA, V106, P8653, DOI 10.1073/pnas.0900850106; van der Hoek L, 2005, PLOS MED, V2, P764, DOI 10.1371/journal.pmed.0020240; Versteeg GA, 2007, VIROLOGY, V361, P18, DOI 10.1016/j.virol.2007.01.020; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Yang Y, 2007, P NATL ACAD SCI USA, V104, P7253, DOI 10.1073/pnas.0611506104; Yoneyama M, 2009, IMMUNOL REV, V227, P54, DOI 10.1111/j.1600-065X.2008.00727.x; Zeng WW, 2010, CELL, V141, P315, DOI 10.1016/j.cell.2010.03.029; Zhang MY, 2008, J BIOL CHEM, V283, P18621, DOI 10.1074/jbc.M801451200; Zhao JC, 2010, J VIROL, V84, P9318, DOI 10.1128/JVI.01049-10; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003; Zhou HX, 2007, J VIROL, V81, P568, DOI 10.1128/JVI.01512-06	59	189	207	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2012	7	2							e30802	10.1371/journal.pone.0030802	http://dx.doi.org/10.1371/journal.pone.0030802			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UG	22312431	gold, Green Published, Green Submitted			2022-12-27	WOS:000301977500018
J	Wu, CL; Wu, JC; Huang, WC; Wu, HTH; Chiou, HJ; Liu, L; Chen, YC; Chen, TJ; Cheng, H; Chang, CY				Wu, Ching-Lan; Wu, Jau-Ching; Huang, Wen-Cheng; Wu, Hung-Ta H.; Chiou, Hong-Jen; Liu, Laura; Chen, Yu-Chun; Chen, Tzeng-Ji; Cheng, Henrich; Chang, Cheng-Yen			The Risk of Stroke after Percutaneous Vertebroplasty for Osteoporosis: A Population-Based Cohort Study	PLOS ONE			English	Article							VERTEBRAL COMPRESSION FRACTURES; PULMONARY CEMENT EMBOLISM; BONE-MINERAL DENSITY; RANDOMIZED-TRIAL; ISCHEMIC-STROKE; EPIDEMIOLOGY; INCREASES; OUTCOMES; LEAKAGE; BODY	Purpose: To investigate the incidence and risk of stroke after percutaneous vertebroplasty in patients with osteoporosis. Methods: A group of 334 patients with osteoporosis, and who underwent percutaneous vertebroplasty during the study period, was compared to 1,655 age-, sex- and propensity score-matched patients who did not undergo vertebroplasty. All demographic covariates and co-morbidities were deliberately matched between the two groups to avoid selection bias. Every subject was followed-up for up to five years for stroke. Adjustments using a Cox regression model and Kaplan-Meier analyses were conducted. Results: A total of 1,989 osteoporotic patients were followed up for 3,760.13 person-years. Overall, the incidence rates of any stroke, hemorrhagic stroke and ischemic stroke were 22.6, 4.2 and 19.6 per 1,000 person-years, respectively. Patients who underwent vertebroplasty were not more likely to have any stroke (crude hazard ratio = 1.13, p = 0.693), hemorrhagic stroke (HR = 2.21, p = 0.170), or ischemic stroke (HR = 0.96, p = 0.90). After adjusting for demographics, co-morbidities and medications, the vertebroplasty group had no significant difference with the comparison group in terms of any, hemorrhagic and ischemic strokes (adjusted HR = 1.22, 3.17, and 0.96, p = 0.518, 0.055, and 0.91, respectively). Conclusions: Osteoporotic patients who undergo percutaneous vertebroplasty are not at higher risk of any stroke in the next five years after the procedure.	[Wu, Ching-Lan; Wu, Hung-Ta H.; Chiou, Hong-Jen; Chang, Cheng-Yen] Taipei Vet Gen Hosp, Dept Radiol, Taipei, Taiwan; [Wu, Jau-Ching; Huang, Wen-Cheng; Cheng, Henrich] Taipei Vet Gen Hosp, Neurol Inst, Dept Neurosurg, Taipei, Taiwan; [Wu, Jau-Ching; Huang, Wen-Cheng; Wu, Hung-Ta H.; Chiou, Hong-Jen; Cheng, Henrich; Chang, Cheng-Yen] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Wu, Jau-Ching; Cheng, Henrich] Natl Yang Ming Univ, Inst Pharmacol, Taipei 112, Taiwan; [Liu, Laura] Chang Gung Mem Hosp, Dept Ophthalmol, Tao Yuan, Taiwan; [Liu, Laura] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan; [Chen, Yu-Chun] Natl Yang Ming Univ Hosp, Dept Med Res & Educ, Ilan, Taiwan; [Chen, Tzeng-Ji] Natl Yang Ming Univ, Sch Med, Inst Hosp & Hlth Care Adm, Taipei 112, Taiwan	Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Chang Gung Memorial Hospital; Chang Gung University; National Yang Ming Chiao Tung University	Wu, CL (corresponding author), Taipei Vet Gen Hosp, Dept Radiol, Taipei, Taiwan.	yuchn.chen@googlemail.com	Wu, Jau-Ching/AAU-4009-2021; Chen, Yu-Chun/B-1227-2012; Chen, TJ/AAH-8430-2021; Chen, YuChun/L-1052-2019; Chen, Yu Chun/K-6635-2019	Wu, Jau-Ching/0000-0002-6996-3409; Chen, Yu-Chun/0000-0002-4124-1949; Chen, YuChun/0000-0002-4124-1949; Huang, Wen-Cheng/0000-0003-4249-710X				Amar AP, 2001, NEUROSURGERY, V49, P1105, DOI 10.1097/00006123-200111000-00017; Baumann A, 2006, EUR J VASC ENDOVASC, V31, P558, DOI 10.1016/j.ejvs.2005.11.008; BONITA R, 1992, LANCET, V339, P342, DOI 10.1016/0140-6736(92)91658-U; Brown DL, 2008, CEREBROVASC DIS, V25, P95, DOI 10.1159/000111997; Buchbinder R, 2010, SPINE J, V10, P241, DOI 10.1016/j.spinee.2010.01.001; Buchbinder R, 2009, NEW ENGL J MED, V361, P557, DOI 10.1056/NEJMoa0900429; Burton Allen W, 2005, Neurosurg Focus, V18, pe1; Cheng CL, 2010, PHARMACOEPIDEMIOL DR; Cortet B, 1999, J RHEUMATOL, V26, P2222; delPuente A, 1996, OSTEOPOROSIS INT, V6, P50, DOI 10.1007/BF01626538; Dennis MS, 2002, STROKE, V33, P728, DOI 10.1161/hs0302.103621; Do HM, 2005, AM J NEURORADIOL, V26, P1623; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Feigin VL, 2005, LANCET, V365, P2160, DOI 10.1016/S0140-6736(05)66755-4; Goldstein LB, 2006, STROKE, V37, P1583, DOI 10.1161/01.STR.0000223048.70103.F1; Goldstein LB, 2011, STROKE, V42, P517, DOI 10.1161/STR.0b013e3181fcb238; Halfon P, 2002, J CLIN EPIDEMIOL, V55, P573, DOI 10.1016/S0895-4356(01)00521-2; Ho JD, 2009, STROKE, V40, P2685, DOI 10.1161/STROKEAHA.109.554642; Ho JD, 2009, AM J OPHTHALMOL, V147, P283, DOI 10.1016/j.ajo.2008.08.006; Kallmes DF, 2009, NEW ENGL J MED, V361, P569, DOI 10.1056/NEJMoa0900563; Kang JH, 2011, STROKE, V42, P336, DOI 10.1161/STROKEAHA.110.595538; Kanis J, 2001, STROKE, V32, P702, DOI 10.1161/01.STR.32.3.702; Kim YJ, 2009, RADIOLOGY, V251, P250, DOI 10.1148/radiol.2511080854; Klazen CAH, 2010, LANCET, V376, P1085, DOI 10.1016/S0140-6736(10)60954-3; Lee MJ, 2009, SPINE, V34, P1228, DOI 10.1097/BRS.0b013e3181a3c742; Lim JB, 2009, J KOREAN NEUROSURG S, V45, P386, DOI 10.3340/jkns.2009.45.6.386; Lin EP, 2004, AM J NEURORADIOL, V25, P175; Lin HC, 2008, STROKE, V39, P2744, DOI 10.1161/STROKEAHA.108.519090; Lin HC, 2010, NEUROLOGY, V74, P792, DOI 10.1212/WNL.0b013e3181d31e5c; Luetmer MT, 2011, AM J NEURORADIOL, V32, P654, DOI 10.3174/ajnr.A2368; Marden FA, 2008, AM J NEURORADIOL, V29, P1986, DOI 10.3174/ajnr.A1159; Pang MYC, 2005, OSTEOPOROSIS INT, V16, P1769, DOI 10.1007/s00198-005-1925-1; Poole KES, 2002, STROKE, V33, P1432, DOI 10.1161/01.STR.0000014510.48897.7D; Ramnemark A, 1998, OSTEOPOROSIS INT, V8, P92, DOI 10.1007/s001980050053; Rollinghoff M, 2010, ACTA ORTHOP BELG, V76, P269; Sheu JJ, 2010, STROKE, V41, P244, DOI 10.1161/STROKEAHA.109.567735; Syed MI, 2006, AM J NEURORADIOL, V27, P343; Teng MMH, 2006, AM J NEURORADIOL, V27, P224; Watts NB, 2001, OSTEOPOROSIS INT, V12, P429, DOI 10.1007/s001980170086; Wen CP, 2008, ANN INTERN MED, V148, P258, DOI 10.7326/0003-4819-148-4-200802190-00004; Wu JC, 2011, NEUROSURG FOCUS, V30, DOI 10.3171/2010.12.FOCUS10268; Wu JC, 2011, J NEUROTRAUMA; Yang YW, 2011, STROKE, V42, P319, DOI 10.1161/STROKEAHA.110.596361	43	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2012	7	1							e31405	10.1371/journal.pone.0031405	http://dx.doi.org/10.1371/journal.pone.0031405			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	912BY	22303486	gold, Green Submitted, Green Published			2022-12-27	WOS:000301770700012
J	Saulnier, N; Guihard, S; Holy, X; Decembre, E; Jurdic, P; Clay, D; Feuillet, V; Pages, G; Pouyssegur, J; Porteu, F; Gaudry, M				Saulnier, Nathalie; Guihard, Soizic; Holy, Xavier; Decembre, Elodie; Jurdic, Pierre; Clay, Denis; Feuillet, Vincent; Pages, Gilles; Pouyssegur, Jacques; Porteu, Francoise; Gaudry, Murielle			ERK1 Regulates the Hematopoietic Stem Cell Niches	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; MAP KINASE; BONE; DIFFERENTIATION; ACTIVATION; RECEPTOR; KNOCKOUT; HETEROGENEITY; OSTEOPETROSIS; OSTEOCLASTS	The mitogen-activated protein kinases (MAPK) ERK1 and ERK2 are among the major signal transduction molecules but little is known about their specific functions in vivo. ERK activity is provided by two isoforms, ERK1 and ERK2, which are ubiquitously expressed and share activators and substrates. However, there are not in vivo studies which have reported a role for ERK1 or ERK2 in HSCs and the bone marrow microenvironment. The present study shows that the ERK1-deficient mice present a mild osteopetrosis phenotype. The lodging and the homing abilities of the ERK1(-/-) HSC are impaired, suggesting that the ERK1(-/-)-defective environment may affect the engrafment of HSCs. Serial transplantations demonstrate that ERK1 is involved in the maintenance of an appropriate medullar microenvironment, but that the intrinsic properties of HSCs are not altered by the ERK1(-/-) defective microenvironment. Deletion of ERK1 impaired in vitro and in vivo osteoclastogenesis while osteoblasts were unaffected. As osteoclasts derive from precursors of the monocyte/macrophage lineage, investigation of the monocytic compartment was performed. In vivo analysis of the myeloid lineage progenitors revealed that the frequency of CMPs increased by approximately 1.3-fold, while the frequency of GMPs significantly decreased by almost 2-fold, compared with the respective WT compartments. The overall mononuclear-phagocyte lineage development was compromised in these mice due to a reduced expression of the M-CSF receptor on myeloid progenitors. These results show that the cellular targets of ERK1 are M-CSFR-responsive cells, upstream to osteoclasts. While ERK1 is well known to be activated by M-CSF, the present results are the first to point out an ERK1-dependent M-CSFR regulation on hematopoietic progenitors. This study reinforces the hypothesis of an active cross-talk between HSCs, their progeny and bone cells in the maintenance of the homeostasis of these compartments.	[Saulnier, Nathalie; Guihard, Soizic; Feuillet, Vincent; Porteu, Francoise; Gaudry, Murielle] Univ Paris 05, Inst Cochin, CNRS, UMR 8104, Paris, France; [Saulnier, Nathalie; Guihard, Soizic; Feuillet, Vincent; Porteu, Francoise; Gaudry, Murielle] INSERM, U1016, Paris, France; [Holy, Xavier] IRBA IMASSA, Serv Histol & Reparat Tissulaire, Bretigny Sur Orge, France; [Decembre, Elodie; Jurdic, Pierre] Univ Lyon 1, Inst Genom Fonct Lyon, CNRS, INRA,Ecole Normale Super Lyon, F-69365 Lyon, France; [Clay, Denis] Hop Paul Brousse, Inst Andre Lwoff, INSERM, U972, Villejuif, France; [Pages, Gilles; Pouyssegur, Jacques] Univ Nice, Inst Rech Signalisat Biol Dev & Canc, F-06108 Nice 2, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	Saulnier, N (corresponding author), Univ Paris 05, Inst Cochin, CNRS, UMR 8104, Paris, France.	murielle.gaudry@inserm.fr	PORTEU, Françoise/I-8445-2016; Gaudry, Murielle/N-5934-2018; Pages, Gilles/N-7135-2017; Feuillet, Vincent/P-4988-2017	PORTEU, Françoise/0000-0002-2403-4163; Feuillet, Vincent/0000-0003-1898-2527; Saulnier, Nathalie/0000-0003-0159-8414; Gaudry, Murielle/0000-0002-9281-2334; Decembre, Elodie/0000-0001-6891-6320	Agence Nationale pour la Recherche [ANR-08-BLAN-0332]; Ministere de l'Enseignement Superieur et de la Recherche; Institut National de la sante et de la recherche medicale (INSERM); Association pour la Recherche contre le Cancer [SFI20101201698]; Ligue Contre le Cancer, comite d'Ile de France [RS11/75-24]; Institut National du Cancer (CSHLE) [2008 INCa]	Agence Nationale pour la Recherche(French National Research Agency (ANR)); Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research Council); Institut National de la sante et de la recherche medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Ligue Contre le Cancer, comite d'Ile de France; Institut National du Cancer (CSHLE)	NS is a recipient of a fellowship from the Agence Nationale pour la Recherche (ANR-08-BLAN-0332). SG is a recipient of a fellowship from the Ministere de l'Enseignement Superieur et de la Recherche. This work was supported by Institut National de la sante et de la recherche medicale (INSERM) and grants from the Agence Nationale pour la Recherche (ANR-08-BLAN-0332), the Association pour la Recherche contre le Cancer (SFI20101201698), the Ligue Contre le Cancer, comite d'Ile de France (RS11/75-24) and the Institut National du Cancer (CSHLE 2008 INCa). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams GB, 2006, NATURE, V439, P599, DOI 10.1038/nature04247; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Bost F, 2005, DIABETES, V54, P402, DOI 10.2337/diabetes.54.2.402; BOYCE BF, 1992, J CLIN INVEST, V90, P1622, DOI 10.1172/JCI116032; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Chan AS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007955; Chow A, 2011, J EXP MED, V208, P261, DOI 10.1084/jem.20101688; Dacquin R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026627; Dai XM, 2002, BLOOD, V99, P111, DOI 10.1182/blood.V99.1.111; Fichelson S, 1999, BLOOD, V94, P1601, DOI 10.1182/blood.V94.5.1601.417k19_1601_1613; Foudi A, 2006, BLOOD, V107, P2243, DOI 10.1182/blood-2005-02-0581; Glantschnig H, 2003, CELL DEATH DIFFER, V10, P1165, DOI 10.1038/sj.cdd.4401285; Glenn G, 2008, FEBS LETT, V582, P911, DOI 10.1016/j.febslet.2008.02.029; Gowen M, 1999, J BONE MINER RES, V14, P1654, DOI 10.1359/jbmr.1999.14.10.1654; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; Guihard S, 2010, BLOOD, V115, P3686, DOI 10.1182/blood-2009-09-242487; He YZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024780; Hodge JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021462; HOFSTETTER W, 1992, P NATL ACAD SCI USA, V89, P9637, DOI 10.1073/pnas.89.20.9637; Hsu CL, 2007, BLOOD, V110, P1420, DOI 10.1182/blood-2007-02-071761; Iwasaki H, 2007, IMMUNITY, V26, P726, DOI 10.1016/j.immuni.2007.06.004; Jones DL, 2008, NAT REV MOL CELL BIO, V9, P11, DOI 10.1038/nrm2319; KODAMA H, 1991, J EXP MED, V173, P269, DOI 10.1084/jem.173.1.269; Kohyama M, 2009, NATURE, V457, P318, DOI 10.1038/nature07472; Kollet O, 2006, NAT MED, V12, P657, DOI 10.1038/nm1417; Kong YY, 1999, NATURE, V402, P304, DOI 10.1038/35005552; Lo Celso C, 2011, J CELL SCI, V124, P3529, DOI 10.1242/jcs.074112; Matsuo K, 2008, ARCH BIOCHEM BIOPHYS, V473, P201, DOI 10.1016/j.abb.2008.03.027; Mazzucchelli C, 2002, NEURON, V34, P807, DOI 10.1016/S0896-6273(02)00716-X; Miranda MB, 2005, LEUKEMIA RES, V29, P1293, DOI 10.1016/j.leukres.2005.03.016; Nagata Y, 1998, BLOOD, V92, P1859, DOI 10.1182/blood.V92.6.1859.418k37_1859_1869; Nutt SL, 2005, J EXP MED, V201, P221, DOI 10.1084/jem.20041535; Pages G, 1999, SCIENCE, V286, P1374, DOI 10.1126/science.286.5443.1374; Ponomaryov T, 2000, J CLIN INVEST, V106, P1331, DOI 10.1172/JCI10329; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rouyez MC, 1997, MOL CELL BIOL, V17, P4991, DOI 10.1128/MCB.17.9.4991; Saltel F, 2004, MOL BIOL CELL, V15, P5231, DOI 10.1091/mbc.E04-06-0522; Sarma U, 1996, BLOOD, V88, P2531, DOI 10.1182/blood.V88.7.2531.bloodjournal8872531; SHERR CJ, 1990, BLOOD, V75, P1; Shivtiel S, 2008, J EXP MED, V205, P2381, DOI 10.1084/jem.20080072; Stier S, 2005, J EXP MED, V201, P1781, DOI 10.1084/jem.20041992; Taylor PR, 2003, EUR J IMMUNOL, V33, P2090, DOI 10.1002/eji.200324003; Trumpp A, 2010, NAT REV IMMUNOL, V10, P201, DOI 10.1038/nri2726; Uchida M, 2001, INT J HEMATOL, V73, P78, DOI 10.1007/BF02981906; WIKTORJEDRZEJCZAK W, 1990, P NATL ACAD SCI USA, V87, P4828, DOI 10.1073/pnas.87.12.4828; Yao Y, 2003, P NATL ACAD SCI USA, V100, P12759, DOI 10.1073/pnas.2134254100; Yeung YG, 2003, MOL CELL PROTEOMICS, V2, P1143, DOI 10.1074/mcp.R300009-MCP200; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	48	18	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2012	7	1							e30788	10.1371/journal.pone.0030788	http://dx.doi.org/10.1371/journal.pone.0030788			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	912BU	22303456	gold, Green Published, Green Submitted			2022-12-27	WOS:000301770300005
J	Andrews, T; Thompson, M; Buckley, DI; Heneghan, C; Deyo, R; Redmond, N; Lucas, PJ; Blair, PS; Hay, AD				Andrews, Talley; Thompson, Matthew; Buckley, David I.; Heneghan, Carl; Deyo, Rick; Redmond, Niamh; Lucas, Patricia J.; Blair, Peter S.; Hay, Alastair D.			Interventions to Influence Consulting and Antibiotic Use for Acute Respiratory Tract Infections in Children: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							ACUTE OTITIS-MEDIA; RANDOMIZED CONTROLLED-TRIAL; PRESCRIBING STRATEGIES; EDUCATIONAL INTERVENTION; PRESCHOOL-CHILDREN; GENERAL-PRACTICE; PARENTS; OUTCOMES; COMMUNICATION; MASTOIDITIS	Background: Respiratory tract infections (RTIs) are common in children and generally self-limiting, yet often result in consultations to primary care. Frequent consultations divert resources from care for potentially more serious conditions and increase the opportunity for antibiotic overuse. Overuse of antibiotics is associated with adverse effects and antimicrobial resistance, and has been shown to influence how patients seek care in ensuing illness episodes. Methodology/Principal Findings: We conducted a systematic review and meta-analysis to assess the effectiveness of interventions directed towards parents or caregivers which were designed to influence consulting and antibiotic use for respiratory tract infections (RTIs) in children in primary care. Main outcomes were parental consulting rate, parental knowledge, and proportion of children subsequently consuming antibiotics. Of 5,714 references, 23 studies (representing 20 interventions) met inclusion criteria. Materials designed to engage children in addition to parents were effective in modifying parental knowledge and behaviour, resulting in reductions in consulting rates ranging from 13 to 40%. Providing parents with delayed prescriptions significantly decreased reported antibiotic use (Risk Ratio (RR) 0.46 (0.40, 0.54); moreover, a delayed or no prescribing approach did not diminish parental satisfaction. Conclusions: In order to be most effective, interventions to influence parental consulting and antibiotic use should: engage children, occur prior to an illness episode, employ delayed prescribing, and provide guidance on specific symptoms. These results support the wider implementation of interventions to reduce inappropriate antibiotic use in children.	[Andrews, Talley; Buckley, David I.; Deyo, Rick] Oregon Hlth & Sci Univ, Dept Family Med, Portland, OR 97201 USA; [Thompson, Matthew; Heneghan, Carl] Univ Oxford, Dept Primary Care Hlth Sci, Oxford, England; [Redmond, Niamh; Hay, Alastair D.] Univ Bristol, Acad Unit Primary Hlth Care, Sch Social & Community Med, Bristol, Avon, England; [Lucas, Patricia J.] Univ Bristol, Sch Policy Studies, Bristol, Avon, England; [Blair, Peter S.] Univ Bristol, Sch Social & Community Med, St Michaels Hosp, Bristol, Avon, England	Oregon Health & Science University; University of Oxford; University of Bristol; University of Bristol; University of Bristol	Andrews, T (corresponding author), Oregon Hlth & Sci Univ, Dept Family Med, Portland, OR 97201 USA.	matthew.thompson@phc.ox.ac.uk	Hay, Alastair/L-1818-2019; Blair, Peter S/C-1213-2009; Lucas, Patricia/P-5349-2017	Blair, Peter/0000-0002-7832-8087; Hay, Alastair/0000-0003-3012-375X; Redmond, Niamh M/0000-0001-8814-3396; Lucas, Patricia Jane/0000-0002-0469-8085	National Institute for Health Research (NIHR) [RP-PG-0608-10018]; National Institute for Health Research [RP-PG-0608-10018] Funding Source: researchfish	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	This article presents independent research commissioned by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research funding scheme (RP-PG-0608-10018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alder SC, 2005, AM J HEALTH EDUC, V36, P132, DOI 10.1080/19325037.2005.10608174; ANDERSON JE, 1980, BRIT MED J, V281, P924, DOI 10.1136/bmj.281.6245.924; Arnold SR, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003539.pub2; Arroll B, 2003, BRIT J GEN PRACT, V53, P871; Ashworth M, 2005, BRIT J GEN PRACT, V55, P603; Bauchner H, 2001, PEDIATRICS, V108, P845, DOI 10.1542/peds.108.4.845; Boonacker CWB, 2010, INT J PEDIATR OTORHI, V74, P1113, DOI 10.1016/j.ijporl.2010.07.008; Chao JH, 2008, PEDIATRICS, V121, pE1352, DOI 10.1542/peds.2007-2278; Clavenna A, 2009, ARCH DIS CHILD, V94, P724, DOI 10.1136/adc.2008.154377; Costelloe C, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2096; Croft Donita R, 2007, WMJ, V106, P78; Fendrick AM, 2003, ARCH INTERN MED, V163, P487, DOI 10.1001/archinte.163.4.487; Ferech M, 2006, J ANTIMICROB CHEMOTH, V58, P401, DOI 10.1093/jac/dkl188; Finch RG, 2004, LANCET INFECT DIS, V4, P44, DOI 10.1016/S1473-3099(03)00860-0; Francis NA, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2885; Glascoe FP, 1998, PEDIATRICS, V101, DOI 10.1542/peds.101.6.e10; Hay AD, 2005, FAM PRACT, V22, P367, DOI 10.1093/fampra/cmi035; Herman A, 2009, PEDIATR EMERG CARE, V25, P434, DOI 10.1097/PEC.0b013e3181ab78c7; Higgins JPT, COCHRANE HDB SYSTEMA, P4; Hollinghurst S, 2008, BMC FAM PRACT, V9, DOI 10.1186/1471-2296-9-10; HOWIE JGR, 1976, BRIT MED J, V2, P1061, DOI 10.1136/bmj.2.6043.1061; Hughes JM, 2011, JAMA-J AM MED ASSOC, V305, P1027, DOI 10.1001/jama.2011.279; Huttner B, 2010, LANCET INFECT DIS, V10, P17, DOI 10.1016/S1473-3099(09)70305-6; ISAACMAN DJ, 1992, PEDIATRICS, V89, P1204; Little P, 2001, BMJ-BRIT MED J, V322, P336, DOI 10.1136/bmj.322.7282.336; Little P, 2006, BRIT J GEN PRACT, V56, P176; Little P, 1997, BRIT MED J, V315, P350; Maor Y, 2011, EUR J PEDIATR, V170, P359, DOI 10.1007/s00431-010-1301-9; McCormick DP, 2005, PEDIATRICS, V115, P1455, DOI 10.1542/peds.2004-1665; MORRELL DC, 1980, BRIT MED J, V280, P769, DOI 10.1136/bmj.280.6216.769; NICE Short Clinical Guidelines Technical Team, 2008, RESP TRACT INF ANT P; Patel SJ, 2007, PEDIATR INFECT DIS J, V26, P531, DOI 10.1097/INF.0b013e3180593170; Pshetizky Y, 2003, FAM PRACT, V20, P417, DOI 10.1093/fampra/cmg414; Ranji SR, 2008, MED CARE, V46, P847, DOI 10.1097/MLR.0b013e318178eabd; Robbins H, 2003, J ADV NURS, V44, P238, DOI 10.1046/j.1365-2648.2003.02798.x; ROBERTS CR, 1983, JAMA-J AM MED ASSOC, V250, P1986, DOI 10.1001/jama.250.15.1986; Schnellinger M, 2010, PEDIATRICS, V125, P990, DOI 10.1542/peds.2009-2916; Sharland M, 2005, BMJ-BRIT MED J, V331, P328, DOI 10.1136/bmj.38503.706887.AE1; Spiro DM, 2006, JAMA-J AM MED ASSOC, V296, P1235, DOI 10.1001/jama.296.10.1235; Spurling GKP, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004417.pub3; Standing Medical Advisory Committee: Sub-group on Antimicrobial Resistance, 1998, PATH LEAST RES; Stanton N, 2010, BRIT J GEN PRACT, V60, DOI 10.3399/bjgp10X544104; Taylor JA, 2005, PEDIATR INFECT DIS J, V24, P489, DOI 10.1097/01.inf.0000164706.91337.5d; Taylor JA, 2003, PEDIATRICS, V111, pE548, DOI 10.1542/peds.111.5.e548; The World Bank, 2011, COUNTR LEND GROUPS H; Thompson PL, 2009, ARCH DIS CHILD, V94, P337, DOI 10.1136/adc.2008.147579; Thompson PL, 2009, PEDIATRICS, V123, P424, DOI 10.1542/peds.2007-3349; Thomson H, 1999, BRIT MED J, V318, P1740, DOI 10.1136/bmj.318.7200.1740; USHERWOOD TP, 1991, BRIT J GEN PRACT, V41, P58; Watson RL, 1999, PEDIATRICS, V104, P1251, DOI 10.1542/peds.104.6.1251; Wheeler JG, 2001, PEDIATRICS, V108, P591, DOI 10.1542/peds.108.3.591	51	98	101	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e30334	10.1371/journal.pone.0030334	http://dx.doi.org/10.1371/journal.pone.0030334			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22299036	gold, Green Published, Green Submitted			2022-12-27	WOS:000301704200013
J	Lue, N; Kang, JW; Yu, CC; Barman, I; Dingari, NC; Feld, MS; Dasari, RR; Fitzmaurice, M				Lue, Niyom; Kang, Jeon Woong; Yu, Chung-Chieh; Barman, Ishan; Dingari, Narahara Chari; Feld, Michael S.; Dasari, Ramachandra R.; Fitzmaurice, Maryann			Portable Optical Fiber Probe-Based Spectroscopic Scanner for Rapid Cancer Diagnosis: A New Tool for Intraoperative Margin Assessment	PLOS ONE			English	Article							DIFFUSE-REFLECTANCE SPECTROSCOPY	There continues to be a significant clinical need for rapid and reliable intraoperative margin assessment during cancer surgery. Here we describe a portable, quantitative, optical fiber probe-based, spectroscopic tissue scanner designed for intraoperative diagnostic imaging of surgical margins, which we tested in a proof of concept study in human tissue for breast cancer diagnosis. The tissue scanner combines both diffuse reflectance spectroscopy (DRS) and intrinsic fluorescence spectroscopy (IFS), and has hyperspectral imaging capability, acquiring full DRS and IFS spectra for each scanned image pixel. Modeling of the DRS and IFS spectra yields quantitative parameters that reflect the metabolic, biochemical and morphological state of tissue, which are translated into disease diagnosis. The tissue scanner has high spatial resolution (0.25 mm) over a wide field of view (10 cm x 10 cm), and both high spectral resolution (2 nm) and high spectral contrast, readily distinguishing tissues with widely varying optical properties (bone, skeletal muscle, fat and connective tissue). Tissue-simulating phantom experiments confirm that the tissue scanner can quantitatively measure spectral parameters, such as hemoglobin concentration, in a physiologically relevant range with a high degree of accuracy (<5% error). Finally, studies using human breast tissues showed that the tissue scanner can detect small foci of breast cancer in a background of normal breast tissue. This tissue scanner is simpler in design, images a larger field of view at higher resolution and provides a more physically meaningful tissue diagnosis than other spectroscopic imaging systems currently reported in literatures. We believe this spectroscopic tissue scanner can provide real-time, comprehensive diagnostic imaging of surgical margins in excised tissues, overcoming the sampling limitation in current histopathology margin assessment. As such it is a significant step in the development of a platform technology for intraoperative management of cancer, a clinical problem that has been inadequately addressed to date.	[Lue, Niyom; Kang, Jeon Woong; Barman, Ishan; Dingari, Narahara Chari; Feld, Michael S.; Dasari, Ramachandra R.; Fitzmaurice, Maryann] MIT, George R Harrison Spect Lab, Cambridge, MA 02139 USA; [Yu, Chung-Chieh] Canon USA Inc, Div Res & Dev, Opt Res Lab, Tucson, AZ USA; [Fitzmaurice, Maryann] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA	Massachusetts Institute of Technology (MIT); Canon Incorporated; Case Western Reserve University	Lue, N (corresponding author), MIT, George R Harrison Spect Lab, Cambridge, MA 02139 USA.	niyom@mit.edu			National Institutes of Health National Center for Research Resources [P41-RR02594, S10-RR031845]; National Cancer Institute [R01-CA97966, R01-CA140288]; Tissue Procurement, Histology and Immunohistochemistry Core Facility of the Case Comprehensive Cancer Center [P30 CA43703]; NATIONAL CANCER INSTITUTE [R01CA140288, R01CA097966, P30CA043703] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR031845, P41RR002594] Funding Source: NIH RePORTER	National Institutes of Health National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Tissue Procurement, Histology and Immunohistochemistry Core Facility of the Case Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This research was supported by the National Institutes of Health National Center for Research Resources (P41-RR02594 and S10-RR031845) and National Cancer Institute (R01-CA97966 and R01-CA140288) and by the Tissue Procurement, Histology and Immunohistochemistry Core Facility of the Case Comprehensive Cancer Center (P30 CA43703). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Backman V, 2000, NATURE, V406, P35, DOI 10.1038/35017638; Barman I, 2011, BIOMED OPT EXPRESS, V2, P592, DOI 10.1364/BOE.2.000592; Brown JQ, 2009, CURR OPIN BIOTECH, V20, P119, DOI 10.1016/j.copbio.2009.02.004; Bydlon TM, 2010, OPT EXPRESS, V18, P8058, DOI 10.1364/OE.18.008058; Cai TT, 2001, APPL SPECTROSC, V55, P1124, DOI 10.1366/0003702011953289; Chauchard F, 2005, APPL OPTICS, V44, P7091, DOI 10.1364/AO.44.007091; Georgakoudi Irene, 2004, Gastrointest Endosc Clin N Am, V14, P519, DOI 10.1016/j.giec.2004.03.008; Keller MD, 2010, LASER SURG MED, V42, P15, DOI 10.1002/lsm.20865; Kennedy S, 2011, PROC SPIE, V7890, DOI 10.1117/12.875735; Krishnaswamy V, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3065540; Lin ZJ, 2009, PROC SPIE, V7161, DOI 10.1117/12.807886; Mcgee S, 2009, ANN OTO RHINOL LARYN, V118, P817, DOI 10.1177/000348941011901112; McLaughlin SA, 2008, J AM COLL SURGEONS, V206, P76, DOI 10.1016/j.jamcollsurg.2007.07.021; Mirkovic J, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3194142; Muller MG, 2001, APPL OPTICS, V40, P4633, DOI 10.1364/AO.40.004633; Rajaram N, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2981797; Rowell NP, 2010, BREAST, V19, P14, DOI 10.1016/j.breast.2009.10.007; Scepanovic OR, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3117832; Smith SW, SCI ENG GUIDE DIGITA, P426; Tunnell JW, 2003, TECHNOL CANCER RES T, V2, P505, DOI 10.1177/153303460300200603; Volynskaya Z, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2909672; Yu CC, 2008, OPT EXPRESS, V16, P16227, DOI 10.1364/OE.16.016227; Zhang QG, 2000, OPT LETT, V25, P1451, DOI 10.1364/OL.25.001451; Zonios G, 1999, APPL OPTICS, V38, P6628, DOI 10.1364/AO.38.006628	24	40	40	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e30887	10.1371/journal.pone.0030887	http://dx.doi.org/10.1371/journal.pone.0030887			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22303465	Green Submitted, Green Published, gold			2022-12-27	WOS:000301704200041
J	Aiello, AE; Perez, V; Coulborn, RM; Davis, BM; Uddin, M; Monto, AS				Aiello, Allison E.; Perez, Vanessa; Coulborn, Rebecca M.; Davis, Brian M.; Uddin, Monica; Monto, Arnold S.			Facemasks, Hand Hygiene, and Influenza among Young Adults: A Randomized Intervention Trial	PLOS ONE			English	Article							NONPHARMACEUTICAL INTERVENTIONS; PANDEMIC INFLUENZA; VIRUS	Limited vaccine availability and the potential for resistance to antiviral medications have led to calls for establishing the efficacy of non-pharmaceutical measures formitigating pandemic influenza. Our objective was to examine if the use of face masks and hand hygiene reduced rates of influenza-like illness (ILI) and laboratory-confirmed influenza in the natural setting. A cluster-randomized intervention trial was designed involving 1,178 young adults living in 37 residence houses in 5 university residence halls during the 2007-2008 influenza season. Participants were assigned to face mask and hand hygiene, face mask only, or control group during the study. Discrete-time survival models using generalized estimating equations to estimate intervention effects on ILI and confirmed influenza A/B infection over a 6-week study period were examined. A significant reduction in the rate of ILI was observed in weeks 3 through 6 of the study, with a maximum reduction of 75% during the final study week (rate ratio [RR] = 0.25, [95% CI, 0.07 to 0.87]). Both intervention groups compared to the control showed cumulative reductions in rates of influenza over the study period, although results did not reach statistical significance. Generalizability limited to similar settings and age groups. Face masks and hand hygiene combined may reduce the rate of ILI and confirmed influenza in community settings. These non-pharmaceutical measures should be recommended in crowded settings at the start of an influenza pandemic.	[Aiello, Allison E.; Perez, Vanessa; Coulborn, Rebecca M.; Davis, Brian M.; Uddin, Monica; Monto, Arnold S.] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Aiello, Allison E.; Perez, Vanessa; Coulborn, Rebecca M.; Davis, Brian M.; Uddin, Monica] Univ Michigan, Sch Publ Hlth, Ctr Social Epidemiol & Populat, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Aiello, AE (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA.	aielloa@umich.edu			Centers for Disease Control (CDC) and Prevention [U01 C1000441]	Centers for Disease Control (CDC) and Prevention	This work was supported by funding from the Centers for Disease Control (CDC) and Prevention Grant U01 C1000441 (www.cdc.gov)(PIs: AM and AA). The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the CDC. The CDC had a role in the design and conduct of the study and interpretation of data; they did not have a role in the collection, management, write-up or analysis of the data. Warner Lambert provided hand sanitizer without any involvement in the study design, analysis, results, or writing of the manuscript.	Aiello AE, 2010, AM J INFECT CONTROL, V38, P251, DOI 10.1016/j.ajic.2009.12.007; Aiello AE, 2010, J INFECT DIS, V201, P491, DOI 10.1086/650396; Allison PD., 1982, SOCIOL METHODOL, V13, P61, DOI 10.2307/270718; Canini L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013998; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Cowling BJ, 2010, EPIDEMIOL INFECT, V138, P449, DOI 10.1017/S0950268809991658; Cowling BJ, 2009, ANN INTERN MED, V151, P437, DOI 10.7326/0003-4819-151-7-200910060-00142; DONNER A, 1989, BIOMETRICS, V45, P605, DOI 10.2307/2531501; DONNER A, 1994, J STAT PLAN INFER, V42, P37, DOI 10.1016/0378-3758(94)90188-0; DONNER A, 1988, J CLIN EPIDEMIOL, V41, P899, DOI 10.1016/0895-4356(88)90107-2; Hayes RJ, 1999, INT J EPIDEMIOL, V28, P319, DOI 10.1093/ije/28.2.319; Jefferson T, 2008, BMJ-BRIT MED J, V336, P77, DOI 10.1136/bmj.b3675; Larson EL, 2010, PUBLIC HEALTH REP, V125, P178, DOI 10.1177/003335491012500206; Lau JTF, 2010, AM J INFECT CONTROL, V38, P374, DOI 10.1016/j.ajic.2010.03.002; Maclntyre CR, 2009, EMERG INFECT DIS, V15, P233, DOI 10.3201/eid1502.081167; Mitchell T, 2011, CLIN INFECT DIS, V52, pS138, DOI 10.1093/cid/ciq056; Ohmit SE, 2006, NEW ENGL J MED, V355, P2513, DOI 10.1056/NEJMoa061850; Piantadosi S, 2005, WILEY SER PROBAB ST, P1, DOI 10.1002/0471740136; Thursky K, 2003, J CLIN VIROL, V27, P170, DOI 10.1016/S1386-6532(02)00172-5; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	20	117	118	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e29744	10.1371/journal.pone.0029744	http://dx.doi.org/10.1371/journal.pone.0029744			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295066	Green Published, Green Submitted, gold			2022-12-27	WOS:000301640600011
J	Bonomini, M; Giardinelli, A; Morabito, C; Di Silvestre, S; Di Cesare, M; Di Pietro, N; Sirolli, V; Formoso, G; Amoroso, L; Mariggio, MA; Pandolfi, A				Bonomini, Mario; Giardinelli, Annalisa; Morabito, Caterina; Di Silvestre, Sara; Di Cesare, Moreno; Di Pietro, Natalia; Sirolli, Vittorio; Formoso, Gloria; Amoroso, Luigi; Mariggio, Maria Addolorata; Pandolfi, Assunta			Calcimimetic R-568 and Its Enantiomer S-568 Increase Nitric Oxide Release in Human Endothelial Cells	PLOS ONE			English	Article							CALCIUM-SENSING RECEPTOR; SMOOTH-MUSCLE-CELLS; CA2+-SENSING RECEPTOR; PARATHYROID CELLS; BLOOD-PRESSURE; SYNTHASE; RATS; HYPERPARATHYROIDISM; CLONING; CA2+	Background: Calcimimetics, such as R-568, are thought to activate G protein-linked Ca2+-sensing receptor (CaSR) by allosterically increasing the affinity of the receptor for Ca2+ allowing for efficient control of uremic hyperparathyroidism. Several recent studies suggest they possess additional vascular actions. Although it has been postulated that calcimimetics may have a direct effect on CaSR in the blood vessels, further studies are needed to elucidate their vascular CaSR-dependent versus CaSR-independent effects. Methodology/Principal Findings: Focusing on human umbilical vein endothelial cells (HUVECs), we studied the CaSR expression and distribution by Immunofluorescence and Western Blot analysis. CaSR function was evaluated by measuring the potential effect of calcimimetic R-568 and its enantiomer S-568 upon the modulation of intracellular Ca2+ levels (using a single cell approach and FURA-2AM), in the presence or absence of Calhex-231, a negative modulator of CaSR. To address their potential vascular functions, we also evaluated R-and S-568-stimulated enzymatic release of Nitric Oxide (NO) by DAF-2DA, by Nitric Oxide Synthase (NOS) radiometric assay (both in HUVECs and in Human Aortic Endothelial Cells) and by measuring eNOS-ser1177 phosphorylation levels (Immunoblotting). We show that, although the CaSR protein was expressed in HUVECs, it was mainly distributed in cytoplasm while the functional CaSR dimers, usually localized on the plasma membrane, were absent. In addition, regardless of the presence or absence of Calhex-231, both R-and S-568 significantly increased intracellular Ca2+ levels by mobilization of Ca2+ from intracellular stores, which in turn augmented NO release by a time-and Ca2+-dependent increase in eNOS-ser1177 phosphorylation levels. Conclusions/Significance: Taken together, these data indicate that in human endothelium there is no stereoselectivity in the responses to calcimimetics and that CaSR is probably not involved in the action of R-and S-568. This suggests an additional mechanism in support of the CaSR-independent role of calcimimetics as vasculotrope agents.	[Bonomini, Mario; Di Cesare, Moreno; Sirolli, Vittorio; Amoroso, Luigi] Univ G dAnnunzio, Dept Med, Inst Nephrol, Chieti, Italy; [Giardinelli, Annalisa; Di Silvestre, Sara; Di Pietro, Natalia; Pandolfi, Assunta] Univ G dAnnunzio, Dept Biomed Sci, Chieti, Italy; [Morabito, Caterina; Mariggio, Maria Addolorata] Univ G dAnnunzio, Dept Neurosci & Imaging, Chieti, Italy; [Bonomini, Mario; Di Cesare, Moreno; Sirolli, Vittorio; Formoso, Gloria; Amoroso, Luigi] Univ G dAnnunzio, Dept Med & Aging Sci, Chieti, Italy; [Giardinelli, Annalisa; Morabito, Caterina; Di Silvestre, Sara; Di Pietro, Natalia; Formoso, Gloria; Mariggio, Maria Addolorata; Pandolfi, Assunta] Univ G dAnnunzio, Ctr Sci Invecchiamento Ce SI, Aging Res Ctr, Chieti, Italy	G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara	Bonomini, M (corresponding author), Univ G dAnnunzio, Dept Med, Inst Nephrol, Chieti, Italy.	pandolfi@unich.it	Mariggiò, Maria Addolorata/T-9047-2017; Sirolli, Vittorio/AAB-2290-2019; Di Pietro, Natalia/K-1604-2016; pandolfi, assunta/K-4595-2016	Mariggiò, Maria Addolorata/0000-0001-5306-7143; Di Pietro, Natalia/0000-0001-9720-2116; pandolfi, assunta/0000-0003-4135-7631; Morabito, Caterina/0000-0002-5144-2584; Mariggio, Maria Addolorata/0000-0002-3508-8706	Amgen, Inc. [200713507]; Amgen, Inc., Thousand Oaks, California, United States of America	Amgen, Inc.(Amgen); Amgen, Inc., Thousand Oaks, California, United States of America	The funding support for the study from Amgen, Inc. (Master Agreement No:200713507, March 14, 2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr Bonomini received materials (R-568 and S-568) and funding support for the study from Amgen, Inc., Thousand Oaks, California, United States of America. A patent relating to this study and Calcimimetic R-568 is held by Amgen (United States PATENT NUMBER: 5,688,938; Date of Patent: Nov 18, 1997; Product Name: NPS-568). This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	AIDA K, 1995, BIOCHEM BIOPH RES CO, V214, P524, DOI 10.1006/bbrc.1995.2318; Al-Aly Z, 2009, KIDNEY INT, V75, P9, DOI 10.1038/ki.2008.563; Andrew PJ, 1999, CARDIOVASC RES, V43, P521, DOI 10.1016/S0008-6363(99)00115-7; Baylis C, 2008, AM J PHYSIOL-RENAL, V294, pF1, DOI 10.1152/ajprenal.00424.2007; Brown E. M., 2007, V45, P139; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; Carrasco FR, 2009, TRANSPL P, V41, P2385, DOI 10.1016/j.transproceed.2009.06.167; Di Pietro R, 2006, J CELL BIOCHEM, V97, P782, DOI 10.1002/jcb.20686; Drueke TB, 2009, CLIN J AM SOC NEPHRO, V4, P234, DOI 10.2215/CJN.04520908; Fleming I, 2003, AM J PHYSIOL-REG I, V284, pR1, DOI 10.1152/ajpregu.00323.2002; GORFIEN S, 1993, EXP CELL RES, V206, P291, DOI 10.1006/excr.1993.1149; Harno E, 2008, CELL CALCIUM, V44, P210, DOI 10.1016/j.ceca.2007.11.011; Inesi G, 2005, J BIOENERG BIOMEMBR, V37, P365, DOI 10.1007/s10863-005-9472-1; Jensen AA, 2007, CURR NEUROPHARMACOL, V5, P180, DOI 10.2174/157015907781695982; Koleganova N, 2009, KIDNEY INT, V75, P60, DOI 10.1038/ki.2008.490; Kone BC, 2003, AM J PHYSIOL-RENAL, V285, pF178, DOI 10.1152/ajprenal.00048.2003; Molostvov G, 2007, AM J PHYSIOL-RENAL, V293, pF946, DOI 10.1152/ajprenal.00474.2006; Nagano N, 2006, PHARMACOL THERAPEUT, V109, P339, DOI 10.1016/j.pharmthera.2005.06.019; Nakagawa K, 2009, PEDIATR NEPHROL, V24, P1385, DOI 10.1007/s00467-009-1153-6; Nemeth EF, 2004, J PHARMACOL EXP THER, V308, P627, DOI 10.1124/jpet.103.057273; Nemeth EF, 2004, CELL CALCIUM, V35, P283, DOI 10.1016/j.ceca.2003.10.020; Odenwald T, 2006, J AM SOC NEPHROL, V17, P655, DOI 10.1681/ASN.2005090914; Ohanian J, 2005, AM J PHYSIOL-HEART C, V288, pH1756, DOI 10.1152/ajpheart.00739.2004; Pace AJ, 1999, J BIOL CHEM, V274, P11629, DOI 10.1074/jbc.274.17.11629; Pandolfi A, 2003, J CELL PHYSIOL, V196, P378, DOI 10.1002/jcp.10325; Pi M, 2005, J BIOL CHEM, V280, P40201, DOI 10.1074/jbc.M505186200; Rybczynska A, 2005, AM J HYPERTENS, V18, P364, DOI 10.1016/j.amjhyper.2004.10.019; Rybczynska A, 2006, PHARMACOL REP, V58, P533; Shaul PW, 2002, ANNU REV PHYSIOL, V64, P749, DOI 10.1146/annurev.physiol.64.081501.155952; Smajilovic S, 2007, CARDIOVASC RES, V75, P457, DOI 10.1016/j.cardiores.2007.03.015; Strippoli GFM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006254; Sutherland SK, 2004, AM J HYPERTENS, V17, P266, DOI 10.1016/j.amjhyper.2003.11.010; Thakore P, 2011, BRIT J PHARMACOL, V162, P749, DOI 10.1111/j.1476-5381.2010.01079.x; Villar IC, 2006, KIDNEY INT, V70, P840, DOI 10.1038/sj.ki.5001680; Wang H, 1999, FREE RADICAL BIO MED, V27, P612, DOI 10.1016/S0891-5849(99)00107-0; Wellendorph P, 2007, GENE, V396, P257, DOI 10.1016/j.gene.2007.03.008; Weston AH, 2005, CIRC RES, V97, P391, DOI 10.1161/01.RES.0000178787.59594.a0; Wonneberger K, 2000, J MEMBRANE BIOL, V175, P203, DOI 10.1007/s002320001068; Ziegelstein RC, 2006, BIOCHEM BIOPH RES CO, V342, P153, DOI 10.1016/j.bbrc.2006.01.135	39	26	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30682	10.1371/journal.pone.0030682	http://dx.doi.org/10.1371/journal.pone.0030682			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295103	gold, Green Submitted, Green Published			2022-12-27	WOS:000301640600048
J	Cronin, M; Akin, AR; Collins, SA; Meganck, J; Kim, JB; Baban, CK; Joyce, SA; van Dam, GM; Zhang, N; van Sinderen, D; O'Sullivan, GC; Kasahara, N; Gahan, CG; Francis, KP; Tangney, M				Cronin, Michelle; Akin, Ali R.; Collins, Sara A.; Meganck, Jeff; Kim, Jae-Beom; Baban, Chwanrow K.; Joyce, Susan A.; van Dam, Gooitzen M.; Zhang, Ning; van Sinderen, Douwe; O'Sullivan, Gerald C.; Kasahara, Noriyuki; Gahan, Cormac G.; Francis, Kevin P.; Tangney, Mark			High Resolution In Vivo Bioluminescent Imaging for the Study of Bacterial Tumour Targeting	PLOS ONE			English	Article							CANCER GENE-THERAPY; MODIFIED SALMONELLA-TYPHIMURIUM; LISTERIA-MONOCYTOGENES; DELIVERY-SYSTEM; NUDE-MICE; BIFIDOBACTERIUM-LONGUM; PROSTATE-CANCER; TOMOGRAPHY; CONSTRUCTION; METASTASIS	The ability to track microbes in real time in vivo is of enormous value for preclinical investigations in infectious disease or gene therapy research. Bacteria present an attractive class of vector for cancer therapy, possessing a natural ability to grow preferentially within tumours following systemic administration. Bioluminescent Imaging (BLI) represents a powerful tool for use with bacteria engineered to express reporter genes such as lux. BLI is traditionally used as a 2D modality resulting in images that are limited in their ability to anatomically locate cell populations. Use of 3D diffuse optical tomography can localize the signals but still need to be combined with an anatomical imaging modality like micro-Computed Tomography (mu CT) for interpretation. In this study, the non-pathogenic commensal bacteria E. coli K-12 MG1655 and Bifidobacterium breve UCC2003, or Salmonella Typhimurium SL7207 each expressing the luxABCDE operon were intravenously (IV) administered to mice bearing subcutaneous (s.c) FLuc-expressing xenograft tumours. Bacterial lux signal was detected specifically in tumours of mice post IV-administration and bioluminescence correlated with the numbers of bacteria recovered from tissue. Through whole body imaging for both lux and FLuc, bacteria and tumour cells were co-localised. 3D BLI and mu CT image analysis revealed a pattern of multiple clusters of bacteria within tumours. Investigation of spatial resolution of 3D optical imaging was supported by ex vivo histological analyses. In vivo imaging of orally-administered commensal bacteria in the gastrointestinal tract (GIT) was also achieved using 3D BLI. This study demonstrates for the first time the potential to simultaneously image multiple BLI reporter genes three dimensionally in vivo using approaches that provide unique information on spatial locations.	[Cronin, Michelle; Collins, Sara A.; Baban, Chwanrow K.; O'Sullivan, Gerald C.; Tangney, Mark] Natl Univ Ireland Univ Coll Cork, Cork Canc Res Ctr, Mercy Univ Hosp, Cork, Ireland; [Cronin, Michelle; Collins, Sara A.; Baban, Chwanrow K.; O'Sullivan, Gerald C.; Tangney, Mark] Natl Univ Ireland Univ Coll Cork, Leslie C Quick Jr Lab, Cork, Ireland; [Akin, Ali R.; Meganck, Jeff; Kim, Jae-Beom; Zhang, Ning; Francis, Kevin P.] Caliper, Alameda, CA USA; [Collins, Sara A.; Kasahara, Noriyuki; Tangney, Mark] Univ Calif Los Angeles, Sch Med, Los Angeles, CA USA; [Joyce, Susan A.; van Sinderen, Douwe; Gahan, Cormac G.] Natl Univ Ireland Univ Coll Cork, Dept Microbiol, Cork, Ireland; [Joyce, Susan A.; van Sinderen, Douwe; Gahan, Cormac G.] Natl Univ Ireland Univ Coll Cork, Alimentary Pharmabiot Ctr, Cork, Ireland; [van Dam, Gooitzen M.] Univ Groningen, Univ Med Ctr Groningen, Dept Surg, Div Surg Oncol,BioOpt Imaging Ctr, Groningen, Netherlands; [Gahan, Cormac G.] Natl Univ Ireland Univ Coll Cork, Sch Pharm, Cork, Ireland	University College Cork; University College Cork; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University College Cork; University College Cork; University of Groningen; University College Cork	Cronin, M (corresponding author), Natl Univ Ireland Univ Coll Cork, Cork Canc Res Ctr, Mercy Univ Hosp, Cork, Ireland.	m.tangney@ucc.ie	Hamblin, Mike/AAB-2511-2022; Gahan, Cormac G/AAE-9346-2019; Hamblin, Michael R/H-2758-2019; Joyce, Susan/ABE-2616-2020; Van Sinderen, Douwe/A-6778-2015	Gahan, Cormac G/0000-0003-2385-8192; Hamblin, Michael R/0000-0001-6431-4605; Joyce, Susan/0000-0003-4771-3123; Van Sinderen, Douwe/0000-0003-1823-7957; Kasahara, Noriyuki/0000-0002-6069-9082; Tangney, Mark/0000-0002-6314-1260	European Commission [PIOF-GA-2009-255466]; Irish Health Research Board [HRA_POR/2010/138]	European Commission(European CommissionEuropean Commission Joint Research Centre); Irish Health Research Board	The authors wish to acknowledge support relevant to this manuscript from the European Commission Seventh Framework Programme (PIOF-GA-2009-255466) and the Irish Health Research Board (HRA_POR/2010/138). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2011, J UROL; Ahmad S, 2011, J UROLOGY, V186, P687, DOI 10.1016/j.juro.2011.03.139; Alvarez-Martin P, 2007, APPL MICROBIOL BIOT, V76, P1395, DOI 10.1007/s00253-007-1115-5; Andreu N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010777; Baban CK, 2010, BIOENGINEERED BUGS, V1; BACHMANN BJ, 1972, BACTERIOL REV, V36, P525, DOI 10.1128/MMBR.36.4.525-557.1972; Beattie BJ, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3120495; BELAS R, 1982, SCIENCE, V218, P791, DOI 10.1126/science.10636771; Briat Arnaud, 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406000044; Burns-Guydish SM, 2005, PEDIATR RES, V58, P153, DOI 10.1203/01.PDR.0000157725.44213.C4; Chaudhari AJ, 2005, PHYS MED BIOL, V50, P5421, DOI 10.1088/0031-9155/50/23/001; Cheng CM, 2008, CANCER GENE THER, V15, P393, DOI 10.1038/cgt.2008.10; Clairmont C, 2000, J INFECT DIS, V181, P1996, DOI 10.1086/315497; Contag CH, 1995, MOL MICROBIOL, V18, P593, DOI 10.1111/j.1365-2958.1995.mmi_18040593.x; Critchley Rebecca J, 2004, Discov Med, V4, P194; Cronin M, 2007, APPL ENVIRON MICROB, V73, P7858, DOI 10.1128/AEM.01630-07; Cronin M, 2010, MOL THER, V18, P1397, DOI 10.1038/mt.2010.59; Cronin M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-161; Cunningham C, 2001, Hum Gene Ther, V12, P1594; Foucault ML, 2010, APPL ENVIRON MICROB, V76, P264, DOI 10.1128/AEM.01686-09; Foucault ML, APPL ENV MICROBIOL, V76, P264; Grillot-Courvalin C, 1998, NAT BIOTECHNOL, V16, P862, DOI 10.1038/nbt0998-862; Guglielmetti S, 2008, INT J FOOD MICROBIOL, V124, P285, DOI 10.1016/j.ijfoodmicro.2008.03.033; Guo XL, 2010, IEEE T BIO-MED ENG, V57, P2876, DOI 10.1109/TBME.2010.2073468; Hayashi K, 2009, J CELL BIOCHEM, V106, P992, DOI 10.1002/jcb.22078; Hayashi K, 2009, CELL CYCLE, V8, P870, DOI 10.4161/cc.8.6.7891; HEPPNER F, 1978, ACTA NEUROCHIR, V42, P123, DOI 10.1007/BF01406639; Hoffman RM, 2011, CURR OPIN BIOTECHNOL; Hoffman RM, 2006, NAT PROTOC, V1, P2988, DOI 10.1038/nprot.2006.376; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Iqbal U, 2010, BRIT J PHARMACOL, V160, P1016, DOI 10.1111/j.1476-5381.2010.00742.x; Kepshire D, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3109903; Kuo C, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2717898; Lemmon MJ, 1997, GENE THER, V4, P791, DOI 10.1038/sj.gt.3300468; Min JJ, 2008, NAT PROTOC, V3, P629, DOI 10.1038/nprot.2008.32; Morrissey D, 2010, CURR GENE THER, V10, P3, DOI 10.2174/156652310790945575; Nagakura C, 2009, ANTICANCER RES, V29, P1873; Nemunaitis J, 2003, CANCER GENE THER, V10, P737, DOI 10.1038/sj.cgt.7700634; Puaux A-L, 2011, INT J MOL IMAGING; Riedel CU, 2007, APPL ENVIRON MICROB, V73, P7092, DOI 10.1128/AEM.01394-07; Riedel CU, 2007, APPL ENVIRON MICROB, V73, P3091, DOI 10.1128/AEM.02940-06; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Simpson PJ, 2003, J BACTERIOL, V185, P2571, DOI 10.1128/JB.185.8.2571-2581.2003; Sleator RD, 2009, MICROBIOL-SGM, V155, P2463, DOI 10.1099/mic.0.030205-0; Spinelli AE, 2011, OPT EXPRESS, V19, P12605, DOI 10.1364/OE.19.012605; Tangney M, 2010, DISCOV MED, V10, P195; Toso JF, 2002, J CLIN ONCOL, V20, P142, DOI 10.1200/JCO.20.1.142; van Pijkeren JP, 2010, HUM GENE THER, V21, P405, DOI 10.1089/hum.2009.022; Vassaux G, 2006, J PATHOL, V208, P290, DOI 10.1002/path.1865; Waidmann MS, BIOENG BUGS, V2, P8; Wiles S, 2006, INFECT IMMUN, V74, P5391, DOI 10.1128/IAI.00848-06; Yazawa K, 2000, CANCER GENE THER, V7, P269, DOI 10.1038/sj.cgt.7700122; Yu YA, 2004, NAT BIOTECHNOL, V22, P313, DOI 10.1038/nbt937; Yu YA, 2008, BIOTECHNOL BIOENG, V100, P567, DOI 10.1002/bit.21785; Zhao M, 2005, P NATL ACAD SCI USA, V102, P755, DOI 10.1073/pnas.0408422102; Zhao M, 2007, P NATL ACAD SCI USA, V104, P10170, DOI 10.1073/pnas.0703867104; Zhao M, 2006, CANCER RES, V66, P7647, DOI 10.1158/0008-5472.CAN-06-0716	57	104	111	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30940	10.1371/journal.pone.0030940	http://dx.doi.org/10.1371/journal.pone.0030940			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295120	Green Published, Green Submitted, gold			2022-12-27	WOS:000301640600065
J	Dzijak, R; Yildirim, S; Kahle, M; Novak, P; Hnilicova, J; Venit, T; Hozak, P				Dzijak, Rastislav; Yildirim, Sukriye; Kahle, Michal; Novak, Petr; Hnilicova, Jarmila; Venit, Tomas; Hozak, Pavel			Specific Nuclear Localizing Sequence Directs Two Myosin Isoforms to the Cell Nucleus in Calmodulin-Sensitive Manner	PLOS ONE			English	Article							POLYMERASE-I TRANSCRIPTION; SEX REVERSAL; ACTIN; LOCALIZATION; EXPORT; RECEPTOR; BINDING; DOMAIN; IDENTIFICATION; TRANSLOCATION	Background: Nuclear myosin I (NM1) was the first molecular motor identified in the cell nucleus. Together with nuclear actin, they participate in crucial nuclear events such as transcription, chromatin movements, and chromatin remodeling. NM1 is an isoform of myosin 1c (Myo1c) that was identified earlier and is known to act in the cytoplasm. NM1 differs from the "cytoplasmic" myosin 1c only by additional 16 amino acids at the N-terminus of the molecule. This amino acid stretch was therefore suggested to direct NM1 into the nucleus. Methodology/Principal Findings: We investigated the mechanism of nuclear import of NM1 in detail. Using over-expressed GFP chimeras encoding for truncated NM1 mutants, we identified a specific sequence that is necessary for its import to the nucleus. This novel nuclear localization sequence is placed within calmodulin-binding motif of NM1, thus it is present also in the Myo1c. We confirmed the presence of both isoforms in the nucleus by transfection of tagged NM1 and Myo1c constructs into cultured cells, and also by showing the presence of the endogenous Myo1c in purified nuclei of cells derived from knock-out mice lacking NM1. Using pull-down and co-immunoprecipitation assays we identified importin beta, importin 5 and importin 7 as nuclear transport receptors that bind NM1. Since the NLS sequence of NM1 lies within the region that also binds calmodulin we tested the influence of calmodulin on the localization of NM1. The presence of elevated levels of calmodulin interfered with nuclear localization of tagged NM1. Conclusions/Significance: We have shown that the novel specific NLS brings to the cell nucleus not only the "nuclear" isoform of myosin I (NM1 protein) but also its "cytoplasmic" isoform (Myo1c protein). This opens a new field for exploring functions of this molecular motor in nuclear processes, and for exploring the signals between cytoplasm and the nucleus.	[Dzijak, Rastislav; Yildirim, Sukriye; Kahle, Michal; Hnilicova, Jarmila; Venit, Tomas; Hozak, Pavel] ASCR, Vvi, Inst Mol Genet, Dept Biol Cell Nucleus, Prague, Czech Republic; [Novak, Petr] ASCR, Vvi, Inst Microbiol, Lab Mol Struct Characterizat, Prague, Czech Republic	Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences	Dzijak, R (corresponding author), ASCR, Vvi, Inst Mol Genet, Dept Biol Cell Nucleus, Prague, Czech Republic.	hozak@img.cas.cz	Hozak, Pavel/J-4182-2014; Dzijak, Rastislav/G-6181-2014; Venit, Tomas/G-3534-2014; Kahle, Michal/K-9936-2016; Hnilicova, Jarmila/J-5019-2014; Novak, Petr/F-9655-2014; Dzijak, Rastislav/AGI-4423-2022; Hozak, Pavel/AAB-5359-2021	Hozak, Pavel/0000-0003-1901-1394; Kahle, Michal/0000-0002-3854-0390; Hnilicova, Jarmila/0000-0002-0953-491X; Novak, Petr/0000-0001-8688-529X; Dzijak, Rastislav/0000-0003-1141-7736; Hozak, Pavel/0000-0003-1901-1394	Grant Agency of the Czech Republic [204/07/1592, 204/09/H084, P305/11/2232]; Ministry of Education, Youth and Sports of the Czech Republic [LC 545, LC06063]; Academy of Sciences of the Czech Republic [AV0Z50520514]; Boehringer Ingelheim Fonds	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Academy of Sciences of the Czech Republic(Czech Academy of Sciences); Boehringer Ingelheim Fonds(Boehringer Ingelheim)	This study was supported by Grant Agency of the Czech Republic (http://www.gacr.cz Reg. Nos. 204/07/1592, 204/09/H084 and P305/11/2232), Ministry of Education, Youth and Sports of the Czech Republic (http://www.msmt.cz/index.php?lang=2 Reg. Nos. LC 545 and LC06063). Institutional research plan Reg. No. AV0Z50520514, was funded by Academy of Sciences of the Czech Republic (http://www.isvav.cz/researchPlanDetail.do?rowId=AV0Z50520514). Dr. Dzijak was supported by the Boehringer Ingelheim Fonds travel grant (http://www.bifonds.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonsson A, 2003, MOL CELL BIOL, V23, P1418, DOI 10.1128/MCB.23.4.1418-1427.2003; Argentaro A, 2003, J BIOL CHEM, V278, P33839, DOI 10.1074/jbc.M302078200; Chen J, 2001, AM J PHYSIOL-RENAL, V280, pF619, DOI 10.1152/ajprenal.2001.280.4.F619; Chuang CH, 2006, CURR BIOL, V16, P825, DOI 10.1016/j.cub.2006.03.059; Cisterna B, 2006, FASEB J, V20, P1901, DOI 10.1096/fj.05-5278fje; Cisterna B, 2009, HISTOCHEM CELL BIOL, V131, P743, DOI 10.1007/s00418-009-0583-3; Cokol M, 2000, EMBO REP, V1, P411, DOI 10.1093/embo-reports/kvd092; Dumont RA, 2002, JARO-J ASSOC RES OTO, V3, P375, DOI 10.1007/s101620020049; Fomproix N, 2004, EXP CELL RES, V294, P140, DOI 10.1016/j.yexcr.2003.10.028; FRANGIONI JV, 1993, J CELL SCI, V105, P481; Galvez T, 2001, EMBO J, V20, P2152, DOI 10.1093/emboj/20.9.2152; Gillespie PG, 2002, BMC BIOCHEM, V3, DOI 10.1186/1471-2091-3-31; Grummt I, 2006, CURR OPIN GENET DEV, V16, P191, DOI 10.1016/j.gde.2006.02.001; Grummt I, 2003, GENE DEV, V17, P1691, DOI 10.1101/gad.1098503R; Harley VR, 1996, FEBS LETT, V391, P24, DOI 10.1016/0014-5793(96)00694-1; Hirono M, 2004, NEURON, V44, P309, DOI 10.1016/j.neuron.2004.09.020; Hofmann WA, 2004, NAT CELL BIOL, V6, P1094, DOI 10.1038/ncb1182; Hofmann WA, 2009, J CELL SCI, V122, P636, DOI 10.1242/jcs.030205; Hokanson DE, 2006, MOL BIOL CELL, V17, P4856, DOI 10.1091/mbc.e06-05-0449; Houdusse A, 2006, P NATL ACAD SCI USA, V103, P19326, DOI 10.1073/pnas.0609436103; Hu X, 2009, P NATL ACAD SCI USA, V106, P10141, DOI 10.1073/pnas.0900437106; Kahl CR, 2003, ENDOCR REV, V24, P719, DOI 10.1210/er.2003-0008; Kahle M, 2007, HISTOCHEM CELL BIOL, V127, P139, DOI 10.1007/s00418-006-0231-0; Kutay U, 1998, MOL CELL, V1, P359, DOI 10.1016/S1097-2765(00)80036-2; Kutay U, 1997, CELL, V90, P1061, DOI 10.1016/S0092-8674(00)80372-4; Kysela K, 2005, HISTOCHEM CELL BIOL, V124, P347, DOI 10.1007/s00418-005-0042-8; Laakso JM, 2008, SCIENCE, V321, P133, DOI 10.1126/science.1159419; Leneuve P, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng021; Lindsay AJ, 2009, CELL MOTIL CYTOSKEL, V66, P1057, DOI 10.1002/cm.20408; Manceva S, 2007, BIOCHEMISTRY-US, V46, P11718, DOI 10.1021/bi700894h; Mehta IS, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r5; Mohr D, 2009, EMBO J, V28, P2541, DOI 10.1038/emboj.2009.200; Nagata T, 2010, ANAL BIOCHEM, V398, P178, DOI 10.1016/j.ab.2009.11.017; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nowak G, 1997, J BIOL CHEM, V272, P17176, DOI 10.1074/jbc.272.27.17176; Obrdlik A, 2010, FASEB J, V24, P146, DOI 10.1096/fj.09-135863; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; Percipalle P, 2006, CURR OPIN CELL BIOL, V18, P267, DOI 10.1016/j.ceb.2006.03.001; Pestic-Dragovich L, 2000, SCIENCE, V290, P337, DOI 10.1126/science.290.5490.337; Philimonenko VV, 2010, HISTOCHEM CELL BIOL, V134, P243, DOI 10.1007/s00418-010-0732-8; Philimonenko VV, 2004, NAT CELL BIOL, V6, P1165, DOI 10.1038/ncb1190; Sim H, 2005, MOL ENDOCRINOL, V19, P1884, DOI 10.1210/me.2004-0334; Suetsugu S, 2003, J BIOL CHEM, V278, P42515, DOI 10.1074/jbc.M302177200; Ye J, 2008, GENE DEV, V22, P322, DOI 10.1101/gad.455908; Yip MF, 2008, CELL METAB, V8, P384, DOI 10.1016/j.cmet.2008.09.011	45	34	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30529	10.1371/journal.pone.0030529	http://dx.doi.org/10.1371/journal.pone.0030529			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295092	Green Published, gold, Green Submitted			2022-12-27	WOS:000301640600037
J	Moum, SJ; Price, CC; Limotai, N; Oyama, G; Ward, H; Jacobson, C; Foote, KD; Okun, MS				Moum, Sarah J.; Price, Catherine C.; Limotai, Natlada; Oyama, Genko; Ward, Herbert; Jacobson, Charles; Foote, Kelly D.; Okun, Michael S.			Effects of STN and GPi Deep Brain Stimulation on Impulse Control Disorders and Dopamine Dysregulation Syndrome	PLOS ONE			English	Article							NONMOTOR SYMPTOMS QUESTIONNAIRE; SUBTHALAMIC NUCLEUS STIMULATION; PARKINSONS-DISEASE; DBS; PREVALENCE; VALPROATE; LEVODOPA	Objective: Impulse control disorders (ICDs) and dopamine dysregulation syndrome (DDS) are important behavioral problems that affect a subpopulation of patients with Parkinson's disease (PD) and typically result in markedly diminished quality of life for patients and their caregivers. We aimed to investigate the effects of subthalamic nucleus (STN) and internal globus pallidus (GPi) deep brain stimulation (DBS) on ICD/DDS frequency and dopaminergic medication usage. Methods: A retrospective chart review was performed on 159 individuals who underwent unilateral or bilateral PD DBS surgery in either STN or GPi. According to published criteria, pre-and post-operative records were reviewed to categorize patients both pre-and post-operatively as having ICD, DDS, both ICD and DDS, or neither ICD nor DDS. Group differences in patient demographics, clinical presentations, levodopa equivalent dose (LED), and change in diagnosis following unilateral/bilateral by brain target (STN or GPi DBS placement) were examined. Results: 28 patients met diagnostic criteria for ICD or DDS pre- or post-operatively. ICD or DDS classification did not differ by GPi or STN target stimulation. There was no change in DDS diagnosis after unilateral or bilateral stimulation. For ICD, diagnosis resolved in 2 of 7 individuals after unilateral or bilateral DBS. Post-operative development of these syndromes was significant; 17 patients developed ICD diagnoses post-operatively with 2 patients with pre-operative ICD developing DDS post-operatively. Conclusions: Unilateral or bilateral DBS did not significantly treat DDS or ICD in our sample, even though a few cases of ICD resolved post-operatively. Rather, our study provides preliminary evidence that DDS and ICD diagnoses may emerge following DBS surgery.	[Moum, Sarah J.; Limotai, Natlada; Oyama, Genko; Ward, Herbert; Jacobson, Charles; Foote, Kelly D.; Okun, Michael S.] Univ Florida, Dept Neurol, Ctr Movement Disorders & Neurorestorat, Gainesville, FL 32610 USA; [Moum, Sarah J.; Foote, Kelly D.; Okun, Michael S.] Univ Florida, Dept Neurosurg, Ctr Movement Disorders & Neurorestorat, Gainesville, FL USA; [Price, Catherine C.] Univ Florida, Dept Clin & Hlth Psychol, Ctr Movement Disorders & Neurorestorat, Gainesville, FL USA; [Limotai, Natlada] Chulalongkorn Univ Hosp, Chulalongkorn Comprehens Movement Disorders Ctr, Bangkok, Thailand; [Limotai, Natlada] Red Cross Soc, Bangkok, Thailand; [Ward, Herbert] Univ Florida, Dept Psychiat, Ctr Movement Disorders & Neurorestorat, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Chulalongkorn University; Thai Red Cross Society; State University System of Florida; University of Florida	Moum, SJ (corresponding author), Univ Florida, Dept Neurol, Ctr Movement Disorders & Neurorestorat, Gainesville, FL 32610 USA.	okun@neurology.ufl.edu		Price, Catherine/0000-0001-5994-0644; Foote, Kelly/0000-0002-2436-4138; Okun, Michael/0000-0002-6247-9358; Jacobson, Charles/0000-0002-7598-5217	National Institutes of Health [T35 07489]; National Institute of Neurological Disorders and Stroke [K23NS060660]; University of Florida (UF) National Parkinson Foundation Center of Excellence; UF Foundation; National Parkinson Foundation; National Institutes of Health (NIH); Michael J. Fox Foundation; Parkinson Alliance; University of Florida Foundation; University of South Florida CME office, PeerView; Vanderbilt University; Medtronic; ANS/St. Jude; Smallwood Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K23NS060660] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); University of Florida (UF) National Parkinson Foundation Center of Excellence(University of Florida); UF Foundation; National Parkinson Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michael J. Fox Foundation; Parkinson Alliance; University of Florida Foundation(University of Florida); University of South Florida CME office, PeerView; Vanderbilt University; Medtronic(Medtronic); ANS/St. Jude; Smallwood Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by National Institutes of Health T35 07489 (SM), National Institute of Neurological Disorders and Stroke K23NS060660 (CP); University of Florida (UF) National Parkinson Foundation Center of Excellence, UF Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; MO serves as a consultant for the National Parkinson Foundation, and has received research grants from National Institutes of Health (NIH), National Parkinson Foundation, the Michael J. Fox Foundation, the Parkinson Alliance, Smallwood Foundation, and the University of Florida Foundation. MO currently receives no support >4 months from industry. MO has received royalties for publications with Demos, Manson, and Cambridge (movement disorders books). MO has participated in CME activities on movement disorders sponsored by the University of South Florida CME office, PeerView, and by Vanderbilt University. The institution and not the PI receives grants from Medtronic and ANS/St. Jude, and the PI has no financial interest in these grants. MO has participated as a site PI and/or co-PI for several NIH, foundation, and industry sponsored trials over the years but has not received honoraria. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials.	Ardouin C, 2006, MOVEMENT DISORD, V21, P1941, DOI 10.1002/mds.21098; Avila A, 2011, J NEUROL SC IN PRESS; Bandini F, 2007, PARKINSONISM RELAT D, V13, P369, DOI 10.1016/j.parkreldis.2006.07.011; Cabrini S, 2009, NEUROL SCI IN PRESS; Chaudhuri KR, 2006, MOVEMENT DISORD, V21, P916, DOI 10.1002/mds.20844; Demetriades P, 2011, PARKINSONS IN PRESS; Evans AH, 2004, MOVEMENT DISORD, V19, P397, DOI 10.1002/mds.20045; FRIEDMAN JH, 1994, BIOL PSYCHIAT, V36, P350, DOI 10.1016/0006-3223(94)90636-X; Giovannoni G, 2000, J NEUROL NEUROSUR PS, V68, P423, DOI 10.1136/jnnp.68.4.423; Halbig TD, 2009, EUR J NEUROL, V16, P493, DOI 10.1111/j.1468-1331.2008.02509.x; Hicks CW, 2011, PARKINSONISM RELAT D, V17, P379, DOI 10.1016/j.parkreldis.2011.03.003; Knobel D, 2008, COGN BEHAV NEUROL, V21, P187, DOI 10.1097/WNN.0b013e318185e6e2; Koran LM, 2002, J CLIN PSYCHIAT, V63, P704, DOI 10.4088/JCP.v63n0808; Martinez-Martin P, 2007, MOVEMENT DISORD, V22, P1623, DOI 10.1002/mds.21586; MCELROY SL, 1994, J CLIN PSYCHIAT, V55, P242; NAUSIEDA PA, 1985, CLIN NEUROPHARMACOL, V8, P318, DOI 10.1097/00002826-198512000-00002; Nazzaro JM, 2011, PARKINSONIS IN PRESS; Nirenberg MJ, 2006, MOVEMENT DISORD, V21, P524, DOI 10.1002/mds.20757; Oei TPS, 2010, BEHAV COGN PSYCHOTH, V38, P233, DOI 10.1017/S1352465809990701; Okun MS, 2010, EXPERT REV NEUROTHER, V10, P1847, DOI 10.1586/ERN.10.156; Pallanti S, 2002, J CLIN PSYCHIAT, V63, P559, DOI 10.4088/JCP.v63n0704; PRIEBE S, 1984, PHARMACOPSYCHIATRY, V17, P109, DOI 10.1055/s-2007-1017418; Rotondo A, 2010, MOVEMENT DISORD, V25, P1994, DOI 10.1002/mds.23177; Smeding HMM, 2007, J NEUROL NEUROSUR PS, V78, P517, DOI 10.1136/jnnp.2006.102061; Stein DJ, 2005, CNS SPECTRUMS, V10, P268, DOI 10.1017/S1092852900022574; Voon V, 2006, NEUROLOGY, V67, P1254, DOI 10.1212/01.wnl.0000238503.20816.13; Voon V, 2011, ANN NEUROL, V69, P986, DOI 10.1002/ana.22356; Voon V, 2009, LANCET NEUROL, V8, P1140, DOI 10.1016/S1474-4422(09)70287-X; Weintraub D, 2010, ARCH NEUROL-CHICAGO, V67, P589, DOI 10.1001/archneurol.2010.65; Witjas T, 2005, MOVEMENT DISORD, V20, P1052, DOI 10.1002/mds.20501	30	80	83	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e29768	10.1371/journal.pone.0029768	http://dx.doi.org/10.1371/journal.pone.0029768			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295068	Green Submitted, Green Published, gold			2022-12-27	WOS:000301640600013
J	Reuter, KC; Loitsch, SM; Dignass, AU; Steinhilber, D; Stein, J				Reuter, Kerstin C.; Loitsch, Stefan M.; Dignass, Axel U.; Steinhilber, Dieter; Stein, Juergen			Selective Non-Steroidal Glucocorticoid Receptor Agonists Attenuate Inflammation but Do Not Impair Intestinal Epithelial Cell Restitution In Vitro	PLOS ONE			English	Article							SIGNAL-REGULATED KINASE; GROWTH-FACTOR; MOLECULAR-MECHANISMS; BOWEL-DISEASE; REPAIR MECHANISMS; MEDICAL THERAPY; PLANT-ORIGIN; WOUND REPAIR; KAPPA-B; MODULATION	Introduction: Despite the excellent anti-inflammatory and immunosuppressive action of glucocorticoids (GCs), their use for the treatment of inflammatory bowel disease (IBD) still carries significant risks in terms of frequently occurring severe side effects, such as the impairment of intestinal tissue repair. The recently-introduced selective glucocorticoid receptor (GR) agonists (SEGRAs) offer anti-inflammatory action comparable to that of common GCs, but with a reduced side effect profile. Methods: The in vitro effects of the non-steroidal SEGRAs Compound A (CpdA) and ZK216348, were investigated in intestinal epithelial cells and compared to those of Dexamethasone (Dex). GR translocation was shown by immunfluorescence and Western blot analysis. Trans-repressive effects were studied by means of NF-kappa B/p65 activity and IL-8 levels, trans-activation potency by reporter gene assay. Flow cytometry was used to assess apoptosis of cells exposed to SEGRAs. The effects on IEC-6 and HaCaT cell restitution were determined using an in vitro wound healing model, cell proliferation by BrdU assay. In addition, influences on the TGF-beta- or EGF/ERK1/2/MAPK-pathway were evaluated by reporter gene assay, Western blot and qPCR analysis. Results: Dex, CpdA and ZK216348 were found to be functional GR agonists. In terms of trans-repression, CpdA and ZK216348 effectively inhibited NF-kappa B activity and IL-8 secretion, but showed less trans-activation potency. Furthermore, unlike SEGRAs, Dex caused a dose-dependent inhibition of cell restitution with no effect on cell proliferation. These differences in epithelial restitution were TGF-beta-independent but Dex inhibited the EGF/ERK1/2/MAPK-pathway important for intestinal epithelial wound healing by induction of MKP-1 and Annexin-1 which was not affected by CpdA or ZK216348. Conclusion: Collectively, our results indicate that, while their anti-inflammatory activity is comparable to Dex, SEGRAs show fewer side effects with respect to wound healing. The fact that SEGRAs did not have a similar effect on cell restitution might be due to a different modulation of EGF/ERK1/2 MAPK signalling.	[Reuter, Kerstin C.; Loitsch, Stefan M.; Steinhilber, Dieter; Stein, Juergen] Goethe Univ Frankfurt, Inst Pharmazeut Chem, Frankfurt, Germany; [Dignass, Axel U.] Markus Hosp, Dept Med 1, Frankfurt, Germany; [Stein, Juergen] Elisabethen Hosp, Dept Internal Med, Frankfurt, Germany; [Stein, Juergen] Crohn Colitis Ctr Frankfurt, Frankfurt, Germany	Goethe University Frankfurt	Reuter, KC (corresponding author), Goethe Univ Frankfurt, Inst Pharmazeut Chem, Campus Riedberg, Frankfurt, Germany.	jstein@em.uni-frankfurt.de	Steinhilber, Dieter/J-3221-2012; Dignass, Axel/AAW-9653-2020; Dignass, Axel/V-5400-2019	Dignass, Axel/0000-0002-9724-054X; Stein, Jurgen/0000-0003-3558-3341	Deutsche Forschungsgemeinschaft (DFG) [GRK757]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by a graduate scholarship grant from the Deutsche Forschungsgemeinschaft (DFG, GRK757) to KCR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anstead G M, 1998, Adv Wound Care, V11, P277; BARNES PJ, 1993, TRENDS PHARMACOL SCI, V14, P436, DOI 10.1016/0165-6147(93)90184-L; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Beer H D, 2000, Vitam Horm, V59, P217, DOI 10.1016/S0083-6729(00)59008-6; Bladh LG, 2009, BBA-MOL CELL RES, V1793, P439, DOI 10.1016/j.bbamcr.2008.11.013; Bonner GF, 1996, SOUTHERN MED J, V89, P556, DOI 10.1097/00007611-199606000-00002; De Bosscher K, 2005, P NATL ACAD SCI USA, V102, P15827, DOI 10.1073/pnas.0505554102; De Bosscher K, 2009, MOL ENDOCRINOL, V23, P281, DOI 10.1210/me.2008-0283; de Chambrun GP, 2010, NAT REV GASTRO HEPAT, V7, P15, DOI 10.1038/nrgastro.2009.203; Dewint P, 2008, J IMMUNOL, V180, P2608, DOI 10.4049/jimmunol.180.4.2608; DIGNASS AU, 1993, GASTROENTEROLOGY, V105, P1323, DOI 10.1016/0016-5085(93)90136-Z; Durer U, 2007, CELL PHYSIOL BIOCHEM, V20, P329, DOI 10.1159/000107519; Eberhardt W, 1998, J IMMUNOL, V160, P4961; Engelbrecht Y, 2003, ENDOCRINOLOGY, V144, P412, DOI 10.1210/en.2002-220769; Goke MN, 2002, REGUL PEPTIDES, V105, P203, DOI 10.1016/S0167-0115(02)00023-X; Gossye V, 2010, ANN RHEUM DIS, V69, P291, DOI 10.1136/ard.2008.102871; Grose R, 2002, EMBO REP, V3, P575, DOI 10.1093/embo-reports/kvf119; Heitzer MD, 2007, REV ENDOCR METAB DIS, V8, P321, DOI 10.1007/s11154-007-9059-8; Herr I, 2007, APOPTOSIS, V12, P271, DOI 10.1007/s10495-006-0624-5; Jung S, 2001, SCAND J GASTROENTERO, V36, P963, DOI 10.1080/003655201750305495; Kleiman A, 2007, MOL CELL ENDOCRINOL, V275, P98, DOI 10.1016/j.mce.2007.05.009; Kozuch PL, 2008, WORLD J GASTROENTERO, V14, P354, DOI 10.3748/wjg.14.354; Okamoto R, 2005, DIGEST DIS SCI, V50, pS34, DOI 10.1007/s10620-005-2804-5; Park JE, 2004, AM J SURG, V187, p11S, DOI 10.1016/S0002-9610(03)00296-4; Piette C, 2009, J BIOL CHEM, V284, P32483, DOI 10.1074/jbc.M109.014589; Podolsky DK, 1997, J GASTROENTEROL, V32, P122, DOI 10.1007/BF01213309; REED BR, 1985, J AM ACAD DERMATOL, V13, P919, DOI 10.1016/S0190-9622(85)70242-3; Resche-Rigon M, 1998, CURR OPIN CHEM BIOL, V2, P501, DOI 10.1016/S1367-5931(98)80126-9; Rieder F, 2007, GUT, V56, P130, DOI 10.1136/gut.2006.090456; Rogler G, 2010, BEST PRACT RES CL GA, V24, P157, DOI 10.1016/j.bpg.2009.10.011; Rosen J, 2005, ENDOCR REV, V26, P452, DOI 10.1210/er.2005-0002; SATO Y, 1988, J CELL BIOL, V107, P1199, DOI 10.1083/jcb.107.3.1199; Schacke H, 2004, P NATL ACAD SCI USA, V101, P227, DOI 10.1073/pnas.0300372101; Schaecke H, 2007, MOL CELL ENDOCRINOL, V275, P109, DOI 10.1016/j.mce.2007.05.014; Stahn C, 2007, MOL CELL ENDOCRINOL, V275, P71, DOI 10.1016/j.mce.2007.05.019; Stanbury RM, 1998, BRIT J OPHTHALMOL, V82, P704, DOI 10.1136/bjo.82.6.704; Sturm A, 2008, WORLD J GASTROENTERO, V14, P348, DOI 10.3748/wjg.14.348; Suer S, 2009, CELL TISSUE RES, V336, P213, DOI 10.1007/s00441-009-0776-z; SUMMERS RW, 1979, GASTROENTEROLOGY, V77, P847; Tetreault MP, 2005, EXP CELL RES, V306, P285, DOI 10.1016/j.yexcr.2005.02.019; van Loo G, 2010, MOL ENDOCRINOL, V24, P310, DOI 10.1210/me.2009-0236; Wicke C, 2000, ARCH SURG-CHICAGO, V135, P1265, DOI 10.1001/archsurg.135.11.1265; Wilson AJ, 1997, CLIN SCI, V93, P97, DOI 10.1042/cs0930097; Wust S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008202; Yan F, 2007, OPHTHALMOLOGICA, V221, P244, DOI 10.1159/000101926; Yemelyanov A, 2008, CANCER RES, V68, P4763, DOI 10.1158/0008-5472.CAN-07-6104; Zhang ZR, 2009, J IMMUNOL, V183, P3081, DOI 10.4049/jimmunol.0901088; Znalesniak EB, 2010, CELL PHYSIOL BIOCHEM, V25, P533, DOI 10.1159/000303057	48	19	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e29756	10.1371/journal.pone.0029756	http://dx.doi.org/10.1371/journal.pone.0029756			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295067	gold, Green Published, Green Submitted			2022-12-27	WOS:000301640600012
J	Severing, EI; van Dijk, ADJ; Morabito, G; Busscher-Lange, J; Immink, RGH; van Ham, RCHJ				Severing, Edouard I.; van Dijk, Aalt D. J.; Morabito, Giuseppa; Busscher-Lange, Jacqueline; Immink, Richard G. H.; van Ham, Roeland C. H. J.			Predicting the Impact of Alternative Splicing on Plant MADS Domain Protein Function	PLOS ONE			English	Article							FLOWERING TIME; BOX GENES; TRANSCRIPTION FACTORS; ARABIDOPSIS-THALIANA; MESSENGER-RNA; EVOLUTIONARY ANALYSIS; EXON DUPLICATION; ORGAN IDENTITY; SEQUENCE; IDENTIFICATION	Several genome-wide studies demonstrated that alternative splicing (AS) significantly increases the transcriptome complexity in plants. However, the impact of AS on the functional diversity of proteins is difficult to assess using genome-wide approaches. The availability of detailed sequence annotations for specific genes and gene families allows for a more detailed assessment of the potential effect of AS on their function. One example is the plant MADS-domain transcription factor family, members of which interact to form protein complexes that function in transcription regulation. Here, we perform an in silico analysis of the potential impact of AS on the protein-protein interaction capabilities of MIKC-type MADS-domain proteins. We first confirmed the expression of transcript isoforms resulting from predicted AS events. Expressed transcript isoforms were considered functional if they were likely to be translated and if their corresponding AS events either had an effect on predicted dimerisation motifs or occurred in regions known to be involved in multimeric complex formation, or otherwise, if their effect was conserved in different species. Nine out of twelve MIKC MADS-box genes predicted to produce multiple protein isoforms harbored putative functional AS events according to those criteria. AS events with conserved effects were only found at the borders of or within the K-box domain. We illustrate how AS can contribute to the evolution of interaction networks through an example of selective inclusion of a recently evolved interaction motif in the MADS AFFECTING FLOWERING1-3 (MAF1-3) subclade. Furthermore, we demonstrate the potential effect of an AS event in SHORT VEGETATIVE PHASE (SVP), resulting in the deletion of a short sequence stretch including a predicted interaction motif, by overexpression of the fully spliced and the alternatively spliced SVP transcripts. For most of the AS events we were able to formulate hypotheses about the potential impact on the interaction capabilities of the encoded MIKC proteins.	[Severing, Edouard I.; van Dijk, Aalt D. J.; van Ham, Roeland C. H. J.] Plant Res Int, Appl Bioinformat, Wageningen, Netherlands; [Severing, Edouard I.; van Ham, Roeland C. H. J.] Wageningen Univ, Lab Bioinformat, Wageningen, Netherlands; [Immink, Richard G. H.] Ctr BioSyst Genom, Wageningen, Netherlands; [Morabito, Giuseppa; Busscher-Lange, Jacqueline; Immink, Richard G. H.] Plant Res Int, Plant Dev Syst, Wageningen, Netherlands	Wageningen University & Research; Centre for BioSystems Genomics	Severing, EI (corresponding author), Plant Res Int, Appl Bioinformat, Wageningen, Netherlands.	aaltjan.vandijk@wur.nl	Immink, Richard G.H./A-9825-2011; Morabito, Giuseppa/AAC-2149-2020	Morabito, Giuseppa/0000-0002-9198-9349; Immink, Richard/0000-0002-0182-4138; van Dijk, Aalt-Jan/0000-0002-8872-5123	Netherlands Bioinformatics Centre [SP 3.2.1]; Netherlands Genomics Initiative; Netherlands Organization for Scientific Research (NWO) [863.08.027]; NGI [40-41009-98-8003]; Leonardo da Vinci project Unipharma-Graduates	Netherlands Bioinformatics Centre; Netherlands Genomics Initiative; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NGI; Leonardo da Vinci project Unipharma-Graduates	This work was supported by the BioRange program (SP 3.2.1) of the Netherlands Bioinformatics Centre, which is supported through the Netherlands Genomics Initiative, by the Netherlands Organization for Scientific Research (NWO, VENI Grant 863.08.027 to ADJvD) and by a NGI Horizon Breakthrough project (Grant 40-41009-98-8003 to RGHI). GM was supported by a scholarship of the Leonardo da Vinci project Unipharma-Graduates (www.unipharmagraduates.it) coordinated by Sapienza University of Rome. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi CA, 2010, P NATL ACAD SCI USA, V107, P18898, DOI 10.1073/pnas.1009050107; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alvarez-Buylla ER, 2000, P NATL ACAD SCI USA, V97, P5328, DOI 10.1073/pnas.97.10.5328; Amoutzias GD, 2008, TRENDS BIOCHEM SCI, V33, P220, DOI 10.1016/j.tibs.2008.02.002; Baek JM, 2008, PLANT MOL BIOL, V67, P499, DOI 10.1007/s11103-008-9334-4; Balasubramanian S, 2006, PLOS GENET, V2, P980, DOI 10.1371/journal.pgen.0020106; Balasubramanian S, 2006, PLANT SIGNAL BEHAV, V1, P227, DOI 10.4161/psb.1.5.3452; Barbazuk WB, 2008, GENOME RES, V18, P1381, DOI 10.1101/gr.053678.106; Becker A, 2003, MOL PHYLOGENET EVOL, V29, P464, DOI 10.1016/S1055-7903(03)00207-0; Caicedo AL, 2004, P NATL ACAD SCI USA, V101, P15670, DOI 10.1073/pnas.0406232101; Caicedo AL, 2009, MOL BIOL EVOL, V26, P699, DOI 10.1093/molbev/msn300; Causier B, 2005, CURR BIOL, V15, P1508, DOI 10.1016/j.cub.2005.07.063; Causier B, 2010, SEMIN CELL DEV BIOL, V21, P73, DOI 10.1016/j.semcdb.2009.10.005; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; De Bodt S, 2003, TRENDS PLANT SCI, V8, P475, DOI 10.1016/j.tplants.2003.09.006; de Folter S, 2005, PLANT CELL, V17, P1424, DOI 10.1105/tpc.105.031831; Dong QF, 2004, NUCLEIC ACIDS RES, V32, pD354, DOI 10.1093/nar/gkh046; Filichkin SA, 2010, GENOME RES, V20, P45, DOI 10.1101/gr.093302.109; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Hartmann U, 2000, PLANT J, V21, P351, DOI 10.1046/j.1365-313x.2000.00682.x; Henschel K, 2002, MOL BIOL EVOL, V19, P801, DOI 10.1093/oxfordjournals.molbev.a004137; Hill K, 2008, PLANT J, V53, P172, DOI 10.1111/j.1365-313X.2007.03336.x; Hori K, 2007, PLANT CELL PHYSIOL, V48, P1072, DOI 10.1093/pcp/pcm075; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Immink RGH, 2010, SEMIN CELL DEV BIOL, V21, P87, DOI 10.1016/j.semcdb.2009.10.004; Immink RGH, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r24; Irimia M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-188; Irimia M, 2010, MOL BIOL EVOL, V27, P1504, DOI 10.1093/molbev/msq018; Jiao YL, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.76; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Kaufmann K, 2005, MOL GENET GENOMICS, V274, P103, DOI 10.1007/s00438-005-0010-y; Kaufmann K, 2005, GENE, V347, P183, DOI 10.1016/j.gene.2004.12.014; Keren H, 2010, NAT REV GENET, V11, P345, DOI 10.1038/nrg2776; Kim S, 2005, INT J PLANT SCI, V166, P185, DOI 10.1086/427479; Kitahara K, 2000, PLANT SCI, V151, P121, DOI 10.1016/S0168-9452(99)00206-X; Kofuji R, 2003, MOL BIOL EVOL, V20, P1963, DOI 10.1093/molbev/msg216; Kondrashov FA, 2001, HUM MOL GENET, V10, P2661, DOI 10.1093/hmg/10.23.2661; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Kyozuka J, 1997, PLANT MOL BIOL, V35, P573, DOI 10.1023/A:1005885808652; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Letunic I, 2002, HUM MOL GENET, V11, P1561, DOI 10.1093/hmg/11.13.1561; Lewis BP, 2003, P NATL ACAD SCI USA, V100, P189, DOI 10.1073/pnas.0136770100; Li D, 2008, DEV CELL, V15, P110, DOI 10.1016/j.devcel.2008.05.002; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lightfoot DJ, 2008, MOL GENET GENOMICS, V279, P75, DOI 10.1007/s00438-007-0297-y; Liu S, 2003, NUCLEIC ACIDS RES, V31, P4828, DOI 10.1093/nar/gkg668; Masiero S, 2004, DEVELOPMENT, V131, P5981, DOI 10.1242/dev.01517; Melamud E, 2009, NUCLEIC ACIDS RES, V37, P4862, DOI 10.1093/nar/gkp444; Modrek B, 2003, NAT GENET, V34, P177, DOI 10.1038/ng1159; MONTAG K, 1995, NUCLEIC ACIDS RES, V23, P2168, DOI 10.1093/nar/23.12.2168; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Nesi N, 2002, PLANT CELL, V14, P2463, DOI 10.1105/tpc.004127; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Parenicova L, 2003, PLANT CELL, V15, P1538, DOI 10.1105/tpc.011544; Ratcliffe OJ, 2003, PLANT CELL, V15, P1159, DOI 10.1105/tpc.009506; Reeves PA, 2007, GENETICS, V176, P295, DOI 10.1534/genetics.106.069336; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Riechmann JL, 1997, BIOL CHEM, V378, P1079; Rosti S, 2007, J MOL EVOL, V65, P316, DOI 10.1007/s00239-007-9013-0; Roy SW, 2007, MOL BIOL EVOL, V24, P171, DOI 10.1093/molbev/msl159; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sayers EW, 2010, NUCLEIC ACIDS RES, V38, pD5, DOI 10.1093/nar/gkp967; Scortecci KC, 2001, PLANT J, V26, P229, DOI 10.1046/j.1365-313x.2001.01024.x; Severing EI, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-154; Shchennikova AV, 2006, PLANT J, V47, P934; Simpson CG, 2008, PLANT J, V53, P1035, DOI 10.1111/j.1365-313X.2007.03392.x; Slotte T, 2009, GENETICS, V183, P337, DOI 10.1534/genetics.109.103705; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Su ZX, 2006, GENOME RES, V16, P182, DOI 10.1101/gr.4197006; Taneri B, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r75; Tang JF, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-438; Terzi LC, 2008, REGULATION FLOWERING, P201; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tress ML, 2007, P NATL ACAD SCI USA, V104, P5495, DOI 10.1073/pnas.0700800104; van Dijk ADJ, 2008, BIOINFORMATICS, V24, P26, DOI 10.1093/bioinformatics/btm539; van Dijk ADJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001017; VERWOERD TC, 1989, NUCLEIC ACIDS RES, V17, P2362, DOI 10.1093/nar/17.6.2362; Wang BB, 2006, P NATL ACAD SCI USA, V103, P7175, DOI 10.1073/pnas.0602039103; Wang BB, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-17; Werner JD, 2005, GENETICS, V170, P1197, DOI 10.1534/genetics.104.036533; Xing Y, 2005, P NATL ACAD SCI USA, V102, P13526, DOI 10.1073/pnas.0501213102; Yang YZ, 2004, PLANT MOL BIOL, V55, P45, DOI 10.1007/s11103-004-0416-7; Yang YZ, 2003, PLANT J, V33, P47, DOI 10.1046/j.0960-7412.2003.01473.x; Yen PM, 2001, PHYSIOL REV, V81, P1097, DOI 10.1152/physrev.2001.81.3.1097; Yu WP, 2003, TRENDS GENET, V19, P180, DOI 10.1016/S0168-9525(03)00048-9; Yuan YX, 2009, J EXP BOT, V60, P1299, DOI 10.1093/jxb/erp010; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhang JZ, 2009, PLANTA, V229, P847, DOI 10.1007/s00425-008-0885-z; Zhang PG, 2010, MOL BIOL EVOL, V27, P1686, DOI 10.1093/molbev/msq054	91	47	54	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30524	10.1371/journal.pone.0030524	http://dx.doi.org/10.1371/journal.pone.0030524			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295091	Green Submitted, Green Published, gold			2022-12-27	WOS:000301640600036
J	Chisholm, KM; Aubert, SD; Freese, KP; Zakian, VA; King, MC; Welcsh, PL				Chisholm, Karen M.; Aubert, Sarah D.; Freese, Krister P.; Zakian, Virginia A.; King, Mary-Claire; Welcsh, Piri L.			A Genomewide Screen for Suppressors of Alu-Mediated Rearrangements Reveals a Role for PIF1	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; BRCA1 PROMOTER REGION; BREAST-CANCER; SPORADIC BREAST; SACCHAROMYCES-CEREVISIAE; MISMATCH REPAIR; OVARIAN-CANCER; MESSENGER-RNA; MUTATIONS; GENES	Alu-mediated rearrangement of tumor suppressor genes occurs frequently during carcinogenesis. In breast cancer, this mechanism contributes to loss of the wild-type BRCA1 allele in inherited disease and to loss of heterozygosity in sporadic cancer. To identify genes required for suppression of Alu-mediated recombination we performed a genomewide screen of a collection of 4672 yeast gene deletion mutants using a direct repeat recombination assay. The primary screen and subsequent analysis identified 12 candidate genes including TSA, ELG1, and RRM3, which are known to play a significant role in maintaining genomic stability. Genetic analysis of the corresponding human homologs was performed in sporadic breast tumors and in inherited BRCA1-associated carcinomas. Sequencing of these genes in high risk breast cancer families revealed a potential role for the helicase PIF1 in cancer predisposition. PIF1 variant L319P was identified in three breast cancer families; importantly, this variant, which is predicted to be functionally damaging, was not identified in a large series of controls nor has it been reported in either dbSNP or the 1000 Genomes Project. In Schizosaccharomyces pombe, Pfh1 is required to maintain both mitochondrial and nuclear genomic integrity. Functional studies in yeast of human PIF1 L319P revealed that this variant cannot complement the essential functions of Pfh1 in either the nucleus or mitochondria. Our results provide a global view of nonessential genes involved in suppressing Alu-mediated recombination and implicate variation in PIF1 in breast cancer predisposition.	[Chisholm, Karen M.; King, Mary-Claire; Welcsh, Piri L.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Chisholm, Karen M.; Freese, Krister P.; King, Mary-Claire; Welcsh, Piri L.] Univ Washington, Div Med Genet, Dept Med, Seattle, WA 98195 USA; [Aubert, Sarah D.; Zakian, Virginia A.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Princeton University	Chisholm, KM (corresponding author), Stanford Univ, Med Ctr, Dept Pathol, Palo Alto, CA 94304 USA.	piri@u.washington.edu		King, Mary-Claire/0000-0001-9426-1743; Chisholm, Karen/0000-0002-1898-1252	National Institute of Environmental Health Sciences (NIEHS), National Institutes of Health (NIH) [F30 ES13069]; Department of Defense [BC010851]; NIH [GM43265, GM26938, R01CA157744, R01ES013160]; NATIONAL CANCER INSTITUTE [R01CA157744, Z01BC010851] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [F30ES013069, R01ES013160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026938, R01GM043265, R37GM026938] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences (NIEHS), National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Department of Defense(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by grant number F30 ES13069 for K. M. C. from the National Institute of Environmental Health Sciences (NIEHS), National Institutes of Health (NIH). Other research support was by a Department of Defense Breast Cancer Research Program (BCRP) Idea Award BC010851 (M.-C. K. and P. L. W.). M.-C. K. is an American Cancer Society Research Professor. Other research support was by NIH grants GM43265 and GM26938 to V. A. Zakian and R01CA157744 and R01ES013160. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Antoniou AC, 2008, BRIT J CANCER, V98, P1457, DOI 10.1038/sj.bjc.6604305; Antoniou AC, 2002, BRIT J CANCER, V86, P76, DOI 10.1038/sj.bjc.6600008; Baldwin RL, 2000, CANCER RES, V60, P5329; Beckmann MW, 1996, BRIT J CANCER, V73, P1220, DOI 10.1038/bjc.1996.234; Begg CB, 2008, JAMA-J AM MED ASSOC, V299, P194, DOI 10.1001/jama.2007.55-a; Bochman ML, 2010, DNA REPAIR, V9, P237, DOI 10.1016/j.dnarep.2010.01.008; BORG A, 1994, J NATL CANCER I, V86, P792, DOI 10.1093/jnci/86.10.792; Catteau A, 1999, ONCOGENE, V18, P1957, DOI 10.1038/sj.onc.1202509; Clark-Knowles KV, 2007, EXP CELL RES, V313, P133, DOI 10.1016/j.yexcr.2006.09.026; CROPP CS, 1994, CANCER RES, V54, P2548; Deininger PL, 1999, MOL GENET METAB, V67, P183, DOI 10.1006/mgme.1999.2864; DEVILEE P, 1994, CRIT REV ONCOGENESIS, V5, P247, DOI 10.1615/CritRevOncog.v5.i2-3.70; Esteller M, 2000, JNCI-J NATL CANCER I, V92, P564, DOI 10.1093/jnci/92.7.564; Evers B, 2006, ONCOGENE, V25, P5885, DOI 10.1038/sj.onc.1209871; Frank TS, 2002, J CLIN ONCOL, V20, P1480, DOI 10.1200/JCO.20.6.1480; FUTREAL PA, 1992, CANCER RES, V52, P2624; FUTREAL PA, 1994, SCIENCE, V266, P120, DOI 10.1126/science.7939630; Geisler JP, 2002, JNCI-J NATL CANCER I, V94, P61; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Hall MC, 1999, MOL MICROBIOL, V34, P867, DOI 10.1046/j.1365-2958.1999.01659.x; Huang J, 1996, P NATL ACAD SCI USA, V93, P9049, DOI 10.1073/pnas.93.17.9049; Huang ME, 2003, P NATL ACAD SCI USA, V100, P11529, DOI 10.1073/pnas.2035018100; JAUNIAUX JC, 1978, J BACTERIOL, V133, P1096, DOI 10.1128/JB.133.3.1096-1107.1978; Ji HP, 2001, HUM MOL GENET, V10, P2737, DOI 10.1093/hmg/10.24.2737; KANTERSMOLER G, 1994, BIOTECHNIQUES, V16, P798; Kolodner R, 1996, GENE DEV, V10, P1433, DOI 10.1101/gad.10.12.1433; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LEA DE, 1949, J GENET, V49, P264, DOI 10.1007/BF02986080; Liu X, 2007, P NATL ACAD SCI USA, V104, P12111, DOI 10.1073/pnas.0702969104; Lloyd J, 2000, J CLIN PATHOL, V53, P742, DOI 10.1136/jcp.53.10.742; Loo LWM, 2004, CANCER RES, V64, P8541, DOI 10.1158/0008-5472.CAN-04-1992; Ludwig T, 2001, GENE DEV, V15, P1188, DOI 10.1101/gad.879201; Marsischky GT, 1996, GENE DEV, V10, P407, DOI 10.1101/gad.10.4.407; Miller BJ, 2003, AM J HUM GENET, V73, P748, DOI 10.1086/378522; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Mueller CR, 2003, BREAST CANCER RES, V5, P45, DOI 10.1186/bcr557; Naylor TL, 2005, BREAST CANCER RES, V7, pR1186, DOI 10.1186/bcr1356; Nessling M, 2005, CANCER RES, V65, P439; Neumann CA, 2003, NATURE, V424, P561, DOI 10.1038/nature01819; Pierga JY, 2007, BRIT J CANCER, V96, P341, DOI 10.1038/sj.bjc.6603483; Pinter SF, 2008, MOL CELL BIOL, V28, P6594, DOI 10.1128/MCB.00191-08; Rebbeck TR, 2002, ENVIRON MOL MUTAGEN, V39, P228, DOI 10.1002/em.10050; Rennstam K, 2003, CANCER RES, V63, P8861; Rice JC, 2000, CARCINOGENESIS, V21, P1761, DOI 10.1093/carcin/21.9.1761; Rio PG, 1998, INT J ONCOL, V13, P849; Russell PA, 2000, INT J CANCER, V87, P317, DOI 10.1002/1097-0215(20000801)87:3<317::AID-IJC2>3.0.CO;2-B; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Simchoni S, 2006, P NATL ACAD SCI USA, V103, P3770, DOI 10.1073/pnas.0511301103; SLUITER MD, 2010, BREAST CANC RES TREA; Smith S, 2004, P NATL ACAD SCI USA, V101, P9039, DOI 10.1073/pnas.0403093101; Smith TM, 1996, GENOME RES, V6, P1029, DOI 10.1101/gr.6.11.1029; Snow BE, 2007, MOL CELL BIOL, V27, P1017, DOI 10.1128/MCB.01866-06; Staff S, 2003, CANCER RES, V63, P4978; THOMPSON ME, 1995, NAT GENET, V9, P444, DOI 10.1038/ng0495-444; Tong D, 2000, INT J CANCER, V88, P319, DOI 10.1002/1097-0215(20001015)88:2<319::AID-IJC27>3.0.CO;2-X; Walsh T, 2006, JAMA-J AM MED ASSOC, V295, P1379, DOI 10.1001/jama.295.12.1379; Werler PJH, 2003, GENE, V304, P133, DOI 10.1016/S0378-1119(03)00402-5; Wilson CA, 1999, NAT GENET, V21, P236, DOI 10.1038/6029; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Woods R. A., 2001, METH MOL B, V177, P85; Xu XL, 1999, NAT GENET, V22, P37, DOI 10.1038/8743; Zhang DH, 2006, NUCLEIC ACIDS RES, V34, P1393, DOI 10.1093/nar/gkl029; Zhou JQ, 2002, MOL BIOL CELL, V13, P2180, DOI 10.1091/mbc.02-02-0021	65	47	50	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2012	7	2							e30748	10.1371/journal.pone.0030748	http://dx.doi.org/10.1371/journal.pone.0030748			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZQ	22347400	Green Submitted, Green Published, gold			2022-12-27	WOS:000302730200007
J	Thompson, DK; Huffman, KM; Kraus, WE; Kraus, VB				Thompson, Dana K.; Huffman, Kim M.; Kraus, William E.; Kraus, Virginia Byers			Critical Appraisal of Four IL-6 Immunoassays	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; INTERLEUKIN-6; METABOLISM; DIAGNOSIS	Background: Interleukin-6 (IL-6) contributes to numerous inflammatory, metabolic, and physiologic pathways of disease. We evaluated four IL-6 immunoassays in order to identify a reliable assay for studies of metabolic and physical function. Serial plasma samples from intravenous glucose tolerance tests (IVGTTs), with expected rises in IL-6 concentrations, were used to test the face validity of the various assays. Methods and Findings: IVGTTs, administered to 14 subjects, were performed with a single infusion of glucose (0.3 g/kg body mass) at time zero, a single infusion of insulin (0.025 U/kg body mass) at 20 minutes, and frequent blood collection from time zero to 180 minutes for subsequent Il-6 measurement. The performance metrics of four IL-6 detection methods were compared: Meso Scale Discovery immunoassay (MSD), an Invitrogen Luminex bead-based multiplex panel (LX), an Invitrogen Ultrasensitive Luminex bead-based singleplex assay (ULX), and R&D High Sensitivity ELISA (R&D). IL-6 concentrations measured with MSD, R& D and ULX correlated with each other (Pearson Correlation Coefficients r = 0.47-0.94, p<0.0001) but only ULX correlated (r=0.31, p = 0.0027) with Invitrogen Luminex. MSD, R& D, and ULX, but not LX, detected increases in IL-6 in response to glucose. All plasma samples were measurable by MSD, while 35%, 1%, and 4.3% of samples were out of range when measured by LX, ULX, and R&D, respectively. Based on representative data from the MSD assay, baseline plasma IL-6 (0.90+/-0.48 pg/mL) increased significantly as expected by 90 minutes (1.29+/-0.59 pg/mL, p = 0.049), and continued rising through 3 hours (4.25+/-3.67 pg/mL, p = 0.0048). Conclusion: This study established the face validity of IL-6 measurement by MSD, R& D, and ULX but not LX, and the superiority of MSD with respect to dynamic range. Plasma IL-6 concentrations increase in response to glucose and insulin, consistent with both an early glucose-dependent response (detectable at 1-2 hours) and a late insulin-dependent response (detectable after 2 hours).	[Thompson, Dana K.; Kraus, Virginia Byers] Duke Univ, Med Ctr, Dept Med, Div Rheumatol, Durham, NC 27710 USA; [Huffman, Kim M.] Vet Affairs Med Ctr, Durham, NC USA; [Kraus, William E.] Duke Univ, Med Ctr, Dept Med, Div Cardiovasc Med, Durham, NC 27710 USA	Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Duke University	Thompson, DK (corresponding author), Duke Univ, Med Ctr, Dept Med, Div Rheumatol, Durham, NC 27710 USA.	vbk@duke.edu		Kraus, William E/0000-0003-1930-9684	National Institute on Aging at the National Institutes of Health (Claude D. Pepper Older Americans Independence Centers) [5P30 AG028716]; National Heart, Lung, and Blood Institute, National Institutes of Health (NIH) [R01HL-57354]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG028716] Funding Source: NIH RePORTER	National Institute on Aging at the National Institutes of Health (Claude D. Pepper Older Americans Independence Centers)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Heart, Lung, and Blood Institute, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by the National Institute on Aging at the National Institutes of Health (Claude D. Pepper Older Americans Independence Centers 5P30 AG028716, HJ Cohen, principal investigator). The STRRIDE project was supported by the National Heart, Lung, and Blood Institute, National Institutes of Health (NIH) (Grant R01HL-57354, WEK, principal investigator). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN DG, 1983, J ROY STAT SOC D-STA, V32, P307, DOI 10.2307/2987937; Bas S, 2004, J IMMUNOL, V172, P4470, DOI 10.4049/jimmunol.172.7.4470; Esposito K, 2002, CIRCULATION, V106, P2067, DOI 10.1161/01.CIR.0000034509.14906.AE; Fain JN, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/513948; Galic S, 2010, MOL CELL ENDOCRINOL, V316, P129, DOI 10.1016/j.mce.2009.08.018; Glund S, 2007, DIABETES, V56, P1630, DOI 10.2337/db06-1733; Gustafson B, 2010, J ATHEROSCLER THROMB, V17, P332, DOI 10.5551/jat.3939; Houmard JA, 2004, J APPL PHYSIOL, V96, P101, DOI 10.1152/japplphysiol.00707.2003; Huffman KM, 2009, DIABETES CARE, V32, P1678, DOI 10.2337/dc08-2075; Krogh-Madsen R, 2004, AM J PHYSIOL-ENDOC M, V286, pE234, DOI 10.1152/ajpendo.00274.2003; Martin H, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.4.e61; Pedersen BK, 2008, PHYSIOL REV, V88, P1379, DOI 10.1152/physrev.90100.2007; Ventetuolo CE, 2008, CLIN CHEST MED, V29, P591, DOI 10.1016/j.ccm.2008.07.001; WEI J, 1992, LIFE SCI, V51, P1953, DOI 10.1016/0024-3205(92)90112-3; Wolsk E, 2010, AM J PHYSIOL-ENDOC M, V299, pE832, DOI 10.1152/ajpendo.00328.2010; Yoshida N, 2002, BRIT J CANCER, V86, P1396, DOI 10.1038/sj.bjc.6600257	16	34	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2012	7	2							e30659	10.1371/journal.pone.0030659	http://dx.doi.org/10.1371/journal.pone.0030659			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZQ	22347395	Green Submitted, gold, Green Published			2022-12-27	WOS:000302730200006
J	Yi, L; Chandrasekaran, P; Venkatesan, S				Yi, Ling; Chandrasekaran, Prabha; Venkatesan, Sundararajan			TLR Signaling Paralyzes Monocyte Chemotaxis through Synergized Effects of p38 MAPK and Global Rap-1 Activation	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-2; CHEMOKINE RECEPTORS; BACTERIAL LIPOPOLYSACCHARIDE; NEUTROPHIL CHEMOTAXIS; DENDRITIC CELLS; PHOSPHOINOSITIDE 3-KINASE; VASCULAR ENDOTHELIUM; LYMPHOCYTE ARREST; GENE-EXPRESSION; TISSUE FACTOR	Toll-like receptors (TLRs) that recognize pathogen associated molecular patterns and chemoattractant receptors (CKRs) that orchestrate leukocyte migration to infected tissue are two arms of host innate immunity. Although TLR signaling induces synthesis and secretion of proinflammatory cytokines and chemokines, which recruit leukocytes, many studies have reported the paradoxical observation that TLR stimulation inhibits leukocyte chemotaxis in vitro and impairs their recruitment to tissues during sepsis. There is consensus that physical loss of chemokine receptor (CKR) at the RNA or protein level or receptor usage switching are the mechanisms underlying this effect. We show here that a brief (<15 min) stimulation with LPS (lipopolysaccharide) at similar to 0.2 ng/ml inhibited chemotactic response from CCR2, CXCR4 and FPR receptors in monocytes without downmodulation of receptors. A 3 min LPS pre-treatment abolished the polarized accumulation of F-actin, integrins and PIP3 (phosphatidylinositol-3,4,5-trisphosphate) in response to chemokines in monocytes, but not in polymorphonuclear neutrophils (PMNs). If chemoattractants were added before or simultaneously with LPS, chemotactic polarization was preserved. LPS did not alter the initial G-protein signaling, or endocytosis kinetics of agonist-occupied chemoattractant receptors (CKRs). The chemotaxis arrest did not result from downmodulation of receptors or from inordinate increase in adhesion. LPS induced rapid p38 MAPK activation, global redistribution of activated Rap1 (Ras-proximate-1 or Ras-related protein 1) GTPase and Rap1GEF (guanylate exchange factor) Epac1 (exchange proteins activated by cyclic AMP) and disruption of intracellular gradient. Co-inhibition of p38 MAPK and Rap1 GTPase reversed the LPS induced breakdown of chemotaxis suggesting that LPS effect requires the combined function of p38 MAPK and Rap1 GTPase.	[Yi, Ling] NIAID, Mol Cell Biol Unit, Lab Mol Immunol, Bethesda, MD 20892 USA; NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA	Yi, L (corresponding author), NIAID, Mol Cell Biol Unit, Lab Mol Immunol, 9000 Rockville Pike, Bethesda, MD 20892 USA.	sv1s@nih.gov			Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, DHHS; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000615] Funding Source: NIH RePORTER	Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, DHHS; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was funded entirely by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, DHHS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Arefieva TI, 2005, CYTOKINE, V31, P439, DOI 10.1016/j.cyto.2005.06.016; Arraes SMA, 2006, BLOOD, V108, P2906, DOI 10.1182/blood-2006-05-024638; Boettner B, 2009, CURR OPIN CELL BIOL, V21, P684, DOI 10.1016/j.ceb.2009.06.004; Bradfield PF, 2008, INT IMMUNOL, V20, P247, DOI 10.1093/intimm/dxm136; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Cathcart MK, 2009, J LIPID RES, V50, pS231, DOI 10.1194/jlr.R800096-JLR200; Constantin G, 2000, IMMUNITY, V13, P759, DOI 10.1016/S1074-7613(00)00074-1; CREAMER HR, 1991, INFLAMMATION, V15, P201, DOI 10.1007/BF00918646; Deane JA, 2004, ANNU REV IMMUNOL, V22, P563, DOI 10.1146/annurev.immunol.22.012703.104721; DOHERTY DE, 1989, J IMMUNOL, V143, P3673; Drbal K, 2000, BIOCHEM BIOPH RES CO, V275, P295, DOI 10.1006/bbrc.2000.3299; Drbal K, 2001, IMMUNOBIOLOGY, V203, P687, DOI 10.1016/S0171-2985(01)80017-6; Ebisuno Y, 2010, BLOOD, V115, P804, DOI 10.1182/blood-2009-03-211979; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; Fan J, 2003, NAT MED, V9, P315, DOI 10.1038/nm832; Faure E, 2001, J IMMUNOL, V166, P2018, DOI 10.4049/jimmunol.166.3.2018; Fergus GJ, 2007, NAT CELL BIOL, V9, P86, DOI 10.1038/ncb1517; Ferreira AM, 2006, MICROCIRCULATION, V13, P439, DOI 10.1080/10739680600776062; Fox JM, 2010, BLOOD; Gambero A, 2002, BIOCHEM PHARMACOL, V63, P65, DOI 10.1016/S0006-2952(01)00841-3; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Ghandour H, 2007, BLOOD, V110, P3682, DOI 10.1182/blood-2007-03-077628; Grabovsky V, 2000, J EXP MED, V192, P495, DOI 10.1084/jem.192.4.495; Grage-Griebenow E, 2001, J LEUKOCYTE BIOL, V69, P11; Guha M, 2001, BLOOD, V98, P1429, DOI 10.1182/blood.V98.5.1429; Hayashi F, 2003, BLOOD, V102, P2660, DOI 10.1182/blood-2003-04-1078; Heit B, 2002, J CELL BIOL, V159, P91, DOI 10.1083/jcb.200202114; Heit B, 2008, NAT IMMUNOL, V9, P743, DOI 10.1038/ni.1623; Heit B, 2008, J CELL SCI, V121, P205, DOI 10.1242/jcs.020412; HerreraVelit P, 1996, J IMMUNOL, V156, P1157; Hmama Z, 1999, J BIOL CHEM, V274, P1050, DOI 10.1074/jbc.274.2.1050; Iijima M, 2002, CELL, V109, P599, DOI 10.1016/S0092-8674(02)00745-6; Katagiri K, 2003, NAT IMMUNOL, V4, P741, DOI 10.1038/ni950; Katagiri K, 2006, NAT IMMUNOL, V7, P919, DOI 10.1038/ni1374; Khan AI, 2005, MICROCIRCULATION, V12, P421, DOI 10.1080/10739680590960368; Kinashi T, 2005, IMMUNOLOGY, V116, P164, DOI 10.1111/j.1365-2567.2005.02214.x; Li Z, 2003, CELL, V114, P215, DOI 10.1016/S0092-8674(03)00559-2; Lorenowicz MJ, 2006, J LEUKOCYTE BIOL, V80, P1542, DOI 10.1189/jlb.0506357; Luyendyk JP, 2008, J IMMUNOL, V180, P4218, DOI 10.4049/jimmunol.180.6.4218; Mahadeo DC, 2007, MOL BIOL CELL, V18, P512, DOI 10.1091/mbc.E06-05-0418; Mandal P, 2005, J IMMUNOL, V175, P6085, DOI 10.4049/jimmunol.175.9.6085; Marcos V, 2010, NAT MED, V16, P1018, DOI 10.1038/nm.2209; McKimmie CS, 2009, BLOOD, V113, P4224, DOI 10.1182/blood-2008-08-174698; Nakamura N, 2008, ATHEROSCLEROSIS, V196, P59, DOI 10.1016/j.atherosclerosis.2007.01.039; Palucka KA, 1999, J LEUKOCYTE BIOL, V65, P232, DOI 10.1002/jlb.65.2.232; Palucka KA, 1998, J IMMUNOL, V160, P4587; Parker LC, 2004, J IMMUNOL, V172, P4977, DOI 10.4049/jimmunol.172.8.4977; Pasvolsky R, 2007, J EXP MED, V204, P1571, DOI 10.1084/jem.20070058; Ponsioen B, 2009, MOL CELL BIOL, V29, P2521, DOI 10.1128/MCB.01630-08; Raab M, 2010, IMMUNITY, V32, P541, DOI 10.1016/j.immuni.2010.03.007; Randolph GJ, 1998, SCIENCE, V282, P480, DOI 10.1126/science.282.5388.480; Randolph GJ, 1999, IMMUNITY, V11, P753, DOI 10.1016/S1074-7613(00)80149-1; Rose JJ, 2008, J BIOMED SCI, V15, P441, DOI 10.1007/s11373-008-9239-x; Rose JJ, 2004, J BIOL CHEM, V279, P24372, DOI 10.1074/jbc.M401364200; Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; Schmidt A, 2001, MOL CELL BIOL, V21, P438, DOI 10.1128/MCB.21.2.438-448.2001; Servant G, 1999, MOL BIOL CELL, V10, P1163, DOI 10.1091/mbc.10.4.1163; Shamri R, 2005, NAT IMMUNOL, V6, P497, DOI 10.1038/ni1194; Shimonaka M, 2003, J CELL BIOL, V161, P417, DOI 10.1083/jcb.200301133; Sica A, 1997, J EXP MED, V185, P969, DOI 10.1084/jem.185.5.969; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Stephens L, 2002, CURR OPIN CELL BIOL, V14, P203, DOI 10.1016/S0955-0674(02)00311-3; Tester AM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000312; van Haastert PJM, 2007, J CELL BIOL, V177, P809, DOI 10.1083/jcb.200701134; Van Haastert PJM, 2004, NAT REV MOL CELL BIO, V5, P626, DOI 10.1038/nrm1435; Venkatesan S, 2003, MOL BIOL CELL, V14, P3305, DOI 10.1091/mbc.e02-11-0714; Williams LM, 2000, J IMMUNOL, V164, P2028, DOI 10.4049/jimmunol.164.4.2028; Xu JS, 2003, CELL, V114, P201, DOI 10.1016/S0092-8674(03)00555-5; Xu L, 1997, J LEUKOCYTE BIOL, V62, P653, DOI 10.1002/jlb.62.5.653; Xu LL, 2000, EUR J IMMUNOL, V30, P227, DOI 10.1002/1521-4141(200001)30:1<227::AID-IMMU227>3.0.CO;2-X	74	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2012	7	2							e30404	10.1371/journal.pone.0030404	http://dx.doi.org/10.1371/journal.pone.0030404			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZQ	22347375	Green Published, gold, Green Submitted			2022-12-27	WOS:000302730200002
J	Brand, T; Spanagel, R; Schneider, M				Brand, Theresa; Spanagel, Rainer; Schneider, Miriam			Decreased Reward Sensitivity in Rats from the Fischer344 Strain Compared to Wistar Rats Is Paralleled by Differences in Endocannabinoid Signaling	PLOS ONE			English	Article							CONDITIONED PLACE PREFERENCE; NUCLEUS-ACCUMBENS DOPAMINE; ANXIETY-RELATED BEHAVIORS; PALATABLE FOOD; CB1 RECEPTOR; BRAIN REWARD; CANNABINOIDS; COCAINE; SYSTEM; DRUG	Background: The aim of the present study was to examine if differences in the endocannabinoid (ECB) system might be linked to strain specific variations in reward-related behavior in Fischer344 (Fischer) and Wistar rats. Methodology/Principal Findings: Two rat strains, the Fischer and the Wistar strain, were tested for different aspects of reward sensitivity for a palatable food reward (sweetened condensed milk, SCM) in a limited-access intake test, a progressive ratio (PR) schedule and the pleasure-attenuated startle (PAS) paradigm. Additionally, basic differences in the ECB system and cannabinoid pharmacology were examined in both rat strains. Fischer rats were found to express lower reward sensitivity towards SCM compared to Wistar rats. These differences were observed for consummatory, motivational and hedonic aspects of the palatable food reward. Western blot analysis for the CB1 receptor and the ECB degrading enzyme fatty acid amide hydrolase (FAAH) revealed a lower expression of both proteins in the hippocampus (HPC) of Fischer rats compared to the Wistar strain. Furthermore, increased cannabinoid-stimulated extracellular-regulated kinase (ERK) phosphorylation was detected in Wistar rats compared to the Fischer strain, indicating alterations in ECB signaling. These findings were further supported by the pharmacological results, where Fischer rats were found to be less sensitive towards the effects of the CB1 receptor antagonist/inverse agonist SR141716 and the cannabinoid agonist WIN 55,212-2. Conclusions/Significance: Our present findings indicate differences in the expression of the CB1 receptor and FAAH, as well as the activation of ECB signaling pathways between Fischer and Wistar rats. These basic differences in the ECB system might contribute to the pronounced differences observed in reward sensitivity between both rat strains.	[Brand, Theresa; Schneider, Miriam] Heidelberg Univ, Res Grp Dev Neuropsychopharmacol, Inst Psychopharmacol, Cent Inst Mental Hlth,Med Fac Mannheim, D-6800 Mannheim, Germany	Central Institute of Mental Health; Ruprecht Karls University Heidelberg	Brand, T (corresponding author), Heidelberg Univ, Res Grp Dev Neuropsychopharmacol, Inst Psychopharmacol, Cent Inst Mental Hlth,Med Fac Mannheim, D-6800 Mannheim, Germany.	miriam.schneider@zi-mannheim.de			Deutsche Forschungsgemeinschaft (DFG) [SP 383/5-1, SCHN 958/3-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This study was supported by the Deutsche Forschungsgemeinschaft (DFG): Reinhart-Koselleck Award SP 383/5-1 and SCHN 958/3-1. The funder had role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold JC, 2001, BRAIN RES, V921, P240, DOI 10.1016/S0006-8993(01)03127-4; Arnold JC, 2010, LIFE SCI, V87, P572, DOI 10.1016/j.lfs.2010.09.018; Arnone M, 1997, PSYCHOPHARMACOLOGY, V132, P104, DOI 10.1007/s002130050326; Bagg HJ, 1920, INDIVIDUAL DIFFERENC; Benyamina A, 2010, ADDICT BIOL; Bergman J, 2008, PHYSIOL BEHAV, V93, P666, DOI 10.1016/j.physbeh.2007.11.007; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Berridge KC, 1996, NEUROSCI BIOBEHAV R, V20, P1, DOI 10.1016/0149-7634(95)00033-B; Bert B, 2002, NEUROBIOL LEARN MEM, V78, P11, DOI 10.1006/nlme.2001.4040; Bolanos CA, 2003, BIOL PSYCHIAT, V54, P1317, DOI 10.1016/S0006-3223(03)00570-5; BOUABOULA M, 1995, BIOCHEM J, V312, P637, DOI 10.1042/bj3120637; Cota D, 2006, BRAIN RES REV, V51, P85, DOI 10.1016/j.brainresrev.2005.10.004; Deiana S, 2007, NEUROPHARMACOLOGY, V52, P646, DOI 10.1016/j.neuropharm.2006.09.007; Derkinderen P, 2003, J NEUROSCI, V23, P2371; Di Marzo V, 2001, NATURE, V410, P822, DOI 10.1038/35071088; Egertova M, 1998, P ROY SOC B-BIOL SCI, V265, P2081, DOI 10.1098/rspb.1998.0543; Fattore L, 2007, EUR J NEUROSCI, V25, P2191, DOI 10.1111/j.1460-9568.2007.05470.x; Filbey FM, 2010, NEUROPSYCHOPHARMACOL, V35, P967, DOI 10.1038/npp.2009.200; Freeman KB, 2009, BEHAV NEUROSCI, V123, P156, DOI 10.1037/a0013727; Friemel CM, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00039; GARDNER EL, 1988, PSYCHOPHARMACOLOGY, V96, P142, DOI 10.1007/BF02431546; Gardner EL, 2005, PHARMACOL BIOCHEM BE, V81, P263, DOI 10.1016/j.pbb.2005.01.032; GOSNELL BA, 1993, PHARMACOL BIOCHEM BE, V44, P919, DOI 10.1016/0091-3057(93)90025-O; Harrold JA, 2002, BRAIN RES, V952, P232, DOI 10.1016/S0006-8993(02)03245-6; Kearns DN, 2006, BEHAV BRAIN RES, V169, P193, DOI 10.1016/j.bbr.2006.01.005; Kelley AE, 2002, PHYSIOL BEHAV, V76, P365, DOI 10.1016/S0031-9384(02)00751-5; Kirkham TC, 2009, INT REV PSYCHIATR, V21, P163, DOI 10.1080/09540260902782810; Koch M, 2000, PSYCHOPHARMACOLOGY, V152, P67, DOI 10.1007/s002130000505; Kosten TA, 1997, BRAIN RES, V778, P418, DOI 10.1016/S0006-8993(97)01205-5; Lange JHM, 2005, DRUG DISCOV TODAY, V10, P693, DOI 10.1016/S1359-6446(05)03427-6; LEPORE M, 1995, LIFE SCI, V56, P2073, DOI 10.1016/0024-3205(95)00191-8; Lopez-Moreno JA, 2010, CURR DRUG TARGETS, V11, P406, DOI 10.2174/138945010790980312; Lupica CR, 2005, NEUROPHARMACOLOGY, V48, P1105, DOI 10.1016/j.neuropharm.2005.03.016; Mahler SV, 2007, NEUROPSYCHOPHARMACOL, V32, P2267, DOI 10.1038/sj.npp.1301376; Maldonado R, 2006, TRENDS NEUROSCI, V29, P225, DOI 10.1016/j.tins.2006.01.008; McLaughlin PJ, 2006, PHARMACOL BIOCHEM BE, V83, P396, DOI 10.1016/j.pbb.2006.02.022; McLaughlin PJ, 2005, PSYCHOPHARMACOLOGY, V180, P286, DOI 10.1007/s00213-005-2171-0; Merritt LL, 2008, J PHARMACOL EXP THER, V326, P483, DOI 10.1124/jpet.108.138321; MITTLEMAN G, 1990, BEHAV NEUROSCI, V104, P399, DOI 10.1037/0735-7044.104.3.399; Palm S, 2011, ALCOHOL, V45, P607, DOI 10.1016/j.alcohol.2010.11.005; Pertwee RG, 2005, LIFE SCI, V76, P1307, DOI 10.1016/j.lfs.2004.10.025; Poncelet M, 2003, NEUROSCI LETT, V343, P216, DOI 10.1016/S0304-3940(03)00397-5; Ramos A, 1997, BEHAV BRAIN RES, V85, P57, DOI 10.1016/S0166-4328(96)00164-7; Rex A, 1996, PHARMACOL BIOCHEM BE, V54, P107, DOI 10.1016/0091-3057(95)02128-0; Rex A, 1999, BEHAV GENET, V29, P187, DOI 10.1023/A:1021644002588; RODGERS RJ, 1993, PHYSIOL BEHAV, V54, P729, DOI 10.1016/0031-9384(93)90084-S; Salamone JD, 2007, PSYCHOPHARMACOLOGY, V191, P389, DOI 10.1007/s00213-006-0623-9; Sanchis-Segura C, 2004, PSYCHOPHARMACOLOGY, V176, P223, DOI 10.1007/s00213-004-1877-8; Schmelzeis MC, 1996, BEHAV NEUROSCI, V110, P1049; Schneider M, 2008, BEHAV BRAIN RES, V189, P226, DOI 10.1016/j.bbr.2007.12.017; Schneider M, 2010, BEHAV BRAIN RES, V208, P466, DOI 10.1016/j.bbr.2009.12.013; Shepard JD, 2008, BEHAV BRAIN RES, V186, P239, DOI 10.1016/j.bbr.2007.08.013; SHOAIB M, 1995, PSYCHOPHARMACOLOGY, V117, P240, DOI 10.1007/BF02245193; Solinas M, 2008, BRIT J PHARMACOL, V154, P369, DOI 10.1038/bjp.2008.130; Solinas M, 2005, NEUROPSYCHOPHARMACOL, V30, P2035, DOI 10.1038/sj.npp.1300720; Stohr T, 1998, PHARMACOL BIOCHEM BE, V59, P813, DOI 10.1016/S0091-3057(97)00542-X; SUZUKI T, 1987, JPN J PHARMACOL, V45, P479, DOI 10.1254/jjp.45.479; Tanda G, 2000, NAT NEUROSCI, V3, P1073, DOI 10.1038/80577; Thanos PK, 2005, BEHAV BRAIN RES, V164, P206, DOI 10.1016/j.bbr.2005.06.021; Tordoff MG, 2008, PHYSIOL BEHAV, V95, P308, DOI 10.1016/j.physbeh.2008.06.010; Tracy AL, 2001, BEHAV BRAIN RES, V127, P13, DOI 10.1016/S0166-4328(01)00364-3; Tsou K, 1998, NEUROSCIENCE, V83, P393, DOI 10.1016/S0306-4522(97)00436-3; Tzschentke TM, 2000, AMINO ACIDS, V19, P211, DOI 10.1007/s007260070051; van der Stelt M, 2003, EUR J PHARMACOL, V480, P133, DOI 10.1016/j.ejphar.2003.08.101; Ward SJ, 2009, BEHAV PHARMACOL, V20, P605, DOI 10.1097/FBP.0b013e328331ba30; WARTMANN M, 1995, FEBS LETT, V359, P133, DOI 10.1016/0014-5793(95)00027-7; Yilmazer-Hanke DM, 2008, BEHAV PHARMACOL, V19, P403, DOI 10.1097/FBP.0b013e32830dc0de; Zhang PW, 2004, MOL PSYCHIATR, V9, P916, DOI 10.1038/sj.mp.4001560; Zuo LJ, 2007, BIOL PSYCHIAT, V62, P616, DOI 10.1016/j.biopsych.2006.12.004; Zuo L, 2009, NEUROPSYCHOPHARMACOL, V34, P1504, DOI 10.1038/npp.2008.206	71	22	22	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31169	10.1371/journal.pone.0031169	http://dx.doi.org/10.1371/journal.pone.0031169			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347447	Green Published, gold, Green Submitted			2022-12-27	WOS:000302730100050
J	Liu, F; Jiang, CM; Thompson, WF; Xu, Y; Yang, YF; Stewart, L				Liu, Fang; Jiang, Cunmei; Thompson, William Forde; Xu, Yi; Yang, Yufang; Stewart, Lauren			The Mechanism of Speech Processing in Congenital Amusia: Evidence from Mandarin Speakers	PLOS ONE			English	Article							GRAINED PITCH DISCRIMINATION; PHONOLOGICAL AWARENESS; TONE-DEAFNESS; LEXICAL TONES; LINGUISTIC EXPERIENCE; TUNE DEAFNESS; PERCEPTION; CHINESE; INTONATION; IDENTIFICATION	Congenital amusia is a neuro-developmental disorder of pitch perception that causes severe problems with music processing but only subtle difficulties in speech processing. This study investigated speech processing in a group of Mandarin speakers with congenital amusia. Thirteen Mandarin amusics and thirteen matched controls participated in a set of tone and intonation perception tasks and two pitch threshold tasks. Compared with controls, amusics showed impaired performance on word discrimination in natural speech and their gliding tone analogs. They also performed worse than controls on discriminating gliding tone sequences derived from statements and questions, and showed elevated thresholds for pitch change detection and pitch direction discrimination. However, they performed as well as controls on word identification, and on statement-question identification and discrimination in natural speech. Overall, tasks that involved multiple acoustic cues to communicative meaning were not impacted by amusia. Only when the tasks relied mainly on pitch sensitivity did amusics show impaired performance compared to controls. These findings help explain why amusia only affects speech processing in subtle ways. Further studies on a larger sample of Mandarin amusics and on amusics of other language backgrounds are needed to consolidate these results.	[Liu, Fang] Stanford Univ, Ctr Study Language & Informat, Stanford, CA 94305 USA; [Jiang, Cunmei] Shanghai Normal Univ, Mus Coll, Shanghai, Peoples R China; [Thompson, William Forde] Macquarie Univ, Dept Psychol, Sydney, NSW 2109, Australia; [Xu, Yi] UCL, Dept Speech Hearing & Phonet Sci, London, England; [Yang, Yufang] Chinese Acad Sci, Inst Psychol, Beijing 100101, Peoples R China; [Stewart, Lauren] Univ London, Dept Psychol, London, England	Stanford University; Shanghai Normal University; Macquarie University; University of London; University College London; Chinese Academy of Sciences; Institute of Psychology, CAS; University of London	Liu, F (corresponding author), Stanford Univ, Ctr Study Language & Informat, Stanford, CA 94305 USA.	liufang@uchicago.edu	Stewart, Lauren/HHC-2911-2022; Xu, Yi/C-4013-2008; Jiang, Jan/ABF-1730-2020; Liu, Fang/AAJ-7344-2021; Xu, Yi/M-9738-2019	Xu, Yi/0000-0002-8541-2658; Liu, Fang/0000-0002-7776-0222; Xu, Yi/0000-0002-8541-2658; stewart, lauren/0000-0002-6221-6064; Thompson, William/0000-0002-4256-1338; Jiang, Cunmei/0000-0002-0264-5924	Economic and Social Research Council [PTA-026-27-2480-A]; Center for the Study of Language and Information, Stanford University; ESRC [PTA-026-27-2480-A, ES/F001940/1] Funding Source: UKRI; Economic and Social Research Council [ES/F001940/1] Funding Source: researchfish	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Center for the Study of Language and Information, Stanford University; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This work was supported by the Economic and Social Research Council (grant number PTA-026-27-2480-A to FL). The authors would also like to thank Professor Patrick Suppes (Center for the Study of Language and Information, Stanford University) for his financial support to FL. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIKEN EG, 1974, PERCEPT PSYCHOPHYS, V15, P449, DOI 10.3758/BF03199284; Ayotte J, 2002, BRAIN, V125, P238, DOI 10.1093/brain/awf028; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Bella SD, 2009, J ACOUST SOC AM, V126, P414, DOI 10.1121/1.3132504; Bent T, 2006, J EXP PSYCHOL HUMAN, V32, P97, DOI 10.1037/0096-1523.32.1.97; Bidelman GM, 2011, J COGNITIVE NEUROSCI, V23, P425, DOI 10.1162/jocn.2009.21362; Boersma Paul, 2002, GLOT INT, V5, P341; Dowling W. J., 1986, MUSIC COGNITION; EADY SJ, 1982, LANG SPEECH, V25, P29, DOI 10.1177/002383098202500103; Foxton JM, 2004, BRAIN, V127, P801, DOI 10.1093/brain/awh105; Francis AL, 2003, J ACOUST SOC AM, V114, P1611, DOI 10.1121/1.1603231; Francis AL, 2008, J PHONETICS, V36, P268, DOI 10.1016/j.wocn.2007.06.005; Fu QJ, 1998, J ACOUST SOC AM, V104, P505, DOI 10.1121/1.423251; GANDOUR J, 1983, J PHONETICS, V11, P149, DOI 10.1016/S0095-4470(19)30813-7; GARDING E, 1986, LANG SPEECH, V29, P281, DOI 10.1177/002383098602900307; GIBSON EJ, 1963, ANNU REV PSYCHOL, V14, P29, DOI 10.1146/annurev.ps.14.020163.000333; Gillon, 2018, PHONOLOGICAL AWARENE; Goldstone RL, 1998, ANNU REV PSYCHOL, V49, P585, DOI 10.1146/annurev.psych.49.1.585; Gottfried TL, 1997, J PHONETICS, V25, P207, DOI 10.1006/jpho.1997.0042; GUION S, 2007, 2 LANGUAGE SPEECH LE, P57; Howie J. M., 1976, ACOUSTICAL STUDIES M; Hutchins S, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00236; Hyde KL, 2004, PSYCHOL SCI, V15, P356, DOI 10.1111/j.0956-7976.2004.00683.x; Jiang CM, 2011, MUSIC PERCEPT, V28, P519, DOI 10.1525/MP.2011.28.5.519; Jiang CM, 2010, NEUROPSYCHOLOGIA, V48, P2630, DOI 10.1016/j.neuropsychologia.2010.05.009; Jones JL, 2009, J COMMUN DISORD, V42, P226, DOI 10.1016/j.jcomdis.2009.01.001; Jones JL, 2009, EAR HEARING, V30, P63, DOI 10.1097/AUD.0b013e31818ff95e; KALMUS H, 1980, ANN HUM GENET, V43, P369, DOI 10.1111/j.1469-1809.1980.tb01571.x; Kishon-Rabin Liat, 2001, Journal of Basic and Clinical Physiology and Pharmacology, V12, P125; KLATT DH, 1973, J ACOUST SOC AM, V53, P8, DOI 10.1121/1.1913333; Lee CY, 2008, J PHONETICS, V36, P537, DOI 10.1016/j.wocn.2008.01.002; Liu F, 2005, PHONETICA, V62, P70, DOI 10.1159/000090090; Liu F, 2009, THESIS U CHICAGO, P187; Liu F, 2010, BRAIN, V133, P1682, DOI 10.1093/brain/awq089; Liu SY, 2004, LANG SPEECH, V47, P109, DOI 10.1177/00238309040470020101; Loui P, 2008, CURR BIOL, V18, pR331, DOI 10.1016/j.cub.2008.02.045; Loui P, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00111; Mantell JT, 2010, P 11 INT C MUS PERC, P338; Mattingly I, 1972, LANGUAGE EAR EYE, P133; Nan Y, 2010, BRAIN, V133, P2635, DOI 10.1093/brain/awq178; Patel A. D., 2008, MUSIC LANGUAGE BRAIN; Patel AD, 2005, BRAIN COGNITION, V59, P310, DOI 10.1016/j.bandc.2004.10.003; Patel AD, 1998, BRAIN LANG, V61, P123, DOI 10.1006/brln.1997.1862; Patel AD, 2008, MUSIC PERCEPT, V25, P357, DOI 10.1525/MP.2008.25.4.357; Peretz I, 2003, ANN NY ACAD SCI, V999, P58, DOI 10.1196/annals.1284.006; Peretz I, 2003, TRENDS COGN SCI, V7, P362, DOI 10.1016/S1364-6613(03)00150-5; Pfordresher P.Q., 2009, P 7 TRIENNIAL C EURO, P425; R Core Team, 2020, R LANG ENV STAT COMP; Semal C, 2006, J ACOUST SOC AM, V120, P3907, DOI 10.1121/1.2357708; Shu H, 2008, DEVELOPMENTAL SCI, V11, P171, DOI 10.1111/j.1467-7687.2007.00654.x; Siok WT, 2001, DEV PSYCHOL, V37, P886, DOI 10.1037//0012-1649.37.6.886; STAHL SA, 1994, J EDUC PSYCHOL, V86, P221, DOI 10.1037/0022-0663.86.2.221; The China National Language and Character Working Committee, 2008, LEX COMM WORDS CONT; Tillmann B, 2009, BRAIN COGNITION, V71, P259, DOI 10.1016/j.bandc.2009.08.003; WHALEN DH, 1992, PHONETICA, V49, P25, DOI 10.1159/000261901; WHALEN DH, 1987, SCIENCE, V237, P169, DOI 10.1126/science.3603014; Williamson VJ, 2010, MEMORY, V18, P657, DOI 10.1080/09658211.2010.501339; Xu Y, 1997, PSYCHOL SCI, V8, P358, DOI 10.1111/j.1467-9280.1997.tb00425.x; Xu Y, 2005, J PHONETICS, V33, P159, DOI 10.1016/j.wocn.2004.11.001; Xu Y, 1997, J PHONETICS, V25, P61, DOI 10.1006/jpho.1996.0034	60	52	54	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e30374	10.1371/journal.pone.0030374	http://dx.doi.org/10.1371/journal.pone.0030374			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	924ZP	22347374	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000302730100010
J	Montegna, EA; Bhave, M; Liu, Y; Bhattacharyya, D; Glick, BS				Montegna, Elisabeth A.; Bhave, Madhura; Liu, Yang; Bhattacharyya, Dibyendu; Glick, Benjamin S.			Sec12 Binds to Sec16 at Transitional ER Sites	PLOS ONE			English	Article							PICHIA-PASTORIS; SUBUNIT INTERACTIONS; EXIT SITES; PROTEIN; YEAST; LOCALIZATION; ORGANIZATION; ENCODES; GENES; REQUIREMENTS	COPII vesicles bud from an ER domain known as the transitional ER (tER). Assembly of the COPII coat is initiated by the transmembrane guanine nucleotide exchange factor Sec12. In the budding yeast Pichia pastoris, Sec12 is concentrated at tER sites. Previously, we found that the tER localization of P. pastoris Sec12 requires a saturable binding partner. We now show that this binding partner is Sec16, a peripheral membrane protein that functions in ER export and tER organization. One line of evidence is that overexpression of Sec12 delocalizes Sec12 to the general ER, but simultaneous overexpression of Sec16 retains overexpressed Sec12 at tER sites. Additionally, when P. pastoris Sec12 is expressed in S. cerevisiae, the exogenous Sec12 localizes to the general ER, but when P. pastoris Sec16 is expressed in the same cells, the exogenous Sec12 is recruited to tER sites. In both of these experimental systems, the ability of Sec16 to recruit Sec12 to tER sites is abolished by deleting a C-terminal fragment of Sec16. Biochemical experiments confirm that this C-terminal fragment of Sec16 binds to the cytosolic domain of Sec12. Similarly, we demonstrate that human Sec12 is concentrated at tER sites, likely due to association with a C-terminal fragment of Sec16A. These results suggest that a Sec12-Sec16 interaction has a conserved role in ER export.	[Montegna, Elisabeth A.; Liu, Yang; Glick, Benjamin S.] Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA; [Bhave, Madhura; Bhattacharyya, Dibyendu] Tata Mem Hosp, ACTREC, Kharghar, Navi Mumbai, India	University of Chicago; Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC); Tata Memorial Hospital	Montegna, EA (corresponding author), Univ Chicago, Dept Mol Genet & Cell Biol, 920 E 58Th St, Chicago, IL 60637 USA.	dbhattacharyya@actrec.gov.in; bsglick@uchicago.edu	Bhave, Madhura/AAC-5297-2020; Bhattacharyya, Dibyendu/AAE-9208-2022; Bhattacharyya, Dibyendu/GRS-5261-2022	Bhave, Madhura/0000-0001-7446-9256; Bhattacharyya, Dibyendu/0000-0003-3252-7440; Bhattacharyya, Dibyendu/0000-0003-3252-7440	National Institute of Health [R01 GM061156, T32 GM7183]; ACTREC (Advanced Centre for Treatment, Research & Education in Cancer) at the Tata Memorial Centre; Council of Scientific and Industrial Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061156, T32GM007183] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ACTREC (Advanced Centre for Treatment, Research & Education in Cancer) at the Tata Memorial Centre; Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research in the Glick lab was supported by National Institute of Health grant R01 GM061156 (BSG) and National Institute of Health training grant T32 GM7183 (EAM). Research in the Bhattacharyya lab was supported by startup funds provided by ACTREC (Advanced Centre for Treatment, Research & Education in Cancer) at the Tata Memorial Centre, and by an Indian government fellowship from the Council of Scientific and Industrial Research (MB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bannykh SI, 1997, J CELL BIOL, V138, P1, DOI 10.1083/jcb.138.1.1; BARLOWE C, 1993, NATURE, V365, P347, DOI 10.1038/365347a0; Bevis BJ, 2002, NAT CELL BIOL, V4, P750, DOI 10.1038/ncb852; Bhattacharyya D, 2007, MOL BIOL CELL, V18, P839, DOI 10.1091/mbc.E06-08-0707; Bhattacharyya D, 2010, METHODS MOL BIOL, V619, P403, DOI 10.1007/978-1-60327-412-8_24; Budnik A, 2009, FEBS LETT, V583, P3796, DOI 10.1016/j.febslet.2009.10.038; Cabantous S, 2005, NAT BIOTECHNOL, V23, P102, DOI 10.1038/nbt1044; Connerly PL, 2005, CURR BIOL, V15, P1439, DOI 10.1016/j.cub.2005.06.065; Deutschbauer AM, 2002, P NATL ACAD SCI USA, V99, P15530, DOI 10.1073/pnas.202604399; ESPENSHADE P, 1995, J CELL BIOL, V131, P311, DOI 10.1083/jcb.131.2.311; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; GIMENO RE, 1995, J CELL BIOL, V131, P325, DOI 10.1083/jcb.131.2.325; Gimeno RE, 1996, MOL BIOL CELL, V7, P1815, DOI 10.1091/mbc.7.11.1815; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; GOULD SJ, 1992, YEAST, V8, P613, DOI 10.1002/yea.320080805; HARDWICK KG, 1992, EMBO J, V11, P4187, DOI 10.1002/j.1460-2075.1992.tb05512.x; Hughes H, 2008, HISTOCHEM CELL BIOL, V129, P129, DOI 10.1007/s00418-007-0363-x; Hughes H, 2009, J CELL SCI, V122, P2924, DOI 10.1242/jcs.044032; Iinuma T, 2007, J BIOL CHEM, V282, P17632, DOI 10.1074/jbc.M611237200; Ivan V, 2008, MOL BIOL CELL, V19, P4352, DOI 10.1091/mbc.E08-03-0246; JOHNSTON M, 1984, MOL CELL BIOL, V4, P1440, DOI 10.1128/MCB.4.8.1440; Kaddoum L, 2010, BIOTECHNIQUES, V49, P727, DOI 10.2144/000113512; KUNZ J, 1993, CELL, V73, P585, DOI 10.1016/0092-8674(93)90144-F; Lee MCS, 2007, SEMIN CELL DEV BIOL, V18, P424, DOI 10.1016/j.semcdb.2007.06.007; Lukyanov KA, 2010, PHOTOCH PHOTOBIO SCI, V9, P1301, DOI 10.1039/c0pp00114g; NISHIKAWA S, 1993, P NATL ACAD SCI USA, V90, P8179, DOI 10.1073/pnas.90.17.8179; PALADE G, 1975, SCIENCE, V189, P347, DOI 10.1126/science.1096303; Papanikou E, 2009, FEBS LETT, V583, P3746, DOI 10.1016/j.febslet.2009.10.072; Payne WE, 2000, YEAST, V16, P979; Rossanese OW, 1999, J CELL BIOL, V145, P69, DOI 10.1083/jcb.145.1.69; Russell C, 2010, TRAFFIC, V11, P303, DOI 10.1111/j.1600-0854.2009.01026.x; Sears IB, 1998, YEAST, V14, P783, DOI 10.1002/(SICI)1097-0061(19980615)14:8<783::AID-YEA272>3.0.CO;2-Y; Shaywitz DA, 1997, J BIOL CHEM, V272, P25413, DOI 10.1074/jbc.272.41.25413; Shindiapina P, 2010, MOL BIOL CELL, V21, P1530, DOI 10.1091/mbc.E09-07-0605; Soderholm J, 2004, DEV CELL, V6, P649, DOI 10.1016/S1534-5807(04)00129-7; Wach A, 1996, YEAST, V12, P259, DOI 10.1002/(SICI)1097-0061(19960315)12:3<259::AID-YEA901>3.0.CO;2-C; Watson P, 2006, TRAFFIC, V7, P1678, DOI 10.1111/j.1600-0854.2006.00493.x; Weissman JT, 2001, TRAFFIC, V2, P465, DOI 10.1034/j.1600-0854.2001.20704.x; Witte K, 2011, NAT CELL BIOL, V13, P550, DOI 10.1038/ncb2225; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	40	38	38	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31156	10.1371/journal.pone.0031156	http://dx.doi.org/10.1371/journal.pone.0031156			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347445	Green Published, gold, Green Submitted			2022-12-27	WOS:000302730100048
J	Trujillo, P; Piroddi, C; Jacquet, J				Trujillo, Pablo; Piroddi, Chiara; Jacquet, Jennifer			Fish Farms at Sea: The Ground Truth from Google Earth	PLOS ONE			English	Article								In the face of global overfishing of wild-caught seafood, ocean fish farming has augmented the supply of fresh fish to western markets and become one of the fastest growing global industries. Accurate reporting of quantities of wild-caught fish has been problematic and we questioned whether similar discrepancies in data exist in statistics for farmed fish production. In the Mediterranean Sea, ocean fish farming is prevalent and stationary cages can be seen off the coasts of 16 countries using satellite imagery available through Google Earth. Using this tool, we demonstrate here that a few trained scientists now have the capacity to ground truth farmed fish production data reported by the Mediterranean countries. With Google Earth, we could examine 91% of the Mediterranean coast and count 248 tuna cages (circular cages >40 m diameter) and 20,976 other fish cages within 10 km offshore, the majority of which were off Greece (49%) and Turkey (31%). Combining satellite imagery with assumptions about cage volume, fish density, harvest rates, and seasonal capacity, we make a conservative approximation of ocean-farmed finfish production for 16 Mediterranean countries. Our overall estimate of 225,736 t of farmed finfish (not including tuna) in the Mediterranean Sea in 2006 is only slightly more than the United Nations Food and Agriculture Organization reports. The results demonstrate the reliability of recent FAO farmed fish production statistics for the Mediterranean as well as the promise of Google Earth to collect and ground truth data.	[Trujillo, Pablo; Piroddi, Chiara; Jacquet, Jennifer] Univ British Columbia, Fisheries Ctr, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Trujillo, P (corresponding author), Univ British Columbia, Fisheries Ctr, Vancouver, BC V5Z 1M9, Canada.	montebruno@gmail.com	Piroddi, Chiara/AAD-8895-2019	Piroddi, Chiara/0000-0003-2168-5830				[Anonymous], 2000, CIHEAM OPT MEDIT; Basurco B, 2001, MEDITERRANEAN AQUACU, P19; Brooks KM, 2002, RESPONSIBLE MARINE AQUACULTURE, P159, DOI 10.1079/9780851996042.0159; Chang AY, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-49; Costanzo M, 2006, ACQUACOLTURA NELLA P; Dominguez LM, 2001, AQUACULTURE, V192, P225, DOI 10.1016/S0044-8486(00)00450-6; Duarte CM, 2009, BIOSCIENCE, V59, P967, DOI 10.1525/bio.2009.59.11.8; FAO, 2022, BLUE TRANSFORMATION, DOI [DOI 10.4060/CC0461EN, 10.4060/cc0461en]; Golomazou E, 2006, TURK J VET ANIM SCI, V30, P389; Halwart M., 2007, CAGE AQUACULTURE REG, V498, P42; Jacquet J, 2010, AFR J MAR SCI, V32, P197, DOI 10.2989/1814232X.2010.501559; Kilic H., 1999, Cahiers Options Mediterraneennes, V43, P25; Lisle RJ, 2006, GEOL TODAY, V22, P29, DOI [10.1111/j.1365-2451.2006.00546.x, DOI 10.1111/J.1365-2451.2006.00546.X]; Machias A, 2006, AQUACULTURE, V261, P809, DOI 10.1016/j.aquaculture.2006.07.019; Madin EMP, 2011, SCI REP-UK, V1, DOI 10.1038/srep00014; Morretti A., 1999, MANUAL HATCHERY PROD; Naylor RL, 2000, NATURE, V405, P1017, DOI 10.1038/35016500; Paquotte P., 2000, Options Mediterraneennes. Serie B, Etudes et Recherches, P45; Roberts CM, 2002, TRENDS ECOL EVOL, V17, P242, DOI 10.1016/S0169-5347(02)02492-8; Sahin M, 1996, SEABASS BREAM FLOATI, P57; Sarusic, 2000, RIBARSTVO, V58, P111; Stephanou D, 2002, COUNTRY REPORT CYPRU, P35; Swartz W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015143; Thomas DC., 2008, AARGNEWS, V37, P22; Volpe JP, 2005, BIOSCIENCE, V55, P301, DOI 10.1641/0006-3568(2005)055[0301:DWSTBF]2.0.CO;2; Watson R, 2001, NATURE, V414, P534, DOI 10.1038/35107050	26	63	64	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e30546	10.1371/journal.pone.0030546	http://dx.doi.org/10.1371/journal.pone.0030546			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347383	Green Published, gold			2022-12-27	WOS:000302730100015
J	Gyetvai, G; Sonderkaer, M; Gobel, U; Basekow, R; Ballvora, A; Imhoff, M; Kersten, B; Nielsen, KL; Gebhardt, C				Gyetvai, Gabor; Sonderkaer, Mads; Goebel, Ulrike; Basekow, Rico; Ballvora, Agim; Imhoff, Maren; Kersten, Birgit; Nielsen, Kare-Lehman; Gebhardt, Christiane			The Transcriptome of Compatible and Incompatible Interactions of Potato (Solanum tuberosum) with Phytophthora infestans Revealed by DeepSAGE Analysis	PLOS ONE			English	Article							DIFFERENTIALLY EXPRESSED GENES; LATE BLIGHT RESISTANCE; PATHOGENESIS-RELATED PROTEIN; BROAD-SPECTRUM RESISTANCE; QUANTITATIVE RESISTANCE; DISEASE RESISTANCE; SUBTRACTIVE HYBRIDIZATION; R1 GENE; PLANT; SEQUENCE	Late blight, caused by the oomycete Phytophthora infestans, is the most important disease of potato (Solanum tuberosum). Understanding the molecular basis of resistance and susceptibility to late blight is therefore highly relevant for developing resistant cultivars, either by marker-assissted selection or by transgenic approaches. Specific P. infestans races having the Avr1 effector gene trigger a hypersensitive resistance response in potato plants carrying the R1 resistance gene (incompatible interaction) and cause disease in plants lacking R1 (compatible interaction). The transcriptomes of the compatible and incompatible interaction were captured by DeepSAGE analysis of 44 biological samples comprising five genotypes, differing only by the presence or absence of the R1 transgene, three infection time points and three biological replicates. 30.859 unique 21 base pair sequence tags were obtained, one third of which did not match any known potato transcript sequence. Two third of the tags were expressed at low frequency (<10 tag counts/million). 20.470 unitags matched to approximately twelve thousand potato transcribed genes. Tag frequencies were compared between compatible and incompatible interactions over the infection time course and between compatible and incompatible genotypes. Transcriptional changes were more numerous in compatible than in incompatible interactions. In contrast to incompatible interactions, transcriptional changes in the compatible interaction were observed predominantly for multigene families encoding defense response genes and genes functional in photosynthesis and CO2 fixation. Numerous transcriptional differences were also observed between near isogenic genotypes prior to infection with P. infestans. Our DeepSAGE transcriptome analysis uncovered novel candidate genes for plant host pathogen interactions, examples of which are discussed with respect to possible function.	[Gyetvai, Gabor; Goebel, Ulrike; Ballvora, Agim; Gebhardt, Christiane] Max Planck Inst Plant Breeding Res, Cologne, Germany; [Sonderkaer, Mads; Nielsen, Kare-Lehman] Aalborg Univ, Dept Biotechnol Chem & Environm Engn, Aalborg, Denmark; [Basekow, Rico; Imhoff, Maren; Kersten, Birgit] Max Planck Inst Mol Plant Physiol, Potsdam, Germany	Max Planck Society; Aalborg University; Max Planck Society	Gyetvai, G (corresponding author), Max Planck Inst Plant Breeding Res, Cologne, Germany.	gebhardt@mpipz.mpg.de	Nielsen, Kåre Lehmann L/A-1181-2013; Gebhardt, Chris/HGD-6090-2022	Nielsen, Kåre Lehmann L/0000-0002-5598-4401; Sonderkaer, Mads/0000-0002-9309-7459; Kersten, Birgit/0000-0001-9900-9133	Danish Strategic Research Council [2101-07-0116, 2106-07-0021]; German Federal Ministry for Education and Research [0315065B]	Danish Strategic Research Council(Danske Strategiske Forskningsrad (DSF)); German Federal Ministry for Education and Research(Federal Ministry of Education & Research (BMBF))	KLN and MS were supported by grants 2101-07-0116 and 2106-07-0021 from the Danish Strategic Research Council. BK and RB were supported by grant 0315065B from the German Federal Ministry for Education and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Armstrong MR, 2005, P NATL ACAD SCI USA, V102, P7766, DOI 10.1073/pnas.0500113102; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ballvora A, 2002, PLANT J, V30, P361, DOI 10.1046/j.1365-313X.2001.01292.x; Ballvora A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-112; Beissbarth T, 2004, BIOINFORMATICS, V20, P31, DOI 10.1093/bioinformatics/bth924; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beyer K, 2001, MOL PLANT PATHOL, V2, P125, DOI 10.1046/j.1364-3703.2001.00059.x; Birch PRJ, 1999, MOL PLANT MICROBE IN, V12, P356, DOI 10.1094/MPMI.1999.12.4.356; Bormann CA, 2003, GENETIC MOL ANAL QUA; Caillau M, 2005, PLANT J, V43, P1, DOI 10.1111/j.1365-313X.2005.02427.x; CATEN CE, 1968, CAN J BOTANY, V46, P329, DOI 10.1139/b68-055; CONSTABEL CP, 1992, PLANTA, V188, P289, DOI 10.1007/BF00192794; Diatchenko L, 1996, P NATL ACAD SCI USA, V93, P6025, DOI 10.1073/pnas.93.12.6025; Eschen-Lippold L, 2010, EUR J PLANT PATHOL, V127, P437, DOI 10.1007/s10658-010-9621-1; Foster SJ, 2009, MOL PLANT MICROBE IN, V22, P589, DOI 10.1094/MPMI-22-5-0589; FRITZEMEIER KH, 1987, PLANT PHYSIOL, V85, P34, DOI 10.1104/pp.85.1.34; Fry W, 2008, MOL PLANT PATHOL, V9, P385, DOI [10.1111/j.1364-3703.2007.00465.x, 10.1111/J.1364-3703.2007.00465.X]; Gebhardt C, 2001, ANNU REV PHYTOPATHOL, V39, P79, DOI 10.1146/annurev.phyto.39.1.79; Goellner K, 2008, EUR J PLANT PATHOL, V121, P233, DOI 10.1007/s10658-007-9251-4; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Hardcastle TJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-422; Heibges A, 2003, MOL GENET GENOMICS, V269, P526, DOI 10.1007/s00438-003-0860-0; Henriquez MA, 2010, J INTEGR PLANT BIOL, V52, P453, DOI 10.1111/j.1744-7909.2010.00943.x; Hoegen E, 2002, MOL PLANT PATHOL, V3, P329, DOI 10.1046/j.1364-3703.2002.00126.x; Huang SW, 2005, PLANT J, V42, P251, DOI 10.1111/j.1365-313X.2005.02365.x; Jones Jonathan D. G., 1992, Transgenic Research, V1, P285, DOI 10.1007/BF02525170; Judelson HS, 2000, PHYTOPATHOLOGY, V90, P1112, DOI 10.1094/PHYTO.2000.90.10.1112; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; LEONARDSSCHIPPERS C, 1992, MOL GEN GENET, V233, P278, DOI 10.1007/BF00587589; LEONARDSSCHIPPERS C, 1994, GENETICS, V137, P67; Lindqvist-Kreuze H, 2010, MOL PLANT PATHOL, V11, P513, DOI [10.1111/J.1364-3703.2010.00622.X, 10.1111/j.1364-3703.2010.00622.x]; Liu F, 2006, PLOS PATHOG, V2, P268, DOI 10.1371/journal.ppat.0020029; Lokossou AA, 2009, MOL PLANT MICROBE IN, V22, P630, DOI 10.1094/MPMI-22-6-0630; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Mangeon A, 2010, PLANT SIGNAL BEHAV, V5, P99, DOI 10.4161/psb.5.2.10336; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Mayrose M, 2006, MOL PLANT PATHOL, V7, P593, DOI [10.1111/j.1364-3703.2006.00364.x, 10.1111/J.1364-3703.2006.00364.X]; Meyer S, 2005, NUCLEIC ACIDS RES, V33, pD666, DOI 10.1093/nar/gki018; Moehs CP, 1996, PLANT MOL BIOL, V32, P447, DOI 10.1007/BF00019096; Nielsen KL, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl714; Nielsen KL, 2008, DEEPSAGE TAG BASED T, P229; Odeny DA, 2010, PLANT CELL ENVIRON, V33, P2149, DOI 10.1111/j.1365-3040.2010.02213.x; Pajerowska-Mukhtar K, 2009, GENETICS, V181, P1115, DOI 10.1534/genetics.108.094268; Pajerowska-Mukhtar KM, 2008, PLANTA, V228, P293, DOI 10.1007/s00425-008-0737-x; Pan QL, 2000, J MOL EVOL, V50, P203, DOI 10.1007/s002399910023; Restrepo S, 2005, MOL PLANT MICROBE IN, V18, P913, DOI 10.1094/MPMI-18-0913; Rickert AM, 2003, PLANT BIOTECHNOL J, V1, P399, DOI 10.1046/j.1467-7652.2003.00036.x; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Ros B, 2004, MOL PLANT PATHOL, V5, P191, DOI [10.1111/j.1364-3703.2004.00221.x, 10.1111/J.1364-3703.2004.00221.X]; Ross H., 1986, POTATO BREEDING PROB, V13, P82; Schaaf Gerben J., 2008, V387, P151; Si-Ammour A, 2003, MOL PLANT PATHOL, V4, P237, DOI 10.1046/J.1364-3703.2003.00168.X; Singh DK, 2011, TRENDS PLAN IN PRESS; Song JQ, 2003, P NATL ACAD SCI USA, V100, P9128, DOI 10.1073/pnas.1533501100; Stewart HE, 2003, PLANT PATHOL, V52, P193, DOI 10.1046/j.1365-3059.2003.00811.x; TAYLOR JL, 1990, MOL PLANT MICROBE IN, V3, P72; Trognitz F, 2002, MOL PLANT MICROBE IN, V15, P587, DOI 10.1094/MPMI.2002.15.6.587; van der Vossen E, 2003, PLANT J, V36, P867, DOI 10.1046/j.1365-313X.2003.01934.x; van der Vossen EAG, 2005, PLANT J, V44, P208, DOI 10.1111/j.1365-313X.2005.02527.x; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; van Poppel PMJA, 2008, MOL PLANT MICROBE IN, V21, P1460, DOI 10.1094/MPMI-21-11-1460; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; Vleeshouwers VGAA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002875; Vlot AC, 2008, CURR OPIN PLANT BIOL, V11, P436, DOI 10.1016/j.pbi.2008.05.003; Wan Jinrong, 2002, Funct Integr Genomics, V2, P259, DOI 10.1007/s10142-002-0080-4; Wang BL, 2005, PLANT SCI, V169, P1155, DOI 10.1016/j.plantsci.2005.07.020; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wasternack C, 2007, ANN BOT-LONDON, V100, P681, DOI 10.1093/aob/mcm079; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158; Youssef A, 2010, PLANT J, V61, P436, DOI 10.1111/j.1365-313X.2009.04067.x	72	47	49	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2012	7	2							e31526	10.1371/journal.pone.0031526	http://dx.doi.org/10.1371/journal.pone.0031526			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LV	22328937	Green Published, gold, Green Submitted			2022-12-27	WOS:000302179300023
J	Zacharias, DG; Kim, SG; Massat, AE; Bachar, AR; Oh, YK; Herrmann, J; Rodriguez-Porcel, M; Cohen, P; Lerman, LO; Lerman, A				Zacharias, David G.; Kim, Sung Gyun; Massat, Alfonso Eirin; Bachar, Adi R.; Oh, Yun K.; Herrmann, Joerg; Rodriguez-Porcel, Martin; Cohen, Pinchas; Lerman, Lilach O.; Lerman, Amir			Humanin, a Cytoprotective Peptide, Is Expressed in Carotid Artherosclerotic Plaques in Humans	PLOS ONE			English	Article							NEURONAL CELL-DEATH; APOE-DEFICIENT MICE; SMOOTH-MUSCLE-CELLS; FACTOR-KAPPA-B; ATHEROSCLEROTIC PLAQUES; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; RESCUE FACTOR; MEMORY IMPAIRMENT; JAK2/STAT3 AXIS	Objective: The mechanism of atherosclerotic plaque progression leading to instability, rupture, and ischemic manifestation involves oxidative stress and apoptosis. Humanin (HN) is a newly emerging endogenously expressed cytoprotective peptide. Our goal was to determine the presence and localization of HN in carotid atherosclerotic plaques. Methods and Results: Plaque specimens from 34 patients undergoing carotid endarterectomy were classified according to symptomatic history. Immunostaining combined with digital microscopy revealed greater expression of HN in the unstable plaques of symptomatic compared to asymptomatic patients (29.42 +/- 2.05 vs. 14.14 +/- 2.13% of plaque area, p<0.0001). These data were further confirmed by immunoblot (density of HN/beta-actin standard symptomatic vs. asymptomatic 1.32 +/- 0.14 vs. 0.79 +/- 0.11, p<0.01). TUNEL staining revealed a higher proportion of apoptotic nuclei in the plaques of symptomatic patients compared to asymptomatic (68.25 +/- 3.61 vs. 33.46 +/- 4.46% of nuclei, p, 0.01). Double immunofluorescence labeling revealed co-localization of HN with macrophages (both M1 and M2 polarization), smooth muscle cells, fibroblasts, and dendritic cells as well as with inflammatory markers MMP2 and MMP9. Conclusions: The study demonstrates a higher expression of HN in unstable carotid plaques that is localized to multiple cell types within the plaque. These data support the involvement of HN in atherosclerosis, possibly as an endogenous response to the inflammatory and apoptotic processes within the atheromatous plaque.	[Zacharias, David G.; Kim, Sung Gyun; Massat, Alfonso Eirin; Bachar, Adi R.; Oh, Yun K.; Herrmann, Joerg; Rodriguez-Porcel, Martin; Lerman, Amir] Mayo Clin, Coll Med, Dept Hypertens & Nephrol, Div Cardiovasc Dis, Rochester, MN 55902 USA; [Cohen, Pinchas] Univ Calif Los Angeles, Dept Pediat, Div Endocrinol, Mattel Childrens Hosp, Los Angeles, CA 90024 USA	Mayo Clinic; University of California System; University of California Los Angeles	Zacharias, DG (corresponding author), Mayo Clin, Coll Med, Dept Hypertens & Nephrol, Div Cardiovasc Dis, Rochester, MN 55902 USA.	lerman.amir@mayo.edu	Lerman, Lilach/M-4962-2017; 王, 强/F-4212-2011; Oh, Yun Kyu/J-5542-2012	Eirin, Alfonso/0000-0002-3864-9644	National Institutes of Health (NIH) [R00 HL88048, AG034430, GM090311, HL92954, AG31750]; National Center for Research Resources (NCRR) [1 TL1 RR024152]; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR024152] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL088048, R01HL092954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES020812] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031750, R01AG034430] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The study was supported by grants R00 HL88048 (to MR), AG034430 and GM090311 (to PC), and HL92954 and AG31750 (to AL) from the National Institutes of Health. It was also supported by Grant Number 1 TL1 RR024152 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH), and the NIH Roadmap for Medical Research. Its contents are solely the responsibility of the authors and do not necessarily represent the official view of NCRR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakawa T, 2008, CURR MED CHEM, V15, P2086, DOI 10.2174/092986708785747616; Bachar AR, 2010, CARDIOVASC RES; Bai X, 2010, VASC PHARMACOL, V52, P224, DOI 10.1016/j.vph.2010.02.001; Bonetti PO, 2003, ARTERIOSCL THROM VAS, V23, P168, DOI 10.1161/01.ATV.0000051384.43104.FC; Canault M, 2006, ATHEROSCLEROSIS, V187, P82, DOI 10.1016/j.atherosclerosis.2005.08.031; Chiba T, 2009, MOL PSYCHIATR, V14, P206, DOI 10.1038/mp.2008.105; Chiba T, 2009, EXPERT OPIN THER TAR, V13, P1155, DOI 10.1517/14728220903213426; Colon E, 2006, J CELL PHYSIOL, V208, P373, DOI 10.1002/jcp.20672; de Nigris F, 2003, TRENDS MOL MED, V9, P351, DOI 10.1016/S1471-4914(03)00139-4; Devosse T, 2009, J IMMUNOL, V182, P4974, DOI 10.4049/jimmunol.0803128; Dickhout JG, 2005, ARTERIOSCL THROM VAS, V25, P2623, DOI 10.1161/01.ATV.0000189159.96900.d9; Erbel C, 2009, J IMMUNOL, V183, P8167, DOI 10.4049/jimmunol.0901126; Fearon IM, 2009, J MOL CELL CARDIOL, V47, P372, DOI 10.1016/j.yjmcc.2009.05.013; Galkina E, 2007, CURR DRUG TARGETS, V8, P1239, DOI 10.2174/138945007783220650; Galle J, 2006, ATHEROSCLEROSIS, V185, P219, DOI 10.1016/j.atherosclerosis.2005.10.005; Garrity MM, 2003, MODERN PATHOL, V16, P389, DOI 10.1097/01.MP.0000062657.30170.92; Guo B, 2003, NATURE, V423, P456, DOI 10.1038/nature01627; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Harada M, 2004, BIOCHEM BIOPH RES CO, V324, P255, DOI 10.1016/j.bbrc.2004.09.046; Hashimoto Y, 2001, P NATL ACAD SCI USA, V98, P6336, DOI 10.1073/pnas.101133498; Hashimoto Y, 2001, BIOCHEM BIOPH RES CO, V283, P460, DOI 10.1006/bbrc.2001.4765; Hashimoto Y, 2009, MOL BIOL CELL, V20, P2864, DOI 10.1091/mbc.E09-02-0168; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Hoang PT, 2010, METABOLISM, V59, P343, DOI 10.1016/j.metabol.2009.08.001; Ikonen M, 2003, P NATL ACAD SCI USA, V100, P13042, DOI 10.1073/pnas.2135111100; Jung SS, 2003, J NEUROCHEM, V84, P266, DOI 10.1046/j.1471-4159.2003.01524.x; Katsiki N, 2010, ATHEROSCLEROSIS, V211, P9, DOI 10.1016/j.atherosclerosis.2009.12.028; Kin T, 2006, J HUM GENET, V51, P555, DOI 10.1007/s10038-006-0397-2; Lee S, 2011, J AM SOC NEPHROL, V22, P317, DOI 10.1681/ASN.2009060615; Libby P, 2009, J AM COLL CARDIOL, V54, P2129, DOI 10.1016/j.jacc.2009.09.009; Luciano F, 2005, J BIOL CHEM, V280, P15825, DOI 10.1074/jbc.M413062200; Lue YH, 2010, ENDOCRINOLOGY, V151, P350, DOI 10.1210/en.2009-0577; Lutgens E, 1999, CARDIOVASC RES, V41, P473, DOI 10.1016/S0008-6363(98)00311-3; Madamanchi NR, 2005, ARTERIOSCL THROM VAS, V25, P950, DOI 10.1161/01.ATV.0000161050.77646.68; Mannheim D, 2008, STROKE, V39, P1448, DOI 10.1161/STROKEAHA.107.503193; Mas J, 2006, NEW ENGL J MED, V355, P1660, DOI 10.1056/NEJMoa061752; Matsuoka Masaaki, 2009, Recent Pat CNS Drug Discov, V4, P37; Matsuoka M, 2010, MOL NEUROBIOL, V41, P22, DOI 10.1007/s12035-009-8090-z; Muzumdar RH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006334; Muzumdar RH, ARTERIOSCLER THROMB; Nemec KN, 2008, YONSEI MED J, V49, P689, DOI 10.3349/ymj.2008.49.5.689; Newby AC, 2009, THROMB HAEMOSTASIS, V101, P1006, DOI 10.1160/TH08-07-0469; Niikura T, 2006, CURR NEUROPHARMACOL, V4, P139, DOI 10.2174/157015906776359577; Niikura T, 2004, MOL NEUROBIOL, V30, P327, DOI 10.1385/MN:30:3:327; Niikura T, 2002, J NEUROSCI RES, V70, P380, DOI 10.1002/jnr.10354; Nishimoto I, 2004, TRENDS MOL MED, V10, P102, DOI 10.1016/j.molmed.2004.01.001; Oh YK, 2011, ATHEROSCLEROSIS, V219, P65, DOI 10.1016/j.atherosclerosis.2011.06.038; Peeters W, 2009, ARTERIOSCL THROM VAS, V29, P128, DOI 10.1161/ATVBAHA.108.173658; Redgrave JNE, 2006, CIRCULATION, V113, P2320, DOI 10.1161/CIRCULATIONAHA.105.589044; Rocha M, 2010, CURR PHARM DESIGN, V16, P3124, DOI 10.2174/138161210793292519; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sattler KJE, 2005, STROKE, V36, P14, DOI 10.1161/01.STR.0000150643.08420.78; SEEGER JM, 1995, J SURG RES, V58, P330, DOI 10.1006/jsre.1995.1051; Seimon T, 2009, J LIPID RES, V50, pS382, DOI 10.1194/jlr.R800032-JLR200; Shah PK, 2003, J AM COLL CARDIOL, V41, p15S, DOI 10.1016/S0735-1097(02)02834-6; Tajima H, 2005, J NEUROSCI RES, V79, P714, DOI 10.1002/jnr.20391; Versari D, 2006, ARTERIOSCL THROM VAS, V26, P2132, DOI 10.1161/01.ATV.0000232501.08576.73; Victor VM, 2009, CURR MED CHEM, V16, P4654, DOI 10.2174/092986709789878265; Virmani R, 2006, J AM COLL CARDIOL, V47, pC13, DOI 10.1016/j.jacc.2005.10.065; Wang YP, 2011, J AM SOC NEPHROL, V22, P21, DOI 10.1681/ASN.2010030269; Wilson SH, 2000, ATHEROSCLEROSIS, V148, P23, DOI 10.1016/S0021-9150(99)00211-7; Woollard KJ, 2010, NAT REV CARDIOL, V7, P77, DOI 10.1038/nrcardio.2009.228; Xu F, 2009, TOHOKU J EXP MED, V218, P25, DOI 10.1620/tjem.218.25; Xu XS, 2006, STROKE, V37, P2613, DOI 10.1161/01.STR.0000242772.94277.1f; Xu XS, 2010, BRAIN RES, V1355, P189, DOI 10.1016/j.brainres.2010.07.080; Yuan XM, 2010, ATHEROSCLEROSIS, V210, P392, DOI 10.1016/j.atherosclerosis.2009.11.048; Zadelaar ASM, 2005, ATHEROSCLEROSIS, V183, P244, DOI 10.1016/j.atherosclerosis.2005.03.044; Zalewski A, 2002, CIRC RES, V91, P652, DOI 10.1161/01.RES.0000038996.97287.9A; Zhai DY, 2005, J BIOL CHEM, V280, P15815, DOI 10.1074/jbc.M411902200; Zmijewski JW, 2005, AM J PHYSIOL-HEART C, V289, pH852, DOI 10.1152/ajpheart.00015.2005	70	39	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2012	7	2							e31065	10.1371/journal.pone.0031065	http://dx.doi.org/10.1371/journal.pone.0031065			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LV	22328926	Green Published, gold			2022-12-27	WOS:000302179300012
J	Zou, YH; Bao, Q; Kumar, S; Hu, M; Wang, GY; Dai, GL				Zou, Yuhong; Bao, Qi; Kumar, Sudhanshu; Hu, Min; Wang, Guo-Ying; Dai, Guoli			Four Waves of Hepatocyte Proliferation Linked with Three Waves of Hepatic Fat Accumulation during Partial Hepatectomy-Induced Liver Regeneration	PLOS ONE			English	Article							RAT-LIVER; MICE; PROGRESSION; APOPTOSIS; GROWTH	Partial hepatectomy (PH) triggers hepatocyte proliferation-mediated liver repair and is widely used to study the mechanisms governing liver regeneration in mice. However, the dynamics of the hepatocyte proliferative response to PH remain unclear. We found that PH-induced mouse liver regrowth was driven by four consecutive waves of hepatocyte replication. The first wave exhibited the highest magnitude followed by two moderate waves and one minor wave. Underlying this continuous hepatocyte replication was persistent activation of cell cycle components throughout the period of liver regeneration. Hepatocyte mitotic activity in the first three proliferative cycles showed a circadian rhythm manifested by three corresponding mitosis peaks, which were always observed at Zeitgeber time 0. The Bmal1-Clock/Wee1/Cdc2 pathway has been proposed by others to govern the circadian rhythm of hepatocyte mitosis during liver regeneration. However, we did not observe the correlations in the expression or phosphorylation of these proteins in regenerating livers. Notably, Bmal1 protein displayed frequent changes in hepatic distribution and cellular localization as the liver regrowth progressed. Further, three waves of hepatic fat accumulation occurred during hepatic regeneration. The first started before and lasted through the first round of hepatocyte proliferation, whereas the second and third occurred concomitantly with the second and third mitotic peaks, respectively. Conclusion: PH-induced liver regeneration consists of four continuous waves of hepatocyte proliferation coupled with three waves of hepatic fat accumulation. Bmal1, Wee1, and Cdc2 may not form a pathway regulating the circadian rhythm of hepatocyte mitosis during liver regeneration.	[Zou, Yuhong; Bao, Qi; Kumar, Sudhanshu; Hu, Min; Wang, Guo-Ying; Dai, Guoli] Indiana Univ Purdue Univ, Dept Biol, Ctr Regenerat Biol & Med, Sch Sci, Indianapolis, IN 46205 USA	Indiana University System; Indiana University-Purdue University Indianapolis	Zou, YH (corresponding author), Indiana Univ Purdue Univ, Dept Biol, Ctr Regenerat Biol & Med, Sch Sci, Indianapolis, IN 46205 USA.	gdai@iupui.edu			National Institute of Diabetes and Digestive and Kidney Diseases [7RO1DK07596]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075968] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a grant from the National Institute of Diabetes and Digestive and Kidney Diseases (7RO1DK07596). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brasaemle DL, 2006, SCIENCE, V313, P1581, DOI 10.1126/science.1133253; BUCHER NLR, 1963, INT REV CYTOL, V15, P245, DOI 10.1016/S0074-7696(08)61119-5; Chan KM, 1996, P NATL ACAD SCI USA, V93, P13943, DOI 10.1073/pnas.93.24.13943; Dai GL, 2008, HEPATOLOGY, V47, P1277, DOI 10.1002/hep.22129; FABRIKANT JI, 1968, J CELL BIOL, V36, P551, DOI 10.1083/jcb.36.3.551; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Fausto N, 2005, J HEPATO-BILIARY-PAN, V12, P181, DOI 10.1007/s00534-005-0979-y; Fernandez MA, 2006, SCIENCE, V313, P1628, DOI 10.1126/science.1130773; Greene AK, 2003, J INVEST SURG, V16, P99, DOI 10.1080/08941930390194424; Koniaris LG, 2003, J AM COLL SURGEONS, V197, P634, DOI 10.1016/S1072-7515(03)00374-0; Liao YJ, 2004, J BIOL CHEM, V279, P43107, DOI 10.1074/jbc.M407969200; Matsuo T, 2003, SCIENCE, V302, P255, DOI 10.1126/science.1086271; Michalopoulos GK, 2007, J CELL PHYSIOL, V213, P286, DOI 10.1002/jcp.21172; Michalopoulos GK, 2010, AM J PATHOL, V176, P2, DOI 10.2353/ajpath.2010.090675; Michalopoulos GK, 2005, ADV BIOCHEM ENG BIOT, V93, P101, DOI 10.1007/b99968; Mitchell C, 2008, NAT PROTOC, V3, P1167, DOI 10.1038/nprot.2008.80; Newberry EP, 2008, HEPATOLOGY, V48, P1097, DOI 10.1002/hep.22473; Picard C, 2002, J HEPATOL, V36, P645, DOI 10.1016/S0168-8278(02)00038-7; Rao MS, 2001, DIGEST DIS SCI, V46, P1821, DOI 10.1023/A:1010654908938; Sakamoto T, 1999, HEPATOLOGY, V29, P403, DOI 10.1002/hep.510290244; SCHOFIELD PS, 1987, BIOCHEM J, V241, P469, DOI 10.1042/bj2410469; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Shteyer E, 2004, HEPATOLOGY, V40, P1322, DOI 10.1002/hep.20462; TIJBURG LBM, 1991, BIOCHEM J, V277, P723, DOI 10.1042/bj2770723; Walldorf J, 2010, SCAND J GASTROENTERO, V45, P468, DOI 10.3109/00365520903583848; Zhang BH, 1999, J GASTROEN HEPATOL, V14, P133, DOI 10.1046/j.1440-1746.1999.01822.x; Zimmermann A, 2004, NEPHROL DIAL TRANSPL, V19, P6, DOI 10.1093/ndt/gfh1034	27	28	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e30675	10.1371/journal.pone.0030675	http://dx.doi.org/10.1371/journal.pone.0030675			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LO	22319576	Green Submitted, Green Published, gold			2022-12-27	WOS:000302178400011
J	Danforth, CM; Orfeo, T; Everse, SJ; Mann, KG; Brummel-Ziedins, KE				Danforth, Christopher M.; Orfeo, Thomas; Everse, Stephen J.; Mann, Kenneth G.; Brummel-Ziedins, Kathleen E.			Defining the Boundaries of Normal Thrombin Generation: Investigations into Hemostasis	PLOS ONE			English	Article							BLOOD-COAGULATION; ANTITHROMBIN DEFICIENCY; MODEL; TESTS; PHARMACOLOGY; PROPAGATION; INHIBITORS; SURFACE; PLASMA	In terms of its soluble precursors, the coagulation proteome varies quantitatively among apparently healthy individuals. The significance of this variability remains obscure, in part because it is the backdrop against which the hemostatic consequences of more dramatic composition differences are studied. In this study we have defined the consequences of normal range variation of components of the coagulation proteome by using a mechanism-based computational approach that translates coagulation factor concentration data into a representation of an individual's thrombin generation potential. A novel graphical method is used to integrate standard measures that characterize thrombin generation in both empirical and computational models (e.g max rate, max level, total thrombin, time to 2 nM thrombin ("clot time'')) to visualize how normal range variation in coagulation factors results in unique thrombin generation phenotypes. Unique ensembles of the 8 coagulation factors encompassing the limits of normal range variation were used as initial conditions for the computational modeling, each ensemble representing "an individual'' in a theoretical healthy population. These "individuals'' with unremarkable proteome composition was then compared to actual normal and "abnormal'' individuals, i.e. factor ensembles measured in apparently healthy individuals, actual coagulopathic individuals or artificially constructed factor ensembles representing individuals with specific factor deficiencies. A sensitivity analysis was performed to rank either individual factors or all possible pairs of factors in terms of their contribution to the overall distribution of thrombin generation phenotypes. Key findings of these analyses include: normal range variation of coagulation factors yields thrombin generation phenotypes indistinguishable from individuals with some, but not all, coagulopathies examined; coordinate variation of certain pairs of factors within their normal ranges disproportionately results in extreme thrombin generation phenotypes, implying that measurement of a smaller set of factors may be sufficient to identify individuals with aberrant thrombin generation potential despite normal coagulation proteome composition.	[Danforth, Christopher M.] Univ Vermont, Dept Math & Stat, Ctr Complex Syst, Vermont Adv Comp Ctr, Burlington, VT 05405 USA; [Orfeo, Thomas; Everse, Stephen J.; Mann, Kenneth G.; Brummel-Ziedins, Kathleen E.] Univ Vermont, Coll Med, Dept Biochem, Burlington, VT 05405 USA	University of Vermont; University of Vermont	Danforth, CM (corresponding author), Univ Vermont, Dept Math & Stat, Ctr Complex Syst, Vermont Adv Comp Ctr, Burlington, VT 05405 USA.	kathleen.brummel@uvm.edu			National Institutes of Health (NIH) [HL46703]; Department of Biochemistry, University of Vermont (UVM); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL046703] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Biochemistry, University of Vermont (UVM); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health (NIH) HL46703 project 5 to Kathleen Brummel-Ziedins and the Department of Biochemistry, University of Vermont (UVM) to Stephen J. Everse. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams TE, 2003, J THROMB HAEMOST, V1, P1024, DOI 10.1046/j.1538-7836.2003.00127.x; Anand M, 2008, J THEOR BIOL, V253, P725, DOI 10.1016/j.jtbi.2008.04.015; Anand M, 2008, J THEOR BIOL; Ansell J, 2004, CHEST, V126, p204S, DOI 10.1378/chest.126.3_suppl.204S; Ataullakhanov FI, 2005, PATHOPHYSIOL HAEMO T, V34, P60, DOI 10.1159/000089927; Bell B, 1995, Pediatr Rev, V16, P290, DOI 10.1542/pir.16-8-290; Brummel-Ziedins K, 2005, J THROMB HAEMOST, V3, P1472, DOI 10.1111/j.1538-7836.2005.01249.x; Brummel-Ziedins K., 2004, WINTROBES CLIN HEMAT, P677; Brummel-Ziedins KE, 2009, J THROMB HAEMOST, V7, P181, DOI 10.1111/j.1538-7836.2009.03426.x; Butenas S, 2004, J BIOL CHEM, V279, P22875, DOI 10.1074/jbc.M400531200; Castoldi E, 2011, THROMB RES, V127, pS21, DOI 10.1016/S0049-3848(11)70007-X; Chatterjee MS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000950; Crawley JTB, 2007, J THROMB HAEMOST, V5, P95, DOI 10.1111/j.1538-7836.2007.02500.x; Danforth CM, 2009, MATH MED BIOL, V26, P323, DOI 10.1093/imammb/dqp011; Fogelson AL, 2005, PATHOPHYSIOL HAEMO T, V34, P91, DOI 10.1159/000089930; Hall CL, 1998, ANN BIOMED ENG, V26, P28, DOI 10.1114/1.120; Hirsh J, 2004, CHEST, V126, p188S, DOI 10.1378/chest.126.3_suppl.188S; Hockin MF, 2002, J BIOL CHEM, V277, P18322, DOI 10.1074/jbc.M201173200; HOYER LW, 1994, NEW ENGL J MED, V330, P38, DOI 10.1056/NEJM199401063300108; Hron G, 2006, JAMA-J AM MED ASSOC, V296, P397, DOI 10.1001/jama.296.4.397; Khor B, 2010, AM J HEMATOL, V85, P947, DOI 10.1002/ajh.21893; Kuharsky AL, 2001, BIOPHYS J, V80, P1050, DOI 10.1016/S0006-3495(01)76085-7; Lancellotti S, 2009, SEMIN THROMB HEMOST, V35, P367, DOI 10.1055/s-0029-1225759; Luan D, 2007, PLOS COMPUT BIOL, V3, P1347, DOI 10.1371/journal.pcbi.0030142; Mann KG, 2009, HAMOSTASEOLOGIE, V29, P7; Mitrophanov AY, 2011, THROMB RES, V128, P381, DOI 10.1016/j.thromres.2011.05.013; Nair SC, 2010, HAEMOPHILIA, V16, P85, DOI 10.1111/j.1365-2516.2010.02304.x; Orfeo T, 2010, J THROMB HAEMOST, V8, P1745, DOI 10.1111/j.1538-7836.2010.03917.x; Orfeo T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027852; Panteleev MA, 2006, BIOPHYS J, V90, P1489, DOI 10.1529/biophysj.105.069062; Patnaik MM, 2008, HAEMOPHILIA, V14, P1229, DOI 10.1111/j.1365-2516.2008.01830.x; Regnault W, 2004, THROMB RES, V114, P539, DOI 10.1016/j.thromres.2004.06.017; Robert S, 2009, PHARMACOL RES, V59, P160, DOI 10.1016/j.phrs.2008.12.003; Rodgers GM, 2004, WINTROBES CLIN HEMAT, P1511; Runyon MK, 2008, J AM CHEM SOC, V130, P3458, DOI 10.1021/ja076301r; Shampine LF, SIAM J SCI COMPUTING, V18, P1; Ten Cate H, 2011, THROMBOSIS RES; van Veen JJ, 2008, BRIT J HAEMATOL, V142, P889, DOI 10.1111/j.1365-2141.2008.07267.x; Wajima T, 2009, CLIN PHARMACOL THER, V86, P290, DOI 10.1038/clpt.2009.87; Xu ZL, 2008, J R SOC INTERFACE, V5, P705, DOI 10.1098/rsif.2007.1202; Xu ZL, 2011, ARTERIOSCL THROM VAS, V31, P500, DOI 10.1161/ATVBAHA.110.213397	41	40	41	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2012	7	2							e30385	10.1371/journal.pone.0030385	http://dx.doi.org/10.1371/journal.pone.0030385			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UV	22319567	Green Submitted, Green Published, gold			2022-12-27	WOS:000301979000005
J	Curriu, M; Fausther-Bovendo, H; Pernas, M; Massanella, M; Carrillo, J; Cabrera, C; Lopez-Galindez, C; Clotet, B; Debre, P; Vieillard, V; Blanco, J				Curriu, Marta; Fausther-Bovendo, Hughes; Pernas, Maria; Massanella, Marta; Carrillo, Jorge; Cabrera, Cecilia; Lopez-Galindez, Cecilio; Clotet, Bonaventura; Debre, Patrice; Vieillard, Vincent; Blanco, Julia			Viremic HIV Infected Individuals with High CD4 T Cells and Functional Envelope Proteins Show Anti-gp41 Antibodies with Unique Specificity and Function	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NKP44L EXPRESSION; NK CYTOTOXICITY; DEPLETION; GP41; MACAQUES; APOPTOSIS; DISEASE; DEATH; AIDS	Background: CD4 T-cell decay is variable among HIV-infected individuals. In exceptional cases, CD4 T-cell counts remain stable despite high plasma viremia. HIV envelope glycoprotein (Env) properties, namely tropism, fusion or the ability to induce the NK ligand NKp44L, or host factors that modulate Env cytopathic mechanisms may be modified in such situation. Methods: We identified untreated HIV-infected individuals showing non-cytopathic replication (VL>10,000 copies/mL and CD4 T-cell decay<50 cells/mu L/year, Viremic Non Progressors, VNP) or rapid progression (CD4 T-cells<350 cells/mu L within three years post-infection, RP). We isolated full-length Env clones and analyzed their functions (tropism, fusion activity and capacity to induce NKp44L expression on CD4 cells). Anti-Env humoral responses were also analyzed. Results: Env clones isolated from VNP or RP individuals showed no major phenotypic differences. The percentage of functional clones was similar in both groups. All clones tested were CCR5-tropic and showed comparable expression and fusogenic activity. Moreover, no differences were observed in their capacity to induce NKp44L expression on CD4 T cells from healthy donors through the 3S epitope of gp41. In contrast, anti-Env antibodies showed clear functional differences: plasma from VNPs had significantly higher capacity than RPs to block NKp44L induction by autologous viruses. Consistently, CD4 T-cells isolated from VNPs showed undetectable NKp44L expression and specific antibodies against a variable region flanking the highly conserved 3S epitope were identified in plasma samples from these patients. Conversely, despite continuous antigen stimulation, VNPs were unable to mount a broad neutralizing response against HIV. Conclusions: Env functions (fusion and induction of NKp44L) were similar in viremic patients with slow or rapid progression to AIDS. However, differences in humoral responses against gp41 epitopes nearby 3S sequence may contribute to the lack of CD4 T cell decay in VNPs by blocking the induction of NKp44L by gp41.	[Curriu, Marta; Massanella, Marta; Carrillo, Jorge; Cabrera, Cecilia; Clotet, Bonaventura; Blanco, Julia] Univ Autonoma Barcelona, Hosp Germans Trias, Inst Rec Ciencies Salut Germans Trias & Pujol, IrsiCaixa HIVACAT, E-08193 Barcelona, Catalonia, Spain; [Fausther-Bovendo, Hughes; Debre, Patrice; Vieillard, Vincent] Univ Paris 06, UPMC, Hop Pitie Salpetriere, INSERM UMR S 945, Paris, France; [Pernas, Maria; Lopez-Galindez, Cecilio] Inst Salud Carlos III, CNM, Madrid, Spain; [Clotet, Bonaventura] Univ Autonoma Barcelona, Hosp Germans Trias, Inst Rec Ciencies Salut Germans Trias & Pujol, Lluita SIDA Fdn, E-08193 Barcelona, Catalonia, Spain	Autonomous University of Barcelona; Hospital Germans Trias i Pujol; Institut de Recerca de la Sida - IrsiCaixa; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Microelectronica (CNM); Instituto de Salud Carlos III; Autonomous University of Barcelona; Hospital Germans Trias i Pujol	Curriu, M (corresponding author), Univ Autonoma Barcelona, Hosp Germans Trias, Inst Rec Ciencies Salut Germans Trias & Pujol, IrsiCaixa HIVACAT, E-08193 Barcelona, Catalonia, Spain.	vincent.vieillard@upmc.fr; jblanco@irsicaixa.es	Lopez-Galindez, Cecilio/A-3603-2008; Massanella, Marta/P-8619-2016; Cabrera, Cecilia/S-1113-2019; Pernas, Maria/E-3998-2018; Vieillard, Vincent/P-3001-2017; Carrillo, Jorge/AAL-9481-2021; Blanco, Julià/A-5347-2008	Lopez-Galindez, Cecilio/0000-0002-2324-9584; Massanella, Marta/0000-0002-3326-151X; Cabrera, Cecilia/0000-0002-9941-6828; Pernas, Maria/0000-0003-2966-0160; Carrillo, Jorge/0000-0003-0221-5948; Blanco, Julià/0000-0002-2225-0217	"Fundacion para la Investigacion y Prevencion del SIDA en Espana" FIPSE [08/36725, 36558/06, 36641/07, 36779/08, 360766/09]; Health Department of the Catalan Government (Generalitat de Catalunya); Instituto de Salud Carlos III [CP04/00271, CES98/3047, CD09/00150]; Spanish AIDS network 'Red Tematica Cooperativa de Investigacion en SIDA', RIS [RD06/0006]; Merck Sharp Domme;  [SAF 2007-61036];  [SAF 2010-17226]	"Fundacion para la Investigacion y Prevencion del SIDA en Espana" FIPSE; Health Department of the Catalan Government (Generalitat de Catalunya)(Generalitat de Catalunya); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Spanish AIDS network 'Red Tematica Cooperativa de Investigacion en SIDA', RIS; Merck Sharp Domme; ; 	Spanish AIDS network 'Red Tematica Cooperativa de Investigacion en SIDA', RIS, RD06/0006 (to JB, CLG, MP and MC). "Fundacion para la Investigacion y Prevencion del SIDA en Espana" FIPSE grant 08/36725 (to CC). Health Department of the Catalan Government (Generalitat de Catalunya) and Instituto de Salud Carlos III (contracts CP04/00271 and CES98/3047 to CC and JB, respectively). Instituto de Salud Carlos III (contract CD09/00150 to JC). Work in CNM is supported by grant SAF 2007-61036 and SAF 2010-17226 and by FIPSE grants 36558/06, 36641/07, 36779/08, 360766/09. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: B. C. has received research funding from Merck Sharp & Domme and has received honoraria for speaking and serving on advisory boards from Abbott, Bristol-Myers Squibb, Boehringer-Ingelheim, Gilead Sciences, GlaxoSmithKline, Roche, Janssen-Cilag, and Merck Sharp & Domme. J.B. has received honoraria as a consultant for GlaxoSmithKline. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. All other authors: no conflicts.	Badley AD, 2000, BLOOD, V96, P2951, DOI 10.1182/blood.V96.9.2951.h8002951_2951_2964; Blanco J, 2001, VIROLOGY, V285, P356, DOI 10.1006/viro.2001.0969; BLANCO J, 1992, BRIT J PHARMACOL, V107, P671, DOI 10.1111/j.1476-5381.1992.tb14505.x; Blanco J, 2003, VIROLOGY, V305, P318, DOI 10.1006/viro.2002.1764; Blanco J, 2004, J LEUKOCYTE BIOL, V76, P804, DOI 10.1189/jlb.0204100; Casado C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011079; Choudhary SK, 2007, J VIROL, V81, P8838, DOI 10.1128/JVI.02663-06; Dalmau J, 2009, CLIN INFECT DIS, V48, P229, DOI 10.1086/595704; Denizot M, 2008, AUTOPHAGY, V4, P998, DOI 10.4161/auto.6880; Doitsh G, 2010, CELL, V143, P789, DOI 10.1016/j.cell.2010.11.001; Doria-Rose NA, 2010, J VIROL, V84, P1631, DOI 10.1128/JVI.01482-09; Etemad-Moghadam B, 2001, J VIROL, V75, P5646, DOI 10.1128/JVI.75.12.5646-5655.2001; Euler Z, 2010, J INFECT DIS, V201, P1045, DOI 10.1086/651144; Fausther-Bovendo H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000975; FREED EO, 1990, P NATL ACAD SCI USA, V87, P4650, DOI 10.1073/pnas.87.12.4650; Gandhi RT, 1998, J EXP MED, V187, P1113, DOI 10.1084/jem.187.7.1113; Garg H, 2007, J BIOL CHEM, V282, P16899, DOI 10.1074/jbc.M701701200; Gougeon ML, 2009, APOPTOSIS, V14, P501, DOI 10.1007/s10495-009-0314-1; Jensen MA, 2006, J VIROL, V80, P4698, DOI 10.1128/JVI.80.10.4698-4704.2006; Karlsson GB, 1998, J EXP MED, V188, P1159, DOI 10.1084/jem.188.6.1159; Labonte JA, 2000, J VIROL, V74, P10690, DOI 10.1128/JVI.74.22.10690-10698.2000; Lassen KG, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000377; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Li Y, 2006, J VIROL, V80, P1414, DOI 10.1128/JVI.80.3.1414-1426.2006; Lum JJ, 2003, J CLIN INVEST, V111, P1547, DOI 10.1172/JCI200316233; MALIM MH, 1988, NATURE, V335, P181, DOI 10.1038/335181a0; McCune JM, 2001, NATURE, V410, P974, DOI 10.1038/35073648; Paiardini M, 2009, ANNU REV MED, V60, P485, DOI 10.1146/annurev.med.60.041807.123753; Pietzsch J, 2010, J VIROL, V84, P5032, DOI 10.1128/JVI.00154-10; Rotger M, 2011, J CLIN INVEST; Sing T, 2007, ANTIVIR THER, V12, P1097; Sterjovski J, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-89; TERSMETTE M, 1989, LANCET, V1, P983; Vieillard V, 2005, P NATL ACAD SCI USA, V102, P10981, DOI 10.1073/pnas.0504315102; Vieillard V, 2008, P NATL ACAD SCI USA, V105, P2100, DOI 10.1073/pnas.0711629105; Vieillard V, 2008, AIDS, V22, P185, DOI 10.1097/QAD.0b013e3282f35551; Vieillard V, 2006, AIDS, V20, P1795, DOI 10.1097/01.aids.0000244198.65263.17; Vieillard V, 2010, JAIDS-J ACQ IMM DEF, V53, P564, DOI 10.1097/QAI.0b013e3181d0c5b4	38	11	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2012	7	2							e30330	10.1371/journal.pone.0030330	http://dx.doi.org/10.1371/journal.pone.0030330			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UG	22312424	Green Submitted, Green Published, gold			2022-12-27	WOS:000301977500008
J	Rigoulot, S; Pell, MD				Rigoulot, Simon; Pell, Marc D.			Seeing Emotion with Your Ears: Emotional Prosody Implicitly Guides Visual Attention to Faces	PLOS ONE			English	Article							AFFECT DECISION TASK; EVENT-RELATED FMRI; FACIAL EXPRESSIONS; HUMAN BRAIN; TIME-COURSE; ANGRY PROSODY; AUDIOVISUAL INTEGRATION; MEANINGLESS SPEECH; CROSSMODAL BINDING; FUNCTIONAL MRI	Interpersonal communication involves the processing of multimodal emotional cues, particularly facial expressions (visual modality) and emotional speech prosody (auditory modality) which can interact during information processing. Here, we investigated whether the implicit processing of emotional prosody systematically influences gaze behavior to facial expressions of emotion. We analyzed the eye movements of 31 participants as they scanned a visual array of four emotional faces portraying fear, anger, happiness, and neutrality, while listening to an emotionally-inflected pseudo-utterance (Someone migged the pazing) uttered in a congruent or incongruent tone. Participants heard the emotional utterance during the first 1250 milliseconds of a five-second visual array and then performed an immediate recall decision about the face they had just seen. The frequency and duration of first saccades and of total looks in three temporal windows ([0-1250 ms], [1250-2500 ms], [2500-5000 ms]) were analyzed according to the emotional content of faces and voices. Results showed that participants looked longer and more frequently at faces that matched the prosody in all three time windows (emotion congruency effect), although this effect was often emotion-specific (with greatest effects for fear). Effects of prosody on visual attention to faces persisted over time and could be detected long after the auditory information was no longer present. These data imply that emotional prosody is processed automatically during communication and that these cues play a critical role in how humans respond to related visual cues in the environment, such as facial expressions.	[Rigoulot, Simon; Pell, Marc D.] McGill Univ, Fac Med, Sch Commun Sci & Disorders, Montreal, PQ, Canada; [Rigoulot, Simon; Pell, Marc D.] McGill Ctr Res Brain Language & Mus, Montreal, PQ, Canada	McGill University	Rigoulot, S (corresponding author), McGill Univ, Fac Med, Sch Commun Sci & Disorders, Montreal, PQ, Canada.	simon.rigoulot@mcgill.ca	Pell, Marc D./AAL-3121-2021; Rigoulot, Simon/ABF-5776-2020	Pell, Marc D./0000-0002-9947-1552; 				Aue T, 2011, PSYCHOPHYSIOLOGY, V48, P385, DOI 10.1111/j.1469-8986.2010.01064.x; Bach DR, 2008, NEUROIMAGE, V42, P919, DOI 10.1016/j.neuroimage.2008.05.034; Batty M, 2003, COGNITIVE BRAIN RES, V17, P613, DOI 10.1016/S0926-6410(03)00174-5; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Becker MW, 2009, Q J EXP PSYCHOL, V62, P1257, DOI 10.1080/17470210902725753; Borod JC, 2000, COGNITION EMOTION, V14, P193, DOI 10.1080/026999300378932; Bostanov V, 2004, PSYCHOPHYSIOLOGY, V41, P259, DOI 10.1111/j.1469-8986.2003.00142.x; Bradley BP, 1998, COGNITION EMOTION, V12, P737, DOI 10.1080/026999398379411; Brosch T, 2008, COGNITION, V106, P1497, DOI 10.1016/j.cognition.2007.05.011; Brosch T, 2007, EMOTION, V7, P685, DOI 10.1037/1528-3542.7.3.685; Brosch T, 2009, J COGNITIVE NEUROSCI, V21, P1670, DOI 10.1162/jocn.2009.21110; Buchanan TW, 2007, PSYCHOL BULL, V133, P761, DOI 10.1037/0033-2909.133.5.761; Calder AJ, 2005, NAT REV NEUROSCI, V6, P641, DOI 10.1038/nrn1724; Calvert GA, 2000, CURR BIOL, V10, P649, DOI 10.1016/S0960-9822(00)00513-3; Calvert GA, 1998, TRENDS COGN SCI, V2, P247, DOI 10.1016/S1364-6613(98)01189-9; Calvo MG, 2006, COGNITION EMOTION, V20, P785, DOI 10.1080/02699930500465224; Calvo MG, 2009, COGN AFFECT BEHAV NE, V9, P398, DOI 10.3758/CABN.9.4.398; Calvo MG, 2005, J EXP PSYCHOL HUMAN, V31, P502, DOI 10.1037/0096-1523.31.3.502; Campanella S, 2007, TRENDS COGN SCI, V11, P535, DOI 10.1016/j.tics.2007.10.001; Collignon O, 2008, BRAIN RES, V1242, P126, DOI 10.1016/j.brainres.2008.04.023; Compton Rebecca J, 2003, Behav Cogn Neurosci Rev, V2, P115, DOI 10.1177/1534582303002002003; Dara C, 2008, BRAIN RES, V1188, P100, DOI 10.1016/j.brainres.2007.10.034; de Gelder B, 2000, COGNITION EMOTION, V14, P289, DOI 10.1080/026999300378824; de Gelder B, 1999, NEUROSCI LETT, V260, P133, DOI 10.1016/S0304-3940(98)00963-X; Dolan RJ, 2001, P NATL ACAD SCI USA, V98, P10006, DOI 10.1073/pnas.171288598; Eastwood JD, 2001, PERCEPT PSYCHOPHYS, V63, P1004, DOI 10.3758/BF03194519; EKMAN P, 1992, PSYCHOL REV, V99, P550, DOI 10.1037/0033-295X.99.3.550; Esslen M, 2004, NEUROIMAGE, V21, P1189, DOI 10.1016/j.neuroimage.2003.10.001; Ethofer T, 2006, NEUROIMAGE, V30, P580, DOI 10.1016/j.neuroimage.2005.09.059; Ethofer T, 2006, PROG BRAIN RES, V156, P345, DOI 10.1016/S0079-6123(06)56019-4; Ethofer T, 2006, HUM BRAIN MAPP, V27, P707, DOI 10.1002/hbm.20212; Ethofer T, 2009, CURR BIOL, V19, P1028, DOI 10.1016/j.cub.2009.04.054; Fox E, 2000, COGNITION EMOTION, V14, P61, DOI 10.1080/026999300378996; Fox E, 2006, EMOTION, V6, P534, DOI 10.1037/1528-3542.6.3.534; Frischen A, 2008, PSYCHOL BULL, V134, P662, DOI 10.1037/0033-2909.134.5.662; Gleitman LR, 2007, J MEM LANG, V57, P544, DOI 10.1016/j.jml.2007.01.007; Grandjean D, 2005, NAT NEUROSCI, V8, P145, DOI 10.1038/nn1392; Green MJ, 2003, COGNITION EMOTION, V17, P779, DOI 10.1080/02699930302282; Hietanen J, 2004, EUR J COGN PSYCHOL, V16, P769, DOI 10.1080/09541440340000330; Huettig F, 2005, COGNITION, V96, pB23, DOI 10.1016/j.cognition.2004.10.003; Juslin PN, 2003, PSYCHOL BULL, V129, P770, DOI 10.1037/0033-2909.129.5.770; Juth P, 2005, EMOTION, V5, P379, DOI 10.1037/1528-3542.5.4.379; Kamachi M, 2003, CURR BIOL, V13, P1709, DOI 10.1016/j.cub.2003.09.005; Kensinger EA, 2009, EMOT REV, V1, P99, DOI 10.1177/1754073908100432; Kiss M, 2008, PSYCHOPHYSIOLOGY, V45, P240, DOI 10.1111/j.1469-8986.2007.00611.x; LANG PJ, 1993, PSYCHOPHYSIOLOGY, V30, P261, DOI 10.1111/j.1469-8986.1993.tb03352.x; Leppanen JM, 2004, PSYCHOL RES-PSYCH FO, V69, P22, DOI 10.1007/s00426-003-0157-2; Massaro DW, 1996, PSYCHON B REV, V3, P215, DOI 10.3758/BF03212421; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; Niedenthal PM, 2007, SCIENCE, V316, P1002, DOI 10.1126/science.1136930; Niedenthal PM, 1999, PSYCHOL REV, V106, P337, DOI 10.1037/0033-295X.106.2.337; Noppeney U, 2010, J NEUROSCI, V30, P7434, DOI 10.1523/JNEUROSCI.0455-10.2010; Nygaard LC, 2008, J EXP PSYCHOL HUMAN, V34, P1017, DOI 10.1037/0096-1523.34.4.1017; Ohman A, 2001, J PERS SOC PSYCHOL, V80, P381, DOI 10.1037//0022-3514.80.3.381; P Boersma, 2010, PRAAT VERSION 5 2 03; Palermo R, 2007, NEUROPSYCHOLOGIA, V45, P75, DOI 10.1016/j.neuropsychologia.2006.04.025; Park JY, 2010, CORTEX, V46, P161, DOI 10.1016/j.cortex.2008.06.008; Paulmann S, 2008, NEUROREPORT, V19, P209, DOI 10.1097/WNR.0b013e3282f454db; Paulmann S, 2012, SPEECH COMMUN, V54, P92, DOI 10.1016/j.specom.2011.07.004; Paulmann S, 2011, MOTIV EMOTION, V35, P192, DOI 10.1007/s11031-011-9206-0; Paulmann S, 2010, COGN AFFECT BEHAV NE, V10, P230, DOI 10.3758/CABN.10.2.230; Paulmann S, 2009, NEUROREPORT, V20, P1603, DOI 10.1097/WNR.0b013e3283320e3f; Paulmann S, 2009, J PSYCHOPHYSIOL, V23, P63, DOI 10.1027/0269-8803.23.2.63; Peelen MV, 2010, J NEUROSCI, V30, P10127, DOI 10.1523/JNEUROSCI.2161-10.2010; Pell MD, 2008, SPEECH COMMUN, V50, P519, DOI 10.1016/j.specom.2008.03.006; Pell MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027256; Pell MD, 2011, COGNITION EMOTION, V25, P834, DOI 10.1080/02699931.2010.516915; Pell MD, 2009, J PHONETICS, V37, P417, DOI 10.1016/j.wocn.2009.07.005; Pell MD, 1997, BRAIN LANG, V57, P80, DOI 10.1006/brln.1997.1638; Pell MD, 2005, J NONVERBAL BEHAV, V29, P193, DOI 10.1007/s10919-005-7720-z; Pell MD, 2005, J NONVERBAL BEHAV, V29, P45, DOI 10.1007/s10919-004-0889-8; Pourtois G, 2000, NEUROREPORT, V11, P1329, DOI 10.1097/00001756-200004270-00036; Pourtois G, 2005, CORTEX, V41, P49, DOI 10.1016/S0010-9452(08)70177-1; Pourtois G, 2004, CEREB CORTEX, V14, P619, DOI 10.1093/cercor/bhh023; Pourtois G, 2002, COGNITIVE BRAIN RES, V14, P99, DOI 10.1016/S0926-6410(02)00064-2; Pourtois G, 2006, NEUROIMAGE, V31, P920, DOI 10.1016/j.neuroimage.2005.12.034; R Rosenthal, 1991, APPL SOC RES METHODS, V6, P19; Reinders AATS, 2006, NEUROIMAGE, V33, P805, DOI 10.1016/j.neuroimage.2006.06.052; Reynolds MG, 2009, VIS COGN, V17, P318, DOI 10.1080/13506280701623704; Russell JA, 2003, ANNU REV PSYCHOL, V54, P329, DOI 10.1146/annurev.psych.54.101601.145102; Sauter DA, 2010, J COGNITIVE NEUROSCI, V22, P474, DOI 10.1162/jocn.2009.21215; SCHERER KR, 1991, MOTIV EMOTION, V15, P123, DOI 10.1007/BF00995674; Schirmer A, 2006, TRENDS COGN SCI, V10, P24, DOI 10.1016/j.tics.2005.11.009; Schirmer A, 2002, COGNITIVE BRAIN RES, V14, P228, DOI 10.1016/S0926-6410(02)00108-8; Schirmer A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009080; Seubert J, 2010, NEUROIMAGE, V53, P746, DOI 10.1016/j.neuroimage.2010.07.012; Seyfarth RM, 2009, P NATL ACAD SCI USA, V106, P669, DOI 10.1073/pnas.0811894106; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Spreckelmeyer KN, 2009, BRAIN COGNITION, V69, P121, DOI 10.1016/j.bandc.2008.06.003; Spruyt A, 2007, MEM COGNITION, V35, P95, DOI 10.3758/BF03195946; SUMMERFIELD Q, 1979, PHONETICA, V36, P314, DOI 10.1159/000259969; Swerts M., 2009, INT J SPEECH LANGUAG, V11, P282; TANENHAUS MK, 1995, SCIENCE, V268, P1632, DOI 10.1126/science.7777863; Thonnessen H, 2010, NEUROIMAGE, V50, P250, DOI 10.1016/j.neuroimage.2009.11.082; Tipples J, 2002, EMOTION, V2, P288, DOI 10.1037/1528-3542.2.3.288; VASEY MW, 1987, PSYCHOPHYSIOLOGY, V24, P479, DOI 10.1111/j.1469-8986.1987.tb00324.x; Vroomen J, 2000, J EXP PSYCHOL HUMAN, V26, P1583, DOI 10.1037/0096-1523.26.5.1583; Vroomen J, 2001, COGN AFFECT BEHAV NE, V1, P382, DOI 10.3758/CABN.1.4.382; Vuilleumier P, 2007, NEUROPSYCHOLOGIA, V45, P174, DOI 10.1016/j.neuropsychologia.2006.06.003; Weymar M, 2009, PSYCHOPHYSIOLOGY, V46, P1200, DOI 10.1111/j.1469-8986.2009.00869.x; Whalen PJ, 2001, EMOTION, V1, P70, DOI 10.1037/1528-3542.1.1.70; Williams MA, 2005, VIS COGN, V12, P29, DOI 10.1080/13506280444000193; Wittfoth M, 2010, CEREB CORTEX, V20, P383, DOI 10.1093/cercor/bhp106; Zhang Q, 2010, BRAIN RES, V1329, P142, DOI 10.1016/j.brainres.2010.03.021; ZUCKERMAN M, 1975, J PERS SOC PSYCHOL, V32, P1068, DOI 10.1037/0022-3514.32.6.1068	105	35	38	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2012	7	1							e30740	10.1371/journal.pone.0030740	http://dx.doi.org/10.1371/journal.pone.0030740			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	912BU	22303454	Green Published, gold			2022-12-27	WOS:000301770300004
J	Shimazawa, M; Ito, Y; Inokuchi, Y; Yamanaka, H; Nakanishi, T; Hayashi, T; Ji, B; Higuchi, M; Suhara, T; Imamura, K; Araie, M; Watanabe, Y; Onoe, H; Hara, H				Shimazawa, Masamitsu; Ito, Yasushi; Inokuchi, Yuta; Yamanaka, Hajime; Nakanishi, Tomohiro; Hayashi, Takuya; Ji, Bin; Higuchi, Makoto; Suhara, Tetsuya; Imamura, Kazuyuki; Araie, Makoto; Watanabe, Yasuyoshi; Onoe, Hirotaka; Hara, Hideaki			An Alteration in the Lateral Geniculate Nucleus of Experimental Glaucoma Monkeys: In vivo Positron Emission Tomography Imaging of Glial Activation	PLOS ONE			English	Article							PERIPHERAL BENZODIAZEPINE-RECEPTOR; PRIMARY VISUAL-CORTEX; OPEN-ANGLE GLAUCOMA; OPTIC-NERVE; MICROGLIAL ACTIVATION; PARVOCELLULAR LAYERS; MULTIPLE-SCLEROSIS; GANGLION-CELLS; BINDING-SITES; DISEASE	We examined lateral geniculate nucleus (LGN) degeneration as an indicator for possible diagnosis of glaucoma in experimental glaucoma monkeys using positron emission tomography (PET). Chronic intraocular pressure (IOP) elevation was induced by laser trabeculoplasty in the left eyes of 5 cynomolgus monkeys. Glial cell activation was detected by PET imaging with [C-11]PK11195, a PET ligand for peripheral-type benzodiazepine receptor (PBR), before and at 4 weeks after laser treatment (moderate glaucoma stage). At mild, moderate, and advanced experimental glaucoma stages (classified by histological changes based on the extent of axonal loss), brains were stained with cresyl violet, or antibodies against PBR, Iba-1 (a microglial marker), and GFAP (an activated astrocyte marker). In laser-treated eyes, IOP was persistently elevated throughout all observation periods. PET imaging showed increased [C-11]PK11195 binding potential in the bilateral LGN at 4 weeks after laser treatment; the increase in the ipsilateral LGN was statistically significant (P<0.05, n = 4). Immunostaining showed bilateral activations of microglia and astrocytes in LGN layers receiving input from the laser-treated eye. PBR-positive cells were observed in LGN layers receiving input from laser-treated eye at all experimental glaucoma stages including the mild glaucoma stage and their localization coincided with Iba-1 positive microglia and GFAP-positive astrocytes. These data suggest that glial activation occurs in the LGN at a mild glaucoma stage, and that the LGN degeneration could be detected by a PET imaging with [C-11]PK11195 during the moderate experimental glaucoma stage after unilateral ocular hypertension. Therefore, activated glial markers such as PBR in the LGN may be useful in noninvasive molecular imaging for diagnosis of glaucoma.	[Shimazawa, Masamitsu; Ito, Yasushi; Inokuchi, Yuta; Nakanishi, Tomohiro; Hara, Hideaki] Gifu Pharmaceut Univ, Dept Biofunct Evaluat, Gifu, Japan; [Yamanaka, Hajime; Hayashi, Takuya; Watanabe, Yasuyoshi; Onoe, Hirotaka] RIKEN Ctr Mol Imaging Sci, Kobe, Hyogo, Japan; [Ji, Bin; Higuchi, Makoto; Suhara, Tetsuya] Natl Inst Radiol Sci, Mol Imaging Ctr, Chiba 260, Japan; [Imamura, Kazuyuki] Maebashi Inst Technol, Dept Syst Life Engn, Maibashi, Japan; [Araie, Makoto] Univ Tokyo, Sch Med, Dept Ophthalmol, Tokyo 113, Japan	Gifu Pharmaceutical University; RIKEN; National Institutes for Quantum Science & Technology; University of Tokyo	Shimazawa, M (corresponding author), Gifu Pharmaceut Univ, Dept Biofunct Evaluat, Gifu, Japan.	hidehara@gifu-pu.ac.jp	Hayashi, Takuya/A-1634-2011	Hayashi, Takuya/0000-0001-7639-0197	Ministry of Education, Culture, Sports, science, and Technology, Japan [21592262]	Ministry of Education, Culture, Sports, science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported in part by grants from the Molecular Imaging Program on "Research Base for Exploring New Drugs" from the Ministry of Education, Culture, Sports, science, and Technology, Japan, and from Grant-in-Aid for Scientific Research (C) (No. 21592262) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	ANHOLT RRH, 1986, J BIOL CHEM, V261, P576; Banati RB, 2000, BRAIN, V123, P2321, DOI 10.1093/brain/123.11.2321; BENAVIDES J, 1984, EUR J PHARMACOL, V99, P1, DOI 10.1016/0014-2999(84)90425-4; Cagnin A, 2001, LANCET, V358, P461, DOI 10.1016/S0140-6736(01)05625-2; Chen MK, 2004, BRAIN, V127, P1379, DOI 10.1093/brain/awh161; Duncan RO, 2007, INVEST OPHTH VIS SCI, V48, P733, DOI 10.1167/iovs.06-0773; Gerhard A, 2006, NEUROBIOL DIS, V21, P404, DOI 10.1016/j.nbd.2005.08.002; Gupta N, 2006, BRIT J OPHTHALMOL, V90, P674, DOI 10.1136/bjo.2005.086769; Gupta N, 2009, BRIT J OPHTHALMOL, V93, P56, DOI 10.1136/bjo.2008.138172; Howell GR, 2007, J CELL BIOL, V179, P1523, DOI 10.1083/jcb.200706181; Imamura K, 2009, NEUROREPORT, V20, P139, DOI 10.1097/WNR.0b013e32831d7f82; Ito Y, 2009, EXP EYE RES, V89, P246, DOI 10.1016/j.exer.2009.03.013; Kerrigan LA, 1997, ARCH OPHTHALMOL-CHIC, V115, P1031, DOI 10.1001/archopht.1997.01100160201010; Lam D, 2009, MOL VIS, V15, P2217; Lammertsma AA, 1996, NEUROIMAGE, V4, P153, DOI 10.1006/nimg.1996.0066; McGeer PL, 2003, ANN NEUROL, V54, P599, DOI 10.1002/ana.10728; Papadopoulos V, 2006, TRENDS PHARMACOL SCI, V27, P402, DOI 10.1016/j.tips.2006.06.005; Pavese N, 2006, NEUROLOGY, V66, P1638, DOI 10.1212/01.wnl.0000222734.56412.17; Qing GP, 2010, INVEST OPHTH VIS SCI, V51, P4627, DOI 10.1167/iovs.09-4834; QUIGLEY HA, 1983, INVEST OPHTH VIS SCI, V24, P1305; QUIGLEY HA, 1995, INVEST OPHTH VIS SCI, V36, P774; SANCHEZ RM, 1986, INVEST OPHTH VIS SCI, V27, P1342; Sasaoka M, 2008, EXP EYE RES, V86, P770, DOI 10.1016/j.exer.2008.02.004; SHAH F, 1994, NUCL MED BIOL, V21, P573, DOI 10.1016/0969-8051(94)90022-1; Shimazawa M, 2006, EXP EYE RES, V82, P427, DOI 10.1016/j.exer.2005.08.001; Vowinckel E, 1997, J NEUROSCI RES, V50, P345, DOI 10.1002/(SICI)1097-4547(19971015)50:2<345::AID-JNR22>3.0.CO;2-5; Weber AJ, 2000, INVEST OPHTH VIS SCI, V41, P1370; Whitmore AV, 2005, PROG RETIN EYE RES, V24, P639, DOI 10.1016/j.preteyeres.2005.04.004; Yucel YH, 2001, INVEST OPHTH VIS SCI, V42, P3216; Yucel YH, 2000, ARCH OPHTHALMOL-CHIC, V118, P378	30	27	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e30526	10.1371/journal.pone.0030526	http://dx.doi.org/10.1371/journal.pone.0030526			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22299044	Green Published, Green Submitted, gold			2022-12-27	WOS:000301704200021
J	Gori, A; Cerboneschi, M; Tegli, S				Gori, Andrea; Cerboneschi, Matteo; Tegli, Stefania			High-Resolution Melting Analysis as a Powerful Tool to Discriminate and Genotype Pseudomonas savastanoi Pathovars and Strains	PLOS ONE			English	Article							SYRINGAE SUBSP SAVASTANOI; REAL-TIME PCR; PV. SAVASTANOI; CURVE ANALYSIS; RAPID IDENTIFICATION; SEMISELECTIVE MEDIUM; SECRETION SYSTEM; OLIVE LEAVES; POPULATIONS; EVOLUTION	Pseudomonas savastanoi is a serious pathogen of Olive, Oleander, Ash, and several other Oleaceae. Its epiphytic or endophytic presence in asymptomatic plants is crucial for the spread of Olive and Oleander knot disease, as already ascertained for P. savastanoi pv. savastanoi (Psv) on Olive and for pv. nerii (Psn) on Oleander, while no information is available for pv. fraxini (Psf) on Ash. Nothing is known yet about the distribution on the different host plants and the real host range of these pathovars in nature, although cross-infections were observed following artificial inoculations. A multiplex Real-Time PCR assay was recently developed to simultaneously and quantitatively discriminate in vitro and in planta these P. savastanoi pathovars, for routine culture confirmation and for epidemiological and diagnostical studies. Here an innovative High-Resolution Melting Analysis (HRMA)-based assay was set up to unequivocally discriminate Psv, Psn and Psf, according to several single nucleotide polymorphisms found in their Type Three Secretion System clusters. The genetic distances among 56 P. savastanoi strains belonging to these pathovars were also evaluated, confirming and refining data previously obtained by fAFLP. To our knowledge, this is the first time that HRMA is applied to a bacterial plant pathogen, and one of the few multiplex HRMA-based assays developed so far. This protocol provides a rapid, sensitive, specific tool to differentiate and detect Psv, Psn and Psf strains, also in vivo and against other related bacteria, with lower costs than conventional multiplex Real-Time PCR. Its application is particularly suitable for sanitary certification programs for P. savastanoi, aimed at avoiding the spreading of this phytopathogen through asymptomatic plants.	[Gori, Andrea; Cerboneschi, Matteo; Tegli, Stefania] Univ Florence, Dipartimento Biotecnol Agr, Lab Patol Vegetale & Mol, Florence, Italy	University of Florence	Gori, A (corresponding author), Univ Florence, Dipartimento Biotecnol Agr, Lab Patol Vegetale & Mol, Florence, Italy.	stefania.tegli@unifi.it	Gori, Andrea/AAC-6078-2022; Tegli, Stefania/K-7297-2014	Tegli, Stefania/0000-0003-1297-186X; Cerboneschi, Matteo/0000-0002-6448-2622	Ente Cassa di Risparmio di Firenze [2007.1005-2010.0972]	Ente Cassa di Risparmio di Firenze(Fondazione Cassa Risparmio Firenze)	The research project was funded by "Ente Cassa di Risparmio di Firenze'' with grant number 2007.1005-2010.0972. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Alvarez F, 1998, EUR J PLANT PATHOL, V104, P603, DOI 10.1023/A:1008604011154; Anonymous, 2006, Bulletin OEPP, V36, P77; AZAD HR, 1995, PHYTOPATHOLOGY, V85, P740, DOI 10.1094/Phyto-85-740; Bella P, 2008, PHYTOPATHOL MEDITERR, V47, P204; Bertolini E, 2003, PHYTOPATHOLOGY, V93, P286, DOI 10.1094/PHYTO.2003.93.3.286; Bertolini E, 2003, J MICROBIOL METH, V52, P261, DOI 10.1016/S0167-7012(02)00163-X; Bull CT, 2011, PHYTOPATHOLOGY, V101, P847, DOI 10.1094/PHYTO-11-10-0318; Bull CT, 2010, SYST APPL MICROBIOL, V33, P105, DOI 10.1016/j.syapm.2010.02.001; Caccamo D, 1999, RES MICROBIOL, V150, P221, DOI 10.1016/S0923-2508(99)80039-4; Caponero A, 1995, PLANT PATHOL, V44, P848, DOI 10.1111/j.1365-3059.1995.tb02744.x; Casano FJ, 1986, EPPO B, V17, P173; Castellanos E, 2010, CLIN MICROBIOL INFEC, V16, P1659, DOI 10.1111/j.1469-0691.2010.03198.x; Cazorla FM, 2002, PHYTOPATHOLOGY, V92, P909, DOI 10.1094/PHYTO.2002.92.8.909; De Koeyer D, 2010, MOL BREEDING, V25, P67, DOI 10.1007/s11032-009-9309-4; ERCOLANI G. L., 1971, Phytopathologia Mediterranea, V10, P130; ERCOLANI GL, 1983, J GEN MICROBIOL, V129, P901; ERCOLANI GL, 1978, J GEN MICROBIOL, V109, P245, DOI 10.1099/00221287-109-2-245; ERCOLANI GL, 1991, MICROBIAL ECOL, V21, P35, DOI 10.1007/BF02539143; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; GARDAN L, 1992, INT J SYST BACTERIOL, V42, P606, DOI 10.1099/00207713-42-4-606; Garritano S, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-5; Gundry CN, 2003, CLIN CHEM, V49, P396, DOI 10.1373/49.3.396; Hewson K, 2009, ARCH VIROL, V154, P649, DOI 10.1007/s00705-009-0357-1; Hoek KGP, 2008, J CLIN MICROBIOL, V46, P1369, DOI 10.1128/JCM.02343-07; Hofinger BJ, 2009, THEOR APPL GENET, V119, P851, DOI 10.1007/s00122-009-1094-2; Iacobellis N. S., 1995, Phytopathologia Mediterranea, V34, P15; Iacobellis NS, 1998, PLANT PATHOL, V47, P73, DOI 10.1046/j.1365-3059.1998.00202.x; Jackson RW, 2011, TRENDS GENET, V27, P32, DOI 10.1016/j.tig.2010.10.001; JANSE JD, 1982, INT J SYST BACTERIOL, V32, P166, DOI 10.1099/00207713-32-2-166; JANSE JD, 1991, SYST APPL MICROBIOL, V14, P79, DOI 10.1016/S0723-2020(11)80365-6; Jeffery N, 2007, MICROBIOL-SGM, V153, P2679, DOI 10.1099/mic.0.2006/005140-0; Jeong HJ, 2010, GENOME, V53, P1029, DOI 10.1139/G10-094; KING EO, 1954, J LAB CLIN MED, V44, P301; Krid S, 2009, J APPL MICROBIOL, V106, P886, DOI 10.1111/j.1365-2672.2008.04058.x; Krypuy M, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-168; Krypuy M, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-295; Lavermicocca P, 1987, PHYTOPATHOLMEDITERR, V26, P136; Liew M, 2006, J MOL DIAGN, V8, P97, DOI 10.2353/jmoldx.2006.050053; Mackay JF, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-8; Mao F, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-76; Marchi G, 2009, PLANT PATHOL, V58, P152, DOI 10.1111/j.1365-3059.2008.01935.x; Matas IM, 2009, APPL ENVIRON MICROB, V75, P1030, DOI 10.1128/AEM.01572-08; McCann HC, 2008, NEW PHYTOL, V177, P33, DOI 10.1111/j.1469-8137.2007.02293.x; McKinney J. T., 2010, The handbook of plant mutation screening: mining of natural and induced alleles, P149, DOI 10.1002/9783527629398.ch9; Montgomery J, 2007, NAT PROTOC, V2, P59, DOI 10.1038/nprot.2007.10; MUGNAI L, 1994, J PHYTOPATHOL, V142, P209, DOI 10.1111/j.1439-0434.1994.tb04531.x; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nasereddin A, 2010, J CLIN MICROBIOL, V48, P2240, DOI 10.1128/JCM.00553-10; Nei M., 2000, MOL EVOLUTION PHYLOG; Parkinson N, 2011, PLANT PATHOL, V60, P338, DOI 10.1111/j.1365-3059.2010.02366.x; Penyalver R, 2000, APPL ENVIRON MICROB, V66, P2673, DOI 10.1128/AEM.66.6.2673-2677.2000; Pietzka AT, 2009, J ANTIMICROB CHEMOTH, V63, P1121, DOI 10.1093/jac/dkp124; Price EP, 2007, APPL ENVIRON MICROB, V73, P3431, DOI 10.1128/AEM.02702-06; Quesada JM, 2010, PLANT PATHOL, V59, P262, DOI 10.1111/j.1365-3059.2009.02200.x; Quesada JM, 2008, RES MICROBIOL, V159, P207, DOI 10.1016/j.resmic.2007.12.010; Quesada JM, 2007, INT MICROBIOL, V10, P77, DOI 10.2436/20.1501.01.11; Renick LJ, 2008, PLANT DIS, V92, P372, DOI 10.1094/PDIS-92-3-0372; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sarkar SF, 2006, GENETICS, V174, P1041, DOI 10.1534/genetics.106.060996; Sarkar SF, 2004, APPL ENVIRON MICROB, V70, P1999, DOI 10.1128/AEM.70.4.1999-2012.2004; Sawada H, 1999, J MOL EVOL, V49, P627, DOI 10.1007/PL00006584; SCHROTH MN, 1973, PHYTOPATHOLOGY, V63, P1064, DOI 10.1094/Phyto-63-1064; SCHROTH MN, 1968, PHYTOPATHOLOGY, V58, P524; Scortichini M, 2004, PLANT PATHOL, V53, P491, DOI 10.1111/j.1365-3059.2004.01051.x; Seipp Michael T, 2009, J Biomol Tech, V20, P160; Sheppard A, 2006, POLITIQUE SANITAIRE; Sisto A, 2007, PLANT PATHOL, V56, P366, DOI 10.1111/j.1365-3059.2007.01567.x; Sisto Angelo, 2002, Phytopathologia Mediterranea, V41, P63; Sneath P.H.A., 1963, NUMERICAL TAXONOMY; Steer PA, 2009, J CLIN MICROBIOL, V47, P311, DOI 10.1128/JCM.01567-08; SURICO G, 1985, PHYSIOL PLANT PATHOL, V26, P309, DOI 10.1016/0048-4059(85)90006-2; SURICO G, 1989, PHYTOPATHOLOGY, V79, P185, DOI 10.1094/Phyto-79-185; Surico G, 1992, MOL SIGNALS PLANT MI, P209; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tegli S, 2011, GENES-BASEL, V2, P957, DOI 10.3390/genes2040957; Tegli S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-156; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Toi CS, 2008, J CLIN VIROL, V43, P18, DOI 10.1016/j.jcv.2008.03.027; Wang J, 2010, CAN J MICROBIOL, V56, P676, DOI [10.1139/w10-054, 10.1139/W10-054]; Wang PW, 2007, MICROBIOL-SGM, V153, P2067, DOI 10.1099/mic.0.2006/001545-0; WILSON EE, 1964, PHYTOPATHOLOGY, V54, P576; Wittwer CT, 2003, CLIN CHEM, V49, P853, DOI 10.1373/49.6.853; Wolff BJ, 2008, ANTIMICROB AGENTS CH, V52, P3542, DOI 10.1128/AAC.00582-08; Wu SB, 2008, THEOR APPL GENET, V118, P1, DOI 10.1007/s00122-008-0870-8; Wynyard S, 2011, J VIROL METHODS, V175, P95, DOI 10.1016/j.jviromet.2011.04.026; Yan SC, 2008, APPL ENVIRON MICROB, V74, P3171, DOI 10.1128/AEM.00180-08; Young J. M., 1996, Review of Plant Pathology, V75, P721; YOUNG JM, 1994, J APPL BACTERIOL, V77, P195, DOI 10.1111/j.1365-2672.1994.tb03064.x	89	27	28	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30199	10.1371/journal.pone.0030199	http://dx.doi.org/10.1371/journal.pone.0030199			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295075	Green Submitted, Green Published, gold			2022-12-27	WOS:000301640600020
J	Lioy, VS; Machon, C; Tabone, M; Gonzalez-Pastor, JE; Daugelavicius, R; Ayora, S; Alonso, JC				Lioy, Virginia S.; Machon, Cristina; Tabone, Mariangela; Gonzalez-Pastor, Jose E.; Daugelavicius, Rimantas; Ayora, Silvia; Alonso, Juan C.			The zeta Toxin Induces a Set of Protective Responses and Dormancy	PLOS ONE			English	Article							BACILLUS-SUBTILIS SPORULATION; PROGRAMMED CELL-DEATH; ESCHERICHIA-COLI; ANTITOXIN SYSTEMS; CRYSTAL-STRUCTURE; FUNCTIONAL-ANALYSIS; NUTRITIONAL STRESS; STREPTOCOCCUS-PNEUMONIAE; STRINGENT RESPONSE; PLASMID PSM19035	The zeta epsilon module consists of a labile antitoxin protein, e, which in dimer form (epsilon(2)) interferes with the action of the long-living monomeric zeta phosphotransferase toxin through protein complex formation. Toxin zeta, which inhibits cell wall biosynthesis and may be bactericide in nature, at or near physiological concentrations induces reversible cessation of Bacillus subtilis proliferation (protective dormancy) by targeting essential metabolic functions followed by propidium iodide (PI) staining in a fraction (20-30%) of the population and selects a subpopulation of cells that exhibit non-inheritable tolerance (1-5x10(-5)). Early after induction zeta toxin alters the expression of similar to 78 genes, with the up-regulation of relA among them. RelA contributes to enforce toxin-induced dormancy. At later times, free active zeta decreases synthesis of macromolecules and releases intracellular K+. We propose that zeta toxin induces reversible protective dormancy and permeation to PI, and expression of epsilon(2) antitoxin reverses these effects. At later times, toxin expression is followed by death of a small fraction (similar to 10%) of PI stained cells that exited earlier or did not enter into the dormant state. Recovery from stress leads to de novo synthesis of epsilon(2) antitoxin, which blocks ATP binding by zeta toxin, thereby inhibiting its phosphotransferase activity.	[Lioy, Virginia S.; Machon, Cristina; Tabone, Mariangela; Ayora, Silvia; Alonso, Juan C.] CNB CSIC, Ctr Nacl Biotecnol, Dept Microbial Biotechnol, Madrid, Spain; [Gonzalez-Pastor, Jose E.] CSIC INTA, Ctr Astrobiol, Dept Mol Evolut, Torrejon De Ardoz, Spain; [Daugelavicius, Rimantas] Vytautas Magnus Univ, Dept Biochem & Biotechnol, Kaunas, Lithuania	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Astrobiologia (INTA); Vytautas Magnus University	Lioy, VS (corresponding author), Inst Pasteur, Unite Agents Antibacteriens, F-75724 Paris, France.	sayora@cnb.csic.es; jcalonso@cnb.csic.es	Alonso, Juan Carlos/D-2595-2009; Lioy, Vicky/AAE-4039-2022; Tabone, Mariangela/ABG-3195-2020; Ayora, Silvia/D-2552-2009; González-Pastor, José/I-2118-2015; Daugelavicius, Rimantas/J-5009-2019; Lioy, Vicky S./AAL-9782-2021; Sobrado, Cristina Machón/K-1634-2014	Alonso, Juan Carlos/0000-0002-5178-7179; Lioy, Vicky/0000-0002-5366-0462; Ayora, Silvia/0000-0003-3121-1786; González-Pastor, José/0000-0002-7615-7042; Daugelavicius, Rimantas/0000-0001-9721-6200; Lioy, Vicky S./0000-0002-5366-0462; Sobrado, Cristina Machón/0000-0001-5363-2958	European Union [Health-F3-2009-223111]; Spanish Ministry of Science and Innovation [BFU2009-07167, CSD2007-00010, BFU2009-09520]; Comunidad de Madrid [CM-BIO0260-2006]	European Union(European Commission); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Comunidad de Madrid(Comunidad de Madrid)	The research was partially financed by the European Union (Grant Health-F3-2009-223111 to J.C.A.), the Spanish Ministry of Science and Innovation (Grants BFU2009-07167 and CSD2007-00010 to J.C.A. and BFU2009-09520 to S. A.) and the Comunidad de Madrid (Grant CM-BIO0260-2006 to S. A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amitai S, 2004, J BACTERIOL, V186, P8295, DOI 10.1128/JB.186.24.8295-8300.2004; Belitskii B R, 1980, Mol Biol (Mosk), V14, P1342; Belitsky M, 2011, MOL CELL, V41, P625, DOI 10.1016/j.molcel.2011.02.023; Blower TR, 2011, CURR OPIN STRUC BIOL, V21, P109, DOI 10.1016/j.sbi.2010.10.009; Britton RA, 2002, J BACTERIOL, V184, P4881, DOI 10.1128/JB.184.17.4881-4890.2002; Camacho AG, 2002, BIOL CHEM, V383, P1701, DOI 10.1515/BC.2002.191; Cashel M., 1996, ESCHERICHIA COLI SAL, P1458; Christensen SK, 2001, P NATL ACAD SCI USA, V98, P14328, DOI 10.1073/pnas.251327898; Daugelavicius R, 2007, J MICROBIOL METH, V69, P174, DOI 10.1016/j.mimet.2006.12.023; De Jonge N, 2009, MOL CELL, V35, P154, DOI 10.1016/j.molcel.2009.05.025; de la Hoz AB, 2000, P NATL ACAD SCI USA, V97, P728, DOI 10.1073/pnas.97.2.728; Dorr T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000317; Dorr T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000760; Engelberg-Kulka H, 2006, PLOS GENET, V2, P1518, DOI 10.1371/journal.pgen.0020135; Eymann C, 2002, J BACTERIOL, V184, P2500, DOI 10.1128/JB.184.9.2500-2520.2002; Fu ZB, 2009, J BACTERIOL, V191, P2051, DOI 10.1128/JB.00907-08; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Gerdes K, 2000, J BACTERIOL, V182, P561, DOI 10.1128/JB.182.3.561-572.2000; Gross M, 2006, MOL MICROBIOL, V59, P590, DOI 10.1111/j.1365-2958.2005.04956.x; Hargreaves D, 2002, STRUCTURE, V10, P1425, DOI 10.1016/S0969-2126(02)00856-0; Hayes F, 2011, CRIT REV BIOCHEM MOL, V46, P386, DOI 10.3109/10409238.2011.600437; IMLAY JA, 1988, SCIENCE, V240, P640, DOI 10.1126/science.2834821; Kamada K, 2003, MOL CELL, V11, P875, DOI 10.1016/S1097-2765(03)00097-2; Kamphuis MB, 2007, PROTEIN PEPTIDE LETT, V14, P113, DOI 10.2174/092986607779816096; Khoo SK, 2007, J BIOL CHEM, V282, P19606, DOI 10.1074/jbc.M701703200; Kolodkin-Gal I, 2007, SCIENCE, V318, P652, DOI 10.1126/science.1147248; Kolodkin-Gal I, 2008, PLOS BIOL, V6, P2774, DOI 10.1371/journal.pbio.0060319; Kostrewa D, 2001, J MOL BIOL, V305, P279, DOI 10.1006/jmbi.2000.4296; Krasny L, 2004, EMBO J, V23, P4473, DOI 10.1038/sj.emboj.7600423; Lee S, 2008, J BIOL CHEM, V283, P15232, DOI 10.1074/jbc.M800479200; Lemos JA, 2007, MOL MICROBIOL, V65, P1568, DOI 10.1111/j.1365-2958.2007.05897.x; Leplae R, 2011, NUCLEIC ACIDS RES, V39, P5513, DOI 10.1093/nar/gkr131; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; Lioy VS, 2006, MICROBIOL-SGM, V152, P2365, DOI 10.1099/mic.0.28950-0; LOPEZ JM, 1981, J BACTERIOL, V146, P605, DOI 10.1128/JB.146.2.605-613.1981; Loris R, 1999, J MOL BIOL, V285, P1667, DOI 10.1006/jmbi.1998.2395; Maisonneuve E, 2011, P NATL ACAD SCI US; Meinhart A, 2003, P NATL ACAD SCI USA, V100, P1661, DOI 10.1073/pnas.0434325100; Meinhart A, 2001, ACTA CRYSTALLOGR D, V57, P745, DOI 10.1107/S0907444901004176; Miallau L, 2009, J BIOL CHEM, V284, P276, DOI 10.1074/jbc.M805061200; Moritz EM, 2007, P NATL ACAD SCI USA, V104, P311, DOI 10.1073/pnas.0601168104; Mutschler H, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001033; Nanamiya H, 2008, MOL MICROBIOL, V67, P291, DOI 10.1111/j.1365-2958.2007.06018.x; Nariya H, 2008, CELL, V132, P55, DOI 10.1016/j.cell.2007.11.044; Nieto C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011289; Nystrom T, 2003, MOL MICROBIOL, V48, P17, DOI 10.1046/j.1365-2958.2003.03385.x; OCHI K, 1982, J BACTERIOL, V151, P1062, DOI 10.1128/JB.151.2.1062-1065.1982; Pellegrini O, 2005, MOL MICROBIOL, V56, P1139, DOI 10.1111/j.1365-2958.2005.04606.x; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; Rosvoll TCS, 2010, FEMS IMMUNOL MED MIC, V58, P254, DOI 10.1111/j.1574-695X.2009.00633.x; Samarrai W, 2011, J BACTERIOL, V193, P723, DOI 10.1128/JB.00708-10; Schumacher MA, 2009, SCIENCE, V323, P396, DOI 10.1126/science.1163806; Srivatsan A, 2008, CURR OPIN MICROBIOL, V11, P100, DOI 10.1016/j.mib.2008.02.001; Stewart EJ, 2005, PLOS BIOL, V3, P295, DOI 10.1371/journal.pbio.0030045; Takagi H, 2005, NAT STRUCT MOL BIOL, V12, P327, DOI 10.1038/nsmb911; Tan QA, 2011, MOL MICROBIOL, V79, P109, DOI 10.1111/j.1365-2958.2010.07433.x; Tsilibaris V, 2007, J BACTERIOL, V189, P6101, DOI 10.1128/JB.00527-07; Unoson C, 2008, MOL MICROBIOL, V70, P258, DOI 10.1111/j.1365-2958.2008.06416.x; Van Melderen L, 2010, CURR OPIN MICROBIOL, V13, P781, DOI 10.1016/j.mib.2010.10.006; Van Melderen L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000437; Wang JD, 2007, CELL, V128, P865, DOI 10.1016/j.cell.2006.12.043; Wendrich TM, 1997, MOL MICROBIOL, V26, P65, DOI 10.1046/j.1365-2958.1997.5511919.x; Yamaguchi Y, 2011, NAT REV MICROBIOL, V9, P779, DOI 10.1038/nrmicro2651; Zielenkiewicz U, 2005, J BACTERIOL, V187, P6094, DOI 10.1128/JB.187.17.6094-6105.2005	64	31	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30282	10.1371/journal.pone.0030282	http://dx.doi.org/10.1371/journal.pone.0030282			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295078	Green Published, gold, Green Submitted			2022-12-27	WOS:000301640600023
J	Norgaard, M; Ehrenstein, V; Nielsen, RB; Bakketeig, LS; Sorensen, HT				Norgaard, Mette; Ehrenstein, Vera; Nielsen, Rikke Beck; Bakketeig, Leiv Sigmund; Sorensen, Henrik Toft			Maternal Use of Antibiotics, Hospitalisation for Infection during Pregnancy, and Risk of Childhood Epilepsy: A Population-Based Cohort Study	PLOS ONE			English	Article							PRENATAL EXPOSURE; BIRTH; SEIZURES; EPIDEMIOLOGY; SEASONALITY; REGISTER; SYSTEM	Background: Maternal infection during pregnancy may be a risk factor for epilepsy in offspring. Use of antibiotics is a valid marker of infection. Methodology/Principal Findings: To examine the relationship between maternal infection during pregnancy and risk of childhood epilepsy we conducted a historical cohort study of singletons born in northern Denmark from 1998 through 2008 who survived >= 29 days. We used population-based medical databases to ascertain maternal use of antibiotics or hospital contacts with infection during pregnancy, as well as first-time hospital contacts with a diagnosis of epilepsy among offspring. We compared incidence rates (IR) of epilepsy among children of mothers with and without infection during pregnancy. We examined the outcome according to trimester of exposure, type of antibiotic, and total number of prescriptions, using Poisson regression to estimate incidence rate ratios (IRRs) while adjusting for covariates. Among 191 383 children in the cohort, 948 (0.5%) were hospitalised or had an outpatient visit for epilepsy during follow-up, yielding an IR of 91 per 100 000 person-years (PY). The five-year cumulative incidence of epilepsy was 4.5 per 1000 children. Among children exposed prenatally to maternal infection, the IR was 117 per 100 000 PY, with an adjusted IRR of 1.40 (95% confidence interval (CI): 1.22-1.61), compared with unexposed children. The association was unaffected by trimester of exposure, antibiotic type, or prescription count. Conclusions/Significance: Prenatal exposure to maternal infection is associated with an increased risk of epilepsy in childhood. The similarity of estimates across types of antibiotics suggests that processes common to all infections underlie this outcome, rather than specific pathogens or drugs.	[Norgaard, Mette; Ehrenstein, Vera; Nielsen, Rikke Beck; Sorensen, Henrik Toft] Aarhus Univ Hosp, Inst Clin Med, Dept Clin Epidemiol, DK-8000 Aarhus, Denmark; [Bakketeig, Leiv Sigmund] Norwegian Inst Publ Hlth, Nydalen, Norway	Aarhus University; Norwegian Institute of Public Health (NIPH)	Norgaard, M (corresponding author), Aarhus Univ Hosp, Inst Clin Med, Dept Clin Epidemiol, DK-8000 Aarhus, Denmark.	mn@dce.au.dk	Sorensen, Henrik Toft/Z-6181-2019	Sorensen, Henrik Toft/0000-0003-4299-7040; Ehrenstein, Vera/0000-0002-3415-3254; Norgaard, Mette/0000-0001-6110-5891	Department of Clinical Epidemiology, Aarhus University Hospital, Denmark	Department of Clinical Epidemiology, Aarhus University Hospital, Denmark	The study was funded by a Research Grant from the Department of Clinical Epidemiology, Aarhus University Hospital, Denmark. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Andersen TF, 1999, DAN MED BULL, V46, P263; Arts WFM, 2009, EUR J PAEDIATR NEURO, V13, P93, DOI 10.1016/j.ejpn.2008.02.010; Balslev Thomas, 2004, Ugeskr Laeger, V166, P3932; Browne TR, 2001, NEW ENGL J MED, V344, P1145, DOI 10.1056/NEJM200104123441507; CAMFIELD C, 1993, J PEDIATR-US, V122, P861, DOI 10.1016/S0022-3476(09)90008-7; Chang BS, 2003, NEW ENGL J MED, V349, P1257, DOI 10.1056/NEJMra022308; Christensen J, 2007, EPILEPSY RES, V75, P162, DOI 10.1016/j.eplepsyres.2007.05.009; Cowan LD, 2002, MENT RETARD DEV D R, V8, P171, DOI 10.1002/mrdd.10035; Crider KS, 2009, ARCH PEDIAT ADOL MED, V163, P978, DOI 10.1001/archpediatrics.2009.188; Ehrenstein V, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-23; Ehrenstein V, 2007, PEDIATRICS, V119, pE554, DOI 10.1542/peds.2006-1308; Ehrenstein Vera, 2010, Clin Epidemiol, V2, P273, DOI 10.2147/CLEP.S13458; Ekman GS, 2010, BRIT J SURG, V97, P1722, DOI 10.1002/bjs.7261; Fabene PF, 2010, J NEUROIMMUNOL, V224, P22, DOI 10.1016/j.jneuroim.2010.05.016; Frank L, 2000, SCIENCE, V287, P2398, DOI 10.1126/science.287.5462.2398; FRIIS H, 1989, SCAND J INFECT DIS, V21, P551, DOI 10.3109/00365548909037884; Glass HC, 2009, J PEDIATR-US, V154, P24, DOI 10.1016/j.jpeds.2008.07.008; Greenwood R, 1998, PAEDIATR PERINAT EP, V12, P76, DOI 10.1046/j.1365-3016.1998.0120s1076.x; Guerrini R, 2006, LANCET, V367, P499, DOI 10.1016/S0140-6736(06)68182-8; HAUSER WA, 1994, EPILEPSIA, V35, pS1, DOI 10.1111/j.1528-1157.1994.tb05932.x; Jurek AM, 2005, INT J EPIDEMIOL, V34, P680, DOI 10.1093/ije/dyi060; Kannoth S, 2009, EPILEPSY BEHAV, V16, P58, DOI 10.1016/j.yebeh.2009.07.019; Knudsen LB, 1998, DAN MED BULL, V45, P320; Koepsell TD, 2003, EPIDEMIOLOGIC METHOD, Vix; Lieberman E, 2000, PEDIATRICS, V106, P983, DOI 10.1542/peds.106.5.983; Nuutinen M, 1989, Arctic Med Res, V48, P175; Olsen J, 2001, SCAND J PUBLIC HEALT, V29, P300, DOI 10.1177/14034948010290040201; Pedersen CB, 2006, DAN MED BULL, V53, P441; Procopio M, 2006, SEIZURE-EUR J EPILEP, V15, P17, DOI 10.1016/j.seizure.2005.10.001; Procopio M, 1998, ACTA NEUROL SCAND, V98, P297; Sen Wu C, 2008, PEDIATRICS, V122, P1072, DOI 10.1542/peds.2007-3666; Sun YL, 2006, EPIDEMIOLOGY, V17, P296, DOI 10.1097/01.ede.0000208478.47401.b6; Sun Y, 2008, PEDIATRICS, V121, pE1100, DOI 10.1542/peds.2007-2316; Sun Y, 2008, AM J EPIDEMIOL, V167, P262, DOI 10.1093/aje/kwm316; Sun YL, 2011, PAEDIATR PERINAT EP, V25, P53, DOI 10.1111/j.1365-3016.2010.01143.x; Vezzani A, 2005, EPILEPSIA, V46, P1724, DOI 10.1111/j.1528-1167.2005.00298.x; Whitehead E, 2006, PEDIATRICS, V117, P1298, DOI 10.1542/peds.2005-1660	37	23	24	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30850	10.1371/journal.pone.0030850	http://dx.doi.org/10.1371/journal.pone.0030850			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295115	Green Submitted, Green Published, gold			2022-12-27	WOS:000301640600060
J	Wu, HY; Hung, KY; Huang, TM; Hu, FC; Peng, YS; Huang, JW; Lin, SL; Chen, YM; Chu, TS; Tsai, TJ; Wu, KD				Wu, Hon-Yen; Hung, Kuan-Yu; Huang, Tao-Min; Hu, Fu-Chang; Peng, Yu-Sen; Huang, Jenq-Wen; Lin, Shuei-Liong; Chen, Yung-Ming; Chu, Tzong-Shinn; Tsai, Tun-Jun; Wu, Kwan-Dun			Safety Issues of Long-Term Glucose Load in Patients on Peritoneal Dialysis-A 7-Year Cohort Study	PLOS ONE			English	Article							STAGE RENAL-DISEASE; HEMODIALYSIS-PATIENTS; SURVIVAL; THERAPY; RISK	Background: Effects of long-term glucose load on peritoneal dialysis (PD) patient safety and outcomes have seldom been reported. This study demonstrates the influence of long-term glucose load on patient and technique survival. Methods: We surveyed 173 incident PD patients. Long-term glucose load was evaluated by calculating the average dialysate glucose concentration since initiation of PD. Risk factors were assessed by fitting Cox's models with repeatedly measured time-dependent covariates. Results: We noted that older age, higher glucose concentration, and lower residual renal function (RRF) were significantly associated with a worse patient survival. We found that female gender, absence of diabetes, lower glucose concentration, use of icodextrin, higher serum high density lipoprotein cholesterol, and higher RRF were significantly associated with a better technique survival. Conclusions: Long-term glucose load predicted mortality and technique failure in chronic PD patients. These findings emphasize the importance of minimizing glucose load in PD patients.	[Wu, Hon-Yen; Peng, Yu-Sen] Far Eastern Mem Hosp, Dept Internal Med, New Taipei City, Taiwan; [Wu, Hon-Yen; Hung, Kuan-Yu; Huang, Tao-Min; Peng, Yu-Sen; Huang, Jenq-Wen; Lin, Shuei-Liong; Chen, Yung-Ming; Chu, Tzong-Shinn; Tsai, Tun-Jun; Wu, Kwan-Dun] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Hung, Kuan-Yu] Natl Taiwan Univ Hosp, Ctr Qual Management, Taipei, Taiwan; [Hu, Fu-Chang] Natl Taiwan Univ Hosp, Natl Ctr Excellence Gen Clin Trial & Res, Taipei, Taiwan; [Wu, Hon-Yen; Huang, Tao-Min; Chen, Yung-Ming] Natl Taiwan Univ Hosp, Dept Internal Med, Yun Lin Branch, Yunlin, Taiwan; [Hu, Fu-Chang] Int Harvard Stat Consulting Co, Taipei, Taiwan	Far Eastern Memorial Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Wu, HY (corresponding author), Far Eastern Mem Hosp, Dept Internal Med, New Taipei City, Taiwan.	kyhung@ntu.edu.tw; 007378@ntuh.gov.tw	Lin, Shuei-Liong/AGR-2002-2022; peng, yu/GXW-2071-2022; Huang, Tao Min/C-5379-2011	Lin, Shuei-Liong/0000-0002-1041-5571; Huang, Tao Min/0000-0002-9387-0798; HUANG, JENQ-WEN/0000-0001-8011-2317; CHU, TZONG-SHINN/0000-0002-5291-2509; CHEN, YUNG-MING/0000-0002-9241-1258; TSAI, TUN-JUN/0000-0002-1666-8940; HUNG, KUAN-YU/0000-0003-3472-5512; WU, KWAN-DUN/0000-0002-3339-1509	National Science Council of Taiwan [NSC-95-2314-B-002-238-MY2]; Ta-Tung Kidney Foundation; Mrs. Hsiu-Chin Lee Kidney Research Foundation (Taipei, Taiwan); Yun-Lin Branch, National Taiwan University Hospital, Yun-Lin, Taiwan [NTUHYL.97.S007, NTUHYL.98.S010]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Ta-Tung Kidney Foundation; Mrs. Hsiu-Chin Lee Kidney Research Foundation (Taipei, Taiwan); Yun-Lin Branch, National Taiwan University Hospital, Yun-Lin, Taiwan	This work was supported by grants from the National Science Council of Taiwan (to Kuan-Yu Hung; NSC-95-2314-B-002-238-MY2), the Ta-Tung Kidney Foundation, and the Mrs. Hsiu-Chin Lee Kidney Research Foundation (Taipei, Taiwan), and grants from the Yun-Lin Branch, National Taiwan University Hospital (to Hon-Yen Wu; NTUHYL.97.S007 and NTUHYL.98.S010, Yun-Lin, Taiwan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi Y, 2006, PERITON DIALYSIS INT, V26, P405; Bergstrom J, 1998, PERITON DIALYSIS INT, V18, P467; Chaudhary K, 2008, PERITON DIALYSIS INT, V28, P113; Davies SJ, 2005, KIDNEY INT, V67, P1609, DOI 10.1111/j.1523-1755.2005.00243.x; Davies SJ, 2001, J AM SOC NEPHROL, V12, P1046, DOI 10.1681/ASN.V1251046; GRODSTEIN GP, 1981, KIDNEY INT, V19, P564, DOI 10.1038/ki.1981.53; Ho-dac-Pannekeet MM, 2006, NEPHROL DIAL TRANSPL, V21, pii60; Holmes C, 2006, KIDNEY INT, V70, pS104, DOI 10.1038/sj.ki.5001924; Laird NM, 1983, KIDNEY INT S, pS101; Li PKT, 2009, PERITON DIALYSIS INT, V29, pS149; Liu J, 2006, SEMIN DIALYSIS, V19, P32, DOI 10.1111/j.1525-139X.2006.00117.x; Lo WK, 2005, KIDNEY INT, V67, P2032, DOI 10.1111/j.1523-1755.2005.00305.x; LOWRIE EG, 1990, AM J KIDNEY DIS, V15, P458, DOI 10.1016/S0272-6386(12)70364-5; Peng YS, 2007, NEPHROL DIAL TRANSPL, V22, P857, DOI 10.1093/ndt/gfl666; *PER DIAL AD WORK, 2006, AM J KIDNEY DIS S, V48, pS98; TWARDOWSKI ZJ, 1987, PERITON DIALYSIS INT, V7, P138; Wolfe RA, 1999, NEW ENGL J MED, V341, P1725, DOI 10.1056/NEJM199912023412303; Wu HY, 2008, AM J NEPHROL, V28, P765, DOI 10.1159/000128608; Wu HY, 2010, PERITON DIALYSIS INT, V30, P448, DOI 10.3747/pdi.2009.00063	19	31	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30337	10.1371/journal.pone.0030337	http://dx.doi.org/10.1371/journal.pone.0030337			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22303440	gold, Green Published, Green Submitted			2022-12-27	WOS:000301570600033
J	Falone, S; D'Alessandro, A; Mirabilio, A; Petruccelli, G; Cacchio, M; Di Ilio, C; Di Loreto, S; Amicarelli, F				Falone, Stefano; D'Alessandro, Antonella; Mirabilio, Alessandro; Petruccelli, Giacomo; Cacchio, Marisa; Di Ilio, Carmine; Di Loreto, Silvia; Amicarelli, Fernanda			Long Term Running Biphasically Improves Methylglyoxal-Related Metabolism, Redox Homeostasis and Neurotrophic Support within Adult Mouse Brain Cortex	PLOS ONE			English	Article							OXIDATIVE STRESS MARKERS; UP-REGULATION; TRANSCRIPTION FACTORS; ANTIOXIDANT SYSTEM; SKELETAL-MUSCLE; EXERCISE; PROTEIN; DAMAGE; AGE; GLUTATHIONE	Oxidative stress and neurotrophic support decline seem to be crucially involved in brain aging. Emerging evidences indicate the pro-oxidant methylglyoxal (MG) as a key player in the age-related dicarbonyl stress and molecular damage within the central nervous system. Although exercise promotes the overproduction of reactive oxygen species, habitual exercise may retard cellular aging and reduce the age-dependent cognitive decline through hormetic adaptations, yet molecular mechanisms underlying beneficial effects of exercise are still largely unclear. In particular, whereas adaptive responses induced by exercise initiated in youth have been broadly investigated, the effects of chronic and moderate exercise begun in adult age on biochemical hallmarks of very early senescence in mammal brains have not been extensively studied. This research investigated whether a long-term, forced and moderate running initiated in adult age may affect the interplay between the redox-related profile and the oxidative-/MG-dependent molecular damage patterns in CD1 female mice cortices; as well, we investigated possible exercise-induced effects on the activity of the brain derived neurotrophic factor (BDNF)-dependent pathway. Our findings suggested that after a transient imbalance in almost all parameters investigated, the lately-initiated exercise regimen strongly reduced molecular damage profiles in brains of adult mice, by enhancing activities of the main ROS- and MG-targeting scavenging systems, as well as by preserving the BDNF-dependent signaling through the transition from adult to middle age.	[Falone, Stefano; D'Alessandro, Antonella; Mirabilio, Alessandro; Amicarelli, Fernanda] Univ Aquila, Dept Basic & Appl Biol, I-67100 Laquila, Italy; [Falone, Stefano; Di Ilio, Carmine] Univ G dAnnunzio, Dept Biomed Sci, Chieti, Italy; [Petruccelli, Giacomo; Cacchio, Marisa] Univ G dAnnunzio, Dept Basic & Appl Med Sci, Chieti, Italy; [Di Loreto, Silvia] CNR, Inst Translat Pharmacol, Laquila, Italy	University of L'Aquila; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; Consiglio Nazionale delle Ricerche (CNR); Istituto di Farmacologia Traslazionale (IFT-CNR)	Falone, S (corresponding author), Univ Aquila, Dept Basic & Appl Biol, I-67100 Laquila, Italy.	fernanda.amicarelli@univaq.it	Falone, Stefano/D-8692-2017; Di Loreto, Silvia/R-1849-2018; Di Loreto, Silvia/AAK-3406-2021	Falone, Stefano/0000-0002-5978-0545; Amicarelli, Fernanda/0000-0003-4528-4660	Foundation of the Cassa di Risparmio dell'Aquila	Foundation of the Cassa di Risparmio dell'Aquila	This work was funded by the Foundation of the Cassa di Risparmio dell'Aquila. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi H, 1984, Methods Enzymol, V105, P121; Aldridge GM, 2008, J NEUROSCI METH, V172, P250, DOI 10.1016/j.jneumeth.2008.05.003; Amicarelli F, 2003, FREE RADICAL BIO MED, V35, P856, DOI 10.1016/S0891-5849(03)00438-6; Amicarelli F, 2001, INT J BIOCHEM CELL B, V33, P1129, DOI 10.1016/S1357-2725(01)00010-3; Amicarelli F, 1997, MECH AGEING DEV, V97, P215, DOI 10.1016/S0047-6374(97)00061-4; Amicarelli F, 1999, BBA-MOL BASIS DIS, V1453, P105, DOI 10.1016/S0925-4439(98)00088-X; BAKER MA, 1990, ANAL BIOCHEM, V190, P360, DOI 10.1016/0003-2697(90)90208-Q; Berchtold NC, 2010, NEUROSCIENCE, V167, P588, DOI 10.1016/j.neuroscience.2010.02.050; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWNLEE M, 1986, SCIENCE, V232, P1629, DOI 10.1126/science.3487117; Castro AA, 2011, MECH AGEING IN PRESS; Chao MV, 2006, CLIN SCI, V110, P167, DOI 10.1042/CS20050163; Desai KM, 2010, CAN J PHYSIOL PHARM, V88, P273, DOI 10.1139/Y10-001; Desai Kaushik M., 2008, Drug Metabolism and Drug Interactions, V23, P151; Devi SA, 2004, NEUROBIOL AGING, V25, P501, DOI 10.1016/S0197-4580(03)00112-X; Di Loreto S, 2004, BRAIN RES, V1006, P157, DOI 10.1016/j.brainres.2004.01.066; Di Loreto S, 2008, INT J BIOCHEM CELL B, V40, P245, DOI 10.1016/j.biocel.2007.07.019; DIILIO C, 1983, BIOCHEM MED METAB B, V29, P143, DOI 10.1016/0006-2944(83)90034-0; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Falone S, 2010, PHYSIOL RES, V59, P953, DOI 10.33549/physiolres.931884; Fano G, 2001, J MUSCLE RES CELL M, V22, P345, DOI 10.1023/A:1013122805060; Flurkey K, 2007, MOUSE BIOMEDICAL RES, P637, DOI DOI 10.1016/B978-012369454-6/50074-1; Fouquet C, 2011, NEUROBIOL AGING, V32, P1881, DOI 10.1016/j.neurobiolaging.2009.11.001; Frazzini V, 2006, BIOGERONTOLOGY, V7, P307, DOI 10.1007/s10522-006-9045-7; Fulle S, 2005, EXP GERONTOL, V40, P189, DOI 10.1016/j.exger.2004.11.006; Gomez-Cabrera MC, 2008, FREE RADICAL BIO MED, V44, P126, DOI 10.1016/j.freeradbiomed.2007.02.001; Gomez-Pinilla F, 2008, AGEING RES REV, V7, P49, DOI 10.1016/j.arr.2007.04.003; Greenwood BN, 2009, HIPPOCAMPUS, V19, P988, DOI 10.1002/hipo.20534; Griffin EW, 2009, HIPPOCAMPUS, V19, P973, DOI 10.1002/hipo.20631; GUHA MK, 1988, BIOCHEMISTRY-US, V27, P8818, DOI 10.1021/bi00424a020; Hipkiss AR, 2006, MECH AGEING DEV, V127, P8, DOI 10.1016/j.mad.2005.09.006; Hof PR, 2004, TRENDS NEUROSCI, V27, P607, DOI 10.1016/j.tins.2004.07.013; Hopkins ME, 2010, NEUROBIOL LEARN MEM, V94, P278, DOI 10.1016/j.nlm.2010.06.006; Iwata E, 1997, MOL BRAIN RES, V50, P213, DOI 10.1016/S0169-328X(97)00190-3; Ji LL, 2008, FREE RADICAL BIO MED, V44, P142, DOI 10.1016/j.freeradbiomed.2007.02.031; Kuhla B, 2006, J NEUROSCI RES, V83, P1591, DOI 10.1002/jnr.20838; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEVINE RL, 1994, METHOD ENZYMOL, V233, P346; Liu YF, 2008, NEUROBIOL LEARN MEM, V90, P81, DOI 10.1016/j.nlm.2008.02.005; Luth HJ, 2005, CEREB CORTEX, V15, P211, DOI 10.1093/cercor/bhh123; Macri MA, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-14; Mannervik B, 1981, Methods Enzymol, V77, P297; MATTSON MP, 1995, J NEUROCHEM, V65, P1740; Miyata T, 1998, FEBS LETT, V437, P24, DOI 10.1016/S0014-5793(98)01079-5; Muscari A, 2010, INT J GERIATR PSYCH, V25, P1055, DOI 10.1002/gps.2462; Nicolle MM, 2001, NEUROSCIENCE, V107, P415, DOI 10.1016/S0306-4522(01)00374-8; O'Callaghan RM, 2009, HIPPOCAMPUS, V19, P1019, DOI 10.1002/hipo.20591; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Powers SK, 2000, HDB OXIDANTS ANTIOXI, P225; Rabbani N, 2008, ANN NY ACAD SCI, V1126, P124, DOI 10.1196/annals.1433.043; Radak Z, 2001, NEUROCHEM INT, V38, P17, DOI 10.1016/S0197-0186(00)00063-2; Radak Z, 2008, FREE RADICAL BIO MED, V44, P153, DOI 10.1016/j.freeradbiomed.2007.01.029; Radak Z, 2006, NEUROCHEM INT, V49, P387, DOI 10.1016/j.neuint.2006.02.004; Rolland Y, 2010, CLIN GERIATR MED, V26, P75, DOI 10.1016/j.cger.2009.11.002; Sayre LM, 2008, CHEM RES TOXICOL, V21, P172, DOI 10.1021/tx700210j; Silva-Adaya D, 2008, J NEUROCHEM, V105, P677, DOI 10.1111/j.1471-4159.2007.05174.x; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; SOMANI SM, 1995, PHARMACOL BIOCHEM BE, V50, P635, DOI 10.1016/0091-3057(94)00357-2; SUN M, 1978, ANAL BIOCHEM, V90, P81, DOI 10.1016/0003-2697(78)90010-6; Tatone C, 2008, HUM REPROD UPDATE, V14, P131, DOI 10.1093/humupd/dmm048; Thornalley Paul J., 2008, Drug Metabolism and Drug Interactions, V23, P125; Toldy A, 2005, BRAIN RES BULL, V65, P487, DOI 10.1016/j.brainresbull.2005.02.028; Tongiorgi E, 1997, J NEUROSCI, V17, P9492; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; van Praag H, 2005, J NEUROSCI, V25, P8680, DOI 10.1523/JNEUROSCI.1731-05.2005; Vaynman SS, 2006, BRAIN RES, V1070, P124, DOI 10.1016/j.brainres.2005.11.062; Vina J, 2000, IUBMB LIFE, V50, P271, DOI 10.1080/15216540051080994; Williamson J, 2010, ARCH INTERN MED, V170, P124, DOI 10.1001/archinternmed.2009.491; Zou J, 2006, CELL MOL NEUROBIOL, V26, P385, DOI 10.1007/s10571-006-9045-9	70	33	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31401	10.1371/journal.pone.0031401	http://dx.doi.org/10.1371/journal.pone.0031401			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347470	Green Submitted, Green Published, gold			2022-12-27	WOS:000302730100066
J	Raut, CP; Boucher, Y; Duda, DG; Morgan, JA; Quek, R; Ancukiewicz, M; Landenranta, J; Eder, JP; Demetri, GD; Jain, RK				Raut, Chandrajit P.; Boucher, Yves; Duda, Dan G.; Morgan, Jeffrey A.; Quek, Richard; Ancukiewicz, Marek; Landenranta, Johanna; Eder, J. Paul; Demetri, George D.; Jain, Rakesh K.			Effects of Sorafenib on Intra-Tumoral Interstitial Fluid Pressure and Circulating Biomarkers in Patients with Refractory Sarcomas (NCI Protocol 6948)	PLOS ONE			English	Article							HUMAN-MELANOMA XENOGRAFTS; SOLID TUMORS; ANTIANGIOGENIC THERAPY; RAF/MEK/ERK PATHWAY; DRUG PENETRATION; HYPERTENSION; VASCULATURE; TARGETS; GROWTH; CANCER	Purpose: Sorafenib is a multi-targeted tyrosine kinase inhibitor with therapeutic efficacy in several malignancies. Sorafenib may exert its anti-neoplastic effect in part by altering vascular permeability and reducing intra-tumoral interstitial hypertension. As correlative science with a phase II study in patients with advanced soft-tissue sarcomas (STS), we evaluated the impact of this agent on intra-tumor interstitial fluid pressure (IFP), serum circulating biomarkers, and vascular density. Patients and Methods: Patients with advanced STS with measurable disease and at least one superficial lesion amenable to biopsy received sorafenib 400 mg twice daily. Intratumoral IFP and plasma and circulating cell biomarkers were measured before and after 1-2 months of sorafenib administration. Results were analyzed in the context of the primary clinical endpoint of time-to-progression (TTP). Results: In 15 patients accrued, the median TTP was 45 days (range 14-228). Intra-tumoral IFP measurements obtained in 6 patients at baseline showed a direct correlation with tumor size. Two patients with stable disease at two months had post-sorafenib IFP evaluations and demonstrated a decline in IFP and vascular density. Sorafenib significantly increased plasma VEGF, PlGF, and SDF1 alpha and decreased sVEGFR-2 levels. Increased plasma SDF1 alpha and decreased sVEGFR-2 levels on day 28 correlated with disease progression. Conclusions: Pretreatment intra-tumoral IFP correlated with tumor size and decreased in two evaluable patients with SD on sorafenib. Sorafenib also induced changes in circulating biomarkers consistent with expected VEGF pathway blockade, despite the lack of more striking clinical activity in this small series.	[Raut, Chandrajit P.] Harvard Univ, Sch Med, Dept Surg, Brigham & Womens Hosp, Boston, MA 02115 USA; [Raut, Chandrajit P.; Morgan, Jeffrey A.; Quek, Richard; Eder, J. Paul; Demetri, George D.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; [Boucher, Yves; Duda, Dan G.; Ancukiewicz, Marek; Landenranta, Johanna; Jain, Rakesh K.] Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02114 USA; [Morgan, Jeffrey A.; Quek, Richard; Eder, J. Paul; Demetri, George D.] Harvard Univ, Sch Med, Dept Med Oncol, Brigham & Womens Hosp, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Raut, CP (corresponding author), Harvard Univ, Sch Med, Dept Surg, Brigham & Womens Hosp, Boston, MA 02115 USA.	craut@partners.org	Jain, Rakesh K/I-1384-2017; Duda, Dan G/H-8523-2014	Jain, Rakesh K/0000-0001-7571-3548; Duda, Dan G/0000-0001-7065-8797	National Institutes of Health [P01CA80124, R01CA115767]; Federal Share Proton Beam Income; Novartis; Pfizer; Ariad; Johnson Johnson; Bristol-Myers Squib; Infinity Pharmaceuticals; Daiichi-Sankyo; Dyax; AstraZeneca; MedImmune;  [U01CA062490]; NATIONAL CANCER INSTITUTE [R01CA115767, P01CA080124, U01CA062490] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Federal Share Proton Beam Income; Novartis(Novartis); Pfizer(Pfizer); Ariad; Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Bristol-Myers Squib; Infinity Pharmaceuticals; Daiichi-Sankyo(Daiichi Sankyo Company Limited); Dyax; AstraZeneca(AstraZeneca); MedImmune(AstraZenecaMedimmune); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was partially supported by the National Institutes of Health grants P01CA80124, R01CA115767 and Federal Share Proton Beam Income (RKJ) and U01CA062490 (JPE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.; Chandrajit P. Raut is a Novartis - Honorarium. Johanna Lahdenranta has an employment/leadership position at Merrimack Pharmaceuticals. J. Paul Eder is currently employed at AstraZeneca PLC. George D. Demetri is a Consultant for Novartis, Pfizer, Ariad, Johnson & Johnson, Genentech, Infinity Pharmaceuticals, ZioPharm, Alnylam, Idera, Momenta Pharma, EMD-Serono, Glaxo Smith Kline, Amgen, Daiichi-Sankyo, ArQule, Enzon, Millenium/Takeda, PamGene (no compensation), Plexxikon, N-of-One (no compensation), Champions Biotechnology, and Kolltan Pharmaceuticals; on the Scientific Advisory Board of ZioPharm, PamGene, Plexxikon, N-of-One, Kolltan Pharmaceuticals (chair); on the Medical Advisory Board at Kolltan Pharmaceuticals (chair); an Honorarium at Novartis and Pfizer; provides research support (to Dana-Farber Cancer Institute for clinical trial) at Novartis, Pfizer, Ariad, Johnson & Johnson, Bristol-Myers Squib, Infinity Pharmaceuticals, and Daiichi-Sankyo; and has equity (minor stake, non-public) at PamGene, Plexxikon, N-of-One, Champions Biotechnology, and Kolltan Pharmaceuticals. Rakesh K. Jain has a Consultant/advisory role at Millenium, Dyax, AstraZeneca, Regeneron, Astellas-Fibrogen, MorphoSys AG, Genzyme, SynDevRx, and Noxxon; is Honoraria at Pfizer and Genzyme (honoraria for lecture); provides research funding/contracted research at Dyax, AstraZeneca and MedImmune; and has ownership interest in SynDevRx. There are no patents or products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. Yves Boucher, Dan G. Duda, Jeffrey A. Morgan, Richard Quek and Marek Ancukiewicz declare no competing interest.	Adnane L, 2006, METHOD ENZYMOL, V407, P597, DOI 10.1016/S0076-6879(05)07047-3; Batchelor TT, 2007, CANCER CELL, V11, P83, DOI 10.1016/j.ccr.2006.11.021; Batchelor TT, 2010, J CLIN ONCOL, V28, P2817, DOI 10.1200/JCO.2009.26.3988; Boucher Y, 1997, BRIT J CANCER, V75, P829, DOI 10.1038/bjc.1997.148; BOUCHER Y, 1991, CANCER RES, V51, P6691; Boucher Y, 1996, CANCER RES, V56, P4264; BROWN MB, 1977, J AM STAT ASSOC, V72, P309, DOI 10.2307/2286793; Chang YS, 2007, CANCER CHEMOTH PHARM, V59, P561, DOI 10.1007/s00280-006-0393-4; Duda DG, 2007, NAT PROTOC, V2, P805, DOI 10.1038/nprot.2007.111; Duda DG, 2011, CLIN CANCER RES, V17, P2074, DOI 10.1158/1078-0432.CCR-10-2636; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Flaherty KT, 2007, EXPERT REV ANTICANC, V7, P617, DOI 10.1586/14737140.7.5.617; Gerstner ER, 2011, J NEURO-ONCOL, V103, P325, DOI 10.1007/s11060-010-0390-7; GUTMANN R, 1993, LARYNGO RHINO OTOL, V72, P338, DOI 10.1055/s-2007-997912; Heldin CH, 2004, NAT REV CANCER, V4, P806, DOI 10.1038/nrc1456; HOLLANDER M, 1973, NONPARAMETRICAL STAT; Horowitz Neil S, 2011, Clin Ovarian Cancer Other Gynecol Malig, V4, P26; Jain RK, 2009, NAT REV CLIN ONCOL, V6, P327, DOI 10.1038/nrclinonc.2009.63; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; LESS JR, 1992, CANCER RES, V52, P6371; Maki RG, 2009, J CLIN ONCOL, V27, P3133, DOI 10.1200/JCO.2008.20.4495; Milosevic M, 2001, CANCER RES, V61, P6400; Nathan SS, 2009, ANN ACAD MED SINGAP, V38, P1041; Nathan SS, 2005, CLIN CANCER RES, V11, P2389, DOI 10.1158/1078-0432.CCR-04-2048; Ogawa Y, 2008, J DERMATOL SCI, V51, P190, DOI 10.1016/j.jdermsci.2008.03.011; Pena C, 2010, CLIN CANCER RES, V16, P4853, DOI 10.1158/1078-0432.CCR-09-3343; Peng CL, 2009, CANCER BIOL THER, V8, P1729, DOI 10.4161/cbt.8.18.9208; Pietras K, 2001, CANCER RES, V61, P2929; ROH HD, 1991, CANCER RES, V51, P6695; Stohrer M, 2000, CANCER RES, V60, P4251; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Tong RT, 2004, CANCER RES, V64, P3731, DOI 10.1158/0008-5472.CAN-04-0074; Tufto I, 1998, ACTA ONCOL, V37, P291, DOI 10.1080/028418698429603; Tufto I, 1999, MICROVASC RES, V58, P205, DOI 10.1006/mvre.1999.2184; Wilhelm SM, 2008, MOL CANCER THER, V7, P3129, DOI 10.1158/1535-7163.MCT-08-0013; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Willett CG, 2004, NAT MED, V10, P145, DOI 10.1038/nm988; Willett CG, 2009, J CLIN ONCOL, V27, P3020, DOI 10.1200/JCO.2008.21.1771; Yeo SG, 2009, CLIN CANCER RES, V15, P6201, DOI 10.1158/1078-0432.CCR-09-0560; Zhu AX, 2011, CLIN CANCER RES, V17, P918, DOI 10.1158/1078-0432.CCR-10-0515; Zhu AX, 2009, EXPERT REV ANTICANC, V9, P143, DOI 10.1586/14737140.9.1.143	41	33	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2012	7	2							e26331	10.1371/journal.pone.0026331	http://dx.doi.org/10.1371/journal.pone.0026331			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917MF	22347360	Green Published, gold, Green Submitted			2022-12-27	WOS:000302180600003
J	Afify, AEMR; El-Beltagi, HS; Abd El-Salam, SM; Omran, AA				Afify, Abd El-Moneim M. R.; El-Beltagi, Hossam S.; Abd El-Salam, Samiha M.; Omran, Azza A.			Protein Solubility, Digestibility and Fractionation after Germination of Sorghum Varieties	PLOS ONE			English	Article							AMINO-ACIDS; PHYTATE; PROFILE; SEEDS; CORN; L.; FERMENTATION; CULTIVARS; DIGESTION; COOKING	The changes in crude protein, free amino acids, amino acid composition, protein solubility, protein fractionation and protein digestibility after germination of sorghum were investigated. Sorghum varieties (Dorado, Shandaweel-6, Giza-15) were soaked for 20 h followed by germination for 72 h; the results revealed that crude protein and free amino acids in raw sorghum varieties ranged from 10.62 to 12.46% and 0.66 to 1.03 mg/g, respectively. Shandaweel-6 was the highest variety in crude protein and free amino acids content. After germination, crude protein was decreased and free amino acids were increased. There was an increase in content of valine and phenylalanine amino acids after germination. On the other hand, there was a decrease in most of amino acids after germination. After germination protein solubility was significantly increased. Regarding protein fractions, there was an increase in albumin, globulin and kafirin proteins and a decrease in cross linked kafirin and cross linked glutelin after germination.	[Afify, Abd El-Moneim M. R.; El-Beltagi, Hossam S.] Cairo Univ, Fac Agr, Dept Biochem, Cairo, Egypt; [Abd El-Salam, Samiha M.; Omran, Azza A.] Agr Res Ctr, Food Technol Res Inst, Dept Crops Technol, Cairo, Egypt	Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Agricultural Research Center - Egypt	Afify, AEMR (corresponding author), Cairo Univ, Fac Agr, Dept Biochem, Cairo, Egypt.	lbltg@yahoo.com	El-Beltagi, Hossam S./L-8546-2019; El-Beltagi, Hossam/T-2547-2018; Omran, Azza A. A./ABF-3888-2021; Omran, Azza A./AAY-3922-2020	El-Beltagi, Hossam/0000-0003-4433-2034; Omran, Azza A. A./0000-0002-9328-8087; Omran, Azza A./0000-0002-9328-8087	Department of Biochemistry, Faculty of Agriculture, Cairo University; Department of Crops Technology; Food Technology Research Institute; Agricultural Research Center	Department of Biochemistry, Faculty of Agriculture, Cairo University(Cairo University); Department of Crops Technology; Food Technology Research Institute; Agricultural Research Center	This work was supported by the Department of Biochemistry, Faculty of Agriculture, Cairo University, the Department of Crops Technology, the Food Technology Research Institute, and the Agricultural Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Rahim E. A., 2010, Electronic Journal of Environmental, Agricultural and Food Chemistry, V9, P1117; Afify Abd El-Moneim M. R., 2012, Asian Pacific Journal of Tropical Biomedicine, V2, P203, DOI 10.1016/S2221-1691(12)60042-2; Afify AMR, 2011, NOT BOT HORTI AGROBO, V39, P90; Afify AMR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025512; AKESON WR, 1964, J NUTR, V83, P257, DOI 10.1093/jn/83.3.257; Asma Abu Baker Abu Baker, 2010, Electronic Journal of Environmental, Agricultural and Food Chemistry, V9, P1495; Association of Official Analytical Chemists-AOAC, 2000, OFFICIAL METHODS ANA, V17th; CHAVAN JK, 1981, J FOOD SCI, V46, P638, DOI 10.1111/j.1365-2621.1981.tb04930.x; Coles LT, 2005, ANIM FEED SCI TECH, V123, P421, DOI 10.1016/j.anifeedsci.2005.04.021; Correia I, 2008, J SCI FOOD AGR, V88, P2598, DOI 10.1002/jsfa.3348; Correia I, 2010, J CEREAL SCI, V51, P146, DOI 10.1016/j.jcs.2009.11.005; DEWREEDE I, 1981, FRESEN Z ANAL CHEM, V308, P431; Dicko MH, 2006, AFR J BIOTECHNOL, V5, P384; Dillon SL, 2007, ANN BOT-LONDON, V100, P975, DOI 10.1093/aob/mcm192; Duodu KG, 2003, J CEREAL SCI, V38, P117, DOI 10.1016/S0733-5210(03)00016-X; Ebadi M. R., 2005, International Journal of Poultry Science, V4, P27; EJETA G, 1987, P NATL ACAD SCI USA, V84, P6016, DOI 10.1073/pnas.84.17.6016; El-Beltagi H. S., 2011, Electronic Journal of Environmental, Agricultural and Food Chemistry, V10, P2711; El-Beltagi H.S., 2011, AN UNIV ORADEA FASC, V18, P39; El-Beltagi HES, 2011, INT J FOOD SCI NUTR, V62, P453, DOI 10.3109/09637486.2010.544642; El-Beltagi HEDS, 2010, GRASAS ACEITES, V61, P143, DOI 10.3989/gya.087009; Elemo G. N., 2011, American Journal of Food Technology, V6, P413; Elkhalifa AEO, 2010, FOOD CHEM, V121, P387, DOI 10.1016/j.foodchem.2009.12.041; Fageer ASM, 2004, FOOD CHEM, V84, P613, DOI 10.1016/S0308-8146(03)00286-3; Hamaker B.R., 2003, WORKSH PROT SORGH MI; Hur SJ, 2011, FOOD CHEM, V125, P1, DOI 10.1016/j.foodchem.2010.08.036; Johnson WB, 2010, CEREAL CHEM, V87, P524, DOI 10.1094/CCHEM-06-10-0087; Kayode APP, 2006, THESIS WAGENINGEN U, P1; Khattak AB, 2007, FOOD CHEM, V104, P1074, DOI 10.1016/j.foodchem.2007.01.022; Kumar V, 2010, FOOD CHEM, V120, P945, DOI 10.1016/j.foodchem.2009.11.052; LANDRY J, 1970, B SOC CHIM BIOL, V52, P1021; Lonnerdal B, 2000, J NUTR, V130, p1378S, DOI 10.1093/jn/130.5.1378S; LOWRY OH, 1951, J BIOL CHEM, V193, P265; McDonough CM, 2004, J CEREAL SCI, V39, P351, DOI 10.1016/j.jcs.2004.01.001; Medugu C. I., 2010, Agriculture and Biology Journal of North America, V1, P321; Mokrane H, 2010, FOOD CHEM, V121, P719, DOI 10.1016/j.foodchem.2010.01.020; Moueium ZSA, 1996, FOOD CHEM, V57, P381, DOI 10.1016/S0308-8146(96)00006-4; ROSEN H, 1957, ARCH BIOCHEM BIOPHYS, V67, P10, DOI 10.1016/0003-9861(57)90241-2; SATHE SK, 1981, J FOOD SCI, V46, P82, DOI 10.1111/j.1365-2621.1981.tb14536.x; Shaker AMH, 1995, B NUTR I, V15, P87; Shallan M. A., 2010, Australian Journal of Basic and Applied Sciences, V4, P114; Shallan M. A., 2010, Electronic Journal of Environmental, Agricultural and Food Chemistry, V9, P958; Shehab GG, 2010, NOT BOT HORTI AGROBO, V38, P139; Soetan KO., 2009, AFRICAN J FOOD SCI, V3, P123; Steiner T, 2007, ANIM FEED SCI TECH, V133, P320, DOI 10.1016/j.anifeedsci.2006.04.007; Traore T, 2004, FOOD CHEM, V88, P105, DOI 10.1016/j.foodchem.2004.01.032; Vinay BJ, 2008, FOOD CHEM, V106, P77, DOI 10.1016/j.foodchem.2007.05.048; Wedad, 2008, Pakistan Journal of Nutrition, V7, P335; Zhao R, 2008, J AGR FOOD CHEM, V56, P946, DOI 10.1021/jf072590r	49	66	66	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e31154	10.1371/journal.pone.0031154	http://dx.doi.org/10.1371/journal.pone.0031154			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LO	22319611	Green Published, gold, Green Submitted			2022-12-27	WOS:000302178400029
J	Anour, R; Andrukhova, O; Ritter, E; Zeitz, U; Erben, RG				Anour, Rene; Andrukhova, Olena; Ritter, Eva; Zeitz, Ute; Erben, Reinhold G.			Klotho Lacks a Vitamin D Independent Physiological Role in Glucose Homeostasis, Bone Turnover, and Steady-State PTH Secretion In Vivo	PLOS ONE			English	Article							MINERAL ION HOMEOSTASIS; D-RECEPTOR; DEFICIENT MICE; INSULIN SENSITIVITY; FUNCTIONAL VARIANT; HORMONE KLOTHO; TRPV5 CHANNEL; GENE; MOUSE; EXPRESSION	Apart from its function as co-receptor for fibroblast growth factor-23 (FGF23), Klotho is thought to regulate insulin signaling, intracellular oxidative stress, and parathyroid hormone (PTH) secretion in an FGF23 independent fashion. Here, we crossed Klotho deficient (Kl(-/-)) mice with vitamin D receptor (VDR) mutant mice to examine further vitamin D independent functions of Klotho. All mice were fed a rescue diet enriched with calcium, phosphorus, and lactose to prevent hyperparathyroidism in VDR mutants, and were killed at 4 weeks of age after double fluorochrome labeling. Kl(-/-) mice displayed hypercalcemia, hyperphosphatemia, dwarfism, organ atrophy, azotemia, pulmonary emphysema, and osteomalacia. In addition, glucose and insulin tolerance tests revealed hypoglycemia and profoundly increased peripheral insulin sensitivity in Kl(-/-) mice. Compound mutants were normocalcemic and normophosphatemic, did not show premature aging or organ atrophy, and were phenocopies of VDR mutant mice in terms of body weight, bone mineral density, bone metabolism, serum calcium, serum phosphate, serum PTH, gene expression in parathyroid glands, as well as urinary calcium and phosphate excretion. Furthermore, ablation of vitamin D signaling in double mutants completely normalized glucose and insulin tolerance, indicating that Klotho has no vitamin D independent effects on insulin signaling. Histomorphometry of pancreas islets showed similar beta cell volume per body weight in all groups of animals. In conclusion, our findings cast doubt on a physiologically relevant vitamin D and Fgf23 independent function of Klotho in the regulation of glucose metabolism, bone turnover, and steady-state PTH secretion in vivo.	[Anour, Rene; Andrukhova, Olena; Ritter, Eva; Zeitz, Ute; Erben, Reinhold G.] Univ Vet Med, Dept Biomed Sci, Inst Physiol Pathophysiol & Biophys, Vienna, Austria	University of Veterinary Medicine Vienna	Anour, R (corresponding author), Univ Vet Med, Dept Biomed Sci, Inst Physiol Pathophysiol & Biophys, Vienna, Austria.	Reinhold.Erben@vetmeduni.ac.at	Erben, Reinhold/AAG-8007-2020	Erben, Reinhold/0000-0003-0801-6958	von Fircks Fond; University of Veterinary Medicine Vienna	von Fircks Fond; University of Veterinary Medicine Vienna	This work was supported by the "von Fircks Fond" and grants from the University of Veterinary Medicine Vienna (www.vetmeduni.ac.at) to R. G. E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander RT, 2009, J AM SOC NEPHROL, V20, P2371, DOI 10.1681/ASN.2008121273; Arking DE, 2005, CIRC RES, V96, P412, DOI 10.1161/01.RES.0000157171.04054.30; Arking DE, 2003, AM J HUM GENET, V72, P1154, DOI 10.1086/375035; Arking DE, 2002, P NATL ACAD SCI USA, V99, P856, DOI 10.1073/pnas.022484299; Cha SK, 2008, P NATL ACAD SCI USA, V105, P9805, DOI 10.1073/pnas.0803223105; Chang Q, 2005, SCIENCE, V310, P490, DOI 10.1126/science.1114245; Erben RG, 1997, J HISTOCHEM CYTOCHEM, V45, P307, DOI 10.1177/002215549704500215; Erben RG, 2002, MOL ENDOCRINOL, V16, P1524, DOI 10.1210/me.16.7.1524; Gattineni J., 2011, AM J PHYSL RENAL PHY; Hesse M, 2007, MATRIX BIOL, V26, P75, DOI 10.1016/j.matbio.2006.10.003; Hofbauer LC, 2009, ARTHRITIS RHEUM, V60, P1427, DOI 10.1002/art.24445; Hu MC, 2010, FASEB J, V24, P3438, DOI 10.1096/fj.10-154765; Ichikawa S, 2007, J CLIN INVEST, V117, P2684, DOI 10.1172/JCI31330; Imura A, 2007, SCIENCE, V316, P1615, DOI 10.1126/science.1135901; Kuro-o M, 2010, MECH AGEING DEV, V131, P270, DOI 10.1016/j.mad.2010.02.008; Kuro-o M, 2009, BBA-GEN SUBJECTS, V1790, P1049, DOI 10.1016/j.bbagen.2009.02.005; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Lambers TT, 2006, KIDNEY INT, V69, P650, DOI 10.1038/sj.ki.5000169; Li H, 2011, AM J PHYSIOL-ENDOC M, V300, pE508, DOI 10.1152/ajpendo.00499.2010; Li YC, 1998, ENDOCRINOLOGY, V139, P4391, DOI 10.1210/en.139.10.4391; Lorenzi O, 2010, PFLUG ARCH EUR J PHY, V459, P465, DOI 10.1007/s00424-009-0735-2; Ohnishi M, 2009, KIDNEY INT, V75, P1166, DOI 10.1038/ki.2009.24; Okano T, 2004, J STEROID BIOCHEM, V89-90, P335, DOI 10.1016/j.jsbmb.2004.03.024; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rodriguez ME, 2007, AM J PHYSIOL-RENAL, V292, pF1390, DOI 10.1152/ajprenal.00262.2006; Shimada T, 2001, P NATL ACAD SCI USA, V98, P6500, DOI 10.1073/pnas.101545198; Sitara D, 2006, AM J PATHOL, V169, P2161, DOI 10.2353/ajpath.2006.060329; Tsujikawa H, 2003, MOL ENDOCRINOL, V17, P2393, DOI 10.1210/me.2003-0048; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Utsugi T, 2000, METABOLISM, V49, P1118, DOI 10.1053/meta.2000.8606; Voshol PJ, 2003, ENDOCRINOLOGY, V144, P3456, DOI 10.1210/en.2002-0036; Weber K, 2009, J BONE MINER RES, V24, P22, DOI [10.1359/jbmr.0080904, 10.1359/JBMR.0080904]; Yamamoto M, 2005, J BIOL CHEM, V280, P38029, DOI 10.1074/jbc.M509039200; Yoshida T, 2002, ENDOCRINOLOGY, V143, P683, DOI 10.1210/en.143.2.683; Zeitz U, 2003, FASEB J, V17, P509, DOI 10.1096/fj.02-0424fje	37	37	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e31376	10.1371/journal.pone.0031376	http://dx.doi.org/10.1371/journal.pone.0031376			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LO	22319626	Green Published, gold, Green Submitted			2022-12-27	WOS:000302178400038
J	Cao, LH; Silvestry, S; Zhao, N; Diehl, J; Sun, JZ				Cao, Longhui; Silvestry, Scott; Zhao, Ning; Diehl, James; Sun, Jianzhong			Effects of Preoperative Aspirin on Cardiocerebral and Renal Complications in Non-Emergent Cardiac Surgery Patients: A Sub-Group and Cohort Study	PLOS ONE			English	Article							BYPASS GRAFT-SURGERY; ANTIPLATELET THERAPY; THORACIC-SURGEONS; CORONARY; GUIDELINE; MORBIDITY; MORTALITY; SOCIETY; CLOPIDOGREL; DISEASE	Background and Objective: Postoperative cardiocerebral and renal complications are a major threat for patients undergoing cardiac surgery. This study was aimed to examine the effect of preoperative aspirin use on patients undergoing cardiac surgery. Methods: An observational cohort study was performed on consecutive patients (n = 1879) receiving cardiac surgery at this institution. The patients excluded from the study were those with preoperative anticoagulants, unknown aspirin use, or underwent emergent cardiac surgery. Outcome events included were 30-day mortality, renal failure, readmission and a composite outcome - major adverse cardiocerebral events (MACE) that include permanent or transient stroke, coma, perioperative myocardial infarction (MI), heart block and cardiac arrest. Results: Of all patients, 1145 patients met the inclusion criteria and were divided into two groups: those taking (n = 858) or not taking (n = 287) aspirin within 5 days preceding surgery. Patients with aspirin presented significantly more with history of hypertension, diabetes, peripheral arterial disease, previous MI, angina and older age. With propensity scores adjusted and multivariate logistic regression, however, this study showed that preoperative aspirin therapy (vs. no aspirin) significantly reduced the risk of MACE (8.4% vs. 12.5%, odds ratio [OR] 0.585, 95% CI 0.355-0.964, P = 0.035), postoperative renal failure (2.6% vs. 5.2%, OR 0.438, CI 0.203-0.945, P = 0.035) and dialysis required (0.8% vs. 3.1%, OR 0.230, CI 0.071-0.742, P = 0.014), but did not significantly reduce 30-day mortality (4.1% vs. 5.8%, OR 0.744, CI 0.376-1.472, P = 0.396) nor it increased readmissions in the patients undergoing cardiac surgery. Conclusions: Preoperative aspirin therapy is associated with a significant decrease in the risk of MACE and renal failure and did not increase readmissions in patients undergoing non-emergent cardiac surgery.	[Cao, Longhui; Sun, Jianzhong] Thomas Jefferson Univ, Jefferson Med Coll, Dept Anesthesiol, Philadelphia, PA 19107 USA; [Silvestry, Scott; Diehl, James] Thomas Jefferson Univ, Jefferson Med Coll, Div Cardiothorac Surg, Philadelphia, PA 19107 USA; [Cao, Longhui] Sun Yat Sen Univ, Ctr Canc, Dept Anesthesiol, Guangzhou 510275, Guangdong, Peoples R China; [Zhao, Ning] Univ Penn Hlth Syst, Dept Psychiat, Philadelphia, PA USA	Jefferson University; Jefferson University; Sun Yat Sen University; University of Pennsylvania	Cao, LH (corresponding author), Thomas Jefferson Univ, Jefferson Med Coll, Dept Anesthesiol, Philadelphia, PA 19107 USA.	jian-zhong.sun@jefferson.edu						[Anonymous], 1988, LANCET, V2, P349; Awtry EH, 2000, CIRCULATION, V101, P1206, DOI 10.1161/01.CIR.101.10.1206; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Barodka V, 2011, J SURG RES, V167, pE63, DOI 10.1016/j.jss.2009.11.702; Berger JS, 2008, AM J MED, V121, P43, DOI 10.1016/j.amjmed.2007.10.002; Berger JS, 2009, AM J CARDIOL, V104, p44C, DOI 10.1016/j.amjcard.2009.06.015; Brown PP, 2008, ANN THORAC SURG, V85, P1980, DOI 10.1016/j.athoracsur.2008.01.053; Bucerius J, 2003, ANN THORAC SURG, V75, P472, DOI 10.1016/S0003-4975(02)04370-9; Bybee KA, 2005, CIRCULATION, V112, pI286, DOI 10.1161/CIRCULATIONAHA.104.522805; Cao LH, 2011, ANN SURG; Chen JC, 2007, CRIT CARE MED, V35, P1296, DOI 10.1097/01.CCM.0000262403.08546.A2; CHESEBRO JH, 1982, NEW ENGL J MED, V307, P73, DOI 10.1056/NEJM198207083070201; D'Agostino RB, 2007, CIRCULATION, V115, P2340, DOI 10.1161/CIRCULATIONAHA.105.594952; Dunning J, 2008, EUR J CARDIO-THORAC, V34, P73, DOI 10.1016/j.ejcts.2008.02.024; Eagle Kim A, 2004, Circulation, V110, P1168, DOI 10.1161/01.CIR.0000138790.14877.7D; Ferguson TB, 2002, JAMA-J AM MED ASSOC, V287, P2221, DOI 10.1001/jama.287.17.2221; Ferraris VA, 2005, ANN THORAC SURG, V79, P1454, DOI 10.1016/j.athoracsur.2005.01.008; FREMES SE, 1993, EUR J CARDIO-THORAC, V7, P169, DOI 10.1016/1010-7940(93)90155-5; Gerrah R, 2004, J CARDIOVASC SURG, V45, P545; GOLDMAN S, 1989, CIRCULATION, V80, P1190, DOI 10.1161/01.CIR.80.5.1190; GOLDMAN S, 1988, CIRCULATION, V77, P1324, DOI 10.1161/01.CIR.77.6.1324; Jacob M, 2011, CIRCULATION, V123, P577, DOI 10.1161/CIRCULATIONAHA.110.957373; Kim DH, 2009, J THORAC CARDIOV SUR, V138, P1377, DOI 10.1016/j.jtcvs.2009.07.027; King SB, 2008, CIRCULATION, V117, P261, DOI 10.1161/CIRCULATIONAHA.107.188208; Kulik A, 2009, EXPERT OPIN DRUG SAF, V8, P169, DOI [10.1517/14740330902797081, 10.1517/14740330902797081 ]; Mangano DT, 2002, NEW ENGL J MED, V347, P1309, DOI 10.1056/NEJMoa020798; Sandercock P, 1997, LANCET, V349, P1569; Shahian DM, 2009, ANN THORAC SURG, V88, pS43, DOI 10.1016/j.athoracsur.2009.05.055; Shroyer ALW, 2003, ANN THORAC SURG, V75, P1856, DOI 10.1016/S0003-4975(03)00179-6; Sun JCJ, 2010, AM HEART J, V160, P1178, DOI 10.1016/j.ahj.2010.07.035; Tolpin DA, 2009, J THORAC CARDIOV SUR, V138, P873, DOI 10.1016/j.jtcvs.2009.02.019; Tran H, 2004, JAMA-J AM MED ASSOC, V292, P1867, DOI 10.1001/jama.292.15.1867; YUSUF S, 1991, JAMA-J AM MED ASSOC, V266, P93, DOI 10.1001/jama.266.1.93	33	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2012	7	2							e30094	10.1371/journal.pone.0030094	http://dx.doi.org/10.1371/journal.pone.0030094			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UV	22319558	Green Published, Green Submitted, gold			2022-12-27	WOS:000301979000001
J	Ishikawa, FH; Souza, EA; Shoji, JY; Connolly, L; Freitag, M; Read, ND; Roca, MG				Ishikawa, Francine H.; Souza, Elaine A.; Shoji, Jun-ya; Connolly, Lanelle; Freitag, Michael; Read, Nick D.; Roca, M. Gabriela			Heterokaryon Incompatibility Is Suppressed Following Conidial Anastomosis Tube Fusion in a Fungal Plant Pathogen	PLOS ONE			English	Article							COLLETOTRICHUM-LINDEMUTHIANUM; FILAMENTOUS FUNGI; SUPERNUMERARY CHROMOSOME; HYPHAL FUSION; VEGETATIVE COMPATIBILITY; HORIZONTAL GENE; MINAS-GERAIS; GLOEOSPORIOIDES; BIOTYPES; BRAZIL	It has been hypothesized that horizontal gene/chromosome transfer and parasexual recombination following hyphal fusion between different strains may contribute to the emergence of wide genetic variability in plant pathogenic and other fungi. However, the significance of vegetative (heterokaryon) incompatibility responses, which commonly result in cell death, in preventing these processes is not known. In this study, we have assessed this issue following different types of hyphal fusion during colony initiation and in the mature colony. We used vegetatively compatible and incompatible strains of the common bean pathogen Colletotrichum lindemuthianum in which nuclei were labelled with either a green or red fluorescent protein in order to microscopically monitor the fates of nuclei and heterokaryotic cells following hyphal fusion. As opposed to fusion of hyphae in mature colonies that resulted in cell death within 3 h, fusions by conidial anastomosis tubes (CAT) between two incompatible strains during colony initiation did not induce the vegetative incompatibility response. Instead, fused conidia and germlings survived and formed heterokaryotic colonies that in turn produced uninucleate conidia that germinated to form colonies with phenotypic features different to those of either parental strain. Our results demonstrate that the vegetative incompatibility response is suppressed during colony initiation in C. lindemuthianum. Thus, CAT fusion may allow asexual fungi to increase their genetic diversity, and to acquire new pathogenic traits.	[Ishikawa, Francine H.; Souza, Elaine A.] Univ Fed Lavras, Dept Biol, Lavras, MG, Brazil; [Connolly, Lanelle; Freitag, Michael] Oregon State Univ, Dept Biochem & Biophys, Ctr Genome Res & Biocomp, Corvallis, OR 97331 USA; [Ishikawa, Francine H.; Shoji, Jun-ya; Read, Nick D.; Roca, M. Gabriela] Univ Edinburgh, Fungal Cell Biol Grp, Inst Cell Biol, Edinburgh, Midlothian, Scotland	Universidade Federal de Lavras; Oregon State University; University of Edinburgh	Ishikawa, FH (corresponding author), Univ Fed Vale Sao Francisco, Colegiado Engn Agron, Petrolina, PE, Brazil.	easouza@dbi.ufla.br	Ishikawa, Francine/F-6962-2015	Ishikawa, Francine/0000-0002-7491-2657; Read, Nick/0000-0002-2286-2862	CNPQ (Brazil); American Cancer Society [RSG-08-030-01-CCG]; Biotechnological and Biological Sciences Research Council [BB/E010741/1]; Biotechnology and Biological Sciences Research Council [BB/E010741/1] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097637] Funding Source: NIH RePORTER; BBSRC [BB/E010741/1] Funding Source: UKRI	CNPQ (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); American Cancer Society(American Cancer Society); Biotechnological and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants and a scholarship from CNPQ (Brazil) to Francine Ishikawa and Elaine Souza, by a grant from the American Cancer Society (RSG-08-030-01-CCG) to Michael Freitag and a grant from the Biotechnological and Biological Sciences Research Council (BB/E010741/1) to Nick Read. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi Y, 2009, EUKARYOT CELL, V8, P1732, DOI 10.1128/EC.00135-09; Barcelos QL, 2011, GENET MOL RES, V10, P230, DOI 10.4238/vol10-1gmr907; Bos C, 1985, INDUCED MUTATION SOM; Camargo OA, 2007, GENET MOL RES, V6, P607; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Ruiz-Roldan MC, 2010, EUKARYOT CELL, V9, P1216, DOI 10.1128/EC.00040-10; Castro-Prado MAA, 2007, GENET MOL RES, V6, P634; Clutterbuck AJ, 1996, J GENET, V75, P281, DOI 10.1007/BF02966308; Coleman JJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000618; Freitag M, 2005, FUNGAL GENET NEWSLET, V52, P14; Glass NL, 2006, CURR OPIN MICROBIOL, V9, P553, DOI 10.1016/j.mib.2006.09.001; Glass NL, 2003, EUKARYOT CELL, V2, P1, DOI 10.1128/EC.2.1.1-8.2003; Glass NL, 2000, ANNU REV GENET, V34, P165, DOI 10.1146/annurev.genet.34.1.165; Goodwin SB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002070; HABGOOD RM, 1970, NATURE, V227, P1268, DOI 10.1038/2271268a0; Harimoto Y, 2007, MOL PLANT MICROBE IN, V20, P1463, DOI 10.1094/MPMI-20-12-1463; He CZ, 1998, GENETICS, V150, P1459; Hickey PC, 2005, METHOD MICROBIOL, V34, P63, DOI 10.1016/S0580-8517(04)3403-1; Ishikawa FH, 2008, BIOLOGIA, V63, P156, DOI 10.2478/s11756-008-0039-6; Ishikawa FH, 2010, FUNGAL BIOL-UK, V114, P2, DOI 10.1016/j.funbio.2009.11.006; Ishikawa FH, 2010, CIENC AGROTEC, V34, P74, DOI 10.1590/S1413-70542010000100009; Ma LJ, 2010, NATURE, V464, P367, DOI 10.1038/nature08850; Mahuku GS, 2004, EUR J PLANT PATHOL, V110, P253, DOI 10.1023/B:EJPP.0000019795.18984.74; Manners JM, 2011, MYCOL PROG, V10, P383, DOI 10.1007/s11557-011-0749-y; Masel AM, 1996, MOL PLANT MICROBE IN, V9, P339, DOI 10.1094/MPMI-9-0339; McGuire JC, 2005, MOL ECOL, V14, P3657, DOI [10.1111/j.1365-294X.2005.02693.x, 10.1111/j.1356-294X.2005.02693.x]; Mehrabi R, 2011, FEMS MICROBIOL REV, V35, P542, DOI 10.1111/j.1574-6976.2010.00263.x; MIAO VP, 1991, SCIENCE, V254, P1773, DOI 10.1126/science.1763326; Milgroom MG, 2009, FUNGAL GENET BIOL, V46, P849, DOI 10.1016/j.fgb.2009.07.007; O'Sullivan D, 1998, CURR GENET, V33, P291, DOI 10.1007/s002940050339; PASTOR-CORRALES M A, 1991, Phytopathology, V81, P694; Read ND, 2010, CELLULAR AND MOLECULAR BIOLOGY OF FILAMENTOUS FUNGI, P260; Read ND, 2009, CURR OPIN MICROBIOL, V12, P608, DOI 10.1016/j.mib.2009.09.008; Read ND, 2006, MOL B INT U, P87; Richards TA, 2006, CURR BIOL, V16, P1857, DOI 10.1016/j.cub.2006.07.052; Richards TA, 2011, CURR BIOL, V21, pR166, DOI 10.1016/j.cub.2011.01.028; Roca MG, 2010, EUKARYOT CELL, V9, P1171, DOI 10.1128/EC.00329-09; Roca M. M. G., 2003, Fitopatologia Brasileira, V28, P367, DOI 10.1590/S0100-41582003000400004; Roca MG, 2005, FEMS MICROBIOL LETT, V249, P191, DOI 10.1016/j.femsle.2005.06.048; Roca MG, 2005, EUKARYOT CELL, V4, P911, DOI 10.1128/EC.4.5.911-919.2005; Roca MG, 2004, MYCOL RES, V108, P1320, DOI 10.1017/S0953756204000838; Roca MG, 2003, FUNGAL GENET BIOL, V40, P138, DOI 10.1016/S1087-1845(03)00088-4; Sambrook J., 2001, MOL CLONING LAB MANU; Sanchez-Leon E, 2011, EUKARYOT CELL, V10, P683, DOI 10.1128/EC.00280-10; Sanders IR, 2006, TRENDS ECOL EVOL, V21, P656, DOI 10.1016/j.tree.2006.10.006; Schoonhoven A.V., 1987, STANDARD SYSTEM EVAL; Silar P, 1995, FUNG GENET NEWSLETT, V42, P73, DOI DOI 10.4148/1941-4765.1353; Silva KJDE, 2007, J PHYTOPATHOL, V155, P241; Souza EA, 2010, GENET MOL RES, V9, P1759, DOI 10.4238/vol9-3gmr863; STROMNAES O, 1963, GENETICS, V48, P653; TU JC, 1985, MICROBIOS, V44, P87	51	62	63	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2012	7	2							e31175	10.1371/journal.pone.0031175	http://dx.doi.org/10.1371/journal.pone.0031175			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UV	22319613	Green Published, gold			2022-12-27	WOS:000301979000025
J	Imielski, Y; Schwamborn, JC; Luningschror, P; Heimann, P; Holzberg, M; Werner, H; Leske, O; Puschel, AW; Memet, S; Heumann, R; Israel, A; Kaltschmidt, C; Kaltschmidt, B				Imielski, Yvonne; Schwamborn, Jens C.; Lueningschroer, Patrick; Heimann, Peter; Holzberg, Magdalena; Werner, Hendrikje; Leske, Oliver; Pueschel, Andreas W.; Memet, Sylvie; Heumann, Rolf; Israel, Alain; Kaltschmidt, Christian; Kaltschmidt, Barbara			Regrowing the Adult Brain: NF-kappa B Controls Functional Circuit Formation and Tissue Homeostasis in the Dentate Gyrus	PLOS ONE			English	Article							HIPPOCAMPAL NEUROGENESIS; PATTERN SEPARATION; PLASTICITY; SURVIVAL; NEURONS; IMPAIRMENT; DEFICITS; GROWTH; CELLS; CA3	Cognitive decline during aging is correlated with a continuous loss of cells within the brain and especially within the hippocampus, which could be regenerated by adult neurogenesis. Here we show that genetic ablation of NF-kappa B resulted in severe defects in the neurogenic region (dentate gyrus) of the hippocampus. Despite increased stem cell proliferation, axogenesis, synaptogenesis and neuroprotection were hampered, leading to disruption of the mossy fiber pathway and to atrophy of the dentate gyrus during aging. Here, NF-kappa B controls the transcription of FOXO1 and PKA, regulating axogenesis. Structural defects culminated in behavioral impairments in pattern separation. Re-activation of NF-kappa B resulted in integration of newborn neurons, finally to regeneration of the dentate gyrus, accompanied by a complete recovery of structural and behavioral defects. These data identify NF-kappa B as a crucial regulator of dentate gyrus tissue homeostasis suggesting NF-kappa B to be a therapeutic target for treating cognitive and mood disorders.	[Imielski, Yvonne; Lueningschroer, Patrick; Heimann, Peter; Holzberg, Magdalena; Kaltschmidt, Christian; Kaltschmidt, Barbara] Univ Bielefeld, Fac Biol, D-33615 Bielefeld, Germany; [Schwamborn, Jens C.] ZMBE, Inst Zellbiol, AG Stammzellbiol & Regenerat, Munster, Germany; [Werner, Hendrikje; Pueschel, Andreas W.] Univ Munster, Inst Mol Zellbiol, Munster, Germany; [Werner, Hendrikje] Immunos, Inst Med Biol, Singapore, Singapore; [Leske, Oliver; Heumann, Rolf] Ruhr Univ Bochum, Bochum, Germany; [Memet, Sylvie] Inst Pasteur, Unite Mycol Mol, CNRS URA3012, Paris, France; [Israel, Alain] Inst Pasteur, Unite Signalisat Mol & Activat Cellulair, CNRS URA 2582, Paris, France	University of Bielefeld; University of Munster; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); Ruhr University Bochum; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Imielski, Y (corresponding author), Univ Bielefeld, Fac Biol, D-33615 Bielefeld, Germany.	barbara.kaltschmidt@uni-bielefeld.de	Heumann, Rolf/AAK-4390-2020; Heumann, Rolf/ABB-9675-2021; Schwamborn, Jens C/F-9395-2011	Heumann, Rolf/0000-0003-4364-2655; Schwamborn, Jens C/0000-0003-4496-0559; Memet, Sylvie/0000-0001-6571-4192; Luningschror, Patrick/0000-0002-3883-6554	Deutsche Forschungsgemeinschaft (DFG) [GZ: KA 1210/5-1]; Walcker Stiftung, Isny, Allgau, Germany; Bielefeld University	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Walcker Stiftung, Isny, Allgau, Germany; Bielefeld University	This study was funded in part by the Deutsche Forschungsgemeinschaft (DFG, GZ: KA 1210/5-1); the Walcker Stiftung, Isny, Allgau, Germany and Institutional Funds of Bielefeld University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Buylla A, 2001, NAT REV NEUROSCI, V2, P287, DOI 10.1038/35067582; Bakker A, 2008, SCIENCE, V319, P1640, DOI 10.1126/science.1152882; Barnes AP, 2007, CELL, V129, P549, DOI 10.1016/j.cell.2007.03.025; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Bhakar AL, 2002, J NEUROSCI, V22, P8466; Boersma MCH, 2011, J NEUROSCI, V31, P5414, DOI 10.1523/JNEUROSCI.2456-10.2011; Bonini SA, 2011, J NEUROSCI, V31, P11697, DOI 10.1523/JNEUROSCI.1113-11.2011; Brun VH, 2002, SCIENCE, V296, P2243, DOI 10.1126/science.1071089; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; de la Torre-Ubieta L, 2010, GENE DEV, V24, P799, DOI 10.1101/gad.1880510; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Denis-Donini S, 2008, J NEUROSCI, V28, P3911, DOI 10.1523/JNEUROSCI.0148-08.2008; Doetsch F, 2003, NAT NEUROSCI, V6, P1127, DOI 10.1038/nn1144; FORSSMANN WG, 1977, ANAT RECORD, V188, P307, DOI 10.1002/ar.1091880304; Fridmacher V, 2003, J NEUROSCI, V23, P9403; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gavalda N, 2009, DEVELOPMENT, V136, P3405, DOI 10.1242/dev.035295; Gould E., 2007, HIPPOCAMPUS BOOK, P321; Gutierrez H, 2005, DEVELOPMENT, V132, P1713, DOI 10.1242/dev.01702; Gutierrez H, 2011, TRENDS NEUROSCI, V34, P316, DOI 10.1016/j.tins.2011.03.001; Hastings NB, 2003, NAT MED, V9, P264, DOI 10.1038/nm0303-264; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Henson PM, 2006, TRENDS IMMUNOL, V27, P244, DOI 10.1016/j.it.2006.03.005; Jagasia R, 2009, J NEUROSCI, V29, P7966, DOI 10.1523/JNEUROSCI.1054-09.2009; Jin KL, 2004, P NATL ACAD SCI USA, V101, P343, DOI 10.1073/pnas.2634794100; Kaltschmidt B, 1999, ONCOGENE, V18, P3213, DOI 10.1038/sj.onc.1202657; Kaltschmidt B, 2006, MOL CELL BIOL, V26, P2936, DOI 10.1128/MCB.26.8.2936-2946.2006; Kaltschmidt B, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001271; Khazaei MR, 2010, J NEUROCHEM; Koo JW, 2010, P NATL ACAD SCI USA, V107, P2669, DOI 10.1073/pnas.0910658107; Lafenetre P, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/neuro.08.034.2009; Leuner B, 2010, ANNU REV PSYCHOL, V61, P111, DOI 10.1146/annurev.psych.093008.100359; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; Mattson MP, 2005, NEUROCHEM RES, V30, P883, DOI 10.1007/s11064-005-6961-x; Mattson MP, 2006, CELL DEATH DIFFER, V13, P852, DOI 10.1038/sj.cdd.4401837; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; Meffert MK, 2003, NAT NEUROSCI, V6, P1072, DOI 10.1038/nn1110; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Mu YL, 2010, CURR OPIN NEUROBIOL, V20, P416, DOI 10.1016/j.conb.2010.04.010; Nakada D, 2011, NEURON, V70, P703, DOI 10.1016/j.neuron.2011.05.011; Paik JH, 2009, CELL STEM CELL, V5, P540, DOI 10.1016/j.stem.2009.09.013; Pasparakis M, 2009, NAT REV IMMUNOL, V9, P778, DOI 10.1038/nri2655; Renault VM, 2009, CELL STEM CELL, V5, P527, DOI 10.1016/j.stem.2009.09.014; Rola R, 2004, EXP NEUROL, V188, P316, DOI 10.1016/j.expneurol.2004.05.005; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Schwamborn JC, 2004, NAT NEUROSCI, V7, P923, DOI 10.1038/nn1295; Schwamborn JC, 2009, CELL, V136, P913, DOI 10.1016/j.cell.2008.12.024; Shelly M, 2007, CELL, V129, P565, DOI 10.1016/j.cell.2007.04.012; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; Suh H, 2009, ANNU REV CELL DEV BI, V25, P253, DOI 10.1146/annurev.cellbio.042308.113256; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174	53	53	58	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2012	7	2							e30838	10.1371/journal.pone.0030838	http://dx.doi.org/10.1371/journal.pone.0030838			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UG	22312433	gold, Green Published, Green Submitted			2022-12-27	WOS:000301977500021
J	Ramazzotti, M; Monsellier, E; Kamoun, C; Degl'Innocenti, D; Melki, R				Ramazzotti, Matteo; Monsellier, Elodie; Kamoun, Choumouss; Degl'Innocenti, Donatella; Melki, Ronald			Polyglutamine Repeats Are Associated to Specific Sequence Biases That Are Conserved among Eukaryotes	PLOS ONE			English	Article							AMINO-ACID REPEATS; CAG REPEATS; TRINUCLEOTIDE REPEATS; PROTEIN SEQUENCES; HUNTINGTIN; INSTABILITY; AGGREGATION; INSIGHTS; SCA1; EXPANSION	Nine human neurodegenerative diseases, including Huntington's disease and several spinocerebellar ataxia, are associated to the aggregation of proteins comprising an extended tract of consecutive glutamine residues (polyQs) once it exceeds a certain length threshold. This event is believed to be the consequence of the expansion of polyCAG codons during the replication process. This is in apparent contradiction with the fact that many polyQs-containing proteins remain soluble and are encoded by invariant genes in a number of eukaryotes. The latter suggests that polyQs expansion and/or aggregation might be counter-selected through a genetic and/or protein context. To identify this context, we designed a software that scrutinize entire proteomes in search for imperfect polyQs. The nature of residues flanking the polyQs and that of residues other than Gln within polyQs (insertions) were assessed. We discovered strong amino acid residue biases robustly associated to polyQs in the 15 eukaryotic proteomes we examined, with an over-representation of Pro, Leu and His and an under-representation of Asp, Cys and Gly amino acid residues. These biases are conserved amongst unrelated proteins and are independent of specific functional classes. Our findings suggest that specific residues have been co-selected with polyQs during evolution. We discuss the possible selective pressures responsible of the observed biases.	[Ramazzotti, Matteo; Degl'Innocenti, Donatella] Univ Florence, Dipartimento Sci Biochim, Florence, Italy; [Monsellier, Elodie; Kamoun, Choumouss] UPR 3082 CNRS, Lab Enzymol & Biochim Struct, Gif Sur Yvette, France	University of Florence; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Ramazzotti, M (corresponding author), Univ Florence, Dipartimento Sci Biochim, Florence, Italy.	matteo.ramazzotti@unifi.it; monsellier@lebs.cnrs-gif.fr	Ramazzotti, Matteo/J-4866-2012; Degl'Innocenti, Donatella/O-8813-2014; Monsellier, Elodie/GRF-5106-2022	Ramazzotti, Matteo/0000-0002-6862-9409; Degl'Innocenti, Donatella/0000-0002-3342-5537; Monsellier, Elodie/0000-0001-7944-7531	Partenariat Hubert Curien (Franco-Italienne University) [22138SJ]; Fondi di Ateneo of the University of Florence; Agence Nationale de la Recherche [ANR-08-NEUR-001-01, ANR-09-MNPS-013-01]; Human Frontier program; EraNet Neuron (Miprotran) program; Centre National de la Recherche Scientifique; Fondation pour la Recherche Medicale [SPF20080512049]	Partenariat Hubert Curien (Franco-Italienne University); Fondi di Ateneo of the University of Florence; Agence Nationale de la Recherche(French National Research Agency (ANR)); Human Frontier program; EraNet Neuron (Miprotran) program; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported by grants from the Partenariat Hubert Curien (Franco-Italienne University, project Galileo not equal 22138SJ), Fondi di Ateneo 2009 of the University of Florence, the Agence Nationale de la Recherche (ANR-08-NEUR-001-01, and ANR-09-MNPS-013-01), the Human Frontier and the EraNet Neuron (Miprotran) programs and the Centre National de la Recherche Scientifique, and by a fellowship from the Fondation pour la Recherche Medicale (project not equal SPF20080512049). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba MM, 2004, GENOME RES, V14, P549, DOI 10.1101/gr.1925704; Alba MM, 2001, J MOL EVOL, V52, P249, DOI 10.1007/s002390010153; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bauer PO, 2009, J NEUROCHEM, V110, P1737, DOI 10.1111/j.1471-4159.2009.06302.x; Bhattacharyya A, 2006, J MOL BIOL, V355, P524, DOI 10.1016/j.jmb.2005.10.053; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; CHUNG MY, 1993, NAT GENET, V5, P254, DOI 10.1038/ng1193-254; Darnell G, 2007, J MOL BIOL, V374, P688, DOI 10.1016/j.jmb.2007.09.023; de Chiara C, 2005, J MOL BIOL, V354, P883, DOI 10.1016/j.jmb.2005.09.083; de Mezer M, 2011, NUCLEIC ACIDS RES, V39, P3852, DOI 10.1093/nar/gkq1323; Dehay B, 2006, J BIOL CHEM, V281, P35608, DOI 10.1074/jbc.M605558200; Dixon MJ, 2004, NUCLEIC ACIDS RES, V32, P1289, DOI 10.1093/nar/gkh292; Duennwald ML, 2006, P NATL ACAD SCI USA, V103, P11045, DOI 10.1073/pnas.0604547103; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; EICHLER EE, 1994, NAT GENET, V8, P88, DOI 10.1038/ng0994-88; Faux NG, 2005, GENOME RES, V15, P537, DOI 10.1101/gr.3096505; Faux NG, 2007, GENOME RES, V17, P1118, DOI 10.1101/gr.6255407; Garvie CW, 2001, MOL CELL, V8, P937, DOI 10.1016/S1097-2765(01)00392-6; Gojobori J, 2011, MOL BIOL EVOL, V28, P543, DOI 10.1093/molbev/msq225; Haerty W, 2010, GENOME RES, V20, P755, DOI 10.1101/gr.101246.109; Haider S, 2009, NUCLEIC ACIDS RES, V37, pW23, DOI 10.1093/nar/gkp265; Hands SL, 2010, ACTA NEUROPATHOL, V120, P419, DOI 10.1007/s00401-010-0703-0; Harris GM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013695; Hsu RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016417; Huang H, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-r47; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Huntley MA, 2007, MOL BIOL EVOL, V24, P2598, DOI 10.1093/molbev/msm129; Jasinska A, 2003, NUCLEIC ACIDS RES, V31, P5463, DOI 10.1093/nar/gkg767; Jayaraman M, 2009, PROTEIN ENG DES SEL, V22, P469, DOI 10.1093/protein/gzp023; Karlin S, 2002, P NATL ACAD SCI USA, V99, P333, DOI 10.1073/pnas.012608599; KARLIN S, 1995, CURR OPIN STRUC BIOL, V5, P360, DOI 10.1016/0959-440X(95)80098-0; Katti MV, 2000, PROTEIN SCI, V9, P1203, DOI 10.1110/ps.9.6.1203; Kersey PJ, 2010, NUCLEIC ACIDS RES, V38, pD563, DOI 10.1093/nar/gkp871; Kiliszek A, 2010, NUCLEIC ACIDS RES, V38, P8370, DOI 10.1093/nar/gkq700; Kozlowski P, 2010, NUCLEIC ACIDS RES, V38, P4027, DOI 10.1093/nar/gkq127; Kumar R, 2011, LIFE SCI, V88, P565, DOI 10.1016/j.lfs.2011.01.021; Kurosaki T, 2006, GENE, V373, P23, DOI 10.1016/j.gene.2005.12.017; Lakhani VV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000772; Langbehn DR, 2010, AM J MED GENET B, V153B, P397, DOI 10.1002/ajmg.b.30992; Lawlor KT, 2011, HUMAN MOL GENETICS P; Li LB, 2008, NATURE, V453, P1107, DOI 10.1038/nature06909; Madsen LB, 2007, NEUROGENETICS, V8, P207, DOI 10.1007/s10048-007-0088-y; Marcotte EM, 1999, J MOL BIOL, V293, P151, DOI 10.1006/jmbi.1999.3136; McKusick VA, 2007, AM J HUM GENET, V80, P588, DOI 10.1086/514346; Menon RP, 2006, CELL MOL LIFE SCI, V63, P1677, DOI 10.1007/s00018-006-6097-4; Michlewski G, 2004, J MOL BIOL, V340, P665, DOI 10.1016/j.jmb.2004.05.021; Miller M, 2009, CURR PROTEIN PEPT SC, V10, P244, DOI 10.2174/138920309788452164; Monsellier E, 2007, EMBO REP, V8, P737, DOI 10.1038/sj.embor.7401034; Mularoni L, 2007, GENOMICS, V89, P316, DOI 10.1016/j.ygeno.2006.11.011; Paulson HL, 1997, NEURON, V19, P333, DOI 10.1016/S0896-6273(00)80943-5; Pearson CE, 2005, NAT REV GENET, V6, P729, DOI 10.1038/nrg1689; Popiel HA, 2004, BIOCHEM BIOPH RES CO, V317, P1200, DOI 10.1016/j.bbrc.2004.03.161; Qin ZH, 2004, J NEUROSCI, V24, P269, DOI 10.1523/JNEUROSCI.1409-03.2004; Rebbeck TR, 2001, CANCER RES, V61, P5420; Reumers J, 2009, HUM MUTAT, V30, P431, DOI 10.1002/humu.20905; Rockabrand E, 2007, HUM MOL GENET, V16, P61, DOI 10.1093/hmg/ddl440; Rolfsmeier ML, 2000, MOL CELL BIOL, V20, P173, DOI 10.1128/MCB.20.1.173-180.2000; Ross CA, 2011, LANCET NEUROL, V10, P83, DOI 10.1016/S1474-4422(10)70245-3; Rousseau F, 2006, J MOL BIOL, V355, P1037, DOI 10.1016/j.jmb.2005.11.035; Sakamoto N, 2001, J BIOL CHEM, V276, P27178, DOI 10.1074/jbc.M101852200; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Sen S, 2003, PROTEIN SCI, V12, P953, DOI 10.1110/ps.0224403; Sharma D, 1999, FEBS LETT, V456, P181, DOI 10.1016/S0014-5793(99)00933-3; Simon M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r59; Siwach P, 2006, MOL BIOL EVOL, V23, P1357, DOI 10.1093/molbev/msk022; Sobczak K, 2005, J BIOL CHEM, V280, P3898, DOI 10.1074/jbc.M409984200; Sobczak K, 2004, J BIOL CHEM, V279, P41563, DOI 10.1074/jbc.M405130200; Sobczak K, 2004, HUM MUTAT, V24, P236, DOI 10.1002/humu.20075; Sobczak K, 2010, J BIOL CHEM, V285, P12755, DOI 10.1074/jbc.M109.078790; Tam S, 2009, NAT STRUCT MOL BIOL, V16, P1279, DOI 10.1038/nsmb.1700; Tartari M, 2008, MOL BIOL EVOL, V25, P330, DOI 10.1093/molbev/msm258; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Thakur AK, 2009, NAT STRUCT MOL BIOL, V16, P380, DOI 10.1038/nsmb.1570; Todd PK, 2010, ANN NEUROL, V67, P291, DOI 10.1002/ana.21948; Wang LC, 2011, CELL MOL LIFE SCI, V68, P1255, DOI 10.1007/s00018-010-0522-4; Wang Y, 2009, FASEB J, V23, P451, DOI 10.1096/fj.08-117614; Wexler NS, 2004, P NATL ACAD SCI USA, V101, P3498, DOI 10.1073/pnas.0308479101; Wong LJC, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-111; Zoghbi HY, 2009, J BIOL CHEM, V284, P7425, DOI 10.1074/jbc.R800041200	80	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2012	7	2							e30824	10.1371/journal.pone.0030824	http://dx.doi.org/10.1371/journal.pone.0030824			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UG	22312432	Green Published, Green Submitted, gold			2022-12-27	WOS:000301977500019
J	Itoh, M; Kojima, M; Nagao-Sato, S; Saijo, E; Lassmann, T; Kanamori-Katayama, M; Kaiho, A; Lizio, M; Kawaji, H; Carninci, P; Forrest, ARR; Hayashizaki, Y				Itoh, Masayoshi; Kojima, Miki; Nagao-Sato, Sayaka; Saijo, Eri; Lassmann, Timo; Kanamori-Katayama, Mutsumi; Kaiho, Ai; Lizio, Marina; Kawaji, Hideya; Carninci, Piero; Forrest, Alistair R. R.; Hayashizaki, Yoshihide			Automated Workflow for Preparation of cDNA for Cap Analysis of Gene Expression on a Single Molecule Sequencer	PLOS ONE			English	Article							TRANSCRIPTOME; CONSTRUCTION; SEQ	Background: Cap analysis of gene expression (CAGE) is a 5' sequence tag technology to globally determine transcriptional starting sites in the genome and their expression levels and has most recently been adapted to the HeliScope single molecule sequencer. Despite significant simplifications in the CAGE protocol, it has until now been a labour intensive protocol. Methodology: In this study we set out to adapt the protocol to a robotic workflow, which would increase throughput and reduce handling. The automated CAGE cDNA preparation system we present here can prepare 96 'HeliScope ready' CAGE cDNA libraries in 8 days, as opposed to 6 weeks by a manual operator. We compare the results obtained using the same RNA in manual libraries and across multiple automation batches to assess reproducibility. Conclusions: We show that the sequencing was highly reproducible and comparable to manual libraries with an 8 fold increase in productivity. The automated CAGE cDNA preparation system can prepare 96 CAGE sequencing samples simultaneously. Finally we discuss how the system could be used for CAGE on Illumina/SOLiD platforms, RNA-seq and full-length cDNA generation.	[Itoh, Masayoshi; Kojima, Miki; Lassmann, Timo; Kanamori-Katayama, Mutsumi; Kaiho, Ai; Lizio, Marina; Kawaji, Hideya; Carninci, Piero; Forrest, Alistair R. R.; Hayashizaki, Yoshihide] RIKEN Yokohama Inst, Omics Sci Ctr, Tsurumi Ku, Yokohama, Kanagawa, Japan; [Nagao-Sato, Sayaka; Saijo, Eri] KK Dnaform, Tsurumi Ku, Yokohama, Kanagawa, Japan	RIKEN	Itoh, M (corresponding author), RIKEN Yokohama Inst, Omics Sci Ctr, Tsurumi Ku, Yokohama, Kanagawa, Japan.	maitoh@riken.jp; rgscerg@gsc.riken.jp	Lassmann, Timo/A-8271-2008; Lassmann, Timo/HCH-4313-2022; Kawaji, Hideya/N-5116-2015; Itoh, Masayoshi/N-5363-2015; Carninci, Piero/K-1568-2014	Lassmann, Timo/0000-0002-0138-2691; Lassmann, Timo/0000-0002-0138-2691; Kawaji, Hideya/0000-0002-0575-0308; Itoh, Masayoshi/0000-0002-1772-318X; Carninci, Piero/0000-0001-7202-7243; Forrest, Alistair/0000-0003-4543-1675	Japanese Ministry of Education, Culture, Sports, Science and Technology	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was funded by a Research Grant from the Japanese Ministry of Education, Culture, Sports, Science and Technology through the Cell Innovation Project and for the RIKEN Omics Science Center to YH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bock C, 2010, NAT BIOTECHNOL, V28, P1106, DOI 10.1038/nbt.1681; Carninci P, 2003, GENOME RES, V13, P1273, DOI 10.1101/gr.1119703; Carninci P, 1997, DNA Res, V4, P61, DOI 10.1093/dnares/4.1.61; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; DEANGELIS MM, 1995, NUCLEIC ACIDS RES, V23, P4742, DOI 10.1093/nar/23.22.4742; Farias-Hesson E, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/617469; Faulkner GJ, 2009, NAT GENET, V41, P563, DOI 10.1038/ng.368; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Goren A, 2010, NAT METHODS, V7, P47, DOI [10.1038/NMETH.1404, 10.1038/nmeth.1404]; Hart C, 2010, METHOD ENZYMOL, V472, P407, DOI 10.1016/S0076-6879(10)72002-4; Haussler D, 2009, J HERED, V100, P659, DOI 10.1093/jhered/esp086; HAWKINS TL, 1994, NUCLEIC ACIDS RES, V22, P4543, DOI 10.1093/nar/22.21.4543; Hestand MS, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq602; Kaiser J, 2008, SCIENCE, V319, P395, DOI 10.1126/science.319.5862.395; Kanamori-Katayama M, 2011, GENOME RES, V21, P1150, DOI 10.1101/gr.115469.110; Lennon NJ, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r15; Maekawa M, 1999, BIOCHEM BIOPH RES CO, V262, P671, DOI 10.1006/bbrc.1999.1230; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Park PJ, 2009, NAT REV GENET, V10, P669, DOI 10.1038/nrg2641; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; SCHERER WF, 1953, J EXP MED, V97, P695, DOI 10.1084/jem.97.5.695; Shiraki T, 2003, P NATL ACAD SCI USA, V100, P15776, DOI 10.1073/pnas.2136655100; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Suzuki H, 2009, NAT GENET, V41, P553, DOI 10.1038/ng.375; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; Valen E, 2009, GENOME RES, V19, P255, DOI 10.1101/gr.084541.108; Vitezic M, 2010, NUCLEIC ACIDS RES, V38, P8141, DOI 10.1093/nar/gkq729; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002	34	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2012	7	1							e30809	10.1371/journal.pone.0030809	http://dx.doi.org/10.1371/journal.pone.0030809			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	912BU	22303458	gold, Green Published, Green Submitted			2022-12-27	WOS:000301770300006
J	von Knorring, N; Gafos, M; Ramokonupi, M; Jentsch, U				von Knorring, Nina; Gafos, Mitzy; Ramokonupi, Motsei; Jentsch, Ute		MDP Team	Quality Control and Performance of HIV Rapid Tests in a Microbicide Clinical Trial in Rural KwaZulu-Natal	PLOS ONE			English	Article							INFECTION; AFRICA	Background: Quality control (QC) and evaluation of HIV rapid test procedures are an important aspect of HIV prevention trials. We describe QC and performance of two rapid tests, Determine (TM) and Uni-Gold (TM) used in a microbicide clinical trial in rural KwaZulu-Natal, South Africa. Methods/Results: Internal QC of both HIV rapid tests was conducted at the trial site using a Uni-Gold control kit (UniGold (TM) Recombigen (R) HIV). Both assays produced the expected results for a total of 4637 QC tests. Study participants were tested for HIV at screening and, if enrolled, at regular time points throughout the study. Positive or discordant results were confirmed by a double HIV immunoassay testing strategy at a local laboratory. Overall, 15292 HIV rapid test were performed. Sensitivity and specificity of Determine was 98.95% (95% CI: 97.72-99.61) and 99.83% (95% CI: 99.70-99.91) respectively [positive predictive value (PPV) 97.91% (95% CI: 96.38-98.92)], for Uni-Gold it was 99.30% (95% CI: 98.21-99.81) and 99.96% (95% CI: 99.88-99.99) respectively [PPV 99.47% (95% CI: 98.46-99.89)]. Conclusions: The results suggest that a Uni-Gold control kit can be used for internal QC of both Uni-Gold and the HIV-1 component of the Determine rapid tests. Both rapid tests performed proficiently in the trial population.	[von Knorring, Nina; Gafos, Mitzy; Ramokonupi, Motsei] Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Mtubatuba, South Africa; [von Knorring, Nina] Wits Reprod Hlth & HIV Inst, Johannesburg, South Africa; [Jentsch, Ute] Univ Witwatersrand, Hlth Consortium, Contract Lab Serv, Johannesburg, South Africa	University of Kwazulu Natal; University of Witwatersrand	von Knorring, N (corresponding author), Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Mtubatuba, South Africa.	nvonknorring@wrhi.ac.za		Gafos, Mitzy/0000-0002-7894-1498	UK government through its Department for International Development; Medical Research Council; Wellcome Trust [G0100137]; Medical Research Council [G0100137] Funding Source: researchfish; MRC [G0100137] Funding Source: UKRI	UK government through its Department for International Development; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The MDP301 clinical trial was funded by the UK government through its Department for International Development and Medical Research Council. The Medical Research Council sponsored the trial. The Africa Centre for Health and Population Studies of the University of KwaZulu-Natal, South Africa, is supported through grants from the Wellcome Trust (G0100137). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	B Awazu, 2000, INT C AIDS 13; Crucitti T, 2011, CLIN VACCINE IMMUNOL, V18, P1480, DOI 10.1128/CVI.05069-11; Dessie Azene, 2008, Ethiop Med J, V46, P1; Gray RH, 2007, BRIT MED J, V335, P188, DOI 10.1136/bmj.39210.582801.BE; McCormack S, 2010, LANCET, V376, P1329, DOI 10.1016/S0140-6736(10)61086-0; Moodley D, 2008, SAMJ S AFR MED J, V98, P707; Nunn A, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-99; Phili R, 2002, SAMJ S AFR MED J, V92, P818; Piwowar-Manning Estelle M, 2010, J Int Assoc Physicians AIDS Care (Chic), V9, P170, DOI 10.1177/1545109710368151; Seed P., 2010, STAT SOFTWARE COMPON; T Barnighausen, 2009, 16 C RETR OPP INF MO; Tanser F, 2008, INT J EPIDEMIOL, V37, P956, DOI 10.1093/ije/dym211; U Jentsch, 2010, MICR 2010 PITTSB US; Welz T, 2007, AIDS, V21, P1467, DOI 10.1097/QAD.0b013e3280ef6af2; WHO, 2009, 44 WHO, V44	15	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2012	7	1							e30728	10.1371/journal.pone.0030728	http://dx.doi.org/10.1371/journal.pone.0030728			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	912BU	22303452	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000301770300003
J	Nakjang, S; Ndeh, DA; Wipat, A; Bolam, DN; Hirt, RP				Nakjang, Sirintra; Ndeh, Didier A.; Wipat, Anil; Bolam, David N.; Hirt, Robert P.			A Novel Extracellular Metallopeptidase Domain Shared by Animal Host-Associated Mutualistic and Pathogenic Microbes	PLOS ONE			English	Article							CARBOHYDRATE-BINDING MODULES; PARASITE ENTAMOEBA-HISTOLYTICA; TRICHOMONAS-VAGINALIS; VIBRIO-CHOLERAE; BACILLUS-THURINGIENSIS; PAENIBACILLUS-LARVAE; ESCHERICHIA-COLI; INTESTINAL MUCIN; BIOLOGICAL ROLES; GENOME SEQUENCE	The mucosal microbiota is recognised as an important factor for our health, with many disease states linked to imbalances in the normal community structure. Hence, there is considerable interest in identifying the molecular basis of human-microbe interactions. In this work we investigated the capacity of microbes to thrive on mucosal surfaces, either as mutualists, commensals or pathogens, using comparative genomics to identify co-occurring molecular traits. We identified a novel domain we named M60-like/PF13402 (new Pfam entry PF13402), which was detected mainly among proteins from animal host mucosa-associated prokaryotic and eukaryotic microbes ranging from mutualists to pathogens. Lateral gene transfers between distantly related microbes explained their shared M60-like/PF13402 domain. The novel domain is characterised by a zinc-metallopeptidase-like motif and is distantly related to known viral enhancin zinc-metallopeptidases. Signal peptides and/or cell surface anchoring features were detected in most microbial M60-like/PF13402 domain-containing proteins, indicating that these proteins target an extracellular substrate. A significant subset of these putative peptidases was further characterised by the presence of associated domains belonging to carbohydrate-binding module family 5/12, 32 and 51 and other glycan-binding domains, suggesting that these novel proteases are targeted to complex glycoproteins such as mucins. An in vitro mucinase assay demonstrated degradation of mammalian mucins by a recombinant form of an M60-like/PF13402-containing protein from the gut mutualist Bacteroides thetaiotaomicron. This study reveals that M60-like domains are peptidases targeting host glycoproteins. These peptidases likely play an important role in successful colonisation of both vertebrate mucosal surfaces and the invertebrate digestive tract by both mutualistic and pathogenic microbes. Moreover, 141 entries across various peptidase families described in the MEROPS database were also identified with carbohydrate-binding modules defining a new functional context for these glycan-binding domains and providing opportunities to engineer proteases targeting specific glycoproteins for both biomedical and industrial applications.	[Nakjang, Sirintra; Ndeh, Didier A.; Wipat, Anil; Bolam, David N.; Hirt, Robert P.] Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Wipat, Anil] Newcastle Univ, Sch Comp Sci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK	Nakjang, S (corresponding author), Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	robert.hirt@newcastle.ac.uk	Hirt, Robert/R-5429-2017	Hirt, Robert/0000-0002-3760-9958; Wipat, Anil/0000-0001-7310-4191; Ndeh, Didier/0000-0001-7875-1638; Bolam, David/0000-0003-0314-3122	Faculty of Medical Sciences; School of Computing Science at Newcastle University; Overseas Research Students Awards Scheme; Commonwealth Scholarship Commission; Department for International Development; Biotechnology and Biological Sciences Research Council [BB/F014163/1] Funding Source: researchfish; BBSRC [BB/F014163/1] Funding Source: UKRI	Faculty of Medical Sciences; School of Computing Science at Newcastle University; Overseas Research Students Awards Scheme; Commonwealth Scholarship Commission; Department for International Development; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	SN's PhD project was supported by the Faculty of Medical Sciences and the School of Computing Science at Newcastle University and an Overseas Research Students Awards Scheme. DN's PhD project is funded by the Commonwealth Scholarship Commission and the Department for International Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott DW, 2008, MOL BIOL EVOL, V25, P155, DOI 10.1093/molbev/msm243; Alsmark U. Cecilia, 2009, V532, P489, DOI 10.1007/978-1-60327-853-9_28; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Antunez K, 2009, J INVERTEBR PATHOL, V102, P129, DOI 10.1016/j.jip.2009.07.010; Arnesen LPS, 2008, FEMS MICROBIOL REV, V32, P579, DOI 10.1111/j.1574-6976.2008.00112.x; AULD DS, 1995, METHOD ENZYMOL, V248, P228; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bolam DN, 2004, J BIOL CHEM, V279, P22953, DOI 10.1074/jbc.M313317200; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Brockhausen I, 2009, ESSENTIALS GLYCOBIOL, P115; Brun E, 1997, BIOCHEMISTRY; Brynestad S, 2002, INT J FOOD MICROBIOL, V74, P195, DOI 10.1016/S0168-1605(01)00680-8; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Carlton JM, 2007, SCIENCE, V315, P207, DOI 10.1126/science.1132894; Carlton JM, 2010, ANAEROBIC PARASITIC PROTOZOA: GENOMICS AND MOLECULAR BIOLOGY, P45, DOI 10.1016/B978-0-12-384876-5.00003-4; Cerda-Costa N, 2011, MOL MICROBIOL, V79, P119, DOI 10.1111/j.1365-2958.2010.07434.x; Clark CG, 2007, ADV PARASIT, V65, P51, DOI 10.1016/S0065-308X(07)65002-7; Cone RA, 2005, MUCOSAL IMMUNOLOGY, 3RD EDITION, P49, DOI 10.1016/B978-012491543-5/50008-5; Davis PH, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000415; de Groot PWJ, 2008, MOL MICROBIOL, V68, P535, DOI 10.1111/j.1365-2958.2008.06182.x; de Miguel N, 2010, MOL CELL PROTEOMICS, V9, P1554, DOI 10.1074/mcp.M000022-MCP201; Derrien M, 2008, APPL ENVIRON MICROB, V74, P1646, DOI 10.1128/AEM.01226-07; Edman U, 1990, J EXPT MED; Ehrlich GD, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-225; Ellrott K, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000798; Fang SL, 2009, APPL ENVIRON MICROB, V75, P5237, DOI 10.1128/AEM.00532-09; Farthing MJG, 2006, NAT CLIN PRACT GASTR, V3, P436, DOI 10.1038/ncpgasthep0557; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; Goulas T, 2011, P NATL ACAD SCI USA, V108, P1856, DOI 10.1073/pnas.1012173108; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Gregg KJ, 2008, J BIOL CHEM, V283, P12604, DOI 10.1074/jbc.M709865200; Guillen D, 2010, APPL MICROBIOL BIOT, V85, P1241, DOI 10.1007/s00253-009-2331-y; Hazen TH, 2010, FEMS MICROBIOL ECOL, V74, P485, DOI 10.1111/j.1574-6941.2010.00937.x; Heermann R, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-40; Hirt RP, 2007, TRENDS PARASITOL, V23, P540, DOI 10.1016/j.pt.2007.08.020; Hobbs MM, 2007, SEX TRANSM DIS, P771; HOOPER NM, 1994, FEBS LETT, V354, P1, DOI 10.1016/0014-5793(94)01079-X; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Ikegami T, 2000, J BIOL CHEM; Johansson MEV, 2011, P NATL ACAD SCI USA, V108, P4659, DOI 10.1073/pnas.1006451107; Kall L, 2005, BIOINFORMATICS, V21, pI251, DOI 10.1093/bioinformatics/bti1014; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Korbel JO, 2005, PLOS BIOL, V3, P815, DOI 10.1371/journal.pbio.0030134; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lebeer S, 2010, NAT REV MICROBIOL, V8, P171, DOI 10.1038/nrmicro2297; Lepore LS, 1996, J INVERTEBR PATHOL, V68, P131, DOI 10.1006/jipa.1996.0070; Letunic I, 2011, NUCL ACIDS RES; Linden SK, 2008, MUCOSAL IMMUNOL, V1, P183, DOI 10.1038/mi.2008.5; Liolios K, 2010, NUCLEIC ACIDS RES, V38, pD346, DOI 10.1093/nar/gkp848; Liu Y, 2006, PLOS COMPUT BIOL, V2, P1419, DOI 10.1371/journal.pcbi.0020159; Loftus B, 2005, NATURE, V433, P865, DOI 10.1038/nature03291; Marion S, 2006, INT J PARASITOL, V36, P131, DOI 10.1016/j.ijpara.2005.10.007; Markiewicz JM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001002; Martens EC, 2008, CELL HOST MICROBE, V4, P447, DOI 10.1016/j.chom.2008.09.007; Medini D, 2008, NAT REV MICROBIOL, V6, P419, DOI 10.1038/nrmicro1901; Mello LV, 2010, FEBS LETT, V584, P2421, DOI 10.1016/j.febslet.2010.04.045; Money P, 2010, ENVIRON MICROBIOL, V12, P2633, DOI 10.1111/j.1462-2920.2010.02293.x; Noel CJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-99; O'Sullivan O, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-50; Okada M, 2005, EUKARYOT CELL, V4, P827, DOI 10.1128/EC.4.4.827-831.2005; Pallen MJ, 2007, NATURE, V449, P835, DOI 10.1038/nature06248; PARSOT C, 1991, P NATL ACAD SCI USA, V88, P1641, DOI 10.1073/pnas.88.5.1641; Pearson JP, 2005, COLONIZATION OF MUCOSAL SURFACES, P3; Pereira-Neves A, 2007, BIOL CELL, V99, P87, DOI 10.1042/BC20060084; Peterson Kenneth M, 2002, Curr Issues Intest Microbiol, V3, P29; Qin X, 2006, INSECT MOL BIOL, V15, P715, DOI 10.1111/j.1365-2583.2006.00694.x; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; Read TD, 2003, NUCLEIC ACIDS RES, V31, P2134, DOI 10.1093/nar/gkg321; Rigden DJ, 2004, TRENDS BIOCHEM SCI, V29, P335, DOI 10.1016/j.tibs.2004.05.002; Sasaki Y, 2002, NUCLEIC ACIDS RES, V30, P5293, DOI 10.1093/nar/gkf667; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Senderovich Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008607; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Songer JG, 2010, VET MICROBIOL, V140, P399, DOI 10.1016/j.vetmic.2009.07.003; Sonnenburg ED, 2010, CELL, V141, P1241, DOI 10.1016/j.cell.2010.05.005; Swiecicka I, 2008, BIOCONTROL SCI TECHN, V18, P221, DOI 10.1080/09583150801942334; Szabady RL, 2011, MICROBIOL-SGM, V157, P516, DOI 10.1099/mic.0.044529-0; Tseng TT, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-S1-S2; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Vilcinskas A, 2010, VIRULENCE, V1, P206, DOI 10.4161/viru.1.3.12072; Wang P, 1997, P NATL ACAD SCI USA, V94, P6977, DOI 10.1073/pnas.94.13.6977; Wang P, 2001, ARCH INSECT BIOCHEM, V47, P110, DOI 10.1002/arch.1041; Wiggins R, 2001, SEX TRANSM INFECT, V77, P402, DOI 10.1136/sti.77.6.402; Wilkinson M, 2007, TRENDS ECOL EVOL, V22, P114, DOI 10.1016/j.tree.2007.01.002; Xu J, 2007, PLOS BIOL, V5, P1574, DOI 10.1371/journal.pbio.0050156; Zhang JC, 2010, CLIN TOXICOL, V48, P867, DOI 10.3109/15563650.2010.535003	87	67	70	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e30287	10.1371/journal.pone.0030287	http://dx.doi.org/10.1371/journal.pone.0030287			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22299034	Green Published, Green Submitted, gold			2022-12-27	WOS:000301704200011
J	Shahi, P; Park, D; Pond, AC; Seethammagari, M; Chiou, SH; Cho, K; Carstens, JL; Decker, WK; McCrea, PD; Ittmann, MM; Rosen, JM; Spencer, DM				Shahi, Payam; Park, Dongsu; Pond, Adam C.; Seethammagari, Mamatha; Chiou, Shin-Heng; Cho, Kyucheol; Carstens, Julienne L.; Decker, William K.; McCrea, Pierre D.; Ittmann, Michael M.; Rosen, Jeffrey M.; Spencer, David M.			Activation of Wnt Signaling by Chemically Induced Dimerization of LRP5 Disrupts Cellular Homeostasis	PLOS ONE			English	Article							BETA-CATENIN; PROSTATE CARCINOMA; MURINE PROSTATE; BREAST-CANCER; STEM-CELLS; RECEPTOR; TRANSDUCTION; PATHWAY; MECHANISM; DOMAINS	Wnt signaling is crucial for a variety of biological processes, including body axis formation, planar polarity, stem cell maintenance and cellular differentiation. Therefore, targeted manipulation of Wnt signaling in vivo would be extremely useful. By applying chemical inducer of dimerization (CID) technology, we were able to modify the Wnt co-receptor, low-density lipoprotein(LDL)-receptor-related protein 5 (LRP5), to generate the synthetic ligand inducible Wnt switch, iLRP5. We show that iLRP5 oligomerization results in its localization to disheveled-containing punctate structures and sequestration of scaffold protein Axin, leading to robust beta-catenin-mediated signaling. Moreover, we identify a novel LRP5 cytoplasmic domain critical for its intracellular localization and casein kinase 1-dependent beta-catenin signaling. Finally, by utilizing iLRP5 as a Wnt signaling switch, we generated the Ubiquitous Activator of beta-catenin (Ubi-Cat) transgenic mouse line. The Ubi-Cat line allows for nearly ubiquitous expression of iLRP5 under control of the H-2K(b) promoter. Activation of iLRP5 in isolated prostate basal epithelial stem cells resulted in expansion of p63(+) cells and development of hyperplasia in reconstituted murine prostate grafts. Independently, iLRP5 induction in adult prostate stroma enhanced prostate tissue regeneration. Moreover, induction of iLRP5 in male Ubi-Cat mice resulted in prostate tumor progression over several months from prostate hyperplasia to adenocarcinoma. We also investigated iLRP5 activation in Ubi-Cat-derived mammary cells, observing that prolonged activation results in mammary tumor formation. Thus, in two distinct experimental mouse models, activation of iLRP5 results in disruption of tissue homeostasis, demonstrating the utility of iLRP5 as a novel research tool for determining the outcome of Wnt activation in a precise spatially and temporally determined fashion.	[Shahi, Payam; Park, Dongsu; Seethammagari, Mamatha; Chiou, Shin-Heng; Carstens, Julienne L.; Decker, William K.; Ittmann, Michael M.; Spencer, David M.] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Pond, Adam C.; Rosen, Jeffrey M.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Cho, Kyucheol; McCrea, Pierre D.] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center	Shahi, P (corresponding author), Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA.	dspencer@bcm.edu		Carstens, Julienne/0000-0001-9914-0430; Park, Dongsu/0000-0002-2570-3250	National Institutes of Health [U01-CA141497, R37-CA16303, T32-AI0749510]; NATIONAL CANCER INSTITUTE [U01CA141497, R01CA016303, R37CA016303] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by National Institutes of Health U01-CA141497, R37-CA16303, and T32-AI0749510. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Brott BK, 2002, MOL CELL BIOL, V22, P6100, DOI 10.1128/MCB.22.17.6100-6110.2002; Bruxvoort KJ, 2007, CANCER RES, V67, P2490, DOI 10.1158/0008-5472.CAN-06-3028; Carron C, 2003, J CELL SCI, V116, P2541, DOI 10.1242/jcs.00451; Chen GP, 2004, CANCER-AM CANCER SOC, V101, P1345, DOI 10.1002/cncr.20518; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Clackson T, 1998, P NATL ACAD SCI USA, V95, P10437, DOI 10.1073/pnas.95.18.10437; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cong F, 2004, DEVELOPMENT, V131, P5103, DOI 10.1242/dev.01318; CUNHA GR, 1978, J EXP ZOOL, V205, P181, DOI 10.1002/jez.1402050203; Dann CE, 2001, NATURE, V412, P86, DOI 10.1038/35083601; DAVID-WATINE B, 1990, IMMUNOL TODAY, V11, P286, DOI 10.1016/0167-5699(90)90114-O; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Gounari F, 2002, ONCOGENE, V21, P4099, DOI 10.1038/sj.onc.1205562; Green JL, 2008, TRENDS CELL BIOL, V18, P536, DOI 10.1016/j.tcb.2008.08.006; Grumolato L, 2010, GENE DEV, V24, P2517, DOI 10.1101/gad.1957710; Ilyas M, 2005, J PATHOL, V205, P130, DOI 10.1002/path.1692; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Li B, 2002, GENE THER, V9, P233, DOI 10.1038/sj.gt.3301641; Li XF, 2005, J BIOL CHEM, V280, P19883, DOI 10.1074/jbc.M413274200; Liu GZ, 2003, MOL CELL BIOL, V23, P5825, DOI 10.1128/MCB.23.16.5825-5835.2003; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; Mi KH, 2005, J CELL BIOCHEM, V95, P328, DOI 10.1002/jcb.20400; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; NUSSE R, 1982, CELL, V31, P99, DOI 10.1016/0092-8674(82)90409-3; Ontiveros CS, 2008, PROSTATE, V68, P1263, DOI 10.1002/pros.20770; Park D, 2006, NAT BIOTECHNOL, V24, P1581, DOI 10.1038/nbt1262; Polakis P, 2000, GENE DEV, V14, P1837; Robinson DR, 2008, CURR DRUG TARGETS, V9, P571; Satija NK, 2007, STEM CELLS DEV, V16, P7, DOI 10.1089/scd.2006.9998; Seto ES, 2006, J CELL BIOL, V173, P95, DOI 10.1083/jcb.200510123; Shahi P, 2011, STEM CELLS, V29, P678, DOI 10.1002/stem.606; Shibata H, 1997, SCIENCE, V278, P120, DOI 10.1126/science.278.5335.120; SPENCER DM, 1993, SCIENCE, V262, P1019, DOI 10.1126/science.7694365; Suzuki H, 2008, BRIT J CANCER, V98, P1147, DOI 10.1038/sj.bjc.6604259; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; van Amerongen R, 2006, TRENDS GENET, V22, P678, DOI 10.1016/j.tig.2006.10.001; Wang BE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002186; Xin L, 2007, STEM CELLS, V25, P2760, DOI 10.1634/stemcells.2007-0355; Yu XP, 2009, PROSTATE, V69, P249, DOI 10.1002/pros.20877; Zardawi SJ, 2009, HISTOL HISTOPATHOL, V24, P385, DOI 10.14670/HH-24.385; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185	44	14	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e30814	10.1371/journal.pone.0030814	http://dx.doi.org/10.1371/journal.pone.0030814			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22303459	Green Published, gold, Green Submitted			2022-12-27	WOS:000301704200035
J	Zorc, M; Skok, DJ; Godnic, I; Calin, GA; Horvat, S; Jiang, ZH; Dovc, P; Kunej, T				Zorc, Minja; Skok, Dasa Jevsinek; Godnic, Irena; Calin, George Adrian; Horvat, Simon; Jiang, Zhihua; Dovc, Peter; Kunej, Tanja			Catalog of MicroRNA Seed Polymorphisms in Vertebrates	PLOS ONE			English	Article							MEDIATED GENE-REGULATION; PROSTATE-CANCER RISK; FUNCTIONAL POLYMORPHISM; PRE-MICRORNAS; GENOMIC VARIATIONS; MIR-146A GENE; DATABASE; ASSOCIATION; VARIANTS; REGION	MicroRNAs (miRNAs) are a class of non-coding RNA that plays an important role in posttranscriptional regulation of mRNA. Evidence has shown that miRNA gene variability might interfere with its function resulting in phenotypic variation and disease susceptibility. A major role in miRNA target recognition is ascribed to complementarity with the miRNA seed region that can be affected by polymorphisms. In the present study, we developed an online tool for the detection of miRNA polymorphisms (miRNA SNiPer) in vertebrates (http://www.integratomics-time.com/miRNA-SNiPer) and generated a catalog of miRNA seed region polymorphisms (miR-seed-SNPs) consisting of 149 SNPs in six species. Although a majority of detected polymorphisms were due to point mutations, two consecutive nucleotide substitutions (double nucleotide polymorphisms, DNPs) were also identified in nine miRNAs. We determined that miR-SNPs are frequently located within the quantitative trait loci (QTL), chromosome fragile sites, and cancer susceptibility loci, indicating their potential role in the genetic control of various complex traits. To test this further, we performed an association analysis between the mmu-miR-717 seed SNP rs30372501, which is polymorphic in a large number of standard inbred strains, and all phenotypic traits in these strains deposited in the Mouse Phenome Database. Analysis showed a significant association between the mmu-miR-717 seed SNP and a diverse array of traits including behavior, blood-clinical chemistry, body weight size and growth, and immune system suggesting that seed SNPs can indeed have major pleiotropic effects. The bioinformatics analyses, data and tools developed in the present study can serve researchers as a starting point in testing more targeted hypotheses and designing experiments using optimal species or strains for further mechanistic studies.	[Zorc, Minja; Skok, Dasa Jevsinek; Godnic, Irena; Horvat, Simon; Dovc, Peter; Kunej, Tanja] Univ Ljubljana, Biotech Fac, Dept Anim Sci, Domzale, Slovenia; [Zorc, Minja] Rothamsted Res, Ctr Math & Computat Biol, Harpenden, Herts, England; [Calin, George Adrian] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Calin, George Adrian] Univ Texas MD Anderson Canc Ctr, Ctr RNA Interference & Noncoding RNAs, Houston, TX 77030 USA; [Horvat, Simon] Natl Inst Chem, Ljubljana, Slovenia; [Jiang, Zhihua] Washington State Univ, Dept Anim Sci, Pullman, WA 99164 USA	University of Ljubljana; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; National Institute of Chemistry - Slovenia; Washington State University	Zorc, M (corresponding author), Univ Ljubljana, Biotech Fac, Dept Anim Sci, Domzale, Slovenia.	tanja.kunej@bf.uni-lj.si	Calin, George/E-9390-2011; Zorc, Minja/AGD-6914-2022; Kunej, Tanja/G-5957-2017; Jiang, Zhihua/A-3378-2008	Zorc, Minja/0000-0003-3330-7909; Kunej, Tanja/0000-0002-0465-1762; Jiang, Zhihua/0000-0003-1986-088X; Calin, George/0000-0002-7427-0578; Calin, George/0000-0001-6704-5615	Slovenian Research Agency (ARRS) [P4-0220]; The University of Texas MD Anderson Research Trust; CLL Global Research Foundation; NIH/NCI [1R01CA135444]; Department of Defense; Developmental Research Awards in Breast Cancer, Ovarian Cancer, Brain Cancer, Multiple Myeloma and Leukemia SPOREs; Laura and John Arnold Foundation; RGK Foundation; NATIONAL CANCER INSTITUTE [R01CA135444] Funding Source: NIH RePORTER	Slovenian Research Agency (ARRS)(Slovenian Research Agency - Slovenia); The University of Texas MD Anderson Research Trust; CLL Global Research Foundation; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense(United States Department of Defense); Developmental Research Awards in Breast Cancer, Ovarian Cancer, Brain Cancer, Multiple Myeloma and Leukemia SPOREs; Laura and John Arnold Foundation; RGK Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Slovenian Research Agency (ARRS) through the Research programme Comparative genomics and genome biodiversity [grant number P4-0220]. G.A.C. is supported as a Fellow at The University of Texas MD Anderson Research Trust, as a University of Texas System Regents Research Scholar and by the CLL Global Research Foundation. Work in Dr. Calin's laboratory is supported in part by the NIH/NCI (1R01CA135444), a Department of Defense Breast Cancer Idea Award, Developmental Research Awards in Breast Cancer, Ovarian Cancer, Brain Cancer, Multiple Myeloma and Leukemia SPOREs, and the Laura and John Arnold Foundation and RGK Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker SJ, 2001, ONCOGENE, V20, P1015, DOI 10.1038/sj.onc.1204209; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Bhartiya D, 2011, HUM MUTAT, V32, pE2226, DOI 10.1002/humu.21482; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Chin LJ, 2008, CANCER RES, V68, P8535, DOI 10.1158/0008-5472.CAN-08-2129; Didiano D, 2006, NAT STRUCT MOL BIOL, V13, P849, DOI 10.1038/nsmb1138; Duan RH, 2007, HUM MOL GENET, V16, P1124, DOI 10.1093/hmg/ddm062; Duan SW, 2009, RNA BIOL, V6, P412, DOI 10.4161/rna.6.4.8830; Fabbri M, 2009, CARCINOGENESIS, V30, P912, DOI 10.1093/carcin/bgp063; Ferdin J, 2010, TECHNOL CANCER RES T, V9, P123, DOI 10.1177/153303461000900202; Fitch MJ, 2004, DEV DYNAM, V230, P316, DOI 10.1002/dvdy.20063; Freudenberg-Hua Y, 2003, GENOME RES, V13, P2271, DOI 10.1101/gr.1299703; George GP, 2011, MOL BIOL REP, V38, P1609, DOI 10.1007/s11033-010-0270-4; Georges M, 2007, CURR OPIN GENET DEV, V17, P166, DOI 10.1016/j.gde.2007.04.005; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grubb SC, 2009, NUCLEIC ACIDS RES, V37, pD720, DOI 10.1093/nar/gkn778; Guo H, 2010, FAM CANCER, V9, P599, DOI 10.1007/s10689-010-9370-5; Hansen T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000873; Hiard S, 2010, NUCLEIC ACIDS RES, V38, pD640, DOI 10.1093/nar/gkp926; Hoffman AE, 2009, CANCER RES, V69, P5970, DOI 10.1158/0008-5472.CAN-09-0236; Hu ZL, 2007, MAMM GENOME, V18, P1, DOI 10.1007/s00335-006-0105-8; Hu ZB, 2009, HUM MUTAT, V30, P79, DOI 10.1002/humu.20837; Huang WF, 2011, NUCLEIC ACIDS RES, V39, P475, DOI 10.1093/nar/gkq818; Institute S, 2002, SAS SYST WIND REL 9; Iwai N, 2005, BIOCHEM BIOPH RES CO, V331, P1439, DOI 10.1016/j.bbrc.2005.04.051; Jazdzewski K, 2009, P NATL ACAD SCI; Jiang QH, 2009, NUCLEIC ACIDS RES, V37, pD98, DOI 10.1093/nar/gkn714; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kunej T, 2011, MUTAT RES-FUND MOL M, V717, P77, DOI 10.1016/j.mrfmmm.2011.03.008; Kunej T, 2010, INT J BIOL SCI, V6, P769; Landi D, 2008, DNA CELL BIOL, V27, P35, DOI 10.1089/dna.2007.0650; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lewis MA, 2009, NAT GENET, V41, P614, DOI 10.1038/ng.369; Li SC, 2007, DNA CELL BIOL, V26, P195, DOI 10.1089/dna.2006.0558; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Mencia A, 2009, NAT GENET, V41, P609, DOI 10.1038/ng.355; Mishra PJ, 2009, PHARMACOGENOMICS, V10, P399, DOI 10.2217/14622416.10.3.399; Mittal RD, 2011, DNA CELL BIOL; Muinos-Gimeno M, 2010, EUR J HUM GENET, V18, P218, DOI 10.1038/ejhg.2009.165; Nicoloso MS, 2010, CANCER RES, V70, P2789, DOI 10.1158/0008-5472.CAN-09-3541; Okubo M, 2011, J CLIN IMMUNOL, V31, P69, DOI 10.1007/s10875-010-9461-y; Okubo M, 2010, HELICOBACTER, V15, P524, DOI 10.1111/j.1523-5378.2010.00806.x; Papadopoulos GL, 2009, NUCLEIC ACIDS RES, V37, pD155, DOI 10.1093/nar/gkn809; Rosenfeld JA, 2010, NUCL ACIDS RES; Saito Y, 2009, BIOCHEM BIOPH RES CO, V379, P726, DOI 10.1016/j.bbrc.2008.12.098; Saunders MA, 2007, P NATL ACAD SCI USA, V104, P3300, DOI 10.1073/pnas.0611347104; Sevignani C, 2007, P NATL ACAD SCI USA, V104, P8017, DOI 10.1073/pnas.0702177104; Shen J, 2008, CARCINOGENESIS, V29, P1963, DOI 10.1093/carcin/bgn172; Sun GH, 2009, RNA, V15, P1640, DOI 10.1261/rna.1560209; Tong Y, 2011, HUM MUTAT; Twigger SN, 2007, NUCLEIC ACIDS RES, V35, pD658, DOI 10.1093/nar/gkl988; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Xu B, 2010, PROSTATE, V70, P467, DOI 10.1002/pros.21080; Xu T, 2008, CARCINOGENESIS, V29, P2126, DOI 10.1093/carcin/bgn195; Zhang C, 2010, B AUST MATH SOC, V82, P459, DOI 10.1017/S0004972710000432; Zhou B, 2011, MOL CARCINOGENESIS, pn/a; Zhou B, 2010, CLIN CHIM ACTA, V411, P1287, DOI 10.1016/j.cca.2010.05.010; Ziebarth JD, 2011, NUCL ACIDS RES	59	52	56	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e30737	10.1371/journal.pone.0030737	http://dx.doi.org/10.1371/journal.pone.0030737			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22303453	gold, Green Published, Green Submitted			2022-12-27	WOS:000301704200031
J	Evison, SEF; Roberts, KE; Laurenson, L; Pietravalle, S; Hui, J; Biesmeijer, JC; Smith, JE; Budge, G; Hughes, WOH				Evison, Sophie E. F.; Roberts, Katherine E.; Laurenson, Lynn; Pietravalle, Stephane; Hui, Jeffrey; Biesmeijer, Jacobus C.; Smith, Judith E.; Budge, Giles; Hughes, William O. H.			Pervasiveness of Parasites in Pollinators	PLOS ONE			English	Article							APIS-MELLIFERA-CAPENSIS; COLONY COLLAPSE DISORDER; ALFALFA LEAFCUTTING BEE; RNA EXTRACTION METHODS; BUMBLEBEES HYMENOPTERA; MEGACHILE-ROTUNDATA; WOLBACHIA SYMBIONTS; FLOWERING PLANTS; VIRAL PATHOGEN; COMMUNAL BEE	Many pollinator populations are declining, with large economic and ecological implications. Parasites are known to be an important factor in the some of the population declines of honey bees and bumblebees, but little is known about the parasites afflicting most other pollinators, or the extent of interspecific transmission or vectoring of parasites. Here we carry out a preliminary screening of pollinators (honey bees, five species of bumblebee, three species of wasp, four species of hoverfly and three genera of other bees) in the UK for parasites. We used molecular methods to screen for six honey bee viruses, Ascosphaera fungi, Microsporidia, and Wolbachia intracellular bacteria. We aimed simply to detect the presence of the parasites, encompassing vectoring as well as actual infections. Many pollinators of all types were positive for Ascosphaera fungi, while Microsporidia were rarer, being most frequently found in bumblebees. We also detected that most pollinators were positive for Wolbachia, most probably indicating infection with this intracellular symbiont, and raising the possibility that it may be an important factor in influencing host sex ratios or fitness in a diversity of pollinators. Importantly, we found that about a third of bumblebees (Bombus pascuorum and Bombus terrestris) and a third of wasps (Vespula vulgaris), as well as all honey bees, were positive for deformed wing virus, but that this virus was not present in other pollinators. Deformed wing virus therefore does not appear to be a general parasite of pollinators, but does interact significantly with at least three species of bumblebee and wasp. Further work is needed to establish the identity of some of the parasites, their spatiotemporal variation, and whether they are infecting the various pollinator species or being vectored. However, these results provide a first insight into the diversity, and potential exchange, of parasites in pollinator communities.	[Evison, Sophie E. F.; Roberts, Katherine E.; Biesmeijer, Jacobus C.; Hughes, William O. H.] Univ Leeds, Inst Integrat & Comparat Biol, Leeds, W Yorkshire, England; [Laurenson, Lynn; Pietravalle, Stephane; Budge, Giles] Food & Environm Res Agcy, Natl Bee Unit, York, N Yorkshire, England; [Hui, Jeffrey] Columbia Univ, Ctr Infect & Immun, New York, NY USA; [Biesmeijer, Jacobus C.] Netherlands Ctr Biodivers NCB Nat, Leiden, Netherlands; [Smith, Judith E.] Univ Salford, Sch Environm & Life Sci, Salford M5 4WT, Lancs, England	University of Leeds; Food & Environment Research Agency; Columbia University; Naturalis Biodiversity Center; University of Salford	Evison, SEF (corresponding author), Univ Leeds, Inst Integrat & Comparat Biol, Leeds, W Yorkshire, England.	w.o.h.hughes@leeds.ac.uk	Evison, Sophie/Y-3993-2019; Hughes, William OH/A-6957-2014	Hughes, William OH/0000-0003-0951-9768; Evison, Sophie/0000-0002-6210-533X; Smith, Judith/0000-0002-2206-3534; Biesmeijer, Koos/0000-0003-0328-0573	UKPopNet; Biotechnology and Biological Sciences Research Council; Leverhulme Foundation; Waterloo Foundation	UKPopNet; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Leverhulme Foundation; Waterloo Foundation	Funding for this study was provided by the UKPopNet (awarded to WOHH, JCB and JES), the Biotechnology and Biological Sciences Research Council (awarded to KR), the Leverhulme Foundation (awarded to WOHH) and the Waterloo Foundation (awarded to GB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizen MA, 2009, CURR BIOL, V19, P915, DOI 10.1016/j.cub.2009.03.071; Anderson DL, 1998, MYCOL RES, V102, P541, DOI 10.1017/S0953756297005261; Arnal C, 1999, J VIROL METHODS, V77, P17, DOI 10.1016/S0166-0934(98)00083-4; Aronstein KA, 2010, J INVERTEBR PATHOL, V103, pS20, DOI 10.1016/j.jip.2009.06.018; BAILEY L, 1964, J INSECT PATHOL, V6, P395; Baldo L, 2006, APPL ENVIRON MICROB, V72, P7098, DOI 10.1128/AEM.00731-06; Berenos C, 2009, J EVOLUTION BIOL, V22, P2049, DOI 10.1111/j.1420-9101.2009.01821.x; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Blanchard P, 2007, J VIROL METHODS, V141, P7, DOI 10.1016/j.jviromet.2006.11.021; Breeze TD, 2011, AGR ECOSYST ENVIRON, V142, P137, DOI 10.1016/j.agee.2011.03.020; Brown MJF, 2009, APIDOLOGIE, V40, P410, DOI 10.1051/apido/2009019; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Chantawannakul P, 2006, J INVERTEBR PATHOL, V91, P69, DOI 10.1016/j.jip.2005.11.001; Colla SR, 2008, BIODIVERS CONSERV, V17, P1379, DOI 10.1007/s10531-008-9340-5; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; CROSS EA, 1992, J KANSAS ENTOMOL SOC, V65, P157; DURRER S, 1995, ECOGRAPHY, V18, P114, DOI 10.1111/j.1600-0587.1995.tb00331.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fontaine C, 2006, PLOS BIOL, V4, P129, DOI 10.1371/journal.pbio.0040001; Fries I, 1999, EUR J PROTISTOL, V35, P183, DOI 10.1016/S0932-4739(99)80036-4; Frost CL, 2010, MOL ECOL, V19, P4077, DOI 10.1111/j.1365-294X.2010.04764.x; Fytrou A, 2006, P R SOC B, V273, P791, DOI 10.1098/rspb.2005.3383; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Genersch E, 2006, J INVERTEBR PATHOL, V91, P61, DOI 10.1016/j.jip.2005.10.002; Goulson D, 2008, ANNU REV ENTOMOL, V53, P191, DOI 10.1146/annurev.ento.53.103106.093454; Goulson D., 2003, BUMBLEBEES BEHAV ECO; Hackett K, 2009, COLONY COLLAPSE DISO; Hale AD, 1996, J VIROL METHODS, V57, P195, DOI 10.1016/0166-0934(95)01966-9; Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418; HERMOSO-DE-MENDOZA M, 1989, J APICULT RES, V28, P61; Higes M, 2008, ENVIRON MICROBIOL, V10, P2659, DOI 10.1111/j.1462-2920.2008.01687.x; Higes M, 2007, J INVERTEBR PATHOL, V94, P211, DOI 10.1016/j.jip.2006.11.001; Higes M, 2010, ENV MICROBIOL REP, V2, P243, DOI 10.1111/j.1758-2229.2009.00099.x; Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x; Hoy MA, 2003, APIDOLOGIE, V34, P53, DOI 10.1051/apido:2002048; Hughes WOH, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-45; Jacobs JH, 2010, ARTHROPOD-PLANT INTE, V4, P19, DOI 10.1007/s11829-009-9080-9; James RR, 2005, J INVERTEBR PATHOL, V90, P98, DOI 10.1016/j.jip.2005.08.004; Jeong G, 2009, J MICROBIOL, V47, P28, DOI 10.1007/s12275-009-0198-3; Jeyaprakash A, 2003, J INVERTEBR PATHOL, V84, P96, DOI 10.1016/j.jip.2003.08.007; Jeyaprakash A, 2009, APIDOLOGIE, V40, P178, DOI 10.1051/apido/2009002; Johnson RM, 2009, P NATL ACAD SCI USA, V106, P14790, DOI 10.1073/pnas.0906970106; Kajobe R, 2010, J INVERTEBR PATHOL, V104, P153, DOI 10.1016/j.jip.2010.02.007; Kearns CA, 1997, BIOSCIENCE, V47, P297, DOI 10.2307/1313191; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Knight TM, 2005, ANNU REV ECOL EVOL S, V36, P467, DOI 10.1146/annurev.ecolsys.36.102403.115320; Martinson VG, 2011, MOL ECOL, V20, P619, DOI 10.1111/j.1365-294X.2010.04959.x; MCMANUS WR, 1984, MYCOLOGIA, V76, P830, DOI 10.2307/3793139; Meeus I, 2011, CONSERV BIOL, V25, P662, DOI 10.1111/j.1523-1739.2011.01707.x; Min KT, 1997, P NATL ACAD SCI USA, V94, P10792, DOI 10.1073/pnas.94.20.10792; Morse R.A., 1997, HONEY BEE PESTS PRED; Ollerton J, 2011, OIKOS, V120, P321, DOI 10.1111/j.1600-0706.2010.18644.x; Otti O, 2007, J INVERTEBR PATHOL, V96, P118, DOI 10.1016/j.jip.2007.03.016; Paxton RJ, 1997, APIDOLOGIE, V28, P129, DOI 10.1051/apido:19970304; Paxton RJ, 2007, APIDOLOGIE, V38, P558, DOI 10.1051/apido:2007037; Plischuk S, 2009, ENV MICROBIOL REP, V1, P131, DOI 10.1111/j.1758-2229.2009.00018.x; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Prendini L, 2005, ORG DIVERS EVOL, V5, P203, DOI 10.1016/j.ode.2004.12.004; Ratnieks FLW, 2010, SCIENCE, V327, P152, DOI 10.1126/science.1185563; Rotenberg D, 2009, PHYTOPATHOLOGY, V99, P404, DOI 10.1094/PHYTO-99-4-0404; Russell JA, 2009, EVOLUTION, V63, P624, DOI 10.1111/j.1558-5646.2008.00579.x; Schmid-Hempel P, 2001, NATURWISSENSCHAFTEN, V88, P147, DOI 10.1007/s001140100222; Schmid-Hempel P., 1998, Parasites in social insects.; Schmid-Hempel P, 1998, APIDOLOGIE, V29, P525, DOI 10.1051/apido:19980605; Singh R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014357; Snook RR, 2000, GENETICS, V155, P167; Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002; Terry RS, 2004, P ROY SOC B-BIOL SCI, V271, P1783, DOI 10.1098/rspb.2004.2793; TORCHIO PF, 1992, ENVIRON ENTOMOL, V21, P1086, DOI 10.1093/ee/21.5.1086; VANDENBERG JD, 1992, J INVERTEBR PATHOL, V60, P213, DOI 10.1016/0022-2011(92)90102-A; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Walker TN, 2011, ECOL ENTOMOL, V36, P588, DOI 10.1111/j.1365-2311.2011.01312.x; Wenseleers T, 1998, P ROY SOC B-BIOL SCI, V265, P1447, DOI 10.1098/rspb.1998.0456; Werren JH, 1997, ANNU REV ENTOMOL, V42, P587, DOI 10.1146/annurev.ento.42.1.587; Williams PH, 2009, APIDOLOGIE, V40, P367, DOI 10.1051/apido/2009025; Youssef NN, 2001, MYCOTAXON, V77, P7	76	124	128	5	162	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2012	7	1							e30641	10.1371/journal.pone.0030641	http://dx.doi.org/10.1371/journal.pone.0030641			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911FX	22347356	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000301703800022
J	Emir, UE; Tuite, PJ; Oz, G				Emir, Uzay E.; Tuite, Paul J.; Oez, Guelin			Elevated Pontine and Putamenal GABA Levels in Mild-Moderate Parkinson Disease Detected by 7 Tesla Proton MRS	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; VIVO H-1-NMR SPECTROSCOPY; GAMMA-AMINOBUTYRIC-ACID; MPTP-INTOXICATED MOUSE; GAD65 GENE-EXPRESSION; IN-VIVO; HUMAN BRAIN; MITOCHONDRIAL DYSFUNCTION; SUBSTANTIA-NIGRA; LOCUS-COERULEUS	Background: Parkinson disease (PD) is characterized by the degeneration of nigrostriatal dopaminergic neurons. However, postmortem evidence indicates that the pathology of lower brainstem regions, such as the pons and medulla, precedes nigral involvement. Consistently, pontomedullary damage was implicated by structural and PET imaging in early PD. Neurochemical correlates of this early pathological involvement in PD are unknown. Methodology/Principal Finding: To map biochemical alterations in the brains of individuals with mild-moderate PD we quantified neurochemical profiles of the pons, putamen and substantia nigra by 7 tesla (T) proton magnetic resonance spectroscopy. Thirteen individuals with idiopathic PD (Hoehn & Yahr stage 2) and 12 age- and gender-matched healthy volunteers participated in the study. gamma-Aminobutyric acid (GABA) concentrations in the pons and putamen were significantly higher in patients (N=11, off medications) than controls (N=11, p<0.001 for pons and p<0.05 for putamen). The GABA elevation was more pronounced in the pons (64%) than in the putamen (32%). No other neurochemical differences were observed between patients and controls. Conclusion/Significance: The GABA elevation in the putamen is consistent with prior postmortem findings in patients with PD, as well as with in vivo observations in a rodent model of PD, while the GABA finding in the pons is novel. The more significant GABA elevation in the pons relative to the putamen is consistent with earlier pathological involvement of the lower brainstem. This study provides in vivo evidence for an alteration in the GABAergic tone in the lower brainstem and striatum in early-moderate PD, which may underlie disease pathogenesis and may provide a biomarker for disease staging.	[Emir, Uzay E.; Oez, Guelin] Univ Minnesota, Dept Radiol, Ctr Magnet Resonance Res, Minneapolis, MN 55455 USA; [Tuite, Paul J.] Univ Minnesota, Dept Neurol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Emir, UE (corresponding author), Univ Minnesota, Dept Radiol, Ctr Magnet Resonance Res, Minneapolis, MN 55455 USA.	emirx001@umn.edu	Oz, Gulin/L-1306-2016; Emir, Uzay/ABB-9979-2020; Tuite, Paul/P-3164-2014	Oz, Gulin/0000-0002-5769-183X; emir, uzay/0000-0001-5376-0431; Tuite, Paul/0000-0003-1413-7924	Dana Foundation; Minnesota Medical Foundation [3444]; National Center for Research Resources (NCRR) [P41RR008079, S10 RR026783]; Neuroscience Center Core Blueprint Award [P30 NS057091]; Keck Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR008079, S10RR026783] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057091] Funding Source: NIH RePORTER	Dana Foundation; Minnesota Medical Foundation; National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Neuroscience Center Core Blueprint Award; Keck Foundation(W.M. Keck Foundation); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Dana Foundation and the Minnesota Medical Foundation Research Fund 3444. The Center for MR Research is supported by the National Center for Research Resources (NCRR) grants P41RR008079 and S10 RR026783, the Neuroscience Center Core Blueprint Award P30 NS057091 and Keck Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriany G, 2008, MAGN RESON MED, V59, P590, DOI 10.1002/mrm.21488; Baudrexel S, 2010, NEUROIMAGE, V51, P512, DOI 10.1016/j.neuroimage.2010.03.005; BEHAR KL, 1994, MAGNET RESON MED, V32, P294, DOI 10.1002/mrm.1910320304; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Braak H, 2006, J NEUROL SCI, V248, P255, DOI 10.1016/j.jns.2006.05.011; Bruck A, 2006, MOVEMENT DISORD, V21, P958, DOI 10.1002/mds.20855; Chassain C, 2008, J NEUROCHEM, V105, P874, DOI 10.1111/j.1471-4159.2007.05185.x; Chassain C, 2010, NMR BIOMED, V23, P547, DOI 10.1002/nbm.1504; Clark JB, 1998, DEV NEUROSCI-BASEL, V20, P271, DOI 10.1159/000017321; Doder M, 2003, NEUROLOGY, V60, P601, DOI 10.1212/01.WNL.0000031424.51127.2B; Dydak U, 2011, ENVIRON HEALTH PERSP, V119, P219, DOI 10.1289/ehp.1002192; Edden RAE, 2007, MAGN RESON MED, V58, P1276, DOI 10.1002/mrm.21383; Emir UE, 2012, NMR BIOMED, V25, P152, DOI 10.1002/nbm.1727; Gelman N, 2001, MAGNET RESON MED, V45, P71, DOI 10.1002/1522-2594(200101)45:1<71::AID-MRM1011>3.0.CO;2-2; Gervasoni D, 1998, EUR J NEUROSCI, V10, P964, DOI 10.1046/j.1460-9568.1998.00106.x; Gervasoni D, 2000, J NEUROSCI, V20, P4217; Govindaraju V, 2000, NMR BIOMED, V13, P129, DOI 10.1002/1099-1492(200005)13:3<129::AID-NBM619>3.0.CO;2-V; HALLIDAY GM, 1990, ANN NEUROL, V27, P373, DOI 10.1002/ana.410270405; Hattingen E, 2009, BRAIN, V132, P3285, DOI 10.1093/brain/awp293; Henchcliffe C, 2008, ANN NY ACAD SCI, V1147, P206, DOI 10.1196/annals.1427.037; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jubault T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008247; Kaiser LG, 2008, NMR BIOMED, V21, P22, DOI 10.1002/nbm.1150; Keren NI, 2009, NEUROIMAGE, V47, P1261, DOI 10.1016/j.neuroimage.2009.06.012; Kickler N, 2007, NMR BIOMED, V20, P757, DOI 10.1002/nbm.1141; KISH SJ, 1988, NEW ENGL J MED, V318, P876, DOI 10.1056/NEJM198804073181402; KISH SJ, 1986, ANN NEUROL, V20, P26, DOI 10.1002/ana.410200106; Lancaster JL, 2007, HUM BRAIN MAPP, V28, P1194, DOI 10.1002/hbm.20345; Laprade N, 1997, MOL BRAIN RES, V48, P333, DOI 10.1016/S0169-328X(97)00112-5; Martin WRW, 2008, NEUROLOGY, V70, P1411, DOI 10.1212/01.wnl.0000286384.31050.b5; Martin WRW, 2001, ADV NEUROL, V86, P197; Moore RY, 2008, NEUROBIOL DIS, V29, P381, DOI 10.1016/j.nbd.2007.09.004; Naidich TP, 2009, INTERNAL ARCHITECTUR, P53; Naidich TP, 2009, GROSS SECTIONAL ANAT, P561; Natt O, 2005, MAGN RESON MED, V53, P3, DOI 10.1002/mrm.20337; O'Neill J, 2002, MOVEMENT DISORD, V17, P917, DOI 10.1002/mds.10214; Obeso JA, 2010, NAT MED, V16, P653, DOI 10.1038/nm.2165; Oz G, 2006, MAGN RESON MED, V55, P296, DOI 10.1002/mrm.20761; Pavese N, 2011, NEUROIMAGE, V56, P1463, DOI 10.1016/j.neuroimage.2011.03.012; Pavese N, 2010, EXP NEUROL, V222, P120, DOI 10.1016/j.expneurol.2009.12.021; PERRY TL, 1983, J NEUROCHEM, V40, P1120, DOI 10.1111/j.1471-4159.1983.tb08102.x; Provencher SW, 2001, NMR BIOMED, V14, P260, DOI 10.1002/nbm.698; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Provencher SW, 2001, LCMODEL LCMGUI USERS; Randall LO, 1938, J BIOL CHEM, V124, P0481; Sasaki M, 2006, NEUROREPORT, V17, P1215, DOI 10.1097/01.wnr.0000227984.84927.a7; Soghomonian JJ, 1997, SYNAPSE, V27, P122, DOI 10.1002/(SICI)1098-2396(199710)27:2<122::AID-SYN3>3.0.CO;2-G; TANAKA Y, 1986, EXP NEUROL, V91, P259, DOI 10.1016/0014-4886(86)90066-X; Terpstra M, 2002, MAGNET RESON MED, V47, P1009, DOI 10.1002/mrm.10146; Tkac I, 1999, MAGNET RESON MED, V41, P649, DOI 10.1002/(SICI)1522-2594(199904)41:4<649::AID-MRM2>3.0.CO;2-G; Tkac I, 2001, MAGNET RESON MED, V46, P451, DOI 10.1002/mrm.1213; Tkac I., 2008, 16 ANN M ISMRM, V16th, P1624; Tkac I, 2009, MAGN RESON MED, V62, P868, DOI 10.1002/mrm.22086; van den Bogaard SJ, 2011, J NEUROL, DOI [10.1007/s00415-00011-06099-00415, DOI 10.1007/S00415-00011-06099-00415]; Watanabe H, 2004, J NEUROL NEUROSUR PS, V75, P103; Whone AL, 2003, ANN NEUROL, V53, P206, DOI 10.1002/ana.10427; Zarow C, 2003, ARCH NEUROL-CHICAGO, V60, P337, DOI 10.1001/archneur.60.3.337	57	124	132	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30918	10.1371/journal.pone.0030918	http://dx.doi.org/10.1371/journal.pone.0030918			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295119	Green Published, gold, Green Submitted			2022-12-27	WOS:000301640600064
J	Kim, SD; Lee, HY; Shim, JW; Kim, HJ; Baek, SH; Zabel, BA; Bae, YS				Kim, Sang Doo; Lee, Ha Young; Shim, Jae Woong; Kim, Hak Jung; Baek, Suk-Hwan; Zabel, Brian A.; Bae, Yoe-Sik			A WKYMVm-Containing Combination Elicits Potent Anti-Tumor Activity in Heterotopic Cancer Animal Model	PLOS ONE			English	Article							FORMYL PEPTIDE RECEPTOR; VAL-D-MET; CD8(+) T-CELLS; DENDRITIC CELLS; PHOSPHOINOSITIDE HYDROLYSIS; SUPEROXIDE GENERATION; GROWTH-INHIBITION; IMMUNOTHERAPY; EXPRESSION; CHEMOATTRACTANT	The development of efficient anti-cancer therapy has been a topic of intense interest for several decades. Combined administration of certain molecules and immune cells has been shown to be an effective form of anti-cancer therapy. Here, we examined the effects of administering an immune stimulating peptide (WKYMVm), 5-fluoro-uracil (5-FU), and mature dendritic cells (mDCs) against heterotopic cancer animal model. Administration of the triple combination strongly reduced tumor volume in CT-26-inoculated heterotopic cancer animal model. The induced anti-tumor activity was well correlated with FAS expression, caspase-3 activation, and cancer cell apoptosis. The triple combination treatment caused recruitment of CD8 T lymphocytes and natural killer (NK) cells into the tumor. The production of two cytokines, IFN-gamma and IL-12, were strongly stimulated by administration of the triple combination. Depletion of CD8 T lymphocytes or NK cells by administration of anti-CD8 or anti-asialoGM1 antibody inhibited the anti-tumor activity and cytokine production of the triple combination. The triple combination strongly inhibited metastasis of colon cancer cells in a heterotopic cancer animal model as well as in a metastatic cancer animal model, and enhanced the survival rate of the mice model. Adoptive transfer of CD8 T lymphocytes and NK cells further increased the survival rate. Taken together, we suggest that the use of triple combination therapy of WKYMVm, 5-FU, and mDCs may have implications in solid tumor and metastasis treatment.	[Kim, Sang Doo; Lee, Ha Young; Shim, Jae Woong; Kim, Hak Jung; Bae, Yoe-Sik] Sungkyunkwan Univ, Dept Biol Sci, Suwon, South Korea; [Kim, Sang Doo; Lee, Ha Young; Kim, Hak Jung; Bae, Yoe-Sik] Dong A Univ, Mitochondria Hub Regulat Ctr, Pusan, South Korea; [Baek, Suk-Hwan] Yeungnam Univ, Coll Med, Dept Biochem & Mol Biol, Taegu, South Korea; [Zabel, Brian A.] Vet Affairs Hosp, Palo Alto Inst Res & Educ, Palo Alto, CA USA	Sungkyunkwan University (SKKU); Dong A University; Yeungnam University	Kim, SD (corresponding author), Sungkyunkwan Univ, Dept Biol Sci, Suwon, South Korea.	yoesik@skku.edu			Ministry for Health, Welfare and Family affairs, Republic of Korea [0920220]; National Research Foundation of Korea; Korea government [2009 0093198]; National Institutes of Health [AI-079320]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079320] Funding Source: NIH RePORTER	Ministry for Health, Welfare and Family affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); National Research Foundation of Korea(National Research Foundation of Korea); Korea government(Korean Government); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from the National Research & Development Program for Cancer Control, Ministry for Health, Welfare and Family affairs, Republic of Korea (0920220) (Y-SB); National Research Foundation of Korea grant funded by the Korea government (2009 0093198) (Y-SB); and National Institutes of Health grant AI-079320 (BZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre-Ghiso JA, 2007, NAT REV CANCER, V7, P834, DOI 10.1038/nrc2256; Alymani NA, 2010, EUR J CANCER, V46, P869, DOI 10.1016/j.ejca.2010.01.001; Bae YS, 1999, J LEUKOCYTE BIOL, V66, P915, DOI 10.1002/jlb.66.6.915; Bae YS, 2000, J IMMUNOL, V164, P4089, DOI 10.4049/jimmunol.164.8.4089; Baek SH, 1996, J BIOL CHEM, V271, P8170, DOI 10.1074/jbc.271.14.8170; Charoensit P, 2010, CANCER GENE THER, V17, P512, DOI 10.1038/cgt.2010.12; Christophe T, 2001, J BIOL CHEM, V276, P21585, DOI 10.1074/jbc.M007769200; Ciavarella S, 2010, BIODRUGS, V24, P77, DOI 10.2165/11530830-000000000-00000; GERMANN T, 1995, INT ARCH ALLERGY IMM, V108, P103, DOI 10.1159/000237126; He R, 2000, J IMMUNOL, V165, P4598, DOI 10.4049/jimmunol.165.8.4598; Helms MW, 2010, CANCER IMMUNOL IMMUN, V59, P1325, DOI 10.1007/s00262-010-0860-y; Henry CJ, 2008, J IMMUNOL, V181, P8576, DOI 10.4049/jimmunol.181.12.8576; Hinrichs CS, 2009, BLOOD, V114, P596, DOI 10.1182/blood-2009-02-203935; Kadhim SA, 1997, CANCER RES, V57, P4803; Kaye SB, 1998, BRIT J CANCER, V78, P1, DOI 10.1038/bjc.1998.747; Kim SD, 2009, J IMMUNOL, V183, P5511, DOI 10.4049/jimmunol.0802986; Le YY, 1999, J IMMUNOL, V163, P6777; Lee HY, 2006, BIOCHEM PHARMACOL, V72, P860, DOI 10.1016/j.bcp.2006.06.022; Lee SJ, 2000, J IMMUNOL, V164, P1277, DOI 10.4049/jimmunol.164.3.1277; Liu HC, 2008, CURR DRUG TARGETS, V9, P878, DOI 10.2174/138945008785909257; Mayo Skye C, 2009, Expert Rev Gastroenterol Hepatol, V3, P131, DOI 10.1586/egh.09.8; Melief CJM, 2008, IMMUNITY, V29, P372, DOI 10.1016/j.immuni.2008.08.004; Melief CJM, 2008, NAT REV CANCER, V8, P351, DOI 10.1038/nrc2373; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Mescher MF, 2006, IMMUNOL REV, V211, P81, DOI 10.1111/j.0105-2896.2006.00382.x; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Seo JK, 1998, CLIN BIOCHEM, V31, P137, DOI 10.1016/S0009-9120(97)00172-0; Seo JK, 1997, J IMMUNOL, V158, P1895; Smyth MJ, 2002, NAT REV CANCER, V2, P850, DOI 10.1038/nrc928; Steinman RM, 2006, CURR TOP MICROBIOL, V311, P17; STEINMAN RM, 1991, ANNU REV IMMUNOL, V9, P271, DOI 10.1146/annurev.iy.09.040191.001415; Talmor M, 1998, EUR J IMMUNOL, V28, P811, DOI 10.1002/(SICI)1521-4141(199803)28:03<811::AID-IMMU811>3.3.CO;2-J; Xu XL, 1998, CANCER RES, V58, P2832; YAMAKI T, 1990, NAT IMMUN CELL GROW, V9, P1; Yang D, 2002, J LEUKOCYTE BIOL, V72, P598	35	10	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30522	10.1371/journal.pone.0030522	http://dx.doi.org/10.1371/journal.pone.0030522			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295090	Green Submitted, Green Published, gold			2022-12-27	WOS:000301640600035
J	Naville, D; Duchampt, A; Vigier, M; Oursel, D; Lessire, R; Poirier, H; Niot, I; Begeot, M; Besnard, P; Mithieux, G				Naville, Danielle; Duchampt, Adeline; Vigier, Michele; Oursel, Delphine; Lessire, Rene; Poirier, Helene; Niot, Isabelle; Begeot, Martine; Besnard, Philippe; Mithieux, Gilles			Link between Intestinal CD36 Ligand Binding and Satiety Induced by a High Protein Diet in Mice	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; BODY-WEIGHT; FOOD-INTAKE; CHOLESTEROL UPTAKE; RECEPTOR; TRANSPORT; RAT; OLEOYLETHANOLAMIDE; ABSORPTION; GLUCONEOGENESIS	CD36 is a ubiquitous membrane glycoprotein that binds long-chain fatty acids. The presence of a functional CD36 is required for the induction of satiety by a lipid load and its role as a lipid receptor driving cellular signal has recently been demonstrated. Our project aimed to further explore the role of intestinal CD36 in the regulation of food intake. Duodenal infusions of vehicle or sulfo-N-succinimidyl-oleate (SSO) was performed prior to acute infusions of saline or Intralipid (IL) in mice. Infusion of minute quantities of IL induced a decrease in food intake (FI) compared to saline. Infusion of SSO had the same effect but no additive inhibitory effect was observed in presence of IL. No IL- or SSO-mediated satiety occurred in CD36-null mice. To determine whether the CD36-mediated hypophagic effect of lipids was maintained in animals fed a satietogen diet, mice were subjected to a High-Protein diet (HPD). Concomitantly with the satiety effect, a rise in intestinal CD36 gene expression was observed. No satiety effect occurred in CD36-null mice. HPD-fed WT mice showed a diminished FI compared to control mice, after saline duodenal infusion. But there was no further decrease after lipid infusion. The lipid-induced decrease in FI observed on control mice was accompanied by a rise in jejunal oleylethanolamide (OEA). Its level was higher in HPD-fed mice than in controls after saline infusion and was not changed by lipids. Overall, we demonstrate that lipid binding to intestinal CD36 is sufficient to produce a satiety effect. Moreover, it could participate in the satiety effect induced by HPD. Intestine can modulate FI by several mechanisms including an increase in OEA production and CD36 gene expression. Furthermore, intestine of mice adapted to HPD have a diminished capacity to modulate their food intake in response to dietary lipids.	[Naville, Danielle; Duchampt, Adeline; Vigier, Michele; Begeot, Martine; Mithieux, Gilles] INSERM, U855, F-69008 Lyon, France; [Naville, Danielle; Duchampt, Adeline; Vigier, Michele; Begeot, Martine; Mithieux, Gilles] Univ Lyon 1, F-69622 Villeurbanne, France; [Naville, Danielle; Duchampt, Adeline; Vigier, Michele; Begeot, Martine; Mithieux, Gilles] Univ Lyon, Lyon, France; [Oursel, Delphine; Lessire, Rene] Univ Bordeaux Segalen, CNRS, UMR 5200, Bordeaux, France; [Poirier, Helene; Niot, Isabelle; Besnard, Philippe] Univ Bourgogne, UMR Inserm U866, AgroSup Dijon, Dijon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne	Naville, D (corresponding author), CarMeN, INSERM U1060, Oullins, France.	danielle.naville@inserm.fr	Naville, Danielle/N-1200-2017	Naville, Danielle/0000-0003-2615-6161; Gilles, Mithieux/0000-0003-3579-8529	Agence Nationale pour la Recherche [ANR-07-PNRA-015]; "Taste, Nutrition, Health" cluster Vitagora	Agence Nationale pour la Recherche(French National Research Agency (ANR)); "Taste, Nutrition, Health" cluster Vitagora	This research project was supported by Agence Nationale pour la Recherche (ANR-07-PNRA-015, SensoFAT project) and by the "Taste, Nutrition, Health" cluster Vitagora. AD is the recipient of subsides from ANR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABUMRAD NA, 1993, J BIOL CHEM, V268, P17665; Andersen M, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-8; Bensaid A, 2003, PHYSIOL BEHAV, V78, P311, DOI 10.1016/S0031-9384(02)00977-0; Bonen A, 2000, J BIOL CHEM, V275, P14501, DOI 10.1074/jbc.275.19.14501; Chen M, 2001, AM J PHYSIOL-ENDOC M, V281, pE916, DOI 10.1152/ajpendo.2001.281.5.E916; COLLINS S, 1991, ANNU REV PHYSIOL, V53, P497, DOI 10.1146/annurev.physiol.53.1.497; Coort SLM, 2002, MOL CELL BIOCHEM, V239, P213, DOI 10.1023/A:1020539932353; de Fonseca FR, 2001, NATURE, V414, P209, DOI 10.1038/35102582; Drover VA, 2005, J CLIN INVEST, V115, P1290, DOI 10.1172/JCI200521514; ENDEMANN G, 1993, J BIOL CHEM, V268, P11811; Febbraio M, 1999, J BIOL CHEM, V274, P19055, DOI 10.1074/jbc.274.27.19055; Fu J, 2003, NATURE, V425, P90, DOI 10.1038/nature01921; Fu J, 2007, J BIOL CHEM, V282, P1518, DOI 10.1074/jbc.M607809200; Gaetani S, 2003, NEUROPSYCHOPHARMACOL, V28, P1311, DOI 10.1038/sj.npp.1300166; Gaillard D, 2008, FASEB J, V22, P1458, DOI 10.1096/fj.07-8415com; Goudriaan JR, 2002, MOL CELL BIOCHEM, V239, P199, DOI 10.1023/A:1020575412789; GREENBERG D, 1990, AM J PHYSIOL, V259, pR110, DOI 10.1152/ajpregu.1990.259.1.R110; Halton TL, 2004, J AM COLL NUTR, V23, P373, DOI 10.1080/07315724.2004.10719381; HARMON CM, 1991, J MEMBRANE BIOL, V121, P261, DOI 10.1007/BF01951559; HARMON CM, 1993, J MEMBRANE BIOL, V133, P43; Laugerette F, 2005, J CLIN INVEST, V115, P3177, DOI 10.1172/JCI25299; Lobo MVT, 2001, J HISTOCHEM CYTOCHEM, V49, P1253, DOI 10.1177/002215540104901007; Martin C, 2011, PHYSL BEHAV IN PRESS; Mithieux G, 2004, AM J PHYSIOL-ENDOC M, V286, pE370, DOI 10.1152/ajpendo.00299.2003; Mithieux G, 2005, CELL METAB, V2, P321, DOI 10.1016/j.cmet.2005.09.010; Nassir F, 2007, J BIOL CHEM, V282, P19493, DOI 10.1074/jbc.M703330200; Nauli AM, 2006, GASTROENTEROLOGY, V131, P1197, DOI 10.1053/j.gastro.2006.08.012; Nickenig G, 1996, MOL PHARMACOL, V50, P743; Petit V, 2007, J LIPID RES, V48, P278, DOI 10.1194/jlr.M600283-JLR200; Pillot B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019107; Pillot B, 2009, ENDOCRINOLOGY, V150, P616, DOI 10.1210/en.2008-0601; Poirier H, 1996, EUR J BIOCHEM, V238, P368, DOI 10.1111/j.1432-1033.1996.0368z.x; Rac ME, 2007, MOL MED, V13, P288, DOI 10.2119/2006-00088.Rac; ROLLS BJ, 1988, PHYSIOL BEHAV, V43, P145, DOI 10.1016/0031-9384(88)90230-2; Schwartz GJ, 2008, CELL METAB, V8, P281, DOI 10.1016/j.cmet.2008.08.005; SILVERSTEIN RL, 1989, J CLIN INVEST, V84, P546, DOI 10.1172/JCI114197; TANDON NN, 1989, J BIOL CHEM, V264, P7576; Testet E, 2005, BIOCHEM J, V387, P617, DOI 10.1042/BJ20041491; Thi TTT, 2011, J BIOL CHEM, V286, P25201, DOI 10.1074/jbc.M111.233551; WELCH IM, 1988, GUT, V29, P306, DOI 10.1136/gut.29.3.306; Westerterp-Plantenga MS, 2004, INT J OBESITY, V28, P57, DOI 10.1038/sj.ijo.0802461; WOLTMAN T, 1995, AM J PHYSIOL-REG I, V269, pR7, DOI 10.1152/ajpregu.1995.269.1.R7; Yang YK, 2007, AM J PHYSIOL-REG I, V292, pR235, DOI 10.1152/ajpregu.00270.2006	43	19	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30686	10.1371/journal.pone.0030686	http://dx.doi.org/10.1371/journal.pone.0030686			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295104	Green Submitted, Green Published, gold			2022-12-27	WOS:000301640600049
J	Rodley, CDM; Grand, RS; Gehlen, LR; Greyling, G; Jones, MB; O'Sullivan, JM				Rodley, Chris D. M.; Grand, Ralph S.; Gehlen, Lutz R.; Greyling, Gary; Jones, M. Beatrix; O'Sullivan, Justin M.			Mitochondrial-Nuclear DNA Interactions Contribute to the Regulation of Nuclear Transcript Levels as Part of the Inter-Organelle Communication System	PLOS ONE			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; GROUP-II INTRONS; GENE-TRANSFER; ENERGY-METABOLISM; INITIATION SITES; GENOME; RNA; MOBILITY; ESCAPE; ARABIDOPSIS	Nuclear and mitochondrial organelles must maintain a communication system. Loci on the mitochondrial genome were recently reported to interact with nuclear loci. To determine whether this is part of a DNA based communication system we used genome conformation capture to map the global network of DNA-DNA interactions between the mitochondrial and nuclear genomes (Mito-nDNA) in Saccharomyces cerevisiae cells grown under three different metabolic conditions. The interactions that form between mitochondrial and nuclear loci are dependent on the metabolic state of the yeast. Moreover, the frequency of specific mitochondrial - nuclear interactions (i.e. COX1-MSY1 and Q0182-RSM7) showed significant reductions in the absence of mitochondrial encoded reverse transcriptase machinery. Furthermore, these reductions correlated with increases in the transcript levels of the nuclear loci (MSY1 and RSM7). We propose that these interactions represent an inter-organelle DNA mediated communication system and that reverse transcription of mitochondrial RNA plays a role in this process.	[Rodley, Chris D. M.; Grand, Ralph S.; Gehlen, Lutz R.; Greyling, Gary; O'Sullivan, Justin M.] Massey Univ, Inst Nat Sci, Albany, New Zealand; [Jones, M. Beatrix] Massey Univ, Ctr Math Biol, Albany, New Zealand	Massey University; Massey University	Rodley, CDM (corresponding author), Massey Univ, Inst Nat Sci, Albany, New Zealand.	J.M.OSullivan@massey.ac.nz	O'Sullivan, Justin/HDO-1639-2022	O'Sullivan, Justin/0000-0003-2927-450X; Grand, Ralph S./0000-0001-9193-5239	Marsden Fund; Auckland Medical Research Foundation; Massey University; Maurice & Phyllis Paykel Trust; HRC [08/554]	Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); Auckland Medical Research Foundation; Massey University; Maurice & Phyllis Paykel Trust; HRC	This work was supported by the Marsden Fund; Auckland Medical Research Foundation; Massey University Research Fund; and Maurice & Phyllis Paykel Trust. HRC Ph.D. scholarship (08/554) to CR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 1999, P NATL ACAD SCI USA, V96, P13863, DOI 10.1073/pnas.96.24.13863; Adams KL, 2002, P NATL ACAD SCI USA, V99, P9905, DOI 10.1073/pnas.042694899; Arnold I, 2006, GENE, V367, P74, DOI 10.1016/j.gene.2005.09.044; Baldwin GS, 2008, J PHYS CHEM B, V112, P1060, DOI 10.1021/jp7112297; Barth C, 1999, CURR GENET, V36, P55, DOI 10.1007/s002940050472; Bassi GS, 2002, P NATL ACAD SCI USA, V99, P128, DOI 10.1073/pnas.012579299; Blank HM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000047; BRENNICKE A, 1993, FEBS LETT, V325, P140, DOI 10.1016/0014-5793(93)81430-8; Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0; CAMPBELL CL, 1994, MOL BIOL CELL, V5, P899, DOI 10.1091/mbc.5.8.899; Campbell CL, 1998, J CELL SCI, V111, P2455; Cheng X, 2010, AGING CELL, V9, P919, DOI 10.1111/j.1474-9726.2010.00607.x; CHRISTIANSON T, 1983, J BIOL CHEM, V258, P4025; COSTANZO MC, 1988, GENETICS, V120, P667; Danilowicz C, 2009, P NATL ACAD SCI USA, V106, P19824, DOI 10.1073/pnas.0911214106; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Duan Z, 2010, NATURE, V465, P363, DOI 10.1038/nature08973; Eskes R, 1997, CELL, V88, P865, DOI 10.1016/S0092-8674(00)81932-7; FARRELLY F, 1983, NATURE, V301, P296, DOI 10.1038/301296a0; Fekkes P, 2000, J CELL BIOL, V151, P333, DOI 10.1083/jcb.151.2.333; Foury F, 1998, FEBS LETT, V440, P325, DOI 10.1016/S0014-5793(98)01467-7; Fujita N, 2004, METHODS, V33, P81, DOI 10.1016/j.ymeth.2003.10.022; GRIFFIN EA, 1995, CHEM BIOL, V2, P761, DOI 10.1016/1074-5521(95)90104-3; Hazkani-Covo E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000834; Holec S, 2006, MOL CELL BIOL, V26, P2869, DOI 10.1128/MCB.26.7.2869-2876.2006; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Kaiser C., 1994, METHODS YEAST GENETI; Knoop V, 1996, GENETICS, V142, P579; KOCH JL, 1992, MOL CELL BIOL, V12, P1950, DOI 10.1128/MCB.12.5.1950; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; LAGUNAS R, 1976, BIOCHIM BIOPHYS ACTA, V440, P661, DOI 10.1016/0005-2728(76)90049-9; LAGUNAS R, 1986, YEAST, V2, P221, DOI 10.1002/yea.320020403; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Liu ZC, 1999, MOL CELL BIOL, V19, P6720; Marienfeld J, 1999, TRENDS PLANT SCI, V4, P495, DOI 10.1016/S1360-1385(99)01502-2; MONTOYA J, 1982, P NATL ACAD SCI-BIOL, V79, P7195, DOI 10.1073/pnas.79.23.7195; MORAN JV, 1995, MOL CELL BIOL, V15, P2828; Naylor K, 2006, J BIOL CHEM, V281, P2177, DOI 10.1074/jbc.M507943200; Neutzner A, 2005, J BIOL CHEM, V280, P18598, DOI 10.1074/jbc.M500807200; O'Sullivan JM, 2009, YEAST, V26, P125, DOI 10.1002/yea.1657; O'Sullivan JM, 2004, NAT GENET, V36, P1014, DOI 10.1038/ng1411; Otterstedt K, 2004, EMBO REP, V5, P532, DOI 10.1038/sj.embor.7400132; PARIKH VS, 1989, MOL CELL BIOL, V9, P1897, DOI 10.1128/MCB.9.5.1897; PARIKH VS, 1987, SCIENCE, V235, P576, DOI 10.1126/science.3027892; Ricchetti M, 1999, NATURE, V402, P96, DOI 10.1038/47076; Richly E, 2004, MOL BIOL EVOL, V21, P1081, DOI 10.1093/molbev/msh110; Rodley CDM, 2009, FUNGAL GENET BIOL, V46, P879, DOI 10.1016/j.fgb.2009.07.006; SERAPHIN B, 1992, GENE, V113, P1, DOI 10.1016/0378-1119(92)90663-A; Shafer KS, 1999, CURR GENET, V36, P183, DOI 10.1007/s002940050489; Shirafuji N, 1997, BLOOD, V90, P4567, DOI 10.1182/blood.V90.11.4567.4567_4567_4577; Spilianakis CG, 2004, NAT IMMUNOL, V5, P1017, DOI 10.1038/ni1115; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; THORSNESS PE, 1993, GENETICS, V134, P21; THORSNESS PE, 1990, NATURE, V346, P376, DOI 10.1038/346376a0; Timmis JN, 2004, NAT REV GENET, V5, P123, DOI 10.1038/nrg1271; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Toor N, 2001, RNA, V7, P1142, DOI 10.1017/S1355838201010251; Turk EM, 2010, J BIOL CHEM, V285, P8585, DOI 10.1074/jbc.M109.090761; Yang J, 1996, NATURE, V381, P332, DOI 10.1038/381332a0; ZIMMERLY S, 1995, CELL, V83, P529, DOI 10.1016/0092-8674(95)90092-6; ZIMMERLY S, 1995, CELL, V82, P545, DOI 10.1016/0092-8674(95)90027-6	61	20	20	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30943	10.1371/journal.pone.0030943	http://dx.doi.org/10.1371/journal.pone.0030943			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22292080	gold, Green Published, Green Submitted			2022-12-27	WOS:000301570600098
J	Gerhart, SV; Eble, DM; Burger, RM; Oline, SN; Vacaru, A; Sadler, KC; Jefferis, R; Iovine, MK				Gerhart, Sarah V.; Eble, Diane M.; Burger, R. Michael; Oline, Stefan N.; Vacaru, Ana; Sadler, Kirsten C.; Jefferis, Rebecca; Iovine, M. Kathryn			The Cx43-like Connexin Protein Cx40.8 Is Differentially Localized during Fin Ontogeny and Fin Regeneration	PLOS ONE			English	Article							GAP-JUNCTION CHANNELS; ZEBRAFISH FINS; HELA-CELLS; MUTATIONS; GJA1; PERMEABILITY; ENDOCYTOSIS; DISEASE; HEALTH; GROWTH	Connexins (Cx) are the subunits of gap junctions, membraneous protein channels that permit the exchange of small molecules between adjacent cells. Cx43 is required for cell proliferation in the zebrafish caudal fin. Previously, we found that a Cx43-like connexin, cx40.8, is co-expressed with cx43 in the population of proliferating cells during fin regeneration. Here we demonstrate that Cx40.8 exhibits novel differential subcellular localization in vivo, depending on the growth status of the fin. During fin ontogeny, Cx40.8 is found at the plasma membrane, but Cx40.8 is retained in the Golgi apparatus during regeneration. We next identified a 30 amino acid domain of Cx40.8 responsible for its dynamic localization. One possible explanation for the differential localization is that Cx40.8 contributes to the regulation of Cx43 in vivo, perhaps modifying channel activity during ontogenetic growth. However, we find that the voltage-gating properties of Cx40.8 are similar to Cx43. Together our findings reveal that Cx40.8 exhibits differential subcellular localization in vivo, dependent on a discrete domain in its carboxy terminus. We suggest that the dynamic localization of Cx40.8 differentially influences Cx43-dependent cell proliferation during ontogeny and regeneration.	[Gerhart, Sarah V.; Eble, Diane M.; Burger, R. Michael; Oline, Stefan N.; Jefferis, Rebecca; Iovine, M. Kathryn] Lehigh Univ, Dept Biol Sci, Bethlehem, PA 18015 USA; [Vacaru, Ana; Sadler, Kirsten C.] Mt Sinai Sch Med, Dept Regenerat & Dev Biol, Dept Med, Div Liver Dis, New York, NY USA	Lehigh University; Icahn School of Medicine at Mount Sinai	Gerhart, SV (corresponding author), Lehigh Univ, Dept Biol Sci, Bethlehem, PA 18015 USA.	mki3@lehigh.edu	Vacaru, Ana/AAR-7370-2021	Vacaru, Ana Maria/0000-0001-7976-8992; Sadler Edepli, Kirsten/0000-0002-1100-4125; Oline, Stefan/0000-0002-7094-3800	National Institutes of Health (NIH) [R03HD06270, R01AA018886, P20AAA017067]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA018886] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by National Institutes of Health (NIH) (http://www.nih.gov/): R03HD06270; NIH (http://www.nih.gov/: R01AA018886; NIH (http://www.nih.gov/: P20AAA017067. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2001, EUR J BIOCHEM, V268, P4544, DOI 10.1046/j.1432-1327.2001.02380.x; Akimenko MA, 2003, DEV DYNAM, V226, P190, DOI 10.1002/dvdy.10248; Bevans CG, 1998, J BIOL CHEM, V273, P2808, DOI 10.1074/jbc.273.5.2808; Brink PR, 1997, AM J PHYSIOL-CELL PH, V273, pC1386, DOI 10.1152/ajpcell.1997.273.4.C1386; Carette D, 2009, TRAFFIC, V10, P1272, DOI 10.1111/j.1600-0854.2009.00949.x; Cottrell GT, 2005, BBA-BIOMEMBRANES, V1711, P126, DOI 10.1016/j.bbamem.2004.11.013; Eastman SD, 2006, GENOMICS, V87, P265, DOI 10.1016/j.ygeno.2005.10.005; ELFGANG C, 1995, J CELL BIOL, V129, P805, DOI 10.1083/jcb.129.3.805; Falk MM, 2000, J CELL SCI, V113, P4109; Fiorini C, 2006, AM J PHYSIOL-CELL PH, V290, pC733, DOI 10.1152/ajpcell.00106.2005; Gerhart SV, 2009, FEBS LETT, V583, P3419, DOI 10.1016/j.febslet.2009.09.054; Gerido DA, 2004, BBA-BIOMEMBRANES, V1662, P159, DOI 10.1016/j.bbamem.2003.10.017; Giepmans BNG, 2001, CURR BIOL, V11, P1364, DOI 10.1016/S0960-9822(01)00424-9; Gilleron J, 2008, J CELL SCI, V121, P4069, DOI 10.1242/jcs.033373; Goldberg GS, 2004, BBA-BIOMEMBRANES, V1662, P96, DOI 10.1016/j.bbamem.2003.11.022; Hoptak-Solga AD, 2008, DEV BIOL, V317, P541, DOI 10.1016/j.ydbio.2008.02.051; Hoptak-Solga AD, 2007, FEBS LETT, V581, P3297, DOI 10.1016/j.febslet.2007.06.030; Hunter AW, 2003, CELL COMMUN ADHES, V10, P211, DOI 10.1080/714040429; Iovine MK, 2005, DEV BIOL, V278, P208, DOI 10.1016/j.ydbio.2004.11.005; Iovine MK, 2000, GENETICS, V155, P1321; Koval M, 1997, J CELL BIOL, V137, P847, DOI 10.1083/jcb.137.4.847; Laird DW, 2006, BIOCHEM J, V394, P527, DOI 10.1042/BJ20051922; Lauf U, 2001, FEBS LETT, V498, P11, DOI 10.1016/S0014-5793(01)02462-0; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; Martin PE, 2000, BIOCHEM J, V350, P943, DOI 10.1042/0264-6021:3500943; Paznekas WA, 2003, AM J HUM GENET, V72, P408, DOI 10.1086/346090; Poss KD, 2003, DEV DYNAM, V226, P202, DOI 10.1002/dvdy.10220; Sims K, 2009, DEV BIOL, V327, P410, DOI 10.1016/j.ydbio.2008.12.027; Sohl G, 2004, CARDIOVASC RES, V62, P228, DOI 10.1016/j.cardiores.2003.11.013; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; White TW, 1999, ANNU REV PHYSIOL, V61, P283, DOI 10.1146/annurev.physiol.61.1.283	31	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31364	10.1371/journal.pone.0031364	http://dx.doi.org/10.1371/journal.pone.0031364			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347467	gold, Green Published, Green Submitted			2022-12-27	WOS:000302730100063
J	Iqbal, A; Lim, YAL; Surin, J; Sim, BLH				Iqbal, Asma; Lim, Yvonne A. L.; Surin, Johari; Sim, Benedict L. H.			High Diversity of Cryptosporidium Subgenotypes Identified in Malaysian HIV/AIDS Individuals Targeting gp60 Gene	PLOS ONE			English	Article							CLINICAL-MANIFESTATIONS; MOLECULAR EPIDEMIOLOGY; SUBTYPE ANALYSES; PARVUM; CHILDREN; HOMINIS; HUMANS; GENOTYPE; CATTLE; SPP.	Background: Currently, there is a lack of vital information in the genetic makeup of Cryptosporidium especially in developing countries. The present study aimed at determining the genotypes and subgenotypes of Cryptosporidium in hospitalized Malaysian human immunodeficiency virus (HIV) positive patients. Methodology/Principal Findings: In this study, 346 faecal samples collected from Malaysian HIV positive patients were genetically analysed via PCR targeting the 60 kDa glycoprotein (gp60) gene. Eighteen (5.2% of 346) isolates were determined as Cryptosporidium positive with 72.2% (of 18) identified as Cryptosporidium parvum whilst 27.7% as Cryptosporidium hominis. Further gp60 analysis revealed C. parvum belonging to subgenotypes IIaA13G1R1 (2 isolates), IIaA13G2R1 (2 isolates), IIaA14G2R1 (3 isolates), IIaA15G2R1 (5 isolates) and IIdA15G1R1 (1 isolate). C. hominis was represented by subgenotypes IaA14R1 (2 isolates), IaA18R1 (1 isolate) and IbA10G2R2 (2 isolates). Conclusions/Significance: These findings highlighted the presence of high diversity of Cryptosporidium subgenotypes among Malaysian HIV infected individuals. The predominance of the C. parvum subgenotypes signified the possibility of zoonotic as well as anthroponotic transmissions of cryptosporidiosis in HIV infected individuals.	[Iqbal, Asma; Lim, Yvonne A. L.; Surin, Johari] Univ Malaya, Fac Med, Dept Parasitol, Kuala Lumpur, Malaysia; [Iqbal, Asma] Hlth Canada, Bur Microbial Hazards, Banting Res Ctr, Ottawa, ON K1A 0L2, Canada; [Sim, Benedict L. H.] Hosp Sungai Buloh, Infect Dis Unit, Dept Med, Sungai Buloh, Selangor Darul, Malaysia	Universiti Malaya; Health Canada	Iqbal, A (corresponding author), Univ Malaya, Fac Med, Dept Parasitol, Kuala Lumpur, Malaysia.	limailian@um.edu.my	LIM, YVONNE AL/B-5276-2010; SURIN, JOHARI/B-5320-2010	LIM, YVONNE AL/0000-0003-4050-6332; 	University of Malaya [HIR J-00000-73587, FS 196/2008B]	University of Malaya(Universiti Malaya)	This study was funded by the research grants from University of Malaya (Research grant No. HIR J-00000-73587 and FS 196/2008B). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abe N, 2006, PARASITOL RES, V99, P303, DOI 10.1007/s00436-006-0140-0; Ajjampur SSR, 2010, J CLIN MICROBIOL, V48, P2075, DOI 10.1128/JCM.02509-09; Alves M, 2003, J EUKARYOT MICROBIOL, V50, P529, DOI 10.1111/j.1550-7408.2003.tb00619.x; Alves M, 2006, PARASITOL RES, V99, P287, DOI 10.1007/s00436-006-0164-5; Anonymous, 2010, NATL STRATEGIC PLAN; Asma L, 2011, TROP BIOMED, V28, P400; Assefa S, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-155; Brook EJ, 2009, VET J, V179, P378, DOI 10.1016/j.tvjl.2007.10.023; Cama VA, 2008, EMERG INFECT DIS, V14, P1567, DOI 10.3201/eid1410.071273; Cama VA, 2007, J INFECT DIS, V196, P684, DOI 10.1086/519842; CAMPBELL AT, 1993, APPL ENVIRON MICROB, V59, P4361, DOI 10.1128/AEM.59.12.4361-4362.1993; Chalmers RM, 2005, INT J PARASITOL, V35, P397, DOI 10.1016/j.ijpara.2005.01.001; Cohen S, 2006, J CLIN MICROBIOL, V44, P589, DOI 10.1128/JCM.44.2.589-591.2006; CURRENT WL, 1991, CLIN MICROBIOL REV, V4, P325, DOI 10.1128/CMR.4.3.325-358.1991; Daryani A, 2009, Pak J Biol Sci, V12, P1277, DOI 10.3923/pjbs.2009.1277.1281; Fayer R, 2010, EXP PARASITOL, V124, P90, DOI 10.1016/j.exppara.2009.03.005; Feltus DC, 2006, J CLIN MICROBIOL, V44, P4303, DOI 10.1128/JCM.01067-06; Feng Y, 2007, APPL ENVIRON MICROB, V73, P6475, DOI 10.1128/AEM.01034-07; Florez Astrid Carolina, 2003, Biomedica, V23, P274; Gatei W, 2007, INFECT GENET EVOL, V7, P197, DOI 10.1016/j.meegid.2006.08.006; GHANI MC, 1984, J MALAYSIAN SOC HLTH, V4, P80; Glaberman S, 2002, EMERG INFECT DIS, V8, P631, DOI 10.3201/eid0806.010368; Goh K L, 1987, Med J Malaysia, V42, P58; Hall B.G., 2004, PHYLOGENETIC TREES M; Hung CC, 2007, J FORMOS MED ASSOC, V106, P31, DOI 10.1016/S0929-6646(09)60213-8; Hunter PR, 2003, J APPL MICROBIOL, V94, p37S, DOI 10.1046/j.1365-2672.94.s1.5.x; Jex AR, 2008, J CLIN MICROBIOL, V46, P2252, DOI 10.1128/JCM.00116-08; Jex AR, 2007, ELECTROPHORESIS, V28, P3875, DOI 10.1002/elps.200700279; Jex AR, 2007, ELECTROPHORESIS, V28, P2818, DOI 10.1002/elps.200600772; Jex AR, 2010, BIOTECHNOL ADV, V28, P17, DOI 10.1016/j.biotechadv.2009.08.003; Jex AR, 2008, ELECTROPHORESIS, V29, P4119, DOI 10.1002/elps.200800422; Kamel A. G. Mohamed, 1994, Southeast Asian Journal of Tropical Medicine and Public Health, V25, P650; Leav BA, 2002, INFECT IMMUN, V70, P3881, DOI 10.1128/IAI.70.7.3881-3890.2002; Lim YAL, 2008, J WATER HEALTH, V6, P239, DOI 10.2166/wh.2008.023; Lim Y A L, 2005, Southeast Asian J Trop Med Public Health, V36 Suppl 4, P30; Lim YAL, 2011, INFECT GENET EVOL, V11, P968, DOI 10.1016/j.meegid.2011.03.007; Lim YAL, 2010, ADV PARASIT, V71, P1, DOI 10.1016/S0065-308X(10)71003-4; Mallon M, 2003, J MOL EVOL, V56, P407, DOI 10.1007/s00239-002-2412-3; Muthusamy D, 2006, J CLIN MICROBIOL, V44, P632, DOI 10.1128/JCM.44.2.632-634.2006; Navin TR, 1999, J ACQ IMMUN DEF SYND, V20, P154, DOI 10.1097/00042560-199902010-00007; Peng MM, 2003, J EUKARYOT MICROBIOL, V50, P557, DOI 10.1111/j.1550-7408.2003.tb00628.x; Peng MM, 2003, PARASITOL RES, V90, P175, DOI 10.1007/s00436-003-0834-5; Peng MM, 2001, J EUKARYOT MICROBIOL, V50, P557; Plutzer J, 2007, VET PARASITOL, V146, P357, DOI 10.1016/j.vetpar.2007.02.030; Quilez J, 2008, APPL ENVIRON MICROB, V74, P6026, DOI 10.1128/AEM.00606-08; Report G., 2010, UNAIDS REPORT GLOBAL; Smith HV, 2005, VET REC, V156, P710, DOI 10.1136/vr.156.22.710; Stantic-Pavlinic M, 2003, WIEN KLIN WOCHENSCHR, V115, P125, DOI 10.1007/BF03040292; Strong WB, 2000, INFECT IMMUN, V68, P4117, DOI 10.1128/IAI.68.7.4117-4134.2000; Sulaiman IM, 2005, J CLIN MICROBIOL, V43, P2805, DOI 10.1128/JCM.43.6.2805-2809.2005; Sulaiman IM, 2001, J EUKARYOT MICROBIOL, p24S; Thompson HP, 2007, PARASITOL RES, V100, P619, DOI 10.1007/s00436-006-0305-x; Traversa D, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-21; Trotz-Williams LA, 2006, PARASITOL RES, V99, P346, DOI 10.1007/s00436-006-0157-4; Wielinga PR, 2008, INT J PARASITOL, V38, P809, DOI 10.1016/j.ijpara.2007.10.014; Wu ZL, 2003, APPL ENVIRON MICROB, V69, P4720, DOI 10.1128/AEM.69.8.4720-4726.2003; XIAO L, 2004, CRYPTOSPORIDIUM MOL, P121; Xiao LH, 2000, APPL ENVIRON MICROB, V66, P5492, DOI 10.1128/AEM.66.12.5492-5498.2000; Xiao LH, 2004, CURR OPIN INFECT DIS, V17, P483, DOI 10.1097/00001432-200410000-00014; Xiao Lihua, 2007, P119; Xiao LH, 2007, PARASITOL RES, V100, P701, DOI 10.1007/s00436-006-0337-2; Zaidah A. R., 2008, Southeast Asian Journal of Tropical Medicine and Public Health, V39, P511	62	54	54	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31139	10.1371/journal.pone.0031139	http://dx.doi.org/10.1371/journal.pone.0031139			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347442	gold, Green Published, Green Accepted			2022-12-27	WOS:000302730100045
J	Jensen, TE; Leutert, R; Rasmussen, ST; Mouatt, JR; Christiansen, MLB; Jensen, BR; Richter, EA				Jensen, Thomas E.; Leutert, Robin; Rasmussen, Soren T.; Mouatt, Joshua R.; Christiansen, Mette L. B.; Jensen, Bente R.; Richter, Erik A.			EMG-Normalised Kinase Activation during Exercise Is Higher in Human Gastrocnemius Compared to Soleus Muscle	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; PROTEIN-KINASE; FIBER-TYPE; GLUCOSE-UPTAKE; AMPK ACTIVATION; INSULIN ACTION; EXPRESSION; PHOSPHORYLATION; MUTATION; GLYCOGEN	In mice, certain proteins show a highly confined expression in specific muscle groups. Also, resting and exercise/contraction-induced phosphorylation responses are higher in rat skeletal muscle with low mitochondrial content compared to muscles with high mitochondrial content, possibly related to differential reactive oxygen species (ROS)-scavenging ability or resting glycogen content. To evaluate these parameters in humans, biopsies from soleus, gastrocnemius and vastus lateralis muscles were taken before and after a 45 min inclined (15%) walking exercise bout at 69% VO2(max) aimed at simultaneously activating soleus and gastrocnemius in a comparable dynamic work-pattern. Hexokinase II and GLUT4 were 46-59% and 26-38% higher (p<0.05) in soleus compared to the two other muscles. The type I muscle fiber percentage was highest in soleus and lowest in vastus lateralis. No differences were found in protein expression of signalling proteins (AMPK subunits, eEF2, ERK1/2, TBC1D1 and 4), mitochondrial markers (F1 ATPase and COX1) or ROS-handling enzymes (SOD2 and catalase). Gastrocnemius was less active than soleus measured as EMG signal and glycogen use yet gastrocnemius displayed larger increases than soleus in phosphorylation of AMPK Thr172, eEF2 Thr56 and ERK 1/2 Thr202/Tyr204 when normalised to the mean relative EMG-signal. In conclusion, proteins with muscle-group restricted expression in mice do not show this pattern in human lower extremity muscle groups. Nonetheless the phosphorylation-response is greater for a number of kinase signalling pathways in human gastrocnemius than soleus at a given activation-intensity. This may be due to the combined subtle effects of a higher type I muscle fiber content and higher training status in soleus compared to gastrocnemius muscle.	[Jensen, Thomas E.; Leutert, Robin; Rasmussen, Soren T.; Mouatt, Joshua R.; Christiansen, Mette L. B.; Richter, Erik A.] Univ Copenhagen, Mol Physiol Grp, Dept Exercise & Sport Sci, Copenhagen, Denmark; [Jensen, Bente R.] Univ Copenhagen, Motor Control & Biomech Grp, Dept Exercise & Sport Sci, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	Jensen, TE (corresponding author), Univ Copenhagen, Mol Physiol Grp, Dept Exercise & Sport Sci, Copenhagen, Denmark.	TEJensen@ifi.ku.dk	Richter, Erik A./Y-8131-2019; Jensen, Thomas/E-1215-2015	Richter, Erik A./0000-0002-6850-3056; Jensen, Thomas/0000-0001-6139-8268	Danish Medical Research Council; Lundbeck Foundation; NovoNordisk Foundation	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lundbeck Foundation(Lundbeckfonden); NovoNordisk Foundation(Novo Nordisk Foundation)	This work was supported by the Danish Medical Research Council, The Lundbeck Foundation and NovoNordisk Foundation. TJ was supported by a postdoctoral fellowship from the Danish Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimoto T, 2004, AM J PHYSIOL-CELL PH, V287, pC1311, DOI 10.1152/ajpcell.00248.2004; Allen DL, 2001, AM J PHYSIOL-CELL PH, V280, pC637, DOI 10.1152/ajpcell.2001.280.3.C637; Anderson EJ, 2006, AM J PHYSIOL-CELL PH, V290, pC844, DOI 10.1152/ajpcell.00402.2005; Barnes BR, 2004, J BIOL CHEM, V279, P38441, DOI 10.1074/jbc.M405533200; Benziane B, 2008, AM J PHYSIOL-ENDOC M, V295, pE1427, DOI 10.1152/ajpendo.90428.2008; Castorena CM, 2011, J APPL PHYSL; Chen ZP, 1999, FEBS LETT, V460, P343, DOI 10.1016/S0014-5793(99)01371-X; Coffey VG, 2005, FASEB J, V19, P190, DOI 10.1096/fj.05-4809fje; Costford SR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000903; Daugaard JR, 2004, PFLUG ARCH EUR J PHY, V447, P452, DOI 10.1007/s00424-003-1195-8; Derave W, 2000, DIABETES, V49, P1281, DOI 10.2337/diabetes.49.8.1281; Frosig C, 2004, AM J PHYSIOL-ENDOC M, V286, pE411, DOI 10.1152/ajpendo.00317.2003; Frosig C, 2007, DIABETES, V56, P2093, DOI 10.2337/db06-1698; Fryer LGD, 2002, BIOCHEM J, V363, P167, DOI 10.1042/0264-6021:3630167; Garcia-Roves PM, 2008, J BIOL CHEM, V283, P35724, DOI 10.1074/jbc.M805078200; Gomez-Cabrera MC, 2008, FREE RADICAL BIO MED, V44, P126, DOI 10.1016/j.freeradbiomed.2007.02.001; Gregory CM, 2001, MUSCLE NERVE, V24, P387, DOI 10.1002/1097-4598(200103)24:3<387::AID-MUS1010>3.0.CO;2-M; Hellsten Y, 2001, FREE RADICAL BIO MED, V31, P1313, DOI 10.1016/S0891-5849(01)00631-1; HICKEY MS, 1995, AM J PHYSIOL-ENDOC M, V269, pE150, DOI 10.1152/ajpendo.1995.269.1.E150; HINTZ CS, 1980, AM J PHYSIOL, V239, pC58, DOI 10.1152/ajpcell.1980.239.3.C58; Hoeg LD, 2011, DIABETES, V60, P64, DOI 10.2337/db10-0698; Houmard JA, 1998, J APPL PHYSIOL, V85, P1337, DOI 10.1152/jappl.1998.85.4.1337; Jackson MJ, 2011, ANTIOXID REDOX SIGN, V15, P2477, DOI 10.1089/ars.2011.3976; Jorgensen SB, 2004, J BIOL CHEM, V279, P1070, DOI 10.1074/jbc.M306205200; Kawanaka K, 2000, AM J PHYSIOL-ENDOC M, V279, pE1311, DOI 10.1152/ajpendo.2000.279.6.E1311; Lee-Young RS, 2009, J APPL PHYSIOL, V107, P283, DOI 10.1152/japplphysiol.91208.2008; Ljubicic V, 2008, AM J PHYSIOL-ENDOC M, V295, pE195, DOI 10.1152/ajpendo.90276.2008; Ljubicic V, 2009, AM J PHYSIOL-ENDOC M, V297, pE749, DOI 10.1152/ajpendo.00130.2009; LUGINBUHL AJ, 1984, HISTOCHEMISTRY, V81, P55, DOI 10.1007/BF00495401; McConell GK, 2008, J APPL PHYSIOL, V105, P1422, DOI 10.1152/japplphysiol.01371.2007; Nielsen JN, 2003, J APPL PHYSIOL, V94, P631, DOI 10.1152/japplphysiol.00642.2002; Pehmoller C, 2009, AM J PHYSIOL-ENDOC M, V297, pE665, DOI 10.1152/ajpendo.00115.2009; Rose AJ, 2005, J PHYSIOL-LONDON, V569, P223, DOI 10.1113/jphysiol.2005.097154; Rose AJ, 2005, PHYSIOLOGY, V20, P260, DOI 10.1152/physiol.00012.2005; Scott JW, 2008, CHEM BIOL, V15, P1220, DOI 10.1016/j.chembiol.2008.10.005; Spangenburg EE, 2003, ACTA PHYSIOL SCAND, V178, P413, DOI 10.1046/j.1365-201X.2003.01158.x; Taylor EB, 2008, J BIOL CHEM, V283, P9787, DOI 10.1074/jbc.M708839200; Treebak JT, 2009, AM J PHYSIOL-CELL PH, V297, pC1041, DOI 10.1152/ajpcell.00051.2009; VANDENBORNE K, 1995, AM J PHYSIOL-CELL PH, V268, pC869, DOI 10.1152/ajpcell.1995.268.4.C869; Wojtaszewski JFP, 2003, AM J PHYSIOL-ENDOC M, V284, pE813, DOI 10.1152/ajpendo.00436.2002; Wojtaszewski JFP, 2006, ESSAYS BIOCHEM, V42, P31, DOI 10.1042/bse0420031; Wright VP, 2009, J PHYSIOL-LONDON, V587, P5767, DOI 10.1113/jphysiol.2009.178285; Yu M, 2003, J PHYSIOL-LONDON, V546, P327, DOI 10.1113/jphysiol.2002.034223	43	19	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31054	10.1371/journal.pone.0031054	http://dx.doi.org/10.1371/journal.pone.0031054			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347426	Green Published, gold, Green Submitted			2022-12-27	WOS:000302730100035
J	Kinjo, AR; Nakamura, H				Kinjo, Akira R.; Nakamura, Haruki			Composite Structural Motifs of Binding Sites for Delineating Biological Functions of Proteins	PLOS ONE			English	Article							LIGAND-BINDING; EVOLUTIONARY RELATIONSHIPS; CRYSTAL-STRUCTURE; ENZYME; INTERFACES; DATABASE; DOMAIN; CLASSIFICATION; SIMILARITIES; REVEALS	Most biological processes are described as a series of interactions between proteins and other molecules, and interactions are in turn described in terms of atomic structures. To annotate protein functions as sets of interaction states at atomic resolution, and thereby to better understand the relation between protein interactions and biological functions, we conducted exhaustive all-against-all atomic structure comparisons of all known binding sites for ligands including small molecules, proteins and nucleic acids, and identified recurring elementary motifs. By integrating the elementary motifs associated with each subunit, we defined composite motifs that represent context-dependent combinations of elementary motifs. It is demonstrated that function similarity can be better inferred from composite motif similarity compared to the similarity of protein sequences or of individual binding sites. By integrating the composite motifs associated with each protein function, we define meta-composite motifs each of which is regarded as a time-independent diagrammatic representation of a biological process. It is shown that meta-composite motifs provide richer annotations of biological processes than sequence clusters. The present results serve as a basis for bridging atomic structures to higher-order biological phenomena by classification and integration of binding site structures.	[Kinjo, Akira R.; Nakamura, Haruki] Osaka Univ, Inst Prot Res, Suita, Osaka 565, Japan	Osaka University	Kinjo, AR (corresponding author), Osaka Univ, Inst Prot Res, Suita, Osaka 565, Japan.	akinjo@protein.osaka-u.ac.jp		Kinjo, Akira/0000-0002-4006-8208	National Bioscience Database Center (NBDC), Japan Science and Technology Agency (JST); Japan Society for the Promotion of Science (JSPS) [22770149, 23370071]	National Bioscience Database Center (NBDC), Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a grant-in-aid by National Bioscience Database Center (NBDC), the Japan Science and Technology Agency (JST). A.R.K. was supported in part by the KAKENHI Grant-in-Aid for Young Scientists B (No. 22770149) from the Japan Society for the Promotion of Science (JSPS). H.N. was supported in part by the KAKENHI Grant-in-Aid for Scientific Researches B (No. 23370071) from the JSPS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amemiya T, 2011, J MOL BIOL, V408, P568, DOI 10.1016/j.jmb.2011.02.058; Aung Zeyar, 2008, Journal of Bioinformatics and Computational Biology, V6, P415, DOI 10.1142/S0219720008003485; Bairoch A, 2005, NUCLEIC ACIDS RES, V33, pD154, DOI 10.1093/nar/gki070; Bashton M, 2007, STRUCTURE, V15, P85, DOI 10.1016/j.str.2006.11.009; Berman H, 2007, NUCLEIC ACIDS RES, V35, pD301, DOI 10.1093/nar/gkl971; Bollobas B, 1998, MODERN GRAPH THEORY; Branden C., 1999, INTRO PROTEIN STRUCT; Brylinski M, 2008, P NATL ACAD SCI USA, V105, P129, DOI 10.1073/pnas.0707684105; Chen K, 2011, STRUCTURE, V19, P613, DOI 10.1016/j.str.2011.02.015; Chipman DM, 2001, CURR OPIN STRUC BIOL, V11, P694, DOI 10.1016/S0959-440X(01)00272-X; Dasgupta B, 2011, J MOL BIOL, V411, P713, DOI 10.1016/j.jmb.2011.06.027; Davis FP, 2011, MOL BIOSYST, V7, P545, DOI 10.1039/c0mb00200c; Davis FP, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000668; Dessailly BH, 2009, CURR OPIN STRUC BIOL, V19, P349, DOI 10.1016/j.sbi.2009.03.009; Fiorillo A, 2010, CRYSTAL STRUCTURE MU, DOI [10.2210/pdb3ku9/pdb, DOI 10.2210/PDB3KU9/PDB]; Friedberg I, 2006, BRIEF BIOINFORM, V7, P225, DOI 10.1093/bib/bbl004; Gold ND, 2006, J MOL BIOL, V355, P1112, DOI 10.1016/j.jmb.2005.11.044; Henrick K, 1998, TRENDS BIOCHEM SCI, V23, P358, DOI 10.1016/S0968-0004(98)01253-5; Holland TA, 2006, J MOL BIOL, V361, P562, DOI 10.1016/j.jmb.2006.05.060; Janin J, 2008, Q REV BIOPHYS, V41, P133, DOI 10.1017/S0033583508004708; Joerger AC, 2004, J BIOL CHEM, V279, P1291, DOI 10.1074/jbc.M309732200; Kadono S, 2004, BIOCHEM BIOPH RES CO, V324, P1227, DOI 10.1016/j.bbrc.2004.09.182; Kawabata T, 2003, NUCLEIC ACIDS RES, V31, P3367, DOI 10.1093/nar/gkg581; Kawabata T, 2000, PROTEINS, V41, P108, DOI 10.1002/1097-0134(20001001)41:1<108::AID-PROT130>3.3.CO;2-J; Keskin O, 2004, PROTEIN SCI, V13, P1043, DOI 10.1110/ps.03484604; Keskin O, 2008, CHEM REV, V108, P1225, DOI 10.1021/cr040409x; Kettenberger H, 2004, MOL CELL, V16, P955, DOI 10.1016/j.molcel.2004.11.040; Kinjo AR, 2010, J MOL BIOL, V399, P526, DOI 10.1016/j.jmb.2010.04.028; Kinjo Akira R, 2007, Biophysics (Nagoya-shi), V3, P75, DOI 10.2142/biophysics.3.75; Kinjo AR, 2009, STRUCTURE, V17, P234, DOI 10.1016/j.str.2008.11.009; Kinoshita K, 1999, PROTEIN ENG, V12, P11, DOI 10.1093/protein/12.1.11; Kinoshita K, 2004, BIOINFORMATICS, V20, P1329, DOI 10.1093/bioinformatics/bth073; Kinoshita K, 2003, PROTEIN SCI, V12, P1589, DOI 10.1110/ps.0368703; Kitayner M, 2006, MOL CELL, V22, P741, DOI 10.1016/j.molcel.2006.05.015; Koike R, 2008, J MOL BIOL, V379, P397, DOI 10.1016/j.jmb.2008.04.019; Koike R, 2009, PROTEIN SCI, V18, P2060, DOI 10.1002/pro.218; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Levitt M, 2007, P NATL ACAD SCI USA, V104, P3183, DOI 10.1073/pnas.0611678104; Loewenstein Y, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-207; Louie B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007546; Mortl M, 2004, J BIOL CHEM, V279, P29718, DOI 10.1074/jbc.M401224200; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nagano N, 2002, J MOL BIOL, V321, P741, DOI 10.1016/S0022-2836(02)00649-6; Nardini M, 2003, EMBO J, V22, P3122, DOI 10.1093/emboj/cdg283; Okazaki K, 2011, STRUCTURE, V19, P588, DOI 10.1016/j.str.2011.01.013; Pawelek PD, 2000, EMBO J, V19, P4204, DOI 10.1093/emboj/19.16.4204; Petrey D, 2009, CURR OPIN STRUC BIOL, V19, P363, DOI 10.1016/j.sbi.2009.02.001; Rausell A, 2010, P NATL ACAD SCI USA, V107, P1995, DOI 10.1073/pnas.0908044107; Redfern OC, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000485; Rentzsch R, 2009, TRENDS BIOTECHNOL, V27, P210, DOI 10.1016/j.tibtech.2009.01.002; Robinson CV, 2007, NATURE, V450, P973, DOI 10.1038/nature06523; Rost B, 2002, J MOL BIOL, V318, P595, DOI 10.1016/S0022-2836(02)00016-5; Santos GM, 2011, TRENDS ENDOCRIN MET, V22, P87, DOI 10.1016/j.tem.2010.11.004; Schnoes AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000605; SCHULLER DJ, 1995, NAT STRUCT BIOL, V2, P69, DOI 10.1038/nsb0195-69; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shi JH, 2004, J BIOL CHEM, V279, P24765, DOI 10.1074/jbc.M311744200; Sinha R, 2010, PROTEINS, V78, P3235, DOI 10.1002/prot.22812; Stark A, 2003, J MOL BIOL, V326, P1307, DOI 10.1016/S0022-2836(03)00045-7; Stenberg K, 1997, PROTEIN SCI, V6, P1009, DOI 10.1002/pro.5560060506; Terwilliger TC, 2009, ANNU REV BIOPHYS, V38, P371, DOI 10.1146/annurev.biophys.050708.133740; Thangudu RR, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-365; Toyota E, 2001, J MOL BIOL, V305, P471, DOI 10.1006/jmbi.2000.4303; Tuncbag N, 2008, J MOL BIOL, V381, P785, DOI 10.1016/j.jmb.2008.04.071; Tuncbag N, 2011, NAT PROTOC, V6, P1341, DOI 10.1038/nprot.2011.367; Tyagi M, 2009, PROTEIN SCI, V18, P1674, DOI 10.1002/pro.181; Wallace AC, 1997, PROTEIN SCI, V6, P2308; Westbrook J, 2005, BIOINFORMATICS, V21, P988, DOI 10.1093/bioinformatics/bti082; Winter C, 2006, NUCLEIC ACIDS RES, V34, pD310, DOI 10.1093/nar/gkj099; XIA ZX, 1990, J MOL BIOL, V212, P837, DOI 10.1016/0022-2836(90)90240-M; Xie L, 2008, P NATL ACAD SCI USA, V105, P5441, DOI 10.1073/pnas.0704422105; Yang MJ, 2006, MOL CELL, V23, P377, DOI 10.1016/j.molcel.2006.07.012; Yeh JI, 2008, P NATL ACAD SCI USA, V105, P3280, DOI 10.1073/pnas.0712331105; Zhao N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019554	75	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31437	10.1371/journal.pone.0031437	http://dx.doi.org/10.1371/journal.pone.0031437			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347478	Green Published, gold, Green Submitted			2022-12-27	WOS:000302730100071
J	Salva, S; Merino, MC; Aguero, G; Gruppi, A; Alvarez, S				Salva, Susana; Cecilia Merino, Maria; Agueero, Graciela; Gruppi, Adriana; Alvarez, Susana			Dietary Supplementation with Probiotics Improves Hematopoiesis in Malnourished Mice	PLOS ONE			English	Article							PNEUMOCOCCAL RESPIRATORY-INFECTION; BONE-MARROW; MALNUTRITION; PROTEIN; LEPTIN; CELLS; CHILDREN; IMMUNITY; FUTURE	Background: Lactobacillus rhamnosus CRL1505 (Lr) administered during the repletion of immunocompromised-malnourished mice improves the resistance against intestinal and respiratory infections. This effect is associated with an increase in the number and functionality of immune cells, indicating that Lr could have some influence on myeloid and lymphoid cell production and maturation. Objective: This study analyzed the extent of the damage caused by malnutrition on myeloid and lymphoid cell development in the spleen and bone marrow (BM). We also evaluated the impact of immunobiotics on the recovery of hematopoiesis affected in malnourished mice. Methods: Protein malnourished mice were fed on a balanced conventional diet for 7 or 14 consecutive d with or without supplemental Lr or fermented goat's milk (FGM). Malnourished mice and well-nourished mice were used as controls. Histological and flow cytometry studies were carried out in BM and spleen to study myeloid and lymphoid cells. Results: Malnutrition induced quantitative alterations in spleen B and T cells; however, no alteration was observed in the ability of splenic B cells to produce immunoglobulins after challenge with LPS or CpG. The analysis of BM B cell subsets based on B220, CD24, IgM and IgD expression showed that malnutrition affected B cell development. In addition, BM myeloid cells decreased in malnourished mice. On the contrary, protein deprivation increased BM T cell number. These alterations were reverted with Lr or FGM repletion treatments since normal numbers of BM myeloid, T and B cells were observed in these groups. Conclusions: Protein malnutrition significantly alters B cell development in BM. The treatment of malnourished mice with L. rhamnosus CRL1505 was able to induce a recovery of B cells that would explain its ability to increase immunity against infections. This work highlights the possibility of using immunobiotics to accelerate the recovery of lymphopoyesis in immunocompromised-malnourished hosts.	[Salva, Susana; Alvarez, Susana] Reference Ctr Lactobacilli CERELA CONICET, San Miguel De Tucuman, Argentina; [Cecilia Merino, Maria; Gruppi, Adriana] Natl Univ Cordoba, Dept Clin Biochem, Sch Chem Sci, Cordoba, Argentina; [Agueero, Graciela; Alvarez, Susana] Natl Univ Tucuman, Sch Biochem Chem & Pharm, San Miguel De Tucuman, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; Universidad Nacional de Tucuman	Salva, S (corresponding author), Reference Ctr Lactobacilli CERELA CONICET, San Miguel De Tucuman, Argentina.	salvarez@cerela.org.ar		Salva, Susana/0000-0001-9571-1259	CIUNT (Consejo de Investigaciones de la Universidad Nacional de Tucuman) [26 D/403]	CIUNT (Consejo de Investigaciones de la Universidad Nacional de Tucuman)	This work was carried out thanks to grants provided by CIUNT 26 D/403 (Consejo de Investigaciones de la Universidad Nacional de Tucuman). The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez S, 2009, J NUTR SCI VITAMINOL, P1; BORELLI P, 1995, NUTR RES, V15, P1477, DOI 10.1016/0271-5317(95)02020-V; Chan JL, 2006, P NATL ACAD SCI USA, V103, P8481, DOI 10.1073/pnas.0505429103; Chandra RK, 1997, AM J CLIN NUTR, V66, P460; CHANDRA RK, 1991, AM J CLIN NUTR, V53, P1087, DOI 10.1093/ajcn/53.5.1087; Clancy R, 2003, FEMS IMMUNOL MED MIC, V38, P9, DOI 10.1016/S0928-8244(03)00147-0; Fillol F, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-116; Fock RA, 2009, NUTRITION, V10, P1021; Forsythe P, 2011, CHEST, V139, P901, DOI 10.1378/chest.10-1861; Goldin BR, 2008, CLIN INFECT DIS, V46, pS96, DOI 10.1086/523333; Ishikawa LL, 2009, GENET VACCINES THER, V16, P7; Kitazawa H., 2009, CURR OPIN IMMUNOL, V3, P87; Lord GM, 1998, NATURE, V394, P897, DOI 10.1038/29795; LOZOFF B, 1991, NEW ENGL J MED, V325, P687, DOI 10.1056/NEJM199109053251004; Monteiro JP, 2005, BRAZ J MED BIOL RES, V38, P1475, DOI 10.1590/S0100-879X2005001000004; Monteiro JP, 2005, BLOOD, V105, P1484, DOI 10.1182/blood-2004-07-2856; Montes CL, 2006, EUR J IMMUNOL, V36, P1474, DOI 10.1002/eji.200535537; Najera O, 2001, CLIN EXP IMMUNOL, V126, P461, DOI 10.1046/j.1365-2249.2001.01694.x; Vinolo MAR, 2008, NUTR RES, V28, P791, DOI 10.1016/j.nutres.2008.08.006; Reid G, 2003, CLIN MICROBIOL REV, V16, P658, DOI 10.1128/CMR.16.4.658-672.2003; Rodriguez L, 2005, CLIN DIAGN LAB IMMUN, V12, P502, DOI 10.1128/CDLI.12.4.502-507.2005; Rodriguez L, 2011, J NEUROSCI REV, V31, P8373; Salva S, 2008, FOOD AGR IMMUNOL, V19, P195, DOI 10.1080/09540100802247243; Salva S, 2011, J SCI FOOD AGR, V91, P2355, DOI 10.1002/jsfa.4467; Salva S, 2010, INT J FOOD MICROBIOL, V141, P82, DOI 10.1016/j.ijfoodmicro.2010.03.013; Savino W, 2002, EUR J CLIN NUTR, V56, pS46, DOI 10.1038/sj.ejcn.1601485; Schrimshaw NS, 1997, AM J CLIN NUTR, V66, p464S; Tanaka M, 2011, J NEUROSCI, V31, P8373, DOI 10.1523/JNEUROSCI.6562-10.2011; Villena J, 2006, BRIT J NUTR, V95, P591, DOI 10.1079/BJN20051663; Villena J, 2005, J NUTR, V135, P1462, DOI 10.1093/jn/135.6.1462; Villena J, 2011, INT IMMUNOPHARMACOL, V11, P1633, DOI 10.1016/j.intimp.2011.06.004; Villena J, 2009, MICROBIOL IMMUNOL, V53, P636, DOI 10.1111/j.1348-0421.2009.00171.x; Vituri CL, 2000, BRAZ J MED BIOL RES, V33, P889, DOI 10.1590/S0100-879X2000000800004; Woodward B, 1998, NUTR REV, V56, pS84; Xavier JG, 2007, HISTOL HISTOPATHOL, V22, P651, DOI 10.14670/HH-22.651; Zuniga E, 2005, EUR J IMMUNOL, V35, P1849, DOI 10.1002/eji.200526005	36	18	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31171	10.1371/journal.pone.0031171	http://dx.doi.org/10.1371/journal.pone.0031171			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347448	Green Published, Green Submitted, gold			2022-12-27	WOS:000302730100051
J	de Castellarnau, M; Aparicio, E; Parera, M; Franco, S; Tural, C; Clotet, B; Martinez, MA				de Castellarnau, Montserrat; Aparicio, Ester; Parera, Mariona; Franco, Sandra; Tural, Cristina; Clotet, Bonaventura; Angel Martinez, Miguel			Deciphering the Interleukin 28B Variants That Better Predict Response to Pegylated Interferon-alpha and Ribavirin Therapy in HCV/HIV-1 Coinfected Patients	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; GENETIC-VARIATION; PLUS RIBAVIRIN; IL28B; PEGINTERFERON; POLYMORPHISMS; ASSOCIATION; NONRESPONSE; EXPRESSION; CLEARANCE	Previous works have documented the contribution of different IL28B-associated SNPs to spontaneous HCV clearance. This study investigated the effect of different interleukin (IL) 28B genetic variants on interferon (IFN)-based therapy response. We genotyped eight IL28B single-nucleotide polymorphisms (SNPs) in a cohort of 197 hepatitis C virus (HCV)/human immunodeficiency virus type 1 (HIV-1) coinfected patients from our clinic unit who received combined pegylated (peg)-IFN-alpha and ribavirin (RBV) therapy. This analysis included the two strongest tag predictors for HCV clearance, rs8099917 and rs12979860, and four causal variants (rs4803219, rs28416813, rs8103142, and rs4803217) located in the IL28B promoter, coding, and 3'-untranslated regions. Haplotypes carrying the major alleles at IL28B SNPs were highly associated with sustained virological responses (SVRs) after treatment with peg-IFN-alpha and RBV [odds ratio (OR) = 2.5, 95% confidence interval (CI) = 1.6-4.0, 4.0x10(-5)]. Three causal SNP genotypes (rs28416813, rs8103142, and rs4803217) displayed the highest association with SVRs (OR = 3.7, 95% CI = 2.0-6.7, p = 1.3x10(-5)). All four causal variants were in high linkage disequilibrium, both among themselves (r(2)>= 0.94) and with the rs12979860 variant (r(2)>= 0.92). In contrast, rs8099917 was in low linkage disequilibrium with the four causal variants (r(2)<= 0.45) and with the rs12979860 variant (r(2) = 0.45). These results demonstrate that rs12979860, compared to rs8099917, may be a better predictor of response to the peg- IFN/RBV treatment among HCV/HIV- 1 coinfected patients. Moreover, causal IL28B variants are strongly associated with treatment SVRs.	[de Castellarnau, Montserrat; Aparicio, Ester; Parera, Mariona; Franco, Sandra; Clotet, Bonaventura; Angel Martinez, Miguel] Univ Autonoma Barcelona, Hosp Univ Germans Trias & Pujol, Fundacio IrsiCaixa, E-08193 Barcelona, Spain; [Tural, Cristina; Clotet, Bonaventura] Hosp Badalona Germans Trias & Pujol, Fundacio Lluita Sida, Badalona, Spain	Autonomous University of Barcelona; Hospital Germans Trias i Pujol; Institut de Recerca de la Sida - IrsiCaixa; Hospital Germans Trias i Pujol	de Castellarnau, M (corresponding author), Univ Autonoma Barcelona, Hosp Univ Germans Trias & Pujol, Fundacio IrsiCaixa, E-08193 Barcelona, Spain.	mmartinez@irsicaixa.es	Franco, Sandra/E-6114-2016; Franco, Sandra/S-6843-2019; Martinez, Miguel Angel/K-6435-2014	Franco, Sandra/0000-0003-4126-2202; Franco, Sandra/0000-0003-4126-2202; Martinez, Miguel Angel/0000-0002-6681-4950; de Castellarnau Serra, Montserrat/0000-0002-9643-2881; Parera Sallent, Mariona/0000-0002-0756-8307	Spanish Ministry of Science and Innovation [BFU2010-15194, SAF2010-21617]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This study was supported by grants from the Spanish Ministry of Science and Innovation (BFU2010-15194 and SAF2010-21617). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aparicio E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013771; Balagopal A, 2010, GASTROENTEROLOGY, V139, P1865, DOI 10.1053/j.gastro.2010.10.004; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Clausen LN, 2011, J VIRAL HEPATITIS, V18, pe66, DOI 10.1111/j.1365-2893.2010.01392.x; di Iulio J, 2011, HEPATOLOGY, V53, P1446, DOI 10.1002/hep.24263; Fried MW, 2000, AM J GASTROENTEROL, V95, P3225, DOI 10.1111/j.1572-0241.2000.03433.x; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Gao B, 2004, HEPATOLOGY, V39, P880, DOI 10.1002/hep.20139; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Gould NS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025704; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; Honda M, 2010, GASTROENTEROLOGY, V139, P499, DOI 10.1053/j.gastro.2010.04.049; Labarga P, 2011, AIDS, V25, P1131, DOI 10.1097/QAD.0b013e3283471d83; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Marcello T, 2006, GASTROENTEROLOGY, V131, P1887, DOI 10.1053/j.gastro.2006.09.052; Pineda JA, 2010, CLIN INFECT DIS, V51, P788, DOI 10.1086/656235; Rallon NI, 2011, AIDS, V25, P1025, DOI 10.1097/QAD.0b013e3283471cae; Rallon NI, 2010, AIDS, V24, pF23, DOI 10.1097/QAD.0b013e3283391d6d; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Robek MD, 2005, J VIROL, V79, P3851, DOI 10.1128/JVI.79.6.3851-3854.2005; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Walsh MJ, 2006, GUT, V55, P529, DOI 10.1136/gut.2005.069674	24	37	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2012	7	2							e31016	10.1371/journal.pone.0031016	http://dx.doi.org/10.1371/journal.pone.0031016			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LV	22328925	Green Published, gold, Green Submitted			2022-12-27	WOS:000302179300011
J	Klanjscek, T; Nisbet, RM; Priester, JH; Holden, PA				Klanjscek, Tin; Nisbet, Roger M.; Priester, John H.; Holden, Patricia A.			Modeling Physiological Processes That Relate Toxicant Exposure and Bacterial Population Dynamics	PLOS ONE			English	Article							PSEUDOMONAS-PUTIDA; CADMIUM UPTAKE; GROWTH; RESISTANCE; TOXICITY; ADAPTATION; EXPRESSION; RESPONSES; COPPER; WATER	Quantifying effects of toxicant exposure on metabolic processes is crucial to predicting microbial growth patterns in different environments. Mechanistic models, such as those based on Dynamic Energy Budget (DEB) theory, can link physiological processes to microbial growth. Here we expand the DEB framework to include explicit consideration of the role of reactive oxygen species (ROS). Extensions considered are: (i) additional terms in the equation for the "hazard rate'' that quantifies mortality risk; (ii) a variable representing environmental degradation; (iii) a mechanistic description of toxic effects linked to increase in ROS production and aging acceleration, and to non-competitive inhibition of transport channels; (iv) a new representation of the "lag time'' based on energy required for acclimation. We estimate model parameters using calibrated Pseudomonas aeruginosa optical density growth data for seven levels of cadmium exposure. The model reproduces growth patterns for all treatments with a single common parameter set, and bacterial growth for treatments of up to 150 mg(Cd)/L can be predicted reasonably well using parameters estimated from cadmium treatments of 20 mg(Cd)/L and lower. Our approach is an important step towards connecting levels of biological organization in ecotoxicology. The presented model reveals possible connections between processes that are not obvious from purely empirical considerations, enables validation and hypothesis testing by creating testable predictions, and identifies research required to further develop the theory.	[Klanjscek, Tin; Nisbet, Roger M.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; [Klanjscek, Tin] Rudjer Boskovic Inst, Zagreb, Croatia; [Priester, John H.; Holden, Patricia A.] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; Rudjer Boskovic Institute; University of California System; University of California Santa Barbara	Klanjscek, T (corresponding author), Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA.	tin@irb.hr	Nisbet, Roger M/B-6951-2014	Klanjscek, Tin/0000-0002-9341-344X	US National Science Foundation [EF-0742521]; US Environmental Protection Agency under Cooperative [EF 0830117]; Croatian Ministry for Science, Education and Sport [098-0982934-2719]	US National Science Foundation(National Science Foundation (NSF)); US Environmental Protection Agency under Cooperative; Croatian Ministry for Science, Education and Sport(Ministry of Science, Education and Sports, Republic of Croatia)	The research was supported by US National Science Foundation under grant EF-0742521. There was also support from the US National Science Foundation and the US Environmental Protection Agency under Cooperative Agreement Number EF 0830117, and Croatian Ministry for Science, Education and Sport grant #098-0982934-2719. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baas J, 2010, SCI TOTAL ENVIRON, V408, P3735, DOI 10.1016/j.scitotenv.2009.10.066; Bandyopadhyay D, 1997, LIFE SCI, V60, P1891, DOI 10.1016/S0024-3205(97)00151-3; Banjerdkij P, 2005, APPL ENVIRON MICROB, V71, P1843, DOI 10.1128/AEM.71.4.1843-1849.2005; BARANYI J, 1994, INT J FOOD MICROBIOL, V23, P277, DOI 10.1016/0168-1605(94)90157-0; Begot C, 1996, J MICROBIOL METH, V25, P225, DOI 10.1016/0167-7012(95)00090-9; Brandt BW, 2004, WATER RES, V38, P1003, DOI 10.1016/j.watres.2003.09.037; Chang W, 2009, ENVIRON MICROBIOL, V11, P1428; Denning GM, 2003, AM J PHYSIOL-LUNG C, V285, pL584, DOI 10.1152/ajplung.00086.2003; Fedorenkova A, 2010, ENVIRON SCI TECHNOL, V44, P4328, DOI 10.1021/es9037287; Fowler BA, 2004, BIOMETALS, V17, P567, DOI 10.1023/B:BIOM.0000045740.52182.9d; Gibbons SM, 2011, APPL ENVIRON MICROB, V77, P108, DOI 10.1128/AEM.01187-10; Hajdu R, 2010, ENVIRON SCI TECHNOL, V44, P4597, DOI 10.1021/es100687h; Hanegraaf PPF, 2001, J THEOR BIOL, V212, P237, DOI 10.1006/jtbi.2001.2369; Hao ZQ, 1999, APPL ENVIRON MICROB, V65, P4741; Hassen A, 1998, BIORESOURCE TECHNOL, V65, P73, DOI 10.1016/S0960-8524(98)00011-X; Heipieper H, HDB HYDROCARBON LIPI, P1615; HIGHAM DP, 1986, ENVIRON HEALTH PERSP, V65, P5, DOI 10.2307/3430155; HILLS BP, 1995, FOOD MICROBIOL, V12, P333, DOI 10.1016/S0740-0020(95)80114-6; Jager T, 2010, P ROYAL S B IN PRESS; Jager T, 2010, ECOTOXICOLOGY, V19, P351, DOI 10.1007/s10646-009-0417-z; Jin YH, 2003, NAT GENET, V34, P326, DOI 10.1038/ng1172; Kocincova AS, 2008, BIOTECHNOL BIOENG, V100, P430, DOI 10.1002/bit.21793; Kooijman S, 2009, ECOTOXICOLOGY MODELI, V2, DOI [10.1007/978-1-4419-0197-2-9, DOI 10.1007/978-1-4419-0197-2-9]; Kooijman S. A. L. M., 2010, DYNAMIC ENERGY BUDGE; LADDAGA RA, 1985, J BACTERIOL, V162, P1100, DOI 10.1128/JB.162.3.1100-1105.1985; Li ZB, 2007, PLOS BIOL, V5, P212, DOI 10.1371/journal.pbio.0050035; McMurray CT, 2003, NAT GENET, V34, P239, DOI 10.1038/ng0703-239; Miller CD, 2009, LETT APPL MICROBIOL, V49, P775, DOI 10.1111/j.1472-765X.2009.02741.x; Muller EB, 2010, ECOTOXICOLOGY, V19, P38, DOI 10.1007/s10646-009-0384-4; Munoz-Cuevas M, 2010, APPL ENVIRON MICROB, V76, P2908, DOI 10.1128/AEM.02572-09; NIES DH, 1995, J IND MICROBIOL, V14, P186, DOI 10.1007/BF01569902; Pages D, 2007, ENVIRON MICROBIOL, V9, P2820, DOI 10.1111/j.1462-2920.2007.01394.x; Popova OB, 2008, RUSS J MAR BIOL, V34, P179, DOI 10.1134/S1063074008030073; Priester JH, 2009, ENVIRON SCI TECHNOL, V43, P2589, DOI 10.1021/es802806n; Ricklefs RE, 2002, J GERONTOL A-BIOL, V57, pB69, DOI 10.1093/gerona/57.2.B69; Silver S, 1996, ANNU REV MICROBIOL, V50, P753, DOI 10.1146/annurev.micro.50.1.753; Sousa T, 2008, PHILOS T R SOC B, V363, P2453, DOI 10.1098/rstb.2007.2230; TYNECKA Z, 1981, J BACTERIOL, V147, P305, DOI 10.1128/JB.147.2.305-312.1981; Wang AY, 2005, J BACTERIOL, V187, P3259, DOI 10.1128/JB.187.9.3259-3266.2005	39	27	28	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2012	7	2							e26955	10.1371/journal.pone.0026955	http://dx.doi.org/10.1371/journal.pone.0026955			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LV	22328915	Green Published, Green Submitted, gold			2022-12-27	WOS:000302179300001
J	Wang, LF; Ge, HM; Hao, CY; Dong, YS; Zhang, XY				Wang, Lanfen; Ge, Hongmei; Hao, Chenyang; Dong, Yushen; Zhang, Xueyong			Identifying Loci Influencing 1,000-Kernel Weight in Wheat by Microsatellite Screening for Evidence of Selection during Breeding	PLOS ONE			English	Article							TRITICUM-AESTIVUM L.; LINEAR UNBIASED PREDICTION; SPATIAL GENETIC-STRUCTURE; SINGLE-CROSS PERFORMANCE; LINKAGE DISEQUILIBRIUM; BREAD WHEAT; POPULATION-STRUCTURE; QTL ANALYSIS; GRAIN-YIELD; ASSOCIATION	Chinese wheat mini core collection (262 accessions) was genotyped at 531 microsatellite loci representing a mean marker density of 5.1 cM. One-thousand-kernel weights (TKW) of lines were measured in five trials (three environments in four growing seasons). Structure analysis based on 42 unlinked SSR loci indicated that the materials formed two sub-populations, viz., landraces and modern varieties. A large difference in TKW (7.08 g, P < 0.001) was found between the two sub-groups. Therefore, TKW is a major yield component that was improved in the past 6 decades; it increased from a mean 31.5 g in the 1940s to 44.64 g in the 2000s, representing a 2.19 g increase in each decade. Analyses based on a mixed linear model (MLM), population structure (Q) and relative kinship (K) revealed 22 SSR loci that were significantly associated with mean TKW (MTKW) of the five trials estimated by the best linear unbiased predictor (BLUP) method. They were mainly distributed on chromosomes of homoeologous groups 1, 2, 3, 5 and 7. Six loci, cfa2234-3A, gwm156-3B, barc56-5A, gwm234-5B, wmc17-7A and cfa2257-7A individually explained more than 11.84% of the total phenotypic variation. Favored alleles for breeding at the 22 loci were inferred according to their estimated effects on MTKW based on mean difference of varieties grouped by genotypes. Statistical simulation showed that these favored alleles have additive genetic effects. Frequency changes of alleles at loci associated with TKW are much more dramatic than those at neutral loci between the sub-groups. The numbers of favored alleles in modern varieties indicate there is still considerable genetic potential for their use as markers for genome selection of TKW in wheat breeding. Alleles that can be used globally to increase TKW were inferred according to their distribution by latitude and frequency of changes between landraces and the modern varieties.	[Wang, Lanfen; Ge, Hongmei; Hao, Chenyang; Dong, Yushen; Zhang, Xueyong] Chinese Acad Agr Sci, Key Lab Crop Germplasm Resources & Utilizat, Natl Key Facil Crop Gene Resources & Genet Improv, Minist Agr,Inst Crop Sci, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Ministry of Agriculture & Rural Affairs	Wang, LF (corresponding author), Chinese Acad Agr Sci, Key Lab Crop Germplasm Resources & Utilizat, Natl Key Facil Crop Gene Resources & Genet Improv, Minist Agr,Inst Crop Sci, Beijing 100193, Peoples R China.	xueyongz@caas.net.cn			Chinese Ministry of Science and Technology [2009CB118306, 2010CB125900]; Chinese Agricultural Research Service; Ministry of Agriculture [CARS-3-1-2]; National Natural Science Foundation of China [30900898]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Chinese Agricultural Research Service; Ministry of Agriculture(Gida Tarim Ve Hayvancilik Bakanligi); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Chinese Ministry of Science and Technology (2009CB118306 and 2010CB125900) and the Chinese Agricultural Research Service, Ministry of Agriculture (CARS-3-1-2) and National Natural Science Foundation of China (30900898). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrama HA, 2007, MOL BREEDING, V19, P341, DOI 10.1007/s11032-006-9066-6; Andolfatto P, 2001, CURR OPIN GENET DEV, V11, P635, DOI 10.1016/S0959-437X(00)00246-X; Barrero RA, 2011, FUNCT INTEGR GENOMIC, V11, P37, DOI 10.1007/s10142-010-0208-x; Bernardo R, 1996, CROP SCI, V36, P50, DOI [10.2135/cropsci1996.0011183X003600040009x, 10.2135/cropsci1996.0011183X003600040007x]; Bernardo R, 1996, THEOR APPL GENET, V93, P262, DOI 10.1007/BF00225755; Bernardo R, 1996, THEOR APPL GENET, V93, P1098, DOI 10.1007/BF00230131; Bonjean APA, 2010, CEREALS CHINA; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Breseghello F, 2006, GENETICS, V172, P1165, DOI 10.1534/genetics.105.044586; Crossa J, 2007, GENETICS, V177, P1889, DOI 10.1534/genetics.107.078659; Cuthbert JL, 2008, THEOR APPL GENET, V117, P595, DOI 10.1007/s00122-008-0804-5; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Dong Y.C., 2003, J PLANT GENET RESOUR, V4, P1, DOI DOI 10.13430/J.CNKI.JPGR.2003.01.001; Ersoz Elhan S., 2009, V63, P173; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; Frisch M, 2010, THEOR APPL GENET, V120, P441, DOI 10.1007/s00122-009-1204-1; Ge HM, 2011, CROP SCI IN PRESS; Gennaro A, 2009, FUNCT INTEGR GENOMIC, V9, P325, DOI 10.1007/s10142-009-0115-1; Glaszmann JC, 2010, CURR OPIN PLANT BIOL, V13, P167, DOI 10.1016/j.pbi.2010.01.004; Groos C, 2003, THEOR APPL GENET, V106, P1032, DOI 10.1007/s00122-002-1111-1; Guo ZA, 2010, NEW PHYTOL, V185, P841, DOI 10.1111/j.1469-8137.2009.03099.x; Gupta PK, 2006, GENOME, V49, P565, DOI 10.1139/G06-063; Hao CY, 2008, CHINESE SCI BULL, V53, P1518, DOI 10.1007/s11434-008-0212-x; Hao CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017279; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Heffner EL, 2009, CROP SCI, V49, P1, DOI 10.2135/cropsci2008.08.0512; Horvath A, 2009, THEOR APPL GENET, V119, P1523, DOI 10.1007/s00122-009-1153-8; Huang XQ, 2004, THEOR APPL GENET, V109, P933, DOI 10.1007/s00122-004-1708-7; Jiang QY, 2011, FUNCT INTEGR GENOMIC, V11, P49, DOI 10.1007/s10142-010-0188-x; Koebner RMD, 2003, TRENDS BIOTECHNOL, V21, P59, DOI 10.1016/S0167-7799(02)00036-7; Li XP, 2011, NEW PHYTOL, V189, P449, DOI 10.1111/j.1469-8137.2010.03490.x; LOISELLE BA, 1995, AM J BOT, V82, P1420, DOI 10.2307/2445869; Mackay TFC, 2009, NAT REV GENET, V10, P565, DOI 10.1038/nrg2612; Nordborg M, 2008, NATURE, V456, P720, DOI 10.1038/nature07629; Ott A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022306; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; Pritchard JK, 2000, GENETICS, V155, P945; Quarrie SA, 2006, J EXP BOT, V57, P2627, DOI 10.1093/jxb/erl026; Quarrie SA, 2005, THEOR APPL GENET, V110, P865, DOI 10.1007/s00122-004-1902-7; Reynolds MP, 2001, EUPHYTICA, V119, P137, DOI 10.1023/A:1017521800795; Roder MS, 1998, GENETICS, V149, P2007; Roeder MIS, 2008, FUNCT INTEGR GENOMIC, V8, P79, DOI 10.1007/s10142-007-0053-8; Schlotterer C, 2003, TRENDS GENET, V19, P32, DOI 10.1016/S0168-9525(02)00012-4; SHARP PJ, 1989, THEOR APPL GENET, V78, P342, DOI 10.1007/BF00265294; Snape JW, 2007, EUPHYTICA, V154, P401, DOI 10.1007/s10681-006-9208-2; Somers DJ, 2004, THEOR APPL GENET, V109, P1105, DOI 10.1007/s00122-004-1740-7; Song XJ, 2007, NAT GENET, V39, P623, DOI 10.1038/ng2014; Su ZQ, 2011, THEOR APPL GENET, V122, P211, DOI 10.1007/s00122-010-1437-z; Sun XY, 2009, EUPHYTICA, V165, P615, DOI 10.1007/s10681-008-9794-2; Sun XC, 2010, THEOR APPL GENET, V120, P1041, DOI 10.1007/s00122-009-1232-x; Tester M, 2010, SCIENCE, V327, P818, DOI 10.1126/science.1183700; Tsilo TJ, 2010, THEOR APPL GENET, V121, P717, DOI 10.1007/s00122-010-1343-4; Wang J, 2008, J CEREAL SCI, V48, P836, DOI 10.1016/j.jcs.2008.06.005; Wang LanFen, 2007, Scientia Agricultura Sinica, V40, P2667; Wang RX, 2009, THEOR APPL GENET, V118, P313, DOI 10.1007/s00122-008-0901-5; Wright SI, 2005, SCIENCE, V308, P1310, DOI 10.1126/science.1107891; Xiao SH, 2003, CHINESE WHEAT IMPROV; Xue WY, 2008, NAT GENET, V40, P761, DOI 10.1038/ng.143; Yan JB, 2011, CROP SCI, V51, P433, DOI 10.2135/cropsci2010.04.0233; Yan JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008451; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhang XueYong, 2007, Agricultural Sciences in China, V6, P255, DOI 10.1016/S1671-2927(07)60043-1; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546; Zhuang QS., 2003, CHINESE WHEAT IMPROV	65	65	83	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2012	7	2							e29432	10.1371/journal.pone.0029432	http://dx.doi.org/10.1371/journal.pone.0029432			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LV	22328917	Green Submitted, Green Published, gold			2022-12-27	WOS:000302179300003
J	Lee, KS; Kalantzis, A; Jackson, CB; O'Connor, L; Murata-Kamiya, N; Hatakeyama, M; Judd, LM; Giraud, AS; Menheniott, TR				Lee, Kai Syin; Kalantzis, Anastasia; Jackson, Cameron B.; O'Connor, Louise; Murata-Kamiya, Naoko; Hatakeyama, Masanori; Judd, Louise M.; Giraud, Andrew S.; Menheniott, Trevelyan R.			Helicobacter pylori CagA Triggers Expression of the Bactericidal Lectin REG3 gamma via Gastric STAT3 Activation	PLOS ONE			English	Article							VIRULENCE FACTOR CAGA; EPITHELIAL-CELLS; TUMOR-DEVELOPMENT; IN-VITRO; CORECEPTOR GP130; MUTANT MICE; INTERLEUKIN-8; INFECTION; PROTEIN; SIGNAL	Background: Most of what is known about the Helicobacter pylori (H. pylori) cytotoxin, CagA, pertains to a much-vaunted role as a determinant of gastric inflammation and cancer. Little attention has been devoted to potential roles of CagA in the majority of H. pylori infected individuals not showing oncogenic progression, particularly in relation to host tolerance. Regenerating islet-derived (REG)3 gamma encodes a secreted C-type lectin that exerts direct bactericidal activity against Gram-positive bacteria in the intestine. Here, we extend this paradigm of lectin-mediated innate immunity, showing that REG3 gamma expression is triggered by CagA in the H. pylori-infected stomach. Methodology/Principal Findings: In human gastric mucosal tissues, REG3 gamma expression was significantly increased in CagA-positive, compared to CagA-negative H. pylori infected individuals. Using transfected CagA-inducible gastric MKN28 cells, we recapitulated REG3 gamma induction in vitro, also showing that tyrosine phosphorylated, not unphosphorylated CagA triggers REG3 gamma transcription. In concert with induced REG3 gamma, pro-inflammatory signalling downstream of the gp130 cytokine co-receptor via the signal transducer and activator of transcription (STAT)3 and transcription of two cognate ligands, interleukin(IL)-11 and IL-6, were significantly increased. Exogenous IL-11, but not IL-6, directly stimulated STAT3 activation and REG3 gamma transcription. STAT3 siRNA knockdown or IL-11 receptor blockade respectively abrogated or subdued CagA-dependent REG3 gamma mRNA induction, thus demonstrating a requirement for uncompromised signalling via the IL-11/STAT3 pathway. Inhibition of the gp130-related SHP2-(Ras)-ERK pathway did not affect CagA-dependent REG3 gamma induction, but strengthened STAT3 activation as well as augmenting transcription of mucosal innate immune regulators, IL-6, IL-8 and interferon-response factor (IRF)1. Conclusions/Significance: Our results support a model of CagA-directed REG3 gamma expression in gastric epithelial cells via activation of the IL-11/gp130/STAT3 pathway. This response might allow Gram-negative H. pylori to manipulate host immunity to favour its own survival, by reducing the fitness of co-habiting Gram-positive bacteria with which it competes for resources in the gastric mucosal niche.	[Lee, Kai Syin; Kalantzis, Anastasia; Jackson, Cameron B.; O'Connor, Louise; Judd, Louise M.; Giraud, Andrew S.; Menheniott, Trevelyan R.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Judd, Louise M.; Giraud, Andrew S.] Univ Melbourne, Dept Paediat, Royal Childrens Hosp, Parkville, Vic 3052, Australia; [Murata-Kamiya, Naoko; Hatakeyama, Masanori] Univ Tokyo, Dept Microbiol, Grad Sch Med, Tokyo, Japan	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Royal Children's Hospital Melbourne; University of Melbourne; University of Tokyo	Lee, KS (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Flemington Rd, Parkville, Vic 3052, Australia.	treve.menheniott@mcri.edu.au	Menheniott, Treve/D-7964-2015	Menheniott, Treve/0000-0003-2349-8238; Judd, Louise/0000-0003-3613-4839	Victorian Government; Australian National Health and Medical Research Council; Grants-in-Aid for Scientific Research [22240085, 22114002, 22114001] Funding Source: KAKEN	Victorian Government; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Victorian Government's Operational Infrastructure Support Program and by a project grant awarded by the Australian National Health and Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2000, ONCOGENE, V19, P2607, DOI 10.1038/sj.onc.1203478; AKIRA S, 1990, FASEB J, V4, P2860, DOI 10.1096/fasebj.4.11.2199284; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Arnold IC, 2011, GASTROENTEROLOGY, V140, P199, DOI 10.1053/j.gastro.2010.06.047; Atherton JC, 2009, J CLIN INVEST, V119, P2475, DOI 10.1172/JCI38605; Backert S, 2008, CELL MICROBIOL, V10, P1573, DOI 10.1111/j.1462-5822.2008.01156.x; Blaser MJ, 2008, GUT, V57, P561, DOI 10.1136/gut.2007.133462; Blaser MJ, 2005, SCI AM, V292, P38, DOI 10.1038/scientificamerican0205-38; Blaser MJ, 1999, P NATL ACAD SCI USA, V96, P8359, DOI 10.1073/pnas.96.15.8359; Brandl K, 2007, J EXP MED, V204, P1891, DOI 10.1084/jem.20070563; Bronte-Tinkew DM, 2009, CANCER RES, V69, P632, DOI 10.1158/0008-5472.CAN-08-1191; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Chen Y, 2008, J INFECT DIS, V198, P553, DOI 10.1086/590158; Churin Y, 2003, J CELL BIOL, V161, P249, DOI 10.1083/jcb.200208039; Correa P, 2008, DIGEST LIVER DIS, V40, P490, DOI 10.1016/j.dld.2008.02.035; CRABTREE JE, 1995, J CLIN PATHOL, V48, P967, DOI 10.1136/jcp.48.10.967; CRABTREE JE, 1995, J CLIN PATHOL, V48, P41, DOI 10.1136/jcp.48.1.41; CRABTREE JE, 1994, J CLIN PATHOL, V47, P945, DOI 10.1136/jcp.47.10.945; CRABTREE JE, 1991, GUT, V32, P1473, DOI 10.1136/gut.32.12.1473; Ernst M, 2008, J CLIN INVEST, V118, P1727, DOI 10.1172/JCI34944; Gharavi NM, 2007, J BIOL CHEM, V282, P31460, DOI 10.1074/jbc.M704267200; Hatakeyama M, 2008, ONCOGENE, V27, P7047, DOI 10.1038/onc.2008.353; Higashi H, 2005, J BIOL CHEM, V280, P23130, DOI 10.1074/jbc.M503583200; Higashi H, 2004, J BIOL CHEM, V279, P17205, DOI 10.1074/jbc.M309964200; Higashi H, 2002, P NATL ACAD SCI USA, V99, P14428, DOI 10.1073/pnas.222375399; Higashi H, 2002, SCIENCE, V295, P683, DOI 10.1126/science.1067147; Howlett M, 2005, GASTROENTEROLOGY, V129, P1005, DOI 10.1053/j.gastro.2005.06.068; Howlett M, 2009, BBA-MOL CELL RES, V1793, P1623, DOI 10.1016/j.bbamcr.2009.07.009; Howlett M, 2009, GASTROENTEROLOGY, V136, P967, DOI 10.1053/j.gastro.2008.12.003; Jackson CB, 2007, J PATHOL, V213, P140, DOI 10.1002/path.2218; Judd LM, 2004, GASTROENTEROLOGY, V126, P196, DOI 10.1053/j.gastro.2003.10.066; Judd LM, 2006, GASTROENTEROLOGY, V131, P1073, DOI 10.1053/j.gastro.2006.07.018; KUIPERS EJ, 1995, J NATL CANCER I, V87, P1777, DOI 10.1093/jnci/87.23.1777; Lee IO, 2010, J BIOL CHEM, V285, P16042, DOI 10.1074/jbc.M110.111054; Lehotzky RE, 2010, P NATL ACAD SCI USA, V107, P7722, DOI 10.1073/pnas.0909449107; Maldonado-Contreras A, 2011, ISME J, V5, P574, DOI 10.1038/ismej.2010.149; Menheniott TR, 2010, GASTROENTEROLOGY, V138, P1823, DOI 10.1053/j.gastro.2010.01.050; Mimuro H, 2002, MOL CELL, V10, P745, DOI 10.1016/S1097-2765(02)00681-0; MOORE AE, 1955, CANCER RES, V15, P598; Mukherjee S, 2009, J BIOL CHEM, V284, P4881, DOI 10.1074/jbc.M808077200; Murata-Kamiya N, 2007, ONCOGENE, V26, P4617, DOI 10.1038/sj.onc.1210251; Nijevitch AA, 2004, J CLIN GASTROENTEROL, V38, P14, DOI 10.1097/00004836-200401000-00005; Ohnishi N, 2008, P NATL ACAD SCI USA, V105, P1003, DOI 10.1073/pnas.0711183105; Peterson AJ, 2010, GASTROENTEROLOGY, V139, P2005, DOI 10.1053/j.gastro.2010.08.043; Poppe M, 2007, ONCOGENE, V26, P3462, DOI 10.1038/sj.onc.1210139; Reibman J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004060; Saito Y, 2010, J EXP MED, V207, P2157, DOI 10.1084/jem.20100602; Sonnenburg JL, 2006, PLOS BIOL, V4, P2213, DOI 10.1371/journal.pbio.0040413; Suzuki M, 2005, J EXP MED, V202, P1235, DOI 10.1084/jem.20051027; Tebbutt NC, 2002, NAT MED, V8, P1089, DOI 10.1038/nm763; Tsutsumi R, 2003, J BIOL CHEM, V278, P3664, DOI 10.1074/jbc.M208155200; Yamaoka Y, 2004, GASTROENTEROLOGY, V126, P1030, DOI 10.1053/j.gastro.2003.12.048; Yeh M, 2004, J BIOL CHEM, V279, P30175, DOI 10.1074/jbc.M312198200; Yoshimura A, 2006, CANCER SCI, V97, P439, DOI 10.1111/j.1349-7006.2006.00197.x; Zhu YL, 2005, ONCOGENE, V24, P3886, DOI 10.1038/sj.onc.1208551	55	47	47	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2012	7	2							e30786	10.1371/journal.pone.0030786	http://dx.doi.org/10.1371/journal.pone.0030786			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UG	22312430	Green Published, gold			2022-12-27	WOS:000301977500017
J	Hisamatsu, T; Okamoto, S; Hashimoto, M; Muramatsu, T; Andou, A; Uo, M; Kitazume, MT; Matsuoka, K; Yajima, T; Inoue, N; Kanai, T; Ogata, H; Iwao, Y; Yamakado, M; Sakai, R; Ono, N; Ando, T; Suzuki, M; Hibi, T				Hisamatsu, Tadakazu; Okamoto, Susumu; Hashimoto, Masaki; Muramatsu, Takahiko; Andou, Ayatoshi; Uo, Michihide; Kitazume, Mina T.; Matsuoka, Katsuyoshi; Yajima, Tomoharu; Inoue, Nagamu; Kanai, Takanori; Ogata, Haruhiko; Iwao, Yasushi; Yamakado, Minoru; Sakai, Ryosei; Ono, Nobukazu; Ando, Toshihiko; Suzuki, Manabu; Hibi, Toshifumi			Novel, Objective, Multivariate Biomarkers Composed of Plasma Amino Acid Profiles for the Diagnosis and Assessment of Inflammatory Bowel Disease	PLOS ONE			English	Article							HEPATIC ENCEPHALOPATHY; TRYPTOPHAN CATABOLISM; RHEUMATOID-ARTHRITIS; CROHNS-DISEASE; HISTIDINE; ANTIBODIES; IMBALANCE; COLITIS; MARKERS; INDEX	Background: Inflammatory bowel disease (IBD) is a chronic intestinal disorder that is associated with a limited number of clinical biomarkers. In order to facilitate the diagnosis of IBD and assess its disease activity, we investigated the potential of novel multivariate indexes using statistical modeling of plasma amino acid concentrations (aminogram). Methodology and Principal Findings: We measured fasting plasma aminograms in 387 IBD patients (Crohn's disease (CD), n = 165; ulcerative colitis (UC), n = 222) and 210 healthy controls. Based on Fisher linear classifiers, multivariate indexes were developed from the aminogram in discovery samples (CD, n = 102; UC, n = 102; age and sex-matched healthy controls, n = 102) and internally validated. The indexes were used to discriminate between CD or UC patients and healthy controls, as well as between patients with active disease and those in remission. We assessed index performances using the area under the curve of the receiver operating characteristic (ROC AUC). We observed significant alterations to the plasma aminogram, including histidine and tryptophan. The multivariate indexes established from plasma aminograms were able to distinguish CD or UC patients from healthy controls with ROC AUCs of 0.940 (95% confidence interval (CI): 0.898-0.983) and 0.894 (95%CI: 0.853-0.935), respectively in validation samples (CD, n = 63; UC, n = 120; healthy controls, n = 108). In addition, other indexes appeared to be a measure of disease activity. These indexes distinguished active CD or UC patients from each remission patients with ROC AUCs of 0.894 (95%CI: 0.853-0.935) and 0.849 (95%CI: 0.770-0.928), and correlated with clinical disease activity indexes for CD (r(s) = 0.592, 95%CI: 0.385-0.742, p<0.001) or UC (r(s) = 0.598, 95%CI: 0.452-0.713, p<0.001), respectively. Conclusions and Significance: In this study, we demonstrated that established multivariate indexes composed of plasma amino acid profiles can serve as novel, non-invasive, objective biomarkers for the diagnosis and monitoring of IBD, providing us with new insights into the pathophysiology of the disease.	[Hisamatsu, Tadakazu; Okamoto, Susumu; Kitazume, Mina T.; Matsuoka, Katsuyoshi; Yajima, Tomoharu; Kanai, Takanori; Hibi, Toshifumi] Keio Univ, Sch Med, Dept Internal Med, Tokyo, Japan; [Inoue, Nagamu; Ogata, Haruhiko; Iwao, Yasushi] Keio Univ, Ctr Diagnost & Therapeut Endoscopy, Tokyo, Japan; [Yamakado, Minoru] Mitsui Mem Hosp, Ctr Multiphas Hlth Testing & Serv, Tokyo 101, Japan; [Hashimoto, Masaki; Muramatsu, Takahiko; Andou, Ayatoshi; Uo, Michihide; Sakai, Ryosei; Ono, Nobukazu; Ando, Toshihiko; Suzuki, Manabu] Ajinomoto Co Inc, Inst Life Sci, Kawasaki, Kanagawa, Japan; [Hashimoto, Masaki; Muramatsu, Takahiko; Andou, Ayatoshi; Uo, Michihide; Sakai, Ryosei; Ono, Nobukazu; Ando, Toshihiko; Suzuki, Manabu] Ajinomoto Co Inc, Pharmaceut Res Labs, Kawasaki, Kanagawa, Japan	Keio University; Keio University; Mitsui Memorial Hospital; Ajinomoto Co Inc; Ajinomoto Co Inc	Hisamatsu, T (corresponding author), Keio Univ, Sch Med, Dept Internal Med, Tokyo, Japan.	hisamachi@a7.keio.jp; thibi@sc.itc.keio.ac.jp	Ogata, H/B-3964-2014; Sakai, Ryosei/AAW-4762-2021; Matsuoka, Katsuyoshi/AAB-1580-2022	Matsuoka, Katsuyoshi/0000-0002-2950-7660; Sakai, Ryosei/0000-0001-5611-0821; Uo, Michihide/0000-0003-1876-1003	Japanese Ministry of Education, Culture and Science; Japanese Ministry of Health, Labor and Welfare; Keio University; Keio Medical Foundation, Tokyo, Japan	Japanese Ministry of Education, Culture and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Keio University; Keio Medical Foundation, Tokyo, Japan	This study was supported by grants-in-aid and "Academic Frontier" Project from the Japanese Ministry of Education, Culture and Science, the Japanese Ministry of Health, Labor and Welfare, Keio University and Keio Medical Foundation, Tokyo, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Akobeng AK, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005984; Andou A, 2009, GASTROENTEROLOGY, V136, P564, DOI 10.1053/j.gastro.2008.09.062; Brosnan JT, 2003, J NUTR, V133, p2068S, DOI 10.1093/jn/133.6.2068S; Dotan I, 2006, GASTROENTEROLOGY, V131, P366, DOI 10.1053/j.gastro.2006.04.030; FELIG P, 1975, ANNU REV BIOCHEM, V44, P933, DOI 10.1146/annurev.bi.44.070175.004441; FERENCI P, 1978, J NEURAL TRANSM, P87; Forrest CM, 2003, ADV EXP MED BIOL, V527, P395; GERBER DA, 1975, J CLIN INVEST, V55, P1164, DOI 10.1172/JCI108033; Hibi T, 2006, J GASTROENTEROL, V41, P10, DOI 10.1007/s00535-005-1744-3; Holm E, 1999, Curr Opin Clin Nutr Metab Care, V2, P47, DOI 10.1097/00075197-199901000-00009; Langhorst J, 2008, AM J GASTROENTEROL, V103, P162, DOI 10.1111/j.1572-0241.2007.01556.x; LICHTIGER S, 1994, NEW ENGL J MED, V330, P1841, DOI 10.1056/NEJM199406303302601; Maeda J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-690; Munn DH, 1998, SCIENCE, V281, P1191, DOI 10.1126/science.281.5380.1191; Noguchi Y, 2006, AM J CLIN NUTR, V83, p513S; PINALS RS, 1977, J RHEUMATOL, V4, P414; Puccetti P, 2007, NAT REV IMMUNOL, V7, P817, DOI 10.1038/nri2163; Romani L, 2008, NATURE, V451, P211, DOI 10.1038/nature06471; SHIOTA T, 1984, BIOCHEM MED METAB B, V32, P181, DOI 10.1016/0006-2944(84)90071-1; SOETERS PB, 1976, LANCET, V2, P880; Targan SR, 2005, GASTROENTEROLOGY, V128, P2020, DOI 10.1053/j.gastro.2005.03.046; Vermeire S, 2004, INFLAMM BOWEL DIS, V10, P661, DOI 10.1097/00054725-200409000-00026; Vernier Gwenola, 2004, Curr Gastroenterol Rep, V6, P482, DOI 10.1007/s11894-004-0070-x; Wall AJ, 1975, INFLAMM BOWEL DIS, P101; Watanabe M, 2008, AM J CLIN NUTR, V87, P1860, DOI 10.1093/ajcn/87.6.1860; WINSHIP DH, 1979, GASTROENTEROLOGY, V77, P829; Wolf AM, 2004, CLIN IMMUNOL, V113, P47, DOI 10.1016/j.clim.2004.05.004; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005	28	123	130	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2012	7	1							e31131	10.1371/journal.pone.0031131	http://dx.doi.org/10.1371/journal.pone.0031131			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	912BY	22303484	gold, Green Published, Green Submitted			2022-12-27	WOS:000301770700011
J	Golzio, C; Havis, E; Daubas, P; Nuel, G; Babarit, C; Munnich, A; Vekemans, M; Zaffran, S; Lyonnet, S; Etchevers, HC				Golzio, Christelle; Havis, Emmanuelle; Daubas, Philippe; Nuel, Gregory; Babarit, Candice; Munnich, Arnold; Vekemans, Michel; Zaffran, Stephane; Lyonnet, Stanislas; Etchevers, Heather C.			ISL1 Directly Regulates FGF10 Transcription during Human Cardiac Outflow Formation	PLOS ONE			English	Article							2ND HEART FIELD; MATTHEW-WOOD-SYNDROME; GREAT-ARTERIES; FACTOR-BINDING; BETA-CATENIN; MOUSE HEART; GENE; MUTATIONS; EXPRESSION; DEFECTS	The LIM homeodomain gene Islet-1 (ISL1) encodes a transcription factor that has been associated with the multipotency of human cardiac progenitors, and in mice enables the correct deployment of second heart field (SHF) cells to become the myocardium of atria, right ventricle and outflow tract. Other markers have been identified that characterize subdomains of the SHF, such as the fibroblast growth factor Fgf10 in its anterior region. While functional evidence of its essential contribution has been demonstrated in many vertebrate species, SHF expression of Isl1 has been shown in only some models. We examined the relationship between human ISL1 and FGF10 within the embryonic time window during which the linear heart tube remodels into four chambers. ISL1 transcription demarcated an anatomical region supporting the conserved existence of a SHF in humans, and transcription factors of the GATA family were co-expressed therein. In conjunction, we identified a novel enhancer containing a highly conserved ISL1 consensus binding site within the FGF10 first intron. ChIP and EMSA demonstrated its direct occupation by ISL1. Transcription mediated by ISL1 from this FGF10 intronic element was enhanced by the presence of GATA4 and TBX20 cardiac transcription factors. Finally, transgenic mice confirmed that endogenous factors bound the human FGF10 intronic enhancer to drive reporter expression in the developing cardiac outflow tract. These findings highlight the interest of examining developmental regulatory networks directly in human tissues, when possible, to assess candidate non-coding regions that may be responsible for congenital malformations.	[Golzio, Christelle] Duke Med Ctr, Dept Cell Biol, Ctr Human Dis Modeling, Durham, NC 27705 USA; [Havis, Emmanuelle] Univ Paris 06, CNRS, UMR 7622, Paris, France; [Daubas, Philippe] Inst Pasteur, CNRS, URA 2578, Paris, France; [Nuel, Gregory] Univ Paris 05, CNRS 8145, Paris, France; [Babarit, Candice; Munnich, Arnold; Vekemans, Michel; Lyonnet, Stanislas] Univ Paris 05, INSERM, U781, Fac Med, Paris, France; [Munnich, Arnold; Vekemans, Michel; Lyonnet, Stanislas] Hop Necker Enfants Malad, Serv Genet Med, Paris, France; [Zaffran, Stephane; Etchevers, Heather C.] INSERM, U910, F-13258 Marseille, France; [Zaffran, Stephane; Etchevers, Heather C.] Aix Marseille Univ, Fac Med, UMR 910, Marseille, France	Duke University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite	Golzio, C (corresponding author), Duke Med Ctr, Dept Cell Biol, Ctr Human Dis Modeling, Durham, NC 27705 USA.	heather.etchevers@inserm.fr	Zaffran, Stéphane/S-7454-2019; Etchevers, Heather C./B-5813-2012; Lyonnet, Stanislas/H-5483-2017; Zaffran, Stéphane/I-2955-2016; Havis, Emmanuelle/K-1874-2017; daubas, philippe/P-4275-2017	Zaffran, Stéphane/0000-0002-0811-418X; Etchevers, Heather C./0000-0003-0201-3799; Lyonnet, Stanislas/0000-0001-5426-9417; Zaffran, Stéphane/0000-0002-0811-418X; Havis, Emmanuelle/0000-0001-5634-3174; Golzio, Christelle/0000-0002-4420-3921	Fondation pour la Recherche Medicale [DEQ20071210511]; Agence Nationale pour la Recherche (ANR); Association Francaise contre les Myopathies; Institut Pasteur	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Agence Nationale pour la Recherche (ANR)(French National Research Agency (ANR)); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Institut Pasteur(European Commission)	This work was supported by the Fondation pour la Recherche Medicale (grant number DEQ20071210511 and a fellowship to C.G.); the Agence Nationale pour la Recherche (ANR2007-CRANIRARE); the Association Francaise contre les Myopathies (MNH-Decrypt-6) and the Institut Pasteur-Necker Transverse Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal P, 2003, DEVELOPMENT, V130, P623, DOI 10.1242/dev.00191; Ahlgren U, 1997, NATURE, V385, P257, DOI 10.1038/385257a0; Arauz RF, 2010, MOL SYNDROMOL, V1, P59, DOI 10.1159/000302285; Benko S, 2009, NAT GENET, V41, P359, DOI 10.1038/ng.329; Blanchette M, 2006, GENOME RES, V16, P656, DOI 10.1101/gr.4866006; Bouillet P, 1997, MECH DEVELOP, V63, P173, DOI 10.1016/S0925-4773(97)00039-7; Brade T, 2007, DEV BIOL, V311, P297, DOI 10.1016/j.ydbio.2007.08.004; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Conlon FL, 2001, DEVELOPMENT, V128, P3749; Delous M, 2007, NAT GENET, V39, P875, DOI 10.1038/ng2039; Desai TJ, 2004, DEV BIOL, V273, P402, DOI 10.1016/j.ydbio.2004.04.039; Dodou E, 2004, DEVELOPMENT, V131, P3931, DOI 10.1242/dev.01256; Entesarian M, 2005, NAT GENET, V37, P125, DOI 10.1038/ng1507; Fairbanks TJ, 2004, J PEDIATR SURG, V39, P360, DOI 10.1016/j.jpedsurg.2003.11.034; Genead R, 2010, STEM CELL RES, V4, P69, DOI 10.1016/j.scr.2009.10.001; Goldmuntz E, 2001, CIRCULATION, V104, P2565, DOI 10.1161/hc4601.098427; Goldmuntz E, 2002, AM J HUM GENET, V70, P776, DOI 10.1086/339079; Golzio C, 2007, AM J HUM GENET, V80, P1179, DOI 10.1086/518177; Gong W, 2001, J MED GENET, V38, pE45, DOI DOI 10.1136/JMG.38.12.E45; Hadchouel J, 2003, DEVELOPMENT, V130, P3415, DOI 10.1242/dev.00552; Havis E, 2006, BIOTECHNIQUES, V40, P34, DOI 10.2144/000112098; Herzog W, 2004, DEVELOPMENT, V131, P3681, DOI 10.1242/dev.01235; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; Kawakami Y, 2011, DEVELOPMENT, V138, P4465, DOI 10.1242/dev.065359; Kelly RG, 2001, DEV CELL, V1, P435, DOI 10.1016/S1534-5807(01)00040-5; Kirk EP, 2007, AM J HUM GENET, V81, P280, DOI 10.1086/519530; Klar J, 2011, J MED GENET, V48, P705, DOI 10.1136/jmedgenet-2011-100166; Kostetskii I, 1999, DEV BIOL, V206, P206, DOI 10.1006/dbio.1998.9139; Lee SK, 2003, NEURON, V38, P731, DOI 10.1016/S0896-6273(03)00296-4; Lickert H, 2004, NATURE, V432, P107, DOI 10.1038/nature03071; Lillevali K, 2006, MECH DEVELOP, V123, P415, DOI 10.1016/j.mod.2006.04.007; Liu W, 2008, BIRTH DEFECTS RES B, V83, P134, DOI 10.1002/bdrb.20154; Loots GG, 2004, NUCLEIC ACIDS RES, V32, pW217, DOI 10.1093/nar/gkh383; Marguerie A, 2006, CARDIOVASC RES, V71, P50, DOI 10.1016/j.cardiores.2006.03.021; Martinovic-Bouriel J, 2007, AM J MED GENET A, V143A, P219, DOI 10.1002/ajmg.a.31599; McBride KL, 2008, HUM MOL GENET, V17, P2886, DOI 10.1093/hmg/ddn187; McCabe MJ, 2011, J CLIN ENDOCR METAB, V96, pE1709, DOI 10.1210/jc.2011-0454; Megarbane A, 2000, EUR J HUM GENET, V8, P704, DOI 10.1038/sj.ejhg.5200526; MERIKA M, 1993, MOL CELL BIOL, V13, P3999, DOI 10.1128/MCB.13.7.3999; Miller SA, 2008, GENE DEV, V22, P2980, DOI 10.1101/gad.1689708; Min HS, 1998, GENE DEV, V12, P3156, DOI 10.1101/gad.12.20.3156; Moorman A, 2003, HEART, V89, P806, DOI 10.1136/heart.89.7.806; O'Rahilly R, 1987, DEV STAGES HUMANS IN; Ohuchi H, 2000, BIOCHEM BIOPH RES CO, V277, P643, DOI 10.1006/bbrc.2000.3721; Ohuchi H, 2005, DEV DYNAM, V233, P177, DOI 10.1002/dvdy.20319; Ovcharenko I, 2004, NUCLEIC ACIDS RES, V32, pW280, DOI 10.1093/nar/gkh355; Pasutto F, 2007, AM J HUM GENET, V80, P550, DOI 10.1086/512203; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; Pinson L, 2004, J MED GENET, V41, P381, DOI 10.1136/jmg.2003.014829; Posch MG, 2008, AM J MED GENET A, V146A, P251, DOI 10.1002/ajmg.a.32042; REZNIKOFF CA, 1973, CANCER RES, V33, P3231; Riazi AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005698; Riley BM, 2007, P NATL ACAD SCI USA, V104, P4512, DOI 10.1073/pnas.0607956104; Rohmann E, 2006, NAT GENET, V38, P414, DOI 10.1038/ng1757; Rojas A, 2005, DEVELOPMENT, V132, P3405, DOI 10.1242/dev.01913; Ryckebusch L, 2008, P NATL ACAD SCI USA, V105, P2913, DOI 10.1073/pnas.0712344105; SANCHEZGARCIA I, 1993, J MOL BIOL, V231, P945, DOI 10.1006/jmbi.1993.1343; Sasaki H, 2002, INT J DEV BIOL, V46, P963; Sekine K, 1999, NAT GENET, V21, P138, DOI 10.1038/5096; Sizarov A, 2011, CIRCULATION, V123, P1125, DOI 10.1161/CIRCULATIONAHA.110.980607; Snarr BS, 2007, CIRC RES, V101, P971, DOI 10.1161/CIRCRESAHA.107.162206; Stennard FA, 2003, DEV BIOL, V262, P206, DOI 10.1016/S0012-1606(03)00385-3; Stevens KN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010855; Stolfi A, 2010, SCIENCE, V329, P565, DOI 10.1126/science.1190181; Takeuchi JK, 2005, DEVELOPMENT, V132, P2463, DOI 10.1242/dev.01827; Takeuchi JK, 2009, NATURE, V459, P708, DOI 10.1038/nature08039; Thienpont B, 2010, AM J HUM GENET, V86, P839, DOI 10.1016/j.ajhg.2010.04.011; Tomita Y, 2005, J CELL BIOL, V170, P1135, DOI 10.1083/jcb.200504061; Urness LD, 2011, DEV BIOL, V356, P383, DOI 10.1016/j.ydbio.2011.05.671; VanderMeer JE, 2011, DEV DYNAM, V240, P920, DOI 10.1002/dvdy.22535; Vega-Hernandez M, 2011, DEVELOPMENT, V138, P3331, DOI 10.1242/dev.064410; VetteseDadey M, 1996, EMBO J, V15, P2508, DOI 10.1002/j.1460-2075.1996.tb00608.x; Vissers LELM, 2004, NAT GENET, V36, P955, DOI 10.1038/ng1407; Vitelli F, 2002, DEVELOPMENT, V129, P4605; Waldo KL, 2001, DEVELOPMENT, V128, P3179; Watanabe Y, 2010, CIRC RES, V106, P495, DOI 10.1161/CIRCRESAHA.109.201665; Waxman JS, 2008, DEV CELL, V15, P923, DOI 10.1016/j.devcel.2008.09.009; Xu HS, 2004, DEVELOPMENT, V131, P3217, DOI 10.1242/dev.01174; Yang L, 2006, DEVELOPMENT, V133, P1575, DOI 10.1242/dev.02322; Yuan SP, 2000, ANAT REC, V260, P204, DOI 10.1002/1097-0185(20001001)260:2<204::AID-AR90>3.0.CO;2-5; Zhou Y, 2011, NATURE, V474, P645, DOI 10.1038/nature10094	81	29	31	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e30677	10.1371/journal.pone.0030677	http://dx.doi.org/10.1371/journal.pone.0030677			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22303449	Green Published, Green Submitted, gold			2022-12-27	WOS:000301704200028
J	Takami, H; Noguchi, H; Takaki, Y; Uchiyama, I; Toyoda, A; Nishi, S; Chee, GJ; Arai, W; Nunoura, T; Itoh, T; Hattori, M; Takai, K				Takami, Hideto; Noguchi, Hideki; Takaki, Yoshihiro; Uchiyama, Ikuo; Toyoda, Atsushi; Nishi, Shinro; Chee, Gab-Joo; Arai, Wataru; Nunoura, Takuro; Itoh, Takehiko; Hattori, Masahira; Takai, Ken			A Deeply Branching Thermophilic Bacterium with an Ancient Acetyl-CoA Pathway Dominates a Subsurface Ecosystem	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; MICROBIAL ECOSYSTEM; HYDROTHERMAL VENTS; RNA GENES; DIVERSITY; ORIGIN; TEMPERATURE; FERREDOXIN; ALGORITHM; EVOLUTION	A nearly complete genome sequence of Candidatus 'Acetothermum autotrophicum', a presently uncultivated bacterium in candidate division OP1, was revealed by metagenomic analysis of a subsurface thermophilic microbial mat community. Phylogenetic analysis based on the concatenated sequences of proteins common among 367 prokaryotes suggests that Ca. 'A. autotrophicum' is one of the earliest diverging bacterial lineages. It possesses a folate-dependent Wood-Ljungdahl (acetyl-CoA) pathway of CO2 fixation, is predicted to have an acetogenic lifestyle, and possesses the newly discovered archaeal-autotrophic type of bifunctional fructose 1,6-bisphosphate aldolase/phosphatase. A phylogenetic analysis of the core gene cluster of the acethyl-CoA pathway, shared by acetogens, methanogens, some sulfur-and iron-reducers and dechlorinators, supports the hypothesis that the core gene cluster of Ca. 'A. autotrophicum' is a particularly ancient bacterial pathway. The habitat, physiology and phylogenetic position of Ca. 'A. autotrophicum' support the view that the first bacterial and archaeal lineages were H-2-dependent acetogens and methanogenes living in hydrothermal environments.	[Takami, Hideto; Takaki, Yoshihiro; Nishi, Shinro; Chee, Gab-Joo; Arai, Wataru] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Microbial Genome Res Grp, Yokosuka, Kanagawa, Japan; [Noguchi, Hideki; Itoh, Takehiko] Tokyo Inst Technol, Dept Biol Sci, Yokohama, Kanagawa 227, Japan; [Uchiyama, Ikuo] Natl Inst Nat Sci, Natl Inst Basic Biol, Lab Genome Informat, Aichi, Japan; [Toyoda, Atsushi] Natl Inst Genet, Mishima, Shizuoka 411, Japan; [Nunoura, Takuro; Takai, Ken] Subground Animalcule Retrieval Sugar Project, Natsushima, Japan; [Hattori, Masahira] Univ Tokyo, Ctr Omics & Bioinformat, Grad Sch Frontier Sci, Kashiwa, Chiba, Japan	Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Tokyo Institute of Technology; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; University of Tokyo	Takami, H (corresponding author), Japan Agcy Marine Earth Sci & Technol JAMSTEC, Microbial Genome Res Grp, Yokosuka, Kanagawa, Japan.	takamih@jamstec.go.jp	Hattori, Masahira/C-6958-2016; Nunoura, Takuro/AAL-6266-2020; Hattori, Masahira/AAD-3785-2019; Takami, Hideto/D-4200-2012; Itoh, Takehiko/E-8873-2014	Hattori, Masahira/0000-0001-9467-0344; Nunoura, Takuro/0000-0003-2323-0880; Takami, Hideto/0000-0003-3433-7018; Itoh, Takehiko/0000-0002-6113-557X; Uchiyama, Ikuo/0000-0002-9197-5000	Ministry of Education, Culture, Sports, Science and Technology of Japan [20310124, 18681030]; Institute for Bioinformatics Research and Development, Japan Science and Technology Agency; National Institute for Basic Biology (NIBB)	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Institute for Bioinformatics Research and Development, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); National Institute for Basic Biology (NIBB)(National Institutes of Natural Sciences (NINS) - Japan)	This research was supported in part by Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan to HT (No. 20310124) and to TN (No. 18681030). And this research was also supported in part by Institute for Bioinformatics Research and Development, Japan Science and Technology Agency to IU and HT, and in part by Grant-in-Aid for Scientific Research on Priority Areas "Comprehensive Genomics" to MH and by collaborative research program of National Institute for Basic Biology (NIBB). Computational resources were partly provided by the Data Integration and Analysis Facility of NIBB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAROSS JA, 1985, ORIGINS LIFE EVOL B, V15, P327, DOI 10.1007/BF01808177; Biegel E, 2011, CELL MOL LIFE SCI, V68, P613, DOI 10.1007/s00018-010-0555-8; Biegel E, 2010, P NATL ACAD SCI USA, V107, P18138, DOI 10.1073/pnas.1010318107; Boussau B, 2008, NATURE, V456, P942, DOI 10.1038/nature07393; Brioukhanov AL, 2004, BIOCHEMISTRY-MOSCOW+, V69, P949, DOI 10.1023/B:BIRY.0000043537.04115.d9; Caspi R, 2008, NUCLEIC ACIDS RES, V36, pD623, DOI [10.1093/nar/gkm900, 10.1093/nar/gkt1103]; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Corliss JB, 1981, OCEANOL ACTA, V4, P56; Costa KC, 2009, EXTREMOPHILES, V13, P447, DOI 10.1007/s00792-009-0230-x; de la Torre JR, 2008, ENVIRON MICROBIOL, V10, P810, DOI 10.1111/j.1462-2920.2007.01506.x; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hirayama H, 2005, EXTREMOPHILES, V9, P169, DOI 10.1007/s00792-005-0433-8; Hugenholtz P, 1998, J BACTERIOL, V180, P366, DOI 10.1128/JB.180.2.366-376.1998; Kaster AK, 2011, P NATL ACAD SCI USA, V108, P2981, DOI 10.1073/pnas.1016761108; Kato S, 2009, ENVIRON MICROBIOL, V11, P2094, DOI 10.1111/j.1462-2920.2009.01930.x; Kelley DS, 2005, SCIENCE, V307, P1428, DOI 10.1126/science.1102556; Kimura H, 2006, APPL ENVIRON MICROB, V72, P21, DOI 10.1128/AEM.72.1.21-27.2006; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Martin W, 2008, NAT REV MICROBIOL, V6, P805, DOI 10.1038/nrmicro1991; Martin W, 2007, PHILOS T R SOC B, V362, P1887, DOI 10.1098/rstb.2006.1881; Mulkidjanian AY, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-13; Muller V, 2003, APPL ENVIRON MICROB, V69, P6345, DOI 10.1128/AEM.69.11.6345-6353.2003; Murata T, 2005, J BIOENERG BIOMEMBR, V37, P411, DOI 10.1007/s10863-005-9481-0; Nikitin Frederic, 2004, Genome Inform, V15, P266; Nisbet EG, 2001, NATURE, V409, P1083, DOI 10.1038/35059210; Noguchi H, 2008, DNA RES, V15, P387, DOI 10.1093/dnares/dsn027; Nunoura T, 2005, ENVIRON MICROBIOL, V7, P1967, DOI 10.1111/j.1462-2920.2005.00881.x; Nunoura T, 2011, NUCLEIC ACIDS RES, V39, P3204, DOI 10.1093/nar/gkq1228; Pierce E, 2008, ENVIRON MICROBIOL, V10, P2550, DOI 10.1111/j.1462-2920.2008.01679.x; Proskurowski G, 2006, CHEM GEOL, V229, P331, DOI 10.1016/j.chemgeo.2005.11.005; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sakiyama T, 2000, BIOSCI BIOTECH BIOCH, V64, P670, DOI 10.1271/bbb.64.670; Say RF, 2010, NATURE, V464, P1077, DOI 10.1038/nature08884; Shibuya T, 2010, PRECAMBRIAN RES, V182, P230, DOI 10.1016/j.precamres.2010.08.011; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Takai K, 2004, EXTREMOPHILES, V8, P269, DOI 10.1007/s00792-004-0386-3; Takai K, 2002, APPL ENVIRON MICROB, V68, P3046, DOI 10.1128/AEM.68.6.3046-3054.2002; Takai Ken, 2006, Paleontological Research, V10, P269; Takami H, 1997, FEMS MICROBIOL LETT, V152, P279, DOI 10.1016/S0378-1097(97)00211-5; Takami H, 2004, NUCLEIC ACIDS RES, V32, P6292, DOI 10.1093/nar/gkh970; Takami H, 2000, NUCLEIC ACIDS RES, V28, P4317, DOI 10.1093/nar/28.21.4317; Teske A, 2002, APPL ENVIRON MICROB, V68, P1994, DOI 10.1128/AEM.68.4.1994-2007.2002; Thauer RK, 2007, SCIENCE, V318, P1732, DOI 10.1126/science.1152209; Tobler DJ, 2011, EXTREMOPHILES, V15, P473, DOI 10.1007/s00792-011-0378-z; Toei M, 2007, P NATL ACAD SCI USA, V104, P20256, DOI 10.1073/pnas.0706914105; Uchiyama I, 2006, NUCLEIC ACIDS RES, V34, P647, DOI 10.1093/nar/gkj448; Uchiyama I, 2010, NUCLEIC ACIDS RES, V38, pD361, DOI 10.1093/nar/gkp948; WACHTERSHAUSER G, 1988, MICROBIOL REV, V52, P452; Werner C, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005094; White O, 1999, SCIENCE, V286, P1571, DOI 10.1126/science.286.5444.1571; Wu DY, 2009, NATURE, V462, P1056, DOI 10.1038/nature08656; Wu M, 2005, PLOS GENET, V1, P563, DOI 10.1371/journal.pgen.0010065; Wu M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r151	56	85	88	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e30559	10.1371/journal.pone.0030559	http://dx.doi.org/10.1371/journal.pone.0030559			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22303444	gold, Green Submitted, Green Published			2022-12-27	WOS:000301704200022
J	Park, BH; Kim, DS; Won, GW; Jeon, HJ; Oh, BC; Lee, Y; Kim, EG; Lee, YH				Park, Byoung Hee; Kim, Dae Soon; Won, Gun Woo; Jeon, Hyun Jeong; Oh, Byung-Chul; Lee, YoungJoo; Kim, Eung-Gook; Lee, Yong Hee			Mammalian Ste20-Like Kinase and SAV1 Promote 3T3-L1 Adipocyte Differentiation by Activation of PPAR gamma	PLOS ONE			English	Article							CELL CONTACT INHIBITION; RECEPTOR-GAMMA; GENE-EXPRESSION; HIPPO PATHWAY; STERILE-20 KINASE; OXIDATIVE-STRESS; HISTONE H2B; APOPTOSIS; ADIPOGENESIS; PHOSPHORYLATION	The mammalian ste20 kinase (MST) signaling pathway plays an important role in the regulation of apoptosis and cell cycle control. We sought to understand the role of MST2 kinase and Salvador homolog 1 (SAV1), a scaffolding protein that functions in the MST pathway, in adipocyte differentiation. MST2 and MST1 stimulated the binding of SAV1 to peroxisome proliferator-activated receptor gamma (PPAR gamma), a transcription factor that plays a key role in adipogenesis. The interaction of endogenous SAV1 and PPAR gamma was detected in differentiating 3T3-L1 adipocytes. This binding required the kinase activity of MST2 and was mediated by the WW domains of SAV1 and the PPYY motif of PPAR gamma. Overexpression of MST2 and SAV1 increased PPAR gamma levels by stabilizing the protein, and the knockdown of SAV1 resulted in a decrease of endogenous PPAR gamma protein in 3T3-L1 adipocytes. During the differentiation of 3T3-L1 cells into adipocytes, MST2 and SAV1 expression began to increase at 2 days when PPAR gamma expression also begins to increase. MST2 and SAV1 significantly increased PPAR gamma transactivation, and SAV1 was shown to be required for the activation of PPAR gamma by rosiglitazone. Finally, differentiation of 3T3-L1 cells was augmented by MST2 and SAV1 expression and inhibited by knockdown of MST1/2 or SAV1. These results suggest that PPAR gamma activation by the MST signaling pathway may be a novel regulatory mechanism of adipogenesis.	[Park, Byoung Hee; Kim, Dae Soon; Won, Gun Woo; Kim, Eung-Gook; Lee, Yong Hee] Chungbuk Natl Univ, Coll Med, Dept Biochem, Chungbuk, South Korea; [Jeon, Hyun Jeong] Chungbuk Natl Univ, Coll Med, Dept Internal Med, Chungbuk, South Korea; [Oh, Byung-Chul] Gachon Univ Med & Sci, Lee Gil Ya Canc & Diabet Inst, Inchon, South Korea; [Lee, YoungJoo] Sejong Univ, Dept Biosci & Biotechnol, Seoul, South Korea	Chungbuk National University; Chungbuk National University; Gachon University; Sejong University	Park, BH (corresponding author), Chungbuk Natl Univ, Coll Med, Dept Biochem, Chungbuk, South Korea.	yh-lee@cbnu.ac.kr		Oh, Byung-Chul/0000-0002-4277-7083	National Research Foundation of Korea (NRF) [2011-0006216, 2011-0027507]; Korean government (MEST)	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by a research grant (2011-0006216) and a research grant (2011-0027507) to Dr. Lee from National Research Foundation of Korea (NRF) funded by the Korean government (MEST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SH, 2005, CELL, V120, P25, DOI 10.1016/j.cell.2004.11.016; Burgermeister E, 2007, MOL CELL BIOL, V27, P803, DOI 10.1128/MCB.00601-06; Burns KA, 2007, BBA-MOL CELL BIOL L, V1771, P952, DOI 10.1016/j.bbalip.2007.04.018; Chan EH, 2005, ONCOGENE, V24, P2076, DOI 10.1038/sj.onc.1208445; Cheung WL, 2003, CELL, V113, P507, DOI 10.1016/S0092-8674(03)00355-6; Choi J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008011; Ge K, 2008, MOL CELL BIOL, V28, P1081, DOI 10.1128/MCB.00967-07; Gerhold DL, 2002, ENDOCRINOLOGY, V143, P2106, DOI 10.1210/en.143.6.2106; Graves JD, 1998, EMBO J, V17, P2224, DOI 10.1093/emboj/17.8.2224; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Katagiri K, 2009, EMBO J, V28, P1319, DOI 10.1038/emboj.2009.82; Lee JH, 2008, EMBO J, V27, P1231, DOI 10.1038/emboj.2008.63; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Li Y, 2002, MOL ENDOCRINOL, V16, P1040, DOI 10.1210/me.16.5.1040; MACDOUGALD OA, 1995, ANNU REV BIOCHEM, V64, P345, DOI 10.1146/annurev.bi.64.070195.002021; Mueller E, 2002, J BIOL CHEM, V277, P41925, DOI 10.1074/jbc.M206950200; Oh S, 2009, MOL CELL BIOL, V29, P6309, DOI 10.1128/MCB.00551-09; Radu M, 2009, CURR BIOL, V19, pR421, DOI 10.1016/j.cub.2009.04.022; Tamori Y, 2002, DIABETES, V51, P2045, DOI 10.2337/diabetes.51.7.2045; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P44, DOI 10.1073/pnas.0137044100; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Ura S, 2001, GENES CELLS, V6, P519, DOI 10.1046/j.1365-2443.2001.00439.x; Valverde P, 2000, BIOCHEM BIOPH RES CO, V276, P990, DOI 10.1006/bbrc.2000.3582; VidalPuig AJ, 1997, J CLIN INVEST, V99, P2416, DOI 10.1172/JCI119424; Willson TM, 2000, J MED CHEM, V43, P527, DOI 10.1021/jm990554g; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Yin YZ, 2006, MOL ENDOCRINOL, V20, P268, DOI 10.1210/me.2005-0197; Yuan ZQ, 2010, J BIOL CHEM, V285, P3815, DOI 10.1074/jbc.M109.059675; Yuan ZQ, 2009, J BIOL CHEM, V284, P11285, DOI 10.1074/jbc.M900461200; Zeng Q, 2008, CANCER CELL, V13, P188, DOI 10.1016/j.ccr.2008.02.011; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907	36	27	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2012	7	1							e30983	10.1371/journal.pone.0030983	http://dx.doi.org/10.1371/journal.pone.0030983			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911FX	22292086	Green Submitted, Green Published, gold			2022-12-27	WOS:000301703800039
J	Ohshiro, K; Schwartz, AM; Levine, PH; Kumar, R				Ohshiro, Kazufumi; Schwartz, Arnold M.; Levine, Paul H.; Kumar, Rakesh			Alternate Estrogen Receptors Promote Invasion of Inflammatory Breast Cancer Cells via Non-Genomic Signaling	PLOS ONE			English	Article							ER-ALPHA; MOLECULAR-BIOLOGY; GENE-EXPRESSION; VARIANT; PROTEIN; GPR30; ER-ALPHA-36; CARCINOMA; 17-BETA-ESTRADIOL; IDENTIFICATION	Although Inflammatory Breast Cancer (IBC) is a rare and an aggressive type of locally advanced breast cancer with a generally worst prognosis, little work has been done in identifying the status of non-genomic signaling in the invasiveness of IBC. The present study was performed to explore the status of non-genomic signaling as affected by various estrogenic and anti-estrogenic agents in IBC cell lines SUM149 and SUM190. We have identified the presence of estrogen receptor alpha (ER alpha) variant, ER alpha 36 in SUM149 and SUM190 cells. This variant as well as ER beta was present in a substantial concentration in IBC cells. The treatment with estradiol (E2), anti-estrogenic agents 4-hydroxytamoxifen and ICI 182780, ER beta specific ligand DPN and GPR30 agonist G1 led to a rapid activation of p-ERK1/2, suggesting the involvement of ER alpha 36, ER beta and GPR30 in the non-genomic signaling pathway in these cells. We also found a substantial increase in the cell migration and invasiveness of SUM149 cells upon the treatment with these ligands. Both basal and ligand-induced migration and invasiveness of SUM149 cells were drastically reduced in the presence of MEK inhibitor U0126, implicating that the phosphorylation of ERK1/2 by MEK is involved in the observed motility and invasiveness of IBC cells. We also provide evidence for the upregulation of p-ERK1/2 through immunostaining in IBC patient samples. These findings suggest a role of non-genomic signaling through the activation of p-ERK1/2 in the hormonal dependence of IBC by a combination of estrogen receptors. These findings only explain the failure of traditional anti-estrogen therapies in ER-positive IBC which induces the non-genomic signaling, but also opens newer avenues for design of modified therapies targeting these estrogen receptors.	[Ohshiro, Kazufumi; Kumar, Rakesh] George Washington Univ, Med Ctr, Dept Biochem & Mol Biol, Washington, DC 20037 USA; [Schwartz, Arnold M.] George Washington Univ, Med Ctr, Dept Pathol, Washington, DC 20037 USA; [Levine, Paul H.] George Washington Univ, Med Ctr, Dept Epidemiol & Biostat, Washington, DC 20037 USA	George Washington University; George Washington University; George Washington University	Ohshiro, K (corresponding author), George Washington Univ, Med Ctr, Dept Biochem & Mol Biol, Washington, DC 20037 USA.	bcmrxk@gwumc.edu	Kumar, Rakesh/ABD-1065-2020	Kumar, Rakesh/0000-0001-7664-0803	National Institutes of Health [CA090970]; NATIONAL CANCER INSTITUTE [R01CA090970] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grant CA090970 (R.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABNER AL, 1993, J CLIN ONCOL, V11, P44, DOI 10.1200/JCO.1993.11.1.44; Anderson William F, 2005, Breast Dis, V22, P9; Carmeci C, 1997, GENOMICS, V45, P607, DOI 10.1006/geno.1997.4972; Charafe-Lauffret E, 2008, SEMIN ONCOL, V35, P41, DOI 10.1053/j.seminoncol.2007.11.015; Deng H, 2010, ONCOL REP, V24, P171, DOI 10.3892/or_00000842; Dirix LY, 2006, CURR OPIN ONCOL, V18, P563, DOI 10.1097/01.cco.0000245307.29026.0a; Filardo E, 2007, ENDOCRINOLOGY, V148, P3236, DOI 10.1210/en.2006-1605; Fraser SP, 2010, J CELL PHYSIOL, V224, P527, DOI 10.1002/jcp.22154; Hance KW, 2005, JNCI-J NATL CANCER I, V97, P966, DOI 10.1093/jnci/dji172; He YY, 2009, CANCER SCI, V100, P1051, DOI 10.1111/j.1349-7006.2009.01148.x; HORTOBAGYI GN, 1988, CANCER, V62, P2507, DOI 10.1002/1097-0142(19881215)62:12<2507::AID-CNCR2820621210>3.0.CO;2-D; Huang GS, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.04.046; Ignatov A, 2010, BREAST CANCER RES TR, V123, P87, DOI 10.1007/s10549-009-0624-6; JAIYESIMI IA, 1992, J CLIN ONCOL, V10, P1014, DOI 10.1200/JCO.1992.10.6.1014; Kang LG, 2010, MOL ENDOCRINOL, V24, P709, DOI 10.1210/me.2009-0317; Kleer CG, 2004, BREAST CANCER RES, V6, pR110, DOI 10.1186/bcr755; Kleer CG, 2002, ONCOGENE, V21, P3172, DOI 10.1038/sj.onc.1205462; Kleer CG, 2000, BREAST CANCER RES, V2, P423, DOI 10.1186/bcr89; Lappano R, 2010, MOL CELL ENDOCRINOL, V320, P162, DOI 10.1016/j.mce.2010.02.006; Lee LMJ, 2008, ANTICANCER RES, V28, P479; Li Y, 2010, MOL ENDOCRINOL, V24, P969, DOI 10.1210/me.2009-0148; Lin SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009013; Lin SL, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-102; Madeo A, 2010, CANCER RES, V70, P6036, DOI 10.1158/0008-5472.CAN-10-0408; McCarthy NJ, 2002, CLIN CANCER RES, V8, P3857; Merajver SD, 1997, J CLIN ONCOL, V15, P2873, DOI 10.1200/JCO.1997.15.8.2873; Moriarty K, 2006, ENDOCRINOLOGY, V147, P5557, DOI 10.1210/en.2006-0729; Nguyen DM, 2006, CLIN CANCER RES, V12, P5047, DOI 10.1158/1078-0432.CCR-05-2248; Ohshiro K, 2006, CLIN CANCER RES, V12, P5994, DOI 10.1158/1078-0432.CCR-06-1251; PARADISO A, 1989, CANCER, V64, P1922, DOI 10.1002/1097-0142(19891101)64:9<1922::AID-CNCR2820640927>3.0.CO;2-I; Plante BJ, 2008, REPROD SCI, V15, p70A; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; Van den Eynden GG, 2006, BREAST CANCER RES TR, V95, P219, DOI 10.1007/s10549-005-9002-1; Van den Eynden GG, 2004, BREAST CANCER RES TR, V85, P13, DOI 10.1023/B:BREA.0000021028.33926.a8; van Golen KL, 1999, CLIN CANCER RES, V5, P2511; Vivacqua A, 2006, MOL ENDOCRINOL, V20, P631, DOI 10.1210/me.2005-0280; Vivacqua A, 2006, MOL PHARMACOL, V70, P1414, DOI 10.1124/mol.106.026344; Wang ZY, 2006, P NATL ACAD SCI USA, V103, P9063, DOI 10.1073/pnas.0603339103; Wang ZY, 2005, BIOCHEM BIOPH RES CO, V336, P1023, DOI 10.1016/j.bbrc.2005.08.226; Zhang GF, 2009, MOL ENDOCRINOL, V23, P146, DOI 10.1210/me.2008-0431; Zhang XT, 2011, ONCOGENE, V30, P770, DOI 10.1038/onc.2010.458; Zou Y, 2009, FEBS LETT, V583, P1368, DOI 10.1016/j.febslet.2009.03.047	42	39	50	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30725	10.1371/journal.pone.0030725	http://dx.doi.org/10.1371/journal.pone.0030725			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295107	Green Published, gold			2022-12-27	WOS:000301640600052
J	Bopp, M; Braun, J; Gutzwiller, F; Faeh, D				Bopp, Matthias; Braun, Julia; Gutzwiller, Felix; Faeh, David		Swiss Natl Cohort Study Grp	Health Risk or Resource? Gradual and Independent Association between Self-Rated Health and Mortality Persists Over 30 Years	PLOS ONE			English	Article							COMMUNITY; PREVENTION; PREDICTORS; SURVIVAL; COHORT; ADULTS; LIFE; WELL	Background: Poor self-rated health (SRH) is associated with increased mortality. However, most studies only adjust for few health risk factors and/or do not analyse whether this association is consistent also for intermediate categories of SRH and for follow-up periods exceeding 5-10 years. This study examined whether the SRH-mortality association remained significant 30 years after assessment when adjusting for a wide range of known clinical, behavioural and socio-demographic risk factors. Methods: We followed-up 8,251 men and women aged >= 16 years who participated 1977-79 in a community based health study and were anonymously linked with the Swiss National Cohort (SNC) until the end of 2008. Covariates were measured at baseline and included education, marital status, smoking, medical history, medication, blood glucose and pressure. Results: 92.8% of the original study participants could be linked to a census, mortality or emigration record of the SNC. Loss to follow-up 1980-2000 was 5.8%. Even after 30 years of follow-up and after adjustment for all covariates, the association between SRH and all-cause mortality remained strong and estimates almost linearly increased from "excellent'' (reference: hazard ratio, HR 1) to "good'' (men: HR 1.07 95% confidence interval 0.92-1.24, women: 1.22, 1.01-1.46) to "fair'' (1.41, 1.18-1.68; 1.39, 1.14-1.70) to "poor''(1.61, 1.15-2.25; 1.49, 1.07-2.06) to "very poor'' (2.85, 1.25-6.51; 1.30, 0.18-9.35). Persons answering the SRH question with "don't know'' (1.87, 1.21-2.88; 1.26, 0.87-1.83) had also an increased mortality risk; this was pronounced in men and in the first years of follow-up. Conclusions: SRH is a strong and "dose-dependent'' predictor of mortality. The association was largely independent from covariates and remained significant after decades. This suggests that SRH provides relevant and sustained health information beyond classical risk factors or medical history and reflects salutogenetic rather than pathogenetic pathways.	[Bopp, Matthias; Braun, Julia; Gutzwiller, Felix; Faeh, David; Swiss Natl Cohort Study Grp] Univ Zurich, Inst Social & Prevent Med, CH-8006 Zurich, Switzerland	University of Zurich	Bopp, M (corresponding author), Univ Zurich, Inst Social & Prevent Med, CH-8006 Zurich, Switzerland.	bopp@ifspm.uzh.ch	Swaibu, Ramadhani A/H-3164-2011	Bopp, Matthias/0000-0003-0766-3723	Swiss National Science Foundation [3347CO-108806, 33CS30-134273, 32473B-125710]; Swiss Federal Statistical Office	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Federal Statistical Office	This work was supported by the Swiss National Science Foundation (grants 3347CO-108806, 33CS30-134273 and 32473B-125710). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.; We thank the Swiss Federal Statistical Office for providing mortality and census data and for the support which made the Swiss National Cohort and this study possible. The members of the Swiss National Cohort Study Group are Felix Gutzwiller (Chairman of Executive Board), Matthias Bopp (both Zurich), Matthias Egger (Chairman of Scientific Board), Adrian Spoerri, Malcolm Sturdy (Data manager) and Marcel Zwahlen (all Bern), Nino Kunzli (Basel), Fred Paccaud (Lausanne) and Michel Oris (Geneva).	[Anonymous], 1982, IARC PUBL, P668; Benyamini Y, 1999, RES AGING, V21, P392, DOI 10.1177/0164027599213002; Bopp M, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-562; Bopp M, 2009, INT J EPIDEMIOL, V38, P379, DOI 10.1093/ije/dyn042; Burstrom B, 2001, J EPIDEMIOL COMMUN H, V55, P836, DOI 10.1136/jech.55.11.836; DeSalvo KB, 2006, J GEN INTERN MED, V21, P267, DOI 10.1111/j.1525-1497.2005.00291.x; Ferraro KF, 2001, J GERONTOL B-PSYCHOL, V56, pS195, DOI 10.1093/geronb/56.4.S195; Ford J, 2008, AGE AGEING, V37, P194, DOI 10.1093/ageing/afm171; GUTZWILLER F, 1980, SOZ PRAVENTIV MED, V25, P239, DOI 10.1007/BF02078487; GUTZWILLER F, 1985, PREV MED, V14, P482, DOI 10.1016/0091-7435(85)90008-8; Heidrich J, 2002, ANN EPIDEMIOL, V12, P338, DOI 10.1016/S1047-2797(01)00300-3; Huisman M, 2007, INT J EPIDEMIOL, V36, P1207, DOI 10.1093/ije/dym095; Idler EL, 2000, AM J EPIDEMIOL, V152, P874, DOI 10.1093/aje/152.9.874; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; Jylha M, 2011, INT HANDB POPUL, V2, P329, DOI 10.1007/978-90-481-9996-9_16; McGee DL, 1999, AM J EPIDEMIOL, V149, P41; Pietilainen O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025004; Sargent-Cox KA, 2010, BMC GERIATR, V10, DOI 10.1186/1471-2318-10-18; Vuorisalmi M, 2005, J CLIN EPIDEMIOL, V58, P680, DOI 10.1016/j.jclinepi.2004.11.025; Xu JP, 2010, HEALTH PSYCHOL, V29, P9, DOI 10.1037/a0016767	20	80	81	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2012	7	2							e30795	10.1371/journal.pone.0030795	http://dx.doi.org/10.1371/journal.pone.0030795			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	924ZQ	22347405	gold, Green Published			2022-12-27	WOS:000302730200009
J	de Breij, A; Eveillard, M; Dijkshoorn, L; van den Broek, PJ; Nibbering, PH; Joly-Guillou, ML				de Breij, Anna; Eveillard, Matthieu; Dijkshoorn, Lenie; van den Broek, Peterhans J.; Nibbering, Peter H.; Joly-Guillou, Marie-Laure			Differences in Acinetobacter baumannii Strains and Host Innate Immune Response Determine Morbidity and Mortality in Experimental Pneumonia	PLOS ONE			English	Article							BIOFILM FORMATION; EPITHELIAL-CELLS; ABIOTIC SURFACES; MICE; IDENTIFICATION; RESISTANCE; INFECTION; NEUTROPHILS; HOSPITALS; ADHERENCE	Despite many reports documenting its epidemicity, little is known on the interaction of Acinetobacter baumannii with its host. To deepen our insight into this relationship, we studied persistence of and host response to different A. baumannii strains including representatives of the European (EU) clones I-III in a mouse pneumonia model. Neutropenic mice were inoculated intratracheally with five A. baumannii strains and an A. junii strain and at several days morbidity, mortality, bacterial counts, airway inflammation, and chemo-and cytokine production in lungs and blood were determined. A. baumannii RUH875 and RUH134 (EU clone I and II, respectively) and sporadic strain LUH8326 resulted in high morbidity/mortality, whereas A. baumannii LUH5875 (EU clone III, which is less widespread than clone I and II) caused less symptoms. A. baumannii type strain RUH3023(T) and A. junii LUH5851 did not cause disease. All strains, except A. baumannii RUH3023(T) and A. junii LUH5851, survived and multiplied in the lungs for several days. Morbidity and mortality were associated with the severity of lung pathology and a specific immune response characterized by low levels of anti-inflammatory (IL-10) and specific pro-inflammatory (IL-12p40 and IL-23) cytokines at the first day of infection. Altogether, a striking difference in behaviour among the A. baumannii strains was observed with the clone I and II strains being most virulent, whereas the A. baumannii type strain, which is frequently used in virulence studies appeared harmless.	[de Breij, Anna; Dijkshoorn, Lenie; van den Broek, Peterhans J.; Nibbering, Peter H.] Leiden Univ, Med Ctr, Dept Infect Dis, Leiden, Netherlands; [Eveillard, Matthieu; Joly-Guillou, Marie-Laure] Univ Angers, Angers Univ Hosp, Angers Med Sch, Study Grp Host Pathogens Interact,Dept Bacteriol, Angers, France	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Universite d'Angers; Centre Hospitalier Universitaire d'Angers	de Breij, A (corresponding author), Leiden Univ, Med Ctr, Dept Infect Dis, Leiden, Netherlands.	a.de_breij@lumc.nl	Joly-Guillou, Marie-Laure/E-8206-2014	Joly-Guillou, Marie-Laure/0000-0003-2593-6684				Breslow JM, 2011, INFECT IMMUN, V79, P3317, DOI 10.1128/IAI.00069-11; de Breij A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010732; de Breij A, 2009, RES MICROBIOL, V160, P213, DOI 10.1016/j.resmic.2009.01.002; Diancourt L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010034; Dijkshoorn L, 2004, ANTIMICROB AGENTS CH, V48, P4919, DOI 10.1128/AAC.48.12.4919-4921.2004; Dijkshoorn L, 1996, J CLIN MICROBIOL, V34, P1519, DOI 10.1128/JCM.34.6.1519-1525.1996; Dijkshoorn L, 1998, SYST APPL MICROBIOL, V21, P33, DOI 10.1016/S0723-2020(98)80006-4; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; Eveillard M, 2010, J INFECTION, V60, P154, DOI 10.1016/j.jinf.2009.09.004; Gaddy JA, 2009, INFECT IMMUN, V77, P3150, DOI 10.1128/IAI.00096-09; GREENBERGER MJ, 1995, J IMMUNOL, V155, P722; Happel KI, 2005, J EXP MED, V202, P761, DOI 10.1084/jem.20050193; Jeong ES, 2009, J MICROBIOL BIOTECHN, V19, P424, DOI 10.4014/jmb.0807.436; Kapetanovic R, 2007, EXPERT OPIN BIOL TH, V7, P907, DOI 10.1517/14712598.7.6.907; King LB, 2009, FEMS IMMUNOL MED MIC, V55, P414, DOI 10.1111/j.1574-695X.2009.00538.x; Knapp S, 2006, AM J RESP CRIT CARE, V173, P122, DOI 10.1164/rccm.200505-730OC; Lee HW, 2008, CLIN MICROBIOL INFEC, V14, P49, DOI 10.1111/j.1469-0691.2007.01842.x; Lee JC, 2006, RES MICROBIOL, V157, P360, DOI 10.1016/j.resmic.2005.09.011; Lee JS, 2010, J MICROBIOL, V48, P387, DOI 10.1007/s12275-010-0155-1; McKenzie BS, 2006, TRENDS IMMUNOL, V27, P17, DOI 10.1016/j.it.2005.10.003; Mednick AJ, 2003, EUR J IMMUNOL, V33, P1744, DOI 10.1002/eji.200323626; Mittal R, 2010, J EXP MED, V207, P1307, DOI 10.1084/jem.20092265; Nemec A, 2001, INT J SYST EVOL MICR, V51, P1891, DOI 10.1099/00207713-51-5-1891; Nwugo CC, 2011, J PROTEOMICS, V74, P44, DOI 10.1016/j.jprot.2010.07.010; Qiu HY, 2009, MICROBES INFECT, V11, P946, DOI 10.1016/j.micinf.2009.06.003; Seifert H, 1997, J CLIN MICROBIOL, V35, P2819, DOI 10.1128/JCM.35.11.2819-2825.1997; Tomaras AP, 2008, MICROBIOL-SGM, V154, P3398, DOI 10.1099/mic.0.2008/019471-0; Tomaras AP, 2003, MICROBIOL-SGM, V149, P3473, DOI 10.1099/mic.0.26541-0; Turton JF, 2007, CLIN MICROBIOL INFEC, V13, P807, DOI 10.1111/j.1469-0691.2007.01759.x; van Dessel H, 2004, RES MICROBIOL, V155, P105, DOI 10.1016/j.resmic.2003.10.003; Van Faassen H, 2007, INFECT IMMUN, V75, P5597, DOI 10.1128/IAI.00762-07; Van Looveren M, 2004, CLIN MICROBIOL INFEC, V10, P684, DOI 10.1111/j.1469-0691.2004.00942.x; vanderPoll T, 1996, J INFECT DIS, V174, P994, DOI 10.1093/infdis/174.5.994; Webster C, 2000, INFECT CONT HOSP EP, V21, P246, DOI 10.1086/503214	34	37	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e30673	10.1371/journal.pone.0030673	http://dx.doi.org/10.1371/journal.pone.0030673			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347396	Green Published, Green Submitted, gold			2022-12-27	WOS:000302730100021
J	Gilpin, NW; Karanikas, CA; Richardson, HN				Gilpin, Nicholas W.; Karanikas, Chrisanthi A.; Richardson, Heather N.			Adolescent Binge Drinking Leads to Changes in Alcohol Drinking, Anxiety, and Amygdalar Corticotropin Releasing Factor Cells in Adulthood in Male Rats	PLOS ONE			English	Article							ELEVATED PLUS-MAZE; WITHDRAWAL-INDUCED ANXIETY; AMINOBUTYRIC-ACID RELEASE; PITUITARY-ADRENAL AXIS; PREFERRING P RATS; ETHANOL-WITHDRAWAL; CENTRAL NUCLEUS; EPIDEMIOLOGIC SURVEY; DEPENDENT RATS; RECEPTOR ANTAGONISTS	Heavy episodic drinking early in adolescence is associated with increased risk of addiction and other stress-related disorders later in life. This suggests that adolescent alcohol abuse is an early marker of innate vulnerability and/or binge exposure impacts the developing brain to increase vulnerability to these disorders in adulthood. Animal models are ideal for clarifying the relationship between adolescent and adult alcohol abuse, but we show that methods of involuntary alcohol exposure are not effective. We describe an operant model that uses multiple bouts of intermittent access to sweetened alcohol to elicit voluntary binge alcohol drinking early in adolescence (similar to postnatal days 28-42) in genetically heterogeneous male Wistar rats. We next examined the effects of adolescent binge drinking on alcohol drinking and anxiety-like behavior in dependent and non-dependent adult rats, and counted corticotropin-releasing factor (CRF) cell in the lateral portion of the central amygdala (CeA), a region that contributes to regulation of anxiety-and alcohol-related behaviors. Adolescent binge drinking did not alter alcohol drinking under baseline drinking conditions in adulthood. However, alcohol-dependent and non-dependent adult rats with a history of adolescent alcohol binge drinking did exhibit increased alcohol drinking when access to alcohol was intermittent. Adult rats that binged alcohol during adolescence exhibited increased exploration on the open arms of the elevated plus maze (possibly indicating either decreased anxiety or increased impulsivity), an effect that was reversed by a history of alcohol dependence during adulthood. Finally, CRF cell counts were reduced in the lateral CeA of rats with adolescent alcohol binge history, suggesting semi-permanent changes in the limbic stress peptide system with this treatment. These data suggest that voluntary binge drinking during early adolescence produces long-lasting neural and behavioral effects with implications for anxiety and alcohol use disorders.	[Gilpin, Nicholas W.] Louisiana State Univ, Hlth Sci Ctr, Dept Physiol, New Orleans, LA 70112 USA; [Karanikas, Chrisanthi A.; Richardson, Heather N.] Univ Massachusetts, Dept Psychol, Div Neurosci, Ctr Neuroendocrine Studies,Neurosci & Behav Progr, Amherst, MA 01003 USA; [Karanikas, Chrisanthi A.; Richardson, Heather N.] Univ Massachusetts, Dept Psychol, Dev Div, Ctr Neuroendocrine Studies,Neurosci & Behav Progr, Amherst, MA 01003 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Gilpin, NW (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Physiol, New Orleans, LA 70112 USA.	hrichardson@cns.umass.edu	Gilpin, Nicholas/V-1266-2019; Gilpin, Nicholas/K-9528-2014	/0000-0001-7659-1212; Gilpin, Nicholas/0000-0001-8901-8917	University of Massachusetts Amherst; National Institutes of Health and the National Institute on Alcohol Abuse and Alcoholism (NIH-NIAAA) [AA06420]; NIH [2 T32 NS007490-10]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007490] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P60AA006420, P50AA006420, F32AA016436, R21AA021013] Funding Source: NIH RePORTER	University of Massachusetts Amherst; National Institutes of Health and the National Institute on Alcohol Abuse and Alcoholism (NIH-NIAAA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This research was supported by start-up funds from the University of Massachusetts Amherst (HNR) and grants from the National Institutes of Health and the National Institute on Alcohol Abuse and Alcoholism (NIH-NIAAA grant AA06420-Animal Models Core: Dr. George F. Koob-PI, HNR-co-PI; NIH grant 2 T32 NS007490-10: CAK). The University of Massachusetts Amherst, National Institutes of Health and National Institute on Alcohol Abuse and Alcoholism had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALDWIN HA, 1991, PSYCHOPHARMACOLOGY, V103, P227, DOI 10.1007/BF02244208; Barr CS, 2008, ARCH GEN PSYCHIAT, V65, P934, DOI 10.1001/archpsyc.65.8.934; Blomeyer D, 2008, BIOL PSYCHIAT, V63, P146, DOI 10.1016/j.biopsych.2007.04.026; Breese GR, 2005, NEUROPSYCHOPHARMACOL, V30, P1662, DOI 10.1038/sj.npp.1300706; Carty ML, 2010, BEHAV BRAIN RES, V208, P609, DOI 10.1016/j.bbr.2010.01.007; CASSELL MD, 1986, J COMP NEUROL, V246, P478, DOI 10.1002/cne.902460406; Cassell MD, 1999, ANN NY ACAD SCI, V877, P217, DOI 10.1111/j.1749-6632.1999.tb09270.x; CHOU SP, 1992, BRIT J ADDICT, V87, P1199; Courtney KE, 2009, PSYCHOL BULL, V135, P142, DOI 10.1037/a0014414; CRUZ APM, 1994, PHARMACOL BIOCHEM BE, V49, P171, DOI 10.1016/0091-3057(94)90472-3; Dawson DA, 2008, ALCOHOL CLIN EXP RES, V32, P2149, DOI 10.1111/j.1530-0277.2008.00806.x; DeWit DJ, 2000, AM J PSYCHIAT, V157, P745, DOI 10.1176/appi.ajp.157.5.745; Donovan JE, 2008, ALCOHOL CLIN EXP RES, V32, P108, DOI 10.1111/j.1530-0277.2007.00565.x; Ehlers CL, 2006, ALCOHOL CLIN EXP RES, V30, P1856, DOI 10.1111/j.1530-0277.2006.00222.x; EHLERS CL, 1992, PSYCHOPHARMACOLOGY, V106, P359, DOI 10.1007/BF02245418; Ehrlich I, 2009, NEURON, V62, P757, DOI 10.1016/j.neuron.2009.05.026; Fernandes C, 1996, PHARMACOL BIOCHEM BE, V54, P31, DOI 10.1016/0091-3057(95)02171-X; Finn DA, 2005, PSYCHOPHARMACOLOGY, V178, P471, DOI 10.1007/s00213-004-2039-8; Fullgrabe MW, 2007, PHARMACOL BIOCHEM BE, V86, P320, DOI 10.1016/j.pbb.2006.10.004; Gilpin NW, 2008, ALCOHOL CLIN EXP RES, V32, P1535, DOI 10.1111/j.1530-0277.2008.00745.x; Gilpin NW, 2011, BIOL PSYCHIAT, V69, P1091, DOI 10.1016/j.biopsych.2011.02.004; Gilpin Nicholas W, 2008, Curr Protoc Neurosci, VChapter 9, DOI 10.1002/0471142301.ns0929s44; Gilpin NW, 2009, ALCOHOL CLIN EXP RES, V33, P2113, DOI 10.1111/j.1530-0277.2009.01051.x; Gilpin NW, 2011, NEUROSCI BIOBEHAV RE; Grant BF, 1998, J SUBST ABUSE, V10, P163, DOI 10.1016/S0899-3289(99)80131-X; Grant BF, 1998, ALCOHOL HEALTH RES W, V22, P144; Grant BF, 1997, J SUBST ABUSE, V9, P103, DOI 10.1016/S0899-3289(97)90009-2; Hill KG, 2000, ALCOHOL CLIN EXP RES, V24, P892, DOI 10.1111/j.1530-0277.2000.tb02071.x; Huang MM, 2010, J PHARMACOL EXP THER, V332, P298, DOI 10.1124/jpet.109.159186; Hwang BH, 2004, BRAIN RES, V1026, P143, DOI 10.1016/j.brainres.2004.08.042; KING JC, 1987, PEPTIDES, V8, P721, DOI 10.1016/0196-9781(87)90049-0; Koob GF, 2008, NEURON, V59, P11, DOI 10.1016/j.neuron.2008.06.012; Lorang E, 1995, J NEUROSCI, V15, P5439; Lowery EG, 2010, NEUROPSYCHOPHARMACOL, V35, P1241, DOI 10.1038/npp.2009.209; MENZAGHI F, 1994, J PHARMACOL EXP THER, V269, P564; Miller JW, 2007, PEDIATRICS, V119, P76, DOI 10.1542/peds.2006-1517; Moreau JL, 1997, NEUROREPORT, V8, P1697, DOI 10.1097/00001756-199705060-00027; Mutschler NH, 1998, PSYCHOPHARMACOLOGY, V135, P161, DOI 10.1007/s002130050497; NIAAA, 2004, NIAAA COUNC APPR DEF; O'Dell LE, 2004, ALCOHOL CLIN EXP RES, V28, P1676, DOI 10.1097/01.ALC.0000145781.11923.4E; Olive MF, 2002, PHARMACOL BIOCHEM BE, V72, P213, DOI 10.1016/S0091-3057(01)00748-1; Overstreet DH, 2004, PHARMACOL BIOCHEM BE, V77, P405, DOI 10.1016/j.pbb.2003.11.010; Pape HC, 2010, PHYSIOL REV, V90, P419, DOI 10.1152/physrev.00037.2009; Paxinos G., 2004, RAT BRAIN STEREOTAXI; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Pitkanen A, 2000, ANN NY ACAD SCI, V911, P369; Pitts MW, 2009, J NEUROSCI, V29, P7379, DOI 10.1523/JNEUROSCI.0740-09.2009; Richardson HN, 2008, EUR J NEUROSCI, V28, P1641, DOI 10.1111/j.1460-9568.2008.06455.x; Richardson HN, 2008, PHARMACOL BIOCHEM BE, V88, P497, DOI 10.1016/j.pbb.2007.10.008; Richardson HN, 1999, BRAIN RES, V817, P232, DOI 10.1016/S0006-8993(98)01255-4; Richardson HN, 2006, ENDOCRINOLOGY, V147, P2506, DOI 10.1210/en.2005-1054; Roberto M, 2010, BIOL PSYCHIAT, V67, P831, DOI 10.1016/j.biopsych.2009.11.007; Roberts AJ, 2000, NEUROPSYCHOPHARMACOL, V22, P581, DOI 10.1016/S0893-133X(99)00167-0; Rodd ZA, 2003, NEUROPSYCHOPHARMACOL, V28, P1614, DOI 10.1038/sj.npp.1300214; Rodd-Henricks ZA, 2000, ALCOHOL CLIN EXP RES, V24, P8, DOI 10.1111/j.1530-0277.2000.tb04546.x; RONCHI E, 1992, NEUROENDOCRINOLOGY, V55, P134, DOI 10.1159/000126108; RUBIN BS, 1994, ENDOCRINOLOGY, V134, P467, DOI 10.1210/en.134.1.467; Russell VA, 2011, CURR PROTOC NEUROSCI, DOI DOI 10.1002/0471142301.NS0935S54; Schramm-Sapyta NL, 2008, ALCOHOL CLIN EXP RES, V32, P754, DOI 10.1111/j.1530-0277.2008.00631.x; Schulenberg, 2007, MONITORING FUTURE NA; SCHULTEIS G, 1995, P NATL ACAD SCI USA, V92, P5880, DOI 10.1073/pnas.92.13.5880; SHIMADA S, 1989, NEUROSCIENCE, V30, P377, DOI 10.1016/0306-4522(89)90259-5; Siegmund S, 2005, ALCOHOL CLIN EXP RES, V29, P1139, DOI 10.1097/01.ALC.0000171928.40418.46; SINCLAIR JD, 1968, Q J STUD ALCOHOL, V29, P863; Sisk CL, 2005, FRONT NEUROENDOCRIN, V26, P163, DOI 10.1016/j.yfrne.2005.10.003; Smith RF, 2003, NEUROTOXICOL TERATOL, V25, P291, DOI 10.1016/S0892-0362(02)00349-5; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Strong MN, 2010, HORM BEHAV, V58, P82, DOI 10.1016/j.yhbeh.2009.10.008; Tambour S, 2008, ALCOHOL CLIN EXP RES, V32, P2100, DOI 10.1111/j.1530-0277.2008.00798.x; Treutlein J, 2006, MOL PSYCHIATR, V11, P594, DOI 10.1038/sj.mp.4001813; Truxell EM, 2007, ALCOHOL CLIN EXP RES, V31, P755, DOI 10.1111/j.1530-0277.2007.00358.x; Valdez GR, 2002, ALCOHOL CLIN EXP RES, V26, P1494, DOI 10.1097/01.ALC.0000033120.51856.F0; Valdez GR, 2003, ALCOHOL, V29, P55, DOI 10.1016/S0741-8329(03)00020-X; Vazquez DM, 2006, BRAIN RES, V1121, P83, DOI 10.1016/j.brainres.2006.08.104; VEENING JG, 1984, BRAIN RES, V303, P337, DOI 10.1016/0006-8993(84)91220-4; Vendruscolo LE, 2010, NEUROPHARMACOLOGY, V59, P388, DOI 10.1016/j.neuropharm.2010.05.015; Walker BM, 2007, ALCOHOL CLIN EXP RES, V31, P11, DOI 10.1111/j.1530-0277.2006.00259.x; Wills TA, 2010, ALCOHOL CLIN EXP RES, V34, P1603, DOI 10.1111/j.1530-0277.2010.01245.x; Windle M, 2008, PEDIATRICS, V121, pS273, DOI 10.1542/peds.2007-2243C; Zeigler DW, 2005, PREV MED, V40, P23, DOI 10.1016/j.ypmed.2004.04.044; Zorrilla EP, 2001, PSYCHOPHARMACOLOGY, V158, P374, DOI 10.1007/s002130100773	81	105	107	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31466	10.1371/journal.pone.0031466	http://dx.doi.org/10.1371/journal.pone.0031466			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347484	Green Published, gold			2022-12-27	WOS:000302730100073
J	Hatano, K; Miyamoto, Y; Mori, M; Nimura, K; Nakai, Y; Nonomura, N; Kaneda, Y				Hatano, Koji; Miyamoto, Yasuhide; Mori, Masaki; Nimura, Keisuke; Nakai, Yasutomo; Nonomura, Norio; Kaneda, Yasufumi			Androgen-Regulated Transcriptional Control of Sialyltransferases in Prostate Cancer Cells	PLOS ONE			English	Article							GAL-BETA-1,3GALNAC ALPHA-2,3-SIALYLTRANSFERASE; KAPPA-B; ANTITUMOR EFFICACY; GENOMIC STRUCTURE; CPG ISLAND; GANGLIOSIDES; RECEPTOR; DNA; PROMOTER; GENE	The expression of gangliosides is often associated with cancer progression. Sialyltransferases have received much attention in terms of their relationship with cancer because they modulate the expression of gangliosides. We previously demonstrated that GD1a production was high in castration-resistant prostate cancer cell lines, PC3 and DU145, mainly due to their high expression of beta-galactoside alpha 2,3-sialyltransferase (ST3Gal) II (not ST3Gal I), and the expression of both ST3Gals was regulated by NF-kappa B, mainly by RelB. We herein demonstrate that GD1a was produced in abundance in cancerous tissue samples from human patients with hormone-sensitive prostate cancers as well as castration-resistant prostate cancers. The expression of ST3Gal II was constitutively activated in castration-resistant prostate cancer cell lines, PC3 and DU145, because of the hypomethylation of CpG island in its promoter. However, in androgen-depleted LNCap cells, a hormone-sensitive prostate cancer cell line, the expression of ST3Gal II was silenced because of the hypermethylation of the promoter region. The expression of ST3Gal II in LNCap cells increased with testosterone treatment because of the demethylation of the CpG sites. This testosterone-dependent ST3Gal II expression was suppressed by RelB siRNA, indicating that RelB activated ST3Gal II transcription in the testosterone-induced demethylated promoter. Therefore, in hormone-sensitive prostate cancers, the production of GD1a may be regulated by androgen. This is the first report indicating that the expression of a sialyltransferase is transcriptionally regulated by androgen-dependent demethylation of the CpG sites in its gene promoter.	[Hatano, Koji; Mori, Masaki; Nimura, Keisuke; Kaneda, Yasufumi] Osaka Univ, Grad Sch Med, Div Gene Therapy Sci, Osaka, Japan; [Hatano, Koji; Nakai, Yasutomo; Nonomura, Norio] Osaka Univ, Grad Sch Med, Dept Urol, Osaka, Japan; [Miyamoto, Yasuhide] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Immunol, Osaka, Japan	Osaka University; Osaka University; Osaka Medical Center for Cancer & Cardiovascular Diseases	Hatano, K (corresponding author), Osaka Univ, Grad Sch Med, Div Gene Therapy Sci, Osaka, Japan.	kaneday@gts.med.osaka-u.ac.jp	Nimura, Keisuke/AAE-9925-2020	Hatano, Koji/0000-0002-8409-5152; Mori, Masaki/0000-0001-7632-3875	National Institute of Biomedical Innovation [10-03]; Northern Osaka (Saito) Biomedical Knowledge-Based Cluster Creation Project	National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Northern Osaka (Saito) Biomedical Knowledge-Based Cluster Creation Project	This study was supported by the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (Project ID: 10-03) and by the Northern Osaka (Saito) Biomedical Knowledge-Based Cluster Creation Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birkle S, 2003, BIOCHIMIE, V85, P455, DOI 10.1016/S0300-9084(03)00006-3; Bollrath J, 2009, EMBO REP, V10, P1314, DOI 10.1038/embor.2009.243; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Castelo-Branco P, 2010, GENE THER, V17, P805, DOI 10.1038/gt.2010.20; Dall'Olio F, 2001, GLYCOCONJUGATE J, V18, P841, DOI 10.1023/A:1022288022969; Freytag SO, 2007, MOL THER, V15, P1042, DOI 10.1038/sj.mt.6300162; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P10231, DOI 10.1073/pnas.172380699; Hatano K, 2011, INT J CANCER, V129, P1838, DOI 10.1002/ijc.25860; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; HOUGHTON AN, 1985, P NATL ACAD SCI USA, V82, P1242, DOI 10.1073/pnas.82.4.1242; Kangaspeska S, 2008, NATURE, V452, P112, DOI 10.1038/nature06640; Kawaguchi Y, 2009, INT J CANCER, V124, P2478, DOI 10.1002/ijc.24234; Keller ET, 1996, J BIOL CHEM, V271, P26267, DOI 10.1074/jbc.271.42.26267; Kim MS, 2009, NATURE, V461, P1007, DOI 10.1038/nature08456; KOJIMA N, 1994, BIOCHEMISTRY-US, V33, P5772, DOI 10.1021/bi00185a014; Kono M, 1997, GLYCOBIOLOGY, V7, P469, DOI 10.1093/glycob/7.4.469; Korekane H, 2007, ANAL BIOCHEM, V364, P37, DOI 10.1016/j.ab.2007.01.034; Lang ZH, 2001, BIOCHEM BIOPH RES CO, V282, P1031, DOI 10.1006/bbrc.2001.4630; LEE YC, 1994, J BIOL CHEM, V269, P10028; Lessard L, 2005, BRIT J CANCER, V93, P1019, DOI 10.1038/sj.bjc.6602796; Li RX, 2001, J BIOL CHEM, V276, P42782, DOI 10.1074/jbc.M101481200; Li XO, 2010, J GENE MED, V12, P516, DOI 10.1002/jgm.1462; Liu YH, 2004, J BIOL CHEM, V279, P36481, DOI 10.1074/jbc.M402880200; Liu YH, 2006, CANCER RES, V66, P10408, DOI 10.1158/0008-5472.CAN-06-1572; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Nakayama M, 2003, AM J PATHOL, V163, P923, DOI 10.1016/S0002-9440(10)63452-9; Nelson WG, 2009, ENDOCRINOLOGY, V150, P3991, DOI 10.1210/en.2009-0573; Ng HH, 1999, NAT GENET, V23, P58, DOI 10.1038/12659; Ravindranath MH, 2005, INT J CANCER, V116, P368, DOI 10.1002/ijc.21023; Ravindranath MH, 2004, BIOCHEM BIOPH RES CO, V324, P154, DOI 10.1016/j.bbrc.2004.09.029; Ripple MO, 1999, JNCI-J NATL CANCER I, V91, P1227, DOI 10.1093/jnci/91.14.1227; Sedelaar JPM, 2009, PROSTATE, V69, P1724, DOI 10.1002/pros.21028; Sharma D, 2005, MOL ENDOCRINOL, V19, P1740, DOI 10.1210/me.2004-0011; Takashima S, 2008, BIOSCI BIOTECH BIOCH, V72, P1155, DOI 10.1271/bbb.80025; Taki T, 1997, CANCER RES, V57, P1882; Taniguchi A, 2003, BIOCHEM BIOPH RES CO, V300, P570, DOI 10.1016/S0006-291X(02)02899-1; Taniguchi A, 2001, GLYCOBIOLOGY, V11, P241, DOI 10.1093/glycob/11.3.241; Tsuji S, 1996, J BIOCHEM-TOKYO, V120, P1; Varki NM, 2007, LAB INVEST, V87, P851, DOI 10.1038/labinvest.3700656; Villar E, 2006, GLYCOCONJUGATE J, V23, P5, DOI 10.1007/s10719-006-5433-0; Wang QB, 2009, CELL, V138, P245, DOI 10.1016/j.cell.2009.04.056; Yamashita T, 1999, P NATL ACAD SCI USA, V96, P9142, DOI 10.1073/pnas.96.16.9142; Yegnasubramanian S, 2008, CANCER RES, V68, P8954, DOI 10.1158/0008-5472.CAN-07-6088; Yu AL, 2010, NEW ENGL J MED, V363, P1324, DOI 10.1056/NEJMoa0911123; Zhang SL, 1997, INT J CANCER, V73, P42, DOI 10.1002/(SICI)1097-0215(19970926)73:1<42::AID-IJC8>3.0.CO;2-1	47	29	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31234	10.1371/journal.pone.0031234	http://dx.doi.org/10.1371/journal.pone.0031234			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347453	Green Published, Green Submitted, gold			2022-12-27	WOS:000302730100056
J	Jayasooriya, S; Hislop, A; Peng, YC; Croom-carter, D; Jankey, Y; Bell, A; Dong, T; Rowland-Jones, S; Rickinson, A; Walther, M; Whittle, H				Jayasooriya, Shamanthi; Hislop, Andrew; Peng, Yanchun; Croom-carter, Debbie; Jankey, Ya; Bell, Andrew; Dong, Tao; Rowland-Jones, Sarah; Rickinson, Alan; Walther, Michael; Whittle, Hilton			Revisiting the Effect of Acute P. falciparum Malaria on Epstein-Barr Virus: Host Balance in the Setting of Reduced Malaria Endemicity	PLOS ONE			English	Article							T-CELL IMMUNITY; B-CELL; BURKITTS-LYMPHOMA; GAMBIAN CHILDREN; AFRICAN CHILDREN; IN-VIVO; DIFFERENTIATION; REACTIVATION; PARASITEMIA; PREVALENCE	Burkitt's lymphoma (BL), an EBV-associated tumour, occurs at high incidence in populations where malaria is holoendemic. Previous studies in one such population suggested that acute P. falciparum infection impairs EBV-specific T-cell surveillance, allowing expansion of EBV infected B-cells from which BL derives. We re-examined the situation in the same area, The Gambia, after a reduction in malaria endemicity. Cellular immune responses to EBV were measured in children with uncomplicated malaria before (day 0) and after treatment (day 28), comparing EBV genome loads in blood and EBV-specific CD8(+) T-cell numbers (assayed by MHC Class I tetramers and IFN gamma ELISPOTS) with those seen in age-and sex-matched healthy controls. No significant changes were seen in EBV genome loads, percentage of EBV-specific CD8(+) T-cells and IFN gamma producing T-cells in acute versus convalescent samples, nor any difference versus controls. Regression assays performed also no longer detected any impairment of EBV-specific T-cell surveillance. Acute uncomplicated malaria infection no longer alters EBV-specific immune responses in children in The Gambia. Given the recent decline in malaria incidence in that country, we hypothesise that gross disturbance of the EBV-host balance may be a specific effect of acute malaria only in children with a history of chronic/recurrent malaria challenge.	[Jayasooriya, Shamanthi; Jankey, Ya; Walther, Michael; Whittle, Hilton] MRC Labs, Fajara, Gambia; [Jayasooriya, Shamanthi; Hislop, Andrew; Croom-carter, Debbie; Bell, Andrew; Rickinson, Alan] Univ Birmingham, Sch Canc Studies, Birmingham, W Midlands, England; [Peng, Yanchun; Dong, Tao; Rowland-Jones, Sarah] Univ Oxford, Weatherall Inst Mol Med, Oxford, England; [Walther, Michael] NIAID, Lab Malaria Immunol & Vaccinol, NIH, Rockville, MD USA; [Whittle, Hilton] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England	MRC Laboratory Molecular Biology; University of Birmingham; University of Oxford; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of London; London School of Hygiene & Tropical Medicine	Jayasooriya, S (corresponding author), MRC Labs, Fajara, Gambia.	hcwhittle@yahoo.co.uk		Jayasooriya, Shamanthi/0000-0002-1147-5744; Bell, Andrew/0000-0001-9520-4417; Dong, Tao/0000-0003-3545-3758	Medical Research Council (MRC), Gambia; MRC; MRC [MC_U190092703, G1001046, G0600520] Funding Source: UKRI; Medical Research Council [G0600520, G1001046, MC_U190092703] Funding Source: researchfish	Medical Research Council (MRC), Gambia; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the Medical Research Council (MRC), Gambia and Dr S Jayasooriya was a recipient of an MRC studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLSOPP CEM, 1992, AM J HUM GENET, V50, P411; Babcock GJ, 2000, IMMUNITY, V13, P497, DOI 10.1016/S1074-7613(00)00049-2; Bunce M., 1995, TISSUE ANTIGENS, V46, P355; Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2; Ceesay SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012242; Corran PH, 2004, INFECT IMMUN, V72, P6185, DOI 10.1128/IAI.72.10.6185-6189.2004; Donati D, 2006, J INFECT DIS, V193, P971, DOI 10.1086/500839; Finney OC, 2009, EUR J IMMUNOL, V39, P1288, DOI 10.1002/eji.200839112; Gudgeon NH, 2005, J VIROL, V79, P5477, DOI 10.1128/JVI.79.9.5477-5488.2005; Jia JY, 2003, VIROLOGY, V306, P236, DOI 10.1016/S0042-6822(02)00027-2; Lalvani A, 1997, J EXP MED, V186, P859, DOI 10.1084/jem.186.6.859; LISSE IM, 1994, T ROY SOC TROP MED H, V88, P709, DOI 10.1016/0035-9203(94)90242-9; Mackenzie G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010568; Miles DJC, 2007, J VIROL, V81, P5766, DOI 10.1128/JVI.00052-07; Miyashita EM, 1997, J VIROL, V71, P4882, DOI 10.1128/JVI.71.7.4882-4891.1997; Moormann AM, 2005, J INFECT DIS, V191, P1233, DOI 10.1086/428910; Moormann AM, 2007, J INFECT DIS, V195, P799, DOI 10.1086/511984; MOSS DJ, 1983, INT J CANCER, V31, P727, DOI 10.1002/ijc.2910310609; Njie R, 2009, J INFECT DIS, V199, P31, DOI 10.1086/594373; Nogaro SI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025582; Obaro S, 2011, LANCET, V378, P1281, DOI 10.1016/S0140-6736(11)61146-X; Rasti N, 2005, SCAND J IMMUNOL, V61, P461, DOI 10.1111/j.1365-3083.2005.01589.x; Rezk SA, 2007, HUM PATHOL, V38, P1293, DOI 10.1016/j.humpath.2007.05.020; Rickinson A, 2002, VIRUS RES, V82, P109; Rochford R, 2005, NAT REV MICROBIOL, V3, P182, DOI 10.1038/nrmicro1089; Satoguina J, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-274; Sauce D, 2007, AIDS, V21, P2005, DOI 10.1097/QAD.0b013e3282eee548; Shah KM, 2009, CLIN MICROBIOL INFEC, V15, P982, DOI 10.1111/j.1469-0691.2009.03033.x; Shannon-Lowe CD, 2006, P NATL ACAD SCI USA, V103, P7065, DOI 10.1073/pnas.0510512103; Snow RW, 2010, LANCET, V376, P137, DOI 10.1016/S0140-6736(10)60577-6; Speck SH, 1997, TRENDS MICROBIOL, V5, P399, DOI 10.1016/S0966-842X(97)01129-3; THOMSON MC, 1994, T ROY SOC TROP MED H, V88, P638, DOI 10.1016/0035-9203(94)90204-6; Walther M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000364; WHITTLE HC, 1984, NATURE, V312, P449, DOI 10.1038/312449a0; WHITTLE HC, 1990, CLIN EXP IMMUNOL, V80, P213, DOI 10.1111/j.1365-2249.1990.tb05236.x; Yone CLRP, 2006, T ROY SOC TROP MED H, V100, P669, DOI 10.1016/j.trstmh.2005.08.009	36	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31142	10.1371/journal.pone.0031142	http://dx.doi.org/10.1371/journal.pone.0031142			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347443	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000302730100046
J	Yu, XZ; Machesky, LM				Yu, Xinzi; Machesky, Laura M.			Cells Assemble Invadopodia-Like Structures and Invade into Matrigel in a Matrix Metalloprotease Dependent Manner in the Circular Invasion Assay	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; TUMOR-CELLS; N-WASP; PERICELLULAR PROTEOLYSIS; FOCAL ADHESIONS; MIGRATION; MT1-MMP; DEGRADATION; DIVERSITY; PODOSOMES	The ability of tumor cells to invade is one of the hallmarks of the metastatic phenotype. To elucidate the mechanisms by which tumor cells acquire an invasive phenotype, in vitro assays have been developed that mimic the process of cancer cell invasion through basement membrane or in the stroma. We have extended the characterization of the circular invasion assay and found that it provides a simple and amenable system to study cell invasion in matrix in an environment that closely mimics 3D invasion. Furthermore, it allows detailed microscopic analysis of both live and fixed cells during the invasion process. We find that cells invade in a protease dependent manner in this assay and that they assemble focal adhesions and invadopodia that resemble structures visualized in 3D embedded cells. We propose that this is a useful assay for routine and medium throughput analysis of invasion of cancer cells in vitro and the study of cells migrating in a 3D environment.	[Yu, Xinzi; Machesky, Laura M.] Univ Glasgow, Beatson Inst Canc Res, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland	Beatson Institute; University of Glasgow	Yu, XZ (corresponding author), Univ Glasgow, Beatson Inst Canc Res, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland.	l.machesky@beatson.gla.ac.uk	Machesky, Laura/Z-4554-2019	Machesky, Laura/0000-0002-7592-9856	Cancer Research UK; Association for International Research [11-0119]; Medical Research Council UK [G117/569]; Cancer Research UK [15673] Funding Source: researchfish; Medical Research Council [G117/569] Funding Source: researchfish; Worldwide Cancer Research [11-0119] Funding Source: researchfish; MRC [G117/569] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Association for International Research; Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Worldwide Cancer Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank Cancer Research UK for core funding to LMM and the Association for International Research for funding XY via a project grant to LMM (11-0119). This work was also supported by Medical Research Council UK G117/569. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbolina MV, 2008, SEMIN CELL DEV BIOL, V19, P24, DOI 10.1016/j.semcdb.2007.06.008; Benesch S, 2005, J CELL SCI, V118, P3103, DOI 10.1242/jcs.02444; Benesch S, 2002, J BIOL CHEM, V277, P37771, DOI 10.1074/jbc.M204145200; Bershadsky AD, 2006, EUR J CELL BIOL, V85, P165, DOI 10.1016/j.ejcb.2005.11.001; Bravo-Cordero JJ, 2007, EMBO J, V26, P1499, DOI 10.1038/sj.emboj.7601606; Buccione R, 2004, NAT REV MOL CELL BIO, V5, P647, DOI 10.1038/nrm1436; Buccione R, 2009, CANCER METAST REV, V28, P137, DOI 10.1007/s10555-008-9176-1; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; Caldieri G, 2009, INT REV CEL MOL BIO, V275, P1, DOI 10.1016/S1937-6448(09)75001-4; Caswell PT, 2007, DEV CELL, V13, P496, DOI 10.1016/j.devcel.2007.08.012; CHEN WT, 1989, J EXP ZOOL, V251, P167, DOI 10.1002/jez.1402510206; Clark ES, 2008, EUR J CELL BIOL, V87, P581, DOI 10.1016/j.ejcb.2008.01.008; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Fisher KE, 2009, J CELL SCI, V122, P4558, DOI 10.1242/jcs.050724; Fraley SI, 2010, NAT CELL BIOL, V12, P598, DOI 10.1038/ncb2062; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Friedl P, 2009, CANCER METAST REV, V28, P129, DOI 10.1007/s10555-008-9174-3; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; HENNIGAN RF, 1994, ONCOGENE, V9, P3591; Hotary K, 2006, GENE DEV, V20, P2673, DOI 10.1101/gad.1451806; Kam Y, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-198; KLEINMAN HK, 1982, BIOCHEMISTRY-US, V21, P6188, DOI 10.1021/bi00267a025; Kleinman HK, 2001, INVASION ASSAYS CURR; Kubow Kristopher E, 2011, Nat Cell Biol, V13, P3, DOI 10.1038/ncb0111-3; Li A, 2010, CURR BIOL, V20, P339, DOI 10.1016/j.cub.2009.12.035; Linder S, 2007, TRENDS CELL BIOL, V17, P107, DOI 10.1016/j.tcb.2007.01.002; Lizarraga F, 2009, CANCER RES, V69, P2792, DOI 10.1158/0008-5472.CAN-08-3709; Marrero-Diaz R, 2009, CELL MOTIL CYTOSKEL, V66, P48, DOI 10.1002/cm.20325; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Poincloux R, 2009, J CELL SCI, V122, P3015, DOI 10.1242/jcs.034561; Sabeh F, 2004, J CELL BIOL, V167, P769, DOI 10.1083/jcb.200408028; Scott RW, 2010, J CELL BIOL, V191, P169, DOI 10.1083/jcb.201002041; Taunton J, 2000, J CELL BIOL, V148, P519, DOI 10.1083/jcb.148.3.519; Ueda J, 2003, ONCOGENE, V22, P8716, DOI 10.1038/sj.onc.1206962; Van Goethem E, 2010, J IMMUNOL, V184, P1049, DOI 10.4049/jimmunol.0902223; Weaver AM, 2006, CLIN EXP METASTAS, V23, P97, DOI 10.1007/s10585-006-9014-1; Wolf K, 2007, NAT CELL BIOL, V9, P893, DOI 10.1038/ncb1616; Wolf K, 2009, CLIN EXP METASTAS, V26, P289, DOI 10.1007/s10585-008-9190-2; Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103	39	75	76	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e30605	10.1371/journal.pone.0030605	http://dx.doi.org/10.1371/journal.pone.0030605			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347388	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000302730100017
J	Thouet, J; Quinet, M; Lutts, S; Kinet, JM; Perilleux, C				Thouet, Johanna; Quinet, Muriel; Lutts, Stanley; Kinet, Jean-Marie; Perilleux, Claire			Repression of Floral Meristem Fate Is Crucial in Shaping Tomato Inflorescence	PLOS ONE			English	Article							FLOWERING-TIME; REGULATE GROWTH; IDENTITY; TRANSITION; JOINTLESS; SIGNALS; GENES; LEAFY; FALSIFLORA; ACTIVATION	Tomato is an important crop and hence there is a great interest in understanding the genetic basis of its flowering. Several genes have been identified by mutations and we constructed a set of novel double mutants to understand how these genes interact to shape the inflorescence. It was previously suggested that the branching of the tomato inflorescence depends on the gradual transition from inflorescence meristem (IM) to flower meristem (FM): the extension of this time window allows IM to branch, as seen in the compound inflorescence (s) and falsiflora (fa) mutants that are impaired in FM maturation. We report here that JOINTLESS (J), which encodes a MADS-box protein of the same clade than SHORT VEGETATIVE PHASE (SVP) and AGAMOUS LIKE 24 (AGL24) in Arabidopsis, interferes with this timing and delays FM maturation, therefore promoting IM fate. This was inferred from the fact that j mutation suppresses the high branching inflorescence phenotype of s and fa mutants and was further supported by the expression pattern of J, which is expressed more strongly in IM than in FM. Most interestingly, FA - the orthologue of the Arabidopsis LEAFY (LFY) gene - shows the complementary expression pattern and is more active in FM than in IM. Loss of J function causes premature termination of flower formation in the inflorescence and its reversion to a vegetative program. This phenotype is enhanced in the absence of systemic florigenic protein, encoded by the SINGLE FLOWER TRUSS (SFT) gene, the tomato orthologue of FLOWERING LOCUS T (FT). These results suggest that the formation of an inflorescence in tomato requires the interaction of J and a target of SFT in the meristem, for repressing FA activity and FM fate in the IM.	[Thouet, Johanna; Perilleux, Claire] Univ Liege, Dept Life Sci, Lab Plant Physiol, Liege, Belgium; [Quinet, Muriel; Lutts, Stanley; Kinet, Jean-Marie] Catholic Univ Louvain, Earth & Life Inst, Grp Rech & Physiol Vegetale, B-1348 Louvain, Belgium	University of Liege; Universite Catholique Louvain	Thouet, J (corresponding author), Univ Liege, Dept Life Sci, Lab Plant Physiol, Liege, Belgium.	cperilleux@ulg.ac.be		Quinet, Muriel/0000-0001-5485-6582; Perilleux, Claire/0000-0001-7653-2431	Fonds pour la Recherche Fondamentale et Collective (FRFC) [2.4534.05]; Fonds pour la Recherche dans l'Industrie et l'Agriculture (FRIA); Fonds National de la Recherche Scientifique (FNRS)	Fonds pour la Recherche Fondamentale et Collective (FRFC)(Fonds de la Recherche Scientifique - FNRS); Fonds pour la Recherche dans l'Industrie et l'Agriculture (FRIA)(Fonds de la Recherche Scientifique - FNRS); Fonds National de la Recherche Scientifique (FNRS)(Fonds de la Recherche Scientifique - FNRS)	This research was funded by the Fonds pour la Recherche Fondamentale et Collective (FRFC, grant n<SUP>o</SUP> 2.4534.05). JT is grateful to the Fonds pour la Recherche dans l'Industrie et l'Agriculture (FRIA) for the award of a Ph.D fellowship. MQ is grateful to the Fonds National de la Recherche Scientifique (FNRS) for her Postdoctoral Researcher grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen KD, 1996, PLANTA, V200, P254, DOI 10.1007/BF00208316; Amasino R, 2010, PLANT J, V61, P1001, DOI 10.1111/j.1365-313X.2010.04148.x; Butler L, 1936, J HERED, V27, P25; Castel R, 2010, J EXP BOT, V61, P2235, DOI 10.1093/jxb/erq061; Fornara F, 2010, CELL, V141, DOI 10.1016/j.cell.2010.04.024; FULTON TM, 1995, PLANT MOL BIOL REP, V13, P207, DOI 10.1007/BF02670897; Hartmann U, 2000, PLANT J, V21, P351, DOI 10.1046/j.1365-313x.2000.00682.x; Hileman LC, 2006, MOL BIOL EVOL, V23, P2245, DOI 10.1093/molbev/msl095; HUALA E, 1992, PLANT CELL, V4, P901, DOI 10.1105/tpc.4.8.901; Irish VF, 2010, PLANT J, V61, P1014, DOI 10.1111/j.1365-313X.2009.04065.x; KINET JM, 1977, SCI HORTIC-AMSTERDAM, V6, P15, DOI 10.1016/0304-4238(77)90074-7; Krizek BA, 2005, NAT REV GENET, V6, P688, DOI 10.1038/nrg1675; Lee I, 1997, CURR BIOL, V7, P95, DOI 10.1016/S0960-9822(06)00053-4; Lee J, 2008, PLANT J, V55, P832, DOI 10.1111/j.1365-313X.2008.03552.x; Leseberg CH, 2008, J EXP BOT, V59, P2253, DOI 10.1093/jxb/ern094; Lifschitz E, 2006, P NATL ACAD SCI USA, V103, P6398, DOI 10.1073/pnas.0601620103; Lifschitz E, 2006, J EXP BOT, V57, P3405, DOI 10.1093/jxb/erl106; Lippman ZB, 2008, PLOS BIOL, V6, P2424, DOI 10.1371/journal.pbio.0060288; Liu C, 2008, DEVELOPMENT, V135, P1481, DOI 10.1242/dev.020255; Liu C, 2007, DEVELOPMENT, V134, P1901, DOI 10.1242/dev.003103; Liu C, 2009, DEV CELL, V16, P711, DOI 10.1016/j.devcel.2009.03.011; Lozano R, 2009, INT J DEV BIOL, V53, P1635, DOI 10.1387/ijdb.072440rl; Mao L, 2000, NATURE, V406, P910, DOI 10.1038/35022611; Mckim S, 2010, CURR OPIN GENET DEV, V20, P448, DOI 10.1016/j.gde.2010.04.007; Molinero-Rosales N, 2004, PLANTA, V218, P427, DOI 10.1007/s00425-003-1109-1; Molinero-Rosales N, 1999, PLANT J, V20, P685, DOI 10.1046/j.1365-313X.1999.00641.x; Parcy F, 1998, NATURE, V395, P561, DOI 10.1038/26903; PHILOUZE J, 1978, ANN AMELIOR PLANT, V28, P431; Prusinkiewicz P, 2007, SCIENCE, V316, P1452, DOI 10.1126/science.1140429; Quinet M, 2006, J EXP BOT, V57, P1381, DOI 10.1093/jxb/erj117; Quinet M., 2007, INT J PLANT DEV BIOL, V1, P64, DOI DOI 10.1093/JXB/ERJ117; Ratcliffe OJ, 1999, DEVELOPMENT, V126, P1109; RuizGarcia L, 1997, PLANT CELL, V9, P1921, DOI 10.1105/tpc.9.11.1921; Samach A, 2007, PLANT BIOTECHNOL-NAR, V24, P71, DOI 10.5511/plantbiotechnology.24.71; Schmitz G, 2002, P NATL ACAD SCI USA, V99, P1064, DOI 10.1073/pnas.022516199; Shalit A, 2009, P NATL ACAD SCI USA, V106, P8392, DOI 10.1073/pnas.0810810106; Szymkowiak EJ, 2006, PLANTA, V223, P646, DOI 10.1007/s00425-005-0115-x; Thouet J, 2008, PLANT PHYSIOL, V148, P61, DOI 10.1104/pp.108.124164; Turck F, 2008, ANNU REV PLANT BIOL, V59, P573, DOI 10.1146/annurev.arplant.59.032607.092755; Wagner D, 1999, SCIENCE, V285, P582, DOI 10.1126/science.285.5427.582; Yu H, 2004, NAT GENET, V36, P157, DOI 10.1038/ng1286	41	33	37	4	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2012	7	2							e31096	10.1371/journal.pone.0031096	http://dx.doi.org/10.1371/journal.pone.0031096			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917MF	22347436	Green Submitted, Green Published, gold			2022-12-27	WOS:000302180600029
J	Owen, CG; Nightingale, CM; Rudnicka, AR; van Sluijs, EMF; Ekelund, U; Cook, DG; Whincup, PH				Owen, Christopher G.; Nightingale, Claire M.; Rudnicka, Alicja R.; van Sluijs, Esther M. F.; Ekelund, Ulf; Cook, Derek G.; Whincup, Peter H.			Travel to School and Physical Activity Levels in 9-10 Year-Old UK Children of Different Ethnic Origin; Child Heart and Health Study in England (CHASE)	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; WALKING; YOUTH; ADOLESCENTS; INTERVENTIONS; OBESITY; TRENDS; SCHOOLCHILDREN; PERCEPTIONS; ADIPOSITY	Background: Travel to school may offer a convenient way to increase physical activity levels in childhood. We examined the association between method of travel to school and physical activity levels in urban multi-ethnic children. Methods and Findings: 2035 children (aged 9-10 years in 2006-7) provided data on their usual method of travel to school and wore an Actigraph-GT1M activity monitor during waking hours. Associations between method of travel and mean level of physical activity (counts per minute [CPM], steps, time spent in light, moderate or vigorous activity per day) were examined in models adjusted for confounding variables. 1393 children (69%) walked or cycled to school; 161 (8%) used public transport and 481 (24%) travelled by car. White European children were more likely to walk/cycle, black African Caribbeans to travel by public transport and South Asian children to travel by car. Children travelling by car spent less time in moderate to vigorous physical activity (-7 mins, 95% CI-9,-5), and had lower CPM (-32 CPM, 95% CI-44,-19) and steps per day (-813 steps, 95% CI,-1043,-582) than walkers/cyclists. Pupils travelling by public transport had similar activity levels to walkers/cyclists. Lower physical activity levels amongst car travellers' were especially marked at travelling times (school days between 8-9 am, 3-5 pm), but were also evident on weekdays at other times and at weekends; they did not differ by gender or ethnic group. Conclusion: Active travel to school is associated with higher levels of objectively measured physical activity, particularly during periods of travel but also at other times. If children travelling by car were to achieve physical activity levels (steps) similar to children using active travel, they would increase their physical activity levels by 9%. However, the population increase would be a modest 2%, because of the low proportion of car travellers in this urban population.	[Owen, Christopher G.; Nightingale, Claire M.; Rudnicka, Alicja R.; Cook, Derek G.; Whincup, Peter H.] Univ London, Div Populat Hlth Sci & Educ, London, England; [van Sluijs, Esther M. F.; Ekelund, Ulf] Addenbrookes Hosp, MRC Epidemiol Unit, Inst Metab Sci, Cambridge, England; [van Sluijs, Esther M. F.; Ekelund, Ulf] Addenbrookes Hosp, CEDAR, Inst Metab Sci, Cambridge, England	University of London; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Owen, CG (corresponding author), Univ London, Div Populat Hlth Sci & Educ, London, England.	cowen@sgul.ac.uk	Cook, Derek G/C-3271-2008; Ekelund, Ulf/AAE-8471-2019	Ekelund, Ulf/0000-0003-2115-9267; Rudnicka, Alicja R/0000-0003-0369-8574; Nightingale, Claire/0000-0002-4803-7617; Owen, Christopher/0000-0003-1135-5977; Nightingale, Claire/0000-0003-2408-757X; Whincup, Peter/0000-0002-5589-4107; van Sluijs, Esther/0000-0001-9141-9082; Cook, Derek/0000-0002-9723-5759	Wellcome Trust [068362/Z/02/Z]; British Heart Foundation [PG/06/003]; BUPA Foundation [TBF-S09-019]; National Prevention Research Initiative (NPRI); British Heart Foundation; Cancer Research UK; Department of Health; Diabetes UK; Economic and Social Research Council; Medical Research Council; Research and Development Office for the Northern Ireland Health and Social Services; Chief Scientist Office; Scottish Executive Health Department; Welsh Assembly Government; ESRC [ES/G007462/1] Funding Source: UKRI; MRC [MC_U106179473, MC_UP_1001/2, G0501295, MC_U106179474] Funding Source: UKRI; Economic and Social Research Council [ES/G007462/1] Funding Source: researchfish; Medical Research Council [MC_UP_1001/2, G0501295, MC_U106179473, MC_U106179474] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); British Heart Foundation(British Heart Foundation); BUPA Foundation; National Prevention Research Initiative (NPRI); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Department of Health; Diabetes UK(Diabetes UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Research and Development Office for the Northern Ireland Health and Social Services; Chief Scientist Office; Scottish Executive Health Department; Welsh Assembly Government; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from the Wellcome Trust (068362/Z/02/Z), the British Heart Foundation (PG/06/003), the BUPA Foundation (TBF-S09-019)', and by the National Prevention Research Initiative (NPRI). The Funding Partners for this NPRI award were: British Heart Foundation; Cancer Research UK; Department of Health; Diabetes UK; Economic and Social Research Council; Medical Research Council; Research and Development Office for the Northern Ireland Health and Social Services; Chief Scientist Office, Scottish Executive Health Department; and Welsh Assembly Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander LM, 2005, BRIT MED J, V331, P1061, DOI 10.1136/bmj.38567.382731.AE; [Anonymous], 2000, STANDARD OCCUPATIONA; Brown T, 2009, OBES REV, V10, P110, DOI 10.1111/j.1467-789X.2008.00515.x; Cooper AR, 2005, AM J PREV MED, V29, P179, DOI 10.1016/j.amepre.2005.05.009; Cooper AR, 2003, AM J PREV MED, V25, P273, DOI 10.1016/S0749-3797(03)00205-8; Cooper AR, 2006, MED SCI SPORT EXER, V38, P1724, DOI 10.1249/01.mss.0000229570.02037.1d; Cooper AR, 2010, AM J PREV MED, V38, P178, DOI 10.1016/j.amepre.2009.10.036; Davison K. K., 2008, Preventing Chronic Disease, V5, pA100; Department for Transport, 2009, NAT TRAV SURV 2008; Department of Education, 2011, POSTC DIST; Department of Health, 2004, LEAST 5 WEEK EV IMP; Department of Transport, 2001, ATT POT TAK ADD HOM; Dobbins M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007651; Ekelund U, 2003, OBES RES, V11, P793, DOI 10.1038/oby.2003.110; Ekelund U, 2006, PLOS MED, V3, P2449, DOI 10.1371/journal.pmed.0030488; Faulkner GEJ, 2009, PREV MED, V48, P3, DOI 10.1016/j.ypmed.2008.10.017; Giles-Corti B, 2007, BRIT MED J, V335, P677, DOI 10.1136/bmj.39345.679514.80; Greves HM, 2007, INT J BEHAV NUTR PHY, V4, DOI 10.1186/1479-5868-4-64; Hume C, 2009, AM J PREV MED, V36, P195, DOI 10.1016/j.amepre.2008.10.011; Jago R, 2004, PREV MED, V39, P157, DOI 10.1016/j.ypmed.2004.01.014; Leary SD, 2008, HYPERTENSION, V51, P92, DOI 10.1161/HYPERTENSIONAHA.107.099051; Mattocks C, 2007, INT J PEDIAT OBES, P1; McCambridge TM, 2006, PEDIATRICS, V117, P1834, DOI 10.1542/peds.2006-0472; McDonald NC, 2007, AM J PREV MED, V32, P509, DOI 10.1016/j.amepre.2007.02.022; Mckee R, 2007, J EPIDEMIOL COMMUN H, V61, P818, DOI 10.1136/jech.2006.048181; Mendoza JA, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-122; Metcalf B, 2004, BMJ-BRIT MED J, V329, P832, DOI 10.1136/bmj.38169.688102.F71; Ness AR, 2007, PLOS MED, V4, P476, DOI 10.1371/journal.pmed.0040097; Nightingale CM, 2011, INT J EPIDEMIOL, V40, P33, DOI 10.1093/ije/dyq180; Ortega FB, 2007, INT J BEHAV NUTR PHY, V4, DOI 10.1186/1479-5868-4-61; Owen CG, 2010, DIABETOLOGIA, V53, P1620, DOI 10.1007/s00125-010-1781-1; Owen CG, 2009, INT J EPIDEMIOL, V38, P1082, DOI 10.1093/ije/dyp176; Panter JR, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-34; Puyau MR, 2002, OBES RES, V10, P150, DOI 10.1038/oby.2002.24; Riddoch CJ, 2004, MED SCI SPORT EXER, V36, P86, DOI 10.1249/01.MSS.0000106174.43932.92; Rowland D, 2003, ARCH DIS CHILD, V88, P8, DOI 10.1136/adc.88.1.8; Saksvig BI, 2007, ARCH PEDIAT ADOL MED, V161, P153, DOI 10.1001/archpedi.161.2.153; Salmon J, 2005, AUST NZ J PUBL HEAL, V29, P337, DOI 10.1111/j.1467-842X.2005.tb00204.x; Salmon J, 2007, EPIDEMIOL REV, V29, P144, DOI 10.1093/epirev/mxm010; Sardinha LB, 2008, DIABETES CARE, V31, P569, DOI 10.2337/dc07-1286; Sirard JR, 2005, MED SCI SPORT EXER, V37, P2062, DOI 10.1249/01.mss.0000179102.17183.6b; Summerbell CD, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001871.pub4, 10.1002/14651858.CD001871.pub2]; Timperio A, 2004, PREV MED, V38, P39, DOI 10.1016/j.ypmed.2003.09.026; Trost SG, 1998, MED SCI SPORT EXER, V30, P629, DOI 10.1097/00005768-199804000-00023; Tudor-Locke C, 2001, SPORTS MED, V31, P309, DOI 10.2165/00007256-200131050-00001; van der Ploeg HP, 2008, PREV MED, V46, P60, DOI 10.1016/j.ypmed.2007.06.002; van Sluijs EMF, 2007, BMJ-BRIT MED J, V335, P703, DOI 10.1136/bmj.39320.843947.BE; van Sluijs EMF, 2009, PREV MED, V48, P519, DOI 10.1016/j.ypmed.2009.03.002; Wen LM, 2008, PREV MED, V47, P612, DOI 10.1016/j.ypmed.2008.09.002; Whincup PH, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000263; Wilkin TJ, 2006, INT J OBESITY, V30, P1050, DOI 10.1038/sj.ijo.0803331	51	53	53	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e30932	10.1371/journal.pone.0030932	http://dx.doi.org/10.1371/journal.pone.0030932			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LO	22319596	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000302178400021
J	Zhang, WY; Kong, GY; Zhang, JP; Wang, T; Ye, LH; Zhang, XD				Zhang, Weiying; Kong, Guangyao; Zhang, Junping; Wang, Tao; Ye, Lihong; Zhang, Xiaodong			MicroRNA-520b Inhibits Growth of Hepatoma Cells by Targeting MEKK2 and Cyclin D1	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; GENE-EXPRESSION; CANCER; ACTIVATION; KINASE; TUMORIGENICITY; METASTASIS; APOPTOSIS; RECEPTOR; PTEN	Growing evidence indicates that the deregulation of microRNAs (miRNAs) contributes to the tumorigenesis. We previously revealed that microRNA-520b (miR-520b) was involved in the complement attack and migration of breast cancer cells. In this report, we show that miR-520b is an important miRNA in the development of hepatocellular carcinoma (HCC). Our data showed that the expression levels of miR-520b were significantly reduced in clinical HCC tissues and hepatoma cell lines. We observed that the introduction of miR-520b dramatically suppressed the growth of hepatoma cells by colony formation assays, 5-ethynyl-2-deoxyuridine (EdU) incorporation assays and 3-(4,5- dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assays. Moreover, ectopic expression of miR-520b was able to inhibit the growth of hepatoma cells in nude mice. Further studies revealed that the mitogen-activated protein kinase kinase kinase 2 (MEKK2) and cyclin D1 were two of direct target genes of miR-520b. Silencing of MEKK2 or cyclin D1 was able to inhibit the growth of hepatoma cells in vitro and in vivo, which is consistent with the effect of miR-520b overexpression on the growth of hepatoma cells. In addition, miR-520b significantly decreased the phosphorylation levels of c-Jun N-terminal kinase (p-JNK, a downstream effector of MEKK2) or retinoblastoma (p-Rb, a downstream effector of cyclin D1). In conclusion, miR-520b is able to inhibit the growth of hepatoma cells by targeting MEKK2 or cyclin D1 in vitro and in vivo. Our findings provide new insights into the role of miR-520b in the development of HCC, and implicate the potential application of miR-520b in cancer therapy.	[Zhang, Weiying; Kong, Guangyao; Zhang, Junping; Wang, Tao; Zhang, Xiaodong] Nankai Univ, Dept Canc Res, Key Lab Mol Microbiol & Technol, Minist Educ,Inst Mol Biol,Coll Life Sci, Tianjin 300071, Peoples R China; [Ye, Lihong] Nankai Univ, Dept Biochem, Coll Life Sci, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China	Nankai University; Nankai University	Zhang, WY (corresponding author), Nankai Univ, Dept Canc Res, Key Lab Mol Microbiol & Technol, Minist Educ,Inst Mol Biol,Coll Life Sci, Tianjin 300071, Peoples R China.	yelihong@nankai.edu.cn; zhangxd@nankai.edu.cn	Kong, Guangyao/L-2162-2013		National Basic Research Program of China (973 Program) [2009CB521702, 2011CB512113]; National Natural Science Foundation of China [81071624, 81000870, 81071623]; Fundamental Research Funding for the Central Universities [65010671]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funding for the Central Universities	This study was supported by grants from the National Basic Research Program of China (973 Program, No. 2009CB521702, 2011CB512113), the National Natural Science Foundation of China (81071624, 81000870, 81071623) and the Fundamental Research Funding for the Central Universities (65010671). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal P, 2010, CANCER CELL, V18, P329, DOI 10.1016/j.ccr.2010.08.012; Bai SM, 2009, J BIOL CHEM, V284, P32015, DOI 10.1074/jbc.M109.016774; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Budhu A, 2008, HEPATOLOGY, V47, P897, DOI 10.1002/hep.22160; Cazares LH, 2009, CLIN CANCER RES, V15, P5541, DOI 10.1158/1078-0432.CCR-08-2892; Chayama K, 2001, P NATL ACAD SCI USA, V98, P4599, DOI 10.1073/pnas.081021898; Cui W, 2010, CANCER BIOL THER, V10, P232; Dong QC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010147; Garofalo M, 2009, CANCER CELL, V16, P498, DOI 10.1016/j.ccr.2009.10.014; GATT ME, 2010, BLOOD, V117, P7188; Harbour JW, 2000, NAT CELL BIOL, V2, pE65, DOI 10.1038/35008695; Hayakawa Y, 2011, P NATL ACAD SCI USA, V108, P780, DOI 10.1073/pnas.1011418108; Hu N, 2011, J BIOL CHEM, V286, P13714, DOI 10.1074/jbc.M110.204131; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lundberg AS, 1998, MOL CELL BIOL, V18, P753, DOI 10.1128/MCB.18.2.753; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Noonan EJ, 2010, ONCOTARGET, V1, P349, DOI 10.18632/oncotarget.167; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Schaefer BC, 1999, IMMUNITY, V11, P411, DOI 10.1016/S1074-7613(00)80116-8; Shan CL, 2010, CELL RES, V20, P563, DOI 10.1038/cr.2010.49; Su B, 2001, J BIOL CHEM, V276, P14784, DOI 10.1074/jbc.M010134200; Sun WY, 2003, MOL CELL BIOL, V23, P2298, DOI 10.1128/MCB.23.7.2298-2308.2003; Tsai WC, 2009, HEPATOLOGY, V49, P1571, DOI 10.1002/hep.22806; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Winsauer G, 2008, CELL SIGNAL, V20, P2107, DOI 10.1016/j.cellsig.2008.08.004; Xu T, 2009, HEPATOLOGY, V50, P113, DOI 10.1002/hep.22919	28	104	106	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e31450	10.1371/journal.pone.0031450	http://dx.doi.org/10.1371/journal.pone.0031450			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LO	22319632	Green Published, gold, Green Submitted			2022-12-27	WOS:000302178400043
J	Zimmer, SM; Welke, KW; Schneider, JM				Zimmer, Stefanie M.; Welke, Klaas W.; Schneider, Jutta M.			Determinants of Natural Mating Success in the Cannibalistic Orb-Web Spider Argiope bruennichi	PLOS ONE			English	Article							SEXUAL SELECTION; DEMOGRAPHIC VARIATION; WATER STRIDERS; WEAVING SPIDER; MALE SACRIFICE; MALE SIZE; EVOLUTION; CONFLICT; WILD; BEHAVIOR	Monogynous mating systems (low male mating rates) occur in various taxa and have evolved several times independently in spiders. Monogyny is associated with remarkable male mating strategies and predicted to evolve under a male-biased sex ratio. While male reproductive strategies are well documented and male mating rates are easy to quantify, especially in sexually cannibalistic species, female reproductive strategies, the optimal female mating rate, and the factors that affect the evolution of female mating rates are still unclear. In this study, we examined natural female mating rates and tested the assumption of a male-biased sex ratio and female polyandry in a natural population of Argiope bruennichi in which we controlled female mating status prior to observations. We predicted variation in female mating frequencies as a result of spatial and temporal heterogeneity in the distribution of mature females and males. Females had a low average mating rate of 1.3 and the majority copulated only once. Polyandry did not entirely result from a male-biased sex-ratio but closely matched the rate of male bigamy. Male activity and the probability of polyandry correlated with factors affecting pheromone presence such as virgin females' density. We conclude that a strong sex ratio bias and high female mating rates are not necessary components of monogynous mating systems as long as males protect their paternity effectively and certain frequencies of bigyny stabilise the mating system.	[Zimmer, Stefanie M.; Welke, Klaas W.; Schneider, Jutta M.] Univ Hamburg, Zool Inst & Museum, Biozentrum Grindel, Hamburg, Germany	University of Hamburg	Zimmer, SM (corresponding author), Univ Hamburg, Zool Inst & Museum, Biozentrum Grindel, Hamburg, Germany.	zimmer.steffi@googlemail.com	Schneider, Jutta M/G-3727-2010	Schneider, Jutta M/0000-0001-8523-7354	DFG [SCHN 561/8-1]	DFG(German Research Foundation (DFG))	The study was supported by a DFG grant (SCHN 561/8-1) to J.M.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade MCB, 1996, SCIENCE, V271, P70, DOI 10.1126/science.271.5245.70; Arnqvist G, 2000, ANIM BEHAV, V60, P145, DOI 10.1006/anbe.2000.1446; Arnqvist Goran, 1997, P146, DOI 10.1017/CBO9780511721946.009; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; Chinta SP, 2010, ANGEW CHEM INT EDIT, V49, P2033, DOI 10.1002/anie.200906311; Foellmer MW, 2005, OECOLOGIA, V142, P653, DOI 10.1007/s00442-004-1756-3; Fromhage L, 2005, EVOLUTION, V59, P1400; Fromhage L, 2008, J THEOR BIOL, V250, P524, DOI 10.1016/j.jtbi.2007.10.008; Gaskett AC, 2007, BIOL REV, V82, P26, DOI 10.1111/j.1469-185X.2006.00002.x; Griffith SC, 2002, MOL ECOL, V11, P2195, DOI 10.1046/j.1365-294X.2002.01613.x; GWYNNE DT, 1993, ECOLOGY, V74, P1406, DOI 10.2307/1940070; Haddrill PR, 2008, MOL ECOL, V17, P3189, DOI 10.1111/j.1365-294X.2008.03812.x; HALLIDAY T, 1987, ANIM BEHAV, V35, P939, DOI 10.1016/S0003-3472(87)80138-0; Higgins L, 2002, OIKOS, V99, P377, DOI 10.1034/j.1600-0706.2002.990220.x; Holland B, 1998, EVOLUTION, V52, P1, DOI 10.1111/j.1558-5646.1998.tb05132.x; Hosken DJ, 2006, CURR BIOL, V16, pR202, DOI 10.1016/j.cub.2006.02.026; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Jones AG, 2002, P ROY SOC B-BIOL SCI, V269, P2533, DOI 10.1098/rspb.2002.2177; Kasumovic MM, 2009, J EVOLUTION BIOL, V22, P324, DOI 10.1111/j.1420-9101.2008.01648.x; Kasumovic MM, 2008, EVOLUTION, V62, P2316, DOI 10.1111/j.1558-5646.2008.00446.x; Kasumovic MM, 2009, ECOLOGY, V90, P2287, DOI 10.1890/08-1540.1; Kasumovic MM, 2006, CURR BIOL, V16, pR242, DOI 10.1016/j.cub.2006.03.017; Kokko H, 2008, CURR BIOL, V18, pR121, DOI 10.1016/j.cub.2007.11.063; Maklakov AA, 2005, AM NAT, V165, pS38, DOI 10.1086/429351; Miller JA, 2007, EVOLUTION, V61, P1301, DOI 10.1111/j.1558-5646.2007.00115.x; Miyashita T, 1996, J ARACHNOL, V24, P9; Nessler SH, 2007, BEHAV ECOL, V18, P174, DOI 10.1093/beheco/arl074; Nessler SH, 2009, ETHOLOGY, V115, P633, DOI 10.1111/j.1439-0310.2009.01646.x; Reinhardt K, 2007, ECOL ENTOMOL, V32, P637, DOI 10.1111/j.1365-2311.2007.00923.x; Rodriguez-Munoz R, 2010, SCIENCE, V328, P1269, DOI 10.1126/science.1188102; Rowe L, 1996, BEHAV ECOL, V7, P474, DOI 10.1093/beheco/7.4.474; ROWE L, 1994, TRENDS ECOL EVOL, V9, P289, DOI 10.1016/0169-5347(94)90032-9; Schneider J, 2011, MATING BEHAV SEXUAL, P215; Schneider J, 2010, ANIMAL BEHAVIOUR: EVOLUTION AND MECHANISMS, P441, DOI 10.1007/978-3-642-02624-9_15; Schneider JM, 2009, P ROY SOC B-BIOL SCI, V276, P3105, DOI 10.1098/rspb.2009.0694; Schulte KF, 2010, ANIM BEHAV, V80, P699, DOI 10.1016/j.anbehav.2010.07.005; Segoli M, 2008, ETHOLOGY, V114, P279, DOI 10.1111/j.1439-0310.2007.01462.x; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; Wanker R, 2002, BIRD RES BREEDING; Zeh JA, 1996, P ROY SOC B-BIOL SCI, V263, P1711, DOI 10.1098/rspb.1996.0250	40	27	28	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e31389	10.1371/journal.pone.0031389	http://dx.doi.org/10.1371/journal.pone.0031389			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LO	22319628	gold, Green Published, Green Submitted			2022-12-27	WOS:000302178400040
J	Papagregoriou, G; Erguler, K; Dweep, H; Voskarides, K; Koupepidou, P; Athanasiou, Y; Pierides, A; Gretz, N; Felekkis, KN; Deltas, C				Papagregoriou, Gregory; Erguler, Kamil; Dweep, Harsh; Voskarides, Konstantinos; Koupepidou, Panayiota; Athanasiou, Yiannis; Pierides, Alkis; Gretz, Norbert; Felekkis, Kyriacos N.; Deltas, Constantinos			A miR-1207-5p Binding Site Polymorphism Abolishes Regulation of HBEGF and Is Associated with Disease Severity in CFHR5 Nephropathy	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; STAGE RENAL-DISEASE; SINGLE-NUCLEOTIDE POLYMORPHISM; VARIANT TRANSLOCATION; HB-EGF; MICRORNAS; MUTATIONS; GENE; IDENTIFICATION; PROLIFERATION	Heparin binding epidermal growth factor (HBEGF) is expressed in podocytes and was shown to play a role in glomerular physiology. MicroRNA binding sites on the 3'UTR of HBEGF were predicted using miRWalk algorithm and followed by DNA sequencing in 103 patients diagnosed with mild or severe glomerulopathy. A single nucleotide polymorphism, miRSNP C1936T (rs13385), was identified at the 3'UTR of HBEGF that corresponds to the second base of the hsa-miR-1207-5p seed region. When AB8/13 undifferentiated podocytes were transfected with miRNA mimics of hsa-miR-1207-5p, the HBEGF protein levels were reduced by about 50%. A DNA fragment containing the miRSNP allele-1936C was cloned into the pMIR-Report Luciferase vector and co-transfected with miRNA mimics of hsa-miR-1207-5p into AB8/13 podocytes. In agreement with western blot data, this resulted in reduced luciferase expression demonstrating the ability of hsa-miR-1207-5p to directly regulate HBEGF expression. On the contrary, in the presence of the miRSNP 1936T allele, this regulation was abolished. Collectively, these results demonstrate that variant 1936T of this miRSNP prevents hsa-miR-1207-5p from down-regulating HBEGF in podocytes. We hypothesized that this variant has a functional role as a genetic modifier. To this end, we showed that in a cohort of 78 patients diagnosed with CFHR5 nephropathy (also known as C3-glomerulopathy), inheritance of miRSNP 1936T allele was significantly increased in the group demonstrating progression to chronic renal failure on long follow-up. No similar association was detected in a cohort of patients with thin basement membrane nephropathy. This is the first report associating a miRSNP as genetic modifier to a monogenic renal disorder.	[Papagregoriou, Gregory; Erguler, Kamil; Voskarides, Konstantinos; Koupepidou, Panayiota; Deltas, Constantinos] Univ Cyprus, Mol Med Res Ctr, Nicosia, Cyprus; [Papagregoriou, Gregory; Erguler, Kamil; Voskarides, Konstantinos; Koupepidou, Panayiota; Deltas, Constantinos] Univ Cyprus, Dept Biol Sci, Lab Mol & Med Genet, Nicosia, Cyprus; [Dweep, Harsh; Gretz, Norbert] Heidelberg Univ, Med Res Ctr, D-6800 Mannheim, Germany; [Athanasiou, Yiannis] Nicosia Gen Hosp, Dept Nephrol, Nicosia, Cyprus; [Pierides, Alkis] Hippocrateon Hosp, Dept Nephrol, Nicosia, Cyprus; [Felekkis, Kyriacos N.] Univ Nicosia, Dept Life & Hlth Sci, Nicosia, Cyprus	University of Cyprus; University of Cyprus; Ruprecht Karls University Heidelberg; Hippocrateon Private Hospital; University of Nicosia	Papagregoriou, G (corresponding author), Univ Cyprus, Mol Med Res Ctr, Nicosia, Cyprus.	felekkis.k@unic.ac.cy; Deltas@ucy.ac.cy	Deltas, Constantinos/A-4936-2013; Erguler, Kamil/Y-5990-2019; Voskarides, Konstantinos/A-4669-2013; Erguler, Kamil/ABD-4636-2020; Deltas, Constantinos/J-9345-2013	Deltas, Constantinos/0000-0001-5549-9169; Erguler, Kamil/0000-0002-2674-592X; Voskarides, Konstantinos/0000-0002-3705-3451; Deltas, Constantinos/0000-0001-5549-9169; Papagregoriou, Gregory/0000-0002-2440-9789; Felekkis, Kyriacos/0000-0002-0919-0037	George & Maria Tyrimos endowment; Pancyprian Gymnasium, Nicosia; Cyprus Research Promotion Foundation;  [NEW INFRASTRUCTURE/STRATEGIC/0308/24]	George & Maria Tyrimos endowment; Pancyprian Gymnasium, Nicosia; Cyprus Research Promotion Foundation; 	This work was supported mainly by the George & Maria Tyrimos endowment through a grant to CD by the Pancyprian Gymnasium, Nicosia, as a scholarship to support GP and by a grant NEW INFRASTRUCTURE/STRATEGIC/0308/24 by the Cyprus Research Promotion Foundation (www.research.org.cy) to CD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson JF, 2005, SCIENCE, V310, P317, DOI 10.1126/science.1116502; Alvarez ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018671; Athanasiou Y, 2011, CJASN IN PRESS; Bao L, 2007, NUCLEIC ACIDS RES, V35, pD51, DOI 10.1093/nar/gkl797; Barisoni L, 2007, CLIN J AM SOC NEPHRO, V2, P529, DOI 10.2215/CJN.04121206; BARNARD GA, 1947, BIOMETRIKA, V34, P123, DOI 10.2307/2332517; Beetz C, 2008, BRAIN, V131, P1078, DOI 10.1093/brain/awn026; Chen KX, 2008, CARCINOGENESIS, V29, P1306, DOI 10.1093/carcin/bgn116; Cohen RA, 2003, NEW ENGL J MED, V348, P2330, DOI 10.1056/NEJMcp012694; Deltas C, 2012, PEDIATR NEPHROL, V27, P1221, DOI 10.1007/s00467-011-1935-5; Enciso-Mora V, 2010, NAT GENET, V42, P1126, DOI 10.1038/ng.696; Farazi TA, 2008, DEVELOPMENT, V135, P1201, DOI 10.1242/dev.005629; Gale DP, 2010, LANCET, V376, P794, DOI 10.1016/S0140-6736(10)60670-8; Georges M, 2006, COLD SPRING HARB SYM, V71, P343, DOI 10.1101/sqb.2006.71.056; GRAHAM M, 1986, EMBO J, V5, P2845, DOI 10.1002/j.1460-2075.1986.tb04578.x; Guan YH, 2007, CLIN CANCER RES, V13, P5745, DOI 10.1158/1078-0432.CCR-06-2882; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hanson RL, 2007, DIABETES, V56, P975, DOI 10.2337/db06-1072; Hariharan M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-108; Harvey SJ, 2008, J AM SOC NEPHROL, V19, P2150, DOI 10.1681/ASN.2008020233; Ho J, 2008, J AM SOC NEPHROL, V19, P2069, DOI 10.1681/ASN.2008020162; Huppi K, 2008, MOL CANCER RES, V6, P212, DOI 10.1158/1541-7786.MCR-07-0105; Iwai N, 2005, BIOCHEM BIOPH RES CO, V331, P1439, DOI 10.1016/j.bbrc.2005.04.051; Jazdzewski K, 2009, P NATL ACAD SCI USA, V106, P1502, DOI 10.1073/pnas.0812591106; Lal A, 2009, MOL CELL, V35, P610, DOI 10.1016/j.molcel.2009.08.020; Lamnissou K, 2004, GENET TEST, V8, P319, DOI 10.1089/gte.2004.8.319; Lewis MA, 2009, NAT GENET, V41, P614, DOI 10.1038/ng.369; Liu M, 2010, J AM SOC NEPHROL, V21, P1510, DOI 10.1681/ASN.2010030237; Ludbrook J, 2008, INT J EPIDEMIOL, V37, P1430, DOI 10.1093/ije/dyn162; Luo CC, 2011, NEONATOLOGY, V99, P241, DOI 10.1159/000318142; Lv K, 2008, BIOCHEM BIOPH RES CO, V374, P101, DOI 10.1016/j.bbrc.2008.06.102; Lydersen S, 2009, STAT MED, V28, P1159, DOI 10.1002/sim.3531; Martin MM, 2007, J BIOL CHEM, V282, P24262, DOI 10.1074/jbc.M701050200; Mehta CP, 1991, AM STAT, V45, P74; MEHTA CR, 1993, AM STAT, V47, P91, DOI 10.2307/2685184; Mencia A, 2009, NAT GENET, V41, P609, DOI 10.1038/ng.355; Millis MP, 2007, DIABETES, V56, P3027, DOI 10.2337/db07-0675; Mulder GM, 2010, J PATHOL, V221, P183, DOI 10.1002/path.2698; Paizis K, 1999, KIDNEY INT, V55, P2310, DOI 10.1046/j.1523-1755.1999.00469.x; Persu A, 2002, HUM MOL GENET, V11, P229, DOI 10.1093/hmg/11.3.229; Pierides A, 2009, NEPHROL DIAL TRANSPL, V24, P2721, DOI 10.1093/ndt/gfp158; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Saunders MA, 2007, P NATL ACAD SCI USA, V104, P3300, DOI 10.1073/pnas.0611347104; Shi SL, 2008, J AM SOC NEPHROL, V19, P2159, DOI 10.1681/ASN.2008030312; Smith JP, 2009, AM J PHYSIOL-RENAL, V296, pF957, DOI 10.1152/ajprenal.90490.2008; Song FJ, 2009, CLIN CANCER RES, V15, P6292, DOI 10.1158/1078-0432.CCR-09-0826; Sun GH, 2009, RNA, V15, P1640, DOI 10.1261/rna.1560209; Takemura T, 1999, J PATHOL, V189, P431; Tan Z, 2007, AM J HUM GENET, V81, P829, DOI 10.1086/521200; Uchiyama-Tanaka Y, 2002, KIDNEY INT, V62, P799, DOI 10.1046/j.1523-1755.2002.00537.x; Voskarides K, 2007, J AM SOC NEPHROL, V18, P3004, DOI 10.1681/ASN.2007040444; Wang G, 2008, AM J HUM GENET, V82, P283, DOI 10.1016/j.ajhg.2007.09.021; Wiggins RC, 2007, KIDNEY INT, V71, P1205, DOI 10.1038/sj.ki.5002222; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Xu J, 2009, HUM MUTAT, V30, P1231, DOI 10.1002/humu.21044; Zhuang S, 2008, AM J PHYSIOL-RENAL, V294, pF459, DOI 10.1152/ajprenal.00473.2007; Zuchner S, 2006, AM J HUM GENET, V79, P365, DOI 10.1086/505361	58	38	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2012	7	2							e31021	10.1371/journal.pone.0031021	http://dx.doi.org/10.1371/journal.pone.0031021			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UV	22319602	gold, Green Published, Green Submitted			2022-12-27	WOS:000301979000018
J	Hanscombe, KB; Trzaskowski, M; Haworth, CMA; Davis, OSP; Dale, PS; Plomin, R				Hanscombe, Ken B.; Trzaskowski, Maciej; Haworth, Claire M. A.; Davis, Oliver S. P.; Dale, Philip S.; Plomin, Robert			Socioeconomic Status (SES) and Children's Intelligence (IQ): In a UK-Representative Sample SES Moderates the Environmental, Not Genetic, Effect on IQ	PLOS ONE			English	Article							GENERAL COGNITIVE-ABILITY; TWINS EARLY DEVELOPMENT; PARENTAL EDUCATION; BEHAVIOR PROBLEMS; MIDDLE CHILDHOOD; PSYCHOPATHOLOGY; HERITABILITY; GENOTYPE; MULTIVARIATE; LANGUAGE	Background: The environment can moderate the effect of genes - a phenomenon called gene-environment (GxE) interaction. Several studies have found that socioeconomic status (SES) modifies the heritability of children's intelligence. Among low-SES families, genetic factors have been reported to explain less of the variance in intelligence; the reverse is found for high-SES families. The evidence however is inconsistent. Other studies have reported an effect in the opposite direction (higher heritability in lower SES), or no moderation of the genetic effect on intelligence. Methods: Using 8716 twin pairs from the Twins Early Development Study (TEDS), we attempted to replicate the reported moderating effect of SES on children's intelligence at ages 2, 3, 4, 7, 9, 10, 12 and 14: i.e., lower heritability in lower-SES families. We used a twin model that allowed for a main effect of SES on intelligence, as well as a moderating effect of SES on the genetic and environmental components of intelligence. Results: We found greater variance in intelligence in low-SES families, but minimal evidence of GxE interaction across the eight ages. A power calculation indicated that a sample size of about 5000 twin pairs is required to detect moderation of the genetic component of intelligence as small as 0.25, with about 80% power - a difference of 11% to 53% in heritability, in low- (-2 standard deviations, SD) and high-SES (+2 SD) families. With samples at each age of about this size, the present study found no moderation of the genetic effect on intelligence. However, we found the greater variance in low-SES families is due to moderation of the environmental effect - an environment-environment interaction. Conclusions: In a UK-representative sample, the genetic effect on intelligence is similar in low-and high-SES families. Children's shared experiences appear to explain the greater variation in intelligence in lower SES.	[Hanscombe, Ken B.; Trzaskowski, Maciej; Haworth, Claire M. A.; Davis, Oliver S. P.; Plomin, Robert] Kings Coll London, Inst Psychiat, Med Res Council, Social Genet & Dev Psychiat Ctr, London WC2R 2LS, England; [Davis, Oliver S. P.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Davis, Oliver S. P.] European Bioinformat Inst, Cambridge, England; [Dale, Philip S.] Univ New Mexico, Dept Speech & Hearing Sci, Albuquerque, NM 87131 USA	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of London; King's College London; University of Oxford; Wellcome Centre for Human Genetics; European Molecular Biology Laboratory (EMBL); University of New Mexico	Hanscombe, KB (corresponding author), Kings Coll London, Inst Psychiat, Med Res Council, Social Genet & Dev Psychiat Ctr, London WC2R 2LS, England.	Ken.Hanscombe@kcl.ac.uk	converis, test/AAX-6783-2020; Haworth, Claire/C-7073-2009; Dale, Philip S/A-2254-2009	Haworth, Claire/0000-0002-8608-289X; Dale, Philip S/0000-0002-7697-8510; Davis, Oliver/0000-0002-6448-3684; Plomin, Robert/0000-0002-0756-3629; Trzaskowski, Maciej/0000-0001-8559-6525	UK Medical Research Council [G0500079]; US National Institutes of Health [HD44454, HD46167]; MRC/ESRC [G0802681]; Sir Henry Wellcome Fellowship [WT088984]; MRC [G0500079, G0802681, G19/2] Funding Source: UKRI; Medical Research Council [G0802681, G0500079, G19/2, G9817803B] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD044454] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD046167] Funding Source: NIH RePORTER	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC/ESRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)Economic & Social Research Council (ESRC)); Sir Henry Wellcome Fellowship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The Twins Early Development Study (TEDS) is supported by a program grant (G0500079) from the UK Medical Research Council; the authors' work on environments and academic achievement is also supported by grants from the US National Institutes of Health (HD44454 and HD46167). CH is supported by an MRC/ESRC Interdisciplinary Fellowship (G0802681); OD is supported by a Sir Henry Wellcome Fellowship (WT088984). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1987, PSYCHOMETRIKA, V52, P317, DOI 10.1007/BF02294359; Asbury K, 2005, INTELLIGENCE, V33, P643, DOI 10.1016/j.intell.2005.03.008; Bayley N, 1993, BAYLEY SCALES INFANT; Bergen SE, 2007, TWIN RES HUM GENET, V10, P423, DOI 10.1375/twin.10.3.423; Birnbaum MH, 2004, ANNU REV PSYCHOL, V55, P803, DOI 10.1146/annurev.psych.55.090902.141601; Boker S, 2011, PSYCHOMETRIKA, V76, P306, DOI 10.1007/s11336-010-9200-6; Boomsma D, 2002, NAT REV GENET, V3, P872, DOI 10.1038/nrg932; Bradley RH, 2002, ANNU REV PSYCHOL, V53, P371, DOI 10.1146/annurev.psych.53.100901.135233; Braveman PA, 2005, JAMA-J AM MED ASSOC, V294, P2879, DOI 10.1001/jama.294.22.2879; Bricker D, 1995, AGES STAGES QUESTION; BRONFENBRENNER U, 1994, PSYCHOL REV, V101, P568, DOI 10.1037/0033-295X.101.4.568; Burt SA, 2009, PSYCHOL BULL, V135, P608, DOI 10.1037/a0015702; Davis OSP, 2008, INTELLIGENCE, V36, P68, DOI 10.1016/j.intell.2007.01.006; Davis OSP, 2009, PSYCHOL SCI, V20, P1301, DOI 10.1111/j.1467-9280.2009.02433.x; Eaves LJ, 2006, TWIN RES HUM GENET, V9, P1, DOI 10.1375/183242706776403073; Evans GW, 2004, AM PSYCHOL, V59, P77, DOI 10.1037/0003-066X.59.2.77; Fenson L, 2000, APPL PSYCHOLINGUIST, V21, P95, DOI 10.1017/S0142716400001053; FISCHBEIN S, 1980, INTELLIGENCE, V4, P51, DOI 10.1016/0160-2896(80)90006-9; Grant MD, 2010, BEHAV GENET, V40, P438, DOI 10.1007/s10519-010-9351-3; Haworth CMA, 2010, MOL PSYCHIATR, V15, P1112, DOI 10.1038/mp.2009.55; Haworth CMA, 2007, TWIN RES HUM GENET, V10, P554, DOI 10.1375/twin.10.4.554; IRETON H, 1974, MINNESOTA CHILD DEV; Jaffee SR, 2007, MOL PSYCHIATR, V12, P432, DOI 10.1038/sj.mp.4001950; Kaplan E, 1999, WISC 3 PROCESS INSTR; Kendler K. S., 2011, DYNAMIC GENOME MENTA, P5; Kendler KS, 2010, BRIT J PSYCHIAT, V197, P170, DOI 10.1192/bjp.bp.110.081331; KENDLER KS, 1986, AM J PSYCHIAT, V143, P279; Kovas Y, 2007, GENETIC ENV ORIGINS, P1; MARTIN NG, 1978, HEREDITY, V40, P97, DOI 10.1038/hdy.1978.10; McCarthy D, 1972, MCCARTHY SCALES CHIL; MCGUE M, 1984, BEHAV GENET, V14, P325, DOI 10.1007/BF01080045; Oliver B, 2002, EARLY CHILD DEV CARE, V172, P337, DOI DOI 10.1080/03004430212713; Oliver BR, 2007, TWIN RES HUM GENET, V10, P96, DOI 10.1375/twin.10.1.96; Petrill SA, 2002, INTELLIGENCE, V30, P353, DOI 10.1016/S0160-2896(02)00087-9; PLOMIN R, 1977, PSYCHOL BULL, V84, P309, DOI 10.1037/0033-2909.84.2.309; PLOMIN R, 1991, BEHAV BRAIN SCI, V14, P373, DOI 10.1017/S0140525X00070278; Plomin R., 2008, BEHAV GENET; Price T S, 2000, Twin Res, V3, P129, DOI 10.1375/136905200320565391; Purcell S, 2002, TWIN RES, V5, P554, DOI 10.1375/136905202762342026; Raven J.C., 1984, LONDON H K LEWIS ITA; Rowe DC, 1999, CHILD DEV, V70, P1151, DOI 10.1111/1467-8624.00084; Rutter M, 2006, J CHILD PSYCHOL PSYC, V47, P226, DOI 10.1111/j.1469-7610.2005.01557.x; Rutter M, 2007, DEVELOPMENTAL SCI, V10, P12, DOI 10.1111/j.1467-7687.2007.00557.x; Saudino KJ, 1998, BRIT J DEV PSYCHOL, V16, P349, DOI 10.1111/j.2044-835X.1998.tb00757.x; SCARR S, 1992, CHILD DEV, V63, P1, DOI 10.2307/1130897; Scarr S., 1981, RACE SOCIAL CLASS IN; SCARRSALAPATEK S, 1971, SCIENCE, V174, P1285, DOI 10.1126/science.174.4016.1285; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Smith P., 2001, COGNITIVE ABILITIES; Team R. D. C, 2011, R LANG ENV STAT COMP; Trouton A, 2002, TWIN RES, V5, P444, DOI 10.1375/136905202320906255; Tucker-Drob EM, 2011, PSYCHOL SCI, V22, P125, DOI 10.1177/0956797610392926; Turkheimer E, 2003, PSYCHOL SCI, V14, P623, DOI 10.1046/j.0956-7976.2003.psci_1475.x; Uher R, 2006, JAMA-J AM MED ASSOC, V295, P1770, DOI 10.1001/jama.295.15.1770-a; van der Sluis S, 2008, BEHAV GENET, V38, P348, DOI 10.1007/s10519-008-9212-5; Venables WN., 2002, MODERN APPL STAT S 4; Wechsler D., 1992, WECHSLER INTELLIGENC	58	155	159	7	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2012	7	2							e30320	10.1371/journal.pone.0030320	http://dx.doi.org/10.1371/journal.pone.0030320			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	914UG	22312423	Green Published, gold, Green Submitted			2022-12-27	WOS:000301977500007
J	Shenoy, K				Shenoy, Kausalya			Environmentally Realistic Exposure to the Herbicide Atrazine Alters Some Sexually Selected Traits in Male Guppies	PLOS ONE			English	Article							MALE-MALE COMPETITION; FEMALE MATE CHOICE; POECILIA-RETICULATA; TESTOSTERONE PRODUCTION; ENDOCRINE DISRUPTION; GEOGRAPHIC-VARIATION; AGGRESSIVE-BEHAVIOR; MALE COLOR; FROGS; EXPRESSION	Male mating signals, including ornaments and courtship displays, and other sexually selected traits, like male-male aggression, are largely controlled by sex hormones. Environmental pollutants, notably endocrine disrupting compounds, can interfere with the proper functioning of hormones, thereby impacting the expression of hormonally regulated traits. Atrazine, one of the most widely used herbicides, can alter sex hormone levels in exposed animals. I tested the effects of environmentally relevant atrazine exposures on mating signals and behaviors in male guppies, a sexually dimorphic freshwater fish. Prolonged atrazine exposure reduced the expression of two honest signals: the area of orange spots (ornaments) and the number of courtship displays performed. Atrazine exposure also reduced aggression towards competing males in the context of mate competition. In the wild, exposure levels vary among individuals because of differential distribution of the pollutants across habitats; hence, differently impacted males often compete for the same mates. Disrupted mating signals can reduce reproductive success as females avoid mating with perceptibly suboptimal males. Less aggressive males are at a competitive disadvantage and lose access to females. This study highlights the effects of atrazine on ecologically relevant mating signals and behaviors in exposed wildlife. Altered reproductive traits have important implications for population dynamics, evolutionary patterns, and conservation of wildlife species.	Univ Kentucky, Dept Biol, Lexington, KY 40506 USA	University of Kentucky	Shenoy, K (corresponding author), Univ Kentucky, Dept Biol, Lexington, KY 40506 USA.	kay.yellowtoad@gmail.com	Shenoy, Kausalya/D-4085-2015		Sigma Xi; Department of Biology, University of Kentucky; University of Kentucky	Sigma Xi; Department of Biology, University of Kentucky; University of Kentucky	The study was funded by the Sigma Xi Grant-In-Aid of Research and the Ribble Mini-Grant, Department of Biology, University of Kentucky. During the course of this study, KS received support from the Kentucky Opportunity Fellowship, University of Kentucky. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarikwu SO, 2010, ARCH ENVIRON CON TOX, V58, P874, DOI 10.1007/s00244-009-9371-2; Andersson Malte, 1994; Ankley GT, 2005, TOXICOL SCI, V86, P300, DOI 10.1093/toxsci/kfi202; Ankley GT, 2002, TOXICOL SCI, V67, P121, DOI 10.1093/toxsci/67.1.121; Arellano-Aguilar O, 2008, P ROY SOC B-BIOL SCI, V275, P1343, DOI 10.1098/rspb.2008.0163; Baatrup E, 2001, ENVIRON HEALTH PERSP, V109, P1063, DOI 10.2307/3454962; BARTKE A, 1977, BIOL REPROD, V17, P645, DOI 10.1095/biolreprod17.5.645; Basrur PK, 2006, ENVIRON RES, V100, P18, DOI 10.1016/j.envres.2005.08.016; Bayley M, 2003, BIOL REPROD, V69, P1951, DOI 10.1095/biolreprod.103.017780; Bayley M, 2002, AQUAT TOXICOL, V56, P227, DOI 10.1016/S0166-445X(01)00210-7; Bell AM, 2001, ANIM BEHAV, V62, P775, DOI 10.1006/anbe.2001.1824; Bernhardt RR, 2008, BEHAVIOUR, V145, P527, DOI 10.1163/156853908792451511; Bokony V, 2008, BEHAV ECOL SOCIOBIOL, V62, P1229, DOI 10.1007/s00265-008-0551-2; Bortolotti GR, 2003, FUNCT ECOL, V17, P651, DOI 10.1046/j.1365-2435.2003.00778.x; Comber SDW, 1999, PESTIC SCI, V55, P696, DOI 10.1002/(SICI)1096-9063(199907)55:7&lt;696::AID-PS11&gt;3.0.CO;2-7; Cotton S, 2009, CONSERV BIOL, V23, P196, DOI 10.1111/j.1523-1739.2008.01053.x; Davis ES, 2002, BEHAV ECOL SOCIOBIOL, V52, P224, DOI 10.1007/s00265-002-0513-z; Devasurendra RS, 2007, P PER U RES SESS SRI; Earley RL, 2008, HORM BEHAV, V53, P442, DOI 10.1016/j.yhbeh.2007.11.017; Earley Ryan L., 2006, P84; ENDLER JA, 1993, ECOL MONOGR, V63, P1, DOI 10.2307/2937121; ENDLER JA, 1995, EVOLUTION, V49, P456, DOI [10.2307/2410270, 10.1111/j.1558-5646.1995.tb02278.x]; ENDLER JA, 1991, VISION RES, V31, P587, DOI 10.1016/0042-6989(91)90109-I; EPA, 1993, EPA821R93010A; Evans JP, 2003, BIOL J LINN SOC, V78, P605, DOI 10.1046/j.0024-4066.2002.00193.x; Evans JP, 1999, ANIM BEHAV, V58, P1001, DOI 10.1006/anbe.1999.1212; Fan WQ, 2007, ENVIRON HEALTH PERSP, V115, P720, DOI 10.1289/ehp.9758; FOLSTAD I, 1992, AM NAT, V139, P603, DOI 10.1086/285346; GODIN JGJ, 1995, OECOLOGIA, V103, P224, DOI 10.1007/BF00329084; Gordon SP, 2012, EVOLUTION, V66, P912, DOI 10.1111/j.1558-5646.2011.01495.x; Grether GF, 2000, EVOLUTION, V54, P1712, DOI 10.1111/j.0014-3820.2000.tb00715.x; Grube A, 733R11001 US EPA; Hallgren SLE, 2006, GEN COMP ENDOCR, V147, P323, DOI 10.1016/j.ygcen.2006.02.005; Haskins C. P., 1961, VERTEBRATE SPECIATIO, P320; Hayes T, 2002, NATURE, V419, P895, DOI 10.1038/419895a; Hayes T, 2003, ENVIRON HEALTH PERSP, V111, P568, DOI 10.1289/ehp.5932; Hayes TB, 2002, P NATL ACAD SCI USA, V99, P5476, DOI 10.1073/pnas.082121499; Hayes TB, 2005, INTEGR COMP BIOL, V45, P321, DOI 10.1093/icb/45.2.321; Hayes TB, 2006, ENVIRON HEALTH PERSP, V114, P134, DOI 10.1289/ehp.8067; Hayes TB, 2010, P NATL ACAD SCI USA, V107, P4612, DOI 10.1073/pnas.0909519107; Hecker M, 2005, TOXICOL SCI, V86, P273, DOI 10.1093/toxsci/kfi203; HERMAN RL, 1988, AQUACULTURE, V72, P165, DOI 10.1016/0044-8486(88)90156-1; Hillgarth Nigella, 1997, P78; Houde A.E., 1997, SEX COLOR MATE CHOIC; HOUDE AE, 1992, HEREDITY, V69, P229, DOI 10.1038/hdy.1992.120; HOUDE AE, 1988, ANIM BEHAV, V36, P888, DOI 10.1016/S0003-3472(88)80171-4; HOUDE AE, 1992, BEHAV ECOL, V3, P346, DOI 10.1093/beheco/3.4.346; HUNT GL, 1977, SCIENCE, V196, P1466, DOI 10.1126/science.196.4297.1466; Jayasooriya AP, 2002, SCIENCE, V296, P847; Jirotkul M, 1999, ANIM BEHAV, V58, P287, DOI 10.1006/anbe.1999.1149; Karino K, 2005, BEHAV ECOL SOCIOBIOL, V59, P1, DOI 10.1007/s00265-005-0001-3; Kelce WR, 1997, J MOL MED, V75, P198, DOI 10.1007/s001090050104; Kempenaers B, 1997, BEHAV ECOL, V8, P481, DOI 10.1093/beheco/8.5.481; Kidd KA, 2007, P NATL ACAD SCI USA, V104, P8897, DOI 10.1073/pnas.0609568104; Kim SK, 2007, ENVIRON TOXICOL, V22, P449, DOI 10.1002/tox.20280; Kodric-Brown A, 2001, BEHAV ECOL SOCIOBIOL, V50, P346, DOI 10.1007/s002650100374; Krisfalusi M, 1998, B ENVIRON CONTAM TOX, V61, P519, DOI 10.1007/s001289900793; Kristensen T, 2007, AQUAT TOXICOL, V81, P245, DOI 10.1016/j.aquatox.2006.12.005; Kristensen T, 2005, BIOL REPROD, V72, P150, DOI 10.1095/biolreprod.104.033001; Larsen MG, 2008, AQUAT TOXICOL, V87, P234, DOI 10.1016/j.aquatox.2008.02.003; LONG KD, 1989, ETHOLOGY, V82, P316; Lopez S, 1998, P ROY SOC B-BIOL SCI, V265, P717, DOI 10.1098/rspb.1998.0352; LUYTEN PH, 1985, BEHAVIOUR, V95, P164, DOI 10.1163/156853985X00109; MAGURRAN AE, 1990, BEHAVIOUR, V112, P194, DOI 10.1163/156853990X00194; Majewski AR, 2002, WATER QUAL RES J CAN, V37, P697, DOI 10.2166/wqrj.2002.047; Markman S, 2007, CHEMOSPHERE, V70, P119, DOI 10.1016/j.chemosphere.2007.06.045; Markman S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001674; Maynard Smith J, 2003, ANIMAL SIGNALS, P176; McGraw KJ, 2006, BEHAV ECOL SOCIOBIOL, V60, P117, DOI 10.1007/s00265-005-0135-3; Milnes MR, 2006, ENVIRON RES, V100, P3, DOI 10.1016/j.envres.2005.04.002; Mockford EJ, 2009, P ROY SOC B-BIOL SCI, V276, P2979, DOI 10.1098/rspb.2009.0586; Mougeot F, 2009, P ROY SOC B-BIOL SCI, V276, P1093, DOI 10.1098/rspb.2008.1570; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; Nakayama K, 2004, CHEMOSPHERE, V55, P1331, DOI 10.1016/j.chemosphere.2003.11.050; Palanza P, 2002, ECO ENV TOX, P377; Palanza P, 2002, NEUROTOXICOL TERATOL, V24, P55, DOI 10.1016/S0892-0362(01)00191-X; Park KJ, 2009, CHEMOSPHERE, V77, P1459, DOI 10.1016/j.chemosphere.2009.08.063; Partridge C, 2010, HORM BEHAV, V58, P800, DOI 10.1016/j.yhbeh.2010.08.002; Peters A, 2001, BEHAV ECOL SOCIOBIOL, V50, P519, DOI 10.1007/s002650100403; PORTER RD, 1969, SCIENCE, V165, P199, DOI 10.1126/science.165.3889.199; Porter WP, 1999, TOXICOL IND HEALTH, V15, P133, DOI 10.1191/074823399678846691; Quader S, 2005, CURR SCI INDIA, V89, P1220; Rasband WS, 1997, IMAGEJ VERSION 1 43U; Robinson CD, 2007, AQUAT TOXICOL, V81, P397, DOI 10.1016/j.aquatox.2006.12.020; Rodd FH, 2002, P ROY SOC B-BIOL SCI, V269, P475, DOI 10.1098/rspb.2001.1891; Rohr JR, 2010, ENVIRON HEALTH PERSP, V118, P20, DOI 10.1289/ehp.0901164; Saaristo M, 2009, HORM BEHAV, V56, P315, DOI 10.1016/j.yhbeh.2009.06.010; SAS Institute Inc, 2002, SAS VERS 9 2; Secondi J, 2009, FUNCT ECOL, V23, P800, DOI 10.1111/j.1365-2435.2009.01558.x; Seehausen O, 1997, SCIENCE, V277, P1808, DOI 10.1126/science.277.5333.1808; Seehausen O, 1998, BEHAV ECOL SOCIOBIOL, V42, P1, DOI 10.1007/s002650050405; Setchell JM, 2008, HORM BEHAV, V54, P365, DOI 10.1016/j.yhbeh.2008.05.004; Shenoy K, 2011, FUNCT ECOL, V25, P433, DOI 10.1111/j.1365-2435.2010.01787.x; Slabbekoorn H, 2008, MOL ECOL, V17, P72, DOI 10.1111/j.1365-294X.2007.03487.x; Solomon KR, 2008, CRIT REV TOXICOL, V38, P721, DOI [10.1080/10408440802116496, 10.1080/10408440802116496 ]; Solomon KR, 1996, ENVIRON TOXICOL CHEM, V15, P31, DOI [10.1002/etc.5620150105, 10.1897/1551-5028(1996)015&lt;0031:ERAOAI&gt;2.3.CO;2]; Soltis J, 2001, ANIM BEHAV, V62, P485, DOI 10.1006/anbe.2001.1774; Tillitt DE, 2010, AQUAT TOXICOL, V99, P149, DOI 10.1016/j.aquatox.2010.04.011; Toft G, 2001, ECOTOX ENVIRON SAFE, V48, P76, DOI 10.1006/eesa.2000.1985; U.S. Environmental Protection Agency, 2006, DEC DOC ATR; US EPA, 2009, PERS ORG POLL GLOB I; Walters DM, 2010, ENVIRON SCI TECHNOL, V44, P2849, DOI 10.1021/es9023139; Willingham EJ, 2005, FRONT ECOL ENVIRON, V3, P309, DOI 10.2307/3868564; ZUK M, 1995, P ROY SOC B-BIOL SCI, V260, P205, DOI 10.1098/rspb.1995.0081	104	35	39	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2012	7	2							e30611	10.1371/journal.pone.0030611	http://dx.doi.org/10.1371/journal.pone.0030611			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UG	22312428	Green Published, Green Submitted, gold			2022-12-27	WOS:000301977500012
J	Holliday, CM; Gardner, NM				Holliday, Casey M.; Gardner, Nicholas M.			A New Eusuchian Crocodyliform with Novel Cranial Integument and Its Significance for the Origin and Evolution of Crocodylia	PLOS ONE			English	Article							MIOCENE URUMACO FORMATION; ALLIGATOR-MISSISSIPPIENSIS; PHYLOGENETIC-RELATIONSHIPS; MORPHOLOGY; REGION; MESOEUCROCODYLIA; BIOGEOGRAPHY	Crocodyliforms were one of the most successful groups of Mesozoic tetrapods, radiating into terrestrial, semiaquatic and marine environments, while occupying numerous trophic niches, including carnivorous, insectivorous, herbivorous, and piscivorous species. Among these taxa were the enigmatic, poorly represented flat-headed crocodyliforms from the late Cretaceous of northern Africa. Here we report a new, giant crocodyliform from the early Late Cretaceous (Cenomanian) Kem Kem Formation of Morocco. Represented by a partial braincase, the taxon has an extremely long, flat skull with large jaw and craniocervical muscles. The skull roof is ridged and ornamented with a broad, rough boss surrounded by significant vascular impressions, likely forming an integumentary structure unique among crocodyliforms. Size estimates using endocranial volume indicate the specimen was very large. The taxon possesses robust laterosphenoids with laterally oriented capitate processes and isolated epipterygoids, features allying it with derived eusuchians. Phylogenetic analysis finds the taxon to be a derived eusuchian and sister taxon to Aegyptosuchus, a poorly understood, early Late Cretaceous taxon from the Bahariya formation. This clade forms the sister clade of crown-group Crocodylia, making these taxa the earliest eusuchian crocodyliforms known from Africa. These results shift phylogenetic and biogeographical hypotheses on the origin of modern crocodylians towards the circum-Tethyean region and provide important new data on eusuchian morphology and evolution.	[Holliday, Casey M.] Univ Missouri, Sch Med, Dept Pathol & Anat Sci, Columbia, MO 65211 USA; [Gardner, Nicholas M.] Marshall Univ, Dept Biol Sci, Huntington, WV USA	University of Missouri System; University of Missouri Columbia; Marshall University	Holliday, CM (corresponding author), Univ Missouri, Sch Med, Dept Pathol & Anat Sci, Columbia, MO 65211 USA.	hollidayca@missouri.edu	Gardner, Nicholas/S-3207-2019; Gardner, Nicholas/GOV-7256-2022	Gardner, Nicholas/0000-0002-5278-7541; Holliday, Casey/0000-0001-8210-8434	Department of Pathology and Anatomical Sciences and University of Missouri; University of Missouri Research Council; Marshall University	Department of Pathology and Anatomical Sciences and University of Missouri; University of Missouri Research Council; Marshall University	C. M. H. was funded by the Department of Pathology and Anatomical Sciences and University of Missouri, University of Missouri Research Council. N. M. G. was funded by Marshall University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera OA, 2006, J SYST PALAEONTOL, V4, P221, DOI 10.1017/S147720190600188X; Baumel Julian J., 1993, Publications of the Nuttall Ornithological Club, V23, P407; BREMER K, 1994, CLADISTICS, V10, P295, DOI 10.1006/clad.1994.1019; Brochu CA, 1997, SYST BIOL, V46, P479, DOI 10.2307/2413693; Brochu CA, 2003, ANNU REV EARTH PL SC, V31, P357, DOI 10.1146/annurev.earth.31.100901.141308; Brochu CA, 2001, CROCODILIAN BIOL EVO, P7; Brochu CA, 2007, ZOOL J LINN SOC-LOND, V150, P835, DOI 10.1111/j.1096-3642.2007.00315.x; BUFFETAUT E, 1977, Palaeontology (Oxford), V20, P203; Buffetaut E., 1981, GEOL RUNDSCH, V70, P611, DOI DOI 10.1007/BF01822139; Carroll RL, 1988, VERTEBRATE PALEONTOL; Cavin L, 2010, J AFR EARTH SCI, V57, P391, DOI 10.1016/j.jafrearsci.2009.12.007; Delfino M, 2008, J VERTEBR PALEONTOL, V28, P111, DOI 10.1671/0272-4634(2008)28[111:ACSOAP]2.0.CO;2; DODSON P, 1975, J ZOOL, V175, P315; Farlow JO, 2005, J VERTEBR PALEONTOL, V25, P354, DOI 10.1671/0272-4634(2005)025[0354:FDABSO]2.0.CO;2; GARRICK LD, 1977, AM ZOOL, V17, P225; George I, 2011, J VERTEBR PALEONTOL, V31, P116; Hieronymus TL, 2009, ANAT REC, V292, P1370, DOI 10.1002/ar.20985; Holliday CM, 2009, J VERTEBR PALEONTOL, V29, P715, DOI 10.1671/039.029.0330; Ibrahim N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010875; Jenkins FA, 2008, J VERTEBR PALEONTOL, V28, P935, DOI 10.1671/0272-4634-28.4.935; Larsson HCE, 2007, ZOOL J LINN SOC-LOND, V149, P533, DOI 10.1111/j.1096-3642.2007.00271.x; Lauprasert K, 2011, PALAEONTOL Z, V85, P37, DOI 10.1007/s12542-010-0071-z; Martin JE, 2010, NATURWISSENSCHAFTEN, V97, P845, DOI 10.1007/s00114-010-0702-y; Martin JE, 2010, PALAEOGEOGR PALAEOCL, V293, P406, DOI 10.1016/j.palaeo.2009.10.021; Nopcsa F. Baron., 1926, Zentralblatt fuer Mineralogie Stuttgart B, V1926, P212; Riff D, 2008, PALAEONTOL Z, V82, P178, DOI 10.1007/BF02988408; Salisbury SW, 2006, P ROY SOC B-BIOL SCI, V273, P2439, DOI 10.1098/rspb.2006.3613; Salisbury SW, 2003, PALAEONTOGR ABT A, V270, P3; Schwimmer DR., 2002, KING CROCODYLIANS PA; Sereno PC, 2009, ZOOKEYS, P1, DOI 10.3897/zookeys.28.325; Sereno PC, 2003, J VERTEBR PALEONTOL, V23, P477, DOI 10.1671/0272-4634(2003)023[0477:ANNFTE]2.0.CO;2; Sereno PC, 1996, SCIENCE, V272, P986, DOI 10.1126/science.272.5264.986; Sereno PC, 2001, SCIENCE, V294, P1516, DOI 10.1126/science.1066521; Smith JB, 2001, SCIENCE, V292, P1704, DOI 10.1126/science.1060561; Stromer E., 1933, Abhandlungen der Bayerischen Akademie der Wissenschaften NF, V15, P1; Stromer E, 1925, ABHANDLUNGEN BAYE MN, V30, P1; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Tsuihiji T, 2005, J MORPHOL, V263, P151, DOI 10.1002/jmor.10294; Turner AH, 2004, P ROY SOC B-BIOL SCI, V271, P2003, DOI 10.1098/rspb.2004.2840; Witmer LM, 2009, ANAT REC, V292, P1266, DOI 10.1002/ar.20983	40	56	57	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2012	7	1							e30471	10.1371/journal.pone.0030471	http://dx.doi.org/10.1371/journal.pone.0030471			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	912BY	22303441	Green Published, gold			2022-12-27	WOS:000301770700006
J	Aitken, EH; Mbewe, B; Luntamo, M; Kulmala, T; Beeson, JG; Ashorn, P; Rogerson, SJ				Aitken, Elizabeth H.; Mbewe, Bernard; Luntamo, Mari; Kulmala, Teija; Beeson, James G.; Ashorn, Per; Rogerson, Stephen J.			Antibody to P. falciparum in Pregnancy Varies with Intermittent Preventive Treatment Regime and Bed Net Use	PLOS ONE			English	Article							SULFADOXINE-PYRIMETHAMINE; MALARIA; WOMEN; MALAWI	Background: Antibodies towards placental-binding P. falciparum are thought to protect against pregnancy malaria; however, environmental factors may affect antibody development. Methods and Findings: Using plasma from pregnant Malawian women, we measured IgG against placental-binding P. falciparum parasites by flow cytometry, and related results to intermittent preventive treatment (IPTp) regime, and bed net use. Bed net use was associated with decreased antibody levels at mid-pregnancy but not at 1 month post partum (1 mpp). At 1 mpp a more intensive IPTp regime was associated with decreased antibody levels in primigravidae, but not multigravidae. Conclusions/Significance: Results suggest bed nets and IPTp regime influence acquisition of pregnancy-specific P. falciparum immunity.	[Aitken, Elizabeth H.; Rogerson, Stephen J.] Univ Melbourne, Dept Med RMH WH, Parkville, Vic 3052, Australia; [Mbewe, Bernard] Univ Malawi, Dept Community Hlth, Coll Med, Blantyre, Malawi; [Luntamo, Mari; Kulmala, Teija; Ashorn, Per] Univ Tampere, Dept Int Hlth, Sch Med, FIN-33101 Tampere, Finland; [Beeson, James G.] Burnet Inst, Melbourne, Vic, Australia; [Ashorn, Per] Tampere Univ Hosp, Dept Paediat, Tampere, Finland	University of Melbourne; University of Malawi; Tampere University; Burnet Institute; Tampere University; Tampere University Hospital	Aitken, EH (corresponding author), Univ Melbourne, Dept Med RMH WH, Parkville, Vic 3052, Australia.	sroger@unimelb.edu.au	Aitken, Elizabeth/I-8756-2019	Aitken, Elizabeth/0000-0002-2677-6208; Rogerson, Stephen/0000-0003-4287-1982; Ashorn, Per/0000-0003-2311-2593	Academy of Finland [79 787]; National Health and Medical Research Council; Australian Research Council	Academy of Finland(Academy of Finland); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	The Lungwena Antenatal Intervention Study was funded by a research grant from the Academy of Finland (grant 79 787) and the Immunity Study was funded by a National Health and Medical Research Council project grant to SJR and JGB. JGB was supported by a Future Fellowship from the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken EH, 2010, J INFECT DIS, V201, P1316, DOI 10.1086/651578; [Anonymous], 2004, STRATEGIC FRAMEWORK; Enosse S, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-115; Feng GA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012012; GREENWOOD AM, 1994, T ROY SOC TROP MED H, V88, P681, DOI 10.1016/0035-9203(94)90228-3; Luntamo M, 2010, AM J TROP MED HYG, V83, P1212, DOI 10.4269/ajtmh.2010.10-0264; Nkhoma S, 2007, ACTA TROP, V102, P138, DOI 10.1016/j.actatropica.2007.04.006; Rantala AM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-269; Rogerson SJ, 2007, LANCET INFECT DIS, V7, P105, DOI 10.1016/S1473-3099(07)70022-1; Serra-Casas E, 2010, J INFECT DIS, V201, P123, DOI 10.1086/648595; Staalsoe T, 2004, INFECT IMMUN, V72, P5027, DOI 10.1128/IAI.72.9.5027-5030.2004; van Eijk AM, 2004, TROP MED INT HEALTH, V9, P351, DOI 10.1111/j.1365-3156.2004.01196.x	12	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e29874	10.1371/journal.pone.0029874	http://dx.doi.org/10.1371/journal.pone.0029874			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22299027	Green Published, gold			2022-12-27	WOS:000301704200004
J	Chevallier, C; Molesworth, C; Happe, F				Chevallier, Coralie; Molesworth, Catherine; Happe, Francesca			Diminished Social Motivation Negatively Impacts Reputation Management: Autism Spectrum Disorders as a Case in Point	PLOS ONE			English	Article							HIGH-FUNCTIONING AUTISM; EARLY RECOGNITION; YOUNG-CHILDREN; ATTENTION; EMERGENCE; DEFICITS; ORIENT; TRUTH; 1ST	Human beings are endowed with a unique motivation to be included in social interactions. This natural social motivation, in turn, is thought to encourage behaviours such as flattery or self-deprecation aimed to ease interaction and to enhance the reputation of the individual who produces them. If this is the case, diminished social interest should affect reputation management. Here, we use Autism Spectrum Disorders (ASDs) -primarily characterised by pervasive social disinterest-as a model to investigate the effect of social motivation on reputation management. Children first rated a set of pictures and were then given the opportunity to inflate their initial ratings in front of an experimenter who declared that she had drawn the picture. Contrary to the controls, children with ASD did not enhance their ratings in the drawer's presence. Moreover, participants' flattery behaviour correlated with self-reports of social enjoyment. Our findings point to a link between diminished social interest and reputation management.	[Chevallier, Coralie; Molesworth, Catherine; Happe, Francesca] Kings Coll London, Inst Psychiat, MRC Social Genet & Dev Psychiat Ctr, London WC2R 2LS, England; [Chevallier, Coralie] Univ Penn, Ctr Autism Res, Philadelphia, PA 19104 USA; [Chevallier, Coralie] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA	University of London; King's College London; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Chevallier, C (corresponding author), Kings Coll London, Inst Psychiat, MRC Social Genet & Dev Psychiat Ctr, London WC2R 2LS, England.	coralie.chevallier@gmail.com	Chevallier, Coralie/L-3120-2017; Happe, Francesca G/D-5544-2012; Chevallier, Coralie/AAR-4748-2020	Chevallier, Coralie/0000-0002-7358-4962; Happe, Francesca/0000-0001-9226-4000	Economic and Social Research Council [RES-000-22-3136, PTA-026-27-2226]; ESRC [ES/G020523/1, ES/G035679/1] Funding Source: UKRI; Economic and Social Research Council [ES/G035679/1, ES/G020523/1] Funding Source: researchfish; Medical Research Council [G9817803B] Funding Source: researchfish	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	FH and CC were supported by the Economic and Social Research Council (grant code RES-000-22-3136). CM was also supported by the Economic and Social Research Council (grant code PTA-026-27-2226). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbaro J, 2007, J AUTISM DEV DISORD, V37, P1235, DOI 10.1007/s10803-006-0267-y; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; BAUMEISTER RF, 1995, PSYCHOL BULL, V117, P497, DOI 10.1037/0033-2909.117.3.497; Boyd B, 2003, PARENTING CHILD ASPE; COLE PM, 1986, CHILD DEV, V57, P1309, DOI 10.2307/1130411; Dawson G, 2002, CHILD DEV, V73, P345, DOI 10.1111/1467-8624.00411; Dawson G, 1998, J AUTISM DEV DISORD, V28, P479, DOI 10.1023/A:1026043926488; Fu GY, 2007, DEVELOPMENTAL SCI, V10, P255, DOI 10.1111/j.1467-7687.2007.00583.x; Gordon RA, 1996, J PERS SOC PSYCHOL, V71, P54, DOI 10.1037/0022-3514.71.1.54; Higgins CA, 2003, J ORGAN BEHAV, V24, P89, DOI 10.1002/job.181; Hudenko WJ, 2009, J AUTISM DEV DISORD, V39, P1392, DOI 10.1007/s10803-009-0752-1; Izuma K, 2011, P NATL ACAD SCI USA, V108, P17302, DOI 10.1073/pnas.1107038108; Jones E. E., 1973, INGRATIATION ATTRIBU; Kanner L, 1943, NERV CHILD, V2, P217; KASARI C, 1990, J AUTISM DEV DISORD, V20, P87, DOI 10.1007/BF02206859; KAZDIN AE, 1989, J AM ACAD CHILD PSY, V28, P364, DOI 10.1097/00004583-198905000-00010; Klin A, 2002, ARCH GEN PSYCHIAT, V59, P809, DOI 10.1001/archpsyc.59.9.809; Klin A, 2003, PHILOS T R SOC B, V358, P345, DOI 10.1098/rstb.2002.1202; Klin A, 2009, NATURE, V459, P257, DOI 10.1038/nature07868; Kuhl P. K., 2005, DEVELOPMENTAL SCI, V8, P1, DOI [10.1111/j.1467-7687.2004.00384.x, DOI 10.1111/J.1467-7687.2004.00384.X]; Leekam S, 1997, BRIT J DEV PSYCHOL, V15, P77, DOI 10.1111/j.2044-835X.1997.tb00726.x; Liebal K, 2008, J AUTISM DEV DISORD, V38, P224, DOI 10.1007/s10803-007-0381-5; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; Maestro S, 2005, CHILD PSYCHIAT HUM D, V35, P383, DOI 10.1007/s10578-005-2695-x; OSTERLING J, 1994, J AUTISM DEV DISORD, V24, P247, DOI 10.1007/BF02172225; Osterling JA, 2002, DEV PSYCHOPATHOL, V14, P239, DOI 10.1017/S0954579402002031; Pradel J, 2009, EVOL HUM BEHAV, V30, P103, DOI 10.1016/j.evolhumbehav.2008.09.003; Reddy V, 2002, BRIT J PSYCHOL, V93, P219, DOI 10.1348/000712602162553; Ross H, 2004, MERRILL PALMER QUART, V50, P61, DOI 10.1353/mpq.2004.0005; SATOW KL, 1975, J EXP SOC PSYCHOL, V11, P501, DOI 10.1016/0022-1031(75)90001-3; Schultz RT, 2005, INT J DEV NEUROSCI, V23, P125, DOI 10.1016/j.ijdevneu.2004.12.012; Stipek D., 1992, MONOGRAPHS SOC RES C, V57; Swettenham J, 1998, J CHILD PSYCHOL PSYC, V39, P747, DOI 10.1111/1469-7610.00373; Talwar V, 2002, MERRILL PALMER QUART, V48, P160, DOI 10.1353/mpq.2002.0009; Talwar V, 2007, INT J BEHAV DEV, V31, P1, DOI 10.1177/0165025406073530; Tennie C, 2010, TRENDS COGN SCI, V14, P482, DOI 10.1016/j.tics.2010.07.003; Tomasello M, 2005, BEHAV BRAIN SCI, V28, P675, DOI 10.1017/S0140525X05000129; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Wetherby AM, 2004, J AUTISM DEV DISORD, V34, P473, DOI 10.1007/s10803-004-2544-y; Xu F, 2010, CHILD DEV, V81, P581, DOI 10.1111/j.1467-8624.2009.01417.x	40	37	37	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e31107	10.1371/journal.pone.0031107	http://dx.doi.org/10.1371/journal.pone.0031107			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	911GB	22303483	Green Published, gold, Green Submitted			2022-12-27	WOS:000301704200062
J	Gaudieri, S; Lucas, M; Lucas, A; McKinnon, E; Albloushi, H; Rauch, A; di Iulio, J; Martino, D; Prescott, SL; Tulic, MK				Gaudieri, Silvana; Lucas, Michaela; Lucas, Andrew; McKinnon, Elizabeth; Albloushi, Hiba; Rauch, Andri; di Iulio, Julia; Martino, David; Prescott, Susan L.; Tulic, Meri K.			Genetic Variations in IL28B and Allergic Disease in Children	PLOS ONE			English	Article							LONGITUDINAL DATA-ANALYSIS; HEPATITIS-C VIRUS; INTERFERON-LAMBDA; SPONTANEOUS CLEARANCE; DENDRITIC CELLS; EXPRESSION; ASTHMA; IL-29	Environmental changes affecting the relationship between the developing immune system and microbial exposure have been implicated in the epidemic rise of allergic disease in developed countries. While early developmental differences in T cell function are well-recognised, there is now emerging evidence that this is related to developmental differences in innate immune function. In this study we sought to examine if differences associated with innate immunity contribute to the altered immune programming recognised in allergic children. Here, we describe for the first time, the association of carriage of the T allele of the tagging single nucleotide polymorphism rs12979860 3 kb upstream of IL28B, encoding the potent innate immune modulator type III interferon lambda (IFN-lambda 3), and allergy in children (p = 0.004; OR 4.56). Strikingly, the association between rs12979860 genotype and allergic disease is enhanced in girls. Furthermore, carriage of the T allele at rs12979860 correlates with differences in the pro-inflammatory profile during the first five years of life suggesting this contributes to the key differences in subsequent innate immune development in children who develop allergic disease. In the context of rising rates of disease, these immunologic differences already present at birth imply very early interaction between genetic predisposition and prenatal environmental influences.	[Gaudieri, Silvana] Univ Western Australia, Sch Anat & Human Biol, Nedlands, WA 6009, Australia; [Gaudieri, Silvana; Albloushi, Hiba] Univ Western Australia, Ctr Forens Sci, Nedlands, WA 6009, Australia; [Gaudieri, Silvana; Lucas, Michaela; Lucas, Andrew; McKinnon, Elizabeth] Murdoch Univ, Inst Immunol & Infect Dis, Murdoch, WA 6150, Australia; [Rauch, Andri] Univ Hosp Bern, Univ Clin Infect Dis, CH-3010 Bern, Switzerland; [Rauch, Andri] Univ Bern, Bern, Switzerland; [di Iulio, Julia] Univ Hosp Ctr, Inst Microbiol, Lausanne, Switzerland; [di Iulio, Julia] Univ Lausanne, Lausanne, Switzerland; [Martino, David; Prescott, Susan L.; Tulic, Meri K.] Univ Western Australia, Sch Paediat & Child Hlth, Nedlands, WA 6009, Australia	University of Western Australia; University of Western Australia; Murdoch University; University of Bern; University Hospital of Bern; University of Bern; University of Lausanne; University of Western Australia	Gaudieri, S (corresponding author), Univ Western Australia, Sch Anat & Human Biol, Nedlands, WA 6009, Australia.	silvana.gaudieri@uwa.edu.au	Prescott, Susan/H-5665-2014; Rauch, Andri/E-9948-2017; Tulic, Meri K/ABB-5138-2020; Martino, DJ/X-1753-2019; Tulic, Meri/P-6613-2016	Rauch, Andri/0000-0001-5297-6062; Tulic, Meri K/0000-0002-2661-2369; Martino, DJ/0000-0001-6823-4696; Tulic, Meri/0000-0002-2661-2369; Lucas, Andrew Douglas/0000-0003-2899-1806; DI IULIO, JULIA/0000-0001-9343-127X; , Silvana/0000-0001-6873-0198; Lucas, Michaela/0000-0001-8881-9990	NHMRC; Raine Medical Research Foundation	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Raine Medical Research Foundation	MKT is supported by an NHMRC Career Development Award and SLP is supported by NHMRC Practitioner Fellowship. ML has been funded from a Raine Medical Research Foundation Priming Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; Contoli M, 2006, NAT MED, V12, P1023, DOI 10.1038/nm1462; di Iulio J, 2011, HEPATOLOGY, V53, P1446, DOI 10.1002/hep.24263; Edwards MR, 2011, EMBO MOL MED, V3, P306, DOI 10.1002/emmm.201100143; Evangelou E, 2011, AM J EPIDEMIOL, V173, P1336, DOI 10.1093/aje/kwr024; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Honda M, 2010, GASTROENTEROLOGY, V139, P499, DOI 10.1053/j.gastro.2010.04.049; Jordan WJ, 2007, GENES IMMUN, V8, P254, DOI 10.1038/sj.gene.6364382; Koltsida O, 2011, EMBO MOL MED, V3, P348, DOI 10.1002/emmm.201100142; Langhans B, 2011, J HEPATOL, V54, P859, DOI 10.1016/j.jhep.2010.08.020; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Martino D, 2011, CHEST, V139, P640, DOI 10.1378/chest.10-1800; Mennechet FJD, 2006, BLOOD, V107, P4417, DOI 10.1182/blood-2005-10-4129; Morrow MP, 2009, BLOOD, V113, P5868, DOI 10.1182/blood-2008-11-190520; Prescott SL, 2008, J ALLERGY CLIN IMMUN, V122, P391, DOI 10.1016/j.jaci.2008.04.042; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Renz H, 2011, NAT IMMUNOL, V12, P273, DOI 10.1038/ni0411-273; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Srinivas S, 2008, IMMUNOLOGY, V125, P492, DOI 10.1111/j.1365-2567.2008.02862.x; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tangye SG, 2009, J IMMUNOL, V182, P21, DOI 10.4049/jimmunol.182.1.21; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Thomas DL, 2000, JAMA-J AM MED ASSOC, V284, P450, DOI 10.1001/jama.284.4.450; Tillmann HL, 2010, GASTROENTEROLOGY, V139, P1586, DOI 10.1053/j.gastro.2010.07.005; Tulic MK, 2011, J ALLERGY CLIN IMMUN, V127, P470, DOI 10.1016/j.jaci.2010.09.020; Urban TJ, 2010, HEPATOLOGY, V52, P1888, DOI 10.1002/hep.23912; Wolk K, 2008, J LEUKOCYTE BIOL, V83, P1181, DOI 10.1189/jlb.0807525; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	28	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30607	10.1371/journal.pone.0030607	http://dx.doi.org/10.1371/journal.pone.0030607			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295096	gold, Green Submitted, Green Published			2022-12-27	WOS:000301640600041
J	Bush, ER; Buesching, CD; Slade, EM; Macdonald, DW				Bush, Emma R.; Buesching, Christina D.; Slade, Eleanor M.; Macdonald, David W.			Woodland Recovery after Suppression of Deer: Cascade effects for Small Mammals, Wood Mice (Apodemus sylvaticus) and Bank Voles (Myodes glareolus)	PLOS ONE			English	Article							RED-BACKED VOLES; WYTHAM-WOODS; CLETHRIONOMYS-GLAREOLUS; TEMPORARY EMIGRATION; VEGETATION STRUCTURE; INCREASING NUMBERS; FOREST; IMPACTS; DENSITY; HABITAT	Over the past century, increases in both density and distribution of deer species in the Northern Hemisphere have resulted in major changes in ground flora and undergrowth vegetation of woodland habitats, and consequentially the animal communities that inhabit them. In this study, we tested whether recovery in the vegetative habitat of a woodland due to effective deer management (from a peak of 0.4-1.5 to <0.17 deer per ha) had translated to the small mammal community as an example of a higher order cascade effect. We compared deer-free exclosures with neighboring open woodland using capture-mark-recapture (CMR) methods to see if the significant difference in bank vole (Myodes glareolus) and wood mouse (Apodemus sylvaticus) numbers between these environments from 2001-2003 persisted in 2010. Using the multi-state Robust Design method in program MARK we found survival and abundance of both voles and mice to be equivalent between the open woodland and the experimental exclosures with no differences in various metrics of population structure (age structure, sex composition, reproductive activity) and individual fitness (weight), although the vole population showed variation both locally and temporally. This suggests that the vegetative habitat - having passed some threshold of complexity due to lowered deer density - has allowed recovery of the small mammal community, although patch dynamics associated with vegetation complexity still remain. We conclude that the response of small mammal communities to environmental disturbance such as intense browsing pressure can be rapidly reversed once the disturbing agent has been removed and the vegetative habitat is allowed to increase in density and complexity, although we encourage caution, as a source/sink dynamic may emerge between old growth patches and the recently disturbed habitat under harsh conditions.	[Bush, Emma R.; Buesching, Christina D.; Slade, Eleanor M.; Macdonald, David W.] Univ Oxford, Dept Zool, Wildlife Conservat Res Unit, Oxford OX1 3PS, England	University of Oxford	Bush, ER (corresponding author), Univ Oxford, Dept Zool, Wildlife Conservat Res Unit, S Parks Rd, Oxford OX1 3PS, England.	emmie.bush@gmail.com	Slade, Eleanor M/O-3874-2014	Slade, Eleanor M/0000-0002-6108-1196; Bush, Emma/0000-0003-4036-125X	People's Trust for Endangered Species; HSBC through Earthwatch Institute	People's Trust for Endangered Species; HSBC through Earthwatch Institute	EB was funded by an internship grant from the People's Trust for Endangered Species. EMS was funded by the HSBC Climate Partnership Programme through the Earthwatch Institute. Additional material costs (such as equipment) were incurred by Oxford University's Wildlife Conservation Research Unit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amar A, 2010, FORESTRY, V83, P345, DOI 10.1093/forestry/cpq017; Anderson CS, 2003, CAN J ZOOL, V81, P897, DOI 10.1139/Z03-074; Brown N, 2000, J APPL ECOL, V37, P1044, DOI 10.1046/j.1365-2664.2000.00573.x; Buesching CD, 2011, BASIC APPL ECOL, V12, P207, DOI 10.1016/j.baae.2011.02.007; Buesching CD, 2010, WYTHAM WOODS: OXFORD'S ECOLOGICAL LABORATORY, P173; Buesching CD, 2008, MAMM BIOL, V73, P318, DOI 10.1016/j.mambio.2007.09.009; Dolman Paul, 2010, British Wildlife, V21, P242; Dolman PM, 2008, WILDLIFE RES, V35, P202, DOI 10.1071/WR07114; Fisher JT, 2005, MAMMAL REV, V35, P51, DOI 10.1111/j.1365-2907.2005.00053.x; Fisher N, 2010, WYTHAM WOODS: OXFORD'S ECOLOGICAL LABORATORY, P197; FLOWERDEW JR, 1978, J ANIM ECOL, V47, P725, DOI 10.2307/3667; Flowerdew JR, 2004, MAMMAL REV, V34, P31, DOI 10.1046/j.0305-1838.2003.00025.x; Flowerdew JR, 2001, FORESTRY, V74, P277, DOI 10.1093/forestry/74.3.277; Flowerdew JR, 1993, MICE VOLES WHITTET B; Fuller RJ, 2001, FORESTRY, V74, P193, DOI 10.1093/forestry/74.3.193; Gill RMA, 2007, IBIS, V149, P119, DOI 10.1111/j.1474-919X.2007.00731.x; Gurnell J., 2006, LIVE TRAPPING SMALL, VFourth edition, revised ed.; HALAMA KJ, 1994, OIKOS, V69, P107, DOI 10.2307/3545289; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Holt CA, 2010, IBIS, V152, P335, DOI 10.1111/j.1474-919X.2010.01012.x; HUTCHINGS MJ, 1978, OIKOS, V31, P351, DOI 10.2307/3543662; ILLIUS AW, 1992, OECOLOGIA, V89, P428, DOI 10.1007/BF00317422; Kendall WL, 1997, ECOLOGY, V78, P563; KENDALL WL, 1995, BIOMETRICS, V51, P293, DOI 10.2307/2533335; Kendall WL, 1995, J APPL STAT, V22, P751, DOI 10.1080/02664769524595; Kendall WL, 2011, PROGRAM MARK GENTLE; Kirby KJ, 2000, J VEG SCI, V11, P871, DOI 10.2307/3236557; KORN H, 1986, OECOLOGIA, V68, P623, DOI 10.1007/BF00378782; Koskela E, 1997, J ANIM ECOL, V66, P341, DOI 10.2307/5980; MacDonald D.W., 1993, MAMMALS BRITAIN EURO; MACDONALD DC, 1998, PROPOSALS FUTURE MON; Mathisen KM, 2010, J VEG SCI, V21, P705, DOI 10.1111/j.1654-1103.2010.01180.x; McDonald RA, 2000, J ZOOL, V252, P363, DOI 10.1111/j.1469-7998.2000.tb00631.x; MILLS LS, 1995, CONSERV BIOL, V9, P395, DOI 10.1046/j.1523-1739.1995.9020395.x; Milner JM, 2006, J APPL ECOL, V43, P721, DOI 10.1111/j.1365-2664.2006.01183.x; Minitab I., 2007, MINITAB 15 STAT SOFT; Monamy V, 2000, AUSTRAL ECOL, V25, P580, DOI 10.1046/j.1442-9993.2000.01057.x; Morecroft MD, 2001, FORESTRY, V74, P251, DOI 10.1093/forestry/74.3.251; Morecroft MD, RECOVERY WOODL UNPUB; Moser BW, 2000, INT BIODETER BIODEGR, V45, P151, DOI 10.1016/S0964-8305(00)00036-6; OSTFELD RS, 1990, TRENDS ECOL EVOL, V5, P411, DOI 10.1016/0169-5347(90)90026-A; Perrins CM, 2001, FORESTRY, V74, P299, DOI 10.1093/forestry/74.3.299; PUTMAN RJ, 1989, BIOL CONSERV, V47, P13, DOI 10.1016/0006-3207(89)90017-7; Runge JP, 2006, AM NAT, V167, P925, DOI 10.1086/503531; Selas V, 2010, EUROPEAN J WILDLIFE, V57, P1; Sibbald S., 2006, PROPOSAL NATL MONITO; Smit R, 2001, PLANT ECOL, V155, P119, DOI 10.1023/A:1013239805915; SOUTHERN HN, 1968, J ANIM ECOL, V37, P75, DOI 10.2307/2712; Stewart AJA, 2001, FORESTRY, V74, P259, DOI 10.1093/forestry/74.3.259; Tallmon DA, 2004, CONSERV BIOL, V18, P1658, DOI 10.1111/j.1523-1739.2004.00439.x; WATKINSON AR, 1995, J ANIM ECOL, V64, P126, DOI 10.2307/5833; WATTS CHS, 1968, J ANIM ECOL, V37, P25, DOI 10.2307/2709; White G. C., 2001, WILDLIFE LAND PEOPLE, P368; Zwolak R, 2008, CAN J ZOOL, V86, P83, DOI 10.1139/Z07-126	55	24	25	2	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31404	10.1371/journal.pone.0031404	http://dx.doi.org/10.1371/journal.pone.0031404			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347472	Green Submitted, gold, Green Published			2022-12-27	WOS:000302730100068
J	Dawson, EH; Chittka, L				Dawson, Erika H.; Chittka, Lars			Conspecific and Heterospecific Information Use in Bumblebees	PLOS ONE			English	Article							SOCIAL INFORMATION; BEES; EXPERIENCE; INSECTS; FLOWERS; TIME	Heterospecific social learning has been understudied in comparison to interactions between members of the same species. However, the learning mechanisms behind such information use can allow animals to be flexible in the cues that are used. This raises the question of whether conspecific cues are inherently more influential than cues provided by heterospecifics, or whether animals can simply use any cue that predicts fitness enhancing conditions, including those provided by heterospecifics. To determine how freely social information travels across species boundaries, we trained bumblebees (Bombus terrestris) to learn to use cues provided by conspecifics and heterospecific honey bees (Apis mellifera) to locate valuable floral resources. We found that heterospecific demonstrators did not differ from conspecifics in the extent to which they guided observers' choices, whereas various types of inorganic visual cues were consistently less effective than conspecifics. This was also true in a transfer test where bees were confronted with a novel flower type. However, in the transfer test, conspecifics were slightly more effective than heterospecific demonstrators. We then repeated the experiment with entirely naive bees that had never foraged alongside conspecifics before. In this case, heterospecific demonstrators were equally efficient as conspecifics both in the initial learning task and the transfer test. Our findings demonstrate that social learning is not a unique process limited to conspecifics and that through associative learning, interspecifically sourced information can be just as valuable as that provided by conspecific individuals. Furthermore the results of this study highlight potential implications for understanding competition within natural pollinator communities.	[Dawson, Erika H.; Chittka, Lars] Queen Mary Univ London, Sch Biol & Chem Sci, Biol & Expt Psychol Grp, London, England	University of London; Queen Mary University London	Dawson, EH (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, Biol & Expt Psychol Grp, London, England.	l.chittka@qmul.ac.uk	Chittka, Lars/C-3110-2012; Dawson, Erika H/D-9734-2017	Chittka, Lars/0000-0001-8153-1732; Dawson, Erika H/0000-0002-1445-3575				Baude M, 2011, P ROY SOC B-BIOL SCI, V278, P2806, DOI 10.1098/rspb.2010.2659; Chittka L, 2005, CURR BIOL, V15, pR869, DOI 10.1016/j.cub.2005.10.018; de Waal FBM, 2010, TRENDS COGN SCI, V14, P201, DOI 10.1016/j.tics.2010.03.003; Dyer AG, 2005, J EXP BIOL, V208, P4709, DOI 10.1242/jeb.01929; Forrest J, 2009, P ROY SOC B-BIOL SCI, V276, P935, DOI 10.1098/rspb.2008.1434; Goodale E, 2010, TRENDS ECOL EVOL, V25, P354, DOI 10.1016/j.tree.2010.01.002; GOULSON D, 2003, BUMBLEBEES THEIR BEH; HEYES CM, 1994, BIOL REV, V69, P207, DOI 10.1111/j.1469-185X.1994.tb01506.x; Kapustjansky A, 2010, NATURWISSENSCHAFTEN, V97, P229, DOI 10.1007/s00114-009-0627-5; Kawaguchi LG, 2007, P ROY SOC B-BIOL SCI, V274, P2661, DOI 10.1098/rspb.2007.0860; Leadbeater E, 2005, CURR BIOL, V15, pR447, DOI 10.1016/j.cub.2005.06.011; Leadbeater E, 2008, P ROY SOC B-BIOL SCI, V275, P1669, DOI 10.1098/rspb.2008.0270; Leadbeater E, 2007, CURR BIOL, V17, pR703, DOI 10.1016/j.cub.2007.06.012; Leadbeater E, 2007, BEHAV ECOL SOCIOBIOL, V61, P1789, DOI 10.1007/s00265-007-0412-4; Leadbeater E, 2009, BIOL LETTERS, V5, P310, DOI 10.1098/rsbl.2008.0692; Lichtenberg EM, 2011, BEHAV ECOL SOCIOBIOL, V65, P763, DOI 10.1007/s00265-010-1080-3; Seppanen JT, 2007, ECOLOGY, V88, P1622, DOI 10.1890/06-1757.1; Slaa EJ, 2003, ECOL ENTOMOL, V28, P369, DOI 10.1046/j.1365-2311.2003.00512.x; Stelzer RJ, 2010, J ZOOL, V282, P75, DOI 10.1111/j.1469-7998.2010.00709.x; Waser NM, 1996, ECOLOGY, V77, P1043, DOI 10.2307/2265575; WASER NM, 1982, OECOLOGIA, V55, P251, DOI 10.1007/BF00384496; Worden BD, 2005, BIOL LETT-UK, V1, P504, DOI 10.1098/rsbl.2005.0368	22	53	54	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31444	10.1371/journal.pone.0031444	http://dx.doi.org/10.1371/journal.pone.0031444			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347479	gold, Green Published			2022-12-27	WOS:000302730100072
J	Lin, IH; Ho, ML; Chen, HY; Lee, HS; Huang, CC; Chu, YH; Lin, SY; Deng, YR; He, YH; Lien, YH; Hsu, CW; Wong, RH				Lin, I-Hsin; Ho, Ming-Lin; Chen, Hsuan-Yu; Lee, Hong-Shen; Huang, Chia-Chen; Chu, Yin-Hung; Lin, Shiau-Yun; Deng, Ya-Ru; He, Yu-Hao; Lien, Yu-Hui; Hsu, Chi-Wen; Wong, Ruey-Hong			Smoking, Green Tea Consumption, Genetic Polymorphisms in the Insulin-Like Growth Factors and Lung Cancer Risk	PLOS ONE			English	Article							FACTOR-I; PROSTATE-CANCER; PLASMA-LEVELS; SERUM-LEVELS; IGF2 GENE; REPEAT; ASSOCIATION; POLYPHENOLS; AGE	Insulin-like growth factors (IGFs) are mediators of growth hormones; they have an influence on cell proliferation and differentiation. In addition, IGF-binding protein (IGFBP)-3 could suppress the mitogenic action of IGFs. Interestingly, tea polyphenols could substantially reduce IGF1 and increase IGFBP3. In this study, we evaluated the effects of smoking, green tea consumption, as well as IGF1, IGF2, and IGFBP3 polymorphisms, on lung cancer risk. Questionnaires were administered to obtain the subjects' characteristics, including smoking habits and green tea consumption from 170 primary lung cancer cases and 340 healthy controls. Genotypes for IGF1, IGF2, and IGFBP3 were identified by polymerase chain reaction. Lung cancer cases had a higher proportion of smoking, green tea consumption of less than one cup per day, exposure to cooking fumes, and family history of lung cancer than controls. After adjusting the confounding effect, an elevated risk was observed in smokers who never drank green tea, as compared to smokers who drank green tea more than one cup per day (odds ratio (OR) = 13.16, 95% confidence interval (CI) = 2.96-58.51). Interaction between smoking and green tea consumption on lung cancer risk was also observed. Among green tea drinkers who drank more than one cup per day, IGF1 (CA)(19)/(CA)(19) and (CA)(19)/X genotypes carriers had a significantly reduced risk of lung cancer (OR = 0.06, 95% CI = 0.01-0.44) compared with IGF1 X/X carriers. Smoking-induced pulmonary carcinogenesis could be modulated by green tea consumption and their growth factor environment.	[Lin, I-Hsin] Chung Shan Med Univ, Inst Publ Hlth, Taichung, Taiwan; [Ho, Ming-Lin] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Ho, Ming-Lin] Changhua Christian Hosp, Dept Internal Med, Div Pulm Med, Changhua, Taiwan; [Chen, Hsuan-Yu] Acad Sinica, Inst Stat Sci, Taipei 11529, Taiwan; [Lee, Hong-Shen; Huang, Chia-Chen; Chu, Yin-Hung; Lin, Shiau-Yun; Deng, Ya-Ru; He, Yu-Hao; Lien, Yu-Hui; Hsu, Chi-Wen; Wong, Ruey-Hong] Chung Shan Med Univ, Dept Publ Hlth, Taichung, Taiwan; [Wong, Ruey-Hong] Chung Shan Med Univ Hosp, Dept Occupat Med, Taichung, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Changhua Christian Hospital; Academia Sinica - Taiwan; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital	Lin, IH (corresponding author), Chung Shan Med Univ, Inst Publ Hlth, Taichung, Taiwan.	rueyhong@csmu.edu.tw	Chen, Hsuan-Yu/AAE-8428-2019		National Science Council, Taiwan [NSC-98-2815-C-040-028-B, NSC 95-2815-C-040-019-B, NSC 93-2815-C-040-008-B]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by National Science Council, Taiwan (NSC-98-2815-C-040-028-B; NSC 95-2815-C-040-019-B; NSC 93-2815-C-040-008-B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhami VM, 2004, CANCER RES, V64, P8715, DOI 10.1158/0008-5472.CAN-04-2840; Chang CH, 2009, AM J EPIDEMIOL, V170, P695, DOI 10.1093/aje/kwp019; Chen KY, 2005, CANCER-AM CANCER SOC, V103, P2566, DOI 10.1002/cncr.21087; Chen X, 2008, J HUM GENET, V53, P227, DOI 10.1007/s10038-007-0241-3; CHURCH DF, 1985, ENVIRON HEALTH PERSP, V64, P111, DOI 10.2307/3430003; Deal C, 2001, J CLIN ENDOCR METAB, V86, P1274, DOI 10.1210/jc.86.3.1274; DeLellis K, 2003, BRIT J CANCER, V88, P277, DOI 10.1038/sj.bjc.6600728; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gaunt TR, 2001, HUM MOL GENET, V10, P1491, DOI 10.1093/hmg/10.14.1491; GRAHAM HN, 1992, PREV MED, V21, P334, DOI 10.1016/0091-7435(92)90041-F; Hernandez W, 2007, CARCINOGENESIS, V28, P2154, DOI 10.1093/carcin/bgm190; Hodgson JM, 2004, BRIT J NUTR, V91, P301, DOI 10.1079/BJN20031046; Jernstrom H, 2001, MOL GENET METAB, V72, P144, DOI 10.1006/mgme.2000.3130; Jian L, 2006, PUBLIC HEALTH NUTR, V9, P928, DOI 10.1017/PHN2005919; Kaklamani VG, 1999, J CLIN ONCOL, V17, P813, DOI 10.1200/JCO.1999.17.3.813; Khan N, 2006, CANCER RES, V66, P2500, DOI 10.1158/0008-5472.CAN-05-3636; Kim YJ, 2006, BIOCHEM BIOPH RES CO, V346, P38, DOI 10.1016/j.bbrc.2006.05.080; KINLEN LJ, 1988, BRIT J CANCER, V58, P397, DOI 10.1038/bjc.1988.227; Li Q, 2008, BRIT J CANCER, V99, P1179, DOI 10.1038/sj.bjc.6604645; MACAULAY VM, 1992, BRIT J CANCER, V65, P311, DOI 10.1038/bjc.1992.65; ODell SD, 1997, INT J OBESITY, V21, P822, DOI 10.1038/sj.ijo.0800483; Ogawa K, 2003, PUBLIC HEALTH NUTR, V6, P147, DOI 10.1079/PHN2002411; Patel R, 2000, J MOL CELL CARDIOL, V32, P2369, DOI 10.1006/jmcc.2000.1267; PRYOR W A, 1987, British Journal of Cancer, V55, P19; Ren ZF, 2004, CANCER EPIDEM BIOMAR, V13, P1290; Rosen CJ, 1998, J CLIN ENDOCR METAB, V83, P2286, DOI 10.1210/jc.83.7.2286; Schildkraut JM, 2005, CANCER EPIDEM BIOMAR, V14, P403, DOI 10.1158/1055-9965.EPI-04-0426; Shankar S, 2007, FRONT BIOSCI-LANDMRK, V12, P4881, DOI 10.2741/2435; Shimizu M, 2005, BIOCHEM BIOPH RES CO, V334, P947, DOI 10.1016/j.bbrc.2005.06.182; Thun MJ, 2002, ONCOGENE, V21, P7307, DOI 10.1038/sj.onc.1205807; Tsubono Y, 2001, NEW ENGL J MED, V344, P632, DOI 10.1056/NEJM200103013440903; Wang LZ, 2003, CANCER RES, V63, P4407; World Health Organization, 1981, HIST TYP LUNG TUM; YANG CS, 1993, J NATL CANCER I, V85, P1038, DOI 10.1093/jnci/85.13.1038; Yu H, 2000, JNCI-J NATL CANCER I, V92, P1472, DOI 10.1093/jnci/92.18.1472; Yu H, 1999, JNCI-J NATL CANCER I, V91, P151, DOI 10.1093/jnci/91.2.151	36	26	29	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2012	7	2							e30951	10.1371/journal.pone.0030951	http://dx.doi.org/10.1371/journal.pone.0030951			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917MF	22347413	Green Published, Green Submitted, gold			2022-12-27	WOS:000302180600018
J	Weiner, B; Gomez, J; Victor, TC; Warren, RM; Sloutsky, A; Plikaytis, BB; Posey, JE; van Helden, PD; Gey van Pittius, NC; Koehrsen, M; Sisk, P; Stolte, C; White, J; Gagneux, S; Birren, B; Hung, D; Murray, M; Galagan, J				Weiner, Brian; Gomez, James; Victor, Thomas C.; Warren, Robert M.; Sloutsky, Alexander; Plikaytis, Bonnie B.; Posey, James E.; van Helden, Paul D.; Gey van Pittius, Nicolass C.; Koehrsen, Michael; Sisk, Peter; Stolte, Christian; White, Jared; Gagneux, Sebastien; Birren, Bruce; Hung, Deborah; Murray, Megan; Galagan, James			Independent Large Scale Duplications in Multiple M. tuberculosis Lineages Overlapping the Same Genomic Region	PLOS ONE			English	Article							LATERAL GENE-TRANSFER; IS6110-MEDIATED DELETION POLYMORPHISM; MYCOBACTERIUM-TUBERCULOSIS; ADAPTIVE EVOLUTION; SEQUENCE; AMPLIFICATION; ASSOCIATION; DIVERSITY; INSIGHTS; REVEALS	Mycobacterium tuberculosis, the causative agent of most human tuberculosis, infects one third of the world's population and kills an estimated 1.7 million people a year. With the world-wide emergence of drug resistance, and the finding of more functional genetic diversity than previously expected, there is a renewed interest in understanding the forces driving genome evolution of this important pathogen. Genetic diversity in M. tuberculosis is dominated by single nucleotide polymorphisms and small scale gene deletion, with little or no evidence for large scale genome rearrangements seen in other bacteria. Recently, a single report described a large scale genome duplication that was suggested to be specific to the Beijing lineage. We report here multiple independent large-scale duplications of the same genomic region of M. tuberculosis detected through whole-genome sequencing. The duplications occur in strains belonging to both M. tuberculosis lineage 2 and 4, and are thus not limited to Beijing strains. The duplications occur in both drug-resistant and drug susceptible strains. The duplicated regions also have substantially different boundaries in different strains, indicating different originating duplication events. We further identify a smaller segmental duplication of a different genomic region of a lab strain of H37Rv. The presence of multiple independent duplications of the same genomic region suggests either instability in this region, a selective advantage conferred by the duplication, or both. The identified duplications suggest that large-scale gene duplication may be more common in M. tuberculosis than previously considered.	[Weiner, Brian; Gomez, James; Koehrsen, Michael; Sisk, Peter; Stolte, Christian; White, Jared; Birren, Bruce; Hung, Deborah; Galagan, James] Broad Inst, Cambridge, MA USA; [Victor, Thomas C.; Warren, Robert M.; van Helden, Paul D.; Gey van Pittius, Nicolass C.] Univ Stellenbosch, Div Mol Biol & Human Genet, Ctr Excellence TB Res,Natl Res Fdn,Dept Biomed Sc, Med Res Council,Ctr Mol & Cellular Biol,Fac Hlth, ZA-7505 Tygerberg, South Africa; [Sloutsky, Alexander] Univ Massachusetts, Sch Med, Ctr Hlth Policy & Res, Massachusetts Supranat TB Reference Lab, Shrewsbury, MA USA; [Plikaytis, Bonnie B.; Posey, James E.] Ctr Dis Control & Prevent, Mycobacteriol Lab Branch, Div TB Eliminat, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA USA; [Gagneux, Sebastien] Natl Inst Med Res, Med Res Council, London NW7 1AA, England; [Murray, Megan] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Galagan, James] Boston Univ, Dept Biomed Engn & Microbiol, Boston, MA 02215 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; National Research Foundation - South Africa; South African Medical Research Council; Stellenbosch University; University of Massachusetts System; Centers for Disease Control & Prevention - USA; MRC National Institute for Medical Research; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); Harvard University; Harvard T.H. Chan School of Public Health; Boston University	Weiner, B (corresponding author), Broad Inst, Cambridge, MA USA.	jgalag@bu.edu	van Pittius, Nicolaas C Gey/D-3434-2015; Gagneux, Sebastien/ABE-7909-2020	van Pittius, Nicolaas C Gey/0000-0002-8807-4105; Weiner, Brian/0000-0002-7285-4385; Gagneux, Sebastien/0000-0001-7783-9048; Galagan, James/0000-0003-0542-3291; Stolte, Christian/0000-0002-8228-4195; Warren, Robin/0000-0001-5741-7358	National Institute of Allergy and Infectious Diseases National Institutes of Health, Department of Health and Human Services [HHSN27220090018C]; Ellison Medical Foundation [ID-SS-0693-04]	National Institute of Allergy and Infectious Diseases National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Ellison Medical Foundation(Lawrence Ellison Foundation)	This project has been funded in whole or in part with Federal funds from the National Institute of Allergy and Infectious Diseases National Institutes of Health, Department of Health and Human Services, under Contract No.: HHSN27220090018C; and Ellison Medical Foundation Grant ID-SS-0693-04. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alland D, 2007, J CLIN MICROBIOL, V45, P39, DOI 10.1128/JCM.02483-05; Andersson DI, 2009, ANNU REV GENET, V43, P167, DOI 10.1146/annurev-genet-102108-134805; Becq J, 2007, MOL BIOL EVOL, V24, P1861, DOI 10.1093/molbev/msm111; Boucher Y, 2003, ANNU REV GENET, V37, P283, DOI 10.1146/annurev.genet.37.050503.084247; Brosch R, 2000, YEAST, V17, P111, DOI 10.1002/1097-0061(20000630)17:2<111::AID-YEA17>3.0.CO;2-G; Brosch R, 2001, TRENDS MICROBIOL, V9, P452, DOI 10.1016/S0966-842X(01)02131-X; Camus JC, 2002, MICROBIOL-SGM, V148, P2967, DOI 10.1099/00221287-148-10-2967; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Comas I, 2010, NAT GENET, V42, P498, DOI 10.1038/ng.590; Darling AE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000128; DeLuna A, 2008, NAT GENET, V40, P676, DOI 10.1038/ng.123; Domenech P, 2010, J BACTERIOL, V192, P4562, DOI 10.1128/JB.00536-10; EDLUND T, 1981, NATURE, V292, P269, DOI 10.1038/292269a0; Fang Z, 1999, J BACTERIOL, V181, P1014, DOI 10.1128/JB.181.3.1014-1020.1999; Fang Z, 1998, J BACTERIOL, V180, P2102, DOI 10.1128/JB.180.8.2102-2109.1998; Fang Z, 2001, J BACTERIOL, V183, P5279, DOI 10.1128/JB.183.18.5279-5284.2001; Fang ZG, 1997, J CLIN MICROBIOL, V35, P479, DOI 10.1128/JCM.35.2.479-481.1997; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Galamba A, 2001, MICROBIOL-SGM, V147, P3281, DOI 10.1099/00221287-147-12-3281; Gey van Pittius NC, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-95; Gray YHM, 2000, TRENDS GENET, V16, P461, DOI 10.1016/S0168-9525(00)02104-1; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gutierrez MC, 2005, PLOS PATHOG, V1, P55, DOI 10.1371/journal.ppat.0010005; Hershberg R, 2008, PLOS BIOL, V6, P2658, DOI 10.1371/journal.pbio.0060311; Hirsh AE, 2004, P NATL ACAD SCI USA, V101, P4871, DOI 10.1073/pnas.0305627101; Ho TBL, 2000, YEAST, V17, P272, DOI 10.1002/1097-0061(200012)17:4&lt;272::AID-YEA48&gt;3.0.CO;2-2; Hughes AL, 2002, EMERG INFECT DIS, V8, P1342, DOI 10.3201/eid0811.020064; Jang J, 2008, TRENDS MICROBIOL, V16, P303, DOI 10.1016/j.tim.2008.04.005; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Kinsella RJ, 2003, P NATL ACAD SCI USA, V100, P10320, DOI 10.1073/pnas.1737230100; Kondrashov FA, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-2-research0008; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Lynch M, 2000, GENETICS, V154, P459; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Ohno S., 1970, EVOLUTION GENE DUPLI; ROGALL T, 1990, INT J SYST BACTERIOL, V40, P323, DOI 10.1099/00207713-40-4-323; Sampson SL, 2004, J CLIN MICROBIOL, V42, P895, DOI 10.1128/JCM.42.2.895-898.2004; Sampson SL, 2003, J BACTERIOL, V185, P2856, DOI 10.1128/JB.185.9.2856-2866.2003; Sandegren L, 2009, NAT REV MICROBIOL, V7, P578, DOI 10.1038/nrmicro2174; Sandgren A, 2009, PLOS MED, V6, P132, DOI 10.1371/journal.pmed.1000002; Sreevatsan S, 1997, P NATL ACAD SCI USA, V94, P9869, DOI 10.1073/pnas.94.18.9869; Stinear TP, 2008, GENOME RES, V18, P729, DOI 10.1101/gr.075069.107; Supply P, 2003, MOL MICROBIOL, V47, P529, DOI 10.1046/j.1365-2958.2003.03315.x; Tsolaki AG, 2004, P NATL ACAD SCI USA, V101, P4865, DOI 10.1073/pnas.0305634101; Veyrier FJ, 2011, TRENDS MICROBIOL, V19, P156, DOI 10.1016/j.tim.2010.12.008	46	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2012	7	2							e26038	10.1371/journal.pone.0026038	http://dx.doi.org/10.1371/journal.pone.0026038			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917MF	22347359	Green Published, Green Accepted, gold			2022-12-27	WOS:000302180600002
J	Chen, V; Staub, RE; Fong, S; Tagliaferri, M; Cohen, I; Shtivelman, E				Chen, Vivian; Staub, Richard E.; Fong, Sylvia; Tagliaferri, Mary; Cohen, Isaac; Shtivelman, Emma			Bezielle Selectively Targets Mitochondria of Cancer Cells to Inhibit Glycolysis and OXPHOS	PLOS ONE			English	Article							SCUTELLARIA-BARBATA; BREAST-CANCER; ANTICANCER ACTIVITY; ROS RELEASE; DEATH; EXTRACT; APOPTOSIS; BZL101; POLY(ADP-RIBOSE); MECHANISMS	Bezielle (BZL101) is a candidate oral drug that has shown promising efficacy and excellent safety in the early phase clinical trials for advanced breast cancer. Bezielle is an aqueous extract from the herb Scutellaria barbata. We have reported previously that Bezielle was selectively cytotoxic to cancer cells while sparing non-transformed cells. In tumor, but not in non-transformed cells, Bezielle induced generation of ROS and severe DNA damage followed by hyperactivation of PARP, depletion of the cellular ATP and NAD, and inhibition of glycolysis. We show here that tumor cells' mitochondria are the primary source of reactive oxygen species induced by Bezielle. Treatment with Bezielle induces progressively higher levels of mitochondrial superoxide as well as peroxide-type ROS. Inhibition of mitochondrial respiration prevents generation of both types of ROS and protects cells from Bezielle-induced death. In addition to glycolysis, Bezielle inhibits oxidative phosphorylation in tumor cells and depletes mitochondrial reserve capacity depriving cells of the ability to produce ATP. Tumor cells lacking functional mitochondria maintain glycolytic activity in presence of Bezielle thus supporting the hypothesis that mitochondria are the primary target of Bezielle. The metabolic effects of Bezielle towards normal cells are not significant, in agreement with the low levels of oxidative damage that Bezielle inflicts on them. Bezielle is therefore a drug that selectively targets cancer cell mitochondria, and is distinguished from other such drugs by its ability to induce not only inhibition of OXPHOS but also of glycolysis. This study provides a better understanding of the mechanism of Bezielle's cytotoxicity, and the basis of its selectivity towards cancer cells.	[Chen, Vivian; Staub, Richard E.; Fong, Sylvia; Tagliaferri, Mary; Cohen, Isaac; Shtivelman, Emma] BioNovo Inc, Emeryville, CA USA		Chen, V (corresponding author), BioNovo Inc, Emeryville, CA USA.	emmas@bionovo.com		Fong, Sylvia/0000-0002-3818-4146	BioNovo, Inc.; BioNovo. Bezielle [BZL101]	BioNovo, Inc.; BioNovo. Bezielle	This research was supported entirely by BioNovo, Inc. No external funding was received for this study. The funder played a role in the decision to research Bezielle as an anti-cancer agent, but had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge that they are paid employees and stock holders of BioNovo, Inc, and that this study, in its entirety, was supported by funds from BioNovo. Bezielle (BZL101) is Bionovo's proprietary botanical drug candidate (FDA-IND: 59,521) for the treatment of metastatic breast cancer. Bionovo's United States Patent No. 7,700,136 covers a method of treating breast cancer using an extract of Scutellaria Barbata. This patent also covers the use of Bionovo's proprietary BezielleR formulation as a monotherapy for the treatment of breast cancer. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Alano CC, 2010, J NEUROSCI, V30, P2967, DOI 10.1523/JNEUROSCI.5552-09.2010; Batandier C, 2002, J CELL MOL MED, V6, P175, DOI 10.1111/j.1582-4934.2002.tb00185.x; Cha YY, 2004, CLIN CHIM ACTA, V348, P41, DOI 10.1016/j.cccn.2004.04.013; Chen G, 2010, MITOCHONDRION, V10, P614, DOI 10.1016/j.mito.2010.08.001; Choi SW, 2009, J NEUROCHEM, V109, P1179, DOI 10.1111/j.1471-4159.2009.06055.x; Chui CH, 2005, INT J MOL MED, V16, P337; Dai Zhi-jun, 2008, Nan Fang Yi Ke Da Xue Xue Bao, V28, P1835; Desouki MM, 2005, CANCER BIOL THER, V4, P1367, DOI 10.4161/cbt.4.12.2233; Dranka BP, 2010, FREE RADICAL BIO MED, V48, P905, DOI 10.1016/j.freeradbiomed.2010.01.015; Fong S, 2008, CANCER BIOL THER, V7, P577, DOI 10.4161/cbt.7.4.5535; Goh D, 2005, J AGR FOOD CHEM, V53, P8197, DOI 10.1021/jf051506+; Graham KA, 2010, CANCER BIOL THER, V10, DOI 10.4161/cbt.10.3.12207; Hegedus C, 2008, FEBS LETT, V582, P1672, DOI 10.1016/j.febslet.2008.04.023; Kim EK, 2007, INT J MOL MED, V20, P123; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Klawitter J, 2011, INT J CANCER, V129, P2945, DOI 10.1002/ijc.25965; LEBEL CP, 1992, CHEM RES TOXICOL, V5, P227, DOI 10.1021/tx00026a012; Lee SB, 2006, J BIOL CHEM, V281, P36228, DOI 10.1074/jbc.M606702200; Li YB, 1998, BIOCHEM BIOPH RES CO, V253, P295, DOI 10.1006/bbrc.1998.9729; MAJANDER A, 1994, J BIOL CHEM, V269, P21037; Marconett CN, 2010, CANCER BIOL THER, V10, P397, DOI 10.4161/cbt.10.4.12424; Neuzil J, 2007, MOL PHARMACOL, V71, P1185, DOI 10.1124/mol.106.030122; Parajuli P, 2009, PLANTA MED, V75, P41, DOI 10.1055/s-0028-1088364; Parajuli P, 2011, J NEURO-ONCOL, V101, P15, DOI 10.1007/s11060-010-0221-x; Perez AT, 2010, BREAST CANCER RES TR, V120, P111, DOI 10.1007/s10549-009-0678-5; Rouleau M, 2010, NAT REV CANCER, V10, P293, DOI 10.1038/nrc2812; Rugo H, 2007, BREAST CANCER RES TR, V105, P17, DOI 10.1007/s10549-006-9430-6; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Shoemaker M, 2005, PHYTOTHER RES, V19, P649, DOI 10.1002/ptr.1702; Sun XG, 2006, CELL CYCLE, V5, P2029, DOI 10.4161/cc.5.17.3312; von Kleist-Retzow JC, 2007, EXP CELL RES, V313, P3076, DOI 10.1016/j.yexcr.2007.04.015; Wong BYY, 2009, EUR J CANCER PREV, V18, P331, DOI 10.1097/CEJ.0b013e32832c3859; Wong BYY, 1996, CANCER BIOTHER RADIO, V11, P51, DOI 10.1089/cbr.1996.11.51; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Yin XL, 2004, LIFE SCI, V75, P2233, DOI 10.1016/j.lfs.2004.05.015; Ying WH, 2003, BIOCHEM BIOPH RES CO, V308, P809, DOI 10.1016/S0006-291X(03)01483-9; Zong WX, 2004, GENE DEV, V18, P1272, DOI 10.1101/gad.1199904; Zorov DB, 2000, J EXP MED, V192, P1001, DOI 10.1084/jem.192.7.1001; Zorov DB, 2006, BBA-BIOENERGETICS, V1757, P509, DOI 10.1016/j.bbabio.2006.04.029	39	34	38	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e30300	10.1371/journal.pone.0030300	http://dx.doi.org/10.1371/journal.pone.0030300			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LO	22319564	Green Published, Green Submitted, gold			2022-12-27	WOS:000302178400006
J	Dotsch, A; Eckweiler, D; Schniederjans, M; Zimmermann, A; Jensen, V; Scharfe, M; Geffers, R; Haussler, S				Doetsch, Andreas; Eckweiler, Denitsa; Schniederjans, Monika; Zimmermann, Ariane; Jensen, Vanessa; Scharfe, Maren; Geffers, Robert; Haeussler, Susanne			The Pseudomonas aeruginosa Transcriptome in Planktonic Cultures and Static Biofilms Using RNA Sequencing	PLOS ONE			English	Article							SIGNAL RECOGNITION PARTICLE; GLOBAL GENE-EXPRESSION; CYSTIC-FIBROSIS LUNG; III SECRETION; DIFFERENTIAL EXPRESSION; AEROBIC RESPIRATION; BACTERIAL BIOFILMS; MATURE BIOFILMS; MECHANISMS; INFECTION	In this study, we evaluated how gene expression differs in mature Pseudomonas aeruginosa biofilms as opposed to planktonic cells by the use of RNA sequencing technology that gives rise to both quantitative and qualitative information on the transcriptome. Although a large proportion of genes were consistently regulated in both the stationary phase and biofilm cultures as opposed to the late exponential growth phase cultures, the global biofilm gene expression pattern was clearly distinct indicating that biofilms are not just surface attached cells in stationary phase. A large amount of the genes found to be biofilm specific were involved in adaptation to microaerophilic growth conditions, repression of type three secretion and production of extracellular matrix components. Additionally, we found many small RNAs to be differentially regulated most of them similarly in stationary phase cultures and biofilms. A qualitative analysis of the RNA-seq data revealed more than 3000 putative transcriptional start sites (TSS). By the use of rapid amplification of cDNA ends (5'-RACE) we confirmed the presence of three different TSS associated with the pqsABCDE operon, two in the promoter of pqsA and one upstream of the second gene, pqsB. Taken together, this study reports the first transcriptome study on P. aeruginosa that employs RNA sequencing technology and provides insights into the quantitative and qualitative transcriptome including the expression of small RNAs in P. aeruginosa biofilms.	[Doetsch, Andreas; Eckweiler, Denitsa; Schniederjans, Monika; Zimmermann, Ariane; Scharfe, Maren; Geffers, Robert; Haeussler, Susanne] Helmholtz Ctr Infect Res, Braunschweig, Germany; [Jensen, Vanessa; Haeussler, Susanne] Ctr Clin & Expt Infect Res, Hannover, Germany	Helmholtz Association; Helmholtz-Center for Infection Research	Dotsch, A (corresponding author), Helmholtz Ctr Infect Res, Braunschweig, Germany.	andreas.doetsch@helmholtz-hzi.de	Eckweiler, Denitsa/I-9009-2019; Häussler, Susanne/I-2605-2014; Dötsch, Andreas/H-1383-2013; Dötsch, Andreas/AAL-6015-2020; Pohl, Sarah/B-3102-2016	Eckweiler, Denitsa/0000-0002-3702-8846; Häussler, Susanne/0000-0001-6141-9102; Dötsch, Andreas/0000-0001-9086-2584; Dötsch, Andreas/0000-0001-9086-2584; Pohl, Sarah/0000-0003-2655-7037	Helmholtz Gemeinschaft [VH-NG-135]; Mukoviszidose e.V. [S07/05]; European Research Council [260276]	Helmholtz Gemeinschaft(Helmholtz Association); Mukoviszidose e.V.; European Research Council(European Research Council (ERC)European Commission)	Financial support from the Helmholtz Gemeinschaft (http://www.helmholtz.de/, grant VH-NG-135), Mukoviszidose e.V. (http://muko.info/, grant S07/05) and the European Research Council (http://erc.europa.eu/, grant 260276) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Ortega C, 2007, MOL MICROBIOL, V65, P153, DOI 10.1111/j.1365-2958.2007.05772.x; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Anderson GG, 2008, INFECT IMMUN, V76, P1423, DOI 10.1128/IAI.01373-07; [Anonymous], 2005, Nat Methods, V2, P629; Beenken KE, 2004, J BACTERIOL, V186, P4665, DOI 10.1128/JB.186.14.4665-4684.2004; Bredenbruch F, 2005, J BACTERIOL, V187, P3630, DOI 10.1128/JB.187.11.3630-3635.2005; Brencic A, 2009, MOL MICROBIOL, V73, P434, DOI 10.1111/j.1365-2958.2009.06782.x; Coleman JP, 2008, J BACTERIOL, V190, P1247, DOI 10.1128/JB.01140-07; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Costerton JW, 2001, TRENDS MICROBIOL, V9, P50, DOI 10.1016/S0966-842X(00)01918-1; Delpin MW, 2009, ISME J, V3, P1053, DOI 10.1038/ismej.2009.54; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Filiatrault MJ, 2010, J BACTERIOL, V192, P2359, DOI 10.1128/JB.01445-09; Folsom JP, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-294; Gallagher LA, 2002, J BACTERIOL, V184, P6472, DOI 10.1128/JB.184.23.6472-6480.2002; Gonzalez N, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-167; Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996; Guell M, 2011, NAT REV MICROBIOL, V9, P658, DOI 10.1038/nrmicro2620; Hall-Stoodley L, 2009, CELL MICROBIOL, V11, P1034, DOI 10.1111/j.1462-5822.2009.01323.x; Hasona A, 2007, J BACTERIOL, V189, P1219, DOI 10.1128/JB.01146-06; Hauser AR, 2009, NAT REV MICROBIOL, V7, P654, DOI 10.1038/nrmicro2199; Hentzer M., 2005, BIOFILMS, V2, P37, DOI DOI 10.1017/S1479050505001699; Hoiby N, 2011, INT J ORAL SCI, V3, P55, DOI 10.4248/IJOS11026; Kawakami T, 2010, ENVIRON MICROBIOL, V12, P1399, DOI 10.1111/j.1462-2920.2009.02109.x; Klausen M, 2003, MOL MICROBIOL, V48, P1511, DOI 10.1046/j.1365-2958.2003.03525.x; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee J, 2009, MICROB BIOTECHNOL, V2, P75, DOI 10.1111/j.1751-7915.2008.00061.x; Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103; Livny J, 2006, NUCLEIC ACIDS RES, V34, P3484, DOI 10.1093/nar/gkl453; Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2; Manos J, 2009, FEMS MICROBIOL LETT, V292, P107, DOI 10.1111/j.1574-6968.2008.01472.x; Manos J, 2008, J MED MICROBIOL, V57, P1454, DOI 10.1099/jmm.0.2008/005009-0; McPhee JB, 2006, J BACTERIOL, V188, P3995, DOI 10.1128/JB.00053-06; Mikkelsen H, 2009, MICROBIOL-SGM, V155, P687, DOI 10.1099/mic.0.025551-0; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Musken M, 2010, NAT PROTOC, V5, P1460, DOI 10.1038/nprot.2010.110; Musken M, 2010, MICROBIOL-SGM, V156, P431, DOI 10.1099/mic.0.033290-0; Petrova OE, 2010, J BACTERIOL, V192, P5275, DOI 10.1128/JB.00387-10; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Ryder C, 2007, CURR OPIN MICROBIOL, V10, P644, DOI 10.1016/j.mib.2007.09.010; Schembri MA, 2003, MOL MICROBIOL, V48, P253, DOI 10.1046/j.1365-2958.2003.03432.x; Schuster M, 2006, INT J MED MICROBIOL, V296, P73, DOI 10.1016/j.ijmm.2006.01.036; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Sonnleitner E, 2008, MICROBIOL-SGM, V154, P3175, DOI 10.1099/mic.0.2008/019703-0; Sonnleitner E, 2011, APPL MICROBIOL BIOT, V91, P63, DOI 10.1007/s00253-011-3332-1; Sonnleitner E, 2011, MOL MICROBIOL, V80, P868, DOI 10.1111/j.1365-2958.2011.07620.x; Soper T, 2010, P NATL ACAD SCI USA, V107, P9602, DOI 10.1073/pnas.1004435107; Trevino J, 2010, MICROBIOL-SGM, V156, P1342, DOI 10.1099/mic.0.036558-0; Ventre I, 2006, P NATL ACAD SCI USA, V103, P171, DOI 10.1073/pnas.0507407103; Wagner VE, 2008, CLIN REV ALLERG IMMU, V35, P124, DOI 10.1007/s12016-008-8079-9; Waite RD, 2005, J BACTERIOL, V187, P6571, DOI 10.1128/JB.187.18.6571-6576.2005; Waite RD, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-162; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wassarman KM, 2007, MOL MICROBIOL, V65, P1425, DOI 10.1111/j.1365-2958.2007.05894.x; Whiteley M, 2001, NATURE, V413, P860, DOI 10.1038/35101627; Winsor GL, 2009, NUCLEIC ACIDS RES, V37, pD483, DOI 10.1093/nar/gkn861; Xiao GP, 2006, MOL MICROBIOL, V62, P1689, DOI 10.1111/j.1365-2958.2006.05462.x; Yi H, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr617; Zheng XB, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-361	61	163	166	1	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e31092	10.1371/journal.pone.0031092	http://dx.doi.org/10.1371/journal.pone.0031092			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LO	22319605	Green Published, Green Submitted, gold			2022-12-27	WOS:000302178400028
J	van den Wijngaard, CC; van Asten, L; Koopmans, MPG; van Pelt, W; Nagelkerke, NJD; Wielders, CCH; van Lier, A; van der Hoek, W; Meijer, A; Donker, GA; Dijkstra, F; Harmsen, C; van der Sande, MAB; Kretzschmar, M				van den Wijngaard, Cees C.; van Asten, Liselotte; Koopmans, Marion P. G.; van Pelt, Wilfrid; Nagelkerke, Nico J. D.; Wielders, Cornelia C. H.; van Lier, Alies; van der Hoek, Wim; Meijer, Adam; Donker, Ge A.; Dijkstra, Frederika; Harmsen, Carel; van der Sande, Marianne A. B.; Kretzschmar, Mirjam			Comparing Pandemic to Seasonal Influenza Mortality: Moderate Impact Overall but High Mortality in Young Children	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; A H1N1; UNITED-STATES; NETHERLANDS; INFECTION; DEATHS	Background: We assessed the severity of the 2009 influenza pandemic by comparing pandemic mortality to seasonal influenza mortality. However, reported pandemic deaths were laboratory-confirmed - and thus an underestimation whereas seasonal influenza mortality is often more inclusively estimated. For a valid comparison, our study used the same statistical methodology and data types to estimate pandemic and seasonal influenza mortality. Methods and Findings: We used data on all-cause mortality (1999-2010, 100% coverage, 16.5 million Dutch population) and influenza-like-illness (ILI) incidence (0.8% coverage). Data was aggregated by week and age category. Using generalized estimating equation regression models, we attributed mortality to influenza by associating mortality with ILI-incidence, while adjusting for annual shifts in association. We also adjusted for respiratory syncytial virus, hot/cold weather, other seasonal factors and autocorrelation. For the 2009 pandemic season, we estimated 612 (range 266-958) influenza-attributed deaths; for seasonal influenza 1,956 (range 0-3,990). 15,845 years-of-life-lost were estimated for the pandemic; for an average seasonal epidemic 17,908. For 0-4 yrs of age the number of influenza-attributed deaths during the pandemic were higher than in any seasonal epidemic; 77 deaths (range 61-93) compared to 16 deaths (range 0-45). The >= 75 yrs of age showed a far below average number of deaths. Using pneumonia/influenza and respiratory/cardiovascular instead of all-cause deaths consistently resulted in relatively low total pandemic mortality, combined with high impact in the youngest age category. Conclusion: The pandemic had an overall moderate impact on mortality compared to 10 preceding seasonal epidemics, with higher mortality in young children and low mortality in the elderly. This resulted in a total number of pandemic deaths far below the average for seasonal influenza, and a total number of years-of-life-lost somewhat below average. Comparing pandemic and seasonal influenza mortality as in our study will help assessing the worldwide impact of the 2009 pandemic.	[van den Wijngaard, Cees C.; van Asten, Liselotte; Koopmans, Marion P. G.; van Pelt, Wilfrid; Wielders, Cornelia C. H.; van Lier, Alies; van der Hoek, Wim; Meijer, Adam; Dijkstra, Frederika; van der Sande, Marianne A. B.; Kretzschmar, Mirjam] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands; [Koopmans, Marion P. G.] Erasmus MC, Rotterdam, Netherlands; [Nagelkerke, Nico J. D.] United Arab Emirates Univ, Al Ain, U Arab Emirates; [Donker, Ge A.] Netherlands Inst Hlth Serv Res, NIVEL, Utrecht, Netherlands; [Harmsen, Carel] Stat Netherlands, The Hague, Netherlands; [van der Sande, Marianne A. B.; Kretzschmar, Mirjam] Univ Med Ctr, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands	Netherlands National Institute for Public Health & the Environment; Erasmus University Rotterdam; Erasmus MC; United Arab Emirates University; Netherlands Institute for Health Services Research; Utrecht University; Utrecht University Medical Center	van den Wijngaard, CC (corresponding author), Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands.	kees.van.den.wijngaard@rivm.nl	Donker, Gé/AAX-8564-2021; Dijkstra, Frederika/ABF-3865-2021; Wielders, Cornelia CH/I-1970-2019	Dijkstra, Frederika/0000-0003-0012-740X; Wielders, Cornelia CH/0000-0002-2413-9088; Koopmans, Marion/0000-0002-5204-2312; van der Sande, Marianne AB/0000-0002-4778-6739; Donker, Ge/0000-0001-6314-9249; Kretzschmar, Mirjam/0000-0002-4394-7697	Dutch Ministry of Public Health	Dutch Ministry of Public Health	This study was funded by the Dutch Ministry of Public Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Andreasen V, 2011, VACCINE, V29, pB49, DOI 10.1016/j.vaccine.2011.03.061; [Anonymous], INFL FACTSH; Brown SM, 2011, EUR RESPIR J, V37, P112, DOI 10.1183/09031936.00008210; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P941; Charu V, 2011, CLIN INFECT DIS, V53, P985, DOI 10.1093/cid/cir644; Chowell G, 2008, EPIDEMIOL INFECT, V136, P852, DOI 10.1017/S0950268807009144; Donker GA, 2010, CONTINUOUS MORBIDITY; Dushoff J, 2006, AM J EPIDEMIOL, V163, P181, DOI 10.1093/aje/kwj024; Gdynia G, 2011, VIRCHOWS ARCH, V458, P371, DOI 10.1007/s00428-010-1035-0; Huynen MMTE, 2001, ENVIRON HEALTH PERSP, V109, P463, DOI 10.2307/3454704; Keatinge WR, 2000, BRIT MED J, V321, P670, DOI 10.1136/bmj.321.7262.670; Kolb SJ, 2011, ARCH NEUROL-CHICAGO, V68, P979, DOI 10.1001/archneurol.2011.74; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Libster R, 2010, NEW ENGL J MED, V362, P45, DOI 10.1056/NEJMoa0907673; Mamas Mamas A, 2007, Exp Clin Cardiol, V12, P214; Meijer A, 2009, TIJDSCHR INFECTIEZIE, V4, P176; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Muscatello DJ, 2010, EMERG INFECT DIS, V16, P1396, DOI 10.3201/eid1609.091723; Newell C, 1994, METHODS MODELS DEMOG; Nielsen J, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-350; PERLMAN J, 1988, PEDIATRICS, V81, P399; PROBY CM, 1986, Q J MED, V60, P887; Sachedina N, 2010, LANCET, V376, P1846, DOI 10.1016/S0140-6736(10)61195-6; Schroth MK, 2009, PEDIATRICS, V123, pS245, DOI 10.1542/peds.2008-2952K; Simoes EAF, 1999, LANCET, V354, P847, DOI 10.1016/S0140-6736(99)80040-3; Simonsen L, 1997, AM J PUBLIC HEALTH, V87, P1944, DOI 10.2105/AJPH.87.12.1944; Simonsen L, 2005, ARCH INTERN MED, V165, P265, DOI 10.1001/archinte.165.3.265; Tamma PD, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-72; Terletskaia-Ladwig E, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-20; Thompson WW, 2009, AM J PUBLIC HEALTH, V99, pS225, DOI 10.2105/AJPH.2008.151944; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Van Asten L, MORTALITY ATTR UNPUB; Van den Brandhof WE, 2002, INFECT B, V13, P137; van den Wijngaard CC, 2010, AM J PUBLIC HEALTH, V100, P2248, DOI 10.2105/AJPH.2009.168245; Van Diem M, 2010, ACTA OBSTET GYN SCAN, V89, P1168, DOI 10.3109/00016349.2010.500468; van Gageldonk-Lafeber AB, 2011, INFLUENZA OTHER RESP, V5, pR513, DOI 10.1111/j.1750-2659.2011.00260.x; van Gageldonk-Lafeber RAB, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-758; van't Klooster TM, 2010, SURVEILLANCE HOSPITA, V15; Viboud C, 2010, PLOS CURR; Viboud C, 2006, VACCINE, V24, P6701, DOI 10.1016/j.vaccine.2006.05.067; WHO, 2011, METR DIS ADJ LIF YEA; Wielders CCH, 2012, EUR J PUBLIC HEALTH, V22, P150, DOI 10.1093/eurpub/ckq187; Xu R, 2010, SCIENCE, V328, P357, DOI 10.1126/science.1186430	44	59	59	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e31197	10.1371/journal.pone.0031197	http://dx.doi.org/10.1371/journal.pone.0031197			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LO	22319616	Green Published, Green Submitted, gold			2022-12-27	WOS:000302178400030
J	Vezzi, F; Narzisi, G; Mishra, B				Vezzi, Francesco; Narzisi, Giuseppe; Mishra, Bud			Feature-by-Feature - Evaluating De Novo Sequence Assembly	PLOS ONE			English	Article								The whole-genome sequence assembly (WGSA) problem is among one of the most studied problems in computational biology. Despite the availability of a plethora of tools (i.e., assemblers), all claiming to have solved the WGSA problem, little has been done to systematically compare their accuracy and power. Traditional methods rely on standard metrics and read simulation: while on the one hand, metrics like N50 and number of contigs focus only on size without proportionately emphasizing the information about the correctness of the assembly, comparisons performed on simulated dataset, on the other hand, can be highly biased by the non-realistic assumptions in the underlying read generator. Recently the Feature Response Curve (FRC) method was proposed to assess the overall assembly quality and correctness: FRC transparently captures the trade-offs between contigs' quality against their sizes. Nevertheless, the relationship among the different features and their relative importance remains unknown. In particular, FRC cannot account for the correlation among the different features. We analyzed the correlation among different features in order to better describe their relationships and their importance in gauging assembly quality and correctness. In particular, using multivariate techniques like principal and independent component analysis we were able to estimate the "excess-dimensionality'' of the feature space. Moreover, principal component analysis allowed us to show how poorly the acclaimed N50 metric describes the assembly quality. Applying independent component analysis we identified a subset of features that better describe the assemblers performances. We demonstrated that by focusing on a reduced set of highly informative features we can use the FRC curve to better describe and compare the performances of different assemblers. Moreover, as a by-product of our analysis, we discovered how often evaluation based on simulated data, obtained with state of the art simulators, lead to not-so-realistic results.	[Vezzi, Francesco] Univ Udine, Dept Math & Informat, I-33100 Udine, Italy; [Vezzi, Francesco] Inst Appl Genom IGA, Udine, Italy; [Narzisi, Giuseppe; Mishra, Bud] NYU, Courant Inst Math Sci, New York, NY USA; [Mishra, Bud] NYU, Sch Med, New York, NY USA	University of Udine; New York University; New York University	Vezzi, F (corresponding author), Univ Udine, Dept Math & Informat, I-33100 Udine, Italy.	mishra@nyu.edu			NSF-CDI; Abraxis, LLC	NSF-CDI(National Science Foundation (NSF)); Abraxis, LLC	NSF-CDI and Abraxis, LLC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bi J., 2003, Journal of Machine Learning Research, V3, P1229, DOI 10.1162/153244303322753643; Boisvert S, 2010, COMPUTATIONAL BIOL, V17; Boutsidis C., 2008, 14 ACM SGKDD INT C K, P61; Earl DA., 2011, GENOME RES; HUANG X, 2005, CURR PROTOC BIOINFOR, pCH11; Hyvarinen A, 1997, NEURAL COMPUT, V9, P1483, DOI 10.1162/neco.1997.9.7.1483; Hyvarinen A, 2001, INDEPENDENT COMPONENT ANALYSIS: PRINCIPLES AND PRACTICE, P71; Imam I, 1994, P FLOR AI RES S FLAI, P66; Johnstone I., 2006, HIGH DIMENSIONAL STA; Jolliffe I., 2005, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; LIN Y, 2011, BIOINFORMATICS, P1; Liu JY, 2009, HUM BRAIN MAPP, V30, P241, DOI 10.1002/hbm.20508; Lu HP, 2011, PATTERN RECOGN, V44, P1540, DOI 10.1016/j.patcog.2011.01.004; Menges F, 2011, BIOINFORMATICS OXFOR, P1; Miller JR, 2008, BIOINFORMATICS, V24, P2818, DOI 10.1093/bioinformatics/btn548; Miller Jim Wayne, 2010, GENOMICS, P1; Nagarajan N, 2009, J COMPUT BIOL, V16, P897, DOI 10.1089/cmb.2009.0005; Nahlawi LI, 2010, IEEE ENG MED BIO, P6186, DOI 10.1109/IEMBS.2010.5627753; Narzisi G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019175; Narzisi G, 2011, BIOINFORMATICS, V27, P153, DOI 10.1093/bioinformatics/btq646; Phillippy AM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r55; Prasad M, 2004, PROCEEDINGS OF THE 2004 INTELLIGENT SENSORS, SENSOR NETWORKS & INFORMATION PROCESSING CONFERENCE, P427; Richter DC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003373; Salzberg SL, 2011, GENOME RES; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Sommer DD, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-64; Sutton G. G., 1995, GENOME SCI TECHNOL, V1, P9, DOI [10.1089/gst.1995.1.9, DOI 10.1089/GST.1995.1.9]; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	31	32	32	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e31002	10.1371/journal.pone.0031002	http://dx.doi.org/10.1371/journal.pone.0031002			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LO	22319599	Green Submitted, Green Published, gold			2022-12-27	WOS:000302178400024
J	Liu, L; Drouet, V; Wu, JW; Witter, MP; Small, SA; Clelland, C; Duff, K				Liu, Li; Drouet, Valerie; Wu, Jessica W.; Witter, Menno P.; Small, Scott A.; Clelland, Catherine; Duff, Karen			Trans-Synaptic Spread of Tau Pathology In Vivo	PLOS ONE			English	Article							ENTORHINAL CORTEX; ORGANIZATION; SECTIONS; DISEASE; REGION; MEMORY; MOUSE	Tauopathy in the brain of patients with Alzheimer's disease starts in the entorhinal cortex (EC) and spreads anatomically in a defined pattern. To test whether pathology initiating in the EC spreads through the brain along synaptically connected circuits, we have generated a transgenic mouse model that differentially expresses pathological human tau in the EC and we have examined the distribution of tau pathology at different timepoints. In relatively young mice (10-11 months old), human tau was present in some cell bodies, but it was mostly observed in axons within the superficial layers of the medial and lateral EC, and at the terminal zones of the perforant pathway. In old mice (>22 months old), intense human tau immunoreactivity was readily detected not only in neurons in the superficial layers of the EC, but also in the subiculum, a substantial number of hippocampal pyramidal neurons especially in CA1, and in dentate gyrus granule cells. Scattered immunoreactive neurons were also seen in the deeper layers of the EC and in perirhinal and secondary somatosensory cortex. Immunoreactivity with the conformation-specific tau antibody MC1 correlated with the accumulation of argyrophilic material seen in old, but not young mice. In old mice, axonal human tau immunoreactivity, especially at the endzones of the perforant pathway, was greatly reduced. Relocalization of tau from axons to somatodendritic compartments and propagation of tauopathy to regions outside of the EC correlated with mature tangle formation in neurons in the EC as revealed by thioflavin-S staining. Our data demonstrate propagation of pathology from the EC and support a trans-synaptic mechanism of spread along anatomically connected networks, between connected and vulnerable neurons. In general, the mouse recapitulates the tauopathy that defines the early stages of AD and provides a model for testing mechanisms and functional outcomes associated with disease progression.	[Liu, Li; Drouet, Valerie; Wu, Jessica W.; Clelland, Catherine; Duff, Karen] Columbia Univ, Taub Inst Alzheimers Dis Res, Dept Pathol & Cell Biol, New York, NY 10027 USA; [Witter, Menno P.] Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, N-7034 Trondheim, Norway; [Witter, Menno P.] Norwegian Univ Sci & Technol, Ctr Biol Memory, N-7034 Trondheim, Norway; [Small, Scott A.] Columbia Univ, Taub Inst Alzheimers Dis Res, Dept Neurol, New York, NY USA; [Duff, Karen] New York State Psychiat Inst & Hosp, Dept Psychiat, New York, NY 10032 USA	Columbia University; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Columbia University; New York State Psychiatry Institute	Liu, L (corresponding author), Columbia Univ, Taub Inst Alzheimers Dis Res, Dept Pathol & Cell Biol, New York, NY 10027 USA.	ked2115@columbia.edu	Clelland, Catherine/AAZ-8551-2021	Drouet, Valerie/0000-0001-9958-8470; Duff, Karen/0000-0002-6177-868X	National Institutes of Health [NS74874, AG033790, AG025161, AG034618]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS074874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG008702, R01AG034618, R01AG025161, R21AG033790] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health grants to KD (NS74874), CC (AG033790) and SAS (AG025161, AG034618). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bancroft J.D., 1996, THEORY PRACTICE HIST, VVolume 6; BIERNAT J, 1992, EMBO J, V11, P1593, DOI 10.1002/j.1460-2075.1992.tb05204.x; Blaizot AX, 2002, J NEUROSCI, V22, P9166; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z; Braak H, 2011, ACTA NEUROPATHOL, V121, P171, DOI 10.1007/s00401-010-0789-4; Jicha GA, 1997, J NEUROSCI RES, V48, P128, DOI 10.1002/(SICI)1097-4547(19970415)48:2<128::AID-JNR5>3.0.CO;2-E; Juntti SA, 2010, NEURON, V66, P260, DOI 10.1016/j.neuron.2010.03.024; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mayford M, 1996, P NATL ACAD SCI USA, V93, P13250, DOI 10.1073/pnas.93.23.13250; Saman S., 2011, J BIOL CHEM; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Sun AY, 2002, J HISTOCHEM CYTOCHEM, V50, P463, DOI 10.1177/002215540205000403; van Groen T, 2003, HIPPOCAMPUS, V13, P133, DOI 10.1002/hipo.10037; Weaver CL, 2000, NEUROBIOL AGING, V21, P719, DOI 10.1016/S0197-4580(00)00157-3; Witter MP, 2007, PROG BRAIN RES, V163, P43, DOI 10.1016/S0079-6123(07)63003-9; Witter MP, 2000, ANN NY ACAD SCI, V911, P1; Yasuda M, 2006, NEURON, V50, P309, DOI 10.1016/j.neuron.2006.03.035	18	695	709	0	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2012	7	2							e31302	10.1371/journal.pone.0031302	http://dx.doi.org/10.1371/journal.pone.0031302			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UG	22312444	Green Published, gold			2022-12-27	WOS:000301977500034
J	Santos-Silva, R; Castro, LS; Taddei, JA; Tufik, S; Bittencourt, LRA				Santos-Silva, Rogerio; Castro, Laura Siqueira; Taddei, Jose Augusto; Tufik, Sergio; Azeredo Bittencourt, Lia Rita			Sleep Disorders and Demand for Medical Services: Evidence from a Population-Based Longitudinal Study	PLOS ONE			English	Article							HEALTH-CARE; RISK-FACTOR; INSOMNIA; APNEA; COMPLAINTS; BURDEN; COSTS; DEATH	Background: The aim of this study was to investigate whether insomnia and obstructive sleep apnea (OSA) were predictors of hospitalizations or emergency department visits during two years following the Sao Paulo Epidemiologic Sleep Study (EPISONO) sample. Methods and Findings: All participants (n = 1,101) who underwent a baseline evaluation between July and December 2007 were contacted in December 2009 and asked to fill out a questionnaire about body weight changes, number of hospitalizations and visits to the emergency department. Participants lost during the follow-up period represented 3.2% (n = 35) and 7 subjects had died. Hospitalizations were reported by 116 volunteers (10.5%) and emergency department visits were reported by 136 participants (12.4%). The average body mass index (BMI) did not vary significantly between the first and the second assessment [26.7(95% CI: 26.3-27.1) vs. 26.9(26.5-27.4) kg/m(2)]. After adjusting for confounders, a multiple logistic regression model revealed that female gender [1.4(1.0-1.9)], age >= 40 years, insomnia diagnosed according to the DSM-IV criteria [1.6(1.0-2.6)], and apnea-hypopnea index >= 15 [1.5(1.0-2.2)] were predictors of hospitalizations and/or demand for emergency services. Conclusion: Our study of a probabilistic sample of the Sao Paulo inhabitants shows that over a period of two years, insomnia and OSA were both associated with health impairment. Considering the high prevalence and public health burden of sleep disorders, the consequences of untreated disease for both the individual and society are undeniable and should be addressed.	[Santos-Silva, Rogerio; Castro, Laura Siqueira; Tufik, Sergio; Azeredo Bittencourt, Lia Rita] Univ Fed Sao Paulo UNIFESP, Dept Psicobiol, Disciplina Med & Biol Sono, Sao Paulo, Brazil; [Taddei, Jose Augusto] Univ Fed Sao Paulo UNIFESP, Dept Pediat, Disciplina Nutr & Metab, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	Santos-Silva, R (corresponding author), Univ Fed Sao Paulo UNIFESP, Dept Psicobiol, Disciplina Med & Biol Sono, Sao Paulo, Brazil.	lia@psicobio.epm.br	Sono, Cepid/I-5371-2013; Bittencourt, Lia/C-6551-2012; Santos-Silva, Rogerio/E-4630-2013; TADDEI, JOSE AUGUSTO A C/D-8216-2015; Tufik, Sergio/D-7606-2012; Castro, Laura/ABB-1293-2021	Bittencourt, Lia/0000-0001-7738-0927; TADDEI, JOSE AUGUSTO A C/0000-0003-3833-392X; Castro, Laura/0000-0002-0852-8235	Associacao Fundo de Incentivo a Pesquisa (AFIP); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [07/50525-1]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (CEPID) [98/14303-3]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico	Associacao Fundo de Incentivo a Pesquisa (AFIP); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (CEPID)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by the Associacao Fundo de Incentivo a Pesquisa (AFIP) and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (#07/50525-1 to RS-S, CEPID # 98/14303-3 to ST). LSC, JAT, ST and LRAB are recipients of fellowships from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS; American Psychiatric Association, 1994, TASK FORC D 1 DSM 4; Ban HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018455; Banno K, 2009, SLEEP, V32, P247, DOI 10.1093/sleep/32.2.247; Budhiraja R, 2010, RESP CARE, V55, P1322; Chien KL, 2010, SLEEP, V33, P177, DOI 10.1093/sleep/33.2.177; Chilcott LA, 1996, PHARMACOECONOMICS, V10, P1, DOI 10.2165/00019053-199600101-00003; Daley M, 2009, SLEEP, V32, P55; Gami AS, 2005, NEW ENGL J MED, V352, P1206, DOI 10.1056/NEJMoa041832; Holty JC, 2011, SLEEP, V34, pA334; Kapur V, 1999, SLEEP, V22, P749, DOI 10.1093/sleep/22.6.749; Kapur Vishesh, 2002, Sleep Breath, V6, P49, DOI 10.1007/s11325-002-0049-5; Kapur VK, 2002, SLEEP, V25, P289; Kish L, 1965, SURVEY SAMPLING; Korn E. L., 1999, ANAL HLTH SURVEYS; Leger D, 2010, SLEEP MED, V11, P999, DOI 10.1016/j.sleep.2010.04.018; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; Marshall NS, 2009, J CLIN SLEEP MED, V5, P15; Morrell MJ, 2010, THORAX, V65, P908, DOI 10.1136/thx.2009.126730; Ohayon MM, 1996, CAN J PSYCHIAT, V41, P457, DOI 10.1177/070674379604100711; Ohayon MM, 2002, SLEEP MED REV, V6, P97, DOI 10.1053/smrv.2002.0186; Santos-Silva R, 2009, SLEEP MED, V10, P679, DOI 10.1016/j.sleep.2008.11.001; Sassani A, 2004, SLEEP, V27, P453, DOI 10.1093/sleep/27.3.453; Simon GE, 1997, AM J PSYCHIAT, V154, P1417; Tufik S, 2010, SLEEP MED, V11, P441, DOI 10.1016/j.sleep.2009.10.005; Yaggi HK, 2005, NEW ENGL J MED, V353, P2034, DOI 10.1056/NEJMoa043104; Young T, 2008, SLEEP, V31, P1071	27	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2012	7	2							e30085	10.1371/journal.pone.0030085	http://dx.doi.org/10.1371/journal.pone.0030085			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UG	22312420	Green Published, Green Submitted, gold			2022-12-27	WOS:000301977500003
J	Nicolas-Chanoine, MH; Jarlier, V; Robert, J; Arlet, G; Drieux, L; Leflon-Guibout, V; Laouenan, C; Larroque, B; Caro, V; Mentre, F				Nicolas-Chanoine, Marie-Helene; Jarlier, Vincent; Robert, Jerome; Arlet, Guillaume; Drieux, Laurence; Leflon-Guibout, Veronique; Laouenan, Cedric; Larroque, Beatrice; Caro, Valerie; Mentre, France		Study Grp Coli	Patient's Origin and Lifestyle Associated with CTX-M-Producing Escherichia coli: A Case-Control-Control Study	PLOS ONE			English	Article							LACTAMASE-PRODUCING ENTEROBACTERIACEAE; SPECTRUM BETA-LACTAMASES; BLOOD-STREAM INFECTIONS; RISK-FACTORS; KLEBSIELLA-PNEUMONIAE; COMMUNITY-ONSET; RESISTANCE; EMERGENCE; ESBL	Background: Global dissemination of Escherichia coli producing CTX-M extended-spectrum beta-lactamases (ESBL) is a public health concern. The aim of the study was to determine factors associated with CTX-M-producing E. coli infections among patients hospitalised in the Assistance Publique-Hopitaux de Paris, the largest hospital system in France (23 000 beds), through a prospective case-control-control study. Methods/Principal Findings: From November 2008 to June 2009, 152 inpatients with a clinical sample positive for CTX-M-producing E. coli (cases), 152 inpatients with a clinical sample positive for non ESBL-producing E. coli on the day or within the three days following case detection (controls C1), and 152 inpatients with culture-negative clinical samples since the beginning of hospitalisation and until three days after case detection (controls C2) were included in ten hospitals of the Paris area. Factors studied were related to patient's origin, lifestyle and medical history as well as care during hospitalisation. Those independently associated with CTX-M-producing E. coli were determined. Three independent factors were common to the two case-control comparisons: birth outside of Europe (cases vs C1: OR1 = 2.4; 95% CI = [1.3-4.5] and cases vs C2: OR2 = 3.1; 95% CI = [1.4-7.0]), chronic infections (OR1 = 2.9; 95% CI = [1.3-6.9] and OR2 = 8.7; 95% CI = [2.0-39.7]), and antibiotic treatment between hospital admission and inclusion (OR1 = 2.0; 95% CI = [1.0-3.8] and OR2 = 3.3; 95% CI = [1.5-7.2]). Cases were also more likely to be (i) functionally dependent before hospitalisation than C2 (OR2 = 7.0; 95% CI = [2.1-23.5]) and (ii) living in collective housing before hospitalisation than C2 (OR2 = 15.2; 95% CI = [1.8-130.7]) when CTX-M-producing E. coli was present at admission. Conclusion: For the first time, patient's origin and lifestyle were demonstrated to be independently associated with isolation of CTX-M-producing E. coli, in addition to health care-related factors.	[Nicolas-Chanoine, Marie-Helene; Leflon-Guibout, Veronique] Hop Beaujon, AP HP, Microbiol Serv, Clichy, France; [Nicolas-Chanoine, Marie-Helene] Fac Med D Diderot, Paris, France; [Nicolas-Chanoine, Marie-Helene] Univ Paris, INSERM, CRB3, U773, F-75252 Paris, France; [Jarlier, Vincent; Robert, Jerome] Hop La Pitie Salpetriere, AP HP, Lab Bacteriol Hyg Hosp, Paris, France; [Jarlier, Vincent; Robert, Jerome; Drieux, Laurence] Univ Paris 06, EA 1541, Paris, France; [Arlet, Guillaume] Hop Tenon, AP HP, Serv Bacteriol, F-75970 Paris, France; [Drieux, Laurence] Hop Charles Foix, AP HP, Equipe Operat Hyg Hosp, Ivry, France; [Laouenan, Cedric; Mentre, France] Univ D Diderot, INSERM, UMR S 738, Paris, France; [Laouenan, Cedric; Mentre, France] Hop Bichat Claude Bernard, AP HP, UF Biostat, F-75877 Paris, France; [Larroque, Beatrice] Hop Beaujon, AP HP, Antenne URC Paris Nord, Unite Epidemiol & Rech Clin, Clichy, France; [Caro, Valerie] Inst Pasteur, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Charles-Foix - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Nicolas-Chanoine, MH (corresponding author), Hop Beaujon, AP HP, Microbiol Serv, Clichy, France.	mhn.chanoine@bjn.aphp.fr	Arlet, Guillaume/P-2990-2017; Laouenan, Cedric/E-1157-2019; Mentre, France/AFU-8218-2022; Arlet, Guillaume/AAW-4918-2020; ROBERT, Jérôme/C-3993-2011	Laouenan, Cedric/0000-0002-3681-6314; Mentre, France/0000-0002-7045-1275; ROBERT, Jérôme/0000-0002-9380-0570; Gallah, Salah/0000-0002-5056-079X	Programme Regional de Recherche Clinique AP-HP/Institut Pasteur, Direction de la Recherche Clinique AP-HP, Paris, France [PASo7010]	Programme Regional de Recherche Clinique AP-HP/Institut Pasteur, Direction de la Recherche Clinique AP-HP, Paris, France	This study was supported by a grant (PASu7010) from the Programme Regional de Recherche Clinique AP-HP/Institut Pasteur, Direction de la Recherche Clinique AP-HP, Paris, France (a publicly funded non profit organization). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apisarnthanarak A, 2007, AM J INFECT CONTROL, V35, P606, DOI 10.1016/j.ajic.2007.05.008; Ben-Ami R, 2009, CLIN INFECT DIS, V49, P682, DOI 10.1086/604713; Bonnet R, 2004, ANTIMICROB AGENTS CH, V48, P1, DOI 10.1128/AAC.48.1.1-14.2004; Carret G, 2003, INT J ANTIMICROB AG, V21, P364, DOI 10.1016/S0924-8579(03)00021-9; Dhanji H, 2011, J ANTIMICROB CHEMOTH, V66, P512, DOI 10.1093/jac/dkq472; Harris AD, 2001, CLIN INFECT DIS, V32, P1055, DOI 10.1086/319600; Iabadene H, 2008, J ANTIMICROB CHEMOTH, V62, P133, DOI 10.1093/jac/dkn145; JARLIER V, 1988, REV INFECT DIS, V10, P867; Kang CI, 2010, INT J ANTIMICROB AG, V36, P284, DOI 10.1016/j.ijantimicag.2010.05.009; Laupland KB, 2008, CLIN MICROBIOL INFEC, V14, P1041, DOI 10.1111/j.1469-0691.2008.02089.x; Laupland KB, 2008, J INFECTION, V57, P441, DOI 10.1016/j.jinf.2008.09.034; Lee DS, 2010, KOREAN J UROL, V51, P492, DOI 10.4111/kju.2010.51.7.492; Leflon-Guibout V, 2004, ANTIMICROB AGENTS CH, V48, P3736, DOI 10.1128/AAC.48.10.3736-3742.2004; Li B, 2011, SCAND J INFECT DIS, V43, P170, DOI 10.3109/00365548.2010.538856; Lopez-Cerero L, 2011, INT J ANTIMICROB AG, V37, P365, DOI 10.1016/j.ijantimicag.2011.01.001; Mamlouk K, 2006, J CLIN MICROBIOL, V44, P4049, DOI 10.1128/JCM.01076-06; MCCABE WR, 1962, ARCH INTERN MED, V110, P847, DOI 10.1001/archinte.1962.03620240029006; Meunier D, 2006, INT J ANTIMICROB AG, V28, P402, DOI 10.1016/j.ijantimicag.2006.08.016; Moor CT, 2008, J HOSP INFECT, V68, P355, DOI 10.1016/j.jhin.2008.02.003; Nicolas-Chanoine MH, 2008, J ANTIMICROB CHEMOTH, V61, P273, DOI 10.1093/jac/dkm464; Nicolas-Chanoine MH, 2008, CLIN MICROBIOL INFEC, V14, P111, DOI 10.1111/j.1469-0691.2007.01862.x; Overdevest I, 2011, EMERG INFECT DIS, V17, P1216, DOI 10.3201/eid1707.110209; Pitout JDD, 2008, LANCET INFECT DIS, V8, P159, DOI 10.1016/S1473-3099(08)70041-0; Pomba C, 2009, ANTIMICROB AGENTS CH, V53, P327, DOI 10.1128/AAC.00896-08; Rodriguez-Bano J, 2010, J CLIN MICROBIOL, V48, P1726, DOI 10.1128/JCM.02353-09; Rodriguez-Bano J, 2010, CLIN INFECT DIS, V50, P40, DOI 10.1086/649537; Rogers BA, 2011, J ANTIMICROB CHEMOTH, V66, P1, DOI 10.1093/jac/dkq415; Rooney PJ, 2009, J ANTIMICROB CHEMOTH, V64, P635, DOI 10.1093/jac/dkp220; Russo TA, 2003, MICROBES INFECT, V5, P449, DOI 10.1016/S1286-4579(03)00049-2; Schoevaerdts D, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-12; Serefhanoglu K, 2009, BRAZ J INFECT DIS, V13, P403, DOI 10.1590/S1413-86702009000600003; Tumbarello M, 2011, ANTIMICROB AGENTS CH, V55, P3485, DOI 10.1128/AAC.00009-11; Valverde A, 2008, J CLIN MICROBIOL, V46, P2796, DOI 10.1128/JCM.01008-08; Wu UI, 2010, J MICROBIOL IMMUNOL, V43, P310, DOI 10.1016/S1684-1182(10)60048-5; Yilmaz E, 2008, J CHEMOTHERAPY, V20, P581, DOI 10.1179/joc.2008.20.5.581	35	33	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e30498	10.1371/journal.pone.0030498	http://dx.doi.org/10.1371/journal.pone.0030498			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22299043	Green Submitted, Green Published, gold			2022-12-27	WOS:000301704200020
J	Taylor, RR; Jagger, DJ; Forge, A				Taylor, Ruth R.; Jagger, Daniel J.; Forge, Andrew			Defining the Cellular Environment in the Organ of Corti following Extensive Hair Cell Loss: A Basis for Future Sensory Cell Replacement in the Cochlea	PLOS ONE			English	Article							MOUSE INNER-EAR; PLURIPOTENT STEM-CELLS; MAMMALIAN COCHLEA; SUPPORTING CELL; POTASSIUM CHANNEL; TRANSPORTER GLAST; ACOUSTIC TRAUMA; GAP-JUNCTIONS; MICE LACKING; GUINEA-PIGS	Background: Following the loss of hair cells from the mammalian cochlea, the sensory epithelium repairs to close the lesions but no new hair cells arise and hearing impairment ensues. For any cell replacement strategy to be successful, the cellular environment of the injured tissue has to be able to nurture new hair cells. This study defines characteristics of the auditory sensory epithelium after hair cell loss. Methodology/Principal Findings: Studies were conducted in C57BL/6 and CBA/Ca mice. Treatment with an aminoglycoside-diuretic combination produced loss of all outer hair cells within 48 hours in both strains. The subsequent progressive tissue re-organisation was examined using immunohistochemistry and electron microscopy. There was no evidence of significant de-differentiation of the specialised columnar supporting cells. Kir4.1 was down regulated but KCC4, GLAST, microtubule bundles, connexin expression patterns and pathways of intercellular communication were retained. The columnar supporting cells became covered with non-specialised cells migrating from the outermost region of the organ of Corti. Eventually non-specialised, flat cells replaced the columnar epithelium. Flat epithelium developed in distributed patches interrupting regions of columnar epithelium formed of differentiated supporting cells. Formation of the flat epithelium was initiated within a few weeks post-treatment in C57BL/6 mice but not for several months in CBA/Ca's, suggesting genetic background influences the rate of re-organisation. Conclusions/Significance: The lack of dedifferentiation amongst supporting cells and their replacement by cells from the outer side of the organ of Corti are factors that may need to be considered in any attempt to promote endogenous hair cell regeneration. The variability of the cellular environment along an individual cochlea arising from patch-like generation of flat epithelium, and the possible variability between individuals resulting from genetic influences on the rate at which remodelling occurs may pose challenges to devising the appropriate regenerative therapy for a deaf patient.	[Taylor, Ruth R.; Jagger, Daniel J.; Forge, Andrew] UCL, Ctr Auditory Res, Ear Inst, London, England	University of London; University College London	Taylor, RR (corresponding author), UCL, Ctr Auditory Res, Ear Inst, London, England.	ruth.r.taylor@ucl.ac.uk	Jagger, Daniel/Q-3466-2019	Jagger, Daniel/0000-0003-2796-5526; Forge, Andrew/0000-0002-0995-0219; Johnson, Colin/0000-0002-2979-8234	Royal National Institute for Deaf People (RNID); Royal Society	Royal National Institute for Deaf People (RNID); Royal Society(Royal Society of London)	The study was supported by a project grant from the Royal National Institute for Deaf People (RNID). DJJ holds a Royal Society University Research Fellowship. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abrashkin KA, 2006, HEARING RES, V218, P20, DOI 10.1016/j.heares.2006.04.001; Adler HJ, 1996, NEUROSCI LETT, V205, P17, DOI 10.1016/0304-3940(96)12367-3; Bermingham NA, 1999, SCIENCE, V284, P1837, DOI 10.1126/science.284.5421.1837; Boettger T, 2002, NATURE, V416, P874, DOI 10.1038/416874a; Bringmann A, 2000, GLIA, V29, P35, DOI 10.1002/(SICI)1098-1136(20000101)29:1<35::AID-GLIA4>3.0.CO;2-A; Cohen-Salmon M, 2004, CELL TISSUE RES, V316, P15, DOI 10.1007/s00441-004-0861-2; Collado MS, 2008, CURR OPIN OTOLARYNGO, V16, P465, DOI 10.1097/MOO.0b013e32830f4ab5; CORWIN JT, 1988, SCIENCE, V240, P1772, DOI 10.1126/science.3381100; Cotanche DA, 2010, HEARING RES, V266, P18, DOI 10.1016/j.heares.2010.04.012; Daudet N, 1998, J COMP NEUROL, V401, P145; DAVIES S, 1987, J MICROSC-OXFORD, V147, P89, DOI 10.1111/j.1365-2818.1987.tb02821.x; FORGE A, 1985, HEARING RES, V19, P171, DOI 10.1016/0378-5955(85)90121-2; Forge A, 1997, SEMIN CELL DEV BIOL, V8, P225, DOI 10.1006/scdb.1997.0147; Forge A, 2003, J COMP NEUROL, V467, P207, DOI 10.1002/cne.10916; FORGE A, 1993, SCIENCE, V259, P1616, DOI 10.1126/science.8456284; Forge A, 1998, J COMP NEUROL, V397, P69; Furness DN, 2003, J NEUROSCI, V23, P11296; Glowatzki E, 2006, J NEUROSCI, V26, P7659, DOI 10.1523/JNEUROSCI.1545-06.2006; Goodyear RJ, 2003, J NEUROSCI, V23, P9208; Hibino H, 1997, J NEUROSCI, V17, P4711; Hori R, 2007, NEUROREPORT, V18, P1911, DOI 10.1097/WNR.0b013e3282f213e0; Izumikawa M, 2005, NAT MED, V11, P271, DOI 10.1038/nm1193; Izumikawa M, 2008, HEARING RES, V240, P52, DOI 10.1016/j.heares.2008.02.007; Jacinto A, 2001, NAT CELL BIOL, V3, pE117, DOI 10.1038/35074643; Jagger DJ, 2006, J NEUROSCI, V26, P1260, DOI 10.1523/JNEUROSCI.4278-05.2006; Jagger DJ, 2010, J ASS RES OTOLARYNGO; Jin ZH, 2003, TOHOKU J EXP MED, V200, P137, DOI 10.1620/tjem.200.137; Kawamoto K, 2009, HEARING RES, V247, P17, DOI 10.1016/j.heares.2008.08.010; Kelsell DP, 1997, NATURE, V387, P80, DOI 10.1038/387080a0; Kikuchi T, 2000, BRAIN RES REV, V32, P163, DOI 10.1016/S0165-0173(99)00076-4; Kudo T, 2003, HUM MOL GENET, V12, P995, DOI 10.1093/hmg/ddg116; LI HS, 1991, ACTA OTO-LARYNGOL, V111, P827, DOI 10.3109/00016489109138418; Li HW, 2003, P NATL ACAD SCI USA, V100, P13495, DOI 10.1073/pnas.2334503100; Li HW, 2003, NAT MED, V9, P1293, DOI 10.1038/nm925; Li L, 1997, INT J DEV NEUROSCI, V15, P433, DOI 10.1016/S0736-5748(96)00102-5; MARTIN P, 1992, NATURE, V360, P179, DOI 10.1038/360179a0; Mori R, 2006, J CELL SCI, V119, P5193, DOI 10.1242/jcs.03320; Nickel R, 2008, CURR OPIN OTOLARYNGO, V16, P452, DOI 10.1097/MOO.0b013e32830e20b0; Oesterle EC, 2008, JARO-J ASSOC RES OTO, V9, P65, DOI 10.1007/s10162-007-0106-7; Oesterle EC, 2009, JARO-J ASSOC RES OTO, V10, P525, DOI 10.1007/s10162-009-0183-x; Ohlemiller KK, 2006, BRAIN RES, V1091, P89, DOI 10.1016/j.brainres.2006.03.017; Oshima K, 2010, CELL, V141, P704, DOI 10.1016/j.cell.2010.03.035; Park KS, 2006, AM J RESP CELL MOL, V34, P151, DOI 10.1165/rcmb.2005-0332OC; Puchelle Edith, 2006, Proc Am Thorac Soc, V3, P726, DOI 10.1513/pats.200605-126SF; RAPHAEL Y, 1991, HEARING RES, V51, P173, DOI 10.1016/0378-5955(91)90034-7; Raphael Y, 2007, INT J DEV BIOL, V51, P649, DOI 10.1387/ijdb.072370yr; Redd MJ, 2004, PHILOS T R SOC B, V359, P777, DOI 10.1098/rstb.2004.1466; Rozengurt N, 2003, HEARING RES, V177, P71, DOI 10.1016/S0378-5955(02)00799-2; RYALS BM, 1988, SCIENCE, V240, P1774, DOI 10.1126/science.3381101; Schuknecht H, 1975, PATHOLOGY EAR; Sha SH, 2008, HEARING RES, V243, P87, DOI 10.1016/j.heares.2008.06.001; Shang JL, 2010, JARO-J ASSOC RES OTO, V11, P203, DOI 10.1007/s10162-009-0206-7; Shaw TJ, 2009, J CELL SCI, V122, P3209, DOI 10.1242/jcs.031187; Slepecky N. B., 1996, COCHLEA, V8, P44; Souter M, 1997, J COMP NEUROL, V386, P635; SPICER SS, 1994, HEARING RES, V79, P161, DOI 10.1016/0378-5955(94)90137-6; Stone JS, 2007, INT J DEV BIOL, V51, P633, DOI 10.1387/ijdb.072408js; Taylor RR, 2005, J COMP NEUROL, V484, P105, DOI 10.1002/cne.20450; Taylor RR, 2010, ENT AUDIOLOGY NEWS, V19, P107; Taylor RR, 2008, JARO-J ASSOC RES OTO, V9, P44, DOI 10.1007/s10162-007-0105-8; Teubner B, 2003, HUM MOL GENET, V12, P13, DOI 10.1093/hmg/ddg001; Wang YF, 2009, BIOCHEM BIOPH RES CO, V385, P33, DOI 10.1016/j.bbrc.2009.05.023; Wangemann P, 2006, J PHYSIOL-LONDON, V576, P11, DOI 10.1113/jphysiol.2006.112888; WARCHOL ME, 1993, SCIENCE, V259, P1619, DOI 10.1126/science.8456285; Weijer CJ, 2009, J CELL SCI, V122, P3215, DOI 10.1242/jcs.036517; Yamamoto N, 2006, J MOL MED, V84, P37, DOI 10.1007/s00109-005-0706-9; Zheng JL, 2000, NAT NEUROSCI, V3, P580, DOI 10.1038/75753	67	56	59	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e30577	10.1371/journal.pone.0030577	http://dx.doi.org/10.1371/journal.pone.0030577			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22299045	Green Submitted, Green Published, gold			2022-12-27	WOS:000301704200023
J	Turcatel, G; Rubin, N; El-Hashash, A; Warburton, D				Turcatel, Gianluca; Rubin, Nicole; El-Hashash, Ahmed; Warburton, David			MIR-99a and MIR-99b Modulate TGF-beta Induced Epithelial to Mesenchymal Plasticity in Normal Murine Mammary Gland Cells	PLOS ONE			English	Article							MIR-200 FAMILY; SIGNALING PATHWAY; REPRESSORS ZEB1; SMOOTH-MUSCLE; MICRORNAS; CANCER; TRANSITION; CADHERIN; DIFFERENTIATION; BIOGENESIS	Epithelial to mesenchymal transition (EMT) is a key process during embryonic development and disease development and progression. During EMT, epithelial cells lose epithelial features and express mesenchymal cell markers, which correlate with increased cell migration and invasion. Transforming growth factor-beta (TGF-beta) is a multifunctional cytokine that induces EMT in multiple cell types. The TGF-beta pathway is regulated by microRNAs (miRNAs), which are small non-coding RNAs regulating the translation of specific messenger RNAs. Herein, we identified mir-99a and mir-99b as two novel TGF-beta target miRNA genes, the expression of which increased during TGF-beta induced EMT of NMUMG cells. Mir-99a and mir-99b inhibition decreased TGF-beta activity by inhibiting SMAD3 phosphorylation, resulting in decreased migration and increased proliferation in response to TGF-beta. However, mir-99a and mir-99b inhibition was insufficient to block TGF-beta induced EMT of NMUMG cells. Mir-99a and mir-99b over-expression in epithelial NMUMG cells resulted in increased proliferation, migration and fibronectin expression, while E-cadherin and ZO-1 expression were negatively regulated. In conclusion, we identified mir-99a and mir-99b as two novel modulators of TGF-beta pathway that alter SMAD3 phosphorylation, in turn altering cell migration and adhesion of mesenchymal NMUMG cells. The effect of mir-99a and mir-99b over-expression on NMUMUG proliferation is dependent upon the epithelial or mesenchymal status of the cells. Our study suggests that mir-99a and mir-99b may function as modulators within a complex network of factors regulating TGF-beta induced breast epithelial to mesenchymal transition, as well as proliferation and migration of breast cancer cells, providing a possible target for future translationally oriented studies in this area.	[Turcatel, Gianluca; Rubin, Nicole; El-Hashash, Ahmed; Warburton, David] Childrens Hosp Los Angeles, Saban Res Inst, Dev Biol & Regenerat Med Program, Los Angeles, CA 90027 USA	Children's Hospital Los Angeles	Turcatel, G (corresponding author), Childrens Hosp Los Angeles, Saban Res Inst, Dev Biol & Regenerat Med Program, Los Angeles, CA 90027 USA.	dwarburton@chla.usc.edu	Warburton, David/AAD-5709-2020		National Institutes of Health-NHLBI [P01 HL 60231, HL 44060, HL44977]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL044977, P01HL060231, R01HL044060] Funding Source: NIH RePORTER	National Institutes of Health-NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was funded by National Institutes of Health-NHLBI P01 HL 60231, HL 44060 and HL44977 grants to DW as well as American Heart Association to GT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bartels CL, 2009, CLIN CHEM, V55, P623, DOI 10.1373/clinchem.2008.112805; Bieri M, 2009, MOL IMMUNOL, V46, P866, DOI 10.1016/j.molimm.2008.09.011; Bierie B, 2006, CYTOKINE GROWTH F R, V17, P29, DOI 10.1016/j.cytogfr.2005.09.006; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Briaud I, 2005, J BIOL CHEM, V280, P2282, DOI 10.1074/jbc.M412179200; Brodersen P, 2009, NAT REV MOL CELL BIO, V10, P141, DOI 10.1038/nrm2619; Chen CH, 2009, J HAND SURG-AM, V34A, P1777, DOI 10.1016/j.jhsa.2009.07.015; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Duursma AM, 2008, RNA, V14, P872, DOI 10.1261/rna.972008; Gal A, 2008, ONCOGENE, V27, P1218, DOI 10.1038/sj.onc.1210741; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Harfe BD, 2005, CURR OPIN GENET DEV, V15, P410, DOI 10.1016/j.gde.2005.06.012; Jimenez RH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007373; Kato M, 2009, NAT CELL BIOL, V11, P881, DOI 10.1038/ncb1897; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kong W, 2008, MOL CELL BIOL, V28, P6773, DOI 10.1128/MCB.00941-08; Korpal M, 2008, RNA BIOL, V5, P115, DOI 10.4161/rna.5.3.6558; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Lamouille S, 2007, J CELL BIOL, V178, P437, DOI 10.1083/jcb.200611146; Li L, 1996, CIRC RES, V78, P188, DOI 10.1161/01.RES.78.2.188; Li X, 2011, MICRORNA 223 PROMOTE; Louafi F, 2010, J BIOL CHEM; Martello G, CELL, V141, P1195; Martello G, 2007, NATURE, V449, P183, DOI 10.1038/nature06100; Martin KA, 2004, AM J PHYSIOL-CELL PH, V286, pC507, DOI 10.1152/ajpcell.00201.2003; Mongroo Perry S, 2010, Cancer Biol Ther, V10, P219; Oneyama C, 2011, ONCOGENE; Orom UA, 2008, MOL CELL, V30, P460, DOI 10.1016/j.molcel.2008.05.001; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Rai D, 2010, P NATL ACAD SCI USA, V107, P3111, DOI 10.1073/pnas.0910667107; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Song KY, 2006, EMBO J, V25, P58, DOI 10.1038/sj.emboj.7600917; Sun DD, 2011, CANCER RES, V71, P1313, DOI 10.1158/0008-5472.CAN-10-1031; WANG Y, 2010, ONCOGENE; Zhong H, 2010, INT J HEMATOL, V92, P129, DOI 10.1007/s12185-010-0626-5	38	88	100	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e31032	10.1371/journal.pone.0031032	http://dx.doi.org/10.1371/journal.pone.0031032			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22299047	Green Published, Green Submitted, gold			2022-12-27	WOS:000301704200054
J	Christie, JD; Wurfel, MM; Feng, R; O'Keefe, GE; Bradfield, J; Ware, LB; Christiani, DC; Calfee, CS; Cohen, MJ; Matthay, M; Meyer, NJ; Kim, C; Li, MY; Akey, J; Barnes, KC; Sevransky, J; Lanken, PN; May, AK; Aplenc, R; Maloney, JP; Hakonarson, H				Christie, Jason D.; Wurfel, Mark M.; Feng, Rui; O'Keefe, Grant E.; Bradfield, Jonathan; Ware, Lorraine B.; Christiani, David C.; Calfee, Carolyn S.; Cohen, Mitchell J.; Matthay, Michael; Meyer, Nuala J.; Kim, Cecilia; Li, Mingyao; Akey, Joshua; Barnes, Kathleen C.; Sevransky, Jonathan; Lanken, Paul N.; May, Addison K.; Aplenc, Richard; Maloney, James P.; Hakonarson, Hakon		Trauma ALI SNP Consortium TASC	Genome Wide Association Identifies PPFIA1 as a Candidate Gene for Acute Lung Injury Risk Following Major Trauma	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; MANNOSE-BINDING LECTIN; CHAIN-KINASE GENE; EARLY RELEASE; POLYMORPHISM; PROTEIN; SUSCEPTIBILITY; MORTALITY; ACTIVATION; EXPRESSION	Acute Lung Injury (ALI) is a syndrome with high associated mortality characterized by severe hypoxemia and pulmonary infiltrates in patients with critical illness. We conducted the first investigation to use the genome wide association (GWA) approach to identify putative risk variants for ALI. Genome wide genotyping was performed using the Illumina Human Quad 610 BeadChip. We performed a two-stage GWA study followed by a third stage of functional characterization. In the discovery phase (Phase 1), we compared 600 European American trauma-associated ALI cases with 2266 European American population-based controls. We carried forward the top 1% of single nucleotide polymorphisms (SNPs) at p<0.01 to a replication phase (Phase 2) comprised of a nested case-control design sample of 212 trauma-associated ALI cases and 283 at-risk trauma non-ALI controls from ongoing cohort studies. SNPs that replicated at the 0.05 level in Phase 2 were subject to functional validation (Phase 3) using expression quantitative trait loci (eQTL) analyses in stimulated Blymphoblastoid cell lines (B-LCL) in family trios. 159 SNPs from the discovery phase replicated in Phase 2, including loci with prior evidence for a role in ALI pathogenesis. Functional evaluation of these replicated SNPs revealed rs471931 on 11q13.3 to exert a cis-regulatory effect on mRNA expression in the PPFIA1 gene (p = 0.0021). PPFIA1 encodes liprin alpha, a protein involved in cell adhesion, integrin expression, and cell-matrix interactions. This study supports the feasibility of future multicenter GWA investigations of ALI risk, and identifies PPFIA1 as a potential functional candidate ALI risk gene for future research.	[Christie, Jason D.; Meyer, Nuala J.; Lanken, Paul N.] Univ Penn, Sch Med, Dept Med, Div Pulm Allergy & Crit Care Med, Philadelphia, PA 19104 USA; [Christie, Jason D.; Feng, Rui; Li, Mingyao] Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [O'Keefe, Grant E.] Univ Washington, Harborview Med Ctr, Dept Surg, Seattle, WA 98104 USA; [Wurfel, Mark M.] Univ Washington, Harborview Med Ctr, Dept Med, Div Pulm & Crit Care Med, Seattle, WA 98104 USA; [Bradfield, Jonathan; Kim, Cecilia; Hakonarson, Hakon] Univ Penn, Childrens Hosp Philadelphia, Sch Med, Div Human Genet,Ctr Appl Genom, Philadelphia, PA 19104 USA; [Ware, Lorraine B.] Vanderbilt Univ, Dept Med, Div Allergy Pulm & Crit Care Med, Nashville, TN USA; [Christiani, David C.] Massachusetts Gen Hosp, Dept Med, Pulm & Crit Care Unit, Boston, MA 02114 USA; [Christiani, David C.] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Calfee, Carolyn S.; Matthay, Michael] Univ Calif San Francisco, Cardiovasc Res Inst, Dept Med, San Francisco, CA 94143 USA; [Calfee, Carolyn S.; Matthay, Michael] Univ Calif San Francisco, Cardiovasc Res Inst, Dept Anesthesia, San Francisco, CA 94143 USA; [Cohen, Mitchell J.] Univ Calif San Francisco, Dept Surg, San Francisco, CA USA; [Akey, Joshua] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Barnes, Kathleen C.; Sevransky, Jonathan] Johns Hopkins Univ, Sch Med, Div Pulm Allergy & Crit Care Med, Baltimore, MD USA; [May, Addison K.] Vanderbilt Univ, Dept Surg Sci, Nashville, TN USA; [Aplenc, Richard] Univ Penn, Childrens Hosp Philadelphia, Sch Med, Div Oncol, Philadelphia, PA 19104 USA; [Maloney, James P.] Univ Colorado, Hlth Sci Ctr, Div Pulm & Crit Care Med, Denver, CO USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Harborview Medical Center; University of Washington; University of Washington Seattle; Harborview Medical Center; University of Washington; University of Washington Seattle; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Vanderbilt University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Washington; University of Washington Seattle; Johns Hopkins University; Vanderbilt University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Christie, JD (corresponding author), Univ Penn, Sch Med, Dept Med, Div Pulm Allergy & Crit Care Med, Philadelphia, PA 19104 USA.	jchristi@mail.med.upenn.edu	maloney, james/K-9428-2015; Ware, Lorraine/AAJ-9307-2021; O'KEEFE, GRANT/GON-5797-2022	maloney, james/0000-0001-8348-4650; Ware, Lorraine/0000-0002-9429-4702; Christie, Jason/0000-0003-0519-218X; Akey, Joshua/0000-0002-4411-1330	NIH [P50HL60290, P01HL079063, HL081332, HL060710]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL103836, R01HL060710, P50HL060290, K23HL102254, P01HL079063] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was funded by the following NIH grants: P50HL60290, P01HL079063, HL081332, HL060710. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; Adamzik M, 2007, EUR RESPIR J, V29, P482, DOI 10.1183/09031936.00046106; Adamzik M, 2008, CRIT CARE MED, V36, P1776, DOI 10.1097/CCM.0b013e318174373d; Adamzik M, 2007, INTENS CARE MED, V33, P1199, DOI 10.1007/s00134-007-0649-4; Agapov E, 2009, AM J RESP CELL MOL, V41, P379, DOI [10.1165/2009-0122R, 10.1165/2009-0122RC]; Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Arcaroli J, 2008, INTENS CARE MED, V34, P300, DOI 10.1007/s00134-007-0930-6; Arcaroli JJ, 2009, AM J RESP CRIT CARE, V179, P105, DOI 10.1164/rccm.200710-1566OC; Asperti C, 2010, EXP CELL RES, V316, P915, DOI 10.1016/j.yexcr.2010.01.017; Asperti C, 2009, J CELL SCI, V122, P3225, DOI 10.1242/jcs.054155; Barnes Kathleen C, 2005, Proc Am Thorac Soc, V2, P195, DOI 10.1513/pats.200502-013AC; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Billerbeck E, 2010, P NATL ACAD SCI USA, V107, P3006, DOI 10.1073/pnas.0914839107; Bornstein P, 2001, J CLIN INVEST, V107, P929, DOI 10.1172/JCI12749; Calfee CS, 2007, CRIT CARE MED, V35, P2243, DOI 10.1097/01.CCM.0000280434.33451.87; Christie JD, 2008, CRIT CARE MED, V36, P2794, DOI 10.1097/CCM.0b013e318186b843; Christie JD, 2008, CRIT CARE MED; CIVIL ID, 1988, J TRAUMA, V28, P87, DOI 10.1097/00005373-198801000-00012; Cohen MJ, 2010, J TRAUMA, V68, P1273, DOI 10.1097/TA.0b013e3181db323e; Cohen MJ, 2009, CRIT CARE, V13, DOI 10.1186/cc8152; Crome SQ, 2010, J IMMUNOL, V185, P3199, DOI 10.4049/jimmunol.1000557; Crosby LM, 2010, AM J PHYSIOL-LUNG C, V298, pL715, DOI 10.1152/ajplung.00361.2009; Flores C, 2008, TRANSL RES, V152, P11, DOI 10.1016/j.trsl.2008.05.006; Flory JH, 2009, J ALLERGY CLIN IMMUN, V124, P605, DOI 10.1016/j.jaci.2009.05.047; Gao L, 2006, AM J RESP CELL MOL, V34, P487, DOI 10.1165/rcmb.2005-0404OC; Gao L, 2007, TRANSL RES, V150, P18, DOI 10.1016/j.trsl.2007.02.007; Garcia-Laorden MI, 2008, J ALLERGY CLIN IMMUN, V122, P368, DOI 10.1016/j.jaci.2008.05.037; Glavan BJ, 2010, AM J RESP CRIT CARE; Glavan BJ, 2011, AM J RESP CRIT CARE, V183, P356, DOI 10.1164/rccm.201003-0351OC; Gong MN, 2007, CRIT CARE MED, V35, P48, DOI 10.1097/01.CCM.0000251132.10689.F3; Gong MN, 2006, CLIN CHEST MED, V27, P705, DOI 10.1016/j.ccm.2006.07.001; Gong MN, 2004, CHEST, V125, P203, DOI 10.1378/chest.125.1.203; Gong MN, 2006, EUR RESPIR J, V27, P674, DOI 10.1183/09031936.06.00046405; Gong MN, 2005, EUR RESPIR J, V26, P382, DOI 10.1183/09031936.05.00000505; Gorovoy M, 2007, CIRC RES, V101, P50, DOI 10.1161/CIRCRESAHA.106.145847; Hardy J, 2009, NEW ENGL J MED, V360, P1759, DOI 10.1056/NEJMra0808700; Hoglinger GU, 2011, NAT GENET, V43, P699, DOI 10.1038/ng.859; IDELL S, 1989, CHEST, V96, P1125, DOI 10.1378/chest.96.5.1125; Ioannidis JPA, 2009, NAT REV GENET, V10, P318, DOI 10.1038/nrg2544; Ip WKE, 2005, J INFECT DIS, V191, P1697, DOI 10.1086/429631; Jerng JS, 2006, CRIT CARE MED, V34, P1001, DOI 10.1097/01.CCM.0000206107.92476.39; Lagan AL, 2008, CHEST, V133, P1302, DOI 10.1378/chest.07-1117; Lim JC, 2011, P NATL ACAD SCI USA, V108, P10472, DOI 10.1073/pnas.1101275108; Lin Z, 2000, CLIN GENET, V58, P181, DOI 10.1034/j.1399-0004.2000.580305.x; Luca D, 2008, AM J HUM GENET, V82, P453, DOI 10.1016/j.ajhg.2007.11.003; Marshall RP, 2002, AM J RESP CRIT CARE, V166, P646, DOI 10.1164/rccm.2108086; Marshall RP, 2002, CHEST, V121, p68S, DOI 10.1378/chest.121.3_suppl.68S; Marzec JM, 2007, FASEB J, V21, P2237, DOI 10.1096/fj.06-7759com; Matsuda M, 2010, EUR J CELL BIOL, V89, P807, DOI 10.1016/j.ejcb.2010.07.009; Medford ARL, 2005, THORAX, V60, P244, DOI 10.1136/thx.2004.034785; Meyer NJ, 2011, AM J RESP CRIT CARE, V183, P1344, DOI 10.1164/rccm.201005-0701OC; Min JW, 2005, J HUM GENET, V50, P118, DOI 10.1007/s10038-005-0230-3; Moreira-Teixeira L, 2011, J IMMUNOL, V186, P5758, DOI 10.4049/jimmunol.1003043; Nonas Stephanie A, 2005, Proc Am Thorac Soc, V2, P188, DOI 10.1513/pats.200501-005AC; Pino-Yanes M, 2010, AM J RESP CELL MOL B; Pope SM, 2005, J IMMUNOL, V175, P5341, DOI 10.4049/jimmunol.175.8.5341; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quasney MW, 2004, CRIT CARE MED, V32, P1115, DOI 10.1097/01.CCM.0000124872.55243.5A; Reddy AJ, 2008, J CELL MOL MED; Reddy AJ, 2009, J CELL MOL MED, V13, P1784, DOI 10.1111/j.1582-4934.2008.00581.x; Reiner AP, 2008, ARTERIOSCL THROM VAS, V28, P1407, DOI 10.1161/ATVBAHA.108.167437; Reutershan J, 2004, CRIT CARE, V8, P453, DOI 10.1186/cc2881; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Sapru A, 2009, ANESTHESIOLOGY, V110, P1086, DOI 10.1097/ALN.0b013e3181a1081d; Satagopan JM, 2003, GENET EPIDEMIOL, V25, P149, DOI 10.1002/gepi.10260; Serra-Pages C, 1998, J BIOL CHEM, V273, P15611, DOI 10.1074/jbc.273.25.15611; Shalhub S, 2009, J TRAUMA, V66, P115, DOI 10.1097/TA.0b013e3181938d50; Sheu CC, 2009, INTENS CARE MED, V35, P1343, DOI 10.1007/s00134-009-1504-6; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Skoll AD, 2007, GENET EPIDEMIOL, V31, P776, DOI 10.1002/gepi.20240; Sleiman PMA, 2010, NEW ENGL J MED, V362, P36, DOI 10.1056/NEJMoa0901867; Sohn MH, 2010, AM J RESP CRIT CARE, V182, P918, DOI 10.1164/rccm.200912-1793OC; Storey JD, 2007, AM J HUM GENET, V80, P502, DOI 10.1086/512017; Su L, 2009, INTENS CARE MED, V35, P1024, DOI 10.1007/s00134-009-1413-8; Sutherland AM, 2005, ARCH INTERN MED, V165, P75, DOI 10.1001/archinte.165.1.75; Suzuki M, 2009, J IMMUNOL, V182, P6485, DOI 10.4049/jimmunol.0802797; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; Tejera P, 2009, AM J RESP CELL MOL, V41, P696, DOI 10.1165/rcmb.2008-0410OC; Visscher PM, 2009, JAMA-J AM MED ASSOC, V302, P2028, DOI 10.1001/jama.2009.1643; Wurfel MM, 2008, AM J RESP CRIT CARE, V178, P710, DOI 10.1164/rccm.200803-462OC; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Ye SQ, 2005, AM J RESP CRIT CARE, V171, P361, DOI 10.1164/rccm.200404-563OC; Zhai R, 2007, THORAX, V62, P718, DOI 10.1136/thx.2006.069393; Zhai RH, 2007, CRIT CARE MED, V35, P893, DOI 10.1097/01.CCM.0000256845.92640.38; Zurner M, 2009, GENOMICS, V93, P243, DOI 10.1016/j.ygeno.2008.10.007	85	56	58	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e28268	10.1371/journal.pone.0028268	http://dx.doi.org/10.1371/journal.pone.0028268			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295056	Green Submitted, Green Published, gold			2022-12-27	WOS:000301640600001
J	Hwang, RY; Stearns, NA; Tracey, WD				Hwang, Richard Y.; Stearns, Nancy A.; Tracey, W. Daniel			The Ankyrin Repeat Domain of the TRPA Protein Painless Is Important for Thermal Nociception but Not Mechanical Nociception	PLOS ONE			English	Article							TIP-LINK; DROSOPHILA; RECEPTOR; CHANNEL; SENSITIVITY; CADHERIN-23	The Drosophila TRPA channel Painless is required for the function of polymodal nociceptors which detect noxious heat and noxious mechanical stimuli. These functions of Painless are reminiscent of mammalian TRPA channels that have also been implicated in thermal and mechanical nociception. A popular hypothesis to explain the mechanosensory functions of certain TRP channels proposes that a string of ankyrin repeats at the amino termini of these channels acts as an intracellular spring that senses force. Here, we describe the identification of two previously unknown Painless protein isoforms which have fewer ankyrin repeats than the canonical Painless protein. We show that one of these Painless isoforms, that essentially lacks ankyrin repeats, is sufficient to rescue mechanical nociception phenotypes of painless mutant animals but does not rescue thermal nociception phenotypes. In contrast, canonical Painless, which contains Ankyrin repeats, is sufficient to largely rescue thermal nociception but is not capable of rescuing mechanical nociception. Thus, we propose that in the case of Painless, ankryin repeats are important for thermal nociception but not for mechanical nociception.	[Hwang, Richard Y.; Tracey, W. Daniel] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Stearns, Nancy A.; Tracey, W. Daniel] Duke Univ, Med Ctr, Dept Anesthesiol, Durham, NC 27710 USA; [Tracey, W. Daniel] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA	Duke University; Duke University; Duke University	Hwang, RY (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.	dan.tracey@duke.edu		Tracey, W. Daniel/0000-0003-4666-8199	Whitehall Foundation; Alfred P. Sloan Foundation; National Institute of Neurological Disorders and Stroke [5R01NS054899-05]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054899] Funding Source: NIH RePORTER	Whitehall Foundation; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants to WDT from the Whitehall Foundation, the Alfred P. Sloan Foundation, and the National Institute of Neurological Disorders and Stroke (5R01NS054899-05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed ZM, 2006, J NEUROSCI, V26, P7022, DOI 10.1523/JNEUROSCI.1163-06.2006; Al-Anzi B, 2006, CURR BIOL, V16, P1034, DOI 10.1016/j.cub.2006.04.002; Brauchi S, 2006, J NEUROSCI, V26, P4835, DOI 10.1523/JNEUROSCI.5080-05.2006; Chung YD, 2001, NEURON, V29, P415, DOI 10.1016/S0896-6273(01)00215-X; Cordero-Morales JF, 2011, P NATL ACAD SCI USA, V108, pE1184, DOI 10.1073/pnas.1114124108; Corey DP, 2004, NATURE, V428, P901, DOI 10.1038/428901a; Damann N, 2008, CURR BIOL, V18, pR880, DOI 10.1016/j.cub.2008.07.063; Gopfert MC, 2006, NAT NEUROSCI, V9, P999, DOI 10.1038/nn1735; Goodman MB, 2002, NATURE, V415, P1039, DOI 10.1038/4151039a; Howard J, 2004, CURR BIOL, V14, pR224, DOI 10.1016/j.cub.2004.02.050; Hwang RY, 2007, CURR BIOL, V17, P2105, DOI 10.1016/j.cub.2007.11.029; Lee G, 2006, NATURE, V440, P246, DOI 10.1038/nature04437; Lee Y, 2005, NAT GENET, V37, P305, DOI 10.1038/ng1513; Li W, 2006, NATURE, V440, P684, DOI 10.1038/nature04538; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; O'Hagan R, 2005, INT REV NEUROBIOL, V69, P169, DOI 10.1016/S0074-7742(05)69006-X; Schumacher MA, 2000, J BIOL CHEM, V275, P2756, DOI 10.1074/jbc.275.4.2756; Sidi S, 2003, SCIENCE, V301, P96, DOI 10.1126/science.1084370; Siemens J, 2004, NATURE, V428, P950, DOI 10.1038/nature02483; Sokabe T, 2008, J NEUROSCI, V28, P9929, DOI 10.1523/JNEUROSCI.2757-08.2008; Sollner C, 2004, NATURE, V428, P955, DOI 10.1038/nature02484; Sotomayor M, 2005, STRUCTURE, V13, P669, DOI 10.1016/j.str.2005.03.001; Tracey WD, 2003, CELL, V113, P261, DOI 10.1016/S0092-8674(03)00272-1; Vlachova V, 2003, J NEUROSCI, V23, P1340, DOI 10.1523/JNEUROSCI.23-04-01340.2003; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229; Watanabe H, 2002, J BIOL CHEM, V277, P47044, DOI 10.1074/jbc.M208277200; Xiang Y, 2010, NATURE; Xu SY, 2006, GENES BRAIN BEHAV, V0, P1; Zhong LX, 2012, CELL REP, V1, P43, DOI 10.1016/j.celrep.2011.11.002; Zhong LX, 2010, CURR BIOL, V20, P429, DOI 10.1016/j.cub.2009.12.057	30	38	43	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30090	10.1371/journal.pone.0030090	http://dx.doi.org/10.1371/journal.pone.0030090			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295071	Green Submitted, gold, Green Published			2022-12-27	WOS:000301640600016
J	Kahn, JG; Muraguri, N; Harris, B; Lugada, E; Clasen, T; Grabowsky, M; Mermin, J; Shariff, S				Kahn, James G.; Muraguri, Nicholas; Harris, Brian; Lugada, Eric; Clasen, Thomas; Grabowsky, Mark; Mermin, Jonathan; Shariff, Shahnaaz			Integrated HIV Testing, Malaria, and Diarrhea Prevention Campaign in Kenya: Modeled Health Impact and Cost-Effectiveness	PLOS ONE			English	Article							INSECTICIDE-TREATED BEDNETS; RESOURCE-LIMITED SETTINGS; RURAL WESTERN KENYA; SUB-SAHARAN AFRICA; ANTIRETROVIRAL THERAPY; DEVELOPING-COUNTRIES; COTRIMOXAZOLE PROPHYLAXIS; SOUTH-AFRICA; UGANDA; STRATEGIES	Background: Efficiently delivered interventions to reduce HIV, malaria, and diarrhea are essential to accelerating global health efforts. A 2008 community integrated prevention campaign in Western Province, Kenya, reached 47,000 individuals over 7 days, providing HIV testing and counseling, water filters, insecticide-treated bed nets, condoms, and for HIV-infected individuals cotrimoxazole prophylaxis and referral for ongoing care. We modeled the potential cost-effectiveness of a scaled-up integrated prevention campaign. Methods: We estimated averted deaths and disability-adjusted life years (DALYs) based on published data on baseline mortality and morbidity and on the protective effect of interventions, including antiretroviral therapy. We incorporate a previously estimated scaled-up campaign cost. We used published costs of medical care to estimate savings from averted illness (for all three diseases) and the added costs of initiating treatment earlier in the course of HIV disease. Results: Per 1000 participants, projected reductions in cases of diarrhea, malaria, and HIV infection avert an estimated 16.3 deaths, 359 DALYs and $85,113 in medical care costs. Earlier care for HIV-infected persons adds an estimated 82 DALYs averted (to a total of 442), at a cost of $37,097 (reducing total averted costs to $48,015). Accounting for the estimated campaign cost of $32,000, the campaign saves an estimated $16,015 per 1000 participants. In multivariate sensitivity analyses, 83% of simulations result in net savings, and 93% in a cost per DALY averted of less than $20. Discussion: A mass, rapidly implemented campaign for HIV testing, safe water, and malaria control appears economically attractive.	[Kahn, James G.; Harris, Brian] Univ Calif San Francisco, Philip R Lee Inst Hlth Policy Studies, San Francisco, CA 94143 USA; [Muraguri, Nicholas; Shariff, Shahnaaz] Govt Kenya, Minist Publ Hlth & Sanitat, Nairobi, Kenya; [Lugada, Eric] CHF Int, Nairobi, Kenya; [Clasen, Thomas] London Sch Hyg & Trop Med, London WC1, England; [Grabowsky, Mark] ESP UN Fdn, Washington, DC USA; [Mermin, Jonathan] Ctr Dis Control & Prevent Kenya, Coordinating Off Global Hlth, CDC, Nairobi, Kenya	University of California System; University of California San Francisco; University of London; London School of Hygiene & Tropical Medicine	Kahn, JG (corresponding author), Univ Calif San Francisco, Philip R Lee Inst Hlth Policy Studies, San Francisco, CA 94143 USA.	jgkahn@ucsf.edu	Mermin, Jonathan/J-9847-2012		Vestergaard Frandsen; U.S. National Institute for Drug Abuse [R01 DA15612]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015612, R37DA015612] Funding Source: NIH RePORTER	Vestergaard Frandsen; U.S. National Institute for Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was funded by Vestergaard Frandsen and by the U.S. National Institute for Drug Abuse, under R01 DA15612. Neither funder exerted any editorial control. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003255, DOI 10.1002/14651858.CD003255]; [Anonymous], 2004, COCHRANE DB SYST REV; [Anonymous], COST EFF RESOUR ALLO, DOI DOI 10.1186/1478-7547-7-3; Bendavid E, 2008, ARCH INTERN MED, V168, P1910, DOI 10.1001/archinternmed.2008.1; Clasen T, 2007, J WATER HEALTH, V5, P599, DOI 10.2166/wh.2007.010; Clasen T, 2009, AM J TROP MED HYG, V80, P819, DOI 10.4269/ajtmh.2009.80.819; CRAIG M., 2003, 11 FOG INT CTR NIH; Crump JA, 2005, BMJ-BRIT MED J, V331, P478, DOI 10.1136/bmj.38512.618681.E0; Denison JA, 2008, AIDS BEHAV, V12, P363, DOI 10.1007/s10461-007-9349-x; Dunkle KL, 2008, LANCET, V371, P2183, DOI 10.1016/S0140-6736(08)60953-8; Forsythe S, 2002, HEALTH POLICY PLANN, V17, P187, DOI 10.1093/heapol/17.2.187; Goldie SJ, 2006, NEW ENGL J MED, V355, P1141, DOI 10.1056/NEJMsa060247; Grabowsky M, 2005, B WORLD HEALTH ORGAN, V83, P195; Grabowsky M, 2007, TROP MED INT HEALTH, V12, P815, DOI 10.1111/j.1365-3156.2007.01862.x; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Hausler HP, 2006, B WORLD HEALTH ORGAN, V84, P528, DOI 10.2471/BLT.04.018606; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; Kahn J, 2010, BMC HLTH SE IN PRESS; Kahn JG, 2006, PLOS MED, V3, P2349, DOI 10.1371/journal.pmed.0030517; Kahn JG, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6884; Kilian A, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-49; Laxminarayan R, 2006, LANCET, V367, P1193, DOI 10.1016/S0140-6736(06)68440-7; Lever D, 2011, ACUTE DIARRHEA DIS M; Lopez AD, 2006, DIS CONTROL PRIORITI; Lubell Y, 2011, B WORLD HEALTH ORGAN, V89, P504, DOI 10.2471/BLT.11.085878; Lugada E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012435; Marseille E, 2009, APPL HEALTH ECON HEA, V7, P229, DOI 10.2165/11318740-000000000-00000; Masanja H, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-142; McConnel CE, 2005, SAMJ S AFR MED J, V95, P968; Menzies N, 2009, AIDS, V23, P395, DOI 10.1097/QAD.0b013e328321e40b; Mermin J, 2006, LANCET, V367, P1256, DOI 10.1016/S0140-6736(06)68541-3; Mermin J, 2006, JAIDS-J ACQ IMM DEF, V41, P129, DOI 10.1097/01.qai.0000179427.11789.a7; Mermin J, 2004, LANCET, V364, P1428, DOI 10.1016/S0140-6736(04)17225-5; Morel CM, 2005, BMJ-BRIT MED J, V331, P1299, DOI 10.1136/bmj.38639.702384.AE; Mueller DH, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-73; Mulligan JA, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-32; National AIDS/STD Control Programme (NASCOP) MoHGoK, 2009, 2007 KEN AIDS IND SU; Shillcutt S, 2008, B WORLD HEALTH ORGAN, V86, P101, DOI 10.2471/BLT.07.042259; Shrestha RK, 2006, AM J TROP MED HYG, V74, P884, DOI 10.4269/ajtmh.2006.74.884; Smith DL, 2011, SCIENCE, V332, P1384, DOI 10.1126/science.1201398; Sweat M, 2000, LANCET, V356, P113, DOI 10.1016/S0140-6736(00)02447-8; Tate JE, 2009, J INFECT DIS, V200, pS76, DOI 10.1086/605058; van Eijk AM, 2008, TROP MED INT HEALTH, V13, P1314, DOI 10.1111/j.1365-3156.2008.02136.x; Walensky RP, 2009, ANN INTERN MED, V151, P157, DOI 10.7326/0003-4819-151-3-200908040-00138; WHO, 2009, WHO REP GLOB TUB CON; Williams BG, 2010, P NATL ACAD SCI USA, V107, P19485, DOI 10.1073/pnas.1005660107; Yukich JO, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-258	47	29	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31316	10.1371/journal.pone.0031316	http://dx.doi.org/10.1371/journal.pone.0031316			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347462	Green Published, gold, Green Submitted			2022-12-27	WOS:000302730100060
J	Tomkins, S; Collier, T; Oralov, A; Saburova, L; McKee, M; Shkolnikov, V; Kiryanov, N; Leon, DA				Tomkins, Susannah; Collier, Tim; Oralov, Alexey; Saburova, Lyudmila; McKee, Martin; Shkolnikov, Vladimir; Kiryanov, Nikolay; Leon, David A.			Hazardous Alcohol Consumption Is a Major Factor in Male Premature Mortality in a Typical Russian City: Prospective Cohort Study 2003-2009	PLOS ONE			English	Article							CRISIS	Introduction: Russia has experienced massive fluctuations in mortality at working ages over the past three decades. Routine data analyses suggest that these are largely driven by fluctuations in heavy alcohol drinking. However, individual-level evidence supporting alcohol having a major role in Russian mortality comes from only two case-control studies, which could be subject to serious biases due to their design. Methods and Findings: A prospective study of mortality (2003-9) of 2000 men aged 25-54 years at recruitment was conducted in the city of Izhevsk, Russia. This cohort was free from key limitations inherent in the design of the two earlier case-control studies. Cox proportional hazards regression was used to estimate hazard ratios of all-cause mortality by alcohol drinking type as reported by a proxy informant. Hazardous drinkers were defined as those who either drank non-beverage alcohols or were reported to regularly have hangovers or other behaviours related to heavy drinking episodes. Over the follow-up period 113 men died. Compared to non-hazardous drinkers and abstainers, men who drank hazardously had appreciably higher mortality (HR = 3.4, 95% CI 2.2, 5.1) adjusted for age, smoking and education. The population attributable risk percent (PAR%) for hazardous drinking was 26% (95% CI 14,37). However, larger effects were seen in the first two years of follow-up, with a HR of 4.6 (2.5, 8.2) and a corresponding PAR% of 37% (17, 51). Interpretation: This prospective cohort study strengthens the evidence that hazardous alcohol consumption has been a major determinant of mortality among working age men in a typical Russian city. As such the similar findings of the previous case-control studies cannot be explained as artefacts of limitations of their design. As Russia struggles to raise life expectancy, which even in 2009 was only 62 years among men, control of hazardous drinking must remain a top public health priority.	[Tomkins, Susannah; Collier, Tim; McKee, Martin; Leon, David A.] London Sch Hyg & Trop Med, London WC1, England; [Oralov, Alexey] Izhevsk State Tech Univ, Izhevsk, Russia; [Saburova, Lyudmila] Social Technol Inst, Izhevsk, Russia; [Shkolnikov, Vladimir] Max Planck Inst Demog Res, Rostock, Germany; [Shkolnikov, Vladimir] New Econ Sch, Moscow, Russia; [Kiryanov, Nikolay] Izhevsk Med Acad, Izhevsk, Russia	University of London; London School of Hygiene & Tropical Medicine; Kalashnikov Izhevsk State Technical University; Max Planck Society; New Economic School	Tomkins, S (corresponding author), London Sch Hyg & Trop Med, London WC1, England.	david.leon@lshtm.ac.uk	Saburova, Lyudmila A./K-2275-2018; McKee, Marc D/E-2187-2011; Shkolnikov, Vladimir/D-2986-2017; Mckee, Martin/E-6673-2018; Leon, David A/G-2195-2010	Saburova, Lyudmila A./0000-0002-7243-652X; McKee, Marc D/0000-0001-8349-965X; Shkolnikov, Vladimir/0000-0003-2259-5423; Mckee, Martin/0000-0002-0121-9683; Leon, David A/0000-0001-9747-1762	Wellcome Trust [067232, 078557]	Wellcome Trust(Wellcome TrustEuropean Commission)	The study was funded by the Wellcome Trust, grant numbers 067232 and 078557. http://www.wellcome.ac.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Deev A, 1998, ANN EPIDEMIOL, V8, P147, DOI 10.1016/S1047-2797(98)00004-0; Fillmore KM, 2007, ANN EPIDEMIOL, V17, pS16, DOI 10.1016/j.annepidem.2007.01.005; Gil A, 2009, ALCOHOL CLIN EXP RES, V33, P79, DOI 10.1111/j.1530-0277.2008.00813.x; GREENLAND S, 1993, BIOMETRICS, V49, P865, DOI 10.2307/2532206; Khaltourina DA, 2008, EVAL HEALTH PROF, V31, P272, DOI 10.1177/0163278708320160; Leon DA, 2007, LANCET, V369, P2001, DOI 10.1016/S0140-6736(07)60941-6; Leon DA, 2011, INT J EPIDEMIOL, V40, P271, DOI 10.1093/ije/dyr061; Leon DA, 2010, INT J EPIDEMIOL, V39, P1279, DOI 10.1093/ije/dyq102; Leon DA, 2009, ADDICTION, V104, P1630, DOI 10.1111/j.1360-0443.2009.02655.x; McKee M, 2005, ALCOHOL CLIN EXP RES, V29, P1884, DOI 10.1097/01.alc.0000183012.93303.90; Tomkins S, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-343; Torvik FA, 2011, SOC PSYCHIAT PSYCHIA; Treisman D, 2010, ECON TRANSIT, V18, P281, DOI 10.1111/j.1468-0351.2009.00382.x; Zaridze D, 2009, LANCET, V373, P2201, DOI 10.1016/S0140-6736(09)61034-5	14	48	54	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e30274	10.1371/journal.pone.0030274	http://dx.doi.org/10.1371/journal.pone.0030274			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	924ZP	22347371	Green Accepted, gold, Green Published			2022-12-27	WOS:000302730100008
J	Zaman, MS; Shahryari, V; Deng, GR; Thamminana, S; Saini, S; Majid, S; Chang, I; Hirata, H; Ueno, K; Yamamura, S; Singh, K; Tanaka, Y; Tabatabai, ZL; Dahiya, R				Zaman, Mohd Saif; Shahryari, Varahram; Deng, Guoren; Thamminana, Sobha; Saini, Sharonjot; Majid, Shahana; Chang, Inik; Hirata, Hiroshi; Ueno, Koji; Yamamura, Soichiro; Singh, Kamaldeep; Tanaka, Yuichiro; Tabatabai, Z. Laura; Dahiya, Rajvir			Up-Regulation of MicroRNA-21 Correlates with Lower Kidney Cancer Survival	PLOS ONE			English	Article							RENAL-CELL CARCINOMA; GENE-EXPRESSION; P21(WAF1/CIP1/SDI1); APOPTOSIS; BREAST; P21; CDK; TRANSCRIPTION; INHIBITION; SENESCENCE	Background: MicroRNA-21 is up-regulated in a variety of cancers like, breast, colorectal, lung, head and neck etc. However, the regulation of miR-21 in renal cell carcinoma (RCC) has not yet been studied systematically. Methods and Results: We measured miR-21 levels in 54 pairs of kidney cancers and their normal matched tissues by real-time PCR. The expression level of miR-21 was correlated with 5 year survival and the pathological stage. Functional studies were done after inhibiting miR-21 in RCC cell lines. We studied in vitro and in vivo effects of the chemo preventive agent genistein on miR-21 expression. In 48 cases (90%), miR-21 was increased. All patients with low miR-21 expression survived 5 years, while with high miR-21 expression, only 50% survived. Higher expression of miR-21 is associated with an increase in the stage of renal cancer. Functional studies after inhibiting miRNA-21 in RCC cell lines show cell cycle arrest, induction of apoptosis and reduced invasive and migratory capabilities. Western blot analysis showed an increase in the expression of p21 and p38 MAP kinase genes and a reduction in cyclin E2. Genistein inhibited the expression of miR-21 in A-498 cells and in the tumors formed after injecting genistein treated A-498 cells in nude mice besides inhibiting tumor formation. Conclusions: The current study shows a clear correlation between miR-21 expression and clinical characteristics of renal cancer. Thus we believe that miR-21 can be used as a tumor marker and its inhibition may prove to be useful in controlling cancers with up-regulated miR-21.	[Zaman, Mohd Saif] San Francisco VA Med Ctr, Dept Urol, San Francisco, CA 94121 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco	Zaman, MS (corresponding author), San Francisco VA Med Ctr, Dept Urol, San Francisco, CA 94121 USA.	rdahiya@urology.ucsf.edu			Veterans Association; National Institutes of Health [RO1CA130860]; NATIONAL CANCER INSTITUTE [R01CA130860] Funding Source: NIH RePORTER	Veterans Association; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the Veterans Association Merit Review, Veterans Association Research Enhancement Award Program and National Institutes of Health Grant RO1CA130860 (to the principal investigator, Dr. R. Dahiya). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Avery AK, 2000, AM J SURG PATHOL, V24, P203, DOI 10.1097/00000478-200002000-00006; Bektic Jasmin, 2005, Clin Prostate Cancer, V4, P124, DOI 10.3816/CGC.2005.n.021; Bloomston M, 2007, JAMA-J AM MED ASSOC, V297, P1901, DOI 10.1001/jama.297.17.1901; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chang BD, 2000, P NATL ACAD SCI USA, V97, P4291, DOI 10.1073/pnas.97.8.4291; CHEN JJ, 1995, NATURE, V374, P386, DOI 10.1038/374386a0; Chow G K, 2001, Can J Urol, V8, P1223; Coqueret O, 2000, J BIOL CHEM, V275, P18794, DOI 10.1074/jbc.M001601200; Day JK, 2002, J NUTR, V132, p2419S, DOI 10.1093/jn/132.8.2419S; Delavaine L, 1999, ONCOGENE, V18, P5381, DOI 10.1038/sj.onc.1202923; Eulalio A, 2008, CELL, V132, P9, DOI 10.1016/j.cell.2007.12.024; Gartel AL, 2005, LEUKEMIA RES, V29, P1237, DOI 10.1016/j.leukres.2005.04.023; Gottifredi V, 2001, MOL CELL BIOL, V21, P1066, DOI 10.1128/MCB.21.4.1066-1076.2001; Hillman GG, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-4; HUNTER T, 1987, CELL, V50, P823, DOI 10.1016/0092-8674(87)90509-5; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jayson M, 1998, UROLOGY, V51, P203, DOI 10.1016/S0090-4295(97)00506-2; Juan D, 2010, UROLOGY, V75, P835, DOI 10.1016/j.urology.2009.10.033; Kaneuchi M, 1999, MOL CARCINOGEN, V26, P44, DOI 10.1002/(SICI)1098-2744(199909)26:1<44::AID-MC6>3.3.CO;2-V; Kitaura H, 2000, J BIOL CHEM, V275, P10477, DOI 10.1074/jbc.275.14.10477; Loffler D, 2007, BLOOD, V110, P1330, DOI 10.1182/blood-2007-03-081133; Lohr K, 2003, J BIOL CHEM, V278, P32507, DOI 10.1074/jbc.M212517200; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; LUO Y, 1995, NATURE, V375, P159, DOI 10.1038/375159a0; Magee PJ, 2004, BRIT J NUTR, V91, P513, DOI 10.1079/BJN20031075; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Nakada C, 2008, J PATHOL, V216, P418, DOI 10.1002/path.2437; Okaichi K, 1999, INT J RADIAT ONCOL, V45, P975, DOI 10.1016/S0360-3016(99)00285-0; Petillo D, 2009, INT J ONCOL, V35, P109, DOI 10.3892/ijo_00000318; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Roninson IB, 2002, CANCER LETT, V179, P1, DOI 10.1016/S0304-3835(01)00847-3; Samuels-Lev Y, 2001, MOL CELL, V8, P781, DOI 10.1016/S1097-2765(01)00367-7; Selcuklu SD, 2009, BIOCHEM SOC T, V37, P918, DOI 10.1042/BST0370918; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; THOENES W, 1986, PATHOL RES PRACT, V181, P125, DOI 10.1016/S0344-0338(86)80001-2; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Zava DT, 1997, NUTR CANCER, V27, P31, DOI 10.1080/01635589709514498; Zhang AM, 2011, UROLOGY, V78, DOI 10.1016/j.urology.2011.03.030	44	97	104	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31060	10.1371/journal.pone.0031060	http://dx.doi.org/10.1371/journal.pone.0031060			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347428	Green Submitted, Green Published, gold			2022-12-27	WOS:000302730100036
J	Liu, FF; Guo, FC; Zhou, Y; He, ZH; Tian, XY; Guo, CH; Ning, T; Pan, YQ; Cai, H; Ke, Y				Liu, Fangfang; Guo, Fangcen; Zhou, Yue; He, Zhonghu; Tian, Xiuyun; Guo, Chuanhai; Ning, Tao; Pan, Yaqi; Cai, Hong; Ke, Yang			The Anyang Esophageal Cancer Cohort Study: Study Design, Implementation of Fieldwork, and Use of Computer-Aided Survey System	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; HUMAN-PAPILLOMAVIRUS; RISK-FACTORS; GASTRIC CANCERS; CHINA; POPULATION; HPV; PARTICIPATION; CHALLENGES; INFECTION	Background: Human papillomavirus (HPV) has been observed repeatedly in esophageal squamous cell carcinoma (ESCC) tissues. However, the causal relationship between HPV infection and the onset of ESCC remains unknown. A large cohort study focusing on this topic is being carried out in rural Anyang, China. Methodology/Principal Findings: The Anyang Esophageal Cancer Cohort Study (AECCS) is a population-based prospective endoscopic cohort study designed to investigate the association of HPV infection and ESCC. This paper provides information regarding the design and implementation of this study. In particular we describe the recruitment strategies and quality control procedures which have been put into place, and the custom designed computer-aided survey system (CASS) used for this project. This system integrates barcode technology and unique identification numbers, and has been developed to facilitate real-time data management throughout the workflow using a wireless local area network. A total of 8,112 (75.3%) of invited subjects participated in the baseline endoscopic examination; of those invited two years later to take part in the first cycle of follow-up, 91.9% have complied. Conclusions/Significance: The AECCS study has high potential for evaluating the causal relationship between HPV infection and the occurrence of ESCC. The experience in setting up the AECCS may be beneficial for others planning to initiate similar epidemiological studies in developing countries.	[Liu, Fangfang; Guo, Fangcen; Zhou, Yue; He, Zhonghu; Tian, Xiuyun; Guo, Chuanhai; Ning, Tao; Pan, Yaqi; Cai, Hong; Ke, Yang] Peking Univ, Key Lab Carcinogenesis & Translat Res, Minist Educ, Sch Oncol,Beijing Canc Hosp & Inst, Beijing 100871, Peoples R China; [Zhou, Yue] Natl Res Inst Family Planning, Beijing, Peoples R China	Peking University; National Research Institute for Family Planning - China	Liu, FF (corresponding author), Peking Univ, Key Lab Carcinogenesis & Translat Res, Minist Educ, Sch Oncol,Beijing Canc Hosp & Inst, Beijing 100871, Peoples R China.	drhcai@gmail.com; keyang@bjmu.edu.cn			Natural Science Foundation of China [30872937, 30930102]; National Ministry of Science and Technology [2011CB504301, 2006AA2Z467]; National Ministry of Health [200902002]; Natural Science Foundation of Beijing [7100001]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Ministry of Science and Technology; National Ministry of Health; Natural Science Foundation of Beijing(Beijing Natural Science Foundation)	This work was supported by Natural Science Foundation of China 30872937 and 30930102, "973'' Project of National Ministry of Science and Technology Grant 2011CB504301,"863'' Key Projects of National Ministry of Science and Technology Grant 2006AA2Z467, Charity Project of National Ministry of Health 200902002, Natural Science Foundation of Beijing 7100001 to Dr. Ke. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aviles W, 2007, PLOS MED, V4, P1578, DOI 10.1371/journal.pmed.0040291; BENAMOUZIG R, 1992, INT J CANCER, V50, P549, DOI 10.1002/ijc.2910500409; BENAMOUZIG R, 1995, GASTROENTEROLOGY, V109, P1876, DOI 10.1016/0016-5085(95)90754-8; Blot W J, 1985, Natl Cancer Inst Monogr, V69, P29; Chang FJ, 2000, ANTICANCER RES, V20, P3935; Chen Z, 2008, 3 NATL SURVEY CAUSES; Farhadi M, 2005, WORLD J GASTROENTERO, V11, P1200, DOI 10.3748/wjg.v11.i8.1200; Fujita S, 2004, CLIN CANCER RES, V10, P6551, DOI 10.1158/1078-0432.CCR-04-0819; Galea S, 2007, ANN EPIDEMIOL, V17, P643, DOI 10.1016/j.annepidem.2007.03.013; He Z, 2010, J HOSP INFECT, V76, P336, DOI 10.1016/j.jhin.2010.06.005; He Z, 2010, BRIT J CANCER, V103, P1085, DOI 10.1038/sj.bjc.6605843; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Koepsell TD, 2003, COHORT STUDIES EPIDE, P365; Li T, 2001, CARCINOGENESIS, V22, P929, DOI 10.1093/carcin/22.6.929; Locker D, 2000, J PUBLIC HEALTH DENT, V60, P72, DOI 10.1111/j.1752-7325.2000.tb03298.x; Mark SD, 2000, J NATL CANCER I, V92, P1753, DOI 10.1093/jnci/92.21.1753; Marshall W W, 2000, JAMA, V284, P1843, DOI 10.1001/jama.284.14.1843; O'Brien RL, 2006, J NATL MED ASSOC, V98, P674; Pourshams A, 2010, INT J EPIDEMIOL, V39, P52, DOI 10.1093/ije/dyp161; Qiao YL, 2009, JNCI-J NATL CANCER I, V101, P507, DOI 10.1093/jnci/djp037; Roberts RJ, 2000, STAT MED, V19, P1645; Schiffman Mark, 2003, J Natl Cancer Inst Monogr, P14; Shen ZY, 2002, J MED VIROL, V68, P412, DOI 10.1002/jmv.10219; Shojania K G, 2001, Evid Rep Technol Assess (Summ), pi; Slattery ML, 2007, AM J EPIDEMIOL, V166, P606, DOI 10.1093/aje/kwm109; SYRJANEN K, 1982, DIAGN HISTOPATHOL, V5, P291; Tran GD, 2005, INT J CANCER, V113, P456, DOI 10.1002/ijc.20616; Umar SB, 2008, NAT CLIN PRACT GASTR, V5, P517, DOI 10.1038/ncpgasthep1223; van Loggerenberg F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001954; Wang XQ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-19; Wei WQ, 2005, GUT, V54, P759, DOI 10.1136/gut.2004.062331; White E, 1998, EPIDEMIOL REV, V20, P43, DOI 10.1093/oxfordjournals.epirev.a017971; Zhao DH, 2011, CHINESE MED J-PEKING, V124, P2328, DOI 10.3760/cma.j.issn.0366-6999.2011.15.015	33	30	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2012	7	2							e31602	10.1371/journal.pone.0031602	http://dx.doi.org/10.1371/journal.pone.0031602			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LV	22328939	Green Published, Green Submitted, gold			2022-12-27	WOS:000302179300025
J	Han, Y; Lui, S; Kuang, WH; Lang, Q; Zou, L; Jia, JP				Han, Ying; Lui, Su; Kuang, Weihong; Lang, Qi; Zou, Ling; Jia, Jianping			Anatomical and Functional Deficits in Patients with Amnestic Mild Cognitive Impairment	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; LOW-FREQUENCY FLUCTUATION; MONKEY VISUAL-CORTEX; GRAY-MATTER LOSS; ALZHEIMERS-DISEASE; EPISODIC MEMORY; BRAIN ACTIVITY; ATROPHY; FMRI; HYPOMETABOLISM	Background Anatomical and functional deficits have been studied in patients with amnestic mild cognitive impairment (MCI). However, it is unclear whether and how the anatomical deficits are related to the functional alterations. Present study aims to characterize the association between anatomical and functional deficits in MCI patients. Methods: Seventeen amnestic MCI patients and 18 healthy aging controls were scanned using a T1 Weighted MPRAGE sequence and a gradient-echo echo-planar imaging sequence. Clinical severity of MCI patients was evaluated by using Clinical Dementia Rating, Mini Mental State Examination (MMSE), Clock Drawing Test, Auditory Verbal Learning Test and Activities of Daily Living. VBM with DARTEL was used to characterize the gray matter deficits in MCI. Regional amplitude of low-frequency (0.01-0.08 Hz) fluctuations (ALFF) was used to evaluate regional functional alteration in MCI and fractional ALFF(fALFF) in slow 4 (0.027-0.073 Hz) and slow 5 (0.01-0.027 Hz) were also calculated. Results: Significantly decreased gray matter volume (GMV) was observed in amnestic MCI group mainly in bilateral prefrontal, left temporal and posterior cingulate cortex. Significant positive correlation was observed between the GMV in left inferior frontal gyrus and MMSE scores. Interestingly, decreased ALFF/fALFF was revealed in MCI group compared to controls mainly in prefrontal, left parietal regions and right fusiform gyrus, while the increased ALFF/fALFF was found in limbic and midbrain. Furthermore, the changes of fALFF in MCI in the slow-5 band were greater than those in the slow-4. No significant correlation was found between the morphometric and functional results. Conclusions: Findings from the study document that wide spread brain volume reduction accompanied with decreased and increased regional function in MCI, while the anatomical and functional changes were independently. Therefore, the combination of structural and functional MRI methods would provide complementary information and together advance our understanding of the pathophysiology underlying the symptoms of MCI.	[Han, Ying; Jia, Jianping] Capital Med Univ, Xuanwu Hosp, Dept Neurol, Beijing, Peoples R China; [Lui, Su; Zou, Ling] Sichuan Univ, W China Hosp, Dept Radiol, Chengdu 610064, Peoples R China; [Kuang, Weihong] Sichuan Univ, W China Hosp, Dept Psychiat, Chengdu 610064, Peoples R China; [Lang, Qi] Sichuan Univ, W China Hosp, Dept Neurol, Chengdu 610064, Peoples R China	Capital Medical University; Sichuan University; Sichuan University; Sichuan University	Han, Y (corresponding author), Capital Med Univ, Xuanwu Hosp, Dept Neurol, Beijing, Peoples R China.	sophiehanying@gmail.com	Lui, Su/S-9132-2019; Han, Ying/H-7111-2017	Jia, Jianping/0000-0003-4624-0336	National Natural Science Foundation [30970823, 30830045, 30900361]; Distinguished Young Scholars of Sichuan [2011JQ0005]; Programs for New Century Excellent Talents in University [NCET-10-0596]; Research Fund for the Doctoral Program of Higher Education of China [20090181120103]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Distinguished Young Scholars of Sichuan; Programs for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This study was supported by National Natural Science Foundation (Grant Nos. 30970823, 30830045, 30900361), the Distinguished Young Scholars of Sichuan (Grant No. 2011JQ0005), the Programs for New Century Excellent Talents in University (Grant No. NCET-10-0596) and Research Fund for the Doctoral Program of Higher Education of China (Grant No. 20090181120103). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Baron JC, 2001, NEUROIMAGE, V14, P298, DOI 10.1006/nimg.2001.0848; Bell-McGinty S, 2005, ARCH NEUROL-CHICAGO, V62, P1393, DOI 10.1001/archneur.62.9.1393; Birn RM, 2006, NEUROIMAGE, V31, P1536, DOI 10.1016/j.neuroimage.2006.02.048; Borroni B, 2006, NEUROBIOL AGING, V27, P24, DOI 10.1016/j.neurobiolaging.2004.12.010; Bozzali M, 2006, NEUROLOGY, V67, P453, DOI 10.1212/01.wnl.0000228243.56665.c2; Callicott JH, 2003, AM J PSYCHIAT, V160, P2209, DOI 10.1176/appi.ajp.160.12.2209; Chetelat G, 2008, BRAIN, V131, P60, DOI 10.1093/brain/awm288; Chetelat G, 2003, BRAIN, V126, P1955, DOI 10.1093/brain/awg196; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; Dickerson BC, 2004, ANN NEUROL, V56, P27, DOI 10.1002/ana.20163; Dickerson BC, 2005, NEUROLOGY, V65, P404, DOI 10.1212/01.wnl.0000171450.97464.49; Gili T, 2011, J NEUROL NEUROSUR PS, V82, P58, DOI 10.1136/jnnp.2009.199935; Goncalves SI, 2006, NEUROIMAGE, V30, P203, DOI 10.1016/j.neuroimage.2005.09.062; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Hamalainen A, 2007, NEUROBIOL AGING, V28, P1889, DOI 10.1016/j.neurobiolaging.2006.08.008; Han Y, 2011, NEUROIMAGE, V55, P287, DOI 10.1016/j.neuroimage.2010.11.059; Harrison BJ, 2008, P NATL ACAD SCI USA, V105, P9781, DOI 10.1073/pnas.0711791105; Ibanez V, 1998, NEUROLOGY, V50, P1585, DOI 10.1212/WNL.50.6.1585; Karas GB, 2004, NEUROIMAGE, V23, P708, DOI 10.1016/j.neuroimage.2004.07.006; Katura T, 2006, NEUROIMAGE, V31, P1592, DOI 10.1016/j.neuroimage.2006.02.010; Kinkingnehum S, 2008, NEUROLOGY, V70, P2201, DOI 10.1212/01.wnl.0000303960.01039.43; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Laufs H, 2003, P NATL ACAD SCI USA, V100, P11053, DOI 10.1073/pnas.1831638100; Leopold DA, 2003, CEREB CORTEX, V13, P422, DOI 10.1093/cercor/13.4.422; Lui S, 2008, J MAGN RESON IMAGING, V27, P1214, DOI 10.1002/jmri.21370; Lui S, 2009, P NATL ACAD SCI USA, V106, P15412, DOI 10.1073/pnas.0812751106; Lui S, 2009, PSYCHIAT RES-NEUROIM, V171, P71, DOI 10.1016/j.pscychresns.2008.02.004; Lui S, 2009, AM J PSYCHIAT, V166, P196, DOI 10.1176/appi.ajp.2008.08020183; Matsuda H, 2002, J NUCL MED, V43, P304; Mosconi L, 2008, J NUCL MED, V49, P390, DOI 10.2967/jnumed.107.045385; Mosconi L, 2007, J NUCL MED, V48, P1129, DOI 10.2967/jnumed.107.040675; Petersen RC, 2001, NEUROLOGY, V56, P1133, DOI 10.1212/WNL.56.9.1133; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Petersen RC, 2009, ARCH NEUROL-CHICAGO, V66, P1447, DOI 10.1001/archneurol.2009.266; Petrella JR, 2011, NEUROLOGY, V76, P511, DOI 10.1212/WNL.0b013e31820af94e; Petrella JR, 2009, AM J NEURORADIOL, V30, P411, DOI 10.3174/ajnr.A1359; Pihlajamaki M, 2009, CURR ALZHEIMER RES, V6, P179, DOI 10.2174/156720509787602898; Price JL, 1999, ANN NEUROL, V45, P358, DOI 10.1002/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X; Prince SE, 2005, J NEUROSCI, V25, P1203, DOI 10.1523/JNEUROSCI.2540-04.2005; Prince SE, 2007, PSYCHOL SCI, V18, P144, DOI 10.1111/j.1467-9280.2007.01864.x; Shmuel A, 2008, HUM BRAIN MAPP, V29, P751, DOI 10.1002/hbm.20580; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Sorg C, 2007, P NATL ACAD SCI USA, V104, P18760, DOI 10.1073/pnas.0708803104; Tisserand DJ, 2004, CEREB CORTEX, V14, P966, DOI 10.1093/cercor/bhh057; Villain N, 2008, J NEUROSCI, V28, P6174, DOI 10.1523/JNEUROSCI.1392-08.2008; Wagner AD, 2001, NEURON, V31, P329, DOI 10.1016/S0896-6273(01)00359-2; Yang H, 2007, NEUROIMAGE, V36, P144, DOI 10.1016/j.neuroimage.2007.01.054; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Zou QH, 2008, J NEUROSCI METH, V172, P137, DOI 10.1016/j.jneumeth.2008.04.012; Zuo XN, 2010, NEUROIMAGE, V49, P1432, DOI 10.1016/j.neuroimage.2009.09.037	54	77	83	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e28664	10.1371/journal.pone.0028664	http://dx.doi.org/10.1371/journal.pone.0028664			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LO	22319555	gold, Green Submitted, Green Published			2022-12-27	WOS:000302178400001
J	Newton, TF; De la Garza, R; Brown, G; Kosten, TR; Mahoney, JJ; Haile, CN				Newton, Thomas F.; De la Garza, Richard, II; Brown, Gregory; Kosten, Thomas R.; Mahoney, James J., III; Haile, Colin N.			Noradrenergic alpha(1) Receptor Antagonist Treatment Attenuates Positive Subjective Effects of Cocaine in Humans: A Randomized Trial	PLOS ONE			English	Article							ABUSE LIABILITY; LOCOMOTOR; REINSTATEMENT; DOXAZOSIN; DOPAMINE; NOREPINEPHRINE; PRAZOSIN; EFFICACY; HISTORY	Background: Preclinical research implicates dopaminergic and noradrenergic mechanisms in mediating the reinforcing effects of drugs of abuse, including cocaine. The objective of this study was to evaluate the impact of treatment with the noradrenergic alpha(1) receptor antagonist doxazosin on the positive subjective effects of cocaine. Methods: Thirteen non-treatment seeking, cocaine-dependent volunteers completed this single-site, randomized, placebo-controlled, within-subjects study. In one study phase volunteers received placebo and in the other they received doxazosin, with the order counterbalanced across participants. Study medication was masked by over-encapsulating doxazosin tablets and matched placebo lactose served as the control. Study medication treatment was initiated at 1 mg doxazosin or equivalent number of placebo capsules PO/day and increased every three days by 1 mg. After receiving 4 mg doxazosin or equivalent number of placebo capsules participants received masked doses of 20 and 40 mg cocaine IV in that order with placebo saline randomly interspersed to maintain the blind. Results: Doxazosin treatment was well tolerated and doxazosin alone produced minimal changes in heart rate and blood pressure. During treatment with placebo, cocaine produced dose-dependent increases in subjective effect ratings of "high'', "stimulated'', "like cocaine'', "desire cocaine'', "any drug effect'', and "likely to use cocaine if had access'' (p<.001). Doxazosin treatment significantly attenuated the effects of 20 mg cocaine on ratings of "stimulated'', "like cocaine'', and "likely to use cocaine if had access'' (p<.05). There were trends for doxazosin to reduce ratings of "stimulated'', "desire cocaine'', and "likely to use cocaine if had access'' (p<.10). Conclusions: Medications that block noradrenergic alpha(1) receptors, such as doxazosin, may be useful as treatments for cocaine dependence, and should be evaluated further.	[Newton, Thomas F.; De la Garza, Richard, II; Brown, Gregory; Kosten, Thomas R.; Mahoney, James J., III; Haile, Colin N.] Baylor Coll Med, Menninger Dept Psychiat & Behav Sci, Michael E DeBakey Vet Affairs Med Ctr, Houston, TX 77030 USA	Baylor College of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Michael E DeBakey VA Medical Center	Newton, TF (corresponding author), Baylor Coll Med, Menninger Dept Psychiat & Behav Sci, Michael E DeBakey Vet Affairs Med Ctr, Houston, TX 77030 USA.	tnewton@bcm.edu	Kosten, Thomas/AAI-5998-2021; De+La+Garza, Richard/GNM-6474-2022; Mahoney, James/ABB-9284-2021; Mahoney, James/I-2753-2014; De La Garza, Richard/B-2489-2014	De+La+Garza, Richard/0000-0003-1943-4469; Mahoney, James/0000-0003-0824-1776; Mahoney, James/0000-0003-0824-1776; De La Garza, Richard/0000-0003-1943-4469; Haile, Colin/0000-0001-8293-7291; newton, thomas/0000-0002-3198-5901	National Institutes of Health [P50 DA18197, M01 RR00188]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000188] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K24DA017754, P50DA018197, R25DA028976, R01DA017705] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by grants from the National Institutes of Health, P50 DA18197 and M01 RR00188. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; CHIOU WL, 1978, J PHARMACOKINET BIOP, V6, P539, DOI 10.1007/BF01062108; Cohen J.E., 1988, STAT POWER ANAL BEHA; Darracq L, 1998, J NEUROSCI, V18, P2729; Drouin C, 2002, J NEUROSCI, V22, P2873, DOI 10.1523/JNEUROSCI.22-07-02873.2002; Drouin C, 2002, SYNAPSE, V43, P51, DOI 10.1002/syn.10023; ELLIOTT HL, 1982, BRIT J CLIN PHARMACO, V13, P699, DOI 10.1111/j.1365-2125.1982.tb01439.x; FISCHMAN MW, 1989, NIDA RES MG, V92, P211; FISCHMAN MW, 1991, BRIT J ADDICT, V86, P1563; Grabowski J, 2004, NEUROPSYCHOPHARMACOL, V29, P969, DOI 10.1038/sj.npp.1300392; GUO TZ, 1991, ANESTHESIOLOGY, V75, P252, DOI 10.1097/00000542-199108000-00013; Haney M, 2008, PSYCHOPHARMACOLOGY, V199, P403, DOI 10.1007/s00213-008-1079-x; JAILLON P, 1980, CLIN PHARMACOKINET, V5, P365, DOI 10.2165/00003088-198005040-00004; JASINSKI DR, 1991, BRIT J ADDICT, V86, P1559; Kirby RS, 2001, BJU INT, V87, P192, DOI 10.1046/j.1464-410x.2001.02032.x; Mooney ME, 2009, DRUG ALCOHOL DEPEN, V101, P34, DOI 10.1016/j.drugalcdep.2008.10.016; MORRISON JH, 1981, NEUROSCIENCE, V6, P139, DOI 10.1016/0306-4522(81)90051-8; Newton TF, 2005, PHARMACOL BIOCHEM BE, V82, P90, DOI 10.1016/j.pbb.2005.07.012; Prys-Roberts C, 2002, WORLD J SURG, V26, P1037, DOI 10.1007/s00268-002-6667-z; Rothman RB, 2002, ANN NY ACAD SCI, V965, P109; Schroeder JP, 2010, NEUROPSYCHOPHARMACOL, V35, P2440, DOI 10.1038/npp.2010.127; Shaham Y, 2003, PSYCHOPHARMACOLOGY, V168, P3, DOI 10.1007/s00213-002-1224-x; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; SNODDY AM, 1985, EUR J PHARMACOL, V116, P221, DOI 10.1016/0014-2999(85)90156-6; Soares BG, 2001, COCHRANE DATABASE SY, P4; Waeber B, 2009, DRUGS, V69, P1761, DOI 10.2165/11316710-000000000-00000; Weinshenker D, 2007, NEUROPSYCHOPHARMACOL, V32, P1433, DOI 10.1038/sj.npp.1301263; WISE RA, 1989, ANNU REV PSYCHOL, V40, P191, DOI 10.1146/annurev.ps.40.020189.001203; WOOLVERTON WL, 1987, PHARMACOL BIOCHEM BE, V26, P835, DOI 10.1016/0091-3057(87)90618-6; WOOLVERTON WL, 1981, DRUG ALCOHOL DEPEN, V8, P69, DOI 10.1016/0376-8716(81)90088-0; Zhang XY, 2005, BIOL PSYCHIAT, V57, P1202, DOI 10.1016/j.biopsych.2005.02.003	31	44	45	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e30854	10.1371/journal.pone.0030854	http://dx.doi.org/10.1371/journal.pone.0030854			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LO	22319592	Green Submitted, gold, Green Published			2022-12-27	WOS:000302178400017
J	Turki-Judeh, W; Courey, AJ				Turki-Judeh, Wiam; Courey, Albert J.			The Unconserved Groucho Central Region Is Essential for Viability and Modulates Target Gene Specificity	PLOS ONE			English	Article							DORSAL-MEDIATED REPRESSION; TRANSCRIPTIONAL REPRESSION; DROSOPHILA-EMBRYO; IN-VIVO; DEPENDENT REPRESSION; HISTONE DEACETYLASE; COREPRESSOR GROUCHO; SIGNALING PATHWAYS; CO-REPRESSORS; PROTEINS	Groucho (Gro) is a Drosophila corepressor required by numerous DNA-binding repressors, many of which are distributed in gradients and provide positional information during development. Gro contains well-conserved domains at its N- and C-termini, and a poorly conserved central region that includes the GP, CcN, and SP domains. All lethal point mutations in gro map to the conserved regions, leading to speculation that the unconserved central domains are dispensable. However, our sequence analysis suggests that the central domains are disordered leading us to suspect that the lack of lethal mutations in this region reflects a lack of order rather than an absence of essential functions. In support of this conclusion, genomic rescue experiments with Gro deletion variants demonstrate that the GP and CcN domains are required for viability. Misexpression assays using these same deletion variants show that the SP domain prevents unrestrained and promiscuous repression by Gro, while the GP and CcN domains are indispensable for repression. Deletion of the GP domain leads to loss of nuclear import, while deletion of the CcN domain leads to complete loss of repression. Changes in Gro activity levels reset the threshold concentrations at which graded repressors silence target gene expression. We conclude that co-regulators such as Gro are not simply permissive components of the repression machinery, but cooperate with graded DNA-binding factors in setting borders of gene expression. We suspect that disorder in the Gro central domains may provide the flexibility that allows this region to mediate multiple interactions required for repression.	[Turki-Judeh, Wiam] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Turki-Judeh, W (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 405 Hilgard Ave, Los Angeles, CA 90024 USA.	courey@chem.ucla.edu			NIH [GM44522, GM86122]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM086122] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by NIH grant GM44522 to AJC and by NIH National Research Service Award GM86122 to WTJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Shaar M, 1999, GENE DEV, V13, P935, DOI 10.1101/gad.13.8.935; Andrioli LP, 2004, DEV BIOL, V276, P541, DOI 10.1016/j.ydbio.2004.09.025; Apidianakis Y, 2001, DEVELOPMENT, V128, P4361; Brantjes H, 2001, NUCLEIC ACIDS RES, V29, P1410, DOI 10.1093/nar/29.7.1410; Burks PJ, 2009, BIOL CELL, V101, P301, DOI 10.1042/BC20080136; Buscarlet M, 2007, TRENDS CELL BIOL, V17, P353, DOI 10.1016/j.tcb.2007.07.002; Buscarlet M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008107; Cai Y, 2003, EMBO J, V22, P5522, DOI 10.1093/emboj/cdg536; Cavallo RA, 1998, NATURE, V395, P604, DOI 10.1038/26982; Chen GQ, 2000, GENE, V249, P1, DOI 10.1016/S0378-1119(00)00161-X; Chen GQ, 1998, MOL CELL BIOL, V18, P7259, DOI 10.1128/MCB.18.12.7259; Chen GQ, 1999, GENE DEV, V13, P2218, DOI 10.1101/gad.13.17.2218; Choi CY, 2005, J BIOL CHEM, V280, P21427, DOI 10.1074/jbc.M500496200; Cinnamon E, 2008, DEVELOPMENT, V135, P829, DOI 10.1242/dev.015206; Courey AJ, 2001, GENE DEV, V15, P2786; deCelis JF, 1997, DEVELOPMENT, V124, P1919; Dresch JM, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-142; Dubnicoff T, 1997, GENE DEV, V11, P2952, DOI 10.1101/gad.11.22.2952; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; Fisher AL, 1996, MOL CELL BIOL, V16, P2670; Flores-Saaib RD, 2000, NUCLEIC ACIDS RES, V28, P4189, DOI 10.1093/nar/28.21.4189; Flores-Saaib RD, 2001, DEVELOPMENT, V128, P1869; Gasperowicz M, 2005, J CELL BIOCHEM, V95, P670, DOI 10.1002/jcb.20476; HARTENSTEIN V, 1990, DEV BIOL, V142, P13, DOI 10.1016/0012-1606(90)90147-B; Hasson P, 2006, BRIT J CANCER, V94, P771, DOI 10.1038/sj.bjc.6603019; Hasson P, 2005, NAT GENET, V37, P101, DOI 10.1038/ng1486; Hasson P, 2001, EMBO J, V20, P5725, DOI 10.1093/emboj/20.20.5725; HECHT A, 1995, CELL, V80, P583, DOI 10.1016/0092-8674(95)90512-X; Hong JW, 2008, P NATL ACAD SCI USA, V105, P20072, DOI 10.1073/pnas.0806476105; Jennings BH, 2008, EMBO REP, V9, P76, DOI 10.1038/sj.embor.7401122; Jennings BH, 2006, MOL CELL, V22, P645, DOI 10.1016/j.molcel.2006.04.024; Jimenez G, 1997, GENE DEV, V11, P3072, DOI 10.1101/gad.11.22.3072; Jimenez G, 2000, GENE DEV, V14, P224; Kaplan T, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001290; Kobayashi M, 2001, DEVELOPMENT, V128, P1805; Kosman D, 2004, SCIENCE, V305, P846, DOI 10.1126/science.1099247; Lee W, 2009, DEV BIOL, V325, P263, DOI 10.1016/j.ydbio.2008.10.029; Mann RS, 2009, CURR TOP DEV BIOL, V88, P63, DOI 10.1016/S0070-2153(09)88003-4; Mannervik M, 1999, P NATL ACAD SCI USA, V96, P6797, DOI 10.1073/pnas.96.12.6797; Martinez CA, 2008, MOL CELL BIOL, V28, P2792, DOI 10.1128/MCB.01203-07; Nie MH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005905; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Nuthall HN, 2004, MOL CELL BIOL, V24, P8395, DOI 10.1128/MCB.24.19.8395-8407.2004; Nuthall HN, 2002, J BIOL CHEM, V277, P51049, DOI 10.1074/jbc.M111660200; Orian A, 2007, P NATL ACAD SCI USA, V104, P15771, DOI 10.1073/pnas.0707418104; Palaparti A, 1997, J BIOL CHEM, V272, P26604, DOI 10.1074/jbc.272.42.26604; Paroush Z, 1997, DEVELOPMENT, V124, P3827; PAROUSH Z, 1994, CELL, V79, P805, DOI 10.1016/0092-8674(94)90070-1; Payankaulam S, 2009, P NATL ACAD SCI USA, V106, P17314, DOI 10.1073/pnas.0904507106; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Ratnaparkhi GS, 2006, DEVELOPMENT, V133, P4409, DOI 10.1242/dev.02643; Rorth P, 1998, MECH DEVELOP, V78, P113, DOI 10.1016/S0925-4773(98)00157-9; RUSCH J, 1994, GENE DEV, V8, P1247, DOI 10.1101/gad.8.11.1247; Sekiya T, 2007, MOL CELL, V28, P291, DOI 10.1016/j.molcel.2007.10.002; Song HY, 2004, MOL CELL BIOL, V24, P4341, DOI 10.1128/MCB.24.10.4341-4350.2004; STIFANI S, 1992, NAT GENET, V2, P119, DOI 10.1038/ng1092-119; Valentine SA, 1998, MOL CELL BIOL, V18, P6584, DOI 10.1128/MCB.18.11.6584; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Winkler CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010166; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Zhang HL, 2001, GENE DEV, V15, P261, DOI 10.1101/gad.861201	61	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e30610	10.1371/journal.pone.0030610	http://dx.doi.org/10.1371/journal.pone.0030610			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LO	22319573	gold, Green Published, Green Submitted			2022-12-27	WOS:000302178400010
J	Hermans, RCJ; Lichtwarck-Aschoff, A; Bevelander, KE; Herman, CP; Larsen, JK; Engels, RCME				Hermans, Roel C. J.; Lichtwarck-Aschoff, Anna; Bevelander, Kirsten E.; Herman, C. Peter; Larsen, Junilla K.; Engels, Rutger C. M. E.			Mimicry of Food Intake: The Dynamic Interplay between Eating Companions	PLOS ONE			English	Article							PEER INFLUENCE; BEHAVIOR; PERCEPTION; CHILDREN; CUES	Numerous studies have shown that people adjust their intake directly to that of their eating companions; they eat more when others eat more, and less when others inhibit intake. A potential explanation for this modeling effect is that both eating companions' food intake becomes synchronized through processes of behavioral mimicry. No study, however, has tested whether behavioral mimicry can partially account for this modeling effect. To capture behavioral mimicry, real-time observations of dyads of young females having an evening meal were conducted. It was assessed whether mimicry depended on the time of the interaction and on the person who took the bite. A total of 70 young female dyads took part in the study, from which the total number of bites (N = 3,888) was used as unit of analyses. For each dyad, the total number of bites and the exact time at which each person took a bite were coded. Behavioral mimicry was operationalized as a bite taken within a fixed 5-second interval after the other person had taken a bite, whereas non-mimicked bites were defined as bites taken outside the 5-second interval. It was found that both women mimicked each other's eating behavior. They were more likely to take a bite of their meal in congruence with their eating companion rather than eating at their own pace. This behavioral mimicry was found to be more prominent at the beginning than at the end of the interaction. This study suggests that behavioral mimicry may partially account for social modeling of food intake.	[Hermans, Roel C. J.; Lichtwarck-Aschoff, Anna; Bevelander, Kirsten E.; Larsen, Junilla K.; Engels, Rutger C. M. E.] Radboud Univ Nijmegen, Dept Dev Psychopathol, Inst Behav Sci, NL-6525 ED Nijmegen, Netherlands; [Herman, C. Peter] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada	Radboud University Nijmegen; University of Toronto	Hermans, RCJ (corresponding author), Radboud Univ Nijmegen, Dept Dev Psychopathol, Inst Behav Sci, NL-6525 ED Nijmegen, Netherlands.	r.hermans@bsi.ru.nl	Hermans, Roel/D-5803-2012; Bevelander, Kirsten E/E-7878-2012	, Kirsten/0000-0003-1011-7862; Hermans, Roel/0000-0003-3560-8158; Engels, Rutger/0000-0003-1944-9126; Herman, C. Peter/0000-0001-5738-6803	Behavioural Science Institute of the Radboud University Nijmegen	Behavioural Science Institute of the Radboud University Nijmegen	The current study was financially supported by the Behavioural Science Institute of the Radboud University Nijmegen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birch LL, 1998, PEDIATRICS, V101, P539; Bot SM, 2005, ADDICTION, V100, P1270, DOI 10.1111/j.1360-0443.2005.01152.x; Brass M, 2001, ACTA PSYCHOL, V106, P3, DOI 10.1016/S0001-6918(00)00024-X; Chartrand TL, 2009, ADV EXP SOC PSYCHOL, V41, P219, DOI 10.1016/S0065-2601(08)00405-X; Chartrand TL, 1999, J PERS SOC PSYCHOL, V76, P893, DOI 10.1037/0022-3514.76.6.893; CONGER JC, 1980, J PERS, V48, P258, DOI 10.1111/j.1467-6494.1980.tb00832.x; DECASTRO JM, 1992, PHYSIOL BEHAV, V51, P121, DOI 10.1016/0031-9384(92)90212-K; Dijksterhuis A, 2001, ADV EXP SOC PSYCHOL, V33, P1, DOI 10.1016/S0065-2601(01)80003-4; Eccles JS, 1999, FUTURE CHILD, V9, P30, DOI 10.2307/1602703; GOLDMAN SJ, 1991, APPETITE, V17, P129, DOI 10.1016/0195-6663(91)90068-4; Herman CP, 2003, PSYCHOL BULL, V129, P873, DOI 10.1037/0033-2909.129.6.873; Herman CP, 2005, PHYSIOL BEHAV, V129, P873; Hermans RCJ, 2011, BRIT J NUTR IN PRESS; Hermans RCJ, 2008, APPETITE, V51, P512, DOI 10.1016/j.appet.2008.03.016; Hermans RCJ, 2009, APPETITE, V52, P801, DOI 10.1016/j.appet.2009.03.008; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Keenan T., 2009, INTRO CHILD DEV; Knoblich G, 2006, CURR DIR PSYCHOL SCI, V15, P99, DOI 10.1111/j.0963-7214.2006.00415.x; Koordeman R, 2011, ALCOHOL ALCOHOLISM, V46, P393, DOI 10.1093/alcalc/agr028; Laible D, 2007, HDB SOCIALIZATION TH; Lakin JL, 2003, J NONVERBAL BEHAV, V27, P145, DOI 10.1023/A:1025389814290; Lakin JL, 2003, PSYCHOL SCI, V14, P334, DOI 10.1111/1467-9280.14481; Larsen H, 2010, ADDICT BEHAV, V35, P49, DOI 10.1016/j.addbeh.2009.08.002; LEARY MR, 1994, J PERS SOC PSYCHOL, V67, P664, DOI 10.1037/0022-3514.67.4.664; Leone T, 2007, APPETITE, V49, P58, DOI 10.1016/j.appet.2006.11.005; Leone T, 2008, PERS SOC PSYCHOL B, V34, P1737, DOI 10.1177/0146167208325414; Lohman T.J., 1998, ANTHROPOMETRIC STAND; Muthen L.K., 2007, MPLUS STAT ANAL LATE; Patel KA, 2001, APPETITE, V36, P111, DOI 10.1006/appe.2000.0385; Pliner P, 2004, APPETITE, V42, P227, DOI 10.1016/j.appet.2003.12.001; ROCK BC, 1995, SEX ROLES, V33, P109; Roth DA, 2001, APPETITE, V36, P165, DOI 10.1006/appe.2000.0388; Salvy SJ, 2007, APPETITE, V49, P177, DOI 10.1016/j.appet.2007.01.011; Stel M, 2008, EUR J SOC PSYCHOL, V38, P965, DOI 10.1002/ejsp.472; van Baaren R, 2009, PHILOS T R SOC B, V364, P2381, DOI 10.1098/rstb.2009.0057; Vartanian LR, 2007, APPETITE, V48, P265, DOI 10.1016/j.appet.2006.10.008	36	59	60	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2012	7	2							e31027	10.1371/journal.pone.0031027	http://dx.doi.org/10.1371/journal.pone.0031027			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	914UG	22312438	gold, Green Published, Green Submitted			2022-12-27	WOS:000301977500026
J	Martel, G; Hevi, C; Wong, A; Zushida, K; Uchida, S; Shumyatsky, GP				Martel, Guillaume; Hevi, Charles; Wong, Alexandra; Zushida, Ko; Uchida, Shusaku; Shumyatsky, Gleb P.			Murine GRPR and Stathmin Control in Opposite Directions both Cued Fear Extinction and Neural Activities of the Amygdala and Prefrontal Cortex	PLOS ONE			English	Article							GLUTAMIC-ACID DECARBOXYLASE; CONDITIONED FEAR; BASOLATERAL AMYGDALA; DISSOCIABLE ROLES; NEURONAL CIRCUITS; MEMORY; EXPRESSION; MICE; ACTIVATION; BRAIN	Extinction is an integral part of normal healthy fear responses, while it is compromised in several fear-related mental conditions in humans, such as post-traumatic stress disorder (PTSD). Although much research has recently been focused on fear extinction, its molecular and cellular underpinnings are still unclear. The development of animal models for extinction will greatly enhance our approaches to studying its neural circuits and the mechanisms involved. Here, we describe two gene-knockout mouse lines, one with impaired and another with enhanced extinction of learned fear. These mutant mice are based on fear memory-related genes, stathmin and gastrin-releasing peptide receptor (GRPR). Remarkably, both mutant lines showed changes in fear extinction to the cue but not to the context. We performed indirect imaging of neuronal activity on the second day of cued extinction, using immediate-early gene c-Fos. GRPR knockout mice extinguished slower (impaired extinction) than wildtype mice, which was accompanied by an increase in c-Fos activity in the basolateral amygdala and a decrease in the prefrontal cortex. By contrast, stathmin knockout mice extinguished faster (enhanced extinction) and showed a decrease in c-Fos activity in the basolateral amygdala and an increase in the prefrontal cortex. At the same time, c-Fos activity in the dentate gyrus was increased in both mutant lines. These experiments provide genetic evidence that the balance between neuronal activities of the amygdala and prefrontal cortex defines an impairment or facilitation of extinction to the cue while the hippocampus is involved in the context-specificity of extinction.	[Martel, Guillaume; Hevi, Charles; Wong, Alexandra; Zushida, Ko; Uchida, Shusaku; Shumyatsky, Gleb P.] Rutgers State Univ, Dept Genet, Piscataway, NJ 08855 USA	Rutgers State University New Brunswick	Martel, G (corresponding author), Rutgers State Univ, Dept Genet, Piscataway, NJ 08855 USA.	gleb@biology.rutgers.edu		Uchida, Shusaku/0000-0002-1451-6222	National Science Foundation; National Institutes of Health [R01 MH080328]; Whitehall Foundation [2008-12-104]; New Jersey Governor's Council for Medical Research and Treatment of Autism, Special Child Health and Early Intervention Services, New Jersey Department of Health and Senior Services; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080328] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Whitehall Foundation; New Jersey Governor's Council for Medical Research and Treatment of Autism, Special Child Health and Early Intervention Services, New Jersey Department of Health and Senior Services; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Science Foundation, National Institutes of Health (R01 MH080328), and Whitehall Foundation (#2008-12-104). Research funded in part by the New Jersey Governor's Council for Medical Research and Treatment of Autism, Special Child Health and Early Intervention Services, New Jersey Department of Health and Senior Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	AMAT JA, 1991, DEV BRAIN RES, V60, P205, DOI 10.1016/0165-3806(91)90049-O; Brocke B, 2010, AM J MED GENET B, V153B, P243, DOI 10.1002/ajmg.b.30989; Ehrlich I, 2009, NEURON, V62, P757, DOI 10.1016/j.neuron.2009.05.026; Frielingsdorf H, 2010, ANN NY ACAD SCI, V1208, P150, DOI 10.1111/j.1749-6632.2010.05722.x; Han JH, 2008, LEARN MEMORY, V15, P443, DOI 10.1101/lm.993608; Herry C, 2008, NATURE, V454, P600, DOI 10.1038/nature07166; Herry C, 2006, EUR J NEUROSCI, V24, P261, DOI 10.1111/j.1460-9568.2006.04893.x; Herry C, 2010, EUR J NEUROSCI, V31, P599, DOI 10.1111/j.1460-9568.2010.07101.x; Kamichi S, 2005, BRAIN RES, V1032, P162, DOI 10.1016/j.brainres.2004.10.068; Kash SF, 1999, P NATL ACAD SCI USA, V96, P1698, DOI 10.1073/pnas.96.4.1698; Knapska E, 2009, LEARN MEMORY, V16, P486, DOI 10.1101/lm.1463909; Lattal KM, 2008, BEHAV NEUROSCI, V122, P1186, DOI 10.1037/a0012993; Lee K, 1999, J PHYSIOL-LONDON, V518, P791, DOI 10.1111/j.1469-7793.1999.0791p.x; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; Maren S, 2011, NEURON, V70, P830, DOI 10.1016/j.neuron.2011.04.023; Martel G, 2008, P NATL ACAD SCI USA, V105, P14620, DOI 10.1073/pnas.0807507105; Myers KM, 2007, MOL PSYCHIATR, V12, P120, DOI 10.1038/sj.mp.4001939; Pape HC, 2010, PHYSIOL REV, V90, P419, DOI 10.1152/physrev.00037.2009; Paxinos G, 2001, MOUSE BRAIN STEREOTA, pxxv; Plendl W, 2010, J NEUROSCI, V30, P4990, DOI 10.1523/JNEUROSCI.6038-09.2010; Sangha S, 2009, J NEUROSCI, V29, P15713, DOI 10.1523/JNEUROSCI.2620-09.2009; Shumyatsky GP, 2005, CELL, V123, P697, DOI 10.1016/j.cell.2005.08.038; Shumyatsky GP, 2002, CELL, V111, P905, DOI 10.1016/S0092-8674(02)01116-9; Sierra-Mercado D, 2011, NEUROPSYCHOPHARMACOL, V36, P529, DOI 10.1038/npp.2010.184; Stork O, 2003, GENES BRAIN BEHAV, V2, P65, DOI 10.1034/j.1601-183X.2003.00008.x; Stork O, 2000, BRAIN RES, V865, P45, DOI 10.1016/S0006-8993(00)02206-X; Thompson BM, 2010, LEARN MEMORY, V17, P591, DOI 10.1101/lm.1920810; Uchida S, 2011, NEURON, V69, P359, DOI 10.1016/j.neuron.2010.12.023; Uchida S, 2011, P NATL ACAD SCI USA, V108, P1681, DOI 10.1073/pnas.1016424108; Uchida S, 2010, J NEUROSCI, V30, P15007, DOI 10.1523/JNEUROSCI.1436-10.2010; Yee BK, 2004, EUR J NEUROSCI, V20, P1928, DOI 10.1111/j.1460-9568.2004.03642.x	31	26	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2012	7	2							e30942	10.1371/journal.pone.0030942	http://dx.doi.org/10.1371/journal.pone.0030942			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UG	22312434	Green Submitted, gold, Green Published			2022-12-27	WOS:000301977500022
J	Pavillon, N; Kuhn, J; Moratal, C; Jourdain, P; Depeursinge, C; Magistretti, PJ; Marquet, P				Pavillon, Nicolas; Kuehn, Jonas; Moratal, Corinne; Jourdain, Pascal; Depeursinge, Christian; Magistretti, Pierre J.; Marquet, Pierre			Early Cell Death Detection with Digital Holographic Microscopy	PLOS ONE			English	Article							PHASE-CONTRAST MICROSCOPY; IONIC HOMEOSTASIS; LIVING CELLS; APOPTOSIS; VIABILITY; IDENTIFICATION; VISUALIZATION; COMPENSATION; RECOGNITION; RECEPTORS	Background: Digital holography provides a non-invasive measurement of the quantitative phase shifts induced by cells in culture, which can be related to cell volume changes. It has been shown previously that regulation of cell volume, in particular as it relates to ionic homeostasis, is crucially involved in the activation/inactivation of the cell death processes. We thus present here an application of digital holographic microscopy (DHM) dedicated to early and label-free detection of cell death. Methods and Findings: We provide quantitative measurements of phase signal obtained on mouse cortical neurons, and caused by early neuronal cell volume regulation triggered by excitotoxic concentrations of L-glutamate. We show that the efficiency of this early regulation of cell volume detected by DHM, is correlated with the occurrence of subsequent neuronal death assessed with the widely accepted trypan blue method for detection of cell viability. Conclusions: The determination of the phase signal by DHM provides a simple and rapid optical method for the early detection of cell death.	[Pavillon, Nicolas; Kuehn, Jonas; Depeursinge, Christian] Ecole Polytech Fed Lausanne, STI, Microvis & Microdiagnost Grp MVD, CH-1015 Lausanne, Switzerland; [Kuehn, Jonas; Magistretti, Pierre J.; Marquet, Pierre] Ctr Neurosci Psychiat, Dept Psychiat CHUV, Prilly, Switzerland; [Moratal, Corinne; Jourdain, Pascal; Magistretti, Pierre J.; Marquet, Pierre] Ecole Polytech Fed Lausanne, Brain Mind Inst, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Pavillon, N (corresponding author), Ecole Polytech Fed Lausanne, STI, Microvis & Microdiagnost Grp MVD, CH-1015 Lausanne, Switzerland.	nicolas.pavillon@a3.epfl.ch	Kühn, Jonas G/H-2338-2011; Pavillon, Nicolas/ABF-6913-2020	Kühn, Jonas G/0000-0002-6344-4835; Pavillon, Nicolas/0000-0003-2606-2675; Magistretti, Pierre Julius/0000-0002-6678-320X	Swiss National Science Foundation (SNSF) [205320-130543, CR32I3-132993]; Commission for Technology and Innovation (CTI/KTI) [9389.1]	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); Commission for Technology and Innovation (CTI/KTI)	This research was supported by the Swiss National Science Foundation (SNSF, http://www.snf.ch/E/Pages/default.aspx) grant #205320-130543 and #CR32I3-132993 and by the Commission for Technology and Innovation (CTI/KTI) (http://www.kti.admin.ch/index.html?lang=en) project #9389.1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN SA, 1993, BIOTECHNOL PROGR, V9, P671, DOI 10.1021/bp00024a017; ANKARCRONA M, 1995, NEURON, V15, P961, DOI 10.1016/0896-6273(95)90186-8; BANK HL, 1987, DIABETOLOGIA, V30, P812; Bortner CD, 2004, PFLUG ARCH EUR J PHY, V448, P313, DOI 10.1007/s00424-004-1266-5; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Carl D, 2004, APPL OPTICS, V43, P6536, DOI 10.1364/AO.43.006536; Chen MJ, 2008, CURR NEUROPHARMACOL, V6, P102, DOI 10.2174/157015908784533879; CHOI DW, 1994, PROG BRAIN RES, V100, P47; Colomb T, 2006, APPL OPTICS, V45, P851, DOI 10.1364/AO.45.000851; Crha I, 2011, J ASSIST REPROD GEN, V28, P725, DOI 10.1007/s10815-011-9584-y; Cuche E, 1999, APPL OPTICS, V38, P6994, DOI 10.1364/AO.38.006994; Duprez L, 2009, MICROBES INFECT, V11, P1050, DOI 10.1016/j.micinf.2009.08.013; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; Hudson L, 1980, PRACTICAL IMMUNOLOGY, P29; Javidi B, 2005, OPT EXPRESS, V13, P4492, DOI 10.1364/OPEX.13.004492; JONES KH, 1985, J HISTOCHEM CYTOCHEM, V33, P77, DOI 10.1177/33.1.2578146; Jourdain P, 2011, J NEUROSCI, V31, P11846, DOI 10.1523/JNEUROSCI.0286-11.2011; Kemmler M, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2804926; Kemper B, 2008, APPL OPTICS, V47, pA52, DOI 10.1364/AO.47.000A52; KORZENIEWSKI C, 1983, J IMMUNOL METHODS, V64, P313, DOI 10.1016/0022-1759(83)90438-6; Krysko DV, 2008, METHODS, V44, P205, DOI 10.1016/j.ymeth.2007.12.001; Langehanenberg P, 2008, APPL OPTICS, V47, pD176, DOI 10.1364/AO.47.00D176; Lecoeur H, 2002, EXP CELL RES, V277, P1, DOI 10.1006/excr.2002.5537; Liu R, 2011, J OPT SOC AM A, V28, P1204, DOI 10.1364/JOSAA.28.001204; Marquet P, 2005, OPT LETT, V30, P468, DOI 10.1364/OL.30.000468; Montfort F, 2006, J OPT SOC AM A, V23, P2944, DOI 10.1364/JOSAA.23.002944; Moon I, 2008, IEEE T MED IMAGING, V27, P1782, DOI 10.1109/TMI.2008.927339; Moon I, 2009, P IEEE, V97, P990, DOI 10.1109/JPROC.2009.2017563; Pache C, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3377960; Pavillon N, 2010, J BIOPHOTONICS, V3, P432, DOI 10.1002/jbio.201000018; Rappaz B, 2005, OPT EXPRESS, V13, P9361, DOI 10.1364/OPEX.13.009361; Schubert D, 2001, J NEUROSCI, V21, P7455, DOI 10.1523/JNEUROSCI.21-19-07455.2001; Stout AK, 1998, NAT NEUROSCI, V1, P366, DOI 10.1038/1577; Strober W, CURRENT PROTOCOLS IM, pA3B1; Wolbers F, 2004, APOPTOSIS, V9, P749, DOI 10.1023/B:APPT.0000045794.03359.c3; Yuan J, 2003, NEURON, V40, P401, DOI 10.1016/S0896-6273(03)00601-9; Zamai L, 1996, CYTOMETRY, V23, P303, DOI 10.1002/(SICI)1097-0320(19960401)23:4<303::AID-CYTO6>3.3.CO;2-B; Zamzami N, 1997, J BIOENERG BIOMEMBR, V29, P185, DOI 10.1023/A:1022694131572	38	144	147	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2012	7	1							e30912	10.1371/journal.pone.0030912	http://dx.doi.org/10.1371/journal.pone.0030912			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	912BY	22303471	Green Published, gold, Green Submitted			2022-12-27	WOS:000301770700009
J	An, CF; Mou, ZL				An, Chuanfu; Mou, Zhonglin			Non-Host Defense Response in a Novel Arabidopsis-Xanthomonas citri subsp citri Pathosystem	PLOS ONE			English	Article							PSEUDOMONAS-SYRINGAE; SALICYLIC-ACID; DISEASE RESISTANCE; POWDERY MILDEW; ACQUIRED-RESISTANCE; SIGNALING PATHWAYS; BASAL RESISTANCE; CALLOSE SYNTHASE; OXIDATIVE BURST; INNATE IMMUNITY	Citrus canker, caused by Xanthomonas citri subsp. citri (Xcc), is one of the most destructive diseases of citrus. Progress of breeding citrus canker-resistant varieties is modest due to limited resistant germplasm resources and lack of candidate genes for genetic manipulation. The objective of this study is to establish a novel heterologous pathosystem between Xcc and the well-established model plant Arabidopsis thaliana for defense mechanism dissection and resistance gene identification. Our results indicate that Xcc bacteria neither grow nor decline in Arabidopsis, but induce multiple defense responses including callose deposition, reactive oxygen species and salicylic aicd (SA) production, and defense gene expression, indicating that Xcc activates non-host resistance in Arabidopsis. Moreover, Xcc-induced defense gene expression is suppressed or attenuated in several well-characterized SA signaling mutants including eds1, pad4, eds5, sid2, and npr1. Interestingly, resistance to Xcc is compromised only in eds1, pad4, and eds5, but not in sid2 and npr1. However, combining sid2 and npr1 in the sid2npr1 double mutant compromises resistance to Xcc, suggesting genetic interactions likely exist between SID2 and NPR1 in the non-host resistance against Xcc in Arabidopsis. These results demonstrate that the SA signaling pathway plays a critical role in regulating non-host defense against Xcc in Arabidopsis and suggest that the SA signaling pathway genes may hold great potential for breeding citrus canker-resistant varieties through modern gene transfer technology.	[An, Chuanfu; Mou, Zhonglin] Univ Florida, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	An, CF (corresponding author), Univ Florida, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA.	zhlmou@ufl.edu			National Science Foundation [IOS-0842716]; United States Department of Agriculture National Institute of Food and Agriculture; Citrus Research and Development Foundation	National Science Foundation(National Science Foundation (NSF)); United States Department of Agriculture National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); Citrus Research and Development Foundation	This work was supported by a grant from the National Science Foundation (IOS-0842716), a special grant from United States Department of Agriculture National Institute of Food and Agriculture, and a grant from the Citrus Research and Development Foundation awarded to ZM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts N, 1998, P NATL ACAD SCI USA, V95, P10306, DOI 10.1073/pnas.95.17.10306; Adam L, 1996, PLANT J, V9, P341, DOI 10.1046/j.1365-313X.1996.09030341.x; Adams-Phillips L, 2010, PLANT PHYSIOL, V152, P267, DOI 10.1104/pp.109.148049; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Azevedo C, 2006, EMBO J, V25, P2007, DOI 10.1038/sj.emboj.7601084; Bindschedler LV, 2006, PLANT J, V47, P851, DOI 10.1111/j.1365-313X.2006.02837.x; Cao H, 1997, CELL, V88, P57, DOI 10.1016/S0092-8674(00)81858-9; CAO H, 1994, PLANT CELL, V6, P1583, DOI 10.1105/tpc.6.11.1583; Century KS, 1997, SCIENCE, V278, P1963, DOI 10.1126/science.278.5345.1963; Clarke JD, 1998, PLANT CELL, V10, P557, DOI 10.1105/tpc.10.4.557; Coemans B, 2008, MOL PLANT PATHOL, V9, P25, DOI [10.1111/J.1364-3703.2007.00440.X, 10.1111/j.1364-3703.2007.00440.x]; Collins NC, 2003, NATURE, V425, P973, DOI 10.1038/nature02076; da Silva ACR, 2002, NATURE, V417, P459, DOI 10.1038/417459a; DeFraia CT, 2010, PLANT J, V64, P511, DOI 10.1111/j.1365-313X.2010.04345.x; Fan J, 2011, SCIENCE, V331, P1185, DOI 10.1126/science.1199707; Feechan A, 2005, P NATL ACAD SCI USA, V102, P8054, DOI 10.1073/pnas.0501456102; Felix G, 2003, J BIOL CHEM, V278, P6201, DOI 10.1074/jbc.M209880200; Fliegmann J, 2004, J BIOL CHEM, V279, P1132, DOI 10.1074/jbc.M308552200; Gentile A, 2007, PLANT BREEDING, V126, P146, DOI 10.1111/j.1439-0523.2007.01297.x; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Gomez-Gomez L, 2002, TRENDS PLANT SCI, V7, P251, DOI 10.1016/S1360-1385(02)02261-6; GOTTWALD TR, 1993, PLANT DIS, V77, P1004, DOI 10.1094/PD-77-1004; Graham JH, 2004, PLANT DIS, V88, P745, DOI 10.1094/PDIS.2004.88.7.745; Grant JJ, 2000, PLANT J, V24, P569, DOI 10.1046/j.1365-313x.2000.00902.x; GUZMAN P, 1990, PLANT CELL, V2, P513, DOI 10.1105/tpc.2.6.513; Ham JH, 2007, PLANT J, V51, P604, DOI 10.1111/j.1365-313X.2007.03165.x; Hao PY, 2008, PLANT PHYSIOL, V146, P1810, DOI 10.1104/pp.107.111484; Hardham AR, 2007, CURR OPIN PLANT BIOL, V10, P342, DOI 10.1016/j.pbi.2007.05.001; Hauck P, 2003, P NATL ACAD SCI USA, V100, P8577, DOI 10.1073/pnas.1431173100; Heath MC, 2000, CURR OPIN PLANT BIOL, V3, P315, DOI 10.1016/S1369-5266(00)00087-X; Heath MC, 2001, PHYSIOL MOL PLANT P, V58, P53, DOI 10.1006/pmpp.2001.0319; Hiruma K, 2011, PLANT J, V67, P980, DOI 10.1111/j.1365-313X.2011.04651.x; Hiruma K, 2010, PLANT CELL, V22, P2429, DOI 10.1105/tpc.110.074344; Holub EB, 2004, TRENDS PLANT SCI, V9, P211, DOI 10.1016/j.tplants.2004.03.002; Huckelhoven R, 2003, PLANTA, V216, P891, DOI 10.1007/s00425-003-0973-z; Huitema E, 2003, MOL PLANT PATHOL, V4, P487, DOI [10.1046/j.1364-3703.2003.00195.x, 10.1046/J.1364-3703.2003.00195.X]; Jacobs AK, 2003, PLANT CELL, V15, P2503, DOI 10.1105/tpc.016097; Jirage D, 1999, P NATL ACAD SCI USA, V96, P13583, DOI 10.1073/pnas.96.23.13583; Kadota Y, 2010, TRENDS BIOCHEM SCI, V35, P199, DOI 10.1016/j.tibs.2009.12.005; Kamoun S, 2001, CURR OPIN PLANT BIOL, V4, P295, DOI 10.1016/S1369-5266(00)00176-X; Kang L, 2003, P NATL ACAD SCI USA, V100, P3519, DOI 10.1073/pnas.0637377100; Kanzaki H, 2003, MOL PLANT PATHOL, V4, P383, DOI [10.1046/j.1364-3703.2003.00186.x, 10.1046/J.1364-3703.2003.00186.X]; Katagiri Fumiaki, 2002, Arabidopsis Book, V1, pe0039, DOI 10.1199/tab.0039; Knoester M, 1998, P NATL ACAD SCI USA, V95, P1933, DOI 10.1073/pnas.95.4.1933; Kwon C, 2008, NATURE, V451, P835, DOI 10.1038/nature06545; Li XY, 2005, P NATL ACAD SCI USA, V102, P12990, DOI 10.1073/pnas.0502425102; Lipka V, 2005, SCIENCE, V310, P1180, DOI 10.1126/science.1119409; Loehrer M, 2008, MOL PLANT MICROBE IN, V21, P1421, DOI 10.1094/MPMI-21-11-1421; Lu M, 2001, PLANT CELL, V13, P437, DOI 10.1105/tpc.13.2.437; MATSUMURA K, 1995, PHYTOPATHOLOGY, V85, P753, DOI 10.1094/Phyto-85-753; MEHDY MC, 1994, PLANT PHYSIOL, V105, P467, DOI 10.1104/pp.105.2.467; Mellersh DG, 2003, MOL PLANT MICROBE IN, V16, P398, DOI 10.1094/MPMI.2003.16.5.398; Mishina TE, 2007, PHYSIOL PLANTARUM, V131, P448, DOI 10.1111/j.1399-3054.2007.00977.x; Mysore KS, 2004, TRENDS PLANT SCI, V9, P97, DOI 10.1016/j.tplants.2003.12.005; Narusaka Y, 2005, MOL PLANT PATHOL, V6, P615, DOI 10.1111/J.1364-3703.2005.00310.X; Navarro L, 2004, PLANT PHYSIOL, V135, P1113, DOI 10.1104/pp.103.036749; Nawrath C, 2002, PLANT CELL, V14, P275, DOI 10.1105/tpc.010376; NIKS RE, 1988, EUPHYTICA, V37, P89, DOI 10.1007/BF00037229; Nimchuk Z, 2003, ANNU REV GENET, V37, P579, DOI 10.1146/annurev.genet.37.110801.142628; Nishimura MT, 2003, SCIENCE, V301, P969, DOI 10.1126/science.1086716; Noel LD, 2007, PLANT CELL, V19, P4061, DOI 10.1105/tpc.107.051896; Nurnberger T, 2005, MOL PLANT PATHOL, V6, P335, DOI 10.1111/j.1364-3703.2005.00279.x; Nurnberger T, 2004, IMMUNOL REV, V198, P249, DOI 10.1111/j.0105-2896.2004.0119.x; Peart JR, 2002, P NATL ACAD SCI USA, V99, P10865, DOI 10.1073/pnas.152330599; Sanchez-Vallet A, 2010, PLANT J, V63, P115, DOI 10.1111/j.1365-313X.2010.04224.x; Senthil-Kumar M, 2010, PLANT SIGNAL BEHAV, V5, P586, DOI 10.4161/psb.11497; Shibata Y, 2011, PHYSIOL MOL PLANT P, V75, P120, DOI 10.1016/j.pmpp.2010.10.001; Shimizu R, 2003, MOL GENET GENOMICS, V269, P21, DOI 10.1007/s00438-003-0817-3; Shirasu K, 2009, ANNU REV PLANT BIOL, V60, P139, DOI 10.1146/annurev.arplant.59.032607.092906; Soylu S, 2005, PHYSIOL MOL PLANT P, V66, P232, DOI 10.1016/j.pmpp.2005.08.005; Staswick PE, 2002, PLANT CELL, V14, P1405, DOI 10.1105/tpc.000885; Stein M, 2006, PLANT CELL, V18, P731, DOI 10.1105/tpc.105.038372; Sun XL, 2011, NEW PHYTOL, V192, P471, DOI 10.1111/j.1469-8137.2011.03820.x; Tao Y, 2003, PLANT CELL, V15, P317, DOI 10.1105/tpc.007591; Thomma BPHJ, 1998, P NATL ACAD SCI USA, V95, P15107, DOI 10.1073/pnas.95.25.15107; Thomma BPHJ, 1999, PLANT J, V19, P163, DOI 10.1046/j.1365-313X.1999.00513.x; Thordal-Christensen H, 2003, CURR OPIN PLANT BIOL, V6, P351, DOI 10.1016/S1369-5266(03)00063-3; Torres MA, 2005, NAT GENET, V37, P1130, DOI 10.1038/ng1639; Truman W, 2006, PLANT J, V46, P14, DOI 10.1111/j.1365-313X.2006.02672.x; UKNES S, 1992, PLANT CELL, V4, P645, DOI 10.1105/tpc.4.6.645; van Baarlen P, 2007, MOL PLANT PATHOL, V8, P41, DOI 10.1111/j.1364-3703.2006.00367.x; van Wees SCM, 2003, PLANT J, V33, P733, DOI 10.1046/j.1365-313X.2003.01665.x; Verberne MC, 2002, PHYTOCHEM ANALYSIS, V13, P45, DOI 10.1002/pca.615; Viloria Z, 2004, PLANT DIS, V88, P1056, DOI 10.1094/PDIS.2004.88.10.1056; Volko SM, 1998, GENETICS, V149, P537; Wan AM, 2004, PLANT DIS, V88, P896, DOI 10.1094/PDIS.2004.88.8.896; Weigel D, 2002, ARABIDOPSIS LAB MANU, P85; Wen YQ, 2011, J EXP BOT, V62, P2117, DOI 10.1093/jxb/erq406; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Yun BW, 2003, PLANT J, V34, P768, DOI 10.1046/j.1365-313X.2003.01773.x; Zhang J, 2010, MOL PLANT MICROBE IN, V23, P940, DOI 10.1094/MPMI-23-7-0940; Zhang XD, 2010, EUR J PLANT PATHOL, V128, P91, DOI 10.1007/s10658-010-9633-x; Zhao BY, 2005, P NATL ACAD SCI USA, V102, P15383, DOI 10.1073/pnas.0503023102; Zhou N, 1999, PLANT CELL, V11, P2419, DOI 10.1105/tpc.11.12.2419; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037; Zurbriggen MD, 2009, PLANT J, V60, P962, DOI 10.1111/j.1365-313X.2009.04010.x	97	23	24	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e31130	10.1371/journal.pone.0031130	http://dx.doi.org/10.1371/journal.pone.0031130			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22299054	Green Published, gold, Green Submitted			2022-12-27	WOS:000301704200063
J	Ozaki, DA; Gao, HM; Todd, CA; Greene, KM; Montefiori, DC; Sarzotti-Kelsoe, M				Ozaki, Daniel A.; Gao, Hongmei; Todd, Christopher A.; Greene, Kelli M.; Montefiori, David C.; Sarzotti-Kelsoe, Marcella			International Technology Transfer of a GCLP-Compliant HIV-1 Neutralizing Antibody Assay for Human Clinical Trials	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; INFECTIONS	The Collaboration for AIDS Vaccine Discovery/Comprehensive Antibody - Vaccine Immune Monitoring Consortium (CAVD/CA-VIMC) assisted an international network of laboratories in transferring a validated assay used to judge HIV-1 vaccine immunogenicity in compliance with Good Clinical Laboratory Practice (GCLP) with the goal of adding quality to the conduct of endpoint assays for Human Immunodeficiency Virus I (HIV-1) vaccine human clinical trials. Eight Regional Laboratories in the international setting (Regional Laboratories), many located in regions where the HIV-1 epidemic is most prominent, were selected to implement the standardized, GCLP-compliant Neutralizing Antibody Assay for HIV-1 in TZM-bl Cells (TZM-bl NAb Assay). Each laboratory was required to undergo initial training and implementation of the immunologic assay on-site and then perform partial assay re-validation, competency testing, and undergo formal external audits for GCLP compliance. Furthermore, using a newly established external proficiency testing program for the TZM-bl NAb Assay has allowed the Regional Laboratories to assess the comparability of assay results at their site with the results of neutralizing antibody assays performed around the world. As a result, several of the CAVD/CA-VIMC Regional Laboratories are now in the process of conducting or planning to conduct the GCLP-compliant TZM-bl NAb Assay as an indicator of vaccine immunogenicity for ongoing human clinical trials.	[Ozaki, Daniel A.; Gao, Hongmei; Todd, Christopher A.; Greene, Kelli M.; Montefiori, David C.; Sarzotti-Kelsoe, Marcella] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Sarzotti-Kelsoe, Marcella] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA	Duke University; Duke University	Ozaki, DA (corresponding author), Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA.	marcella.sarzottikelsoe@duke.edu			Bill & Melinda Gates Foundation's Collaboration for AIDS Vaccine Discovery/Comprehensive Antibody - Vaccine Immune Monitoring Consortium [38619]	Bill & Melinda Gates Foundation's Collaboration for AIDS Vaccine Discovery/Comprehensive Antibody - Vaccine Immune Monitoring Consortium	This study was supported by the Bill & Melinda Gates Foundation's Collaboration for AIDS Vaccine Discovery/Comprehensive Antibody - Vaccine Immune Monitoring Consortium, grant number 38619. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, NAT MED, V16, P981; [Anonymous], 2005, ICH TRIP GUID VAL AN, P1; Ezzelle J, 2008, J PHARMACEUT BIOMED, V46, P18, DOI 10.1016/j.jpba.2007.10.010; Fenyo EM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004505; Gilmour JW, 2007, CURR OPIN HIV AIDS, V2, P201, DOI 10.1097/COH.0b013e3280eec77a; Gotch F, 2007, NAT IMMUNOL, V8, P1273, DOI 10.1038/ni1531; Huang Y, 2009, STAT DESIGN ANAL CAV; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Montefiori D, 2007, PLOS MED, V4, P1867, DOI 10.1371/journal.pmed.0040348; Montefiori DC., 2005, CURR PROTOC IMMUNOL, VChapter 12:12.11.11-12.11.15, DOI [10.1002/0471142735.im1211s64, DOI 10.1002/0471142735.IM1211S64]; Piehler B, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-33; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Sarzotti-Kelsoe M, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000067; Stevens W, 2003, Qual Assur, V10, P83; Stiles T, 2003, GOOD CLIN LAB PRACTI; Todd CA, 2011, J IMMUNOL METHODS; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; 2005, PLOS MED, V2, pE25	18	28	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e30963	10.1371/journal.pone.0030963	http://dx.doi.org/10.1371/journal.pone.0030963			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22303476	Green Published, Green Submitted, gold			2022-12-27	WOS:000301704200050
J	Polania, R; Paulus, W; Nitsche, MA				Polania, Rafael; Paulus, Walter; Nitsche, Michael A.			Reorganizing the Intrinsic Functional Architecture of the Human Primary Motor Cortex during Rest with Non-Invasive Cortical Stimulation	PLOS ONE			English	Article							PAIRED ASSOCIATIVE STIMULATION; COMPLEX BRAIN NETWORKS; TRANSCRANIAL DIRECT; DC-STIMULATION; SMALL-WORLD; EXCITABILITY SHIFTS; CEREBRAL-CORTEX; STROKE PATIENTS; ORGANIZATION; PLASTICITY	The primary motor cortex (M1) is the main effector structure implicated in the generation of voluntary movements and is directly involved in motor learning. The intrinsic horizontal neuronal connections of M1 exhibit short-term and long-term plasticity, which is a strong substrate for learning-related map reorganization. Transcranial direct current stimulation (tDCS) applied for few minutes over M1 has been shown to induce relatively long-lasting plastic alterations and to modulate motor performance. Here we test the hypothesis that the relatively long-lasting synaptic modification induced by tDCS over M1 results in the alteration of associations among populations of M1 neurons which may be reflected in changes of its functional architecture. fMRI resting-state datasets were acquired immediately before and after 10 minutes of tDCS during rest, with the anode/cathode placed over the left M1. For each functional dataset, grey-matter voxels belonging to Brodmann area 4 (BA4) were labelled and afterwards BA4 voxel-based synchronization matrices were calculated and thresholded to construct undirected graphs. Nodal network parameters which characterize the architecture of functional networks (connectivity degree, clustering coefficient and characteristic path-length) were computed, transformed to volume maps and compared before and after stimulation. At the dorsolateral-BA4 region cathodal tDCS boosted local connectedness, while anodal-tDCS enhanced long distance functional communication within M1. Additionally, the more efficient the functional architecture of M1 was at baseline, the more efficient the tDCS-induced functional modulations were. In summary, we show here that it is possible to non-invasively reorganize the intrinsic functional architecture of M1, and to image such alterations.	[Polania, Rafael; Paulus, Walter; Nitsche, Michael A.] Univ Gottingen, Dept Clin Neurophysiol, Gottingen, Germany	University of Gottingen	Polania, R (corresponding author), Univ Gottingen, Dept Clin Neurophysiol, Gottingen, Germany.	rafael.polania@med.uni-goettingen.de	Nitsche, Michael A/B-6755-2012; Paulus, Walter/A-3544-2009	Paulus, Walter/0000-0001-5549-8377; Polania, Rafael/0000-0002-6176-6806	Rose Foundation	Rose Foundation	This study was supported by the Rose Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Amunts K, 2000, NEUROPSYCHOLOGIA, V38, P304, DOI 10.1016/S0028-3932(99)00075-5; Antal A, 2004, J COGNITIVE NEUROSCI, V16, P521, DOI 10.1162/089892904323057263; Antal A, 2011, NEUROIMAGE, V55, P590, DOI 10.1016/j.neuroimage.2010.11.085; BINDMAN LJ, 1964, J PHYSIOL-LONDON, V172, P369, DOI 10.1113/jphysiol.1964.sp007425; Birn RM, 2006, NEUROIMAGE, V31, P1536, DOI 10.1016/j.neuroimage.2006.02.048; Boggio PS, 2007, RESTOR NEUROL NEUROS, V25, P123; Boggio PS, 2006, NEUROSCI LETT, V404, P232, DOI 10.1016/j.neulet.2006.05.051; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Butefisch CM, 2000, P NATL ACAD SCI USA, V97, P3661, DOI 10.1073/pnas.050350297; Cirillo J, 2009, J PHYSIOL-LONDON, V587, P5831, DOI 10.1113/jphysiol.2009.181834; de Xivry JJO, 2011, J NEUROSCI, V31, P7102, DOI 10.1523/JNEUROSCI.0273-11.2011; DONOGHUE JP, 1992, EXP BRAIN RES, V89, P1; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fregni F, 2005, NEUROREPORT, V16, P1551, DOI 10.1097/01.wnr.0000177010.44602.5e; Fritsch B, 2010, NEURON, V66, P198, DOI 10.1016/j.neuron.2010.03.035; Gandiga PC, 2006, CLIN NEUROPHYSIOL, V117, P845, DOI 10.1016/j.clinph.2005.12.003; HESS G, 1994, J NEUROPHYSIOL, V71, P2543, DOI 10.1152/jn.1994.71.6.2543; Hummel F, 2005, BRAIN, V128, P490, DOI 10.1093/brain/awh369; Iezzi E, 2011, EUR J NEUROSCI, V33, P1908, DOI 10.1111/j.1460-9568.2011.07674.x; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Kelly C, 2009, J NEUROSCI, V29, P7364, DOI 10.1523/JNEUROSCI.0810-09.2009; Korchounov A, 2011, NEUROMODULATORY NEUR; Lang N, 2004, EXP BRAIN RES, V156, P439, DOI 10.1007/s00221-003-1800-2; Liebetanz D, 2002, BRAIN, V125, P2238, DOI 10.1093/brain/awf238; Meier JD, 2008, J NEUROPHYSIOL, V100, P1800, DOI 10.1152/jn.90531.2008; Moliadze V, 2010, CLIN NEUROPHYSIOL, V121, P2165, DOI 10.1016/j.clinph.2010.04.033; Nitsche MA, 2004, EUR J NEUROSCI, V19, P2720, DOI 10.1111/j.0953-816X.2004.03398.x; Nitsche MA, 2001, NEUROLOGY, V57, P1899, DOI 10.1212/WNL.57.10.1899; Nitsche MA, 2003, J COGNITIVE NEUROSCI, V15, P619, DOI 10.1162/089892903321662994; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Nitsche MA, 2003, J PHYSIOL-LONDON, V553, P293, DOI 10.1113/jphysiol.2003.049916; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Polania R, 2011, HUM BRAIN MAPP, DOI [10.1002/hbm.21380, DOI 10.1002/HBM.21380]; Polania R, 2011, HUM BRAIN MAPP, V32, P1236, DOI 10.1002/hbm.21104; Polania R, 2011, NEUROIMAGE, V54, P2287, DOI 10.1016/j.neuroimage.2010.09.085; PURPURA DP, 1965, J NEUROPHYSIOL, V28, P166, DOI 10.1152/jn.1965.28.1.166; RASMUSSEN T, 1947, FED PROC, V6, P184; Reis J, 2009, P NATL ACAD SCI USA, V106, P1590, DOI 10.1073/pnas.0805413106; Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533; Sanes JN, 2000, CURR BIOL, V10, pR495, DOI 10.1016/S0960-9822(00)00557-1; Sanes JN, 1997, ADV NEUROL, V73, P277; Sanes JN, 2000, NEUROIMAGE, V11, P370, DOI 10.1006/nimg.2000.0550; SANES JN, 1992, CEREB CORTEX, V2, P141, DOI 10.1093/cercor/2.2.141; Sanes JN, 2001, NEUROIMAGE, V13, P968, DOI 10.1006/nimg.2000.0733; Sanes JN, 2000, ANNU REV NEUROSCI, V23, P393, DOI 10.1146/annurev.neuro.23.1.393; Schambra HM, 2003, CLIN NEUROPHYSIOL, V114, P130, DOI 10.1016/S1388-2457(02)00342-5; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Stam CJ, 2010, INT J PSYCHOPHYSIOL, V77, P186, DOI 10.1016/j.ijpsycho.2010.06.024; Stefan K, 2002, J PHYSIOL-LONDON, V543, P699, DOI 10.1113/jphysiol.2002.023317; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; van den Heuvel MP, 2008, NEUROIMAGE, V43, P528, DOI 10.1016/j.neuroimage.2008.08.010; van den Heuvel MP, 2009, J NEUROSCI, V29, P7619, DOI 10.1523/JNEUROSCI.1443-09.2009	54	72	72	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e30971	10.1371/journal.pone.0030971	http://dx.doi.org/10.1371/journal.pone.0030971			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22303478	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000301704200052
J	von Ruesten, A; Weikert, C; Fietze, I; Boeing, H				von Ruesten, Anne; Weikert, Cornelia; Fietze, Ingo; Boeing, Heiner			Association of Sleep Duration with Chronic Diseases in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; RISK-FACTOR; BREAST-CANCER; DAYTIME SLEEPINESS; HEALTHY-ADULTS; EPIC-GERMANY; FOLLOW-UP; METABOLIC CONSEQUENCES; CARDIOVASCULAR-DISEASE; GENERAL-POPULATION	Background: In view of the reduced number of hours devoted to sleep in modern western societies the question arises what effects might result from sleep duration on occurrence of chronic diseases. Methods: Data from 23 620 middle-aged participants of the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam study, that were recruited between 1994-1998, were analyzed by using Cox proportional hazard regression to examine the association between self-reported sleep duration at baseline and incidence of chronic diseases, such as diabetes, myocardial infarction, stroke, and cancer. Results: During a mean follow-up period of 7.8 years 841 incident cases of type 2 diabetes, 197 cases of myocardial infarction, 169 incident strokes, and 846 tumor cases were observed. Compared to persons sleeping 7-<8 h/day, participants with sleep duration of <6 h had a significantly increased risk of stroke (Hazard Ratio (HR)=2.06, 95% confidence interval (CI): 1.18-3.59), cancer (HR=1.43, 95% CI: 1.09-1.87), and overall chronic diseases (HR=1.31, 95% CI: 1.10-1.55) in multivariable adjusted models. Self-reported daytime sleep at baseline was not associated with incident chronic diseases in the overall study sample. However, there had been an effect modification of daytime sleep by hypertension showing that daytime sleep was inversely related to chronic disease risk among non-hypertensive participants but directly related to chronic diseases among hypertensives. Conclusion: Sleep duration of less than 6 h is a risky behavior for the development of chronic diseases, particularly stroke and cancer, and should be therefore addressed in public health campaigns.	[von Ruesten, Anne; Weikert, Cornelia; Boeing, Heiner] German Inst Human Nutr Potsdam Rehbrucke, Dept Epidemiol, Nuthetal, Germany; [Fietze, Ingo] Charite, Dept Cardiol & Angiol, Ctr Sleep Med, CCM, D-13353 Berlin, Germany	Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	von Ruesten, A (corresponding author), German Inst Human Nutr Potsdam Rehbrucke, Dept Epidemiol, Nuthetal, Germany.	Anne.von.Ruesten@dife.de		Fietze, Ingo/0000-0001-5567-5206	Federal Ministry of Science, Germany [01 EA 9401]; European Community [SOC 95 201408 05F02, SOC 98 200769 05F02]; German Cancer Aid [70-2488-Ha I]	Federal Ministry of Science, Germany; European Community(European Commission); German Cancer Aid(Deutsche Krebshilfe)	The recruitment phase of the EPIC (European Prospective Investigation into Cancer and Nutrition)-Potsdam Study was supported by the Federal Ministry of Science, Germany (grant 01 EA 9401). Further financial support was provided by the `Europe against Cancer' program of the European Community (grant SOC 95 201408 05F02). The EPIC-Potsdam Study is now supported by the German Cancer Aid (grant 70-2488-Ha I) and the European Community (grant SOC 98 200769 05F02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amagai Y, 2010, J EPIDEMIOL, V20, P106, DOI 10.2188/jea.JE20090053; Asplund R, 1996, J INTERN MED, V239, P261, DOI 10.1046/j.1365-2796.1996.453806000.x; Asplund R, 1998, SCAND J PRIM HEALTH, V16, P112; Ayas NT, 2003, DIABETES CARE, V26, P380, DOI 10.2337/diacare.26.2.380; Ayas NT, 2003, ARCH INTERN MED, V163, P205, DOI 10.1001/archinte.163.2.205; Beihl DA, 2009, ANN EPIDEMIOL, V19, P351, DOI 10.1016/j.annepidem.2008.12.001; Bergmann MM, 1999, ANN NUTR METAB, V43, P225, DOI 10.1159/000012789; Bjorkelund C, 2005, DIABETES CARE, V28, P2739, DOI 10.2337/diacare.28.11.2739; Blask DE, 2009, SLEEP MED REV, V13, P257, DOI 10.1016/j.smrv.2008.07.007; Bliwise DL, 1996, SLEEP, V19, P462, DOI 10.1093/sleep/19.6.462; Boeing H, 1999, ANN NUTR METAB, V43, P205, DOI 10.1159/000012787; Boeing H, 1999, ANN NUTR METAB, V43, P195, DOI 10.1159/000012786; Cappuccio FP, 2011, EUR HEART J; Cappuccio FP, 2010, DIABETES CARE, V33, P414, DOI 10.2337/dc09-1124; Chandola T, 2010, SLEEP, V33, P739, DOI 10.1093/sleep/33.6.739; Chaput JP, 2009, SLEEP MED, V10, P919, DOI 10.1016/j.sleep.2008.09.016; Chatzitheochari S, 2009, WORK EMPLOY SOC, V23, P30, DOI 10.1177/0950017008099776; Chen JC, 2008, STROKE, V39, P3185, DOI 10.1161/STROKEAHA.108.521773; Dhand R, 2006, CURR OPIN PULM MED, V12, P379; Foley DJ, 2007, AM J GERIAT PSYCHIAT, V15, P344, DOI 10.1097/01.JGP.0000249385.50101.67; Gangwisch JE, 2009, OBES REV, V10, P37, DOI 10.1111/j.1467-789X.2009.00663.x; Gangwisch JE, 2007, SLEEP, V30, P1667, DOI 10.1093/sleep/30.12.1667; Gangwisch JE, 2006, HYPERTENSION, V47, P833, DOI 10.1161/01.HYP.0000217362.34748.e0; Gottlieb DJ, 2006, SLEEP, V29, P1009, DOI 10.1093/sleep/29.8.1009; Hayashino Y, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-129; Irwin M, 2002, BRAIN BEHAV IMMUN, V16, P503, DOI 10.1016/S0889-1591(02)00003-X; Kakizaki M, 2008, BRIT J CANCER, V99, P1502, DOI 10.1038/sj.bjc.6604684; Knutson KL, 2008, ANN NY ACAD SCI, V1129, P287, DOI 10.1196/annals.1417.033; Knutson KL, 2007, SLEEP MED REV, V11, P163, DOI 10.1016/j.smrv.2007.01.002; Knutson KL, 2010, SLEEP, V33, P37, DOI 10.1093/sleep/33.1.37; Kripke DF, 2002, ARCH GEN PSYCHIAT, V59, P131, DOI 10.1001/archpsyc.59.2.131; Lauderdale DS, 2008, EPIDEMIOLOGY, V19, P838, DOI 10.1097/EDE.0b013e318187a7b0; Lauderdale DS, 2006, AM J EPIDEMIOL, V164, P5, DOI 10.1093/aje/kwj199; Leproult R, 1997, SLEEP, V20, P865; Lockley SW, 1999, J SLEEP RES, V8, P175, DOI 10.1046/j.1365-2869.1999.00155.x; Mallon L, 2005, DIABETES CARE, V28, P2762, DOI 10.2337/diacare.28.11.2762; Meier-Ewert HK, 2004, J AM COLL CARDIOL, V43, P678, DOI 10.1016/j.jacc.2003.07.050; Meisinger C, 2007, SLEEP, V30, P1121, DOI 10.1093/sleep/30.9.1121; Miller MA, 2007, CURR VASC PHARMACOL, V5, P93, DOI 10.2174/157016107780368280; Milner CE, 2009, J SLEEP RES, V18, P272, DOI 10.1111/j.1365-2869.2008.00718.x; Mullington JM, 2009, PROG CARDIOVASC DIS, V51, P294, DOI 10.1016/j.pcad.2008.10.003; Naska A, 2007, ARCH INTERN MED, V167, P296, DOI 10.1001/archinte.167.3.296; Patel SR, 2006, AM J EPIDEMIOL, V164, P947, DOI 10.1093/aje/kwj280; Patel SR, 2004, SLEEP, V27, P440, DOI 10.1093/sleep/27.3.440; Pinheiro SP, 2006, CANCER RES, V66, P5521, DOI 10.1158/0008-5472.CAN-05-4652; Qureshi AI, 1997, NEUROLOGY, V48, P904, DOI 10.1212/WNL.48.4.904; Roth Thomas, 2007, J Clin Sleep Med, V3, pS7; Siegel JM, 2005, NATURE, V437, P1264, DOI 10.1038/nature04285; Signal TL, 2005, AVIAT SPACE ENVIR MD, V76, P1058; Sigurdson K, 2007, CAN J PHYSIOL PHARM, V85, P179, DOI 10.1139/Y06-095; Spiegel K, 1999, LANCET, V354, P1435, DOI 10.1016/S0140-6736(99)01376-8; Stang A, 2007, SLEEP, V30, P1111, DOI 10.1093/sleep/30.9.1111; Stranges S, 2008, AM J EPIDEMIOL, V168, P1353, DOI 10.1093/aje/kwn337; Tamakoshi A, 2004, SLEEP, V27, P51; Tanabe N, 2010, INT J EPIDEMIOL, V39, P233, DOI 10.1093/ije/dyp327; US-Sleep-Foundation, 2005, SLEEP AM POLL SUMM F; Verkasalo PK, 2005, CANCER RES, V65, P9595, DOI 10.1158/0008-5472.CAN-05-2138; Volzke H, 2011, INT J EPIDEMIOL, V40, P294, DOI 10.1093/ije/dyp394; Wu AH, 2008, CARCINOGENESIS, V29, P1244, DOI 10.1093/carcin/bgn100; Xu Q, 2010, DIABETES CARE, V33, P78, DOI 10.2337/dc09-1143; Yaggi HK, 2006, DIABETES CARE, V29, P657, DOI 10.2337/diacare.29.03.06.dc05-0879	61	150	150	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30972	10.1371/journal.pone.0030972	http://dx.doi.org/10.1371/journal.pone.0030972			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295122	Green Published, gold, Green Submitted			2022-12-27	WOS:000301640600067
J	Bevins, SN; Carver, S; Boydston, EE; Lyren, LM; Alldredge, M; Logan, KA; Riley, SPD; Fisher, RN; Vickers, TW; Boyce, W; Salman, M; Lappin, MR; Crooks, KR; VandeWoude, S				Bevins, Sarah N.; Carver, Scott; Boydston, Erin E.; Lyren, Lisa M.; Alldredge, Mat; Logan, Kenneth A.; Riley, Seth P. D.; Fisher, Robert N.; Vickers, T. Winston; Boyce, Walter; Salman, Mo; Lappin, Michael R.; Crooks, Kevin R.; VandeWoude, Sue			Three Pathogens in Sympatric Populations of Pumas, Bobcats, and Domestic Cats: Implications for Infectious Disease Transmission	PLOS ONE			English	Article							FELINE IMMUNODEFICIENCY VIRUS; TOXOPLASMA-GONDII INFECTION; HABITAT FRAGMENTATION; BARTONELLA INFECTION; LEUKEMIA-VIRUS; PREVALENCE; WILD; ANTIBODIES; URBAN; SEROPREVALENCE	Anthropogenic landscape change can lead to increased opportunities for pathogen transmission between domestic and non-domestic animals. Pumas, bobcats, and domestic cats are sympatric in many areas of North America and share many of the same pathogens, some of which are zoonotic. We analyzed bobcat, puma, and feral domestic cat samples collected from targeted geographic areas. We examined exposure to three pathogens that are taxonomically diverse (bacterial, protozoal, viral), that incorporate multiple transmission strategies (vector-borne, environmental exposure/ingestion, and direct contact), and that vary in species-specificity. Bartonella spp., Feline Immunodeficiency Virus (FIV), and Toxoplasma gondii IgG were detected in all three species with mean respective prevalence as follows: puma 16%, 41% and 75%; bobcat 31%, 22% and 43%; domestic cat 45%, 10% and 1%. Bartonella spp. were highly prevalent among domestic cats in Southern California compared to other cohort groups. Feline Immunodeficiency Virus exposure was primarily associated with species and age, and was not influenced by geographic location. Pumas were more likely to be infected with FIV than bobcats, with domestic cats having the lowest infection rate. Toxoplasma gondii seroprevalence was high in both pumas and bobcats across all sites; in contrast, few domestic cats were seropositive, despite the fact that feral, free ranging domestic cats were targeted in this study. Interestingly, a directly transmitted species-specific disease (FIV) was not associated with geographic location, while exposure to indirectly transmitted diseases - vector-borne for Bartonella spp. and ingestion of oocysts via infected prey or environmental exposure for T. gondii - varied significantly by site. Pathogens transmitted by direct contact may be more dependent upon individual behaviors and intra-specific encounters. Future studies will integrate host density, as well as landscape features, to better understand the mechanisms driving disease exposure and to predict zones of cross-species pathogen transmission among wild and domestic felids.	[Bevins, Sarah N.] USDA, Natl Wildlife Dis Program, Ft Collins, CO 80528 USA; [Carver, Scott; VandeWoude, Sue] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Boydston, Erin E.; Lyren, Lisa M.] US Geol Survey, Western Ecol Res Ctr, Thousand Oaks, CA USA; [Alldredge, Mat] Colorado Pk & Wildlife, Ft Collins, CO USA; [Logan, Kenneth A.] Colorado Pk & Wildlife, Montrose, CO USA; [Riley, Seth P. D.] Natl Pk Serv, Thousand Oaks, CA USA; [Vickers, T. Winston; Boyce, Walter] Univ Calif Davis, Wildlife Hlth Ctr, Davis, CA 95616 USA; [Salman, Mo; Lappin, Michael R.] Colorado State Univ, Dept Clin Sci, Ft Collins, CO 80523 USA; [Crooks, Kevin R.] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA; [Fisher, Robert N.] US Geol Survey, Western Ecol Res Ctr, San Diego, CA USA	United States Department of Agriculture (USDA); Colorado State University; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; University of California System; University of California Davis; Colorado State University; Colorado State University; United States Department of the Interior; United States Geological Survey	Bevins, SN (corresponding author), USDA, Natl Wildlife Dis Program, Ft Collins, CO 80528 USA.	bevins@rams.colostate.edu	Fisher, Robert/AAA-7301-2022; Carver, Scott/J-7654-2014	Fisher, Robert/0000-0002-2956-3240; Carver, Scott/0000-0002-3579-7588; VandeWoude, Sue/0000-0001-9227-1622	NSF [NSF EF-0723676]	NSF(National Science Foundation (NSF))	This study was supported by NSF Ecology of Infectious Disease research program (NSF EF-0723676). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEIER P, 1993, CONSERV BIOL, V7, P94, DOI 10.1046/j.1523-1739.1993.07010094.x; Beier P, 2010, URBAN CARNIVORES ECO; Bevins SN, 2009, EMERG INFECT DIS, V15, P2021, DOI 10.3201/eid1512.090526; Biek R, 2006, CAN J ZOOL, V84, P365, DOI 10.1139/z06-006; Billeter SA, 2008, MED VET ENTOMOL, V22, P1, DOI 10.1111/j.1365-2915.2008.00713.x; Breitschwerdt EB, 2000, CLIN MICROBIOL REV, V13, P428, DOI 10.1128/CMR.13.3.428-438.2000; BREITSCHWERDT EB, 1995, J CLIN MICROBIOL, V33, P154, DOI 10.1128/JCM.33.1.154-160.1995; Breitschwerdt EB, 2008, VET IMMUNOL IMMUNOP, V123, P167, DOI 10.1016/j.vetimm.2008.01.025; Brennan G, 2006, J CLIN MICROBIOL, V44, P4345, DOI 10.1128/JCM.00577-06; Brown MA, 2008, EMERG INFECT DIS, V14, P252, DOI 10.3201/eid1402.070981; Buchmann AU, 2010, J CLIN MICROBIOL, V48, P3295, DOI 10.1128/JCM.00750-10; Burnham K, MODEL SELECTION MULT, P1; Butera ST, 2000, J AM VET MED ASSOC, V217, P1475, DOI 10.2460/javma.2000.217.1475; Carpenter MA, 1996, J VIROL, V70, P6682, DOI 10.1128/JVI.70.10.6682-6693.1996; Chomel BB, 2006, ANN NY ACAD SCI, V1078, P410, DOI 10.1196/annals.1374.080; Chua KB, 2000, SCIENCE, V288, P1432, DOI 10.1126/science.288.5470.1432; Courchamp F, 2000, WILDLIFE RES, V27, P603, DOI 10.1071/WR99049; Crooks K. R., 2006, CONNECTIVITY CONSERV; Dabritz HA, 2010, ZOONOSES PUBLIC HLTH, V57, P34, DOI 10.1111/j.1863-2378.2009.01273.x; Dabritz HA, 2007, J PARASITOL, V93, P806, DOI 10.1645/GE-996R.1; Dabritz HA, 2006, JAVMA-J AM VET MED A, V229, P74, DOI 10.2460/javma.229.1.74; Dubey JP, 2008, INT J PARASITOL, V38, P1257, DOI 10.1016/j.ijpara.2008.03.007; DUBEY JP, 1994, AM J VET RES, V55, P982; Dubey JP., 2022, TOXOPLASMOSIS ANIMAL, V3rd, P1; ENGLISH RV, 1994, J INFECT DIS, V170, P543, DOI 10.1093/infdis/170.3.543; Franklin SP, 2007, J VIROL, V81, P10961, DOI 10.1128/JVI.00997-07; Franklin SP, 2007, J WILDLIFE DIS, V43, P700, DOI 10.7589/0090-3558-43.4.700; FRENKEL JK, 1970, SCIENCE, V167, P893, DOI 10.1126/science.167.3919.893; Friggens MM, 2010, OECOLOGIA, V164, P809, DOI 10.1007/s00442-010-1747-5; Fromont E, 1996, ACTA OECOL, V17, P609; Goldberg TL, 2008, EMERG INFECT DIS, V14, P1375, DOI [10.3201/eid14.9.071196, 10.3201/eid1409.071196]; Hess G, 1996, ECOLOGY, V77, P1617, DOI 10.2307/2265556; Inc SI, 2007, SAS ONLINEDOC 9 2; JAMESON P, 1995, J INFECT DIS, V172, P1145, DOI 10.1093/infdis/172.4.1145; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kapperud G, 1996, AM J EPIDEMIOL, V144, P405, DOI 10.1093/oxfordjournals.aje.a008942; Lappin MR, 2009, J FELINE MED SURG, V11, P141, DOI 10.1016/j.jfms.2008.06.005; LAPPIN MR, 1994, J PARASITOL, V80, P73, DOI 10.2307/3283348; LAPPIN MR, 1991, J ZOO WILDLIFE MED, V22, P169; LAPPIN MR, 1989, AM J VET RES, V50, P1580; Lappin MR, 2006, J FELINE MED SURG, V8, P85, DOI 10.1016/j.jfms.2005.08.003; Lelu M, 2010, THEOR POPUL BIOL, V78, P139, DOI 10.1016/j.tpb.2010.05.005; Logan K.A., 2001, DESERT PUMA EVOLUTIO; LoGiudice K, 2003, P NATL ACAD SCI USA, V100, P567, DOI 10.1073/pnas.0233733100; McCallum H, 2002, P ROY SOC B-BIOL SCI, V269, P2041, DOI 10.1098/rspb.2002.2079; Miller MA, 2002, INT J PARASITOL, V32, P997, DOI 10.1016/S0020-7519(02)00069-3; MIYAZAWA T, 1989, ARCH VIROL, V108, P59, DOI 10.1007/BF01313743; Ordenana MA, 2010, J MAMMAL, V91, P1322, DOI 10.1644/09-MAMM-A-312.1; Page LK, 2008, J WILDLIFE DIS, V44, P594, DOI 10.7589/0090-3558-44.3.594; Pontier D, 1998, P ROY SOC B-BIOL SCI, V265, P167, DOI 10.1098/rspb.1998.0278; Reis C, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001186; Riley SPD, 2004, J WILDLIFE DIS, V40, P11, DOI 10.7589/0090-3558-40.1.11; Riley SPD, 2003, CONSERV BIOL, V17, P566, DOI 10.1046/j.1523-1739.2003.01458.x; Riley SPD, 2011, URBAN CARNIVORES ECO; Roelke ME, 2006, J WILDLIFE DIS, V42, P234, DOI 10.7589/0090-3558-42.2.234; Roelke ME, 2009, VIROLOGY, V390, P1, DOI 10.1016/j.virol.2009.04.011; Ruell EW, 2009, J MAMMAL, V90, P129, DOI 10.1644/07-MAMM-A-249.1; Smith KF, 2009, ANIM CONSERV, V12, P1, DOI 10.1111/j.1469-1795.2008.00228.x; TerWee JA, 2005, J VIROL, V79, P2797, DOI 10.1128/JVI.79.5.2797-2806.2005; Troyer JL, 2005, J VIROL, V79, P8282, DOI 10.1128/JVI.79.13.8282-8294.2005; VandeWoude S, 2006, CLIN MICROBIOL REV, V19, P728, DOI 10.1128/CMR.00009-06; Vollaire MR, 2005, AM J VET RES, V66, P874, DOI 10.2460/ajvr.2005.66.874; Wheeler DC, 2010, SPAT SPATIO-TEMPORAL, V1, P151, DOI 10.1016/j.sste.2010.03.009	63	67	69	5	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31403	10.1371/journal.pone.0031403	http://dx.doi.org/10.1371/journal.pone.0031403			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347471	Green Published, gold, Green Submitted			2022-12-27	WOS:000302730100067
J	Fan, JB; Chen, J; April, CS; Fisher, JS; Klotzle, B; Bibikova, M; Kaper, F; Ronaghi, M; Linnarsson, S; Ota, T; Chien, J; Laurent, LC; Nisperos, SV; Chen, GY; Zhong, JF				Fan, Jian-Bing; Chen, Jing; April, Craig S.; Fisher, Jeffrey S.; Klotzle, Brandy; Bibikova, Marina; Kaper, Fiona; Ronaghi, Mostafa; Linnarsson, Sten; Ota, Takayo; Chien, Jeremy; Laurent, Louise C.; Nisperos, Sean V.; Chen, Gina Y.; Zhong, Jiang F.			Highly Parallel Genome-Wide Expression Analysis of Single Mammalian Cells	PLOS ONE			English	Article							GENE-EXPRESSION; MICROARRAY ANALYSIS; MESSENGER-RNA; AMPLIFICATION TECHNIQUES; TRANSCRIPTOME ANALYSIS; SMALL SAMPLES; STEM; IDENTIFICATION; TECHNOLOGY; PCR	Background: We have developed a high-throughput amplification method for generating robust gene expression profiles using single cell or low RNA inputs. Methodology/Principal Findings: The method uses tagged priming and template-switching, resulting in the incorporation of universal PCR priming sites at both ends of the synthesized cDNA for global PCR amplification. Coupled with a whole-genome gene expression microarray platform, we routinely obtain expression correlation values of R-2 similar to 0.76-0.80 between individual cells and R-2 similar to 0.69 between 50 pg total RNA replicates. Expression profiles generated from single cells or 50 pg total RNA correlate well with that generated with higher input (1 ng total RNA) (R-2 similar to 0.80). Also, the assay is sufficiently sensitive to detect, in a single cell, approximately 63% of the number of genes detected with 1 ng input, with approximately 97% of the genes detected in the single-cell input also detected in the higher input. Conclusions/Significance: In summary, our method facilitates whole-genome gene expression profiling in contexts where starting material is extremely limiting, particularly in areas such as the study of progenitor cells in early development and tumor stem cell biology.	[Fan, Jian-Bing; Chen, Jing; April, Craig S.; Fisher, Jeffrey S.; Klotzle, Brandy; Bibikova, Marina; Kaper, Fiona; Ronaghi, Mostafa] Illumina Inc, Res & Dev, San Diego, CA 92122 USA; [Linnarsson, Sten] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden; [Ota, Takayo; Chien, Jeremy] Mayo Clin, Dept Expt Pathol, Rochester, MN USA; [Laurent, Louise C.] Univ Calif San Diego, Dept Reprod Med, San Diego, CA 92103 USA; [Laurent, Louise C.] Scripps Res Inst, Ctr Regenerat Med, La Jolla, CA 92037 USA; [Nisperos, Sean V.; Chen, Gina Y.; Zhong, Jiang F.] Univ So Calif, Dept Pathol, Los Angeles, CA 90089 USA	Illumina; Karolinska Institutet; Mayo Clinic; University of California System; University of California San Diego; Scripps Research Institute; University of Southern California	Fan, JB (corresponding author), Illumina Inc, Res & Dev, San Diego, CA 92122 USA.	jfan@illumina.com	Linnarsson, Sten/HCH-3909-2022; Chien, Jeremy/AID-8939-2022; Ota, Takayo/AAH-7095-2021; Loring, Jeanne F/A-1620-2011	Ota, Takayo/0000-0003-1630-8301; Loring, Jeanne F/0000-0001-6226-9767; Laurent, Louise/0000-0002-2095-7534; Chien, Jeremy/0000-0003-4744-8374	National Institutes of Health [K12HD001259-11, R21CA134391]; Hartwell Foundation; National Science Foundation [AW 0852720]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD001259] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R21CA134391] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hartwell Foundation; National Science Foundation(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health (K12HD001259-11) and Hartwell Foundation grants to LCL; National Institutes of Health (R21CA134391) and National Science Foundation (AW 0852720) grants to JFZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appay V, 2007, J IMMUNOL, V179, P7406, DOI 10.4049/jimmunol.179.11.7406; April C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008162; Bahar R, 2006, NATURE, V441, P1011, DOI 10.1038/nature04844; Bengtsson M, 2005, GENOME RES, V15, P1388, DOI 10.1101/gr.3820805; Brandt SP, 2005, J EXP BOT, V56, P495, DOI 10.1093/jxb/eri066; Brouzes E, 2009, P NATL ACAD SCI USA, V106, P14195, DOI 10.1073/pnas.0903542106; Che SL, 2004, LAB INVEST, V84, P131, DOI 10.1038/labinvest.3700005; Clement-Ziza M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-246; Dafforn A, 2004, BIOTECHNIQUES, V37, P854, DOI 10.2144/04375PF01; Diercks A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006326; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; Esumi S, 2008, NEUROSCI RES, V60, P439, DOI 10.1016/j.neures.2007.12.011; Froussard P, 1993, PCR Methods Appl, V2, P185, DOI 10.1101/gr.2.3.185; Gibson JD, 2009, INTEGR BIOL-UK, V1, P540, DOI 10.1039/b908276j; Gonzalez-Roca E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014418; Hartmann CH, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl740; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Irimia D, 2009, INTEGR BIOL, V1, P99, DOI 10.1039/b814329c; Islam S, 2011, GENOME RES, V21, P1160, DOI 10.1101/gr.110882.110; Jensen KB, 2006, P NATL ACAD SCI USA, V103, P11958, DOI 10.1073/pnas.0601886103; Kamme F, 2003, J NEUROSCI, V23, P3607; Kang Y, 2011, GENOME RES, V21, P925, DOI 10.1101/gr.116103.110; Kapteyn J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-413; Kiguchi K, 1998, JPN J CANCER RES, V89, P923, DOI 10.1111/j.1349-7006.1998.tb00650.x; Kim TK, 2011, P NATL ACAD SCI USA, V108, P11918, DOI 10.1073/pnas.1101223108; Koirala S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009198; Kurimoto K, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl050; Lang JE, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-326; Morris J, 2011, JOVE-J VIS EXP, DOI 10.3791/2634; Morse Alison M, 2010, J Biomol Tech, V21, P141; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Nygaard V, 2006, NUCLEIC ACIDS RES, V34, P996, DOI 10.1093/nar/gkj499; Peixoto A, 2004, GENOME RES, V14, P1938, DOI 10.1101/gr.2890204; Petalidis L, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng142; Plessy C, 2010, NAT METHODS, V7, P528, DOI [10.1038/NMETH.1470, 10.1038/nmeth.1470]; Punnoose EA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012517; Ramos CA, 2006, PLOS GENET, V2, P1487, DOI 10.1371/journal.pgen.0020159; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Schmidt W M, 1999, Nucleic Acids Res, V27, pe31, DOI 10.1093/nar/27.21.e31; Seshi B, 2003, BLOOD CELL MOL DIS, V31, P268, DOI 10.1016/S1079-9796(03)00150-5; Singh R, 2005, AM J PHYSIOL-CELL PH, V288, pC1179, DOI 10.1152/ajpcell.00258.2004; Sooknanan R, 2010, NAT METHODS, V7, pI, DOI 10.1038/nmeth.f.313; Spiess AN, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-44; Stahlberg A, 2010, METHODS, V50, P282, DOI 10.1016/j.ymeth.2010.01.002; Subkhankulova T, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r18; Talasaz AH, 2009, P NATL ACAD SCI USA, V106, P3970, DOI 10.1073/pnas.0813188106; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Warren L, 2006, P NATL ACAD SCI USA, V103, P17807, DOI 10.1073/pnas.0608512103; Zhang S, 2008, CANCER RES, V68, P4311, DOI 10.1158/0008-5472.CAN-08-0364; Zhao HJ, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-31; Zhong JF, 2008, LAB CHIP, V8, P68, DOI 10.1039/b712116d; Zhu YY, 2001, BIOTECHNIQUES, V30, P892, DOI 10.2144/01304pf02	54	23	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e30794	10.1371/journal.pone.0030794	http://dx.doi.org/10.1371/journal.pone.0030794			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347404	gold, Green Published, Green Submitted			2022-12-27	WOS:000302730100025
J	Ghotra, VPS; He, SN; de Bont, H; van der Ent, W; Spaink, HP; van de Water, B; Snaar-Jagalska, BE; Danen, EHJ				Ghotra, Veerander P. S.; He, Shuning; de Bont, Hans; van der Ent, Wietske; Spaink, Herman P.; van de Water, Bob; Snaar-Jagalska, B. Ewa; Danen, Erik H. J.			Automated Whole Animal Bio-Imaging Assay for Human Cancer Dissemination	PLOS ONE			English	Article							PROSTATE-CANCER; BREAST-TUMORS; CELL-LINES; ZEBRAFISH; MODEL; XENOGRAFTS; EXPRESSION; ADHESION; GROWTH; LNCAP	A quantitative bio-imaging platform is developed for analysis of human cancer dissemination in a short-term vertebrate xenotransplantation assay. Six days after implantation of cancer cells in zebrafish embryos, automated imaging in 96 well plates coupled to image analysis algorithms quantifies spreading throughout the host. Findings in this model correlate with behavior in long-term rodent xenograft models for panels of poorly-versus highly malignant cell lines derived from breast, colorectal, and prostate cancer. In addition, cancer cells with scattered mesenchymal characteristics show higher dissemination capacity than cell types with epithelial appearance. Moreover, RNA interference establishes the metastasis-suppressor role for E-cadherin in this model. This automated quantitative whole animal bio-imaging assay can serve as a first-line in vivo screening step in the anti-cancer drug target discovery pipeline.	[Ghotra, Veerander P. S.; de Bont, Hans; van de Water, Bob; Danen, Erik H. J.] Leiden Univ, Leiden Amsterdam Ctr Drug Res, Div Toxicol, Leiden, Netherlands; [He, Shuning; van der Ent, Wietske; Spaink, Herman P.; Snaar-Jagalska, B. Ewa] Leiden Univ, Inst Biol, Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC	Ghotra, VPS (corresponding author), Leiden Univ, Leiden Amsterdam Ctr Drug Res, Div Toxicol, Leiden, Netherlands.	b.e.snaar-jagalska@biology.leidenuniv.nl; e.danen@lacdr.leidenuniv.nl	Spaink, Herman P./S-3586-2017	Spaink, Herman P./0000-0003-4128-9501; van der Ent, Wietske/0000-0003-2165-9624; danen, erik/0000-0002-0491-6345	Dutch Cancer Society [UL-2010-4670]; EU [HEALTH-F2-2008-201439]	Dutch Cancer Society(KWF Kankerbestrijding); EU(European Commission)	This work was supported by the Dutch Cancer Society (UL-2010-4670) and EU FP7 ZF Cancer project (HEALTH-F2-2008-201439). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amatruda JF, 2008, INT REV CEL MOL BIO, V271, P1, DOI 10.1016/S1937-6448(08)01201-X; Amatruda JF, 2002, CANCER CELL, V1, P229, DOI 10.1016/S1535-6108(02)00052-1; Berghmans S, 2005, BIOTECHNOLOGY, V39, P27; Buck E, 2007, MOL CANCER THER, V6, P532, DOI 10.1158/1535-7163.MCT-06-0462; GIROLDI LA, 1993, CANCER METAST REV, V12, P29, DOI 10.1007/BF00689788; Haldi Maryann, 2006, Angiogenesis, V9, P139, DOI 10.1007/s10456-006-9040-2; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kukreja SD, 1998, CLIN EXP METASTAS, V6, P401; Lacroix M, 2004, BREAST CANCER RES TR, V83, P249, DOI 10.1023/B:BREA.0000014042.54925.cc; Lam SH, 2006, CELL CYCLE, V5, P573, DOI 10.4161/cc.5.6.2550; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Lee LMJ, 2005, DEV DYNAM, V233, P1560, DOI 10.1002/dvdy.20471; LIM DJ, 1993, PROSTATE, V22, P109, DOI 10.1002/pros.2990220203; Nicoli S, 2007, CANCER RES, V67, P2927, DOI 10.1158/0008-5472.CAN-06-4268; Rembrink K, 1997, PROSTATE, V31, P168; Ross DT, 2001, DIS MARKERS, V17, P99, DOI 10.1155/2001/850531; Stoletov K, 2007, P NATL ACAD SCI USA, V104, P17406, DOI 10.1073/pnas.0703446104; Stoletov K, 2010, J CELL SCI, V123, P2332, DOI 10.1242/jcs.069443; VANSLOOTEN HJ, 1995, BRIT J CANCER, V72, P22, DOI 10.1038/bjc.1995.271; WARE JL, 1982, J UROLOGY, V128, P1064, DOI 10.1016/S0022-5347(17)53345-5; Wu TT, 1998, INT J CANCER, V77, P887, DOI 10.1002/(SICI)1097-0215(19980911)77:6<887::AID-IJC15>3.0.CO;2-Z; Zhang LR, 1997, ONCOGENE, V15, P2093, DOI 10.1038/sj.onc.1201386; Zon LI, 2005, NAT REV DRUG DISCOV, V4, P35, DOI 10.1038/nrd1606	24	64	67	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31281	10.1371/journal.pone.0031281	http://dx.doi.org/10.1371/journal.pone.0031281			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347456	gold, Green Published, Green Submitted			2022-12-27	WOS:000302730100058
J	Sokolov, MV; Panyutin, IV; Neumann, RD				Sokolov, Mykyta V.; Panyutin, Irina V.; Neumann, Ronald D.			Unraveling the Global microRNAome Responses to Ionizing Radiation in Human Embryonic Stem Cells	PLOS ONE			English	Article							HUMAN FIBROBLASTS; INTEGRATIVE ANALYSIS; GENE-EXPRESSION; DOWN-REGULATION; CYCLE ARREST; DNA-REPAIR; TARGETS; DIFFERENTIATION; RNA; IDENTIFICATION	MicroRNAs (miRNA) comprise a group of short ribonucleic acid molecules implicated in regulation of key biological processes and functions at the post-transcriptional level. Ionizing radiation (IR) causes DNA damage and generally triggers cellular stress response. However, the role of miRNAs in IR-induced response in human embryonic stem cells (hESC) has not been defined yet. Here, by using system biology approaches, we show for the first time, that miRNAome undergoes global alterations in hESC (H1 and H9 lines) after IR. Interrogation of expression levels of 1,090 miRNA species in irradiated hESC showed statistically significant changes in 54 genes following 1 Gy of X-ray exposures; global miRNAome alterations were found to be highly temporally and cell line - dependent in hESC. Time-course studies showed that the 16 hr miRNAome radiation response of hESC is much more robust compared to 2 hr-response signature (only eight genes), and may be involved in regulating the cell cycle. Quantitative real-time PCR performed on some miRNA species confirms the robustness of our miRNA microarray platform. Positive regulation of differentiation-, cell cycle-, ion transport-and endomembrane system-related processes were predicted to be negatively affected by miRNAome changes in irradiated hESC. Our findings reveal a fundamental role of miRNAome in modulating the radiation response, and identify novel molecular targets of radiation in hESC.	[Sokolov, Mykyta V.; Panyutin, Irina V.; Neumann, Ronald D.] NIH, Ctr Clin, Div Nucl Med, Dept Radiol & Imaging Sci, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Sokolov, MV (corresponding author), NIH, Ctr Clin, Div Nucl Med, Dept Radiol & Imaging Sci, Bethesda, MD 20892 USA.	sokolovm@mail.nih.gov			National Institutes of Health, Clinical Center; CLINICAL CENTER [ZIACL060001] Funding Source: NIH RePORTER	National Institutes of Health, Clinical Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CLINICAL CENTER	This research was supported in part by the Intramural Research Program of the National Institutes of Health, Clinical Center. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi K, 2010, GENES CELLS, V15, P455, DOI 10.1111/j.1365-2443.2010.01400.x; Adams Bret R, 2010, Aging (Albany NY), V2, P582; Adams BR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010001; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bandiera S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020746; Banuelos CA, 2008, DNA REPAIR, V7, P1471, DOI 10.1016/j.dnarep.2008.05.005; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Borgdorff V, 2010, ONCOGENE, V29, P2262, DOI 10.1038/onc.2009.497; Cao H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002820; Card DAG, 2008, MOL CELL BIOL, V28, P6426, DOI 10.1128/MCB.00359-08; Cha HJ, 2009, ONCOL REP, V22, P863, DOI 10.3892/or_00000510; Cha HJ, 2009, INT J ONCOL, V34, P1661, DOI 10.3892/ijo_00000297; Chaudhry MA, 2010, DNA CELL BIOL, V29, P553, DOI 10.1089/dna.2009.0978; Chaudhry MA, 2009, CANCER BIOTHER RADIO, V24, P49, DOI 10.1089/cbr.2008.0513; Chen ZL, 2011, J BIOL CHEM, V286, P10725, DOI 10.1074/jbc.M110.165654; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Fang L, 2011, ONCOGENE, V30, P806, DOI 10.1038/onc.2010.465; Foshay KM, 2009, DEV BIOL, V326, P431, DOI 10.1016/j.ydbio.2008.11.016; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Guled M, 2009, GENE CHROMOSOME CANC, V48, P615, DOI 10.1002/gcc.20669; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Jesus ABD, 2009, CELL CYCLE, V8, P394; Ji AR, 2010, EXP MOL MED, V42, P175, DOI 10.3858/emm.2010.42.3.018; Josson S, 2008, PROSTATE, V68, P1599, DOI 10.1002/pros.20827; Kovalchuk O, 2010, CARCINOGENESIS, V31, P1882, DOI 10.1093/carcin/bgq119; Lal A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001864; Lal A, 2009, MOL CELL, V35, P610, DOI 10.1016/j.molcel.2009.08.020; Lal A, 2009, NAT STRUCT MOL BIOL, V16, P492, DOI 10.1038/nsmb.1589; Latronico MVG, 2009, NAT REV CARDIOL, V6, P418, DOI 10.1038/nrcardio.2009.56; Li YF, 2010, ONCOL REP, V24, P1443, DOI 10.3892/or_00001004; Lin RJ, 2010, MOL CARCINOGEN, V49, P719, DOI 10.1002/mc.20647; Maes OC, 2008, J CELL BIOCHEM, V105, P824, DOI 10.1002/jcb.21878; Maynard S, 2008, STEM CELLS, V26, P2266, DOI 10.1634/stemcells.2007-1041; Momcilovic O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013410; Momcilovic O, 2009, STEM CELLS, V27, P1822, DOI 10.1002/stem.123; Ni CW, 2011, AM J PHYSIOL-HEART C, V300, pH1762, DOI 10.1152/ajpheart.00829.2010; Niemoeller OM, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-29; Nikiforova MN, 2011, THYROID, V21, P261, DOI 10.1089/thy.2010.0376; Nishi H, 2010, J BIOL CHEM, V285, P4920, DOI 10.1074/jbc.M109.082610; Nurul-Syakima AM, 2011, INT J MOL MED; Nymark P, 2011, GENE CHROMOSOME CANC, V50, P585, DOI 10.1002/gcc.20880; Ofir M, 2011, MOL CANCER RES, V9, P440, DOI 10.1158/1541-7786.MCR-10-0344; Pan JA, 2010, ONCOL REP, V24, P105, DOI 10.3892/or_00000834; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Pilkinton M, 2007, J BIOL CHEM, V282, P168, DOI 10.1074/jbc.M609924200; Pizzimenti S, 2009, FREE RADICAL BIO MED, V46, P282, DOI 10.1016/j.freeradbiomed.2008.10.035; Qian S, 2008, BIOCHEM BIOPH RES CO, V377, P668, DOI 10.1016/j.bbrc.2008.10.052; Rizzo M, 2010, J CELL MOL MED, V14, P2633, DOI 10.1111/j.1582-4934.2010.01173.x; Saretzki G, 2008, STEM CELLS, V26, P455, DOI 10.1634/stemcells.2007-0628; Schmitz KJ, 2011, J CLIN PATHOL, V64, P529, DOI 10.1136/jcp.2010.085621; Shigoka M, 2010, PATHOL INT, V60, P351, DOI 10.1111/j.1440-1827.2010.02526.x; Shin S, 2009, INT J ONCOL, V35, P81, DOI 10.3892/ijo_00000315; Shin S, 2009, INT J ONCOL, V34, P1645, DOI 10.3892/ijo_00000295; Simone NL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006377; Sokolov MV, 2006, GENE, V382, P47, DOI 10.1016/j.gene.2006.06.008; Sokolov MV, 2011, MUTAT RES-FUND MOL M, V709-10, P40, DOI 10.1016/j.mrfmmm.2011.02.008; Sokolov MV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014195; Sokolov MV, 2010, GENE, V455, P8, DOI 10.1016/j.gene.2010.01.006; Sokolov MV, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-192; SS Lo, 2011, ONCOGENE; Subramanyam D, 2011, NAT BIOTECHNOL, V29, P443, DOI 10.1038/nbt.1862; Templin T., 2011, INT J RAD ONCOL BIOL; Trompeter HI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016138; Van Hoof D, 2009, CELL STEM CELL, V5, P214, DOI 10.1016/j.stem.2009.05.021; Vincenti S, 2011, RAD RES; Wagner-Ecker M, 2010, RADIAT ONCOL, V5, DOI 10.1186/1748-717X-5-25; Wei GW, 2010, INT J BIOMED IMAGING, V2010, DOI 10.1155/2010/918467; Williams AE, 2008, CELL MOL LIFE SCI, V65, P545, DOI 10.1007/s00018-007-7355-9; Wright GW, 2003, BIOINFORMATICS, V19, P2448, DOI 10.1093/bioinformatics/btg345; Xia L, 2008, INT J CANCER, V123, P372, DOI 10.1002/ijc.23501; Yao Y, 2009, MOL MED REP, V2, P963, DOI 10.3892/mmr_00000199; Zhao JJ, 2009, CHILD NERV SYST, V25, P13, DOI 10.1007/s00381-008-0701-x	75	26	26	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31028	10.1371/journal.pone.0031028	http://dx.doi.org/10.1371/journal.pone.0031028			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347422	Green Submitted, Green Published, gold			2022-12-27	WOS:000302730100033
J	Metges, CC; Lang, IS; Hennig, U; Brussow, KP; Kanitz, E; Tuchscherer, M; Schneider, F; Weitzel, JM; Steinhoff-Ooster, A; Sauerwein, H; Bellmann, O; Nurnberg, G; Rehfeldt, C; Otten, W				Metges, Cornelia C.; Lang, Iris S.; Hennig, Ulf; Bruessow, Klaus-Peter; Kanitz, Ellen; Tuchscherer, Margret; Schneider, Falk; Weitzel, Joachim M.; Steinhoff-Ooster, Anika; Sauerwein, Helga; Bellmann, Olaf; Nuernberg, Gerd; Rehfeldt, Charlotte; Otten, Winfried			Intrauterine Growth Retarded Progeny of Pregnant Sows Fed High Protein:Low Carbohydrate Diet Is Related to Metabolic Energy Deficit	PLOS ONE			English	Article							WEIGHT-LOSS; LIPOPROTEIN CHOLESTEROL; COMPOSITIONAL TRAITS; STEROL-METABOLISM; BODY-COMPOSITION; GENE-EXPRESSION; EARLY GESTATION; CORTISOL; TRYPTOPHAN; PLASMA	High and low protein diets fed to pregnant adolescent sows led to intrauterine growth retardation (IUGR). To explore underlying mechanisms, sow plasma metabolite and hormone concentrations were analyzed during different pregnancy stages and correlated with litter weight (LW) at birth, sow body weight and back fat thickness. Sows were fed diets with low (6.5%, LP), adequate (12.1%, AP), and high (30%, HP) protein levels, made isoenergetic by adjusted carbohydrate content. At -5, 24, 66, and 108 days post coitum (dpc) fasted blood was collected. At 92 dpc, diurnal metabolic profiles were determined. Fasted serum urea and plasma glucagon were higher due to the HP diet. High density lipoprotein cholesterol (HDLC), %HDLC and cortisol were reduced in HP compared with AP sows. Lowest concentrations were observed for serum urea and protein, plasma insulin-like growth factor-I, low density lipoprotein cholesterol, and progesterone in LP compared with AP and HP sows. Fasted plasma glucose, insulin and leptin concentrations were unchanged. Diurnal metabolic profiles showed lower glucose in HP sows whereas non-esterified fatty acids (NEFA) concentrations were higher in HP compared with AP and LP sows. In HP and LP sows, urea concentrations were 300% and 60% of AP sows, respectively. Plasma total cholesterol was higher in LP than in AP and HP sows. In AP sows, LW correlated positively with insulin and insulin/glucose and negatively with glucagon/insulin at 66 dpc, whereas in HP sows LW associated positively with NEFA. In conclusion, IUGR in sows fed high protein:low carbohydrate diet was probably due to glucose and energy deficit whereas in sows with low protein:high carbohydrate diet it was possibly a response to a deficit of indispensable amino acids which impaired lipoprotein metabolism and favored maternal lipid disposal.	[Metges, Cornelia C.; Lang, Iris S.; Hennig, Ulf] Leibniz Inst Farm Anim Biol FBN, Res Unit Nutr Physiol Oskar Kellner, Dummerstorf, Germany; [Bruessow, Klaus-Peter; Schneider, Falk; Weitzel, Joachim M.] Leibniz Inst Farm Anim Biol FBN, Res Unit Reprod Biol, Dummerstorf, Germany; [Kanitz, Ellen; Tuchscherer, Margret; Otten, Winfried] Leibniz Inst Farm Anim Biol FBN, Res Unit Behav Physiol, Dummerstorf, Germany; [Steinhoff-Ooster, Anika; Sauerwein, Helga] Univ Bonn, Inst Anim Sci, Physiol & Hyg Unit, Bonn, Germany; [Nuernberg, Gerd] Leibniz Inst Farm Anim Biol FBN, Res Unit Genet & Biometry, Dummerstorf, Germany; [Rehfeldt, Charlotte] Leibniz Inst Farm Anim Biol FBN, Res Unit Muscle Biol & Growth, Dummerstorf, Germany	Forschungsinstitut fur Nutztierbiologie (FBN); Forschungsinstitut fur Nutztierbiologie (FBN); Forschungsinstitut fur Nutztierbiologie (FBN); University of Bonn; Forschungsinstitut fur Nutztierbiologie (FBN); Forschungsinstitut fur Nutztierbiologie (FBN)	Metges, CC (corresponding author), Leibniz Inst Farm Anim Biol FBN, Res Unit Nutr Physiol Oskar Kellner, Dummerstorf, Germany.	otten@fbn-dummerstorf.de	Sauerwein, Helga/R-8242-2019; Otten, Winfried/V-8376-2019	Otten, Winfried/0000-0002-5613-5356; Weitzel, Joachim/0000-0002-4073-6691	Deutsche Forschungsgemeinschaft [ME 1420/8-1, OT137/3-1, PAK 24]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Supported by the Deutsche Forschungsgemeinschaft (www.dfg.de; grant numbers: ME 1420/8-1;OT137/3-1; PAK 24). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown KR, 2007, J ANIM SCI, V85, P1687, DOI 10.2527/jas.2006-569; Christian P, 2009, NESTLE NUTR WORKS SE, V63, P59, DOI 10.1159/000209973; Divino JC, 1999, AM J PHYSIOL-ENDOC M, V277, pE693, DOI 10.1152/ajpendo.1999.277.4.E693; El Khattabi I, 2003, AM J PHYSIOL-ENDOC M, V285, pE991, DOI 10.1152/ajpendo.00037.2003; Fernandez-Twinn DS, 2003, BRIT J NUTR, V90, P815, DOI 10.1079/BJN2003967; Firk C, 2009, CLIN NUTR, V28, P266, DOI 10.1016/j.clnu.2009.03.002; Gardner D. K., 2004, Reproduction Fertility and Development, V16, P190, DOI 10.1071/RDv16n1Ab136; GfE (Gesellschaft fur Erna hrungsphysiologie), 2006, EMPF EN NAHRST SCHW; Govoni N, 2007, REPROD DOMEST ANIM, V42, P39, DOI 10.1111/j.1439-0531.2006.00722.x; GRUMMER RR, 1988, J ANIM SCI, V66, P3160; Guzik AC, 2006, J ANIM SCI, V84, P2251, DOI 10.2527/jas.2005-292; Halton TL, 2004, J AM COLL NUTR, V23, P373, DOI 10.1080/07315724.2004.10719381; Henson MC, 2006, BIOL REPROD, V74, P218, DOI 10.1095/biolreprod.105.045120; Jackson AA, 2001, AM J PHYSIOL-GASTR L, V281, pG1179, DOI 10.1152/ajpgi.2001.281.5.G1179; Jahoor F, 1996, J NUTR, V126, P1489, DOI 10.1093/jn/126.5.1489; Jia Y, 2010, J NUTR, V140, P1646, DOI 10.3945/jn.110.123034; Jindal R, 1997, J ANIM SCI, V75, P1063; Kalhan S C, 1999, Curr Opin Clin Nutr Metab Care, V2, P359, DOI 10.1097/00075197-199909000-00001; Kanitz E, 2009, PHYSIOL BEHAV, V98, P176, DOI 10.1016/j.physbeh.2009.05.007; Koopmans SJ, 2006, J ANIM SCI, V84, P963, DOI 10.2527/2006.844963x; Koopmans SJ, 2005, PHYSIOL BEHAV, V85, P469, DOI 10.1016/j.physbeh.2005.05.010; Kucia M, 2011, ANIMAL, V5, P268, DOI 10.1017/S1751731110001734; Lacroix M, 2004, AM J PHYSIOL-REG I, V287, pR934, DOI 10.1152/ajpregu.00100.2004; Lane M, 2003, BIOL REPROD, V69, P1109, DOI 10.1095/biolreprod.103.018093; Langley-Evans SC, 2001, P NUTR SOC, V60, P505, DOI 10.1079/PNS2001111; Markus CR, 2000, AM J CLIN NUTR, V71, P1536; Martens MJI, 2010, PHYSIOL BEHAV, V101, P563, DOI 10.1016/j.physbeh.2010.09.007; McConihay JA, 2000, J LIPID RES, V41, P424; McConihay JA, 2001, J LIPID RES, V42, P1111; McPherson RL, 2004, J ANIM SCI, V82, P2534; Meza-Herrera CA, 2010, REPROD DOMEST ANIM, V45, P723, DOI 10.1111/j.1439-0531.2009.01341.x; Mooradian AD, 2006, ENDOCR REV, V27, P2, DOI 10.1210/er.2005-0013; Musser RE, 2004, J ANIM SCI, V82, P3154; Nissen PM, 2005, ANIM SCI, V80, P299, DOI 10.1079/ASC40700299; Noakes M, 2005, AM J CLIN NUTR, V81, P1298; Nordmann AJ, 2006, ARCH INTERN MED, V166, P285, DOI 10.1001/archinte.166.3.285; Okereke NC, 2004, AM J PHYSIOL-ENDOC M, V287, pE472, DOI 10.1152/ajpendo.00589.2003; Peters JC, 2008, J ANIM SCI, V86, P2247, DOI 10.2527/jas.2007-0431; Rehfeldt C, 2011, J ANIM SCI, V89, P329, DOI 10.2527/jas.2010-2970; Rehfeldt C, 2001, J ANIM SCI, V79, P1789; Rehfeldt C, 2012, EUR J NUTR, V51, P151, DOI 10.1007/s00394-011-0201-8; REMESY C, 1988, J NUTR, V118, P569, DOI 10.1093/jn/118.5.569; ROBERTSON HA, 1974, J REPROD FERTIL, V40, P133, DOI 10.1530/jrf.0.0400133; RODRIGUEZ H, 1983, ACTA VET SCAND, V24, P318; Sauerwein H, 2004, LIVEST PROD SCI, V87, P189, DOI 10.1016/j.livprodsci.2003.08.001; Schneider F, 2006, REPROD FERT DEVELOP, V18, P857, DOI 10.1071/RD06027; SCHOLL TO, 1994, AM J CLIN NUTR, V60, P183, DOI 10.1093/ajcn/60.2.183; Sferruzzi-Perri AN, 2011, J PHYSIOL-LONDON, V589, P7, DOI 10.1113/jphysiol.2010.198622; Spurlock ME, 2008, J NUTR, V138, P397, DOI 10.1093/jn/138.2.397; Stepien M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014664; Stepien M, 2010, J NUTR, V140, P939, DOI 10.3945/jn.109.120139; Toscano MJ, 2007, J ANIM SCI, V85, P441, DOI 10.2527/jas.2006-316; Wallace J, 2001, REPRODUCTION, V122, P347, DOI 10.1530/rep.0.1220347; Wallace JM, 2006, PLACENTA, V27, pS61, DOI 10.1016/j.placenta.2005.12.002; Wallace JM, 2010, BIOL REPROD, V82, P320, DOI 10.1095/biolreprod.109.080069; Wiseman TG, 2007, J ANIM SCI, V85, P1816, DOI 10.2527/jas.2006-406	56	35	37	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2012	7	2							e31390	10.1371/journal.pone.0031390	http://dx.doi.org/10.1371/journal.pone.0031390			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LV	22328932	gold, Green Published, Green Submitted			2022-12-27	WOS:000302179300018
J	Wang, JJ; Wang, AN; Han, ZJ; Zhang, Z; Li, F; Li, XC				Wang, Jianjun; Wang, Aina; Han, Zhaojun; Zhang, Zan; Li, Fei; Li, Xianchun			Characterization of Three Novel SINE Families with Unusual Features in Helicoverpa armigera	PLOS ONE			English	Article							DNA-SEQUENCE FAMILY; TRANSPOSABLE ELEMENTS; RNA; GENOME; GENES; MOSQUITO; LINES; RETROTRANSPOSONS; IDENTIFICATION; SUPERFAMILY	Although more than 120 families of short interspersed nuclear elements (SINEs) have been isolated from the eukaryotic genomes, little is known about SINEs in insects. Here, we characterize three novel SINEs from the cotton bollworm, Helicoverpa armigera. Two of them, HaSE1 and HaSE2, share similar 5'-structure including a tRNA-related region immediately followed by conserved central domain. The 3'-tail of HaSE1 is significantly similar to that of one LINE retrotransposon element, HaRTE1.1, in H. armigera genome. The 3'-region of HaSE2 showed high identity with one mariner-like element in H. armigera. The third family, termed HaSE3, is a 5S rRNA-derived SINE and shares both body part and 3'-tail with HaSE1, thus may represent the first example of a chimera generated by recombination between 5S rRNA and tRNA-derived SINE in insect species. Further database searches revealed the presence of these SINEs in several other related insect species, but not in the silkworm, Bombyx mori, indicating a relatively narrow distribution of these SINEs in Lepidopterans. Apart from above, we found a copy of HaSE2 in the GenBank EST entry for the cotton aphid, Aphis gossypii, suggesting the occurrence of horizontal transfer.	[Wang, Jianjun; Wang, Aina] Yangzhou Univ, Coll Hort & Plant Protect, Yangzhou, Peoples R China; [Li, Xianchun] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA; [Li, Xianchun] Univ Arizona, Inst BIO5, Tucson, AZ USA; [Han, Zhaojun; Zhang, Zan; Li, Fei] Nanjing Agr Univ, Coll Plant Protect, Nanjing, Jiangsu, Peoples R China	Yangzhou University; University of Arizona; University of Arizona; Nanjing Agricultural University	Wang, JJ (corresponding author), Yangzhou Univ, Coll Hort & Plant Protect, Yangzhou, Peoples R China.	wangjj@yzu.edu.cn; lxc@email.arizona.edu	Li, Fei/B-3687-2012	Li, Fei/0000-0002-8410-5250	National Natural Science Foundation of China [30871642]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant 30871642 to JW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS DS, 1986, J MOL BIOL, V187, P465, DOI 10.1016/0022-2836(86)90327-X; Akasaki T, 2010, GENE, V454, P8, DOI 10.1016/j.gene.2009.11.005; Behere GT, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-117; Betley JN, 2002, CURR BIOL, V12, P1756, DOI 10.1016/S0960-9822(02)01220-4; BRADFIELD JY, 1985, DNA-J MOLEC CELL BIO, V4, P357, DOI 10.1089/dna.1985.4.357; Brosius J, 1999, GENE, V238, P115, DOI 10.1016/S0378-1119(99)00227-9; Buzdin A, 2003, NUCLEIC ACIDS RES, V31, P4385, DOI 10.1093/nar/gkg496; Buzdin AA, 2004, CELL MOL LIFE SCI, V61, P2046, DOI 10.1007/s00018-004-4041-z; Chen S, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-46; d'Alencon E, 2010, P NATL ACAD SCI USA, V107, P7680, DOI 10.1073/pnas.0910413107; Deininger PL, 2003, CURR OPIN GENET DEV, V13, P651, DOI 10.1016/j.gde.2003.10.013; Dewannieux M, 2003, NAT GENET, V35, P41, DOI 10.1038/ng1223; Feschotte C, 2001, MOL BIOL EVOL, V18, P74, DOI 10.1093/oxfordjournals.molbev.a003721; Feyereisen R, 2006, BIOCHEM SOC T, V34, P1252, DOI 10.1042/BST0341252; Gilbert N, 1999, P NATL ACAD SCI USA, V96, P2869, DOI 10.1073/pnas.96.6.2869; Gogolevsky KP, 2008, GENE, V407, P75, DOI 10.1016/j.gene.2007.09.021; Gogolevsky KP, 2009, GENOMICS, V93, P494, DOI 10.1016/j.ygeno.2009.02.001; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jurka J, 2010, REPBASE REPORTS, V10, P1055; Kajikawa M, 2002, CELL, V111, P433, DOI 10.1016/S0092-8674(02)01041-3; Kapitonov V., 2007, REPBASE REP, V7, P1180; Kapitonov VV, 2003, MOL BIOL EVOL, V20, P694, DOI 10.1093/molbev/msg075; Kosushkin SA, 2006, MOL BIOL+, V40, P378; Kramerov DA, 2005, INT REV CYTOL, V247, P165, DOI 10.1016/S0074-7696(05)47004-7; Kramerov DA, 2011, WIRES RNA, V2, P772, DOI 10.1002/wrna.91; Krull M, 2005, MOL BIOL EVOL, V22, P1702, DOI 10.1093/molbev/msi164; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Loytynoja A, 2001, BIOINFORMATICS, V17, P573, DOI 10.1093/bioinformatics/17.6.573; Luchetti A, 2005, DNA SEQUENCE, V16, P304, DOI 10.1080/10425170500061467; Luchetti A, 2011, MOL GENET GENOMICS, V285, P175, DOI 10.1007/s00438-010-0595-7; Luchetti A, 2009, J MOL EVOL, V69, P589, DOI 10.1007/s00239-009-9285-7; Matveev V, 2007, MOL BIOL EVOL, V24, P1656, DOI 10.1093/molbev/msm083; Melamed P, 2004, NAT GENET, V36, P786, DOI 10.1038/ng0804-786; Nishihara H, 2002, MOL BIOL EVOL, V19, P1964, DOI 10.1093/oxfordjournals.molbev.a004020; Nishihara H, 2006, GENOME RES, V16, P864, DOI 10.1101/gr.5255506; Ogiwara I, 2002, GENOME RES, V12, P316, DOI 10.1101/gr.212302; Ohshima K, 2005, CYTOGENET GENOME RES, V110, P475, DOI 10.1159/000084981; Piskurek O, 2007, P NATL ACAD SCI USA, V104, P12046, DOI 10.1073/pnas.0700531104; Santolamazza F, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-163; Schmitz J, 2004, GENOME RES, V14, P1911, DOI 10.1101/gr.2720104; Shedlock AM, 2000, BIOESSAYS, V22, P148, DOI 10.1002/(SICI)1521-1878(200002)22:2&lt;148::AID-BIES6&gt;3.0.CO;2-Z; Sorek R, 2002, GENOME RES, V12, P1060, DOI 10.1101/gr.229302; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tay WT, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-144; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tu ZJ, 1999, MOL BIOL EVOL, V16, P760, DOI 10.1093/oxfordjournals.molbev.a026161; ULLU E, 1984, NATURE, V312, P171, DOI 10.1038/312171a0; Vassetzky NS, 2003, GENE, V319, P149, DOI 10.1016/S0378-1119(03)00805-9; Volff JN, 2006, BIOESSAYS, V28, P913, DOI 10.1002/bies.20452; Wang J, 2005, INSECT MOL BIOL, V14, P547, DOI 10.1111/j.1365-2583.2005.00585.x; Wang JJ, 2011, INSECT SCI, V18, P619, DOI 10.1111/j.1744-7917.2010.01389.x; Weiner AM, 2002, CURR OPIN CELL BIOL, V14, P343, DOI 10.1016/S0955-0674(02)00338-1; WEINER AM, 1980, CELL, V22, P209, DOI 10.1016/0092-8674(80)90169-5; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Xu JS, 2010, J GENET GENOMICS, V37, P125, DOI 10.1016/S1673-8527(09)60031-X; Yue Li-Na, 2007, Acta Entomologica Sinica, V50, P234	57	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e31355	10.1371/journal.pone.0031355	http://dx.doi.org/10.1371/journal.pone.0031355			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LO	22319625	Green Submitted, gold, Green Published			2022-12-27	WOS:000302178400037
J	Cruchaga, C; Chakraverty, S; Mayo, K; Vallania, FLM; Mitra, RD; Faber, K; Williamson, J; Bird, T; Diaz-Arrastia, R; Foroud, TM; Boeve, BF; Graff-Radford, NR; Jean, PS; Lawson, M; Ehm, MG; Mayeux, R; Goate, AM				Cruchaga, Carlos; Chakraverty, Sumitra; Mayo, Kevin; Vallania, Francesco L. M.; Mitra, Robi D.; Faber, Kelley; Williamson, Jennifer; Bird, Tom; Diaz-Arrastia, Ramon; Foroud, Tatiana M.; Boeve, Bradley F.; Graff-Radford, Neill R.; Jean, Pamela St.; Lawson, Michael; Ehm, Margaret G.; Mayeux, Richard; Goate, Alison M.		NIA-LOAD NCRAD Family Study Consor	Rare Variants in APP, PSEN1 and PSEN2 Increase Risk for AD in Late-Onset Alzheimer's Disease Families	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; FRONTOTEMPORAL DEMENTIA; PROGRANULIN MUTATIONS; IDENTIFIES VARIANTS; PRECURSOR PROTEIN; COMMON VARIANTS; GENE MUTATION; PRESENILIN 2; PHENOTYPE; FOUNDER	Pathogenic mutations in APP, PSEN1, PSEN2, MAPT and GRN have previously been linked to familial early onset forms of dementia. Mutation screening in these genes has been performed in either very small series or in single families with late onset AD (LOAD). Similarly, studies in single families have reported mutations in MAPT and GRN associated with clinical AD but no systematic screen of a large dataset has been performed to determine how frequently this occurs. We report sequence data for 439 probands from late-onset AD families with a history of four or more affected individuals. Sixty sequenced individuals (13.7%) carried a novel or pathogenic mutation. Eight pathogenic variants, (one each in APP and MAPT, two in PSEN1 and four in GRN) three of which are novel, were found in 14 samples. Thirteen additional variants, present in 23 families, did not segregate with disease, but the frequency of these variants is higher in AD cases than controls, indicating that these variants may also modify risk for disease. The frequency of rare variants in these genes in this series is significantly higher than in the 1,000 genome project (p = 5.09 x 10(-5); OR = 2.21; 95%CI = 1.49-3.28) or an unselected population of 12,481 samples (p = 6.82 x 10(-5); OR = 2.19; 95%CI = 1.347-3.26). Rare coding variants in APP, PSEN1 and PSEN2, increase risk for or cause late onset AD. The presence of variants in these genes in LOAD and early-onset AD demonstrates that factors other than the mutation can impact the age at onset and penetrance of at least some variants associated with AD. MAPT and GRN mutations can be found in clinical series of AD most likely due to misdiagnosis. This study clearly demonstrates that rare variants in these genes could explain an important proportion of genetic heritability of AD, which is not detected by GWAS.	[Cruchaga, Carlos; Chakraverty, Sumitra; Mayo, Kevin; Goate, Alison M.] Washington Univ, Dept Psychiat, St Louis, MO 63130 USA; [Cruchaga, Carlos; Chakraverty, Sumitra; Mayo, Kevin; Goate, Alison M.] Washington Univ, Hope Ctr Program Prot Aggregat & Neurodegenerat, St Louis, MO USA; [Vallania, Francesco L. M.; Mitra, Robi D.; Goate, Alison M.] Washington Univ, Dept Genet, St Louis, MO 63110 USA; [Faber, Kelley; Foroud, Tatiana M.] Indiana Univ, Dept Med & Mol Genet, Indianapolis, IN 46204 USA; [Williamson, Jennifer; Mayeux, Richard] Columbia Univ Coll Phys & Surg, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10032 USA; [Bird, Tom] Univ Washington, VA Med Ctr, Seattle, WA 98195 USA; [Bird, Tom] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Bird, Tom] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Diaz-Arrastia, Ramon] Univ Texas SW Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA; [Boeve, Bradley F.] Mayo Clin, Dept Neurol, Rochester, MN USA; [Graff-Radford, Neill R.] Mayo Clin, Dept Neurol, Jacksonville, FL 32224 USA; [Jean, Pamela St.; Lawson, Michael; Ehm, Margaret G.] GlaxoSmithKline Inc, Genet, Res Triangle Pk, NC USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Indiana University System; Indiana University-Purdue University Indianapolis; Columbia University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Texas System; University of Texas Southwestern Medical Center Dallas; Mayo Clinic; Mayo Clinic; GlaxoSmithKline	Cruchaga, C (corresponding author), Washington Univ, Dept Psychiat, St Louis, MO 63130 USA.	cruchagc@psychiatry.wustl.edu; goatea@psychiatry.wustl.edu	Cruchaga, Carlos/ABF-4065-2020; Mayeux, Richard/E-9788-2013	Cruchaga, Carlos/0000-0002-0276-2899; Mayeux, Richard/0000-0001-6519-9696; Diaz-Arrastia, Ramon/0000-0001-6051-3594; DeKosky, Steven/0000-0003-3743-2758; Haller, Gabriel/0000-0002-3884-5776; Goate, Alison/0000-0002-0576-2472	NIA-LOAD/NCRAD Family Study Consortium [U24 AG026395]; NIH [AG16208, AG035083, P01AG03991, P50AG05681, P01AG026276, 1P30NS069329-01]; Barnes-Jewish Hospital Foundation; Department of Veterans Affairs; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS069329] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U24AG026395, R37AG015473, R01AG035083, P30AG013846, P01AG026276, P50AG008702, P50AG005681, R01AG041797, P01AG003991, U24AG021886, R01AG016208] Funding Source: NIH RePORTER	NIA-LOAD/NCRAD Family Study Consortium; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Barnes-Jewish Hospital Foundation; Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by federal grants U24 AG026395 "NIA-LOAD/NCRAD Family Study Consortium." This work was supported by grants from NIH (AG16208, AG035083, P01AG03991, P50AG05681, P01AG026276 and 1P30NS069329-01), the Barnes-Jewish Hospital Foundation, the Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; [Anonymous], EXOME VARIANT SERVER; Arango D, 2001, AM J MED GENET, V103, P138, DOI 10.1002/1096-8628(20011001)103:2<138::AID-AJMG1529>3.0.CO;2-8; Athan ES, 2001, JAMA-J AM MED ASSOC, V286, P2257, DOI 10.1001/jama.286.18.2257; Azzopardi D, 2008, CANCER RES, V68, P358, DOI 10.1158/0008-5472.CAN-07-5733; Bernardi L, 2009, NEUROBIOL AGING, V30, P1825, DOI 10.1016/j.neurobiolaging.2008.01.005; Brickell KL, 2007, J NEUROL NEUROSUR PS, V78, P1050, DOI 10.1136/jnnp.2006.113803; Brouwers N, 2007, ARCH NEUROL-CHICAGO, V64, P1436, DOI 10.1001/archneur.64.10.1436; BRUNAK S, 1991, J MOL BIOL, V220, P49, DOI 10.1016/0022-2836(91)90380-O; Cortini F, 2008, EUR J NEUROL, V15, P1111, DOI 10.1111/j.1468-1331.2008.02266.x; Cruts M, 1998, HUM MOL GENET, V7, P43, DOI 10.1093/hmg/7.1.43; de Silva R, 2001, NEUROSCI LETT, V311, P145, DOI 10.1016/S0304-3940(01)02109-7; Devi G, 2000, ARCH NEUROL-CHICAGO, V57, P1454, DOI 10.1001/archneur.57.10.1454; Druley TE, 2009, NAT METHODS, V6, P263, DOI [10.1038/NMETH.1307, 10.1038/nmeth.1307]; Ertekin-Taner N, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt26; Foster NL, 2007, BRAIN, V130, P2616, DOI 10.1093/brain/awm177; Gass J, 2006, HUM MOL GENET, V15, P2988, DOI 10.1093/hmg/ddl241; Gatz M, 2006, ARCH GEN PSYCHIAT, V63, P168, DOI 10.1001/archpsyc.63.2.168; Genin E, 2011, MOL PSYCHIAT; Gerrish A, 2011, J ALZHEIMERS DIS; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; HOULDEN H, 1993, NEUROSCI LETT, V154, P161, DOI 10.1016/0304-3940(93)90196-R; Huey ED, 2006, ANN NEUROL, V60, P374, DOI 10.1002/ana.20969; Jayadev S, 2010, BRAIN, V133, P1143, DOI 10.1093/brain/awq033; Kamboh MI, 1999, NEUROSCI LETT, V263, P129, DOI 10.1016/S0304-3940(99)00129-9; KAMINO K, 1992, AM J HUM GENET, V51, P998; Kauwe JSK, 2007, ANN NEUROL, V61, P446, DOI 10.1002/ana.21099; Kelley BJ, 2010, ARCH NEUROL-CHICAGO, V67, P171, DOI 10.1001/archneurol.2010.113; Kim M, 2009, HUM MOL GENET, V18, P3987, DOI 10.1093/hmg/ddp323; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Larner AJ, 2007, J NEUROL SCI, V252, P173, DOI 10.1016/j.jns.2006.11.013; Le Ber I, 2007, HUM MUTAT, V28, P846, DOI 10.1002/humu.20520; Lindquist SG, 2008, EUR J NEUROL, V15, P377, DOI 10.1111/j.1468-1331.2008.02069.x; Llado A, 2010, EUR J NEUROL, V17, P994, DOI 10.1111/j.1468-1331.2010.02949.x; Ludolph AC, 2009, EUR J NEUROL, V16, P297, DOI 10.1111/j.1468-1331.2008.02513.x; Ma X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001318; Marcon G, 2009, J ALZHEIMERS DIS, V16, P509, DOI 10.3233/JAD-2009-0986; Masson E, 2008, HUM GENET, V123, P83, DOI 10.1007/s00439-007-0459-3; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mendez Mario F, 2006, Am J Alzheimers Dis Other Demen, V21, P281, DOI 10.1177/1533317506290448; Mesulam M, 2007, ARCH NEUROL-CHICAGO, V64, P43, DOI 10.1001/archneur.64.1.43; Momeni P, 2009, NEUROBIOL AGING, V30, P388, DOI 10.1016/j.neurobiolaging.2007.07.013; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Pickering-Brown SM, 2006, BRAIN, V129, P3124, DOI 10.1093/brain/awl289; Rademakers R, 2003, HUM MUTAT, V22, P409, DOI 10.1002/humu.10269; Rademakers R, 2007, LANCET NEUROL, V6, P857, DOI 10.1016/S1474-4422(07)70221-1; Reed LA, 1997, ANN NEUROL, V42, P564, DOI 10.1002/ana.410420406; Rogaeva EA, 2001, NEUROLOGY, V57, P621, DOI 10.1212/WNL.57.4.621; Rossor MN, 1996, LANCET, V347, P1560, DOI 10.1016/S0140-6736(96)90715-1; Scacchi R, 2007, NEUROSCI LETT, V418, P282, DOI 10.1016/j.neulet.2007.03.035; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; Silverman JM, 2005, ARCH GEN PSYCHIAT, V62, P565, DOI 10.1001/archpsyc.62.5.565; Silverman JM, 2003, ARCH GEN PSYCHIAT, V60, P190, DOI 10.1001/archpsyc.60.2.190; So HC, 2011, GENET EPIDEMIOL, V35, P310, DOI 10.1002/gepi.20579; SPINA S, 2007, NEUROLOGY; Taddei K, 2002, MOL PSYCHIATR, V7, P776, DOI 10.1038/sj.mp.4001072; TANZI RE, 1992, AM J HUM GENET, V51, P273; The AlzGene Database, ALZGENE DAT; Tomaino C, 2007, J NEUROL, V254, P391, DOI 10.1007/s00415-006-0373-y; Vallania FLM, 2010, GENOME RES, V20, P1711, DOI 10.1101/gr.109157.110; Van Deerlin VM, 2007, ARCH NEUROL-CHICAGO, V64, P1148, DOI 10.1001/archneur.64.8.1148; Wijsman EM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001308; Yu CE, 2010, ARCH NEUROL-CHICAGO, V67, P161, DOI 10.1001/archneurol.2009.328	66	208	212	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2012	7	2							e31039	10.1371/journal.pone.0031039	http://dx.doi.org/10.1371/journal.pone.0031039			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UG	22312439	Green Published, gold, Green Submitted			2022-12-27	WOS:000301977500027
J	Hosoda, Y; Sasaki, N; Kameda, Y; Torigoe, D; Agui, T				Hosoda, Yayoi; Sasaki, Nobuya; Kameda, Yayoi; Torigoe, Daisuke; Agui, Takashi			Identifying Quantitative Trait Loci Affecting Resistance to Congenital Hypothyroidism in 129(+Ter)/SvJcl Strain Mice	PLOS ONE			English	Article							TRANSCRIPTIONAL REPRESSOR DREAM; GLYCOPROTEIN HORMONE-RECEPTORS; THYROID DYSGENESIS; MISSENSE MUTATION; GENE-EXPRESSION; MOUSE; GLAND; IMPAIRMENT; RELATIVES; DWARFISM	Tyrosylprotein sulfotransferase 2 (TPST2) is one of the enzymes responsible for tyrosine O-sulfation and catalyzes the sulfation of the specific tyrosine residue of thyroid stimulating hormone receptor (TSHR). Since this modification is indispensable for the activation of TSH signaling, a non-functional TPST2 mutation (Tpst2(grt)) in DW/J-grt mice leads to congenital hypothyroidism (CH) characterized by severe thyroid hypoplasia and dwarfism related to TSH hyporesponsiveness. Previous studies indicated that the genetic background of the 129(+Ter)/SvJcl (129) mouse strain ameliorates Tpst2(grt)-induced CH. To identify loci responsible for CH resistance in 129 mice, we performed quantitative trait locus (QTL) analysis using backcross progenies from susceptible DW/J and resistant 129 mice. We used the first principal component calculated from body weights at 5, 8 and 10 weeks as an indicator of CH, and QTL analysis mapped a major QTL showing a highly significant linkage to the distal portion of chromosome (Chr) 2; between D2Mit62 and D2Mit304, particularly close to D2Mit255. In addition, two male-specific QTLs showing statistically suggestive linkage were also detected on Chrs 4 and 18, respectively. All QTL alleles derived from the 129 strain increased resistance to growth retardation. There was also a positive correlation between recovery from thyroid hypoplasia and the presence of the 129 allele at D2Mit255 in male progenies. These results suggested that the major QTL on Chr 2 is involved in thyroid development. Moreover, since DW/J congenic strain mice carrying both a Tpst2(grt) mutation and 129 alleles in the major QTL show resistance to dwarfism and thyroid hypoplasia, we confirmed the presence of the resistant gene in this region, and that it is involved in thyroid development. Further genetical analysis should lead to identification of genes for CH tolerance and, from a better understanding of thyroid organogenesis and function, the subsequent development of new treatments for thyroid disorders.	[Hosoda, Yayoi; Sasaki, Nobuya; Kameda, Yayoi; Torigoe, Daisuke; Agui, Takashi] Hokkaido Univ, Lab Lab Anim Sci & Med, Dept Dis Control, Grad Sch Vet Med, Sapporo, Hokkaido, Japan	Hokkaido University	Hosoda, Y (corresponding author), Hokkaido Univ, Lab Lab Anim Sci & Med, Dept Dis Control, Grad Sch Vet Med, Sapporo, Hokkaido, Japan.	nobsasa@vetmed.hokudai.ac.jp	Sasaki, Nobuya/F-6579-2012		Ministry of Education, Culture, Sports, Science and Technology, KAKENHI [18500323]; Japan Society for the promotion of Science, KAKENHI [09J05638]; Kurata Memorial Hitachi Science and Technology Foundation	Ministry of Education, Culture, Sports, Science and Technology, KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Society for the promotion of Science, KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Kurata Memorial Hitachi Science and Technology Foundation	This work was supported by the Ministry of Education, Culture, Sports, Science and Technology, Grant-in-Aid for Scientific Research, KAKENHI (18500323) to NS; Japan Society for the promotion of Science, KAKENHI (09J05638) to YH; and the Kurata Memorial Hitachi Science and Technology Foundation to NS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amendola E, 2005, ENDOCRINOLOGY, V146, P5038, DOI 10.1210/en.2005-0882; Amendola E, 2010, ENDOCRINOLOGY, V151, P1948, DOI 10.1210/en.2009-1240; Bonomi M, 2006, MOL ENDOCRINOL, V20, P3351, DOI 10.1210/me.2005-0521; Carrion AM, 1999, NATURE, V398, P80, DOI 10.1038/18044; Castanet M, 2005, EUR J HUM GENET, V13, P232, DOI 10.1038/sj.ejhg.5201321; Castanet M, 2010, HORM RES PAEDIAT, V73, P231, DOI 10.1159/000284386; Cheng JM, 2002, NAGOYA MED J, V45, P133; Costagliola S, 2002, EMBO J, V21, P504, DOI 10.1093/emboj/21.4.504; D'Andrea B, 2005, EXP CELL RES, V305, P166, DOI 10.1016/j.yexcr.2004.12.012; De Deken X, 2000, J BIOL CHEM, V275, P23227, DOI 10.1074/jbc.M000916200; Dentice M, 2006, J CLIN ENDOCR METAB, V91, P1428, DOI 10.1210/jc.2005-1350; Fagman H, 2011, J MOL ENDOCRINOL, V46, pR33, DOI 10.1677/JME-10-0084; Fagman H, 2010, MOL CELL ENDOCRINOL, V323, P35, DOI 10.1016/j.mce.2009.12.008; Grasberger H, 2006, J BIOL CHEM, V281, P18269, DOI 10.1074/jbc.C600095200; Grasberger H, 2010, MOL CELL ENDOCRINOL, V322, P99, DOI 10.1016/j.mce.2010.01.029; Hashemipour M, 2010, PEDIATR INT, V52, P467, DOI 10.1111/j.1442-200X.2009.03016.x; Hosoda Y, 2010, BIOMED RES-TOKYO, V31, P207, DOI 10.2220/biomedres.31.207; Johnson KR, 2007, MOL ENDOCRINOL, V21, P1593, DOI 10.1210/me.2007-0085; Kopp P, 2002, ENDOCRINOLOGY, V143, P2019, DOI 10.1210/en.143.6.2019; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Leger J, 2002, J CLIN ENDOCR METAB, V87, P575, DOI 10.1210/jc.87.2.575; Manly KF, 2001, MAMM GENOME, V12, P930, DOI 10.1007/s00335-001-1016-3; Markel P, 1997, NAT GENET, V17, P280, DOI 10.1038/ng1197-280; Persani L, 2010, MOL CELL ENDOCRINOL, V322, P72, DOI 10.1016/j.mce.2010.01.008; Postiglione MP, 2002, P NATL ACAD SCI USA, V99, P15462, DOI 10.1073/pnas.242328999; Rigutto S, 2009, J BIOL CHEM, V284, P6725, DOI 10.1074/jbc.M806893200; Rivas M, 2004, J BIOL CHEM, V279, P33114, DOI 10.1074/jbc.M403526200; Rivas M, 2009, MOL ENDOCRINOL, V23, P862, DOI 10.1210/me.2008-0466; Sasaki N, 2007, MOL ENDOCRINOL, V21, P1713, DOI 10.1210/me.2007-0040; TOMITA K, 1995, J ENDOCRINOL, V144, P209, DOI 10.1677/joe.0.1440209; Van Vliet G, 2003, CLIN GENET, V63, P445	31	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e31035	10.1371/journal.pone.0031035	http://dx.doi.org/10.1371/journal.pone.0031035			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22299049	Green Published, gold			2022-12-27	WOS:000301704200056
J	Kawakami, F; Yabata, T; Ohta, E; Maekawa, T; Shimada, N; Suzuki, M; Maruyama, H; Ichikawa, T; Obata, F				Kawakami, Fumitaka; Yabata, Takatoshi; Ohta, Etsuro; Maekawa, Tatsunori; Shimada, Naoki; Suzuki, Minori; Maruyama, Hiroko; Ichikawa, Takafumi; Obata, Fumiya			LRRK2 Phosphorylates Tubulin-Associated Tau but Not the Free Molecule: LRRK2-Mediated Regulation of the Tau-Tubulin Association and Neurite Outgrowth	PLOS ONE			English	Article							PROTEIN; DISEASE; PARKINSONISM; DEGENERATION; EXPRESSION; SULFATIDE; MUTATIONS; ISOFORMS; BRAIN; CELLS	Leucine-rich repeat kinase 2 (LRRK2), a large protein kinase containing multi-functional domains, has been identified as the causal molecule for autosomal-dominant Parkinson's disease (PD). In the present study, we demonstrated for the first time that (i) LRRK2 interacts with tau in a tubulin-dependent manner; (ii) LRRK2 directly phosphorylates tubulin-associated tau, but not free tau; (iii) LRRK2 phosphorylates tau at Thr181 as one of the target sites; and (iv) The PD-associated LRRK2 mutations, G2019S and I2020T, elevated the degree of tau-phosphorylation. These results provide direct proof that tau is a physiological substrate for LRRK2. Furthermore, we revealed that LRRK2-mediated phosphorylation of tau reduces its tubulin-binding ability. Our results suggest that LRRK2 plays an important role as a physiological regulator for phosphorylation-mediated dissociation of tau from microtubules, which is an integral aspect of microtubule dynamics essential for neurite outgrowth and axonal transport.	[Kawakami, Fumitaka; Yabata, Takatoshi; Shimada, Naoki; Suzuki, Minori; Ichikawa, Takafumi] Kitasato Univ, Grad Sch Med Sci, Dept Biochem, Sagamihara, Kanagawa 228, Japan; [Ohta, Etsuro; Maekawa, Tatsunori; Obata, Fumiya] Kitasato Univ, Grad Sch Med Sci, Dept Clin Immunol, Sagamihara, Kanagawa 228, Japan; [Maruyama, Hiroko] Kitasato Univ, Grad Sch Med Sci, Lab Cytopathol, Sagamihara, Kanagawa 228, Japan; [Obata, Fumiya] Kitasato Univ, Sch Allied Hlth Sci, Inst Regenerat Med & Cell Design, Res & Dev Ctr Cell Design, Sagamihara, Kanagawa 228, Japan	Kitasato University; Kitasato University; Kitasato University; Kitasato University	Kawakami, F (corresponding author), Kitasato Univ, Grad Sch Med Sci, Dept Biochem, Sagamihara, Kanagawa 228, Japan.	kawakami@kitasato-u.ac.jp		MAEKAWA, TATSUNORI/0000-0002-1214-9959	Kitasato University School of Allied Health Science [2009-6708, 2009]	Kitasato University School of Allied Health Science	This work was supported by the Kitasato University School of Allied Health Science (Grant-in-Aid for Research Project, No. 2009-6708, 2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avila J, 2004, PHYSIOL REV, V84, P361, DOI 10.1152/physrev.00024.2003; Biskup S, 2009, BBA-MOL BASIS DIS, V1792, P625, DOI 10.1016/j.bbadis.2008.09.015; Chan D, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.234005; Cookson MR, 2007, J NEUROSCI, V27, P11865, DOI 10.1523/JNEUROSCI.3695-07.2007; Cookson MR, 2010, NAT REV NEUROSCI, V11, P791, DOI 10.1038/nrn2935; Dachsel JC, 2007, PARKINSONISM RELAT D, V13, P382, DOI 10.1016/j.parkreldis.2007.01.008; Dachsel JC, 2010, ARCH NEUROL-CHICAGO, V67, P542, DOI 10.1001/archneurol.2010.79; Deas E, 2010, J NEUROSCI, V30, P1577, DOI 10.1523/JNEUROSCI.5531-09.2010; Dickson DW, 2010, INT J CLIN EXP PATHO, V3, P1; Gillardon F, 2009, J NEUROCHEM, V110, P1514, DOI 10.1111/j.1471-4159.2009.06235.x; Gloeckner CJ, 2009, J NEUROCHEM, V109, P959, DOI 10.1111/j.1471-4159.2009.06024.x; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Iaccarino C, 2007, HUM MOL GENET, V16, P1319, DOI 10.1093/hmg/ddm080; Imai Y, 2008, EMBO J, V27, P2432, DOI 10.1038/emboj.2008.163; Iqbal K, 2010, CURR ALZHEIMER RES, V7, P656, DOI 10.2174/156720510793611592; Iqbal K, 2009, ACTA NEUROPATHOL, V118, P53, DOI 10.1007/s00401-009-0486-3; Jaleel M, 2007, BIOCHEM J, V405, P307, DOI 10.1042/BJ20070209; Kawakami F, 2008, J BIOCHEM, V143, P359, DOI 10.1093/jb/mvm228; Kawakami F, 2008, BIOL PHARM BULL, V31, P193, DOI 10.1248/bpb.31.193; Kubo M, 2010, J NEUROIMMUNOL, V229, P123, DOI 10.1016/j.jneuroim.2010.07.021; Li YP, 2009, NAT NEUROSCI, V12, P826, DOI 10.1038/nn.2349; Lin CH, 2010, J NEUROSCI, V30, P13138, DOI 10.1523/JNEUROSCI.1737-10.2010; MacLeod D, 2006, NEURON, V52, P587, DOI 10.1016/j.neuron.2006.10.008; Maekawa T, 2010, BIOCHEM BIOPH RES CO, V392, P431, DOI 10.1016/j.bbrc.2010.01.041; Maldonado H, 2011, J NEUROSCI RES, V89, P1489, DOI 10.1002/jnr.22678; Maldonado H, 2008, BIOL RES, V41, P239, DOI [/S0716-97602008000300001, 10.4067/S0716-97602008000300001]; Meixner A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.001172; Melrose HL, 2010, NEUROBIOL DIS, V40, P503, DOI 10.1016/j.nbd.2010.07.010; Miklossy J, 2007, ACTA NEUROPATHOL, V114, P243, DOI 10.1007/s00401-007-0230-9; Miklossy J, 2006, J NEUROPATH EXP NEUR, V65, P953, DOI 10.1097/01.jnen.0000235121.98052.54; Ohta E, 2011, FEBS LETT, V585, P2165, DOI 10.1016/j.febslet.2011.05.044; Ohta E, 2010, BIOCHEM BIOPH RES CO, V391, P242, DOI 10.1016/j.bbrc.2009.11.043; Ohta E, 2009, BIOCHEM BIOPH RES CO, V390, P710, DOI 10.1016/j.bbrc.2009.10.034; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Parisiadou L, 2009, J NEUROSCI, V29, P13971, DOI 10.1523/JNEUROSCI.3799-09.2009; Plowey ED, 2008, J NEUROCHEM, V105, P1048, DOI 10.1111/j.1471-4159.2008.05217.x; Rajput A, 2006, NEUROLOGY, V67, P1506, DOI 10.1212/01.wnl.0000240220.33950.0c; Ramonet D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018568; Webber PJ, 2009, FEBS J, V276, P6436, DOI 10.1111/j.1742-4658.2009.07342.x; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; Zach S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013191; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	42	93	94	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e30834	10.1371/journal.pone.0030834	http://dx.doi.org/10.1371/journal.pone.0030834			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22303461	Green Published, gold, Green Submitted			2022-12-27	WOS:000301704200037
J	Chang, YC; She, ZG; Sakimura, K; Roberts, A; Kucharova, K; Rowitch, DH; Stallcup, WB				Chang, Yunchao; She, Zhi-Gang; Sakimura, Kenji; Roberts, Amanda; Kucharova, Karolina; Rowitch, David H.; Stallcup, William B.			Ablation of NG2 Proteoglycan Leads to Deficits in Brown Fat Function and to Adult Onset Obesity	PLOS ONE			English	Article							PDGF ALPHA-RECEPTOR; ADIPOSE-TISSUE; TRANSCRIPTIONAL CONTROL; ADAPTIVE THERMOGENESIS; SIGNALING PATHWAYS; CELL MOTILITY; GROWTH-FACTOR; NULL MOUSE; EXPRESSION; PROTEIN	Obesity is a major health problem worldwide. We are studying the causes and effects of obesity in C57Bl/6 mice following genetic ablation of NG2, a chondroitin sulfate proteoglycan widely expressed in progenitor cells and also in adipocytes. Although global NG2 ablation delays early postnatal adipogenesis in mouse skin, adult NG2 null mice are paradoxically heavier than wild-type mice, exhibiting larger white fat deposits. This adult onset obesity is not due to NG2-dependent effects on CNS function, since specific ablation of NG2 in oligodendrocyte progenitors yields the opposite phenotype; i.e. abnormally lean mice. Metabolic analysis reveals that, while activity and food intake are unchanged in global NG2 null mice, O-2 consumption and CO2 production are decreased, suggesting a decrease in energy expenditure. Since brown fat plays important roles in regulating energy expenditure, we have investigated brown fat function via cold challenge and high fat diet feeding, both of which induce the adaptive thermogenesis that normally occurs in brown fat. In both tests, body temperatures in NG2 null mice are reduced compared to wild-type mice, indicating a deficit in brown fat function in the absence of NG2. In addition, adipogenesis in NG2 null brown pre-adipocytes is dramatically impaired compared to wild-type counterparts. Moreover, mRNA levels for PR domain containing 16 (PRDM16) and peroxisome proliferator-activated receptor gamma coactivator (PGC)1-alpha, proteins important for brown adipocyte differentiation, are decreased in NG2 null brown fat deposits in vivo and NG2 null brown pre-adipocytes in vitro. Altogether, these results indicate that brown fat dysfunction in NG2 null mice results from deficits in the recruitment and/or development of brown pre-adipocytes. As a consequence, obesity in NG2 null mice may occur due to disruptions in brown fat-dependent energy homeostasis, with resulting effects on lipid storage in white adipocytes.	[Chang, Yunchao; She, Zhi-Gang; Kucharova, Karolina; Stallcup, William B.] Sanford Burnham Med Res Inst, Ctr Canc, La Jolla, CA USA; [Sakimura, Kenji] Niigata Univ, Brain Res Inst, Dept Cellular Neurobiol, Niigata, Japan; [Roberts, Amanda] Scripps Res Inst, Mol & Integrat Neurosci Dept, La Jolla, CA 92037 USA; [Rowitch, David H.] Univ Calif San Francisco, Dept Pediat Oncol, San Francisco, CA 94143 USA	Sanford Burnham Prebys Medical Discovery Institute; Niigata University; Scripps Research Institute; University of California System; University of California San Francisco	Chang, YC (corresponding author), Sanford Burnham Med Res Inst, Ctr Canc, La Jolla, CA USA.	yunchaochang@gmail.com		Kucharova, Karolina/0000-0002-3196-748X; Rowitch, David/0000-0002-0079-0060	National Institutes of Health (NIH) [RO1 CA95287, PO1 HD25938];  [NS057096]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD025938] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA095287] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057096] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (NIH) grants RO1 CA95287 (Dr. Stallcup), PO1 HD25938 (Dr. Stallcup), and Blueprint NS057096 (Dr. Roberts). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alenghat FJ, 2009, J CELL BIOCHEM, V106, P529, DOI 10.1002/jcb.22001; Barraud P, 2010, EXP CELL RES, V316, P1489, DOI 10.1016/j.yexcr.2010.03.001; Bartness TJ, 2010, INT J OBESITY, V34, pS36, DOI 10.1038/ijo.2010.182; Bayatti N, 2001, J NEUROCHEM, V78, P972, DOI 10.1046/j.1471-4159.2001.00464.x; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Chekenya M, 2008, ONCOGENE, V27, P5182, DOI 10.1038/onc.2008.157; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; Fukushi J, 2004, MOL BIOL CELL, V15, P3580, DOI 10.1091/mbc.E04-03-0236; Fukushi J, 2003, DEV DYNAM, V228, P143, DOI 10.1002/dvdy.10359; Goretzki L, 1999, J BIOL CHEM, V274, P16831, DOI 10.1074/jbc.274.24.16831; Grako KA, 1999, J CELL SCI, V112, P905; GRAKO KA, 1995, EXP CELL RES, V221, P231, DOI 10.1006/excr.1995.1371; Hossain P, 2007, NEW ENGL J MED, V356, P213, DOI 10.1056/NEJMp068177; Huang FJ, 2010, DEV BIOL, V344, P1035, DOI 10.1016/j.ydbio.2010.06.023; Kadoya K, 2008, J HISTOCHEM CYTOCHEM, V56, P295, DOI 10.1369/jhc.7A7349.2007; Kajimura S, 2010, CELL METAB, V11, P257, DOI 10.1016/j.cmet.2010.03.005; Kucharova K, 2010, NEUROSCIENCE, V166, P185, DOI 10.1016/j.neuroscience.2009.12.014; Liang HY, 2006, ADV PHYSIOL EDUC, V30, P145, DOI 10.1152/advan.00052.2006; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Makagiansar IT, 2007, J CELL BIOL, V178, P155, DOI 10.1083/jcb.200612084; Makagiansar IT, 2004, J BIOL CHEM, V279, P55262, DOI 10.1074/jbc.M411045200; Nasu-Tada K, 2005, GLIA, V52, P98, DOI 10.1002/glia.20224; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; NISHIYAMA A, 1991, DEVELOPMENT, V111, P933; Nishiyama A, 1996, J NEUROSCI RES, V43, P299, DOI 10.1002/(SICI)1097-4547(19960201)43:3<299::AID-JNR5>3.0.CO;2-E; Orava J, 2011, CELL METAB, V14, P272, DOI 10.1016/j.cmet.2011.06.012; Ozerdem U, 2002, MICROVASC RES, V63, P129, DOI 10.1006/mvre.2001.2376; Ozerdem U, 2001, DEV DYNAM, V222, P218, DOI 10.1002/dvdy.1200; Ozerdem Ugur, 2004, Angiogenesis, V7, P269, DOI 10.1007/s10456-004-4182-6; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Pursiheimo JP, 2000, P NATL ACAD SCI USA, V97, P168, DOI 10.1073/pnas.97.1.168; Schuller U, 2008, CANCER CELL, V14, P123, DOI 10.1016/j.ccr.2008.07.005; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Simpson D, 2000, MOL VIS, V6, P178; Soto I, 2006, J NEUROCHEM, V96, P82, DOI 10.1111/j.1471-4159.2005.03510.x; Stallcup WB, 2002, J NEUROCYTOL, V31, P423, DOI 10.1023/A:1025731428581; Stallcup WB, 2008, CELL ADHES MIGR, V2, P192, DOI 10.4161/cam.2.3.6279; Terada N, 2006, HISTOCHEM CELL BIOL, V126, P483, DOI 10.1007/s00418-006-0184-3; TEVETHIA MJ, 1984, VIROLOGY, V137, P414, DOI 10.1016/0042-6822(84)90234-4; Tseng YH, 2008, NATURE, V454, P1000, DOI 10.1038/nature07221; Vila-Bedmar Rocio, 2011, Archives of Physiology and Biochemistry, V117, P195, DOI 10.3109/13813455.2011.560951; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wang H, 2008, MOL CELL BIOL, V28, P2187, DOI 10.1128/MCB.01479-07; Wang ZY, 2006, CELL METAB, V3, P111, DOI 10.1016/j.cmet.2006.01.002; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Westcott DJ, 2009, J EXP MED, V206, P3143, DOI 10.1084/jem.20091333; Woost PG, 1996, KIDNEY INT, V50, P125, DOI 10.1038/ki.1996.295	51	21	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30637	10.1371/journal.pone.0030637	http://dx.doi.org/10.1371/journal.pone.0030637			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295099	gold, Green Submitted, Green Published			2022-12-27	WOS:000301640600044
J	Fujiwara, K; Hasegawa, K; Ohkumo, T; Miyoshi, H; Tseng, YH; Yoshikawa, K				Fujiwara, Kazushiro; Hasegawa, Koichi; Ohkumo, Tsuyoshi; Miyoshi, Hiroyuki; Tseng, Yu-Hua; Yoshikawa, Kazuaki			Necdin Controls Proliferation of White Adipocyte Progenitor Cells	PLOS ONE			English	Article							PRADER-WILLI-SYNDROME; MOUSE MODEL; STEM-CELLS; PREADIPOCYTE DIFFERENTIATION; POSTMITOTIC NEURONS; GROWTH SUPPRESSOR; SKELETAL-MUSCLE; ADIPOSE-TISSUE; IN-VIVO; GENE	White adipose tissues are composed mainly of white fat cells adipocytes), which play a key role in energy storage and metabolism. White adipocytes are terminally differentiated postmitotic cells and arise from their progenitor cells (preadipocytes) or mesenchymal stem cells residing in white adipose tissues. Thus, white adipocyte number is most likely controlled by the rate of preadipocyte proliferation, which may contribute to the etiology of obesity. However, little is known about the molecular mechanisms that regulate preadipocyte proliferation during adipose tissue development. Necdin, which is expressed predominantly in postmitotic neurons, is a pleiotropic protein that possesses anti-mitotic and pro-survival activities. Here we show that necdin functions as an intrinsic regulator of white preadipocyte proliferation in developing adipose tissues. Necdin is expressed in early preadipocytes or mesenchymal stem cells residing in the stromal compartment of white adipose tissues in juvenile mice. Lentivirus-mediated knockdown of endogenous necdin expression in vivo in adipose tissues markedly increases fat mass in juvenile mice fed a high-fat diet until adulthood. Furthermore, necdin-null mutant mice exhibit a greater expansion of adipose tissues due to adipocyte hyperplasia than wild-type mice when fed the high-fat diet during the juvenile and adult periods. Adipose stromal-vascular cells prepared from necdin-null mice differentiate in vitro into a significantly larger number of adipocytes in response to adipogenic inducers than those from wild-type mice. These results suggest that necdin prevents excessive preadipocyte proliferation induced by adipogenic stimulation to control white adipocyte number during adipose tissue development.	[Fujiwara, Kazushiro; Hasegawa, Koichi; Ohkumo, Tsuyoshi; Yoshikawa, Kazuaki] Osaka Univ, Inst Prot Res, Suita, Osaka 565, Japan; [Miyoshi, Hiroyuki] RIKEN Tsukuba Inst, BioResource Ctr, Tsukuba, Ibaraki, Japan; [Tseng, Yu-Hua] Harvard Univ, Sch Med, Joslin Diabet Ctr, Div Res, Boston, MA 02115 USA	Osaka University; RIKEN; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.	Fujiwara, K (corresponding author), Osaka Univ, Inst Prot Res, Suita, Osaka 565, Japan.	yoshikaw@protein.osaka-u.ac.jp	Miyoshi, Hiroyuki/G-9808-2013; Tseng, Yu-Hua/AAE-6471-2021	Tseng, Yu-Hua/0000-0003-2053-9559	Japan Society for the Promotion of Science [21300138]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant-in-Aid for Scientific Research B2 (21300138) from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Arner P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018284; Brunelli S, 2004, CIRC RES, V94, P1571, DOI 10.1161/01.RES.0000132747.12860.10; Calo E, 2010, NATURE, V466, P1110, DOI 10.1038/nature09264; CATTANACH BM, 1992, NAT GENET, V2, P270, DOI 10.1038/ng1292-270; Deponti D, 2007, J CELL BIOL, V179, P305, DOI 10.1083/jcb.200701027; Ding F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001709; Gabriel JM, 1999, P NATL ACAD SCI USA, V96, P9258, DOI 10.1073/pnas.96.16.9258; GELOEN A, 1992, AM J PHYSIOL, V263, pR1176, DOI 10.1152/ajpregu.1992.263.6.R1176; Gerard M, 1999, NAT GENET, V23, P199, DOI 10.1038/13828; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Hansen JB, 2004, P NATL ACAD SCI USA, V101, P4112, DOI 10.1073/pnas.0301964101; Haqq AM, 2011, J CLIN ENDOCR METAB, V96, pE225, DOI 10.1210/jc.2010-1733; Hasegawa K, 2008, J NEUROSCI, V28, P8772, DOI 10.1523/JNEUROSCI.3052-08.2008; HAYASHI Y, 1995, BIOCHEM BIOPH RES CO, V213, P317, DOI 10.1006/bbrc.1995.2132; Jay P, 1997, NAT GENET, V17, P357, DOI 10.1038/ng1197-357; Joe AWB, 2009, STEM CELLS, V27, P2563, DOI 10.1002/stem.190; Kobayashi M, 2002, J BIOL CHEM, V277, P42128, DOI 10.1074/jbc.M205024200; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Kubota Y, 2009, BLOOD, V114, P4383, DOI 10.1182/blood-2009-07-230292; Kurita M, 2006, J NEUROSCI, V26, P12003, DOI 10.1523/JNEUROSCI.3002-06.2006; Kuwajima T, 2004, J BIOL CHEM, V279, P40484, DOI 10.1074/jbc.M404143200; Kuwako K, 2005, J NEUROSCI, V25, P7090, DOI 10.1523/JNEUROSCI.2083-05.2005; Liu Y, 2009, CELL STEM CELL, V4, P37, DOI 10.1016/j.stem.2008.11.006; MacDonald HR, 1997, HUM MOL GENET, V6, P1873, DOI 10.1093/hmg/6.11.1873; MARUYAMA K, 1991, BIOCHEM BIOPH RES CO, V178, P291, DOI 10.1016/0006-291X(91)91812-Q; Miyoshi H, 1998, J VIROL, V72, P8150, DOI 10.1128/JVI.72.10.8150-8157.1998; Muscatelli F, 2000, HUM MOL GENET, V9, P3101, DOI 10.1093/hmg/9.20.3101; Niinobe M, 2000, DEV NEUROSCI-BASEL, V22, P310, DOI 10.1159/000017455; Rodeheffer MS, 2008, CELL, V135, P240, DOI 10.1016/j.cell.2008.09.036; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Schulz TJ, 2011, P NATL ACAD SCI USA, V108, P143, DOI 10.1073/pnas.1010929108; Scime A, 2005, CELL METAB, V2, P283, DOI 10.1016/j.cmet.2005.10.002; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Tang W, 2008, SCIENCE, V322, P583, DOI 10.1126/science.1156232; Taniura H, 1999, J BIOL CHEM, V274, P16242, DOI 10.1074/jbc.274.23.16242; Taniura H, 1998, J BIOL CHEM, V273, P720, DOI 10.1074/jbc.273.2.720; Tchoukalova YD, 2010, P NATL ACAD SCI USA, V107, P18226, DOI 10.1073/pnas.1005259107; Tran TT, 2010, NAT REV ENDOCRINOL, V6, P195, DOI 10.1038/nrendo.2010.20; Tseng YH, 2005, NAT CELL BIOL, V7, P601, DOI 10.1038/ncb1259; Tseng YH, 2008, NATURE, V454, P1000, DOI 10.1038/nature07221; Tseng YH, 2010, NAT REV DRUG DISCOV, V9, P465, DOI 10.1038/nrd3138; Uetsuki T, 1996, J BIOL CHEM, V271, P918, DOI 10.1074/jbc.271.2.918; van Tienen FHJ, 2011, INT J OBESITY, V35, P1154, DOI 10.1038/ijo.2010.275; Yang T, 1998, NAT GENET, V19, P25, DOI 10.1038/ng0598-25; Yoshikawa K, 2000, NEUROSCI RES, V37, P1, DOI 10.1016/S0168-0102(00)00101-2; Zhang JW, 2004, P NATL ACAD SCI USA, V101, P43, DOI 10.1073/pnas.0307229101; Zhu NL, 2010, J BIOL CHEM, V285, P30463, DOI 10.1074/jbc.M110.156703	48	39	40	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30948	10.1371/journal.pone.0030948	http://dx.doi.org/10.1371/journal.pone.0030948			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22292082	Green Published, Green Submitted, gold			2022-12-27	WOS:000301570600100
J	Heil, M; Ibarra-Laclette, E; Adame-Alvarez, RM; Martinez, O; Ramirez-Chavez, E; Molina-Torres, J; Herrera-Estrella, L				Heil, Martin; Ibarra-Laclette, Enrique; Adame-Alvarez, Rosa M.; Martinez, Octavio; Ramirez-Chavez, Enrique; Molina-Torres, Jorge; Herrera-Estrella, Luis			How Plants Sense Wounds: Damaged-Self Recognition Is Based on Plant-Derived Elicitors and Induces Octadecanoid Signaling	PLOS ONE			English	Article							PROTEINASE-INHIBITOR; GENE-EXPRESSION; JASMONIC ACID; NICOTIANA-ATTENUATA; EXTRACELLULAR ATP; PARASITIC WASPS; ORAL SECRETIONS; DEFENSIVE GENES; GROWTH; RESPONSES	Background: Animal-derived elicitors can be used by plants to detect herbivory but they function only in specific insect-plant interactions. How can plants generally perceive damage caused by herbivores? Damaged-self recognition occurs when plants perceive molecular signals of damage: degraded plant molecules or molecules localized outside their original compartment. Methodology/Principal Findings: Flame wounding or applying leaf extract or solutions of sucrose or ATP to slightly wounded lima bean (Phaseolus lunatus) leaves induced the secretion of extrafloral nectar, an indirect defense mechanism. Chemically related molecules that would not be released in high concentrations from damaged plant cells (glucose, fructose, salt, and sorbitol) did not elicit a detectable response, excluding osmotic shock as an alternative explanation. Treatments inducing extrafloral nectar secretion also enhanced endogenous concentrations of the defense hormone jasmonic acid (JA). Endogenous JA was also induced by mechanically damaging leaves of lima bean, Arabidopsis, maize, strawberry, sesame and tomato. In lima bean, tomato and sesame, the application of leaf extract further increased endogenous JA content, indicating that damaged-self recognition is taxonomically widely distributed. Transcriptomic patterns obtained with untargeted 454 pyrosequencing of lima bean in response to flame wounding or the application of leaf extract or JA were highly similar to each other, but differed from the response to mere mechanical damage. We conclude that the amount or concentration of damaged-self signals can quantitatively determine the intensity of the wound response and that the full damaged-self response requires the disruption of many cells. Conclusions/Significance: Numerous compounds function as JA-inducing elicitors in different plant species. Most of them are, contain, or release, plant-derived molecular motifs. Damaged-self recognition represents a taxonomically widespread mechanism that contributes to the perception of herbivore feeding by plants. This strategy is independent of insect-derived elicitors and, therefore, allows plants to maintain evolutionary control over their interaction with herbivores.	[Heil, Martin; Adame-Alvarez, Rosa M.] Ctr Invest & Estudios Avanzados CINVESTAV, Dept Ingn Genet, Guanajuato, Mexico; [Ibarra-Laclette, Enrique; Martinez, Octavio; Herrera-Estrella, Luis] Ctr Invest & Estudios Avanzados CINVESTAV, Lab Nacl Genom Biodiversidad, Guanajuato, Mexico; [Ramirez-Chavez, Enrique; Molina-Torres, Jorge] Ctr Invest & Estudios Avanzados CINVESTAV, Dept Biotecnol & Bioquim, Guanajuato, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional	Heil, M (corresponding author), Ctr Invest & Estudios Avanzados CINVESTAV, Dept Ingn Genet, Guanajuato, Mexico.	mheil@ira.cinvestav.mx	Estrella, Luis R Herrera/G-7351-2011; Martinez, Octavio/F-3951-2014; Heil, Martin/AAC-2730-2022; Herrera-Estrella, Luis/ABC-7431-2020; Heil, Martin/T-3960-2019; Heil, Martin/I-1797-2012; Herrera-Estrella, Luis/AAL-2472-2020; Torres, Jorge Molina/B-9325-2019	Estrella, Luis R Herrera/0000-0001-7936-3856; Martinez, Octavio/0000-0002-7590-0041; Heil, Martin/0000-0001-8036-8697; Herrera-Estrella, Luis/0000-0001-7936-3856; Molina Torres, Jorge/0000-0003-2371-0307; Ramirez-Chavez, Enrique/0000-0003-1689-7759	CONACyT (Consejo Nacional de Ciencia y Tecnologia de Mexico) [130656]	CONACyT (Consejo Nacional de Ciencia y Tecnologia de Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	The study was supported by grant no. 130656 from CONACyT (Consejo Nacional de Ciencia y Tecnologia de Mexico; www.conacyt.mx). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alborn HT, 2007, P NATL ACAD SCI USA, V104, P12976, DOI 10.1073/pnas.0705947104; Baena-Gonzalez E, 2007, NATURE, V448, P938, DOI 10.1038/nature06069; Bergey DR, 1999, P NATL ACAD SCI USA, V96, P1756, DOI 10.1073/pnas.96.4.1756; Bonaventure G, 2011, TRENDS PLANT SCI, V16, P294, DOI 10.1016/j.tplants.2011.01.006; Bonaventure Gustavo, 2010, Commun Integr Biol, V3, P313; Bonaventure G, 2010, PLANT SIGNAL BEHAV, V5, P287, DOI 10.4161/psb.5.3.10713; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Chini A, 2009, FEBS J, V276, P4682, DOI 10.1111/j.1742-4658.2009.07194.x; Coker JS, 2005, PHYSIOL PLANTARUM, V124, P311, DOI 10.1111/j.1399-3054.2005.00488.x; Creelman RA, 1997, PLANT CELL, V9, P1211, DOI 10.1105/tpc.9.7.1211; Davies E, 1997, ACTA PHYSIOL PLANT, V19, P571, DOI 10.1007/s11738-997-0055-0; DOARES SH, 1995, P NATL ACAD SCI USA, V92, P4095, DOI 10.1073/pnas.92.10.4095; Doss RP, 2000, P NATL ACAD SCI USA, V97, P6218, DOI 10.1073/pnas.110054697; Felton GW, 2008, CURR OPIN PLANT BIOL, V11, P457, DOI 10.1016/j.pbi.2008.07.001; Franco G R, 1997, DNA Res, V4, P231, DOI 10.1093/dnares/4.3.231; GREEN TR, 1972, SCIENCE, V175, P776, DOI 10.1126/science.175.4023.776; Halitschke R, 2001, PLANT PHYSIOL, V125, P711, DOI 10.1104/pp.125.2.711; Heil M, 2001, P NATL ACAD SCI USA, V98, P1083, DOI 10.1073/pnas.031563398; Heil M, 2008, TRENDS PLANT SCI, V13, P264, DOI 10.1016/j.tplants.2008.03.005; Heil M, 2008, NEW PHYTOL, V178, P41, DOI 10.1111/j.1469-8137.2007.02330.x; Heil M, 2009, TRENDS PLANT SCI, V14, P356, DOI 10.1016/j.tplants.2009.04.002; Huffaker A, 2007, P NATL ACAD SCI USA, V104, P10732, DOI 10.1073/pnas.0703343104; Katari MS, 2010, PLANT PHYSIOL, V152, P500, DOI 10.1104/pp.109.147025; LEE NH, 1995, P NATL ACAD SCI USA, V92, P8303, DOI 10.1073/pnas.92.18.8303; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Martinez O, 2008, P NATL ACAD SCI USA, V105, P9709, DOI 10.1073/pnas.0803479105; MATTIACCI L, 1995, P NATL ACAD SCI USA, V92, P2036, DOI 10.1073/pnas.92.6.2036; Meyer M, 2008, NAT PROTOC, V3, P267, DOI 10.1038/nprot.2007.520; Mithofer A, 2008, PLANT PHYSIOL, V146, P825, DOI 10.1104/pp.107.113118; MUELLER MJ, 1994, ANAL BIOCHEM, V218, P425, DOI 10.1006/abio.1994.1202; OKUBO K, 1992, NAT GENET, V2, P173, DOI 10.1038/ng1192-173; Pearce G, 2007, J BIOL CHEM, V282, P17777, DOI 10.1074/jbc.M701543200; Pearce G, 2010, P NATL ACAD SCI USA, V107, P14921, DOI 10.1073/pnas.1007568107; Peiffer M, 2009, J CHEM ECOL, V35, P326, DOI 10.1007/s10886-009-9604-x; Pluskota WE, 2007, J EXP BOT, V58, P4071, DOI 10.1093/jxb/erm263; Radhika V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009265; Ramirez-Chavez E, 2004, PLANT PHYSIOL, V134, P1058, DOI 10.1104/pp.103.034553; Reinbothe C, 2009, FEBS J, V276, P4666, DOI 10.1111/j.1742-4658.2009.07193.x; Rolland F, 2006, ANNU REV PLANT BIOL, V57, P675, DOI 10.1146/annurev.arplant.57.032905.105441; Roux SJ, 2007, TRENDS PLANT SCI, V12, P522, DOI 10.1016/j.tplants.2007.09.003; Ryan CA, 2003, P NATL ACAD SCI USA, V100, P14577, DOI 10.1073/pnas.1934788100; RYAN CA, 1974, PLANT PHYSIOL, V54, P328, DOI 10.1104/pp.54.3.328; Schmelz EA, 2006, P NATL ACAD SCI USA, V103, P8894, DOI 10.1073/pnas.0602328103; Schmelz EA, 2009, P NATL ACAD SCI USA, V106, P653, DOI 10.1073/pnas.0811861106; Schwiebert EM, 2003, BBA-BIOMEMBRANES, V1615, P7, DOI 10.1016/S0005-2736(03)00210-4; Stankovic B, 1996, FEBS LETT, V390, P275, DOI 10.1016/0014-5793(96)00672-2; Stankovic B, 1998, PLANT CELL PHYSIOL, V39, P268, DOI 10.1093/oxfordjournals.pcp.a029367; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; TURLINGS TCJ, 1993, J CHEM ECOL, V19, P411, DOI 10.1007/BF00994314; Wasternack C, 2007, ANN BOT-LONDON, V100, P681, DOI 10.1093/aob/mcm079; Wu JQ, 2010, ANNU REV GENET, V44, P1, DOI 10.1146/annurev-genet-102209-163500; Zhang S, 2012, SCIENCE, V12, P234; Zimmermann MR, 2009, PLANTA, V229, P539, DOI 10.1007/s00425-008-0850-x	53	91	93	0	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2012	7	2							e30537	10.1371/journal.pone.0030537	http://dx.doi.org/10.1371/journal.pone.0030537			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZQ	22347382	Green Submitted, Green Published, gold			2022-12-27	WOS:000302730200003
J	Lepore, E; Marchioro, A; Isaia, M; Buehler, MJ; Pugno, NM				Lepore, Emiliano; Marchioro, Andrea; Isaia, Marco; Buehler, Markus J.; Pugno, Nicola M.			Evidence of the Most Stretchable Egg Sac Silk Stalk, of the European Spider of the Year Meta menardi	PLOS ONE			English	Article							ORB-WEAVING SPIDERS; MECHANICAL-PROPERTIES; DRAGLINE SILK; PHYSICAL-PROPERTIES; TENSILE PROPERTIES; ARANEAE; FIBERS; STRENGTH; SEQUENCE; BIOMECHANICS	Spider silks display generally strong mechanical properties, even if differences between species and within the same species can be observed. While many different types of silks have been tested, the mechanical properties of stalks of silk taken from the egg sac of the cave spider Meta menardi have not yet been analyzed. Meta menardi has recently been chosen as the "European spider of the year 2012", from the European Society of Arachnology. Here we report a study where silk stalks were collected directly from several caves in the north-west of Italy. Field emission scanning electron microscope (FESEM) images showed that stalks are made up of a large number of threads, each of them with diameter of 6.03 +/- 0.58 mu m. The stalks were strained at the constant rate of 2 mm/min, using a tensile testing machine. The observed maximum stress, strain and toughness modulus, defined as the area under the stress-strain curve, are 0.64 GPa, 751% and 130.7 MJ/m(3), respectively. To the best of our knowledge, such an observed huge elongation has never been reported for egg sac silk stalks and suggests a huge unrolling microscopic mechanism of the macroscopic stalk that, as a continuation of the protective egg sac, is expected to be composed by fibres very densely and randomly packed. The Weibull statistics was used to analyze the results from mechanical testing, and an average value of Weibull modulus (m) is deduced to be in the range of 1.5-1.8 with a Weibull scale parameter (sigma(0)) in the range of 0.33-0.41 GPa, showing a high coefficient of correlation (R-2=0.97).	[Lepore, Emiliano; Marchioro, Andrea; Pugno, Nicola M.] Politecn Torino, Dept Struct Engn, Lab Bioinspired Nanomech Giuseppe Maria Pugno, Turin, Italy; [Isaia, Marco] Univ Turin, Dept Human & Anim Biol, Lab Ecol & Terr Ecosyst, Turin, Italy; [Buehler, Markus J.] MIT, Dept Civil & Environm Engn, Ctr Mat Sci & Engn, Lab Atomist & Mol Mech, Cambridge, MA 02139 USA; [Buehler, Markus J.] MIT, Ctr Computat Engn, Cambridge, MA 02139 USA; [Pugno, Nicola M.] Natl Labs Frascati, Natl Inst Nucl Phys, Frascati, Italy; [Pugno, Nicola M.] Natl Inst Metrol Res, Turin, Italy	Polytechnic University of Turin; University of Turin; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Istituto Nazionale di Fisica Nucleare (INFN); Istituto Nazionale di Ricerca Metrologica (INRIM)	Lepore, E (corresponding author), Politecn Torino, Dept Struct Engn, Lab Bioinspired Nanomech Giuseppe Maria Pugno, Turin, Italy.	nicola.pugno@polito.it	Buehler, Markus J./C-4580-2008; Isaia, Marco/I-1629-2015; Pugno, Nicola/C-2289-2014	Buehler, Markus J./0000-0002-4173-9659; Isaia, Marco/0000-0001-5434-2127; 	"Metrology on a Cellular and Macromolecular Scale for Regenerative Medicine" - Metregen; European Research Council under the European Union [279985]; ONR-PECASE [N00014-10-1-0562]	"Metrology on a Cellular and Macromolecular Scale for Regenerative Medicine" - Metregen; European Research Council under the European Union(European Research Council (ERC)); ONR-PECASE(Office of Naval Research)	NMP is supported by "Metrology on a Cellular and Macromolecular Scale for Regenerative Medicine" - Metregen (2009-2012), supporting theoretical research for scaffold design. The research related to these results has received funding from the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC Grant agreement no [279985] (ERC StG Ideas Award to NMP on "Bio-inspired hierarchical super nanomaterials"; the funding will officially start in 2012). MJB acknowledges support from an ONR-PECASE award (award number N00014-10-1-0562), no role in the results reported in this paper. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnarsson I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011234; Allmeling C, 2006, J CELL MOL MED, V10, P770, DOI 10.1111/j.1582-4934.2006.tb00436.x; Alvarez-Padilla F, 2009, CLADISTICS, V25, P109, DOI 10.1111/j.1096-0031.2008.00242.x; Blackledge TA, 2006, J EXP BIOL, V209, P2452, DOI 10.1242/jeb.02275; Blackledge TA, 2011, ADV INSECT PHYSIOL, V41, P175, DOI 10.1016/B978-0-12-415919-8.00004-5; Bosia F, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.056103; Boutry C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022467; Brunetta L., 2010, SPIDER SILK EVOLUTIO; Craig C.L., 2003, SPIDER WEBS SILK TRA; Craig CL, 2003, SPIDERWEBS SILK TRAC; Cunniff P.M., 1994, POLYM ADVAN TECHNOL, V5, P401; Dal Pra I, 2005, BIOMATERIALS, V26, P1987, DOI 10.1016/j.biomaterials.2004.06.036; Dal Pra I, 2006, INT J MOL MED, V18, P241; DENNY M, 1976, J EXP BIOL, V65, P483; DUNAWAY DL, 1995, J APPL POLYM SCI, V58, P675, DOI 10.1002/app.1995.070580322; Eberhard WG, 2010, J ARACHNOL, V38, P407, DOI 10.1636/B09-97.1; Elices M, 2005, JOM-US, V57, P60, DOI 10.1007/s11837-005-0218-7; Foelix R., 2011, BIOL SPIDERS, V3; Foradori MJ, 2002, J MORPHOL, V252, P218, DOI 10.1002/jmor.1100; Gheysens T, 2005, J ARACHNOL, V33, P549, DOI 10.1636/CS05-12.1; GOSLINE JM, 1984, NATURE, V309, P551, DOI 10.1038/309551a0; GOSLINE JM, 1986, ENDEAVOUR, V10, P37, DOI 10.1016/0160-9327(86)90049-9; Gosline JM, 1999, J EXP BIOL, V202, P3295; Guinea GV, 2003, POLYMER, V44, P5785, DOI 10.1016/S0032-3861(03)00625-6; Hajer J, 2009, J MORPHOL, V270, P1269, DOI 10.1002/jmor.10757; Hayashi CY, 2004, MOL BIOL EVOL, V21, P1950, DOI 10.1093/molbev/msh204; Keten S, 2010, J R SOC INTERFACE, V7, P1709, DOI 10.1098/rsif.2010.0149; Keten S, 2010, NAT MATER, V9, P359, DOI [10.1038/nmat2704, 10.1038/NMAT2704]; KOHLER T, 1995, J EXP ZOOL, V271, P1, DOI 10.1002/jez.1402710102; Kovoor J., 1987, P160; Krasnov I, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.048104; Madsen B, 1999, INT J BIOL MACROMOL, V24, P301, DOI 10.1016/S0141-8130(98)00094-4; Moore AMF, 1999, INT J BIOL MACROMOL, V24, P277, DOI 10.1016/S0141-8130(98)00090-7; Nova A, 2010, NANO LETT, V10, P2626, DOI 10.1021/nl101341w; Opell BD, 2000, BIOL J LINN SOC, V70, P107, DOI 10.1111/j.1095-8312.2000.tb00203.x; Ortlepp C, 2008, J EXP BIOL, V211, P2832, DOI 10.1242/jeb.014191; Perez-Rigueiro J, 1998, J APPL POLYM SCI, V70, P2439, DOI 10.1002/(SICI)1097-4628(19981219)70:12<2439::AID-APP16>3.0.CO;2-J; Perez-Rigueiro J, 2000, J APPL POLYM SCI, V75, P1270, DOI 10.1002/(SICI)1097-4628(20000307)75:10<1270::AID-APP8>3.3.CO;2-3; Perez-Riguero J, 2001, J APPL POLYM SCI, V82, P2245, DOI 10.1002/app.2072; Platnick N.I., 2013, WORLD SPIDER CATALOG, DOI [10.5531/db.iz.0001, DOI 10.5531/DB.IZ.0001]; Poza P, 2002, ENG FRACT MECH, V69, P1035, DOI 10.1016/S0013-7944(01)00120-5; Pugno NM, 2010, J MECH PHYS SOLIDS, V58, P1397, DOI 10.1016/j.jmps.2010.05.007; Romer L, 2008, PRION, V2, P154; Rousseau ME, 2009, BIOMACROMOLECULES, V10, P2945, DOI 10.1021/bm9007919; Sensenig A, 2010, J EVOLUTION BIOL, V23, P1839, DOI 10.1111/j.1420-9101.2010.02048.x; Shao ZZ, 1999, POLYMER, V40, P1799, DOI 10.1016/S0032-3861(98)00266-3; STAUFFER SL, 1994, J ARACHNOL, V22, P5; Swanson BO, 2006, APPL PHYS A-MATER, V82, P213, DOI 10.1007/s00339-005-3427-6; Van Nimmen E, 2005, J ARACHNOL, V33, P629, DOI 10.1636/CS05-5.1; Van Nimmen E, 2005, AUTEX RES J, V5, P120; Van Nimmen E, 2006, TEXT RES J, V76, P619, DOI 10.1177/0040517506068057; Vasanthavada K, 2007, J BIOL CHEM, V282, P35088, DOI 10.1074/jbc.M705791200; Vehoff T, 2007, BIOPHYS J, V93, P4425, DOI 10.1529/biophysj.106.099309; Vollrath F, 1996, P ROY SOC B-BIOL SCI, V263, P147, DOI 10.1098/rspb.1996.0023; Vollrath F, 2001, P ROY SOC B-BIOL SCI, V268, P2339, DOI 10.1098/rspb.2001.1590; Xiao T, 2008, COMPOS SCI TECHNOL, V68, P2937, DOI 10.1016/j.compscitech.2007.10.004; Zhao AC, 2006, BIOCHEMISTRY-US, V45, P3348, DOI 10.1021/bi052414g	57	24	24	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e30500	10.1371/journal.pone.0030500	http://dx.doi.org/10.1371/journal.pone.0030500			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347380	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000302730100014
J	Bansback, N; Tsuchiya, A; Brazier, J; Anis, A				Bansback, Nick; Tsuchiya, Aki; Brazier, John; Anis, Aslam			Canadian Valuation of EQ-5D Health States: Preliminary Value Set and Considerations for Future Valuation Studies	PLOS ONE			English	Article							COST-EFFECTIVENESS; ECONOMIC-EVALUATION; UTILITIES; EUROQOL	Background: The EQ-5D is a preference based instrument which provides a description of a respondent's health status, and an empirically derived value for that health state often from a representative sample of the general population. It is commonly used to derive Quality Adjusted Life Year calculations (QALY) in economic evaluations. However, values for health states have been found to differ between countries. The objective of this study was to develop a set of values for the EQ-5D health states for use in Canada. Methods: Values for 48 different EQ-5D health states were elicited using the Time Trade Off (TTO) via a web survey in English. A random effect model was fitted to the data to estimate values for all 243 health states of the EQ-5D. Various model specifications were explored. Comparisons with EQ-5D values from the UK and US were made. Sensitivity analysis explored different transformations of values worse than dead, and exclusion criteria of subjects. Results: The final model was estimated from the values of 1145 subjects with socio-demographics broadly representative of Canadian general population with the exception of Quebec. This yielded a good fit with observed TTO values, with an overall R2 of 0.403 and a mean absolute error of 0.044. Conclusion: A preference-weight algorithm for Canadian studies that include the EQ-5D is developed. The primary limitations regarded the representativeness of the final sample, given the language used (English only), the method of recruitment, and the difficulty in the task. Insights into potential issues for conducting valuation studies in countries as large and diverse as Canada are gained.	[Bansback, Nick; Anis, Aslam] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [Bansback, Nick; Anis, Aslam] St Pauls Hosp, Ctr Hlth Evaluat & Outcome Sci, Vancouver, BC V6Z 1Y6, Canada; [Bansback, Nick; Tsuchiya, Aki; Brazier, John] Univ Sheffield, Sch Hlth & Related Res, Sheffield, S Yorkshire, England; [Tsuchiya, Aki] Univ Sheffield, Dept Econ, Sheffield, S Yorkshire, England	University of British Columbia; St. Paul's Hospital; University of Saskatchewan; University of Sheffield; University of Sheffield	Bansback, N (corresponding author), Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada.	nick.bansback@ubc.ca	brazier, john e/B-1936-2008	Tsuchiya, Aki/0000-0003-4245-5399; Brazier, John/0000-0001-8645-4780; Bansback, Nick/0000-0002-1510-3462	Canadian Institute for Health Research	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR))	The study was funded as part of a grant through the Canadian Institute for Health Research (http://www.cihr-irsc.gc.ca/e/193.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attema AE, 2011, LEAD TIME TTO LEADIN; Bansback N, 2011, J HLTH EC IN PRESS; Brauer CA, 2006, VALUE HEALTH, V9, P213, DOI 10.1111/j.1524-4733.2006.00116.x; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Cameron C, 2010, CAN MED ASSOC J, V182, P28, DOI 10.1503/cmaj.090765; Cameron CG, 2009, CAN MED ASSOC J, V180, P400, DOI 10.1503/cmaj.081180; Conner-Spady B, 2008, CAN MED ASSOC J, V179, P327, DOI 10.1503/cmaj.071659; Dendukuri N, 2007, CAN MED ASSOC J, V176, P1429, DOI 10.1503/cmaj.061011; Devlin NJ, 2011, HEALTH ECON, V20, P348, DOI 10.1002/hec.1596; Devlin NJ, 2003, HEALTH ECON, V12, P529, DOI 10.1002/hec.741; Dolan P, 1997, MED CARE, V35, P1095, DOI 10.1097/00005650-199711000-00002; Drolet M, 2010, CAN MED ASSOC J, V182, P1731, DOI 10.1503/cmaj.091711; FEENY D, 1995, PHARMACOECONOMICS, V7, P490, DOI 10.2165/00019053-199507060-00004; Gudex C, 1994, 20 CTR HLTH EC; Herdman M, 2011, QUAL LIFE RES, V20, P1727, DOI 10.1007/s11136-011-9903-x; Jelsma Jennifer, 2003, Popul Health Metr, V1, P11, DOI 10.1186/1478-7954-1-11; Johnson JA, 2005, MED CARE, V43, P221, DOI 10.1097/00005650-200503000-00004; Johnson JA, 2000, MED CARE, V38, P115, DOI 10.1097/00005650-200001000-00013; Kuhfeld W, 1997, ORTHOGONAL ARRAYS; Lamers LM, 2006, HEALTH ECON, V15, P1121, DOI 10.1002/hec.1124; Lamers LM, 2007, MED CARE, V45, P238, DOI 10.1097/01.mlr.0000252166.76255.68; McIntosh Cameron N, 2007, Chronic Dis Can, V28, P29; Neumann PJ, 2000, ANNU REV PUBL HEALTH, V21, P587, DOI 10.1146/annurev.publhealth.21.1.587; Norman R, 2010, QUAL LIFE RES, V19, P499, DOI 10.1007/s11136-010-9609-5; Ratcliffe J, 2007, MEASURING VALUING HL, P344; Regier DA, 2006, CAN MED ASSOC J, V174, P1847, DOI 10.1503/cmaj.051104; Salomon Joshua A, 2003, Popul Health Metr, V1, P12, DOI 10.1186/1478-7954-1-12; Shaw JW, 2005, MED CARE, V43, P203, DOI 10.1097/00005650-200503000-00003; Shrive FM, 2005, CAN MED ASSOC J, V172, P345, DOI 10.1503/cmaj.1041062; Statistics Canada, 2008, RES TEL SERV SURV; Statistics Canada, 2006, CAN COMM HLTH SURV C; Statistics Canada, 2009, CAN INT US SURV CIUS; Statistics Canada, 2006, CENS PROF FED EL DIS; Stolk EA, 2010, VALUE HEALTH, V13, P1005, DOI 10.1111/j.1524-4733.2010.00783.x; Sumukadas D, 2007, CAN MED ASSOC J, V177, P867, DOI 10.1503/cmaj.061339; Szende AGOTA., 2007, EUROQOL GROUP MONOGR, V2; Torrance G W, 1972, Health Serv Res, V7, P118; Tsuchiya A, 2002, HEALTH ECON, V11, P341, DOI 10.1002/hec.673; Ware MA, 2010, CAN MED ASSOC J, V182, DOI [DOI 10.1503/cmaj.091414, 10.1503/cmaj.091414]; Weinstein MC, 2009, VALUE HEALTH, V12, pS5, DOI 10.1111/j.1524-4733.2009.00515.x; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Williams A, 1995, 136 CTR HLTH EC; Wittrup-Jensen KU, 2009, SCAND J PUBLIC HEALT, V37, P459, DOI 10.1177/1403494809105287	43	137	138	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2012	7	2							e31115	10.1371/journal.pone.0031115	http://dx.doi.org/10.1371/journal.pone.0031115			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	917LV	22328929	gold, Green Submitted, Green Accepted, Green Published			2022-12-27	WOS:000302179300015
J	Couto, CR; Pannuti, CS; Paz, JP; Fink, MCD; Machado, AA; de Marchi, M; Machado, CM				Couto, Carla R.; Pannuti, Claudio S.; Paz, Jose P., Jr.; Fink, Maria C. D.; Machado, Alessandra A.; de Marchi, Michela; Machado, Clarisse M.			Fighting Misconceptions to Improve Compliance with Influenza Vaccination among Health Care Workers: An Educational Project	PLOS ONE			English	Article							BONE-MARROW-TRANSPLANTATION; VIRUS-INFECTIONS; RAPID DIAGNOSIS; WORKING ADULTS; RATES; IMMUNIZATION; FREQUENCY; ATTITUDES; PCR	The compliance with influenza vaccination is poor among health care workers (HCWs) due to misconceptions about safety and effectiveness of influenza vaccine. We proposed an educational prospective study to demonstrate to HCWs that influenza vaccine is safe and that other respiratory viruses (RV) are the cause of respiratory symptoms in the months following influenza vaccination. 398 HCWs were surveyed for adverse events (AE) occurring within 48 h of vaccination. AE were reported by 30% of the HCWs. No severe AE was observed. A subset of 337 HCWs was followed up during four months, twice a week, for the detection of respiratory symptoms. RV was diagnosed by direct immunofluorescent assay (DFA) and real time PCR in symptomatic HCWs. Influenza A was detected in five episodes of respiratory symptoms (5.3%) and other RV in 26 (27.9%) episodes. The incidence density of influenza and other RV was 4.3 and 10.8 episodes per 100 HCW-month, respectively. The educational nature of the present study may persuade HCWs to develop a more positive attitude to influenza vaccination.	[Couto, Carla R.; Pannuti, Claudio S.; Paz, Jose P., Jr.; Fink, Maria C. D.; Machado, Alessandra A.; de Marchi, Michela; Machado, Clarisse M.] Univ Sao Paulo, Inst Trop Med, Virol Lab LIM HCFMUSP 52, Sao Paulo, Brazil	Universidade de Sao Paulo	Couto, CR (corresponding author), Univ Sao Paulo, Inst Trop Med, Virol Lab LIM HCFMUSP 52, Sao Paulo, Brazil.	clarimm@usp.br	Fink, Maria Cristina/M-8718-2015		State of Sao Paulo Secretary of Health; Aventis Pasteur	State of Sao Paulo Secretary of Health; Aventis Pasteur	This study was supported by The State of Sao Paulo Secretary of Health. CC and JP received grants from Aventis Pasteur. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, MORBID MORTAL WKLY R, V59, P38; [Anonymous], SUMMARY 2010 2011 TR; ARRUDA E, 1993, MOL CELL PROBE, V7, P373, DOI 10.1006/mcpr.1993.1055; Bellei N, 2008, J MED VIROL, V80, P1824, DOI 10.1002/jmv.21295; Bishburg E, 2008, INFECT CONT HOSP EP, V29, P89, DOI 10.1086/524322; Boivin G, 2000, CLIN INFECT DIS, V31, P1166, DOI 10.1086/317425; Bridges CB, 2000, JAMA-J AM MED ASSOC, V284, P1655, DOI 10.1001/jama.284.13.1655; Christini AB, 2007, INFECT CONT HOSP EP, V28, P171, DOI 10.1086/511796; Donalisio Maria Rita, 2003, Rev. Soc. Bras. Med. Trop., V36, P467, DOI 10.1590/S0037-86822003000400006; Englund JA, 1996, J CLIN MICROBIOL, V34, P1649, DOI 10.1128/JCM.34.7.1649-1653.1996; Fiore Anthony E., 2009, Morbidity and Mortality Weekly Report, V58, P1; GROSS PA, 1995, ANN INTERN MED, V123, P518, DOI 10.7326/0003-4819-123-7-199510010-00008; Hollmeyer HG, 2009, VACCINE, V27, P3935, DOI 10.1016/j.vaccine.2009.03.056; Igari H, 2010, MICROBIOL IMMUNOL, V54, P618, DOI 10.1111/j.1348-0421.2010.00254.x; Lopes MH, 2008, INFECT CONT HOSP EP, V29, P285, DOI 10.1086/528700; Lopes MH, 2008, CLINICS, V63, P21, DOI 10.1590/S1807-59322008000100005; Machado CM, 2004, BONE MARROW TRANSPL, V34, P111, DOI 10.1038/sj.bmt.1704534; Machado CM, 2003, BONE MARROW TRANSPL, V31, P695, DOI 10.1038/sj.bmt.1703900; MARGOLIS KL, 1990, AM J MED, V88, P27, DOI 10.1016/0002-9343(90)90123-U; Morris DJ, 1996, J INFECTION, V32, P113, DOI 10.1016/S0163-4453(96)91250-5; NICHOL KL, 1995, NEW ENGL J MED, V333, P889, DOI 10.1056/NEJM199510053331401; Oliveira RR, 2008, BONE MARROW TRANSPL, V42, P265, DOI 10.1038/bmt.2008.153; Park SW, 2011, AM J INFECT CONTROL, V39, P69, DOI 10.1016/j.ajic.2010.08.007; Rothman KJ, 1998, MODERN EPIDEMIOLOGY, P29; Smedley J, 2007, OCCUP ENVIRON MED, V64, P223, DOI 10.1136/oem.2005.023564; Takayanagi IJ, 2007, AM J INFECT CONTROL, V35, P56, DOI 10.1016/j.ajic.2006.06.002; van Elden LJR, 2001, J CLIN MICROBIOL, V39, P196, DOI 10.1128/JCM.39.1.196-200.2001	27	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2012	7	2							e30670	10.1371/journal.pone.0030670	http://dx.doi.org/10.1371/journal.pone.0030670			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LV	22328920	Green Published, gold, Green Submitted			2022-12-27	WOS:000302179300006
J	Brown, AP; Kroon, JTM; Swarbreck, D; Febrer, M; Larson, TR; Graham, IA; Caccamo, M; Slabas, AR				Brown, Adrian P.; Kroon, Johan T. M.; Swarbreck, David; Febrer, Melanie; Larson, Tony R.; Graham, Ian A.; Caccamo, Mario; Slabas, Antoni R.			Tissue-Specific Whole Transcriptome Sequencing in Castor, Directed at Understanding Triacylglycerol Lipid Biosynthetic Pathways	PLOS ONE			English	Article							RICINOLEIC ACID BIOSYNTHESIS; UNUSUAL FATTY-ACIDS; RICINUS-COMMUNIS L; DIACYLGLYCEROL ACYLTRANSFERASE; MICROSOMAL PREPARATIONS; ENDOPLASMIC-RETICULUM; 1-ACYL-SN-GLYCEROL-3-PHOSPHATE ACYLTRANSFERASE; OLEATE 12-HYDROXYLASE; BRASSICA TAPETUM; SEED DEVELOPMENT	Background: Storage triacylglycerols in castor bean seeds are enriched in the hydroxylated fatty acid ricinoleate. Extensive tissue-specific RNA-Seq transcriptome and lipid analysis will help identify components important for its biosynthesis. Methodology/Findings: Storage triacylglycerols (TAGs) in the endosperm of developing castor (Ricinus communis) seeds are highly enriched in ricinoleic acid (18:1-OH). We have analysed neutral lipid fractions from other castor tissues using TLC, GLC and mass spectrometry. Cotyledons, like the endosperm, contain high levels of 18:1-OH in TAG. Pollen and male developing flowers accumulate TAG but do not contain 18:1-OH and leaves do not contain TAG or 18:1-OH. Analysis of acyl-CoAs in developing endosperm shows that ricinoleoyl-CoA is not the dominant acyl-CoA, indicating that either metabolic channelling or enzyme substrate selectivity are important in the synthesis of tri-ricinolein in this tissue. RNA-Seq transcriptomic analysis, using Illumina sequencing by synthesis technology, has been performed on mRNA isolated from two stages of developing seeds, germinating seeds, leaf and pollen-producing male flowers in order to identify differences in lipid-metabolic pathways and enzyme isoforms which could be important in the biosynthesis of TAG enriched in 18:1-OH. This study gives comprehensive coverage of gene expression in a variety of different castor tissues. The potential role of differentially expressed genes is discussed against a background of proteins identified in the endoplasmic reticulum, which is the site of TAG biosynthesis, and transgenic studies aimed at increasing the ricinoleic acid content of TAG. Conclusions/Significance: Several of the genes identified in this tissue-specific whole transcriptome study have been used in transgenic plant research aimed at increasing the level of ricinoleic acid in TAG. New candidate genes have been identified which might further improve the level of ricinoleic acid in transgenic crops.	[Brown, Adrian P.; Kroon, Johan T. M.; Slabas, Antoni R.] Univ Durham, Sch Biol & Biomed Sci, Durham, England; [Swarbreck, David; Febrer, Melanie; Caccamo, Mario] Genome Anal Ctr, Norwich, Norfolk, England; [Larson, Tony R.; Graham, Ian A.] Univ York, Dept Biol, Ctr Novel Agr Prod, York YO10 5DD, N Yorkshire, England	Durham University; The Genome Analysis Centre (TGAC); University of York - UK	Brown, AP (corresponding author), Univ Durham, Sch Biol & Biomed Sci, Durham, England.	a.r.slabas@durham.ac.uk	Kroon, Johan Theodorus Maria/S-8415-2019; Larson, Tony/AAI-4782-2020	Kroon, Johan Theodorus Maria/0000-0003-2086-6074; Larson, Tony/0000-0003-1337-3482; Swarbreck, David/0000-0002-5453-1013	Biotechnology and Biological Sciences Research Council [BB/F004354/1]; Linnaeus, Inc.; Arkema as industrial; BBSRC [BBS/E/T/000PR6193, BB/F004354/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/T/000PR6193] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Linnaeus, Inc.; Arkema as industrial; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Biotechnology and Biological Sciences Research Council (http://www.bbsrc.ac.uk/), grant no. BB/F004354/1, a LINK grant with Linnaeus, Inc. and Arkema as industrial partners. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts MGM, 1995, PLANT CELL, V7, P2115, DOI 10.1105/tpc.7.12.2115; Ariizumi T, 2011, ANNU REV PLANT BIOL, V62, P437, DOI 10.1146/annurev-arplant-042809-112312; BAFOR M, 1991, BIOCHEM J, V280, P507, DOI 10.1042/bj2800507; Bates PD, 2007, J BIOL CHEM, V282, P31206, DOI 10.1074/jbc.M705447200; Bates PD, 2011, PLANT J, V68, P387, DOI 10.1111/j.1365-313X.2011.04693.x; Bates PD, 2009, PLANT PHYSIOL, V150, P55, DOI 10.1104/pp.109.137737; Baud S, 2007, PLANT J, V50, P825, DOI 10.1111/j.1365-313X.2007.03092.x; Beisson F, 2003, PLANT PHYSIOL, V132, P681, DOI 10.1104/pp.103.022988; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brough CL, 1996, MOL BREEDING, V2, P133, DOI 10.1007/BF00441428; Broun P, 1998, PLANT J, V13, P201, DOI 10.1046/j.1365-313X.1998.00023.x; Broun P, 2004, P NATL ACAD SCI USA, V101, P4706, DOI 10.1073/pnas.0305574101; Brown AP, 2011, J PROTEOME RES, V10, P3565, DOI 10.1021/pr2002066; Brown AP, 2009, ADV PHOTOSYNTH RESP, V30, P11; BROWN AP, 1995, PLANT MOL BIOL, V29, P267, DOI 10.1007/BF00043651; Burgal J, 2008, PLANT BIOTECHNOL J, V6, P819, DOI 10.1111/j.1467-7652.2008.00361.x; Chan AP, 2010, NAT BIOTECHNOL, V28, P951, DOI 10.1038/nbt.1674; Chen GQ, 2007, LIPIDS, V42, P263, DOI 10.1007/s11745-007-3022-z; Costa GGL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-462; Dahlqvist A, 2000, P NATL ACAD SCI USA, V97, P6487, DOI 10.1073/pnas.120067297; Eastmond PJ, 2010, PLANT CELL, V22, P2796, DOI 10.1105/tpc.109.071423; Eastmond PJ, 2004, J BIOL CHEM, V279, P45540, DOI 10.1074/jbc.M408686200; FOLCH J, 1957, J BIOL CHEM, V226, P497; Footitt S, 2007, PLANT PHYSIOL, V144, P1467, DOI 10.1104/pp.107.099903; Graham IA, 2008, ANNU REV PLANT BIOL, V59, P115, DOI 10.1146/annurev.arplant.59.032607.092938; GREENWOOD JS, 1982, CAN J BOT, V60, P1751, DOI 10.1139/b82-222; He XH, 2004, LIPIDS, V39, P311, DOI 10.1007/s11745-004-1234-2; Hsieh K, 2005, PLANT J, V43, P889, DOI 10.1111/j.1365-313X.2005.02502.x; Hsieh K, 2007, PLANT CELL, V19, P582, DOI 10.1105/tpc.106.049049; Hsu FF, 1999, J AM SOC MASS SPECTR, V10, P587, DOI 10.1016/S1044-0305(99)00035-5; Jessen D, 2011, PLANT J, V68, P715, DOI 10.1111/j.1365-313X.2011.04722.x; Kannangara R, 2007, PLANT CELL, V19, P1278, DOI 10.1105/tpc.106.047076; Kim HU, 2011, PLANT CELL PHYSIOL, V52, P983, DOI 10.1093/pcp/pcr051; Kroon JTM, 2006, PHYTOCHEMISTRY, V67, P2541, DOI 10.1016/j.phytochem.2006.09.020; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Larson TR, 2002, PLANT J, V32, P519, DOI 10.1046/j.1365-313X.2002.01440.x; Larson TR, 2001, PLANT J, V25, P115, DOI 10.1046/j.1365-313x.2001.00929.x; LASSNER MW, 1995, PLANT PHYSIOL, V109, P1389, DOI 10.1104/pp.109.4.1389; Li XC, 2012, MOL PLANT, V5, P131, DOI 10.1093/mp/ssr057; Li-Beisson Yonghua, 2010, Arabidopsis Book, V8, pe0133, DOI [10.1199/tab.0133, 10.1199/tab.0161]; Li-Beisson Y, 2009, P NATL ACAD SCI USA, V106, P22008, DOI 10.1073/pnas.0909090106; Lu CF, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-42; Lu CF, 2009, P NATL ACAD SCI USA, V106, P18837, DOI 10.1073/pnas.0908848106; Mancha M, 1997, PLANTA, V203, P51, DOI 10.1007/s004250050164; McConn M, 1996, PLANT CELL, V8, P403, DOI 10.1105/tpc.8.3.403; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Napier JA, 2007, ANNU REV PLANT BIOL, V58, P295, DOI 10.1146/annurev.arplant.58.032806.103811; Peng FY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-286; Perez-Rodriquez P, 2009, NUCLEIC ACIDS RES, V38, DOI [10.1093/nar/gkp805, DOI 10.1093/NAR/GKP805]; Quettier AL, 2009, PLANT PHYSIOL BIOCH, V47, P485, DOI 10.1016/j.plaphy.2008.12.005; Saha S, 2006, PLANT PHYSIOL, V141, P1533, DOI 10.1104/pp.106.082198; Santos-Mendoza M, 2008, PLANT J, V54, P608, DOI 10.1111/j.1365-313X.2008.03461.x; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Severin AJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-160; Shindou H, 2009, J BIOL CHEM, V284, P1, DOI 10.1074/jbc.R800046200; SLACK CR, 1983, BIOCHIM BIOPHYS ACTA, V754, P10, DOI 10.1016/0005-2760(83)90076-0; Smith MA, 2003, PLANTA, V217, P507, DOI 10.1007/s00425-003-1015-6; SMITH MA, 1992, BIOCHEM J, V287, P141, DOI 10.1042/bj2870141; Stahl U, 2008, FEBS LETT, V582, P305, DOI 10.1016/j.febslet.2007.12.020; STYMNE S, 1984, BIOCHEM J, V223, P305, DOI 10.1042/bj2230305; Testerink C, 2011, J EXP BOT, V62, P2349, DOI 10.1093/jxb/err079; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; van Erp H, 2011, PLANT PHYSIOL, V155, P683, DOI 10.1104/pp.110.167239; VANDELOO FJ, 1995, P NATL ACAD SCI USA, V92, P6743, DOI 10.1073/pnas.92.15.6743; Yang Peizhen, 2010, BMC Plant Biol, V10, P250, DOI 10.1186/1471-2229-10-250; Yang WL, 2010, P NATL ACAD SCI USA, V107, P12040, DOI 10.1073/pnas.0914149107; Yang ZL, 2009, PLANT PHYSIOL, V150, P1981, DOI 10.1104/pp.109.140491; Zhang M, 2009, PLANT CELL, V21, P3885, DOI 10.1105/tpc.109.071795; Zhao LF, 2010, PLANT J, V64, P1048, DOI 10.1111/j.1365-313X.2010.04396.x	70	94	104	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e30100	10.1371/journal.pone.0030100	http://dx.doi.org/10.1371/journal.pone.0030100			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LO	22319559	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000302178400004
J	Talebian, F; Liu, JQ; Liu, ZZ; Khattabi, M; He, YK; Ganju, R; Bai, XF				Talebian, Fatemeh; Liu, Jin-Qing; Liu, Zhenzhen; Khattabi, Mazin; He, Yukai; Ganju, Ramesh; Bai, Xue-Feng			Melanoma Cell Expression of CD200 Inhibits Tumor Formation and Lung Metastasis via Inhibition of Myeloid Cell Functions	PLOS ONE			English	Article							THERAPEUTIC TARGET; EFFECTOR FUNCTION; PROGNOSTIC-FACTOR; RECEPTOR; MACROPHAGES; CANCER; RECRUITMENT; PROGRESSION; ANTIBODIES; SEVERITY	CD200 is a cell surface glycoprotein that functions through engaging CD200 receptor on cells of the myeloid lineage and inhibits their functions. Expression of CD200 has been implicated in a variety of human cancer cells including melanoma cells and has been thought to play a protumor role. To investigate the role of cancer cell expression of CD200 in tumor formation and metastasis, we generated CD200-positive and CD200-negative B16 melanoma cells. Subcutaneous injection of CD200-positive B16 melanoma cells inhibited tumor formation and growth in C57BL/6 mice but not in Rag1(-/-)C57BL/6 mice. However, i.v. injection of CD200-positive B16 melanoma cells dramatically inhibited tumor foci formation in the lungs of both C57BL/6 and Rag1(-/-)C57BL6 mice. Flow cytometry analysis revealed higher expression of CD200R in Gr1(+) myeloid cells in the lung than in peripheral myeloid cells. Depletion of Gr1(+) cells or stimulation of CD200R with an agonistic antibody in vivo dramatically inhibited tumor foci formation in the lungs. In addition, treatment with tumor antigen specific CD4 or CD8 T cells or their combination yielded a survival advantage for CD200 positive tumor bearing mice over mice bearing CD200-negative tumors. Taken together, we have revealed a novel role for CD200-CD200R interaction in inhibiting tumor formation and metastasis. Targeting CD200R may represent a novel approach for cancer immunotherapy.	[Talebian, Fatemeh; Liu, Jin-Qing; Liu, Zhenzhen; Khattabi, Mazin; Ganju, Ramesh; Bai, Xue-Feng] Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA; [Talebian, Fatemeh; Liu, Jin-Qing; Liu, Zhenzhen; Khattabi, Mazin; Ganju, Ramesh; Bai, Xue-Feng] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Talebian, Fatemeh] Ohio State Univ, Integrated Biomed Sci Grad Program, Columbus, OH 43210 USA; [Liu, Zhenzhen] Ohio State Univ, Ohio State Biochem Program, Columbus, OH 43210 USA; [He, Yukai] Georgia Hlth Sci Univ, Immunol Immunotherapy Program, Augusta, GA USA	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Georgia; Augusta University	Talebian, F (corresponding author), Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA.	Xue-Feng.Bai@osumc.edu	Bai, Xue-Feng/H-5164-2013; Bai, Xue-feng/E-2681-2011	Bai, Xue-Feng/0000-0001-9476-8376; talebian, fatemeh/0000-0003-1172-1252; Talebian, Fatemeh/0000-0002-8336-0348	National Cancer Institute [R01CA138427]; American cancer society [RSG-09-188-01-LIB]; NATIONAL CANCER INSTITUTE [R01CA138427] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American cancer society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study is supported by Grants from National Cancer Institute (R01CA138427 to XFB) and American cancer society (RSG-09-188-01-LIB to XFB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn GO, 2010, P NATL ACAD SCI USA, V107, P8363, DOI 10.1073/pnas.0911378107; Bai XF, 2003, J CLIN INVEST, V111, P1487, DOI 10.1172/JCI200317656; BARCLAY AN, 1986, BIOCHEM SOC SYMP, P149; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Dick AD, 2001, INVEST OPHTH VIS SCI, V42, P170; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Hoek RM, 2000, SCIENCE, V290, P1768, DOI 10.1126/science.290.5497.1768; Jenmalm MC, 2006, J IMMUNOL, V176, P191, DOI 10.4049/jimmunol.176.1.191; Koning N, 2009, J NEUROPATH EXP NEUR, V68, P159, DOI 10.1097/NEN.0b013e3181964113; Kretz-Rommel A, 2007, J IMMUNOL, V178, P5595, DOI 10.4049/jimmunol.178.9.5595; Kretz-Ronlmel A, 2008, J IMMUNOL, V180, P699, DOI 10.4049/jimmunol.180.2.699; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Luo YP, 2006, J CLIN INVEST, V116, P2132, DOI 10.1172/JCI27648; McWhirter JR, 2006, P NATL ACAD SCI USA, V103, P1041, DOI 10.1073/pnas.0510081103; Mihrshahi R, 2010, J IMMUNOL, V185, P7216, DOI 10.4049/jimmunol.1002858; Mihrshahi R, 2009, J IMMUNOL, V183, P4879, DOI 10.4049/jimmunol.0901531; Minas K, 2006, CRIT REV IMMUNOL, V26, P213, DOI 10.1615/CritRevImmunol.v26.i3.20; Moreaux J, 2008, BIOCHEM BIOPH RES CO, V366, P117, DOI 10.1016/j.bbrc.2007.11.103; Moreaux J, 2006, BLOOD, V108, P4194, DOI 10.1182/blood-2006-06-029355; PEKAREK LA, 1995, J EXP MED, V181, P435, DOI 10.1084/jem.181.1.435; Petermann KB, 2007, J CLIN INVEST, V117, P3922, DOI 10.1172/JCI32163; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Ragheb R, 1999, IMMUNOL LETT, V68, P311, DOI 10.1016/S0165-2478(99)00060-7; Rosenblum MD, 2004, J INVEST DERMATOL, V123, P880, DOI 10.1111/j.0022-202X.2004.23461.x; Simelyte E, 2010, CLIN EXP IMMUNOL, V162, P163, DOI 10.1111/j.1365-2249.2010.04227.x; Siva A, 2007, CANC IMMUNOL IMMUNOT; Snelgrove RJ, 2008, NAT IMMUNOL, V9, P1074, DOI 10.1038/ni.1637; Steidl C, 2010, NEW ENGL J MED, V362, P875, DOI 10.1056/NEJMoa0905680; Stumpfova M, 2010, CANCER RES, V70, P2962, DOI 10.1158/0008-5472.CAN-09-4380; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Tonks A, 2007, LEUKEMIA, V21, P566, DOI 10.1038/sj.leu.2404559; Wang LX, 2010, EUR J IMMUNOL, V40, P2569, DOI 10.1002/eji.201040472; Wright GJ, 2003, J IMMUNOL, V171, P3034, DOI 10.4049/jimmunol.171.6.3034; Wright GJ, 2001, IMMUNOLOGY, V102, P173, DOI 10.1046/j.1365-2567.2001.01163.x; Zhang SL, 2004, J IMMUNOL, V173, P6786, DOI 10.4049/jimmunol.173.11.6786; Zhou QF, 2010, J IMMUNOL, V185, P5082, DOI 10.4049/jimmunol.1001821	36	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e31442	10.1371/journal.pone.0031442	http://dx.doi.org/10.1371/journal.pone.0031442			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LO	22319630	Green Published, gold, Green Submitted			2022-12-27	WOS:000302178400042
J	Li, XQ; Li, L; Xiao, CH; Feng, YM				Li, Xiao-Qing; Li, Lin; Xiao, Chun-Hua; Feng, Yu-Mei			NEFL mRNA Expression Level Is a Prognostic Factor for Early-Stage Breast Cancer Patients	PLOS ONE			English	Article							SHORT ARM; PROSTATE CARCINOMAS; COLORECTAL-CANCER; CHROMOSOME 8P; ALLELIC LOSS; LUNG-CANCER; HETEROZYGOSITY; GENE; 8P12-P21; DISEASE	Neurofilament, light polypeptide (NEFL) was demonstrated to be ectopically expressed in breast cancer tissues and decreased in lymph node metastases compared to the paired primary breast cancers in our previous study. Moreover, in several studies, NEFL was regarded as a tumor suppressor gene, and its loss of heterozygosity (LOH) was related to carcinogenesis and metastasis in several types of cancer. To explore the role of NEFL in the progression of breast cancer and to evaluate its clinical significance, we detected the NEFL mRNA level in normal breast tissues, primary breast cancer samples and lymph node metastases, and then analyzed the association between the NEFL expression level and several clinicopathological parameters and disease-free survival (DFS). NEFL mRNA was found to be expressed in 92.3% of breast malignancies and down-regulated in lymph node metastases compared to the paired primary tumors. NEFL mRNA level was lower in primary breast cancers with positive lymph nodes than in cancers with negative lymph nodes. Moreover, a low expression level of NEFL mRNA indicated a poor five-year DFS for early-stage breast cancer patients. Thus, NEFL mRNA is ectopically expressed in breast malignancies and could be a potential prognostic factor for early-stage breast cancer patients.	[Li, Xiao-Qing; Li, Lin; Feng, Yu-Mei] Tianjin Med Univ Canc Inst & Hosp, Dept Biochem & Mol Biol, Tianjin, Peoples R China; [Xiao, Chun-Hua] Tianjin Med Univ Canc Inst & Hosp, Dept Breast Surg, Tianjin, Peoples R China; [Li, Xiao-Qing; Xiao, Chun-Hua; Feng, Yu-Mei] Tianjin Med Univ Canc Inst & Hosp, Minist Educ, Key Lab Breast Canc Prevent & Treatment, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University	Feng, YM (corresponding author), Tianjin Med Univ Canc Inst & Hosp, Dept Biochem & Mol Biol, Tianjin, Peoples R China.	ymfeng@tijmu.edu.cn			National Natural Science Foundation of China [30872518]; Major Program of Applied Basic Research Projects of Tianjin [09JCZDJC19800]; Tianjin Health Bureau [07KZ76]; Science Technology Development Project of Colleges and Universities in Tianjin [20090134]; Program for Changjiang Scholars and Innovative Research Team in University by the Ministry of Education [URT0743]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Program of Applied Basic Research Projects of Tianjin; Tianjin Health Bureau; Science Technology Development Project of Colleges and Universities in Tianjin; Program for Changjiang Scholars and Innovative Research Team in University by the Ministry of Education(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by the National Natural Science Foundation of China (No. 30872518), the Major Program of Applied Basic Research Projects of Tianjin (No. 09JCZDJC19800), the Science Technology Development Project of Colleges and Universities in Tianjin [20090134], the Science Technology Development Project of Tianjin Health Bureau [07KZ76], and the Program for Changjiang Scholars and Innovative Research Team in University by the Ministry of Education [URT0743]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buckland PR, 2004, BBA-MOL BASIS DIS, V1690, P238, DOI 10.1016/j.bbadis.2004.06.023; Burke B, 2006, GYNECOL ONCOL, V103, P642, DOI 10.1016/j.ygyno.2006.04.015; Coon SW, 2004, INT J CANCER, V111, P206, DOI 10.1002/ijc.20254; EMI M, 1992, CANCER RES, V52, P5368; Feng YM, 2007, BREAST CANCER RES TR, V103, P319, DOI 10.1007/s10549-006-9385-7; Haggman MJ, 1997, UROLOGY, V50, P643, DOI 10.1016/S0090-4295(97)00304-X; Imbert A, 1996, GENOMICS, V32, P29, DOI 10.1006/geno.1996.0073; Julien JP, 1998, PROG NUCLEIC ACID RE, V61, P1, DOI 10.1016/S0079-6603(08)60823-5; KAGAN J, 1995, ONCOGENE, V11, P2121; KERANGUEVEN F, 1995, ONCOGENE, V10, P1023; KNOWLES MA, 1993, ONCOGENE, V8, P1357; Kochanski A, 2004, FOLIA NEUROPATHOL, V42, P187; Kurimoto F, 2001, INT J MOL MED, V8, P89; Lerebours F, 1999, INT J CANCER, V81, P854, DOI 10.1002/(SICI)1097-0215(19990611)81:6<854::AID-IJC3>3.0.CO;2-1; Lerebours F, 1999, GENE CHROMOSOME CANC, V25, P147, DOI 10.1002/(SICI)1098-2264(199906)25:2<147::AID-GCC10>3.0.CO;2-Z; Li XQ, 2007, CANCER SCI, V98, P1592, DOI 10.1111/j.1349-7006.2007.00565.x; LIEM RKH, 1978, J CELL BIOL, V79, P637, DOI 10.1083/jcb.79.3.637; MACOSKA JA, 1995, CANCER RES, V55, P5390; Mersiyanova IV, 2000, AM J HUM GENET, V67, P37, DOI 10.1086/302962; Monceviciute-Eringiene E, 2005, MED HYPOTHESES, V65, P595, DOI 10.1016/j.mehy.2005.02.033; Rogaev E., 1992, Human Molecular Genetics, V1, P781, DOI 10.1093/hmg/1.9.781; Schmidt H, 2007, Verh Dtsch Ges Pathol, V91, P302; Seitz S, 2000, EUR J CANCER, V36, P1507, DOI 10.1016/S0959-8049(00)00135-0; Takanishi DM, 1997, MOL DIAGN, V2, P3, DOI 10.1016/S1084-8592(97)80003-3; Takimoto Y, 2001, CANCER, V91, P362; Vocke CD, 1996, CANCER RES, V56, P2411; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; WiedauPazos M, 1996, SCIENCE, V271, P515, DOI 10.1126/science.271.5248.515; YAREMKO ML, 1995, GENE CHROMOSOME CANC, V13, P186, DOI 10.1002/gcc.2870130308; Yaremko ML, 1996, GENE CHROMOSOME CANC, V16, P189, DOI 10.1002/(SICI)1098-2264(199607)16:3<189::AID-GCC6>3.0.CO;2-V	30	10	12	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2012	7	2							e31146	10.1371/journal.pone.0031146	http://dx.doi.org/10.1371/journal.pone.0031146			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UV	22319610	Green Published, gold, Green Submitted			2022-12-27	WOS:000301979000023
J	Joling, KJ; van Marwijk, HWJ; Smit, F; van der Horst, HE; Scheltens, P; van de Ven, PM; Mittelman, MS; van Hout, HPJ				Joling, Karlijn J.; van Marwijk, Harm W. J.; Smit, Filip; van der Horst, Henriette E.; Scheltens, Philip; van de Ven, Peter M.; Mittelman, Mary S.; van Hout, Hein P. J.			Does a Family Meetings Intervention Prevent Depression and Anxiety in Family Caregivers of Dementia Patients? A Randomized Trial	PLOS ONE			English	Article							NURSING-HOME PLACEMENT; ALZHEIMER-DISEASE; PSYCHOSOCIAL INTERVENTIONS; HOSPITAL ANXIETY; FOLLOW-UP; LATE-LIFE; PEOPLE; METAANALYSIS; PREVALENCE; VALIDATION	Background: Family caregivers of dementia patients are at increased risk of developing depression or anxiety. A multicomponent program designed to mobilize support of family networks demonstrated effectiveness in decreasing depressive symptoms in caregivers. However, the impact of an intervention consisting solely of family meetings on depression and anxiety has not yet been evaluated. This study examines the preventive effects of family meetings for primary caregivers of community-dwelling dementia patients. Methods: A randomized multicenter trial was conducted among 192 primary caregivers of community dwelling dementia patients. Caregivers did not meet the diagnostic criteria for depressive or anxiety disorder at baseline. Participants were randomized to the family meetings intervention (n = 96) or usual care (n = 96) condition. The intervention consisted of two individual sessions and four family meetings which occurred once every 2 to 3 months for a year. Outcome measures after 12 months were the incidence of a clinical depressive or anxiety disorder and change in depressive and anxiety symptoms (primary outcomes), caregiver burden and quality of life (secondary outcomes). Intention-to-treat as well as per protocol analyses were performed. Results: A substantial number of caregivers (72/192) developed a depressive or anxiety disorder within 12 months. The intervention was not superior to usual care either in reducing the risk of disorder onset (adjusted IRR 0.98; 95% CI 0.69 to 1.38) or in reducing depressive (randomization-by-time interaction coefficient = -1.40; 95% CI -3.91 to 1.10) or anxiety symptoms (randomization-by-time interaction coefficient = -0.55; 95% CI -1.59 to 0.49). The intervention did not reduce caregiver burden or their health related quality of life. Conclusion: This study did not demonstrate preventive effects of family meetings on the mental health of family caregivers. Further research should determine whether this intervention might be more beneficial if provided in a more concentrated dose, when applied for therapeutic purposes or targeted towards subgroups of caregivers.	[Joling, Karlijn J.; van Marwijk, Harm W. J.; van der Horst, Henriette E.; van Hout, Hein P. J.] Vrije Univ Amsterdam Med Ctr, Dept Gen Practice, Amsterdam, Netherlands; [Joling, Karlijn J.; van Marwijk, Harm W. J.; van der Horst, Henriette E.; van Hout, Hein P. J.] Vrije Univ Amsterdam Med Ctr, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Smit, Filip; van de Ven, Peter M.] Vrije Univ Amsterdam Med Ctr, Dept Epidemiol & Biostat, EMGO Inst Hlth & Hlth Care Res, Amsterdam, Netherlands; [Smit, Filip] Trimbos Inst Netherlands Inst Mental Hlth & Addic, Utrecht, Netherlands; [Scheltens, Philip] Vrije Univ Amsterdam Med Ctr, Alzheimer Ctr, Dept Neurol, Amsterdam, Netherlands; [Mittelman, Mary S.] NYU, Sch Med, Dept Psychiat, New York, NY USA	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Trimbos Institute; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; New York University	Joling, KJ (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Gen Practice, Amsterdam, Netherlands.	k.joling@vumc.nl	Scheltens, Philip/AAL-9631-2020; Scheltens, Philip/E-1205-2012; Van Marwijk, Harm/K-6306-2013	Scheltens, Philip/0000-0002-1046-6408; Van Marwijk, Harm/0000-0001-6206-485X; Mittelman, Mary/0000-0002-4074-8537; van Hout, Hein/0000-0002-2495-4808	Netherlands Organization for Health Research and Development (ZonMw) [62300040]; NATIONAL INSTITUTE ON AGING [P30AG008051] Funding Source: NIH RePORTER	Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding from this study was obtained from the Netherlands Organization for Health Research and Development (ZonMw), grant number 62300040. (www.zonmw.nl/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acton Gayle J, 2002, Annu Rev Nurs Res, V20, P149; Ballard CG, 1996, BRIT MED J, V312, P947; Beekman ATF, 2010, CURR OPIN PSYCHIATR, V23, P8, DOI 10.1097/YCO.0b013e328333e17f; Brodaty H, 2003, J AM GERIATR SOC, V51, P657, DOI 10.1034/j.1600-0579.2003.00210.x; Chisholm D, 2004, BRIT J PSYCHIAT, V184, P393, DOI 10.1192/bjp.184.5.393; Cooper C, 2007, INT PSYCHOGERIATR, V19, P175, DOI 10.1017/S1041610206004297; Cuijpers P, 2005, AGING MENT HEALTH, V9, P325, DOI 10.1080/13607860500090078; Cuijpers P, 2008, AM J PSYCHIAT, V165, P1272, DOI 10.1176/appi.ajp.2008.07091422; GIVEN CW, 1992, RES NURS HEALTH, V15, P271, DOI 10.1002/nur.4770150406; Hofman A, 1995, Ned Tijdschr Geneeskd, V139, P1975; HOFMAN A, 1991, INT J EPIDEMIOL, V20, P736, DOI 10.1093/ije/20.3.736; Joling Karlijn J, 2008, BMC Geriatr, V8, P2, DOI 10.1186/1471-2318-8-2; Joling KJ, 2010, AM J GERIAT PSYCHIAT, V18, P146, DOI 10.1097/JGP.0b013e3181bf9f0f; Li XM, 2006, STAT MED, V25, P2107, DOI 10.1002/sim.2343; Luijendijk HJ, 2008, ARCH GEN PSYCHIAT, V65, P1394, DOI 10.1001/archpsyc.65.12.1394; Mittelman MS, 2006, NEUROLOGY, V67, P1592, DOI 10.1212/01.wnl.0000242727.81172.91; Mittelman MS, 2008, AM J GERIAT PSYCHIAT, V16, P893, DOI 10.1097/JGP.0b013e3181898095; Mittelman MS, 2004, AM J PSYCHIAT, V161, P850, DOI 10.1176/appi.ajp.161.5.850; MITTELMAN MS, 1995, GERONTOLOGIST, V35, P792, DOI 10.1093/geront/35.6.792; Mittelman MS, 1996, JAMA-J AM MED ASSOC, V276, P1725, DOI 10.1001/jama.276.21.1725; Munoz RF, 2010, ANNU REV CLIN PSYCHO, V6, P181, DOI 10.1146/annurev-clinpsy-033109-132040; Norton MC, 2006, AM J GERIAT PSYCHIAT, V14, P237, DOI 10.1097/01.JGP.0000196626.34881.42; Olazaran J, 2010, DEMENT GERIATR COGN, V30, P161, DOI 10.1159/000316119; Palsson SP, 2001, PSYCHOL MED, V31, P1159, DOI 10.1017/S0033291701004524; Pinquart M, 2006, INT PSYCHOGERIATR, V18, P577, DOI 10.1017/S1041610206003462; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Schoenmakers B, 2010, AGING MENT HEALTH, V14, P44, DOI 10.1080/13607860902845533; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Smit F, 2004, J AFFECT DISORDERS, V81, P241, DOI 10.1016/j.jad.2003.08.007; Smits CHM, 2007, INT J GERIATR PSYCH, V22, P1181, DOI 10.1002/gps.1805; Sorensen S, 2002, GERONTOLOGIST, V42, P356, DOI 10.1093/geront/42.3.356; Spinhoven P, 1997, PSYCHOL MED, V27, P363, DOI 10.1017/S0033291796004382; Van Mierlo LD, 2012, INT J GERIATR PSYCH, V27, P1, DOI 10.1002/gps.2694; van't Veer-Tazelaar PJ, 2009, ARCH GEN PSYCHIAT, V66, P297, DOI 10.1001/archgenpsychiatry.2008.555; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Zarit S, 2008, AM J NURS, V108, P47, DOI 10.1097/01.NAJ.0000336415.60495.34; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	37	60	62	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e30936	10.1371/journal.pone.0030936	http://dx.doi.org/10.1371/journal.pone.0030936			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	911GB	22303473	gold, Green Published, Green Submitted			2022-12-27	WOS:000301704200048
J	Donnem, T; Fenton, CG; Lonvik, K; Berg, T; Eklo, K; Andersen, S; Stenvold, H; Al-Shibli, K; Al-Saad, S; Bremnes, RM; Busund, LT				Donnem, Tom; Fenton, Christopher G.; Lonvik, Kenneth; Berg, Thomas; Eklo, Katrine; Andersen, Sigve; Stenvold, Helge; Al-Shibli, Khalid; Al-Saad, Samer; Bremnes, Roy M.; Busund, Lill-Tove			MicroRNA Signatures in Tumor Tissue Related to Angiogenesis in Non-Small Cell Lung Cancer	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; PROGNOSTIC IMPACT; STROMAL CELLS; EXPRESSION PROFILES; MICROARRAY DATA; POOR SURVIVAL; CARCINOMA; HYPOXIA; COEXPRESSION; HISTOLOGY	Background: Angiogenesis is regarded as a hallmark in cancer development, and anti-angiogenic treatment is presently used in non-small cell lung cancer (NSCLC) patients. MicroRNAs (miRs) are small non-coding, endogenous, single stranded RNAs that regulate gene expression. In this study we aimed to identify significantly altered miRs related to angiogenesis in NSCLC. Methods: From a large cohort of 335 NSCLC patients, paraffin-embedded samples from 10 patients with a short disease specific survival (DSS), 10 with a long DSS and 10 normal controls were analyzed. The miRs were quantified by microarray hybridization and selected miRs were validated by real-time qPCR. The impacts of different pathways, including angiogenesis, were evaluated by Gene Set Enrichment Analysis (GSEA) derived from Protein ANalysis THrough Evolutionary Relationship (PANTHER). One of the most interesting candidate markers, miR-155, was validated by in situ hybridization (ISH) in the total cohort (n = 335) and correlation analyses with several well-known angiogenic markers were done. Results: 128 miRs were significantly up-or down-regulated; normal versus long DSS (n = 68) and/or normal versus short DSS (n = 63) and/or long versus short DSS (n = 37). The pathway analysis indicates angiogenesis-related miRs to be involved in NSCLC. There were strong significant correlations between the array hybridization and qPCR validation data. The significantly altered angiogenesis-related miRs of high interest were miR-21, miR-106a, miR-126, miR-155, miR-182, miR-210 and miR-424. miR-155 correlated significantly with fibroblast growth factor 2 (FGF2) in the total cohort (r = 0.17, P = 0.002), though most prominent in the subgroup with nodal metastasis (r = 0.34, P<0.001). Conclusions: Several angiogenesis-related miRs are significantly altered in NSCLC. Further studies to understand their biological functions and explore their clinical relevance are warranted.	[Donnem, Tom; Andersen, Sigve; Stenvold, Helge; Bremnes, Roy M.] Univ Hosp N Norway, Dept Oncol, Tromso, Norway; [Donnem, Tom; Fenton, Christopher G.; Andersen, Sigve; Stenvold, Helge; Bremnes, Roy M.] Univ Tromso, Inst Clin Med, Tromso, Norway; [Lonvik, Kenneth; Berg, Thomas; Eklo, Katrine; Al-Saad, Samer; Busund, Lill-Tove] Univ Hosp N Norway, Dept Clin Pathol, Tromso, Norway; [Lonvik, Kenneth; Berg, Thomas; Eklo, Katrine; Al-Saad, Samer; Busund, Lill-Tove] Univ Tromso, Inst Med Biol, Tromso, Norway; [Al-Shibli, Khalid] Nordland Cent Hosp, Dept Pathol, Bodo, Norway	UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso	Donnem, T (corresponding author), Univ Hosp N Norway, Dept Oncol, Tromso, Norway.	tom.donnem@uit.no	Pillay, Nischalan/F-9536-2012	Al-Saad, Samer/0000-0003-3707-9667	Northern Norway Regional Health Authority (Helse Nord RHF)	Northern Norway Regional Health Authority (Helse Nord RHF)	The study was solely funded by the Northern Norway Regional Health Authority (Helse Nord RHF), which is responsible for the public hospitals in northern Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Saad S, 2009, ANTICANCER RES, V29, P4175; Andersen S, 2011, LUNG CANCER, V72, P294, DOI 10.1016/j.lungcan.2010.10.006; Andersen S, 2009, J THORAC ONCOL, V4, P463, DOI 10.1097/JTO.0b013e3181991d18; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bishop JA, 2010, CLIN CANCER RES, V16, P610, DOI 10.1158/1078-0432.CCR-09-2638; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Cho WCS, 2010, INT J BIOCHEM CELL B, V42, P1273, DOI 10.1016/j.biocel.2009.12.014; Cho WCS, 2009, EXPERT REV MOL DIAGN, V9, P773, DOI [10.1586/erm.09.57, 10.1586/ERM.09.57]; Devlin C, 2011, IUBMB LIFE, V63, P94, DOI [10.1002/iub.00427, 10.1002/iub.427]; Donnem T, 2010, ANN ONCOL, V21, P223, DOI 10.1093/annonc/mdp296; Donnem T, 2008, J THORAC ONCOL, V3, P963, DOI 10.1097/JTO.0b013e3181834f52; Donnem T, 2007, CLIN CANCER RES, V13, P6649, DOI 10.1158/1078-0432.CCR-07-0414; Donnem T, 2011, CANCER-AM CANCER SOC, V117, P3193, DOI 10.1002/cncr.25907; Donnem T, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-6; Donnem T, 2010, CANCER-AM CANCER SOC, V116, P5676, DOI 10.1002/cncr.25551; Donnem T, 2010, CANCER-AM CANCER SOC, V116, P4318, DOI 10.1002/cncr.25333; Donnem T, 2009, J THORAC ONCOL, V4, P578, DOI 10.1097/JTO.0b013e31819f2e38; Donnem T, 2009, LUNG CANCER, V63, P277, DOI 10.1016/j.lungcan.2008.05.022; Du LQ, 2010, CANCER METAST REV, V29, P109, DOI 10.1007/s10555-010-9204-9; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Faraoni I, 2009, BBA-MOL BASIS DIS, V1792, P497, DOI 10.1016/j.bbadis.2009.02.013; Ghosh G, 2010, J CLIN INVEST, V120, P4141, DOI 10.1172/JCI42980; Gidskehaug L, 2004, J CHEMOMETR, V18, P208, DOI 10.1002/cem.862; Goldstraw P, 2009, J THORAC ONCOL, V4, P671, DOI 10.1097/JTO.0b013e31819e7814; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hu ZB, 2010, J CLIN ONCOL, V28, P1721, DOI 10.1200/JCO.2009.24.9342; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jiang LL, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-318; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Kuehbacher A, 2008, TRENDS PHARMACOL SCI, V29, P12, DOI 10.1016/j.tips.2007.10.014; Kuehbacher A, 2007, CIRC RES, V101, P59, DOI 10.1161/CIRCRESAHA.107.153916; Kulshreshtha R, 2008, CELL DEATH DIFFER, V15, P667, DOI 10.1038/sj.cdd.4402310; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Landi MT, 2010, CLIN CANCER RES, V16, P430, DOI 10.1158/1078-0432.CCR-09-1736; Lebanony D, 2009, J CLIN ONCOL, V27, P2030, DOI 10.1200/JCO.2008.19.4134; Lin PY, 2010, BRIT J CANCER, V103, P1144, DOI 10.1038/sj.bjc.6605901; Liu L.Z., 2011, PLOS ONE, V6; Meister J, 2010, THESCIENTIFICWORLDJO, V10, P2090, DOI 10.1100/tsw.2010.198; Nakashima T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014334; Nguewa PA, 2011, EXPERT OPIN INV DRUG, V20, P61, DOI 10.1517/13543784.2011.541153; Nikolic Iva, 2010, J Angiogenes Res, V2, P9, DOI 10.1186/2040-2384-2-9; Olson P, 2009, GENE DEV, V23, P2152, DOI 10.1101/gad.1820109; Patnaik SK, 2010, CANCER RES, V70, P36, DOI 10.1158/0008-5472.CAN-09-3153; Puissegur MP, 2011, CELL DEATH DIFFER, V18, P465, DOI 10.1038/cdd.2010.119; Raponi M, 2009, CANCER RES, V69, P5776, DOI 10.1158/0008-5472.CAN-09-0587; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Scagliotti G, 2009, ONCOLOGIST, V14, P253, DOI 10.1634/theoncologist.2008-0232; Seike M, 2009, P NATL ACAD SCI USA, V106, P12085, DOI 10.1073/pnas.0905234106; Suarez Y, 2009, CIRC RES, V104, P442, DOI 10.1161/CIRCRESAHA.108.191270; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun YQ, 2010, BIOCHEM BIOPH RES CO, V391, P1483, DOI 10.1016/j.bbrc.2009.12.098; Voortman J, 2010, CANCER RES, V70, P8288, DOI 10.1158/0008-5472.CAN-10-1348; Wang SS, 2008, DEV CELL, V15, P261, DOI 10.1016/j.devcel.2008.07.002; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; *WHO, 1999, HLTH PROM HOSP SER, P3; Wu FS, 2009, BIOCHEM BIOPH RES CO, V386, P549, DOI 10.1016/j.bbrc.2009.06.075; Wu X, 2009, J THORAC ONCOL, V4, P1028, DOI 10.1097/JTO.0b013e3181a99c77; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Zhang CX, 2010, J CARDIOVASC TRANSL, V3, P235, DOI 10.1007/s12265-010-9164-z; Zhou WC, 2009, CELL RES, V19, P1165, DOI 10.1038/cr.2009.95	61	86	97	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e29671	10.1371/journal.pone.0029671	http://dx.doi.org/10.1371/journal.pone.0029671			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295063	Green Published, gold, Green Submitted			2022-12-27	WOS:000301640600008
J	Linklater, WL; Gedir, JV; Law, PR; Swaisgood, RR; Adcock, K; du Preez, P; Knight, MH; Kerley, GIH				Linklater, Wayne L.; Gedir, Jay V.; Law, Peter R.; Swaisgood, Ron R.; Adcock, Keryn; du Preez, Pierre; Knight, Michael H.; Kerley, Graham I. H.			Translocations as Experiments in the Ecological Resilience of an Asocial Mega-Herbivore	PLOS ONE			English	Article							CONSERVATION; SUCCESS; POPULATION; EXPERIENCE; SELECTION; DENSITY; WILD	Species translocations are remarkable experiments in evolutionary ecology, and increasingly critical to biodiversity conservation. Elaborate socio-ecological hypotheses for translocation success, based on theoretical fitness relationships, are untested and lead to complex uncertainty rather than parsimonious solutions. We used an extraordinary 89 reintroduction and 102 restocking events releasing 682 black rhinoceros (Diceros bicornis) to 81 reserves in southern Africa (1981-2005) to test the influence of interacting socio-ecological and individual characters on post-release survival. We predicted that the socio-ecological context should feature more prominently after restocking than reintroduction because released rhinoceros interact with resident conspecifics. Instead, an interaction between release cohort size and habitat quality explained reintroduction success but only individuals' ages explained restocking outcomes. Achieving translocation success for many species may not be as complicated as theory suggests. Black rhino, and similarly asocial generalist herbivores without substantial predators, are likely to be resilient to ecological challenges and robust candidates for crisis management in a changing world.	[Linklater, Wayne L.; Gedir, Jay V.] Victoria Univ Wellington, Sch Biol Sci, Ctr Biodivers & Restorat Ecol, Wellington, New Zealand; [Linklater, Wayne L.; Knight, Michael H.; Kerley, Graham I. H.] Nelson Mandela Metropolitan Univ, Dept Zool, Ctr African Conservat Ecol, Port Elizabeth, South Africa; [Law, Peter R.] PRLDB Modeling, Monroe, LA USA; [Swaisgood, Ron R.] San Diego Zoo Global Inst Conservat Res, Escondido, CA USA; [Adcock, Keryn] IUCN African Rhino Specialist Grp, Hilton, KwaZulu Natal, South Africa; [du Preez, Pierre] Minist Environm & Tourism, Directorate Sci Serv, Windhoek, Namibia; [Knight, Michael H.] S African Natl Pk, Pk Planning & Dev, Port Elizabeth, South Africa	Victoria University Wellington; Nelson Mandela University	Linklater, WL (corresponding author), Victoria Univ Wellington, Sch Biol Sci, Ctr Biodivers & Restorat Ecol, Wellington, New Zealand.	wayne.linklater@vuw.ac.nz	Swaisgood, Ronald R/AAL-3198-2020	Swaisgood, Ronald R/0000-0001-5353-2148; Linklater, Wayne/0000-0003-2627-693X; Law, Peter/0000-0003-3382-0286	U.S. Fish and Wildlife Service [98210-2-G363, 98210-4-G920, 98210-6-G102]	U.S. Fish and Wildlife Service(US Fish & Wildlife Service)	U.S. Fish and Wildlife Service administered Rhinoceros and Tiger Conservation Act of 1994 (e. g., grant agreement numbers 98210-2-G363, 98210-4-G920, and 98210-6-G102); http://www.fws.gov/international/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock K, 2005, VISUAL ASSESSMENT BL; Adcock K, 2001, RHINO MANAGEMENT GRO; Adcock K, 1995, SEQUENCE REPORTS STA; [Anonymous], 1987, POS STAT TRANSL LIV; Armstrong D, 2007, TRENDS ECOLOGY EVOLU; Banks PB, 2002, BIOL CONSERV, V103, P133, DOI 10.1016/S0006-3207(01)00110-0; Beech H, 2011, TIME, P28; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Brett Rob, 1998, Pachyderm, V26, P69; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cameron EZ, 2009, P NATL ACAD SCI USA, V106, P13850, DOI 10.1073/pnas.0900639106; Castley J. Guy, 2003, Pachyderm, V34, P33; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; DODD CK, 1991, HERPETOLOGICA, V47, P336; Fischer J, 2000, BIOL CONSERV, V96, P1, DOI 10.1016/S0006-3207(00)00048-3; Frair JL, 2007, J WILDLIFE MANAGE, V71, P541, DOI 10.2193/2006-141; Gelman A., 2007, DATA ANAL USING REGR; GRIFFITH B, 1989, SCIENCE, V245, P477, DOI 10.1126/science.245.4917.477; HITCHINS PM, 1978, S AFR J WILDL RES, V8, P71; Hoegh-Guldberg O, 2008, SCIENCE, V321, P345, DOI 10.1126/science.1157897; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Linklater WL, 2008, J WILDLIFE MANAGE, V72, P1059, DOI 10.2193/2007-398; Linklater WL, 2011, J APPL ECOL, V48, P493, DOI 10.1111/j.1365-2664.2011.01960.x; Matson TK, 2004, BIOL CONSERV, V116, P359, DOI 10.1016/S0006-3207(03)00229-5; Morell V, 2008, SCIENCE, V320, P742, DOI 10.1126/science.320.5877.742; Nicoll MAC, 2003, J ANIM ECOL, V72, P917, DOI 10.1046/j.1365-2656.2003.00768.x; Owen-Smith N., 2003, ANIMAL BEHAV WILDLIF; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Sarrazin F, 1996, TRENDS ECOL EVOL, V11, P474, DOI 10.1016/0169-5347(96)20092-8; Scott JM, 2010, CONSERV LETT, V3, P91, DOI 10.1111/j.1755-263X.2010.00096.x; Shrader AM, 2002, BEHAV ECOL SOCIOBIOL, V52, P255, DOI 10.1007/s00265-002-0506-y; Somers MJ, 2008, OECOLOGIA, V158, P239, DOI 10.1007/s00442-008-1134-7; Stamps JA, 2007, APPL ANIM BEHAV SCI, V102, P392, DOI 10.1016/j.applanim.2006.05.038; Whittingham MJ, 2006, J ANIM ECOL, V75, P1182, DOI 10.1111/j.1365-2656.2006.01141.x; Wolf CM, 1998, BIOL CONSERV, V86, P243	35	16	16	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30664	10.1371/journal.pone.0030664	http://dx.doi.org/10.1371/journal.pone.0030664			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295100	Green Published, gold			2022-12-27	WOS:000301640600045
J	Taruttis, A; Morscher, S; Burton, NC; Razansky, D; Ntziachristos, V				Taruttis, Adrian; Morscher, Stefan; Burton, Neal C.; Razansky, Daniel; Ntziachristos, Vasilis			Fast Multispectral Optoacoustic Tomography (MSOT) for Dynamic Imaging of Pharmacokinetics and Biodistribution in Multiple Organs	PLOS ONE			English	Article							IN-VIVO; PHOTOACOUSTIC TOMOGRAPHY; SYSTEM; TUMORS; BRAIN	The characterization of pharmacokinetic and biodistribution profiles is an essential step in the development process of new candidate drugs or imaging agents. Simultaneously, the assessment of organ function related to the uptake and clearance of drugs is of great importance. To this end, we demonstrate an imaging platform capable of high-rate characterization of the dynamics of fluorescent agents in multiple organs using multispectral optoacoustic tomography (MSOT). A spatial resolution of approximately 150 mm through mouse cross-sections allowed us to image blood vessels, the kidneys, the liver and the gall bladder. In particular, MSOT was employed to characterize the removal of indocyanine green from the systemic circulation and its time-resolved uptake in the liver and gallbladder. Furthermore, it was possible to track the uptake of a carboxylate dye in separate regions of the kidneys. The results demonstrate the acquisition of agent concentration metrics at rates of 10 samples per second at a single wavelength and 17 s per multispectral sample with 10 signal averages at each of 5 wavelengths. Overall, such imaging performance introduces previously undocumented capabilities of fast, high resolution in vivo imaging of the fate of optical agents for drug discovery and basic biological research.	[Taruttis, Adrian; Morscher, Stefan; Burton, Neal C.; Razansky, Daniel; Ntziachristos, Vasilis] Tech Univ Munich, Inst Biol & Med Imaging, Helmholtz Zentrum Munich, Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Taruttis, A (corresponding author), Tech Univ Munich, Inst Biol & Med Imaging, Helmholtz Zentrum Munich, Munich, Germany.	taruttis@gmail.com	Razansky, Daniel/B-8590-2015	Razansky, Daniel/0000-0001-8676-0964; Morscher, Stefan/0000-0002-6552-8944	German Research Foundation (DFG) [RA 1848/1]; European Research Council (ERC); German Ministry of Education (BMBF)	German Research Foundation (DFG)(German Research Foundation (DFG)); European Research Council (ERC)(European Research Council (ERC)); German Ministry of Education (BMBF)(Federal Ministry of Education & Research (BMBF))	Dr. Razansky acknowledges support from the German Research Foundation (DFG) Research Grant (Grant No. RA 1848/1) and the European Research Council (ERC) Starting Grant. Dr. Ntziachristos acknowledges support from the ERC Advanced Investigator Award and the German Ministry of Education (BMBF) Innovation in Medicine Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buehler A, 2010, OPT LETT, V35, P2475, DOI 10.1364/OL.35.002475; De La Zerda A, 2008, NAT NANOTECHNOL, V3, P557, DOI 10.1038/nnano.2008.231; Dufort S, 2010, BBA-BIOMEMBRANES, V1798, P2266, DOI 10.1016/j.bbamem.2010.03.016; Gamelin J, 2009, OPT EXPRESS, V17, P10489, DOI 10.1364/OE.17.010489; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; Glatz J, 2011, OPT EXPRESS, V19, P3175, DOI 10.1364/OE.19.003175; HUNTON DB, 1960, GASTROENTEROLOGY, V39, P713; Kruger Robert A, 2003, Mol Imaging, V2, P113, DOI 10.1162/153535003322331993; Li ML, 2008, P IEEE, V96, P481, DOI 10.1109/JPROC.2007.913515; Marshall MV, 2010, MOL IMAGING BIOL, V12, P583, DOI 10.1007/s11307-010-0317-x; Ntziachristos V, 2005, NAT BIOTECHNOL, V23, P313, DOI 10.1038/nbt1074; Ntziachristos V, 2010, NAT METHODS, V7, P603, DOI [10.1038/NMETH.1483, 10.1038/nmeth.1483]; Ntziachristos V, 2010, CHEM REV, V110, P2783, DOI 10.1021/cr9002566; Ntziachristos V, 2002, NAT MED, V8, P757, DOI 10.1038/nm729; Razansky D, 2009, NAT PHOTONICS, V3, P412, DOI 10.1038/NPHOTON.2009.98; Rosenthal A, 2010, IEEE T MED IMAGING, V29, P1275, DOI 10.1109/TMI.2010.2044584; Sarantopoulos A., 2010, MOL IMAGING BIOL; Schulz RB, 2010, IEEE T MED IMAGING, V29, P465, DOI 10.1109/TMI.2009.2035310; Taruttis A, 2010, OPT EXPRESS, V18, P19592, DOI 10.1364/OE.18.019592; Wang XD, 2003, NAT BIOTECHNOL, V21, P803, DOI 10.1038/nbt839; Weissleder R, 1999, NAT BIOTECHNOL, V17, P375, DOI 10.1038/7933	21	109	111	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30491	10.1371/journal.pone.0030491	http://dx.doi.org/10.1371/journal.pone.0030491			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295087	Green Published, gold			2022-12-27	WOS:000301640600032
J	Liu, W; Xue, L				Liu, Wei; Xue, Lei			Functional Conservation of the Drosophila gooseberry Gene and Its Evolutionary Alleles	PLOS ONE			English	Article							SEGMENT POLARITY GENES; PAIR-RULE GENES; WAARDENBURG SYNDROME; SEXUAL-BEHAVIOR; CELL FATE; PAX GENES; EXPRESSION; PATTERN; NEUROGENESIS; WINGLESS	The Drosophila Pax gene gooseberry (gsb) is required for development of the larval cuticle and CNS, survival to adulthood, and male fertility. These functions can be rescued in gsb mutants by two gsb evolutionary alleles, gsb-Prd and gsb-Pax3, which express the Drosophila Paired and mouse Pax3 proteins under the control of gooseberry cis-regulatory region. Therefore, both Paired and Pax3 proteins have conserved all the Gsb functions that are required for survival of embryos to fertile adults, despite the divergent primary sequences in their C-terminal halves. As gsb-Prd and gsb-Pax3 uncover a gsb function involved in male fertility, construction of evolutionary alleles may provide a powerful strategy to dissect hitherto unknown gene functions. Our results provide further evidence for the essential role of cis-regulatory regions in the functional diversification of duplicated genes during evolution.	[Liu, Wei] NW Agr & Forest Univ, Coll Vet Med, Yangling, Shaanxi, Peoples R China; [Xue, Lei] Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China; [Liu, Wei; Xue, Lei] Univ Zurich, Inst Mol Biol, Zurich, Switzerland	Northwest A&F University - China; Tongji University; University of Zurich	Liu, W (corresponding author), NW Agr & Forest Univ, Coll Vet Med, Yangling, Shaanxi, Peoples R China.	lei.xue@tongji.edu.cn			Swiss National Science Foundation [31-40874.94]; National Natural Science Foundation of China [30971681]; NWAF [Z11021005]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NWAF	This work has been supported by the following three funds: 1. Swiss National Science Foundation, Grant No. 31-40874.94; 2. National Natural Science Foundation of China, Grant No. 30971681; 3. Fund from NWAF (No. Z11021005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALDWIN CT, 1992, NATURE, V355, P637, DOI 10.1038/355637a0; BAUMGARTNER S, 1990, MECH DEVELOP, V33, P1, DOI 10.1016/0925-4773(90)90130-E; BAUMGARTNER S, 1987, GENE DEV, V1, P1247, DOI 10.1101/gad.1.10.1247; Baylies MK, 1998, CELL, V93, P921, DOI 10.1016/S0092-8674(00)81198-8; BERLETH T, 1988, EMBO J, V7, P1749, DOI 10.1002/j.1460-2075.1988.tb03004.x; Bertuccioli C, 1996, DEVELOPMENT, V122, P2673; Bhat KM, 1999, BIOESSAYS, V21, P472, DOI 10.1002/(SICI)1521-1878(199906)21:6<472::AID-BIES4>3.0.CO;2-W; Bhat KM, 1996, DEVELOPMENT, V122, P2921; BOPP D, 1986, CELL, V47, P1033, DOI 10.1016/0092-8674(86)90818-4; Borycki AG, 1997, CURR BIOL, V7, P620; Brook WJ, 1996, SCIENCE, V273, P1373, DOI 10.1126/science.273.5280.1373; COTE S, 1987, EMBO J, V6, P2793, DOI 10.1002/j.1460-2075.1987.tb02575.x; Deshpande N, 2001, DEVELOPMENT, V128, P3253; DumanScheel M, 1997, DEVELOPMENT, V124, P2855; EPSTEIN DJ, 1991, CELL, V67, P767, DOI 10.1016/0092-8674(91)90071-6; FRIGERIO G, 1986, CELL, V47, P735, DOI 10.1016/0092-8674(86)90516-7; GOULDING MD, 1991, EMBO J, V10, P1135, DOI 10.1002/j.1460-2075.1991.tb08054.x; GUTJAHR T, 1993, DEVELOPMENT, V117, P609; GUTJAHR T, 1993, DEVELOPMENT, V118, P21; Jiao RJ, 2001, DEVELOPMENT, V128, P3307; LI XL, 1993, EMBO J, V12, P4499, DOI 10.1002/j.1460-2075.1993.tb06139.x; Marie B, 2010, J NEUROSCI, V30, P8071, DOI 10.1523/JNEUROSCI.5467-09.2010; NOLL M, 1993, CURR OPIN GENET DEV, V3, P595, DOI 10.1016/0959-437X(93)90095-7; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Nutt SL, 1999, BIOL CHEM, V380, P601, DOI 10.1515/BC.1999.077; PATEL NH, 1989, GENE DEV, V3, P890, DOI 10.1101/gad.3.6.890; PEIFER M, 1992, TRENDS GENET, V8, P243, DOI 10.1016/0168-9525(92)90394-J; RICHMOND RC, 1980, SCIENCE, V207, P1483, DOI 10.1126/science.6767273; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Schedl A, 1996, CELL, V86, P71, DOI 10.1016/S0092-8674(00)80078-1; Small S, 1991, CURR OPIN GENET DEV, V1, P255, DOI 10.1016/S0959-437X(05)80079-6; STJOHNSTON D, 1992, CELL, V68, P201; TASSABEHJI M, 1992, NATURE, V355, P635, DOI 10.1038/355635a0; TREISMAN J, 1991, GENE DEV, V5, P594, DOI 10.1101/gad.5.4.594; Whittle J R, 1990, Semin Cell Biol, V1, P241; Xue L, 2002, DEVELOPMENT, V129, P339; Xue L, 1996, EMBO J, V15, P3722, DOI 10.1002/j.1460-2075.1996.tb00742.x; Xue L, 2001, DEVELOPMENT, V128, P395; Xue L, 2000, P NATL ACAD SCI USA, V97, P3272, DOI 10.1073/pnas.060018897; Yamamoto D, 1997, ANNU REV ENTOMOL, V42, P551, DOI 10.1146/annurev.ento.42.1.551; ZHANG Y, 1994, DEVELOPMENT, V120, P1151	41	0	0	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30980	10.1371/journal.pone.0030980	http://dx.doi.org/10.1371/journal.pone.0030980			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22292084	Green Published, Green Submitted, gold			2022-12-27	WOS:000301570600102
J	Chyu, KY; Zhao, XN; Dimayuga, PC; Zhou, JC; Li, XJ; Yano, J; Lio, WM; Chan, LF; Kirzner, J; Trinidad, P; Cercek, B; Shah, PK				Chyu, Kuang-Yuh; Zhao, Xiaoning; Dimayuga, Paul C.; Zhou, Jianchang; Li, Xiaojun; Yano, Juliana; Lio, Wai Man; Chan, Lai Fan; Kirzner, Jonathan; Trinidad, Portia; Cercek, Bojan; Shah, Prediman K.			CD8(+) T Cells Mediate the Athero-Protective Effect of Immunization with an ApoB-100 Peptide	PLOS ONE			English	Article							ATHEROSCLEROTIC LESIONS; APOLIPOPROTEIN B-100; DENDRITIC CELLS; DEFICIENT MICE; ADOPTIVE TRANSFER; IMMUNE-RESPONSES; LDL IMMUNIZATION; DENSITY; SEQUENCES; POPULATIONS	Immunization of hypercholesterolemic mice with selected apoB-100 peptide antigens reduces atherosclerosis but the precise immune mediators of athero-protection remain unclear. In this study we show that immunization of apoE (-/-) mice with p210, a 20 amino acid apoB-100 related peptide, reduced aortic atherosclerosis compared with PBS or adjuvant/carrier controls. Immunization with p210 activated CD8(+) T cells, reduced dendritic cells (DC) at the site of immunization and within the plaque with an associated reduction in plaque macrophage immunoreactivity. Adoptive transfer of CD8(+) T cells from p210 immunized mice recapitulated the athero-protective effect of p210 immunization in naive, non-immunized mice. CD8(+) T cells from p210 immunized mice developed a preferentially higher cytolytic response against p210-loaded dendritic cells in vitro. Although p210 immunization profoundly modulated DCs and cellular immune responses, it did not alter the efficacy of subsequent T cell dependent or independent immune response to other irrelevant antigens. Our data define, for the first time, a role for CD8(+) T cells in mediating the athero-protective effects of apoB-100 related peptide immunization in apoE (-/-) mice.	[Chyu, Kuang-Yuh; Zhao, Xiaoning; Dimayuga, Paul C.; Zhou, Jianchang; Li, Xiaojun; Yano, Juliana; Lio, Wai Man; Chan, Lai Fan; Kirzner, Jonathan; Trinidad, Portia; Cercek, Bojan; Shah, Prediman K.] Cedars Sinai Med Ctr, Div Cardiol, Oppenheimer Atherosclerosis Res Ctr, Cedars Sinai Heart Inst, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center	Chyu, KY (corresponding author), Cedars Sinai Med Ctr, Div Cardiol, Oppenheimer Atherosclerosis Res Ctr, Cedars Sinai Heart Inst, 8700 Beverly Blvd, Los Angeles, CA 90048 USA.	ShahP@cshs.org			Heart Foundation; Shapell and Guerin Family; Feintech Family; Corday Foundation; Skirball Foundation; Cardiovax Inc.; Cardiovax	Heart Foundation; Shapell and Guerin Family; Feintech Family; Corday Foundation; Skirball Foundation; Cardiovax Inc.; Cardiovax	This work received support from the Heart Foundation, Spielberg Cardiovascular Research Fund, the Shapell and Guerin Family, the Feintech Family, the Corday Foundation, the Skirball Foundation and Cardiovax Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr. Shah is a co-inventor of apoB-100 peptide vaccines and has assigned patent rights to Cedars-Sinai Medical Center. Dr. Shah is a scientific advisor to Cardiovax Inc. The funding support from Cardiovax does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. The other authors have no competing interests to declare.	Ait-Oufella H, 2006, NAT MED, V12, P178, DOI 10.1038/nm1343; Ameli S, 1996, ARTERIOSCL THROM VAS, V16, P1074, DOI 10.1161/01.ATV.16.8.1074; Bobryshev YV, 2001, HISTOL HISTOPATHOL, V16, P801, DOI 10.14670/HH-16.801; Caligiuri G, 2002, J CLIN INVEST, V109, P745, DOI 10.1172/JCI200207272; Chyu KY, 2005, BIOCHEM BIOPH RES CO, V338, P1982, DOI 10.1016/j.bbrc.2005.10.141; Chyu KY, 2004, ATHEROSCLEROSIS, V176, P27, DOI 10.1016/j.atherosclerosis.2004.04.016; Dimayuga P, 2002, ARTERIOSCL THROM VAS, V22, P644, DOI 10.1161/01.ATV.0000012455.62765.BF; Dimayuga PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020214; Fredrikson GN, 2005, AUTOIMMUNITY, V38, P171, DOI 10.1080/08916930500050525; Fredrikson GN, 2003, ARTERIOSCL THROM VAS, V23, P879, DOI 10.1161/01.ATV.0000067937.93716.DB; Fredrikson GN, 2003, ARTERIOSCL THROM VAS, V23, P872, DOI 10.1161/01.ATV.0000067935.02679.B0; Fredrikson GN, 2008, J INTERN MED, P1; Freigang S, 1998, ARTERIOSCL THROM VAS, V18, P1972, DOI 10.1161/01.ATV.18.12.1972; FYFE AI, 1994, J CLIN INVEST, V94, P2516, DOI 10.1172/JCI117622; George J, 1998, ATHEROSCLEROSIS, V138, P147, DOI 10.1016/S0021-9150(98)00015-X; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Klingenberg R, 2010, ARTERIOSCL THROM VAS, V30, P946, DOI 10.1161/ATVBAHA.109.202671; Kolbus D, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-58; Lecoeur H, 2001, J IMMUNOL METHODS, V253, P177, DOI 10.1016/S0022-1759(01)00359-3; Liu P, 2008, ARTERIOSCL THROM VAS, V28, P243, DOI 10.1161/ATVBAHA.107.158675; Mor A, 2007, ARTERIOSCL THROM VAS, V27, P893, DOI 10.1161/01.ATV.0000259365.31469.89; Niessner A, 2010, CLIN IMMUNOL, V134, P25, DOI 10.1016/j.clim.2009.05.006; PALINSKI W, 1995, P NATL ACAD SCI USA, V92, P821, DOI 10.1073/pnas.92.3.821; Paulson KE, 2010, CIRC RES, V106, P383, DOI 10.1161/CIRCRESAHA.109.210781; Roselaar SE, 1996, ARTERIOSCL THROM VAS, V16, P1013, DOI 10.1161/01.ATV.16.8.1013; Sakamoto N, 2007, BLOOD, V110, P501, DOI 10.1182/blood-2007-01-066522; Schiopu A, 2004, CIRCULATION, V110, P2047, DOI 10.1161/01.CIR.0000143162.56057.B5; Shah PK, 2005, NAT CLIN PRACT CARD, V2, P639, DOI 10.1038/ncpcardio0372; Sjogren P, 2008, EUR HEART J, V29, P2218, DOI 10.1093/eurheartj/ehn336; van den Elzen P, 2005, NATURE, V437, P906, DOI 10.1038/nature04001; Wigren M, 2011, J INTERN MED, V269, P546, DOI 10.1111/j.1365-2796.2010.02311.x; Wu HZ, 2009, CIRCULATION, V119, P2708, DOI 10.1161/CIRCULATIONAHA.108.823740; Yang GX, 2008, HEPATOLOGY, V47, P1974, DOI 10.1002/hep.22226; Yang KP, 2006, CELL IMMUNOL, V243, P90, DOI 10.1016/j.cellimm.2007.01.002; Zhou XH, 2000, CIRCULATION, V102, P2919; Zhou XH, 2005, CIRC RES, V96, P427, DOI 10.1161/01.RES.0000156889.22364.f1; Zhou XH, 1996, AM J PATHOL, V149, P359; Zhou XH, 2006, ARTERIOSCL THROM VAS, V26, P864, DOI 10.1161/01.ATV.0000206122.61591.ff; Zhou XH, 2001, ARTERIOSCL THROM VAS, V21, P108, DOI 10.1161/01.ATV.21.1.108	40	69	78	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2012	7	2							e30780	10.1371/journal.pone.0030780	http://dx.doi.org/10.1371/journal.pone.0030780			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZQ	22347402	Green Submitted, Green Published, gold			2022-12-27	WOS:000302730200008
J	Kim, S; Roopra, A; Alexander, CM				Kim, Soyoung; Roopra, Avtar; Alexander, Caroline M.			A Phenotypic Mouse Model of Basaloid Breast Tumors	PLOS ONE			English	Article							CANCER STEM-CELLS; GENE-EXPRESSION PROFILES; MAMMARY-TUMORS; INITIATING CELLS; BRCA1; RECEPTOR; RESISTANCE; GLAND; P53; RADIORESISTANCE	Chemotherapeutic strategies that target basal-like breast tumors are difficult to design without understanding their cellular and molecular basis. Here, we induce tumors in mice by carcinogen administration, creating a phenocopy of tumors with the diagnostic and functional aspects of human triple negative disease (including EGFR expression/lack of erbB, estrogen-independent growth and co-clustering of the transcriptome with other basaloid models). These tumor strains are a complement to established mouse models that are based on mutations in Brca1 and/or p53. Tumors comprise two distinct cell subpopulations, basal and luminal epithelial cells. These cell fractions were purified by flow cytometry, and only basal cell fractions found to have tumor initiating activity (cancer stem cells). The phenotype of serially regenerated tumors was stable, and irrespective of tumor precursor cell. Tumors were passaged entirely in vivo and serial generations tested for their phenotypic stability. The relative chemo-sensitivity of basal and luminal cells were evaluated. Upon treatment with anthracycline, tumors were effectively de-bulked, but recurred; this correlated with maintenance of a high rate of basal cell division throughout the treatment period. Thus, these tumors grow as robust cell mixtures of basal bipotential tumor initiating cells alongside a luminal majority, and the cellular response to drug administration is dominated by the distinct biology of the two cell types. Given the ability to separate basal and luminal cells, and the discovery potential of this approach, we propose that this mouse model could be a convenient one for preclinical studies.	[Kim, Soyoung; Alexander, Caroline M.] Univ Wisconsin, McArdle Lab Canc Res, Madison, WI 53706 USA; [Roopra, Avtar] Univ Wisconsin, Dept Neurosci, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Kim, S (corresponding author), Univ Wisconsin, McArdle Lab Canc Res, 1400 Univ Ave, Madison, WI 53706 USA.	alexander@oncology.wisc.edu			DOD-BCRP [W81XWH-06-1-0491]; University of Wisconsin NCDDG [U19, CA113297]; NATIONAL CANCER INSTITUTE [U19CA113297, P30CA014520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065067] Funding Source: NIH RePORTER	DOD-BCRP(United States Department of Defense); University of Wisconsin NCDDG; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by an Era of Hope Scholars Award from the DOD-BCRP to CMA (W81XWH-06-1-0491). Also, this project was supported by the University of Wisconsin NCDDG (U19; CA113297) and the University of Wisconsin Carbone Cancer Center that provided shared services to complete this research (P30 CA014520). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander CM, 2009, CELL STEM CELL, V5, P579, DOI 10.1016/j.stem.2009.11.008; Badders NM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006594; Bade LK, 2011, J CELL SCI, V124, P3106, DOI 10.1242/jcs.082651; Badve S, 2010, MOD PATHOL; Bhargava R, 2008, AM J CLIN PATHOL, V130, P724, DOI 10.1309/AJCP3KFF1LTYWQIY; CARDIFF RD, 1988, ONCOGENE, V3, P205; Carey LA, 2007, CLIN CANCER RES, V13, P2329, DOI 10.1158/1078-0432.CCR-06-1109; Chan MM, 2007, INT J CANCER, V121, P474, DOI 10.1002/ijc.22684; Cheang MCU, 2008, CLIN CANCER RES, V14, P1368, DOI 10.1158/1078-0432.CCR-07-1658; Cho RW, 2008, STEM CELLS, V26, P364, DOI 10.1634/stemcells.2007-0440; Collis SJ, 2005, ONCOGENE, V24, P949, DOI 10.1038/sj.onc.1208332; Currier N, 2005, TOXICOL PATHOL, V33, P726, DOI 10.1080/01926230500352226; DeRose YS, 2011, NAT MED, V17, P1514, DOI 10.1038/nm.2454; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; El-Rehim DMA, 2004, J PATHOL, V203, P661, DOI 10.1002/path.1559; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Gonzalez-Angulo AM, 2011, CLIN CANCER RES, V17, P1082, DOI 10.1158/1078-0432.CCR-10-2560; Graeser M, 2010, CLIN CANCER RES, V16, P6159, DOI 10.1158/1078-0432.CCR-10-1027; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Hochgrafe F, 2010, CANCER RES, V70, P9391, DOI 10.1158/0008-5472.CAN-10-0911; Ivanov O, 2008, BREAST CANCER RES TR, V111, P411, DOI 10.1007/s10549-007-9796-0; JERRY DJ, 1994, MOL CARCINOGEN, V9, P175, DOI 10.1002/mc.2940090309; JONES LP, 2007, ONCOGENE; Kellen E, 2009, BREAST CANCER RES TR, V114, P13, DOI 10.1007/s10549-008-9990-8; Kim S, 2011, PLOS ONE, V6; Korkaya H, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000121; Kunigal S, 2008, CLIN CANCER RES, V14, P3617, DOI 10.1158/1078-0432.CCR-07-2060; Li Y, 2010, NAT MED, V16, P214, DOI 10.1038/nm.2090; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Lin SCJ, 2004, CANCER RES, V64, P3525, DOI 10.1158/0008-5472.CAN-03-3524; Liu GZ, 2003, MOL CELL BIOL, V23, P5825, DOI 10.1128/MCB.23.16.5825-5835.2003; Liu X, 2007, P NATL ACAD SCI USA, V104, P12111, DOI 10.1073/pnas.0702969104; Lomonaco SL, 2009, INT J CANCER, V125, P717, DOI 10.1002/ijc.24402; Luetteke NC, 1999, DEVELOPMENT, V126, P2739; Marangoni E, 2007, CLIN CANCER RES, V13, P3989, DOI 10.1158/1078-0432.CCR-07-0078; Martin SA, 2009, J PATHOL; Mastroianni M, 2009, CANC LETT; McDermott SP, 2006, ONCOGENE; Mehta RG, 2000, EUR J CANCER, V36, P1275, DOI 10.1016/S0959-8049(00)00100-3; Michalak EM, 2010, J MAMMARY GLAND BIOL; Millikan RC, 2008, BREAST CANCER RES TR, V109, P123, DOI 10.1007/s10549-007-9632-6; Molyneux G, 2010, CELL STEM CELL, V7, P403, DOI 10.1016/j.stem.2010.07.010; Mote PA, 2006, ENDOCRINOLOGY, V147, P5503, DOI 10.1210/en.2006-0040; Pajic M, 2010, CELL CYCLE, V9, P3780, DOI 10.4161/cc.9.18.13002; Pasic L, 2011, GENE DEV, V25, P1641, DOI 10.1101/gad.2025611; Rakha EA, 2007, HISTOPATHOLOGY, V50, P434, DOI 10.1111/j.1365-2559.2007.02638.x; Rakha EA, 2008, MODERN PATHOL, V21, P1060, DOI 10.1038/modpathol.2008.67; Rakha EA, 2009, CLIN CANCER RES, V15, P2302, DOI 10.1158/1078-0432.CCR-08-2132; Rodriguez AA, 2010, BREAST CANCER RES TR, V123, P189, DOI 10.1007/s10549-010-0983-z; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shafee N, 2008, CANCER RES, V68, P3243, DOI 10.1158/0008-5472.CAN-07-5480; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Toft DJ, 2011, MOL ENDOCRINOL, V25, P199, DOI 10.1210/me.2010-0164; Turner NC, 2006, ONCOGENE, V25, P5846, DOI 10.1038/sj.onc.1209876; Vaillant F, 2008, CANCER RES, V68, P7711, DOI 10.1158/0008-5472.CAN-08-1949; van de Rijn M, 2002, AM J PATHOL, V161, P1991, DOI 10.1016/S0002-9440(10)64476-8; Varela I, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r100; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Weigelt B, 2003, P NATL ACAD SCI USA, V100, P15901, DOI 10.1073/pnas.2634067100; Williams ES, 2009, CANCER RES, V69, P2100, DOI 10.1158/0008-5472.CAN-08-2854; Wirapati P, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2124; Yan HH, 2010, AM J PATHOL, V176, P1421, DOI 10.2353/ajpath.2010.090438; Zhang M, 2008, CANCER RES, V68, P4674, DOI 10.1158/0008-5472.CAN-07-6353; Zhang M, 2010, P NATL ACAD SCI USA, V107, P3522, DOI 10.1073/pnas.0910179107	65	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2012	7	2							e30979	10.1371/journal.pone.0030979	http://dx.doi.org/10.1371/journal.pone.0030979			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZQ	22347416	Green Published, gold, Green Submitted			2022-12-27	WOS:000302730200012
J	Rodger, J; Drummond, ES; Hellstrom, M; Robertson, D; Harvey, AR				Rodger, Jennifer; Drummond, Eleanor S.; Hellstroem, Mats; Robertson, Donald; Harvey, Alan R.			Long-Term Gene Therapy Causes Transgene-Specific Changes in the Morphology of Regenerating Retinal Ganglion Cells	PLOS ONE			English	Article							PERIPHERAL-NERVE GRAFTS; LEBERS CONGENITAL AMAUROSIS; NEUROTROPHIC FACTOR; NEURITE OUTGROWTH; DENDRITIC GROWTH; PROTEASE NEXIN-1; ADULT CATS; SYMPATHETIC NEURONS; HIPPOCAMPAL-NEURONS; AXONAL REGENERATION	Recombinant adeno-associated viral (rAAV) vectors can be used to introduce neurotrophic genes into injured CNS neurons, promoting survival and axonal regeneration. Gene therapy holds much promise for the treatment of neurotrauma and neurodegenerative diseases; however, neurotrophic factors are known to alter dendritic architecture, and thus we set out to determine whether such transgenes also change the morphology of transduced neurons. We compared changes in dendritic morphology of regenerating adult rat retinal ganglion cells (RGCs) after long-term transduction with rAAV2 encoding: (i) green fluorescent protein (GFP), or (ii) bi-cistronic vectors encoding GFP and ciliary neurotrophic factor (CNTF), brain-derived neurotrophic factor (BDNF) or growth-associated protein-43 (GAP43). To enhance regeneration, rats received an autologous peripheral nerve graft onto the cut optic nerve of each rAAV2 injected eye. After 5-8 months, RGCs with regenerated axons were retrogradely labeled with fluorogold (FG). Live retinal wholemounts were prepared and GFP positive (transduced) or GFP negative (non-transduced) RGCs injected iontophoretically with 2% lucifer yellow. Dendritic morphology was analyzed using Neurolucida software. Significant changes in dendritic architecture were found, in both transduced and non-transduced populations. Multivariate analysis revealed that transgenic BDNF increased dendritic field area whereas GAP43 increased dendritic complexity. CNTF decreased complexity but only in a subset of RGCs. Sholl analysis showed changes in dendritic branching in rAAV2-BDNF-GFP and rAAV2-CNTF-GFP groups and the proportion of FG positive RGCs with aberrant morphology tripled in these groups compared to controls. RGCs in all transgene groups displayed abnormal stratification. Thus in addition to promoting cell survival and axonal regeneration, vector-mediated expression of neurotrophic factors has measurable, gene-specific effects on the morphology of injured adult neurons. Such changes will likely alter the functional properties of neurons and may need to be considered when designing vector-based protocols for the treatment of neurotrauma and neurodegeneration.	[Rodger, Jennifer] Univ Western Australia, Sch Anim Biol, Perth, WA 6009, Australia; [Drummond, Eleanor S.; Hellstroem, Mats; Harvey, Alan R.] Univ Western Australia, Sch Anat & Human Biol, Perth, WA 6009, Australia; [Robertson, Donald] Univ Western Australia, Discipline Physiol, Sch Biomed & Biomol Sci, Perth, WA 6009, Australia	University of Western Australia; University of Western Australia; University of Western Australia	Rodger, J (corresponding author), Univ Western Australia, Sch Anim Biol, Perth, WA 6009, Australia.	alan.harvey@uwa.edu.au	Harvey, Alan R/A-4911-2008; Drummond, Eleanor/AAB-9731-2021; Rodger, Jennifer/H-5735-2014	Rodger, Jennifer/0000-0003-3413-4229; Drummond, Eleanor/0000-0002-5466-4609; , Alan/0000-0002-2590-831X	National Health and Medical Research Council (NHMRC); WA Neurotrauma Research Program; Raine Foundation of Western Australia; International Postgraduate Student Scholarship	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); WA Neurotrauma Research Program; Raine Foundation of Western Australia; International Postgraduate Student Scholarship	The research was supported by the National Health and Medical Research Council (NHMRC) and the WA Neurotrauma Research Program. JR was funded by the Raine Foundation of Western Australia and a Senior Research Fellowship from NHMRC. MH was funded by an International Postgraduate Student Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Baumgartner BJ, 1997, J NEUROSCI, V17, P6504; BIFFO S, 1990, EUR J NEUROSCI, V2, P487, DOI 10.1111/j.1460-9568.1990.tb00440.x; Bjorklund T, 2010, MOVEMENT DISORD, V25, pS161, DOI 10.1002/mds.22785; BRAY GM, 1987, J EXP BIOL, V132, P5; Chacon PJ, 2010, MOL CELL NEUROSCI, V43, P384, DOI 10.1016/j.mcn.2010.01.005; Chiwitt C, 2011, RESTOR NEUROL NEUROS, V29, P127, DOI 10.3233/RNN-2011-0586; CHOI BH, 1995, NEUROBIOL AGING, V16, P557, DOI 10.1016/0197-4580(95)00060-R; Cideciyan AV, 2009, HUM GENE THER, V20, P999, DOI 10.1089/hum.2009.086; Cohen-Cory S, 2004, INT J DEV BIOL, V48, P947, DOI 10.1387/ijdb.041883sc; Cui Q, 2000, NEUROREPORT, V11, P3999, DOI 10.1097/00001756-200012180-00019; D Kuipers S, 2006, CURR OPIN DRUG DISC, V9, P580; de Winter W, 2001, NATURE, V409, P710, DOI 10.1038/35055547; Deplano S, 2004, DEV NEUROSCI-BASEL, V26, P396, DOI 10.1159/000082282; Deplano S, 1999, J COMP NEUROL, V405, P262, DOI 10.1002/(SICI)1096-9861(19990308)405:2<262::AID-CNE9>3.0.CO;2-4; DIAZNIDO J, 1991, J CELL SCI, V98, P409; Dijkhuizen PA, 2005, PROG BRAIN RES, V147, P17, DOI 10.1016/S0079-6123(04)47002-2; DREHER B, 1985, BRAIN BEHAV EVOLUT, V26, P10, DOI 10.1159/000118764; Du JL, 2004, NATURE, V429, P878, DOI 10.1038/nature02618; Eberling JL, 2008, NEUROLOGY, V70, P1980, DOI 10.1212/01.wnl.0000312381.29287.ff; FAMIGLIETTI EV, 1976, SCIENCE, V194, P193, DOI 10.1126/science.959847; Frey D, 2000, J CELL BIOL, V149, P1443, DOI 10.1083/jcb.149.7.1443; FUKUDA Y, 1977, BRAIN RES, V119, P327, DOI 10.1016/0006-8993(77)90314-6; Fukuda Y, 1998, VISION RES, V38, P1545, DOI 10.1016/S0042-6989(98)00005-4; Gauthier-Campbell C, 2004, MOL BIOL CELL, V15, P2205, DOI 10.1091/mbc.E03-07-0493; Germain F, 2003, EUR J NEUROSCI, V18, P1103, DOI 10.1046/j.1460-9568.2003.02842.x; Guo X, 1999, J NEUROSCI, V19, P2113; GURWITZ D, 1990, J CELL PHYSIOL, V142, P155, DOI 10.1002/jcp.1041420119; Harvey AR, 2006, PROG RETIN EYE RES, V25, P449, DOI 10.1016/j.preteyeres.2006.07.002; Hellstrom M, 2011, MOL CELL NEUROSCI, V46, P507, DOI 10.1016/j.mcn.2010.12.003; Hellstrom M, 2011, J NEUROTRAUM, V28, P2475, DOI 10.1089/neu.2011.1928; Hellstrom M, 2011, CURR GENE THER, V11, P116, DOI 10.2174/156652311794940746; Horch HW, 2004, REV NEUROSCIENCE, V15, P117; Horch HW, 2002, NAT NEUROSCI, V5, P1177, DOI 10.1038/nn927; Huberman AD, 2008, NEURON, V59, P425, DOI 10.1016/j.neuron.2008.07.018; Huxlin KR, 1997, J COMP NEUROL, V385, P309; Kells AP, 2008, GENE THER, V15, P966, DOI 10.1038/gt.2008.23; Klein RL, 1999, BRAIN RES, V832, P136, DOI 10.1016/S0006-8993(99)01482-1; Klein RL, 1999, NEUROSCIENCE, V90, P815, DOI 10.1016/S0306-4522(98)00537-5; Kong JH, 2005, J COMP NEUROL, V489, P293, DOI 10.1002/cne.20631; Kwon M, 2011, J NEUROSCI, V31, P9735, DOI 10.1523/JNEUROSCI.6785-10.2011; Lagriffoul A, 1996, J BIOL CHEM, V271, P31508, DOI 10.1074/jbc.271.49.31508; LAU KC, 1991, RESTOR NEUROL NEUROS, V3, P235, DOI 10.3233/RNN-1991-3502; Leaver SG, 2006, GENE THER, V13, P1328, DOI 10.1038/sj.gt.3302791; Liang FQ, 2001, MOL THER, V3, P241, DOI 10.1006/mthe.2000.0252; Lin B, 2004, NEURON, V43, P475, DOI 10.1016/j.neuron.2004.08.002; Luikart BW, 2008, J NEUROSCI, V28, P7006, DOI 10.1523/JNEUROSCI.0195-08.2008; Mandel RJ, 2010, CURR OPIN MOL THER, V12, P240; Marks WJ, 2008, LANCET NEUROL, V7, P400, DOI 10.1016/S1474-4422(08)70065-6; MARTIN PR, 1986, EXP BRAIN RES, V62, P77; Meins M, 2001, J NEUROSCI, V21, P8830, DOI 10.1523/JNEUROSCI.21-22-08830.2001; Miller FD, 2003, CURR OPIN NEUROBIOL, V13, P391, DOI 10.1016/s0959-4388(03)00072-2; Milosevic NT, 2009, J THEOR BIOL, V259, P142, DOI 10.1016/j.jtbi.2009.03.011; Miyoshi T, 1999, EXP BRAIN RES, V124, P383, DOI 10.1007/s002210050635; Mizuguchi H, 2000, MOL THER, V1, P376, DOI 10.1006/mthe.2000.0050; Niclou SP, 1998, EUR J NEUROSCI, V10, P1590, DOI 10.1046/j.1460-9568.1998.00183.x; Park KK, 2009, MOL CELL NEUROSCI, V41, P313, DOI 10.1016/j.mcn.2009.04.002; Parrish JZ, 2007, ANNU REV NEUROSCI, V30, P399, DOI 10.1146/annurev.neuro.29.051605.112907; PERRY VH, 1979, PROC R SOC SER B-BIO, V204, P363, DOI 10.1098/rspb.1979.0033; Quan MZ, 1999, INVEST OPHTH VIS SCI, V40, P2360; Ramaswamy S, 2009, NEUROBIOL DIS, V34, P40, DOI 10.1016/j.nbd.2008.12.005; REINHARD E, 1994, J NEUROSCI RES, V37, P256, DOI 10.1002/jnr.490370211; Richardson RM, 2011, MOL THER, V19, P1048, DOI 10.1038/mt.2011.11; Robinson GA, 2004, VISION RES, V44, P2667, DOI 10.1016/j.visres.2004.06.010; Ruitenberg MJ, 2004, NEUROBIOL DIS, V15, P394, DOI 10.1016/j.nbd.2003.11.018; Sapieha PS, 2003, MOL CELL NEUROSCI, V24, P656, DOI 10.1016/S1044-7431(03)00228-8; Schmeer C, 2002, EUR J NEUROSCI, V15, P637, DOI 10.1046/j.1460-9568.2002.01893.x; SHOLL DA, 1953, J ANAT, V87, P387; Simonelli F, 2010, MOL THER, V18, P643, DOI 10.1038/mt.2009.277; Smith PD, 2009, NEURON, V64, P617, DOI 10.1016/j.neuron.2009.11.021; Sommerfeld MT, 2000, J BIOL CHEM, V275, P8982, DOI 10.1074/jbc.275.12.8982; STRITTMATTER SM, 1994, J NEUROSCI, V14, P5503; SUIDAN HS, 1992, NEURON, V8, P363, DOI 10.1016/0896-6273(92)90302-T; Sun WZ, 2002, VISUAL NEUROSCI, V19, P483, DOI 10.1017/S0952523802194107; THANOS S, 1995, J NEUROSCI, V15, P1057, DOI 10.1523/jneurosci.15-02-01057.1995; THANOS S, 1988, CELL TISSUE RES, V254, P599; Tolwani RJ, 2002, NEUROSCIENCE, V114, P795, DOI 10.1016/S0306-4522(02)00301-9; Tuszynski MH, 2005, NAT MED, V11, P551, DOI 10.1038/nm1239; WASSLE H, 1988, TRENDS NEUROSCI, V11, P87, DOI 10.1016/0166-2236(88)90147-6; WATANABE M, 1993, J NEUROSCI, V13, P2105; Weber AJ, 2008, INVEST OPHTH VIS SCI, V49, P2456, DOI 10.1167/iovs.07-1325; Wu K, 2003, HUM GENE THER, V14, P1463, DOI 10.1089/104303403769211673; Yacoubian TA, 2000, NAT NEUROSCI, V3, P342, DOI 10.1038/73911; Yang Y, 2009, J GENE MED, V11, P899, DOI 10.1002/jgm.1377; Yata T, 2007, NEUROSCIENCE, V148, P53, DOI 10.1016/j.neuroscience.2007.05.042; Zagrebelsky M, 2005, J NEUROSCI, V25, P9989, DOI 10.1523/JNEUROSCI.2492-05.2005; ZURN AD, 1988, DEV NEUROSCI-BASEL, V10, P17, DOI 10.1159/000111951	87	33	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31061	10.1371/journal.pone.0031061	http://dx.doi.org/10.1371/journal.pone.0031061			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347429	Green Published, Green Submitted, gold			2022-12-27	WOS:000302730100037
J	Kraus, D; Winter, J; Jepsen, S; Jager, A; Meyer, R; Deschner, J				Kraus, Dominik; Winter, Jochen; Jepsen, Soren; Jaeger, Andreas; Meyer, Rainer; Deschner, James			Interactions of Adiponectin and Lipopolysaccharide from Porphyromonas gingivalis on Human Oral Epithelial Cells	PLOS ONE			English	Article							KERATINOCYTE GROWTH-FACTOR; I PERIODONTAL TREATMENT; CREVICULAR FLUID LEVELS; MATRIX METALLOPROTEINASE-1; TISSUE INHIBITOR; TNF-ALPHA; EXPRESSION; MACROPHAGES; INDUCTION; RESPONSES	Background: Periodontitis is an inflammatory disease caused by pathogenic microorganisms, such as Porphyromonas gingivalis, and characterized by the destruction of the periodontium. Obese individuals have an increased risk for periodontitis and show decreased serum levels of adiponectin. This in-vitro study was established to examine whether adiponectin modulates critical effects of lipopolysaccharide (LPS) from P. gingivalis on oral epithelial cells (OECs). Methodology/Principal Findings: The presence of adiponectin and its receptors in human gingival tissue samples and OECs was analyzed by immunohistochemistry and PCR. Furthermore, OECs were treated with LPS and/or adiponectin for up to 72 h, and the gene expression and protein synthesis of pro-and anti-inflammatory mediators, matrix metalloproteinases (MMPs) and growth factors were analyzed by real-time PCR and ELISA. Additionally, cell proliferation, differentiation and invitro wound healing were studied. The nuclear translocation of NF kappa B was investigated by immunofluorescence. Gingival tissue sections showed a strong synthesis of adiponectin and its receptors in the epithelial layer. In cell cultures, LPS induced a significant up-regulation of interleukin (IL) 1 beta, IL6, IL8, MMP1 and MMP3. Adiponectin abrogated significantly the stimulatory effects of LPS on these molecules. Similarly, adiponectin inhibited significantly the LPS-induced decrease in cell viability and increase in cell proliferation and differentiation. Adiponectin led to a time-dependent induction of the anti-inflammatory mediators IL10 and heme oxygenase 1, and blocked the LPS-stimulated NF kappa B nuclear translocation. Conclusions/Significance: Adiponectin may counteract critical actions of P. gingivalis on oral epithelial cells. Low levels of adiponectin, as observed in obese individuals, may increase the risk for periodontal inflammation and destruction.	[Kraus, Dominik] Univ Bonn, Dept Prosthodont Preclin Educ & Mat Sci, Bonn, Germany; [Kraus, Dominik; Winter, Jochen; Jepsen, Soren; Jaeger, Andreas; Deschner, James] Univ Bonn, Clin Res Unit 208, Bonn, Germany; [Winter, Jochen; Jepsen, Soren] Univ Bonn, Dept Periodontol Operat & Prevent Dent, Bonn, Germany; [Jaeger, Andreas] Univ Bonn, Dept Orthodont, Bonn, Germany; [Meyer, Rainer] Univ Bonn, Inst Physiol 2, Bonn, Germany	University of Bonn; University of Bonn; University of Bonn; University of Bonn; University of Bonn	Kraus, D (corresponding author), Univ Bonn, Dept Prosthodont Preclin Educ & Mat Sci, Bonn, Germany.	james.deschner@uni-bonn.de	Meyer, Rainer/H-5871-2013; Kraus, Dominik/K-6481-2015; DESCHNER, JAMES/AAW-3998-2021	Kraus, Dominik/0000-0002-0273-5065; 	German Research Foundation [KFO 208/TP4/TP9]; University of Bonn, Germany	German Research Foundation(German Research Foundation (DFG)); University of Bonn, Germany	This study was supported by a grant from the German Research Foundation (KFO 208/TP4/TP9) and the University of Bonn, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajuwon KM, 2005, AM J PHYSIOL-REG I, V288, pR1220, DOI 10.1152/ajpregu.00397.2004; Albandar JM, 2011, J PERIODONTOL, V82, P337, DOI 10.1902/jop.2011.100638; Andrian E, 2005, J CELL PHYSIOL, V204, P178, DOI 10.1002/jcp.20287; Beikler T, 2011, PERIODONTOL 2000, V55, P87, DOI 10.1111/j.1600-0757.2010.00360.x; Brochu-Gaudreau K, 2010, ENDOCRINE, V37, P11, DOI 10.1007/s12020-009-9278-8; Cai XJ, 2010, MOL ENDOCRINOL, V24, P218, DOI 10.1210/me.2009-0128; Chaffee BW, 2010, J PERIODONTOL, V81, P1708, DOI 10.1902/jop.2010.100321; Choi HM, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2844; Dieudonne MN, 2006, BIOCHEM BIOPH RES CO, V345, P271, DOI 10.1016/j.bbrc.2006.04.076; Dos Santos E, 2008, ONCOL REP, V20, P971, DOI 10.3892/or_00000098; Eckert RL, 2004, J INVEST DERMATOL, V123, P13, DOI 10.1111/j.0022-202X.2004.22723.x; Engebretson SP, 2002, J CLIN PERIODONTOL, V29, P48, DOI 10.1034/j.1600-051x.2002.290108.x; FINCH PW, 1989, SCIENCE, V245, P752, DOI 10.1126/science.2475908; Firth JD, 2004, J INVEST DERMATOL, V122, P222, DOI 10.1046/j.0022-202X.2003.22124.x; Fitzpatrick RE, 2009, FUTURE MICROBIOL, V4, P471, DOI 10.2217/FMB.09.18; Folco EJ, 2009, J BIOL CHEM, V284, P25569, DOI 10.1074/jbc.M109.019786; Garlet GP, 2010, J DENT RES, V89, P1349, DOI 10.1177/0022034510376402; HONIG J, 1989, J PERIODONTAL RES, V24, P362, DOI 10.1111/j.1600-0765.1989.tb00883.x; [黄慧娟 HUANG Huijuan], 2008, [西北林学院学报, Journal of Northwest Forestry College], V23, P50; Inadera Hidekuni, 2008, Int J Med Sci, V5, P248; Jain S, 2010, PERIODONTOL 2000, V54, P53, DOI 10.1111/j.1600-0757.2009.00333.x; Johnson GK, 2010, J PERIODONTAL RES, V45, P583, DOI 10.1111/j.1600-0765.2009.01262.x; Jortay J, 2010, ENDOCRINOLOGY, V151, P4840, DOI 10.1210/en.2009-1462; Jotwani R, 2010, ANN NY ACAD SCI, V1192, P278, DOI 10.1111/j.1749-6632.2009.05247.x; Ka H, 2000, BIOL REPROD, V62, P1772, DOI 10.1095/biolreprod62.6.1772; Kalinin AE, 2002, BIOESSAYS, V24, P789, DOI 10.1002/bies.10144; Kamio N, 2009, FEMS IMMUNOL MED MIC, V56, P241, DOI 10.1111/j.1574-695X.2009.00573.x; Katz RW, 2002, BONE, V31, P288, DOI 10.1016/S8756-3282(02)00824-4; Kinane DF, 2008, FRONT BIOSCI-LANDMRK, V13, P966, DOI 10.2741/2736; Kocgozlu L, 2009, J DENT RES, V88, P741, DOI 10.1177/0022034509341166; Kou Y, 2008, J PERIODONTOL, V79, P174, DOI [10.1902/jop.2008.070364, 10.1902/jop.2008.070364 ]; Lackler KP, 2000, J PERIODONTOL, V71, P226, DOI 10.1902/jop.2000.71.2.226; Lago F, 2007, NAT CLIN PRACT RHEUM, V3, P716, DOI 10.1038/ncprheum0674; Li M, 2005, J PERIODONTAL RES, V40, P118, DOI 10.1111/j.1600-0765.2004.00780.x; Mandal P, 2010, HEPATOLOGY, V51, P1420, DOI 10.1002/hep.23427; Mantel PY, 2011, METHODS MOL BIOL, V677, P303, DOI 10.1007/978-1-60761-869-0_21; Neumeier M, 2006, J LEUKOCYTE BIOL, V79, P803, DOI 10.1189/jlb.0905521; O'Dowd LK, 2010, J CLIN PERIODONTOL, V37, P334, DOI 10.1111/j.1600-051X.2010.01545.x; Ogunwobi OO, 2006, REGUL PEPTIDES, V134, P105, DOI 10.1016/j.regpep.2006.02.001; Ornitz DM, 2001, GENOME BIOL, V2; Otterbein LE, 2003, TRENDS IMMUNOL, V24, P449, DOI 10.1016/S1471-4906(03)00181-9; Park PH, 2008, J BIOL CHEM, V283, P26850, DOI 10.1074/jbc.M802787200; Park PH, 2007, J BIOL CHEM, V282, P21695, DOI 10.1074/jbc.M701419200; Peake PW, 2006, BIOCHEM BIOPH RES CO, V341, P108, DOI 10.1016/j.bbrc.2005.12.162; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Preshaw PM, 2007, PERIODONTOL 2000, V45, P138, DOI 10.1111/j.1600-0757.2007.00221.x; Presland RB, 2000, CRIT REV ORAL BIOL M, V11, P383, DOI 10.1177/10454411000110040101; RUBIN JS, 1989, P NATL ACAD SCI USA, V86, P802, DOI 10.1073/pnas.86.3.802; Seymour GJ, 2007, CLIN MICROBIOL INFEC, V13, P3, DOI 10.1111/j.1469-0691.2007.01798.x; Skaleric U, 1997, EUR J ORAL SCI, V105, P136, DOI 10.1111/j.1600-0722.1997.tb00192.x; Soell M, 2002, J DENT RES, V81, P174, DOI 10.1177/154405910208100306; Sorsa T, 2006, ANN MED, V38, P306, DOI 10.1080/07853890600800103; Steele IA, 2001, ONCOGENE, V20, P5878, DOI 10.1038/sj.onc.1204755; Stofkova A, 2009, Endocr Regul, V43, P157; Suvan J, 2011, OBES REV, V12, pe381, DOI 10.1111/j.1467-789X.2010.00808.x; Takahashi N, 2010, J PERIODONTAL RES, V45, P512, DOI 10.1111/j.1600-0765.2009.01266.x; Taylor JJ, 2010, PERIODONTOL 2000, V54, P160, DOI 10.1111/j.1600-0757.2009.00344.x; TSAI CC, 1995, J PERIODONTOL, V66, P852, DOI 10.1902/jop.1995.66.10.852; Tsatsanis C, 2005, BIOCHEM BIOPH RES CO, V335, P1254, DOI 10.1016/j.bbrc.2005.07.197; Turner JJO, 2009, SCAND J IMMUNOL, V69, P329, DOI 10.1111/j.1365-3083.2008.02224.x; Tuter G, 2005, J CLIN PERIODONTOL, V32, P1011, DOI 10.1111/j.1600-051X.2005.00816.x; Tuter G, 2002, J PERIODONTOL, V73, P487, DOI 10.1902/jop.2002.73.5.487; Wulster-Radcliffe MC, 2004, BIOCHEM BIOPH RES CO, V316, P924, DOI 10.1016/j.bbrc.2004.02.130	64	96	96	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2012	7	2							e30716	10.1371/journal.pone.0030716	http://dx.doi.org/10.1371/journal.pone.0030716			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UV	22319581	Green Submitted, gold, Green Published			2022-12-27	WOS:000301979000012
J	Reinhold, P; Ostermann, C; Liebler-Tenorio, E; Berndt, A; Vogel, A; Lambertz, J; Rothe, M; Ruttger, A; Schubert, E; Sachse, K				Reinhold, Petra; Ostermann, Carola; Liebler-Tenorio, Elisabeth; Berndt, Angela; Vogel, Anette; Lambertz, Jacqueline; Rothe, Michael; Ruettger, Anke; Schubert, Evelyn; Sachse, Konrad			A Bovine Model of Respiratory Chlamydia psittaci Infection: Challenge Dose Titration	PLOS ONE			English	Article							CHLAMYDOPHILA-PSITTACI; ANIMAL-MODELS; BIOMEDICAL-RESEARCH; AIRWAY-OBSTRUCTION; DOMESTIC-ANIMALS; EPITHELIAL-CELLS; IN-VITRO; PNEUMONIA; CATTLE; MOUSE	This study aimed to establish and evaluate a bovine respiratory model of experimentally induced acute C. psittaci infection. Calves are natural hosts and pathogenesis may resemble the situation in humans. Intrabronchial inoculation of C. psittaci strain DC15 was performed in calves aged 2-3 months via bronchoscope at four different challenge doses from 10(6) to 10(9) inclusion-forming units (ifu) per animal. Control groups received either UV-inactivated C. psittaci or cell culture medium. While 10(6) ifu/calf resulted in a mild respiratory infection only, the doses of 10(7) and 10(8) induced fever, tachypnea, dry cough, and tachycardia that became apparent 2-3 days post inoculation (dpi) and lasted for about one week. In calves exposed to 10(9) ifu C. psittaci, the respiratory disease was accompanied by severe systemic illness (apathy, tremor, markedly reduced appetite). At the time point of most pronounced clinical signs (3 dpi) the extent of lung lesions was below 10% of pulmonary tissue in calves inoculated with 10(6) and 10(7) ifu, about 15% in calves inoculated with 10(8) and more than 30% in calves inoculated with 10(9) ifu C. psittaci. Beside clinical signs and pathologic lesions, the bacterial load of lung tissue and markers of pulmonary inflammation (i.e., cell counts, concentration of proteins and eicosanoids in broncho-alveolar lavage fluid) were positively associated with ifu of viable C. psittaci. While any effect of endotoxin has been ruled out, all effects could be attributed to infection by the replicating bacteria. In conclusion, the calf represents a suitable model of respiratory chlamydial infection. Dose titration revealed that both clinically latent and clinically manifest infection can be reproduced experimentally by either 10(6) or 10(8) ifu/calf of C. psittaci DC15 while doses above 10(8) ifu C. psittaci cannot be recommended for further studies for ethical reasons. This defined model of different clinical expressions of chlamydial infection allows studying host-pathogen interactions.	[Reinhold, Petra; Ostermann, Carola; Liebler-Tenorio, Elisabeth; Berndt, Angela; Vogel, Anette; Lambertz, Jacqueline; Ruettger, Anke; Schubert, Evelyn; Sachse, Konrad] Fed Res Inst Anim Hlth, Friedrich Loeffler Inst, Inst Mol Pathogenesis, Jena, Germany; [Schubert, Evelyn; Sachse, Konrad] Fed Res Inst Anim Hlth, Friedrich Loeffler Inst, OIE Reference Lab Chlamydiosis, Jena, Germany; [Rothe, Michael] LIPIDOMIX GmbH, Berlin, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Friedrich Loeffler Institute; Friedrich Loeffler Institute	Reinhold, P (corresponding author), Fed Res Inst Anim Hlth, Friedrich Loeffler Inst, Inst Mol Pathogenesis, Jena, Germany.	petra.reinhold@fli.bund.de	Sachse, Konrad/GWC-4999-2022	Sachse, Konrad/0000-0003-1230-1786	Federal Ministry of Education and Research (BMBF) of Germany [01 KI 0720]	Federal Ministry of Education and Research (BMBF) of Germany(Federal Ministry of Education & Research (BMBF))	This study was financially supported by the Federal Ministry of Education and Research (BMBF) of Germany under Grant no. 01 KI 0720 "Zoonotic chlamydiae - Models of chronic and persistent infections in humans and animals". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAZALA E, 1992, BERL MUNCH TIERARZTL, V105, P145; BOVARNICK MR, 1950, J BACTERIOL, V59, P509, DOI 10.1128/JB.59.4.509-522.1950; CAY B, 1989, VET MICROBIOL, V20, P123, DOI 10.1016/0378-1135(89)90035-7; Coers J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000333; Coleman RA, 2003, DRUG DISCOV TODAY, V8, P233, DOI 10.1016/S1359-6446(03)02613-8; Coraux C, 2005, EUR RESPIR REV, V14, P131, DOI 10.1183/09059180.05.00009702; CROSSE BA, 1990, J INFECTION, V21, P251, DOI 10.1016/0163-4453(90)93909-C; Del Rio L, 2000, J COMP PATHOL, V123, P171, DOI 10.1053/jcpa.2000.0411; Ehricht R, 2006, MOL CELL PROBE, V20, P60, DOI 10.1016/j.mcp.2005.09.003; Elferink Ronald Oude, 2009, J Hepatol, V50, P838, DOI 10.1016/j.jhep.2008.12.014; Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588; Everett KDE, 1999, INT J SYST BACTERIOL, V49, P415, DOI 10.1099/00207713-49-2-415; Farrar JD, 2000, NAT IMMUNOL, V1, P65, DOI 10.1038/76932; Fukuda EY, 2005, INFECT IMMUN, V73, P4017, DOI 10.1128/IAI.73.7.4017-4024.2005; Gaede W, 2008, ZOONOSES PUBLIC HLTH, V55, P184, DOI 10.1111/j.1863-2378.2008.01108.x; Goellner S, 2006, INFECT IMMUN, V74, P4801, DOI 10.1128/IAI.01487-05; Graphodatsky AS, 2011, MOL CYTOGENET, V4, DOI 10.1186/1755-8166-4-22; Haas L E M, 2006, Ned Tijdschr Geneeskd, V150, P117; Haley PJ, 2003, TOXICOLOGY, V188, P49, DOI 10.1016/S0300-483X(03)00043-X; Harkinezhad T, 2009, J MED MICROBIOL, V58, P1207, DOI 10.1099/jmm.0.011379-0; Harkinezhad T, 2009, VET MICROBIOL, V135, P68, DOI 10.1016/j.vetmic.2008.09.046; HARRIS JW, 1984, COMP IMMUNOL MICROB, V7, P19, DOI 10.1016/0147-9571(84)90012-2; Hein WR, 2003, NAT REV IMMUNOL, V3, P79, DOI 10.1038/nri977; Ireland JJ, 2008, J ANIM SCI, V86, P2797, DOI 10.2527/jas.2008-1088; Jaeger J, 2007, VET RES, V38, P711, DOI 10.1051/vetres:2007027; Jee JB, 2004, J CLIN MICROBIOL, V42, P5664, DOI 10.1128/JCM.42.12.5664-5672.2004; Kauffold J, 2006, THERIOGENOLOGY, V65, P1750, DOI 10.1016/j.theriogenology.2005.10.010; Kauffold J, 2006, THERIOGENOLOGY, V66, P1816, DOI 10.1016/j.theriogenology.2006.04.042; KIELSTEIN P, 1983, ARCH EXP VET MED, V37, P569; Kips JC, 2003, EUR RESPIR J, V22, P374, DOI 10.1183/09031936.03.00026403; Kirschvink N, 2008, CURR DRUG TARGETS, V9, P470, DOI 10.2174/138945008784533525; Krausse-Opatz B, MICROB PATHOG, V37, P155; Lanzas C, 2010, NAT REV MICROBIOL, V8, P139, DOI 10.1038/nrmicro2268; Laroucau K, 2009, VET MICROBIOL, V135, P82, DOI 10.1016/j.vetmic.2008.09.048; Lenzko H, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-29; Liu W, 2006, MICROBES INFECT, V8, P478, DOI 10.1016/j.micinf.2005.07.026; Liu W, 2008, IMMUNOLOGY, V123, P290, DOI 10.1111/j.1365-2567.2007.02642.x; MARTIN J, 1983, ARCH EXP VET MED, V37, P939; Martinez-Olondris P, 2010, EUR RESPIR J, V35, P198, DOI 10.1183/09031936.00113908; MCLAUGHLIN R, 1961, AM J ANAT, V108, P149, DOI 10.1002/aja.1001080203; MCMARTIN DA, 1979, VET REC, V105, P574; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Mitnzer W, 1991, LUNG SCI F, P1053; MULLER G, 1988, ARCH EXP VET MED, V42, P52; Otter P, 2003, VET REC, V152, P787; Pabst R., 2008, ALLERGY ALLERGIC DIS, P1214; Pandeli V, 2006, Crit Care Resusc, V8, P40; Pantchev A, 2009, VET J, V181, P145, DOI 10.1016/j.tvjl.2008.02.025; Paster BJ, 2011, BERGEYS MANUAL SYSTE, V4, P845; Pastoret PP, HDB VERTEBRATE IMMUN; Persson CGA, 2002, AM J RESP CRIT CARE, V166, P6, DOI 10.1164/rccm.2204001; Raso TD, 2004, J ZOO WILDLIFE MED, V35, P94, DOI 10.1638/02-090; Reinhold P, 2008, VET J, V175, P202, DOI 10.1016/j.tvjl.2007.01.004; Reinhold P, 2011, VET J, V189, P257, DOI 10.1016/j.tvjl.2010.09.003; Reinhold P, 2008, VET RES, V39, DOI 10.1051/vetres:2008012; Reynolds LP, 2009, J NUTR, V139, P427, DOI 10.3945/jn.108.103564; Rogers CS, 2008, SCIENCE, V321, P1837, DOI 10.1126/science.1163600; Rohde G, 2010, DTSCH ARZTEBL INT, V107, P174, DOI 10.3238/arztebl.2010.0174; Rupp J, 2004, BIOCHEM BIOPH RES CO, V320, P738, DOI 10.1016/j.bbrc.2004.05.210; Sachse K, 2009, VET MICROBIOL, V135, P22, DOI 10.1016/j.vetmic.2008.09.041; Sprague LD, 2009, VET J, V181, P274, DOI 10.1016/j.tvjl.2008.04.002; Tellam RL, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-193; Theegarten D, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-14; Twomey DF, 2006, VET J, V171, P574, DOI 10.1016/j.tvjl.2004.12.012; Twomey DF, 2003, VET REC, V152, P340; Van Rhijn I, 2008, MICROBES INFECT, V10, P711, DOI 10.1016/j.micinf.2008.04.005; VANROMPAY D, 1995, VET MICROBIOL, V45, P93, DOI 10.1016/0378-1135(95)00033-7; Zosky GR, 2007, CLIN EXP ALLERGY, V37, P973, DOI 10.1111/j.1365-2222.2007.02740.x	68	41	42	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e30125	10.1371/journal.pone.0030125	http://dx.doi.org/10.1371/journal.pone.0030125			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22299031	Green Published, gold			2022-12-27	WOS:000301704200008
J	Lin, TY; Lo, YH; Tseng, PW; Chang, SF; Lin, YT; Chen, TS				Lin, Tiao-Yin; Lo, Yi-Haw; Tseng, Pin-Wei; Chang, Shun-Fu; Lin, Yann-Tsyr; Chen, Ton-Seng			A T3 and T7 Recombinant Phage Acquires Efficient Adsorption and a Broader Host Range	PLOS ONE			English	Article							DNA-BINDING-PROTEIN; COMPLETE NUCLEOTIDE-SEQUENCE; STRAND-BREAK REPAIR; ESCHERICHIA-COLI; BACTERIOPHAGE T7; DEOXYRIBONUCLEIC-ACID; GENETIC-RECOMBINATION; RNA POLYMERASES; HOMOLOGOUS DNA; INFECTION	It is usually thought that bacteriophage T7 is female specific, while phage T3 can propagate on male and female Escherichia coli. We found that the growth patterns of phages T7M and T3 do not match the above characteristics, instead showing strain dependent male exclusion. Furthermore, a T3/7 hybrid phage exhibits a broader host range relative to that of T3, T7, as well as T7M, and is able to overcome the male exclusion. The T7M sequence closely resembles that of T3. T3/7 is essentially T3 based, but a DNA fragment containing part of the tail fiber gene 17 is replaced by the T7 sequence. T3 displays inferior adsorption to strains tested herein compared to T7. The T3 and T7 recombinant phage carries altered tail fibers and acquires better adsorption efficiency than T3. How phages T3 and T7 recombine was previously unclear. This study is the first to show that recombination can occur accurately within only 8 base-pair homology, where four-way junction structures are identified. Genomic recombination models based on endonuclease I cleavages at equivalent and nonequivalent sites followed by strand annealing are proposed. Retention of pseudo-palindromes can increase recombination frequency for reviving under stress.	[Lin, Tiao-Yin; Lo, Yi-Haw; Tseng, Pin-Wei; Chang, Shun-Fu; Lin, Yann-Tsyr; Chen, Ton-Seng] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan	National Yang Ming Chiao Tung University	Lin, TY (corresponding author), Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan.	tylin@cc.nctu.edu.tw						ARAKI H, 1981, VIROLOGY, V111, P509, DOI 10.1016/0042-6822(81)90353-6; Bartel PL, 1996, NAT GENET, V12, P72, DOI 10.1038/ng0196-72; BEIER H, 1977, J VIROL, V21, P753, DOI 10.1128/JVI.21.2.753-765.1977; BEIER H, 1974, NATURE, V251, P538, DOI 10.1038/251538a0; Berry J, 2008, MOL MICROBIOL, V70, P341, DOI 10.1111/j.1365-2958.2008.06408.x; BIENKOWSKASZEWCZYK K, 1980, BIOCHIM BIOPHYS ACTA, V615, P489, DOI 10.1016/0005-2744(80)90515-X; BRUTLAG D, 1972, J BIOL CHEM, V247, P241; Cai L, 2004, J BIOCHEM, V135, P397, DOI 10.1093/jb/mvh047; Casjens S, 1992, SEMINARS VIROLOGY, V3, P383; CONDREAY JP, 1989, J MOL BIOL, V207, P543, DOI 10.1016/0022-2836(89)90463-4; CONDREAY JP, 1989, J MOL BIOL, V207, P555, DOI 10.1016/0022-2836(89)90464-6; CRAM D, 1984, MOL GEN GENET, V197, P137, DOI 10.1007/BF00327934; DAVIS RW, 1971, J MOL BIOL, V62, P287, DOI 10.1016/0022-2836(71)90428-1; DAVISON PF, 1962, J MOL BIOL, V5, P635, DOI 10.1016/S0022-2836(62)80091-6; Declais AC, 2006, J MOL BIOL, V359, P1261, DOI 10.1016/j.jmb.2006.04.037; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; DUNN JJ, 1971, NATURE-NEW BIOL, V230, P94, DOI 10.1038/newbio230094a0; DUNN JJ, 1983, J MOL BIOL, V166, P477, DOI 10.1016/S0022-2836(83)80282-4; ENGLER MJ, 1983, J BIOL CHEM, V258, P1197; HAMADA K, 1984, VIROLOGY, V139, P251, DOI 10.1016/0042-6822(84)90372-6; HAUSMANN R., 1967, J VIROL, V1, P779; Hausmann R, 1988, BACTERIOPHAGES, P259; HUBER HE, 1986, J BIOL CHEM, V261, P5006; HYMAN RW, 1973, J MOL BIOL, V77, P189, DOI 10.1016/0022-2836(73)90330-6; Kedzierska S, 1996, GENE, V168, P1, DOI 10.1016/0378-1119(95)00712-1; Kemp P, 2005, VIROLOGY, V340, P307, DOI 10.1016/j.virol.2005.06.039; KERR C, 1972, J BIOL CHEM, V247, P311; KERR C, 1975, VIROLOGY, V65, P281, DOI 10.1016/0042-6822(75)90031-8; KOIKE M, 1971, J BACTERIOL, V108, P1402, DOI 10.1128/JB.108.3.1402-1411.1971; Kong DC, 1996, EMBO J, V15, P2010, DOI 10.1002/j.1460-2075.1996.tb00552.x; Lai YT, 2000, MOL MICROBIOL, V36, P437, DOI 10.1046/j.1365-2958.2000.01861.x; Lin TY, 2004, BIOCHEMISTRY-US, V43, P945, DOI 10.1021/bi0355138; LU M, 1991, J BIOL CHEM, V266, P2531; LUNN CA, 1984, J BIOL CHEM, V259, P469; MORITA M, 1995, VIROLOGY, V211, P516, DOI 10.1006/viro.1995.1433; Pajunen MI, 2002, J MOL BIOL, V319, P1115, DOI 10.1016/S0022-2836(02)00384-4; POWLING A, 1974, MOL GEN GENET, V134, P173, DOI 10.1007/BF00268418; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; RUSSEL M, 1984, J BACTERIOL, V157, P526, DOI 10.1128/JB.157.2.526-532.1984; SCHMITT CK, 1991, J BACTERIOL, V173, P1536, DOI 10.1128/jb.173.4.1536-1543.1991; SHEN P, 1986, GENETICS, V112, P441; STEVEN AC, 1988, J MOL BIOL, V200, P351, DOI 10.1016/0022-2836(88)90246-X; STUDIER FW, 1976, J VIROL, V19, P136, DOI 10.1128/JVI.19.1.136-145.1976; STUDIER FW, 1979, VIROLOGY, V95, P70; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; WEIDEL W, 1958, ANNU REV MICROBIOL, V12, P27, DOI 10.1146/annurev.mi.12.100158.000331; YAMAGISHI M, 1985, VIROLOGY, V144, P502, DOI 10.1016/0042-6822(85)90290-9; Yu M, 2001, J BACTERIOL, V183, P1862, DOI 10.1128/JB.183.6.1862-1869.2001; Zhang X, 2004, J MOL BIOL, V340, P707, DOI 10.1016/j.jmb.2004.05.006; ZHANG X, 1995, J MOL BIOL, V250, P156, DOI 10.1006/jmbi.1995.0367	50	41	50	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2012	7	2							e30954	10.1371/journal.pone.0030954	http://dx.doi.org/10.1371/journal.pone.0030954			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZQ	22347414	gold, Green Published, Green Submitted			2022-12-27	WOS:000302730200010
J	Das, D; Cherbuin, N; Butterworth, P; Anstey, KJ; Easteal, S				Das, Debjani; Cherbuin, Nicolas; Butterworth, Peter; Anstey, Kaarin J.; Easteal, Simon			A Population-Based Study of Attention Deficit/Hyperactivity Disorder Symptoms and Associated Impairment in Middle-Aged Adults	PLOS ONE			English	Article							DEFICIT-HYPERACTIVITY-DISORDER; NATIONAL COMORBIDITY SURVEY; REPORT SCALE ASRS; SELF-REPORT; REPRESENTATIVE SAMPLE; PSYCHIATRIC-DISORDERS; LATE-ONSET; ADHD; PREVALENCE; VALIDITY	Attention deficit/hyperactivity disorder (ADHD) is the most prevalent childhood psychiatric condition. It frequently persists into adulthood and can have serious health and other adverse consequences. The majority of previous adult ADHD studies have focused on young adults so that relatively little is known about ADHD symptoms and their effects in mid and late life. In addition, effects of subclinical levels of attention deficit and hyperactivity have not been studied in detail. In this study we investigated ADHD symptoms and related impairment in a large population-based sample of middle-aged Australian adults (n = 2091; 47% male). Applying the WHO adult ADHD Self Report Screener (ASRS) we observed that 6.2% of participants had scores that were previously associated with ADHD diagnosis. No significant gender difference in the distribution of ASRS scores was observed. Multiple regression analyses indicated strong positive correlations between symptoms of ADHD and depression/anxiety and significant negative associations (p<0.01) with employment, financial stress, relationship quality, health and well-being measures in this age group. Importantly, associations were highly significant even when few ADHD symptoms were reported. Compared to the hyperactivity component, the inattention trait was particularly strongly associated and remained significant after controlling for depression/anxiety symptoms. Our study confirms previous findings and significantly adds to existing literature especially for an age-group that has not been well-studied. Our results suggest that ADHD symptoms continue to be associated with ill-health and functional impairment in mid-life and are, therefore, likely to be a major, previously unrecognized source of late-life morbidity with associated social and economic costs. Thus, there is a compelling need for better understanding and development of age-appropriate approaches to the diagnosis and treatment of ADHD in mid- to late-life.	[Das, Debjani; Easteal, Simon] Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia; [Cherbuin, Nicolas; Butterworth, Peter; Anstey, Kaarin J.] Australian Natl Univ, Ctr Res Ageing Hlth & Wellbeing, Canberra, ACT 2601, Australia	Australian National University; John Curtin School of Medical Research; Australian National University	Das, D (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia.	debjani.das@anu.edu.au	Das, Debjani/A-8162-2008; Cherbuin, Nicolas/A-8515-2008; Butterworth, Peter/AFK-2636-2022; Anstey, Kaarin/A-3852-2008	Cherbuin, Nicolas/0000-0001-6481-0748; Anstey, Kaarin/0000-0002-9706-9316; Butterworth, Peter/0000-0002-1531-3881; Easteal, Simon/0000-0002-0462-502X	National Health and Medical Research Council of Australia [973302, 179805, 418039, 418020, 471501, 525410, 366756]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by the National Health and Medical Research Council of Australia (Unit Grant 973302, Program Grant 179805, Project Grant 418039). DD is funded by National Health and Medical Research Council of Australia Capacity Building Grant No. 418020 in Population Health Research, NC is funded by National Health and Medical Research Council of Australia Research Fellowship No. 471501, PB is funded by National Health and Medical Research Council of Australia Research Fellowship No. 525410 and KA is funded by National Health and Medical Research Council of Australia Research Fellowship No. 366756. The funders did not have any role in the design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Andrews FM, 1976, SOCIAL INDICATORS WE, P435; Anstey KJ, 2011, INT J EPIDEMIOL, DOI [10.1093/ije/dyr1025, DOI 10.1093/IJE/DYR1025]; Antshel KM, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-72; Arcos-Burgos M, 2007, CURR OPIN GENET DEV, V17, P234, DOI 10.1016/j.gde.2007.04.011; Barbaresi W, 2004, ACTA PAEDIATR, V93, P55, DOI 10.0180/08035320310021282; Barkley R. A., 2010, ATTENTION DEFICIT HY; Barkley RA, 2006, HDB DIAGNOSIS; Barkley RA, 2008, CNS SPECTRUMS, V13, P977, DOI 10.1017/S1092852900014036; Bernfort L, 2008, ACTA PAEDIATR, V97, P239, DOI 10.1111/j.1651-2227.2007.00611.x; BERRY CA, 1985, PEDIATRICS, V76, P801; BIEDERMAN J, 1993, AM J PSYCHIAT, V150, P1792; Biederman J, 2005, LANCET, V366, P237, DOI 10.1016/S0140-6736(05)66915-2; Biederman Joseph, 2006, MedGenMed, V8, P12; Birnbaum HG, 2005, CURR MED RES OPIN, V21, P195, DOI 10.1185/030079904X20303; Bitter I, 2010, EUR ARCH PSY CLIN N, V260, P287, DOI 10.1007/s00406-009-0076-3; BREWIN CR, 1993, PSYCHOL BULL, V113, P82, DOI 10.1037/0033-2909.113.1.82; Brod M, 2011, QUAL LIFE RES, DOI [10.1007/s11136-11011-19981-11139, DOI 10.1007/S11136-11011-19981-11139]; de Zwaan M, 2011, EUR ARCH PSYCHIAT CL; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; DuPaul GJ, 2001, J LEARN DISABIL-US, V34, P370, DOI 10.1177/002221940103400412; Faraone SV, 2006, AM J PSYCHIAT, V163, P1720, DOI 10.1176/appi.ajp.163.10.1720; Faraone Stephen V, 2005, J Atten Disord, V9, P384, DOI 10.1177/1087054705281478; Fayyad J, 2007, BRIT J PSYCHIAT, V190, P402, DOI 10.1192/bjp.bp.106.034389; Gadow Kenneth D, 2007, J Atten Disord, V11, P374, DOI 10.1177/1087054706295609; Gershon J, 2002, J Atten Disord, V5, P143, DOI 10.1177/108705470200500302; Guldberg-Kjar T, 2009, NORD J PSYCHIAT, P1; Heiligenstein E, 1998, J AM COLL HEALTH, V46, P185, DOI 10.1080/07448489809595609; Hyman SE, 2010, ANNU REV CLIN PSYCHO, V6, P155, DOI 10.1146/annurev.clinpsy.3.022806.091532; Karam RG, 2009, J PSYCHIATR RES, V43, P697, DOI 10.1016/j.jpsychires.2008.10.001; Kessler RC, 2005, J OCCUP ENVIRON MED, V47, P565, DOI 10.1097/01.jom.0000166863.33541.39; Kessler RC, 2005, PSYCHOL MED, V35, P245, DOI 10.1017/S0033291704002892; Kessler RC, 2006, AM J PSYCHIAT, V163, P716, DOI 10.1176/appi.ajp.163.4.716; Kessler RC, 2007, INT J METH PSYCH RES, V16, P52, DOI 10.1002/mpr.208; Kooij JJS, 2005, PSYCHOL MED, V35, P817, DOI 10.1017/S003329170400337X; Lubben J, 2006, GERONTOLOGIST, V46, P503, DOI 10.1093/geront/46.4.503; Maddigan SL, 2004, QUAL LIFE RES, V13, P435, DOI 10.1023/B:QURE.0000018497.06539.8f; Manor I, 2008, CHILD PSYCHIAT HUM D, V39, P273, DOI 10.1007/s10578-007-0087-0; Manor I, 2011, CLIN NEUROPHARMACOL, V34, P148, DOI 10.1097/WNF.0b013e3182206dc1; Matza Louis S, 2005, Cost Eff Resour Alloc, V3, P5, DOI 10.1186/1478-7547-3-5; Medina-Mora ME, 2005, PSYCHOL MED, V35, P1773, DOI 10.1017/S0033291705005672; MONTES LGA, 2007, J ATTEN DISORD, V11, P150; Murphy K., 1996, J ATTEN DISORD, V1, P147; NEUGEBAUER R, 1990, J CLIN EPIDEMIOL, V43, P1337, DOI 10.1016/0895-4356(90)90100-4; Rosler M, 2010, WORLD J BIOL PSYCHIA, V11, P684, DOI 10.3109/15622975.2010.483249; Secnik K, 2005, PHARMACOECONOMICS, V23, P93, DOI 10.2165/00019053-200523010-00008; Simon V, 2009, BRIT J PSYCHIAT, V194, P204, DOI 10.1192/bjp.bp.107.048827; SPANIER GB, 1976, J MARRIAGE FAM, V38, P15, DOI 10.2307/350547; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Swensen AR, 2003, J AM ACAD CHILD PSY, V42, P1415, DOI 10.1097/00004583-200312000-00008; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063	51	134	137	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31500	10.1371/journal.pone.0031500	http://dx.doi.org/10.1371/journal.pone.0031500			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	924ZP	22347487	Green Published, gold			2022-12-27	WOS:000302730100076
J	Dubois, L; Kyvik, KO; Girard, M; Tatone-Tokuda, F; Perusse, D; Hjelmborg, J; Skytthe, A; Rasmussen, F; Wright, MJ; Lichtenstein, P; Martin, NG				Dubois, Lise; Kyvik, Kirsten Ohm; Girard, Manon; Tatone-Tokuda, Fabiola; Perusse, Daniel; Hjelmborg, Jacob; Skytthe, Axel; Rasmussen, Finn; Wright, Margaret J.; Lichtenstein, Paul; Martin, Nicholas G.			Genetic and Environmental Contributions to Weight, Height, and BMI from Birth to 19 Years of Age: An International Study of Over 12,000 Twin Pairs	PLOS ONE			English	Article							BODY-MASS INDEX; CHILDHOOD OBESITY; SEX-DIFFERENCES; SOCIOECONOMIC-STATUS; FOOD ENVIRONMENT; SWEDISH TWIN; HERITABILITY; OVERWEIGHT; GENDER; ADOLESCENCE	Objective: To examine the genetic and environmental influences on variances in weight, height, and BMI, from birth through 19 years of age, in boys and girls from three continents. Design and Settings: Cross-sectional twin study. Data obtained from a total of 23 twin birth-cohorts from four countries: Canada, Sweden, Denmark, and Australia. Participants were Monozygotic (MZ) and dizygotic (DZ) (same-and opposite-sex) twin pairs with data available for both height and weight at a given age, from birth through 19 years of age. Approximately 24,036 children were included in the analyses. Results: Heritability for body weight, height, and BMI was low at birth (between 6.4 and 8.7% for boys, and between 4.8 and 7.9% for girls) but increased over time, accounting for close to half or more of the variance in body weight and BMI after 5 months of age in both sexes. Common environmental influences on all body measures were high at birth (between 74.1-85.9% in all measures for boys, and between 74.2 and 87.3% in all measures for girls) and markedly reduced over time. For body height, the effect of the common environment remained significant for a longer period during early childhood (up through 12 years of age). Sex-limitation of genetic and shared environmental effects was observed. Conclusion: Genetics appear to play an increasingly important role in explaining the variation in weight, height, and BMI from early childhood to late adolescence, particularly in boys. Common environmental factors exert their strongest and most independent influence specifically in pre-adolescent years and more significantly in girls. These findings emphasize the need to target family and social environmental interventions in early childhood years, especially for females. As gene-environment correlation and interaction is likely, it is also necessary to identify the genetic variants that may predispose individuals to obesity.	[Dubois, Lise; Girard, Manon; Tatone-Tokuda, Fabiola] Univ Ottawa, Inst Populat Hlth, Ottawa, ON, Canada; [Dubois, Lise] Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON, Canada; [Kyvik, Kirsten Ohm] Univ So Denmark, Inst Reg Hlth Serv Res, Odense, Denmark; [Kyvik, Kirsten Ohm; Skytthe, Axel] Odense Univ Hosp, Odense Patient Data Explorat Network, DK-5000 Odense, Denmark; [Perusse, Daniel] Univ Montreal, Fac Arts & Sci, Montreal, PQ, Canada; [Hjelmborg, Jacob] Univ So Denmark, Dept Biostat, Odense, Denmark; [Rasmussen, Finn] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [Wright, Margaret J.; Martin, Nicholas G.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Lichtenstein, Paul] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden	University of Ottawa; University of Ottawa; University of Southern Denmark; University of Southern Denmark; Odense University Hospital; Universite de Montreal; University of Southern Denmark; Karolinska Institutet; QIMR Berghofer Medical Research Institute; Karolinska Institutet	Dubois, L (corresponding author), Univ Ottawa, Inst Populat Hlth, Ottawa, ON, Canada.	lise.dubois@uottawa.ca	Wright, Margaret J/H-3308-2014; Martin, Nicholas/R-9235-2019; Kyvik, Kirsten O/K-5680-2016; Wright, Margaret Jane/A-4560-2016; Pérusse, Daniel/I-4494-2012; Hjelmborg, Jacob/AAN-5966-2020; Skytthe, Axel E/G-4820-2019	Martin, Nicholas/0000-0003-4069-8020; Kyvik, Kirsten O/0000-0003-2981-0245; Wright, Margaret Jane/0000-0001-7133-4970; Hjelmborg, Jacob/0000-0001-9630-9149; Skytthe, Axel E/0000-0002-8629-4913; Rasmussen, Finn/0000-0001-7915-7809; lichtenstein, paul/0000-0003-3037-5287				Bergen SE, 2007, TWIN RES HUM GENET, V10, P423, DOI 10.1375/twin.10.3.423; BETZ NE, 1994, SEX ROLES, V30, P543, DOI 10.1007/BF01420801; Boomsma D, 2002, NAT REV GENET, V3, P872, DOI 10.1038/nrg932; Campbell KJ, 2007, OBESITY, V15, P719, DOI 10.1038/oby.2007.553; Christiansen L, 2003, TWIN RES, V6, P275, DOI 10.1375/136905203322296610; Cornes BK, 2007, BEHAV GENET, V37, P648, DOI 10.1007/s10519-007-9165-0; CRAWLEY HF, 1995, INT J OBESITY, V19, P579; Danielzik S, 2004, INT J OBESITY, V28, P1494, DOI 10.1038/sj.ijo.0802756; Davis OSP, 2009, PSYCHOL SCI, V20, P1301, DOI 10.1111/j.1467-9280.2009.02433.x; Derks EM, 2006, TWIN RES HUM GENET, V9, P403, DOI 10.1375/183242706777591290; Dubois L, 2007, TWIN RES HUM GENET, V10, P479, DOI 10.1375/twin.10.3.479; Dunger DB, 2007, P NUTR SOC, V66, P451, DOI 10.1017/S0029665107005721; EAVES LJ, 1999, AM PSYCHOP, P269; Elgar FJ, 2004, PSYCHOL HLTH S, V19, P49; Faith MS, 2004, PEDIATRICS, V114, pE429, DOI 10.1542/peds.2003-1075-L; Forget-Dubois N, 2003, TWIN RES, V6, P479, DOI 10.1375/twin.6.6.479; Fox MK, 2009, J AM DIET ASSOC, V109, pS108, DOI 10.1016/j.jada.2008.10.065; GOLDSMITH HH, 1991, BEHAV GENET, V21, P257; Goldstein H, 1995, MULTILEVEL STAT MODE, DOI 10.1002/9780470973394; GRAYSON DA, 1989, BEHAV GENET, V19, P593, DOI 10.1007/BF01066256; Guo G, 2002, BEHAV GENET, V32, P37, DOI 10.1023/A:1014455812027; Haire-Joshu D, 2002, DIABETES EDUCATOR, V28, P415, DOI 10.1177/014572170202800311; Hannelius U, 2007, TWIN RES HUM GENET, V10, P604, DOI 10.1375/twin.10.4.604; HARRIS JR, 1995, GENET EPIDEMIOL, V12, P251, DOI 10.1002/gepi.1370120303; Haworth CMA, 2008, OBESITY, V16, P1585, DOI 10.1038/oby.2008.240; Haworth CMA, 2008, OBESITY, V16, P2663, DOI 10.1038/oby.2008.434; He Q, 2002, J CLIN ENDOCR METAB, V87, P2164, DOI 10.1210/jc.87.5.2164; HEWITT JK, 1989, BEHAV GENET, V19, P605, DOI 10.1007/BF01066257; Hjelmborg JVB, 2008, OBESITY, V16, P847, DOI 10.1038/oby.2007.135; Hur YM, 2008, INT J OBESITY, V32, P1455, DOI 10.1038/ijo.2008.144; Hur YM, 2007, OBESITY, V15, P2908, DOI 10.1038/oby.2007.346; Jaffee SR, 2007, MOL PSYCHIATR, V12, P432, DOI 10.1038/sj.mp.4001950; Johannsson E, 2006, INT J OBESITY, V30, P1265, DOI 10.1038/sj.ijo.0803253; Kumanyika S, 2002, INT J OBESITY, V26, P425, DOI 10.1038/sj.ijo.0801938; Lajunen HR, 2009, INT J OBESITY, V33, P559, DOI 10.1038/ijo.2009.51; Lichtenstein P, 2007, TWIN RES HUM GENET, V10, P67, DOI 10.1375/twin.10.1.67; Lichtenstein P, 2006, TWIN RES HUM GENET, V9, P875, DOI 10.1375/twin.9.6.875; Lobstein T., 2004, OBESITY REV OFFIC S1, V5, P4, DOI [10.1111/j.1467-789X.2004.00133.x, DOI 10.1111/J.1467-789X.2004.00133.X]; Maes HHM, 1997, BEHAV GENET, V27, P600; Mann DR, 2003, J CLIN ENDOCR METAB, V88, P3339, DOI 10.1210/jc.2002-022030; MASCIETAYLOR CGN, 1987, ANN HUM BIOL, V14, P59, DOI 10.1080/03014468700008841; McHale SM, 2001, J CLIN CHILD PSYCHOL, V30, P338, DOI 10.1207/S15374424JCCP3003_6; Monteiro CA, 2004, B WORLD HEALTH ORGAN, V82, P940; Murphy MJ, 2004, PEDIATRICS, V113, P82, DOI 10.1542/peds.113.1.82; Neale MC, 1992, METHODOLOGY GENETIC; Nelson MC, 2006, AM J PREV MED, V31, P109, DOI 10.1016/j.amepre.2006.03.026; PERUSSE D, 1995, QUEBEC LONGITUDINAL; Petridou E, 2005, CLIN ENDOCRINOL, V62, P366, DOI 10.1111/j.1365-2265.2005.02225.x; Pietilainen KH, 2002, OBES RES, V10, P875, DOI 10.1038/oby.2002.120; Pietilainen KH, 1999, INT J OBESITY, V23, P107, DOI 10.1038/sj.ijo.0800767; Plomin R, 1994, GENETICS EXPERIENCE, VXvi; Purcell S, 2002, TWIN RES, V5, P554, DOI 10.1375/136905202762342026; Rhee K, 2008, ANN AM ACAD POLIT SS, V615, P12, DOI 10.1177/0002716207308400; Scholtens S, 2007, EUR J PUBLIC HEALTH, V17, P369, DOI 10.1093/eurpub/ckl253; Schousboe K, 2003, TWIN RES, V6, P409, DOI 10.1375/twin.6.5.409; Silventoinen K, 2003, TWIN RES, V6, P399, DOI 10.1375/twin.6.5.399; Silventoinen K, 2007, INT J OBESITY, V31, P615, DOI 10.1038/sj.ijo.0803577; Silventoinen K, 2003, AM J HUM BIOL, V15, P620, DOI 10.1002/ajhb.10183; Silventoinen K, 2010, INT J OBESITY, V34, P29, DOI 10.1038/ijo.2009.177; Silventoinen K, 2007, TWIN RES HUM GENET, V10, P354, DOI 10.1375/twin.10.2.354; Silventoinen K, 2009, OBESITY FACTS, V2, P196, DOI 10.1159/000219675; Skytthe A, 2002, TWIN RES, V5, P352; Skytthe A, 2006, TWIN RES HUM GENET, V9, P763; Sorensen TIA, 2001, BRIT MED J, V322, P630, DOI 10.1136/bmj.322.7287.630; SPUHLER JN, 1982, SOC BIOL, V29, P53; STUNKARD AJ, 1990, NEW ENGL J MED, V322, P1483, DOI 10.1056/NEJM199005243222102; Tschumper A, 2006, INT J PEDIATR OBES, V1, P153, DOI 10.1080/17477160600881767; Vandenbroeck P, 2007, FORESIGHT TACKLING O; Visscher PM, 2008, NAT REV GENET, V9, P255, DOI 10.1038/nrg2322; VLIETINCK R, 1989, BEHAV GENET, V19, P151, DOI 10.1007/BF01065890; Wardle J, 2008, AM J CLIN NUTR, V87, P398, DOI 10.1093/ajcn/87.2.398; Waterland RA, 2008, NUTR REV, V66, pS21, DOI 10.1111/j.1753-4887.2008.00060.x; Whitfield J B, 2001, Twin Res, V4, P365, DOI 10.1375/twin.4.5.365; Wisniewski AB, 2009, GENDER MED, V6, P76, DOI 10.1016/j.genm.2008.12.001; World Health Organization, 2006, OB OV FACT SHEET; Wright MJ, 2004, AUST J PSYCHOL, V56, P65, DOI 10.1080/00049530410001734865; Zhu G, 1999, AM J HUM GENET, V65, P483, DOI 10.1086/302494; Zhu G, 2007, EUR J HUM GENET, V15, P94, DOI 10.1038/sj.ejhg.5201729	78	171	177	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e30153	10.1371/journal.pone.0030153	http://dx.doi.org/10.1371/journal.pone.0030153			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347368	Green Submitted, gold, Green Published			2022-12-27	WOS:000302730100006
J	Soriano, S; Alonso-Magdalena, P; Garcia-Arevalo, M; Novials, A; Muhammed, SJ; Salehi, A; Gustafsson, JA; Quesada, I; Nadal, A				Soriano, Sergi; Alonso-Magdalena, Paloma; Garcia-Arevalo, Marta; Novials, Anna; Muhammed, Sarheed J.; Salehi, Albert; Gustafsson, Jan-Ake; Quesada, Ivan; Nadal, Angel			Rapid Insulinotropic Action of Low Doses of Bisphenol-A on Mouse and Human Islets of Langerhans: Role of Estrogen Receptor beta	PLOS ONE			English	Article							PANCREATIC-ISLETS; INTACT ISLETS; HUMAN HEALTH; GLUCOSE; SECRETION; CELLS; ALPHA; OSCILLATIONS; ACTIVATION; MECHANISMS	Bisphenol-A (BPA) is a widespread endocrine-disrupting chemical (EDC) used as the base compound in the manufacture of polycarbonate plastics. It alters pancreatic beta-cell function and can be considered a risk factor for type 2 diabetes in rodents. Here we used ER beta(-/-) mice to study whether ER beta is involved in the rapid regulation of K-ATP channel activity, calcium signals and insulin release elicited by environmentally relevant doses of BPA (1 nM). We also investigated these effects of BPA in beta-cells and whole islets of Langerhans from humans. 1 nM BPA rapidly decreased K-ATP channel activity, increased glucose-induced [Ca2+](i) signals and insulin release in beta-cells from WT mice but not in cells from ER beta(-/-) mice. The rapid reduction in the K-ATP channel activity and the insulinotropic effect was seen in human cells and islets. BPA actions were stronger in human islets compared to mouse islets when the same BPA concentration was used. Our findings suggest that BPA behaves as a strong estrogen via nuclear ER beta and indicate that results obtained with BPA in mouse beta-cells may be extrapolated to humans. This supports that BPA should be considered as a risk factor for metabolic disorders in humans.	[Soriano, Sergi; Alonso-Magdalena, Paloma; Garcia-Arevalo, Marta; Quesada, Ivan; Nadal, Angel] Univ Miguel Hernandez Elche, Inst Bioingn, Alicante, Spain; [Soriano, Sergi; Alonso-Magdalena, Paloma; Garcia-Arevalo, Marta; Quesada, Ivan; Nadal, Angel] Univ Miguel Hernandez Elche, CIBER Diabet & Enfermedades Metab Asociadas CIBER, Alicante, Spain; [Novials, Anna] IDIBAPS, Barcelona, Spain; [Novials, Anna] CIBERDEM, Barcelona, Spain; [Muhammed, Sarheed J.; Salehi, Albert] Lund Univ, Dept Clin Sci, Malmo, Sweden; [Gustafsson, Jan-Ake] Univ Houston, Dept Cell Biol & Biochem, Ctr Nucl Receptors & Cell Signaling, Houston, TX USA	Universidad Miguel Hernandez de Elche; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Universidad Miguel Hernandez de Elche; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Lund University; University of Houston System; University of Houston	Soriano, S (corresponding author), Univ Miguel Hernandez Elche, Inst Bioingn, Alicante, Spain.	nadal@umh.es	Nadal, Angel/G-6721-2014; Ivan, Quesada/P-6541-2014; Soriano, Sergi/M-5255-2017; García-Arévalo, Marta/C-9440-2014; Alonso-Magdalena, Paloma/AAH-2076-2021; Salehi, Albert/F-7768-2018	Nadal, Angel/0000-0003-4178-2152; Ivan, Quesada/0000-0002-9808-514X; Soriano, Sergi/0000-0001-9844-7027; Salehi, Albert/0000-0001-6120-3539; Novials, Anna/0000-0003-0465-2949; ALONSO MAGDALENA, PALOMA/0000-0003-1065-5388; Garcia-Arevalo Provencio, Marta/0000-0001-7238-9498	Ministerio de Ciencia e Innovacion [BFU2008-01492, BFU2011-28358, BFU2010-21773]; Generalitat Valenciana [Prometeo/2011/080, ACOMP/2010/113]; European Commission	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre)	This research was supported by grants from Ministerio de Ciencia e Innovacion grants BFU2008-01492, BFU2011-28358 and BFU2010-21773, Generalitat Valenciana grants Prometeo/2011/080 and ACOMP/2010/113, the European Commission (Program PEOPLE). The "Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas" is an initiative of the Instituto de Salud Carlos III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Magdalena P, 2006, ENVIRON HEALTH PERSP, V114, P106, DOI [10.1289/ehp.8451, 10.1289/ehp.8062]; Alonso-Magdalena P, 2005, ENVIRON HEALTH PERSP, V113, P969, DOI 10.1289/ehp.8002; Alonso-Magdalena P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002069; Alonso-Magdalena P, 2011, NAT REV ENDOCRINOL, V7, P346, DOI 10.1038/nrendo.2011.56; Alonso-Magdalena P, 2010, ENVIRON HEALTH PERSP, V118, P1243, DOI 10.1289/ehp.1001993; ASHCROFT FM, 1984, NATURE, V312, P446, DOI 10.1038/312446a0; Ashcroft FM, 2005, J CLIN INVEST, V115, P2047, DOI 10.1172/JCI25495; Balhuizen A, 2010, MOL CELL ENDOCRINOL, V320, P16, DOI 10.1016/j.mce.2010.01.030; Barbosa RM, 1998, J PHYSIOL-LONDON, V510, P135, DOI 10.1111/j.1469-7793.1998.135bz.x; Ben-Jonathan N, 2009, MOL CELL ENDOCRINOL, V304, P49, DOI 10.1016/j.mce.2009.02.022; Biddinger SB, 2006, ANNU REV PHYSIOL, V68, P123, DOI 10.1146/annurev.physiol.68.040104.124723; Bouskine A, 2009, ENVIRON HEALTH PERSP, V117, P1053, DOI 10.1289/ehp.0800367; Brissova M, 2005, J HISTOCHEM CYTOCHEM, V53, P1087, DOI 10.1369/jhc.5C6684.2005; Cabrera O, 2006, P NATL ACAD SCI USA, V103, P2334, DOI 10.1073/pnas.0510790103; Dyachok O, 2008, CELL METAB, V8, P26, DOI 10.1016/j.cmet.2008.06.003; FENWICK EM, 1982, J PHYSIOL-LONDON, V331, P577, DOI 10.1113/jphysiol.1982.sp014393; GILON P, 1993, J BIOL CHEM, V268, P22265; Hectors TLM, 2011, DIABETOLOGIA, V54, P1273, DOI 10.1007/s00125-011-2109-5; Hugo ER, 2008, ENVIRON HEALTH PERSP, V116, P1642, DOI 10.1289/ehp.11537; Krege JH, 1998, P NATL ACAD SCI USA, V95, P15677, DOI 10.1073/pnas.95.26.15677; Kuiper GGJM, 1998, ENDOCRINOLOGY, V139, P4252, DOI 10.1210/en.139.10.4252; Kumar R, 2011, ENDOCRINOLOGY, V152, P2568, DOI 10.1210/en.2010-1361; Lang IA, 2008, JAMA-J AM MED ASSOC, V300, P1303, DOI 10.1001/jama.300.11.1303; Levin ER, 2011, MOL ENDOCRINOL, V25, P377, DOI 10.1210/me.2010-0284; Liu SH, 2009, ISLETS, V1, P273, DOI 10.4161/isl.1.3.9781; Liu SH, 2009, DIABETES, V58, P2292, DOI 10.2337/db09-0257; Melzer D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008673; Nadal A, 2004, STEROIDS, V69, P531, DOI 10.1016/j.steroids.2004.05.010; Nadal A, 1999, J PHYSIOL-LONDON, V517, P85, DOI 10.1111/j.1469-7793.1999.0085z.x; Nadal A, 2001, NEWS PHYSIOL SCI, V16, P251; Nadal A, 2011, FRONT BIOSCI-LANDMRK, V16, P251, DOI 10.2741/3686; Nadal A, 2009, MOL CELL ENDOCRINOL, V304, P63, DOI 10.1016/j.mce.2009.02.016; Neel BA, 2011, DIABETES, V60, P1838, DOI 10.2337/db11-0153; NOVIALS A, 1993, DIABETES, V42, P1514, DOI 10.2337/diabetes.42.10.1514; Park CJ, 2011, J CLIN INVEST, V121, P604, DOI 10.1172/JCI41702; Prado CL, 2004, P NATL ACAD SCI USA, V101, P2924, DOI 10.1073/pnas.0308604100; Ropero AB, 1999, J PHYSIOL-LONDON, V521, P397, DOI 10.1111/j.1469-7793.1999.00397.x; Rorsman P, 2000, NEWS PHYSIOL SCI, V15, P72; Safe SH, 2002, ENVIRON HEALTH PERSP, V110, P925, DOI 10.1289/ehp.02110s6925; SANTOS RM, 1991, PFLUG ARCH EUR J PHY, V418, P417, DOI 10.1007/BF00550880; Sato Y, 1998, DIABETES, V47, P1713, DOI 10.2337/diabetes.47.11.1713; Shankar A, 2011, J CLIN ENDOCR METAB, V96, P3822, DOI 10.1210/jc.2011-1682; Sharma G, 2011, ENDOCRINOLOGY, V152, P3030, DOI 10.1210/en.2011-0091; Sheeler CQ, 2000, ENVIRON HEALTH PERSP, V108, P97, DOI 10.2307/3454506; Soriano S, 2009, MOL ENDOCRINOL, V23, P1973, DOI 10.1210/me.2009-0287; Straub SG, 1998, DIABETES, V47, P758, DOI 10.2337/diabetes.47.5.758; Thomas C, 2011, NAT REV CANCER, V11, P597, DOI 10.1038/nrc3093; Tiano JP, 2011, J CLIN INVEST, V121, P3331, DOI 10.1172/JCI44564; VALDEOLMILLOS M, 1992, J PHYSIOL-LONDON, V455, P173, DOI 10.1113/jphysiol.1992.sp019295; vom Saal FS, 2007, REPROD TOXICOL, V24, P131, DOI 10.1016/j.reprotox.2007.07.005; vom Saal FS, 2005, TOXICOLOGY, V212, P244, DOI 10.1016/j.tox.2005.05.006; Wang TG, 2012, J CLIN ENDOCR METAB, V97, pE223, DOI 10.1210/jc.2011-1989; Wei J, 2011, ENDOCRINOLOGY, V152, P3049, DOI 10.1210/en.2011-0045; Wong WPS, 2010, P NATL ACAD SCI USA, V107, P13057, DOI 10.1073/pnas.0914501107	54	137	141	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31109	10.1371/journal.pone.0031109	http://dx.doi.org/10.1371/journal.pone.0031109			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347437	Green Submitted, Green Published, gold			2022-12-27	WOS:000302730100042
J	Vallin, E; Gallagher, J; Granger, L; Martin, E; Belougne, J; Maurizio, J; Duverger, Y; Scaglione, S; Borrel, C; Cortier, E; Abouzid, K; Carre-Pierrat, M; Gieseler, K; Segalat, L; Kuwabara, PE; Ewbank, JJ				Vallin, Elodie; Gallagher, Joseph; Granger, Laure; Martin, Edwige; Belougne, Jerome; Maurizio, Julien; Duverger, Yohann; Scaglione, Sarah; Borrel, Caroline; Cortier, Elisabeth; Abouzid, Karima; Carre-Pierrat, Maite; Gieseler, Kathrin; Segalat, Laurent; Kuwabara, Patricia E.; Ewbank, Jonathan J.			A Genome-Wide Collection of Mos1 Transposon Insertion Mutants for the C. elegans Research Community	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; MUTAGENESIS; GENERATION; WORMBASE	Methods that use homologous recombination to engineer the genome of C. elegans commonly use strains carrying specific insertions of the heterologous transposon Mos1. A large collection of known Mos1 insertion alleles would therefore be of general interest to the C. elegans research community. We describe here the optimization of a semi-automated methodology for the construction of a substantial collection of Mos1 insertion mutant strains. At peak production, more than 5,000 strains were generated per month. These strains were then subject to molecular analysis, and more than 13,300 Mos1 insertions characterized. In addition to targeting directly more than 4,700 genes, these alleles represent the potential starting point for the engineered deletion of essentially all C. elegans genes and the modification of more than 40% of them. This collection of mutants, generated under the auspices of the European NEMAGENETAG consortium, is publicly available and represents an important research resource.	[Vallin, Elodie; Granger, Laure; Martin, Edwige; Borrel, Caroline; Cortier, Elisabeth; Abouzid, Karima; Carre-Pierrat, Maite; Gieseler, Kathrin; Segalat, Laurent] CNRS, Ctr Genet & Physiol Mol & Cellulaires, UMR 5534, Villeurbanne, France; [Vallin, Elodie; Granger, Laure; Martin, Edwige; Borrel, Caroline; Cortier, Elisabeth; Abouzid, Karima; Carre-Pierrat, Maite; Gieseler, Kathrin; Segalat, Laurent] Univ Lyon 1, F-69622 Villeurbanne, France; [Gallagher, Joseph; Kuwabara, Patricia E.] Univ Bristol, Sch Biochem, Bristol, Avon, England; [Belougne, Jerome; Maurizio, Julien; Duverger, Yohann; Scaglione, Sarah; Ewbank, Jonathan J.] Aix Marseille Univ, Ctr Immunol Marseille Luminy, Marseille, France; [Belougne, Jerome; Maurizio, Julien; Duverger, Yohann; Scaglione, Sarah; Ewbank, Jonathan J.] INSERM, U1104, F-13258 Marseille, France; [Belougne, Jerome; Maurizio, Julien; Duverger, Yohann; Scaglione, Sarah; Ewbank, Jonathan J.] CNRS, UMR7280, Marseille, France; [Carre-Pierrat, Maite] CNRS, UMS3421, Villeurbanne, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of Bristol; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Vallin, E (corresponding author), CNRS, Ctr Genet & Physiol Mol & Cellulaires, UMR 5534, Campus Doua, Villeurbanne, France.	ewbank@ciml.univ-mrs.fr	Gieseler, Kathrin/Q-8161-2016; Ewbank, Jonathan J/G-4948-2010	Ewbank, Jonathan J/0000-0002-1257-6862; Kuwabara, Patricia/0000-0002-1108-7776; Maurizio, Julien/0000-0002-6387-5125; Gieseler, Kathrin/0000-0003-0222-9450	European Community; CNRS; INSERM; Reseau National des Genopoles; Marseille-Nice Genopole	European Community(European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Reseau National des Genopoles; Marseille-Nice Genopole	This research was funded primarily by the European Community's FP6 STREP NEMAGENETAG, supplemented by institutional grants from the CNRS and INSERM, as well as funding from the Reseau National des Genopoles and Marseille-Nice Genopole. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bazopoulou D, 2009, GENETICA, V137, P39, DOI 10.1007/s10709-009-9361-3; Bessereau JL, 2001, NATURE, V413, P70, DOI 10.1038/35092567; Boulin T, 2007, NAT PROTOC, V2, P1276, DOI 10.1038/nprot.2007.192; Duverger Y, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1046; Engelmann I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019055; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Frokjaer-Jensen C, 2010, NAT METHODS, V7, P451, DOI [10.1038/NMETH.1454, 10.1038/nmeth.1454]; Gendrel M, 2009, NATURE, V461, P992, DOI 10.1038/nature08430; Granger L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh111; Harris TW, 2010, NUCLEIC ACIDS RES, V38, pD463, DOI 10.1093/nar/gkp952; Kim SK, 2001, SCIENCE, V293, P2087, DOI 10.1126/science.1061603; Paruzynski A, 2010, NAT PROTOC, V5, P1379, DOI 10.1038/nprot.2010.87; Pauli F, 2006, DEVELOPMENT, V133, P287, DOI 10.1242/dev.02185; Pujol N, 2008, CURR BIOL, V18, P481, DOI 10.1016/j.cub.2008.02.079; Robert V, 2007, EMBO J, V26, P170, DOI 10.1038/sj.emboj.7601463; Schwarz EM, 2006, NUCLEIC ACIDS RES, V34, pD475, DOI 10.1093/nar/gkj061; Stiernagle Theresa, 2006, WormBook, P1	17	34	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e30482	10.1371/journal.pone.0030482	http://dx.doi.org/10.1371/journal.pone.0030482			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347378	Green Submitted, Green Published, gold			2022-12-27	WOS:000302730100013
J	Paget, V; Lechevrel, M; Andre, R; Le Goff, J; Pottier, D; Billet, S; Garcon, G; Shirali, P; Sichel, F				Paget, Vincent; Lechevrel, Mathilde; Andre, Ronique; Le Goff, Jeremie; Pottier, Didier; Billet, Sylvain; Garcon, Guillaume; Shirali, Pirouz; Sichel, Francois			Benzo[a]pyrene, Aflatoxine B-1 and Acetaldehyde Mutational Patterns in TP53 Gene Using a Functional Assay: Relevance to Human Cancer Aetiology	PLOS ONE			English	Article							DEOXYADENOSINE N-6-AMINO GROUP; NMR SOLUTION STRUCTURE; TUMOR-SUPPRESSOR GENE; DG MISMATCH OPPOSITE; DIOL EPOXIDE; P53 MUTATIONS; NONANUCLEOTIDE DUPLEX; SEPARATED ALLELES; METHYLATED CPG; TRANS ADDITION	Mutations in the TP53 gene are the most common alterations in human tumours. TP53 mutational patterns have sometimes been linked to carcinogen exposure. In hepatocellular carcinoma, a specific G>T transversion on codon 249 is classically described as a fingerprint of aflatoxin B-1 exposure. Likewise G>T transversions in codons 157 and 158 have been related to tobacco exposure in human lung cancers. However, controversies remain about the interpretation of TP53 mutational pattern in tumours as the fingerprint of genotoxin exposure. By using a functional assay, the Functional Analysis of Separated Alleles in Yeast (FASAY), the present study depicts the mutational pattern of TP53 in normal human fibroblasts after in vitro exposure to well-known carcinogens: benzo[a]pyrene, aflatoxin B-1 and acetaldehyde. These in vitro patterns of mutations were then compared to those found in human tumours by using the IARC database of TP53 mutations. The results show that the TP53 mutational patterns found in human tumours can be only partly ascribed to genotoxin exposure. A complex interplay between the functional impact of the mutations on p53 phenotype and the cancer natural history may affect these patterns. However, our results strongly support that genotoxins exposure plays a major role in the aetiology of the considered cancers.	[Paget, Vincent; Lechevrel, Mathilde; Andre, Ronique; Le Goff, Jeremie; Pottier, Didier; Sichel, Francois] Univ Caen Basse Normandie, Grp Reg Etud Canc, EA 1772, Caen, France; [Paget, Vincent; Andre, Ronique; Le Goff, Jeremie; Pottier, Didier; Sichel, Francois] Ctr Reg Lutte Canc Francois Baclesse, Grp Reg Etud Canc, Caen, France; [Paget, Vincent; Billet, Sylvain; Garcon, Guillaume; Shirali, Pirouz] Univ Littoral Cote dOpale, EA 4492, Unite Chim Environm & Interact Vivant, Dunkerque, France; [Paget, Vincent; Billet, Sylvain; Garcon, Guillaume; Shirali, Pirouz] Univ Lille Nord France, Lille, France	Universite de Caen Normandie; UNICANCER; Centre Francois Baclesse; Universite du Littoral-Cote-d'Opale; Universite de Lille - ISITE; Universite de Lille	Paget, V (corresponding author), Univ Caen Basse Normandie, Grp Reg Etud Canc, EA 1772, Caen, France.	francois.sichel@unicaen.fr		Billet, Sylvain/0000-0003-1363-4515; GARCON, Guillaume/0000-0002-4530-7175	Agence Francaise de Securite Sanitaire de l'Environnement et du Travail (AFSSET) [EST-2007-48]; Ministere de l'Enseignement Superieur et de la Recherche [16848-2005]; Region Nord-Pas de Calais [08070005]; Ligue Nationale Contre le Cancer; Comite de l'Orne; Region Nord-Pas de Calais; Ministere de l'Enseignement Superieur et de la Recherche; European Funds (FEDER)	Agence Francaise de Securite Sanitaire de l'Environnement et du Travail (AFSSET); Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission); Region Nord-Pas de Calais(Region Hauts-de-FranceEuropean Commission); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Comite de l'Orne; Region Nord-Pas de Calais(Region Hauts-de-FranceEuropean Commission); Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission); European Funds (FEDER)(European Commission)	This work was supported by the Agence Francaise de Securite Sanitaire de l'Environnement et du Travail (AFSSET; Convention noEST-2007-48), the Ministere de l'Enseignement Superieur et de la Recherche (Convention no16848-2005), the Region Nord-Pas de Calais (Convention no08070005) and the Ligue Nationale Contre le Cancer, Comite de l'Orne. The Unite de Chimie Environnementale et Interactions sur le Vivant (UCEIV-EA 4492) works in partnership with the Institut de Recherches en ENvironnement Industriel (IRENI), which is financed by the Region Nord-Pas de Calais, the Ministere de l'Enseignement Superieur et de la Recherche, and European Funds (FEDER). V.P. received a post-PhD fellowship from the Region Nord-Pas de Calais. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki Y, 2007, CANCER RES, V67, P5643, DOI 10.1158/0008-5472.CAN-06-3355; Arlt VM, 2007, CARCINOGENESIS, V28, P2253, DOI 10.1093/carcin/bgm082; Baan R, 2007, LANCET ONCOL, V8, P292, DOI 10.1016/S1470-2045(07)70099-2; Balu N, 2004, CHEM RES TOXICOL, V17, P827, DOI 10.1021/tx034207s; Besaratinia A, 2010, FASEB J, V24, P2612, DOI 10.1096/fj.10-157263; Bitton A, 2005, LANCET, V365, P531; Chen JX, 1998, CANCER RES, V58, P2070; CHENG SC, 1989, CHEM RES TOXICOL, V2, P334, DOI 10.1021/tx00011a011; Culp SJ, 2000, CARCINOGENESIS, V21, P1433, DOI 10.1093/carcin/21.7.1433; Dearth LR, 2007, CARCINOGENESIS, V28, P289, DOI 10.1093/carcin/bgl132; Denissenko MF, 1996, SCIENCE, V274, P430, DOI 10.1126/science.274.5286.430; Divi RL, 2002, CARCINOGENESIS, V23, P2043, DOI 10.1093/carcin/23.12.2043; FLAMAN JM, 1995, P NATL ACAD SCI USA, V92, P3963, DOI 10.1073/pnas.92.9.3963; Hainaut P, 2000, ADV CANCER RES, V77, P81; Hakura A, 2000, MUTAT RES-FUND MOL M, V447, P239, DOI 10.1016/S0027-5107(99)00213-4; Hussain SP, 2007, ONCOGENE, V26, P2166, DOI 10.1038/sj.onc.1210279; ISHIOKA C, 1993, NAT GENET, V5, P124, DOI 10.1038/ng1093-124; Le Goff J, 2005, MUTAT RES-GEN TOX EN, V587, P90, DOI 10.1016/j.mrgentox.2005.05.013; Liu ZP, 2005, CANCER RES, V65, P2583, DOI 10.1158/0008-5472.CAN-04-3675; Luo JL, 2001, CANCER RES, V61, P8158; Olivier M, 2002, HUM MUTAT, V19, P607, DOI 10.1002/humu.10081; Paget V, 2008, MUTAT RES-GEN TOX EN, V656, P55, DOI 10.1016/j.mrgentox.2008.07.009; Paget V, 2008, MUTAT RES-GEN TOX EN, V652, P12, DOI 10.1016/j.mrgentox.2007.11.010; Penning TM, 1999, CHEM RES TOXICOL, V12, P1, DOI 10.1021/tx980143n; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Pfeifer GP, 2002, ONCOGENE, V21, P7435, DOI 10.1038/sj.onc.1205803; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; REDDY MV, 1986, CARCINOGENESIS, V7, P1543, DOI 10.1093/carcin/7.9.1543; Reinbold M, 2008, ONCOGENE, V27, P2788, DOI 10.1038/sj.onc.1210932; RUGGERI B, 1993, P NATL ACAD SCI USA, V90, P1013, DOI 10.1073/pnas.90.3.1013; SCHURTER EJ, 1995, BIOCHEMISTRY-US, V34, P1364, DOI 10.1021/bi00004a031; SCUDIERO DA, 1988, CANCER RES, V48, P4827; Shen YM, 2006, CHEM RES TOXICOL, V19, P1441, DOI 10.1021/tx0601206; SHOU M, 1993, CARCINOGENESIS, V14, P475, DOI 10.1093/carcin/14.3.475; Smela ME, 2001, CARCINOGENESIS, V22, P535, DOI 10.1093/carcin/22.4.535; Smith LE, 2000, JNCI-J NATL CANCER I, V92, P803, DOI 10.1093/jnci/92.10.803; Sohn S, 2000, MUTAT RES-DNA REPAIR, V460, P17, DOI 10.1016/S0921-8777(00)00010-0; Tang MS, 1999, CARCINOGENESIS, V20, P1085, DOI 10.1093/carcin/20.6.1085; WEI SJC, 1993, CANCER RES, V53, P3294; Xie ZW, 2003, BIOCHEMISTRY-US, V42, P11253, DOI 10.1021/bi0346704; YEH HJC, 1995, BIOCHEMISTRY-US, V34, P13570, DOI 10.1021/bi00041a037; Yoon JH, 2003, CARCINOGENESIS, V24, P113, DOI 10.1093/carcin/24.1.113; Yoon JH, 2001, CANCER RES, V61, P7110	43	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e30921	10.1371/journal.pone.0030921	http://dx.doi.org/10.1371/journal.pone.0030921			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LO	22319594	Green Published, Green Submitted, gold			2022-12-27	WOS:000302178400019
J	Fielding, J; Kilpatrick, T; Millist, L; Clough, M; White, O				Fielding, Joanne; Kilpatrick, Trevor; Millist, Lynette; Clough, Meaghan; White, Owen			Longitudinal Assessment of Antisaccades in Patients with Multiple Sclerosis	PLOS ONE			English	Article							EYE-MOVEMENTS; EARLY-STAGE; COGNITION; MS; IMPAIRMENT; DISABILITY; DIAGNOSIS; ATROPHY	We have previously demonstrated that assessment of antisaccades (AS) provides not only measures of motor function in multiple sclerosis (MS), but measures of cognitive control processes in particular, attention and working memory. This study sought to demonstrate the potential for AS measures to sensitively reflect change in functional status in MS. Twenty-four patients with relapsing-remitting MS and 12 age-matched controls were evaluated longitudinally using an AS saccade task. Compared to control subjects, a number of saccade parameters changed significantly over a two year period for MS patients. These included saccade error rates, latencies, and accuracy measures. Further, for MS patients, correlations were retained between OM measures and scores on the PASAT, which is considered the reference task for the cognitive evaluation of MS patients. Notably, EDSS scores for these patients did not change significantly over this period. These results demonstrate that OM measures may reflect disease evolution in MS, in the absence of clinically evident changes as measured using conventional techniques. With replication, these markers could ultimately be developed into a cost-effective, non-invasive, and well tolerated assessment tool to assist in confirming progression early in the disease process, and in measuring and predicting response to therapy.	[Fielding, Joanne; Clough, Meaghan] Monash Univ, Sch Psychol & Psychiat, Clayton, Vic, Australia; [Fielding, Joanne; Kilpatrick, Trevor; Millist, Lynette; White, Owen] Royal Melbourne Hosp, Dept Neurol, Parkville, Vic 3050, Australia; [Kilpatrick, Trevor; White, Owen] Univ Melbourne, Ctr Neurosci, Parkville, Vic 3052, Australia	Monash University; Royal Melbourne Hospital; University of Melbourne	Fielding, J (corresponding author), Monash Univ, Sch Psychol & Psychiat, Clayton, Vic, Australia.	joanne.fielding@monash.edu		Fielding, Joanne/0000-0002-1131-0587; Kilpatrick, Trevor/0000-0003-3999-085X; White, Owen/0000-0002-2836-7344	National Health and Medical Research Council, Australia [454811]	National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by the National Health and Medical Research Council, Australia (#454811). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achiron A, 2000, ARCH NEUROL-CHICAGO, V57, P974, DOI 10.1001/archneur.57.7.974; Audoin B, 2006, J NEUROL SCI, V245, P87, DOI 10.1016/j.jns.2005.08.026; Benedict RHB, 2004, ARCH NEUROL-CHICAGO, V61, P226, DOI 10.1001/archneur.61.2.226; Bobholz JA, 2006, NEUROLOGY, V67, P1640, DOI 10.1212/01.wnl.0000242885.71725.76; Derwenskus J, 2005, ANN NY ACAD SCI, V1039, P521, DOI 10.1196/annals.1325.058; Fielding J, 2009, CORTEX, V45, P900, DOI 10.1016/j.cortex.2009.02.016; Fielding J, 2009, NEUROPSYCHOLOGIA, V47, P1647, DOI 10.1016/j.neuropsychologia.2009.01.040; Fielding J, 2009, J NEUROL SCI, V277, P32, DOI 10.1016/j.jns.2008.10.001; Gronwall D. M. A., 1977, PACED AUDITORY SERIA; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Sahraian MA, 2010, CLIN NEUROL NEUROSUR, V112, P609, DOI 10.1016/j.clineuro.2010.03.022; Schulz D, 2006, J NEUROL, V253, P1002, DOI 10.1007/s00415-006-0145-8; Zivadinov R, 2001, J NEUROL NEUROSUR PS, V70, P773, DOI 10.1136/jnnp.70.6.773	13	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2012	7	2							e30475	10.1371/journal.pone.0030475	http://dx.doi.org/10.1371/journal.pone.0030475			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UV	22319570	Green Published, gold			2022-12-27	WOS:000301979000007
J	Looyenga, BD; Hutchings, D; Cherni, I; Kingsley, C; Weiss, GJ; MacKeigan, JP				Looyenga, Brendan D.; Hutchings, Danielle; Cherni, Irene; Kingsley, Chris; Weiss, Glen J.; MacKeigan, Jeffrey P.			STAT3 Is Activated by JAK2 Independent of Key Oncogenic Driver Mutations in Non-Small Cell Lung Carcinoma	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; CANCER; RESISTANCE; INHIBITOR; EGFR; TRANSFORMATION; AMPLIFICATION; INFLAMMATION; SENSITIVITY; INCB018424	Constitutive activation of STAT3 is a common feature in many solid tumors including non-small cell lung carcinoma (NSCLC). While activation of STAT3 is commonly achieved by somatic mutations to JAK2 in hematologic malignancies, similar mutations are not often found in solid tumors. Previous work has instead suggested that STAT3 activation in solid tumors is more commonly induced by hyperactive growth factor receptors or autocrine cytokine signaling. The interplay between STAT3 activation and other well-characterized oncogenic "driver'' mutations in NSCLC has not been fully characterized, though constitutive STAT3 activation has been proposed to play an important role in resistance to various small-molecule therapies that target these oncogenes. In this study we demonstrate that STAT3 is constitutively activated in human NSCLC samples and in a variety of NSCLC lines independent of activating KRAS or tyrosine kinase mutations. We further show that genetic or pharmacologic inhibition of the gp130/JAK2 signaling pathway disrupts activation of STAT3. Interestingly, treatment of NSCLC cells with the JAK1/2 inhibitor ruxolitinib has no effect on cell proliferation and viability in two-dimensional culture, but inhibits growth in soft agar and xenograft assays. These data demonstrate that JAK2/STAT3 signaling operates independent of known driver mutations in NSCLC and plays critical roles in tumor cell behavior that may not be effectively inhibited by drugs that selectively target these driver mutations.	[Looyenga, Brendan D.; Hutchings, Danielle; MacKeigan, Jeffrey P.] Van Andel Res Inst, Grand Rapids, MI USA; [Cherni, Irene; Weiss, Glen J.] Translat Genom Res Inst TGen, Canc & Cell Biol Div, Lung Canc Unit, Phoenix, AZ USA; [Kingsley, Chris] TGen, Diabet Cardiovasc & Metab Dis Div, Phoenix, AZ USA; [Weiss, Glen J.] Scottsdale Healthcare, Virginia G Piper Canc Ctr Clin Trials, Scottsdale, AZ USA	Van Andel Institute; Translational Genomics Research Institute; Translational Genomics Research Institute; Scottsdale Healthcare Osborn	Looyenga, BD (corresponding author), Van Andel Res Inst, Grand Rapids, MI USA.	brendan.looyenga@vai.org; jeff.mackeigan@vai.org		MacKeigan, Jeffrey/0000-0002-0198-5679; Looyenga, Brendan/0000-0002-0661-0956	VARI-TGen Integration Grant; TGen Foundation; Scottsdale-Healthcare Foundation	VARI-TGen Integration Grant; TGen Foundation; Scottsdale-Healthcare Foundation	The internal funding sources for this work include VARI-TGen Integration Grant, TGen Foundation, and Scottsdale-Healthcare Foundation. No external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez JV, 2006, CANCER RES, V66, P3162, DOI 10.1158/0008-5472.CAN-05-3757; Amann J, 2005, CANCER RES, V65, P226; Astsaturov I, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001083; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bromberg J, 2002, J CLIN INVEST, V109, P1139, DOI 10.1172/JCI200215617; Bromberg JF, 1998, MOL CELL BIOL, V18, P2553, DOI 10.1128/MCB.18.5.2553; Chen KF, 2010, CLIN CANCER RES, V16, P5189, DOI 10.1158/1078-0432.CCR-09-3389; Chiarle R, 2005, NAT MED, V11, P623, DOI 10.1038/nm1249; D'Angelo SP, 2011, J THORAC CARDIOV SUR, V141, P476, DOI 10.1016/j.jtcvs.2010.08.026; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Edge SB., 2010, AJCC CANC STAGING MA, V7th; Engelman JA, 2008, CLIN CANCER RES, V14, P2895, DOI 10.1158/1078-0432.CCR-07-2248; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; Gadina M, 2001, CURR OPIN IMMUNOL, V13, P363, DOI 10.1016/S0952-7915(00)00228-4; Gao SP, 2007, J CLIN INVEST, V117, P3846, DOI 10.1172/JCI31871; Gilbert LA, 2010, CELL, V143, P355, DOI 10.1016/j.cell.2010.09.043; Gough DJ, 2009, SCIENCE, V324, P1713, DOI 10.1126/science.1171721; Haura EB, 2005, CLIN CANCER RES, V11, P8288, DOI 10.1158/1078-0432.CCR-05-0827; He B, 2003, P NATL ACAD SCI USA, V100, P14133, DOI 10.1073/pnas.2232790100; Hedvat M, 2009, CANCER CELL, V16, P487, DOI 10.1016/j.ccr.2009.10.015; Jackman DM, 2009, CLIN CANCER RES, V15, P5267, DOI 10.1158/1078-0432.CCR-09-0888; Janne PA, 2009, NAT REV DRUG DISCOV, V8, P709, DOI 10.1038/nrd2871; Jarnicki A, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-14; Jenkins BJ, 2005, NAT MED, V11, P845, DOI 10.1038/nm1282; Jones AV, 2005, BLOOD, V106, P2162, DOI 10.1182/blood-2005-03-1320; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Leslie K, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2725; Looyenga BD, 2011, TRANSLATION IN PRESS; Lucia E, 2011, EXPERT OPIN INV DRUG, V20, P41, DOI 10.1517/13543784.2011.538382; MCCARTY KS, 1986, CANCER RES, V46, P4244; Meads MB, 2009, NAT REV CANCER, V9, P665, DOI 10.1038/nrc2714; Mukohara T, 2003, LUNG CANCER, V41, P123, DOI 10.1016/S0169-5002(03)00225-3; Pignon JP, 2008, J CLIN ONCOL, V26, P3552, DOI 10.1200/JCO.2007.13.9030; Quintas-Cardama A, 2010, BLOOD, V115, P3109, DOI 10.1182/blood-2009-04-214957; Ramos AH, 2009, CANCER BIOL THER, V8, P2042, DOI 10.4161/cbt.8.21.9764; Rosell R, 2006, CLIN CANCER RES, V12, P7222, DOI 10.1158/1078-0432.CCR-06-0627; Rumi E, 2010, CRIT REV EUKAR GENE, V20, P61, DOI 10.1615/CritRevEukarGeneExpr.v20.i1.50; Seruga B, 2010, NAT REV CLIN ONCOL; Veeriah S, 2009, P NATL ACAD SCI USA, V106, P9435, DOI 10.1073/pnas.0900571106; Verstovsek S, 2010, NEW ENGL J MED, V363, P1117, DOI 10.1056/NEJMoa1002028; Vultur A, 2005, MOL BIOL CELL, V16, P3832, DOI 10.1091/mbc.E04-12-1104; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; Yao Z, 2010, P NATL ACAD SCI USA, V107, P15535, DOI 10.1073/pnas.1009472107; Yoon YK, 2010, MOL CARCINOGEN, V49, P353, DOI 10.1002/mc.20607; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734	47	88	90	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2012	7	2							e30820	10.1371/journal.pone.0030820	http://dx.doi.org/10.1371/journal.pone.0030820			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UV	22319590	Green Submitted, gold, Green Published			2022-12-27	WOS:000301979000016
J	Lyytinen, A; Mappes, J; Lindstrom, L				Lyytinen, Anne; Mappes, Johanna; Lindstrom, Leena			Variation in Hsp70 Levels after Cold Shock: Signs of Evolutionary Responses to Thermal Selection among Leptinotarsa decemlineata Populations	PLOS ONE			English	Article							COLORADO POTATO BEETLE; GENETIC-VARIATION; DROSOPHILA-MELANOGASTER; PHENOTYPIC PLASTICITY; EXPRESSION; TEMPERATURE; DIAPAUSE; THERMOTOLERANCE; ACCLIMATION; TRANSCRIPTS	Individuals of widely spread species are expected to show local adaption in temperature tolerance as they encounter a range of thermal conditions. We tracked thermal adaptations of the Colorado potato beetle (Leptinotarsa decemlineata) that invaded Europe within the last 100 years. It has occupied various conditions although, like the majority of invasive species, it lost a measurable amount of neutral genetic variation due to bottleneck effect when it invaded Europe. We exposed diapausing beetles originated from three different latitudes (54 degrees N, 59 degrees N, 60 degrees N) to cold shock (-5 degrees C, 1.5 hrs) in order to test if beetles from the northern populations express differential levels of cold-induced and constitutive Hsp70 compared to the beetles from milder temperature regime. The level of cold-induced Hsp70 was lowest in the northernmost beetle populations while the level of constitutive Hsp70 did not differ with the population. Moreover, the southernmost beetles were more plastic in their response to cold shock than the northernmost beetles. These results suggest that physiological adaptation, like the synthesis of Hsp70, can evolve very quickly.	[Lyytinen, Anne; Mappes, Johanna; Lindstrom, Leena] Univ Jyvaskyla, Dept Biol & Environm Sci, Ctr Excellence Evolutionary Res, Jyvaskyla, Finland	University of Jyvaskyla	Lyytinen, A (corresponding author), Univ Jyvaskyla, Dept Biol & Environm Sci, Ctr Excellence Evolutionary Res, Jyvaskyla, Finland.	anne.m.lyytinen@jyu.fi	Lindstrom, Leena/B-2326-2012; Mappes, Johanna/AAZ-3627-2021	Lindstrom, Leena/0000-0002-6452-4538; Mappes, Johanna/0000-0002-1117-5629; Lyytinen, Anne/0000-0002-1281-1797	Academy of Finland [108335, 118456/131406]; Ministry of Agriculture and Forestry	Academy of Finland(Academy of Finland); Ministry of Agriculture and Forestry	This research project was supported by funds from the Academy of Finland (n:o: 108335, 118456/131406) and the Ministry of Agriculture and Forestry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barua D, 2004, J THERM BIOL, V29, P185, DOI 10.1016/j.jtherbio.2004.01.004; Boman S, 2008, BIOL INVASIONS, V10, P1135, DOI 10.1007/s10530-007-9191-0; Buckley BA, 2001, J EXP BIOL, V204, P3571; FEDER JH, 1992, GENE DEV, V6, P1402, DOI 10.1101/gad.6.8.1402; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Ghalambor CK, 2007, FUNCT ECOL, V21, P394, DOI 10.1111/j.1365-2435.2007.01283.x; Goto SG, 1998, J INSECT PHYSIOL, V44, P1233, DOI 10.1016/S0022-1910(98)00101-2; Grapputo A, 2005, MOL ECOL, V14, P4207, DOI 10.1111/j.1365-294X.2005.02740.x; Hiiesaar Kulli, 2001, Norwegian Journal of Entomology, V48, P87; Hochachka P. W., 2002, BIOCH ADAPTATION MEC, DOI 10.1002/bmb.2002.494030030071; Johnson C.G., 1967, EUR J PLANT PATHOL, V73, P21, DOI DOI 10.1007/BF01974421; Karl I, 2009, J EVOLUTION BIOL, V22, P172, DOI 10.1111/j.1420-9101.2008.01630.x; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; KREBS RA, 1994, FUNCT ECOL, V8, P730, DOI 10.2307/2390232; Lansing E, 2000, J THERM BIOL, V25, P443, DOI 10.1016/S0306-4565(00)00008-5; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Lyytinen A, 2008, ENTOMOL EXP APPL, V127, P157, DOI 10.1111/j.1570-7458.2008.00685.x; Maisov A.V., 2007, CELL TISSUE BIOL, V1, P434, DOI [10.1134/S1990519X07050094, DOI 10.1134/S1990519X07050094]; Piiroinen S, 2011, FUNCT ECOL, V25, P527, DOI 10.1111/j.1365-2435.2010.01804.x; Richards CL, 2006, ECOL LETT, V9, P981, DOI 10.1111/j.1461-0248.2006.00950.x; Rinehart JP, 2000, INSECT BIOCHEM MOLEC, V30, P515, DOI 10.1016/S0965-1748(00)00021-7; Sexton JP, 2002, ECOL APPL, V12, P1652, DOI 10.1890/1051-0761(2002)012[1652:PAGDMA]2.0.CO;2; Sorensen JG, 1999, HEREDITAS, V131, P155, DOI 10.1111/j.1601-5223.1999.00155.x; Sorensen JG, 2001, FUNCT ECOL, V15, P289, DOI 10.1046/j.1365-2435.2001.00525.x; Sorensen JG, 2003, ECOL LETT, V6, P1025, DOI 10.1046/j.1461-0248.2003.00528.x; Tomanek L, 1999, J EXP BIOL, V202, P2925; Vilkova NA, 2005, PLANT PROTECTION NEW, V1, P3; Watson P, 1987, TEMPERATURE ANIMAL C, P311; Yocum GD, 2001, J INSECT PHYSIOL, V47, P1139, DOI 10.1016/S0022-1910(01)00095-6; ZACHARIASSEN KE, 1985, PHYSIOL REV, V65, P799, DOI 10.1152/physrev.1985.65.4.799; Zhang QR, 2010, J INSECT PHYSIOL, V56, P138, DOI 10.1016/j.jinsphys.2009.09.013	31	29	31	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2012	7	2							e31446	10.1371/journal.pone.0031446	http://dx.doi.org/10.1371/journal.pone.0031446			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UV	22319631	Green Submitted, gold, Green Published			2022-12-27	WOS:000301979000028
J	Zhang, WC; Li, F; Qin, SZ; Luo, J				Zhang, Wencai; Li, Fan; Qin, Shaozheng; Luo, Jing			The Integrative Effects of Cognitive Reappraisal on Negative Affect: Associated Changes in Secretory Immunoglobulin A, Unpleasantness and ERP Activity	PLOS ONE			English	Article							EMOTION REGULATION; STRESS-MANAGEMENT; CARDIOVASCULAR REACTIONS; INDIVIDUAL-DIFFERENCES; ADRENERGIC-BLOCKADE; IMMUNE-SYSTEM; COPING STYLE; RESPONSES; PICTURES; MOOD	Although the regulatory role of cognitive reappraisal in negative emotional responses is widely recognized, this reappraisal's effect on acute saliva secretory immunoglobulin A (SIgA), as well as the relationships among affective, immunological, and event-related potential (ERP) changes, remains unclear. In this study, we selected only people with low positive coping scores (PCSs) as measured by the Trait Coping Style Questionnaire to avoid confounding by intrinsic coping styles. First, we found that the acute stress of viewing unpleasant pictures consistently decreased SIgA concentration and secretion rate, increased perceptions of unpleasantness and amplitude of late positive potentials (LPPs) between 200-300 ms and 400-1000 ms. After participants used cognitive reappraisal, their SIgA concentration and secretion rate significantly increased and their unpleasantness and LPP amplitudes significantly decreased compared with a control condition. Second, we found a significantly positive correlation between the increases in SIgA and the decreases in unpleasantness and a significantly negative correlation between the increases in SIgA and the increases in LPP across the two groups. This study is the first to demonstrate that cognitive reappraisal reverses the decrease of SIgA. In addition, it revealed strong correlations among affective, SIgA and electrophysiological changes with convergent multilevel evidence.	[Zhang, Wencai; Li, Fan; Luo, Jing] Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China; [Qin, Shaozheng] Stanford Univ, Dept Psychiat & Behav Sci, Sch Med, Stanford, CA 94305 USA; [Luo, Jing] Capital Normal Univ, Dept Psychol, Beijing Key Lab Learning & Cognit, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS; Stanford University; Capital Normal University	Zhang, WC (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China.	luoj@psych.ac.cn	Qin, Shaozheng/AAD-2107-2019	Qin, Shaozheng/0000-0002-1859-2150	National Natural Science Foundation of China [30970890, 30770708, 31100746]; Scientific Foundation of Institute of Psychology, Chinese Academy of Sciences [Y0CX451S01]; National Basic Research Program of China [2010CB833904]; Chinese Academy of Sciences [KSCX2-EW-J-8]; Key Laboratory of Mental Health, Institute of Psychology, Chinese Academy of Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Foundation of Institute of Psychology, Chinese Academy of Sciences(Chinese Academy of Sciences); National Basic Research Program of China(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); Key Laboratory of Mental Health, Institute of Psychology, Chinese Academy of Sciences(Chinese Academy of Sciences)	This research was supported by the National Natural Science Foundation of China (Grants No. 30970890, 30770708 and 31100746), the Scientific Foundation of Institute of Psychology, Chinese Academy of Sciences (Grant No. Y0CX451S01), the National Basic Research Program of China (Grant No. 2010CB833904), the Knowledge Innovation Program of the Chinese Academy of Sciences (Grant No. KSCX2-EW-J-8) and Key Laboratory of Mental Health, Institute of Psychology, Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTONI MH, 1991, J CONSULT CLIN PSYCH, V59, P906, DOI 10.1037/0022-006X.59.6.906; [白露 BAI Lu], 2005, [中国心理卫生杂志, Chinese Mental Health Journal], V19, P719; Barling N. R., 2005, AUST J CLIN EXP HYPN, V33, P160; BLALOCK JE, 1994, IMMUNOL TODAY, V15, P504, DOI 10.1016/0167-5699(94)90205-4; Bosch JA, 2001, PSYCHOPHYSIOLOGY, V38, P836, DOI 10.1017/S0048577201000488; Bosch JA, 2002, INT REV NEUROBIOL, V52, P213; Cahill L, 2001, NEUROBIOL LEARN MEM, V75, P1, DOI 10.1006/nlme.2000.3999; Calkins SD, 2010, J PSYCHOPATHOL BEHAV, V32, P92, DOI 10.1007/s10862-009-9169-6; Canli T, 2002, P NATL ACAD SCI USA, V99, P10789, DOI 10.1073/pnas.162356599; Carroll D, 1996, INT J BEHAV MED, V3, P266, DOI 10.1207/s15327558ijbm0303_6; Cuthbert BN, 2000, BIOL PSYCHOL, V52, P95, DOI 10.1016/S0301-0511(99)00044-7; Denson TF, 2009, PSYCHOL BULL, V135, P823, DOI 10.1037/a0016909; Dien J, 2004, PSYCHOPHYSIOLOGY, V41, P665, DOI 10.1111/j.1469-8986.2004.00193.x; Dimitrov Dimiter M, 2003, Work, V20, P159; Drabant EM, 2009, BIOL PSYCHIAT, V65, P367, DOI 10.1016/j.biopsych.2008.09.007; Foti D, 2008, J COGNITIVE NEUROSCI, V20, P977, DOI 10.1162/jocn.2008.20066; Gross J.J., 2014, HDB EMOTION REGULATI, P3, DOI DOI 10.1080/00140130600971135; Gross JJ, 2003, J PERS SOC PSYCHOL, V85, P348, DOI 10.1037/0022-3514.85.2.348; Gross JJ, 1998, J PERS SOC PSYCHOL, V74, P224, DOI 10.1037/0022-3514.74.1.224; Gross JJ, 2002, PSYCHOPHYSIOLOGY, V39, P281, DOI 10.1017/S0048577201393198; Hajcak G, 2006, COGN AFFECT BEHAV NE, V6, P291, DOI 10.3758/CABN.6.4.291; Hennig J, 1996, PERS INDIV DIFFER, V20, P589, DOI 10.1016/0191-8869(95)00218-9; HERBERT TB, 1993, PSYCHOSOM MED, V55, P364, DOI 10.1097/00006842-199307000-00004; Koh KB, 2008, BRAIN BEHAV IMMUN, V22, P1130, DOI 10.1016/j.bbi.2008.06.009; Koolhaas JM, 2008, BRAIN BEHAV IMMUN, V22, P662, DOI 10.1016/j.bbi.2007.11.006; Krompinger JW, 2008, EMOTION, V8, P132, DOI 10.1037/1528-3542.8.1.132; Kugler J, 1996, EUR J ORAL SCI, V104, P17, DOI 10.1111/j.1600-0722.1996.tb00040.x; Lang PJ, A5 U FLOR; Li F, 2008, CHINESE SCI BULL, V53, P1861, DOI 10.1007/s11434-008-0233-5; Lutgendorf SK, 1997, J CONSULT CLIN PSYCH, V65, P31, DOI 10.1037/0022-006X.65.1.31; Matsubara Y, 2010, ACUPUNCT MED, V28, P28, DOI 10.1136/aim.2009.001677; McRae K, 2010, J COGNITIVE NEUROSCI, V22, P248, DOI 10.1162/jocn.2009.21243; Miller GE, 2001, HEALTH PSYCHOL, V20, P47, DOI 10.1037/0278-6133.20.1.47; Moser JS, 2010, COGN AFFECT BEHAV NE, V10, P195, DOI 10.3758/CABN.10.2.195; Moser JS, 2009, PSYCHOPHYSIOLOGY, V46, P17, DOI 10.1111/j.1469-8986.2008.00721.x; Moser JS, 2006, PSYCHOPHYSIOLOGY, V43, P292, DOI 10.1111/j.1469-8986.2006.00402.x; Ochsner KN, 2008, CURR DIR PSYCHOL SCI, V17, P153, DOI 10.1111/j.1467-8721.2008.00566.x; Ochsner KN, 2002, J COGNITIVE NEUROSCI, V14, P1215, DOI 10.1162/089892902760807212; Ochsner KN, 2004, NEUROIMAGE, V23, P483, DOI 10.1016/j.neuroimage.2004.06.030; Ohira H, 2004, PERCEPT MOTOR SKILL, V98, P1241, DOI 10.2466/PMS.98.4.1241-1250; Olofsson JK, 2008, BIOL PSYCHOL, V77, P247, DOI 10.1016/j.biopsycho.2007.11.006; Pawlow LA, 2005, APPL PSYCHOPHYS BIOF, V30, P375, DOI 10.1007/s10484-005-8423-2; Reid MR, 2001, J PSYCHOSOM RES, V51, P721, DOI 10.1016/S0022-3999(01)00234-3; Ring C, 2000, PSYCHOPHYSIOLOGY, V37, P634, DOI 10.1017/S0048577200991030; Ring C, 1999, PSYCHOPHYSIOLOGY, V36, P602, DOI 10.1111/1469-8986.3650602; Schupp HT, 2004, PSYCHOPHYSIOLOGY, V41, P441, DOI 10.1111/j.1469-8986.2004.00174.x; Schupp HT, 2000, PSYCHOPHYSIOLOGY, V37, P257, DOI 10.1017/S0048577200001530; Segerstrom SC, 2004, PSYCHOL BULL, V130, P601, DOI 10.1037/0033-2909.130.4.601; Segerstrom SC, 1998, J PERS SOC PSYCHOL, V74, P1646, DOI 10.1037/0022-3514.74.6.1646; SEMLITSCH HV, 1986, PSYCHOPHYSIOLOGY, V23, P695, DOI 10.1111/j.1469-8986.1986.tb00696.x; Takagi S, 2004, PERCEPT MOTOR SKILL, V98, P1187, DOI 10.2466/PMS.98.4.1187-1198; Taniguchi T, 2007, ACTA MED OKAYAMA, V61, P139; Valdimarsdottir HB, 1997, CRIT REV ORAL BIOL M, V8, P461, DOI 10.1177/10454411970080040601; Willemsen G, 2002, PSYCHOPHYSIOLOGY, V39, P222, DOI 10.1017/S048577201392132; Willemsen G, 2000, BIOL PSYCHOL, V52, P127, DOI 10.1016/S0301-0511(99)00028-9; Winzer A, 1999, PSYCHOPHYSIOLOGY, V36, P591, DOI 10.1111/1469-8986.3650591; Zozulya AA, 2008, J IMMUNOTOXICOL, V5, P221, DOI 10.1080/15476910802131444	57	7	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2012	7	2							e30761	10.1371/journal.pone.0030761	http://dx.doi.org/10.1371/journal.pone.0030761			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	914UV	22319586	Green Published, Green Submitted, gold			2022-12-27	WOS:000301979000013
J	Norian, LA; Kresowik, TP; Rosevear, HM; James, BR; Rosean, TR; Lightfoot, AJ; Kucaba, TA; Schwarz, C; Weydert, CJ; Henry, MD; Griffith, TS				Norian, Lyse A.; Kresowik, Timothy P.; Rosevear, Henry M.; James, Britnie R.; Rosean, Timothy R.; Lightfoot, Andrew J.; Kucaba, Tamara A.; Schwarz, Christopher; Weydert, Christine J.; Henry, Michael D.; Griffith, Thomas S.			Eradication of Metastatic Renal Cell Carcinoma after Adenovirus-Encoded TNF-Related Apoptosis-Inducing Ligand (TRAIL)/CpG Immunotherapy	PLOS ONE			English	Article							CD8(+) T-CELLS; IN-VIVO; IMMUNE SUPPRESSION; KIDNEY CANCER; PRIMARY TUMOR; GENE-THERAPY; GROWTH; MICE; INTERLEUKIN-2; COMBINATION	Despite evidence that antitumor immunity can be protective against renal cell carcinoma (RCC), few patients respond objectively to immunotherapy and the disease is fatal once metastases develop. We asked to what extent combinatorial immunotherapy with Adenovirus-encoded murine TNF-related apoptosis-inducing ligand (Ad5mTRAIL) plus CpG oligonucleotide, given at the primary tumor site, would prove efficacious against metastatic murine RCC. To quantitate primary renal and metastatic tumor growth in mice, we developed a luciferase-expressing Renca cell line, and monitored tumor burdens via bioluminescent imaging. Orthotopic tumor challenge gave rise to aggressive primary tumors and lung metastases that were detectable by day 7. Intra-renal administration of Ad5mTRAIL+CpG on day 7 led to an influx of effector phenotype CD4 and CD8 T cells into the kidney by day 12 and regression of established primary renal tumors. Intra-renal immunotherapy also led to systemic immune responses characterized by splenomegaly, elevated serum IgG levels, increased CD4 and CD8 T cell infiltration into the lungs, and elimination of metastatic lung tumors. Tumor regression was primarily dependent upon CD8 T cells and resulted in prolonged survival of treated mice. Thus, local administration of Ad5mTRAIL+CpG at the primary tumor site can initiate CD8-dependent systemic immunity that is sufficient to cause regression of metastatic lung tumors. A similar approach may prove beneficial for patients with metastatic RCC.	[Norian, Lyse A.; Kresowik, Timothy P.; Rosevear, Henry M.; Lightfoot, Andrew J.; Schwarz, Christopher] Univ Iowa, Carver Coll Med, Dept Urol, Iowa City, IA 52242 USA; [James, Britnie R.; Griffith, Thomas S.] Univ Minnesota, Microbiol Immunol & Canc Biol Program, Minneapolis, MN USA; [Rosean, Timothy R.] Univ Iowa, Carver Coll Med, Interdisciplinary Grad Program Immunol, Iowa City, IA USA; [Kucaba, Tamara A.; Griffith, Thomas S.] Univ Minnesota, Dept Urol, Minneapolis, MN USA; [Weydert, Christine J.; Henry, Michael D.] Univ Iowa, Carver Coll Med, Dept Physiol, Iowa City, IA USA	University of Iowa; University of Minnesota System; University of Minnesota Twin Cities; University of Iowa; University of Minnesota System; University of Minnesota Twin Cities; University of Iowa	Norian, LA (corresponding author), Univ Iowa, Carver Coll Med, Dept Urol, Iowa City, IA 52242 USA.	tgriffit@umn.edu	Griffith, Thomas/ABF-8225-2020	Henry, Michael/0000-0002-7871-245X; Norian, Lyse/0000-0003-1016-313X	National Institutes of Health (NIH) [CA109446]; NATIONAL CANCER INSTITUTE [R01CA109446] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a National Institutes of Health (NIH) grant # CA109446, grants.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulghani J, 2010, EXPERT OPIN THER TAR, V14, P1091, DOI 10.1517/14728222.2010.519701; Ather MH, 2010, UROL J, V7, P1; Atzpodien J, 2004, J CLIN ONCOL, V22, P1188, DOI 10.1200/JCO.2004.06.155; Cao QH, 2008, DNA CELL BIOL, V27, P91, DOI 10.1089/dna.2007.0633; Clausen BE, 2010, IMMUNOL CELL BIOL, V88, P351, DOI 10.1038/icb.2010.40; Rocha FGD, 2010, CANCER IMMUNOL IMMUN, V59, P1357, DOI 10.1007/s00262-010-0865-6; Drake JM, 2005, CLIN EXP METASTAS, V22, P674, DOI 10.1007/s10585-006-9011-4; Elliott MR, 2010, J CELL BIOL, V189, P1059, DOI 10.1083/jcb.201004096; Elzey BD, 2003, IMMUNITY, V19, P9, DOI 10.1016/S1074-7613(03)00177-8; Flanigan Robert C, 2003, Curr Treat Options Oncol, V4, P385, DOI 10.1007/s11864-003-0039-2; Frankenberger B, 2007, SEMIN CANCER BIOL, V17, P330, DOI 10.1016/j.semcancer.2007.06.004; FYFE G, 1995, J CLIN ONCOL, V13, P688, DOI 10.1200/JCO.1995.13.3.688; Godley PA, 2001, CURR OPIN ONCOL, V13, P199, DOI 10.1097/00001622-200105000-00012; Griffith TS, 2009, CURR GENE THER, V9, P9, DOI 10.2174/156652309787354612; Gruys ME, 2001, CANCER RES, V61, P6255; Hofmann MA, 2008, J IMMUNOTHER, V31, P520, DOI 10.1097/CJI.0b013e318174a4df; Holoch PA, 2009, EUR J PHARMACOL, V625, P63, DOI 10.1016/j.ejphar.2009.06.066; Kemp TJ, 2003, APOPTOSIS, V8, P587, DOI 10.1023/A:1026286108366; Ko JS, 2010, CANCER RES, V70, P3526, DOI 10.1158/0008-5472.CAN-09-3278; Kobayashi H, 2010, ANTICANCER RES, V30, P575; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Krieg AM, 2007, J CLIN INVEST, V117, P1184, DOI 10.1172/JCI31414; Kusmartsev S, 2008, J IMMUNOL, V181, P346, DOI 10.4049/jimmunol.181.1.346; Lv S, 2005, IMMUNOL LETT, V99, P217, DOI 10.1016/j.imlet.2005.03.019; Matin SF, 2010, J UROLOGY, V183, P333, DOI 10.1016/j.juro.2009.08.110; McDermott DF, 2009, CANCER-AM CANCER SOC, V115, P2298, DOI 10.1002/cncr.24236; Norian LA, 2009, CANCER RES, V69, P3086, DOI 10.1158/0008-5472.CAN-08-2826; Ochoa AC, 2007, CLIN CANCER RES, V13, p721S, DOI 10.1158/1078-0432.CCR-06-2197; Patil S, 2010, CANCER-AM CANCER SOC, V116, P347, DOI 10.1002/cncr.24713; Pitt RM, 1996, J BIOL CHEM, V271, P12687, DOI 10.1074/jbc.271.22.12687; Quezada SA, 2010, J EXP MED, V207, P637, DOI 10.1084/jem.20091918; Rini BI, 2010, CLIN CANCER RES, V16, P1348, DOI 10.1158/1078-0432.CCR-09-2273; SALUP RR, 1986, CANCER RES, V46, P3358; SAYERS TJ, 1990, CANCER RES, V50, P5414; Seki N, 2003, CANCER RES, V63, P207; Seki N, 2002, J IMMUNOL, V168, P3484, DOI 10.4049/jimmunol.168.7.3484; Shablak A, 2009, CLIN CANCER RES, V15, P6503, DOI 10.1158/1078-0432.CCR-09-1605; Shanker A, 2008, JNCI-J NATL CANCER I, V100, P649, DOI 10.1093/jnci/djn113; Shanker A, 2009, CANCER RES, V69, P6615, DOI 10.1158/0008-5472.CAN-09-0685; Shvarts O, 2006, UROLOGY, V68, P1132, DOI 10.1016/j.urology.2006.08.1073; SPARANO JA, 1993, J CLIN ONCOL, V11, P1969, DOI 10.1200/JCO.1993.11.10.1969; Svensson RU, 2007, CANCER RES, V67, P10445, DOI 10.1158/0008-5472.CAN-07-1955; Teng MWL, 2010, CANCER RES, V70, P2665, DOI 10.1158/0008-5472.CAN-09-1574; VanOosten RL, 2007, CANCER RES, V67, P11980, DOI 10.1158/0008-5472.CAN-07-1526; Wang LX, 2010, CLIN CANCER RES, V16, P164, DOI 10.1158/1078-0432.CCR-09-1758; Webster WS, 2006, CANCER-AM CANCER SOC, V107, P46, DOI 10.1002/cncr.21951; Westwood JA, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-42; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Wysocki PJ, 2010, CANCER GENE THER, V17, P465, DOI 10.1038/cgt.2010.2; Xin H, 2009, CANCER RES, V69, P2506, DOI 10.1158/0008-5472.CAN-08-4323; Yockman JW, 2007, GENE THER, V14, P1399, DOI 10.1038/sj.gt.3302999; Yu P, 2007, J IMMUNOL, V179, P1960, DOI 10.4049/jimmunol.179.3.1960; Zea AH, 2005, CANCER RES, V65, P3044, DOI 10.1158/0008-5472.CAN-04-4505	53	43	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2012	7	2							e31085	10.1371/journal.pone.0031085	http://dx.doi.org/10.1371/journal.pone.0031085			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UG	22312440	Green Published, Green Submitted, gold			2022-12-27	WOS:000301977500028
J	Patel, RK; Jain, M				Patel, Ravi K.; Jain, Mukesh			NGS QC Toolkit: A Toolkit for Quality Control of Next Generation Sequencing Data	PLOS ONE			English	Article							METAGENOMIC DATASETS; GENE DISCOVERY; IDENTIFICATION; CHICKPEA	Next generation sequencing (NGS) technologies provide a high-throughput means to generate large amount of sequence data. However, quality control (QC) of sequence data generated from these technologies is extremely important for meaningful downstream analysis. Further, highly efficient and fast processing tools are required to handle the large volume of datasets. Here, we have developed an application, NGS QC Toolkit, for quality check and filtering of high-quality data. This toolkit is a standalone and open source application freely available at http://www.nipgr.res.in/ngsqctoolkit.html. All the tools in the application have been implemented in Perl programming language. The toolkit is comprised of user-friendly tools for QC of sequencing data generated using Roche 454 and Illumina platforms, and additional tools to aid QC (sequence format converter and trimming tools) and analysis (statistics tools). A variety of options have been provided to facilitate the QC at user-defined parameters. The toolkit is expected to be very useful for the QC of NGS data to facilitate better downstream analysis.	[Patel, Ravi K.; Jain, Mukesh] Natl Inst Plant Genome Res NIPGR, Funct Genom & Bioinformat Lab, New Delhi, India	Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR)	Patel, RK (corresponding author), Natl Inst Plant Genome Res NIPGR, Funct Genom & Bioinformat Lab, New Delhi, India.	mjain@nipgr.res.in	Jain, Mukesh/AAP-5816-2021; Patel, Ravi K/W-4441-2019	Jain, Mukesh/0000-0002-7622-1083; Patel, Ravi K/0000-0001-5203-899X	Department of Biotechnology, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was financially supported by the Department of Biotechnology, Government of India, under the Next Generation Challenge Programme on Chickpea Genomics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blankenberg D, 2010, BIOINFORMATICS, V26, P1783, DOI 10.1093/bioinformatics/btq281; Cock PJA, 2010, NUCLEIC ACIDS RES, V38, P1767, DOI 10.1093/nar/gkp1137; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; Garg R, 2011, PLANT PHYSIOL, V156, P1661, DOI 10.1104/pp.111.178616; Garg R, 2011, DNA RES, V18, P53, DOI 10.1093/dnares/dsq028; Lassmann T, 2009, BIOINFORMATICS, V25, P2839, DOI 10.1093/bioinformatics/btp527; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Martinez-Alcantara A, 2009, BIOINFORMATICS, V25, P2438, DOI 10.1093/bioinformatics/btp429; Morgan M, 2009, BIOINFORMATICS, V25, P2607, DOI 10.1093/bioinformatics/btp450; Pandey Ram Vinay, 2010, BMC Res Notes, V3, P3, DOI 10.1186/1756-0500-3-3; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Schmieder R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-341; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484	14	1919	1998	5	200	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2012	7	2							e30619	10.1371/journal.pone.0030619	http://dx.doi.org/10.1371/journal.pone.0030619			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UG	22312429	Green Published, Green Submitted, gold			2022-12-27	WOS:000301977500013
J	Melega, WP; Lacan, G; Gorgulho, AA; Behnke, EJ; De Salles, AAF				Melega, William P.; Lacan, Goran; Gorgulho, Alessandra A.; Behnke, Eric J.; De Salles, Antonio A. F.			Hypothalamic Deep Brain Stimulation Reduces Weight Gain in an Obesity-Animal Model	PLOS ONE			English	Article							HIGH-FREQUENCY STIMULATION; FEMALE GOTTINGEN MINIPIGS; VENTROMEDIAL HYPOTHALAMUS; BARIATRIC SURGERY; GASTRIC BYPASS; FOOD-INTAKE; MORBID-OBESITY; BEHAVIOR; GROWTH; MODULATION	Prior studies of appetite regulatory networks, primarily in rodents, have established that targeted electrical stimulation of ventromedial hypothalamus (VMH) can alter food intake patterns and metabolic homeostasis. Consideration of this method for weight modulation in humans with severe overeating disorders and morbid obesity can be further advanced by modeling procedures and assessing endpoints that can provide preclinical data on efficacy and safety. In this study we adapted human deep brain stimulation (DBS) stereotactic methods and instrumentation to demonstrate in a large animal model the modulation of weight gain with VMH-DBS. Female Gottingen minipigs were used because of their dietary habits, physiologic characteristics, and brain structures that resemble those of primates. Further, these animals become obese on extra-feeding regimens. DBS electrodes were first bilaterally implanted into the VMH of the animals (n = 8) which were then maintained on a restricted food regimen for 1 mo following the surgery. The daily amount of food was then doubled for the next 2 mo in all animals to produce obesity associated with extra calorie intake, with half of the animals (n = 4) concurrently receiving continuous low frequency (50 Hz) VMH-DBS. Adverse motoric or behavioral effects were not observed subsequent to the surgical procedure or during the DBS period. Throughout this 2 mo DBS period, all animals consumed the doubled amount of daily food. However, the animals that had received VMH-DBS showed a cumulative weight gain (6.1 +/- 0.4 kg; mean +/- SEM) that was lower than the nonstimulated VMH-DBS animals (9.4 +/- 1.3 kg; p<0.05), suggestive of a DBS-associated increase in metabolic rate. These results in a porcine obesity model demonstrate the efficacy and behavioral safety of a low frequency VMH-DBS application as a potential clinical strategy for modulation of body weight.	[Melega, William P.; Lacan, Goran] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Gorgulho, Alessandra A.; Behnke, Eric J.; De Salles, Antonio A. F.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Melega, WP (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.	wmelega@mednet.ucla.edu			WPM (Neurosigma Inc.) [bio08-129970]; National Institutes of Health [1R21RR025398-01A1]; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR025398] Funding Source: NIH RePORTER	WPM (Neurosigma Inc.); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by grants to WPM from the UC Discovery Grant Program (bio08-129970 with Neurosigma Inc.) and the National Institutes of Health (1R21RR025398-01A1). The implantable pulse generators and channel extensions were kindly donated by ANS/St. Jude Medical Company, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison DB, 1999, AM J PSYCHIAT, V156, P1686; Andersen F, 2005, BRAIN RES BULL, V66, P17, DOI 10.1016/j.brainresbull.2005.02.033; ARAVICH PF, 1982, PHYSIOL BEHAV, V29, P195, DOI 10.1016/0031-9384(82)90003-8; ATRENS DM, 1987, BRAIN RES BULL, V18, P303, DOI 10.1016/0361-9230(87)90007-4; Berg EP, 2003, J ANIM SCI, V81, P167; BIELAJEW C, 1994, BEHAV BRAIN RES, V62, P143, DOI 10.1016/0166-4328(94)90021-3; Bjarkam CR, 2008, J NEUROSCI METH, V168, P151, DOI 10.1016/j.jneumeth.2007.09.008; Bjarkam CR, 2009, J NEUROSCI METH, V183, P119, DOI 10.1016/j.jneumeth.2009.06.019; Bjarkam CR, 2004, J NEUROSCI METH, V139, P293, DOI 10.1016/j.jneumeth.2004.05.004; Bollen P, 2000, COMPARATIVE MED, V50, P585; Bollen PJA, 2006, SCAND J LAB ANIM SCI, V33, P149; Bollen P, 2006, EXP TOXICOL PATHOL, V57, P347, DOI 10.1016/j.etp.2006.03.005; Bollen PJA, 2005, LAB ANIM-UK, V39, P80, DOI 10.1258/0023677052886565; Brolin RE, 2002, JAMA-J AM MED ASSOC, V288, P2793, DOI 10.1001/jama.288.22.2793; Butson CR, 2006, J NEURAL ENG, V3, P1, DOI 10.1088/1741-2560/3/1/001; Butson CR, 2006, CLIN NEUROPHYSIOL, V117, P447, DOI 10.1016/j.clinph.2005.10.007; Christou NV, 2006, ANN SURG, V244, P734, DOI 10.1097/01.sla.0000217592.04061.d5; Covalin A, 2005, P 2 INT IEEE EMBS C; Crampton NA, 1997, OBES SURG, V7, P489, DOI 10.1381/096089297765555232; DeSalles AAF, 1996, AM J NEURORADIOL, V17, P1451; Dyrby TB, 2007, NEUROIMAGE, V37, P1267, DOI 10.1016/j.neuroimage.2007.06.022; Ettrup KS, 2010, J CHEM NEUROANAT, V39, P151, DOI 10.1016/j.jchemneu.2009.12.004; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Franzini A, 2007, ACTA NEUROCHIR SUPPL, V97, P399; Franzini A, 2003, NEUROSURGERY, V52, P1095, DOI 10.1227/01.NEU.0000057698.29634.D6; Gorgulho AA, 2009, J NEUROSURG, V110, P1317, DOI 10.3171/JNS.2008.10.JNS08835; Halpern CH, 2008, J NEUROSURG, V109, P625, DOI 10.3171/JNS/2008/109/10/0625; Hamani C, 2008, ANN NEUROL, V63, P119, DOI 10.1002/ana.21295; Handforth A, 2006, EPILEPSIA, V47, P1239, DOI 10.1111/j.1528-1167.2006.00563.x; Hauptman JS, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC/2008/25/7/E3; Hernando V, 2008, STEREOT FUNCT NEUROS, V86, P219, DOI 10.1159/000131659; Higa KD, 2000, OBES SURG, V10, P509, DOI 10.1381/096089200321593706; Jensen KN, 2009, ACTA NEUROCHIR, V151, P785, DOI 10.1007/s00701-009-0334-1; Johansen T, 2001, COMPARATIVE MED, V51, P150; King BA, 2006, PHYSIOL BEHAV, V87, P221, DOI 10.1016/j.physbeh.2005.10.007; Kuhn Jens, 2008, Neurosurgery, V62, pE1182, DOI 10.1227/01.neu.0000325889.84785.69; Kuncel AM, 2004, CLIN NEUROPHYSIOL, V115, P2431, DOI 10.1016/j.clinph.2004.05.031; Lacan G, 2008, J NEUROSURG, V108, P336, DOI 10.3171/JNS/2008/108/2/0336; Larsen MO, 2004, ILAR J, V45, P303, DOI 10.1093/ilar.45.3.303; Lind NM, 2007, NEUROSCI BIOBEHAV R, V31, P728, DOI 10.1016/j.neubiorev.2007.02.003; Lonergan RP, 1998, J APPL PHYSIOL, V84, P531, DOI 10.1152/jappl.1998.84.2.531; MINOKOSHI Y, 1986, AM J PHYSIOL, V251, P1005, DOI 10.1152/ajpregu.1986.251.5.R1005; MORGANE PJ, 1961, SCIENCE, V133, P887, DOI 10.1126/science.133.3456.887; Nunoya T., 2007, J TOXICOL PATHOL, V20, P125, DOI [DOI 10.1293/T0X.20.125, 10.1293/TOX.20.125]; Pisapia JM, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.5.FOCUS10109; Raun K, 2007, OBESITY, V15, P1710, DOI 10.1038/oby.2007.204; Rocha D, 2006, DRUG DISCOV TODAY, V11, P475, DOI 10.1016/j.drudis.2006.04.009; Rosendal F, 2009, BRAIN RES BULL, V80, P403, DOI 10.1016/j.brainresbull.2009.08.012; Rosendal F, 2009, BRAIN RES BULL, V79, P41, DOI 10.1016/j.brainresbull.2009.01.002; Ruffin MP, 1999, BRAIN RES, V846, P23, DOI 10.1016/S0006-8993(99)01922-8; Salfen BE, 2004, J ANIM SCI, V82, P1957; Schernthaner G, 2008, DIABETES CARE, V31, pS297, DOI 10.2337/dc08-s270; SOLBERG TD, 1994, ACTA NEUROCHIR SUPPL, V62, P28; STENGER J, 1991, PHYSIOL BEHAV, V50, P1209, DOI 10.1016/0031-9384(91)90584-B; TAKAHASHI A, 1981, J AUTONOM NERV SYST, V4, P195, DOI 10.1016/0165-1838(81)90044-8; THORNHILL J, 1993, BRAIN RES, V615, P289, DOI 10.1016/0006-8993(93)90040-T; Torres N, 2011, ADV TECH STAND NEURO, V36, P17, DOI 10.1007/978-3-7091-0179-7_2; Vitek JL, 2002, MOVEMENT DISORD, V17, pS69, DOI 10.1002/mds.10144; Watanabe H, 2001, NEUROIMAGE, V14, P1089, DOI 10.1006/nimg.2001.0910; Wilent WB, 2010, J NEUROSURG, V112, P1295, DOI 10.3171/2009.9.JNS09577	60	33	34	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30672	10.1371/journal.pone.0030672	http://dx.doi.org/10.1371/journal.pone.0030672			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295102	gold, Green Published, Green Submitted			2022-12-27	WOS:000301640600047
J	Shao, L; Fan, XH; Cheng, NT; Wu, LH; Xiong, HS; Fang, H; Ding, D; Shi, LM; Cheng, YY; Tong, WD				Shao, Li; Fan, Xiaohui; Cheng, Ningtao; Wu, Leihong; Xiong, Haoshu; Fang, Hong; Ding, Don; Shi, Leming; Cheng, Yiyu; Tong, Weida			Shifting from Population-wide to Personalized Cancer Prognosis with Microarrays	PLOS ONE			English	Article							GENE-EXPRESSION PROFILES; BREAST-CANCER; CLASSIFICATION; PREDICTION; CYCLOPHOSPHAMIDE; FLUOROURACIL; CHEMOTHERAPY; DOXORUBICIN; CARCINOMAS; PACLITAXEL	The era of personalized medicine for cancer therapeutics has taken an important step forward in making accurate prognoses for individual patients with the adoption of high-throughput microarray technology. However, microarray technology in cancer diagnosis or prognosis has been primarily used for the statistical evaluation of patient populations, and thus excludes inter-individual variability and patient-specific predictions. Here we propose a metric called clinical confidence that serves as a measure of prognostic reliability to facilitate the shift from population-wide to personalized cancer prognosis using microarray-based predictive models. The performance of sample-based models predicted with different clinical confidences was evaluated and compared systematically using three large clinical datasets studying the following cancers: breast cancer, multiple myeloma, and neuroblastoma. Survival curves for patients, with different confidences, were also delineated. The results show that the clinical confidence metric separates patients with different prediction accuracies and survival times. Samples with high clinical confidence were likely to have accurate prognoses from predictive models. Moreover, patients with high clinical confidence would be expected to live for a notably longer or shorter time if their prognosis was good or grim based on the models, respectively. We conclude that clinical confidence could serve as a beneficial metric for personalized cancer prognosis prediction utilizing microarrays. Ascribing a confidence level to prognosis with the clinical confidence metric provides the clinician an objective, personalized basis for decisions, such as choosing the severity of the treatment.	[Shao, Li; Fan, Xiaohui; Wu, Leihong; Xiong, Haoshu; Cheng, Yiyu] Zhejiang Univ, Coll Pharmaceut Sci, Pharmaceut Informat Inst, Hangzhou 310003, Zhejiang, Peoples R China; [Cheng, Ningtao] Emory Univ, Atlanta, GA 30322 USA; [Cheng, Ningtao] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Fang, Hong; Ding, Don] ICF Int NCTR FDA, Jefferson, AR USA; [Shi, Leming; Tong, Weida] US FDA, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA	Zhejiang University; Emory University; University System of Georgia; Georgia Institute of Technology; US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Shao, L (corresponding author), Zhejiang Univ, Coll Pharmaceut Sci, Pharmaceut Informat Inst, Hangzhou 310003, Zhejiang, Peoples R China.	chengyy@zju.edu.cn; weida.tong@fda.hhs.gov	Shi, Leming/B-3150-2010; Wu, Leihong/AAM-9483-2020; FAN, Xiaohui/F-6458-2010	Shi, Leming/0000-0002-7143-2033; Wu, Leihong/0000-0002-4093-3708; FAN, Xiaohui/0000-0002-6336-3007	National Science Foundation of China [30801556, 30830121]; National ST Major Project [2008ZX09312-001]; Science Foundation of Chinese University [2009QNA7031]; Zhejiang Provincial Natural Science Foundation of China [R2080693]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National ST Major Project; Science Foundation of Chinese University(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	This work was supported by the National Science Foundation of China (No. 30801556 and 30830121), National S&T Major Project (No. 2008ZX09312-001), Science Foundation of Chinese University (No. 2009QNA7031), and the Zhejiang Provincial Natural Science Foundation of China (No. R2080693). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams E., 2009, GENET ENG BIOTECHNOL, V29; Ayers M, 2004, J CLIN ONCOL, V22, P2284, DOI 10.1200/JCO.2004.05.166; Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Balleine RL, 2008, CLIN CANCER RES, V14, P8244, DOI 10.1158/1078-0432.CCR-08-0939; Bertucci F, 2006, OMICS, V10, P429, DOI 10.1089/omi.2006.10.429; Cantor MN, 2009, PERS MED, V6, P589, DOI [10.2217/pme.09.35, 10.2217/PME.09.35]; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Ely S, 2009, TRANSL RES, V154, P303, DOI 10.1016/j.trsl.2009.08.001; Fan XH, 2010, CLIN CANCER RES, V16, P629, DOI 10.1158/1078-0432.CCR-09-1815; Hess KR, 2006, J CLIN ONCOL, V24, P4236, DOI 10.1200/JCO.2006.05.6861; Holmes E, 2008, CELL, V134, P714, DOI 10.1016/j.cell.2008.08.026; Iwao-Koizumi K, 2005, J CLIN ONCOL, V23, P422, DOI 10.1200/JCO.2005.09.078; Loscalzo J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100163; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; Oberthuer A, 2006, J CLIN ONCOL, V24, P5070, DOI 10.1200/JCO.2006.06.1879; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Radmacher MD, 2002, J COMPUT BIOL, V9, P505, DOI 10.1089/106652702760138592; Roepman P, 2005, NAT GENET, V37, P182, DOI 10.1038/ng1502; Shao L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011055; Shaughnessy JD, 2007, BLOOD, V109, P2276, DOI 10.1182/blood-2006-07-038430; Shi LM, 2010, NAT BIOTECHNOL, V28, P827, DOI 10.1038/nbt.1665; Slodkowska EA, 2009, EXPERT REV MOL DIAGN, V9, P417, DOI 10.1586/ERM.09.32; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2003, P NATL ACAD SCI USA, V100, P10393, DOI 10.1073/pnas.1732912100; Theodoridis S, 2006, PATTERN RECOGNITION, 3RD EDITION, P1; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Williams PD, 2009, CANCER RES, V69, P8302, DOI 10.1158/0008-5472.CAN-09-0798	30	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e29534	10.1371/journal.pone.0029534	http://dx.doi.org/10.1371/journal.pone.0029534			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295060	Green Submitted, gold, Green Published			2022-12-27	WOS:000301640600005
J	Gormanns, P; Reckow, S; Poczatek, JC; Turck, CW; Lechene, C				Gormanns, Philipp; Reckow, Stefan; Poczatek, J. Collin; Turck, Christoph W.; Lechene, Claude			Segmentation of Multi-Isotope Imaging Mass Spectrometry Data for Semi-Automatic Detection of Regions of Interest	PLOS ONE			English	Article							SUPPORT; BACTERIA	Multi-isotope imaging mass spectrometry (MIMS) associates secondary ion mass spectrometry (SIMS) with detection of several atomic masses, the use of stable isotopes as labels, and affiliated quantitative image-analysis software. By associating image and measure, MIMS allows one to obtain quantitative information about biological processes in subcellular domains. MIMS can be applied to a wide range of biomedical problems, in particular metabolism and cell fate [1,2,3]. In order to obtain morphologically pertinent data from MIMS images, we have to define regions of interest (ROIs). ROIs are drawn by hand, a tedious and time-consuming process. We have developed and successfully applied a support vector machine (SVM) for segmentation of MIMS images that allows fast, semi-automatic boundary detection of regions of interests. Using the SVM, high-quality ROIs (as compared to an expert's manual delineation) were obtained for 2 types of images derived from unrelated data sets. This automation simplifies, accelerates and improves the post-processing analysis of MIMS images. This approach has been integrated into "Open MIMS,'' an ImageJ-plugin for comprehensive analysis of MIMS images that is available online at http://www.nrims.hms.harvard.edu/NRIMS_ImageJ.php.	[Gormanns, Philipp; Reckow, Stefan; Turck, Christoph W.] Max Planck Inst Psychiat, Munich, Germany; [Poczatek, J. Collin; Lechene, Claude] Harvard Univ, Sch Med, Cambridge, MA 02138 USA; [Poczatek, J. Collin; Lechene, Claude] Brigham & Womens Hosp, Cambridge, MA USA	Max Planck Society; Harvard University; Harvard University; Brigham & Women's Hospital	Gormanns, P (corresponding author), Max Planck Inst Psychiat, Munich, Germany.	cpl@harvard.edu			National Institutes of Health/National Institute of Biomedical Imaging and Bioengineering [5P41 EB001974-10]; National Institutes of Health/National Institute on Aging [1R21AG034641-01, RFA-AG-11-001]; Ellison Medical Foundation [AG-SS-2215-08]; NIH/NCRR Center for Integrative Biomedical Computing [2P41 RR0112553-12]; DOE SciDAC Visualization and Analytics Center for Enabling Technologies [DEFC0206ER25781]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB001974] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG034641] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); National Institutes of Health/National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Ellison Medical Foundation(Lawrence Ellison Foundation); NIH/NCRR Center for Integrative Biomedical Computing(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); DOE SciDAC Visualization and Analytics Center for Enabling Technologies(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded through the following grants: National Institutes of Health/National Institute of Biomedical Imaging and Bioengineering 5P41 EB001974-10, National Institutes of Health/National Institute on Aging 1R21AG034641-01 and RFA-AG-11-001, and Ellison Medical Foundation AG-SS-2215-08. http://www.nibib.nih.gov/ http://www.nia.nih.gov/ http://www.ellisonfoundation.org/index.jsp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank R. Whitaker for suggesting and F. Kashem for implementing the Nelder-Mead parameter search, and H. Miniman for manuscript editing. Part of this work was made possible in part by software funded by the NIH/NCRR Center for Integrative Biomedical Computing, 2P41 RR0112553-12 and the DOE SciDAC Visualization and Analytics Center for Enabling Technologies, DEFC0206ER25781.	[Anonymous], IMAGEVIS3D REAL TIM; [Anonymous], SEG3D VOL IM SEGM VI; Boser B. E., 1992, Proceedings of the Fifth Annual ACM Workshop on Computational Learning Theory, P144, DOI 10.1145/130385.130401; Brown MPS, 2000, P NATL ACAD SCI USA, V97, P262, DOI 10.1073/pnas.97.1.262; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Cohen G., 2005, FLAIRS C, P431; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Cristianini Nello, 2000, INTRO SUPPORT VECTOR; El-Naqa I, 2002, IEEE T MED IMAGING, V21, P1552, DOI 10.1109/TMI.2002.806569; Frank E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007821; Guyon I, 2002, MACHINE LEARNING, V46; Hsu CW, 2002, IEEE T NEURAL NETWOR, V13, P415, DOI 10.1109/72.991427; Hua SJ, 2001, J MOL BIOL, V308, P397, DOI 10.1006/jmbi.2001.4580; Kressel UHG, 1999, ADVANCES IN KERNEL METHODS, P255; Lechene Claude, 2006, J Biol, V5, P20, DOI 10.1186/jbiol42; Lechene CP, 2007, SCIENCE, V317, P1563, DOI 10.1126/science.1145557; McMahon G, 2006, J AM SOC MASS SPECTR, V17, P1181, DOI 10.1016/j.jasms.2006.04.031; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; PAL NR, 1993, PATTERN RECOGN, V26, P1277, DOI 10.1016/0031-3203(93)90135-J; Scholkopf B., 2004, KERNEL METHODS COMPU; Steinhauser M, NATURE IN PRESS; Szekely G, 2000, KUENSTLICHE INTELLIG, V3, P18; Zawadzki RJ, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2772658; Zhang D-S, NATURE IN PRESS; Zhang XG, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-197	26	26	26	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2012	7	2							e30576	10.1371/journal.pone.0030576	http://dx.doi.org/10.1371/journal.pone.0030576			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZQ	22347386	Green Published, Green Submitted, gold			2022-12-27	WOS:000302730200004
J	Liger-Belair, G; Bourget, M; Pron, H; Polidori, G; Cilindre, C				Liger-Belair, Gerard; Bourget, Marielle; Pron, Herve; Polidori, Guillaume; Cilindre, Clara			Monitoring Gaseous CO2 and Ethanol above Champagne Glasses: Flute versus Coupe, and the Role of Temperature	PLOS ONE			English	Article							TASTING CONDITIONS; BUBBLE NUCLEATION; CARBONATED WATER; FLOW PATTERNS; PERCEPTION; WINE; ATTRIBUTES; KINETICS; LEVEL; SHAPE	In champagne tasting, gaseous CO2 and volatile organic compounds progressively invade the headspace above glasses, thus progressively modifying the chemical space perceived by the consumer. Simultaneous quantification of gaseous CO2 and ethanol was monitored through micro-gas chromatography (mu GC), all along the first 15 minutes following pouring, depending on whether a volume of 100 mL of champagne was served into a flute or into a coupe. The concentration of gaseous CO2 was found to be significantly higher above the flute than above the coupe. Moreover, a recently developed gaseous CO2 visualization technique based on infrared imaging was performed, thus confirming this tendency. The influence of champagne temperature was also tested. As could have been expected, lowering the temperature of champagne was found to decrease ethanol vapor concentrations in the headspace of a glass. Nevertheless, and quite surprisingly, this temperature decrease had no impact on the level of gaseous CO2 found above the glass. Those results were discussed on the basis of a multiparameter model which describes fluxes of gaseous CO2 escaping the liquid phase into the form of bubbles.	[Liger-Belair, Gerard] UFR Sci Exactes & Nat, CNRS, Grp Spectrometrie Mol & Atmospher, Equipe Effervescence,UMR 7331, Reims, France; [Liger-Belair, Gerard; Cilindre, Clara] Univ Reims, Lab Oenol & Chim Appl, URVVC SE UPRES EA 2069, Reims, France; [Bourget, Marielle; Pron, Herve; Polidori, Guillaume] Univ Reims, Lab Thermomecan, Grp Rech Sci Ingenieur, Reims, France; [Cilindre, Clara] Univ Reims, Lab Stress Def & Reprod Plantes, URVVC SE UPRES EA 2069, Reims, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Reims Champagne-Ardenne; Universite de Reims Champagne-Ardenne; Universite de Reims Champagne-Ardenne; Universite de Reims Champagne-Ardenne	Liger-Belair, G (corresponding author), UFR Sci Exactes & Nat, CNRS, Grp Spectrometrie Mol & Atmospher, Equipe Effervescence,UMR 7331, BP 1039, Reims, France.	gerard.liger-belair@univ-reims.fr; clara.cilindre@univ-reims.fr		Cilindre, Clara/0000-0003-0639-9078; Polidori, Guillaume/0000-0002-6078-6397	Association Recherche Oenologie Champagne et Universite (Reims, France); Region Champagne-Ardenne; Ville de Reims; Conseil General de la Marne	Association Recherche Oenologie Champagne et Universite (Reims, France); Region Champagne-Ardenne(Region Grand-Est); Ville de Reims; Conseil General de la Marne	The authors express their gratitude to the Association Recherche Oenologie Champagne et Universite (Reims, France) for financial support. The authors are also indebted to the Region Champagne-Ardenne, the Ville de Reims, and the Conseil General de la Marne for supporting their research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brand G, 2006, NEUROSCI BIOBEHAV R, V30, P908, DOI 10.1016/j.neubiorev.2006.01.002; CAIN WS, 1980, NATURE, V284, P255, DOI 10.1038/284255a0; Chandrashekar J, 2009, SCIENCE, V326, P443, DOI 10.1126/science.1174601; Cilindre C, 2011, J AGR FOOD CHEM, V59, P7317, DOI 10.1021/jf200748t; COMETTOMUNIZ JE, 1984, CHEM SENSES, V8, P315, DOI 10.1093/chemse/8.4.315; COMETTOMUNIZ JE, 1990, PERCEPT PSYCHOPHYS, V47, P391, DOI 10.3758/BF03210879; COOK JM, 1985, J CHROMATOGR SCI, V23, P57, DOI 10.1093/chromsci/23.2.57; Cowart BJ, 1998, CHEM SENSES, V23, P397, DOI 10.1093/chemse/23.4.397; Dessirier JM, 2000, CHEM SENSES, V25, P277, DOI 10.1093/chemse/25.3.277; Dunkel A, 2010, ANGEW CHEM INT EDIT, V49, P2975, DOI 10.1002/anie.200906978; Duteurtre B, 2010, CHAMPAGNE TRADITION; Etiope G, 1997, J CHROMATOGR A, V775, P243, DOI 10.1016/S0021-9673(97)00297-5; GOLDNER MC, 2009, J SENS STUD, V24, P243, DOI 10.1111/j.1745-459X.2009.00208.x; GORDGE DN, 1993, EXP FLUIDS, V14, P409, DOI 10.1007/BF00190195; GREEN BG, 1992, CHEM SENSES, V17, P435, DOI 10.1093/chemse/17.4.435; HARPER SJ, 1993, J FOOD SCI, V58, P893, DOI 10.1111/j.1365-2621.1993.tb09386.x; Hewson L, 2009, CHEMOSENS PERCEPT, V2, P94, DOI 10.1007/s12078-009-9043-7; Hummel T, 2003, APPETITE, V41, P197, DOI 10.1016/S0195-6663(03)00082-5; Kleemann AM, 2009, PHYSIOL BEHAV, V97, P401, DOI 10.1016/j.physbeh.2009.03.013; Lawless H. T., 2010, SENSORY EVALUATION F; Liger-Belair G, 2006, ANN PHYS-PARIS, V31, P1, DOI 10.1051/anphys:2006007; Liger-Belair G, 2008, CHEM SOC REV, V37, P2490, DOI 10.1039/b717798b; Liger-Belair G, 2007, LANGMUIR, V23, P10976, DOI 10.1021/la7017693; Liger-Belair G, 2007, J AGR FOOD CHEM, V55, P882, DOI 10.1021/jf062973+; Liger-Belair G, 2006, J PHYS CHEM B, V110, P21145, DOI 10.1021/jp0640427; Liger-Belair G, 2012, ANAL CHIM ACTA, V732, P1, DOI 10.1016/j.aca.2011.10.007; Liger-Belair G, 2010, J AGR FOOD CHEM, V58, P8768, DOI 10.1021/jf101239w; Liger-Belair G, 2009, P NATL ACAD SCI USA, V106, P16545, DOI 10.1073/pnas.0906483106; Liger-Belair G, 2009, J AGR FOOD CHEM, V57, P4939, DOI 10.1021/jf900804j; Liger-Belair G, 2009, J AGR FOOD CHEM, V57, P1997, DOI 10.1021/jf803278b; Livermore A, 2004, CHEM SENSES, V29, P41, DOI 10.1093/chemse/bjh013; Mattes RD, 2001, PHYSIOL BEHAV, V72, P217, DOI 10.1016/S0031-9384(00)00397-8; Meusel T, 2010, PAIN, V151, P516, DOI 10.1016/j.pain.2010.08.013; Mondini C, 2010, TALANTA, V81, P849, DOI 10.1016/j.talanta.2010.01.026; Polaskova P, 2008, CHEM SOC REV, V37, P2478, DOI 10.1039/b714455p; Polidori G, 2009, AM SCI, V97, P294, DOI 10.1511/2009.79.294; Robinson AL, 2009, J AGR FOOD CHEM, V57, P10313, DOI 10.1021/jf902586n; Ryan D, 2008, TRENDS FOOD SCI TECH, V19, P383, DOI 10.1016/j.tifs.2008.01.007; THURAUF N, 1991, NEUROSCI LETT, V128, P297, DOI 10.1016/0304-3940(91)90283-Y; Tsachaki M, 2008, J AGR FOOD CHEM, V56, P5308, DOI 10.1021/jf800225y; Vilanova M, 2008, J SENS STUD, V23, P114, DOI 10.1111/j.1745-459X.2007.00145.x; YAU NJN, 1991, CHEM SENSES, V16, P337, DOI 10.1093/chemse/16.4.337	42	26	27	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e30628	10.1371/journal.pone.0030628	http://dx.doi.org/10.1371/journal.pone.0030628			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347390	Green Published, gold, Green Submitted			2022-12-27	WOS:000302730100019
J	Rentas, S; Saberianfar, R; Grewal, C; Kanippayoor, R; Mishra, M; McCollum, D; Karagiannis, J				Rentas, Stefan; Saberianfar, Reza; Grewal, Charnpal; Kanippayoor, Rachelle; Mishra, Mithilesh; McCollum, Dannel; Karagiannis, Jim			The SET Domain Protein, Set3p, Promotes the Reliable Execution of Cytokinesis in Schizosaccharomyces pombe	PLOS ONE			English	Article							SEPTATION INITIATION NETWORK; FISSION YEAST; GENOMIC EXPRESSION; CELL-DIVISION; STRESS; KINASE; PERTURBATION; TETRAPLOIDY; PROGRESSION; CHECKPOINT	In response to perturbation of the cell division machinery fission yeast cells activate regulatory networks that ensure the faithful completion of cytokinesis. For instance, when cells are treated with drugs that impede constriction of the actomyosin ring (low doses of Latrunculin A, for example) these networks ensure that cytokinesis is complete before progression into the subsequent mitosis. Here, we identify three previously uncharacterized genes, hif2, set3, and snt1, whose deletion results in hyper-sensitivity to LatA treatment and in increased rates of cytokinesis failure. Interestingly, these genes are orthologous to TBL1X, MLL5, and NCOR2, human genes that encode components of a histone deacetylase complex with a known role in cytokinesis. Through co-immunoprecipitation experiments, localization studies, and phenotypic analysis of gene deletion mutants, we provide evidence for an orthologous complex in fission yeast. Furthermore, in light of the putative role of the complex in chromatin modification, together with our results demonstrating an increase in Set3p levels upon Latrunculin A treatment, global gene expression profiles were generated. While this analysis demonstrated that the expression of cytokinesis genes was not significantly affected in set3 Delta backgrounds, it did reveal defects in the ability of the mutant to regulate genes with roles in the cellular response to stress. Taken together, these findings support the existence of a conserved, multi-protein complex with a role in promoting the successful completion of cytokinesis.	[Rentas, Stefan; Saberianfar, Reza; Grewal, Charnpal; Kanippayoor, Rachelle; Karagiannis, Jim] Univ Western Ontario, Dept Biol, London, ON, Canada; [Mishra, Mithilesh] Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117548, Singapore; [McCollum, Dannel] Univ Massachusetts, Sch Med, Dept Mol Genet & Microbiol, Worcester, MA 01655 USA	Western University (University of Western Ontario); National University of Singapore; University of Massachusetts System; University of Massachusetts Worcester	Rentas, S (corresponding author), Univ Western Ontario, Dept Biol, London, ON, Canada.	jkaragia@uwo.ca		Karagiannis, Jim/0000-0002-7901-1815	National Sciences and Engineering Research Council of Canada; University of Western Ontario; Canada Foundation for Innovation	National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); University of Western Ontario; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR)	This work was supported by the National Sciences and Engineering Research Council of Canada, the University of Western Ontario Academic Development Fund, and the Canada Foundation for Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AASLAND R, 1995, TRENDS BIOCHEM SCI, V20, P56, DOI 10.1016/S0968-0004(00)88957-4; Alejandro-Osorio AL, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r57; Ayscough KR, 1997, J CELL BIOL, V137, P399, DOI 10.1083/jcb.137.2.399; Balasubramanian MK, 2004, CURR BIOL, V14, pR806, DOI 10.1016/j.cub.2004.09.022; Balasubramanian MK, 1998, GENETICS, V149, P1265; Berry DB, 2008, MOL BIOL CELL, V19, P4580, DOI 10.1091/mbc.E07-07-0680; Boyer LA, 2004, NAT REV MOL CELL BIO, V5, P158, DOI 10.1038/nrm1314; Chen CT, 2008, CURR BIOL, V18, P1594, DOI 10.1016/j.cub.2008.08.067; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; Choi HK, 2008, MOL ENDOCRINOL, V22, P1093, DOI 10.1210/me.2007-0396; Cohen TJ, 2008, EUKARYOT CELL, V7, P1191, DOI 10.1128/EC.00059-08; Damm F, 2011, J CLIN ONCOL, V29, P682, DOI 10.1200/JCO.2010.31.1118; Daniels MJ, 2004, SCIENCE, V306, P876, DOI 10.1126/science.1102574; Emerling BM, 2002, ONCOGENE, V21, P4849, DOI 10.1038/sj.onc.1205615; Forsburg SL, 2006, YEAST, V23, P173, DOI 10.1002/yea.1347; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Galipeau PC, 1996, P NATL ACAD SCI USA, V93, P7081, DOI 10.1073/pnas.93.14.7081; Ganem NJ, 2007, CURR OPIN GENET DEV, V17, P157, DOI 10.1016/j.gde.2007.02.011; Guertin DA, 2002, MICROBIOL MOL BIOL R, V66, P155, DOI 10.1128/MMBR.66.2.155-178.2002; Hachet O, 2008, GENE DEV, V22, P3205, DOI 10.1101/gad.1697208; Harris Henry, 2008, J Cell Sci, V121 Suppl 1, pv, DOI 10.1242/jcs.025759; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Karagiannis J, 2005, MOL BIOL CELL, V16, P358, DOI 10.1091/mbc.E04-06-0502; Karagiannis J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000433; King RW, 2008, BBA-REV CANCER, V1786, P4, DOI 10.1016/j.bbcan.2008.07.007; Kittler R, 2007, NAT CELL BIOL, V9, P1401, DOI 10.1038/ncb1659; Krapp A, 2008, BIOCHEM SOC T, V36, P411, DOI 10.1042/BST0360411; Kurdistani SK, 2003, NAT REV MOL CELL BIO, V4, P276, DOI 10.1038/nrm1075; Le Goff X, 1999, MOL GEN GENET, V262, P163; Liu JH, 2000, J CELL SCI, V113, P1223; Ma Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023422; Mazumdar M, 2006, CURR BIOL, V16, P1559, DOI 10.1016/j.cub.2006.06.029; Mishra M, 2004, J CELL SCI, V117, P3897, DOI 10.1242/jcs.01244; Olaharski AJ, 2006, CARCINOGENESIS, V27, P337, DOI 10.1093/carcin/bgi218; Pijnappel WWMP, 2001, GENE DEV, V15, P2991, DOI 10.1101/gad.207401; Pollard TD, 2010, NAT REV MOL CELL BIO, V11, P149, DOI 10.1038/nrm2834; Saberianfar R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024694; Sagona AP, 2010, FEBS LETT, V584, P2652, DOI 10.1016/j.febslet.2010.03.044; Selvi B. Ruthrotha, 2009, Biotechnology Journal, V4, P375, DOI 10.1002/biot.200900032; Song L, 2005, CANCER RES, V65, P4554, DOI 10.1158/0008-5472.CAN-04-4108; Trautmann S, 2001, CURR BIOL, V11, P931, DOI 10.1016/S0960-9822(01)00268-8; Yang XL, 2004, NAT CELL BIOL, V6, P609, DOI 10.1038/ncb1140; YOSHIDA T, 1994, J CELL SCI, V107, P1725	43	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31224	10.1371/journal.pone.0031224	http://dx.doi.org/10.1371/journal.pone.0031224			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347452	gold, Green Submitted, Green Published			2022-12-27	WOS:000302730100055
J	Fang, ZD; Du, RF; Cui, XQ				Fang, Zhide; Du, Ruofei; Cui, Xiangqin			Uniform Approximation Is More Appropriate for Wilcoxon Rank-Sum Test in Gene Set Analysis	PLOS ONE			English	Article							FUNCTIONAL CATEGORIES; RNA-SEQ; EXPRESSION	Gene set analysis is widely used to facilitate biological interpretations in the analyses of differential expression from high throughput profiling data. Wilcoxon Rank-Sum (WRS) test is one of the commonly used methods in gene set enrichment analysis. It compares the ranks of genes in a gene set against those of genes outside the gene set. This method is easy to implement and it eliminates the dichotomization of genes into significant and non-significant in a competitive hypothesis testing. Due to the large number of genes being examined, it is impractical to calculate the exact null distribution for the WRS test. Therefore, the normal distribution is commonly used as an approximation. However, as we demonstrate in this paper, the normal approximation is problematic when a gene set with relative small number of genes is tested against the large number of genes in the complementary set. In this situation, a uniform approximation is substantially more powerful, more accurate, and less intensive in computation. We demonstrate the advantage of the uniform approximations in Gene Ontology (GO) term analysis using simulations and real data sets.	[Fang, Zhide; Du, Ruofei] Louisiana State Univ, Hlth Sci Ctr, Sch Publ Hlth, Biostat Program, New Orleans, LA 70112 USA; [Cui, Xiangqin] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; University of Alabama System; University of Alabama Birmingham	Fang, ZD (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Sch Publ Hlth, Biostat Program, New Orleans, LA 70112 USA.	xcui@ms.soph.uab.edu	; Du, Ruofei/Q-6245-2017	Cui, Xiangqin/0000-0003-0621-9313; Du, Ruofei/0000-0002-4006-7416	NIDDK (National Institute of Diabetes and Digestive and Kidney Diseases) [P30DK07022]; NIAMS (The National Institute of Arthritis and Musculoskeletal and Skin Diseases) [P60AR048095]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P60AR048095] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007022] Funding Source: NIH RePORTER	NIDDK (National Institute of Diabetes and Digestive and Kidney Diseases)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAMS (The National Institute of Arthritis and Musculoskeletal and Skin Diseases); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	XC is partially funded by NIDDK (National Institute of Diabetes and Digestive and Kidney Diseases) P30DK07022 and NIAMS (The National Institute of Arthritis and Musculoskeletal and Skin Diseases) P60AR048095. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry WT, 2008, ANN APPL STAT, V2, P286, DOI 10.1214/07-AOAS146; Barry WT, 2005, BIOINFORMATICS, V21, P1943, DOI 10.1093/bioinformatics/bti260; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; Bellera CA, 2010, J STAT EDUC, V18, DOI 10.1080/10691898.2010.11889486; BUCKLE N, 1969, J AM STAT ASSOC, V64, P591, DOI 10.2307/2283641; Fang ZD, 2011, BRIEF BIOINFORM, V12, P280, DOI 10.1093/bib/bbr004; Gatti DM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-574; Goeman JJ, 2007, BIOINFORMATICS, V23, P980, DOI 10.1093/bioinformatics/btm051; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hung JH, 2011, BRIEF BIOINFORM; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kim H, 2010, NAT MED, V16, P804, DOI 10.1038/nm.2173; Lehmann E. L., 1998, NONPARAMETRICS STAT; Liu Q, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-431; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sadooghi-Alvandi SM, 2009, STAT PAP, V50, P171, DOI 10.1007/s00362-007-0049-4; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Song XW, 2009, HUM MOL GENET, V18, P2328, DOI 10.1093/hmg/ddp165; STEPHENS MA, 1966, BIOMETRIKA, V53, P235, DOI 10.2307/2334070; Streitberg B, 1986, STATISTICAL SOFTWARE, V12, P10; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269	23	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2012	7	2							e31505	10.1371/journal.pone.0031505	http://dx.doi.org/10.1371/journal.pone.0031505			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917MF	22347488	gold, Green Published, Green Submitted			2022-12-27	WOS:000302180600040
J	Zhu, F; Sams, S; Moural, T; Haynes, KF; Potter, MF; Palli, SR				Zhu, Fang; Sams, Sarah; Moural, Tim; Haynes, Kenneth F.; Potter, Michael F.; Palli, Subba R.			RNA Interference of NADPH-Cytochrome P450 Reductase Results in Reduced Insecticide Resistance in the Bed Bug, Cimex lectularius	PLOS ONE			English	Article							DELTAMETHRIN RESISTANCE; 3-DIMENSIONAL STRUCTURE; ESCHERICHIA-COLI; EXPRESSION; OXIDOREDUCTASE; FMN; HEMIPTERA; FAD; BIOSYNTHESIS; INVOLVEMENT	Background: NADPH-cytochrome P450 reductase (CPR) plays a central role in cytochrome P450 action. The genes coding for P450s are not yet fully identified in the bed bug, Cimex lectularius. Hence, we decided to clone cDNA and knockdown the expression of the gene coding for CPR which is suggested to be required for the function of all P450s to determine whether or not P450s are involved in resistance of bed bugs to insecticides. Methodology/Principal Findings: The full length Cimex lectularius CPR (ClCPR) cDNA was isolated from a deltamethrin resistant bed bug population (CIN-1) using a combined PCR strategy. Bioinformatics and in silico modeling were employed to identify three conserved binding domains (FMN, FAD, NADP), a FAD binding motif, and the catalytic residues. The critical amino acids involved in FMN, FAD, NADP binding and their putative functions were also analyzed. No signal peptide but a membrane anchor domain with 21 amino acids which facilitates the localization of ClCPR on the endoplasmic reticulum was identified in ClCPR protein. Phylogenetic analysis showed that ClCPR is closer to the CPR from the body louse, Pediculus humanus corporis than to the CPRs from the other insect species studied. The ClCPR gene was ubiquitously expressed in all tissues tested but showed an increase in expression as immature stages develop into adults. We exploited the traumatic insemination mechanism of bed bugs to inject dsRNA and successfully knockdown the expression of the gene coding for ClCPR. Suppression of the ClCPR expression increased susceptibility to deltamethrin in resistant populations but not in the susceptible population of bed bugs. Conclusions/Significance: These data suggest that P450-mediated metabolic detoxification may serve as one of the resistance mechanisms in bed bugs.	[Zhu, Fang; Sams, Sarah; Haynes, Kenneth F.; Potter, Michael F.; Palli, Subba R.] Univ Kentucky, Dept Entomol, Coll Agr, Lexington, KY 40546 USA; [Sams, Sarah] Univ Kentucky, Bluegrass Community & Tech Coll, Div Nat Sci, Lexington, KY USA	University of Kentucky; University of Kentucky	Zhu, F (corresponding author), Univ Kentucky, Dept Entomol, Coll Agr, Lexington, KY 40546 USA.	RPALLI@UKY.EDU	PALLI, SUBBA REDDY/AAU-8289-2020	PALLI, SUBBA REDDY/0000-0002-0873-3247	Bayer; Kentucky Agricultural experimental station; Bayer Environmental Sciences	Bayer(Bayer AG); Kentucky Agricultural experimental station; Bayer Environmental Sciences	This work was funded by grants from Bayer and Kentucky Agricultural experimental station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: Funding for this study was provided by a grant from Bayer Environmental Sciences. There are no patents, products in development or marketed product to declare. The authors' grant agreement with Bayer does not alter their adherence to all the PLoS ONE policies on sharing data and materials.	Adelman ZN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026228; ANDERSEN JF, 1994, BIOCHEMISTRY-US, V33, P2171, DOI 10.1021/bi00174a025; Bai XD, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016336, 10.1371/journal.pone.0016368]; Boase C., 2001, Pesticide Outlook, V12, P159, DOI 10.1039/b106301b; Carayon J., 1966, MONOGRAPH CIMICIDAE, P81, DOI DOI 10.1002/(SICI)1097-0029(19971215)39:6<506::AID-JEMT5>3.0.CO;2-B; Feyereisen R., 2005, P1; Gilbert LI, 2004, MOL CELL ENDOCRINOL, V215, P1, DOI 10.1016/j.mce.2003.11.003; Hall B. G., 2008, PHYLOGENETIC TREES M; Henderson CJ, 2003, J BIOL CHEM, V278, P13480, DOI 10.1074/jbc.M212087200; Horike N, 2000, EUR J BIOCHEM, V267, P6914, DOI 10.1046/j.1432-1033.2000.01796.x; Hovemann BT, 1997, GENE, V189, P213, DOI 10.1016/S0378-1119(96)00851-7; Hubbard PA, 2001, J BIOL CHEM, V276, P29163, DOI 10.1074/jbc.M101731200; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Ingelman M, 1997, J MOL BIOL, V268, P147, DOI 10.1006/jmbi.1997.0957; Kaewpa D, 2007, J ECON ENTOMOL, V100, P946, DOI 10.1603/0022-0493(2007)100[946:FEOMNP]2.0.CO;2; Kida Y, 1998, ARCH BIOCHEM BIOPHYS, V351, P175, DOI 10.1006/abbi.1997.0553; KOENER JF, 1993, INSECT BIOCHEM MOLEC, V23, P439, DOI 10.1016/0965-1748(93)90051-S; Lamb DC, 2006, STRUCTURE, V14, P51, DOI 10.1016/j.str.2005.09.015; Lian L-Y, 2011, PLOS ONE, V6; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LU AYH, 1969, J BIOL CHEM, V244, P3714; Lycett GJ, 2006, INSECT MOL BIOL, V15, P321, DOI 10.1111/j.1365-2583.2006.00647.x; Maibeche-Coisne M, 2005, GENE, V346, P195, DOI 10.1016/j.gene.2004.11.010; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Montes C, 2002, J MED ENTOMOL, V39, P675, DOI 10.1603/0022-2585-39.4.675; Murataliev MB, 1999, INSECT BIOCHEM MOLEC, V29, P233, DOI 10.1016/S0965-1748(98)00131-3; Nishino H, 2000, ARCH BIOCHEM BIOPHYS, V374, P293, DOI 10.1006/abbi.1999.1602; ONO T, 1977, BIOCHIM BIOPHYS ACTA, V486, P401; OPRIAN DD, 1982, J BIOL CHEM, V257, P8935; Pandey AV, 2007, MOL ENDOCRINOL, V21, P2579, DOI 10.1210/me.2007-0245; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; PORTER TD, 1987, ARCH BIOCHEM BIOPHYS, V254, P353, DOI 10.1016/0003-9861(87)90111-1; Potter M. F., 2005, Pest Control Technology, V33, P82; Potter M.F., 2010, PEST WORLD       SEP, V18, P8; Reinhardt K, 2003, P ROY SOC B-BIOL SCI, V270, P2371, DOI 10.1098/rspb.2003.2515; Rewitz KF, 2007, INSECT BIOCHEM MOLEC, V37, P741, DOI 10.1016/j.ibmb.2007.02.012; Romero A, 2007, J MED ENTOMOL, V44, P175, DOI 10.1603/0022-2585(2007)44[175:IRITBB]2.0.CO;2; Romero A, 2009, J ECON ENTOMOL, V102, P2310, DOI 10.1603/029.102.0637; Romero A, 2009, J MED ENTOMOL, V46, P51, DOI 10.1603/033.046.0107; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Schenkman JB, 1999, DRUG METAB REV, V31, P351, DOI 10.1081/DMR-100101923; Shen AL, 1999, J BIOL CHEM, V274, P5391, DOI 10.1074/jbc.274.9.5391; Shen AL, 2002, J BIOL CHEM, V277, P6536, DOI 10.1074/jbc.M111408200; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; VERMILION JL, 1981, J BIOL CHEM, V256, P266; Wang JL, 2003, J BIOL CHEM, V278, P20069, DOI 10.1074/jbc.M300989200; Wang M, 1997, P NATL ACAD SCI USA, V94, P8411, DOI 10.1073/pnas.94.16.8411; Yoon KS, 2008, J MED ENTOMOL, V45, P1092, DOI 10.1603/0022-2585(2008)45[1092:BAMAOD]2.0.CO;2; Zhu F, 2010, P NATL ACAD SCI USA, V107, P8557, DOI 10.1073/pnas.1000059107; Zhu F, 2010, ARCH INSECT BIOCHEM, V73, P245, DOI 10.1002/arch.20355	50	51	61	2	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2012	7	2							e31037	10.1371/journal.pone.0031037	http://dx.doi.org/10.1371/journal.pone.0031037			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917MF	22347424	Green Submitted, gold, Green Published			2022-12-27	WOS:000302180600025
J	Oswald, E; Sesarman, A; Franzke, CW; Wolfle, U; Bruckner-Tuderman, L; Jakob, T; Martin, SF; Sitaru, C				Oswald, Eva; Sesarman, Alina; Franzke, Claus-Werner; Woelfle, Ute; Bruckner-Tuderman, Leena; Jakob, Thilo; Martin, Stefan F.; Sitaru, Cassian			The Flavonoid Luteolin Inhibits Fc gamma-Dependent Respiratory Burst in Granulocytes, but Not Skin Blistering in a New Model of Pemphigoid in Adult Mice	PLOS ONE			English	Article							DERMAL-EPIDERMAL SEPARATION; HERPES-GESTATIONIS; VII COLLAGEN; IGG AUTOANTIBODIES; PASSIVE TRANSFER; ANTIGEN; COMPLEMENT; ANTIBODIES; EPITOPES; DISEASE	Bullous pemphigoid is an autoimmune blistering skin disease associated with autoantibodies against the dermal-epidermal junction. Passive transfer of antibodies against BP180/collagen (C) XVII, a major hemidesmosomal pemphigoid antigen, into neonatal mice results in dermal-epidermal separation upon applying gentle pressure to their skin, but not in spontaneous skin blistering. In addition, this neonatal mouse model precludes treatment and observation of diseased animals beyond 2-3 days. Therefore, in the present study we have developed a new disease model in mice reproducing the spontaneous blistering and the chronic course characteristic of the human condition. Adult mice were pre-immunized with rabbit IgG followed by injection of BP180/CXVII rabbit IgG. Mice pre-immunized against rabbit IgG and injected 6 times every second day with the BP180/CXVII-specific antibodies (n = 35) developed spontaneous sustained blistering of the skin, while mice pre-immunized and then treated with normal rabbit IgG (n = 5) did not. Blistering was associated with IgG and complement C3 deposits at the epidermal basement membrane and recruitment of inflammatory cells, and was partly dependent on Ly-6G-positive cells. We further used this new experimental model to investigate the therapeutic potential of luteolin, a plant flavonoid with potent anti-inflammatory and anti-oxidative properties and good safety profile, in experimental BP. Luteolin inhibited the Fc gamma-dependent respiratory burst in immune complex-stimulated granulocytes and the autoantibody-induced dermal-epidermal separation in skin cryosections, but was not effective in suppressing the skin blistering in vivo. These studies establish a robust animal model that will be a useful tool for dissecting the mechanisms of blister formation and will facilitate the development of more effective therapeutic strategies for managing pemphigoid diseases.	[Oswald, Eva; Jakob, Thilo; Martin, Stefan F.] Univ Freiburg, Dept Dermatol, Med Ctr, Allergy Res Grp, Freiburg, Germany; [Woelfle, Ute] Univ Freiburg, Dept Dermatol, Competence Ctr Skintegral, Med Ctr, Freiburg, Germany; [Oswald, Eva] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany; [Bruckner-Tuderman, Leena; Sitaru, Cassian] BIOSS Ctr Biol Signalling Studies, Freiburg, Germany; [Bruckner-Tuderman, Leena] Freiburg Inst Adv Studies, Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg	Oswald, E (corresponding author), Univ Freiburg, Dept Dermatol, Med Ctr, Allergy Res Grp, Hauptstr 7, Freiburg, Germany.	cassian.sitaru@uniklinik-freiburg.de	Sitaru, Cassian/E-5830-2010; Jakob, Thilo/J-1621-2012; Sesarman, Alina/F-6841-2011; Wölfle, Ute/AAG-6972-2021	Sitaru, Cassian/0000-0002-0370-1270; Sesarman, Alina/0000-0002-7491-9955; Wölfle, Ute/0000-0003-0093-560X	Deutsche Forschungsgemeinschaft [SI-1281/4-1, MA-1567/9-1, SFB850-B6]; BIOSS; Medical Faculty of the Freiburg University; Freiburg Institute for Advanced Studies	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); BIOSS; Medical Faculty of the Freiburg University; Freiburg Institute for Advanced Studies	The authors acknowledge support by grants from the Deutsche Forschungsgemeinschaft SI-1281/4-1 (CS), MA-1567/9-1 (SM), SFB850-B6 (LB-T, C-WF), and BIOSS (LB-T, CS), from the Medical Faculty of the Freiburg University (CS) and by the Freiburg Institute for Advanced Studies (LB-T). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anhalt G J, 1987, Clin Dermatol, V5, P117, DOI 10.1016/0738-081X(87)90056-3; Binstadt BA, 2006, NAT IMMUNOL, V7, P284, DOI 10.1038/ni1306; Budinger L, 1998, J CLIN INVEST, V102, P2082, DOI 10.1172/JCI3335; Chen CY, 2007, LIFE SCI, V81, P1602, DOI 10.1016/j.lfs.2007.09.028; Chiriac MT, 2012, NOVEL MODEL AD UNPUB; Csorba K, 2010, CELL MOL LIFE SCI, V67, P1343, DOI 10.1007/s00018-009-0256-3; Di Zenzo G, 2008, CLIN IMMUNOL, V128, P415, DOI 10.1016/j.clim.2008.04.012; DIAZ LA, 1990, J CLIN INVEST, V86, P1088, DOI 10.1172/JCI114812; Egan CA, 1999, J INVEST DERMATOL, V112, P148, DOI 10.1046/j.1523-1747.1999.00490.x; Feliciani C, 2009, BRIT J DERMATOL, V161, P306, DOI 10.1111/j.1365-2133.2009.09266.x; GIUDICE GJ, 1993, J IMMUNOL, V151, P5742; GIUDICE GJ, 1992, J INVEST DERMATOL, V99, P243, DOI 10.1111/1523-1747.ep12616580; Haase C, 1998, J INVEST DERMATOL, V110, P282, DOI 10.1046/j.1523-1747.1998.00126.x; HALL RP, 1993, J INVEST DERMATOL, V101, P9, DOI 10.1111/1523-1747.ep12358276; Herrero-Gonzalez JE, 2006, EUR J IMMUNOL, V36, P1039, DOI 10.1002/eji.200535349; Iwata Y, 2008, ARCH DERMATOL, V144, P41, DOI 10.1001/archdermatol.2007.9; KATZ SI, 1976, J CLIN INVEST, V57, P1434, DOI 10.1172/JCI108413; Kiss M, 2005, J AUTOIMMUN, V24, P1, DOI 10.1016/j.jaut.2004.09.007; Lin MS, 1999, J IMMUNOL, V162, P4991; Liu Z, 1997, J CLIN INVEST, V100, P1256, DOI 10.1172/JCI119639; LIU Z, 1993, J CLIN INVEST, V92, P2480, DOI 10.1172/JCI116856; Liu Z, 2000, CELL, V102, P647, DOI 10.1016/S0092-8674(00)00087-8; Liu Z, 2008, J AUTOIMMUN, V31, P331, DOI 10.1016/j.jaut.2008.08.009; Mihai S, 2007, J CELL MOL MED, V11, P1117, DOI 10.1111/j.1582-4934.2007.00081.x; Mihai S, 2007, J CELL MOL MED, V11, P462, DOI 10.1111/j.1582-4934.2007.00033.x; NAGAI H, 1982, JPN J PHARMACOL, V32, P1117, DOI 10.1254/jjp.32.1117; NAITO K, 1984, J INVEST DERMATOL, V82, P227, DOI 10.1111/1523-1747.ep12260057; NEALE TJ, 1982, SPRINGER SEMIN IMMUN, V5, P221, DOI 10.1007/BF01892087; Nishie W, 2007, NAT MED, V13, P378, DOI 10.1038/nm1496; Nishie W, 2009, J IMMUNOL, V183, P4088, DOI 10.4049/jimmunol.0800389; Perriard J, 1999, J INVEST DERMATOL, V112, P141, DOI 10.1046/j.1523-1747.1999.00497.x; Schmidt E, 2000, ARCH DERMATOL, V136, P174, DOI 10.1001/archderm.136.2.174; Seelinger G, 2008, PLANTA MED, V74, P1667, DOI 10.1055/s-0028-1088314; Sesarman A, 2008, BRIT J DERMATOL, V158, P463, DOI 10.1111/j.1365-2133.2007.08388.x; Sesarman A, 2012, INTERACTION HU UNPUB; Sesarman A, 2008, J MOL MED, V86, P951, DOI 10.1007/s00109-008-0366-7; Shimanovich I, 2004, J PATHOL, V204, P519, DOI 10.1002/path.1674; Sitaru AG, 2010, J IMMUNOL, V184, P1596, DOI 10.4049/jimmunol.0901412; Sitaru C, 2005, J CLIN INVEST, V115, P870, DOI 10.1172/JCI200521386; Sitaru C, 2002, AM J PATHOL, V161, P301, DOI 10.1016/S0002-9440(10)64182-X; Sitaru C, 2002, J INVEST DERMATOL, V118, P664, DOI 10.1046/j.1523-1747.2002.01720.x; Sitaru C, 2006, J IMMUNOL, V177, P3461, DOI 10.4049/jimmunol.177.5.3461; Sitaru C, 2009, J INVEST DERMATOL, V129, P822, DOI 10.1038/jid.2009.12; STANLEY JR, 1988, J CLIN INVEST, V82, P1864, DOI 10.1172/JCI113803; STANLEY JR, 1981, CELL, V24, P897, DOI 10.1016/0092-8674(81)90115-X; Ujiie H, 2010, J IMMUNOL, V184, P2166, DOI 10.4049/jimmunol.0903101; Woelfle U, 2010, PHYTOTHER RES, V24, P1033, DOI 10.1002/ptr.3069; Yamamoto K, 2002, J INVEST DERMATOL, V118, P485, DOI 10.1046/j.0022-202x.2001.01683.x	48	19	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2012	7	2							e31066	10.1371/journal.pone.0031066	http://dx.doi.org/10.1371/journal.pone.0031066			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LV	22328927	Green Published, gold, Green Submitted			2022-12-27	WOS:000302179300013
J	Lau, WKW; Chan-Yeung, MMW; Yip, BHK; Cheung, AHK; Ip, MSM; Mak, JCW				Lau, Way K. W.; Chan-Yeung, Moira M. W.; Yip, Benjamin H. K.; Cheung, Amy H. K.; Ip, Mary S. M.; Mak, Judith C. W.		COPD Study Grp Hong Kong Thoracic	The Role of Circulating Serotonin in the Development of Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							MONOAMINE-OXIDASE; TRANSPORTER GENE; PLASMA; HYPERTENSION; INHIBITOR; CHINESE	Background: Cigarette smoking is a major risk factor in the development of age-related chronic obstructive pulmonary disease (COPD). The serotonin transporter (SERT) gene polymorphism has been reported to be associated with COPD, and the degree of cigarette smoking has been shown to be a significant mediator in this relationship. The interrelation between circulating serotonin (5-hydroxytyptamine, 5-HT), cigarette smoking and COPD is however largely unknown. The current study aimed at investigating the mediation effects of plasma 5-HT on cigarette smoking-induced COPD and the relation between plasma 5-HT levels and age. Methods: The association between plasma 5-HT, age and COPD was analyzed in a total of 62 COPD patients (ever-smokers) and 117 control subjects (healthy non-smokers and ever-smokers). Plasma 5-HT levels were measured by enzyme-linked immuno assay (EIA). Results: The elevated plasma 5-HT levels were significantly associated with increased odds for COPD (OR = 1.221, 95% CI = 1.123 to 1.319, p<0.0001). The effect remained significant after being adjusted for age and pack-years smoked (OR = 1.271, 95% CI = 1.134 to 1.408, p = 0.0003). Furthermore, plasma 5-HT was found to mediate the relation between pack-years smoked and COPD. A positive correlation (r = 0.303, p = 0.017) was found between plasma 5-HT levels and age in COPD, but not in the control subjects (r = -0.149, p = 0.108). Conclusion: Our results suggest that cigarette smoke-induced COPD is partially mediated by the plasma levels of 5-HT, and that these become elevated with increased age in COPD. The elevated plasma 5-HT levels in COPD might contribute to the pathogenesis of this disease.	[Lau, Way K. W.; Chan-Yeung, Moira M. W.; Cheung, Amy H. K.; Ip, Mary S. M.; Mak, Judith C. W.] Univ Hong Kong, Dept Med, Div Resp Med, Hong Kong, Hong Kong, Peoples R China; [Yip, Benjamin H. K.] Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China; [Mak, Judith C. W.] Univ Hong Kong, Dept Pharmacol & Pharm, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong	Lau, WKW (corresponding author), Univ Hong Kong, Dept Med, Div Resp Med, Hong Kong, Hong Kong, Peoples R China.	judithmak@hku.hk	Yip, Benjamin/AAC-7845-2019; YIP, Benjamin HK/I-2336-2013; Ip, Mary Sau Man/C-4284-2009	Yip, Benjamin/0000-0002-4749-7611; Mak, Judith/0000-0002-8234-1313; Ip, Mary Sau Man/0000-0002-8692-6933; Lau, Way/0000-0003-1493-5002	Hong Kong Lung Foundation	Hong Kong Lung Foundation	This study is supported by Hong Kong Lung Foundation Research Grant (HKLF 2007-2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; Ban Y, 2007, ATHEROSCLEROSIS, V195, P153, DOI 10.1016/j.atherosclerosis.2006.09.005; Brenner B, 2007, J NEUROCHEM, V102, P206, DOI 10.1111/j.1471-4159.2007.04542.x; Chan-Yeung M, 2007, INT J TUBERC LUNG D, V11, P502; Eddahibi S, 2003, CIRCULATION, V108, P1839, DOI 10.1161/01.CIR.0000091409.53101.E8; HART CM, 1989, CLIN CHEST MED, V10, P59; Herr N., MEDIATION DICHOTOMOU; Herraiz T, 2005, BIOCHEM BIOPH RES CO, V326, P378, DOI 10.1016/j.bbrc.2004.11.033; Hogg JC, 2004, LANCET, V364, P709, DOI 10.1016/S0140-6736(04)16900-6; Ip MSM, 2006, CHEST, V129, P384, DOI 10.1378/chest.129.2.384; Ishii T, 2011, J HUM GENET, V56, P41, DOI 10.1038/jhg.2010.133; Kereveur A, 2000, ARTERIOSCL THROM VAS, V20, P2233, DOI 10.1161/01.ATV.20.10.2233; Khalil AA, 2000, CHEM RES TOXICOL, V13, P31, DOI 10.1021/tx990146f; Khalil AA, 2006, BIOORGAN MED CHEM, V14, P3392, DOI 10.1016/j.bmc.2005.12.057; Kumar AM, 1998, GERONTOLOGY, V44, P211, DOI 10.1159/000022012; Lechin F, 1996, ANN ALLERG ASTHMA IM, V77, P245, DOI 10.1016/S1081-1206(10)63263-2; Lee JJ, 2001, CLIN EXP PHARMACOL P, V28, P285, DOI 10.1046/j.1440-1681.2001.03439.x; Maclay JD, 2011, THORAX, V66, P769, DOI 10.1136/thx.2010.157529; MendezAlvarez E, 1997, LIFE SCI, V60, P1719, DOI 10.1016/S0024-3205(97)00114-8; Mercado CP, 2010, MOL INTERV, V10, P231, DOI 10.1124/mi.10.4.6; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; ORTIZ J, 1988, LIFE SCI, V43, P983, DOI 10.1016/0024-3205(88)90543-7; Pauwels Romain A., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1256; Preacher KJ, CALCULATION SOBEL TE; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Rabe KF, 2007, AM J RESP CRIT CARE, V175, P1222, DOI 10.1164/rccm.200704-586UP; RAUSCH JL, 1989, PROG NEURO-PSYCHOPH, V13, P907, DOI 10.1016/0278-5846(89)90042-0; Repapi E, 2010, NAT GENET, V42, P36, DOI 10.1038/ng.501; Sciurba FC, 2004, CHEST, V126, p807S, DOI 10.1378/chest.126.2_suppl_1.117S; Topsakal R, 2009, BLOOD PRESSURE, V18, P367, DOI 10.3109/08037050903350788; U.S. Census Bureau, INT DAT BAS IDB; Ulrich S, 2010, RESPIRATION, V79, P288, DOI 10.1159/000226243; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.2471/BLT.07.045120	33	21	32	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e31617	10.1371/journal.pone.0031617	http://dx.doi.org/10.1371/journal.pone.0031617			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LO	22319639	Green Submitted, Green Published, gold			2022-12-27	WOS:000302178400047
J	Arizpe, J; Kravitz, DJ; Yovel, G; Baker, CI				Arizpe, Joseph; Kravitz, Dwight J.; Yovel, Galit; Baker, Chris I.			Start Position Strongly Influences Fixation Patterns during Face Processing: Difficulties with Eye Movements as a Measure of Information Use	PLOS ONE			English	Article							PERCEPTION; RECOGNITION; EXPLORATION; FAMILIARITY; ASYMMETRIES; INVERSION; STIMULUS; REVEAL; SPAN; TASK	Fixation patterns are thought to reflect cognitive processing and, thus, index the most informative stimulus features for task performance. During face recognition, initial fixations to the center of the nose have been taken to indicate this location is optimal for information extraction. However, the use of fixations as a marker for information use rests on the assumption that fixation patterns are predominantly determined by stimulus and task, despite the fact that fixations are also influenced by visuo-motor factors. Here, we tested the effect of starting position on fixation patterns during a face recognition task with upright and inverted faces. While we observed differences in fixations between upright and inverted faces, likely reflecting differences in cognitive processing, there was also a strong effect of start position. Over the first five saccades, fixation patterns across start positions were only coarsely similar, with most fixations around the eyes. Importantly, however, the precise fixation pattern was highly dependent on start position with a strong tendency toward facial features furthest from the start position. For example, the often-reported tendency toward the left over right eye was reversed for the left starting position. Further, delayed initial saccades for central versus peripheral start positions suggest greater information processing prior to the initial saccade, highlighting the experimental bias introduced by the commonly used center start position. Finally, the precise effect of face inversion on fixation patterns was also dependent on start position. These results demonstrate the importance of a non-stimulus, non-task factor in determining fixation patterns. The patterns observed likely reflect a complex combination of visuo-motor effects and simple sampling strategies as well as cognitive factors. These different factors are very difficult to tease apart and therefore great caution must be applied when interpreting absolute fixation locations as indicative of information use, particularly at a fine spatial scale.	[Arizpe, Joseph; Kravitz, Dwight J.; Baker, Chris I.] NIMH, Lab Brain & Cognit, NIH, Bethesda, MD 20892 USA; [Arizpe, Joseph] UCL, Inst Cognit Neurosci, Visual Cognit Grp, London, England; [Yovel, Galit] Tel Aviv Univ, Dept Psychol, IL-69978 Tel Aviv, Israel	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of London; University College London; Tel Aviv University	Arizpe, J (corresponding author), NIMH, Lab Brain & Cognit, NIH, Bethesda, MD 20892 USA.	arizpej@mail.nih.gov; bakerchris@mail.nih.gov	Baker, Chris/P-8442-2019; Yovel, Galit/GPT-4409-2022; Arizpe, Joseph M/N-1399-2014; Kravitz, Dwight/B-8430-2012; Kravitz, Dwight/AAO-5860-2020	Baker, Chris/0000-0001-6861-8964; Yovel, Galit/0000-0003-0971-2357; Arizpe, Joseph M/0000-0001-8958-7757; Kravitz, Dwight/0000-0002-8108-1329	National Institutes of Mental Health; United States-Israel Binational Science Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002909] Funding Source: NIH RePORTER	National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Intramural Program of the National Institutes of Mental Health and by the United States-Israel Binational Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afraz A, 2010, CURR BIOL, V20, P2112, DOI 10.1016/j.cub.2010.11.017; Althoff RR, 1999, J EXP PSYCHOL LEARN, V25, P997, DOI 10.1037/0278-7393.25.4.997; Armann R, 2009, ATTEN PERCEPT PSYCHO, V71, P1107, DOI 10.3758/APP.71.5.1107; Barton JJS, 2006, PERCEPTION, V35, P1089, DOI 10.1068/p5547; Bindemann M, 2009, J VISION, V9, DOI 10.1167/9.2.7; Blais C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003022; Burt DM, 1997, NEUROPSYCHOLOGIA, V35, P685, DOI 10.1016/S0028-3932(96)00111-X; Butler S, 2005, NEUROPSYCHOLOGIA, V43, P52, DOI 10.1016/j.neuropsychologia.2004.06.005; Caldara R, 2011, BEHAV RES METHODS, V43, P864, DOI 10.3758/s13428-011-0092-x; Caldara R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009708; Dahl CD, 2009, CURR BIOL, V19, P509, DOI 10.1016/j.cub.2009.01.061; Findlay J. M., 2003, ACTIVE VISION PSYCHO; Findlay JM, 1997, PERCEPTION, V26, P1159, DOI 10.1068/p261159; Foulsham T, 2011, ATTEN PERCEPT PSYCHO, V73, P266, DOI 10.3758/s13414-010-0014-5; GILBERT C, 1973, NEUROPSYCHOLOGIA, V11, P355, DOI 10.1016/0028-3932(73)90049-3; Goldinger SD, 2009, J EXP PSYCHOL LEARN, V35, P1105, DOI 10.1037/a0016548; Gosselin F, 2001, VISION RES, V41, P2261, DOI 10.1016/S0042-6989(01)00097-9; Gosselin F, 2003, PSYCHOL SCI, V14, P505, DOI 10.1111/1467-9280.03452; HAITH MM, 1977, SCIENCE, V198, P853, DOI 10.1126/science.918670; Heisz JJ, 2008, J VISION, V8, DOI 10.1167/8.1.9; Henderson JM, 2005, MEM COGNITION, V33, P98, DOI 10.3758/BF03195300; HENDERSON JM, 1993, CAN J EXP PSYCHOL, V47, P79, DOI 10.1037/h0078776; Henderson JM, 2003, TRENDS COGN SCI, V7, P498, DOI 10.1016/j.tics.2003.09.006; Hsiao JHW, 2008, PSYCHOL SCI, V19, P998, DOI 10.1111/j.1467-9280.2008.02191.x; Jack RE, 2009, CURR BIOL, V19, P1543, DOI 10.1016/j.cub.2009.07.051; Jack RE, 2011, J EXP PSYCHOL GEN; JANIK SW, 1978, PERCEPT MOTOR SKILL, V47, P857, DOI 10.2466/pms.1978.47.3.857; JUST MA, 1980, PSYCHOL REV, V87, P329, DOI 10.1037/0033-295X.87.4.329; Kanwisher N, 2006, PHILOS T R SOC B, V361, P2109, DOI 10.1098/rstb.2006.1934; KAPOULA Z, 1985, VISION RES, V25, P1155, DOI 10.1016/0042-6989(85)90105-1; KAPOULA Z, 1986, VISION RES, V26, P735, DOI 10.1016/0042-6989(86)90087-8; Kealey R, 2008, J VIS, V8, P892, DOI DOI 10.1167/8.6.892; Kliemann D, 2010, J NEUROSCI, V30, P12281, DOI 10.1523/JNEUROSCI.0688-10.2010; Klin A, 2002, ARCH GEN PSYCHIAT, V59, P809, DOI 10.1001/archpsyc.59.9.809; Kravitz DJ, 2010, CEREB CORTEX, V20, P2916, DOI 10.1093/cercor/bhq042; Leonards U, 2005, VISION RES, V45, P2677, DOI 10.1016/j.visres.2005.03.009; Leonards U, 2007, CURR BIOL, V17, pR8, DOI 10.1016/j.cub.2006.11.046; Malcolm GL, 2008, J VISION, V8, DOI 10.1167/8.8.2; MCCONKIE GW, 1988, VISION RES, V28, P1107, DOI 10.1016/0042-6989(88)90137-X; MCCONKIE GW, 1975, PERCEPT PSYCHOPHYS, V17, P578, DOI 10.3758/BF03203972; MERTENS I, 1993, NEUROPSYCHOLOGIA, V31, P989, DOI 10.1016/0028-3932(93)90154-R; Minear M, 2004, BEHAV RES METH INS C, V36, P630, DOI 10.3758/BF03206543; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Pelphrey KA, 2002, J AUTISM DEV DISORD, V32, P249, DOI 10.1023/A:1016374617369; Radach R., 1998, EYE GUIDANCE READING, P77, DOI DOI 10.1016/B978-008043361-5/50005-5; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; Rayner K, 2009, PERCEPTION, V38, P895, DOI 10.1068/ldmk-ray; Renninger LW, 2007, J VISION, V7, DOI 10.1167/7.3.6; Rodger H, 2010, PERCEPTION, V39, P1491, DOI 10.1068/p6750; Rossion Bruno, 2002, Behav Cogn Neurosci Rev, V1, P63, DOI 10.1177/1534582302001001004; Stacey PC, 2005, BRIT J PSYCHOL, V96, P407, DOI 10.1348/000712605X47422; van Belle G, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00020; WALKERSMITH GJ, 1977, PERCEPTION, V6, P313, DOI 10.1068/p060313; Williams CC, 2007, MEM COGNITION, V35, P1977, DOI 10.3758/BF03192930; Yarbus A.L., 1967, EYE MOVEMENTS VISION, DOI 10.1007/978-1-4899-5379-7; YIN RK, 1969, J EXP PSYCHOL, V81, P141, DOI 10.1037/h0027474	56	60	63	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2012	7	2							e31106	10.1371/journal.pone.0031106	http://dx.doi.org/10.1371/journal.pone.0031106			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	914UV	22319606	Green Submitted, gold, Green Published			2022-12-27	WOS:000301979000019
J	Dafik, L; Albertelli, M; Stamnaes, J; Sollid, LM; Khosla, C				Dafik, Laila; Albertelli, Megan; Stamnaes, Jorunn; Sollid, Ludvig M.; Khosla, Chaitan			Activation and Inhibition of Transglutaminase 2 in Mice	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; TISSUE TRANSGLUTAMINASE; SELECTIVE INHIBITORS; FLUOROMETRIC ASSAY; STRUCTURAL BASIS; RECOGNITION; POLY(I-C); DISEASE; ANALOGS; INJURY	Transglutaminase 2 (TG2) is an allosterically regulated enzyme with transamidating, deamidating and cell signaling activities. It is thought to catalyze sequence-specific deamidation of dietary gluten peptides in the small intestines of celiac disease patients. Because this modification has profound consequences for disease pathogenesis, there is considerable interest in the design of small molecule TG2 inhibitors. Although many classes of TG2 inhibitors have been reported, thus far an animal model for screening them to identify promising celiac drug candidates has remained elusive. Using intraperitoneal administration of the toll-like receptor 3 (TLR3) ligand, polyinosinic-polycytidylic acid (poly(I:C)), we induced rapid TG2 activation in the mouse small intestine. Dose dependence was observed in the activation of TG2 as well as the associated villous atrophy, gross clinical response, and rise in serum concentration of the IL-15/IL-15R complex. TG2 activity was most pronounced in the upper small intestine. No evidence of TG2 activation was observed in the lung mucosa, nor were TLR7/8 ligands able to elicit an analogous response. Introduction of ERW1041E, a small molecule TG2 inhibitor, in this mouse model resulted in TG2 inhibition in the small intestine. TG2 inhibition had no effect on villous atrophy, suggesting that activation of this enzyme is a consequence, rather than a cause, of poly(I:C) induced enteropathy. Consistent with this finding, administration of poly(I:C) to TG2 knockout mice also induced villous atrophy. Our findings pave the way for pharmacological evaluation of small molecule TG2 inhibitors as drug candidates for celiac disease.	[Dafik, Laila; Khosla, Chaitan] Stanford Univ, Dept Chem & Chem Engn, Stanford, CA 94305 USA; [Albertelli, Megan] Stanford Univ, Dept Comparat Med, Stanford, CA 94305 USA; [Stamnaes, Jorunn; Sollid, Ludvig M.] Univ Oslo, Dept Immunol, Oslo, Norway; [Stamnaes, Jorunn; Sollid, Ludvig M.] Univ Oslo, Ctr Immune Regulat, Oslo, Norway; [Sollid, Ludvig M.] Univ Oslo, Rikshosp, Oslo Univ Hosp, N-0027 Oslo, Norway; [Khosla, Chaitan] Stanford Univ, Dept Biochem, Stanford, CA 94305 USA	Stanford University; Stanford University; University of Oslo; University of Oslo; University of Oslo; National Hospital Norway; Stanford University	Khosla, C (corresponding author), Stanford Univ, Dept Chem & Chem Engn, Stanford, CA 94305 USA.	khosla@stanford.edu	Albertelli, Megan A/C-7650-2011; Sollid, Ludvig/N-9691-2015	Albertelli, Megan A/0000-0001-9433-229X; Sollid, Ludvig/0000-0001-8860-704X; Khosla, Chaitan/0000-0001-6529-495X; Stamnaes, Jorunn/0000-0002-0257-2112	National Institutes of Health [R01 DK063158]; Research Council of Norway; "Fonds de Recherche sur la Nature et les Technologies'' (Canada); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063158] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Council of Norway(Research Council of Norway); "Fonds de Recherche sur la Nature et les Technologies'' (Canada); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a grant from the National Institutes of Health (R01 DK063158) to CK and by the Research Council of Norway (to LMS). LD is a recipient of a postdoctoral fellowship from "Fonds de Recherche sur la Nature et les Technologies'' (Canada). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Choi K, 2005, CHEM BIOL, V12, P469, DOI 10.1016/j.chembiol.2005.02.007; Cui ZR, 2006, CANCER IMMUNOL IMMUN, V55, P1267, DOI 10.1007/s00262-005-0114-6; Dafik L, 2011, CHEM BIOL, V18, P58, DOI 10.1016/j.chembiol.2010.11.004; De Laurenzi V, 2001, MOL CELL BIOL, V21, P148, DOI 10.1128/MCB.21.1.148-155.2001; DePaolo RW, 2011, NATURE, V471, P220, DOI 10.1038/nature09849; FOLK JE, 1985, METHOD ENZYMOL, V113, P358; Gillet SMFG, 2005, ANAL BIOCHEM, V347, P221, DOI 10.1016/j.ab.2005.09.035; Griffin M, 2002, BIOCHEM J, V368, P377, DOI 10.1042/BJ20021234; Halim D, 2007, BIOORG MED CHEM LETT, V17, P305, DOI 10.1016/j.bmcl.2006.10.061; Hausch F, 2003, CHEM BIOL, V10, P225, DOI 10.1016/S1074-5521(03)00045-0; Jeitner TM, 2001, ANAL BIOCHEM, V292, P198, DOI 10.1006/abio.2001.5040; Jurk M, 2002, NAT IMMUNOL, V3, P499, DOI 10.1038/ni0602-499; Liu SP, 2002, P NATL ACAD SCI USA, V99, P2743, DOI 10.1073/pnas.042454899; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Pardin C, 2008, J ORG CHEM, V73, P5766, DOI 10.1021/jo8004843; Pardin C, 2006, BIOORGAN MED CHEM, V14, P8379, DOI 10.1016/j.bmc.2006.09.011; Pinkas DM, 2007, PLOS BIOL, V5, P2788, DOI 10.1371/journal.pbio.0050327; Schaertl S, 2010, J BIOMOL SCREEN, V15, P478, DOI 10.1177/1087057110366035; Shan L, 2002, SCIENCE, V297, P2275, DOI 10.1126/science.1074129; Siegel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001861; Siegel M, 2007, PHARMACOL THERAPEUT, V115, P232, DOI 10.1016/j.pharmthera.2007.05.003; Sollid LM, 2002, NAT REV IMMUNOL, V2, P647, DOI 10.1038/nri885; Stamnaes J, 2010, J BIOL CHEM, V285, P25402, DOI 10.1074/jbc.M109.097162; Verdijk RM, 1999, J IMMUNOL, V163, P57; Watts RE, 2006, J MED CHEM, V49, P7493, DOI 10.1021/jm060839a; Zhou RB, 2007, P NATL ACAD SCI USA, V104, P7512, DOI 10.1073/pnas.0700822104; Zhou RB, 2007, J IMMUNOL, V178, P4548, DOI 10.4049/jimmunol.178.7.4548	27	48	48	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2012	7	2							e30642	10.1371/journal.pone.0030642	http://dx.doi.org/10.1371/journal.pone.0030642			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UV	22319575	Green Submitted, Green Published, gold			2022-12-27	WOS:000301979000009
J	Chen, CY; Chien, TY; Lin, CK; Lin, CW; Weng, YZ; Chang, DTH				Chen, Chien-Yu; Chien, Ting-Ying; Lin, Chih-Kang; Lin, Chih-Wei; Weng, Yi-Zhong; Chang, Darby Tien-Hao			Predicting Target DNA Sequences of DNA-Binding Proteins Based on Unbound Structures	PLOS ONE			English	Article							ENERGY FUNCTION; SITES; DISCOVERY; MODEL; SPECIFICITY; PROFILES; FAMILIES	DNA-binding proteins such as transcription factors use DNA-binding domains (DBDs) to bind to specific sequences in the genome to initiate many important biological functions. Accurate prediction of such target sequences, often represented by position weight matrices (PWMs), is an important step to understand many biological processes. Recent studies have shown that knowledge-based potential functions can be applied on protein-DNA co-crystallized structures to generate PWMs that are considerably consistent with experimental data. However, this success has not been extended to DNA-binding proteins lacking co-crystallized structures. This study aims at investigating the possibility of predicting the DNA sequences bound by DNA-binding proteins from the proteins' unbound structures (structures of the unbound state). Given an unbound query protein and a template complex, the proposed method first employs structure alignment to generate synthetic protein-DNA complexes for the query protein. Once a complex is available, an atomic-level knowledge-based potential function is employed to predict PWMs characterizing the sequences to which the query protein can bind. The evaluation of the proposed method is based on seven DNA-binding proteins, which have structures of both DNA-bound and unbound forms for prediction as well as annotated PWMs for validation. Since this work is the first attempt to predict target sequences of DNA-binding proteins from their unbound structures, three types of structural variations that presumably influence the prediction accuracy were examined and discussed. Based on the analyses conducted in this study, the conformational change of proteins upon binding DNA was shown to be the key factor. This study sheds light on the challenge of predicting the target DNA sequences of a protein lacking co-crystallized structures, which encourages more efforts on the structure alignment-based approaches in addition to docking-and homology modeling-based approaches for generating synthetic complexes.	[Chen, Chien-Yu] Natl Taiwan Univ, Dept Bioind Mechatron Engn, Taipei 10764, Taiwan; [Chen, Chien-Yu; Lin, Chih-Kang] Natl Taiwan Univ, Ctr Syst Biol, Taipei 10764, Taiwan; [Chen, Chien-Yu] Natl Taiwan Univ, Ctr Biotechnol, Taipei 10764, Taiwan; [Chien, Ting-Ying; Lin, Chih-Kang; Lin, Chih-Wei; Weng, Yi-Zhong] Natl Taiwan Univ, Dept Comp Sci & Informat Engn, Taipei 10764, Taiwan; [Chang, Darby Tien-Hao] Natl Cheng Kung Univ, Dept Elect Engn, Tainan 70101, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Cheng Kung University	Chen, CY (corresponding author), Natl Taiwan Univ, Dept Bioind Mechatron Engn, Taipei 10764, Taiwan.	darby@ee.ncku.edu.tw		CHEN, CHIEN-YU/0000-0002-6940-6389	National Science Council of Republic of China, Taiwan [NSC 98-2627-B-002-011]	National Science Council of Republic of China, Taiwan(Ministry of Science and Technology, Taiwan)	The authors would like to thank National Science Council of Republic of China, Taiwan, for the financial support under the contracts: NSC 98-2627-B-002-011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Bulyk ML, 2004, GENOME BIOL, V5; Cheatham TE, 2001, BIOPOLYMERS, V56, P232; Dan A, 2010, PROTEINS, V78, P236, DOI 10.1002/prot.22531; Donald JE, 2007, NUCLEIC ACIDS RES, V35, P1039, DOI 10.1093/nar/gkl1103; Endres RG, 2004, PROTEINS, V57, P262, DOI 10.1002/prot.20199; Gao M, 2008, NUCLEIC ACIDS RES, V36, P3978, DOI 10.1093/nar/gkn332; Havranek JJ, 2004, J MOL BIOL, V344, P59, DOI 10.1016/j.jmb.2004.09.029; Hogg R.V., 2010, PROBABILITY STAT INF, V9th ed.; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kirchmair J, 2008, J MED CHEM, V51, P7021, DOI 10.1021/jm8005977; Liu ZJ, 2008, PROTEINS, V72, P1114, DOI 10.1002/prot.22002; Liu ZJ, 2005, NUCLEIC ACIDS RES, V33, P546, DOI 10.1093/nar/gki204; MacIsaac KD, 2006, BIOINFORMATICS, V22, P423, DOI 10.1093/bioinformatics/bti815; Mahony S, 2005, BIOINFORMATICS, V21, pI283, DOI 10.1093/bioinformatics/bti1025; Mahony S, 2005, BIOINFORMATICS, V21, P1807, DOI 10.1093/bioinformatics/bti256; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Morozov AV, 2007, P NATL ACAD SCI USA, V104, P7068, DOI 10.1073/pnas.0701356104; Morozov AV, 2005, NUCLEIC ACIDS RES, V33, P5781, DOI 10.1093/nar/gki875; Ponder JW, 2003, ADV PROTEIN CHEM, V66, P27; Sandelin A, 2004, J MOL BIOL, V338, P207, DOI 10.1016/j.jmb.2004.02.048; Siggia ED, 2005, CURR OPIN GENET DEV, V15, P214, DOI 10.1016/j.gde.2005.02.004; Stormo GD, 2000, BIOINFORMATICS, V16, P16, DOI 10.1093/bioinformatics/16.1.16; van Dijk M, 2006, NUCLEIC ACIDS RES, V34, P3317, DOI 10.1093/nar/gkl412; Xing EP, 2004, P NATL ACAD SCI USA, V101, P10523, DOI 10.1073/pnas.0403564101; Xu BS, 2009, PROTEINS, V76, P718, DOI 10.1002/prot.22384; Zhang C, 2005, J MED CHEM, V48, P2325, DOI 10.1021/jm049314d; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264	31	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2012	7	2							e30446	10.1371/journal.pone.0030446	http://dx.doi.org/10.1371/journal.pone.0030446			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UG	22312425	Green Published, gold, Green Submitted			2022-12-27	WOS:000301977500009
J	Costantino, CM; Spooner, E; Ploegh, HL; Hafler, DA				Costantino, Cristina Maria; Spooner, Eric; Ploegh, Hidde L.; Hafler, David A.			Class II MHC Self-Antigen Presentation in Human B and T Lymphocytes	PLOS ONE			English	Article							NATURALLY PROCESSED PEPTIDES; HLA-DR ALLELES; LYSOSOMAL CYSTEINE; INVARIANT CHAIN; FOREIGN ANTIGEN; CELLS; MOLECULES; RECOGNITION; BINDING; SPECIFICITY	Human CD4(+) T cells process and present functional class II MHC-peptide complexes, but the endogenous peptide repertoire of these non-classical antigen presenting cells remains unknown. We eluted and sequenced HLA-DR-bound self-peptides presented by CD4(+) T cells in order to compare the T cell-derived peptide repertoire to sequences derived from genetically identical B cells. We identified several novel epitopes derived from the T cell-specific proteome, including fragments of CD4 and IL-2. While these data confirm that T cells can present peptides derived from the T-cell specific proteome, the vast majority of peptides sequenced after elution from MHC were derived from the common proteome. From this pool, we identified several identical peptide epitopes in the T and B cell repertoire derived from common endogenous proteins as well as novel endogenous epitopes with promiscuous binding. These findings indicate that the endogenous HLA-DR-bound peptide repertoire, regardless of APC type and across MHC isotype, is largely derived from the same pool of self-protein.	[Costantino, Cristina Maria; Hafler, David A.] Harvard Univ, Sch Med, Program Immunol, Boston, MA 02114 USA; [Spooner, Eric; Ploegh, Hidde L.] MIT, Dept Biol, Whitehead Inst, Cambridge, MA USA; [Hafler, David A.] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA; [Hafler, David A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA	Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Whitehead Institute; Yale University; Yale University	Costantino, CM (corresponding author), Harvard Univ, Sch Med, Program Immunol, Boston, MA 02114 USA.	David.Hafler@yale.edu		Costantino, Cristina/0000-0002-3705-8519	National Institutes of Health [P01AI039671, P01AI045757]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI039671, P01AI045757] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grants P01AI039671 and P01AI045757. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKARI H, 1995, ARCH VIROL, V140, P375, DOI 10.1007/BF01309871; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Baecher-Allan C, 2006, J IMMUNOL, V176, P4622, DOI 10.4049/jimmunol.176.8.4622; BIDDISON WE, 2001, CURR PROTOC CELL BIO, pCH2; BODMER H, 1994, SCIENCE, V263, P1284, DOI 10.1126/science.7510069; CHICZ RM, 1993, J EXP MED, V178, P27, DOI 10.1084/jem.178.1.27; Cohen IR, 2004, J CLIN INVEST, V114, P1227, DOI 10.1172/JCI200422396; Costantino CM, 2008, J IMMUNOL, V180, P2876, DOI 10.4049/jimmunol.180.5.2876; Costantino CM, 2009, J IMMUNOL, V183, P945, DOI 10.4049/jimmunol.0900921; DAVENPORT MP, 1995, P NATL ACAD SCI USA, V92, P6567, DOI 10.1073/pnas.92.14.6567; DEMOTZ S, 1990, SCIENCE, V249, P1028, DOI 10.1126/science.2118680; DENZIN LK, 1995, CELL, V82, P155, DOI 10.1016/0092-8674(95)90061-6; Dongre AR, 2001, EUR J IMMUNOL, V31, P1485, DOI 10.1002/1521-4141(200105)31:5<1485::AID-IMMU1485>3.0.CO;2-A; ENGELHARD VH, 1994, ANNU REV IMMUNOL, V12, P181, DOI 10.1146/annurev.iy.12.040194.001145; Fissolo N, 2009, MOL CELL PROTEOMICS, V8, P2090, DOI 10.1074/mcp.M900001-MCP200; HARDING CV, 1990, NATURE, V346, P574, DOI 10.1038/346574a0; HEWITT CRA, 1989, J IMMUNOL, V143, P762; Honey K, 2003, NAT REV IMMUNOL, V3, P472, DOI 10.1038/nri1110; Kassiotis G, 2002, NAT IMMUNOL, V3, P244, DOI 10.1038/ni766; Kent SC, 2005, NATURE, V435, P224, DOI 10.1038/nature03625; KIRSCHMANN DA, 1995, J IMMUNOL, V155, P5655; Kropshofer H, 1996, EMBO J, V15, P6144, DOI 10.1002/j.1460-2075.1996.tb01002.x; LANZAVECCHIA A, 1988, NATURE, V334, P530, DOI 10.1038/334530a0; LASALLE JM, 1991, J IMMUNOL, V147, P774; LASALLE JM, 1992, J EXP MED, V176, P177, DOI 10.1084/jem.176.1.177; MARRACK P, 1993, J EXP MED, V178, P2173, DOI 10.1084/jem.178.6.2173; Micheletti F, 2000, J IMMUNOL, V165, P4264, DOI 10.4049/jimmunol.165.8.4264; Nielsen M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-238; Nielsen M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-296; Quintana FJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004026; Rohn TA, 2004, NAT IMMUNOL, V5, P909, DOI 10.1038/ni1108; RUDENSKY AY, 1991, NATURE, V353, P622, DOI 10.1038/353622a0; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; SHAW S, 1985, HUM IMMUNOL, V12, P191, DOI 10.1016/0198-8859(85)90336-2; Stefanova I, 2003, IMMUNOL REV, V191, P97, DOI 10.1034/j.1600-065X.2003.00006.x; Stefanova I, 2002, NATURE, V420, P429, DOI 10.1038/nature01146; VOGT AB, 1994, J IMMUNOL, V153, P1665; Vyas JM, 2008, NAT REV IMMUNOL, V8, P607, DOI 10.1038/nri2368; WUCHERPFENNIG KW, 1994, J IMMUNOL, V152, P5581; Wulfing C, 2002, NAT IMMUNOL, V3, P42, DOI 10.1038/ni741; Yi W, 2010, J CLIN INVEST, V120, P1324, DOI 10.1172/JCI40220; YU DTY, 1980, J EXP MED, V151, P91, DOI 10.1084/jem.151.1.91	42	22	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e29805	10.1371/journal.pone.0029805	http://dx.doi.org/10.1371/journal.pone.0029805			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22299025	Green Published, gold, Green Submitted			2022-12-27	WOS:000301704200002
J	Hughes, S; Fernandez, H; Cucchi, T; Duffraisse, M; Casabianca, F; Istria, D; Pompanon, F; Vigne, JD; Hanni, C; Taberlet, P				Hughes, Sandrine; Fernandez, Helena; Cucchi, Thomas; Duffraisse, Marilyne; Casabianca, Francois; Istria, Daniel; Pompanon, Francois; Vigne, Jean-Denis; Haenni, Catherine; Taberlet, Pierre			A Dig into the Past Mitochondrial Diversity of Corsican Goats Reveals the Influence of Secular Herding Practices	PLOS ONE			English	Article							DNA ANALYSIS; ANCIENT DNA; BROWN BEAR; PHYLOGENETIC-RELATIONSHIPS; PHYLOGEOGRAPHIC STRUCTURE; INITIAL DOMESTICATION; POPULATION-GENETICS; URSUS-SPELAEUS; CAPRA-HIRCUS; BREEDS	The goat (Capra hircus) is one of the earliest domesticated species ca. 10,500 years ago in the Middle-East where its wild ancestor, the bezoar (Capra aegagrus), still occurs. During the Neolithic dispersal, the domestic goat was then introduced in Europe, including the main Mediterranean islands. Islands are interesting models as they maintain traces of ancient colonization, historical exchanges or of peculiar systems of husbandry. Here, we compare the mitochondrial genetic diversity of both medieval and extant goats in the Island of Corsica that presents an original and ancient model of breeding with free-ranging animals. We amplified a fragment of the Control Region for 21 medieval and 28 current goats. Most of them belonged to the A haplogroup, the most worldwide spread and frequent today, but the C haplogroup is also detected at low frequency in the current population. Present Corsican goats appeared more similar to medieval goats than to other European goat populations. Moreover, 16 out of the 26 haplotypes observed were endemic to Corsica and the inferred demographic history suggests that the population has remained constant since the Middle Ages. Implications of these results on management and conservation of endangered Corsican goats currently decimated by a disease are addressed.	[Hughes, Sandrine; Duffraisse, Marilyne; Haenni, Catherine] Univ Lyon 1, Ecole Normale Super Lyon, Inst Genom Fonct Lyon, INRA,CNRS UMR 5242, F-69364 Lyon 07, France; [Fernandez, Helena; Pompanon, Francois; Taberlet, Pierre] Univ Grenoble 1, Lab Ecol Alpine, CNRS UMR 5553, F-38041 Grenoble 9, France; [Cucchi, Thomas; Vigne, Jean-Denis] Museum Natl Hist Nat, CNRS, Dept Ecol & Gest Biodiversite CP 56, Archeobot Soc Prat & Environm,UMR 7209, F-75005 Paris, France; [Cucchi, Thomas] Univ Aberdeen, Dept Archaeol, Aberdeen, Scotland; [Casabianca, Francois] INRA, UR Lab Rech Dev Elevage 045, F-20250 Quartier Grossetti, Corte, France; [Istria, Daniel] CNRS UMR 6572, Lab Archeol Medievale Mediterraneenne, F-13094 Aix En Provence, France	INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Universite de Savoie; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); University of Aberdeen; INRAE; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Hughes, S (corresponding author), Univ Lyon 1, Ecole Normale Super Lyon, Inst Genom Fonct Lyon, INRA,CNRS UMR 5242, 46 Allee Italie, F-69364 Lyon 07, France.	Sandrine.Hughes@ens-lyon.fr	Taberlet, Pierre/D-1178-2010; Pompanon, François/D-3459-2009; Cucchi, Thomas/Q-4014-2018	Taberlet, Pierre/0000-0002-3554-5954; Pompanon, François/0000-0003-4600-0172; Cucchi, Thomas/0000-0001-6021-5001	Centre National de la Recherche Scientifique; French "Agence Nationale de la Recherche" [ANR-05-GANI-004]	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); French "Agence Nationale de la Recherche"(French National Research Agency (ANR))	This work was supported by the Centre National de la Recherche Scientifique and by the CHRONOBOS project from the French "Agence Nationale de la Recherche" (ANR-05-GANI-004, coordinator SH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Azor PJ, 2005, ANIM GENET, V36, P423, DOI 10.1111/j.1365-2052.2005.01327.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Boessneck J., 1969, SCI ARCHAEOLOGY COMP, P331; Bouche R, 2009, OPTIONS MEDITERRAN A, V91, P209; Bouche R, 2004, AVENIR CEST DURER QU, P319; Bruford MW, 2003, NAT REV GENET, V4, P900, DOI 10.1038/nrg1203; Calvignac S, 2008, MOL ECOL, V17, P1962, DOI 10.1111/j.1365-294X.2008.03631.x; Calvignac S, 2009, DIVERS DISTRIB, V15, P742, DOI 10.1111/j.1472-4642.2009.00586.x; Canon J, 2006, ANIM GENET, V37, P327, DOI 10.1111/j.1365-2052.2006.01461.x; Charlet P, 1977, OPTIONS MEDITERRANEE, V35, P45; Chen SY, 2005, MOL PHYLOGENET EVOL, V37, P804, DOI 10.1016/j.ympev.2005.06.014; Clutton-Brock J., 1990, Bulletin of the British Museum (Natural History) Zoology, V56, P1; Collins M, 2010, SPECTROSCOPY EUROPE, V22, P11; Cucchi T., 2003, B DARCH OL DHISTOIRE, V1, P70; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fan B, 2007, SMALL RUMINANT RES, V73, P262, DOI 10.1016/j.smallrumres.2006.12.007; FAOSTAT, 2009, PREL DAT PROD LIV AN; Fernandez H, 2006, P NATL ACAD SCI USA, V103, P15375, DOI 10.1073/pnas.0602753103; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Guilaine J., 2003, VAGUE TOMBE CONQUETE; Helmer D, 2000, ANTHROPOZOOLOGICA, V31; Helmer D, ATLAS SQUELETTE APPE; Hofreiter M, 2001, NUCLEIC ACIDS RES, V29, P4793, DOI 10.1093/nar/29.23.4793; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hughes S, 2006, MOL PHYLOGENET EVOL, V40, P285, DOI 10.1016/j.ympev.2006.02.004; Hugot S, 1999, OPTIONS MEDITERRANEE, V38, P137; Istria D, 2005, POUVOIRS FORTIFICATI; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Loreille O, 1997, J ARCHAEOL SCI, V24, P33, DOI 10.1006/jasc.1995.0094; Loreille O, 2001, CURR BIOL, V11, P200, DOI 10.1016/S0960-9822(01)00046-X; Luikart G, 2001, P NATL ACAD SCI USA, V98, P5927, DOI 10.1073/pnas.091591198; Naderi S, 2008, P NATL ACAD SCI USA, V105, P17659, DOI 10.1073/pnas.0804782105; Naderi S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001012; Orlando L, 2002, MOL BIOL EVOL, V19, P1920, DOI 10.1093/oxfordjournals.molbev.a004016; Orlando L, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-121; Pariset Lorraine, 2009, BMC Ecology, V9, P20, DOI 10.1186/1472-6785-9-20; PAYNE S, 1985, J ARCHAEOL SCI, V12, P139, DOI 10.1016/0305-4403(85)90058-5; Pereira F, 2005, MOL ECOL, V14, P2313, DOI 10.1111/j.1365-294X.2005.02594.x; Pereira F, 2009, MOL BIOL EVOL, V26, P2765, DOI 10.1093/molbev/msp200; Pernet F, 1977, BERGER CORSE ESSAI Q; Peters J, 2005, 1 STEPS ANIMAL DOMES; POPLIN F, 1979, ANN GENET SEL ANIM, V11, P133, DOI 10.1186/1297-9686-11-2-133; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Ravis-Giordani G, 1983, BERGERS CORSES; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ruas M-P, 1995, PERSPECTIVES ARCHEOB, P113; Sardina MT, 2006, ANIM GENET, V37, P376, DOI 10.1111/j.1365-2052.2006.01451.x; Taberlet P, 2008, MOL ECOL, V17, P275, DOI 10.1111/j.1365-294X.2007.03475.x; Tresset A, 2009, BECOMING ELOQUENT: ADVANCES IN THE EMERGENCE OF LANGUAGE, HUMAN COGNITION, AND MODERN CULTURES, P69; Vacca GM, 2010, J ANIM BREED GENET, V127, P352, DOI 10.1111/j.1439-0388.2010.00863.x; Vigne JD, MAMMIFERES POSTGLACI; Vigne JD, 2011, CR BIOL, V334, P171, DOI 10.1016/j.crvi.2010.12.009; Vigne Jean-Denis, 1999, P295; Villesen P, 2007, MOL ECOL NOTES, V7, P965, DOI 10.1111/j.1471-8286.2007.01821.x; Wang J, 2008, SMALL RUMINANT RES, V74, P231, DOI 10.1016/j.smallrumres.2007.03.007; Zeder MA, 2000, SCIENCE, V287, P2254, DOI 10.1126/science.287.5461.2254	57	9	9	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e30272	10.1371/journal.pone.0030272	http://dx.doi.org/10.1371/journal.pone.0030272			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22299033	Green Published, gold, Green Submitted			2022-12-27	WOS:000301704200010
J	Hernesniemi, JA; Seppala, I; Lyytikainen, LP; Mononen, N; Oksala, N; Hutri-Kahonen, N; Juonala, M; Taittonen, L; Smith, EN; Schork, NJ; Chen, W; Srinivasan, SR; Berenson, GS; Murray, SS; Laitinen, T; Jula, A; Kettunen, J; Ripatti, S; Laaksonen, R; Viikari, J; Kahonen, M; Raitakari, OT; Lehtimaki, T				Hernesniemi, Jussi A.; Seppala, Ilkka; Lyytikainen, Leo-Pekka; Mononen, Nina; Oksala, Niku; Hutri-Kahonen, Nina; Juonala, Markus; Taittonen, Leena; Smith, Erin N.; Schork, Nicholas J.; Chen, Wei; Srinivasan, Sathanur R.; Berenson, Gerald S.; Murray, Sarah S.; Laitinen, Tomi; Jula, Antti; Kettunen, Johannes; Ripatti, Samuli; Laaksonen, Reijo; Viikari, Jorma; Kahonen, Mika; Raitakari, Olli T.; Lehtimaki, Terho			Genetic Profiling Using Genome-Wide Significant Coronary Artery Disease Risk Variants Does Not Improve the Prediction of Subclinical Atherosclerosis: The Cardiovascular Risk in Young Finns Study, the Bogalusa Heart Study and the Health 2000 Survey - A Meta-Analysis of Three Independent Studies	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; CAROTID ATHEROSCLEROSIS; MYOCARDIAL-INFARCTION; ASSOCIATION ANALYSIS; CHROMOSOME 9P21; SUSCEPTIBILITY; PROGRESSION; LOCUS; CHILDHOOD; PHENOTYPE	Background: Genome-wide association studies (GWASs) have identified a large number of variants (SNPs) associating with an increased risk of coronary artery disease (CAD). Recently, the CARDIoGRAM consortium published a GWAS based on the largest study population so far. They successfully replicated twelve already known associations and discovered thirteen new SNPs associating with CAD. We examined whether the genetic profiling of these variants improves prediction of subclinical atherosclerosis - i.e., carotid intima-media thickness (CIMT) and carotid artery elasticity (CAE) - beyond classical risk factors. Subjects and Methods: We genotyped 24 variants found in a population of European ancestry and measured CIMT and CAE in 2001 and 2007 from 2,081, and 2,015 subjects (aged 30-45 years in 2007) respectively, participating in the Cardiovascular Risk in Young Finns Study (YFS). The Bogalusa Heart Study (BHS; n = 1179) was used as a replication cohort (mean age of 37.5). For additional replication, a sub-sample of 5 SNPs was genotyped for 1,291 individuals aged 46-76 years participating in the Health 2000 population survey. We tested the impact of genetic risk score (GRS(24SNP/CAD)) calculated as a weighted (by allelic odds ratios for CAD) sum of CAD risk alleles from the studied 24 variants on CIMT, CAE, the incidence of carotid atherosclerosis and the progression of CIMT and CAE during a 6-year follow-up. Results: CIMT or CAE did not significantly associate with GRS(24SNP/CAD) before or after adjusting for classical CAD risk factors (p>0.05 for all) in YFS or in the BHS. CIMT and CAE associated with only one SNP each in the YFS. The findings were not replicated in the replication cohorts. In the meta-analysis CIMT or CAE did not associate with any of the SNPs. Conclusion: Genetic profiling, by using known CAD risk variants, should not improve risk stratification for subclinical atherosclerosis beyond conventional risk factors among healthy young adults.	[Hernesniemi, Jussi A.; Seppala, Ilkka; Lyytikainen, Leo-Pekka; Mononen, Nina; Oksala, Niku; Laaksonen, Reijo; Lehtimaki, Terho] Univ Tampere, Sch Med, Dept Clin Chem, FIN-33101 Tampere, Finland; [Hernesniemi, Jussi A.; Seppala, Ilkka; Lyytikainen, Leo-Pekka; Mononen, Nina; Oksala, Niku; Hutri-Kahonen, Nina; Laaksonen, Reijo; Kahonen, Mika; Lehtimaki, Terho] Tampere Univ Hosp, Tampere, Finland; [Kahonen, Mika] Univ Tampere, Sch Med, Dept Clin Physiol, FIN-33101 Tampere, Finland; [Hutri-Kahonen, Nina] Univ Tampere, Dept Pediat, Sch Med, FIN-33101 Tampere, Finland; [Oksala, Niku] Univ Tampere, Dept Surg, Sch Med, FIN-33101 Tampere, Finland; [Kettunen, Johannes; Ripatti, Samuli] Inst Mol Med Finland, FIMM, Helsinki, Finland; [Juonala, Markus; Viikari, Jorma] Univ Turku, Dept Med, Turku, Finland; [Juonala, Markus; Viikari, Jorma; Raitakari, Olli T.] Turku Univ Hosp, FIN-20520 Turku, Finland; [Raitakari, Olli T.] Univ Turku, Dept Clin Physiol, Turku, Finland; [Juonala, Markus; Raitakari, Olli T.] Univ Turku, Res Ctr Appl & Prevent Cardiovasc Med, Turku, Finland; [Taittonen, Leena] Univ Oulu, Dept Pediat, SF-90100 Oulu, Finland; [Taittonen, Leena] Oulu Univ Hosp, Oulu, Finland; [Taittonen, Leena] Vaasa Cent Hosp, Dept Pediat, Vaasa, Finland; [Laitinen, Tomi] Univ Eastern Finland, Dept Clin Physiol & Nucl Med, Kuopio Univ Hosp, Kuopio, Finland; [Jula, Antti] Natl Publ Hlth Inst, Dept Hlth & Funct Capac, Turku, Finland; [Smith, Erin N.; Schork, Nicholas J.; Murray, Sarah S.] Scripps Translat Sci Inst, La Jolla, CA USA; [Smith, Erin N.; Schork, Nicholas J.; Murray, Sarah S.] Scripps Hlth, La Jolla, CA USA; [Schork, Nicholas J.; Murray, Sarah S.] Scripps Res Inst, La Jolla, CA 92037 USA; [Chen, Wei; Srinivasan, Sathanur R.; Berenson, Gerald S.] Tulane Univ, Dept Epidemiol, New Orleans, LA 70118 USA	Tampere University; Tampere University; Tampere University Hospital; Tampere University; Tampere University; Tampere University; University of Turku; University of Turku; University of Turku; University of Turku; University of Oulu; University of Oulu; Vaasa Central Hospital; Kuopio University Hospital; University of Eastern Finland; Finland National Institute for Health & Welfare; Scripps Research Institute; Scripps Research Institute; Tulane University	Hernesniemi, JA (corresponding author), Univ Tampere, Sch Med, Dept Clin Chem, FIN-33101 Tampere, Finland.	jussi.hernesniemi@uta.fi	Raitakari, Olli/AAQ-7389-2021; Hernesniemi, Jussi/ABH-1842-2021; Lyytikäinen, Leo-Pekka/C-8544-2016; Ripatti, Samuli/H-9446-2014; Laaksonen, Reijo/D-6323-2014; Smith, Erin/E-5933-2011; Lehtimäki, Terho/AAD-1094-2022	Hernesniemi, Jussi/0000-0002-8111-6421; Lyytikäinen, Leo-Pekka/0000-0002-7200-5455; Ripatti, Samuli/0000-0002-0504-1202; Lehtimäki, Terho/0000-0002-2555-4427; Kahonen, Mika/0000-0002-4510-7341; Schork, Nicholas/0000-0003-0920-5013; Juonala, Markus/0000-0001-9498-364X	European Union [201668]; Academy of Finland [117797, 126925, 121584, 117941]; Social Insurance Institution of Finland; Turku University Foundation; Finnish Cultural Foundation; Yrjo Jahnsson Foundation; Emil Aaltonen Foundation; Tampere University Hospital; Turku University Hospital; Juho Vainio Foundation; Finnish Foundation for Cardiovascular Research; Tampere Tuberculosis Foundation; National Institutes of Health/National Center for Research Resources [UL1 RR025774]; National Institute of Child Health and Human Development [HD-061437, HD-062783]; National Institute on Aging [AG-16592]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD061437, R03HD062783] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016592] Funding Source: NIH RePORTER	European Union(European Commission); Academy of Finland(Academy of Finland); Social Insurance Institution of Finland; Turku University Foundation; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Yrjo Jahnsson Foundation; Emil Aaltonen Foundation; Tampere University Hospital; Turku University Hospital; Juho Vainio Foundation; Finnish Foundation for Cardiovascular Research; Tampere Tuberculosis Foundation; National Institutes of Health/National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The study has been funded by a European Union 7th Framework Programme grant number 201668 for the AtheroRemo Project. The Young Finns Study has been financially supported by the Academy of Finland (grants no. 117797, 126925, 121584, 117941), the Social Insurance Institution of Finland, the Turku University Foundation, the Finnish Cultural Foundation, the Yrjo Jahnsson Foundation, the Emil Aaltonen Foundation (to T. Lehtimaki), Medical Research Fund of Tampere University Hospital, Turku University Hospital Medical Fund, the Juho Vainio Foundation, and the Finnish Foundation for Cardiovascular Research and Tampere Tuberculosis Foundation. ENS, SSM, and NJS are supported in part by National Institutes of Health/National Center for Research Resources grant number UL1 RR025774. The Bogalusa Heart Study study was supported by grants HD-061437 and HD-062783 from the National Institute of Child Health and Human Development and AG-16592 from the National Institute on Aging. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bis JC, 2011, NAT GENET, V43, P940, DOI 10.1038/ng.920; Bjorck HM, 2009, J INTERN MED, V265, P373, DOI 10.1111/j.1365-2796.2008.02020.x; Brindle P, 2006, HEART, V92, P1752, DOI 10.1136/hrt.2006.087932; BURKE GL, 1995, STROKE, V26, P386, DOI 10.1161/01.STR.26.3.386; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Conde L, 2011, ATHEROSCLEROSIS; Cunnington MS, 2009, ATHEROSCLEROSIS, V203, P41, DOI 10.1016/j.atherosclerosis.2008.06.025; Erdmann J, 2009, NAT GENET, V41, P280, DOI 10.1038/ng.307; Evans DM, 2009, HUM MOL GENET, V18, P3525, DOI 10.1093/hmg/ddp295; Gerszten RE, 2008, NATURE, V451, P949, DOI 10.1038/nature06802; Greenland P, 2000, CIRCULATION, V101, P723; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Jostins L, 2011, HUM MOL GENET, V20, pR182, DOI 10.1093/hmg/ddr378; Juonala M, 2010, EUR HEART J, V31, P1745, DOI 10.1093/eurheartj/ehq141; Kang J, 2011, HUM MOL GENET, V20, P2435, DOI 10.1093/hmg/ddr116; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Kiechl S, 2010, ARTERIOSCL THROM VAS, V30, P2678, DOI 10.1161/ATVBAHA.110.213785; Lanktree MB, 2010, CIRC-CARDIOVASC GENE, V3, P215, DOI 10.1161/CIRCGENETICS.109.934505; Larson MG, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S5; Li SX, 2003, JAMA-J AM MED ASSOC, V290, P2271, DOI 10.1001/jama.290.17.2271; Lorenz MW, 2007, CIRCULATION, V115, P459, DOI 10.1161/CIRCULATIONAHA.106.628875; Lorenz MW, 2006, STROKE, V37, P87, DOI 10.1161/01.STR.0000196964.24024.ea; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Morrison AC, 2007, AM J EPIDEMIOL, V166, P28, DOI 10.1093/aje/kwm060; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; Okser S, 2010, PLOS GENET, V30, P6; Raitakari OT, 2003, JAMA-J AM MED ASSOC, V290, P2277, DOI 10.1001/jama.290.17.2277; Ripatti S, 2010, LANCET, V376, P1393, DOI 10.1016/S0140-6736(10)61267-6; Samani NJ, 2008, ARTERIOSCL THROM VAS, V28, P1679, DOI 10.1161/ATVBAHA.108.170332; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Schork NJ, 2000, AM J HUM GENET, V67, P1208, DOI 10.1086/321201; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Simon A, 2010, ARTERIOSCL THROM VAS, V30, P182, DOI 10.1161/ATVBAHA.109.196980; Smith EN, 2010, PLOS GENET, V6; Teo YY, 2007, BIOINFORMATICS, V23, P2741, DOI 10.1093/bioinformatics/btm443; Tregouet DA, 2009, NAT GENET, V41, P283, DOI 10.1038/ng.314; Wang TJ, 2006, NEW ENGL J MED, V355, P2631, DOI 10.1056/NEJMoa055373; Ye S, 2008, J AM COLL CARDIOL, V52, P378, DOI 10.1016/j.jacc.2007.11.087; Zhang G, 2006, PHARMACOGENET GENOM, V16, P401, DOI 10.1097/01.fpc.0000204995.99429.0f	39	21	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e28931	10.1371/journal.pone.0028931	http://dx.doi.org/10.1371/journal.pone.0028931			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295058	gold, Green Published			2022-12-27	WOS:000301640600003
J	Zheng, YH; Fan, F; Liu, XC; Mo, L				Zheng, Yuhong; Fan, Fang; Liu, Xianchen; Mo, Lei			Life Events, Coping, and Posttraumatic Stress Symptoms among Chinese Adolescents Exposed to 2008 Wenchuan Earthquake, China	PLOS ONE			English	Article							CHILDREN; DISORDER; DISASTER; MODERATOR; SURVIVORS; ANXIETY; TAIWAN; PSYCHOPATHOLOGY; POSTDISASTER; PREDICTORS	Purpose: To examine the relationship between negative life events, coping styles, and symptoms of post-traumatic stress disorder (PTSD) among adolescent survivors exposed to 2008 Wenchuan Earthquake, China. Methods: A survey was conducted in a sample of 2250 adolescent students from two schools in Dujiangyan District, a seriously damaged area, 20 kilometers away from the epicenter, 6 months after the earthquake. Participants completed a self-administered questionnaire including demographics, negative life events, coping styles, and PTSD symptoms. Results: Academic pressure was the strongest predictor of adolescents' PTSD symptoms among all negative life events. Main effects of negative life events, positive coping and negative coping on PTSD symptoms were significant in both younger adolescents and older adolescents, while the moderator effects of two coping styles were found significant only within older adolescents. Conclusions: Coping may play a role to moderate the relationship between post-earthquake negative life events and PTSD symptom, but the function seems to depend on the age of participants. Psychosocial coping skills training may be important in the prevention and intervention of mental health problems in adolescent survivors of traumatic earthquake.	[Zheng, Yuhong; Fan, Fang; Liu, Xianchen; Mo, Lei] S China Normal Univ, Ctr Studies Psychol Applicat, Guangzhou, Guangdong, Peoples R China; [Liu, Xianchen] Indiana Univ, Dept Psychiat, Indianapolis, IN 46204 USA	South China Normal University; Indiana University System; Indiana University-Purdue University Indianapolis	Zheng, YH (corresponding author), S China Normal Univ, Ctr Studies Psychol Applicat, Guangzhou, Guangdong, Peoples R China.	fangfan@scnu.edu.cn	Fan, Fang/GRO-2696-2022; fan, fang/GQY-9173-2022		National Natural Science Foundation of China [31070920]; Chinese Ministry of Education [09YJAXLX008]; Key Laboratory of Mental Health and Cognitive Science of Guangdong Province; South China Normal University; Research Center for Crisis Intervention and Psychological Service of Guangdong Province, South China Normal University; Women's Federation of Chengdu, Sichuan Province; Research Program for Humanities and Social Science	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Education(Ministry of Education, China); Key Laboratory of Mental Health and Cognitive Science of Guangdong Province; South China Normal University; Research Center for Crisis Intervention and Psychological Service of Guangdong Province, South China Normal University; Women's Federation of Chengdu, Sichuan Province; Research Program for Humanities and Social Science	The present study was funded by National Natural Science Foundation of China (No. 31070920, http://www.nsfc.gov.cn/) and Research Program for Humanities and Social Science Granted by Chinese Ministry of Education (09YJAXLX008, http://www.sinoss.net/). This study was also supported by Key Laboratory of Mental Health and Cognitive Science of Guangdong Province, South China Normal University, and Research Center for Crisis Intervention and Psychological Service of Guangdong Province, South China Normal University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Boris Birmaher (University of Pittsburgh), who kindly assisted with the proofreading of the first draft. We also thank Dr. Elizabeth Ruiz (Governors State University) for her assistance in manuscript revision. We thank Fulei Geng and Lan Zhang in the work of data collection. We also want to express our sincere gratitude to the Women's Federation of Chengdu, Sichuan Province, for their support.	American Psychiatric Association, 1994, DIAGN STAT MAN; Asarnow J, 1999, J AM ACAD CHILD PSY, V38, P1016, DOI 10.1097/00004583-199908000-00018; Bal A, 2007, EUR CHILD ADOLES PSY, V16, P449, DOI 10.1007/s00787-007-0618-z; CARR VJ, 1995, PSYCHOL MED, V25, P539, DOI 10.1017/S0033291700033468; Chen SH, 2002, J CHIN INST ENG, V25, P597, DOI 10.1080/02533839.2002.9670734; Chengzhi Z, 2001, CHINESE MENTAL HLTH, V15, P145; Chinese Society of Psychiatry, 1995, CHIN CLASS MENT DISO; Cohen J., 2003, APPL MULTIPLE REGRES; Compas BE, 2001, PSYCHOL BULL, V127, P87, DOI 10.1037//0033-2909.127.1.87; Connor-Smith JK, 2002, COGNITIVE THER RES, V26, P39, DOI 10.1023/A:1013889504101; Edlynn ES, 2008, AM J ORTHOPSYCHIAT, V78, P249, DOI 10.1037/a0013948; Fan F, 2011, J TRAUMA STRESS, V24, P44, DOI 10.1002/jts.20599; Frazier PA, 2004, J COUNS PSYCHOL, V51, P115, DOI 10.1037/0022-0167.51.1.115; Giannopoulou I, 2006, EUR PSYCHIAT, V21, P160, DOI 10.1016/j.eurpsy.2005.09.005; Hsu CC, 2002, J AM ACAD CHILD PSY, V41, DOI 10.1097/00004583-200207000-00022; John Prashantham Baddam, 2007, Disaster Manag Response, V5, P3; Kishore Vimal, 2008, Am J Disaster Med, V3, P345; Lai TJ, 2004, J PSYCHIATR RES, V38, P313, DOI 10.1016/j.jpsychires.2003.08.005; Liu X., 1998, CHINESE J BEHAV MED, V7, P93, DOI DOI 10.1177/1524838015585313; Liu X.C., 1997, CHIN J CLIN PSYCHOL, V5, P39, DOI DOI 10.16128/J.CNKI.1005-3611.1997.01.011; Liu XC, 2005, J AFFECT DISORDERS, V86, P195, DOI 10.1016/j.jad.2005.01.016; Liu XC, 2004, PSYCHIAT RES, V126, P275, DOI 10.1016/j.psychres.2004.02.006; Liu XC, 1997, SOC PSYCH PSYCH EPID, V32, P63, DOI 10.1007/BF00788922; Liu XC, 2000, SLEEP, V23, P1053; Luthar SS, 2000, CHILD DEV, V71, P543, DOI 10.1111/1467-8624.00164; Maes M, 2001, PSYCHIAT RES, V105, P1, DOI 10.1016/S0165-1781(01)00325-0; MCFARLANE AC, 1987, J AM ACAD CHILD PSY, V26, P764, DOI 10.1097/00004583-198709000-00025; Neria Y, 2008, PSYCHIATRY, V71, P339, DOI 10.1521/psyc.2008.71.4.339; Norris FH, 2006, J TRAUMA STRESS, V19, P173, DOI 10.1002/jts.20109; Pina AA, 2008, J CLIN CHILD ADOLESC, V37, P564, DOI 10.1080/15374410802148228; Pineles SL, 2011, J ABNORM PSYCHOL, V120, P240, DOI 10.1037/a0022123; PYNOOS RS, 1993, BRIT J PSYCHIAT, V163, P239, DOI 10.1192/bjp.163.2.239; Roussos A, 2005, AM J PSYCHIAT, V162, P530, DOI 10.1176/appi.ajp.162.3.530; Schnider KR, 2007, J COUNS PSYCHOL, V54, P344, DOI 10.1037/0022-0167.54.3.344; Seiffge-Krenke I, 2005, J RES ADOLESCENCE, V15, P561, DOI 10.1111/j.1532-7795.2005.00111.x; Seiffge-Krenke I, 2004, EUR J DEV PSYCHOL, V1, P367, DOI 10.1080/17405629.2004.11453396; Stallard P, 2001, BRIT J CLIN PSYCHOL, V40, P197, DOI 10.1348/014466501163643; Thienkrua W, 2006, JAMA-J AM MED ASSOC, V296, P549, DOI 10.1001/jama.296.5.549; Udwin O, 2000, J CHILD PSYCHOL PSYC, V41, P969, DOI 10.1111/1469-7610.00685; Vernberg EM, 1996, J ABNORM PSYCHOL, V105, P237, DOI 10.1037/0021-843X.105.2.237; Weiten W., 2004, PSYCHOL THEMES VARIA, V6th; Wright M, 2010, J ABNORM CHILD PSYCH, V38, P405, DOI 10.1007/s10802-009-9375-4; Xie Y., 1998, CHINESE J CLIN PSYCH, V6, P114, DOI DOI 10.16128/J.CNKI.1005-3611.1998.02.018; [赵玉芳 ZHAO Yu-Fang], 2009, [心理科学进展, Advances in Psychological Science], V17, P511	44	30	34	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e29404	10.1371/journal.pone.0029404	http://dx.doi.org/10.1371/journal.pone.0029404			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	910ME	22295059	Green Published, gold			2022-12-27	WOS:000301640600004
J	Kim, YI; Hirai, S; Goto, T; Ohyane, C; Takahashi, H; Tsugane, T; Konishi, C; Fujii, T; Inai, S; Iijima, Y; Aoki, K; Shibata, D; Takahashi, N; Kawada, T				Kim, Young-il; Hirai, Shizuka; Goto, Tsuyoshi; Ohyane, Chie; Takahashi, Haruya; Tsugane, Taneaki; Konishi, Chiaki; Fujii, Takashi; Inai, Shuji; Iijima, Yoko; Aoki, Koh; Shibata, Daisuke; Takahashi, Nobuyuki; Kawada, Teruo			Potent PPAR alpha Activator Derived from Tomato Juice, 13-oxo-9,11-Octadecadienoic Acid, Decreases Plasma and Hepatic Triglyceride in Obese Diabetic Mice	PLOS ONE			English	Article							ADIPOSE-TISSUE; INSULIN-RESISTANCE; METABOLIC SYNDROME; 3T3-L1 ADIPOCYTES; LIPID-METABOLISM; PROLIFERATOR; INFLAMMATION; RECEPTORS; EXPRESSION; MOUSE	Dyslipidemia is a major risk factor for development of several obesity-related diseases. The peroxisome proliferator-activated receptor alpha (PPAR alpha) is a ligand-activated transcription factor that regulates energy metabolism. Previously, we reported that 9-oxo-10,12-octadecadienoic acid (9-oxo-ODA) is presented in fresh tomato fruits and acts as a PPAR alpha agonist. In addition to 9-oxo-ODA, we developed that 13-oxo-9,11-octadecadienoic acid (13-oxo-ODA), which is an isomer of 9-oxo-ODA, is present only in tomato juice. In this study, we explored the possibility that 13-oxo-ODA acts as a PPAR alpha agonist in vitro and whether its effect ameliorates dyslipidemia and hepatic steatosis in vivo. In vitro luciferase assay experiments revealed that 13-oxo-ODA significantly induced PPAR alpha activation; moreover, the luciferase activity of 13-oxo-ODA was stronger than that of 9-oxo-ODA and conjugated linoleic acid (CLA), which is a precursor of 13-oxo-ODA and is well-known as a potent PPAR alpha activator. In addition to in vitro experiment, treatment with 13-oxo-ODA decreased the levels of plasma and hepatic triglycerides in obese KK-Ay mice fed a high-fat diet. In conclusion, our findings indicate that 13-oxo-ODA act as a potent PPAR alpha agonist, suggesting a possibility to improve obesity-induced dyslipidemia and hepatic steatosis.	[Kim, Young-il; Hirai, Shizuka; Goto, Tsuyoshi; Ohyane, Chie; Takahashi, Haruya; Takahashi, Nobuyuki; Kawada, Teruo] Kyoto Univ, Grad Sch Agr, Lab Mol Funct Food, Div Food Sci & Biotechnol, Kyoto, Japan; [Tsugane, Taneaki] Chiba Prefectural Agr & Forestry Res Ctr, Chiba, Japan; [Konishi, Chiaki; Fujii, Takashi; Inai, Shuji] Nippon Del Monte Corp, Gunma, Japan; [Iijima, Yoko; Aoki, Koh; Shibata, Daisuke] Kazusa DNA Res Inst, Chiba, Japan	Kyoto University; Kazusa DNA Research Institute	Kim, YI (corresponding author), Kyoto Univ, Grad Sch Agr, Lab Mol Funct Food, Div Food Sci & Biotechnol, Kyoto, Japan.	fat@kais.kyoto-u.ac.jp	Takahashi, Nobuyuki/AAX-8671-2021; Goto, Tsuyoshi/AAY-2344-2020	Takahashi, Nobuyuki/0000-0002-9705-662X; Goto, Tsuyoshi/0000-0003-1283-147X; Takahashi, Nobuyuki/0000-0003-0126-6292	Research and Development Projects for Application in Promoting New Policies Agriculture, Forestry, and Fisheries, Japan; Research and Development Program for New Bio-industry Initiatives, Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan [22228001, 22380075]	Research and Development Projects for Application in Promoting New Policies Agriculture, Forestry, and Fisheries, Japan; Research and Development Program for New Bio-industry Initiatives, Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Research and Development Projects for Application in Promoting New Policies Agriculture, Forestry, and Fisheries, Japan, by the Research and Development Program for New Bio-industry Initiatives, Japan, and by Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (22228001 and 22380075). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizawa K, 2009, J AGR FOOD CHEM, V57, P10964, DOI 10.1021/jf902401u; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Chinetti G, 2000, INFLAMM RES, V49, P497, DOI 10.1007/s000110050622; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Devchand PR, 1996, NATURE, V384, P39, DOI 10.1038/384039a0; Duval C, 2002, TRENDS MOL MED, V8, P422, DOI 10.1016/S1471-4914(02)02385-7; Escher P, 2000, MUTAT RES-FUND MOL M, V448, P121, DOI 10.1016/S0027-5107(99)00231-6; Ginsberg HN, 2000, J CLIN INVEST, V106, P453, DOI 10.1172/JCI10762; Goldenberg I, 2008, VASC HEALTH RISK MAN, V4, P131, DOI 10.2147/vhrm.2008.04.01.131; Goto T, 2005, BIOCHEM BIOPH RES CO, V337, P440, DOI 10.1016/j.bbrc.2005.09.077; Gudbrandsen OA, 2009, BRIT J NUTR, V102, P803, DOI 10.1017/S0007114509297200; Hiuge A, 2007, ARTERIOSCL THROM VAS, V27, P635, DOI 10.1161/01.ATV.0000256469.06782.d5; Hostetler HA, 2005, J BIOL CHEM, V280, P18667, DOI 10.1074/jbc.M412062200; Ibrahim HS, 2008, J MED FOOD, V11, P551, DOI 10.1089/jmf.2007.0517; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Khan SA, 2003, J NUTR BIOCHEM, V14, P554, DOI 10.1016/S0955-2863(03)00098-6; Kim S, 2004, MOL CELL ENDOCRINOL, V220, P51, DOI 10.1016/j.mce.2004.03.011; Kim YI, 2011, MOL NUTR FOOD RES, V55, P585, DOI 10.1002/mnfr.201000264; Lefebvre P, 2006, J CLIN INVEST, V116, P571, DOI 10.1172/JCI27989; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Mandard S, 2004, CELL MOL LIFE SCI, V61, P393, DOI 10.1007/s00018-003-3216-3; Miranda PJ, 2005, AM HEART J, V149, P33, DOI 10.1016/j.ahj.2004.07.013; Moya-Camarena SY, 1999, J LIPID RES, V40, P1426; Park MK, 2007, J KOREAN MED SCI, V22, P235, DOI 10.3346/jkms.2007.22.2.235; Priore P, 2007, BBA-MOL CELL BIOL L, V1771, P1299, DOI 10.1016/j.bbalip.2007.08.005; Rakhshandehroo M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006796; Reilly MP, 2003, CIRCULATION, V108, P1546, DOI 10.1161/01.CIR.0000088846.10655.E0; Roepstorff C, 2005, AM J PHYSIOL-ENDOC M, V288, pE133, DOI 10.1152/ajpendo.00379.2004; Schoonjans K, 1996, J LIPID RES, V37, P907; Shen YC, 2007, J AGR FOOD CHEM, V55, P6475, DOI 10.1021/jf070799z; Suto J, 1998, EUR J ENDOCRINOL, V139, P654, DOI 10.1530/eje.0.1390654; Takahashi H, 2011, BIOSCI BIOT IN PRESS; Takahashi N, 2003, FEBS LETT, V550, P190, DOI 10.1016/S0014-5793(03)00859-7; Takahashi N, 2002, FEBS LETT, V514, P315, DOI 10.1016/S0014-5793(02)02390-6; Tsuchida A, 2005, DIABETES, V54, P3358, DOI 10.2337/diabetes.54.12.3358; TUGWOOD JD, 1992, EMBO J, V11, P433, DOI 10.1002/j.1460-2075.1992.tb05072.x; Uemura T, 2010, MOL NUTR FOOD RES, V54, P1596, DOI 10.1002/mnfr.200900609; Vellosillo T, 2007, PLANT CELL, V19, P831, DOI 10.1105/tpc.106.046052; Xu HE, 2002, NATURE, V415, P813, DOI 10.1038/415813a	41	51	55	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2012	7	2							e31317	10.1371/journal.pone.0031317	http://dx.doi.org/10.1371/journal.pone.0031317			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZQ	22347463	Green Published, gold, Green Submitted			2022-12-27	WOS:000302730200020
J	Pereira, SMP; Ki, M; Power, C				Pereira, Snehal M. Pinto; Ki, Myung; Power, Chris			Sedentary Behaviour and Biomarkers for Cardiovascular Disease and Diabetes in Mid-Life: The Role of Television-Viewing and Sitting at Work	PLOS ONE			English	Article							BRITISH BIRTH COHORT; TIME PHYSICAL-ACTIVITY; METABOLIC SYNDROME; EPIC-NORFOLK; RISK-FACTORS; MEAL INTAKE; ALL-CAUSE; OBESITY; ADULTS; POPULATION	Background: Knowledge of sedentary behaviour associations with health has relied mainly on television-viewing as a proxy and studies with other measures are less common. To clarify whether sedentary behaviour is associated with disease-risk, we examined associations for television-viewing and sitting at work. Methods: Using the 1958 British birth cohort (n = 7660), we analysed cross-sectional associations between television-viewing and work sitting (four categories, 0-1 to >= 3 h/d) with total, high-density lipoprotein (HDL) and low-density lipoprotein (LDL)-cholesterol, triglycerides, blood pressure, glycated haemoglobin, fibrinogen, C-reactive protein, hypertension and metabolic syndrome at 45 y. We adjusted for lifestyle and socio-demographic factors and assessed mediation of associations by body mass index (BMI) and diet. We also assessed whether the sedentary indicators are related similarly to factors linked to disease-risk. Results: There was a general trend of adverse socio-demographic and lifestyle characteristics with higher h/d television-viewing, but trends in the opposite direction for work sitting. Television-viewing was associated with most biomarkers and associations were mediated by BMI: e. g. for each category increase in television-viewing, HDL-cholesterol in men was lower by 2.3% (95% CI: 1.5%, 3.2%) and, in BMI and diet adjusted analyses, by 1.6% (0.8%, 2.4%); for women, by 2.0% (1.2%, 2.9%) and 0.9% (0.1%, 1.6%) respectively. Few, weaker associations for work sitting were found, in men only: e. g. corresponding values for HDL-cholesterol were 1.2% (0.5%, 1.9%) and 0.9% (0.3%, 1.5%). Odds for metabolic syndrome were elevated by 82% and 33% respectively for men watching television or work sitting for >= 3 vs. 0-1 h/d. Conclusions: Associations with cardiovascular disease and diabetes biomarkers in mid-adulthood differed for television-viewing and work sitting. The role of sedentary behaviour may vary by leisure and work domains or the two indicators reflect differing associations with other disease-related influences.	[Pereira, Snehal M. Pinto; Ki, Myung; Power, Chris] UCL Inst Child Hlth, MRC Ctr Epidemiol Child Hlth, London, England	University of London; University College London	Pereira, SMP (corresponding author), UCL Inst Child Hlth, MRC Ctr Epidemiol Child Hlth, London, England.	c.power@ich.ucl.ac.uk		Pinto Pereira, Snehal/0000-0002-0876-8757; Ki, Myung/0000-0001-8479-0254	Department of Health through the Public Health Research Consortium; Medical Research Council [G0000934]; Department of Health's NIHR Biomedical Research Centre; MRC [G0000934] Funding Source: UKRI	Department of Health through the Public Health Research Consortium; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health's NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Department of Health Policy Research Programme through the Public Health Research Consortium. The views expressed in the publication are those of the authors and not necessarily those of the Department of Health. Information about the wider programme of the PHRC is available from www.york.ac.uk/phrc. The Medical Research Council funded for the 45 y biomedical survey (grant: G0000934). The GOSH/UCL Institute of Child Health was supported in part by the Department of Health's NIHR Biomedical Research Centre. The Centre for Paediatric Epidemiology and Biostatistics was supported in part by the Medical Research Council in its capacity as the MRC Centre of Epidemiology for Child Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Aadahl M, 2007, EUR J CARDIOV PREV R, V14, P660, DOI 10.1097/HJR.0b013e3280c284c5; Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Atherton K, 2008, J EPIDEMIOL COMMUN H, V62, P216, DOI 10.1136/jech.2006.058966; Bellisle F, 2004, APPETITE, V43, P175, DOI 10.1016/j.appet.2004.04.004; Bennett WL, 2011, ANN INTERN MED, V154, P602, DOI 10.7326/0003-4819-154-9-201105030-00336; Bertrais S, 2005, OBES RES, V13, P936, DOI 10.1038/oby.2005.108; Blass EM, 2006, PHYSIOL BEHAV, V88, P597, DOI 10.1016/j.physbeh.2006.05.035; Chalmers J, 1999, CLIN EXP HYPERTENS, V21, P1009; Chang PC, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-193; Charreire H, 2011, BRIT J NUTR, V105, P902, DOI 10.1017/S000711451000440X; Clark BK, 2009, OBES REV, V10, P7, DOI 10.1111/j.1467-789X.2008.00508.x; Cole TJ, 2000, STAT MED, V19, P3109, DOI 10.1002/1097-0258(20001130)19:22<3109::AID-SIM558>3.0.CO;2-F; Dunstan DW, 2010, CIRCULATION, V121, P384, DOI 10.1161/CIRCULATIONAHA.109.894824; Dunstan DW, 2005, DIABETOLOGIA, V48, P2254, DOI 10.1007/s00125-005-1963-4; Ford ES, 2005, OBES RES, V13, P608, DOI 10.1038/oby.2005.65; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Fung TT, 2000, AM J EPIDEMIOL, V152, P1171, DOI 10.1093/aje/152.12.1171; Gore Stacy A, 2003, Eat Behav, V4, P399, DOI 10.1016/S1471-0153(03)00053-9; Hamilton MT, 2007, DIABETES, V56, P2655, DOI 10.2337/db07-0882; Healy GN, 2011, AM J PREV MED, V41, P216, DOI 10.1016/j.amepre.2011.05.005; Hetherington MM, 2006, PHYSIOL BEHAV, V88, P498, DOI 10.1016/j.physbeh.2006.04.025; Hu FB, 2003, JAMA-J AM MED ASSOC, V289, P1785, DOI 10.1001/jama.289.14.1785; Hu FB, 2001, ARCH INTERN MED, V161, P1542, DOI 10.1001/archinte.161.12.1542; Inoue M, 2008, ANN EPIDEMIOL, V18, P522, DOI 10.1016/j.annepidem.2008.03.008; Jakes RW, 2003, EUR J CLIN NUTR, V57, P1089, DOI 10.1038/sj.ejcn.1601648; Katzmarzyk PT, 2009, MED SCI SPORT EXER, V41, P998, DOI 10.1249/MSS.0b013e3181930355; Ki M, 2011, ATHEROSCLEROSIS, V219, P361, DOI 10.1016/j.atherosclerosis.2011.07.109; Kronenberg F, 2000, ATHEROSCLEROSIS, V153, P433, DOI 10.1016/S0021-9150(00)00426-3; Matthews CE, 2008, AM J EPIDEMIOL, V167, P875, DOI 10.1093/aje/kwm390; Parsons TJ, 2009, EUR J CLIN NUTR, V63, P978, DOI 10.1038/ejcn.2009.6; Parsons TJ, 2005, INT J OBESITY, V29, P1212, DOI 10.1038/sj.ijo.0802932; Pate RR, 2008, EXERC SPORT SCI REV, V36, P173, DOI 10.1097/JES.0b013e3181877d1a; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Power C, 2006, INT J EPIDEMIOL, V35, P34, DOI 10.1093/ije/dyi183; Power C, 2010, ATHEROSCLEROSIS, V211, P643, DOI 10.1016/j.atherosclerosis.2010.03.015; Sarwar N, 2007, CIRCULATION, V115, P450, DOI 10.1161/CIRCULATIONAHA.106.637793; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Sisson SB, 2009, METAB SYNDR RELAT D, V7, P529, DOI 10.1089/met.2009.0023; Stamatakis E, 2011, J AM COLL CARDIOL, V57, P292, DOI 10.1016/j.jacc.2010.05.065; Stroebele N, 2004, APPETITE, V42, P111, DOI 10.1016/j.appet.2003.09.001; The Nielsen Company, 2011, STAT MED TV US TREND; Thorp AA, 2011, AM J PREV MED, V41, P207, DOI 10.1016/j.amepre.2011.05.004; Tobin MD, 2005, STAT MED, V24, P2911, DOI 10.1002/sim.2165; Wareham NJ, 2007, APPL PHYSIOL NUTR ME, V32, P778, DOI 10.1139/H07-032; Wareham NJ, 2002, INT J EPIDEMIOL, V31, P168, DOI 10.1093/ije/31.1.168; Warren JM, 2010, EUR J CARDIOV PREV R, V17, P127, DOI 10.1097/HJR.0b013e32832ed875; Warren TY, 2010, MED SCI SPORT EXER, V42, P879, DOI 10.1249/MSS.0b013e3181c3aa7e; Wijndaele K, 2011, INT J EPIDEMIOL, V40, P150, DOI 10.1093/ije/dyq105; Wood A, 2006, INT J EPIDEMIOL, V35, P1570, DOI 10.1093/ije/dyl233; Zhang M, 2004, CANCER CAUSE CONTROL, V15, P83, DOI 10.1023/B:CACO.0000016633.47025.2a; ZWEERS A, 1968, CLIN CHIM ACTA, V19, P267, DOI 10.1016/0009-8981(68)90335-5	51	108	109	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2012	7	2							e31132	10.1371/journal.pone.0031132	http://dx.doi.org/10.1371/journal.pone.0031132			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZQ	22347441	gold, Green Published, Green Submitted			2022-12-27	WOS:000302730200014
J	van der Vlugt, LEPM; Labuda, LA; Ozir-Fazalalikhan, A; Lievers, E; Gloudemans, AK; Liu, KY; Barr, TA; Sparwasser, T; Boon, L; Ngoa, UA; Feugap, EN; Adegnika, AA; Kremsner, PG; Gray, D; Yazdanbakhsh, M; Smits, HH				van der Vlugt, Lucien E. P. M.; Labuda, Lucja A.; Ozir-Fazalalikhan, Arifa; Lievers, Ellen; Gloudemans, Anouk K.; Liu, Kit-Yeng; Barr, Tom A.; Sparwasser, Tim; Boon, Louis; Ngoa, Ulysse Ateba; Feugap, Eliane Ngoune; Adegnika, Ayola A.; Kremsner, Peter G.; Gray, David; Yazdanbakhsh, Maria; Smits, Hermelijn H.			Schistosomes Induce Regulatory Features in Human and Mouse CD1d(hi) B Cells: Inhibition of Allergic Inflammation by IL-10 and Regulatory T Cells	PLOS ONE			English	Article							AIRWAY INFLAMMATION; IMMUNE-RESPONSES; B10 CELLS; MICE; SUPPRESSION; INFECTION; AUTOIMMUNITY; CHILDREN; DISEASE; ASTHMA	Chronic helminth infections, such as schistosomes, are negatively associated with allergic disorders. Here, using B cell IL-10-deficient mice, Schistosoma mansoni-mediated protection against experimental ovalbumin-induced allergic airway inflammation (AAI) was shown to be specifically dependent on IL-10-producing B cells. To study the organs involved, we transferred B cells from lungs, mesenteric lymph nodes or spleen of OVA-infected mice to recipient OVA-sensitized mice, and showed that both lung and splenic B cells reduced AAI, but only splenic B cells in an IL-10-dependent manner. Although splenic B cell protection was accompanied by elevated levels of pulmonary FoxP3(+) regulatory T cells, in vivo ablation of FoxP3(+) T cells only moderately restored AAI, indicating an important role for the direct suppressory effect of regulatory B cells. Splenic marginal zone CD1d(+) B cells proved to be the responsible splenic B cell subset as they produced high levels of IL-10 and induced FoxP3(+) T cells in vitro. Indeed, transfer of CD1d(+) MZ-depleted splenic B cells from infected mice restored AAI. Markedly, we found a similarly elevated population of CD1d(hi) B cells in peripheral blood of Schistosoma haematobium-infected Gabonese children compared to uninfected children and these cells produced elevated levels of IL-10. Importantly, the number of IL-10-producing CD1d(hi) B cells was reduced after anti-schistosome treatment. This study points out that in both mice and men schistosomes have the capacity to drive the development of IL-10-producing regulatory CD1d(hi) B cells and furthermore, these are instrumental in reducing experimental allergic inflammation in mice.	[van der Vlugt, Lucien E. P. M.; Labuda, Lucja A.; Ozir-Fazalalikhan, Arifa; Lievers, Ellen; Gloudemans, Anouk K.; Liu, Kit-Yeng; Adegnika, Ayola A.; Yazdanbakhsh, Maria; Smits, Hermelijn H.] Leiden Univ, Dept Parasitol, Med Ctr, Leiden, Netherlands; [Gloudemans, Anouk K.] Erasmus MC, Dept Pulmonol, Rotterdam, Netherlands; [Barr, Tom A.; Gray, David] Univ Edinburgh, Inst Immunol & Infect Res, Sch Biol Sci, Edinburgh, Midlothian, Scotland; [Sparwasser, Tim] Twincore Ctr Expt & Clin Infect Res, Inst Infect Immunol, Hannover, Germany; [Boon, Louis] Bioceros BV, Dept Cell Biol, Utrecht, Netherlands; [Ngoa, Ulysse Ateba; Feugap, Eliane Ngoune; Adegnika, Ayola A.; Kremsner, Peter G.] Albert Schweitzer Hosp, Med Res Unit, Lambarene, Gabon; [Adegnika, Ayola A.; Kremsner, Peter G.] Univ Tubingen, Inst Trop Med, Tubingen, Germany	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC; University of Edinburgh; Helmholtz Association; Helmholtz-Center for Infection Research; Bioceros B.V.; Eberhard Karls University of Tubingen	van der Vlugt, LEPM (corresponding author), Leiden Univ, Dept Parasitol, Med Ctr, Leiden, Netherlands.	H.H.Smits@lumc.nl	Smits, Hermelijn/V-4216-2018; Sparwasser, Tim/AAF-7085-2019; Boon, Laurence/HCI-3629-2022; Sparwasser, Tim D/AAA-4306-2022; ADEGNIKA, Ayola Akim/AAK-7307-2020; Gray, David/L-8295-2013; Yazdanbakhsh, Maria/AAI-3996-2020; Ozir-Fazalalikhan, A/V-5436-2018	Smits, Hermelijn/0000-0001-9279-2890; Sparwasser, Tim/0000-0001-5645-902X; Gray, David/0000-0003-3785-4934; Yazdanbakhsh, Maria/0000-0002-7666-1441; Ozir-Fazalalikhan, A/0000-0002-0613-8372; Boon, Louis/0000-0002-0937-9171	Netherlands Asthma Foundation (NAF) [3.2.10.072]; EU [HEALTH-F3-2009-241642]	Netherlands Asthma Foundation (NAF); EU(European Commission)	This project was supported by Netherlands Asthma Foundation (NAF grant 3.2.10.072) and EU-funded project Immunological Interplay between Poverty Related Diseases and Helminth infections: An African-European Research Initiative "IDEA" (HEALTH-F3-2009-241642). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adegnika AA, 2006, AM J TROP MED HYG, V75, P798, DOI 10.4269/ajtmh.2006.75.798; Amu S, 2010, J ALLERGY CLIN IMMUN, V125, P1114, DOI 10.1016/j.jaci.2010.01.018; Blair PA, 2010, IMMUNITY, V32, P129, DOI 10.1016/j.immuni.2009.11.009; Blair PA, 2009, J IMMUNOL, V182, P3492, DOI 10.4049/jimmunol.0803052; Carter NA, 2011, J IMMUNOL, V186, P5569, DOI 10.4049/jimmunol.1100284; Correale J, 2008, ANN NEUROL, V64, P187, DOI 10.1002/ana.21438; Croese J, 2006, GUT, V55, P136, DOI 10.1136/gut.2005.079129; DiLillo DJ, 2010, ANN NY ACAD SCI, V1183, P38, DOI 10.1111/j.1749-6632.2009.05137.x; Fillatreau S, 2002, NAT IMMUNOL, V3, P944, DOI 10.1038/ni833; Fleming JO, 2011, J NEUROIMMUNOL, V233, P3, DOI 10.1016/j.jneuroim.2011.01.003; Hartl D, 2007, J ALLERGY CLIN IMMUN, V119, P1258, DOI 10.1016/j.jaci.2007.02.023; Hussaarts L, 2011, J ALLERGY CLIN IMMUN, V128, P733, DOI 10.1016/j.jaci.2011.05.012; Iwata Y, 2011, BLOOD, V117, P530, DOI 10.1182/blood-2010-07-294249; Jankovic D, 1998, J EXP MED, V187, P619, DOI 10.1084/jem.187.4.619; Karlsson MR, 2004, J EXP MED, V199, P1679, DOI 10.1084/jem.20032121; Katz N, 1972, Rev Inst Med Trop Sao Paulo, V14, P397; Lahl K, 2011, METHODS MOL BIOL, V707, P157, DOI 10.1007/978-1-61737-979-6_10; Lloyd CM, 2009, IMMUNITY, V31, P438, DOI 10.1016/j.immuni.2009.08.007; Madan R, 2009, J IMMUNOL, V183, P2312, DOI 10.4049/jimmunol.0900185; Maizels Rick M., 2008, V94, P112, DOI 10.1159/000154944; Mangan NE, 2004, J IMMUNOL, V173, P6346, DOI 10.4049/jimmunol.173.10.6346; Mauri C, 2008, TRENDS IMMUNOL, V29, P34, DOI 10.1016/j.it.2007.10.004; Mizoguchi A, 2006, J IMMUNOL, V176, P705, DOI 10.4049/jimmunol.176.2.705; Park HK, 2011, EXP PARASITOL, V127, P539, DOI 10.1016/j.exppara.2010.10.004; Ronet C, 2010, J IMMUNOL, V184, P886, DOI 10.4049/jimmunol.0901114; Shreffler WG, 2009, J ALLERGY CLIN IMMUN, V123, P43, DOI [10.1016/j.jaci.2008.09.051, 10.1016/j.jaci.2008.12.1128]; Smits HH, 2007, J ALLERGY CLIN IMMUN, V120, P932, DOI 10.1016/j.jaci.2007.06.009; van den Biggelaar AHJ, 2000, LANCET, V356, P1723, DOI 10.1016/S0140-6736(00)03206-2; Velupillai P, 1997, J IMMUNOL, V158, P338; Watanabe R, 2007, AM J PATHOL, V171, P560, DOI 10.2353/ajpath.2007.061279; Wilson MS, 2010, EUR J IMMUNOL, V40, P1682, DOI 10.1002/eji.200939721; Wilson MS, 2005, J EXP MED, V202, P1199, DOI 10.1084/jem.20042572; Yazdanbakhsh M, 2002, SCIENCE, V296, P490, DOI 10.1126/science.296.5567.490	33	135	136	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e30883	10.1371/journal.pone.0030883	http://dx.doi.org/10.1371/journal.pone.0030883			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347409	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000302730100028
J	Van Goethem, E; Silva, EA; Xiao, H; Franc, NC				Van Goethem, Emeline; Silva, Elizabeth A.; Xiao, Hui; Franc, Nathalie C.			The Drosophila TRPP Cation Channel, PKD2 and Dmel/Ced-12 Act in Genetically Distinct Pathways during Apoptotic Cell Clearance	PLOS ONE			English	Article							RECEPTOR-MEDIATED PHAGOCYTOSIS; SYSTEMIC-LUPUS-ERYTHEMATOSUS; GLOBULE-EGF FACTOR-8; C-ELEGANS; CAENORHABDITIS-ELEGANS; INTRACELLULAR CALCIUM; CORPSE ENGULFMENT; CRKII/DOCK180/RAC PATHWAY; MOUSE MEGAKARYOCYTES; MALE-FERTILITY	Apoptosis, a genetically programmed cell death, allows for homeostasis and tissue remodelling during development of all multi-cellular organisms. Phagocytes swiftly recognize, engulf and digest apoptotic cells. Yet, to date the molecular mechanisms underlying this phagocytic process are still poorly understood. To delineate the molecular mechanisms of apoptotic cell clearance in Drosophila, we have carried out a deficiency screen and have identified three overlapping phagocytosis-defective mutants, which all delete the fly homologue of the ced-12 gene, known as Dmel\ced12. As anticipated, we have found that Dmel\ced-12 is required for apoptotic cell clearance, as for its C. elegans and mammalian homologues, ced-12 and elmo, respectively. However, the loss of Dmel\ced-12 did not solely account for the phenotypes of all three deficiencies, as zygotic mutations and germ line clones of Dmel\ced-12 exhibited weaker phenotypes. Using a nearby genetically interacting deficiency, we have found that the polycystic kidney disease 2 gene, pkd2, which encodes a member of the TRPP channel family, is also required for phagocytosis of apoptotic cells, thereby demonstrating a novel role for PKD2 in this process. We have also observed genetic interactions between pkd2, simu, drpr, rya-r44F, and retinophilin (rtp), also known as undertaker (uta), a gene encoding a MORN-repeat containing molecule, which we have recently found to be implicated in calcium homeostasis during phagocytosis. However, we have not found any genetic interaction between Dmel\ced-12 and simu. Based on these genetic interactions and recent reports demonstrating a role for the mammalian pkd-2 gene product in ER calcium release during store-operated calcium entry, we propose that PKD2 functions in the DRPR/RTP pathway to regulate calcium homeostasis during this process. Similarly to its C. elegans homologue, Dmel\Ced-12 appears to function in a genetically distinct pathway.	[Van Goethem, Emeline; Silva, Elizabeth A.] UCL, Med Res Council Cell Biol Unit, MRC Lab Mol Cell Biol, London, England; [Xiao, Hui; Franc, Nathalie C.] Scripps Res Inst, Dept Immunol & Microbial Sci, Dept Genet, La Jolla, CA 92037 USA; [Van Goethem, Emeline; Silva, Elizabeth A.] UCL, Dept Anat & Dev Biol, London, England	MRC Laboratory Molecular Biology; University of London; University College London; Scripps Research Institute; University of London; University College London	Van Goethem, E (corresponding author), CNRS UMR 5089, Inst Pharmacol & Biol Struct, Toulouse, France.	nfranc@scripps.edu	XIAO, HUI/H-2342-2013; xiao, hui/O-8437-2014	xiao, hui/0000-0001-5709-3365; Franc, Nathalie/0000-0002-1617-385X; Silva, Elizabeth/0000-0002-0684-9473; Silva, Elizabeth/0000-0002-0524-929X	Medical Research Council United Kingdom; Medical Research Council; Cancer Research Institute; Scripps Research Institute Advanced Discovery Institute; Novartis	Medical Research Council United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research Institute; Scripps Research Institute Advanced Discovery Institute; Novartis(Novartis)	This work was funded in part by a Programme Leader career-Track grant from the Medical Research Council United Kingdom to NCF, and Medical Research Council core support to the Medical Research Council Cell Biology Unit. HX is funded by an Irvington Institute Post-doctoral Fellowship from the Cancer Research Institute. NCF and her laboratory are funded by The Scripps Research Institute Advanced Discovery Institute start-up grant provided by Novartis to NCF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS JM, 1993, DEVELOPMENT, V117, P29; Ambudkar IS, 2007, CELL CALCIUM, V42, P213, DOI 10.1016/j.ceca.2007.01.013; Awasaki T, 2006, NEURON, V50, P855, DOI 10.1016/j.neuron.2006.04.027; Bianco A, 2007, NATURE, V448, P362, DOI 10.1038/nature05965; Briddon SJ, 1999, BLOOD, V93, P3847, DOI 10.1182/blood.V93.11.3847.411k17_3847_3855; Cohen PL, 2002, J EXP MED, V196, P135, DOI 10.1084/jem.20012094; Cuttell L, 2008, CELL, V135, P524, DOI 10.1016/j.cell.2008.08.033; deCathelineau AM, 2003, ESSAYS BIOCHEM, V39, P105, DOI 10.1042/bse0390105; Dewitt S, 2002, J CELL BIOL, V159, P181, DOI 10.1083/jcb.200206089; ELLIS RE, 1991, GENETICS, V129, P79; Franc NC, 1996, IMMUNITY, V4, P431, DOI 10.1016/S1074-7613(00)80410-0; Franc NC, 2002, FRONT BIOSCI-LANDMRK, V7, pD1298, DOI 10.2741/franc; Franc NC, 1999, SCIENCE, V284, P1991, DOI 10.1126/science.284.5422.1991; Freeman MR, 2003, NEURON, V38, P567, DOI 10.1016/S0896-6273(03)00289-7; FRIGERIO G, 1986, CELL, V47, P735, DOI 10.1016/0092-8674(86)90516-7; Gaipl US, 2006, CURR TOP MICROBIOL, V305, P161, DOI 10.1007/3-540-29714-6_8; Gao ZQ, 2004, J BIOL CHEM, V279, P14225, DOI 10.1074/jbc.M312223200; Gao ZQ, 2003, CURR BIOL, V13, P2175, DOI 10.1016/j.cub.2003.11.053; Geisbrecht ER, 2008, DEV BIOL, V314, P137, DOI 10.1016/j.ydbio.2007.11.022; GREENBERG S, 1991, J CELL BIOL, V113, P757, DOI 10.1083/jcb.113.4.757; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Hauwel M, 2005, BRAIN RES REV, V48, P220, DOI 10.1016/j.brainresrev.2004.12.012; HISHIKAWA T, 1991, J CELL BIOL, V115, P59, DOI 10.1083/jcb.115.1.59; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; Kinchen JM, 2005, NATURE, V434, P93, DOI 10.1038/nature03263; Kurant E, 2008, CELL, V133, P498, DOI 10.1016/j.cell.2008.02.052; Link TM, 2010, NAT IMMUNOL, V11, P232, DOI 10.1038/ni.1842; Manaka J, 2004, J BIOL CHEM, V279, P48466, DOI 10.1074/jbc.M408597200; Mangahas PM, 2005, SEMIN CELL DEV BIOL, V16, P295, DOI 10.1016/j.semcdb.2004.12.005; MCNEIL PL, 1986, J CELL BIOL, V102, P1586, DOI 10.1083/jcb.102.5.1586; Melford SK, 1997, J BIOL CHEM, V272, P27539, DOI 10.1074/jbc.272.44.27539; Ong HL, 2007, J BIOL CHEM, V282, P9105, DOI 10.1074/jbc.M608942200; Papp S, 2007, J BIOL CHEM, V282, P16585, DOI 10.1074/jbc.M701011200; Pazdera TM, 1998, DEVELOPMENT, V125, P3427; Pittoni Valerio, 2002, Autoimmunity Reviews, V1, P154, DOI 10.1016/S1568-9972(02)00032-0; RAFF MC, 1994, PHILOS T ROY SOC B, V345, P265, DOI 10.1098/rstb.1994.0104; Reddien PW, 2000, NAT CELL BIOL, V2, P131, DOI 10.1038/35004000; Rubartelli A, 1997, EUR J IMMUNOL, V27, P1893, DOI 10.1002/eji.1830270812; Santoso NG, 2011, CELL PHYSIOL BIOCHEM, V27, P715, DOI 10.1159/000330080; Savill J, 2003, SCIENCE, V302, P1516, DOI 10.1126/science.1092533; Silva E, 2007, IMMUNITY, V27, P585, DOI 10.1016/j.immuni.2007.08.016; Smits E, 1999, CURR BIOL, V9, P1351, DOI 10.1016/S0960-9822(00)80062-7; SONNENFELD MJ, 1995, J COMP NEUROL, V359, P644, DOI 10.1002/cne.903590410; Spirli C, 2011, HEPATOLOGY; Tejle K, 2002, BIOSCIENCE REP, V22, P529, DOI 10.1023/A:1022025903688; TEPASS U, 1994, DEVELOPMENT, V120, P1829; Venkatachalam K, 2008, CELL, V135, P838, DOI 10.1016/j.cell.2008.09.041; WANG XY, 1994, J BIOCHEM-TOKYO, V116, P858, DOI 10.1093/oxfordjournals.jbchem.a124607; Watnick TJ, 2003, CURR BIOL, V13, P2179, DOI 10.1016/S0960-9822(03)00913-8; Watson S, 2006, CURR DIRECT AUTOIMMU, V9, P188; Wu YC, 2001, DEV CELL, V1, P491, DOI 10.1016/S1534-5807(01)00056-9; Wu YC, 1998, NATURE, V392, P501, DOI 10.1038/33163; Wu YC, 1998, CELL, V93, P951, DOI 10.1016/S0092-8674(00)81201-5; Wyllie A H, 1980, Int Rev Cytol, V68, P251; Yamaguchi H, 2008, J LEUKOCYTE BIOL, V83, P1300, DOI 10.1189/jlb.1107730; Yamaguchi H, 2010, EUR J IMMUNOL, V40, P1778, DOI 10.1002/eji.200940096; Zhou Z, 2001, DEV CELL, V1, P477, DOI 10.1016/S1534-5807(01)00058-2; Zhou Z, 2001, CELL, V104, P43, DOI 10.1016/S0092-8674(01)00190-8; Ziegenfuss JS, 2008, NATURE, V453, P935, DOI 10.1038/nature06901	59	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31488	10.1371/journal.pone.0031488	http://dx.doi.org/10.1371/journal.pone.0031488			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347485	Green Published, Green Submitted, gold			2022-12-27	WOS:000302730100074
J	Rowell, JL; Dowling, NF; Yu, W; Yesupriya, A; Zhang, L; Gwinn, M				Rowell, Jessica L.; Dowling, Nicole F.; Yu, Wei; Yesupriya, Ajay; Zhang, Lyna; Gwinn, Marta			Trends in Population-Based Studies of Human Genetics in Infectious Diseases	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; EPIDEMIOLOGY; INFLUENZA	Pathogen genetics is already a mainstay of public health investigation and control efforts; now advances in technology make it possible to investigate the role of human genetic variation in the epidemiology of infectious diseases. To describe trends in this field, we analyzed articles that were published from 2001 through 2010 and indexed by the HuGE Navigator, a curated online database of PubMed abstracts in human genome epidemiology. We extracted the principal findings from all meta-analyses and genome-wide association studies (GWAS) with an infectious disease-related outcome. Finally, we compared the representation of diseases in HuGE Navigator with their contributions to morbidity worldwide. We identified 3,730 articles on infectious diseases, including 27 meta-analyses and 23 GWAS. The number published each year increased from 148 in 2001 to 543 in 2010 but remained a small fraction (about 7%) of all studies in human genome epidemiology. Most articles were by authors from developed countries, but the percentage by authors from resource-limited countries increased from 9% to 25% during the period studied. The most commonly studied diseases were HIV/AIDS, tuberculosis, hepatitis B infection, hepatitis C infection, sepsis, and malaria. As genomic research methods become more affordable and accessible, population-based research on infectious diseases will be able to examine the role of variation in human as well as pathogen genomes. This approach offers new opportunities for understanding infectious disease susceptibility, severity, treatment, control, and prevention.	[Rowell, Jessica L.; Dowling, Nicole F.; Yu, Wei; Yesupriya, Ajay] Ctr Dis Control & Prevent, Off Publ Hlth Genom, Off Epidemiol Surveillance & Lab Serv, Atlanta, GA 30333 USA; [Zhang, Lyna] Ctr Dis Control & Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA USA; [Gwinn, Marta] McKing Consulting Corp, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Rowell, JL (corresponding author), Ctr Dis Control & Prevent, Off Publ Hlth Genom, Off Epidemiol Surveillance & Lab Serv, Atlanta, GA 30333 USA.	jlrowel@emory.edu			Oak Ridge Institute for Science and Education (ORISE)	Oak Ridge Institute for Science and Education (ORISE)	Jessica L Rowell is a fellow funded by Oak Ridge Institute for Science and Education (ORISE). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afdhal NH, 2011, HEPATOLOGY, V53, P336, DOI 10.1002/hep.24052; Albright FS, 2008, J INFECT DIS, V197, P18, DOI 10.1086/524064; Alcais A, 2009, J CLIN INVEST, V119, P2506, DOI 10.1172/JCI38111; Bowcock AM, 2010, CRIT REV IMMUNOL, V30, P305, DOI 10.1615/CritRevImmunol.v30.i3.80; Burgner D, 2006, LANCET INFECT DIS, V6, P653, DOI 10.1016/S1473-3099(06)70601-6; Casanova JL, 2007, EMBO J, V26, P915, DOI 10.1038/sj.emboj.7601558; Centers for Disease Control and Prevention, 2010, 2008 CDCP, V20; Crawford DC, 2008, EMERG INFECT DIS, V14, P1138, DOI 10.3201/eid1407.071287; Davila S, 2009, GENOME MED, V1, DOI 10.1186/gm19; de Bakker PIW, 2010, NAT GENET, V42, P731, DOI 10.1038/ng0910-731; Dowling NF, 2009, GENOME MED, V1, DOI 10.1186/gm119; Fauci AS, 2006, CELL, V124, P665, DOI 10.1016/j.cell.2006.02.010; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Fellay J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001033; Foley SL, 2009, INFECT GENET EVOL, V9, P430, DOI 10.1016/j.meegid.2009.03.004; Haagmans BL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000557; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Honey K, 2009, J CLIN INVEST, V119, P2452, DOI 10.1172/JCI40662; Inoue M, 2005, POSTGRAD MED J, V81, P419, DOI 10.1136/pgmj.2004.029330; Kaslow R, GENETIC SUSCEPTIBILI, P464; Kellam P, 2006, CELL, V124, P695, DOI 10.1016/j.cell.2006.02.003; Le Clerc S, 2009, J INFECT DIS, V200, P1194, DOI 10.1086/605892; LopalcoLucia, 2010, VIRUSES, V2, P26; Mathers C, 2008, GLOBAL BURDEN OF DISEASE: 2004 UPDATE, P1; O'Brien SJ, 2004, NAT GENET, V36, P565, DOI 10.1038/ng1369; Rinaudo CD, 2009, J CLIN INVEST, V119, P2515, DOI 10.1172/JCI38330; Seib KL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000612; Singer PA, 2001, SCIENCE, V294, P87, DOI 10.1126/science.1062633; Withee J, 2007, ENVIRON MOL MUTAGEN, V48, P363, DOI 10.1002/em.20303; Wonkam A, 2011, DEV WORLD BIOETH; World Health Organization Regional Office for the Western Pacific, 2006, PREV MOTH TO CHILD T; Yu W, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-205; Yu W, 2008, NAT GENET, V40, P124, DOI 10.1038/ng0208-124; YuWei, 2007, BMC BIOINFORMATICS, V8, P436	34	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2012	7	2							e25431	10.1371/journal.pone.0025431	http://dx.doi.org/10.1371/journal.pone.0025431			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917MF	22347358	Green Submitted, Green Published, gold			2022-12-27	WOS:000302180600001
J	Svensson, H; Olofsson, V; Lundin, S; Yakkala, C; Bjorck, S; Borjesson, L; Gustavsson, B; Quiding-Jarbrink, M				Svensson, Helena; Olofsson, Veronica; Lundin, Samuel; Yakkala, Chakradhar; Bjorck, Stellan; Borjesson, Lars; Gustavsson, Bengt; Quiding-Jarbrink, Marianne			Accumulation of CCR4(+) CTLA-4(hi) FOXP3(+)CD25(hi) Regulatory T Cells in Colon Adenocarcinomas Correlate to Reduced Activation of Conventional T Cells	PLOS ONE			English	Article							COLORECTAL-CANCER; CHEMOKINE RECEPTORS; IMMUNE-RESPONSES; VASCULAR ADDRESSIN; EXPRESSION; RECRUITMENT; EFFECTOR; FOXP3; SUPPRESSION; PROGRESSION	Background: Colorectal cancer usually gives rise to a specific anti-tumor immune response, but for unknown reasons the resulting immunity is not able to clear the tumor. Recruitment of activated effector lymphocytes to the tumor is important for efficient anti-tumor responses, while the presence of regulatory T cells (Treg) down-modulate tumor-specific immunity. We therefore aimed to determine homing mechanisms and activation stage of Treg and effector T cell infiltrating colon tumors compared to cells from the unaffected mucosa in patients suffering from colon adenocarcinoma. Methodology/Principal Findings: Lymphocytes were isolated from unaffected and tumor mucosa from patients with colon adenocarcinoma, and flow cytometry, immunohistochemistry, and quantitative PCR was used to investigate the homing mechanisms and activation stage of infiltrating Treg and conventional lymphocytes. We detected significantly higher frequencies of CD25(high)FOXP3(+)CD127(low) putative Treg in tumors than unaffected mucosa, which had a complete demethylation in the FOXP3 promotor. Tumor-associated Treg had a high expression of CTLA-4, and some appeared to be antigen experienced effector/memory cells based on their expression of alpha E beta 7 (CD103). There were also significantly fewer activated T cells and more CTLA-4(+) conventional T cells susceptible to immune regulation in the tumor-associated mucosa. In contrast, CD8(+) granzyme B+ putative cytotoxic cells were efficiently recruited to the tumors. The frequencies of cells expressing alpha 4 beta 7 and the Th1 associated chemokine receptor CXCR3 were significantly decreased among CD4(+) T cells in the tumor, while frequencies of CD4(+)CCR4(+) lymphocytes were significantly increased. Conclusions/Significance: This study shows that CCR4(+)CTLA4(hi) Treg accumulate in colon tumors, while the frequencies of activated conventional Th1 type T cells are decreased. The altered lymphocyte composition in colon tumors will probably diminish the ability of the immune system to effectively attack tumor cells, and reducing the Treg activity is an important challenge for future immunotherapy protocols.	[Svensson, Helena; Olofsson, Veronica; Lundin, Samuel; Yakkala, Chakradhar; Quiding-Jarbrink, Marianne] Univ Gothenburg, Inst Biomed, Dept Microbiol & Immunol, Gothenburg, Sweden; [Bjorck, Stellan; Borjesson, Lars; Gustavsson, Bengt] Univ Gothenburg, Inst Clin Sci, Dept Surg, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg	Svensson, H (corresponding author), Univ Gothenburg, Inst Biomed, Dept Microbiol & Immunol, Gothenburg, Sweden.	helena.svensson@microbio.gu.se	Quiding-JÃrbrink, Marianne/AAU-5746-2021	Quiding-JÃrbrink, Marianne/0000-0002-1978-8091; Svensson, Helena/0000-0001-6332-430X	Swedish Science Council [56X-13428]; Swedish Cancer Foundation [09 0748]; Sahlgrenska University Hospital [ALFGBG-144381]; Inga-Britt and Arne Lundberg's Foundation [354]; Professor Nanna Svartz's Foundation	Swedish Science Council; Swedish Cancer Foundation; Sahlgrenska University Hospital; Inga-Britt and Arne Lundberg's Foundation; Professor Nanna Svartz's Foundation	The work was supported by Swedish Science Council, 56X-13428 (www.vr.se); Swedish Cancer Foundation, 09 0748 (www.cancerfonden.se); Sahlgrenska University Hospital, ALFGBG-144381 (www.fou.nu/is/alfgbg); Inga-Britt and Arne Lundberg's Foundation, 354 (www.lundbergsstiftelsen.com); Professor Nanna Svartz's Foundation, (www.seb.se/pow/wcp/index). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agace WW, 2000, CURR OPIN CELL BIOL, V12, P563, DOI 10.1016/S0955-0674(00)00132-0; Anz D, 2011, INT J CANC; Bergquist C, 2000, J IMMUNOL METHODS, V234, P51, DOI 10.1016/S0022-1759(99)00213-6; BERLIN C, 1993, CELL, V74, P185, DOI 10.1016/0092-8674(93)90305-A; Bonecchi R, 1998, J EXP MED, V187, P129, DOI 10.1084/jem.187.1.129; Bonertz A, 2009, J CLIN INVEST, V119, P3311, DOI 10.1172/JCI39608; Cao XF, 2007, IMMUNITY, V27, P635, DOI 10.1016/j.immuni.2007.08.014; Christensen JE, 2006, J IMMUNOL, V176, P4235, DOI 10.4049/jimmunol.176.7.4235; Clarke SL, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000129; Correale P, 2010, J IMMUNOTHER, V33, P435, DOI 10.1097/CJI.0b013e3181d32f01; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Enarsson K, 2006, CLIN IMMUNOL, V118, P24, DOI 10.1016/j.clim.2005.08.001; Enarsson K, 2006, CLIN IMMUNOL, V121, P358, DOI 10.1016/j.clim.2006.07.002; Frey DM, 2010, INT J CANCER, V126, P2635, DOI 10.1002/ijc.24989; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Ganss R, 2004, EUR J IMMUNOL, V34, P2635, DOI 10.1002/eji.200425474; Han YM, 2009, J IMMUNOL, V182, P111, DOI 10.4049/jimmunol.182.1.111; Hiraoka N, 2006, CLIN CANCER RES, V12, P5423, DOI 10.1158/1078-0432.CCR-06-0369; Hung K, 1998, J EXP MED, V188, P2357, DOI 10.1084/jem.188.12.2357; Iellem A, 2001, J EXP MED, V194, P847, DOI 10.1084/jem.194.6.847; Janson PCJ, 2011, J IMMUNOL, V186, P92, DOI 10.4049/jimmunol.1000960; Jass JR, 2007, HISTOPATHOLOGY, V50, P113, DOI 10.1111/j.1365-2559.2006.02549.x; Kobayashi N, 2007, CLIN CANCER RES, V13, P902, DOI 10.1158/1078-0432.CCR-06-2363; Le Gouvello S, 2008, GUT, V57, P772, DOI 10.1136/gut.2007.123794; Ling Khoon Lin, 2007, Cancer Immun, V7, P7; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Lundgren A, 2005, INFECT IMMUN, V73, P523, DOI 10.1128/IAI.73.1.523-531.2005; Malmberg KJ, 2004, CANCER IMMUNOL IMMUN, V53, P879, DOI 10.1007/s00262-004-0577-x; Marelli-Berg FM, 2008, J PATHOL, V214, P179, DOI 10.1002/path.2269; Michel S, 2008, BRIT J CANCER, V99, P1867, DOI 10.1038/sj.bjc.6604756; MICHIE SA, 1993, AM J PATHOL, V143, P1688; Mohan K, 2005, EUR J IMMUNOL, V35, P1702, DOI 10.1002/eji.200425885; Nosho K, 2010, J PATHOL, V222, P350, DOI 10.1002/path.2774; Ren ZG, 2001, J GASTROEN HEPATOL, V16, P142, DOI 10.1046/j.1440-1746.2001.02385.x; Roncador G, 2005, EUR J IMMUNOL, V35, P1681, DOI 10.1002/eji.200526189; Ryschich E, 2002, INT J CANCER, V97, P719, DOI 10.1002/ijc.10074; Sakaguchi S, 2008, EUR J IMMUNOL, V38, P901, DOI 10.1002/eji.200890012; Salama P, 2009, J CLIN ONCOL, V27, P186, DOI 10.1200/JCO.2008.18.7229; Sallusto F, 2000, ANNU REV IMMUNOL, V18, P593, DOI 10.1146/annurev.immunol.18.1.593; Sansom DM, 2006, IMMUNOL REV, V212, P131, DOI 10.1111/j.0105-2896.2006.00419.x; Shen ZB, 2010, J CANCER RES CLIN, V136, P1585, DOI 10.1007/s00432-010-0816-9; Shibahara T, 2001, GASTROENTEROLOGY, V120, P60, DOI 10.1053/gast.2001.20904; Siewert C, 2008, J IMMUNOL, V180, P146, DOI 10.4049/jimmunol.180.1.146; Sinicrope FA, 2009, GASTROENTEROLOGY, V137, P1270, DOI 10.1053/j.gastro.2009.06.053; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Suzuki H, 2010, CANCER IMMUNOL IMMUN, V59, P653, DOI 10.1007/s00262-009-0781-9; Weitz J, 2005, LANCET, V365, P153, DOI 10.1016/S0140-6736(05)17706-X; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Yoon SH, 2009, EXP MOL MED, V41, P161, DOI 10.3858/emm.2009.41.3.019	49	50	53	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2012	7	2							e30695	10.1371/journal.pone.0030695	http://dx.doi.org/10.1371/journal.pone.0030695			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UG	22319577	gold, Green Submitted, Green Published			2022-12-27	WOS:000301977500015
J	Lu, YL; Zhang, K; Li, C; Yao, YL; Tao, DC; Liu, YQ; Zhang, SZ; Ma, YX				Lu, Yilu; Zhang, Kun; Li, Chao; Yao, Youlin; Tao, Dachang; Liu, Yunqiang; Zhang, Sizong; Ma, Yongxin			Piwil2 Suppresses P53 by Inducing Phosphorylation of Signal Transducer and Activator of Transcription 3 in Tumor Cells	PLOS ONE			English	Article							DNA-BINDING ACTIVITY; V-SRC; ARGONAUTE FAMILY; PROTEIN PIWIL2; GROWTH-FACTOR; HELA-CELLS; SMALL RNAS; STAT3; PATHWAY; IDENTIFICATION	Piwi proteins have been implicated in germ cell proliferation, differentiation, germline stem cell maintenance and transposon control in germline from Drosophila to mammals. The Piwi-like2 (piwil2) gene is mainly expressed in testis or embryonic cells among normal tissues but widely expressed in tumors. However, it remains to be fully determined through which mechanism piwil2 is involved in tumorigenesis. Here we report that Human piwil2, or Hili represses the tumor suppressor P53 in human cancer cells. Immunoprecipitation analysis shows that Piwil2 can directly associate with Signal Transducer and Activator of Transcription 3 (STAT3) protein via its PAZ domain and form a Piwil2/STAT3/c-Src triple protein-protein complex. Furthermore, STAT3 is phosphorylated by c-Src and translocated to nucleus, then binds to P53 promoter and represses its transcription. The present study demonstrated that Piwil2 plays a role in anti-apoptosis in tumor cells possessing P53 as a positive regulator of STAT3 signaling pathway, providing novel sights into roles of Piwil2 in tumorigenesis.	[Lu, Yilu; Zhang, Kun; Li, Chao; Yao, Youlin; Tao, Dachang; Liu, Yunqiang; Zhang, Sizong; Ma, Yongxin] Sichuan Univ, Dept Med Genet, W China Hosp, State Key Lab Biotherapy,Div Morbid Genom, Chengdu 610064, Peoples R China	Sichuan University	Lu, YL (corresponding author), Sichuan Univ, Dept Med Genet, W China Hosp, State Key Lab Biotherapy,Div Morbid Genom, Chengdu 610064, Peoples R China.	mayongxin@gmail.com			National Natural Science Foundation of China [90919006, 31070676]; Trans-Century Training Programme Foundation for the Talents by the Ministry of Education of China [NCET-07-0580]; Ministry of Education of China [Z2009-1-61003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Trans-Century Training Programme Foundation for the Talents by the Ministry of Education of China; Ministry of Education of China(Ministry of Education, China)	This work is supported by the National Natural Science Foundation of China (90919006 and 31070676), Trans-Century Training Programme Foundation for the Talents by the Ministry of Education of China (grant no. NCET-07-0580) and Spring Sunshine Programme by the Ministry of Education of China (grant no. Z2009-1-61003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Bromberg JF, 1998, MOL CELL BIOL, V18, P2553, DOI 10.1128/MCB.18.5.2553; Burdon T, 2002, TRENDS CELL BIOL, V12, P432, DOI 10.1016/S0962-8924(02)02352-8; Cao XM, 1996, MOL CELL BIOL, V16, P1595; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; Chaturvedi P, 1997, MOL CELL BIOL, V17, P3295, DOI 10.1128/MCB.17.6.3295; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; Farazi TA, 2008, DEVELOPMENT, V135, P1201, DOI 10.1242/dev.005629; Feng DQ, 2009, ONCOL REP, V22, P1129, DOI 10.3892/or_00000545; Fridman JS, 2003, ONCOGENE, V22, P9030, DOI 10.1038/sj.onc.1207116; HAUPT Y, 1995, GENE DEV, V9, P2170, DOI 10.1101/gad.9.17.2170; HOPPESEYLER F, 1993, J VIROL, V67, P3111, DOI 10.1128/JVI.67.6.3111-3117.1993; Houwing S, 2007, CELL, V129, P69, DOI 10.1016/j.cell.2007.03.026; Kuramochi-Miyagawa S, 2004, DEVELOPMENT, V131, P839, DOI 10.1242/dev.00973; Lee JH, 2010, CANCER RES, V70, P4569, DOI 10.1158/0008-5472.CAN-09-2670; Lee JH, 2006, MOL REPROD DEV, V73, P173, DOI 10.1002/mrd.20391; Lee JH, 2006, HUM MOL GENET, V15, P201, DOI 10.1093/hmg/ddi430; Liang SF, 2010, PROTEOMICS, V10, P1474, DOI 10.1002/pmic.200900649; Lin J, 2002, ONCOGENE, V21, P3082, DOI 10.1038/sj.onc.1205426; Lu YL, 2010, BMB REP, V43, P635, DOI 10.3858/BMBRep.2010.43.9.635; Murray PJ, 2007, J IMMUNOL, V178, P2623, DOI 10.4049/jimmunol.178.5.2623; Niu GL, 2005, MOL CELL BIOL, V25, P7432, DOI 10.1128/MCB.25.17.7432-7440.2005; SADOWSKI HB, 1993, SCIENCE, V261, P1739, DOI 10.1126/science.8397445; Sasaki T, 2003, GENOMICS, V82, P323, DOI 10.1016/S0888-7543(03)00129-0; SEIDEL HM, 1995, P NATL ACAD SCI USA, V92, P3041, DOI 10.1073/pnas.92.7.3041; Seto AG, 2007, MOL CELL, V26, P603, DOI 10.1016/j.molcel.2007.05.021; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Ye Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013406; YU CL, 1995, SCIENCE, V269, P81, DOI 10.1126/science.7541555; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422	35	67	70	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e30999	10.1371/journal.pone.0030999	http://dx.doi.org/10.1371/journal.pone.0030999			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22303479	Green Published, Green Submitted, gold			2022-12-27	WOS:000301704200053
J	Sun, Q; Prasad, R; Rosenthal, E; Katiyar, SK				Sun, Qian; Prasad, Ram; Rosenthal, Eben; Katiyar, Santosh K.			Grape Seed Proanthocyanidins Inhibit the Invasiveness of Human HNSCC Cells by Targeting EGFR and Reversing the Epithelial-To-Mesenchymal Transition	PLOS ONE			English	Article							NF-KAPPA-B; GROWTH-FACTOR RECEPTOR; MOUSE SKIN; CARCINOMA; HEAD; CANCER; FLUOROURACIL; DOCETAXEL; CISPLATIN; SURVIVAL	Head and neck squamous cell carcinoma (HNSCC) is responsible for approximately 20,000 deaths per year in the United States. Most of the deaths are due to the metastases. To develop more effective strategies for the prevention of metastasis of HNSCC cells, we have determined the effect of grape seed proanthocyanidins (GSPs) on the invasive potential of HNSCC cell and the mechanisms underlying these effects using OSC19 cells as an in vitro model. Using cell invasion assays, we established that treatment of the OSC19 cells with GSPs resulted in a dose-dependent inhibition of cell invasion. EGFR is over-expressed in 90% of HNSCCs and the EGFR inhibitors, erlotinib and gefitinib, are being explored as therapies for this disease. We found that GSPs treatment reduced the levels of expression of EGFR in the OSC19 cells as well as reducing the activation of NF-kappa B/p65, a downstream target of EGFR, and the expression of NF-kappa B-responsive proteins. GSPs treatment also reduced the activity of ERK1/2, an upstream regulator of NF-kappa B and treatment of the cells with caffeic acid phenethyl ester, an inhibitor of NF-kappa B, inhibited cell invasion. Overexpression of EGFR and high NF-kappa B activity play a key role in the epithelial-to-mesenchymal transition, which is of critical importance in the processes underlying metastasis, and we found treatment with GSPs enhanced the levels of epithelial (E-cadherin, cytokeratins and desmoglein-2) and reduced the levels of mesenchymal (vimentin, fibronectin, N-cadherin and Slug) biomarkers in the OSC19 cells. These results indicate that GSPs have the ability to inhibit HNSCC cell invasion, and do so by targeting the expression of EGFR and activation of NF-kappa B as well as inhibiting the epithelial-to-mesenchymal transition.	[Sun, Qian; Prasad, Ram; Katiyar, Santosh K.] Univ Alabama Birmingham, Dept Dermatol, Birmingham, AL 35294 USA; [Katiyar, Santosh K.] Birmingham Vet Affairs Med Ctr, Birmingham, AL USA; [Rosenthal, Eben] Univ Alabama Birmingham, Dept Surg Otolaryngol, Birmingham, AL USA; [Rosenthal, Eben; Katiyar, Santosh K.] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Sun, Q (corresponding author), Univ Alabama Birmingham, Dept Dermatol, Birmingham, AL 35294 USA.	skatiyar@uab.edu		Rosenthal, Eben/0000-0003-0294-5203	Veterans Administration	Veterans Administration(US Department of Veterans Affairs)	This work was supported by funds from the Veterans Administration Merit Review Award (SKK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar S, 2009, CLIN CANCER RES, V15, P821, DOI 10.1158/1078-0432.CCR-08-1901; Arbes SJ, 1999, CANCER CAUSE CONTROL, V10, P513, DOI 10.1023/A:1008911300100; Casiglia Jeffrey, 2001, General Dentistry, V49, P72; Chua HL, 2007, ONCOGENE, V26, P711, DOI 10.1038/sj.onc.1209808; Grandis JR, 1996, CANCER-AM CANCER SOC, V78, P1284, DOI 10.1002/(SICI)1097-0142(19960915)78:6<1284::AID-CNCR17>3.0.CO;2-X; Grandis JR, 1998, JNCI-J NATL CANCER I, V90, P824, DOI 10.1093/jnci/90.11.824; He YK, 1998, JNCI-J NATL CANCER I, V90, P1080, DOI 10.1093/jnci/90.14.1080; Holt RR, 2002, AM J CLIN NUTR, V76, P798, DOI 10.1093/ajcn/76.4.798; Huber MA, 2004, CELL CYCLE, V3, P1477, DOI 10.4161/cc.3.12.1280; Huber MA, 2004, J CLIN INVEST, V114, P569, DOI 10.1172/JCI200421358; Hunter KD, 2005, NAT REV CANCER, V5, P127, DOI 10.1038/nrc1549; Leeman-Neill RJ, 2011, CANCER PREV RES, V4, P230, DOI 10.1158/1940-6207.CAPR-10-0249; Leon X, 2001, Expert Rev Anticancer Ther, V1, P125, DOI 10.1586/14737140.1.1.125; Maier Harald J, 2010, Cancers (Basel), V2, P2058, DOI 10.3390/cancers2042058; Mantena SK, 2006, CARCINOGENESIS, V27, P2018, DOI 10.1093/carcin/bgl043; Meeran SM, 2009, NEOPLASIA, V11, P846, DOI 10.1593/neo.09528; Meeran SM, 2009, CARCINOGENESIS, V30, P520, DOI 10.1093/carcin/bgp019; Min CY, 2008, J CELL BIOCHEM, V104, P733, DOI 10.1002/jcb.21695; Mittal A, 2003, CARCINOGENESIS, V24, P1379, DOI 10.1093/carcin/bgg095; Nandakumar V, 2008, CANCER LETT, V269, P378, DOI 10.1016/j.canlet.2008.03.049; Posner MR, 2007, NEW ENGL J MED, V357, P1705, DOI 10.1056/NEJMoa070956; Sano A, 2003, BIOSCI BIOTECH BIOCH, V67, P1140, DOI 10.1271/bbb.67.1140; Singh RP, 2004, INT J CANCER, V108, P733, DOI 10.1002/ijc.11620; Singh T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025224; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Vaid M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023000; Vermorken JB, 2007, NEW ENGL J MED, V357, P1695, DOI 10.1056/NEJMoa071028; Williamson G, 2005, AM J CLIN NUTR, V81, p243S, DOI [10.1093/ajcn/81.1.243S, 10.1093/ajcn/81.1.230S]; Zuo JH, 2011, J CELL BIOCHEM, V112, P2508, DOI 10.1002/jcb.23175	29	28	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e31093	10.1371/journal.pone.0031093	http://dx.doi.org/10.1371/journal.pone.0031093			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22299051	Green Published, Green Submitted, gold			2022-12-27	WOS:000301704200059
J	Whalan, S; Webster, NS; Negri, AP				Whalan, Steve; Webster, Nicole S.; Negri, Andrew P.			Crustose Coralline Algae and a Cnidarian Neuropeptide Trigger Larval Settlement in Two Coral Reef Sponges	PLOS ONE			English	Article							SCLERACTINIAN CORAL; BALANUS-AMPHITRITE; BROODING CORALS; METAMORPHOSIS; BEHAVIOR; RECRUITMENT; INDUCTION; BIOFILMS; QUALITY; LIGHT	In sessile marine invertebrates, larval settlement is fundamental to population maintenance and persistence. Cues contributing to the settlement choices and metamorphosis of larvae have important implications for the success of individuals and populations, but cues mediating larval settlement for many marine invertebrates are largely unknown. This study assessed larval settlement in two common Great Barrier Reef sponges, Coscinoderma matthewsi and Rhopaloeides odorabile, to cues that enhance settlement and metamorphosis in various species of scleractinian coral larvae. Methanol extracts of the crustose coralline algae (CCA), Porolithon onkodes, corresponding to a range of concentrations, were used to determine the settlement responses of sponge larvae. Cnidarian neuropeptides (GLW-amide neuropeptides) were also tested as a settlement cue. Settlement in both sponge species was approximately two-fold higher in response to live chips of CCA and optimum concentrations of CCA extract compared to 0.2 mu m filtered sea water controls. Metamorphosis also increased when larvae were exposed to GLW-amide neuropeptides; R. odorabile mean metamorphosis reached 42.0 +/- 5.8% compared to 16.0 +/- 2.4% in seawater controls and in C. matthewsi mean metamorphosis reached 68.3 +/- 5.4% compared to 36.7 +/- 3.3% in seawater controls. These results demonstrate the contributing role chemosensory communication plays in the ability of sponge larvae to identify suitable habitat for successful recruitment. It also raises the possibility that larvae from distinct phyla may share signal transduction pathways involved in metamorphosis.	[Whalan, Steve] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Webster, Nicole S.; Negri, Andrew P.] Australian Inst Marine Sci, Townsville, Qld 4810, Australia	James Cook University; Australian Institute of Marine Science	Whalan, S (corresponding author), So Cross Univ, Sch Environm Sci & Management, Lismore, NSW 2480, Australia.	stephen.whalan@scu.edu.au	Webster, Nicole S/G-4980-2011; Negri, Andrew P/G-9909-2017	Webster, Nicole S/0000-0002-4753-5278; Negri, Andrew P/0000-0003-1388-7395; Whalan, Steve/0000-0001-6786-8945	Australian Research Council [LP990664]	Australian Research Council(Australian Research Council)	This work was funded through an Australian Research Council linkage grant with Reef HQ to SW (LP990664). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul Wahab MA, 2011, CORAL REEFS, V30, P451, DOI 10.1007/s00338-011-0727-5; Baird AH, 2004, MAR FRESHWATER RES, V55, P469, DOI 10.1071/MF03121; Bannister RJ, 2007, MAR FRESHWATER RES, V58, P624, DOI 10.1071/MF07011; Campbell AH, 2011, BIOFOULING, V27, P255, DOI 10.1080/08927014.2011.560384; Elbourne PD, 2010, J EXP MAR BIOL ECOL, V392, P99, DOI 10.1016/j.jembe.2010.04.013; Erwin PM, 2010, CORAL REEFS, V29, P929, DOI 10.1007/s00338-010-0634-1; Ettinger-Epstein P, 2008, MAR ECOL PROG SER, V365, P103, DOI 10.3354/meps07503; Fabricius K, 2001, CORAL REEFS, V19, P303, DOI 10.1007/s003380000120; Golbuu Y, 2007, MAR BIOL, V152, P639, DOI 10.1007/s00227-007-0717-x; Grasso LC, 2011, DEV BIOL, V353, P411, DOI 10.1016/j.ydbio.2011.02.010; Hadfield MG, 2011, ANNU REV MAR SCI, V3, P453, DOI 10.1146/annurev-marine-120709-142753; Harii S, 2002, MAR BIOL, V141, P39, DOI 10.1007/s00227-002-0812-y; Harrington L, 2004, ECOLOGY, V85, P3428, DOI 10.1890/04-0298; Hay ME, 2009, ANNU REV MAR SCI, V1, P193, DOI 10.1146/annurev.marine.010908.163708; Heyward AJ, 1999, CORAL REEFS, V18, P273, DOI 10.1007/s003380050193; Iwao K, 2002, CORAL REEFS, V21, P127, DOI 10.1007/s00338-002-0219-8; Kitamura M, 2007, J EXP MAR BIOL ECOL, V340, P96, DOI 10.1016/j.jembe.2006.08.012; Lasker HR, 1996, J EXP MAR BIOL ECOL, V207, P161, DOI 10.1016/S0022-0981(96)02625-1; MAIDA M, 1994, J EXP MAR BIOL ECOL, V180, P189, DOI 10.1016/0022-0981(94)90066-3; Maldonado M, 1998, MAR ECOL PROG SER, V174, P141, DOI 10.3354/meps174141; Maruzzo D, 2011, BIOFOULING, V27, P225, DOI 10.1080/08927014.2011.555534; Mercier A, 2009, CAN J ZOOL, V87, P967, DOI 10.1139/Z09-085; Morse ANC, 1996, BIOL BULL, V191, P149, DOI 10.2307/1542917; MORSE ANC, 1984, J EXP MAR BIOL ECOL, V75, P191, DOI 10.1016/0022-0981(84)90166-7; MORSE DE, 1988, J EXP MAR BIOL ECOL, V116, P193, DOI 10.1016/0022-0981(88)90027-5; Mundy CN, 1998, J EXP MAR BIOL ECOL, V223, P235, DOI 10.1016/S0022-0981(97)00167-6; Nelson WA, 2009, MAR FRESHWATER RES, V60, P787, DOI 10.1071/MF08335; Nozawa Y, 2011, ZOOL STUD, V50, P53; PAWLIK JR, 1992, OCEANOGR MAR BIOL, V30, P273; Raimondi PT, 2000, ECOLOGY, V81, P3193, DOI 10.1890/0012-9658(2000)081[3193:TCOCLB]2.0.CO;2; Ritson-Williams R, 2010, CORAL REEFS, V29, P71, DOI 10.1007/s00338-009-0555-z; Schmich J, 1998, DEV GENES EVOL, V208, P267, DOI 10.1007/s004270050181; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Takahashi T, 1997, P NATL ACAD SCI USA, V94, P1241, DOI 10.1073/pnas.94.4.1241; Tebben J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019082; TOONEN RJ, 1994, NATURE, V370, P511, DOI 10.1038/370511a0; Webster NS, 2004, APPL ENVIRON MICROB, V70, P1213, DOI 10.1128/AEM.70.2.1213-1221.2004; Whalan S, 2008, MAR ECOL PROG SER, V368, P145, DOI 10.3354/meps07573; Whalan S, 2008, CORAL REEFS, V27, P783, DOI 10.1007/s00338-008-0400-9; Whalan S, 2007, MAR BIOL, V153, P163, DOI 10.1007/s00227-007-0792-z; Whalan S, 2007, CORAL REEFS, V26, P655, DOI 10.1007/s00338-007-0236-8	41	36	36	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30386	10.1371/journal.pone.0030386	http://dx.doi.org/10.1371/journal.pone.0030386			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295083	Green Published, Green Accepted, gold			2022-12-27	WOS:000301640600028
J	Wilczek, E; Szparecki, G; Lukasik, D; Koperski, L; Winiarska, M; Wilczynski, GM; Wasiutynski, A; Gornicka, B				Wilczek, Ewa; Szparecki, Grzegorz; Lukasik, Dominika; Koperski, Lukasz; Winiarska, Magdalena; Wilczynski, Grzegorz M.; Wasiutynski, Aleksander; Gornicka, Barbara			Loss of the Orphan Nuclear Receptor SHP Is More Pronounced in Fibrolamellar Carcinoma than in Typical Hepatocellular Carcinoma	PLOS ONE			English	Article							SMALL HETERODIMER PARTNER; SUPPRESSES; EXPRESSION; SURVIVAL	Hepatocellular carcinoma (HCC) remains a major problem in oncology. The molecular mechanisms which underlie its pathogenesis are poorly understood. Recently the Small Heterodimer Partner (SHP), an orphan nuclear receptor, was suggested to be involved as a tumor suppressor in hepatocellular carcinoma development. To date, there are no such studies regarding fibrolamellar carcinoma, a less common variant of HCC, which usually affects young people and displays distinct morphological features The aim of our project was to evaluate the SHP levels in typical and fibrolamellar hepatocellular carcinoma with respect to the levels of one of the cell cycle regulators, cyclin D1. We assessed the immunoreactivity levels of SHP and cyclin D1 in 48 typical hepatocellular carcinomas 9 tumors representing the fibrolamellar variant 29 non malignant liver tissues and 7 macroregenerative nodules. We detected significantly lower SHP immunoreactivity in hepatocellular carcinoma when compared to non malignant liver tissue. Moreover, we found that SHP immunoreactivity is reduced in fibrolamellar carcinoma when compared to typical hepatocellular carcinomal. We also found that SHP is more commonly lost in HCC which arises in the liver with steatosis. The comparison between the cyclin D1 and SHP expression revealed the negative correlation between these proteins in the high grade HCC Our results indicate that the impact of loss of SHP protein may be even more pronounced in fibrolamellar carcinoma than in a typical form of HCC. Further investigation of mechanisms through which the loss of SHP function may influence HCC formation may provide important information in order to design more effective HCC therapy.	[Wilczek, Ewa; Szparecki, Grzegorz; Lukasik, Dominika; Koperski, Lukasz; Wasiutynski, Aleksander; Gornicka, Barbara] Med Univ Warsaw, Dept Pathol, Warsaw, Poland; [Winiarska, Magdalena] Med Univ Warsaw, Dept Immunol, Warsaw, Poland; [Wilczynski, Grzegorz M.] M Nencki Inst Expt Biol, Lab Mol & Syst Neuromorphol, PL-02093 Warsaw, Poland	Medical University of Warsaw; Medical University of Warsaw; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences	Wilczek, E (corresponding author), Med Univ Warsaw, Dept Pathol, Warsaw, Poland.	ewa.wilczek@wum.edu.pl	Wolinska, Ewa/AAE-4628-2021; Koperski, Lukasz/U-4594-2018	Koperski, Lukasz/0000-0001-8163-1813; Wolinska, Ewa/0000-0001-9592-1301; Wilczynski, Grzegorz/0000-0001-6667-0291; Winiarska, Magdalena/0000-0001-5605-3329; Szparecki, Grzegorz/0000-0003-3294-8229	Polish State Committee for Scientific Research [3509/B/P01/2010/38]; Foundation for Polish Science; EU; Ministry of Science and Higher Education of Poland [N N402 352938]; Iuventus Plus [0465/P01/2010/70]	Polish State Committee for Scientific Research(Polish State Committee for Scientific Research); Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); EU(European Commission); Ministry of Science and Higher Education of Poland(Ministry of Science and Higher Education, Poland); Iuventus Plus	The presented work was supported by the grant no 3509/B/P01/2010/38 from the Polish State Committee for Scientific Research. Contributing author M.W. is a member of TEAM Programme co-financed by the Foundation for Polish Science and the EU European Regional Development Fund, and is supported by grants from the Ministry of Science and Higher Education of Poland: N N402 352938 (M.W.) and "Iuventus Plus" 0465/P01/2010/70. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aupperlee Mark, 2005, Breast Dis, V24, P37; Auwerx J, 2002, AM J PHYSIOL-GASTR L, V282, pG581, DOI 10.1152/ajpgi.00508.2001; Bavner A, 2005, TRENDS ENDOCRIN MET, V16, P478, DOI 10.1016/j.tem.2005.10.005; Dehm SM, 2006, J CELL BIOCHEM, V99, P333, DOI 10.1002/jcb.20794; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; He N, 2008, GASTROENTEROLOGY, V134, P793, DOI 10.1053/j.gastro.2008.01.006; Inamoto T, 2010, CANCER-AM CANCER SOC, V116, P340, DOI 10.1002/cncr.24737; Kakar S, 2005, MODERN PATHOL, V18, P1417, DOI 10.1038/modpathol.3800449; Kim K, 2010, BIOCHEM J, V427, P413, DOI 10.1042/BJ20091445; Lee HK, 1998, J BIOL CHEM, V273, P14398, DOI 10.1074/jbc.273.23.14398; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Maniaci V, 2009, EJSO-EUR J SURG ONC, V35, P617, DOI 10.1016/j.ejso.2008.12.009; McKenna NJ, 2010, CELL, V142, DOI 10.1016/j.cell.2010.08.026; Nemenoff RA, 2005, EUR J CANCER, V41, P2561, DOI 10.1016/j.ejca.2005.08.015; Park YY, 2010, MOL CELLS, V30, P485, DOI 10.1007/s10059-010-0136-6; Zhang YX, 2008, HEPATOLOGY, V48, P289, DOI 10.1002/hep.22342; Zhang YX, 2010, MOL CELL BIOL, V30, P1341, DOI 10.1128/MCB.01076-09	18	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30944	10.1371/journal.pone.0030944	http://dx.doi.org/10.1371/journal.pone.0030944			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22292081	gold, Green Submitted, Green Published			2022-12-27	WOS:000301570600099
J	Predazzi, IM; Norata, GD; Vecchione, L; Garlaschelli, K; Amati, F; Grigore, L; Cutuli, L; Pirillo, A; Tramontana, S; Romeo, F; Novelli, G; Catapano, AL				Predazzi, Irene Marta; Norata, Giuseppe Danilo; Vecchione, Lucia; Garlaschelli, Katia; Amati, Francesca; Grigore, Liliana; Cutuli, Lucia; Pirillo, Angela; Tramontana, Simona; Romeo, Francesco; Novelli, Giuseppe; Catapano, Alberico Luigi			Association between OLR1 K167N SNP and Intima Media Thickness of the Common Carotid Artery in the General Population	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; RECEPTOR; POLYMORPHISM; DISEASE; SUSCEPTIBILITY; VARIANTS; SEVERITY; LOX-1; G501C	Background and Purpose: The lectin-like oxidised LDL receptor-1 (OLR1) gene encodes a scavenger receptor implicated in the pathogenesis of atherosclerosis. Although functional roles have been suggested for two variants, epidemiological studies on OLR1 have been inconsistent. Methods - We tested the association between the non-synonymous substitution K167N (rs11053646) and intima media thickness of the common carotid artery (CCA-IMT) in 2,141 samples from the Progression of Lesions in the Intima of the Carotid (PLIC) study (a prospective population-based study). Results: Significantly increased IMT was observed in male carriers of the minor C (N) allele compared to GC and GG (KN and KK) genotype. Functional analysis on macrophages suggested a decreased association to Ox-LDL in NN carriers compared to KN and KK carriers which is also associated with a reduced OLR1 mRNA expression. Macrophages from NN carriers present also a specific inflammatory gene expression pattern compared to cells from KN and KK carriers. Conclusions: These data suggest that the 167N variant of LOX-1 receptor affects the atherogenic process in the carotid artery prior to evidence of disease through an inflammatory process.	[Predazzi, Irene Marta; Vecchione, Lucia; Amati, Francesca] Univ Roma Tor Vergata, Dept Biopathol & Diagnost Imaging, Med Genet Sect, Sch Med, Rome, Italy; [Predazzi, Irene Marta] Vanderbilt Univ, Med Ctr, Ctr Human Genet Resesarch, Nashville, TN USA; [Norata, Giuseppe Danilo; Garlaschelli, Katia; Grigore, Liliana; Pirillo, Angela; Tramontana, Simona; Catapano, Alberico Luigi] Osped Bassini, Ctr Study Atherosclerosis, Soc Italiana Studio Aterosclerosi, Gorki, Cinisello Balsa, Italy; [Norata, Giuseppe Danilo; Cutuli, Lucia] Univ Milan, Dept Pharmacol Sci, Milan, Italy; [Grigore, Liliana; Catapano, Alberico Luigi] Multimed IRCCS, Ss Giovanni, Italy; [Romeo, Francesco] Univ Roma Tor Vergata, Dept Internal Med, Rome, Italy; [Novelli, Giuseppe] Osped San Pietro FBF, Rome, Italy; [Novelli, Giuseppe] ANVUR, Natl Agcy Evaluat Univ & Res, Rome, Italy	University of Rome Tor Vergata; Vanderbilt University; University of Milan; IRCCS Multimedica; University of Rome Tor Vergata	Predazzi, IM (corresponding author), Univ Roma Tor Vergata, Dept Biopathol & Diagnost Imaging, Med Genet Sect, Sch Med, Rome, Italy.	irene.m.predazzi@Vanderbilt.Edu	Novelli, Giuseppe/T-8822-2019; Pirillo, Angela/C-4228-2014; Novelli, Giuseppe/GQB-3329-2022; Catapano, alberico/AAC-2827-2019; Amati, Francesca/J-8439-2012; Novelli, Giuseppe/A-5195-2013; Norata, Giuseppe Danilo/AAC-2863-2019	Pirillo, Angela/0000-0002-2948-6257; Novelli, Giuseppe/0000-0002-7781-602X; Catapano, alberico/0000-0002-7593-2094; Amati, Francesca/0000-0003-2209-2156; Novelli, Giuseppe/0000-0002-7781-602X; Norata, Giuseppe Danilo/0000-0002-6081-1257	Research for Drug Development; Fondazione G. B. Bietti (ONLUS); Fondazione Umberto Veronesi per il progresso delle Scienze and Societa Italiana Studio Aterosclerosi Lombardia Chapter; Istituto Nazionale Ricerca Cardiovascolari; ASPREMARE; Istituto di Ricovero e Cura a Carattere Scientifico Multimedica; National Institutes of Health [2T32HL007751-16A2]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007751] Funding Source: NIH RePORTER	Research for Drug Development; Fondazione G. B. Bietti (ONLUS); Fondazione Umberto Veronesi per il progresso delle Scienze and Societa Italiana Studio Aterosclerosi Lombardia Chapter(Fondazione Umberto Veronesi); Istituto Nazionale Ricerca Cardiovascolari; ASPREMARE; Istituto di Ricovero e Cura a Carattere Scientifico Multimedica; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The study was funded by Research for Drug Development (RE. D. D., Tor Vergata University of Rome), Fondazione G. B. Bietti (ONLUS), Fondazione Umberto Veronesi per il progresso delle Scienze and Societa Italiana Studio Aterosclerosi Lombardia Chapter, the Istituto Nazionale Ricerca Cardiovascolari, ASPREMARE, Istituto di Ricovero e Cura a Carattere Scientifico Multimedica and National Institutes of Health grant 2T32HL007751-16A2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyama T, 1998, FEBS LETT, V440, P29; Biocca S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004648; Chen HW, 2008, CARDIOLOGY, V110, P252, DOI 10.1159/000112409; Cheng YM, 2011, CARDIOLOGY, V119, P90, DOI 10.1159/000330412; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Cominacini L, 2000, J BIOL CHEM, V275, P12633, DOI 10.1074/jbc.275.17.12633; Dunn S, 2008, BIOCHEM J, V409, P349, DOI 10.1042/BJ20071196; Haffner SM, 1996, METABOLISM, V45, P876, DOI 10.1016/S0026-0495(96)90163-8; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; Hou XW, 2008, CLIN CHIM ACTA, V388, P200, DOI 10.1016/j.cca.2007.11.016; Jeannin P, 2005, IMMUNITY, V22, P551, DOI 10.1016/j.immuni.2005.03.008; Knowles JW, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-23; KODAMA T, 1990, NATURE, V343, P531, DOI 10.1038/343531a0; Li DY, 2009, CIRC RES, V104, P566, DOI 10.1161/CIRCRESAHA.109.194209; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mango R, 2005, CIRC RES, V97, P152, DOI 10.1161/01.RES.0000174563.62625.8e; Mango R, 2003, J MED GENET, V40, P933, DOI 10.1136/jmg.40.12.933; Norata GD, 2007, J INTERN MED, V262, P104, DOI 10.1111/j.1365-2796.2007.01787.x; Norata GD, 2007, EUR J ENDOCRINOL, V156, P279, DOI 10.1530/eje.1.02338; Norata GD, 2006, STROKE, V37, P1558, DOI 10.1161/01.STR.0000221803.16897.22; Norata GD, 2005, J INTERN MED, V258, P21, DOI 10.1111/j.1365-2796.2005.01509.x; Norata GD, 2007, STROKE, V38, P2844, DOI 10.1161/STROKEAHA.107.485540; Norata GD, 2010, ATHEROSCLEROSIS, V208, P177, DOI 10.1016/j.atherosclerosis.2009.06.023; Norata GD, 2009, ATHEROSCLEROSIS, V206, P556, DOI 10.1016/j.atherosclerosis.2009.03.017; Ohmori R, 2004, CLIN CARDIOL, V27, P641, DOI 10.1002/clc.4960271112; Pirillo A, 2011, ATHEROSCLEROSIS, V214, P331, DOI 10.1016/j.atherosclerosis.2010.11.006; Sawamura T, 1997, NATURE, V109, P684; Sentinelli F, 2006, NUTR METAB CARDIOVAS, V16, P345, DOI 10.1016/j.numecd.2005.06.002; Shoji T, 2000, ATHEROSCLEROSIS, V148, P171, DOI 10.1016/S0021-9150(99)00218-X; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; Tatsuguchi M, 2003, BIOCHEM BIOPH RES CO, V303, P247, DOI 10.1016/S0006-291X(03)00326-7; Wang LY, 2011, STROKE, V42, P588, DOI 10.1161/STROKEAHA.110.596841; Watkins H, 2006, NAT REV GENET, V7, P163, DOI 10.1038/nrg1805; Winnier DA, 2007, GENET EPIDEMIOL, V31, P66, DOI 10.1002/gepi.20191	34	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2012	7	2							e31086	10.1371/journal.pone.0031086	http://dx.doi.org/10.1371/journal.pone.0031086			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZQ	22347434	Green Submitted, Green Published, gold			2022-12-27	WOS:000302730200013
J	Baitsch, L; Legat, A; Barba, L; Marraco, SAF; Rivals, JP; Baumgaertner, P; Christiansen-Jucht, C; Bouzourene, H; Rimoldi, D; Pircher, H; Rufer, N; Matter, M; Michielin, O; Speiser, DE				Baitsch, Lukas; Legat, Amandine; Barba, Leticia; Marraco, Silvia A. Fuertes; Rivals, Jean-Paul; Baumgaertner, Petra; Christiansen-Jucht, Celine; Bouzourene, Hanifa; Rimoldi, Donata; Pircher, Hanspeter; Rufer, Nathalie; Matter, Maurice; Michielin, Olivier; Speiser, Daniel E.			Extended Co-Expression of Inhibitory Receptors by Human CD8 T-Cells Depending on Differentiation, Antigen-Specificity and Anatomical Localization	PLOS ONE			English	Article							CHRONIC VIRAL-INFECTION; EFFECTOR FUNCTION; MELANOMA PATIENTS; CENTRAL MEMORY; PD-1; EXHAUSTION; EXPRESSION; RESPONSES; LYMPHOCYTES; TIM-3	Inhibitory receptors mediate CD8 T-cell hyporesponsiveness against cancer and infectious diseases. PD-1 and CTLA-4 have been extensively studied, and blocking antibodies have already shown clinical benefit for cancer patients. Only little is known on extended co-expression of inhibitory receptors and their ligands. Here we analyzed the expression of eight inhibitory receptors by tumor-antigen specific CD8 T-cells. We found that the majority of effector T-cells simultaneously expressed four or more of the inhibitory receptors BTLA, TIM-3, LAG-3, KRLG-1, 2B4, CD160, PD-1 and CTLA-4. There were major differences depending on antigen-specificity, differentiation and anatomical localization of T-cells. On the other hand, naive T-cells were only single or double positive for BTLA and TIM-3. Extended co-expression is likely relevant for effector T-cells, as we found expression of multiple ligands in metastatic lesions of melanoma patients. Together, our data suggest that naive T-cells are primarily regulated by BTLA and TIM-3, whereas effector cells interact via larger numbers of inhibitory receptors. Blocking multiple inhibitory receptors simultaneously or sequentially may improve T-cell based therapies, but further studies are necessary to clarify the role of each receptor-ligand pair.	[Baitsch, Lukas; Legat, Amandine; Barba, Leticia; Marraco, Silvia A. Fuertes; Baumgaertner, Petra; Christiansen-Jucht, Celine; Rimoldi, Donata; Rufer, Nathalie; Michielin, Olivier; Speiser, Daniel E.] Univ Lausanne, Clin Tumor Biol & Immunotherapy Unit, Ludwig Ctr, Lausanne, Switzerland; [Rivals, Jean-Paul; Bouzourene, Hanifa; Rufer, Nathalie; Matter, Maurice; Michielin, Olivier] Univ Lausanne, Univ Hosp Ctr, Lausanne, Switzerland; [Pircher, Hanspeter] Univ Freiburg, Dept Immunol, Inst Med Microbiol & Hyg, D-79106 Freiburg, Germany; [Speiser, Daniel E.] Univ Lausanne Hosp, Serv Radiat Oncol, Lausanne, Switzerland	University of Lausanne; University of Lausanne; University of Freiburg; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Baitsch, L (corresponding author), Univ Lausanne, Clin Tumor Biol & Immunotherapy Unit, Ludwig Ctr, Lausanne, Switzerland.	doc@dspeiser.ch	Speiser, Daniel E./F-2173-2013; Michielin, Olivier/ABE-7924-2020; Maurice Joseph, César Matter/J-6717-2017	Maurice Joseph, César Matter/0000-0003-1816-3003; Fuertes Marraco, Silvia A/0000-0002-3456-3317	Ludwig Institute for Cancer Research, United States of America; Cancer Research Institute, United States of America; Cancer Vaccine Collaborative, United States of America; OPO-Stiftung, Switzerland [2010/11-0039]; Swiss Cancer League [02279-08-2008]; Swiss National Science Foundation [3200B0-118123]; Swiss National Center of Competence in Research (NCCR) Molecular Oncology	Ludwig Institute for Cancer Research, United States of America; Cancer Research Institute, United States of America; Cancer Vaccine Collaborative, United States of America; OPO-Stiftung, Switzerland; Swiss Cancer League; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss National Center of Competence in Research (NCCR) Molecular Oncology(Swiss National Science Foundation (SNSF))	This work was supported by the Ludwig Institute for Cancer Research, the Cancer Research Institute and the Cancer Vaccine Collaborative, United States of America, the OPO-Stiftung (2010/11-0039), Switzerland, the Swiss Cancer League (02279-08-2008), the Swiss National Science Foundation (3200B0-118123), and the Swiss National Center of Competence in Research (NCCR) Molecular Oncology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadzadeh M, 2009, BLOOD, V114, P1537, DOI 10.1182/blood-2008-12-195792; Baitsch L, 2011, J CLIN INVEST, V121, P2350, DOI 10.1172/JCI46102; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Baumgaertner P, 2006, CANCER RES, V66, P1912, DOI 10.1158/0008-5472.CAN-05-3793; Bengsch B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000947; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Brahmer JR, 2010, J CLIN ONCOL, V28, P3167, DOI 10.1200/JCO.2009.26.7609; Christofori G, 1999, TRENDS BIOCHEM SCI, V24, P73, DOI 10.1016/S0968-0004(98)01343-7; Demeure CE, 2001, EUR J CANCER, V37, P1709, DOI 10.1016/S0959-8049(01)00184-8; Derre L, 2010, J CLIN INVEST, V120, P157, DOI 10.1172/JCI40070; Di Giacomo AM, 2011, CANCER IMMUNOL IMMUN, V60, P467, DOI 10.1007/s00262-010-0958-2; Eggermont AMM, 2010, SEMIN ONCOL, V37, P455, DOI 10.1053/j.seminoncol.2010.09.009; Fourcade J, 2010, J EXP MED, V207, P2175, DOI 10.1084/jem.20100637; Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292; Grosso JF, 2007, J CLIN INVEST, V117, P3383, DOI 10.1172/JCI31184; Grundemann C, 2010, EUR J IMMUNOL, V40, P1303, DOI 10.1002/eji.200939771; Haining WN, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-44; Holmes S, 2005, P NATL ACAD SCI USA, V102, P5519, DOI 10.1073/pnas.0501437102; Jin HT, 2010, P NATL ACAD SCI US; Jones RB, 2008, J EXP MED, V205, P2763, DOI 10.1084/jem.20081398; Juran BD, 2008, HEPATOLOGY, V47, P563, DOI 10.1002/hep.22048; Lienard Danielle, 2004, Cancer Immun, V4, P4; Mangsbo SM, 2010, J IMMUNOTHER, V33, P225, DOI 10.1097/CJI.0b013e3181c01fcb; Matsuzaki J, 2010, P NATL ACAD SCI USA, V107, P7875, DOI 10.1073/pnas.1003345107; Miller JD, 2008, IMMUNITY, V28, P710, DOI 10.1016/j.immuni.2008.02.020; Pittet MJ, 1999, J EXP MED, V190, P705, DOI 10.1084/jem.190.5.705; Quigley M, 2010, NAT MED, V16, P1147, DOI 10.1038/nm.2232; Raziorrouh B, 2010, HEPATOLOGY, V52, P1934, DOI 10.1002/hep.23936; Ribas A, 2010, SEMIN ONCOL, V37, P450, DOI 10.1053/j.seminoncol.2010.09.010; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; Sakuishi K, 2010, J EXP MED, V207, P2187, DOI 10.1084/jem.20100643; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Samaik AA, 2011, CLIN CANCER RES, V17, P896, DOI 10.1158/1078-0432.CCR-10-2463; Shi F, 2010, INT J CANC; Speiser DE, 2005, J CLIN INVEST, V115, P739, DOI 10.1172/JCI200523373; Takamura S, 2010, J IMMUNOL, V184, P4696, DOI 10.4049/jimmunol.0903478; Tsujimura K, 2006, IMMUNOL LETT, V106, P48, DOI 10.1016/j.imlet.2006.04.006; Valsesia A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018369; Vazquez-Cintron EJ, 2010, J IMMUNOL, V185, P7133, DOI 10.4049/jimmunol.1001157; Watanabe N, 2003, NAT IMMUNOL, V4, P670, DOI 10.1038/ni944; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Willinger T, 2005, J IMMUNOL, V175, P5895, DOI 10.4049/jimmunol.175.9.5895; Zippelius A, 2004, CANCER RES, V64, P2865, DOI 10.1158/0008-5472.CAN-03-3066	43	136	153	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e30852	10.1371/journal.pone.0030852	http://dx.doi.org/10.1371/journal.pone.0030852			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347406	Green Published, gold, Green Submitted			2022-12-27	WOS:000302730100026
J	Xu, H; Gao, Y; Wang, JB				Xu, Hong; Gao, Yi; Wang, Jianbo			Transcriptomic Analysis of Rice (Oryza sativa) Developing Embryos Using the RNA-Seq Technique	PLOS ONE			English	Article							GENE-EXPRESSION PROFILES; ARABIDOPSIS-THALIANA; GENOME; ANNOTATION; REVEALS; ATLAS	Rice (Oryza sativa) is an excellent model monocot with a known genome sequence for studying embryogenesis. Here we report the transcriptome profiling analysis of rice developing embryos using RNA-Seq as an attempt to gain insight into the molecular and cellular events associated with rice embryogenesis. RNA-Seq analysis generated 17,755,890 sequence reads aligned with 27,190 genes, which provided abundant data for the analysis of rice embryogenesis. A total of 23,971, 23,732, and 23,592 genes were identified from embryos at three developmental stages (3-5, 7, and 14 DAP), while an analysis between stages allowed the identification of a subset of stage-specific genes. The number of genes expressed stage-specifically was 1,131, 1,443, and 1,223, respectively. In addition, we investigated transcriptomic changes during rice embryogenesis based on our RNA-Seq data. A total of 1,011 differentially expressed genes (DEGs) (log(2)Ratio >= 1, FDR <= 0.001) were identified; thus, the transcriptome of the developing rice embryos changed considerably. A total of 672 genes with significant changes in expression were detected between 3-5 and 7 DAP; 504 DEGs were identified between 7 and 14 DAP. A large number of genes related to metabolism, transcriptional regulation, nucleic acid replication/processing, and signal transduction were expressed predominantly in the early and middle stages of embryogenesis. Protein biosynthesis-related genes accumulated predominantly in embryos at the middle stage. Genes for starch/sucrose metabolism and protein modification were highly expressed in the middle and late stages of embryogenesis. In addition, we found that many transcription factor families may play important roles at different developmental stages, not only in embryo initiation but also in other developmental processes. These results will expand our understanding of the complex molecular and cellular events in rice embryogenesis and provide a foundation for future studies on embryo development in rice and other cereal crops.	[Xu, Hong; Gao, Yi; Wang, Jianbo] Wuhan Univ, Coll Life Sci, State Key Lab Hybrid Rice, Wuhan 430072, Peoples R China	Wuhan University	Xu, H (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Hybrid Rice, Wuhan 430072, Peoples R China.	jbwang@whu.edu.cn			State Key Basic Research and Development Plan of China [2007CB108700]; National Natural Science Foundation of China [30821064]	State Key Basic Research and Development Plan of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the State Key Basic Research and Development Plan of China (2007CB108700), and the National Natural Science Foundation of China (30821064). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisimov SV, 2008, CURR PHARM BIOTECHNO, V9, P338, DOI 10.2174/138920108785915148; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Brown JA, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100043; Chandler JW, 2007, DEVELOPMENT, V134, P1653, DOI 10.1242/dev.001016; Cheong YH, 2002, PLANT PHYSIOL, V129, P661, DOI 10.1104/pp.002857; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; Colombo M, 2008, PLANT J, V54, P1037, DOI 10.1111/j.1365-313X.2008.03485.x; Eveland AL, 2010, PLANT PHYSIOL, V154, P1024, DOI 10.1104/pp.110.159673; Garber M, 2011, NAT METHODS, V8, P469, DOI [10.1038/nmeth.1613, 10.1038/NMETH.1613]; Guo J, 2010, PLANTA, V231, P293, DOI 10.1007/s00425-009-1051-y; Hadfi K, 1998, DEVELOPMENT, V125, P879; HECK GR, 1995, PLANT CELL, V7, P1271, DOI 10.1105/tpc.7.8.1271; Itoh J, 2005, PLANT CELL PHYSIOL, V46, P23, DOI 10.1093/pcp/pci501; Jiao YL, 2009, NAT GENET, V41, P258, DOI 10.1038/ng.282; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Lan LF, 2004, PLANT MOL BIOL, V54, P471, DOI 10.1023/B:PLAN.0000038254.58491.c7; Lee JM, 2002, FUNCT INTEGR GENOMIC, V2, P13, DOI 10.1007/s10142-002-0046-6; Luo M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002125; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Nambara E, 2000, DEV BIOL, V220, P412, DOI 10.1006/dbio.2000.9632; Nuccio ML, 1999, PLANT MOL BIOL, V39, P1153, DOI 10.1023/A:1006101404867; Ozsolak F, 2010, NAT METHODS, V7, P619, DOI [10.1038/NMETH.1480, 10.1038/nmeth.1480]; Sasaki T, 2000, CURR OPIN PLANT BIOL, V3, P138, DOI 10.1016/S1369-5266(99)00047-3; Sentoku N, 2000, DEV BIOL, V220, P358, DOI 10.1006/dbio.2000.9624; Severin AJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-160; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wei G, 2009, P NATL ACAD SCI USA, V106, P7695, DOI 10.1073/pnas.0902340106; Weijers D, 2006, DEV CELL, V10, P265, DOI 10.1016/j.devcel.2005.12.001; Weijers D, 2005, EMBO J, V24, P1874, DOI 10.1038/sj.emboj.7600659; Wilhelm BT, 2009, METHODS, V48, P249, DOI 10.1016/j.ymeth.2009.03.016; Xiang DQ, 2011, PLANT PHYSIOL, V156, P346, DOI 10.1104/pp.110.171702; Zhang GJ, 2010, GENOME RES, V20, P646, DOI 10.1101/gr.100677.109	34	84	87	5	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e30646	10.1371/journal.pone.0030646	http://dx.doi.org/10.1371/journal.pone.0030646			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347394	gold, Green Submitted, Green Published			2022-12-27	WOS:000302730100020
J	Avery, JW; Smith, GM; Owino, SO; Sarr, D; Nagy, T; Mwalimu, S; Matthias, J; Kelly, LF; Poovassery, JS; Middii, JD; Abramowsky, C; Moore, JM				Avery, John W.; Smith, Geoffrey M.; Owino, Simon O.; Sarr, Demba; Nagy, Tamas; Mwalimu, Stephen; Matthias, James; Kelly, Lauren F.; Poovassery, Jayakumar S.; Middii, Joab D.; Abramowsky, Carlos; Moore, Julie M.			Maternal Malaria Induces a Procoagulant and Antifibrinolytic State That Is Embryotoxic but Responsive to Anticoagulant Therapy	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; MOLECULAR-WEIGHT HEPARINS; DISSEMINATED INTRAVASCULAR COAGULATION; INTRAUTERINE GROWTH RESTRICTION; TISSUE FACTOR; PLACENTAL MALARIA; BLOOD-COAGULATION; INFECTED ERYTHROCYTES; VENOOCCLUSIVE DISEASE; ADHESION MOLECULES	Low birth weight and fetal loss are commonly attributed to malaria in endemic areas, but the cellular and molecular mechanisms that underlie these poor birth outcomes are incompletely understood. Increasing evidence suggests that dysregulated hemostasis is important in malaria pathogenesis, but its role in placental malaria (PM), characterized by intervillous sequestration of Plasmodium falciparum, proinflammatory responses, and excessive fibrin deposition is not known. To address this question, markers of coagulation and fibrinolysis were assessed in placentae from malaria-exposed primigravid women. PM was associated with significantly elevated placental monocyte and proinflammatory marker levels, enhanced perivillous fibrin deposition, and increased markers of activated coagulation and suppressed fibrinolysis in placental plasma. Submicroscopic PM was not proinflammatory but tended to be procoagulant and antifibrinolytic. Birth weight trended downward in association with placental parasitemia and high fibrin score. To directly assess the importance of coagulation in malaria-induced compromise of pregnancy, Plasmodium chabaudi AS-infected pregnant C57BL/6 mice were treated with the anticoagulant, low molecular weight heparin. Treatment rescued pregnancy at midgestation, with substantially decreased rates of active abortion and reduced placental and embryonic hemorrhage and necrosis relative to untreated animals. Together, the results suggest that dysregulated hemostasis may represent a novel therapeutic target in malaria-compromised pregnancies.	[Avery, John W.; Smith, Geoffrey M.; Owino, Simon O.; Sarr, Demba; Mwalimu, Stephen; Kelly, Lauren F.; Poovassery, Jayakumar S.; Middii, Joab D.; Moore, Julie M.] Univ Georgia, Dept Infect Dis, Athens, GA 30602 USA; [Avery, John W.; Smith, Geoffrey M.; Owino, Simon O.; Sarr, Demba; Mwalimu, Stephen; Kelly, Lauren F.; Poovassery, Jayakumar S.; Middii, Joab D.; Moore, Julie M.] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA; [Owino, Simon O.; Mwalimu, Stephen; Middii, Joab D.] Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Kisumu, Kenya; [Nagy, Tamas] Univ Georgia, Dept Vet Pathol, Athens, GA 30602 USA; [Matthias, James] Univ Georgia, Dept Epidemiol & Biostat, Athens, GA 30602 USA; [Abramowsky, Carlos] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Kenya Medical Research Institute; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Emory University	Avery, JW (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA.	julmoore@uga.edu	Sarr, Demba/GOG-9376-2022; Sarr, Demba/AAP-7125-2020	Sarr, Demba/0000-0002-8306-0433; Collins, Lauren/0000-0002-0170-5454	National Institutes of Health [R01 AI050240, R01 HD046860]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD046860] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050240] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health grants R01 AI050240 and R01 HD046860 to JMM. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases (NIAID), the National Institute of Child Health and Human Development (NICHD) or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ani B, 2010, HYPERTENSION, V55, P689, DOI 10.1161/HYPERTENSIONAHA.109.136333; Aziken ME, 2011, INT J GYNECOL OBSTET, V112, P30, DOI 10.1016/j.ijgo.2010.07.027; Badawy AM, 2008, J OBSTET GYNAECOL, V28, P280, DOI 10.1080/01443610802042688; BOROCHOV.D, 1970, BRIT MED J, V2, P710, DOI 10.1136/bmj.2.5711.710; Bowen JA, 1999, BIOL REPROD, V60, P428, DOI 10.1095/biolreprod60.2.428; Brabin BJ, 2004, PLACENTA, V25, P359, DOI 10.1016/j.placenta.2003.10.019; Brenner B, 2000, THROMB HAEMOSTASIS, V83, P693; Brenner B, 2005, WOMENS HEALTH, V1, P153, DOI 10.2217/17455057.1.2.153; Camerer E, 1996, THROMB RES, V81, P1, DOI 10.1016/0049-3848(95)00209-X; CARLSON J, 1992, AM J TROP MED HYG, V46, P595, DOI 10.4269/ajtmh.1992.46.595; Chaisavaneeyakorn S, 2003, CLIN DIAGN LAB IMMUN, V10, P631, DOI 10.1128/CDLI.10.4.631-636.2003; CLEMENS R, 1994, BRIT J HAEMATOL, V87, P100, DOI 10.1111/j.1365-2141.1994.tb04877.x; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Crocker IP, 2004, PLACENTA, V25, P273, DOI 10.1016/j.placenta.2003.09.010; de Jonge E, 2000, BLOOD, V95, P1124, DOI 10.1182/blood.V95.4.1124.002k20_1124_1129; Dellicour S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000221; Demas A, 2011, J CLIN MICROBIOL, V49, P2411, DOI 10.1128/JCM.02603-10; DENNIS LH, 1968, LANCET, V1, P769; DENNIS LH, 1967, BLOOD-J HEMATOL, V29, P713; Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X; Dusse LM, 2011, CLIN CHIM ACTA, V412, P17, DOI 10.1016/j.cca.2010.09.030; Estrada-Gutierrez G, 2011, AM J PATHOL, V178, P451, DOI 10.1016/j.ajpath.2010.11.003; Francischetti IMB, 2007, J THROMB HAEMOST, V5, P155, DOI 10.1111/j.1538-7836.2006.02232.x; Francischetti IM, 2011, ARTERIOSCLER THROMB; Francischetti IMB, 2008, TRENDS PARASITOL, V24, P258, DOI 10.1016/j.pt.2008.03.009; Francischetti IMB, 2008, MICROCIRCULATION, V15, P81, DOI 10.1080/10739680701451516; Freeman BD, 2003, SHOCK, V20, P5, DOI 10.1097/01.shk.0000068327.26733.10; Fried M, 1998, J IMMUNOL, V160, P2523; Greer IA, 2005, BLOOD, V106, P401, DOI 10.1182/blood-2005-02-0626; Guo YH, 2009, BLOOD, V113, P4431, DOI 10.1182/blood-2008-07-169433; Gutierrez G, 2004, AM J REPROD IMMUNOL, V51, P160, DOI 10.1046/j.8755-8920.2003.00131.x; HALL AP, 1976, BMJ-BRIT MED J, V1, P323, DOI 10.1136/bmj.1.6005.323; Havlik I, 2005, T ROY SOC TROP MED H, V99, P333, DOI 10.1016/j.trstmh.2004.05.005; HOWARD WA, 1972, LANCET, V2, P738; Imamura T, 2002, J INFECT DIS, V186, P436, DOI 10.1086/341507; Isermann B, 2001, DEVELOPMENT, V128, P827; Isermann B, 2003, NAT MED, V9, P331, DOI 10.1038/nm825; Kornblum N, 2006, OLIGONUCLEOTIDES, V16, P105, DOI 10.1089/oli.2006.16.105; Kyriacou HM, 2007, ANTIMICROB AGENTS CH, V51, P1321, DOI 10.1128/AAC.01216-06; Landis SH, 2009, EPIDEMIOL INFECT, V137, P294, DOI 10.1017/S0950268808000915; Larocca A, 2008, EXPERT OPIN BIOL TH, V8, P1201, DOI [10.1517/14712598.8.8.1201, 10.1517/14712598.8.8.1201 ]; Laskin CA, 2009, J RHEUMATOL, V36, P279, DOI [10.3899/jrheum.080763), 10.3899/jrheum.080763]; Leitgeb AM, 2011, AM J TROP MED HYG, V84, P390, DOI 10.4269/ajtmh.2011.10-0256; Levi M, 1997, EUR J CLIN INVEST, V27, P3, DOI 10.1046/j.1365-2362.1997.570614.x; Levi M, 2010, HAMOSTASEOLOGIE, V30, P10; Levi M, 2001, CRIT CARE MED, V29, pS90, DOI 10.1097/00003246-200107001-00028; Levi M, 2010, SEMIN THROMB HEMOST, V36, P550, DOI 10.1055/s-0030-1255449; Levi M, 2010, CRIT CARE MED, V38, pS26, DOI 10.1097/CCM.0b013e3181c98d21; Linhardt RJ, 1999, SEMIN THROMB HEMOST, V25, P5; Lucchi NW, 2011, PLACENTA, V32, P579, DOI 10.1016/j.placenta.2011.05.003; Lucchi NW, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-42; Luxemburger C, 2001, AM J EPIDEMIOL, V154, P459, DOI 10.1093/aje/154.5.459; Mackinnon MJ, 2002, EXP PARASITOL, V101, P121, DOI 10.1016/S0014-4894(02)00103-0; Mackintosh CL, 2004, TRENDS PARASITOL, V20, P597, DOI 10.1016/j.pt.2004.09.006; Mackman N, 2009, J THROMB HAEMOST, V7, P136, DOI 10.1111/j.1538-7836.2009.03368.x; Matthay MA, 2001, NEW ENGL J MED, V344, P759, DOI 10.1056/NEJM200103083441009; Menendez C, 2000, J INFECT DIS, V181, P1740, DOI 10.1086/315449; Merli Geno J, 2010, P T, V35, P95; Moore JM, 2004, INFECT IMMUN, V72, P7022, DOI 10.1128/IAI.72.12.7022-7029.2004; Moore JM, 2003, PLACENTA, V24, P779, DOI 10.1016/S0143-4004(03)00112-7; MUNIR M, 1980, Paediatrica Indonesiana, V20, P47; Othoro C, 2006, CLIN VACCINE IMMUNOL, V13, P568, DOI 10.1128/CVI.13.5.568-574.2006; Perrault SD, 2009, AM J TROP MED HYG, V80, P119, DOI 10.4269/ajtmh.2009.80.119; Petaja J, 2011, THROMB RES, V127, pS34, DOI 10.1016/S0049-3848(10)70153-5; Poovassery J, 2006, INFECT IMMUN, V74, P2839, DOI 10.1128/IAI.74.5.2839-2848.2006; Poovassery J, 2009, INFECT IMMUN, V77, P4998, DOI 10.1128/IAI.00617-09; Poovassery JS, 2009, J IMMUNOL, V183, P5342, DOI 10.4049/jimmunol.0901669; Prasad R, 2009, J TROP PEDIAT; Rampengan T H, 1991, Paediatr Indones, V31, P59; REID HA, 1972, LANCET, V2, P1110; REID HA, 1975, LANCET, V1, P167; Reyburn H, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2637; Richardson P, 2009, EXPERT REV HEMATOL, V2, P365, DOI 10.1586/ehm.09.30; Rogerson SJ, 2003, AM J TROP MED HYG, V68, P115, DOI 10.4269/ajtmh.2003.68.1.0680115; Rogerson SJ, 2007, LANCET INFECT DIS, V7, P105, DOI 10.1016/S1473-3099(07)70022-1; Rojanasthien S, 1993, Southeast Asian J Trop Med Public Health, V24 Suppl 1, P225; Rojanasthien Sophark, 1992, Journal of the Medical Association of Thailand, V75, P190; Rowan JA, 2003, AUST NZ J OBSTET GYN, V43, P123, DOI 10.1046/j.0004-8666.2003.00034.x; ROWE A, 1994, EXP PARASITOL, V79, P506, DOI 10.1006/expr.1994.1111; Scifres CM, 2009, J PHYSIOL-LONDON, V587, P3453, DOI 10.1113/jphysiol.2009.173252; SMITSKAM.H, 1971, BRIT MED J, V1, P714, DOI 10.1136/bmj.1.5751.714; STONE WJ, 1972, ARCH INTERN MED, V129, P620, DOI 10.1001/archinte.129.4.620; Teng YC, 2009, J PERINAT MED, V37, P343, DOI 10.1515/JPM.2009.060; van Eijk AM, 2003, AIDS, V17, P595, DOI 10.1097/00002030-200303070-00015; VANDERPOLL T, 1994, J EXP MED, V179, P1253, DOI 10.1084/jem.179.4.1253; Vogetseder A, 2004, TROP MED INT HEALTH, V9, P767, DOI 10.1111/j.1365-3156.2004.01265.x; Vogt AM, 2006, PLOS PATHOG, V2, P853, DOI 10.1371/journal.ppat.0020100	87	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2012	7	2							e31090	10.1371/journal.pone.0031090	http://dx.doi.org/10.1371/journal.pone.0031090			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917MF	22347435	Green Published, Green Submitted, gold			2022-12-27	WOS:000302180600028
J	Dana, CE; Glauber, KM; Chan, TA; Bridge, DM; Steele, RE				Dana, Catherine E.; Glauber, Kristine M.; Chan, Titus A.; Bridge, Diane M.; Steele, Robert E.			Incorporation of a Horizontally Transferred Gene into an Operon during Cnidarian Evolution	PLOS ONE			English	Article							TRANSFECTED BRUGIA-MALAYI; CLASS-LEVEL RELATIONSHIPS; CELL-CYCLE KINETICS; HYDRA-ATTENUATA; STEM-CELLS; CIONA-INTESTINALIS; PHYLUM CNIDARIA; MESSENGER-RNAS; GENOME; SEQUENCES	Genome sequencing has revealed examples of horizontally transferred genes, but we still know little about how such genes are incorporated into their host genomes. We have previously reported the identification of a gene (flp) that appears to have entered the Hydra genome through horizontal transfer. Here we provide additional evidence in support of our original hypothesis that the transfer was from a unicellular organism, and we show that the transfer occurred in an ancestor of two medusozoan cnidarian species. In addition we show that the gene is part of a bicistronic operon in the Hydra genome. These findings identify a new animal phylum in which trans-spliced leader addition has led to the formation of operons, and define the requirements for evolution of an operon in Hydra. The identification of operons in Hydra also provides a tool that can be exploited in the construction of transgenic Hydra strains.	[Dana, Catherine E.; Glauber, Kristine M.; Chan, Titus A.; Steele, Robert E.] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92717 USA; [Dana, Catherine E.; Glauber, Kristine M.; Chan, Titus A.; Steele, Robert E.] Univ Calif Irvine, Ctr Dev Biol, Irvine, CA 92717 USA; [Bridge, Diane M.] Elizabethtown Coll, Dept Biol, Elizabethtown, PA 17022 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Dana, CE (corresponding author), Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92717 USA.	resteele@uci.edu		Glauber, Kristine/0000-0002-1093-6481; Dana, Catherine/0000-0003-3788-7955	National Institute of General Medical Sciences [1R24GM080537-01A1]; National Institute of Aging [1RO1AG037965-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R24GM080537] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG037965] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The work described in this manuscript was supported by grant 1R24GM080537-01A1 to R.E.S. from the National Institute of General Medical Sciences and grant 1RO1AG037965-01 to D.M.B. from the National Institute of Aging. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Andersson JO, 2009, ANNU REV MICROBIOL, V63, P177, DOI 10.1146/annurev.micro.091208.073203; Andersson JO, 2005, CELL MOL LIFE SCI, V62, P1182, DOI 10.1007/s00018-005-4539-z; Blumenthal Thomas, 2004, Briefings in Functional Genomics & Proteomics, V3, P199, DOI 10.1093/bfgp/3.3.199; Bode HR, 1996, J CELL SCI, V109, P1155; BONNEFOY AM, 1972, CR ACAD SCI D NAT, V275, P2163; BOSCH TCG, 1987, DEV BIOL, V121, P182, DOI 10.1016/0012-1606(87)90151-5; Bottger A, 2002, DEV GENES EVOL, V212, P302, DOI 10.1007/s00427-002-0245-0; BRIDGE D, 1995, MOL BIOL EVOL, V12, P679; BRIDGE D, 1992, P NATL ACAD SCI USA, V89, P8750, DOI 10.1073/pnas.89.18.8750; Campbell R.D., 1983, P5; CAMPBELL RD, 1974, J CELL SCI, V16, P349; Cartwright P, 2008, J MAR BIOL ASSOC UK, V88, P1663, DOI 10.1017/S0025315408002257; Chapman JA, 2010, NATURE, V464, P592, DOI 10.1038/nature08830; Crouch MLV, 2001, ARCH MED RES, V32, P102, DOI 10.1016/S0188-4409(01)00262-4; DAVID CN, 1974, J CELL SCI, V16, P359; DAVIS LE, 1968, Z ZELLFORSCH MIK ANA, V92, P149, DOI 10.1007/BF00335643; Davis RE, 1997, MOL BIOCHEM PARASIT, V89, P25, DOI 10.1016/S0166-6851(97)00097-2; Denker E, 2008, DEV BIOL, V315, P99, DOI 10.1016/j.ydbio.2007.12.023; Derelle R, 2010, RNA, V16, P696, DOI 10.1261/rna.1975210; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FISHER DA, 1989, GENE, V84, P55, DOI 10.1016/0378-1119(89)90139-X; Frank U, 2009, STEM CELLS IN MARINE ORGANISMS, P33, DOI 10.1007/978-90-481-2767-2_3; Fraune S, 2007, P NATL ACAD SCI USA, V104, P13146, DOI 10.1073/pnas.0703375104; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Habetha M, 2005, J EXP BIOL, V208, P2157, DOI 10.1242/jeb.01571; Higazi TB, 2004, MOL BIOCHEM PARASIT, V137, P181, DOI 10.1016/j.molbiopara.2004.04.014; Huang T, 2001, MOL CELL BIOL, V21, P1111, DOI 10.1128/MCB.21.4.1111-1120.2001; HUFNAGEL LA, 1977, T AM MICROSC SOC, V96, P406, DOI 10.2307/3225874; Jackson RJ, 2005, BIOCHEM SOC T, V33, P1231, DOI 10.1042/BST0331231; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; Koonin EV, 2008, NUCLEIC ACIDS RES, V36, P6688, DOI 10.1093/nar/gkn668; Larsen Liza S Z, 2008, Int J Bioinform Res Appl, V4, P324, DOI 10.1504/IJBRA.2008.019578; LENHOFF H M, 1970, Laboratory Animals (London), V4, P139, DOI 10.1258/002367770781036463; Liu CH, 2007, MOL BIOCHEM PARASIT, V156, P62, DOI 10.1016/j.molbiopara.2007.07.012; Liu CH, 2010, INT J PARASITOL, V40, P63, DOI 10.1016/j.ijpara.2009.07.001; Martin VJ, 1997, BIOL BULL, V192, P345, DOI 10.2307/1542745; Martinez DE, 2010, MOL PHYLOGENET EVOL, V57, P403, DOI 10.1016/j.ympev.2010.06.016; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Satou Y, 2006, NUCLEIC ACIDS RES, V34, P3378, DOI 10.1093/nar/gkl418; Satou Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r152; Shalchian-Tabrizi K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002098; Shinzato C, 2011, NATURE, V476, P320, DOI 10.1038/nature10249; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Steele RE, 2004, CURR BIOL, V14, pR298, DOI 10.1016/j.cub.2004.03.047; Stover NA, 2001, P NATL ACAD SCI USA, V98, P5693, DOI 10.1073/pnas.101049998; Swofford DL, 2003, CURR BIOL; Tannreuther GW, 1909, BIOL BULL-US, V16, P205, DOI 10.2307/1536150; TARDENT P, 1974, AM ZOOL, V14, P447; Technau U, 2005, TRENDS GENET, V21, P633, DOI 10.1016/j.tig.2005.09.007; Wittlieb J, 2006, P NATL ACAD SCI USA, V103, P6208, DOI 10.1073/pnas.0510163103; ZIHLER J, 1972, ROUX ARCH DEV BIOL, V169, P239, DOI 10.1007/BF00582555	54	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2012	7	2							e31643	10.1371/journal.pone.0031643	http://dx.doi.org/10.1371/journal.pone.0031643			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LV	22328943	Green Published, gold			2022-12-27	WOS:000302179300029
J	Snary, EL; Ramnial, V; Breed, AC; Stephenson, B; Field, HE; Fooks, AR				Snary, Emma L.; Ramnial, Vick; Breed, Andrew C.; Stephenson, Ben; Field, Hume E.; Fooks, Anthony R.			Qualitative Release Assessment to Estimate the Likelihood of Henipavirus Entering the United Kingdom	PLOS ONE			English	Article							NIPAH-VIRUS-INFECTION; FLYING FOXES; PTEROPUS-VAMPYRUS; MOUTH-DISEASE; BATS; HENDRA; OUTBREAK; HORSES; RISK; TRANSMISSION	The genus Henipavirus includes Hendra virus (HeV) and Nipah virus (NiV), for which fruit bats (particularly those of the genus Pteropus) are considered to be the wildlife reservoir. The recognition of henipaviruses occurring across a wider geographic and host range suggests the possibility of the virus entering the United Kingdom (UK). To estimate the likelihood of henipaviruses entering the UK, a qualitative release assessment was undertaken. To facilitate the release assessment, the world was divided into four zones according to location of outbreaks of henipaviruses, isolation of henipaviruses, proximity to other countries where incidents of henipaviruses have occurred and the distribution of Pteropus spp. fruit bats. From this release assessment, the key findings are that the importation of fruit from Zone 1 and 2 and bat bushmeat from Zone 1 each have a Low annual probability of release of henipaviruses into the UK. Similarly, the importation of bat meat from Zone 2, horses and companion animals from Zone 1 and people travelling from Zone 1 and entering the UK was estimated to pose a Very Low probability of release. The annual probability of release for all other release routes was assessed to be Negligible. It is recommended that the release assessment be periodically re-assessed to reflect changes in knowledge and circumstances over time.	[Snary, Emma L.; Ramnial, Vick; Breed, Andrew C.; Stephenson, Ben] Anim Hlth & Vet Labs Agcy, Ctr Epidemiol & Risk Anal, Addlestone, Surrey, England; [Field, Hume E.] Biosecur Queensland, Queensland Ctr Emerging Infect Dis, Brisbane, Qld, Australia; [Fooks, Anthony R.] Anim Hlth & Vet Labs Agcy, Dept Virol, Wildlife Zoonoses & Vector Borne Dis Res Grp, Addlestone, Surrey, England; [Fooks, Anthony R.] Univ Liverpool, Natl Consortium Zoonosis Res, Neston, Cheshire, England	Veterinary Laboratories Agency; Queensland Department of Agriculture & Fisheries; Veterinary Laboratories Agency; University of Liverpool	Snary, EL (corresponding author), Anim Hlth & Vet Labs Agcy, Ctr Epidemiol & Risk Anal, Addlestone, Surrey, England.	emma.Snary@ahvla.gsi.gov.uk	Fooks, Anthony R/F-5418-2010; Breed, Andrew C/A-5682-2011; Snary, Emma/C-7932-2011	Breed, Andrew C/0000-0002-3439-9510; 	Science and Technology Directorate; Department of Homeland Security and Fogarty International Center; National Institutes of Health, USA	Science and Technology Directorate; Department of Homeland Security and Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)United States Department of Homeland Security (DHS)); National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This release assessment was commissioned by the UK Department for Environment, Food and Rural Affairs (Defra), Project SV3700, as part of their ongoing evaluation of risks to animal health in the UK. We wish to acknowledge support from the Research and Policy for Infectious Disease Dynamics (RAPIDD) program of the Science and Technology Directorate, Department of Homeland Security and Fogarty International Center, National Institutes of Health, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, VET REC, V165, P303; [Anonymous], 2004, ECOLOGY HENDRA VIRUS; Australian Veterinary Emergency Plan AUSVETPLAN, 2009, RESP POL BRIEFS BRIE; Baldock F. C., 1996, Singapore Veterinary Journal, V20, P57; Breed AC, 2006, BIOL CONSERV, V131, P211, DOI 10.1016/j.biocon.2006.04.007; Calix M., 2018, EUROPEAN RED LIST SA; Chaber AL, 2010, CONSERV LETT, V3, P317, DOI 10.1111/j.1755-263X.2010.00121.x; Chadha MS, 2006, EMERG INFECT DIS, V12, P235, DOI 10.3201/eid1202.051247; Chua KB, 2000, SCIENCE, V288, P1432, DOI 10.1126/science.288.5470.1432; Chua KB, 2002, MICROBES INFECT, V4, P145, DOI 10.1016/S1286-4579(01)01522-2; Defra, 2011, RESTR; Defra, 2011, BRING YOUR PET DOG C; Defra, 2009, INT TRAD IMP INF NOT; Drexler JF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006367; Eaton BT, 2006, NAT REV MICROBIOL, V4, P23, DOI 10.1038/nrmicro1323; EFSA, 2007, EFSA J, V584, P1; EFSA, 2006, EFSA J, V357; Epstein JH, 2008, EMERG INFECT DIS, V14, P1309, DOI 10.3201/eid1408.071492; Epstein JH, 2006, EMERG INFECT DIS, V12, P1178, DOI 10.3201/eid1207.050799; Field HE, 2007, AUST VET J, V85, P268, DOI 10.1111/j.1751-0813.2007.00170.x; Field H, 2010, EMERG INFECT DIS, V16, P338, DOI 10.3201/eid1602.090780; Fogarty R, 2008, VIRUS RES, V132, P140, DOI 10.1016/j.virusres.2007.11.010; GALE P, 2009, EPIDEMIOL INFECT, V7, P1; Gurley ES, 2007, EMERG INFECT DIS, V13, P1031, DOI 10.3201/eid1307.061128; Hall L, 2000, AUSTR NATURAL HIST S; Hartnett E, 2007, RISK ANAL, V27, P187, DOI 10.1111/j.1539-6924.2006.00869.x; Hayman DTS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002739; Heller J, 2010, RISK ANAL, V30, P458, DOI 10.1111/j.1539-6924.2009.01342.x; Hsu VP, 2004, EMERG INFECT DIS, V10, P2082, DOI 10.3201/eid1012.040701; Iehle C, 2007, EMERG INFECT DIS, V13, P159, DOI 10.3201/eid1301.060791; Jenkins Richard K.B., 2008, Madagascar Conservation & Development, V3, P22; Johara MY, 2001, EMERG INFECT DIS, V7, P439; Li MY, 2010, VET RES, V41, DOI 10.1051/vetres/2010005; Li Y, 2008, EMERG INFECT DIS, V14, P1974, DOI 10.3201/eid1412.080359; Ling A, 1999, SINGAPORE MED J, V40; Luby SP, 2006, EMERG INFECT DIS, V12, P1888; Luby SP, 2009, CLIN INFECT DIS, V49, P1743, DOI 10.1086/647951; Mickleburgh S, 2009, ORYX, V43, P217, DOI 10.1017/S0030605308000938; Middleton DJ, 2002, J COMP PATHOL, V126, P124, DOI 10.1053/jcpa.2001.0532; Mills JN, 2009, EMERG INFECT DIS, V15, P950, DOI 10.3201/eid1506.080453; Moutou F, 2001, REV SCI TECH OIE, V20, P723, DOI 10.20506/rst.20.3.1307; Mungall BA, 2006, J VIROL, V80, P12293, DOI 10.1128/JVI.01619-06; MURRAY K, 1995, SCIENCE, V268, P94, DOI 10.1126/science.7701348; Nor M, 2000, INT COMM REG COMM OI, P237; Nor MNM, 2000, REV SCI TECH OIE, V19, P160; Office for National Statistics, 2009, TRAV TRENDS; OIE (World Organisation for animal health), 2004, HDB IMP RISK AN AN A, V1; Paton NI, 1999, LANCET, V354, P1253, DOI 10.1016/S0140-6736(99)04379-2; Pulliam JRC, 2012, J R SOC INTERFACE, V9, P89, DOI 10.1098/rsif.2011.0223; Queensland Government, 2011, GUID VET HANDL POT H; Queensland Government, 2010, HENDR VIR INF; Radostits OM., 2007, TXB DIS CATTLE HORSE, P1452; Reynes JM, 2005, EMERG INFECT DIS, V11, P1042, DOI 10.3201/eid1107.041350; Sahani M, 2001, INT J EPIDEMIOL, V30, P1017, DOI 10.1093/ije/30.5.1017; SELVEY LA, 1995, MED J AUSTRALIA, V162, P642, DOI 10.5694/j.1326-5377.1995.tb126050.x; Sendow I, 2006, EMERG INFECT DIS, V12, P711, DOI 10.3201/eid1204.051181; Sharifah SH, 2009, NEUROL ASIA, V14, P67; Shirai J, 2007, JARQ-JPN AGR RES Q, V41, P69, DOI 10.6090/jarq.41.69; Wacharapluesadee S, 2005, EMERG INFECT DIS, V11, P1949, DOI 10.3201/eid1112.050613; Wacharapluesadee S, 2010, VECTOR-BORNE ZOONOT, V10, P183, DOI 10.1089/vbz.2008.0105; WHO, 2001, NIP VIR; WHO, 2009, HENDR VIR; World Organisation for Animal Health, 2010, IMP RISK AN	63	7	7	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2012	7	2							e27918	10.1371/journal.pone.0027918	http://dx.doi.org/10.1371/journal.pone.0027918			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LV	22328916	Green Published, gold			2022-12-27	WOS:000302179300002
J	Wood, CR; Wang, ZH; Diener, D; Zones, JM; Rosenbaum, J; Umen, JG				Wood, Christopher R.; Wang, Zhaohui; Diener, Dennis; Zones, James Matt; Rosenbaum, Joel; Umen, James G.			IFT Proteins Accumulate during Cell Division and Localize to the Cleavage Furrow in Chlamydomonas	PLOS ONE			English	Article							INTRAFLAGELLAR TRANSPORT IFT; FLAGELLAR LENGTH; PRIMARY CILIA; BASAL BODIES; MITOTIC SPINDLE; GENE-EXPRESSION; CYCLE CONTROL; KINESIN-II; MITOSIS; COMPLEX	Intraflagellar transport (IFT) proteins are well established as conserved mediators of flagellum/cilium assembly and disassembly. However, data has begun to accumulate in support of IFT protein involvement in other processes elsewhere in the cell. Here, we used synchronous cultures of Chlamydomonas to investigate the temporal patterns of accumulation and localization of IFT proteins during the cell cycle. Their mRNAs showed periodic expression that peaked during S and M phase (S/M). Unlike most proteins that are synthesized continuously during G1 phase, IFT27 and IFT46 levels were found to increase only during S/M phase. During cell division, IFT27, IFT46, IFT72, and IFT139 re-localized from the flagella and basal bodies to the cleavage furrow. IFT27 was further shown to be associated with membrane vesicles in this region. This localization pattern suggests a role for IFT in cell division.	[Wood, Christopher R.; Wang, Zhaohui; Diener, Dennis; Rosenbaum, Joel] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06511 USA; [Zones, James Matt] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Zones, James Matt; Umen, James G.] Donald Danforth Plant Sci Ctr, St Louis, MO USA	Yale University; University of California System; University of California San Diego; Donald Danforth Plant Science Center	Wood, CR (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06511 USA.	jumen@danforthcenter.org	Umen, James G/K-9120-2013	Umen, James G/0000-0003-4094-9045	National Institutes of Health National Research Service [5F32GM084566-02]; American Cancer Society [RSG-05-196-01-CCG]; National Science Foundation Integrative Graduate Education [0504645]; National Institutes of Health [R01 GM 014642]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM084566, R01GM092744, R01GM014642] Funding Source: NIH RePORTER	National Institutes of Health National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); National Science Foundation Integrative Graduate Education(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health National Research Service Award Fellowship 5F32GM084566-02 to CRW, American Cancer Society grant RSG-05-196-01-CCG to JGU, National Science Foundation Integrative Graduate Education and Research Traineeship Fellowship 0504645 to JMZ, and National Institutes of Health grant R01 GM 014642 to JR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018425; Avidor-Reiss T, 2004, CELL, V117, P527, DOI 10.1016/S0092-8674(04)00412-X; Bahler J, 2005, ANNU REV GENET, V39, P69, DOI 10.1146/annurev.genet.39.110304.095808; Baldari CT, 2010, CURR OPIN CELL BIOL, V22, P75, DOI 10.1016/j.ceb.2009.10.010; Beales PL, 2007, NAT GENET, V39, P727, DOI 10.1038/ng2038; Berckmans B, 2009, CURR OPIN PLANT BIOL, V12, P599, DOI 10.1016/j.pbi.2009.07.005; Bisova K, 2005, PLANT PHYSIOL, V137, P475, DOI 10.1104/pp.104.054155; Bloodgood RA, 2009, METHOD CELL BIOL, V94, P3, DOI 10.1016/S0091-679X(08)94001-2; Bradley BA, 2005, J CELL SCI, V118, P3317, DOI 10.1242/jcs.02455; Canty A., 2010, BOOT BOOTSTRAP R S P; Christensen ST, 2008, CURR TOP DEV BIOL, V85, P261, DOI 10.1016/S0070-2153(08)00810-7; Cole DG, 2003, TRAFFIC, V4, P435, DOI 10.1034/j.1600-0854.2003.t01-1-00103.x; Cole DG, 1998, J CELL BIOL, V141, P993, DOI 10.1083/jcb.141.4.993; COLE DG, 2008, CHLAMYDOMONAS SOURCE, V3, P71; COSS RA, 1974, J CELL BIOL, V63, P325, DOI 10.1083/jcb.63.1.325; Dagoneau N, 2009, AM J HUM GENET, V84, P706, DOI 10.1016/j.ajhg.2009.04.016; Davis EE, 2011, NAT GENET, V43, P189, DOI 10.1038/ng.756; Deane JA, 2001, CURR BIOL, V11, P1586, DOI 10.1016/S0960-9822(01)00484-5; Delaval B, 2011, NAT CELL BIOL, V13, P461, DOI 10.1038/ncb2202; EHLER LL, 1995, GENETICS, V141, P945; Fang SC, 2006, PLOS GENET, V2, P1565, DOI 10.1371/journal.pgen.0020167; Finetti F, 2009, NAT CELL BIOL, V11, P1332, DOI 10.1038/ncb1977; Follit JA, 2006, MOL BIOL CELL, V17, P3781, DOI 10.1091/mbc.E06-02-0133; Follit JA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000315; Griffiths GM, 2010, J CELL BIOL, V189, P397, DOI 10.1083/jcb.201002027; Harris E, 2008, CHLAMYDOMONAS SOURCE, V1, P65; HOLMES JA, 1989, J CELL SCI, V94, P273; Hou YQ, 2007, J CELL BIOL, V176, P653, DOI 10.1083/jcb.200608041; Jekely G, 2006, BIOESSAYS, V28, P191, DOI 10.1002/bies.20369; JOHNSON UG, 1968, J CELL BIOL, V38, P403, DOI 10.1083/jcb.38.2.403; Jonassen JA, 2008, J CELL BIOL, V183, P377, DOI 10.1083/jcb.200808137; Kohl L, 2003, EMBO J, V22, P5336, DOI 10.1093/emboj/cdg518; KOZMINSKI KG, 1993, P NATL ACAD SCI USA, V90, P5519, DOI 10.1073/pnas.90.12.5519; Lefebvre P, 2008, CHLAMYDOMONAS SOURCE, V3, P115; LEFEBVRE PA, 1986, ANNU REV CELL BIOL, V2, P517, DOI 10.1146/annurev.cb.02.110186.002505; Mahjoub MR, 2002, J CELL SCI, V115, P1759; Marshall W, 2008, CHLAMYDOMONAS SOURCE, V3, P431; Marshall WF, 2001, J CELL BIOL, V155, P405, DOI 10.1083/jcb.200106141; Matsuura K, 2002, CELL MOTIL CYTOSKEL, V52, P195, DOI 10.1002/cm.10051; Parker JDK, 2010, CYTOSKELETON, V67, P425, DOI 10.1002/cm.20454; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Pazour GJ, 1998, J CELL BIOL, V141, P979, DOI 10.1083/jcb.141.4.979; Pazour GJ, 2005, J CELL BIOL, V170, P103, DOI 10.1083/jcb.200504008; Pedersen LB, 2008, CURR TOP DEV BIOL, V85, P23, DOI 10.1016/S0070-2153(08)00802-8; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Piperno G, 1997, P NATL ACAD SCI USA, V94, P4457, DOI 10.1073/pnas.94.9.4457; Plotnikova OV, 2009, METHOD CELL BIOL, V94, P137, DOI 10.1016/S0091-679X(08)94007-3; Pugacheva EN, 2007, CELL, V129, P1351, DOI 10.1016/j.cell.2007.04.035; Qin HM, 2004, J CELL BIOL, V164, P255, DOI 10.1083/jcb.200308132; Qin HM, 2007, CURR BIOL, V17, P193, DOI 10.1016/j.cub.2006.12.040; Quarmby LM, 2005, J CELL BIOL, V169, P707, DOI 10.1083/jcb.200503053; Quarmby LM, 2008, CHLAMYDOMONAS SOURCE, V3, P43; Rasi MQ, 2009, MOL BIOL CELL, V20, P379, DOI 10.1091/mbc.E07-10-1007; RIEDER CL, 1979, J ULTRA MOL STRUCT R, V68, P173, DOI 10.1016/S0022-5320(79)90152-7; Robert A, 2007, J CELL SCI, V120, P628, DOI 10.1242/jcs.03366; ROSENBAU.JL, 1969, J CELL BIOL, V41, P600, DOI 10.1083/jcb.41.2.600; Satir P, 2008, CURR TOP DEV BIOL, V85, P63, DOI 10.1016/S0070-2153(08)00803-X; Scholey JM, 2003, ANNU REV CELL DEV BI, V19, P423, DOI 10.1146/annurev.cellbio.19.111401.091318; Sedmak T, 2010, J CELL BIOL, V189, P171, DOI 10.1083/jcb.200911095; Stolc V, 2005, P NATL ACAD SCI USA, V102, P3703, DOI 10.1073/pnas.0408358102; SUEOKA N, 1960, P NATL ACAD SCI USA, V46, P83, DOI 10.1073/pnas.46.1.83; TAMM SL, 1969, J CELL SCI, V4, P171; Team RDC, 2010, R LANG ENV STAT COMP; TUCKER RW, 1979, CELL, V17, P527, DOI 10.1016/0092-8674(79)90261-7; Tuxhorn J, 1998, CELL MOTIL CYTOSKEL, V40, P133, DOI 10.1016/j.semcdb.2008.07.005; Umen JG, 2005, CURR OPIN CELL BIOL, V17, P435, DOI 10.1016/j.ceb.2005.06.001; Umen JG, 2001, GENE DEV, V15, P1652, DOI 10.1101/gad.892101; Walczak-Sztulpa J, 2010, AM J HUM GENET, V86, P949, DOI 10.1016/j.ajhg.2010.04.012; Wang ZH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005384; Wemmer KA, 2007, INT REV CYTOL, V260, P175, DOI 10.1016/S0074-7696(06)60004-1; Wheatley DN, 1996, CELL BIOL INT, V20, P73, DOI 10.1006/cbir.1996.0011; Wittenberg C, 2005, ONCOGENE, V24, P2746, DOI 10.1038/sj.onc.1208606; Zhu WC, 2005, CELL CYCLE, V4, P633, DOI 10.4161/cc.4.5.1650	73	32	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2012	7	2							e30729	10.1371/journal.pone.0030729	http://dx.doi.org/10.1371/journal.pone.0030729			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LV	22328921	Green Published, gold, Green Submitted			2022-12-27	WOS:000302179300007
J	Knoflach, M; Kiechl, S; Mantovani, A; Cuccovillo, I; Bottazzi, B; Xu, QB; Xiao, QZ; Gasperi, A; Mayr, A; Kehrer, M; Willeit, J; Wick, G				Knoflach, Michael; Kiechl, Stefan; Mantovani, Alberto; Cuccovillo, Ivan; Bottazzi, Barbara; Xu, Qingbo; Xiao, Qingzhong; Gasperi, Arno; Mayr, Agnes; Kehrer, Marlene; Willeit, Johann; Wick, Georg			Pentraxin-3 as a Marker of Advanced Atherosclerosis Results from the Bruneck, ARMY and ARFY Studies	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; LONG PENTRAXIN; VASCULAR INFLAMMATION; UNSTABLE ANGINA; PTX3; DISEASE; ASSOCIATIONS; IMMUNITY; INNATE	Objective: Pentraxins like C-reactive protein are key components of the innate immune system. Recently, pentraxin-3 (PTX3) has been proposed to be a specific marker of vascular inflammation, yet its association with atherosclerosis is still unclear. Methods and Results: PTX3 serum levels were measured in three independent studies of 132 young men (ARMY Study), 205 young women (ARFY Study) and 562 individuals 55 to 94 years old (Bruneck Study). In contrast to C-reactive protein, PTX3 showed little relationships with classic vascular risk factors and pro-inflammatory conditions. In the population based Bruneck Study, PTX3 level was independently associated with prevalent cardiovascular diseases (multivariable odds ratio [95%CI] 3.09 [1.65-5.79]; P<0.001). Moreover, PTX3 level correlated with the severity of carotid and femoral atherosclerosis and was highest in individuals with multiple vascular territories affected. In contrast, there was no association with elevated intima-media thickness, a precursor lesion of atherosclerosis, in any of the three populations investigated. Conclusions: Level of PTX3 is independently associated with atherosclerosis and manifest cardiovascular disease but not early vessel pathology. Unlike C-reactive protein, PTX3 is not a component of the classic acute phase response (systemic inflammation) but appears to be more specific for vascular inflammation.	[Knoflach, Michael; Kiechl, Stefan; Willeit, Johann] Med Univ, Dept Neurol, Innsbruck, Austria; [Mantovani, Alberto; Bottazzi, Barbara] Ist Clin Humanitas IRCCS, Milan, Italy; [Mantovani, Alberto] Univ Milan, Dept Translat Med, Milan, Italy; [Cuccovillo, Ivan] Fdn Humanitas Ric, Milan, Italy; [Xu, Qingbo; Xiao, Qingzhong] Kings Coll London, BHF Ctr, Div Cardiovasc, London WC2R 2LS, England; [Gasperi, Arno] Bruneck Hosp, Dept Neurol, Brunico, Italy; [Mayr, Agnes] Bruneck Hosp, Dept Lab Med, Brunico, Italy; [Kehrer, Marlene] Bruneck Hosp, Dept Internal Med, Brunico, Italy; [Wick, Georg] Bioctr, Lab Autoimmun, Innsbruck, Austria	Medical University of Innsbruck; IRCCS Humanitas Research Hospital; University of Milan; University of London; King's College London	Knoflach, M (corresponding author), Med Univ, Dept Neurol, Innsbruck, Austria.	michael.knoflach@i-med.ac.at	Cuccovillo, Ivan/AAN-2209-2020; bottazzi, barbara/ABH-9274-2020; Mantovani, Alberto/HCI-7449-2022	Cuccovillo, Ivan/0000-0003-0394-5539; bottazzi, barbara/0000-0002-1930-9257; Mantovani, Alberto/0000-0001-5578-236X; , Agnes Mayr/0000-0001-9363-873X; Knoflach, Michael/0000-0001-5576-6562	EU (TOLERAGE) [HEALTH-F4-2008-202156]; Austrian Ministry of Defense; Austrian Research Fund (FWF) [Austrian Research Fund (FWF Project 14741]; Austrian Ministry of Health and Women; Ministry of Social Security, Generations and Consumer Protection; Daniel Swarovski Forschungsfoerderungsfond; Pustertaler Verein zur Pravention von Herz- und Hirngefaesserkrankungen; Sanitaetseinheit Ost; "Assessorat fuer Gesundheit", Province of Bolzano, Italy; Fondazione CARIPLO [2009-2582]; British Heart Foundation [FS/09/044/28007] Funding Source: researchfish	EU (TOLERAGE); Austrian Ministry of Defense; Austrian Research Fund (FWF)(Austrian Science Fund (FWF)); Austrian Ministry of Health and Women; Ministry of Social Security, Generations and Consumer Protection; Daniel Swarovski Forschungsfoerderungsfond; Pustertaler Verein zur Pravention von Herz- und Hirngefaesserkrankungen; Sanitaetseinheit Ost; "Assessorat fuer Gesundheit", Province of Bolzano, Italy; Fondazione CARIPLO(Fondazione Cariplo); British Heart Foundation(British Heart Foundation)	The Cooperation was funded by an EU Framework Program 7, Large Scale Integrated Project: Novel approaches to reconstitute normal immune function at old age (TOLERAGE Health research grant; HEALTH-F4-2008-202156). The ARMY Study was supported by the Austrian Ministry of Defense and the Austrian Research Fund (FWF Project 14741). The ARFY Study was funded by the Austrian Ministry of Health and Women and the Ministry of Social Security, Generations and Consumer Protection as well as by "Daniel Swarovski Forschungsfoerderungsfond". The Bruneck Study was supported by "Pustertaler Verein zur Pravention von Herz- und Hirngefaesserkrankungen", "Sanitaetseinheit Ost", and "Assessorat fuer Gesundheit", Province of Bolzano, Italy. The contribution of Fondazione CARIPLO (Project 2009-2582) to AM is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Back M, 2010, PROG CARDIOVASC DIS, V52, P410, DOI 10.1016/j.pcad.2009.12.002; BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; Bottazzi B, 2010, ANNU REV IMMUNOL, V28, P157, DOI 10.1146/annurev-immunol-030409-101305; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Inoue K, 2007, ARTERIOSCL THROM VAS, V27, P161, DOI 10.1161/01.ATV.0000252126.48375.d5; Jenny NS, 2009, ARTERIOSCL THROM VAS, V29, P594, DOI 10.1161/ATVBAHA.108.178947; Jylhava J, 2011, CLIN EXP IMMUNOL, V164, P211, DOI 10.1111/j.1365-2249.2011.04354.x; Kaess BM, 2011, NAT REV CARDIOL, V8, P246, DOI 10.1038/nrcardio.2011.50; Kanbay M, 2011, AM J NEPHROL, V33, P325, DOI 10.1159/000324916; Kiechl S, 2001, CIRCULATION, V103, P1064, DOI 10.1161/01.CIR.103.8.1064; Kiechl S, 1999, ARTERIOSCL THROM VAS, V19, P1484, DOI 10.1161/01.ATV.19.6.1484; Knoflach M, 2003, CIRCULATION, V108, P1064, DOI 10.1161/01.CIR.0000085996.95532.FF; Knoflach M, 2009, STROKE, V40, P1063, DOI 10.1161/STROKEAHA.108.525675; Latini R, 2004, CIRCULATION, V110, P2349, DOI 10.1161/01.CIR.0000145167.30987.2E; Mantovani A, 2006, VASC PHARMACOL, V45, P326, DOI 10.1016/j.vph.2006.08.011; Matsui S, 2010, ATHEROSCLEROSIS, V210, P220, DOI 10.1016/j.atherosclerosis.2009.10.033; Nishi K, 2011, RENAL FAILURE, V33, P398, DOI 10.3109/0886022X.2011.568136; Norata GD, 2009, CIRCULATION, V120, P699, DOI 10.1161/CIRCULATIONAHA.108.806547; Olson FJ, 2008, J INTERN MED, V263, P626, DOI 10.1111/j.1365-2796.2008.01927.x; Peri G, 2000, CIRCULATION, V102, P636, DOI 10.1161/01.CIR.102.6.636; Rohde LEP, 1999, AM J CARDIOL, V84, P1018, DOI 10.1016/S0002-9149(99)00491-9; Rolph MS, 2002, ARTERIOSCL THROM VAS, V22, pE10, DOI 10.1161/01.ATV.0000015595.95497.2F; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Savchenko AS, 2008, J PATHOL, V215, P48, DOI 10.1002/path.2314; Suzuki S, 2008, AM HEART J, V155, P75, DOI 10.1016/j.ahj.2007.08.013; Wick G, 2004, ANNU REV IMMUNOL, V22, P361, DOI 10.1146/annurev.immunol.22.012703.104644; Xu Y, 2011, RENAL FAILURE, V33, P998, DOI 10.3109/0886022X.2011.618969; Yilmaz MI, 2011, CLIN J AM SOC NEPHRO, V6, P785, DOI 10.2215/CJN.09231010; Yudkin JS, 2000, ATHEROSCLEROSIS, V148, P209, DOI 10.1016/S0021-9150(99)00463-3	30	52	52	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e31474	10.1371/journal.pone.0031474	http://dx.doi.org/10.1371/journal.pone.0031474			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LO	22319633	Green Published, Green Submitted, gold			2022-12-27	WOS:000302178400044
J	Cabras, T; Melis, M; Castagnola, M; Padiglia, A; Tepper, BJ; Messana, I; Barbarossa, IT				Cabras, Tiziana; Melis, Melania; Castagnola, Massimo; Padiglia, Alessandra; Tepper, Beverly J.; Messana, Irene; Barbarossa, Iole Tomassini			Responsiveness to 6-n-Propylthiouracil (PROP) Is Associated with Salivary Levels of Two Specific Basic Proline-Rich Proteins in Humans	PLOS ONE			English	Article							GENETIC TASTE SENSITIVITY; BODY-MASS INDEX; BITTER-TASTE; RECEPTOR GENES; DIETARY RESTRAINT; PERCEPTION; COMPLEX; FOOD; PHENYLTHIOCARBAMIDE; PROTEOMICS	Thiourea tasting can be predictive of individual differences in bitter taste responses, general food preferences and eating behavior, and could be correlated with saliva chemical composition. We investigated the possible relationship between PROP bitter taste responsiveness and the salivary proteome in subjects genotyped for TAS2R38 and gustin gene polymorphisms. Taste perception intensity evoked by PROP and NaCl solutions was measured in sixty-three volunteers (21 males, 42 females, age 25 +/- 3 y) to establish their PROP taster status, and 24 PROP super-tasters and 21 nontasters were selected to participate in the study. TAS2R38 and gustin gene molecular analysis were performed using PCR techniques. Qualitative and quantitative determination of salivary proteins was performed by HPLC-ESI-MS before and after PROP taste stimulation. PROP super-tastings was strongly associated with the 'taster' variant (PAV haplotype) of TAS2R38 and the A allele of rs2274333 polymorphism in the gustin gene and nontasting was associated with the minor alleles at both loci. ANOVA revealed that basal levels of II-2 and Ps-1 proteins, belonging to the basic proline-rich protein (bPRPs) family, were significantly higher in PROP super-taster than in nontaster un-stimulated saliva, and that PROP stimulation elicited a rapid increase in the levels of these same proteins only in PROP super-taster saliva. These data show for the first time that responsiveness to PROP is associated with salivary levels of II-2 peptide and Ps-1 protein, which are products of the PRB1 gene. These findings suggest that PRB1, in addition to TAS2R38 and gustin, could contribute to individual differences in thiourea sensitivity, and the expression of the PROP phenotype as a complex genetic trait.	[Cabras, Tiziana; Padiglia, Alessandra; Messana, Irene] Univ Cagliari, Dept Life & Environm Sci, Macrosect Biomed, Cagliari, Italy; [Melis, Melania; Barbarossa, Iole Tomassini] Univ Cagliari, Dept Biomed Sci, Cagliari, Italy; [Castagnola, Massimo] Catholic Univ, Inst Biochem & Clin Biochem, Rome, Italy; [Tepper, Beverly J.] Rutgers State Univ, Dept Food Sci, Sch Environm & Biol Sci, New Brunswick, NJ 08903 USA	University of Cagliari; University of Cagliari; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Rutgers State University New Brunswick	Cabras, T (corresponding author), Univ Cagliari, Dept Life & Environm Sci, Macrosect Biomed, Cagliari, Italy.	tomassin@unica.it	Cabras, Tiziana/AAF-6231-2020; Messana, Irene/L-2478-2019; Castagnola, Massimo/AAM-6355-2021; Castagnola, Massimo/AAB-2825-2019	Messana, Irene/0000-0002-1436-6105; Castagnola, Massimo/0000-0002-0959-7259; MELIS, MELANIA/0000-0003-3410-3158; TOMASSINI BARBAROSSA, IOLE/0000-0002-2849-4052	Italian Ministry of University and Research; Fondazione Banco di Sardegna; Nando Peretti Foundation	Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); Fondazione Banco di Sardegna(Fondazione Banco di Sardegna); Nando Peretti Foundation	This work was supported by the Italian Ministry of University and Research, Fondazione Banco di Sardegna and Nando Peretti Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AZEN EA, 1993, AM J HUM GENET, V53, P264; AZEN EA, 1989, GENOMICS, V5, P415, DOI 10.1016/0888-7543(89)90004-9; Azen EA, 1991, CHEM SENSES, V3, P279; Bartoshuk L. M., 1993, Food Quality and Preference, V4, P21, DOI 10.1016/0950-3293(93)90310-3; BARTOSHUK LM, 1994, PHYSIOL BEHAV, V56, P1165, DOI 10.1016/0031-9384(94)90361-1; Behrens M, 2006, CELL MOL LIFE SCI, V63, P1501, DOI 10.1007/s00018-006-6113-8; Behrens M, 2009, ANN NY ACAD SCI, V1170, P111, DOI 10.1111/j.1749-6632.2009.03897.x; Bell KI, 2006, AM J CLIN NUTR, V84, P245, DOI 10.1093/ajcn/84.1.245; BENNICK A, 1982, MOL CELL BIOCHEM, V45, P83; Bennick A, 2002, CRIT REV ORAL BIOL M, V13, P184, DOI 10.1177/154411130201300208; Biarnes X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012394; Blakeslee AF, 1932, P NATL ACAD SCI USA, V18, P120, DOI 10.1073/pnas.18.1.120; Bufe B, 2005, CURR BIOL, V15, P322, DOI 10.1016/j.cub.2005.01.047; Cabras T, 2009, J PROTEOME RES, V8, P4126, DOI 10.1021/pr900212u; Calo C, 2011, PHYSIOL BEHAV, V104, P1065, DOI 10.1016/j.physbeh.2011.06.013; CAPELESS CG, 1992, BEHAV GENET, V22, P655, DOI 10.1007/BF01066636; Castagnola M, 2004, J BIOL CHEM, V279, P41436, DOI 10.1074/jbc.M404322200; D'Archivio Massimo, 2007, Ann Ist Super Sanita, V43, P348; Del Rio JA, 1998, PLANTA MED, V64, P575, DOI 10.1055/s-2006-957519; Dinehart ME, 2006, PHYSIOL BEHAV, V87, P304, DOI 10.1016/j.physbeh.2005.10.018; Dinnella C, 2011, APPETITE, V56, P633, DOI 10.1016/j.appet.2011.02.017; Dinnella C, 2010, CHEM SENSES, V35, P75, DOI 10.1093/chemse/bjp084; Dinnella C, 2009, CHEM SENSES, V34, P295, DOI 10.1093/chemse/bjp003; Drayna D, 2003, HUM GENET, V112, P567, DOI 10.1007/s00439-003-0911-y; Drewnowski A, 2000, AM J CLIN NUTR, V72, P1424; Duffy VB, 2000, J AM DIET ASSOC, V100, P647, DOI 10.1016/S0002-8223(00)00191-7; Duffy VB, 2004, ALCOHOL CLIN EXP RES, V28, P1629, DOI 10.1097/01.ALC.0000145789.55183.D4; FENWICK GR, 1983, J SCI FOOD AGR, V34, P73, DOI 10.1002/jsfa.2740340111; FENWICK GR, 1983, CRC CR REV FOOD SCI, V18, P123, DOI 10.1080/10408398209527361; Fox AL, 1932, P NATL ACAD SCI USA, V18, P115, DOI 10.1073/pnas.18.1.115; GLANVILL.EV, 1965, NATURE, V205, P930, DOI 10.1038/205930a0; GREEN BG, 1993, CHEM SENSES, V18, P683, DOI 10.1093/chemse/18.6.683; Guo SW, 2001, ANN HUM BIOL, V28, P111; Hayes JE, 2008, CHEM SENSES, V33, P255, DOI 10.1093/chemse/bjm084; Hayes JE, 2007, CHEM SENSES, V32, P225, DOI 10.1093/chemse/bjl050; Hayes JE, 2011, CHEM SENSES, V36, P311, DOI 10.1093/chemse/bjq132; Henkin RI, 1999, AM J MED SCI, V318, P380, DOI 10.1097/00000441-199912000-00005; Henkin RI, 1999, AM J MED SCI, V318, P392, DOI 10.1097/00000441-199912000-00006; Inzitari R, 2005, PROTEOMICS, V5, P805, DOI 10.1002/pmic.200401156; Inzitari R, 2006, PROTEOMICS, V6, P6370, DOI 10.1002/pmic.200600395; Keller KL, 2002, APPETITE, V38, P3, DOI 10.1006/appe.2001.0441; Kim UK, 2003, SCIENCE, V299, P1221, DOI 10.1126/science.1080190; KINGSBURG JOHN M., 1964; Lupi A, 2003, PROTEOMICS, V3, P461, DOI 10.1002/pmic.200390060; LUSH IE, 1988, GENET RES, V52, P207, DOI 10.1017/S0016672300027671; Mennella JA, 2011, CHEM SENSES, V36, P161, DOI 10.1093/chemse/bjq106; Messana I, 2004, J PROTEOME RES, V3, P792, DOI 10.1021/pr049953c; Messana I, 2008, J SEP SCI, V31, P1948, DOI 10.1002/jssc.200800100; Messana I, 2008, MOL CELL PROTEOMICS, V7, P911, DOI 10.1074/mcp.M700501-MCP200; Meyerhof W, 2010, CHEM SENSES, V35, P157, DOI 10.1093/chemse/bjp092; Neyraud E, 2006, J PROTEOME RES, V5, P2474, DOI 10.1021/pr060189z; OLSON JM, 1989, GENET EPIDEMIOL, V6, P423, DOI 10.1002/gepi.1370060305; Ong SE, 2005, NAT CHEM BIOL, V1, P252, DOI 10.1038/nchembio736; Padiglia A, 2010, AM J CLIN NUTR, V92, P539, DOI 10.3945/ajcn.2010.29418; Pronin AN, 2007, CURR BIOL, V17, P1403, DOI 10.1016/j.cub.2007.07.046; Quintana M, 2009, CHEMOSENS PERCEPT, V2, P133, DOI 10.1007/s12078-009-9048-2; Rankin KM, 2004, GENETIC VARIATION TA, P63, DOI DOI 10.1201/9780203023433.CH3; Rayment SA, 2001, J DENT RES, V80, P1584; Reed DR, 2010, HUM MOL GENET, V19, P4278, DOI 10.1093/hmg/ddq324; Roper SD, 2007, PFLUG ARCH EUR J PHY, V454, P759, DOI 10.1007/s00424-007-0247-x; Roudnitzky N, 2011, HUM MOL GENET, V20, P3437, DOI 10.1093/hmg/ddr252; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Shi P, 2003, MOL BIOL EVOL, V20, P805, DOI 10.1093/molbev/msg083; Soares S, 2011, J AGR FOOD CHEM, V59, P5535, DOI 10.1021/jf104975d; Stubbs M, 1998, ARCH ORAL BIOL, V43, P753, DOI 10.1016/S0003-9969(98)00068-5; STUNKARD AJ, 1985, J PSYCHOSOM RES, V29, P71, DOI 10.1016/0022-3999(85)90010-8; Tepper BJ, 2008, ANNU REV NUTR, V28, P367, DOI 10.1146/annurev.nutr.28.061807.155458; Tepper BJ, 2009, ANN NY ACAD SCI, V1170, P126, DOI 10.1111/j.1749-6632.2009.03916.x; Tepper BJ, 1998, ANN NY ACAD SCI, V855, P802, DOI 10.1111/j.1749-6632.1998.tb10662.x; Tepper BJ, 2002, PHYSIOL BEHAV, V75, P305, DOI 10.1016/S0031-9384(01)00664-3; Tepper BJ, 2001, PHYSIOL BEHAV, V73, P571, DOI 10.1016/S0031-9384(01)00500-5; Wiener A, 2012, NUCLEIC ACIDS RES, V40, pD413, DOI 10.1093/nar/gkr755; WILLIAMSON MP, 1994, BIOCHEM J, V297, P249, DOI 10.1042/bj2970249; Wooding S, 2004, AM J HUM GENET, V74, P637, DOI 10.1086/383092; YAN QY, 1995, BIOCHEM J, V311, P341, DOI 10.1042/bj3110341; Zhang ZQ, 1998, J AM SOC MASS SPECTR, V9, P225, DOI 10.1016/S1044-0305(97)00284-5	76	70	70	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2012	7	2							e30962	10.1371/journal.pone.0030962	http://dx.doi.org/10.1371/journal.pone.0030962			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UG	22312435	Green Published, gold			2022-12-27	WOS:000301977500023
J	Kumar, P; Pandit, SS; Baldwin, IT				Kumar, Pavan; Pandit, Sagar Subhash; Baldwin, Ian T.			Tobacco Rattle Virus Vector: A Rapid and Transient Means of Silencing Manduca sexta Genes by Plant Mediated RNA Interference	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; NICOTIANA-ATTENUATA PLANTS; BOMBYX-MORI; ECOLOGICAL RESEARCH; EXPRESSION; SILKWORM; DSRNASE; MIDGUT; TRANSFORMATION; ARABIDOPSIS	Background: RNAi can be achieved in insect herbivores by feeding them host plants stably transformed to express double stranded RNA (dsRNA) of selected midgut-expressed genes. However, the development of stably transformed plants is a slow and laborious process and here we developed a rapid, reliable and transient method. We used viral vectors to produce dsRNA in the host plant Nicotiana attenuata to transiently silence midgut genes of the plant's lepidopteran specialist herbivore, Manduca sexta. To compare the efficacy of longer, undiced dsRNA for insect gene silencing, we silenced N. attenuata's dicer genes (NaDCL1-4) in all combinations in a plant stably transformed to express dsRNA targeting an insect gene. Methodology/Principal Findings: Stable transgenic N. attenuata plants harboring a 312 bp fragment of MsCYP6B46 in an inverted repeat orientation (ir-CYP6B46) were generated to produce CYP6B46 dsRNA. After consuming these plants, transcripts of CYP6B46 were significantly reduced in M. sexta larval midguts. The same 312 bp cDNA was cloned in an antisense orientation into a TRV vector and Agro-infiltrated into N. attenuata plants. When larvae ingested these plants, similar reductions in CYP6B46 transcripts were observed without reducing transcripts of the most closely related MsCYP6B45. We used this transient method to rapidly silence the expression of two additional midgut-expressed MsCYPs. CYP6B46 transcripts were further reduced in midguts, when the larvae fed on ir-CYP6B46 plants transiently silenced for two combinations of NaDCLs (DCL1/3/4 and DCL2/3/4) and contained higher concentrations of longer, undiced CYP6B46 dsRNA. Conclusions: Both stable and transient expression of CYP6B46 dsRNA in host plants provides a specific and robust means of silencing this gene in M. sexta larvae, but the transient system is better suited for high throughput analyses. Transiently silencing NaDCLs in ir-CYP6B46 plants increased the silencing of MsCYP6B46, suggested that insect's RNAi machinery is more efficient with longer lengths of ingested dsRNA.	[Kumar, Pavan; Pandit, Sagar Subhash; Baldwin, Ian T.] Max Planck Inst Chem Ecol, Dept Mol Ecol, Jena, Germany	Max Planck Society	Kumar, P (corresponding author), Max Planck Inst Chem Ecol, Dept Mol Ecol, Jena, Germany.	baldwin@ice.mpg.de	Baldwin, Ian T/K-1809-2013	kumar, Pavan/0000-0003-4718-3601; Baldwin, Ian/0000-0001-5371-2974	Max Planck Society; DAAD	Max Planck Society(Max Planck SocietyFoundation CELLEX); DAAD(Deutscher Akademischer Austausch Dienst (DAAD))	This work was funded by the Max Planck Society. PK was funded by a DAAD PhD fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimatsu Yuji, 2007, Journal of Insect Biotechnology and Sericology, V76, P57; Arimatsu Y, 2007, INSECT BIOCHEM MOLEC, V37, P176, DOI 10.1016/j.ibmb.2006.11.004; Arimatsu Yuji, 2010, Journal of Insect Biotechnology and Sericology, V79, P125; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Bautista MAM, 2009, INSECT BIOCHEM MOLEC, V39, P38, DOI 10.1016/j.ibmb.2008.09.005; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Bubner B, 2006, PLANT CELL REP, V25, P668, DOI 10.1007/s00299-005-0111-4; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Dubreuil G, 2009, J EXP BOT, V60, P4041, DOI 10.1093/jxb/erp237; Dzitoyeva S, 2001, MOL PSYCHIATR, V6, P665, DOI 10.1038/sj.mp.4000955; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gase K, 2011, MOL ECOL RESOUR, V11, P890, DOI 10.1111/j.1755-0998.2011.03017.x; Gordon KHJ, 2007, NAT BIOTECHNOL, V25, P1231, DOI 10.1038/nbt1107-1231; Govind G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008735; Halitschke R, 2003, PLANT J, V36, P794, DOI 10.1046/j.1365-313X.2003.01921.x; Henderson IR, 2006, NAT GENET, V38, P721, DOI 10.1038/ng1804; Hutvagner G, 2002, CURR OPIN GENET DEV, V12, P225, DOI 10.1016/S0959-437X(02)00290-3; Huvenne H, 2010, J INSECT PHYSIOL, V56, P227, DOI 10.1016/j.jinsphys.2009.10.004; Kim HH, 2009, GENE DEV, V23, P1743, DOI 10.1101/gad.1812509; Krugel T, 2002, CHEMOECOLOGY, V12, P177, DOI 10.1007/PL00012666; Lacomme C, 2003, PLANT J, V34, P543, DOI 10.1046/j.1365-313X.2003.01733.x; Lin HF, 2007, SCIENCE, V316, P397, DOI 10.1126/science.1137543; Lynch JA, 2006, NAT PROTOC, V1, P486, DOI 10.1038/nprot.2006.70; Mao YB, 2007, NAT BIOTECHNOL, V25, P1307, DOI 10.1038/nbt1352; Mao YB, 2011, TRANSGENIC RES, V20, P665, DOI 10.1007/s11248-010-9450-1; Meyering-Vos M, 2007, J INSECT PHYSIOL, V53, P840, DOI 10.1016/j.jinsphys.2007.04.003; Mlotshwa S, 2002, PLANT CELL, V14, pS289, DOI 10.1105/tpc.001677; Pitino M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025709; Price DRG, 2008, TRENDS BIOTECHNOL, V26, P393, DOI 10.1016/j.tibtech.2008.04.004; Rajagopal R, 2002, J BIOL CHEM, V277, P46849, DOI 10.1074/jbc.C200523200; ROGERS SO, 1985, PLANT MOL BIOL, V5, P69, DOI 10.1007/BF00020088; Rozen S, 2000, PRIMER3 WWW GEN USER; Saedler R, 2004, J EXP BOT, V55, P151, DOI 10.1093/jxb/erh004; Sambrook J, MOL CLONING LAB MANU, V1, P42; SNYDER MJ, 1995, ARCH BIOCHEM BIOPHYS, V321, P13, DOI 10.1006/abbi.1995.1362; Swevers L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020250; Terenius O, 2011, J INSECT PHYSIOL, V57, P231, DOI 10.1016/j.jinsphys.2010.11.006; Tomoyasu Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r10; Turner CT, 2006, INSECT MOL BIOL, V15, P383, DOI 10.1111/j.1365-2583.2006.00656.x; Valentine TA, 2007, PLANT BIOTECHNOL J, V5, P827, DOI 10.1111/j.1467-7652.2007.00289.x; Whyard S, 2009, INSECT BIOCHEM MOLEC, V39, P824, DOI 10.1016/j.ibmb.2009.09.007; Wink M, 2002, CHEMOECOLOGY, V12, P29, DOI 10.1007/s00049-002-8324-2; Zha WJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020504; Zhou XG, 2008, INSECT BIOCHEM MOLEC, V38, P805, DOI 10.1016/j.ibmb.2008.05.005	45	94	105	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2012	7	2							e31347	10.1371/journal.pone.0031347	http://dx.doi.org/10.1371/journal.pone.0031347			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UG	22312445	Green Published, gold			2022-12-27	WOS:000301977500035
J	Abou-Kandil, A; Chamias, R; Huleihel, M; Godbey, WT; Aboud, M				Abou-Kandil, Ammar; Chamias, Rachel; Huleihel, Mahmoud; Godbey, W. T.; Aboud, Mordechai			Differential Role of PKC-Induced c-Jun in HTLV-1 LTR Activation by 12-O-Tetradecanoylphorbol-13-acetate in Different Human T-cell Lines	PLOS ONE			English	Article							PROTEIN-KINASE-C; LONG TERMINAL REPEAT; VIRUS TYPE-I; NF-KAPPA-B; TYPE-1 TAX PROTEIN; DNA-DAMAGE; TRANSCRIPTION FACTORS; IMMUNE-RESPONSE; GENOMIC INSTABILITY; NUCLEAR-PROTEIN	We have previously shown that TPA activates HTLV-1 LTR in Jurkat T-cells by inducing the binding of Sp1-p53 complex to the Sp1 site residing within the Ets responsive region 1 (ERR-1) of the LTR and that this activation is inhibited by PKCalpha and PKCepsilon. However, in H9 T-cells TPA has been noted to activate the LTR in two consecutive stages. The first stage is activation is mediated by PKCetta and requires the three 21 bp TRE repeats. The second activation mode resembles that of Jurkat cells, except that it is inhibited by PKCdelta. The present study revealed that the first LTR activation in H9 cells resulted from PKCetta-induced elevation of non-phosphorylated c-Jun which bound to the AP-1 site residing within each TRE. In contrast, this TRE-dependent activation did not occur in Jurkat cells, since there was no elevation of non-phosphorylated c-Jun in these cells. However, we found that PKCalpha and PKCepsilon, in Jurkat cells, and PKCetta and PKCdelta, in H9 cells, increased the level of phosphorylated c-Jun that interacted with the Sp1-p53 complex. This interaction prevented the Sp1-p53 binding to ERR-1 and blocked, thereby, the ERR-1-mediated LTR activation. Therefore, this PKC-inhibited LTR activation started in both cell types after depletion of the relevant PKCs by their downregulation. In view of these variable activating mechanisms we assume that there might be additional undiscovered yet modes of HTLV-1 LTR activation which vary in different cell types. Moreover, in line with this presumption we speculate that in HTLV-1 carriers the LTR of the latent provirus may also be reactivated by different mechanisms that vary between its different host T-lymphocyte subclones. Since this reactivation may initiate the ATL process, understanding of these mechanisms is essential for establishing strategies to block the possibility of reactivating the latent virus as preventive means for ATL development in carriers.	[Abou-Kandil, Ammar; Chamias, Rachel; Aboud, Mordechai] Ben Gurion Univ Negev, Fac Hlth Sci, Shraga Segal Dept Microbiol & Immunol, Beer Sheva, Israel; [Huleihel, Mahmoud] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Virol & Dev Genet, Beer Sheva, Israel; [Godbey, W. T.] Tulane Univ, Lab Gene Therapy & Cellular Engn, Dept Chem & Biomol Engn, New Orleans, LA 70118 USA	Ben Gurion University; Ben Gurion University; Tulane University	Abou-Kandil, A (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Shraga Segal Dept Microbiol & Immunol, Beer Sheva, Israel.	aboud@bgu.ac.il	HULEIHEL, MAHMOUD/F-1837-2012; Godbey, W T/H-9407-2012		Israel Science Foundation; Israel Cancer Research Fund; Directorate For Engineering [0846395] Funding Source: National Science Foundation	Israel Science Foundation(Israel Science Foundation); Israel Cancer Research Fund; Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This study was supported by grants from the Israel Science Foundation and from the Israel Cancer Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso PV, 2010, BLOOD, V116, P3802, DOI 10.1182/blood-2010-02-270751; Ahmed AA, 2010, J PATHOL, V221, P49, DOI 10.1002/path.2696; Akimoto M, 2007, J MED VIROL, V79, P977, DOI 10.1002/jmv.20807; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Arima N, 2004, EXP HEMATOL, V32, P195, DOI 10.1016/j.exphem.2003.11.008; Asquith B, 2000, PHILOS T ROY SOC B, V355, P1013, DOI 10.1098/rstb.2000.0638; Avesani F, 2010, VIROLOGY, V408, P39, DOI 10.1016/j.virol.2010.08.023; Azran I, 2005, ONCOGENE, V24, P4521, DOI 10.1038/sj.onc.1208645; Azran Inbal, 2004, Retrovirology, V1, P20; Azran-Shaish I, 2008, J MOL MED, V86, P799, DOI 10.1007/s00109-008-0335-1; Bangham CRM, 2005, ONCOGENE, V24, P6035, DOI 10.1038/sj.onc.1208970; Bangham CRM, 2003, J GEN VIROL, V84, P3177, DOI 10.1099/vir.0.19334-0; Barbeau B, 2011, VIRUSES-BASEL, V3, P456, DOI 10.3390/v3050456; Bellon M, 2009, BLOOD, V113, P4914, DOI 10.1182/blood-2008-11-189845; Bogoyevitch MA, 2006, MICROBIOL MOL BIOL R, V70, P1061, DOI 10.1128/MMBR.00025-06; BOSSELUT R, 1990, EMBO J, V9, P3137, DOI 10.1002/j.1460-2075.1990.tb07511.x; Boxus M, 2009, BRIT J CANCER, V101, P1497, DOI 10.1038/sj.bjc.6605345; Brosh R, 2009, NAT REV CANCER, V9, P701, DOI 10.1038/nrc2693; Chamias R, 2010, LEUKEMIA RES, V34, P93, DOI 10.1016/j.leukres.2009.03.032; Chlichlia K, 2010, CHEM-BIOL INTERACT, V188, P359, DOI 10.1016/j.cbi.2010.06.005; CLARK NM, 1993, J VIROL, V67, P5522, DOI 10.1128/JVI.67.9.5522-5528.1993; de la Fuente C, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-43; de Souza JG, 2011, J CLIN VIROL, V50, P13, DOI 10.1016/j.jcv.2010.09.007; DITTMER D, 1993, NAT GENET, V4, P42, DOI 10.1038/ng0593-42; Dodon MD, 2010, M S-MED SCI, V26, P391, DOI 10.1051/medsci/2010264391; Durkin SS, 2008, J BIOL CHEM, V283, P36311, DOI 10.1074/jbc.M804931200; Faris M, 2008, INT REV IMMUNOL, V27, P71, DOI 10.1080/08830180701777475; Felsher DW, 1999, P NATL ACAD SCI USA, V96, P3940, DOI 10.1073/pnas.96.7.3940; Florins A, 2007, FRONT BIOSCI-LANDMRK, V12, P1520, DOI 10.2741/2165; FRENKEL K, 1989, ENVIRON HEALTH PERSP, V81, P45, DOI 10.2307/3430803; Gaudray G, 2002, J VIROL, V76, P12813, DOI 10.1128/JVI.76.24.12813-12822.2002; GEGONNE A, 1993, EMBO J, V12, P1169, DOI 10.1002/j.1460-2075.1993.tb05758.x; Giam CZ, 2007, FRONT BIOSCI, V12, P1496, DOI 10.2741/2163; GITLIN SD, 1991, J VIROL, V65, P5513, DOI 10.1128/JVI.65.10.5513-5523.1991; Gonelli A, 2009, MINI-REV MED CHEM, V9, P498, DOI 10.2174/138955709787847967; Gruhne B, 2009, P NATL ACAD SCI USA, V106, P2313, DOI 10.1073/pnas.0810619106; GUALBERTO A, 1995, J BIOL CHEM, V270, P19680, DOI 10.1074/jbc.270.34.19680; GUALBERTO A, 1995, MOL CELL BIOL, V15, P3450; Hai T, ATF TRANSCRIPTION FA, P322; HAI TW, 1989, GENE DEV, V3, P2083, DOI 10.1101/gad.3.12b.2083; Halicka HD, 2009, INT J MOL MED, V23, P695, DOI 10.3892/ijmm_00000182; Heinrich R, 1997, J CLIN ENDOCR METAB, V82, P1839, DOI 10.1210/jc.82.6.1839; Ishitsuka K, 2008, EUR J HAEMATOL, V80, P185, DOI 10.1111/j.1600-0609.2007.01016.x; JEANG KT, 1991, VIROLOGY, V181, P218, DOI 10.1016/0042-6822(91)90487-V; Jeang KT, 2010, ONCOTARGET, V1, P453; Kannagi M, 2007, INT J HEMATOL, V86, P113, DOI 10.1532/IJH97.07092; Kannagi Mari, 2004, Expert Rev Anticancer Ther, V4, P369, DOI 10.1586/14737140.4.3.369; KARIN M, 1992, TRENDS BIOCHEM SCI, V17, P418, DOI 10.1016/0968-0004(92)90012-X; Kato S, 2003, P NATL ACAD SCI USA, V100, P8424, DOI 10.1073/pnas.1431692100; Kazanietz MG, 2000, MEDICINA-BUENOS AIRE, V60, P685; Kinjo T, 2010, J VIROL, V84, P5431, DOI 10.1128/JVI.02460-09; Koivunen J, 2006, CANCER LETT, V235, P1, DOI 10.1016/j.canlet.2005.03.033; Lee AC, 1999, J BIOL CHEM, V274, P7936, DOI 10.1074/jbc.274.12.7936; Lee KH, 2010, TOXICOL LETT, V194, P42, DOI 10.1016/j.toxlet.2010.01.021; Lemasson I, 2004, MOL CELL BIOL, V24, P6117, DOI 10.1128/MCB.24.14.6117-6126.2004; Lemasson I, 2002, J BIOL CHEM, V277, P49459, DOI 10.1074/jbc.M209566200; Li MY, 2011, NULL MATH BIOL  0421, V21; Lin CW, 2010, J CELL PHYSIOL, V225, P472, DOI 10.1002/jcp.22226; Lin CT, 2006, INT J CANCER, V119, P1776, DOI 10.1002/ijc.22068; Livneh E, 1996, ONCOGENE, V12, P1545; Lu ZM, 1998, MOL CELL BIOL, V18, P839, DOI 10.1128/MCB.18.2.839; MacLachlan TK, 2002, MOL CELL BIOL, V22, P4280, DOI 10.1128/MCB.22.12.4280-4292.2002; Maor SB, 2000, MOL GENET METAB, V69, P130, DOI 10.1006/mgme.1999.2958; Marriott SJ, 2005, ONCOGENE, V24, P5986, DOI 10.1038/sj.onc.1208976; Martelli AM, 1999, J CELL BIOCHEM, V74, P499, DOI 10.1002/(SICI)1097-4644(19990915)74:4<499::AID-JCB1>3.0.CO;2-X; Matsuoka M, 2011, ONCOGENE, V30, P1379, DOI 10.1038/onc.2010.537; Matsuoka M, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-71; MONTMINY MR, 1987, NATURE, V328, P175, DOI 10.1038/328175a0; MorVaknin N, 1997, VIROLOGY, V232, P337, DOI 10.1006/viro.1997.8566; Newbound GC, 1999, J ACQ IMMUN DEF SYND, V20, P1, DOI 10.1097/00042560-199901010-00001; PAPAVASSILIOU AG, 1994, ANTICANCER RES, V14, P1801; Park SA, 2007, ANN NY ACAD SCI, V1095, P545, DOI 10.1196/annals.1397.059; Pichler K, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-100; Pise-Masison CA, 1998, J VIROL, V72, P1165, DOI 10.1128/JVI.72.2.1165-1170.1998; Raivich G, 2008, J NEUROCHEM, V107, P898, DOI 10.1111/j.1471-4159.2008.05684.x; Ratner L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004420; Reyland ME, 2009, FRONT BIOSCI-LANDMRK, V14, P2386, DOI 10.2741/3385; Ruggero K, 2010, MOL ASPECTS MED, V31, P367, DOI 10.1016/j.mam.2010.05.001; Saggioro D, 2003, ANN NY ACAD SCI, V1010, P591, DOI 10.1196/annals.1299.111; Saggioro D, 2011, VIRUSES-BASEL, V3, P1001, DOI 10.3390/v3071001; Sangfelt O, 1997, CELL GROWTH DIFFER, V8, P343; Schavinsky-Khrapunsky Y, 2003, ONCOGENE, V22, P5315, DOI 10.1038/sj.onc.1206782; Schavinsky-Khrapunsky Y, 2008, INT J CANCER, V122, P305, DOI 10.1002/ijc.23091; Shrotriya S, 2010, CANCER RES, V70, P1932, DOI 10.1158/0008-5472.CAN-09-3501; Sun SC, 2005, ONCOGENE, V24, P5952, DOI 10.1038/sj.onc.1208969; Torgeman A, 2001, VIROLOGY, V281, P10, DOI 10.1006/viro.2000.0779; Torgeman A, 2001, EXP CELL RES, V271, P169, DOI 10.1006/excr.2001.5363; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; Tsukasaki K, 2009, J CLIN ONCOL, V27, P453, DOI 10.1200/JCO.2008.18.2428; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8; Vigorito E, 1999, HEMATOL CELL THER, V41, P153, DOI 10.1007/s00282-999-0153-0; WEI HC, 1992, CANCER RES, V52, P2298; Yasunaga Jun-ichirou, 2007, Cancer Control, V14, P133; Yoshida M, 2010, P JPN ACAD B-PHYS, V86, P117, DOI 10.2183/pjab.86.117; Yu XF, 2006, BIOCHEM BIOPH RES CO, V342, P286, DOI 10.1016/j.bbrc.2006.01.147; Zhang HB, 1998, ONCOGENE, V16, P1713, DOI 10.1038/sj.onc.1201932; Zhi H, 2011, LOS PATHOG, V7	97	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e29934	10.1371/journal.pone.0029934	http://dx.doi.org/10.1371/journal.pone.0029934			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22299029	gold, Green Published, Green Submitted			2022-12-27	WOS:000301704200006
J	Tyrka, AR; Price, LH; Marsit, C; Walters, OC; Carpenter, LL				Tyrka, Audrey R.; Price, Lawrence H.; Marsit, Carmen; Walters, Oakland C.; Carpenter, Linda L.			Childhood Adversity and Epigenetic Modulation of the Leukocyte Glucocorticoid Receptor: Preliminary Findings in Healthy Adults	PLOS ONE			English	Article							PARENTAL BONDING INSTRUMENT; CORTISOL RESPONSES; EARLY STRESS; MALTREATMENT; METHYLATION; PSYCHOPATHOLOGY; PATHOPHYSIOLOGY; CONSEQUENCES; NEUROBIOLOGY; EXPERIENCES	Background: A history of early adverse experiences is an important risk factor for adult psychopathology. Changes in stress sensitivity and functioning of the hypothalamic-pituitary-adrenal (HPA) axis may underlie the association between stress and risk for psychiatric disorders. Preclinical work in rodents has linked low levels of maternal care to increased methylation of the promoter region of the glucocorticoid receptor (GR) gene, as well as to exaggerated hormonal and behavioral responses to stress. Recent studies have begun to examine whether early-life stress leads to epigenetic modifications of the GR gene in humans. Methods: We examined the degree of methylation of a region of the promoter of the human GR gene (NR3C1) in leukocyte DNA from 99 healthy adults. Participants reported on their childhood experiences of parental behavior, parental death or desertion, and childhood maltreatment. On a separate day, participants completed the dexamethasone/corticotropinreleasing hormone (Dex/CRH) test, a standardized neuroendocrine challenge test. Results: Disruption or lack of adequate nurturing, as measured by parental loss, childhood maltreatment, and parental care, was associated with increased NR3C1 promoter methylation (p<.05). In addition, NR3C1 promoter methylation was linked to attenuated cortisol responses to the Dex/CRH test (p<.05). Conclusions: These findings suggest that childhood maltreatment or adversity may lead to epigenetic modifications of the human GR gene. Alterations in methylation of this gene could underlie the associations between childhood adversity, alterations in stress reactivity, and risk for psychopathology.	[Tyrka, Audrey R.; Price, Lawrence H.; Walters, Oakland C.; Carpenter, Linda L.] Butler Hosp, Mood Disorders Res Program, Lab Clin Neurosci, Providence, RI 02906 USA; [Tyrka, Audrey R.; Price, Lawrence H.; Carpenter, Linda L.] Brown Med Sch, Dept Psychiat & Human Behav, Providence, RI USA; [Marsit, Carmen] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Pharmacol & Toxicol,Dept Community & Family, Hanover, NH 03756 USA	Butler Hospital Rhode Island; Brown University; Dartmouth College	Tyrka, AR (corresponding author), Butler Hosp, Mood Disorders Res Program, Lab Clin Neurosci, Providence, RI 02906 USA.	Audrey_Tyrka@Brown.edu	Tyrka, Audrey/L-2504-2014	Walters, Oakland C./0000-0002-0597-8994; Marsit, Carmen/0000-0003-4566-150X	National Institute of Mental Health (NIMH) [R01 MH083704, R01 MH068767]; Centers of Biomedical Research Excellence (COBRE) [P20RR018728]; National Institutes of Mental Health; NARSAD; UCB Pharma; Sepracor; Cyberonics; Department of Defense; Medtronic; Neuronetics; NeoSync; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018728] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH091508, R01MH068767, R01MH083704] Funding Source: NIH RePORTER	National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Centers of Biomedical Research Excellence (COBRE)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NARSAD(NARSAD); UCB Pharma(UCB Pharma SA); Sepracor; Cyberonics; Department of Defense(United States Department of Defense); Medtronic(Medtronic); Neuronetics; NeoSync; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funding for this study was provided by National Institute of Mental Health (NIMH; www.nimh.nih.gov) grants R01 MH083704 (Dr. Tyrka) and R01 MH068767 (Dr. Carpenter), and Centers of Biomedical Research Excellence (COBRE) grant P20RR018728 (Dr. Marsit). Acthrel was purchased at a discounted rate for research from Ferring Pharmaceuticals, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and report the following interests: In the last three years, Dr. Tyrka, Dr. Carpenter, and Dr. Price have received research support from the National Institutes of Mental Health, NARSAD, UCB Pharma, Sepracor, Cyberonics, the Department of Defense, Medtronic, Neuronetics, and NeoSync. Dr. Tyrka received honoraria for continuing medical education from Lundbeck and Takeda. Dr. Price received speaker honoraria from MD Conferences/Psychiatry Review Course and served as a paid consultant to Gerson Lehrman, Wiley, Springer, Qatar National Research Fund, Alberta Heritage Foundation for Medical Research, Abbott, and AstraZeneca. Dr. Carpenter served as a paid consultant to Abbott, Cyberonics, Novartis, Wyeth, AstraZenica, and Neuronetics, on the speakers bureau for Neuronetics, and received honoraria for continuing medical education from AstraZenica. Dr. Marsit and Oakland Walters report no biomedical financial interests. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Alt SR, 2010, PSYCHONEUROENDOCRINO, V35, P544, DOI 10.1016/j.psyneuen.2009.09.001; Baschant U, 2010, J STEROID BIOCHEM, V120, P69, DOI 10.1016/j.jsbmb.2010.03.058; BERNSTEIN DP, 1994, AM J PSYCHIAT, V151, P1132, DOI 10.1176/ajp.151.8.1132; Bernstein DP, 1998, CHILDHOOD TRAUMA QUE; Bjornsson HT, 2008, JAMA-J AM MED ASSOC, V299, P2877, DOI 10.1001/jama.299.24.2877; BREIER A, 1988, ARCH GEN PSYCHIAT, V45, P987; Carpenter LL, 2007, BIOL PSYCHIAT, V62, P1080, DOI 10.1016/j.biopsych.2007.05.002; Carpenter LL, 2011, PSYCHOPHARMACOLOGY, V214, P367, DOI 10.1007/s00213-010-2007-4; Carpenter LL, 2009, BIOL PSYCHIAT, V66, P69, DOI 10.1016/j.biopsych.2009.02.030; Carpenter LL, 2010, NEUROPSYCHO IN PRESS; Ceccatelli S, 2007, PHYSIOL BEHAV, V92, P87, DOI 10.1016/j.physbeh.2007.05.048; Champagne FA, 2009, NEUROSCI BIOBEHAV R, V33, P593, DOI 10.1016/j.neubiorev.2007.10.009; Cicchetti D, 2001, DEV PSYCHOPATHOL, V13, P783, DOI 10.1017/S0954579401004035; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Daniels WMU, 2009, METAB BRAIN DIS, V24, P615, DOI 10.1007/s11011-009-9163-4; Dozier M, 2006, CHILD MALTREATMENT, V11, P189, DOI 10.1177/1077559505285779; Dranovsky A, 2006, BIOL PSYCHIAT, V59, P1136, DOI 10.1016/j.biopsych.2006.03.082; Duman Ronald S, 2009, Dialogues Clin Neurosci, V11, P239; Elzinga BM, 2008, PSYCHONEUROENDOCRINO, V33, P227, DOI 10.1016/j.psyneuen.2007.11.004; Epel ES, 2009, HORM-INT J ENDOCRINO, V8, P7, DOI 10.14310/horm.2002.1217; First M. B., 1997, STRUCTURED CLIN INTE; Gunnar MR, 2007, PROG BRAIN RES, V167, P137, DOI 10.1016/S0079-6123(07)67010-1; Gunnar MR, 2006, DEV PSYCHOPATHOL, V18, P651, DOI 10.1017/S0954579406060330; Heim C, 2000, PSYCHONEUROENDOCRINO, V25, P1, DOI 10.1016/S0306-4530(99)00035-9; Kaufman J, 2001, DEV PSYCHOPATHOL, V13, P451, DOI 10.1017/S0954579401003030; Kaufman J, 1997, BIOL PSYCHIAT, V42, P669, DOI 10.1016/S0006-3223(96)00470-2; Kessler RC, 1997, PSYCHOL MED, V27, P1101, DOI 10.1017/S0033291797005588; Klaassens ER, 2009, PROG NEURO-PSYCHOPH, V33, P889, DOI 10.1016/j.pnpbp.2009.04.011; Langevin SM, 2011, EPIGENETICS, P6; Lee RS, 2010, ENDOCRINOLOGY, V151, P4332, DOI 10.1210/en.2010-0225; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; Meinlschmidt G. P, 2005, LONG TERM PSYCHOBIOL; Miller AH, 2009, BIOL PSYCHIAT, V65, P732, DOI 10.1016/j.biopsych.2008.11.029; Mitra R, 2008, P NATL ACAD SCI USA, V105, P5573, DOI 10.1073/pnas.0705615105; Moser D, 2007, WORLD J BIOL PSYCHIA, V8, P262, DOI 10.1080/15622970701429862; Nelson CA, 2000, HDB INFANT MENTAL HL, P37; O'Donovan A., 2011, BIOL PSYCHIAT; Oberlander TF, 2008, EPIGENETICS-US, V3, P97, DOI 10.4161/epi.3.2.6034; Pariante CM, 2004, STRESS, V7, P209, DOI 10.1080/10253890500069650; PARKER G, 1989, PSYCHIAT DEV, V7, P317; Pryce CR, 2005, NEUROSCI BIOBEHAV R, V29, P649, DOI 10.1016/j.neubiorev.2005.03.011; Rice CJ, 2008, ENDOCRINOLOGY, V149, P4892, DOI 10.1210/en.2008-0633; Rush AJ, 1996, PSYCHOL MED, V26, P477, DOI 10.1017/S0033291700035558; Sanchez MM, 2001, DEV PSYCHOPATHOL, V13, P419, DOI 10.1017/S0954579401003029; Schilling EA, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-30; Simon NM, 2006, BIOL PSYCHIAT, V60, P432, DOI 10.1016/j.biopsych.2006.02.004; Spielberger C. D., 1989, STATE TRAIT ANXIETY; Teicher MH, 2006, ANN NY ACAD SCI, V1071, P313, DOI 10.1196/annals.1364.024; Tyrka AR, 2008, BIOL PSYCHIAT, V63, P1147, DOI 10.1016/j.biopsych.2008.01.011; Tyrka AR, 2010, BIOL PSYCHIAT, V67, P531, DOI 10.1016/j.biopsych.2009.08.014; Weaver ICG, 2007, EPIGENETICS, V2, P22, DOI 10.4161/epi.2.1.3881; Weaver ICG, 2007, J NEUROSCI, V27, P1756, DOI 10.1523/JNEUROSCI.4164-06.2007; Weaver ICG, 2005, J NEUROSCI, V25, P11045, DOI 10.1523/JNEUROSCI.3652-05.2005; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Wilhelm K, 2005, PSYCHOL MED, V35, P387, DOI 10.1017/S0033291704003538; Wolkowitz OM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017837; Yehuda R, 2009, ANN NY ACAD SCI, V1179, P56, DOI 10.1111/j.1749-6632.2009.04979.x	58	318	330	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30148	10.1371/journal.pone.0030148	http://dx.doi.org/10.1371/journal.pone.0030148			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295073	Green Published, gold, Green Submitted			2022-12-27	WOS:000301640600018
J	Okumu, FO; Moore, J; Mbeyela, E; Sherlock, M; Sangusangu, R; Ligamba, G; Russell, T; Moore, SJ				Okumu, Fredros O.; Moore, Jason; Mbeyela, Edgar; Sherlock, Mark; Sangusangu, Robert; Ligamba, Godfrey; Russell, Tanya; Moore, Sarah J.			A Modified Experimental Hut Design for Studying Responses of Disease-Transmitting Mosquitoes to Indoor Interventions: The Ifakara Experimental huts	PLOS ONE			English	Article							ANOPHELES-GAMBIAE GILES; MANSONIA-UNIFORMIS THEO; HOUSE-FREQUENTING HABITS; VERANDAH-TRAP HUT; MALARIA VECTORS; CULEX-QUINQUEFASCIATUS; RESIDUAL EFFICACY; FIELD-EVALUATION; TREATED NETS; INSECTICIDES	Differences between individual human houses can confound results of studies aimed at evaluating indoor vector control interventions such as insecticide treated nets (ITNs) and indoor residual insecticide spraying (IRS). Specially designed and standardised experimental huts have historically provided a solution to this challenge, with an added advantage that they can be fitted with special interception traps to sample entering or exiting mosquitoes. However, many of these experimental hut designs have a number of limitations, for example: 1) inability to sample mosquitoes on all sides of huts, 2) increased likelihood of live mosquitoes flying out of the huts, leaving mainly dead ones, 3) difficulties of cleaning the huts when a new insecticide is to be tested, and 4) the generally small size of the experimental huts, which can misrepresent actual local house sizes or airflow dynamics in the local houses. Here, we describe a modified experimental hut design - The Ifakara Experimental Huts-and explain how these huts can be used to more realistically monitor behavioural and physiological responses of wild, free-flying disease-transmitting mosquitoes, including the African malaria vectors of the species complexes Anopheles gambiae and Anopheles funestus, to indoor vector control-technologies including ITNs and IRS. Important characteristics of the Ifakara experimental huts include: 1) interception traps fitted onto eave spaces and windows, 2) use of eave baffles (panels that direct mosquito movement) to control exit of live mosquitoes through the eave spaces, 3) use of replaceable wall panels and ceilings, which allow safe insecticide disposal and reuse of the huts to test different insecticides in successive periods, 4) the kit format of the huts allowing portability and 5) an improved suite of entomological procedures to maximise data quality.	[Okumu, Fredros O.; Moore, Jason; Mbeyela, Edgar; Sangusangu, Robert; Ligamba, Godfrey; Moore, Sarah J.] Ifakara Hlth Inst, Biomed & Environm Sci Themat Grp, Ifakara, Tanzania; [Okumu, Fredros O.; Moore, Jason; Moore, Sarah J.] London Sch Hyg & Trop Med, Dept Dis Control, Fac Infect & Trop Dis, London WC1, England; [Sherlock, Mark] Swansea Univ, Coll Med, Swansea, W Glam, Wales; [Russell, Tanya] James Cook Univ, Fac Med Hlth & Mol Sci, Townsville, Qld 4811, Australia; [Russell, Tanya] Univ Sunshine Coast, Fac Sci Hlth & Educ, Maroochydore, Qld, Australia	Ifakara Health Institute; University of London; London School of Hygiene & Tropical Medicine; Swansea University; James Cook University; University of the Sunshine Coast	Okumu, FO (corresponding author), Ifakara Hlth Inst, Biomed & Environm Sci Themat Grp, Ifakara, Tanzania.	fredros@ihi.or.tz	Russell, Tanya/AAF-2296-2020; Moore, Sarah J/HGE-7143-2022	Russell, Tanya/0000-0002-0920-6844; Moore, Sarah J/0000-0002-0938-6654	American people through United States of America President's Malaria Initiative via United States Agency for International Development (USAID); Bill and Melinda Gates Foundation [51431]	American people through United States of America President's Malaria Initiative via United States Agency for International Development (USAID)(United States Agency for International Development (USAID)President's Malaria Initiative (PMI)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This study is made possible in part by the generous support of the American people through the United States of America President's Malaria Initiative via United States Agency for International Development (USAID). The contents are the responsibility of Fredros Okumu and Sarah Moore and do not necessarily reflect the views of USAID or the United States Government. The study was also supported by Bill and Melinda Gates Foundation Grant No. 51431. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achee NL, 2005, J AM MOSQUITO CONTR, V21, P366, DOI 10.2987/8756-971X(2006)21[366:AMSUAN]2.0.CO;2; Akogbeto MC, 2010, MALARIA J, V9; [Anonymous], 1975, MANUAL PRACTICAL ENT; [Anonymous], 1987, SUPPLEMENT ANOPHELIN; BAR-ZEEV M., 1966, Mosquito News, V26, P205; Beier JC, 1999, AM J TROP MED HYG, V61, P109, DOI 10.4269/ajtmh.1999.61.109; Bogh C, 1998, MED VET ENTOMOL, V12, P52, DOI 10.1046/j.1365-2915.1998.00091.x; BURNETT G. F., 1957, BULL ENT RES, V48, P631, DOI 10.1017/S0007485300002807; Carroll SP, 2006, J AM MOSQUITO CONTR, V22, P507, DOI 10.2987/8756-971X(2006)22[507:PARBMR]2.0.CO;2; Clements AN., 1999, SENSORY RECEPTION BE; Cullen JR, 1963, OBSERVATIONS EFFECT, P1; Curtis CF, 1996, MED VET ENTOMOL, V10, P1, DOI 10.1111/j.1365-2915.1996.tb00075.x; Curtis CF, 1998, TROP MED INT HEALTH, V3, P619, DOI 10.1046/j.1365-3156.1998.00281.x; Darriet F, 1998, Med Trop (Mars), V58, P349; DAVIDSON G, 1953, B ENTOMOL RES, V44, P231, DOI 10.1017/S0007485300023051; de Arias AR, 2003, MEM I OSWALDO CRUZ, V98, P975, DOI 10.1590/S0074-02762003000700020; DE ZULUETA J, 1961, East Afr Med J, V38, P1; Garrett-Jones C, 1975, WHOMAL75851; Grieco JP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000716; Grieco JP, 2000, J VECTOR ECOL, V25, P62; HADAWAY AB, 1952, B ENTOMOL RES, V43, P281, DOI 10.1017/S0007485300040499; Haddow A. J., 1942, BULL ENT RES, V33, P91, DOI 10.1017/S0007485300026389; HOCKING K S, 1960, Bull World Health Organ, V22, P757; Killeen GF, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-121; Killeen GF, 2007, PLOS MED, V4, P1246, DOI 10.1371/journal.pmed.0040229; Killeen GF, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-161; Kirby MJ, 2009, LANCET, V374, P998, DOI 10.1016/S0140-6736(09)60871-0; Kirby MJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-2; Koekemoer LL, 2002, AM J TROP MED HYG, V66, P804, DOI 10.4269/ajtmh.2002.66.804; Konradsen F, 2003, AM J TROP MED HYG, V68, P177, DOI 10.4269/ajtmh.2003.68.177; LINDSAY SW, 1993, J MED ENTOMOL, V30, P368, DOI 10.1093/jmedent/30.2.368; Lindsay SW, 2002, TRENDS PARASITOL, V18, P510, DOI 10.1016/S1471-4922(02)02382-6; LINES JD, 1987, MED VET ENTOMOL, V1, P37, DOI 10.1111/j.1365-2915.1987.tb00321.x; London L, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-50; Malima RC, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-38; Mboera LEG, 1998, AM J TROP MED HYG, V59, P595, DOI 10.4269/ajtmh.1998.59.595; Mnyone L, 2010, MALARIA J, V9, pP23; Moore SJ, 2002, J AM MOSQUITO CONTR, V18, P107; Mosha FW, 2008, ANN TROP MED PARASIT, V102, P367, DOI 10.1179/136485908X278829; MUIRHEAD-THOMSON R C, 1960, Bull World Health Organ, V22, P721; MUIRHEADTHOMSON RC, 1950, T ROY SOC TROP MED H, V43, P401, DOI 10.1016/0035-9203(50)90036-8; Mukabana W. R., 2002, DIFFERENTIAL ATTRACT; N'Guessan R, 2007, EMERG INFECT DIS, V13, P199, DOI 10.3201/eid1302.060631; Ogoma SB, 2010, PLOS NEG TROP DIS, V4, P77; Okumu FO, 2011, MALAR J IN PRESS; Okumu FO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011573; Okumu FO, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-12; Okumu FO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008951; OKUMU OF, 2008, OPEN TROPICAL MED J, V1, P68; Pates H, 2005, ANNU REV ENTOMOL, V50, P53, DOI 10.1146/annurev.ento.50.071803.130439; RAPLEY RE, 1961, B WORLD HEALTH ORGAN, V24, P659; Ribeiro JMC, 1996, B WORLD HEALTH ORGAN, V74, P299; Russell TL, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-187; SCOTT JA, 1993, AM J TROP MED HYG, V49, P520, DOI 10.4269/ajtmh.1993.49.520; Service MW, 1964, T ROY SOC TROP MED H, V58; SHARP BL, 1990, J AM MOSQUITO CONTR, V6, P197; SHARP BL, 1993, J AM MOSQUITO CONTR, V9, P414; Silver J. B, 2008, MOSQUITO ECOLOGY FIE; SMITH A, 1962, East Afr Med J, V39, P631; SMITH A, 1969, B ENTOMOL RES, V59, P33, DOI 10.1017/S000748530000300X; SMITH A, 1972, B ENTOMOL RES, V61, P415, DOI 10.1017/S0007485300047313; SMITH A, 1965, B ENTOMOL RES, V56, P275, DOI 10.1017/S0007485300056364; SMITH A, 1963, NATURE, V197, P1227, DOI 10.1038/1971227b0; SMITH A, 1962, East Afr Med J, V39, P15; SMITH A, 1965, B ENTOMOL RES, V56, P161, DOI 10.1017/S0007485300057114; Smith A, 1968, REV INSECTICIDES TES; Smith A, 1972, MODIFICATION EXPT HU; Smith DL, 2004, PLOS BIOL, V2, P1957, DOI 10.1371/journal.pbio.0020368; Takken W, 1999, ANNU REV ENTOMOL, V44, P131, DOI 10.1146/annurev.ento.44.1.131; Tanzania National Bureau of Statistics, 2005, TANZ DEM HLTH SURV 2; Tanzania National Bureau of Statistics and ICF Macro, 2011, TANZ DEM HLTH SURV 2; THOMSON RCM, 1948, B ENTOMOL RES, V38, P527, DOI 10.1017/S0007485300023221; THOMSON RCM, 1947, B ENTOMOL RES, V38, P449, DOI 10.1017/S0007485300022276; van der Hoek W, 2003, INT J EPIDEMIOL, V32, P280, DOI 10.1093/ije/dyg055; Victora CG, 2004, AM J PUBLIC HEALTH, V94, P400, DOI 10.2105/AJPH.94.3.400; WHO, 2007, 10 WHOPES WORK GROUP; WHO, 2006, WHOCDCNTDWHOPESGCDPP	77	40	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2012	7	2							e30967	10.1371/journal.pone.0030967	http://dx.doi.org/10.1371/journal.pone.0030967			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZQ	22347415	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000302730200011
J	Maulucci, G; De Spirito, M; Arcovito, G; Papi, M				Maulucci, Giuseppe; De Spirito, Marco; Arcovito, Giuseppe; Papi, Massimiliano			The Thermal Structural Transition of Alpha-Crystallin Modulates Subunit Interactions and Increases Protein Solubility	PLOS ONE			English	Article							CHAPERONE-LIKE ACTIVITY; QUATERNARY STRUCTURE; AGGREGATION; STABILITY	Background: Alpha crystallin is an oligomer composed of two types of subunits, alpha-A and alpha-B crystallin, and is the major constituent of human lens. The temperature induced condensation of alpha-crystallin, the main cause for eye lens opacification (cataract), is a two step-process, a nucleation followed by an aggregation phase, and a protective effect towards the aggregation is exhibited over the alpha crystallin phase transition temperature (Tc = 318.16 K). Methods/Results: To investigate if a modulation of the subunit interactions over Tc could trigger the protective mechanism towards the aggregation, we followed, by using simultaneously static and dynamic light scattering, the temperature induced condensation of alpha-crystallin. By developing a mathematical model able to uncouple the nucleation and aggregation processes, we find a previously unobserved transition in the nucleation rate constant. Its temperature dependence allows to determine fundamental structural parameters, the chemical potential (Delta mu) and the interfacial tension (gamma) of the aggregating phase, that characterize subunit interactions. Conclusions/General Significance: The decrease of both Delta mu and gamma at Tc, and a relative increase in solubility, reveal a significative decrease in the strenght of alpha-crystallin subunits interactions, which protects from supramolecolar condensation in hypertermic conditions. On the whole, we suggest a general approach able to understand the structural and kinetic mechanisms involved in aggregation-related diseases and in drugs development and testing.	[Maulucci, Giuseppe; De Spirito, Marco; Arcovito, Giuseppe; Papi, Massimiliano] Univ Cattolica Sacro Cuore, Ist Fis, Rome, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Maulucci, G (corresponding author), Univ Cattolica Sacro Cuore, Ist Fis, Rome, Italy.	m.despirito@rm.unicatt.it	Papi, Massimiliano/AAC-3657-2022; Maulucci, Giuseppe/C-7400-2009; De Spirito, Marco/C-5386-2008; Papi, Massimiliano/B-3168-2012; De Spirito, Marco/U-3817-2019	Papi, Massimiliano/0000-0002-0029-1309; Maulucci, Giuseppe/0000-0002-2154-319X; De Spirito, Marco/0000-0003-4260-5107; De Spirito, Marco/0000-0003-4260-5107				Bassi FA, 1995, BIOPHYS J, V69, P2720, DOI 10.1016/S0006-3495(95)80143-8; BERNE B. J., 1976, DYNAMIC LIGHT SCATTE; BIOSCA JA, 1983, FEBS LETT, V153, P217, DOI 10.1016/0014-5793(83)80151-3; CHEN SH, 1986, PHYS REV LETT, V57, P2583, DOI 10.1103/PhysRevLett.57.2583; Clark JI, 2000, CURR OPIN STRUC BIOL, V10, P52, DOI 10.1016/S0959-440X(99)00048-2; de Hoog EHA, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.021407; Debenedetti P.G., 1996, METASTABLE LIQUIDS C; DELAYE M, 1983, NATURE, V302, P415, DOI 10.1038/302415a0; Doss-Pepe EW, 1998, EXP EYE RES, V67, P657, DOI 10.1006/exer.1998.0561; Eaton W A, 1990, Adv Protein Chem, V40, P63, DOI 10.1016/S0065-3233(08)60287-9; Garland DL, 1996, EXP EYE RES, V62, P285, DOI 10.1006/exer.1996.0034; GUPTASARMA P, 1992, BIOCHEMISTRY-US, V31, P4296, DOI 10.1021/bi00132a021; Horwitz J, 2004, EXP EYE RES, V79, P817, DOI 10.1016/j.exer.2004.05.007; Horwitz J, 2003, EXP EYE RES, V76, P145, DOI 10.1016/S0014-4835(02)00278-6; JEDZINIAK JA, 1972, INVEST OPHTH VISUAL, V11, P905; KOPPEL DE, 1972, J CHEM PHYS, V57, P4814, DOI 10.1063/1.1678153; KRAMPS HA, 1975, EUR J BIOCHEM, V50, P503, DOI 10.1111/j.1432-1033.1975.tb09889.x; Kusumoto Y, 1998, P NATL ACAD SCI USA, V95, P12277, DOI 10.1073/pnas.95.21.12277; Lasaga AC, 1998, KINETIC THEORY; Lattuada M, 2003, J COLLOID INTERF SCI, V268, P96, DOI 10.1016/j.jcis.2003.07.028; LUTHRA M, 1993, J BIOL CHEM, V268, P18119; Maulucci G, 2005, BIOPHYS J, V88, P3545, DOI 10.1529/biophysj.104.048876; Maulucci G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018906; MIESBAUER LR, 1994, J BIOL CHEM, V269, P12494; Milton K, 1969, SCATTERING LIGHT OTH SCATTERING LIGHT OTH, P414; Papi M, 2010, EUR BIOPHYS J BIOPHY, V39, P1597, DOI 10.1007/s00249-010-0617-8; Parasassi T, 2008, FASEB J, V22, P2350, DOI 10.1096/fj.07-097774; Putilina T, 2003, J BIOL CHEM, V278, P13747, DOI 10.1074/jbc.M208157200; Raman B, 1997, J BIOL CHEM, V272, P23559, DOI 10.1074/jbc.272.38.23559; RAMAN B, 1995, FEBS LETT, V365, P133, DOI 10.1016/0014-5793(95)00440-K; RAMAN B, 1994, J BIOL CHEM, V269, P27264; Ramkrishna B, 2000, POPULATION BALANCE; SANTINI SA, 1992, BIOCHEM J, V287, P107, DOI 10.1042/bj2870107; Seinfeld J. H., 1998, ATMOSPHERIC CHEM PHY; THORN M, 1994, PHYS REV LETT, V72, P3622, DOI 10.1103/PhysRevLett.72.3622; Tirado-Miranda M, 2003, EUR BIOPHYS J BIOPHY, V32, P128, DOI 10.1007/s00249-002-0275-6; WALSH MT, 1991, J BIOL CHEM, V266, P20079; WEITZ DA, 1986, PHYS REV LETT, V57, P2037, DOI 10.1103/PhysRevLett.57.2037; XIA JZ, 1994, BIOPHYS J, V66, P861, DOI 10.1016/S0006-3495(94)80862-8; ZHU PW, 1994, PHYS REV E, V50, P1360, DOI 10.1103/PhysRevE.50.1360	40	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2012	7	2							e30705	10.1371/journal.pone.0030705	http://dx.doi.org/10.1371/journal.pone.0030705			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917MF	22347398	Green Submitted, Green Published, gold			2022-12-27	WOS:000302180600014
J	Amorocho, DF; Abreu-Grobois, FA; Dutton, PH; Reina, RD				Amorocho, Diego F.; Alberto Abreu-Grobois, F.; Dutton, Peter H.; Reina, Richard D.			Multiple Distant Origins for Green Sea Turtles Aggregating off Gorgona Island in the Colombian Eastern Pacific	PLOS ONE			English	Article							CHELONIA-MYDAS-AGASSIZII; MITOCHONDRIAL-DNA; CONTROL REGION; POPULATION-STRUCTURE; MARINE TURTLES; NATIONAL-PARK; GENETICS; PHYLOGEOGRAPHY; STRATEGIES; DISPERSAL	Mitochondrial DNA analyses have been useful for resolving maternal lineages and migratory behavior to foraging grounds (FG) in sea turtles. However, little is known about source rookeries and haplotype composition of foraging green turtle aggregations in the southeastern Pacific. We used mitochondrial DNA control region sequences to identify the haplotype composition of 55 green turtles, Chelonia mydas, captured in foraging grounds of Gorgona National Park in the Colombian Pacific. Amplified fragments of the control region (457 bp) revealed the presence of seven haplotypes, with haplotype (h) and nucleotide (pi) diversities of h = 0.300 +/- 0.080 and pi = 0.009 +/- 0.005 respectively. The most common haplotype was CMP4 observed in 83% of individuals, followed by CMP22 (5%). The genetic composition of the Gorgona foraging population primarily comprised haplotypes that have been found at eastern Pacific rookeries including Mexico and the Galapagos, as well as haplotypes of unknown stock origin that likely originated from more distant western Pacific rookeries. Mixed stock analysis suggests that the Gorgona FG population is comprised mostly of animals from the Galapagos rookery (80%). Lagrangian drifter data showed that movement of turtles along the eastern Pacific coast and eastward from distant western and central Pacific sites was possible through passive drift. Our results highlight the importance of this protected area for conservation management of green turtles recruited from distant sites along the eastern Pacific Ocean.	[Amorocho, Diego F.; Reina, Richard D.] Monash Univ, Sch Biol Sci, Clayton, Vic, Australia; [Amorocho, Diego F.] Res Ctr Environm Management & Dev, Cali, Colombia; [Alberto Abreu-Grobois, F.] Univ Nacl Autonoma Mexico, Inst Ciencias Mar & Limnol, Unidad Acad Mazatlan, Mazatlan, Sinaloa, Mexico; [Dutton, Peter H.] NOAA, Protected Resources Div, SW Fisheries Sci Ctr, La Jolla, CA USA	Monash University; Universidad Nacional Autonoma de Mexico; National Oceanic Atmospheric Admin (NOAA) - USA	Amorocho, DF (corresponding author), Monash Univ, Sch Biol Sci, Clayton, Vic, Australia.	richard.reina@monash.edu	Grobois, Alberto Abreu/A-3560-2017; Reina, Richard/AAC-7017-2019	Grobois, Alberto Abreu/0000-0002-7350-757X; 	United States National Fish and Wildlife Foundation; Chelonian Research Foundation; Rufford Foundation; Monash University	United States National Fish and Wildlife Foundation; Chelonian Research Foundation; Rufford Foundation; Monash University(Monash University)	Funding was received from the following: United States National Fish and Wildlife Foundation funded fieldwork and analysis costs; the Chelonian Research Foundation funded fieldwork and analysis costs; the Rufford Foundation funded fieldwork, administrative and analysis costs; Monash University funded travel and analysis costs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amorocho DF, 2001, CONSERVACION TORTUGA; Amorocho DF, 2001, GORGONA MARINA CONTR, P141; Amorocho DF, 1992, CONTRIBUCION CONOCIM, P155; Amorocho Diego F., 2007, Endangered Species Research, V3, P43, DOI 10.3354/esr003043; Amorocho DF, 2008, J EXP MAR BIOL ECOL, V360, P117, DOI 10.1016/j.jembe.2008.04.009; Balazs George H., 1999, P101; Balazs George H., 2006, Atoll Research Bulletin, P147; Baquero Gallegos A, 2008, S TORT MAR PAC OR LI, P116; Bass AL, 1998, COPEIA, P1064; Bass AL, 2000, HERPETOLOGICA, V56, P357; Bass AL, 2006, J HERED, V97, P346, DOI 10.1093/jhered/esl004; Bjorndal KA, 2005, MAR BIOL, V147, P1449, DOI 10.1007/s00227-005-0045-y; Bolker BM, 2007, MOL ECOL, V16, P685, DOI 10.1111/j.1365-294X.2006.03161.x; Bourjea J, 2007, MOL ECOL, V16, P175, DOI 10.1111/j.1365-294X.2006.03122.x; Bowen BW, 2007, MOL ECOL, V16, P4886, DOI 10.1111/j.1365-294X.2007.03542.x; Bowen BW, 2007, MOL ECOL, V16, P49, DOI 10.1111/j.1365-294X.2006.03096.x; Bowen B. W., 1995, CONSERV GENET, P190; Bowen Brian W., 1997, P29; BOWEN BW, 1992, EVOLUTION, V46, P865, DOI 10.1111/j.1558-5646.1992.tb00605.x; Bowen BW, 2000, MARINE TURTLE NEWSLE, P20; Broderick AC, 2007, P ROY SOC B-BIOL SCI, V274, P1533, DOI 10.1098/rspb.2007.0211; Chassin-Noria O, 2004, GENETICA, V121, P195, DOI 10.1023/B:GENE.0000040394.47843.e4; Davenport J, 1997, J THERM BIOL, V22, P479, DOI 10.1016/S0306-4565(97)00066-1; Dethmers KEM, 2006, MOL ECOL, V15, P3931, DOI 10.1111/j.1365-294X.2006.03070.x; Dutton Peter, 1995, Marine Turtle Newsletter, V69, P9; Dutton PH, 2008, OCEAN DEV INT LAW, V39, P200, DOI 10.1080/00908320802013685; Dutton PH, 2009, MOL ECOL RESOUR, V9, P354, DOI 10.1111/j.1755-0998.2008.02443.x; Dutton Peter H., 2008, Endangered Species Research, V5, P37, DOI 10.3354/esr00101; Dutton PH, 2007, P 22 ANN S SEA TURTL; Dutton PH, 1994, P 14 ANN S SEA TURTL; Eguchi T, 2010, MAR BIOL, V157, P1869, DOI 10.1007/s00227-010-1458-9; Encalada SE, 1996, MOL ECOL, V5, P473; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FitzSimmons NN, 1997, P NATL ACAD SCI USA, V94, P8912, DOI 10.1073/pnas.94.16.8912; Hansen L, 2007, P 24 ANN S SEA TURTL; HIRTH HF, 1997, SYNOPSIS BIOL DATA G; Juarez-Ceron JA, 2002, P 22 ANN S SEA TURTL, P70; Kessler WS, 2006, PROG OCEANOGR, V69, P181, DOI 10.1016/j.pocean.2006.03.009; Koch V, 2007, MAR BIOL, V153, P35, DOI 10.1007/s00227-007-0782-1; LAHANAS PN, 1994, GENETICA, V94, P57, DOI 10.1007/BF01429220; Lopez-Castro Melania C., 2010, Endangered Species Research, V11, P35, DOI 10.3354/esr00264; Luke K, 2004, MAR BIOL, V144, P799, DOI 10.1007/s00227-003-1241-2; Luschi P, 2003, OIKOS, V103, P293, DOI 10.1034/j.1600-0706.2003.12123.x; Meylan AB., 1982, BIOL CONSERVATION SE, P91; Monzon-Arguello C, 2010, J BIOGEOGR, V37, P1752, DOI 10.1111/j.1365-2699.2010.02326.x; Musick John A., 1997, P137; Naro-Maciel E, 2007, J HERED, V98, P29, DOI 10.1093/jhered/esl050; Nei M., 1987, MOL EVOLUTIONARY GEN; Nishizawa H, 2010, ZOOL SCI, V27, P14, DOI 10.2108/zsj.27.14; NORMAN JA, 1994, MOL ECOL, V3, P363, DOI 10.1111/j.1365-294X.1994.tb00076.x; Pritchard Peter C.H., 1999, P21; Roden SE, 2009, MOL ECOL RESOUR, V9, P1055, DOI 10.1111/j.1755-0998.2009.02573.x; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Seminoff JA, 2007, 130 NAT MAR FISH SER; Seminoff Jeffrey A., 2008, Endangered Species Research, V4, P57, DOI 10.3354/esr00066; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Velez-Zuazo X, 2008, MOL ECOL, V17, P839, DOI 10.1111/j.1365-294X.2007.03635.x; Wallace BP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015465; Zarate P, EVALUACION AREAS ALI; Zarate P, 2007, P 24 ANN S SEA TURTL; Zarate PM, 2006, 26 ANN S SEA TURTL B	65	42	46	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2012	7	2							e31486	10.1371/journal.pone.0031486	http://dx.doi.org/10.1371/journal.pone.0031486			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UV	22319635	Green Submitted, gold, Green Published			2022-12-27	WOS:000301979000030
J	Arnaud-Haond, S; Duarte, CM; Diaz-Almela, E; Marba, N; Sintes, T; Serrao, EA				Arnaud-Haond, Sophie; Duarte, Carlos M.; Diaz-Almela, Elena; Marba, Nuria; Sintes, Tomas; Serrao, Ester A.			Implications of Extreme Life Span in Clonal Organisms: Millenary Clones in Meadows of the Threatened Seagrass Posidonia oceanica	PLOS ONE			English	Article							POPULATION-DYNAMICS; GENETIC DIVERSITY; GROWTH; PATTERNS; EFFICIENCY; ECOSYSTEMS; EVOLUTION; MUTATION; DECLINE; MARKERS	The maximum size and age that clonal organisms can reach remains poorly known, although we do know that the largest natural clones can extend over hundreds or thousands of metres and potentially live for centuries. We made a review of findings to date, which reveal that the maximum clone age and size estimates reported in the literature are typically limited by the scale of sampling, and may grossly underestimate the maximum age and size of clonal organisms. A case study presented here shows the occurrence of clones of slow-growing marine angiosperm Posidonia oceanica at spatial scales ranging from metres to hundreds of kilometres, using microsatellites on 1544 sampling units from a total of 40 locations across the Mediterranean Sea. This analysis revealed the presence, with a prevalence of 3.5 to 8.9%, of very large clones spreading over one to several (up to 15) kilometres at the different locations. Using estimates from field studies and models of the clonal growth of P. oceanica, we estimated these large clones to be hundreds to thousands of years old, suggesting the evolution of general purpose genotypes with large phenotypic plasticity in this species. These results, obtained combining genetics, demography and model-based calculations, question present knowledge and understanding of the spreading capacity and life span of plant clones. These findings call for further research on these life history traits associated with clonality, considering their possible ecological and evolutionary implications.	[Arnaud-Haond, Sophie] IFREMER, DEEP Ctr Brest, Plouzane, France; [Arnaud-Haond, Sophie] Univ Algarve, Lab BEE, CCMAR, Faro, Portugal; [Duarte, Carlos M.; Diaz-Almela, Elena; Marba, Nuria] IMEDEA CSIC UIB, Dept Global Change Res, Mallorca, Spain; [Duarte, Carlos M.] Univ Western Australia, Oceans Inst, Nedlands, WA 6009, Australia; [Sintes, Tomas] IFISC CSIC UIB, Inst Fis Interdisciplinar & Sistemas Complejos, Mallorca, Spain	Ifremer; Universidade do Algarve; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Universitat de les Illes Balears; University of Western Australia; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat de les Illes Balears; CSIC-UIB - Instituto de Fisica Interdisciplinar y Sistemas Complejos (IFISC)	Arnaud-Haond, S (corresponding author), IFREMER, DEEP Ctr Brest, Plouzane, France.	sarnaud@ualg.pt	Sintes, Tomas/G-9153-2015; Serrao, Ester A/C-6686-2012; Duarte, Carlos M/A-7670-2013; Duarte Quesada, Carlos Manuel/ABD-6208-2021; Arnaud-Haond, Sophie/B-2479-2008; Marba, Nuria/H-8136-2015; Marbà, Nuria/N-8143-2019	Sintes, Tomas/0000-0003-2149-8592; Serrao, Ester A/0000-0003-1316-658X; Duarte, Carlos M/0000-0002-1213-1361; Arnaud-Haond, Sophie/0000-0001-5814-8452; Marba, Nuria/0000-0002-8048-6789; Marbà, Nuria/0000-0002-8048-6789; Diaz-Almela, Elena/0000-0002-5904-3297	Foundation BBVA (Spain); European Commission (MMS EU); European Commission (FEDER/POCI); European Commission (FCT); Spanish MEC [FIS2007-60327]	Foundation BBVA (Spain)(BBVA Foundation); European Commission (MMS EU); European Commission (FEDER/POCI); European Commission (FCT); Spanish MEC(Spanish Government)	This research was supported by the Foundation BBVA (Spain), the European Commission (M&MS EU project; FEDER/POCI 2010, FCT, project NETWORK&DIVSTAB). These funders are national (Portuguese FCT) or European (FP5) agencies funding research projects. T. Sintes acknowledges the Project FIS2007-60327, funded by the Spanish MEC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aires T, 2011, MAR ECOL PROG SER, V421, P117, DOI 10.3354/meps08879; Alberto F, 2003, MOL ECOL NOTES, V3, P253, DOI 10.1046/j.1471-8286.2003.00415.x; Alberto F, 2001, MAR ECOL PROG SER, V221, P299, DOI 10.3354/meps221299; Ally D, 2008, MOL ECOL, V17, P4897, DOI 10.1111/j.1365-294X.2008.03962.x; Arnaud-Haond S, 2007, MOL ECOL, V16, P5115, DOI 10.1111/j.1365-294X.2007.03535.x; Arnaud-Haond S, 2005, J HERED, V96, P434, DOI 10.1093/jhered/esi043; Arnaud-Haond S, 2007, J BIOGEOGR, V34, P963, DOI 10.1111/j.1365-2699.2006.01671.x; Arnaud-Haond S, 2007, MOL ECOL NOTES, V7, P15, DOI 10.1111/j.1471-8286.2006.01522.x; Arnaud-Haond S, 2010, ESTUAR COAST, V33, P878, DOI 10.1007/s12237-009-9238-9; Ayala FJ, 1998, P NATL ACAD SCI USA, V95, P3346, DOI 10.1073/pnas.95.7.3346; Balestri E, 2008, ESTUAR COAST SHELF S, V76, P634, DOI 10.1016/j.ecss.2007.07.048; Becheler R, 2010, MOL ECOL, V19, P2394, DOI 10.1111/j.1365-294X.2010.04649.x; Butlin RK, 1999, J EVOLUTION BIOL, V12, P1020; Charlesworth D, 2001, CURR OPIN GENET DEV, V11, P685, DOI 10.1016/S0959-437X(00)00254-9; COOK RE, 1983, AM SCI, V71, P244; Dehmer KJ, 2004, GENET RESOUR CROP EV, V51, P551, DOI 10.1023/B:GRES.0000024163.86762.fc; Diaz-Almela E, 2006, MAR BIOL, V148, P723, DOI 10.1007/s00227-005-0127-x; Diaz-Almela E, 2008, AQUAT BOT, V89, P497; Diaz-Almela E, 2007, CONSERV GENET, V8, P1377, DOI 10.1007/s10592-007-9288-0; Dorken ME, 2002, EVOLUTION, V56, P31, DOI 10.1111/j.0014-3820.2002.tb00847.x; Doyle J. J., 1987, PHYTOCHEM B, P11; Drake JW, 1998, GENETICS, V148, P1667; HARBERD D. J., 1961, NEW PHYTOL, V60, P184, DOI 10.1111/j.1469-8137.1961.tb06251.x; HARBERD D. J., 1962, NEW PHYTOL, V61, P85, DOI 10.1111/j.1469-8137.1962.tb06277.x; HARBERD DJ, 1967, NEW PHYTOL, V66, P401, DOI 10.1111/j.1469-8137.1967.tb06019.x; Hemminga M.A., 2000, SEAGRASS ECOLOGY, DOI [10.1017/CBO9780511525551, DOI 10.1017/CBO9780511525551]; Honnay O, 2005, OIKOS, V108, P427, DOI 10.1111/j.0030-1299.2005.13569.x; Hughes AR, 2004, P NATL ACAD SCI USA, V101, P8998, DOI 10.1073/pnas.0402642101; Judson Olivia P., 1996, Trends in Ecology and Evolution, V11, P41, DOI 10.1016/0169-5347(96)81040-8; KEMPERMAN JA, 1976, CAN J BOT, V54, P2603, DOI 10.1139/b76-280; Kendrick GA, 2005, MAR ECOL PROG SER, V290, P291, DOI 10.3354/meps290291; KONDRASHOV AS, 1993, J HERED, V84, P372, DOI 10.1093/oxfordjournals.jhered.a111358; Laberge MJ, 2000, J ECOL, V88, P584, DOI 10.1046/j.1365-2745.2000.00471.x; LEGERE A, 1981, ARCTIC ALPINE RES, V13, P261, DOI 10.2307/1551033; Lynch AJJ, 1998, AUST J BOT, V46, P25, DOI 10.1071/BT96120; LYNCH M, 1984, Q REV BIOL, V59, P257, DOI 10.1086/413902; Marba N, 2005, ESTUARIES, V28, P53, DOI 10.1007/BF02732753; Marba N, 1996, MAR ECOL PROG SER, V137, P203, DOI 10.3354/meps137203; Marba N, 1998, MAR ECOL PROG SER, V174, P269, DOI 10.3354/meps174269; Marba N, 2010, GLOBAL CHANGE BIOL, V16, P2366, DOI 10.1111/j.1365-2486.2009.02130.x; Mateo MA, 1997, ESTUAR COAST SHELF S, V44, P103, DOI 10.1006/ecss.1996.0116; Nabholz B, 2008, MOL BIOL EVOL, V25, P120, DOI 10.1093/molbev/msm248; O'Connell LM, 2004, J HERED, V95, P172, DOI 10.1093/jhered/esh024; OINONEN E, 1969, Acta Forestalia Fennica, V97, P1; Oinonen E., 1967, ACTA FOR FENN, V83, P1, DOI DOI 10.14214/AFF.7180; Oinonen E, 1967, ACTA FOR FENN, V83, P76; Orth RJ, 2006, BIOSCIENCE, V56, P987, DOI 10.1641/0006-3568(2006)56[987:AGCFSE]2.0.CO;2; Otto SP, 2002, NAT REV GENET, V3, P252, DOI 10.1038/nrg761; PARKS JC, 1993, AM J BOT, V80, P537, DOI 10.2307/2445369; Reusch TBH, 1999, MAR ECOL PROG SER, V183, P301, DOI 10.3354/meps183301; Reusch TBH, 2005, P NATL ACAD SCI USA, V102, P2826, DOI 10.1073/pnas.0500008102; Schon I, 2009, LOST SEX: THE EVOLUTIONARY BIOLOGY OF PARTHENOGENESIS, P1; SHEFFIELD E, 1989, WEED RES, V29, P455, DOI 10.1111/j.1365-3180.1989.tb01318.x; Sintes T, 2005, OIKOS, V108, P165, DOI 10.1111/j.0030-1299.2005.13331.x; Sintes T, 2006, ESTUAR COAST, V29, P72, DOI 10.1007/BF02784700; SMITH ML, 1992, NATURE, V356, P428, DOI 10.1038/356428a0; Steinger T, 1996, OECOLOGIA, V105, P94, DOI 10.1007/BF00328796; STEWART CN, 1995, INT J PLANT SCI, V156, P698, DOI 10.1086/297292; TIBAYRENC M, 1990, P NATL ACAD SCI USA, V87, P2414, DOI 10.1073/pnas.87.7.2414; VASEK FC, 1980, AM J BOT, V67, P246, DOI 10.2307/2442649; VRIJENHOEK RC, 1979, AM ZOOL, V19, P787; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; Wherry, 1972, CASTANEA, V37, P94; Young AG, 2002, BIOL CONSERV, V106, P71, DOI 10.1016/S0006-3207(01)00230-0	64	131	131	1	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2012	7	2							e30454	10.1371/journal.pone.0030454	http://dx.doi.org/10.1371/journal.pone.0030454			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UG	22312426	Green Published, gold			2022-12-27	WOS:000301977500010
J	Richard, A; Rossignol, G; Comet, JP; Bernot, G; Guespin-Michel, J; Merieau, A				Richard, Adrien; Rossignol, Gaelle; Comet, Jean-Paul; Bernot, Gilles; Guespin-Michel, Jannine; Merieau, Annabelle			Boolean Models of Biosurfactants Production in Pseudomonas fluorescens	PLOS ONE			English	Article							LIPOPEPTIDE PRODUCTION; PHENOTYPIC VARIATION; BIOSYNTHESIS; REGULON	Cyclolipopeptides (CLPs) are biosurfactants produced by numerous Pseudomonas fluorescens strains. CLP production is known to be regulated at least by the GacA/GacS two-component pathway, but the full regulatory network is yet largely unknown. In the clinical strain MFN1032, CLP production is abolished by a mutation in the phospholipase C gene (plcC) and not restored by plcC complementation. Their production is also subject to phenotypic variation. We used a modelling approach with Boolean networks, which takes into account all these observations concerning CLP production without any assumption on the topology of the considered network. Intensive computation yielded numerous models that satisfy these properties. All models minimizing the number of components point to a bistability in CLP production, which requires the presence of a yet unknown key self-inducible regulator. Furthermore, all suggest that a set of yet unexplained phenotypic variants might also be due to this epigenetic switch. The simplest of these Boolean networks was used to propose a biological regulatory network for CLP production. This modelling approach has allowed a possible regulation to be unravelled and an unusual behaviour of CLP production in P. fluorescens to be explained.	[Richard, Adrien; Comet, Jean-Paul; Bernot, Gilles] Univ Nice Sophia Antipolis, Lab Informat Signaux & Syst Complexes Sophia Anit, Sophia Antipolis, France; [Richard, Adrien; Comet, Jean-Paul; Bernot, Gilles] CNRS, Sophia Antipolis, France; [Rossignol, Gaelle; Guespin-Michel, Jannine; Merieau, Annabelle] Univ Rouen, Lab Microbiol Froid Signaux & Microenvironm LMDF, Evreux, France	UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); Universite de Rouen Normandie	Richard, A (corresponding author), Univ Nice Sophia Antipolis, Lab Informat Signaux & Syst Complexes Sophia Anit, Sophia Antipolis, France.	richard@i3s.unice.fr		Comet, Jean-Paul/0000-0002-6681-3501	French National Agency for Research [ANR-10-BLANC-0218]; CNRS; Universite de Nice-Sophia Antipolis	French National Agency for Research(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite de Nice-Sophia Antipolis	This work is partially supported by the French National Agency for Research (ANR-10-BLANC-0218 BioTempo project), the CNRS, and Universite de Nice-Sophia Antipolis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernot G, 2004, J THEOR BIOL, V229, P339, DOI 10.1016/j.jtbi.2004.04.003; Brencic A, 2009, MOL MICROBIOL, V72, P612, DOI 10.1111/j.1365-2958.2009.06670.x; Cui X, 2005, EUR J PLANT PATHOL; de Bruijn I, 2008, J BACTERIOL, V190, P2777, DOI 10.1128/JB.01563-07; de Bruijn I, 2007, MOL MICROBIOL, V63, P417, DOI 10.1111/j.1365-2958.2006.05525.x; Filopon D, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-272; Hallet B, 2001, CURR OPIN MICROBIOL, V4, P570, DOI 10.1016/S1369-5274(00)00253-8; Hassan KA, 2010, ENVIRON MICROBIOL, V12, P899, DOI 10.1111/j.1462-2920.2009.02134.x; Khalis Z, 2009, GENES GENOMES GENOMI; Koch B, 2002, APPL ENVIRON MICROB, V68, P4509, DOI 10.1128/AEM.68.9.4509-4516.2002; Lapouge K, 2008, MOL MICROBIOL, V67, P241, DOI 10.1111/j.1365-2958.2007.06042.x; MacLean D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009101; Nielsen TH, 2002, APPL ENVIRON MICROB, V68, P3416, DOI 10.1128/AEM.68.7.3416-3423.2002; Raaijmakers JM, 2006, MOL PLANT MICROBE IN, V19, P699, DOI 10.1094/MPMI-19-0699; Raaijmakers JM, 2010, FEMS MICROBIOL REV, V34, P1037, DOI 10.1111/j.1574-6976.2010.00221.x; Remy E, 2008, ADV APPL MATH, V41, P335, DOI 10.1016/j.aam.2007.11.003; Richard A, 2007, DISCRETE APPL MATH; Rigali S, 2004, NUCLEIC ACIDS RES, V32, P3418, DOI 10.1093/nar/gkh673; Rossignol G, 2009, RES MICROBIOL, V160, P337, DOI 10.1016/j.resmic.2009.04.004; Rossignol G, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-189; Soule Christophe, 2003, ComPlexUs, V1, P123, DOI 10.1159/000076100; Thomas R., 1990, BIOL FEEDBACK; Thomas R, 1981, SPRINGER SERIES SYNE, V9, P180; Tran H, 2008, J APPL MICROBIOL, V104, P839, DOI 10.1111/j.1365-2672.2007.03618.x; van den Broek D, 2005, ENVIRON MICROBIOL, V7, P1686, DOI 10.1111/j.1462-2920.2005.00912.x	25	14	14	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2012	7	1							e24651	10.1371/journal.pone.0024651	http://dx.doi.org/10.1371/journal.pone.0024651			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	912BY	22303435	Green Published, Green Submitted, gold			2022-12-27	WOS:000301770700002
J	Zhang, Y; Zhang, GQ; Hendrix, LR; Tesh, VL; Samuel, JE				Zhang, Yan; Zhang, Guoquan; Hendrix, Laura R.; Tesh, Vernon L.; Samuel, James E.			Coxiella burnetii Induces Apoptosis during Early Stage Infection via a Caspase-Independent Pathway in Human Monocytic THP-1 Cells	PLOS ONE			English	Article							Q-FEVER; BACTERIAL PATHOGENS; PHASE VARIATION; DEATH; LIPOPOLYSACCHARIDE; MACROPHAGES; MODEL; MITOCHONDRIA; INTRASTRAIN; MECHANISMS	The ability of Coxiella burnetii to modulate host cell death may be a critical factor in disease development. In this study, human monocytic THP-1 cells were used to examine the ability of C. burnetii Nine Mile phase II (NMII) to modulate apoptotic signaling. Typical apoptotic cell morphological changes and DNA fragmentation were detected in NMII infected cells at an early stage of infection. FACS analysis using Annexin-V-PI double staining showed the induction of a significant number of apoptotic cells at an early stage of NMII infection. Double staining of apoptotic cell DNA and intracellular C. burnetii indicates that NMII infected cells undergoing apoptosis. Interestingly, caspase-3 was not cleaved in NMII infected cells and the caspase-inhibitor Z-VAD-fmk did not prevent NMII induced apoptosis. Surprisingly, the caspase-3 downstream substrate PARP was cleaved in NMII infected cells. These results suggest that NMII induces apoptosis during an early stage of infection through a caspase-independent pathway in THP-1 cells. In addition, NMII-infected monocytes were unable to prevent exogenous staurosporine-induced apoptotic death. Western blot analysis indicated that NMII infection induced the translocation of AIF from mitochondria into the nucleus. Cytochrome c release and cytosol-to-mitochondrial translocation of the pore-forming protein Bax in NMII infected cells occurred at 24 h post infection. These data suggest that NMII infection induced caspase-independent apoptosis through a mechanism involving cytochrome c release, cytosol-to-mitochondrial translocation of Bax and nuclear translocation of AIF in THP-1 monocytes. Furthermore, NMII infection increased TNF-alpha production and neutralization of TNF-alpha in NMII infected cells partially blocked PARP cleavage, suggesting TNF-alpha may play a role in the upstream signaling involved in NMII induced apoptosis. Antibiotic inhibition of C. burnetii RNA synthesis blocked NMII infection-induced PARP activation. These results suggest that both intracellular C. burnetii replication and secreted TNF-alpha contribute to NMII infection-triggered apoptosis during an early stage of infection.	[Zhang, Yan; Hendrix, Laura R.; Tesh, Vernon L.; Samuel, James E.] Texas A&M Hlth Sci Ctr, Coll Med, Dept Microbial & Mol Pathogenesis, Bryan, TX USA; [Zhang, Yan; Zhang, Guoquan] Univ Missouri Columbia, Coll Vet Med, Dept Vet Pathobiol, Columbia, MO USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Missouri System; University of Missouri Columbia	Zhang, Y (corresponding author), Texas A&M Hlth Sci Ctr, Coll Med, Dept Microbial & Mol Pathogenesis, Bryan, TX USA.	zhangguo@missouri.edu; jsamuel@medicine.tamhsc.edu	Zhang, Guoquan/ABA-9613-2020		United States, National Institutes of Health [AI037744]; University of Missouri; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI037744, R01AI037744, R29AI037744] Funding Source: NIH RePORTER	United States, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Missouri; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the United States, National Institutes of Health grant AI037744 to JS and University of Missouri start-up funds to GZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASSEFFA A, 1993, ONCOL RES, V5, P11; AUWERX J, 1991, EXPERIENTIA, V47, P22, DOI 10.1007/BF02041244; BACA OG, 1983, MICROBIOL REV, V47, P127, DOI 10.1128/MMBR.47.2.127-149.1983; BACA OG, 1981, INFECT IMMUN, V33, P258, DOI 10.1128/IAI.33.1.258-266.1981; Beare PA, 2006, J BACTERIOL, V188, P2309, DOI 10.1128/JB.188.7.2309-2324.2006; Brennan RE, 2003, J CLIN MICROBIOL, V41, P1869, DOI 10.1128/JCM.41.5.1869-1874.2003; Broker LE, 2005, CLIN CANCER RES, V11, P3155, DOI 10.1158/1078-0432.CCR-04-2223; Capo C, 1999, J IMMUNOL, V163, P6078; Capo C, 2003, J IMMUNOL, V170, P4217, DOI 10.4049/jimmunol.170.8.4217; Capo C, 1996, INFECT IMMUN, V64, P1638, DOI 10.1128/IAI.64.5.1638-1642.1996; Cregan SP, 2004, ONCOGENE, V23, P2785, DOI 10.1038/sj.onc.1207517; Dellacasagrande J, 1999, J IMMUNOL, V162, P2259; Fink SL, 2005, INFECT IMMUN, V73, P1907, DOI 10.1128/IAI.73.4.1907-1916.2005; Gao LY, 2000, TRENDS MICROBIOL, V8, P306, DOI 10.1016/S0966-842X(00)01784-4; Ghigo E, 2002, J IMMUNOL, V169, P4488, DOI 10.4049/jimmunol.169.8.4488; Hacker G, 2006, MED MICROBIOL IMMUN, V195, P11, DOI 10.1007/s00430-005-0239-4; HACKSTADT T, 1985, INFECT IMMUN, V48, P359, DOI 10.1128/IAI.48.2.359-365.1985; HACKSTADT T, 1990, ANN NY ACAD SCI, V590, P27, DOI 10.1111/j.1749-6632.1990.tb42203.x; Harrison LM, 2005, MICROB PATHOGENESIS, V38, P63, DOI 10.1016/j.micpath.2004.12.003; Heinzen RA, 1999, TRENDS MICROBIOL, V7, P149, DOI 10.1016/S0966-842X(99)01475-4; Hong SJ, 2004, TRENDS PHARMACOL SCI, V25, P259, DOI 10.1016/j.tips.2004.03.005; Hornef MW, 2002, NAT IMMUNOL, V3, P1033, DOI 10.1038/ni1102-1033; Howe D, 2003, CELL MICROBIOL, V5, P469, DOI 10.1046/j.1462-5822.2003.00293.x; Ismail N, 2002, FEMS MICROBIOL LETT, V207, P111, DOI 10.1111/j.1574-6968.2002.tb11038.x; Kim R, 2005, ONCOL REP, V14, P595; Kohro Takahide, 2004, J Atheroscler Thromb, V11, P88; Lai XH, 2001, INFECT IMMUN, V69, P4691, DOI 10.1128/IAI.69.7.4691-4694.2001; Lee J, 2006, J IMMUNOL, V176, P4267, DOI 10.4049/jimmunol.176.7.4267; Luhrmann A, 2007, INFECT IMMUN, V75, P5282, DOI 10.1128/IAI.00863-07; Maurin M, 1999, CLIN MICROBIOL REV, V12, P518, DOI 10.1128/CMR.12.4.518; Mege JL, 1997, FEMS MICROBIOL REV, V19, P209, DOI 10.1016/S0168-6445(96)00030-7; MOOS A, 1987, INFECT IMMUN, V55, P1144, DOI 10.1128/IAI.55.5.1144-1150.1987; Nagata S, 2000, EXP CELL RES, V256, P12, DOI 10.1006/excr.2000.4834; Neumeister B, 2002, MICROBIOL-SGM, V148, P3639, DOI 10.1099/00221287-148-11-3639; Ojcius DM, 1998, J IMMUNOL, V161, P4220; Perfettini JL, 2002, INFECT IMMUN, V70, P55, DOI 10.1128/IAI.70.1.55-61.2002; Raoult D, 2005, LANCET INFECT DIS, V5, P219, DOI 10.1016/S1473-3099(05)70052-9; Santucci MB, 2000, J INFECT DIS, V181, P1506, DOI 10.1086/315371; Shannon JG, 2005, P NATL ACAD SCI USA, V102, P8722, DOI 10.1073/pnas.0501863102; Shen HM, 2006, FASEB J, V20, P1589, DOI 10.1096/fj.05-5603rev; Sordet O, 2001, BLOOD, V97, P3931, DOI 10.1182/blood.V97.12.3931; STOKER MGP, 1956, CAN J MICROBIOL, V2, P310, DOI 10.1139/m56-036; Vega-Manriquez X, 2007, INFECT IMMUN, V75, P1223, DOI 10.1128/IAI.01047-06; VISHWANATH S, 1988, INFECT IMMUN, V56, P40, DOI 10.1128/IAI.56.1.40-44.1988; Voth DE, 2007, INFECT IMMUN, V75, P4263, DOI 10.1128/IAI.00594-07; Weinrauch Y, 1999, ANNU REV MICROBIOL, V53, P155, DOI 10.1146/annurev.micro.53.1.155; Zamboni DS, 2004, J BIOL CHEM, V279, P54405, DOI 10.1074/jbc.M410340200; Zamboni DS, 2002, MICROBES INFECT, V4, P591, DOI 10.1016/S1286-4579(02)01577-0; Zhang GQ, 2007, J IMMUNOL, V179, P8372, DOI 10.4049/jimmunol.179.12.8372	49	21	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e30841	10.1371/journal.pone.0030841	http://dx.doi.org/10.1371/journal.pone.0030841			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22303462	gold, Green Published, Green Submitted			2022-12-27	WOS:000301704200038
J	Gall, JM; Wang, ZY; Liesa, M; Molina, A; Havasi, A; Schwartz, JH; Shirihai, O; Borkan, SC; Bonegio, RGB				Gall, Jonathan M.; Wang, Zhiyong; Liesa, Marc; Molina, Anthony; Havasi, Andrea; Schwartz, John H.; Shirihai, Orian; Borkan, Steven C.; Bonegio, Ramon G. B.			Role of Mitofusin 2 in the Renal Stress Response	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; NECROSIS-FACTOR-ALPHA; CYTOCHROME-C RELEASE; ACUTE KIDNEY INJURY; MITOCHONDRIAL FISSION; ATP DEPLETION; EPITHELIAL-CELLS; TUBULAR CELLS; BETA-CATENIN; EMBRYONIC-DEVELOPMENT	The role of mitofusin 2 (MFN2), a key regulator of mitochondrial morphology and function in the renal stress response is unknown. To assess its role, the MFN2 floxed gene was conditionally deleted in the kidney of mice (MFN2 cKO) by Pax2 promoter driven Cre expression (Pax2Cre). MFN2 cKO caused severe mitochondrial fragmentation in renal epithelial cells that are critical for normal kidney tubular function. However, despite a small (20%) decrease in nephron number, newborn cKO pups had organ or tubular function that did not differ from littermate Cre-negative pups. MFN2 deficiency in proximal tubule epithelial cells in primary culture induced mitochondrial fragmentation but did not significantly alter ATP turnover, maximal mitochondrial oxidative reserve capacity, or the low level of oxygen consumption during cyanide exposure. MFN2 deficiency also did not increase apoptosis of tubule epithelial cells under non-stress conditions. In contrast, metabolic stress caused by ATP depletion exacerbated mitochondrial outer membrane injury and increased apoptosis by 80% in MFN2 deficient vs. control cells. Despite similar stress-induced Bax 6A7 epitope exposure in MFN2 deficient and control cells, MFN2 deficiency significantly increased mitochondrial Bax accumulation and was associated with greater release of both apoptosis inducing factor and cytochrome c. In conclusion, MFN2 deficiency in the kidney causes mitochondrial fragmentation but does not affect kidney or tubular function during development or under non-stress conditions. However, MFN2 deficiency exacerbates renal epithelial cell injury by promoting Bax-mediated mitochondrial outer membrane injury and apoptosis.	[Gall, Jonathan M.; Wang, Zhiyong; Havasi, Andrea; Schwartz, John H.; Borkan, Steven C.; Bonegio, Ramon G. B.] Boston Med Ctr, Renal Sect, Boston, MA 02118 USA; [Liesa, Marc; Molina, Anthony; Shirihai, Orian] Boston Med Ctr, Obes Ctr, Boston, MA USA	Boston Medical Center; Boston Medical Center	Gall, JM (corresponding author), Boston Med Ctr, Renal Sect, Boston, MA 02118 USA.	ygall@bu.edu	Liesa, Marc/K-8590-2019; Schwartz, John/AAO-8158-2021	Liesa, Marc/0000-0002-5909-8570; Schwartz, John/0000-0002-1660-8681; Shirihai, Orian/0000-0002-9502-2661; Molina, Anthony/0000-0002-5786-4622; Havasi, Andrea/0000-0002-8758-0823; Borkan, Steven/0000-0003-3062-9486; Bonegio, Ramon/0000-0002-1286-141X; Wang, Zhiyon/0000-0002-6471-266X	National Institutes of Health [(RO-1) DK-52898, DK-53387]; Ruth L. Kirschstein National Research Service [DK-082150]; American Society of Nephrology; ARC from the Evans Center for Interdisciplinary Research at Boston University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052898, R01DK035914, K08DK090143, R01DK053387, R01DK074778, F30DK082150] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Society of Nephrology; ARC from the Evans Center for Interdisciplinary Research at Boston University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health research Grants (RO-1) DK-52898 (JHS), DK-53387 (SCB), a Ruth L. Kirschstein National Research Service Award DK-082150 (JMG) (www.nih.gov), a James A. Scherbenske Award from the American Society of Nephrology (SCB) (www.asn-online.org) and an ARC award from the Evans Center for Interdisciplinary Research at Boston University (www.bumc.bu.edu/evanscenteribr/the-arcs/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonsson B, 2001, J BIOL CHEM, V276, P11615, DOI 10.1074/jbc.M010810200; Arnoult D, 2005, J BIOL CHEM, V280, P35742, DOI 10.1074/jbc.M505970200; Arnoult D, 2003, EMBO J, V22, P4385, DOI 10.1093/emboj/cdg423; Ashrafian H, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001000; Autret A, 2010, CELL MOL LIFE SCI, V67, P1599, DOI 10.1007/s00018-010-0286-x; Autret A, 2009, MOL CELL, V36, P355, DOI 10.1016/j.molcel.2009.10.011; Bach D, 2005, DIABETES, V54, P2685, DOI 10.2337/diabetes.54.9.2685; Bach D, 2003, J BIOL CHEM, V278, P17190, DOI 10.1074/jbc.M212754200; Basile DP, 1997, AM J PHYSIOL-RENAL, V272, pF640, DOI 10.1152/ajprenal.1997.272.5.F640; Bonegio RGB, 2011, KIDNEY INT, V79, P1099, DOI 10.1038/ki.2010.553; Borkan SC, 1997, AM J PHYSIOL-RENAL, V272, pF347, DOI 10.1152/ajprenal.1997.272.3.F347; BREZIS M, 1995, NEW ENGL J MED, V332, P647, DOI 10.1056/NEJM199503093321006; Brooks C, 2010, AM J PHYSL CELL PHYS; Brooks C, 2007, P NATL ACAD SCI USA, V104, P11649, DOI 10.1073/pnas.0703976104; Brooks C, 2009, J CLIN INVEST, V119, P1275, DOI 10.1172/JCI37829; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Cullen-McEwen LA, 2003, HYPERTENSION, V41, P335, DOI 10.1161/01.HYP.0000050961.70182.56; Davies VJ, 2007, HUM MOL GENET, V16, P1307, DOI 10.1093/hmg/ddm079; DONOHOE JF, 1978, KIDNEY INT, V13, P208, DOI 10.1038/ki.1978.31; Fannjiang Y, 2004, GENE DEV, V18, P2785, DOI 10.1101/gad.1247904; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; George NM, 2010, J BIOL CHEM, V285, P1384, DOI 10.1074/jbc.M109.049924; Gobe G, 2000, J AM SOC NEPHROL, V11, P454, DOI 10.1681/ASN.V113454; Gobe G, 1999, KIDNEY INT, V56, P1299, DOI 10.1046/j.1523-1755.1999.00701.x; Goping IS, 1998, J CELL BIOL, V143, P207, DOI 10.1083/jcb.143.1.207; Goyal G, 2007, DEV CELL, V12, P807, DOI 10.1016/j.devcel.2007.02.002; Hall AM, 2008, QJM-INT J MED, V101, P755, DOI 10.1093/qjmed/hcn060; Hall AM, 2009, J AM SOC NEPHROL, V20, P1293, DOI 10.1681/ASN.2008070759; Havasi A, 2008, J BIOL CHEM, V283, P12305, DOI 10.1074/jbc.M801291200; Heyman SN, 2011, CONTRIB NEPHROL, V169, P286, DOI 10.1159/000313957; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Ishihara N, 2009, NAT CELL BIOL, V11, P958, DOI 10.1038/ncb1907; Jagasia R, 2005, NATURE, V433, P754, DOI 10.1038/nature03316; Karbowski M, 2002, J CELL BIOL, V159, P931, DOI 10.1083/jcb.200209124; Karbowski M, 2006, NATURE, V443, P658, DOI 10.1038/nature05111; Li F, 2002, AM J PHYSIOL-CELL PH, V283, pC917, DOI 10.1152/ajpcell.00517.2001; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Lieberthal W, 1998, AM J PHYSIOL-RENAL, V274, pF315, DOI 10.1152/ajprenal.1998.274.2.F315; Liesa M, 2009, PHYSIOL REV, V89, P799, DOI 10.1152/physrev.00030.2008; Nakada K, 2001, NAT MED, V7, P934, DOI 10.1038/90976; Ohyama T, 2004, GENESIS, V38, P195, DOI 10.1002/gene.20017; Ono T, 2001, NAT GENET, V28, P272, DOI 10.1038/90116; Pich S, 2005, HUM MOL GENET, V14, P1405, DOI 10.1093/hmg/ddi149; Price VR, 2002, J AM SOC NEPHROL, V13, P1152, DOI 10.1097/01.ASN.0000012609.22035.44; Ruchalski K, 2006, J BIOL CHEM, V281, P7873, DOI 10.1074/jbc.M513728200; Saikumar P, 1998, ONCOGENE, V17, P3401, DOI 10.1038/sj.onc.1202590; Schwartz JH, 1999, J AM SOC NEPHROL, V10, P2297; Sheridan C, 2008, MOL CELL, V31, P570, DOI 10.1016/j.molcel.2008.08.002; Su B, 2010, BBA-MOL BASIS DIS, V1802, P135, DOI 10.1016/j.bbadis.2009.09.013; Sundararajan R, 2001, J VIROL, V75, P7506, DOI 10.1128/JVI.75.16.7506-7516.2001; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; Tang WX, 2011, ENDOCRINE; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; VENKATACHALAM MA, 1978, KIDNEY INT, V14, P31, DOI 10.1038/ki.1978.87; Wang YH, 1996, AM J PHYSIOL-RENAL, V270, pF1057, DOI 10.1152/ajprenal.1996.270.6.F1057; Wang YH, 2002, CELL STRESS CHAPERON, V7, P137, DOI 10.1379/1466-1268(2002)007<0137:HEESIA>2.0.CO;2; Wang ZY, 2011, KIDNEY INT, V79, P861, DOI 10.1038/ki.2010.527; Wang ZY, 2010, J AM SOC NEPHROL, V21, P284, DOI 10.1681/ASN.2009080828; Wang ZY, 2009, J AM SOC NEPHROL, V20, P1919, DOI 10.1681/ASN.2009030253; Wasiak S, 2007, J CELL BIOL, V177, P439, DOI 10.1083/jcb.200610042; Wei Q, 2007, KIDNEY INT, V72, P53, DOI 10.1038/sj.ki.5002256; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Zorzano A, 2009, INT J BIOCHEM CELL B, V41, P1846, DOI 10.1016/j.biocel.2009.02.004	66	42	46	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2012	7	1							e31074	10.1371/journal.pone.0031074	http://dx.doi.org/10.1371/journal.pone.0031074			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911FX	22292091	Green Published, Green Submitted, gold			2022-12-27	WOS:000301703800041
J	Mafra, V; Kubo, KS; Alves-Ferreira, M; Ribeiro-Alves, M; Stuart, RM; Boava, LP; Rodrigues, CM; Machado, MA				Mafra, Valeria; Kubo, Karen S.; Alves-Ferreira, Marcio; Ribeiro-Alves, Marcelo; Stuart, Rodrigo M.; Boava, Leonardo P.; Rodrigues, Carolina M.; Machado, Marcos A.			Reference Genes for Accurate Transcript Normalization in Citrus Genotypes under Different Experimental Conditions	PLOS ONE			English	Article							TIME RT-PCR; POLYMERASE-CHAIN-REACTION; SINENSIS L. OSBECK; INTERNAL CONTROL; FUNCTIONAL-CHARACTERIZATION; REAL; EXPRESSION; SELECTION; VALIDATION; ORANGE	Real-time reverse transcription PCR (RT-qPCR) has emerged as an accurate and widely used technique for expression profiling of selected genes. However, obtaining reliable measurements depends on the selection of appropriate reference genes for gene expression normalization. The aim of this work was to assess the expression stability of 15 candidate genes to determine which set of reference genes is best suited for transcript normalization in citrus in different tissues and organs and leaves challenged with five pathogens (Alternaria alternata, Phytophthora parasitica, Xylella fastidiosa and Candidatus Liberibacter asiaticus). We tested traditional genes used for transcript normalization in citrus and orthologs of Arabidopsis thaliana genes described as superior reference genes based on transcriptome data. geNorm and NormFinder algorithms were used to find the best reference genes to normalize all samples and conditions tested. Additionally, each biotic stress was individually analyzed by geNorm. In general, FBOX (encoding a member of the F-box family) and GAPC2 (GAPDH) was the most stable candidate gene set assessed under the different conditions and subsets tested, while CYP (cyclophilin), TUB (tubulin) and CtP (cathepsin) were the least stably expressed genes found. Validation of the best suitable reference genes for normalizing the expression level of the WRKY70 transcription factor in leaves infected with Candidatus Liberibacter asiaticus showed that arbitrary use of reference genes without previous testing could lead to misinterpretation of data. Our results revealed FBOX, SAND (a SAND family protein), GAPC2 and UPL7 (ubiquitin protein ligase 7) to be superior reference genes, and we recommend their use in studies of gene expression in citrus species and relatives. This work constitutes the first systematic analysis for the selection of superior reference genes for transcript normalization in different citrus organs and under biotic stress.	[Mafra, Valeria; Kubo, Karen S.; Stuart, Rodrigo M.; Boava, Leonardo P.; Rodrigues, Carolina M.; Machado, Marcos A.] Ctr Citricultura Sylvio Moreira, Lab Biotecnol, Cordeiropolis, SP, Brazil; [Mafra, Valeria; Kubo, Karen S.; Stuart, Rodrigo M.] Univ Estadual Campinas, Inst Biol, Campinas, SP, Brazil; [Alves-Ferreira, Marcio] Univ Fed Rio de Janeiro, Lab Genet Mol Vegetal, Dept Genet, Inst Biol, Rio De Janeiro, Brazil; [Ribeiro-Alves, Marcelo] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Rio De Janeiro, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz	Mafra, V (corresponding author), Ctr Citricultura Sylvio Moreira, Lab Biotecnol, Cordeiropolis, SP, Brazil.	marcos@centrodecitricultura.br	Machado, Marcos/G-3582-2012; Alves-Ferreira, Marcio/C-5849-2009; Citros, Inct/I-2442-2013	Machado, Marcos/0000-0001-9780-3990; Alves-Ferreira, Marcio/0000-0002-6107-3700; Ribeiro-Alves, Marcelo/0000-0002-8663-3364	Instituto Nacional de Ciencia e Tecnologia de Genomica para Melhoramento de Citros	Instituto Nacional de Ciencia e Tecnologia de Genomica para Melhoramento de Citros	This work is part of Valeria Mafra's Ph.D. thesis in the Department of Genetics and Evolution, State University of Campinas, Brazil, and was supported by Instituto Nacional de Ciencia e Tecnologia de Genomica para Melhoramento de Citros. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht U, 2008, PLANT SCI, V175, P291, DOI 10.1016/j.plantsci.2008.05.001; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Artico S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-49; Boava LP, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-39; Boava Leonardo P, 2010, BMC Res Notes, V3, P43, DOI 10.1186/1756-0500-3-43; Carvalho K, 2010, ANAL BIOCHEM, V402, P197, DOI 10.1016/j.ab.2010.03.038; Cernadas RA, 2008, MOL PLANT PATHOL, V9, P609, DOI 10.1111/J.1364-3703.2008.00486.X; Chai LJ, 2011, MOL BIOL REP, V38, P1, DOI 10.1007/s11033-010-0070-x; Cottage A, 2004, CELL MOL BIOL LETT, V9, P739; Cruz F, 2009, MOL BREEDING, V23, P607, DOI 10.1007/s11032-009-9259-x; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Demidenko NV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019434; Endo T, 2006, SCI HORTIC-AMSTERDAM, V109, P315, DOI 10.1016/j.scienta.2006.06.008; Exposito-Rodriguez M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-131; Fan J, 2010, PLANT PATHOL, V59, P1037, DOI 10.1111/j.1365-3059.2010.02328.x; Gachon C, 2004, J EXP BOT, V55, P1445, DOI 10.1093/jxb/erh181; Guenin S, 2009, J EXP BOT, V60, P487, DOI 10.1093/jxb/ern305; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hong SY, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-112; Hruz T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-156; Huerta L, 2008, PLANT CELL ENVIRON, V31, P1620, DOI 10.1111/j.1365-3040.2008.01870.x; Huis R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-71; Iglesias Domingo J., 2007, Braz. J. Plant Physiol., V19, P333, DOI 10.1590/S1677-04202007000400006; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Kraft E, 2005, PLANT PHYSIOL, V139, P1597, DOI 10.1104/pp.105.067983; Li QF, 2010, PLANT MOL BIOL REP, V28, P49, DOI 10.1007/s11105-009-0124-1; Libault M, 2008, PLANT GENOME-US, V1, P44, DOI 10.3835/plantgenome2008.02.0091; Lilly ST, 2011, MOL PLANT MICROBE IN, V24, P294, DOI 10.1094/MPMI-10-10-0236; Liu Q, 2007, J EXP BOT, V58, P4161, DOI 10.1093/jxb/erm273; Liu Q, 2009, J EXP BOT, V60, P801, DOI 10.1093/jxb/ern329; Mallona I, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-4; Matta BP, 2011, DEV GENES EVOL, V221, P49, DOI 10.1007/s00427-011-0356-6; Miao HX, 2011, PLANT SCI, V180, P358, DOI 10.1016/j.plantsci.2010.10.012; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Nishikawa F, 2009, TREE PHYSIOL, V29, P921, DOI 10.1093/treephys/tpp021; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Poteryaev D, 2005, BIOCHEM SOC T, V33, P606, DOI 10.1042/BST0330606; Reid KE, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-27; Remans T, 2008, PLANTA, V227, P1343, DOI 10.1007/s00425-008-0706-4; Sharifi-Sirchi GR, 2011, AFR J BIOTECHNOL, V10, P3818; Silveira ED, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-84; Talon Manuel, 2008, Int J Plant Genomics, V2008, P528361, DOI 10.1155/2008/528361; Tan FC, 2007, PHYSIOL PLANTARUM, V131, P481, DOI 10.1111/j.1399-3054.2007.00971.x; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vierstra RD, 2003, TRENDS PLANT SCI, V8, P135, DOI 10.1016/S1360-1385(03)00014-1; Volkov RA, 2003, J EXP BOT, V54, P2343, DOI 10.1093/jxb/erg244; Wan HJ, 2010, ANAL BIOCHEM, V399, P257, DOI 10.1016/j.ab.2009.12.008; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01; Yan J., 2011, MOL BIOL REP, V38, P1; Zheng TG, 2011, BIOL PLANTARUM, V55, P431, DOI 10.1007/s10535-011-0107-6	51	235	267	4	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2012	7	2							e31263	10.1371/journal.pone.0031263	http://dx.doi.org/10.1371/journal.pone.0031263			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZQ	22347455	Green Submitted, Green Published, gold			2022-12-27	WOS:000302730200016
J	Sun, EC; Zhao, J; Liu, NH; Yang, T; Xu, QY; Qin, YL; Bu, ZG; Yang, YH; Lunt, RA; Wang, LF; Wu, DL				Sun, Encheng; Zhao, Jing; Liu, Nihong; Yang, Tao; Xu, Qingyuan; Qin, Yongli; Bu, Zhigao; Yang, Yinhui; Lunt, Ross A.; Wang, Linfa; Wu, Donglai			Comprehensive Mapping of Common Immunodominant Epitopes in the West Nile Virus Nonstructural Protein 1 Recognized by Avian Antibody Responses	PLOS ONE			English	Article							JAPANESE ENCEPHALITIS-VIRUS; LINKED-IMMUNOSORBENT-ASSAY; NEW-YORK-CITY; NS1 PROTEIN; EXPERIMENTAL-INFECTION; MONOCLONAL-ANTIBODIES; FLAVIVIRUS INFECTION; PROTECTIVE IMMUNITY; PEPTIDE LIBRARY; DOMESTIC GEESE	West Nile virus (WNV) is a mosquito-borne flavivirus that primarily infects birds but occasionally infects humans and horses. Certain species of birds, including crows, house sparrows, geese, blue jays and ravens, are considered highly susceptible hosts to WNV. The nonstructural protein 1 (NS1) of WNV can elicit protective immune responses, including NS1-reactive antibodies, during infection of animals. The antigenicity of NS1 suggests that NS1-reactive antibodies could provide a basis for serological diagnostic reagents. To further define serological reagents for diagnostic use, the antigenic sites in NS1 that are targeted by host immune responses need to be identified and the potential diagnostic value of individual antigenic sites also needs to be defined. The present study describes comprehensive mapping of common immunodominant linear B-cell epitopes in the WNV NS1 using avian WNV NS1 antisera. We screened antisera from chickens, ducks and geese immunized with purified NS1 for reactivity against 35 partially overlapping peptides covering the entire WNV NS1. This study identified twelve, nine and six peptide epitopes recognized by chicken, duck and goose antibody responses, respectively. Three epitopes (NS1-3, 14 and 24) were recognized by antibodies elicited by immunization in all three avian species tested. We also found that NS1-3 and 24 were WNV-specific epitopes, whereas the NS1-14 epitope was conserved among the Japanese encephalitis virus (JEV) serocomplex viruses based on the reactivity of avian WNV NS1 antisera against polypeptides derived from the NS1 sequences of viruses of the JEV serocomplex. Further analysis showed that the three common polypeptide epitopes were not recognized by antibodies in Avian Influenza Virus (AIV), Newcastle Disease Virus (NDV), Duck Plague Virus (DPV) and Goose Parvovirus (GPV) antisera. The knowledge and reagents generated in this study have potential applications in differential diagnostic approaches and subunit vaccines development for WNV and other viruses of the JEV serocomplex.	[Sun, Encheng; Zhao, Jing; Liu, Nihong; Yang, Tao; Xu, Qingyuan; Qin, Yongli; Bu, Zhigao; Wu, Donglai] Chinese Acad Agr Sci, Key Lab Vet Publ Hlth, State Key Lab Vet Biotechnol, Harbin Vet Res Inst,Minist Agr, Harbin, Peoples R China; [Sun, Encheng; Zhao, Jing; Qin, Yongli] Chinese Acad Agr Sci, Grad Sch, Beijing 100193, Peoples R China; [Yang, Yinhui] Beijing Inst Microbiol & Epidemiol, Beijing, Peoples R China; [Lunt, Ross A.; Wang, Linfa] CSIRO Livestock Ind, Australian Anim Hlth Lab, Geelong, Vic, Australia	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Chinese Academy of Agricultural Sciences; Graduate School, CAAS; Beijing Institute of Microbiology & Epidemiology; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Sun, EC (corresponding author), Chinese Acad Agr Sci, Key Lab Vet Publ Hlth, State Key Lab Vet Biotechnol, Harbin Vet Res Inst,Minist Agr, Harbin, Peoples R China.	dlwu@hvri.ac.cn	wang, lin/GSE-3040-2022; Lunt, Ross A/I-4941-2013	Lunt, Ross A/0000-0002-9630-8493	National High-Tech Research and Development Program of China [2011AA10A212]; Heilongjiang Natural Science Foundation of China [ZJN-0602-01]; State Key Laboratory of Veterinary Biotechnology [SKLVBP201018]	National High-Tech Research and Development Program of China(National High Technology Research and Development Program of China); Heilongjiang Natural Science Foundation of China(Natural Science Foundation of Heilongjiang Province); State Key Laboratory of Veterinary Biotechnology	This study was supported by National High-Tech Research and Development Program of China (No. 2011AA10A212), Heilongjiang Natural Science Foundation of China (No. ZJN-0602-01) and grants from State Key Laboratory of Veterinary Biotechnology (SKLVBP201018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amorim JH, 2010, J VIROL METHODS, V167, P186, DOI 10.1016/j.jviromet.2010.04.003; Bernard KA, 2001, EMERG INFECT DIS, V7, P679; CARDOSA MJ, 1986, J VIROL, V57, P952, DOI 10.1128/JVI.57.3.952-959.1986; Centers for Disease Control and Prevention, 2011, W NIL VIR HUM INF US; Chung KM, 2006, J VIROL, V80, P1340, DOI 10.1128/JVI.80.3.1340-1351.2006; Chung KM, 2006, P NATL ACAD SCI USA, V103, P19111, DOI 10.1073/pnas.0605668103; Eidson M, 2001, EMERG INFECT DIS, V7, P631, DOI 10.3201/eid0704.010405; Eidson M, 2001, EMERG INFECT DIS, V7, P615; Garmendia AE, 2001, MICROBES INFECT, V3, P223, DOI 10.1016/S1286-4579(01)01374-0; HENCHAL EA, 1988, J GEN VIROL, V69, P2101, DOI 10.1099/0022-1317-69-8-2101; Julian KG, 2002, VECTOR-BORNE ZOONOT, V2, P145, DOI 10.1089/15303660260613710; Kitai Y, 2007, CLIN VACCINE IMMUNOL, V14, P1024, DOI 10.1128/CVI.00051-07; Kitai Y, 2011, VECTOR-BORNE ZOONOT, V11, P1093, DOI 10.1089/vbz.2010.0094; Kitai Y, 2011, J VIROL METHODS, V171, P123, DOI 10.1016/j.jviromet.2010.10.012; Kitai Y, 2010, CLIN VACCINE IMMUNOL, V17, P875, DOI 10.1128/CVI.00217-09; Komar N, 2003, EMERG INFECT DIS, V9, P311, DOI 10.3201/eid0903.020628; Komar N, 2002, EMERG INFECT DIS, V8, P741, DOI 10.3201/eid0807.020157; Komar N, 2001, EMERG INFECT DIS, V7, P621; Komar N, 2001, VECTOR-BORNE ZOONOT, V1, P191, DOI 10.1089/153036601753552558; Koraka P, 2002, MICROBES INFECT, V4, P1209, DOI 10.1016/S1286-4579(02)01647-7; Kramer LD, 2001, ANN NY ACAD SCI, V951, P84; Kuno G, 2001, REV MED VIROL, V11, P165, DOI 10.1002/rmv.314; Langevin SA, 2001, EMERG INFECT DIS, V7, P726, DOI 10.3201/eid0704.010422; Langevin SA, 2011, J GEN VIROL, V92, P2810, DOI 10.1099/vir.0.035535-0; Lee TH, 2012, J GEN VIROL, V93, P20, DOI 10.1099/vir.0.036640-0; Lin CW, 2008, BIOTECHNOL LETT, V30, P205, DOI 10.1007/s10529-007-9529-9; Lin YL, 1998, J VIROL, V72, P191, DOI 10.1128/JVI.72.1.191-200.1998; Lindenbach BD, 1997, J VIROL, V71, P9608, DOI 10.1128/JVI.71.12.9608-9617.1997; LVOV DK, 1975, MED BIOL, V53, P325; Malkinson M, 2001, ANN NY ACAD SCI, V951, P255; Mehlhop E, 2007, CELL HOST MICROBE, V2, P417, DOI 10.1016/j.chom.2007.09.015; *OFF INT EP, 1999, DIS INFORMATION, V12, P166; Office International des Epizooties, 2000, DIS INF, V13, P150; Oliphant T, 2005, NAT MED, V11, P522, DOI 10.1038/nm1240; Panella NA, 2001, EMERG INFECT DIS, V7, P754; PEIRIS JSM, 1981, NATURE, V289, P189, DOI 10.1038/289189a0; Pierson TC, 2007, CELL HOST MICROBE, V1, P135, DOI 10.1016/j.chom.2007.03.002; Sardelis MR, 2001, EMERG INFECT DIS, V7, P1018, DOI 10.3201/eid0706.010617; SCHLESINGER JJ, 1993, VIROLOGY, V192, P132, DOI 10.1006/viro.1993.1015; SCHLESINGER JJ, 1985, J IMMUNOL, V135, P2805; SEMENOV B F, 1973, Vestnik Akademii Meditsinskikh Nauk SSSR, V28, P79; Senne DA, 2000, AVIAN DIS, V44, P642, DOI 10.2307/1593105; Shi PY, 2003, EXPERT REV MOL DIAGN, V3, P733, DOI 10.1586/14737159.3.6.733; Steele KE, 2000, VET PATHOL, V37, P208, DOI 10.1354/vp.37-3-208; Sun EC, 2012, J GEN VIROL, V93, P50, DOI 10.1099/vir.0.034900-0; Sun EC, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-160; Sun EC, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-100; Swayne DE, 2001, EMERG INFECT DIS, V7, P751; Swayne DE, 2000, AVIAN DIS, V44, P932, DOI 10.2307/1593067; TAYLOR RM, 1956, AM J TROP MED HYG, V5, P579, DOI 10.4269/ajtmh.1956.5.579; Turell MJ, 2000, AM J TROP MED HYG, V62, P413, DOI 10.4269/ajtmh.2000.62.413; Weissenbock H, 2002, EMERG INFECT DIS, V8, P652, DOI 10.3201/eid0807.020094; Williams DT, 2001, AM J TROP MED HYG, V65, P379, DOI 10.4269/ajtmh.2001.65.379; WORK TH, 1955, AM J TROP MED HYG, V4, P872, DOI 10.4269/ajtmh.1955.4.872; Xu GY, 2004, VACCINE, V22, P1846, DOI 10.1016/j.vaccine.2003.09.015; 1999, MMWR MORB MORTAL WKL, V48, P845	56	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2012	7	2							e31434	10.1371/journal.pone.0031434	http://dx.doi.org/10.1371/journal.pone.0031434			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZQ	22347477	gold, Green Published, Green Submitted			2022-12-27	WOS:000302730200022
J	Kenett, DY; Raddant, M; Lux, T; Ben-Jacob, E				Kenett, Dror Y.; Raddant, Matthias; Lux, Thomas; Ben-Jacob, Eshel			Evolvement of Uniformity and Volatility in the Stressed Global Financial Village	PLOS ONE			English	Article							STOCK; CONTAGION	Background: In the current era of strong worldwide market couplings the global financial village became highly prone to systemic collapses, events that can rapidly sweep throughout the entire village. Methodology/Principal Findings: We present a new methodology to assess and quantify inter-market relations. The approach is based on the correlations between the market index, the index volatility, the market Index Cohesive Force and the meta-correlations (correlations between the intra-correlations.) We investigated the relations between six important world markets-U.S., U.K., Germany, Japan, China and India-from January 2000 until December 2010. We found that while the developed "western" markets (U.S., U.K., Germany) are highly correlated, the interdependencies between these markets and the developing "eastern" markets (India and China) are volatile and with noticeable maxima at times of global world events. The Japanese market switches "identity"-it switches between periods of high meta-correlations with the "western" markets and periods when it behaves more similarly to the "eastern" markets. Conclusions/Significance: The methodological framework presented here provides a way to quantify the evolvement of interdependencies in the global market, evaluate a world financial network and quantify changes in the world inter market relations. Such changes can be used as precursors to the agitation of the global financial village. Hence, the new approach can help to develop a sensitive "financial seismograph" to detect early signs of global financial crises so they can be treated before they develop into worldwide events.	[Kenett, Dror Y.; Ben-Jacob, Eshel] Tel Aviv Univ, Sch Phys & Astron, IL-69978 Tel Aviv, Israel; [Raddant, Matthias; Lux, Thomas] Kiel Inst World Econ, Kiel, Germany; [Raddant, Matthias; Lux, Thomas] Univ Kiel, Dept Econ, Kiel, Germany; [Lux, Thomas] Univ Jaume 1, Bank Spain Chair, Castellon de La Plana, Spain	Tel Aviv University; Institut fur Weltwirtschaft an der Universitat Kiel (IFW); University of Kiel; Universitat Jaume I	Kenett, DY (corresponding author), Tel Aviv Univ, Sch Phys & Astron, IL-69978 Tel Aviv, Israel.	eshelbj@gmail.com		Raddant, Matthias/0000-0001-6157-7733	Tauber family Foundation; Tel Aviv University; Volkswagen Foundation	Tauber family Foundation; Tel Aviv University; Volkswagen Foundation(Volkswagen)	DYK and EBJ acknowledge financial support by the Tauber family Foundation and the Maguy-Glass Chair in the Physics of Complex Systems at Tel Aviv University. MR acknowledges financial support by the Volkswagen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Ahlgren N, 2010, Q REV ECON FINANC, V50, P157, DOI 10.1016/j.qref.2009.12.004; Aste T, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/8/085009; Baba K, 2004, AUST NZ J STAT, V46, P657, DOI 10.1111/j.1467-842X.2004.00360.x; Beile M, 2011, QUANTITATIVE FINANCE, V12, P299; BEKAERT G, 1995, J FINANC, V50, P403, DOI 10.2307/2329414; Carrieri F, 2007, J FINANC QUANT ANAL, V42, P915, DOI 10.1017/S0022109000003446; Chen ZA, 2010, EMERG MARK FINANC TR, V46, P140, DOI 10.2753/REE1540-496X460609; ENGLE RF, 1990, ECONOMETRICA, V58, P525, DOI 10.2307/2938189; Forbes KJ, 2002, J FINANC, V57, P2223, DOI 10.1111/0022-1082.00494; Gopikrishnan P, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.035106; Goswami B, 2011, INTERRELATIONS RECUR; Harmon D, 2011, ARXIV11022620; Kenett D. Y., 2010, AUCO CZECH EC REV, V4; Kenett DY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019378; Kenett DY, 2009, HINDAWI J PROBABILIT, DOI [10.1155/2009/249370, DOI 10.1155/2009/249370]; KING M, 1994, ECONOMETRICA, V62, P901, DOI 10.2307/2951737; Lux T, 2009, NAT PHYS, V5, P2, DOI 10.1038/nphys1163; MANTEGNA RN, 2000, INTRO ECONOPHYSICS C; Plerou V, 2000, PHYSICA A, V287, P374, DOI 10.1016/S0378-4371(00)00376-9; Preis T, 2011, P NATL ACAD SCI USA, V108, P7674, DOI 10.1073/pnas.1019484108; Preis T, 2010, J STAT PHYS, V138, P431, DOI 10.1007/s10955-009-9914-y; Shapira Y, 2009, EUR PHYS J B, V72, P657, DOI 10.1140/epjb/e2009-00384-y; Song DM, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.026108; Tumminello M, 2005, P NATL ACAD SCI USA, V102, P10421, DOI 10.1073/pnas.0500298102; Zhu H, 2011, CHINAS EC POSTWTO EN	25	56	56	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31144	10.1371/journal.pone.0031144	http://dx.doi.org/10.1371/journal.pone.0031144			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	924ZP	22347444	gold, Green Submitted, Green Published			2022-12-27	WOS:000302730100047
J	Lembo, A; Di Cunto, F; Provero, P				Lembo, Antonio; Di Cunto, Ferdinando; Provero, Paolo			Shortening of 3 ' UTRs Correlates with Poor Prognosis in Breast and Lung Cancer	PLOS ONE			English	Article							3' UNTRANSLATED REGIONS; MESSENGER-RNA POLYADENYLATION; ALTERNATIVE POLYADENYLATION; AURORA-A; BASAL-LIKE; EXPRESSION; CELLS; GENE; METASTASIS; SURVIVAL	A major part of the post-transcriptional regulation of gene expression is affected by trans-acting elements, such as microRNAs, binding the 3' untraslated region (UTR) of their target mRNAs. Proliferating cells partly escape this type of negative regulation by expressing shorter 3' UTRs, depleted of microRNA binding sites, compared to non-proliferating cells. Using large-scale gene expression datasets, we show that a similar phenomenon takes place in breast and lung cancer: tumors expressing shorter 3' UTRs tend to be more aggressive and to result in shorter patient survival. Moreover, we show that a gene expression signature based only on the expression ratio of alternative 3' UTRs is a strong predictor of survival in both tumors. Genes undergoing 3 ' UTR shortening in aggressive tumors of the two tissues significantly overlap, and several of them are known to be involved in tumor progression. However the pattern of 3' UTR shortening in aggressive tumors in vivo is clearly distinct from analogous patterns involved in proliferation and transformation.	[Lembo, Antonio] Univ Turin, Dept Genet Biol & Biochem, Turin, Italy; Univ Turin, Ctr Mol Biotechnol, Turin, Italy	University of Turin; University of Turin	Lembo, A (corresponding author), Univ Turin, Dept Genet Biol & Biochem, Turin, Italy.	paolo.provero@unito.it	Provero, Paolo/AAC-1930-2019; Di Cunto, Ferdinando/K-5575-2016	di cunto, ferdinando/0000-0001-9367-6357	Italian Association for Cancer Research [IG-9408]	Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro)	PP and AL are supported by the Italian Association for Cancer Research under grant IG-9408. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbano R, 2010, INT J CANC; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Bradshaw AD, 2003, P NATL ACAD SCI USA, V100, P6045, DOI 10.1073/pnas.1030790100; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Cappelli E, 2011, EXP CELL RES, V317, P1203, DOI 10.1016/j.yexcr.2011.01.021; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; Dodson H, 2004, EMBO J, V23, P3864, DOI 10.1038/sj.emboj.7600393; Dutertre S, 2002, ONCOGENE, V21, P6175, DOI 10.1038/sj.onc.1205775; Elsheikh SE, 2008, BRIT J CANCER, V99, P327, DOI 10.1038/sj.bjc.6604463; Foekens JA, 2008, P NATL ACAD SCI USA, V105, P13021, DOI 10.1073/pnas.0803304105; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fu YG, 2011, GENOME RES, V21, P741, DOI 10.1101/gr.115295.110; Gautier L, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-111; Grande-Garcia A, 2008, EUR J CELL BIOL, V87, P641, DOI 10.1016/j.ejcb.2008.02.001; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Guttilla IK, 2009, J BIOL CHEM, V284, P23204, DOI 10.1074/jbc.M109.031427; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Ji Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008419; Ji Z, 2009, P NATL ACAD SCI USA, V106, P7028, DOI 10.1073/pnas.0900028106; Jorissen RN, 2009, CLIN CANCER RES, V15, P7642, DOI 10.1158/1078-0432.CCR-09-1431; Kais Z, 2011, MOL CANC RES; Kao KJ, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-143; Kastl L, 2012, BREAST CANCER RES TR, V131, P445, DOI 10.1007/s10549-011-1424-3; Ko JC, 2009, LUNG CANCER, V65, P290, DOI 10.1016/j.lungcan.2008.12.008; Kumar MS, 2009, GENE DEV, V23, P2700, DOI 10.1101/gad.1848209; Laurent C, 2011, CANCER RES, V71, P666, DOI 10.1158/0008-5472.CAN-10-0605; Le Scodan R, 2010, INT J RADIAT ONCOL, V78, P328, DOI 10.1016/j.ijrobp.2009.07.1735; Lee JY, 2007, NUCLEIC ACIDS RES, V35, pD165, DOI 10.1093/nar/gkl870; Lin HX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015797; Martello G, 2010, CELL, V141, P1195, DOI 10.1016/j.cell.2010.05.017; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Melo SA, 2009, NAT GENET, V41, P365, DOI 10.1038/ng.317; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Millevoi S, 2010, NUCLEIC ACIDS RES, V38, P2757, DOI 10.1093/nar/gkp1176; Nagai MA, 2011, BREAST CANCER RES TR, V126, P1, DOI 10.1007/s10549-010-0867-2; Nie F, 2010, INT J ONCOL, V37, P1261, DOI 10.3892/ijo_00000777; Ogawa E, 2008, ANN SURG ONCOL, V15, P547, DOI 10.1245/s10434-007-9653-8; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Pogribny IP, 2010, INT J CANCER, V127, P1785, DOI 10.1002/ijc.25191; Reddy SDN, 2008, CANCER RES, V68, P8195, DOI 10.1158/0008-5472.CAN-08-2103; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Sankaran S, 2007, CANCER RES, V67, P11186, DOI 10.1158/0008-5472.CAN-07-2578; Savage K, 2008, BREAST CANCER RES TR, V110, P245, DOI 10.1007/s10549-007-9718-1; Schneider G, 2010, BBA-MOL CELL RES, V1803, P1308, DOI 10.1016/j.bbamcr.2010.07.003; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Shevde LA, 2010, J CELL MOL MED, V14, P1693, DOI 10.1111/j.1582-4934.2009.00821.x; Shi M, 2010, CANCER METAST REV, V29, P785, DOI 10.1007/s10555-010-9265-9; Shi XB, 2008, CELL CYCLE, V7, P1529, DOI 10.4161/cc.7.11.5977; Singh P, 2009, CANCER RES, V69, P9422, DOI 10.1158/0008-5472.CAN-09-2236; Soderlund K, 2007, RADIOTHER ONCOL, V84, P242, DOI 10.1016/j.radonc.2007.06.012; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Suzuki M, 2005, BRIT J CANCER, V92, P942, DOI 10.1038/sj.bjc.6602376; Thomsen S, 2010, DEVELOPMENT, V137, P2951, DOI 10.1242/dev.047324; Toziu-Kara S, 2007, J MOL ENDOCRINOL, V39, P305, DOI 10.1677/JME-07-0001; Uhlmann S, 2010, ONCOGENE, V29, P4297, DOI 10.1038/onc.2010.201; Wang JS, 2008, MOL CANCER RES, V6, P372, DOI 10.1158/1541-7786.MCR-07-0162; Wang LH, 2010, CANCER RES, V70, P9118, DOI 10.1158/0008-5472.CAN-10-1246; Wang NJ, 2010, WORLD J SURG, V34, P2545, DOI 10.1007/s00268-010-0690-2; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Webster RJ, 2009, J BIOL CHEM, V284, P5731, DOI 10.1074/jbc.M804280200; Wiestner A, 2007, BLOOD, V109, P4599, DOI 10.1182/blood-2006-08-039859; Xu XE, 2010, PROTEOMICS, V10, P1374, DOI 10.1002/pmic.200900380; Yang XM, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.050237; Zhang HB, 2005, NUCLEIC ACIDS RES, V33, pD116, DOI 10.1093/nar/gki055; Zhang HB, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r100; Zhu CQ, 2010, J CLIN ONCOL, V28, P4417, DOI 10.1200/JCO.2009.26.4325	69	73	76	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31129	10.1371/journal.pone.0031129	http://dx.doi.org/10.1371/journal.pone.0031129			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347440	Green Published, gold, Green Submitted			2022-12-27	WOS:000302730100044
J	Rabuffetti, M; Farina, E; Alberoni, M; Pellegatta, D; Appollonio, I; Affanni, P; Forni, M; Ferrarin, M				Rabuffetti, Marco; Farina, Elisabetta; Alberoni, Margherita; Pellegatta, Daniele; Appollonio, Ildebrando; Affanni, Paola; Forni, Marco; Ferrarin, Maurizio			Spatio-Temporal Features of Visual Exploration in Unilaterally Brain-Damaged Subjects with or without Neglect: Results from a Touchscreen Test	PLOS ONE			English	Article							RIGHT-HEMISPHERE STROKE; SPATIAL WORKING-MEMORY; MINI-MENTAL-STATE; VISUOSPATIAL NEGLECT; HEMISPATIAL NEGLECT; REACTION-TIME; CANCELLATION; ATTENTION; SEARCH; SPACE	Cognitive assessment in a clinical setting is generally made by pencil-and-paper tests, while computer-based tests enable the measurement and the extraction of additional performance indexes. Previous studies have demonstrated that in a research context exploration deficits occur also in patients without evidence of unilateral neglect at pencil-and-paper tests. The objective of this study is to apply a touchscreen-based cancellation test, feasible also in a clinical context, to large groups of control subjects and unilaterally brain-damaged patients, with and without unilateral spatial neglect (USN), in order to assess disturbances of the exploratory skills. A computerized cancellation test on a touchscreen interface was used for assessing the performance of 119 neurologically unimpaired control subjects and 193 patients with unilateral right or left hemispheric brain damage, either with or without USN. A set of performance indexes were defined including Latency, Proximity, Crossings and their spatial lateral gradients, and Preferred Search Direction. Classic outcome scores were computed as well. Results show statistically significant differences among groups (assumed p<0.05). Right-brain-damaged patients with USN were significantly slower (median latency per detected item was 1.18 s) and less efficient (about 13 search-path crossings) in the search than controls (median latency 0.64 s; about 3 crossings). Their preferred search direction (53.6% downward, 36.7% leftward) was different from the one in control patients (88.2% downward, 2.1% leftward). Right-brain-damaged patients without USN showed a significantly abnormal behavior (median latency 0.84 s, about 5 crossings, 83.3% downward and 9.1% leftward direction) situated half way between controls and right-brain-damaged patients with USN. Left-brain-damaged patients without USN were significantly slower and less efficient than controls (latency 1.19 s, about 7 crossings), preserving a normal preferred search direction (93.7% downward). Therefore, the proposed touchscreen-based assessment had evidenced disorders in spatial exploration also in patients without clinically diagnosed USN.	[Rabuffetti, Marco; Farina, Elisabetta; Alberoni, Margherita; Pellegatta, Daniele; Affanni, Paola; Forni, Marco; Ferrarin, Maurizio] Fdn Don Carlo Gnocchi ONLUS, Ancona, Italy; [Appollonio, Ildebrando] Osped San Gerardo, Neurol Clin, Monza, Italy; [Appollonio, Ildebrando] Univ Milano Bicocca, Dipartimento Neurosci, Milan, Italy	IRCCS Fondazione Don Carlo Gnocchi Onlus; San Gerardo Hospital; University of Milano-Bicocca	Rabuffetti, M (corresponding author), Fdn Don Carlo Gnocchi ONLUS, Ancona, Italy.	mrabuffetti@dongnocchi.it	Ferrarin, Maurizio/I-3230-2012; Appollonio, Ildebrando/U-7384-2019	Ferrarin, Maurizio/0000-0002-7797-2399; APPOLLONIO, ILDEBRANDO/0000-0003-4717-6479; Rabuffetti, Marco/0000-0003-1638-7978	Italian Ministery of Health	Italian Ministery of Health(Ministry of Health, Italy)	The study was partially funded by Governative Agencies ("Ricerca Finalizzata-2001-146" and Ricerca Corrente funds by Italian Ministery of Health). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Adair JC, 2008, ANN NY ACAD SCI, V1142, P21, DOI 10.1196/annals.1444.008; ALBERT ML, 1973, NEUROLOGY, V23, P658, DOI 10.1212/WNL.23.6.658; Azouvi P, 2002, J NEUROL NEUROSUR PS, V73, P160, DOI 10.1136/jnnp.73.2.160; Barrett AM, 2006, J COGNITIVE NEUROSCI, V18, P1223, DOI 10.1162/jocn.2006.18.7.1223; Behrmann M, 1997, NEUROPSYCHOLOGIA, V35, P1445, DOI 10.1016/S0028-3932(97)00058-4; Behrmann M, 1998, CONSCIOUS COGN, V7, P381, DOI 10.1006/ccog.1998.0363; Berti A, 2002, NEUROPSYCHOLOGY, V16, P390, DOI 10.1037//0894-4105.16.3.390; Bisiach E., 2000, HDB NEUROPSYCHOLOGY, P459; Blangero A, 2010, CORTEX, V46, P77, DOI 10.1016/j.cortex.2009.02.015; Butler BC, 2004, NEUROPSYCHOLOGIA, V42, P346, DOI 10.1016/j.neuropsychologia.2003.08.008; Cherney Leora Reiff, 2004, Top Stroke Rehabil, V11, P22; Deouell LY, 2005, J INT NEUROPSYCH SOC, V11, P697, DOI 10.1017/S13556177050824; Diller L., 1977, HEMIINATTENTION HEMI, P62; Donnelly N, 1999, BEHAV RES METH INS C, V31, P668, DOI 10.3758/BF03200743; Eglin M, 1994, NEUROPSYCHOLOGY, V4, P451; Eramudugolla R, 2009, NEUROCASE, V15, P24, DOI 10.1080/13554790802570472; Erez ABH, 2009, NEUROPSYCHOL REHABIL, V19, P677, DOI 10.1080/09602010802711160; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GAUTHIER L, 1989, INT J CLIN NEUROPSYC, V11, P49; Guest RM, 2002, PATTERN ANAL APPL, V5, P261, DOI 10.1007/s100440200023; HALLIGAN PW, 1992, J NEUROL NEUROSUR PS, V55, P1060, DOI 10.1136/jnnp.55.11.1060; Heilman K, 2003, CLIN NEUROPSYCHOLOGY, P296, DOI DOI 10.1016/J.NEUR0PSYCHOLOGIA.2011.09.030; Hillstrom AP, 2004, CORTEX, V40, P433, DOI 10.1016/S0010-9452(08)70137-0; Husain M, 2001, BRAIN, V124, P941, DOI 10.1093/brain/124.5.941; Husain M, 2000, BRAIN, V123, P1643, DOI 10.1093/brain/123.8.1643; Husain Masud, 2008, Handb Clin Neurol, V88, P359, DOI 10.1016/S0072-9752(07)88018-3; Karnath HO, 1998, BRAIN, V121, P2357, DOI 10.1093/brain/121.12.2357; Kinsbourne M., 1987, NEUROPHYSIOLOGICAL N, P69, DOI DOI 10.1016/S0166-4115(08)61709-4; Kinsbourne M., 1993, UNILATERAL NEGLECT C, P63, DOI 10.4324/9780203765258; Konczak J, 1999, EXP BRAIN RES, V128, P219, DOI 10.1007/s002210050840; LADAVAS E, 1990, CORTEX, V26, P307, DOI 10.1016/S0010-9452(13)80083-4; Lafosse C, 2003, J CLIN EXP NEUROPSYC, V25, P308, DOI 10.1076/jcen.25.3.308.13807; Lanyon LJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011128; Larose D.T., 2006, DATA MINING METHODS; Liang Y, 2007, PATTERN ANAL APPL, V10, P361, DOI 10.1007/s10044-007-0074-x; Malhotra P, 2005, BRAIN, V128, P424, DOI 10.1093/brain/awh372; Manly T, 2009, NEUROPSYCHOLOGY, V23, P519, DOI 10.1037/a0015413; Mapstone M, 2003, NEUROPSYCHOLOGIA, V41, P1396, DOI 10.1016/S0028-3932(03)00043-5; Mark VW, 2004, NEUROLOGY, V63, P78, DOI 10.1212/01.WNL.0000131947.08670.D4; MASSIRONI M, 1988, NEUROPSYCHOLOGIA, V26, P161, DOI 10.1016/0028-3932(88)90039-5; MATTINGLEY JB, 1994, J NEUROL NEUROSUR PS, V57, P597, DOI 10.1136/jnnp.57.5.597; MEASSO G, 1993, DEV NEUROPSYCHOL, V9, P77, DOI 10.1080/87565649109540545; Muri RM, 2009, PSYCHOL RES-PSYCH FO, V73, P147, DOI 10.1007/s00426-008-0204-0; Parton A, 2006, NEUROREPORT, V17, P833, DOI 10.1097/01.wnr.0000220130.86349.a7; Pignatti R, 2005, J CLIN EXP NEUROPSYC, V27, P436, DOI 10.1080/13803390490520427; Potter J, 2000, CLIN REHABIL, V14, P441, DOI 10.1191/0269215500cr344oa; Ptak R, 2006, BRAIN RES, V1092, P190, DOI 10.1016/j.brainres.2006.03.069; Rabuffetti M, 2002, MED BIOL ENG COMPUT, V40, P675, DOI 10.1007/BF02345306; Samuelsson H, 2002, J INT NEUROPSYCH SOC, V8, P382, DOI 10.1017/S1355617702813194; Sarri M, 2009, NEUROPSYCHOLOGIA, V47, P91, DOI 10.1016/j.neuropsychologia.2008.08.020; Schendel KL, 2002, J CLIN EXP NEUROPSYC, V24, P941, DOI 10.1076/jcen.24.7.941.8390; Shimodozono M, 2006, NEUROPSYCHOLOGIA, V44, P1752, DOI 10.1016/j.neuropsychologia.2006.03.012; Siegel S, 1988, NONPARAMETRIC STAT B, V2; Sunderland A, 2000, STROKE, V31, P430, DOI 10.1161/01.STR.31.2.430; Vallar G., 1994, Archivio di Psicologia Neurologia e Psichiatria, V55, P827; VALLAR G, 1986, NEUROPSYCHOLOGIA, V24, P609, DOI 10.1016/0028-3932(86)90001-1; WEINTRAUB S, 1988, J NEUROL NEUROSUR PS, V51, P1481, DOI 10.1136/jnnp.51.12.1481; Wilson B. A., 1987, BEHAV INATTENTION TE; Woods AJ, 2007, J CLIN EXP NEUROPSYC, V29, P719, DOI 10.1080/13825580600954264; ZOCCOLOTTI P, 1989, INT J NEUROSCI, V47, P209, DOI 10.3109/00207458908987435	60	28	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31511	10.1371/journal.pone.0031511	http://dx.doi.org/10.1371/journal.pone.0031511			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347489	Green Submitted, Green Published, gold			2022-12-27	WOS:000302730100077
J	Raju, I; Oonthonpan, L; Abraham, EC				Raju, Ilangovan; Oonthonpan, Lalita; Abraham, Edathara C.			Mutations in Human alpha A-Crystallin/sHSP Affect Subunit Exchange Interaction with alpha B-Crystallin	PLOS ONE			English	Article							AMINO-ACID-SEQUENCE; MOLECULAR CHAPERONE; CATARACT; GENE; LENS; CRYAA; CHAIN; IDENTIFICATION; AGGREGATION; MUTANT	Background: Mutation in alpha A-crystallin contributes to the development of congenital cataract in humans. Heterooligomerization of alpha A-crystallin and alpha B-crystallin is essential for maintaining transparency in the eye lens. The effect of congenital cataract causing mutants of alpha A-crystallin on subunit exchange and interaction with alpha B-crystallin is unknown. In the present study, interaction of the mutants of alpha A-crystallin with alpha B-crystallin was studied both in vitro and in situ by the fluorescence resonance energy transfer (FRET) technique. Methodology/Principal Findings: In vitro FRET technique was used to demonstrate the rates of subunit exchange of alpha B-wt with the following alpha A-crystallin mutants: R12C, R21L, R21W, R49C, R54C, and R116C. The subunit exchange rates (k values) of R21W and R116C with alpha B-wt decreased drastically as compared to alpha A-wt interacting with alpha B-wt. Moderately decreased k values were seen with R12C, R49C and R54C while R21L showed nearly normal k value. The interaction of alpha A-mutants with alpha B-wt was also assessed by in situ FRET. YFP-tagged alpha A mutants were co-expressed with CFP-tagged alpha B-wt in HeLa cells and the spectral signals were captured with a confocal microscope before and after acceptor laser photobleaching. The interaction of R21W and R116C with alpha B-wt was decreased nearly 50% as compared to alpha A-wt while the rest of the mutants showed slightly decreased interaction. Thus, there is good agreement between the in vitro and in situ FRET data. Conclusions/Significance: Structural changes occurring in these mutants, as reported earlier, could be the underlying cause for the decreased interaction with alpha B may contribute to development of congenital cataract.	[Raju, Ilangovan; Oonthonpan, Lalita; Abraham, Edathara C.] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences	Raju, I (corresponding author), Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA.	ecabraham@uams.edu		Oonthonpan, Lalita/0000-0001-9425-8448	National Institutes of Health [EY011352-15]; NATIONAL EYE INSTITUTE [R01EY011352] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by National Institutes of Health, grant number: EY011352-15. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andley UP, 1996, J BIOL CHEM, V271, P31973, DOI 10.1074/jbc.271.50.31973; Augusteyn RC, 1998, INT J BIOL MACROMOL, V22, P253, DOI 10.1016/S0141-8130(98)00023-3; Bera S, 2002, BIOCHEMISTRY-US, V41, P297, DOI 10.1021/bi011010v; Bova MP, 1997, J BIOL CHEM, V272, P29511, DOI 10.1074/jbc.272.47.29511; Brady JP, 1997, P NATL ACAD SCI USA, V94, P884, DOI 10.1073/pnas.94.3.884; CARVER JA, 1992, FEBS LETT, V311, P143, DOI 10.1016/0014-5793(92)81386-Z; DEJONG WW, 1975, FEBS LETT, V58, P310, DOI 10.1016/0014-5793(75)80286-9; Devi RR, 2008, MOL VIS, V14, P1157; DUBIN RA, 1990, GENOMICS, V7, P594, DOI 10.1016/0888-7543(90)90204-8; FORSTER T, 1959, DISCUSS FARADAY SOC, P7; Graw J, 2006, GRAEF ARCH CLIN EXP, V244, P912, DOI 10.1007/s00417-005-0234-x; Gupta R, 2004, J BIOL CHEM, V279, P44258, DOI 10.1074/jbc.M405648200; Hansen L, 2007, INVEST OPHTH VIS SCI, V48, P3937, DOI 10.1167/iovs.07-0013; HERMAN B, 1989, METHOD CELL BIOL, V30, P219; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; JAKOB U, 1993, J BIOL CHEM, V268, P1517; Jovin TM, 1989, CELL STRUCT FUNCT, P117; Kallur LS, 2008, MOL CELL BIOCHEM, V308, P85, DOI 10.1007/s11010-007-9615-2; Kore R, 2011, MOL CELL BI IN PRESS; Lindner RA, 2001, BIOCHEM J, V354, P79, DOI 10.1042/0264-6021:3540079; Litt M, 1998, HUM MOL GENET, V7, P471, DOI 10.1093/hmg/7.3.471; Mackay DS, 2003, EUR J HUM GENET, V11, P784, DOI 10.1038/sj.ejhg.5201046; Raju I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028085; Raju I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019876; Rao PV, 1995, BBA-GEN SUBJECTS, V1245, P439, DOI 10.1016/0304-4165(95)00125-5; Santhiya S, 2006, MOL VIS, V12, P768; Singh D, 2007, J MOL BIOL, V373, P1293, DOI 10.1016/j.jmb.2007.08.062; STRYER L, 1978, ANNU REV BIOCHEM, V47, P819, DOI 10.1146/annurev.bi.47.070178.004131; VANDEROU.FJ, 1974, EUR J BIOCHEM, V49, P157; VANDEROU.FJ, 1973, EUR J BIOCHEM, V39, P207; WANG KY, 1994, J BIOL CHEM, V269, P13601; Xia XH, 2006, INVEST OPHTH VIS SCI, V47, P3004	32	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31421	10.1371/journal.pone.0031421	http://dx.doi.org/10.1371/journal.pone.0031421			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347476	gold, Green Published, Green Submitted			2022-12-27	WOS:000302730100070
J	Rossi, A; Coccia, M; Trotta, E; Angelini, M; Santoro, MG				Rossi, Antonio; Coccia, Marta; Trotta, Edoardo; Angelini, Mara; Santoro, M. Gabriella			Regulation of Cyclooxygenase-2 Expression by Heat: A Novel Aspect of Heat Shock Factor 1 Function in Human Cells	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; NUCLEAR-FACTOR; KAPPA-B; GENE-TRANSCRIPTION; STRESS-RESPONSE; UP-REGULATION; FACTOR-I; FEVER; PROSTAGLANDINS; TEMPERATURE	The heat-shock response, a fundamental defense mechanism against proteotoxic stress, is regulated by a family of heat-shock transcription factors (HSF). In humans HSF1 is considered the central regulator of heat-induced transcriptional responses. The main targets for HSF1 are specific promoter elements (HSE) located upstream of heat-shock genes encoding cytoprotective heat-shock proteins (HSP) with chaperone function. In addition to its cytoprotective function, HSF1 was recently hypothesized to play a more complex role, regulating the expression of non-HSP genes; however, the non-canonical role of HSF1 is still poorly understood. Herein we report that heat-stress promotes the expression of cyclooxygenase-2 (COX-2), a key regulator of inflammation controlling prostanoid and thromboxane synthesis, resulting in the production of high levels of prostaglandin-E-2 in human cells. We show that heat-induced COX-2 expression is regulated at the transcriptional level via HSF1-mediated signaling and identify, by in-vitro reporter gene activity assay and deletion-mutant constructs analysis, the COX-2 heat-responsive promoter region and a new distal cis-acting HSE located at position - 2495 from the transcription start site. As shown by ChIP analysis, HSF1 is recruited to the COX-2 promoter rapidly after heat treatment; by using shRNA-mediated HSF1 suppression and HSE-deletion from the COX-2 promoter, we demonstrate that HSF1 plays a central role in the transcriptional control of COX-2 by heat. Finally, COX-2 transcription is also induced at febrile temperatures in endothelial cells, suggesting that HSF1-dependent COX-2 expression could contribute to increasing blood prostaglandin levels during fever. The results identify COX-2 as a human non-classical heat-responsive gene, unveiling a new aspect of HSF1 function.	[Rossi, Antonio; Coccia, Marta; Trotta, Edoardo; Santoro, M. Gabriella] CNR, Inst Translat Pharmacol, Rome, Italy; [Coccia, Marta; Angelini, Mara; Santoro, M. Gabriella] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Farmacologia Traslazionale (IFT-CNR); University of Rome Tor Vergata	Rossi, A (corresponding author), CNR, Inst Translat Pharmacol, Rome, Italy.	santoro@bio.uniroma2.it	Trotta, Edoardo/AAW-4697-2020	Trotta, Edoardo/0000-0002-1417-9238; Santoro, Maria Gabriella/0000-0003-1432-4949; ROSSI, ANTONIO/0000-0003-0383-3828	Italian Ministry of Health; ISS [7OCF/7, ACC12]; EU-EICOSANOX	Italian Ministry of Health(Ministry of Health, Italy); ISS; EU-EICOSANOX	This work was supported by grants from the Italian Ministry of Health, ISS projects 'Ricerca Oncologica' [N. 7OCF/7] and 'Alleanza contro il Cancro' [N. ACC12], and the EU-EICOSANOX project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAVAYA K, 1991, GENE DEV, V5, P2117, DOI 10.1101/gad.5.11.2117; Anckar J, 2007, ADV EXP MED BIOL, V594, P78; Arnaud C, 2003, CARDIOVASC RES, V58, P582, DOI 10.1016/S0008-6363(03)00295-5; Blatteis CM, 2005, PROSTAG OTH LIPID M, V76, P1, DOI 10.1016/j.prostaglandins.2005.01.001; CALDERWOOD SK, 1989, J CELL PHYSIOL, V141, P325, DOI 10.1002/jcp.1041410214; Caughey GE, 2001, J BIOL CHEM, V276, P37839; Chen Q, 2006, NAT IMMUNOL, V7, P1299, DOI 10.1038/ni1406; de Gregorio R, 2001, J BIOL CHEM, V276, P27003, DOI 10.1074/jbc.M100885200; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Egan K., 2006, V176, P189; Evers LH, 2010, EXP DERMATOL, V19, P777, DOI 10.1111/j.1600-0625.2010.01105.x; Fujimoto M, 2010, FEBS J, V277, P4112, DOI 10.1111/j.1742-4658.2010.07827.x; Gothard LQ, 2003, J BIOL CHEM, V278, P9322, DOI 10.1074/jbc.M209412200; Guertin MJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001114; Hasday JD, 2000, CELL STRESS CHAPERON, V5, P471, DOI 10.1379/1466-1268(2000)005<0471:FATHSR>2.0.CO;2; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hill JM, 2001, VIRUS GENES, V23, P273, DOI 10.1023/A:1012517221937; Holmberg CI, 2002, TRENDS BIOCHEM SCI, V27, P619, DOI 10.1016/S0968-0004(02)02207-7; Inouye S, 2007, J BIOL CHEM, V282, P33210, DOI 10.1074/jbc.M704471200; Jaattela M, 1999, ANN MED, V31, P261, DOI 10.3109/07853899908995889; Jia DW, 2010, EXPERT REV MED DEVIC, V7, P407, DOI [10.1586/erd.10.13, 10.1586/ERD.10.13]; Kang YJ, 2007, PROG LIPID RES, V46, P108, DOI 10.1016/j.plipres.2007.01.001; Kline MP, 1997, MOL CELL BIOL, V17, P2107, DOI 10.1128/MCB.17.4.2107; Lu YB, 2005, J IMMUNOL, V175, P5423, DOI 10.4049/jimmunol.175.8.5423; Maity TK, 2011, CYTOKINE, V54, P61, DOI 10.1016/j.cyto.2010.12.017; Marnett LJ, 2000, CURR OPIN CHEM BIOL, V4, P545, DOI 10.1016/S1367-5931(00)00130-7; Mbonye UR, 2006, J BIOL CHEM, V281, P35770, DOI 10.1074/jbc.M608281200; Mbonye UR, 2009, BMB REP, V42, P552, DOI 10.5483/BMBRep.2009.42.9.552; Morimoto RI, 1998, NAT BIOTECHNOL, V16, P833, DOI 10.1038/nbt0998-833; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; MOSSER DD, 1988, MOL CELL BIOL, V8, P4736, DOI 10.1128/MCB.8.11.4736; Murapa P, 2007, J IMMUNOL, V179, P8305, DOI 10.4049/jimmunol.179.12.8305; Pang LH, 2003, J IMMUNOL, V170, P1043, DOI 10.4049/jimmunol.170.2.1043; Parfenova H, 2001, AM J PHYSIOL-CELL PH, V281, pC166, DOI 10.1152/ajpcell.2001.281.1.C166; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; Rao Wei, 2010, Critical Reviews in Biomedical Engineering, V38, P101, DOI 10.1615/CritRevBiomedEng.v38.i1.80; Ray S, 2004, J BIOL CHEM, V279, P35604, DOI 10.1074/jbc.M401851200; Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449; Robertson AG, 2008, GENOME RES, V18, P1906, DOI 10.1101/gr.078519.108; Rossi A, 2000, NATURE, V403, P103, DOI 10.1038/47520; Rossi A, 1997, P NATL ACAD SCI USA, V94, P746, DOI 10.1073/pnas.94.2.746; Rossi A, 2010, J BIOL CHEM, V285, P13607, DOI 10.1074/jbc.M109.082693; Sakurai H, 2010, FEBS J, V277, P4140, DOI 10.1111/j.1742-4658.2010.07829.x; Sandqvist A, 2009, MOL BIOL CELL, V20, P1340, DOI 10.1091/mbc.E08-08-0864; Sawaoka H, 2003, J BIOL CHEM, V278, P13928, DOI 10.1074/jbc.M300016200; Shin YK, 2005, CANCER RES, V65, P9501, DOI 10.1158/0008-5472.CAN-05-0220; Singh IS, 2000, J BIOL CHEM, V275, P9841, DOI 10.1074/jbc.275.13.9841; Singh IS, 2008, AM J RESP CELL MOL, V39, P235, DOI 10.1165/rcmb.2007-0294OC; Tanabe T, 2002, PROSTAG OTH LIPID M, V68-9, P95, DOI 10.1016/S0090-6980(02)00024-2; Trinklein ND, 2004, MOL BIOL CELL, V15, P1254, DOI 10.1091/mbc.E03-10-0738; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946; Xie Y, 2002, J BIOL CHEM, V277, P11802, DOI 10.1074/jbc.M109296200; Zhao YH, 2009, ONCOGENE, V28, P3689, DOI 10.1038/onc.2009.229	55	31	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31304	10.1371/journal.pone.0031304	http://dx.doi.org/10.1371/journal.pone.0031304			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347460	gold, Green Published, Green Submitted			2022-12-27	WOS:000302730100059
J	Newman, SH; Hill, NJ; Spragens, KA; Janies, D; Voronkin, IO; Prosser, DJ; Yan, BP; Lei, FM; Batbayar, N; Natsagdorj, T; Bishop, CM; Butler, PJ; Wikelski, M; Balachandran, S; Mundkur, T; Douglas, DC; Takekawa, JY				Newman, Scott H.; Hill, Nichola J.; Spragens, Kyle A.; Janies, Daniel; Voronkin, Igor O.; Prosser, Diann J.; Yan, Baoping; Lei, Fumin; Batbayar, Nyambayar; Natsagdorj, Tseveenmyadag; Bishop, Charles M.; Butler, Patrick J.; Wikelski, Martin; Balachandran, Sivananinthaperumal; Mundkur, Taej; Douglas, David C.; Takekawa, John Y.			Eco-Virological Approach for Assessing the Role of Wild Birds in the Spread of Avian Influenza H5N1 along the Central Asian Flyway	PLOS ONE			English	Article							DOMESTIC DUCKS; MIGRATORY WATERFOWL; VIRUS-INFECTION; CHINA; OUTBREAKS; POULTRY; PERSISTENCE; EVOLUTION; DYNAMICS; REVEALS	A unique pattern of highly pathogenic avian influenza (HPAI) H5N1 outbreaks has emerged along the Central Asia Flyway, where infection of wild birds has been reported with steady frequency since 2005. We assessed the potential for two hosts of HPAI H5N1, the bar-headed goose (Anser indicus) and ruddy shelduck (Tadorna tadorna), to act as agents for virus dispersal along this 'thoroughfare'. We used an eco-virological approach to compare the migration of 141 birds marked with GPS satellite transmitters during 2005-2010 with: 1) the spatio-temporal patterns of poultry and wild bird outbreaks of HPAI H5N1, and 2) the trajectory of the virus in the outbreak region based on phylogeographic mapping. We found that biweekly utilization distributions (UDs) for 19.2% of bar-headed geese and 46.2% of ruddy shelduck were significantly associated with outbreaks. Ruddy shelduck showed highest correlation with poultry outbreaks owing to their wintering distribution in South Asia, where there is considerable opportunity for HPAI H5N1 spillover from poultry. Both species showed correlation with wild bird outbreaks during the spring migration, suggesting they may be involved in the northward movement of the virus. However, phylogeographic mapping of HPAI H5N1 clades 2.2 and 2.3 did not support dissemination of the virus in a northern direction along the migration corridor. In particular, two subclades (2.2.1 and 2.3.2) moved in a strictly southern direction in contrast to our spatio-temporal analysis of bird migration. Our attempt to reconcile the disciplines of wild bird ecology and HPAI H5N1 virology highlights prospects offered by both approaches as well as their limitations.	[Newman, Scott H.] Food & Agr Org United Nations, EMPRES Wildlife Unit, Ctr Transboundary Anim Dis, Anim Prod & Hlth Div, Rome, Italy; [Hill, Nichola J.; Spragens, Kyle A.; Takekawa, John Y.] US Geol Survey, Western Ecol Res Ctr, San Francisco Bay Estuary Field Stn, Vallejo, CA USA; [Hill, Nichola J.] Univ Calif Davis, Sch Vet Med, Wildlife Hlth Ctr, Davis, CA 95616 USA; [Janies, Daniel; Voronkin, Igor O.] Ohio State Univ, Dept Biomed Informat, Columbus, OH 43210 USA; [Prosser, Diann J.] US Geol Survey, Patuxent Wildlife Res Ctr, Beltsville Lab, Beltsville, MD USA; [Yan, Baoping] Chinese Acad Sci, Comp Network Informat Ctr, Beijing, Peoples R China; [Lei, Fumin] Chinese Acad Sci, Inst Zool, Beijing, Peoples R China; [Batbayar, Nyambayar] Wildlife Sci & Conservat Ctr, Bayanzurkh Dist Ulaanbaa, Mongolia; [Natsagdorj, Tseveenmyadag] Mongolian Acad Sci, Ornithol Lab, Inst Biol, Ulaanbaatar, Mongolia; [Bishop, Charles M.] Bangor Univ, Sch Biol Sci, Brambell Labs, Bangor, Gwynedd, Wales; [Butler, Patrick J.] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [Wikelski, Martin] Max Planck Inst Ornithol, Radolfzell am Bodensee, Germany; [Balachandran, Sivananinthaperumal] Bombay Nat Hist Soc, Bombay, Maharashtra, India; [Mundkur, Taej] Wetlands Int, NL-6700 AL Wageningen, Netherlands; [Douglas, David C.] US Geol Survey, Alaska Sci Ctr, Juneau, AK USA	Food & Agriculture Organization of the United Nations (FAO); United States Department of the Interior; United States Geological Survey; University of California System; University of California Davis; University System of Ohio; Ohio State University; United States Department of the Interior; United States Geological Survey; Chinese Academy of Sciences; Computer Network Information Center, CAS; Chinese Academy of Sciences; Institute of Zoology, CAS; Mongolian Academy of Sciences; Bangor University; University of Birmingham; Max Planck Society; United States Department of the Interior; United States Geological Survey	Newman, SH (corresponding author), Food & Agr Org United Nations, EMPRES Wildlife Unit, Ctr Transboundary Anim Dis, Anim Prod & Hlth Div, Rome, Italy.	john_takekawa@usgs.gov	Batbayar, Nyambayar/N-3761-2019; Douglas, David C./AAU-1087-2021; Batbayar, Nyambayar/N-7066-2015; Hill, Nichola/G-4003-2011	Batbayar, Nyambayar/0000-0002-9138-9626; Douglas, David C./0000-0003-0186-1104; Batbayar, Nyambayar/0000-0002-9138-9626; Prosser, Diann/0000-0002-5251-1799; /0000-0003-3213-6693	Food and Agriculture Organization of the United Nations through the EMPRES Wildlife Unit; United States Geological Survey (Western Ecological Research Center); United States Geological Survey (Patuxent Wildlife Research Center); United States Geological Survey (Alaska Science Center); National Science Foundation [0713027]; Biotechnology and Biological Science Research Council of the United Kingdom; Chinese Academy of Sciences [2007FY210700, INFO-115-D02, KSCX2-YW-N-063, 2005CB523007]; BBSRC [BB/F015615/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F015615/1] Funding Source: researchfish	Food and Agriculture Organization of the United Nations through the EMPRES Wildlife Unit; United States Geological Survey (Western Ecological Research Center); United States Geological Survey (Patuxent Wildlife Research Center)(United States Geological Survey); United States Geological Survey (Alaska Science Center)(United States Geological Survey); National Science Foundation(National Science Foundation (NSF)); Biotechnology and Biological Science Research Council of the United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Chinese Academy of Sciences(Chinese Academy of Sciences); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Food and Agriculture Organization of the United Nations through the EMPRES Wildlife Unit, the United States Geological Survey (Western Ecological Research Center, Patuxent Wildlife Research Center, Alaska Science Center, and Wild Bird Avian Influenza Program), the National Science Foundation Small Grants for Exploratory Research (No. 0713027), and the Biotechnology and Biological Science Research Council of the United Kingdom and the Chinese Academy of Sciences (No. 2007FY210700, INFO-115-D02, KSCX2-YW-N-063 and 2005CB523007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barua A, 1997, WORLD POULTRY SCI J, V53, P387, DOI 10.1079/WPS19970031; Bin Muzaffar S, 2010, WATERBIRDS, V33, P219, DOI 10.1675/063.033.s116; Bishop MA, 2007, CHINA CRANE NEWS, V11, P24; Bishop Mary A., 1997, Wildfowl, V48, P118; Biswas PK, 2008, EMERG INFECT DIS, V14, P1909, DOI 10.3201/eid1412.071567; Brown IH, 2010, AVIAN DIS, V54, P187, DOI 10.1637/8949-053109-Reg.1; Brown JD, 2008, EMERG INFECT DIS, V14, P136, DOI 10.3201/eid1401.070740; Brown JD, 2006, EMERG INFECT DIS, V12, P1663, DOI 10.3201/eid1211.060652; Butler D, 2006, NATURE, V441, P263, DOI 10.1038/441263a; Chakrabarti AK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007846; Chen HL, 2006, J VIROL, V80, P5976, DOI 10.1128/JVI.00110-06; Cui P, 2011, VECTOR-BORNE ZOONOT, V11, P567, DOI 10.1089/vbz.2009.0240; FAO, 2010, EMPRES I GLOB AN HLT; Feare CJ, 2010, J WILDLIFE DIS, V46, P1340, DOI 10.7589/0090-3558-46.4.1340; Gaidet N, 2010, J APPL ECOL, V47, P1147, DOI 10.1111/j.1365-2664.2010.01845.x; Galvin KA, 2009, ANNU REV ANTHROPOL, V38, P185, DOI 10.1146/annurev-anthro-091908-164442; Gauthier-Clerc M, 2007, IBIS, V149, P202, DOI 10.1111/j.1474-919X.2007.00699.x; Gilbert M, 2006, EMERG INFECT DIS, V12, P227, DOI 10.3201/eid1202.050640; Gilbert M, 2007, AGR ECOSYST ENVIRON, V119, P409, DOI 10.1016/j.agee.2006.09.001; Gilbert M, 2006, EMERG INFECT DIS, V12, P1650, DOI 10.3201/eid1211.060223; Gilbert M, 2010, ECOHEALTH, V7, P448, DOI 10.1007/s10393-010-0672-8; Goloboff P, 2008, CLADISTICS, V24, P91; Gopal B, 1994, WETLANDS SHALLOW CON, P457; Hogerwerf L, 2010, ECOHEALTH, V7, P213, DOI 10.1007/s10393-010-0324-z; Hooge PN, 1997, ANIMAL MOVEMENT EXTE; Hovmoller R, 2010, CLADISTICS, V26, P1, DOI 10.1111/j.1096-0031.2009.00297.x; Hoye BJ, 2011, OIKOS, V120, P748, DOI 10.1111/j.1600-0706.2010.18961.x; Hulse-Post DJ, 2005, P NATL ACAD SCI USA, V102, P10682, DOI 10.1073/pnas.0504662102; Iverson SA, IBIS IN PRESS; Janies D, 2007, SYST BIOL, V56, P321, DOI 10.1080/10635150701266848; Javed Salim, 2000, Global Environmental Research, V4, P195; Kamal RP, 2007, ARCH VIROL, V152, P1637, DOI 10.1007/s00705-007-1002-5; Keating KA, 2009, ECOLOGY, V90, P1971, DOI 10.1890/08-1131.1; Keawcharoen J, 2008, EMERG INFECT DIS, V14, P600, DOI 10.3201/eid1404.071016; Kilpatrick AM, 2006, P NATL ACAD SCI USA, V103, P19368, DOI 10.1073/pnas.0609227103; Kou Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006926; Kwon YK, 2010, VET PATHOL, V47, P495, DOI 10.1177/0300985809359602; Lebarbenchon C, 2010, EMERG INFECT DIS, V16, P1057, DOI 10.3201/eid1607.090389; Lei FM, 2007, AVIAN DIS, V51, P568, DOI 10.1637/0005-2086(2007)51[568:COHIVI]2.0.CO;2; Li KB, 2003, BIOINFORMATICS, V19, P1585, DOI 10.1093/bioinformatics/btg192; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; Li YB, 2010, J VIROL, V84, P8389, DOI 10.1128/JVI.00413-10; Liang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013575; Liu J, 2005, SCIENCE, V309, P1206, DOI 10.1126/science.1115273; Liu Y, 2004, INT J REMOTE SENS, V25, P4177, DOI 10.1080/01431160410001680419; Lvov D. K., 2006, Voprosy Virusologii, V51, P11; Middleton B, 1989, THESIS IOWA STATE U; Mishra AC, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-26; Miyabayashi Y, 1999, ATLAS KEY SITES ANAT; Newman SH, 2010, FAO EMPRES WILDLIFE; ODUM EP, 1960, AM J CLIN NUTR, V8, P621, DOI 10.1093/ajcn/8.5.621; Ottaviani D, 2010, ECOHEALTH, V7, P226, DOI 10.1007/s10393-010-0316-z; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Prosser DJ, 2009, IBIS, V151, P568, DOI 10.1111/j.1474-919X.2009.00932.x; Sakoda Y, 2010, VIROLOGY, V406, P88, DOI 10.1016/j.virol.2010.07.007; Sharshov K, 2010, EMERG INFECT DIS, V16, P349, DOI 10.3201/eid1602.090974; Si YL, 2009, GEOSPATIAL HEALTH, V4, P65, DOI 10.4081/gh.2009.211; SLATKIN M, 1989, GENETICS, V123, P603; Smith GJD, 2009, EMERG INFECT DIS, V15, P402, DOI 10.3201/eid1503.081190; Songserm T, 2006, EMERG INFECT DIS, V12, P575, DOI 10.3201/eid1204.051614; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Sturm-Ramirez KM, 2005, J VIROL, V79, P11269, DOI 10.1128/JVI.79.17.11269-11279.2005; U.S. Geological Survey, 2010, SAT TRACK MIGR BIRDS; Van Borm S, 2005, EMERG INFECT DIS, V11, P702, DOI 10.3201/eid1105.050211; Vijayan VS, 1988, KEOLADEO NATL PARK E; Wallace R, 2009, AVIAN INFLUENZA FARM, P141; Wallace RG, 2007, P NATL ACAD SCI USA, V104, P4473, DOI 10.1073/pnas.0700435104; Webster RG, 2007, AVIAN DIS, V51, P269, DOI 10.1637/7641-050206R.1; WHO, 2010, CUM NUMB CONF HUM CA; Xiao XM, 2007, J WILDLIFE DIS, V43, pS40; Zhang FY, 1997, BIRD MIGRATION RES C; Zhang ZJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015314; Zhou JY, 2009, J VIROL, V83, P8957, DOI 10.1128/JVI.00793-09	73	57	59	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2012	7	2							e30636	10.1371/journal.pone.0030636	http://dx.doi.org/10.1371/journal.pone.0030636			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917MF	22347393	Green Published, Green Submitted, gold			2022-12-27	WOS:000302180600013
J	Zhang, XY; Liang, J; Chen, DC; Xiu, MH; He, JC; Cheng, W; Wu, ZW; Yang, DF; Haile, CN; Sun, HQ; Lu, L; Kosten, TA; Kosten, TR				Zhang, Xiang Yang; Liang, Jun; Chen, Da Chun; Xiu, Mei Hong; He, Jincai; Cheng, Wei; Wu, Zhiwei; Yang, Fu De; Haile, Colin N.; Sun, Hongqiang; Lu, Lin; Kosten, Therese A.; Kosten, Thomas R.			Cigarette Smoking in Male Patients with Chronic Schizophrenia in a Chinese Population: Prevalence and Relationship to Clinical Phenotypes	PLOS ONE			English	Article							NICOTINE DEPENDENCE; TOBACCO SMOKING; TARDIVE-DYSKINESIA; PARKINSONS-DISEASE; MENTAL-ILLNESS; SYMPTOMS; INDIVIDUALS; MEDICATION; INPATIENTS; DOPAMINE	The high prevalence of smoking in schizophrenia of European background may be related to smoking's reducing clinical symptoms and medication side effects. Because smoking prevalence and its associations with clinical phenotypes are less well characterized in Chinese than European patients with schizophrenia, we assessed these smoking behaviors using clinician-administered questionnaires and the Fagerstrom Test for Nicotine Dependence (FTND) in 776 Chinese male schizophrenia and 560 control subjects. Patients also were rated on the Positive and Negative Symptom Scale (PANSS), the Simpson and Angus Extrapyramidal Symptom Rating Scale (SAES), and the Abnormal Involuntary Movement Scale (AIMS). We found that the schizophrenia patients had a higher lifetime incidence of smoking (79% vs 63%), were more likely to be heavy smokers (61% vs 31%), and had lower smoking cessation rates (4% vs 9%) (all p<0.0001) than controls. Among the schizophrenia patients smoking prevalence increased with age, with the largest difference from controls in the age cohort of 55-75 years: 75% vs 46% (p<0.0001). Among the schizophrenia smokers 73% started to smoke before the onset of their illness by an average of 7.6 years. The patients with schizophrenia who were current smokers scored significantly lower on the PANSS negative symptom subscore (p<0.005), and on the SAES symptom scale (p<0.04; Bonferroni corrected p>0.05) than the non-smoking patients. These results suggest that Chinese males with schizophrenia smoke more frequently than the general population. Further, smokers with schizophrenia may display fewer negative symptoms and possibly less parkinsonism than non-smokers with schizophrenia.	[Zhang, Xiang Yang; Haile, Colin N.; Kosten, Therese A.; Kosten, Thomas R.] Baylor Coll Med, Menninger Dept Psychiat & Behav Sci, Houston, TX 77030 USA; [Zhang, Xiang Yang; Chen, Da Chun; Xiu, Mei Hong; Yang, Fu De; Sun, Hongqiang; Kosten, Thomas R.] Peking Univ, Beijing HuiLongGuan Hosp, Beijing 100871, Peoples R China; [Liang, Jun] Peking Univ, Inst Mental Hlth, Beijing 100871, Peoples R China; [He, Jincai; Cheng, Wei; Wu, Zhiwei] First Affiliated Hosp, Wenzhou Med Coll, Wenzhou, Peoples R China; [Sun, Hongqiang] Peking Univ, Natl Inst Drug Dependence, Beijing 100871, Peoples R China	Baylor College of Medicine; Peking University; Peking University; Wenzhou Medical University; Peking University	Zhang, XY (corresponding author), Baylor Coll Med, Menninger Dept Psychiat & Behav Sci, Houston, TX 77030 USA.	xyzhang@bcm.edu; kosten@bcm.edu	Kosten, Thomas/AAI-5998-2021; KOSTEN, Therese/R-2506-2019	Haile, Colin/0000-0001-8293-7291	United States National Institutes of Health [U01-MH79639, K05-DA0454, P50-DA18827]; Stanley Medical Research Institute [03T-459, 05T-726]; Department of Veterans Affairs, Mental Illness Research, Education and Clinical Center (MIRECC) [VISN 16]; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH079639] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA000454] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanley Medical Research Institute; Department of Veterans Affairs, Mental Illness Research, Education and Clinical Center (MIRECC)(US Department of Veterans Affairs); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was funded by the United States National Institutes of Health U01-MH79639, K05-DA0454 and P50-DA18827, the Stanley Medical Research Institute (03T-459 and 05T-726), and the Department of Veterans Affairs, VISN 16, Mental Illness Research, Education and Clinical Center (MIRECC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar MC, 2005, BRIT J PSYCHIAT, V186, P215, DOI 10.1192/bjp.186.3.215; Barnes M, 2006, AUST NZ J PSYCHIAT, V40, P575, DOI 10.1111/j.1440-1614.2006.01841.x; Chong SA, 1996, AUST NZ J PSYCHIAT, V30, P350, DOI 10.3109/00048679609064998; Chong SA, 2003, J PSYCHIATR NEUROSCI, V28, P185; CLARKE PBS, 1985, BRAIN RES, V348, P355, DOI 10.1016/0006-8993(85)90456-1; Dalack GW, 1998, AM J PSYCHIAT, V155, P1490, DOI 10.1176/ajp.155.11.1490; DAVIS KL, 1991, AM J PSYCHIAT, V148, P1474; de Leon J, 2005, SCHIZOPHR RES, V76, P135, DOI 10.1016/j.schres.2005.02.010; deLeon J, 1996, SCHIZOPHRENIA BULL, V22, P405, DOI 10.1093/schbul/22.3.405; Diehl A, 2009, EUR PSYCHIAT, V24, P33, DOI 10.1016/j.eurpsy.2008.07.007; Drew AE, 2000, SYNAPSE, V38, P10, DOI 10.1002/1098-2396(200010)38:1<10::AID-SYN2>3.0.CO;2-T; Elbaz A, 2007, J NEUROL SCI, V262, P37, DOI 10.1016/j.jns.2007.06.024; Esterberg ML, 2007, SCHIZOPHR RES, V97, P6, DOI 10.1016/j.schres.2007.08.024; Fagerstrom K O, 1996, Tob Control, V5, P52, DOI 10.1136/tc.5.1.52; FAGERSTROM KO, 1978, ADDICT BEHAV, V3, P235, DOI 10.1016/0306-4603(78)90024-2; Fawzi MH, 2007, SCHIZOPHR RES, V95, P236, DOI 10.1016/j.schres.2007.06.005; Freedman R, 1997, P NATL ACAD SCI USA, V94, P587, DOI 10.1073/pnas.94.2.587; GOETZ CG, 1983, ARCH NEUROL-CHICAGO, V40, P325, DOI 10.1001/archneur.1983.04050050093019; GOFF DC, 1992, AM J PSYCHIAT, V149, P1189; Hennekens CH, 2005, AM HEART J, V150, P1115, DOI 10.1016/j.ahj.2005.02.007; Kelly C, 1999, AM J PSYCHIAT, V156, P1751; KIRCH DG, 1987, CLIN NEUROPHARMACOL, V10, P376, DOI 10.1097/00002826-198708000-00009; Lasser K, 2000, JAMA-J AM MED ASSOC, V284, P2606, DOI 10.1001/jama.284.20.2606; Lee S, 2009, ADDICT BEHAV, V34, P969, DOI 10.1016/j.addbeh.2009.05.005; Leonard Sherry, 2007, J Dual Diagn, V3, P43, DOI 10.1300/J374v03n03_05; Liao DL, 2002, NEUROPSYCHOBIOLOGY, V45, P172, DOI 10.1159/000063666; Llerena A, 2003, SCHIZOPHR RES, V60, P311, DOI 10.1016/S0920-9964(02)00508-X; Olincy A, 1997, BIOL PSYCHIAT, V42, P1, DOI 10.1016/S0006-3223(96)00302-2; Salokangas RKR, 1997, SCHIZOPHR RES, V23, P55, DOI 10.1016/S0920-9964(96)00083-7; Silvestri S, 2004, ACTA PSYCHIAT SCAND, V109, P313, DOI 10.1111/j.1600-0447.2004.00293.x; Smith Robert C., 2001, Subst Abus, V22, P175, DOI 10.1023/A:1011136218194; Taiminen TJ, 1998, ADDICT BEHAV, V23, P263, DOI 10.1016/S0306-4603(97)00028-2; Tang YL, 2007, SCHIZOPHR RES, V97, P88, DOI 10.1016/j.schres.2007.05.025; Wiles NJ, 2006, BRIT J PSYCHIAT, V188, P519, DOI 10.1192/bjp.bp.105.012179; Williams JM, 2010, NICOTINE TOB RES, V12, P855, DOI 10.1093/ntr/ntq102; Williams JM, 2004, ADDICT BEHAV, V29, P1067, DOI 10.1016/j.addbeh.2004.03.009; Zhang XY, 2010, J PSYCHIATR RES, V44, P986, DOI 10.1016/j.jpsychires.2010.02.015; ZIEDONIS DM, 1994, HOSP COMMUNITY PSYCH, V45, P204; Ziedonis D, 2008, NICOTINE TOB RES, V10, P1691, DOI 10.1080/14622200802443569	39	33	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2012	7	2							e30937	10.1371/journal.pone.0030937	http://dx.doi.org/10.1371/journal.pone.0030937			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	917MF	22347412	Green Published, gold, Green Submitted			2022-12-27	WOS:000302180600017
J	Song, M; Xiong, JX; Wang, YY; Tang, J; Zhang, B; Bai, Y				Song, Min; Xiong, Jia-xiang; Wang, Yan-yan; Tang, Jun; Zhang, Bo; Bai, Yun			VIP Enhances Phagocytosis of Fibrillar Beta-Amyloid by Microglia and Attenuates Amyloid Deposition in the Brain of APP/PS1 Mice	PLOS ONE			English	Article							VASOACTIVE-INTESTINAL-PEPTIDE; NITRIC-OXIDE SYNTHASE; ALZHEIMER-DISEASE; TNF-ALPHA; POLYPEPTIDE; RAT; STIMULATION; INFLAMMATION; MACROPHAGES; ACTIVATION	Vasoactive intestinal peptide (VIP) is a multifunctional neuropeptide with demonstrated immunosuppressive and neuroprotective activities. It has been shown to inhibit Amyloid beta (A beta)-induced neurodegeneration by indirectly suppressing the production and release of a variety of inflammatory and neurotoxic factors by activated microglia. We demonstrated that VIP markedly increased microglial phagocytosis of fibrillar A beta 42 and that this enhanced phagocytotic activity depended on activation of the Protein kinase C (PKC) signaling pathway. In addition, VIP suppressed the release of tumor necrosis factor alpha (TNF-alpha) and nitric oxide(NO) from microglia activated by combined treatment with fibrillar A beta 42 and low dose interferon-gamma (IFN-gamma). We utilized an adenovirus-mediated gene delivery method to overexpress VIP constitutively in the hippocampus of APPswPS1 transgenic mice. The A beta load was significantly reduced in the hippocampus of this animal model of Alzheimer's disease, possibly due to the accumulation and activation of cd11b-immunoactive microglial cells. The modulation of microglial activation, phagocytosis, and secretion by VIP is a promising therapeutic option for the treatment of Alzheimer's disease(AD).	[Song, Min; Wang, Yan-yan; Tang, Jun; Zhang, Bo; Bai, Yun] Third Mil Med Univ, Dept Med Genet, Chongqing, Peoples R China; [Xiong, Jia-xiang] Third Mil Med Univ, Dept Med Physiol, Chongqing, Peoples R China	Army Medical University; Army Medical University	Song, M (corresponding author), Third Mil Med Univ, Dept Med Genet, Chongqing, Peoples R China.	baiyungene@gmail.com			National Natural Science Foundation of China [81000147, 30228018]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (NO. 81000147, NO. 30228018) and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAI H, 1984, NEUROSCI LETT, V52, P73, DOI 10.1016/0304-3940(84)90353-7; Bedoui S, 2003, J IMMUNOL, V171, P3451, DOI 10.4049/jimmunol.171.7.3451; Choucair-Jaafar N, 2011, FUND CLIN PHARMACOL, V25, P115, DOI 10.1111/j.1472-8206.2010.00811.x; Combs CK, 2001, J NEUROSCI, V21, P1179; DELAFUENTE M, 1993, REGUL PEPTIDES, V48, P345, DOI 10.1016/0167-0115(93)90163-3; Delgado M, 2003, FASEB J, V17, P944, DOI 10.1096/fj.02-0799fje; Delgado M, 2002, GLIA, V39, P148, DOI 10.1002/glia.10098; Delgado M, 2004, PHARMACOL REV, V56, P249, DOI 10.1124/pr.56.2.7; Delgado M, 2008, GLIA, V56, P1091, DOI 10.1002/glia.20681; DiCarlo G, 2001, NEUROBIOL AGING, V22, P1007, DOI 10.1016/S0197-4580(01)00292-5; El Zein N, 2008, J LEUKOCYTE BIOL, V83, P972, DOI 10.1189/jlb.0507327; FARMERY SM, 1984, NEUROPHARMACOLOGY, V23, P101, DOI 10.1016/0028-3908(84)90224-7; GLOWA JR, 1992, BRAIN RES, V570, P49, DOI 10.1016/0006-8993(92)90562-N; Gonzalez-Rey Elena, 2005, Curr Opin Investig Drugs, V6, P1116; Gozes I, 1996, P NATL ACAD SCI USA, V93, P427, DOI 10.1073/pnas.93.1.427; GOZES I, 1993, J MOL NEUROSCI, V4, P185, DOI 10.1007/BF02782501; Grimm MC, 2003, J IMMUNOL, V171, P4990, DOI 10.4049/jimmunol.171.10.4990; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Heneka MT, 1998, J NEUROCHEM, V71, P88; Joo KM, 2004, J COMP NEUROL, V476, P388, DOI 10.1002/cne.20231; Krishnadas A, 2003, CURR PHARM DESIGN, V9, P1005, DOI 10.2174/1381612033455206; Liu J, 2000, IMMUNOLOGY, V101, P61, DOI 10.1046/j.1365-2567.2000.00082.x; Lodde BM, 2004, BIOCHEM BIOPH RES CO, V319, P189, DOI 10.1016/j.bbrc.2004.04.171; LOREN I, 1979, NEUROSCIENCE, V4, P1953, DOI 10.1016/0306-4522(79)90068-X; Mandrekar-Colucci S, 2010, CNS NEUROL DISORD-DR, V9, P156, DOI 10.2174/187152710791012071; Martinez C, 2002, P NATL ACAD SCI USA, V99, P1053, DOI 10.1073/pnas.012367999; Monsonego A, 2003, SCIENCE, V302, P834, DOI 10.1126/science.1088469; MUHVIC D, 1992, ANN NY ACAD SCI, V650, P170; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Reinke E, 2006, IMMUNOL LETT, V104, P102, DOI 10.1016/j.imlet.2005.11.009; Rivest S, 2009, NAT REV IMMUNOL, V9, P429, DOI 10.1038/nri2565; Tan J, 1999, SCIENCE, V286, P2352, DOI 10.1126/science.286.5448.2352; Weldon DT, 1998, J NEUROSCI, V18, P2161; Wu RQ, 2003, REGUL PEPTIDES, V112, P19, DOI 10.1016/S0167-0115(03)00018-1; Wyss-Coray T, 2006, NAT MED, V12, P1005, DOI 10.1038/nml1484; ZHOU JN, 1995, NEUROBIOL AGING, V16, P571, DOI 10.1016/0197-4580(95)00043-E; Zhu YN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002135	38	22	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2012	7	2							e29790	10.1371/journal.pone.0029790	http://dx.doi.org/10.1371/journal.pone.0029790			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LV	22328918	Green Published, Green Submitted, gold			2022-12-27	WOS:000302179300004
J	Parameshwaran, D; Crone, NE; Thiagarajan, TC				Parameshwaran, Dhanya; Crone, Nathan E.; Thiagarajan, Tara C.			Coherence Potentials Encode Simple Human Sensorimotor Behavior	PLOS ONE			English	Article							ELECTROCORTICOGRAPHIC SPECTRAL-ANALYSIS; CATS VISUAL-CORTEX; CORTICAL ACTIVITY; NEURONAL AVALANCHES; CELL ASSEMBLIES; PREFRONTAL CORTEX; WORKING-MEMORY; BRAIN; VARIABILITY; SYNCHRONIZATION	Recent work has shown that large amplitude negative periods in the local field potential (nLFPs) are able to spread in saltatory manner across large distances in the cortex without distortion in their temporal structure forming 'coherence potentials'. Here we analysed subdural electrocorticographic (ECoG) signals recorded at 59 sites in the sensorimotor cortex in the left hemisphere of a human subject performing a simple visuomotor task (fist clenching and foot dorsiflexion) to understand how coherence potentials arising in the recordings relate to sensorimotor behavior. In all behaviors we found a particular coherence potential (i.e. a cascade of a particular nLFP wave pattern) arose consistently across all trials with temporal specificity. During contrateral fist clenching, but not the foot dorsiflexion or ipsilateral fist clenching, the coherence potential most frequently originated in the hand representation area in the somatosensory cortex during the anticipation and planning periods of the trial, moving to other regions during the actual motor behavior. While these 'expert' sites participated more consistently, other sites participated only a small fraction of the time. Furthermore, the timing of the coherence potential at the hand representation area after onset of the cue predicted the timing of motor behavior. We present the hypothesis that coherence potentials encode information relevant for behavior and are generated by the 'expert' sites that subsequently broadcast to other sites as a means of 'sharing knowledge'.	[Parameshwaran, Dhanya; Thiagarajan, Tara C.] TIFR, Natl Ctr Biol Sci, Bangalore, Karnataka, India; [Crone, Nathan E.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Johns Hopkins University	Parameshwaran, D (corresponding author), TIFR, Natl Ctr Biol Sci, Bangalore, Karnataka, India.	tara@ncbs.res.in			National Center for Biological Sciences/Tata Institute of Fundamental Research, India; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040596] Funding Source: NIH RePORTER	National Center for Biological Sciences/Tata Institute of Fundamental Research, India; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	National Center for Biological Sciences/Tata Institute of Fundamental Research, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allman BL, 2007, J NEUROPHYSIOL, V98, P545, DOI 10.1152/jn.00173.2007; Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Baars BJ, 2003, TRENDS NEUROSCI, V26, P671, DOI 10.1016/j.tins.2003.09.015; Beggs JM, 2003, J NEUROSCI, V23, P11167; BRUGGE JF, 1973, J NEUROPHYSIOL, V36, P1138, DOI 10.1152/jn.1973.36.6.1138; Buzsaki G, 2010, NEURON, V68, P362, DOI 10.1016/j.neuron.2010.09.023; Churchland MM, 2010, NAT NEUROSCI, V13, P369, DOI 10.1038/nn.2501; Crone NE, 1998, BRAIN, V121, P2271, DOI 10.1093/brain/121.12.2271; Crone NE, 1998, BRAIN, V121, P2301, DOI 10.1093/brain/121.12.2301; EICHENBAUM H, 1993, SCIENCE, V261, P993, DOI 10.1126/science.8351525; Eimer M, 2002, J COGNITIVE NEUROSCI, V14, P254, DOI 10.1162/089892902317236885; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Friston KJ, 2010, NAT REV NEUROSCI, V11, P127, DOI 10.1038/nrn2787; Fuster JM, 2000, NATURE, V405, P347, DOI 10.1038/35012613; Gerhard F, 2011, FRONT COMPUT NEUROSC, V5, P1, DOI [10.3389/fncom.2011.00004, 10.3389/fncom.2011.00023]; Ghazanfar AA, 2006, TRENDS COGN SCI, V10, P278, DOI 10.1016/j.tics.2006.04.008; GILBERT CD, 1979, NATURE, V280, P120, DOI 10.1038/280120a0; Gur M, 1997, J NEUROSCI, V17, P2914; Hebb DO, 1993, ORG BEHAV NEUROPSYCH; HIRSCH JA, 1991, J NEUROSCI, V11, P1800; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Izhikevich EM, 2006, NEURAL COMPUT, V18, P245, DOI 10.1162/089976606775093882; Komiyama T, 2010, NATURE, V464, P1182, DOI 10.1038/nature08897; LASHLEY KS, 1929, MECH INTELLIGENCE QU; LESSER RP, 1987, J CLIN NEUROPHYSIOL, V4, P27, DOI 10.1097/00004691-198701000-00003; McAdams CJ, 1999, NEURON, V23, P765, DOI 10.1016/S0896-6273(01)80034-9; Miller KJ, 2010, P NATL ACAD SCI USA, V107, P4430, DOI 10.1073/pnas.0913697107; Pareti G, 2004, NEUROL SCI, V25, P41, DOI 10.1007/s10072-004-0235-2; Pesaran B, 2002, NAT NEUROSCI, V5, P805, DOI 10.1038/nn890; Petermann T, 2009, P NATL ACAD SCI USA, V106, P15921, DOI 10.1073/pnas.0904089106; Pillow JW, 2008, NATURE, V454, P995, DOI 10.1038/nature07140; Plenz D, 2007, TRENDS NEUROSCI, V30, P101, DOI 10.1016/j.tins.2007.01.005; Prut Y, 1998, J NEUROPHYSIOL, V79, P2857, DOI 10.1152/jn.1998.79.6.2857; Quiroga RQ, 2005, NATURE, V435, P1102, DOI 10.1038/nature03687; Rao SC, 1997, SCIENCE, V276, P821, DOI 10.1126/science.276.5313.821; Rizzolatti G, 2001, NEURON, V31, P889, DOI 10.1016/S0896-6273(01)00423-8; Sakurai Y, 2006, J NEUROSCI, V26, P10141, DOI 10.1523/JNEUROSCI.2423-06.2006; Scaglione A, 2011, P NATL ACAD SCI USA, V108, P14956, DOI 10.1073/pnas.1103168108; Schall JD, 2001, NAT REV NEUROSCI, V2, P33, DOI 10.1038/35049054; Shadlen Michael N., 1994, Current Opinion in Neurobiology, V4, P569, DOI 10.1016/0959-4388(94)90059-0; Stein BE, 2008, NAT REV NEUROSCI, V9, P255, DOI 10.1038/nrn2331; Stettler DD, 2009, NEURON, V63, P854, DOI 10.1016/j.neuron.2009.09.005; Thiagarajan TC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000278; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Yu J, NEURON, V68, P1187; Yu S, 2011, J NEUROSCI, V31, P17514, DOI 10.1523/JNEUROSCI.3127-11.2011	46	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e30514	10.1371/journal.pone.0030514	http://dx.doi.org/10.1371/journal.pone.0030514			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LO	22319572	Green Published, gold, Green Submitted			2022-12-27	WOS:000302178400009
J	Turner, RM; Lloyd-Jones, M; Anumba, DOC; Smith, GCS; Spiegelhalter, DJ; Squires, H; Stevens, JW; Sweeting, MJ; Urbaniak, SJ; Webster, R; Thompson, SG				Turner, Rebecca M.; Lloyd-Jones, Myfanwy; Anumba, Dilly O. C.; Smith, Gordon C. S.; Spiegelhalter, David J.; Squires, Hazel; Stevens, John W.; Sweeting, Michael J.; Urbaniak, Stanislaw J.; Webster, Robert; Thompson, Simon G.			Routine Antenatal Anti-D Prophylaxis in Women Who Are Rh(D) Negative: Meta-Analyses Adjusted for Differences in Study Design and Quality	PLOS ONE			English	Article							RHD HEMOLYTIC-DISEASE; D IMMUNOGLOBULIN; SYSTEMATIC REVIEWS; TRIAL; ISOIMMUNIZATION; PREGNANCY; PROGRAM	Background: To estimate the effectiveness of routine antenatal anti-D prophylaxis for preventing sensitisation in pregnant Rhesus negative women, and to explore whether this depends on the treatment regimen adopted. Methods: Ten studies identified in a previous systematic literature search were included. Potential sources of bias were systematically identified using bias checklists, and their impact and uncertainty were quantified using expert opinion. Study results were adjusted for biases and combined, first in a random-effects meta-analysis and then in a random-effects meta-regression analysis. Results: In a conventional meta-analysis, the pooled odds ratio for sensitisation was estimated as 0.25 (95% CI 0.18, 0.36), comparing routine antenatal anti-D prophylaxis to control, with some heterogeneity (I-2 = 19%). However, this naive analysis ignores substantial differences in study quality and design. After adjusting for these, the pooled odds ratio for sensitisation was estimated as 0.31 (95% CI 0.17, 0.56), with no evidence of heterogeneity (I-2 = 0%). A meta-regression analysis was performed, which used the data available from the ten anti-D prophylaxis studies to inform us about the relative effectiveness of three licensed treatments. This gave an 83% probability that a dose of 1250 IU at 28 and 34 weeks is most effective and a 76% probability that a single dose of 1500 IU at 28-30 weeks is least effective. Conclusion: There is strong evidence for the effectiveness of routine antenatal anti-D prophylaxis for prevention of sensitisation, in support of the policy of offering routine prophylaxis to all non-sensitised pregnant Rhesus negative women. All three licensed dose regimens are expected to be effective.	[Turner, Rebecca M.; Spiegelhalter, David J.; Sweeting, Michael J.] MRC, Biostat Unit, Inst Publ Hlth, Cambridge CB2 2BW, England; [Anumba, Dilly O. C.] Univ Sheffield, Sch Med, Acad Unit Reprod & Dev Med, Sheffield, S Yorkshire, England; [Smith, Gordon C. S.] Univ Cambridge, Dept Obstet & Gynaecol, Cambridge, England; [Spiegelhalter, David J.] Univ Cambridge, Stat Lab, Cambridge CB2 1SB, England; [Stevens, John W.] Univ Sheffield, Ctr Bayesian Stat Hlth Econ, Sheffield, S Yorkshire, England; [Urbaniak, Stanislaw J.] Univ Aberdeen, Acad Transfus Med Unit, Foresterhill, Scotland; [Webster, Robert] Natl Blood Serv Sheffield Ctr, Natl Hlth Serv Blood & Transplant, Sheffield, S Yorkshire, England; [Thompson, Simon G.] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England	MRC Biostatistics Unit; University of Cambridge; University of Sheffield; University of Cambridge; University of Cambridge; University of Sheffield; University of Aberdeen; NHS Blood & Transplant (NHSBT); University of Cambridge	Turner, RM (corresponding author), MRC, Biostat Unit, Inst Publ Hlth, Cambridge CB2 2BW, England.	rebecca.turner@mrc-bsu.cam.ac.uk	Squires, Hazel/GSO-3900-2022; Sweeting, Michael John/U-3917-2019; Smith, Gordon/A-8070-2008; Professor Dilly Anumba MBBS, FWACS/A-6358-2011	Sweeting, Michael John/0000-0003-0980-8965; Smith, Gordon/0000-0003-2124-0997; Professor Dilly Anumba MBBS, FWACS/0000-0003-2502-3033; Squires, Hazel/0000-0002-2776-4014; Stevens, John/0000-0002-9867-7209; Sharples, Linda/0000-0003-0894-966X	United Kingdom Medical Research Council [U.1052.00.001, U.1052.00.011, U.1052.00.005]; National Institute on Health Research (NIHR); NIHR Cambridge Comprehensive Biomedical Research Centre; British Heart Foundation [RG/08/014/24067] Funding Source: researchfish; Medical Research Council [MC_U105260792, MC_U105232027, MC_U105285807, MC_U105260557] Funding Source: researchfish; MRC [MC_U105260792, MC_U105285807, MC_U105260557, MC_U105232027] Funding Source: UKRI	United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute on Health Research (NIHR); NIHR Cambridge Comprehensive Biomedical Research Centre; British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	RT, DS, MS and ST were supported by the United Kingdom Medical Research Council grants U.1052.00.001, U.1052.00.011 and U.1052.00.005. MLJ and HS were supported by grants awarded by the National Institute on Health Research (NIHR) Health Technology Assessment Programme. GS was supported by the NIHR Cambridge Comprehensive Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowman J M, 1987, Transfus Med Rev, V1, P101, DOI 10.1016/S0887-7963(87)70010-8; BOWMAN JM, 1978, CAN MED ASSOC J, V118, P627; BOWMAN JM, 1978, CAN MED ASSOC J, V118, P623; Chilcott J, 2003, HLTH TECHNOLOGY ASSE, V7; Clemen RT, 1999, RISK ANAL, V19, P187, DOI 10.1023/A:1006917509560; de Craen AJM, 2005, J CLIN EPIDEMIOL, V58, P311, DOI 10.1016/j.jclinepi.2004.07.002; Greenland S, 2005, J R STAT SOC A STAT, V168, P267, DOI 10.1111/j.1467-985X.2004.00349.x; Hermann M, 1984, Acta Obstet Gynecol Scand Suppl, V124, P1; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; HUCHET J, 1987, Journal de Gynecologie Obstetrique et biologie de la Reproduction, V16, P101; LEE D, 1995, TRANSFUSION MED, V5, P15, DOI 10.1111/j.1365-3148.1995.tb00180.x; MacKenzie IZ, 1999, BRIT J OBSTET GYNAEC, V106, P492, DOI 10.1111/j.1471-0528.1999.tb08304.x; Mayne S, 1997, BRIT MED J, V315, P1588, DOI 10.1136/bmj.315.7122.1588; Moja LP, 2005, BMJ-BRIT MED J, V330, P1053, DOI 10.1136/bmj.38414.515938.8F; Pilgrim H, 2009, HLTH TECHNOLOGY ASSE, V13; Stockman JA, 2001, J PEDIAT HEMATOL ONC, V23, P385, DOI 10.1097/00043426-200108000-00017; Szczepura A, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-5; Thompson SG, 1999, STAT MED, V18, P2693, DOI 10.1002/(SICI)1097-0258(19991030)18:20<2693::AID-SIM235>3.0.CO;2-V; TOVEY LAD, 1983, LANCET, V2, P244; TROLLE B, 1989, ACTA OBSTET GYN SCAN, V68, P45, DOI 10.3109/00016348909087688; Turner RM, 2009, J R STAT SOC A STAT, V172, P21, DOI 10.1111/j.1467-985X.2008.00547.x; Urbaniak SJ, 2000, BLOOD REV, V14, P44, DOI 10.1054/blre.1999.0123; Whitfield CR, 1997, BRIT MED J, V315, P1504, DOI 10.1136/bmj.315.7121.1504	23	43	45	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e30711	10.1371/journal.pone.0030711	http://dx.doi.org/10.1371/journal.pone.0030711			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LO	22319580	Green Published, Green Accepted, gold			2022-12-27	WOS:000302178400012
J	Raffaello, T; Kerio, S; Asiegbu, FO				Raffaello, Tommaso; Kerio, Susanna; Asiegbu, Fred O.			Role of the HaHOG1 MAP Kinase in Response of the Conifer Root and But Rot Pathogen (Heterobasidion annosum) to Osmotic and Oxidative Stress	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; SIGNAL-TRANSDUCTION; HOG PATHWAY; YEAST; GENE; EXPRESSION; ENCODES; GROWTH; DIFFERENTIATION; RESISTANCE	The basidiomycete Heterobasidion annosum (Fr.) Bref. s.l. is a filamentous white rot fungus, considered to be the most economically important pathogen of conifer trees. Despite the severity of the tree infection, very little is known about the molecular and biochemical aspects related to adaptation to abiotic stresses. In this study, the osmotic and oxidative tolerance as well as the role of the HaHOG1 Mitogen Activated Protein Kinase (MAPK) gene were investigated. The transcript levels of the yeast orthologues GPD1, HSP78, STL1, GRE2 and the ATPase pumps ENA1, PMR1, PMC1 known to have an important role in osmotolerance were also quantified under salt osmotic conditions. The HaHOG1 gene was used for a heterologous expression and functional study in the Saccharomyces cerevisiae Delta hog1 strain. Moreover, the phosphorylation level of HaHog1p was studied under salt osmotic and oxidative stress. The result showed that H. annosum displayed a decreased growth when exposed to an increased concentration of osmotic and oxidative stressors. GPD1, HSP78, STL1 and GRE2 showed an induction already at 10 min after exposure to salt stress. Among the ATPase pumps studied, PMC1 was highly induced when the fungus was exposed to 0.2 M CaCl2 for 60 min. The heterologous expression of the HaHOG1 sequence in yeast confirmed that the gene is able to restore the osmotolerance and oxidative tolerance in the S. cerevisiae hog1 Delta mutant strain. The HaHog1p was strongly phosphorylated in the presence of NaCl, KCl, H2O2 but not in the presence of CaCl2 and MgCl2. The GFP-HaHog1p fusion protein accumulated in the nuclei of the S. cerevisiae hog1 Delta cells when exposed to high osmotic conditions but not under oxidative stress. These results provide the first insights about the response of H. annosum to osmotic and oxidative stress and elucidate the role of the HaHOG1 gene in such conditions.	[Raffaello, Tommaso; Kerio, Susanna; Asiegbu, Fred O.] Univ Helsinki, Dept Forest Sci, Helsinki, Finland; [Raffaello, Tommaso; Asiegbu, Fred O.] Viikki Grad Sch Mol Biosci VGSB, Helsinki, Finland	University of Helsinki	Raffaello, T (corresponding author), Univ Helsinki, Dept Forest Sci, Helsinki, Finland.	tommaso.raffaello@helsinki.fi		Raffaello, Tommaso/0000-0002-4074-0682; Kerio, Susanna/0000-0002-1637-5451; Asiegbu, Fred O/0000-0003-0223-7194	Helsinki University [490025]; Academy of Finland [131660]; Viikki Graduate School in Molecular Biosciences (VGSB)	Helsinki University; Academy of Finland(Academy of Finland); Viikki Graduate School in Molecular Biosciences (VGSB)	This work was supported by Helsinki University Research grant (490025) to FOA, the Academy of Finland grant (131660) and Viikki Graduate School in Molecular Biosciences (VGSB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam AL, 2008, J BASIC MICROB, V48, P151, DOI 10.1002/jobm.200700403; ALBERTYN J, 1994, MOL CELL BIOL, V14, P4135, DOI 10.1128/MCB.14.6.4135; Alonso-Monge R, 2003, EUKARYOT CELL, V2, P351, DOI 10.1128/EC.2.2.351-361.2003; ANTEBI A, 1992, MOL BIOL CELL, V3, P633, DOI 10.1091/mbc.3.6.633; Asiegbu FO, 2005, MOL PLANT PATHOL, V6, P395, DOI 10.1111/J.1364-3703.2005.00295.X; Bahn YS, 2005, MOL BIOL CELL, V16, P2285, DOI 10.1091/mbc.E04-11-0987; Benito B, 2002, MICROBIOL-SGM, V148, P933, DOI 10.1099/00221287-148-4-933; Benito B, 2009, EUKARYOT CELL, V8, P821, DOI 10.1128/EC.00252-08; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bilsland E, 2004, MOL MICROBIOL, V53, P1743, DOI 10.1111/j.1365-2958.2004.04238.x; Bilsland-Marchesan E, 2003, YEAST, V20, pS203; BREWSTER JL, 1993, SCIENCE, V259, P1760, DOI 10.1126/science.7681220; Chen CN, 2003, YEAST, V20, P545, DOI 10.1002/yea.979; Dixon KP, 1999, PLANT CELL, V11, P2045, DOI 10.1105/tpc.11.10.2045; Eaton CJ, 2008, CURR GENET, V53, P163, DOI 10.1007/s00294-007-0174-6; Ferreira C, 2005, MOL BIOL CELL, V16, P2068, DOI 10.1091/mbc.E04-10-0884; Hernandez-Lopez MJ, 2006, EUKARYOT CELL, V5, P1410, DOI 10.1128/EC.00068-06; Igbaria A, 2008, MOL PLANT MICROBE IN, V21, P769, DOI 10.1094/MPMI-21-6-0769; Jin Y, 2005, P NATL ACAD SCI USA, V102, P18992, DOI 10.1073/pnas.0509653102; JONES AS, 1953, BIOCHIM BIOPHYS ACTA, V10, P607, DOI 10.1016/0006-3002(53)90304-7; Kawasaki L, 2002, MOL MICROBIOL, V45, P1153, DOI 10.1046/j.1365-2958.2002.03087.x; Kayingo G, 2009, MICROBIOL-SGM, V155, P1547, DOI 10.1099/mic.0.023457-0; Korhonen K, 1998, HETEROBASIDION ANNOSUM: BIOLOGY, ECOLOGY, IMPACT AND CONTROL, P43; Lee SJ, 2002, FEMS MICROBIOL LETT, V209, P9, DOI 10.1016/S0378-1097(01)00491-8; LEONHARDT SA, 1993, MOL CELL BIOL, V13, P6304, DOI 10.1128/MCB.13.10.6304; Lin CH, 2010, FUNGAL GENET BIOL, V47, P818, DOI 10.1016/j.fgb.2010.06.009; Marchi V, 1999, FEBS LETT, V454, P181, DOI 10.1016/S0014-5793(99)00803-0; Miura T, 2006, EXTREMOPHILES, V10, P279, DOI 10.1007/s00792-005-0496-6; Niemela T, 1998, HETEROBASIDION ANNOSUM: BIOLOGY, ECOLOGY, IMPACT AND CONTROL, P27; Nikolaou E, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-44; Oliva J, 2011, FOREST ECOL MANAG, V262, P1378, DOI 10.1016/j.foreco.2011.06.033; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pinson-Gadais L, 2008, MYCOPATHOLOGIA, V165, P51, DOI 10.1007/s11046-007-9076-x; Posas F, 2000, J BIOL CHEM, V275, P17249, DOI 10.1074/jbc.M910016199; Posas F, 1996, CELL, V86, P865, DOI 10.1016/S0092-8674(00)80162-2; Qian JC, 2011, BIOTECHNOL LETT, V33, P571, DOI 10.1007/s10529-010-0458-7; Reiser V, 1999, MOL BIOL CELL, V10, P1147, DOI 10.1091/mbc.10.4.1147; Rodaki A, 2009, MOL BIOL CELL, V20, P4845, DOI 10.1091/mbc.E09-01-0002; Segmuller N, 2007, EUKARYOT CELL, V6, P211, DOI 10.1128/EC.00153-06; Silverman-Gavrila LB, 2001, EUR J CELL BIOL, V80, P379, DOI 10.1078/0171-9335-00175; Smith DA, 2010, FEMS MICROBIOL LETT, V306, P1, DOI 10.1111/j.1574-6968.2010.01937.x; Takatsume Y, 2010, BIOCHEM J, V427, P275, DOI 10.1042/BJ20091334; Vasiliauskas R, 1998, CAN J FOREST RES, V28, P961, DOI 10.1139/cjfr-28-7-961; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Zhang Y, 2002, APPL ENVIRON MICROB, V68, P532, DOI 10.1128/AEM.68.2.532-538.2002	45	10	10	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2012	7	2							e31186	10.1371/journal.pone.0031186	http://dx.doi.org/10.1371/journal.pone.0031186			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UG	22319614	Green Submitted, Green Published, gold			2022-12-27	WOS:000301977500030
J	Montecinos, VP; Godoy, A; Hinklin, J; Vethanayagam, RR; Smith, GJ				Montecinos, Viviana P.; Godoy, Alejandro; Hinklin, Jennifer; Vethanayagam, R. Robert; Smith, Gary J.			Primary Xenografts of Human Prostate Tissue as a Model to Study Angiogenesis Induced by Reactive Stroma	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; RAT VENTRAL PROSTATE; BLOOD-VESSELS; IN-VIVO; RADICAL PROSTATECTOMY; ANDROGEN DEPRIVATION; CANCER PROGRESSION; CELL PROLIFERATION; TUMOR ANGIOGENESIS; VEGF	Characterization of the mechanism(s) of androgen-driven human angiogenesis could have significant implications for modeling new forms of anti-angiogenic therapies for CaP and for developing targeted adjuvant therapies to improve efficacy of androgen-deprivation therapy. However, models of angiogenesis by human endothelial cells localized within an intact human prostate tissue architecture are until now extremely limited. This report characterizes the burst of angiogenesis by endogenous human blood vessels in primary xenografts of fresh surgical specimens of benign prostate or prostate cancer (CaP) tissue that occurs between Days 6-14 after transplantation into SCID mice pre-implanted with testosterone pellets. The wave of human angiogenesis was preceded by androgen-mediated up-regulation of VEGF-A expression in the stromal compartment. The neo-vessel network anastomosed to the host mouse vascular system between Days 6-10 post-transplantation, the angiogenic response ceased by Day 15, and by Day 30 the vasculature had matured and stabilized, as indicated by a lack of leakage of serum components into the interstitial tissue space and by association of nascent endothelial cells with mural cells/pericytes. The angiogenic wave was concurrent with the appearance of a reactive stroma phenotype, as determined by staining for alpha-SMA, Vimentin, Tenascin, Calponin, Desmin and Masson's trichrome, but the reactive stroma phenotype appeared to be largely independent of androgen availability. Transplantation-induced angiogenesis by endogenous human endothelial cells present in primary xenografts of benign and malignant human prostate tissue was preceded by induction of androgen-driven expression of VEGF by the prostate stroma, and was concurrent with and the appearance of a reactive stroma phenotype. Androgen-modulated expression of VEGF-A appeared to be a causal regulator of angiogenesis, and possibly of stromal activation, in human prostate xenografts.	[Montecinos, Viviana P.; Godoy, Alejandro; Hinklin, Jennifer; Vethanayagam, R. Robert; Smith, Gary J.] Roswell Pk Canc Inst, Dept Urol, Buffalo, NY 14263 USA; [Vethanayagam, R. Robert] Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USA; [Montecinos, Viviana P.] Pontificia Univ Catolica Chile, Fac Med, Dept Hematol Oncol, Santiago, Chile	Roswell Park Cancer Institute; Roswell Park Cancer Institute; Pontificia Universidad Catolica de Chile	Montecinos, VP (corresponding author), Roswell Pk Canc Inst, Dept Urol, Buffalo, NY 14263 USA.	gary.smith@roswellpark.org	Godoy, Alejandro/GPS-4942-2022		National Institutes of Health [PO1-CA-77739]; Department of Defense [W81XWH-08-1-0299, W81XWH-08-1-0330, W81XWH-04-1-0264]; National Cancer Institute Cancer Center [CA-016156]; NATIONAL CANCER INSTITUTE [P01CA077739] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); National Cancer Institute Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grant PO1-CA-77739 (G. J. Smith), Department of Defense Grants W81XWH-08-1-0299 (V. P. Montecinos), W81XWH-08-1-0330 (A. Godoy), and W81XWH-04-1-0264 (G. J. Smith), and, in part, by the National Cancer Institute Cancer Center Support Grant CA-016156 to the Roswell Park Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad SA, 2002, SEMIN CANCER BIOL, V12, P105, DOI 10.1006/scbi.2001.0418; Alonzi R, 2011, INT J RADIAT ONCOL, V80, P721, DOI 10.1016/j.ijrobp.2010.02.060; Asahara T, 1999, EMBO J, V18, P3964, DOI 10.1093/emboj/18.14.3964; Ayala G, 2003, CLIN CANCER RES, V9, P4792; Basanta D, 2009, CANCER RES, V69, P7111, DOI 10.1158/0008-5472.CAN-08-3957; Benjamin LE, 1997, P NATL ACAD SCI USA, V94, P8761, DOI 10.1073/pnas.94.16.8761; Benjamin LE, 1999, J CLIN INVEST, V103, P159, DOI 10.1172/JCI5028; Bergers G, 2003, J CLIN INVEST, V111, P1287, DOI 10.1172/JCI200317929; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Bettencourt MC, 1998, J UROLOGY, V160, P459, DOI 10.1016/S0022-5347(01)62925-2; Blouw B, 2003, CANCER CELL, V4, P133, DOI 10.1016/S1535-6108(03)00194-6; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Cascone T, 2011, J CLIN INVEST, V121, P1313, DOI 10.1172/JCI42405; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Dvorak HF, 2003, AM J PATHOL, V162, P1747, DOI 10.1016/S0002-9440(10)64309-X; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Ebos JML, 2011, NAT REV CLIN ONCOL, V8, P316, DOI 10.1038/nrclinonc.2011.74; Ellis LM, 2008, NAT REV CANCER, V8, P579, DOI 10.1038/nrc2403; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Francia G, 2009, CANCER CELL, V15, P3, DOI 10.1016/j.ccr.2008.12.011; Garber K, 2009, J NATL CANCER I, V101, P6, DOI 10.1093/jnci/djn481; Godoy A, 2008, ENDOCRINOLOGY, V149, P2959, DOI 10.1210/en.2007-1078; Godoy A, 2011, AM J PHYSIOL-ENDOC M, V300, pE263, DOI 10.1152/ajpendo.00210.2010; Gray DR, 2004, CANCER RES, V64, P1712, DOI 10.1158/0008-5472.CAN-03-2700; Greenberg JI, 2008, NATURE, V456, P809, DOI 10.1038/nature07424; Grunewald M, 2006, CELL, V124, P175, DOI 10.1016/j.cell.2005.10.036; Haggstrom S, 1998, PROSTATE, V36, P71; Haggstrom S, 1999, J UROLOGY, V161, P1620, DOI 10.1016/S0022-5347(05)68994-X; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hellstrom M, 2001, J CELL BIOL, V153, P543, DOI 10.1083/jcb.153.3.543; Inai T, 2004, AM J PATHOL, V165, P35, DOI 10.1016/S0002-9440(10)63273-7; Jain RK, 1998, P NATL ACAD SCI USA, V95, P10820, DOI 10.1073/pnas.95.18.10820; Joseph IBJK, 1997, CANCER RES, V57, P1054; Kravchick S, 2009, UROLOGY, V73, P1274, DOI 10.1016/j.urology.2008.08.461; Lee S, 2007, CELL, V130, P691, DOI 10.1016/j.cell.2007.06.054; Lissbrant IF, 2004, PROSTATE, V58, P57, DOI 10.1002/pros.10312; Lissbrant IF, 2003, BIOL REPROD, V68, P1107, DOI 10.1095/biolreprod.102.008284; Lissbrant IF, 1997, PROSTATE, V33, P38; Lissbrant IF, 2001, SCAND J UROL NEPHROL, V35, P437; Mancuso MR, 2006, J CLIN INVEST, V116, P2610, DOI 10.1172/JCI24612; Morrison C, 2009, PROSTATE, V69, P770, DOI 10.1002/pros.20925; Nicholson B, 2004, J CELL BIOCHEM, V91, P125, DOI 10.1002/jcb.10772; Nissen NN, 1998, AM J PATHOL, V152, P1445; Olumi AF, 1999, CANCER RES, V59, P5002; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Pettersson A, 2000, LAB INVEST, V80, P99, DOI 10.1038/labinvest.3780013; Phung TL, 2007, CANCER RES, V67, P5070, DOI 10.1158/0008-5472.CAN-06-3341; Pietras K, 2005, J CLIN ONCOL, V23, P939, DOI 10.1200/JCO.2005.07.093; Pinto MP, 2010, CANCER RES, V70, P2655, DOI 10.1158/0008-5472.CAN-09-4373; Presnell SC, 2001, AM J PATHOL, V159, P855, DOI 10.1016/S0002-9440(10)61761-0; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Reinders MEJ, 2003, TRANSPLANTATION, V76, P224, DOI 10.1097/01.TP.0000071363.55007.D0; Reinders MEJ, 2003, J CLIN INVEST, V112, P1655, DOI 10.1172/JCI200317712; Shabsigh A, 1998, PROSTATE, V36, P201, DOI 10.1002/(SICI)1097-0045(19980801)36:3<201::AID-PROS9>3.0.CO;2-J; Sordello S, 1998, BIOCHEM BIOPH RES CO, V251, P287, DOI 10.1006/bbrc.1998.9328; Sun JZ, 2005, ONCOGENE, V24, P4701, DOI 10.1038/sj.onc.1208391; Sundberg C, 2001, AM J PATHOL, V158, P1145, DOI 10.1016/S0002-9440(10)64062-X; Thurston G, 1996, AM J PHYSIOL-HEART C, V271, pH2547, DOI 10.1152/ajpheart.1996.271.6.H2547; Torry RJ, 1995, TRANSPLANTATION, V60, P1451, DOI 10.1097/00007890-199560120-00014; Tuxhorn JA, 2002, CLIN CANCER RES, V8, P2912; Tuxhorn JA, 2001, J UROLOGY, V166, P2472, DOI 10.1016/S0022-5347(05)65620-0; Vartanian RK, 1995, LAB INVEST, V73, P844; WEIDNER N, 1993, AM J PATHOL, V143, P401; Weinberg RA, 2007, BIOL CANC, P527	64	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2012	7	1							e29623	10.1371/journal.pone.0029623	http://dx.doi.org/10.1371/journal.pone.0029623			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	912BY	22303438	Green Published, gold, Green Submitted			2022-12-27	WOS:000301770700005
J	Westin, K; Buchhave, P; Nielsen, H; Minthon, L; Janciauskiene, S; Hansson, O				Westin, Karin; Buchhave, Peder; Nielsen, Henrietta; Minthon, Lennart; Janciauskiene, Sabina; Hansson, Oskar			CCL2 Is Associated with a Faster Rate of Cognitive Decline during Early Stages of Alzheimer's Disease	PLOS ONE			English	Article							CEREBROSPINAL-FLUID; CSF BIOMARKERS; INFLAMMATION; MICROGLIA; LIPOPOLYSACCHARIDE; PROGRESSION; IMPAIRMENT; MODEL	Chemokine (C-C motif) receptor 2 (CCR2)-signaling can mediate accumulation of microglia at sites affected by neuroinflammation. CCR2 and its main ligand CCL2 (MCP-1) might also be involved in the altered metabolism of beta-amyloid (A beta) underlying Alzheimer's disease (AD). We therefore measured the levels of CCL2 and three other CCR2 ligands, i.e. CCL11 (eotaxin), CCL13 (MCP-4) and CCL26 (eotaxin-3), in the cerebrospinal fluid (CSF) and plasma of 30 controls and 119 patients with mild cognitive impairment (MCI) at baseline. During clinical follow-up 52 MCI patients were clinically stable for five years, 47 developed AD (i.e. cases with prodromal AD at baseline) and 20 developed other dementias. Only CSF CCL26 was statistically significantly elevated in patients with prodromal AD when compared to controls (p = 0.002). However, in patients with prodromal AD, the CCL2 levels in CSF at baseline correlated with a faster cognitive decline during follow-up (r(s) = 0.42, p = 0.004). Furthermore, prodromal AD patients in the highest tertile of CSF CCL2 exhibited a significantly faster cognitive decline (p<0.001) and developed AD dementia within a shorter time period (p<0.003) compared to those in the lowest tertile. Finally, in the entire MCI cohort, CSF CCL2 could be combined with CSF Tau, P-tau and A beta 42 to predict both future conversion to AD and the rate of cognitive decline. If these results are corroborated in future studies, CCL2 in CSF could be a candidate biomarker for prediction of future disease progression rate in prodromal AD. Moreover, CCR2-related signaling pathways might be new therapeutic targets for therapies aiming at slowing down the disease progression rate of AD.	[Westin, Karin; Buchhave, Peder; Nielsen, Henrietta; Minthon, Lennart; Hansson, Oskar] Lund Univ, Dept Clin Sci Malmo, Clin Memory Res Unit, Malmo, Sweden; [Westin, Karin; Buchhave, Peder; Minthon, Lennart; Hansson, Oskar] Skane Univ Hosp, Neuropsychiat Clin, Malmo, Sweden; [Nielsen, Henrietta] Lund Univ, Skane Univ Hosp, Dept Clin Sci Malmo, Mol Memory Res Unit, Malmo, Sweden; [Janciauskiene, Sabina] Hannover Med Sch, D-3000 Hannover, Germany	Lund University; Lund University; Skane University Hospital; Lund University; Skane University Hospital; Hannover Medical School	Westin, K (corresponding author), Lund Univ, Dept Clin Sci Malmo, Clin Memory Res Unit, Malmo, Sweden.	oskar.hansson@med.lu.se	Hansson, Oskar/A-7134-2013; Nielsen, Henrietta M/B-1746-2013	Hansson, Oskar/0000-0001-8467-7286; Westin, Karin/0000-0003-4497-7596; Nielsen, Henrietta M/0000-0001-9664-7068	Swedish Research Council; Swedish Brain Power; Skane County Council's Research and Development Foundation; Swedish Alzheimer Foundation; Swedish Foundations of the National Board of Health and Welfare; Torsten and Ragnar Soderberg Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Brain Power; Skane County Council's Research and Development Foundation; Swedish Alzheimer Foundation; Swedish Foundations of the National Board of Health and Welfare; Torsten and Ragnar Soderberg Foundation	This work was supported by the Swedish Research Council, the Swedish Brain Power, Skane County Council's Research and Development Foundation, The Swedish Alzheimer Foundation. The Swedish Foundations of the National Board of Health and Welfare, and the Torsten and Ragnar Soderberg Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A Schuitemaker, 2010, NEUROBIOL AGING; Association AP, 1987, DIAGN STAT MAN MENT; Barrientos RM, 2010, AGING DIS, V1, P212; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Blennow K, 2010, NAT REV NEUROL, V6, P131, DOI 10.1038/nrneurol.2010.4; Cameron B, 2010, NEUROBIOL DIS, V37, P503, DOI 10.1016/j.nbd.2009.10.006; El Khoury J, 2008, TRENDS PHARMACOL SCI, V29, P626, DOI 10.1016/j.tips.2008.08.004; Galimbert D, 2003, ANN NEUROL, V53, P547, DOI 10.1002/ana.10531; Hansson O, 2006, LANCET NEUROL, V5, P228, DOI 10.1016/S1474-4422(06)70355-6; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Herrup K, 2010, J NEUROSCI, V30, P16755, DOI 10.1523/JNEUROSCI.4521-10.2010; Holmes C, 2009, NEUROLOGY, V73, P768, DOI 10.1212/WNL.0b013e3181b6bb95; Kitazawa M, 2005, J NEUROSCI, V25, P8843, DOI 10.1523/JNEUROSCI.2868-05.2005; Kiyota T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006197; Maezawa I, 2011, J BIOL CHEM, V286, P3693, DOI 10.1074/jbc.M110.135244; Mattsson N, 2009, JAMA-J AM MED ASSOC, V302, P385, DOI 10.1001/jama.2009.1064; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; Sly LM, 2001, BRAIN RES BULL, V56, P581, DOI 10.1016/S0361-9230(01)00730-4; Sokolova A, 2009, BRAIN PATHOL, V19, P392, DOI 10.1111/j.1750-3639.2008.00188.x; Struthers M, 2010, CURR TOP MED CHEM, V10, P1278, DOI 10.2174/156802610791561255; Yamamoto M, 2005, AM J PATHOL, V166, P1475, DOI 10.1016/S0002-9440(10)62364-4	24	177	182	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2012	7	1							e30525	10.1371/journal.pone.0030525	http://dx.doi.org/10.1371/journal.pone.0030525			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	912BU	22303443	Green Published, Green Submitted, gold			2022-12-27	WOS:000301770300002
J	Anteau, MJ; Sherfy, MH; Wiltermuth, MT				Anteau, Michael J.; Sherfy, Mark H.; Wiltermuth, Mark T.			Selection Indicates Preference in Diverse Habitats: A Ground-Nesting Bird (Charadrius melodus) Using Reservoir Shoreline	PLOS ONE			English	Article							PIPING PLOVER; SITE SELECTION; SPRING MIGRATION; UPPER-MIDWEST; NORTH-DAKOTA; LESSER SCAUP; PREDATION; SURVIVAL; SUCCESS; TRAPS	Animals use proximate cues to select resources that maximize individual fitness. When animals have a diverse array of available habitats, those selected could give insights into true habitat preferences. Since the construction of the Garrison Dam on the Missouri River in North Dakota, Lake Sakakawea (SAK) has become an important breeding area for federally threatened piping plovers (Charadrius melodus; hereafter plovers). We used conditional logistic regression to examine nest-site selection at fine scales (1, 3, and 10 m) during summers 2006-2009 by comparing characteristics at 351 nests to those of 668 random sites within nesting territories. Plovers selected sites (1 m(2)) that were lower than unused random sites, increasing the risk of nest inundation. Plovers selected nest sites that were flat, had little silt, and at least 1 cobble; they also selected for 3-m radius nest areas that were relatively flat and devoid of vegetation and litter. Ninety percent of nests had <38% coverage of silt and <10% slope at the site, and <15% coverage of vegetation or litter and <31% slope within the 3-m radius. Gravel was selected for at nest sites (11% median), but against in the area 10-m from the nest, suggesting plovers select for patches or strips of gravel. Although elevation is rarely evaluated in studies of ground-nesting birds, our results underscore its importance in habitat-selection studies. Relative to where plovers historically nested, habitat at SAK has more diverse topography, substrate composition, vegetation communities, and greater water-level fluctuations. Accordingly, our results provide an example of how habitat-selection results can be interpreted as habitat preferences because they are not influenced by desired habitats being scarce or absent. Further, our results will be useful for directing habitat conservation for plovers and interpreting other habitat-selection studies.	[Anteau, Michael J.; Sherfy, Mark H.; Wiltermuth, Mark T.] US Geol Survey, No Prairie Wildlife Res Ctr, Jamestown, ND USA	United States Department of the Interior; United States Geological Survey	Anteau, MJ (corresponding author), US Geol Survey, No Prairie Wildlife Res Ctr, Jamestown, ND USA.	manteau@usgs.gov		Wiltermuth, Mark/0000-0002-8871-2816; Anteau, Michael/0000-0002-5173-5870	U.S. Army Corps of Engineers' Missouri River Recovery Program; Corps' Omaha District Threatened and Endangered Species Section; Garrison Project Office	U.S. Army Corps of Engineers' Missouri River Recovery Program; Corps' Omaha District Threatened and Endangered Species Section; Garrison Project Office	This study was funded by the U.S. Army Corps of Engineers' Missouri River Recovery Program through financial and logistical support from the Corps' Omaha District Threatened and Endangered Species Section and Garrison Project Office. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anteau MJ, 2008, WATERBIRDS, V31, P97, DOI 10.1675/1524-4695(2008)31[97:DOLSDS]2.0.CO;2; Anteau MJ, 2010, WETLANDS, V30, P757, DOI 10.1007/s13157-010-0066-2; Anteau MJ, 2009, WETLANDS, V29, P704, DOI 10.1672/08-157.1; Anteau MJ, 2011, NEST SURVIVAL GROUND; BURGER J, 1987, CONDOR, V89, P811, DOI 10.2307/1368529; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Callicutt JT, 2011, J FISH WILDL MANAG, V2, P29, DOI 10.3996/102010-JFWM-038; CHESSON J, 1978, ECOLOGY, V59, P211, DOI 10.2307/1936364; Clark RG, 1999, ECOLOGY, V80, P272, DOI 10.1890/0012-9658(1999)080[0272:AHSPFP]2.0.CO;2; Cohen JB, 2008, WILSON J ORNITHOL, V120, P404, DOI 10.1676/06-169.1; Elliott-Smith E., 2009, DATA SERIES S GEOLOG, V426, DOI [10.3133/ds426, DOI 10.3133/DS426]; Elliott-Smith E., 2004, BIRDS N AM ONLINE; Espie RHM, 1996, CAN J ZOOL, V74, P1069, DOI 10.1139/z96-118; FLEMMING SP, 1992, J WILDLIFE MANAGE, V56, P578, DOI 10.2307/3808875; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; GAINES EP, 1988, J WILDLIFE MANAGE, V52, P266, DOI 10.2307/3801233; Ganier A. F., 1930, Wilson Bulletin, V42, P103; HAYS H, 1971, WILSON BULL, V83, P425; Huhta E, 1996, ECOGRAPHY, V19, P85, DOI 10.1111/j.1600-0587.1996.tb00158.x; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Jones J, 2001, AUK, V118, P557, DOI 10.1642/0004-8038(2001)118[0557:HSSIAE]2.0.CO;2; Jones L.K., 1997, PIPING PLOVER HABITA; Knetter JM, 2002, WILDLIFE SOC B, V30, P683; Long RA, 2009, J WILDLIFE MANAGE, V73, P294, DOI 10.2193/2008-052; Marcus JF, 2007, WATERBIRDS, V30, P251, DOI 10.1675/1524-4695(2007)30[251:DNSSOL]2.0.CO;2; Martin TE, 1998, ECOLOGY, V79, P656, DOI 10.1890/0012-9658(1998)079[0656:AMPOCS]2.0.CO;2; MELVIN SM, 1992, WILDLIFE SOC B, V20, P143; MONTEVECCHI WA, 1978, BEHAV ECOL SOCIOBIOL, V4, P143, DOI 10.1007/BF00354977; Murphy RK, 2001, WILSON BULL, V113, P331, DOI 10.1676/0043-5643(2001)113[0331:RASOPP]2.0.CO;2; National Geodetic Survey, 2010, ONL POS US SERV; Palacios E, 1996, J FIELD ORNITHOL, V67, P48; PURDUE JR, 1976, CONDOR, V78, P180, DOI 10.2307/1366853; Robertson BA, 2006, ECOLOGY, V87, P1075, DOI 10.1890/0012-9658(2006)87[1075:AFFUET]2.0.CO;2; SAS Institute, 2002, SAS STAT US GUID VER, VSixth; Shaffer TL, 2004, AUK, V121, P526, DOI 10.1642/0004-8038(2004)121[0526:AUATAN]2.0.CO;2; Sherfy MH, 2009, MISSOURI RIVER EMERG, V2008-1223, P51; Sherfy MH, 2012, J WILDLIFE IN PRESS; Sovada MA, 2000, J WILDLIFE MANAGE, V64, P820, DOI 10.2307/3802752; Thompson B.C., 1982, Colonial Waterbirds, V5, P161, DOI 10.2307/1521048; Thompson W.L., 1998, MONITORING VERTEBRAT; U.S. Army Corps of Engineers, 2010, MONTHL RES SUMM; U. S. Fish and Wildlife Service, 2003, US FISH WILDL SERV 2; U.S. Fish and Wildlife Service, 2000, US FISH WILDL SERV B; Whittingham MJ, 2002, J AVIAN BIOL, V33, P184, DOI 10.1034/j.1600-048X.2002.330210.x; Wiltermuth MT, 2009, CONDOR, V111, P550, DOI 10.1525/cond.2009.080106; [No title captured]	46	26	27	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e30347	10.1371/journal.pone.0030347	http://dx.doi.org/10.1371/journal.pone.0030347			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22299037	Green Published, gold, Green Submitted			2022-12-27	WOS:000301704200014
J	Shen, L; Ciesielski, M; Ramakrishnan, S; Miles, KM; Ellis, L; Sotomayor, P; Shrikant, P; Fenstermaker, R; Pili, R				Shen, Li; Ciesielski, Michael; Ramakrishnan, Swathi; Miles, Kiersten M.; Ellis, Leigh; Sotomayor, Paula; Shrikant, Protul; Fenstermaker, Robert; Pili, Roberto			Class I Histone Deacetylase Inhibitor Entinostat Suppresses Regulatory T Cells and Enhances Immunotherapies in Renal and Prostate Cancer Models	PLOS ONE			English	Article							PERIPHERAL-BLOOD; DNA-BINDING; ANTITUMOR IMMUNITY; INTERLEUKIN-2; TUMOR; ACTIVATION; ACETYLATION; EXPRESSION; MS-275; GENE	Background: Immunosuppressive factors such as regulatory T cells (Tregs) limit the efficacy of immunotherapies. Histone deacetylase (HDAC) inhibitors have been reported to have antitumor activity in different malignancies and immunomodulatory effects. Herein, we report the Tregs-targeting and immune-promoting effect of a class I specific HDAC inhibitor, entinostat, in combination with either IL-2 in a murine renal cell carcinoma (RENCA) model or a survivin-based vaccine therapy (SurVaxM) in a castration resistant prostate cancer (CR Myc-CaP) model. Methods and Results: RENCA or CR Myc-CaP tumors were implanted orthotopically or subcutaneously, respectively. Inoculated mice were randomized into four treatment groups: vehicle, entinostat, cytokine or vaccine, and combination. Tregs in the blood were assessed by FACS analysis. Real time quantitative PCR and Western blot analysis of isolated T cell subpopulations from spleen were performed to determine Foxp3 gene and protein expression. The suppressive function of Tregs was tested by T cell proliferation assay. Low dose (5 mg/kg) entinostat reduced Foxp3 levels in Tregs and this was associated with enhanced tumor growth inhibition in combination with either IL-2 or a SurVaxM vaccine. Entinostat down-regulated Foxp3 expression transcriptionally and blocked Tregs suppressive function without affecting T effector cells (Teffs). In vitro low dose entinostat (0.5 mu M) induced STAT3 acetylation and a specific inhibitor of STAT3 partially rescued entinostat-induced down-regulation of Foxp3, suggesting that STAT3 signaling is involved in Foxp3 down-regulation by entinostat. Conclusions: These results demonstrate a novel immunomodulatory effect of class I HDAC inhibition and provide a rationale for the clinical testing of entinostat to enhance cancer immunotherapy.	[Shen, Li; Ramakrishnan, Swathi; Miles, Kiersten M.; Ellis, Leigh; Sotomayor, Paula; Pili, Roberto] Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USA; [Ciesielski, Michael; Fenstermaker, Robert] Roswell Pk Canc Inst, Dept Neurooncol, Buffalo, NY 14263 USA; [Shrikant, Protul] Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA	Roswell Park Cancer Institute; Roswell Park Cancer Institute; Roswell Park Cancer Institute	Shen, L (corresponding author), Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USA.	Roberto.Pili@RoswellPark.org	Ramakrishnan, Swathi/O-5054-2019		National Cancer Institute [23 R21CA137649]; NATIONAL CANCER INSTITUTE [R21CA137649] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by a research grant by the National Cancer Institute-23 R21CA137649. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS JS, 1990, J NATL CANCER I, V82, P1202, DOI 10.1093/jnci/82.14.1202; Ahmadzadeh M, 2006, BLOOD, V107, P2409, DOI 10.1182/blood-2005-06-2399; Antony PA, 2002, J IMMUNOTHER, V25, P202, DOI 10.1097/00002371-200205000-00002; Barnett B, 2005, AM J REPROD IMMUNOL, V54, P369, DOI 10.1111/j.1600-0897.2005.00330.x; Brogdon JL, 2007, BLOOD, V109, P1123, DOI 10.1182/blood-2006-04-019711; Cesana GC, 2006, J CLIN ONCOL, V24, P1169, DOI 10.1200/JCO.2005.03.6830; Chen LP, 2004, NAT REV IMMUNOL, V4, P336, DOI 10.1038/nri1349; Chen LW, 2005, MOL CANCER THER, V4, P1311, DOI 10.1158/1535-7163.MCT-04-0287; Chen X, 2005, J LEUKOCYTE BIOL, V78, P114, DOI 10.1189/jlb.0604341; Ciesielski MJ, 2010, CANCER IMMUNOL IMMUN, V59, P1211, DOI 10.1007/s00262-010-0845-x; Dannull J, 2005, J CLIN INVEST, V115, P3623, DOI 10.1172/JCI25947; de Zoeten EF, 2010, GASTROENTEROLOGY, V138, P583, DOI 10.1053/j.gastro.2009.10.037; Doganci A, 2005, J CLIN INVEST, V115, P313, DOI 10.1172/JCI200522433; Duong V, 2008, MOL CANCER RES, V6, P1908, DOI 10.1158/1541-7786.MCR-08-0299; Ellis L, 2011, PROSTATE; Ellwood-Yen K, 2003, CANCER CELL, V4, P223, DOI 10.1016/S1535-6108(03)00197-1; Fong L, 2009, CANCER RES, V69, P609, DOI 10.1158/0008-5472.CAN-08-3529; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Fournel M, 2008, MOL CANCER THER, V7, P759, DOI 10.1158/1535-7163.MCT-07-2026; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Hess-Stumpp H, 2005, P AM ASSOC CANC RES, V46, P607; Huber M, 2008, INT IMMUNOL, V20, P223, DOI 10.1093/intimm/dxm139; Jabion J, 2002, CANCER RES, V62, P6108; Johnstone RW, 2002, NAT REV DRUG DISCOV, V1, P287, DOI 10.1038/nrd772; Jonuleit H, 2001, J EXP MED, V193, P1285, DOI 10.1084/jem.193.11.1285; Kato Y, 2007, CLIN CANCER RES, V13, P4538, DOI 10.1158/1078-0432.CCR-07-0014; Kishi H, 2004, J UROLOGY, V171, P1855, DOI 10.1097/01.ju.0000120317.88372.03; Liyanage UK, 2002, J IMMUNOL, V169, P2756, DOI 10.4049/jimmunol.169.5.2756; Maeda T, 2000, BLOOD, V96, P3847, DOI 10.1182/blood.V96.12.3847.h8003847_3847_3856; Magner WJ, 2000, J IMMUNOL, V165, P7017, DOI 10.4049/jimmunol.165.12.7017; Marks PA, 2001, NAT REV CANCER, V1, P194, DOI 10.1038/35106079; Miller AM, 2006, J IMMUNOL, V177, P7398, DOI 10.4049/jimmunol.177.10.7398; Negrier S, 1998, NEW ENGL J MED, V338, P1272, DOI 10.1056/NEJM199804303381805; Onizuka S, 1999, CANCER RES, V59, P3128; Qian DZ, 2006, CLIN CANCER RES, V12, P634, DOI 10.1158/1078-0432.CCR-05-1132; Qian DZ, 2005, PROSTATE, V64, P20, DOI 10.1002/pros.20209; Read S, 2001, CURR OPIN IMMUNOL, V13, P644, DOI 10.1016/S0952-7915(01)00273-4; Reddy P, 2004, P NATL ACAD SCI USA, V101, P3921, DOI 10.1073/pnas.0400380101; Rudra D, 2009, NAT IMMUNOL, V10, P1170, DOI 10.1038/ni.1795; Saito A, 1999, P NATL ACAD SCI USA, V96, P4592, DOI 10.1073/pnas.96.8.4592; Sanderson L, 2004, DRUG METAB DISPOS, V32, P1132, DOI 10.1124/dmd.104.000638; Shariat SF, 2001, J CLIN ONCOL, V19, P2856, DOI 10.1200/JCO.2001.19.11.2856; Tao R, 2007, NAT MED, V13, P1299, DOI 10.1038/nm1652; Turkson J, 2001, J BIOL CHEM, V276, P45443, DOI 10.1074/jbc.M107527200; van Loosdregt J, 2010, BLOOD, V115, P965, DOI 10.1182/blood-2009-02-207118; Wang R, 2005, J BIOL CHEM, V280, P11528, DOI 10.1074/jbc.M413930200; Wang XF, 2005, CLIN CANCER RES, V11, P3535, DOI 10.1158/1078-0432.CCR-04-1092; Yokokawa J, 2008, CLIN CANCER RES, V14, P1032, DOI 10.1158/1078-0432.CCR-07-2056; Yuan ZL, 2005, SCIENCE, V307, P269, DOI 10.1126/science.1105166; Zhang H, 2005, NAT MED, V11, P1238, DOI 10.1038/nm1312	51	124	131	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e30815	10.1371/journal.pone.0030815	http://dx.doi.org/10.1371/journal.pone.0030815			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22303460	Green Published, gold, Green Submitted			2022-12-27	WOS:000301704200036
J	Torres, JB; Doura, MB; Keita, SOY; Kittles, RA				Torres, Jada Benn; Doura, Menahem B.; Keita, Shomarka O. Y.; Kittles, Rick A.			Y Chromosome Lineages in Men of West African Descent	PLOS ONE			English	Article							ATLANTIC SLAVE-TRADE; PROSTATE-CANCER; GENETIC-STRUCTURE; MITOCHONDRIAL-DNA; HUMAN-POPULATIONS; LINKAGE DISEQUILIBRIUM; EASTERN AFRICA; MODERN HUMANS; ETHNIC-GROUPS; HAPLOTYPES	The early African experience in the Americas is marked by the transatlantic slave trade from,1619 to 1850 and the rise of the plantation system. The origins of enslaved Africans were largely dependent on European preferences as well as the availability of potential laborers within Africa. Rice production was a key industry of many colonial South Carolina low country plantations. Accordingly, rice plantations owners within South Carolina often requested enslaved Africans from the so-called "Grain Coast'' of western Africa (Senegal to Sierra Leone). Studies on the African origins of the enslaved within other regions of the Americas have been limited. To address the issue of origins of people of African descent within the Americas and understand more about the genetic heterogeneity present within Africa and the African Diaspora, we typed Y chromosome specific markers in 1,319 men consisting of 508 west and central Africans (from 12 populations), 188 Caribbeans (from 2 islands), 532 African Americans (AAs from Washington, DC and Columbia, SC), and 91 European Americans. Principal component and admixture analyses provide support for significant Grain Coast ancestry among African American men in South Carolina. AA men from DC and the Caribbean showed a closer affinity to populations from the Bight of Biafra. Furthermore, 30-40% of the paternal lineages in African descent populations in the Americas are of European ancestry. Diverse west African ancestries and sex-biased gene flow from EAs has contributed greatly to the genetic heterogeneity of African populations throughout the Americas and has significant implications for gene mapping efforts in these populations.	[Torres, Jada Benn] Univ Notre Dame, Dept Anthropol, Notre Dame, IN 46556 USA; [Doura, Menahem B.] George Washington Univ, Dept Physiol & Pharmacol, Washington, DC USA; [Keita, Shomarka O. Y.] Howard Univ, Natl Human Genome Ctr, Washington, DC 20059 USA; [Kittles, Rick A.] Univ Illinois, Dept Med, Chicago, IL USA; [Kittles, Rick A.] Univ Illinois, Div Epidemiol & Biostat, Chicago, IL USA; [Kittles, Rick A.] Univ Illinois, Inst Human Genet, Chicago, IL USA	University of Notre Dame; George Washington University; Howard University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Torres, JB (corresponding author), Univ Notre Dame, Dept Anthropol, Notre Dame, IN 46556 USA.	rkittles@uic.edu		Benn Torres, Jada/0000-0001-9678-4038; Kittles, Rick/0000-0002-5004-4437				Adeyemo AA, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-38; Agrawal S, 2005, CURR SCI INDIA, V88, P1977; Ajayi JFA, 1985, HIST W AFRICA; Alves-Silva J, 2000, AM J HUM GENET, V67, P444, DOI 10.1086/303004; Ballantyne KN, 2010, AM J HUM GENET, V87, P341, DOI 10.1016/j.ajhg.2010.08.006; Bandelt HJ, 2001, ANN HUM GENET, V65, P549, DOI [10.1046/j.1469-1809.2001.6560549.x, 10.1017/S0003480001008892]; Benn-Torres J, 2008, ANN HUM GENET, V72, P90, DOI 10.1111/j.1469-1809.2007.00398.x; Bonilla C, 2006, PROSTATE, V66, P546, DOI 10.1002/pros.20374; Carney J.A., 2001, BLACK RICE AFRICAN O; Cerny V, 2004, ANN HUM BIOL, V31, P554, DOI 10.1080/03014460412331287182; Collins-Schramm HE, 2002, HUM GENET, V111, P566, DOI 10.1007/s00439-002-0818-z; Conniff ML, 1994, AFRICANS AM HIST BLA; Cruciani F, 2002, AM J HUM GENET, V70, P1197, DOI 10.1086/340257; Curtin P., 1969, ATLANTIC SLAVE TRADE; Destro-Bisol G, 2000, AM J PHYS ANTHROPOL, V112, P319, DOI 10.1002/1096-8644(200007)112:3<319::AID-AJPA4>3.0.CO;2-F; Edelson S. M., 2006, PLANTATION ENTERPRIS; Ely B, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-34; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gomez Michael, 1998, EXCHANGING OUR COUNT; Gonzalez AM, 2006, ANN HUM GENET, V70, P631, DOI 10.1111/j.1469-1809.2006.00259.x; Hall G. M., 2005, SLAVERY AFRICAN ETHN; HAMMER MF, 1994, MOL BIOL EVOL, V11, P749; Hammer MF, 2002, ANNU REV ANTHROPOL, V31, P303, DOI 10.1146/annurev.anthro.31.040402.085413; Higman Barry W., 1984, SLAVE POPULATIONS BR; Hilton Anne, 1985, KINGDOM KONGO; Jackson BA, 2005, AM J PHYS ANTHROPOL, V128, P156, DOI 10.1002/ajpa.20040; Jackson F, 1997, Seton Hall Law Rev, V27, P951; Kayser M, 2003, GENOME RES, V13, P624, DOI 10.1101/gr.463003; Kidd LR, 2006, PROSTATE CANCER P D, V9, P284, DOI 10.1038/sj.pcan.4500884; Kittles RA, 2002, HUM GENET, V110, P553, DOI 10.1007/s00439-002-0731-5; Kittles RA, 2001, HUM GENET, V109, P253, DOI 10.1007/s004390100576; Kittles RA, 2001, CANCER EPIDEM BIOMAR, V10, P943; Klein Herbert S, 1999, ATLANTIC SLAVE TRADE; Lind JM, 2007, HUM GENET, V120, P713, DOI 10.1007/s00439-006-0261-7; Littlefield Daniel, 1981, RICE SLAVES ETHNICIT; LONG JC, 1991, GENETICS, V127, P417; LOVEJOY PE, 1989, J AFR HIST, V30, P365, DOI 10.1017/S0021853700024439; Ogot B. A., 1992, AFRICA 16 18 CENTURY; Panguluri RCK, 2004, CARCINOGENESIS, V25, P961, DOI 10.1093/carcin/bgh100; Parra EJ, 2001, AM J PHYS ANTHROPOL, V114, P18, DOI 10.1002/1096-8644(200101)114:1<18::AID-AJPA1002>3.0.CO;2-2; PHILLIPSON DW, 2005, AFRICAN ARCHAEOLOGY; Plaza S, 2004, HUM GENET, V115, P439, DOI 10.1007/s00439-004-1164-0; Pollitzer William S, 1999, GULLAH PEOPLE THEIR; POLONI ES, 1995, ANN HUM GENET, V59, P43, DOI 10.1111/j.1469-1809.1995.tb01605.x; Quinn Charlotte, 1972, MANDINGO KINGDOMS SE; Quintana-Murci L, 1999, NAT GENET, V23, P437, DOI 10.1038/70550; Reed FA, 2006, CURR OPIN GENET DEV, V16, P597, DOI 10.1016/j.gde.2006.10.008; Rodney W.A., 1970, HIST UPPER GUINEA CO; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Salas A, 2005, AM J HUM GENET, V77, P676, DOI 10.1086/491675; Salas A, 2004, AM J HUM GENET, V74, P454, DOI 10.1086/382194; Salas A, 2002, AM J HUM GENET, V71, P1082, DOI 10.1086/344348; Silva WA, 2006, HUM BIOL, V78, P29, DOI 10.1353/hub.2006.0028; Stephens JC, 2001, SCIENCE, V293, P489, DOI 10.1126/science.1059431; STRINGER CB, 1988, SCIENCE, V239, P1263, DOI 10.1126/science.3125610; Su B, 1999, AM J HUM GENET, V65, P1718, DOI 10.1086/302680; Thomas Hugh, 1997, THE SLAVE TRADE; Torres JB, 2007, ANN HUM GENET, V71, P782, DOI 10.1111/j.1469-1809.2007.00380.x; WAX DD, 1973, J NEGRO HIST, V58, P371, DOI 10.2307/2716746; Wood ET, 2005, EUR J HUM GENET, V13, P867, DOI 10.1038/sj.ejhg.5201408; Wood P. H., 1974, BLACK MAJORITY NEGRO	62	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e29687	10.1371/journal.pone.0029687	http://dx.doi.org/10.1371/journal.pone.0029687			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295064	Green Submitted, Green Published, gold			2022-12-27	WOS:000301640600009
J	van Dijk, ADJ; van Mourik, S; van Ham, RCHJ				van Dijk, Aalt D. J.; van Mourik, Simon; van Ham, Roeland C. H. J.			Mutational Robustness of Gene Regulatory Networks	PLOS ONE			English	Article							CHIP-SEQ; TRANSCRIPTIONAL REGULATION; EVOLUTION; EVOLVABILITY; BINDING; NOISE; DIMERIZATION; MECHANISMS; STABILITY; SEQUENCE	Mutational robustness of gene regulatory networks refers to their ability to generate constant biological output upon mutations that change network structure. Such networks contain regulatory interactions (transcription factor - target gene interactions) but often also protein-protein interactions between transcription factors. Using computational modeling, we study factors that influence robustness and we infer several network properties governing it. These include the type of mutation, i.e. whether a regulatory interaction or a protein-protein interaction is mutated, and in the case of mutation of a regulatory interaction, the sign of the interaction (activating vs. repressive). In addition, we analyze the effect of combinations of mutations and we compare networks containing monomeric with those containing dimeric transcription factors. Our results are consistent with available data on biological networks, for example based on evolutionary conservation of network features. As a novel and remarkable property, we predict that networks are more robust against mutations in monomer than in dimer transcription factors, a prediction for which analysis of conservation of DNA binding residues in monomeric vs. dimeric transcription factors provides indirect evidence.	[van Dijk, Aalt D. J.; van Ham, Roeland C. H. J.] Wageningen UR, PRI, Wageningen, Netherlands; [van Dijk, Aalt D. J.; van Mourik, Simon] Wageningen UR, Plant Sci Grp, Wageningen, Netherlands; [van Dijk, Aalt D. J.] NCSB, Amsterdam, Netherlands	Wageningen University & Research; Wageningen University & Research	van Dijk, ADJ (corresponding author), Wageningen UR, PRI, Wageningen, Netherlands.	aaltjan.vandijk@wur.nl	van Mourik, Simon/D-9006-2013	van Dijk, Aalt-Jan/0000-0002-8872-5123	Netherlands Organization for Scientific Research (NWO) [863.08.027]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was carried out within the research programme of the Netherlands Consortium for Systems Biology (NCSB), which is part of the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research. This work was also supported by the Netherlands Organization for Scientific Research (NWO, VENI Grant 863.08.027 to ADJvD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldana M, 2007, J THEOR BIOL, V245, P433, DOI 10.1016/j.jtbi.2006.10.027; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amoutzias GD, 2008, TRENDS BIOCHEM SCI, V33, P220, DOI 10.1016/j.tibs.2008.02.002; Balaji S, 2007, J MOL BIOL, V372, P1108, DOI 10.1016/j.jmb.2007.06.084; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Buchler NE, 2005, P NATL ACAD SCI USA, V102, P9559, DOI 10.1073/pnas.0409553102; Buchler NE, 2008, J MOL BIOL, V384, P1106, DOI 10.1016/j.jmb.2008.09.079; Bundschuh R, 2003, J THEOR BIOL, V220, P261, DOI 10.1006/jtbi.2003.3164; Calzone L, 2006, BIOINFORMATICS, V22, P1805, DOI 10.1093/bioinformatics/btl172; Cavelier G, 2004, PROTEINS, V55, P339, DOI 10.1002/prot.20056; Chen L, 2011, BIOINFORMATICS, V27, P1447, DOI 10.1093/bioinformatics/btr156; Ciliberti S, 2007, P NATL ACAD SCI USA, V104, P13591, DOI 10.1073/pnas.0705396104; Ciliberti S, 2007, PLOS COMPUT BIOL, V3, P164, DOI 10.1371/journal.pcbi.0030015; Daniels BC, 2008, CURR OPIN BIOTECH, V19, P389, DOI 10.1016/j.copbio.2008.06.008; Doniger SW, 2007, PLOS COMPUT BIOL, V3, P932, DOI 10.1371/journal.pcbi.0030099; Geisel N, 2011, BIOPHYS J, V101, P1569, DOI 10.1016/j.bpj.2011.08.041; Grigoryan G, 2009, NATURE, V458, P859, DOI 10.1038/nature07885; Gu ZL, 2003, NATURE, V421, P63, DOI 10.1038/nature01198; Guelzim N, 2002, NAT GENET, V31, P60, DOI 10.1038/ng873; Hinman VF, 2009, BBA-GENE REGUL MECH, V1789, P326, DOI 10.1016/j.bbagrm.2009.01.004; Homann OR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000783; Hornung G, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040008; Ihmels J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100127; Isalan M, 2008, NATURE, V452, P840, DOI 10.1038/nature06847; Kaneko K, 2008, IET SYST BIOL, V2, P234, DOI 10.1049/iet-syb:20070078; Kauffman S, 2004, P NATL ACAD SCI USA, V101, P17102, DOI 10.1073/pnas.0407783101; Kawabata T, 2002, NUCLEIC ACIDS RES, V30, P294, DOI 10.1093/nar/30.1.294; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Kwon YK, 2007, BMC BIOINFORMATICS, V8; McManus CJ, 2010, GENOME RES, V20, P816, DOI 10.1101/gr.102491.109; Morishita Y, 2005, J THEOR BIOL, V235, P241, DOI 10.1016/j.jtbi.2005.01.007; Muino JM, 2011, NUCLEIC ACIDS RES, V39, pW524, DOI 10.1093/nar/gkr373; Munteanu A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000226; Nuzhdin SV, 2004, MOL BIOL EVOL, V21, P1308, DOI 10.1093/molbev/msh128; Pomerance A, 2009, P NATL ACAD SCI USA, V106, P8209, DOI 10.1073/pnas.0900142106; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Prill RJ, 2005, PLOS BIOL, V3, P1881, DOI 10.1371/journal.pbio.0030343; Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044; Rosenfeld N, 2002, J MOL BIOL, V323, P785, DOI 10.1016/S0022-2836(02)00994-4; Sakata A, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.148101; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; Shou C, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001050; Smolen P, 2000, NEURON, V26, P567, DOI 10.1016/S0896-6273(00)81194-0; Tan K, 2007, P NATL ACAD SCI USA, V104, P1283, DOI 10.1073/pnas.0606914104; Tirosh I, 2009, SCIENCE, V324, P659, DOI 10.1126/science.1169766; Townsend JP, 2003, MOL BIOL EVOL, V20, P955, DOI 10.1093/molbev/msg106; Tsong AE, 2006, NATURE, V443, P415, DOI 10.1038/nature05099; Tuch BB, 2008, PLOS BIOL, V6, P352, DOI 10.1371/journal.pbio.0060038; van Dijk ADJ, 2008, BIOINFORMATICS, V24, P26, DOI 10.1093/bioinformatics/btm539; van Dijk ADJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001017; Wagner A, 2000, NAT GENET, V24, P355, DOI 10.1038/74174; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Wu YL, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000442	55	10	11	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30591	10.1371/journal.pone.0030591	http://dx.doi.org/10.1371/journal.pone.0030591			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295094	gold, Green Submitted, Green Published			2022-12-27	WOS:000301640600039
J	Weiner, AMJ; Scampoli, NL; Calcaterra, NB				Weiner, Andrea M. J.; Scampoli, Nadia L.; Calcaterra, Nora B.			Fishing the Molecular Bases of Treacher Collins Syndrome	PLOS ONE			English	Article							NUCLEOLAR PROTEIN TREACLE; ACID-BINDING-PROTEIN; TCOF1 GENE-PRODUCT; JAW DEVELOPMENT; NUCLEIC-ACIDS; CELL-SURVIVAL; ZEBRAFISH; MUTATIONS; PROLIFERATION; MORPHOGENESIS	Treacher Collins syndrome (TCS) is an autosomal dominant disorder of craniofacial development, and mutations in the TCOF1 gene are responsible for over 90% of TCS cases. The knowledge about the molecular mechanisms responsible for this syndrome is relatively scant, probably due to the difficulty of reproducing the pathology in experimental animals. Zebrafish is an emerging model for human disease studies, and we therefore assessed it as a model for studying TCS. We identified in silico the putative zebrafish TCOF1 ortholog and cloned the corresponding cDNA. The derived polypeptide shares the main structural domains found in mammals and amphibians. Tcof1 expression is restricted to the anterior-most regions of zebrafish developing embryos, similar to what happens in mouse embryos. Tcof1 loss-of-function resulted in fish showing phenotypes similar to those observed in TCS patients, and enabled a further characterization of the mechanisms underlying craniofacial malformation. Besides, we initiated the identification of potential molecular targets of treacle in zebrafish. We found that Tcof1 loss-of-function led to a decrease in the expression of cellular proliferation and craniofacial development. Together, results presented here strongly suggest that it is possible to achieve fish with TCS-like phenotype by knocking down the expression of the TCOF1 ortholog in zebrafish. This experimental condition may facilitate the study of the disease etiology during embryonic development.	[Weiner, Andrea M. J.; Scampoli, Nadia L.; Calcaterra, Nora B.] Univ Nacl Rosario, Inst Biol Mol & Celular Rosario IBR, Consejo Nacl Invest Cient & Tecn CONICET, Area Biol Gen,Dept Ciencias Biol,Fac Ciencias Bio, RA-2000 Rosario, Santa Fe, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario	Weiner, AMJ (corresponding author), Univ Nacl Rosario, Inst Biol Mol & Celular Rosario IBR, Consejo Nacl Invest Cient & Tecn CONICET, Area Biol Gen,Dept Ciencias Biol,Fac Ciencias Bio, RA-2000 Rosario, Santa Fe, Argentina.	calcaterra@ibr.gov.ar	Calcaterra, Nora/AAP-7469-2021	, Nora/0000-0003-4259-9800	Agencia Nacional de Promocion Cientifica y Tecnica (ANPCyT)-PICT [00648]; Universidad Nacional de Rosario (UNR) [BIO19]	Agencia Nacional de Promocion Cientifica y Tecnica (ANPCyT)-PICT(ANPCyT); Universidad Nacional de Rosario (UNR)	This work was supported by Agencia Nacional de Promocion Cientifica y Tecnica (ANPCyT)-PICT 00648 and Universidad Nacional de Rosario (UNR)-BIO19. AMJW is a fellow and NBC a staff member of CONICET and UNR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angst E, 2011, SURGERY, V149, P614, DOI 10.1016/j.surg.2010.11.002; Armas P, 2004, GENE, V337, P151, DOI 10.1016/j.gene.2004.04.031; Armas P, 2008, J MOL BIOL, V382, P1043, DOI 10.1016/j.jmb.2008.07.079; Armas P, 2008, J CELL BIOCHEM, V103, P1013, DOI 10.1002/jcb.21474; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Borgognone M, 2010, BIOCHEM J, V428, P491, DOI 10.1042/BJ20100038; Calcaterra NB, 2010, IUBMB LIFE, V62, P707, DOI 10.1002/iub.379; Dixon J, 2000, HUM MOL GENET, V9, P1473, DOI 10.1093/hmg/9.10.1473; Dixon J, 2004, DEV DYNAM, V229, P907, DOI 10.1002/dvdy.20004; Dixon J, 1997, HUM MOL GENET, V6, P727, DOI 10.1093/hmg/6.5.727; Dixon J, 2006, P NATL ACAD SCI USA, V103, P13403, DOI 10.1073/pnas.0603730103; Duffy KT, 2005, NUCLEIC ACIDS RES, V33, P4914, DOI 10.1093/nar/gki799; Eberhart JK, 2006, DEVELOPMENT, V133, P1069, DOI 10.1242/dev.02281; Edwards SJ, 1997, AM J HUM GENET, V60, P515; Fong SH, 2005, DEVELOPMENT, V132, P3587, DOI 10.1242/dev.01933; Gonzales B, 2005, GENE, V359, P73, DOI 10.1016/j.gene.2005.04.042; Hayano T, 2003, J BIOL CHEM, V278, P34309, DOI 10.1074/jbc.M304304200; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; Jacobs JJL, 2000, NAT GENET, V26, P291, DOI 10.1038/81583; Jones NC, 2008, NAT MED, V14, P125, DOI 10.1038/nm1725; JOWETT T, 1994, TRENDS GENET, V10, P73, DOI 10.1016/0168-9525(94)90220-8; Kimmel CB, 2001, DEV BIOL, V233, P239, DOI 10.1006/dbio.2001.0201; Kovacevic Z, 2011, CARCINOGENESIS, V32, P732, DOI 10.1093/carcin/bgr046; Loeb-Hennard C, 2005, GENE EXPR PATTERNS, V5, P341, DOI 10.1016/j.modgep.2004.10.003; Marsh KL, 1998, HUM MOL GENET, V7, P1795, DOI 10.1093/hmg/7.11.1795; Marszalek B, 2003, AM J MED GENET A, V123A, P169, DOI 10.1002/ajmg.a.20312; Mogass M, 2004, BIOCHEM BIOPH RES CO, V325, P124, DOI 10.1016/j.bbrc.2004.10.004; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Parsons KJ, 2011, METHOD CELL BIOL, V101, P225, DOI 10.1016/B978-0-12-387036-0.00011-6; Passos-Bueno MR, 2009, AM J MED GENET A, V149A, P1853, DOI 10.1002/ajmg.a.32950; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Schilling TF, 1997, DEVELOPMENT, V124, P2945; Solomon KS, 2003, DEVELOPMENT, V130, P929, DOI 10.1242/dev.00308; Splendore A, 2000, HUM MUTAT, V16, P315, DOI 10.1002/1098-1004(200010)16:4<315::AID-HUMU4>3.0.CO;2-H; Splendore A, 2005, HUM MUTAT, V25, P429, DOI 10.1002/humu.20159; Splendore A, 2003, EUR J HUM GENET, V11, P718, DOI 10.1038/sj.ejhg.5201029; Splendore A, 2002, J MED GENET, V39, P493, DOI 10.1136/jmg.39.7.493; Steventon B, 2005, SEMIN CELL DEV BIOL, V16, P647, DOI 10.1016/j.semcdb.2005.06.001; Tang RY, 2007, ACTA BIOCH BIOPH SIN, V39, P384, DOI 10.1111/j.1745-7270.2007.00283.x; Uhlmann-Schiffler H, 2009, ONCOGENE, V28, P2065, DOI 10.1038/onc.2009.75; Valdez BC, 2004, P NATL ACAD SCI USA, V101, P10709, DOI 10.1073/pnas.0402492101; Wada N, 2005, DEVELOPMENT, V132, P3977, DOI 10.1242/dev.01943; Walker MB, 2006, CLIN GENET, V69, P471, DOI 10.1111/j.0009-9163.2006.00615.x; Weiner AMJ, 2007, J CELL BIOCHEM, V102, P1553, DOI 10.1002/jcb.21380; Weiner AM, 2011, DEV GROWTH IN PRESS; Winokur ST, 1998, HUM MOL GENET, V7, P1947, DOI 10.1093/hmg/7.12.1947; Wise CA, 1997, P NATL ACAD SCI USA, V94, P3110, DOI 10.1073/pnas.94.7.3110; Wullimann MF, 2000, ANAT EMBRYOL, V202, P385, DOI 10.1007/s004290000115; Yan YL, 2005, DEVELOPMENT, V132, P1069, DOI 10.1242/dev.01674	49	35	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e29574	10.1371/journal.pone.0029574	http://dx.doi.org/10.1371/journal.pone.0029574			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295061	Green Published, gold, Green Submitted			2022-12-27	WOS:000301640600006
J	Xu, MY; Chen, XJ; Qiu, MD; Zeng, XW; Xu, J; Deng, DY; Sun, GP; Li, X; Guo, J				Xu, Meiying; Chen, Xingjuan; Qiu, Mengde; Zeng, Xiaowei; Xu, Jian; Deng, Daiyong; Sun, Guoping; Li, Xiang; Guo, Jun			Bar-Coded Pyrosequencing Reveals the Responses of PBDE-Degrading Microbial Communities to Electron Donor Amendments	PLOS ONE			English	Article							POLYBROMINATED DIPHENYL ETHERS; SP NOV.; REDUCTIVE DEBROMINATION; ANAEROBIC DEGRADATION; CONTAMINATED AQUIFER; GEN. NOV.; DIVERSITY; URANIUM; ENVIRONMENT; SEDIMENTS	Polybrominated diphenyl ethers (PBDEs) can be reductively degraded by microorganisms under anaerobic conditions. However, little is known about the effect of electron donors on microbial communities involved in PBDEs degradation. Here we employed 454 Titanium pyrosequencing to examine the phylogenetic diversity, composition, structure and dynamics of microbial communities from microcosms under the conditions of different electron donor amendments. The community structures in each of the five alternate electron donor enrichments were significantly shifted in comparison with those of the control microcosm. Commonly existing OTUs between the treatment and control consortia increased from 5 to 17 and more than 50% of OTUs increased around 13.7 to 186 times at least in one of the microcosms after 90-days enrichment. Although the microbial communities at different taxonomic levels were significantly changed by different environmental variable groups in redundancy analysis, significant correlations were observed between the microbial communities and PBDE congener profiles. The lesser-brominated PBDE congeners, tri-BDE congener (BDE-32) and hexa-BDE, were identified as the key factors shaping the microbial community structures at OTU level. Some rare populations, including the known dechlorinating bacterium, Dehalobacter, showed significant positive-correlation with the amounts of PBDE congeners in the consortia. The same results were also observed on some unclassified bacteria. These results suggest that PBDEs-degrading microbial communities can be successfully enriched, and their structures and compositions can be manipulated through adjusting the environmental parameters.	[Xu, Meiying; Chen, Xingjuan; Qiu, Mengde; Deng, Daiyong; Sun, Guoping; Guo, Jun] Guangdong Inst Microbiol, Guangdong Prov Key Lab Microbial Culture Collect, Guangzhou, Guangdong, Peoples R China; [Zeng, Xiaowei; Xu, Jian] Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, Shandong Key Lab Energy Genet, Qingdao, Shandong, Peoples R China; [Zeng, Xiaowei; Xu, Jian] Chinese Acad Sci, Bioenergy Genome Ctr, Qingdao, Shandong, Peoples R China; [Xu, Meiying; Chen, Xingjuan; Deng, Daiyong; Sun, Guoping; Guo, Jun] Minist Guangdong Prov Jointly Breeding Base, State Key Lab Appl Microbiol, Guangzhou, Guangdong, Peoples R China; [Xu, Meiying; Chen, Xingjuan; Deng, Daiyong; Sun, Guoping; Guo, Jun] Guangdong Open Lab Appl Microbiol, Guangzhou, Guangdong, Peoples R China; [Li, Xiang] Chinese Acad Sci, S China Sea Inst Oceanol, Key Lab Marine Bioresources Sustainable Utilizat, Guangzhou, Guangdong, Peoples R China	Guangdong Academy of Sciences; Institute of Microbiology, Guangdong Academy of Sciences; Chinese Academy of Sciences; Qingdao Institute of Bioenergy & Bioprocess Technology, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS	Xu, MY (corresponding author), Guangdong Inst Microbiol, Guangdong Prov Key Lab Microbial Culture Collect, Guangzhou, Guangdong, Peoples R China.	xumy@gdim.cn; guojun@gzb.ac.cn	Qiu, Meng/J-7264-2019; Li, Xiang/AAX-3390-2020; , dengdaiyong/ABC-2618-2020; Xu, Meiying/AAM-1646-2020; Xu, Jian/G-8430-2012	Qiu, Meng/0000-0002-0178-3479; Xu, Jian/0000-0002-0548-8477	Natural Science Foundation of Guangdong, China [9351007002000001]; Natural Science Foundation of Guangdong Province [S2011010004267]; Outstanding Scholarship Foundation of Guangdong Academy of Sciences [200902]; Guangdong-Hongkong Technology Cooperation Funding [2009A030902003]; Guangdong Province - Chinese Academy of Sciences [2009B091300023, 2010B090301048]; Science and Technology Planning Project of Foshan City [2010YS023]; Science and Technology Planning Project of Ronggui District	Natural Science Foundation of Guangdong, China(National Natural Science Foundation of Guangdong Province); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Outstanding Scholarship Foundation of Guangdong Academy of Sciences; Guangdong-Hongkong Technology Cooperation Funding; Guangdong Province - Chinese Academy of Sciences; Science and Technology Planning Project of Foshan City; Science and Technology Planning Project of Ronggui District	The authors acknowledge the Team Project of the Natural Science Foundation of Guangdong, China (9351007002000001), the Natural Science Foundation of Guangdong Province (S2011010004267), the Outstanding Scholarship Foundation of Guangdong Academy of Sciences (200902), the Guangdong-Hongkong Technology Cooperation Funding (2009A030902003), Guangdong Province - Chinese Academy of Sciences Strategic Cooperative Project (2009B091300023, 2010B090301048), Science and Technology Planning Project of Foshan City (2010YS023) and Science and Technology Planning Project of Ronggui District. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram F, 2011, J APPL MICROBIOL, V110, P1550, DOI 10.1111/j.1365-2672.2011.05011.x; Anderson RT, 2003, APPL ENVIRON MICROB, V69, P5884, DOI 10.1128/AEM.69.10.5884-5891.2003; Behnisch PA, 2003, ENVIRON INT, V29, P861, DOI 10.1016/S0160-4120(03)00105-3; Bunge M, 2008, ENVIRON MICROBIOL, V10, P2670, DOI 10.1111/j.1462-2920.2008.01688.x; Chakraborty R, 2005, APPL ENVIRON MICROB, V71, P8649, DOI 10.1128/AEM.71.12.8649-8655.2005; Claesson MJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq873; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; de Boer J, 2000, HANDB ENVIRON CHEM, V3, P61; Deng DY, 2011, INT BIODETER BIODEGR, V65, P465, DOI 10.1016/j.ibiod.2011.01.008; Dojka MA, 1998, APPL ENVIRON MICROB, V64, P3869; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Freeborn RA, 2005, ENVIRON SCI TECHNOL, V39, P8358, DOI 10.1021/es048003p; Gerecke AC, 2005, ENVIRON SCI TECHNOL, V39, P1078, DOI 10.1021/es048634j; Godon JJ, 1997, APPL ENVIRON MICROB, V63, P2802, DOI 10.1128/AEM.63.7.2802-2813.1997; Hites RA, 2004, ENVIRON SCI TECHNOL, V38, P945, DOI 10.1021/es035082g; Horinouchi M, 2003, APPL ENVIRON MICROB, V69, P4421, DOI 10.1128/AEM.69.8.4421-4430.2003; Istok JD, 2004, ENVIRON SCI TECHNOL, V38, P468, DOI 10.1021/es034639p; Kellermann C, 2009, INT J SYST EVOL MICR, V59, P583, DOI 10.1099/ijs.0.002808-0; Krumholz LR, 1997, INT J SYST BACTERIOL, V47, P1262, DOI 10.1099/00207713-47-4-1262; Lee LK, 2010, APPL ENVIRON MICROB, V76, P794, DOI 10.1128/AEM.01872-09; Lee SH, 2007, J HAZARD MATER, V143, P65, DOI 10.1016/j.jhazmat.2006.08.059; Luo Q, 2007, SCI TOTAL ENVIRON, V383, P115, DOI 10.1016/j.scitotenv.2007.05.009; Mai BX, 2005, ENVIRON SCI TECHNOL, V39, P3521; Mazzoli R, 2007, ARCH MICROBIOL, V188, P55, DOI 10.1007/s00203-007-0223-z; Meerts IATM, 2001, ENVIRON HEALTH PERSP, V109, P399, DOI 10.1289/ehp.01109399; Niu LL, 2008, INT J SYST EVOL MICR, V58, P12, DOI 10.1099/ijs.0.65108-0; Oros DR, 2005, ENVIRON SCI TECHNOL, V39, P33, DOI 10.1021/es048905q; Qiu MD, 2012, BIODEGRADATION, V23, P351, DOI 10.1007/s10532-011-9514-9; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Tanabe S, 2008, J ENVIRON MONITOR, V10, P188, DOI 10.1039/b709928b; Teng Y, 2010, BIODEGRADATION, V21, P167, DOI 10.1007/s10532-009-9291-x; Tokarz JA, 2008, ENVIRON SCI TECHNOL, V42, P1157, DOI 10.1021/es071989t; Watanabe I, 2003, ENVIRON INT, V29, P665, DOI 10.1016/S0160-4120(03)00123-5; WOLIN EA, 1963, J BIOL CHEM, V238, P2882; Wolterink A, 2005, INT J SYST EVOL MICR, V55, P2063, DOI 10.1099/ijs.0.63404-0; Xu MY, 2010, ISME J, V4, P1060, DOI 10.1038/ismej.2010.31; Yamada T, 2006, INT J SYST EVOL MICR, V56, P1331, DOI 10.1099/ijs.0.64169-0; Yen JH, 2009, J HAZARD MATER, V165, P518, DOI 10.1016/j.jhazmat.2008.10.007	39	37	40	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30439	10.1371/journal.pone.0030439	http://dx.doi.org/10.1371/journal.pone.0030439			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295086	Green Submitted, Green Published, gold			2022-12-27	WOS:000301640600031
J	Yu, H; Compton, SG				Yu, Hui; Compton, Stephen G.			Moving Your Sons to Safety: Galls Containing Male Fig Wasps Expand into the Centre of Figs, Away From Enemies	PLOS ONE			English	Article							AGAONIDAE HYMENOPTERA CHALCIDOIDEA; SEX-RATIO ADJUSTMENT; FICUS MORACEAE; SPECIES RICHNESS; ALLOCATION; EVOLUTION; REFUGES; ECOLOGY; SIZE; EXPLOITATION	Figs are the inflorescences of fig trees (Ficus spp., Moraceae). They are shaped like a hollow ball, lined on their inner surface by numerous tiny female flowers. Pollination is carried out by host-specific fig wasps (Agaonidae). Female pollinators enter the figs through a narrow entrance gate and once inside can walk around on a platform generated by the stigmas of the flowers. They lay their eggs into the ovules, via the stigmas and styles, and also gall the flowers, causing the ovules to expand and their pedicels to elongate. A single pollinator larva develops in each galled ovule. Numerous species of non-pollinating fig wasps (NPFW, belonging to other families of Chalcidoidea) also make use of galled ovules in the figs. Some initiate galls, others make use of pollinator-generated galls, killing pollinator larvae. Most NPFW oviposit from the outside of figs, making peripherally-located pollinator larvae more prone to attack. Style length variation is high among monoecious Ficus spp. and pollinators mainly oviposit into more centrally-located ovules, with shorter styles. Style length variation is lower in male (wasp-producing) figs of dioecious Ficus spp., making ovules equally vulnerable to attack by NPFW at the time that pollinators oviposit. We recorded the spatial distributions of galled ovules in mature male figs of the dioecious Ficus hirta in Southern China. The galls contained pollinators and three NPFW that kill them. Pollinators were concentrated in galls located towards the centre of the figs, NPFW towards the periphery. Due to greater pedicel elongation by male galls, male pollinators became located in more central galls than their females, and so were less likely to be attacked. This helps ensure that sufficient males survive, despite strongly female-biased sex ratios, and may be a consequence of the pollinator females laying mostly male eggs at the start of oviposition sequences.	[Yu, Hui] Chinese Acad Sci, S China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China; [Compton, Stephen G.] Univ Leeds, Fac Biol Sci, Sch Biol, Leeds, W Yorkshire, England	Chinese Academy of Sciences; South China Botanical Garden, CAS; University of Leeds	Yu, H (corresponding author), Chinese Acad Sci, S China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China.	yuhui@scib.ac.cn		Compton, Stephen/0000-0002-1247-8058	National Natural Science Foundation of China [30970441, 30910103088]; Chinese Academy of Sciences [KSCX2-EW-Q-8]; National Basic Research Program of China (973 Program) [2007CB411600]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	The work was supported by the National Natural Science Foundation of China (30970441, 30910103088), Key Project of Knowledge Innovation Program, Chinese Academy of Sciences (KSCX2-EW-Q-8) and the National Basic Research Program of China (973 Program) (2007CB411600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananthakrishnan T.N., 1984, BIOL GALL INSECTS; Anstett MC, 1996, J EVOLUTION BIOL, V9, P417, DOI 10.1046/j.1420-9101.1996.9040417.x; Anstett MC, 2001, OIKOS, V95, P476, DOI 10.1034/j.1600-0706.2001.950313.x; Berg C.C., 1992, AFRICAN FIG TREES FI; Berg CC, 2005, FLORA MALESIANA 1, V17, P1702; BRONSTEIN JL, 1991, OIKOS, V61, P175, DOI 10.2307/3545335; Compton S., 1988, Antenna, V12, P102; COMPTON S G, 1990, Mitteilungen aus dem Institut fuer Allgemeine Botanik Hamburg, V23, P441; COMPTON SG, 1992, OECOLOGIA, V91, P68, DOI 10.1007/BF00317243; Compton Stephen G., 1994, P343; Cruaud A, 2010, CLADISTICS, V26, P359, DOI 10.1111/j.1096-0031.2009.00291.x; Cuevas-Reyes P, 2003, BIODIVERS CONSERV, V12, P411, DOI 10.1023/A:1022415907109; Dunn DW, 2008, PLOS BIOL, V6, P490, DOI 10.1371/journal.pbio.0060059; GALIL J, 1971, NEW PHYTOL, V70, P773, DOI 10.1111/j.1469-8137.1971.tb02578.x; GALIL J, 1968, NEW PHYTOL, V67, P745, DOI 10.1111/j.1469-8137.1968.tb05497.x; GANESHAIAH KN, 1995, J GENET, V74, P25, DOI 10.1007/BF02924244; Godfray H.C.J., 1997, P211, DOI 10.1017/CBO9780511721946.013; Greeff JM, 2011, EVOLUTION, V65, P203, DOI 10.1111/j.1558-5646.2010.01116.x; Hardy ICW, 2000, ETHOLOGY, V106, P1021, DOI 10.1046/j.1439-0310.2000.00621.x; HARDY ICW, 1995, OECOLOGIA, V103, P162, DOI 10.1007/BF00329076; Hardy NB, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-257; HEIMPEL GE, 1994, ECOL ENTOMOL, V19, P299, DOI 10.1111/j.1365-2311.1994.tb00421.x; Herre EA, 1997, P ROY SOC B-BIOL SCI, V264, P1501, DOI 10.1098/rspb.1997.0208; HERRE EA, 1985, SCIENCE, V228, P896, DOI 10.1126/science.228.4701.896; Herre EA, 1997, SOCIAL COMPETITION C, P226; HOCHBERG ME, 1992, SCIENCE, V255, P973, DOI 10.1126/science.255.5047.973; JANZEN DH, 1979, ANNU REV ECOL SYST, V10, P13, DOI 10.1146/annurev.es.10.110179.000305; JEFFRIES MJ, 1984, BIOL J LINN SOC, V23, P269, DOI 10.1111/j.1095-8312.1984.tb00145.x; Jousselin E, 2003, EVOLUTION, V57, P1255, DOI 10.1111/j.0014-3820.2003.tb00334.x; Jousselin E, 2004, INT J PLANT SCI, V165, P587, DOI 10.1086/386558; Kathuria P, 1999, OIKOS, V87, P520, DOI 10.2307/3546816; Kerdelhue C, 2000, ECOLOGY, V81, P2832, DOI 10.1890/0012-9658(2000)081[2832:CCESOO]2.0.CO;2; Kerdelhue C, 1996, OIKOS, V77, P163, DOI 10.2307/3545597; Kjellberg F, 2005, CR BIOL, V328, P471, DOI 10.1016/j.crvi.2004.11.005; Marchosky RJ, 2004, ENVIRON ENTOMOL, V33, P709, DOI 10.1603/0046-225X-33.3.709; MURRAY MG, 1990, ANIM BEHAV, V39, P434, DOI 10.1016/S0003-3472(05)80406-3; NAGELKERKE CJ, 1994, BEHAV ECOL, V5, P401, DOI 10.1093/beheco/5.4.401; NAIR PB, 1981, ORIENT INSECTS, V15, P433; Nefdt RJC, 1996, J ANIM ECOL, V65, P170, DOI 10.2307/5720; Pereira RAS, 2005, OIKOS, V110, P613, DOI 10.1111/j.0030-1299.2005.13234.x; PRICE PW, 1988, J ANIM ECOL, V57, P89, DOI 10.2307/4765; PRICE PW, 1986, ECOLOGY, V67, P1593, DOI 10.2307/1939090; PRICE PW, 1987, ENVIRON ENTOMOL, V16, P15, DOI 10.1093/ee/16.1.15; Raja S, 2008, SYMBIOSIS, V45, P25; ROMSTOCKVOLKL M, 1990, ECOL ENTOMOL, V15, P321, DOI 10.1111/j.1365-2311.1990.tb00814.x; Sun Bao-fa, 2009, Zoological Research, V30, P559, DOI 10.3724/SP.J.1141.2009.05559; Tarachai Y, 2008, SYMBIOSIS, V45, P29; VERKERKE W, 1989, EXPERIENTIA, V45, P612, DOI 10.1007/BF01975678; VERKERKE W, 1986, P K NED AKAD C BIOL, V89, P443; WALTON R, 1988, ENVIRON ENTOMOL, V17, P654, DOI 10.1093/ee/17.4.654; Weiblen GD, 2000, AM J BOT, V87, P1342, DOI 10.2307/2656726; Weiblen GD, 2002, ANNU REV ENTOMOL, V47, P299, DOI 10.1146/annurev.ento.47.091201.145213; WEIS AE, 1985, ECOLOGY, V66, P1261, DOI 10.2307/1939179; WEIS AE, 1988, ANNU REV ENTOMOL, V33, P467, DOI 10.1146/annurev.en.33.010188.002343; West SA, 1996, J BIOGEOGR, V23, P447, DOI 10.1111/j.1365-2699.1996.tb00006.x; WEST SA, 1994, P ROY SOC B-BIOL SCI, V258, P67, DOI 10.1098/rspb.1994.0143; West SA, 1997, ANIM BEHAV, V54, P437, DOI 10.1006/anbe.1996.0494; WIEBES JT, 1993, P K NED AKAD WETENSC, V96, P347; Yu DW, 2004, P ROY SOC B-BIOL SCI, V271, P1185, DOI 10.1098/rspb.2003.2630; Yu H, 2008, SYMBIOSIS, V45, P121; Yu H, 2006, BOT STUD, V47, P435; Zavodna M, 2005, ECOL ENTOMOL, V30, P210, DOI 10.1111/j.0307-6946.2005.00674.x	62	21	24	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30833	10.1371/journal.pone.0030833	http://dx.doi.org/10.1371/journal.pone.0030833			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295113	gold, Green Published, Green Submitted			2022-12-27	WOS:000301640600058
J	Wen, XY; Klockow, LC; Nekorchuk, M; Sharifi, HJ; de Noronha, CMC				Wen, Xiaoyun; Klockow, Laurieann Casey; Nekorchuk, Michael; Sharifi, Hamayun J.; de Noronha, Carlos M. C.			The HIV1 Protein Vpr Acts to Enhance Constitutive DCAF1-Dependent UNG2 Turnover	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; URACIL-DNA GLYCOSYLASE; CELL-CYCLE REGULATION; UBIQUITIN LIGASE; TERMINAL DOMAIN; T-CELLS; IN-VIVO; DEGRADATION; APOBEC3G; BINDING	Background: The HIV1 protein Vpr assembles with and acts through an ubiquitin ligase complex that includes DDB1 and cullin 4 (CRL4) to cause G2 cell cycle arrest and to promote degradation of both uracil DNA glycosylase 2 (UNG2) and single-strand selective mono-functional uracil DNA glycosylase 1 (SMUG1). DCAF1, an adaptor protein, is required for Vpr-mediated G2 arrest through the ubiquitin ligase complex. In work described here, we used UNG2 as a model substrate to study how Vpr acts through the ubiquitin ligase complex. We examined whether DCAF1 is essential for Vpr-mediated degradation of UNG2 and SMUG1. We further investigated whether Vpr is required for recruiting substrates to the ubiquitin ligase or acts to enhance its function and whether this parallels Vpr-mediated G2 arrest. Methodology/Principal Findings: We found that DCAF1 plays an important role in Vpr-independent UNG2 and SMUG1 depletion. UNG2 assembled with the ubiquitin ligase complex in the absence of Vpr, but Vpr enhanced this interaction. Further, Vpr-mediated enhancement of UNG2 degradation correlated with low Vpr expression levels. Vpr concentrations exceeding a threshold blocked UNG2 depletion and enhanced its accumulation in the cell nucleus. A similar dose-dependent trend was seen for Vpr-mediated cell cycle arrest. Conclusions/Significance: This work identifies UNG2 and SMUG1 as novel targets for CRL4(DCAF1)-mediated degradation. It further shows that Vpr enhances rather than enables the interaction between UNG2 and the ubiquitin ligase. Vpr augments CRL4(DCAF1)-mediated UNG2 degradation at low concentrations but antagonizes it at high concentrations, allowing nuclear accumulation of UNG2. Further, the protein that is targeted to cause G2 arrest behaves much like UNG2. Our findings provide the basis for determining whether the CRL4(DCAF1) complex is alone responsible for cell cycle-dependent UNG2 turnover and will also aid in establishing conditions necessary for the identification of additional targets of Vpr-enhanced degradation.	[Wen, Xiaoyun; Klockow, Laurieann Casey; Nekorchuk, Michael; Sharifi, Hamayun J.; de Noronha, Carlos M. C.] Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA	Albany Medical College	de Noronha, CMC (corresponding author), Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA.	deNoroC@mail.AMC.edu			National Institutes of Health [5R01AI073178]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073178] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant 5R01AI073178. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2010, J BIOL CHEM, V285, P37333, DOI 10.1074/jbc.M110.133181; Belzile JP, 2007, PLOS PATHOG, V3, P882, DOI 10.1371/journal.ppat.0030085; BouHamdan M, 1998, J BIOL CHEM, V273, P8009, DOI 10.1074/jbc.273.14.8009; Bouhamdan M, 1996, J VIROL, V70, P697, DOI 10.1128/JVI.70.2.697-704.1996; DeHart JL, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-57; Fischer JA, 2004, DNA REPAIR, V3, P505, DOI 10.1016/j.dnarep.2004.01.012; Goh WC, 1998, NAT MED, V4, P65, DOI 10.1038/nm0198-065; Hagen L, 2008, EMBO J, V27, P51, DOI 10.1038/sj.emboj.7601958; Hrecka K, 2007, P NATL ACAD SCI USA, V104, P11778, DOI 10.1073/pnas.0702102104; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Huang J, 2008, ONCOGENE, V27, P4056, DOI 10.1038/onc.2008.44; Jacquot G, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-84; Jenkins Y, 1998, J CELL BIOL, V143, P875, DOI 10.1083/jcb.143.4.875; JOWETT JBM, 1995, J VIROL, V69, P6304, DOI 10.1128/JVI.69.10.6304-6313.1995; Kaiser SM, 2006, J VIROL, V80, P875, DOI 10.1128/JVI.80.2.875-882.2006; Kewalramani VN, 1996, VIROLOGY, V218, P326, DOI 10.1006/viro.1996.0201; Laguette N, 2011, NATURE; Le Rouzic E, 2007, CELL CYCLE, V6, P182, DOI 10.4161/cc.6.2.3732; Mansky LM, 2000, J VIROL, V74, P7039, DOI 10.1128/JVI.74.15.7039-7047.2000; Mbisa JL, 2007, J VIROL, V81, P7099, DOI 10.1128/JVI.00272-07; MULLER SJ, 1993, J BIOL CHEM, V268, P1310; NAGELHUS TA, 1995, EXP CELL RES, V220, P292, DOI 10.1006/excr.1995.1318; Norman JM, 2011, NAT IMMUNOL, V12, P975, DOI 10.1038/ni.2087; Priet S, 2005, MOL CELL, V17, P479, DOI 10.1016/j.molcel.2005.01.016; Richard J, 2010, BLOOD, V115, P1354, DOI 10.1182/blood-2009-08-237370; ROGEL ME, 1995, J VIROL, V69, P882, DOI 10.1128/JVI.69.2.882-888.1995; Roshal M, 2003, J BIOL CHEM, V278, P25879, DOI 10.1074/jbc.M303948200; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Schrofelbauer B, 2007, P NATL ACAD SCI USA, V104, P4130, DOI 10.1073/pnas.0610167104; Schrofelbauer B, 2005, J VIROL, V79, P10978, DOI 10.1128/JVI.79.17.10978-10987.2005; Schuler W, 1999, J MOL BIOL, V285, P2105, DOI 10.1006/jmbi.1998.2381; Selig L, 1997, J VIROL, V71, P4842, DOI 10.1128/JVI.71.6.4842-4846.1997; Sharova N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000057; Sherman MP, 2001, J VIROL, V75, P1522, DOI 10.1128/JVI.75.3.1522-1532.2001; Singh SP, 2000, VIROLOGY, V268, P364, DOI 10.1006/viro.2000.0191; Srivastava S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000059; Tan L, 2007, J VIROL, V81, P10822, DOI 10.1128/JVI.01380-07; Ward J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000613; Wen XY, 2007, J BIOL CHEM, V282, P27046, DOI 10.1074/jbc.M703955200; Yan N, 2011, P NATL ACAD SCI U S; ZHAO LJ, 1994, J BIOL CHEM, V269, P32131	41	28	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30939	10.1371/journal.pone.0030939	http://dx.doi.org/10.1371/journal.pone.0030939			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22292079	Green Published, Green Submitted, gold			2022-12-27	WOS:000301639600067
J	Wu, YQ; Chen, DJ; He, HB; Chen, DS; Chen, LL; Chen, HC; Liu, ZF				Wu, Yi-Quan; Chen, Di-Jun; He, Hua-Bin; Chen, Dong-Sheng; Chen, Ling-Ling; Chen, Huan-Chun; Liu, Zheng-Fei			Pseudorabies Virus Infected Porcine Epithelial Cell Line Generates a Diverse Set of Host MicroRNAs and a Special Cluster of Viral MicroRNAs	PLOS ONE			English	Article							LATENCY-ASSOCIATED TRANSCRIPT; LOOP RT-PCR; GENE-EXPRESSION; MESSENGER-RNA; IDENTIFICATION; SUPPRESSION; PROMOTER; DETERMINANTS; BIOGENESIS; TARGETS	Pseudorabies virus (PRV) belongs to Alphaherpesvirinae subfamily that causes huge economic loss in pig industry worldwide. It has been recently demonstrated that many herpesviruses encode microRNAs (miRNAs), which play crucial roles in viral life cycle. However, the knowledge about PRV-encoded miRNAs is still limited. Here, we report a comprehensive analysis of both viral and host miRNA expression profiles in PRV-infected porcine epithelial cell line (PK-15). Deep sequencing data showed that the,4.6 kb intron of the large latency transcript (LLT) functions as a primary microRNA precursor (pri-miRNA) that encodes a cluster of 11 distinct miRNAs in the PRV genome, and 209 known and 39 novel porcine miRNAs were detected. Viral miRNAs were further confirmed by stem-loop RT-PCR and northern blot analysis. Intriguingly, all of these viral miRNAs exhibited terminal heterogeneity both at the 59 and 39 ends. Seven miRNA genes produced mature miRNAs from both arms and two of the viral miRNA genes showed partially overlapped in their precursor regions. Unexpectedly, a terminal loop-derived small RNA with high abundance and one special miRNA offset RNA (moRNA) were processed from a same viral miRNA precursor. The polymorphisms of viral miRNAs shed light on the complexity of host miRNA-processing machinery and viral miRNA-regulatory mechanism. The swine genes and PRV genes were collected for target prediction of the viral miRNAs, revealing a complex network formed by both host and viral genes. GO enrichment analysis of host target genes suggests that PRV miRNAs are involved in complex cellular pathways including cell death, immune system process, metabolic pathway, indicating that these miRNAs play significant roles in virus-cells interaction of PRV and its hosts. Collectively, these data suggest that PRV infected epithelial cell line generates a diverse set of host miRNAs and a special cluster of viral miRNAs, which might facilitate PRV replication in cells.	[Wu, Yi-Quan; Chen, Dong-Sheng; Chen, Huan-Chun; Liu, Zheng-Fei] Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, Wuhan, Peoples R China; [Chen, Di-Jun; Chen, Ling-Ling] Huazhong Agr Univ, Coll Life Sci & Technol, Ctr Bioinformat, Wuhan, Peoples R China; [He, Hua-Bin] Huazhong Agr Univ, Key Lab Agr Anim Genet Breeding & Reprod, Minist Educ, Wuhan, Peoples R China; [He, Hua-Bin] Huazhong Agr Univ, Key Lab Swine Genet & Breeding, Minist Agr, Coll Anim Sci, Wuhan, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University; Huazhong Agricultural University; Huazhong Agricultural University; Ministry of Agriculture & Rural Affairs	Liu, ZF (corresponding author), Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, Wuhan, Peoples R China.	lzf6789@mail.hzau.edu.cn	Chen, Ling-Ling/AAY-3547-2021; WU, YIQUAN/AAZ-2364-2021; Chen, Dijun/P-3877-2014	WU, YIQUAN/0000-0002-2898-3585; Chen, Dijun/0000-0002-7456-2511	Ministry of Funding for Transgenic Animals [2009ZX08006-006B-2]; Natural Science Foundation of China [31070133]; State Key Laboratory of Agricultural Microbiology, HZAU [4002-08201008]	Ministry of Funding for Transgenic Animals; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Agricultural Microbiology, HZAU	This work was supported partially by the Ministry of Funding for Transgenic Animals (2009ZX08006-006B-2) to Z-FL, partially by Natural Science Foundation of China (31070133) to Z-FL, and partially by autonomous research grant (4002-08201008) from State Key Laboratory of Agricultural Microbiology, HZAU, to H-CC and Z-FL. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anselmo A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017374; BABIC N, 1994, VIROLOGY, V204, P616, DOI 10.1006/viro.1994.1576; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Berezikov E, 2011, GENOME RES, V21, P203, DOI 10.1101/gr.116657.110; Besecker MI, 2009, J VIROL, V83, P3413, DOI 10.1128/JVI.02419-08; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Boss IW, 2009, TRENDS MICROBIOL, V17, P544, DOI 10.1016/j.tim.2009.09.002; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Cai XZ, 2005, P NATL ACAD SCI USA, V102, P5570, DOI 10.1073/pnas.0408192102; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen DJ, 2011, RNA, V17, P1012, DOI 10.1261/rna.2589011; Chen HuanChun, 1998, Acta Veterinaria et Zootechnica Sinica, V29, P156; Chen SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012745; CHEUNG AK, 1989, J VIROL, V63, P2908, DOI 10.1128/JVI.63.7.2908-2913.1989; CHEUNG AK, 1991, J VIROL, V65, P5260, DOI 10.1128/JVI.65.10.5260-5271.1991; Cui C, 2006, J VIROL, V80, P5499, DOI 10.1128/JVI.00200-06; Cullen BR, 2009, NATURE, V457, P421, DOI 10.1038/nature07757; Enquist LW, 1999, ARCH VIROL, P87; FARRELL MJ, 1991, P NATL ACAD SCI USA, V88, P790, DOI 10.1073/pnas.88.3.790; Geenen K, 2005, J GEN VIROL, V86, P1251, DOI 10.1099/vir.0.80760-0; Ghosh Z, 2009, NUCLEIC ACIDS RES, V37, P1035, DOI 10.1093/nar/gkn1004; Glazov EA, 2010, J GEN VIROL, V91, P32, DOI 10.1099/vir.0.014290-0; Gottwein E, 2008, CELL HOST MICROBE, V3, P375, DOI 10.1016/j.chom.2008.05.002; Granzow H, 2005, J VIROL, V79, P3200, DOI 10.1128/JVI.79.5.3200-3205.2005; Grey F, 2005, J VIROL, V79, P12095, DOI 10.1128/JVI.79.18.12095-12099.2005; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Grundhoff A, 2011, VIROLOGY, V411, P325, DOI 10.1016/j.virol.2011.01.002; Guo H, 2009, VIRUS GENES, V38, P269, DOI 10.1007/s11262-008-0320-3; Jin L, 2000, J VIROL, V74, P6333, DOI 10.1128/JVI.74.14.6333-6338.2000; Jurak I, 2010, J VIROL, V84, P4659, DOI 10.1128/JVI.02725-09; Klupp BG, 2004, J VIROL, V78, P424, DOI 10.1128/JVI.78.1.424-440.2004; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Kunin V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-401; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Mukerjee R, 2004, VIROLOGY, V324, P340, DOI 10.1016/j.virol.2004.03.043; Ou CJ, 2002, VIRUS GENES, V25, P227, DOI 10.1023/A:1020959521745; Ouellet DL, 2008, NUCLEIC ACIDS RES, V36, P2353, DOI 10.1093/nar/gkn076; Perng Guey-Chuen, 2010, Interdiscip Perspect Infect Dis, V2010, P262415, DOI 10.1155/2010/262415; Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; Pomeranz LE, 2005, MICROBIOL MOL BIOL R, V69, P462, DOI 10.1128/MMBR.69.3.462-500.2005; Riley KJL, 2010, J VIROL, V84, P5148, DOI 10.1128/JVI.00110-10; Shi WY, 2009, NAT STRUCT MOL BIOL, V16, P183, DOI 10.1038/nsmb.1536; STEINER I, 1994, NEUROPATH APPL NEURO, V20, P253, DOI 10.1111/j.1365-2990.1994.tb00967.x; STEVENS JG, 1987, SCIENCE, V235, P1056, DOI 10.1126/science.2434993; Taharaguchi S, 2002, VET MICROBIOL, V85, P197, DOI 10.1016/S0378-1135(01)00513-2; Triboulet R, 2007, SCIENCE, V315, P1579, DOI 10.1126/science.1136319; Umbach JL, 2010, VIROLOGY, V405, P592, DOI 10.1016/j.virol.2010.06.036; Umbach JL, 2010, J VIROL, V84, P695, DOI 10.1128/JVI.02013-09; Varkonyi-Gasic E, 2011, METHODS MOL BIOL, V744, P145, DOI 10.1007/978-1-61779-123-9_10; Volk N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019391; Wang FZ, 2008, J VIROL, V82, P9065, DOI 10.1128/JVI.00961-08; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031	54	40	58	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30988	10.1371/journal.pone.0030988	http://dx.doi.org/10.1371/journal.pone.0030988			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22292087	Green Published, gold, Green Submitted			2022-12-27	WOS:000301570600104
J	Johnson, RC; Weber, PK; Wikert, JD; Workman, ML; MacFarlane, RB; Grove, MJ; Schmitt, AK				Johnson, Rachel C.; Weber, Peter K.; Wikert, John D.; Workman, Michelle L.; MacFarlane, R. Bruce; Grove, Marty J.; Schmitt, Axel K.			Managed Metapopulations: Do Salmon Hatchery 'Sources' Lead to In-River 'Sinks' in Conservation?	PLOS ONE			English	Article							ONCORHYNCHUS-TSHAWYTSCHA; ANADROMOUS SALMONIDS; SOCKEYE-SALMON; CHINOOK SALMON; WILD; OTOLITHS; SULFUR; FITNESS; TROUT; POPULATIONS	Maintaining viable populations of salmon in the wild is a primary goal for many conservation and recovery programs. The frequency and extent of connectivity among natal sources defines the demographic and genetic boundaries of a population. Yet, the role that immigration of hatchery-produced adults may play in altering population dynamics and fitness of natural populations remains largely unquantified. Quantifying, whether natural populations are self-sustaining, functions as sources (population growth rate in the absence of dispersal, lambda>1), or as sinks (lambda<1) can be obscured by an inability to identify immigrants. In this study we use a new isotopic approach to demonstrate that a natural spawning population of Chinook salmon, (Oncorhynchus tshawytscha) considered relatively healthy, represents a sink population when the contribution of hatchery immigrants is taken into consideration. We retrieved sulfur isotopes (S-34/S-32, referred to as delta S-34) in adult Chinook salmon otoliths (ear bones) that were deposited during their early life history as juveniles to determine whether individuals were produced in hatcheries or naturally in rivers. Our results show that only 10.3% (CI = 5.5 to 18.1%) of adults spawning in the river had otolith delta S-34 values less than 8.5%, which is characteristic of naturally produced salmon. When considering the total return to the watershed (total fish in river and hatchery), we estimate that 90.7 to 99.3% (CI) of returning adults were produced in a hatchery (best estimate = 95.9%). When population growth rate of the natural population was modeled to account for the contribution of previously unidentified hatchery immigrants, we found that hatchery-produced fish caused the false appearance of positive population growth. These findings highlight the potential dangers in ignoring source-sink dynamics in recovering natural populations, and question the extent to which declines in natural salmon populations are undetected by monitoring programs.	[Johnson, Rachel C.] Univ Calif Santa Cruz, Inst Marine Sci, Santa Cruz, CA 95064 USA; [Weber, Peter K.] Lawrence Livermore Natl Lab, Div Chem Sci, Livermore, CA USA; [Wikert, John D.] US Fish & Wildlife Serv, Anadromous Fish Restorat Program, Stockton, CA USA; [Workman, Michelle L.] E Bay Municipal Util Dist, Lodi, CA USA; [MacFarlane, R. Bruce] Natl Marine Fisheries Serv, SW Fisheries Sci Ctr, Santa Cruz, CA USA; [Grove, Marty J.; Schmitt, Axel K.] Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90024 USA	University of California System; University of California Santa Cruz; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; United States Department of the Interior; US Fish & Wildlife Service; National Oceanic Atmospheric Admin (NOAA) - USA; University of California System; University of California Los Angeles	Johnson, RC (corresponding author), US Bur Reclamat, Bay Delta Off, Sacramento, CA 95825 USA.	rbarnettjohnson@usbr.gov	Weber, Peter Kilian/AAP-9517-2020	Weber, Peter Kilian/0000-0001-6022-6050; Schmitt, Axel/0000-0002-9029-4211	U.S. Fish and Wildlife Service; Division of Earth Sciences, National Science Foundation	U.S. Fish and Wildlife Service(US Fish & Wildlife Service); Division of Earth Sciences, National Science Foundation(National Science Foundation (NSF))	RBJ, PW, and RBM gratefully acknowledge the U.S. Fish and Wildlife Service's Anadromous Fish Restoration Program for awarding the grant that funded this project. The ion microprobe facility at UCLA is partly supported by a grant from the Instrumentation and Facilities Program, Division of Earth Sciences, National Science Foundation. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Araki H, 2007, SCIENCE, V318, P100, DOI 10.1126/science.1145621; Araki H, 2007, CONSERV BIOL, V21, P181, DOI 10.1111/j.1523-1739.2006.00564.x; BACHMAN RA, 1984, T AM FISH SOC, V113, P1, DOI 10.1577/1548-8659(1984)113&lt;1:FBOFWA&gt;2.0.CO;2; Barnett-Johnson R, 2005, CAN J FISH AQUAT SCI, V62, P2425, DOI 10.1139/F05-194; Barnett-Johnson R, 2007, CANADIAN J FISHERIES, V318, P100; Barnett-Johnson R, 2008, LIMNOL OCEANOGR, V53, P1633, DOI 10.4319/lo.2008.53.4.1633; Barnett-Johnson R, 2007, CAN J FISH AQUAT SCI, V64, P1683, DOI 10.1139/F07-129; Blanchet S, 2008, BIOL CONSERV, V141, P1989, DOI 10.1016/j.biocon.2008.05.014; Brawn JD, 1996, ECOLOGY, V77, P3, DOI 10.2307/2265649; Campana SE, 1999, MAR ECOL PROG SER, V188, P263, DOI 10.3354/meps188263; Campana SE, 2001, CAN J FISH AQUAT SCI, V58, P30, DOI 10.1139/f00-177; Carlson SM, 2008, EVOL APPL, V1, P222, DOI 10.1111/j.1752-4571.2008.00025.x; Carr M. H., 2003, ECOLOGICAL APPL, V13, P90; Chilcote MW, 2011, CAN J FISH AQUAT SCI, V68, P511, DOI 10.1139/F10-168; Cooper AB, 1999, FISH B-NOAA, V97, P213; Ding T, 2001, GEOCHIM COSMOCHIM AC, V65, P2433, DOI 10.1016/S0016-7037(01)00611-1; Dunham JB, 1999, ECOL APPL, V9, P642, DOI 10.2307/2641151; FISHER FW, 1994, CONSERV BIOL, V8, P870, DOI 10.1046/j.1523-1739.1994.08030863-5.x; Ford MJ, 2002, CONSERV BIOL, V16, P815, DOI 10.1046/j.1523-1739.2002.00257.x; Fry B, 2011, LIMNOL OCEANOGR, V56, P1563, DOI 10.4319/lo.2011.56.5.1563; Gilpin M.E., 1991, METAPOPULATION DYNAM; Godbout L, 2010, ENVIRON BIOL FISH, V89, P521, DOI 10.1007/s10641-010-9689-7; Gowan C, 1996, ECOL APPL, V6, P931, DOI 10.2307/2269496; Hanski Ilkka, 1997, P5, DOI 10.1016/B978-012323445-2/50003-1; Hendry AP, 2000, SCIENCE, V290, P516, DOI 10.1126/science.290.5491.516; HESSLEIN RH, 1993, CAN J FISH AQUAT SCI, V50, P2071, DOI 10.1139/f93-230; Hill MF, 2002, AM NAT, V160, P389, DOI 10.1086/341526; Ingram BL, 1999, GEOLOGY, V27, P851; Kennedy BP, 1997, NATURE, V387, P766, DOI 10.1038/42835; Kostow KE, 2004, CAN J FISH AQUAT SCI, V61, P577, DOI [10.1139/f04-019, 10.1139/F04-019]; Krouse H. R., 1991, Stable isotopes: natural and anthropogenic sulphur in the environment., P267; Laplace PS., 1820, THEORIE ANAL PROBABI; Levin PS, 2001, P ROY SOC B-BIOL SCI, V268, P1153, DOI 10.1098/rspb.2001.1634; LEVINS R, 1969, Bulletin of the Entomological Society of America, V15, P237; Lewis JR, 2006, J USABILITY STUD, V1, P136; Lichatocwich J, 1999, SALMON RIVERS; Lindley ST, 2007, SAN FRANCISCO ESTUAR, V5, P26; Mann CC, 2000, SCIENCE, V52, P119; McClure MM, 2003, ECOL APPL, V13, P964, DOI 10.1890/1051-0761(2003)13[964:ALMSAA]2.0.CO;2; McGinnity P, 2003, P ROY SOC B-BIOL SCI, V270, P2443, DOI 10.1098/rspb.2003.2520; Merz JE, 2004, N AM J FISH MANAGE, V24, P397, DOI 10.1577/M03-038.1; Merz JE, 2006, ECOL APPL, V16, P999, DOI 10.1890/1051-0761(2006)016[0999:SWAWMN]2.0.CO;2; MOYLE PB, 1994, CONSERV BIOL, V8, P869, DOI 10.1046/j.1523-1739.1994.08030863-4.x; NEHLSEN W, 1991, FISHERIES, V16, P4, DOI 10.1577/1548-8446(1991)016&lt;0004:PSATCS&gt;2.0.CO;2; Nriagu J.O., 1991, STABLE ISOTOPES NATU, P177; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; Rhodes Justin S., 1999, North American Journal of Fisheries Management, V19, P670, DOI 10.1577/1548-8675(1999)019&lt;0670:CPOGSH&gt;2.0.CO;2; Ruggerone GT, 2010, MAR COAST FISH, V2, P306, DOI 10.1577/C09-054.1; Schtickzelle N, 2007, FISH FISH, V8, P297, DOI 10.1111/j.1467-2979.2007.00256.x; Snyder NFR, 1996, CONSERV BIOL, V10, P338, DOI 10.1046/j.1523-1739.1996.10020338.x; TAYLOR EB, 1991, AQUACULTURE, V98, P185, DOI 10.1016/0044-8486(91)90383-I; VANHORNE B, 1983, J WILDLIFE MANAGE, V47, P893; Walther BD, 2006, MAR ECOL PROG SER, V311, P125, DOI 10.3354/meps311125; Weber ED, 2003, CAN J FISH AQUAT SCI, V60, P1018, DOI 10.1139/F03-087; Weber PK, 2002, CAN J FISH AQUAT SCI, V59, P587, DOI [10.1139/f02-038, 10.1139/F02-038]; WIENS JA, 1996, METAPOPULATIONS WILD; Williams J.G, 2006, SAN FRANC ESTUARY WA, V4, P3, DOI [10.15447/sfews.2006v4iss3art2, DOI 10.15447/SFEWS.2006V4ISS3ART2]	58	23	23	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e28880	10.1371/journal.pone.0028880	http://dx.doi.org/10.1371/journal.pone.0028880			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347362	Green Submitted, Green Published, gold			2022-12-27	WOS:000302730100003
J	Kirchhofer, KC; Zimmermann, F; Kaminski, J; Tomasello, M				Kirchhofer, Katharina C.; Zimmermann, Felizitas; Kaminski, Juliane; Tomasello, Michael			Dogs (Canis familiaris), but Not Chimpanzees (Pan troglodytes), Understand Imperative Pointing	PLOS ONE			English	Article							WOLVES; COMMUNICATION; COMPREHENSION; GESTURES; CUES; APES	Chimpanzees routinely follow the gaze of humans to outside targets. However, in most studies using object choice they fail to use communicative gestures (e. g. pointing) to find hidden food. Chimpanzees' failure to do this may be due to several difficulties with this paradigm. They may, for example, misinterpret the gesture as referring to the opaque cup instead of the hidden food. Or perhaps they do not understand informative communicative intentions. In contrast, dogs seem to be skilful in using human communicative cues in the context of finding food, but as of yet there is not much data showing whether they also use pointing in the context of finding non-food objects. Here we directly compare chimpanzees' (N = 20) and dogs' (N = 32) skills in using a communicative gesture directed at a visible object out of reach of the human but within reach of the subject. Pairs of objects were placed in view of and behind the subjects. The task was to retrieve the object the experimenter wanted. To indicate which one she desired, the experimenter pointed imperatively to it and directly rewarded the subject for handing over the correct one. While dogs performed well on this task, chimpanzees failed to identify the referent. Implications for great apes' and dogs' understanding of human communicative intentions are discussed.	[Kirchhofer, Katharina C.; Zimmermann, Felizitas; Kaminski, Juliane; Tomasello, Michael] Max Planck Inst Evolutionary Anthropol, Leipzig, Germany	Max Planck Society	Kirchhofer, KC (corresponding author), Max Planck Inst Evolutionary Anthropol, Leipzig, Germany.	katharina.kirchhofer@gmail.com		Kaminski, Juliane/0000-0002-3437-3484	Ngamba Island Chimpanzee Sanctuary; Volkswagenstiftung	Ngamba Island Chimpanzee Sanctuary; Volkswagenstiftung(Volkswagen)	We are grateful to the caregivers of the Wolfgang Kohler Primate Research Center in Leipzig Zoo, Germany, for their help in collecting the data. In particular we thank D. Geissler, S. Leideritz and N. Schenk. We are also grateful to L. Ajarova, and the trustees and staff of Ngamba Island Chimpanzee Sanctuary for their enthusiasm, help, and support. In particular, we appreciate the hard work of the animal caregivers: S. Nyadwi, G. Muyingo, B. Ainebyona, P. Nyenje, R. Lematia, M. Musumba, A. Okello and S. Birungi. We also appreciate the permission from the Uganda National Council for Science and Technology and the Uganda Wildlife Authority for allowing us to conduct our research in Uganda. We thank S. Keupp, M. Koestel, K. Schumann and B. Muller for their assistance in the experiments, F. Buttelmann. and A. Schell for reliability coding and K. Schuppli for designing Figure 1. The reported experiments comply with all laws of the country in which they were performed.; JK was funded by a grant of the Volkswagenstiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Behne T, 2005, DEVELOPMENTAL SCI, V8, P492, DOI 10.1111/j.1467-7687.2005.00440.x; Brauer J, 2005, J COMP PSYCHOL, V119, P145, DOI 10.1037/0735-7036.119.2.145; Brauer J, 2006, J COMP PSYCHOL, V120, P38, DOI 10.1037/0735-7036.120.1.38; Call J, 2008, TRENDS COGN SCI, V12, P187, DOI 10.1016/j.tics.2008.02.010; Call Josep., 2005, JOINT ATTENTION COMM, P45, DOI [10.1093/acprof:oso/9780199245635.003.0003, DOI 10.1093/ACPROF:OSO/9780199245635.003.0003]; Gacsi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006584; Hare B, 2004, ANIM BEHAV, V68, P571, DOI 10.1016/j.anbehav.2003.11.011; Hare B, 2002, SCIENCE, V298, P1634, DOI 10.1126/science.1072702; Herrmann E, 2006, DEVELOPMENTAL SCI, V9, P518, DOI 10.1111/j.1467-7687.2006.00519.x; Itakura S, 1999, DEVELOPMENTAL SCI, V2, P448, DOI 10.1111/1467-7687.00089; Kaminski J, 2011, COORDINATION IN HUMAN AND PRIMATE GROUPS, P245, DOI 10.1007/978-3-642-15355-6_14; Kaminski J, 2009, RES PER NEUROSCI, P103, DOI 10.1007/978-3-540-85897-3_9; Lyn H, 2010, PSYCHOL SCI, V21, P360, DOI 10.1177/0956797610362218; Miklosi A, 2003, CURR BIOL, V13, P763, DOI 10.1016/S0960-9822(03)00263-X; Miklosi A, 2006, ANIM COGN, V9, P81, DOI 10.1007/s10071-005-0008-1; Mulcahy NJ, 2009, J COMP PSYCHOL, V123, P304, DOI 10.1037/a0016222; Okamoto-Barth S, 2008, DEVELOPMENTAL SCI, V11, P98, DOI 10.1111/j.1467-7687.2007.00658.x; Okamoto-Barth S, 2007, PSYCHOL SCI, V18, P462, DOI 10.1111/j.1467-9280.2007.01922.x; Povinelli DJ, 1997, COGNITIVE DEV, V12, P327, DOI 10.1016/S0885-2014(97)90017-4; Riedel J, 2008, ANIM BEHAV, V75, P1003, DOI 10.1016/j.anbehav.2007.08.010; Tomasello M, 2008, JEAN NICOD LECT, P1; Topal J, 2009, SCIENCE, V325, P1269, DOI 10.1126/science.1176960; Udell MAR, 2008, ANIM BEHAV, V76, P1767, DOI 10.1016/j.anbehav.2008.07.028; Viranyi Z, 2008, ANIM COGN, V11, P373, DOI 10.1007/s10071-007-0127-y; Wobber V, 2011, DOGS BIOL BEHAV HLTH; Wynne C, 2010, ANIMALS AFFECT US EX, P101	26	62	64	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e30913	10.1371/journal.pone.0030913	http://dx.doi.org/10.1371/journal.pone.0030913			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347411	gold, Green Submitted, Green Published			2022-12-27	WOS:000302730100031
J	Li, L; Xu, ZF; Zhou, Y; Sun, LL; Liu, ZD; Chen, HC; Zhou, R				Li, Lu; Xu, Zhuofei; Zhou, Yang; Sun, Lili; Liu, Ziduo; Chen, Huanchun; Zhou, Rui			Global Effects of Catecholamines on Actinobacillus pleuropneumoniae Gene Expression	PLOS ONE			English	Article							ESCHERICHIA-COLI O157-H7; BIOFILM FORMATION; MICROBIAL ENDOCRINOLOGY; INFECTIOUS-DISEASE; RTX-TOXINS; YERSINIA-ENTEROCOLITICA; PERIODONTAL BACTERIA; SALMONELLA-ENTERICA; UREASE ACTIVITY; INDUCED GROWTH	Bacteria can use mammalian hormones to modulate pathogenic processes that play essential roles in disease development. Actinobacillus pleuropneumoniae is an important porcine respiratory pathogen causing great economic losses in the pig industry globally. Stress is known to contribute to the outcome of A. pleuropneumoniae infection. To test whether A. pleuropneumoniae could respond to stress hormone catecholamines, gene expression profiles after epinephrine (Epi) and norepinephrine (NE) treatment were compared with those from untreated bacteria. The microarray results showed that 158 and 105 genes were differentially expressed in the presence of Epi and NE, respectively. These genes were assigned to various functional categories including many virulence factors. Only 18 genes were regulated by both hormones. These genes included apxIA (the ApxI toxin structural gene), pgaB (involved in biofilm formation), APL_0443 (an autotransporter adhesin) and genes encoding potential hormone receptors such as tyrP2, the ygiY-ygiX (qseC-qseB) operon and narQ-narP (involved in nitrate metabolism). Further investigations demonstrated that cytotoxic activity was enhanced by Epi but repressed by NE in accordance with apxIA gene expression changes. Biofilm formation was not affected by either of the two hormones despite pgaB expression being affected. Adhesion to host cells was induced by NE but not by Epi, suggesting that the hormones affect other putative adhesins in addition to APL_0443. This study revealed that A. pleuropneumoniae gene expression, including those encoding virulence factors, was altered in response to both catecholamines. The differential regulation of A. pleuropneumoniae gene expression by the two hormones suggests that this pathogen may have multiple responsive systems for the two catecholamines.	[Li, Lu; Xu, Zhuofei; Zhou, Yang; Sun, Lili; Liu, Ziduo; Chen, Huanchun; Zhou, Rui] Huazhong Agr Univ, Div Anim Infect Dis, State Key Lab Agr Microbiol, Coll Vet Med, Wuhan, Peoples R China	Huazhong Agricultural University	Zhou, R (corresponding author), Huazhong Agr Univ, Div Anim Infect Dis, State Key Lab Agr Microbiol, Coll Vet Med, Wuhan, Peoples R China.	rzhou@mail.hzau.edu.cn	Zhou, Yang/GSE-6288-2022		National Natural Science Foundation of China [31070113]; National Basic Research Program of China (973 Program) [2012CB518802]; Special Fund for Agro-scientific Research in the Public Interest [200903036-05]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Special Fund for Agro-scientific Research in the Public Interest	This work was supported by the National Natural Science Foundation of China (31070113), National Basic Research Program of China (973 Program, 2012CB518802) and Special Fund for Agro-scientific Research in the Public Interest (200903036-05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abul-Milh M, 1999, INFECT IMMUN, V67, P4983, DOI 10.1128/IAI.67.10.4983-4987.1999; Anderson MT, 2008, J BACTERIOL, V190, P3940, DOI 10.1128/JB.00086-08; Auger E, 2009, INFECT IMMUN, V77, P1426, DOI 10.1128/IAI.00297-08; Baltes N, 2004, INFECT IMMUN, V72, P6711, DOI 10.1128/IAI.72.11.6711-6716.2004; Baltes N, 2001, INFECT IMMUN, V69, P472, DOI 10.1128/IAI.69.1.472-478.2001; Bansal T, 2007, INFECT IMMUN, V75, P4597, DOI 10.1128/IAI.00630-07; BELANGER M, 1994, INFECT IMMUN, V62, P868; BELANGER M, 1990, INFECT IMMUN, V58, P3523; Boekema BKHL, 2004, INFECT IMMUN, V72, P691, DOI 10.1128/IAI.72.2.691-700.2004; Bosse JT, 2010, J BACTERIOL, V192, P2414, DOI 10.1128/JB.01513-09; Bosse JT, 1997, INFECT IMMUN, V65, P4389; Bosse JT, 2002, MICROBES INFECT, V4, P225, DOI 10.1016/S1286-4579(01)01534-9; Bosse JT, 2000, CAN J VET RES, V64, P145; Boyce JD, 2002, INFECT IMMUN, V70, P6871, DOI 10.1128/IAI.70.12.6871-6879.2002; Brennan RG, 2007, CURR OPIN MICROBIOL, V10, P125, DOI 10.1016/j.mib.2007.03.015; Brown SW, 2003, J NEUROIMMUNOL, V135, P47, DOI 10.1016/S0165-5728(02)00435-6; Buettner FFR, 2008, INFECT IMMUN, V76, P2284, DOI 10.1128/IAI.01540-07; Buettner FFR, 2008, VET MICROBIOL, V127, P106, DOI 10.1016/j.vetmic.2007.08.005; Burton CL, 2002, INFECT IMMUN, V70, P5913, DOI 10.1128/IAI.70.11.5913-5923.2002; Chen CS, 2006, EUR J PHARMACOL, V539, P116, DOI 10.1016/j.ejphar.2006.03.081; Chiers K, 2010, VET RES, V41, DOI 10.1051/vetres/2010037; Clarke MB, 2006, P NATL ACAD SCI USA, V103, P10420, DOI 10.1073/pnas.0604343103; CURTIS SE, 1976, AM J VET RES, V37, P299; Dalai B, 2009, MICROB PATHOGENESIS, V46, P128, DOI 10.1016/j.micpath.2008.11.005; Deslandes V, BMC GENOMICS, V11, P98; Deslandes V, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-72; Diez A, 2000, MOL MICROBIOL, V36, P1494, DOI 10.1046/j.1365-2958.2000.01979.x; Domka J, 2006, APPL ENVIRON MICROB, V72, P2449, DOI 10.1128/AEM.72.4.2449-2459.2006; Everest P, 2007, GUT, V56, P1037, DOI 10.1136/gut.2006.117150; Flierl MA, 2007, NATURE, V449, P721, DOI 10.1038/nature06185; Freestone PPE, 2000, J BACTERIOL, V182, P6091, DOI 10.1128/JB.182.21.6091-6098.2000; Freestone PPE, 2008, TRENDS MICROBIOL, V16, P55, DOI 10.1016/j.tim.2007.11.005; Freestone PPE, 2007, FEMS MICROBIOL LETT, V269, P221, DOI 10.1111/j.1574-6968.2006.00619.x; Freestone PPE, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-8; FREY J, 1995, TRENDS MICROBIOL, V3, P257, DOI 10.1016/S0966-842X(00)88939-8; FREY J, 1993, J GEN MICROBIOL, V139, P1723, DOI 10.1099/00221287-139-8-1723; GRUCHOW HW, 1979, J HUM STRESS, V5, P11, DOI 10.1080/0097840X.1979.9934523; Hendrickson BA, 1999, INFECT IMMUN, V67, P745, DOI 10.1128/IAI.67.2.745-753.1999; Horn G, 2007, CELL MOL LIFE SCI, V64, P1457, DOI 10.1007/s00018-007-6388-4; Hughes DT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000553; Jacobsen I, 2005, INFECT IMMUN, V73, P226, DOI 10.1128/IAI.73.1.226-234.2005; Jacques M, 2004, CAN J VET RES, V68, P81; Jarma E, 2004, MICROB PATHOGENESIS, V36, P197, DOI 10.1016/j.micpath.2003.11.005; KAMP EM, 1991, INFECT IMMUN, V59, P3079, DOI 10.1128/IAI.59.9.3079-3085.1991; Kaplan JB, 2004, J BACTERIOL, V186, P8213, DOI 10.1128/JB.186.24.8213-8220.2004; Kaplan JB, 2005, VET MICROBIOL, V108, P89, DOI 10.1016/j.vetmic.2005.02.011; KELLEY KW, 1980, ANN RECH VET, V11, P445; Kihara A, 1998, J MOL BIOL, V279, P175, DOI 10.1006/jmbi.1998.1781; LEDIVIDICH J, 1991, BIOL NEONATE, V59, P268, DOI 10.1159/000243360; Li L, MICROB PATHOG; Li L, 2008, MICROB PATHOGENESIS, V45, P192, DOI 10.1016/j.micpath.2008.05.008; Lone AG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006139; Lyte M, 1996, FEMS MICROBIOL LETT, V139, P155, DOI 10.1016/0378-1097(96)00135-8; Lyte M, 1997, BIOCHEM BIOPH RES CO, V232, P682, DOI 10.1006/bbrc.1997.6356; Lyte M, 2004, TRENDS MICROBIOL, V12, P14, DOI 10.1016/j.tim.2003.11.004; LYTE M, 1993, J ENDOCRINOL, V137, P343, DOI 10.1677/joe.0.1370343; Negrete-Abascal E, 1998, CAN J VET RES, V62, P183; NEGRETEABASCAL E, 1994, CAN J VET RES, V58, P83; Oneal MJ, 2008, MICROBIOL-SGM, V154, P2581, DOI 10.1099/mic.0.2008/020230-0; PARADIS SE, 1994, INFECT IMMUN, V62, P3311, DOI 10.1128/IAI.62.8.3311-3319.1994; PETERSON PK, 1991, REV INFECT DIS, V13, P710; Ramjeet M, 2005, J BIOL CHEM, V280, P39104, DOI 10.1074/jbc.M502852200; Ramjeet M, 2008, MOL MICROBIOL, V70, P221, DOI 10.1111/j.1365-2958.2008.06409.x; Reading NC, 2009, P NATL ACAD SCI USA, V106, P5889, DOI 10.1073/pnas.0811409106; Roberts A, 2005, ORAL MICROBIOL IMMUN, V20, P147, DOI 10.1111/j.1399-302X.2004.00196.x; Roberts A, 2002, ORAL MICROBIOL IMMUN, V17, P296, DOI 10.1034/j.1399-302X.2002.170506.x; Salak-Johnson JL, 2007, J ANIM SCI, V85, pE81, DOI 10.2527/jas.2006-538; Sandrini SM, 2010, J BACTERIOL, V192, P587, DOI 10.1128/JB.01028-09; Smoot LM, 2001, P NATL ACAD SCI USA, V98, P10416, DOI 10.1073/pnas.191267598; Sperandio V, 2003, P NATL ACAD SCI USA, V100, P8951, DOI 10.1073/pnas.1537100100; Stevenson A, 2003, VET MICROBIOL, V92, P121, DOI 10.1016/S0378-1135(02)00351-6; Stewart V, 2003, MOL MICROBIOL, V50, P1391, DOI 10.1046/j.1365-2958.2003.03776.x; Tegetmeyer HE, 2009, VET MICROBIOL, V137, P392, DOI 10.1016/j.vetmic.2009.01.026; Thanabalu T, 1998, EMBO J, V17, P6487, DOI 10.1093/emboj/17.22.6487; Vendeville A, 2005, NAT REV MICROBIOL, V3, P383, DOI 10.1038/nrmicro1146; Vlisidou I, 2004, INFECT IMMUN, V72, P5446, DOI 10.1128/IAI.72.9.5446-5451.2004; Voigt W, 2006, J CLIN MICROBIOL, V44, P2247, DOI 10.1128/JCM.00330-05; Walters M, 2006, J BACTERIOL, V188, P5668, DOI 10.1128/JB.00648-06; Whitehead RN, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-35; Wojtarowicz Aleksandra, 2003, Folia Morphol (Warsz), V62, P215; Xu ZF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001450; YOUNG JB, 1998, WILLIAMS TXB ENDOCRI, P665	82	34	37	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31121	10.1371/journal.pone.0031121	http://dx.doi.org/10.1371/journal.pone.0031121			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347439	Green Published, Green Submitted, gold			2022-12-27	WOS:000302730100043
J	Perlman, AI; Ali, A; Njike, VY; Hom, D; Davidi, A; Gould-Fogerite, S; Milak, C; Katz, DL				Perlman, Adam I.; Ali, Ather; Njike, Valentine Yanchou; Hom, David; Davidi, Anna; Gould-Fogerite, Susan; Milak, Carl; Katz, David L.			Massage Therapy for Osteoarthritis of the Knee: A Randomized Dose-Finding Trial	PLOS ONE			English	Article							ALTERNATIVE MEDICINE; MODERATE PRESSURE; VISUAL ANALOG; REDUCES PAIN; BACK-PAIN; WOMAC; COMPLEMENTARY; ANXIETY; SAFETY; NECK	Background: In a previous trial of massage for osteoarthritis (OA) of the knee, we demonstrated feasibility, safety and possible efficacy, with benefits that persisted at least 8 weeks beyond treatment termination. Methods: We performed a RCT to identify the optimal dose of massage within an 8-week treatment regimen and to further examine durability of response. Participants were 125 adults with OA of the knee, randomized to one of four 8-week regimens of a standardized Swedish massage regimen (30 or 60 min weekly or biweekly) or to a Usual Care control. Outcomes included the Western Ontario and McMaster Universities Arthritis Index (WOMAC), visual analog pain scale, range of motion, and time to walk 50 feet, assessed at baseline, 8-, 16-, and 24-weeks. Results: WOMAC Global scores improved significantly (24.0 points, 95% CI ranged from 15.3-32.7) in the 60-minute massage groups compared to Usual Care (6.3 points, 95% CI 0.1-12.8) at the primary endpoint of 8-weeks. WOMAC subscales of pain and functionality, as well as the visual analog pain scale also demonstrated significant improvements in the 60-minute doses compared to usual care. No significant differences were seen in range of motion at 8-weeks, and no significant effects were seen in any outcome measure at 24-weeks compared to usual care. A dose-response curve based on WOMAC Global scores shows increasing effect with greater total time of massage, but with a plateau at the 60-minute/week dose. Conclusion: Given the superior convenience of a once-weekly protocol, cost savings, and consistency with a typical real-world massage protocol, the 60-minute once weekly dose was determined to be optimal, establishing a standard for future trials.	[Perlman, Adam I.] Duke Univ, Sch Med, Durham, NC 27708 USA; [Ali, Ather; Njike, Valentine Yanchou; Davidi, Anna; Katz, David L.] Yale Univ, Sch Med, Prevent Res Ctr, Derby, CT USA; [Hom, David] Boston Med Ctr, Clin Trials Unit, Infect Dis Sect, Boston, MA USA; [Hom, David; Gould-Fogerite, Susan; Milak, Carl] Univ Med & Dent New Jersey, Sch Hlth Related Profess, Newark, NJ 07103 USA	Duke University; Yale University; Boston Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Perlman, AI (corresponding author), Duke Univ, Sch Med, Durham, NC 27708 USA.	adam.perlman@duke.edu		Njike, Valentine/0000-0001-5468-3175; Katz, David/0000-0001-6845-6192	National Center for Complementary and Alternative Medicine (NCCAM) at the National Institutes of Health [R01 AT004623]; National Center for Complementary & Integrative Health [R01AT004623] Funding Source: NIH RePORTER	National Center for Complementary and Alternative Medicine (NCCAM) at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This publication was made possible by grant number R01 AT004623 from the National Center for Complementary and Alternative Medicine (NCCAM) at the National Institutes of Health. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of NCCAM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahles TA, 1999, J PAIN SYMPTOM MANAG, V18, P157, DOI 10.1016/S0885-3924(99)00061-5; ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; Anagnostis C, 2003, SPINE, V28, P1051, DOI 10.1097/00007632-200305150-00018; Angst F, 2002, J RHEUMATOL, V29, P131; Arden N, 2006, BEST PRACT RES CL RH, V20, P3, DOI 10.1016/j.berh.2005.09.007; Back C, 2009, HOLIST NURS PRACT, V23, P19, DOI 10.1097/01.HNP.0000343206.71957.a9; Barnes Patricia M, 2008, Natl Health Stat Report, P1; Bauer Brent A, 2010, Complement Ther Clin Pract, V16, P70, DOI 10.1016/j.ctcp.2009.06.012; Bellamy N, 2005, CLIN EXP RHEUMATOL, V23, pS148; BELLAMY N, 1988, J RHEUMATOL, V15, P1833; Billhult A, 2008, AUTON NEUROSCI-BASIC, V140, P88, DOI 10.1016/j.autneu.2008.03.006; Billhult A, 2009, AUTON NEUROSCI-BASIC, V150, P111, DOI 10.1016/j.autneu.2009.03.010; Billhult Annika, 2009, Complement Ther Clin Pract, V15, P96, DOI 10.1016/j.ctcp.2008.10.003; Bouchet C, 1996, J CLIN EPIDEMIOL, V49, P15, DOI 10.1016/0895-4356(95)00540-4; Bronfort Gert, 2010, Chiropr Osteopat, V18, P3, DOI 10.1186/1746-1340-18-3; Cambron JA, 2007, J ALTERN COMPLEM MED, V13, P793, DOI 10.1089/acm.2006.6401; Cherkin DC, 2003, ANN INTERN MED, V138, P898, DOI 10.7326/0003-4819-138-11-200306030-00011; Corbin LW, 2009, J PALLIAT MED, V12, P7, DOI 10.1089/jpm.2008.0198; Diego MA, 2004, INT J NEUROSCI, V114, P31, DOI 10.1080/00207450490249446; Diego MA, 2001, INT J NEUROSCI, V106, P35, DOI 10.3109/00207450109149736; Diego M, 2009, INT J NEUROSCI, V119, P630, DOI 10.1080/00207450802329605; Downey L, 2009, J PALLIAT CARE, V25, P100, DOI 10.1177/082585970902500204; Ernst E, 2003, RHEUMATOLOGY, V42, P1101, DOI 10.1093/rheumatology/keg306; Ernst E, 2002, CURR OPIN RHEUMATOL, V14, P58, DOI 10.1097/00002281-200201000-00011; Escobar A, 2007, OSTEOARTHR CARTILAGE, V15, P273, DOI 10.1016/j.joca.2006.09.001; Ezzo J, 2007, SPINE, V32, P353, DOI 10.1097/01.brs.0000254099.07294.21; Felson DT, 2004, RADIOL CLIN N AM, V42, P1, DOI 10.1016/S0033-8389(03)00161-1; Field T, 2005, INT J NEUROSCI, V115, P1397, DOI 10.1080/00207450590956459; Field T, 1996, INT J NEUROSCI, V86, P197, DOI 10.3109/00207459608986710; Field T, 2008, J BODYW MOV THER, V12, P146, DOI 10.1016/j.jbmt.2007.06.003; Field T, 2010, INT J NEUROSCI, V120, P381, DOI 10.3109/00207450903579475; Fisher NM, 1997, SCAND J REHABIL MED, V29, P213; Hernandez-Reif M, 2001, INT J NEUROSCI, V106, P131, DOI 10.3109/00207450109149744; Hunter DJ, 2006, BMJ-BRIT MED J, V332, P639, DOI 10.1136/bmj.332.7542.639; Jane SW, 2009, J PAIN SYMPTOM MANAG, V37, P754, DOI 10.1016/j.jpainsymman.2008.04.021; Kaptchuk TJ, 1998, LANCET, V351, P1722, DOI 10.1016/S0140-6736(97)10111-8; Kato T, 2004, CURR OPIN RHEUMATOL, V16, P604, DOI 10.1097/01.bor.0000133661.52599.bf; Kirby BS, 2007, J PHYSIOL-LONDON, V583, P861, DOI 10.1113/jphysiol.2007.131250; Kotlarz H, 2009, ARTHRITIS RHEUM-US, V60, P3546, DOI 10.1002/art.24984; Kutner JS, 2008, ANN INTERN MED, V149, P369, DOI 10.7326/0003-4819-149-6-200809160-00003; Law LAF, 2008, J PAIN, V9, P714, DOI 10.1016/j.jpain.2008.03.009; Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176; Listing M, 2009, PSYCHO-ONCOLOGY, V18, P1290, DOI 10.1002/pon.1508; Matchaba P, 2005, CLIN THER, V27, P1196, DOI 10.1016/j.clinthera.2005.07.019; McConnell S, 2001, ARTHRIT RHEUM-ARTHR, V45, P453, DOI 10.1002/1529-0131(200110)45:5<453::AID-ART365>3.0.CO;2-W; MESSIER SP, 1992, ARCH PHYS MED REHAB, V73, P29; Naesdall J, 2006, DRUG SAFETY, V29, P119; National Center for Complementary and Alternative Medicine, 2010, NCCAM BACKGR MASS TH; Nayak S, 2001, J Spinal Cord Med, V24, P54; Perlman A, 2003, COMPLEMENTARY ALTERN, P352; Perlman A, 2003, INTEGRATIVE MED, P414; Perlman A, 2006, OWN YOUR OWN HLTH BE; Perlman AI, 2006, ARCH INTERN MED, V166, P2533, DOI 10.1001/archinte.166.22.2533; Poole AR, 2004, J IMMUNOL METHODS, V294, P145, DOI 10.1016/j.jim.2004.09.005; Preyde M, 2000, CAN MED ASSOC J, V162, P1815; PRICE DD, 1994, PAIN, V56, P217, DOI 10.1016/0304-3959(94)90097-3; Rapaport MH, 2010, J ALTERN COMPLEM MED, V16, P1079, DOI 10.1089/acm.2009.0634; Richmond J, 2009, J AM ACAD ORTHOP SUR, V17, P591, DOI 10.5435/00124635-200909000-00006; Sagar Stephen M, 2007, J Soc Integr Oncol, V5, P155, DOI 10.2310/7200.2007.017; SCHAIBLE HG, 1993, PAIN, V55, P5, DOI 10.1016/0304-3959(93)90183-P; Schnyer RN, 2002, J ALTERN COMPLEM MED, V8, P623, DOI 10.1089/107555302320825147; Sefton JM, 2010, J ALTERN COMPLEM MED, V16, P723, DOI 10.1089/acm.2009.0441; Sherman Karen J, 2005, BMC Complement Altern Med, V5, P13, DOI 10.1186/1472-6882-5-13; Sherman KJ, 2010, DEPRESS ANXIETY, V27, P441, DOI 10.1002/da.20671; Sherman KJ, 2009, CLIN J PAIN, V25, P233, DOI 10.1097/AJP.0b013e31818b7912; Smith Marlaine, 2007, J Soc Integr Oncol, V5, P139, DOI 10.2310/7200.2007.014; Stringer J, 2008, PSYCHO-ONCOL, V17, P1024, DOI 10.1002/pon.1331; Wentworth Laura J, 2009, Prog Cardiovasc Nurs, V24, P155, DOI 10.1111/j.1751-7117.2009.00054.x	68	58	58	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e30248	10.1371/journal.pone.0030248	http://dx.doi.org/10.1371/journal.pone.0030248			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347369	Green Published, Green Submitted, gold			2022-12-27	WOS:000302730100007
J	Wing, JB; Smart, L; Borrow, R; Findlow, J; Findlow, H; Lees, A; Read, RC; Heath, AW				Wing, James B.; Smart, Lynne; Borrow, Ray; Findlow, Jamie; Findlow, Helen; Lees, Andrew; Read, Robert C.; Heath, Andrew W.			Correlation of Group C Meningococcal Conjugate Vaccine Response with B- and T-Lymphocyte Activity	PLOS ONE			English	Article							ANTI-IG ANTIBODIES; UNITED-KINGDOM; IN-VITRO; CELLS; POLYSACCHARIDE; DISEASE; IMMUNIZATION; PROTECTION; SECRETION; ENGLAND	Despite the success of conjugate vaccination against meningococcal group C (MenC) disease, post-vaccination, some individuals still exhibit rapid waning of initially protective bactericidal antibody levels. The mechanism of this relative loss of humoral protection remains undetermined. In this report we have investigated the relationship between T- and B-cell activation and co-stimulation and the loss of protective antibody titers. We have found that healthy volunteers who lose protective MenC antibody levels one year after receipt of glycoconjugate vaccine exhibit no detectable cellular defect in polyclonal B- or T-cell activation, proliferation or the B-memory pool. This suggests that the processes underlying the more rapid loss of antibody levels are independent of defects in either initial T- or B-cell activation.	[Wing, James B.; Smart, Lynne; Read, Robert C.; Heath, Andrew W.] Univ Sheffield, Sch Med, Dept Infect & Immun, Sheffield, S Yorkshire, England; [Borrow, Ray; Findlow, Jamie; Findlow, Helen] Manchester Royal Infirm, Vaccine Evaluat Unit, Hlth Protect Agcy, Manchester M13 9WL, Lancs, England; [Borrow, Ray; Findlow, Jamie] Univ Manchester, Inflammat Sci Res Grp, Manchester, Lancs, England; [Lees, Andrew] Fina Biosolut LLC, Rockville, MD USA	University of Sheffield; Health Protection Agency; University of Manchester; University of Manchester	Wing, JB (corresponding author), Univ Sheffield, Sch Med, Dept Infect & Immun, Sheffield, S Yorkshire, England.	r.c.read@sheffield.ac.uk	Lees, Andrew J/A-6605-2009; Wing, James Badger/H-6256-2019; Lees, Andrew/R-2787-2019	Lees, Andrew J/0000-0002-2476-4385; Wing, James Badger/0000-0002-3462-1003; Lees, Andrew/0000-0002-8370-4876; Read, Robert/0000-0002-4297-6728	Meningitis Research Foundation [0604.0]	Meningitis Research Foundation(Meningitis Research Foundation (MRF))	This work was supported by the Meningitis Research Foundation (0604.0) (http://www.meningitis.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews N, 2003, CLIN DIAGN LAB IMMUN, V10, P780, DOI 10.1128/CDLI.10.5.780-786.2003; ARPIN C, 1995, SCIENCE, V268, P720, DOI 10.1126/science.7537388; Auckland C, 2006, J INFECT DIS, V194, P1745, DOI 10.1086/509619; Borrow R, 2001, INFECT IMMUN, V69, P1568, DOI 10.1128/IAI.69.3.1568-1573.2001; BRUNSWICK M, 1988, J IMMUNOL, V140, P3364; Colonna-Romano G, 2009, MECH AGEING DEV, V130, P681, DOI 10.1016/j.mad.2009.08.003; Darton TC, 2011, CLIN INFECT DIS, V52, P1133, DOI 10.1093/cid/cir126; Elgueta R, 2009, IMMUNOL REV, V229, P152, DOI 10.1111/j.1600-065X.2009.00782.x; Foster RA, 2010, CLIN VACCINE IMMUNOL, V17, P1104, DOI 10.1128/CVI.00481-09; Foster RA, 2009, CLIN VACCINE IMMUNOL, V16, P692, DOI 10.1128/CVI.00485-08; Goldblatt D, 2000, CLIN EXP IMMUNOL, V119, P1, DOI 10.1046/j.1365-2249.2000.01109.x; GOLDSCHNEIDER I, 1969, J EXP MED, V129, P1327, DOI 10.1084/jem.129.6.1327; Henneken M, 2010, VACCINE, V28, P2097, DOI 10.1016/j.vaccine.2009.12.039; Khan AQ, 2004, J IMMUNOL, V172, P532, DOI 10.4049/jimmunol.172.1.532; Lanzavecchia A, 2006, IMMUNOL REV, V211, P303, DOI 10.1111/j.0105-2896.2006.00403.x; Miller E, 2001, VACCINE, V20, pS58, DOI 10.1016/S0264-410X(01)00299-7; Nanan R, 2001, VACCINE, V20, P498, DOI 10.1016/S0264-410X(01)00328-0; OBrien KL, 1996, PEDIATR INFECT DIS J, V15, P425, DOI 10.1097/00006454-199605000-00009; PECANHA LMT, 1993, J IMMUNOL, V150, pA61; PECANHA LMT, 1991, FASEB J, V5, pA1000; Rezaei N, 2010, HUM IMMUNOL; Santos GF, 2001, CLIN DIAGN LAB IMMUN, V8, P616, DOI 10.1128/CDLI.8.3.616-623.2001; Shi YH, 2003, CLIN IMMUNOL, V108, P128, DOI 10.1016/S1521-6616(03)00092-5; SNAPPER CM, 1992, J EXP MED, V175, P1367, DOI 10.1084/jem.175.5.1367; Trotter CL, 2008, CLIN VACCINE IMMUNOL, V15, P1694, DOI 10.1128/CVI.00279-08; Trotter CL, 2004, LANCET, V364, P365, DOI 10.1016/S0140-6736(04)16725-1; Wei C, 2007, J IMMUNOL, V178, P6624, DOI 10.4049/jimmunol.178.10.6624; Wing JB, 2011, CLIN INFECT DIS, V52, P1317, DOI 10.1093/cid/cir198	28	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31160	10.1371/journal.pone.0031160	http://dx.doi.org/10.1371/journal.pone.0031160			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347446	gold, Green Published, Green Accepted			2022-12-27	WOS:000302730100049
J	Jin, M; Lang, J; Shen, ZQ; Chen, ZL; Qiu, ZG; Wang, XW; Li, JW				Jin, Min; Lang, Jing; Shen, Zhi-Qiang; Chen, Zhao-Li; Qiu, Zhi-Gang; Wang, Xin-Wei; Li, Jun-Wen			A Rapid Subtractive Immunization Method to Prepare Discriminatory Monoclonal Antibodies for Food E. coli O157:H7 Contamination	PLOS ONE			English	Article							IMMUNOGOLD FILTRATION ASSAY; ESCHERICHIA-COLI; GENERATION; PROTEINS; ANTIGENS; TOLERIZATION; EPITOPES; STRATEGY; AFFINITY; SURFACE	To detect food E. coli O157:H7 contamination rapidly and accurately, it is essential to prepare high specific monoclonal antibodies (mAbs) against the pathogen. Cyclophosphamide (Cy)-mediated subtractive immunization strategy was performed in mice to generate mAbs that react with E. coli O157:H7, but not with other affiliated bacteria. Specificity of 19 mAbs was evaluated by ELISA and/or dot-immunogold filtration assay (DIGFA). Immunogloubin typing, affinity and binding antigens of 5 selected mAbs were also analysed. MAbs 1D8, 4A7, 5A2 were found to have high reactivity with E. coli O157:H7 and no cross-reactivity with 80 other strains of bacteria including Salmonella sp., Shigella sp., Proteus sp., Yersinia enterocolitica, Staphylococcus aureus, Klebsiella pneumoniae, Citrobacter freundii and other non-E. coli O157:H7 enteric bacteria. Their ascetic titers reached 1:10(6) with E. coli O157:H7 and affinity constants ranged from 1.57x10(10) to 2.79x10(10) L/mol. The antigens recognized by them were different localized proteins. Furthermore, immune-colloidal gold probe coated with mAb 5A2 could specifically distinguish minced beef contaminated by E. coli O157:H7 from 84 other bacterial contaminations. The Cy-mediated subtractive immunization procedure coupled with hybridoma technology is a rapid and efficient approach to prepare discriminatory mAbs for detection of E. coli O157:H7 contamination in food.	[Jin, Min; Lang, Jing; Shen, Zhi-Qiang; Chen, Zhao-Li; Qiu, Zhi-Gang; Wang, Xin-Wei; Li, Jun-Wen] Inst Hlth & Environm Med, Dept Environm & Hlth, Key Lab Risk Assessment & Control Environm & Food, Tianjin, Peoples R China		Jin, M (corresponding author), Inst Hlth & Environm Med, Dept Environm & Hlth, Key Lab Risk Assessment & Control Environm & Food, Tianjin, Peoples R China.	junwen9999@hotmail.com		Qiu, Zhigang/0000-0003-1199-3397	National High Technology Research and Development Program of China [2009AA06Z404, 2009AA03Z332]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This research was supported by the National High Technology Research and Development Program of China (2009AA06Z404, 2009AA03Z332). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEATTY JD, 1987, J IMMUNOL METHODS, V100, P173, DOI 10.1016/0022-1759(87)90187-6; Fukushima H, 2007, APPL ENVIRON MICROB, V73, P92, DOI 10.1128/AEM.01772-06; Han FC, 2000, WORLD J GASTROENTERO, V6, P400; Holbrook FL, 2002, IMMUNOL CELL BIOL, V80, P319, DOI 10.1046/j.1440-1711.2002.01095.x; Hooper JD, 2003, ONCOGENE, V22, P1783, DOI 10.1038/sj.onc.1206220; Joshi SA, 2003, REPRODUCTION, V125, P495, DOI 10.1530/reprod/125.4.495; Krueger P, 2001, J IMMUNOTHER, V24, P334, DOI 10.1097/00002371-200107000-00009; LANE RD, 1986, METHOD ENZYMOL, V121, P183; Lefebvre DJ, 2008, J GEN VIROL, V89, P177, DOI 10.1099/vir.0.83280-0; LOOMANS EEMG, 1995, J IMMUNOL METHODS, V184, P207, DOI 10.1016/0022-1759(95)00089-S; Luciani M., 2006, Veterinaria Italiana, V42, P173; Luciani M, 2006, Vet Ital, V42, P183; MCKINNEY MM, 1987, J IMMUNOL METHODS, V96, P271, DOI 10.1016/0022-1759(87)90324-3; Mernaugh RL, 2005, J IMMUNOL METHODS, V306, P115, DOI 10.1016/j.jim.2005.08.006; Navarro A, 2007, J MED MICROBIOL, V56, P1447, DOI 10.1099/jmm.0.47201-0; Ning YS, 2006, PROTEOMICS, V6, P438, DOI 10.1002/pmic.200500327; OU SK, 1991, J IMMUNOL METHODS, V145, P111, DOI 10.1016/0022-1759(91)90316-8; Park CH, 1998, J CLIN MICROBIOL, V36, P1408, DOI 10.1128/JCM.36.5.1408-1409.1998; Rasmussen N, 2009, J PROTEOME RES, V8, P5048, DOI 10.1021/pr9004635; Sakakibara K, 2005, GENES CELLS, V10, P345, DOI 10.1111/j.1365-2443.2005.00838.x; Sleister HM, 2002, J IMMUNOL METHODS, V261, P213, DOI 10.1016/S0022-1759(01)00567-1; Sleister HM, 2001, J IMMUNOL METHODS, V252, P121, DOI 10.1016/S0022-1759(01)00346-5; Sowers EG, 1996, J CLIN MICROBIOL, V34, P1286, DOI 10.1128/JCM.34.5.1286-1289.1996; Villavedra M, 2007, J FISH DIS, V30, P191, DOI 10.1111/j.1365-2761.2007.00800.x; Wang XJ, 2006, J VIROL METHODS, V132, P212, DOI 10.1016/j.jviromet.2005.09.012; Watanabe Y, 1999, EMERG INFECT DIS, V5, P424, DOI 10.3201/eid0503.990313; Westerman RB, 1997, J CLIN MICROBIOL, V35, P679, DOI 10.1128/JCM.35.3.679-684.1997; Xin ZT, 2004, J IMMUNOL METHODS, V293, P13, DOI 10.1016/j.jim.2004.06.006; Yang LJ, 2002, WORLD J GASTROENTERO, V8, P808, DOI 10.3748/wjg.v8.i5.808	29	15	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2012	7	2							e31352	10.1371/journal.pone.0031352	http://dx.doi.org/10.1371/journal.pone.0031352			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917MF	22347466	Green Submitted, Green Published, gold			2022-12-27	WOS:000302180600035
J	Moon, JJ; Suh, H; Polhemus, ME; Ockenhouse, CF; Yadava, A; Irvine, DJ				Moon, James J.; Suh, Heikyung; Polhemus, Mark E.; Ockenhouse, Christian F.; Yadava, Anjali; Irvine, Darrell J.			Antigen-Displaying Lipid-Enveloped PLGA Nanoparticles as Delivery Agents for a Plasmodium vivax Malaria Vaccine	PLOS ONE			English	Article							IMMUNE-RESPONSES; ANTIBODY-RESPONSES; EPITOPE DENSITY; IMMUNOGENICITY; IMMUNIZATION	The parasite Plasmodium vivax is the most frequent cause of malaria outside of sub-Saharan Africa, but efforts to develop viable vaccines against P. vivax so far have been inadequate. We recently developed pathogen-mimicking polymeric vaccine nanoparticles composed of the FDA-approved biodegradable polymer poly(lactide-co-glycolide) acid (PLGA) "enveloped'' by a lipid membrane. In this study, we sought to determine whether this vaccine delivery platform could be applied to enhance the immune response against P. vivax sporozoites. A candidate malaria antigen, VMP001, was conjugated to the lipid membrane of the particles, and an immunostimulatory molecule, monophosphoryl lipid A (MPLA), was incorporated into the lipid membranes, creating pathogen-mimicking nanoparticle vaccines (VMP001-NPs). Vaccination with VMP001-NPs promoted germinal center formation and elicited durable antigen-specific antibodies with significantly higher titers and more balanced Th1/Th2 responses in vivo, compared with vaccines composed of soluble protein mixed with MPLA. Antibodies raised by NP vaccinations also exhibited enhanced avidity and affinity toward the domains within the circumsporozoite protein implicated in protection and were able to agglutinate live P. vivax sporozoites. These results demonstrate that these VMP001-NPs are promising vaccines candidates that may elicit protective immunity against P. vivax sporozoites.	[Moon, James J.; Suh, Heikyung; Irvine, Darrell J.] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA; [Moon, James J.; Suh, Heikyung; Irvine, Darrell J.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Polhemus, Mark E.; Ockenhouse, Christian F.; Yadava, Anjali] Walter Reed Army Inst Res, Div Malaria Vaccine Dev, Silver Spring, MD USA; [Irvine, Darrell J.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Irvine, Darrell J.] Ragon Inst MGH MIT & Harvard, Boston, MA USA; [Suh, Heikyung; Irvine, Darrell J.] Howard Hughes Med Inst, Chevy Chase, MD USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; Howard Hughes Medical Institute	Moon, JJ (corresponding author), MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA.	djirvine@mit.edu	Moon, James J/ABE-4429-2021	Moon, James J/0000-0003-2238-2372	Ragon Institute of MGH, MIT, and Harvard; Department of Defense [W911NF-07-D-0004]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354] Funding Source: NIH RePORTER	Ragon Institute of MGH, MIT, and Harvard; Department of Defense(United States Department of Defense); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the Ragon Institute of MGH, MIT, and Harvard, and the Department of Defense (contract W911NF-07-D-0004). DJI is an investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ataman-Onal Y, 2006, J CONTROL RELEASE, V112, P175, DOI 10.1016/j.jconrel.2006.02.006; Ballou WR, 2009, PARASITE IMMUNOL, V31, P492, DOI 10.1111/j.1365-3024.2009.01143.x; Bell BA, 2009, VACCINE, V27, P1448, DOI 10.1016/j.vaccine.2008.12.027; Bershteyn A, 2011, J CONTROL R IN PRESS; Bershteyn A, 2008, SOFT MATTER, V4, P1787, DOI 10.1039/b804933e; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; CHAROENVIT Y, 1991, SCIENCE, V251, P668, DOI 10.1126/science.1704150; Cui ZR, 2004, VACCINE, V22, P2631, DOI 10.1016/j.vaccine.2003.12.013; Demento SL, 2010, J IMMUNOL, V185, P2989, DOI 10.4049/jimmunol.1000768; Demento SL, 2009, VACCINE, V27, P3013, DOI 10.1016/j.vaccine.2009.03.034; Fifis T, 2004, J IMMUNOL, V173, P3148, DOI 10.4049/jimmunol.173.5.3148; Jegerlehner A, 2002, EUR J IMMUNOL, V32, P3305, DOI 10.1002/1521-4141(200211)32:11<3305::AID-IMMU3305>3.0.CO;2-J; Jewell CM, 2011, P NATL ACAD SCI US; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; JONES TR, 1992, AM J TROP MED HYG, V47, P837, DOI 10.4269/ajtmh.1992.47.837; Kasturi SP, 2011, NATURE, V470, P543, DOI 10.1038/nature09737; Kazzaz J, 2006, J CONTROL RELEASE, V110, P566, DOI 10.1016/j.jconrel.2005.10.010; KOVACSOVICSBANKOWSKI M, 1993, P NATL ACAD SCI USA, V90, P4942, DOI 10.1073/pnas.90.11.4942; Liu HP, 2011, ANGEW CHEM INT EDIT, V50, P7052, DOI 10.1002/anie.201101266; Liu WL, 2005, EUR J IMMUNOL, V35, P505, DOI 10.1002/eji.200425749; McHeyzer-Williams LJ, 2005, ANNU REV IMMUNOL, V23, P487, DOI 10.1146/annurev.immunol.23.021704.115732; Moon JJ, 2012, P NATL ACAD SCI USA, V109, P1080, DOI 10.1073/pnas.1112648109; Moon JJ, 2011, NAT MATER, V10, P243, DOI 10.1038/NMAT2960; Mueller I, 2009, LANCET INFECT DIS, V9, P555, DOI 10.1016/S1473-3099(09)70177-X; Nutt SL, 2011, NAT IMMUNOL, V12, P472, DOI 10.1038/ni.2019; Otten G, 2003, J VIROL, V77, P6087, DOI 10.1128/JVI.77.10.6087-6092.2003; Price RN, 2007, AM J TROP MED HYG, V77, P79, DOI 10.4269/ajtmh.2007.77.79; Reddy ST, 2007, NAT BIOTECHNOL, V25, P1159, DOI [10.1038/nbt1332, 10.1038/nbtl332]; Sharp FA, 2009, P NATL ACAD SCI USA, V106, P870, DOI 10.1073/pnas.0804897106; Udhayakumar V, 1998, VACCINE, V16, P982, DOI 10.1016/S0264-410X(97)00290-9; Vanderberg JP, 2004, INT J PARASITOL, V34, P991, DOI 10.1016/j.ijpara.2004.05.005; Vogel G, 2010, SCIENCE, V329, P618, DOI 10.1126/science.329.5992.618; Yadava A, 2007, INFECT IMMUN, V75, P1177, DOI 10.1128/IAI.01667-06; Yue Y, 2009, VIROLOGY, V386, P438, DOI 10.1016/j.virol.2009.01.029; Zhang XQ, 2007, J PHARM SCI-US, V96, P3283, DOI 10.1002/jps.20978	35	102	106	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2012	7	2							e31472	10.1371/journal.pone.0031472	http://dx.doi.org/10.1371/journal.pone.0031472			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LV	22328935	Green Published, gold, Green Submitted			2022-12-27	WOS:000302179300021
J	Parthasarathy, S; Fitzgerald, M; Goodwin, JL; Unruh, M; Guerra, S; Quan, SF				Parthasarathy, Sairam; Fitzgerald, MaryPat; Goodwin, James L.; Unruh, Mark; Guerra, Stefano; Quan, Stuart F.			Nocturia, Sleep-Disordered Breathing, and Cardiovascular Morbidity in a Community-Based Cohort	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; POSITIVE AIRWAY PRESSURE; RISK-FACTOR; NATRIURETIC-PEPTIDE; APNEA-HYPOPNEA; OLDER-ADULTS; BACH SURVEY; MORTALITY; HEALTH; WOMEN	Background: Nocturia has been independently associated with cardiovascular morbidity and all-cause mortality, but such studies did not adjust for sleep-disordered breathing (SDB), which may have mediated such a relationship. Our aims were to determine whether an association between nocturia and cardiovascular morbidity exists that is independent of SDB. We also determined whether nocturia is independently associated with SDB. Methodology/Principal Findings: In order to accomplish these aims we performed a cross-sectional analysis of the Sleep Heart Health Study that contained information regarding SDB, nocturia, and cardiovascular morbidity in a middle-age to elderly community-based population. In 6342 participants (age 63 +/- 11 [SD] years, 53% women), after adjusting for known confounders such as age, body mass index, diuretic use, diabetes mellitus, alpha-blocker use, nocturia was independently associated with SDB (measured as Apnea Hypopnea index >15 per hour; OR 1.3; 95%CI, 1.2-1.5). After adjusting for SDB and other known confounders, nocturia was independently associated with prevalent hypertension (OR 1.23; 95%CI 1.08-140; P = 0.002), cardiovascular disease (OR 1.26; 95%CI 1.05-1.52; P = 0.02) and stroke (OR 1.62; 95%CI 1.14-2.30; P = 0.007). Moreover, nocturia was also associated with adverse objective alterations of sleep as measured by polysomnography and self-reported excessive daytime sleepiness (P<0.05). Conclusions/Significance: Nocturia is independently associated with sleep-disordered breathing. After adjusting for SDB, there remained an association between nocturia and cardiovascular morbidity. Such results support screening for SDB in patients with nocturia, but the mechanisms underlying the relationship between nocturia and cardiovascular morbidity requires further study. MeSH terms: Nocturia, sleep-disordered breathing, obstructive sleep apnea, sleep apnea, polysomnography, hypertension.	[Parthasarathy, Sairam; Quan, Stuart F.] Univ Arizona, Dept Med, Tucson, AZ 85719 USA; [Parthasarathy, Sairam; Goodwin, James L.; Guerra, Stefano; Quan, Stuart F.] Univ Arizona, Arizona Resp Ctr, Tucson, AZ USA; [Fitzgerald, MaryPat] Hines Vet Affairs Hosp, Dept Surg, Hines, IL USA; [Unruh, Mark] Univ Pittsburgh, Dept Med, Renal Electrolyte Div, Pittsburgh, PA USA; [Guerra, Stefano] Consorcio Invest Biomed Epidemiol & Salud Publ CI, Ctr Res Environm Epidemiol, Inst Municipal Invest Med, Barcelona, Spain; [Quan, Stuart F.] Harvard Univ, Sch Med, Div Sleep Med, Boston, MA USA	University of Arizona; University of Arizona; US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Harvard University; Harvard Medical School	Parthasarathy, S (corresponding author), Univ Arizona, Dept Med, Tucson, AZ 85719 USA.	spartha@arc.arizona.edu	Parthasarathy, Sairam/L-1612-2013; Quan, Stuart/J-5026-2019	Quan, Stuart/0000-0002-9474-7679	National Institutes of Health (National Heart, Lung and Blood Institute [NHLBI]); University of Washington [U01HL53940]; Boston University [U01HL53941]; University of Arizona [U01HL53938]; University of California, Davis [U01HL53916]; University of Minnesota [U01HL53934]; New York University [U01HL53931]; Johns Hopkins University [U01HL53937, U01HL64360]; Case Western Reserve University [U01HL63463]; Missouri Breaks Research [U01HL63429]; National Heart, Lung and Blood Institute;  [1R01HL095748];  [5R01DK077785];  [DK075967-03]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL053940, U01HL053938, U01HL064360, U01HL053934, U01HL053916, U01HL053941, U01HL053937, U01HL053931, R01HL095748, U01HL063429, U01HL063463] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077785, K24DK075967] Funding Source: NIH RePORTER	National Institutes of Health (National Heart, Lung and Blood Institute [NHLBI])(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); University of Washington(University of Washington); Boston University; University of Arizona; University of California, Davis(University of California System); University of Minnesota(University of Minnesota System); New York University; Johns Hopkins University(Johns Hopkins University); Case Western Reserve University; Missouri Breaks Research; National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The study was funded by the National Institutes of Health (National Heart, Lung and Blood Institute [NHLBI]). The sponsor was involved in oversight of human subject safety through an independent Data Safety Monitoring Board (DSMB), and had non-voting representation in the steering committee that approved this manuscript submission. This work was supported by National Heart, Lung and Blood Institute cooperative agreements U01HL53940 (University of Washington), U01HL53941 (Boston University), U01HL53938 (University of Arizona), U01HL53916 (University of California, Davis), U01HL53934 (University of Minnesota), U01HL53931 (New York University), U01HL53937 and U01HL64360 (Johns Hopkins University), U01HL63463 (Case Western Reserve University), U01HL63429 (Missouri Breaks Research). Investigators were funded through the following grants during the data analysis and manuscript preparation 1R01HL095748 (S.P), 5R01DK077785 (M.U.), DK075967-03 (M.F). This is not an industry-funded study. SP, MF, JLG, MU, SG, and SFQ have no relevant financial interest in this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1989, AM J EPIDEMIOL, V129, P687; Asplund R, 1999, BJU INT, V84, P297; Ayas NT, 2003, ARCH INTERN MED, V163, P205, DOI 10.1001/archinte.163.2.205; Bing MH, 2008, BJU INT, V102, P808, DOI 10.1111/j.1464-410X.2008.07813.x; Bursztyn M, 2006, AM J CARDIOL, V98, P1311, DOI 10.1016/j.amjcard.2006.06.024; Chasens ER, 2002, DIABETES EDUCATOR, V28, P424, DOI 10.1177/014572170202800312; DAWBER TR, 1963, ANN NY ACAD SCI, V107, P539, DOI 10.1111/j.1749-6632.1963.tb13299.x; de Lemos JA, 2003, LANCET, V362, P316, DOI 10.1016/S0140-6736(03)13976-1; FitzGerald MP, 2007, J UROLOGY, V177, P1385, DOI 10.1016/j.juro.2006.11.057; FitzGerald MP, 2006, AM J OBSTET GYNECOL, V194, P1399, DOI 10.1016/j.ajog.2006.01.048; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Friedman O, 2010, HYPERTENSION, V56, P1077, DOI 10.1161/HYPERTENSIONAHA.110.154427; Gooneratne NS, 2011, SLEEP, V34, P435, DOI 10.1093/sleep/34.4.435; Guilleminault C, 2004, J PSYCHOSOM RES, V56, P511, DOI 10.1016/S0022-3999(04)00021-2; Hajduk IA, 2003, SLEEP, V26, P61; Hsieh CH, 2008, AUST NZ J OBSTET GYN, V48, P312, DOI 10.1111/j.1479-828X.2008.00870.x; Johnson TM, 2005, J AM GERIATR SOC, V53, P1011, DOI 10.1111/j.1532-5415.2005.53321.x; Kiely JL, 1999, EUR RESPIR J, V13, P1086, DOI 10.1034/j.1399-3003.1999.13e24.x; Kragelund C, 2005, NEW ENGL J MED, V352, P666, DOI 10.1056/NEJMoa042330; Kramer NR, 1998, CHEST, V114, P634, DOI 10.1378/chest.114.2.634; Kupelian V, 2009, J UROLOGY, V181, P694, DOI 10.1016/j.juro.2008.10.039; Kupelian V, 2011, J UROLOGY, V185, P571, DOI 10.1016/j.juro.2010.09.108; LEBOWITZ MD, 1975, AM J EPIDEMIOL, V102, P137, DOI 10.1093/oxfordjournals.aje.a112141; LEE ET, 1990, AM J EPIDEMIOL, V132, P1141, DOI 10.1093/oxfordjournals.aje.a115757; Leung RST, 2001, AM J RESP CRIT CARE, V164, P2147, DOI 10.1164/ajrccm.164.12.2107045; Margel D, 2006, UROLOGY, V67, P974, DOI 10.1016/j.urology.2005.11.054; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; Marshall NS, 2008, SLEEP, V31, P1079; Mullington JM, 2009, PROG CARDIOVASC DIS, V51, P294, DOI 10.1016/j.pcad.2008.10.003; Nieto FJ, 2000, JAMA-J AM MED ASSOC, V283, P1829, DOI 10.1001/jama.283.14.1829; O'Connor GT, 2009, AM J RESP CRIT CARE, V179, P1159, DOI 10.1164/rccm.200712-1809OC; Pressman MR, 1996, ARCH INTERN MED, V156, P545, DOI 10.1001/archinte.156.5.545; Punjabi NM, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000132; Quan SF, 1997, SLEEP, V20, P1077; Rechtschaffen A, 1968, NIH PUBLICATION, V204; Redline S, 1998, SLEEP, V21, P759; Romero E, 2009, SLEEP BREATH; STEWART RB, 1992, J AM GERIATR SOC, V40, P1217, DOI 10.1111/j.1532-5415.1992.tb03645.x; Van Kerrebroeck P, 2002, BJU INT, V90, P11, DOI 10.1046/j.1464-410X.90.s3.3.x; Vassalle C, 2007, CLIN CHEM, V53, P1886, DOI 10.1373/clinchem.2007.088302; Yoshimura K, 2004, INT J UROL, V11, P282, DOI 10.1111/j.1442-2042.2004.00791.x; Young T, 2008, SLEEP, V31, P1071; Zethelius B, 2008, NEW ENGL J MED, V358, P2107, DOI 10.1056/NEJMoa0707064	43	65	66	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2012	7	2							e30969	10.1371/journal.pone.0030969	http://dx.doi.org/10.1371/journal.pone.0030969			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LV	22328924	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000302179300010
J	Nummenmaa, L; Hirvonen, J; Hannukainen, JC; Immonen, H; Lindroos, MM; Salminen, P; Nuutila, P				Nummenmaa, Lauri; Hirvonen, Jussi; Hannukainen, Jarna C.; Immonen, Heidi; Lindroos, Markus M.; Salminen, Paulina; Nuutila, Pirjo			Dorsal Striatum and Its Limbic Connectivity Mediate Abnormal Anticipatory Reward Processing in Obesity	PLOS ONE			English	Article							VISUAL FOOD STIMULI; CEREBRAL-BLOOD-FLOW; NUCLEUS-ACCUMBENS; HIGH-CALORIE; HUMAN BRAIN; INDIVIDUAL-DIFFERENCES; APPETITIVE MOTIVATION; INTRAVENOUS GLUCOSE; ACTIVATION; ADDICTION	Obesity is characterized by an imbalance in the brain circuits promoting reward seeking and those governing cognitive control. Here we show that the dorsal caudate nucleus and its connections with amygdala, insula and prefrontal cortex contribute to abnormal reward processing in obesity. We measured regional brain glucose uptake in morbidly obese (n = 19) and normal weighted (n = 16) subjects with 2-[18F]fluoro-2-deoxyglucose ([F-18]FDG) positron emission tomography (PET) during euglycemic hyperinsulinemia and with functional magnetic resonance imaging (fMRI) while anticipatory food reward was induced by repeated presentations of appetizing and bland food pictures. First, we found that glucose uptake rate in the dorsal caudate nucleus was higher in obese than in normal-weight subjects. Second, obese subjects showed increased hemodynamic responses in the caudate nucleus while viewing appetizing versus bland foods in fMRI. The caudate also showed elevated task-related functional connectivity with amygdala and insula in the obese versus normal-weight subjects. Finally, obese subjects had smaller responses to appetizing versus bland foods in the dorsolateral and orbitofrontal cortices than did normal-weight subjects, and failure to activate the dorsolateral prefrontal cortex was correlated with high glucose metabolism in the dorsal caudate nucleus. These findings suggest that enhanced sensitivity to external food cues in obesity may involve abnormal stimulus-response learning and incentive motivation subserved by the dorsal caudate nucleus, which in turn may be due to abnormally high input from the amygdala and insula and dysfunctional inhibitory control by the frontal cortical regions. These functional changes in the responsiveness and interconnectivity of the reward circuit could be a critical mechanism to explain overeating in obesity.	[Nummenmaa, Lauri] Aalto Univ, Sch Sci, Olli Viktor Lounasmaa Lab, Brain Res Unit, Espoo, Finland; [Nummenmaa, Lauri] Aalto Univ, Sch Sci, Dept Biomed Engn & Computat Sci, Espoo, Finland; [Nummenmaa, Lauri; Hirvonen, Jussi; Hannukainen, Jarna C.; Immonen, Heidi; Lindroos, Markus M.; Nuutila, Pirjo] Turku Positron Emiss Tomog PET, Turku, Finland; [Immonen, Heidi; Nuutila, Pirjo] Univ Turku, Dept Med, Turku, Finland; [Salminen, Paulina] Univ Turku, Dept Surg, Turku, Finland	Aalto University; Aalto University; University of Turku; University of Turku	Nummenmaa, L (corresponding author), Aalto Univ, Sch Sci, Olli Viktor Lounasmaa Lab, Brain Res Unit, Espoo, Finland.	nummenmaa@neuro.hut.fi	Immonen, Heidi/AAX-8893-2020; Nummenmaa, Lauri/G-6910-2012; Salminen, Paulina Taru Pipsa (T.P.)/ABB-8883-2020; Nuutila, Pirjo/J-2087-2012; Hirvonen, Jussi/AAC-1864-2020; Hirvonen, Jussi/H-2521-2012	Nummenmaa, Lauri/0000-0002-2497-9757; Salminen, Paulina Taru Pipsa (T.P.)/0000-0001-6435-9264; Nuutila, Pirjo/0000-0001-9597-338X; Hannukainen, Jarna/0000-0002-8692-4049	Academy of Finland [256147, 251125]; Aalto University (AivoAALTO); Sigrid Juselius foundation; Turku University Hospital (EVO)	Academy of Finland(Academy of Finland); Aalto University (AivoAALTO); Sigrid Juselius foundation(Sigrid Juselius Foundation); Turku University Hospital (EVO)	This work was supported by the Academy of Finland (grants #256147 and #251125 http://www.aka.fi) to LN, by the Aalto University (AivoAALTO Grant, http://www.aalto.fi) Sigrid Juselius foundation (www.sigridjuselius.fi/foundation) Turku University Hospital (EVO grant http://www.tyks.fi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaro E, 2006, BRAIN COGNITION, V60, P220, DOI 10.1016/j.bandc.2005.11.009; Ambroggi F, 2008, NEURON, V59, P648, DOI 10.1016/j.neuron.2008.07.004; Baicy K, 2007, P NATL ACAD SCI USA, V104, P18276, DOI 10.1073/pnas.0706481104; Baldo BA, 2005, BEHAV NEUROSCI, V119, P1195, DOI 10.1037/0735-7044.119.5.1195; Balleine BW, 2007, J NEUROSCI, V27, P8161, DOI 10.1523/JNEUROSCI.1554-07.2007; Beaver JD, 2006, J NEUROSCI, V26, P5160, DOI 10.1523/JNEUROSCI.0350-06.2006; Berridge KC, 1996, NEUROSCI BIOBEHAV R, V20, P1, DOI 10.1016/0149-7634(95)00033-B; Berridge KC, 2010, BRAIN RES, V1350, P43, DOI 10.1016/j.brainres.2010.04.003; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Cornell CE, 1989, PHYSL BEHAV, V45; Cornier MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006310; Dagher A, 2009, INT J OBESITY, V33, pS30, DOI 10.1038/ijo.2009.69; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; Franken IHA, 2005, APPETITE, V45, P198, DOI 10.1016/j.appet.2005.04.004; Friedman DP, 2002, J COMP NEUROL, V450, P345, DOI 10.1002/cne.10336; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Gitelman DR, 2003, NEUROIMAGE, V19, P200, DOI 10.1016/S1053-8119(03)00058-2; Graham MM, 2002, J NUCL MED, V43, P1157; Green EA, 2009, TECH REP SER, V68, P791; Haltia LT, 2007, SYNAPSE, V61, P748, DOI 10.1002/syn.20418; Haltia LT, 2010, SCAND J CLIN LAB INV, V70, P275, DOI 10.3109/00365511003792975; HAMACHER K, 1986, J NUCL MED, V27, P235; Ikemoto S, 1999, BRAIN RES REV, V31, P6, DOI 10.1016/S0165-0173(99)00023-5; Kaisti KK, 2002, ANESTHESIOLOGY, V96, P1358, DOI 10.1097/00000542-200206000-00015; Kaisti KK, 2003, ANESTHESIOLOGY, V99, P603, DOI 10.1097/00000542-200309000-00015; Kelley AE, 2004, NEUROSCI BIOBEHAV R, V27, P765, DOI 10.1016/j.neubiorev.2003.11.015; Kelley AE, 2002, J NEUROSCI, V22, P3306; Killgore WDS, 2003, NEUROIMAGE, V19, P1381, DOI 10.1016/S1053-8119(03)00191-5; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; LaBar KS, 2001, BEHAV NEUROSCI, V115, P493, DOI 10.1037//0735-7044.115.2.493; Lemmens SG, PHYSL BEHAV IN PRESS; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Naqvi NH, 2009, TRENDS NEUROSCI, V32, P56, DOI 10.1016/j.tins.2008.09.009; Nathan PJ, 2009, INT J NEUROPSYCHOPH, V12, P995, DOI 10.1017/S146114570900039X; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; Passamonti L, 2009, J NEUROSCI, V29, P43, DOI 10.1523/JNEUROSCI.4966-08.2009; Passamonti L, 2008, NEUROIMAGE, V43, P562, DOI 10.1016/j.neuroimage.2008.07.045; Pelchat ML, 2004, NEUROIMAGE, V23, P1486, DOI 10.1016/j.neuroimage.2004.08.023; Rosenbaum M, 2008, J CLIN INVEST, V118, P2583, DOI 10.1172/JCI35055; Rothemund Y, 2007, NEUROIMAGE, V37, P410, DOI 10.1016/j.neuroimage.2007.05.008; RUSSCHEN FT, 1985, BRAIN RES, V329, P241, DOI 10.1016/0006-8993(85)90530-X; Small DM, 2001, BRAIN, V124, P1720, DOI 10.1093/brain/124.9.1720; Small DM, 2003, NEUROIMAGE, V19, P1709, DOI 10.1016/S1053-8119(03)00253-2; Sokoloff L, 1999, NEUROCHEM RES, V24, P321, DOI 10.1023/A:1022534709672; Stice E, 2008, J ABNORM PSYCHOL, V117, P924, DOI 10.1037/a0013600; Stoeckel LE, 2008, NEUROIMAGE, V41, P636, DOI 10.1016/j.neuroimage.2008.02.031; Stoeckel LE, 2009, BRAIN RES BULL, V79, P388, DOI 10.1016/j.brainresbull.2009.05.016; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Verdejo-Garcia A, 2009, NEUROPHARMACOLOGY, V56, P48, DOI 10.1016/j.neuropharm.2008.07.035; Volkow ND, 2004, MOL PSYCHIATR, V9, P557, DOI 10.1038/sj.mp.4001507; Volkow ND, 2005, NAT NEUROSCI, V8, P555, DOI 10.1038/nn1452; Volkow ND, 2002, SYNAPSE, V44, P175, DOI 10.1002/syn.10075; Volkow ND, 2008, PHILOS T R SOC B, V363, P3191, DOI 10.1098/rstb.2008.0107; Volkow ND, 2008, NEUROIMAGE, V42, P1537, DOI 10.1016/j.neuroimage.2008.06.002; Wang GJ, 2004, NEUROIMAGE, V21, P1790, DOI 10.1016/j.neuroimage.2003.11.026; Wang GJ, 2001, LANCET, V357, P354, DOI 10.1016/S0140-6736(00)03643-6; Will MJ, 2004, NEUROREPORT, V15, P1857, DOI 10.1097/00001756-200408260-00004	58	153	156	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e31089	10.1371/journal.pone.0031089	http://dx.doi.org/10.1371/journal.pone.0031089			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LO	22319604	Green Submitted, Green Published, gold			2022-12-27	WOS:000302178400027
J	Tourtas, T; Birke, MT; Kruse, FE; Welge-Lussen, UC; Birke, K				Tourtas, Theofilos; Birke, Marco T.; Kruse, Friedrich E.; Welge-Luessen, Ulrich-Christoph; Birke, Kerstin			Preventive Effects of Omega-3 and Omega-6 Fatty Acids on Peroxide Mediated Oxidative Stress Responses in Primary Human Trabecular Meshwork Cells	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; OUTFLOW PATHWAY; AQUEOUS-HUMOR; DISEASE; OMEGA-3-FATTY-ACIDS; SENESCENCE; PROTECTION; MARKERS; RETINA; HEALTH	Pathologic processes in glaucoma include increased apoptosis, accumulation of extracellular material in the trabecular meshwork and optic nerve, condensations of the cytoskeleton and precocious cellular senescence. Oxidative stress was shown to generate these alterations in primary ocular cells. Fatty acids omega-3 and -6 are alleged to constitute a prophylaxis against these deleterious effects. Here, we tested actual preventive effects omega-3 and -6 against peroxide induced stress responses in primary human trabecular meshwork cells. Changes of mitochondrial activity, proliferation, heat shock proteins, extracellular matrix components, and inflammatory markers were evaluated. Alterations of the cytoskeleton were evaluated by phalloidin labeling. Here we report a repressive effect of omega-6 on metabolic activity and proliferation, which was not detected for omega-3. Both agents were able to prevent the anti-proliferative effect of H2O2, but only omega-3 prevented metabolic repression. Expression of heat shock protein 27 was unaltered by both fatty acids, whereas heat shock protein 90 was significantly induced by both. Omega-6 increased fibronectin and connective tissue growth factor synthesis, as well as the amount of secreted fibronectin. Omega-3, instead, induced plasminogen activator inhibitor 1 synthesis. H2O2 further increased fibronectin production in omega-6 supplemented cells, which was not the case in omega-3 treated cells. H2O2 stimulation of plasminogen activator inhibitor 1 and connective tissue growth factor was repressed by both fatty acids. Both fatty acids appeared to abolish H2O2 mediated stimulation of nuclear factor kappa B and IL-6, but not IL-1 alpha and IL-8. H2O2 induced formation of cross-linked actin networks and stress fibers, which was reduced by preemptive application of omega-3. Omega-6, in contrast, had no protective effect on that, and even seemed to promote condensation. Based on the observed side effects of omega-6, omega-3 appears to be the more beneficial fatty acid in respect of prophylactic intake for prevention of a glaucomatous disease.	[Tourtas, Theofilos; Birke, Marco T.; Kruse, Friedrich E.; Welge-Luessen, Ulrich-Christoph; Birke, Kerstin] Univ Hosp Erlangen, Dept Ophthalmol, Erlangen, Germany	University of Erlangen Nuremberg	Tourtas, T (corresponding author), Univ Hosp Erlangen, Dept Ophthalmol, Erlangen, Germany.	kerstin.birke@uk-erlangen.de		Tourtas, Theofilos/0000-0002-3465-9837				Abu-Amero KK, 2006, INVEST OPHTH VIS SCI, V47, P2533, DOI 10.1167/iovs.05-1639; Bougnoux P, 2006, CANCER EPIDEM BIOMAR, V15, P416, DOI 10.1158/1055-9965.EPI-05-0546; Calder PC, 2001, LIPIDS, V36, P1007, DOI 10.1007/s11745-001-0812-7; Chilton FH, 2011, PHYSL BEHAV; Clark A F, 1995, J Glaucoma, V4, P183; Clark AF, 2005, CELL MOTIL CYTOSKEL, V60, P83, DOI 10.1002/cm.20049; CLARK AF, 1994, INVEST OPHTH VIS SCI, V35, P281; Den Ruijter HM, 2007, CARDIOVASC RES, V73, P316, DOI 10.1016/j.cardiores.2006.06.014; Dumont P, 2000, FREE RADICAL BIO MED, V28, P361, DOI 10.1016/S0891-5849(99)00249-X; Ebrahimi M, 2010, MOL VIS, V16, P1680; Ferreira SM, 2004, AM J OPHTHALMOL, V137, P62, DOI 10.1016/S0002-9394(03)00788-8; Filla MS, 2009, INVEST OPHTH VIS SCI, V50, P5723, DOI 10.1167/iovs.08-3215; Fuchshofer R, 2007, INVEST OPHTH VIS SCI, V48, P715, DOI 10.1167/iovs.06-0226; Gabelt BT, 2005, PROG RETIN EYE RES, V24, P612, DOI 10.1016/j.preteyeres.2004.10.003; Galimberti Daniela, 2011, Front Biosci (Schol Ed), V3, P252, DOI 10.2741/s149; Ghanem AA, 2010, CURR EYE RES, V35, P295, DOI 10.3109/02713680903548970; Hallahan B, 2005, BRIT J PSYCHIAT, V186, P275, DOI 10.1192/bjp.186.4.275; He Y, 2008, INVEST OPHTH VIS SCI, V49, P1447, DOI 10.1167/iovs.07-1361; He Y, 2009, MOL VIS, V15, P815; ISHIKAWA H, 1977, COMP BIOCHEM PHYS B, V58, P1, DOI 10.1016/0305-0491(77)90116-X; Izzotti A, 2006, MUTAT RES-REV MUTAT, V612, P105, DOI 10.1016/j.mrrev.2005.11.001; Izzotti A, 2003, AM J MED, V114, P638, DOI 10.1016/S0002-9343(03)00114-1; Joachim S, 2011, INVEST OPHTHALMOL VI; Kang JH, 2003, AM J EPIDEMIOL, V158, P337, DOI 10.1093/aje/kwg167; Lanneau D, 2010, THESCIENTIFICWORLDJO, V10, P1543, DOI 10.1100/tsw.2010.152; Li GR, 2007, MOL VIS, V13, P2282; Lin YZ, 2010, INVEST OPHTH VIS SCI, V51, P6483, DOI 10.1167/iovs.10-5410; Liton PB, 2009, EXP EYE RES, V88, P724, DOI 10.1016/j.exer.2008.11.002; Liton PB, 2005, EXP GERONTOL, V40, P745, DOI 10.1016/j.exger.2005.06.005; Lou YR, 2011, CARCINOGENESIS; Lutjen-Drecoll E, 2005, EXP EYE RES, V81, P1, DOI 10.1016/j.exer.2005.02.008; Pache M, 2006, SURV OPHTHALMOL, V51, P179, DOI 10.1016/j.survophthal.2006.02.008; Roman AS, 2006, AM J OBSTET GYNECOL, V195, P1693, DOI 10.1016/j.ajog.2006.04.009; Sacca SC, 2005, ARCH OPHTHALMOL-CHIC, V123, P458, DOI 10.1001/archopht.123.4.458; Sacca SC, 2007, EXP EYE RES, V84, P389, DOI 10.1016/j.exer.2006.10.008; SanGiovanni JP, 2005, PROG RETIN EYE RES, V24, P87, DOI 10.1016/j.preteyeres.2004.06.002; Simopoulos AP, 2011, MOL NEUROBIOL; Simopoulos AP, 2008, EXP BIOL MED, V233, P674, DOI 10.3181/0711-MR-311; Tanwar M, 2010, MOL VIS, V16, P518; Temple MD, 2005, TRENDS CELL BIOL, V15, P319, DOI 10.1016/j.tcb.2005.04.003; Terman A, 2006, ANTIOXID REDOX SIGN, V8, P197, DOI 10.1089/ars.2006.8.197; Tezel G, 2007, INVEST OPHTH VIS SCI, V48, P1201, DOI 10.1167/iovs.06-0737; Walgren JL, 2004, METABOLISM, V53, P165, DOI 10.1016/j.metabol.2003.09.008; Wall R, 2010, NUTR REV, V68, P280, DOI 10.1111/j.1753-4887.2010.00287.x; Welge-Lussen U, 2010, KLIN MONATSBL AUGENH, V227, P99, DOI 10.1055/s-0029-1245171; WILSON K, 1993, CURR EYE RES, V12, P783, DOI 10.3109/02713689309020383; Wordinger RJ, 1999, PROG RETIN EYE RES, V18, P629, DOI 10.1016/S1350-9462(98)00035-4; Yoshida Y, 2004, J BIOL CHEM, V279, P1768, DOI 10.1074/jbc.M311498200; Yu AL, 2008, INVEST OPHTH VIS SCI, V49, P4872, DOI 10.1167/iovs.07-0984; Zanon-Moreno V, 2009, EUR J OPHTHALMOL, V19, P565, DOI 10.1177/112067210901900408; Zhou LL, 1999, J CELL PHYSIOL, V180, P182, DOI 10.1002/(SICI)1097-4652(199908)180:2<182::AID-JCP6>3.0.CO;2-X	51	23	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e31340	10.1371/journal.pone.0031340	http://dx.doi.org/10.1371/journal.pone.0031340			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LO	22319624	gold, Green Published			2022-12-27	WOS:000302178400036
J	Wangpraseurt, D; Weber, M; Roy, H; Polerecky, L; de Beer, D; Suharsono; Nugues, MM				Wangpraseurt, Daniel; Weber, Miriam; Roy, Hans; Polerecky, Lubos; de Beer, Dirk; Suharsono; Nugues, Maggy M.			In Situ Oxygen Dynamics in Coral-Algal Interactions	PLOS ONE			English	Article							DIFFUSIVE BOUNDARY-LAYERS; CARIBBEAN CORAL; PHASE-SHIFTS; GORGONIAN CORALS; WATER VELOCITY; CLIMATE-CHANGE; SOFT CORALS; TURF ALGAE; BROWN ALGA; REEFS	Background: Coral reefs degrade globally at an alarming rate, with benthic algae often replacing corals. However, the extent to which benthic algae contribute to coral mortality, and the potential mechanisms involved, remain disputed. Recent laboratory studies suggested that algae kill corals by inducing hypoxia on the coral surface, through stimulated microbial respiration. Methods/Findings: We examined the main premise of this hypothesis by measuring in situ oxygen microenvironments at the contact interface between the massive coral Porites spp. and turf algae, and between Porites spp. and crustose coralline algae (CCA). Oxygen levels at the interface were similar to healthy coral tissue and ranged between 300-400 mu M during the day. At night, the interface was hypoxic (similar to 70 mu M) in coral-turf interactions and close to anoxic (similar to 2 mu M) in coral-CCA interactions, but these values were not significantly different from healthy tissue. The diffusive boundary layer (DBL) was about three times thicker at the interface than above healthy tissue, due to a depression in the local topography. A numerical model, developed to analyze the oxygen profiles above the irregular interface, revealed strongly reduced net photosynthesis and dark respiration rates at the coral-algal interface compared to unaffected tissue during the day and at night, respectively. Conclusions/Significance: Our results showed that hypoxia was not a consistent feature in the microenvironment of the coral-algal interface under in situ conditions. Therefore, hypoxia alone is unlikely to be the cause of coral mortality. Due to the modified topography, the interaction zone is distinguished by a thicker diffusive boundary layer, which limits the local metabolic activity and likely promotes accumulation of potentially harmful metabolic products (e.g., allelochemicals and protons). Our study highlights the importance of mass transfer phenomena and the need for direct in situ measurements of microenvironmental conditions in studies on coral stress.	[Wangpraseurt, Daniel; Nugues, Maggy M.] Leibniz Ctr Trop Marine Ecol, Dept Ecol, Coral Reef Ecol Grp CORE, Bremen, Germany; [Wangpraseurt, Daniel; Weber, Miriam; Polerecky, Lubos; de Beer, Dirk] Max Planck Inst Marine Microbiol, Bremen, Germany; [Roy, Hans] HYDRA Inst Marine Sci, Elba Field Stn, Campo Nellelba, Italy; [Roy, Hans] Aarhus Univ, Dept Biol Sci, Ctr Geomicrobiol, Aarhus, Denmark; [Suharsono] Indonesian Inst Sci, Res Ctr Oceanog, Jakarta, Indonesia	Leibniz Zentrum fur Marine Tropenforschung (ZMT); Max Planck Society; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze Marine (ISMAR-CNR); Aarhus University; Indonesian Institute of Sciences	Wangpraseurt, D (corresponding author), Univ Technol Sydney, Sch Environm, Sydney, NSW 2007, Australia.	daniel.wangpraseurt@student.uts.edu.au	Nugues, Maggy M/O-4314-2015; de Beer, Dirk/L-4840-2013; Polerecky, Lubos/E-1134-2014; Røy, Hans/G-3842-2010	Nugues, Maggy M/0000-0002-1399-9787; de Beer, Dirk/0000-0001-5274-1781; Polerecky, Lubos/0000-0003-4425-585X; Røy, Hans/0000-0002-6477-3091; Wangpraseurt, Daniel/0000-0003-4834-8981	Leibniz Center for Tropical Marine Ecology; Max Planck Institute for Marine Microbiology; German Academic Exchange Service (DAAD)	Leibniz Center for Tropical Marine Ecology; Max Planck Institute for Marine Microbiology; German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	This research was funded by the Leibniz Center for Tropical Marine Ecology and the Max Planck Institute for Marine Microbiology. Dr. Wangpraseurt was supported by a scholarship from the German Academic Exchange Service (DAAD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Horani FA, 2005, CORAL REEFS, V24, P173, DOI 10.1007/s00338-004-0461-3; ATKINSON MJ, 1992, LIMNOL OCEANOGR, V37, P273, DOI 10.4319/lo.1992.37.2.0273; Barott K, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0008043, 10.1371/journal.pone.0010950]; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; de Beer D, 2000, MAR ECOL PROG SER, V194, P75, DOI 10.3354/meps194075; de Voogd NJ, 2009, MAR ECOL PROG SER, V396, P169, DOI 10.3354/meps08349; DENYS R, 1991, MAR BIOL, V108, P315, DOI 10.1007/BF01344346; Diaz-Pulido G, 2011, ECOL LETT, V14, P156, DOI 10.1111/j.1461-0248.2010.01565.x; DONE TJ, 1992, HYDROBIOLOGIA, V247, P121, DOI 10.1007/BF00008211; GARCIA HE, 1992, LIMNOL OCEANOGR, V37, P1307, DOI 10.4319/lo.1992.37.6.1307; Gardella DJ, 1999, MAR BIOL, V135, P289, DOI 10.1007/s002270050626; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Heyward AJ, 1999, CORAL REEFS, V18, P273, DOI 10.1007/s003380050193; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; HUTCHINGS PA, 1986, CORAL REEFS, V4, P239, DOI 10.1007/BF00298083; Jensen PR, 1996, MAR BIOL, V125, P411, DOI 10.1007/BF00346321; Jompa J, 2003, MAR ECOL PROG SER, V258, P87, DOI 10.3354/meps258087; Jompa J, 2003, MAR ECOL PROG SER, V258, P79, DOI 10.3354/meps258079; Jompa J, 2002, LIMNOL OCEANOGR, V47, P527, DOI 10.4319/lo.2002.47.2.0527; JORGENSEN BB, 1990, LIMNOL OCEANOGR, V35, P1343, DOI 10.4319/lo.1990.35.6.1343; JORGENSEN BB, 1985, LIMNOL OCEANOGR, V30, P111, DOI 10.4319/lo.1985.30.1.0111; Kim K, 2000, MAR BIOL, V137, P393, DOI 10.1007/s002270000333; KUHL M, 1995, MAR ECOL PROG SER, V117, P159, DOI 10.3354/meps117159; LABARRE SC, 1986, MAR ECOL PROG SER, V28, P147, DOI 10.3354/meps028147; Larkum AWD, 2003, MAR BIOL, V142, P1073, DOI 10.1007/s00227-003-1022-y; Ledlie MH, 2007, CORAL REEFS, V26, P641, DOI 10.1007/s00338-007-0230-1; LI YH, 1974, GEOCHIM COSMOCHIM AC, V38, P703; Littler MM, 1997, CORAL REEFS, V16, P168; McCook LJ, 2001, CORAL REEFS, V19, P400, DOI 10.1007/s003380000129; Morrow KM, 2011, CORAL REEFS, V30, P309, DOI 10.1007/s00338-011-0747-1; Nugues MM, 2009, CORAL REEFS, V28, P507, DOI 10.1007/s00338-009-0468-x; Nugues MM, 2006, MAR ECOL PROG SER, V315, P75, DOI 10.3354/meps315075; Nugues MM, 2003, CORAL REEFS, V22, P507, DOI 10.1007/s00338-003-0338-x; Nugues MM, 2004, ECOL LETT, V7, P919, DOI 10.1111/j.1461-0248.2004.00651.x; Quan-Young LI, 2006, LIMNOL OCEANOGR, V51, P1159, DOI 10.4319/lo.2006.51.2.1159; Rasher DB, 2010, P NATL ACAD SCI USA, V107, P9683, DOI 10.1073/pnas.0912095107; Renema W, 2006, CORAL REEFS, V25, P351, DOI 10.1007/s00338-006-0119-4; REVSBECH NP, 1989, LIMNOL OCEANOGR, V34, P474, DOI 10.4319/lo.1989.34.2.0474; River GF, 2001, J EXP MAR BIOL ECOL, V261, P159, DOI 10.1016/S0022-0981(01)00266-0; Roy H, 2002, LIMNOL OCEANOGR, V47, P837, DOI 10.4319/lo.2002.47.3.0837; Sammarco P.W., 1983, Coral Reefs, V1, P173, DOI 10.1007/BF00571194; SHASHAR N, 1993, BIOL BULL, V185, P455, DOI 10.2307/1542485; SLATTERY M, 1995, J EXP MAR BIOL ECOL, V190, P61, DOI 10.1016/0022-0981(95)00032-M; Smith JE, 2006, ECOL LETT, V9, P835, DOI 10.1111/j.1461-0248.2006.00937.x; STENECK RS, 1994, OIKOS, V69, P476, DOI 10.2307/3545860; Thomas FIM, 1997, LIMNOL OCEANOGR, V42, P81, DOI 10.4319/lo.1997.42.1.0081; Titlyanov EA, 2007, J EXP MAR BIOL ECOL, V342, P282, DOI 10.1016/j.jembe.2006.11.007; Vermeij MJA, 2011, MAR ECOL PROG SER, V422, P1, DOI 10.3354/meps08964; Vermeij MJA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014312; Vu I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004514; Weber M, 2009, THESIS U BREMEN GERM; Weber M, 2007, ENVIRON SCI TECHNOL, V41, P6210, DOI 10.1021/es070200b; Wilsanand V, 1999, MICROBIOS, V99, P137	55	54	54	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2012	7	2							e31192	10.1371/journal.pone.0031192	http://dx.doi.org/10.1371/journal.pone.0031192			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UV	22319615	Green Published, gold, Green Submitted			2022-12-27	WOS:000301979000026
J	Rosenbaum, MA; Bar, HY; Beg, QK; Segre, D; Booth, J; Cotta, MA; Angenent, LT				Rosenbaum, Miriam A.; Bar, Haim Y.; Beg, Qasim K.; Segre, Daniel; Booth, James; Cotta, Michael A.; Angenent, Largus T.			Transcriptional Analysis of Shewanella oneidensis MR-1 with an Electrode Compared to Fe(III)Citrate or Oxygen as Terminal Electron Acceptor	PLOS ONE			English	Article							RHODOBACTER-SPHAEROIDES 2.4.1; TETRAHEME CYTOCHROME CYMA; MICROBIAL FUEL-CELLS; C-TYPE CYTOCHROMES; STRAIN MR-1; ANAEROBIC RESPIRATION; PUTREFACIENS MR-1; GEOBACTER-SULFURREDUCENS; MICROARRAY ANALYSIS; DIMETHYL-SULFOXIDE	Shewanella oneidensis is a target of extensive research in the fields of bioelectrochemical systems and bioremediation because of its versatile metabolic capabilities, especially with regard to respiration with extracellular electron acceptors. The physiological activity of S. oneidensis to respire at electrodes is of great interest, but the growth conditions in thin-layer biofilms make physiological analyses experimentally challenging. Here, we took a global approach to evaluate physiological activity with an electrode as terminal electron acceptor for the generation of electric current. We performed expression analysis with DNA microarrays to compare the overall gene expression with an electrode to that with soluble iron(III) or oxygen as the electron acceptor and applied new hierarchical model-based statistics for the differential expression analysis. We confirmed the differential expression of many genes that have previously been reported to be involved in electrode respiration, such as the entire mtr operon. We also formulate hypotheses on other possible gene involvements in electrode respiration, for example, a role of ScyA in inter-protein electron transfer and a regulatory role of the cbb3-type cytochrome c oxidase under anaerobic conditions. Further, we hypothesize that electrode respiration imposes a significant stress on S. oneidensis, resulting in higher energetic costs for electrode respiration than for soluble iron(III) respiration, which fosters a higher metabolic turnover to cover energy needs. Our hypotheses now require experimental verification, but this expression analysis provides a fundamental platform for further studies into the molecular mechanisms of S. oneidensis electron transfer and the physiologically special situation of growth on a poise-dpotential surface.	[Rosenbaum, Miriam A.; Angenent, Largus T.] Cornell Univ, Dept Biol & Environm Engn, Ithaca, NY USA; [Bar, Haim Y.; Booth, James] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY USA; [Beg, Qasim K.; Segre, Daniel] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Segre, Daniel] Boston Univ, Dept Biol, Boston, MA 02215 USA; [Segre, Daniel] Boston Univ, Bioinformat Program, Boston, MA 02215 USA; [Cotta, Michael A.] ARS, Bioenergy Res Unit, USDA, NCAUR, Peoria, IL USA	Cornell University; Cornell University; Boston University; Boston University; Boston University; United States Department of Agriculture (USDA)	Rosenbaum, MA (corresponding author), Rhein Westfal TH Aachen, Inst Appl Microbiol, Aachen, Germany.	la249@cornell.edu	Segrè, Daniel/A-1993-2009; Angenent, Largus T/A-6219-2018; Rosenbaum, Miriam A./E-5317-2011	Segrè, Daniel/0000-0003-4859-1914; Angenent, Largus T/0000-0003-0180-1865; Rosenbaum, Miriam A./0000-0002-4566-8624; Cotta, Michael/0000-0003-4565-7754	Fermentation Biotechnology Research Unit, USDA, Agricultural Research Service, Peoria, Illinois; National Science Foundation [0939882]; US Department of Energy [DE-FG02-07ER64388, DE-FG02-07ER64483]	Fermentation Biotechnology Research Unit, USDA, Agricultural Research Service, Peoria, Illinois(United States Department of Agriculture (USDA)USDA Agricultural Research Service); National Science Foundation(National Science Foundation (NSF)); US Department of Energy(United States Department of Energy (DOE))	The financial support for this work was provided through a specific collaborative agreement between Largus Angenent and the Fermentation Biotechnology Research Unit, USDA, Agricultural Research Service, Peoria, Illinois and the National Science Foundation through CAREER grant no. 0939882 to LTA, DS, and QKB are partially supported by US Department of Energy grants DE-FG02-07ER64388 and DE-FG02-07ER64483. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar H, 2010, STAT SCI, V25, P388, DOI 10.1214/10-STS339; Beliaev Alex S., 2002, OMICS A Journal of Integrative Biology, V6, P39, DOI 10.1089/15362310252780834; Beliaev AS, 2005, J BACTERIOL, V187, P7138, DOI 10.1128/JB.187.20.7138-7145.2005; Beliaev AS, 2002, J BACTERIOL, V184, P4612, DOI 10.1128/JB.184.16.4612-4616.2002; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bouhenni R, 2005, APPL ENVIRON MICROB, V71, P4935, DOI 10.1128/AEM.71.8.4935-4937.2005; Bretschger O, 2007, APPL ENVIRON MICROB, V73, P7003, DOI 10.1128/AEM.01087-07; Carpentier W, 2005, J BACTERIOL, V187, P3293, DOI 10.1128/JB.187.10.3293-3301.2005; Coursolle D, 2010, MOL MICROBIOL, V77, P995, DOI 10.1111/j.1365-2958.2010.07266.x; Coursolle D, 2010, J BACTERIOL, V192, P467, DOI 10.1128/JB.00925-09; Cury JA, 2007, ANAL BIOCHEM, V365, P208, DOI 10.1016/j.ab.2007.03.021; DiChristina TJ, 2002, J BACTERIOL, V184, P142, DOI 10.1128/JB.184.1.142-151.2002; Elias DA, 2007, J MICROBIOL METH, V68, P367, DOI 10.1016/j.mimet.2006.09.023; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Franks AE, 2009, ENERG ENVIRON SCI, V2, P113, DOI 10.1039/b816445b; Franks AE, 2010, ISME J, V4, P509, DOI 10.1038/ismej.2009.137; Gao HC, 2010, MICROB BIOTECHNOL, V3, P455, DOI 10.1111/j.1751-7915.2010.00181.x; Gao HC, 2009, ISME J, V3, P966, DOI 10.1038/ismej.2009.40; Gescher JS, 2008, MOL MICROBIOL, V68, P706, DOI 10.1111/j.1365-2958.2008.06183.x; Gorby YA, 2006, P NATL ACAD SCI USA, V103, P11358, DOI 10.1073/pnas.0604517103; Gralnick JA, 2006, P NATL ACAD SCI USA, V103, P4669, DOI 10.1073/pnas.0505959103; Harris HW, 2010, P NATL ACAD SCI USA, V107, P326, DOI 10.1073/pnas.0907468107; Hau HH, 2008, APPL ENVIRON MICROB, V74, P6880, DOI 10.1128/AEM.00840-08; Hau HH, 2007, ANNU REV MICROBIOL, V61, P237, DOI 10.1146/annurev.micro.61.080706.093257; Holmes DE, 2006, ENVIRON MICROBIOL, V8, P1805, DOI 10.1111/j.1462-2920.2006.01065.x; Ji HK, 2010, NAT BIOTECHNOL, V28, P337, DOI 10.1038/nbt.1619; Kaplan S, 2005, BIOCHEM SOC T, V33, P51, DOI 10.1042/BST0330051; Kim BC, 2008, BIOELECTROCHEMISTRY, V73, P70, DOI 10.1016/j.bioelechem.2008.04.023; Logan BE, 2006, ENVIRON SCI TECHNOL, V40, P5181, DOI 10.1021/es0605016; Lovley DR, 2008, CURR OPIN BIOTECH, V19, P564, DOI 10.1016/j.copbio.2008.10.005; Meyer TE, 2004, OMICS, V8, P57, DOI 10.1089/153623104773547499; Murphy JN, 2007, J BACTERIOL, V189, P2283, DOI 10.1128/JB.01698-06; Myers CR, 1997, J BACTERIOL, V179, P1143, DOI 10.1128/jb.179.4.1143-1152.1997; MYERS CR, 1988, SCIENCE, V240, P1319, DOI 10.1126/science.240.4857.1319; Myers JM, 2001, APPL ENVIRON MICROB, V67, P260, DOI 10.1128/AEM.67.1.260-269.2001; Myers JM, 2000, J BACTERIOL, V182, P67, DOI 10.1128/JB.182.1.67-75.2000; Nealson KH, 2002, ANTON LEEUW INT J G, V81, P215, DOI 10.1023/A:1020518818647; Oh JI, 1999, BIOCHEMISTRY-US, V38, P2688, DOI 10.1021/bi9825100; Pinchuk GE, 2009, P NATL ACAD SCI USA, V106, P2874, DOI 10.1073/pnas.0806798106; Pitts KE, 2003, J BIOL CHEM, V278, P27758, DOI 10.1074/jbc.M302582200; Qiu XY, 2006, J BACTERIOL, V188, P1199, DOI 10.1128/JB.188.3.1199-1204.2006; Ringeisen BR, 2010, ELECTROANAL, V22, P875, DOI 10.1002/elan.200880012; Rosenbaum M, 2010, BIOTECHNOL BIOENG, V105, P880, DOI 10.1002/bit.22621; Rosenbaum MA, 2011, BIORESOURCE TECHNOL, V102, P2623, DOI 10.1016/j.biortech.2010.10.033; Ross DE, 2007, APPL ENVIRON MICROB, V73, P5797, DOI 10.1128/AEM.00146-07; Ruebush SS, 2006, APPL ENVIRON MICROB, V72, P2925, DOI 10.1128/AEM.72.4.2925-2935.2006; Sani RK, 2008, WATER RES, V42, P2993, DOI 10.1016/j.watres.2008.04.003; Saville RM, 2010, FEMS MICROBIOL LETT, V308, P76, DOI 10.1111/j.1574-6968.2010.01995.x; Schwalb C, 2003, BIOCHEMISTRY-US, V42, P9491, DOI 10.1021/bi034456f; Schwalb C, 2002, BIOCHEM SOC T, V30, P658, DOI 10.1042/bst0300658; Shi L, 2007, MOL MICROBIOL, V65, P12, DOI 10.1111/j.1365-2958.2007.05783.x; Takeno N., 2005, ATLAS EH PH DIAGRAMS; Thormann KM, 2006, J BACTERIOL, V188, P2681, DOI 10.1128/JB.188.7.2681-2691.2006; Thormann KM, 2004, J BACTERIOL, V186, P8096, DOI 10.1128/JB.186.23.8096-8104.2004; Velasquez-Orta SB, 2010, APPL MICROBIOL BIOT, V85, P1373, DOI 10.1007/s00253-009-2172-8; Viamajala S, 2002, BIOTECHNOL BIOENG, V78, P770, DOI 10.1002/bit.10261; Watanabe K, 2009, CURR OPIN BIOTECH, V20, P633, DOI 10.1016/j.copbio.2009.09.006; Weber KA, 2006, NAT REV MICROBIOL, V4, P752, DOI 10.1038/nrmicro1490	58	42	45	9	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2012	7	2							e30827	10.1371/journal.pone.0030827	http://dx.doi.org/10.1371/journal.pone.0030827			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UG	22319591	Green Submitted, Green Published, gold			2022-12-27	WOS:000301977500020
J	Zhao, Y; Yu, H; Zhu, Y; Ter-Minassian, M; Peng, ZH; Shen, HB; Diao, N; Chen, F				Zhao, Yang; Yu, Hao; Zhu, Ying; Ter-Minassian, Monica; Peng, Zhihang; Shen, Hongbing; Diao, Nancy; Chen, Feng			Genetic Association Analysis Using Sibship Data: A Multilevel Model Approach	PLOS ONE			English	Article							GENERALIZED ESTIMATING EQUATIONS; GENOME-WIDE ASSOCIATION; LINKAGE DISEQUILIBRIUM; EFFICIENCY; DESIGN; TDT	Family based association study (FBAS) has the advantages of controlling for population stratification and testing for linkage and association simultaneously. We propose a retrospective multilevel model (rMLM) approach to analyze sibship data by using genotypic information as the dependent variable. Simulated data sets were generated using the simulation of linkage and association (SIMLA) program. We compared rMLM to sib transmission/disequilibrium test (S-TDT), sibling disequilibrium test (SDT), conditional logistic regression (CLR) and generalized estimation equations (GEE) on the measures of power, type I error, estimation bias and standard error. The results indicated that rMLM was a valid test of association in the presence of linkage using sibship data. The advantages of rMLM became more evident when the data contained concordant sibships. Compared to GEE, rMLM had less underestimated odds ratio (OR). Our results support the application of rMLM to detect gene-disease associations using sibship data. However, the risk of increasing type I error rate should be cautioned when there is association without linkage between the disease locus and the genotyped marker.	[Zhao, Yang; Yu, Hao; Peng, Zhihang; Shen, Hongbing; Chen, Feng] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China; [Zhao, Yang; Ter-Minassian, Monica; Diao, Nancy] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Environm & Occupat Med & Epidemiol Program, Boston, MA 02115 USA; [Zhu, Ying] Univ London Imperial Coll Sci Technol & Med, Imperial Coll Business Sch, London, England	Nanjing Medical University; Harvard University; Harvard T.H. Chan School of Public Health; Imperial College London	Zhao, Y (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China.	fengchen@njmu.edu.cn	zhao, yang/GXF-4424-2022	Chen, Feng/0000-0002-2699-7190; Ter-Minassian, Monica/0000-0002-9497-2585	National Natural Science Foundation of China (NSFC) [30571619]; NSFC [30901232]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); NSFC(National Natural Science Foundation of China (NSFC))	This study was funded by National Natural Science Foundation of China (NSFC) grant 30571619 and NSFC grant for young scientists 30901232. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bass M P, 2004, Pac Symp Biocomput, P93; Benyamin B, 2009, PHARMACOGENOMICS, V10, P181, DOI 10.2217/14622416.10.2.181; Bull SB, 2001, GENET EPIDEMIOL, V20, P149, DOI 10.1002/1098-2272(200102)20:2<149::AID-GEPI1>3.0.CO;2-A; Burton PR, 2003, GENET EPIDEMIOL, V24, P24, DOI 10.1002/gepi.10206; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; Devlin B, 2001, THEOR POPUL BIOL, V60, P155, DOI 10.1006/tpbi.2001.1542; GOLDSTEIN H, 1986, BIOMETRIKA, V73, P43; Goldstein H, 2002, STAT MED, V21, P3291, DOI 10.1002/sim.1264; Goldstein H, MULTILEVEL STAT MODE; Goldstein H, 2009, STAT MODEL, V9, P173, DOI 10.1177/1471082X0800900301; Hancock DB, 2007, GENET EPIDEMIOL, V31, P883, DOI 10.1002/gepi.20249; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Hinrichs Anthony L, 2009, BMC Proc, V3 Suppl 7, pS106; Hu FB, 1998, AM J EPIDEMIOL, V147, P694; Kraft P, 2000, AM J HUM GENET, V66, P1119, DOI 10.1086/302808; Laird NM, 2006, NAT REV GENET, V7, P385, DOI 10.1038/nrg1839; Liu Y-J, 2010, OBESITY SILVER SPRIN; McGinnis R, 2002, BEHAV GENET, V32, P135, DOI 10.1023/A:1015205924326; Miller RD, 2005, GENOMICS, V86, P117, DOI 10.1016/j.ygeno.2005.04.012; NEUHAUS JM, 1991, INT STAT REV, V59, P25, DOI 10.2307/1403572; Peng G, 2010, EUR J HUM GENET, V18, P111, DOI 10.1038/ejhg.2009.115; PRENTICE R, 1976, BIOMETRICS, V32, P599, DOI 10.2307/2529748; Price AL, 2010, NAT REV GENET, V11, P459, DOI 10.1038/nrg2813; Rasbash J, 2009, MLWIN 2 1; Siegmund KD, 2000, AM J HUM GENET, V67, P244, DOI 10.1086/302973; Spielman RS, 1996, AM J HUM GENET, V59, P983; Spielman RS, 1998, AM J HUM GENET, V62, P450, DOI 10.1086/301714; Yang SH, 2010, NEW ENGL J MED, V362, P2425; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734; Zou GY, 2006, ANN HUM GENET, V70, P262, DOI 10.1111/j.1529-8817.2005.00213.x	30	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2012	7	2							e31134	10.1371/journal.pone.0031134	http://dx.doi.org/10.1371/journal.pone.0031134			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UG	22312441	Green Published, Green Submitted, gold			2022-12-27	WOS:000301977500029
J	Mazeiras, G; Roze, JC; Ancel, PY; Caillaux, G; Frondas-Chauty, A; Denizot, S; Flamant, C				Mazeiras, Gael; Roze, Jean-Christophe; Ancel, Pierre-Yves; Caillaux, Gaelle; Frondas-Chauty, Anne; Denizot, Sophie; Flamant, Cyril			Hyperbilirubinemia and Neurodevelopmental Outcome of Very Low Birthweight Infants: Results from the LIFT Cohort	PLOS ONE			English	Article							SERUM BILIRUBIN; FOLLOW-UP; PHOTOTHERAPY; KERNICTERUS; QUESTIONNAIRE; ASSOCIATION; JAUNDICE; CHILDREN; RISK; AGES	Background: Bilirubin-related neurotoxicity is an important clinical issue in very low birthweight (VLBW) infants, and the existing literature is inconsistent. Objective: To analyze the relationship between maximal serum unconjugated bilirubin levels (SBL) and neurodevelopmental outcome at 2-year corrected age in VLBW infants. Methods: Phototherapy was initiated in all infants born before 33 weeks of gestation, according to Maisels' recommendations. Neurodevelopmental assessment at 2-year corrected age was performed in all infants that survived. SBLs collected during the first week of life were used to define three tertiles of max-SBL. The first tertile corresponded to infants with the lowest max-SBL. Results and Conclusions: A total of 724 infants were included in the study, and among them, 631 (87%) were evaluated at two years old. The infants of the first tertile were younger and smaller than the infants of the other two tertiles, in accordance with Maisels' recommendations for very small infants. No difference in the risk of impaired functional outcome among the three groups was observed. However, among infants weighing less than 1001 g, those in the third tertile had a poorer neurodevelopmental prognosis as compared to those in the second tertile (adjusted odds ratio = 6.8, 95% CI: 1.2-36.7, p = 0.03). Considering the results obtained, we propose 196 mu mol/L (11.5 mg/dL) when birthweight varies between 1001 and 1500 g, and 170 mu mol/L (9.9 mg/dL) when birthweight is less than 1001 g, as recommended max-SBLs (defined as maximal levels of 95th percentile curves of SBLs in infants with an optimal outcome). When Maisels' recommendations were applied, max SBLs were higher in 8% of infants weighing 1001-1500 g and in 15% of infants weighing less than 1001 g. Our data seems to validate Maisels' recommendations in the overall population of infants born before 33 weeks of gestation, but not in infants weighing less than 1001 g.	[Mazeiras, Gael] St Leon Hosp, Dept Neonatal Med, Bayonne, France; [Roze, Jean-Christophe; Caillaux, Gaelle; Frondas-Chauty, Anne; Denizot, Sophie; Flamant, Cyril] Nantes Univ Hosp, Dept Neonatal Med, Nantes, France; [Roze, Jean-Christophe; Caillaux, Gaelle; Frondas-Chauty, Anne; Denizot, Sophie; Flamant, Cyril] Nantes Univ Hosp, Natl Inst Hlth & Med Res CIC004, Nantes, France; [Roze, Jean-Christophe; Caillaux, Gaelle; Frondas-Chauty, Anne; Denizot, Sophie; Flamant, Cyril] LIFT, Pays De Loire, France; [Ancel, Pierre-Yves] Tenon Univ Hosp, Natl Inst Hlth, Paris, France; [Ancel, Pierre-Yves] Tenon Univ Hosp, Med Res Mixed Res Unit S149, Fed Inst Res 69, Epidemiol Res Unit Perinatal & Womens Hlth, Paris, France; [Ancel, Pierre-Yves] Univ Paris 06, Paris, France	Nantes Universite; CHU de Nantes; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Mazeiras, G (corresponding author), St Leon Hosp, Dept Neonatal Med, Bayonne, France.	cyril.flamant@chu-nantes.fr	roze, jean christophe/B-5433-2012; Rozé, Jean-Christophe/AAS-1314-2021	ANCEL, pierre-yves/0000-0001-9632-7494; Roze, Jean-Christophe/0000-0003-3367-512X				Bratlid D, 2001, J Perinatol, V21 Suppl 1, pS88, DOI 10.1038/sj.jp.7210656; Cashore WJ, 2000, CLIN PERINATOL, V27, P171, DOI 10.1016/S0095-5108(05)70012-9; COCKINGTON RA, 1979, J PEDIATR-US, V95, P281; Fily A, 2006, PEDIATRICS, V117, P357, DOI 10.1542/peds.2005-0236; Flamant C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020004; GARTNER LM, 1970, PEDIATRICS, V45, P906; GOPINATHAN V, 1994, FEBS LETT, V349, P197, DOI 10.1016/0014-5793(94)00666-0; Hack M, 2000, ARCH PEDIAT ADOL MED, V154, P725, DOI 10.1001/archpedi.154.7.725; Josse D, 1997, REVISED BRUNETLEZINE; Klamer A, 2005, ACTA PAEDIATR, V94, P1327, DOI 10.1080/08035250510042825; Maisels MJ, 2004, PEDIATRICS, V114, P297; McCoy L, 1999, ARCH DIS CHILD-FETAL, V80, pF38; Moll M, 2011, NEONATOLOGY, V99, P90, DOI 10.1159/000302719; Morris BH, 2008, NEW ENGL J MED, V359, P1885, DOI 10.1056/NEJMoa0803024; Newman TB, 2000, PEDIATRICS, V105, P242; Oh W, 2003, PEDIATRICS, V112, P773, DOI 10.1542/peds.112.4.773; Oh W, 2010, ACTA PAEDIATR, V99, P673, DOI 10.1111/j.1651-2227.2010.01688.x; OSHEA TM, 1992, PEDIATRICS, V90, P888; Roze JC, 2007, ARCH PEDIATRIE, V14, pS65, DOI 10.1016/S0929-693X(07)80014-5; Skellern CY, 2001, J PAEDIATR CHILD H, V37, P125, DOI 10.1046/j.1440-1754.2001.00604.x; Squires J, 1997, J PEDIATR PSYCHOL, V22, P313, DOI 10.1093/jpepsy/22.3.313; TOZZI E, 1989, BIOL NEONATE, V56, P204; VANDEBOR M, 1989, PEDIATRICS, V83, P915; Vreman HJ, 2004, SEMIN PERINATOL, V28, P326, DOI 10.1053/j.semperi.2004.09.003	24	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e30900	10.1371/journal.pone.0030900	http://dx.doi.org/10.1371/journal.pone.0030900			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22303470	gold, Green Published, Green Submitted			2022-12-27	WOS:000301704200046
J	Ricci, M; Xu, YJ; Hammond, HL; Willoughby, DA; Nathanson, L; Rodriguez, MM; Vatta, M; Lipshultz, SE; Lincoln, J				Ricci, Marco; Xu, Yanji; Hammond, Harriet L.; Willoughby, David A.; Nathanson, Lubov; Rodriguez, Maria M.; Vatta, Matteo; Lipshultz, Steven E.; Lincoln, Joy			Myocardial Alternative RNA Splicing and Gene Expression Profiling in Early Stage Hypoplastic Left Heart Syndrome	PLOS ONE			English	Article							FAILURE; VENTRICLE; SETS	Hypoplastic Left Heart Syndrome (HLHS) is a congenital defect characterized by underdevelopment of the left ventricle and pathological compensation of the right ventricle. If untreated, HLHS is invariably lethal due to the extensive increase in right ventricular workload and eventual failure. Despite the clinical significance, little is known about the molecular pathobiological state of HLHS. Splicing of mRNA transcripts is an important regulatory mechanism of gene expression. Tissue specific alterations of this process have been associated with several cardiac diseases, however, transcriptional signature profiles related to HLHS are unknown. In this study, we performed genome-wide exon array analysis to determine differentially expressed genes and alternatively spliced transcripts in the right ventricle (RV) of six neonates with HLHS, compared to the RV and left ventricle (LV) from non-diseased control subjects. In HLHS, over 180 genes were differentially expressed and 1800 were differentially spliced, leading to changes in a variety of biological processes involving cell metabolism, cytoskeleton, and cell adherence. Additional hierarchical clustering analysis revealed that differential gene expression and mRNA splicing patterns identified in HLHS are unique compared to non-diseased tissue. Our findings suggest that gene expression and mRNA splicing are broadly dysregulated in the RV myocardium of HLHS neonates. In addition, our analysis identified transcriptome profiles representative of molecular biomarkers of HLHS that could be used in the future for diagnostic and prognostic stratification to improve patient outcome.	[Ricci, Marco] Univ Miami, Miller Sch Med, Div Cardiothorac Surg, Miami, FL 33136 USA; [Ricci, Marco; Rodriguez, Maria M.; Lipshultz, Steven E.] Jackson Mem Hosp, Holtz Childrens Hosp, Miami, FL 33136 USA; [Xu, Yanji] Shaun & Lilly Int LLC, Palm City, FL USA; [Hammond, Harriet L.; Lincoln, Joy] Ohio State Univ, Dept Pediat, Nationwide Childrens Hosp, Ctr Cardiovasc & Pulm Res, Columbus, OH 43210 USA; [Willoughby, David A.] Ocean Ridge Biosci LLC, Palm Beach Gardens, FL USA; [Nathanson, Lubov] Univ Miami, Miller Sch Med, Inst Human Genom, Miami, FL 33136 USA; [Rodriguez, Maria M.] Univ Miami, Miller Sch Med, Dept Pathol, Miami, FL 33136 USA; [Vatta, Matteo] Texas Childrens Hosp, Baylor Coll Med, Div Pediat Cardiol, Houston, TX 77030 USA; [Vatta, Matteo] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Lipshultz, Steven E.] Univ Miami, Miller Sch Med, Dept Pediat, Miami, FL 33136 USA	University of Miami; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University of Miami; University of Miami; Baylor College of Medicine; Baylor College of Medicine; University of Miami	Ricci, M (corresponding author), Univ Miami, Miller Sch Med, Div Cardiothorac Surg, Miami, FL 33136 USA.	mricci@med.miami.edu	HCFMUSP, Pós-Graduação DOG -/F-1162-2013; Nathanson, Lubov/ABC-2642-2021	Nathanson, Lubov/0000-0003-1038-9083; Lincoln, Joy/0000-0003-1517-6888	private University of Miami; National Heart, Lung, and Blood Institute [R01HL091878]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091878] Funding Source: NIH RePORTER	private University of Miami; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Study supported by private University of Miami research Fund (Jonathan and Eileen Otto Research Fund) and National Heart, Lung, and Blood Institute R01HL091878 (JL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann K, 2000, AM J CARDIOL, V86, P964, DOI 10.1016/S0002-9149(00)01131-0; Angelucci F, 2010, ADDICT BIOL, V15, P365, DOI 10.1111/j.1369-1600.2010.00221.x; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bittel DC, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-1; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Bracco L, 2006, PROG MOLEC, V44, P1; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Doenst T, 2010, CARDIOVASC RES, V86, P461, DOI 10.1093/cvr/cvp414; Einstein R, 2008, P NATL ACAD SCI USA, V105, P5230, DOI 10.1073/pnas.0801319105; Farina G, 2010, ARTHRITIS RHEUM-US, V62, P580, DOI 10.1002/art.27220; Gardina PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-325; Georges R, 2008, MOL CELL BIOL, V28, P4052, DOI 10.1128/MCB.02100-07; Heidecker B, 2011, CIRCULATION, V123, P1174, DOI 10.1161/CIRCULATIONAHA.110.002857; Hinton RB, 2009, J AM COLL CARDIOL, V53, P1065, DOI 10.1016/j.jacc.2008.12.023; Hinton RB, 2007, J AM COLL CARDIOL, V50, P1590, DOI 10.1016/j.jacc.2007.07.021; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Kong SW, 2010, CIRC-CARDIOVASC GENE, V3, P138, DOI 10.1161/CIRCGENETICS.109.904698; Langer W, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-676; Margulies KB, 2009, J AM COLL CARDIOL, V53, P1752, DOI 10.1016/j.jacc.2008.12.064; Pavan M, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-113; Pizarro C, 2003, CIRCULATION, V108, P155, DOI 10.1161/01.cir.0000087390.94142.1d; Purdom E, 2008, BIOINFORMATICS, V24, P1707, DOI 10.1093/bioinformatics/btn284; Ricci M, 2006, J THORAC CARDIOV SUR, V132, P252, DOI 10.1016/j.jtcvs.2006.03.050; Ricci M, 2010, J CARD FAIL, V16, P628, DOI 10.1016/j.cardfail.2010.03.007; Rosca MG, 2008, CARDIOVASC RES, V80, P30, DOI 10.1093/cvr/cvn184; Tazi J, 2009, BBA-MOL BASIS DIS, V1792, P14, DOI 10.1016/j.bbadis.2008.09.017; Xing Y, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000088; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475	28	22	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e29784	10.1371/journal.pone.0029784	http://dx.doi.org/10.1371/journal.pone.0029784			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22299024	Green Submitted, Green Published, gold			2022-12-27	WOS:000301704200001
J	Zhang, Y; Morimoto, K; Danilova, N; Zhang, B; Lin, S				Zhang, Ying; Morimoto, Kenji; Danilova, Nadia; Zhang, Bo; Lin, Shuo			Zebrafish Models for Dyskeratosis Congenita Reveal Critical Roles of p53 Activation Contributing to Hematopoietic Defects through RNA Processing	PLOS ONE			English	Article							TELOMERASE COMPONENT; GENE; MUTATIONS; PROTEIN; STRESS; CANCER; LENGTH; RIBONUCLEOPROTEINS; EXPRESSION; SNORNPS	Dyskeratosis congenita (DC) is a rare bone marrow failure syndrome in which hematopoietic defects are the main cause of mortality. The most studied gene responsible for DC pathogenesis is DKC1 while mutations in several other genes encoding components of the H/ACA RNP telomerase complex, which is involved in ribosomal RNA(rRNA) processing and telomere maintenance, have also been implicated. GAR1/nola1 is one of the four core proteins of the H/ACA RNP complex. Through comparative analysis of morpholino oligonucleotide induced knockdown of dkc1 and a retrovirus insertion induced mutation of GAR1/nola1 in zebrafish, we demonstrate that hematopoietic defects are specifically recapitulated in these models and that these defects are significantly reduced in a p53 null mutant background. We further show that changes in telomerase activity are undetectable at the early stages of DC pathogenesis but rRNA processing is clearly defective. Our data therefore support a model that deficiency in dkc1 and nola1 in the H/ACA RNP complex likely contributes to the hematopoietic phenotype through p53 activation associated with rRNA processing defects rather than telomerase deficiency during the initial stage of DC pathogenesis.	[Zhang, Ying; Lin, Shuo] Peking Univ, Lab Chem Genom, Shenzhen Grad Sch, Shenzhen, Peoples R China; [Zhang, Ying; Zhang, Bo] Peking Univ, Key Lab Cell Proliferat & Differentiat, Minist Educ, Ctr Dev Biol & Genet,Coll Life Sci, Beijing 100871, Peoples R China; [Zhang, Ying; Morimoto, Kenji; Danilova, Nadia; Lin, Shuo] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA USA	Peking University; University Town of Shenzhen; Peking University; University of California System; University of California Los Angeles	Zhang, Y (corresponding author), Peking Univ, Lab Chem Genom, Shenzhen Grad Sch, Shenzhen, Peoples R China.	shuolin@ucla.edu	Zhang, Bo/K-7162-2012		National Institutes of Health [DK54508, HL097561]; 973 program [2012CB945101]; NSFC [30730056]; China Scholarship Council, Ministry of Education; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054508, Z01DK054508] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 973 program(National Basic Research Program of China); NSFC(National Natural Science Foundation of China (NSFC)); China Scholarship Council, Ministry of Education(China Scholarship Council); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by research grants from the National Institutes of Health to Dr. Lin (DK54508 and HL097561) and by research grants from 973 program (2012CB945101) and NSFC (30730056) to Dr. Bo Zhang. Ying Zhang was supported in part by China Scholarship Council, Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alawi F, 2011, MOL CARCINOGEN, V50, P334, DOI 10.1002/mc.20715; Alter BP, 2009, BLOOD, V113, P6549, DOI 10.1182/blood-2008-12-192880; Armanios MY, 2007, NEW ENGL J MED, V356, P1317, DOI 10.1056/NEJMoa066157; Azuma M, 2006, J BIOL CHEM, V281, P13309, DOI 10.1074/jbc.M601892200; Berghmans S, 2005, P NATL ACAD SCI USA, V102, P407, DOI 10.1073/pnas.0406252102; BousquetAntonelli C, 1997, EMBO J, V16, P4770, DOI 10.1093/emboj/16.15.4770; Danilova N, 2011, BRIT J HAEMATOL, V152, P217, DOI 10.1111/j.1365-2141.2010.08396.x; Danilova N, 2008, BLOOD, V112, P5228, DOI 10.1182/blood-2008-01-132290; Dei Cas A, 2011, NUTR METAB CARDIOVAS; Ge JP, 2010, MOL CELL BIOL, V30, P413, DOI 10.1128/MCB.01128-09; Giordano E, 1999, J CELL BIOL, V144, P1123, DOI 10.1083/jcb.144.6.1123; GIRARD JP, 1992, EMBO J, V11, P673, DOI 10.1002/j.1460-2075.1992.tb05099.x; Heiss NS, 1998, NAT GENET, V19, P32, DOI 10.1038/ng0598-32; Henras A, 1998, EMBO J, V17, P7078, DOI 10.1093/emboj/17.23.7078; Imamura S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003364; Kirwan M, 2009, BBA-MOL BASIS DIS, V1792, P371, DOI 10.1016/j.bbadis.2009.01.010; Kishi S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000152; Kiss T, 2010, MOL CELL, V37, P597, DOI 10.1016/j.molcel.2010.01.032; Lafontaine DLJ, 1998, TRENDS BIOCHEM SCI, V23, P383, DOI 10.1016/S0968-0004(98)01260-2; Langheinrich U, 2002, CURR BIOL, V12, P2023, DOI 10.1016/S0960-9822(02)01319-2; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meier UT, 2005, CHROMOSOMA, V114, P1, DOI 10.1007/s00412-005-0333-9; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; Nelson ND, 2011, MUTAT RES; Nelson ND, 2011, MUTAT RES EPUB; Pereboom TC, 2011, BLOOD; Ruggero D, 2003, SCIENCE, V299, P259, DOI 10.1126/science.1079447; Salpea KD, 2010, ATHEROSCLEROSIS, V209, P42, DOI 10.1016/j.atherosclerosis.2009.09.070; Savage SA, 2008, AM J HUM GENET, V82, P501, DOI 10.1016/j.ajhg.2007.10.004; Simon NM, 2006, BIOL PSYCHIAT, V60, P432, DOI 10.1016/j.biopsych.2006.02.004; THISSE C, 1993, DEVELOPMENT, V119, P1203; Tsai SB, 2007, AGING CELL, V6, P209, DOI 10.1111/j.1474-9726.2007.00278.x; Venteicher AS, 2009, CELL CYCLE, V8, P1329, DOI 10.4161/cc.8.9.8288; Vulliamy T, 2008, P NATL ACAD SCI USA, V105, P8073, DOI 10.1073/pnas.0800042105; Vulliamy TJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024383; Walne AJ, 2010, HUM MOL GENET, V19, P4453, DOI 10.1093/hmg/ddq371; Wang DW, 2007, P NATL ACAD SCI USA, V104, P12428, DOI 10.1073/pnas.0705502104; Willeit P, 2010, JAMA-J AM MED ASSOC, V304, P69, DOI 10.1001/jama.2010.897; Zhong F, 2011, GENE DEV, V25, P11, DOI 10.1101/gad.2006411	39	32	33	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e30188	10.1371/journal.pone.0030188	http://dx.doi.org/10.1371/journal.pone.0030188			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22299032	Green Submitted, Green Published, gold			2022-12-27	WOS:000301704200009
J	Bieghs, V; Van Gorp, PJ; Wouters, K; Hendrikx, T; Gijbels, MJ; van Bilsen, M; Bakker, J; Binder, CJ; Lutjohann, D; Staels, B; Hofker, MH; Shiri-Sverdlov, R				Bieghs, Veerle; Van Gorp, Patrick J.; Wouters, Kristiaan; Hendrikx, Tim; Gijbels, Marion J.; van Bilsen, Marc; Bakker, Jaap; Binder, Christoph J.; Luetjohann, Dieter; Staels, Bart; Hofker, Marten H.; Shiri-Sverdlov, Ronit			LDL Receptor Knock-Out Mice Are a Physiological Model Particularly Vulnerable to Study the Onset of Inflammation in Non-Alcoholic Fatty Liver Disease	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; APOLIPOPROTEIN-E; SCAVENGER RECEPTOR; HEPATIC STEATOSIS; DEFICIENT MICE; ANIMAL-MODELS; MOUSE MODELS; IN-VIVO; STEATOHEPATITIS; ATHEROSCLEROSIS	Background & Aims: Non-alcoholic steatohepatitis (NASH) involves steatosis combined with inflammation, which can progress into fibrosis and cirrhosis. Exploring the molecular mechanisms of NASH is highly dependent on the availability of animal models. Currently, the most commonly used animal models for NASH imitate particularly late stages of human disease. Thus, there is a need for an animal model that can be used for investigating the factors that potentiate the inflammatory response within NASH. We have previously shown that 7-day high-fat-high-cholesterol (HFC) feeding induces steatosis and inflammation in both APOE2ki and Ldlr(-/-) mice. However, it is not known whether the early inflammatory response observed in these mice will sustain over time and lead to liver damage. We hypothesized that the inflammatory response in both models is sufficient to induce liver damage over time. Methods: APOE2ki and Ldlr(-/-) mice were fed a chow or HFC diet for 3 months. C57Bl6/J mice were used as control. Results: Surprisingly, hepatic inflammation was abolished in APOE2ki mice, while it was sustained in Ldlr(-/-) mice. In addition, increased apoptosis and hepatic fibrosis was only demonstrated in Ldlr(-/-) mice. Finally, bone-marrow-derived-macrophages of Ldlr(-/-) mice showed an increased inflammatory response after oxidized LDL (oxLDL) loading compared to APOE2ki mice. Conclusion: Ldlr(-/-) mice, but not APOE2ki mice, developed sustained hepatic inflammation and liver damage upon long term HFC feeding due to increased sensitivity for oxLDL uptake. Therefore, the Ldlr(-/-) mice are a promising physiological model particularly vulnerable for investigating the onset of hepatic inflammation in non-alcoholic steatohepatitis.	[Bieghs, Veerle; Van Gorp, Patrick J.; Hendrikx, Tim; Gijbels, Marion J.; van Bilsen, Marc; Bakker, Jaap; Shiri-Sverdlov, Ronit] Univ Maastricht, Dept Mol Genet Pathol Physiol & Clin Genet Nutr &, Maastricht, Netherlands; [Bieghs, Veerle; Van Gorp, Patrick J.; Hendrikx, Tim; Gijbels, Marion J.; van Bilsen, Marc; Bakker, Jaap; Shiri-Sverdlov, Ronit] Univ Maastricht, Cardiovasc Res CARIM Inst Maastricht, Maastricht, Netherlands; [Wouters, Kristiaan; Staels, Bart] Univ Lille Nord France, Lille, France; [Wouters, Kristiaan; Staels, Bart] INSERM, U1011, F-59045 Lille, France; [Wouters, Kristiaan; Staels, Bart] UDSL, Lille, France; [Wouters, Kristiaan; Staels, Bart] Inst Pasteur, F-59019 Lille, France; [Binder, Christoph J.] Austrian Acad Sci, Ctr Mol Med, A-1010 Vienna, Austria; [Binder, Christoph J.] Med Univ Vienna, Dept Lab Med, Vienna, Austria; [Luetjohann, Dieter] Univ Bonn, Inst Clin Chem & Clin Pharmacol, Bonn, Germany; [Hofker, Marten H.] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Lab Med, Groningen, Netherlands	Maastricht University; Maastricht University; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Austrian Academy of Sciences; Medical University of Vienna; University of Bonn; University of Groningen	Bieghs, V (corresponding author), Univ Maastricht, Dept Mol Genet Pathol Physiol & Clin Genet Nutr &, Maastricht, Netherlands.	r.sverdlov@maastrichtuniversity.nl	van Gorp, Patrick/S-3892-2019; Staels, Bart/N-9497-2016; Hendrikx, Tim/AAI-8252-2021; Shiri-Sverdlov, Ronit/E-5571-2017; Wouters, Kristiaan/A-8536-2013; van Bilsen, Marc/E-8342-2016; Hendrikx, Tim/AAE-2329-2020; Shiri-Sverdlov, Ronit/X-2642-2019; van Gorp, Patrick/L-9580-2018; Bakker, J. A./H-7910-2019	van Gorp, Patrick/0000-0002-0355-5349; Staels, Bart/0000-0002-3784-1503; Hendrikx, Tim/0000-0002-3381-2107; Shiri-Sverdlov, Ronit/0000-0002-6736-7814; Wouters, Kristiaan/0000-0001-7127-6950; Shiri-Sverdlov, Ronit/0000-0002-6736-7814; van Gorp, Patrick/0000-0002-0355-5349; Bakker, Jaap A./0000-0002-2918-7361; Binder, Christoph J./0000-0001-8313-7050	Veni [916.76.070 (2006/00496/MW)]; Maag Lever Darm Stichting (MLDS) [WO 08-16 + WO 10-65]; Dutch Heart Foundation (NHS) [2002B18]	Veni(Netherlands Organization for Scientific Research (NWO)); Maag Lever Darm Stichting (MLDS); Dutch Heart Foundation (NHS)(Netherlands Heart Foundation)	The work was supported by the following: Veni: 916.76.070 (2006/00496/MW); Maag Lever Darm Stichting (MLDS) (WO 08-16 + WO 10-65); Dutch Heart Foundation (NHS) (2002B18). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiru S, 2006, LIVER INT, V26, P39, DOI 10.1111/j.1478-3231.2005.01191.x; Adams LA, 2005, J HEPATOL, V42, P132, DOI 10.1016/j.jhep.2004.09.012; Anstee QM, 2006, INT J EXP PATHOL, V87, P1, DOI 10.1111/j.0959-9673.2006.00465.x; BASU SK, 1981, P NATL ACAD SCI-BIOL, V78, P7545, DOI 10.1073/pnas.78.12.7545; Bieghs V, 2010, GASTROENTEROLOGY, V138, P2477, DOI 10.1053/j.gastro.2010.02.051; Binder CJ, 2004, J CLIN INVEST, V114, P427, DOI 10.1172/jci200420479; CHOI SSY, 1991, J CLIN INVEST, V88, P1173, DOI 10.1172/JCI115419; Collins AR, 2009, CIRC RES, V104, pe42, DOI 10.1161/CIRCRESAHA.108.188771; Dam-Larsen S, 2004, GUT, V53, P750, DOI 10.1136/gut.2003.019984; Donati G, 2004, GUT, V53, P1020, DOI 10.1136/gut.2003.027086; Ekstedt M, 2006, HEPATOLOGY, V44, P865, DOI 10.1002/hep.21327; ELSHOURBAGY NA, 1985, P NATL ACAD SCI USA, V82, P203, DOI 10.1073/pnas.82.1.203; Feldstein AE, 2009, GUT, V58, P1538, DOI 10.1136/gut.2008.171280; Floreani A, 2007, DIGEST DIS, V25, P138, DOI 10.1159/000099478; Gabay C, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1917; GOLDSTEIN JL, 1979, P NATL ACAD SCI USA, V76, P333, DOI 10.1073/pnas.76.1.333; Han JH, 1997, J BIOL CHEM, V272, P21654, DOI 10.1074/jbc.272.34.21654; HENRIKSEN T, 1981, P NATL ACAD SCI-BIOL, V78, P6499, DOI 10.1073/pnas.78.10.6499; Horkko S, 1999, J CLIN INVEST, V103, P117, DOI 10.1172/JCI4533; Ikejima K, 2005, HEPATOL RES, V33, P151, DOI 10.1016/j.hepres.2005.09.024; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; Kanters E, 2003, J CLIN INVEST, V112, P1176, DOI 10.1172/JCI18580; Koliwad SK, 2010, J CLIN INVEST, V120, P756, DOI 10.1172/JCI36066; Kong B, 2009, J PHARMACOL EXP THER, V328, P116, DOI 10.1124/jpet.108.144600; Larter CZ, 2008, J GASTROEN HEPATOL, V23, P1635, DOI 10.1111/j.1440-1746.2008.05543.x; LIN CT, 1986, J CLIN INVEST, V78, P947, DOI 10.1172/JCI112685; LUDWIG J, 1980, MAYO CLIN PROC, V55, P434; Ludwig J, 1997, J GASTROEN HEPATOL, V12, P398, DOI 10.1111/j.1440-1746.1997.tb00450.x; Mari M, 2006, CELL METAB, V4, P185, DOI 10.1016/j.cmet.2006.07.006; Miyata M, 1996, NAT GENET, V14, P55, DOI 10.1038/ng0996-55; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; Rinella ME, 2008, J LIPID RES, V49, P1068, DOI 10.1194/jlr.M800042-JLR200; Schattenberg JM, 2010, DIGEST DIS, V28, P247, DOI 10.1159/000282097; Sullivan PM, 1998, J CLIN INVEST, V102, P130, DOI 10.1172/JCI2673; Wouters K, 2005, CLIN CHEM LAB MED, V43, P470, DOI 10.1515/CCLM.2005.085; Wouters K, 2008, HEPATOLOGY, V48, P474, DOI 10.1002/hep.22363; Wouters K, 2010, FEBS LETT, V584, P1001, DOI 10.1016/j.febslet.2010.01.046; Yamaguchi K, 2007, HEPATOLOGY, V45, P1366, DOI 10.1002/hep.21655; Yoshimatsu M, 2004, INT J EXP PATHOL, V85, P335, DOI 10.1111/j.0959-9673.2004.00401.x; Zannis VI, 2001, CURR OPIN LIPIDOL, V12, P181, DOI 10.1097/00041433-200104000-00012; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543; ZHANG SH, 1994, J CLIN INVEST, V94, P937, DOI 10.1172/JCI117460	42	113	122	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30668	10.1371/journal.pone.0030668	http://dx.doi.org/10.1371/journal.pone.0030668			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295101	Green Published, gold, Green Submitted			2022-12-27	WOS:000301640600046
J	Leblanc, P; Hasenkrug, K; Ward, A; Myers, L; Messer, RJ; Alais, S; Timmes, A; Priola, S				Leblanc, Pascal; Hasenkrug, Kim; Ward, Anne; Myers, Lara; Messer, Ronald J.; Alais, Sandrine; Timmes, Andrew; Priola, Sue			Co-Infection with the Friend Retrovirus and Mouse Scrapie Does Not Alter Prion Disease Pathogenesis in Susceptible Mice	PLOS ONE			English	Article							FOLLICULAR DENDRITIC CELLS; MURINE LEUKEMIA-VIRUS; IN-VITRO; INFECTION; NEUROINVASION; REPLICATION; SPLEEN; EXPRESSION; PROTEIN; RELEASE	Prion diseases are fatal, transmissible neurodegenerative diseases of the central nervous system. An abnormally protease-resistant and insoluble form (PrPSc) of the normally soluble protease-sensitive host prion protein (PrPC) is the major component of the infectious prion. During the course of prion disease, PrPSc accumulates primarily in the lymphoreticular and central nervous systems. Recent studies have shown that co-infection of prion-infected fibroblast cells with the Moloney murine leukemia virus (Mo-MuLV) strongly enhanced the release and spread of scrapie infectivity in cell culture, suggesting that retroviral coinfection might significantly influence prion spread and disease incubation times in vivo. We now show that another retrovirus, the murine leukemia virus Friend (F-MuLV), also enhanced the release and spread of scrapie infectivity in cell culture. However, peripheral co-infection of mice with both Friend virus and the mouse scrapie strain 22L did not alter scrapie disease incubation times, the levels of PrPSc in the brain or spleen, or the distribution of pathological lesions in the brain. Thus, retroviral co-infection does not necessarily alter prion disease pathogenesis in vivo, most likely because of different cell-specific sites of replication for scrapie and F-MuLV.	[Leblanc, Pascal; Alais, Sandrine] Univ Lyon, Lyon, France; [Leblanc, Pascal; Alais, Sandrine] INSERM, U758, Lab Virol Humaine, F-69008 Lyon, France; [Leblanc, Pascal] UMR5239, Lab Biol Mol Cellule, Lyon, France; [Leblanc, Pascal; Alais, Sandrine] Ecole Normale Super Lyon, F-69364 Lyon, France; [Hasenkrug, Kim; Ward, Anne; Myers, Lara; Messer, Ronald J.; Timmes, Andrew; Priola, Sue] NIAID, Rocky Mt Labs, Persistent Viral Dis Lab, NIH, Hamilton, MT 59840 USA	Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); Universite Jean Monnet; Ecole Normale Superieure de Lyon (ENS de LYON); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Leblanc, P (corresponding author), Univ Lyon, Lyon, France.	spriola@niaid.nih.gov	Leblanc, Pascal/D-4027-2019	Leblanc, Pascal/0000-0003-3214-5880; ALAIS, Sandrine/0000-0001-9588-5435	National Institutes of Health's Institute of Allergy and Infectious Diseases; CNRS; INSERM; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000753, ZIAAI000752] Funding Source: NIH RePORTER	National Institutes of Health's Institute of Allergy and Infectious Diseases; CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Intramural Research Program of the National Institutes of Health's Institute of Allergy and Infectious Diseases (S. Priola and K. Hasenkrug) and by CNRS and INSERM (P. Leblanc). The funders had no role in study design, data collection and analysis, or preparation of the manuscript. Clearance to publish was obtained from the Intramural Research Program of the National Institutes of Health, Institute of Allergy and Infectious Diseases.	Alais S, 2008, BIOL CELL, V100, P603, DOI 10.1042/BC20080025; Brown KL, 1999, NAT MED, V5, P1308, DOI 10.1038/15264; Carp RI, 1999, J GEN VIROL, V80, P5, DOI 10.1099/0022-1317-80-1-5; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; CHANDLER RL, 1965, J COMP PATHOL THERAP, V75, P323, DOI 10.1016/0021-9975(65)90037-X; Chaplin DD, 1998, CURR OPIN IMMUNOL, V10, P289, DOI 10.1016/S0952-7915(98)80167-2; CLARKE MC, 1971, RES VET SCI, V12, P195; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Dietze KK, 2011, P NATL ACAD SCI USA, V108, P2420, DOI 10.1073/pnas.1015148108; EHRESMANN DW, 1986, INTERVIROLOGY, V25, P103, DOI 10.1159/000149663; Fraser H., 1979, Slow transmissible diseases of the nervous system. Volume 1., P387; Fraser H, 1996, J GEN VIROL, V77, P1935, DOI 10.1099/0022-1317-77-8-1935; FRASER H, 1978, J COMP PATHOL, V88, P563, DOI 10.1016/0021-9975(78)90010-5; Friedman-Levi Y, 2007, J VIROL, V81, P9942, DOI 10.1128/JVI.00780-07; Glatzel M, 2000, J GEN VIROL, V81, P2813, DOI 10.1099/0022-1317-81-11-2813; Glatzel M, 2001, NEURON, V31, P25, DOI 10.1016/S0896-6273(01)00331-2; Greenwood AD, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-44; Hasenkrug Kim J, 2003, Novartis Found Symp, V252, P194; Heikenwalder M, 2005, SCIENCE, V307, P1107, DOI 10.1126/science.1106460; KABAT D, 1989, CURR TOP MICROBIOL, V148, P1; KIMBERLIN RH, 1979, J COMP PATHOL, V89, P551, DOI 10.1016/0021-9975(79)90046-X; KIMBERLIN RH, 1989, VIRUS RES, V12, P201, DOI 10.1016/0168-1702(89)90039-7; Klein MA, 1998, NAT MED, V4, P1429, DOI 10.1038/4022; Leblanc P, 2006, EMBO J, V25, P2674, DOI 10.1038/sj.emboj.7601162; Lee KH, 2006, BIOCHEM BIOPH RES CO, V349, P122, DOI 10.1016/j.bbrc.2006.08.016; Ligios C, 2011, J VIROL, V85, P1136, DOI 10.1128/JVI.02022-10; Lotscher M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001158; Mabbott NA, 2000, NAT MED, V6, P719, DOI 10.1038/77401; Mabbott NA, 2003, J VIROL, V77, P6845, DOI 10.1128/JVI.77.12.6845-6854.2003; MOLONEY JB, 1964, ANNU REV MED, V15, P383, DOI 10.1146/annurev.me.15.020164.002123; Montrasio F, 2000, SCIENCE, V288, P1257, DOI 10.1126/science.288.5469.1257; Murakami T, 2007, BLOOD, V110, P1215, DOI 10.1182/blood-2007-01-068387; Nishida N, 2000, J VIROL, V74, P320, DOI 10.1128/JVI.74.1.320-325.2000; Priola SA, 2001, ADV PROTEIN CHEM, V57, P1; Robertson SJ, 2008, J VIROL, V82, P408, DOI 10.1128/JVI.01413-07; Seeger H, 2005, SCIENCE, V310, P324, DOI 10.1126/science.1118829; Stanton JB, 2008, J VIROL, V82, P9839, DOI 10.1128/JVI.01137-08; Stengel A, 2006, BIOCHEM BIOPH RES CO, V343, P825, DOI 10.1016/j.bbrc.2006.03.021; Vorberg I, 2004, J INFECT DIS, V189, P431, DOI 10.1086/381166; WEISSMANN C, 1994, ANN NY ACAD SCI, V724, P235, DOI 10.1111/j.1749-6632.1994.tb38913.x	40	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30872	10.1371/journal.pone.0030872	http://dx.doi.org/10.1371/journal.pone.0030872			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295118	Green Submitted, Green Published, gold			2022-12-27	WOS:000301640600063
J	Outinen, TK; Kuparinen, T; Jylhava, J; Leppanen, S; Mustonen, J; Makela, S; Porsti, I; Syrjanen, J; Vaheri, A; Hurme, M				Outinen, Tuula K.; Kuparinen, Taru; Jylhava, Juulia; Leppanen, Sonja; Mustonen, Jukka; Makela, Satu; Porsti, Ilkka; Syrjanen, Jaana; Vaheri, Antti; Hurme, Mikko			Plasma Cell-Free DNA Levels Are Elevated in Acute Puumala Hantavirus Infection	PLOS ONE			English	Article							INDUCED NEPHROPATHIA-EPIDEMICA; C-REACTIVE PROTEIN; VERO E6 CELLS; PROGNOSTIC MARKER; CLINICAL CORRELATIONS; RADIOLOGICAL FINDINGS; COLORECTAL-CANCER; HEMORRHAGIC-FEVER; VIRUS-INFECTION; RENAL SYNDROME	Introduction: Puumala hantavirus (PUUV) causes a hemorrhagic fever with renal syndrome called nephropathia epidemica (NE). The aim of the present study was to evaluate plasma cell-free DNA (cf-DNA) levels and urinary cf-DNA excretion in acute NE as well as their associations with the severity of the disease. Methods: Total plasma cf-DNA was quantified directly in plasma of 61 patients and urine of 20 patients with acute NE. We also carried out a qualitative high-sensitivity lab-on-a-chip DNA assay in 20 patients to elucidate the appearance of cf-DNA in plasma and urine. Results: The maximum plasma cf-DNA values taken during acute NE were significantly higher than the control values taken after the hospitalization period (median 1.33 mu g/ml, range 0.94-3.29 mu g/ml vs. median 0.77 mu g/ml, range 0.55-0.99 mu g/ml, P < 0.001). The maximum plasma cf-DNA levels correlated positively with maximum blood leukocyte count (r = 0.388, P = 0.002) and the length of hospital stay (r = 0.376, P = 0.003), and inversely with minimum blood platelet count (r = -0.297, P = 0.020). Qualitative analysis of plasma cf-DNA revealed that in most of the patients cf-DNA displayed a low-molecular weight appearance, corresponding to the size of apoptotic DNA (150-200 bp). The visually graded maximum cf-DNA band intensity correlated positively with the maximum quantity of total plasma cf-DNA (r = 0.513, P = 0.021). Maximum urinary excretion of cf-DNA in turn was not markedly increased during the acute phase of NE and did not correlate with any of the variables reflecting severity of the disease or with the maximum plasma cf-DNA level. Conclusions: The plasma levels of cf-DNA are elevated during acute PUUV infection and correlate with the apoptotic cf-DNA-band intensity. The plasma cf-DNA concentration correlates with some variables reflecting the severity of the disease. The urinary excretion of cf-DNA does not reflect the degree of inflammation in the kidney.	[Outinen, Tuula K.; Mustonen, Jukka; Makela, Satu; Porsti, Ilkka; Syrjanen, Jaana] Tampere Univ Hosp, Dept Internal Med, Tampere, Finland; [Kuparinen, Taru; Jylhava, Juulia; Leppanen, Sonja; Mustonen, Jukka; Makela, Satu; Porsti, Ilkka; Syrjanen, Jaana; Hurme, Mikko] Univ Tampere, Sch Med, Tampere, Finland; [Vaheri, Antti] Univ Helsinki, Haartman Inst, Infect Biol Res Program, Dept Virol, Helsinki, Finland; [Hurme, Mikko] Fimlab Labs, Tampere, Finland	Tampere University; Tampere University Hospital; Tampere University; University of Helsinki	Outinen, TK (corresponding author), Tampere Univ Hosp, Dept Internal Med, Tampere, Finland.	Tuula.Outinen@uta.fi	Vaheri, Antti/AAV-1523-2020	Outinen, Tuula/0000-0002-2773-4077; Makela, Satu/0000-0001-6967-2401; Hurme, Mikko/0000-0002-8614-1044; Jylhava, Juulia/0000-0003-0250-4491; Syrjanen, Jaana/0000-0002-7335-573X	Tampere 15 University Hospital; European Commission [QLK2-CT-2002-01358]; Finnish Kidney Foundation	Tampere 15 University Hospital; European Commission(European CommissionEuropean Commission Joint Research Centre); Finnish Kidney Foundation	This study was financially supported by the Competitive Research Funding of the Tampere 15 University Hospital, the European Commission Project "Diagnosis and control of rodent-borne viral 16 zoonoses in Europe'' (QLK2-CT-2002-01358) and Finnish Kidney Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonatos D, 2006, ANN NY ACAD SCI, V1075, P278, DOI 10.1196/annals.1368.037; Bhargava A, 2010, VIRUS RES, V153, P143, DOI 10.1016/j.virusres.2010.07.023; Botezatu I, 2000, CLIN CHEM, V46, P1078; Bottazzi B, 2009, IMMUNOL REV, V227, P9, DOI 10.1111/j.1600-065X.2008.00719.x; BRUMMERKORVENKONTIO M, 1980, J INFECT DIS, V141, P131, DOI 10.1093/infdis/141.2.131; Butt AN, 2008, ANN NY ACAD SCI, V1137, P236, DOI 10.1196/annals.1448.002; COSGRIFF TM, 1991, REV INFECT DIS, V13, P97; Courouble P, 2001, Eur J Emerg Med, V8, P17, DOI 10.1097/00063110-200103000-00004; Moreira VG, 2010, ANN CLIN BIOCHEM, V47, P253, DOI 10.1258/acb.2010.009173; Moreira VG, 2009, CLIN BIOCHEM, V42, P729, DOI 10.1016/j.clinbiochem.2008.12.021; Hung ECW, 2009, CLIN CHEM, V55, P715, DOI 10.1373/clinchem.2008.113530; Huttunen R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021700; Jahr S, 2001, CANCER RES, V61, P1659; Jylhava J, 2011, MECH AGEING DEV, V132, P20, DOI 10.1016/j.mad.2010.11.001; Kanerva M, 1998, REV MED VIROL, V8, P67, DOI 10.1002/(SICI)1099-1654(199804/06)8:2&lt;67::AID-RMV217&gt;3.0.CO;2-U; Kanerva M, 1996, CLIN NEPHROL, V46, P369; Klingstrom J, 2006, J VIROL, V80, P8279, DOI 10.1128/JVI.00742-06; Koide K, 2005, PRENATAL DIAG, V25, P604, DOI 10.1002/pd.1213; LAHDEVIRTA J, 1971, ANN CLIN RES, V3, P1; Laich A, 2002, CLIN CHEM, V48, P579; Laine O, 2011, BLOOD COAGUL FIBRIN, V22, P468, DOI 10.1097/MBC.0b013e328346a420; Laine O, 2010, THROMB RES, V126, P154, DOI 10.1016/j.thromres.2010.05.025; Li XD, 2005, VIROLOGY, V333, P180, DOI 10.1016/j.virol.2005.01.002; Li XD, 2004, J GEN VIROL, V85, P3261, DOI 10.1099/vir.0.80243-0; Linderholm M, 1996, J INFECT DIS, V173, P38, DOI 10.1093/infdis/173.1.38; Lo YMD, 2000, CLIN CHEM, V46, P319; Makary P, 2010, EPIDEMIOL INFECT, V138, P1484, DOI 10.1017/S0950268810000087; Makela S, 2004, AM J KIDNEY DIS, V43, P809, DOI 10.1053/j.ajkd.2003.12.044; Makela S, 2009, SCAND J INFECT DIS, V41, P57, DOI 10.1080/00365540802502629; Margraf S, 2008, SHOCK, V30, P352, DOI 10.1097/SHK.0b013e31816a6bb1; Mori M, 1999, J INFECT DIS, V179, P295, DOI 10.1086/314597; Mosca M, 2009, CLIN RHEUMATOL, V28, P1437, DOI 10.1007/s10067-009-1245-5; MUSTONEN J, 1994, SCAND J INFECT DIS, V26, P7, DOI 10.3109/00365549409008583; Mustonen J, 1996, KIDNEY INT, V49, P217, DOI 10.1038/ki.1996.29; Outinen TK, 2011, EUR J CLIN MICROBIOL; Outinen TK, 2011, J MED VIROL, V83, P731, DOI 10.1002/jmv.22018; Outinen TK, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-132; Paakkala A, 2007, ACTA RADIOL, V48, P345, DOI 10.1080/02841850701199629; Paakkala A, 2008, SCAND J INFECT DIS, V40, P254, DOI 10.1080/00365540701633012; Rainer TH, 2003, CLIN CHEM, V49, P562, DOI 10.1373/49.4.562; Rhodes A, 2006, CRIT CARE, V10, DOI 10.1186/cc4894; Sane J, 2011, ANN MED; Saukkonen K, 2008, CLIN CHEM, V54, P1000, DOI 10.1373/clinchem.2007.101030; Schrocksnadel K, 2006, CLIN CHIM ACTA, V364, P82, DOI 10.1016/j.cca.2005.06.013; Su YH, 2004, J MOL DIAGN, V6, P101, DOI 10.1016/S1525-1578(10)60497-7; Su Ying-Hsiu, 2005, Cancer Biomarkers, V1, P177; Temonen M, 1996, CLIN IMMUNOL IMMUNOP, V78, P47, DOI 10.1006/clin.1996.0007; TEMONEN M, 1993, J GEN VIROL, V74, P515, DOI 10.1099/0022-1317-74-3-515; Vapalahti O, 2003, LANCET INFECT DIS, V3, P653, DOI 10.1016/S1473-3099(03)00774-6; Vapalahti O, 1996, J CLIN MICROBIOL, V34, P119, DOI 10.1128/JCM.34.1.119-125.1996; YANAGIHARA R, 1985, J VIROL, V55, P34, DOI 10.1128/JVI.55.1.34-38.1985; Zeerleder S, 2003, CRIT CARE MED, V31, P1947, DOI 10.1097/01.CCM.0000074719.40109.95; Zhong XY, 2007, ANN HEMATOL, V86, P139, DOI 10.1007/s00277-006-0182-5; Zhong XY, 2007, CLIN CHEM, V53, P1609, DOI 10.1373/clinchem.2006.084509	54	28	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2012	7	2							e31455	10.1371/journal.pone.0031455	http://dx.doi.org/10.1371/journal.pone.0031455			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917MF	22347483	Green Published, gold, Green Submitted			2022-12-27	WOS:000302180600039
J	Uras, IZ; List, T; Nijman, SMB				Uras, Iris Z.; List, Thomas; Nijman, Sebastian M. B.			Ubiquitin-Specific Protease 4 Inhibits Mono-Ubiquitination of the Master Growth Factor Signaling Kinase PDK1	PLOS ONE			English	Article							NUCLEAR TRANSLOCATION; IN-VIVO; UBIQUITYLATION; ACTIVATION; SYSTEM; DOMAIN; USP4; P53; PHOSPHORYLATION; IDENTIFICATION	Background: Phosphorylation by the phospho-inositide-dependent kinase 1 (PDK1) is essential for many growth factor-activated kinases and thus plays a critical role in various processes such as cell proliferation and metabolism. However, the mechanisms that control PDK1 have not been fully explored and this is of great importance as interfering with PDK1 signaling may be useful to treat diseases, including cancer and diabetes. Methodology/Principal Findings: In human cells, few mono-ubiquitinated proteins have been described but in all cases this post-translational modification has a key regulatory function. Unexpectedly, we find that PDK1 is mono-ubiquitinated in a variety of human cell lines, indicating that PDK1 ubiquitination is a common and regulated process. Ubiquitination occurs in the kinase domain of PDK1 yet is independent of its kinase activity. By screening a library of ubiquitin proteases, we further identify the Ubiquitin-Specific Protease 4 (USP4) as an enzyme that removes ubiquitin from PDK1 in vivo and in vitro and co-localizes with PDK1 at the plasma membrane when the two proteins are overexpressed, indicating direct deubiquitination. Conclusions: The regulated mono-ubiquitination of PDK1 provides an unanticipated layer of complexity in this central signaling network and offers potential novel avenues for drug discovery.	[Uras, Iris Z.; List, Thomas; Nijman, Sebastian M. B.] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1010 Vienna, Austria	Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences	Uras, IZ (corresponding author), Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1010 Vienna, Austria.	snijman@cemm.oeaw.ac.at	Uras, Iris/AAH-2221-2021	Uras, Iris/0000-0002-2434-2756; Nijman, Sebastian/0000-0003-0464-6661	WWTF [LS09-009]	WWTF	IZU has been funded by the Vienna Science and Technology Fund (WWTF) through project LS09-009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar RC, 2003, CURR OPIN CELL BIOL, V15, P184, DOI 10.1016/S0955-0674(03)00010-3; Baker RT, 1999, GENOMICS, V59, P264, DOI 10.1006/geno.1999.5879; Bayascas JR, 2008, MOL CELL BIOL, V28, P3258, DOI 10.1128/MCB.02032-07; Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Casamayor A, 1999, BIOCHEM J, V342, P287, DOI 10.1042/0264-6021:3420287; Chan WM, 2006, MOL CANCER RES, V4, P15, DOI 10.1158/1541-7786.MCR-05-0097; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; Cohen P, 2010, CELL, V143, P686, DOI 10.1016/j.cell.2010.11.016; Currie RA, 1999, BIOCHEM J, V337, P575, DOI 10.1042/0264-6021:3370575; Downward J, 2004, SEMIN CELL DEV BIOL, V15, P177, DOI 10.1016/j.semcdb.2004.01.002; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Fan YH, 2011, CELL DEATH DIFFER; Filippa N, 2000, MOL CELL BIOL, V20, P5712, DOI 10.1128/MCB.20.15.5712-5721.2000; Giasson BI, 2003, CELL, V114, P1, DOI 10.1016/S0092-8674(03)00509-9; Hanada M, 2004, BBA-PROTEINS PROTEOM, V1697, P3, DOI 10.1016/j.bbapap.2003.11.009; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hoeller D, 2009, NATURE, V458, P438, DOI 10.1038/nature07960; Huang TT, 2006, NAT REV MOL CELL BIO, V7, P323, DOI 10.1038/nrm1908; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; King RW, 1996, MOL BIOL CELL, V7, P1343, DOI 10.1091/mbc.7.9.1343; Komander D, 2004, EMBO J, V23, P3918, DOI 10.1038/sj.emboj.7600379; Lawlor MA, 2001, J CELL SCI, V114, P2903; Lee BH, 2010, NATURE, V467, P179, DOI 10.1038/nature09299; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Lim MA, 2003, P NATL ACAD SCI USA, V100, P14006, DOI 10.1073/pnas.2335486100; Lopez-Otin C, 2010, NAT REV CANCER, V10, P278, DOI 10.1038/nrc2823; Marmor MD, 2004, ONCOGENE, V23, P2057, DOI 10.1038/sj.onc.1207390; McManus EJ, 2004, EMBO J, V23, P2071, DOI 10.1038/sj.emboj.7600218; Milojevic T, 2006, MOL PHARMACOL, V69, P1083, DOI 10.1124/mol.105.015818; Mora A, 2004, SEMIN CELL DEV BIOL, V15, P161, DOI 10.1016/j.semcdb.2003.12.022; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; RodriguezViciana P, 1997, CELL, V89, P457, DOI 10.1016/S0092-8674(00)80226-3; Scheid MP, 2005, MOL CELL BIOL, V25, P2347, DOI 10.1128/MCB.25.6.2347-2363.2005; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Toker A, 1997, NATURE, V387, P673, DOI 10.1038/42648; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; Vanhaesebroeck B, 1997, TRENDS BIOCHEM SCI, V22, P267, DOI 10.1016/S0968-0004(97)01061-X; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; Yang WL, 2009, SCIENCE, V325, P1134, DOI 10.1126/science.1175065; Zhang XN, 2011, EMBO J, V30, P2177, DOI 10.1038/emboj.2011.125; Zhao B, 2009, J CELL MOL MED, V13, P1886, DOI 10.1111/j.1582-4934.2009.00682.x	46	19	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2012	7	2							e31003	10.1371/journal.pone.0031003	http://dx.doi.org/10.1371/journal.pone.0031003			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917MF	22347420	Green Published, gold, Green Submitted			2022-12-27	WOS:000302180600022
J	Holmes, I; Harris, K; Quince, C				Holmes, Ian; Harris, Keith; Quince, Christopher			Dirichlet Multinomial Mixtures: Generative Models for Microbial Metagenomics	PLOS ONE			English	Article							DIVERSITY; SEQUENCES	We introduce Dirichlet multinomial mixtures (DMM) for the probabilistic modelling of microbial metagenomics data. This data can be represented as a frequency matrix giving the number of times each taxa is observed in each sample. The samples have different size, and the matrix is sparse, as communities are diverse and skewed to rare taxa. Most methods used previously to classify or cluster samples have ignored these features. We describe each community by a vector of taxa probabilities. These vectors are generated from one of a finite number of Dirichlet mixture components each with different hyperparameters. Observed samples are generated through multinomial sampling. The mixture components cluster communities into distinct 'metacommunities', and, hence, determine envirotypes or enterotypes, groups of communities with a similar composition. The model can also deduce the impact of a treatment and be used for classification. We wrote software for the fitting of DMM models using the 'evidence framework' (http://code.google.com/p/microbedmm/). This includes the Laplace approximation of the model evidence. We applied the DMM model to human gut microbe genera frequencies from Obese and Lean twins. From the model evidence four clusters fit this data best. Two clusters were dominated by Bacteroides and were homogenous; two had a more variable community composition. We could not find a significant impact of body mass on community structure. However, Obese twins were more likely to derive from the high variance clusters. We propose that obesity is not associated with a distinct microbiota but increases the chance that an individual derives from a disturbed enterotype. This is an example of the 'Anna Karenina principle (AKP)' applied to microbial communities: disturbed states having many more configurations than undisturbed. We verify this by showing that in a study of inflammatory bowel disease (IBD) phenotypes, ileal Crohn's disease (ICD) is associated with a more variable community.	[Holmes, Ian] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Harris, Keith; Quince, Christopher] Univ Glasgow, Sch Engn, Glasgow, Lanark, Scotland	University of California System; University of California Berkeley; University of Glasgow	Holmes, I (corresponding author), Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.	christopher.quince@glasgow.ac.uk	Harris, Keith/ABG-7349-2021	Quince, Christopher/0000-0003-1884-8440; Holmes, Ian/0000-0001-7639-5369	EPSRC [EP/H003851/1]; University of Glasgow; NIH/NIGMS [R01-GM076705]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076705] Funding Source: NIH RePORTER; Engineering and Physical Sciences Research Council [EP/H003851/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); University of Glasgow; NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	CQ is funded by an EPSRC Career Acceleration Fellowship EP/H003851/1. KH by a Unilever directly funded research grant to the University of Glasgow. IH was supported by NIH/NIGMS grant R01-GM076705. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 1997, GUNS GERMS STEEL; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Bishop C. M, 2006, PATTERN RECOGNITION; Bouguila N, 2011, IEEE T NEURAL NETWOR, V22, P186, DOI 10.1109/TNN.2010.2091428; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Dorigo U, 2005, WATER RES, V39, P2207, DOI 10.1016/j.watres.2005.04.007; Galassi M., 2009, GNU SCI LIB REFERENC, DOI [10.5555/1538674, DOI 10.5555/1538674]; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Knights D, 2011, NAT METHODS, V8, P761, DOI 10.1038/nmeth.1650; Knights D, 2011, FEMS MICROBIOL REV, V35, P343, DOI 10.1111/j.1574-6976.2010.00251.x; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; MACKAY DJC, 1992, NEURAL COMPUT, V4, P415, DOI [10.1162/neco.1992.4.3.415, 10.1162/neco.1992.4.3.448]; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Quince C, 2008, ISME J, V2, P997, DOI 10.1038/ismej.2008.69; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Ramette A, 2007, FEMS MICROBIOL ECOL, V62, P142, DOI 10.1111/j.1574-6941.2007.00375.x; Schloss PD, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-34; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Sjolander K, 1996, COMPUT APPL BIOSCI, V12, P327; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Streit WR, 2004, CURR OPIN MICROBIOL, V7, P492, DOI 10.1016/j.mib.2004.08.002; Sun YJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq872; Tolstoy, 2014, A KARENINA; Turnbaugh PJ, 2010, P NATL ACAD SCI USA, V107, P7503, DOI 10.1073/pnas.1002355107; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Willing BP, 2010, GASTROENTEROLOGY, V139, P1844, DOI 10.1053/j.gastro.2010.08.049; Ye XG, 2010, J COMPUT BIOL, V17, P1607, DOI 10.1089/cmb.2010.0117	34	364	374	3	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e30126	10.1371/journal.pone.0030126	http://dx.doi.org/10.1371/journal.pone.0030126			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LO	22319561	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000302178400005
J	Humphreys, DT; Hynes, CJ; Patel, HR; Wei, GH; Cannon, L; Fatkin, D; Suter, CM; Clancy, JL; Preiss, T				Humphreys, David T.; Hynes, Carly J.; Patel, Hardip R.; Wei, Grace H.; Cannon, Leah; Fatkin, Diane; Suter, Catherine M.; Clancy, Jennifer L.; Preiss, Thomas			Complexity of Murine Cardiomyocyte miRNA Biogenesis, Sequence Variant Expression and Function	PLOS ONE			English	Article							MESSENGER-RNA TRANSLATION; CARDIOVASCULAR BIOLOGY; MICRORNA TARGETS; STRUCTURAL BASIS; HEART-DISEASE; CELLS; DROSOPHILA; GENES; TRANSCRIPTOME; CONTRIBUTES	microRNAs (miRNAs) are critical to heart development and disease. Emerging research indicates that regulated precursor processing can give rise to an unexpected diversity of miRNA variants. We subjected small RNA from murine HL-1 cardiomyocyte cells to next generation sequencing to investigate the relevance of such diversity to cardiac biology. similar to 40 million tags were mapped to known miRNA hairpin sequences as deposited in miRBase version 16, calling 403 generic miRNAs as appreciably expressed. Hairpin arm bias broadly agreed with miRBase annotation, although 44 miR* were unexpectedly abundant (>20% of tags); conversely, 33 -5p/-3p annotated hairpins were asymmetrically expressed. Overall, variability was infrequent at the 5' start but common at the 3' end of miRNAs (5.2% and 52.3% of tags, respectively). Nevertheless, 105 miRNAs showed marked 5' isomiR expression (>20% of tags). Among these was miR-133a, a miRNA with important cardiac functions, and we demonstrated differential mRNA targeting by two of its prevalent 5' isomiRs. Analyses of miRNA termini and base-pairing patterns around Drosha and Dicer cleavage regions confirmed the known bias towards uridine at the 5' most position of miRNAs, as well as supporting the thermodynamic asymmetry rule for miRNA strand selection and a role for local structural distortions in fine tuning miRNA processing. We further recorded appreciable expression of 5 novel miR*, 38 extreme variants and 8 antisense miRNAs. Analysis of genome-mapped tags revealed 147 novel candidate miRNAs. In summary, we revealed pronounced sequence diversity among cardiomyocyte miRNAs, knowledge of which will underpin future research into the mechanisms involved in miRNA biogenesis and, importantly, cardiac function, disease and therapy.	[Humphreys, David T.; Hynes, Carly J.; Patel, Hardip R.; Wei, Grace H.; Suter, Catherine M.; Clancy, Jennifer L.; Preiss, Thomas] Victor Chang Cardiac Res Inst, Div Mol Genet, Sydney, NSW, Australia; [Hynes, Carly J.; Patel, Hardip R.; Clancy, Jennifer L.; Preiss, Thomas] Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia; [Cannon, Leah; Fatkin, Diane] Victor Chang Cardiac Res Inst, Mol Cardiol Div, Sydney, NSW, Australia; [Fatkin, Diane; Suter, Catherine M.; Clancy, Jennifer L.; Preiss, Thomas] Univ New S Wales, St Vincents Clin Sch, Sydney, NSW, Australia; [Fatkin, Diane] St Vincents Hosp, Dept Cardiol, Sydney, NSW 2010, Australia; [Preiss, Thomas] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia	Victor Chang Cardiac Research Institute; Australian National University; John Curtin School of Medical Research; Victor Chang Cardiac Research Institute; University of New South Wales Sydney; St Vincents Hospital Sydney; University of New South Wales Sydney	Humphreys, DT (corresponding author), Victor Chang Cardiac Res Inst, Div Mol Genet, Sydney, NSW, Australia.	jennifer.clancy@anu.edu.au; thomas.preiss@anu.edu.au	Preiss, Thomas/F-7355-2010; Wei, Grace/GPX-0836-2022; Patel, Hardip R/K-6376-2012	Preiss, Thomas/0000-0001-6273-784X; Patel, Hardip/0000-0003-3169-049X; Humphreys, David/0000-0003-4140-0089	Victor Chang Cardiac Research Institute; National Health & Medical Research Council [573726, 573731, 514904]	Victor Chang Cardiac Research Institute; National Health & Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by by the Victor Chang Cardiac Research Institute and grants 573726, 573731 and 514904 from the National Health & Medical Research Council awarded to TP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Beilharz TH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006783; Burroughs AM, 2011, RNA BIOL, V8, P158, DOI 10.4161/rna.8.1.14300; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Catalucci D, 2009, CIRC-CARDIOVASC GENE, V2, P402, DOI 10.1161/CIRCGENETICS.109.857425; Cheng YH, 2010, J CARDIOVASC TRANSL, V3, P251, DOI 10.1007/s12265-010-9169-7; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Cifuentes D, 2010, SCIENCE, V328, P1694, DOI 10.1126/science.1190809; Clancy JL, 2007, METHOD ENZYMOL, V431, P83, DOI 10.1016/S0076-6879(07)31006-9; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Corsten MF, 2010, CIRC-CARDIOVASC GENE, V3, P499, DOI 10.1161/CIRCGENETICS.110.957415; Czech B, 2011, NAT REV GENET, V12, P19, DOI 10.1038/nrg2916; Davis-Dusenbery BN, 2010, J BIOCHEM, V148, P381, DOI 10.1093/jb/mvq096; Dorn GW, 2011, TRANSL RES, V157, P226, DOI 10.1016/j.trsl.2010.12.013; Duisters RF, 2009, CIRC RES, V104, P170, DOI 10.1161/CIRCRESAHA.108.182535; Ebhardt H Alexander, 2010, Silence, V1, P12, DOI 10.1186/1758-907X-1-12; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Fernandez-Valverde SL, 2010, RNA, V16, P1881, DOI 10.1261/rna.2379610; Frank F, 2010, NATURE, V465, P818, DOI 10.1038/nature09039; Ghosh G, 2010, J CLIN INVEST, V120, P4141, DOI 10.1172/JCI42980; Han BW, 2011, CURR BIOL, V21, P1878, DOI 10.1016/j.cub.2011.09.034; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Hu HY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-413; Hu SJ, 2010, CIRCULATION, V122, pS124, DOI 10.1161/CIRCULATIONAHA.109.928424; Huang ZP, 2010, ARTERIOSCL THROM VAS, V30, P2575, DOI 10.1161/ATVBAHA.110.213306; Hwang HW, 2009, P NATL ACAD SCI USA, V106, P7016, DOI 10.1073/pnas.0811523106; Jeffries CD, 2011, RNA, V17, P675, DOI 10.1261/rna.2006511; Kai ZS, 2010, NAT STRUCT MOL BIOL, V17, P5, DOI 10.1038/nsmb.1762; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Krol J, 2004, J BIOL CHEM, V279, P42230, DOI 10.1074/jbc.M404931200; Kuchen S, 2010, IMMUNITY, V32, P828, DOI 10.1016/j.immuni.2010.05.009; Kuchenbauer F, 2008, GENOME RES, V18, P1787, DOI 10.1101/gr.077578.108; Lee LW, 2010, RNA, V16, P2170, DOI 10.1261/rna.2225110; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu N, 2011, CURR BIOL, V21, P1888, DOI 10.1016/j.cub.2011.10.006; Liu N, 2010, DEV CELL, V18, P510, DOI 10.1016/j.devcel.2010.03.010; Liu N, 2008, GENE DEV, V22, P3242, DOI 10.1101/gad.1738708; Matkovich SJ, 2011, CIRC RES, V108, P18, DOI 10.1161/CIRCRESAHA.110.233528; Michlewski G, 2010, ADV EXP MED BIOL, V700, P28; Miyoshi K, 2010, MOL GENET GENOMICS, V284, P95, DOI 10.1007/s00438-010-0556-1; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Newman MA, 2010, GENE DEV, V24, P1086, DOI 10.1101/gad.1919710; Okamura K, 2008, NAT STRUCT MOL BIOL, V15, P354, DOI 10.1038/nsmb.1409; Patel N, 2011, BIOCHEM J, V434, P473, DOI 10.1042/BJ20101585; Rajkowitsch L, 2007, RNA BIOL, V4, P118, DOI 10.4161/rna.4.3.5445; Rao PK, 2009, CIRC RES, V105, P585, DOI 10.1161/CIRCRESAHA.109.200451; Ro S, 2007, NUCLEIC ACIDS RES, V35, P5944, DOI 10.1093/nar/gkm641; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Sarkar S, 2010, MOL BIOL CELL, V21, P2138, DOI 10.1091/mbc.E10-01-0062; Schroen B, 2009, HYPERTENSION, V54, P1189, DOI 10.1161/HYPERTENSIONAHA.109.133942; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Seitz Herve, 2011, Silence, V2, P4, DOI 10.1186/1758-907X-2-4; Shao NY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-409; Small EM, 2011, NATURE, V469, P336, DOI 10.1038/nature09783; Spierings DC, 2011, BLOOD, V117, P5340, DOI 10.1182/blood-2010-10-316034; Starega-Roslan J, 2011, CELL MOL LIFE SCI, V68, P2859, DOI 10.1007/s00018-011-0726-2; Starega-Roslan J, 2011, NUCLEIC ACIDS RES, V39, P257, DOI 10.1093/nar/gkq727; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Tian G, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-64; Tyler DM, 2008, GENE DEV, V22, P26, DOI 10.1101/gad.1615208; van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Warf MB, 2011, RNA, V17, P563, DOI 10.1261/rna.2432311; White SM, 2004, AM J PHYSIOL-HEART C, V286, pH823, DOI 10.1152/ajpheart.00986.2003; Wyman SK, 2011, GENOME RES, V21, P1450, DOI 10.1101/gr.118059.110; Xin M, 2009, GENE DEV, V23, P2166, DOI 10.1101/gad.1842409; Xu XD, 2011, J CELL PHYSL; Yang JH, 2010, NUCLEIC ACIDS RES, V38, pD123, DOI 10.1093/nar/gkp943; Yang JS, 2011, RNA, V17, P312, DOI 10.1261/rna.2537911	71	71	175	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e30933	10.1371/journal.pone.0030933	http://dx.doi.org/10.1371/journal.pone.0030933			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LO	22319597	Green Published, gold			2022-12-27	WOS:000302178400022
J	Schilbach, L; Bzdok, D; Timmermans, B; Fox, PT; Laird, AR; Vogeley, K; Eickhoff, SB				Schilbach, Leonhard; Bzdok, Danilo; Timmermans, Bert; Fox, Peter T.; Laird, Angela R.; Vogeley, Kai; Eickhoff, Simon B.			Introspective Minds: Using ALE Meta-Analyses to Study Commonalities in the Neural Correlates of Emotional Processing, Social & Unconstrained Cognition	PLOS ONE			English	Article							DEFAULT MODE NETWORK; CINGULATE CORTEX; ANTERIOR INSULA; WANDERING MINDS; AMYGDALA; BRAIN; SYSTEM; PAIN; SELF; INFORMATION	Previous research suggests overlap between brain regions that show task-induced deactivations and those activated during the performance of social-cognitive tasks. Here, we present results of quantitative meta-analyses of neuroimaging studies, which confirm a statistical convergence in the neural correlates of social and resting state cognition. Based on the idea that both social and unconstrained cognition might be characterized by introspective processes, which are also thought to be highly relevant for emotional experiences, a third meta-analysis was performed investigating studies on emotional processing. By using conjunction analyses across all three sets of studies, we can demonstrate significant overlap of task-related signal change in dorso-medial prefrontal and medial parietal cortex, brain regions that have, indeed, recently been linked to introspective abilities. Our findings, therefore, provide evidence for the existence of a core neural network, which shows task-related signal change during socio-emotional tasks and during resting states.	[Schilbach, Leonhard] Max Planck Inst Neurol Res, D-50931 Cologne, Germany; [Schilbach, Leonhard; Timmermans, Bert; Vogeley, Kai] Univ Cologne, Dept Psychiat, D-50931 Cologne, Germany; [Bzdok, Danilo; Eickhoff, Simon B.] Res Ctr Juelich, Inst Neurosci & Med INM 1, Julich, Germany; [Bzdok, Danilo; Eickhoff, Simon B.] Univ Aachen, Dept Psychiat, Aachen, Germany; [Fox, Peter T.; Laird, Angela R.] UT Hlth Sci Ctr, Res Imaging Ctr, San Antonio, TX USA; [Vogeley, Kai] Res Ctr Juelich, Inst Neurosci & Med INM 3, Julich, Germany; [Eickhoff, Simon B.] Univ Duesseldorf, Inst Clin Neurosci & Med Psychol, Cognit Neurosci Grp, Dusseldorf, Germany	Max Planck Society; University of Cologne; Helmholtz Association; Research Center Julich; RWTH Aachen University; University of Texas System; University of Texas Health San Antonio; Helmholtz Association; Research Center Julich	Schilbach, L (corresponding author), Max Planck Inst Neurol Res, Gleueler Str 50, D-50931 Cologne, Germany.	leonhard.schilbach@nf.mpg.de	Vogeley, K/E-4860-2012; Eickhoff, Simon B./K-2061-2013; Schilbach, Leonhard/G-5832-2010; Laird, Angela R/B-5800-2010; Fox, Peter/B-4725-2010	Vogeley, K/0000-0002-5891-5831; Eickhoff, Simon B./0000-0001-6363-2759; Schilbach, Leonhard/0000-0001-5547-8309; Laird, Angela R/0000-0003-3379-8744; Fox, Peter/0000-0002-0465-2028; Timmermans, Bert/0000-0002-0404-8912	German Research Council (DFG) [IRTG 1328]; Human Brain Project [01-MH074457-01A1]; Koeln Fortune Program/Medical Faculty; University of Cologne; VolkswagenFoundation; German Ministery of Research and Education; Helmholtz Initiative on Systems Biology "The Human Brain Model"; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH074457] Funding Source: NIH RePORTER	German Research Council (DFG)(German Research Foundation (DFG)); Human Brain Project(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Koeln Fortune Program/Medical Faculty; University of Cologne; VolkswagenFoundation(Volkswagen); German Ministery of Research and Education; Helmholtz Initiative on Systems Biology "The Human Brain Model"; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by the German Research Council (DFG, IRTG 1328: SBE & DB), the Human Brain Project/01-MH074457-01A1: SBE), the Koeln Fortune Program/Medical Faculty, University of Cologne (LS), the VolkswagenFoundation (LS, BT & KV), the German Ministery of Research and Education (Project: "Other minds", KV) and the Helmholtz Initiative on Systems Biology "The Human Brain Model" (SBE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2010, ANN NY ACAD SCI, V1191, P42, DOI 10.1111/j.1749-6632.2010.05445.x; Allen M, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00020; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Andrews-Hanna JR, 2010, J NEUROPHYSIOL, V104, P322, DOI 10.1152/jn.00830.2009; Bach DR, 2011, J NEUROSCI, V31, P618, DOI 10.1523/JNEUROSCI.2744-10.2011; Bahrami B, 2010, SCIENCE, V329, P1081, DOI 10.1126/science.1185718; Balleine BW, 2007, J NEUROSCI, V27, P8161, DOI 10.1523/JNEUROSCI.1554-07.2007; Bickart KC, 2011, NAT NEUROSCI, V14, P163, DOI 10.1038/nn.2724; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2007, TRENDS COGN SCI, V11, P49, DOI 10.1016/j.tics.2006.11.004; Burgess PW, 2007, TRENDS COGN SCI, V11, P290, DOI 10.1016/j.tics.2007.05.004; Bzdok D, 2011, BRAIN STRUCT FUNCT, V215, P209, DOI 10.1007/s00429-010-0287-4; Cannon WB, 1929, BODILY CHANGES PAIN, V2; Carruthers P, 2009, BEHAV BRAIN SCI, V32, P121, DOI 10.1017/S0140525X09000545; Caspers S, 2010, NEUROIMAGE, V50, P1148, DOI 10.1016/j.neuroimage.2009.12.112; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Christoff K, 2009, P NATL ACAD SCI USA, V106, P8719, DOI 10.1073/pnas.0900234106; Cleeremans A, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00086; Craig AD, 2010, BRAIN STRUCT FUNCT, V214, P563, DOI 10.1007/s00429-010-0248-y; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Darwin Charles, 1998, EXPRESS EMOT MAN, V3rd, DOI [10.1037/h0076058, DOI 10.1037/10001-000]; Dunbar RIM, 2004, REV GEN PSYCHOL, V8, P100, DOI 10.1037/1089-2680.8.2.100; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Eickhoff SB, 2007, NEUROIMAGE, V36, P511, DOI 10.1016/j.neuroimage.2007.03.060; Eickhoff SB, 2009, HUM BRAIN MAPP, V30, P2907, DOI 10.1002/hbm.20718; Ekman P., 1982, EMOTION HUMAN FACE; Etzel JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003690; Fleming SM, PHILOS T ROYAL SOC B; Fleming SM, 2010, SCIENCE, V329, P1541, DOI 10.1126/science.1191883; Fox PT, 2002, NAT REV NEUROSCI, V3, P319, DOI 10.1038/nrn789; Fransson P, 2008, NEUROIMAGE, V42, P1178, DOI 10.1016/j.neuroimage.2008.05.059; Fransson P, 2007, P NATL ACAD SCI USA, V104, P15531, DOI 10.1073/pnas.0704380104; Frith CD, 2008, PHILOS T R SOC B, V363, P2033, DOI 10.1098/rstb.2008.0005; Frith U, 2010, PHILOS T R SOC B, V365, P165, DOI 10.1098/rstb.2009.0160; Gilbert SJ, 2007, SCIENCE, V317, P43, DOI 10.1126/science.1140801; Glahn DC, 2010, P NATL ACAD SCI USA, V107, P1223, DOI 10.1073/pnas.0909969107; Gosselin F, 2010, SOC COGN AFFECT NEUR; Grosbras MH, 2011, HUM BRAIN MAPP; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Heider F, 1944, AM J PSYCHOL, V57, P243, DOI 10.2307/1416950; Immordino-Yang MH, 2011, EMOT REV, V3, P313, DOI 10.1177/1754073911402391; James W., 1884, MIND, V9, P34, DOI [10.1093/mind/os-IX.34.188, DOI 10.1093/MIND/OS-IX.34.188]; Jimura K, 2010, BRAIN RES, V1328, P104, DOI 10.1016/j.brainres.2010.03.016; Kennedy DP, 2010, NEUROPSYCHOLOGIA, V48, P3392, DOI 10.1016/j.neuropsychologia.2010.06.025; Kennedy DP, 2009, NAT NEUROSCI, V12, P1226, DOI 10.1038/nn.2381; Kober H, 2008, NEUROIMAGE, V42, P998, DOI 10.1016/j.neuroimage.2008.03.059; Kunisato Y, 2011, NEUROSCI RES, V69, P129, DOI 10.1016/j.neures.2010.11.005; Kurth F, 2010, BRAIN STRUCT FUNCT, V214, P519, DOI 10.1007/s00429-010-0255-z; Laird Angela R, 2009, Front Neuroinform, V3, P23, DOI 10.3389/neuro.11.023.2009; Laird AR, 2009, NEUROIMAGE, V48, P18, DOI 10.1016/j.neuroimage.2009.06.047; Lamm C, 2011, NEUROIMAGE, V54, P2492, DOI 10.1016/j.neuroimage.2010.10.014; Lau H, 2010, SCIENCE, V329, P1478, DOI 10.1126/science.1195983; Leech R, 2011, J NEUROSCI, V31, P3217, DOI 10.1523/JNEUROSCI.5626-10.2011; Legrain V, 2011, PROG NEUROBIOL, V93, P111, DOI 10.1016/j.pneurobio.2010.10.005; Lou HC, 2010, EXP BRAIN RES, V207, P27, DOI 10.1007/s00221-010-2425-x; Mar RA, 2011, ANNU REV PSYCHOL, V62, P103, DOI 10.1146/annurev-psych-120709-145406; Margulies DS, 2009, P NATL ACAD SCI USA, V106, P20069, DOI 10.1073/pnas.0905314106; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; MELTZOFF AN, 1977, SCIENCE, V198, P75, DOI 10.1126/science.198.4312.75; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Mesoudi A, 2006, BRIT J PSYCHOL, V97, P405, DOI 10.1348/000712605X85871; Mitchell JP, 2009, TRENDS COGN SCI, V13, P246, DOI 10.1016/j.tics.2009.03.008; Nagano-Saito A, 2009, NEUROSCI LETT, V458, P1, DOI 10.1016/j.neulet.2009.04.025; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; Ochsner KN, 2008, BIOL PSYCHIAT, V64, P48, DOI 10.1016/j.biopsych.2008.04.024; Pasquali A, 2010, COGNITION, V117, P182, DOI 10.1016/j.cognition.2010.08.010; Pessoa L, 2010, NAT REV NEUROSCI, V11, P773, DOI 10.1038/nrn2920; Price JL, 2003, ANN NY ACAD SCI, V985, P50; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rochat P, 2002, CHILD DEV, V73, P35, DOI 10.1111/1467-8624.00390; Rosenthal D., 2005, CONSCIOUSNESS MIND; Salgado-Pineda P, 2011, SCHIZOPHR RES, V125, P101, DOI 10.1016/j.schres.2010.10.027; Sanfey AG, 2007, SCIENCE, V318, P598, DOI 10.1126/science.1142996; Schilbach L, 2010, SOC COGN AFFECT NEUR; Schilbach L, 2008, CONSCIOUS COGN, V17, P457, DOI 10.1016/j.concog.2008.03.013; Schilbach L, 2010, J COGNITIVE NEUROSCI, V22, P2702, DOI 10.1162/jocn.2009.21401; Shackman AJ, 2011, NAT REV NEUROSCI, V12, P154, DOI 10.1038/nrn2994; Shannon BJ, 2004, J NEUROSCI, V24, P10084, DOI 10.1523/JNEUROSCI.2625-04.2004; Sohn MH, 2007, P NATL ACAD SCI USA, V104, P10330, DOI 10.1073/pnas.0703225104; Spreng RN, 2009, J COGNITIVE NEUROSCI, V21, P489, DOI 10.1162/jocn.2008.21029; Timmermans B, PHILOS T ROYAL SOC B; Toro R, 2008, CEREB CORTEX, V18, P2553, DOI 10.1093/cercor/bhn014; Turkeltaub P.E., 2011, HUM BRAIN MAPP; Turkeltaub PE, 2002, NEUROIMAGE, V16, P765, DOI 10.1006/nimg.2002.1131; van den Bos W, 2011, PSYCHOL SCI, V22, P60, DOI 10.1177/0956797610391102; Van Overwalle F, 2009, NEUROIMAGE, V48, P564, DOI 10.1016/j.neuroimage.2009.06.009; Van Overwalle F, 2009, HUM BRAIN MAPP, V30, P829, DOI 10.1002/hbm.20547; Weil RS, 2010, CURR OPIN NEUROL, V23, P649, DOI 10.1097/WCO.0b013e32834028c7; Whitfield-Gabrieli S, 2011, NEUROIMAGE, V55, P225, DOI 10.1016/j.neuroimage.2010.11.048; Wiebking C, 2011, NEUROSCI LETT, V491, P87, DOI 10.1016/j.neulet.2011.01.012; Wiech K, 2010, J NEUROSCI, V30, P16324, DOI 10.1523/JNEUROSCI.2087-10.2010; Zahn R, 2007, P NATL ACAD SCI USA, V104, P6430, DOI 10.1073/pnas.0607061104	92	176	179	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e30920	10.1371/journal.pone.0030920	http://dx.doi.org/10.1371/journal.pone.0030920			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	917LO	22319593	gold, Green Published, Green Submitted			2022-12-27	WOS:000302178400018
J	Hengen, KB; Nelson, NR; Stang, KM; Johnson, SM; Crader, SM; Watters, JJ; Mitchell, GS; Behan, M				Hengen, Keith B.; Nelson, Nathan R.; Stang, Kyle M.; Johnson, Stephen M.; Crader, Stephanie M.; Watters, Jyoti J.; Mitchell, Gordon S.; Behan, Mary			Increased GABA(A) Receptor epsilon-Subunit Expression on Ventral Respiratory Column Neurons Protects Breathing during Pregnancy	PLOS ONE			English	Article							SYNAPTIC PLASTICITY; DELTA-SUBUNIT; RHYTHM; MODULATION; INSENSITIVITY; EXCITABILITY; ORGANIZATION; INHIBITION; MECHANISMS; ARC/ARG3.1	GABAergic signaling is essential for proper respiratory function. Potentiation of this signaling with allosteric modulators such as anesthetics, barbiturates, and neurosteroids can lead to respiratory arrest. Paradoxically, pregnant animals continue to breathe normally despite nearly 100-fold increases in circulating neurosteroids. epsilon subunit-containing GABA(A)Rs are insensitive to positive allosteric modulation, thus we hypothesized that pregnant rats increase e subunit-containing GABA(A)R expression on brainstem neurons of the ventral respiratory column (VRC). In vivo, pregnancy rendered respiratory motor output insensitive to otherwise lethal doses of pentobarbital, a barbiturate previously used to categorize the e subunit. Using electrode array recordings in vitro, we demonstrated that putative respiratory neurons of the preBotzinger Complex (preBotC) were also rendered insensitive to the effects of pentobarbital during pregnancy, but unit activity in the VRC was rapidly inhibited by the GABA(A)R agonist, muscimol. VRC unit activity from virgin and post-partum females was potently inhibited by both pentobarbital and muscimol. Brainstem e subunit mRNA and protein levels were increased in pregnant rats, and GABA(A)R epsilon subunit expression co-localized with a marker of rhythm generating neurons (neurokinin 1 receptors) in the preBotC. These data support the hypothesis that pregnancy renders respiratory motor output and respiratory neuron activity insensitive to barbiturates, most likely via increased epsilon subunit-containing GABA(A)R expression on respiratory rhythm-generating neurons. Increased epsilon subunit expression may be critical to preserve respiratory function (and life) despite increased neurosteroid levels during pregnancy.	[Hengen, Keith B.; Johnson, Stephen M.; Mitchell, Gordon S.; Behan, Mary] Univ Wisconsin, Neurosci Training Program, Madison, WI 53706 USA; [Nelson, Nathan R.; Stang, Kyle M.; Johnson, Stephen M.; Crader, Stephanie M.; Watters, Jyoti J.; Mitchell, Gordon S.; Behan, Mary] Univ Wisconsin, Dept Comparat Biomed Sci, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Hengen, KB (corresponding author), Univ Wisconsin, Neurosci Training Program, Madison, WI 53706 USA.	khengen@brandeis.edu		Hengen, Keith/0000-0001-5017-4090; Smith, Stephanie/0000-0002-2063-0515	National Institute on Aging [AG18760]; National Institutes of Health (PI GM) [T32 HL 7654-24]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007654] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049033] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG018760] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institutes of Health (PI GM); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The laboratory of MB is supported by a Research Project Grant from the National Institute on Aging (AG18760). At the time this work was completed, KH was supported by a training grant provided by the National Institutes of Health (PI GM; T32 HL 7654-24). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamos DA, 2008, COMPUT METH PROG BIO, V91, P232, DOI 10.1016/j.cmpb.2008.04.011; Alheid GF, 2004, RESP PHYSIOL NEUROBI, V143, P105, DOI 10.1016/j.resp.2004.06.016; Alheid GF, 2002, J NEUROCYTOL, V31, P693, DOI 10.1023/A:1025799830302; Backstrom T, 2003, ANN NY ACAD SCI, V1007, P42, DOI 10.1196/annals.1286.005; BAYLISS DA, 1987, P NATL ACAD SCI USA, V84, P7788, DOI 10.1073/pnas.84.21.7788; BAYLISS DA, 1992, J APPL PHYSIOL, V73, P393, DOI 10.1152/jappl.1992.73.2.393; BIANCHI AL, 1995, PHYSIOL REV, V75, P1, DOI 10.1152/physrev.1995.75.1.1; Bouvier J, 2010, NAT NEUROSCI, V13, P1066, DOI 10.1038/nn.2622; Davies PA, 1997, NATURE, V385, P820, DOI 10.1038/385820a0; Del Negro CA, 2002, NEURON, V34, P821, DOI 10.1016/S0896-6273(02)00712-2; Duffin J, 2004, EXP PHYSIOL, V89, P517, DOI 10.1113/expphysiol.2004.028027; Feldman JL, 2003, ANNU REV NEUROSCI, V26, P239, DOI 10.1146/annurev.neuro.26.041002.131103; FELDMAN JL, 1999, FUNDAMENTAL NEUROSCI, P1063; Feng HJ, 2010, J BIOL CHEM, V285, P23614, DOI 10.1074/jbc.M110.122564; Gao M, 2010, J NEUROSCI, V30, P7168, DOI 10.1523/JNEUROSCI.1067-10.2010; Hengen KB, 2011, AM J PHYSIOL-REG I, V300, pR272, DOI 10.1152/ajpregu.00607.2010; Hengen KB, 2009, AM J PHYSIOL-REG I, V297, pR1028, DOI 10.1152/ajpregu.00239.2009; Irnaten M, 2002, ANESTHESIOLOGY, V97, P717, DOI 10.1097/00000542-200209000-00027; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maguire J, 2008, NEURON, V59, P207, DOI 10.1016/j.neuron.2008.06.019; Maguire J, 2009, J NEUROSCI, V29, P9592, DOI 10.1523/JNEUROSCI.2162-09.2009; MANI SK, 1994, P NATL ACAD SCI USA, V91, P6468, DOI 10.1073/pnas.91.14.6468; Martyniuk CJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000894; Mortensen M, 2010, J PHYSIOL-LONDON, V588, P1251, DOI 10.1113/jphysiol.2009.182444; Paxinos G., 2004, RAT BRAIN STEREOTAXI; Pierrefiche O, 1998, J PHYSIOL-LONDON, V509, P245, DOI 10.1111/j.1469-7793.1998.245bo.x; Pintchovski SA, 2009, J NEUROSCI, V29, P1525, DOI 10.1523/JNEUROSCI.5575-08.2009; POKORSKI M, 1994, RESP PHYSIOL, V97, P33, DOI 10.1016/0034-5687(94)90010-8; Ramanan N, 2005, NAT NEUROSCI, V8, P759, DOI 10.1038/nn1462; Rekling JC, 1998, ANNU REV PHYSIOL, V60, P385, DOI 10.1146/annurev.physiol.60.1.385; Ren J, 2006, J NEUROSCI, V26, P3721, DOI 10.1523/JNEUROSCI.0026-06.2006; Ren J, 2006, J PHYSIOL-LONDON, V574, P535, DOI 10.1113/jphysiol.2006.108829; Rybak IA, 2007, PROG BRAIN RES, V165, P201, DOI 10.1016/S0079-6123(06)65013-9; Sebe JY, 2010, EUR J NEUROSCI, V32, P1310, DOI 10.1111/j.1460-9568.2010.07373.x; Smith JC, 1991, PREBOTZINGER COMPLEX; Smith JC, 2009, PHILOS T R SOC B, V364, P2577, DOI 10.1098/rstb.2009.0081; Smith SS, 2007, PHARMACOL THERAPEUT, V116, P58, DOI 10.1016/j.pharmthera.2007.03.008; Stell BM, 2003, P NATL ACAD SCI USA, V100, P14439, DOI 10.1073/pnas.2435457100; Stornetta RL, 2003, J COMP NEUROL, V455, P113, DOI 10.1002/cne.10486; Wagner DA, 2005, J NEUROSCI, V25, P10462, DOI 10.1523/JNEUROSCI.1658-05.2005; Wang H, 2001, J COMP NEUROL, V434, P128, DOI 10.1002/cne.1169; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Zeller A, 2007, MOL PHARMACOL, V71, P852, DOI 10.1124/mol.106.030049; Zuperku EJ, 2002, RESP PHYSIOL NEUROBI, V131, P121, DOI 10.1016/S1569-9048(02)00042-3	44	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2012	7	1							e30608	10.1371/journal.pone.0030608	http://dx.doi.org/10.1371/journal.pone.0030608			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	912BY	22303446	Green Published, Green Submitted, gold			2022-12-27	WOS:000301770700008
J	Smith, KF; Stefaniak, L; Saito, Y; Gemmill, CEC; Cary, SC; Fidler, AE				Smith, Kirsty F.; Stefaniak, Lauren; Saito, Yasunori; Gemmill, Chrissen E. C.; Cary, S. Craig; Fidler, Andrew E.			Increased Inter-Colony Fusion Rates Are Associated with Reduced COI Haplotype Diversity in an Invasive Colonial Ascidian Didemnum vexillum	PLOS ONE			English	Article							GERM-CELL PARASITISM; GENETIC DIVERSITY; NATURAL CHIMERISM; EVOLUTIONARY GENETICS; MITOCHONDRIAL GENOME; POPULATION; ALLORECOGNITION; BOTRYLLUS; PATTERNS; SUCCESS	Considerable progress in our understanding of the population genetic changes associated with biological invasions has been made over the past decade. Using selectively neutral loci, it has been established that reductions in genetic diversity, reflecting founder effects, have occurred during the establishment of some invasive populations. However, some colonial organisms may actually gain an ecological advantage from reduced genetic diversity because of the associated reduction in inter-colony conflict. Here we report population genetic analyses, along with colony fusion experiments, for a highly invasive colonial ascidian, Didemnum vexillum. Analyses based on mitochondrial cytochrome oxidase I (COI) partial coding sequences revealed two distinct D. vexillum clades. One COI clade appears to be restricted to the probable native region (i.e., north-west Pacific Ocean), while the other clade is present in widely dispersed temperate coastal waters around the world. This clade structure was supported by 18S ribosomal DNA (rDNA) sequence data, which revealed a one base-pair difference between the two clades. Recently established populations of D. vexillum in New Zealand displayed greatly reduced COI genetic diversity when compared with D. vexillum in Japan. In association with this reduction in genetic diversity was a significantly higher inter-colony fusion rate between randomly paired New Zealand D. vexillum colonies (80%, standard deviation +/- 18%) when compared with colonies found in Japan (27%, standard deviation +/- 15%). The results of this study add to growing evidence that for colonial organisms reductions in population level genetic diversity may alter colony interaction dynamics and enhance the invasive potential of newly colonizing species.	[Smith, Kirsty F.; Fidler, Andrew E.] Cawthron Inst, Nelson, New Zealand; [Smith, Kirsty F.; Gemmill, Chrissen E. C.; Cary, S. Craig] Univ Waikato, Dept Biol Sci, Hamilton, New Zealand; [Stefaniak, Lauren] Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA; [Saito, Yasunori] Univ Tsukuba, Shimoda Marine Res Ctr, Shimoda, Shizuoka, Japan	Cawthron Institute; University of Waikato; University of Connecticut; University of Tsukuba	Smith, KF (corresponding author), Cawthron Inst, Nelson, New Zealand.	kirsty.smith@cawthron.org.nz	Gemmill, Chrissen E C/E-5305-2013	Gemmill, Chrissen E C/0000-0002-1704-9893; Cary, Stephen/0000-0002-2876-2387	New Zealand Ministry of Science and Innovation [CAWX0802]; Education New Zealand Postgraduate Study Abroad Award	New Zealand Ministry of Science and Innovation; Education New Zealand Postgraduate Study Abroad Award	This research was funded by the New Zealand Ministry of Science and Innovation (CAWX0802) and an Education New Zealand Postgraduate Study Abroad Award to KFS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Shlomo R, 2008, BIOESSAYS, V30, P1048, DOI 10.1002/bies.20848; Ben-Shlomo R, 2008, GENETICA, V132, P51, DOI 10.1007/s10709-007-9148-3; Benabentos R, 2009, CURR BIOL, V19, P567, DOI 10.1016/j.cub.2009.02.037; Bishop JDD, 1999, P ROY SOC B-BIOL SCI, V266, P241, DOI 10.1098/rspb.1999.0628; BLOSSEY B, 1995, J ECOL, V83, P887, DOI 10.2307/2261425; Bullard SG, 2007, J EXP MAR BIOL ECOL, V342, P99, DOI 10.1016/j.jembe.2006.10.020; Caputi L, 2007, P NATL ACAD SCI USA, V104, P9364, DOI 10.1073/pnas.0610158104; CHAPMAN JW, 1991, J CRUSTACEAN BIOL, V11, P386, DOI 10.2307/1548465; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Coffey B., 2001, POTENTIALLY INVASIVE; Colautti RI, 2004, ECOL LETT, V7, P721, DOI 10.1111/j.1461-0248.2004.00616.x; Corin SE, 2007, INSECT SOC, V54, P275, DOI 10.1007/s00040-007-0942-9; Cote J, 2010, P ROY SOC B-BIOL SCI, V277, P1571, DOI 10.1098/rspb.2009.2128; Coutts ADM, 2002, BIOSECURITY INVESTIG; Coutts ADM, 2007, J EXP MAR BIOL ECOL, V342, P154, DOI 10.1016/j.jembe.2006.10.042; Crawford KM, 2010, MOL ECOL, V19, P1253, DOI 10.1111/j.1365-294X.2010.04550.x; Darling JA, 2008, MOL ECOL, V17, P4992, DOI 10.1111/j.1365-294X.2008.03978.x; De Tomaso AW, 2005, NATURE, V438, P454, DOI 10.1038/nature04150; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; Estoup A, 2010, MOL ECOL, V19, P4113, DOI 10.1111/j.1365-294X.2010.04773.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Forslund H, 2010, OECOLOGIA, V164, P833, DOI 10.1007/s00442-010-1767-1; Geller JB, 2010, ANNU REV MAR SCI, V2, P367, DOI 10.1146/annurev.marine.010908.163745; Gittenberger A, 2007, J EXP MAR BIOL ECOL, V342, P122, DOI 10.1016/j.jembe.2006.10.022; Gotzek D, 2007, Q REV BIOL, V82, P201, DOI 10.1086/519965; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; GROSBERG RK, 1988, Q REV BIOL, V63, P377, DOI 10.1086/416026; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Helantera H, 2009, TRENDS ECOL EVOL, V24, P341, DOI 10.1016/j.tree.2009.01.013; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Iannelli F, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-155; Kelly DW, 2006, MOL ECOL, V15, P3641, DOI 10.1111/j.1365-294X.2006.03012.x; Kolbe JJ, 2004, NATURE, V431, P177, DOI 10.1038/nature02807; Kott P, 2002, J MAR BIOL ASSOC UK, V82, P625, DOI 10.1017/S0025315402005970; Lambert Gretchen, 2009, Aquatic Invasions, V4, P5, DOI 10.3391/ai.2009.4.1.2; Lee CE, 2002, TRENDS ECOL EVOL, V17, P386, DOI 10.1016/S0169-5347(02)02554-5; Lopez-Legentil S, 2005, ZOOL SCR, V34, P3, DOI 10.1111/j.1463-6409.2005.00167.x; Lopez-Legentil S, 2006, MOL ECOL, V15, P3957, DOI 10.1111/j.1365-294X.2006.03087.x; McKitrick TR, 2010, SEMIN IMMUNOL, V22, P34, DOI 10.1016/j.smim.2009.12.001; Minchin Dan, 2006, Aquatic Invasions, V1, P143, DOI 10.3391/ai.2006.1.3.8; Mooney HA, 2001, P NATL ACAD SCI USA, V98, P5446, DOI 10.1073/pnas.091093398; MUKAI H, 1974, BIOL BULL-US, V147, P411, DOI 10.2307/1540458; Nakagawa H, 1965, SCI REP TOHOKU U, V37, P31; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; Nentwig W, 2007, ECOLOGICAL STUDIES, V193; Nydam ML, 2011, EVOLUTION, V65, P429, DOI 10.1111/j.1558-5646.2010.01153.x; Nydam ML, 2010, MOL PHYLOGENET EVOL, V56, P718, DOI 10.1016/j.ympev.2010.03.042; Nylander J.A.A., 2004, MRMODELTEST V2 PROGR; Payne CM, 2004, ANN ZOOL FENN, V41, P843; Perez-Portela R, 2008, ZOOLOGY, V111, P163, DOI 10.1016/j.zool.2007.06.006; Phillips BL, 2010, J EVOLUTION BIOL, V23, P2595, DOI 10.1111/j.1420-9101.2010.02118.x; Pimentel D, 2000, BIOSCIENCE, V50, P53, DOI 10.1641/0006-3568(2000)050[0053:EAECON]2.3.CO;2; Price A, 2005, 200601 GSO U RHOD IS; Puillandre N, 2008, BIOL INVASIONS, V10, P319, DOI 10.1007/s10530-007-9132-y; Ramstad KM, 2007, AM FISH S S, V54, P31; Rinkevich B, 2005, J EXP MAR BIOL ECOL, V322, P93, DOI 10.1016/j.jembe.2005.02.020; Rinkevich B, 2005, CAN J ZOOL, V83, P101, DOI 10.1139/Z04-161; Rinkevich B, 2004, J EXP BIOL, V207, P3531, DOI 10.1242/jeb.01184; Roman J, 2007, TRENDS ECOL EVOL, V22, P454, DOI 10.1016/j.tree.2007.07.002; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; SAITO Y, 1994, INT J DEV BIOL, V38, P237; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Salo P, 2007, P ROY SOC B-BIOL SCI, V274, P1237, DOI 10.1098/rspb.2006.0444; Sax DF, 2000, GLOBAL ECOL BIOGEOGR, V9, P363, DOI 10.1046/j.1365-2699.2000.00217.x; Silva N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002552; Sommerfeldt AD, 1999, MOL ECOL, V8, P885; Sommerfeldt AD, 2003, BIOL J LINN SOC, V79, P183, DOI 10.1046/j.1095-8312.2003.00179.x; Stefaniak Lauren, 2009, Aquatic Invasions, V4, P29, DOI 10.3391/ai.2009.4.1.3; Stoner DS, 1996, P NATL ACAD SCI USA, V93, P15254, DOI 10.1073/pnas.93.26.15254; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tarjuelo I, 2004, MOL ECOL, V13, P3125, DOI 10.1111/j.1365-294X.2004.02306.x; Tarjuelo I, 2001, MAR BIOL, V139, P455; Tsagkogeorga G, 2010, J MOL EVOL, V71, P153, DOI 10.1007/s00239-010-9372-9; Tsutsui ND, 2000, P NATL ACAD SCI USA, V97, P5948, DOI 10.1073/pnas.100110397; Turon X, 2003, HYDROBIOLOGIA, V503, P29, DOI 10.1023/B:HYDR.0000008481.10705.c2; Valentine PC, 2007, J EXP MAR BIOL ECOL, V342, P109, DOI 10.1016/j.jembe.2006.10.021; Van Bocxlaer I, 2010, SCIENCE, V327, P679, DOI 10.1126/science.1181707; van Wilgenburg E, 2010, EVOL APPL, V3, P136, DOI 10.1111/j.1752-4571.2009.00114.x; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Voisin M, 2005, P NATL ACAD SCI USA, V102, P5432, DOI 10.1073/pnas.0501754102; Westerman EL, 2009, MAR BIOL, V156, P2613, DOI 10.1007/s00227-009-1287-x; Williamson MH, 1996, BIOL CONSERV, V78, P163, DOI 10.1016/0006-3207(96)00025-0; Winchell CJ, 2002, MOL BIOL EVOL, V19, P762, DOI 10.1093/oxfordjournals.molbev.a004134; Winkler G, 2008, MOL ECOL, V17, P415, DOI 10.1111/j.1365-294X.2007.03480.x; Yokobori S, 2005, MOL PHYLOGENET EVOL, V34, P273, DOI 10.1016/j.ympev.2004.10.002; Zhan AB, 2010, MOL ECOL, V19, P4678, DOI 10.1111/j.1365-294X.2010.04837.x	87	22	22	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2012	7	1							e30473	10.1371/journal.pone.0030473	http://dx.doi.org/10.1371/journal.pone.0030473			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	912BY	22303442	Green Submitted, Green Published, gold			2022-12-27	WOS:000301770700007
J	Park, JES; Shao, DM; Upton, PD; deSouza, P; Adcock, IM; Davies, RJ; Morrell, NW; Griffiths, MJD; Wort, SJ				Park, John E. S.; Shao, Dongmin; Upton, Paul D.; deSouza, Patricia; Adcock, Ian M.; Davies, Rachel J.; Morrell, Nicholas W.; Griffiths, Mark J. D.; Wort, Stephen J.			BMP-9 Induced Endothelial Cell Tubule Formation and Inhibition of Migration Involves Smad1 Driven Endothelin-1 Production	PLOS ONE			English	Article							PULMONARY ARTERIAL-HYPERTENSION; MORPHOGENETIC PROTEIN BMP; GERMLINE MUTATIONS; KINASE INHIBITORS; RECEPTOR; EXPRESSION; ACTIVATION; PATHWAY; BINDING; GENE	Background: Bone morphogenetic proteins (BMPs) and their receptors, such as bone morphogenetic protein receptor (BMPR) II, have been implicated in a wide variety of disorders including pulmonary arterial hypertension (PAH). Similarly, endothelin-1 (ET-1), a mitogen and vasoconstrictor, is upregulated in PAH and endothelin receptor antagonists are used in its treatment. We sought to determine whether there is crosstalk between BMP signalling and the ET-1 axis in human pulmonary artery endothelial cells (HPAECs), possible mechanisms involved in such crosstalk and functional consequences thereof. Methodology/Principal Finding: Using western blot, real time RT-PCR, ELISA and small RNA interference methods we provide evidence that in HPAECs BMP-9, but not BMP-2, -4 and -6 significantly stimulated ET-1 release under physiological concentrations. This release is mediated by both Smad1 and p38 MAPK and is independent of the canonical Smad4 pathway. Moreover, knocking down the ALK1 receptor or BMPR II attenuates BMP-9 stimulated ET-1 release, whilst causing a significant increase in prepro ET-1 mRNA transcription and mature peptide release. Finally, BMP-9 induced ET-1 release is involved in both inhibition of endothelial cell migration and promotion of tubule formation. Conclusions/Significance: Although our data does not support an important role for BMP-9 as a source of increased endothelial ET-1 production seen in human PAH, BMP-9 stimulated ET-1 production is likely to be important in angiogenesis and vascular stability. However, increased ET-1 production by endothelial cells as a consequence of BMPR II dysfunction may be clinically relevant in the pathogenesis of PAH.	[Park, John E. S.; Shao, Dongmin; deSouza, Patricia; Griffiths, Mark J. D.; Wort, Stephen J.] Univ London Imperial Coll Sci Technol & Med, Royal Brompton Hosp, Crit Care Unit, Natl Heart & Lung Inst,Fac Med, London, England; [Upton, Paul D.; Davies, Rachel J.; Morrell, Nicholas W.] Univ Cambridge, Addenbrookes Hosp, Dept Med, Sch Clin Med, Cambridge CB2 2QQ, England; [Adcock, Ian M.] Univ London Imperial Coll Sci Technol & Med, Airways Dis Sect, Natl Heart & Lung Inst, Fac Med, London, England	Imperial College London; Royal Brompton Hospital; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Imperial College London	Park, JES (corresponding author), Univ London Imperial Coll Sci Technol & Med, Royal Brompton Hosp, Crit Care Unit, Natl Heart & Lung Inst,Fac Med, London, England.	m.griffiths@imperial.ac.uk; s.wort@imperial.ac.uk	wei, wei/HHR-8613-2022; Adcock, Ian/L-3217-2019	Morrell, Nicholas/0000-0001-5700-9792; Griffiths, Mark/0000-0002-1615-1896; Adcock, Ian/0000-0003-2101-8843	British Heart Foundation [PG/07/032/22768, RG/08/002/24718]; Medical Research Council [G0701361]; NIHR (National Institute for Health Research) Respiratory Disease BRU (Biomedical Research Unit) at the Royal Brompton; Harefield NHS Foundation Trust; Imperial College London; MRC [G0800784, G1000847, G0701361] Funding Source: UKRI; Medical Research Council [G1000847, G0800784, G1000758B, G1000758] Funding Source: researchfish; National Institute for Health Research [NF-SI-0509-10174, NF-SI-0508-10212] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR (National Institute for Health Research) Respiratory Disease BRU (Biomedical Research Unit) at the Royal Brompton; Harefield NHS Foundation Trust; Imperial College London(General Electric); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This study was supported by the British Heart Foundation (PG/07/032/22768 and RG/08/002/24718) and Medical Research Council (G0701361). It was also supported by the NIHR (National Institute for Health Research) Respiratory Disease BRU (Biomedical Research Unit) at the Royal Brompton and Harefield NHS Foundation Trust and Imperial College London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson C, 2002, CIRCULATION, V105, P1672, DOI 10.1161/01.CIR.0000012754.72951.3D; Bagnall AJ, 2006, HYPERTENSION, V48, P286, DOI 10.1161/01.HYP.0000229907.58470.4c; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bhalla A, 2009, EUR J CLIN INVEST, V39, P74, DOI 10.1111/j.1365-2362.2009.02123.x; Cacoub P, 1997, CARDIOVASC RES, V33, P196, DOI 10.1016/S0008-6363(96)00189-7; Castanares C, 2007, J CELL SCI, V120, P1256, DOI 10.1242/jcs.03419; Daher Z, 2008, CELL SIGNAL, V20, P2256, DOI 10.1016/j.cellsig.2008.08.021; David L, 2008, CIRC RES, V102, P914, DOI 10.1161/CIRCRESAHA.107.165530; David L, 2007, BLOOD, V109, P1953, DOI 10.1182/blood-2006-07-034124; Descargues P, 2008, P NATL ACAD SCI USA, V105, P2487, DOI 10.1073/pnas.0712044105; Du Lingling, 2003, New England Journal of Medicine, V348, P500, DOI 10.1056/NEJMoa021650; Fernandez-Lopez A, 2007, HUM MOL GENET, V16, P1515, DOI 10.1093/hmg/ddm069; Hall SM, 2011, EUR RESPIR J, V38, P851, DOI 10.1183/09031936.00167010; He W, 2006, CELL, V125, P929, DOI 10.1016/j.cell.2006.03.045; Hong KH, 2008, CIRCULATION, V118, P722, DOI 10.1161/CIRCULATIONAHA.107.736801; Huang MS, 2007, J BIOL CHEM, V282, P21237, DOI 10.1074/jbc.M701341200; Humbert M, 2005, NAT CLIN PRACT RHEUM, V1, P93, DOI 10.1038/ncprheum0048; Kern JM, 2009, THROMB HAEMOSTASIS, V102, P743, DOI 10.1160/TH09-02-0128; Kimura N, 2000, J BIOL CHEM, V275, P17647, DOI 10.1074/jbc.M908622199; Lane KB, 2000, NAT GENET, V26, P81, DOI 10.1038/79226; Lee NY, 2009, FASEB J, V23, P3712, DOI 10.1096/fj.09-131607; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lux Andreas, 2006, BMC Cardiovasc Disord, V6, P13, DOI 10.1186/1471-2261-6-13; Machado RD, 2001, AM J HUM GENET, V68, P92, DOI 10.1086/316947; Mayer RJ, 2006, DRUG DISCOV TODAY, V3, p[38, 6]; Meoli DF, 2010, CAN J PHYSIOL PHARM, V88, P830, DOI 10.1139/Y10-059; Morikawa M, 2011, NUCLEIC ACIDS RES, V39, P8712, DOI 10.1093/nar/gkr572; Morrell Nicholas W, 2006, Proc Am Thorac Soc, V3, P680, DOI 10.1513/pats.200605-118SF; Mukhopadhyay A, 2009, DEVELOPMENT, V136, P2633, DOI 10.1242/dev.034439; NISHIMURA J, 1995, BRIT J PHARMACOL, V115, P1369, DOI 10.1111/j.1476-5381.1995.tb16625.x; Nohe A, 2002, J BIOL CHEM, V277, P5330, DOI 10.1074/jbc.M102750200; Park J, 2010, AM J RESP CRIT CARE, V181, pA5240; Park JK, 2007, HYPERTENSION, V49, P481, DOI 10.1161/01.HYP.0000256831.33459.ea; Price LC, 2011, EUR RESPIR J, V37, P813, DOI 10.1183/09031936.00028310; Rodriguez-Pascual F, 2004, J CARDIOVASC PHARM, V44, pS39, DOI 10.1097/01.fjc.0000166216.27544.22; Rondelet B, 2004, CIRCULATION, V110, P2220, DOI 10.1161/01.CIR.0000143836.40431.F5; Rothhammer T, 2007, ONCOGENE, V26, P4158, DOI 10.1038/sj.onc.1210182; Rubin LJ, 2002, NEW ENGL J MED, V346, P896, DOI 10.1056/NEJMoa012212; Salani D, 2000, AM J PATHOL, V157, P1537, DOI 10.1016/S0002-9440(10)64791-8; Scharpfenecker M, 2007, J CELL SCI, V120, P964, DOI 10.1242/jcs.002949; Shao DM, 2011, PHARMACOL RES, V63, P504, DOI 10.1016/j.phrs.2011.03.003; Star GP, 2010, MICROVASC RES, V80, P349, DOI 10.1016/j.mvr.2010.05.010; Su D, 2010, BIOCHEM J, V433, P333; Suzuki Y, 2010, J CELL SCI, V123, P1684, DOI 10.1242/jcs.061556; Takahashi H, 2006, AM J PHYSIOL-LUNG C, V290, pL450, DOI 10.1152/ajplung.00206.2005; Talati M, 2010, AM J PHYSIOL-LUNG C, V299, pL363, DOI 10.1152/ajplung.00295.2009; Thomson JR, 2000, J MED GENET, V37, P741, DOI 10.1136/jmg.37.10.741; Upton PD, 2008, MOL PHARMACOL, V73, P539, DOI 10.1124/mol.107.041673; Upton PD, 2009, J BIOL CHEM, V284, P15794, DOI 10.1074/jbc.M109.002881; Wang HH, 2010, J NEUROCHEM, V113, P1133, DOI 10.1111/j.1471-4159.2010.06680.x; Wendel M, 2004, HISTOCHEM CELL BIOL, V122, P507, DOI 10.1007/s00418-004-0708-7; Wort SJ, 2009, J BIOL CHEM, V284, P24297, DOI 10.1074/jbc.M109.032524; Yang XD, 2005, CIRC RES, V96, P1053, DOI 10.1161/01.RES.0000166926.54293.68; Yang XD, 2007, AM J RESP CELL MOL, V37, P598, DOI 10.1165/rcmb.2006-0360OC; YOSHIBAYASHI M, 1991, CIRCULATION, V84, P2280, DOI 10.1161/01.CIR.84.6.2280; Zeng S, 2010, CELL SIGNAL, V22, P888, DOI 10.1016/j.cellsig.2009.12.007	57	27	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e30075	10.1371/journal.pone.0030075	http://dx.doi.org/10.1371/journal.pone.0030075			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22299030	Green Published, Green Submitted, gold			2022-12-27	WOS:000301704200007
J	Pascoal, S; Carvalho, G; Creer, S; Rock, J; Kawaii, K; Mendo, S; Hughes, R				Pascoal, Sonia; Carvalho, Gary; Creer, Simon; Rock, Jenny; Kawaii, Kei; Mendo, Sonia; Hughes, Roger			Plastic and Heritable Components of Phenotypic Variation in Nucella lapillus: An Assessment Using Reciprocal Transplant and Common Garden Experiments	PLOS ONE			English	Article							INTERTIDAL SNAIL; DOG-WHELK; SHELL FORM; FORAGING BEHAVIOR; LIFE-HISTORY; GROWTH-RATE; CHROMOSOMAL-POLYMORPHISM; GEOMETRIC MORPHOMETRICS; LOCAL EXTINCTION; MARINE SNAIL	Assessment of plastic and heritable components of phenotypic variation is crucial for understanding the evolution of adaptive character traits in heterogeneous environments. We assessed the above in relation to adaptive shell morphology of the rocky intertidal snail Nucella lapillus by reciprocal transplantation of snails between two shores differing in wave action and rearing snails of the same provenance in a common garden. Results were compared with those reported for similar experiments conducted elsewhere. Microsatellite variation indicated limited gene flow between the populations. Intrinsic growth rate was greater in exposed-site than sheltered-site snails, but the reverse was true of absolute growth rate, suggesting heritable compensation for reduced foraging opportunity at the exposed site. Shell morphology of reciprocal transplants partially converged through plasticity toward that of native snails. Shell morphology of F(2)s in the common garden partially retained characteristics of the P-generation, suggesting genetic control. A maternal effect was revealed by greater resemblance of F(1)s than F(2)s to the P-generation. The observed synergistic effects of plastic, maternal and genetic control of shell-shape may be expected to maximise fitness when environmental characteristics become unpredictable through dispersal.	[Pascoal, Sonia; Carvalho, Gary; Creer, Simon; Hughes, Roger] Bangor Univ, Sch Biol Sci, Environm Ctr Wales, Mol Ecol & Fisheries Genet Lab, Bangor, Gwynedd, Wales; [Pascoal, Sonia; Mendo, Sonia] Univ Aveiro, Dept Biol, Ctr Environm & Marine Studies CESAM, P-3800 Aveiro, Portugal; [Rock, Jenny] Univ Otago, Dept Zool, Ctr Sci Commun, Dunedin, New Zealand; [Kawaii, Kei] Kagoshima Univ, Res Ctr Pacific Isl, Kagoshima 890, Japan	Bangor University; Universidade de Aveiro; University of Otago; Kagoshima University	Pascoal, S (corresponding author), Bangor Univ, Sch Biol Sci, Environm Ctr Wales, Mol Ecol & Fisheries Genet Lab, Bangor, Gwynedd, Wales.	r.n.hughes@bangor.ac.uk	; Mendo, Sonia/E-1095-2011	Rock, Jenny/0000-0001-7250-6463; Mendo, Sonia/0000-0001-5057-5660	Fundacao para a Ciencia e a Tecnologia (FCT) [SFRH/BD/27711/2006]	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by Fundacao para a Ciencia e a Tecnologia (FCT) through Ph.D. grant SFRH/BD/27711/2006 awarded to Dr. Pascoal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DC, 2004, ITAL J ZOOL, V71, P5, DOI 10.1080/11250000409356545; APPLETON RD, 1988, P NATL ACAD SCI USA, V85, P4387, DOI 10.1073/pnas.85.12.4387; BANTOCK CR, 1975, HEREDITY, V34, P231, DOI 10.1038/hdy.1975.26; BOULDING EG, 1993, EVOLUTION, V47, P576, DOI 10.1111/j.1558-5646.1993.tb02114.x; BRADSHAW A. D., 1965, ADVANCE GENET, V13, P115, DOI 10.1016/S0065-2660(08)60048-6; Bronmark C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021773; BURROWS MT, 1989, J MOLLUS STUD, V55, P285, DOI 10.1093/mollus/55.2.285; BURROWS MT, 1991, FUNCT ECOL, V5, P461, DOI 10.2307/2389628; BURROWS MT, 1990, J ANIM ECOL, V59, P723, DOI 10.2307/4891; Carvajal-Rodriguez A, 2005, J MOLLUS STUD, V71, P313, DOI 10.1093/mollus/eyi037; Carvajal-Rodriguez A, 2005, ONLINE J BIOINFORMAT, V6, P34; Cavalcanti MJ, 1999, ZOOL STUD, V38, P287; Colson I, 2004, MOL ECOL, V13, P2223, DOI 10.1111/j.1365-294X.2004.02245.x; Colson I, 2006, INTEGR ZOOL, V1, P104, DOI 10.1111/j.1749-4877.2006.00022.x; COOMBS VA, 1973, J ZOOL, V171, P57; CROTHERS J H, 1985, Field Studies, V6, P291; CURREY JD, 1982, J ANIM ECOL, V51, P47, DOI 10.2307/4309; DAY AJ, 1988, MAR BIOL, V99, P93, DOI 10.1007/BF00644981; DAY AJ, 1990, BIOL J LINN SOC, V40, P245, DOI 10.1111/j.1095-8312.1990.tb00538.x; Denny M. W., 1988, BIOL MECH WAVE SWEPT; DeWitt TJ, 1998, J EVOLUTION BIOL, V11, P465, DOI 10.1007/s000360050100; Endler J.A., 1986, Monographs in Population Biology, pviii; Etter RJ, 1996, J EXP MAR BIOL ECOL, V196, P341, DOI 10.1016/0022-0981(95)00139-5; ETTER RJ, 1988, EVOLUTION, V42, P660, DOI 10.1111/j.1558-5646.1988.tb02485.x; ETTER RJ, 1988, EVOLUTION, V42, P322, DOI 10.1111/j.1558-5646.1988.tb04136.x; GOUDET J, 1994, GENETICS AND EVOLUTION OF AQUATIC ORGANISMS, P81; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; GOULD SJ, 1966, BIOL REV, V41, P587, DOI 10.1111/j.1469-185X.1966.tb01624.x; Guerra-Varela J, 2009, EVOL ECOL, V23, P261, DOI 10.1007/s10682-007-9221-5; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hellberg ME, 2002, B MAR SCI, V70, P273; Hollander J, 2006, J EVOLUTION BIOL, V19, P1861, DOI 10.1111/j.1420-9101.2006.01171.x; Hollander J, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-333; HUGHES RN, 1979, J ANIM ECOL, V48, P65, DOI 10.2307/4100; Hughes RN, 1997, P ROY SOC B-BIOL SCI, V264, P417, DOI 10.1098/rspb.1997.0059; HUGHES RN, 1972, OECOLOGIA, V8, P356, DOI 10.1007/BF00367538; HUGHES RN, 1992, J EXP MAR BIOL ECOL, V155, P199, DOI 10.1016/0022-0981(92)90063-G; JANSON K, 1982, MAR BIOL, V69, P73, DOI 10.1007/BF00396963; Johannesson B, 1996, J ZOOL, V240, P475, DOI 10.1111/j.1469-7998.1996.tb05299.x; Johannesson K, 1997, BIOL J LINN SOC, V61, P267; Johnson MS, 1998, MAR BIOL, V132, P295, DOI 10.1007/s002270050395; Kawai K, 2001, MOL ECOL NOTES, V1, P270, DOI 10.1046/j.1471-8278 .2001.00103.x; Kirby RR, 2004, J MOL EVOL, V58, P97, DOI 10.1007/s00239-003-2528-0; Kirby RR, 2000, MOL BIOL EVOL, V17, P1816, DOI 10.1093/oxfordjournals.molbev.a026282; KIRBY RR, 1994, BIOL J LINN SOC, V53, P255; Kirby RR, 1997, BIOL J LINN SOC, V62, P299, DOI 10.1006/bijl.1997.0164; Kirby RR, 2000, GENE, V245, P81, DOI 10.1016/S0378-1119(00)00036-6; KITCHING JA, 1977, J EXP MAR BIOL ECOL, V26, P275, DOI 10.1016/0022-0981(77)90087-9; KITCHING JA, 1966, J ANIM ECOL, V35, P113, DOI 10.2307/2693; KITCHING JA, 1976, J EXP MAR BIOL ECOL, V23, P109, DOI 10.1016/0022-0981(76)90135-0; LAM PKS, 1988, J MOLLUS STUD, V54, P197, DOI 10.1093/mollus/54.2.197; LEVINS RICHARD, 1968; Marshall DJ, 2008, OCEANOGR MAR BIOL, V46, P203, DOI 10.1201/9781420065756.ch5; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; McQuaid C.D., 1988, NATO ASI (Advanced Science Institutes) Series Series A Life Sciences, P213; MENGE BA, 1978, OECOLOGIA, V34, P1, DOI 10.1007/BF00346237; MORAN NA, 1992, AM NAT, V139, P971, DOI 10.1086/285369; PALMER AR, 1990, HYDROBIOLOGIA, V193, P155, DOI 10.1007/BF00028074; PALUMBI SR, 1994, ANNU REV ECOL SYST, V25, P547, DOI 10.1146/annurev.es.25.110194.002555; PALUMBI SR, 1984, SCIENCE, V225, P1478, DOI 10.1126/science.225.4669.1478; Pardo LM, 2005, MAR ECOL PROG SER, V296, P229, DOI 10.3354/meps296229; Pascoe PL, 2006, BIOL J LINN SOC, V87, P195, DOI 10.1111/j.1095-8312.2006.00567.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pigliucci M., 2001, SYN ECO EVO; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rock J, 1996, CYTOGENET CELL GENET, V73, P187, DOI 10.1159/000134336; Rohlf FJ, 2003, SYST BIOL, V52, P66, DOI 10.1080/10635150390132759; Rohlf FJ, 1998, SYST BIOL, V47, P147, DOI 10.1080/106351598261094; Rolan E, 2004, J MOLLUS STUD, V70, P179, DOI 10.1093/mollus/70.2.179; Sanford E, 2010, ECOLOGY, V91, P891, DOI 10.1890/09-0536.1; Schlichting CD, 1998, PHENOTYPIC EVOLUTION; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; Staiger H, 1957, ANN BIOL, V5/6; STEARNS SC, 1989, BIOSCIENCE, V39, P436, DOI 10.2307/1311135; STRUHSAKER JW, 1968, EVOLUTION, V22, P459, DOI 10.1111/j.1558-5646.1968.tb03986.x; THOMAS MLH, 1986, OPHELIA, V25, P1; Travis Joseph, 1994, P99; Trussell GC, 2000, EVOL ECOL RES, V2, P803; Trussell GC, 1997, ECOLOGY, V78, P1033, DOI 10.2307/2265856; Trussell GC, 2002, MAR ECOL PROG SER, V243, P123, DOI 10.3354/meps243123; Trussell GC, 1996, EVOLUTION, V50, P448, DOI 10.1111/j.1558-5646.1996.tb04507.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; VERMEIJ GJ, 1982, NATURE, V299, P349, DOI 10.1038/299349a0; VIA S, 1995, TRENDS ECOL EVOL, V10, P212, DOI 10.1016/S0169-5347(00)89061-8; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wilding CS, 2001, J EVOLUTION BIOL, V14, P611, DOI 10.1046/j.1420-9101.2001.00304.x	87	18	18	2	122	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e30289	10.1371/journal.pone.0030289	http://dx.doi.org/10.1371/journal.pone.0030289			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22299035	Green Published, Green Submitted, gold			2022-12-27	WOS:000301704200012
J	Yan, XC; Ding, L; Li, YC; Zhang, XF; Liang, Y; Sun, XW; Teng, CB				Yan, Xuechun; Ding, Lei; Li, Yunchao; Zhang, Xiaofeng; Liang, Yang; Sun, Xiaowen; Teng, Chun-Bo			Identification and Profiling of MicroRNAs from Skeletal Muscle of the Common Carp	PLOS ONE			English	Article							CYPRINUS-CARPIO; MYOGENIC DIFFERENTIATION; MYOBLAST DIFFERENTIATION; C-ELEGANS; EXPRESSION; MIR-206; TARGETS; PROTEIN; GROWTH; RHABDOMYOSARCOMA	The common carp is one of the most important cultivated species in the world of freshwater aquaculture. The cultivation of this species is particularly productive due to its high skeletal muscle mass; however, the molecular mechanisms of skeletal muscle development in the common carp remain unknown. It has been shown that a class of non-coding,22 nucleotide RNAs called microRNAs (miRNAs) play important roles in vertebrate development. They regulate gene expression through sequence-specific interactions with the 39 untranslated regions (UTRs) of target mRNAs and thereby cause translational repression or mRNA destabilization. Intriguingly, the role of miRNAs in the skeletal muscle development of the common carp remains unknown. In this study, a small-RNA cDNA library was constructed from the skeletal muscle of the common carp, and Solexa sequencing technology was used to perform high throughput sequencing of the library. Subsequent bioinformatics analysis identified 188 conserved miRNAs and 7 novel miRNAs in the carp skeletal muscle. The miRNA expression profiling showed that, miR-1, miR-133a-3p, and miR-206 were specifically expressed in muscle-containing organs, and that miR-1, miR-21, miR-26a, miR-27a, miR-133a-3p, miR-206, miR-214 and miR-222 were differentially expressed in the process of skeletal muscle development of the common carp. This study provides a first identification and profiling of miRNAs related to the muscle biology of the common carp. Their identification could provide clues leading towards a better understanding of the molecular mechanisms of carp skeletal muscle development.	[Yan, Xuechun; Zhang, Xiaofeng; Sun, Xiaowen] Chinese Acad Fishery Sci, Heilongjiang River Fisheries Res Inst, Key Lab Aquat Biotechnol, Harbin, Peoples R China; [Ding, Lei; Li, Yunchao; Liang, Yang; Teng, Chun-Bo] NE Forestry Univ, Coll Life Sci, Harbin, Peoples R China	Chinese Academy of Fishery Sciences; Heilongjiang River Fisheries Research Institute, CAFS; Northeast Forestry University - China	Yan, XC (corresponding author), Chinese Acad Fishery Sci, Heilongjiang River Fisheries Res Inst, Key Lab Aquat Biotechnol, Harbin, Peoples R China.	sxw2002@163.com; chunboteng@nefu.edu.cn	Sun, Xiaowen/F-1516-2014		National High Technology Research and Development Program of China (863 Program) [2009AA10Z105, 2011AA100400, 2011AA100404GRAM09]; Fundamental Research Funds for the Central Universities [DL09CA16]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the grants from the National High Technology Research and Development Program of China (863 Program) (No. 2009AA10Z105, 2011AA100400, 2011AA100404GRAM09), and the Fundamental Research Funds for the Central Universities (No. DL09CA16). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DL, 2011, AM J PHYSIOL-CELL PH, V300, pC124, DOI 10.1152/ajpcell.00142.2010; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Anderson C, 2006, NUCLEIC ACIDS RES, V34, P5863, DOI 10.1093/nar/gkl743; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Blenkiron C, 2007, HUM MOL GENET, V16, pR106, DOI 10.1093/hmg/ddm056; Braun T, 2011, NAT REV MOL CELL BIO, V12, P349, DOI 10.1038/nrm3118; Buckingham M, 2001, CURR OPIN GENET DEV, V11, P440, DOI 10.1016/S0959-437X(00)00215-X; Cardinali B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007607; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen JF, 2010, J CELL BIOL, V190, P867, DOI 10.1083/jcb.200911036; Cheng L, 2010, ANIM GENET, V41, P191, DOI 10.1111/j.1365-2052.2009.01985.x; Chi W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023549; Crippa S, 2011, J CELL BIOL, V193, P1197, DOI 10.1083/jcb.201011099; Crist CG, 2009, P NATL ACAD SCI USA, V106, P13383, DOI 10.1073/pnas.0900210106; Drummond MJ, 2009, J NUTR, V139, P2279, DOI 10.3945/jn.109.112797; Du TT, 2005, DEVELOPMENT, V132, P4645, DOI 10.1242/dev.02070; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; *FAO, 2002, YB FISH STAT SUMM TA; Flynt AS, 2007, NAT GENET, V39, P259, DOI 10.1038/ng1953; Gagan J, 2011, J BIOL CHEM, V286, P19431, DOI 10.1074/jbc.M111.219006; Ge YJ, 2011, CELL CYCLE, V10, P441, DOI 10.4161/cc.10.3.14710; Ge YJ, 2011, J CELL BIOL, V192, P69, DOI 10.1083/jcb.201007165; Guller I, 2010, J PHYSIOL-LONDON, V588, P4075, DOI 10.1113/jphysiol.2010.194175; Haider KH, 2010, CARDIOVASC RES, V88, P168, DOI 10.1093/cvr/cvq151; Huang TH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003225; Juan AH, 2009, MOL CELL, V36, P61, DOI 10.1016/j.molcel.2009.08.008; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; Kim J, 2010, MOL BIOL REP, V37, P3567, DOI 10.1007/s11033-010-0005-6; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Liu J, 2010, J BIOL CHEM, V285, P26599, DOI 10.1074/jbc.M110.115824; Mishima Y, 2009, GENE DEV, V23, P619, DOI 10.1101/gad.1760209; Naguibneva I, 2006, NAT CELL BIOL, V8, P278, DOI 10.1038/ncb1373; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Rosenberg MI, 2006, J CELL BIOL, V175, P77, DOI 10.1083/jcb.200603039; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Seok HY, 2011, J BIOL CHEM, V286, P35339, DOI 10.1074/jbc.M111.273276; Sun Q, 2008, NUCLEIC ACIDS RES, V36, P2690, DOI 10.1093/nar/gkn032; Sun XW, 2004, AQUACULTURE, V238, P165, DOI 10.1016/S0044-8486(03)00445-9; Tanck MWT, 2001, GENOME, V44, P743, DOI 10.1139/gen-44-5-743; Taulli R, 2009, J CLIN INVEST, V119, P2366, DOI 10.1172/JCI38075; Urbich C, 2008, CARDIOVASC RES, V79, P581, DOI 10.1093/cvr/cvn156; Vandeputte M, 2003, AQUAT LIVING RESOUR, V16, P399, DOI 10.1016/S0990-7440(03)00056-1; Wang H, 2008, CANCER CELL, V14, P369, DOI 10.1016/j.ccr.2008.10.006; Wei YY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r6; Wong CF, 2008, J BIOL CHEM, V283, P9836, DOI 10.1074/jbc.M709614200; Yan D, 2009, J BIOL CHEM, V284, P29596, DOI 10.1074/jbc.M109.020511	50	59	203	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e30925	10.1371/journal.pone.0030925	http://dx.doi.org/10.1371/journal.pone.0030925			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22303472	gold, Green Submitted, Green Published			2022-12-27	WOS:000301704200047
J	Farallo, VR; Forstner, MRJ				Farallo, Vincent R.; Forstner, Michael R. J.			Predation and the Maintenance of Color Polymorphism in a Habitat Specialist Squamate	PLOS ONE			English	Article							MOTTLED ROCK RATTLESNAKES; CROTALUS-LEPIDUS LEPIDUS; CORRELATIONAL SELECTION; GEOGRAPHIC-VARIATION; ANTIPREDATOR BEHAVIOR; VIPERA-BERUS; PATTERN; EVOLUTION; POPULATIONS; MIMICRY	Multiple studies have addressed the mechanisms maintaining polymorphism within a population. However, several examples exist where species inhabiting diverse habitats exhibit local population-specific polymorphism. Numerous explanations have been proposed for the maintenance of geographic variation in color patterns. For example, spatial variation in patterns of selection or limited gene flow can cause entire populations to become fixed for a single morph, resulting in separate populations of the same species exhibiting separate and distinct color morphs. The mottled rock rattlesnake (Crotalus lepidus lepidus) is a montane species that exhibits among-population color polymorphism that correlates with substrate color. Habitat substrate in the eastern part of its range is composed primarily of light colored limestone and snakes have light dorsal coloration, whereas in the western region the substrate is primarily dark and snakes exhibit dark dorsal coloration. We hypothesized that predation on high contrast color and blotched patterns maintain these distinct color morphs. To test this we performed a predation experiment in the wild by deploying model snakes at 12 sites evenly distributed within each of the two regions where the different morphs are found. We employed a 262 factorial design that included two color and two blotched treatments. Our results showed that models contrasting with substrate coloration suffered significantly more avian attacks relative to models mimicking substrates. Predation attempts on blotched models were similar in each substrate type. These results support the hypothesis that color pattern is maintained by selective predation.	[Farallo, Vincent R.; Forstner, Michael R. J.] Texas State Univ San Marcos, Dept Biol, San Marcos, TX USA	Texas State University System; Texas State University San Marcos	Farallo, VR (corresponding author), Ohio Univ, Dept Biol Sci, Athens, OH 45701 USA.	vfarallo@gmail.com	Farallo, Vincent/W-3254-2019	Farallo, Vincent/0000-0001-6571-2015	Sigma Xi: The Scientific Research Society [G2009100838]; Western New York Herpetological Society	Sigma Xi: The Scientific Research Society; Western New York Herpetological Society	This research was funded by Sigma Xi: The Scientific Research Society (Grants-in-Aid of Research; http://www.sigmaxi.org/; G2009100838) and the Western New York Herpetological Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; BEAUPRE SJ, 1995, ECOLOGY, V76, P1655, DOI 10.2307/1938166; Beaupre SJ, 1996, COPEIA, P319; BEAUPRE SJ, 1995, HERPETOLOGICA, V51, P45; Bittner TD, 2003, OHIO J SCI, V103, P62; Blair WF, 1947, CONTRIBUTIONS LABORA, V37, P1; Bond AB, 2006, P NATL ACAD SCI USA, V103, P3214, DOI 10.1073/pnas.0509963103; Bond AB, 2007, ANNU REV ECOL EVOL S, V38, P489, DOI 10.1146/annurev.ecolsys.38.091206.095728; BRODIE ED, 1992, EVOLUTION, V46, P1284, DOI 10.1111/j.1558-5646.1992.tb01124.x; BRODIE ED, 1993, EVOLUTION, V47, P227, DOI 10.1111/j.1558-5646.1993.tb01212.x; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; BYERS BA, 1990, BIOL J LINN SOC, V40, P3, DOI 10.1111/j.1095-8312.1990.tb00530.x; CAIN AJ, 1950, HEREDITY, V4, P275, DOI 10.1038/hdy.1950.22; CALDWELL GS, 1986, AUK, V103, P494, DOI 10.1093/auk/103.3.494; Creer DA, 2005, ETHOLOGY, V111, P287, DOI 10.1111/j.1439-0310.2004.01062.x; Dice L, 1947, CONTRIBUTION U MICHI, V50, P1; Dice LR, 1940, AM NAT, V74, P212, DOI 10.1086/280889; Dixon JR., 2005, TEXAS SNAKES FIELD G, DOI [DOI 10.7560/320419, 10.7560/706750]; ENDLER JA, 1981, BIOL J LINN SOC, V16, P25, DOI 10.1111/j.1095-8312.1981.tb01840.x; Endler JA, 2005, BIOL J LINN SOC, V86, P405, DOI 10.1111/j.1095-8312.2005.00540.x; Forsman A, 1998, BEHAV ECOL, V9, P409, DOI 10.1093/beheco/9.4.409; FORSMAN A, 1987, OIKOS, V50, P13, DOI 10.2307/3565396; Forsman A, 2002, EVOLUTION, V56, P349, DOI 10.1111/j.0014-3820.2002.tb01345.x; FORSMAN A, 1995, BIOL J LINN SOC, V55, P273, DOI 10.1111/j.1095-8312.1995.tb01066.x; Forstner MRJ, 1997, J HERPETOL, V31, P277, DOI 10.2307/1565397; Gelbach FR, 1981, MOUNTAIN ISLANDS DES; Gomez D., 2006, AVICOL PROGRAM ANAL; GOULSON D, 1994, HEREDITY, V73, P471, DOI 10.1038/hdy.1994.145; Gray SM, 2007, TRENDS ECOL EVOL, V22, P71, DOI 10.1016/j.tree.2006.10.005; HOAGLAND KE, 1977, BIOL BULL, V152, P360, DOI 10.2307/1540424; Hoekstra HE, 2004, EVOLUTION, V58, P1329; Holycross AT, 2001, SOUTHWEST NAT, V46, P363, DOI 10.2307/3672434; JACKSON JF, 1976, AM NAT, V110, P1029, DOI 10.1086/283125; Johnston G, 1996, J ZOOL, V239, P187, DOI 10.1111/j.1469-7998.1996.tb05446.x; KAVALIERS M, 1992, J COMP PHYSIOL B, V162, P172, DOI 10.1007/BF00398344; KLAUBER L. M., 1972, RATTLESNAKES THEIR H, V2nd; Kuchta SR, 2001, AM ZOOL, V41, P1499; Lai YC, 2008, J ZOOL, V274, P270, DOI 10.1111/j.1469-7998.2007.00382.x; Maan ME, 2008, COPEIA, P621, DOI 10.1643/CE-07-114; McCullagh P, 1989, GEN LINEAR MODELS; Monney JC, 1996, REV SUISSE ZOOL, V103, P81, DOI 10.5962/bhl.part.79939; Mullen LM, 2008, EVOLUTION, V62, P1555, DOI 10.1111/j.1558-5646.2008.00425.x; Osorio D, 1999, EVOL ECOL, V13, P673, DOI 10.1023/A:1011059715610; Phifer-Rixey M, 2008, J EVOLUTION BIOL, V21, P966, DOI 10.1111/j.1420-9101.2008.01549.x; POUGH FH, 1976, COPEIA, P834, DOI 10.2307/1443481; Punzalan D, 2005, EVOL ECOL, V19, P303, DOI 10.1007/s10682-005-2777-z; Rosenblum EB, 2006, AM NAT, V167, P1, DOI 10.1086/498397; Sandoval CP, 2008, BIOL J LINN SOC, V94, P1, DOI 10.1111/j.1095-8312.2007.00941.x; Saporito RA, 2007, COPEIA, P1006, DOI 10.1643/0045-8511(2007)7[1006:EEFAIT]2.0.CO;2; Sinervo B, 2001, EVOLUTION, V55, P2040; Sinervo B, 2007, AM NAT, V170, P663, DOI 10.1086/522092; SMITH SM, 1976, BEHAVIOUR, V56, P309, DOI 10.1163/156853976X00082; SMITH SM, 1973, BEHAVIOUR, V44, P113, DOI 10.1163/156853973X00355; SWEET SS, 1985, J HERPETOL, V19, P55, DOI 10.2307/1564420; Vanderpool Robert, 2005, Herpetological Review, V36, P191; Venesky MD, 2007, HERPETOLOGICA, V63, P450, DOI 10.1655/0018-0831(2007)63[450:AAAPAB]2.0.CO;2; Vignieri SN, 2010, EVOLUTION, V64, P2153, DOI 10.1111/j.1558-5646.2010.00976.x; VINCENT JW, 1982, SOUTHWEST NAT, V27, P263, DOI 10.2307/3670874; Vorobyev M, 1998, P ROY SOC B-BIOL SCI, V265, P351, DOI 10.1098/rspb.1998.0302; Wheeler B., 2010, IMPERM PERMUTATION T; Wuster W, 2004, P ROY SOC B-BIOL SCI, V271, P2495, DOI 10.1098/rspb.2004.2894	61	47	49	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30316	10.1371/journal.pone.0030316	http://dx.doi.org/10.1371/journal.pone.0030316			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295080	Green Submitted, Green Published, gold			2022-12-27	WOS:000301640600025
J	Kannathasan, S; Murugananthan, A; Rajeshkannan, N; de Silva, NR				Kannathasan, Selvam; Murugananthan, Arumugam; Rajeshkannan, Nadarajah; de Silva, Nilanthy Renuka			Cutaneous Larva Migrans among Devotees of the Nallur Temple in Jaffna, Sri Lanka	PLOS ONE			English	Article								Background: Many cases of Cutaneous Larva Migrans (CLM) have been observed among devotees, during and immediately after the annual festival at the Nallur Hindu temple in Jaffna. Objective: To ascertain the risk factors associated with infestation and devotees' knowledge and practices regarding the condition. Methodology/Principal Findings: A cross-sectional study using an interviewer-administered questionnaire and observation was conducted in August 2010. Out of 200 selected devotees 194(97%) responded. Soil and dog faecal samples were collected from the temple premises and examined for the presence of nematode larva and egg respectively. Among 194 male respondents, 58.2%(95% CI: 51.2%-65.0%) had lesions of CLM. One hundred and thirty (67%) respondents performed the ritual everyday; whereas 33% did so on special days. One hundred and twelve (57.7%) participants performed the ritual before 5.00am and remaining 42.3% performed after 5.00am. Among the participants, 77(36.7%) had the similar condition in previous years. One hundred and fifty seven (80.9%) were aware about this disease and 52(27%) devotees adopted some kind of precautionary measures. Bivariate analysis showed significant association between occurrence of CLM lesions and frequency of performing the ritual (p<0.001, OR-15.1; 95% CI: 7.2-32.0), the timing of ritual performance (p = 0.022, OR-1.96; 95% CI: 1.10-3.52), similar condition in previous year (p<0.001, OR-6.83; 95% CI: 3.39-13.76) and previous awareness of the condition (p = 0.005; OR-0.59; 95% CI:0.43-0.82). Multivariate analysis showed that the frequency of ritual performance (OR-11.75; 95% CI 5.37-25.74) and similar conditions in previous years (OR-4.71; 95% CI: 2.14-10.39) were the independent risk factors. Two of the 20 soil samples were positive for the nematode larvae and three out of five dog faeces were positive for hookworm eggs. Conclusions/Significance: Deworming the stray dogs around the temple premises combined with the awareness programs among the public may be the effective and feasible precautionary measures to control similar epidemics in future.	[Kannathasan, Selvam; Murugananthan, Arumugam] Univ Jaffna, Fac Med, Dept Pathol, Div Parasitol, Jaffna, Sri Lanka; [Rajeshkannan, Nadarajah] Univ Jaffna, Fac Med, Dept Community Med, Jaffna, Sri Lanka; [de Silva, Nilanthy Renuka] Univ Kelaniya, Fac Med, Dept Parasitol, Ragama, Sri Lanka	University Jaffna; University Jaffna; University Kelaniya	Kannathasan, S (corresponding author), Univ Jaffna, Fac Med, Dept Pathol, Div Parasitol, Jaffna, Sri Lanka.	selvamkannathasan@gmail.com	Nadarajah, Rajeshkannan/AFS-0100-2022	Nadarajah, Rajeshkannan/0000-0001-9045-3369				BARDACH H, 1980, WIEN MED WOCHENSCHR, V130, P761; Chopra S, 2009, MANSONS TROPICAL DIS, P333; Heukelbach J, 2008, ANN TROP MED PARASIT, V102, P53, DOI 10.1179/136485908X252205; Heukelbach J, 2008, LANCET INFECT DIS, V8, P302, DOI 10.1016/S1473-3099(08)70098-7; Hochedez P, 2007, J TRAVEL MED, V14, P326, DOI 10.1111/j.1708-8305.2007.00148.x; Kannathasan S, 2003, P JAFFNA SCI ASS, V11, P32; Kim Tae-Heung, 2006, Korean Journal of Parasitology, V44, P145, DOI 10.3347/kjp.2006.44.2.145; Mabaso MLH, 2003, TROP MED INT HEALTH, V8, P722, DOI 10.1046/j.1365-3156.2003.01086.x; Tremblay A, 2000, TROP MED INT HEALTH, V5, P330, DOI 10.1046/j.1365-3156.2000.00557.x; World Health Organization scientific group, 1964, WHO TECH REP SER, V277, P1	10	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30516	10.1371/journal.pone.0030516	http://dx.doi.org/10.1371/journal.pone.0030516			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295089	gold, Green Published, Green Submitted			2022-12-27	WOS:000301640600034
J	Genius, J; Geiger, J; Bender, A; Moller, HJ; Klopstock, T; Rujescu, D				Genius, Just; Geiger, Johanna; Bender, Andreas; Moeller, Hans-Juergen; Klopstock, Thomas; Rujescu, Dan			Creatine Protects against Excitoxicity in an In Vitro Model of Neurodegeneration	PLOS ONE			English	Article							NMR MAGNETIZATION-TRANSFER; ENERGY-METABOLISM; RAT-BRAIN; GLUTAMATE METABOLISM; ORAL SUPPLEMENTATION; HUNTINGTONS-DISEASE; KINASE; GENERATION; NEURONS; CYCLOCREATINE	Creatine has been shown to be neuroprotective in aging, neurodegenerative conditions and brain injury. As a common molecular background, oxidative stress and disturbed cellular energy homeostasis are key aspects in these conditions. Moreover, in a recent report we could demonstrate a life-enhancing and health-promoting potential of creatine in rodents, mainly due to its neuroprotective action. In order to investigate the underlying pharmacology mediating these mainly neuroprotective properties of creatine, cultured primary embryonal hippocampal and cortical cells were challenged with glutamate or H2O2. In good agreement with our in vivo data, creatine mediated a direct effect on the bioenergetic balance, leading to an enhanced cellular energy charge, thereby acting as a neuroprotectant. Moreover, creatine effectively antagonized the H2O2-induced ATP depletion and the excitotoxic response towards glutamate, while not directly acting as an antioxidant. Additionally, creatine mediated a direct inhibitory action on the NMDA receptor-mediated calcium response, which initiates the excitotoxic cascade. Even excessive concentrations of creatine had no neurotoxic effects, so that high-dose creatine supplementation as a health-promoting agent in specific pathological situations or as a primary prophylactic compound in risk populations seems feasible. In conclusion, we were able to demonstrate that the protective potential of creatine was primarily mediated by its impact on cellular energy metabolism and NMDA receptor function, along with reduced glutamate spillover, oxidative stress and subsequent excitotoxicity.	[Genius, Just; Geiger, Johanna; Moeller, Hans-Juergen; Rujescu, Dan] Univ Munich, Dept Psychiat, D-8000 Munich, Germany; [Bender, Andreas; Klopstock, Thomas] Univ Munich, Dept Neurol, D-8000 Munich, Germany	University of Munich; University of Munich	Genius, J (corresponding author), Univ Munich, Dept Psychiat, D-8000 Munich, Germany.	dan.rujescu@med.uni-muenchen.de	Rujescu, Dan/GRS-3875-2022	Bender, Andreas/0000-0002-6328-7104; Genius, Just/0000-0003-3270-3491				Adcock KH, 2002, DEV NEUROSCI-BASEL, V24, P382, DOI 10.1159/000069043; Ames A, 2000, BRAIN RES REV, V34, P42, DOI 10.1016/S0165-0173(00)00038-2; Beal MF, 2005, ANN NEUROL, V58, P495, DOI 10.1002/ana.20624; Beal MF, 1998, BBA-BIOENERGETICS, V1366, P211, DOI 10.1124/jpet.112.192138; Bellocchio EE, 2000, SCIENCE, V289, P957, DOI 10.1126/science.289.5481.957; Bender A, 2008, NEUROBIOL AGING, V29, P1404, DOI 10.1016/j.neurobiolaging.2007.03.001; Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769; Blagosklonny MV, 2011, AGING-US, V3, P685, DOI 10.18632/aging.100352; Bordelon YM, 1997, J NEUROCHEM, V69, P1629; Brewer GJ, 2000, J NEUROCHEM, V74, P1968, DOI 10.1046/j.1471-4159.2000.0741968.x; Budd SL, 1997, FEBS LETT, V415, P21, DOI 10.1016/S0014-5793(97)01088-0; Chen LL, 1995, J COMP NEUROL, V363, P389, DOI 10.1002/cne.903630305; CORBETT RJT, 1994, J CEREBR BLOOD F MET, V14, P1070, DOI 10.1038/jcbfm.1994.140; Dechent P, 1999, AM J PHYSIOL-REG I, V277, pR698, DOI 10.1152/ajpregu.1999.277.3.R698; DUNANT Y, 1988, J NEUROCHEM, V50, P431, DOI 10.1111/j.1471-4159.1988.tb02930.x; ERECINSKA M, 1988, J NEUROCHEM, V51, P892, DOI 10.1111/j.1471-4159.1988.tb01826.x; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Guerrero ML, 1997, AM J PHYSIOL-CELL PH, V272, pC697, DOI 10.1152/ajpcell.1997.272.2.C697; HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x; HEMMER W, 1993, DEV NEUROSCI-BASEL, V15, P249, DOI 10.1159/000111342; Ide T, 2010, CELL CYCLE, V9, P1706, DOI 10.4161/cc.9.9.11473; Ipsiroglu OS, 2001, LIFE SCI, V69, P1805, DOI 10.1016/S0024-3205(01)01268-1; Juravleva E, 2005, J NEUROSCI RES, V79, P224, DOI 10.1002/jnr.20291; KANNER BI, 1987, CRIT REV BIOCHEM MOL, V22, P1, DOI 10.3109/10409238709082546; Klivenyi P, 1999, NAT MED, V5, P347, DOI 10.1038/6568; Lawler JM, 2002, BIOCHEM BIOPH RES CO, V290, P47, DOI 10.1006/bbrc.2001.6164; Lin YS, 2011, AGING-US, V3, P657, DOI 10.18632/aging.100338; Matthews RT, 1998, J NEUROSCI, V18, P156; MILLER EE, 1993, P NATL ACAD SCI USA, V90, P3304, DOI 10.1073/pnas.90.8.3304; MITANI A, 1994, J NEUROCHEM, V62, P626; NORWOOD WI, 1983, AM J PHYSIOL, V244, pC205, DOI 10.1152/ajpcell.1983.244.3.C205; Rothman DL, 1999, PHILOS T R SOC B, V354, P1165, DOI 10.1098/rstb.1999.0472; SAUTER A, 1993, J BIOL CHEM, V268, P13166; Stout AK, 1998, NAT NEUROSCI, V1, P366, DOI 10.1038/1577; Trotti D, 1998, TRENDS PHARMACOL SCI, V19, P328, DOI 10.1016/S0165-6147(98)01230-9; TSUJI K, 1995, J NEUROCHEM, V65, P1816; Weber JD, 1997, J BIOL CHEM, V272, P32966, DOI 10.1074/jbc.272.52.32966; Wyss M, 2000, PHYSIOL REV, V80, P1107, DOI 10.1152/physrev.2000.80.3.1107; YUDKOFF M, 1993, DEV NEUROSCI-BASEL, V15, P343, DOI 10.1159/000111354; ZELEZNIKAR RJ, 1991, J BIOL CHEM, V266, P15110	40	22	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e30554	10.1371/journal.pone.0030554	http://dx.doi.org/10.1371/journal.pone.0030554			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347384	gold, Green Published, Green Submitted			2022-12-27	WOS:000302730100016
J	Togashi, Y; Soda, M; Sakata, S; Sugawara, E; Hatano, S; Asaka, R; Nakajima, T; Mano, H; Takeuchi, K				Togashi, Yuki; Soda, Manabu; Sakata, Seiji; Sugawara, Emiko; Hatano, Satoko; Asaka, Reimi; Nakajima, Takashi; Mano, Hiroyuki; Takeuchi, Kengo			KLC1-ALK: A Novel Fusion in Lung Cancer Identified Using a Formalin-Fixed Paraffin-Embedded Tissue Only	PLOS ONE			English	Article							LARGE-CELL LYMPHOMA; KINASE GENE; ALK KINASE; CRIZOTINIB; IMMUNOHISTOCHEMISTRY; EXPRESSION; TPM3-ALK; PROTEINS; PARTNER	The promising results of anaplastic lymphoma kinase (ALK) inhibitors have changed the significance of ALK fusions in several types of cancer. These fusions are no longer mere research targets or diagnostic markers, but they are now directly linked to the therapeutic benefit of patients. However, most available tumor tissues in clinical settings are formalin-fixed and paraffin-embedded (FFPE), and this significantly limits detailed genetic studies in many clinical cases. Although recent technical improvements have allowed the analysis of some known mutations in FFPE tissues, identifying unknown fusion genes by using only FFPE tissues remains difficult. We developed a 59-rapid amplification of cDNA ends-based system optimized for FFPE tissues and evaluated this system on a lung cancer tissue with ALK rearrangement and without the 2 known ALK fusions EML4-ALK and KIF5B-ALK. With this system, we successfully identified a novel ALK fusion, KLC1-ALK. The result was confirmed by reverse transcription-polymerase chain reaction and fluorescence in situ hybridization. Then, we synthesized the putative full-length cDNA of KLC1-ALK and demonstrated the transforming potential of the fusion kinase with assays using mouse 3T3 cells. To the best of our knowledge, KLC1-ALK is the first novel oncogenic fusion identified using only FFPE tissues. This finding will broaden the potential value of archival FFPE tissues and provide further biological and clinical insights into ALK-positive lung cancer.	[Togashi, Yuki; Sakata, Seiji; Sugawara, Emiko; Hatano, Satoko; Asaka, Reimi; Takeuchi, Kengo] Japanese Fdn Canc Res, Inst Canc, Pathol Project Mol Targets, Tokyo 170, Japan; [Togashi, Yuki; Hatano, Satoko; Asaka, Reimi; Takeuchi, Kengo] Japanese Fdn Canc Res, Inst Canc, Div Pathol, Tokyo 170, Japan; [Soda, Manabu; Mano, Hiroyuki] Jichi Med Univ, Div Funct Genom, Shimotsuke, Tochigi, Japan; [Sugawara, Emiko] Tokyo Med & Dent Univ, Grad Sch, Dept Comprehens Pathol, Tokyo, Japan; [Nakajima, Takashi] Shizuoka Canc Ctr, Div Diagnost Pathol, Nagaizumi, Shizuoka, Japan; [Mano, Hiroyuki] Univ Tokyo, Grad Sch Med, Dept Med Genom, Tokyo, Japan	Japanese Foundation for Cancer Research; Japanese Foundation for Cancer Research; Jichi Medical University; Tokyo Medical & Dental University (TMDU); Shizuoka Cancer Center; University of Tokyo	Togashi, Y (corresponding author), Japanese Fdn Canc Res, Inst Canc, Pathol Project Mol Targets, Tokyo 170, Japan.	kentakeuchi-tky@umin.net	Takeuchi, Kengo/C-3614-2008	Takeuchi, Kengo/0000-0002-1599-5800	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Science; Ministry of Health, Labor, and Welfare of Japan; Vehicle Racing Commemorative Foundation of Japan; Princess Takamatsu Cancer Research Fund; Uehara Memorial Foundation	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Vehicle Racing Commemorative Foundation of Japan; Princess Takamatsu Cancer Research Fund; Uehara Memorial Foundation(Uehara Memorial Foundation)	This work was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan as well as by grants from the Japan Society for the Promotion of Science; the Ministry of Health, Labor, and Welfare of Japan; the Vehicle Racing Commemorative Foundation of Japan; the Princess Takamatsu Cancer Research Fund; and the Uehara Memorial Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bridge JA, 2001, AM J PATHOL, V159, P411, DOI 10.1016/S0002-9440(10)61711-7; Butrynski JE, 2010, NEW ENGL J MED, V363, P1727, DOI 10.1056/NEJMoa1007056; Choi YL, 2008, CANCER RES, V68, P4971, DOI 10.1158/0008-5472.CAN-07-6158; Colleoni GWB, 2000, AM J PATHOL, V156, P781, DOI 10.1016/S0002-9440(10)64945-0; Cools J, 2002, GENE CHROMOSOME CANC, V34, P354, DOI 10.1002/gcc.10033; Debelenko LV, 2011, MODERN PATHOL, V24, P430, DOI 10.1038/modpathol.2010.213; Debiec-Rychter M, 2003, GENE CHROMOSOME CANC, V38, P187, DOI 10.1002/gcc.10267; Delsol G, 1997, BLOOD, V89, P1483, DOI 10.1182/blood.V89.5.1483.1483_1483_1490; Du XL, 2007, J MOL MED, V85, P863, DOI 10.1007/s00109-007-0159-4; Gambacorti-Passerini C, 2011, NEW ENGL J MED, V364, P775, DOI 10.1056/NEJMc1013224; Gascoyne RD, 2003, BLOOD, V102, P2568, DOI 10.1182/blood-2003-03-0786; Hernandez L, 1999, BLOOD, V94, P3265; Houtman SH, 2007, NEUROSCIENCE, V144, P1373, DOI 10.1016/j.neuroscience.2006.11.015; Jazii FR, 2006, WORLD J GASTROENTERO, V12, P7104, DOI 10.3748/wjg.v12.i44.7104; Kijima T, 2011, CANCER SCI, V102, P1602, DOI 10.1111/j.1349-7006.2011.01970.x; Kimura H, 2011, LUNG CANC; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Lamant L, 2003, GENE CHROMOSOME CANC, V37, P427, DOI 10.1002/gcc.10232; Lamant L, 1999, BLOOD, V93, P3088; Lawrence B, 2000, AM J PATHOL, V157, P377, DOI 10.1016/S0002-9440(10)64550-6; Lin E, 2009, MOL CANCER RES, V7, P1466, DOI 10.1158/1541-7786.MCR-08-0522; Ma ZG, 2003, GENE CHROMOSOME CANC, V37, P98, DOI 10.1002/gcc.10177; Martelli MP, 2009, AM J PATHOL, V174, P661, DOI 10.2353/ajpath.2009.080755; Meech SJ, 2001, BLOOD, V98, P1209, DOI 10.1182/blood.V98.4.1209; MORRIS SW, 1994, SCIENCE, V263, P1281, DOI 10.1126/science.8122112; Nakajima T, 2010, J THORAC ONCOL, V5, P2041, DOI 10.1097/JTO.0b013e3181f77b58; Onishi M, 1996, EXP HEMATOL, V24, P324; Panagopoulos I, 2006, INT J CANCER, V118, P1181, DOI 10.1002/ijc.21490; Rahman A, 1999, J CELL BIOL, V146, P1277, DOI 10.1083/jcb.146.6.1277; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Sablin EP, 2000, CURR OPIN CELL BIOL, V12, P35, DOI 10.1016/S0955-0674(99)00054-X; SHIOTA M, 1994, ONCOGENE, V9, P1567; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Stenoien DL, 1997, MOL BIOL CELL, V8, P675, DOI 10.1091/mbc.8.4.675; Sugawara E, CANCER IN PRESS; Takeuchi K, 2010, HAEMATOLOGICA; Takeuchi K, 2008, CLIN CANCER RES, V14, P6618, DOI 10.1158/1078-0432.CCR-08-1018; Takeuchi K, 2011, CLIN CANCER RES, V17, P3341, DOI 10.1158/1078-0432.CCR-11-0063; Takeuchi K, 2009, CLIN CANCER RES, V15, P3143, DOI 10.1158/1078-0432.CCR-08-3248; Tort F, 2001, LAB INVEST, V81, P419, DOI 10.1038/labinvest.3780249; Touriol C, 2000, BLOOD, V95, P3204, DOI 10.1182/blood.V95.10.3204.010k04_3204_3207; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Van Roosbroeck K, 2010, HAEMATOL-HEMATOL J, V95, P509, DOI 10.3324/haematol.2009.014761; Yamamoto M, CANC SCI IN PRESS	44	183	191	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31323	10.1371/journal.pone.0031323	http://dx.doi.org/10.1371/journal.pone.0031323			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347464	gold, Green Published, Green Submitted			2022-12-27	WOS:000302730100061
J	Yu, Y; Fay, NC; Smoligovets, AA; Wu, HJ; Groves, JT				Yu, Yan; Fay, Nicole C.; Smoligovets, Alexander A.; Wu, Hung-Jen; Groves, Jay T.			Myosin IIA Modulates T Cell Receptor Transport and CasL Phosphorylation during Early Immunological Synapse Formation	PLOS ONE			English	Article							SUBSTRATE-RELATED PROTEIN; TYROSINE PHOSPHORYLATION; PROTEASOMAL DEGRADATION; ANTIGEN RECEPTOR; ACTIN; CRK; FORCE; TCR; MICROCLUSTERS; MECHANISMS	Activation of T cell receptor (TCR) by antigens occurs in concert with an elaborate multi-scale spatial reorganization of proteins at the immunological synapse, the junction between a T cell and an antigen-presenting cell (APC). The directed movement of molecules, which intrinsically requires physical forces, is known to modulate biochemical signaling. It remains unclear, however, if mechanical forces exert any direct influence on the signaling cascades. We use T cells from AND transgenic mice expressing TCRs specific to the moth cytochrome c 88-103 peptide, and replace the APC with a synthetic supported lipid membrane. Through a series of high spatiotemporal molecular tracking studies in live T cells, we demonstrate that the molecular motor, non-muscle myosin IIA, transiently drives TCR transport during the first one to two minutes of immunological synapse formation. Myosin inhibition reduces calcium influx and colocalization of active ZAP-70 (zeta-chain associated protein kinase 70) with TCR, revealing an influence on signaling activity. More tellingly, its inhibition also significantly reduces phosphorylation of the mechanosensing protein CasL (Crk-associated substrate the lymphocyte type), raising the possibility of a direct mechanical mechanism of signal modulation involving CasL.	[Yu, Yan; Fay, Nicole C.; Smoligovets, Alexander A.; Wu, Hung-Jen; Groves, Jay T.] Univ Calif Berkeley, Howard Hughes Med Inst, Dept Chem, Berkeley, CA 94720 USA; [Fay, Nicole C.; Smoligovets, Alexander A.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Yu, Yan; Fay, Nicole C.; Smoligovets, Alexander A.; Wu, Hung-Jen; Groves, Jay T.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Groves, Jay T.] Natl Univ Singapore, Mechanobiol Inst, Singapore 117548, Singapore	Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; National University of Singapore	Yu, Y (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Dept Chem, Berkeley, CA 94720 USA.	jtgroves@lbl.gov	Yu, Yan/A-3919-2015; Yu, Yan/A-3919-2015; Wu, Hung-Jen/H-3769-2016	Yu, Yan/0000-0001-6496-5045; Yu, Yan/0000-0002-6482-5672; Wu, Hung-Jen/0000-0003-3082-7431	Office of Science, Office of Basic Energy Sciences, the Materials Sciences and Engineering Division and the Chemical Sciences, Geosciences, and Biosciences Division under the U.S. Department of Energy (DOE) [DE-AC02-05CH11231]; National Science Foundation (NSF); Office of Science, Office of Basic Energy Sciences, Scientific User Facilities Division, of the U.S. DOE [DE-AC02-05CH11231]; U.S. Department of Defense [BC102681]; U.S. Department of Defense under U.S. Army Medical Research Acquisition Activity [W81XWH-11-1-0256]; National Cancer Institute (NCI) [U54 CA143836]; NATIONAL CANCER INSTITUTE [U54CA143836] Funding Source: NIH RePORTER	Office of Science, Office of Basic Energy Sciences, the Materials Sciences and Engineering Division and the Chemical Sciences, Geosciences, and Biosciences Division under the U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); National Science Foundation (NSF)(National Science Foundation (NSF)); Office of Science, Office of Basic Energy Sciences, Scientific User Facilities Division, of the U.S. DOE(United States Department of Energy (DOE)); U.S. Department of Defense(United States Department of Defense); U.S. Department of Defense under U.S. Army Medical Research Acquisition Activity; National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	YY, AAS, and H-JW were supported by the Director, Office of Science, Office of Basic Energy Sciences, the Materials Sciences and Engineering Division and the Chemical Sciences, Geosciences, and Biosciences Division under the U. S. Department of Energy (DOE) contract No. DE-AC02-05CH11231. NCF was supported by a Graduate Fellowship from the National Science Foundation (NSF). Patterned substrate fabrication was performed, in part, at the Molecular Foundry, Lawrence Berkeley National Laboratory (LBNL), and was supported by the Office of Science, Office of Basic Energy Sciences, Scientific User Facilities Division, of the U.S. DOE under contract No. DE-AC02-05CH11231. Support for mechanosignaling aspects of this work was provided by the U.S. Department of Defense DA Congressionally Directed Medical Research Program Idea Award BC102681 under U.S. Army Medical Research Acquisition Activity No. W81XWH-11-1-0256 and by Award U54 CA143836 from the National Cancer Institute (NCI). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NCI or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander NR, 2008, CURR BIOL, V18, P1295, DOI 10.1016/j.cub.2008.07.090; Aratyn-Schaus Y, 2010, CURR BIOL, V20, P1145, DOI 10.1016/j.cub.2010.05.049; Barda-Saad M, 2005, NAT IMMUNOL, V6, P80, DOI 10.1038/ni1143; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bubb MR, 2000, J BIOL CHEM, V275, P5163, DOI 10.1074/jbc.275.7.5163; Bunnell SC, 2002, J CELL BIOL, V158, P1263, DOI 10.1083/jcb.200203043; Burkel BM, 2007, CELL MOTIL CYTOSKEL, V64, P822, DOI 10.1002/cm.20226; Cai YF, 2006, BIOPHYS J, V91, P3907, DOI 10.1529/biophysj.106.084806; Campi G, 2005, J EXP MED, V202, P1031, DOI 10.1084/jem.20051182; DeMond AL, 2008, BIOPHYS J, V94, P3286, DOI 10.1529/biophysj.107.119099; Doh J, 2006, P NATL ACAD SCI USA, V103, P5700, DOI 10.1073/pnas.0509404103; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Gelkop S, 2001, J BIOL CHEM, V276, P36174, DOI 10.1074/jbc.M100731200; Giannone G, 2004, CELL, V116, P431, DOI 10.1016/S0092-8674(04)00058-3; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Grecco HE, 2011, CELL, V144, P897, DOI 10.1016/j.cell.2011.01.029; Groves JT, 2008, ANNU REV BIOMED ENG, V10, P311, DOI 10.1146/annurev.bioeng.10.061807.160431; Groves JT, 2010, NAT STRUCT MOL BIOL, V17, P659, DOI 10.1038/nsmb.1844; Groves JT, 1997, SCIENCE, V275, P651, DOI 10.1126/science.275.5300.651; Hartman NC, 2009, P NATL ACAD SCI USA, V106, P12729, DOI 10.1073/pnas.0902621106; Hashimoto-Tane A, 2011, IMMUNITY, V34, P919, DOI 10.1016/j.immuni.2011.05.012; Huppa JB, 2010, NATURE, V463, P963, DOI 10.1038/nature08746; Husson J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019680; Ilani T, 2009, NAT IMMUNOL, V10, P531, DOI 10.1038/ni.1723; Ingber DE, 2003, ANN MED, V35, P564, DOI 10.1080/07853890310016333; Irvine DJ, 2002, NATURE, V419, P845, DOI 10.1038/nature01076; Jacobelli J, 2004, NAT IMMUNOL, V5, P531, DOI 10.1038/ni1065; Kaizuka Y, 2007, P NATL ACAD SCI USA, V104, P20296, DOI 10.1073/pnas.0710258105; Kanda H, 1999, IMMUNOLOGY, V97, P56; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; Kim ST, 2009, J BIOL CHEM, V284, P31028, DOI 10.1074/jbc.M109.052712; Kovacs M, 2007, P NATL ACAD SCI USA, V104, P9994, DOI 10.1073/pnas.0701181104; Lee KH, 2003, SCIENCE, V302, P1218, DOI 10.1126/science.1086507; Lee KH, 2002, SCIENCE, V295, P1539, DOI 10.1126/science.1067710; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; Li YC, 2010, J IMMUNOL, V184, P5959, DOI 10.4049/jimmunol.0900775; Liu XH, 2000, EMBO J, V19, P6759, DOI 10.1093/emboj/19.24.6759; Loose M, 2008, SCIENCE, V320, P789, DOI 10.1126/science.1154413; Manza BN, 2011, P NATL ACAD SCI USA, V108, P9089, DOI 10.1073/pnas.1018771108; Minegishi M, 1996, J EXP MED, V184, P1365, DOI 10.1084/jem.184.4.1365; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Mossman KD, 2005, SCIENCE, V310, P1191, DOI 10.1126/science.1119238; Nye JA, 2008, LANGMUIR, V24, P4145, DOI 10.1021/la703788h; Ohashi Y, 1999, J IMMUNOL, V163, P3727; Ohashi Y, 1998, J BIOL CHEM, V273, P6446, DOI 10.1074/jbc.273.11.6446; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Reedquist KA, 1996, J BIOL CHEM, V271, P8435, DOI 10.1074/jbc.271.14.8435; Sakamoto T, 2005, BIOCHEMISTRY-US, V44, P584, DOI 10.1021/bi0483357; Salaita K, 2010, SCIENCE, V327, P1380, DOI 10.1126/science.1181729; Sawada Y, 2006, CELL, V127, P1015, DOI 10.1016/j.cell.2006.09.044; Scott JD, 2009, SCIENCE, V326, P1220, DOI 10.1126/science.1175668; Smith A, 2003, J CELL SCI, V116, P3123, DOI 10.1242/jcs.00606; Smith AW, 2011, J PHYS CHEM A, V115, P3867, DOI 10.1021/jp108295s; Smoligovets AA, 2011, J CELL SCI IN PRESS; Takacs B, 2010, P NATL ACAD SCI USA, V107, P6799, DOI 10.1073/pnas.0907585107; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Wei QZ, 2000, MOL BIOL CELL, V11, P3617, DOI 10.1091/mbc.11.10.3617; Wulfing C, 1998, SCIENCE, V282, P2266, DOI 10.1126/science.282.5397.2266; Yu CH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011878; Zheng MZ, 2006, J CELL SCI, V119, P96, DOI 10.1242/jcs.02712	63	50	50	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e30704	10.1371/journal.pone.0030704	http://dx.doi.org/10.1371/journal.pone.0030704			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347397	gold, Green Published, Green Submitted			2022-12-27	WOS:000302730100022
J	Carrillo-de Sauvage, MA; Gomez, A; Ros, CM; Ros-Bernal, F; Martin, ED; Perez-Valles, A; Gallego-Sanchez, JM; Fernandez-Villalba, E; Barcia, C; Barcia, C; Herrero, MT				Angeles Carrillo-de Sauvage, Maria; Gomez, Aurora; Maria Ros, Carmen; Ros-Bernal, Francisco; Martin, Eduardo D.; Perez-Valles, Ana; Gallego-Sanchez, Jose M.; Fernandez-Villalba, Emiliano; Barcia, Carlos, Sr.; Barcia, Carlos, Jr.; Herrero, Maria-Trinidad			CCL2-Expressing Astrocytes Mediate the Extravasation of T Lymphocytes in the Brain. Evidence from Patients with Glioma and Experimental Models In Vivo	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; IMMUNOLOGICAL SYNAPSES; HIGH-CAPACITY; EXPRESSION; MCP-1; CHEMOKINES; IMMUNITY; VECTORS; ANIMALS	CCL2 is a chemokine involved in brain inflammation, but the way in which it contributes to the entrance of lymphocytes in the parenchyma is unclear. Imaging of the cell type responsible for this task and details on how the process takes place in vivo remain elusive. Herein, we analyze the cell type that overexpresses CCL2 in multiple scenarios of T-cell infiltration in the brain and in three different species. We observe that CCL2(+) astrocytes play a part in the infiltration of T-cells in the brain and our analysis shows that the contact of T-cells with perivascular astrocytes occurs, suggesting that may be an important event for lymphocyte extravasation.	[Angeles Carrillo-de Sauvage, Maria; Gomez, Aurora; Maria Ros, Carmen; Ros-Bernal, Francisco; Fernandez-Villalba, Emiliano; Barcia, Carlos, Jr.; Herrero, Maria-Trinidad] Univ Murcia, Sch Med, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Murcia, Spain; [Martin, Eduardo D.] Univ Castilla La Mancha, Inst Invest Discapacidades Neurol IDINE, Albacete, Spain; [Gallego-Sanchez, Jose M.; Barcia, Carlos, Sr.] Hosp Gen Univ Valencia, Dept Neurosurg, Valencia, Spain; [Perez-Valles, Ana] Hosp Gen Univ Valencia, Dept Pathol, Valencia, Spain	CIBERNED; University of Murcia; Universidad de Castilla-La Mancha; Hospital Clinic Universitari de Valencia; Hospital Clinic Universitari de Valencia	Carrillo-de Sauvage, MA (corresponding author), Univ Murcia, Sch Med, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Murcia, Spain.	mtherrer@um.es	Sánchez, José María Gallego/I-3105-2015; BERNAL, FRANCISCO ROS/H-9129-2015; Martín, Eduardo D./V-3344-2017; Villalba, Emiliano Fernández/AAP-1187-2021; Barcia, Carlos/I-8205-2014	Sánchez, José María Gallego/0000-0001-5345-2797; BERNAL, FRANCISCO ROS/0000-0001-9072-929X; Martín, Eduardo D./0000-0003-1768-3488; Barcia, Carlos/0000-0003-0976-4245; HERRERO, MARIA TRINIDAD/0000-0003-4953-1446	Spanish Ministry of Science and Innovation [FIS PI10 02827, SAF 2004 07656 C02-02, SAF 2010 21274, RYC-2010-06729]; Fundacion Seneca [FS/15329/PI/10]; CIBERNED (Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas)	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion Seneca(Fundacion Seneca); CIBERNED (Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas)	This work was supported by grants from: the Spanish Ministry of Science and Innovation (FIS PI10 02827, SAF 2004 07656 C02-02, SAF 2010 21274, RYC-2010-06729), Fundacion Seneca (FS/15329/PI/10) and CIBERNED (Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barcia C, 2008, J VIROL, V82, P9978, DOI 10.1128/JVI.01326-08; Barcia C, 2007, MOL THER, V15, P2154, DOI 10.1038/sj.mt.6300305; Barcia C, 2009, AM J PATHOL, V175, P786, DOI 10.2353/ajpath.2009.081034; Conductier G, 2010, J NEUROIMMUNOL, V224, P93, DOI 10.1016/j.jneuroim.2010.05.010; delPozo MA, 1997, J CELL BIOL, V137, P493; DELPOZO MA, 1995, J CELL BIOL, V131, P495, DOI 10.1083/jcb.131.2.495; DESBAILLETS I, 1994, INT J CANCER, V58, P240, DOI 10.1002/ijc.2910580216; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Glabinski AR, 1996, J IMMUNOL, V156, P4363; OPPENHEIM JJ, 1991, ANNU REV IMMUNOL, V9, P617, DOI 10.1146/annurev.iy.09.040191.003153; Platten M, 2003, ANN NEUROL, V54, P388, DOI 10.1002/ana.10679; Sanchez-Madrid F, 2009, NAT REV MOL CELL BIO, V10, P353, DOI 10.1038/nrm2680; Thomas CE, 2000, P NATL ACAD SCI USA, V97, P7482, DOI 10.1073/pnas.120474397; Van der Voorn P, 1999, AM J PATHOL, V154, P45, DOI 10.1016/S0002-9440(10)65249-2; Zhu X, 2010, J NEUROONCOL; Zirger JM, 2006, VIRAL IMMUNOL, V19, P508, DOI 10.1089/vim.2006.19.508	16	32	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2012	7	2							e30762	10.1371/journal.pone.0030762	http://dx.doi.org/10.1371/journal.pone.0030762			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UV	22319587	Green Published, Green Submitted, gold			2022-12-27	WOS:000301979000014
J	Bianca, RDD; Mitidieri, E; Fusco, F; D'Aiuto, E; Grieco, P; Novellino, E; Imbimbo, C; Mirone, V; Cirino, G; Sorrentino, R				Bianca, Roberta d'Emmanuele di Villa; Mitidieri, Emma; Fusco, Ferdinando; D'Aiuto, Elena; Grieco, Paolo; Novellino, Ettore; Imbimbo, Ciro; Mirone, Vincenzo; Cirino, Giuseppe; Sorrentino, Raffaella			Endogenous Urotensin II Selectively Modulates Erectile Function through eNOS	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; HUMAN CORPUS CAVERNOSUM; AKT-DEPENDENT PHOSPHORYLATION; ENDOTHELIAL-CELLS; PENILE ERECTION; HUMAN PULMONARY; LOCALIZATION; ACTIVATION; RESPONSES; ARTERIES	Background: Urotensin II (U-II) is a cyclic peptide originally isolated from the neurosecretory system of the teleost fish and subsequently found in other species, including man. U-II was identified as the natural ligand of a G-protein coupled receptor, namely UT receptor. U-II and UT receptor are expressed in a variety of peripheral organs and especially in cardiovascular tissue. Recent evidence indicates the involvement of U-II/UT pathway in penile function in human, but the molecular mechanism is still unclear. On these bases the aim of this study is to investigate the mechanism(s) of U-II-induced relaxation in human corpus cavernosum and its relationship with L-arginine/Nitric oxide (NO) pathway. Methodology/Principal Findings: Human corpus cavernosum tissue was obtained following in male-to-female transsexuals undergoing surgical procedure for sex reassignment. Quantitative RT-PCR clearly demonstrated the U-II expression in human corpus cavernosum. U-II (0.1 nM-10 mu M) challenge in human corpus cavernosum induced a significant increase in NO production as revealed by fluorometric analysis. NO generation was coupled to a marked increase in the ratio eNOS phosphorilated/eNOS as determined by western blot analysis. A functional study in human corpus cavernosum strips was performed to asses eNOS involvement in U-II-induced relaxation by using a pharmacological modulation. Pre-treatment with both wortmannin or geldanamycinin (inhibitors of eNOS phosphorylation and heath shock protein 90 recruitment, respectively) significantly reduced U-II-induced relaxation (0.1 nM-10 mu M) in human corpus cavernosum strips. Finally, a co-immunoprecipitation study demonstrated that UT receptor and eNOS co-immunoprecipitate following U-II challenge of human corpus cavernosum tissue. Conclusion/Significance: U-II is endogenously synthesized and locally released in human corpus cavernosum. U-II elicited penile erection through eNOS activation. Thus, U-II/UT pathway may represent a novel therapeutical target in erectile dysfunction.	[Bianca, Roberta d'Emmanuele di Villa; Fusco, Ferdinando; Imbimbo, Ciro; Mirone, Vincenzo; Cirino, Giuseppe; Sorrentino, Raffaella] Univ Naples Federico 2, Interdept Res Ctr Sexual Med CIRMS, Naples, Italy; [Bianca, Roberta d'Emmanuele di Villa; Mitidieri, Emma; Cirino, Giuseppe; Sorrentino, Raffaella] Univ Naples Federico 2, Dept Expt Pharmacol, Naples, Italy; [D'Aiuto, Elena] Univ Naples 2, Dept Clin & Expt Med, Clin Immunol Sect, Naples, Italy; [Grieco, Paolo; Novellino, Ettore] Univ Naples Federico 2, Dept Pharmaceut & Toxicol Chem, Naples, Italy	University of Naples Federico II; University of Naples Federico II; Universita della Campania Vanvitelli; University of Naples Federico II	Bianca, RDD (corresponding author), Univ Naples Federico 2, Interdept Res Ctr Sexual Med CIRMS, Naples, Italy.	rafsorre@unina.it	Grieco, Paolo/AAB-9034-2019	Grieco, Paolo/0000-0002-6854-8123; D'EMMANUELE DI VILLA BIANCA, Roberta/0000-0003-0992-6400; Fusco, Ferdinando/0000-0002-5158-5526; Novellino, Ettore/0000-0002-2181-2142; MIRONE, Vincenzo/0000-0002-7639-2560; Cirino, Giuseppe/0000-0003-3954-4083	European Society for Sexual Medicine (ESSM);  [n.5/2002]	European Society for Sexual Medicine (ESSM); 	The present study was supported by European Society for Sexual Medicine (ESSM) grant for Medical Research 2009 and by Regional grant for research n.5/2002, 2007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Ames RS, 1999, NATURE, V401, P282, DOI 10.1038/45809; Bianca RDD, 2006, J PHARMACOL EXP THER, V316, P703, DOI 10.1124/jpet.105.093419; Bianca RDD, 2010, J SEX MED, V7, P1778, DOI 10.1111/j.1743-6109.2009.01450.x; Bohm F, 2002, BRIT J PHARMACOL, V135, P25, DOI 10.1038/sj.bjp.0704448; Boo YC, 2006, FREE RADICAL BIO MED, V41, P144, DOI 10.1016/j.freeradbiomed.2006.03.024; Bottrill FE, 2000, BRIT J PHARMACOL, V130, P1865, DOI 10.1038/sj.bjp.0703513; Burnett AL, 2004, INT J IMPOT RES, V16, pS15, DOI 10.1038/sj.ijir.3901209; BURNETT AL, 1993, J UROLOGY, V150, P73, DOI 10.1016/S0022-5347(17)35401-0; BURNETT AL, 1992, SCIENCE, V257, P401, DOI 10.1126/science.1378650; BUSSE R, 1990, FEBS LETT, V265, P133, DOI 10.1016/0014-5793(90)80902-U; Chen YH, 2009, CLIN CHEM, V55, P2040, DOI 10.1373/clinchem.2009.131748; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Douglas SA, 2000, J CARDIOVASC PHARM, V36, pS163, DOI 10.1097/00005344-200036051-00051; Fulton D, 2001, J PHARMACOL EXP THER, V299, P818; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Gallis B, 1999, J BIOL CHEM, V274, P30101, DOI 10.1074/jbc.274.42.30101; Garcia-Cardena G, 1998, NATURE, V392, P821, DOI 10.1038/33934; Gratton JP, 2000, J BIOL CHEM, V275, P22268, DOI 10.1074/jbc.M001644200; Grieco P, 2002, J MED CHEM, V45, P4391, DOI 10.1021/jm025549i; Hurt KJ, 2002, P NATL ACAD SCI USA, V99, P4061, DOI 10.1073/pnas.052712499; IGNARRO LJ, 1990, BIOCHEM BIOPH RES CO, V170, P843, DOI 10.1016/0006-291X(90)92168-Y; MacLean MR, 2000, BRIT J PHARMACOL, V130, P201, DOI 10.1038/sj.bjp.0703314; Maguire JJ, 2000, BRIT J PHARMACOL, V131, P441, DOI 10.1038/sj.bjp.0703601; McMahon CN, 2006, BMJ-BRIT MED J, V332, P589, DOI 10.1136/bmj.332.7541.589; MICHEL T, 1993, P NATL ACAD SCI USA, V90, P6252, DOI 10.1073/pnas.90.13.6252; Mirone V, 2000, J PHARMACOL TOXICOL, V44, P477, DOI 10.1016/S1056-8719(00)00114-3; MISKO TP, 1993, ANAL BIOCHEM, V214, P11, DOI 10.1006/abio.1993.1449; NATHAN C, 1994, CELL, V78, P915, DOI 10.1016/0092-8674(94)90266-6; Rossowski WJ, 2002, EUR J PHARMACOL, V438, P159, DOI 10.1016/S0014-2999(02)01341-9; Russell FD, 2004, PHARMACOL THERAPEUT, V103, P223, DOI 10.1016/j.pharmthera.2004.07.004; Russell KS, 2000, J BIOL CHEM, V275, P5026, DOI 10.1074/jbc.275.7.5026; Stirrat A, 2001, AM J PHYSIOL-HEART C, V280, pH925, DOI 10.1152/ajpheart.2001.280.2.H925; Takahashi K, 2001, PEPTIDES, V22, P1175, DOI 10.1016/S0196-9781(01)00441-7; Toda N, 2005, PHARMACOL THERAPEUT, V106, P233, DOI 10.1016/j.pharmthera.2004.11.011; Zhu YC, 2006, BRIT J PHARMACOL, V148, P884, DOI 10.1038/sj.bjp.0706800	36	14	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2012	7	2							e31019	10.1371/journal.pone.0031019	http://dx.doi.org/10.1371/journal.pone.0031019			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UV	22319601	Green Published, gold, Green Submitted			2022-12-27	WOS:000301979000017
J	Elman, I; Becerra, L; Tschibelu, E; Yamamoto, R; George, E; Borsook, D				Elman, Igor; Becerra, Lino; Tschibelu, Evelyne; Yamamoto, Rinah; George, Edward; Borsook, David			Yohimbine-Induced Amygdala Activation in Pathological Gamblers: A Pilot Study	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING-FACTOR; AUTONOMIC AROUSAL; M-CHLOROPHENYLPIPERAZINE; BRAIN ACTIVATION; NERVOUS-SYSTEM; HEART-RATE; STRESS; COCAINE; SEEKING; ALCOHOLICS	Rationale and Objectives: There is evidence that drug addiction is associated with increased physiological and psychological responses to stress. In this pilot functional magnetic resonance imaging (fMRI) study we assessed whether a prototype behavioral addiction, pathological gambling (PG), is likewise associated with an enhanced response to stress. Methods: We induced stress by injecting yohimbine (0.2-0.3 mg/kg, IV), an alpha-2 adrenoceptor antagonist that elicits stress-like physiological and psychological effects in humans and in laboratory animals, to four subjects with PG and to five non-gamblers mentally healthy control subjects. Their fMRI brain responses were assessed along with subjective stress and gambling urges ratings. Results: Voxelwise analyses of data sets from individual subjects, utilizing generalized linear model approach, revealed significant left amygdala activation in response to yohimbine across all PG subjects. This amygdala effect was not observed in the five control individuals. Yohimbine elicited subjective stress ratings in both groups with greater (albeit not statically significantly) average response in the PG subjects. On the other hand, yohimbine did not induce urges to gamble. Conclusions: The present data support the hypothesis of brain sensitization to pharmacologically-induced stress in PG.	[Elman, Igor] Harvard Univ, Sch Med, Cambridge Hlth Alliance, Bedford Vet Adm Med Ctr, Somerville, MA USA; [Elman, Igor] Harvard Univ, Sch Med, Cambridge Hlth Alliance, Dept Psychiat, Somerville, MA USA; [Becerra, Lino; Tschibelu, Evelyne; Yamamoto, Rinah; George, Edward; Borsook, David] Harvard Univ, Sch Med, Belmont, MA 02178 USA; [Becerra, Lino; George, Edward; Borsook, David] McLean Hosp, PAIN Grp, Belmont, MA 02178 USA; [Tschibelu, Evelyne; Yamamoto, Rinah] McLean Hosp, Clin Psychopathol Lab, Belmont, MA 02178 USA	Harvard University; Cambridge Health Alliance; Harvard University; Cambridge Health Alliance; Harvard University; Harvard University; McLean Hospital; Harvard University; McLean Hospital	Elman, I (corresponding author), Harvard Univ, Sch Med, Cambridge Hlth Alliance, Bedford Vet Adm Med Ctr, Somerville, MA USA.	ielman@cha.harvard.edu	Elman, Igor/O-2884-2017	Elman, Igor/0000-0002-1345-2677	National Institute on Drug Abuse [DA017959]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017959] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the Grant DA017959 from the National Institute on Drug Abuse, awarded to Dr. Igor Elman. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Angrist B M, 1970, Biol Psychiatry, V2, P95; ANTELMAN SM, 1980, SCIENCE, V207, P329, DOI 10.1126/science.7188649; Baas D, 2004, BRAIN RES REV, V45, P96, DOI 10.1016/j.brainresrev.2004.02.004; Becerra L, 2006, ANESTH ANALG, V103, P208, DOI 10.1213/01.ane.0000221457.71536.e0; Belujon P, 2011, ANN NY ACAD SCI, V1216, P114, DOI 10.1111/j.1749-6632.2010.05896.x; Bergh C, 1997, PSYCHOL MED, V27, P473, DOI 10.1017/S0033291796003789; Biddle D, 2005, J TRAUMA STRESS, V18, P759, DOI 10.1002/jts.20084; Bremner JD, 1996, SYNAPSE, V23, P39, DOI 10.1002/(SICI)1098-2396(199605)23:1<39::AID-SYN5>3.3.CO;2-Y; Bremner JD, 1996, SYNAPSE, V23, P28, DOI 10.1002/(SICI)1098-2396(199605)23:1<28::AID-SYN4>3.0.CO;2-J; Chamberlain SR, 2007, CURR OPIN PSYCHIATR, V20, P255, DOI 10.1097/yco.0b013e3280ba4989; Cippitelli A, 2010, PSYCHOPHARMACOLOGY, V208, P417, DOI 10.1007/s00213-009-1741-y; Crockford DN, 2005, BIOL PSYCHIAT, V58, P787, DOI 10.1016/j.biopsych.2005.04.037; Cunningham-Williams RM, 2005, J PSYCHIATR RES, V39, P377, DOI 10.1016/j.jpsychires.2004.09.002; Daughters SB, 2005, J GAMBL STUD, V21, P363, DOI 10.1007/s10899-005-5554-6; de Castro V, 2007, ADDICT BEHAV, V32, P1555, DOI 10.1016/j.addbeh.2006.11.014; DeCaria CM, 1996, J CLIN PSYCHIAT, V57, P80; Egli RE, 2005, NEUROPSYCHOPHARMACOL, V30, P657, DOI 10.1038/sj.npp.1300639; Elman I, 2010, AM J ADDICTION, V19, P332, DOI 10.1111/j.1521-0391.2010.00055.x; Everitt BS, 1999, HUM BRAIN MAPP, V7, P1; First M. B., 2002, USERS GUIDE SCID 1 S; Folstein M, 2010, NUTR REV, V68, pS70, DOI 10.1111/j.1753-4887.2010.00351.x; Ghitza UE, 2006, NEUROPSYCHOPHARMACOL, V31, P2188, DOI 10.1038/sj.npp.1300964; Goeders NE, 2003, EUR NEUROPSYCHOPHARM, V13, P435, DOI 10.1016/j.euroneuro.2003.08.004; Goodman A, 2008, BIOCHEM PHARMACOL, V75, P266, DOI 10.1016/j.bcp.2007.07.030; Goudriaan AE, 2004, NEUROSCI BIOBEHAV R, V28, P123, DOI 10.1016/j.neubiorev.2004.03.001; Goudriaan AE, 2010, ADDICT BIOL, V15, P491, DOI 10.1111/j.1369-1600.2010.00242.x; Grinols EL., 2004, GAMBLING AM COSTS BE; GUTHRIE SK, 1990, EUR J CLIN PHARMACOL, V39, P409, DOI 10.1007/BF00315421; GUTHRIE SK, 1993, BIOL PSYCHIAT, V34, P558, DOI 10.1016/0006-3223(93)90199-N; HEDNER T, 1992, EUR J CLIN PHARMACOL, V43, P651, DOI 10.1007/BF02284967; Heilig M, 2007, TRENDS NEUROSCI, V30, P399, DOI 10.1016/j.tins.2007.06.006; Hollander E, 2005, WORLD J BIOL PSYCHIA, V6, P113, DOI 10.1080/15622970510029768; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Koob GF, 2008, NEURON, V59, P11, DOI 10.1016/j.neuron.2008.06.012; Krueger THC, 2005, NEUROPSYCHOBIOLOGY, V52, P206, DOI 10.1159/000089004; Krystal JH, 1997, PSYCHOPHARMACOLOGY, V131, P207, DOI 10.1007/s002130050285; Krystal JH, 1996, AM J PSYCHIAT, V153, P83; Langleben DD, 2008, AM J PSYCHIAT, V165, P390, DOI 10.1176/appi.ajp.2007.07010070; Lee B, 2004, NEUROPSYCHOPHARMACOL, V29, P686, DOI 10.1038/sj.npp.1300391; LESIEUR HR, 1987, AM J PSYCHIAT, V144, P1184; Meyer G, 2000, BIOL PSYCHIAT, V48, P948, DOI 10.1016/S0006-3223(00)00888-X; Meyer G, 2004, PSYCHONEUROENDOCRINO, V29, P1272, DOI 10.1016/j.psyneuen.2004.03.005; Moodie C, 2005, ADDICTION, V100, P51, DOI 10.1111/j.1360-0443.2005.00942.x; Neumeister A, 2005, PHARMACOGENET GENOM, V15, P143, DOI 10.1097/01213011-200503000-00002; Pendse G, 2009, NEUROIMAGE, V47, P231, DOI 10.1016/j.neuroimage.2009.02.035; POST RM, 1982, J NERV MENT DIS, V170, P717, DOI 10.1097/00005053-198212000-00002; Potenza MN, 2008, PHILOS T R SOC B, V363, P3181, DOI 10.1098/rstb.2008.0100; Potenza MN, 2002, J GEN INTERN MED, V17, P721, DOI 10.1046/j.1525-1497.2002.10812.x; Potenza MN, 2001, JAMA-J AM MED ASSOC, V286, P141, DOI 10.1001/jama.286.2.141; Rasmusson AM, 2000, BIOL PSYCHIAT, V47, P526, DOI 10.1016/S0006-3223(99)00185-7; Ritchey M, 2011, NEUROPSYCHOLOGIA, V49, P640, DOI 10.1016/j.neuropsychologia.2010.09.009; Roalf DR, 2009, NEUROBIOL AGING; Rohan M, 2001, P INT SOC MAGN RESO, V9, P1237; ROY A, 1988, ARCH GEN PSYCHIAT, V45, P369; SATEL SL, 1991, AM J PSYCHIAT, V148, P495; SEYMOUR GE, 1976, J PSYCHOSOM RES, V20, P469, DOI 10.1016/0022-3999(76)90011-8; Shaffer HJ, 1997, PATHOLOGICAL PROBLEM, p[67, 104]; Shalev U, 2010, BRAIN RES, V1314, P15, DOI 10.1016/j.brainres.2009.07.028; SHARPE L, 1995, ADDICTION, V90, P1529, DOI 10.1111/j.1360-0443.1995.tb02815.x; Sharpe L, 2004, J GAMBL STUD, V20, P95, DOI 10.1023/B:JOGS.0000016706.96540.43; Shepard JD, 2000, BRAIN RES, V861, P288, DOI 10.1016/S0006-8993(00)02019-9; Shepard JD, 2003, BRAIN RES, V963, P203, DOI 10.1016/S0006-8993(02)03978-1; Sinha R, 2001, PSYCHOPHARMACOLOGY, V158, P343, DOI 10.1007/s002130100917; Sinha R, 2011, ARCH GEN PSYCHIAT; Sodano R, 2010, J GAMBL STUD, V26, P53, DOI 10.1007/s10899-009-9146-8; SORG BA, 1991, BRAIN RES, V559, P29, DOI 10.1016/0006-8993(91)90283-2; Southwick SM, 1997, ARCH GEN PSYCHIAT, V54, P749; Southwick SM, 1999, BIOL PSYCHIAT, V46, P1192, DOI 10.1016/S0006-3223(99)00219-X; Stine SM, 2002, BIOL PSYCHIAT, V51, P642, DOI 10.1016/S0006-3223(01)01292-6; Stine SM, 2001, PSYCHOPHARMACOLOGY, V154, P274, DOI 10.1007/s002130000644; Strakowski SM, 1996, BIOL PSYCHIAT, V40, P872, DOI 10.1016/0006-3223(95)00497-1; Tamminga CA, 2006, AM J PSYCHIAT, V163, P180, DOI 10.1176/appi.ajp.163.2.180; Tavares H, 2005, ALCOHOL CLIN EXP RES, V29, P1427, DOI 10.1097/01.alc.0000175071.22872.98; Umhau JC, 2011, NEUROPSYCHOPHARMACOL, V36, P1178, DOI 10.1038/npp.2010.253; Weinstock J, 2006, AM J ADDICTION, V15, P144, DOI 10.1080/10550490500528449; Yamamoto RT, 2007, SUBST ABUSE TREAT PR, V2, DOI 10.1186/1747-597X-2-30; YEHUDA R, 1993, BIOL PSYCHIAT, V33, P479, DOI 10.1016/0006-3223(93)90001-T	78	20	20	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2012	7	2							e31118	10.1371/journal.pone.0031118	http://dx.doi.org/10.1371/journal.pone.0031118			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UV	22319607	Green Submitted, Green Published, gold			2022-12-27	WOS:000301979000020
J	Song, JN; Tan, H; Wang, MJ; Webb, GI; Akutsu, T				Song, Jiangning; Tan, Hao; Wang, Mingjun; Webb, Geoffrey I.; Akutsu, Tatsuya			TANGLE: Two-Level Support Vector Regression Approach for Protein Backbone Torsion Angle Prediction from Primary Sequences	PLOS ONE			English	Article							SECONDARY STRUCTURE PREDICTION; ACCESSIBLE SURFACE-AREAS; REAL-VALUE PREDICTION; EVOLUTIONARY INFORMATION; SOLVENT ACCESSIBILITY; DIHEDRAL ANGLES; NEURAL-NETWORKS; LOCAL-STRUCTURE; WEB-SERVER; PSI-BLAST	Protein backbone torsion angles (Phi) and (Psi) involve two rotation angles rotating around the C-alpha-N bond (Phi) and the C-alpha-C bond (Psi). Due to the planarity of the linked rigid peptide bonds, these two angles can essentially determine the backbone geometry of proteins. Accordingly, the accurate prediction of protein backbone torsion angle from sequence information can assist the prediction of protein structures. In this study, we develop a new approach called TANGLE (Torsion ANGLE predictor) to predict the protein backbone torsion angles from amino acid sequences. TANGLE uses a two-level support vector regression approach to perform real-value torsion angle prediction using a variety of features derived from amino acid sequences, including the evolutionary profiles in the form of position-specific scoring matrices, predicted secondary structure, solvent accessibility and natively disordered region as well as other global sequence features. When evaluated based on a large benchmark dataset of 1,526 non-homologous proteins, the mean absolute errors (MAEs) of the Phi and Psi angle prediction are 27.8 degrees and 44.6 degrees, respectively, which are 1% and 3% respectively lower than that using one of the state-of-the-art prediction tools ANGLOR. Moreover, the prediction of TANGLE is significantly better than a random predictor that was built on the amino acid-specific basis, with the p-value, 1.46e-147 and 7.97e-150, respectively by the Wilcoxon signed rank test. As a complementary approach to the current torsion angle prediction algorithms, TANGLE should prove useful in predicting protein structural properties and assisting protein fold recognition by applying the predicted torsion angles as useful restraints. TANGLE is freely accessible at http://sunflower.kuicr.kyoto-u.ac.jp/similar to sjn/TANGLE/.	[Song, Jiangning; Tan, Hao] Monash Univ, Fac Med, Dept Biochem & Mol Biol, Melbourne, Vic 3004, Australia; [Song, Jiangning; Wang, Mingjun] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Key Lab Syst Microbial Biotechnol, Tianjin, Peoples R China; [Song, Jiangning; Wang, Mingjun] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Natl Engn Lab Ind Enzymes, Tianjin, Peoples R China; [Song, Jiangning; Akutsu, Tatsuya] Kyoto Univ, Inst Chem Res, Bioinformat Ctr, Uji, Kyoto, Japan; [Webb, Geoffrey I.] Monash Univ, Fac Informat Technol, Melbourne, Vic 3004, Australia	Monash University; Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS; Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS; Kyoto University; Monash University	Song, JN (corresponding author), Monash Univ, Fac Med, Dept Biochem & Mol Biol, Melbourne, Vic 3004, Australia.	Jiangning.Song@monash.edu; Geoff.Webb@monash.edu; takutsu@kuicr.kyoto-u.ac.jp	wang, mingjun/C-8042-2013; Webb, Geoff i/R-9967-2017; Song, Jiangning/F-9787-2010; Webb, Geoffrey/Q-7270-2019	Webb, Geoff i/0000-0001-9963-5169; Song, Jiangning/0000-0001-8031-9086; Webb, Geoffrey/0000-0001-9963-5169; Akutsu, Tatsuya/0000-0001-9763-797X	National Health and Medical Research Council of Australia (NHMRC) [490989]; Australian Research Council (ARC) [LP110200333]; Chinese Academy of Sciences (CAS) [KSCX2-EW-G-8]; Japan Society for the Promotion of Science (JSPS) [S11156]; Tianjin Municipal Science & Technology Commission [10ZCKFSY05600]; Bioinformatics Center, Institute for Chemical Research, Kyoto University, Japan	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC)(Australian Research Council); Chinese Academy of Sciences (CAS)(Chinese Academy of Sciences); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Tianjin Municipal Science & Technology Commission; Bioinformatics Center, Institute for Chemical Research, Kyoto University, Japan	This work was supported by grants from the National Health and Medical Research Council of Australia (NHMRC) (No. 490989), the Australian Research Council (ARC) (No. LP110200333), the Hundred Talents Program of the Chinese Academy of Sciences (CAS), the Japan Society for the Promotion of Science (JSPS) (No. S11156), the Knowledge Innovative Program of CAS (No. KSCX2-EW-G-8), and the Tianjin Municipal Science & Technology Commission (No. 10ZCKFSY05600). JS is a NHMRC Peter Doherty Fellow and the Recipient of the Hundred Talents Program of the CAS and the JSPS Short-Term Fellowship to Bioinformatics Center, Institute for Chemical Research, Kyoto University, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-33; Ahmad S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-533; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Berjanskii MV, 2006, NUCLEIC ACIDS RES, V34, pW63, DOI 10.1093/nar/gkl341; Bystroff C, 2000, J MOL BIOL, V301, P173, DOI 10.1006/jmbi.2000.3837; Chauhan JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-301; Chen K, 2007, BIOINFORMATICS, V23, P2843, DOI 10.1093/bioinformatics/btm475; Chen K, 2011, AMINO ACIDS, V40, P963, DOI 10.1007/s00726-010-0721-1; Chen L, 2010, BIOINFORMATICS, V26, P1416, DOI 10.1093/bioinformatics/btq144; Chen PC, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-44; Chen P, 2010, AMINO ACIDS, V39, P713, DOI 10.1007/s00726-010-0506-6; Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396; de Brevern AG, 2000, PROTEINS, V41, P271, DOI 10.1002/1097-0134(20001115)41:3<271::AID-PROT10>3.0.CO;2-Z; Dor O, 2007, PROTEINS, V68, P76, DOI 10.1002/prot.21408; Dor O, 2007, PROTEINS, V66, P838, DOI 10.1002/prot.21298; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Faraggi E, 2009, STRUCTURE, V17, P1515, DOI 10.1016/j.str.2009.09.006; Faraggi E, 2009, PROTEINS, V74, P847, DOI 10.1002/prot.22193; Gao JJ, 2010, MOL CELL PROTEOMICS, V9, P2586, DOI 10.1074/mcp.M110.001388; Gaudet R, 1999, MOL CELL, V3, P649, DOI 10.1016/S1097-2765(00)80358-5; Gsponer J, 2008, SCIENCE, V322, P1365, DOI 10.1126/science.1163581; Haynes C, 2006, PLOS COMPUT BIOL, V2, P890, DOI 10.1371/journal.pcbi.0020100; Helles G, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-338; Huang YM, 2006, BIOINFORMATICS, V22, P413, DOI 10.1093/bioinformatics/bti828; Ishida T, 2006, PROTEINS, V64, P940, DOI 10.1002/prot.21047; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kalita MK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002605; KANG HS, 1993, J MOL BIOL, V229, P448, DOI 10.1006/jmbi.1993.1045; Karchin R, 2003, PROTEINS, V51, P504, DOI 10.1002/prot.10369; Ke Chen, 2008, Journal of Biomedical Science & Engineering, V1, P1, DOI 10.4236/jbise.2008.11001; Kountouris P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-407; Kountouris P, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-437; Kuang R, 2004, BIOINFORMATICS, V20, P1612, DOI 10.1093/bioinformatics/bth136; Kumar M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-463; Kurgan L, 2011, CURR PROTEIN PEPT SC, V12, P470, DOI 10.2174/138920311796957711; Liang SD, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-381; Liu W, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-182; Markovic-Housley Z, 2000, STRUCTURE, V8, P1025, DOI 10.1016/S0969-2126(00)00511-6; Miao Xijiang, 2008, Journal of Bioinformatics and Computational Biology, V6, P163, DOI 10.1142/S0219720008003370; Mizianty MJ, 2011, PROTEINS, V79, P294, DOI 10.1002/prot.22882; Mooney C, 2006, J COMPUT BIOL, V13, P1489, DOI 10.1089/cmb.2006.13.1489; Nguyen MN, 2006, PROTEINS, V63, P542, DOI 10.1002/prot.20883; Nguyen MN, 2005, PROTEINS, V59, P30, DOI 10.1002/prot.20404; Ofran Y, 2007, PLOS COMPUT BIOL, V3, P1169, DOI 10.1371/journal.pcbi.0030119; Ofran Y, 2007, BIOINFORMATICS, V23, pI347, DOI 10.1093/bioinformatics/btm174; Pan XY, 2009, PROTEIN PEPTIDE LETT, V16, P1447, DOI 10.2174/092986609789839250; Qiu SB, 2009, IEEE ACM T COMPUT BI, V6, P190, DOI 10.1109/TCBB.2008.139; Raghava GPS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-59; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; ROOMAN MJ, 1991, J MOL BIOL, V221, P961, DOI 10.1016/0022-2836(91)80186-X; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; Rost B, 2001, J STRUCT BIOL, V134, P204, DOI 10.1006/jsbi.2001.4336; ROST B, 1993, P NATL ACAD SCI USA, V90, P7558, DOI 10.1073/pnas.90.16.7558; Schlessinger A, 2007, BIOINFORMATICS, V23, P2376, DOI 10.1093/bioinformatics/btm349; Schlessinger A, 2007, PLOS COMPUT BIOL, V3, P1335, DOI 10.1371/journal.pcbi.0030140; Schlessinger A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004433; Sliz P, 1997, STRUCTURE, V5, P775, DOI 10.1016/S0969-2126(97)00232-3; Song JN, 2008, BIOINFORMATICS, V24, P1489, DOI 10.1093/bioinformatics/btn222; Song JN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-425; Song JN, 2007, BIOINFORMATICS, V23, P3147, DOI 10.1093/bioinformatics/btm505; Song JN, 2010, BIOINFORMATICS, V26, P752, DOI 10.1093/bioinformatics/btq043; Song JN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007072; Song JN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-124; Vapnik V., 1998, STAT LEARNING THEORY; Vapnik V.N., 1995, NATURE STAT LEARNING; Verma R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-201; Wang X, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-32; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Wood MJ, 2005, PROTEINS, V59, P476, DOI 10.1002/prot.20435; Wu ST, 2008, PROTEINS, V72, P547, DOI 10.1002/prot.21945; Wu ST, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003400; Xie D, 2005, NUCLEIC ACIDS RES, V33, pW105, DOI 10.1093/nar/gki359; Xue B, 2008, PROTEINS, V72, P427, DOI 10.1002/prot.21940; Yuan Z, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-248; Yuan Z, 2005, PROTEINS, V58, P905, DOI 10.1002/prot.20375; Yuan Z, 2004, PROTEINS, V57, P558, DOI 10.1002/prot.20234; Yuan Z, 2002, PROTEINS, V48, P566, DOI 10.1002/prot.10176; Zhang C, 2002, P NATL ACAD SCI USA, V99, P3581, DOI 10.1073/pnas.052003799; Zhang H, 2011, BRIEF BIOINFORM, V12, P672, DOI 10.1093/bib/bbq088; Zhang H, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-388; Zhang T, 2008, BIOINFORMATICS, V24, P2329, DOI 10.1093/bioinformatics/btn433; Zhang T, 2010, PROTEINS, V78, P3353, DOI 10.1002/prot.22842; Zhang W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002325; Zheng C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-430; Zimmermann O, 2006, BIOINFORMATICS, V22, P3009, DOI 10.1093/bioinformatics/btl489	86	25	26	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2012	7	2							e30361	10.1371/journal.pone.0030361	http://dx.doi.org/10.1371/journal.pone.0030361			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UV	22319565	Green Published, gold			2022-12-27	WOS:000301979000004
J	Ramos, D; Ades, C				Ramos, Daniela; Ades, Cesar			Two-Item Sentence Comprehension by a Dog (Canis familiaris)	PLOS ONE			English	Article							COMMUNICATION; ABILITY; SEARCH	Syntax use by non-human animals remains a controversial issue. We present here evidence that a dog may respond to verbal requests composed of two independent terms, one referring to an object and the other to an action to be performed relative to the object. A female mongrel dog, Sofia, was initially trained to respond to action (point and fetch) and object (ball, key, stick, bottle and bear) terms which were then presented as simultaneous, combinatorial requests (e. g. ball fetch, stick point). Sofia successfully responded to object-action requests presented as single sentences, and was able to flexibly generalize her performance across different contexts. These results provide empirical evidence that dogs are able to extract the information contained in complex messages and to integrate it in directed performance, an ability which is shared with other linguistically trained animals and may represent a forerunner of syntactic functioning.	[Ramos, Daniela] Univ Sao Paulo, Fac Vet Med & Anim Sci, Dept Clin Med, Sao Paulo, Brazil; [Ades, Cesar] Univ Sao Paulo, Dept Expt Psychol, Inst Psychol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Ramos, D (corresponding author), Univ Sao Paulo, Fac Vet Med & Anim Sci, Dept Clin Med, Sao Paulo, Brazil.	daniela.ramos@usp.br			Brazilian National Council for Research and Development - CNPQ (PIBIC)	Brazilian National Council for Research and Development - CNPQ (PIBIC)	Brazilian National Council for Research and Development - CNPQ (PIBIC) funded this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnetta B., 2000, ANIMAL COGNITION, V3, P107, DOI [10.1007/s100710000070, DOI 10.1007/S100710000070, DOI 10.1177/0963721416667718]; Bloom P, 2004, SCIENCE, V304, P1605, DOI 10.1126/science.1099899; Caplan D, 1999, BEHAV BRAIN SCI, V22, P77; Eckstein G, 1949, SCIENCE, V13, P109; Ferreira F, 2002, CURR DIR PSYCHOL SCI, V11, P11, DOI 10.1111/1467-8721.00158; Fukuzawa M, 2005, APPL ANIM BEHAV SCI, V91, P129, DOI 10.1016/j.applanim.2004.08.025; Fukuzawa M, 2005, J COMP PSYCHOL, V119, P117, DOI 10.1037/0735-7036.119.1.117; Gardner RA., 1989, TEACHING SIGN LANGUA; HERMAN LM, 1984, COGNITION, V16, P129, DOI 10.1016/0010-0277(84)90003-9; Herman LM., 2010, INT J COMP PSYCHOL, V23, P310; Kaminski J, 2004, SCIENCE, V304, P1682, DOI 10.1126/science.1097859; Kaminski J, 2008, ANIM COGN, V11, P367, DOI 10.1007/s10071-007-0124-1; Kaminski J, 2009, DEVELOPMENTAL SCI, V12, P831, DOI 10.1111/j.1467-7687.2009.00815.x; Markman EM, 2004, TRENDS COGN SCI, V8, P479, DOI 10.1016/j.tics.2004.09.007; Miklosi A., 2008, DOG BEHAV EVOLUTION; Miklosi A, 2006, ANIM COGN, V9, P81, DOI 10.1007/s10071-005-0008-1; Nowak MA, 2000, NATURE, V404, P495, DOI 10.1038/35006635; Ouattara K, 2009, P NATL ACAD SCI USA, V106, P22026, DOI 10.1073/pnas.0908118106; Ouattara K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007808; Pepperberg IM, 2002, BRAIN BEHAV EVOLUT, V59, P54, DOI 10.1159/000063733; Pilley JW, 2011, BEHAV PROCESS, V86, P184, DOI 10.1016/j.beproc.2010.11.007; Pongracz P, 2003, ETHOLOGY, V109, P809, DOI 10.1046/j.0179-1613.2003.00923.x; Pongracz P, 2001, CAH PSYCHOL COGN, V20, P87; Ramos D, 2009, 31 INT ETH C RENN FR; Ramos D, 2006, UFAW C QUAL LIF HEAR; Riedel J, 2008, ANIM BEHAV, V75, P1003, DOI 10.1016/j.anbehav.2007.08.010; Rossi AP, 2008, ANIM COGN, V11, P329, DOI 10.1007/s10071-007-0122-3; Sarris E. G., 1931, SIND WIR BERECHTIGT; SAVAGERUMBAUGH ES, 1990, DEV PSYCHOBIOL, V23, P599, DOI 10.1002/dev.420230706; SCHUSTERMAN RJ, 1984, PSYCHOL REC, V34, P3, DOI 10.1007/BF03394849; Warden CJ, 1928, Q REV BIOL, V3, P1, DOI 10.1086/394292; YOUNG CA, 1991, APPL ANIM BEHAV SCI, V32, P75, DOI 10.1016/S0168-1591(05)80165-0	32	17	17	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2012	7	2							e29689	10.1371/journal.pone.0029689	http://dx.doi.org/10.1371/journal.pone.0029689			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UG	22312419	Green Published, Green Submitted, gold			2022-12-27	WOS:000301977500002
J	Fitzgerald, JP; Nayak, B; Shanmugasundaram, K; Friedrichs, W; Sudarshan, S; Eid, AA; DeNapoli, T; Parekh, DJ; Gorin, Y; Block, K				Fitzgerald, John P.; Nayak, Bijaya; Shanmugasundaram, Karthigayan; Friedrichs, William; Sudarshan, Sunil; Eid, Assaad A.; DeNapoli, Thomas; Parekh, Dipen J.; Gorin, Yves; Block, Karen			Nox4 Mediates Renal Cell Carcinoma Cell Invasion through Hypoxia-Induced Interleukin 6-and 8-Production	PLOS ONE			English	Article							NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; OXIDASE SUBUNIT NOX4; INDUCIBLE FACTOR-I; ENDOTHELIAL-CELLS; OXIDATIVE STRESS; NAD(P)H OXIDASE; ACTIVATION; EXPRESSION; INFLAMMATION	Background: Inflammatory cytokines are detected in the plasma of patients with renal cell carcinoma (RCC) and are associated with poor prognosis. However, the primary cell type involved in producing inflammatory cytokines and the biological significance in RCC remain unknown. Inflammation is associated with oxidative stress, upregulation of hypoxia inducible factor 1-alpha, and production of pro-inflammatory gene products. Solid tumors are often heterogeneous in oxygen tension together suggesting that hypoxia may play a role in inflammatory processes in RCC. Epithelial cells have been implicated in cytokine release, although the stimuli to release and molecular mechanisms by which they are released remain unclear. AMP-activated protein kinase (AMPK) is a highly conserved sensor of cellular energy status and a role for AMPK in the regulation of cell inflammatory processes has recently been demonstrated. Methods and Principal Findings: We have identified for the first time that interleukin-6 and interleukin-8 (IL-6 and IL-8) are secreted solely from RCC cells exposed to hypoxia. Furthermore, we demonstrate that the NADPH oxidase isoform, Nox4, play a key role in hypoxia-induced IL-6 and IL-8 production in RCC. Finally, we have characterized that enhanced levels of IL-6 and IL-8 result in RCC cell invasion and that activation of AMPK reduces Nox4 expression, IL-6 and IL-8 production, and RCC cell invasion. Conclusions/Significance: Together, our data identify novel mechanisms by which AMPK and Nox4 may be linked to inflammation-induced RCC metastasis and that pharmacological activation of AMPK and/or antioxidants targeting Nox4 may represent a relevant therapeutic intervention to reduce IL-6- and IL-8-induced inflammation and cell invasion in RCC.	[Fitzgerald, John P.; Shanmugasundaram, Karthigayan; Sudarshan, Sunil; Parekh, Dipen J.] Univ Texas Hlth Sci Ctr San Antonio, Dept Urol, San Antonio, TX 78229 USA; [Block, Karen] Univ Texas Hlth Sci Ctr San Antonio, S Texas Vet Hlth Care Syst, Audie L Murphy Mem Hosp Div, San Antonio, TX 78229 USA; [Nayak, Bijaya; Eid, Assaad A.; Gorin, Yves; Block, Karen] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Div Nephrol, San Antonio, TX 78229 USA; [DeNapoli, Thomas] Univ Texas Hlth Sci Ctr San Antonio, Dept Pathol, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Fitzgerald, JP (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Urol, San Antonio, TX 78229 USA.	block@uthscsa.edu		Gorin, Yves/0000-0003-4048-6925	Veterans Administration Research Service; National Institutes of Health, National Cancer Institute (NCI) [R01:CA131272, K08:CA138774]; Cancer Center Support Grant, National Cancer Institute [5 P30 CA054174-18]; NATIONAL CANCER INSTITUTE [R01CA131272, K08CA138774, P30CA054174] Funding Source: NIH RePORTER	Veterans Administration Research Service(US Department of Veterans Affairs); National Institutes of Health, National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Center Support Grant, National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Veterans Administration Research Service, Career Scientist Award (KB) and the National Institutes of Health, National Cancer Institute (NCI) grants R01:CA131272 (KB) and K08:CA138774 (SS). This work was also supported in part by the Cancer Center Support Grant, National Cancer Institute, 5 P30 CA054174-18 (DJP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLAY JY, 1992, CANCER RES, V52, P3317; Block K, 2007, J BIOL CHEM, V282, P8019, DOI 10.1074/jbc.M611569200; Block K, 2010, AM J PATHOL, V176, P2447, DOI 10.2353/ajpath.2010.090606; Brar SS, 2002, AM J PHYSIOL-CELL PH, V282, pC1212, DOI 10.1152/ajpcell.00496.2001; Corica FA, 1999, J UROLOGY, V161, P408, DOI 10.1016/S0022-5347(01)61903-7; Csanyi G, 2009, FREE RADICAL BIO MED, V47, P1254, DOI 10.1016/j.freeradbiomed.2009.07.022; Desbaillets I, 1999, ONCOGENE, V18, P1447, DOI 10.1038/sj.onc.1202424; Diebold I, 2010, MOL BIOL CELL, V21, P2087, DOI 10.1091/mbc.E09-12-1003; DOSQUET C, 1994, EUR J CANCER, V30A, P162, DOI 10.1016/0959-8049(94)90079-5; Eid AA, 2010, J BIOL CHEM, V285, P37503, DOI 10.1074/jbc.M110.136796; Feurino LW, 2007, CANCER BIOL THER, V6, P1096, DOI 10.4161/cbt.6.7.4328; Giri DK, 1998, J BIOL CHEM, V273, P14008, DOI 10.1074/jbc.273.22.14008; Hattori Y, 2006, HYPERTENSION, V47, P1183, DOI 10.1161/01.HYP.0000221429.94591.72; Jeong HW, 2009, AM J PHYSIOL-ENDOC M, V296, pE955, DOI 10.1152/ajpendo.90599.2008; Liu J, 2011, UROL ONCOL; Lo YYC, 1996, J BIOL CHEM, V271, P15703, DOI 10.1074/jbc.271.26.15703; MAEDA Y, 1994, J EXP MED, V180, P2297, DOI 10.1084/jem.180.6.2297; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Maranchie JK, 2005, CANCER RES, V65, P9190, DOI 10.1158/0008-5472.CAN-05-2105; Maxwell PH, 1997, P NATL ACAD SCI USA, V94, P8104, DOI 10.1073/pnas.94.15.8104; McCarty MF, 2009, MED HYPOTHESES, V72, P468, DOI 10.1016/j.mehy.2008.12.024; Mittal M, 2007, CIRC RES, V101, P258, DOI 10.1161/CIRCRESAHA.107.148015; Peairs A, 2009, CLIN EXP IMMUNOL, V156, P542, DOI 10.1111/j.1365-2249.2009.03924.x; Reuter S, 2010, FREE RADICAL BIO MED, V49, P1603, DOI 10.1016/j.freeradbiomed.2010.09.006; Schulze-Osthoff K, 1998, EUR J BIOCHEM, V254, P439, DOI 10.1046/j.1432-1327.1998.2540439.x; Schulze-Osthoff K, 1997, IMMUNOBIOLOGY, V198, P35, DOI 10.1016/S0171-2985(97)80025-3; Semenza GL, 2002, TRENDS MOL MED, V8, pS62, DOI 10.1016/S1471-4914(02)02317-1; Shono T, 1996, MOL CELL BIOL, V16, P4231; Wang SX, 2010, CIRC RES, V106, P1117, DOI 10.1161/CIRCRESAHA.109.212530; Webster WS, 2006, CANCER-AM CANCER SOC, V107, P46, DOI 10.1002/cncr.21951; Woodard J, 2010, CANCER BIOL THER, V10, P1169, DOI 10.4161/cbt.10.11.13629; Xu L, 1999, CANCER RES, V59, P5822	32	76	79	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e30712	10.1371/journal.pone.0030712	http://dx.doi.org/10.1371/journal.pone.0030712			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22303451	Green Published, Green Submitted, gold			2022-12-27	WOS:000301704200030
J	Hashimoto, K; Sasajima, Y; Ando, M; Yonemori, K; Hirakawa, A; Furuta, K; Tsuda, H; Fujiwara, Y				Hashimoto, Ken; Sasajima, Yanji; Ando, Masashi; Yonemori, Kan; Hirakawa, Akihiro; Furuta, Koh; Tsuda, Hitoshi; Fujiwara, Yasuhiro			Immunohistochemical Profile for Unknown Primary Adenocarcinoma	PLOS ONE			English	Article							PHASE-III TRIAL; PRIMARY SITE; PLUS CISPLATIN; CANCER; CARCINOMAS; EXPRESSION; FLUOROURACIL; OXALIPLATIN; LEUCOVORIN; SORAFENIB	Hypoplastic Left Heart Syndrome (HLHS) is a congenital defect characterized by underdevelopment of the left ventricle and pathological compensation of the right ventricle. If untreated, HLHS is invariably lethal due to the extensive increase in right ventricular workload and eventual failure. Despite the clinical significance, little is known about the molecular pathobiological state of HLHS. Splicing of mRNA transcripts is an important regulatory mechanism of gene expression. Tissue specific alterations of this process have been associated with several cardiac diseases, however, transcriptional signature profiles related to HLHS are unknown. In this study, we performed genome-wide exon array analysis to determine differentially expressed genes and alternatively spliced transcripts in the right ventricle (RV) of six neonates with HLHS, compared to the RV and left ventricle (LV) from non-diseased control subjects. In HLHS, over 180 genes were differentially expressed and 1800 were differentially spliced, leading to changes in a variety of biological processes involving cell metabolism, cytoskeleton, and cell adherence. Additional hierarchical clustering analysis revealed that differential gene expression and mRNA splicing patterns identified in HLHS are unique compared to non-diseased tissue. Our findings suggest that gene expression and mRNA splicing are broadly dysregulated in the RV myocardium of HLHS neonates. In addition, our analysis identified transcriptome profiles representative of molecular biomarkers of HLHS that could be used in the future for diagnostic and prognostic stratification to improve patient outcome.	[Hashimoto, Ken; Sasajima, Yanji; Furuta, Koh] Natl Canc Ctr, Dept Breast Oncol & Med Oncol, Tokyo, Japan; [Ando, Masashi; Yonemori, Kan; Tsuda, Hitoshi] Natl Canc Ctr, Dept Pathol & Clin Labs, Tokyo, Japan; Tokyo Univ Sci, Dept Management Sci, Grad Sch Engn, Tokyo 162, Japan	National Cancer Center - Japan; National Cancer Center - Japan; Tokyo University of Science	Hashimoto, K (corresponding author), Natl Canc Ctr, Dept Breast Oncol & Med Oncol, 1-1 Tsukiji 5 Chome, Tokyo, Japan.	gonmusao@k6.dion.ne.jp	Hirakawa, Akihiro/AAE-5936-2019	Hirakawa, Akihiro/0000-0002-1193-8104; Fujiwara, Yasuhiro/0000-0002-1229-5446; Hashimoto, Kenji/0000-0001-8826-2037	private University of Miami; National Heart, Lung, and Blood Institute [R01HL091878]	private University of Miami; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Study supported by private University of Miami research Fund (Jonathan and Eileen Otto Research Fund) and National Heart, Lung, and Blood Institute R01HL091878 (JL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Batran SE, 2008, J CLIN ONCOL, V26, P1435, DOI 10.1200/JCO.2007.13.9378; Allred DC, 1998, MODERN PATHOL, V11, P155; Centeno BA, 2010, J MOL DIAGN, V12, P476, DOI 10.2353/jmoldx.2010.090197; Chhieng DC, 2001, CANCER CYTOPATHOL, V93, P330, DOI 10.1002/cncr.9048; Chia SY, 2010, BREAST, V19, P355, DOI 10.1016/j.breast.2010.02.007; Chu PG, 2005, AM J SURG PATHOL, V29, P359, DOI 10.1097/01.pas.0000149708.12335.6a; Ciampa A, 2004, CANCER CYTOPATHOL, V102, P368, DOI 10.1002/cncr.20627; Colucci G, 2010, J CLIN ONCOL, V28, P1645, DOI 10.1200/JCO.2009.25.4433; Dennis JL, 2005, CLIN CANCER RES, V11, P3766, DOI 10.1158/1078-0432.CCR-04-2236; Dupont J, 2004, GYNECOL ONCOL, V94, P449, DOI 10.1016/j.ygyno.2004.05.014; Escudier B, 2009, J CLIN ONCOL, V27, P3312, DOI 10.1200/JCO.2008.19.5511; Goldberg RM, 2004, J CLIN ONCOL, V22, P23, DOI 10.1200/JCO.2004.09.046; Goldstein NS, 2002, AM J CLIN PATHOL, V117, P471, DOI 10.1309/G6PR-Y774-X738-FG2K; Golfinopoulos V, 2009, CANCER TREAT REV, V35, P570, DOI 10.1016/j.ctrv.2009.05.005; Horlings HM, 2008, J CLIN ONCOL, V26, P4435, DOI 10.1200/JCO.2007.14.6969; Lai YQ, 2010, UROLOGY, V76, DOI 10.1016/j.urology.2009.11.045; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Lotan TL, 2009, AM J SURG PATHOL, V33, P1037, DOI 10.1097/PAS.0b013e3181962dcd; Mhawech P, 2002, HUM PATHOL, V33, P1136, DOI 10.1053/hupa.2002.129416; Monzon FA, 2009, J CLIN ONCOL, V27, P2503, DOI 10.1200/JCO.2008.17.9762; Morris JP, 2010, NAT REV CANCER, V10, P683, DOI 10.1038/nrc2899; Mukai H, 2010, AM J CLIN ONCOL-CANC, V33, P32, DOI 10.1097/COC.0b013e31819ccc55; Nomura H, 2011, ANN ONCOL, V22, P636, DOI 10.1093/annonc/mdq401; Nonaka D, 2008, AM J SURG PATHOL, V32, P1566, DOI 10.1097/PAS.0b013e31816d71ad; Park do Y, 2009, MODERN PATHOL, V23, P54, DOI DOI 10.1038/MODPATHOL.2009.135; Parmar MKB, 2003, LANCET, V361, P2099; Pavlidis N, 2005, CRIT REV ONCOL HEMAT, V54, P243, DOI 10.1016/j.critrevonc.2004.10.002; Pavlidis N, 2003, EUR J CANCER, V39, P1990, DOI 10.1016/S0959-8049(03)00547-1; Pavlidis N, 2010, ANN ONCOL, V21, pv228, DOI 10.1093/annonc/mdq193; Pentheroudakis G, 2007, EUR J CANCER, V43, P2026, DOI 10.1016/j.ejca.2007.06.023; Pentheroudakis G, 2007, ONCOLOGIST, V12, P418, DOI 10.1634/theoncologist.12-4-418; Perry A, 1997, HUM PATHOL, V28, P938, DOI 10.1016/S0046-8177(97)90009-5	32	18	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e31181	10.1371/journal.pone.0031181	http://dx.doi.org/10.1371/journal.pone.0031181			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22299055	Green Published, Green Submitted, gold			2022-12-27	WOS:000301704200064
J	Huang, QL; Gong, CG; Li, JH; Zhuo, Z; Chen, Y; Wang, J; Hua, ZC				Huang, Qilai; Gong, Chenguang; Li, Jiahuang; Zhuo, Zhu; Chen, Yuan; Wang, Jin; Hua, Zi-Chun			Distance and Helical Phase Dependence of Synergistic Transcription Activation in cis-Regulatory Module	PLOS ONE			English	Article							FACTOR-BINDING-SITES; CRYSTAL-STRUCTURE; DNA RECOGNITION; STRUCTURAL BASIS; GENE; DISCOVERY; ELEMENT; PROTEIN; MECHANISM; GAL4	Deciphering of the spatial and stereospecific constraints on synergistic transcription activation mediated between activators bound to cis-regulatory elements is important for understanding gene regulation and remains largely unknown. It has been commonly believed that two activators will activate transcription most effectively when they are bound on the same face of DNA double helix and within a boundary distance from the transcription initiation complex attached to the TATA box. In this work, we studied the spatial and stereospecific constraints on activation by multiple copies of bound model activators using a series of engineered relative distances and stereospecific orientations. We observed that multiple copies of the activators GAL4-VP16 and ZEBRA bound to engineered promoters activated transcription more effectively when bound on opposite faces of the DNA double helix. This phenomenon was not affected by the spatial relationship between the proximal activator and initiation complex. To explain these results, we proposed the novel concentration field model, which posits the effective concentration of bound activators, and therefore the transcription activation potential, is affected by their stereospecific positioning. These results could be used to understand synergistic transcription activation anew and to aid the development of predictive models for the identification of cis-regulatory elements.	[Huang, Qilai; Gong, Chenguang; Li, Jiahuang; Zhuo, Zhu; Chen, Yuan; Wang, Jin; Hua, Zi-Chun] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Nanjing, Jiangsu, Peoples R China; [Huang, Qilai; Gong, Chenguang; Li, Jiahuang; Zhuo, Zhu; Chen, Yuan; Wang, Jin; Hua, Zi-Chun] Nanjing Univ, Affiliated Stomatol Hosp, Nanjing, Jiangsu, Peoples R China; [Huang, Qilai; Hua, Zi-Chun] Macau Univ Sci & Technol, State Key Lab Qual Res Chinese Med, Macau, Peoples R China; [Huang, Qilai; Hua, Zi-Chun] Macau Univ Sci & Technol, Macau Inst Appl Res Med, Macau, Peoples R China; [Huang, Qilai; Hua, Zi-Chun] Nanjing Univ, Changzhou High Tech Res Inst, Changzhou, Peoples R China; [Huang, Qilai; Hua, Zi-Chun] Jiangsu TargetPharma Labs Inc, Changzhou, Peoples R China	Nanjing University; Nanjing University; Macau University of Science & Technology; Macau University of Science & Technology; Nanjing University	Huang, QL (corresponding author), Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Nanjing, Jiangsu, Peoples R China.	jwang@nju.edu.cn; huazc@nju.edu.cn	z, z/HHN-3970-2022; Huang, Qilai/B-4725-2015; z, z/GXZ-4805-2022; Gong, Chenguang/F-5791-2014; Z, Z/AEN-2153-2022	Huang, Qilai/0000-0002-4252-3980; 	National Natural Science Foundation of China [90208021, 39970184, 79970116]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (90208021, 39970184, 79970116 to JW; http://www.nsfc.gov.cn/e_nsfc/desktop/zn/0101.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beer MA, 2004, CELL, V117, P185, DOI 10.1016/S0092-8674(04)00304-6; Benfante R, 2005, BIOCHEM J, V386, P63, DOI 10.1042/BJ20041294; Blais A, 2005, GENE DEV, V19, P1499, DOI 10.1101/gad.1325605; Brown BL, 2011, J BIOL CHEM, V286, P2285, DOI 10.1074/jbc.M110.172643; Bruce A., 2002, MOL BIOL CELL, V4th ed.; Brutinel ED, 2009, J BACTERIOL, V191, P3811, DOI 10.1128/JB.00002-09; Bussemaker HJ, 2001, NAT GENET, V27, P167, DOI 10.1038/84792; CAREY M, 1992, J VIROL, V66, P4803, DOI 10.1128/JVI.66.8.4803-4813.1992; Carey M, 1998, CELL, V92, P5, DOI 10.1016/S0092-8674(00)80893-4; CAREY M, 1990, NATURE, V345, P361, DOI 10.1038/345361a0; CHI TH, 1993, MOL CELL BIOL, V13, P7045, DOI 10.1128/MCB.13.11.7045; Cliften P, 2003, SCIENCE, V301, P71, DOI 10.1126/science.1084337; Collins T, 2001, MOL CELL BIOL, V21, P3609, DOI 10.1128/MCB.21.11.3609-3615.2001; Cooper GM, 2003, CURR OPIN GENET DEV, V13, P604, DOI 10.1016/j.gde.2003.10.001; CRESS WD, 1991, SCIENCE, V251, P87, DOI 10.1126/science.1846049; Dong W, 2006, ACTA BIOCH BIOPH SIN, V38, P780, DOI 10.1111/j.1745-7270.2006.00220.x; Elemento O, 2007, MOL CELL, V28, P337, DOI 10.1016/j.molcel.2007.09.027; FLEMINGTON EK, 1992, J VIROL, V66, P922, DOI 10.1128/JVI.66.2.922-929.1992; Gertz J, 2009, NATURE, V457, P215, DOI 10.1038/nature07521; GINIGER E, 1988, P NATL ACAD SCI USA, V85, P382, DOI 10.1073/pnas.85.2.382; GROGAN E, 1987, P NATL ACAD SCI USA, V84, P1332, DOI 10.1073/pnas.84.5.1332; GuhaThakurta D, 2001, BIOINFORMATICS, V17, P608, DOI 10.1093/bioinformatics/17.7.608; Gupta M, 2005, P NATL ACAD SCI USA, V102, P7079, DOI 10.1073/pnas.0408743102; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Harley VR, 2003, P NATL ACAD SCI USA, V100, P7045, DOI 10.1073/pnas.1137864100; Hong MQ, 2008, STRUCTURE, V16, P1019, DOI 10.1016/j.str.2008.03.015; Huang QL, 2006, J IMMUNOL METHODS, V309, P130, DOI 10.1016/j.jim.2005.11.009; JANSON L, 1990, P NATL ACAD SCI USA, V87, P4732, DOI 10.1073/pnas.87.12.4732; Johnson KM, 2002, GENE DEV, V16, P1852, DOI 10.1101/gad.995702; Kadonaga JT, 2004, CELL, V116, P247, DOI 10.1016/S0092-8674(03)01078-X; Lewin, 2000, GENES-BASEL; Li T, 1998, NUCLEIC ACIDS RES, V26, P5707, DOI 10.1093/nar/26.24.5707; Liberati C, 1999, J MOL BIOL, V285, P1441, DOI 10.1006/jmbi.1998.2384; LIN YS, 1990, NATURE, V345, P359, DOI 10.1038/345359a0; MARMORSTEIN R, 1992, NATURE, V356, P408, DOI 10.1038/356408a0; MARMORSTEIN R, 1994, GENE DEV, V8, P2504, DOI 10.1101/gad.8.20.2504; MARTINEZ E, 1987, EMBO J, V6, P3719, DOI 10.1002/j.1460-2075.1987.tb02706.x; Mo Y, 2001, J MOL BIOL, V314, P495, DOI 10.1006/jmbi.2001.5138; MOSSING MC, 1986, SCIENCE, V233, P889, DOI 10.1126/science.3090685; Murphy KF, 2007, P NATL ACAD SCI USA, V104, P12726, DOI 10.1073/pnas.0608451104; Newberry KJ, 2004, J BIOL CHEM, V279, P20356, DOI 10.1074/jbc.M400960200; Pearce D, 1998, J BIOL CHEM, V273, P30081, DOI 10.1074/jbc.273.46.30081; Petosa C, 2006, MOL CELL, V21, P565, DOI 10.1016/j.molcel.2006.01.006; Pilpel Y, 2001, NAT GENET, V29, P153, DOI 10.1038/ng724; Ptashne M, 1997, NATURE, V386, P569, DOI 10.1038/386569a0; Roberts SGE, 2000, CELL MOL LIFE SCI, V57, P1149, DOI 10.1007/PL00000755; RUDEN DM, 1988, P NATL ACAD SCI USA, V85, P4262, DOI 10.1073/pnas.85.12.4262; SADOWSKI I, 1988, NATURE, V335, P563, DOI 10.1038/335563a0; Sayle RA, 1995, TRENDS BIOCH SCI, P20; SCHUMACHER MA, 1994, SCIENCE, V266, P763, DOI 10.1126/science.7973627; SEGAL R, 1991, J BIOL CHEM, V266, P20406; SMITH KP, 1995, J BIOL CHEM, V270, P4484, DOI 10.1074/jbc.270.9.4484; TAYLOR ICA, 1991, GENE DEV, V5, P1285, DOI 10.1101/gad.5.7.1285; THOMPSON JF, 1988, NUCLEIC ACIDS RES, V16, P9687, DOI 10.1093/nar/16.20.9687; Tompa M, 2005, NAT BIOTECHNOL, V23, P137, DOI 10.1038/nbt1053; USHIDA C, 1990, NUCLEIC ACIDS RES, V18, P6325, DOI 10.1093/nar/18.21.6325; Vallania F, 2009, P NATL ACAD SCI USA, V106, P5117, DOI 10.1073/pnas.0900473106; Vandenbon A, 2010, NUCLEIC ACIDS RES, V38, P17, DOI 10.1093/nar/gkp866; Vardhanabhuti S, 2007, NUCLEIC ACIDS RES, V35, P3203, DOI 10.1093/nar/gkm201; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; Wasserman WW, 2000, NAT GENET, V26, P225, DOI 10.1038/79965; WING HJ, 1995, J BACTERIOL, V177, P6704, DOI 10.1128/jb.177.23.6704-6710.1995; Wray GA, 2003, MOL BIOL EVOL, V20, P1377, DOI 10.1093/molbev/msg140; WU L, 1988, GENE DEV, V2, P403, DOI 10.1101/gad.2.4.403; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Yokoyama KD, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp423; Yu XP, 2006, NUCLEIC ACIDS RES, V34, P4925, DOI 10.1093/nar/gkl595	67	10	10	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e31198	10.1371/journal.pone.0031198	http://dx.doi.org/10.1371/journal.pone.0031198			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KO	22299056	Green Published, gold, Green Submitted			2022-12-27	WOS:000305693600002
J	Wikan, N; Sakoonwatanyoo, P; Ubol, S; Yoksan, S; Smith, DR				Wikan, Nitwara; Sakoonwatanyoo, Prirayapak; Ubol, Sukathida; Yoksan, Sutee; Smith, Duncan R.			Chikungunya Virus Infection of Cell Lines: Analysis of the East, Central and South African Lineage	PLOS ONE			English	Article							AEDES-ALBOPICTUS; REUNION ISLAND; OUTBREAK; EPIDEMIC; FEVER; DISEASE; GLOBALIZATION; ESTABLISHMENT; REEMERGENCE; EMERGENCE	Chikungunya virus (CHIKV) is a re-emerging mosquito borne alphavirus that has caused large scale epidemics in the countries around the Indian Ocean, as well as leading to autochthonous transmission in some European countries. The transmission of the disease has been driven by the emergence of an African lineage of CHIKV with enhanced transmission and dissemination in Aedes mosquito hosts. Two main genotypes of this lineage have been circulating, characterized by the presence of a substitution of a valine for an alanine at position 226 of the E1 protein. The outbreak, numbering in millions of cases in the infected areas, has been associated with increasing numbers of cases with non-classical presentation including encephalitis and meningitis. This study sought to compare the original Ross strain with two isolates from the recent outbreak of chikungunya fever in respect of infectivity and the induction of apoptosis in eight mammalian cell lines and two insect cell lines, in addition to generating a comprehensive virus production profile for one of the newer isolates. Results showed that in mammalian cells there were few differences in either tropism or pathogenicity as assessed by induction of apoptosis with the exception of Hela cells were the recent valine isolate showed less infectivity. The Aedes albopictus C6/36 cell line was however significantly more permissive for both of the more recent isolates than the Ross strain. The results suggest that the increased infectivity seen in insect cells derives from an evolution of the CHIKV genome not solely associated with the E1:226 substitution.	[Wikan, Nitwara; Yoksan, Sutee; Smith, Duncan R.] Mahidol Univ, Inst Mol Biosci, Bangkok 10700, Thailand; [Sakoonwatanyoo, Prirayapak] Navamindradhiraj Univ, Fac Med, Vajira Hosp, Dept Clin Pathol, Bangkok, Thailand; [Ubol, Sukathida] Mahidol Univ, Fac Sci, Dept Microbiol, Bangkok 10400, Thailand; [Ubol, Sukathida; Yoksan, Sutee; Smith, Duncan R.] Mahidol Univ, Ctr Emerging & Neglected Infect Dis, Bangkok 10700, Thailand	Mahidol University; Mahidol University; Mahidol University	Wikan, N (corresponding author), Mahidol Univ, Inst Mol Biosci, Bangkok 10700, Thailand.	duncan_r_smith@hotmail.com	Wikan, Nitwara/V-9296-2017; Smith, Duncan R/C-6891-2011; Wikan, Nitwara/GSN-6014-2022	Wikan, Nitwara/0000-0002-0708-0328; Smith, Duncan R/0000-0002-6592-9852; Wikan, Nitwara/0000-0002-0708-0328	Office of the Higher Education Commission; Mahidol University under the National Research Universities Initiative; Mahidol University; TRF	Office of the Higher Education Commission; Mahidol University under the National Research Universities Initiative; Mahidol University; TRF(Thailand Research Fund (TRF))	This work was supported by grants from the Office of the Higher Education Commission and Mahidol University under the National Research Universities Initiative and Mahidol University. N.W. is supported by a TRF and Mahidol University (Thai Royal Golden Jubilee) Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIKAT BK, 1964, INDIAN J MED RES, V52, P660; Arankalle VA, 2007, J GEN VIROL, V88, P1967, DOI 10.1099/vir.0.82714-0; Beesoon S, 2008, EMERG INFECT DIS, V14, P337, DOI 10.3201/eid1402.071024; Bhavana K, 2008, INT J PEDIATR OTORHI, V72, P257, DOI 10.1016/j.ijporl.2007.09.022; Blair CD, 2011, FUTURE MICROBIOL, V6, P265, DOI [10.2217/FMB.11.11, 10.2217/fmb.11.11]; Bordi L, 2008, CLIN INFECT DIS, V47, P428, DOI 10.1086/589925; Borgherini G, 2007, CLIN INFECT DIS, V44, P1401, DOI 10.1086/517537; Brackney DE, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000856; Charrel RN, 2007, NEW ENGL J MED, V356, P769, DOI 10.1056/NEJMp078013; Chen LH, 2010, CURR OPIN INFECT DIS, V23, P438, DOI 10.1097/QCO.0b013e32833c1d16; Cherian SS, 2009, INFECT GENET EVOL, V9, P16, DOI 10.1016/j.meegid.2008.09.004; Chow A, 2011, J INFECT DIS, V203, P149, DOI 10.1093/infdis/jiq042; Chua H H, 2010, Med J Malaysia, V65, P83; Chusri S, 2011, AM J TROP MED HYG, V85, P386, DOI 10.4269/ajtmh.2011.10-0725; Das S, 2007, J Commun Dis, V39, P37; Das T, 2010, PROG NEUROBIOL, V91, P121, DOI 10.1016/j.pneurobio.2009.12.006; de Lamballerie X, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-33; Gerardin P, 2008, PLOS MED, V5, P413, DOI 10.1371/journal.pmed.0050060; Grandadam M, 2011, EMERG INFECT DIS, V17, P910, DOI 10.3201/eid1705.101873; Hapuarachchi HC, 2010, J GEN VIROL, V91, P1067, DOI 10.1099/vir.0.015743-0; Her ZS, 2010, J IMMUNOL, V184, P5903, DOI 10.4049/jimmunol.0904181; Her Z, 2009, MICROBES INFECT, V11, P1165, DOI 10.1016/j.micinf.2009.09.004; JACOBS JP, 1970, NATURE, V227, P168, DOI 10.1038/227168a0; Jaffar-Bandjee MC, 2010, EXPERT REV ANTI-INFE, V8, P987, DOI [10.1586/eri.10.92, 10.1586/ERI.10.92]; JANABI N, 1995, NEUROSCI LETT, V195, P105, DOI 10.1016/0304-3940(94)11792-H; Josseran L, 2006, EMERG INFECT DIS, V12, P1994; KANAMITSU M, 1979, AM J TROP MED HYG, V28, P351, DOI 10.4269/ajtmh.1979.28.351; Ketting RF, 2011, DEV CELL, V20, P148, DOI 10.1016/j.devcel.2011.01.012; Khan AH, 2002, J GEN VIROL, V83, P3075, DOI 10.1099/0022-1317-83-12-3075; Krejbich-Trotot P, 2011, FASEB J, V25, P314, DOI 10.1096/fj.10-164178; Labadie K, 2010, J CLIN INVEST, V120, P894, DOI 10.1172/JCI40104; Lalitha P, 2007, AM J OPHTHALMOL, V144, P552, DOI 10.1016/j.ajo.2007.06.002; Manimunda SP, 2007, EMERG INFECT DIS, V13, P1259, DOI 10.3201/eid1308.070193; MARCHETTE N J, 1980, Southeast Asian Journal of Tropical Medicine and Public Health, V11, P14; Mittal A, 2007, ARCH OPHTHALMOL-CHIC, V125, P1381, DOI 10.1001/archopht.125.10.1381; Mittal A, 2007, OPHTHALMOLOGY, V114, P1798, DOI 10.1016/j.ophtha.2007.03.045; Nandha B, 2009, Indian J Public Health, V53, P209; Ng LC, 2010, INFECT GENET EVOL, V10, P876, DOI 10.1016/j.meegid.2010.07.012; Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X; Powers AM, 2000, J GEN VIROL, V81, P471, DOI 10.1099/0022-1317-81-2-471; Pulmanausahakul R, 2011, INT J INFECT DIS, V15, pE671, DOI 10.1016/j.ijid.2011.06.002; Rampal, 2007, J Assoc Physicians India, V55, P765; Rampal, 2007, J Assoc Physicians India, V55, P598; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; ROBINSON M C, 1955, Trans R Soc Trop Med Hyg, V49, P28, DOI [10.1016/0035-9203(57)90022-6, 10.1016/0035-9203(55)90080-8]; ROSS R. W., 1956, JOUR HYG, V54, P177; Sam IC, 2010, TROP BIOMED, V27, P343; Santhosh SR, 2008, VIRUS RES, V135, P36, DOI 10.1016/j.virusres.2008.02.004; SARKAR JK, 1964, INDIAN J MED RES, V52, P684; Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263; Schwartz O, 2010, NAT REV MICROBIOL, V8, P491, DOI 10.1038/nrmicro2368; Simon F, 2008, MED CLIN N AM, V92, P1323, DOI 10.1016/j.mcna.2008.07.008; SINGH KRP, 1967, CURR SCI INDIA, V36, P506; Sissoko D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000389; Solignat M, 2009, VIROLOGY, V393, P183, DOI 10.1016/j.virol.2009.07.024; Soumahoro MK, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001197; Soumahoro MK, 2009, PLOS ONE, V4, pA221, DOI 10.1371/journal.pone.0007800; Sourisseau M, 2007, PLOS PATHOG, V3, P804, DOI 10.1371/journal.ppat.0030089; Staples JE, 2009, CLIN INFECT DIS, V49, P942, DOI 10.1086/605496; Sudeep AB, 2008, J BIOSCIENCES, V33, P443, DOI 10.1007/s12038-008-0063-2; SUNDSTROM C, 1976, INT J CANCER, V17, P565, DOI 10.1002/ijc.2910170504; Theamboonlers A, 2009, JPN J INFECT DIS, V62, P303; Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201; Tsetsarkin KA, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-376; Tsetsarkin KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006835	67	67	68	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e31102	10.1371/journal.pone.0031102	http://dx.doi.org/10.1371/journal.pone.0031102			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22299053	gold, Green Published, Green Submitted			2022-12-27	WOS:000301704200061
J	Lev, A; Simon, AJ; Bareket, M; Bielorai, B; Hutt, D; Amariglio, N; Rechavi, G; Somech, R				Lev, Atar; Simon, Amos J.; Bareket, Mor; Bielorai, Bella; Hutt, Daphna; Amariglio, Ninette; Rechavi, Gideon; Somech, Raz			The Kinetics of Early T and B Cell Immune Recovery after Bone Marrow Transplantation in RAG-2-Deficient SCID Patients	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; SEVERE COMBINED IMMUNODEFICIENCY; ALLOGENEIC TRANSPLANTATION; REPERTOIRE DIVERSITY; NEGATIVE SELECTION; LEUKEMIA PATIENTS; THYMIC OUTPUT; RECONSTITUTION; LYMPHOCYTES; DEFICIENCY	The kinetics of T and B cell immune recovery after bone marrow transplantation (BMT) is affected by many pre- and post-transplant factors. Because of the profoundly depleted baseline T and B cell immunity in recombination activating gene 2 (RAG-2)-deficient severe combined immunodeficiency (SCID) patients, some of these factors are eliminated, and the immune recovery after BMT can then be clearly assessed. This process was followed in ten SCID patients in parallel to their associated transplant-related complications. Early peripheral presence of T and B cells was observed in 8 and 4 patients, respectively. The latter correlated with pre-transplant conditioning therapy. Cells from these patients carried mainly signal joint DNA episomes, indicative of newly derived B and T cells. They were present before the normalization of the T cell receptor (TCR) and the B cell receptor (BCR) repertoire. Early presentation of the ordered TCR gene rearrangements after BMT occurred simultaneously, but this pattern was heterogeneous over time, suggesting different and individual thymic recovery processes. Our findings early after transplant could suggest the long-term patients' clinical outcome. Early peripheral presence of newly produced B and T lymphocytes from their production and maturation sites after BMT suggests donor stem cell origin rather than peripheral expansion, and is indicative of successful outcome. Peripheral detection of TCR excision circles and kappa-deleting recombination excision circles in RAG-2-deficient SCID post-BMT are early markers of T and B cell reconstitution, and can be used to monitor outcome and tailor specific therapy for patients undergoing BMT.	[Lev, Atar; Simon, Amos J.; Amariglio, Ninette; Rechavi, Gideon; Somech, Raz] Canc Res Ctr, Tel Hashomer, Israel; [Lev, Atar; Simon, Amos J.; Bareket, Mor; Bielorai, Bella; Hutt, Daphna; Amariglio, Ninette; Rechavi, Gideon; Somech, Raz] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Lev, Atar; Simon, Amos J.; Bareket, Mor; Somech, Raz] Jeffery Modell Fdn JMF Ctr, Pediat Immunol Serv, Tel Hashomer, Israel; [Bielorai, Bella; Hutt, Daphna] Safra Childrens Hosp, Sheba Med Ctr, Div Pediat Hematol Oncol, Tel Hashomer, Israel; [Bielorai, Bella; Hutt, Daphna] Safra Childrens Hosp, Sheba Med Ctr, Bone Marrow Transplantat Unit, Tel Hashomer, Israel; [Amariglio, Ninette] Sheba Med Ctr, Hematol Lab, Tel Hashomer, Israel	Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Chaim Sheba Medical Center	Lev, A (corresponding author), Canc Res Ctr, Tel Hashomer, Israel.	rsomech@hotmail.com		Hutt, Daphna/0000-0003-4354-5193				Amariglio N, 2010, PEDIATR RES, V67, P211, DOI 10.1203/PDR.0b013e3181c6e554; [Anonymous], 2011, EBMT ESID GUID HEM S; Bains I, 2009, J IMMUNOL, V183, P4329, DOI 10.4049/jimmunol.0900743; Brown L, 2011, BLOOD, V117, P3243, DOI 10.1182/blood-2010-08-300384; Buckley RH, 1999, NEW ENGL J MED, V340, P508, DOI 10.1056/NEJM199902183400703; Cavadini P, 2005, J CLIN INVEST, V115, P728, DOI 10.1172/JCI200523087; Champlin RE, 2000, BLOOD, V95, P3702; Clave E, 2009, BLOOD, V113, P6477, DOI 10.1182/blood-2008-09-176594; Cuvelier GDE, 2009, CLIN IMMUNOL, V131, P179, DOI 10.1016/j.clim.2009.01.003; Dik WA, 2005, J EXP MED, V201, P1715, DOI 10.1084/jem.20042524; Farge D, 2005, ARTHRITIS RHEUM, V52, P1555, DOI 10.1002/art.21036; FRY AM, 1989, SCIENCE, V246, P1044, DOI 10.1126/science.2511630; Giver CR, 2004, IMMUNOL RES, V29, P269, DOI 10.1385/IR:29:1-3:269; Godthelp BC, 1999, BLOOD, V94, P4358, DOI 10.1182/blood.V94.12.4358.424k02_4358_4369; Griffith LM, 2009, J ALLERGY CLIN IMMUN, V124, P1152, DOI 10.1016/j.jaci.2009.10.022; Hazenberg MD, 2003, NAT IMMUNOL, V4, P97, DOI 10.1038/ni0203-97; Heitger A, 2000, TRANSPLANTATION, V69, P2366, DOI 10.1097/00007890-200006150-00026; Hochberg EP, 2001, BLOOD, V98, P1116, DOI 10.1182/blood.V98.4.1116; HODES RJ, 1989, SCIENCE, V246, P1041, DOI 10.1126/science.2587987; Lamb LS, 1998, BONE MARROW TRANSPL, V21, P461; Lev A, 2010, BONE MARROW TRANSPL, V45, P1084, DOI 10.1038/bmt.2009.314; Lewin SR, 2002, BLOOD, V100, P2235, DOI 10.1182/blood.V100.6.2235.h81802002235_2235_2242; Motta M, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-111; NOSSAL GJV, 1994, CELL, V76, P229, DOI 10.1016/0092-8674(94)90331-X; Olkinuora H, 2007, BONE MARROW TRANSPL, V39, P149, DOI 10.1038/sj.bmt.1705557; Peterson P, 2008, NAT REV IMMUNOL, V8, P948, DOI 10.1038/nri2450; Puck JM, 2007, J ALLERGY CLIN IMMUN, V120, P760, DOI 10.1016/j.jaci.2007.08.043; Roifman CM, 2008, BONE MARROW TRANSPL, V41, P947, DOI 10.1038/bmt.2008.11; Sarantopoulos S, 2007, CLIN CANCER RES, V13, P6107, DOI 10.1158/1078-0432.CCR-07-1290; Sarantopoulos S, 2009, BLOOD, V113, P3865, DOI 10.1182/blood-2008-09-177840; Sarzotti M, 2003, J IMMUNOL, V170, P2711, DOI 10.4049/jimmunol.170.5.2711; Serana F, 2010, J IMMUNOL, V185, P7713, DOI 10.4049/jimmunol.1001770; Somech R, 2009, J ALLERGY CLIN IMMUN, V124, P793, DOI 10.1016/j.jaci.2009.06.048; Sottini A, 2010, CLIN IMMUNOL, V136, P217, DOI 10.1016/j.clim.2010.04.005; Storek J, 2002, TRANSPLANTATION, V73, P1154, DOI 10.1097/00007890-200204150-00026; Storek J, 2001, BLOOD, V98, P3505, DOI 10.1182/blood.V98.13.3505; Talvensarri K, 2002, BLOOD, V99, P1458, DOI 10.1182/blood.V99.4.1458; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; van Zelm MC, 2007, J EXP MED, V204, P645, DOI 10.1084/jem.20060964; Wu CJ, 2000, BLOOD, V95, P352; Ye P, 2002, CRIT REV IMMUNOL, V22, P483	41	44	44	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30494	10.1371/journal.pone.0030494	http://dx.doi.org/10.1371/journal.pone.0030494			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295088	Green Published, Green Submitted, gold			2022-12-27	WOS:000301640600033
J	Maatouk, I; Wild, B; Wesche, D; Herzog, W; Raum, E; Muller, H; Rothenbacher, D; Stegmaier, C; Schellberg, D; Brenner, H				Maatouk, Imad; Wild, Beate; Wesche, Daniela; Herzog, Wolfgang; Raum, Elke; Mueller, Heiko; Rothenbacher, Dietrich; Stegmaier, Christa; Schellberg, Dieter; Brenner, Hermann			Elderly People with Diabetes: Results of a German Cohort Study	PLOS ONE			English	Article							QUALITY-OF-LIFE; HEALTH SURVEY; ASSOCIATION; POPULATION; DEPRESSION; ADULTS; COMPLICATIONS; VARIABLES; REDUCE; RISK	Background: The aim of the study was to determine predictors that influence health-related quality of life (HRQOL) in a large cohort of elderly diabetes patients from primary care over a follow-up period of five years. Methods and Results: At the baseline measurement of the ESTHER cohort study (2000-2002), 1375 out of 9953 participants suffered from diabetes (13.8%). 1057 of these diabetes patients responded to the second-follow up (2005-2007). HRQOL at baseline and follow-up was measured using the SF-12; mental component scores (MCS) and physical component scores (PCS) were calculated; multiple linear regression models were used to determine predictors of HRQOL at follow-up. As possible predictors for HRQOL, the following baseline variables were examined: treatment with insulin, glycated hemoglobin (HbA1c), number of diabetes related complications, number of comorbid diseases, Body-Mass-Index (BMI), depression and HRQOL. Regression analyses were adjusted for sociodemographic variables and smoking status. 1034 patients (97.8%) responded to the SF-12 both at baseline and after five years and were therefore included in the study. Regression analyses indicated that significant predictors of decreased MCS were a lower HRQOL, a higher number of diabetes related complications and a reported history of depression at baseline. Complications, BMI, smoking and HRQOL at baseline significantly predicted PCS at the five year follow-up. Conclusions: Our findings expand evidence from previous cross-sectional data indicating that in elderly diabetes patients, depression, diabetes related complications, smoking and BMI are temporally predictive for HRQOL.	[Maatouk, Imad; Wild, Beate; Wesche, Daniela; Herzog, Wolfgang; Schellberg, Dieter] Med Univ Hosp Heidelberg, Dept Gen Internal Med & Psychosomat, Heidelberg, Germany; [Raum, Elke; Mueller, Heiko; Rothenbacher, Dietrich; Brenner, Hermann] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, D-6900 Heidelberg, Germany; [Rothenbacher, Dietrich] Univ Ulm, Inst Epidemiol & Med Biometry, Ulm, Germany; [Stegmaier, Christa] Saarland Minist Publ Hlth, Saarland Canc Registry, Saarbrucken, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ulm University	Maatouk, I (corresponding author), Med Univ Hosp Heidelberg, Dept Gen Internal Med & Psychosomat, Heidelberg, Germany.	imad.maatouk@med.uni-heidelberg.de	Brenner, Hermann/ABE-6383-2020; Brenner, Hermann/B-4627-2017	Brenner, Hermann/0000-0002-6129-1572; Brenner, Hermann/0000-0002-6129-1572	Baden Wurttemberg Ministry of Science, Research and Arts; German Federal Ministry of Education and Research; German Federal Ministry of Family, Senior Citizens, Women and Youth; German Ministry of Research and Education [01ET0718]	Baden Wurttemberg Ministry of Science, Research and Arts; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Federal Ministry of Family, Senior Citizens, Women and Youth; German Ministry of Research and Education(Federal Ministry of Education & Research (BMBF))	The ESTHER study was funded by grants from the Baden Wurttemberg Ministry of Science, Research and Arts, the German Federal Ministry of Education and Research and the German Federal Ministry of Family, Senior Citizens, Women and Youth. This analysis was done as part of the consortium "Multimorbidity and frailty at old age: epidemiology, biology, psychiatric comorbidity, medical care and costs" funded by the German Ministry of Research and Education (grant number 01ET0718). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahola AJ, 2010, NEPHROL DIAL TRANSPL, V25, P1903, DOI 10.1093/ndt/gfp709; Ali S, 2010, DIABETES-METAB RES, V26, P75, DOI 10.1002/dmrr.1065; BENDEL RB, 1977, J AM STAT ASSOC, V72, P46, DOI 10.2307/2286904; Damush TM, 2002, J AGING HEALTH, V14, P195, DOI 10.1177/089826430201400202; Glasgow RE, 1997, DIABETES CARE, V20, P562, DOI 10.2337/diacare.20.4.562; Haley WE, 2011, QUAL LIFE RES, V20, P799, DOI 10.1007/s11136-010-9810-6; Hopman WM, 2006, QUAL LIFE RES, V15, P527, DOI 10.1007/s11136-005-2096-4; HOSMER DW, 1989, APPL LOGISTIC REGRES; Jimenez-Garcia R, 2008, DIABETES CARE, V31, P90, DOI 10.2337/dc07-1382; Jorm AF, 2000, PSYCHOL MED, V30, P11, DOI 10.1017/S0033291799001452; Landman GWD, 2010, DIABETES CARE, V33, P2378, DOI 10.2337/dc10-0979; Low M, 2004, DEUT MED WOCHENSCHR, V129, P2643, DOI 10.1055/s-2004-836089; Nelson JC, 2008, AM J GERIAT PSYCHIAT, V16, P558, DOI 10.1097/JGP.0b013e3181693288; Peyrot M, 2010, DIABETES CARE, V33, P240, DOI 10.2337/dc09-1348; Richards JB, 2007, ARCH INTERN MED, V167, P188, DOI 10.1001/archinte.167.2.188; Rose M, 2002, DIABETES CARE, V25, P35, DOI 10.2337/diacare.25.1.35; Rubin RR, 1999, DIABETES-METAB RES, V15, P205, DOI 10.1002/(SICI)1520-7560(199905/06)15:3<205::AID-DMRR29>3.0.CO;2-O; Selim A, 2009, QUAL LIFE RES, V18, P43, DOI 10.1007/s11136-008-9418-2; Simson U, 2008, DIABETIC MED, V25, P206, DOI 10.1111/j.1464-5491.2007.02370.x; Spiro, 2004, IMPUTING PHYS MENTAL; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Testa MA, 1996, NEW ENGL J MED, V334, P835, DOI 10.1056/NEJM199603283341306; Tokuda Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003985; UK Prospective Diabetes Study Grp, 1999, DIABETES CARE, V22, P1125; *UN, 2005, POP CHALL DEV GOALS; Vitry AI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014024; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; WEINBERGER M, 1994, MED CARE, V32, P1173, DOI 10.1097/00005650-199412000-00002; Wikman A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018952; Wild B, 2012, INT J GERIATR PSYCH, V27, P375, DOI 10.1002/gps.2728; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Williamson DA, 2009, ARCH INTERN MED, V169, P163, DOI 10.1001/archinternmed.2008.544; WILSON IB, 1995, JAMA-J AM MED ASSOC, V273, P59, DOI 10.1001/jama.273.1.59	33	36	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e31088	10.1371/journal.pone.0031088	http://dx.doi.org/10.1371/journal.pone.0031088			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	910LV	22292092	gold, Green Published, Green Submitted			2022-12-27	WOS:000301639600068
J	Beran, RKF; Sharma, R; Corsa, AC; Tian, Y; Golde, J; Lundgaard, G; Delaney, WE; Zhong, WD; Greenstein, AE				Beran, Rudolf K. F.; Sharma, Ruchi; Corsa, Amoreena C.; Tian, Yang; Golde, Justin; Lundgaard, Greta; Delaney, William E.; Zhong, Weidong; Greenstein, Andrew E.			Cellular Growth Kinetics Distinguish a Cyclophilin Inhibitor from an HSP90 Inhibitor as a Selective Inhibitor of Hepatitis C Virus	PLOS ONE			English	Article							HCV REPLICATION; POLYMERASE INHIBITOR; PROTEIN; COMBINATION; RNA; THERAPY; 17-AAG; CELLS	During antiviral drug discovery, it is critical to distinguish molecules that selectively interrupt viral replication from those that reduce virus replication by adversely affecting host cell viability. In this report we investigate the selectivity of inhibitors of the host chaperone proteins cyclophilin A (CypA) and heat-shock protein 90 (HSP90) which have each been reported to inhibit replication of hepatitis C virus (HCV). By comparing the toxicity of the HSP90 inhibitor, 17-(Allylamino)-17-demethoxygeldanamycin (17-AAG) to two known cytostatic compounds, colchicine and gemcitabine, we provide evidence that 17-AAG exerts its antiviral effects indirectly through slowing cell growth. In contrast, a cyclophilin inhibitor, cyclosporin A (CsA), exhibited selective antiviral activity without slowing cell proliferation. Furthermore, we observed that 17-AAG had little antiviral effect in a non-dividing cell-culture model of HCV replication, while CsA reduced HCV titer by more than two orders of magnitude in the same model. The assays we describe here are useful for discriminating selective antivirals from compounds that indirectly affect virus replication by reducing host cell viability or slowing cell growth.	[Beran, Rudolf K. F.; Sharma, Ruchi; Corsa, Amoreena C.; Tian, Yang; Golde, Justin; Lundgaard, Greta; Delaney, William E.; Zhong, Weidong; Greenstein, Andrew E.] Gilead Sci Inc, Dept Biol, Foster City, CA 94404 USA	Gilead Sciences	Beran, RKF (corresponding author), Gilead Sci Inc, Dept Biol, 353 Lakeside Dr, Foster City, CA 94404 USA.	andrew.greenstein@gilead.com		Greenstein, Andrew/0000-0002-1470-1970	Gilead Sciences	Gilead Sciences(Gilead Sciences)	No current external funding sources for this study. This study was funded exclusively through Gilead Sciences internal research funds.	ALLEN DW, 1962, BIOCHIM BIOPHYS ACTA, V55, P865; Chase G, 2008, VIROLOGY, V377, P431, DOI 10.1016/j.virol.2008.04.040; Cheng GF, 2011, ANTIMICROB AGENTS CH, V55, P2197, DOI 10.1128/AAC.01382-10; Flajolet M, 2000, GENE, V242, P369, DOI 10.1016/S0378-1119(99)00511-9; Fraser JS, 2009, NATURE, V462, P669, DOI 10.1038/nature08615; HANDSCHUMACHER RE, 1984, SCIENCE, V226, P544, DOI 10.1126/science.6238408; Hu JM, 1996, P NATL ACAD SCI USA, V93, P1060, DOI 10.1073/pnas.93.3.1060; Hu JM, 1997, EMBO J, V16, P59, DOI 10.1093/emboj/16.1.59; Kamal A, 2003, NATURE, V425, P407, DOI 10.1038/nature01913; Kneteman NM, 2009, HEPATOLOGY, V49, P745, DOI 10.1002/hep.22717; Le Pogam S, 2010, J INFECT DIS, V202, P1510, DOI 10.1086/656774; MALAWIST.SE, 1967, SCIENCE, V156, P521, DOI 10.1126/science.156.3774.521; MILAD M, 1995, MOL ENDOCRINOL, V9, P838, DOI 10.1210/me.9.7.838; Modi S, 2007, J CLIN ONCOL, V25, P5410, DOI 10.1200/JCO.2007.11.7960; Nakagawa S, 2007, BIOCHEM BIOPH RES CO, V353, P882, DOI 10.1016/j.bbrc.2006.12.117; Nelson HB, 2006, J VIROL, V80, P1181, DOI 10.1128/JVI.80.3.1181-1190.2006; Okamoto T, 2006, EMBO J, V25, P5015, DOI 10.1038/sj.emboj.7601367; Patel H, 2010, GUT, V58, P1644; Paulson MS, 2009, ANTIVIR RES, V83, P135, DOI 10.1016/j.antiviral.2009.04.003; Pietschmann T, 2001, J VIROL, V75, P1252, DOI 10.1128/JVI.75.3.1252-1264.2001; Pokrovskii MV, 2011, J VIROL, V85, P3978, DOI 10.1128/JVI.01760-10; Prodromou C, 2003, CURR CANCER DRUG TAR, V3, P301, DOI 10.2174/1568009033481877; Reichard O, 1997, HEPATOLOGY, V26, pS108, DOI 10.1002/hep.510260719; Robinson M, 2011, P NATL ACAD SCI USA, V108, P10290, DOI 10.1073/pnas.1101515108; Robinson M, 2010, ANTIMICROB AGENTS CH, V54, P3099, DOI 10.1128/AAC.00289-10; Rong LB, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000544; Sainz B, 2006, J VIROL, V80, P10253, DOI 10.1128/JVI.01059-06; Sausville EA, 2003, CURR CANCER DRUG TAR, V3, P377, DOI 10.2174/1568009033481831; Smith DR, 2010, ANTIVIR RES, V87, P187, DOI 10.1016/j.antiviral.2010.04.015; Stuyver LJ, 2003, J VIROL, V77, P10689, DOI 10.1128/JVI.77.19.10689-10694.2003; Tai AW, 2009, CELL HOST MICROBE, V5, P298, DOI 10.1016/j.chom.2009.02.001; Ujino Saneyuki, 2010, Antiviral Chemistry & Chemotherapy, V20, P161, DOI 10.3851/IMP1479; Ujino S, 2009, J BIOL CHEM, V284, P6841, DOI 10.1074/jbc.M806452200; Yang F, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001118	34	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e30286	10.1371/journal.pone.0030286	http://dx.doi.org/10.1371/journal.pone.0030286			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347373	Green Submitted, gold, Green Published			2022-12-27	WOS:000302730100009
J	Liu, XL; Zhao, ZD; Xu, CF; Sun, L; Chen, JL; Zhang, LF; Liu, WJ				Liu, Xiaoling; Zhao, Zhendong; Xu, Chongfeng; Sun, Lei; Chen, Jilong; Zhang, Lianfeng; Liu, Wenjun			Cyclophilin A Restricts Influenza A Virus Replication through Degradation of the M1 Protein	PLOS ONE			English	Article							TIME RT-PCR; TRANSLATIONAL CONTROL; INITIATION-FACTOR; MESSENGER-RNA; HUMAN-CELLS; T-CELLS; INFECTION; UBIQUITIN; KINASE; HIV-1	Cyclophilin A (CypA) is a typical member of the cyclophilin family of peptidyl-prolyl isomerases and is involved in the replication of several viruses. Previous studies indicate that CypA interacts with influenza virus M1 protein and impairs the early stage of the viral replication. To further understand the molecular mechanism by which CypA impairs influenza virus replication, a 293T cell line depleted for endogenous CypA was established. The results indicated that CypA inhibited the initiation of virus replication. In addition, the infectivity of influenza virus increased in the absence of CypA. Further studies indicated that CypA had no effect on the stages of virus genome replication or transcription and also did not impair the nuclear export of the viral mRNA. However, CypA decreased the viral protein level. Additional studies indicated that CypA enhanced the degradation of M1 through the ubiquitin/proteasome-dependent pathway. Our results suggest that CypA restricts influenza virus replication through accelerating degradation of the M1 protein.	[Liu, Xiaoling; Zhao, Zhendong; Xu, Chongfeng; Sun, Lei; Chen, Jilong; Liu, Wenjun] Chinese Acad Sci, Ctr Mol Virol, CAS Key Lab Pathogen Microbiol & Immunol, Inst Microbiol, Beijing, Peoples R China; [Zhao, Zhendong; Xu, Chongfeng; Chen, Jilong; Liu, Wenjun] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Liu, Wenjun] Chinese Acad Sci, China Japan Joint Lab Mol Immunol & Mol Microbiol, Inst Microbiol, Beijing, Peoples R China; [Zhang, Lianfeng] Chinese Acad Med Sci, Key Lab Human Dis Comparat Med, Minist Hlth, Inst Lab Anim Sci, Beijing 100730, Peoples R China; [Zhang, Lianfeng] Peking Union Med Coll, Comparat Med Ctr, Beijing 100021, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Laboratory Animal Science - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Liu, XL (corresponding author), Chinese Acad Sci, Ctr Mol Virol, CAS Key Lab Pathogen Microbiol & Immunol, Inst Microbiol, Beijing, Peoples R China.	liuwj@im.ac.cn	Liu, Xiaoling/HGD-3566-2022; Chen, Ji-Long/AAJ-2134-2021; SUN, LEI/B-3288-2018	Chen, Ji-Long/0000-0002-4274-0563; SUN, LEI/0000-0003-0141-2093	National Basic Research Program of China [2011CB504705, 2012CB518900]; National Natural Science Foundation of China [30972185, 81101253, 30901073]; Chinese Academy of Sciences [KSCX2-YW-N-054, KSCX2-YW-R-158]; National Key Technologies Research and Development Program of China [2010BAD04B01]; Beijing Municipal Natural Science Foundation [6102018]; Innovative Research Group of the National Natural Science Foundation of China [81021003]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); National Key Technologies Research and Development Program of China(National Key Technology R&D Program); Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation); Innovative Research Group of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (www.973.gov.cn, Grant No. 2011CB504705, 2012CB518900), the National Natural Science Foundation of China (www.nsfc.gov.cn, Grant No. 30972185, 81101253, 30901073), the Chinese Academy of Sciences Innovation projects (www.cas.cn, Grant No. KSCX2-YW-N-054, KSCX2-YW-R-158), the National Key Technologies Research and Development Program of China (www.most.gov.cn, Grant No. 2010BAD04B01), and the Beijing Municipal Natural Science Foundation (www.bjkw.gov.cn, Grant No. 6102018). Wenjun Liu is the principal investigator of the Innovative Research Group of the National Natural Science Foundation of China (www.nsfc.gov.cn, Grant No. 81021003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerson B, 1998, J VIROL, V72, P303, DOI 10.1128/JVI.72.1.303-308.1998; Bose S, 2003, J GEN VIROL, V84, P1687, DOI 10.1099/vir.0.19074-0; Braaten D, 2001, EMBO J, V20, P1300, DOI 10.1093/emboj/20.6.1300; Brazin KN, 2002, P NATL ACAD SCI USA, V99, P1899, DOI 10.1073/pnas.042529199; Castro APV, 2003, J VIROL, V77, P9052, DOI 10.1128/JVI.77.16.9052-9068.2003; Chatterji U, 2006, J BIOL CHEM, V281, P37025, DOI 10.1074/jbc.M606066200; Colgan J, 2004, IMMUNITY, V21, P189, DOI 10.1016/j.immuni.2004.07.005; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Gack MU, 2009, CELL HOST MICROBE, V5, P439, DOI 10.1016/j.chom.2009.04.006; Galat A, 2003, CURR TOP MED CHEM, V3, P1315, DOI 10.2174/1568026033451862; Garcia-Robles I, 2005, VIROLOGY, V332, P329, DOI 10.1016/j.virol.2004.09.036; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Jeong SJ, 2009, BIOCHEM BIOPH RES CO, V381, P294, DOI 10.1016/j.bbrc.2009.02.024; Kash JC, 2006, VIRUS RES, V119, P111, DOI 10.1016/j.virusres.2005.10.013; KATZE MG, 1986, MOL CELL BIOL, V6, P1741, DOI 10.1128/MCB.6.5.1741; Khor R, 2003, TRAFFIC, V4, P857, DOI 10.1046/j.1398-9219.2003.0140.x; KOESTLER TP, 1984, P NATL ACAD SCI-BIOL, V81, P4505, DOI 10.1073/pnas.81.14.4505; Lai JP, 2003, CLIN DIAGN LAB IMMUN, V10, P1123, DOI 10.1128/CDLI.10.6.1123-1128.2003; Li Y, 2009, J VIROL, V83, P10951, DOI 10.1128/JVI.00682-09; Liao TL, 2010, EMBO J, V29, P3879, DOI 10.1038/emboj.2010.250; Liu N, 2008, PROTEOMICS, V8, P1851, DOI 10.1002/pmic.200700757; Liu XL, 2009, CELL MICROBIOL, V11, P730, DOI 10.1111/j.1462-5822.2009.01286.x; LU Y, 1995, VIROLOGY, V214, P222, DOI 10.1006/viro.1995.9937; Luban J, 2007, J VIROL, V81, P1054, DOI 10.1128/JVI.01519-06; Min L, 2005, FRONT BIOSCI-LANDMRK, V10, P385, DOI 10.2741/1536; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Reinhardt J, 2000, VET MICROBIOL, V74, P87, DOI 10.1016/S0378-1135(00)00169-3; Rold CJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000074; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; Sayah DM, 2004, NATURE, V430, P569, DOI 10.1038/nature02777; Shaw ML, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000085; Tian XC, 2010, J VIROL, V84, P3373, DOI 10.1128/JVI.02555-09; Towers GJ, 2003, NAT MED, V9, P1138, DOI 10.1038/nm910; Wang P, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-226; Wang YM, 2006, METHODS, V39, P356, DOI 10.1016/j.ymeth.2006.06.010; Watanabe K, 2006, FEBS LETT, V580, P5785, DOI 10.1016/j.febslet.2006.09.040; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700; Widjaja I, 2010, J VIROL, V84, P9625, DOI 10.1128/JVI.01048-10; Xu CF, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-372; Yang F, 2008, J VIROL, V82, P5269, DOI 10.1128/JVI.02614-07; Yin L, 1998, J VIROL, V72, P6430, DOI 10.1128/JVI.72.8.6430-6436.1998; Ylinen LMJ, 2009, J VIROL, V83, P2044, DOI 10.1128/JVI.01876-08; Zhirnov O. P., 1997, Molekulyarnaya Biologiya (Moscow), V31, P137	43	66	71	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31063	10.1371/journal.pone.0031063	http://dx.doi.org/10.1371/journal.pone.0031063			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347431	Green Published, Green Submitted, gold			2022-12-27	WOS:000302730100039
J	Wei, DT; Ren, CC; Chen, XY; Zhao, H				Wei, Dingtai; Ren, Chuancheng; Chen, Xiaoyuan; Zhao, Heng			The Chronic Protective Effects of Limb Remote Preconditioning and the Underlying Mechanisms Involved in Inflammatory Factors in Rat Stroke	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; CEREBRAL-ISCHEMIA; FOCAL ISCHEMIA; MILD HYPOTHERMIA; BRAIN; TIM-3; REPERFUSION; EXPRESSION; DAMAGE; CARDIOPROTECTION	We recently demonstrated that limb remote preconditioning (LRP) protects against focal ischemia measured 2 days post-stroke. Here, we studied whether LRP provides long-term protection and improves neurological function. We also investigated whether LRP transmits its protective signaling via the afferent nerve pathways from the preconditioned limb to the ischemic brain and whether inflammatory factors are involved in LRP, including the novel galectin-9/Tim-3 inflammatory cell signaling pathway, which induces cell death in lymphocytes. LRP in the left hind femoral artery was performed immediately before stroke. LRP reduced brain injury size both at 2 days and 60 days post-stroke and improved behavioral outcomes for up to 2 months. The sensory nerve inhibitors capsaicin and hexamethonium, a ganglion blocker, abolished the protective effects of LRP. In addition, LRP inhibited edema formation and blood-brain barrier (BBB) permeability measured 2 days post-stroke. Western blot and immunostaining analysis showed that LRP inhibited protein expression of both galectin-9 and T-cell immunoglobulin domain and mucin domain 3 (Tim-3), which were increased after stroke. In addition, LRP decreased iNOS and nitrotyrosine protein expression after stroke. In conclusion, LRP executes long-term protective effects against stroke and may block brain injury by inhibiting activities of the galectin-9/Tim-3 pathway, iNOS, and nitrotyrosine.	[Wei, Dingtai; Ren, Chuancheng; Zhao, Heng] Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA; [Wei, Dingtai; Ren, Chuancheng; Zhao, Heng] Stanford Univ, Stroke Ctr, Stanford, CA 94305 USA; [Wei, Dingtai] Tianjin Med Univ, Dept Radiol, Gen Hosp, Tianjin, Peoples R China; [Wei, Dingtai] Fujian Med Univ, Dept Radiol, Ningde Hosp, Fuzhou, Fujian, Peoples R China; [Ren, Chuancheng] Fudan Univ, Shanghai Hosp 5, Shanghai 200433, Peoples R China; [Chen, Xiaoyuan] NIBIB, Lab Mol Imaging & Nanomed LOMIN, NIH, Bethesda, MD USA	Stanford University; Stanford University; Tianjin Medical University; Fujian Medical University; Fudan University; National Institutes of Health (NIH) - USA; NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)	Wei, DT (corresponding author), Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA.	hzhao@stanford.edu	Chen, Xiaoyuan/D-1860-2014	Chen, Xiaoyuan/0000-0002-9622-0870	NINDS [1R21NS057750-01A2, 1R01NS 064136-01]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [ZIAEB000073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS057750, R01NS064136] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by NINDS grants 1R21NS057750-01A2 (HZ) and 1R01NS 064136-01 (HZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AC, 2007, SCIENCE, V318, P1141, DOI 10.1126/science.1148536; Anderson AC, 2006, CURR OPIN IMMUNOL, V18, P665, DOI 10.1016/j.coi.2006.09.009; Brzozowski T, 2004, EUR J PHARMACOL, V499, P201, DOI 10.1016/j.ejphar.2004.07.072; Brzozowski T, 2004, J PHYSIOL PHARMACOL, V55, P165; Chapman CML, 2004, STROKE, V35, P1619, DOI 10.1161/01.STR.0000130857.19423.ad; Dave KR, 2006, NEUROSCI LETT, V404, P170, DOI 10.1016/j.neulet.2006.05.037; DIETRICH WD, 1993, J CEREBR BLOOD F MET, V13, P541, DOI 10.1038/jcbfm.1993.71; Dumas TC, 2001, TRENDS NEUROSCI, V24, P695, DOI 10.1016/S0166-2236(00)01956-1; Gao XW, 2008, J NEUROSCI RES, V86, P2505, DOI 10.1002/jnr.21703; Gao XW, 2008, J NEUROCHEM, V105, P943, DOI 10.1111/j.1471-4159.2008.05218.x; Gelderblom M, 2009, STROKE, V40, P1849, DOI 10.1161/STROKEAHA.108.534503; Gidday JM, 1999, J CEREBR BLOOD F MET, V19, P331, DOI 10.1097/00004647-199903000-00011; Gielen AW, 2005, J NEUROIMMUNOL, V164, P93, DOI 10.1016/j.jneuroim.2005.04.004; Han HS, 2002, J NEUROSCI, V22, P3921, DOI 10.1523/JNEUROSCI.22-10-03921.2002; Hirabayashi H, 2000, BRAIN RES, V852, P319, DOI 10.1016/S0006-8993(99)02117-4; Hurn PD, 2007, J CEREBR BLOOD F MET, V27, P1798, DOI 10.1038/sj.jcbfm.9600482; Jensen HA, 2011, CIRCULATION, V123, P714, DOI 10.1161/CIRCULATIONAHA.110.986497; Karabiyikoglu M, 2003, J NEUROSURG, V98, P1271, DOI 10.3171/jns.2003.98.6.1271; Limbourg FP, 2002, J CLIN INVEST, V110, P1729, DOI 10.1172/JCI200215481; Malhotra S, 2011, BRAIN RES, V1386, P184, DOI 10.1016/j.brainres.2011.02.032; Martinez-Murillo R, 2007, NEUROSCI LETT, V415, P149, DOI 10.1016/j.neulet.2007.01.011; Nakae S, 2007, BLOOD, V110, P2565, DOI 10.1182/blood-2006-11-058800; Nanetti L, 2007, MOL CELL BIOCHEM, V303, P19, DOI 10.1007/s11010-007-9451-4; Perez-Pinzon MA, 2004, J BIOENERG BIOMEMBR, V36, P323, DOI 10.1023/B:JOBB.0000041762.47544.ff; PerezPinzon MA, 1997, J CEREBR BLOOD F MET, V17, P175, DOI 10.1097/00004647-199702000-00007; Polidori C, 2005, ENDOCRINOLOGY, V146, P3861, DOI 10.1210/en.2005-0397; Ren C, 2008, NEUROSCIENCE, V151, P1099, DOI 10.1016/j.neuroscience.2007.11.056; Ren CC, 2009, BRAIN RES, V1288, P88, DOI 10.1016/j.brainres.2009.07.029; Ren CC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003851; Sanchez-Fueyo A, 2003, NAT IMMUNOL, V4, P1093, DOI 10.1038/ni987; Sander M, 2010, J APPL PHYSIOL, V108, P1691, DOI 10.1152/japplphysiol.91539.2008; Schoemaker RG, 2000, AM J PHYSIOL-HEART C, V278, pH1571, DOI 10.1152/ajpheart.2000.278.5.H1571; Su EW, 2008, CYTOKINE, V44, P9, DOI 10.1016/j.cyto.2008.06.013; Walsh SR, 2007, BRIT J ANAESTH, V99, P611, DOI 10.1093/bja/aem273; Walsh SR, 2010, VASC ENDOVASC SURG, V44, P434, DOI 10.1177/1538574410369709; Weinbrenner C, 2002, CARDIOVASC RES, V55, P590, DOI 10.1016/S0008-6363(02)00446-7; Wolfrum S, 2005, REGUL PEPTIDES, V127, P217, DOI 10.1016/j.regpep.2004.12.008; Wolfrum S, 2002, CARDIOVASC RES, V55, P583, DOI 10.1016/S0008-6363(02)00408-X; Zhao D, 2011, J CLIN IMMUNOL; Zhao H, 2005, J NEUROSCI, V25, P9794, DOI 10.1523/JNEUROSCI.3163-05.2005; Zhao H, 2003, J NEUROCHEM, V85, P1026, DOI 10.1046/j.1471-4159.2003.01756.x; Zhao H, 2006, J CEREBR BLOOD F MET, V26, P1114, DOI 10.1038/sj.jcbfm.9600348; Zhao Hong-Gang, 2004, Shengli Xuebao, V56, P407	43	73	80	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e30892	10.1371/journal.pone.0030892	http://dx.doi.org/10.1371/journal.pone.0030892			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347410	Green Published, Green Submitted, gold			2022-12-27	WOS:000302730100029
J	Lenaerts, L; van Dam, W; Persoons, L; Naesens, L				Lenaerts, Liesbeth; van Dam, Wim; Persoons, Leentje; Naesens, Lieve			Interaction between Mouse Adenovirus Type 1 and Cell Surface Heparan Sulfate Proteoglycans	PLOS ONE			English	Article							FACTOR-X; GENE DELIVERY; BINDING SITE; FIBER SHAFT; HEXON; GLYCOSAMINOGLYCANS; INFECTION; ATTACHMENT; SEROTYPE-5; RECEPTORS	Application of human adenovirus type 5 (Ad5) derived vectors for cancer gene therapy has been limited by the poor cell surface expression, on some tumor cell types, of the primary Ad5 receptor, the coxsackie-adenovirus-receptor (CAR), as well as the accumulation of Ad5 in the liver following interaction with blood coagulation factor X (FX) and subsequent tethering the FX-Ad5 complex to heparan sulfate proteoglycan (HSPG) on liver cells. As an alternative vector, mouse adenovirus type 1 (MAV-1) is particularly attractive, since this non-human adenovirus displays pronounced endothelial cell tropism and does not use CAR as a cellular attachment receptor. We here demonstrate that MAV-1 uses cell surface heparan sulfate proteoglycans (HSPGs) as primary cellular attachment receptor. Direct binding of MAV-1 to heparan sulfate-coated plates proved to be markedly more efficient compared to that of Ad5. Experiments with modified heparins revealed that the interaction of MAV-1 to HSPGs depends on their N-sulfation and, to a lesser extent, 6-O-sulfation rate. Whereas the interaction between Ad5 and HSPGs was enhanced by FX, this was not the case for MAV-1. A slot blot assay demonstrated he ability of MAV-1 to directly interact with FX, although the amount of FX complexed to MAV-1 was much lower than observed for Ad5. Analysis of the binding of MAV-1 and Ad5 to the NCI-60 panel of different human tumor cell lines revealed the preference of MAV-1 for ovarian carcinoma cells. Together, the data presented here enlarge our insight into the HSPG receptor usage of MAV-1 and support the development of an MAV-1-derived gene vector for human cancer therapy.	[Lenaerts, Liesbeth; van Dam, Wim; Persoons, Leentje; Naesens, Lieve] Katholieke Univ Leuven, Rega Inst Med Res, Louvain, Belgium	KU Leuven	Lenaerts, L (corresponding author), Katholieke Univ Leuven, Rega Inst Med Res, Louvain, Belgium.	lieve.naesens@rega.kuleuven.be	Naesens, Lieve MJ/V-8581-2017; Naesens, Lieve/V-8725-2019	Naesens, Lieve MJ/0000-0001-9742-9302; Naesens, Lieve/0000-0001-9742-9302	Flemish Fonds voor Wetenschappelijk Onderzoek [G.0267.04]; PDM-BOF [PDMK/08/187]; Centers of Excellence from the Katholieke Universiteit Leuven [EF/05/15]	Flemish Fonds voor Wetenschappelijk Onderzoek(FWO); PDM-BOF; Centers of Excellence from the Katholieke Universiteit Leuven	These investigations were supported by grants from the Flemish Fonds voor Wetenschappelijk Onderzoek (PhD Grant to Liesbeth Lenaerts and FWO project number G.0267.04), PDM-BOF (PDMK/08/187 grant to Liesbeth Lenaerts) and the Centers of Excellence from the Katholieke Universiteit Leuven (EF/05/15). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba R, 2009, BLOOD, V114, P965, DOI 10.1182/blood-2009-03-208835; Alemany R, 2001, GENE THER, V8, P1347, DOI 10.1038/sj.gt.3301515; Bayo-Puxan N, 2006, J GEN VIROL, V87, P2487, DOI 10.1099/vir.0.81889-0; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Bradshaw AC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001142; Charles PC, 1998, VIROLOGY, V245, P216, DOI 10.1006/viro.1998.9180; Chen Y, 2008, MOL CELLS, V26, P415; CrawfordMiksza L, 1996, J VIROL, V70, P1836, DOI 10.1128/JVI.70.3.1836-1844.1996; Dechecchi MC, 2000, VIROLOGY, V268, P382, DOI 10.1006/viro.1999.0171; Dechecchi MC, 2001, J VIROL, V75, P8772, DOI 10.1128/JVI.75.18.8772-8780.2001; Di Paolo NC, 2007, J VIROL, V81, P12249, DOI 10.1128/JVI.01584-07; Duffy MR, 2011, J VIROL, V85, P10914, DOI 10.1128/JVI.05382-11; Filmus J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-224; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; Gupta P, 1998, BLOOD, V92, P4641, DOI 10.1182/blood.V92.12.4641.424k10_4641_4651; Habuchi H, 2003, BIOCHEM J, V371, P131, DOI 10.1042/BJ20021259; Jonsson MI, 2009, J VIROL, V83, P3816, DOI 10.1128/JVI.02562-08; Kalyuzhniy O, 2008, P NATL ACAD SCI USA, V105, P5483, DOI 10.1073/pnas.0711757105; Kritz AB, 2007, MOL THER, V15, P741, DOI 10.1038/sj.mt.6300094; Laremore TN, 2009, CURR OPIN CHEM BIOL, V13, P633, DOI 10.1016/j.cbpa.2009.08.017; Lenaerts L, 2006, FEBS LETT, V580, P3937, DOI 10.1016/j.febslet.2006.06.027; Lenaerts L, 2005, ANTIMICROB AGENTS CH, V49, P4689, DOI 10.1128/AAC.49.11.4689-4699.2005; Lenaerts L, 2009, J GENE MED, V11, P119, DOI 10.1002/jgm.1283; Monteiro RQ, 2008, PROTEIN SCI, V17, P146, DOI 10.1110/ps.073016308; Nogami K, 2004, J BIOL CHEM, V279, P33104, DOI 10.1074/jbc.M405537200; Parker AL, 2006, BLOOD, V108, P2554, DOI 10.1182/blood-2006-04-008532; Raman S, 2009, J VIROL, V83, P2831, DOI 10.1128/JVI.02368-08; Rein Daniel T, 2006, Future Oncol, V2, P137, DOI 10.2217/14796694.2.1.137; Rezaie AR, 2000, TRENDS CARDIOVAS MED, V10, P333, DOI 10.1016/S1050-1738(01)00070-6; Sarrazin S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004952; Smith T, 2002, MOL THER, V5, P770, DOI 10.1006/mthe.2002.0613; Waddington SN, 2008, CELL, V132, P397, DOI 10.1016/j.cell.2008.01.016; Xie JS, 2006, J VIROL, V80, P11833, DOI 10.1128/JVI.00857-06; Yip GW, 2006, MOL CANCER THER, V5, P2139, DOI 10.1158/1535-7163.MCT-06-0082; Zaiss AK, 2011, J BIOL CHEM, V286, P24535, DOI 10.1074/jbc.M111.241562	35	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2012	7	2							e31454	10.1371/journal.pone.0031454	http://dx.doi.org/10.1371/journal.pone.0031454			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917MF	22347482	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000302180600038
J	Loeth, N; Assing, K; Madsen, HO; Vindelov, L; Buus, S; Stryhn, A				Loeth, Nina; Assing, Kristian; Madsen, Hans O.; Vindelov, Lars; Buus, Soren; Stryhn, Anette			Humoral and Cellular CMV Responses in Healthy Donors; Identification of a Frequent Population of CMV-Specific, CD4+T Cells in Seronegative Donors	PLOS ONE			English	Article							CYTOTOXIC T-LYMPHOCYTES; HUMAN CYTOMEGALOVIRUS; ADOPTIVE TRANSFER; DENDRITIC CELLS; TRANSPLANT RECIPIENTS; CROSS-REACTIVITY; SEROLOGIC STATUS; BONE-MARROW; VIRUS; GENERATION	CMV status is an important risk factor in immune compromised patients. In hematopoeitic cell transplantations (HCT), both donor and recipient are tested routinely for CMV status by serological assays; however, one might argue that it might also be of relevance to examine CMV status by cellular (i.e., T lymphocyte) assays. Here, we have analyzed the CMV status of 100 healthy blood bank donors using both serology and cellular assays. About half (56%) were found to be CMV seropositive, and they all mounted strong CD8+ and/or moderate CD4+ T cell responses ex vivo against the immunodominant CMV protein, pp65. Of the 44 seronegative donors, only five (11%) mounted ex vivo T cell responses; surprisingly, 33 (75%) mounted strong CD4+ T cell responses after a brief in vitro peptide stimulation culture. This may have significant implications for the analysis and selection of HCT donors.	[Loeth, Nina; Buus, Soren; Stryhn, Anette] Univ Copenhagen, Fac Hlth Sci, Expt Immunol Lab, Copenhagen, Denmark; [Madsen, Hans O.] Copenhagen Univ Hosp, Rigshosp, Dept Clin Immunol, Tissue Typing Lab, Copenhagen, Denmark; [Vindelov, Lars] Copenhagen Univ Hosp, Rigshosp, Dept Hematol, Allogene Hematopoiet Cell Transplantat Lab, Copenhagen, Denmark	University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen	Loeth, N (corresponding author), Univ Copenhagen, Fac Hlth Sci, Expt Immunol Lab, Copenhagen, Denmark.	astryhn@sund.ku.dk	Madsen, Hans O/Q-2035-2015; Buus, Soren/F-5446-2010	Madsen, Hans O/0000-0001-5551-4787; Stryhn, Anette/0000-0002-4581-3553; Buus, Soren/0000-0001-8363-1999	Danish Cancer Society; Faculty of Health Sciences; Lundbeck Foundation [26375]; Research Council for Technology and Production; National Institutes of Health [HHSN 272 2009 00045C]	Danish Cancer Society(Danish Cancer Society); Faculty of Health Sciences(European Commission); Lundbeck Foundation(Lundbeckfonden); Research Council for Technology and Production; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This project was funded by the Danish Cancer Society, the Faculty of Health Sciences, the Lundbeck Foundation (26375), the Research Council for Technology and Production, and National Institutes of Health (HHSN 272 2009 00045C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almyroudis NG, 2007, TRANSPL INFECT DIS, V9, P286, DOI 10.1111/j.1399-3062.2007.00235.x; Boeckh M, 2004, BLOOD, V103, P2003, DOI 10.1182/blood-2003-10-3616; Boeckh M, 2003, BIOL BLOOD MARROW TR, V9, P543, DOI 10.1016/S1083-8791(03)00287-8; Boeckh M, 2003, BLOOD, V101, P407, DOI 10.1182/blood-2002-03-0993; Bonasio R, 2006, CURR OPIN IMMUNOL, V18, P503, DOI 10.1016/j.coi.2006.05.011; Boscardin SB, 2006, J EXP MED, V203, P599, DOI 10.1084/jem.20051639; Broers AEC, 2000, BLOOD, V95, P2240, DOI 10.1182/blood.V95.7.2240.007k08_2240_2245; Cobbold M, 2005, J EXP MED, V202, P379, DOI 10.1084/jem.20040613; Damle RG, 1998, ACTA VIROL, V42, P389; EDSON CM, 1985, J VIROL, V56, P333, DOI 10.1128/JVI.56.1.333-336.1985; Einsele H, 2002, BLOOD, V99, P3916, DOI 10.1182/blood.V99.11.3916; EMANUEL D, 1988, ANN INTERN MED, V109, P777, DOI 10.7326/0003-4819-109-10-777; Emery VC, 2001, J CLIN PATHOL, V54, P84, DOI 10.1136/jcp.54.2.84; Fonteneau JF, 2001, J IMMUNOL METHODS, V258, P111, DOI 10.1016/S0022-1759(01)00477-X; Gamadia LE, 2004, HUM IMMUNOL, V65, P486, DOI 10.1016/j.humimm.2004.02.020; Gandhi MK, 2004, LANCET INFECT DIS, V4, P725, DOI 10.1016/S1473-3099(04)01202-2; HO M, 1990, REV INFECT DIS, V12, pS701; Kern F, 2000, EUR J IMMUNOL, V30, P1676, DOI 10.1002/1521-4141(200006)30:6<1676::AID-IMMU1676>3.0.CO;2-V; Kern F, 2002, J INFECT DIS, V185, P1709, DOI 10.1086/340637; KIMURAKURODA J, 1986, J GEN VIROL, V67, P2663, DOI 10.1099/0022-1317-67-12-2663; KITAMURA K, 1986, VIROLOGY, V149, P74, DOI 10.1016/0042-6822(86)90088-7; Krause H, 1997, BONE MARROW TRANSPL, V19, P1111, DOI 10.1038/sj.bmt.1700801; La Rosa C, 2007, J INFECT DIS, V195, P633, DOI 10.1086/511307; Ljungman P, 2003, BLOOD, V102, P4255, DOI 10.1182/blood-2002-10-3263; Ljungman P, 2007, BEST PRACT RES CL HA, V20, P209, DOI 10.1016/j.beha.2006.09.003; Ljungman P, 2006, HAEMATOLOGICA, V91, P78; Lutz MB, 2002, TRENDS IMMUNOL, V23, P445, DOI 10.1016/S1471-4906(02)02281-0; Maecker HT, 2001, J IMMUNOL METHODS, V255, P27, DOI 10.1016/S0022-1759(01)00416-1; Moser JM, 2010, J IMMUNOL METHODS, V353, P8, DOI 10.1016/j.jim.2009.11.006; Ocadlikova D, 2010, NEOPLASMA, V57, P455, DOI 10.4149/neo_2010_05_455; Oelke M, 2000, CLIN CANCER RES, V6, P1997; Peggs KS, 2003, LANCET, V362, P1375, DOI 10.1016/S0140-6736(03)14634-X; RIDDELL SR, 1992, SCIENCE, V257, P238; Sester M, 2003, TRANSPLANTATION, V76, P1229, DOI 10.1097/01.TP.0000083894.61333.56; Sester M, 2001, TRANSPLANTATION, V71, P1287, DOI 10.1097/00007890-200105150-00018; Sinclair E, 2004, VIRAL IMMUNOL, V17, P445, DOI 10.1089/0882824041857049; Slezak SL, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-17; Staras SAS, 2006, CLIN INFECT DIS, V43, P1143, DOI 10.1086/508173; Sylwester AW, 2005, J EXP MED, V202, P673, DOI 10.1084/jem.20050882; Tsai V, 1998, CRIT REV IMMUNOL, V18, P65, DOI 10.1615/CritRevImmunol.v18.i1-2.80; VAFAI A, 1990, VIRUS RES, V15, P163, DOI 10.1016/0168-1702(90)90006-W; Waldrop SL, 1997, J CLIN INVEST, V99, P1739, DOI 10.1172/JCI119338; WALTER EA, 1995, NEW ENGL J MED, V333, P1038, DOI 10.1056/NEJM199510193331603; Widmann T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003634; Zhou WD, 2009, BLOOD, V113, P6465, DOI 10.1182/blood-2009-02-203307	45	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2012	7	2							e31420	10.1371/journal.pone.0031420	http://dx.doi.org/10.1371/journal.pone.0031420			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917MF	22347475	Green Published, Green Submitted, gold			2022-12-27	WOS:000302180600036
J	Barba, M; Sobolev, AP; Zobnina, V; di Patti, MCB; Cervoni, L; Spiezia, MC; Schinina, ME; Pietraforte, D; Mannina, L; Musci, G; Polticelli, F				Barba, Marco; Sobolev, Anatoli P.; Zobnina, Veranika; di Patti, Maria Carmela Bonaccorsi; Cervoni, Laura; Spiezia, Maria Carolina; Schinina, M. Eugenia; Pietraforte, Donatella; Mannina, Luisa; Musci, Giovanni; Polticelli, Fabio			Cupricyclins, Novel Redox-Active Metallopeptides Based on Conotoxins Scaffold	PLOS ONE			English	Article							CU,ZN SUPEROXIDE-DISMUTASE; METAL-BINDING; CONTRYPHAN-VN; COPPER; PROTEIN; PEPTIDE; MODEL; SITE; DENATURATION; PLASTOCYANIN	Highly stable natural scaffolds which tolerate multiple amino acid substitutions represent the ideal starting point for the application of rational redesign strategies to develop new catalysts of potential biomedical and biotechnological interest. The knottins family of disulphide-constrained peptides display the desired characteristics, being highly stable and characterized by hypervariability of the inter-cysteine loops. The potential of knottins as scaffolds for the design of novel copper-based biocatalysts has been tested by engineering a metal binding site on two different variants of an v-conotoxin, a neurotoxic peptide belonging to the knottins family. The binding site has been designed by computational modelling and the redesigned peptides have been synthesized and characterized by optical, fluorescence, electron spin resonance and nuclear magnetic resonance spectroscopy. The novel peptides, named Cupricyclin-1 and -2, bind one Cu2+ ion per molecule with nanomolar affinity. Cupricyclins display redox activity and catalyze the dismutation of superoxide anions with an activity comparable to that of non-peptidic superoxide dismutase mimics. We thus propose knottins as a novel scaffold for the design of catalytically-active mini metalloproteins.	[Barba, Marco; Zobnina, Veranika; Spiezia, Maria Carolina; Musci, Giovanni; Polticelli, Fabio] Univ Roma Tre, Dept Biol, Rome, Italy; [Sobolev, Anatoli P.; Mannina, Luisa] CNR, Inst Chem Methodol, Monterotondo Stn, I-00185 Rome, Italy; [di Patti, Maria Carmela Bonaccorsi; Cervoni, Laura; Schinina, M. Eugenia] Univ Roma La Sapienza, Dept Biochem Sci, I-00185 Rome, Italy; [Pietraforte, Donatella] Ist Super Sanita, Dept Cell Biol & Neurosci, I-00161 Rome, Italy; [Mannina, Luisa] Univ Roma La Sapienza, Dept Drug Sci & Technol, Rome, Italy; [Musci, Giovanni] Univ Molise, STAAM Dept, Campobasso, Italy; [Polticelli, Fabio] Natl Inst Nucl Phys, Roma Tre Sect, Rome, Italy	Roma Tre University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Metodologie Chimiche (IMC-CNR); Sapienza University Rome; Istituto Superiore di Sanita (ISS); Sapienza University Rome; University of Molise; Istituto Nazionale di Fisica Nucleare (INFN)	Barba, M (corresponding author), Univ Roma Tre, Dept Biol, Rome, Italy.	polticel@uniroma3.it	Mannina, Luisa/AGY-1694-2022; Bonaccorsi di Patti, Maria Carmela/F-1198-2011; Pietraforte, Donatella/G-1816-2011; Polticelli, Fabio/A-4573-2009; Sobolev, Anatoly/AAX-1170-2020; Musci, Giovanni/H-2862-2012	Bonaccorsi di Patti, Maria Carmela/0000-0002-4794-7037; Polticelli, Fabio/0000-0002-7657-2019; Sobolev, Anatoly/0000-0001-8709-7666; Musci, Giovanni/0000-0002-5196-709X; Pietraforte, Donatella/0000-0001-6370-912X; Mannina, Luisa/0000-0001-8659-5890	italian Ministry of Education University [RBAU01YMY5]	italian Ministry of Education University(Ministry of Education, Universities and Research (MIUR))	This work was supported by the italian Ministry of Education University and Research, Fund for Investments in Basic Research (http://firb.miur.it) grant no. RBAU01YMY5 to FP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babu CS, 2006, J PHYS CHEM A, V110, P691, DOI 10.1021/jp054177x; Barba M, 2009, PROTEIN SCI, V18, P559, DOI 10.1002/pro.58; BEEM KM, 1974, J BIOL CHEM, V249, P7298; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; Berry SM, 2011, ENCY LIFE SCI ELS, P1; BRYCE GF, 1966, J BIOL CHEM, V241, P122; Buczek O, 2004, BIOCHEMISTRY-US, V43, P1093, DOI 10.1021/bi0354233; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Case D.A., 2006, AMBER, V9; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; CUPANE A, 1994, BIOCHEMISTRY-US, V33, P15103, DOI 10.1021/bi00254a020; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DESIDERI A, 1992, J MOL BIOL, V223, P337, DOI 10.1016/0022-2836(92)90734-2; Eliseo T, 2004, BIOPOLYMERS, V74, P189, DOI 10.1002/bip.20025; ENGESETH HR, 1986, BIOCHEMISTRY-US, V25, P2448, DOI 10.1021/bi00357a023; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Gracy J, 2008, NUCLEIC ACIDS RES, V36, pD314, DOI 10.1093/nar/gkm939; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Han TS, 2008, CURR PHARM DESIGN, V14, P2462, DOI 10.2174/138161208785777469; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Jackel C, 2008, ANNU REV BIOPHYS, V37, P153, DOI 10.1146/annurev.biophys.37.032807.125832; Jitsukawa K, 2001, INORG CHIM ACTA, V324, P108, DOI 10.1016/S0020-1693(01)00567-9; Kolmar H, 2009, CURR OPIN PHARMACOL, V9, P608, DOI 10.1016/j.coph.2009.05.004; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lu Y, 2009, NATURE, V460, P855, DOI 10.1038/nature08304; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469; Massilia GR, 2003, BIOCHEM BIOPH RES CO, V303, P238, DOI 10.1016/S0006-291X(03)00331-0; Massilia GR, 2001, BIOCHEM BIOPH RES CO, V288, P908, DOI 10.1006/bbrc.2001.5833; Mejare M, 2001, TRENDS BIOTECHNOL, V19, P67, DOI 10.1016/S0167-7799(00)01534-1; Miller AF, 2004, CURR OPIN CHEM BIOL, V8, P162, DOI 10.1016/j.cbpa.2004.02.011; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Mobley DL, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2221683; Olivera BM, 2007, MOL INTERV, V7, P251, DOI 10.1124/mi.7.5.7; Pallaghy PK, 1999, J PEPT RES, V53, P343, DOI 10.1034/j.1399-3011.1999.00040.x; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; PEISACH J, 1974, ARCH BIOCHEM BIOPHYS, V165, P691, DOI 10.1016/0003-9861(74)90298-7; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Podtetenieff J, 2010, ANGEW CHEM INT EDIT, V49, P5151, DOI 10.1002/anie.201002106; Pogni R, 1999, J INORG BIOCHEM, V73, P157, DOI 10.1016/S0162-0134(99)00012-4; Polticelli F, 1998, PROTEIN SCI, V7, P2354, DOI 10.1002/pro.5560071112; Polticelli F, 1999, BIOL CHEM, V380, P1247, DOI 10.1515/BC.1999.159; Riley DP, 1999, CHEM REV, V99, P2573, DOI 10.1021/cr980432g; Roberts BR, 2007, J MOL BIOL, V373, P877, DOI 10.1016/j.jmb.2007.07.043; ROTILIO G, 1972, BIOCHIM BIOPHYS ACTA, V268, P605, DOI 10.1016/0005-2744(72)90359-2; SAKAGUCHI U, 1979, J CHEM SOC DALTON, P600, DOI 10.1039/dt9790000600; Sandberg A, 2003, BIOCHEMISTRY-US, V42, P10301, DOI 10.1021/bi034371e; Schaffer AA, 2001, NUCLEIC ACIDS RES, V29, P2994, DOI 10.1093/nar/29.14.2994; Shosheva A, 2005, BBA-PROTEINS PROTEOM, V1748, P116, DOI 10.1016/j.bbapap.2004.12.012; TAINER JA, 1982, J MOL BIOL, V160, P181, DOI 10.1016/0022-2836(82)90174-7; Valentine JS, 2005, ANNU REV BIOCHEM, V74, P563, DOI 10.1146/annurev.biochem.72.121801.161647; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; VITA C, 1995, P NATL ACAD SCI USA, V92, P6404, DOI 10.1073/pnas.92.14.6404; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F	53	6	6	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e30739	10.1371/journal.pone.0030739	http://dx.doi.org/10.1371/journal.pone.0030739			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LO	22319584	gold, Green Published, Green Submitted			2022-12-27	WOS:000302178400014
J	Eissens, DN; Spanholtz, J; van der Meer, A; van Cranenbroek, B; Dolstra, H; Kwekkeboom, J; Preijers, FWMB; Joosten, I				Eissens, Diana N.; Spanholtz, Jan; van der Meer, Arnold; van Cranenbroek, Bram; Dolstra, Harry; Kwekkeboom, Jaap; Preijers, Frank W. M. B.; Joosten, Irma			Defining Early Human NK Cell Developmental Stages in Primary and Secondary Lymphoid Tissues	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; UMBILICAL-CORD BLOOD; HLA-E; TRANSPLANTATION; RECEPTORS; BIOLOGY; RECONSTITUTION; EXPRESSION; SUBSET; NKG2A	A better understanding of human NK cell development in vivo is crucial to exploit NK cells for immunotherapy. Here, we identified seven distinctive NK cell developmental stages in bone marrow of single donors using 10-color flow cytometry and found that NK cell development is accompanied by early expression of stimulatory co-receptor CD244 in vivo. Further analysis of cord blood (CB), peripheral blood (PB), inguinal lymph node (inLN), liver lymph node (liLN) and spleen (SPL) samples showed diverse distributions of the NK cell developmental stages. In addition, distinctive expression profiles of early development marker CD33 and C-type lectin receptor NKG2A between the tissues, suggest that differential NK cell differentiation may take place at different anatomical locations. Differential expression of NKG2A and stimulatory receptors (e.g. NCR, NKG2D) within the different subsets of committed NK cells demonstrated the heterogeneity of the CD56(bright)CD16(+/-) and CD56(dim)CD16(+) subsets within the different compartments and suggests that microenvironment may play a role in differential in situ development of the NK cell receptor repertoire of committed NK cells. Overall, differential in situ NK cell development and trafficking towards multiple tissues may give rise to a broad spectrum of mature NK cell subsets found within the human body.	[Eissens, Diana N.; van der Meer, Arnold; van Cranenbroek, Bram; Joosten, Irma] Radboud Univ Nijmegen, Med Ctr, Lab Med Immunol, Dept Lab Med, NL-6525 ED Nijmegen, Netherlands; [Spanholtz, Jan; Dolstra, Harry; Preijers, Frank W. M. B.] Radboud Univ Nijmegen, Med Ctr, Hematol Lab, Dept Lab Med, NL-6525 ED Nijmegen, Netherlands; [Kwekkeboom, Jaap] Erasmus MC, Lab Gastroenterol & Hepatol, Rotterdam, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Erasmus University Rotterdam; Erasmus MC	Eissens, DN (corresponding author), Radboud Univ Nijmegen, Med Ctr, Lab Med Immunol, Dept Lab Med, NL-6525 ED Nijmegen, Netherlands.	I.Joosten@labgk.umcn.nl	van der Meer, Arnold/E-8793-2018; van der Meer, Arnold/M-1693-2016; Preijers, Frank/L-4586-2015; Dolstra, H./L-4276-2015; Joosten, Irma/N-4418-2013; van Cranenbroek, Bram/K-1549-2016	van der Meer, Arnold/0000-0001-8274-414X; Dolstra, H./0000-0002-3998-687X; Joosten, Irma/0000-0003-2950-4977; van Cranenbroek, Bram/0000-0001-5135-1183; Spanholtz, Jan/0000-0001-7152-6956	Radboud University Nijmegen Medical Centre	Radboud University Nijmegen Medical Centre	This work was financially supported by the Radboud University Nijmegen Medical Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braud VM, 1998, NATURE, V391, P795, DOI 10.1038/35869; Colucci F, 2003, NAT REV IMMUNOL, V3, P413, DOI 10.1038/nri1088; Cooley S, 2007, BLOOD, V110, P578, DOI 10.1182/blood-2006-07-036228; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; Crellin NK, 2010, J EXP MED, V207, P281, DOI 10.1084/jem.20091509; Dalle JH, 2005, PEDIATR RES, V57, P649, DOI 10.1203/01.PDR.0000156501.55431.20; Di Santo JP, 2006, ANNU REV IMMUNOL, V24, P257, DOI 10.1146/annurev.immunol.24.021605.090700; Dulphy N, 2008, J IMMUNOL, V181, P2227, DOI 10.4049/jimmunol.181.3.2227; Eissens DN, 2010, LEUKEMIA, V24, P583, DOI 10.1038/leu.2009.269; Farag SS, 2006, BLOOD REV, V20, P123, DOI 10.1016/j.blre.2005.10.001; Fathman JW, 2011, BLOOD, V118, P5439, DOI 10.1182/blood-2011-04-348912; Fehniger TA, 2003, BLOOD, V101, P3052, DOI 10.1182/blood-2002-09-2876; Ferlazzo G, 2004, J IMMUNOL, V172, P1455, DOI 10.4049/jimmunol.172.3.1455; Freud AG, 2006, J EXP MED, V203, P1033, DOI 10.1084/jem.20052507; Freud AG, 2005, IMMUNITY, V22, P295, DOI 10.1016/j.immuni.2005.01.013; Freud AG, 2006, IMMUNOL REV, V214, P56, DOI 10.1111/j.1600-065X.2006.00451.x; Kaiser BK, 2008, P NATL ACAD SCI USA, V105, P6696, DOI 10.1073/pnas.0802736105; Kobari L, 2001, J HEMATOTH STEM CELL, V10, P273, DOI 10.1089/15258160151134980; Ljunggren HG, 2007, NAT REV IMMUNOL, V7, P329, DOI 10.1038/nri2073; Male V, 2010, J IMMUNOL, V185, P3913, DOI 10.4049/jimmunol.1001637; Moroso V, 2010, LIVER TRANSPLANT, V16, P895, DOI 10.1002/lt.22080; Nguyen S, 2005, BLOOD, V105, P4135, DOI 10.1182/blood-2004-10-4113; Papamichail M, 2004, CANCER IMMUNOL IMMUN, V53, P176, DOI 10.1007/s00262-003-0478-4; Peruzzi G, 2009, IMMUNOL RES, V43, P210, DOI 10.1007/s12026-008-8072-7; Raulet DH, 1999, CURR OPIN IMMUNOL, V11, P129, DOI 10.1016/S0952-7915(99)80023-5; ROBERTSON MJ, 1990, BLOOD, V76, P2421; Shilling HG, 2003, BLOOD, V101, P3730, DOI 10.1182/blood-2002-08-2568; Sivori S, 2000, EUR J IMMUNOL, V30, P787, DOI 10.1002/1521-4141(200003)30:3<787::AID-IMMU787>3.0.CO;2-I; Sivori S, 2002, P NATL ACAD SCI USA, V99, P4526, DOI 10.1073/pnas.072065999; Spanholtz J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009221; SPITS H, 1995, BLOOD, V85, P2654, DOI 10.1182/blood.V85.10.2654.bloodjournal85102654; Tanaka H, 2003, EUR J HAEMATOL, V71, P29, DOI 10.1034/j.1600-0609.2003.00081.x; Thomson AW, 2010, NAT REV IMMUNOL, V10, P753, DOI 10.1038/nri2858; Wang YY, 2007, CELL MOL IMMUNOL, V4, P377; Yokoyama WM, 2004, ANNU REV IMMUNOL, V22, P405, DOI 10.1146/annurev.immunol.22.012703.104711; Yu J, 2009, BLOOD BLOOD 2009; Zhao XY, 2007, BIOL BLOOD MARROW TR, V13, P734, DOI 10.1016/j.bbmt.2007.02.010	37	41	43	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e30930	10.1371/journal.pone.0030930	http://dx.doi.org/10.1371/journal.pone.0030930			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LO	22319595	Green Published, Green Submitted, gold			2022-12-27	WOS:000302178400020
J	Garbuzova-Davis, S; Rodrigues, MCO; Mirtyl, S; Turner, S; Mitha, S; Sodhi, J; Suthakaran, S; Eve, DJ; Sanberg, CD; Kuzmin-Nichols, N; Sanberg, PR				Garbuzova-Davis, Svitlana; Rodrigues, Maria C. O.; Mirtyl, Santhia; Turner, Shanna; Mitha, Shazia; Sodhi, Jasmine; Suthakaran, Subatha; Eve, David J.; Sanberg, Cyndy D.; Kuzmin-Nichols, Nicole; Sanberg, Paul R.			Multiple Intravenous Administrations of Human Umbilical Cord Blood Cells Benefit in a Mouse Model of ALS	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; HEMATOPOIETIC STEM-CELLS; MARROW STROMAL CELLS; ADULT BONE-MARROW; MOTOR-NEURON LOSS; DISEASE PROGRESSION; SPINAL-CORD; TRANSGENIC MICE; BRAIN REPAIR; FAMILIAL ALS	Background: A promising therapeutic strategy for amyotrophic lateral sclerosis (ALS) is the use of cell-based therapies that can protect motor neurons and thereby retard disease progression. We recently showed that a single large dose (25x10(6) cells) of mononuclear cells from human umbilical cord blood (MNC hUCB) administered intravenously to pre-symptomatic G93A SOD1 mice is optimal in delaying disease progression and increasing lifespan. However, this single high cell dose is impractical for clinical use. The aim of the present pre-clinical translation study was therefore to evaluate the effects of multiple low dose systemic injections of MNC hUCB cell into G93A SOD1 mice at different disease stages. Methodology/Principal Findings: Mice received weekly intravenous injections of MNC hUCB or media. Symptomatic mice received 10(6) or 2.5x10(6) cells from 13 weeks of age. A third, pre-symptomatic, group received 10(6) cells from 9 weeks of age. Control groups were media-injected G93A and mice carrying the normal hSOD1 gene. Motor function tests and various assays determined cell effects. Administered cell distribution, motor neuron counts, and glial cell densities were analyzed in mouse spinal cords. Results showed that mice receiving 10(6) cells pre-symptomatically or 2.5x10(6) cells symptomatically significantly delayed functional deterioration, increased lifespan and had higher motor neuron counts than media mice. Astrocytes and microglia were significantly reduced in all cell-treated groups. Conclusions/Significance: These results demonstrate that multiple injections of MNC hUCB cells, even beginning at the symptomatic disease stage, could benefit disease outcomes by protecting motor neurons from inflammatory effectors. This multiple cell infusion approach may promote future clinical studies.	[Garbuzova-Davis, Svitlana; Rodrigues, Maria C. O.; Mirtyl, Santhia; Turner, Shanna; Mitha, Shazia; Sodhi, Jasmine; Suthakaran, Subatha; Eve, David J.; Sanberg, Paul R.] Univ S Florida, Coll Med, Ctr Excellence Aging & Brain Repair, Tampa, FL 33620 USA; [Garbuzova-Davis, Svitlana; Eve, David J.; Sanberg, Paul R.] Univ S Florida, Coll Med, Dept Neurosurg & Brain Repair, Tampa, FL USA; [Garbuzova-Davis, Svitlana] Univ S Florida, Coll Med, Dept Mol Pharmacol & Physiol, Tampa, FL USA; [Garbuzova-Davis, Svitlana; Sanberg, Paul R.] Univ S Florida, Coll Med, Dept Pathol & Cell Biol, Tampa, FL USA; [Sanberg, Paul R.] Univ S Florida, Coll Med, Dept Psychiat, Tampa, FL USA; [Sanberg, Cyndy D.; Kuzmin-Nichols, Nicole] Saneron CCEL Therapeut Inc, Tampa, FL USA; [Rodrigues, Maria C. O.] Univ Sao Paulo, Ribeirao Preto Sch Med, Sao Paulo, Brazil	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; Universidade de Sao Paulo	Garbuzova-Davis, S (corresponding author), Univ S Florida, Coll Med, Ctr Excellence Aging & Brain Repair, Tampa, FL 33620 USA.	sgarbuzo@health.usf.edu	Rodrigues, Maria Carolina Oliveira/A-2302-2012; Garbuzova-Davis, Svitlana/Q-3687-2019; Eve, David/I-6164-2012	Rodrigues, Maria Carolina Oliveira/0000-0003-0691-2222; Eve, David/0000-0003-1736-9755; Sanberg, Paul/0000-0001-9130-4592	Department of Neurosurgery and Brain Repair, at the University of South Florida (USF); Sao Paulo Research Foundation	Department of Neurosurgery and Brain Repair, at the University of South Florida (USF); Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by the Department of Neurosurgery and Brain Repair, at the University of South Florida (USF). MCOR, received a fellowship from the Sao Paulo Research Foundation which supported her work at USF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Alexander GM, 2004, MOL BRAIN RES, V130, P7, DOI 10.1016/j.molbrainres.2004.07.002; Alexianu ME, 2001, NEUROLOGY, V57, P1282, DOI 10.1212/WNL.57.7.1282; Appel SH, 2008, NEUROLOGY, V71, P1326, DOI 10.1212/01.wnl.0000327668.43541.22; Appel S H, 2001, Curr Neurol Neurosci Rep, V1, P303, DOI 10.1007/s11910-001-0081-z; Bachstetter AD, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-22; Barbeito LH, BRAIN RES BRAIN RES, V47, P263; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Borlongan CV, 2004, STROKE, V35, P2385, DOI 10.1161/01.STR.0000141680.49960.d7; BROXMEYER HE, 1992, P NATL ACAD SCI USA, V89, P4109, DOI 10.1073/pnas.89.9.4109; BROXMEYER HE, 1989, P NATL ACAD SCI USA, V86, P3828, DOI 10.1073/pnas.86.10.3828; Bruijn LI, 2002, BIOTECHNIQUES, V32, P1112, DOI 10.2144/02325dd01; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Chen N, 2005, STEM CELLS, V23, P1560, DOI 10.1634/stemcells.2004-0284; Chen N, 2010, AGING DIS, V1, P173; Chen Ruifeng, 2000, Journal of Medicine (Westbury), V31, P21; Cho KJ, 1999, NEUROREPORT, V10, P3939, DOI 10.1097/00001756-199912160-00039; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Eglitis MA, 1999, NEUROREPORT, V10, P1289, DOI 10.1097/00001756-199904260-00025; Feeney SJ, 2001, MUSCLE NERVE, V24, P1510, DOI 10.1002/mus.1176; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; FREIREICH EMIL J., 1966, CANCER CHEMOTHERAP REP, V50, P219; Garbuzova-Davis S, 2003, J HEMATOTH STEM CELL, V12, P255, DOI 10.1089/152581603322022990; Garbuzova-Davis S, 2009, CELL TRANSPLANT, V18, P214; Garbuzova-Davis S, 2006, PROG BRAIN RES, V157, P207, DOI 10.1016/S0079-6123(06)57014-1; Garbuzova-Davis S, 2011, BRAIN RES, V1398, P113, DOI 10.1016/j.brainres.2011.04.049; Garbuzova-Davis S, 2009, EXP NEUROL, V216, P3, DOI 10.1016/j.expneurol.2008.11.004; Garbuzova-Davis S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002494; GIULIAN D, 1985, J CELL BIOL, V101, P2411, DOI 10.1083/jcb.101.6.2411; Hall ED, 1998, GLIA, V23, P249, DOI 10.1002/(SICI)1098-1136(199807)23:3<249::AID-GLIA7>3.0.CO;2-#; Heiman-Patterson TD, 2005, J NEUROL SCI, V236, P1, DOI 10.1016/j.jns.2005.02.006; Hendrikx PJ, 1996, EXP HEMATOL, V24, P129; Henkel JS, 2009, J NEUROIMMUNE PHARM, V4, P389, DOI 10.1007/s11481-009-9171-5; Henkel JS, 2004, ANN NEUROL, V55, P221, DOI 10.1002/ana.10805; Jozwiak S, 2010, CELL MED, V1, P71, DOI 10.3727/215517910X536618; Lee ST, 2008, BRAIN, V131, P616, DOI 10.1093/brain/awm306; Levine JB, 1999, GLIA, V28, P215; Lindvall O, 2004, NAT MED, V10, pS42, DOI 10.1038/nm1064; Lu DY, 2002, CELL TRANSPLANT, V11, P275; Mayani H, 1998, STEM CELLS, V16, P153, DOI 10.1002/stem.160153; Mazzini L, 2003, AMYOTROPH LATERAL SC, V4, P158, DOI 10.1080/14660820310014653; Mazzini L, 2008, J NEUROL SCI, V265, P78, DOI 10.1016/j.jns.2007.05.016; McGeer PL, 2002, MUSCLE NERVE, V26, P459, DOI 10.1002/mus.10191; Mitrecic D, 2010, CELL TRANSPLANT, V19, P537, DOI 10.3727/096368910X498269; NAKAHATA T, 1982, J CLIN INVEST, V70, P1324, DOI 10.1172/JCI110734; Nayar B, 2002, INT J GYNECOL OBSTET, V79, P31, DOI 10.1016/S0020-7292(02)00187-X; Nikolic WV, 2008, STEM CELLS DEV, V17, P423, DOI 10.1089/scd.2008.0018; Ohnishi S, 2009, BRAIN RES, V1296, P216, DOI 10.1016/j.brainres.2009.08.012; Philips T, 2011, LANCET NEUROL, V10, P253, DOI 10.1016/S1474-4422(11)70015-1; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Rainsford E, 2002, BRIT J HAEMATOL, V116, P702, DOI 10.1046/j.0007-1048.2001.03321.x; Riley J, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/3-4/E9; Rizvanov AA, 2008, NEUROCHEM INT, V53, P389, DOI 10.1016/j.neuint.2008.09.011; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Sanberg P R, 2001, Clin Neurosurg, V48, P113; Sanberg PR, 2002, NEUROTOX RES, V4, P95, DOI 10.1080/10298420290015917; Sanberg PR, 2011, CELL TRANSPLANT, V20, P85, DOI 10.3727/096368910X532855; Sanberg PR, 2005, ANN NY ACAD SCI, V1049, P67, DOI 10.1196/annals.1334.008; Sanchez-Ramos J, 2000, EXP NEUROL, V164, P247, DOI 10.1006/exnr.2000.7389; Sanchez-Ramos JR, 2001, EXP NEUROL, V171, P109, DOI 10.1006/exnr.2001.7748; Sanchez-Ramos JR, 2002, J NEUROSCI RES, V69, P880, DOI 10.1002/jnr.10337; Saporta S, 2003, J HEMATOTH STEM CELL, V12, P271, DOI 10.1089/152581603322023007; Souayah N, 2012, STEM CELL REV REP, V8, P224, DOI 10.1007/s12015-011-9281-3; Strong MJ, 2003, PHARMACOL THERAPEUT, V98, P379, DOI 10.1016/S0163-7258(03)00040-8; Suzuki M, 2008, TRENDS NEUROSCI, V31, P192, DOI 10.1016/j.tins.2008.01.006; Szilvassy SJ, 1999, BLOOD, V93, P1557, DOI 10.1182/blood.V93.5.1557; Teng YD, 2011, CURR NEUROPHARMACOL, V9, P574, DOI 10.2174/157015911798376299; Todaro AM, 2000, BLOOD PURIFICAT, V18, P144, DOI 10.1159/000014438; Van Den Bosch L, 2008, EXP NEUROL, V211, P1, DOI 10.1016/j.expneurol.2008.01.008; Vendrame M, 2005, STEM CELLS DEV, V14, P595, DOI 10.1089/scd.2005.14.595; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Willing AE, 2003, J NEUROSCI RES, V73, P296, DOI 10.1002/jnr.10659; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047; Zhao WH, 2010, GLIA, V58, P231, DOI 10.1002/glia.20919; ZOLA H, 1995, PEDIATR RES, V38, P397, DOI 10.1203/00006450-199509000-00021	76	39	45	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e31254	10.1371/journal.pone.0031254	http://dx.doi.org/10.1371/journal.pone.0031254			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LO	22319620	Green Published, Green Submitted, gold			2022-12-27	WOS:000302178400033
J	Maiga, M; Agarwal, N; Ammerman, NC; Gupta, R; Guo, HD; Maiga, MC; Lun, SC; Bishai, WR				Maiga, Mamoudou; Agarwal, Nisheeth; Ammerman, Nicole C.; Gupta, Radhika; Guo, Haidan; Maiga, Marama C.; Lun, Shichun; Bishai, William R.			Successful Shortening of Tuberculosis Treatment Using Adjuvant Host-Directed Therapy with FDA-Approved Phosphodiesterase Inhibitors in the Mouse Model	PLOS ONE			English	Article							CYCLIC-AMP; MYCOBACTERIUM-TUBERCULOSIS; IMMUNOTHERAPY; CHEMOTHERAPY; ACTIVATION; IMMUNITY; RABBITS; CELLS; MICE; CAMP	Global control of tuberculosis (TB), an infectious disease that claims nearly 2 million lives annually, is hindered by the long duration of chemotherapy required for curative treatment. Lack of adherence to this intense treatment regimen leads to poor patient outcomes, development of new or additional drug resistance, and continued spread of M.tb. within communities. Hence, shortening the duration of TB therapy could increase drug adherence and cure in TB patients. Here, we report that addition of the United Stated Food and Drug Administration-approved phosphodiesterase inhibitors (PDE-Is) cilostazol and sildenafil to the standard TB treatment regimen reduces tissue pathology, leads to faster bacterial clearance and shortens the time to lung sterilization by one month, compared to standard treatment alone, in a murine model of TB. Our data suggest that these PDE-Is could be repurposed for use as adjunctive drugs to shorten TB treatment in humans.	[Maiga, Mamoudou; Agarwal, Nisheeth; Ammerman, Nicole C.; Gupta, Radhika; Guo, Haidan; Maiga, Marama C.; Lun, Shichun; Bishai, William R.] Johns Hopkins Univ, Sch Med, Ctr TB Res, Baltimore, MD 21218 USA; [Agarwal, Nisheeth] Translat Hlth Sci & Technol Inst, Vaccine & Infect Dis Res Ctr, Gurgaon, India; [Bishai, William R.] KwaZulu Natal Res Inst TB & HIV K RITH, Durban, South Africa; [Bishai, William R.] Howard Hughes Med Inst, Chevy Chase, MD USA	Johns Hopkins University; Department of Biotechnology (DBT) India; Translational Health Science & Technology Institute (THSTI); Howard Hughes Medical Institute	Maiga, M (corresponding author), Johns Hopkins Univ, Sch Med, Ctr TB Res, Baltimore, MD 21218 USA.	wbishai1@jhmi.edu		Ammerman, Nicole C./0000-0001-9359-9144; Gupta, Radhika/0000-0002-0445-0194	National Institute of Allergy and Infectious Diseases [AI30036, AI37856, AI36973]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI036973, R01AI030036, R29AI036973, R01AI037856] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The project described in this communication was supported by awards AI30036, AI37856 and AI36973 from the National Institute of Allergy and Infectious Diseases and by the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal N, 2009, NATURE, V460, P98, DOI 10.1038/nature08123; Agarwal N, 2009, INDIAN J EXP BIOL, V47, P393; Aizawa T, 2003, CIRC RES, V93, P406, DOI 10.1161/01.RES.0000091074.33584.F0; Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5; Churchyard GJ, 2009, CLIN CHEST MED, V30, P769, DOI 10.1016/j.ccm.2009.08.009; COURTADE ET, 1975, AM J PATHOL, V78, P243; Dhillon J, 1996, ANTIMICROB AGENTS CH, V40, P552, DOI 10.1128/AAC.40.3.552; Gao L, 2006, J PHARMACOL EXP THER, V318, P53, DOI 10.1124/jpet.106.101444; Harris J, 2010, CLIN EXP IMMUNOL, V161, P1, DOI 10.1111/j.1365-2249.2010.04146.x; Hattori Y, 2009, CARDIOVASC RES, V81, P133, DOI 10.1093/cvr/cvn226; Jassal MS, 2010, CLIN INFECT DIS, V50, pS156, DOI 10.1086/651486; Koo MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017091; Lienhardt C, 2010, CURR OPIN PULM MED, V16, P186, DOI 10.1097/MCP.0b013e328337580c; LOWRIE DB, 1975, NATURE, V254, P600, DOI 10.1038/254600a0; Mayanja-Kizza H, 2005, J INFECT DIS, V191, P856, DOI 10.1086/427995; Mendes JB, 2009, LIFE SCI, V84, P537, DOI 10.1016/j.lfs.2009.01.023; Moens MJU, 2007, FRONT BIOSCI-LANDMRK, V12, P1814; Nuermberger EL, 2010, RESPIROLOGY, V15, P764, DOI 10.1111/j.1440-1843.2010.01775.x; Omori K, 2007, CIRC RES, V100, P309, DOI 10.1161/01.RES.0000256354.95791.f1; Paige C, 2010, CELL MICROBIOL, V12, P301, DOI 10.1111/j.1462-5822.2009.01424.x; Pan H, 2005, NATURE, V434, P767, DOI 10.1038/nature03419; Quesniaux VFJ, 2010, CURR DIR AUTOIMMUN, V11, P157, DOI 10.1159/000289204; Russell DG, 2007, NAT REV MICROBIOL, V5, P39, DOI 10.1038/nrmicro1538; Serezani CH, 2008, AM J RESP CELL MOL, V39, P127, DOI 10.1165/rcmb.2008-0091TR; Shenoy AR, 2006, TRENDS MICROBIOL, V14, P543, DOI 10.1016/j.tim.2006.10.005; Spina D, 2008, BRIT J PHARMACOL, V155, P308, DOI 10.1038/bjp.2008.307; Subbian S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002262; Subbian S, 2011, AM J PATHOL, V179, P289, DOI 10.1016/j.ajpath.2011.03.039; Szczypka M, 2010, PHARMACOL REP, V62, P1148, DOI 10.1016/S1734-1140(10)70377-7; Wallis RS, 2005, CLIN INFECT DIS, V41, P201, DOI 10.1086/430914; WHO, 2010, GLOB TUB CONTR 2010; Word Health Organization, 2007, REP EXP CONS IMM INT, P29	32	42	42	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e30749	10.1371/journal.pone.0030749	http://dx.doi.org/10.1371/journal.pone.0030749			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LO	22319585	Green Published, gold, Green Submitted			2022-12-27	WOS:000302178400015
J	Leisher, C; Hess, S; Boucher, TM; van Beukering, P; Sanjayan, M				Leisher, Craig; Hess, Sebastiaan; Boucher, Timothy M.; van Beukering, Pieter; Sanjayan, M.			Measuring the Impacts of Community-based Grasslands Management in Mongolia's Gobi	PLOS ONE			English	Article							DRIVEN DEVELOPMENT; CONSERVATION; PRODUCTIVITY; SUSTAINABILITY; DIVERSITY; FRAMEWORK; BIOMASS; NDVI	We assessed a donor-funded grassland management project designed to create both conservation and livelihood benefits in the rangelands of Mongolia's Gobi desert. The project ran from 1995 to 2006, and we used remote sensing Normalized Differential Vegetation Index data from 1982 to 2009 to compare project grazing sites to matched control sites before and after the project's implementation. We found that the productivity of project grazing sites was on average within 1% of control sites for the 20 years before the project but generated 11% more biomass on average than the control areas from 2000 to 2009. To better understand the benefits of the improved grasslands to local people, we conducted 280 household interviews, 8 focus group discussions, and 31 key informant interviews across 6 districts. We found a 12% greater median annual income as well as a range of other socioeconomic benefits for project households compared to control households in the same areas. Overall, the project generated measurable benefits to both nature and people. The key factors underlying project achievements that may be replicable by other conservation projects include the community-driven approach of the project, knowledge exchanges within and between communities inside and outside the country, a project-supported local community organizer in each district, and strong community leadership.	[Leisher, Craig; Boucher, Timothy M.; Sanjayan, M.] Nature Conservancy, Cent Sci, Arlington, VA USA; [Hess, Sebastiaan] Hess Environm Econ Analyst, Haarlem, Netherlands; [van Beukering, Pieter] Vrije Univ Amsterdam, Inst Environm Studies, Dept Environm Econ, Amsterdam, Netherlands	Nature Conservancy; Vrije Universiteit Amsterdam	Leisher, C (corresponding author), Nature Conservancy, Cent Sci, 1815 N Lynn St, Arlington, VA USA.	cleisher@tnc.org	van Beukering, Pieter/L-3509-2013	van Beukering, Pieter/0000-0001-7146-4409	Schooner Foundation; HRH Foundation; Nature Conservancy	Schooner Foundation; HRH Foundation; Nature Conservancy	The Schooner Foundation, along with Harry and Shirley Hagey of the HRH Foundation, and The Nature Conservancy provided the funding to make this study possible. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler RF, 2003, J HYDROMETEOROL, V4, P1147, DOI 10.1175/1525-7541(2003)004<1147:TVGPCP>2.0.CO;2; Angerer J., 2008, RANGELANDS, V30, P46, DOI [DOI 10.2111/1551-501X(2008)30[46:CCAEOA]2.0.CO;2, 10.2111/1551-501X(2008)30]; Barthel H, 1983, STUDIA GEOGRAPHICA, V34, P1; Bullock JM, 2007, J APPL ECOL, V44, P6, DOI 10.1111/j.1365-2664.2006.01252.x; Cardinale BJ, 2007, P NATL ACAD SCI USA, V104, P18123, DOI 10.1073/pnas.0709069104; Dasgupta A, 2007, DEV CHANGE, V38, P229, DOI 10.1111/j.1467-7660.2007.00410.x; GEORGIADIS NJ, 1989, OECOLOGIA, V81, P316, DOI 10.1007/BF00377077; Guo QF, 2007, BASIC APPL ECOL, V8, P199, DOI 10.1016/j.baae.2006.02.005; Gutierrez NL, 2011, NATURE, V470, P386, DOI 10.1038/nature09689; Henwood William D., 2010, Great Plains Research, V20, P121; Jacobs SM, 2008, J ARID ENVIRON, V72, P891, DOI 10.1016/j.jaridenv.2007.11.015; Kawamura Kensuke, 2005, Grassland Science, V51, P33, DOI 10.1111/j.1744-697X.2005.00006.x; Knight AT, 2006, CONSERV BIOL, V20, P408, DOI 10.1111/j.1523-1739.2006.00305.x; Mansuri G, 2004, WORLD BANK RES OBSER, V19, P1, DOI 10.1093/wbro/lkh012; MCNAUGHTON SJ, 1979, AM NAT, V113, P691, DOI 10.1086/283426; Morton DC, 2005, EARTH INTERACT, V9; Murray S., 2000, PILOT ANAL GLOBAL EC; National Statistical Office of Mongolia, 2022, GEN STAT DAT; NSOM, 2009, MONTHLY B STAT   DEC; Ostrom E, 2009, SCIENCE, V325, P419, DOI 10.1126/science.1172133; Peters AJ, 2002, PHOTOGRAMM ENG REM S, V68, P71; Pollnac RB, 2001, OCEAN COAST MANAGE, V44, P683, DOI 10.1016/S0964-5691(01)00075-8; Reading RP, 1999, BIODIVERS CONSERV, V8, P1115, DOI 10.1023/A:1008900427566; Salafsky N, 2002, CONSERV BIOL, V16, P1469, DOI 10.1046/j.1523-1739.2002.01232.x; Singh A., 2005, ONE PLANET MANY PEOP; Sullivan S, 2002, J BIOGEOGR, V29, P1595, DOI 10.1046/j.1365-2699.2002.00799.x; Tilman D, 1996, NATURE, V379, P718, DOI 10.1038/379718a0; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; UNDERWOOD AJ, 1994, ECOL APPL, V4, P3, DOI 10.2307/1942110; Wang J., 2005, GEOCARTO INT, V20, P5, DOI DOI 10.1080/10106040508542350; Wang Q, 2003, ENVIRON MONIT ASSESS, V82, P119, DOI 10.1023/A:1021898531229; World Bank, 2001, ATT POV WORLD DEV RE; Yang LM, 1998, REMOTE SENS ENVIRON, V65, P25, DOI 10.1016/S0034-4257(98)00012-1; Zhou L, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002510	34	28	32	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2012	7	2							e30991	10.1371/journal.pone.0030991	http://dx.doi.org/10.1371/journal.pone.0030991			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UG	22312436	Green Submitted, Green Published, gold			2022-12-27	WOS:000301977500024
J	de Jong, MC; Knapen, T; van Ee, R				de Jong, Maartje Cathelijne; Knapen, Tomas; van Ee, Raymond			Opposite Influence of Perceptual Memory on Initial and Prolonged Perception of Sensory Ambiguity	PLOS ONE			English	Article							BINOCULAR-RIVALRY; MOTION; ADAPTATION; DOMINANCE; ATTENTION; TIME; PLASTICITY; AWARENESS; DYNAMICS; ROTATION	Observers continually make unconscious inferences about the state of the world based on ambiguous sensory information. This process of perceptual decision-making may be optimized by learning from experience. We investigated the influence of previous perceptual experience on the interpretation of ambiguous visual information. Observers were pre-exposed to a perceptually stabilized sequence of an ambiguous structure-from-motion stimulus by means of intermittent presentation. At the subsequent re-appearance of the same ambiguous stimulus perception was initially biased toward the previously stabilized perceptual interpretation. However, prolonged viewing revealed a bias toward the alternative perceptual interpretation. The prevalence of the alternative percept during ongoing viewing was largely due to increased durations of this percept, as there was no reliable decrease in the durations of the pre-exposed percept. Moreover, the duration of the alternative percept was modulated by the specific characteristics of the pre-exposure, whereas the durations of the pre-exposed percept were not. The increase in duration of the alternative percept was larger when the pre-exposure had lasted longer and was larger after ambiguous pre-exposure than after unambiguous pre-exposure. Using a binocular rivalry stimulus we found analogous perceptual biases, while pre-exposure did not affect eye-bias. We conclude that previously perceived interpretations dominate at the onset of ambiguous sensory information, whereas alternative interpretations dominate prolonged viewing. Thus, at first instance ambiguous information seems to be judged using familiar percepts, while re-evaluation later on allows for alternative interpretations.	[de Jong, Maartje Cathelijne; van Ee, Raymond] Univ Utrecht, Helmholtz Inst, Utrecht, Netherlands; [Knapen, Tomas] Univ Amsterdam, Brain & Cognit Grp, Amsterdam, Netherlands; [van Ee, Raymond] Philips Res Labs, Dept Brain Body & Behav, Eindhoven, Netherlands; [van Ee, Raymond] Univ Louvain, Expt Psychol Lab, Louvain, Belgium; [van Ee, Raymond] Radboud Univ Nijmegen, Donders Inst, Dept Biophys, NL-6525 ED Nijmegen, Netherlands	Utrecht University; University of Amsterdam; Philips; Philips Research; Radboud University Nijmegen	de Jong, MC (corresponding author), Univ Utrecht, Helmholtz Inst, Utrecht, Netherlands.	dejongmc@gmail.com	van Ee, Raymond/C-4881-2013; Knapen, Tomas/H-4431-2019	Knapen, Tomas/0000-0001-5863-8689; van Ee, Raymond/0000-0002-1134-8665	Utrecht University; Flemish Methusalem program [METH/08/02]	Utrecht University; Flemish Methusalem program	MCdJ and RvE were supported by a Utrecht University High Potential grant. RvE is supported by a grant from the Flemish Methusalem program (METH/08/02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartels A, 2010, J VISION, V10, DOI 10.1167/10.12.3; Brascamp JW, 2009, J VISION, V9, DOI 10.1167/9.3.3; Brascamp JW, 2006, J VISION, V6, P1244, DOI 10.1167/6.11.8; Brascamp JW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001497; Brascamp JW, 2007, J VISION, V7, DOI 10.1167/7.12.12; Brascamp JW, 2010, J NEUROSCI, V30, P760, DOI 10.1523/JNEUROSCI.4171-09.2010; BRAUNSTEIN ML, 1977, PERCEPT PSYCHOPHYS, V21, P553, DOI 10.3758/BF03198736; Brouwer GJ, 2007, J NEUROSCI, V27, P1015, DOI 10.1523/JNEUROSCI.4593-06.2007; Carter O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000343; Chong SC, 2005, J VISION, V5, P1004, DOI 10.1167/5.11.6; Chong SC, 2006, VISION RES, V46, P1794, DOI 10.1016/j.visres.2005.10.031; Chopin A, 2011, J VISION, V11, DOI 10.1167/11.7.18; COHEN L, 1959, AM J PSYCHOL, V72, P327, DOI 10.2307/1420037; Daelli V, 2010, BRAIN RES, V1322, P81, DOI 10.1016/j.brainres.2010.01.060; HARRIS JP, 1980, AM J PSYCHOL, V93, P445, DOI 10.2307/1422723; Harrison SJ, 2010, VISION RES, V50, P1905, DOI 10.1016/j.visres.2010.06.013; Harrison SJ, 2011, VISION RES, V51, P978, DOI 10.1016/j.visres.2011.02.011; HOCHBERG JE, 1950, J EXP PSYCHOL, V40, P682, DOI 10.1037/h0060078; Hock HS, 1996, VISION RES, V36, P3311, DOI 10.1016/0042-6989(95)00277-4; Hupe JM, 2003, VISION RES, V43, P531, DOI 10.1016/S0042-6989(02)00593-X; Jackson S, 2010, J NEUROSCI, V30, P838, DOI 10.1523/JNEUROSCI.3116-09.2010; Kanai R, 2005, VISION RES, V45, P3109, DOI 10.1016/j.visres.2005.05.014; Klink PC, 2008, J VISION, V8, DOI 10.1167/8.5.16; Klink PC, 2010, CURR BIOL, V20, P1464, DOI 10.1016/j.cub.2010.06.057; Knapen T, 2009, J VISION, V9, DOI [10.1167/9.13.16, 10.1167/9.5.16]; Kourtzi Z, 2010, VISION RES, V50, P433, DOI 10.1016/j.visres.2009.09.025; Kristjansson A, 2010, ATTEN PERCEPT PSYCHO, V72, P5, DOI 10.3758/APP.72.1.5; Leopold DA, 2002, NAT NEUROSCI, V5, P605, DOI 10.1038/nn0602-851; LEVELT WJM, 1967, BRIT J PSYCHOL, V58, P143, DOI 10.1111/j.2044-8295.1967.tb01068.x; Long GM, 2004, PSYCHOL BULL, V130, P748, DOI 10.1037/0033-2909.130.5.748; LONG GM, 1992, PERCEPT PSYCHOPHYS, V52, P609, DOI 10.3758/BF03211697; Maier A, 2003, CURR BIOL, V13, P1076, DOI 10.1016/S0960-9822(03)00414-7; Mamassian P, 2005, J VISION, V5, P361, DOI 10.1167/5.4.7; Naber M, 2010, VISION RES, V50, P818, DOI 10.1016/j.visres.2010.02.004; NAWROT M, 1991, PERCEPT PSYCHOPHYS, V49, P230, DOI 10.3758/BF03214308; Noest AJ, 2007, J VISION, V7, DOI 10.1167/7.8.10; ORBACH J, 1963, Percept Mot Skills, V17, P439; Pastukhov A, 2008, J VISION, V8, DOI 10.1167/8.13.7; Pearson J, 2005, VISION RES, V45, P707, DOI 10.1016/j.visres.2004.09.040; Pearson J, 2004, J VISION, V4, P196, DOI 10.1167/4.3.6; Pearson J, 2008, TRENDS COGN SCI, V12, P334, DOI 10.1016/j.tics.2008.05.006; PETERSIK JT, 1984, PERCEPTION, V13, P489, DOI 10.1068/p130489; Sasaki Y, 2010, NAT REV NEUROSCI, V11, P53, DOI 10.1038/nrn2737; Southall JPC, 1911, HDB PHYSL OPTIK; Suzuki S, 2002, NEURON, V36, P143, DOI 10.1016/S0896-6273(02)00934-0; Suzuki S, 2007, NEURON, V56, P741, DOI 10.1016/j.neuron.2007.09.028; Thompson P, 2009, CURR BIOL, V19, pR11, DOI 10.1016/j.cub.2008.10.014; van Dam LCJ, 2010, J VISION, V10, DOI 10.1167/10.8.15; van Ee R, 2009, J OPT SOC AM A, V26, P2612, DOI 10.1364/JOSAA.26.002612; VIRSU V, 1975, NATURE, V257, P786, DOI 10.1038/257786a0; Von Gruenau Michael, 1993, Spatial Vision, V7, P199, DOI 10.1163/156856893X00360; WALLACH H, 1953, J EXP PSYCHOL, V45, P205, DOI 10.1037/h0056880	52	28	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30595	10.1371/journal.pone.0030595	http://dx.doi.org/10.1371/journal.pone.0030595			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	910ME	22295095	Green Published, gold			2022-12-27	WOS:000301640600040
J	Linheiro, RS; Bergman, CM				Linheiro, Raquel S.; Bergman, Casey M.			Whole Genome Resequencing Reveals Natural Target Site Preferences of Transposable Elements in Drosophila melanogaster	PLOS ONE			English	Article							DNA; INSERTION; INTEGRATION; GENES; SEQUENCES; COMMON; SCREEN; FAMILY; HIV-1; RETROTRANSPOSON	Transposable elements are mobile DNA sequences that integrate into host genomes using diverse mechanisms with varying degrees of target site specificity. While the target site preferences of some engineered transposable elements are well studied, the natural target preferences of most transposable elements are poorly characterized. Using population genomic resequencing data from 166 strains of Drosophila melanogaster, we identified over 8,000 new insertion sites not present in the reference genome sequence that we used to decode the natural target preferences of 22 families of transposable element in this species. We found that terminal inverted repeat transposon and long terminal repeat retrotransposon families present clade-specific target site duplications and target site sequence motifs. Additionally, we found that the sequence motifs at transposable element target sites are always palindromes that extend beyond the target site duplication. Our results demonstrate the utility of population genomics data for high-throughput inference of transposable element targeting preferences in the wild and establish general rules for terminal inverted repeat transposon and long terminal repeat retrotransposon target site selection in eukaryotic genomes.	[Linheiro, Raquel S.; Bergman, Casey M.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Manchester	Linheiro, RS (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	casey.bergman@manchester.ac.uk	Bergman, Casey/F-7854-2010	Bergman, Casey/0000-0002-5462-9854; Linheiro, Raquel/0000-0003-2659-0910	Fundacao para a Ciencia e a Tecnologia; Biotechnology and Biological Sciences Research Council [BB/E012868/1]; BBSRC [BB/E012868/1] Funding Source: UKRI	Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Fundacao para a Ciencia e a Tecnologia fellowship (to Dr. Linheiro) and Biotechnology and Biological Sciences Research Council grant BB/E012868/1 (to Dr. Bergman). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], GENOME COORDINATE SY; [Anonymous], DROSOPHILA GENETIC R; Beall EL, 1998, EMBO J, V17, P2122, DOI 10.1093/emboj/17.7.2122; BERNSTEIN M, 1995, GENETICS, V139, P631; Berry C, 2006, PLOS COMPUT BIOL, V2, P1450, DOI 10.1371/journal.pcbi.0020157; Biemont C, 2006, NATURE, V443, P521, DOI 10.1038/443521a; Bowen NJ, 2001, GENOME RES, V11, P1527, DOI 10.1101/gr.164201; CHARLESWORTH B, 1989, ANNU REV GENET, V23, P251, DOI 10.1146/annurev.ge.23.120189.001343; COLLINS JJ, 1994, GENETICS, V137, P771; Craig N. L., 2002, MOBILE DNA, P3; Delelis O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000608; DUNSMUIR P, 1980, CELL, V21, P575, DOI 10.1016/0092-8674(80)90495-X; Eickbush TH, 2002, MOBILE DNA, P1111; Ellinghaus D, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-18; ELLISON V, 1995, J BIOL CHEM, V270, P3320, DOI 10.1074/jbc.270.7.3320; FAWCETT DH, 1986, CELL, V47, P1007, DOI 10.1016/0092-8674(86)90815-9; Fiston-Lavier AS, 2010, NUCL ACIDS RES; Gawronski JD, 2009, P NATL ACAD SCI USA, V106, P16422, DOI 10.1073/pnas.0906627106; Goodman AL, 2009, CELL HOST MICROBE, V6, P279, DOI 10.1016/j.chom.2009.08.003; Grandgenett DP, 2005, P NATL ACAD SCI USA, V102, P5903, DOI 10.1073/pnas.0502045102; Haren L, 1999, ANNU REV MICROBIOL, V53, P245, DOI 10.1146/annurev.micro.53.1.245; Holman AG, 2005, P NATL ACAD SCI USA, V102, P6103, DOI 10.1073/pnas.0501646102; Iskow RC, 2010, CELL, V141, P1253, DOI 10.1016/j.cell.2010.05.020; Kaminker JS, 2002, GENOME BIOL, V3, P0084, DOI DOI 10.1186/GB-2002-3-12-RFESEARCH84; Kapitonov VV, 2003, P NATL ACAD SCI USA, V100, P6569, DOI 10.1073/pnas.0732024100; Keng VW, 2009, NAT BIOTECHNOL, V27, P264, DOI 10.1038/nbt.1526; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kondrychyn I, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-418; Koudijs MJ, 2011, GENOME RES; Langridge GC, 2009, GENOME RES, V19, P2308, DOI 10.1101/gr.097097.109; Levy A, 2010, NUCLEIC ACIDS RES, V38, P1515, DOI 10.1093/nar/gkp1134; Liao GC, 2000, P NATL ACAD SCI USA, V97, P3347, DOI 10.1073/pnas.050017397; Linheiro RS, 2008, NUCLEIC ACIDS RES, V36, P6199, DOI 10.1093/nar/gkn563; Llorens C, 2011, NUCLEIC ACIDS RES, V39, pD70, DOI 10.1093/nar/gkq1061; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; Maertens GN, 2010, NATURE, V468, P326, DOI 10.1038/nature09517; MERRIMAN PJ, 1995, GENETICS, V141, P1425; Miyao A, 2003, PLANT CELL, V15, P1771, DOI 10.1105/tpc.012559; Moalic Y, 2006, J VIROL, V80, P10980, DOI 10.1128/JVI.00904-06; MORI I, 1988, P NATL ACAD SCI USA, V85, P861, DOI 10.1073/pnas.85.3.861; Nefedova LN, 2011, VIRUS GENES, V42, P297, DOI 10.1007/s11262-010-0566-4; O'Brochta DA, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-108; OHARE K, 1983, CELL, V34, P25, DOI 10.1016/0092-8674(83)90133-2; Quesneville H, 2005, PLOS COMPUT BIOL, V1, P166, DOI 10.1371/journal.pcbi.0010022; Quinlan AR, 2010, GENOME RES, V20, P623, DOI 10.1101/gr.102970.109; Reiss D, 2003, MOL BIOL EVOL, V20, P869, DOI 10.1093/molbev/msg090; Richardson JM, 2009, CELL, V138, P1096, DOI 10.1016/j.cell.2009.07.012; Sackton TB, 2009, GENOME BIOL EVOL, V1, P449, DOI 10.1093/gbe/evp048; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Starr TK, 2009, SCIENCE, V323, P1747, DOI 10.1126/science.1163040; Stewart C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002236; TUDOR M, 1992, MOL GEN GENET, V232, P126, DOI 10.1007/BF00299145; van Opijnen T, 2009, NAT METHODS, V6, P767, DOI [10.1038/NMETH.1377, 10.1038/nmeth.1377]; Vigdal TJ, 2002, J MOL BIOL, V323, P441, DOI 10.1016/S0022-2836(02)00991-9; Viggiano L, 1997, GENE, V197, P29, DOI 10.1016/S0378-1119(97)00217-5; Wang WC, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-328; Whalen JH, 1998, MOL GEN GENET, V260, P401, DOI 10.1007/s004380050910; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Witherspoon DJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-410; Wu XL, 2005, J VIROL, V79, P5211, DOI 10.1128/JVI.79.8.5211-5214.2005; Zerjal T, 2009, PLANT MOL BIOL, V71, P99, DOI 10.1007/s11103-009-9511-0	61	75	77	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2012	7	2							e30008	10.1371/journal.pone.0030008	http://dx.doi.org/10.1371/journal.pone.0030008			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZQ	22347367	Green Published, Green Submitted, gold			2022-12-27	WOS:000302730200001
J	Eixarch, E; Batalle, D; Illa, M; Munoz-Moreno, E; Arbat-Plana, A; Amat-Roldan, I; Figueras, F; Gratacos, E				Eixarch, Elisenda; Batalle, Dafnis; Illa, Miriam; Munoz-Moreno, Emma; Arbat-Plana, Ariadna; Amat-Roldan, Ivan; Figueras, Francesc; Gratacos, Eduard			Neonatal Neurobehavior and Diffusion MRI Changes in Brain Reorganization Due to Intrauterine Growth Restriction in a Rabbit Model	PLOS ONE			English	Article							WHITE-MATTER INJURY; AGE TERM FETUSES; PRETERM INFANTS; CEREBRAL-PALSY; HUMAN NEWBORN; RAT MODEL; FETAL; RETARDATION; PREMATURE; CHILDREN	Background: Intrauterine growth restriction (IUGR) affects 5-10% of all newborns and is associated with a high risk of abnormal neurodevelopment. The timing and patterns of brain reorganization underlying IUGR are poorly documented. We developed a rabbit model of IUGR allowing neonatal neurobehavioral assessment and high resolution brain diffusion magnetic resonance imaging (MRI). The aim of the study was to describe the pattern and functional correlates of fetal brain reorganization induced by IUGR. Methodology/Principal Findings: IUGR was induced in 10 New Zealand fetal rabbits by ligation of 40-50% of uteroplacental vessels in one horn at 25 days of gestation. Ten contralateral horn fetuses were used as controls. Cesarean section was performed at 30 days (term 31 days). At postnatal day +1, neonates were assessed by validated neurobehavioral tests including evaluation of tone, spontaneous locomotion, reflex motor activity, motor responses to olfactory stimuli, and coordination of suck and swallow. Subsequently, brains were collected and fixed and MRI was performed using a high resolution acquisition scheme. Global and regional (manual delineation and voxel based analysis) diffusion tensor imaging parameters were analyzed. IUGR was associated with significantly poorer neurobehavioral performance in most domains. Voxel based analysis revealed fractional anisotropy (FA) differences in multiple brain regions of gray and white matter, including frontal, insular, occipital and temporal cortex, hippocampus, putamen, thalamus, claustrum, medial septal nucleus, anterior commissure, internal capsule, fimbria of hippocampus, medial lemniscus and olfactory tract. Regional FA changes were correlated with poorer outcome in neurobehavioral tests. Conclusions: IUGR is associated with a complex pattern of brain reorganization already at birth, which may open opportunities for early intervention. Diffusion MRI can offer suitable imaging biomarkers to characterize and monitor brain reorganization due to fetal diseases.	[Eixarch, Elisenda; Batalle, Dafnis; Illa, Miriam; Munoz-Moreno, Emma; Arbat-Plana, Ariadna; Amat-Roldan, Ivan; Figueras, Francesc; Gratacos, Eduard] Hosp Clin Barcelona, ICGON, Dept Maternal Fetal Med, Barcelona, Spain; [Eixarch, Elisenda; Batalle, Dafnis; Illa, Miriam; Munoz-Moreno, Emma; Arbat-Plana, Ariadna; Amat-Roldan, Ivan; Figueras, Francesc; Gratacos, Eduard] Univ Barcelona, IDIBAPS, Barcelona, Spain; [Eixarch, Elisenda; Batalle, Dafnis; Illa, Miriam; Munoz-Moreno, Emma; Arbat-Plana, Ariadna; Amat-Roldan, Ivan; Figueras, Francesc; Gratacos, Eduard] CIBERER, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Eixarch, E (corresponding author), Hosp Clin Barcelona, ICGON, Dept Maternal Fetal Med, Barcelona, Spain.	egratacos@clinic.ub.es	Gratacos, Eduard/AAR-4939-2020; Muñoz-Moreno, Emma/A-2363-2016; Muñoz-Moreno, Emma/ABD-6424-2021; Batalle, Dafnis/C-1718-2013; Batalle, Dafnis/H-7531-2019	Gratacos, Eduard/0000-0002-7405-7224; Muñoz-Moreno, Emma/0000-0003-2104-7265; Muñoz-Moreno, Emma/0000-0003-2104-7265; Batalle, Dafnis/0000-0003-2097-979X; Batalle, Dafnis/0000-0003-2097-979X; Eixarch, Elisenda/0000-0001-7379-9608; Illa, Miriam/0000-0002-8366-830X; Arbat-Plana, Ariadna/0000-0003-0479-8323	Fondo the Investigacion Sanitaria (Spain) [PI/060347]; Obra Social La Caixa (Barcelona, Spain); Carlos III Institute of Health (Spain) [CM08/00105]; Hospital Clinic (Barcelona, Spain)	Fondo the Investigacion Sanitaria (Spain)(Instituto de Salud Carlos III); Obra Social La Caixa (Barcelona, Spain)(La Caixa Foundation); Carlos III Institute of Health (Spain)(Instituto de Salud Carlos III); Hospital Clinic (Barcelona, Spain)	This work was supported by Fondo the Investigacion Sanitaria (PI/060347) (Spain), Obra Social La Caixa (Barcelona, Spain); Rio Hortega grant from Carlos III Institute of Health (Spain) [CM08/00105 to E.E.] and Emili Letang fellowship by Hospital Clinic (Barcelona, Spain) [to M.I.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2010, NEURORADIOLOGY, V52, P699, DOI 10.1007/s00234-010-0716-3; Baschat AA, 2004, OBSTET GYNECOL SURV, V59, P617, DOI 10.1097/01.OGX.0000133943.54530.76; Bassan H, 2000, PEDIATR NEPHROL, V15, P192, DOI 10.1007/s004670000457; Bassan H, 2011, PEDIATR NEUROL, V44, P122, DOI 10.1016/j.pediatrneurol.2010.09.012; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Berman J I, 2011, AJNR Am J Neuroradiol, V32, pE21, DOI 10.3174/ajnr.A1975; D'Arceuil H, 2008, DEV NEUROSCI-BASEL, V30, P262, DOI 10.1159/000110503; Derrick M, 2004, J NEUROSCI, V24, P24, DOI 10.1523/JNEUROSCI.2816-03.2004; Derrick M, 2007, STROKE, V38, P731, DOI 10.1161/01.STR.0000251445.94697.64; Derrick M, 2009, INT J DEV NEUROSCI, V27, P549, DOI 10.1016/j.ijdevneu.2009.06.008; Dieni S, 2003, J NEUROBIOL, V55, P41, DOI 10.1002/neu.10194; Drobyshevsky A, 2007, J CEREBR BLOOD F MET, V27, P270, DOI 10.1038/sj.jcbfm.9600333; Drobyshevsky A, 2006, NEUROIMAGE, V32, P1106, DOI 10.1016/j.neuroimage.2006.06.002; Dubois J, 2008, BRAIN, V131, P2028, DOI 10.1093/brain/awn137; Eixarch E, 2011, PLACENTA, V32, P304, DOI 10.1016/j.placenta.2011.01.014; Eixarch E, 2009, FETAL DIAGN THER, V26, P203, DOI 10.1159/000264063; Eixarch E, 2008, ULTRASOUND OBST GYN, V32, P894, DOI 10.1002/uog.6249; Esteban FJ, 2010, NEUROIMAGE, V53, P1225, DOI 10.1016/j.neuroimage.2010.07.019; Feldman R, 2006, PEDIATRICS, V118, pE869, DOI 10.1542/peds.2005-2040; Figueras F, 2009, PEDIATRICS, V124, pE934, DOI 10.1542/peds.2008-3346; Geva R, 2006, BRAIN RES, V1117, P186, DOI 10.1016/j.brainres.2006.08.004; Geva R, 2006, PEDIATRICS, V118, P91, DOI 10.1542/peds.2005-2343; Huppi PS, 1998, PEDIATR RES, V44, P584; Jiang SZ, 2009, MAGN RESON MED, V62, P645, DOI 10.1002/mrm.22032; Jones DK, 2002, NEUROIMAGE, V17, P592, DOI 10.1006/nimg.2002.1148; Kasprian G, 2008, NEUROIMAGE, V43, P213, DOI 10.1016/j.neuroimage.2008.07.026; Kochunov P, 2010, NEUROBIOLOG IN PRESS; Lee JE, 2009, NEUROIMAGE, V44, P870, DOI 10.1016/j.neuroimage.2008.09.041; Leitner Y, 2007, J CHILD NEUROL, V22, P580, DOI 10.1177/0883073807302605; Lodygensky GA, 2008, PEDIATR RES, V63, P438, DOI 10.1203/PDR.0b013e318165c005; Lodygensky GA, 2008, INT J DEV NEUROSCI, V26, P13, DOI 10.1016/j.ijdevneu.2007.08.018; Mallard C, 2000, NEUROSCIENCE, V100, P327, DOI 10.1016/S0306-4522(00)00271-2; Mallard EC, 1998, PEDIATR RES, V43, P262, DOI 10.1203/00006450-199802000-00018; Mattes D, 2001, PROC SPIE, V4322, P1609, DOI 10.1117/12.431046; McCarton CM, 1996, PEDIATRICS, V98, P1167; Merino JG, 2010, NAT REV NEUROL, V6, P560, DOI 10.1038/nrneurol.2010.129; Miller KL, 2011, NEUROIMAGE, V57, P167, DOI 10.1016/j.neuroimage.2011.03.070; Miller SP, 2007, NEW ENGL J MED, V357, P1928, DOI 10.1056/NEJMoa067393; Mori S, 2006, NEURON, V51, P527, DOI 10.1016/j.neuron.2006.08.012; Neil J, 2002, NMR BIOMED, V15, P543, DOI 10.1002/nbm.784; Neil JJ, 1998, RADIOLOGY, V209, P57, DOI 10.1148/radiology.209.1.9769812; NITSOS I, 1990, INT J DEV NEUROSCI, V8, P233, DOI 10.1016/0736-5748(90)90029-2; Olivier P, 2007, NEUROBIOL DIS, V26, P253, DOI 10.1016/j.nbd.2007.01.001; Padilla N, 2011, BRAIN RES, V1382, P98, DOI 10.1016/j.brainres.2011.01.032; Pallotto EK, 2006, CLIN OBSTET GYNECOL, V49, P257, DOI 10.1097/00003081-200606000-00008; Rees S, 2008, INT J DEV NEUROSCI, V26, P3, DOI 10.1016/j.ijdevneu.2007.08.020; Rees S, 2011, INT J DEV NEUROSCI, V29, P551, DOI 10.1016/j.ijdevneu.2011.04.004; Rivers CS, 2005, CEREBROVASC DIS, V19, P328, DOI 10.1159/000084691; ROYSTON P, 1993, STAT MED, V12, P181, DOI 10.1002/sim.4780120209; Saadani-Makki F, 2009, J CHILD NEUROL, V24, P1179, DOI 10.1177/0883073809338213; Saadani-Makki F, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.090; Sanz-Cortes M, 2010, ULTRASOUND OBST GYN, V36, P159, DOI 10.1002/uog.7724; Scherjon S, 2000, PEDIATRICS, V105, P385, DOI 10.1542/peds.105.2.385; Shedeed SA, 2011, PEDIATR CARDIOL, V32, P47, DOI 10.1007/s00246-010-9813-7; Sizonenko SPV, 2007, CEREB CORTEX, V17, P2609, DOI 10.1093/cercor/bhl168; Snook L, 2007, NEUROIMAGE, V34, P243, DOI 10.1016/j.neuroimage.2006.07.021; Sun SW, 2003, MAGN RESON MED, V50, P743, DOI 10.1002/mrm.10605; Tolcos M, 2011, EXP NEUROL, V232, P53, DOI 10.1016/j.expneurol.2011.08.002; Tolsa CB, 2004, PEDIATR RES, V56, P132, DOI 10.1203/01.PDR.0000128983.54614.7E; Toussaint N., 2007, P MICCAI 07 WORKSH I; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; Tyszka JM, 2006, NEUROIMAGE, V29, P1058, DOI 10.1016/j.neuroimage.2005.08.037; Val-Laillet D, 2008, APPL ANIM BEHAV SCI, V111, P173, DOI 10.1016/j.applanim.2007.06.003; Van Camp N, 2009, NMR BIOMED, V22, P697, DOI 10.1002/nbm.1381; Vercauteren T, 2009, NEUROIMAGE, V45, pS61, DOI 10.1016/j.neuroimage.2008.10.040; Walker DM, 2008, ARCH DIS CHILD-FETAL, V93, pF322, DOI 10.1136/adc.2007.120485; Wang SL, 2008, STROKE, V39, P2348, DOI 10.1161/STROKEAHA.107.509927; Westin CF, 2002, MED IMAGE ANAL, V6, P93, DOI 10.1016/S1361-8415(02)00053-1; WIMBERGER DM, 1995, J COMPUT ASSIST TOMO, V19, P28, DOI 10.1097/00004728-199501000-00005; Zhan L, 2008, 13 ANN M ORG HUM BRA	70	64	65	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31497	10.1371/journal.pone.0031497	http://dx.doi.org/10.1371/journal.pone.0031497			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347486	Green Published, gold, Green Submitted			2022-12-27	WOS:000302730100075
J	Frazier-Wood, AC; Kabagambe, EK; Borecki, IB; Tiwari, HK; Ordovas, JM; Arnett, DK				Frazier-Wood, Alexis C.; Kabagambe, Edmond K.; Borecki, Ingrid B.; Tiwari, Hemant K.; Ordovas, Jose M.; Arnett, Donna K.			Preliminary Evidence for an Association between LRP-1 Genotype and Body Mass Index in Humans	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; CORONARY-ARTERY-DISEASE; LDL RECEPTOR; PLASMA-LIPOPROTEINS; CZECH POPULATION; PROTEIN; POLYMORPHISMS; MODULATION; EXPRESSION; OBESITY	Background/Aims: The LDL receptor-related protein-1 gene (LRP-1) has been associated with obesity in animal models, but no such association has yet been reported in humans. As data suggest this increase in fat mass may be mediated through a mechanism involving the clearance of plasma triglyceride-rich lipoproteins (TGRL), where the LRP interacts with apolipoprotein E (ApoE) on chylomicron remnants, we aimed to examine (1) whether there was an association between 3 single nucleotide polymorphisms (SNPs) on LRP-1 with body mass index (BMI) and (2) whether any association between LRP-1 SNPs and BMI could be modified by polymorphisms on the ApoE gene when comparing the wild type epsilon 3/epsilon 3 genotype against mutant ApoE allele (epsilon 2/epsilon 4) carriers. Methods/Results: We used data from 1,036 men and women (mean age +/- SD = 49 +/- 16 y) participating in the Genetics of Lipid Lowering Drugs and Diet Network (GOLDN) Study. Mixed linear models, which controlled for age, sex, alcohol intake and smoking, as well as family pedigree and center of data collection were calculated. Models that used LRP-1 genotype as a predictor of BMI revealed that individuals who were homozygous for the minor allele at the LRP-1 I10701 locus had BMIs, on average, 1.03 kg/m(2) higher than major allele carriers (P = 0.03). In subsequent mixed linear models that included main effects of LRP-1 I10701 SNP and ApoE alleles, and an interaction term the two genotypes, there was no interaction detected between the LRP-1 I70701 genotype with either the ApoE epsilon 2 or epsilon 4 allele carriers (P>0.05). Conclusions: This has implications for starting to understand pathways from genotype to human BMI, which may operate through TGRL uptake at the LRP-1 receptor. This may pave the way for future research into individualized dietary interventions.	[Frazier-Wood, Alexis C.; Kabagambe, Edmond K.; Arnett, Donna K.] Univ Alabama, Sch Publ Hlth, Dept Epidemiol, Birmingham, AL 35294 USA; [Frazier-Wood, Alexis C.; Tiwari, Hemant K.] Univ Alabama, Sch Publ Hlth, Sect Stat Genet, Birmingham, AL 35294 USA; [Frazier-Wood, Alexis C.] Univ Alabama, Sch Publ Hlth, Off Energet, Birmingham, AL 35294 USA; [Kabagambe, Edmond K.; Arnett, Donna K.] Univ Alabama, Sch Publ Hlth, Nutr Obes Res Ctr, Birmingham, AL 35294 USA; [Borecki, Ingrid B.] Washington Univ, Sch Med, Dept Genet, Div Stat Genom, St Louis, MO 63110 USA; [Ordovas, Jose M.] Tufts Univ, Human Nutr Res Ctr Aging, Jean Mayer US Dept Agr, Nutr & Genom Lab, Boston, MA 02111 USA; [Ordovas, Jose M.] CNIC, Dept Epidemiol & Populat Genet, Madrid, Spain; [Ordovas, Jose M.] IMDEA Food, Madrid, Spain	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Washington University (WUSTL); Tufts University; United States Department of Agriculture (USDA); Centro Nacional de Investigaciones Cardiovasculares (CNIC)	Frazier-Wood, AC (corresponding author), Univ Alabama, Sch Publ Hlth, Dept Epidemiol, Birmingham, AL 35294 USA.	LekkiWood@Gmail.com	Wood, Lekki/B-8053-2010; Ordovas, Jose/B-8727-2013	Wood, Lekki/0000-0001-7616-2119; Ordovas, Jose/0000-0002-7581-5680; Kabagambe, Edmond/0000-0002-8993-3186	National Heart, Lung, and Blood Institute (NHLBI) [U01HL072524]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL072524] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was funded by National Heart, Lung, and Blood Institute (NHLBI) grant number U01HL072524. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benes P, 2002, HUM BIOL, V74, P129, DOI 10.1353/hub.2002.0001; Benes P, 2001, J MOL MED-JMM, V79, P116, DOI 10.1007/s001090100196; DALLONGEVILLE J, 1992, J LIPID RES, V33, P447; DANIEL TO, 1983, J BIOL CHEM, V258, P4606; HERZ J, 1990, J BIOL CHEM, V265, P21355; Hofmann SM, 2007, J CLIN INVEST, V117, P3271, DOI 10.1172/JCI31929; Kabagambe EK, 2009, ATHEROSCLEROSIS, V203, P633, DOI 10.1016/j.atherosclerosis.2008.08.005; KROON PA, 1984, BIOCHEM J, V223, P329, DOI 10.1042/bj2230329; Liu QA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000575; Mamo JCL, 2001, AM J PHYSIOL-ENDOC M, V281, pE626, DOI 10.1152/ajpendo.2001.281.3.E626; Masson O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007422; Peters BJ, 2011, ATHEROSCLEROSIS, V2011, P1879; Pocathikorn A, 2003, ATHEROSCLEROSIS, V168, P115, DOI 10.1016/S0021-9150(03)00087-X; Schreyer SA, 2002, AM J PHYSIOL-ENDOC M, V282, pE207, DOI 10.1152/ajpendo.2002.282.1.E207; Spilke J, 2005, J AGRON CROP SCI, V191, P47, DOI 10.1111/j.1439-037X.2004.00120.x; STEINMETZ A, 1989, ARTERIOSCLEROSIS, V9, P405, DOI 10.1161/01.ATV.9.3.405; Terrand J, 2009, J BIOL CHEM, V284, P381, DOI 10.1074/jbc.M806538200	17	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e30732	10.1371/journal.pone.0030732	http://dx.doi.org/10.1371/journal.pone.0030732			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347399	Green Published, gold, Green Submitted			2022-12-27	WOS:000302730100023
J	Moumne, L; Campbell, K; Howland, D; Ouyang, YB; Bates, GP				Moumne, Lara; Campbell, Ken; Howland, David; Ouyang, Yingbin; Bates, Gillian P.			Genetic Knock-Down of Hdac3 Does Not Modify Disease-Related Phenotypes in a Mouse Model of Huntington's Disease	PLOS ONE			English	Article							NEURONAL INTRANUCLEAR INCLUSIONS; SUBEROYLANILIDE HYDROXAMIC ACID; HISTONE DEACETYLASE 3; MOTOR DEFICITS; MICE; R6/2; HD; AGGREGATION; INHIBITION; EXPRESSION	Huntington's disease (HD) is an autosomal dominant progressive neurodegenerative disorder caused by an expansion of a CAG/polyglutamine repeat for which there are no disease modifying treatments. In recent years, transcriptional dysregulation has emerged as a pathogenic process that appears early in disease progression and has been recapitulated across multiple HD models. Altered histone acetylation has been proposed to underlie this transcriptional dysregulation and histone deacetylase (HDAC) inhibitors, such as suberoylanilide hydroxamic acid (SAHA), have been shown to improve polyglutamine-dependent phenotypes in numerous HD models. However potent pan-HDAC inhibitors such as SAHA display toxic side-effects. To better understand the mechanism underlying this potential therapeutic benefit and to dissociate the beneficial and toxic effects of SAHA, we set out to identify the specific HDAC(s) involved in this process. For this purpose, we are exploring the effect of the genetic reduction of specific HDACs on HD-related phenotypes in the R6/2 mouse model of HD. The study presented here focuses on HDAC3, which, as a class I HDAC, is one of the preferred targets of SAHA and is directly involved in histone deacetylation. To evaluate a potential benefit of Hdac3 genetic reduction in R6/2, we generated a mouse carrying a critical deletion in the Hdac3 gene. We confirmed that the complete knock-out of Hdac3 is embryonic lethal. To test the effects of HDAC3 inhibition, we used Hdac3(+/-) heterozygotes to reduce nuclear HDAC3 levels in R6/2 mice. We found that Hdac3 knock-down does not ameliorate physiological or behavioural phenotypes and has no effect on molecular changes including dysregulated transcripts. We conclude that HDAC3 should not be considered as the major mediator of the beneficial effect induced by SAHA and other HDAC inhibitors in HD.	[Moumne, Lara; Bates, Gillian P.] Kings Coll London, Dept Med & Mol Genet, London WC2R 2LS, England; [Campbell, Ken; Ouyang, Yingbin] Taconic, Cranbury, NJ USA; [Howland, David] CHDI Management CHDI Fdn, Princeton, NJ USA	University of London; King's College London	Moumne, L (corresponding author), Kings Coll London, Dept Med & Mol Genet, London WC2R 2LS, England.	gillian.bates@kcl.ac.uk	Bates, Gillian/E-1146-2012	Bates, Gillian/0000-0002-4041-6305	CHDI Foundation	CHDI Foundation	This work was funded by CHDI Foundation, a privately-funded non-profit biomedical research organization exclusively dedicated to discovering and developing therapeutics that slow the progression of Huntington's disease. DH was involved in the design and generation of the Hdac3 KO mouse. With the exception of this, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avalos JL, 2005, MOL CELL, V17, P855, DOI 10.1016/j.molcel.2005.02.022; Bardai FH, 2011, J NEUROSCI, V31, P1746, DOI 10.1523/JNEUROSCI.5704-10.2011; Bates EA, 2006, J NEUROSCI, V26, P2830, DOI 10.1523/JNEUROSCI.3344-05.2006; BATES G, 2002, HUNTINGTONS DIS; Benn CL, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-17; Benn CL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005747; Bhaskara S, CANC CELL, V18, P436; Bobrowska A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020696; Broide RS, 2007, J MOL NEUROSCI, V31, P47, DOI 10.1007/BF02686117; Carter RJ, 1999, J NEUROSCI, V19, P3248; Cha JHJ, 2007, PROG NEUROBIOL, V83, P228, DOI 10.1016/j.pneurobio.2007.03.004; Codd R, 2009, INT J BIOCHEM CELL B, V41, P736, DOI 10.1016/j.biocel.2008.05.026; Crook ZR, 2011, NEURON, V69, P423, DOI 10.1016/j.neuron.2010.12.035; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Ferrante RJ, 2003, J NEUROSCI, V23, P9418; Fischle W, 2002, MOL CELL, V9, P45, DOI 10.1016/S1097-2765(01)00429-4; Gardian G, 2005, J BIOL CHEM, V280, P556, DOI 10.1074/jbc.M410210200; Guenther MG, 2001, MOL CELL BIOL, V21, P6091, DOI 10.1128/MCB.21.18.6091-6101.2001; Hockly E, 2006, NEUROBIOL DIS, V21, P228, DOI 10.1016/j.nbd.2005.07.007; Hockly E, 2003, P NATL ACAD SCI USA, V100, P2041, DOI 10.1073/pnas.0437870100; Hockly E, 2003, BRAIN RES BULL, V61, P469, DOI 10.1016/S0361-9230(03)00185-0; Ko J, 2001, BRAIN RES BULL, V56, P319, DOI 10.1016/S0361-9230(01)00599-8; Kuhn A, 2007, HUM MOL GENET, V16, P1845, DOI 10.1093/hmg/ddm133; Kuo MH, 1998, BIOESSAYS, V20, P615, DOI 10.1002/(SICI)1521-1878(199808)20:8<615::AID-BIES4>3.0.CO;2-H; Landles C, 2010, J BIOL CHEM, V285, P8808, DOI 10.1074/jbc.M109.075028; Lin CH, 2001, HUM MOL GENET, V10, P137, DOI 10.1093/hmg/10.2.137; Lione LA, 1999, J NEUROSCI, V19, P10428; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; McQuown SC, 2011, J NEUROSCI, V31, P764, DOI 10.1523/JNEUROSCI.5052-10.2011; Mielcarek M, 2011, PLOS ONE IN PRESS; Moffitt H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008025; Montgomery RL, 2008, J CLIN INVEST, V118, P3588, DOI 10.1172/JCI35847; Pallos J, 2008, HUM MOL GENET, V17, P3767, DOI 10.1093/hmg/ddn273; Ryu H, 2003, P NATL ACAD SCI USA, V100, P4281, DOI 10.1073/pnas.0737363100; Sadri-Vakili G, 2007, HUM MOL GENET, V16, P1293, DOI 10.1093/hmg/ddm078; Salisbury CM, 2007, P NATL ACAD SCI USA, V104, P1171, DOI 10.1073/pnas.0608659104; Sathasivam K, 2001, HUM MOL GENET, V10, P2425, DOI 10.1093/hmg/10.21.2425; Sathasivam K, 2010, HUM MOL GENET, V19, P65, DOI 10.1093/hmg/ddp467; Schuettengruber B, 2003, MOL CELL BIOL, V23, P6993, DOI 10.1128/MCB.23.19.6993-7004.2003; Soriano FX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021056; Stack EC, 2005, J COMP NEUROL, V490, P354, DOI 10.1002/cne.20680; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Thomas EA, 2008, P NATL ACAD SCI US; Woodman B, 2007, BRAIN RES BULL, V72, P83, DOI 10.1016/j.brainresbull.2006.11.004; Xu CP, 2009, CHEM BIOL, V16, P980, DOI 10.1016/j.chembiol.2009.07.010; Yang WM, 2002, J BIOL CHEM, V277, P9447, DOI 10.1074/jbc.M105993200; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346	49	46	47	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31080	10.1371/journal.pone.0031080	http://dx.doi.org/10.1371/journal.pone.0031080			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347433	Green Submitted, Green Published, gold			2022-12-27	WOS:000302730100041
J	Ren, LC; Wang, Y; Shi, ML; Wang, XN; Yang, Z; Zhao, ZH				Ren, Licheng; Wang, Yang; Shi, Minglei; Wang, Xiaoning; Yang, Zhong; Zhao, Zhihu			CTCF Mediates the Cell-Type Specific Spatial Organization of the Kcnq5 Locus and the Local Gene Regulation	PLOS ONE			English	Article							CHROMOSOME CONFORMATION; NUCLEAR-ORGANIZATION; HUMAN GENOME; CHROMATIN INTERACTIONS; EXPRESSION; CHANNELS; COHESIN	Chromatin loops play important roles in the dynamic spatial organization of genes in the nucleus. Growing evidence has revealed that the multivalent functional zinc finger protein CCCTC-binding factor (CTCF) is a master regulator of genome spatial organization, and mediates the ubiquitous chromatin loops within the genome. Using circular chromosome conformation capture (4C) methodology, we discovered that CTCF may be a master organizer in mediating the spatial organization of the kcnq5 gene locus. We characterized the cell-type specific spatial organization of the kcnq5 gene locus mediated by CTCF in detail using chromosome conformation capture (3C) and 3C-derived techniques. Cohesion also participated in mediating the organization of this locus. RNAi-mediated knockdown of CTCF sharply diminished the interaction frequencies between the chromatin loops of the kcnq5 gene locus and down-regulated local gene expression. Functional analysis showed that the interacting chromatin loops of the kcnq5 gene locus can repress the gene expression in a luciferase reporter assay. These interacting chromatin fragments were a series of repressing elements whose contacts were mediated by CTCF. Therefore, these findings suggested that the dynamical spatial organization of the kcnq5 locus regulates local gene expression.	[Ren, Licheng; Wang, Xiaoning; Yang, Zhong] E China Univ Sci & Technol, State Key Lab Bioreactor Engn, Shanghai 200237, Peoples R China; [Wang, Yang; Shi, Minglei; Zhao, Zhihu] Beijing Inst Biotechnol, Beijing, Peoples R China; [Wang, Xiaoning; Yang, Zhong] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Wang, Xiaoning; Yang, Zhong] Fudan Univ, Sch Life Sci, Dept Microbiol & Microbial Engn, Shanghai 200433, Peoples R China	East China University of Science & Technology; Fudan University; Fudan University	Ren, LC (corresponding author), Hainan Med Coll, Dept Biol, Haikou, Hainan, Peoples R China.	xnwang88@gmail.com; yangzzh@163.com; zhaozh@nic.bmi.ac.cn	yang, zhong/E-9993-2012		National Natural Science Foundation of China [30871374, 31071119, 31030026]; National Key Basis Research Program of China (973) [2009CB825602]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basis Research Program of China (973)	The project was supported by the National Natural Science Foundation of China (30871374, 31071119, 31030026), National Key Basis Research Program of China (973) (2009CB825602). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Cai ST, 2006, NAT GENET, V38, P1278, DOI 10.1038/ng1913; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Ekberg J, 2007, J BIOL CHEM, V282, P12135, DOI 10.1074/jbc.M609385200; Fraser P, 2007, NATURE, V447, P413, DOI 10.1038/nature05916; Fu YT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000138; Fullwood MJ, 2009, J CELL BIOCHEM, V107, P30, DOI 10.1002/jcb.22116; Giresi PG, 2007, GENOME RES, V17, P877, DOI 10.1101/gr.5533506; Gondor A, 2008, NAT PROTOC, V3, P303, DOI 10.1038/nprot.2007.540; Gondor A, 2009, NATURE, V461, P212, DOI 10.1038/nature08453; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Hogan GJ, 2006, PLOS GENET, V2, P1433, DOI 10.1371/journal.pgen.0020158; Horike S, 2005, NAT GENET, V37, P31, DOI 10.1038/ng1491; Hu H, 2007, J NEUROSCI, V27, P1853, DOI 10.1523/JNEUROSCI.4463-06.2007; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kumaran RI, 2008, CELL, V132, P929, DOI 10.1016/j.cell.2008.03.004; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Majumder P, 2008, J EXP MED, V205, P785, DOI 10.1084/jem.20071843; Majumder P, 2006, J BIOL CHEM, V281, P18435, DOI 10.1074/jbc.M601298200; Nasmyth K, 2009, ANNU REV GENET, V43, P525, DOI 10.1146/annurev-genet-102108-134233; Ohlsson R, 2010, BIOESSAYS, V32, P37, DOI 10.1002/bies.200900118; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Schroeder BC, 2000, J BIOL CHEM, V275, P24089, DOI 10.1074/jbc.M003245200; Simonis M, 2007, NAT METHODS, V4, P895, DOI 10.1038/NMETH1114; Splinter E, 2004, METHOD ENZYMOL, V375, P493; Wallace JA, 2007, CURR OPIN GENET DEV, V17, P400, DOI 10.1016/j.gde.2007.08.005; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Williams A, 2008, J EXP MED, V205, P747, DOI 10.1084/jem.20080066; Xi HL, 2007, PLOS GENET, V3, P1377, DOI 10.1371/journal.pgen.0030136; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891	35	12	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31416	10.1371/journal.pone.0031416	http://dx.doi.org/10.1371/journal.pone.0031416			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347474	Green Published, gold, Green Submitted			2022-12-27	WOS:000302730100069
J	Altorf-van der Kuill, W; Engberink, MF; Vedder, MM; Boer, JMA; Verschuren, WMM; Geleijnse, JM				Altorf-van der Kuill, Wieke; Engberink, Marielle F.; Vedder, Moniek M.; Boer, Jolanda M. A.; Verschuren, W. M. Monique; Geleijnse, Johanna M.			Sources of Dietary Protein in Relation to Blood Pressure in a General Dutch Population	PLOS ONE			English	Article							DISEASE RISK-FACTORS; MEN; HYPERTENSION; WOMEN; CANCER; TRIAL	Background: Little is known about the relation of different dietary protein types with blood pressure (BP). We examined whether intake of total, plant, animal, dairy, meat, and grain protein was related to BP in a cross sectional cohort of 20,820 Dutch adults, aged 20-65 y and not using antihypertensive medication. Design: Mean BP levels were calculated in quintiles of energy-adjusted protein with adjustment for age, sex, BMI, education, smoking, and intake of energy, alcohol, and other nutrients including protein from other sources. In addition, mean BP difference after substitution of 3 en% carbohydrates or MUFA with protein was calculated. Results: Total protein and animal protein were not associated with BP (p(trend)=0.62 and 0.71 respectively), both at the expense of carbohydrates and MUFA. Systolic BP was 1.8 mmHg lower (p(trend)<0.01) in the highest (>36 g/d) than in the lowest (, 27 g/d) quintile of plant protein. This inverse association was present both at the expense of carbohydrates and MUFA and more pronounced in individuals with untreated hypertension (-3.6 mmHg) than in those with normal (+0.1 mmHg) or prehypertensive BP (-0.3 mmHg; p(interaction)<0.01). Meat and grain protein were not related to BP. Dairy protein was directly associated with systolic BP (+1.6 mmHg, p(trend)<0.01), but not with diastolic BP (p(trend)=0.24). Conclusions: Total protein and animal protein were not associated with BP in this general untreated Dutch population. Plant protein may be beneficial to BP, especially in people with elevated BP. However, because high intake of plant protein may be a marker of a healthy diet and lifestyle in general, confirmation from randomized controlled trials is warranted.	[Altorf-van der Kuill, Wieke; Engberink, Marielle F.; Geleijnse, Johanna M.] Top Inst Food & Nutr, Wageningen, Netherlands; [Altorf-van der Kuill, Wieke; Engberink, Marielle F.; Vedder, Moniek M.; Geleijnse, Johanna M.] Wageningen Univ, Div Human Nutr, Wageningen, Netherlands; [Altorf-van der Kuill, Wieke; Vedder, Moniek M.; Boer, Jolanda M. A.; Verschuren, W. M. Monique] Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands	Top Institute Food & Nutrition; Wageningen University & Research; Netherlands National Institute for Public Health & the Environment	Altorf-van der Kuill, W (corresponding author), Top Inst Food & Nutr, Wageningen, Netherlands.	Wieke.Altorf-vanderKuil@wur.nl	Geleijnse, Johanna Marianna M/B-5749-2012	Geleijnse, Johanna Marianna M/0000-0001-7638-0589	Ministry of Health, Welfare and Sport of the Netherlands; National Institute for Public Health and the Environment, Bilthoven, The Netherlands; European Union; Top Institute (TI) Food and Nutrition; Alpro Foundation, Belgium	Ministry of Health, Welfare and Sport of the Netherlands; National Institute for Public Health and the Environment, Bilthoven, The Netherlands(Netherlands Government); European Union(European Commission); Top Institute (TI) Food and Nutrition; Alpro Foundation, Belgium	The Monitoring Project on Risk Factors and Chronic Diseases in the Netherlands (MORGEN) Study was supported by the Ministry of Health, Welfare and Sport of the Netherlands, the National Institute for Public Health and the Environment, Bilthoven, The Netherlands and the Europe Against Cancer Program of the European Union. For the current analysis Wageningen University was supported by Top Institute (TI) Food and Nutrition, which is a public/private partnership that generates vision on scientific breakthroughs in food and nutrition, resulting in the development of innovative products and technologies. Partners are major Dutch Food companies and research organizations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: For the current analysis Wageningen University was supported by Top Institute (TI) Food and Nutrition. Johanna M. Geleijnse received an unrestricted grant from the Alpro Foundation, Belgium for an epidemiological analysis on fruit and vegetable intake in relation to cardiovascular diseases, which bears no relation to the present study. All other authors have no conflict of interest. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Alonso A, 2006, ARCH MED RES, V37, P778, DOI 10.1016/j.arcmed.2006.01.007; Altorf-van der Kuil W, 2010, J HYPERTENS, V28, P2394, DOI 10.1097/HJH.0b013e32833eff63; Altorf-van Der Kuil W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012102; Appel LJ, 2006, HYPERTENSION, V47, P296, DOI 10.1161/01.HYP.0000202568.01167.B6; Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; Appel LJ, 2005, JAMA-J AM MED ASSOC, V294, P2455, DOI 10.1001/jama.294.19.2455; Blokstra A, 2005, MONITORING RISK FACT; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Delbridge EA, 2009, AM J CLIN NUTR, V90, P1203, DOI 10.3945/ajcn.2008.27209; Elliott P, 2006, ARCH INTERN MED, V166, P79, DOI 10.1001/archinte.166.1.79; Halkjaer J, 2009, EUR J CLIN NUTR, V63, pS16, DOI 10.1038/ejcn.2009.73; He J, 2011, CIRCULATION, V124, P589, DOI 10.1161/CIRCULATIONAHA.110.009159; Hochstenbach-Waelen A, 2010, PHYSIOL BEHAV, V101, P237, DOI 10.1016/j.physbeh.2010.05.005; KESTIN M, 1989, AM J CLIN NUTR, V50, P280, DOI 10.1093/ajcn/50.2.280; Masala G, 2008, J HYPERTENS, V26, P2112, DOI 10.1097/HJH.0b013e32830ef75c; Muzio F, 2007, AM J CLIN NUTR, V86, P946, DOI 10.1093/ajcn/86.4.946; NEVO, 1996, DUTCH FOOD COMP TABL; Ocke MC, 1997, INT J EPIDEMIOLOGY, V26; PRESCOTT SL, 1988, CLIN SCI, V74, P665, DOI 10.1042/cs0740665; Savica V, 2010, ANNU REV NUTR, V30, P365, DOI 10.1146/annurev-nutr-010510-103954; Simpson SJ, 2003, APPETITE, V41, P123, DOI 10.1016/S0195-6663(03)00049-7; Stamler J, 1996, CIRCULATION, V94, P1629, DOI 10.1161/01.CIR.94.7.1629; Stamler J, 2002, HYPERTENSION, V39, P1000, DOI 10.1161/01.HYP.0000016178.80811.D9; Stamler J, 2009, CIRCULATION, V120, P221, DOI 10.1161/CIRCULATIONAHA.108.839241; Umesawa M, 2009, AM J CLIN NUTR, V90, P377, DOI 10.3945/ajcn.2008.27109; Wang YF, 2008, J HUM HYPERTENS, V22, P745, DOI 10.1038/jhh.2008.64; Willett WC, 1997, AM J CLIN NUTR, V65, P1220, DOI 10.1093/ajcn/65.4.1220S	28	18	18	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2012	7	2							e30582	10.1371/journal.pone.0030582	http://dx.doi.org/10.1371/journal.pone.0030582			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917MF	22347387	gold, Green Published			2022-12-27	WOS:000302180600011
J	Zwart, SR; Jessup, JM; Ji, JP; Smith, SM				Zwart, Sara R.; Jessup, J. Milburn; Ji, Jiuping; Smith, Scott M.			Saturation Diving Alters Folate Status and Biomarkers of DNA Damage and Repair	PLOS ONE			English	Article							RED-CELL MASS; NUTRITIONAL-STATUS; BODY IRON; BED REST; CANCER; DIVE; HUMANS; NEOCYTOLYSIS; GAMMA-H2AX; DISEASE	Exposure to oxygen-rich environments can lead to oxidative damage, increased body iron stores, and changes in status of some vitamins, including folate. Assessing the type of oxidative damage in these environments and determining its relationships with changes in folate status are important for defining nutrient requirements and designing countermeasures to mitigate these effects. Responses of humans to oxidative stressors were examined in participants undergoing a saturation dive in an environment with increased partial pressure of oxygen, a NASA Extreme Environment Mission Operations mission. Six participants completed a 13-d saturation dive in a habitat 19 m below the ocean surface near Key Largo, FL. Fasting blood samples were collected before, twice during, and twice after the dive and analyzed for biochemical markers of iron status, oxidative damage, and vitamin status. Body iron stores and ferritin increased during the dive (P < 0.001), with a concomitant decrease in RBC folate (P < 0.001) and superoxide dismutase activity (P < 0.001). Folate status was correlated with serum ferritin (Pearson r = -0.34, P < 0.05). Peripheral blood mononuclear cell poly(ADP-ribose) increased during the dive and the increase was significant by the end of the dive (P < 0.001); gamma-H2AX did not change during the mission. Together, the data provide evidence that when body iron stores were elevated in a hyperoxic environment, a DNA damage repair response occurred in peripheral blood mononuclear cells, but double-stranded DNA damage did not. In addition, folate status decreases quickly in this environment, and this study provides evidence that folate requirements may be greater when body iron stores and DNA damage repair responses are elevated.	[Zwart, Sara R.] Univ Space Res Assoc, Houston, TX USA; [Jessup, J. Milburn; Ji, Jiuping] Natl Canc Inst, Bethesda, MD USA; [Smith, Scott M.] NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA	Universities Space Research Association (USRA); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER	Zwart, SR (corresponding author), Univ Space Res Assoc, Houston, TX USA.	sara.zwart-1@nasa.gov			NASA; NATIONAL CANCER INSTITUTE [ZIABC011199] Funding Source: NIH RePORTER	NASA(National Aeronautics & Space Administration (NASA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the NASA Human Research Program Human Health and Countermeasures Element. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfrey CP, 1996, J APPL PHYSIOL, V81, P98, DOI 10.1152/jappl.1996.81.1.98; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Cook JD, 2003, BLOOD, V101, P3359, DOI 10.1182/blood-2002-10-3071; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Djurhuus R, 2006, AVIAT SPACE ENVIR MD, V77, P597; GILMAN SC, 1982, AVIAT SPACE ENVIR MD, V53, P1014; Gliszczynska-Swiglo A, 2006, FOOD CHEM, V96, P131, DOI 10.1016/j.foodchem.2005.02.018; Gliszczynska-Swiglo A, 2007, FOOD CHEM, V101, P1480, DOI 10.1016/j.foodchem.2006.04.022; Gliszczynska-Swiglo A, 2007, J AGR FOOD CHEM, V55, P8237, DOI 10.1021/jf070986x; Henning BF, 2001, GERONTOLOGY, V47, P30, DOI 10.1159/000052767; Ho PI, 2002, J NEUROSCI RES, V70, P694, DOI 10.1002/jnr.10416; Juiping J, 2011, PLOS ONE, V6; Kinders RJ, 2010, CLIN CANCER RES, V16, P5447, DOI 10.1158/1078-0432.CCR-09-3076; Krog J, 2010, AVIAT SPACE ENVIR MD, V81, P467, DOI 10.3357/ASEM.2528.2010; MURRAY RD, 1977, AVIAT SPACE ENVIR MD, V48, P1012; Patro Birija S, 2006, Med Chem, V2, P407, DOI 10.2174/157340606777724059; Redon CE, 2010, CLIN CANCER RES, V16, P4532, DOI 10.1158/1078-0432.CCR-10-0523; Rice L, 2005, CELL PHYSIOL BIOCHEM, V15, P245, DOI 10.1159/000087234; Rice L, 2001, ANN INTERN MED, V134, P652, DOI 10.7326/0003-4819-134-8-200104170-00010; Smith SM, 2006, J NUTR, V136, P2534, DOI 10.1093/jn/136.10.2534; Smith SM, 2005, J NUTR, V135, P437, DOI 10.1093/jn/135.3.437; Smith SM, 2004, J NUTR, V134, P1765, DOI 10.1093/jn/134.7.1765; Solier S, 2009, CELL CYCLE, V8, P1853, DOI 10.4161/cc.8.12.8865; STEVENS RG, 1994, INT J CANCER, V56, P364, DOI 10.1002/ijc.2910560312; Suh JR, 2000, J BIOL CHEM, V275, P35646, DOI 10.1074/jbc.M005864200; Tang DL, 2011, ANTIOXID REDOX SIGN, V14, P1315, DOI 10.1089/ars.2010.3356; Toyokuni S, 2009, CANCER SCI, V100, P9, DOI 10.1111/j.1349-7006.2008.01001.x; Zacharski LR, 2008, JNCI-J NATL CANCER I, V100, P996, DOI 10.1093/jnci/djn209; Zwart SR, 2009, J APPL PHYSIOL, V107, P54, DOI 10.1152/japplphysiol.91136.2008; Zwart SR, 2009, AVIAT SPACE ENVIR MD, V80, pA15, DOI 10.3357/ASEM.BR07.2009; Zwart SR, 2009, J NUTR, V139, P90, DOI 10.3945/jn.108.097592	31	15	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2012	7	2							e31058	10.1371/journal.pone.0031058	http://dx.doi.org/10.1371/journal.pone.0031058			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917MF	22347427	Green Published, Green Submitted, gold			2022-12-27	WOS:000302180600027
J	Ferrari, MCO; Manassa, RP; Dixson, DL; Munday, PL; McCormick, MI; Meekan, MG; Sih, A; Chivers, DP				Ferrari, Maud C. O.; Manassa, Rachel P.; Dixson, Danielle L.; Munday, Philip L.; McCormick, Mark I.; Meekan, Mark G.; Sih, Andrew; Chivers, Douglas P.			Effects of Ocean Acidification on Learning in Coral Reef Fishes	PLOS ONE			English	Article							CLIMATE-CHANGE; CARBONIC-ACID; PREDATOR; PREY; DISSOCIATION; ADAPTATION; MORTALITY; CONSTANTS; SEAWATER; ANIMALS	Ocean acidification has the potential to cause dramatic changes in marine ecosystems. Larval damselfish exposed to concentrations of CO2 predicted to occur in the mid- to late-century show maladaptive responses to predator cues. However, there is considerable variation both within and between species in CO2 effects, whereby some individuals are unaffected at particular CO2 concentrations while others show maladaptive responses to predator odour. Our goal was to test whether learning via chemical or visual information would be impaired by ocean acidification and ultimately, whether learning can mitigate the effects of ocean acidification by restoring the appropriate responses of prey to predators. Using two highly efficient and widespread mechanisms for predator learning, we compared the behaviour of pre-settlement damselfish Pomacentrus amboinensis that were exposed to 440 mu atm CO2 (current day levels) or 850 mu atm CO2, a concentration predicted to occur in the ocean before the end of this century. We found that, regardless of the method of learning, damselfish exposed to elevated CO2 failed to learn to respond appropriately to a common predator, the dottyback, Pseudochromis fuscus. To determine whether the lack of response was due to a failure in learning or rather a short-term shift in trade-offs preventing the fish from displaying overt antipredator responses, we conditioned 440 or 700 mu atm-CO2 fish to learn to recognize a dottyback as a predator using injured conspecific cues, as in Experiment 1. When tested one day post-conditioning, CO2 exposed fish failed to respond to predator odour. When tested 5 days post-conditioning, CO2 exposed fish still failed to show an antipredator response to the dottyback odour, despite the fact that both control and CO2-treated fish responded to a general risk cue (injured conspecific cues). These results indicate that exposure to CO2 may alter the cognitive ability of juvenile fish and render learning ineffective.	[Ferrari, Maud C. O.; Sih, Andrew] Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA; [Manassa, Rachel P.; Dixson, Danielle L.; Munday, Philip L.; McCormick, Mark I.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Manassa, Rachel P.; Dixson, Danielle L.; Munday, Philip L.; McCormick, Mark I.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Meekan, Mark G.] Australian Inst Marine Sci, UWA Ocean Sci Ctr MO96, Crawley, WA, Australia; [Chivers, Douglas P.] Univ Saskatchewan, Dept Biol, Saskatoon, SK S7N 0W0, Canada	University of California System; University of California Davis; James Cook University; James Cook University; Australian Institute of Marine Science; University of Western Australia; University of Saskatchewan	Ferrari, MCO (corresponding author), Univ Saskatchewan, Western Coll Vet Med, Dept Biomed Sci, Saskatoon, SK S7N 0W0, Canada.	maud.ferrari@usask.ca	Manassa, Rachel/E-1232-2013; Dixson, Danielle L/B-9253-2018; Sih, Andrew/P-7985-2015; Munday, Philip L/F-5443-2011; McCormick, Mark I/J-8301-2014	Dixson, Danielle L/0000-0003-1493-1482; Sih, Andrew/0000-0001-6161-1663; Munday, Philip L/0000-0001-9725-2498; McCormick, Mark I/0000-0001-9289-1645; Meekan, Mark/0000-0002-3067-9427; Chivers, Douglas/0000-0002-9497-4329	Natural Sciences and Engineering Council of Canada; Australian Research Council; ARC Centre of Excellence for Coral Reef Studies; Australian Institute of Marine Science	Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Australian Research Council(Australian Research Council); ARC Centre of Excellence for Coral Reef Studies(Australian Research Council); Australian Institute of Marine Science	This work was supported by funding to MCOF and DPC from the Natural Sciences and Engineering Council of Canada, to MIM, PLM, MCOF, and DPC from the Australian Research Council and the ARC Centre of Excellence for Coral Reef Studies, and to MGM from the Australian Institute of Marine Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almany GR, 2006, CORAL REEFS, V25, P19, DOI 10.1007/s00338-005-0044-y; Beck B. B., 1994, P265; Brown GE, 1996, ETHOLOGY, V102, P776; Brown Grant E., 2005, P34; Chivers DP, 1998, ECOSCIENCE, V5, P338, DOI 10.1080/11956860.1998.11682471; CRIPPS IL, PLOS ONE IN PRESS; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Dixson DL, 2010, ECOL LETT, V13, P68, DOI 10.1111/j.1461-0248.2009.01400.x; DOHERTY PJ, 1987, B MAR SCI, V41, P423; Domenici P, BIOL LETT IN PRESS; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; DUGATKIN LA, 1992, AM NAT, V139, P1384, DOI 10.1086/285392; Fabry VJ, 2008, ICES J MAR SCI, V65, P414, DOI 10.1093/icesjms/fsn048; Ferrari MCO, 2011, ECOL LETT, V14, P1143, DOI 10.1111/j.1461-0248.2011.01683.x; Ferrari MCO, 2011, GLOBAL CHANGE BIOL, V17, P2980, DOI 10.1111/j.1365-2486.2011.02439.x; Ferrari MCO, 2010, CAN J ZOOL, V88, P698, DOI 10.1139/Z10-029; Ferrari MCO, FUNCTIONAL IN PRESS; Galef BG, 2001, ANIM BEHAV, V61, P3, DOI 10.1006/anbe.2000.1557; Gattuso J.P., 2010, GUIDE BEST PRACTICES; Grieco F, 2002, SCIENCE, V296, P136, DOI 10.1126/science.1068287; Griffin AS, 2000, CONSERV BIOL, V14, P1317, DOI 10.1046/j.1523-1739.2000.99326.x; Griffin AS, 2004, LEARN BEHAV, V32, P131; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Holmes TH, 2010, MAR ECOL PROG SER, V399, P273, DOI 10.3354/meps08337; Holmes TH, 2009, OECOLOGIA, V159, P401, DOI 10.1007/s00442-008-1220-x; Ishimatsu A, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002564; Ishimatsu A, 2008, MAR ECOL PROG SER, V373, P295, DOI 10.3354/meps07823; KLEIMAN DG, 1989, BIOSCIENCE, V39, P152, DOI 10.2307/1311025; Kleypas J., 2006, IMPACTS OCEAN ACIDIF; Kroeker KJ, ECOLOGY LET IN PRESS; Leis JM, 2007, MAR ECOL PROG SER, V347, P185, DOI 10.3354/meps06977; McCormick MI, 2006, J FISH BIOL, V68, P969, DOI 10.1111/j.1095-8649.2006.00982.x; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; MEEKAN MG, 1993, MAR ECOL PROG SER, V93, P217, DOI 10.3354/meps093217; Meekan MG, 2001, MAR BIOL, V139, P373; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; Melzner F, 2009, BIOGEOSCIENCES, V6, P2313, DOI 10.5194/bg-6-2313-2009; Mitchell MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015764; Munday PL, 2008, FISH FISH, V9, P261, DOI 10.1111/j.1467-2979.2008.00281.x; Munday PL, 2010, P NATL ACAD SCI USA, V107, P12930, DOI 10.1073/pnas.1004519107; Munday PL, 2009, P NATL ACAD SCI USA, V106, P1848, DOI 10.1073/pnas.0809996106; Nilsson GE, 2012, NATURE CLIMATE CHANG; Ohde S, 1999, B MAR SCI, V65, P559; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Panchuk K, 2008, GEOLOGY, V36, P315, DOI 10.1130/G24474A.1; Royal Society, 2005, OC AC DUE INCR ATM C; Shamberger KEF, 2011, MAR CHEM, V127, P64, DOI 10.1016/j.marchem.2011.08.003; Shettleworth SJ, 2001, ANIM BEHAV, V61, P277, DOI 10.1006/anbe.2000.1606; SIH A, EVOLUTIONAR IN PRESS; Sih A, INTEGRATIVE IN PRESS; SIMPSON S, BIOL LETT IN PRESS; Sokal RR, 1995, BIOMETRY; Visser ME, 2008, P ROY SOC B-BIOL SCI, V275, P649, DOI 10.1098/rspb.2007.0997; Zachos JC, 2005, SCIENCE, V308, P1611, DOI 10.1126/science.1109004	54	100	103	2	131	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2012	7	2							e31478	10.1371/journal.pone.0031478	http://dx.doi.org/10.1371/journal.pone.0031478			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LV	22328936	Green Accepted, gold, Green Submitted, Green Published			2022-12-27	WOS:000302179300022
J	Kao, CL; Chan, TC; Tsai, CH; Chu, KY; Chuang, SF; Lee, CC; Li, ZRT; Wu, KW; Chang, LY; Shen, YH; Huang, LM; Lee, PI; Yang, CL; Compans, R; Rouse, BT; King, CC				Kao, Chuan-Liang; Chan, Ta-Chien; Tsai, Chu-Han; Chu, Kuan-Ying; Chuang, Shu-Fang; Lee, Chang-Chun; Li, Zheng-Rong Tiger; Wu, Ko-Wen; Chang, Luan-Yin; Shen, Yea-Huei; Huang, Li-Min; Lee, Ping-Ing; Yang, ChingLai; Compans, Richard; Rouse, Barry T.; King, Chwan-Chuen			Emerged HA and NA Mutants of the Pandemic Influenza H1N1 Viruses with Increasing Epidemiological Significance in Taipei and Kaohsiung, Taiwan, 2009-10	PLOS ONE			English	Article							SWINE-ORIGIN 2009; VIRAL LOAD; ANTIGENIC SITES; A VIRUSES; HONG-KONG; HEMAGGLUTININ; EVOLUTION; REPLICATION; INFECTION; A(H1N1)	The 2009 influenza pandemic provided an opportunity to observe dynamic changes of the hemagglutinin (HA) and neuraminidase (NA) of pH1N1 strains that spread in two metropolitan areas - Taipei and Kaohsiung. We observed cumulative increases of amino acid substitutions of both HA and NA that were higher in the post-peak than in the pre-peak period of the epidemic. About 14.94% and 3.44% of 174 isolates had one and two amino acids changes, respective, in the four antigenic sites. One unique adaptive mutation of HA2 (E374K) was first detected three weeks before the epidemic peak. This mutation evolved through the epidemic, and finally emerged as the major circulated strain, with significantly higher frequency in the post-peak period than in the pre-peak (64.65% vs 9.28%, p<0.0001). E374K persisted until ten months post-nationwide vaccination without further antigenic changes (e. g. prior to the highest selective pressure). In public health measures, the epidemic peaked at seven weeks after oseltamivir treatment was initiated. The emerging E374K mutants spread before the first peak of school class suspension, extended their survival in high-density population areas before vaccination, dominated in the second wave of class suspension, and were fixed as herd immunity developed. The tempospatial spreading of E374K mutants was more concentrated during the post-peak (p = 0.000004) in seven districts with higher spatial clusters (p<0.001). This is the first study examining viral changes during the naive phase of a pandemic of influenza through integrated virological/serological/clinical surveillance, tempo-spatial analysis, and intervention policies. The vaccination increased the percentage of E374K mutants (22.86% vs 72.34%, p<0.001) and significantly elevated the frequency of mutations in Sa antigenic site (2.36% vs 23.40%, p<0.001). Future pre-vaccination public health efforts should monitor amino acids of HA and NA of pandemic influenza viruses isolated at exponential and peak phases in areas with high cluster cases.	[Kao, Chuan-Liang; Chan, Ta-Chien; Chu, Kuan-Ying; Chuang, Shu-Fang; Lee, Chang-Chun; Li, Zheng-Rong Tiger; King, Chwan-Chuen] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Kao, Chuan-Liang; Tsai, Chu-Han; Chuang, Shu-Fang] Natl Taiwan Univ, Coll Med, Dept Clin Lab Sci & Med Biotechnol, Taipei 10764, Taiwan; [Kao, Chuan-Liang] NTU Hosp, Dept Lab Med, Taipei, Taiwan; [Chang, Luan-Yin; Huang, Li-Min; Lee, Ping-Ing] NTU Hosp, Dept Pediat, Taipei, Taiwan; [Wu, Ko-Wen] Natl Yang Ming Univ, Sch Life Sci, Inst Biomed Informat, Taipei 112, Taiwan; [Shen, Yea-Huei] Yuans Gen Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Yang, ChingLai; Compans, Richard] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Yang, ChingLai; Compans, Richard] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA USA; [Rouse, Barry T.] Univ Tennessee, Coll Vet Med, Dept Pathobiol, Knoxville, TN 37901 USA	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Yang Ming Chiao Tung University; Emory University; Emory University; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture	Kao, CL (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan.	chwanchuen@gmail.com	Yang, Chinglai/D-1409-2014; Compans, Richard W/I-4087-2013	Yang, Chinglai/0000-0002-9308-7760; Compans, Richard W/0000-0003-2360-335X; King, Chwan-Chuen/0000-0002-6078-2601; HUANG, LI-MIN/0000-0002-9291-260X; KAO, CHUAN-LIANG/0000-0002-1020-2605; CHANG, LUAN-YIN/0000-0003-2632-1956; LEE, PING-ING/0000-0002-7299-2825	Taiwan's National Science Council [98-2321-B-002-016]; National Institutes of Health (NIH) in the United States [2U19AI05726606, HHSN266200700006C]	Taiwan's National Science Council; National Institutes of Health (NIH) in the United States(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by three grants: NSC #98-2321-B-002-016 from Taiwan's National Science Council, and financial support from the National Institutes of Health in the United States (NIH grant #2U19AI05726606 and NIH grant #HHSN266200700006C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2004, J VIROL, V78, P9605, DOI 10.1128/JVI.78.18.9605-9611.2004; [Anonymous], 2010, Wkly Epidemiol Rec, V85, P21; Ansart S, 2009, INFLUENZA OTHER RESP, V3, P99, DOI 10.1111/j.1750-2659.2009.00080.x; ARCHETTI I, 1950, J EXP MED, V92, P441, DOI 10.1084/jem.92.5.441; Balcan D, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-45; Barr IG, 2010, EURO SURVEILL, V15; Blackburne BP, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000058; Boni MF, 2008, VACCINE, V26, pC8, DOI 10.1016/j.vaccine.2008.04.011; Boni MF, 2006, P ROY SOC B-BIOL SCI, V273, P1307, DOI 10.1098/rspb.2006.3466; Bradley KC, 2011, VIROLOGY, V413, P169, DOI 10.1016/j.virol.2011.01.027; Brookes SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009068; Chan MCW, 2010, AM J PATHOL, V176, P1828, DOI 10.2353/ajpath.2010.091087; Chan PKS, 2011, J CLIN VIROL, V50, P320, DOI 10.1016/j.jcv.2011.01.013; Chen HL, 2010, J INFECT DIS, V201, P1517, DOI 10.1086/652661; Cherry Joshua L, 2009, PLoS Curr, V1, pRRN1001; Chi CY, 2010, CLIN VACCINE IMMUNOL, V17, P1958, DOI 10.1128/CVI.00212-10; COLMAN PM, 1983, NATURE, V303, P41, DOI 10.1038/303041a0; Das SR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001211; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; de Wit E, 2010, J VIROL, V84, P1597, DOI 10.1128/JVI.01783-09; DRAKE JW, 1993, P NATL ACAD SCI USA, V90, P4171, DOI 10.1073/pnas.90.9.4171; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Ertek M, 2010, JPN J INFECT DIS, V63, P239; Ferguson NM, 2003, NATURE, V422, P428, DOI 10.1038/nature01509; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Ghedin E, 2011, J INFECT DIS, V203, P168, DOI 10.1093/infdis/jiq040; Ginsberg M., 2009, Morbidity and Mortality Weekly Report, V58, P400; Glinsky GV, 2010, CELL CYCLE, V9, P958, DOI 10.4161/cc.9.5.10913; Graham M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016087; Ho TS, 2010, PEDIATR NEONATOL, V51, P83, DOI 10.1016/S1875-9572(10)60016-2; Hoper D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019075; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Hsueh PR, 2010, EMERG INFECT DIS, V16, P1309, DOI 10.3201/eid1608.100310; Huang JW, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S41; Huang WT, 2010, EUROSURVEILLANCE, V15, P2; Hughes MT, 2001, J VIROL, V75, P3766, DOI 10.1128/JVI.75.8.3766-3770.2001; Igarashi M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008553; Ikonen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013329; Jayaraman A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017616; Kilander A, 2010, EURO SURVEILL, V15; Kobasa D, 2001, J VIROL, V75, P11773, DOI 10.1128/JVI.75.23.11773-11780.2001; Kuroda M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010256; Langley WA, 2009, VIROLOGY, V394, P321, DOI 10.1016/j.virol.2009.08.031; Lee CW, 2004, J VIROL, V78, P8372, DOI [10.1128/JVI.78.15.8372-8381.2004, 10.1128/jvi.78.15.8372-8381.2004]; Lee SS, 2011, J INFECTION, V63, P274, DOI 10.1016/j.jinf.2011.03.011; Lee VJ, 2010, J INFECT DIS, V202, P1319, DOI 10.1086/656480; Li IW, 2010, CHEST, V137, P759, DOI 10.1378/chest.09-3072; Malato L, 2011, EURO SURVEILL, V16; Maurer-Stroh Sebastian, 2010, PLoS Curr, V2, pRRN1162; Mehle A, 2009, P NATL ACAD SCI USA, V106, P21312, DOI 10.1073/pnas.0911915106; Melidou A, 2010, VIRUS RES, V151, P192, DOI 10.1016/j.virusres.2010.05.005; Miller MA, 2009, NEW ENGL J MED, V360, P2595, DOI 10.1056/NEJMp0903906; Mitchell T, 2011, CLIN INFECT DIS, V52, pS138, DOI 10.1093/cid/ciq056; Morlighem JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018956; Muller V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000454; Nelson M., 2009, PLOS CURR, V1, DOI [DOI 10.1371/CURRENTS.RRN1126, 10.1371/currents.RRN1126]; Nelson MI, 2007, NAT REV GENET, V8, P196, DOI 10.1038/nrg2053; Nunes B, 2008, J MOL EVOL, V67, P427, DOI 10.1007/s00239-008-9154-9; ORTIN J, 1980, GENE, V11, P319, DOI 10.1016/0378-1119(80)90072-4; Ozawa M, 2011, J VIROL, V85, P4596, DOI 10.1128/JVI.00029-11; Pan CE, 2010, PLOS ONE, V5, pA31, DOI 10.1371/journal.pone.0009549; Poon LLM, 2011, J CLIN VIROL, V52, P146, DOI 10.1016/j.jcv.2011.06.022; Potter CW, 2001, J APPL MICROBIOL, V91, P572, DOI 10.1046/j.1365-2672.2001.01492.x; Puzelli S, 2010, EMERG INFECT DIS, V16, P863, DOI [10.3201/eid1605.091858, 10.3201/eid1605.091815]; Rabadan R, 2007, EVOL BIOINFORM, V3, P299; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; Shih ACC, 2007, P NATL ACAD SCI USA, V104, P6283, DOI 10.1073/pnas.0701396104; Skountzou I, 2010, J IMMUNOL, V185, P1642, DOI 10.4049/jimmunol.1000091; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Steinhauer DA, 2002, ANNU REV GENET, V36, P305, DOI 10.1146/annurev.genet.36.052402.152757; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; To KKW, 2010, CLIN INFECT DIS, V50, P850, DOI 10.1086/650581; To KKW, 2010, J MED VIROL, V82, P1, DOI 10.1002/jmv.21664; Tsai KN, 2011, MICROBES INFECT, V13, P479, DOI 10.1016/j.micinf.2011.01.013; van der Vries E, 2010, NEW ENGL J MED, V363, P1381, DOI 10.1056/NEJMc1003749; Wang CC, 2009, P NATL ACAD SCI USA, V106, P18137, DOI 10.1073/pnas.0909696106; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Wen TH, 2010, INT J INFECT DIS, V14, pE334, DOI 10.1016/j.ijid.2009.06.006; WILSON IA, 1990, ANNU REV IMMUNOL, V8, P737, DOI 10.1146/annurev.iy.08.040190.003513; World Health Organization, 2009, PAND H1N1 2009 BRIEF; Xu LL, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-325; Yang H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008905; Ye JQ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001145; Zambon MC, 2001, REV MED VIROL, V11, P227, DOI 10.1002/rmv.319; Zepeda HM, 2010, J CLIN VIROL, V48, P36, DOI 10.1016/j.jcv.2010.02.008	85	26	26	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2012	7	2							e31162	10.1371/journal.pone.0031162	http://dx.doi.org/10.1371/journal.pone.0031162			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LV	22328930	Green Submitted, Green Published, gold			2022-12-27	WOS:000302179300016
J	Perez, C; Martinez-Calle, N; Martin-Subero, JI; Segura, V; Delabesse, E; Fernandez-Mercado, M; Garate, L; Alvarez, S; Rifon, J; Varea, S; Boultwood, J; Wainscoat, JS; Cigudosa, JC; Calasanz, MJ; Cross, NCP; Prosper, F; Agirre, X				Perez, Cristina; Martinez-Calle, Nicolas; Ignacio Martin-Subero, Jose; Segura, Victor; Delabesse, Eric; Fernandez-Mercado, Marta; Garate, Leire; Alvarez, Sara; Rifon, Jose; Varea, Sara; Boultwood, Jacqueline; Wainscoat, James S.; Cruz Cigudosa, Juan; Jose Calasanz, Maria; Cross, Nicholas C. P.; Prosper, Felipe; Agirre, Xabier			TET2 Mutations Are Associated with Specific 5-Methylcytosine and 5-Hydroxymethylcytosine Profiles in Patients with Chronic Myelomonocytic Leukemia	PLOS ONE			English	Article							CHRONIC MYELOPROLIFERATIVE DISORDERS; WORLD-HEALTH-ORGANIZATION; ACUTE MYELOID-LEUKEMIA; CELL SELF-RENEWAL; DNA METHYLATION; MYELODYSPLASTIC SYNDROMES; MICROARRAY DATA; GENE; REVEALS; HYPERMETHYLATION	Chronic myelomonocytic leukemia (CMML) has recently been associated with a high incidence of diverse mutations in genes such as TET2 or EZH2 that are implicated in epigenetic mechanisms. We have performed genome-wide DNA methylation arrays and mutational analysis of TET2, IDH1, IDH2, EZH2 and JAK2 in a group of 24 patients with CMML. 249 genes were differentially methylated between CMML patients and controls. Using Ingenuity pathway analysis, we identified enrichment in a gene network centered around PLC, JNK and ERK suggesting that these pathways, whose deregulation has beenrecently described in CMML, are affected by epigenetic mechanisms. Mutations of TET2, JAK2 and EZH2 were found in 15 patients (65%), 4 patients (17%) and 1 patient (4%) respectively while no mutations in the IDH1 and IDH2 genes were identified. Interestingly, patients with wild type TET2 clustered separately from patients with TET2 mutations, showed a higher degree of hypermethylation and were associated with higher risk karyotypes. Our results demonstrate the presence of aberrant DNA methylation in CMML and identifies TET2 mutant CMML as a biologically distinct disease subtype with a different epigenetic profile.	[Perez, Cristina; Martinez-Calle, Nicolas; Garate, Leire; Prosper, Felipe; Agirre, Xabier] Univ Navarra, Lab Myeloproliferat Syndromes, Oncol Area, E-31080 Pamplona, Spain; [Ignacio Martin-Subero, Jose] Univ Barcelona, Dept Anat Pathol Pharmacol & Microbiol, Barcelona, Spain; [Segura, Victor] Univ Navarra, Dept Bioinformat, Fdn Appl Med Res, E-31080 Pamplona, Spain; [Delabesse, Eric] Univ Toulouse 3, CHU Toulouse, Hematol Lab, Hop Purpan,Inserm U1037, F-31062 Toulouse, France; [Fernandez-Mercado, Marta; Boultwood, Jacqueline; Wainscoat, James S.] John Radcliffe Hosp, LLR Mol Haematol Unit, NDCLS, Oxford OX3 9DU, England; [Alvarez, Sara; Cruz Cigudosa, Juan] CNIO, Mol Cytogenet Grp, Madrid, Spain; [Rifon, Jose; Varea, Sara; Prosper, Felipe] Univ Navarra, Hematol Serv, E-31080 Pamplona, Spain; [Rifon, Jose; Varea, Sara; Prosper, Felipe] Univ Navarra, Area Cell Therapy, Univ Navarra Clin, E-31080 Pamplona, Spain; [Jose Calasanz, Maria] Univ Navarra, Dept Genet, E-31080 Pamplona, Spain; [Cross, Nicholas C. P.] Wessex Reg Genet Lab, Salisbury, Wilts, England; [Cross, Nicholas C. P.] Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England	University of Navarra; University of Barcelona; University of Navarra; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Oxford; Centro Nacional de Investigaciones Oncologicas (CNIO); University of Navarra; University of Navarra; University of Navarra; University of Southampton	Perez, C (corresponding author), Univ Navarra, Lab Myeloproliferat Syndromes, Oncol Area, E-31080 Pamplona, Spain.	fprosper@unav.es; xaguirre@unav.es	DELABESSE, Eric/I-5221-2016; Agirre, Xabier/ABE-4110-2020; Segura, Victor/E-4531-2010; Calasanz, MJ/R-5813-2016; Cross, Nicholas/B-4817-2009; Martinez-Calle, Nicolas/ABE-4394-2020; Prosper, Felipe/H-6859-2017	DELABESSE, Eric/0000-0002-0928-0753; Segura, Victor/0000-0002-7740-6290; Calasanz, MJ/0000-0002-0374-3008; Cross, Nicholas/0000-0001-5481-2555; Martinez-Calle, Nicolas/0000-0002-5184-9464; Prosper, Felipe/0000-0001-6115-8790; Martin-Subero, Jose Ignacio/0000-0001-8809-5195; Fernandez-Mercado, Marta/0000-0003-3458-9231; Boultwood, Jacqueline/0000-0002-4330-2928	Ministerio de Ciencia e Innovacion; Instituto de Salud Carlos III (ISCIII) [PI10/01691, PI10/02983, PI08/0440, SAF2009-08663, RTICC RD06/0020]; Contrato Miguel Servet [CP07/00215]; European FEDER funds Interreg IVA (CITTIL); Leukemia and Lymphoma Research UK; Programa Tu Eliges; Tu Decides (CAN); Gobierno de Navarra; Departamento de Salud; UTE	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIEuropean Commission); Contrato Miguel Servet; European FEDER funds Interreg IVA (CITTIL); Leukemia and Lymphoma Research UK(Leukemia and Lymphoma Society); Programa Tu Eliges; Tu Decides (CAN); Gobierno de Navarra; Departamento de Salud; UTE	This work have been supported in part by grants from Ministerio de Ciencia e Innovacion and Instituto de Salud Carlos III (ISCIII) PI10/01691, PI10/02983, PI08/0440, SAF2009-08663 and RTICC RD06/0020, Contrato Miguel Servet CP07/00215, European FEDER funds Interreg IVA (CITTIL), Leukemia and Lymphoma Research UK, Programa Tu Eliges, Tu Decides (CAN), Gobierno de Navarra, Departamento de Salud, Beca Ortiz de Landazuri 2009 (6/2009) and funds from the "UTE project CIMA''. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bibikova M, 2009, EPIGENOMICS-UK, V1, P177, DOI [10.2217/epi.09.14, 10.2217/EPI.09.14]; Cheadle C, 2003, J MOL DIAGN, V5, P73, DOI 10.1016/S1525-1578(10)60455-2; Costa R, 2011, CANCER; Draghici S, 2006, TRENDS GENET, V22, P101, DOI 10.1016/j.tig.2005.12.005; Elliot MA, 2006, BEST PRACT RES CL HA, V19, P571, DOI 10.1016/j.beha.2005.07.012; Ernst T, 2010, NAT GENET, V42, P722, DOI 10.1038/ng.621; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Gelsi-Boyer V, 2009, BRIT J HAEMATOL, V145, P788, DOI 10.1111/j.1365-2141.2009.07697.x; Gentleman RC, 2005, STAT BIOL HLTH; Grossmann V, 2011, LEUKEMIA, V25, P877, DOI 10.1038/leu.2011.10; Harris NL, 1999, J CLIN ONCOL, V17, P3835, DOI 10.1200/JCO.1999.17.12.3835; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jankowska AM, 2011, BLOOD           0809; Jiang Y, 2009, BLOOD, V113, P1315, DOI 10.1182/blood-2008-06-163246; Jones AV, 2005, BLOOD, V106, P2162, DOI 10.1182/blood-2005-03-1320; Kantarjian H, 2007, BLOOD, V109, P52, DOI 10.1182/blood-2006-05-021162; Kantarjian HM, 2010, BLOOD, V116, P3163, DOI 10.1182/blood-2010-03-274753; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Kohlmann A, 2010, J CLIN ONCOL, V28, P3858, DOI 10.1200/JCO.2009.27.1361; Kosmider O, 2009, BLOOD, V114, P3285, DOI 10.1182/blood-2009-04-215814; Lagadinou ED, 2008, LEUKEMIA, V22, P1899, DOI 10.1038/leu.2008.192; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Levine RL, 2005, BLOOD, V106, P3377, DOI 10.1182/blood-2005-05-1898; Li Z, 2011, BLOOD           0729; Lin P, 2006, AM J CLIN PATHOL, V126, P530, DOI 10.1309/JT5BE2L1FGG8P8Y6; Martin-Subero JI, 2009, BLOOD, V113, P2488, DOI 10.1182/blood-2008-04-152900; Milani L, 2010, BLOOD, V115, P1214, DOI 10.1182/blood-2009-04-214668; Moran-Crusio K, 2011, CANCER CELL, V20, P11, DOI 10.1016/j.ccr.2011.06.001; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Oki Y, 2008, BLOOD, V111, P2382, DOI 10.1182/blood-2007-07-103960; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Puissant A, 2010, CANCER RES, V70, P1042, DOI 10.1158/0008-5472.CAN-09-3537; Quivoron C, 2011, CANCER CELL, V20, P25, DOI 10.1016/j.ccr.2011.06.003; Shannon K, 2005, CANCER CELL, V7, P291, DOI 10.1016/j.ccr.2005.04.002; Smith AE, 2010, BLOOD, V116, P3923, DOI 10.1182/blood-2010-03-274704; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; STEPHENSON J, 1993, LEUKEMIA RES, V17, P291, DOI 10.1016/0145-2126(93)90014-C; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Such E, 2010, HAEMATOLOGICA, V96, P375; Tessema M, 2003, LEUKEMIA, V17, P910, DOI 10.1038/sj.leu.2402891; Thol F, 2010, HAEMATOL-HEMATOL J, V95, P1668, DOI 10.3324/haematol.2010.025494; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; Vilas-Zornoza A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017012; Voso MT, 2009, CLIN CANCER RES, V15, P5002, DOI 10.1158/1078-0432.CCR-09-0494; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Xiao WB, 2010, BLOOD, V116, P6003, DOI 10.1182/blood-2010-05-283937; Xiao WB, 2009, CANCER CELL, V16, P161, DOI 10.1016/j.ccr.2009.05.018; Yang SH, 2008, CELL BIOL TOXICOL, V24, P291, DOI 10.1007/s10565-007-9038-6; Zhang HK, 2010, CELL RES, V20, P1390, DOI 10.1038/cr.2010.156	49	56	59	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2012	7	2							e31605	10.1371/journal.pone.0031605	http://dx.doi.org/10.1371/journal.pone.0031605			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LV	22328940	Green Published, gold, Green Accepted			2022-12-27	WOS:000302179300026
J	De Palma, G; Capilla, A; Nova, E; Castillejo, G; Varea, V; Pozo, T; Garrote, JA; Polanco, I; Lopez, A; Ribes-Koninckx, C; Marcos, A; Garcia-Novo, MD; Calvo, C; Ortigosa, L; Pena-Quintana, L; Palau, F; Sanz, Y				De Palma, Giada; Capilla, Amalia; Nova, Esther; Castillejo, Gemma; Varea, Vicente; Pozo, Tamara; Antonio Garrote, Jose; Polanco, Isabel; Lopez, Ana; Ribes-Koninckx, Carmen; Marcos, Ascension; Dolores Garcia-Novo, Maria; Calvo, Carmen; Ortigosa, Luis; Pena-Quintana, Luis; Palau, Francesc; Sanz, Yolanda			Influence of Milk-Feeding Type and Genetic Risk of Developing Coeliac Disease on Intestinal Microbiota of Infants: The PROFICEL Study	PLOS ONE			English	Article							MICROFLORA; CHILDREN; BACTERIA; GUT; COLONIZATION; PRIMERS; CELLS; PCR	Interactions between environmental factors and predisposing genes could be involved in the development of coeliac disease (CD). This study has assessed whether milk-feeding type and HLA-genotype influence the intestinal microbiota composition of infants with a family history of CD. The study included 164 healthy newborns, with at least one first-degree relative with CD, classified according to their HLA-DQ genotype by PCR-SSP DQB1 and DQA1 typing. Faecal microbiota was analysed by quantitative PCR at 7 days, and at 1 and 4 months of age. Significant interactions between milk-feeding type and HLA-DQ genotype on bacterial numbers were not detected by applying a linear mixed-model analysis for repeated measures. In the whole population, breast-feeding promoted colonization of C. leptum group, B. longum and B. breve, while formula-feeding promoted that of Bacteroides fragilis group, C. coccoides-E. rectale group, E. coli and B. lactis. Moreover, increased numbers of B. fragilis group and Staphylococcus spp., and reduced numbers of Bifidobacterium spp. and B. longum were detected in infants with increased genetic risk of developing CD. Analyses within subgroups of either breast-fed or formula-fed infants indicated that in both cases increased risk of CD was associated with lower numbers of B. longum and/or Bifidobacterium spp. In addition, in breast-fed infants the increased genetic risk of developing CD was associated with increased C. leptum group numbers, while in formula-fed infants it was associated with increased Staphylococcus and B. fragilis group numbers. Overall, milk-feeding type in conjunction with HLA-DQ genotype play a role in establishing infants' gut microbiota; moreover, breast-feeding reduced the genotype-related differences in microbiota composition, which could partly explain the protective role attributed to breast milk in this disorder.	[De Palma, Giada; Sanz, Yolanda] CSIC, Inst Agroquim & Tecnol Alimentos, E-46010 Valencia, Spain; [Capilla, Amalia; Palau, Francesc] CIBER Enfermedades Raras CIBERER, CSIC, Inst Biomed Valencia, Valencia, Spain; [Nova, Esther; Pozo, Tamara; Marcos, Ascension] CSIC, ICTAN, Dept Metab & Nutr, Madrid, Spain; [Castillejo, Gemma] Hosp Univ St Joan de Reus, Unidad Gastroenterol Pediat, Tarragona, Spain; [Varea, Vicente] Hosp Univ St Joan de Deu, Barcelona, Spain; [Varea, Vicente] Inst Dexeus, Unidad Gastroenterol Pediat, Barcelona, Spain; [Antonio Garrote, Jose; Calvo, Carmen] Hosp Clin Univ Valladolid, Unidad Gastroenterol Pediat, Valladolid, Spain; [Polanco, Isabel] Hosp Univ La Paz, Serv Gastroenterol & Nutr Pediat, Madrid, Spain; [Lopez, Ana; Ribes-Koninckx, Carmen] Hosp Univ La Fe, Unidad Gastroenterol Pediat, Valencia, Spain; [Dolores Garcia-Novo, Maria] Hosp Univ Infantil Nino Jesus, Unidad Gastroenterol, Madrid, Spain; [Ortigosa, Luis] Hosp Univ Nuestra Senora Candelaria, Unidad Gastroenterol Hepatol & Nutr Pediat, Santa Cruz De Tenerife, Canarias, Spain; [Pena-Quintana, Luis] Univ Las Palmas Gran Canaria, Hosp Univ Maternoinfantil Canarias, Unidad Gastroenterol Hepatol & Nutr Pediat, Las Palmas Gran Canaria, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Agroquimica y Tecnologia de los Alimentos (IATA); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencia y Tecnologia de Alimentos y Nutricion (ICTAN); Hospital Universitario La Paz; Hospital Universitari i Politecnic La Fe; Universidad de Las Palmas de Gran Canaria	De Palma, G (corresponding author), CSIC, Inst Agroquim & Tecnol Alimentos, Jaime Roig 11, E-46010 Valencia, Spain.	yolsanz@iata.csic.es	Capilla, Amalia/AAW-5955-2021; Sanz, Yolanda/H-5498-2012; Ribes-Koninckx, Maria Carmen/ABH-5577-2020; Rebato, Esther Nova/AAA-8744-2020; Garrote, Jose A/B-1257-2013; Sanchez, Ascension Marcos/K-4965-2014; Peña-Quintana, Luis/AAR-3421-2020; Palau, Francesc/A-9391-2014; De Palma, Giada/AAP-8806-2020	Capilla, Amalia/0000-0002-9546-9818; Sanz, Yolanda/0000-0002-1615-1976; Rebato, Esther Nova/0000-0002-1995-2955; Garrote, Jose A/0000-0003-1797-6520; Sanchez, Ascension Marcos/0000-0002-8022-9563; Peña-Quintana, Luis/0000-0001-6052-5894; Palau, Francesc/0000-0002-8635-5421; De Palma, Giada/0000-0002-2063-7741	Spanish Ministry of Science and Innovation [AGL2007-66126-C03-01-03/ALI, CSD2007-00063]; Consejo Superior de Investigaciones Cientificas (CSIC), Spain	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Consejo Superior de Investigaciones Cientificas (CSIC), Spain	This study was supported by public grants AGL2007-66126-C03-01-03/ALI and Consolider Fun-C-Food CSD2007-00063 from the Spanish Ministry of Science and Innovation. GDP was recipient of I3P scholarship from Consejo Superior de Investigaciones Cientificas (CSIC), Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEZIRTZOGLOU E, 1990, J PERINAT MED, V18, P139; Bezirtzoglou E, 1997, ANAEROBE, V3, P173, DOI 10.1006/anae.1997.0102; Bezirtzoglou E, 2011, ANAEROBE, V17, P478, DOI 10.1016/j.anaerobe.2011.03.009; Bourgey M, 2007, GUT, V56, P1054, DOI 10.1136/gut.2006.108530; Collado MC, 2009, J CLIN PATHOL, V62, P264, DOI 10.1136/jcp.2008.061366; De Palma G, 2010, CURR ISSUES MOL BIOL, V12, P1; Donat E, 2009, TISSUE ANTIGENS, V73, P255, DOI 10.1111/j.1399-0039.2008.01191.x; Dubois PC, 2008, CLIN EXP IMMUNOL, V153, P162, DOI 10.1111/j.1365-2249.2008.03704.x; Fasano A, 2005, BEST PRACT RES CL GA, V19, P467, DOI 10.1016/j.bpg.2005.01.008; Frank DN, 2011, INFLAMM BOWEL DIS, V17, P179, DOI 10.1002/ibd.21339; Hapfelmeier S, 2008, J EXP MED, V205, P437, DOI 10.1084/jem.20070633; Ivarsson A, 2002, AM J CLIN NUTR, V75, P914, DOI 10.1093/ajcn/75.5.914; Kagnoff MF, 2007, J CLIN INVEST, V117, P41, DOI 10.1172/JCI30253; KAISERLIAN D, 1993, IMMUNOL TODAY, V14, P144, DOI 10.1016/0167-5699(93)90222-7; Kalliomaki M, 2001, J ALLERGY CLIN IMMUN, V107, P129, DOI 10.1067/mai.2001.111237; Malinen E, 2003, MICROBIOL-SGM, V149, P269, DOI 10.1099/mic.0.25975-0; Martin R, 2003, J PEDIATR-US, V143, P754, DOI 10.1016/j.jpeds.2003.09.028; Martin R, 2009, APPL ENVIRON MICROB, V75, P965, DOI 10.1128/AEM.02063-08; Matsuki T, 2002, APPL ENVIRON MICROB, V68, P5445, DOI 10.1128/AEM.68.11.5445-5451.2002; Nadal I, 2007, J MED MICROBIOL, V56, P1669, DOI 10.1099/jmm.0.47410-0; Newburg DS, 2005, J NUTR, V135, P1308, DOI 10.1093/jn/135.5.1308; OLERUP O, 1993, TISSUE ANTIGENS, V41, P119, DOI 10.1111/j.1399-0039.1993.tb01991.x; Penders J, 2006, PEDIATRICS, V118, P511, DOI 10.1542/peds.2005-2824; Plot L, 2009, INFECTIONS MAY HAVE, P670; Plot L, 2009, AUTOIMMUN REV, V8, P316, DOI 10.1016/j.autrev.2008.10.001; Rajagopalan G, 2008, TISSUE ANTIGENS, V71, P135, DOI 10.1111/j.1399-0039.2007.00986.x; Reviriego C, 2005, J HUM LACT, V21, P131, DOI 10.1177/0890334405275394; Salminen S, 2006, J PEDIATR-US, V149, pS115, DOI 10.1016/j.jpeds.2006.06.062; Sanz Y, 2008, CHILD NUTR PHYSL, P210; Sanz Yolanda, 2007, Recent Pat Antiinfect Drug Discov, V2, P148, DOI 10.2174/157489107780832596; Sanz Y, 2009, MINI-REV MED CHEM, V9, P359, DOI 10.2174/1389557510909030359; Sollid LM, 2002, NAT REV IMMUNOL, V2, P647, DOI 10.1038/nri885; Stewart JA, 2005, J MED MICROBIOL, V54, P1239, DOI 10.1099/jmm.0.46189-0; Zoetendal Erwin G., 2001, Microbial Ecology in Health and Disease, V13, P129, DOI 10.1080/089106001750462669	34	95	96	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e30791	10.1371/journal.pone.0030791	http://dx.doi.org/10.1371/journal.pone.0030791			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LO	22319588	Green Published, gold, Green Submitted			2022-12-27	WOS:000302178400016
J	Velez-Juarbe, J; Domning, DP; Pyenson, ND				Velez-Juarbe, Jorge; Domning, Daryl P.; Pyenson, Nicholas D.			Iterative Evolution of Sympatric Seacow (Dugongidae, Sirenia) Assemblages during the Past similar to 26 Million Years	PLOS ONE			English	Article							CETACEANS CENOZOIC DRIVERS; BODY-SIZE; ENVIRONMENTAL-CHANGE; ECOLOGICAL CHANGE; CARIBBEAN REGION; FOSSIL SIRENIA; WEST ATLANTIC; MIOCENE; COMMUNITY; MAMMALIA	Extant sirenians show allopatric distributions throughout most of their range. However, their fossil record shows evidence of multispecies communities throughout most of the past similar to 26 million years, in different oceanic basins. Morphological differences among co-occurring sirenian taxa suggest that resource partitioning played a role in structuring these communities. We examined body size and ecomorphological differences (e.g., rostral deflection and tusk morphology) among sirenian assemblages from the late Oligocene of Florida, early Miocene of India and early Pliocene of Mexico; each with three species of the family Dugongidae. Although overlapping in several ecomorphological traits, each assemblage showed at least one dominant trait in which coexisting species differed. Fossil sirenian occurrences occasionally are monotypic, but the assemblages analyzed herein show iterative evolution of multispecies communities, a phenomenon unparalleled in extant sirenian ecology. As primary consumers of seagrasses, these communities likely had a strong impact on past seagrass ecology and diversity, although the sparse fossil record of seagrasses limits direct comparisons. Nonetheless, our results provide robust support for previous suggestions that some sirenians in these extinct assemblages served as keystone species, controlling the dominance of climax seagrass species, permitting more taxonomically diverse seagrass beds (and sirenian communities) than many of those observed today.	[Velez-Juarbe, Jorge; Domning, Daryl P.] Howard Univ, Dept Anat, Lab Evolutionary Biol, Washington, DC 20059 USA; [Velez-Juarbe, Jorge; Domning, Daryl P.; Pyenson, Nicholas D.] Smithsonian Inst, Natl Museum Nat Hist, Dept Paleobiol, Washington, DC 20560 USA; [Pyenson, Nicholas D.] Univ Washington, Burke Museum Nat Hist & Culture, Dept Mammal, Seattle, WA 98195 USA; [Pyenson, Nicholas D.] Univ Washington, Burke Museum Nat Hist & Culture, Dept Paleontol, Seattle, WA 98195 USA	Howard University; Smithsonian Institution; Smithsonian National Museum of Natural History; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Velez-Juarbe, J (corresponding author), Howard Univ, Dept Anat, Lab Evolutionary Biol, Washington, DC 20059 USA.	velezjuarbe@gmail.com		Pyenson, Nicholas/0000-0003-4678-5782	Washington-Baltimore-Hampton-Roads Louis Stokes Alliance for Minority Participation Bridge; National Museum of Natural History, Smithsonian Institution; Smithsonian Institution; National Science Foundation [0929117]	Washington-Baltimore-Hampton-Roads Louis Stokes Alliance for Minority Participation Bridge; National Museum of Natural History, Smithsonian Institution(Smithsonian InstitutionSmithsonian National Museum of Natural History); Smithsonian Institution(Smithsonian Institution); National Science Foundation(National Science Foundation (NSF))	JVJ was partially supported by the Washington-Baltimore-Hampton-Roads Louis Stokes Alliance for Minority Participation Bridge to the Doctorate Program at Howard University and a predoctoral fellowship from the National Museum of Natural History, Smithsonian Institution. NDP was also supported by funding from the Smithsonian Institution. Ongoing work by DPD and JVJ is supported by National Science Foundation Earth Sciences grant no. 0929117. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajpai S, 1997, J VERTEBR PALEONTOL, V17, P219, DOI 10.1080/02724634.1997.10010965; Bajpai S, 2010, NEUES JAHRB GEOL P-A, V258, P39, DOI 10.1127/0077-7749/2010/0082; Barnosky AD, 2004, P NATL ACAD SCI USA, V101, P9297, DOI 10.1073/pnas.0402592101; Barry JC, 2002, PALEOBIOLOGY, V28, P1, DOI 10.1666/0094-8373(2002)28[1:FAECIT]2.0.CO;2; Benzecry A, 2008, BOT J LINN SOC, V157, P19, DOI 10.1111/j.1095-8339.2007.00749.x; Calandra I, 2008, NATURWISSENSCHAFTEN, V95, P831, DOI 10.1007/s00114-008-0391-y; Clementz MT, 2006, J VERTEBR PALEONTOL, V26, P355, DOI 10.1671/0272-4634(2006)26[355:IRFEWA]2.0.CO;2; Clementz MT, 2009, GEOLOGY, V37, P307, DOI 10.1130/G25533A.1; Clyde WC, 1998, GEOLOGY, V26, P1011, DOI 10.1130/0091-7613(1998)026<1011:MCRTTL>2.3.CO;2; de Toledo PM., 1991, B MUSEU PARAENSE EMI, V1, P119; Diamond J.M., 1975, P342; Domning D.P., 1989, Journal of Vertebrate Paleontology, V9, P415; Domning D.P., 1989, Journal of Vertebrate Paleontology, V9, P429; Domning D.P., 1990, Journal of Vertebrate Paleontology, V10, P361; Domning DP, 2008, J VERTEBR PALEONTOL, V28, P479, DOI 10.1671/0272-4634(2008)28[479:FSOTWA]2.0.CO;2; Domning DP, 2007, ANAT REC, V290, P523, DOI 10.1002/ar.20540; Domning Daryl P., 1994, Contributions from the Museum of Paleontology University of Michigan, V29, P69; Domning Daryl P., 1994, Proceedings of the San Diego Society of Natural History, V29, P177; Domning DP, 1997, J VERTEBR PALEONTOL, V17, P397, DOI 10.1080/02724634.1997.10010984; Domning DP, 2001, PALAEOGEOGR PALAEOCL, V166, P27, DOI 10.1016/S0031-0182(00)00200-5; DOMNING DP, 1981, PALEOBIOLOGY, V7, P417, DOI 10.1017/S009483730002546X; Domning DP, 2001, NATURE, V413, P625, DOI 10.1038/35098072; DOMNING DP, 1982, J PALEONTOL, V56, P599; Domning DP., 1978, U CALIFORNIA PUBLICA, V118, P1; Edwards L. E, 2000, 00049B USGS; Eronen JT, 2010, INTEGR ZOOL, V5, P88, DOI 10.1111/j.1749-4877.2010.00192.x; Eva A.N., 1980, Palaeontology (Oxford), V23, P231; FORDYCE RE, 1977, PALAEOGEOGR PALAEOCL, V21, P265; FORDYCE RE, 1980, PALAEOGEOGR PALAEOCL, V31, P319, DOI 10.1016/0031-0182(80)90024-3; GINGERICH PD, 1992, U MICHIGAN PAPERS PA, V30, P1; Goloboff P, 2008, CLADISTICS, V24, P91; Gotelli NJ, 2002, ECOLOGY, V83, P2091, DOI 10.2307/3072040; Hamilton H, 2001, P ROY SOC B-BIOL SCI, V268, P549, DOI 10.1098/rspb.2000.1385; IVANY L C, 1990, Palaios, V5, P244, DOI 10.2307/3514943; Janis CM, 2002, PALAEOGEOGR PALAEOCL, V177, P183, DOI 10.1016/S0031-0182(01)00359-5; Jernvall J, 2004, AM NAT, V164, P614, DOI 10.1086/424967; Klumpp DW, 1989, BIOL SEAGRASSES, P394; LOSOS JB, 1994, ANNU REV ECOL SYST, V25, P467, DOI 10.1146/annurev.es.25.110194.002343; LUMBERT SH, 1984, AQUAT BOT, V20, P121, DOI 10.1016/0304-3770(84)90032-9; MacFadden BJ, 2004, OECOLOGIA, V140, P169, DOI 10.1007/s00442-004-1571-x; MacFadden BJ, 2004, PALEOBIOLOGY, V30, P297, DOI 10.1666/0094-8373(2004)030<0297:DHPAND>2.0.CO;2; MacFadden BJ, 2000, ANNU REV ECOL SYST, V31, P33, DOI 10.1146/annurev.ecolsys.31.1.33; Marx FG, 2010, SCIENCE, V327, P993, DOI 10.1126/science.1185581; Marx FG, 2009, P ROY SOC B-BIOL SCI, V276, P887, DOI 10.1098/rspb.2008.1473; McRoy C. P., 1980, HDB SEAGRASS BIOL EC, P297; Miller KG, 2005, SCIENCE, V310, P1293, DOI 10.1126/science.1116412; Morgan G.S., 1983, Plaster Jacket, P4; MORGAN ME, 1995, PALAEOGEOGR PALAEOCL, V115, P287, DOI 10.1016/0031-0182(94)00116-P; MURRAY RM, 1977, COMP BIOCHEM PHYS A, V56, P7, DOI 10.1016/0300-9629(77)90432-7; O'Dea A, 2007, P NATL ACAD SCI USA, V104, P5501, DOI 10.1073/pnas.0610947104; Parham JF, 2010, J PALEONTOL, V84, P231, DOI 10.1666/09-077R.1; Polly PD, 2011, P ROY SOC B-BIOL SCI, V278, P1131, DOI 10.1098/rspb.2010.2233; Pyenson ND, 2011, J MAMM EVOL, V18, P269, DOI 10.1007/s10914-011-9170-1; Pyenson ND, 2010, SCIENCE, V330, DOI 10.1126/science.1189866; Raia P, 2010, PALAIOS, V25, P327, DOI 10.2110/palo.2009.p09-154r; REINHART R H, 1976, Bulletin of the Florida State Museum Biological Sciences, V20, P187; Sarko DK, 2010, MAR MAMMAL SCI, V26, P937, DOI 10.1111/j.1748-7692.2010.00384.x; SCHOENER TW, 1974, SCIENCE, V185, P27, DOI 10.1126/science.185.4145.27; Terborgh J., 2010, TROPHIC CASCADES PRE, P488; Thewissen JGM, 2009, ACTA PALAEONTOL POL, V54, P7, DOI 10.4202/app.2009.0102; Uhen Mark D., 2007, Palaeontologia Electronica, V10, P1; VANVALKENBURGH B, 1991, PALEOBIOLOGY, V17, P340, DOI 10.1017/S0094837300010691; Velez-Juarbe J, 2009, GEOL SOC AM ABSTR, V41, P634; Vianna JA, 2006, MOL ECOL, V15, P433, DOI 10.1111/j.1365-294X.2005.02771.x	64	60	62	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e31294	10.1371/journal.pone.0031294	http://dx.doi.org/10.1371/journal.pone.0031294			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LO	22319622	Green Published, gold, Green Submitted			2022-12-27	WOS:000302178400034
J	Yan, TT; Li, Q; Zhou, HT; Zhao, YT; Yu, SQ; Xu, GL; Yin, ZM; Li, ZJ; Zhao, ZH				Yan, TingTing; Li, Qing; Zhou, HuiTing; Zhao, YueTao; Yu, ShuQin; Xu, GuangLin; Yin, ZhiMin; Li, ZhongJun; Zhao, ZhiHui			Gu-4 Suppresses Affinity and Avidity Modulation of CD11b and Improves the Outcome of Mice with Endotoxemia and Sepsis	PLOS ONE			English	Article							EARLY LACTATE CLEARANCE; MOLECULAR-MECHANISMS; CECAL LIGATION; LEUKOCYTE; SHOCK; INFLAMMATION; ACTIVATION; MORTALITY; INTEGRIN; ADHESION	Background: Systemic leukocyte activation and disseminated leukocyte adhesion will impair the microcirculation and cause severe decrements in tissue perfusion and organ function in the process of severe sepsis. Gu-4, a lactosyl derivative, could selectively target CD11b to exert therapeutic effect in a rat model of severe burn shock. Here, we addressed whether Gu-4 could render protective effects on septic animals. Methodology/Principal Findings: On a murine model of endotoxemia induced by lipopolysaccharide (LPS), we found that the median effective dose (ED50) of Gu-4 was 0.929 mg/kg. In vivo treatment of Gu-4 after LPS challenge prominently attenuated LPS-induced lung injury and decreased lactic acid level in lung tissue. Using the ED50 of Gu-4, we also demonstrated that Gu-4 treatment significantly improved the survival rate of animals underwent sepsis induced by cecal ligation and puncture. By adhesion and transwell migration assays, we found that Gu-4 treatment inhibited the adhesion and transendothelial migration of LPS-stimulated THP-1 cells. By flow cytometry and microscopy, we demonstrated that Gu-4 treatment inhibited the exposure of active I-domain and the cluster formation of CD11b on the LPS-stimulated polymorphonuclear leukocytes. Western blot analyses further revealed that Gu-4 treatment markedly inhibited the activation of spleen tyrosine kinase in LPS-stimulated THP-1 cells. Conclusions/Significance: Gu-4 improves the survival of mice underwent endotoxemia and sepsis, our in vitro investigations indicate that the possible underlying mechanism might involve the modulations of the affinity and avidity of CD11b on the leukocyte. Our findings shed light on the potential use of Gu-4, an interacting compound to CD11b, in the treatment of sepsis and septic shock.	[Yan, TingTing; Zhou, HuiTing; Yu, ShuQin; Xu, GuangLin; Yin, ZhiMin; Zhao, ZhiHui] Nanjing Normal Univ, Coll Life Sci, Jiangsu Prov Key Lab Mol & Med Biotechnol, Nanjing, Jiangsu, Peoples R China; [Li, Qing; Zhao, YueTao; Li, ZhongJun] Peking Univ, Sch Pharmaceut Sci, State Key Lab Nat & Biomimet Drugs, Beijing 100871, Peoples R China	Nanjing Normal University; Peking University	Yan, TT (corresponding author), Nanjing Normal Univ, Coll Life Sci, Jiangsu Prov Key Lab Mol & Med Biotechnol, Nanjing, Jiangsu, Peoples R China.	zjli@bjmu.edu.cn; zhaozhihui_1964@yahoo.com.cn	Yu, Shu-Qin/K-5982-2012	Yu, Shu-Qin/0000-0002-2824-4651	Natural Science Foundation of China [2008104GZ40166]; State New Drug Innovation Plan [2009ZX09103-044]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State New Drug Innovation Plan; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was financially supported by the Natural Science Foundation of China (Grant No. 2008104GZ40166), the State New Drug Innovation Plan (Grant No. 2009ZX09103-044), and a project from the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler V, 1999, ONCOGENE, V18, P6104, DOI 10.1038/sj.onc.1203128; Alencar NMN, 2010, INFLAMM RES, V59, P245, DOI 10.1007/s00011-009-0092-9; BAKER CC, 1983, SURGERY, V94, P331; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chandra Abhijit, 2006, Clinics, V61, P71, DOI 10.1590/S1807-59322006000100012; Chishti AD, 2004, INTENS CARE MED, V30, P605, DOI 10.1007/s00134-004-2175-y; De Petrocellis L, 2010, J NEUROIMMUNE PHARM, V5, P103, DOI 10.1007/s11481-009-9177-z; Decking J, 2001, INFLAMM RES, V50, P609, DOI 10.1007/PL00000242; Ellis CG, 2005, CRIT CARE, V9, pS3, DOI 10.1186/cc3751; Engel C, 2007, INTENS CARE MED, V33, P606, DOI 10.1007/s00134-006-0517-7; Ghezzi Pietro, 2004, Methods Mol Med, V98, P1; Gutierrez G, 1996, INTENS CARE MED, V22, P6, DOI 10.1007/BF01728325; Haji-Michael PG, 1999, METABOLISM, V48, P779, DOI 10.1016/S0026-0495(99)90179-8; Hirahashi J, 2006, IMMUNITY, V25, P271, DOI 10.1016/j.immuni.2006.05.014; Hodgson JC, 2006, J COMP PATHOL, V135, P157, DOI 10.1016/j.jcpa.2006.09.001; Hollenberg SM, 2007, CRIT CARE, V11, DOI 10.1186/cc6190; Hu G, 2008, CIRC RES, V102, pE120, DOI 10.1161/CIRCRESAHA.107.167486; Hubbard WJ, 2005, SHOCK, V24, P52, DOI 10.1097/01.shk.0000191414.94461.7e; Ince C, 2005, CRIT CARE, V9, pS13, DOI 10.1186/cc3753; Joshi A, 2006, J CLIN PHARMACOL, V46, P10, DOI 10.1177/0091270005283282; Karima R, 1999, MOL MED TODAY, V5, P123, DOI 10.1016/S1357-4310(98)01430-0; Kim M, 2004, J CELL BIOL, V167, P1241, DOI 10.1083/jcb.200404160; LEE JO, 1995, CELL, V80, P631, DOI 10.1016/0092-8674(95)90517-0; Lefort CT, 2009, J IMMUNOL, V183, P6460, DOI 10.4049/jimmunol.0900983; Lehmann C, 2001, INTENS CARE MED, V27, P258, DOI 10.1007/s001340000782; Levy MM, 2010, INTENS CARE MED, V36, P222, DOI 10.1007/s00134-009-1738-3; Liu LX, 2003, THROMB HAEMOSTASIS, V89, P213; Liu ZW, 2008, FEBS LETT, V582, P1643, DOI 10.1016/j.febslet.2008.04.016; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; McCuskey RS, 1996, CARDIOVASC RES, V32, P752, DOI 10.1016/S0008-6363(96)00113-7; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; Murakami K, 2002, CRIT CARE MED, V30, P2083, DOI 10.1097/00003246-200209000-00022; Nguyen HB, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-6; Nguyen HB, 2004, CRIT CARE MED, V32, P1637, DOI 10.1097/01.CCM.0000132904.35713.A7; Ploppa A, 2010, CRIT CARE, V14, DOI 10.1186/cc9322; Pruitt JH, 1996, BLOOD, V87, P3282; Rittirsch D, 2008, NAT REV IMMUNOL, V8, P776, DOI 10.1038/nri2402; Schnare M, 2001, NAT IMMUNOL, V2, P947, DOI 10.1038/ni712; Soriano FG, 2011, SHOCK, V35, P560, DOI 10.1097/SHK.0b013e31820fe5d5; van Kooyk Y, 2000, CURR OPIN CELL BIOL, V12, P542, DOI 10.1016/S0955-0674(00)00129-0; Winters BD, 2010, CRIT CARE MED, V38, P1276, DOI 10.1097/CCM.0b013e3181d8cc1d; Zhao ZH, 2009, GLYCOCONJUGATE J, V26, P173, DOI 10.1007/s10719-008-9174-0	42	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2012	7	2							e30110	10.1371/journal.pone.0030110	http://dx.doi.org/10.1371/journal.pone.0030110			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UV	22319560	Green Published, gold, Green Submitted			2022-12-27	WOS:000301979000002
J	Maggini, I; Bairlein, F				Maggini, Ivan; Bairlein, Franz			Innate Sex Differences in the Timing of Spring Migration in a Songbird	PLOS ONE			English	Article							CHIFFCHAFFS PHYLLOSCOPUS-COLLYBITA; WHEATEAR OENANTHE-OENANTHE; NORTHERN WHEATEAR; CIRCANNUAL CLOCKS; PROXIMATE CONTROL; WINTER; AGE; SETTLEMENT; FEMALES; AFRICA	In migrating animals protandry is the phenomenon whereby males of a species arrive at the breeding grounds earlier than females. In the present study we investigated the proximate causes of protandry in a migratory songbird, the northern wheatear Oenanthe oenanthe. Previous experiments with caged birds revealed that males and females show differentiated photoperiod-induced migratory habits. However, it remained open whether protandry would still occur without photoperiodic cues. In this study we kept captive first-year birds under constant photoperiod and environmental conditions in a "common garden" experiment. Male northern wheatears started their spring migratory activity earlier than females, even in the absence of environmental cues. This indicates that protandry in the northern wheatear has an endogenous basis with an innate earlier spring departure of males than females.	[Maggini, Ivan; Bairlein, Franz] Inst Avian Res Vogelwarte Helgoland, Wilhelmshaven, Germany		Maggini, I (corresponding author), Inst Avian Res Vogelwarte Helgoland, Wilhelmshaven, Germany.	ivan.maggini@ifv-vogelwarte.de	Maggini, Ivan/I-1744-2014	Maggini, Ivan/0000-0002-1528-2288	Deutsche Forschungsgemeinschaft DFG [Ba 815/16]	Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG))	The study has been funded by the Deutsche Forschungsgemeinschaft DFG (Ba 815/16). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAIRLEIN F, 1986, J ORNITHOL, V127, P338, DOI 10.1007/BF01640417; Catry P, 2005, J AVIAN BIOL, V36, P184, DOI 10.1111/j.0908-8857.2005.03445.x; Catry P, 2004, J AVIAN BIOL, V35, P204, DOI 10.1111/j.0908-8857.2004.03266.x; Catry P, 2007, J ORNITHOL, V148, P241, DOI 10.1007/s10336-007-0130-8; Coppack T, 2008, BIOL LETTERS, V4, P619, DOI 10.1098/rsbl.2008.0388; Coppack T, 2009, INTEGR COMP BIOL, V49, P493, DOI 10.1093/icb/icp029; Cramp S., 1988, BIRDS W PALEARCTIC, V5; Currie D, 2000, IBIS, V142, P389, DOI 10.1111/j.1474-919X.2000.tb04435.x; Dierschke V, 2005, BEHAV ECOL SOCIOBIOL, V57, P470, DOI 10.1007/s00265-004-0872-8; Gordo O, 2007, CLIM RES, V35, P37, DOI 10.3354/cr00713; Gwinner E, 1996, IBIS, V138, P47, DOI 10.1111/j.1474-919X.1996.tb04312.x; Gwinner E, 1990, BIRD MIGRATION PHYSL; GWINNER EBERHARD, 1968, J ORNITHOL, V109, P70, DOI 10.1007/BF01678108; HEDENSTROM A, 1986, ORNIS SCAND, V17, P182, DOI 10.2307/3676868; Maggini I, 2010, J BIOL RHYTHM, V25, P268, DOI 10.1177/0748730410373442; Marra PP, 1998, SCIENCE, V282, P1884, DOI 10.1126/science.282.5395.1884; Morbey YE, 2001, ECOL LETT, V4, P663, DOI 10.1046/j.1461-0248.2001.00265.x; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; Part T, 2001, ANIM BEHAV, V62, P379, DOI 10.1006/anbe.2001.1754; Pulido F, 2004, ADV ECOL RES, V35, P151, DOI 10.1016/S0065-2504(04)35008-7; SPINA F, 1994, OSTRICH, V65, P137, DOI 10.1080/00306525.1994.9639676; Stouffer PC, 2003, AUK, V120, P836, DOI 10.1642/0004-8038(2003)120[0836:SWDATO]2.0.CO;2; TERRILL SB, 1990, OECOLOGIA, V85, P266, DOI 10.1007/BF00319412; Widmer M., 1999, THESIS U ZURICH SWIT; Wikelski M, 2008, PHILOS T R SOC B, V363, P411, DOI 10.1098/rstb.2007.2147	25	45	47	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2012	7	2							e31271	10.1371/journal.pone.0031271	http://dx.doi.org/10.1371/journal.pone.0031271			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UG	22312443	gold, Green Submitted, Green Published			2022-12-27	WOS:000301977500032
J	Spivak, DI; Kent, RE				Spivak, David I.; Kent, Robert E.			Ologs: A Categorical Framework for Knowledge Representation	PLOS ONE			English	Article								In this paper we introduce the olog, or ontology log, a category-theoretic model for knowledge representation (KR). Grounded in formal mathematics, ologs can be rigorously formulated and cross-compared in ways that other KR models ( such as semantic networks) cannot. An olog is similar to a relational database schema; in fact an olog can serve as a data repository if desired. Unlike database schemas, which are generally difficult to create or modify, ologs are designed to be user-friendly enough that authoring or reconfiguring an olog is a matter of course rather than a difficult chore. It is hoped that learning to author ologs is much simpler than learning a database definition language, despite their similarity. We describe ologs carefully and illustrate with many examples. As an application we show that any primitive recursive function can be described by an olog. We also show that ologs can be aligned or connected together into a larger network using functors. The various methods of information flow and institutions can then be used to integrate local and global world-views. We finish by providing several different avenues for future research.	[Spivak, David I.] MIT, Dept Math, Cambridge, MA 02139 USA; [Kent, Robert E.] Ontologos, Pullman, WA USA	Massachusetts Institute of Technology (MIT)	Spivak, DI (corresponding author), MIT, Dept Math, Cambridge, MA 02139 USA.	dspivak@math.mit.edu			ONR [N000141010841]	ONR(Office of Naval Research)	This project was supported by ONR grant N000141010841 and a generous contribution by Clark Barwick, Jacob Lurie, and the mathematics department at Massachusetts Institute of Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awodey S., 2010, OXFORD LOGIC GUIDES, VVolume 52; Barr M, 1985, FUNDAMENTAL PRINCIPL, V278; Barr M., 1990, SERIES COMPUTER SCI; Barwise J., 1997, INFORM FLOW LOGIC DI, V44; Boolos G., 2007, COMPUTABILITY LOGIC, V5th ed.; Borgida A, 2007, CFUR WORKSHOP P, V250, P1; Chein M, 2009, ADV INFORM KNOWL PRO, P1; Ganter B, 1999, CAMBRIDGE TRACTS THE, V44; GOGUEN JA, 1992, J ACM, V39, P95, DOI 10.1145/147508.147524; Healy MJ, 2004, TR04020 U NEW MEX; Johnson M., 2002, THEORY APPL CATEGORI, V10, P94; Kent R.E., 2003, CAT CLASSIF Q, V37, P187; Kent RE, 2003, P16001 IEEE SUO WG; Kent RE, 2005, DAGSTUHL SEMINAR P; Kent RE, 2009, LECT NOTES ARTIF INT, V5662, P201, DOI 10.1007/978-3-642-03079-6_16; Lawvere F.W., 2009, CONCEPTUAL MATH 1 IN; Mac Lane S., 1998, GRADUATE TEXTS MATH, V5, DOI DOI 10.1007/978-1-4612-9839-7; Makkai M, 1997, J PURE APPL ALGEBRA, V115, P49, DOI 10.1016/S0022-4049(96)00007-2; Members The Information Flow Framework (IFF), P16001 IEEE SUO WG; Mineau GW, 1992, CONCEPTUAL STRUCTURE, V754, P34; Mitchell TM, 2009, LECT NOTES COMPUT SC, V5823, P998, DOI 10.1007/978-3-642-04930-9_66; nLab contributors Epimorphism, WIK LAB COLL WORK MA; nLab contributors Monomorphism, WIK LAB COLL WORK MA; Pierce B. C., 1991, BASIC CATEGORY THEOR; Sica G., 2006, WHAT IS CATEGORY THE; Sowa J. F., 2000, KNOWLEDGE REPRESENTA; TARLECKI A, 1991, THEOR COMPUT SCI, V91, P239, DOI 10.1016/0304-3975(91)90085-G; Wikipedia, FREE ENC; Yeung R.W., 2006, COMMUN INF THEORY, V2, P241	29	43	45	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2012	7	1							e24274	10.1371/journal.pone.0024274	http://dx.doi.org/10.1371/journal.pone.0024274			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	912BY	22303434	Green Submitted, Green Published, gold			2022-12-27	WOS:000301770700001
J	Kam, WWY; Meikle, SR; Dunstan, CR; Banati, RB				Kam, Winnie Wai-Ying; Meikle, Steven R.; Dunstan, Colin R.; Banati, Richard B.			The 18 kDa Translocator Protein (Peripheral Benzodiazepine Receptor) Expression in the Bone of Normal, Osteoprotegerin or Low Calcium Diet Treated Mice	PLOS ONE			English	Article							BINDING-SITES; AFFINITY BINDING; BRAIN; CELLS; INVOLVEMENT; ACTIVATION; RESORPTION; MICROGLIA; PK-11195; PET	The presence of the translocator protein (TSPO), previously named as the mitochondrial or peripheral benzodiazepine receptor, in bone cells was studied in vitro and in situ using RT-qPCR, and receptor autoradiography using the selective TSPO ligand PK11195. In vitro, the TSPO is highly expressed in osteoblastic and osteoclastic cells. In situ, constitutive expression of TSPO is found in bone marrow and trabecular bone, e. g., spongiosa. Mice with a reduction of bone turnover induced by a 4-day treatment of osteoprotegerin reduces [H-3]PK11195 binding in the spongiosa (320 +/- 128 Bq.mg(-1), 499 +/- 106 Bq.mg(-1) in saline-treated controls). In contrast, mice with an increase in bone turnover caused by a 4-day low calcium diet increases [H-3]PK11195 binding in the spongiosa (615 +/- 90 Bq.mg(-1)). Further, our study includes technical feasibility data on [F-18]fluoride microPET imaging of rodent bone with altered turnover. Despite [F-18]fluoride having high uptake, the in vivo signal differences were small. Using a phantom model, we describe the spillover effect and partial volume loss that affect the quantitative microPET imaging of the small bone structures in experimental mouse models. In summary, we demonstrate the expression of TSPO in small rodent bone tissues, including osteoblasts and osteoclasts. A trend increase in TSPO expression was observed in the spongiosa from low to high bone turnover conditions. However, despite the potential utility of TSPO expression as an in vivo biomarker of bone turnover in experimental rodent models, our small animal PET imaging data using [F-18]fluoride show that even under the condition of a good biological signal-to-noise ratio and high tracer uptake, the currently achievable instrument sensitivity and spatial resolution is unlikely to be sufficient to detect subtle differences in small structures, such as mouse bone.	[Kam, Winnie Wai-Ying; Meikle, Steven R.; Banati, Richard B.] Univ Sydney, Fac Hlth Sci, Discipline Med Radiat Sci, Cumberland, MD USA; [Kam, Winnie Wai-Ying; Meikle, Steven R.; Banati, Richard B.] Univ Sydney, Ramaciotti Imaging Ctr, Brain & Mind Res Inst, Camperdown, NSW, Australia; [Dunstan, Colin R.] Univ Sydney, Anzac Res Inst, Bone Res Program, Concord, NSW, Australia; [Kam, Winnie Wai-Ying; Banati, Richard B.] Australian Nucl Sci & Technol Org, Lucas Heights, NSW, Australia; [Dunstan, Colin R.] Univ Sydney, Sch Aerosp Mech & Mechatron Engn, Camperdown, NSW, Australia	University of Sydney; University of Sydney; University of Sydney; ANZAC Research Institute; Australian Nuclear Science & Technology Organisation; University of Sydney	Kam, WWY (corresponding author), Univ Sydney, Fac Hlth Sci, Discipline Med Radiat Sci, Cumberland, MD USA.	wik@ansto.gov.au	Meikle, Steven R/A-5470-2009; Dunstan, Colin/G-6214-2013; Meikle, Steven/AAH-4973-2020; Kam, Winnie/AAI-8622-2021; Ekanayake, Kanchana/P-8817-2016; Research Institute, ANZAC/CAE-9030-2022; Kam, Winnie WY/B-7407-2013	Meikle, Steven R/0000-0001-7397-0364; Dunstan, Colin/0000-0001-7586-4071; Meikle, Steven/0000-0001-7397-0364; Kam, Winnie WY/0000-0002-5508-2432; Zheng, Yu/0000-0002-6324-8148; Seibel, Markus J/0000-0002-2701-378X				Banati RB, 2002, J PHYSIOLOGY-PARIS, V96, P289, DOI 10.1016/S0928-4257(02)00018-9; Banati RB, 1997, J NEUROCYTOL, V26, P77, DOI 10.1023/A:1018567510105; Banati RB, 2000, BRAIN, V123, P2321, DOI 10.1093/brain/123.11.2321; BENAVIDES J, 1984, BIOCHEM PHARMACOL, V33, P2467, DOI 10.1016/0006-2952(84)90719-6; BERKOVICH A, 1993, LIFE SCI, V52, P1265, DOI 10.1016/0024-3205(93)90087-J; Bianco P, 2000, J CLIN INVEST, V105, P1663, DOI 10.1172/JCI10413; BRAESTRUP C, 1977, P NATL ACAD SCI USA, V74, P3805, DOI 10.1073/pnas.74.9.3805; Brenner W, 2004, J NUCL MED, V45, P1493; Cagnin A, 2001, BRAIN, V124, P2014, DOI 10.1093/brain/124.10.2014; CANAT X, 1993, LIFE SCI, V52, P107, DOI 10.1016/0024-3205(93)90293-C; Carayon P, 1996, BLOOD, V87, P3170, DOI 10.1182/blood.V87.8.3170.bloodjournal8783170; Casellas P, 2002, NEUROCHEM INT, V40, P475, DOI 10.1016/S0197-0186(01)00118-8; DESOUZA EB, 1985, ENDOCRINOLOGY, V116, P567, DOI 10.1210/endo-116-2-567; Duan Y, 1997, BONE, V21, P447, DOI 10.1016/S8756-3282(97)00177-4; Dveksler G S, 1992, PCR Methods Appl, V1, P283; Gavish M, 1999, PHARMACOL REV, V51, P629; Gerhard A, 2004, MOVEMENT DISORD, V19, P1221, DOI 10.1002/mds.20162; Giatzakis C, 2004, ENDOCRINOLOGY, V145, P1113, DOI 10.1210/en.2003-1330; Granholm S, 2007, J ENDOCRINOL, V195, P415, DOI 10.1677/JOE-07-0338; HOFFMAN EJ, 1979, J COMPUT ASSIST TOMO, V3, P299, DOI 10.1097/00004728-197906000-00001; Kim YJ, 2004, J BIOL CHEM, V279, P50773, DOI 10.1074/jbc.M404145200; LEFUR G, 1983, LIFE SCI, V33, P449, DOI 10.1016/0024-3205(83)90794-4; LEFUR G, 1983, LIFE SCI, V32, P1839, DOI 10.1016/0024-3205(83)90062-0; LIN KP, 1995, PHYS MED BIOL, V40, P629, DOI 10.1088/0031-9155/40/4/009; Miltyk W, 2006, Adv Med Sci, V51, P156; Morony S, 1999, J BONE MINER RES, V14, P1478, DOI 10.1359/jbmr.1999.14.9.1478; MYERS R, 1991, J CEREBR BLOOD F MET, V11, P314, DOI 10.1038/jcbfm.1991.64; Nothdurfter C, 2012, J NEUROENDOCRINOL, V24, P82, DOI 10.1111/j.1365-2826.2011.02166.x; OLSON JMM, 1988, EUR J PHARMACOL, V152, P47, DOI 10.1016/0014-2999(88)90834-5; Owen DRJ, 2011, J NUCL MED, V52, P24, DOI 10.2967/jnumed.110.079459; Papadopoulos V, 2006, TRENDS PHARMACOL SCI, V27, P402, DOI 10.1016/j.tips.2006.06.005; PENNEY JB, 1981, EUR J PHARMACOL, V72, P421, DOI 10.1016/0014-2999(81)90591-4; Qi JY, 1998, PHYS MED BIOL, V43, P1001, DOI 10.1088/0031-9155/43/4/027; Rosenberg N, 2006, J BONE JOINT SURG BR, V88-B, P342; RUFF MR, 1985, SCIENCE, V229, P1281, DOI 10.1126/science.2994216; Schule C, 2011, NEUROSCIENCE, V191, P55, DOI 10.1016/j.neuroscience.2011.03.025; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Wilms H, 2003, NEUROBIOL DIS, V14, P417, DOI 10.1016/j.nbd.2003.07.002; WOODARD HQ, 1975, J NUCL MED, V16, P958; Zheng Y, 2007, CANCER RES, V67, P9542, DOI 10.1158/0008-5472.CAN-07-1046	40	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30623	10.1371/journal.pone.0030623	http://dx.doi.org/10.1371/journal.pone.0030623			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295097	Green Published, Green Submitted, gold			2022-12-27	WOS:000301640600042
J	Kawai, Y; Kimura, Y; Lezhava, A; Kanamori, H; Usui, K; Hanami, T; Soma, T; Morlighem, JE; Saga, S; Ishizu, Y; Aoki, S; Endo, R; Oguchi-Katayama, A; Kogo, Y; Mitani, Y; Ishidao, T; Kawakami, C; Kurata, H; Furuya, Y; Saito, T; Okazaki, N; Chikahira, M; Hayashi, E; Tsuruoka, S; Toguchi, T; Saito, Y; Ban, T; Izumi, S; Uryu, H; Kudo, K; Sakai-Tagawa, Y; Kawaoka, Y; Hirai, A; Hayashizaki, Y; Ishikawa, T				Kawai, Yuki; Kimura, Yasumasa; Lezhava, Alexander; Kanamori, Hajime; Usui, Kengo; Hanami, Takeshi; Soma, Takahiro; Morlighem, Jean-Etienne; Saga, Satomi; Ishizu, Yuri; Aoki, Shintaro; Endo, Ryuta; Oguchi-Katayama, Atsuko; Kogo, Yasushi; Mitani, Yasumasa; Ishidao, Takefumi; Kawakami, Chiharu; Kurata, Hideshi; Furuya, Yumiko; Saito, Takayuki; Okazaki, Norio; Chikahira, Masatsugu; Hayashi, Eiji; Tsuruoka, Sei-ichi; Toguchi, Tokumichi; Saito, Yoshitomo; Ban, Toshiaki; Izumi, Shinyu; Uryu, Hideko; Kudo, Koichiro; Sakai-Tagawa, Yuko; Kawaoka, Yoshihiro; Hirai, Aizan; Hayashizaki, Yoshihide; Ishikawa, Toshihisa			One-Step Detection of the 2009 Pandemic Influenza A(H1N1) Virus by the RT-SmartAmp Assay and Its Clinical Validation	PLOS ONE			English	Article							ISOTHERMAL AMPLIFICATION; SNP DETECTION; ORIGIN; DIAGNOSIS; INFECTION; ACCURATE; PRIMER	Background: In 2009, a pandemic (pdm) influenza A(H1N1) virus infection quickly circulated globally resulting in about 18,000 deaths around the world. In Japan, infected patients accounted for 16% of the total population. The possibility of human-to-human transmission of highly pathogenic novel influenza viruses is becoming a fear for human health and society. Methodology: To address the clinical need for rapid diagnosis, we have developed a new method, the "RT-SmartAmp assay'', to rapidly detect the 2009 pandemic influenza A(H1N1) virus from patient swab samples. The RT-SmartAmp assay comprises both reverse transcriptase (RT) and isothermal DNA amplification reactions in one step, where RNA extraction and PCR reaction are not required. We used an exciton-controlled hybridization-sensitive fluorescent primer to specifically detect the HA segment of the 2009 pdm influenza A(H1N1) virus within 40 minutes without cross-reacting with the seasonal A(H1N1), A(H3N2), or B-type (Victoria) viruses. Results and Conclusions: We evaluated the RT-SmartAmp method in clinical research carried out in Japan during a pandemic period of October 2009 to January 2010. A total of 255 swab samples were collected from outpatients with influenza-like illness at three hospitals and eleven clinics located in the Tokyo and Chiba areas in Japan. The 2009 pdm influenza A(H1N1) virus was detected by the RT-SmartAmp assay, and the detection results were subsequently compared with data of current influenza diagnostic tests (lateral flow immuno-chromatographic tests) and viral genome sequence analysis. In conclusion, by the RT-SmartAmp assay we could detect the 2009 pdm influenza A(H1N1) virus in patients' swab samples even in early stages after the initial onset of influenza symptoms. Thus, the RT-SmartAmp assay is considered to provide a simple and practical tool to rapidly detect the 2009 pdm influenza A(H1N1) virus.	[Kawai, Yuki; Kimura, Yasumasa; Lezhava, Alexander; Kanamori, Hajime; Usui, Kengo; Hanami, Takeshi; Soma, Takahiro; Morlighem, Jean-Etienne; Saga, Satomi; Ishizu, Yuri; Aoki, Shintaro; Endo, Ryuta; Oguchi-Katayama, Atsuko; Kogo, Yasushi; Mitani, Yasumasa; Ishidao, Takefumi; Hayashizaki, Yoshihide; Ishikawa, Toshihisa] RIKEN Yokohama Inst, Om Sci Ctr, Tsurumi Ku, Yokohama, Kanagawa, Japan; [Kawakami, Chiharu; Kurata, Hideshi] Yokohama City Inst Hlth, Isogo Ku, Yokohama, Kanagawa 2350012, Japan; [Furuya, Yumiko; Saito, Takayuki; Okazaki, Norio] Kanagawa Prefectural Inst Publ Hlth, Chigasaki, Kanagawa 2530087, Japan; [Chikahira, Masatsugu] Hyogo Prefectural Inst Publ Hlth & Consumer Sci, Hyogo Ku, Kobe, Hyogo, Japan; [Hayashi, Eiji; Tsuruoka, Sei-ichi; Toguchi, Tokumichi; Hirai, Aizan] Chiba Prefectural Togane Hosp, Togane, Japan; [Saito, Yoshitomo; Ban, Toshiaki] Isumi Med Ctr, Isumi, Japan; [Izumi, Shinyu; Uryu, Hideko; Kudo, Koichiro] Natl Ctr Global Hlth & Med, Shinjuku Ku, Tokyo, Japan; [Sakai-Tagawa, Yuko; Kawaoka, Yoshihiro] Univ Tokyo, Inst Med Sci, Minato Ku, Tokyo, Japan	RIKEN; National Center for Global Health & Medicine - Japan; University of Tokyo	Kawai, Y (corresponding author), RIKEN Yokohama Inst, Om Sci Ctr, Tsurumi Ku, Yokohama, Kanagawa, Japan.	toshi-i@gsc.riken.jp	Hanami, Takeshi/C-3653-2017; Kimura, Yasumasa/M-9720-2013; Hayashizaki, Yoshihide/N-6590-2015; Kogo, Yasushi/N-5385-2015; Usui, Kengo/A-7203-2016	Hanami, Takeshi/0000-0003-1868-1409; Morlighem, Jean-Etienne/0000-0003-2754-8677	Special Coordination Funds for Promoting Science and Technology; RIKEN Omics Science Center from the Ministry of Education, Culture, Sports, Science and Technology; Grants-in-Aid for Scientific Research [23590145] Funding Source: KAKEN	Special Coordination Funds for Promoting Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); RIKEN Omics Science Center from the Ministry of Education, Culture, Sports, Science and Technology; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Special Coordination Funds for Promoting Science and Technology and a research grant for RIKEN Omics Science Center (to YH) from the Ministry of Education, Culture, Sports, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; Anonymous, 2009, Morbidity and Mortality Weekly Report, V58, P453; [Anonymous], 2009, NOV INFL; Claas ECJ, 1998, LANCET, V351, P472, DOI 10.1016/S0140-6736(97)11212-0; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fereidouni SR, 2009, EUROSURVEILLANCE, V14; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Gill P, 2008, NUCLEOS NUCLEOT NUCL, V27, P224, DOI 10.1080/15257770701845204; Hatano B, 2011, J MED VIROL, V83, P568, DOI 10.1002/jmv.22031; Ikeda S, 2009, ANGEW CHEM INT EDIT, V48, P6480, DOI 10.1002/anie.200902000; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Jeong YJ, 2009, CELL MOL LIFE SCI, V66, P3325, DOI 10.1007/s00018-009-0094-3; Jhung M., 2010, Morbidity and Mortality Weekly Report, V59, P423; Kimura Y, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr041; Kiso M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001079; Kubo T, 2010, J CLIN MICROBIOL, V48, P728, DOI 10.1128/JCM.01481-09; Lezhava A, 2009, METHODS MOL BIOL, V578, P437, DOI 10.1007/978-1-60327-411-1_28; Lezhava A, 2010, HUM MUTAT, V31, P208, DOI 10.1002/humu.21177; LUOH SM, 1992, J VIROL, V66, P1066, DOI 10.1128/JVI.66.2.1066-1073.1992; Mitani Y, 2007, NAT METHODS, V4, P257, DOI 10.1038/NMETH1007; Mitani Y, 2009, PHARMACOGENOMICS, V10, P1187, DOI [10.2217/pgs.09.39, 10.2217/PGS.09.39]; Mori Y, 2009, J INFECT CHEMOTHER, V15, P62, DOI 10.1007/s10156-009-0669-9; Morlighem JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018956; Nakauchi M, 2011, J MED VIROL, V83, P10, DOI 10.1002/jmv.21934; Nelson M., 2009, PLOS CURR, V1, DOI [DOI 10.1371/CURRENTS.RRN1126, 10.1371/currents.RRN1126]; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Niemz A, 2011, TRENDS BIOTECHNOL, V29, P240, DOI 10.1016/j.tibtech.2011.01.007; Pan CE, 2010, PLOS ONE, V5, pA31, DOI 10.1371/journal.pone.0009549; Reid AH, 1999, P NATL ACAD SCI USA, V96, P1651, DOI 10.1073/pnas.96.4.1651; Sakai-Tagawa Y, 2010, J CLIN MICROBIOL, V48, P2872, DOI 10.1128/JCM.00439-10; Schnitzler SU, 2009, VIRUS GENES, V39, P279, DOI 10.1007/s11262-009-0404-8; Shiino T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011057; Subbarao K, 1998, SCIENCE, V279, P393, DOI 10.1126/science.279.5349.393; Tanaka Y, 2010, BIOTECHNIQUES, V49, P888, DOI 10.2144/000113566; Taubenberger JK, 1997, SCIENCE, V275, P1793, DOI 10.1126/science.275.5307.1793; Trifonov V, 2009, NEW ENGL J MED, V361, P115, DOI 10.1056/NEJMp0904572; World Health Organization, 2010, PAND H1N1 2009; Xu R, 2010, SCIENCE, V328, P357, DOI 10.1126/science.1186430; Yuen KY, 1998, LANCET, V351, P467, DOI 10.1016/S0140-6736(98)01182-9; Zhou B, 2009, J VIROL, V83, P10309, DOI 10.1128/JVI.01109-09	41	17	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30236	10.1371/journal.pone.0030236	http://dx.doi.org/10.1371/journal.pone.0030236			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295077	gold, Green Submitted, Green Published			2022-12-27	WOS:000301640600022
J	Rao, HL; Chen, JW; Li, M; Xiao, YB; Fu, J; Zeng, YX; Cai, MY; Xie, D				Rao, Hui-Lan; Chen, Jie-Wei; Li, Mei; Xiao, Yong-Bo; Fu, Jia; Zeng, Yi-Xin; Cai, Mu-Yan; Xie, Dan			Increased Intratumoral Neutrophil in Colorectal Carcinomas Correlates Closely with Malignant Phenotype and Predicts Patients' Adverse Prognosis	PLOS ONE			English	Article							CANCER PROGRESSION; EXPRESSION; CELLS; METASTASIS; INVASION; MODEL	Background: Substantial evidence suggests that the presence of inflammatory cells plays a critical role in the development and/or progression of human tumors. Neutrophils are the common inflammatory cells in tumors; however, the infiltration of intratumoral neutrophils in colorectal carcinoma (CRC) and its effect on CRC patients' prognosis are poorly understood. Methodology/Principal Findings: In this study, the methods of tissue microarray and immunohistochemistry (IHC) were used to investigate the prognostic significance of intratumoral CD66b+ neutrophil in CRC. According to receiver operating characteristic curve analysis, the cutoff score for high intratumoral CD66b+ neutrophil in CRC was defined when the mean counts were more than 60 per TMA spot. In our study, high intratumoral CD66b+ neutrophil was observed in 104/229 (45.4%) of CRCs and in 29/229 (12.7%) of adjacent mucosal tissues. Further correlation analysis showed that high intratumoral neutrophil was positively correlated with pT status, pM status and clinical stage (P<0.05). In univariate survival analysis, a significant association between high intratumoral neutrophil and shortened patients' survival was found (P<0.0001). In different subsets of CRC patients, intratumoral neutrophil was also a prognostic indicator in patients with stage II, stage III, grade 2, grade 3, pT1, pT2, pN0 and pN1 (P<0.05). Importantly, high intratumoral neutrophil was evaluated as an independent prognostic factor in multivariate analysis (P<0.05). Conclusions/Significance: Our results provide evidence that increased intratumoral neutrophil in CRC may be important in the acquisition of a malignant phenotype, indicating that the presence of intratumoral neutrophil is an independent factor for poor prognosis of patients with CRC.	[Rao, Hui-Lan; Chen, Jie-Wei; Li, Mei; Xiao, Yong-Bo; Fu, Jia; Zeng, Yi-Xin; Cai, Mu-Yan; Xie, Dan] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol S China, Guangzhou 510275, Guangdong, Peoples R China; [Rao, Hui-Lan; Chen, Jie-Wei; Li, Mei; Xiao, Yong-Bo; Fu, Jia; Cai, Mu-Yan; Xie, Dan] Sun Yat Sen Univ, Ctr Canc, Dept Pathol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Rao, HL (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol S China, Guangzhou 510275, Guangdong, Peoples R China.	caimuyan@hotmail.com; xied@mail.sysu.edu.cn			Medical Science Technology Research Foundation of Guangdong [303041012001]; Nature Science Foundation of China [30972884]	Medical Science Technology Research Foundation of Guangdong; Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Medical Science Technology Research Foundation of Guangdong (No. 303041012001) and the Nature Science Foundation of China (No. 30972884). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cai MY, 2011, GUT, V60, P967, DOI 10.1136/gut.2010.231993; Cai MY, 2010, CANCER SCI, V101, P1543, DOI 10.1111/j.1349-7006.2010.01560.x; Campregher C, 2008, GUT, V57, P780, DOI 10.1136/gut.2007.141556; Chua W, 2011, BRIT J CANCER, V104, P1288, DOI 10.1038/bjc.2011.100; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; Eck M, 2003, CLIN EXP IMMUNOL, V134, P508, DOI 10.1111/j.1365-2249.2003.02305.x; Fridlender ZG, 2009, CANCER CELL, V16, P183, DOI 10.1016/j.ccr.2009.06.017; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; GRISHAM MB, 1992, GASTROENTEROLOGY, V103, P1260, DOI 10.1016/0016-5085(92)91513-4; Hu LM, 2009, LAB INVEST, V89, P531, DOI 10.1038/labinvest.2009.17; Ilie M, 2011, CANCER IN PRESS; Jensen HK, 2009, J CLIN ONCOL, V27, P4709, DOI 10.1200/JCO.2008.18.9498; Jensen TO, 2011, CANCER IN PRESS; Kuang DM, 2011, J HEPATOL, V54, P948, DOI 10.1016/j.jhep.2010.08.041; Li YW, 2011, J HEPATOL, V54, P497, DOI 10.1016/j.jhep.2010.07.044; Mantovani A, 2009, CANCER CELL, V16, P173, DOI 10.1016/j.ccr.2009.08.014; Mantovani A, 2009, NATURE, V457, P36, DOI 10.1038/457036b; McLean MH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015366; Mookerjee RP, 2007, HEPATOLOGY, V46, P831, DOI 10.1002/hep.21737; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Nielsen HJ, 1999, J PATHOL, V189, P487, DOI 10.1002/(SICI)1096-9896(199912)189:4<487::AID-PATH484>3.0.CO;2-I; O'Connell JB, 2004, JNCI-J NATL CANCER I, V96, P1420, DOI 10.1093/jnci/djh275; Obrand DI, 1997, DIS COLON RECTUM, V40, P15, DOI 10.1007/BF02055676; Shojaei F, 2008, P NATL ACAD SCI USA, V105, P2640, DOI 10.1073/pnas.0712185105; Sun Y, 2011, CLIN CANCER RES, V17, P4331, DOI 10.1158/1078-0432.CCR-11-0226; Sun ZF, 2004, LANCET ONCOL, V5, P182, DOI 10.1016/S1470-2045(04)01414-7; Vermeer ITM, 2004, TOXICOL LETT, V154, P175, DOI 10.1016/j.toxlet.2004.07.013; You Wei-Cheng, 2002, J Cancer Epidemiol Prev, V7, P143; Zafirellis K, 2008, J SURG RES, V147, P99, DOI 10.1016/j.jss.2007.05.041; Zhu W, 2011, GUT IN PRESS	31	150	162	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30806	10.1371/journal.pone.0030806	http://dx.doi.org/10.1371/journal.pone.0030806			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295111	Green Published, Green Submitted, gold			2022-12-27	WOS:000301640600056
J	Ettorre, M; Lorenzetto, E; Laperchia, C; Baiguera, C; Branca, C; Benarese, M; Spano, P; Pizzi, M; Buffelli, M				Ettorre, Michele; Lorenzetto, Erika; Laperchia, Claudia; Baiguera, Cristina; Branca, Caterina; Benarese, Manuela; Spano, PierFranco; Pizzi, Marina; Buffelli, Mario			Glutamatergic Neurons Induce Expression of Functional Glutamatergic Synapses in Primary Myotubes	PLOS ONE			English	Article							RAT SKELETAL-MUSCLE; CEREBELLAR GRANULE CELLS; NEUROMUSCULAR-JUNCTION; AMPA RECEPTORS; SYNAPTIC PLASTICITY; DISTINCT MECHANISMS; NEURITE OUTGROWTH; IN-VIVO; AGRIN; NEUROTRANSMITTER	Background: The functioning of the nervous system depends upon the specificity of its synaptic contacts. The mechanisms triggering the expression of the appropriate receptors on postsynaptic membrane and the role of the presynaptic partner in the differentiation of postsynaptic structures are little known. Methods and Findings: To address these questions we cocultured murine primary muscle cells with several glutamatergic neurons, either cortical, cerebellar or hippocampal. Immunofluorescence and electrophysiology analyses revealed that functional excitatory synaptic contacts were formed between glutamatergic neurons and muscle cells. Moreover, immunoprecipitation and immunofluorescence experiments showed that typical anchoring proteins of central excitatory synapses coimmunoprecipitate and colocalize with rapsyn, the acetylcholine receptor anchoring protein at the neuromuscular junction. Conclusions: These results support an important role of the presynaptic partner in the induction and differentiation of the postsynaptic structures.	[Ettorre, Michele; Lorenzetto, Erika; Laperchia, Claudia; Buffelli, Mario] Univ Verona, Dept Neurol Neuropsychol Morphol & Movement Sci, Sect Physiol & Psychol, I-37100 Verona, Italy; [Baiguera, Cristina; Branca, Caterina; Benarese, Manuela; Spano, PierFranco; Pizzi, Marina] Univ Brescia, Dept Biomed Sci & Biotechnol, Brescia, Italy; [Ettorre, Michele; Lorenzetto, Erika; Laperchia, Claudia; Baiguera, Cristina; Branca, Caterina; Benarese, Manuela; Spano, PierFranco; Pizzi, Marina; Buffelli, Mario] Natl Inst Neurosci, Rome, Italy; [Ettorre, Michele; Buffelli, Mario] Univ Verona, Ctr Biomed Comp, I-37100 Verona, Italy; [Spano, PierFranco; Pizzi, Marina] San Camillo Hosp, Ist Ricovero & Cura Carattere Sci, Venice, Italy	University of Verona; University of Brescia; University of Verona; IRCCS Ospedale San Camillo	Ettorre, M (corresponding author), Univ Verona, Dept Neurol Neuropsychol Morphol & Movement Sci, Sect Physiol & Psychol, I-37100 Verona, Italy.	Mario.buffelli@univr.it	Buffelli, Mario/C-6953-2018; Spano, Pier Franco A/E-7621-2010; SPANO, PIERFRANCO/J-9944-2016; Pizzi, Marina/K-2064-2016	Buffelli, Mario/0000-0002-3709-013X; SPANO, PIERFRANCO/0000-0002-9906-0964; Pizzi, Marina/0000-0002-4857-5204	University of Verona; Fondazione Cariverona	University of Verona; Fondazione Cariverona(Fondazione Cariverona)	This study was supported by University of Verona (http://www.univr.it) and Fondazione Cariverona (http://www.fondazionecariverona.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bleakman D, 1996, NEUROPHARMACOLOGY, V35, P1689, DOI 10.1016/S0028-3908(96)00156-6; Borodinsky LN, 2007, P NATL ACAD SCI USA, V104, P335, DOI 10.1073/pnas.0607450104; Borodinsky LN, 2004, NATURE, V429, P523, DOI 10.1038/nature02518; Bruneau EG, 2009, FASEB J, V23, P679, DOI 10.1096/fj.08-107946; Brunelli G, 2005, P NATL ACAD SCI USA, V102, P8752, DOI 10.1073/pnas.0500530102; Burgess RW, 1999, NEURON, V23, P33, DOI 10.1016/S0896-6273(00)80751-5; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Craig AM, 2006, TRENDS NEUROSCI, V29, P8, DOI 10.1016/j.tins.2005.11.002; Craig AM, 2007, CURR OPIN NEUROBIOL, V17, P43, DOI 10.1016/j.conb.2007.01.011; D'MELLO SR, 1993, P NATL ACAD SCI USA, V90, P10989, DOI 10.1073/pnas.90.23.10989; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9; Escher P, 2005, SCIENCE, V308, P1920, DOI 10.1126/science.1108258; FIELDS RD, 1990, J NEUROSCI, V10, P2950; Francolini M, 2009, J NEUROPATH EXP NEUR, V68, P1103, DOI 10.1097/NEN.0b013e3181b7bfc8; Gallant EM, 1996, MUSCLE NERVE, V19, P450, DOI 10.1002/(SICI)1097-4598(199604)19:4<450::AID-MUS4>3.0.CO;2-B; GALLI C, 1995, J NEUROSCI, V15, P1172; Garner CC, 2006, CELL TISSUE RES, V326, P249, DOI 10.1007/s00441-006-0278-1; GAUTAM M, 1995, NATURE, V377, P232, DOI 10.1038/377232a0; Goda Y, 2003, NEURON, V40, P243, DOI 10.1016/S0896-6273(03)00608-1; Herbst R, 2002, DEVELOPMENT, V129, P5449, DOI 10.1242/dev.00112; Hirai H, 2005, NAT NEUROSCI, V8, P1534, DOI 10.1038/nn1576; Jin CY, 2002, EUR J NEUROSCI, V15, P1125, DOI 10.1046/j.1460-9568.2002.01951.x; JO SA, 1995, NATURE, V373, P158, DOI 10.1038/373158a0; Kummer TT, 2006, CURR OPIN NEUROBIOL, V16, P74, DOI 10.1016/j.conb.2005.12.003; Mays TA, 2009, MUSCLE NERVE, V39, P343, DOI 10.1002/mus.21099; McAllister AM, 2007, ANNU REV NEUROSCI, V30, P425, DOI 10.1146/annurev.neuro.29.051605.112830; MCMAHAN UJ, 1990, COLD SPRING HARB SYM, V55, P407; Misgeld T, 2002, NEURON, V36, P635, DOI 10.1016/S0896-6273(02)01020-6; NITKIN RM, 1987, J CELL BIOL, V105, P2471, DOI 10.1083/jcb.105.6.2471; O'Brien RJ, 1999, NEURON, V23, P309, DOI 10.1016/S0896-6273(00)80782-5; OBATA K, 1977, BRAIN RES, V119, P141, DOI 10.1016/0006-8993(77)90096-8; Pinard A, 2003, EUR J NEUROSCI, V18, P3241, DOI 10.1111/j.1460-9568.2003.03028.x; Pizzi M, 2006, CURR OPIN NEUROBIOL, V16, P323, DOI 10.1016/j.conb.2006.05.013; Prakash YS, 1999, AM J PHYSIOL-CELL PH, V276, pC1038, DOI 10.1152/ajpcell.1999.276.5.C1038; Sandrock AW, 1997, SCIENCE, V276, P599, DOI 10.1126/science.276.5312.599; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Sans N, 2001, J NEUROSCI, V21, P7506, DOI 10.1523/JNEUROSCI.21-19-07506.2001; Shen K, 2010, ANN REV NEUROSCI; So KL, 1996, FEBS LETT, V379, P63, DOI 10.1016/0014-5793(95)01486-1; Spitzer NC, 2008, PHILOS T R SOC B, V363, P1393, DOI 10.1098/rstb.2007.2257; Szabados T, 2001, BRAIN RES BULL, V55, P387, DOI 10.1016/S0361-9230(01)00516-0; Takayama C, 2004, DEV BRAIN RES, V150, P177, DOI 10.1016/j.devbrainres.2004.03.011; Trinidad JC, 2000, J NEUROSCI, V20, P8762; Tsui CC, 1996, J NEUROSCI, V16, P2463; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Wu HT, 2010, DEVELOPMENT, V137, P1017, DOI 10.1242/dev.038711; Yu XY, 2002, CELL MOL NEUROBIOL, V22, P197, DOI 10.1023/A:1019870022977; Zhang B, 2008, NEURON, V60, P285, DOI 10.1016/j.neuron.2008.10.006	51	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2012	7	2							e31451	10.1371/journal.pone.0031451	http://dx.doi.org/10.1371/journal.pone.0031451			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZQ	22347480	Green Published, Green Submitted, gold			2022-12-27	WOS:000302730200023
J	Li, XS; Liu, ZB; Xu, X; Blair, CA; Sun, Z; Xie, J; Lilly, MB; Zi, XL				Li, Xuesen; Liu, Zhongbo; Xu, Xia; Blair, Christopher A.; Sun, Zheng; Xie, Jun; Lilly, Michael B.; Zi, Xiaolin			Kava Components Down-Regulate Expression of AR and AR Splice Variants and Reduce Growth in Patient-Derived Prostate Cancer Xenografts in Mice	PLOS ONE			English	Article							ANDROGEN RECEPTOR PROMOTER; TUMOR-GROWTH; FLAVOKAWAIN; CHALCONE; ANTIANDROGEN; RESISTANCE; MORTALITY; APOPTOSIS; THERAPY; CELLS	Men living in Fiji and drinking kava have low incidence of prostate cancer (PCa). However, the PCa incidence among Fijian men who had migrated to Australia, increased by 5.1-fold. We therefore examined the potential effects of kava root extracts and its active components (kavalactones and flavokawains) on PCa growth and androgen receptor (AR) expression. PCa cell lines (LNCaP, LAPC-4, 22Rv1, C4-2B, DU145 and PC-3) with different AR expression, and a transformed prostate myofibroblast cell line (WPMY-1), were treated with a commercial kava extract, kavalactones (kawain, 5'6'-dehydrokawain, yangonin, methysticin) and flavokawain B. Expression of AR and its target genes (PSA and TMPRSS2) was examined. Two novel patient-derived PCa xenograft models from high grade PCa specimens were established by implanting the specimens into nude mice and passing tumor pieces through subcutaneous injection in nude mice, and then treated with kava extract and flavokawain B to examine their effects on tumor growth, AR expression and serum PSA levels. The kava extract and flavokawain B effectively down-regulated the expression of both the full-length AR and AR splice variants. The kava extract and kavalactones accelerated AR protein degradation, while flavokawain B inhibited AR mRNA transcription via decreasing Sp1 expression and the binding of Sp1 to the AR promoter. The kava root extract and flavokawain B reduce tumor growth, AR expression in tumor tissues and levels of serum PSA in the patient-derived PCa xenograft models. These results suggest a potential usefulness of a safe kava product or its active components for prevention and treatment of advanced PCa by targeting AR.	[Li, Xuesen; Liu, Zhongbo; Xu, Xia; Blair, Christopher A.; Sun, Zheng; Zi, Xiaolin] Univ Calif Irvine, Dept Urol, Orange, CA 92668 USA; [Xie, Jun; Zi, Xiaolin] Univ Calif Irvine, Dept Pharmaceut Sci, Orange, CA 92668 USA; [Blair, Christopher A.; Zi, Xiaolin] Univ Calif Irvine, Dept Pharmacol, Orange, CA 92668 USA; [Lilly, Michael B.] Univ Calif Irvine, Dept Med, Orange, CA 92668 USA; [Lilly, Michael B.; Zi, Xiaolin] Univ Calif Irvine, Chao Family Comprehens Canc Ctr, Orange, CA 92668 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Li, XS (corresponding author), Univ Calif Irvine, Dept Urol, Orange, CA 92668 USA.	xzi@uci.edu	Liu, Zhongbo/U-3004-2017		National Institutes of Health [CA129793, CA122558]; American Institute for Cancer Research [41493]; NATIONAL CANCER INSTITUTE [R01CA122558, R21CA152804, P30CA062203, R21CA129793] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Institute for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health grants CA129793 and CA122558 (http://www.cancer.gov/)and American Institute for Cancer Research grant 41493(http://www.aicr.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen RJ, 2010, CANCER CELL, V17, P535, DOI 10.1016/j.ccr.2010.04.027; Andriole GL, 2010, NEW ENGL J MED, V362, P1192, DOI 10.1056/NEJMoa0908127; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; FABER PW, 1993, J BIOL CHEM, V268, P9296; Foster WR, 2011, PROSTATE, V71, P480, DOI 10.1002/pros.21263; HAENSZEL W, 1968, JNCI-J NATL CANCER I, V40, P43; Henderson B E, 1985, Natl Cancer Inst Monogr, V69, P73; Hu R, 2011, PROSTATE, V71, P1656, DOI 10.1002/pros.21382; Jansen AAAJ, 1991, FOOD NUTR FIJI HIST; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Mostaghel EA, 2011, CLIN CANCER RES, V17, P5913, DOI 10.1158/1078-0432.CCR-11-0728; Scher HI, 2010, LANCET, V375, P1437, DOI 10.1016/S0140-6736(10)60172-9; Sharifi N, 2010, ENDOCR-RELAT CANCER, V17, pR305, DOI 10.1677/ERC-10-0187; SINGH YN, 1992, J ETHNOPHARMACOL, V37, P13, DOI 10.1016/0378-8741(92)90003-A; Steiner G G, 2000, Hawaii Med J, V59, P420; Supramaniam Rajah, 2006, CANC NEW S WALES MIG, P33; Takane KK, 1996, MOL CELL ENDOCRINOL, V119, P83, DOI 10.1016/0303-7207(96)03800-2; Tang YX, 2010, INT J CANCER, V127, P1758, DOI 10.1002/ijc.25210; Tang YX, 2008, CANCER PREV RES, V1, P439, DOI 10.1158/1940-6207.CAPR-08-0165; Tang YX, 2009, MOL CANCER THER, V8, P458, DOI 10.1158/1535-7163.MCT-08-0885; Thompson IM, 2003, NEW ENGL J MED, V349, P215, DOI 10.1056/NEJMoa030660; Tran C, 2009, SCIENCE, V324, P787, DOI 10.1126/science.1168175; Wang LG, 2008, CANCER RES, V68, P2678, DOI 10.1158/0008-5472.CAN-07-6017; Wang YW, 2005, LAB INVEST, V85, P1392, DOI 10.1038/labinvest.3700335; Wang YZ, 2005, PROSTATE, V64, P149, DOI 10.1002/pros.20225; Webber MM, 1999, CARCINOGENESIS, V20, P1185, DOI 10.1093/carcin/20.7.1185; Yu S., 2011, PROSTATE; Zi XL, 2005, CANCER RES, V65, P3479, DOI 10.1158/0008-5472.CAN-04-3803	28	44	44	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2012	7	2							e31213	10.1371/journal.pone.0031213	http://dx.doi.org/10.1371/journal.pone.0031213			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZQ	22347450	Green Published, gold			2022-12-27	WOS:000302730200015
J	Rijken, MJ; Papageorghiou, AT; Thiptharakun, S; Kiricharoen, S; Dwell, SLM; Wiladphaingern, J; Pimanpanarak, M; Kennedy, SH; Nosten, F; McGready, R				Rijken, Marcus J.; Papageorghiou, Aris T.; Thiptharakun, Supan; Kiricharoen, Suporn; Dwell, Saw Lu Mu; Wiladphaingern, Jacher; Pimanpanarak, Mupawjay; Kennedy, Stephen H.; Nosten, Francois; McGready, Rose			Ultrasound Evidence of Early Fetal Growth Restriction after Maternal Malaria Infection	PLOS ONE			English	Article							THAI-BURMESE BORDER; LOW-BIRTH-WEIGHT; FALCIPARUM-MALARIA; PLASMODIUM-VIVAX; PREGNANCY; 1ST-TRIMESTER; VELOCITY; PATHOGENESIS; ENDEMICITY; REFUGEES	Background: Intermittent preventive treatment (IPT), the main strategy to prevent malaria and reduce anaemia and low birthweight, focuses on the second half of pregnancy. However, intrauterine growth restriction may occur earlier in pregnancy. The aim of this study was to measure the effects of malaria in the first half of pregnancy by comparing the fetal biparietal diameter (BPD) of infected and uninfected women whose pregnancies had been accurately dated by crown rump length (CRL) before 14 weeks of gestation. Methodology/Principal Findings: In 3,779 women living on the Thai-Myanmar border who delivered a normal singleton live born baby between 2001-10 and who had gestational age estimated by CRL measurement <14 weeks, the observed and expected BPD z-scores (<24 weeks) in pregnancies that were (n = 336) and were not (n = 3,443) complicated by malaria between the two scans were compared. The mean (standard deviation) fetal BPD z-scores in women with Plasmodium (P) falciparum and/or P. vivax malaria infections were significantly lower than in non-infected pregnancies; -0.57 (1.13) versus -0.10 (1.17), p<0.001. Even a single or an asymptomatic malaria episode resulted in a significantly lower z-score. Fetal female sex (p<0.001) and low body mass index (p = 0.01) were also independently associated with a smaller BPD in multivariate analysis. Conclusions/Significance: Despite early treatment in all positive women, one or more (a) symptomatic P. falciparum or P. vivax malaria infections in the first half of pregnancy result in a smaller than expected mid-trimester fetal head diameter. Strategies to prevent malaria in pregnancy should include early pregnancy.	[Rijken, Marcus J.; Thiptharakun, Supan; Kiricharoen, Suporn; Dwell, Saw Lu Mu; Wiladphaingern, Jacher; Pimanpanarak, Mupawjay; Nosten, Francois; McGready, Rose] Shoklo Malaria Res Unit, Mae Sot, Tak, Thailand; [Papageorghiou, Aris T.; Kennedy, Stephen H.] Univ Oxford, Nuffield Dept Obstet & Gynaecol, Green Templeton Coll, Oxford, England; [Papageorghiou, Aris T.; Kennedy, Stephen H.] Univ Oxford, Oxford Maternal & Perinatal Hlth Inst, Green Templeton Coll, Oxford, England; [Nosten, Francois; McGready, Rose] Mahidol Univ, Mahidol Oxford Trop Med Res Unit, Bangkok 10700, Thailand; [Nosten, Francois; McGready, Rose] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford, England	Mahidol University; University of Oxford; University of Oxford; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Oxford	Rijken, MJ (corresponding author), Shoklo Malaria Res Unit, Mae Sot, Tak, Thailand.	marcus@shoklo-unit.com	McGready, Rose/A-3290-2014; Nosten, Francois/AAC-5509-2019	McGready, Rose/0000-0003-1621-3257; Nosten, Francois/0000-0002-7951-0745; Rijken, Marcus/0000-0003-0914-5508; Papageorghiou, Aris T./0000-0001-8143-2232	Wellcome Trust of Great Britain; Oxford Partnership Comprehensive Biomedical Research Centre; Department of Health NIHR Biomedical Research Centres	Wellcome Trust of Great Britain(Wellcome Trust); Oxford Partnership Comprehensive Biomedical Research Centre; Department of Health NIHR Biomedical Research Centres(National Institute for Health Research (NIHR))	This research was a part of the Wellcome Trust Mahidol University Oxford Tropical Medicine Research Programme, supported by the Wellcome Trust of Great Britain (Major Overseas Programme-Thailand Unit Core Grant). A T Papageorghiou is supported by the Oxford Partnership Comprehensive Biomedical Research Centre with funding from the Department of Health NIHR Biomedical Research Centres funding scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], BURMESE BORDER GUIDE; Arbeille P, 2003, PARASITOLOGY, V126, P513, DOI 10.1017/S0031182003003160; Bertino E, 1996, ARCH DIS CHILD-FETAL, V74, pF10, DOI 10.1136/fn.74.1.F10; Huynh BT, 2011, AM J TROP MED HYG, V85, P214, DOI 10.4269/ajtmh.2011.11-0103; Bottomley C, 2009, HUM REPROD, V24, P284, DOI 10.1093/humrep/den389; Brabin BJ, 2004, PLACENTA, V25, P359, DOI 10.1016/j.placenta.2003.10.019; Carrara VI, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-45; Carrara VI, 2006, PLOS MED, V3, P856, DOI 10.1371/journal.pmed.0030183; Carvalho BO, 2010, J INFECT DIS, V202, P638, DOI 10.1086/654815; Cottrell G, 2007, AM J TROP MED HYG, V76, P849, DOI 10.4269/ajtmh.2007.76.849; Dellicour S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000221; Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X; Dorman EK, 2002, ULTRASOUND OBST GYN, V19, P165, DOI 10.1046/j.0960-7692.2001.00545.x; Harris RD, 2009, J ULTRAS MED, V28, P1067, DOI 10.7863/jum.2009.28.8.1067; Hofmeyr GJ, 2009, ULTRASOUND OBST GYN, V34, P367, DOI 10.1002/uog.7352; Lampl M, 2003, AM J HUM BIOL, V15, P667, DOI 10.1002/ajhb.10204; Lampl M, 2001, ANN HUM BIOL, V28, P403, DOI 10.1080/03014460010016662; Lampl M, 2007, AM J HUM BIOL, V19, P643, DOI 10.1002/ajhb.20707; Lampl M, 2009, AM J HUM BIOL, V21, P782, DOI 10.1002/ajhb.20880; Landis SH, 2009, EPIDEMIOL INFECT, V137, P294, DOI 10.1017/S0950268808000915; Leung TN, 2008, ULTRASOUND OBST GYN, V31, P321, DOI 10.1002/uog.5192; Liabsuetrakul T, 2011, J HEALTH POPUL NUTR, V29, P218, DOI 10.3329/jhpn.v29i3.7869; Luxemburger C, 2003, T ROY SOC TROP MED H, V97, P251, DOI 10.1016/S0035-9203(03)90134-9; McGready R, 2011, LANCET INFECT DIS; Milani S, 2005, PEDIATR RES, V57, P205, DOI 10.1203/01.PDR.0000148452.98518.D5; Mook-Kanamori DO, 2010, JAMA-J AM MED ASSOC, V303, P527, DOI 10.1001/jama.2010.78; Mukri F, 2008, BJOG-INT J OBSTET GY, V115, P1273, DOI 10.1111/j.1471-0528.2008.01833.x; Neilson JP, 2000, COCHRANE DB SYST REV; Nosten F, 2004, TRENDS PARASITOL, V20, P425, DOI 10.1016/j.pt.2004.06.007; NOSTEN F, 1991, T ROY SOC TROP MED H, V85, P424, DOI 10.1016/0035-9203(91)90205-D; Nosten F, 1999, LANCET, V354, P546, DOI 10.1016/S0140-6736(98)09247-2; Nosten F, 2007, LANCET INFECT DIS, V7, P118, DOI 10.1016/S1473-3099(07)70023-3; Pedersen NG, 2008, ULTRASOUND OBST GYN, V32, P147, DOI 10.1002/uog.6109; Pedersen NG, 2008, OBSTET GYNECOL, V112, P765, DOI 10.1097/AOG.0b013e318187d034; Poespoprodjo JR, 2008, CLIN INFECT DIS, V46, P1374, DOI 10.1086/586743; Price RN, 2007, AM J TROP MED HYG, V77, P79, DOI 10.4269/ajtmh.2007.77.79; Rijken MJ, 2011, BJOG-INT J OBSTET GY, V118, P671, DOI 10.1111/j.1471-0528.2010.02880.x; Rijken MJ, 2009, ULTRASOUND OBST GYN, V34, P395, DOI 10.1002/uog.7350; Rijken MJ, 2012, LANCET INFECT DIS, V12, P75, DOI 10.1016/S1473-3099(11)70315-2; Rijken MJ, 2011, THAI BURMES IN PRESS; ROBINSON HP, 1975, BRIT J OBSTET GYNAEC, V82, P702, DOI 10.1111/j.1471-0528.1975.tb00710.x; Rogerson SJ, 2007, AM J TROP MED HYG, V77, P14; Rogerson SJ, 2007, LANCET INFECT DIS, V7, P105, DOI 10.1016/S1473-3099(07)70022-1; Salomon LJ, 2006, ULTRASOUND OBST GYN, V28, P193, DOI 10.1002/uog.2733; Salomon LJ, 2005, ULTRASOUND OBST GYN, V26, P750, DOI 10.1002/uog.2640; Smith GCS, 2004, SEMIN PERINATOL, V28, P41, DOI 10.1053/j.semperi.2003.10.012; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; TAHA TE, 1993, AM J EPIDEMIOL, V138, P318, DOI 10.1093/oxfordjournals.aje.a116861; Umbers AJ, 2011, TRENDS PARASITOL, V27, P168, DOI 10.1016/j.pt.2011.01.007; Villar J, 1982, Obstet Gynecol Surv, V37, P499, DOI 10.1097/00006254-198208000-00001; WHO, WHO STRAT FRAM MAL C; WHO, 2010, GUID TREATM MAL, V2nd	52	54	54	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2012	7	2							e31411	10.1371/journal.pone.0031411	http://dx.doi.org/10.1371/journal.pone.0031411			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZQ	22347473	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000302730200021
J	Jacobberger, JW; Avva, J; Sreenath, SN; Weis, MC; Stefan, T				Jacobberger, James W.; Avva, Jayant; Sreenath, Sree N.; Weis, Michael C.; Stefan, Tammy			Dynamic Epitope Expression from Static Cytometry Data: Principles and Reproducibility	PLOS ONE			English	Article							CELL-CYCLE; GENE-EXPRESSION; FLOW-CYTOMETRY; ANTIGEN LEVELS; QUANTIFICATION; PROTEIN; MITOSIS; LINES; B1	Background: An imprecise quantitative sense for the oscillating levels of proteins and their modifications, interactions, and translocations as a function of the cell cycle is fundamentally important for a cartoon/narrative understanding for how the cell cycle works. Mathematical modeling of the same cartoon/narrative models would be greatly enhanced by an open-ended methodology providing precise quantification of many proteins and their modifications, etc. Here we present methodology that fulfills these features. Methodology: Multiparametric flow cytometry was performed on Molt4 cells to measure cyclins A2 and B1, phospho-S10-histone H3, DNA content, and light scatter (cell size). The resulting 5 dimensional data were analyzed as a series of bivariate plots to isolate the data as segments of an N-dimensional "worm" through the data space. Sequential, unidirectional regions of the data were used to assemble expression profiles for each parameter as a function of cell frequency. Results: Analysis of synthesized data in which the true values where known validated the approach. Triplicate experiments demonstrated exceptional reproducibility. Comparison of three triplicate experiments stained by two methods (single cyclin or dual cyclin measurements with common DNA and phospho-histone H3 measurements) supported the feasibility of combining an unlimited number of epitopes through this methodology. The sequential degradations of cyclin A2 followed by cyclin B1 followed by de-phosphorylation of histone H3 were precisely mapped. Finally, a two phase expression rate during interphase for each cyclin was robustly identified. Conclusions: Very precise, correlated expression profiles for important cell cycle regulating and regulated proteins and their modifications can be produced, limited only by the number of available high-quality antibodies. These profiles can be assembled into large information libraries for calibration and validation of mathematical models.	[Jacobberger, James W.; Stefan, Tammy] Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Avva, Jayant; Sreenath, Sree N.; Weis, Michael C.] Case Western Reserve Univ, Dept Elect Engn & Comp Sci, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Jacobberger, JW (corresponding author), Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA.	jwj@case.edu	Jacobberger, James/P-9183-2014	Jacobberger, James/0000-0002-3092-5157	National Cancer Institute [R01CA73413, P30CA43703]; NATIONAL CANCER INSTITUTE [P30CA043703, R01CA073413] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants R01CA73413 (JWJ) and P30CA43703 (Case Comprehensive Cancer Center Core Facility Support) from the National Cancer Institute (http://www.cancer.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagwell CB, 2011, METHODS MOL BIOL, V699, P31, DOI 10.1007/978-1-61737-950-5_2; Darzynkiewicz Z, 2004, CYTOM PART A, V58A, P21, DOI 10.1002/cyto.a.20003; Darzynkiewicz Z, 1996, CYTOMETRY, V25, P1; FRIED J, 1976, COMPUT BIOMED RES, V9, P263, DOI 10.1016/0010-4809(76)90006-9; Frisa PS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007064; Frisa PS, 2000, CYTOMETRY, V39, P79, DOI 10.1002/(SICI)1097-0320(20000101)39:1<79::AID-CYTO11>3.0.CO;2-3; Frisa PS, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-10; Gray JW, 1990, FLOW CYTOMETRY CELL; Jacobberger JW, 2008, CYTOM PART A, V73A, P5, DOI 10.1002/cyto.a.20501; Jacobberger JW, 2011, METHODS MOL BIOL, V699, P229, DOI 10.1007/978-1-61737-950-5_11; Jacobberger JW, 1999, CYTOMETRY, V35, P284, DOI 10.1002/(SICI)1097-0320(19990301)35:3<284::AID-CYTO12>3.0.CO;2-K; Laoukili J, 2008, MOL CELL BIOL, V28, P3076, DOI 10.1128/MCB.01710-07; MINOWADA J, 1972, J NATL CANCER I, V49, P891; Perfetto SP, 2004, NAT REV IMMUNOL, V4, P648, DOI 10.1038/nri1416; Pines J, 2006, TRENDS CELL BIOL, V16, P55, DOI 10.1016/j.tcb.2005.11.006; Sible JC, 2007, METHODS, V41, P238, DOI 10.1016/j.ymeth.2006.08.003; SLADEK TL, 1993, CYTOMETRY, V14, P23, DOI 10.1002/cyto.990140106; Soni DV, 2008, CELL CYCLE, V7, P1285, DOI 10.4161/cc.7.9.5711; Sramkoski RM, 1999, CYTOMETRY, V35, P274, DOI 10.1002/(SICI)1097-0320(19990301)35:3<274::AID-CYTO11>3.0.CO;2-O; Stefan T, 2011, METHOD CELL BIOL, V102, P341, DOI 10.1016/B978-0-12-374912-3.00014-6; Tomasoni D, 2003, EXP CELL RES, V288, P158, DOI 10.1016/S0014-4827(03)00207-6; WALKER PMB, 1954, J EXP BIOL, V31, P8; Watson JV, 1991, INTRO FLOW CYTOMETRY	23	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e30870	10.1371/journal.pone.0030870	http://dx.doi.org/10.1371/journal.pone.0030870			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347408	Green Submitted, Green Published, gold			2022-12-27	WOS:000302730100027
J	Bol, SM; Booiman, T; van Manen, D; Bunnik, EM; van Sighem, AI; Sieberer, M; Boeser-Nunnink, B; de Wolf, F; Schuitemaker, H; Portegies, P; Kootstra, NA; van 't Wout, AB				Bol, Sebastiaan M.; Booiman, Thijs; van Manen, Danielle; Bunnik, Evelien M.; van Sighem, Ard I.; Sieberer, Margit; Boeser-Nunnink, Brigitte; de Wolf, Frank; Schuitemaker, Hanneke; Portegies, Peter; Kootstra, Neeltje A.; van 't Wout, Angelique B.			Single Nucleotide Polymorphism in Gene Encoding Transcription Factor Prep1 Is Associated with HIV-1-Associated Dementia	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NECROSIS-FACTOR-ALPHA; AIDS DEMENTIA; TYPE-1 INFECTION; CLINICAL-COURSE; HIV-SUBTYPE; BRAIN; EXPRESSION; PROMOTER; GENOTYPE	Background: Infection with HIV-1 may result in severe cognitive and motor impairment, referred to as HIV-1-associated dementia (HAD). While its prevalence has dropped significantly in the era of combination antiretroviral therapy, milder neurocognitive disorders persist with a high prevalence. To identify additional therapeutic targets for treating HIV-associated neurocognitive disorders, several candidate gene polymorphisms have been evaluated, but few have been replicated across multiple studies. Methods: We here tested 7 candidate gene polymorphisms for association with HAD in a case-control study consisting of 86 HAD cases and 246 non-HAD AIDS patients as controls. Since infected monocytes and macrophages are thought to play an important role in the infection of the brain, 5 recently identified single nucleotide polymorphisms (SNPs) affecting HIV-1 replication in macrophages in vitro were also tested. Results: The CCR5 wt/Delta 32 genotype was only associated with HAD in individuals who developed AIDS prior to 1991, in agreement with the observed fading effect of this genotype on viral load set point. A significant difference in genotype distribution among all cases and controls irrespective of year of AIDS diagnosis was found only for a SNP in candidate gene PREP1 (p = 1.2x10(-5)). Prep1 has recently been identified as a transcription factor preferentially binding the -2,518 G allele in the promoter of the gene encoding MCP-1, a protein with a well established role in the etiology of HAD. Conclusion: These results support previous findings suggesting an important role for MCP-1 in the onset of HIV-1-associated neurocognitive disorders.	[Bol, Sebastiaan M.; Booiman, Thijs; van Manen, Danielle; Bunnik, Evelien M.; Sieberer, Margit; Boeser-Nunnink, Brigitte; Schuitemaker, Hanneke; Kootstra, Neeltje A.; van 't Wout, Angelique B.] Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, Landsteiner Lab, NL-1105 AZ Amsterdam, Netherlands; [Bol, Sebastiaan M.; Booiman, Thijs; van Manen, Danielle; Bunnik, Evelien M.; Sieberer, Margit; Boeser-Nunnink, Brigitte; Schuitemaker, Hanneke; Kootstra, Neeltje A.; van 't Wout, Angelique B.] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, NL-1105 AZ Amsterdam, Netherlands; [van Sighem, Ard I.; de Wolf, Frank] Univ Amsterdam, Acad Med Ctr, HIV Monitoring Fdn, NL-1105 AZ Amsterdam, Netherlands; [de Wolf, Frank] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England; [Portegies, Peter] Univ Amsterdam, Acad Med Ctr, Dept Neurol, NL-1105 AZ Amsterdam, Netherlands; [Portegies, Peter] OLVG Hosp, Dept Neurol, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Imperial College London; University of Amsterdam; Academic Medical Center Amsterdam	Bol, SM (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, Landsteiner Lab, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	a.b.vantwout@amc.uva.nl		Kootstra, Neeltje A./0000-0001-9429-7754; Bunnik, Evelien/0000-0003-4003-3053; Bol, Sebastiaan/0000-0002-3843-6657	Center for Infectious Disease Control of the Netherlands National Institute for Public Health and the Environment; Landsteiner Foundation Blood Research [0526]; European Union [029167]	Center for Infectious Disease Control of the Netherlands National Institute for Public Health and the Environment; Landsteiner Foundation Blood Research; European Union(European Commission)	The Amsterdam Cohort Studies on HIV infection and AIDS, a collaboration between the Public Health Service of Amsterdam, the Academic Medical Center of the University of Amsterdam, the Sanquin Blood Supply Foundation, Jan van Goyen Medical Center, and the University Medical Center Utrecht, are part of the Netherlands HIV Monitoring Foundation and financially supported by the Center for Infectious Disease Control of the Netherlands National Institute for Public Health and the Environment.; Landsteiner Foundation Blood Research (registration number 0526) and the European Union (Marie Curie International Reintegration Grant 029167). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHIM CL, 1993, J CLIN INVEST, V91, P2769, DOI 10.1172/JCI116518; Antinori A, 2007, NEUROLOGY, V69, P1789, DOI 10.1212/01.WNL.0000287431.88658.8b; Ashton Katie A, 2006, Hered Cancer Clin Pract, V4, P94, DOI 10.1186/1897-4287-4-2-94; Banisadr G, 2005, J COMP NEUROL, V489, P275, DOI 10.1002/cne.20598; Bhaskaran K, 2008, ANN NEUROL, V63, P213, DOI 10.1002/ana.21225; Birchler JA, 2003, PLANT CELL, V15, P2236, DOI 10.1105/tpc.151030; Boivin MJ, 2010, AIDS, V24, P1163, DOI 10.1097/QAD.0b013e3283389dcc; Bol SM, 2011, FUTURE VIROL, V6, P187, DOI 10.2217/FVL.10.93; Bol SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017190; Bol SM, 2009, VIROLOGY, V390, P205, DOI 10.1016/j.virol.2009.05.027; BUKRINSKY MI, 1995, J EXP MED, V181, P735, DOI 10.1084/jem.181.2.735; Chen Y, 2008, KIDNEY INT, V74, P115, DOI 10.1038/ki.2008.113; Cirulli ET, 2010, EUR J HUM GENET, V18, P815, DOI 10.1038/ejhg.2010.2; Comings DE, 2000, MOL GENET METAB, V71, P19, DOI 10.1006/mgme.2000.3015; Corder EH, 1998, NAT MED, V4, P1182, DOI 10.1038/2677; Diaz-Arrastia R, 2004, J NEUROVIROL, V10, P67, DOI 10.1080/13550280490270770; Dunlop O, 1997, ACTA NEUROL SCAND, V95, P315, DOI 10.1111/j.1600-0404.1997.tb00217.x; GELBARD HA, 1994, J VIROL, V68, P4628, DOI 10.1128/JVI.68.7.4628-4635.1994; GENIS P, 1992, J EXP MED, V176, P1703, DOI 10.1084/jem.176.6.1703; GLASS JD, 1995, ANN NEUROL, V38, P755, DOI 10.1002/ana.410380510; Gonzalez E, 2002, P NATL ACAD SCI USA, V99, P13795, DOI 10.1073/pnas.202357499; Gonzalez-Scarano F, 2005, NAT REV IMMUNOL, V5, P69, DOI 10.1038/nri1527; GRIFFIN DE, 1994, ANN NEUROL, V35, P592, DOI 10.1002/ana.410350513; Harezlak J, 2011, AIDS; Heaton RK, 2010, NEUROLOGY, V75, P2087, DOI 10.1212/WNL.0b013e318200d727; Husman AMD, 1997, ANN INTERN MED, V127, P882, DOI 10.7326/0003-4819-127-10-199711150-00004; JANSSEN RS, 1991, NEUROLOGY, V41, P778; Jiang ZG, 2001, J NEUROIMMUNOL, V117, P97, DOI 10.1016/S0165-5728(01)00315-0; Kaul M, 1999, P NATL ACAD SCI USA, V96, P8212, DOI 10.1073/pnas.96.14.8212; Kroeger KM, 1997, MOL IMMUNOL, V34, P391, DOI 10.1016/S0161-5890(97)00052-7; Leduc V, 2010, TRENDS MOL MED, V16, P469, DOI 10.1016/j.molmed.2010.07.008; Levine Andrew J, 2009, Neurobehav HIV Med, V1, P1; MAGNUSON DSK, 1995, ANN NEUROL, V37, P373, DOI 10.1002/ana.410370314; Mishra M, 2008, ANN NEUROL, V63, P366, DOI 10.1002/ana.21292; Monforte AD, 2004, ANN NEUROL, V55, P320, DOI 10.1002/ana.10827; NAVIA BA, 1986, ANN NEUROL, V19, P517, DOI 10.1002/ana.410190602; Patel CA, 2000, J VIROL, V74, P9717, DOI 10.1128/JVI.74.20.9717-9726.2000; PELUSO R, 1985, VIROLOGY, V147, P231, DOI 10.1016/0042-6822(85)90246-6; Pemberton LA, 2008, HIV MED, V9, P677, DOI 10.1111/j.1468-1293.2008.00614.x; PORTEGIES P, 1993, AIDS, V7, P669, DOI 10.1097/00002030-199305000-00010; PULLIAM L, 1993, AIDS RES HUM RETROV, V9, P439, DOI 10.1089/aid.1993.9.439; Quasney MW, 2001, ANN NEUROL, V50, P157, DOI 10.1002/ana.1284.abs; Rovin BH, 1999, BIOCHEM BIOPH RES CO, V259, P344, DOI 10.1006/bbrc.1999.0796; Sacktor N, 2009, CLIN INFECT DIS, V49, P780, DOI 10.1086/605284; Sato-Matsumura KC, 1998, J NEUROIMMUNOL, V91, P89, DOI 10.1016/S0165-5728(98)00161-1; Schmidtmayerova H, 1996, P NATL ACAD SCI USA, V93, P700, DOI 10.1073/pnas.93.2.700; Schouten J, 2010, AIDS; Seilhean D, 1997, ACTA NEUROPATHOL, V93, P508, DOI 10.1007/s004010050646; Shiramizu B, 2006, J INVEST MED, V54, P468, DOI 10.2310/6650.2006.06007; Simioni S, 2010, AIDS, V24, P1243, DOI 10.1097/QAD.0b013e3283354a7b; Singh KK, 2004, J NEUROIMMUNOL, V157, P185, DOI 10.1016/j.jneuroim.2004.08.027; Takahashi K, 1996, ANN NEUROL, V39, P705, DOI 10.1002/ana.410390606; Thomas DC, 2002, CANCER EPIDEM BIOMAR, V11, P505; VAGO L, 1993, J ACQ IMMUN DEF SYND, V6, P42; van Manen D, 2011, AIDS, V25, P2217, DOI 10.1097/QAD.0b013e32834bec9c; van Manen D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022208; van Rij RP, 1998, J INFECT DIS, V178, P1806, DOI 10.1086/314522; van Rij RP, 1999, J INFECT DIS, V180, P854, DOI 10.1086/314940; Vivithanaporn P, 2010, NEUROLOGY, V75, P1150, DOI 10.1212/WNL.0b013e3181f4d5bb; WILEY CA, 1986, P NATL ACAD SCI USA, V83, P7089, DOI 10.1073/pnas.83.18.7089; Wilson AG, 1997, P NATL ACAD SCI USA, V94, P3195, DOI 10.1073/pnas.94.7.3195; Wright EK, 2008, GENES IMMUN, V9, P419, DOI 10.1038/gene.2008.33; Zemunik T, 2009, CROAT MED J, V50, P23, DOI 10.3325/cmj.2009.50.23; Zivelin A, 1997, CLIN CHEM, V43, P1657	64	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2012	7	2							e30990	10.1371/journal.pone.0030990	http://dx.doi.org/10.1371/journal.pone.0030990			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917MF	22347417	Green Published, Green Submitted, gold			2022-12-27	WOS:000302180600019
J	Kim, J; Yip, MLR; Shen, XM; Li, H; Hsin, LYC; Labarge, S; Heinrich, EL; Lee, W; Lu, JM; Vaidehi, N				Kim, Joseph; Yip, M. L. Richard; Shen, Xiaoming; Li, Hubert; Hsin, Li-Yu Charlie; Labarge, Samuel; Heinrich, Eileen L.; Lee, Wendy; Lu, Jianming; Vaidehi, Nagarajan			Identification of Anti-Malarial Compounds as Novel Antagonists to Chemokine Receptor CXCR4 in Pancreatic Cancer Cells	PLOS ONE			English	Article							SMALL-MOLECULE; PLASMODIUM-FALCIPARUM; BETA-ARRESTIN; EXPRESSION; GEMCITABINE; CHLOROQUINE; AUTOPHAGY; BICYCLAM; SCREEN; PROLIFERATION	Despite recent advances in targeted therapies, patients with pancreatic adenocarcinoma continue to have poor survival highlighting the urgency to identify novel therapeutic targets. Our previous investigations have implicated chemokine receptor CXCR4 and its selective ligand CXCL12 in the pathogenesis and progression of pancreatic intraepithelial neoplasia and invasive pancreatic cancer; hence, CXCR4 is a promising target for suppression of pancreatic cancer growth. Here, we combined in silico structural modeling of CXCR4 to screen for candidate anti-CXCR4 compounds with in vitro cell line assays and identified NSC56612 from the National Cancer Institute's (NCI) Open Chemical Repository Collection as an inhibitor of activated CXCR4. Next, we identified that NSC56612 is structurally similar to the established anti-malarial drugs chloroquine and hydroxychloroquine. We evaluated these compounds in pancreatic cancer cells in vitro and observed specific antagonism of CXCR4-mediated signaling and cell proliferation. Recent in vivo therapeutic applications of chloroquine in pancreatic cancer mouse models have demonstrated decreased tumor growth and improved survival. Our results thus provide a molecular target and basis for further evaluation of chloroquine and hydroxychloroquine in pancreatic cancer. Historically safe in humans, chloroquine and hydroxychloroquine appear to be promising agents to safely and effectively target CXCR4 in patients with pancreatic cancer.	[Kim, Joseph; Shen, Xiaoming; Heinrich, Eileen L.; Lee, Wendy; Lu, Jianming] City Hope Natl Med Ctr, Dept Surg, Duarte, CA USA; [Yip, M. L. Richard; Hsin, Li-Yu Charlie; Labarge, Samuel] City Hope Natl Med Ctr, Dept Mol Med, Duarte, CA USA; [Li, Hubert; Vaidehi, Nagarajan] City Hope Natl Med Ctr, Dept Immunol, Duarte, CA USA	City of Hope; City of Hope; City of Hope	Kim, J (corresponding author), City Hope Natl Med Ctr, Dept Surg, Duarte, CA USA.	jokim@coh.org	Yip, Richard/J-5289-2012		National Cancer Institute [P30 CA33572]; National Institutes of Health (NIH) [NIH CA134637]; American Cancer Society (ACS) [RSG-11-070-01-TBE]; NATIONAL CANCER INSTITUTE [K22CA134637, P30CA033572] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society (ACS)(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by grants from the National Cancer Institute [P30 CA33572 to JK, MLRY, and NV]; the National Institutes of Health (NIH) [NIH CA134637 to JK]; and the American Cancer Society (ACS) [RSG-11-070-01-TBE to JK]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The contents are solely the responsibility of the authors and do not represent the official views of the National Cancer Institute, NIH or ACS.	Ben-Zvi I, 2011, CLIN REV ALLERGY IMM; Bhattacharya S, 2010, J AM CHEM SOC, V132, P5205, DOI 10.1021/ja910700y; COATNEY GR, 1963, AM J TROP MED HYG, V12, P121, DOI 10.4269/ajtmh.1963.12.121; De Clercq E, 2005, MINI-REV MED CHEM, V5, P805, DOI 10.2174/1389557054867075; Denizot M, 2008, AUTOPHAGY, V4, P998, DOI 10.4161/auto.6880; Di Marco M, 2010, ONCOL REP, V23, P1183, DOI 10.3892/or_00000749; Doucette C, 2009, J BIOMOL SCREEN, V14, P381, DOI 10.1177/1087057109333974; Endres MJ, 1996, CELL, V87, P745, DOI 10.1016/S0092-8674(00)81393-8; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Ghosh A, 1998, J PHYS CHEM B, V102, P10983, DOI 10.1021/jp982533o; Gravel S, 2010, J BIOL CHEM, V285, P37939, DOI 10.1074/jbc.C110.147470; Hanson BJ, 2009, J BIOMOL SCREEN, V14, P798, DOI 10.1177/1087057109335260; Hatse S, 2002, FEBS LETT, V527, P255, DOI 10.1016/S0014-5793(02)03143-5; Hempelmann E, 2007, PARASITOL RES, V100, P671, DOI 10.1007/s00436-006-0313-x; Hendrix CW, 2004, JAIDS-J ACQ IMM DEF, V37, P1253, DOI 10.1097/01.qai.0000137371.80695.ef; Heo J, 2007, CHEMBIOCHEM, V8, P1527, DOI 10.1002/cbic.200700188; Ihlenfeldt WD, 2002, J CHEM INF COMP SCI, V42, P46, DOI 10.1021/ci010056s; Kalatskaya I, 2009, MOL PHARMACOL, V75, P1240, DOI 10.1124/mol.108.053389; Kilts JD, 2002, J PHARMACOL EXP THER, V301, P1179, DOI 10.1124/jpet.301.3.1179; Kim J, 2005, J CLIN ONCOL, V23, P2744, DOI 10.1200/JCO.2005.07.078; Kim J, 2006, ANN SURG, V244, P113, DOI 10.1097/01.sla.0000217690.65909.9c; Koshiba T, 2000, CLIN CANCER RES, V6, P3530; Kufareva I, 2011, STATUS GPCR IN PRESS; Lam AR, 2011, J CHEM INF MODEL, V51, P139, DOI 10.1021/ci1003027; Leyris JP, 2011, ANAL BIOCHEM, V408, P253, DOI 10.1016/j.ab.2010.09.030; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Lipinski MM, 2010, DEV CELL, V18, P1041, DOI 10.1016/j.devcel.2010.05.005; Maclean KH, 2008, J CLIN INVEST, V118, P79, DOI 10.1172/JCI33700; Marchesi F, 2004, CANCER RES, V64, P8420, DOI 10.1158/0008-5472.CAN-04-1343; McCormick PJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008102; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; Moss RA, 2009, AUTOPHAGY ANTIANGIOG; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Philip PA, 2007, J CLIN ONCOL, V25, P1145, DOI 10.1200/JCO.2006.09.6040; Ratajczak MZ, 2006, LEUKEMIA, V20, P1915, DOI 10.1038/sj.leu.2404357; Rosenkilde MM, 2007, J BIOL CHEM, V282, P27354, DOI 10.1074/jbc.M704739200; Rubin JB, 2003, P NATL ACAD SCI USA, V100, P13513, DOI 10.1073/pnas.2235846100; Sasaki K, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-370; Saur D, 2005, GASTROENTEROLOGY, V129, P1237, DOI 10.1053/j.gastro.2005.06.056; Schertler GFX, 1998, EYE, V12, P504, DOI 10.1038/eye.1998.138; Shen XM, 2010, PANCREAS, V39, P81, DOI 10.1097/MPA.0b013e3181bb2ab7; Singh S, 2010, BRIT J CANCER, V103, P1671, DOI 10.1038/sj.bjc.6605968; Sotelo J, 2006, ANN INTERN MED, V144, P337, DOI 10.7326/0003-4819-144-5-200603070-00008; Trabanino RJ, 2004, BIOPHYS J, V86, P1904, DOI 10.1016/S0006-3495(04)74256-3; Wang Zi-xuan, 2006, V332, P115; Warhurst DC, 2003, J ANTIMICROB CHEMOTH, V52, P188, DOI 10.1093/jac/dkg319; Whalen EJ, 2011, TRENDS MOL MED, V17, P126, DOI 10.1016/j.molmed.2010.11.004; Wong RSY, 2008, MOL PHARMACOL, V74, P1485, DOI 10.1124/mol.108.049775; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Yang SH, 2011, GENE DEV, V25, P717, DOI 10.1101/gad.2016111; Zeelenberg IS, 2003, CANCER RES, V63, P3833; Zwier JM, 2010, J BIOMOL SCREEN, V15, P1248, DOI 10.1177/1087057110384611	52	50	52	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e31004	10.1371/journal.pone.0031004	http://dx.doi.org/10.1371/journal.pone.0031004			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LO	22319600	gold, Green Published, Green Submitted			2022-12-27	WOS:000302178400025
J	Cerqueira, FM; Brandizzi, LI; Cunha, FM; Laurindo, FRM; Kowaltowski, AJ				Cerqueira, Fernanda M.; Brandizzi, Laura I.; Cunha, Fernanda M.; Laurindo, Francisco R. M.; Kowaltowski, Alicia J.			Serum from Calorie-Restricted Rats Activates Vascular Cell eNOS through Enhanced Insulin Signaling Mediated by Adiponectin	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; PROTEIN-KINASE-B; ENDOTHELIAL-CELLS; MITOCHONDRIAL BIOGENESIS; AKT; GLUCOSE; PHOSPHORYLATION; EXPRESSION; AGE; ADIPOCYTES	eNOS activation resulting in mitochondrial biogenesis is believed to play a central role in life span extension promoted by calorie restriction (CR). We investigated the mechanism of this activation by treating vascular cells with serum from CR rats and found increased Akt and eNOS phosphorylation, in addition to enhanced nitrite release. Inhibiting Akt phosphorylation or immunoprecipitating adiponectin (found in high quantities in CR serum) completely prevented the increment in nitrite release and eNOS activation. Overall, we demonstrate that adiponectin in the serum from CR animals increases NO center dot signaling by activating the insulin pathway. These results suggest this hormone may be a determinant regulator of the beneficial effects of CR.	[Cerqueira, Fernanda M.; Cunha, Fernanda M.; Kowaltowski, Alicia J.] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil; [Brandizzi, Laura I.; Laurindo, Francisco R. M.] Univ Sao Paulo, Fac Med, Inst Coracao, Sao Paulo, Brazil; [Cunha, Fernanda M.] Univ Sao Paulo, Escola Artes Ciencias & Humanidades, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Cerqueira, FM (corresponding author), Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil.	alicia@iq.usp.br	da Cunha, Fernanda M/G-3575-2012; Kowaltowski, Alicia J/H-8698-2012; Laurindo, Francisco R/J-6575-2015; cerqueira, fernanda/C-8326-2014; DA CUNHA, FERNANDA MARQUES/AAY-4000-2020	da Cunha, Fernanda M/0000-0002-1583-5380; 	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Instituto Nacional de Ciencia e Tecnologia de Processos Redox em Biomedicina (Redoxoma); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento do Pessoal de Nivel Superior (CAPES); John Simon Guggenheim Memorial Foundation	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Instituto Nacional de Ciencia e Tecnologia de Processos Redox em Biomedicina (Redoxoma); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento do Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); John Simon Guggenheim Memorial Foundation	This work is supported by grants from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Instituto Nacional de Ciencia e Tecnologia de Processos Redox em Biomedicina (Redoxoma), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento do Pessoal de Nivel Superior (CAPES) and the John Simon Guggenheim Memorial Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barros MH, 2010, MECH AGEING DEV, V131, P494, DOI 10.1016/j.mad.2010.04.008; Baylis C, 1998, CURR OPIN NEPHROL HY, V7, P59, DOI 10.1097/00041552-199801000-00010; Benard G, 2006, AM J PHYSIOL-CELL PH, V291, pC1172, DOI 10.1152/ajpcell.00195.2006; Brazil DP, 2001, TRENDS BIOCHEM SCI, V26, P657, DOI 10.1016/S0968-0004(01)01958-2; Cerqueira FM, 2011, FREE RADICAL BIO MED, V51, P1454, DOI 10.1016/j.freeradbiomed.2011.07.006; Cerqueira FM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018433; Cerqueira FM, 2010, AGEING RES REV, V9, P424, DOI 10.1016/j.arr.2010.05.002; Chen H, 2003, J BIOL CHEM, V278, P45021, DOI 10.1074/jbc.M307878200; da Silva CCC, 2008, AGING CELL, V7, P552, DOI 10.1111/j.1474-9726.2008.00407.x; de Cabo R, 2003, EXP GERONTOL, V38, P631, DOI 10.1016/S0531-5565(03)00055-X; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Fisslthaler B, 2003, NITRIC OXIDE-BIOL CH, V8, P253, DOI 10.1016/S1089-8603(03)00042-9; Fukuzawa K, 2004, BIOCHEMISTRY-MOSCOW+, V69, P50, DOI 10.1023/B:BIRY.0000016351.77553.74; Gao F, 2002, CIRCULATION, V105, P1497, DOI 10.1161/01.CIR.0000012529.00367.0F; Gopalsamy A, 2007, J MED CHEM, V50, P5547, DOI 10.1021/jm070851i; Han SH, 2009, PROG CARDIOVASC DIS, V52, P126, DOI 10.1016/j.pcad.2009.06.004; Hartell NA, 2005, BIOCHEM PHARMACOL, V69, P781, DOI 10.1016/j.bcp.2004.11.022; Hayashi H, 2008, EXP GERONTOL, V43, P827, DOI 10.1016/j.exger.2008.05.011; Head E, 2009, EXP NEUROL, V220, P171, DOI 10.1016/j.expneurol.2009.08.014; Heilbronn LK, 2003, CURR PHARM DESIGN, V9, P1411, DOI 10.2174/1381612033454766; Hepple RT, 2006, REJUV RES, V9, P219, DOI 10.1089/rej.2006.9.219; Hepple RT, 2005, FASEB J, V19, P1320, DOI 10.1096/fj.04-3535fje; Koh EH, 2010, AM J PHYSIOL-ENDOC M, V298, pE846, DOI 10.1152/ajpendo.00008.2010; Le Gouill E, 2007, DIABETES, V56, P2690, DOI 10.2337/db06-1228; Leite PF, 2003, ARTERIOSCL THROM VAS, V23, P2197, DOI 10.1161/01.ATV.0000093980.46838.41; Lev-Ran A, 1998, MECH AGEING DEV, V102, P95, DOI 10.1016/S0047-6374(98)00027-X; Li B., 2011, J AGING RES; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Lopez-Lluch G, 2008, EXP GERONTOL, V43, P813, DOI 10.1016/j.exger.2008.06.014; Mahoney LB, 2006, LIPIDS HLTH DIS, V18, P5; MASORO EJ, 1992, J GERONTOL, V47, pB202, DOI 10.1093/geronj/47.6.B202; McConell GK, 2010, J APPL PHYSIOL, V108, P589, DOI 10.1152/japplphysiol.00377.2009; Motoshima H, 2004, BIOCHEM BIOPH RES CO, V315, P264, DOI 10.1016/j.bbrc.2004.01.049; NECHAD M, 1983, EXP CELL RES, V149, P119, DOI 10.1016/0014-4827(83)90385-3; Nisoli E, 2003, SCIENCE, V299, P896, DOI 10.1126/science.1079368; Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728; Oberley TD, 2008, J HISTOCHEM CYTOCHEM, V56, P615, DOI 10.1369/jhc.2008.950873; Okado-Matsumoto A, 2000, ANTIOXID REDOX SIGN, V2, P631, DOI 10.1089/ars.2000.2.4-631; Partridge L, 2002, NAT REV GENET, V3, P165, DOI 10.1038/nrg753; Picard Martin, 2010, Aging Cell, V9, P1032, DOI 10.1111/j.1474-9726.2010.00628.x; Reynolds JD, 1998, J PHARMACOL TOXICOL, V39, P125, DOI 10.1016/S1056-8719(98)00007-0; Ritchie SA, 2010, BIOCHEM J, V426, P85, DOI 10.1042/BJ20091580; Rogozina OP, 2011, CANCER PREV RES, V4, P568, DOI 10.1158/1940-6207.CAPR-10-0140; Roth GS, 2004, SCIENCE, V305, P1423, DOI 10.1126/science.1102541; Sobrevia L, 1996, J PHYSIOL-LONDON, V490, P775, DOI 10.1113/jphysiol.1996.sp021185; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Symons JD, 2009, CIRC RES, V104, P1085, DOI 10.1161/CIRCRESAHA.108.189316; Tahara EB, 2007, FASEB J, V21, P274, DOI 10.1096/fj.06-6686com; Takahashi S, 2003, J BIOL CHEM, V278, P30821, DOI 10.1074/jbc.M304471200; van Diepeningen AD, 2010, EXP GERONTOL, V45, P516, DOI 10.1016/j.exger.2010.01.002; Wenz T, 2009, IUBMB LIFE, V61, P1051, DOI 10.1002/iub.261; Xi W, 2005, BIOCHEM BIOPH RES CO, V332, P200, DOI 10.1016/j.bbrc.2005.04.111; Zeng GY, 1996, J CLIN INVEST, V98, P894, DOI 10.1172/JCI118871; Zhu M, 2007, EXP GERONTOL, V42, P733, DOI 10.1016/j.exger.2007.05.011	54	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2012	7	2							e31155	10.1371/journal.pone.0031155	http://dx.doi.org/10.1371/journal.pone.0031155			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UV	22319612	Green Published, gold, Green Submitted			2022-12-27	WOS:000301979000024
J	Luykx, JJ; Bakker, SC; Lentjes, E; Boks, MPM; van Geloven, N; Eijkemans, MJC; Janson, E; Strengman, E; de Lepper, AM; Westenberg, H; Klopper, KE; Hoorn, HJ; Gelissen, HPMM; Jordan, J; Tolenaar, NM; van Dongen, EPA; Michel, B; Abramovic, L; Horvath, S; Kappen, T; Bruins, P; Keijzers, P; Borgdorff, P; Ophoff, RA; Kahn, RS				Luykx, Jurjen J.; Bakker, Steven C.; Lentjes, Eef; Boks, Marco P. M.; van Geloven, Nan; Eijkemans, Marinus J. C.; Janson, Esther; Strengman, Eric; de Lepper, Anne M.; Westenberg, Herman; Klopper, Kai E.; Hoorn, Hendrik J.; Gelissen, Harry P. M. M.; Jordan, Julian; Tolenaar, Noortje M.; van Dongen, Eric P. A.; Michel, Bregt; Abramovic, Lucija; Horvath, Steve; Kappen, Teus; Bruins, Peter; Keijzers, Peter; Borgdorff, Paul; Ophoff, Roel A.; Kahn, Rene S.			Season of Sampling and Season of Birth Influence Serotonin Metabolite Levels in Human Cerebrospinal Fluid	PLOS ONE			English	Article							MALE RHESUS MACAQUES; CSF MONOAMINE METABOLITES; GENERAL-POPULATION; NORTHERN FINLAND; SCHIZOPHRENIA; HIBERNATION; BEHAVIORS; MELATONIN; SUICIDES; SUMMER	Background: Animal studies have revealed seasonal patterns in cerebrospinal fluid (CSF) monoamine (MA) turnover. In humans, no study had systematically assessed seasonal patterns in CSF MA turnover in a large set of healthy adults. Methodology/Principal Findings: Standardized amounts of CSF were prospectively collected from 223 healthy individuals undergoing spinal anesthesia for minor surgical procedures. The metabolites of serotonin (5-hydroxyindoleacetic acid, 5-HIAA), dopamine (homovanillic acid, HVA) and norepinephrine (3-methoxy-4-hydroxyphenylglycol, MPHG) were measured using high performance liquid chromatography (HPLC). Concentration measurements by sampling and birth dates were modeled using a non-linear quantile cosine function and locally weighted scatterplot smoothing (LOESS, span = 0.75). The cosine model showed a unimodal season of sampling 5-HIAA zenith in April and a nadir in October (p-value of the amplitude of the cosine = 0.00050), with predicted maximum (PCmax) and minimum (PCmin) concentrations of 173 and 108 nmol/L, respectively, implying a 60% increase from trough to peak. Season of birth showed a unimodal 5-HIAA zenith in May and a nadir in November (p = 0.00339; PCmax = 172 and PCmin = 126). The non-parametric LOESS showed a similar pattern to the cosine in both season of sampling and season of birth models, validating the cosine model. A final model including both sampling and birth months demonstrated that both sampling and birth seasons were independent predictors of 5-HIAA concentrations. Conclusion: In subjects without mental illness, 5-HT turnover shows circannual variation by season of sampling as well as season of birth, with peaks in spring and troughs in fall.	[Luykx, Jurjen J.; Bakker, Steven C.; Boks, Marco P. M.; de Lepper, Anne M.; Westenberg, Herman; Abramovic, Lucija; Ophoff, Roel A.; Kahn, Rene S.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Psychiat, Utrecht, Netherlands; [Luykx, Jurjen J.] ZNA Hosp, Dept Psychiat, Antwerp, Belgium; [Lentjes, Eef] Univ Med Ctr Utrecht, Dept Clin Chem & Hematol, Utrecht, Netherlands; [Eijkemans, Marinus J. C.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Dept Biostat, Utrecht, Netherlands; [van Geloven, Nan] Univ Amsterdam, Acad Med Ctr, Clin Res Unit, NL-1105 AZ Amsterdam, Netherlands; [Janson, Esther; Strengman, Eric] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands; [Strengman, Eric; Ophoff, Roel A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Klopper, Kai E.; Hoorn, Hendrik J.; Borgdorff, Paul] Diakonessen Hosp, Dept Anesthesiol Intens Care & Pain Management, Utrecht, Netherlands; [Gelissen, Harry P. M. M.; Jordan, Julian; Keijzers, Peter] Cent Mil Hosp, Utrecht, Netherlands; [Gelissen, Harry P. M. M.] Vrije Univ Amsterdam, Med Ctr, Intens Care Unit, Amsterdam, Netherlands; [Tolenaar, Noortje M.; van Dongen, Eric P. A.; Bruins, Peter] St Antonius Hosp, Dept Anesthesiol Intens Care & Pain Management, Nieuwegein, Netherlands; [Michel, Bregt; Kappen, Teus] Univ Med Ctr Utrecht, Div Anesthesiol Intens Care & Emergency Med, Utrecht, Netherlands; [Horvath, Steve] Univ Calif Los Angeles, Biostat Sch Publ Hlth, Los Angeles, CA USA; [Ophoff, Roel A.] Univ Calif Los Angeles, Ctr Neurobehav Genet, Semel Inst Neurosci & Human Behav, Los Angeles, CA USA	Utrecht University; Utrecht University Medical Center; ZNA Middelheim Hospital; ZNA Stuivenberg; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam; Utrecht University; Utrecht University Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Diakonessenhuis; Vrije Universiteit Amsterdam; St. Antonius Hospital Utrecht; Utrecht University; Utrecht University Medical Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Luykx, JJ (corresponding author), Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Psychiat, Utrecht, Netherlands.	rophoff@mednet.ucla.edu	Kappen, Teus H/J-8733-2015	Kappen, Teus H/0000-0003-1895-0998; Luykx, Jurjen/0000-0002-6439-2774; Boks, Marco/0000-0001-6163-7484				Arendt J, PINEAL GLAND PINEAL; Bjorksten KS, 2005, PSYCHIAT RES, V133, P205, DOI 10.1016/j.psychres.2004.12.002; BREWERTON TD, 1988, PSYCHIAT RES, V23, P257, DOI 10.1016/0165-1781(88)90016-9; CHEW KSY, 1995, SOC SCI MED, V40, P223, DOI 10.1016/0277-9536(94)E0070-9; Chotai J, 2004, NORD J PSYCHIAT, V58, P429, DOI 10.1080/08039480410006052; Chotai J, 1999, NEUROPSYCHOBIOLOGY, V39, P57, DOI 10.1159/000026561; Chotai J, 2001, NEUROPSYCHOBIOLOGY, V44, P19, DOI 10.1159/000054909; Chotai J, 2006, PSYCHIAT RES, V145, P189, DOI 10.1016/j.psychres.2005.11.008; Chotai J, 2009, COMPR PSYCHIAT, V50, P562, DOI 10.1016/j.comppsych.2008.11.010; Davies G, 2003, SCHIZOPHRENIA BULL, V29, P587, DOI 10.1093/oxfordjournals.schbul.a007030; Dome P, 2010, BIOL PSYCHIAT, V68, P148, DOI 10.1016/j.biopsych.2010.03.005; Eisenberg DTA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001216; Eisenberg DP, 2010, J NEUROSCI, V30, P14691, DOI 10.1523/JNEUROSCI.1953-10.2010; Fellman J, 2009, BIODEMOGR SOC BIOL, V55, P103, DOI 10.1080/19485560903054788; Fowler JS, 2007, BIOL PSYCHIAT, V62, P355, DOI 10.1016/j.biopsych.2006.08.038; Friedman E, 2006, ACTA PSYCHIAT SCAND, V113, P510, DOI 10.1111/j.1600-0447.2005.00701.x; Garidou ML, 2003, AM J PHYSIOL-REG I, V284, pR1043, DOI 10.1152/ajpregu.00457.2002; HARRIS S, 1993, PSYCHIAT RES, V49, P77, DOI 10.1016/0165-1781(93)90031-B; Heerlein A, 2006, PSYCHOPATHOLOGY, V39, P75, DOI 10.1159/000090596; Hetsroni I, 2011, J BONE JOINT SURG BR, V93B, P47, DOI 10.1302/0301-620X.93B1.25498; Higley JD, 1996, ARCH GEN PSYCHIAT, V53, P537; Howell S, 2007, AM J PRIMATOL, V69, P851, DOI 10.1002/ajp.20369; Juul S, 1999, HUM REPROD, V14, P1250, DOI 10.1093/humrep/14.5.1250; LEWY AJ, 1987, SCIENCE, V235, P352, DOI 10.1126/science.3798117; Macchi MM, 2004, FRONT NEUROENDOCRIN, V25, P177, DOI 10.1016/j.yfrne.2004.08.001; MACCHI MM, 2002, SOC RES BIOL RHYTHMS, V9, P157; MANICKAM P, 1989, GEN COMP ENDOCR, V75, P437, DOI 10.1016/0016-6480(89)90179-2; Mehlman PT, 1997, PSYCHIAT RES, V72, P89, DOI 10.1016/S0165-1781(97)00084-X; Messias E, 2004, ARCH GEN PSYCHIAT, V61, P985, DOI 10.1001/archpsyc.61.10.985; Murakami N, 2000, J VET MED SCI, V62, P763, DOI 10.1292/jvms.62.763; Nagayama H, 1998, PSYCHOPHARMACOLOGY, V135, P279, DOI 10.1007/s002130050510; Partonen T, 2004, J AFFECT DISORDERS, V78, P11, DOI 10.1016/S0165-0327(02)00236-7; POPOVA NK, 1981, PHARMACOL BIOCHEM BE, V14, P773, DOI 10.1016/0091-3057(81)90360-9; Riala K, 2009, CHRONOBIOL INT, V26, P1660, DOI 10.3109/07420520903534484; Rocchi Marco B L, 2002, Crisis, V23, P161, DOI 10.1027//0227-5910.23.4.161; ROENNEBERG T, 1990, J BIOL RHYTHM, V5, P195, DOI 10.1177/074873049000500303; ROY A, 1991, ACTA PSYCHIAT SCAND, V84, P579, DOI 10.1111/j.1600-0447.1991.tb03199.x; SACK RL, 1990, ARCH GEN PSYCHIAT, V47, P343; SWEDO SE, 1989, ACTA PSYCHIAT SCAND, V80, P644, DOI 10.1111/j.1600-0447.1989.tb03038.x; Zajicek KB, 2000, NEUROPSYCHOPHARMACOL, V22, P240, DOI 10.1016/S0893-133X(99)00097-4	40	17	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2012	7	2							e30497	10.1371/journal.pone.0030497	http://dx.doi.org/10.1371/journal.pone.0030497			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UG	22312427	Green Submitted, Green Published, gold			2022-12-27	WOS:000301977500011
J	Casaca, VI; Illi, S; Suttner, K; Schleich, I; Ballenberger, N; Klucker, E; Turan, E; von Mutius, E; Kabesch, M; Schaub, B				Casaca, Vera Isabel; Illi, Sabina; Suttner, Kathrin; Schleich, Isolde; Ballenberger, Nikolaus; Klucker, Elizabeth; Turan, Elif; von Mutius, Erika; Kabesch, Michael; Schaub, Bianca			TBX21 and HLX1 Polymorphisms Influence Cytokine Secretion at Birth	PLOS ONE			English	Article							T-BET; TRANSCRIPTION FACTOR; CORD BLOOD; LINEAGE COMMITMENT; ASTHMA; CELLS; ATOPY; ASSOCIATION; HAPLOTYPE; EXPOSURE	Background: TBX21 (T cell specific T-box transcription factor) and HLX1 (H.20-like homeobox 1) are crucial transcription factors of T(H)1-cells, inducing their differentiation and suppressing T(H)2 commitment, particularly important for early life immune development. This study investigated the influence of TBX21 and HLX1 single nucleotide polymorphisms (SNPs), which have previously been shown to be associated with asthma, on T(H)1/T(H)2 lineage cytokines at birth. Methods and Findings: Cord blood mononuclear cells (CBMCs) of 200 neonates were genotyped for two TBX21 and three HLX1 SNPs. CBMCs were stimulated with innate (Lipid A, LpA; Peptidoglycan, Ppg), adaptive stimuli (house dust mite Dermatophagoides pteronyssinus 1, Derp1) or mitogen (phytohemagglutinin, PHA). Cytokines, T-cells and mRNA expression of T(H)1/T(H)2-related genes were assessed. Atopic diseases during the first 3 years of life were assessed by questionnaire answered by the parents. Carriers of TBX21 promoter SNP rs17250932 and HLX1 promoter SNP rs2738751 showed reduced or trendwise reduced (p <= 0.07) IL-5, IL-13 and TNF-alpha secretion after LpA-stimulation. Carriers of HLX1 SNP rs2738751 had lower IL-13 levels following Ppg-stimulation (p = 0.08). Carriers of HLX1 exon 1 SNP rs12141189 showed increased IL-5 (LpA, p = 0.007; Ppg, p = 0.10), trendwise increased IL-13 (LpA), higher GM-CSF (LpA/Ppg, p <= 0.05) and trendwise decreased IFN-c secretion (Derp1+LpA-stimulation, p = 0.1). Homozygous carriers of HLX1 promoter SNP rs3806325 showed increased IL-13 and IL-6 (unstimulated, p <= 0.03). In carriers of TBX21 intron 3 SNP rs11079788 no differences in cytokine secretion were observed. mRNA expression of T(H)1/T(H)2-related genes partly correlated with cytokines at protein level. TBX21 SNP rs11079788 carriers developed less symptoms of atopic dermatitis at 3 years of age (p = 0.03). Conclusions: Polymorphisms in TBX21 and HLX1 influenced primarily IL-5 and IL-13 secretion after LpA-stimulation in cord blood suggesting that genetic variations in the transcription factors essential for the T(H)1-pathway may contribute to modified T(H)2-immune responses already early in life. Further follow-up of the cohort is required to study the polymorphisms' relevance for immune-mediated diseases such as childhood asthma.	[Casaca, Vera Isabel; Illi, Sabina; Schleich, Isolde; Ballenberger, Nikolaus; Klucker, Elizabeth; Turan, Elif; von Mutius, Erika; Schaub, Bianca] Univ Childrens Hosp Munich, Dept Pulm & Allergy, Munich, Germany; [Suttner, Kathrin; Kabesch, Michael] Hannover Med Sch, Dept Paediat Pneumol Allergy & Neonatol, D-3000 Hannover, Germany	University of Munich; Hannover Medical School	Casaca, VI (corresponding author), Univ Childrens Hosp Munich, Dept Pulm & Allergy, Munich, Germany.	Bianca.Schaub@med.uni-muenchen.de	Schaub, Bianca/B-9935-2019; Kabesch, Michael/AAB-5701-2020; Kabesch, Michael/GZM-1583-2022	Schaub, Bianca/0000-0003-1652-8873; von Mutius, Erika/0000-0002-8893-4515	Bayerische Forschungsstiftung [DOK-111-09]; Comprehensive Pneumology Centre (CPC); German Ministry of Education and Research (BMBF) as part of the National Genome Research Network (NGFN); NGFN [01GS0810]	Bayerische Forschungsstiftung; Comprehensive Pneumology Centre (CPC); German Ministry of Education and Research (BMBF) as part of the National Genome Research Network (NGFN)(Federal Ministry of Education & Research (BMBF)); NGFN	This work was funded by Bayerische Forschungsstiftung (DOK-111-09)(VC), Comprehensive Pneumology Centre (CPC)(Dr. Schaub), and the German Ministry of Education and Research (BMBF) as part of the National Genome Research Network (NGFN), with grant NGFN 01GS0810 (Dr. Kabesch, Dr. Sutter). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akahoshi M, 2005, HUM GENET, V117, P16, DOI 10.1007/s00439-005-1285-0; B Schaub, 2009, J ALLERGY CLIN IMMUN, V123, p[774, e775]; Braun-Fahrlander C, 2002, NEW ENGL J MED, V347, P869, DOI 10.1056/NEJMoa020057; Chung Hun Taek, 2003, Hum Mutat, V22, P257, DOI 10.1002/humu.9169; Finkelman FD, 2007, J ALLERGY CLIN IMMUN, V120, P544, DOI 10.1016/j.jaci.2007.05.025; Fusaro AE, 2009, IMMUNOLOGY, V128, pe541, DOI 10.1111/j.1365-2567.2008.03028.x; J Liu, 2011, ALLERGY; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kormann MSD, 2009, ALLERGY, V64, P636, DOI 10.1111/j.1398-9995.2008.01891.x; Lakos G, 2006, PATHOBIOLOGY, V73, P224, DOI 10.1159/000098208; Macaubas C, 2003, LANCET, V362, P1192, DOI 10.1016/S0140-6736(03)14542-4; Mullen AC, 2002, NAT IMMUNOL, V3, P652, DOI 10.1038/ni807; Munthe-Kaas MC, 2008, J ALLERGY CLIN IMMUN, V121, P51, DOI 10.1016/j.jaci.2007.07.068; Pfefferle PI, 2010, J ALLERGY CLIN IMMUN, V125, P108, DOI 10.1016/j.jaci.2009.09.019; Pinto LA, 2008, J PEDIAT, V84, pS68, DOI [10.1590/S0021-75572008000500010, 10.2223/JPED.1781]; PRENTICE RL, 1978, BIOMETRIKA, V65, P167, DOI 10.1093/biomet/65.1.167; Raby BA, 2006, AM J RESP CRIT CARE, V173, P64, DOI 10.1164/rccm.200503-505OC; Sandberg M, 2009, PEDIAT ALLERG IMM-UK, V20, P519, DOI 10.1111/j.1399-3038.2008.00794.x; Schaub B, 2008, J ALLERGY CLIN IMMUN, V121, P1491, DOI 10.1016/j.jaci.2008.04.010; Schedel M, 2004, J ALLERGY CLIN IMMUN, V114, P1100, DOI 10.1016/j.jaci.2004.07.048; Schedel M, 2008, AM J RESP CRIT CARE, V177, P613, DOI 10.1164/rccm.200703-373OC; Schedel M, 2009, J ALLERGY CLIN IMMUN, V124, P583, DOI 10.1016/j.jaci.2009.06.024; Suttner K, 2009, J ALLERGY CLIN IMMUN, V123, P82, DOI 10.1016/j.jaci.2008.09.047; Suttner K, 2009, J ALLERGY CLIN IMMUN, V123, P1062, DOI 10.1016/j.jaci.2009.02.025; Suzuki K, 2008, INT ARCH ALLERGY IMM, V146, P33, DOI 10.1159/000126058; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; Tadaki H, 2009, PEDIAT ALLERG IMM-UK, V20, P227, DOI 10.1111/j.1399-3038.2008.00783.x; von Mutius E, 2009, J ALLERGY CLIN IMMUN, V123, P3, DOI 10.1016/j.jaci.2008.10.046; Williams TJ, 2000, J ALLERGY CLIN IMMUN, V105, P951, DOI 10.1067/mai.2000.106211; Wilson CB, 2009, NAT REV IMMUNOL, V9, P91, DOI 10.1038/nri2487; Woodruff PG, 2009, AM J RESP CRIT CARE, V180, P388, DOI 10.1164/rccm.200903-0392OC	32	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2012	7	1							e31069	10.1371/journal.pone.0031069	http://dx.doi.org/10.1371/journal.pone.0031069			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	912BU	22303482	Green Published, Green Submitted, gold			2022-12-27	WOS:000301770300008
J	He, WM; Li, JJ; Peng, PH				He, Wei-Ming; Li, Jing-Ji; Peng, Pei-Hao			Simulated Warming Differentially Affects the Growth and Competitive Ability of Centaurea maculosa Populations from Home and Introduced Ranges	PLOS ONE			English	Article							INVASION; PLANTS; KNAPWEED; AMERICA; CLIMATE; STOEBE	Climate warming may drive invasions by exotic plants, thereby raising concerns over the risks of invasive plants. However, little is known about how climate warming influences the growth and competitive ability of exotic plants from their home and introduced ranges. We conducted a common garden experiment with an invasive plant Centaurea maculosa and a native plant Poa pratensis, in which a mixture of sand and vermiculite was used as a neutral medium, and contrasted the total biomass, competitive effects, and competitive responses of C. maculosa populations from Europe (home range) and North America (introduced range) under two different temperatures. The warming-induced inhibitory effects on the growth of C. maculosa alone were stronger in Europe than in North America. The competitive ability of C. maculosa plants from North America was greater than that of plants from Europe under the ambient condition whereas this competitive ability followed the opposite direction under the warming condition, suggesting that warming may enable European C. maculosa to be more invasive. Across two continents, warming treatment increased the competitive advantage instead of the growth advantage of C. maculosa, suggesting that climate warming may facilitate C. maculosa invasions through altering competitive outcomes between C. maculosa and its neighbors. Additionally, the growth response of C. maculosa to warming could predict its ability to avoid being suppressed by its neighbors.	[He, Wei-Ming] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China; [Li, Jing-Ji; Peng, Pei-Hao] Chengdu Univ Technol, Dept Landscape Architecture, Chengdu, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chengdu University of Technology	He, WM (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China.	weiminghe@ibcas.ac.cn		jingji, li/0000-0002-0611-1364	National Natural Science Foundation of China [31170507]; State Key Laboratory of Vegetation and Environmental Change [2011zyts02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Vegetation and Environmental Change	Funding was provided by the National Natural Science Foundation of China (31170507; www.nsfc.gov.cn) and the State Key Laboratory of Vegetation and Environmental Change (2011zyts02; www.plantcenter.inbcas.ac.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alward RD, 1999, SCIENCE, V283, P229, DOI 10.1126/science.283.5399.229; Armas C, 2004, ECOLOGY, V85, P2682, DOI 10.1890/03-0650; BLOSSEY B, 1995, J ECOL, V83, P887, DOI 10.2307/2261425; Bradley BA, 2010, TRENDS ECOL EVOL, V25, P310, DOI 10.1016/j.tree.2009.12.003; Bradley BA, 2010, BIOL INVASIONS, V12, P1855, DOI 10.1007/s10530-009-9597-y; Broennimann O, 2008, BIOL LETTERS, V4, P585, DOI 10.1098/rsbl.2008.0254; Callaway RM, 2000, SCIENCE, V290, P521, DOI 10.1126/science.290.5491.521; Callaway RM, 2004, ECOLOGY, V85, P1062, DOI 10.1890/02-0775; Callaway RM, 2004, NATURE, V427, P731, DOI 10.1038/nature02322; Dukes JS, 1999, TRENDS ECOL EVOL, V14, P135, DOI 10.1016/S0169-5347(98)01554-7; He WM, 2010, BIOL INVASIONS, V12, P3591, DOI 10.1007/s10530-010-9753-4; He WM, 2009, OECOLOGIA, V159, P803, DOI 10.1007/s00442-008-1234-4; Henery ML, 2010, J ECOL, V98, P800, DOI 10.1111/j.1365-2745.2010.01672.x; IPCC, 2007, CLIM CHANG 2007 PHYS; Maron JL, 2007, EVOLUTION, V61, P1912, DOI 10.1111/j.1558-5646.2007.00153.x; Marrs RA, 2008, MOL ECOL, V17, P4197, DOI 10.1111/j.1365-294X.2008.03903.x; McCormick AJ, 2006, NEW PHYTOL, V171, P759, DOI 10.1111/j.1469-8137.2006.01785.x; Morrien E, 2010, ANN BOT-LONDON, V105, P843, DOI 10.1093/aob/mcq064; Ridenour WM, 2008, ECOL MONOGR, V78, P369, DOI 10.1890/06-1926.1; Roche BF, 1988, NW SCI, V62, P242; Seabloom EW, 2003, P NATL ACAD SCI USA, V100, P13384, DOI 10.1073/pnas.1835728100; Treier UA, 2009, ECOLOGY, V90, P1366, DOI 10.1890/08-0420.1; Turnbull MH, 2002, PLANT CELL ENVIRON, V25, P1729, DOI 10.1046/j.1365-3040.2002.00947.x; Verlinden M, 2010, BIOL INVASIONS, V12, P2777, DOI 10.1007/s10530-009-9683-1; Walther GR, 2009, TRENDS ECOL EVOL, V24, P686, DOI 10.1016/j.tree.2009.06.008; Weigelt A, 2003, J ECOL, V91, P707, DOI 10.1046/j.1365-2745.2003.00805.x; Williams AL, 2007, NEW PHYTOL, V176, P365, DOI 10.1111/j.1469-8137.2007.02170.x; Woodward F.I., 1987, CLIMATE PLANT DISTRI	28	6	8	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2012	7	1							e31170	10.1371/journal.pone.0031170	http://dx.doi.org/10.1371/journal.pone.0031170			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	912BU	22303485	Green Published, gold, Green Submitted			2022-12-27	WOS:000301770300009
J	Ioannidou, K; Anderson, KI; Strachan, D; Edgar, JM; Barnett, SC				Ioannidou, Kalliopi; Anderson, Kurt I.; Strachan, David; Edgar, Julia M.; Barnett, Susan C.			Time-Lapse Imaging of the Dynamics of CNS Glial-Axonal Interactions In Vitro and Ex Vivo	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; MYELIN-BASIC-PROTEIN; MURINE SPINAL-CORD; MAJOR DENSE LINE; MUTANT MOUSE; SHIVERER; OLIGODENDROCYTE; GROWTH; MICE; CELL	Background: Myelination is an exquisite and dynamic example of heterologous cell-cell interaction, which consists of the concentric wrapping of multiple layers of oligodendrocyte membrane around neuronal axons. Understanding the mechanism by which oligodendrocytes ensheath axons may bring us closer to designing strategies to promote remyelination in demyelinating diseases. The main aim of this study was to follow glial-axonal interactions over time both in vitro and ex vivo to visualize the various stages of myelination. Methodology/Principal Findings: We took two approaches to follow myelination over time: i) time-lapse imaging of mixed CNS myelinating cultures generated from mouse spinal cord to which exogenous GFP-labelled murine cells were added, and ii) ex vivo imaging of the spinal cord of shiverer (Mbp mutant) mice, transplanted with GFP-labelled murine neurospheres. We demonstrate that oligodendrocyte-axonal interactions are dynamic events with continuous retraction and extension of oligodendroglial processes. Using cytoplasmic and membrane-GFP labelled cells to examine different components of the myelin-like sheath, we provide evidence from time-lapse fluorescence microscopy and confocal microscopy that the oligodendrocytes' cytoplasm-filled processes initially spiral around the axon in a corkscrew-like manner. This is followed subsequently by focal expansion of the corkscrew process to form short cuffs, which then extend longitudinally along the axons. We predict from this model that these spiral cuffs must extend over each other first before extending to form internodes of myelin. Conclusion: These experiments show the feasibility of visualizing the dynamics of glial-axonal interaction during myelination over time. Moreover, these approaches complement each other with the in vitro approach allowing visualization of an entire internodal length of myelin and the ex vivo approach validating the in vitro data.	[Ioannidou, Kalliopi; Edgar, Julia M.; Barnett, Susan C.] Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland; [Anderson, Kurt I.; Strachan, David] Beatson Inst Canc Res, Inst Canc Sci, Glasgow G61 1BD, Lanark, Scotland	University of Glasgow; Beatson Institute; University of Glasgow	Ioannidou, K (corresponding author), Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland.	Susan.Barnett@glasgow.ac.uk	Edgar, Julia M/U-8456-2019; Edgar, Julia M/G-3275-2012	Edgar, Julia M/0000-0002-3869-0962; Anderson, Kurt/0000-0002-9324-9598; Strachan, David/0000-0003-0553-8670; Gilbey, Thomas/0000-0001-5677-3318	MRC; Cancer Research UK [15565] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK)	The work was funded by a MRC Capacity Build Studentship (http://www.mrc.ac.uk/Fundingopportunities/Studentships/index.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARBARESE E, 1983, J NEUROCHEM, V40, P1680, DOI 10.1111/j.1471-4159.1983.tb08142.x; Bauer NG, 2009, GLIA, V57, P1691, DOI 10.1002/glia.20885; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; BUNGE MB, 1962, J CELL BIOL, V12, P448, DOI 10.1083/jcb.12.2.448; BUNGE MB, 1961, J BIOPHYS BIOCHEM CY, V10, P67, DOI 10.1083/jcb.10.1.67; CHERNOFF GF, 1981, J HERED, V72, P128, DOI 10.1093/oxfordjournals.jhered.a109442; COLMAN DR, 1982, J CELL BIOL, V95, P598, DOI 10.1083/jcb.95.2.598; Czopka T, 2011, METHOD CELL BIOL, P10525; DUPOUEY P, 1979, NEUROSCI LETT, V12, P113, DOI 10.1016/0304-3940(79)91490-3; Edgar JM, 2004, J CELL BIOL, V166, P121, DOI 10.1083/jcb.200312012; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; HIRANO A, 1967, J CELL BIOL, V34, P555, DOI 10.1083/jcb.34.2.555; Kerschensteiner M, 2008, NAT PROTOC, V3, P1645, DOI 10.1038/nprot.2008.160; KIMURA M, 1985, J NEUROCHEM, V44, P692, DOI 10.1111/j.1471-4159.1985.tb12870.x; Kirby BB, 2006, NAT NEUROSCI, V9, P1506, DOI 10.1038/nn1803; KNOBLER RL, 1976, J ULTRA MOL STRUCT R, V55, P417, DOI 10.1016/S0022-5320(76)80097-4; Laursen LS, 2009, J NEUROSCI, V29, P9174, DOI 10.1523/JNEUROSCI.5942-08.2009; Li HL, 2007, J NEUROSCI, V27, P14375, DOI 10.1523/JNEUROSCI.4456-07.2007; LUSE SA, 1956, J BIOPHYS BIOCHEM CY, V2, P777, DOI 10.1083/jcb.2.6.777; MATTHEWS MA, 1971, J COMP NEUROL, V142, P1, DOI 10.1002/cne.901420102; MOLINEAUX SM, 1986, P NATL ACAD SCI USA, V83, P7542, DOI 10.1073/pnas.83.19.7542; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Pedraza L, 2009, J NEUROSCI RES, V87, P3480, DOI 10.1002/jnr.22004; PETERS A, 1960, J BIOPHYS BIOCHEM CY, V8, P431, DOI 10.1083/jcb.8.2.431; Pfeiffer Steve E., 1993, Trends in Cell Biology, V3, P191, DOI 10.1016/0962-8924(93)90213-K; PRIVAT A, 1979, NEUROSCI LETT, V12, P107, DOI 10.1016/0304-3940(79)91489-7; RAFF MC, 1983, NATURE, V303, P390, DOI 10.1038/303390a0; REMAHL S, 1990, J NEUROCYTOL, V19, P883, DOI 10.1007/BF01186817; Ridley AJ, 2011, CELL, V145, P1012, DOI 10.1016/j.cell.2011.06.010; Sherman DL, 2005, NAT REV NEUROSCI, V6, P683, DOI 10.1038/nrn1743; Sobottka B, 2011, GLIA, V59, P1841, DOI 10.1002/glia.21228; SOMMER I, 1981, DEV BIOL, V83, P311, DOI 10.1016/0012-1606(81)90477-2; Sorensen A, 2008, GLIA, V56, P750, DOI 10.1002/glia.20650; Thomson CE, 2008, EUR J NEUROSCI, V28, P1518, DOI 10.1111/j.1460-9568.2008.06415.x; Thomson CE, 2006, J NEUROSCI RES, V84, P1703, DOI 10.1002/jnr.21084; Trajkovic K, 2006, J CELL BIOL, V172, P937, DOI 10.1083/jcb.200509022; UZMAN BG, 1964, J ULTRA MOL STRUCT R, V11, P208, DOI 10.1016/S0022-5320(64)80104-0; Watkins TA, 2008, NEURON, V60, P555, DOI 10.1016/j.neuron.2008.09.011; WEBSTER HD, 1971, J CELL BIOL, V48, P348, DOI 10.1083/jcb.48.2.348; Werner HB, 2010, EXPERT REV PROTEOMIC, V7, P159, DOI 10.1586/EPR.09.105; Yamada M, 1999, J NEUROSCI, V19, P2143	42	28	30	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e30775	10.1371/journal.pone.0030775	http://dx.doi.org/10.1371/journal.pone.0030775			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22303455	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000301704200032
J	Stachowiak, B; Weingartl, HM				Stachowiak, Beata; Weingartl, Hana M.			Nipah Virus Infects Specific Subsets of Porcine Peripheral Blood Mononuclear Cells	PLOS ONE			English	Article							EMERGENT DEADLY PARAMYXOVIRUS; CENTRAL-NERVOUS-SYSTEM; ENDOTHELIAL-CELLS; PIGS; HOST; PROTECTION; CHALLENGE; PATHOLOGY; RESPONSES; RECEPTOR	Nipah virus (NiV), a zoonotic paramyxovirus, is highly contagious in swine, and can cause fatal infections in humans following transmission from the swine host. The main viral targets in both species are the respiratory and central nervous systems, with viremia implicated as a mode of dissemination of NiV throughout the host. The presented work focused on the role of peripheral blood mononuclear cells (PBMC) in the viremic spread of the virus in the swine host. B lymphocytes, CD4-CD8-, as well as CD4+CD8- T lymphocytes were not permissive to NiV, and expansion of the CD4+CD8- cells early post infection was consistent with functional humoral response to NiV infection observed in swine. In contrast, significant drop in the CD4+CD8- T cell frequency was observed in piglets which succumbed to the experimental infection, supporting the hypothesis that antibody development is the critical component of the protective immune response. Productive viral replication was detected in monocytes, CD6+CD8+ T lymphocytes and NK cells by recovery of infectious virus in the cell supernatants. Virus replication was supported by detection of the structural N and the non-structural C proteins or by detection of genomic RNA increase in the infected cells. Infection of T cells carrying CD6 marker, a strong ligand for the activated leukocyte cell adhesion molecule ALCAM (CD166) highly expressed on the microvascular endothelial cell of the blood-air and the blood-brain barrier may explain NiV preferential tropism for small blood vessels of the lung and brain.	[Stachowiak, Beata; Weingartl, Hana M.] Univ Manitoba, Dept Med Microbiol, Fac Med, Winnipeg, MB, Canada; [Weingartl, Hana M.] Canadian Food Inspect Agcy, Natl Ctr Anim Dis NCFAD, Winnipeg, MB, Canada	University of Manitoba; Canadian Food Inspection Agency	Stachowiak, B (corresponding author), Univ Manitoba, Dept Med Microbiol, Fac Med, Winnipeg, MB, Canada.	hana.weingartl@inspection.gc.ca			National Science and Engineering Research Council [327187-06]; internal Canadian Food Inspection Agency [W1001]	National Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); internal Canadian Food Inspection Agency	The funding for the project was provided by National Science and Engineering Research Council grant #327187-06 and from the internal Canadian Food Inspection Agency Research partnership strategy project W1001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berhane Y, 2008, TRANSBOUND EMERG DIS, V55, P165, DOI 10.1111/j.1865-1682.2008.01021.x; Cayrol R, 2008, NAT IMMUNOL, V9, P137, DOI 10.1038/ni1551; Chua KB, 2000, SCIENCE, V288, P1432, DOI 10.1126/science.288.5470.1432; Chua KB, 2003, J CLIN VIROL, V26, P265, DOI 10.1016/S1386-6532(02)00268-8; Dawson HD, 2005, INFECT IMMUN, V73, P1116, DOI 10.1128/IAI.73.2.1116-1128.2005; Erbar S, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-305; Garcia-Briones MM, 2000, VACCINE, V19, P1167, DOI 10.1016/S0264-410X(00)00313-3; Gerner W, 2009, DEV COMP IMMUNOL, V33, P310, DOI 10.1016/j.dci.2008.06.003; GRIFFIN DE, 1995, CURR TOP MICROBIOL, V191, P117; Guillaume V, 2004, J VIROL METHODS, V120, P229, DOI 10.1016/j.jviromet.2004.05.018; Guillaume V, 2004, J VIROL, V78, P834, DOI 10.1128/JVI.78.2.834-840.2004; Hooper P, 2001, MICROBES INFECT, V3, P315, DOI 10.1016/S1286-4579(01)01385-5; Hossain MJ, 2008, CLIN INFECT DIS, V46, P977, DOI 10.1086/529147; Lee BPL, 2008, NAT IMMUNOL, V9, P117, DOI 10.1038/ni0208-117; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo MK, 2010, VIROLOGY, V404, P78, DOI 10.1016/j.virol.2010.05.005; Lo MK, 2009, J GEN VIROL, V90, P398, DOI 10.1099/vir.0.007294-0; Luby SP, 2009, CLIN INFECT DIS, V49, P1743, DOI 10.1086/647951; Maisner A, 2009, THROMB HAEMOSTASIS, V102, P1014, DOI 10.1160/TH09-05-0310; Mathieu C, 2011, J VIROL, V85, P7863, DOI 10.1128/JVI.00549-11; Middleton DJ, 2002, J COMP PATHOL, V126, P124, DOI 10.1053/jcpa.2001.0532; Mungall BA, 2007, J INFECT DIS, V196, P812, DOI 10.1086/520818; Negrete OA, 2005, NATURE, V436, P401, DOI 10.1038/nature03838; Negrete Oscar A, 2006, PLoS Pathog, V2, pe7; Nor MNM, 2000, REV SCI TECH OIE, V19, P160; Ofori-Acquah SF, 2008, MICROVASC RES, V75, P391, DOI 10.1016/j.mvr.2007.10.006; Seo YJ, 2010, ADV APPL MICROBIOL, V73, P83, DOI 10.1016/S0065-2164(10)73004-5; van Reeth K, 2000, VET RES, V31, P187, DOI 10.1051/vetres:2000113; Virtue ER, 2011, J VIROL, V85, P4031, DOI 10.1128/JVI.02412-10; Volf J, 2007, ZOONOSES PUBLIC HLTH, V54, P286, DOI 10.1111/j.1863-2378.2007.01064.x; Wang LF, 2001, MICROBES INFECT, V3, P279, DOI 10.1016/S1286-4579(01)01381-8; Weingartl H, 2005, J VIROL, V79, P7528, DOI 10.1128/JVI.79.12.7528-7534.2005; Weingartl HM, 2006, J VIROL, V80, P7929, DOI 10.1128/JVI.00263-06; Weingartl HM, 2010, J VIROL, V84, P2245, DOI 10.1128/JVI.02118-09; Weingartl HM, 2002, J VIROL METHODS, V104, P203, DOI 10.1016/S0166-0934(02)00085-X; Wong KT, 2002, AM J PATHOL, V161, P2153, DOI 10.1016/S0002-9440(10)64493-8; Yu G, 2003, J IMMUNOL, V171, P106, DOI 10.4049/jimmunol.171.1.106; ZACHARY JF, 2007, PATHOLOGIC BASIS VET, P833	38	25	26	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e30855	10.1371/journal.pone.0030855	http://dx.doi.org/10.1371/journal.pone.0030855			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22303463	gold, Green Submitted, Green Published			2022-12-27	WOS:000301704200039
J	Ventura, BA; Siewerdt, F; Estevez, I				Ventura, Beth A.; Siewerdt, Frank; Estevez, Inma			Access to Barrier Perches Improves Behavior Repertoire in Broilers	PLOS ONE			English	Article							DOMESTIC-FOWL; STOCKING DENSITY; LEG WEAKNESS; GROUP-SIZE; ENVIRONMENTAL ENRICHMENT; VERTICAL PANELS; ENCLOSURE SIZE; CHICKENS; SPACE; WELFARE	Restriction of behavioral opportunities and uneven use of space are considerable welfare concerns in modern broiler production, particularly when birds are kept at high densities. We hypothesized that increased environmental complexity by provision of barrier perches would help address these issues by encouraging perching and enhancing use of the pen space across a range of stocking densities. 2,088 day-old broiler chicks were randomly assigned to one of the following barrier and density treatment combinations over four replications: simple barrier, complex barrier, or control (no barrier) and low (8 birds/m(2)), moderate (13 birds/m(2)), or high (18 birds/m(2)) density. Data were collected on focal birds via instantaneous scan sampling from 2 to 6 weeks of age. Mean estimates per pen for percent of observations seen performing each behavior, as well as percent of observations in the pen periphery vs. center, were quantified and submitted to an analysis of variance with week as the repeated measure. Barrier perches, density and age affected the behavioral time budget of broilers. Both simple and complex barrier perches effectively stimulated high perching rates. Aggression and disturbances were lower in both barrier treatments compared to controls (P<0.05). Increasing density to 18 birds/m(2) compared to the lower densities suppressed activity levels, with lower foraging (P<0.005), decreased perching (P<0.0001) and increased sitting (P = 0.001) earlier in the rearing period. Disturbances also increased at higher densities (P<0.05). Use of the central pen area was higher in simple barrier pens compared to controls (P<0.001), while increasing density above 8 birds/m(2) suppressed use of the central space (P<0.05). This work confirms some negative effects of increasing density and suggests that barrier perches have the potential to improve broiler welfare by encouraging activity (notably by providing accessible opportunities to perch), decreasing aggression and disturbances, and promoting more even distribution of birds throughout the pen space.	[Ventura, Beth A.; Siewerdt, Frank; Estevez, Inma] Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA; [Estevez, Inma] Basque Fdn Sci, IKERBASQUE, Alameda Urquijo, Spain; [Estevez, Inma] Neiker Tecnalia, Vitoria, Spain	University System of Maryland; University of Maryland College Park; Basque Foundation for Science	Ventura, BA (corresponding author), Univ British Columbia, Anim Welf Program, Vancouver, BC V5Z 1M9, Canada.	iestevez@neiker.net	Ventura, Beth/H-7085-2019	Ventura, Beth/0000-0001-9476-6901; Estevez, Inma/0000-0002-9054-9528	University of Maryland; Department of Animal and Avian Sciences, University of Maryland, College Park	University of Maryland; Department of Animal and Avian Sciences, University of Maryland, College Park	This work was funded by the University of Maryland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the staff and most especially Mark Spicknall at the University of Maryland Applied Poultry Research facility (Upper Marlboro, MD) for their assistance during the research phase of this study. We are also indebted to Erin Leone, Kathleen Baczynski, Taylor Callicrate, Avanti Mallapur and W. Ray Stricklin (Department of Animal and Avian Sciences, University of Maryland, College Park) for their support during various stages of this project.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Arnould C, 2004, APPL ANIM BEHAV SCI, V87, P153, DOI 10.1016/j.applanim.2003.11.001; Berg CC, 1998, VETERINARIA, V36; Bizeray D, 2002, APPL ANIM BEHAV SCI, V79, P27, DOI 10.1016/S0168-1591(02)00083-7; Cornetto T, 2002, APPL ANIM BEHAV SCI, V75, P325, DOI 10.1016/S0168-1591(01)00195-2; Cornetto T, 2001, APPL ANIM BEHAV SCI, V71, P141, DOI 10.1016/S0168-1591(00)00171-4; Cornetto T, 2001, POULTRY SCI, V80, P1455, DOI 10.1093/ps/80.10.1455; Deeming DC, 2011, BRIT POULTRY SCI, V52, P403, DOI 10.1080/00071668.2011.590796; Dozier WA, 2005, POULTRY SCI, V84, P1328, DOI 10.1093/ps/84.8.1328; Estevez I, 2007, POULTRY SCI, V86, P1265, DOI 10.1093/ps/86.6.1265; Estevez I, 2006, APPL ANIM BEHAV SCI, V97, P221, DOI 10.1016/j.applanim.2005.01.013; Estevez I, 1999, POULTRY PERSPECTIVES, V1, P4; evez I. R. C., 1997, ETOLOGIA, V5, P19; FAURE JM, 1982, APPL ANIM ETHOL, V8, P281, DOI 10.1016/0304-3762(82)90211-5; FRANKENHUIS MT, 1991, BRIT POULTRY SCI, V32, P227, DOI 10.1080/00071669108417344; Hall AL, 2001, ANIM WELFARE, V10, P23; KESTIN SC, 1992, VET REC, V131, P190, DOI 10.1136/vr.131.9.190; Leone EH, 2008, POULTRY SCI, V87, P14, DOI 10.3382/ps.2007-00154; Leone EH, 2008, ANIM BEHAV, V76, P1673, DOI 10.1016/j.anbehav.2008.08.004; LeVan NF, 2000, APPL ANIM BEHAV SCI, V65, P349, DOI 10.1016/S0168-1591(99)00059-3; LEWIS NJ, 1990, POULTRY SCI, V69, P1087, DOI 10.3382/ps.0691087; Mallapur A, 2009, APPL ANIM BEHAV SCI, V117, P28, DOI 10.1016/j.applanim.2008.11.005; MANKOVICH NJ, 1982, APPL ANIM ETHOL, V9, P177, DOI 10.1016/0304-3762(82)90193-6; National Agricultural Statistics Service (NASS) Agricultural Statistics Board US Department of Agriculture, 2002, US BROIL IND STRUCT; NEWBERRY RC, 1995, APPL ANIM BEHAV SCI, V44, P229, DOI 10.1016/0168-1591(95)00616-Z; NEWBERRY RC, 1990, APPL ANIM BEHAV SCI, V25, P125, DOI 10.1016/0168-1591(90)90075-O; Pettit-Riley R, 2002, APPL ANIM BEHAV SCI, V79, P11, DOI 10.1016/S0168-1591(02)00116-8; Pettit-Riley R, 2001, APPL ANIM BEHAV SCI, V71, P127, DOI 10.1016/S0168-1591(00)00174-X; Reiter K, 2000, ARCH GEFLUGELKD, V64, P93; Reiter K, 2001, ARCH GEFLUGELKD, V65, P137; *SAS I INC, 2003, SAS VERS 9 1 3; *SCAHAW, 2000, SANCOB3AHR152000 SCA; Steel R., 1997, PRINCIPLES PROCEDURE; Su G, 2000, POULTRY SCI, V79, P1259, DOI 10.1093/ps/79.9.1259; Ventura BA, 2010, POULTRY SCI, V89, P1574, DOI 10.3382/ps.2009-00576	35	65	67	0	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e29826	10.1371/journal.pone.0029826	http://dx.doi.org/10.1371/journal.pone.0029826			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22299026	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000301704200003
J	Verove, J; Bernarde, C; Bohn, YST; Boulay, F; Rabiet, MJ; Attree, I; Cretin, F				Verove, Julien; Bernarde, Cedric; Bohn, Yu-Sing Tammy; Boulay, Francois; Rabiet, Marie-Josephe; Attree, Ina; Cretin, Francois			Injection of Pseudomonas aeruginosa Exo Toxins into Host Cells Can Be Modulated by Host Factors at the Level of Translocon Assembly and/or Activity	PLOS ONE			English	Article							III SECRETION SYSTEM; YERSINIA-PSEUDOTUBERCULOSIS; PLASMA-MEMBRANE; PORE FORMATION; LEADING-EDGE; BACTERIAL INVASION; EPITHELIAL-CELLS; EXOENZYME-S; TIP COMPLEX; PROTEIN	Pseudomonas aeruginosa type III secretion apparatus exports and translocates four exotoxins into the cytoplasm of the host cell. The translocation requires two hydrophobic bacterial proteins, PopB and PopD, that are found associated with host cell membranes following infection. In this work we examined the influence of host cell elements on exotoxin translocation efficiency. We developed a quantitative flow cytometry based assay of translocation that used protein fusions between either ExoS or ExoY and the beta-lactamase reporter enzyme. In parallel, association of translocon proteins with host plasma membranes was evaluated by immunodetection of PopB/D following sucrose gradient fractionation of membranes. A promyelocytic cell line (HL-60) and a pro-monocytic cell line (U937) were found resistant to toxin injection even though PopB/D associated with host cell plasma membranes. Differentiation of these cells to either macrophage-or neutrophil-like cell lines resulted in injection-sensitive phenotype without significantly changing the level of membrane-inserted translocon proteins. As previous in vitro studies have indicated that the lysis of liposomes by PopB and PopD requires both cholesterol and phosphatidyl-serine, we first examined the role of cholesterol in translocation efficiency. Treatment of sensitive HL-60 cells with methyl-beta-cyclodextrine, a cholesterol-depleting agent, resulted in a diminished injection of ExoS-Bla. Moreover, the PopB translocator was found in the membrane fraction, obtained from sucrose-gradient purifications, containing the lipid-raft marker flotillin. Examination of components of signalling pathways influencing the toxin injection was further assayed through a pharmacological approach. A systematic detection of translocon proteins within host membranes showed that, in addition to membrane composition, some general signalling pathways involved in actin polymerization may be critical for the formation of a functional pore. In conclusion, we provide new insights in regulation of translocation process and suggest possible cross-talks between eukaryotic cell and the pathogen at the level of exotoxin translocation.	[Verove, Julien; Bernarde, Cedric; Bohn, Yu-Sing Tammy; Boulay, Francois; Rabiet, Marie-Josephe; Attree, Ina; Cretin, Francois] INSERM, U1036, Grenoble, France; [Verove, Julien; Bernarde, Cedric; Bohn, Yu-Sing Tammy; Boulay, Francois; Rabiet, Marie-Josephe; Attree, Ina; Cretin, Francois] CNRS, ERL 5261, Grenoble, France; [Verove, Julien; Bernarde, Cedric; Bohn, Yu-Sing Tammy; Boulay, Francois; Rabiet, Marie-Josephe; Attree, Ina; Cretin, Francois] Univ Grenoble 1, Grenoble, France; [Verove, Julien; Bernarde, Cedric; Bohn, Yu-Sing Tammy; Boulay, Francois; Rabiet, Marie-Josephe; Attree, Ina; Cretin, Francois] CEA, DSV iRTSV, Grenoble, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA	Verove, J (corresponding author), INSERM, U1036, Grenoble, France.	francois.cretin@cea.fr		Attree, Ina/0000-0002-2580-764X; Cretin, Francois/0000-0001-9939-0931	CEA DSV; Rhone Alpes region; cluster 10 "Infectiology"; ANR [ANR-08-MIEN-020-01]	CEA DSV(French Atomic Energy Commission); Rhone Alpes region(Region Auvergne-Rhone-Alpes); cluster 10 "Infectiology"(Region Auvergne-Rhone-Alpes); ANR(French National Research Agency (ANR))	Y.-S.T. Bohn received a fellowship from the CEA DSV program "Membrane proteins". J. Verove was a PhD fellow from the Rhone Alpes region and was supported by cluster 10 "Infectiology". The project was in part financed by ANR grant ANR-08-MIEN-020-01 to M.-J. Rabiet and I. Attree. C. Bernarde was a postdoctoral fellow financed by ANR. CEA: French Alternative Energies and Atomic Energy Commission (Commissariat a l'Energie Atomique et aux Energies Alternatives). DSV: Life Sciences Division (Departement des Sciences du Vivant). ANR: National Research Agency (Agence Nationale de la Recherche). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akopyan K, 2011, P NATL ACAD SCI USA, V108, P1639, DOI 10.1073/pnas.1013888108; Aktories K, 2005, NAT REV MICROBIOL, V3, P397, DOI 10.1038/nrmicro1150; Alli M, 2008, INT J MED MICROBIOL, V298, P183, DOI 10.1016/j.ijmm.2007.04.007; Allmond LR, 2003, INFECT IMMUN, V71, P2230, DOI 10.1128/IAI.71.4.2230-2233.2003; Auerbuch V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000686; Bleves S, 2010, INT J MED MICROBIOL, V300, P534, DOI 10.1016/j.ijmm.2010.08.005; Bridge DR, 2010, MICROBIOL-SGM, V156, P356, DOI 10.1099/mic.0.033241-0; Broz P, 2007, MOL MICROBIOL, V65, P1311, DOI 10.1111/j.1365-2958.2007.05871.x; Caroline G, 2008, J BIOL CHEM, V283, P23940, DOI 10.1074/jbc.M803146200; Charpentier X, 2004, J BACTERIOL, V186, P5486, DOI 10.1128/JB.186.16.5486-5495.2004; Charpentier X, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000501; Christophe T, 2001, J BIOL CHEM, V276, P21585, DOI 10.1074/jbc.M007769200; Chuanchuen R, 2002, BIOTECHNIQUES, V33, P760, DOI 10.2144/02334bm08; Cisz M, 2008, J BACTERIOL, V190, P2726, DOI 10.1128/JB.01553-07; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Dewoody R, 2011, MOL MICROBIOL, V79, P1445, DOI 10.1111/j.1365-2958.2011.07534.x; Diaz MH, 2010, INFECT IMMUN, V78, P1447, DOI 10.1128/IAI.01134-09; Eitel J, 2005, CELL MICROBIOL, V7, P63, DOI 10.1111/j.1462-5822.2004.00434.x; Engel J, 2009, CURR OPIN MICROBIOL, V12, P61, DOI 10.1016/j.mib.2008.12.007; Faudry E, 2007, FEBS J, V274, P3601, DOI 10.1111/j.1742-4658.2007.05893.x; Faudry E, 2006, BIOCHEMISTRY-US, V45, P8117, DOI 10.1021/bi060452+; Fenteany G, 2003, CURR TOP MED CHEM, V3, P593, DOI 10.2174/1568026033452348; Franchi L, 2007, EUR J IMMUNOL, V37, P3030, DOI 10.1002/eji.200737532; Gomez-Mouton C, 2001, P NATL ACAD SCI USA, V98, P9642, DOI 10.1073/pnas.171160298; Goure J, 2005, J INFECT DIS, V192, P218, DOI 10.1086/430932; Goure J, 2004, INFECT IMMUN, V72, P4741, DOI 10.1128/IAI.72.8.4741-4750.2004; Grassme H, 2003, NAT MED, V9, P322, DOI 10.1038/nm823; HAKANSSON S, 1993, INFECT IMMUN, V61, P71; Hakansson S, 1996, EMBO J, V15, P5812, DOI 10.1002/j.1460-2075.1996.tb00968.x; Hauser AR, 2009, NAT REV MICROBIOL, V7, P654, DOI 10.1038/nrmicro2199; Hayward RD, 2005, MOL MICROBIOL, V56, P590, DOI 10.1111/j.1365-2958.2005.04568.x; Hudson KJ, 2005, CELL MICROBIOL, V7, P1474, DOI 10.1111/j.1462-5822.2005.00571.x; Ireton K, 1996, SCIENCE, V274, P780, DOI 10.1126/science.274.5288.780; Job V, 2010, J BIOL CHEM, V285, P23222, DOI 10.1074/jbc.M110.111278; Kierbel A, 2005, MOL BIOL CELL, V16, P2577, DOI 10.1091/mbc.E04-08-0717; Lafont F, 2002, EMBO J, V21, P4449, DOI 10.1093/emboj/cdf457; Manes S, 2004, TRENDS CELL BIOL, V14, P275, DOI 10.1016/j.tcb.2004.04.008; Marketon MM, 2005, SCIENCE, V309, P1739, DOI 10.1126/science.1114580; Mattei PJ, 2011, FEBS J, V278, P414, DOI 10.1111/j.1742-4658.2010.07974.x; McGhie EJ, 2002, MOL MICROBIOL, V44, P1309, DOI 10.1046/j.1365-2958.2002.02958.x; McGuffie EM, 1999, INFECT IMMUN, V67, P3494, DOI 10.1128/IAI.67.7.3494-3503.1999; Mejia E, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040003; Miao EA, 2008, P NATL ACAD SCI USA, V105, P2562, DOI 10.1073/pnas.0712183105; Mueller CA, 2008, MOL MICROBIOL, V68, P1085, DOI 10.1111/j.1365-2958.2008.06237.x; Nanao M, 2003, BMC MICROBIOL, V3, DOI 10.1186/1471-2180-3-21; Neyt C, 1999, MOL MICROBIOL, V33, P971, DOI 10.1046/j.1365-2958.1999.01537.x; Pastor A, 2005, FEMS MICROBIOL LETT, V253, P95, DOI 10.1016/j.femsle.2005.09.028; Peterson LR, 2009, CLIN INFECT DIS, V49, P992, DOI 10.1086/605539; Roehrich AD, 2010, INFECT IMMUN, V78, P1682, DOI 10.1128/IAI.00645-09; Rucks EA, 2005, INFECT IMMUN, V73, P638, DOI 10.1128/IAI.73.1.638-643.2005; Schoehn G, 2003, EMBO J, V22, P4957, DOI 10.1093/emboj/cdg499; SCHWEIZER HP, 1992, MOL MICROBIOL, V6, P1195, DOI 10.1111/j.1365-2958.1992.tb01558.x; SCHWEIZER HP, 1991, GENE, V97, P109, DOI 10.1016/0378-1119(91)90016-5; Seveau S, 2001, MOL BIOL CELL, V12, P3550, DOI 10.1091/mbc.12.11.3550; Shin H, 2007, CELL MICROBIOL, V9, P2893, DOI 10.1111/j.1462-5822.2007.01004.x; Skoudy A, 2000, CELL MICROBIOL, V2, P19, DOI 10.1046/j.1462-5822.2000.00028.x; Sutterwala FS, 2007, J EXP MED, V204, P3235, DOI 10.1084/jem.20071239; Uliczka F, 2009, CELL MICROBIOL, V11, P1782, DOI 10.1111/j.1462-5822.2009.01371.x; Vance RE, 2005, INFECT IMMUN, V73, P1706, DOI 10.1128/IAI.73.3.1706-1713.2005; Vasanji A, 2004, DEV CELL, V6, P29, DOI 10.1016/S1534-5807(03)00397-6; Yu XJ, 2010, SCIENCE, V328, P1040, DOI 10.1126/science.1189000	61	25	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e30488	10.1371/journal.pone.0030488	http://dx.doi.org/10.1371/journal.pone.0030488			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22299042	Green Published, Green Submitted, gold			2022-12-27	WOS:000301704200019
J	Liu, XY; Liu, B; Huang, ZM; Shi, T; Chen, YY; Zhang, J				Liu, Xinyi; Liu, Bin; Huang, Zhimin; Shi, Ting; Chen, Yingyi; Zhang, Jian			SPPS: A Sequence-Based Method for Predicting Probability of Protein-Protein Interaction Partners	PLOS ONE			English	Article							BINDING-SITE PREDICTION; CORRELATED MUTATIONS; WEB SERVER; INFORMATION; NETWORK; SYSTEMS; DISCOVERY; DOCKING	Background: The molecular network sustained by different types of interactions among proteins is widely manifested as the fundamental driving force of cellular operations. Many biological functions are determined by the crosstalk between proteins rather than by the characteristics of their individual components. Thus, the searches for protein partners in global networks are imperative when attempting to address the principles of biology. Results: We have developed a web-based tool "Sequence-based Protein Partners Search'' (SPPS) to explore interacting partners of proteins, by searching over a large repertoire of proteins across many species. SPPS provides a database containing more than 60,000 protein sequences with annotations and a protein-partner search engine in two modes (Single Query and Multiple Query). Two interacting proteins of human FBXO6 protein have been found using the service in the study. In addition, users can refine potential protein partner hits by using annotations and possible interactive network in the SPPS web server. Conclusions: SPPS provides a new type of tool to facilitate the identification of direct or indirect protein partners which may guide scientists on the investigation of new signaling pathways. The SPPS server is available to the public at http://mdl.shsmu.edu.cn/SPPS/.	[Liu, Xinyi; Liu, Bin; Huang, Zhimin; Shi, Ting; Chen, Yingyi; Zhang, Jian] Shanghai Jiao Tong Univ, Dept Pathophysiol, Key Lab Cell Differentiat & Apoptosis, Chinese Minist Educ,Sch Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Liu, XY (corresponding author), Shanghai Jiao Tong Univ, Dept Pathophysiol, Key Lab Cell Differentiat & Apoptosis, Chinese Minist Educ,Sch Med, Shanghai 200030, Peoples R China.	jian.zhang@sjtu.edu.cn	liu, Bin/AAP-1252-2020; huang, zhimin/H-7878-2013; liu, xinyi/GWZ-8739-2022; huang, zhimin o/R-4712-2018; Zhang, Jian/GXA-1303-2022	huang, zhimin o/0000-0001-9230-6039; Zhang, Jian/0000-0002-6558-791X; liu, bin/0000-0003-1569-2604	National Basic Research Program of China (973 Program) [2011CB504001]; National Natural Science Foundation of China [21002062]; Innovative Research Team of Shanghai Municipal Education Commission; Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning and Shanghai PuJiang Program [10PJ406800]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovative Research Team of Shanghai Municipal Education Commission; Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning and Shanghai PuJiang Program	This work was supported in part by grants from the National Basic Research Program of China (973 Program) (2011CB504001), the National Natural Science Foundation of China (21002062), the Innovative Research Team of Shanghai Municipal Education Commission, the Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning and Shanghai PuJiang Program (10PJ406800). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloy P, 2003, J MOL BIOL, V332, P989, DOI 10.1016/j.jmb.2003.07.006; Amos-Binks A, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-225; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Aytuna AS, 2005, BIOINFORMATICS, V21, P2850, DOI 10.1093/bioinformatics/bti443; Barker D, 2005, PLOS COMPUT BIOL, V1, P24, DOI 10.1371/journal.pcbi.0010003; Beckouet F, 2011, FEBS LETT, V585, P3355, DOI 10.1016/j.febslet.2011.09.011; Betel D, 2007, PLOS COMPUT BIOL, V3, P1783, DOI 10.1371/journal.pcbi.0030182; Braun B, 2011, FEBS LETT, V585, P3856, DOI 10.1016/j.febslet.2011.10.038; Chen J, 2006, BIOINFORMATICS, V22, P1998, DOI 10.1093/bioinformatics/btl335; Chen LN, 2006, PROTEINS, V62, P833, DOI 10.1002/prot.20783; Chen Z, 2011, J VIROL IN PRESS; Cheng YG, 2007, BIOCHEMISTRY-US, V46, P13468, DOI 10.1021/bi7012273; Clauset A, 2008, NATURE, V453, P98, DOI 10.1038/nature06830; Cockell SJ, 2007, BIOINFORMATICS, V23, P573, DOI 10.1093/bioinformatics/btl661; Date SV, 2003, NAT BIOTECHNOL, V21, P1055, DOI 10.1038/nbt861; Dosztanyi Z, 2009, BIOINFORMATICS, V25, P2745, DOI 10.1093/bioinformatics/btp518; Fiorucci S, 2010, PROTEINS, V78, P3131, DOI 10.1002/prot.22808; Fiorucci S, 2010, BIOPHYS J, V98, P1921, DOI 10.1016/j.bpj.2009.12.4332; Galperin MY, 2000, NAT BIOTECHNOL, V18, P609, DOI 10.1038/76443; Ge H, 2003, TRENDS GENET, V19, P551, DOI 10.1016/j.tig.2003.08.009; Goh CS, 2000, J MOL BIOL, V299, P283, DOI 10.1006/jmbi.2000.3732; Guruharsha KG, 2011, CELL, V147, P690, DOI 10.1016/j.cell.2011.08.047; Halperin I, 2006, PROTEINS, V63, P832, DOI 10.1002/prot.20933; Hwang D, 2005, P NATL ACAD SCI USA, V102, P17296, DOI 10.1073/pnas.0508647102; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; Koonin EV, 2001, GENOME RES, V11, P240, DOI 10.1101/gr.162001; Lee HJ, 2010, J BIOL CHEM, V285, P41549, DOI 10.1074/jbc.M110.193383; Lewis ACF, 2010, MOL BIOSYST, V6, P55, DOI 10.1039/b916371a; Lu N, 2011, MOL BIOL CELL, V22, P354, DOI 10.1091/mbc.E10-09-0756; Marcotte EM, 1999, SCIENCE, V285, P751, DOI 10.1126/science.285.5428.751; McDowall MD, 2009, NUCLEIC ACIDS RES, V37, pD651, DOI 10.1093/nar/gkn870; Meszaros B, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000376; Mizushima T, 2004, NAT STRUCT MOL BIOL, V11, P365, DOI 10.1038/nsmb732; Ofran Y, 2003, FEBS LETT, V544, P236, DOI 10.1016/S0014-5793(03)00456-3; Overbeek R, 1999, P NATL ACAD SCI USA, V96, P2896, DOI 10.1073/pnas.96.6.2896; Pawson T, 2004, CELL, V116, P191, DOI 10.1016/S0092-8674(03)01077-8; Pazos F, 1997, J MOL BIOL, V271, P511, DOI 10.1006/jmbi.1997.1198; Pazos F, 2001, PROTEIN ENG, V14, P609, DOI 10.1093/protein/14.9.609; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Petsalaki E, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000335; Platt JC, 2000, ADV NEUR IN, P61; Res I, 2005, BIOINFORMATICS, V21, P2496, DOI 10.1093/bioinformatics/bti340; Russell RB, 2004, CURR OPIN STRUC BIOL, V14, P313, DOI 10.1016/j.sbi.2004.04.006; Sato T, 2005, BIOINFORMATICS, V21, P3482, DOI 10.1093/bioinformatics/bti564; Shen JW, 2007, P NATL ACAD SCI USA, V104, P4337, DOI 10.1073/pnas.0607879104; Shoemaker BA, 2007, PLOS COMPUT BIOL, V3, P595, DOI 10.1371/journal.pcbi.0030043; Shoemaker BA, 2010, NUCLEIC ACIDS RES, V38, pD518, DOI 10.1093/nar/gkp842; Smith GR, 2002, CURR OPIN STRUC BIOL, V12, P28, DOI 10.1016/S0959-440X(02)00285-3; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tan JJ, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-4; Walhout AJM, 2000, SCIENCE, V287, P116, DOI 10.1126/science.287.5450.116; Wang J, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.67; Wang L, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.201814; Wass MN, 2011, CURR OPIN STRUC BIOL, V21, P382, DOI 10.1016/j.sbi.2011.03.013; Yook SH, 2004, PROTEOMICS, V4, P928, DOI 10.1002/pmic.200300636; Yu CY, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-167; Zacharias M, 2010, CURR OPIN STRUC BIOL, V20, P180, DOI 10.1016/j.sbi.2010.02.001; Zencir S, 2011, BIOCHEM BIOPH RES CO, V411, P792, DOI 10.1016/j.bbrc.2011.07.029	58	15	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2012	7	1							e30938	10.1371/journal.pone.0030938	http://dx.doi.org/10.1371/journal.pone.0030938			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911FX	22292078	Green Submitted, Green Published, gold			2022-12-27	WOS:000301703800038
J	Carew, JS; Esquivel, JA; Espitia, CM; Schultes, CM; Mulbaier, M; Lewis, JD; Janssen, B; Giles, FJ; Nawrocki, ST				Carew, Jennifer S.; Esquivel, Juan A., II; Espitia, Claudia M.; Schultes, Christoph M.; Muelbaier, Marcel; Lewis, Joe D.; Janssen, Bernd; Giles, Francis J.; Nawrocki, Steffan T.			ELR510444 Inhibits Tumor Growth and Angiogenesis by Abrogating HIF Activity and Disrupting Microtubules in Renal Cell Carcinoma	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; HIPPEL-LINDAU PROTEIN; SUPPRESSOR PROTEIN; FACTOR 1-ALPHA; ORAL 2-METHOXYESTRADIOL; UNFAVORABLE PROGNOSIS; FACTORS HIF-1-ALPHA; COLCHICINE-BINDING; BREAST-CANCER; GENE	Background: Hypoxia-inducible factor (HIF) is an attractive therapeutic target for renal cell carcinoma (RCC) as its high expression due to the loss of von Hippel-Lindau (VHL) promotes RCC progression. Considering this, we hypothesized that ELR510444, a novel orally available small molecule inhibitor of HIF activity, would reduce angiogenesis and possess significant activity in RCC. The mechanism of action and therapeutic efficacy of ELR510444 were investigated in in vitro and in vivo models of RCC. Principal Findings: ELR510444 decreased HIF-1 alpha and HIF-2 alpha levels, reduced RCC cell viability and clonogenic survival, and induced apoptosis. VHL-deficient RCC cells were more sensitive to ELR510444-mediated apoptosis and restoration of VHL promoted drug resistance. Higher concentrations of ELR51044 promoted apoptosis independently of VHL status, possibly due to the microtubule destabilizing properties of this agent. ELR510444 significantly reduced tumor burden in the 786-O and A498 RCC xenograft models. These effects were associated with increased necrosis and apoptosis and inhibition of angiogenesis. Conclusions: ELR510444 is a promising new HIF inhibitor that reduced RCC cell viability, induced apoptosis, and diminished tumor burden in RCC xenograft models. ELR510444 also destabilized microtubules suggesting that it possesses vascular disrupting and anti-angiogenic properties. Further investigation of ELR510444 for the therapy of RCC is warranted.	[Carew, Jennifer S.; Esquivel, Juan A., II; Espitia, Claudia M.; Giles, Francis J.; Nawrocki, Steffan T.] Univ Texas Hlth Sci Ctr San Antonio, Canc Therapy & Res Ctr, Dept Med, San Antonio, TX 78229 USA; [Carew, Jennifer S.; Esquivel, Juan A., II; Espitia, Claudia M.; Giles, Francis J.; Nawrocki, Steffan T.] Univ Texas Hlth Sci Ctr San Antonio, Canc Therapy & Res Ctr, Inst Drug Dev, San Antonio, TX 78229 USA; [Schultes, Christoph M.; Muelbaier, Marcel; Lewis, Joe D.; Janssen, Bernd] Elara Pharmaceut GmbH, Heidelberg, Germany	Cancer Therapy & Research Center; University of Texas System; University of Texas Health San Antonio; Cancer Therapy & Research Center; University of Texas System; University of Texas Health San Antonio	Carew, JS (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Canc Therapy & Res Ctr, Dept Med, San Antonio, TX 78229 USA.	Nawrocki@uthscsa.edu		Lewis, Joe/0000-0002-9926-1328	Congressionally directed Medical Research Programs (CDMRP) [W81XWH-07-2-0025]; National Cancer Institute P30 Cancer Center [CA054174]; Institute for Drug Development, Cancer Therapy and Research Center at University of Texas Health Science Center at San Antonio; Bundesministerium fur Bildung und Forschung, Germany [0315418]; NATIONAL CANCER INSTITUTE [P30CA054174] Funding Source: NIH RePORTER	Congressionally directed Medical Research Programs (CDMRP)(United States Department of Defense); National Cancer Institute P30 Cancer Center; Institute for Drug Development, Cancer Therapy and Research Center at University of Texas Health Science Center at San Antonio; Bundesministerium fur Bildung und Forschung, Germany(Federal Ministry of Education & Research (BMBF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Congressionally directed Medical Research Programs (CDMRP) Grant #W81XWH-07-2-0025, National Cancer Institute P30 Cancer Center Support Grant #CA054174, and funds provided by The Institute for Drug Development, Cancer Therapy and Research Center at University of Texas Health Science Center at San Antonio. CMS and MM were supported by the Bundesministerium fur Bildung und Forschung, Germany (Grant 0315418). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Beasley NJP, 2002, CANCER RES, V62, P2493; Birner P, 2000, CANCER RES, V60, P4693; Blancher C, 2000, CANCER RES, V60, P7106; Bos R, 2001, JNCI-J NATL CANCER I, V93, P309, DOI 10.1093/jnci/93.4.309; Burkitt K, 2009, MOL CANCER THER, V8, P1148, DOI 10.1158/1535-7163.MCT-08-0944; Carew JS, 2011, J BIOL CHEM, V286, P6602, DOI 10.1074/jbc.M110.151324; Dahut WL, 2006, CANCER BIOL THER, V5, P22, DOI 10.4161/cbt.5.1.2349; Fortin S, 2010, BIOL PROCED ONLINE, V12, P113, DOI 10.1007/s12575-010-9029-5; Giatromanolaki A, 2001, BRIT J CANCER, V85, P881, DOI 10.1054/bjoc.2001.2018; Gnarra JR, 1996, P NATL ACAD SCI USA, V93, P10589, DOI 10.1073/pnas.93.20.10589; Heng DYC, 2008, CURR CANCER DRUG TAR, V8, P676, DOI 10.2174/156800908786733450; Hergovich A, 2003, NAT CELL BIOL, V5, P64, DOI 10.1038/ncb899; Iliopoulos O, 1996, P NATL ACAD SCI USA, V93, P10595, DOI 10.1073/pnas.93.20.10595; ILIOPOULOS O, 1995, NAT MED, V1, P822, DOI 10.1038/nm0895-822; Kaelin WG, 2007, CLIN CANCER RES, V13, p680S, DOI 10.1158/1078-0432.CCR-06-1865; Kelly KR, 2011, REOVIRUS TH IN PRESS; Kondo K, 2002, CANCER CELL, V1, P237, DOI 10.1016/S1535-6108(02)00043-0; Krieg M, 2000, ONCOGENE, V19, P5435, DOI 10.1038/sj.onc.1203938; Kurokawa T, 2003, BRIT J CANCER, V89, P1042, DOI 10.1038/sj.bjc.6601186; LITTLE M, 1985, EMBO J, V4, P51, DOI 10.1002/j.1460-2075.1985.tb02316.x; Mabjeesh NJ, 2003, CANCER CELL, V3, P363, DOI 10.1016/S1535-6108(03)00077-1; Mahalingam D, 2010, CLIN CANCER RES, V16, P141, DOI 10.1158/1078-0432.CCR-09-1385; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Pasquier E, 2010, MOL CANCER THER, V9, P1408, DOI 10.1158/1535-7163.MCT-09-0894; Patel PH, 2006, CLIN CANCER RES, V12, P7215, DOI 10.1158/1078-0432.CCR-06-2254; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Powis G, 2004, MOL CANCER THER, V3, P647; Rajkumar SV, 2007, CLIN CANCER RES, V13, P6162, DOI 10.1158/1078-0432.CCR-07-0807; Risinger AL, 2011, J PHARMACOL EXP THER, V336, P652, DOI 10.1124/jpet.110.175331; Schindl M, 2002, CLIN CANCER RES, V8, P1831; Siemann DW, 2008, ANTICANCER RES, V28, P2027; Sosman JA, 2007, CLIN CANCER RES, V13, p764S, DOI 10.1158/1078-0432.CCR-06-1975; Staller P, 2003, NATURE, V425, P307, DOI 10.1038/nature01874; Sweeney C, 2005, CLIN CANCER RES, V11, P6625, DOI 10.1158/1078-0432.CCR-05-0440; Thoma CR, 2010, J CELL BIOL, V190, P991, DOI 10.1083/jcb.201006059; Thomas GV, 2006, NAT MED, V12, P122, DOI 10.1038/nm1337; Turner KJ, 2002, CANCER RES, V62, P2957; Verheul HMW, 2008, CLIN CANCER RES, V14, P3589, DOI 10.1158/1078-0432.CCR-07-4306; Welsh S, 2004, MOL CANCER THER, V3, P233; Welsh SJ, 2003, MOL CANCER THER, V2, P235; Yeo EJ, 2003, J NATL CANCER I, V95, P516, DOI 10.1093/jnci/95.7.516	41	19	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e31120	10.1371/journal.pone.0031120	http://dx.doi.org/10.1371/journal.pone.0031120			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295124	Green Submitted, Green Published, gold			2022-12-27	WOS:000301640600069
J	Skinner, B				Skinner, Brian			The Problem of Shot Selection in Basketball	PLOS ONE			English	Article							HOT HAND	In basketball, every time the offense produces a shot opportunity the player with the ball must decide whether the shot is worth taking. In this article, I explore the question of when a team should shoot and when they should pass up the shot by considering a simple theoretical model of the shot selection process, in which the quality of shot opportunities generated by the offense is assumed to fall randomly within a uniform distribution. Within this model I derive an answer to the question "how likely must the shot be to go in before the player should take it?" and I show that this lower cutoff for shot quality f depends crucially on the number n of shot opportunities remaining (say, before the shot clock expires), with larger n demanding that only higher-quality shots should be taken. The function f(n) is also derived in the presence of a finite turnover rate and used to predict the shooting rate of an optimal-shooting team as a function of time. The theoretical prediction for the optimal shooting rate is compared to data from the National Basketball Association (NBA). The comparison highlights some limitations of the theoretical model, while also suggesting that NBA teams may be overly reluctant to shoot the ball early in the shot clock.	Univ Minnesota, Fine Theoret Phys Inst, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Skinner, B (corresponding author), Univ Minnesota, Fine Theoret Phys Inst, Minneapolis, MN 55455 USA.	bskinner@physics.umn.edu		Skinner, Brian/0000-0003-0774-3563				Alferink LA, 2009, J APPL BEHAV ANAL, V42, P595, DOI 10.1901/jaba.2009.42-595; Arkes J, 2010, J QUANT ANAL SPORTS, V6, DOI 10.2202/1559-0410.1198; Duch J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010937; Gabel A, 2011, ARXIV11092825; GILOVICH T, 1985, COGNITIVE PSYCHOL, V17, P295, DOI 10.1016/0010-0285(85)90010-6; Goldman MR, MIT SLOAN SPORTS AN; Huizinga J, 2009, MIT SLOAN SPORTS AN; Kubatko J, 2007, J QUANT ANAL SPORTS, V3, DOI 10.2202/1559-0410.1070; Neiman T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1580; Oliver D., 2004, BASKETBALL PAPER RUL; Raab M, 2012, J EXP PSYCHOL-APPL, V18, P81, DOI 10.1037/a0025951; Radicchi F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017249; Sire C, 2009, EUR PHYS J B, V67, P473, DOI 10.1140/epjb/e2008-00405-5; Skinner B, 2011, J QUANT ANAL SPORTS, V7, DOI 10.2202/1559-0410.1364; Skinner B, 2010, J QUANT ANAL SPORTS, V6, DOI 10.2202/1559-0410.1217; VANMOERBEKE P, 1976, ARCH RATION MECH AN, V60, P101, DOI 10.1007/BF00250676; WARDROP RL, 1995, AM STAT, V49, P24, DOI 10.2307/2684806; Weisstein EW, QUADRATIC MAP; Yaari G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024532	19	25	25	5	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30776	10.1371/journal.pone.0030776	http://dx.doi.org/10.1371/journal.pone.0030776			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295109	Green Submitted, gold, Green Published			2022-12-27	WOS:000301640600054
J	Virtanen, M; Stansfeld, SA; Fuhrer, R; Ferrie, JE; Kivimaki, M				Virtanen, Marianna; Stansfeld, Stephen A.; Fuhrer, Rebecca; Ferrie, Jane E.; Kivimaeki, Mika			Overtime Work as a Predictor of Major Depressive Episode: A 5-Year Follow-Up of the Whitehall II Study	PLOS ONE			English	Article							BRITISH CIVIL-SERVANTS; CORONARY-HEART-DISEASE; STRESSFUL LIFE EVENTS; PSYCHOSOCIAL FACTORS; MENTAL-DISORDERS; PSYCHIATRIC-DISORDERS; PROSPECTIVE COHORT; HEALTH; JOB; SYMPTOMS	Background: The association between overtime work and depression is still unclear. This study examined the association between overtime work and the onset of a major depressive episode (MDE). Methodology/Principal Findings: Prospective cohort study with a baseline examination of working hours, psychological morbidity (an indicator of baseline depression) and depression risk factors in 1991-1993 and a follow-up of major depressive episode in 1997-1999 (mean follow-up 5.8 years) among British civil servants (the Whitehall II study; 1626 men, 497 women, mean age 47 years at baseline). Onset of 12-month MDE was assessed by the Composite International Diagnostic Interview (CIDI) at follow-up. In prospective analysis of participants with no psychological morbidity at baseline, the odds ratio for a subsequent major depressive episode was 2.43 (95% confidence interval 1.11 to 5.30) times higher for those working 11+ hours a day compared to employees working 7-8 hours a day, when adjusted for socio-demographic factors at baseline. Further adjustment for chronic physical disease, smoking, alcohol use, job strain and work-related social support had little effect on this association (odds ratio 2.52; 95% confidence interval 1.12 to 5.65). Conclusions/Significance: Data from middle-aged civil servants suggest that working long hours of overtime may predispose to major depressive episodes.	[Virtanen, Marianna] Finnish Inst Occupat Hlth, Helsinki, Finland; [Stansfeld, Stephen A.] Queen Mary Univ London, Wolfson Inst Prevent Med, London, England; [Fuhrer, Rebecca] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Ferrie, Jane E.; Kivimaeki, Mika] UCL, Dept Epidemiol & Publ Hlth, London, England; [Ferrie, Jane E.] Univ Bristol, Sch Community & Social Med, Bristol, Avon, England	Finnish Institute of Occupational Health; University of London; Queen Mary University London; McGill University; University of London; University College London; University of Bristol	Virtanen, M (corresponding author), Finnish Inst Occupat Hlth, Helsinki, Finland.	marianna.virtanen@ttl.fi	Ferrie, Jane/AAZ-2009-2020; Kivimaki, Mika/B-3607-2012	Kivimaki, Mika/0000-0002-4699-5627	Medical Research Council; British Heart Foundation; Stroke Association; National Heart Lung and Blood Institute [HL36310]; National Institute on Aging [AG13196]; Academy of Finland [124271, 124322, 129264, 132944]; EU; BUPA Foundation, UK; MRC [G0902037] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG013196, R01AG013196] Funding Source: NIH RePORTER; British Heart Foundation [RG/07/008/23674] Funding Source: researchfish; Medical Research Council [G19/35, G8802774, G0100222, G0902037] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Stroke Association; National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Academy of Finland(Academy of Finland); EU(European Commission); BUPA Foundation, UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The Whitehall II study has been supported by grants from the Medical Research Council, www.mrc.ac.uk/, British Heart Foundation www.bhf.org.uk/, Stroke Association, http://www.stroke.org.uk/, National Heart Lung and Blood Institute, http://www.nhlbi.nih.gov/ (HL36310), National Institute on Aging, http://www.nia.nih.gov/ (AG13196). Dr. Kivimaki is supported by the Academy of Finland, http://www.aka.fi/en-GB/A/ (124271, 124322, 129264 and 132944), the EU New OSH ERA Programme, http://www.newoshera.eu/en/index_html, and the BUPA Foundation, UK, http://www.bupafoundation.com/; Dr. Ferrie is supported by the National Institute of Aging, http://www.nia.nih.gov/. Dr. Fuhrer holds the CIHR Canada; http://www.cihr-irsc.gc.ca/e/193.html Research Chair in Psychosocial Epidemiology. The funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler DA, 2006, AM J PSYCHIAT, V163, P1569, DOI 10.1176/appi.ajp.163.9.1569; American Psychiatric Association, 1987, DIAGN STAT MAN MENT; Bonde JPE, 2008, OCCUP ENVIRON MED, V65, P438, DOI 10.1136/oem.2007.038430; Caruso CC, 2006, IND HEALTH, V44, P531, DOI 10.2486/indhealth.44.531; Crouter AC, 2001, J MARRIAGE FAM, V63, P404, DOI 10.1111/j.1741-3737.2001.00404.x; Demyttenaere K, 2004, JAMA-J AM MED ASSOC, V291, P2581, DOI 10.1001/jama.291.21.2581; Eaton WW, 2008, EPIDEMIOL REV, V30, P1, DOI 10.1093/epirev/mxn011; Ettner SL, 1997, IND LABOR RELAT REV, V51, P64, DOI 10.2307/2525035; Goldberg D.P, 1972, DETECTION PSYCHIAT I; Goldberg DP, 1997, PSYCHOL MED, V27, P191, DOI 10.1017/S0033291796004242; Harkonmaki K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003402; Harris T, 2001, BRIT MED BULL, V57, P17, DOI 10.1093/bmb/57.1.17; Honkonen T, 2007, SCAND J WORK ENV HEA, V33, P29, DOI 10.5271/sjweh.1061; Isometsa E, 2008, PSYKIATRIA, P157; Jansen NWH, 2004, SCAND J WORK ENV HEA, V30, P139, DOI 10.5271/sjweh.771; Karasek R, 1990, HLTH WORK STRESS PRO; KARASEK RA, 1979, ADMIN SCI QUART, V24, P285, DOI 10.2307/2392498; Kendler KS, 1999, AM J PSYCHIAT, V156, P837, DOI 10.1176/ajp.156.6.837; Kessler RC, 1997, ANNU REV PSYCHOL, V48, P191, DOI 10.1146/annurev.psych.48.1.191; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Kivimaki M, 2007, AM J HYPERTENS, V20, P1146, DOI 10.1016/j.amjhyper.2007.06.006; Kuper H, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4265; Lorant V, 2003, AM J EPIDEMIOL, V157, P98, DOI 10.1093/aje/kwf182; Lundberg U, 2002, WORK STRESS, V16, P356, DOI 10.1080/0267837021000064427; MacKinnon D P, 2000, Prev Sci, V1, P173, DOI 10.1023/A:1026595011371; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Michelsen H, 2003, OCCUP ENVIRON MED, V60, P489, DOI 10.1136/oem.60.7.489; Netterstrom B, 2008, EPIDEMIOL REV, V30, P118, DOI 10.1093/epirev/mxn004; Paterniti S, 2002, BRIT J PSYCHIAT, V181, P111; RISSLER A, 1977, ERGONOMICS, V20, P577; Shields M, 1999, Health Rep, V11, P33; Stansfeld S, 2002, BRIT J PSYCHIAT, V181, P96; STANSFELD SA, 1992, PSYCHOL MED, V22, P739, DOI 10.1017/S0033291700038186; Stansfeld SA, AM J PUBLIC IN PRESS; Stansfeld S, 2006, SCAND J WORK ENV HEA, V32, P443, DOI 10.5271/sjweh.1050; Suwazono Y, 2003, OCCUP MED-OXFORD, V53, P436, DOI 10.1093/occmed/kqg102; Tarumi K, 2003, IND HEALTH, V41, P101, DOI 10.2486/indhealth.41.101; TZELGOV J, 1991, PSYCHOL BULL, V109, P524, DOI 10.1037/0033-2909.109.3.524; van der Hulst M, 2003, SCAND J WORK ENV HEA, V29, P171, DOI 10.5271/sjweh.720; Virtanen M, 2011, PSYCHOL MED, V41, P2485, DOI 10.1017/S0033291711000171; Virtanen M, 2009, AM J EPIDEMIOL, V169, P596, DOI 10.1093/aje/kwn382; Virtanen M, 2010, EUR HEART J, V31, P1737, DOI 10.1093/eurheartj/ehq124; Virtanen M, 2009, SLEEP, V32, P737, DOI 10.1093/sleep/32.6.737; Wang PS, 2004, AM J PSYCHIAT, V161, P1885, DOI 10.1176/appi.ajp.161.10.1885; White IR, 2004, ADDICTION, V99, P749, DOI 10.1111/j.1360-0443.2004.00710.x; WITTCHEN HU, 1994, J PSYCHIAT RES, V28, P57, DOI 10.1016/0022-3956(94)90036-1	47	114	119	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30719	10.1371/journal.pone.0030719	http://dx.doi.org/10.1371/journal.pone.0030719			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	910ME	22295106	Green Published, gold, Green Submitted			2022-12-27	WOS:000301640600051
J	Prinja, S; Bahuguna, P; Pinto, AD; Sharma, A; Bharaj, G; Kumar, V; Tripathy, JP; Kaur, M; Kumar, R				Prinja, Shankar; Bahuguna, Pankaj; Pinto, Andrew D.; Sharma, Atul; Bharaj, Gursimer; Kumar, Vishal; Tripathy, Jaya Prasad; Kaur, Manmeet; Kumar, Rajesh			The Cost of Universal Health Care in India: A Model Based Estimate	PLOS ONE			English	Article							POOR	Introduction: As high out-of-pocket healthcare expenses pose heavy financial burden on the families, Government of India is considering a variety of financing and delivery options to universalize health care services. Hence, an estimate of the cost of delivering universal health care services is needed. Methods: We developed a model to estimate recurrent and annual costs for providing health services through a mix of public and private providers in Chandigarh located in northern India. Necessary health services required to deliver good quality care were defined by the Indian Public Health Standards. National Sample Survey data was utilized to estimate disease burden. In addition, morbidity and treatment data was collected from two secondary and two tertiary care hospitals. The unit cost of treatment was estimated from the published literature. For diseases where data on treatment cost was not available, we collected data on standard treatment protocols and cost of care from local health providers. Results: We estimate that the cost of universal health care delivery through the existing mix of public and private health institutions would be INR 1713 (USD 38, 95% CI USD 18-73) per person per annum in India. This cost would be 24% higher, if branded drugs are used. Extrapolation of these costs to entire country indicates that Indian government needs to spend 3.8% (2.1%-6.8%) of the GDP for universalizing health care services. Conclusion: The cost of universal health care delivered through a combination of public and private providers is estimated to be INR 1713 per capita per year in India. Important issues such as delivery strategy for ensuring quality, reducing inequities in access, and managing the growth of health care demand need be explored.	[Prinja, Shankar; Bahuguna, Pankaj; Sharma, Atul; Bharaj, Gursimer; Kumar, Vishal; Tripathy, Jaya Prasad; Kaur, Manmeet; Kumar, Rajesh] Post Grad Inst Med Educ & Res, Sch Publ Hlth, Chandigarh, India; [Pinto, Andrew D.] St Michaels Hosp, Dept Family & Community Med, Toronto, ON M5B 1W8, Canada; [Pinto, Andrew D.] St Michaels Hosp, Ctr Res Inner City Hlth, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto	Prinja, S (corresponding author), Post Grad Inst Med Educ & Res, Sch Publ Hlth, Chandigarh, India.	dr.rajeshkumar@gmail.com		Pinto, Ameet/0000-0003-1089-5664; Pinto, Andrew/0000-0003-1841-9347; Tripathy, Jaya Prasad/0000-0002-2626-5977; Bahuguna, Pankaj/0000-0001-9952-6077				*AFMC, 2007, STAND TREATM GUID ME; AKERLOF GA, 1970, Q J ECON, V84, P488, DOI 10.2307/1879431; Balarajan Y, 2011, LANCET, V377, P505, DOI 10.1016/S0140-6736(10)61894-6; Bank W, 2010, WORLD DEV IND; Berman P, 2010, 59886 WORLD BANK HUM, P59886; Chollet D, 1997, PRIVATE INSURANCE PR; Dror DM, 2008, INDIAN J MED RES, V127, P347; Frenk J., 2011, NEW VISION HLTH SYST; Gupta I., 2000, WORLD HLTH POPULATIO, V3; Gupta M, 2010, RATE CONTRACT CONSUM; Hammer J., 2007, Economic and Political Weekly, V42, P4049; Health Do, 2010, SURG CARE PACKAGE; Hotchkiss DR, 1999, HEALTH POLICY, V46, P195, DOI 10.1016/S0168-8510(98)00063-3; Le Grand J., 2003, MOTIVATION AGENCY PU; Levesque JF, 2007, INT J HEALTH PLAN M, V22, P159, DOI 10.1002/hpm.879; Mahal A, 2011, ACHIEVING UNIVERSAL; Mathur Neeta, 2010, Indian J Community Med, V35, P153, DOI 10.4103/0970-0218.62585; Ministry of Health and Family Welfare (MoHFW) Government of India & UNICEF, 2019, NAT POP POL 2000; MOF, 2009, FISC CHALL; MOHFW, 2005, NAT HLTH ACC IND; MOHFW, 2005, NAT COMM MACR HLTH; MOHFW, 2009, NAT HLTH BILL 2009; MOHFW, 2005, BACKGR PAP BURD DIS; MOHFW, 2006, REP WORK GROUP HLTH; MOHFW, 2007, IND PUBL HLTH STAND; MOHFW, 2005, NAT RUR HLTH MISS IM; Moody A, 2011, EC TIMES; National Sample Survey Organisation (NSSO), 2006, MORB HLTH CAR COND A; Palacios R, 2010, NEW APPR PROV HLTH I; Peters D, 2002, BETTER HLTH SYSTEMS, P233; Prinja S, 2011, INDIAN J ME IN PRESS; Rama Baru, 2010, Economic and Political Weekly, V45, P49; Rane W, 1996, EC POLITICAL WE 0824, V24, P2331; Reddy KS, 2011, LANCET, V377, P760, DOI 10.1016/S0140-6736(10)61960-5; Sengupta A, 2005, BMJ-BRIT MED J, V331, P1157, DOI 10.1136/bmj.331.7526.1157; Singh M, 2006, NEUROL INDIA, V54, P78; Srivastava NM, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-61; Sur D, 2009, J HEALTH POPUL NUTR, V27, P725; Suryanarayana M, 2011, IN ADJ HUM DEV IND I; Tancharoensathien V, 2006, ACHIEVING UNIVERSAL; UNDP, 2011, HUM DEV REP 2010; van Doorslaer E, 2005, PAYING OUT OF POCKET; van Doorslaer E, 2006, LANCET, V368, P1357, DOI 10.1016/S0140-6736(06)69560-3; Wagstaff A, 1999, J HEALTH ECON, V18, P263, DOI 10.1016/S0167-6296(98)00044-7; WHO, 2010, WOR HEALT REP, P1; WHO, 2005, CHOOSING INT AR COST	46	106	108	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e30362	10.1371/journal.pone.0030362	http://dx.doi.org/10.1371/journal.pone.0030362			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	911GB	22905208	gold, Green Published, Green Submitted			2022-12-27	WOS:000301704200015
J	Collins, RA; Armstrong, KF; Meier, R; Yi, YG; Brown, SDJ; Cruickshank, RH; Keeling, S; Johnston, C				Collins, Rupert A.; Armstrong, Karen F.; Meier, Rudolf; Yi, Youguang; Brown, Samuel D. J.; Cruickshank, Robert H.; Keeling, Suzanne; Johnston, Colin			Barcoding and Border Biosecurity: Identifying Cyprinid Fishes in the Aquarium Trade	PLOS ONE			English	Article							FRESH-WATER FISHES; DNA BARCODES; MITOCHONDRIAL-DNA; ORNAMENTAL FISH; TUNA SUSHI; IDENTIFICATION; BIODIVERSITY; TELEOSTEI; HOMOGENIZATION; CONSEQUENCES	Background: Poorly regulated international trade in ornamental fishes poses risks to both biodiversity and economic activity via invasive alien species and exotic pathogens. Border security officials need robust tools to confirm identifications, often requiring hard-to-obtain taxonomic literature and expertise. DNA barcoding offers a potentially attractive tool for quarantine inspection, but has yet to be scrutinised for aquarium fishes. Here, we present a barcoding approach for ornamental cyprinid fishes by: (1) expanding current barcode reference libraries; (2) assessing barcode congruence with morphological identifications under numerous scenarios (e. g. inclusion of GenBank data, presence of singleton species, choice of analytical method); and (3) providing supplementary information to identify difficult species. Methodology/Principal Findings: We sampled 172 ornamental cyprinid fish species from the international trade, and provide data for 91 species currently unrepresented in reference libraries (GenBank/Bold). DNA barcodes were found to be highly congruent with our morphological assignments, achieving success rates of 90-99%, depending on the method used (neighbour-joining monophyly, bootstrap, nearest neighbour, GMYC, percent threshold). Inclusion of data from GenBank (additional 157 spp.) resulted in a more comprehensive library, but at a cost to success rate due to the increased number of singleton species. In addition to DNA barcodes, our study also provides supporting data in the form of specimen images, morphological characters, taxonomic bibliography, preserved vouchers, and nuclear rhodopsin sequences. Using this nuclear rhodopsin data we also uncovered evidence of interspecific hybridisation, and highlighted unrecognised diversity within popular aquarium species, including the endangered Indian barb Puntius denisonii. Conclusions/Significance: We demonstrate that DNA barcoding provides a highly effective biosecurity tool for rapidly identifying ornamental fishes. In cases where DNA barcodes are unable to offer an identification, we improve on previous studies by consolidating supplementary information from multiple data sources, and empower biosecurity agencies to confidently identify high-risk fishes in the aquarium trade.	[Collins, Rupert A.; Armstrong, Karen F.] Lincoln Univ, Bioprotect Res Ctr, Canterbury, New Zealand; [Meier, Rudolf; Yi, Youguang] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Meier, Rudolf; Yi, Youguang] Natl Univ Singapore, Univ Scholars Programme, Singapore 117548, Singapore; [Brown, Samuel D. J.; Cruickshank, Robert H.] Lincoln Univ, Dept Ecol, Fac Agr & Life Sci, Canterbury, New Zealand; [Keeling, Suzanne; Johnston, Colin] Minist Agr & Forestry, Hlth Anim Lab, Invest & Diagnost Ctr, Upper Hutt, New Zealand	Lincoln University - New Zealand; National University of Singapore; National University of Singapore; Lincoln University - New Zealand	Collins, RA (corresponding author), Lincoln Univ, Bioprotect Res Ctr, Canterbury, New Zealand.	rupertcollins@gmail.com	Meier, Rudolf/AAB-3848-2021; Meier, Rudolf/A-7099-2011; Brown, Samuel/P-8847-2017; Armstrong, Karen F/J-3460-2013; Schuler, Herwig/E-5751-2011; Arner, Elias/J-5832-2012	Meier, Rudolf/0000-0002-4452-2885; Meier, Rudolf/0000-0002-4452-2885; Brown, Samuel/0000-0001-7112-421X; Armstrong, Karen F/0000-0003-4973-2651; Hogbom, Martin/0000-0001-5574-9383; Schuler, Herwig/0000-0003-4059-3501; Collins, Rupert A./0000-0002-9135-1169; Arner, Elias/0000-0002-4807-6114	Ministry of Agriculture and Forestry Biosecurity New Zealand; Ministry of Education (Singapore) [R377-000-040-112]	Ministry of Agriculture and Forestry Biosecurity New Zealand; Ministry of Education (Singapore)(Ministry of Education, Singapore)	This work was supported by a Ministry of Agriculture and Forestry Biosecurity New Zealand scholarship for RAC; grant R377-000-040-112 by the Ministry of Education (Singapore) for RM and YY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali A, 2010, IUCN 2011 IUCN RED L; Armstrong KF, 2005, PHILOS T R SOC B, V360, P1813, DOI 10.1098/rstb.2005.1713; Austerlitz F, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S14-S10; Baensch HA, 2007, AQUARIUM ATLAS PHOTO; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Broughton RE, 2001, GENOME RES, V11, P1958, DOI 10.1101/gr.156801; Brown SDJ, 2012, MOL ECOL RESOUR, V12, P562, DOI 10.1111/j.1755-0998.2011.03108.x; Buhay JE, 2009, J CRUSTACEAN BIOL, V29, P96, DOI 10.1651/08-3020.1; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Chen WJ, 2008, GENE, V423, P125, DOI 10.1016/j.gene.2008.07.016; Chen WJ, 2003, MOL PHYLOGENET EVOL, V26, P262, DOI 10.1016/S1055-7903(02)00371-8; Cohen NJ, 2009, J FOOD PROTECT, V72, P810, DOI 10.4315/0362-028X-72.4.810; Collins RA, 2012, METHODS ECOL EVOL, V3, P457, DOI 10.1111/j.2041-210X.2011.00176.x; Copp GH, 2010, AQUAT CONSERV, V20, P595, DOI 10.1002/aqc.1129; Darling JA, 2007, BIOL INVASIONS, V9, P751, DOI 10.1007/s10530-006-9079-4; Dasmahapatra KK, 2006, HEREDITY, V97, P254, DOI 10.1038/sj.hdy.6800858; Dasmahapatra KK, 2010, MOL ECOL RESOUR, V10, P264, DOI 10.1111/j.1755-0998.2009.02763.x; deWaard JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014280; Dinca V, 2011, P ROY SOC B-BIOL SCI, V278, P347, DOI 10.1098/rspb.2010.1089; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Elias M, 2007, P ROY SOC B-BIOL SCI, V274, P2881, DOI 10.1098/rspb.2007.1035; Eschmeyer WN, 2010, CATALOG FISHES ELECT; Fang Fang, 2000, Ichthyological Exploration of Freshwaters, V11, P149; Fang F, 2009, ZOOL SCR, V38, P237, DOI 10.1111/j.1463-6409.2008.00373.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Frezal L, 2008, INFECT GENET EVOL, V8, P727, DOI 10.1016/j.meegid.2008.05.005; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Galtier N, 2009, MOL ECOL, V18, P4541, DOI 10.1111/j.1365-294X.2009.04380.x; Gerson H, 2008, CONSERV BIOL, V22, P4, DOI 10.1111/j.1523-1739.2007.00857.x; Gerstner CL, 2006, J FISH BIOL, V68, P862, DOI 10.1111/j.1095.8649.2006.00978.x; Glez-Pena D, 2010, NUCLEIC ACIDS RES, V38, pW14, DOI 10.1093/nar/gkq321; Go J, 2006, AQUACULTURE, V258, P140, DOI 10.1016/j.aquaculture.2006.04.033; Gozlan RE, 2005, NATURE, V435, P1046, DOI 10.1038/4351046a; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Han MV, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-356; Harris DJ, 2003, TRENDS ECOL EVOL, V18, P317, DOI 10.1016/S0169-5347(03)00150-2; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hensen RR, 2010, STANDARD NAMES FRESH; Hickerson MJ, 2006, SYST BIOL, V55, P729, DOI 10.1080/10635150600969898; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Holmes BH, 2009, FISH RES, V95, P280, DOI 10.1016/j.fishres.2008.09.036; Hubert N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002490; Hui TH, 2008, RAFFLES B ZOOL, V56, P423; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; Kottelat M., 2007, HDB EUROPEAN FRESHWA, P646; Liao TY, 2011, RAFFLES B ZOOL, V59, P77; Lim GS, 2012, SYST BIOL, V61, P165, DOI 10.1093/sysbio/syr030; Linthoingambi I., 2007, Zootaxa, V1450, P45; Lowenstein JH, 2010, BIOL LETTERS, V6, P692, DOI 10.1098/rsbl.2010.0156; Lowenstein JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007866; MAF Biosecurity New Zealand, 2011, IMP HLTH STAND ORN F; McDowall RM, 2004, NEW ZEAL J MAR FRESH, V38, P503, DOI 10.1080/00288330.2004.9517256; Meier R, 2008, SYST BIOL, V57, P809, DOI 10.1080/10635150802406343; Meier R, 2008, SYST ASSOC SPEC VOL, V76, P95; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; Nelson JS, 2006, FISHES WORLD; NG PKL, 1993, BIOL CONSERV, V64, P19, DOI 10.1016/0006-3207(93)90379-F; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Padilla DK, 2004, FRONT ECOL ENVIRON, V2, P131, DOI 10.1890/1540-9295(2004)002[0131:BBWAAO]2.0.CO;2; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Ploeg A, 2008, OFI J, V58, P21; Ploeg A, 2009, BIOSECURITY ORNAMENT; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; R Core Team, 2021, R LANGUAGE ENV STAT; Raghavan R, 2007, CURR SCI INDIA, V92, P1671; Rahel FJ, 2002, ANNU REV ECOL SYST, V33, P291, DOI 10.1146/annurev.ecolsys.33.010802.150429; Rahel FJ, 2007, FRESHWATER BIOL, V52, P696, DOI 10.1111/j.1365-2427.2006.01708.x; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Rosenberg NA, 2007, EVOLUTION, V61, P317, DOI 10.1111/j.1558-5646.2007.00023.x; Ross HA, 2003, J HERED, V94, P111, DOI 10.1093/jhered/esg027; Ross HA, 2008, SYST BIOL, V57, P216, DOI 10.1080/10635150802032990; Rubinoff D, 2006, J HERED, V97, P581, DOI 10.1093/jhered/esl036; Rubinoff D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016361; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sarkar IN, 2008, MOL ECOL RESOUR, V8, P1256, DOI 10.1111/j.1755-0998.2008.02235.x; Sevilla RG, 2007, MOL ECOL NOTES, V7, P730, DOI 10.1111/j.1471-8286.2007.01863.x; Silva A, 2010, ICHTHYOL EXPLOR FRES, V21, P27; Smits SA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012267; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Srivathsan A, 2012, CLADISTICS, V28, P190, DOI 10.1111/j.1096-0031.2011.00370.x; Steinke D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006300; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang KL, 2010, MOL PHYLOGENET EVOL, V57, P189, DOI 10.1016/j.ympev.2010.05.021; Valdez-Moreno M, 2009, J FISH BIOL, V74, P377, DOI 10.1111/j.1095-8649.2008.02077.x; Vogler AP, 2007, J ZOOL SYST EVOL RES, V45, P1, DOI 10.1111/j.1439-0469.2006.00384.x; Ward RD, 2009, J FISH BIOL, V74, P329, DOI 10.1111/j.1095-8649.2008.02080.x; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Whittington RJ, 2007, PREV VET MED, V81, P92, DOI 10.1016/j.prevetmed.2007.04.007; Will KW, 2004, CLADISTICS, V20, P47, DOI 10.1111/j.1096-0031.2003.00008.x; Wong EHK, 2009, MOL ECOL RESOUR, V9, P243, DOI 10.1111/j.1755-0998.2009.02653.x; Wong YT, 2011, BIOL INVASIONS, V13, P341, DOI 10.1007/s10530-010-9825-5; YOKOYAMA R, 1995, INVEST OPHTH VIS SCI, V36, P939; Zemlak TS, 2009, MOL ECOL RESOUR, V9, P237, DOI 10.1111/j.1755-0998.2009.02649.x	99	110	115	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e28381	10.1371/journal.pone.0028381	http://dx.doi.org/10.1371/journal.pone.0028381			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276096	Green Published, gold, Green Submitted			2022-12-27	WOS:000301568100003
J	Jin, Y; Liu, Z; Cao, W; Ma, XY; Fan, YH; Yu, Y; Bai, J; Chen, F; Rosales, J; Lee, KY; Fu, SB				Jin, Yan; Liu, Zheng; Cao, Wei; Ma, Xinying; Fan, Yihui; Yu, Yang; Bai, Jing; Chen, Feng; Rosales, Jesusa; Lee, Ki-Young; Fu, Songbin			Novel Functional MAR Elements of Double Minute Chromosomes in Human Ovarian Cells Capable of Enhancing Gene Expression	PLOS ONE			English	Article							MATRIX ATTACHMENT REGIONS; DNA; AMPLIFICATION; ONCOGENE; CARCINOMA; SCAFFOLD; SITES; ORGANIZATION; SEQUENCES; LOOP	Double minute chromosomes or double minutes (DMs) are cytogenetic hallmarks of extrachromosomal genomic amplification and play a critical role in tumorigenesis. Amplified copies of oncogenes in DMs have been associated with increased growth and survival of cancer cells but DNA sequences in DMs which are mostly non-coding remain to be characterized. Following sequencing and bioinformatics analyses, we have found 5 novel matrix attachment regions (MARs) in a 682 kb DM in the human ovarian cancer cell line, UACC-1598. By electrophoretic mobility shift assay (EMSA), we determined that all 5 MARs interact with the nuclear matrix in vitro. Furthermore, qPCR analysis revealed that these MARs associate with the nuclear matrix in vivo, indicating that they are functional. Transfection of MARs constructs into human embryonic kidney 293T cells showed significant enhancement of gene expression as measured by luciferase assay, suggesting that the identified MARS, particularly MARs 1 to 4, regulate their target genes in vivo and are potentially involved in DM-mediated oncogene activation.	[Jin, Yan; Liu, Zheng; Cao, Wei; Ma, Xinying; Fan, Yihui; Yu, Yang; Bai, Jing; Chen, Feng; Fu, Songbin] Harbin Med Univ, Med Genet Lab, Harbin, Peoples R China; [Rosales, Jesusa] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada; [Lee, Ki-Young] Univ Calgary, Dept Cell Biol & Anat, Calgary, AB, Canada	Harbin Medical University; University of Calgary; University of Calgary	Jin, Y (corresponding author), Harbin Med Univ, Med Genet Lab, Harbin, Peoples R China.	fusb@ems.hrbmu.edu.cn	; Jin, Guangze/F-5271-2017	Liu, Zhili/0000-0001-7704-5133; Jin, Guangze/0000-0002-9852-0965; Rosales, Jesusa/0000-0002-2543-3801	National Basic Research Program of China [2010CB534901]; National Natural Science Foundation of China [30971583, 30800268, 81000906]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Basic Research Program of China (No. 2010CB534901) and the National Natural Science Foundation of China (No. 30971583, No. 30800268, and No. 81000906). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI Y, 1989, EMBO J, V8, P3997, DOI 10.1002/j.1460-2075.1989.tb08582.x; ALITALO K, 1983, P NATL ACAD SCI-BIOL, V80, P1707, DOI 10.1073/pnas.80.6.1707; Allen GC, 2000, PLANT MOL BIOL, V43, P361, DOI 10.1023/A:1006424621037; Bode J, 2000, CRIT REV EUKAR GENE, V10, P73; Bode J, 2000, J CELL BIOCH SUPPL S, P353; COCKERILL PN, 1986, FEBS LETT, V204, P5, DOI 10.1016/0014-5793(86)81377-1; FAKHARZADEH SS, 1993, GENOMICS, V15, P283, DOI 10.1006/geno.1993.1058; Fan YH, 2011, J APPL GENET, V52, P53, DOI 10.1007/s13353-010-0007-z; Fukuda Y, 1999, PLANT MOL BIOL, V39, P1051, DOI 10.1023/A:1006133003283; GEBHART E, 1984, INT J CANCER, V34, P369, DOI 10.1002/ijc.2910340313; Gebhart Erich, 2005, Clin Transl Oncol, V7, P477, DOI 10.1007/BF02717000; Girod PA, 2005, BIOTECHNOL BIOENG, V91, P1, DOI 10.1002/bit.20563; Guan XY, 2001, CANCER RES, V61, P3806; HAHN PJ, 1993, BIOESSAYS, V15, P477, DOI 10.1002/bies.950150707; Kim JM, 2004, J BIOTECHNOL, V107, P95, DOI 10.1016/j.jbiotec.2003.09.015; Kuttler F, 2007, SEMIN CANCER BIOL, V17, P56, DOI 10.1016/j.semcancer.2006.10.007; Kwaks THJ, 2006, TRENDS BIOTECHNOL, V24, P137, DOI 10.1016/j.tibtech.2006.01.007; Lestou VS, 2003, BRIT J HAEMATOL, V122, P745, DOI 10.1046/j.1365-2141.2003.04502.x; Martins RP, 2004, J BIOL CHEM, V279, P51862, DOI 10.1074/jbc.M409415200; MCGILL JR, 1993, CANCER GENET CYTOGEN, V71, P125, DOI 10.1016/0165-4608(93)90017-G; MIRKOVITCH J, 1984, CELL, V39, P223, DOI 10.1016/0092-8674(84)90208-3; Morales C, 2009, MOL CANCER THER, V8, P424, DOI 10.1158/1535-7163.MCT-08-0759; MULERIS M, 1994, ONCOGENE, V9, P2717; Neznanov N, 1996, MOL BIOL CELL, V7, P541, DOI 10.1091/mbc.7.4.541; PEACH C, 1991, PLANT MOL BIOL, V17, P49, DOI 10.1007/BF00036805; Singer MJ, 2000, P NATL ACAD SCI USA, V97, P7921, DOI 10.1073/pnas.130194897; SLOVAK ML, 1994, GENE CHROMOSOME CANC, V9, P62, DOI 10.1002/gcc.2870090111; SPRIGGS AI, 1962, BRIT MED J, P1431, DOI 10.1136/bmj.2.5317.1431; SREEKANTAIAH C, 1992, CANCER GENET CYTOGEN, V58, P134, DOI 10.1016/0165-4608(92)90099-T; Tetko IV, 2006, PLOS COMPUT BIOL, V2, P136, DOI 10.1371/journal.pcbi.0020021; van Leeuwen W, 2001, PLANT MOL BIOL, V47, P543, DOI 10.1023/A:1011840310436; VANDEVANTER DR, 1990, J NATL CANCER I, V82, P1815, DOI 10.1093/jnci/82.23.1815; WAHL GM, 1989, CANCER RES, V49, P1333; Yoshimoto M, 1999, AM J PATHOL, V155, P1439, DOI 10.1016/S0002-9440(10)65457-0	34	55	60	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e30419	10.1371/journal.pone.0030419	http://dx.doi.org/10.1371/journal.pone.0030419			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LO	22427822	gold, Green Published, Green Submitted			2022-12-27	WOS:000302178400008
J	Li, LQ; Zhang, Y; Zou, LY; Li, CQ; Yu, B; Zheng, XQ; Zhou, Y				Li, Liqi; Zhang, Yuan; Zou, Lingyun; Li, Changqing; Yu, Bo; Zheng, Xiaoqi; Zhou, Yue			An Ensemble Classifier for Eukaryotic Protein Subcellular Location Prediction Using Gene Ontology Categories and Amino Acid Hydrophobicity	PLOS ONE			English	Article							SUPPORT VECTOR MACHINE; LOCALIZATION PREDICTION; MULTIPLE SITES; WEB SERVER; EUK-MPLOC; PSI-BLAST; SEQUENCE; FEATURES; PLOC; COMPLEXITY	With the rapid increase of protein sequences in the post-genomic age, it is challenging to develop accurate and automated methods for reliably and quickly predicting their subcellular localizations. Till now, many efforts have been tried, but most of which used only a single algorithm. In this paper, we proposed an ensemble classifier of KNN (k-nearest neighbor) and SVM (support vector machine) algorithms to predict the subcellular localization of eukaryotic proteins based on a voting system. The overall prediction accuracies by the one-versus-one strategy are 78.17%, 89.94% and 75.55% for three benchmark datasets of eukaryotic proteins. The improved prediction accuracies reveal that GO annotations and hydrophobicity of amino acids help to predict subcellular locations of eukaryotic proteins.	[Li, Liqi; Zhang, Yuan; Li, Changqing; Zhou, Yue] Third Mil Med Univ, Xinqiao Hosp, Dept Orthoped, Chongqing, Peoples R China; [Zou, Lingyun] Third Mil Med Univ, Coll Basic Med Sci, Dept Microbiol, Chongqing, Peoples R China; [Yu, Bo] Yichun Peoples Hosp, Dept Orthoped, Yichun, Peoples R China; [Zheng, Xiaoqi] Shanghai Normal Univ, Dept Math, Shanghai, Peoples R China; [Zheng, Xiaoqi] Sci Comp Key Lab Shanghai Univ, Shanghai, Peoples R China	Army Medical University; Army Medical University; Shanghai Normal University; Shanghai Key Laboratory of Scalable Computing & System	Li, LQ (corresponding author), Third Mil Med Univ, Xinqiao Hosp, Dept Orthoped, Chongqing, Peoples R China.	xqzheng@shnu.edu.cn; zhouyxq@163.com			National Natural Science Foundation of China [30901512, 31100953]; Shanghai Leading Academic Discipline Project [S30405]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This work was supported by grants from the National Natural Science Foundation of China (No. 30901512 and No. 31100953) and the Shanghai Leading Academic Discipline Project (No. S30405). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari HR, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-160; B Panwar, 2011, AMINO ACIDS; Bhasin M, 2004, NUCLEIC ACIDS RES, V32, pW414, DOI 10.1093/nar/gkh350; Bulashevska A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-298; Cai YD, 2005, J THEOR BIOL, V234, P145, DOI 10.1016/j.jtbi.2004.11.017; Cai Yu-Dong, 2000, Molecular Cell Biology Research Communications, V4, P172, DOI 10.1006/mcbr.2001.0269; Chou KC, 2008, NAT PROTOC, V3, P153, DOI 10.1038/nprot.2007.494; Chou KC, 2007, J PROTEOME RES, V6, P1728, DOI 10.1021/pr060635i; Chou KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018258; Chou KC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011335; Chou KC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009931; Cuo Jian, 2006, Journal of Bioinformatics and Computational Biology, V4, P1181; Currie RA, 2005, REPROD TOXICOL, V20, P433, DOI 10.1016/j.reprotox.2005.03.014; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Gu Q, 2010, AMINO ACIDS, V38, P975, DOI 10.1007/s00726-008-0209-4; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Huang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016036; Huang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025297; Huang WL, 2009, BIOSYSTEMS, V98, P73, DOI 10.1016/j.biosystems.2009.06.007; Jia PL, 2007, BIOCHEM BIOPH RES CO, V357, P366, DOI 10.1016/j.bbrc.2007.03.139; Khan A, 2011, COMPUT BIOL CHEM, V35, P218, DOI 10.1016/j.compbiolchem.2011.05.003; Khan A, 2010, AMINO ACIDS, V38, P347, DOI 10.1007/s00726-009-0238-7; Kim JK, 2006, PATTERN RECOGN LETT, V27, P996, DOI 10.1016/j.patrec.2005.11.014; Laurila K, 2011, AMINO ACIDS, V40, P975, DOI 10.1007/s00726-010-0724-y; Lei ZD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-491; Liao B, 2011, PROTEIN PEPTIDE LETT, V18, P1086, DOI 10.2174/092986611797200931; Lin TH, 2011, IEEE ACM T COMPUT BI, V8, P441, DOI 10.1109/TCBB.2009.82; Liqi L., 2011, J COMPUT BIOL BIOINF, V3, P15; Marinov M, 2001, HUM HERED, V51, P169, DOI 10.1159/000053338; Mei SY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-44; Mount D.W., 2009, COLD SPRING HARB PRO; NAKASHIMA H, 1994, J MOL BIOL, V238, P54, DOI 10.1006/jmbi.1994.1267; Park KJ, 2003, BIOINFORMATICS, V19, P1656, DOI 10.1093/bioinformatics/btg222; Pierleoni A, 2011, BIOINFORMATICS, V27, P1224, DOI 10.1093/bioinformatics/btr108; Qian ZL, 2006, BIOCHEM BIOPH RES CO, V348, P1034, DOI 10.1016/j.bbrc.2006.07.149; Qiu JD, 2010, AMINO ACIDS, V38, P1201, DOI 10.1007/s00726-009-0331-y; Rao HB, 2011, NUCLEIC ACIDS RES, V39, pW385, DOI 10.1093/nar/gkr284; Rashid M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-337; Sahu SS, 2010, COMPUT BIOL CHEM, V34, P320, DOI 10.1016/j.compbiolchem.2010.09.002; Seo MJ, 2005, GYNECOL ONCOL, V96, P621, DOI 10.1016/j.ygyno.2004.11.032; Shen HB, 2007, AMINO ACIDS, V33, P57, DOI 10.1007/s00726-006-0478-8; Shen HB, 2009, ANAL BIOCHEM, V394, P269, DOI 10.1016/j.ab.2009.07.046; Shen YQ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-563; Shi RJ, 2011, PROTEIN PEPTIDE LETT, V18, P625, DOI 10.2174/092986611795222768; Shi SP, 2011, BBA-MOL CELL RES, V1813, P424, DOI 10.1016/j.bbamcr.2011.01.011; SMITH TF, 1980, NATURE, V285, P620, DOI 10.1038/285620a0; Wang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024498; Wang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018476; Wang T, 2010, PROTEIN PEPTIDE LETT, V17, P32, DOI 10.2174/092986610789909494; Wang W, 2011, PROTEIN PEPTIDE LETT, V18, P480, DOI 10.2174/092986611794927947; Xie D, 2005, NUCLEIC ACIDS RES, V33, pW105, DOI 10.1093/nar/gki359; Xu QA, 2011, IEEE ACM T COMPUT BI, V8, P748, DOI 10.1109/TCBB.2010.22; Yu NY, 2011, NUCLEIC ACIDS RES, V39, pD241, DOI 10.1093/nar/gkq1093; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249; Yu X., 2011, AMINO ACIDS; Yuan Z, 1999, FEBS LETT, V451, P23, DOI 10.1016/S0014-5793(99)00506-2; Zhang Y, 2010, ACTA BIOMATER, V6, P776, DOI 10.1016/j.actbio.2009.08.025; Zhang Y, 2009, BIOSCI BIOTECH BIOCH, V73, P1999, DOI 10.1271/bbb.90187; Zheng XQ, 2009, AMINO ACIDS, V37, P427, DOI 10.1007/s00726-008-0172-0; Zhou XB, 2008, AMINO ACIDS, V35, P383, DOI 10.1007/s00726-007-0608-y; Zou Lingyun, 2007, Journal of Genetics and Genomics, V34, P1080, DOI 10.1016/S1673-8527(07)60123-4	62	93	98	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2012	7	1							e31057	10.1371/journal.pone.0031057	http://dx.doi.org/10.1371/journal.pone.0031057			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	912BU	22984619	gold, Green Submitted, Green Published			2022-12-27	WOS:000301770300007
J	Sanchez-Vidal, A; Canals, M; Calafat, AM; Lastras, G; Pedrosa-Pamies, R; Menendez, M; Medina, R; Company, JB; Hereu, B; Romero, J; Alcoverro, T				Sanchez-Vidal, Anna; Canals, Miquel; Calafat, Antoni M.; Lastras, Galderic; Pedrosa-Pamies, Rut; Menendez, Melisa; Medina, Raul; Company, Joan B.; Hereu, Bernat; Romero, Javier; Alcoverro, Teresa			Impacts on the Deep-Sea Ecosystem by a Severe Coastal Storm	PLOS ONE			English	Article							MARINE-SEDIMENTS; ORGANIC-MATTER; INNER-SHELF; DYNAMICS; MODEL; PRESERVATION; OCEAN; GULF; SIZE	Major coastal storms, associated with strong winds, high waves and intensified currents, and occasionally with heavy rains and flash floods, are mostly known because of the serious damage they can cause along the shoreline and the threats they pose to navigation. However, there is a profound lack of knowledge on the deep-sea impacts of severe coastal storms. Concurrent measurements of key parameters along the coast and in the deep-sea are extremely rare. Here we present a unique data set showing how one of the most extreme coastal storms of the last decades lashing the Western Mediterranean Sea rapidly impacted the deep-sea ecosystem. The storm peaked the 26th of December 2008 leading to the remobilization of a shallow-water reservoir of marine organic carbon associated with fine particles and resulting in its redistribution across the deep basin. The storm also initiated the movement of large amounts of coarse shelf sediment, which abraded and buried benthic communities. Our findings demonstrate, first, that severe coastal storms are highly efficient in transporting organic carbon from shallow water to deep water, thus contributing to its sequestration and, second, that natural, intermittent atmospheric drivers sensitive to global climate change have the potential to tremendously impact the largest and least known ecosystem on Earth, the deep-sea ecosystem.	[Sanchez-Vidal, Anna; Canals, Miquel; Calafat, Antoni M.; Lastras, Galderic; Pedrosa-Pamies, Rut] Univ Barcelona, Grp Recerca Consilidat GRC Geociencies Marines, Dept Estratig Paleontol & Geociencies Marines, Barcelona, Spain; [Menendez, Melisa; Medina, Raul] Univ Cantabria, Inst Hidraul Ambiental IH Cantabria, E-39005 Santander, Spain; [Company, Joan B.] CSIC, Inst Ciencies Mar, Barcelona, Spain; [Hereu, Bernat; Romero, Javier] Univ Barcelona, Dept Ecol, E-08028 Barcelona, Spain; [Alcoverro, Teresa] CSIC, Ctr Estudis Avancats Blanes, Blanes, Spain	University of Barcelona; Universidad de Cantabria; IHCantabria - Instituto de Hidraulica Ambiental de la Universidad de Cantabria; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB)	Sanchez-Vidal, A (corresponding author), Univ Barcelona, Grp Recerca Consilidat GRC Geociencies Marines, Dept Estratig Paleontol & Geociencies Marines, Barcelona, Spain.	anna.sanchez@ub.edu	Romero, Javier/A-8905-2013; Sanchez-Vidal, Anna/B-6919-2016; Menendez, Melisa/L-4600-2014; Pamies, Rut Pedrosa/I-1119-2015; Hereu, Bernat/K-9150-2015; Company, Joan B./K-7274-2014; Lastras, Galderic/A-6487-2013; Alcoverro, Teresa/J-9258-2012; Medina, Raul/L-2456-2014; Calafat, Antoni/J-5848-2017; Canals, Miquel/F-4922-2013; Etter, Andres/E-1860-2011	Romero, Javier/0000-0002-2772-8486; Sanchez-Vidal, Anna/0000-0002-8209-1959; Menendez, Melisa/0000-0002-5168-257X; Pamies, Rut Pedrosa/0000-0003-3504-4727; Hereu, Bernat/0000-0001-6247-7638; Company, Joan B./0000-0002-5878-7155; Lastras, Galderic/0000-0002-8756-3855; Alcoverro, Teresa/0000-0002-3910-9594; Medina, Raul/0000-0002-0126-2710; Calafat, Antoni/0000-0001-7927-3105; Canals, Miquel/0000-0001-5267-7601; Etter, Andres/0000-0003-0665-9300	European Community [226354, PERG04-GA-2008-239175]; Spanish project ROV-CANONES [CTM2009-06778]; Spanish project GRACCIE-CONSOLIDER [CSD2007-00067]; Spanish project DOS MARES [CTM2010-21810-C03]; Spanish project REDECO [CTM2008-04973-E]; Spanish project PIE-CSIC [200430E599]; Catalan Government Grups de Recerca Consolidats [2009 SGR 1305]	European Community(European Commission); Spanish project ROV-CANONES; Spanish project GRACCIE-CONSOLIDER; Spanish project DOS MARES; Spanish project REDECO; Spanish project PIE-CSIC; Catalan Government Grups de Recerca Consolidats	This work was supported by the European Community's Seventh Framework Programme projects HERMIONE (226354) and ARISTEUS (PERG04-GA-2008-239175), the Spanish projects ROV-CANONES (CTM2009-06778), GRACCIE-CONSOLIDER (CSD2007-00067), DOS MARES (CTM2010-21810-C03), REDECO (CTM2008-04973-E) and PIE-CSIC (200430E599) and a Catalan Government Grups de Recerca Consolidats grant (2009 SGR 1305). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnarson TS, 2007, GEOCHIM COSMOCHIM AC, V71, P3545, DOI 10.1016/j.gca.2007.04.027; Bolanos R, 2009, J MARINE SYST, V77, P237, DOI 10.1016/j.jmarsys.2007.12.018; Canals M, 2004, MAR GEOL, V213, P9, DOI 10.1016/j.margeo.2004.10.001; Canals M, 2006, NATURE, V444, P354, DOI 10.1038/nature05271; Company JB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001431; Dee DP, 2009, Q J ROY METEOR SOC, V135, P1830, DOI 10.1002/qj.493; Dickens AF, 2006, GEOCHIM COSMOCHIM AC, V70, P666, DOI 10.1016/j.gca.2005.10.024; Ferre B, 2005, CONT SHELF RES, V25, P2410, DOI 10.1016/j.csr.2005.08.017; FRY B, 1984, CONTRIB MAR SCI, V27, P13; Galy V, 2007, NATURE, V450, P407, DOI 10.1038/nature06273; Garcia-Rubies A, 2009, PLIN C; Guillen J, 2006, MAR GEOL, V234, P129, DOI 10.1016/j.margeo.2006.09.018; Guillen J, 2000, SCI MAR, V64, P427, DOI 10.3989/scimar.2000.64n4427; HEDGES JI, 1995, MAR CHEM, V49, P81, DOI 10.1016/0304-4203(95)00008-F; Hedges JI, 1997, ORG GEOCHEM, V27, P195, DOI 10.1016/S0146-6380(97)00066-1; HEUSSNER S, 1990, CONT SHELF RES, V10, P943, DOI 10.1016/0278-4343(90)90069-X; Hilton RG, 2008, NAT GEOSCI, V1, P759, DOI 10.1038/ngeo333; Keil RG, 1998, GEOCHIM COSMOCHIM AC, V62, P1347, DOI 10.1016/S0016-7037(98)00080-5; Kennedy H, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2010GB003848; Lastras G, 2011, MAR GEOL, V280, P20, DOI 10.1016/j.margeo.2010.11.005; Li MZ, 2001, COMPUT GEOSCI-UK, V27, P619, DOI 10.1016/S0098-3004(00)00120-5; Lionello P, 2006, DEV EARTH ENV SCI, V4, P5463; Marcos M, 2011, GLOBAL PLANET CHANGE, V77, P116, DOI 10.1016/j.gloplacha.2011.04.002; MAYER LM, 1994, GEOCHIM COSMOCHIM AC, V58, P1271, DOI 10.1016/0016-7037(94)90381-6; Mendoza ET, 2009, P I CIVIL ENG-MAR EN, V162, P127, DOI 10.1680/maen.2009.162.3.127; Navarro L, 2011, ESTUAR COAST SHELF S, V95, P52, DOI 10.1016/j.ecss.2011.08.002; Skamarock W.C., 2008, NCARTN475STR, DOI [10.5065/D68S4MVH, DOI 10.5065/D68S4MVH]; Somot S, 2006, CLIM DYNAM, V27, P851, DOI 10.1007/s00382-006-0167-z; Tolman HL, 2002, 222 NOAA NWS NCEP MM, P133; Ulbrich U, 2009, THEOR APPL CLIMATOL, V96, P117, DOI 10.1007/s00704-008-0083-8; Young IR, 2011, SCIENCE, V332, P451, DOI 10.1126/science.1197219	31	158	166	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30395	10.1371/journal.pone.0030395	http://dx.doi.org/10.1371/journal.pone.0030395			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22952816	Green Published, gold			2022-12-27	WOS:000301640600029
J	Brown, JC; Huedo-Medina, TB; Pescatello, LS; Ryan, SM; Pescatello, SM; Moker, E; LaCroix, JM; Ferrer, RA; Johnson, BT				Brown, Justin C.; Huedo-Medina, Tania B.; Pescatello, Linda S.; Ryan, Stacey M.; Pescatello, Shannon M.; Moker, Emily; LaCroix, Jessica M.; Ferrer, Rebecca A.; Johnson, Blair T.			The Efficacy of Exercise in Reducing Depressive Symptoms among Cancer Survivors: A Meta-Analysis	PLOS ONE			English	Article							QUALITY-OF-LIFE; RANDOMIZED CONTROLLED-TRIAL; BREAST-CANCER; PHYSICAL-ACTIVITY; REHABILITATION PROGRAM; CLINICAL DEPRESSION; AEROBIC EXERCISE; META-REGRESSION; WOMEN; FATIGUE	Introduction: The purpose of this meta-analysis was to examine the efficacy of exercise to reduce depressive symptoms among cancer survivors. In addition, we examined the extent to which exercise dose and clinical characteristics of cancer survivors influence the relationship between exercise and reductions in depressive symptoms. Methods: We conducted a systematic search identifying randomized controlled trials of exercise interventions among adult cancer survivors, examining depressive symptoms as an outcome. We calculated effect sizes for each study and performed weighted multiple regression moderator analysis. Results: We identified 40 exercise interventions including 2,929 cancer survivors. Diverse groups of cancer survivors were examined in seven exercise interventions; breast cancer survivors were examined in 26; prostate cancer, leukemia, and lymphoma were examined in two; and colorectal cancer in one. Cancer survivors who completed an exercise intervention reduced depression more than controls, d(+) = 20.13 (95% CI: -0.26, -0.01). Increases in weekly volume of aerobic exercise reduced depressive symptoms in dose-response fashion (beta = -0.24, p = 0.03), a pattern evident only in higher quality trials. Exercise reduced depressive symptoms most when exercise sessions were supervised (beta = -0.26, p = 0.01) and when cancer survivors were between 47-62 yr (beta = 0.27, p = 0.01). Conclusion: Exercise training provides a small overall reduction in depressive symptoms among cancer survivors but one that increased in dose-response fashion with weekly volume of aerobic exercise in high quality trials. Depressive symptoms were reduced to the greatest degree among breast cancer survivors, among cancer survivors aged between 47-62 yr, or when exercise sessions were supervised.	[Brown, Justin C.] Univ Penn, Perelman Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Brown, Justin C.] Univ Penn, Perelman Sch Med, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA; [Huedo-Medina, Tania B.; Pescatello, Linda S.; Moker, Emily; LaCroix, Jessica M.; Johnson, Blair T.] Univ Connecticut, Ctr Hlth Intervent & Prevent, Storrs, CT USA; [Ryan, Stacey M.] Univ Texas MD Anderson Canc Ctr, Dept Phys Therapy, Houston, TX 77030 USA; [Pescatello, Shannon M.] Western New England Coll, Dept Psychol, Springfield, MA USA; [Ferrer, Rebecca A.] NCI, Rockville, MD USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Connecticut; University of Texas System; UTMD Anderson Cancer Center; Western New England University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Brown, JC (corresponding author), Univ Penn, Perelman Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA.	brownjus@mail.med.upenn.edu	Brown, Jennifer Valeska Elli/C-6947-2019	Brown, Jennifer Valeska Elli/0000-0003-0943-5177; Byrne, Thirimon Moe/0000-0002-2827-9715	University of Connecticut Research Advisory Council Foundation [433527]	University of Connecticut Research Advisory Council Foundation	Funding was provided by the University of Connecticut Research Advisory Council Foundation grant no. 433527 (PIs: Blair T. Johnson and Linda S. Pescatello). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Becker B. J., 2000, HDB APPL MULTIVARIAT, P499, DOI [DOI 10.1016/B978-012691360-6/50018-5, 10.1016/B978-012691360-6/50018-5]; BECKER BJ, 1988, BRIT J MATH STAT PSY, V41, P257, DOI 10.1111/j.2044-8317.1988.tb00901.x; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; BERGLUND G, 1994, EUR J CANCER, V30A, P1744, DOI 10.1016/0959-8049(94)00330-8; Brosse AL, 2002, SPORTS MED, V32, P741, DOI 10.2165/00007256-200232120-00001; Brown JC, 2011, CANCER EPIDEM BIOMAR, V20, P123, DOI 10.1158/1055-9965.EPI-10-0988; Burnham TR, 2002, MED SCI SPORT EXER, V34, P1863, DOI 10.1097/00005768-200212000-00001; Cadmus LA, 2009, PSYCHO-ONCOLOGY, V18, P343, DOI 10.1002/pon.1525; Chandwani Kavita D, 2010, J Soc Integr Oncol, V8, P43; Chang PH, 2008, J PAIN SYMPTOM MANAG, V35, P524, DOI 10.1016/j.jpainsymman.2007.06.013; Clark AM, 2010, EUR J CARDIOV PREV R, V17, P261, DOI 10.1097/HJR.0b013e32833090ef; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cohen L, 2004, CANCER-AM CANCER SOC, V100, P2253, DOI 10.1002/cncr.20236; Conn VS, 2010, ANN BEHAV MED, V39, P128, DOI 10.1007/s12160-010-9172-x; Courneya KS, 2007, J CLIN ONCOL, V25, P4396, DOI 10.1200/JCO.2006.08.2024; Courneya KS, 2009, J CLIN ONCOL, V27, P4605, DOI 10.1200/JCO.2008.20.0634; Courneya KS, 2003, EUR J CANCER CARE, V12, P347, DOI 10.1046/j.1365-2354.2003.00437.x; Courneya KS, 2003, PSYCHO-ONCOLOGY, V12, P357, DOI 10.1002/pon.658; Coventry PA, 2007, J PSYCHOSOM RES, V63, P551, DOI 10.1016/j.jpsychores.2007.08.002; Craft L, 2011, CANC EPIDEMIOL BIOMA; Culos-Reed SN, 2006, PSYCHO-ONCOLOGY, V15, P891, DOI 10.1002/pon.1021; Culos-Reed SN, 2010, SUPPORT CARE CANCER, V18, P591, DOI 10.1007/s00520-009-0694-3; Daley AJ, 2007, J CLIN ONCOL, V25, P1713, DOI 10.1200/JCO.2006.09.5083; Danhauer SC, 2009, PSYCHO-ONCOLOGY, V18, P360, DOI 10.1002/pon.1503; Demark-Wahnefried W, 2008, CLIN BREAST CANCER, V8, P70, DOI 10.3816/CBC.2008.n.005; Dimeo FC, 1999, CANCER, V85, P2273, DOI 10.1002/(SICI)1097-0142(19990515)85:10<2273::AID-CNCR24>3.0.CO;2-B; Dodd MJ, 2010, CANCER NURS, V33, P245, DOI 10.1097/NCC.0b013e3181ddc58c; Drown JS, 2005, REHABIL ONCOL, V23, P11, DOI 10.1097/01893697-200523010-00004; Duijts SFA, 2011, PSYCHO-ONCOLOGY, V20, P115, DOI 10.1002/pon.1728; Dunn AL, 2005, AM J PREV MED, V28, P1, DOI 10.1016/j.amepre.2004.09.003; Duval S, 2000, J AM STAT ASSOC, V95, P89, DOI 10.2307/2669529; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eyigor S, 2010, EUR J PHYS REHAB MED, V46, P481; Ferrer RA, 2011, ANN BEHAV MED, V41, P32, DOI 10.1007/s12160-010-9225-1; GILBAR O, 1989, J PSYCHOSOM RES, V33, P1, DOI 10.1016/0022-3999(89)90100-1; Greenwood BN, 2011, EXERC SPORT SCI REV, V39, P140, DOI 10.1097/JES.0b013e31821f7e45; Harbord RM, 2008, STATA J, V8, P493, DOI 10.1177/1536867X0800800403; Hedges L. V., 1985, STAT METHODS META AN, DOI [DOI 10.1016/B978-0-08-057065-5.50005-1, 10.2307/1164953, DOI 10.2307/1164953]; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Holland JC, 2010, J NATL COMPR CANC NE, V8, P448, DOI 10.6004/jnccn.2010.0034; Huedo-Medina TB, 2006, PSYCHOL METHODS, V11, P193, DOI 10.1037/1082-989X.11.2.193; Jarden M, 2009, J PAIN SYMPTOM MANAG, V38, P174, DOI 10.1016/j.jpainsymman.2008.09.005; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Johnson BT, 2011, RES SYN METHOD; Jones LW, 2010, LANCET ONCOL, V11, P914, DOI 10.1016/S1470-2045(10)70184-4; Kelly CM, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c693; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kohout F J, 1993, J Aging Health, V5, P179, DOI 10.1177/089826439300500202; Latka RN, 2009, J CANCER SURVIV, V3, P148, DOI 10.1007/s11764-009-0088-z; LEBOVITS AH, 1990, CANCER, V65, P17, DOI 10.1002/1097-0142(19900101)65:1<17::AID-CNCR2820650106>3.0.CO;2-I; Lee SA, 2010, CLIN REHABIL, V24, P600, DOI 10.1177/0269215510362324; Lipsey MW, 2001, PRACTICAL METAANALYS, P247; Maher CG, 2003, PHYS THER, V83, P713, DOI 10.1093/ptj/83.8.713; Mao JJ, 2007, J AM BOARD FAM MED, V20, P434, DOI 10.3122/jabfm.2007.05.060225; McClure MK, 2010, AM J OCCUP THER, V64, P59, DOI 10.5014/ajot.64.1.59; Mock V, 1994, Oncol Nurs Forum, V21, P899; Mock V, 1997, Oncol Nurs Forum, V24, P991; Monga U, 2007, ARCH PHYS MED REHAB, V88, P1416, DOI 10.1016/j.apmr.2007.08.110; MOR V, 1994, CANCER-AM CANCER SOC, V74, P2118, DOI 10.1002/1097-0142(19941001)74:7+<2118::AID-CNCR2820741720>3.0.CO;2-N; Morris SB, 2002, PSYCHOL METHODS, V7, P105, DOI 10.1037//1082-989X.7.1.105; Mutrie N, 2007, BMJ-BRIT MED J, V334, P517, DOI 10.1136/bmj.39094.648553.AE; Newport DJ, 1998, J PSYCHOSOM RES, V45, P215, DOI 10.1016/S0022-3999(98)00011-7; North T C, 1990, Exerc Sport Sci Rev, V18, P379; O'Brien Kelly, 2010, Cochrane Database Syst Rev, pCD001796, DOI 10.1002/14651858.CD001796.pub3; Ohira T, 2006, CANCER-AM CANCER SOC, V106, P2076, DOI 10.1002/cncr.21829; Papakostas GI, 2008, J CLIN PSYCHIAT, V69, P1287, DOI 10.4088/JCP.v69n0812; Pasquini Massimo, 2007, Clin Pract Epidemiol Ment Health, V3, P2, DOI 10.1186/1745-0179-3-2; Patel SR, 2004, THESIS; Payne JK, 2008, ONCOL NURS FORUM, V35, P635, DOI 10.1188/08.ONF.635-642; Perna FM, 2010, INT J SPORT EXERC PS, V8, P36, DOI 10.1080/1612197X.2010.9671932; Pinto BM, 2003, PSYCHO-ONCOLOGY, V12, P118, DOI 10.1002/pon.618; Raghavendra RM, 2009, INTEGR CANCER THER, V8, P37, DOI 10.1177/1534735409331456; Rausch SM, 2007, THESIS; REDDON JR, 1985, J PSYCHOPATHOL BEHAV, V7, P243, DOI 10.1007/BF00960756; Reich M, 2008, BREAST CANCER RES TR, V110, P9, DOI 10.1007/s10549-007-9706-5; Salkind M R, 1969, J R Coll Gen Pract, V18, P267; Schmitz KH, 2010, MED SCI SPORT EXER, V42, P1409, DOI 10.1249/MSS.0b013e3181e0c112; Speck RM, 2010, J CANCER SURVIV, V4, P87, DOI 10.1007/s11764-009-0110-5; Spence RR, 2011, EUR J CANCER CARE, V20, P257, DOI 10.1111/j.1365-2354.2010.01214.x; SUTHERLAND HJ, 1988, CANCER NURS, V11, P303; Targ EF, 2002, GEN HOSP PSYCHIAT, V24, P238, DOI 10.1016/S0163-8343(02)00191-3; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; Thompson WR, ACSMS GUIDELINES EXE; Thorsen L, 2005, J CLIN ONCOL, V23, P2378, DOI 10.1200/JCO.2005.04.106; Velthuis MJ, 2010, CLIN ONCOL-UK, V22, P208, DOI 10.1016/j.clon.2009.12.005; Vito NL, 2007, THESIS; Watson M, 1999, LANCET, V354, P1331, DOI 10.1016/S0140-6736(98)11392-2; Whitehead S, 2009, QUAL HEALTH RES, V19, P894, DOI 10.1177/1049732309337523; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	90	216	222	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e30955	10.1371/journal.pone.0030955	http://dx.doi.org/10.1371/journal.pone.0030955			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	911GB	22586491	gold, Green Published			2022-12-27	WOS:000301704200049
J	Johnson, RM; Mao, WF; Pollock, HS; Niu, GD; Schuler, MA; Berenbaum, MR				Johnson, Reed M.; Mao, Wenfu; Pollock, Henry S.; Niu, Guodong; Schuler, Mary A.; Berenbaum, May R.			Ecologically Appropriate Xenobiotics Induce Cytochrome P450s in Apis mellifera	PLOS ONE			English	Article							HELICOVERPA-ARMIGERA HUBNER; DRUG-METABOLIZING-ENZYMES; FALL ARMYWORM LARVAE; HONEY-BEE; DROSOPHILA-MELANOGASTER; PYRETHROID INSECTICIDE; MOLECULAR-CLONING; DETOXIFYING ENZYMES; RESISTANT STRAINS; MICROARRAY DATA	Background: Honey bees are exposed to phytochemicals through the nectar, pollen and propolis consumed to sustain the colony. They may also encounter mycotoxins produced by Aspergillus fungi infesting pollen in beebread. Moreover, bees are exposed to agricultural pesticides, particularly in-hive acaricides used against the parasite Varroa destructor. They cope with these and other xenobiotics primarily through enzymatic detoxificative processes, but the regulation of detoxificative enzymes in honey bees remains largely unexplored. Methodology/Principal Findings: We used several approaches to ascertain effects of dietary toxins on bee susceptibility to synthetic and natural xenobiotics, including the acaricide tau-fluvalinate, the agricultural pesticide imidacloprid, and the naturally occurring mycotoxin aflatoxin. We administered potential inducers of cytochrome P450 enzymes, the principal biochemical system for Phase 1 detoxification in insects, to investigate how detoxification is regulated. The drug phenobarbital induces P450s in many insects, yet feeding bees with phenobarbital had no effect on the toxicity of taufluvalinate, a pesticide known to be detoxified by bee P450s. Similarly, no P450 induction, as measured by tau-fluvalinate tolerance, occurred in bees fed xanthotoxin, salicylic acid, or indole-3-carbinol, all of which induce P450s in other insects. Only quercetin, a common pollen and honey constituent, reduced tau-fluvalinate toxicity. In microarray comparisons no change in detoxificative gene expression was detected in phenobarbital-treated bees. However, northern blot analyses of guts of bees fed extracts of honey, pollen and propolis showed elevated expression of three CYP6AS P450 genes. Diet did not influence tau-fluvalinate or imidacloprid toxicity in bioassays; however, aflatoxin toxicity was higher in bees consuming sucrose or high-fructose corn syrup than in bees consuming honey. Conclusions/Significance: These results suggest that regulation of honey bee P450s is tuned to chemicals occurring naturally in the hive environment and that, in terms of toxicological capacity, a diet of sugar is not equivalent to a diet of honey.	[Johnson, Reed M.; Mao, Wenfu; Pollock, Henry S.; Niu, Guodong; Berenbaum, May R.] Univ Illinois, Dept Entomol, Urbana, IL USA; [Schuler, Mary A.] Univ Illinois, Dept Cell & Dev Biol, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Johnson, RM (corresponding author), Ohio State Univ, Ohio Agr Res & Dev Ctr, Dept Entomol, Wooster, OH 44691 USA.	johnson.5005@osu.edu	Johnson, Reed M./H-3742-2011; Niu, Guodong/E-5846-2012	Johnson, Reed M./0000-0002-2431-0180; Niu, Guodong/0000-0002-1406-6698; Johnson, Rebecca/0000-0003-2249-2643	United States Department of Agriculture, Agriculture and Food Research Initiative (USDA-AFRI)	United States Department of Agriculture, Agriculture and Food Research Initiative (USDA-AFRI)(United States Department of Agriculture (USDA))	United States Department of Agriculture, Agriculture and Food Research Initiative (USDA-AFRI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGOSIN M, 1976, MOL CELL BIOCHEM, V12, P33, DOI 10.1007/BF01731901; Amichot M, 1998, COMP BIOCHEM PHYS C, V121, P311, DOI 10.1016/S0742-8413(98)10052-X; Anspaugh DD, 2005, J INSECT PHYSIOL, V51, P523, DOI 10.1016/j.jinsphys.2004.12.008; Berenbaum M.R., 1990, P257; BRATTSTEN LB, 1975, BIOCHEM J, V150, P97, DOI 10.1042/bj1500097; Brodschneider R, 2010, APIDOLOGIE, V41, P278, DOI 10.1051/apido/2010012; Brown D, 2003, ARCH INSECT BIOCHEM, V53, P119, DOI 10.1002/arch.10089; Brun A, 1996, INSECT BIOCHEM MOLEC, V26, P697, DOI 10.1016/S0965-1748(96)00036-7; BULL DL, 1986, J CHEM ECOL, V12, P885, DOI 10.1007/BF01020258; Calderone, 2000, BEE CULT, V128, P1, DOI DOI 10.3896/IBRA.1.49.1.01; Campos M, 1997, PHYTOCHEM ANALYSIS, V8, P181, DOI 10.1002/(SICI)1099-1565(199707)8:4&lt;181::AID-PCA359&gt;3.0.CO;2-A; CARINO FA, 1994, INSECT BIOCHEM MOLEC, V24, P411, DOI 10.1016/0965-1748(94)90034-5; Claudianos C, 2006, INSECT MOL BIOL, V15, P615, DOI 10.1111/j.1365-2583.2006.00672.x; COHEN MB, 1992, P NATL ACAD SCI USA, V89, P10920, DOI 10.1073/pnas.89.22.10920; Cresswell JE, 2011, ECOTOXICOLOGY, V20, P149, DOI 10.1007/s10646-010-0566-0; Danielson PB, 1997, P NATL ACAD SCI USA, V94, P10797, DOI 10.1073/pnas.94.20.10797; DENISON MS, 1995, J BIOL CHEM, V270, P18175, DOI 10.1074/jbc.270.31.18175; Dunkov BC, 1997, DNA CELL BIOL, V16, P1345, DOI 10.1089/dna.1997.16.1345; Felsenstein J, PHYLIP PHYLOGENY INF; Feyereisen R., 2005, P1; ffrench-Constant RH, 2004, TRENDS GENET, V20, P163, DOI 10.1016/j.tig.2004.01.003; Finney D.J., 1971, PROBIT ANAL; Fisher T, 2003, ECOTOX ENVIRON SAFE, V54, P1, DOI 10.1016/S0147-6513(02)00031-3; Furgala B., 1992, HIVE HONEY BEE, P829; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gonzalez G, 2005, INT J FOOD MICROBIOL, V105, P1, DOI 10.1016/j.ijfoodmicro.2005.05.001; GUIRGUIS GN, 1976, ENVIRON ENTOMOL, V5, P590, DOI 10.1093/ee/5.3.590; Hardstone MC, 2010, PEST MANAG SCI, V66, P1171, DOI 10.1002/ps.2001; Johansen C.A., 1990, POLLINATOR PROTECTIO; Johnson RM, 2006, J ECON ENTOMOL, V99, P1046, DOI 10.1603/0022-0493-99.4.1046; Johnson RM, 2010, APIDOLOGIE, V41, P312, DOI 10.1051/apido/2010018; Johnson RM, 2009, J ECON ENTOMOL, V102, P474, DOI 10.1603/029.102.0202; Kasai S, 2001, INSECT BIOCHEM MOLEC, V32, P1, DOI 10.1016/S0965-1748(01)00073-X; Kenjeric D, 2007, FOOD CHEM, V102, P683, DOI 10.1016/j.foodchem.2006.05.055; KEZIC N, 1992, APIDOLOGIE, V23, P217, DOI 10.1051/apido:19920304; King-Jones K, 2005, NAT REV GENET, V6, P311, DOI 10.1038/nrg1581; Le Goff G, 2006, INSECT BIOCHEM MOLEC, V36, P674, DOI 10.1016/j.ibmb.2006.05.009; LeBlanc BW, 2009, J AGR FOOD CHEM, V57, P7369, DOI 10.1021/jf9014526; Lewis DFV, 2002, J CHEM TECHNOL BIOT, V77, P1095, DOI 10.1002/jctb.648; Li XC, 2002, NATURE, V419, P712, DOI 10.1038/nature01003; Li XC, 2000, INSECT BIOCHEM MOLEC, V30, P75, DOI 10.1016/S0965-1748(99)00102-2; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Liu FL, 2006, BEHAV ECOL SOCIOBIOL, V59, P582, DOI 10.1007/s00265-005-0084-x; Liu XN, 2006, PESTIC BIOCHEM PHYS, V84, P127, DOI 10.1016/j.pestbp.2005.06.002; Mao WF, 2006, J CHEM ECOL, V32, P523, DOI 10.1007/s10886-005-9018-3; Mao WF, 2011, P NATL ACAD SCI USA, V108, P12657, DOI 10.1073/pnas.1109535108; Mao WF, 2009, COMP BIOCHEM PHYS B, V154, P427, DOI 10.1016/j.cbpb.2009.08.008; Medina A, 2004, SYST APPL MICROBIOL, V27, P261, DOI 10.1078/072320204322881880; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Natsuhara K, 2004, PESTIC BIOCHEM PHYS, V79, P33, DOI 10.1016/j.pestbp.2004.04.002; NEBERT DW, 1987, ANNU REV BIOCHEM, V56, P945, DOI 10.1146/annurev.biochem.56.1.945; Niu GD, 2011, APIDOLOGIE, V42, P79, DOI 10.1051/apido/2010039; Oakeshott JG, 2010, INSECT MOL BIOL, V19, P147, DOI 10.1111/j.1365-2583.2009.00961.x; Oshlack A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r2; PILLING ED, 1995, PESTIC BIOCHEM PHYS, V51, P1, DOI 10.1006/pest.1995.1001; PILLING ED, 1993, PESTIC SCI, V39, P293, DOI 10.1002/ps.2780390407; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ranasinghe C, 1999, INSECT MOL BIOL, V8, P443, DOI 10.1046/j.1365-2583.1999.00135.x; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; REMMER H, 1963, SCIENCE, V142, P1657, DOI 10.1126/science.142.3600.1657; RISKALLAH MR, 1986, PESTIC BIOCHEM PHYS, V25, P233, DOI 10.1016/0048-3575(86)90050-7; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Schell R, 2005, AM BEE J, V145, P392; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; SCOTT JG, 1993, INSECT BIOCHEM MOLEC, V23, P729, DOI 10.1016/0965-1748(93)90047-V; Sen Zeng R, 2007, J CHEM ECOL, V33, P449, DOI 10.1007/s10886-006-9238-1; Simone-Finstrom M, 2010, APIDOLOGIE, V41, P295, DOI 10.1051/apido/2010016; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; SNYDER MJ, 1995, ARCH BIOCHEM BIOPHYS, V321, P13, DOI 10.1006/abbi.1995.1362; Stevens JL, 2000, INSECT BIOCHEM MOLEC, V30, P559, DOI 10.1016/S0965-1748(00)00024-2; Suchail S, 2000, ENVIRON TOXICOL CHEM, V19, P1901, DOI [10.1897/1551-5028(2000)019&lt;1901:COITIT&gt;2.3.CO;2, 10.1002/etc.5620190726]; Suchail S, 2004, PEST MANAG SCI, V60, P291, DOI 10.1002/ps.772; Sun W, 2006, INSECT MOL BIOL, V15, P455, DOI 10.1111/j.1365-2583.2006.00662.x; Tanaka E, 1999, J CLIN PHARM THER, V24, P87, DOI 10.1046/j.1365-2710.1999.00201.x; TERRIERE LC, 1974, J AGR FOOD CHEM, V22, P366, DOI 10.1021/jf60193a057; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Treutter D, 2005, PLANT BIOLOGY, V7, P581, DOI 10.1055/s-2005-873009; Tushar T, 2007, BASIC CLIN PHARMACOL, V100, P269, DOI 10.1111/j.1742-7843.2006.00039.x; VanEngelsdorp D, 2007, AM BEE J, V147, P603; Venables WN., 2002, MODERN APPL STAT S 4; Wanner KW, 2007, P NATL ACAD SCI USA, V104, P14383, DOI 10.1073/pnas.0705459104; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; WIERMANN R, 1968, BER DEUT BOT GES, V81, P3; WILKINSON CF, 1972, DRUG METAB REV, V1, P153, DOI 10.3109/03602537208993912; Willoughby L, 2006, INSECT BIOCHEM MOLEC, V36, P934, DOI 10.1016/j.ibmb.2006.09.004; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; YU SJ, 1983, PESTIC BIOCHEM PHYS, V19, P330, DOI 10.1016/0048-3575(83)90061-5; YU SJ, 1984, PESTIC BIOCHEM PHYS, V22, P360, DOI 10.1016/0048-3575(84)90029-4; YU SJ, 1984, COMP BIOCHEM PHYS C, V78, P145, DOI 10.1016/0742-8413(84)90062-8; YU SJ, 1995, ARCH INSECT BIOCHEM, V28, P365, DOI 10.1002/arch.940280406	90	153	158	2	126	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e31051	10.1371/journal.pone.0031051	http://dx.doi.org/10.1371/journal.pone.0031051			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LO	22319603	Green Published, gold, Green Submitted			2022-12-27	WOS:000302178400026
J	Lin, HP; Jiang, SS; Chuu, CP				Lin, Hui-Ping; Jiang, Shih Sheng; Chuu, Chih-Pin			Caffeic Acid Phenethyl Ester Causes p21(Cip1) Induction, Akt Signaling Reduction, and Growth Inhibition in PC-3 Human Prostate Cancer Cells	PLOS ONE			English	Article							ANDROGEN RECEPTOR; IN-VITRO; DOWN-REGULATION; PROTEIN-KINASE; TRANSCRIPTION FACTOR; LUNG ADENOCARCINOMA; UP-REGULATION; KAPPA-B; APOPTOSIS; PHOSPHORYLATION	Caffeic acid phenethyl ester (CAPE) treatment suppressed proliferation, colony formation, and cell cycle progression in PC-3 human prostate cancer cells. CAPE decreased protein expression of cyclin D1, cyclin E, SKP2, c-Myc, Akt1, Akt2, Akt3, total Akt, mTOR, Bcl-2, Rb, as well as phosphorylation of Rb, ERK1/2, Akt, mTOR, GSK3 alpha, GSK3 beta, PDK1; but increased protein expression of KLF6 and p21(Cip1). Microarray analysis indicated that pathways involved in cellular movement, cell death, proliferation, and cell cycle were affected by CAPE. Co-treatment of CAPE with chemotherapeutic drugs vinblastine, paclitaxol, and estramustine indicated synergistic suppression effect. CAPE administration may serve as a potential adjuvant therapy for prostate cancer.	[Lin, Hui-Ping; Chuu, Chih-Pin] Natl Hlth Res Inst, Inst Cellular & Syst Med, Miaoli, Taiwan; [Lin, Hui-Ping; Jiang, Shih Sheng; Chuu, Chih-Pin] Natl Hlth Res Inst, Translat Ctr Glandular Malignancies, Miaoli, Taiwan; [Jiang, Shih Sheng] Natl Hlth Res Inst, Natl Inst Canc Res, Miaoli, Taiwan; [Chuu, Chih-Pin] China Med Univ, Grad Program Aging, Taichung, Taiwan	National Health Research Institutes - Taiwan; National Health Research Institutes - Taiwan; National Health Research Institutes - Taiwan; China Medical University Taiwan	Lin, HP (corresponding author), Natl Hlth Res Inst, Inst Cellular & Syst Med, Miaoli, Taiwan.	cpchuu@nhri.org.tw	Chuu, Chih-Pin/B-1086-2010; Jiang, Shih Sheng/J-9671-2019; Jiang, Shih Sheng/C-6187-2011; Chuu, Chih-Pin/N-6697-2019	Jiang, Shih Sheng/0000-0003-1909-437X; Lin, Hua/0000-0001-5001-5567	National Health Research Institutes [CS-100-PP-12]; National Science Council, NSC in Taiwan [NSC 99-2320-B-400-015-MY3]; Department of Health [DOH100-TD-C-111-014]; Protein Chemistry Core Facility of Core Instrument Center in NHRI; Taiwan Bioinformatics Institute by NSC [NSC100-2319-B-400-001]	National Health Research Institutes(National Health Research Institutes, Japan); National Science Council, NSC in Taiwan(Ministry of Science and Technology, Taiwan); Department of Health; Protein Chemistry Core Facility of Core Instrument Center in NHRI; Taiwan Bioinformatics Institute by NSC	This work was supported by CS-100-PP-12 (National Health Research Institutes) and NSC 99-2320-B-400-015-MY3 (National Science Council, NSC) in Taiwan for CPC, as well as DOH100-TD-C-111-014 (Department of Health) for SSJ and CPC. We thank support from Protein Chemistry Core Facility of Core Instrument Center in NHRI and Taiwan Bioinformatics Institute Core Facility of the National Core Facility Program for Biotechnology by NSC (NSC100-2319-B-400-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alao JP, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-24; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Bektic J, 2005, PROSTATE, V64, P332, DOI 10.1002/pros.20243; BHIMANI RS, 1993, CANCER RES, V53, P4528; Bubendorf L, 2000, HUM PATHOL, V31, P578, DOI 10.1053/hp.2000.6698; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Celli N, 2007, J AGR FOOD CHEM, V55, P3398, DOI 10.1021/jf063477o; CHELLAPPAN SP, 1991, CELL, V65, P1053, DOI 10.1016/0092-8674(91)90557-F; Chen XM, 2001, J BIOL CHEM, V276, P30423, DOI 10.1074/jbc.M101194200; Chen YJ, 2001, J AGR FOOD CHEM, V49, P5615, DOI 10.1021/jf0107252; Chuu CP, 2007, J BIOMED SCI, V14, P543, DOI 10.1007/s11373-007-9160-8; Chuu CP, 2007, BIOCHEM BIOPH RES CO, V357, P341, DOI 10.1016/j.bbrc.2007.03.116; Chuu CP, 2011, CANCER SCI, V102, P2022, DOI 10.1111/j.1349-7006.2011.02043.x; Chuu CP, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-63; Chuu CP, 2010, ANTICANCER RES, V30, P3643; Chuu CP, 2009, CANCER LETT, V275, P86, DOI 10.1016/j.canlet.2008.10.001; Coffer PJ, 1998, BIOCHEM J, V335, P1; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Ding H, 2003, BIOCHEM BIOPH RES CO, V305, P950, DOI 10.1016/S0006-291X(03)00873-8; Duchene J, 2007, J IMMUNOL, V179, P4849, DOI 10.4049/jimmunol.179.7.4849; ELLEDGE SJ, 1994, CURR OPIN CELL BIOL, V6, P847, DOI 10.1016/0955-0674(94)90055-8; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Gao H, 2005, J BIOL CHEM, V280, P10988, DOI 10.1074/jbc.M412720200; Gartel AL, 2005, CANCER RES, V65, P3980, DOI 10.1158/0008-5472.CAN-04-3995; Gilligan T, 2002, UROLOGY, V60, P94, DOI 10.1016/S0090-4295(02)01583-2; Gonzalez E, 2009, CELL CYCLE, V8, P2502, DOI 10.4161/cc.8.16.9335; HARPER JW, 1993, CELL, V75, P805; He YJ, 2006, WORLD J GASTROENTERO, V12, P4981, DOI 10.3748/wjg.v12.i31.4981; Heliez C, 2003, ONCOGENE, V22, P3260, DOI 10.1038/sj.onc.1206409; Hellerstedt BA, 2002, CA-CANCER J CLIN, V52, P154, DOI 10.3322/canjclin.52.3.154; Ho HC, 2009, CELL MOL BIOL, V55, P1161, DOI 10.1170/132; Horiguchi-Yamada J, 2002, ANTICANCER RES, V22, P3827; Huggins C, 1941, ARCH SURG-CHICAGO, V43, P15; Ibrahim T, 2010, CANCER-AM CANCER SOC, V116, P1406, DOI 10.1002/cncr.24896; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Jiang SS, 2010, CLIN CANCER RES, V16, P4363, DOI 10.1158/1078-0432.CCR-10-0138; Jin SQ, 2000, J BIOL CHEM, V275, P16602, DOI 10.1074/jbc.M000284200; Katsuki Y, 2008, BIOCHEM BIOPH RES CO, V368, P808, DOI 10.1016/j.bbrc.2008.02.010; Keller ET, 2001, CANCER METAST REV, V20, P333, DOI 10.1023/A:1015599831232; Kolomeichuk SN, 2008, MOL PHARMACOL, V73, P128, DOI 10.1124/mol.108.039750; Kreisberg JI, 2004, CANCER RES, V64, P5232, DOI 10.1158/0008-5472.CAN-04-0272; Kuo HC, 2006, CANCER LETT, V234, P199, DOI 10.1016/j.canlet.2005.03.046; Lebedeva I, 2000, CANCER RES, V60, P6052; Liang JY, 2003, CELL CYCLE, V2, P339, DOI 10.4161/cc.2.4.433; Liu QY, 1997, CLIN CANCER RES, V3, P2039; Liu RH, 2009, CANCER RES, V69, P2252, DOI 10.1158/0008-5472.CAN-08-3717; Majumder PK, 2005, ONCOGENE, V24, P7465, DOI 10.1038/sj.onc.1209096; Malhotra S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020293; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; McEleny K, 2004, BJU INT, V94, P402, DOI 10.1111/j.1464-410X.2004.04936.x; Nakatani K, 1999, J BIOL CHEM, V274, P21528, DOI 10.1074/jbc.274.31.21528; Narla G, 2001, SCIENCE, V294, P2563, DOI 10.1126/science.1066326; Natarajan K, 1996, P NATL ACAD SCI USA, V93, P9090, DOI 10.1073/pnas.93.17.9090; PIENTA KJ, 1993, J UROLOGY, V149, P1622, DOI 10.1016/S0022-5347(17)36463-7; Pinto AC, 2011, PROSTATE, V71, P81, DOI 10.1002/pros.21224; Polin L, 1997, INVEST NEW DRUG, V15, P99, DOI 10.1023/A:1005856605726; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sasaki T, 2010, BIOCHEM BIOPH RES CO, V399, P79, DOI 10.1016/j.bbrc.2010.07.045; Schutyser E, 2000, J IMMUNOL, V165, P4470, DOI 10.4049/jimmunol.165.8.4470; Shankar S, 2005, PROSTATE, V62, P165, DOI 10.1002/pros.20126; Shigeoka Y, 2004, J CANCER RES CLIN, V130, P146, DOI 10.1007/s00432-003-0520-0; Wang LC, 2010, CLIN EXP IMMUNOL, V160, P223, DOI 10.1111/j.1365-2249.2009.04067.x; Watabe M, 2004, J BIOL CHEM, V279, P6017, DOI 10.1074/jbc.M306040200; Williams JF, 2000, PROSTATE, V44, P275, DOI 10.1002/1097-0045(20000901)44:4<275::AID-PROS3>3.0.CO;2-9; WOLPE SD, 1989, P NATL ACAD SCI USA, V86, P612, DOI 10.1073/pnas.86.2.612; Yagi A, 2003, J CELL BIOCHEM, V90, P1242, DOI 10.1002/jcb.10711; Zhang WQ, 2000, J BIOL CHEM, V275, P18391, DOI 10.1074/jbc.C000062200; Zhao HC, 2000, EXP CELL RES, V258, P92, DOI 10.1006/excr.2000.4906; Zhao H, 2010, CYTOM PART A, V77A, P999, DOI 10.1002/cyto.a.20983; Zimmers TA, 2008, J CANCER RES CLIN, V134, P753, DOI 10.1007/s00432-007-0336-4	70	308	321	4	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2012	7	2							e31286	10.1371/journal.pone.0031286	http://dx.doi.org/10.1371/journal.pone.0031286			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917MF	22506074	Green Published, gold, Green Submitted			2022-12-27	WOS:000302180600033
J	Wang, YS; Chou, WW; Chen, KC; Cheng, HY; Lin, RT; Juo, SHH				Wang, Yung-Song; Chou, Wen-Wen; Chen, Ku-Chung; Cheng, Hsin-Yun; Lin, Ruey-Tay; Juo, Suh-Hang Hank			microRNA-152 Mediates DNMT1-Regulated DNA Methylation in the Estrogen Receptor alpha Gene	PLOS ONE			English	Article							MUSCLE-CELL-PROLIFERATION; ATHEROSCLEROSIS; EXPRESSION; HYPOMETHYLATION; INHIBITION; DISEASE; INFLAMMATION; MECHANISMS; MIGRATION; DNMT3B	Background: Estrogen receptor alpha (ER alpha) has been shown to protect against atherosclerosis. Methylation of the ER alpha gene can reduce ER alpha expression leading to a higher risk for cardiovascular disease. Recently, microRNAs have been found to regulate DNA methyltransferases (DNMTs) and thus control methylation status in several genes. We first searched for microRNAs involved in DNMT-associated DNA methylation in the ER alpha gene. We also tested whether statin and a traditional Chinese medicine (San-Huang-Xie-Xin-Tang, SHXXT) could exert a therapeutic effect on microRNA, DNMT and ER alpha methylation. Methodology/Principal Findings: The ER alpha expression was decreased and ER alpha methylation was increased in LPS-treated human aortic smooth muscle cells (HASMCs) and the aorta from rats under a high-fat diet. microRNA-152 was found to be down regulated in the LPS-treated HASMCs. We validated that microRNA-152 can knock down DNMT1 in HASMCs leading to hypermethylation of the ER alpha gene. Statin had no effect on microRNA-152, DNMT1 or ER alpha expression. On the contrary, SHXXT could restore microRNA-152, decrease DNMT1 and increase ER alpha expression in both cellular and animal studies. Conclusions/Significance: The present study showed that microRNA-152 decreases under the pro-atherosclerotic conditions. The reduced microRNA-152 can lose an inhibitory effect on DNA methyltransferase, which leads to hypermethylation of the ER alpha gene and a decrease of ER alpha level. Although statin can not reverse these cascade proatherosclerotic changes, the SHXXT shows a promising effect to inhibit this unwanted signaling pathway.	[Wang, Yung-Song; Chou, Wen-Wen; Chen, Ku-Chung; Cheng, Hsin-Yun; Juo, Suh-Hang Hank] Kaohsiung Med Univ, Dept Med Genet, Kaohsiung, Taiwan; [Lin, Ruey-Tay] Kaohsiung Med Univ, Dept Neurol, Kaohsiung, Taiwan; [Lin, Ruey-Tay] Kaohsiung Med Univ Hosp, Dept Neurol, Kaohsiung, Taiwan; [Juo, Suh-Hang Hank] Kaohsiung Med Univ Hosp, Dept Med Res, Kaohsiung, Taiwan; [Juo, Suh-Hang Hank] Kaohsiung Med Univ Hosp, Ctr Canc, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Wang, YS (corresponding author), Kaohsiung Med Univ, Dept Med Genet, Kaohsiung, Taiwan.	tay@kmu.edu.tw; hjuo@kmu.edu.tw	Juo, Suh-Hang/C-9545-2009; Liu, Xingyue/A-3019-2013	Liu, Xingyue/0000-0002-9168-0659; Gao, Yanzheng/0000-0002-3814-3555	Ministry of Economic Affairs (Taiwan, R.O.C.) [98-EC-17-A-20-S1-134]; National Science Council (Taiwan, R.O.C.) [NSC 99-2628-B-037-037-MY3]; National Health Research Institutes (Taiwan, R.O.C.) [NHRI-Ex96-9607PI]; Department of Health, Executive Yuan (Taiwan, R.O.C.) [DOH99-TD-C-111-002]; Kaohsiung Medical University Hospital [KMUH98-8I11, KMUH99-9M19]	Ministry of Economic Affairs (Taiwan, R.O.C.)(Ministry of Economic Affairs, Taiwan); National Science Council (Taiwan, R.O.C.)(Ministry of Science and Technology, Taiwan); National Health Research Institutes (Taiwan, R.O.C.)(National Health Research Institutes - Taiwan); Department of Health, Executive Yuan (Taiwan, R.O.C.); Kaohsiung Medical University Hospital	This work was supported by the following grants: No. 98-EC-17-A-20-S1-134 from the Ministry of Economic Affairs (Taiwan, R.O.C., Website: www.moea.gov.tw), NSC 99-2628-B-037-037-MY3 from the National Science Council (Taiwan, R.O.C., Website: web1.nsc.gov.tw), NHRI-Ex96-9607PI from the National Health Research Institutes (Taiwan, R.O.C., Website: www.nhri.org.tw), Excellence for Cancer Research Center Grant (DOH99-TD-C-111-002) from the Department of Health, Executive Yuan (Taiwan, R.O.C., Website: www.doh.gov.tw), and Kaohsiung Medical University Hospital intramural grants (KMUH98-8I11 and KMUH99-9M19; Website: www.kmuh.org.tw). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham ST, 1997, CIRC RES, V81, P575, DOI 10.1161/01.RES.81.4.575; Ashton AW, 1999, J BIOL CHEM, V274, P35562, DOI 10.1074/jbc.274.50.35562; Braconi C, 2010, HEPATOLOGY, V51, P881, DOI 10.1002/hep.23381; Chen KC, 2011, FASEB J; Christian RC, 2006, J CLIN ENDOCR METAB, V91, P2713, DOI 10.1210/jc.2005-2672; Diomede L, 2001, ARTERIOSCL THROM VAS, V21, P1327, DOI 10.1161/hq0801.094222; Dong CM, 2002, J NUTR, V132, p2406S, DOI 10.1093/jn/132.8.2406S; Duursma AM, 2008, RNA, V14, P872, DOI 10.1261/rna.972008; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Farmer J A, 2000, Curr Atheroscler Rep, V2, P208, DOI 10.1007/s11883-000-0022-3; Gitan RS, 2002, GENOME RES, V12, P158, DOI 10.1101/gr.202801; Hiltunen M, 2002, VASC MED, V7, P5, DOI 10.1191/1358863x02vm418oa; Hiltunen MO, 2003, ARTERIOSCL THROM VAS, V23, P1750, DOI 10.1161/01.ATV.0000092871.30563.41; Huang JF, 2010, HEPATOLOGY, V52, P60, DOI 10.1002/hep.23660; Jiang YD, 2007, DNA CELL BIOL, V26, P603, DOI 10.1089/dna.2007.0584; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Laukkanen MO, 1999, ARTERIOSCL THROM VAS, V19, P2171, DOI 10.1161/01.ATV.19.9.2171; Lee ME, 1999, TRENDS CARDIOVAS MED, V9, P49, DOI 10.1016/S1050-1738(99)00002-X; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Libby P, 2002, NAT MED, V8, P1257, DOI 10.1038/nm1102-1257; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Lund G, 2004, J BIOL CHEM, V279, P29147, DOI 10.1074/jbc.M403618200; Matouk CC, 2008, CIRC RES, V102, P873, DOI 10.1161/CIRCRESAHA.107.171025; Millette E, 2005, CIRC RES, V96, P172, DOI 10.1161/01.RES.0000154595.87608.db; Nakamura Y, 2004, MOL CELL ENDOCRINOL, V219, P17, DOI 10.1016/j.mce.2004.02.013; Newman PE, 1999, MED HYPOTHESES, V53, P421, DOI 10.1054/mehy.1998.0794; Nishimura T, 2003, CIRCULATION, V108, P1640, DOI 10.1161/01.CIR.0000087592.47401.37; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Okubo T, 2000, ENDOCR J, V47, P205, DOI 10.1507/endocrj.47.205; Porter KE, 2002, J VASC SURG, V36, P150, DOI 10.1067/mva.2002.122029; Post WS, 1999, CARDIOVASC RES, V43, P985, DOI 10.1016/S0008-6363(99)00153-4; Pussinen PJ, 2007, ARTERIOSCL THROM VAS, V27, P1433, DOI 10.1161/ATVBAHA.106.138743; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Rubanyi GM, 2002, VASC PHARMACOL, V38, P81, DOI 10.1016/S0306-3623(02)00130-1; Schwartz SM, 1997, J CLIN INVEST, V100, pS87; Seeger H, 2001, MENOPAUSE, V8, P5, DOI 10.1097/00042192-200101000-00003; Sharma P, 2008, DNA CELL BIOL, V27, P357, DOI 10.1089/dna.2007.0694; Turunen MP, 2009, BBA-GEN SUBJECTS, V1790, P886, DOI 10.1016/j.bbagen.2009.02.008; Wang YS, 2011, J ETHNOPHARMACOL, V133, P442, DOI 10.1016/j.jep.2010.10.018; Yang AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh032; Ying AK, 2000, CARDIOVASC RES, V46, P172, DOI 10.1016/S0008-6363(00)00004-3	42	140	155	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30635	10.1371/journal.pone.0030635	http://dx.doi.org/10.1371/journal.pone.0030635			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	23056623	Green Published, gold, Green Submitted			2022-12-27	WOS:000301640600043
J	Chen, L; Huang, LZ; Min, DH; Phillips, A; Wang, SQ; Madgwick, PJ; Parry, MAJ; Hu, YG				Chen, Liang; Huang, Linzhou; Min, Donghong; Phillips, Andy; Wang, Shiqiang; Madgwick, Pippa J.; Parry, Martin A. J.; Hu, Yin-Gang			Development and Characterization of a New TILLING Population of Common Bread Wheat (Triticum aestivum L.)	PLOS ONE			English	Article							CHEMICALLY-INDUCED MUTATIONS; DETECT INDUCED MUTATIONS; GENE-FUNCTION; INSERTIONAL MUTAGENESIS; FUNCTIONAL GENOMICS; POINT MUTATIONS; INDUCED MUTANTS; DISCOVERY; RESOURCE; RICE	Mutagenesis is an important tool in crop improvement. However, the hexaploid genome of wheat (Triticum aestivum L.) presents problems in identifying desirable genetic changes based on phenotypic screening due to gene redundancy. TILLING (Targeting Induced Local Lesions IN Genomes), a powerful reverse genetic strategy that allows the detection of induced point mutations in individuals of the mutagenized populations, can address the major challenge of linking sequence information to the biological function of genes and can also identify novel variation for crop breeding. Wheat is especially well-suited for TILLING due to the high mutation densities tolerated by polyploids. However, only a few wheat TILLING populations are currently available in the world, which is far from satisfying the requirement of researchers and breeders in different growing environments. In addition, current TILLING screening protocols require costly fluorescence detection systems, limiting their use, especially in developing countries. We developed a new TILLING resource comprising 2610 M-2 mutants in a common wheat cultivar 'Jinmai 47'. Numerous phenotypes with altered morphological and agronomic traits were observed from the M-2 and M-3 lines in the field. To simplify the procedure and decrease costs, we use unlabeled primers and either non-denaturing polyacrylamide gels or agarose gels for mutation detection. The value of this new resource was tested using PCR with RAPD and Intron-spliced junction (ISJ) primers, and also TILLING in three selected candidate genes, in 300 and 512 mutant lines, revealing high mutation densities of 1/34 kb by RAPD/ISJ analysis and 1/47 kb by TILLING. In total, 31 novel alleles were identified in the 3 targeted genes and confirmed by sequencing. The results indicate that this mutant population represents a useful resource for the wheat research community. We hope that the use of this reverse genetics resource will provide novel allelic diversity for wheat improvement and functional genomics.	[Chen, Liang; Huang, Linzhou; Min, Donghong; Wang, Shiqiang; Hu, Yin-Gang] NW A&F Univ, Coll Agron, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Phillips, Andy; Madgwick, Pippa J.; Parry, Martin A. J.] Rothamsted Res, Dept Plant Sci, Ctr Crop Genet Improvement, Harpenden, Herts, England; NW A&F Univ, Inst Water Saving Agr Arid Reg China, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; Northwest A&F University - China	Hu, YG (corresponding author), NW A&F Univ, Coll Agron, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.	huyingang@nwsuaf.edu.cn	Chen, Lei/A-2275-2011	Chen, Lei/0000-0003-3068-1583; Parry, Martin/0000-0002-4477-672X; cai, yudong/0000-0001-5664-7979	Ministry of Science and Technology [2006AA100201, 2006AA100223, 2006CB708208]; 111 Program of Introducing Talents of Discipline to Universities P. R. China [111-2-16]; ACIAR Project of Australia [CIM/2005/111]; Biotechnology and Biological Sciences Research Council [BBS/E/C/00004820, BBS/E/C/00005202, BBS/E/C/00004952, BB/E025161/1, BB/I000607/1] Funding Source: researchfish	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); 111 Program of Introducing Talents of Discipline to Universities P. R. China; ACIAR Project of Australia(Australian Ctr Intl Agr Res); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the sub-project of the 863 Program (2006AA100201, 2006AA100223), the pre-phase project of the 973 Program (2006CB708208) of the Ministry of Science and Technology, and the 111 Program of Introducing Talents of Discipline to Universities (111-2-16), P. R. China, as well as the ACIAR Project (CIM/2005/111) of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldrich C, 1993, PLANT MOL BIOL REP, V11, P128, DOI DOI 10.1007/BF02670471; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; BASSAM BJ, 1991, ANAL BIOCHEM, V196, P80, DOI 10.1016/0003-2697(91)90120-I; Bentley A, 2000, GENETICS, V156, P1169; Bibi S, 2009, PAK J BOT, V41, P1022; Caldwell DG, 2004, PLANT J, V40, P143, DOI 10.1111/j.1365-313X.2004.02190.x; Chawade A, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-86; Chen LA, 2011, AUST J CROP SCI, V5, P318; Chua NH, 2006, CURR OPIN BIOTECH, V17, P103, DOI 10.1016/j.copbio.2006.03.002; Cooper JL, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-9; Dahmani-Mardas F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015776; Dong CM, 2009, PLANT GENOME-US, V2, P39, DOI 10.3835/plantgenome2008.10.0012; Eversole K, 2009, ANN WHEAT N IN PRESS, P55; Fox JL, 2004, NAT BIOTECHNOL, V22, P1062, DOI 10.1038/nbt0904-1062; Fu DL, 2007, TRANSGENIC RES, V16, P689, DOI 10.1007/s11248-007-9150-7; Gonzalez FG, 2005, EUPHYTICA, V146, P253, DOI 10.1007/s10681-005-9021-3; Gottwald Sven, 2009, BMC Res Notes, V2, P258, DOI 10.1186/1756-0500-2-258; Greene EA, 2003, GENETICS, V164, P731; HALLORAN GM, 1982, ANN BOT-LONDON, V49, P115, DOI 10.1093/oxfordjournals.aob.a086220; Henikoff S, 2004, PLANT PHYSIOL, V135, P630, DOI 10.1104/pp.104.041061; Hirochika H, 2001, CURR OPIN PLANT BIOL, V4, P118, DOI 10.1016/S1369-5266(00)00146-1; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jeon JS, 2000, PLANT J, V22, P561, DOI 10.1046/j.1365-313x.2000.00767.x; Knoll JE, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-81; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; McCallum CM, 2000, PLANT PHYSIOL, V123, P439, DOI 10.1104/pp.123.2.439; MERRIL CR, 1984, ELECTROPHORESIS, V5, P289, DOI 10.1002/elps.1150050509; Minoia Silvia, 2010, BMC Res Notes, V3, P69, DOI 10.1186/1756-0500-3-69; Muth J, 2008, PLANT BIOTECHNOL J, V6, P576, DOI 10.1111/j.1467-7652.2008.00340.x; Naghavi Mohammad Reza, 2004, Iranian Journal of Biotechnology, V2, P195; Nomura T, 2005, P NATL ACAD SCI USA, V102, P16490, DOI 10.1073/pnas.0505156102; Oleykowski CA, 1998, NUCLEIC ACIDS RES, V26, P4597, DOI 10.1093/nar/26.20.4597; Parry MAJ, 2009, J EXP BOT, V60, P2817, DOI 10.1093/jxb/erp189; Piron F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011313; Przetakiewicz J, 2002, CELL MOL BIOL LETT, V7, P671; Raghavan C, 2007, MOL BREEDING, V19, P87, DOI 10.1007/s11032-006-9046-x; Rothe N, 2010, THESIS KANSASS STATE; Sabetta W, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-20; Slade AJ, 2005, NAT BIOTECHNOL, V23, P75, DOI 10.1038/nbt1043; Slafer GA, 1996, FIELD CROP RES, V46, P1, DOI 10.1016/0378-4290(95)00081-X; SONG WN, 1995, GENET RESOUR CROP EV, V42, P273, DOI 10.1007/BF02431262; Stephenson P, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-62; Suzuki T, 2008, MOL GENET GENOMICS, V279, P213, DOI 10.1007/s00438-007-0293-2; Talame V, 2008, PLANT BIOTECHNOL J, V6, P477, DOI 10.1111/j.1467-7652.2008.00341.x; Till B. J., 2007, GENOMICS ASSISTED CR, P333; Till BJ, 2003, METH MOL B, V236, P205; Till BJ, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-19; Till Bradley J., 2004, BMC Plant Biology, V4, P12, DOI 10.1186/1471-2229-4-12; Uauy C, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-115; Wang N, 2008, NEW PHYTOL, V180, P751, DOI 10.1111/j.1469-8137.2008.02619.x; Weigel D, 2000, PLANT PHYSIOL, V122, P1003, DOI 10.1104/pp.122.4.1003; Wu JL, 2005, PLANT MOL BIOL, V59, P85, DOI 10.1007/s11103-004-5112-0; Xin ZG, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-103	53	254	259	6	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41570	10.1371/journal.pone.0041570	http://dx.doi.org/10.1371/journal.pone.0041570			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844501	Green Published, gold, Green Submitted			2022-12-27	WOS:000306687700113
J	Chen, L; Ma, YL; Kim, EY; Yu, W; Schwartz, RJ; Qian, L; Wang, J				Chen, Li; Ma, Yanlin; Kim, Eun Young; Yu, Wei; Schwartz, Robert J.; Qian, Ling; Wang, Jun			Conditional Ablation of Ezh2 in Murine Hearts Reveals Its Essential Roles in Endocardial Cushion Formation, Cardiomyocyte Proliferation and Survival	PLOS ONE			English	Article							HISTONE METHYLTRANSFERASE ACTIVITY; CARDIAC DEVELOPMENT; TRANSCRIPTION FACTOR; MOUSE DEVELOPMENT; NOTCH ACTIVATION; GENE-EXPRESSION; OUTFLOW-TRACT; BHLH FACTORS; CELL FATE; METHYLATION	Ezh2 is a histone trimethyltransferase that silences genes mainly via catalyzing trimethylation of histone 3 lysine 27 (H3K27Me3). The role of Ezh2 as a regulator of gene silencing and cell proliferation in cancer development has been extensively investigated; however, its function in heart development during embryonic cardiogenesis has not been well studied. In the present study, we used a genetically modified mouse system in which Ezh2 was specifically ablated in the mouse heart. We identified a wide spectrum of cardiovascular malformations in the Ezh2 mutant mice, which collectively led to perinatal death. In the Ezh2 mutant heart, the endocardial cushions (ECs) were hypoplastic and the endothelial-to-mesenchymal transition (EMT) process was impaired. The hearts of Ezh2 mutant mice also exhibited decreased cardiomyocyte proliferation and increased apoptosis. We further identified that the Hey2 gene, which is important for cardiomyocyte proliferation and cardiac morphogenesis, is a downstream target of Ezh2. The regulation of Hey2 expression by Ezh2 may be independent of Notch signaling activity. Our work defines an indispensible role of the chromatin remodeling factor Ezh2 in normal cardiovascular development.	[Chen, Li; Kim, Eun Young; Qian, Ling; Wang, Jun] Texas Heart Inst, Basic Res Labs, Dept Stem Cell Engn, Houston, TX 77025 USA; [Ma, Yanlin] Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX USA; [Kim, Eun Young] Univ Texas Hlth Sci Ctr Houston, Program Genes & Dev, Houston, TX USA; [Yu, Wei; Schwartz, Robert J.] Univ Houston, Dept Biochem & Mol Biol, Houston, TX USA	Texas Heart Institute; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston; University of Houston System; University of Houston	Chen, L (corresponding author), Texas Heart Inst, Basic Res Labs, Dept Stem Cell Engn, Houston, TX 77025 USA.	junwang@heart.thi.tmc.edu	Chen, Lei/A-2275-2011	Chen, Lei/0000-0003-3068-1583; Parry, Martin/0000-0002-4477-672X; cai, yudong/0000-0001-5664-7979	American Heart Association; National Health Institute; American Heart Association Southern Central Affiliate; Biotechnology and Biological Sciences Research Council [BBS/E/C/00004820, BBS/E/C/00005202, BBS/E/C/00004952, BB/E025161/1, BB/I000607/1] Funding Source: researchfish	American Heart Association(American Heart Association); National Health Institute; American Heart Association Southern Central Affiliate; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by grants from the American Heart Association to JW. JW is also supported by a P30 grant from the National Health Institute as a Newly Independent Investigator (NII). LC is supported by a Postdoctoral Fellowship from the American Heart Association Southern Central Affiliate. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2004, P NATL ACAD SCI USA, V101, P6502, DOI 10.1073/pnas.0401711101; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Brutsaert DL, 2003, PHYSIOL REV, V83, P59, DOI 10.1152/physrev.00017.2002; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Caretti G, 2004, GENE DEV, V18, P2627, DOI 10.1101/gad.1241904; Cha TL, 2005, SCIENCE, V310, P306, DOI 10.1126/science.1118947; Chase A, 2011, CLIN CANCER RES, V17, P2613, DOI 10.1158/1078-0432.CCR-10-2156; Conerly ML, 2011, GENE DEV, V25, P997, DOI 10.1101/gad.2054311; Curry CL, 2005, ONCOGENE, V24, P6333, DOI 10.1038/sj.onc.1208783; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; de la Pompa JL, 1998, NATURE, V392, P182, DOI 10.1038/32419; Diez H, 2007, EXP CELL RES, V313, P1, DOI 10.1016/j.yexcr.2006.09.009; Doetzlhofer A, 2009, DEV CELL, V16, P58, DOI 10.1016/j.devcel.2008.11.008; Donovan J, 2002, CURR BIOL, V12, P1605, DOI 10.1016/S0960-9822(02)01149-1; Esteller M, 2007, HUM MOL GENET, V16, pR50, DOI 10.1093/hmg/ddm018; Ezhkova E, 2011, GENE DEV, V25, P485, DOI 10.1101/gad.2019811; Fischer A, 2007, NUCLEIC ACIDS RES, V35, P4583, DOI 10.1093/nar/gkm477; Fouse SD, 2008, CELL STEM CELL, V2, P160, DOI 10.1016/j.stem.2007.12.011; Fussbroich B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021651; Gessler M, 2002, CURR BIOL, V12, P1601, DOI 10.1016/S0960-9822(02)01150-8; Gordadze AV, 2001, J VIROL, V75, P5899, DOI 10.1128/JVI.75.13.5899-5912.2001; Han P, 2011, CIRC RES, V108, P378, DOI 10.1161/CIRCRESAHA.110.224287; Harrelson Z, 2004, DEVELOPMENT, V131, P5041, DOI 10.1242/dev.01378; High FA, 2008, NAT REV GENET, V9, P49, DOI 10.1038/nrg2279; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Jiang XB, 2000, DEVELOPMENT, V127, P1607; Kim EY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020803; Lee ST, 2011, MOL CELL, V43, P798, DOI 10.1016/j.molcel.2011.08.011; Leimeister C, 2000, DEV BIOL, V227, P91, DOI 10.1006/dbio.2000.9884; Leimeister C, 1999, MECH DEVELOP, V85, P173, DOI 10.1016/S0925-4773(99)00080-5; Li X, 2009, AM J PATHOL, V175, P1246, DOI 10.2353/ajpath.2009.090042; Liu W, 2004, P NATL ACAD SCI USA, V101, P4489, DOI 10.1073/pnas.0308466101; Liu YG, 2010, AM J PHYSIOL-HEART C, V298, pH2082, DOI 10.1152/ajpheart.00747.2009; Ma Q, 2008, DEV BIOL, V323, P98, DOI 10.1016/j.ydbio.2008.08.013; Moses Kelvin A., 2001, Genesis The Journal of Genetics and Development, V31, P176, DOI 10.1002/gene.10022; Niessen K, 2008, CIRC RES, V102, P1169, DOI 10.1161/CIRCRESAHA.108.174318; Niessen K, 2008, J CELL BIOL, V182, P315, DOI 10.1083/jcb.200710067; Noseda M, 2004, CIRC RES, V94, P910, DOI 10.1161/01.RES.0000124300.76171.C9; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Olson EN, 2004, NAT MED, V10, P467, DOI 10.1038/nm0504-467; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Person AD, 2005, INT REV CYTOL, V243, P287, DOI 10.1016/S0074-7696(05)43005-3; Riising EM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002704; Rutenberg JB, 2006, DEVELOPMENT, V133, P4381, DOI 10.1242/dev.02607; Sakata Y, 2006, J MOL CELL CARDIOL, V40, P267, DOI 10.1016/j.yjmcc.2005.09.006; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Shi B, 2007, MOL CELL BIOL, V27, P5105, DOI 10.1128/MCB.00162-07; Shirai M, 2009, P NATL ACAD SCI USA, V106, P18604, DOI 10.1073/pnas.0900635106; Su IH, 2003, NAT IMMUNOL, V4, P124, DOI 10.1038/ni876; Tanay A, 2007, P NATL ACAD SCI USA, V104, P5521, DOI 10.1073/pnas.0609746104; Timmerman LA, 2004, GENE DEV, V18, P99, DOI 10.1101/gad.276304; van Weerd JH, 2011, CARDIOVASC RES, V91, P203, DOI 10.1093/cvr/cvr138; Wang J, 2008, J BIOL CHEM, V283, P23235, DOI 10.1074/jbc.M709748200; Wang J, 2007, MOL CELL BIOL, V27, P622, DOI 10.1128/MCB.01160-06; Wang J, 2011, WIRES SYST BIOL MED, V3, P446, DOI 10.1002/wsbm.130; Wang J, 2011, BIRTH DEFECTS RES A, V91, P468, DOI 10.1002/bdra.20816; Wilkinson FH, 2006, P NATL ACAD SCI USA, V103, P19296, DOI 10.1073/pnas.0603564103; Wu JC, 2004, CURR PROB CARDIOLOGY, V29, P641, DOI 10.1016/j.cpcardiol.2004.04.003; Wu SC, 2011, J BIOL CHEM, V286, P28511, DOI 10.1074/jbc.M111.240515; Wu ZL, 2010, CELL DEATH DIFFER, V17, P801, DOI 10.1038/cdd.2009.162; Wyngaarden LA, 2011, DEVELOPMENT, V138, P3759, DOI 10.1242/dev.063180	61	254	259	6	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2012	7	2							e31005	10.1371/journal.pone.0031005	http://dx.doi.org/10.1371/journal.pone.0031005			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UG	22844501	Green Published, Green Submitted, gold			2022-12-27	WOS:000301977500025
J	Chen, LC; Hsu, C; Chiueh, CC; Lee, WS				Chen, Li-Ching; Hsu, Chin; Chiueh, Chuang Chin; Lee, Wen-Sen			Ferrous Citrate Up-Regulates the NOS2 through Nuclear Translocation of NF kappa B Induced by Free Radicals Generation in Mouse Cerebral Endothelial Cells	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; TRANSIENT FOREBRAIN ISCHEMIA; SUBARACHNOID HEMORRHAGE; OXIDATIVE STRESS; BRAIN-INJURY; PUTATIVE ROLE; IRON; ACTIVATION; EXPRESSION; FERRITIN	Previous studies indicate that the inducible nitric oxide synthase 2 (NOS2) of the brain vascular tissue in experimental subarachnoid hemorrhage (SAH) rats is a critical factor for inducing cerebral vasospasm. However, the underlying molecular mechanisms remain to be elucidated. Here, we applied ferrous citrate (FC) complexes to the primary cultured mouse cerebral endothelial cell (CEC) to mimic the SAH conditions and to address the issue how SAH-induced NOS2 up-regulation. Using immunocytochemical staining technique, we demonstrated that NOS2 was expressed in the cultured CEC. Treatment of the CEC with FC induced increases of the intracellular level of ROS, nuclear factor kappa-light-chain-enhancer of activated B cells (NF kappa B) nuclear translocation as well as NF kappa B binding onto the NOS promoter, and the levels of NOS2 mRNA and protein. These effects were abolished by pre-treatment of the cell with N-Acetyl-Cysteine (NAC), a reactive oxygen species (ROS) scavenger. In the present study, two previously predicted NFkB binding sites were confirmed in the NOS2 promoter within the range of -1529 bp to -1516 bp and -1224 bp to -1210 bp. Interestingly, both NF kappa B binding sites are involved in the FC-activated NOS2 transcriptional activity; the binding site located at -1529 bp to -1516 bp played a greater role than the other binding site located at -1224 bp to -1210 bp in the mouse CEC. These findings highlight the molecular mechanism underlying FC-induced up-regulation of NOS2 in the mouse CEC.	[Chen, Li-Ching; Lee, Wen-Sen] Taipei Med Univ, Grad Inst Med Sci, Sch Med, Taipei, Taiwan; [Hsu, Chin] Kaohsiung Med Univ, Dept Physiol, Kaohsiung, Taiwan; [Chiueh, Chuang Chin] Taipei Med Univ, Shuang Ho Hosp, Taipei, Taiwan; [Lee, Wen-Sen] Taipei Med Univ, Dept Physiol, Sch Med, Taipei, Taiwan; [Lee, Wen-Sen] Taipei Med Univ Hosp, Canc Res Ctr, Taipei, Taiwan	Taipei Medical University; Kaohsiung Medical University; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital	Lee, WS (corresponding author), Taipei Med Univ, Grad Inst Med Sci, Sch Med, Taipei, Taiwan.	wslee@tmu.edu.tw	Chen, Lei/A-2275-2011	Chen, Lei/0000-0003-3068-1583; Parry, Martin/0000-0002-4477-672X; cai, yudong/0000-0001-5664-7979	National Science Council of Taiwan [NSC-101-2320-B-038-005, NSC-101-2629-B-037-001, NSC-95-2320-B-037-032-MY2, NSC97-2314-B-037-039-MY2, NSC-95-2320-B-038-027-MY2]; Biotechnology and Biological Sciences Research Council [BBS/E/C/00004820, BBS/E/C/00005202, BBS/E/C/00004952, BB/E025161/1, BB/I000607/1] Funding Source: researchfish	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by research grants from the National Science Council of Taiwan (NSC-101-2320-B-038-005 and NSC-101-2629-B-037-001 to W. S. L.; NSC-95-2320-B-037-032-MY2 and NSC97-2314-B-037-039-MY2 to C. H.; NSC-95-2320-B-038-027-MY2 to C. C. C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aladag MA, 2009, NEUROCHEM RES, V34, P1935, DOI 10.1007/s11064-009-9979-7; ALLEN DR, 1994, ARCH BIOCHEM BIOPHYS, V315, P235, DOI 10.1006/abbi.1994.1495; Amberg GC, 2010, CIRC RES, V107, P1002, DOI 10.1161/CIRCRESAHA.110.217018; Asehnoune K, 2004, J IMMUNOL, V172, P2522, DOI 10.4049/jimmunol.172.4.2522; Ayer RE, 2008, ACTA NEUROCHIR SUPPL, V104, P33; Berra L V, 2007, J Neurosurg Sci, V51, P1; BIEMOND P, 1988, FREE RADICAL BIO MED, V4, P185, DOI 10.1016/0891-5849(88)90026-3; Bishop GM, 2001, BRAIN RES, V907, P175, DOI 10.1016/S0006-8993(01)02303-4; Chen LC, 2009, J AGR FOOD CHEM, V57, P7331, DOI 10.1021/jf901477g; Chen TY, 2010, STROKE, V41, P160, DOI 10.1161/STROKEAHA.109.562850; Chiueh CC, 2001, PEDIATR NEUROL, V25, P138, DOI 10.1016/S0887-8994(01)00266-1; Chiueh CC, 2000, NEUROTOX RES, V2, P293, DOI 10.1007/BF03033799; Defrere S, 2008, MOL HUM REPROD, V14, P377, DOI 10.1093/molehr/gan033; del Zoppo G, 2000, BRAIN PATHOL, V10, P95; Du WL, 2005, CHEST, V128, p556S, DOI 10.1378/chest.128.6_suppl.556S; Dumont AS, 2003, NEUROSURGERY, V53, P123, DOI 10.1227/01.NEU.0000068863.37133.9E; Gaasch JA, 2007, NEUROCHEM RES, V32, P1196, DOI 10.1007/s11064-007-9290-4; Hanggi D, 2006, ACTA NEUROCHIR, V148, P605, DOI 10.1007/s00701-005-0721-1; Ho PY, 2006, MOL CANCER THER, V5, P3130, DOI 10.1158/1535-7163.MCT-06-0457; Horky LL, 1998, J NEUROSURG, V88, P298, DOI 10.3171/jns.1998.88.2.0298; Hua Y, 2007, STROKE, V38, P759, DOI 10.1161/01.STR.0000247868.97078.10; Ishimaru H, 1996, BRAIN RES, V726, P23, DOI 10.1016/0006-8993(96)00294-6; Janjua Nazli, 2003, Curr Opin Crit Care, V9, P113, DOI 10.1097/00075198-200304000-00006; Jaramillo M, 2003, J IMMUNOL, V171, P4243, DOI 10.4049/jimmunol.171.8.4243; KONDO Y, 1995, J CEREBR BLOOD F MET, V15, P216, DOI 10.1038/jcbfm.1995.27; Lin CL, 2006, J NEUROSURG, V104, P298, DOI 10.3171/jns.2006.104.2.298; Lopez-Ongil S, 1998, BRIT J PHARMACOL, V124, P447, DOI 10.1038/sj.bjp.0701847; Mills E, 2010, FUTURE MED CHEM, V2, P51, DOI 10.4155/FMC.09.140; MOHANAKUMAR KP, 1994, ANN NY ACAD SCI, V738, P392; MORRIS SM, 1994, AM J PHYSIOL, V266, pE829, DOI 10.1152/ajpendo.1994.266.6.E829; Ong WY, 2005, REPROD NUTR DEV, V45, P647, DOI 10.1051/rnd:2005051; Ortego M, 2005, J CARDIOVASC PHARM, V45, P468, DOI 10.1097/01.fjc.0000159042.50488.e5; Osuka K, 2009, J NEUROTRAUM, V26, P1157, DOI 10.1089/neu.2008-0836; Otani H, 2009, ANTIOXID REDOX SIGN, V11, P1913, DOI [10.1089/ars.2009.2453, 10.1089/ARS.2009.2453]; Palmer C, 1999, J NEUROSCI RES, V56, P60, DOI 10.1002/(SICI)1097-4547(19990401)56:1<60::AID-JNR8>3.0.CO;2-A; Ql WN, 2004, MICROSURG, V24, P316, DOI 10.1002/micr.20030; Rauhala P, 1998, FREE RADICAL BIO MED, V24, P1065, DOI 10.1016/S0891-5849(97)00386-9; Regunathan S, 2003, ANN NY ACAD SCI, V1009, P20, DOI 10.1196/annals.1304.002; Shih HC, 2006, STROKE, V37, P3025, DOI 10.1161/01.STR.0000249008.18669.5a; Sorond FA, 2000, ANTIOXID REDOX SIGN, V2, P421, DOI 10.1089/15230860050192206; Taylor BS, 2001, PROG INFLAM RES, P1; Taylor BS, 2000, SHOCK, V13, P413, DOI 10.1097/00024382-200006000-00001; Van Bergen P, 1999, FREE RADICAL RES, V31, P631, DOI 10.1080/10715769900301201; Vijay A, 2006, NEUROL RES, V28, P759, DOI 10.1179/016164106X152034; West KA, 2003, J CLIN INVEST, V111, P81, DOI 10.1172/JCI200316147; Wilkinson DS, 2005, MOL CELL BIOL, V25, P1200, DOI 10.1128/MCB.25.3.1200-1212.2005; Won SM, 2011, EXP MOL MED, V43, P121, DOI 10.3858/emm.2011.43.2.020; Wong J M, 1995, Adv Pharmacol, V34, P155; Xu J, 2000, STROKE, V31, P1744, DOI 10.1161/01.STR.31.7.1744; Young HM, 1997, HISTOCHEM CELL BIOL, V107, P19, DOI 10.1007/s004180050085; Zhen JH, 2008, AM J HYPERTENS, V21, P28, DOI 10.1038/ajh.2007.14	51	254	259	6	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46239	10.1371/journal.pone.0046239	http://dx.doi.org/10.1371/journal.pone.0046239			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	22844501	Green Submitted, gold, Green Published			2022-12-27	WOS:000309973900115
